Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavourable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 15.0 35.1 13.4 22.0 16.6 19.9 16.5 19.2 18.4 17.6 16.4 22.6 20.9 15.4 19.3 26.1 18.2 25.3 19.4 20.7 13.2 11.8 20.4 26.0 13.4 23.4 19.3 10.1 19.7 27.3 33.1 27.3 23.6 15.8 17.3 19.3 21.5 22.8 18.5 19.7 22.2 17.5 21.2 16.4 22.0 19.1 26.6 19.5 39.1 19.5 24.6 24.4 17.2 16.9 15.3 17.2 8.2 14.7 10.0 16.7 10.1 10.1 30.9 24.2 14.8 11.5 14.0 15.5 11.6 12.6 29.2 16.9 21.0 21.6 24.4 20.0 14.7 14.8 42.1 31.0 17.3 15.4 27.2 19.8 13.7 21.1 11.7 17.5 15.0 13.3 15.6 19.4 18.9 23.0 26.2 28.3 14.1 32.9 27.4 18.1 16.6 21.6 27.0 16.1 27.3 20.7 8.4 13.0 16.5 8.5 19.4 9.0 24.8 15.3 10.4 13.9 21.1 11.0 12.2 12.7 16.0 22.1 11.2 15.2 16.0 1.2 12.1 8.2 13.7 14.0 16.5 15.2 12.3 12.6 13.7 15.3 16.7 16.2 1.1 10.0 14.7 17.2 12.6 10.1 13.4 16.6 19.2 18.4 13.2 11.8 19.3 10.1 15.8 19.5 AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favourable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.1 5.4 16.4 0.0 3.2 12.8 5.9 5.6 2.7 3.2 3.3 5.2 0.6 0.0 0.9 6.2 1.9 7.3 2.6 2.3 0.0 6.3 0.0 6.1 8.8 2.6 0.0 2.4 5.2 1.6 2.6 3.4 3.0 0.9 0.1 12.3 5.5 2.6 0.1 12.4 4.9 0.0 5.1 0.0 2.9 9.8 13.2 15.5 4.4 1.1 5.4 0.0 1.0 2.0 8.3 8.9 9.3 8.7 0.0 0.0 0.0 8.3 0.0 9.7 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67201033-67255195 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favourable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (1.53e-1)" 19.3 23.6 17.0 15.6 22.5 15.6 20.3 13.3 29.8 16.7 23.6 14.7 24.1 13.3 18.1 24.7 22.3 14.6 16.1 14.8 15.9 22.5 29.5 22.2 15.2 15.4 17.7 20.2 14.4 18.0 29.9 39.1 16.0 31.5 16.9 29.7 14.9 19.3 19.0 33.4 14.3 21.9 18.4 13.8 18.2 20.1 23.8 13.4 25.9 28.8 18.1 21.4 19.8 14.1 16.1 23.9 28.4 24.7 27.7 26.8 20.1 18.0 32.7 23.6 24.2 23.5 19.1 11.8 19.0 28.1 23.0 26.6 24.2 19.6 17.4 19.5 19.9 36.5 49.1 22.2 24.2 24.2 23.2 16.5 24.6 9.9 25.4 28.0 19.4 18.6 30.6 17.1 36.8 18.2 34.1 24.7 22.4 22.0 17.0 12.0 20.2 11.9 19.1 30.3 21.0 21.2 42.6 33.8 21.6 22.8 16.5 26.9 26.9 21.5 18.9 21.1 25.4 18.7 26.4 12.8 43.1 26.1 19.9 26.2 20.9 28.4 18.9 18.5 23.5 24.6 26.8 16.1 20.8 22.1 23.9 12.5 17.7 19.4 10.1 27.7 24.7 17.7 25.1 20.1 17.0 22.5 13.3 29.8 15.9 22.5 17.7 20.2 31.5 13.4 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavourable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 5.1 5.9 11.0 5.7 11.9 7.8 6.9 25.2 26.5 4.8 4.2 3.9 6.3 3.8 4.7 7.1 3.8 4.9 4.3 7.9 14.4 12.8 7.2 3.1 7.5 6.8 9.4 11.6 3.3 6.7 109.7 10.3 6.9 10.2 5.0 4.6 4.7 3.6 12.3 6.8 3.7 3.7 5.4 9.3 5.5 5.4 4.1 6.9 4.7 16.0 2.1 5.3 4.9 5.8 1.0 0.8 4.1 3.9 2.8 5.6 1.3 16.5 9.9 9.1 8.8 8.7 9.7 29.3 13.5 10.7 8.2 7.2 10.0 6.6 0.5 3.3 17.5 7.7 7.0 7.0 16.7 12.3 2.9 9.0 6.0 6.8 7.9 6.3 21.4 8.3 6.2 15.4 19.9 17.3 1.9 9.3 14.2 2.8 5.8 3.3 4.4 5.5 3.9 9.9 1.4 6.4 34.7 3.0 4.8 7.8 6.0 7.0 3.5 8.9 17.2 18.3 12.3 13.1 13.2 9.2 2.4 1.0 15.3 10.7 12.5 2.5 1.4 0.6 4.5 0.6 4.2 0.4 4.0 3.0 0.8 1.0 5.6 4.5 4.1 2.8 3.9 0.7 3.1 1.3 11.0 11.9 25.2 26.5 14.4 12.8 9.4 11.6 10.2 6.9 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Cell line enhanced" "Detected in all" "CACO-2: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 18.8 42.2 7.5 7.5 11.4 5.2 16.2 10.9 8.6 13.8 15.8 9.5 16.9 10.1 18.0 9.5 12.4 13.4 11.8 35.0 7.5 6.4 12.8 15.5 11.8 3.5 13.0 6.8 14.3 18.1 6.9 11.1 7.9 9.9 12.6 8.3 10.0 16.7 14.5 155.8 13.0 13.6 21.0 15.3 7.4 14.2 14.4 13.1 6.5 14.1 15.7 5.0 14.4 17.0 8.1 13.2 43.3 11.9 13.7 18.0 6.4 7.6 6.3 9.8 7.0 28.7 20.0 2.7 12.7 8.7 11.6 14.5 72.2 11.6 5.2 12.4 21.4 4.3 14.7 8.5 13.9 11.9 11.9 5.0 10.9 13.2 14.2 2.8 4.5 26.6 5.9 12.2 6.5 34.3 5.7 8.4 24.4 9.1 5.9 11.1 4.6 10.7 5.7 16.8 5.0 15.3 4.6 3.5 13.1 16.2 7.0 9.0 10.9 5.6 35.7 12.3 6.7 23.2 4.2 9.1 14.2 9.5 4.7 4.6 6.8 43.3 11.9 12.3 6.1 6.6 7.8 7.0 11.9 10.0 12.7 8.1 10.4 7.8 6.9 13.7 6.4 13.2 18.0 6.4 7.5 11.4 10.9 8.6 7.5 6.4 13.0 6.8 9.9 13.1 AAMP ENSG00000127837 "Angio associated migratory cell protein" Q13685 2 218264123-218270257 "Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017717, HPA031868" Approved Supported Microtubules,Cytosol Microtubules Cytosol "CAB017717: , HPA031868: " "unprognostic (1.57e-1)" "unprognostic (6.12e-2)" "unprognostic (8.11e-3)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.39e-2)" "unprognostic (5.04e-2)" "prognostic unfavourable (4.94e-7)" "unprognostic (8.94e-2)" "unprognostic (7.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (4.22e-2)" "unprognostic (5.51e-2)" "unprognostic (1.23e-3)" "unprognostic (5.26e-2)" "unprognostic (1.92e-1)" "unprognostic (9.09e-2)" 36.3 40.4 41.2 35.5 49.1 15.9 36.7 40.8 48.5 36.5 48.5 30.8 48.3 38.7 38.2 34.1 50.0 40.1 50.2 39.7 37.3 35.7 38.2 49.8 28.8 29.0 39.0 51.4 53.1 59.2 44.0 37.9 40.4 40.8 39.3 37.2 28.7 43.9 41.4 47.8 42.6 39.0 42.8 32.8 32.2 51.4 50.9 36.5 27.8 46.6 33.6 32.1 39.9 34.6 30.2 50.9 15.7 53.2 27.2 31.6 41.8 32.1 27.1 19.2 26.4 29.9 20.8 36.9 22.4 35.7 43.4 32.3 57.9 25.3 16.0 33.1 28.6 24.4 39.0 34.1 34.4 26.3 49.4 36.7 27.8 65.6 41.5 34.3 24.3 26.2 39.9 45.4 39.8 25.2 49.5 21.2 28.5 47.4 30.0 58.2 32.0 19.0 22.4 25.5 28.7 26.7 41.3 25.1 23.8 15.0 33.7 32.8 26.7 26.8 21.7 32.1 21.2 20.8 26.9 27.5 49.3 27.3 30.3 22.4 20.8 15.7 44.2 14.9 28.8 53.2 29.3 27.3 25.4 26.1 50.9 30.2 31.6 28.8 7.0 27.2 50.2 29.7 27.2 41.8 41.2 49.1 40.8 48.5 37.3 35.7 39.0 51.4 40.8 36.5 AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 11.2 13.5 16.2 9.9 20.5 9.1 13.7 20.5 25.2 13.2 10.5 11.9 14.3 8.3 15.6 14.8 12.6 13.9 12.7 21.7 14.8 15.7 13.6 16.0 8.0 10.2 14.1 21.7 18.2 29.6 16.7 12.4 9.5 19.2 12.5 11.7 13.1 16.6 13.0 41.1 10.1 8.1 15.6 11.1 9.7 11.3 58.4 9.5 8.8 14.4 20.6 14.4 10.0 10.0 17.2 18.4 2.3 15.1 14.5 16.3 9.2 14.0 19.4 15.1 15.0 18.4 17.7 11.4 15.4 13.0 17.9 12.0 16.8 11.9 38.3 0.7 16.0 12.0 20.8 23.1 20.6 12.8 16.4 15.0 21.0 9.0 24.2 29.7 8.4 16.0 12.6 12.4 31.5 14.5 27.3 8.1 17.0 8.0 29.4 21.0 10.3 9.7 19.4 30.9 39.2 17.7 13.3 19.5 12.2 7.3 7.6 19.5 20.7 24.7 13.5 18.5 16.7 9.4 21.3 12.8 16.3 23.6 12.3 18.3 19.7 2.3 10.6 0.8 12.3 15.1 16.2 15.4 12.9 14.6 17.1 17.2 16.3 15.7 0.3 14.5 12.6 18.4 12.2 9.2 16.2 20.5 20.5 25.2 14.8 15.7 14.1 21.7 19.2 9.5 AASS "LKRSDH, LORSDH" ENSG00000008311 "Aminoadipate-semialdehyde synthase" Q9UDR5 7 122075647-122144280 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.1;NTERA-2: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020637, HPA020728, HPA020734" Enhanced Enhanced Vesicles,Mitochondria 17000 Mitochondria Vesicles "HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417" "unprognostic (4.84e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-4)" "unprognostic (6.08e-2)" "unprognostic (1.49e-2)" "unprognostic (8.00e-2)" "prognostic favourable (9.81e-4)" "unprognostic (4.48e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (1.99e-1)" "unprognostic (7.76e-3)" "unprognostic (8.56e-3)" "unprognostic (1.55e-1)" "unprognostic (6.50e-2)" "unprognostic (2.67e-1)" 13.9 9.5 7.4 4.8 11.8 1.6 11.2 2.7 9.8 16.0 8.1 12.5 8.2 2.2 16.8 11.6 6.4 14.9 6.7 12.6 8.8 3.7 14.4 35.8 9.1 3.3 15.2 5.0 36.7 10.7 14.9 10.4 7.1 9.9 9.2 3.8 9.2 5.4 10.4 11.3 4.4 5.5 9.3 12.1 5.2 9.0 5.1 13.2 0.8 7.8 8.3 3.1 11.0 9.0 1.0 0.4 3.5 0.1 0.3 1.2 0.1 0.1 0.0 16.2 26.1 13.5 8.7 6.3 4.4 4.7 4.6 6.7 7.4 0.2 0.0 0.3 3.1 2.8 18.6 8.4 6.3 0.0 6.8 5.6 3.6 4.8 11.1 0.0 1.8 7.6 0.2 5.5 5.8 11.0 1.5 10.3 3.1 0.0 0.5 0.0 25.5 1.0 8.4 8.6 0.3 2.1 1.8 1.6 0.5 1.4 0.0 2.7 0.4 0.0 5.0 9.0 2.7 4.1 4.2 2.2 1.6 0.0 3.3 0.5 3.4 3.5 0.1 0.0 0.7 0.0 0.1 0.5 0.8 0.0 0.4 1.0 1.2 0.5 0.0 0.3 0.0 0.0 0.7 0.1 7.4 11.8 2.7 7.3 8.8 3.7 15.2 5.0 9.9 13.2 AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948875-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 8.2 6.8 5.7 11.4 9.8 14.4 7.1 7.5 6.9 7.5 8.8 9.2 7.5 6.2 9.7 6.3 7.6 8.2 7.5 9.8 5.9 7.6 8.7 6.8 11.0 10.1 4.5 11.1 8.8 8.5 5.2 11.1 8.3 7.1 8.6 4.6 6.7 9.2 13.0 8.3 8.5 8.5 7.9 11.2 7.0 8.7 10.2 18.5 9.5 7.2 13.1 10.4 13.5 19.4 18.8 32.1 27.3 20.5 27.2 19.0 20.4 33.1 7.2 14.4 9.7 11.3 13.3 13.2 9.7 15.0 13.3 22.7 14.3 37.0 16.8 11.4 18.1 27.2 15.2 20.3 18.8 20.3 17.2 13.1 15.9 11.9 27.7 14.6 9.9 27.3 19.4 17.3 10.8 23.8 11.2 12.9 15.0 30.3 20.9 9.1 12.7 19.7 21.7 19.9 12.5 18.1 15.7 6.8 19.4 8.0 17.7 13.9 14.3 12.1 11.6 19.7 24.5 41.3 12.6 17.9 27.9 14.5 20.7 20.5 14.2 20.2 32.1 23.9 27.3 23.5 18.0 21.5 25.0 18.8 19.4 19.6 19.6 26.1 20.5 25.9 17.4 27.2 19.0 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781002-104928237 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" "Atherosclerosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 16.9;U-87 MG: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;neutrophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: " "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 25.7 38.1 6.3 9.8 13.1 15.8 23.0 2.3 8.5 8.2 14.8 8.0 6.5 4.4 7.8 9.6 7.0 7.9 13.6 10.7 7.5 3.7 7.1 33.3 12.7 29.4 18.9 2.3 8.7 5.4 1.8 3.3 20.1 10.2 9.4 9.4 7.7 6.3 8.7 21.3 12.1 8.1 25.2 16.1 12.8 7.3 8.8 8.0 16.9 5.8 2.2 5.0 16.4 20.0 1.8 0.2 11.6 1.5 0.1 0.6 0.1 0.0 2.6 2.2 0.0 6.5 2.4 2.0 2.8 10.8 0.9 1.0 0.4 0.3 3.8 3.1 2.8 0.0 1.2 0.1 0.8 0.0 0.0 0.4 0.9 9.4 11.7 0.0 6.7 16.9 0.7 11.0 0.2 1.0 0.0 9.7 0.2 0.3 2.3 5.1 3.1 0.8 0.0 0.0 0.2 1.8 1.8 0.3 0.1 2.9 0.5 0.6 0.0 1.9 0.9 2.9 0.2 3.8 3.1 3.8 1.8 2.3 38.7 0.0 0.0 2.2 0.8 11.6 0.2 1.0 0.2 1.2 0.3 0.0 0.2 1.8 0.6 0.0 10.6 0.1 1.5 0.1 0.1 0.1 6.3 13.1 2.3 4.0 7.5 3.7 18.9 2.3 10.2 8.0 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Cell line enhanced" "Detected in some" "hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: " "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 2.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.1 0.0 6.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell line enhanced" "Detected in some" "HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol Vesicles "Centrosome, Cytosol" "HPA063601: " "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.5 1.2 2.1 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.1 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.6 10.2 0.4 1.5 3.0 4.1 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.8;T-47d: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.5 1.8 14.8 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.1 0.2 8.5 0.1 0.3 14.9 5.7 0.9 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 14.4 10.2 0.0 0.0 12.7 0.0 1.0 2.0 4.6 2.3 0.3 1.6 8.5 0.3 20.8 14.9 1.8 10.5 0.2 34.2 0.9 4.1 0.1 0.5 4.0 4.2 2.8 1.2 0.0 2.1 5.1 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1040101-1065572 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.2" "Cell line enhanced" "Detected in many" "HeLa: 26.2;HMC-1: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: " "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (7.26e-4)" "prognostic favourable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 6.0 3.5 6.2 20.2 4.8 35.2 7.6 13.6 11.1 5.0 5.8 1.9 4.7 4.9 2.1 3.9 7.5 2.8 5.5 2.3 5.3 6.5 5.3 3.6 9.5 17.7 5.2 5.1 1.0 7.0 5.6 34.5 3.1 7.7 4.9 4.2 34.7 9.9 6.5 5.5 11.1 11.1 1.8 6.7 26.6 7.9 1.6 4.3 19.8 7.0 3.9 14.5 5.1 4.9 1.5 9.9 10.8 2.5 1.9 2.6 1.2 5.6 5.3 1.1 3.3 6.5 2.9 5.4 0.8 0.8 0.3 0.6 4.0 2.1 11.0 3.8 0.7 5.6 2.3 5.0 0.3 7.3 2.1 8.5 26.2 4.0 2.5 3.1 31.6 2.7 1.8 1.5 2.8 1.8 8.5 6.8 1.0 1.3 3.1 2.3 0.6 2.5 2.8 0.6 7.9 2.7 10.6 0.7 2.1 6.2 1.9 0.6 3.6 5.1 2.7 0.6 1.3 2.8 0.8 8.0 7.7 6.0 1.4 7.6 1.3 4.3 2.5 7.0 2.6 1.7 1.6 1.0 1.5 1.8 2.8 1.5 1.4 2.1 10.8 1.9 1.6 9.9 0.6 1.2 6.2 4.8 13.6 11.1 5.3 6.5 5.2 5.1 7.7 4.3 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 16.2;ASC TERT1: 36.1;HSkMC: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 16.2 36.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.0 0.0 0.0 27.3 0.0 0.4 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell line enhanced" "Detected in some" "CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "CAB001716, HPA002199" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "CAB001716: , HPA002199: AB_1844428" "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favourable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favourable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 9.0 16.3 1.9 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.3 0.0 0.4 36.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.6;PC-3: 1.0;THP-1: 2.5;TIME: 1.8;U-2197: 2.8" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Group enriched" "Detected in some" 5 "SH-SY5Y: 11.7;WM-115: 22.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: , HPA053288: " "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 11.7 0.0 0.5 2.2 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.7 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 ABCB6 "EST45597, MTABC3, umat" ENSG00000115657 "ATP binding cassette subfamily B member 6 (Langereis blood group)" Q9NP58 2 219209766-219219017 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dyskeratosis congenita, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046723, HPA058011" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol" 22000 "Golgi apparatus" "Nucleoplasm, Plasma membrane, Mitochondria, Cytosol" "HPA046723: AB_10960288, HPA058011: " "unprognostic (8.04e-2)" "unprognostic (3.22e-2)" "unprognostic (4.53e-3)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.11e-2)" "prognostic unfavourable (9.45e-7)" "unprognostic (2.26e-1)" "unprognostic (3.62e-2)" "unprognostic (1.53e-1)" "unprognostic (1.18e-4)" "unprognostic (3.02e-3)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.51e-1)" "unprognostic (9.55e-2)" "unprognostic (7.75e-2)" "unprognostic (2.30e-1)" 10.1 8.4 8.2 3.9 13.5 10.2 9.2 7.6 9.1 6.9 7.6 5.4 8.3 8.1 7.1 10.1 9.0 8.4 8.5 9.5 5.6 8.2 6.9 16.2 7.2 4.9 9.8 7.6 13.1 7.1 8.0 6.0 3.7 9.2 9.2 4.2 6.0 5.6 11.3 24.0 5.5 8.0 9.5 9.2 3.2 6.8 19.5 7.7 0.8 9.9 11.3 4.7 14.8 6.0 2.8 5.6 1.3 1.1 1.2 3.2 2.4 0.1 10.0 2.0 12.6 14.1 5.0 12.4 3.7 3.5 4.1 4.1 15.3 2.2 0.1 19.3 3.6 21.6 0.2 1.5 1.3 6.4 2.2 15.6 11.0 28.2 17.0 0.0 5.2 7.4 1.8 2.7 0.0 7.2 13.3 1.9 2.8 5.1 1.0 0.1 3.2 4.1 5.2 6.4 0.6 2.2 0.2 7.4 7.9 7.8 18.5 8.2 5.5 0.3 3.2 5.5 0.2 7.4 4.3 5.1 4.0 0.0 6.3 0.1 7.4 1.3 1.1 0.0 1.7 0.9 0.5 2.8 1.3 0.7 0.9 2.3 3.2 2.1 0.0 1.2 0.8 5.6 1.1 2.4 8.2 13.5 7.6 9.1 5.6 8.2 9.8 7.6 9.2 7.7 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favourable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favourable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favourable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.4 19.6 5.0 15.9 8.0 4.7 10.1 6.6 6.8 10.5 11.1 7.8 20.8 6.5 8.8 6.9 13.2 7.3 13.6 4.7 8.1 8.0 5.2 7.8 9.3 5.2 4.0 12.9 8.0 10.3 12.4 5.2 10.4 27.1 9.0 7.8 27.8 15.1 7.5 3.4 22.3 7.2 3.2 23.2 7.0 5.3 4.9 9.8 7.0 20.0 6.3 7.9 5.2 6.4 9.8 2.6 7.0 9.8 9.1 4.5 4.7 13.8 9.6 9.9 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Group enriched" "Detected in many" 4 "HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favourable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.4 7.8 1.3 2.3 2.4 3.2 0.3 3.6 3.6 3.2 2.8 10.8 3.3 2.5 2.3 4.8 6.0 2.0 1.7 4.0 7.3 3.0 60.4 2.4 2.1 5.0 6.9 66.1 2.4 0.8 2.3 4.7 4.1 6.2 0.1 4.3 1.4 1.2 1.1 1.5 1.9 1.8 3.6 6.5 17.8 10.0 3.2 2.3 1.2 0.2 2.5 0.0 3.7 6.7 3.4 2.2 2.8 4.2 0.0 0.0 1.0 6.5 3.9 1.6 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: , HPA052295: " "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavourable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.0 9.3 11.1 9.3 10.6 14.4 5.9 4.7 5.3 5.8 6.3 5.6 7.9 14.0 5.6 29.5 11.4 6.5 7.0 8.6 11.1 16.7 10.1 5.7 3.8 5.1 13.1 16.9 6.6 5.7 3.8 6.2 15.5 11.0 9.1 19.3 13.9 5.8 9.6 7.8 9.7 3.1 4.7 19.4 47.5 17.0 10.1 6.1 33.6 10.0 20.2 1.6 7.1 6.2 6.1 7.9 8.1 4.2 8.2 7.3 4.6 10.2 6.3 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 5 "A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: " "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797401-21942529 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 17.2;BJ hTERT+: 9.9;CACO-2: 15.7;HSkMC: 20.5;U-138 MG: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavourable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 21.6 4.7 5.5 2.6 5.4 1.2 25.8 1.5 8.6 12.4 6.8 4.8 5.1 3.0 15.3 6.3 9.1 9.5 9.6 26.2 5.7 2.6 5.6 31.1 6.2 2.7 2.9 4.2 11.8 5.8 1.7 2.7 2.8 5.5 7.0 1.6 10.8 4.8 8.4 33.2 3.3 4.1 17.1 4.9 3.5 9.1 3.4 4.2 0.1 6.3 14.5 1.2 9.5 8.4 1.6 0.9 1.8 0.8 0.5 0.9 0.0 0.6 0.1 7.3 0.2 17.2 7.8 0.2 4.0 9.9 4.4 2.2 15.7 0.6 0.3 0.8 0.4 0.2 0.0 0.0 4.6 0.2 0.1 0.3 0.5 0.2 0.0 0.3 0.4 20.5 0.0 4.4 1.6 0.0 0.2 0.9 0.2 0.9 0.1 0.2 1.0 0.4 0.3 0.2 0.2 0.0 0.8 0.3 1.2 0.2 0.3 0.1 0.8 0.2 0.2 17.1 1.2 1.4 5.2 0.7 0.8 0.3 4.2 0.2 0.3 0.9 0.5 0.4 0.9 0.4 0.6 0.7 0.7 0.7 0.2 1.6 0.6 0.8 1.8 0.5 0.8 0.9 0.4 0.0 5.5 5.4 1.5 8.6 5.7 2.6 2.9 4.2 5.5 4.2 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 13.0 47.0 18.9 10.6 19.7 12.4 12.7 23.0 27.2 15.3 12.1 15.4 33.8 13.1 13.5 11.1 16.1 15.0 10.8 22.9 15.4 16.8 16.5 22.3 12.1 12.7 15.4 15.1 17.8 19.7 41.6 17.9 16.0 19.8 13.3 11.8 15.5 21.4 30.1 33.8 15.2 12.8 10.8 12.3 14.9 13.3 12.6 18.6 8.8 15.4 14.4 14.2 12.5 13.8 16.1 16.4 13.9 19.4 14.5 25.4 21.5 21.9 13.6 7.8 15.0 22.7 12.8 15.4 15.9 17.8 21.7 17.0 23.2 8.8 13.2 32.3 17.1 21.1 12.1 16.8 11.3 16.9 11.6 11.4 11.9 13.6 19.2 12.8 11.7 18.8 15.5 15.3 15.3 15.5 10.5 16.0 15.3 26.4 12.5 8.2 11.8 18.8 12.6 13.0 22.3 11.9 13.3 13.5 7.8 16.5 31.8 14.7 43.0 11.2 15.1 11.6 12.7 18.2 23.6 18.2 17.5 17.1 18.1 12.8 14.2 5.3 18.6 13.9 22.7 19.4 23.5 16.0 20.1 18.7 16.4 16.1 25.4 20.5 9.3 14.5 19.1 10.1 17.2 21.5 18.9 19.7 23.0 27.2 15.4 16.8 15.4 15.1 19.8 18.6 ABCG1 ABC8 ENSG00000160179 "ATP binding cassette subfamily G member 1" P45844 21 42199689-42297244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 15.0;MCF7: 18.7;MOLT-4: 17.3;RPMI-8226: 14.2;SCLC-21H: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 19.2;neutrophil: 20.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031470, HPA031471" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA031470: AB_10599188, HPA031471: AB_10600201" "unprognostic (2.89e-2)" "unprognostic (2.53e-2)" "unprognostic (9.96e-2)" "unprognostic (4.20e-3)" "unprognostic (2.87e-1)" "unprognostic (3.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (3.66e-3)" "unprognostic (6.37e-2)" "prognostic favourable (7.16e-6)" "unprognostic (1.40e-2)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (2.42e-2)" 19.9 36.4 14.2 10.0 17.6 6.2 13.3 15.9 15.3 7.7 12.1 17.8 3.8 15.3 5.6 3.8 4.1 6.5 11.9 9.7 12.4 8.0 8.2 5.6 25.2 23.1 20.8 12.2 6.0 4.7 15.4 11.1 12.0 9.6 6.3 13.5 12.1 13.7 6.7 26.8 15.1 18.6 5.8 7.0 29.4 13.7 1.9 19.5 15.4 8.5 5.2 10.4 12.5 12.6 4.8 1.4 20.5 0.9 3.7 4.0 1.0 0.0 3.4 2.7 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.4 0.0 0.5 0.0 5.0 0.0 4.7 0.3 5.7 11.4 0.0 10.5 0.0 0.2 1.2 15.0 0.0 2.3 10.6 0.0 0.0 0.0 18.7 17.3 0.1 0.8 5.9 0.2 0.0 14.2 0.0 1.6 13.1 3.4 2.1 7.9 0.0 3.3 0.5 6.7 0.0 2.8 0.0 0.0 7.7 2.2 0.0 0.0 1.9 0.3 0.9 0.9 19.2 1.8 0.3 3.4 3.1 3.7 3.6 0.6 4.8 3.5 2.9 20.5 3.7 0.1 1.4 4.0 1.0 14.2 17.6 15.9 15.3 12.4 8.0 20.8 12.2 9.6 19.5 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell line enhanced" "Detected in many" "A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.7 19.9 5.9 0.0 0.2 0.0 34.7 0.7 0.6 1.0 1.7 4.4 0.2 0.0 0.2 0.1 5.8 0.2 0.6 1.5 5.6 0.9 0.2 0.1 5.9 0.0 0.3 0.0 0.1 2.4 2.3 0.1 1.8 0.4 0.0 0.6 11.5 2.7 0.1 2.0 0.0 1.3 0.0 17.4 0.0 4.2 0.1 0.2 4.1 0.4 0.5 0.1 0.0 0.0 0.8 0.7 0.2 0.0 5.5 2.1 0.0 1.5 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favourable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favourable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favourable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.1 8.7 0.7 10.2 28.4 25.3 2.6 4.0 4.8 7.5 8.7 6.4 20.2 11.5 3.2 14.1 5.1 6.3 5.8 5.7 15.6 6.8 18.0 7.5 25.1 15.3 10.1 18.6 32.7 20.1 7.6 10.3 9.1 10.4 18.3 14.4 9.9 4.4 7.7 0.9 22.2 11.4 1.4 51.6 13.6 4.2 4.3 4.6 10.2 19.1 32.6 27.5 6.9 8.5 4.0 18.8 9.0 2.4 23.4 10.9 4.7 8.6 32.3 6.9 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 14.9 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.8 3.4 2.0 5.7 3.9 5.6 10.6 6.6 2.2 2.9 17.6 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.1 5.1 0.9 3.8 3.0 5.5 2.8 5.2 5.6 6.9 0.4 4.5 13.1 7.3 13.2 9.4 5.9 1.3 2.2 7.9 3.6 2.0 9.1 13.7 4.7 3.0 3.9 7.6 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2" P08910 15 89087459-89202360 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEL: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 29.0;neutrophil: 22.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favourable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 13.2 24.8 14.8 9.5 19.3 15.6 11.7 25.2 23.4 10.7 16.1 12.0 6.5 23.4 18.2 34.7 9.0 12.1 32.2 24.5 12.2 11.3 11.8 76.4 22.2 11.2 11.1 14.8 13.1 28.3 11.2 18.1 5.6 19.8 22.9 9.6 22.6 11.8 10.0 19.3 7.5 18.5 11.4 8.3 14.2 35.8 42.9 7.6 7.7 8.6 8.1 12.1 13.5 10.4 1.1 3.0 29.0 7.0 4.7 3.5 2.5 8.0 15.5 3.8 4.1 7.5 10.2 2.1 5.4 16.2 5.2 4.9 3.9 14.0 2.3 6.3 6.7 10.7 8.4 6.6 7.3 12.0 3.8 83.5 3.6 2.9 3.9 5.7 19.7 5.2 4.7 18.5 11.9 6.3 7.4 7.2 14.2 3.3 3.5 1.4 1.7 4.6 5.1 8.0 17.4 6.9 12.6 6.6 9.9 10.3 4.9 8.6 5.4 4.5 9.6 18.3 6.2 6.6 13.6 5.9 11.7 2.7 14.9 5.3 14.2 3.1 5.6 29.0 1.6 4.8 0.9 1.1 1.5 1.5 3.0 1.1 1.4 1.5 22.7 4.7 7.0 2.4 3.5 2.5 14.8 19.3 25.2 23.4 12.2 11.3 11.1 14.8 19.8 7.6 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.1;RPMI-8226: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.4 5.4 5.3 3.4 3.4 2.2 0.0 4.9 2.0 3.5 4.8 5.6 7.7 21.4 9.0 1.6 24.8 8.6 4.0 4.9 13.4 6.0 2.3 9.1 9.6 5.2 10.1 7.8 2.0 4.8 5.2 2.4 2.3 5.9 12.8 3.1 3.0 9.7 11.3 2.6 12.8 54.1 4.0 60.2 9.7 7.2 4.5 2.0 11.2 10.0 2.8 3.1 17.9 1.8 3.4 4.9 6.0 7.5 14.4 9.3 22.1 4.4 13.3 7.8 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: " "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favourable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.1 8.0 1.2 5.3 15.1 2.7 14.0 5.6 5.1 5.9 8.1 4.2 2.9 4.0 0.5 3.1 6.3 5.4 2.5 5.3 6.9 2.7 3.4 5.4 5.8 5.1 1.0 18.4 2.6 11.6 5.4 2.7 3.3 4.1 9.4 4.8 1.6 7.0 0.4 3.9 17.7 2.6 2.4 9.1 9.1 2.9 7.0 2.8 6.2 3.4 11.6 2.3 2.8 3.5 4.3 4.7 10.6 6.6 2.8 8.0 0.2 11.0 10.3 5.8 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell line enhanced" "Detected in many" "PC-3: 27.9;U-266/70: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: " "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.2 3.2 1.7 6.5 2.2 0.7 17.7 2.3 3.1 2.5 3.2 2.8 7.7 0.8 3.2 1.8 1.5 1.6 4.0 0.5 13.2 10.9 3.7 4.9 4.8 7.2 0.2 5.2 2.0 2.4 4.2 0.5 1.8 3.2 6.5 1.0 0.5 4.4 0.6 3.1 27.9 6.7 5.2 3.2 2.2 1.1 2.0 11.1 5.1 1.7 7.0 7.1 6.4 1.1 2.3 5.1 11.8 4.0 21.3 16.0 4.0 7.9 4.4 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 ABI1 "ABI-1, E3B1, SSH3BP1" ENSG00000136754 "Abl interactor 1" Q8IZP0 10 26746593-26861087 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008375, HPA029973, HPA068407" Approved Enhanced "Plasma membrane,Cell Junctions,Cytosol" 400000 "Plasma membrane, Cell Junctions" Cytosol "CAB008375: AB_592744, HPA029973: , HPA068407: " "unprognostic (2.83e-3)" "unprognostic (8.69e-2)" "unprognostic (1.12e-1)" "unprognostic (3.96e-1)" "unprognostic (2.51e-2)" "unprognostic (9.24e-3)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (6.04e-2)" "unprognostic (4.38e-1)" "unprognostic (2.40e-2)" "unprognostic (5.48e-2)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" 24.0 14.0 32.0 28.1 32.6 54.1 21.4 28.2 35.5 22.5 22.7 19.8 14.8 24.8 23.9 15.4 45.1 20.3 21.6 14.1 47.3 23.1 21.9 17.8 22.5 32.1 25.0 26.4 25.3 17.0 19.1 14.4 22.7 20.9 19.1 24.8 26.7 30.9 17.0 16.6 33.0 26.0 21.6 27.5 25.5 23.9 12.4 20.5 43.5 18.8 27.3 40.9 25.2 30.3 36.1 26.8 51.5 28.0 20.5 44.5 31.5 23.2 13.1 10.7 10.5 16.2 20.0 16.0 23.6 16.1 17.5 20.4 15.3 27.6 42.8 12.1 25.0 26.1 12.9 15.3 19.5 28.5 11.5 18.8 8.9 10.8 11.1 9.1 19.0 13.6 19.5 17.1 10.2 21.1 13.8 27.4 17.8 10.0 21.3 8.7 8.8 6.3 23.1 19.9 27.5 18.6 10.8 8.9 9.5 19.6 19.2 19.7 12.4 14.5 26.2 13.4 16.5 16.9 12.0 6.1 9.8 50.9 19.3 23.3 9.6 35.5 23.8 51.5 27.0 28.0 25.8 36.1 25.9 30.0 26.8 28.6 24.4 26.5 37.9 20.5 26.7 22.3 44.5 31.5 32.0 32.6 28.2 31.9 47.3 23.1 25.0 26.4 20.9 20.5 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA070567: " "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.4 11.6 41.7 26.2 9.9 17.0 9.1 13.1 11.7 11.4 13.2 10.7 14.2 0.0 9.0 15.3 8.3 18.9 13.8 22.8 3.7 10.8 18.9 12.5 8.3 15.1 8.1 8.6 12.0 6.6 20.8 16.2 21.1 13.3 16.9 20.0 13.6 20.3 7.7 21.6 26.0 13.4 21.1 1.3 11.7 7.8 16.8 22.0 2.5 7.7 14.6 10.1 9.4 15.6 21.0 17.8 11.3 14.2 12.0 10.9 10.4 22.6 3.4 13.3 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713946-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 20.1 11.6 12.4 15.0 18.1 10.7 22.0 6.7 16.0 28.9 34.3 29.1 12.1 11.9 26.6 16.9 21.4 20.8 30.9 14.2 10.3 8.4 9.9 6.7 13.8 8.7 24.1 9.4 24.2 12.2 27.7 14.5 13.6 17.1 27.3 15.8 19.4 14.6 18.0 10.8 14.2 17.0 66.6 14.3 10.8 21.9 9.8 21.2 5.8 19.5 11.4 9.1 35.8 31.9 3.1 3.1 1.1 5.0 2.4 2.6 1.6 7.0 15.7 16.9 20.4 24.8 30.3 6.2 12.4 19.5 14.6 12.4 12.3 9.2 11.6 7.2 16.5 13.7 8.5 11.5 10.8 7.3 5.3 7.6 26.9 10.5 16.9 11.7 10.7 22.1 12.7 26.1 16.2 20.2 42.6 9.3 17.8 13.4 14.8 9.6 18.7 11.6 17.2 21.9 12.6 14.7 8.3 15.8 19.7 20.8 8.1 10.0 15.9 10.8 23.1 56.0 14.5 21.4 19.5 2.8 6.6 15.6 23.1 9.7 17.7 0.2 2.1 1.1 2.0 1.2 2.6 3.1 2.0 1.9 2.0 1.4 1.9 1.7 0.2 2.4 5.0 3.1 0.9 1.6 12.4 18.1 6.7 16.0 10.3 8.4 24.1 9.4 17.1 21.2 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Group enriched" "Detected in some" 5 "SCLC-21H: 12.9;SiHa: 5.7;U-2197: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.8 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.6 1.9 0.1 0.0 1.1 0.9 0.1 1.0 0.6 0.2 0.0 12.9 1.0 5.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 19.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavourable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.3 1.5 0.0 0.0 13.1 25.2 0.0 5.1 14.3 2.9 5.2 0.0 5.1 0.0 0.8 6.4 0.1 0.0 6.0 5.8 0.0 0.0 0.0 0.3 0.1 25.8 0.0 0.0 29.7 1.6 10.5 29.7 13.1 0.0 2.3 17.1 2.8 0.0 0.0 0.0 20.2 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.8 0.4 0.0 32.9 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell line enhanced" "Detected in some" "Daudi: 19.2;HEK 293: 10.4;LHCN-M2: 12.9;RPMI-8226: 11.0;TIME: 21.3;U-251 MG: 21.5;U-698: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA053618: , HPA054824: " "unprognostic (1.69e-1)" "prognostic favourable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favourable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 19.2 0.3 0.1 0.1 2.1 0.0 0.4 5.9 10.4 0.0 0.2 0.0 0.4 2.3 6.8 0.2 0.0 0.1 6.8 0.0 0.0 0.0 12.9 0.8 0.0 2.6 0.1 0.1 0.1 0.0 11.0 0.1 0.2 0.2 0.3 0.1 0.0 1.0 6.0 3.0 21.3 0.1 0.2 2.1 21.5 0.0 0.2 15.7 1.0 4.2 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028682-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Cell line enhanced" "Detected in many" "HL-60: 71.8;NB-4: 76.3;U-937: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol 7400000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favourable (1.65e-6)" 12.2 4.2 12.0 25.5 10.1 23.1 22.1 1.8 19.0 6.5 28.4 2.4 10.6 22.6 10.3 43.8 23.5 6.0 10.9 7.9 15.1 7.1 29.0 26.8 14.0 39.0 5.5 10.3 5.1 9.5 10.3 9.3 12.9 4.8 8.2 26.9 4.3 19.9 9.7 2.3 12.8 35.5 7.1 5.1 45.6 13.7 20.1 5.0 60.2 13.2 19.2 26.0 23.0 9.0 17.1 37.2 30.5 82.9 24.6 48.8 51.8 11.0 5.9 15.2 14.2 6.0 9.5 16.6 8.8 6.3 6.6 13.7 13.1 12.9 0.0 16.1 8.7 16.8 13.3 19.0 7.8 29.3 24.6 43.1 3.3 4.5 8.8 71.8 19.8 8.5 16.0 8.9 7.4 34.8 5.4 15.1 19.0 23.2 44.7 76.3 18.2 11.6 28.9 9.4 3.4 17.9 32.7 34.0 3.7 6.0 16.8 27.5 6.7 53.9 25.8 4.3 3.6 8.8 15.6 8.2 23.4 3.0 5.4 74.2 12.5 30.5 31.7 18.9 29.8 55.8 46.1 15.3 48.8 38.1 33.8 17.1 47.7 44.3 8.6 24.6 82.9 37.2 43.5 51.8 12.0 10.1 1.8 19.0 15.1 7.1 5.5 10.3 4.8 5.0 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680920 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 107.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 20.4 13.7 11.7 17.7 20.1 42.3 14.2 43.4 27.2 15.4 14.3 13.8 12.9 12.3 15.6 10.9 9.6 13.1 17.6 20.4 10.9 8.2 11.4 8.3 15.5 22.1 9.7 15.8 15.8 11.2 7.8 15.3 12.0 11.4 13.5 4.9 12.4 15.2 14.5 25.1 11.6 13.0 13.3 7.5 41.4 11.7 5.9 12.5 17.8 10.2 9.1 10.4 14.6 17.4 2.9 3.8 107.3 8.6 3.2 5.8 5.1 3.1 7.5 0.7 1.5 7.2 6.8 5.7 5.0 8.6 3.4 4.8 0.2 6.6 1.4 8.9 3.8 1.4 0.0 3.7 0.8 14.5 2.1 2.3 13.4 1.8 5.7 0.3 7.0 8.5 4.0 3.5 0.9 3.6 0.1 10.2 3.7 5.0 3.4 9.8 0.6 8.3 2.1 4.2 9.7 5.1 1.9 7.0 4.6 3.6 4.3 18.1 1.1 2.5 6.5 3.6 3.0 6.4 1.6 8.3 2.7 0.4 8.4 2.9 5.6 4.5 8.6 20.5 2.4 6.2 2.3 2.5 2.6 2.3 3.8 2.9 2.2 1.9 107.3 3.2 5.4 2.4 5.8 5.1 11.7 20.1 43.4 27.2 10.9 8.2 9.7 15.8 11.4 12.5 AC004556.1 ENSG00000276345 Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.0" "Cell line enhanced" "Detected in some" "CACO-2: 25.2;K-562: 21.1;MOLT-4: 23.7;NB-4: 45.7;PC-3: 42.6;WM-115: 30.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA050406: " 0.9 0.0 0.9 0.0 8.3 3.7 0.0 3.8 0.0 1.3 5.9 0.0 1.5 1.7 9.3 1.6 3.0 0.0 0.0 2.4 2.0 0.0 0.0 1.5 0.0 2.2 0.0 6.1 1.4 3.6 0.0 0.9 1.2 0.0 0.3 0.0 1.4 2.8 4.7 13.0 9.6 3.2 6.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 8.3 11.8 12.8 9.2 25.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 8.5 21.1 11.6 0.1 0.1 23.7 45.7 0.0 42.6 0.1 7.5 0.0 11.9 7.2 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 30.7 13.0 5.6 3.1 2.8 9.6 2.4 2.5 4.5 6.0 4.1 2.8 4.5 5.2 1.0 3.2 4.0 4.7 5.9 4.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA011651: , HPA071871: " "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.5 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 0.7 0.0 0.3 0.0 2.2 0.0 0.2 1.2 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 AC004922.1 ENSG00000284292 7 99325879-99394653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004334 Uncertain Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "HPA004334: AB_1078215" 6.0 5.2 4.2 9.4 6.2 6.9 7.8 3.2 9.1 5.3 6.6 4.6 5.6 13.8 5.8 3.8 5.3 5.0 4.5 4.9 7.1 4.1 6.3 4.6 8.1 3.2 6.0 3.9 6.4 3.0 4.1 5.2 6.2 5.0 3.1 4.9 3.3 5.4 4.6 2.4 9.6 4.2 3.0 6.5 7.0 3.9 3.2 2.9 6.0 6.4 4.4 4.6 4.1 7.9 13.0 18.1 16.3 5.1 11.9 18.0 4.1 3.9 0.4 1.0 0.5 2.8 5.0 3.3 1.8 3.0 3.1 7.1 5.8 4.4 10.8 3.4 2.8 1.2 3.7 0.6 2.1 7.4 2.5 2.9 1.9 0.9 2.7 3.1 2.6 1.1 3.1 1.2 4.3 3.8 4.0 2.1 7.8 4.8 1.2 2.6 11.8 2.1 1.1 1.5 0.6 2.0 1.1 1.0 2.8 4.6 8.3 2.1 1.7 2.9 4.8 2.6 7.1 4.2 0.0 2.2 4.7 2.9 4.1 5.7 9.2 15.5 18.1 7.1 16.3 5.1 7.3 7.0 6.9 13.0 7.9 6.1 6.1 13.9 5.1 15.0 8.9 11.9 18.0 AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: " "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 6.5 0.0 0.0 0.1 1.0 0.2 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Cell line enhanced" "Detected in some" "A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.4 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.5 0.0 0.9 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.6 3.4 0.0 0.8 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 AC008403.1 ENSG00000268465 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.7;intestine: 3.6;testis: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.7;U-698: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA060662 Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA060662: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.5 0.1 3.6 0.0 2.7 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 1.6 0.0 0.2 0.1 0.5 4.7 0.1 0.0 0.0 0.0 1.0 0.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.9 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.6 2.3 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.3 0.0 3.6 0.0 0.0 3.7 1.9 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.9 1.8 0.0 0.0 0.9 0.9 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.2 1.0 0.3 0.4 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.5 1.0 0.0 AC008560.1 ENSG00000253251 "Uncharacterized protein FLJ26957 " Q6ZNX1 5 65624765-65630891 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA066071: , HPA068764: " "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favourable (1.17e-4)" 5.8 7.1 7.3 6.5 13.1 31.5 10.0 8.7 13.3 5.4 6.6 7.1 5.5 7.0 5.9 7.4 6.3 5.3 6.1 4.9 8.2 7.9 11.6 9.7 6.2 9.9 9.9 8.0 5.9 8.7 3.8 13.1 6.5 11.3 10.7 7.6 5.7 6.4 6.6 6.6 7.0 7.6 7.8 9.1 8.9 6.0 7.5 8.6 10.4 6.9 6.4 8.3 5.3 5.0 5.0 4.4 13.4 4.1 6.3 8.8 2.9 2.8 3.7 5.7 12.0 3.3 3.8 6.8 4.3 3.8 6.1 7.8 6.4 8.7 5.1 4.9 5.0 3.6 5.5 5.2 9.2 6.7 6.9 4.6 9.7 8.5 2.6 5.0 8.0 2.3 7.3 6.4 6.8 4.1 6.5 12.0 5.0 7.1 7.2 7.3 4.5 2.2 5.0 5.4 7.9 5.1 6.1 7.8 5.9 3.8 3.5 10.8 4.2 4.5 3.2 5.7 7.5 4.4 6.8 7.6 13.9 11.3 4.2 6.2 5.3 13.4 4.1 7.5 5.4 3.7 5.7 5.0 6.5 5.6 3.7 4.9 8.8 8.1 4.3 6.3 4.1 4.4 7.9 2.9 7.3 13.1 8.7 13.3 8.2 7.9 9.9 8.0 11.3 8.6 AC008695.1 ENSG00000273217 5 131425891-131796983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 6.9;HL-60: 1.3;HMC-1: 2.7;U-937: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Lineage enriched" "Detected in many" 5 "T-cells: 11.1" "HPA037982, HPA037983" Uncertain Approved Centrosome,Cytosol Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: " 4.0 2.5 3.6 2.4 4.3 3.8 2.9 3.4 4.1 2.7 2.7 3.8 2.1 2.4 3.5 2.4 2.5 2.5 2.4 2.6 2.5 2.5 2.5 2.5 2.6 3.5 5.8 2.6 4.0 2.5 2.4 6.1 4.5 3.5 2.5 2.4 1.4 2.5 2.4 4.2 2.5 2.5 3.0 3.3 2.5 2.5 4.2 5.2 2.4 2.5 1.1 2.4 3.0 4.0 2.0 0.3 2.3 0.9 2.4 11.1 2.8 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 1.6 0.0 0.6 0.9 2.3 3.3 0.4 5.7 1.4 3.6 3.8 0.3 2.0 11.1 5.0 0.6 2.4 0.9 0.0 2.8 2.8 3.6 4.3 3.4 4.1 2.5 2.5 5.8 2.6 3.5 5.2 AC008758.5 ENSG00000268870 19 12391949-12441082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 7.5;RT4: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA003150, HPA018683" Uncertain Uncertain "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: " 2.1 1.3 1.3 4.3 1.4 1.4 3.3 6.5 2.3 3.3 3.6 0.2 10.8 1.2 2.7 1.4 1.7 0.8 1.5 1.1 1.4 0.7 4.9 3.0 1.7 3.1 1.5 0.7 1.4 2.3 0.3 1.3 3.0 1.8 2.9 2.5 0.1 3.5 6.2 1.9 1.8 4.0 1.0 2.3 1.6 1.3 1.6 1.4 8.4 2.0 1.1 1.2 3.4 4.4 2.5 1.6 0.6 0.4 1.1 2.6 1.2 1.6 0.0 1.1 2.4 0.2 0.0 3.6 1.1 0.0 0.3 0.0 1.5 0.1 1.1 3.7 1.0 0.0 0.0 0.9 0.0 0.0 0.7 3.5 0.0 2.3 0.0 2.0 3.9 0.0 1.6 1.9 0.0 1.4 1.5 0.0 0.0 0.2 1.8 0.6 1.8 0.0 0.9 7.5 0.0 0.0 6.0 0.0 1.1 0.1 0.7 0.0 3.5 2.6 0.6 0.4 0.4 3.0 0.3 0.0 1.0 1.9 0.8 0.2 1.1 0.0 0.4 0.6 1.7 0.2 2.6 2.5 2.2 1.9 1.6 1.7 2.5 0.1 0.3 1.1 0.1 0.3 2.2 1.2 1.3 1.4 6.5 2.3 1.4 0.7 1.5 0.7 1.8 1.4 AC010422.5 ENSG00000269590 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 13.9;RT4: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.7" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" "Nuclear membrane, Endoplasmic reticulum" "HPA065685: " 4.5 8.7 3.7 5.1 3.8 3.1 7.5 5.1 8.3 5.6 5.8 3.6 5.9 11.3 4.5 6.7 6.9 5.4 7.8 5.5 4.2 4.1 6.0 8.3 8.0 13.1 3.5 2.4 6.4 13.2 2.3 3.8 7.5 2.2 6.9 2.8 3.3 8.2 6.2 10.9 6.0 5.9 4.6 3.7 4.1 3.8 4.5 2.6 2.7 10.4 6.9 3.9 4.7 7.1 1.2 0.0 6.7 0.2 0.0 0.2 0.5 2.0 0.0 0.0 3.2 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 2.2 0.0 1.3 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.0 2.6 0.0 0.4 1.2 0.2 0.0 0.3 3.7 0.0 13.9 3.5 0.4 0.9 0.0 1.4 0.0 0.0 1.0 7.3 2.1 1.8 0.0 1.7 0.3 2.4 0.7 0.0 5.2 0.1 1.9 2.1 2.3 3.1 1.4 4.7 0.8 2.0 2.0 0.2 1.8 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.8 0.0 0.1 6.7 0.0 0.2 0.0 0.1 0.5 3.7 3.8 5.1 4.4 4.2 4.1 3.5 2.4 2.2 2.6 AC010487.3 ENSG00000283088 19 52880663-52962768 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 22.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA062474 Uncertain "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "HPA062474: " 2.4 0.1 1.7 3.3 3.5 1.1 2.9 1.6 2.6 4.5 2.5 1.5 5.7 2.2 4.7 4.4 3.5 4.1 4.3 2.2 1.7 4.1 0.3 2.8 2.3 4.6 0.8 5.6 1.6 9.7 5.3 4.9 2.3 7.3 3.0 1.5 2.9 4.3 1.1 0.0 2.9 3.3 3.9 4.9 1.9 1.9 3.8 9.1 4.5 2.1 2.6 6.2 4.1 1.0 2.2 2.8 2.2 4.6 2.6 1.4 2.0 0.0 3.7 3.9 0.2 0.0 2.2 2.0 1.7 1.9 3.2 1.3 0.5 2.4 1.5 1.2 0.3 0.0 0.7 1.2 0.0 0.5 1.5 3.3 0.0 2.0 0.0 1.8 0.6 0.0 2.0 0.8 2.3 1.8 0.0 2.3 0.0 2.5 0.0 3.9 2.3 2.0 2.4 1.5 0.3 22.1 1.8 4.6 0.0 0.7 0.0 2.2 0.1 1.3 1.0 1.8 0.2 1.8 1.5 6.4 1.5 0.0 0.0 2.2 2.8 0.7 0.8 1.9 1.6 2.0 0.5 1.4 1.1 1.8 1.0 2.6 0.8 0.3 4.6 2.2 2.2 0.9 1.4 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.1;T-47d: 4.3;U-251 MG: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA052730: , HPA056957: " "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.1 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.1 0.5 1.1 0.3 1.9 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.3 0.2 0.0 1.4 1.3 0.0 6.3 0.0 0.5 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012476.1 ENSG00000285396 15 40695129-40732158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 19.5;testis: 16.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039310 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA039310: " 0.4 0.8 0.0 4.2 0.0 0.9 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.8 2.1 0.2 1.4 0.9 0.0 0.2 0.3 0.8 0.9 0.0 0.0 0.3 0.5 0.9 0.0 3.9 0.0 0.1 0.0 0.0 0.3 0.0 1.8 0.9 1.2 0.0 0.2 3.0 1.6 16.7 0.0 19.5 0.1 2.1 6.1 0.0 0.0 1.3 1.0 2.3 0.4 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 1.2 0.2 1.0 0.2 1.1 0.3 0.4 1.3 0.2 0.3 2.3 1.2 0.1 1.0 0.3 0.1 AC023055.1 ENSG00000257390 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 6.4;testis: 12.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.3 0.1 0.1 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.6 0.2 0.1 0.7 0.2 0.2 0.1 0.1 0.3 0.1 0.5 0.2 0.0 0.1 0.4 0.1 0.0 0.3 0.7 0.0 0.0 0.4 0.2 0.7 0.0 0.1 0.1 0.2 12.9 0.0 0.3 0.4 0.0 6.4 4.1 5.3 5.9 5.7 5.8 4.7 0.3 0.0 2.8 4.0 3.0 0.0 3.2 1.7 1.4 0.3 1.2 1.1 0.8 3.1 0.6 2.0 1.5 2.4 3.0 1.3 0.0 2.7 2.2 0.6 0.3 1.2 2.6 2.8 0.7 0.0 1.4 0.6 0.4 1.3 0.0 0.6 0.0 1.6 2.4 4.5 0.0 2.8 3.2 1.8 1.6 0.8 4.2 1.3 0.9 4.4 6.4 1.0 1.1 0.0 0.0 0.3 0.6 0.9 0.0 2.2 1.8 0.8 0.3 0.5 2.8 2.6 5.3 5.6 3.2 3.5 6.4 4.9 4.5 4.1 3.5 3.9 5.8 1.5 5.7 5.9 2.7 5.2 4.7 AC023509.3 ENSG00000267281 12 53506688-53625979 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA003384 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (1.14e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (8.37e-4)" "unprognostic (6.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.08e-5)" "unprognostic (1.91e-2)" "unprognostic (2.26e-7)" "unprognostic (9.21e-2)" "unprognostic (2.50e-1)" "unprognostic (3.72e-1)" "unprognostic (9.77e-3)" 4.5 2.4 3.9 2.0 6.0 4.5 4.6 14.9 5.2 3.3 2.7 7.8 2.1 1.4 4.5 1.8 3.2 3.6 3.8 3.7 4.4 2.8 2.4 3.8 7.0 3.6 6.8 2.3 5.1 3.5 1.4 3.6 2.9 5.1 3.3 3.5 3.1 3.0 4.3 4.5 3.4 2.4 5.7 4.7 2.9 3.1 4.7 6.6 1.9 2.4 1.7 4.1 5.9 2.5 0.7 1.4 2.9 2.2 0.2 2.5 0.5 0.6 4.4 0.0 0.5 1.8 2.3 0.0 0.0 1.4 1.6 0.3 0.5 0.7 1.7 0.4 0.0 1.4 0.3 1.2 1.3 1.8 0.9 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.5 0.9 0.0 1.9 0.0 1.8 0.0 0.0 0.0 0.2 0.8 0.7 0.3 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.3 2.3 1.8 0.0 0.6 0.6 0.0 0.3 0.0 0.6 1.5 0.8 0.9 0.0 2.9 1.7 0.5 2.5 2.2 0.5 0.2 0.2 0.4 0.9 0.7 0.0 0.4 2.4 0.2 0.0 1.4 0.3 0.5 3.9 6.0 14.9 5.2 4.4 2.8 6.8 2.3 5.1 6.6 AC073610.3 ENSG00000272822 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 27.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA068942 Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA068942: " "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 6.8 3.4 10.5 2.2 20.7 3.6 4.6 7.7 27.5 6.4 4.9 6.3 2.6 2.2 9.7 7.3 5.1 4.7 7.6 7.2 8.8 7.2 5.0 4.1 5.5 5.5 5.7 13.7 6.1 7.4 2.2 5.3 3.3 10.6 5.4 4.6 3.5 4.8 4.5 3.4 4.4 4.2 10.6 4.6 4.7 4.0 8.4 4.3 3.3 5.0 2.3 4.4 4.9 3.9 0.8 1.8 1.1 1.1 1.3 3.2 2.0 1.1 0.4 4.0 3.1 4.3 1.7 0.0 1.7 8.3 2.4 1.1 0.0 1.2 1.2 2.5 1.5 0.4 1.5 0.0 2.3 5.4 0.7 1.1 0.7 0.0 3.0 0.0 1.1 0.5 2.1 0.7 1.4 1.1 0.1 1.5 1.4 0.5 0.2 0.6 0.0 1.2 2.3 0.7 0.2 0.2 0.3 2.0 0.6 1.0 0.8 0.9 0.2 0.6 4.6 0.8 0.5 0.2 0.5 2.1 0.3 0.8 1.9 1.2 0.4 0.9 1.1 0.3 2.7 0.4 3.2 0.6 0.9 1.8 0.9 0.8 2.3 2.6 1.1 1.3 0.4 1.8 0.5 2.0 10.5 20.7 7.7 27.5 8.8 7.2 5.7 13.7 10.6 4.3 AC073896.1 ENSG00000144785 12 56285916-56316059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038466, HPA068007" Uncertain Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA038466: AB_10672646, HPA068007: " "unprognostic (3.07e-2)" "unprognostic (9.89e-3)" "unprognostic (8.23e-2)" "unprognostic (3.45e-2)" "unprognostic (8.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.13e-1)" "unprognostic (1.38e-1)" "unprognostic (3.74e-3)" "unprognostic (2.83e-1)" "unprognostic (1.04e-1)" "unprognostic (9.26e-4)" "unprognostic (2.22e-1)" "unprognostic (3.01e-1)" "unprognostic (1.93e-1)" 6.4 12.2 6.7 7.8 7.4 4.5 5.4 12.4 13.6 7.2 20.3 7.2 13.3 15.3 6.5 10.9 6.9 5.7 5.9 8.3 5.0 5.5 8.5 18.1 5.3 5.1 6.4 6.6 8.5 20.5 6.9 12.5 13.2 6.6 7.1 4.8 5.6 15.5 10.9 8.6 5.9 8.3 2.9 7.5 10.6 10.0 5.8 6.1 3.4 12.5 4.3 4.6 5.4 4.8 22.5 19.3 7.9 13.2 9.7 12.5 18.8 6.4 3.7 4.8 6.6 2.9 1.9 5.1 9.6 3.0 3.2 1.8 0.8 5.5 3.0 22.4 2.3 14.2 6.2 1.0 2.0 7.7 4.3 1.0 4.4 2.8 0.2 7.4 11.6 3.4 0.4 2.4 0.2 3.9 2.7 3.3 1.6 1.8 4.0 4.0 14.1 11.1 18.3 6.9 4.7 0.6 1.7 8.3 11.1 2.8 9.5 9.3 5.0 15.2 0.0 8.8 5.7 4.9 14.1 10.9 25.3 7.6 15.0 6.4 10.9 7.9 7.6 4.1 12.4 13.2 10.0 22.5 7.7 12.5 15.1 19.0 9.0 11.8 1.6 9.7 6.6 19.3 11.4 18.8 6.7 7.4 12.4 8.3 5.0 5.5 6.4 6.6 6.6 6.1 AC105001.2 ENSG00000258724 8 10725399-10839847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;HBEC3-KT: 2.4;SiHa: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.5" "Low region specificity" "Detected in some" HPA009065 Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (2.57e-1)" "unprognostic (6.34e-2)" 6.7 2.7 1.9 3.7 3.1 1.7 2.7 2.9 3.9 9.8 3.1 2.6 0.9 3.3 3.6 1.7 4.0 2.1 3.1 3.2 2.0 1.9 2.2 4.8 4.7 2.2 2.8 2.1 3.8 4.1 1.7 2.3 3.3 4.2 2.7 1.8 3.6 3.4 2.0 8.7 4.6 3.0 2.1 2.5 3.3 3.2 6.3 1.7 4.6 2.6 4.3 3.8 2.2 15.2 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.2 0.0 0.1 0.2 0.4 0.0 0.1 0.0 6.0 0.4 2.4 0.0 0.1 0.1 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 0.3 0.1 1.1 0.0 0.0 0.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.3 0.2 0.0 0.1 0.9 0.1 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 3.1 2.9 3.9 2.0 1.9 2.8 2.1 4.2 1.7 AC118549.1 ENSG00000036549 "ZZ-type zinc finger-containing protein 3 " Q8IYH5 1 77562416-77683419 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053663, HPA054913, HPA066197" Uncertain Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053663: , HPA054913: , HPA066197: " "unprognostic (1.30e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-2)" "unprognostic (2.13e-3)" "unprognostic (5.38e-3)" "unprognostic (8.77e-2)" "prognostic unfavourable (6.96e-5)" "unprognostic (2.91e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "unprognostic (2.83e-1)" "unprognostic (1.91e-1)" "unprognostic (1.71e-1)" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (3.05e-2)" "unprognostic (1.43e-1)" 17.8 17.4 20.8 14.1 23.6 11.6 21.6 20.4 20.3 18.1 16.2 16.1 18.3 12.1 18.3 14.3 14.5 15.3 12.1 13.7 16.9 11.7 18.8 20.0 12.3 15.8 24.1 17.8 24.1 14.5 19.0 28.2 13.9 14.4 16.0 13.0 10.5 15.2 16.8 19.0 16.9 12.4 17.0 16.2 11.5 13.5 9.9 23.6 17.9 26.5 8.6 16.0 20.1 14.9 7.9 7.4 5.6 5.1 7.4 10.4 5.0 13.2 6.8 12.5 9.6 11.0 17.5 13.3 17.0 15.7 15.7 17.3 7.6 7.1 17.4 15.3 14.2 12.2 16.5 11.0 23.8 13.6 13.1 21.6 13.7 9.4 17.0 22.2 6.1 13.3 17.0 17.4 34.1 16.0 20.9 13.6 15.2 6.3 11.1 6.9 18.6 15.5 13.1 21.5 8.9 11.0 14.1 15.8 13.3 10.2 11.7 30.0 7.0 12.2 13.1 13.7 16.8 22.1 21.9 10.2 14.3 18.5 13.4 19.5 10.4 0.1 4.6 5.6 6.9 5.1 10.4 7.9 8.2 8.1 7.4 7.9 10.2 9.2 0.9 7.4 4.7 5.0 10.4 5.0 20.8 23.6 20.4 20.3 16.9 11.7 24.1 17.8 14.4 23.6 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.3 0.0 0.0 0.8 4.7 0.3 0.5 1.3 3.0 1.5 0.6 0.0 1.8 0.2 0.8 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.6 2.8 1.2 0.0 1.0 0.9 0.0 0.1 0.0 0.0 3.2 0.0 3.0 0.9 1.6 2.8 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.9 0.9 0.0 0.0 0.7 2.9 0.1 2.2 0.7 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 AC240274.1 ENSG00000271254 Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " 1.1 5.4 0.7 0.5 1.0 1.0 1.6 3.1 2.3 2.6 1.7 0.8 2.9 1.4 0.3 2.0 0.4 1.4 0.0 5.4 0.0 7.0 1.8 1.3 3.5 1.0 0.8 0.7 1.1 3.9 2.3 1.2 0.5 6.9 1.3 0.2 0.7 2.1 1.4 2.7 2.1 6.4 3.1 0.9 10.9 14.6 16.5 11.7 5.5 6.1 3.7 16.6 10.1 15.5 13.1 5.3 4.3 8.6 1.3 15.2 6.2 6.3 3.1 21.1 5.7 13.0 2.3 8.0 7.2 7.5 7.4 5.1 4.0 4.5 8.8 7.1 4.3 10.3 3.0 6.0 15.0 9.1 3.2 2.6 35.4 16.5 10.6 1.2 3.7 6.1 12.3 20.0 16.4 13.9 6.8 12.5 2.2 5.8 9.6 9.9 23.8 7.4 3.5 11.9 7.3 2.3 11.5 3.4 2.7 1.7 2.7 1.7 2.1 3.1 1.5 1.0 1.1 0.7 2.1 1.8 1.9 2.0 6.4 1.5 1.4 0.1 0.9 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Cell line enriched" "Detected in some" 5 "U-2197: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: " "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.7 18.5 0.3 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 ACACA "ACAC, ACC, ACC1" ENSG00000278540 "Acetyl-CoA carboxylase alpha" Q13085 17 37084988-37406818 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013715, HPA036650, HPA063018" Approved Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" Cytosol "Nucleoli fibrillar center, Actin filaments" "CAB013715: , HPA036650: , HPA063018: " "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.04e-2)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.24e-5)" "unprognostic (8.81e-2)" "unprognostic (6.56e-2)" "unprognostic (2.38e-3)" "unprognostic (3.38e-1)" "unprognostic (2.24e-1)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (4.89e-1)" "unprognostic (4.49e-2)" "unprognostic (2.03e-2)" 10.7 4.8 5.6 2.5 7.7 3.0 18.5 6.0 11.5 5.3 4.2 6.9 12.7 3.8 4.5 11.7 9.2 3.8 3.6 2.3 4.9 3.0 5.8 7.3 3.5 6.3 4.6 4.3 2.3 13.6 7.9 2.6 6.1 12.2 5.1 4.8 4.6 14.4 11.3 5.4 2.5 7.8 4.2 2.3 3.9 5.5 5.7 2.0 4.2 4.5 5.0 4.3 4.6 4.4 3.2 1.3 4.1 2.0 3.9 2.0 14.6 3.0 17.9 18.8 25.0 24.7 6.2 6.6 9.3 6.8 12.4 11.9 2.5 2.0 5.4 10.5 15.2 3.3 22.3 10.7 5.8 9.8 11.7 7.7 12.1 4.0 6.3 2.4 19.9 13.0 18.1 13.5 12.0 27.9 1.4 1.0 12.4 6.7 9.7 13.6 9.7 10.3 11.3 2.7 16.2 16.7 20.3 8.0 11.8 5.5 5.2 11.1 7.2 10.6 5.8 9.3 8.1 1.6 3.9 4.7 18.3 5.3 5.3 8.0 1.1 2.8 0.3 2.3 4.1 2.1 2.7 2.5 2.7 3.2 4.4 3.9 2.7 1.3 2.0 2.7 2.4 3.2 2.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell line enhanced" "Detected in many" "HMC-1: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Mitochondria 15000 Mitochondria Nucleoplasm "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.3 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 3.3 4.3 1.3 0.5 10.5 5.3 5.2 2.2 12.0 6.2 0.4 23.7 10.3 2.0 1.7 0.1 4.0 4.2 0.0 1.7 4.2 7.2 12.0 1.3 3.0 5.4 2.7 1.4 7.3 11.6 0.7 4.0 6.2 0.0 9.9 5.0 8.2 4.4 0.1 3.1 3.0 0.6 10.1 5.7 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol 19000000 "Nucleoli, Mitochondria" "Nucleoplasm, Cytosol" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favourable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.2 31.9 13.1 18.0 56.6 20.8 24.8 24.5 34.1 28.0 17.4 12.9 30.2 17.8 20.5 51.4 25.7 8.8 26.8 24.8 56.5 9.0 9.5 22.7 19.6 27.2 9.0 24.8 23.2 24.6 23.4 36.9 25.1 12.2 21.8 44.9 12.6 9.4 10.9 6.2 12.6 13.1 14.5 42.4 62.2 30.4 3.5 8.6 34.6 44.0 20.1 20.2 13.9 25.0 24.8 18.6 12.5 23.9 20.4 9.5 0.9 45.6 16.0 18.0 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292376-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA049317: , HPA058381: " "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 8.7 7.8 16.4 4.2 24.5 10.4 7.3 42.0 23.6 6.4 6.4 11.5 4.3 7.9 5.9 4.2 10.6 3.7 5.1 7.9 19.5 8.7 4.8 4.9 4.7 4.0 13.0 15.4 5.5 8.2 5.1 11.2 4.3 10.4 5.8 3.4 5.6 14.6 7.7 14.2 26.5 7.7 11.8 8.1 6.0 8.0 3.1 12.8 3.1 2.7 4.5 3.5 5.6 6.4 0.9 1.2 1.5 2.0 0.0 1.4 0.7 5.2 5.9 2.7 4.7 7.0 4.8 2.9 13.3 4.3 3.8 3.0 7.5 4.6 5.8 6.9 7.4 12.1 2.7 3.6 0.9 6.4 11.8 2.4 21.9 14.0 4.8 4.9 6.1 3.3 2.9 3.2 2.0 1.8 6.7 8.0 4.3 7.3 10.3 7.1 2.9 13.8 10.0 6.3 22.3 2.3 2.9 21.0 14.8 7.9 5.0 12.5 5.3 3.8 5.8 7.1 5.0 5.7 4.6 6.5 4.7 5.0 9.9 13.1 3.1 0.0 1.4 1.5 1.3 2.0 0.0 0.9 1.0 0.6 1.2 0.8 1.4 1.2 0.2 0.0 1.4 1.0 0.5 0.7 16.4 24.5 42.0 22.1 19.5 8.7 13.0 15.4 10.4 12.8 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159760328-159779055 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 20.4;liver: 31.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 48.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Supported Nucleoplasm,Cytosol 16000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favourable (1.12e-4)" "prognostic unfavourable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 1.6 2.6 2.7 1.5 1.7 1.6 2.2 2.2 6.3 2.1 4.3 3.2 1.4 4.8 5.7 1.0 0.7 0.7 2.9 3.6 3.0 31.0 1.8 2.5 2.9 2.1 0.7 1.3 1.2 0.9 4.2 3.9 2.3 0.5 0.1 2.4 1.6 1.4 5.1 1.1 1.7 6.6 0.9 4.2 1.1 2.6 13.3 9.5 12.3 8.4 10.0 20.4 12.2 6.9 6.5 44.3 16.9 6.3 11.8 1.5 6.2 7.3 14.7 25.4 25.4 8.9 5.9 3.1 4.8 6.7 18.3 48.0 17.4 3.5 18.8 13.6 10.6 42.2 6.4 7.8 3.7 6.4 3.5 24.2 10.4 7.1 14.6 9.9 8.9 12.4 13.5 12.5 14.9 4.8 8.4 9.9 18.0 34.2 9.1 11.9 6.7 7.1 4.6 2.4 8.9 15.7 4.4 5.4 4.7 7.6 15.8 4.7 8.7 14.4 1.6 15.5 8.1 6.1 7.1 12.3 13.9 8.4 13.7 13.3 15.9 13.8 9.5 13.3 16.0 12.3 3.2 10.0 5.6 8.7 20.4 12.2 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA051772: " "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favourable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favourable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favourable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.7 1.5 3.3 2.7 5.2 4.1 2.2 4.8 3.7 7.3 4.5 8.4 6.4 5.8 3.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 3.6 2.0 10.2 1.8 4.0 4.4 1.6 0.2 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 15.7 2.3 1.3 0.9 2.9 1.4 1.4 16.1 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 6.5 7.5 7.3 9.7 7.7 9.1 7.1 17.4 8.1 8.0 5.2 6.5 9.6 5.8 8.6 7.6 5.4 6.0 7.1 8.9 6.6 6.8 5.5 6.8 11.2 6.1 7.9 10.5 9.7 6.8 10.5 11.3 5.8 6.8 5.0 6.5 7.2 7.6 9.5 6.3 5.2 7.8 4.0 6.8 6.1 18.2 7.3 8.1 8.1 7.7 7.1 7.6 6.9 11.5 14.5 2.7 13.3 16.4 10.9 7.7 20.9 15.6 13.5 9.9 9.4 16.4 28.1 9.7 19.5 16.8 15.3 22.0 15.4 18.5 20.1 9.5 15.1 9.9 17.9 10.7 14.0 19.2 14.6 14.1 12.5 24.2 24.9 13.2 14.8 25.5 10.5 16.5 18.8 22.8 15.1 13.5 19.0 21.3 23.6 14.8 7.4 21.5 11.2 35.5 14.3 10.9 21.2 27.0 12.9 21.7 12.9 22.8 18.7 15.1 12.6 15.1 15.4 20.8 31.9 16.5 42.1 13.8 15.4 14.9 1.9 8.4 2.7 9.3 13.3 10.7 11.5 8.0 7.9 14.5 8.8 10.0 10.9 0.6 16.4 10.0 11.8 7.4 7.7 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell line enhanced" "Detected in many" "MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043326: , HPA062478: " "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.6 0.6 10.5 5.0 0.6 0.5 1.2 0.7 0.6 1.9 3.2 2.9 3.2 2.4 3.6 2.4 0.6 6.2 1.9 2.7 5.4 8.5 2.6 0.8 1.6 0.1 0.5 1.1 0.1 0.2 0.7 0.1 2.6 2.0 2.9 2.1 8.3 21.7 2.3 5.2 1.9 11.7 3.7 5.7 1.2 1.0 8.6 5.2 2.6 5.9 1.1 8.5 0.7 0.7 0.4 5.8 1.0 2.2 8.2 16.3 18.7 1.7 0.5 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 43.8;skeletal muscle: 98.2" "Cell line enhanced" "Detected in some" "BEWO: 8.0;CACO-2: 12.6;K-562: 14.8;Karpas-707: 24.7;U-2 OS: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 650000 "Golgi apparatus" Vesicles "HPA027098: " "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavourable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.8 5.8 3.5 16.1 10.3 1.4 22.8 11.8 1.4 4.2 2.7 1.4 5.7 1.9 2.6 2.8 1.8 3.1 4.5 5.5 43.8 1.4 1.8 1.8 5.9 22.2 4.8 1.7 1.6 7.0 3.2 2.0 37.9 3.3 3.4 4.6 6.5 3.3 98.2 1.4 7.9 1.9 8.7 2.3 2.1 1.9 2.6 3.5 1.6 15.9 3.2 2.1 1.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.2 0.5 0.0 8.0 0.3 0.0 0.1 0.2 12.6 0.3 0.0 0.4 0.0 0.4 2.1 0.1 0.0 4.3 0.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 14.8 24.7 0.1 3.5 0.0 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.0 0.0 0.0 0.0 0.1 0.7 5.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.1 22.8 11.8 5.5 43.8 22.2 4.8 37.9 2.6 ACIN1 "ACINUS, fSAP152, KIAA0670" ENSG00000100813 "Apoptotic chromatin condensation inducer 1" Q9UKV3 14 23058564-23095614 "Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000657 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA000657: AB_1078091" "unprognostic (2.54e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.89e-3)" "prognostic unfavourable (4.88e-5)" "unprognostic (1.49e-3)" "unprognostic (9.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.00e-2)" "unprognostic (6.64e-3)" "unprognostic (1.35e-3)" "unprognostic (4.34e-2)" "unprognostic (2.78e-2)" "unprognostic (2.28e-2)" "unprognostic (7.33e-2)" 32.4 44.4 34.6 46.6 36.2 57.6 32.5 45.7 41.8 36.6 30.1 39.1 35.2 28.5 52.9 32.2 39.3 34.6 33.3 29.7 33.1 28.3 34.9 35.5 28.8 41.1 34.4 27.7 43.9 34.5 51.1 48.3 37.0 33.7 35.4 34.6 31.5 33.0 38.3 43.8 38.1 35.1 40.1 35.0 52.9 34.0 34.5 40.6 44.2 38.5 27.1 45.9 30.5 47.8 6.9 6.8 13.4 4.9 9.7 5.5 2.7 23.2 24.0 37.9 30.7 23.7 19.1 38.1 26.0 18.4 31.4 25.7 31.8 27.4 43.2 15.4 21.5 25.7 52.4 29.7 32.3 30.3 23.2 38.0 25.4 43.7 13.6 41.2 33.8 22.3 18.4 32.2 27.1 27.4 35.0 17.3 23.7 29.1 46.7 40.7 42.6 23.0 42.4 29.5 23.0 26.1 41.1 25.3 18.6 34.5 22.6 20.5 18.6 33.4 28.0 21.5 21.6 20.4 24.0 18.4 20.7 44.8 19.2 31.3 23.3 4.1 4.9 5.6 5.5 4.5 4.4 4.4 3.7 4.2 4.1 6.9 5.1 4.6 13.4 9.7 3.7 6.8 3.8 2.7 34.6 36.2 45.7 41.8 33.1 28.3 34.4 27.7 33.7 40.6 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Cell line enhanced" "Detected in some" "BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Low region specificity" "Detected in all" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: " "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.4 0.1 31.4 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.0 0.2 1.7 0.0 0.1 1.1 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 4.4 0.1 0.1 0.7 16.8 0.0 1.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 6.4 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582358 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 22.8;MCF7: 16.8;RT4: 66.7;SiHa: 20.4;U-2197: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 6.1;T-cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA032003: , HPA049718: " "unprognostic (1.65e-2)" "prognostic unfavourable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavourable (1.76e-6)" "prognostic unfavourable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavourable (2.93e-4)" 56.1 2.9 5.4 6.9 5.6 1.7 28.5 2.2 6.4 10.7 15.2 8.9 9.1 5.7 9.9 20.4 23.6 14.6 15.3 30.2 8.4 3.0 3.8 29.6 10.9 7.2 3.8 6.5 19.3 25.7 2.2 10.7 59.6 8.4 14.2 12.8 25.2 8.9 8.9 36.4 16.0 15.7 32.6 7.2 70.9 12.6 9.4 5.5 0.2 34.3 22.3 8.6 59.2 17.8 1.0 0.2 0.1 0.5 6.1 6.1 0.6 0.0 0.0 1.3 0.0 2.3 0.0 9.8 0.5 0.3 0.4 1.0 0.1 0.0 0.0 1.1 0.0 14.3 0.0 5.1 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.6 13.1 0.0 0.0 2.3 0.2 0.0 0.0 16.8 0.0 0.0 2.3 0.1 0.0 1.6 0.1 0.0 66.7 0.0 0.0 20.4 0.1 0.0 0.0 0.0 0.0 0.1 5.3 70.1 0.0 0.2 0.0 0.0 0.2 1.4 0.1 0.0 0.1 0.0 4.1 0.3 6.1 0.6 2.1 5.0 0.2 1.0 1.8 2.3 0.1 6.1 0.5 0.0 3.1 0.6 5.4 5.6 2.2 6.4 8.4 3.0 3.8 6.5 8.4 5.5 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 86.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 3.4 0.0 14.2 86.6 0.8 2.4 0.0 0.1 0.9 0.0 8.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866908-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 2100000 "Plasma membrane, Cytosol" Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavourable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 38.3 24.0 16.7 26.2 22.9 19.1 35.7 21.5 29.1 22.9 22.2 25.1 18.0 30.7 27.0 24.9 23.2 23.7 28.2 18.4 18.3 33.7 37.8 22.2 23.3 27.4 23.1 17.9 19.0 30.6 27.1 19.5 26.7 49.0 41.3 23.2 15.6 25.4 19.6 10.9 19.6 29.6 27.2 26.2 24.5 24.6 20.7 21.4 32.0 21.3 18.2 24.6 20.3 21.3 16.1 23.9 25.2 26.3 16.0 23.9 21.4 23.2 79.1 37.4 32.2 57.8 54.3 34.4 32.7 35.8 41.2 51.8 40.1 26.8 37.8 21.0 45.8 37.0 48.2 56.0 34.5 34.0 46.1 21.6 45.6 41.7 26.9 34.9 28.3 43.1 16.9 72.4 14.6 43.4 26.6 30.2 34.1 23.7 57.4 19.6 24.3 14.4 37.7 45.2 48.4 42.2 41.4 70.4 38.7 23.3 73.0 25.0 43.5 33.4 46.6 32.2 26.5 32.3 53.6 17.7 22.5 35.9 54.4 27.1 26.1 18.9 20.7 25.2 23.8 22.1 22.5 16.1 19.0 21.3 23.9 13.8 14.6 16.1 10.7 16.0 26.3 13.9 23.9 21.4 16.7 22.9 21.5 27.7 18.3 33.7 23.1 17.9 49.0 21.4 ACO1 "IREB1, IREBP, IRP1" ENSG00000122729 "Aconitase 1" P21399 9 32384603-32454769 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Lyase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell line enhanced" "Detected in many" "ASC diff: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019371, HPA024157" Enhanced Supported Mitochondria,Cytosol 8000000 "Mitochondria, Cytosol" "HPA019371: AB_1844519, HPA024157: AB_1844520" "unprognostic (2.11e-1)" "unprognostic (5.61e-2)" "unprognostic (8.38e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-1)" "unprognostic (3.12e-2)" "unprognostic (4.25e-3)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (1.19e-1)" "unprognostic (2.55e-1)" "unprognostic (3.08e-1)" "prognostic favourable (5.73e-5)" "unprognostic (2.54e-1)" "unprognostic (6.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.23e-2)" 41.4 27.2 9.6 7.1 9.4 1.5 30.1 8.9 8.1 9.3 19.7 6.2 6.4 21.9 12.8 14.6 12.8 7.2 8.9 15.1 6.5 7.6 40.5 80.9 9.2 9.4 6.1 6.2 14.1 27.9 8.9 8.7 11.3 7.7 10.7 9.8 11.7 11.7 9.5 11.2 5.5 28.4 14.5 6.0 6.4 13.5 11.4 5.9 6.0 18.4 7.2 5.1 13.9 11.7 4.7 7.1 21.4 8.8 4.7 7.4 6.2 9.4 8.7 6.7 10.6 52.5 28.5 3.0 17.9 44.1 8.2 6.5 9.1 2.9 1.9 5.7 18.7 1.3 13.3 17.1 16.6 6.0 3.6 13.8 9.4 9.9 26.4 1.3 5.6 24.8 5.3 21.2 15.0 21.3 4.9 4.1 23.4 2.4 7.3 6.6 7.0 9.2 5.7 10.0 1.9 31.4 8.7 0.8 2.8 18.6 0.7 1.9 4.3 3.4 23.0 30.1 10.2 10.0 4.6 2.0 3.8 3.7 21.0 4.6 2.6 21.4 8.7 2.4 7.4 8.8 6.4 4.7 5.2 5.7 7.1 4.2 6.8 7.0 1.0 4.7 7.2 3.4 2.8 6.2 9.6 9.4 8.9 8.1 6.5 7.6 6.1 6.2 7.7 5.9 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.4;Karpas-707: 1.8;SK-MEL-30: 4.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: " "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favourable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.4 0.1 0.0 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavourable (2.31e-5)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.4 20.4 20.2 21.7 4.6 7.7 7.6 20.2 10.5 30.0 18.0 70.5 7.6 28.7 14.9 16.4 23.2 32.5 54.0 11.3 25.2 28.4 15.1 16.2 24.9 19.0 17.6 12.6 6.8 10.3 24.8 29.4 16.8 12.3 6.2 15.8 27.3 36.8 18.7 10.1 47.4 44.1 23.2 19.4 16.8 9.0 11.0 31.3 18.2 28.0 64.4 9.9 8.3 27.2 27.3 16.0 27.1 31.9 5.2 21.4 40.4 17.3 30.9 16.6 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favourable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 7.0 22.6 23.5 10.9 24.3 16.5 8.7 14.4 32.6 6.8 17.1 13.5 9.9 23.3 6.5 13.1 15.8 12.2 10.1 27.0 22.8 19.3 15.3 19.0 9.7 12.1 22.1 19.0 8.3 17.4 5.9 11.4 8.1 19.5 9.6 14.3 10.4 14.4 7.3 21.7 16.7 22.2 7.3 14.6 9.1 16.7 12.8 11.1 17.1 12.4 8.6 12.2 10.9 7.2 20.5 27.0 31.0 26.2 11.2 22.5 18.8 7.6 9.2 3.1 6.3 8.9 5.4 5.5 5.2 4.2 7.3 6.8 13.4 10.7 9.6 23.6 7.1 15.0 6.0 13.0 2.5 7.1 10.6 9.6 12.4 12.8 8.0 9.1 9.0 6.3 9.9 7.0 5.0 4.5 8.5 11.9 5.1 21.5 13.0 11.9 5.6 24.5 6.3 5.8 17.1 7.7 8.7 10.9 5.1 11.5 29.4 17.8 16.1 22.5 5.1 18.1 4.0 9.3 8.6 10.1 15.0 6.0 22.4 9.6 9.6 20.0 26.2 31.0 18.8 25.0 17.1 20.5 18.1 17.0 27.0 19.3 16.1 17.3 18.7 11.2 23.4 17.0 22.5 18.8 23.5 24.3 14.4 32.6 22.8 19.3 22.1 19.0 19.5 11.1 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.4 18.1 7.9 17.4 13.0 14.8 4.0 21.0 18.3 20.9 20.3 16.0 24.0 1.3 13.5 23.4 16.2 9.9 26.8 29.1 6.2 15.1 9.0 19.0 11.6 17.5 3.5 11.4 13.1 18.3 24.4 27.8 30.4 5.7 9.1 22.5 9.2 4.8 8.5 11.5 22.1 5.1 30.1 11.2 24.7 9.9 1.5 7.6 22.8 9.6 13.5 10.8 4.6 28.2 17.4 11.6 25.2 11.4 2.2 5.2 0.1 12.9 3.5 14.7 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979363 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.6" "Cell line enhanced" "Detected in all" "BEWO: 34.6;RT4: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 22.9;neutrophil: 38.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes 160000 Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favourable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 21.8 12.9 8.8 8.3 10.2 4.2 13.6 6.4 9.8 6.4 26.5 8.2 9.6 31.0 6.6 6.7 19.5 6.0 12.3 16.0 8.3 7.9 20.8 95.6 9.2 7.5 8.2 8.3 7.6 28.7 9.8 8.9 13.6 7.8 9.5 14.3 11.3 9.5 9.1 18.3 13.4 53.1 7.9 6.7 7.2 13.6 6.2 6.3 7.1 9.1 11.4 10.6 10.6 7.9 1.6 3.3 38.6 5.8 2.1 2.7 2.2 5.3 7.6 2.5 3.8 13.0 5.5 34.6 3.9 3.9 4.7 5.4 5.3 8.8 3.1 4.2 6.6 3.2 10.5 4.1 7.4 2.8 3.1 4.0 4.3 17.3 7.1 3.4 2.6 9.1 3.2 5.3 3.5 11.7 4.0 3.0 5.2 15.7 7.4 2.5 1.8 6.5 4.1 7.6 3.6 8.0 46.6 3.0 4.5 11.1 17.5 3.7 10.7 3.8 7.8 6.5 4.8 5.3 3.7 5.0 3.4 1.2 3.8 3.1 3.8 22.9 5.8 1.6 2.1 4.5 2.7 1.6 2.0 2.7 3.3 1.6 2.4 2.3 38.6 2.1 2.8 2.9 2.6 2.2 8.8 10.2 6.4 9.8 8.3 7.9 8.2 8.3 7.8 6.3 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537319 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 70.5" "Cell line enhanced" "Detected in some" "ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol 190000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 4.0 5.3 1.9 3.8 2.5 0.1 3.4 1.6 2.1 4.4 10.2 2.7 9.5 10.0 9.0 6.2 3.8 4.4 4.8 8.8 2.4 1.4 17.1 70.5 2.8 0.7 2.0 1.7 5.1 2.9 3.8 3.0 1.4 4.0 7.2 3.4 11.4 3.0 5.9 4.2 1.7 13.7 10.6 2.5 0.9 2.6 4.0 2.0 1.0 7.7 2.7 1.6 5.4 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.2 20.2 3.5 2.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.8 0.0 0.0 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.6 2.1 2.4 1.4 2.0 1.7 4.0 2.0 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Group enriched" "Detected in some" 4 "A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035392, HPA035393" Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA035392: , HPA035393: " "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favourable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 8.9 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.1 0.1 1.0 0.0 0.0 0.0 0.2 3.1 0.2 0.4 0.2 0.0 0.1 0.2 0.1 0.9 0.0 0.1 0.0 1.4 1.4 0.1 3.2 0.7 0.4 3.1 0.4 0.1 0.1 16.2 0.0 20.8 2.0 0.4 0.1 0.4 0.1 0.2 0.9 0.3 0.2 0.4 0.2 0.1 14.1 3.6 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol 3700000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 22.3 59.7 38.0 20.8 40.3 38.0 33.0 27.9 43.7 23.1 29.7 27.4 24.4 31.1 25.2 36.2 24.8 29.5 26.9 27.4 34.6 33.7 42.1 54.8 24.7 29.4 31.5 34.6 33.7 53.0 28.4 43.9 39.7 39.7 27.0 32.8 28.5 46.0 23.8 35.4 21.6 34.5 24.2 28.6 28.1 34.2 38.3 21.2 33.0 32.5 32.8 29.8 22.7 20.3 33.9 20.3 17.3 23.0 35.3 41.0 33.1 17.6 26.4 41.1 22.6 18.7 18.7 33.5 21.5 22.9 21.5 19.1 36.1 17.8 11.1 16.8 20.1 17.4 39.9 23.3 19.4 27.0 40.7 32.5 23.9 79.1 25.9 36.9 18.7 19.0 21.3 20.1 24.9 24.4 32.8 21.7 25.4 24.0 39.7 35.7 49.7 29.8 26.3 41.8 25.4 33.6 25.3 44.9 44.5 13.4 31.7 43.0 18.8 19.8 20.1 23.7 15.8 19.5 32.4 29.5 58.6 34.7 28.1 32.0 27.9 17.3 19.8 17.1 30.1 22.7 39.7 33.9 34.3 34.4 17.7 31.1 41.0 39.7 3.5 35.3 23.0 20.3 35.6 33.1 38.0 40.3 27.9 43.7 34.6 33.7 31.5 34.6 39.7 21.2 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Cell line enhanced" "Detected in some" "HEL: 5.4;HMC-1: 7.2;U-266/70: 16.0;U-266/84: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.8 2.7 0.9 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.0 0.5 0.0 0.2 0.6 0.0 5.4 0.6 0.0 2.0 0.1 7.2 0.1 3.6 1.0 0.1 0.6 3.6 0.0 0.1 0.4 0.2 1.9 1.6 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.1 0.0 0.7 1.2 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.0 10.5 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell line enhanced" "Detected in many" "RT4: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Cytosol" Microtubules "HPA024693: " "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favourable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.4 5.0 15.3 2.3 3.4 5.0 9.8 12.2 18.4 6.0 5.1 2.8 5.8 1.8 11.3 6.0 7.5 4.4 10.3 1.5 21.7 4.6 1.3 9.6 22.1 17.4 6.4 0.8 6.8 1.2 3.4 5.4 11.6 3.1 4.1 0.4 4.6 7.8 1.9 15.1 1.6 37.5 8.5 4.6 4.5 6.8 4.7 6.0 8.8 5.1 9.1 2.8 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Cell line enhanced" "Detected in many" "ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favourable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 5.9 1.8 1.1 3.1 147.8 35.9 1.0 3.3 1.6 2.0 1.4 0.4 1.7 2.5 0.3 3.9 3.7 5.3 2.1 1.6 12.1 1.9 1.8 1.6 4.9 23.8 4.8 4.5 78.5 18.2 1.6 8.5 2.6 0.8 7.6 9.6 3.1 0.3 6.7 0.2 2.6 0.9 1.0 3.1 46.8 17.1 4.5 4.2 3.0 9.1 10.2 3.4 4.9 2.8 1.7 2.0 4.2 1.0 2.9 1.5 1.1 5.7 6.7 2.7 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell line enhanced" "Detected in all" "SK-MEL-30: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Lipid droplets" Nucleoli "Lipid droplets" "HPA011315: AB_1848344, HPA071021: " "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavourable (2.75e-4)" "prognostic unfavourable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 9.9 17.6 27.0 29.3 11.8 29.3 7.5 12.7 33.0 15.2 32.2 15.8 25.7 4.8 7.4 12.1 29.4 5.8 28.3 19.8 8.6 11.1 11.2 14.3 17.7 26.0 7.4 5.5 15.1 40.1 25.2 44.0 16.6 21.2 18.3 21.5 21.2 14.4 8.7 13.7 9.2 7.9 22.9 8.1 21.9 40.9 14.2 10.6 7.5 20.3 92.7 10.2 18.1 11.4 10.2 16.3 8.8 9.3 6.5 3.1 16.5 11.0 6.9 30.9 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" 100000 "Golgi apparatus" Mitochondria "HPA000286: , HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favourable (5.73e-4)" 29.5 31.1 16.3 25.5 18.0 9.2 30.0 13.9 22.8 34.7 10.5 8.8 4.6 10.0 13.7 11.7 11.2 10.7 20.1 20.3 27.6 20.3 31.2 9.6 27.8 29.6 15.2 19.0 13.1 8.8 16.7 12.9 33.9 21.1 9.7 9.7 8.0 10.7 11.0 42.5 9.1 9.0 15.8 24.6 17.0 12.9 17.7 9.7 9.5 12.8 8.5 11.9 19.5 21.0 2.2 6.5 20.3 10.9 2.2 4.0 3.8 13.7 4.4 5.5 5.9 20.7 13.0 4.3 20.1 22.3 19.7 20.5 4.3 9.6 9.8 7.8 14.5 3.9 4.7 19.4 31.0 3.4 4.9 38.7 6.3 45.8 9.5 9.2 80.3 11.2 7.6 22.5 16.4 14.7 1.1 12.1 22.5 0.9 8.0 12.1 6.9 8.0 5.8 10.1 8.1 28.2 4.4 3.6 2.8 24.0 0.0 12.4 0.3 9.8 27.2 18.0 5.1 28.4 18.4 6.0 6.9 9.2 31.7 20.6 11.4 15.5 7.0 20.3 2.8 9.8 2.0 2.2 2.5 2.2 6.5 2.2 2.0 2.4 19.8 2.2 10.9 2.6 4.0 3.8 16.3 18.0 13.9 22.6 27.6 20.3 15.2 19.0 21.1 9.7 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.4 0.2 0.2 0.0 0.8 0.1 1.0 0.3 2.2 0.0 0.1 10.4 42.4 14.0 2.6 0.5 0.1 0.0 0.0 0.2 11.6 0.0 10.9 0.4 18.1 2.8 16.9 18.5 1.9 0.0 0.2 0.0 0.8 0.0 6.3 0.0 0.0 0.0 7.8 0.0 0.4 3.8 0.0 8.5 1.1 43.4 0.0 0.2 16.9 6.5 0.0 0.0 9.5 12.3 0.1 0.1 0.7 0.7 4.6 0.0 6.8 0.3 21.2 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favourable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.6 1.6 1.1 1.6 8.3 8.8 12.2 7.0 5.4 1.9 3.4 4.2 6.5 0.0 7.9 3.0 8.9 2.9 17.6 1.4 0.0 2.8 16.3 0.8 2.0 6.1 1.5 9.0 6.0 3.8 2.9 2.7 3.0 10.3 1.2 2.7 1.3 0.5 7.1 0.8 19.9 4.3 7.6 25.7 6.7 1.2 1.0 5.3 8.5 6.3 6.8 3.1 3.6 11.5 2.3 3.2 4.2 2.3 11.1 8.1 3.8 6.6 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562880-179588408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavourable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavourable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavourable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 18.8 17.9 9.9 23.4 16.8 8.7 21.3 8.7 9.6 16.8 21.3 15.3 15.6 14.5 24.8 16.4 23.2 16.3 14.9 24.2 8.7 7.4 19.6 18.6 14.6 17.4 16.7 5.4 24.8 20.9 13.7 23.4 20.1 13.7 17.7 23.5 10.4 19.0 17.4 12.8 19.4 19.8 16.1 14.8 19.3 16.7 47.5 17.0 46.1 21.9 20.4 23.8 18.7 22.7 17.5 19.8 8.0 16.1 14.5 22.4 13.8 46.1 14.0 34.9 18.4 13.3 14.6 27.4 18.6 14.5 34.8 29.5 31.5 22.7 36.1 33.5 17.5 21.3 30.4 22.9 43.4 35.8 25.4 29.6 15.5 23.8 15.3 36.7 18.5 10.2 23.5 22.5 19.0 19.8 23.0 20.7 25.0 31.6 32.1 22.7 30.9 31.4 30.2 29.2 66.8 27.5 18.7 28.7 20.5 28.7 28.8 28.8 56.1 30.2 14.9 24.9 21.5 25.5 56.2 13.5 20.1 55.5 13.8 39.0 27.3 3.3 11.3 8.0 15.1 14.3 20.0 17.5 17.5 17.4 19.8 13.7 19.2 19.4 1.5 14.5 16.1 11.2 22.4 13.8 9.9 16.8 8.7 9.6 8.7 7.4 16.7 5.4 13.7 17.0 ACTN1 ENSG00000072110 "Actinin alpha 1" P12814 14 68874143-68979440 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 71.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004303, HPA006035" Approved Approved "Plasma membrane,Actin filaments,Focal adhesion sites" 780000000 "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB004303: AB_626633, HPA006035: AB_1078095" "unprognostic (4.40e-2)" "unprognostic (1.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (6.19e-3)" "prognostic unfavourable (7.63e-5)" "unprognostic (3.62e-1)" "unprognostic (3.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (9.08e-10)" "unprognostic (2.87e-2)" "unprognostic (2.00e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (8.00e-4)" 27.6 10.8 18.7 33.1 28.4 31.0 38.8 4.1 20.0 30.5 101.8 3.1 43.7 11.6 80.3 24.6 48.3 38.7 53.3 31.2 9.9 6.2 11.2 20.3 23.9 23.1 4.7 15.0 27.8 12.4 2.3 7.9 22.0 8.7 43.2 26.4 11.1 30.1 72.7 7.1 14.6 25.9 135.4 10.3 19.4 52.3 9.5 9.6 7.0 9.3 9.9 11.3 81.1 53.1 0.0 8.8 71.8 12.5 0.7 22.0 14.9 83.8 25.9 16.0 12.1 28.4 18.8 60.0 74.2 71.1 78.1 58.4 20.7 19.6 0.0 26.1 73.2 36.6 12.6 78.3 98.8 0.4 3.8 11.4 13.6 17.3 51.2 8.2 1.4 23.9 15.4 48.5 55.2 42.8 5.4 0.1 61.2 23.9 0.9 17.4 12.5 19.8 5.7 29.7 3.1 29.7 22.2 5.7 6.9 64.4 9.7 17.9 14.6 16.6 53.9 111.0 44.2 12.8 64.5 11.5 4.4 0.3 32.1 11.3 58.3 11.2 12.5 25.6 1.1 5.7 1.4 0.0 4.6 2.5 8.8 0.0 22.0 18.7 71.8 0.7 1.6 0.4 1.8 14.9 18.7 28.4 4.1 20.0 9.9 6.2 4.7 15.0 8.7 9.6 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731583 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" 230000000 "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favourable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 38.3 39.2 19.2 30.1 24.4 28.1 34.1 16.6 26.6 45.2 47.9 31.8 23.4 51.0 70.1 22.2 61.4 37.9 41.5 25.0 19.6 16.2 48.4 34.1 39.5 17.7 27.8 18.7 33.6 34.1 17.8 21.0 65.9 21.8 33.7 22.4 29.2 41.4 35.4 16.0 40.4 69.4 54.0 32.9 40.8 34.3 13.4 24.6 11.6 29.2 30.5 42.9 40.3 41.1 2.6 8.5 12.9 5.7 17.5 9.7 5.6 44.3 90.6 13.3 6.3 7.7 9.4 26.4 20.2 27.2 30.1 24.2 32.5 34.5 9.8 48.6 45.1 21.3 8.0 31.9 9.0 24.2 8.4 13.9 41.8 28.1 16.9 10.2 17.3 15.5 10.6 26.2 17.6 18.5 16.2 10.6 22.9 23.2 3.3 6.8 9.4 21.5 9.9 12.4 5.2 32.5 46.5 9.9 5.8 36.6 29.2 13.3 12.0 12.2 31.5 34.4 16.7 16.4 67.1 4.8 10.8 8.1 30.4 10.8 61.5 4.5 5.1 10.9 9.7 5.7 7.8 2.4 4.5 9.7 4.6 2.6 0.8 3.3 12.9 17.5 4.6 8.5 7.1 5.6 19.2 24.4 16.6 26.6 19.6 16.2 27.8 18.7 21.8 24.6 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "ARP6 actin related protein 6 homolog" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavourable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 7.6 8.0 12.6 6.6 13.8 5.6 20.5 14.8 20.2 10.3 9.9 10.2 6.9 7.5 8.6 7.2 10.4 9.6 5.9 8.1 15.2 15.7 12.3 12.5 8.2 11.6 13.8 15.4 9.9 5.9 15.8 14.0 11.6 21.2 11.0 10.6 6.7 7.7 12.2 8.3 6.8 9.2 8.3 12.8 9.6 7.3 13.9 14.6 13.4 9.6 5.8 11.9 11.6 8.6 6.1 6.1 4.6 5.8 7.9 10.9 6.6 17.8 7.0 9.0 10.9 8.9 11.0 18.3 5.0 8.8 8.4 5.8 5.0 5.3 9.4 7.0 7.9 5.8 13.0 8.2 15.3 8.9 11.8 5.8 7.2 5.4 9.7 8.8 5.9 6.5 10.0 7.1 9.2 11.4 10.0 3.8 11.6 3.9 11.7 9.9 8.7 8.8 7.3 8.7 11.0 11.3 10.3 7.8 13.7 9.2 19.6 9.0 12.8 8.5 5.7 5.1 3.8 6.8 5.4 6.3 16.1 12.1 3.6 5.8 7.5 3.8 2.8 4.6 8.0 5.8 9.9 6.0 8.8 7.5 4.1 6.1 10.9 10.0 2.1 7.9 4.5 6.1 7.7 6.6 12.6 13.8 14.8 20.2 15.2 15.7 13.8 15.4 21.2 14.6 ACTR8 INO80N ENSG00000113812 "ARP8 actin related protein 8 homolog" Q9H981 3 53867066-53882202 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 28.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065236 Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA065236: " "unprognostic (9.05e-2)" "unprognostic (2.06e-1)" "prognostic favourable (2.21e-4)" "unprognostic (2.97e-1)" "unprognostic (5.67e-2)" "unprognostic (1.88e-1)" "prognostic unfavourable (5.11e-6)" "unprognostic (2.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.82e-1)" "unprognostic (5.68e-2)" "prognostic favourable (7.88e-9)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.84e-1)" "unprognostic (1.15e-1)" 13.2 11.2 19.8 12.6 20.0 11.3 12.9 25.6 24.5 13.7 12.4 13.9 10.5 9.9 14.1 14.3 14.1 12.8 11.3 24.3 18.2 13.7 17.9 11.8 12.4 17.0 17.7 15.5 15.0 15.8 21.9 22.0 14.8 16.0 13.0 16.8 12.5 14.2 12.6 20.1 14.5 11.9 15.3 16.1 14.4 12.6 27.5 19.9 19.9 16.8 10.5 19.2 16.1 11.8 6.1 6.3 28.8 7.1 8.6 8.5 4.4 6.4 7.9 15.6 12.9 12.8 16.2 11.7 15.3 19.5 20.7 16.5 12.4 7.9 19.7 4.5 20.9 5.5 11.7 10.5 19.6 7.9 4.9 19.6 12.4 13.2 15.2 20.8 17.5 12.7 10.8 21.4 13.4 15.9 8.8 6.9 20.8 7.5 6.9 12.4 14.5 12.7 9.1 9.8 11.7 15.6 18.0 4.6 13.4 9.9 8.7 8.7 5.6 11.6 10.8 15.8 10.3 14.5 13.7 19.3 24.5 20.1 11.7 15.2 9.8 28.8 4.7 5.8 5.8 7.1 5.8 6.1 5.4 5.5 6.3 3.8 5.7 6.1 2.4 8.6 4.2 4.6 8.5 4.4 19.8 20.0 25.6 24.5 18.2 13.7 17.7 15.5 16.0 19.9 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: " "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavourable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.2 4.9 6.4 25.0 26.1 6.9 15.1 25.2 12.1 13.0 3.3 4.7 0.0 7.0 16.4 5.9 3.5 8.2 13.1 14.5 3.0 8.6 2.5 4.8 19.8 0.6 10.2 32.6 15.6 24.9 31.8 13.2 3.1 2.4 15.3 3.7 0.1 0.2 7.4 7.7 1.4 6.6 1.8 15.8 7.9 4.4 5.4 5.8 3.3 20.7 1.7 2.3 19.0 18.5 6.1 9.1 5.7 1.6 1.2 0.1 19.0 0.5 19.9 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 16.6;NTERA-2: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "CAB025115: , HPA007398: , HPA040384: " "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.6 1.4 0.6 0.4 8.9 0.3 0.5 0.3 0.7 2.4 1.1 0.1 1.3 0.4 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.6 3.5 0.8 3.0 1.6 0.7 0.9 0.5 1.8 1.1 7.0 1.4 0.3 1.3 5.1 1.9 20.5 0.7 1.7 5.5 1.0 1.1 2.0 3.9 6.8 0.5 2.5 2.2 1.4 4.0 0.9 0.6 2.7 0.4 1.4 4.0 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053221-75069483 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol 92000 Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favourable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 8.7 27.4 23.0 13.9 20.4 12.7 16.2 24.0 25.2 10.6 14.9 14.8 14.3 11.3 10.2 26.9 11.6 21.4 7.1 10.8 19.9 30.2 12.2 5.2 10.9 17.6 28.7 19.3 9.1 7.0 8.9 38.2 10.4 24.4 10.0 19.8 9.4 9.7 12.9 22.3 24.4 11.3 11.4 27.5 10.9 14.0 16.7 22.9 8.3 20.2 10.3 19.0 7.5 12.0 10.6 7.6 12.3 6.6 10.0 17.8 5.1 24.6 13.6 19.6 12.0 8.0 9.3 10.9 14.2 5.5 14.4 20.6 13.7 27.8 27.3 8.7 5.9 22.3 12.9 6.3 23.7 39.6 15.9 17.7 35.8 9.7 4.7 11.1 18.5 5.1 9.1 20.0 10.3 19.0 13.9 33.0 19.0 16.9 24.9 20.8 6.0 13.7 20.0 25.9 12.7 20.4 13.1 36.0 14.6 9.7 6.6 22.0 14.7 11.0 8.9 9.9 18.4 19.9 15.2 7.9 15.9 28.6 15.1 13.1 10.6 3.9 2.2 12.3 8.6 4.3 9.7 10.0 14.5 9.9 3.8 10.6 12.2 11.3 0.9 10.0 6.6 7.6 17.8 5.1 23.0 20.4 24.0 25.2 19.9 30.2 28.7 19.3 24.4 22.9 ADA ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0" "Cell line enriched" "Detected in many" 8 "MOLT-4: 197.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 64.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" 650000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavourable (6.77e-5)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 8.1 3.2 2.5 5.4 6.5 5.3 5.1 0.9 5.0 2.8 7.4 5.0 1.8 142.2 1.7 3.4 4.6 2.4 3.0 9.2 2.7 0.8 1.3 2.1 2.8 8.9 3.6 2.3 1.2 2.4 0.8 0.3 1.8 3.9 1.8 1.5 0.7 2.6 1.3 2.0 2.8 5.0 2.1 1.3 9.5 19.7 1.6 6.1 99.0 2.8 2.1 7.6 3.6 2.6 1.3 41.6 0.5 64.0 16.9 10.3 9.6 1.4 3.9 2.0 1.3 3.9 5.4 3.3 1.4 0.8 1.4 1.0 1.8 1.5 4.0 1.7 1.8 0.2 1.4 5.8 0.8 0.3 1.8 0.8 0.7 1.4 1.6 0.6 2.1 26.1 2.5 0.5 0.9 5.4 2.0 3.3 0.6 3.4 197.1 2.9 0.5 1.4 10.6 2.8 9.8 0.2 0.0 0.0 0.9 2.1 0.4 2.5 0.4 1.9 1.7 1.0 2.0 2.2 0.2 4.3 2.7 8.3 0.3 3.3 0.9 0.0 1.8 0.2 8.7 30.7 5.7 1.3 7.3 10.3 6.8 1.0 5.7 8.1 0.5 16.9 64.0 41.6 5.3 9.6 2.5 6.5 0.9 5.0 2.7 0.8 3.6 2.3 3.9 6.1 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavourable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 11.8 26.9 7.3 8.0 9.4 13.6 18.5 10.2 30.4 7.5 10.5 12.4 15.7 5.5 31.6 9.1 24.3 4.4 10.8 10.0 8.2 5.6 9.4 9.8 11.5 10.5 6.6 27.2 11.9 8.0 5.2 7.7 14.6 5.9 15.0 13.2 4.4 21.9 7.6 10.0 3.8 9.1 24.0 14.1 17.5 32.1 8.0 5.2 11.1 12.9 17.6 7.7 13.3 10.3 9.9 11.0 76.0 9.8 8.4 18.1 6.0 13.8 12.9 17.3 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell line enriched" "Detected in some" 8 "CAPAN-2: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" "Plasma membrane" Mitochondria "HPA074034: " "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favourable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.7 0.2 0.7 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell line enhanced" "Detected in some" "MCF7: 2.7;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: " "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.3 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 0.1 0.2 0.5 1.3 2.7 0.4 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.4 0.2 0.3 0.0 1.1 0.0 0.0 2.6 3.7 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell line enhanced" "Detected in some" "ASC diff: 30.7;ASC TERT1: 39.7;BJ: 13.5;BJ hTERT+: 23.2;fHDF/TERT166: 13.8;U-2197: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Uncertain "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA067152: , HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 39.7 0.1 13.5 23.2 4.0 7.9 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 6.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996869-39105144 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" 640000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavourable (1.14e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 36.7 25.0 14.7 21.7 13.6 10.4 17.1 20.9 14.4 21.8 24.4 13.2 21.8 19.4 24.9 19.8 24.1 15.5 31.7 28.5 12.5 10.1 29.4 11.6 39.2 20.3 19.2 12.9 17.6 11.1 37.5 10.4 30.1 15.8 23.8 23.8 15.4 44.5 21.4 18.3 12.8 25.4 32.8 22.0 25.7 33.2 13.7 12.7 2.4 24.0 14.9 11.7 34.8 19.2 0.6 8.1 3.4 11.4 3.1 0.8 2.8 41.1 29.8 11.8 7.2 19.1 61.6 15.3 55.9 61.1 31.4 29.4 14.1 29.9 2.1 21.1 38.4 17.6 5.0 39.5 60.9 2.0 5.1 2.2 20.7 12.2 38.7 1.6 4.8 47.4 23.5 30.9 35.2 42.7 4.3 14.0 65.3 4.0 1.6 1.0 1.7 9.6 1.4 21.3 7.1 51.0 11.8 1.6 2.4 14.9 17.9 13.6 14.5 3.0 73.4 24.0 23.1 45.3 25.6 4.5 6.9 2.3 39.8 2.7 16.3 1.4 11.4 2.2 0.6 6.1 0.3 0.1 0.3 0.8 8.1 0.6 0.1 0.6 3.4 3.1 2.6 2.7 0.4 2.8 14.7 13.6 20.9 14.4 12.5 10.1 19.2 12.9 15.8 12.7 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892192 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.3;BJ hTERT+: 15.7;hTEC/SVTERT24-B: 22.6;U-2 OS: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: " "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavourable (6.78e-4)" 13.7 5.4 0.2 2.5 0.8 0.0 17.6 0.3 1.0 6.0 3.0 2.3 2.6 0.6 13.0 4.4 1.4 3.1 5.9 1.4 0.3 0.6 2.0 2.1 9.4 4.2 1.2 0.2 4.9 8.7 1.2 0.9 5.5 2.1 6.7 1.4 2.7 4.4 4.2 4.1 2.0 1.6 9.4 6.5 0.6 1.8 5.0 0.3 0.1 2.6 4.1 1.6 4.3 7.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.9 0.4 11.7 0.0 17.3 8.3 0.0 6.0 15.7 8.0 9.8 0.0 0.0 0.0 0.0 4.2 0.4 0.3 7.9 11.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 6.5 0.0 22.6 5.9 0.0 0.0 0.0 12.9 0.0 0.0 0.0 2.4 0.0 0.0 13.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 17.5 0.1 3.6 2.0 1.5 0.0 12.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.3 1.0 0.3 0.6 1.2 0.2 2.1 0.3 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favourable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.6 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.2 3.3 0.0 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.9 0.1 0.0 0.3 0.1 0.0 0.0 6.2 0.2 0.0 0.8 0.4 1.2 0.1 0.1 0.3 1.7 2.5 0.5 3.3 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 3.3 4.9 9.1 2.1 0.5 0.2 0.1 4.7 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 12.1;TIME: 3.7;U-87 MG: 7.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 8 "MCF7: 11.7;SH-SY5Y: 27.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" "Vesicles, Midbody" "HPA056171: , HPA058438: " "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110851-179345430 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 24.2 4.3 0.9 5.8 0.7 0.7 29.1 0.9 2.3 16.3 10.1 0.4 3.9 2.7 12.0 9.5 6.0 7.2 9.5 10.1 0.7 1.2 4.2 7.4 13.1 25.9 1.0 1.3 6.3 2.7 1.0 8.7 15.1 2.4 6.0 2.6 3.8 2.5 3.8 3.8 4.6 4.6 13.8 0.7 16.5 4.2 4.3 0.5 0.8 3.2 5.9 1.2 8.8 14.7 1.4 1.3 2.1 0.3 0.8 0.6 0.1 0.0 0.0 0.0 0.3 13.7 13.7 0.0 12.1 2.0 4.6 4.9 0.0 0.0 0.0 0.1 14.2 0.0 0.7 0.0 2.0 0.0 0.6 0.0 0.0 0.9 44.5 0.0 0.0 35.5 0.0 1.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.5 0.0 0.0 0.1 0.0 3.9 0.0 7.7 1.2 10.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.5 0.3 0.4 0.6 0.2 0.3 0.6 0.5 0.4 1.3 1.4 0.5 0.5 2.1 0.8 0.1 0.8 0.5 0.1 0.9 0.7 0.9 2.3 0.7 1.2 1.0 1.3 2.4 0.5 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 51.4" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: " "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 51.4 4.7 5.6 12.0 11.5 0.5 15.2 3.9 8.0 10.4 10.4 2.8 7.2 1.6 13.9 5.6 6.8 7.7 8.2 29.6 5.7 2.7 9.0 3.1 11.5 7.7 6.8 0.3 17.4 9.9 17.2 2.4 30.5 12.4 7.4 3.2 0.7 3.5 4.3 10.8 2.6 3.2 12.2 12.6 4.4 4.6 3.1 5.9 0.0 6.4 3.7 1.6 19.6 29.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 3.5 1.0 0.0 0.0 0.2 9.4 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.0 11.2 0.1 0.0 52.2 0.0 0.0 0.0 0.0 0.2 2.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 11.5 3.9 8.0 5.7 2.7 6.8 0.3 12.4 5.9 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.5;BEWO: 62.2;HSkMC: 13.9;K-562: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavourable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.5 0.1 0.1 1.2 6.0 29.5 62.2 6.3 5.6 3.8 2.2 0.5 2.5 0.0 1.3 4.3 3.3 0.2 0.9 1.5 0.5 0.1 1.8 0.7 2.6 4.8 0.0 0.9 13.9 0.2 0.9 2.1 0.0 19.9 0.1 0.6 0.1 0.0 0.3 1.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 4.9 0.0 1.4 3.4 1.1 0.2 1.8 2.6 0.1 0.5 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell line enhanced" "Detected in many" "A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favourable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 35.6 1.3 0.0 1.2 0.5 0.0 0.4 1.1 0.0 0.3 0.1 14.2 25.7 0.0 3.5 0.2 16.3 1.9 2.7 0.1 0.2 1.5 0.0 2.2 8.0 0.6 0.2 24.6 0.6 7.6 0.0 0.0 0.0 0.1 0.0 0.0 11.4 0.0 9.6 1.1 0.0 4.8 0.0 0.1 1.9 8.6 1.1 0.3 1.1 0.4 0.1 9.2 41.9 0.2 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 1.3 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase, RNA specific" P55265 1 154582062-154627999 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB056157: , HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavourable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 36.1 33.1 30.3 36.6 44.4 43.1 29.7 41.4 50.8 30.7 28.2 33.3 19.9 31.4 38.0 26.5 27.7 32.9 28.9 24.0 25.7 38.1 31.5 36.0 34.7 41.3 27.3 32.6 39.2 29.5 46.2 38.4 33.9 39.8 28.8 31.1 32.2 36.7 30.2 14.0 27.0 40.6 36.3 24.4 47.7 29.1 21.9 26.9 57.6 32.8 16.7 41.9 29.7 27.6 7.8 6.1 25.1 8.6 6.4 9.7 5.6 26.1 30.3 26.0 32.0 26.3 27.3 31.0 18.0 36.3 60.5 52.6 26.1 25.8 47.2 29.2 28.8 25.5 33.2 34.3 30.8 45.8 16.7 24.6 21.5 14.8 28.7 34.7 27.3 26.5 25.1 31.0 31.8 31.0 23.2 36.3 21.1 32.0 41.9 17.9 43.0 22.9 40.1 21.4 37.9 20.8 29.2 25.9 30.9 31.2 50.4 37.0 33.9 42.7 28.2 21.8 21.4 17.9 20.9 43.1 47.1 50.7 21.1 22.9 24.5 6.9 6.6 12.0 9.4 8.3 8.8 7.8 9.4 9.7 6.1 6.2 8.8 8.6 25.1 6.4 8.6 5.5 7.1 5.6 30.3 44.4 41.4 50.8 25.7 38.1 27.3 32.6 39.8 26.9 ADARB1 "ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1" ENSG00000197381 "Adenosine deaminase, RNA specific B1" P78563 21 45073853-45226560 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 59.9" "Cell line enhanced" "Detected in many" "HeLa: 27.3;HHSteC: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029645 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029645: AB_10602106" "unprognostic (2.69e-1)" "unprognostic (7.65e-2)" "prognostic unfavourable (8.16e-5)" "unprognostic (1.82e-2)" "unprognostic (1.07e-2)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (6.97e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.44e-1)" "prognostic unfavourable (3.56e-4)" "unprognostic (4.57e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-2)" "unprognostic (2.38e-2)" 12.2 5.3 7.1 10.4 8.4 4.5 8.9 33.1 11.6 11.7 17.2 2.5 5.6 2.9 13.4 6.6 14.0 8.8 11.1 6.7 7.3 8.1 4.6 4.0 19.9 11.8 7.4 8.1 5.3 4.7 19.0 3.7 12.0 13.6 14.7 5.0 11.0 4.6 8.7 11.8 10.8 5.9 59.9 3.5 10.5 11.7 3.8 4.0 3.9 3.8 4.5 8.4 34.6 20.3 6.1 2.1 4.8 0.6 0.5 2.6 0.5 3.1 0.4 2.4 2.9 3.0 2.1 3.3 2.1 3.5 6.7 4.3 4.9 0.5 1.0 5.7 10.3 0.3 3.6 8.7 7.5 0.7 3.2 6.8 27.3 3.2 31.7 4.6 3.3 11.3 3.8 2.4 7.1 7.1 1.5 0.4 19.6 2.3 3.0 4.4 4.0 4.7 0.9 2.3 3.1 1.5 1.0 14.4 3.8 16.7 0.7 5.3 1.6 3.7 7.4 2.2 2.7 9.0 7.8 3.1 1.4 0.8 2.0 10.9 11.9 1.3 0.2 4.8 1.1 0.6 1.8 2.4 2.6 1.6 0.0 6.1 1.8 1.4 0.2 0.5 0.3 2.1 1.6 0.5 7.1 8.4 33.1 11.6 7.3 8.1 7.4 8.1 13.6 4.0 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase, tRNA specific 2" Q7Z6V5 6 143422832-143450673 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 7.3 9.5 6.6 15.1 9.4 17.1 8.6 7.7 8.8 6.6 9.5 4.9 4.7 9.9 8.3 5.3 12.0 7.9 7.6 4.2 5.2 3.8 7.5 13.2 11.3 17.6 4.9 8.0 7.5 13.3 7.1 9.6 4.0 7.3 8.6 13.3 6.0 10.1 6.2 13.3 17.1 10.0 6.5 6.7 13.1 10.8 4.1 5.3 8.6 10.8 10.1 13.5 6.6 8.7 2.8 3.2 0.4 1.4 1.9 6.6 2.3 2.9 2.5 3.1 10.5 2.6 8.4 4.7 4.1 1.9 2.9 4.0 6.6 7.5 10.4 4.5 2.8 8.5 5.8 5.8 5.7 5.5 12.9 14.7 10.4 13.5 3.3 20.6 7.4 2.8 8.7 5.6 9.0 6.2 16.0 9.0 4.4 4.2 8.0 11.7 3.9 4.7 9.8 9.1 8.5 4.4 3.3 6.9 4.7 3.5 9.4 2.8 4.0 7.6 4.8 4.2 3.6 8.7 8.0 9.3 6.6 7.9 4.0 17.4 4.9 0.0 0.9 0.0 3.2 1.4 4.7 2.8 3.0 2.9 3.2 2.0 3.4 5.1 0.4 1.9 0.2 3.0 6.6 2.3 6.6 9.4 7.7 8.8 5.2 3.8 4.9 8.0 7.3 5.3 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favourable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 15.9 11.5 2.7 12.7 10.0 11.4 16.4 8.3 10.1 8.7 5.8 10.5 11.3 21.4 12.6 5.8 13.2 13.8 9.4 2.6 15.8 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 28.9 4.9 6.9 7.4 7.9 10.5 3.1 19.9 22.4 7.4 4.0 12.5 17.7 0.1 10.4 4.7 16.0 10.8 7.5 11.4 16.6 11.4 14.7 6.1 7.8 10.9 3.8 18.0 16.0 7.3 11.2 15.8 16.0 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 4.1 10.0 4.8 8.9 4.5 4.5 4.3 11.5 9.1 4.6 18.3 2.8 7.6 19.1 5.8 4.2 7.2 4.2 6.3 3.8 3.9 4.1 4.8 6.9 3.7 5.0 3.4 8.4 5.5 5.6 4.7 4.1 3.7 4.5 4.7 4.0 4.6 7.4 4.7 5.6 8.3 17.0 2.7 2.4 6.7 5.6 7.7 3.8 6.8 4.1 4.9 6.1 5.1 5.0 4.7 6.3 2.5 5.4 1.8 4.1 2.8 3.8 4.8 1.0 3.3 0.9 0.8 5.7 3.3 1.8 2.6 0.9 5.2 4.2 1.7 2.3 0.7 5.1 0.2 3.5 0.2 4.3 1.6 4.4 3.6 5.8 2.6 1.0 3.4 1.3 2.1 0.9 0.8 1.8 2.9 3.0 1.5 10.1 3.2 4.4 0.6 3.6 4.2 1.6 3.0 1.7 3.6 0.7 1.8 4.8 3.9 2.7 3.3 3.0 1.2 1.4 5.1 3.5 2.2 1.4 0.4 1.5 3.2 3.8 2.0 1.8 4.2 2.5 2.3 5.4 3.0 1.8 2.8 1.8 6.3 4.7 2.9 1.5 0.7 1.8 5.0 4.0 4.1 2.8 4.8 4.5 11.5 9.1 3.9 4.1 3.4 8.4 4.5 3.8 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" 1400000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favourable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favourable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 44.0 31.7 43.1 27.9 52.1 26.7 35.6 46.3 66.6 37.5 43.3 47.2 27.3 30.8 47.9 29.2 35.1 43.0 33.1 41.1 39.5 34.1 36.8 23.4 38.0 27.9 40.5 46.7 65.3 25.0 31.3 28.4 31.2 44.7 43.1 30.7 36.3 26.2 54.9 69.5 25.5 33.6 58.1 33.8 34.9 32.6 25.2 37.0 25.5 27.9 19.6 28.5 45.3 34.9 21.3 16.2 21.5 6.5 16.4 12.9 9.1 18.3 15.4 36.7 18.9 54.4 40.7 13.8 31.2 37.5 32.6 27.6 22.6 23.4 9.6 16.4 53.4 11.8 27.4 26.2 27.3 12.3 12.6 27.2 13.4 21.8 26.6 16.1 19.4 40.1 24.6 28.6 11.5 40.5 28.2 23.4 37.0 10.8 49.6 22.6 20.6 21.9 22.0 20.3 11.3 23.8 40.8 22.0 28.6 22.5 9.2 19.3 21.6 15.4 48.8 26.7 13.8 21.8 25.7 18.8 15.2 12.3 25.7 20.1 25.7 11.0 4.8 21.5 12.9 4.5 11.8 16.1 7.2 10.8 7.5 21.3 6.8 8.1 6.7 16.4 6.5 16.2 9.2 9.1 43.1 52.1 46.3 66.6 39.5 34.1 40.5 46.7 44.7 37.0 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell line enhanced" "Detected in some" "HAP1: 14.1;K-562: 18.5;NTERA-2: 36.5;RPMI-8226: 17.4;SCLC-21H: 18.1;U-251 MG: 19.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: , HPA034510: " "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.0 8.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.1 0.0 14.1 0.0 0.0 0.0 8.3 0.7 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.1 0.6 36.5 0.2 0.0 0.2 17.4 2.4 0.0 18.1 8.2 8.9 0.0 0.0 0.0 4.3 0.3 0.0 0.4 0.0 19.2 5.9 6.9 0.0 0.3 2.9 3.2 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036340: , HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell line enhanced" "Detected in some" "BJ: 5.0;fHDF/TERT166: 5.7;HeLa: 10.3;HHSteC: 6.6;HMC-1: 14.2;U-2 OS: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" HPA042395 Uncertain Approved Nucleoplasm,Cytosol 600000 "Nucleoplasm, Cytosol" "HPA042395: AB_10796906" "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.5 0.0 0.0 0.1 5.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 6.6 0.0 14.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.5 7.0 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell line enhanced" "Detected in some" "HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" HPA055200 Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.6 1.7 0.3 0.1 0.0 0.2 0.2 10.1 3.2 0.2 0.5 3.7 16.3 0.8 1.4 3.6 0.6 0.1 2.3 0.4 1.2 0.5 1.3 9.8 0.4 0.2 0.1 1.4 7.2 0.0 0.3 0.1 0.2 2.1 1.7 0.4 0.3 4.7 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.2 1.0 12.9 0.5 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell line enhanced" "Detected in some" "A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.1 0.0 0.0 0.1 0.9 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.4 0.2 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.7 2.0 0.0 0.1 4.4 0.0 1.2 2.3 7.0 1.5 0.1 0.0 0.1 0.1 0.1 0.2 0.4 15.3 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 0.4" "Low region specificity" "Detected in single" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favourable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306160-81992436 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 62.8;hTEC/SVTERT24-B: 31.2;NTERA-2: 26.3;SH-SY5Y: 42.1;U-2197: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane,Cell Junctions" 280000 "Plasma membrane, Cell Junctions" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavourable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 8.9 10.5 21.1 3.6 20.9 0.0 8.8 1.5 45.8 7.5 7.0 1.4 1.2 2.7 6.1 8.6 12.0 12.0 11.5 17.6 12.2 6.6 10.9 18.7 32.7 3.5 3.5 22.8 18.8 4.9 20.3 11.8 24.4 6.2 15.6 5.4 9.4 19.1 10.1 2.0 6.3 6.1 6.0 3.2 10.0 7.6 2.0 3.3 0.6 22.4 15.0 5.0 6.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.3 62.8 0.0 7.8 8.9 0.8 1.5 3.5 0.6 0.7 0.0 0.0 0.0 17.2 8.0 2.5 5.0 6.6 0.5 0.1 10.2 0.0 1.8 4.4 2.9 0.0 0.1 7.6 0.4 31.2 3.1 10.3 0.0 0.0 0.8 0.0 0.0 0.0 26.3 1.8 0.0 8.6 0.0 14.3 0.9 3.1 42.1 0.0 1.7 0.0 0.1 18.5 6.7 6.4 7.3 28.7 2.2 0.0 0.0 0.0 3.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 20.9 1.5 45.8 12.2 6.6 3.5 22.8 6.2 3.3 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell line enriched" "Detected in some" 5 "ASC diff: 10.9" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: , HPA060902: " "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favourable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 10.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell line enriched" "Detected in some" 7 "ASC diff: 385.0" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" 16000000 "Plasma membrane, Cytosol" "HPA047814: , HPA060902: " "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavourable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 385.0 56.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336492-99353027 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 47.1;liver: 149.4;stomach 1: 43.1" "Group enriched" "Detected in some" 4 "ASC TERT1: 5.1;HSkMC: 15.1" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" 9700000 "Plasma membrane, Cytosol" "HPA047814: , HPA060902: " "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favourable (4.55e-4)" "prognostic favourable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 4.7 0.0 0.0 18.5 0.0 0.0 1.1 0.0 0.0 1.1 37.9 0.0 1.1 43.4 0.3 1.2 1.7 0.0 12.0 2.0 0.0 8.3 149.4 1.1 0.0 0.2 0.0 1.1 11.4 0.0 0.0 0.0 0.0 2.5 13.6 0.0 1.1 0.8 6.0 0.0 47.1 0.9 0.5 0.0 43.1 1.6 0.0 0.0 0.5 2.0 0.2 1.3 0.7 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.0 2.2 0.0 0.1 1.7 5.1 1.1 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.5 1.4 0.3 15.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.9 0.4 0.1 0.1 0.9 2.1 0.9 0.0 0.4 1.6 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.6 0.3 0.2 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell line enriched" "Detected in some" 11 "Hep G2: 21.9" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favourable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.3 0.0 0.2 0.4 0.2 0.1 0.5 0.8 21.9 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.1 0.4 1.0 0.1 0.3 0.3 0.6 0.3 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.5 0.0 0.4 0.5 0.2 0.4 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7" "Group enriched" "Detected in some" 7 "ASC TERT1: 3.9;HaCaT: 4.4" "Group enriched" "Detected in some" 17 "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 68.7 30.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497361-3519736 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 127.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: " "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 13.5 19.1 10.8 9.0 11.5 6.4 15.1 5.2 9.2 12.5 60.6 9.3 29.9 27.3 11.7 17.8 16.3 11.4 35.5 49.5 9.0 7.9 42.6 127.7 10.8 12.4 11.3 9.4 12.8 14.7 9.2 8.4 18.7 9.6 24.5 11.8 10.7 22.7 27.0 43.1 7.9 38.9 17.3 11.7 16.6 18.3 8.0 7.9 4.9 12.9 18.9 10.4 14.7 17.9 14.2 37.8 64.7 26.5 10.1 17.7 32.2 12.0 14.7 13.3 10.6 46.7 22.8 24.9 25.2 32.6 27.4 19.9 20.9 13.8 5.7 39.9 26.7 11.0 15.7 11.8 14.1 10.2 35.1 17.6 9.5 33.8 39.1 18.2 39.5 25.2 15.7 12.8 16.0 17.2 13.1 10.0 21.5 27.1 6.1 32.1 11.6 23.0 6.5 8.5 32.4 19.0 18.0 14.9 15.0 13.9 14.7 9.6 15.6 19.3 14.3 18.9 7.7 9.2 14.1 9.9 23.9 23.4 13.9 28.3 9.9 14.2 26.5 64.7 6.3 25.2 6.8 14.2 14.9 5.9 25.6 11.2 17.7 5.9 12.3 10.1 22.0 37.8 13.8 32.2 10.8 11.5 5.2 9.2 9.0 7.9 11.3 9.4 9.6 7.9 ADIRF "AFRO, APM2, C10orf116" ENSG00000148671 "Adipogenesis regulatory factor" Q15847 10 86968192-86983934 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 25.2;HaCaT: 65.1;PC-3: 35.5;RT4: 45.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 11 "T-cells: 3.9" "Low region specificity" "Detected in many" HPA026810 Approved Supported Nucleoplasm,Cytosol 580000 "Nucleoplasm, Cytosol" "HPA026810: " 123.4 9.5 15.7 21.4 6.1 1.5 109.7 1.6 8.4 44.3 65.3 6.8 21.6 66.2 25.3 34.6 24.3 34.7 29.9 24.8 17.3 6.1 20.3 10.3 32.5 5.4 10.5 9.3 54.7 12.6 7.2 11.7 8.7 7.2 38.6 7.0 23.6 41.5 38.8 30.5 23.7 69.5 19.8 9.6 10.0 12.2 12.5 9.9 1.2 29.7 38.6 8.3 39.5 41.6 0.0 0.3 0.0 0.3 0.0 3.9 0.6 25.2 0.3 0.0 0.0 2.1 12.4 1.7 8.8 9.5 0.0 0.0 0.9 3.2 0.0 0.3 10.8 65.1 0.0 2.1 0.1 0.9 0.0 0.0 2.7 0.2 1.2 0.0 0.4 0.3 4.1 0.0 5.8 3.6 0.1 3.5 0.3 3.1 0.1 0.6 0.1 35.5 0.1 0.0 0.3 0.4 45.2 1.6 0.1 3.0 13.5 0.1 16.7 0.3 9.6 0.3 2.0 1.7 0.0 0.5 0.4 0.0 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.3 0.0 3.9 2.8 0.0 0.0 0.0 0.0 0.2 0.6 15.7 6.1 1.6 7.9 17.3 6.1 10.5 9.3 7.2 9.9 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409" Approved Supported Nucleoplasm,Cytosol 320000 "Nucleoplasm, Cytosol" "CAB032876: AB_2242229, HPA038391: , HPA038409: AB_10675798" "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (1.93e-4)" "prognostic favourable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 37.5 8.5 9.0 12.0 9.0 13.9 20.7 32.6 25.9 25.3 28.4 23.7 39.2 19.7 8.2 13.1 34.4 10.5 34.7 40.6 13.2 12.1 12.5 13.9 25.5 10.3 20.0 5.1 12.8 23.0 18.4 45.9 22.0 9.9 6.4 19.0 21.0 23.5 27.1 2.5 60.0 22.7 15.6 16.9 27.7 20.7 7.1 8.4 14.3 55.8 10.8 37.1 15.1 18.8 8.4 15.5 22.4 26.9 9.2 10.4 22.2 15.9 28.8 5.1 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 ADNP2 "KIAA0863, ZNF508" ENSG00000101544 "ADNP homeobox 2" Q6IQ32 18 80109031-80147523 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007126 Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA007126: AB_1080729" "unprognostic (4.93e-2)" "unprognostic (1.45e-1)" "unprognostic (1.05e-2)" "unprognostic (2.25e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.24e-1)" "unprognostic (6.05e-2)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "prognostic favourable (6.39e-5)" "unprognostic (8.64e-2)" "unprognostic (3.59e-1)" "prognostic unfavourable (9.90e-4)" "unprognostic (5.19e-2)" 11.3 8.8 9.1 7.6 10.4 40.5 10.9 8.4 12.5 7.7 8.6 14.4 7.1 10.8 10.2 13.5 12.5 10.0 11.1 10.2 9.8 7.0 8.4 11.3 10.3 11.6 8.0 10.4 12.7 10.4 12.7 12.4 11.4 10.4 9.2 8.2 12.6 9.1 8.9 4.0 16.5 9.7 13.1 10.1 8.7 11.2 24.4 6.7 14.3 10.1 8.1 10.4 11.3 10.8 2.4 2.3 1.7 3.0 1.4 4.4 1.5 11.1 8.7 18.3 13.4 4.1 5.9 13.8 8.2 9.2 9.7 12.2 8.1 5.7 0.1 3.1 6.4 10.2 17.7 10.4 10.5 10.1 8.8 15.7 6.7 8.9 7.6 22.9 17.5 6.1 9.8 9.9 13.4 9.7 15.1 16.6 5.6 7.8 21.0 4.7 12.4 10.2 7.9 20.4 7.9 5.8 14.9 12.4 16.0 9.2 9.0 6.3 8.8 17.4 6.4 11.5 28.8 4.8 8.9 6.0 10.9 23.1 7.7 9.6 7.7 0.0 1.1 0.7 3.4 1.7 2.4 2.4 4.4 2.9 0.6 1.1 2.4 4.1 1.7 1.4 3.0 2.3 2.1 1.5 9.1 10.4 8.4 12.5 9.8 7.0 8.0 10.4 10.4 6.7 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 15.7;HEL: 11.3;HMC-1: 12.7;Karpas-707: 17.3;U-266/70: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB001701: , HPA036961: " "prognostic favourable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 14.3 8.5 2.3 10.9 4.6 2.5 14.8 1.2 2.4 7.1 6.2 4.7 14.6 1.9 7.9 6.2 5.0 5.4 6.6 8.4 2.3 2.4 5.1 5.5 17.4 18.9 3.7 2.7 3.6 11.9 8.1 2.8 23.0 4.0 6.3 3.9 6.8 6.5 14.5 19.7 3.1 6.4 8.8 4.7 13.6 5.1 4.1 3.6 5.3 7.4 5.8 12.0 7.1 6.9 8.2 8.0 13.3 13.0 3.4 9.6 4.9 1.5 2.0 0.4 0.0 1.7 1.9 0.0 1.4 0.3 1.2 1.6 0.6 1.3 0.4 0.6 2.1 0.1 1.4 0.0 1.1 15.7 0.1 11.3 0.2 0.0 2.7 0.0 12.7 2.8 0.0 0.6 0.0 4.9 1.0 17.3 7.4 0.5 0.0 2.7 4.7 3.9 0.0 5.6 0.7 0.7 0.6 0.3 0.0 0.0 0.1 4.2 3.0 7.0 4.0 0.0 0.8 3.1 0.3 16.9 3.7 0.0 2.1 0.0 3.1 7.8 13.0 13.3 0.6 12.0 0.6 8.2 1.4 1.3 8.0 4.9 0.2 0.6 0.4 3.4 9.2 7.0 9.6 4.9 2.3 4.6 1.2 2.4 2.3 2.4 3.7 2.7 4.0 3.6 ADRM1 "ARM1, GP110, Rpn13" ENSG00000130706 "Adhesion regulating molecule 1" Q16186 20 62302093-62308862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042266 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042266: AB_10794044" "unprognostic (5.49e-2)" "unprognostic (5.14e-3)" "unprognostic (7.34e-2)" "unprognostic (6.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-3)" "unprognostic (2.14e-2)" "unprognostic (3.56e-2)" "unprognostic (2.13e-3)" "unprognostic (8.98e-2)" "unprognostic (3.50e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (4.15e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.47e-2)" 22.9 22.9 14.8 23.4 16.8 30.5 17.0 24.1 29.3 14.7 16.9 18.8 12.4 24.0 19.9 15.3 23.9 14.0 20.4 24.6 14.6 15.1 21.7 54.5 15.7 22.1 15.5 13.4 17.2 34.9 9.5 13.4 27.6 21.4 14.8 7.9 14.8 21.0 18.3 86.6 26.4 19.5 17.3 15.4 23.5 20.1 30.0 10.1 23.8 16.4 29.1 29.4 17.3 14.6 79.2 67.2 69.4 78.0 51.7 77.6 70.9 33.7 37.8 10.6 22.6 10.2 7.5 28.9 22.3 15.2 41.9 16.8 112.7 35.8 18.2 40.8 12.7 38.2 13.4 32.8 12.9 21.2 27.3 44.1 27.4 59.4 17.2 22.7 42.1 9.4 20.2 27.3 10.9 16.2 32.2 19.9 9.6 45.4 28.5 44.6 36.0 56.5 23.0 18.7 28.8 11.2 25.4 19.0 23.7 24.1 38.3 26.8 26.6 25.1 23.7 41.9 44.4 40.8 44.7 42.5 33.4 24.3 44.1 22.9 30.3 48.3 66.3 69.4 66.0 78.0 58.9 79.2 59.8 62.7 67.2 75.5 45.1 51.4 62.2 51.7 65.0 62.7 77.6 70.9 14.8 16.8 24.1 29.3 14.6 15.1 15.5 13.4 21.4 10.1 ADSS ENSG00000035687 "Adenylosuccinate synthase" P30520 1 244408494-244452134 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024400 Supported Supported "Plasma membrane,Cytosol" 620000 Cytosol "Plasma membrane" "HPA024400: AB_1844623" "unprognostic (4.24e-3)" "unprognostic (2.63e-1)" "unprognostic (3.95e-2)" "unprognostic (8.68e-2)" "unprognostic (6.91e-2)" "unprognostic (2.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" 19.4 17.8 23.2 23.8 31.2 29.2 26.3 18.3 26.3 20.9 20.9 35.9 27.1 21.1 18.9 23.3 27.7 18.3 15.8 9.8 24.9 23.4 25.1 19.3 19.2 21.2 42.5 16.6 20.9 21.2 26.6 17.7 21.0 34.9 19.8 22.7 13.1 25.0 21.7 11.0 26.5 23.2 22.9 29.3 24.9 24.7 48.9 36.7 26.7 26.3 17.9 24.8 26.5 21.8 10.9 13.6 24.6 21.3 15.5 16.0 11.9 25.4 14.1 12.3 10.8 14.4 20.7 22.7 25.8 21.7 18.5 14.1 18.5 24.7 22.8 17.1 19.8 19.3 13.4 16.8 20.8 16.9 23.7 15.2 14.1 14.0 17.4 35.8 19.6 14.1 20.4 17.2 17.5 66.0 26.3 17.0 18.4 6.1 23.0 24.1 32.7 15.6 21.3 11.7 24.6 30.7 15.9 16.7 14.7 21.9 20.4 25.7 14.1 19.1 28.8 17.2 9.4 19.8 26.7 20.6 27.0 17.2 14.2 42.1 25.3 24.6 15.8 13.0 15.0 20.5 16.0 10.9 13.7 12.8 13.6 8.6 11.8 13.3 11.9 15.5 21.3 5.5 14.7 11.9 23.2 31.2 18.3 26.3 24.9 23.4 42.5 16.6 34.9 36.7 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: , HPA063595: , HPA064970: " "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 35.0 12.4 0.2 46.1 30.4 5.2 1.1 0.0 0.0 1.2 5.1 49.4 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 2.3 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 16.6 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.2 0.1 3.3 8.1 0.0 21.4 0.1 0.0 0.2 0.2 24.3 0.1 0.0 28.3 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favourable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.2 13.9 11.9 6.2 7.5 29.5 17.8 16.3 13.7 16.9 18.2 9.7 21.5 5.7 9.7 7.2 51.2 14.4 11.6 5.2 20.2 11.5 9.0 30.1 15.2 9.5 11.6 9.2 12.7 17.1 14.1 11.4 18.1 12.2 16.7 11.6 11.7 8.0 33.5 12.9 15.4 9.9 15.9 5.7 10.8 11.0 10.1 7.2 8.2 13.7 6.8 10.9 10.4 14.0 19.6 5.7 23.9 23.7 15.9 18.4 12.9 10.7 27.4 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 AFAP1 "AFAP, AFAP-110" ENSG00000196526 "Actin filament associated protein 1" Q8N556 4 7758714-7939926 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Group enriched" "Detected in many" 5 "granulocytes: 6.0;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015642, CAB024712" Enhanced Supported "Actin filaments,Focal adhesion sites,Cytosol" "Actin filaments, Cytosol" "Focal adhesion sites" "CAB024712: , HPA015642: AB_1844632" "unprognostic (1.12e-1)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (7.29e-2)" "unprognostic (2.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (2.84e-4)" "unprognostic (2.00e-1)" "unprognostic (3.39e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (8.18e-4)" "unprognostic (1.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.44e-2)" 14.0 3.9 9.5 11.6 10.2 1.0 15.8 10.3 12.2 11.0 17.8 4.4 6.5 6.7 18.7 6.6 13.1 9.0 14.7 11.0 7.1 5.8 5.2 1.8 8.7 5.3 4.7 6.9 12.1 6.6 31.9 13.0 14.4 5.6 10.3 11.7 12.4 9.6 12.7 5.7 5.8 8.8 32.1 8.3 4.6 8.4 21.7 3.2 3.3 8.6 5.6 6.1 16.2 13.1 0.0 0.0 6.0 0.9 0.0 2.9 1.5 10.3 7.7 5.5 4.3 5.3 9.7 7.2 15.4 22.9 14.9 13.7 2.4 2.4 0.0 5.2 24.9 5.0 2.9 6.2 9.8 0.2 1.9 0.0 11.1 1.4 15.0 0.0 0.1 6.0 4.7 18.5 12.2 17.8 0.2 2.3 7.7 3.3 0.1 0.0 2.3 14.9 0.0 4.1 0.5 1.6 1.3 10.8 18.1 5.3 3.7 4.1 1.3 0.1 42.0 18.2 4.1 23.6 7.5 0.0 0.0 0.0 6.5 0.0 20.7 0.0 0.9 6.0 1.1 0.2 1.4 0.0 1.6 1.5 0.0 0.0 2.9 1.3 2.3 0.0 0.1 0.0 1.3 1.5 9.5 10.2 10.3 10.8 7.1 5.8 4.7 6.9 5.6 3.2 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 47.9" "Cell line enhanced" "Detected in some" "A-431: 25.8;CAPAN-2: 27.9;EFO-21: 20.8;HaCaT: 35.5;RPMI-8226: 18.2;RPTEC TERT1: 21.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;T-cells: 4.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 169.5;olfactory region: 48.1" HPA037843 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavourable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 4.5 1.7 9.0 5.9 6.3 0.3 7.1 24.7 8.8 12.9 7.1 5.3 30.5 2.4 22.3 9.7 5.9 13.8 3.6 2.9 7.8 7.1 9.1 1.2 3.2 2.4 8.0 6.7 9.3 8.2 35.1 1.8 10.6 5.5 7.9 3.2 8.1 4.2 28.4 1.8 5.7 4.0 11.1 5.7 39.9 4.1 1.5 6.5 3.4 47.9 7.5 4.3 3.7 14.0 4.0 0.3 0.4 0.0 0.8 4.0 1.4 25.8 3.8 3.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 27.9 0.0 20.8 0.2 35.5 0.0 9.7 0.0 0.5 0.0 0.0 0.2 0.0 1.1 0.0 1.0 0.0 10.5 2.9 2.6 0.1 0.0 0.0 0.0 1.0 0.6 0.0 0.2 0.2 0.3 0.3 18.2 21.9 0.2 0.1 0.1 0.8 0.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 3.8 2.7 2.8 0.0 4.0 0.9 2.2 0.4 0.8 0.0 0.3 4.0 1.4 9.0 6.3 24.7 8.5 7.8 7.1 8.0 6.7 5.5 6.5 AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: " "prognostic unfavourable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 19.4 6.1 42.4 15.1 4.1 3.5 31.6 7.9 4.0 6.8 8.5 25.9 12.1 3.4 14.7 4.7 9.4 17.6 16.2 12.3 21.9 18.2 0.1 2.6 19.6 6.2 2.1 9.3 2.4 10.9 11.5 27.1 12.6 38.9 13.6 4.4 8.3 0.2 0.1 10.4 2.8 12.5 11.1 14.7 12.5 9.5 19.7 12.0 8.0 30.5 12.0 3.6 0.8 18.5 3.2 15.4 13.7 13.0 0.2 16.5 7.1 9.5 4.5 27.8 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA069947: " "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.8 7.2 6.0 6.3 9.9 11.8 8.5 7.9 11.6 6.0 9.0 7.6 14.5 8.9 10.8 9.6 3.6 9.4 11.9 8.4 15.1 3.7 18.4 18.7 6.3 7.7 17.6 14.6 9.6 8.6 10.3 9.1 22.1 11.3 25.1 2.5 2.1 15.9 5.1 7.9 2.5 12.6 3.5 11.3 17.7 7.5 13.6 2.5 12.0 7.9 3.8 4.7 14.8 11.0 11.2 10.2 6.8 4.3 21.8 12.1 15.3 9.2 20.4 4.0 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100142739 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.6" "Cell line enhanced" "Detected in many" "Daudi: 23.3;T-47d: 11.7;U-698: 34.5" "Cancer enhanced" "Detected in many" "breast cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 16 "B-cells: 27.5;dendritic cells: 12.8" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: " "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavourable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.2 2.4 6.0 40.2 6.1 10.3 16.6 20.5 9.9 4.2 4.2 1.8 0.8 1.2 8.9 1.7 4.1 4.1 2.3 4.9 6.3 6.2 1.8 2.4 7.6 23.3 5.4 6.8 7.5 1.1 0.3 5.2 6.9 4.4 18.9 2.3 5.5 6.6 3.3 1.0 1.0 5.9 8.6 6.6 43.6 4.8 6.0 2.5 34.7 1.7 0.7 42.0 7.4 2.7 27.5 12.8 0.2 0.2 0.9 1.2 0.4 0.1 0.0 9.8 3.4 0.0 0.4 0.0 1.3 0.3 2.9 1.0 0.0 0.0 23.3 0.1 1.5 0.1 0.2 0.0 1.7 5.9 2.8 0.0 0.1 0.0 0.2 0.1 6.7 0.6 0.0 6.1 0.1 0.0 0.1 0.0 0.0 0.1 1.9 0.3 1.3 1.6 3.2 0.0 0.1 0.0 0.0 9.7 3.4 0.1 0.1 6.3 11.7 10.7 3.9 9.3 2.5 0.3 1.5 0.2 0.0 34.5 8.7 0.8 0.7 0.2 0.2 0.0 0.0 0.2 0.2 16.2 0.1 0.0 2.9 27.5 1.2 0.0 0.1 0.9 0.2 12.8 0.0 0.4 6.0 6.1 20.5 9.9 6.3 6.2 5.4 6.8 4.4 2.5 AFF4 "AF5Q31, MCEF" ENSG00000072364 "AF4/FMR2 family member 4" Q9UHB7 5 132875379-132963634 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023690, HPA029634" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA023690: AB_1844633, HPA029634: " "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.17e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (2.56e-2)" "unprognostic (7.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.13e-2)" "unprognostic (4.94e-2)" "unprognostic (3.52e-1)" "unprognostic (1.16e-2)" "unprognostic (2.77e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (6.44e-4)" "unprognostic (1.69e-1)" 22.9 29.6 22.8 19.1 38.7 38.3 23.6 37.8 25.6 26.2 21.8 25.2 22.1 14.6 27.6 19.5 29.8 20.8 26.8 21.3 18.7 18.7 25.7 24.2 24.8 19.6 19.0 19.7 34.0 24.9 48.8 40.1 20.4 18.3 26.7 18.5 27.5 25.2 25.1 32.1 22.2 17.8 24.4 18.8 17.3 24.8 17.6 24.4 26.6 33.9 15.7 19.2 26.3 24.7 8.7 5.2 12.2 4.9 3.8 5.5 1.5 16.8 13.6 18.8 20.8 14.5 17.5 14.7 18.3 19.7 16.9 21.6 20.1 11.1 8.6 21.8 23.9 8.5 15.1 22.6 28.3 6.1 9.7 10.6 18.6 7.1 18.6 3.7 11.1 20.5 15.1 29.2 29.8 16.1 7.6 7.3 21.0 6.4 10.2 4.0 7.2 5.6 6.9 18.3 3.2 14.7 23.8 14.7 15.5 20.8 5.1 20.7 10.8 6.0 22.7 20.3 17.3 17.8 19.4 10.1 17.2 7.8 19.1 6.9 13.8 12.2 2.4 3.8 5.5 2.0 4.1 7.7 5.1 3.7 2.9 8.7 5.3 4.6 5.2 3.8 4.9 5.2 2.5 1.5 22.8 38.7 37.8 25.6 18.7 18.7 19.0 19.7 18.3 24.4 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294894-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 4.9 7.3 7.6 6.5 6.6 4.3 5.7 6.2 7.3 4.1 5.7 7.3 6.9 8.9 3.7 4.9 5.5 5.1 4.8 9.4 6.3 4.9 11.0 7.6 9.1 4.8 7.3 7.4 4.1 5.2 11.6 6.9 4.7 6.1 3.9 7.0 5.5 4.7 5.4 9.0 4.2 6.3 4.0 5.6 4.4 6.0 25.4 6.5 5.6 6.6 4.1 4.5 4.8 4.3 5.7 3.0 5.1 7.2 4.2 4.4 1.7 3.4 1.8 4.6 8.1 4.8 7.0 4.5 3.9 5.9 6.5 6.4 7.3 4.3 6.2 5.2 6.0 1.9 5.8 5.8 7.3 3.6 3.5 7.4 2.3 8.4 4.7 6.5 3.6 6.5 4.8 4.8 7.8 3.4 7.4 2.9 6.0 3.2 1.2 6.1 3.0 3.6 4.3 6.2 3.6 8.1 3.8 5.0 4.4 3.2 4.6 8.6 3.8 12.8 4.3 4.0 1.0 3.4 4.4 2.1 3.2 4.8 4.9 7.8 6.0 0.0 3.1 5.1 2.0 2.2 2.6 4.8 3.2 3.8 2.7 5.7 4.4 2.9 0.8 4.2 7.2 3.0 4.1 1.7 7.6 6.6 6.2 7.3 6.3 4.9 7.3 7.4 6.1 6.5 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 4.3;liver: 9.6;lung: 2.9" "Cell line enriched" "Detected in some" 190 "Hep G2: 214.4" "Group enriched" "Detected in some" 14 "liver cancer: 208.8;testis cancer: 49.4" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" 6000000 930000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.4 0.1 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.3 0.3 0.0 0.0 9.6 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 214.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 AFTPH "FLJ20080, FLJ23793, MGC33965, Nbla10388" ENSG00000119844 Aftiphilin Q6ULP2 2 64524305-64593005 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034990, HPA034991" Approved Supported "Golgi apparatus,Vesicles,Cytosol" Cytosol "Golgi apparatus, Vesicles" "HPA034990: AB_2674398, HPA034991: AB_10603577" "unprognostic (7.30e-2)" "unprognostic (4.72e-2)" "unprognostic (9.16e-2)" "unprognostic (8.54e-2)" "unprognostic (3.24e-1)" "unprognostic (4.25e-2)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (8.44e-2)" "unprognostic (3.42e-2)" "unprognostic (4.65e-2)" "prognostic favourable (2.37e-5)" "prognostic favourable (8.44e-4)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "prognostic favourable (1.83e-4)" 12.4 14.8 18.0 25.8 20.0 11.4 20.8 29.8 22.9 14.9 20.1 9.5 16.7 14.1 12.9 28.6 20.7 14.7 16.9 13.5 15.6 14.5 34.8 20.3 18.7 20.7 12.8 21.4 13.1 19.4 26.8 22.6 9.8 16.3 22.3 21.5 9.8 18.5 17.4 12.2 21.8 19.0 14.7 12.2 17.1 20.0 15.1 16.7 20.0 16.0 9.9 24.7 16.5 20.9 16.4 11.8 21.4 10.2 4.9 9.0 4.2 14.0 9.3 7.0 8.4 9.0 7.7 11.6 8.1 12.2 13.4 10.1 10.7 10.7 20.9 8.0 10.0 11.5 12.0 11.3 17.5 20.3 6.6 10.0 5.9 12.5 9.6 19.0 17.2 3.8 24.1 8.6 19.8 10.4 7.4 19.1 8.2 8.0 10.2 23.3 6.4 7.0 8.4 11.2 13.6 24.1 15.2 12.9 6.5 8.6 19.6 16.6 11.8 14.6 8.9 10.0 11.6 8.4 9.0 21.6 12.8 32.3 7.6 21.7 11.0 21.4 6.9 11.6 5.8 6.7 6.9 16.4 7.3 7.0 9.0 14.8 7.0 5.6 12.1 4.9 10.2 11.8 9.0 4.2 18.0 20.0 29.8 22.9 15.6 14.5 12.8 21.4 16.3 16.7 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell line enhanced" "Detected in many" "HMC-1: 17.6;Karpas-707: 17.2;RH-30: 43.0" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.4 8.6 2.5 0.0 0.0 4.9 2.0 0.4 0.0 0.2 0.5 2.8 7.7 0.6 0.0 1.9 0.0 0.0 0.0 8.4 1.3 8.5 0.7 1.4 0.0 8.7 17.6 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 5.2 15.4 5.6 1.4 4.6 6.4 43.0 5.5 0.0 2.5 2.4 8.9 1.1 1.5 1.8 1.1 6.2 4.7 2.4 4.0 4.5 1.5 7.3 4.3 3.9 4.3 5.8 4.0 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 AGBL3 "CCP3, MGC32955" ENSG00000146856 "ATP/GTP binding protein like 3" Q8NEM8 7 134986508-135147963 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020397, HPA024150" Uncertain Uncertain "Nuclear speckles,Mitochondria,Cytosol" "Nuclear speckles, Mitochondria, Cytosol" "HPA020397: AB_2242453, HPA024150: AB_1844639" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (4.72e-2)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-3)" "unprognostic (3.32e-3)" "unprognostic (4.18e-2)" "unprognostic (7.15e-4)" "unprognostic (5.00e-3)" "unprognostic (6.10e-4)" "unprognostic (3.16e-2)" "prognostic unfavourable (4.02e-4)" "unprognostic (2.18e-2)" "unprognostic (2.14e-1)" "unprognostic (8.13e-2)" "unprognostic (1.11e-3)" 3.2 2.7 4.2 4.1 8.4 3.8 4.6 8.7 4.5 4.3 2.4 4.4 4.5 1.6 5.5 15.4 2.2 3.6 3.1 2.4 5.0 3.4 5.3 2.6 3.6 4.0 2.7 4.5 6.8 4.5 0.6 9.2 1.9 3.3 3.8 3.0 3.1 4.9 4.3 4.2 4.7 3.7 3.3 2.9 6.5 4.4 18.7 3.7 2.7 5.4 0.8 2.8 3.3 2.5 2.2 1.7 0.5 0.2 2.2 5.0 1.7 2.6 1.4 3.6 0.8 1.0 1.4 2.2 0.7 0.0 0.5 0.8 4.7 3.0 4.3 1.3 0.0 2.8 1.3 0.5 0.0 3.4 8.8 3.6 5.3 4.6 0.0 1.6 0.0 0.2 0.0 2.1 0.0 1.5 2.6 2.5 0.6 2.5 0.9 1.5 3.1 0.3 2.5 0.2 1.2 2.6 0.5 2.1 2.4 0.5 0.0 0.3 1.9 3.5 0.0 0.4 0.9 0.5 1.6 5.3 1.6 1.9 1.8 4.3 4.4 0.0 0.2 0.4 2.4 0.0 1.8 2.1 1.2 2.5 0.5 2.2 2.0 5.0 0.5 2.2 0.1 1.7 1.7 1.7 4.2 8.4 8.7 4.5 5.0 3.4 2.7 4.5 3.3 3.7 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 91.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 3.8 8.1 3.9 3.5 4.8 3.8 4.2 3.1 6.6 5.0 6.8 6.6 11.7 2.8 5.4 9.3 6.3 7.2 6.6 4.1 3.4 3.9 8.2 3.0 3.6 3.2 3.5 3.4 5.9 5.9 11.2 6.2 6.3 5.4 6.8 3.8 7.7 8.2 5.9 2.6 6.8 3.9 8.6 3.4 4.6 5.4 91.6 3.5 8.4 9.9 4.9 4.4 7.8 3.5 5.7 5.4 7.1 2.3 11.2 6.3 4.6 22.8 14.8 24.3 16.2 5.2 10.5 27.2 4.7 10.2 13.6 14.1 12.8 17.5 12.7 14.8 8.1 10.5 19.4 21.2 15.1 10.6 28.8 18.6 18.5 27.6 10.6 8.9 6.3 10.9 16.1 11.9 9.8 14.2 15.9 10.4 13.1 9.0 26.0 13.5 17.2 10.2 26.9 27.5 19.9 13.9 5.8 16.3 23.3 9.2 7.3 15.1 10.9 6.9 6.7 12.7 17.5 6.1 10.0 20.7 10.8 26.0 14.1 10.3 11.3 7.1 2.3 5.7 4.5 1.3 3.4 5.7 5.7 6.3 5.4 3.0 5.1 2.8 1.4 11.2 0.9 3.0 3.6 4.6 3.9 4.8 3.1 6.6 3.4 3.9 3.5 3.4 5.4 3.5 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.3;MCF7: 4.5;RPTEC TERT1: 5.5;U-266/70: 6.6" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: , HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favourable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.3 2.1 2.9 0.1 0.3 0.1 0.2 0.1 0.5 0.2 2.3 0.5 2.3 0.2 1.2 0.4 0.4 5.3 1.4 0.1 0.0 0.0 0.6 2.4 0.3 0.3 0.1 0.2 0.4 0.0 0.8 0.3 4.5 0.3 1.7 0.0 0.0 0.1 0.3 0.3 5.5 0.1 0.1 0.5 0.1 0.0 2.0 1.3 0.1 0.3 0.0 1.6 1.6 0.2 6.6 3.4 2.4 2.3 0.5 0.6 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: " "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.2 13.3 13.2 10.9 10.5 13.0 9.0 13.0 12.7 20.9 20.9 10.3 9.5 13.8 11.7 12.4 9.1 18.4 15.1 22.5 16.2 16.4 12.8 6.3 10.2 15.6 8.8 6.9 14.4 13.3 18.3 18.0 16.0 19.0 19.7 10.1 12.3 23.9 4.1 14.0 15.0 15.5 2.3 41.2 13.3 10.4 11.6 15.9 13.5 16.3 13.4 8.7 9.7 8.9 9.7 7.6 12.9 18.7 15.0 14.8 6.6 15.9 4.1 26.6 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: " "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favourable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 11.8 3.5 4.2 6.9 7.0 6.6 14.2 3.8 5.6 3.3 5.9 13.3 4.0 15.6 7.3 6.4 6.7 24.6 7.4 6.3 8.3 7.8 9.1 12.2 7.4 4.6 8.0 5.5 8.1 4.8 4.6 3.9 5.2 14.9 1.1 3.4 3.7 9.4 2.5 6.7 4.6 0.0 1.4 0.8 10.1 16.1 10.5 7.3 10.9 10.5 5.8 7.5 5.4 5.3 4.0 5.8 5.4 3.7 4.5 3.5 18.1 7.1 2.1 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 AGO2 "CASC7, EIF2C2, hAGO2, LINC00980, Q10" ENSG00000123908 "Argonaute 2, RISC catalytic component" Q9UKV8 8 140520156-140635619 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019309, HPA058075" Approved Supported "Nucleoplasm,Cell Junctions" 35000000 "Nucleoplasm, Cell Junctions" "CAB019309: , HPA058075: " "unprognostic (2.75e-2)" "unprognostic (1.79e-3)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.46e-1)" "unprognostic (2.15e-1)" "unprognostic (1.49e-3)" "unprognostic (8.86e-2)" "unprognostic (2.21e-1)" "unprognostic (8.50e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (1.82e-5)" "unprognostic (1.32e-1)" "unprognostic (2.77e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-1)" 11.2 6.6 7.7 9.9 13.1 16.2 25.0 9.9 11.4 7.5 9.2 12.1 12.8 5.3 10.2 10.4 10.6 8.6 8.8 12.4 8.8 5.3 6.9 7.4 13.2 12.5 13.4 5.0 11.8 8.4 13.2 8.8 9.9 10.7 7.5 6.9 5.6 8.1 12.6 37.1 14.1 7.5 15.0 11.7 6.9 10.0 5.9 12.7 11.1 8.6 8.2 8.9 10.4 18.4 2.5 2.1 6.4 2.6 2.4 3.0 1.5 12.6 10.5 10.8 12.3 7.1 8.4 9.1 8.0 5.8 3.6 4.5 11.6 3.8 14.6 10.1 7.7 8.6 18.2 8.6 8.0 8.2 9.5 17.1 18.0 7.4 6.4 7.0 5.8 5.7 7.8 10.0 10.4 8.3 17.8 9.2 11.7 19.2 12.1 5.6 8.0 18.3 12.5 9.1 6.6 4.6 13.2 12.7 9.2 12.5 4.3 8.9 11.0 10.3 11.6 6.3 17.5 9.8 12.8 8.2 2.6 10.3 4.6 12.8 9.2 1.8 2.6 0.7 2.7 2.3 3.0 1.3 2.6 2.3 2.1 2.5 2.7 2.7 6.4 2.4 2.3 1.5 2.1 1.5 7.7 13.1 9.9 11.4 8.8 5.3 13.4 5.0 10.7 12.7 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute 3, RISC catalytic component" Q9H9G7 1 35930718-36072500 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA075436" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "HPA048342: , HPA075436: " "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavourable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 9.8 8.1 8.8 16.2 11.7 20.6 9.6 12.8 9.6 9.4 7.4 13.8 10.4 4.6 9.5 10.9 7.8 7.4 8.8 9.5 8.0 7.4 8.2 11.3 9.6 9.3 11.5 6.1 10.8 9.7 13.3 28.0 11.0 9.1 9.8 7.1 8.7 7.7 14.1 8.3 12.5 7.3 12.0 10.9 8.3 8.0 21.4 13.5 14.4 9.7 4.7 10.1 8.4 13.9 6.5 5.1 14.0 6.0 6.0 5.5 2.3 6.6 4.6 5.9 4.6 8.2 5.0 7.0 5.5 5.7 8.5 9.1 5.0 7.5 7.3 6.8 5.6 5.6 6.2 4.0 11.3 10.2 3.9 9.0 8.0 3.8 4.4 8.7 7.6 2.4 3.6 12.2 7.7 7.2 9.7 10.8 7.4 2.5 6.3 4.7 10.1 8.1 7.7 7.9 7.3 2.7 6.5 7.2 4.5 9.7 2.4 3.4 3.7 3.6 5.6 5.9 15.1 5.2 5.9 5.9 10.2 10.3 3.0 5.6 5.6 8.5 4.7 13.2 5.5 4.2 3.5 6.2 3.6 3.9 5.1 6.5 5.0 5.0 14.0 6.0 6.0 4.5 3.4 2.3 8.8 11.7 12.8 9.6 8.0 7.4 11.5 6.1 9.1 13.5 AGPAT1 LPAAT-alpha ENSG00000204310 "1-acylglycerol-3-phosphate O-acyltransferase 1" Q99943 6 32168212-32178096 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.4;fHDF/TERT166: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048478, HPA073355" Approved Supported "Endoplasmic reticulum,Rods & Rings" "Endoplasmic reticulum" "Rods & Rings" "HPA048478: , HPA073355: " "prognostic unfavourable (1.93e-4)" "unprognostic (9.35e-3)" "unprognostic (1.87e-3)" "prognostic unfavourable (5.21e-4)" "unprognostic (4.79e-2)" "unprognostic (7.05e-2)" "unprognostic (7.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.79e-1)" "unprognostic (4.24e-3)" "unprognostic (1.84e-3)" "unprognostic (1.77e-1)" "unprognostic (6.58e-2)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.92e-3)" "unprognostic (7.00e-2)" 11.7 32.3 21.5 8.3 33.1 7.4 12.1 18.7 32.4 26.9 22.1 19.6 19.6 32.0 25.1 53.3 13.8 26.9 22.3 19.4 22.8 21.1 26.4 20.3 24.3 10.7 20.3 23.6 33.1 18.5 1.3 16.6 18.5 22.4 18.5 24.8 17.5 17.4 19.5 25.5 9.1 46.9 17.9 18.6 11.7 27.8 27.7 17.4 12.1 33.4 9.0 14.6 19.3 12.7 6.7 13.8 13.2 9.6 8.9 10.1 5.7 0.0 0.1 13.5 0.0 35.4 23.9 12.6 0.0 0.0 0.0 0.0 27.6 0.0 0.0 11.6 33.8 3.3 29.1 9.6 0.0 0.0 22.6 0.0 0.0 29.0 0.0 0.0 27.4 13.3 12.5 0.0 12.6 8.2 17.4 17.8 29.3 7.3 0.0 6.3 0.0 4.2 0.1 0.0 0.1 8.8 0.0 0.0 0.0 13.4 4.3 15.1 16.9 0.0 5.8 0.0 5.0 0.0 0.0 10.7 10.1 4.4 17.4 0.0 0.0 2.7 5.7 13.2 9.2 9.6 8.7 6.7 5.8 10.1 10.3 5.9 5.0 7.3 11.0 8.9 6.6 13.8 7.8 5.7 21.5 33.1 18.7 32.4 22.8 21.1 20.3 23.6 22.4 17.4 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: , HPA060525: " "unprognostic (5.69e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 4.6 7.3 6.8 1.8 0.0 1.0 1.6 4.7 7.6 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859405-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 40.5;intestine: 99.1" "Cell line enriched" "Detected in some" 41 "T-47d: 86.2" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 5.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 31000 "Endoplasmic reticulum" Vesicles "HPA053942: " "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.0 0.6 7.5 0.7 0.0 13.1 0.7 0.6 4.4 45.8 0.6 0.6 29.2 1.2 5.4 0.9 40.5 11.8 0.6 0.6 0.3 1.5 0.6 26.3 0.6 0.6 0.6 5.1 1.9 0.0 12.9 2.8 1.9 1.1 38.9 0.6 9.4 0.6 0.6 0.3 99.1 1.2 0.8 0.6 17.1 1.0 0.6 0.6 1.4 1.9 3.9 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 0.1 0.0 0.1 0.0 86.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 0.6 0.6 0.3 0.6 0.6 1.9 0.6 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 45.6;EFO-21: 53.1;HaCaT: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 15000000 "Plasma membrane, Cytosol" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavourable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 26.5 16.5 3.2 10.7 0.5 0.7 28.8 13.4 4.3 9.0 5.5 13.9 45.6 0.5 53.1 2.0 46.2 1.1 16.5 1.0 1.0 6.3 0.0 21.6 14.5 3.9 0.3 5.4 2.4 7.2 2.8 6.2 1.5 5.5 0.1 0.7 21.8 0.2 3.8 6.9 12.0 4.2 6.3 4.0 15.8 11.8 0.8 6.4 27.3 29.6 26.0 26.0 2.0 23.5 11.1 39.3 1.5 10.8 0.3 0.2 0.9 7.0 2.4 2.9 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057208 Approved Approved Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA057208: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 7.9 5.7 13.1 8.6 14.6 48.2 6.0 14.2 21.4 5.1 5.0 21.6 1.8 3.8 5.0 4.2 5.4 4.2 5.3 11.2 17.3 13.5 6.8 4.5 11.9 16.0 18.8 14.5 3.5 6.4 8.0 4.8 6.0 23.5 4.9 5.9 7.4 3.9 3.4 13.6 6.0 4.3 6.4 24.1 12.8 5.3 12.5 14.4 8.8 5.8 4.3 7.8 5.7 3.8 1.6 10.7 20.3 9.5 4.5 6.6 5.7 2.9 5.7 16.8 6.7 3.5 3.8 6.4 4.4 3.8 4.5 5.1 3.0 5.1 18.3 3.7 4.5 1.7 7.8 5.6 4.3 19.4 6.9 3.1 6.9 5.4 7.3 14.1 3.7 3.5 6.6 4.2 14.5 7.2 3.9 14.7 2.0 4.6 10.9 8.4 11.7 4.0 10.0 6.2 5.6 7.8 3.2 20.4 14.5 5.0 5.5 9.1 2.1 4.6 7.1 2.9 5.2 18.5 5.2 10.1 8.4 8.4 6.2 13.9 5.9 20.3 9.5 8.3 6.6 5.7 6.4 1.6 3.3 5.1 10.7 1.2 2.7 5.2 14.0 4.5 4.3 1.7 3.4 5.7 13.1 14.6 14.2 21.4 17.3 13.5 18.8 14.5 23.5 14.4 AHCYL2 KIAA0828 ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 72.4" "Cell line enriched" "Detected in all" 8 "HDLM-2: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favourable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favourable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 4.3 6.6 12.8 5.9 20.3 1.5 4.3 7.2 16.9 7.1 61.8 13.3 5.1 23.1 6.1 3.3 5.7 4.4 22.7 3.4 16.5 9.6 11.9 3.4 26.1 4.2 10.7 14.9 5.7 5.8 9.1 12.8 5.1 19.8 5.0 72.4 24.3 15.0 3.3 20.7 9.8 15.0 5.3 11.4 2.9 16.5 8.1 9.6 4.6 24.1 4.0 4.0 5.4 4.7 0.9 1.3 2.0 2.5 3.3 5.0 0.5 2.6 4.2 8.1 4.8 2.2 3.2 1.7 2.1 2.9 2.4 2.1 2.4 1.8 1.6 2.2 2.3 1.8 4.0 3.3 2.7 71.8 5.0 3.8 4.6 1.9 1.3 2.8 4.9 3.0 4.3 1.9 2.9 4.7 1.7 9.1 3.1 2.5 4.1 3.6 4.0 3.0 2.7 2.2 4.3 4.8 3.5 3.7 2.3 4.8 2.0 2.8 1.9 2.0 2.7 2.0 1.2 5.4 2.2 3.8 4.3 2.2 5.3 3.0 3.1 0.1 1.2 2.0 0.9 2.5 1.2 0.9 1.5 0.7 1.3 0.5 1.3 0.5 0.4 3.3 1.2 0.4 5.0 0.5 12.8 20.3 7.2 16.9 16.5 9.6 10.7 14.9 19.8 9.6 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 84.9;fHDF/TERT166: 79.0;TIME: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" 950000 "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavourable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (3.47e-6)" 85.2 8.2 15.3 35.3 9.3 10.0 91.1 9.3 10.8 69.7 66.3 16.8 36.4 13.0 52.2 47.4 96.9 39.4 59.2 55.8 20.9 6.0 18.4 16.0 54.9 16.6 16.2 13.4 40.2 8.9 8.0 5.3 39.8 15.9 42.6 26.8 29.6 35.5 36.8 64.8 88.4 38.2 101.5 16.1 16.9 38.3 16.9 16.2 5.8 18.4 72.9 44.0 54.3 86.1 8.2 28.9 15.3 30.1 11.1 16.7 12.2 26.0 15.4 1.4 6.4 63.3 84.9 10.2 23.7 29.1 15.1 8.5 13.2 9.3 0.0 9.0 79.0 34.8 5.9 29.2 19.4 21.1 0.9 3.1 22.9 3.9 12.1 4.3 20.8 30.6 34.3 29.7 27.2 31.1 2.9 20.2 30.6 10.1 0.0 8.4 0.4 23.4 0.0 6.5 15.6 33.6 17.1 0.0 1.3 23.9 10.1 10.1 19.4 4.0 82.6 27.0 17.6 33.5 10.4 3.6 0.7 0.0 20.5 1.4 8.8 15.3 30.1 0.1 16.7 17.5 11.0 8.2 10.7 13.1 28.9 5.2 1.4 7.6 0.4 11.1 14.0 7.9 7.9 12.2 15.3 9.3 9.3 10.8 20.9 6.0 16.2 13.4 15.9 16.2 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.1;ASC TERT1: 32.0;HBEC3-KT: 28.1;hTCEpi: 70.8;hTERT-HME1: 30.2;TIME: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA000878: , HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: " "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 19.7 0.0 1.3 28.1 32.0 0.0 2.4 5.0 0.8 0.4 0.0 8.8 0.0 3.3 18.5 14.2 0.0 28.1 0.4 0.0 0.1 0.0 13.0 0.1 2.6 0.0 0.9 4.1 70.8 2.8 30.2 12.3 0.0 0.0 14.2 1.6 0.0 0.0 0.0 9.7 0.0 1.3 0.0 19.2 0.0 0.1 0.1 10.4 0.0 0.4 1.3 0.0 31.7 6.8 4.2 7.7 2.1 0.0 0.0 0.0 20.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.6" "Cell line enhanced" "Detected in many" "hTCEpi: 28.3;hTERT-HME1: 29.5;RT4: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 23.1 12.2 2.5 13.2 3.5 19.8 19.1 1.6 3.5 14.6 14.0 5.7 8.7 8.5 11.9 10.1 14.2 11.2 22.2 14.8 3.2 2.2 7.3 23.9 26.4 20.0 6.5 2.5 21.3 6.8 4.5 3.8 69.6 3.7 21.4 8.9 10.9 11.1 8.5 5.2 16.6 13.7 12.1 4.8 15.6 13.3 6.8 4.0 7.1 12.4 7.9 12.3 26.7 26.6 1.1 9.3 5.6 7.6 3.1 2.9 2.0 3.0 2.5 1.0 0.0 7.7 5.3 0.4 6.3 9.2 2.9 4.3 3.1 6.8 0.0 1.9 9.3 8.5 0.6 5.8 7.8 0.1 1.4 1.8 3.2 2.7 14.5 3.0 4.5 7.2 28.3 11.2 29.5 9.8 0.2 0.0 13.3 1.6 0.0 4.8 0.8 4.0 0.0 0.0 0.1 9.4 24.3 0.9 0.0 4.7 5.2 4.6 3.6 1.0 1.6 1.2 0.0 16.1 0.0 1.3 0.0 0.0 20.6 11.9 20.2 0.7 7.6 5.6 0.7 3.6 1.1 0.8 2.6 1.4 9.3 1.1 1.5 1.1 0.8 3.1 1.3 2.2 2.9 2.0 2.5 3.5 1.6 3.5 3.2 2.2 6.5 2.5 3.7 4.0 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 304176-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 44.3" "Cell line enhanced" "Detected in many" "HeLa: 23.4;HMC-1: 35.1;NB-4: 42.2;WM-115: 24.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA021483 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 0.8 0.4 1.0 4.6 0.8 0.2 2.4 0.4 1.4 2.4 1.2 0.7 1.4 0.7 1.6 0.9 1.4 0.5 4.4 0.3 1.2 1.0 0.6 0.4 6.2 0.4 0.3 0.0 2.1 1.0 0.1 1.3 2.1 0.9 0.6 1.2 2.7 0.9 0.3 0.6 5.8 1.7 0.9 0.3 4.7 0.7 44.3 0.3 0.1 0.9 1.8 4.2 2.0 3.6 0.9 2.3 1.0 0.5 0.0 1.0 0.3 0.1 3.9 0.6 0.5 2.1 4.5 4.6 8.3 11.2 4.7 9.3 0.1 3.1 0.3 4.4 15.1 0.2 0.7 0.2 2.1 0.6 1.7 3.9 23.4 0.1 1.6 1.1 35.1 0.9 0.3 3.2 0.4 1.7 0.6 0.3 5.0 0.3 0.3 42.2 0.1 3.9 0.6 0.2 0.4 0.1 0.0 5.5 0.2 11.1 2.1 5.7 0.2 14.4 2.0 8.7 1.1 9.8 0.3 1.3 2.1 0.3 3.7 0.3 24.7 0.0 0.5 1.0 0.3 0.0 0.1 0.2 0.6 0.3 0.0 0.9 0.1 0.1 0.5 0.0 0.1 2.3 1.0 0.3 1.0 0.8 0.4 1.4 1.2 1.0 0.3 0.0 0.9 0.3 AIDA "C1orf80, FLJ12806" ENSG00000186063 "Axin interactor, dorsalization associated" Q96BJ3 1 222668013-222713210 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027935 Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Microtubules, Cytokinetic bridge" "HPA027935: AB_10602226" "unprognostic (2.33e-1)" "prognostic unfavourable (7.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (2.63e-2)" "unprognostic (7.28e-2)" "unprognostic (2.58e-2)" "unprognostic (2.26e-2)" "unprognostic (2.73e-1)" "unprognostic (4.43e-2)" "unprognostic (2.09e-3)" "unprognostic (2.08e-1)" "prognostic unfavourable (4.37e-4)" "unprognostic (1.28e-1)" "unprognostic (2.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" 37.7 20.7 22.6 20.2 28.1 9.8 33.7 19.8 20.4 28.7 32.6 13.3 20.1 13.7 22.3 32.7 31.5 17.9 22.7 43.2 21.6 23.8 27.9 27.6 30.5 25.0 25.2 17.0 25.4 21.0 16.4 22.5 26.0 25.7 29.6 20.5 13.7 16.1 24.9 20.2 14.9 19.5 33.3 27.5 24.9 19.7 23.1 22.5 21.1 30.5 13.5 27.9 42.0 39.7 14.2 6.7 4.4 4.4 3.3 9.1 3.8 17.8 13.8 16.5 17.6 46.9 44.3 18.1 33.6 36.1 24.1 22.3 15.7 15.4 9.6 17.1 39.7 11.1 20.3 22.2 29.5 14.3 7.4 12.2 16.6 15.0 24.7 14.9 7.2 26.9 20.0 28.7 27.8 29.3 18.3 13.6 45.2 6.6 9.7 9.2 41.1 29.7 10.6 46.4 14.0 27.9 12.2 10.9 18.3 22.5 13.4 20.4 10.9 9.4 23.2 32.6 16.1 31.5 39.6 10.2 19.1 8.7 30.2 9.4 31.9 4.4 2.6 2.6 5.7 4.0 4.9 13.7 7.3 6.2 2.4 14.2 7.6 5.8 1.5 3.3 4.4 6.7 9.1 3.8 22.6 28.1 19.8 20.4 21.6 23.8 25.2 17.0 25.7 22.5 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" Apoptosis "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell line enhanced" "Detected in many" "Hep G2: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA028961: , HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favourable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favourable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.6 15.1 0.4 3.9 9.1 3.4 0.1 3.5 8.6 7.2 8.1 11.6 16.8 1.2 8.9 4.8 9.4 4.3 1.2 2.0 16.9 0.7 0.0 8.9 56.6 19.6 0.0 2.2 4.6 2.8 11.5 2.4 3.2 6.6 7.5 3.7 11.0 0.3 0.4 1.5 4.9 0.2 1.4 4.1 3.8 6.4 1.3 0.3 6.4 5.6 9.8 0.2 2.4 3.9 0.1 8.9 5.3 10.1 5.6 10.4 2.4 4.8 0.3 4.7 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Cell line enhanced" "Detected in some" "Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: " "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.2 0.0 0.3 0.0 0.0 4.3 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.3 43.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 2.8 0.0 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 14.5 10.9 0.2 13.4 1.1 2.2 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Cell line enhanced" "Detected in some" "HaCaT: 5.4;HeLa: 2.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026578: " "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.2 2.0 0.6 0.2 0.1 0.1 0.5 0.0 0.4 0.1 0.7 0.1 0.2 0.4 0.2 0.0 5.4 0.2 0.2 0.3 0.3 0.4 0.6 2.2 0.6 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.5 0.3 0.1 1.1 1.7 0.2 0.0 0.0 0.1 1.4 0.2 0.3 1.1 0.4 0.0 0.3 0.0 0.0 0.4 0.3 0.6 0.4 0.4 0.2 0.1 0.9 0.6 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;testis: 15.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.7" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 11 "dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 1.1 1.9 4.6 1.3 6.3 1.4 1.1 22.7 7.9 1.1 4.0 1.1 1.1 3.3 1.2 1.1 1.1 0.3 1.1 1.2 4.4 3.1 1.1 1.1 1.1 1.1 2.1 1.1 1.1 7.6 1.1 5.2 1.1 1.1 2.6 1.1 1.1 2.0 2.2 3.9 1.5 4.3 1.1 1.3 3.6 2.3 15.0 1.1 1.1 1.1 1.1 1.1 2.6 1.1 0.2 3.9 0.1 1.6 0.2 1.9 0.8 3.6 2.9 0.4 1.1 0.5 0.4 4.8 2.9 0.5 0.4 0.2 1.0 2.0 2.2 2.5 0.8 4.1 0.4 1.1 0.0 5.7 2.2 0.6 5.5 0.8 1.6 1.3 4.1 0.9 1.4 0.5 0.3 0.2 3.4 1.5 0.7 4.1 0.4 4.5 1.1 3.8 2.7 0.9 7.2 0.8 0.7 7.3 2.6 1.9 7.5 3.9 5.9 2.8 3.1 5.0 3.4 1.7 1.7 6.5 4.4 0.8 8.7 4.5 1.2 0.0 1.6 0.1 1.9 1.0 0.4 0.2 0.5 0.9 1.5 0.0 0.2 0.9 0.1 0.2 1.5 3.9 0.1 0.8 4.6 6.3 22.7 6.8 4.4 3.1 2.1 1.1 1.1 1.1 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971174-22982642 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 49.0;hTCEpi: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 2.9 2.0 1.1 2.4 1.8 0.0 4.1 1.1 1.6 11.1 2.0 1.6 4.9 0.5 8.8 4.4 12.3 4.7 7.9 3.2 2.3 0.6 15.6 55.0 8.5 2.2 1.5 1.3 8.2 5.6 5.5 1.4 12.5 2.6 9.2 1.1 7.1 5.5 11.0 1.5 31.3 1.7 4.3 0.5 2.9 2.6 4.1 1.3 7.1 15.4 5.3 6.6 3.7 10.0 1.3 1.0 2.6 1.2 2.9 2.5 0.6 10.2 12.2 16.3 6.2 1.6 2.9 13.1 10.1 13.4 23.7 21.3 26.0 10.7 0.2 10.6 20.8 33.4 12.4 49.0 29.0 0.9 1.1 0.7 19.8 29.2 18.6 1.0 0.7 9.1 51.3 9.9 38.3 9.1 0.4 0.6 21.9 8.2 1.0 1.2 1.0 16.8 2.8 13.6 0.2 23.8 16.0 0.0 1.4 30.5 9.0 1.9 12.6 1.0 8.1 10.3 20.8 1.6 9.6 0.1 0.3 0.1 1.6 0.9 4.6 2.2 1.2 0.5 1.4 0.5 0.5 0.4 1.2 2.5 0.4 1.3 1.5 0.9 2.6 2.9 0.8 1.0 0.2 0.6 1.1 1.8 1.1 1.6 2.3 0.6 1.5 1.3 2.6 1.3 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282051-77559969 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 10.9;naive CD4 T-cell: 14.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.9;T-cells: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: " "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favourable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.8 2.1 43.8 1.9 35.7 3.7 14.1 1.3 95.5 2.0 1.8 20.4 0.0 1.8 1.6 1.5 1.8 1.8 1.7 1.5 35.8 11.8 2.0 1.2 1.4 2.5 13.0 41.1 1.5 2.1 2.4 1.4 1.8 11.4 2.7 1.8 0.0 3.1 2.7 1.3 2.4 1.7 1.7 14.2 2.4 2.9 7.3 13.9 0.0 1.7 0.0 2.1 1.5 0.4 0.8 10.9 0.7 0.7 0.1 14.2 1.9 0.0 1.1 0.8 0.0 10.9 29.7 0.4 20.3 4.3 3.3 1.4 0.1 0.5 0.1 0.1 23.1 0.1 0.0 0.0 1.7 0.7 0.2 0.1 0.1 0.0 0.5 0.1 0.0 3.6 0.1 0.6 1.3 9.5 0.2 0.2 58.2 0.2 0.0 0.1 1.1 7.4 0.5 2.1 0.3 9.0 0.3 4.5 1.1 0.0 0.0 1.2 0.1 0.1 2.3 8.0 18.2 0.4 0.6 4.7 4.2 0.0 1.6 1.0 2.9 0.7 0.7 0.0 3.4 0.1 0.5 0.8 3.2 1.6 10.9 0.8 14.2 7.8 0.5 0.1 0.2 1.2 1.4 1.9 43.8 35.7 1.3 47.1 35.8 11.8 13.0 41.1 11.4 13.9 AK6 CINAP ENSG00000085231 "Adenylate kinase 6" Q9Y3D8 5 69350984-69370013 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005361, HPA070217" Supported Supported "Nuclear speckles,Centrosome,Cytosol" "Nuclear speckles" "Centrosome, Cytosol" "CAB005361: AB_2302969, HPA070217: " "unprognostic (5.47e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (8.58e-2)" "unprognostic (8.73e-2)" "unprognostic (4.09e-2)" "prognostic unfavourable (9.54e-4)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-2)" "unprognostic (1.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" 27.6 27.7 25.1 16.9 25.4 14.8 23.3 21.5 23.6 17.6 22.7 11.3 16.4 18.3 18.3 30.4 26.7 15.4 15.1 17.9 23.2 22.2 30.2 42.3 17.0 18.7 20.9 16.2 18.8 17.2 15.8 26.3 21.5 23.3 18.2 20.6 12.3 14.5 14.6 41.4 11.9 24.0 16.7 19.6 21.8 17.0 46.1 17.5 25.2 24.3 24.2 18.8 19.7 13.7 22.2 22.0 14.3 15.9 16.6 21.2 10.0 17.2 9.6 12.6 16.8 20.7 13.8 23.7 26.0 9.8 12.8 15.9 26.8 14.9 37.0 24.6 11.8 5.8 19.7 12.4 19.6 15.1 9.5 18.2 20.5 20.4 16.9 21.6 7.9 8.0 16.4 12.7 18.3 8.3 17.0 12.2 16.4 20.0 19.9 14.6 10.5 6.4 23.4 15.7 20.5 20.1 14.1 6.5 6.4 13.4 10.8 18.6 11.5 24.4 10.9 9.6 15.4 17.9 21.5 14.7 30.6 32.8 12.4 31.8 12.4 13.7 13.0 14.3 15.5 15.9 16.1 22.2 18.4 19.3 18.0 18.1 20.1 21.2 2.1 16.6 14.2 22.0 18.1 10.0 25.1 25.4 21.5 23.6 23.2 22.2 20.9 16.2 23.3 17.5 AK9 "AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954" ENSG00000155085 "Adenylate kinase 9" Q5TCS8 6 109492856-109691217 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA030804: , HPA030805: , HPA031779: AB_10603674, HPA031781: , HPA036324: , HPA036711: " "unprognostic (9.68e-3)" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (2.36e-2)" "unprognostic (3.42e-1)" "unprognostic (7.28e-2)" "unprognostic (1.41e-3)" "unprognostic (6.76e-3)" "unprognostic (1.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-4)" "unprognostic (2.58e-1)" "unprognostic (2.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (8.39e-2)" "unprognostic (5.56e-2)" 4.6 4.7 7.7 5.6 8.4 4.7 8.3 13.5 8.7 5.0 6.5 8.5 4.1 5.0 6.3 11.1 6.2 11.3 5.2 6.9 9.1 10.3 7.6 4.5 6.7 5.5 9.4 4.9 6.7 4.6 15.4 33.3 4.4 11.5 5.9 6.7 3.7 7.0 6.3 6.1 5.5 6.2 5.7 11.7 6.5 6.1 22.0 7.7 20.5 11.4 4.1 5.0 5.9 4.4 11.2 2.9 15.1 4.1 4.9 6.4 1.6 2.6 1.8 7.7 13.7 7.2 4.5 5.7 4.0 5.0 4.2 5.8 2.9 5.3 5.6 2.1 3.8 4.6 2.2 4.4 9.0 11.9 4.8 4.2 4.5 2.9 5.9 5.3 2.6 3.6 8.5 7.8 10.2 5.5 4.0 4.7 3.1 5.3 4.6 3.6 1.7 2.9 6.1 4.3 5.2 6.2 5.1 9.4 8.0 4.9 4.7 6.7 6.0 6.5 5.9 4.1 2.7 5.9 2.6 2.5 2.1 3.3 8.2 6.7 2.2 15.1 2.8 6.5 5.1 1.5 4.4 10.5 5.1 6.1 2.0 11.2 6.4 5.5 5.4 4.9 4.1 2.9 3.6 1.6 7.7 8.4 13.5 8.7 9.1 10.3 9.4 4.9 11.5 7.7 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 20.5 24.2 22.5 19.4 25.5 16.1 21.2 22.8 27.9 21.2 19.4 17.4 13.4 16.1 22.3 15.9 18.5 19.2 18.4 14.4 20.1 17.9 22.7 14.9 18.5 24.3 22.4 23.2 24.3 16.2 28.0 20.3 20.3 19.2 19.5 20.3 16.1 17.8 21.3 13.7 17.5 18.5 22.9 19.0 28.6 20.2 22.9 24.2 25.9 26.0 9.1 20.5 22.2 22.7 7.3 6.1 24.4 10.3 5.1 7.9 3.0 11.0 13.3 8.9 6.2 11.8 14.9 16.4 12.9 13.9 14.4 17.4 14.4 6.7 9.5 8.8 10.2 11.8 11.4 10.8 19.7 7.8 9.8 8.1 13.0 6.9 11.2 5.9 13.4 12.5 13.6 13.1 16.3 11.6 5.2 4.8 15.0 8.0 10.9 8.8 5.8 4.6 7.3 29.2 4.9 12.0 7.0 3.0 9.1 14.9 7.0 12.3 17.0 6.6 10.1 11.2 9.3 9.5 11.9 6.0 6.4 11.6 14.8 7.1 10.7 3.6 7.3 8.8 6.7 10.3 6.1 6.0 6.5 7.2 6.1 7.3 7.9 7.0 24.4 5.1 9.3 4.6 4.9 3.0 22.5 25.5 22.8 27.9 20.1 17.9 22.4 23.2 19.2 24.2 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavourable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.2 9.5 11.7 6.9 15.4 18.9 5.1 12.6 10.5 7.6 7.2 10.4 7.7 19.1 4.9 14.1 11.1 10.1 10.5 14.7 20.3 4.7 5.4 6.6 5.1 12.1 13.4 13.3 13.8 10.9 15.5 13.6 11.1 17.7 7.8 15.3 7.0 7.8 4.3 6.9 4.5 6.5 8.2 9.2 7.6 6.9 5.0 7.2 9.6 6.4 4.5 5.5 7.3 15.4 12.9 6.7 19.5 9.5 3.0 3.7 9.9 16.5 6.9 9.0 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 AKAP12 "AKAP250, SSeCKS" ENSG00000131016 "A-kinase anchoring protein 12" Q02952 6 151239999-151358557 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 43.1;TIME: 42.9;U-251 MG: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 184 "basophil: 20.4" "Lineage enriched" "Detected in single" 184 "granulocytes: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006344, CAB026379, HPA056230" Enhanced Enhanced "Plasma membrane,Cytosol" 6400000 "Plasma membrane, Cytosol" "CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (9.90e-3)" "prognostic unfavourable (7.08e-4)" "unprognostic (2.61e-2)" "unprognostic (8.88e-2)" "unprognostic (5.05e-2)" "prognostic unfavourable (6.34e-5)" "unprognostic (1.34e-1)" "unprognostic (8.26e-3)" "unprognostic (2.59e-1)" "unprognostic (4.72e-2)" "unprognostic (4.51e-3)" "unprognostic (1.10e-3)" "unprognostic (3.51e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-2)" 52.5 11.2 11.5 11.0 18.1 2.0 38.5 31.3 21.2 11.5 23.4 1.9 5.9 6.1 20.5 13.6 12.8 15.6 32.3 22.8 9.8 17.4 14.9 20.6 18.2 6.9 11.4 9.9 49.0 7.6 2.0 11.1 24.1 28.7 13.5 9.4 26.6 3.3 14.7 11.3 4.1 10.6 27.9 14.1 8.1 12.4 62.0 6.6 0.3 11.4 6.6 2.8 34.5 24.7 0.0 0.0 20.4 0.0 0.0 0.1 0.0 1.7 8.6 12.4 0.0 23.4 35.1 4.3 10.0 5.4 4.5 4.5 0.2 32.5 0.0 4.0 7.5 0.2 23.5 7.4 4.0 11.1 8.6 0.1 9.6 7.9 2.6 0.0 2.2 24.8 0.0 19.1 1.0 29.4 2.1 0.2 16.3 0.1 0.0 0.0 7.7 10.1 43.1 0.5 0.0 26.1 1.4 8.8 5.1 3.2 0.1 5.7 0.6 0.1 42.9 0.6 8.0 25.6 45.9 0.0 0.0 0.0 14.9 0.0 8.6 20.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.1 31.3 19.1 9.8 17.4 11.4 9.9 28.7 6.6 AKAP17A "721P, CCDC133, CXYorf3, DXYS155E, MGC39904, SFRS17A, XE7, XE7Y" ENSG00000197976 "A-kinase anchoring protein 17A" Q02040 X 1591593-1602514 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043247, HPA051020" Supported Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043247: AB_10964776, HPA051020: " "unprognostic (4.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favourable (3.40e-4)" "unprognostic (5.38e-2)" "unprognostic (1.59e-2)" "unprognostic (9.73e-3)" "unprognostic (6.25e-2)" "unprognostic (2.09e-1)" "unprognostic (7.91e-3)" "prognostic favourable (2.42e-4)" "unprognostic (1.55e-3)" "prognostic unfavourable (3.52e-7)" "unprognostic (1.86e-2)" "unprognostic (2.71e-1)" "unprognostic (4.03e-2)" "prognostic favourable (1.11e-5)" 7.4 10.3 28.1 14.5 42.3 18.0 24.5 27.5 25.2 32.8 7.2 2.5 2.5 14.2 40.9 9.7 9.2 9.1 7.4 12.5 27.1 3.4 20.3 16.4 12.2 15.4 37.6 27.1 38.0 15.6 5.2 31.0 42.7 33.7 12.6 4.3 2.5 17.0 7.8 6.9 12.3 11.6 3.2 27.8 21.4 14.2 7.0 37.2 2.5 16.1 2.5 8.9 6.8 47.6 1.8 1.8 7.0 1.0 1.3 1.6 0.4 9.5 12.3 9.8 11.1 4.8 6.2 24.1 10.4 4.2 8.4 7.1 13.6 8.8 14.4 6.7 5.1 8.4 6.0 5.2 5.0 11.8 20.5 17.9 11.8 12.6 10.4 6.9 30.1 5.5 9.6 6.2 6.9 5.7 11.2 9.1 4.9 6.3 15.3 30.0 14.7 10.7 11.6 11.7 12.0 5.6 6.6 11.0 16.1 8.1 13.2 12.5 8.6 12.7 11.0 13.1 6.0 11.3 8.9 39.6 6.6 20.0 5.3 11.3 3.4 7.0 1.0 1.9 0.8 0.5 0.9 1.8 1.0 1.6 0.6 1.2 0.8 0.8 4.1 1.3 0.8 1.8 0.5 0.4 28.1 42.3 27.5 25.2 27.1 3.4 37.6 27.1 33.7 37.2 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940867-92110673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favourable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 13.7 15.9 18.0 22.6 17.1 14.9 15.6 35.8 17.5 14.4 24.5 4.7 17.2 25.5 13.0 17.1 15.3 12.4 15.0 14.8 13.3 7.0 19.5 25.1 19.9 13.2 12.4 12.3 22.3 21.3 22.1 40.5 12.9 14.0 11.9 25.3 11.1 20.1 25.9 29.6 16.1 29.1 12.0 11.1 10.4 15.0 6.9 14.4 10.3 14.9 15.7 8.6 14.0 14.2 34.4 39.5 31.9 16.6 10.6 20.3 3.4 11.2 7.0 10.4 6.6 14.9 11.0 7.4 8.4 5.7 4.3 5.5 11.9 9.8 10.2 12.2 7.4 10.4 10.0 5.5 8.1 9.2 8.5 11.2 12.2 7.8 6.1 18.5 11.9 6.9 8.8 8.9 10.2 9.3 16.6 16.7 7.3 16.3 12.6 7.3 8.0 8.7 7.7 17.4 8.2 5.9 12.4 17.0 11.9 17.8 20.0 8.6 5.2 9.0 17.1 8.7 11.2 15.2 11.4 12.0 13.2 13.7 7.7 9.4 9.8 31.9 16.6 21.4 18.4 9.3 15.4 31.4 18.7 16.7 7.2 34.4 20.3 19.3 23.2 10.6 16.3 39.5 14.9 3.4 18.0 17.1 35.8 17.5 13.3 7.0 12.4 12.3 14.0 14.4 AKIRIN1 "C1orf108, FLJ12666" ENSG00000174574 "Akirin 1" Q9H9L7 1 38991223-39006059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051871 Approved Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA051871: " "unprognostic (1.16e-1)" "unprognostic (2.13e-2)" "unprognostic (1.05e-1)" "unprognostic (5.35e-3)" "unprognostic (1.40e-1)" "unprognostic (1.39e-3)" "prognostic unfavourable (5.39e-7)" "unprognostic (3.53e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-2)" "unprognostic (9.49e-3)" "unprognostic (1.47e-2)" "unprognostic (3.89e-2)" "unprognostic (1.22e-1)" "unprognostic (7.13e-2)" "unprognostic (3.77e-3)" "unprognostic (5.17e-2)" 30.2 20.8 28.3 21.1 29.4 43.1 16.8 17.6 30.3 16.2 23.3 35.0 20.4 15.9 20.6 29.5 19.8 19.5 28.6 40.8 30.1 34.0 29.2 35.0 19.8 25.5 32.1 21.0 17.0 18.2 25.9 34.5 19.5 31.3 25.5 25.0 20.3 18.2 25.7 20.7 12.0 19.2 28.2 41.8 20.5 24.3 68.0 23.6 25.6 24.5 11.2 27.1 22.6 22.4 14.8 22.7 43.1 15.8 29.3 28.6 20.1 16.9 7.9 34.1 27.7 16.7 19.8 24.1 19.9 20.9 20.2 20.6 20.2 14.2 13.5 18.6 18.9 11.9 32.9 17.9 32.6 20.0 16.5 39.8 12.0 25.6 22.1 37.9 21.9 20.3 23.5 26.3 21.6 18.6 27.1 13.4 25.2 6.9 16.0 16.4 71.8 13.3 25.7 24.8 13.4 22.4 20.9 23.6 16.1 22.1 11.8 43.2 10.9 19.6 16.5 12.3 20.1 13.4 20.2 19.5 25.0 28.8 21.3 22.5 20.9 12.2 15.8 33.2 14.6 13.5 22.4 14.8 24.1 22.6 22.7 13.0 28.6 18.3 43.1 29.3 15.0 17.1 21.7 20.1 28.3 29.4 17.6 30.3 30.1 34.0 32.1 21.0 31.3 23.6 AKNA KIAA1968 ENSG00000106948 "AT-hook transcription factor" Q7Z591 9 114334156-114394405 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 71.2" "Cell line enhanced" "Detected in many" "HDLM-2: 31.6;MOLT-4: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052367, HPA063993" Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA052367: , HPA063993: " "unprognostic (5.19e-3)" "prognostic favourable (1.22e-4)" "unprognostic (5.38e-3)" "prognostic favourable (2.14e-5)" "unprognostic (3.12e-1)" "prognostic favourable (1.25e-4)" "unprognostic (1.88e-1)" "unprognostic (3.28e-2)" "unprognostic (4.13e-2)" "unprognostic (6.62e-2)" "unprognostic (5.85e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.55e-5)" "unprognostic (1.19e-2)" "unprognostic (6.61e-3)" "unprognostic (2.93e-1)" "prognostic favourable (2.29e-4)" 7.2 2.8 4.6 41.8 4.9 17.5 6.1 2.0 4.5 13.9 7.3 5.9 2.4 5.7 13.4 4.5 3.3 11.4 12.9 2.8 4.9 3.8 3.9 5.6 11.2 30.4 4.9 3.3 9.9 3.4 0.8 3.6 2.8 4.9 5.3 4.7 7.1 10.2 4.2 1.6 2.5 18.4 8.8 3.6 43.1 7.3 3.9 4.8 71.2 4.0 4.5 42.9 6.1 6.4 7.2 8.8 16.6 6.1 11.9 16.6 6.4 1.4 1.5 1.8 1.3 12.7 1.4 7.9 1.5 1.9 1.5 1.2 2.7 1.6 17.2 1.6 1.4 3.3 1.2 0.4 0.5 31.6 0.7 1.8 0.7 1.7 15.1 16.7 18.9 2.5 2.8 1.3 1.4 2.7 1.6 20.8 0.6 2.4 30.0 21.7 6.8 1.7 18.6 0.3 3.9 14.4 0.8 0.9 1.7 0.4 1.4 4.6 3.9 9.2 4.3 0.8 1.7 0.3 1.4 4.4 4.8 14.6 1.0 8.5 0.7 8.0 6.1 9.6 16.6 4.6 13.1 6.5 8.9 14.1 4.1 7.2 7.9 10.6 16.6 11.9 4.1 8.8 7.0 6.4 4.6 4.9 2.0 4.5 4.9 3.8 4.9 3.3 4.9 4.8 AKR1A1 "ALR, DD3" ENSG00000117448 "Aldo-keto reductase family 1 member A1" P14550 1 45550543-45570049 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006246, HPA017919, HPA019649, HPA027734" Approved Supported Nucleoplasm,Cytosol 8100000 Cytosol Nucleoplasm "CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976" "unprognostic (1.73e-1)" "prognostic favourable (2.66e-6)" "unprognostic (4.03e-1)" "prognostic favourable (2.92e-4)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (1.31e-3)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (8.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.56e-2)" "unprognostic (2.46e-1)" "unprognostic (2.89e-2)" "unprognostic (4.57e-2)" 20.0 20.4 12.0 27.9 13.9 9.7 31.8 11.5 23.6 21.7 39.6 18.7 20.0 43.6 18.5 31.7 39.0 21.8 31.7 18.5 11.2 12.0 79.6 80.4 26.0 33.8 15.0 13.9 18.3 44.2 11.3 27.5 20.2 13.1 19.4 28.9 16.7 59.8 24.1 13.4 18.2 69.7 19.4 16.3 25.6 27.7 10.5 13.1 24.8 24.6 31.3 33.2 17.4 18.6 23.3 46.8 26.8 56.3 13.8 18.7 38.4 16.4 23.8 21.8 16.8 47.4 34.5 15.4 19.6 45.7 17.1 34.5 9.9 12.7 40.7 15.7 22.3 21.1 22.9 28.5 16.1 16.4 20.6 23.5 20.2 43.4 39.6 30.3 26.4 38.0 25.8 21.6 40.2 39.5 12.0 32.6 20.0 11.9 32.4 13.2 23.7 16.4 37.4 26.2 47.1 48.6 22.5 26.0 15.0 16.9 67.6 24.7 18.9 17.4 24.0 7.9 17.6 27.4 11.6 22.5 29.9 19.1 15.5 39.6 6.8 26.8 56.3 10.5 16.3 51.8 17.8 23.3 15.3 16.0 46.8 22.7 13.1 13.5 2.6 13.8 38.1 40.8 18.7 38.4 12.0 13.9 11.5 23.6 11.2 12.0 15.0 13.9 13.1 13.1 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell line enhanced" "Detected in many" "A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: " "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavourable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.3 121.0 13.6 19.3 58.9 16.0 36.3 13.0 222.0 19.1 24.8 5.6 12.3 0.0 6.0 21.7 5.7 14.8 12.9 15.2 4.8 13.6 6.8 18.2 16.4 84.4 0.0 0.0 14.9 9.7 27.3 7.3 26.9 0.0 4.5 21.1 0.2 20.0 9.2 22.7 0.1 20.9 8.7 10.1 105.0 65.4 10.2 22.7 90.9 0.1 9.5 0.0 10.2 21.2 18.9 8.8 1.7 14.1 12.5 13.7 33.8 99.9 0.0 11.3 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in some" 82 "A549: 252.0;Hep G2: 69.9" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: " "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favourable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavourable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 252.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 69.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549136-134579875 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 61.7;placenta: 31.8" "Cell line enhanced" "Detected in some" "A549: 15.1;HDLM-2: 12.0;Hep G2: 10.5;SK-BR-3: 5.1;U-87 MG: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: " "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favourable (8.36e-4)" "prognostic unfavourable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavourable (1.90e-5)" 2.7 0.1 0.1 0.1 0.1 0.0 61.7 0.1 0.2 1.6 0.6 0.2 0.1 5.6 0.1 1.5 3.8 0.0 2.2 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 31.8 0.2 0.8 0.2 0.5 2.9 0.1 11.6 1.9 1.7 0.8 0.4 0.1 5.0 0.6 0.1 0.3 0.4 16.1 1.8 1.5 3.0 0.1 0.0 1.8 0.1 0.4 0.0 0.3 0.0 15.1 0.1 0.0 0.6 0.5 0.9 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 12.0 0.0 0.1 0.1 10.5 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.2 3.1 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.5 5.1 0.0 0.0 0.3 0.0 0.1 0.7 0.3 0.0 0.2 0.2 0.2 6.5 0.2 0.2 1.8 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Group enriched" "Detected in many" 10 "ASC diff: 186.6;Hep G2: 316.4" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: " "unprognostic (1.54e-2)" "prognostic favourable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favourable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.6 0.1 25.8 186.6 22.5 0.0 0.8 5.7 0.3 0.2 0.5 0.0 0.0 0.3 5.8 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.2 316.4 1.8 0.1 0.0 11.4 1.6 2.7 1.6 0.6 5.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Group enriched" "Detected in some" 4 "A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: " "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 134.6 0.1 14.2 167.1 5.7 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 3.8 0.0 0.7 0.0 0.0 0.0 0.0 38.0 251.2 0.3 0.0 0.0 14.9 8.4 0.7 0.7 0.0 5.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.2 76.9 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.9 0.0 0.0 0.0 0.0 1.7 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell line enhanced" "Detected in many" "A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: " "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavourable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 149.2 0.1 43.6 85.8 30.9 0.0 0.0 2.1 0.0 0.1 4.4 2.5 0.0 8.1 2.0 1.2 0.1 2.9 0.0 0.3 0.0 0.2 46.2 62.6 0.4 0.0 0.0 17.1 6.1 2.0 0.0 2.8 0.9 0.0 3.9 0.3 1.0 0.2 0.0 0.4 0.3 0.9 4.4 14.7 58.9 0.0 0.3 21.4 0.0 0.0 0.0 0.0 20.8 0.5 0.4 9.0 0.3 0.0 0.0 0.0 5.0 5.9 0.4 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell line enriched" "Detected in some" 6 "HDLM-2: 11.8" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: , HPA068265: " "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.5" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA057002 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057002: " "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favourable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 AKR1E2 "AKR1CL2, AKRDC1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 35.0" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;RT4: 9.6;U-2197: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037821, HPA037822" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA037821: , HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 3.3 1.6 1.8 3.2 2.6 2.4 4.2 1.4 2.5 2.6 2.3 0.7 3.4 1.8 5.0 1.7 1.9 1.4 5.0 2.7 1.5 1.5 1.8 1.1 4.4 2.8 1.4 2.1 1.5 2.7 3.7 1.2 2.6 1.9 1.7 1.7 5.0 1.9 2.6 2.3 2.0 1.7 2.9 2.1 1.5 2.1 35.0 0.9 0.8 4.5 2.0 0.6 1.7 2.9 0.1 1.8 3.2 0.4 0.0 1.4 0.3 0.4 5.3 2.0 0.9 0.0 0.0 0.1 2.1 0.1 0.1 0.0 8.2 0.8 0.0 0.0 5.3 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 1.0 5.6 1.0 0.0 6.0 4.6 0.0 0.0 4.9 0.6 0.0 2.2 3.9 0.0 0.0 0.0 1.5 9.6 0.0 4.5 7.7 2.1 4.1 4.1 2.2 3.6 0.0 1.8 18.3 0.0 2.5 0.0 0.0 0.1 0.0 1.5 3.2 0.4 0.3 0.1 0.2 0.0 0.1 0.4 0.2 1.6 0.0 1.4 0.4 0.1 0.0 0.0 1.8 0.0 0.3 1.8 2.6 1.4 2.5 1.5 1.5 1.4 2.1 1.9 0.9 AKT1 "AKT, PKB, PRKBA, RAC" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 30.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 30.7" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favourable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favourable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 31.7 45.4 22.9 24.2 23.6 20.3 40.0 20.9 29.5 24.7 32.6 20.0 30.8 22.5 27.0 21.5 33.0 25.5 30.3 47.7 22.9 19.1 26.3 49.2 31.3 21.0 22.1 14.7 25.9 43.0 20.3 16.7 28.4 21.5 31.1 18.2 25.3 30.4 36.1 23.8 20.4 24.0 40.5 17.5 35.4 32.6 16.2 18.8 26.3 32.7 22.4 29.3 36.7 35.9 3.2 5.2 30.7 5.8 5.7 6.2 3.0 15.1 30.3 25.0 37.2 19.4 20.1 28.0 27.9 34.0 41.3 33.1 19.8 18.3 18.3 21.5 38.2 19.7 17.7 26.0 18.0 41.8 7.2 13.9 18.1 21.3 21.5 22.6 36.3 28.8 21.9 20.7 13.8 30.8 12.1 20.4 26.4 113.2 28.4 28.9 6.5 21.7 26.8 23.2 12.5 19.1 37.7 28.7 23.9 23.3 30.5 17.5 39.9 33.7 24.6 27.7 13.3 39.4 28.0 22.2 10.7 15.8 23.3 19.1 33.3 3.3 5.3 30.7 5.4 5.2 4.0 2.9 4.8 6.2 3.6 3.2 2.5 5.7 11.8 5.7 5.8 5.2 4.7 3.0 22.9 23.6 20.9 29.5 22.9 19.1 22.1 14.7 21.5 18.8 AKT2 ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: " "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavourable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 31.1 20.3 15.4 17.6 15.2 21.3 18.2 46.3 18.2 23.3 18.2 23.4 21.2 12.3 22.8 28.0 22.1 22.7 14.0 23.1 15.4 10.0 23.0 62.5 14.6 17.8 17.9 13.3 27.8 24.5 21.1 24.0 17.5 14.7 19.7 12.3 26.8 18.5 24.3 48.5 18.3 17.1 20.0 16.8 18.7 15.5 21.3 15.7 26.6 52.6 29.5 23.6 19.6 19.9 6.3 8.8 7.7 4.4 3.2 4.9 2.4 22.4 55.4 21.1 21.7 26.3 32.2 11.7 15.0 22.2 31.1 27.8 24.3 20.9 22.9 13.4 33.1 9.8 23.4 31.3 20.1 21.9 26.7 15.0 35.1 15.3 16.5 17.2 18.1 29.7 18.8 21.1 20.1 6.7 19.3 24.0 17.3 18.7 27.3 8.4 11.4 14.9 18.2 11.5 16.5 24.2 36.8 29.1 17.8 15.4 26.4 12.5 20.8 22.2 6.7 19.0 18.8 17.0 23.5 22.4 19.2 18.8 18.6 20.4 15.5 7.6 4.4 3.6 4.5 2.0 4.5 3.9 3.6 3.0 3.0 6.3 3.5 4.9 7.7 3.2 2.6 8.8 2.7 2.4 15.4 15.2 46.3 18.2 15.4 10.0 17.9 13.3 14.7 15.7 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.0;HUVEC TERT2: 24.4;TIME: 29.9;U-2197: 25.5" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.7 0.0 8.2 3.7 1.1 1.0 0.0 4.2 0.0 0.9 5.6 0.9 0.1 19.0 1.8 0.8 0.1 0.1 3.3 0.3 0.4 0.2 0.5 1.3 1.3 0.4 6.7 24.4 0.2 3.2 7.0 0.4 0.7 0.3 0.2 11.2 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.7 0.4 0.0 29.9 3.1 1.2 25.5 3.2 1.7 1.5 0.1 7.2 0.0 7.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.7 7.7 3.8 2.6 8.9 0.5 2.3 6.4 6.1 0.7 0.9 5.5 0.5 1.8 7.6 3.4 4.8 14.8 22.4 0.9 0.3 5.0 2.0 2.0 3.0 9.8 5.8 0.0 14.1 4.5 7.3 7.8 0.9 7.8 5.2 2.8 1.7 0.8 2.1 0.0 0.3 4.0 5.3 4.8 4.6 7.7 2.0 0.2 6.3 3.1 4.9 6.4 0.0 8.3 0.4 7.0 5.2 1.7 8.3 1.5 5.0 1.6 5.5 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 AL132780.3 ENSG00000259132 14 22946270-22982258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA029803 Approved Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA029803: AB_10601428" 4.8 6.2 4.5 4.7 5.5 6.6 5.3 3.5 2.4 16.1 7.1 2.3 7.1 5.5 12.4 9.2 16.2 6.6 11.2 6.0 4.6 3.8 20.4 24.5 10.5 7.9 5.3 1.9 11.8 13.8 0.0 3.5 18.1 3.8 13.1 6.1 10.4 5.7 16.0 6.2 8.8 4.5 3.5 4.5 11.3 4.5 6.0 1.9 10.3 22.1 7.7 9.6 5.0 7.9 3.3 5.7 10.2 5.9 1.1 4.1 2.8 4.0 8.7 6.1 2.0 6.0 7.1 3.9 0.7 5.7 3.6 3.8 2.9 3.1 0.0 2.4 6.7 1.5 2.8 3.1 2.6 0.0 0.7 1.3 6.7 27.6 3.9 3.2 2.6 3.1 8.1 2.8 6.8 5.0 0.0 6.0 3.9 16.5 6.9 11.8 3.0 1.9 3.3 4.3 3.8 10.1 8.2 3.4 2.0 2.7 3.6 1.7 5.4 6.9 1.0 4.6 3.4 1.9 3.4 5.9 7.2 6.2 1.5 3.2 2.8 0.5 5.9 2.1 2.5 4.2 1.2 2.7 1.8 2.1 5.7 3.3 3.4 1.7 10.2 1.1 2.9 2.6 4.1 2.8 4.5 5.5 3.5 2.4 4.6 3.8 5.3 1.9 3.8 1.9 AL136454.1 ENSG00000231767 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 7.4;SK-MEL-30: 6.5;THP-1: 7.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: , HPA049132: , HPA054087: " "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favourable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 1.7 0.9 0.3 2.3 0.6 1.9 2.6 0.9 0.9 1.3 0.7 0.0 3.9 2.8 1.8 2.5 0.8 0.7 1.8 0.8 0.5 1.2 0.4 1.3 3.3 1.7 0.2 2.6 7.3 0.0 0.0 0.6 0.8 1.5 0.0 0.4 5.9 4.2 3.4 0.1 1.6 0.6 0.7 3.0 1.2 0.4 1.0 0.2 0.6 2.5 0.8 3.0 2.3 6.1 2.6 1.3 1.9 4.5 7.4 6.4 1.7 0.7 0.5 1.0 0.5 0.0 4.3 0.2 0.9 0.0 0.6 0.0 1.3 0.4 4.3 0.0 1.7 0.3 0.5 0.0 1.4 0.9 0.7 0.9 3.2 0.4 1.2 2.2 0.5 0.8 0.3 0.0 0.3 0.2 1.3 0.0 0.9 1.5 7.4 1.9 0.4 1.7 0.5 1.0 0.6 2.1 1.3 2.7 0.3 2.6 6.5 1.7 7.6 0.8 1.1 2.0 1.4 3.9 2.5 1.8 1.4 1.4 1.2 0.2 1.3 1.4 0.7 3.2 1.9 4.6 6.1 5.7 3.5 2.6 5.8 7.4 7.0 0.4 4.5 1.4 2.4 3.6 6.4 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0;THP-1: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.4 0.8 0.0 0.8 0.2 6.6 1.0 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 0.5 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 AL139260.3 ENSG00000274944 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.3;testis: 15.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.3" "Low lineage specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: " "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.2 0.0 0.4 1.3 0.9 0.0 0.4 0.4 1.0 0.4 3.3 0.6 0.4 2.0 0.4 0.4 3.0 0.0 0.4 0.4 0.4 0.5 1.5 0.4 2.7 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.6 0.4 2.3 1.8 2.3 0.4 0.4 1.5 2.1 0.4 0.4 0.4 2.4 15.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 7.3 2.8 4.0 0.0 1.7 0.0 12.3 1.3 3.2 0.0 0.6 0.0 3.6 0.4 0.0 0.0 0.5 6.6 13.1 2.4 11.2 0.2 9.1 0.0 0.9 0.0 7.8 2.1 2.7 2.5 2.2 0.0 16.8 4.9 0.0 0.0 1.6 1.1 2.0 6.3 4.5 1.6 3.2 6.8 15.9 6.5 7.7 7.8 7.9 12.5 0.0 6.9 6.2 3.3 7.6 7.2 1.5 4.1 5.2 5.8 2.3 6.4 6.2 11.4 1.5 11.6 9.3 5.6 7.3 2.6 0.0 1.3 0.2 0.5 1.9 1.1 3.0 0.2 0.5 4.2 2.0 0.4 0.4 2.8 0.0 4.0 7.3 1.7 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: , HPA052450: " "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 11.9 13.1 1.1 7.2 8.9 5.7 18.3 14.1 20.7 13.1 7.2 9.6 16.0 11.9 13.2 6.2 8.7 10.5 13.1 5.4 1.0 6.1 6.2 6.7 9.6 8.4 3.7 6.9 2.8 9.8 11.3 11.8 8.2 4.1 14.9 11.9 13.1 3.1 9.0 14.9 5.8 10.3 8.6 10.6 7.3 17.1 10.5 10.9 4.6 10.2 10.1 4.8 8.3 9.1 7.2 14.6 8.6 5.3 6.2 18.3 15.3 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: " "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 5.9 5.4 7.0 4.5 2.2 4.9 4.7 1.4 2.9 3.4 0.9 2.3 0.0 0.6 3.1 1.3 3.5 1.6 0.5 12.6 0.6 0.0 27.7 1.7 1.1 2.5 4.4 2.4 1.9 1.8 1.8 0.8 3.1 7.2 2.1 0.0 0.5 2.6 4.5 1.5 0.0 5.2 0.9 5.3 0.0 5.6 9.1 3.3 1.1 7.9 2.8 7.2 1.1 10.4 14.5 3.3 1.1 7.7 2.6 1.0 12.9 1.5 14.3 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;HUVEC TERT2: 2.1;REH: 9.6;U-2 OS: 2.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: , HPA070714: " 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 2.8 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 AL592490.1 ENSG00000197991 13 61409858-61427849 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 1.6;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.5;Karpas-707: 2.4;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Cell line enhanced" "Detected in many" "Daudi: 16.8;HDLM-2: 11.2;HEL: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.0 3.1 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.2 16.8 2.0 0.2 7.6 1.6 1.7 0.6 11.2 0.2 12.2 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 3.0 2.8 0.2 0.6 1.4 0.9 0.2 2.8 5.9 0.6 5.4 0.0 0.0 0.3 0.3 0.5 5.2 1.3 5.0 1.3 0.0 1.2 1.9 0.4 0.6 1.4 2.8 7.5 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favourable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favourable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.4 16.2 11.5 10.6 18.0 13.4 31.4 15.4 14.3 20.6 20.0 21.6 19.8 9.8 3.9 10.7 6.2 16.5 12.6 16.9 19.0 6.4 12.6 12.8 16.4 25.5 20.4 25.3 16.7 11.9 32.7 10.9 18.8 7.4 8.1 18.7 8.5 9.6 31.0 9.9 28.2 5.8 7.2 15.5 18.1 63.4 6.1 4.0 24.9 12.3 13.9 7.0 29.0 13.5 11.5 11.4 23.7 22.2 12.0 20.8 14.8 12.9 22.1 18.3 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 ALB ENSG00000163631 Albumin P02768 4 73397114-73421412 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 3075.8" "Cell line enriched" "Detected in some" 39 "Hep G2: 308.4" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 4.9 3075.8 0.1 0.1 0.1 0.1 0.1 38.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 308.4 0.0 7.9 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 6.8 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 0.0 2.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.1 ALDH1A3 "ALDH6, RALDH3" ENSG00000184254 "Aldehyde dehydrogenase 1 family member A3" P47895 15 100877714-100916626 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 42.0;HaCaT: 52.3;HBEC3-KT: 129.5;U-2197: 74.4;U-87 MG: 59.2;WM-115: 61.1" "Group enriched" "Detected in many" 7 "melanoma: 16.8;prostate cancer: 80.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA046271, HPA064749" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046271: AB_10965992, HPA064749: " "unprognostic (6.87e-2)" "unprognostic (2.23e-1)" "unprognostic (6.20e-3)" "unprognostic (1.21e-3)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (6.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.62e-2)" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (2.56e-1)" "unprognostic (1.25e-2)" "unprognostic (2.61e-2)" "unprognostic (2.12e-1)" "unprognostic (7.34e-2)" "unprognostic (6.07e-3)" 30.3 5.7 2.3 14.9 1.6 0.0 11.1 4.1 2.6 14.2 11.5 1.6 10.5 5.2 5.9 37.9 10.5 11.5 15.0 6.1 2.1 2.0 3.7 1.7 4.2 5.5 2.6 1.7 9.0 7.4 3.2 13.2 5.1 3.9 51.9 3.2 49.9 41.5 19.2 6.1 1.7 15.6 14.2 6.4 1.5 5.3 15.9 0.7 0.6 0.9 15.2 18.9 18.0 9.8 0.3 1.5 2.1 0.2 0.0 0.0 0.1 42.0 5.6 0.0 0.0 9.3 4.1 0.1 0.3 0.3 0.2 0.1 0.1 33.7 0.3 0.5 11.3 52.3 1.0 129.5 0.8 0.0 0.2 0.2 2.3 0.0 3.1 0.1 0.2 2.9 3.6 2.9 0.5 0.4 0.0 0.2 0.2 0.4 0.0 0.2 1.1 34.2 0.0 0.5 0.2 0.0 35.3 0.0 3.0 13.1 11.5 3.9 1.1 0.3 6.6 0.0 0.1 74.4 1.6 0.0 0.3 0.2 59.2 0.0 61.1 1.0 0.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 2.3 1.6 4.1 2.6 2.1 2.0 2.6 1.7 3.9 0.7 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021037 Approved Supported Nucleoplasm,Vesicles,Mitochondria 210000 Mitochondria "Nucleoplasm, Vesicles" "HPA021037: AB_1844724" "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favourable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 23.9 22.3 6.9 11.0 9.8 11.7 5.5 11.5 5.8 9.7 10.0 14.9 4.7 15.1 6.9 16.1 3.4 22.7 24.3 9.7 16.9 9.8 7.5 16.4 44.2 7.1 11.9 8.5 13.9 5.3 7.9 6.9 9.2 21.6 14.8 14.7 9.1 0.0 4.8 20.5 10.0 4.9 41.8 11.5 8.7 10.8 15.1 7.0 8.7 5.8 6.7 5.5 9.3 6.2 11.2 18.6 9.3 14.3 2.2 4.3 6.0 5.8 12.2 7.6 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell line enriched" "Detected in some" 20 "A549: 321.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: , HPA063783: " "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favourable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 321.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 16.1 0.0 0.1 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023296 Enhanced Supported Mitochondria,Cytosol 140000 Mitochondria Cytosol "HPA023296: AB_1844738" "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favourable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 14.8 9.8 27.8 46.0 23.2 13.8 35.5 17.8 22.0 20.7 26.8 27.6 14.3 0.0 18.2 13.9 11.1 8.6 60.2 19.1 0.0 10.4 2.8 14.7 23.4 11.3 0.0 0.0 16.9 14.2 16.1 11.6 16.5 0.0 0.0 18.2 9.7 0.6 0.0 18.8 8.3 8.9 31.6 0.0 19.7 11.3 9.5 11.3 0.0 9.8 10.3 17.7 0.6 20.0 6.0 18.6 6.9 12.2 0.0 0.0 0.0 3.2 0.0 9.6 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 62.2;U-266/70: 42.9" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavourable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.4 0.5 3.5 14.4 7.2 7.4 0.7 3.8 8.6 2.9 18.1 4.3 0.7 3.5 4.6 3.4 9.7 2.3 23.6 5.5 3.0 2.2 6.7 2.7 7.4 6.8 2.4 7.8 6.8 3.3 0.3 5.9 1.3 4.6 18.8 2.5 3.5 2.8 8.1 5.4 3.9 2.4 0.4 62.2 0.4 1.0 9.2 16.4 2.2 17.7 0.1 9.6 5.5 0.9 0.3 1.4 0.5 0.6 42.9 12.3 2.6 28.1 7.0 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033960-5087379 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favourable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.0 22.2 8.7 10.8 12.8 6.6 12.8 9.3 18.8 13.7 16.4 14.9 10.1 14.7 12.1 17.0 11.7 12.4 14.3 8.1 8.8 10.4 18.9 31.6 9.9 12.7 10.5 6.5 10.1 27.9 21.5 13.6 10.7 14.6 10.8 17.2 15.5 20.6 12.0 7.3 9.1 12.8 12.1 9.4 16.2 16.5 19.4 11.4 16.0 15.0 8.7 14.5 12.1 8.7 20.7 24.3 7.8 23.3 20.9 26.5 31.7 6.4 17.6 4.4 8.3 17.0 10.1 8.2 14.5 20.4 19.0 19.0 14.5 23.9 13.7 12.5 18.5 17.4 12.1 14.3 12.9 11.2 13.8 7.7 14.6 29.9 13.9 13.4 13.5 12.3 10.9 14.9 9.4 11.3 9.6 18.0 14.1 17.5 8.6 16.5 16.8 10.1 16.0 6.1 38.2 11.8 7.0 7.5 7.6 15.5 24.3 8.3 15.8 11.0 10.8 8.8 8.2 45.0 12.1 13.1 15.8 9.3 7.3 14.4 12.5 3.3 23.3 7.8 26.5 21.6 23.1 19.8 22.9 25.4 24.3 20.7 21.0 23.7 1.5 20.9 21.2 21.2 21.6 31.7 8.7 12.8 9.3 18.8 8.8 10.4 10.5 6.5 14.6 11.4 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA031829: " "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.1 3.3 2.8 2.5 2.2 3.7 2.5 3.7 4.0 3.9 3.3 3.8 1.8 2.7 3.9 4.6 3.6 3.2 3.6 4.7 5.7 5.4 1.5 3.6 5.8 3.5 3.6 1.0 4.1 3.6 2.9 2.9 3.3 2.8 3.5 3.7 2.5 3.8 2.3 1.7 4.7 2.4 5.6 2.9 4.3 3.0 2.5 3.2 2.1 7.1 6.2 3.1 3.1 2.5 2.5 2.7 4.4 7.8 2.2 2.1 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 ALG1L2 ENSG00000251287 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 3.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;HDLM-2: 1.9;HEL: 1.7;Karpas-707: 1.3;REH: 2.8" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 4.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 4.0" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favourable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.1 0.7 4.0 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.5 0.1 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.6 0.3 0.3 0.4 0.1 0.0 0.0 0.0 4.0 0.9 0.1 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2, alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216426-99221956 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Enhanced "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favourable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favourable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 12.5 28.0 9.2 9.4 9.7 10.5 16.4 13.1 12.5 18.8 12.9 11.6 31.1 11.0 15.2 39.2 12.3 15.8 13.9 12.1 8.3 9.5 24.8 45.5 16.0 12.8 10.8 6.5 18.4 43.4 14.7 22.4 22.5 12.0 16.7 14.9 14.7 24.1 32.6 13.3 8.7 15.5 12.6 11.3 15.9 15.0 12.6 9.7 14.8 26.0 9.9 15.8 12.9 11.8 16.8 41.0 18.2 18.5 17.5 26.4 17.8 8.1 11.0 8.1 11.6 30.1 19.6 16.7 16.7 26.6 17.1 14.9 13.1 11.8 8.8 7.8 19.2 32.3 13.7 17.9 17.2 13.3 6.3 5.2 8.7 19.4 36.2 9.2 9.9 21.4 23.4 14.5 26.4 19.1 9.1 19.9 15.8 17.1 4.6 10.9 10.5 15.5 5.4 16.5 13.7 22.9 10.4 8.7 7.1 12.3 22.7 21.5 9.2 7.8 13.6 11.7 11.6 14.9 10.4 18.7 10.1 3.8 22.0 7.3 5.7 18.2 18.5 11.2 18.6 14.6 26.4 16.8 17.7 18.4 23.0 13.3 15.4 15.0 5.0 17.5 12.9 41.0 18.8 17.8 9.2 9.7 13.1 12.5 8.3 9.5 10.8 6.5 12.0 9.7 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708020 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" Nucleoplasm "Endoplasmic reticulum" "HPA044087: , HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favourable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 8.2 8.5 6.2 6.7 8.6 2.7 9.7 9.6 8.8 9.7 9.1 8.2 4.5 6.5 7.0 5.9 7.1 8.0 5.8 11.1 5.4 5.7 7.9 9.4 5.9 8.3 6.5 3.7 8.3 7.9 8.4 11.2 10.2 6.4 9.3 9.1 9.9 7.2 8.7 16.5 8.2 6.7 7.8 5.5 8.3 7.8 9.9 6.6 12.7 8.8 6.5 10.3 8.5 9.4 5.4 4.9 11.4 5.7 5.2 5.3 3.2 5.2 7.8 6.4 4.3 6.9 7.5 8.0 5.5 7.2 12.2 13.7 7.9 3.2 8.1 3.1 5.0 4.8 13.9 5.9 14.4 5.5 5.4 4.3 4.6 6.6 9.7 4.5 2.8 6.4 9.9 7.1 11.3 9.9 6.6 4.7 6.5 8.3 6.0 5.9 7.0 10.1 6.1 6.5 5.4 7.0 4.7 8.2 6.1 4.5 4.7 5.9 11.6 4.7 4.5 5.1 5.2 5.6 4.4 5.9 9.3 7.9 3.4 6.5 5.0 11.4 5.0 2.2 5.0 5.7 4.3 5.4 4.7 5.0 4.9 4.9 5.0 3.9 1.4 5.2 3.8 2.6 5.3 3.2 6.2 8.6 9.6 8.8 5.4 5.7 6.5 3.7 6.4 6.6 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase" Q96Q83 11 43880811-43920266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: " "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 17.6 14.2 14.3 13.2 16.7 8.6 26.5 21.2 22.7 19.1 15.7 19.5 12.8 13.2 22.6 31.2 16.2 20.0 16.4 12.5 14.3 13.4 15.6 25.8 15.1 17.3 15.0 14.4 21.8 23.5 22.1 16.6 9.1 15.6 19.1 16.6 19.5 25.5 19.1 29.1 20.2 15.0 18.3 14.8 17.8 17.0 17.3 12.1 14.5 16.4 21.4 22.2 15.2 17.4 14.9 18.5 21.2 21.0 17.1 21.3 13.8 7.4 12.9 5.1 0.0 10.0 12.9 0.0 9.0 20.0 18.1 17.8 6.0 5.7 1.1 5.7 13.6 10.1 7.0 15.6 16.9 0.0 24.7 10.8 8.7 12.6 24.9 19.8 14.5 13.6 27.1 8.0 39.1 13.0 15.3 11.8 9.0 8.8 17.8 10.2 9.4 19.0 5.2 11.1 13.9 10.9 11.6 9.7 7.8 7.0 11.0 16.5 15.9 12.2 9.1 10.3 5.7 16.8 12.9 10.7 11.2 12.0 15.3 8.4 8.4 21.2 12.9 7.1 17.0 14.1 16.2 14.4 17.4 15.1 18.5 14.9 21.3 18.9 2.3 17.1 21.0 16.3 16.2 13.8 14.3 16.7 21.2 22.7 14.3 13.4 15.0 14.4 15.6 12.1 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favourable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavourable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.5 32.4 13.2 23.7 19.4 13.4 11.5 16.2 20.1 26.7 24.9 36.6 8.9 21.3 24.0 17.8 22.2 19.8 17.1 13.7 24.3 27.0 15.6 18.4 20.4 18.1 11.2 20.9 12.8 11.7 20.0 11.9 15.4 16.9 9.7 14.8 24.9 24.2 12.6 11.1 16.6 22.0 26.0 37.3 7.8 11.6 13.6 17.9 20.2 14.1 18.5 14.2 9.7 15.6 25.7 18.0 37.7 31.7 11.4 8.6 12.8 46.7 18.5 16.8 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 ALKBH6 MGC15677 ENSG00000239382 "AlkB homolog 6" Q3KRA9 19 36009120-36014239 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073835, HPA074340" Approved Supported "Nucleoplasm,Focal adhesion sites" Nucleoplasm "Focal adhesion sites" "HPA073835: , HPA074340: " "unprognostic (1.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (5.86e-5)" "unprognostic (6.21e-2)" "unprognostic (4.53e-2)" "unprognostic (3.95e-1)" "unprognostic (3.56e-2)" "unprognostic (8.78e-4)" "unprognostic (1.77e-2)" "unprognostic (2.31e-5)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (3.82e-1)" "unprognostic (1.05e-3)" 8.4 7.0 14.1 6.4 15.2 6.8 6.3 7.8 18.9 5.8 8.2 7.8 2.5 6.6 6.5 6.6 6.5 8.2 7.7 9.2 13.0 14.9 5.7 12.6 6.8 8.7 14.8 12.5 5.4 3.4 8.2 8.5 6.2 19.5 9.7 4.6 6.5 8.7 9.9 6.3 5.8 6.4 8.5 10.5 8.9 9.6 4.2 4.9 5.7 6.2 3.7 8.4 7.2 4.7 18.1 13.5 29.5 15.0 15.7 19.5 9.4 10.3 11.1 4.2 6.2 6.6 4.0 7.1 10.3 6.9 12.1 12.3 4.6 5.5 9.1 16.5 5.7 4.1 4.4 11.9 6.4 14.3 8.0 5.2 4.2 4.9 7.5 4.5 16.0 6.0 8.6 10.0 3.4 8.2 8.1 6.9 6.5 10.8 10.8 5.9 3.3 7.2 6.9 5.8 6.5 8.7 4.6 5.1 5.3 7.0 8.4 8.6 6.7 10.2 3.5 6.3 9.3 14.3 10.0 13.0 7.7 6.4 13.7 5.1 6.7 29.5 11.4 27.3 17.1 15.0 13.0 18.1 15.5 16.1 9.6 14.6 13.2 12.8 9.6 15.7 11.7 13.5 19.5 9.4 14.1 15.2 7.8 18.9 13.0 14.9 14.8 12.5 19.5 4.9 ALKBH8 "MGC10235, TRM9, TRMT9A" ENSG00000137760 "AlkB homolog 8, tRNA methyltransferase" Q96BT7 11 107502726-107565746 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Oxidoreductase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038724, HPA038725, HPA061514" Approved Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038724: , HPA038725: AB_10674838, HPA061514: " "unprognostic (2.66e-2)" "unprognostic (3.82e-1)" "unprognostic (8.19e-2)" "unprognostic (3.76e-1)" "unprognostic (4.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (1.95e-1)" "unprognostic (4.45e-2)" "unprognostic (7.67e-2)" "unprognostic (1.89e-2)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.34e-3)" "unprognostic (1.01e-1)" 9.7 6.7 7.2 14.1 12.6 6.1 11.3 9.9 11.7 8.6 7.4 7.6 9.4 6.7 9.5 7.1 9.8 7.4 6.0 12.4 7.4 7.6 9.2 9.5 7.5 11.5 7.2 5.5 9.9 7.0 13.4 10.0 6.9 7.9 8.9 7.9 8.1 7.7 7.5 12.6 9.7 7.8 9.0 7.0 10.8 6.8 5.8 5.8 9.2 11.1 5.7 12.0 8.9 8.1 3.7 3.3 0.5 4.1 4.8 6.2 2.2 4.9 6.0 6.3 6.8 3.5 7.7 5.1 9.5 7.0 7.0 7.6 11.1 9.0 11.5 5.5 9.1 8.9 9.3 7.6 9.2 10.3 6.1 9.6 2.3 5.1 5.2 12.2 11.9 4.7 8.7 9.0 11.5 8.7 13.6 3.9 5.5 4.4 11.0 6.2 8.2 9.9 10.1 9.7 8.0 5.6 5.4 5.7 6.3 5.4 4.1 4.0 6.8 3.7 8.1 15.3 9.2 5.0 11.8 3.6 3.8 9.0 4.3 8.3 15.0 0.0 2.0 0.5 4.5 4.1 4.3 1.9 3.3 3.9 3.3 3.7 6.2 5.2 0.0 4.8 2.7 2.0 3.5 2.2 7.2 12.6 9.9 11.7 7.4 7.6 7.2 5.5 7.9 5.8 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell line enhanced" "Detected in all" "RH-30: 23.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035276, HPA035277, HPA043200" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA035277: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.4 3.3 6.2 4.5 2.4 4.0 3.9 2.9 3.2 4.8 3.6 3.7 1.1 7.9 1.8 4.8 3.7 10.4 3.2 7.2 4.7 2.9 5.3 3.7 2.9 2.1 7.3 2.6 3.1 1.9 6.6 3.3 4.2 5.9 4.2 4.0 2.5 6.9 3.3 8.0 3.1 7.7 23.8 3.3 1.2 3.0 5.1 6.0 6.6 1.1 2.7 1.4 1.8 2.6 6.7 7.0 5.3 6.9 4.9 2.5 8.5 2.5 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 5 "A-431: 17.1;HEL: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Cytosol" 5800000 Cytosol "Nuclear speckles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.1 2.9 1.3 1.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 2.5 0.6 0.8 0.6 0.0 2.2 0.0 0.1 0.0 1.8 2.2 27.4 3.8 1.8 0.1 0.2 4.5 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.2 0.3 0.6 0.9 0.6 0.9 0.5 0.4 0.0 2.2 0.1 0.6 0.5 0.5 0.2 1.0 0.7 3.2 1.5 0.8 1.4 0.7 0.5 0.2 0.5 0.8 2.0 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell line enhanced" "Detected in some" "HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA010562: " "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 12.7 26.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell line enhanced" "Detected in some" "A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: " "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.5 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 0.4 0.9 10.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.8 0.1 14.8 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 4.7 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell line enhanced" "Detected in many" "HMC-1: 52.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA046588: " "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.5 9.1 12.4 12.2 14.1 8.4 5.1 0.6 4.0 9.5 5.3 5.0 9.2 15.4 1.7 5.0 12.1 3.5 4.8 7.4 9.6 52.8 5.6 5.2 10.2 8.8 12.2 5.7 3.6 9.2 4.1 3.4 12.6 7.3 5.5 2.8 4.9 1.8 7.7 7.0 4.1 5.4 5.3 5.8 8.2 3.7 4.0 7.3 10.7 5.1 3.7 4.6 4.1 5.6 2.1 7.8 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.9;U-2197: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.0 1.4 5.6 2.2 0.1 1.5 0.5 1.2 0.8 0.0 0.4 0.7 1.2 2.1 2.0 0.7 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.8 1.0 0.5 1.3 0.3 0.2 1.0 2.9 1.2 0.0 1.1 1.8 0.6 1.2 0.5 1.0 1.3 0.7 0.5 0.5 1.3 1.6 0.0 6.9 1.5 2.4 1.5 2.8 1.7 9.4 1.0 1.6 3.0 1.0 2.7 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280107-85301784 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.9" "Cell line enhanced" "Detected in some" "HAP1: 6.8;HEK 293: 15.2;HUVEC TERT2: 11.1;SK-MEL-30: 18.3;THP-1: 12.0;WM-115: 9.7" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 1.9 0.0 0.1 0.0 0.2 0.0 4.8 0.0 0.2 5.4 0.1 0.0 0.8 0.0 5.4 8.5 0.1 4.7 0.0 0.1 0.2 0.2 8.3 0.0 0.1 0.0 0.2 0.0 3.6 0.1 0.0 1.6 0.1 0.0 1.6 0.0 13.9 3.8 2.0 0.4 3.3 0.1 1.1 0.0 0.0 0.1 1.5 0.0 0.0 0.2 4.0 0.0 2.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.3 0.0 0.0 15.2 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 5.6 0.0 0.0 0.0 1.8 3.9 0.0 0.0 18.3 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell line enhanced" "Detected in many" "U-266/70: 58.5;U-266/84: 30.5" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favourable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.0 6.5 3.7 4.7 2.6 4.0 6.3 5.4 4.0 2.5 1.9 21.1 4.9 1.3 2.9 7.6 1.9 0.9 3.9 2.6 4.0 3.4 3.1 4.7 6.1 1.8 1.9 1.0 6.1 1.9 3.2 1.2 2.8 1.1 4.8 7.3 2.9 1.5 2.4 3.3 10.6 1.9 6.1 2.0 11.1 20.3 2.0 2.8 8.9 6.4 5.4 4.9 1.9 5.0 8.3 1.8 2.0 4.3 58.5 30.5 2.3 2.3 3.9 6.1 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.1" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078472 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "liver: 592.2" "Cell line enriched" "Detected in some" 154 "Hep G2: 164.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" 71000000000 "Golgi apparatus" Cytosol "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favourable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.1 0.0 0.0 1.7 592.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 164.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AMBRA1 "DCAF3, FLJ20294, KIAA1736, WDR94" ENSG00000110497 "Autophagy and beclin 1 regulator 1" Q9C0C7 11 46396414-46594125 "Predicted intracellular proteins" "Autophagy, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017825, HPA038535" Approved Approved Vesicles,Mitochondria Vesicles Mitochondria "CAB017825: , HPA038535: " "unprognostic (1.76e-3)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.56e-1)" "unprognostic (6.00e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-3)" "unprognostic (7.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.98e-2)" "unprognostic (5.53e-3)" "unprognostic (2.32e-1)" "prognostic favourable (1.61e-4)" "unprognostic (2.90e-1)" "unprognostic (8.17e-2)" "unprognostic (1.61e-2)" "unprognostic (7.98e-2)" 15.4 26.4 15.8 18.4 20.6 19.4 20.5 25.6 24.6 16.6 15.4 23.5 12.0 18.9 18.7 15.1 15.5 18.0 15.5 13.1 14.5 11.4 13.7 14.6 14.7 15.0 15.5 18.4 21.4 13.7 33.5 23.2 17.8 15.8 15.3 14.0 20.2 17.0 20.4 18.7 25.8 17.0 17.4 12.7 17.4 15.7 18.9 17.4 26.3 16.9 10.8 18.2 14.6 14.9 3.4 3.0 12.9 2.9 2.0 4.5 2.2 6.8 18.5 12.8 13.8 13.6 10.2 8.0 6.8 13.2 11.2 11.8 13.9 12.1 13.9 7.1 12.2 12.5 6.4 12.1 8.3 12.0 20.8 9.4 11.7 17.7 8.9 13.6 12.1 14.1 9.6 7.1 13.6 11.6 16.2 9.6 8.3 16.9 17.3 9.6 21.4 10.2 17.0 17.5 7.7 10.9 12.4 10.4 11.6 11.9 13.6 12.5 14.1 9.2 12.3 10.4 9.3 12.0 10.2 11.0 8.7 14.5 9.2 7.7 9.2 12.9 2.9 2.2 3.8 1.5 3.2 3.4 2.8 2.9 2.8 3.4 2.9 2.6 3.4 2.0 2.6 3.0 4.5 2.2 15.8 20.6 25.6 24.6 14.5 11.4 15.5 18.4 15.8 17.4 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell line enhanced" "Detected in many" "A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.1 4.2 0.3 2.8 0.1 0.0 4.3 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 3.6 0.1 0.0 0.1 6.6 0.7 1.8 2.9 3.7 0.0 2.5 21.1 0.0 0.1 0.3 0.0 0.1 1.3 26.1 0.0 2.9 1.6 4.7 2.0 1.0 3.5 0.1 2.1 0.0 1.8 2.2 3.1 17.5 19.6 2.2 2.0 3.6 0.0 2.7 9.5 3.4 2.4 21.1 24.7 2.6 1.9 5.1 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol 69000 "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favourable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 12.8 16.9 8.6 11.4 10.1 12.7 10.9 7.3 16.0 9.4 8.8 11.1 11.3 19.5 10.4 11.9 8.4 9.0 14.6 11.8 7.1 4.8 15.3 10.5 20.0 15.8 9.8 11.3 8.1 10.1 6.5 7.5 10.7 8.9 8.6 2.4 10.9 16.1 9.6 10.2 15.0 19.1 7.2 8.3 22.2 11.5 25.7 7.9 7.3 9.9 11.0 8.9 9.3 8.0 9.8 17.1 16.6 15.8 4.9 8.1 4.8 6.4 8.8 1.9 4.0 2.1 1.7 14.3 5.9 2.5 4.7 5.9 6.3 11.6 3.0 4.2 1.1 5.9 1.1 1.6 0.1 3.8 5.3 4.3 7.9 8.2 8.0 3.1 14.1 4.0 1.7 3.4 0.5 2.9 9.8 7.2 1.9 15.6 5.0 8.6 4.1 6.8 19.7 3.0 11.0 1.3 3.6 7.3 7.2 3.8 9.2 15.5 9.5 0.8 4.0 5.3 8.1 10.5 3.0 15.2 9.7 5.9 5.9 5.9 6.6 9.9 6.1 16.5 7.4 15.8 5.5 9.8 5.9 5.3 2.3 7.4 5.0 4.2 16.6 4.9 15.2 17.1 8.1 4.8 8.6 10.1 7.3 16.0 7.1 4.8 9.8 11.3 8.9 7.9 AMER1 "FAM123B, FLJ39827, RP11-403E24.2, WTX" ENSG00000184675 "APC membrane recruitment protein 1" Q5JTC6 X 64185117-64205744 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065214, HPA065265" Approved Supported "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies" "Vesicles, Plasma membrane" "HPA065214: , HPA065265: " "unprognostic (1.56e-2)" "unprognostic (8.85e-2)" "unprognostic (6.86e-2)" "unprognostic (2.74e-1)" "unprognostic (2.12e-2)" "unprognostic (1.86e-1)" "unprognostic (3.57e-2)" "unprognostic (1.48e-1)" "unprognostic (8.02e-2)" "unprognostic (1.75e-1)" "unprognostic (6.31e-2)" "unprognostic (3.43e-1)" "unprognostic (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (1.13e-1)" "unprognostic (6.19e-2)" "unprognostic (2.89e-1)" 3.0 3.4 3.0 2.8 5.6 2.3 3.0 8.8 4.9 6.8 4.7 3.1 7.8 3.3 9.8 11.3 6.9 5.2 2.4 3.5 3.0 3.4 4.2 7.1 2.8 2.6 4.5 1.6 15.5 8.1 5.1 3.9 2.0 6.3 4.5 3.2 6.8 7.0 5.3 9.0 4.8 3.7 6.6 2.9 3.7 5.1 1.4 4.3 2.4 3.4 6.5 3.4 4.3 5.7 0.4 0.2 0.0 0.3 2.0 1.0 0.1 2.9 2.2 5.6 4.5 2.2 2.1 4.5 1.4 1.2 2.0 1.3 7.1 1.0 5.6 1.8 2.9 4.1 12.0 3.9 2.0 2.6 2.4 3.4 4.4 4.5 1.6 7.2 0.9 3.0 5.2 1.5 3.1 1.2 5.2 5.7 1.1 3.4 4.7 3.9 15.1 4.3 11.3 9.2 4.1 0.9 0.9 2.5 3.8 3.5 4.8 1.9 1.5 2.1 0.7 2.5 5.8 6.5 1.8 2.9 2.0 4.3 1.1 8.2 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.4 0.0 0.3 1.0 0.0 0.0 2.0 0.0 0.2 0.9 0.1 3.0 5.6 8.8 4.9 3.0 3.4 4.5 1.6 6.3 4.3 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: " "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 15.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425538 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: , HPA077835: " "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 13.9 25.9 21.3 10.6 23.8 14.1 28.7 12.6 25.0 17.2 21.0 24.5 18.5 21.6 16.6 25.2 20.8 15.3 13.7 17.6 20.6 20.2 35.2 50.0 13.3 19.3 22.3 14.3 20.5 14.0 33.3 13.0 41.6 18.9 14.9 11.8 23.8 12.6 18.6 71.6 11.9 18.8 16.0 25.0 14.3 12.2 36.8 17.5 14.6 18.6 10.1 19.3 15.5 16.9 18.3 10.6 21.4 13.1 11.7 9.7 4.0 17.4 24.4 10.7 19.6 33.4 18.8 9.4 18.9 23.4 25.7 20.2 21.6 16.6 45.6 21.9 25.5 16.4 16.3 14.7 24.6 10.2 16.8 13.8 10.1 23.2 29.3 10.7 16.0 21.8 21.3 20.5 24.6 14.9 14.3 6.3 18.6 11.1 16.0 11.4 5.0 16.8 18.1 21.5 17.1 15.9 18.3 10.7 8.2 44.4 15.6 14.3 46.9 11.2 19.3 24.3 13.3 12.3 12.7 13.6 11.9 24.2 17.6 7.8 11.1 21.4 8.5 10.9 6.9 9.9 9.7 18.3 8.7 7.1 7.8 15.6 9.1 9.5 10.5 11.7 13.1 10.6 9.0 4.0 21.3 23.8 12.6 25.0 20.6 20.2 22.3 14.3 18.9 17.5 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell line enhanced" "Detected in some" "HEK 293: 17.4;NTERA-2: 6.7;REH: 6.9;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" 56000 "Vesicles, Aggresome" "HPA066973: " "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavourable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.3 0.2 1.0 0.3 2.8 0.3 0.3 4.8 1.4 0.3 0.5 0.3 0.3 0.2 0.4 0.6 0.3 0.2 0.3 0.3 0.5 1.3 0.3 0.3 0.4 0.5 0.3 0.3 1.1 0.7 0.2 3.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 2.6 0.4 0.6 0.3 0.3 0.5 0.6 35.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.1 0.4 0.0 0.0 4.4 0.7 0.0 0.0 0.0 0.1 0.2 0.5 1.7 0.0 0.0 0.0 0.0 0.0 2.9 17.4 0.1 0.6 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.5 0.1 1.3 6.7 1.5 6.9 1.4 0.9 0.0 0.2 0.5 8.0 0.1 0.0 1.5 0.8 0.0 0.7 0.6 1.3 0.9 2.5 4.9 3.6 0.8 0.3 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 4.8 1.4 0.5 1.3 0.3 0.3 0.3 0.3 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 18 "HEL: 27.6;K-562: 15.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved "Nucleoplasm,Vesicles,Centriolar satellite,Cytosol" Vesicles "Nucleoplasm, Centriolar satellite, Cytosol" "HPA060228: , HPA069636: " "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 27.6 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046152: " "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.5 1.2 2.7 9.3 3.5 1.5 3.3 4.3 2.2 5.0 2.4 0.5 0.1 0.2 1.2 2.7 1.4 7.2 0.3 4.2 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.3 0.7 3.2 1.7 0.0 1.2 2.0 0.0 0.1 4.3 0.4 4.3 1.6 2.9 0.7 0.0 0.3 5.8 1.2 9.4 3.1 1.0 12.3 3.5 3.6 3.0 1.1 0.1 5.8 3.4 1.8 0.2 0.0 0.0 1.8 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.9;fHDF/TERT166: 42.2;LHCN-M2: 42.2;RT4: 57.8;U-2 OS: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: " "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.7 24.1 1.5 0.0 0.6 0.0 3.9 3.3 9.1 1.1 0.9 0.0 43.9 0.0 11.0 42.2 14.6 0.0 27.0 1.3 1.9 0.1 0.0 2.4 0.0 0.9 0.2 0.4 0.2 4.8 28.9 14.3 3.5 1.8 0.0 42.2 0.4 0.7 0.0 1.0 6.1 0.0 10.9 0.0 12.5 57.8 4.4 0.0 17.4 2.1 0.1 2.6 0.2 0.9 0.6 35.0 0.4 26.9 0.4 0.0 0.0 2.3 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 AMMECR1 ENSG00000101935 "Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1" Q9Y4X0 X 110194186-110440233 "Disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA000590: , HPA051762: " "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favourable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favourable (8.44e-4)" "unprognostic (7.82e-2)" 7.2 6.6 2.4 10.1 4.5 17.0 5.3 2.9 6.5 6.3 6.2 3.9 5.0 4.6 5.3 6.0 15.9 6.3 6.5 3.0 3.1 2.9 7.5 8.5 5.9 5.8 2.6 3.2 12.4 7.4 5.0 9.5 22.7 6.6 4.3 6.1 9.7 6.5 7.0 3.2 14.2 7.8 4.5 2.4 9.7 5.8 4.0 2.3 12.5 6.0 11.1 11.3 6.8 8.9 4.3 2.9 1.5 4.8 1.2 6.7 1.9 11.1 5.5 4.0 1.9 4.6 6.9 4.5 7.8 7.0 6.4 9.4 8.8 8.2 6.6 3.7 10.3 5.4 12.9 8.8 6.6 4.7 5.8 9.2 12.8 1.8 11.7 7.3 3.9 3.9 15.7 7.3 13.1 5.1 25.6 20.0 4.8 9.4 3.5 2.6 18.7 10.8 7.6 4.4 11.8 10.8 9.5 6.5 3.1 13.1 12.9 10.9 3.1 7.3 2.3 4.4 2.7 13.1 7.0 4.1 4.6 10.7 6.8 15.3 14.8 1.3 1.9 1.5 3.4 1.3 4.6 3.3 6.7 5.4 2.9 4.3 4.6 3.9 1.3 1.2 4.8 1.3 4.6 1.9 2.4 4.5 2.9 6.5 3.1 2.9 2.6 3.2 6.6 2.3 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000590: , HPA057234: " "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavourable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.2 8.2 16.9 13.8 16.1 13.1 16.0 14.5 13.2 16.0 14.5 18.2 9.2 11.9 9.7 14.3 12.2 16.4 12.1 17.6 14.1 12.0 15.1 12.2 10.3 19.2 14.9 15.5 14.4 26.5 19.6 26.5 16.7 13.8 12.0 12.8 8.7 13.9 14.5 13.4 15.2 14.6 13.6 6.8 12.7 10.7 11.2 12.6 12.0 18.8 29.1 8.7 10.4 16.6 19.8 18.6 9.2 10.9 10.1 14.8 12.3 9.5 9.6 13.1 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.0;epididymis: 102.0" "Cell line enhanced" "Detected in many" "AF22: 17.6;HAP1: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA067290: , HPA067853: " "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favourable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favourable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 3.7 2.3 18.4 2.0 17.9 1.3 5.5 3.0 14.0 8.1 3.5 13.9 40.0 3.1 4.7 102.0 3.8 9.7 3.1 3.7 15.4 10.9 8.2 2.5 3.0 1.6 14.4 10.3 5.4 2.7 8.4 7.0 14.9 18.0 5.6 4.3 1.2 6.9 27.6 25.2 2.7 3.6 3.5 15.7 2.1 3.3 2.7 13.5 0.1 3.8 9.3 1.8 3.2 4.3 0.5 0.2 0.0 0.6 1.9 1.5 0.2 3.0 0.0 17.6 0.7 0.3 0.3 6.5 0.6 0.0 0.0 0.0 7.4 0.6 0.4 3.6 2.7 6.4 19.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 3.9 0.5 0.1 0.0 0.0 0.4 0.3 4.8 0.2 7.8 0.1 6.1 5.4 0.1 8.2 8.1 0.0 6.0 0.1 0.0 6.8 0.6 0.1 0.1 2.2 5.2 0.0 7.0 0.5 0.0 0.0 0.8 0.1 4.5 0.0 0.0 0.0 1.1 0.4 1.5 0.5 0.7 1.0 0.2 0.2 0.7 0.6 0.0 1.9 0.6 0.2 1.0 0.2 18.4 17.9 3.0 14.0 15.4 10.9 14.4 10.3 18.0 13.5 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876753 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 78.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 36.0;WM-115: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" 11000 Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favourable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 14.4 5.7 3.3 6.9 4.0 0.6 9.2 3.7 4.8 12.8 15.4 2.7 9.1 2.2 16.4 11.4 19.3 7.5 10.9 10.1 3.1 3.9 4.4 4.8 10.0 2.5 3.2 2.5 7.3 10.8 13.5 13.9 25.4 3.5 18.7 4.0 11.3 8.9 13.6 78.2 11.7 4.8 32.8 2.6 6.2 8.1 7.1 1.8 12.9 8.6 21.9 10.1 24.4 9.5 2.3 1.0 0.0 0.7 2.3 0.1 0.5 18.0 5.1 13.8 0.0 14.9 12.9 6.6 10.0 17.5 4.6 5.4 9.4 0.5 0.8 4.9 13.5 23.5 6.5 36.0 4.8 1.4 5.0 9.7 5.4 0.0 3.4 2.1 0.0 7.6 22.3 15.7 26.3 9.5 24.5 0.9 10.8 5.2 6.6 1.3 2.0 3.4 0.0 25.1 1.5 6.5 7.6 10.5 12.7 0.6 13.9 3.6 0.7 3.0 8.7 12.6 9.3 0.2 6.8 0.5 0.0 5.1 3.5 0.0 34.4 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.6 2.3 0.0 0.0 0.0 2.3 0.2 1.0 0.0 0.5 3.3 4.0 3.7 3.0 3.1 3.9 3.2 2.5 3.5 1.8 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favourable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 8.0 0.0 31.8 18.8 0.0 1.1 0.0 12.3 14.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 11.3 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.1 8.5 4.2 4.5 0.0 0.1 0.0 8.2 0.1 10.8 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favourable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.2 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.2 0.1 0.4 0.1 0.2 0.1 0.0 0.3 29.5 1.1 0.0 0.1 0.3 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.2 0.2 5.3 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68247574-68257164 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: " "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavourable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavourable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 22.3 21.3 29.3 13.7 43.3 14.2 20.8 29.2 35.8 19.8 19.8 20.3 19.6 11.9 19.0 25.3 22.3 24.6 17.7 33.6 26.8 23.7 26.8 16.6 14.1 22.4 26.0 27.0 23.4 20.4 29.4 25.4 18.9 28.3 21.1 15.0 19.0 17.9 25.1 39.9 15.5 13.5 19.3 27.8 16.6 15.7 77.2 20.5 15.5 28.4 20.6 22.4 20.2 14.9 20.9 17.2 31.4 21.1 34.8 31.2 19.7 23.3 25.9 22.0 18.6 16.9 29.5 34.6 16.9 22.9 29.5 24.8 10.6 15.0 35.0 19.1 26.2 11.5 17.9 49.9 38.7 12.3 16.9 12.8 11.5 20.7 32.0 11.7 22.2 25.1 56.0 27.4 51.0 29.8 13.1 22.4 37.2 17.4 26.3 10.9 10.3 24.3 10.0 59.9 26.2 17.7 12.4 22.2 17.4 15.7 32.5 31.6 25.6 8.0 15.5 39.7 18.9 14.2 18.3 31.4 28.8 60.3 28.0 16.6 20.0 31.4 14.4 19.6 22.1 16.6 28.6 17.4 27.3 29.0 17.2 20.9 24.4 26.3 25.2 34.8 21.1 15.7 31.2 19.7 29.3 43.3 29.2 35.8 26.8 23.7 26.0 27.0 28.3 20.5 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA044547: " "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 19.0 15.6 16.4 11.9 22.1 14.0 23.4 29.8 24.6 19.3 14.4 16.6 10.6 7.1 19.3 21.3 13.8 17.5 12.5 21.4 17.2 17.6 21.2 21.0 15.8 15.0 18.1 16.2 19.9 14.2 15.1 28.6 19.6 25.9 15.4 16.7 15.9 14.5 15.5 23.8 13.7 11.7 19.4 20.2 14.8 13.1 27.3 20.5 20.4 19.2 13.3 16.7 15.4 15.5 13.5 13.9 18.2 8.4 14.1 15.1 6.7 9.0 5.1 13.8 5.1 13.0 14.1 8.9 10.9 11.6 14.7 10.6 11.3 12.4 14.1 7.2 8.2 5.6 11.5 15.4 15.0 12.0 9.1 7.6 3.9 9.3 16.6 15.5 8.9 11.6 10.7 11.7 18.7 11.7 20.7 18.5 14.7 6.7 26.5 18.6 9.0 11.5 12.5 11.4 8.2 15.9 5.9 9.3 7.6 7.9 6.3 14.0 6.0 12.9 9.4 9.2 6.0 8.9 14.6 15.4 16.9 21.4 12.8 19.7 12.4 18.2 6.8 8.6 11.9 8.4 12.0 13.5 12.8 12.2 9.4 10.9 13.0 12.9 2.0 14.1 8.2 13.9 15.1 6.7 16.4 22.1 29.8 24.6 17.2 17.6 18.1 16.2 25.9 20.5 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 29.3 26.1 44.9 21.9 34.1 39.6 27.2 19.5 31.8 19.4 26.3 14.8 30.3 26.1 19.2 27.5 31.7 24.6 26.0 63.6 32.9 26.7 25.9 38.4 18.5 26.7 35.2 31.8 17.2 40.3 12.6 20.6 25.7 29.8 25.4 12.2 18.1 48.8 24.0 94.2 21.6 24.8 25.4 27.6 18.9 25.9 42.2 27.3 18.5 32.5 45.7 17.0 23.5 25.5 54.9 107.5 74.0 80.1 43.1 52.8 80.4 40.9 96.2 22.9 33.9 18.3 20.9 26.3 19.9 15.6 18.0 20.6 39.5 36.1 12.9 22.2 17.5 23.9 9.1 25.4 6.5 19.0 69.7 19.3 42.7 59.5 20.5 14.4 17.1 23.1 23.1 18.4 15.1 28.9 26.4 37.7 18.7 73.7 35.0 23.8 21.6 71.8 14.6 21.8 25.9 16.4 36.8 28.8 46.8 21.4 33.8 38.8 41.3 35.2 17.2 35.1 28.1 37.6 37.2 18.5 7.7 16.3 36.9 22.0 28.0 70.1 80.1 74.0 45.3 63.7 42.8 54.9 46.4 49.5 64.6 51.6 45.2 43.5 40.5 43.1 59.3 107.5 52.8 80.4 44.9 34.1 19.5 31.8 32.9 26.7 35.2 31.8 29.8 27.3 ANAPC13 "APC13, DKFZP566D193, SWM1" ENSG00000129055 "Anaphase promoting complex subunit 13" Q9BS18 3 134477706-134486716 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046114 Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA046114: AB_10961429" "unprognostic (2.84e-2)" "prognostic favourable (1.66e-4)" "unprognostic (2.98e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (1.67e-4)" "unprognostic (3.57e-1)" "unprognostic (2.90e-1)" "unprognostic (2.28e-3)" "unprognostic (6.44e-2)" "unprognostic (4.36e-1)" "prognostic favourable (2.66e-7)" "unprognostic (3.10e-1)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.16e-1)" 35.5 29.5 29.0 10.8 24.0 9.7 26.2 14.6 26.7 21.3 20.0 14.8 19.6 13.2 18.7 46.5 24.5 19.2 19.3 37.5 25.3 36.3 47.1 54.4 22.1 17.3 33.3 13.3 30.1 36.0 29.6 34.3 34.8 29.2 29.1 18.3 23.4 30.5 22.6 36.8 14.4 25.4 20.7 23.2 19.2 20.1 20.4 12.4 14.1 44.3 22.2 13.4 27.3 16.9 25.5 26.9 69.4 30.5 18.7 30.0 22.8 20.8 13.1 20.7 17.6 35.2 46.9 16.0 27.2 25.1 19.9 18.8 16.3 12.4 14.2 59.0 39.8 12.3 19.3 19.4 28.8 7.1 9.0 14.4 10.6 27.2 25.4 23.6 10.3 31.1 21.2 20.0 37.5 30.8 19.2 12.1 62.7 26.8 12.0 23.2 14.1 12.8 9.7 16.3 25.7 38.8 12.9 8.4 13.9 24.1 8.9 23.6 22.1 23.3 21.4 27.7 11.3 38.9 11.9 13.4 14.5 29.3 17.1 13.1 23.6 28.9 28.3 24.2 16.4 30.5 21.3 25.5 24.6 21.4 26.9 18.6 30.0 25.2 69.4 18.7 29.6 20.5 20.5 22.8 29.0 24.0 14.6 26.7 25.3 36.3 33.3 13.3 29.2 12.4 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favourable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 10.7 14.9 29.5 13.8 30.1 40.3 14.0 9.1 32.5 9.9 20.0 13.7 13.2 14.9 15.3 19.9 17.2 13.4 13.3 22.2 23.6 19.8 16.0 16.9 12.2 19.5 25.2 20.6 8.0 16.6 9.4 11.7 12.7 19.3 17.4 20.5 11.6 18.2 20.6 41.5 14.1 14.8 21.8 17.7 14.4 15.1 22.1 12.6 22.5 21.6 23.1 20.9 12.8 9.4 27.0 45.6 39.9 52.7 20.5 44.0 35.5 19.7 29.9 24.5 15.5 7.3 11.9 11.6 21.1 19.4 34.1 22.7 34.9 21.6 26.7 20.6 30.0 33.7 36.9 39.5 32.3 17.1 17.5 30.4 34.2 22.6 8.7 29.5 28.5 12.4 15.7 19.3 25.9 22.3 22.0 18.6 22.1 34.0 56.6 27.5 19.8 17.3 24.0 60.9 18.1 29.3 13.8 17.4 15.2 21.7 21.3 33.5 24.9 15.8 20.2 15.7 20.7 31.0 22.3 19.1 18.5 34.1 9.6 23.7 8.7 7.5 52.7 39.9 24.0 33.4 25.4 27.0 30.9 27.9 45.6 19.9 37.1 33.9 21.7 20.5 30.4 36.6 44.0 35.5 29.5 30.1 9.1 32.5 23.6 19.8 25.2 20.6 19.3 12.6 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 15.6 20.3 17.8 14.7 25.1 12.2 19.9 24.8 25.1 20.6 16.2 16.8 12.2 11.9 21.4 19.8 34.2 20.9 15.6 18.8 19.1 18.5 21.4 16.8 16.6 20.8 16.2 22.1 18.1 16.7 26.6 14.9 9.6 17.6 21.8 18.9 16.4 19.7 21.3 29.7 16.0 13.3 24.0 17.1 16.8 14.9 36.3 16.3 25.8 23.2 24.5 22.2 19.2 22.5 14.9 17.7 17.6 15.1 20.1 22.4 12.5 18.3 25.3 18.6 15.8 19.5 9.9 10.6 12.9 11.8 23.9 16.6 25.8 11.8 29.4 13.2 17.3 18.7 27.6 17.7 24.4 15.6 22.3 26.0 18.8 21.3 14.2 23.2 12.3 10.7 12.8 20.7 13.8 23.1 40.7 6.0 18.7 19.7 35.1 17.3 16.1 22.1 27.2 18.4 35.0 16.2 23.6 24.2 13.9 20.2 15.9 21.2 33.7 21.1 14.5 14.3 13.4 12.7 15.2 10.6 21.7 39.6 15.9 19.9 16.5 14.3 10.5 17.6 17.2 15.1 20.2 13.3 18.5 16.5 17.7 14.9 15.5 16.5 8.3 20.1 13.1 9.7 22.4 12.5 17.8 25.1 24.8 25.1 19.1 18.5 16.2 22.1 17.6 16.3 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.6" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Actin filaments" "Secreted to blood" 307535000 230000000 Nucleoli "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favourable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favourable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.4 3.7 0.9 0.0 9.3 11.2 0.1 1.6 3.2 0.4 1.5 2.2 1.9 0.1 0.4 4.5 1.4 1.0 1.1 0.5 6.2 1.4 0.3 2.0 56.6 2.0 1.4 0.2 9.0 0.9 0.5 1.9 2.1 0.0 10.4 1.3 0.2 0.3 0.4 0.2 4.1 0.2 1.5 4.2 0.9 1.1 0.0 0.1 1.6 0.6 2.5 1.5 0.2 1.8 0.6 1.1 0.5 0.2 2.2 1.7 0.2 1.1 0.7 1.8 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015826 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Supported "Nucleoplasm,Nuclear bodies,Mitochondria" Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavourable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.20e-4)" 11.4 11.7 18.0 10.8 32.6 9.5 17.8 21.6 22.7 14.5 9.3 16.9 8.6 8.6 14.8 14.2 10.2 12.2 10.4 9.2 17.4 13.8 13.3 13.0 11.0 15.8 17.0 13.9 19.1 10.5 15.5 14.8 10.8 13.8 14.5 11.0 12.3 9.8 11.2 11.0 15.1 10.7 12.2 14.9 15.5 10.5 9.0 15.9 19.5 14.0 7.9 14.9 10.8 9.7 7.8 7.2 7.6 5.9 14.1 11.3 6.7 8.6 6.9 11.3 9.6 8.6 12.7 10.1 7.1 11.9 11.4 11.4 4.6 6.4 8.4 6.5 7.0 6.8 12.9 6.8 11.5 15.7 7.8 8.4 5.5 4.5 9.5 8.3 10.1 7.8 8.8 8.9 9.1 9.6 9.7 8.7 13.0 2.8 9.5 5.6 26.5 5.0 4.8 20.2 8.7 8.9 5.8 5.5 16.1 8.5 11.6 13.1 8.9 6.1 7.1 9.4 5.0 11.5 10.7 6.4 6.1 5.6 10.5 6.2 8.6 7.4 5.9 7.6 7.4 5.5 9.1 7.8 9.2 7.6 7.2 5.3 9.8 8.1 4.0 14.1 4.4 4.4 11.3 6.7 18.0 32.6 21.6 22.7 17.4 13.8 17.0 13.9 13.8 15.9 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374373 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.5;liver: 68.4;pancreas: 51.7" "Cell line enhanced" "Detected in some" "ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0" "Cancer enhanced" "Detected in all" "renal cancer: 212.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 5.8;neutrophil: 2.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" 7750000 1500000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavourable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavourable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 55.5 9.6 23.3 13.5 24.7 2.3 33.0 5.1 37.6 3.3 11.8 9.2 0.3 10.6 5.9 1.5 11.8 3.2 8.8 11.4 17.1 5.5 9.4 68.4 9.0 2.7 21.4 3.1 2.9 51.7 2.3 3.3 21.4 36.8 6.7 2.1 2.5 3.9 3.7 5.9 6.5 23.5 6.0 20.6 2.5 4.4 3.7 27.7 0.0 7.1 2.5 3.5 10.7 6.0 0.5 0.3 5.8 0.4 0.8 0.6 0.2 0.0 0.6 0.3 0.9 16.1 3.5 0.1 1.2 0.1 0.2 0.0 0.0 5.9 0.0 8.8 2.4 0.8 0.0 64.0 0.1 0.5 0.1 0.1 0.2 0.1 0.3 0.0 0.0 1.6 0.2 9.8 0.2 4.9 0.3 0.2 17.3 0.5 0.0 0.5 0.1 0.5 0.3 0.0 0.2 3.2 1.1 0.0 0.1 7.4 0.7 1.1 1.9 0.1 32.2 19.0 0.1 9.5 0.0 0.0 0.0 0.0 13.0 0.0 3.5 5.8 0.4 0.9 0.4 0.2 0.3 0.5 0.5 0.4 0.2 0.4 0.3 0.3 2.3 0.8 0.2 0.3 0.6 0.2 23.3 24.7 5.1 37.6 17.1 5.5 21.4 3.1 36.8 27.7 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 81.0" "Group enriched" "Detected in some" 27 "Hep G2: 26.2;MCF7: 15.2" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" 835950 320000 "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 8.0 0.1 0.0 0.6 0.0 0.0 5.1 0.0 0.1 0.1 5.7 0.0 0.0 0.2 0.1 0.8 0.1 0.1 1.0 0.6 0.0 0.0 1.5 81.0 0.1 3.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.8 0.1 0.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.7 26.2 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 15.2 0.0 0.5 0.1 0.0 0.1 0.3 0.7 0.0 0.2 0.0 0.2 0.2 0.7 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.3;testis: 9.0" "Cell line enhanced" "Detected in some" "TIME: 2.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.2 0.0 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.0 0.3 0.7 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 0.2 1.2 0.3 0.1 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.6 9.0 0.6 0.1 0.2 0.2 2.3 0.3 0.5 0.4 0.0 0.6 0.1 0.6 0.5 0.4 0.5 0.4 1.0 0.0 0.0 0.7 0.2 0.5 0.9 1.1 0.3 0.3 1.0 0.8 0.7 0.0 0.3 0.9 0.6 0.6 0.4 1.3 0.0 1.8 0.2 1.3 0.2 0.3 1.4 0.0 0.1 0.9 0.3 0.4 0.0 0.5 0.0 0.7 0.3 0.4 0.0 0.6 2.2 0.0 0.0 0.5 0.3 0.8 2.4 1.8 2.7 0.8 1.1 0.0 0.0 1.0 0.4 0.1 0.4 0.1 0.2 0.0 0.0 0.5 0.6 0.4 0.1 0.6 0.3 0.1 0.1 2.3 0.2 0.5 0.0 0.0 0.3 0.3 0.0 0.1 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.0;testis: 22.7" "Cell line enhanced" "Detected in many" "U-266/84: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavourable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favourable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.58e-4)" "unprognostic (3.11e-1)" 5.6 2.9 1.4 2.3 2.4 0.5 3.7 5.7 2.0 2.7 3.1 0.8 11.3 2.9 1.9 4.2 4.7 4.9 4.0 3.2 2.3 2.5 5.7 6.7 2.3 1.3 1.5 1.1 3.6 25.0 5.3 13.6 1.7 4.1 3.4 3.0 3.0 4.2 13.0 1.7 2.9 3.6 1.0 1.2 1.8 5.1 22.7 1.0 3.2 8.6 2.5 3.9 2.1 2.6 2.5 1.6 0.7 0.1 1.5 5.4 1.3 10.1 10.3 1.4 2.5 2.1 1.2 5.9 1.9 0.1 1.8 0.9 6.0 9.2 0.0 3.2 0.4 8.8 1.8 12.1 2.2 0.0 1.6 1.3 2.0 5.5 1.4 1.1 0.2 3.7 8.6 1.6 1.7 1.5 3.8 9.0 0.4 3.2 1.6 0.0 4.3 2.4 0.0 0.0 6.9 4.4 6.5 7.8 3.9 4.7 10.3 0.0 9.0 0.9 1.1 1.3 1.5 0.1 2.0 9.3 17.9 1.6 2.6 0.3 1.7 0.0 0.0 0.0 2.8 0.1 5.4 2.5 3.3 2.6 0.2 2.3 4.1 3.0 0.7 1.5 0.0 1.6 3.8 1.3 1.4 2.4 5.7 2.0 2.3 2.5 1.5 1.1 4.1 1.0 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell line enhanced" "Detected in some" "HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.8 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.1 0.4 16.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.3 5.7 0.0 0.0 0.0 0.4 5.5 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 ANKIB1 "DKFZP434A0225, KIAA1386" ENSG00000001629 "Ankyrin repeat and IBR domain containing 1" Q9P2G1 7 92246234-92401384 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019358, HPA021780" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019358: AB_1844831, HPA021780: " "unprognostic (1.77e-1)" "unprognostic (5.96e-3)" "unprognostic (1.23e-1)" "unprognostic (4.97e-3)" "unprognostic (2.75e-1)" "unprognostic (7.67e-2)" "unprognostic (4.88e-3)" "unprognostic (2.14e-1)" "unprognostic (4.24e-2)" "unprognostic (1.87e-2)" "unprognostic (1.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-3)" "unprognostic (4.05e-2)" "unprognostic (3.00e-1)" "unprognostic (3.00e-2)" "unprognostic (3.20e-1)" 11.9 11.8 21.4 9.2 29.2 5.8 12.3 15.0 25.5 13.6 12.1 34.9 16.0 10.7 12.6 16.4 11.8 10.0 14.7 9.7 22.7 20.0 25.3 10.1 10.6 11.5 31.1 18.4 13.1 12.7 28.5 10.9 12.2 23.4 10.2 12.6 8.4 12.7 18.4 8.6 14.0 11.3 13.4 23.8 11.4 10.9 19.4 35.0 11.5 17.1 4.5 11.1 13.1 13.3 4.8 4.5 3.1 2.0 3.2 4.9 1.1 17.3 10.6 9.4 14.2 17.4 18.6 10.0 13.6 15.6 13.2 17.4 7.7 26.8 10.0 12.0 20.1 8.4 8.6 14.3 20.2 16.9 7.1 6.3 12.2 6.2 11.9 9.0 14.0 12.6 12.1 15.6 20.6 14.9 8.0 21.6 15.6 14.0 19.1 8.4 10.2 12.0 7.2 11.5 10.7 14.0 15.0 13.0 15.4 19.4 21.9 11.5 9.1 5.1 13.3 25.6 20.7 28.8 13.8 13.6 24.2 12.6 14.8 10.9 29.2 2.8 1.3 3.1 2.7 2.0 2.2 3.9 2.6 3.8 1.1 4.8 2.2 2.8 0.8 3.2 1.6 4.5 4.9 1.1 21.4 29.2 15.0 25.5 22.7 20.0 31.1 18.4 23.4 35.0 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Cell line enhanced" "Detected in many" "Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Low region specificity" "Detected in many" "HPA026789, HPA073498" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: " "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavourable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.7 0.0 0.3 1.4 0.5 0.1 0.3 0.2 6.9 0.4 30.2 0.3 0.1 0.6 11.7 0.1 0.2 9.1 1.5 12.3 4.8 0.0 0.1 13.3 5.1 0.1 0.4 1.2 0.0 0.2 1.6 3.6 0.1 0.2 9.1 17.0 3.7 1.0 7.3 0.0 3.1 0.1 0.1 0.4 2.7 2.9 0.2 0.2 0.0 8.7 0.5 0.1 0.5 0.5 0.3 0.3 0.3 10.7 0.1 23.7 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavourable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavourable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 20.8 19.5 20.5 12.6 11.9 18.8 25.7 25.5 19.1 25.6 19.7 22.2 14.3 16.4 13.4 22.4 25.2 17.8 23.2 24.6 7.0 22.1 20.8 32.7 10.4 13.3 22.4 14.7 17.4 23.8 24.3 18.1 18.2 18.7 6.5 26.1 15.0 20.8 37.0 17.3 18.8 24.0 13.4 6.9 18.4 27.3 25.1 15.5 32.9 13.9 11.2 24.4 16.3 26.0 30.9 22.3 16.4 28.4 12.1 11.9 20.1 23.9 14.9 17.3 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favourable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.2 11.5 2.5 4.6 2.3 3.3 10.4 2.5 3.8 2.1 2.8 3.7 10.8 5.2 0.4 2.8 5.8 4.8 5.9 2.5 9.6 3.9 10.3 5.6 9.6 1.9 5.7 10.0 5.2 14.5 1.9 13.8 2.1 9.6 6.7 3.5 5.0 5.3 9.4 2.1 6.9 14.9 7.6 8.2 3.2 11.3 5.9 4.4 2.0 5.5 7.6 4.8 8.9 2.7 7.8 2.7 3.1 4.4 15.6 3.9 5.0 4.4 8.8 6.0 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 ANKMY2 "DKFZP564O043, ZMYND20" ENSG00000106524 "Ankyrin repeat and MYND domain containing 2" Q8IV38 7 16599776-16645817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050447, HPA067100" Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA050447: , HPA067100: " "unprognostic (3.07e-1)" "unprognostic (4.20e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (1.99e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.11e-2)" "unprognostic (3.00e-2)" "prognostic favourable (1.05e-7)" "unprognostic (5.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.85e-2)" 9.6 10.3 14.5 6.6 30.1 10.0 11.8 14.6 28.7 12.4 13.6 9.0 13.3 12.2 10.8 10.4 9.4 13.1 11.1 30.2 18.5 12.7 13.3 8.9 9.4 6.7 12.7 21.2 21.5 9.6 13.2 14.9 7.3 20.4 11.3 14.1 11.8 11.4 16.3 17.3 8.5 13.5 14.4 11.9 8.8 19.1 8.0 7.8 8.9 17.7 7.5 7.1 14.6 11.6 6.7 4.9 18.5 8.9 10.6 10.2 5.2 11.5 9.9 13.5 13.4 12.8 13.5 7.3 14.2 17.4 10.9 17.0 16.4 17.8 2.3 16.6 14.8 12.1 9.1 5.4 16.4 5.2 6.3 21.0 11.9 7.4 8.4 15.6 8.2 11.7 2.9 11.0 11.1 9.8 21.5 3.9 15.5 3.1 6.6 10.9 9.0 11.8 10.9 12.2 5.6 17.1 10.1 8.5 5.1 9.6 7.1 5.7 8.3 14.1 6.1 8.5 7.6 18.9 9.6 14.2 10.3 3.6 13.1 12.9 13.5 18.5 3.2 14.3 10.0 4.3 9.6 6.7 8.2 10.2 4.9 6.7 6.9 8.2 2.7 10.6 8.9 4.7 8.3 5.2 14.5 30.1 14.6 28.7 18.5 12.7 12.7 21.2 20.4 7.8 ANKRA2 ENSG00000164331 "Ankyrin repeat family A member 2" Q9H9E1 5 73552335-73565686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003968, HPA065263" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003968: , HPA065263: " "unprognostic (1.75e-1)" "unprognostic (5.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-1)" "unprognostic (3.31e-1)" "unprognostic (3.89e-2)" "unprognostic (5.68e-2)" "unprognostic (6.19e-2)" "unprognostic (3.47e-2)" "unprognostic (1.09e-1)" "unprognostic (1.06e-2)" "unprognostic (1.79e-1)" "unprognostic (9.80e-3)" "unprognostic (3.36e-1)" "unprognostic (3.31e-1)" "unprognostic (6.65e-2)" "unprognostic (1.13e-3)" 13.0 19.4 11.9 9.2 17.1 18.7 20.9 22.8 18.3 15.7 13.5 16.6 13.1 15.0 20.0 21.0 13.3 18.5 15.0 12.2 18.1 15.8 9.6 15.9 20.7 13.9 20.6 12.3 23.3 19.7 11.4 30.2 15.4 23.1 19.8 16.4 17.5 19.0 14.3 14.5 13.4 15.3 17.8 30.7 13.0 16.2 10.3 15.8 18.1 22.2 4.5 14.7 14.9 13.3 10.7 5.9 16.9 7.4 7.0 15.5 7.3 5.1 3.9 5.7 6.0 10.5 16.0 17.5 7.0 10.5 6.1 9.2 1.1 7.9 4.8 5.7 6.9 3.7 2.7 12.5 8.8 10.0 4.7 4.2 3.0 5.4 8.2 2.5 8.3 16.5 16.9 7.4 7.6 6.8 4.1 8.1 7.0 3.1 4.3 6.4 3.1 2.9 2.6 6.2 6.6 4.8 6.4 7.7 6.0 5.3 4.3 8.3 6.4 4.1 8.5 2.5 3.0 3.9 5.0 15.8 11.4 4.1 6.2 4.1 7.1 16.9 5.7 11.3 8.7 4.6 10.5 10.7 10.2 12.1 4.9 8.4 15.5 14.2 9.0 7.0 7.4 5.9 11.7 7.3 11.9 17.1 22.8 18.3 18.1 15.8 20.6 12.3 23.1 15.8 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921276 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 81 "heart muscle: 398.9;skeletal muscle: 333.3" "Cell line enhanced" "Detected in some" "CACO-2: 37.6;EFO-21: 103.9;HUVEC TERT2: 35.4;LHCN-M2: 127.6;TIME: 177.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA038736: " "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavourable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 1.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 2.1 1.5 0.1 0.1 398.9 0.0 0.0 0.1 0.1 4.5 0.2 0.0 0.0 0.1 0.4 0.1 0.1 0.7 0.1 0.9 0.1 0.0 0.8 0.1 333.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 2.9 1.6 0.5 0.3 0.0 0.4 0.5 1.9 0.6 0.9 0.4 0.2 2.9 0.8 0.5 0.0 0.4 0.5 0.0 1.7 0.1 0.4 0.9 37.6 1.4 0.0 103.9 0.1 1.0 0.1 0.2 1.3 0.1 0.1 0.0 0.2 11.6 2.3 0.0 0.0 3.7 0.0 0.7 1.8 35.4 0.0 0.0 127.6 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 177.6 0.3 13.6 0.2 13.9 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.4 0.4 0.3 0.7 0.9 0.6 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 ANKRD10 FLJ20093 ENSG00000088448 "Ankyrin repeat domain 10" Q9NXR5 13 110878540-110915069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034211, HPA038878, HPA038879" Uncertain Approved Microtubules,Cytosol Microtubules Cytosol "CAB034211: AB_2058024, HPA038878: , HPA038879: " "unprognostic (3.29e-2)" "unprognostic (2.38e-1)" "unprognostic (9.26e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" "unprognostic (2.49e-1)" "unprognostic (4.97e-3)" "unprognostic (9.60e-2)" "unprognostic (1.16e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (2.92e-2)" "prognostic unfavourable (1.25e-6)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (8.32e-2)" "prognostic favourable (6.41e-6)" 35.1 23.1 19.1 36.8 21.5 44.3 49.7 26.2 19.3 34.9 31.9 33.1 30.6 25.4 44.2 55.6 20.1 28.8 31.7 25.3 18.0 18.3 32.5 27.9 30.8 33.3 28.5 13.9 37.3 34.1 18.8 36.2 41.9 21.9 38.1 30.5 37.4 27.3 29.4 79.3 28.4 30.5 33.1 27.3 48.9 25.9 18.2 23.4 35.4 30.4 27.8 33.4 33.1 45.1 30.8 21.2 20.5 16.6 18.6 24.5 15.8 12.3 10.3 23.9 20.0 18.4 17.9 10.6 8.4 17.6 8.4 10.5 10.7 24.3 17.1 18.5 6.3 28.6 10.3 7.9 11.5 40.8 15.3 20.3 23.2 22.2 7.3 29.2 17.8 16.9 12.1 5.9 8.8 11.3 8.9 11.8 22.7 3.7 16.8 32.7 13.2 6.4 26.0 8.7 16.9 23.1 13.7 19.1 14.3 6.3 11.3 13.2 8.0 37.4 9.8 10.0 8.3 4.9 8.5 14.7 15.6 9.9 18.7 14.4 15.6 20.5 16.6 13.7 21.0 13.1 17.7 28.0 19.8 17.0 21.2 30.8 21.4 22.9 10.3 18.6 13.1 19.8 24.5 15.8 19.1 21.5 26.2 19.3 18.0 18.3 28.5 13.9 21.9 23.4 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267619-89490561 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA049470" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB019288: , HPA049470: " "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavourable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.2 23.3 22.8 25.6 23.1 48.7 41.4 32.3 31.7 22.0 24.1 22.9 22.0 22.4 26.9 18.9 25.0 23.4 23.4 22.2 24.6 20.0 17.8 15.1 32.3 33.8 20.8 21.0 32.6 27.9 33.7 31.5 18.8 19.3 20.5 14.9 23.3 21.4 25.8 27.0 35.8 24.1 26.7 20.3 26.1 22.6 21.3 22.1 26.1 21.6 19.3 19.6 23.4 34.4 4.2 7.2 11.7 5.9 9.8 4.5 1.8 22.0 27.6 27.8 21.3 17.2 17.8 26.9 25.2 16.9 15.3 10.8 32.2 23.7 20.5 17.5 18.3 22.4 19.0 23.2 17.3 10.1 22.7 16.1 19.1 25.7 26.0 11.8 18.4 19.7 23.6 20.0 25.9 18.3 34.6 16.4 19.1 20.9 19.6 29.9 24.4 25.5 40.6 32.1 17.1 15.8 18.5 16.4 20.1 36.4 7.6 26.1 17.9 18.7 33.8 32.2 30.1 17.8 27.7 29.9 10.5 25.5 25.9 19.7 17.3 7.5 3.9 3.7 3.8 4.0 4.3 3.1 4.3 4.5 2.1 4.2 3.8 3.5 11.7 9.8 5.9 7.2 4.2 1.8 22.8 23.1 32.3 31.7 24.6 20.0 20.8 21.0 19.3 22.1 ANKRD12 "FLJ20053, GAC-1, KIAA0874" ENSG00000101745 "Ankyrin repeat domain 12" Q6UB98 18 9136228-9285985 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040705 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040705: AB_10673301" "unprognostic (2.20e-1)" "unprognostic (1.14e-1)" "unprognostic (3.59e-1)" "unprognostic (1.37e-1)" "unprognostic (1.46e-1)" "unprognostic (3.41e-3)" "unprognostic (7.25e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (6.71e-4)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" "unprognostic (2.39e-2)" "unprognostic (4.62e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.03e-2)" 17.0 10.9 22.2 23.1 26.1 19.6 15.4 48.1 25.4 17.8 18.8 10.1 18.2 13.7 14.6 15.4 16.1 12.1 16.1 12.3 19.9 13.5 14.7 16.5 14.6 22.1 20.2 18.3 16.3 16.7 15.5 16.4 19.2 17.4 15.9 13.6 9.5 15.7 20.6 25.8 21.8 18.1 17.2 21.3 20.3 15.3 29.3 23.8 11.4 18.2 13.0 19.5 24.2 22.6 18.7 19.2 51.2 10.7 8.8 19.0 5.2 4.1 2.8 3.9 2.6 6.3 6.5 3.2 6.5 6.1 2.3 3.2 2.5 3.2 5.8 3.8 4.5 3.9 2.9 2.5 6.3 6.1 3.5 2.6 2.0 3.7 4.6 6.1 8.5 3.4 5.7 3.3 5.4 3.9 6.0 45.8 5.7 2.3 4.1 4.2 1.4 2.9 3.7 5.5 21.1 3.0 6.6 9.1 3.3 6.4 3.2 4.6 3.9 5.2 8.4 17.3 8.0 13.8 6.0 13.4 20.6 10.8 8.5 3.3 6.5 27.4 8.7 25.5 14.5 7.7 16.1 18.7 18.7 13.9 5.9 17.3 19.0 14.8 51.2 8.8 10.7 19.2 13.0 5.2 22.2 26.1 48.1 25.4 19.9 13.5 20.2 18.3 17.4 23.8 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67288547-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.8" "Cell line enhanced" "Detected in many" "NB-4: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavourable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 9.1 9.1 18.2 18.1 17.6 80.8 18.9 20.2 18.7 9.0 7.6 7.7 13.7 8.0 9.0 10.4 14.6 10.2 11.9 8.8 20.2 14.0 8.3 4.5 12.4 20.8 12.4 11.4 9.4 7.7 6.0 17.0 9.2 10.7 12.7 4.5 10.9 17.5 12.0 4.2 28.1 8.6 9.9 9.6 24.1 8.9 6.8 12.0 9.6 6.4 6.2 14.4 14.3 13.4 2.6 8.1 11.4 4.6 3.8 6.7 1.9 6.2 4.4 3.4 7.9 5.1 5.0 6.3 3.8 3.8 4.5 2.8 5.2 6.9 6.7 6.4 4.3 10.4 2.4 4.9 0.7 9.5 2.9 5.7 6.6 2.9 7.9 6.3 23.0 5.4 7.7 4.0 5.1 4.2 4.0 8.3 4.0 10.0 8.4 48.7 3.8 5.6 21.2 3.6 4.7 6.4 8.5 3.9 6.7 3.3 10.0 26.6 10.3 17.9 5.4 7.1 4.6 7.2 5.0 8.4 5.9 4.0 9.4 17.6 4.6 7.2 3.3 11.4 6.7 4.6 4.4 2.6 3.8 5.4 1.9 2.4 2.4 5.8 10.8 3.8 3.8 8.1 2.8 1.9 18.2 17.6 20.2 18.7 20.2 14.0 12.4 11.4 10.7 12.0 ANKRD17 "FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16" ENSG00000132466 "Ankyrin repeat domain 17" O75179 4 73073376-73258798 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045024, HPA063731" Approved Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA045024: AB_10964778, HPA063731: " "unprognostic (3.86e-3)" "unprognostic (3.59e-2)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (1.73e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-3)" "unprognostic (3.29e-2)" "unprognostic (3.10e-2)" "unprognostic (1.78e-1)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (3.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.13e-1)" "unprognostic (4.00e-2)" "unprognostic (4.07e-1)" 19.6 20.2 28.9 23.2 32.4 10.3 24.8 41.2 29.9 22.8 19.4 21.2 19.5 18.2 19.3 24.2 22.2 23.5 18.8 20.4 23.4 21.6 25.3 25.3 18.0 17.4 22.3 19.4 23.4 22.8 40.2 34.6 23.2 31.8 19.7 24.2 21.5 23.1 23.1 32.7 22.2 18.5 20.7 18.0 17.7 19.2 13.5 25.1 22.3 22.7 15.9 21.1 21.1 18.9 4.5 7.6 3.2 2.8 9.3 5.3 1.7 12.1 13.4 21.5 16.9 24.1 21.3 11.7 18.0 21.2 16.2 15.7 16.3 16.1 33.2 15.0 18.4 10.3 26.7 15.9 22.5 12.9 11.4 22.5 14.6 23.6 13.0 29.4 14.0 17.9 17.4 23.2 18.6 21.5 31.5 12.3 19.4 11.3 24.1 10.5 13.9 13.6 19.3 23.6 13.7 17.3 18.5 20.8 14.1 17.4 19.7 9.4 10.5 11.7 25.9 17.1 16.4 15.3 14.1 10.2 5.2 25.4 13.9 13.0 17.5 2.3 2.8 3.0 5.3 1.8 2.7 3.0 3.3 3.6 2.3 4.5 3.2 3.6 3.2 9.3 2.1 7.6 2.0 1.7 28.9 32.4 41.2 29.9 23.4 21.6 22.3 19.4 31.8 25.1 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell line enhanced" "Detected in many" "HL-60: 16.9;THP-1: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.6 3.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.0 0.0 0.9 3.5 3.3 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.9 0.4 0.0 2.3 0.0 3.1 0.0 1.6 0.4 0.3 4.3 0.1 0.8 3.7 2.1 0.0 6.4 6.4 2.1 1.9 1.5 3.0 2.3 0.5 0.1 2.5 8.0 4.4 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Cell line enhanced" "Detected in many" "NB-4: 20.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA046346: , HPA046695: , HPA049923: , HPA051288: " "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.4 8.4 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.5 0.2 0.2 0.4 0.2 1.7 4.5 1.6 2.8 0.1 4.5 8.1 9.8 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.5 3.8 4.4 2.1 2.6 1.2 0.2 20.5 7.2 3.7 0.0 10.3 1.5 1.2 1.8 0.2 7.2 3.4 0.3 0.5 5.9 10.0 3.8 1.7 7.5 3.4 2.9 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA036201 Approved Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.8 0.7 0.3 0.4 0.1 0.1 0.5 1.3 0.2 0.2 0.4 0.0 0.1 0.6 29.0 0.2 0.7 0.3 0.6 0.3 0.2 1.0 0.0 3.6 0.1 0.6 1.0 0.1 0.2 0.5 0.0 0.8 0.0 0.2 0.3 0.4 0.5 0.0 1.3 0.4 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell line enhanced" "Detected in some" "Karpas-707: 5.5;U-266/70: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol "Microtubules, Cytosol" "HPA041534: , HPA048498: " "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favourable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.3 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.1 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.7 0.1 0.3 0.8 0.1 0.1 5.5 0.0 0.7 0.0 0.1 2.4 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.5 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 ANKRD26 "KIAA1074, THC2" ENSG00000107890 "Ankyrin repeat domain 26" Q9UPS8 10 26991914-27100498 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040654, HPA041460" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA040654: AB_10795370, HPA041460: AB_10795120" "unprognostic (1.92e-1)" "unprognostic (3.41e-1)" "unprognostic (2.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (4.08e-2)" "unprognostic (1.53e-2)" "unprognostic (1.03e-2)" "unprognostic (2.53e-3)" "unprognostic (5.35e-2)" "unprognostic (1.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.99e-1)" 6.5 7.2 11.8 5.0 18.2 3.8 9.2 16.9 15.7 7.3 6.7 4.6 6.3 4.6 8.7 7.8 6.0 7.0 5.9 8.6 11.0 5.6 7.4 6.7 5.5 8.3 9.0 10.7 10.0 6.2 10.1 24.4 7.5 9.9 7.6 7.2 6.6 7.0 8.6 14.1 7.0 5.4 6.0 7.0 6.6 5.6 9.7 8.4 6.4 9.1 4.7 6.2 7.0 7.3 3.4 5.0 1.7 1.0 3.4 4.6 0.5 7.8 5.1 9.4 5.8 6.1 7.3 4.3 9.4 3.6 8.8 8.5 4.9 5.6 18.1 3.2 4.5 8.4 9.2 4.5 10.6 7.7 7.4 1.2 7.1 8.2 4.4 4.2 2.0 5.6 3.8 9.0 3.3 7.8 12.9 5.2 9.6 4.7 5.2 4.1 4.0 3.4 5.9 13.0 4.7 6.4 2.8 8.9 4.9 8.7 2.4 9.3 8.4 2.7 6.3 8.2 5.6 9.7 5.5 2.4 2.9 11.5 6.7 10.9 3.4 1.7 1.0 0.2 2.3 0.7 2.0 2.8 2.7 2.5 1.2 3.4 4.6 3.9 0.6 3.4 1.0 5.0 1.4 0.5 11.8 18.2 16.9 15.7 11.0 5.6 9.0 10.7 9.9 8.4 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.6;BJ hTERT+: 12.0;hTCEpi: 11.9;PC-3: 11.4;U-2197: 14.9;U-87 MG: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favourable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favourable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favourable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.6 0.1 4.7 12.0 1.9 2.4 2.1 0.4 0.0 0.7 2.2 2.4 0.0 6.2 0.4 0.1 4.3 0.0 3.1 0.1 0.2 0.0 0.3 3.3 11.9 1.9 3.2 1.2 0.0 0.2 3.2 0.5 0.0 0.0 0.8 11.4 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 1.4 0.0 2.8 0.3 1.7 14.9 4.2 0.0 0.0 0.0 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 45.8" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 45.8 0.0 0.1 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;THP-1: 7.2;TIME: 9.2;U-87 MG: 9.2;U-937: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favourable (9.35e-4)" "prognostic favourable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 10.8 0.3 1.5 3.9 0.5 1.3 0.4 0.0 0.0 0.3 1.2 0.2 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 1.2 3.0 0.1 3.7 0.5 0.3 0.1 0.4 0.0 0.0 2.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 7.2 9.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.1 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113496-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 5.1 3.3 8.8 6.0 14.5 22.0 6.8 20.5 10.2 5.6 4.6 4.8 2.2 3.0 8.5 7.7 2.4 6.0 3.8 3.9 7.6 3.3 3.2 1.8 5.0 5.0 4.0 11.3 8.9 5.1 5.3 9.2 2.3 6.8 4.8 5.2 4.7 4.3 3.1 2.2 5.9 4.3 4.7 3.7 5.9 5.1 13.3 8.2 5.6 5.4 2.1 3.7 4.0 4.9 9.9 11.7 9.3 3.3 4.9 9.2 1.7 6.3 1.6 5.3 3.3 1.2 2.7 2.4 2.5 1.7 1.9 2.0 1.6 3.3 8.2 1.7 2.3 3.2 1.9 2.2 1.6 3.9 2.9 6.2 7.0 3.0 0.5 4.5 2.7 1.8 1.4 1.4 2.5 3.5 4.2 14.3 0.9 1.1 5.7 5.9 1.2 2.9 5.5 2.2 2.3 1.5 3.1 3.7 2.7 2.6 1.5 0.8 1.6 2.6 5.3 5.5 5.4 6.3 2.9 8.4 3.6 6.7 3.2 6.5 1.8 9.3 2.6 3.5 9.2 1.2 9.1 9.9 8.4 7.3 1.2 9.9 8.6 9.2 3.9 4.9 3.3 11.7 7.0 1.7 8.8 14.5 20.5 10.2 7.6 3.3 4.0 11.3 6.8 8.2 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 1.0 1.5 2.0 2.8 7.0 16.4 3.3 6.8 6.7 1.4 1.7 1.6 0.2 1.3 3.8 2.0 0.5 2.0 2.1 0.8 3.1 1.1 0.4 2.2 2.3 4.3 6.2 3.8 1.7 1.8 3.3 0.7 3.9 1.8 2.7 1.0 2.6 3.0 0.7 3.6 2.1 1.9 1.9 1.7 1.7 7.5 4.0 4.2 1.3 2.8 2.1 1.2 0.8 3.5 2.6 3.4 0.7 2.6 3.0 0.3 4.0 2.5 2.9 2.5 1.7 3.9 1.9 2.8 1.8 1.8 2.1 2.4 4.9 5.6 1.5 2.3 1.8 1.8 1.3 1.9 1.6 4.5 4.4 5.1 1.8 1.3 3.5 2.6 2.6 2.3 2.3 3.8 2.4 6.0 4.8 2.2 1.0 4.4 6.3 1.4 3.0 5.4 1.4 1.9 2.0 2.5 3.3 4.7 2.1 1.8 1.5 2.8 3.3 3.5 3.3 3.8 3.8 3.7 6.6 8.4 5.3 2.0 4.7 1.7 3.4 0.7 0.9 2.2 0.3 2.0 2.2 2.6 1.8 0.3 3.5 3.0 2.3 0.5 2.6 0.2 2.6 1.3 0.3 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.6" "Cell line enhanced" "Detected in many" "PC-3: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.2 1.0 4.2 1.8 4.1 13.2 5.3 8.0 5.8 3.1 3.1 0.5 2.8 0.7 3.2 1.9 1.8 2.6 4.0 1.5 3.3 1.8 1.2 0.8 2.0 2.7 1.6 1.7 5.6 3.1 1.2 3.9 0.9 3.1 1.6 2.1 2.1 9.2 1.5 0.9 2.9 2.6 1.5 1.9 2.4 4.5 10.1 1.1 2.8 1.6 2.4 4.0 2.5 2.2 11.1 19.6 18.1 2.0 7.2 12.5 0.7 6.6 1.3 2.7 1.9 1.8 4.9 1.0 1.6 1.1 2.1 2.7 1.5 1.5 6.6 2.1 1.1 1.5 2.4 1.2 2.6 3.7 3.3 2.7 3.2 1.9 0.4 7.8 2.0 1.4 0.9 1.6 0.8 3.5 2.5 8.4 2.3 0.9 5.9 2.9 0.6 25.4 3.2 2.0 2.6 1.0 1.3 2.5 2.2 1.0 1.7 1.1 0.8 1.9 3.8 2.6 2.8 2.0 1.9 3.2 2.6 7.1 0.7 5.4 1.0 18.1 2.0 1.5 12.5 0.3 8.1 9.2 10.0 8.1 1.4 11.1 8.7 8.5 0.1 7.2 0.5 19.6 8.3 0.7 4.2 4.1 8.0 5.8 3.3 1.8 1.6 1.7 3.1 1.1 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: " "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.6 1.0 0.7 3.8 5.2 3.3 3.6 3.1 2.3 2.3 5.0 1.6 1.9 3.2 1.3 5.6 2.5 3.6 4.0 2.9 9.0 1.0 2.2 3.4 4.8 2.2 2.0 4.9 0.6 4.3 2.1 3.0 2.8 3.3 5.4 6.2 1.7 1.7 8.0 1.1 5.3 0.5 1.0 8.7 2.8 0.5 5.3 9.5 2.1 2.1 9.2 1.9 1.3 3.7 4.9 3.9 2.8 3.5 10.2 2.9 1.4 14.0 1.5 5.7 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858095 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favourable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavourable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favourable (5.21e-4)" 8.9 16.2 17.1 9.2 19.2 12.0 6.9 29.4 20.8 7.4 8.3 15.0 7.2 11.2 11.7 5.9 7.6 10.9 7.9 17.6 14.8 14.7 6.5 12.6 7.6 13.0 13.5 14.0 7.3 11.2 11.7 14.2 7.4 13.4 10.4 5.6 10.3 9.5 10.1 6.3 10.9 8.4 9.5 10.7 8.9 7.9 3.7 13.0 5.4 6.3 4.3 8.7 9.0 5.8 15.5 29.0 7.1 9.0 14.4 27.8 8.7 6.2 4.1 2.4 5.2 0.8 1.6 5.7 4.9 2.3 6.1 4.7 10.2 2.6 4.0 7.3 3.5 2.7 3.0 4.6 1.3 4.6 9.1 2.8 3.7 13.8 4.1 6.5 7.1 3.0 2.7 5.6 2.1 4.4 6.0 71.9 2.2 9.9 6.0 5.0 3.0 9.6 4.6 1.7 22.5 3.1 3.2 5.5 3.6 3.5 8.3 6.2 2.5 3.5 2.1 3.8 3.8 4.3 8.6 3.7 4.0 6.5 3.9 7.5 4.0 7.1 6.9 5.3 19.6 8.3 16.4 15.5 19.4 17.2 6.8 13.6 10.8 13.3 3.5 14.4 9.0 29.0 27.8 8.7 17.1 19.2 29.4 20.8 14.8 14.7 13.5 14.0 13.4 13.0 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693190-50707924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavourable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 25.1 13.0 39.1 9.3 44.1 4.4 20.2 13.7 27.0 12.3 11.3 42.9 7.8 7.4 14.6 9.2 11.9 9.2 10.4 14.8 42.1 29.0 11.5 11.2 14.1 9.6 58.5 15.1 13.8 10.9 19.0 4.9 14.4 26.1 12.2 10.7 7.6 8.8 16.7 59.2 7.8 7.7 17.9 67.2 12.2 9.1 6.4 34.1 4.7 10.9 8.6 8.9 10.6 16.4 9.5 13.3 6.6 10.8 9.6 13.8 3.8 18.8 18.2 16.5 16.6 23.8 19.8 14.5 17.0 18.8 20.0 18.9 38.5 9.7 20.1 23.9 21.8 10.7 23.5 13.9 32.7 18.4 15.1 27.4 11.9 18.8 13.1 19.0 11.6 16.9 14.2 19.4 24.4 15.6 15.4 20.2 16.4 14.8 23.7 6.9 18.2 17.2 16.2 29.8 14.3 15.6 16.3 8.7 24.5 9.5 13.1 18.2 15.0 12.7 19.0 27.2 21.5 14.0 21.7 21.4 19.5 18.2 14.9 7.4 22.1 6.6 7.1 2.8 10.9 10.3 12.4 9.5 12.2 12.3 6.6 9.4 11.5 13.8 1.8 9.6 10.8 13.3 8.5 3.8 39.1 44.1 13.7 27.0 42.1 29.0 58.5 15.1 26.1 34.1 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell line enhanced" "Detected in all" "U-2197: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.8 3.2 6.7 10.6 11.1 3.0 8.0 6.2 4.7 2.9 4.1 4.7 1.6 10.3 7.1 8.4 3.4 5.4 3.9 2.1 2.7 2.7 9.2 2.7 7.2 7.7 6.5 6.5 6.5 11.9 6.4 4.9 8.0 1.5 6.8 5.7 1.1 8.5 2.8 4.3 1.8 4.9 2.0 15.8 4.7 2.6 3.5 10.3 6.5 2.0 9.8 4.3 7.0 7.4 5.1 26.8 3.7 2.0 4.6 3.3 5.8 4.8 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.7;lymphoid tissue: 38.2" "Cell line enhanced" "Detected in many" "HDLM-2: 26.1;HMC-1: 20.3;Karpas-707: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: " "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 6.0 6.0 4.9 29.4 8.8 12.5 4.3 3.7 5.1 8.6 6.7 10.8 3.9 3.2 6.5 3.9 4.3 4.9 7.6 6.4 6.4 4.7 5.6 4.5 15.4 36.7 9.4 4.7 5.1 3.5 6.0 6.1 6.4 6.4 5.0 4.8 7.4 8.0 4.7 2.9 3.0 12.6 9.6 8.0 17.8 5.6 7.1 8.9 38.2 5.1 3.0 27.0 9.0 9.8 15.7 9.4 34.7 11.4 12.0 13.4 6.3 1.0 0.6 1.6 1.7 3.8 1.5 0.3 2.4 1.1 1.3 1.2 0.4 0.5 8.8 1.1 2.0 0.1 0.5 0.5 1.0 26.1 2.2 0.3 3.1 0.1 0.2 6.4 20.3 0.8 0.3 1.3 0.1 1.7 1.4 14.7 1.9 1.5 3.1 5.2 0.2 1.6 5.6 1.8 12.0 3.1 0.8 1.6 7.2 0.8 0.6 6.9 0.9 6.3 9.1 4.5 2.5 1.3 1.8 3.7 4.3 11.2 3.1 8.0 2.6 21.8 9.5 21.0 13.1 9.8 12.4 11.6 9.8 11.1 9.4 15.7 11.3 13.4 34.7 12.0 11.4 6.2 9.3 6.3 4.9 8.8 3.7 5.1 6.4 4.7 9.4 4.7 6.4 8.9 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Cell line enhanced" "Detected in some" "AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 11.8 0.0 0.0 0.9 2.0 0.1 4.2 3.8 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.7 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: " "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavourable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favourable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.5 6.5 7.4 9.5 9.1 10.1 9.0 10.6 12.5 14.0 12.6 16.9 15.5 7.1 14.0 9.1 6.9 8.5 13.1 7.4 14.5 11.3 4.7 8.5 12.7 11.6 6.6 17.2 8.2 11.4 8.3 13.7 10.0 7.0 4.4 13.5 23.2 4.3 7.2 11.0 8.4 8.4 10.0 6.8 7.5 7.7 6.9 6.9 6.3 14.1 8.6 5.1 9.6 6.8 10.5 5.0 5.8 13.5 17.9 3.2 15.4 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664052-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 21.7;HUVEC TERT2: 21.6;TIME: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.4;monocytes: 3.8" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavourable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 10.1 4.8 6.6 8.2 6.8 4.7 7.6 4.0 8.3 17.1 10.0 4.3 8.7 3.7 17.5 7.4 11.4 5.9 10.2 7.3 6.2 6.5 9.8 6.9 13.4 5.4 5.5 6.5 9.0 5.2 12.5 3.9 17.1 6.2 19.1 6.9 6.7 7.7 7.9 3.2 12.9 7.9 14.2 4.8 7.1 8.2 16.8 4.8 15.4 9.2 5.8 4.4 16.5 10.9 0.1 2.4 0.5 3.8 0.4 0.1 0.4 2.2 4.2 12.0 5.5 9.6 6.1 1.2 5.8 5.0 3.0 1.9 1.8 3.0 0.0 1.8 8.3 2.1 7.9 4.5 5.4 0.0 1.7 1.9 5.5 1.8 6.9 3.1 2.5 6.2 6.2 4.8 21.7 21.6 3.4 4.1 5.7 5.1 3.9 1.1 2.5 6.3 3.2 3.7 0.5 3.8 9.4 3.5 4.3 4.0 2.6 4.7 2.7 2.7 54.4 6.5 5.0 3.2 5.0 3.0 0.0 0.8 2.9 1.3 7.4 0.0 1.5 0.5 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.4 2.3 0.9 0.0 0.4 6.6 6.8 4.0 8.3 6.2 6.5 5.5 6.5 6.2 4.8 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 10.7 23.2 12.3 13.2 19.6 12.1 10.8 23.1 23.5 10.8 11.6 15.6 9.1 11.9 13.8 8.9 10.9 11.5 12.7 12.0 12.7 13.4 13.2 8.3 9.8 12.3 13.3 14.7 14.6 14.1 28.4 14.5 12.6 22.8 11.9 12.1 14.8 11.6 13.6 30.8 15.8 13.0 15.8 8.8 11.9 10.9 8.5 13.5 10.5 12.4 11.4 13.4 12.3 11.8 1.1 1.1 2.4 0.6 0.3 1.2 0.5 11.6 28.8 12.9 23.2 10.5 8.3 9.0 23.3 10.4 20.9 9.5 18.6 6.5 12.4 14.9 22.7 15.2 14.1 10.1 12.1 12.0 14.3 22.3 18.8 7.1 7.2 17.5 13.0 8.5 11.5 19.4 9.9 12.1 9.1 6.8 19.6 16.2 14.0 5.8 5.4 13.4 11.1 8.9 4.9 13.8 14.9 9.7 8.8 25.4 16.2 9.3 13.1 6.8 16.7 21.9 19.3 12.2 14.5 6.3 8.3 6.2 22.5 5.8 14.2 2.4 0.6 0.9 1.2 0.1 1.0 0.8 0.4 0.7 0.3 1.1 0.6 0.7 0.3 0.3 0.4 1.1 0.3 0.5 12.3 19.6 23.1 23.5 12.7 13.4 13.3 14.7 22.8 13.5 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody "Microtubules, Midbody" Nucleoplasm "HPA071287: " "unprognostic (5.36e-2)" "prognostic favourable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favourable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favourable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.8 11.1 9.3 13.7 12.6 7.1 5.0 15.1 11.7 25.7 15.8 7.0 4.3 10.6 6.3 9.9 9.8 11.9 8.4 12.5 8.4 24.1 5.2 10.0 16.6 11.3 10.5 12.7 6.4 8.7 13.9 8.1 15.7 6.9 7.4 11.7 11.4 10.1 12.0 2.7 10.1 11.9 11.4 6.6 14.1 3.6 16.3 8.7 12.6 11.2 17.9 11.5 16.6 9.1 14.9 16.1 7.8 11.0 8.3 6.6 8.4 12.4 8.9 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 6 "HEL: 23.9;HMC-1: 12.4;NB-4: 15.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: , HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.1 0.9 0.0 1.1 12.4 0.0 0.0 0.0 0.0 3.0 1.9 0.8 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 ANKS1A "ANKS1, KIAA0229" ENSG00000064999 "Ankyrin repeat and sterile alpha motif domain containing 1A" Q92625 6 34889265-35091413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036768, HPA036769" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036768: AB_10670923, HPA036769: AB_10672473" "unprognostic (3.75e-2)" "unprognostic (2.67e-1)" "unprognostic (2.59e-2)" "unprognostic (7.79e-3)" "unprognostic (5.73e-2)" "prognostic favourable (7.48e-4)" "unprognostic (1.18e-3)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "prognostic favourable (8.05e-5)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.23e-2)" "unprognostic (7.80e-2)" 13.6 15.6 11.8 10.5 20.7 5.0 11.5 19.2 19.9 8.8 20.3 11.6 33.9 9.8 10.2 11.0 15.4 19.8 9.9 14.8 11.7 8.0 10.3 11.6 14.5 8.0 15.0 8.8 14.6 11.0 13.9 12.8 27.3 12.8 9.3 8.7 19.7 8.5 30.4 14.8 11.6 10.9 13.9 10.6 18.6 12.3 23.6 13.9 9.5 11.3 4.2 9.1 22.7 9.9 1.3 3.4 2.4 4.3 0.5 1.5 1.1 7.9 3.5 8.2 7.9 3.7 3.4 12.6 3.3 3.7 3.8 4.9 9.9 4.8 5.3 5.3 3.2 8.1 9.5 9.0 4.1 4.2 11.2 3.8 4.6 7.5 2.3 6.1 3.8 4.2 8.3 4.8 6.1 9.0 6.6 2.5 3.5 5.3 3.6 6.9 6.0 4.3 4.7 4.3 5.7 8.1 15.4 32.2 8.1 4.8 7.8 24.5 6.0 7.1 7.7 4.1 5.1 4.2 4.8 3.7 5.7 2.6 3.2 9.2 11.2 0.0 2.0 1.2 0.9 2.9 1.2 1.3 0.8 1.5 1.5 0.5 1.0 0.8 2.4 0.5 4.3 3.4 1.0 1.1 11.8 20.7 19.2 19.9 11.7 8.0 15.0 8.8 12.8 13.9 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell line enhanced" "Detected in some" "AF22: 11.8;ASC TERT1: 7.0;SCLC-21H: 12.9" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 11.8 2.8 4.8 7.0 0.7 0.0 1.2 0.9 0.9 0.2 0.9 1.0 0.5 1.7 0.5 0.1 0.1 0.2 1.4 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.3 0.3 0.9 0.2 0.7 0.5 0.5 3.4 2.2 0.8 0.0 0.3 0.1 0.0 12.9 1.4 1.1 3.8 1.5 4.4 0.1 0.1 1.0 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 ANKS3 "FLJ32345, FLJ32767, KIAA1977" ENSG00000168096 "Ankyrin repeat and sterile alpha motif domain containing 3" Q6ZW76 16 4696510-4734378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041409, HPA041482" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041409: AB_10794375, HPA041482: AB_10795594" "unprognostic (3.02e-1)" "unprognostic (2.19e-1)" "unprognostic (3.06e-2)" "unprognostic (2.55e-2)" "unprognostic (5.44e-2)" "unprognostic (1.31e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "unprognostic (4.42e-2)" "unprognostic (7.36e-3)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (9.96e-2)" "unprognostic (1.57e-3)" 6.9 10.1 7.4 6.4 12.0 4.2 8.9 14.5 11.1 8.1 9.3 8.2 5.0 6.2 8.7 6.7 8.2 9.3 6.8 5.6 8.3 8.5 10.5 5.0 5.8 8.6 10.0 10.9 15.7 16.5 6.8 14.2 5.6 9.7 9.1 3.2 10.9 14.4 10.2 7.7 8.3 4.8 11.7 7.0 5.2 6.1 8.0 7.5 3.2 9.4 3.4 4.7 7.6 7.5 3.3 5.3 0.0 1.6 1.3 3.8 1.1 1.9 23.1 3.0 6.6 5.8 4.8 6.9 8.6 7.0 8.0 7.2 11.9 4.8 4.4 10.9 5.7 3.9 6.5 4.7 3.6 5.6 12.4 3.9 10.7 2.9 6.4 2.1 3.6 3.0 5.1 7.7 7.4 1.5 9.4 1.4 4.8 7.1 4.2 7.8 8.1 4.4 6.7 7.4 7.8 6.1 2.4 9.7 9.4 4.5 6.6 3.7 6.5 2.8 2.6 5.9 8.1 11.0 4.4 6.9 12.2 6.5 3.1 2.2 6.8 0.0 1.1 0.0 2.4 1.6 2.9 3.3 2.7 1.7 1.9 3.3 3.8 2.5 0.0 1.3 1.4 5.3 1.7 1.1 7.4 12.0 14.5 11.1 8.3 8.5 10.0 10.9 9.7 7.5 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 4 "HDLM-2: 5.3;Hep G2: 12.7" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.0" HPA043523 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043523: AB_10966687" "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.1 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favourable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.4 8.3 7.7 13.4 6.4 5.2 5.2 4.0 6.9 4.5 5.4 4.6 4.0 10.2 3.1 5.7 16.5 5.6 6.8 2.4 14.2 5.8 2.5 5.0 1.9 6.3 1.3 1.7 6.4 8.5 6.2 6.3 5.1 17.2 2.4 3.4 9.1 0.5 2.6 12.1 9.1 6.8 19.1 0.8 8.2 3.4 5.0 5.7 1.7 9.9 4.5 0.0 2.8 5.2 4.8 5.2 12.9 3.9 4.8 8.0 1.7 6.7 4.6 6.8 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 ANKZF1 "FLJ10415, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger domain containing 1" Q9H8Y5 2 219229757-219236669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavourable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavourable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 10.1 11.1 14.8 19.0 19.8 13.7 12.9 38.4 25.9 13.8 15.4 17.5 21.7 17.5 14.3 14.7 17.1 21.1 11.7 13.8 12.7 9.6 15.2 15.8 13.2 23.2 19.6 13.5 19.6 19.0 12.3 22.7 11.3 16.4 16.6 10.4 13.6 18.2 22.7 18.9 21.7 19.5 9.5 18.5 21.0 15.1 8.7 18.8 18.7 14.0 8.8 19.8 16.8 16.2 11.7 8.3 10.7 10.6 20.6 17.8 11.0 19.2 3.9 5.1 7.5 7.1 5.9 20.2 6.4 6.4 8.9 11.3 9.4 8.2 4.1 11.5 2.7 14.2 6.8 10.9 6.5 8.5 7.0 9.0 11.5 8.7 7.0 5.5 8.9 5.9 21.7 6.6 10.5 6.0 15.1 9.4 4.5 8.5 8.5 14.5 8.4 7.0 8.8 6.1 13.1 4.8 4.9 6.6 6.2 6.5 15.4 12.3 4.0 13.6 6.5 7.3 5.6 5.9 8.0 20.6 11.7 7.3 12.4 8.4 3.2 8.4 7.7 8.8 14.6 7.5 15.4 11.0 14.7 14.4 7.8 11.7 17.8 16.3 10.7 20.6 10.6 8.3 14.0 11.0 14.8 19.8 38.4 25.9 12.7 9.6 19.6 13.5 16.4 18.8 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: , CAB068175: , HPA005680: , HPA050556: " "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (5.97e-7)" "prognostic unfavourable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavourable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 67.1 14.1 11.7 8.9 1.6 4.1 12.7 42.4 24.8 51.2 38.4 9.6 20.8 3.4 12.3 21.4 34.6 9.2 24.8 98.4 2.2 6.7 4.6 15.9 8.0 0.2 6.6 5.4 0.9 1.1 33.3 22.0 15.9 9.7 7.1 41.7 10.1 5.6 7.7 13.0 15.0 4.1 35.3 2.2 11.3 11.0 5.0 5.9 22.3 25.9 3.9 17.5 7.6 15.1 32.1 36.1 18.9 49.5 3.0 4.7 6.2 10.9 10.7 67.3 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Group enriched" "Detected in some" 5 "A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA032148: , HPA057356: " "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favourable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavourable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavourable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavourable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 33.8 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.6 0.0 63.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 4.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.8 0.2 4.1 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA016624: , HPA051569: " "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favourable (6.70e-4)" "prognostic favourable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 8.8 7.1 7.9 8.3 32.2 17.3 9.7 26.2 43.6 13.4 17.1 4.8 8.3 1.0 8.4 34.5 4.9 6.2 14.3 16.3 9.9 4.4 11.6 9.6 5.2 14.1 2.0 9.5 16.1 11.4 16.5 22.5 31.3 8.7 7.6 29.6 6.3 2.2 1.5 9.4 8.3 1.8 5.7 3.0 26.4 9.4 1.9 5.8 10.3 8.5 6.0 18.1 4.3 25.4 20.4 7.6 21.4 11.9 4.9 6.4 0.3 18.6 4.4 13.4 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: " "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.1 0.0 3.9 0.0 0.0 0.2 1.8 0.0 8.4 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 1.6 0.0 0.8 0.0 0.0 4.0 0.0 1.6 0.0 0.9 0.1 0.1 0.0 0.0 2.0 1.4 0.0 1.1 0.0 0.2 0.0 22.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45440404 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" 1500000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavourable (7.56e-5)" "prognostic unfavourable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 40.7 15.3 6.4 17.3 7.0 3.8 42.8 2.5 7.3 22.2 29.7 6.1 34.8 16.5 33.2 16.0 21.2 18.5 20.2 20.7 6.7 5.4 21.6 25.4 25.6 11.7 7.6 4.2 27.4 12.7 20.1 7.1 23.3 8.8 21.6 6.9 14.2 16.8 39.3 40.3 10.0 41.3 42.8 14.6 12.5 13.5 10.4 5.8 21.6 11.2 14.7 9.6 37.6 38.1 2.1 7.1 4.4 9.3 3.1 4.0 5.0 13.8 15.9 8.9 12.1 41.1 21.4 34.2 19.5 24.5 13.4 12.5 23.9 20.9 7.2 18.2 30.4 18.4 8.1 10.8 15.7 10.5 5.8 8.3 6.5 20.1 13.1 12.9 6.7 17.8 10.8 11.3 16.6 17.7 6.3 11.7 14.3 3.6 13.7 4.1 10.0 6.0 7.9 11.6 7.9 12.4 22.0 4.0 13.9 20.3 12.7 9.3 14.9 20.3 24.1 14.4 9.2 14.5 9.8 6.2 7.1 8.7 12.9 41.3 11.5 4.4 7.7 1.9 3.3 9.3 3.4 2.1 3.2 2.8 7.1 1.7 2.9 2.0 0.9 3.1 8.6 3.6 4.0 5.0 6.4 7.0 2.5 7.3 6.7 5.4 7.6 4.2 8.8 5.8 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334829 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031787, HPA049206" Uncertain Uncertain "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA031787: , HPA049206: " "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 8.5 18.1 19.2 6.6 17.9 3.8 6.6 25.1 30.6 4.3 4.3 11.6 4.9 6.6 5.1 2.2 12.5 4.0 7.9 7.1 15.7 10.6 6.1 6.0 6.6 6.2 13.3 10.3 3.2 7.0 14.4 4.0 5.3 23.3 5.4 4.0 3.2 7.9 4.8 11.1 23.2 6.2 4.5 20.1 5.4 12.2 3.4 14.1 5.3 5.2 5.2 4.4 5.1 5.2 0.1 1.8 0.1 0.1 0.0 0.8 0.1 4.1 3.7 10.1 11.5 3.1 2.2 17.6 4.2 2.4 2.2 2.5 1.6 8.9 0.3 4.6 4.1 3.9 2.1 3.4 1.3 18.7 5.2 2.8 10.7 2.4 1.6 0.6 4.8 2.5 3.2 2.8 2.1 1.6 2.0 4.2 1.4 3.1 3.6 1.1 5.8 15.2 6.1 2.1 4.9 3.7 6.8 3.8 12.3 4.6 4.4 3.5 6.3 1.8 1.7 5.2 2.9 15.8 4.6 7.5 6.1 0.7 8.1 5.2 4.9 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.5 0.5 0.0 0.0 0.1 1.8 0.8 0.1 19.2 17.9 25.1 18.6 15.7 10.6 13.3 10.3 23.3 14.1 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol 740000 "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: , HPA067561: " "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 25.8 20.4 32.7 32.0 40.1 46.0 28.2 50.7 33.7 24.5 30.7 40.5 16.0 27.0 26.8 21.7 28.8 30.0 23.4 47.8 32.3 23.6 30.0 29.6 27.2 55.0 33.9 30.0 26.7 25.6 24.2 18.3 38.6 26.6 30.4 35.4 27.2 23.6 27.8 41.7 18.9 28.9 30.5 42.7 40.1 29.8 9.4 36.7 75.0 29.0 18.5 52.4 35.7 27.6 12.7 19.8 27.7 19.9 18.1 12.3 9.6 26.0 32.0 42.1 36.3 14.8 13.0 28.0 13.7 18.5 27.0 22.8 26.4 49.1 84.6 25.8 15.5 38.3 97.4 28.1 32.5 38.1 33.1 64.0 27.1 33.0 9.2 50.3 34.6 10.4 19.9 14.8 29.6 39.2 46.5 33.1 23.1 18.2 50.5 41.3 37.4 16.2 70.9 39.1 50.2 23.8 41.2 55.9 34.7 20.9 23.6 38.7 31.4 66.0 17.5 28.0 44.6 19.3 36.7 20.1 55.7 98.0 18.6 84.7 25.6 8.1 17.6 27.7 11.9 19.9 10.0 12.7 9.8 12.3 19.8 12.7 12.1 10.6 18.1 18.1 16.8 17.6 11.2 9.6 32.7 40.1 50.7 33.7 32.3 23.6 33.9 30.0 26.6 36.7 ANP32B "APRIL, PHAPI2, SSP29" ENSG00000136938 "Acidic nuclear phosphoprotein 32 family member B" Q92688 9 97983361-98015943 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063133, HPA067561, HPA069657" Supported Enhanced Nucleoplasm,Centrosome,Cytosol 290000 Nucleoplasm "Centrosome, Cytosol" "HPA063133: , HPA067561: , HPA069657: " "unprognostic (2.82e-1)" "unprognostic (2.05e-2)" "unprognostic (4.57e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-1)" "unprognostic (5.52e-2)" "prognostic unfavourable (1.98e-7)" "unprognostic (6.76e-3)" "unprognostic (5.70e-2)" "unprognostic (7.16e-2)" "unprognostic (3.50e-1)" "unprognostic (6.39e-2)" "unprognostic (9.22e-3)" "unprognostic (5.20e-2)" "unprognostic (2.36e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-2)" 43.0 24.6 37.9 46.5 55.5 105.7 37.7 15.6 30.1 43.2 38.9 81.0 24.6 32.7 46.3 38.4 40.4 28.4 39.2 27.0 41.8 32.0 26.0 35.9 35.0 70.4 55.7 21.7 51.1 46.0 29.3 20.7 37.5 41.8 38.9 42.3 26.2 32.5 29.7 29.4 38.6 34.9 45.3 88.3 38.6 36.7 19.0 47.6 85.9 37.0 31.9 81.8 64.5 58.6 34.8 32.6 36.8 44.6 22.7 51.3 25.1 70.9 38.4 42.8 35.7 24.1 42.7 39.0 36.9 32.7 39.7 33.5 48.1 34.9 87.1 22.1 24.7 47.0 57.7 41.6 45.6 56.5 32.5 75.3 33.0 51.9 31.0 129.1 43.9 32.3 30.5 31.8 65.8 34.4 144.9 61.7 30.5 94.8 97.4 114.8 16.7 38.2 58.2 66.8 41.4 25.9 29.8 34.6 30.2 43.3 42.3 37.8 23.9 48.3 41.7 25.9 42.0 32.5 38.7 56.0 63.2 52.6 24.0 51.8 48.2 23.1 27.2 36.8 22.7 30.9 31.3 34.8 42.7 31.9 32.6 29.6 51.3 38.7 11.3 22.7 44.6 31.8 50.8 25.1 37.9 55.5 15.6 30.1 41.8 32.0 55.7 21.7 41.8 47.6 ANP32D PP32R2 ENSG00000139223 "Acidic nuclear phosphoprotein 32 family member D" O95626 12 48472665-48473624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NB-4: 1.3;REH: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063133, HPA067561" Uncertain Enhanced Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA063133: , HPA067561: " "unprognostic (2.20e-1)" "unprognostic (3.75e-1)" "unprognostic (3.18e-1)" "unprognostic (3.23e-2)" "unprognostic (5.11e-2)" "unprognostic (1.72e-3)" "unprognostic (2.30e-2)" "unprognostic (3.62e-3)" "unprognostic (2.76e-2)" "unprognostic (3.48e-1)" 0.1 0.9 0.3 0.0 0.2 0.1 0.2 0.2 0.6 0.0 0.5 0.0 0.6 0.8 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.7 0.0 0.2 1.1 0.1 0.0 0.2 0.5 0.3 0.2 0.4 0.3 0.2 0.0 0.1 0.2 0.2 0.5 0.2 0.9 0.8 0.0 0.4 0.1 0.1 0.1 0.6 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.4 0.4 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.3 0.0 ANP32E "LANP-L, LANPL, MGC5350" ENSG00000143401 "Acidic nuclear phosphoprotein 32 family member E" Q9BTT0 1 150218417-150236156 "Predicted intracellular proteins" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021114, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol 18000 "Nucleoplasm, Centrosome" Cytosol "CAB021114: AB_10057407, HPA063133: , HPA067561: " "unprognostic (1.04e-1)" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (8.95e-2)" "unprognostic (1.69e-2)" "unprognostic (1.47e-3)" "prognostic unfavourable (4.50e-5)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (3.91e-2)" "unprognostic (7.73e-3)" "unprognostic (2.47e-1)" "prognostic unfavourable (3.82e-8)" "unprognostic (1.76e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (3.52e-1)" 11.5 18.3 31.2 21.0 30.9 38.4 10.6 50.3 20.6 14.3 11.3 18.3 13.5 12.9 16.5 21.0 12.8 12.8 11.9 19.8 22.9 25.9 18.6 16.8 13.3 38.4 26.5 19.5 19.1 6.9 20.1 14.7 12.3 21.2 14.2 10.9 20.1 9.2 20.9 25.5 12.5 14.5 25.2 32.7 20.3 9.9 6.0 17.8 52.2 18.1 13.6 34.7 20.6 12.1 24.5 8.2 20.7 10.5 14.6 27.0 15.7 33.7 21.9 45.7 22.7 3.6 5.3 17.4 18.2 10.3 17.6 16.9 16.1 24.0 61.6 16.2 10.4 11.8 25.7 11.3 25.3 70.5 15.6 42.7 27.2 23.2 3.4 85.6 21.7 4.3 1.8 16.4 15.2 13.0 40.8 36.5 16.1 35.1 34.9 22.3 46.1 10.0 37.2 25.4 32.4 12.5 13.6 15.0 25.8 38.0 6.1 10.7 16.5 43.8 13.4 9.0 25.5 9.3 36.4 47.2 47.3 60.4 10.3 61.9 16.4 20.7 10.5 16.3 18.0 7.3 27.0 24.5 24.2 19.7 8.2 17.0 17.4 21.6 7.2 14.6 8.8 5.7 25.7 15.7 31.2 30.9 50.3 20.6 22.9 25.9 26.5 19.5 21.2 17.8 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: , HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favourable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favourable (4.57e-5)" "prognostic unfavourable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 65.9 104.2 4.7 4.9 66.5 63.3 0.3 114.3 71.4 47.3 32.1 3.0 59.7 0.1 37.8 99.7 81.2 10.1 69.2 37.5 37.3 0.7 5.0 31.0 0.1 53.1 11.0 2.5 36.4 57.4 47.8 94.0 67.0 20.9 2.8 58.3 0.2 19.4 6.0 5.9 42.4 0.0 26.6 0.2 106.4 14.0 0.0 0.0 39.3 1.0 26.4 0.2 1.7 82.7 55.5 34.9 76.2 58.6 0.4 0.1 0.2 128.1 10.2 83.4 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 6 "PC-3: 41.0;RT4: 55.4" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005469 Enhanced Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849" "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favourable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ANXA11 ANX11 ENSG00000122359 "Annexin A11" P50995 10 80150889-80205572 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004851, HPA027545" Supported Supported Nucleoplasm,Cytosol 530000 Nucleoplasm Cytosol "CAB004851: AB_626682, HPA027545: AB_1844851" "unprognostic (1.85e-2)" "unprognostic (2.85e-2)" "unprognostic (5.35e-3)" "unprognostic (5.06e-2)" "unprognostic (8.18e-3)" "unprognostic (1.99e-1)" "unprognostic (4.01e-3)" "unprognostic (6.28e-2)" "unprognostic (2.32e-2)" "unprognostic (4.88e-2)" "unprognostic (3.46e-2)" "unprognostic (2.56e-2)" "prognostic favourable (6.69e-8)" "unprognostic (2.69e-3)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (2.02e-1)" 44.1 7.3 19.4 27.8 23.8 37.0 61.1 22.8 24.4 26.4 34.4 8.6 18.4 28.6 20.2 36.4 49.5 23.9 47.5 57.1 17.2 8.3 39.1 21.9 35.1 38.1 10.8 14.2 27.3 24.0 26.2 9.7 35.0 7.5 28.9 27.6 16.7 20.2 27.8 39.5 18.6 44.1 28.1 11.2 22.9 29.3 15.1 6.6 45.7 18.9 39.2 31.8 34.9 39.6 12.7 14.4 77.9 12.1 11.6 21.9 13.0 34.7 30.5 1.8 9.0 39.1 38.6 19.5 26.0 67.0 16.2 16.8 27.6 54.4 2.3 18.8 38.9 45.5 7.8 21.7 9.8 59.1 13.9 14.2 18.1 21.4 22.9 15.6 35.3 40.7 13.2 9.0 6.9 23.0 13.9 26.4 12.8 20.7 19.0 34.5 3.3 64.7 14.5 2.7 52.6 27.4 32.3 0.8 6.3 11.2 45.0 25.4 13.3 19.2 27.7 11.4 17.1 26.0 13.6 16.1 21.9 15.1 11.9 26.1 7.5 22.6 12.1 77.9 14.5 9.6 15.3 12.7 18.3 20.3 9.1 10.9 17.3 14.9 43.8 11.6 10.7 14.4 21.9 13.0 19.4 23.8 22.8 24.4 17.2 8.3 10.8 14.2 7.5 6.6 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6" "Group enriched" "Detected in some" 13 "A549: 23.3;HDLM-2: 12.0" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.1 0.3 0.7 0.5 0.0 0.4 0.1 0.4 0.2 30.3 0.4 41.9 66.5 1.1 2.6 0.2 13.3 38.7 0.1 0.5 0.6 2.1 4.3 0.1 0.1 3.0 0.1 0.9 0.3 0.0 0.1 0.1 0.7 1.1 8.1 0.2 0.2 20.7 0.1 0.1 108.6 0.4 8.0 0.1 0.7 2.3 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.5 0.6 3.0 0.1 0.7 0.3 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" 16000000 "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favourable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavourable (2.54e-5)" "prognostic unfavourable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavourable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavourable (6.59e-5)" 91.7 29.8 4.9 23.5 7.1 6.6 50.1 4.5 5.6 65.1 39.1 8.6 38.2 26.4 38.3 40.3 158.8 26.2 54.9 29.9 4.7 5.5 36.7 28.5 62.0 46.6 10.8 5.7 23.3 94.3 29.7 12.8 84.1 25.7 29.5 35.2 31.7 74.7 27.9 22.7 77.3 71.9 37.1 15.1 32.6 25.6 18.7 7.1 14.6 31.0 122.7 81.4 34.0 87.4 35.5 209.6 183.3 138.0 15.2 83.9 150.8 142.1 158.7 8.4 3.7 114.7 184.1 36.5 169.9 109.6 108.0 94.8 75.2 68.6 0.3 139.9 219.8 152.1 37.3 319.1 118.4 30.3 3.9 2.8 76.4 29.2 69.2 0.1 2.1 89.8 87.1 76.7 165.4 201.2 11.3 16.6 230.6 16.5 0.6 8.4 18.2 123.6 1.6 46.1 7.9 191.4 86.7 11.0 6.2 67.2 15.3 66.7 32.8 5.9 229.5 92.1 125.5 308.8 166.8 6.2 20.3 2.7 86.8 1.6 183.2 183.3 138.0 17.7 33.4 122.6 36.5 35.5 38.5 38.5 209.6 16.9 4.5 18.1 3.9 15.2 129.1 32.0 83.9 150.8 4.9 7.1 4.5 5.6 4.7 5.5 10.8 5.7 25.7 7.1 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell line enhanced" "Detected in many" "HSkMC: 10.0;MOLT-4: 10.7;REH: 11.2;U-937: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: " "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavourable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 2.9 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.7 2.4 0.5 0.3 1.8 0.2 0.1 4.5 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.0 0.1 0.8 0.1 5.6 0.5 3.6 0.7 1.0 10.7 1.4 0.0 5.4 11.2 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.5 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Approved Nucleoplasm,Cytosol 540000 Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: " "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favourable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 27.4 27.1 28.0 18.5 28.7 24.1 29.3 23.5 33.1 25.2 21.1 25.0 15.5 13.0 25.1 28.2 24.7 19.7 20.7 36.6 27.2 26.8 39.4 40.8 21.5 33.0 26.0 28.8 26.2 24.2 103.3 28.1 23.3 24.9 24.1 25.4 22.8 26.0 25.3 75.4 21.5 17.3 32.3 25.4 21.3 18.0 11.7 15.5 17.1 30.2 28.2 26.7 27.6 20.5 35.3 36.4 53.0 34.9 33.0 44.4 42.5 24.2 17.6 6.9 16.8 27.0 26.6 15.0 16.2 42.9 21.3 18.0 25.6 28.8 9.7 16.5 30.6 20.4 12.8 19.2 21.2 23.9 9.5 13.7 8.8 22.8 23.8 19.5 6.3 16.5 18.7 26.6 47.7 18.9 17.8 27.6 27.0 19.4 11.0 12.6 7.7 122.1 9.1 19.6 17.6 36.9 14.9 5.5 7.6 18.3 42.3 15.3 26.4 10.4 17.6 8.7 15.8 26.3 20.9 17.9 25.4 13.7 20.6 25.3 6.7 53.0 34.9 45.1 22.2 26.2 30.1 35.3 34.4 27.7 36.4 24.0 31.5 27.7 35.4 33.0 25.6 15.6 44.4 42.5 28.0 28.7 23.5 33.1 27.2 26.8 26.0 28.8 24.9 15.5 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982017-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 62.0;seminal vesicle: 78.1" "Cell line enhanced" "Detected in many" "CACO-2: 12.0;CAPAN-2: 14.4;Hep G2: 14.5;MCF7: 19.3;T-47d: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favourable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.4 1.1 1.2 0.9 1.2 0.3 2.6 1.3 2.5 2.3 0.9 0.6 62.0 1.4 6.0 11.6 10.7 2.3 12.5 1.9 1.4 1.0 12.1 15.8 1.2 0.5 1.8 0.8 1.8 32.0 9.9 1.2 0.7 1.3 4.1 0.0 1.2 2.5 78.1 0.9 18.9 1.2 0.9 3.2 1.0 1.3 3.6 0.6 1.3 10.4 9.1 21.1 4.5 4.4 0.5 3.8 2.5 3.1 0.1 0.8 0.8 3.9 0.9 1.4 1.4 0.0 0.0 4.1 0.3 0.2 0.0 0.0 12.0 14.4 0.1 0.8 0.0 2.4 0.0 0.2 0.0 1.2 1.4 2.0 1.4 14.5 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.9 4.4 0.0 19.3 0.1 1.0 0.3 0.2 0.9 0.2 4.7 0.0 5.6 2.1 1.2 0.8 9.9 0.5 48.0 1.2 1.5 0.3 0.4 0.2 0.2 1.3 4.0 6.2 2.1 1.3 1.1 0.0 3.1 1.8 0.1 1.8 0.8 0.5 0.3 0.5 3.8 0.1 0.8 0.2 2.5 0.1 0.4 0.0 0.0 0.8 1.2 1.2 1.3 0.9 1.4 1.0 1.8 0.8 1.3 0.6 AOC3 "HPAO, VAP-1, VAP1" ENSG00000131471 "Amine oxidase, copper containing 3" Q16853 17 42851184-42858130 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "ASC diff: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "HPA000980, CAB025797" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted - unknown location" 240000000 Cytosol "Golgi apparatus" "CAB025797: , HPA000980: AB_1078170" "unprognostic (2.20e-1)" "unprognostic (4.49e-2)" "prognostic unfavourable (3.68e-4)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (2.64e-1)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (4.00e-2)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavourable (1.79e-5)" "unprognostic (5.61e-2)" "unprognostic (1.67e-1)" "unprognostic (8.39e-2)" "prognostic unfavourable (6.98e-4)" 97.0 11.5 0.4 18.7 1.0 0.0 67.7 0.5 1.3 26.9 44.3 1.0 16.3 3.6 44.7 34.8 36.1 18.5 50.9 12.1 0.4 0.4 5.8 8.3 48.0 7.9 0.5 1.2 23.8 2.4 2.2 1.3 10.8 2.0 36.5 9.4 32.1 8.0 24.7 7.7 5.5 15.0 79.2 0.6 7.5 17.7 16.2 0.3 1.0 6.6 11.6 2.6 75.9 20.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 83.5 0.1 1.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.2 0.3 1.4 0.1 0.1 4.6 0.2 0.0 0.2 0.9 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.7 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.3 0.1 1.2 1.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.5 1.3 0.4 0.4 0.5 1.2 2.0 0.3 AP001273.2 ENSG00000284057 11 93741664-93812378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA040511, HPA046619" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA040511: AB_10795369, HPA046619: " 2.4 3.0 1.8 4.2 3.4 0.6 2.7 2.8 2.4 3.6 6.1 3.5 3.6 8.2 2.6 3.0 2.9 2.5 3.3 4.0 2.0 16.9 17.6 3.6 1.7 3.9 1.9 4.8 5.4 5.3 5.9 2.8 3.2 4.5 2.7 4.2 3.8 2.8 4.2 3.7 11.1 2.9 4.5 1.9 3.7 2.6 3.6 4.2 5.7 2.0 1.8 3.0 1.0 2.7 2.9 4.4 2.9 3.0 3.8 2.0 0.2 0.0 4.7 0.9 3.5 0.0 0.6 0.0 1.5 1.0 2.0 1.5 1.2 0.3 4.2 2.5 1.8 5.2 0.7 0.0 1.4 0.0 0.0 1.5 0.0 0.9 0.0 1.0 0.0 0.7 0.0 0.6 0.0 1.0 0.5 5.4 0.0 2.2 3.7 2.0 0.0 1.0 2.7 1.7 5.1 0.0 0.3 0.4 0.0 1.3 3.7 2.1 1.0 2.3 0.0 0.8 0.7 1.9 0.9 0.9 3.9 0.4 1.1 1.7 2.9 2.9 4.4 3.2 2.1 3.0 2.7 2.6 2.6 2.9 1.0 2.9 3.6 4.4 3.0 2.3 1.5 3.8 2.0 AP1B1 "ADTB1, AP105A, BAM22, CLAPB2" ENSG00000100280 "Adaptor related protein complex 1 beta 1 subunit" Q10567 22 29327680-29423179 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065226, HPA068520" Approved Enhanced "Golgi apparatus,Vesicles,Cytosol" 1000000 "Golgi apparatus, Vesicles" Cytosol "HPA065226: AB_2685438, HPA068520: AB_2685998" "unprognostic (1.78e-1)" "prognostic favourable (4.81e-4)" "unprognostic (2.40e-1)" "unprognostic (2.21e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (5.55e-5)" "unprognostic (4.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-3)" "unprognostic (1.60e-1)" "prognostic favourable (7.24e-6)" "unprognostic (1.85e-2)" "unprognostic (3.78e-2)" "unprognostic (2.94e-2)" "unprognostic (3.76e-2)" 22.2 25.8 28.0 32.3 35.2 29.9 17.2 37.3 43.1 17.2 23.9 26.5 23.9 32.1 14.8 18.4 46.4 17.7 22.0 16.6 24.4 30.4 24.2 25.8 21.2 37.2 29.4 24.1 12.7 28.4 48.2 31.1 32.3 31.9 27.3 21.8 24.1 29.5 31.2 31.3 34.0 28.7 19.3 22.4 33.0 24.9 23.4 16.7 25.2 21.6 25.5 37.4 25.6 21.0 12.2 16.9 3.1 17.3 4.0 5.8 11.6 26.9 15.4 16.0 17.0 12.3 9.0 20.0 19.0 21.2 23.4 22.4 23.5 11.1 14.9 12.6 21.6 24.3 22.9 32.0 14.9 19.1 33.4 24.7 20.0 13.3 13.7 35.2 34.2 12.9 11.9 22.3 18.0 32.4 16.9 18.2 15.4 29.5 14.8 11.7 12.4 17.5 28.4 17.6 39.6 16.5 61.4 25.4 18.0 23.5 27.6 11.8 22.4 16.1 27.9 27.0 16.7 15.4 19.8 19.8 10.3 27.3 19.2 15.3 15.7 0.0 15.5 3.1 5.8 17.3 5.8 10.1 3.9 4.9 16.9 12.2 3.2 3.2 1.7 4.0 17.3 5.2 5.2 11.6 28.0 35.2 37.3 43.1 24.4 30.4 29.4 24.1 31.9 16.7 AP1G1 "ADTG, CLAPG1" ENSG00000166747 "Adaptor related protein complex 1 gamma 1 subunit" O43747 16 71729000-71809201 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009049, HPA041224" Approved Enhanced Vesicles,Cytosol 150000 Vesicles Cytosol "CAB009049: AB_2058329, HPA041224: " "unprognostic (4.84e-2)" "unprognostic (5.07e-2)" "unprognostic (2.65e-2)" "unprognostic (2.91e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (8.90e-2)" "unprognostic (9.16e-2)" "unprognostic (2.72e-1)" "unprognostic (2.22e-2)" "unprognostic (4.30e-2)" "prognostic favourable (2.96e-8)" "unprognostic (1.27e-1)" "unprognostic (2.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-1)" 23.2 29.8 20.4 19.2 26.3 59.1 22.4 31.8 29.2 19.7 20.4 29.2 19.8 19.2 19.6 23.9 30.1 17.9 18.7 14.5 18.5 17.4 32.8 29.5 23.8 20.0 24.2 20.1 18.3 25.6 53.5 27.4 25.1 27.9 20.8 23.4 20.8 28.2 20.2 30.0 27.7 24.4 16.0 20.3 24.3 24.8 26.5 26.7 30.0 23.1 21.8 28.3 18.1 20.1 7.5 8.5 17.6 8.8 7.6 9.0 4.2 16.2 23.8 18.3 18.6 19.7 18.7 15.9 16.9 16.2 22.7 21.9 22.9 18.1 20.2 16.3 23.0 20.8 24.8 18.6 30.6 8.1 12.7 13.2 12.5 17.4 11.6 15.8 43.9 15.6 13.2 30.2 18.7 19.2 17.5 8.6 22.2 29.0 14.6 13.3 16.7 10.4 23.6 14.7 21.6 21.2 18.7 16.9 10.1 20.9 13.2 9.4 23.1 12.5 22.6 19.5 15.2 10.4 12.3 13.6 17.5 41.8 15.7 12.8 16.6 5.8 7.9 10.9 8.3 8.8 8.3 6.3 7.3 9.0 8.5 7.5 5.9 7.2 17.6 7.6 6.8 6.0 7.3 4.2 20.4 26.3 31.8 29.2 18.5 17.4 24.2 20.1 27.9 26.7 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 sigma 1 subunit" P61966 7 101154400-101161596 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA060945: " "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 7.6 9.7 30.6 7.9 41.1 3.0 10.8 7.9 45.8 6.8 16.5 6.4 4.6 23.3 6.6 10.6 10.9 8.9 9.3 4.2 22.9 14.6 16.6 15.5 6.7 6.9 12.3 25.3 7.9 8.0 6.3 10.5 10.2 10.1 10.9 14.2 4.6 10.4 6.1 3.5 12.3 18.0 7.9 8.7 7.7 13.2 6.9 9.3 4.7 9.3 7.4 8.5 8.7 6.1 4.4 8.2 2.1 5.5 1.9 5.9 4.2 26.2 21.3 14.3 27.1 10.6 17.5 31.1 17.6 11.9 12.0 12.8 11.4 33.5 5.9 30.8 19.2 13.0 8.2 27.1 10.7 13.3 13.3 4.0 13.4 14.2 13.1 10.7 19.9 19.5 20.7 11.8 5.1 17.7 12.8 23.7 29.6 65.4 8.9 23.1 22.9 43.0 5.6 6.5 12.3 28.8 22.4 11.3 37.0 10.0 26.6 32.1 11.7 10.0 18.3 17.3 30.2 6.5 12.1 5.3 11.2 11.3 44.0 11.9 34.8 0.8 5.5 0.5 4.2 4.9 3.7 4.4 5.9 4.7 7.4 3.8 3.5 3.2 2.1 1.9 2.8 8.2 5.5 4.2 30.6 41.1 7.9 35.1 22.9 14.6 12.3 25.3 10.1 9.3 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 sigma 2 subunit" P56377 X 15825806-15854931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 218.0" "Cell line enhanced" "Detected in many" "Karpas-707: 66.0;SK-MEL-30: 87.3" "Cancer enhanced" "Detected in all" "melanoma: 49.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 55.2;monocytes: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA049894: , HPA060945: " "prognostic favourable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favourable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 10.1 8.2 21.2 11.7 17.9 12.6 9.7 13.0 17.6 12.0 17.3 9.8 12.6 4.8 25.7 218.0 9.8 5.6 7.0 34.2 12.7 19.9 5.2 5.8 8.9 11.6 16.1 11.8 4.5 4.1 8.2 11.7 13.1 39.7 5.5 8.0 13.3 5.1 13.2 41.4 5.0 8.7 24.9 18.5 14.1 9.9 8.6 11.4 9.8 10.7 8.6 9.6 8.5 5.9 8.2 55.2 12.5 74.9 5.5 8.4 44.8 3.3 2.8 31.9 15.7 6.0 4.1 1.1 10.0 4.7 7.8 10.0 2.0 3.5 5.7 44.7 14.6 3.9 8.8 2.7 13.0 8.1 14.1 3.4 5.0 3.1 5.3 12.7 3.8 2.4 2.8 7.4 7.6 15.6 3.1 66.0 14.0 1.8 3.3 6.7 42.5 10.5 7.2 23.3 11.5 8.7 0.8 3.9 15.5 4.5 1.3 87.3 14.9 13.0 8.2 13.3 5.1 18.5 9.3 7.6 17.3 12.1 7.1 5.7 32.3 8.2 74.9 8.0 5.6 67.8 5.4 8.2 5.7 4.5 55.2 7.5 4.1 4.0 12.5 5.5 34.7 17.9 8.4 44.8 21.2 17.9 13.0 17.6 12.7 19.9 16.1 11.8 39.7 11.4 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 alpha 2 subunit" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles 93000 Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: " "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favourable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 21.9 11.1 20.2 8.7 20.7 18.4 23.2 50.9 32.4 17.5 13.9 9.5 10.4 16.8 16.3 8.5 12.2 21.5 10.1 14.7 22.6 20.0 19.4 16.3 13.3 18.1 16.1 21.1 11.2 14.7 7.8 15.5 16.3 16.9 15.5 16.3 11.5 21.7 14.7 13.3 16.5 12.0 18.5 18.1 34.5 17.0 16.4 6.7 12.4 12.1 5.0 9.1 10.5 10.5 3.4 3.7 6.8 4.6 3.4 5.4 1.7 5.5 2.5 3.0 8.7 11.3 11.6 7.3 7.9 2.7 4.9 4.0 0.9 6.0 5.8 6.9 9.4 7.3 7.0 4.4 3.1 4.2 18.1 1.7 7.7 3.0 4.4 2.2 4.1 13.7 4.8 2.4 4.9 6.7 5.8 4.5 4.9 0.5 2.0 2.5 1.7 14.1 3.5 2.0 6.3 7.4 5.0 9.4 8.0 8.9 7.3 1.1 4.2 0.8 10.5 1.6 1.9 2.2 4.0 3.6 2.9 4.3 3.0 2.8 2.4 3.3 4.6 3.8 3.1 4.6 1.8 1.7 3.2 1.8 3.7 3.4 3.4 3.5 6.8 3.4 3.8 3.7 5.4 1.7 20.2 20.7 50.9 32.4 22.6 20.0 16.1 21.1 16.9 6.7 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 beta 1 subunit" O00203 5 78000525-78294755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: " "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favourable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favourable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 30.1 19.9 16.5 23.1 20.7 16.5 19.0 15.2 16.6 21.7 20.8 17.4 21.1 17.0 21.2 50.3 26.5 14.6 14.2 16.6 15.6 15.1 28.3 13.7 16.1 27.1 22.2 11.4 18.3 22.0 29.4 36.1 20.1 17.4 18.8 25.6 15.0 23.3 18.8 12.9 18.9 24.8 18.1 20.2 25.5 19.1 13.0 20.9 38.0 24.0 18.6 22.9 19.4 18.2 26.2 10.1 9.0 9.2 5.2 6.7 4.5 20.0 16.2 18.8 25.7 22.5 27.2 16.4 22.7 26.6 20.5 27.9 12.4 17.8 21.2 13.4 27.9 14.8 18.1 38.1 26.4 24.1 12.8 14.8 14.8 22.5 13.2 13.0 19.4 19.7 14.2 17.3 17.6 26.0 10.4 13.9 35.6 12.4 16.8 21.2 9.9 9.7 17.6 32.9 29.3 30.5 19.2 6.5 10.6 20.9 13.7 19.5 16.6 22.3 26.1 15.5 12.2 18.6 22.8 10.8 16.6 14.5 20.1 19.4 19.5 8.5 7.3 6.3 6.0 7.5 6.7 18.5 5.1 6.2 10.1 26.2 4.4 5.6 9.0 5.2 9.2 8.6 6.0 4.5 16.5 20.7 15.2 16.6 15.6 15.1 22.2 11.4 17.4 20.9 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell line enhanced" "Detected in some" "RT4: 11.5;SCLC-21H: 18.8;SH-SY5Y: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.1 1.9 0.5 0.1 4.5 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.4 0.1 0.7 0.5 0.0 0.1 1.5 0.5 0.3 0.4 0.2 0.3 0.3 1.2 0.5 0.6 0.1 0.2 0.1 0.6 0.5 0.1 0.8 0.3 0.3 5.9 0.1 0.3 0.1 0.1 0.0 11.5 18.8 14.6 2.8 0.7 1.3 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.6 0.5 1.4 0.2 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: , HPA067880: " "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favourable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.0 7.8 1.8 10.2 4.9 2.5 14.7 4.3 4.1 4.5 3.6 6.7 4.7 5.7 8.3 3.7 12.0 5.0 3.2 1.4 9.1 8.7 5.2 8.8 3.3 3.9 6.8 11.1 4.8 6.2 3.1 1.6 3.5 11.8 7.6 2.3 7.0 4.3 6.7 3.6 8.9 13.8 0.3 12.6 3.3 11.4 2.4 4.2 3.1 2.0 19.2 3.9 9.9 5.5 8.3 7.5 10.5 4.3 7.8 7.8 5.8 5.8 5.8 7.9 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 sigma 1 subunit" Q9NUS5 20 3820524-3828837 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: , HPA048244: " "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favourable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 9.4 14.9 10.1 8.6 13.4 10.7 6.8 7.9 15.3 6.7 10.6 12.0 13.9 10.4 7.1 11.8 8.5 8.2 10.6 13.2 10.2 9.3 12.4 18.9 7.9 19.3 8.9 10.7 8.1 16.9 12.1 9.4 13.0 7.1 8.2 7.5 13.4 13.8 7.0 27.2 7.3 9.9 6.7 8.2 10.2 9.9 19.9 6.3 11.2 13.2 11.2 8.3 7.0 5.8 7.8 10.8 4.7 12.9 6.5 11.9 6.6 10.9 20.9 2.9 2.0 4.1 5.2 3.6 6.7 5.4 6.6 5.3 17.7 11.8 6.3 7.2 7.0 9.8 2.5 10.8 2.3 3.4 7.0 10.5 6.1 15.2 6.9 7.2 6.4 8.9 6.1 8.2 6.5 7.7 7.4 12.5 8.7 18.0 16.7 6.4 2.6 17.1 7.1 4.9 6.5 7.4 8.9 9.1 3.6 6.6 20.3 11.0 10.0 3.7 10.5 13.9 6.7 7.1 12.5 6.7 7.4 3.5 4.8 6.5 11.9 1.7 8.3 4.7 11.9 12.9 9.2 6.1 10.1 9.9 10.8 7.8 9.4 8.7 2.1 6.5 7.0 8.7 10.3 6.6 10.1 13.4 7.9 15.3 10.2 9.3 8.9 10.7 7.1 6.3 AP5Z1 "KIAA0415, SPG48, zeta" ENSG00000242802 "Adaptor related protein complex 5 zeta 1 subunit" O43299 7 4775622-4794312 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035693 Supported Supported "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA035693: AB_10960687" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (3.01e-3)" "unprognostic (4.24e-2)" "unprognostic (2.43e-3)" "unprognostic (5.19e-1)" "prognostic unfavourable (1.35e-5)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.26e-2)" "unprognostic (5.32e-3)" "unprognostic (8.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.95e-2)" "unprognostic (2.22e-1)" 15.2 18.6 9.5 19.2 11.1 20.8 11.3 14.3 14.9 10.7 12.6 13.5 6.3 22.2 14.0 11.0 10.8 10.6 9.9 8.0 8.6 6.8 9.9 9.2 12.6 18.6 10.9 9.7 12.6 16.9 5.6 11.5 9.6 10.3 11.6 4.6 13.1 15.0 12.8 8.4 21.8 19.1 13.0 8.5 23.4 17.1 10.1 12.6 18.2 11.3 6.6 16.9 13.2 10.6 11.7 11.3 15.7 17.0 12.3 13.4 9.8 11.2 5.0 1.3 8.9 5.7 4.0 12.4 8.9 5.1 7.0 5.7 9.7 10.4 7.7 5.4 5.8 13.5 1.2 5.5 0.7 5.8 5.4 5.7 11.9 7.0 18.7 9.9 16.3 8.2 4.3 5.8 2.3 4.6 9.8 8.5 2.9 12.0 2.9 22.6 8.4 12.3 7.3 4.4 7.1 2.2 10.7 5.1 9.5 7.5 11.9 8.5 10.5 16.1 11.5 7.3 8.6 14.7 6.6 17.8 11.4 4.6 10.9 12.4 14.7 1.7 12.9 15.7 13.4 17.0 10.7 10.5 9.2 11.8 11.3 11.7 10.1 8.4 13.5 12.3 14.2 10.2 8.6 9.8 9.5 11.1 14.3 14.9 8.6 6.8 10.9 9.7 10.3 12.6 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645141-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favourable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 10.5 4.7 10.3 11.0 11.0 36.1 8.8 13.4 11.5 10.8 11.6 8.2 5.5 7.0 10.6 7.5 6.2 6.3 11.6 5.8 10.2 8.6 5.8 6.8 11.8 11.2 8.8 6.7 10.8 7.4 5.7 6.2 10.1 8.2 9.1 12.9 8.5 8.2 6.4 6.0 7.5 14.9 7.2 10.9 15.9 8.6 6.1 9.3 15.7 7.0 3.9 14.2 9.5 9.0 2.8 6.3 33.0 8.7 1.1 1.9 1.5 4.3 6.6 20.2 7.7 6.9 12.2 5.6 11.0 8.3 8.4 8.5 4.2 3.2 6.6 3.1 9.2 7.3 14.1 8.0 10.6 4.6 5.7 12.0 6.3 5.2 2.4 11.7 15.5 5.0 2.5 8.5 4.4 14.4 5.6 3.4 12.3 1.2 6.2 12.3 5.5 3.8 7.8 16.1 2.1 4.9 7.8 2.9 5.0 8.6 3.6 3.2 6.3 17.6 11.1 5.7 4.5 6.5 3.5 2.3 4.3 7.3 2.2 16.5 7.5 6.2 8.7 7.2 1.9 3.6 1.5 2.4 1.4 1.1 6.3 2.8 1.4 0.9 33.0 1.1 3.6 4.6 0.9 1.5 10.3 11.0 13.4 11.5 10.2 8.6 8.8 6.7 8.2 9.3 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438203-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2;lymphoid tissue: 100.5" "Cell line enhanced" "Detected in many" "Daudi: 25.2;MOLT-4: 21.6;REH: 48.6;U-698: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA017009: , HPA063903: " "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favourable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 18.3 3.9 7.9 27.7 14.2 25.8 10.1 1.2 7.3 2.6 3.9 16.6 0.0 4.5 2.0 1.5 2.9 4.9 7.5 4.8 7.3 4.9 4.8 25.4 11.1 28.2 14.5 3.2 1.5 3.0 1.3 2.7 5.5 11.1 2.5 4.5 1.6 4.0 1.6 1.5 2.8 12.0 4.7 21.9 41.5 5.4 1.3 12.1 100.5 3.0 0.7 26.2 8.0 3.9 11.0 14.8 54.2 10.3 5.3 9.5 3.5 0.0 0.4 0.0 0.0 3.4 5.6 2.9 9.4 1.8 5.4 5.2 0.0 0.0 25.2 0.1 6.2 0.0 0.0 0.0 7.5 0.0 0.0 18.2 0.0 0.0 0.0 3.4 0.0 8.0 0.0 0.1 0.0 0.0 0.0 16.0 0.0 0.0 21.6 4.8 0.0 0.0 48.6 0.0 17.8 1.5 0.0 0.0 0.0 0.8 0.1 0.0 0.0 11.9 0.0 0.0 0.1 1.7 0.0 4.4 0.0 51.7 4.4 17.8 0.0 19.0 7.1 16.1 9.5 6.9 7.7 9.5 8.1 7.9 4.4 11.0 9.3 9.0 54.2 5.3 10.3 14.8 7.6 3.5 7.9 14.2 1.2 7.3 7.3 4.9 14.5 3.2 11.1 12.1 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Supported "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favourable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 4.2 5.6 7.5 4.3 9.2 3.3 3.4 26.6 23.8 4.5 4.3 8.2 5.7 2.0 4.7 6.3 4.2 6.0 7.8 8.2 9.7 13.1 3.3 3.4 3.2 2.6 7.9 7.3 4.3 3.5 8.2 11.0 5.7 10.9 5.9 3.6 8.7 8.8 7.4 2.5 3.4 2.8 4.1 4.2 4.7 4.4 11.8 5.5 2.0 6.7 3.3 3.4 3.8 2.3 1.4 1.8 7.7 3.6 0.7 1.4 1.1 0.6 0.7 0.5 2.9 0.0 1.2 5.7 1.4 1.7 2.1 3.9 1.9 1.7 2.4 3.3 2.5 1.1 0.0 2.2 0.6 2.3 1.2 0.8 5.2 0.1 3.5 0.8 1.0 7.6 0.9 1.8 1.4 1.5 0.4 6.5 2.2 1.4 0.3 1.8 1.2 3.6 0.4 0.7 1.4 1.8 1.5 9.0 4.4 3.8 1.3 5.1 4.0 3.9 1.1 0.4 1.0 0.0 0.2 2.5 1.9 0.3 0.9 0.6 0.8 7.7 1.4 0.0 1.4 3.6 0.9 0.5 1.0 1.3 1.0 1.4 0.6 1.3 3.3 0.7 0.6 1.8 1.0 1.1 7.5 9.2 26.6 17.4 9.7 13.1 7.9 7.3 10.9 5.5 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" "Cytokinetic bridge, Midbody" Cytosol "HPA078002: " "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.3 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.7 0.0 0.0 7.6 25.9 0.9 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 APEX2 "APE2, APEXL2, XTH2, ZGRF2" ENSG00000169188 "Apurinic/apyrimidinic endodeoxyribonuclease 2" Q9UBZ4 X 55000357-55009057 "Enzymes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" "DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048577 Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center" Vesicles "HPA048577: " "unprognostic (2.90e-2)" "prognostic favourable (6.17e-4)" "unprognostic (4.32e-2)" "unprognostic (2.39e-1)" "unprognostic (1.62e-1)" "unprognostic (5.62e-2)" "prognostic unfavourable (6.13e-7)" "unprognostic (5.89e-2)" "unprognostic (4.87e-2)" "prognostic favourable (5.21e-4)" "unprognostic (7.46e-2)" "unprognostic (3.16e-1)" "unprognostic (6.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.17e-2)" "unprognostic (1.40e-1)" "prognostic favourable (6.63e-4)" 11.1 12.8 8.6 12.0 12.3 11.9 10.2 8.7 11.8 10.0 12.3 13.7 8.2 12.3 11.5 12.6 20.8 10.7 13.9 10.6 8.7 7.2 15.4 18.5 10.3 14.2 9.7 6.0 14.4 10.7 10.7 12.7 17.8 8.8 11.0 15.1 9.1 10.4 10.0 10.3 16.7 18.7 10.0 9.9 18.0 10.8 7.7 8.9 21.9 10.6 10.2 27.4 11.6 12.7 6.7 9.4 9.2 9.9 26.6 7.5 6.3 22.0 19.8 7.9 11.4 11.5 7.7 13.4 9.1 12.3 17.6 17.3 10.8 18.6 14.6 14.3 8.5 16.6 18.0 17.3 13.4 11.8 13.7 17.7 19.8 10.9 7.4 10.9 16.8 7.6 14.2 24.9 9.0 14.0 9.1 9.9 13.1 21.5 14.7 14.3 15.6 24.0 13.1 13.1 15.9 9.5 11.1 7.3 8.0 17.2 20.9 8.8 16.4 8.5 8.1 10.5 15.2 21.1 11.8 10.3 13.3 12.1 11.2 18.7 12.4 9.2 7.8 8.5 7.5 9.9 6.2 6.1 7.1 7.4 9.4 6.7 6.4 6.2 2.9 26.6 8.3 5.1 7.5 6.3 8.6 12.3 8.7 11.8 8.7 7.2 9.7 6.0 8.8 8.9 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916499 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol 77000 Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 23.2 29.8 12.0 13.7 18.7 9.6 15.8 7.6 12.6 12.7 13.8 17.9 16.8 10.5 15.3 10.8 12.2 13.9 12.1 15.4 14.5 11.7 24.8 21.8 16.2 14.4 21.5 11.7 13.2 19.7 13.4 10.3 12.5 21.1 14.1 12.6 10.4 18.5 20.4 48.7 6.8 13.9 16.0 27.8 13.9 19.1 9.7 21.1 23.9 19.0 12.9 11.5 19.0 16.1 14.2 25.6 14.9 19.8 17.5 15.8 10.6 8.5 9.1 10.9 2.5 8.9 8.8 4.9 12.6 12.2 12.4 14.2 5.4 7.5 26.2 7.7 4.6 10.2 19.8 8.5 16.1 16.1 18.8 13.5 9.7 13.7 13.7 37.4 10.4 8.6 6.3 7.9 13.0 10.2 31.7 16.1 8.6 8.2 17.9 17.3 8.6 21.7 11.5 31.8 8.9 12.8 12.3 9.2 4.4 15.8 12.7 15.5 13.3 11.6 8.5 9.4 9.4 24.0 3.0 15.8 11.9 29.5 11.7 8.0 11.9 4.7 16.9 14.9 11.0 17.5 13.6 14.2 13.4 11.9 25.6 13.4 13.8 11.7 4.1 17.5 19.8 16.5 15.8 10.6 12.0 18.7 7.6 12.6 14.5 11.7 21.5 11.7 21.1 21.1 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837950 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 573.5" "Cell line enriched" "Detected in some" 18 "Hep G2: 247.4" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;T-cells: 2.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" 2185000000000 220000000000 Vesicles Cytosol "CAB016778: , HPA046715: " "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favourable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavourable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 24.6 0.2 0.2 55.6 0.2 0.3 0.2 0.1 0.3 1.3 0.2 0.0 0.2 573.5 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 127.9 0.2 0.2 0.4 0.3 11.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.5 3.6 0.0 0.7 0.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 13.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 247.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 1.2 1.5 0.0 0.2 0.4 1.7 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 2.4 0.7 0.3 0.0 0.2 1.8 0.8 0.5 0.8 1.7 0.0 0.7 0.0 3.6 2.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 145 "intestine: 224.8;liver: 442.2" "Cell line enriched" "Detected in some" 30 "Hep G2: 151.8" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" 1290000000000 89000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: " "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.1 0.1 68.9 0.0 0.0 24.9 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.1 0.1 442.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 224.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.9 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.9 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 APOBEC3F "ARP8, BK150C2.4.MRNA, KA6" ENSG00000128394 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3F" Q8IUX4 22 39040604-39053910 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA073637 Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA073637: " "unprognostic (1.38e-3)" "unprognostic (1.28e-3)" "unprognostic (4.63e-2)" "unprognostic (1.63e-2)" "unprognostic (6.16e-2)" "unprognostic (3.51e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" "unprognostic (6.03e-2)" "unprognostic (1.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.88e-1)" "unprognostic (2.06e-3)" "unprognostic (9.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.49e-1)" "prognostic favourable (8.28e-4)" 6.9 9.0 1.9 7.9 2.3 2.5 3.1 0.7 2.0 9.6 5.4 3.9 14.5 3.1 8.2 5.6 5.6 8.1 3.1 6.7 2.4 1.7 5.9 4.5 5.4 13.1 1.8 1.2 14.1 5.5 3.9 4.9 1.7 2.6 6.4 2.4 6.6 6.4 16.3 3.2 1.6 5.0 3.9 3.6 14.3 4.3 11.9 1.9 7.3 4.2 2.5 15.9 5.4 4.5 23.2 4.3 5.9 9.1 9.3 6.9 4.7 4.4 3.5 1.4 5.4 4.0 6.0 1.9 3.3 6.2 8.0 12.7 3.0 7.9 10.5 3.5 7.0 5.6 1.3 5.3 3.1 9.8 4.4 14.1 0.0 1.5 8.0 1.5 5.9 7.9 2.3 4.1 1.4 7.3 1.0 17.4 3.9 3.1 3.1 1.9 0.6 0.5 5.3 0.5 2.3 6.6 5.8 0.7 1.1 4.1 1.0 2.2 4.2 1.2 1.9 1.7 4.6 0.2 1.5 3.0 1.5 0.5 4.8 1.4 2.6 1.4 3.3 5.9 6.1 6.6 6.9 16.4 4.0 6.2 4.3 23.2 2.5 3.9 1.5 9.3 9.1 3.7 5.4 4.7 1.9 2.3 0.7 2.0 2.4 1.7 1.8 1.2 2.6 1.9 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.6;Daudi: 19.7;HDLM-2: 16.4;Karpas-707: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favourable (4.78e-4)" "prognostic favourable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favourable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavourable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favourable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.4 4.8 0.1 0.4 8.1 9.4 14.6 0.7 11.7 19.7 0.2 3.3 0.0 0.1 0.6 2.8 16.4 0.0 10.1 0.0 0.1 10.9 3.3 4.8 7.3 0.2 5.1 1.1 1.3 0.9 22.6 1.4 0.0 3.7 3.4 0.3 0.7 7.6 0.0 12.5 0.0 8.7 0.0 0.0 0.2 0.0 1.0 0.0 6.4 0.0 1.4 0.1 0.0 0.0 0.0 1.8 0.2 1.7 3.0 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Group enriched" "Detected in some" 19 "CACO-2: 27.8;Hep G2: 75.2" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" 88520000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: , HPA073918: " "prognostic favourable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 27.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 75.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 APOL2 APOL-II ENSG00000128335 "Apolipoprotein L2" Q9BQE5 22 36226203-36239954 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001078 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" 10000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA001078: AB_10602432" "unprognostic (4.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.50e-2)" "unprognostic (4.26e-3)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.38e-2)" "unprognostic (7.39e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.22e-7)" "unprognostic (1.80e-1)" "unprognostic (6.79e-2)" "unprognostic (2.66e-2)" "prognostic favourable (5.06e-6)" 21.5 14.2 17.4 25.3 12.0 6.9 20.3 26.5 30.1 16.7 15.6 11.1 11.1 25.0 20.3 17.9 10.2 15.3 25.6 17.3 15.1 19.3 18.2 39.7 23.6 22.0 20.2 11.9 12.6 10.1 11.2 57.1 14.6 28.7 19.0 16.1 15.9 15.2 18.8 16.5 9.6 21.7 22.2 16.2 26.2 22.7 7.2 12.0 14.9 23.0 12.7 17.0 25.8 19.4 6.2 6.0 43.0 17.0 9.9 15.5 4.6 7.4 5.5 5.4 4.1 21.2 16.5 10.3 10.1 23.7 27.6 37.5 2.2 6.1 9.0 17.2 18.2 3.5 5.9 8.1 13.7 30.4 6.7 4.2 11.7 10.4 35.8 9.0 8.2 20.8 5.5 19.3 5.1 17.9 7.5 25.6 17.2 2.7 9.1 4.0 2.0 5.1 9.4 7.0 5.3 27.8 19.7 9.8 2.8 6.9 13.2 5.4 4.1 1.3 17.3 16.7 8.3 3.4 5.6 15.5 7.7 2.8 14.4 4.7 6.3 8.9 8.6 5.8 15.5 17.0 14.1 6.2 11.2 12.7 6.0 4.1 6.5 10.9 43.0 9.9 11.4 3.7 10.5 4.6 17.4 12.0 26.5 30.1 15.1 19.3 20.2 11.9 28.7 12.0 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648395-35668409 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favourable (6.61e-4)" 40.6 9.2 4.8 18.8 5.5 10.1 32.3 1.9 4.2 7.4 17.9 4.1 5.0 14.0 8.8 9.5 9.8 5.9 12.5 9.3 4.0 4.3 15.4 36.9 15.8 17.0 4.6 2.2 17.0 4.7 3.7 5.1 8.9 5.9 11.7 8.9 6.4 10.1 5.6 7.4 3.6 36.6 6.4 7.6 19.5 10.1 2.5 4.5 12.7 24.8 7.7 13.4 8.5 14.1 1.2 2.8 9.2 9.0 5.9 9.1 4.2 7.0 2.3 0.2 0.8 17.9 9.0 10.0 3.0 8.1 10.1 12.7 1.1 8.1 9.9 1.5 7.9 9.3 0.0 4.9 2.6 18.6 0.1 4.2 1.5 2.2 14.1 5.7 7.3 11.4 3.3 3.4 1.9 2.0 0.4 18.0 1.8 0.7 8.0 1.8 0.3 3.0 3.4 3.9 4.8 4.4 16.3 0.2 0.1 4.8 4.2 5.6 0.7 6.7 2.2 2.5 1.5 1.7 1.6 9.6 7.6 0.9 4.8 9.1 3.5 6.4 5.6 2.9 9.1 8.9 7.7 1.2 6.1 7.2 2.8 1.0 6.0 6.7 9.2 5.9 9.0 0.3 6.3 4.2 4.8 5.5 1.9 4.2 4.0 4.3 4.6 2.2 5.9 4.5 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell line enhanced" "Detected in many" "AF22: 26.1;HDLM-2: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA052462: , HPA058882: " "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.1 0.8 0.8 1.5 0.2 4.2 6.9 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.3 3.2 0.4 1.8 2.2 0.8 0.7 0.7 0.1 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.5 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.4 2.8 4.8 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 APOO "FAM121B, MGC4825, Mic23, MIC26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907934 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favourable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favourable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 5.6 13.1 25.5 5.4 21.2 4.4 9.0 18.5 30.9 9.1 10.9 8.5 5.5 9.2 7.2 13.5 7.2 13.6 6.1 38.4 26.0 23.8 29.5 12.2 5.5 6.6 24.9 17.5 7.1 9.0 20.1 15.8 7.1 21.5 9.3 12.5 11.7 14.6 10.4 26.0 4.3 7.6 7.8 18.1 5.4 10.3 10.5 6.8 7.7 13.3 10.4 7.2 6.3 5.8 9.8 14.2 8.5 13.3 7.8 15.0 6.6 14.6 13.4 22.6 15.7 3.8 8.6 3.6 7.4 9.1 15.7 16.5 7.9 7.0 12.7 9.3 6.7 12.1 28.3 14.6 17.5 13.4 20.2 6.4 13.3 12.5 9.0 16.2 7.2 9.6 8.8 17.3 12.9 10.9 9.1 14.4 14.5 13.8 16.2 17.4 20.5 21.7 12.6 11.2 30.5 30.7 7.6 15.3 11.1 16.0 15.3 15.7 26.4 7.2 2.7 10.2 6.1 36.2 11.2 11.2 19.7 11.5 16.4 8.0 14.8 8.5 4.2 1.5 11.5 13.3 15.0 9.8 12.7 11.3 12.0 8.3 10.3 10.1 2.5 7.8 12.6 14.2 11.5 6.6 25.5 21.2 18.5 30.9 26.0 23.8 24.9 17.5 21.5 6.8 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 6 "dendritic cells: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" 15000000 "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favourable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 44.8 92.5 89.9 26.3 109.3 21.2 79.9 64.5 139.1 51.7 63.4 86.9 72.0 39.7 52.2 57.2 33.0 57.6 63.4 69.1 104.6 97.7 102.2 54.5 50.2 12.9 97.4 95.8 58.9 57.1 36.4 34.1 79.7 83.2 49.2 59.6 48.9 47.2 66.6 17.2 38.2 34.9 69.3 109.0 26.3 37.9 32.2 67.5 13.9 85.0 21.5 16.7 52.5 58.4 1.5 24.0 0.9 3.9 0.3 1.5 1.8 31.5 40.8 44.8 37.3 61.1 75.8 48.4 64.1 85.6 32.5 38.3 23.4 77.6 0.0 74.7 50.1 21.6 27.3 75.3 27.5 1.2 22.0 0.0 24.6 16.4 59.6 29.9 1.6 68.3 83.3 38.1 70.0 145.5 0.0 3.3 51.0 35.4 0.5 0.3 35.2 36.5 19.6 43.2 26.3 110.1 22.2 22.8 33.3 68.8 45.3 32.2 40.1 32.6 155.5 72.4 30.7 26.3 30.3 19.9 0.2 0.3 58.9 0.1 69.5 0.4 3.9 0.0 0.1 1.2 0.2 0.5 1.4 0.5 3.4 1.5 1.5 0.4 0.9 0.3 0.9 24.0 0.3 1.8 89.9 109.3 64.5 124.6 104.6 97.7 97.4 95.8 83.2 67.5 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227737-57273468 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "naive B-cell: 20.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011138, HPA073477" Approved Uncertain "Mitotic spindle,Centrosome" 28000 "Mitotic spindle, Centrosome" "HPA011138: AB_1844959, HPA073477: " "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favourable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 18.3 14.0 20.9 15.3 17.9 13.7 22.5 25.2 23.7 18.5 15.7 12.8 16.8 12.6 19.2 14.5 21.0 16.0 13.2 23.7 15.8 15.4 17.0 14.3 15.3 24.3 15.4 18.8 24.0 38.2 28.4 20.4 14.1 18.8 15.7 14.4 11.0 18.0 22.2 40.5 19.9 14.5 20.5 16.7 15.0 16.3 10.5 15.7 20.9 20.0 15.2 18.9 17.7 20.8 20.7 12.0 2.5 3.9 4.7 3.5 1.7 14.6 6.4 6.3 22.8 10.8 15.2 13.2 7.8 4.8 7.9 9.0 7.4 8.8 23.8 3.2 12.0 2.9 16.7 13.4 13.5 17.9 7.5 13.4 10.2 7.8 11.7 29.8 9.9 11.2 12.3 10.0 10.9 12.5 4.5 15.0 8.8 5.0 23.5 7.3 9.8 11.0 0.8 25.5 12.7 13.8 8.3 6.3 13.5 10.7 16.0 10.2 7.8 19.4 11.8 13.0 9.2 18.9 15.0 13.8 20.2 16.7 14.1 14.4 8.4 1.6 3.9 2.5 2.6 3.0 3.5 11.3 2.8 2.4 7.2 20.7 2.6 1.9 1.0 4.7 2.5 12.0 1.1 1.7 20.9 17.9 25.2 23.7 15.8 15.4 15.4 18.8 18.8 15.7 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811944 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Supported Nucleoplasm,Cytosol 1200000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 22.9 37.1 10.9 33.6 13.2 32.9 31.6 10.1 15.3 22.7 31.1 10.7 33.6 27.1 19.9 28.3 50.7 21.0 30.4 22.5 9.1 8.2 27.7 60.4 30.6 94.2 14.8 10.7 17.9 58.2 19.4 15.6 19.3 11.0 25.1 15.1 13.9 48.2 37.4 26.2 49.8 24.3 18.4 12.1 30.4 27.5 16.0 12.2 37.9 29.5 49.7 35.8 18.5 32.8 65.4 92.1 24.2 70.2 58.2 83.7 104.7 25.4 37.4 7.3 33.0 9.0 17.9 39.1 19.3 17.2 22.8 8.9 38.5 30.9 23.7 37.8 10.9 27.3 12.0 31.7 4.6 16.7 71.6 20.2 17.7 40.2 28.6 13.8 16.5 19.1 34.3 18.1 23.0 28.4 42.4 17.8 11.5 93.8 39.0 40.8 28.2 49.0 42.0 11.4 56.1 25.1 17.3 36.5 22.4 36.8 21.5 20.8 71.0 27.5 18.3 20.6 18.0 16.6 18.9 35.0 29.3 65.2 30.3 36.8 18.1 8.5 70.2 24.2 63.0 57.7 83.7 63.2 81.9 67.5 71.6 65.4 75.9 64.3 4.3 58.2 37.1 92.1 66.1 104.7 10.9 13.2 10.1 15.3 9.1 8.2 14.8 10.7 11.0 12.2 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32972606-33025168 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA064930: " "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favourable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 12.9 20.3 17.5 11.2 18.4 19.9 16.5 15.1 21.7 12.0 15.2 19.3 9.3 11.7 14.7 12.9 19.1 14.7 8.0 11.9 13.3 13.9 17.9 23.4 12.6 11.8 16.4 16.5 11.8 14.3 15.8 14.3 12.1 20.2 12.1 18.1 14.6 12.5 11.9 14.1 20.6 13.8 14.6 15.7 11.7 12.5 18.2 14.5 8.8 10.5 12.6 16.1 13.4 12.1 17.1 18.4 16.1 20.8 26.4 19.4 15.0 21.2 16.1 12.3 10.6 12.5 11.0 16.2 14.2 14.8 17.4 19.2 21.4 7.5 16.6 8.6 11.9 11.3 20.0 19.1 21.6 22.4 8.2 9.8 23.1 21.8 14.6 15.8 9.4 14.7 23.4 19.9 25.9 16.6 14.8 16.5 16.2 9.1 14.2 23.2 18.7 17.3 12.8 8.5 11.8 14.3 12.9 8.5 7.2 13.0 11.7 9.5 13.3 6.5 10.2 9.7 12.9 16.7 14.6 7.2 11.8 16.6 14.4 12.9 7.7 9.1 17.7 14.9 13.4 16.3 17.6 17.0 15.2 15.5 18.4 17.1 18.0 14.6 16.1 26.4 20.8 17.9 19.4 15.0 17.5 18.4 15.1 21.7 13.3 13.9 16.4 16.5 20.2 14.5 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Cell line enhanced" "Detected in some" "HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Approved "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies, Vesicles, Plasma membrane" "HPA062621: , HPA065947: " "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell line enhanced" "Detected in many" "CACO-2: 8.7;Hep G2: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favourable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.1 3.6 1.5 2.4 3.5 0.9 1.6 1.9 0.8 1.8 0.8 8.7 1.7 1.8 0.9 0.8 1.1 0.6 0.1 0.9 5.3 1.5 1.4 1.2 14.4 1.1 3.0 1.7 0.9 0.3 1.0 0.2 0.3 0.9 1.1 2.0 1.8 1.1 2.0 1.6 3.4 1.6 3.9 0.6 1.0 1.4 1.5 1.1 2.4 0.5 0.9 1.8 0.4 1.0 1.4 4.6 2.8 1.2 1.2 0.8 1.4 0.5 0.2 2.0 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Cell line enhanced" "Detected in many" "HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA014924: " "unprognostic (4.29e-2)" "prognostic favourable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.5 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 28.0 1.3 0.1 0.0 13.3 1.3 0.9 50.9 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.1 14.3 13.0 1.5 6.2 12.7 4.9 1.1 0.1 0.2 21.2 2.3 0.2 47.4 0.4 1.0 7.1 32.8 0.0 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.0 44.0 3.1 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell line enhanced" "Detected in some" "AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 ARAF ARAF1 ENSG00000078061 "A-Raf proto-oncogene, serine/threonine kinase" P10398 X 47561100-47571920 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046188, HPA066326" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA046188: AB_2679578, HPA066326: AB_2685659" "unprognostic (1.21e-1)" "unprognostic (5.69e-3)" "unprognostic (2.47e-2)" "unprognostic (2.10e-2)" "unprognostic (7.63e-2)" "unprognostic (9.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "unprognostic (6.75e-2)" "unprognostic (8.65e-2)" "prognostic favourable (1.45e-6)" "unprognostic (1.97e-1)" "unprognostic (2.01e-1)" "unprognostic (6.37e-2)" "unprognostic (4.71e-2)" 22.2 24.2 10.9 16.5 15.5 41.9 19.5 16.0 13.7 18.0 23.2 21.1 24.1 17.8 21.3 18.4 19.4 18.7 21.0 28.6 12.8 7.3 28.0 49.6 21.8 20.2 16.4 9.5 23.4 35.1 28.1 16.9 25.3 13.5 23.5 15.8 25.4 22.1 18.5 60.8 18.9 23.8 18.6 11.2 27.4 24.2 10.2 16.3 27.7 23.1 23.9 27.3 20.2 16.9 23.9 34.3 36.1 38.4 22.4 29.1 27.5 19.9 28.8 12.3 19.9 18.8 15.0 16.7 16.8 17.8 25.2 23.3 23.4 24.5 11.9 13.9 22.6 28.2 21.8 23.3 14.5 21.8 25.6 11.9 30.5 12.1 26.5 23.6 36.5 19.7 23.7 24.0 21.1 19.4 22.0 23.5 17.0 33.8 17.1 25.4 17.7 32.2 15.9 16.1 26.8 14.4 19.1 14.0 10.8 18.2 16.8 9.9 31.6 17.8 18.4 16.4 18.4 32.7 17.0 30.5 19.5 9.2 21.8 26.7 13.0 23.9 29.0 36.1 29.1 35.4 26.9 21.4 25.5 26.7 34.3 23.9 22.7 26.7 23.6 22.4 38.4 24.7 25.1 27.5 10.9 15.5 16.0 13.7 12.8 7.3 16.4 9.5 13.5 16.3 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: " "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavourable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favourable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favourable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.1 15.1 5.8 7.0 24.8 16.8 8.7 9.8 17.7 11.2 11.1 20.7 19.0 15.8 19.8 16.5 24.1 8.8 23.4 4.8 18.6 10.3 13.4 14.3 28.5 17.2 9.1 37.7 17.9 24.9 18.3 8.8 11.8 11.2 6.4 5.2 14.7 13.8 31.8 3.6 9.8 13.5 8.8 7.7 10.4 22.8 6.0 12.3 7.1 10.6 31.6 9.3 20.8 14.0 15.9 11.0 16.1 6.0 10.3 5.0 8.3 8.4 13.7 8.4 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 ARAP2 "CENTD1, PARX" ENSG00000047365 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2" Q8WZ64 4 35948221-36244509 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 12.1;hTCEpi: 11.4;MOLT-4: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035925 Approved Approved "Actin filaments,Focal adhesion sites" "Focal adhesion sites" "Actin filaments" "HPA035925: AB_10672075" "unprognostic (2.97e-2)" "unprognostic (8.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.04e-1)" "unprognostic (8.86e-2)" "unprognostic (2.72e-3)" "unprognostic (1.09e-1)" "unprognostic (3.78e-3)" "unprognostic (2.04e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-3)" "unprognostic (2.96e-1)" "unprognostic (4.48e-2)" "unprognostic (4.54e-2)" "unprognostic (3.43e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" 5.2 2.5 16.3 9.1 27.5 32.5 5.2 4.8 20.8 4.2 5.1 18.3 0.3 8.5 3.5 4.1 12.7 3.5 9.2 2.5 16.0 9.5 3.9 8.8 12.7 13.7 24.4 12.1 1.9 6.8 8.2 5.1 3.5 18.4 2.9 5.8 0.7 5.8 3.3 1.4 16.1 8.2 4.4 15.3 10.4 5.8 5.9 32.0 26.4 22.4 4.0 10.2 6.2 7.2 2.4 1.7 0.6 5.8 8.6 5.7 0.7 7.3 0.6 0.7 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.6 12.1 3.5 2.9 0.3 2.8 1.1 5.8 0.0 0.0 6.7 0.1 2.5 0.2 1.5 4.7 0.0 0.4 11.4 0.0 2.5 0.0 0.2 0.6 0.0 3.1 10.8 3.8 0.8 2.3 5.6 0.0 4.0 8.3 7.5 6.5 0.0 0.4 1.9 2.4 5.0 1.4 0.0 2.0 6.8 0.0 1.0 0.0 0.0 6.8 0.8 5.3 1.7 0.0 0.8 0.0 5.7 2.7 5.3 2.4 3.2 3.9 0.4 1.4 1.1 2.9 0.6 8.6 5.8 1.7 1.5 0.7 16.3 27.5 4.8 20.8 16.0 9.5 24.4 12.1 18.4 32.0 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611044-142614472 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.8;seminal vesicle: 67.7" "Cell line enhanced" "Detected in some" "AN3-CA: 6.8;HEK 293: 8.4;SCLC-21H: 20.0;U-2 OS: 9.7;U-87 MG: 10.9" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5" "Group enriched" "Detected in many" 7 "basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules "Vesicles, Microtubules" "CAB079013: , HPA056430: " "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 18.1 15.9 6.1 1.0 6.5 0.7 1.0 0.8 17.0 1.5 0.9 4.2 11.8 0.8 1.4 1.8 0.9 1.2 3.5 0.5 13.9 7.1 1.5 0.7 2.7 0.4 2.4 2.1 0.5 6.2 0.4 25.8 1.8 4.0 1.0 0.6 0.0 0.5 67.7 0.5 3.5 0.7 0.9 1.2 0.7 2.1 0.6 1.1 0.0 1.5 0.8 1.9 0.6 1.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.1 0.3 6.8 0.1 0.7 0.0 1.4 0.0 0.3 0.1 0.1 0.0 0.0 0.9 0.2 0.1 0.4 0.0 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 3.1 1.5 0.0 0.6 0.0 0.0 0.0 20.0 4.7 0.4 0.0 0.2 0.0 0.1 0.0 1.1 9.7 0.7 0.2 1.8 0.0 0.0 10.9 0.0 2.9 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 6.5 0.8 17.0 13.9 7.1 2.4 2.1 4.0 1.1 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Enhanced "Golgi apparatus,Vesicles" 340000 Vesicles "Golgi apparatus" "HPA037573: AB_10696938, HPA044874: " "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavourable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 46.9 37.4 26.7 30.3 32.9 15.0 35.7 34.4 38.8 48.8 36.7 37.3 39.9 36.0 39.8 61.6 38.6 32.6 38.0 39.5 28.7 30.6 39.1 61.4 34.0 27.3 30.4 24.7 45.1 65.2 49.7 64.7 46.0 38.3 42.4 39.6 29.3 62.0 46.9 25.8 31.9 47.1 41.9 34.3 34.9 38.1 37.9 29.7 39.0 44.1 29.3 39.2 46.9 42.1 22.7 29.1 46.2 33.0 34.1 39.5 26.7 24.3 20.4 35.8 26.1 44.1 47.1 19.3 61.5 54.7 27.9 33.3 64.4 32.3 25.7 52.8 68.6 33.0 40.0 36.2 38.9 35.3 18.7 55.1 14.8 35.0 50.1 33.8 32.3 41.1 30.1 46.0 42.9 42.2 28.4 36.1 52.4 39.1 30.4 30.1 22.5 27.3 26.5 34.8 39.1 33.7 26.5 24.6 24.7 34.2 33.4 17.3 42.5 30.3 38.5 35.2 17.3 33.2 28.4 21.2 18.8 37.4 20.7 31.7 41.8 46.2 26.4 26.3 30.5 33.0 39.5 22.7 30.2 29.3 29.1 20.7 29.1 26.6 23.1 34.1 32.1 24.4 28.3 26.7 26.7 32.9 34.4 38.8 28.7 30.6 30.4 24.7 38.3 29.7 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 72.0 70.1 64.8 51.0 82.5 111.1 59.3 50.0 116.9 76.0 76.7 53.5 63.6 73.6 71.1 63.3 81.1 66.8 58.5 101.1 70.3 65.9 81.7 135.9 77.4 55.6 52.7 56.5 73.5 109.2 64.9 79.7 129.6 61.4 70.1 55.7 67.8 106.7 68.6 96.5 57.5 91.6 54.7 45.9 81.5 66.0 73.0 33.8 75.6 102.9 60.5 76.5 72.6 57.6 37.4 73.3 111.7 70.0 41.5 64.7 110.7 65.5 45.4 37.3 37.0 43.1 54.6 62.0 58.1 62.3 64.7 56.8 53.6 63.1 33.4 62.5 61.9 42.5 45.6 56.9 32.5 49.1 72.9 32.5 31.9 53.3 83.5 46.9 48.5 52.1 69.5 59.5 62.8 63.7 62.2 76.7 62.2 47.2 47.6 69.4 47.8 92.9 38.6 33.0 104.0 45.7 34.0 52.7 46.6 37.5 113.8 64.8 78.2 95.4 57.0 47.6 37.8 69.2 87.1 72.5 40.4 45.9 65.4 40.0 95.9 104.5 70.0 77.2 53.1 66.5 64.7 37.4 45.7 49.1 54.5 34.9 36.2 39.4 111.7 41.5 63.0 73.3 51.8 110.7 64.8 82.5 50.0 116.9 70.3 65.9 52.7 56.5 61.4 33.8 ARFGAP1 "ARF1GAP, bA261N11.3, FLJ10767" ENSG00000101199 "ADP ribosylation factor GTPase activating protein 1" Q8N6T3 20 63272785-63289793 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051019, HPA056273" Approved Supported "Nuclear membrane,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "Nuclear membrane" "HPA051019: AB_2681313, HPA056273: AB_2683084" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-1)" "unprognostic (1.38e-1)" "unprognostic (1.24e-1)" "unprognostic (1.57e-3)" "unprognostic (7.76e-2)" "unprognostic (8.86e-3)" "unprognostic (8.62e-2)" "prognostic favourable (4.57e-4)" "unprognostic (3.23e-2)" "prognostic unfavourable (3.48e-7)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (4.34e-2)" "unprognostic (2.86e-1)" 12.3 13.8 17.8 16.7 21.8 12.4 10.4 29.2 28.9 16.0 16.6 27.1 15.3 14.8 17.3 17.9 13.4 16.0 20.0 14.3 17.5 17.2 13.7 14.8 13.1 16.6 26.0 19.9 16.7 32.8 13.7 40.9 17.9 19.2 16.2 11.7 20.1 21.3 18.1 10.4 21.9 15.7 14.8 15.9 17.2 21.1 19.9 22.7 11.2 15.0 10.3 15.5 16.0 11.9 7.4 8.2 8.3 12.6 6.6 9.9 7.0 11.0 21.0 9.2 10.9 11.0 12.5 18.0 16.2 13.4 33.0 16.6 50.0 12.4 8.4 14.9 19.4 15.3 8.3 26.2 10.3 5.5 9.3 6.5 20.3 42.1 16.9 9.8 13.6 10.7 16.9 15.9 9.0 11.6 11.7 9.8 8.8 18.2 17.6 9.2 12.2 18.1 9.9 13.2 8.1 8.1 13.5 9.8 10.8 19.4 20.7 20.2 15.2 12.6 15.0 20.2 27.4 12.2 12.8 10.1 6.5 9.2 20.5 6.9 12.5 6.9 7.6 8.3 8.8 10.5 9.9 4.8 4.8 8.0 8.2 7.4 4.9 4.6 3.6 6.6 12.6 6.2 5.9 7.0 17.8 21.8 29.2 28.9 17.5 17.2 26.0 19.9 19.2 22.7 ARFGAP3 ARFGAP1 ENSG00000242247 "ADP ribosylation factor GTPase activating protein 3" Q9NP61 22 42796502-42858106 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000638 Approved Supported "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA000638: AB_1078188" "unprognostic (3.29e-2)" "unprognostic (6.08e-2)" "unprognostic (3.22e-1)" "prognostic favourable (8.97e-6)" "unprognostic (5.83e-2)" "unprognostic (8.85e-3)" "unprognostic (5.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.31e-1)" "unprognostic (9.06e-3)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (2.52e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (2.65e-4)" "unprognostic (1.73e-1)" 19.0 48.7 12.5 14.5 13.4 18.4 18.8 15.9 12.8 26.6 15.0 14.2 26.5 16.1 18.4 24.8 13.0 13.4 16.6 14.6 12.3 11.0 28.9 42.1 18.6 12.3 17.5 9.9 17.9 53.9 16.3 41.7 21.8 13.4 30.2 13.9 13.6 49.1 31.2 17.6 12.1 36.4 15.2 13.9 16.5 21.4 23.4 15.2 15.4 37.9 9.0 16.2 21.5 23.7 12.8 27.7 32.4 23.9 23.4 31.5 13.9 18.1 5.9 13.1 7.7 18.1 30.5 5.4 35.1 23.6 15.9 19.3 7.1 10.2 9.2 7.8 31.3 4.5 5.7 10.0 17.3 5.6 7.8 10.8 8.2 11.1 25.2 9.7 16.9 13.4 17.9 13.3 23.9 16.2 4.8 41.5 27.5 4.7 14.8 5.2 2.1 7.1 9.5 29.5 11.4 25.1 8.4 4.6 2.9 17.0 6.8 13.7 7.1 7.2 20.9 18.8 13.7 16.4 9.4 30.1 14.4 10.2 13.5 10.4 14.5 32.4 17.0 18.0 24.3 21.9 31.5 12.6 16.1 21.2 16.6 12.8 10.6 14.7 26.5 23.4 23.9 27.7 13.8 13.9 12.5 13.4 15.9 12.8 12.3 11.0 17.5 9.9 13.4 15.2 ARFGEF1 "ARFGEP1, BIG1, DKFZP434L057, p200" ENSG00000066777 "ADP ribosylation factor guanine nucleotide exchange factor 1" Q9Y6D6 8 67173511-67343677 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023399, HPA023822" Supported Supported Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA023399: AB_1844981, HPA023822: AB_1844982" "prognostic unfavourable (8.76e-4)" "unprognostic (1.62e-1)" "unprognostic (4.60e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (4.52e-1)" "unprognostic (5.38e-2)" "unprognostic (4.67e-2)" "unprognostic (2.13e-3)" "unprognostic (1.31e-1)" "prognostic favourable (2.48e-4)" "unprognostic (1.13e-1)" "unprognostic (2.84e-1)" "unprognostic (1.62e-1)" "unprognostic (1.61e-2)" 17.0 17.1 14.5 24.3 15.6 24.9 14.0 20.4 16.3 17.7 24.7 9.5 24.7 16.8 15.4 20.3 23.8 13.1 16.0 12.0 11.3 11.7 23.9 15.3 18.6 22.7 11.4 9.5 15.1 21.4 38.6 21.8 17.4 16.7 15.8 17.7 13.2 20.7 29.4 20.9 18.4 26.9 13.8 12.0 20.1 19.5 27.1 12.6 36.7 22.9 15.7 16.8 22.9 17.7 2.1 3.7 8.4 3.7 3.7 6.1 1.3 15.5 10.1 9.9 3.7 11.4 15.8 11.7 10.9 12.3 11.2 11.4 6.2 15.2 11.8 4.8 13.8 11.2 11.8 15.4 13.8 15.1 8.3 19.8 6.2 6.6 9.9 10.1 19.8 9.6 11.1 10.1 17.2 15.9 12.1 12.8 12.9 3.5 23.8 4.8 21.7 9.3 11.6 7.1 2.4 18.6 29.0 3.9 7.7 7.1 17.2 9.7 29.7 9.1 19.3 7.7 10.3 10.1 8.2 11.3 12.3 8.9 12.2 10.4 7.2 8.0 2.6 6.6 4.8 3.7 6.1 2.1 3.2 3.9 2.6 2.1 5.3 4.5 8.4 3.7 1.5 3.7 5.9 1.3 14.5 15.6 20.4 16.3 11.3 11.7 11.4 9.5 16.7 12.6 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: , HPA063759: " "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favourable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favourable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.8 15.6 12.2 22.6 13.2 2.8 22.3 15.7 12.3 22.8 25.3 17.5 25.6 20.9 21.1 23.8 23.4 17.6 20.8 11.9 12.6 13.2 23.6 15.3 20.3 14.9 16.1 9.5 22.9 18.8 20.4 22.5 29.0 13.5 23.8 26.4 19.1 19.6 23.9 12.7 19.1 29.9 18.5 18.3 18.5 20.2 12.7 13.9 14.7 23.9 10.2 17.9 24.3 20.4 8.4 10.9 35.7 13.8 12.3 7.6 7.7 13.0 9.8 13.7 13.4 21.6 22.1 16.9 15.8 22.3 15.9 15.2 11.4 27.5 10.5 5.3 21.9 9.4 14.1 15.9 19.9 8.8 8.8 10.4 10.0 11.2 15.3 19.5 22.0 15.5 17.8 13.5 13.4 14.6 12.1 22.8 22.3 15.2 10.9 10.9 11.5 10.0 6.3 7.7 9.7 28.8 17.6 17.3 14.3 11.9 22.4 15.7 20.1 10.5 9.1 15.5 11.0 14.9 11.1 25.1 20.6 14.4 19.6 19.5 21.3 12.1 12.0 17.9 6.7 13.8 6.7 8.4 5.3 5.5 10.9 7.7 4.1 5.5 35.7 12.3 12.6 1.3 7.6 7.7 12.2 13.2 15.7 12.3 12.6 13.2 16.1 9.5 13.5 13.9 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favourable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favourable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 13.3 20.5 19.7 15.2 19.4 12.6 33.0 24.0 32.0 24.5 22.9 16.4 29.5 20.2 17.5 23.1 22.0 25.5 21.5 13.2 16.5 17.2 21.3 32.7 17.5 13.0 15.5 22.0 20.3 36.0 36.1 29.9 27.3 16.8 30.9 31.2 18.6 46.6 29.4 12.1 21.6 23.5 17.8 14.9 15.0 31.2 14.9 16.0 12.3 28.4 16.3 24.2 16.0 19.8 11.5 17.4 7.8 12.7 15.6 15.5 10.8 14.0 18.8 11.5 11.7 18.1 16.9 16.4 11.4 31.2 25.7 30.7 17.8 23.7 11.4 4.9 23.0 20.1 14.5 24.3 21.5 8.8 25.7 6.1 25.0 16.9 21.8 9.9 12.7 17.9 19.5 12.3 30.1 16.3 9.8 13.5 16.7 27.8 11.7 11.3 19.4 21.4 9.0 6.5 10.8 17.9 14.7 15.3 18.6 13.9 62.0 7.1 25.5 9.2 10.3 11.0 10.6 11.4 8.4 20.2 9.0 6.9 19.7 6.2 12.5 7.4 12.7 7.8 15.5 8.8 15.2 10.7 14.6 12.7 17.4 11.5 14.5 14.8 5.3 15.6 5.4 13.6 14.7 10.8 19.7 19.4 24.0 32.0 16.5 17.2 15.5 22.0 16.8 16.0 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: " "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favourable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavourable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favourable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.1 14.4 66.0 14.8 10.5 18.2 14.7 29.0 8.8 9.8 14.9 29.6 38.0 31.7 10.0 11.3 29.5 13.9 12.0 18.4 41.2 14.8 36.5 89.5 15.2 9.3 58.7 24.2 16.2 15.8 8.9 12.0 12.4 13.1 24.7 12.6 9.2 23.2 31.2 17.4 5.5 40.0 16.5 15.1 11.0 30.4 17.3 24.7 13.7 22.0 6.5 17.3 30.4 22.5 13.1 13.1 14.5 16.3 27.7 22.8 38.0 27.1 37.6 15.0 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favourable (8.15e-5)" "prognostic unfavourable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.6 3.9 2.1 4.4 16.4 22.4 22.3 13.4 11.2 8.6 6.7 10.1 5.6 0.0 2.3 11.4 4.8 7.8 11.0 10.5 5.3 5.2 3.3 3.1 0.3 25.3 3.2 3.9 11.5 8.6 10.7 9.2 10.4 0.4 18.3 15.4 11.8 2.0 0.0 1.9 1.9 3.7 6.1 11.3 5.9 8.9 5.2 2.4 3.5 14.1 3.7 1.7 0.3 10.4 8.2 6.3 4.9 6.4 6.8 0.8 0.0 12.4 0.4 7.2 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639949 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4;lymphoid tissue: 35.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040419, HPA040830" Enhanced Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA040419: AB_10796121, HPA040830: AB_10805830" "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavourable (2.05e-4)" "prognostic unfavourable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavourable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.9 1.5 2.0 17.2 2.9 16.4 3.3 1.1 3.9 1.6 5.4 1.6 0.5 4.3 2.3 0.5 7.5 0.5 4.1 1.4 2.2 1.9 0.8 1.2 2.0 9.4 4.4 0.8 0.8 3.1 0.9 1.0 4.7 2.0 1.2 6.7 0.8 2.0 0.5 1.7 3.2 9.6 3.3 8.9 5.0 2.6 6.4 1.9 35.0 1.0 5.3 10.3 2.6 2.7 0.9 1.7 2.6 1.8 0.5 3.8 1.1 23.3 25.1 20.2 13.3 1.4 3.7 12.0 23.7 13.7 22.6 17.5 17.3 11.9 13.5 7.5 13.9 17.4 14.2 12.4 30.5 26.7 8.2 43.0 22.7 8.8 0.5 31.9 17.3 1.2 1.5 18.2 14.4 16.6 29.8 32.3 26.1 9.5 16.8 10.7 12.6 14.8 19.9 45.1 10.6 8.0 12.4 19.4 13.4 24.8 12.9 5.4 18.3 30.7 12.8 30.5 22.6 12.8 25.2 11.8 18.6 37.4 13.1 38.1 26.6 0.1 1.1 2.6 2.3 1.8 0.9 0.9 3.8 3.3 1.7 0.7 1.5 2.0 0.0 0.5 0.3 0.6 2.8 1.1 2.0 2.9 1.1 3.9 2.2 1.9 4.4 0.8 2.0 1.9 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell line enhanced" "Detected in some" "Daudi: 18.0;HEL: 25.0;HL-60: 35.3;MOLT-4: 23.3;NB-4: 27.3;THP-1: 37.2;U-698: 28.0;U-937: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 25.0 0.1 0.0 0.0 35.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 23.3 27.3 0.1 0.0 13.1 0.1 6.6 0.0 0.0 0.1 0.1 0.1 0.0 0.2 1.2 37.2 0.1 0.1 0.8 0.0 0.0 0.3 0.1 28.0 0.2 18.7 1.0 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 ARHGAP17 "FLJ10308, FLJ13219, NADRIN, RICH1, WBP15" ENSG00000140750 "Rho GTPase activating protein 17" Q68EM7 16 24919385-25015666 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041703 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041703: AB_10794304" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (8.11e-2)" "prognostic favourable (3.59e-4)" "unprognostic (4.42e-2)" "unprognostic (3.49e-2)" "prognostic unfavourable (4.95e-4)" "unprognostic (3.02e-2)" "unprognostic (6.62e-2)" "unprognostic (8.81e-3)" "unprognostic (4.99e-2)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.76e-4)" 25.0 23.2 12.3 22.5 21.7 10.1 20.6 12.2 15.8 15.1 15.8 22.9 6.8 14.3 21.4 12.4 19.1 16.8 15.4 18.9 13.4 5.4 15.0 12.6 17.8 28.7 28.0 8.7 15.1 14.0 17.0 20.5 62.6 16.3 13.7 16.0 19.3 16.4 10.9 22.0 19.2 25.5 15.1 19.6 40.8 16.5 18.6 24.8 16.9 17.1 12.4 29.6 13.4 16.8 25.7 24.6 8.0 17.2 5.7 7.2 6.8 20.2 11.6 15.6 16.4 16.1 16.9 17.5 14.4 13.7 15.2 14.8 18.0 8.1 9.5 9.5 25.2 5.7 15.4 9.0 16.0 14.7 21.4 8.3 27.6 29.5 18.3 10.9 7.7 21.5 5.5 16.2 11.7 25.1 10.2 0.0 16.6 14.2 10.1 13.7 18.7 10.7 47.8 13.2 3.6 18.4 4.4 10.8 11.3 14.2 14.5 5.4 8.0 27.7 34.3 11.4 9.3 25.4 10.8 9.8 12.1 5.5 13.9 16.1 10.0 3.5 9.0 8.0 6.3 17.2 5.7 25.7 5.6 6.4 13.9 24.0 6.4 6.2 4.7 5.7 14.0 24.6 7.2 6.8 12.3 21.7 12.2 15.8 13.4 5.4 28.0 8.7 16.3 24.8 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710225 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 91.0;LHCN-M2: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" 840000 "Plasma membrane, Cytosol" "Nuclear speckles" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavourable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 23.8 32.2 4.1 14.1 4.0 1.7 19.7 2.5 2.4 9.6 19.5 2.9 12.0 13.3 7.8 25.8 5.8 15.7 11.8 16.9 4.4 6.8 33.2 4.5 38.8 15.5 4.1 1.4 8.0 38.2 10.6 22.0 16.7 12.2 9.6 8.2 10.4 16.7 24.2 12.1 5.4 40.6 6.5 9.0 15.8 15.1 10.9 3.8 5.1 12.7 12.1 6.4 10.3 5.8 2.9 11.8 13.0 5.9 2.5 5.8 6.0 1.8 4.2 0.4 0.5 4.1 5.9 3.4 14.3 11.0 6.3 4.3 2.2 3.1 1.5 7.0 9.6 2.4 3.0 4.7 11.9 1.5 1.3 10.2 3.3 12.5 5.9 1.5 91.0 3.7 0.7 11.5 10.3 18.0 5.4 3.9 25.6 0.5 0.0 1.4 0.4 1.0 0.0 1.9 2.9 19.3 1.0 0.0 0.0 1.1 2.0 7.0 2.2 1.8 13.7 6.6 0.9 0.5 11.4 1.8 1.3 1.0 2.2 2.8 9.2 8.9 5.2 13.0 5.3 5.9 3.3 2.9 2.8 5.8 4.8 1.7 0.5 2.9 4.0 2.5 3.1 11.8 2.7 6.0 4.1 4.0 2.5 2.4 4.4 6.8 4.1 1.4 12.2 3.8 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723668 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: " "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 19.6 13.6 34.5 7.1 38.5 4.7 15.6 37.9 39.3 16.2 12.0 39.1 4.4 9.4 14.8 6.0 8.4 14.0 13.5 15.0 43.1 25.2 8.5 9.8 15.7 3.5 42.3 24.0 25.5 11.0 12.4 9.7 12.1 27.3 8.2 14.1 6.7 16.0 9.1 10.9 4.7 11.5 13.7 54.8 6.0 19.5 10.4 43.7 2.7 9.8 3.7 4.2 9.2 9.3 0.2 1.6 3.6 1.9 1.0 2.0 1.0 22.6 10.0 24.7 20.9 17.4 25.1 8.5 16.3 10.8 10.0 14.2 7.3 14.4 4.2 5.6 25.8 15.0 13.0 16.3 14.8 13.9 8.3 24.9 21.6 5.2 10.4 0.0 3.9 10.2 17.9 13.1 14.2 17.1 10.5 38.1 19.6 4.4 11.7 0.8 3.8 5.4 2.6 8.7 2.3 6.7 4.0 4.2 4.3 11.1 6.2 13.2 6.5 3.5 19.0 14.4 9.2 15.8 11.7 4.2 7.5 3.0 14.9 4.3 9.7 3.6 0.8 1.6 0.5 1.9 0.4 0.2 0.6 1.6 1.3 0.0 2.0 1.2 0.1 1.0 0.9 1.6 1.0 1.0 34.5 38.5 37.9 36.1 43.1 25.2 42.3 24.0 27.3 43.7 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: , HPA064439: " "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.5 0.5 0.1 0.0 2.2 8.8 1.7 13.5 6.2 1.2 1.7 2.7 0.3 0.0 0.5 5.2 4.9 0.1 4.5 2.2 0.2 4.6 7.1 0.0 0.0 1.1 0.8 0.8 2.1 4.6 15.4 1.2 8.4 6.7 1.3 26.1 0.1 0.1 0.0 2.9 0.2 0.0 0.0 3.2 2.6 0.2 0.4 2.7 0.6 0.0 0.2 0.1 0.1 27.7 12.7 0.2 1.6 9.4 0.0 0.0 0.0 34.4 0.1 2.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell line enhanced" "Detected in many" "HaCaT: 75.4;RT4: 29.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: " "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavourable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.1 4.3 3.9 1.3 2.5 8.3 4.9 11.1 12.5 9.8 5.7 14.3 14.2 0.1 9.2 25.7 75.4 0.4 15.7 7.0 0.8 0.8 0.0 13.8 0.1 12.5 0.8 0.0 4.8 3.0 7.1 4.5 10.0 0.1 2.1 5.5 0.0 2.4 1.5 2.3 1.6 4.2 8.5 2.6 4.1 29.3 0.9 2.2 6.7 0.0 0.0 1.7 1.9 14.5 16.5 5.8 3.3 2.9 1.7 1.7 0.4 4.1 2.0 14.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell line enhanced" "Detected in many" "ASC diff: 35.7;ASC TERT1: 21.6;HHSteC: 20.8;HUVEC TERT2: 38.4;RPTEC TERT1: 21.5;TIME: 27.1;U-138 MG: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favourable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 35.7 21.6 1.5 6.7 9.0 1.6 2.7 0.0 0.0 0.8 2.4 15.1 0.0 0.0 2.8 3.5 0.0 0.3 1.1 0.2 0.0 20.8 0.1 0.0 15.8 0.3 3.3 1.5 38.4 1.9 0.1 14.6 0.0 0.0 0.0 0.1 3.5 0.1 7.1 3.6 21.5 0.0 0.7 0.7 0.7 1.1 2.4 0.1 0.0 27.1 19.3 0.4 1.4 0.1 0.1 0.0 1.1 3.3 0.7 6.2 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 94.2;lymphoid tissue: 48.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 94.2" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favourable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 7.4 3.5 2.6 33.1 3.6 14.6 5.7 0.9 3.2 3.1 4.9 6.7 1.6 2.5 4.0 10.5 3.5 3.5 7.2 4.3 2.8 2.3 5.7 4.6 12.9 39.0 5.9 1.9 8.1 2.2 0.6 3.1 4.5 4.2 3.7 4.2 3.1 5.7 1.5 2.0 3.3 14.3 3.5 6.3 48.7 3.4 2.2 3.3 20.9 4.0 2.3 40.6 6.1 4.7 23.6 7.5 94.2 12.5 22.8 26.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.7 0.0 5.7 0.0 0.6 0.0 18.3 0.0 0.0 0.2 4.0 73.6 0.0 0.7 0.1 2.3 0.0 0.1 6.7 0.0 0.0 4.6 12.9 0.3 0.0 5.1 1.2 0.2 0.0 1.5 1.1 0.1 0.0 0.0 0.4 0.0 3.4 0.9 0.0 0.2 0.0 0.1 14.5 7.7 4.6 0.0 9.1 0.1 27.5 8.7 72.8 26.3 10.9 16.4 23.6 11.8 22.7 5.3 14.5 8.5 15.0 94.2 22.8 12.5 7.5 14.2 15.7 2.6 3.6 0.9 3.2 2.8 2.3 5.9 1.9 4.2 3.3 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 47.6;hTERT-HME1: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavourable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 47.6 2.0 2.9 0.0 10.4 24.7 10.6 16.0 26.1 13.6 19.8 5.7 2.4 0.0 36.1 32.1 10.2 0.1 10.9 28.0 0.0 1.5 0.2 2.7 2.5 1.0 0.0 0.0 4.8 2.0 10.3 43.0 36.5 0.0 0.0 13.4 1.6 0.9 0.0 3.9 32.9 0.6 2.4 0.0 28.6 4.2 0.0 0.6 9.8 7.7 0.7 2.3 0.1 32.8 8.2 11.3 12.6 12.3 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell line enhanced" "Detected in many" "RT4: 21.4;SK-BR-3: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: , HPA038389: AB_10670972, HPA061505: " "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.5 3.5 10.9 0.0 3.6 3.6 7.9 2.4 3.4 1.6 1.9 8.0 13.5 0.0 3.8 4.7 14.9 5.0 6.2 3.0 0.0 1.7 0.1 1.7 3.0 1.7 0.0 0.0 3.5 8.1 1.5 9.2 1.9 0.3 0.1 2.7 5.0 5.3 0.1 2.9 3.7 13.2 3.3 1.3 1.7 21.4 10.8 4.4 3.7 23.4 4.5 12.1 2.1 3.6 5.6 2.9 3.3 4.7 0.1 0.0 0.0 2.4 14.9 3.5 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 ARHGAP33 "FLJ39019, SNX26, TCGAP" ENSG00000004777 "Rho GTPase activating protein 33" O14559 19 35774532-35788822 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030117, HPA030118" Supported Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "HPA030117: AB_10599306, HPA030118: AB_10601238" "unprognostic (1.44e-3)" "unprognostic (3.40e-2)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (2.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.61e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" "unprognostic (2.97e-3)" "unprognostic (2.40e-2)" "prognostic unfavourable (3.09e-8)" "unprognostic (5.70e-2)" "unprognostic (2.66e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-2)" 4.8 7.6 17.2 6.6 21.9 27.8 4.0 18.1 27.1 6.0 3.8 22.0 2.8 6.8 8.4 2.9 3.6 6.1 4.9 4.5 14.9 11.7 3.8 2.0 4.7 8.7 18.4 13.8 11.8 7.3 6.2 13.2 3.3 12.7 5.8 2.9 6.8 8.9 6.2 4.7 12.9 6.0 4.0 15.4 7.8 7.2 18.2 17.9 12.2 6.8 2.3 4.2 3.1 5.3 0.1 0.0 0.7 0.0 0.0 0.4 0.0 4.8 3.1 8.8 6.6 0.3 0.9 0.7 4.0 0.5 1.5 1.1 1.2 3.7 2.8 1.5 1.1 1.3 1.1 1.1 0.5 8.9 2.0 4.1 4.1 1.1 0.4 1.5 33.2 1.3 0.2 1.2 0.4 0.9 2.0 12.5 1.3 3.7 10.1 4.0 2.0 1.4 13.9 1.4 1.3 0.7 0.8 8.8 5.4 1.8 3.2 0.6 4.7 4.1 1.7 6.3 6.3 3.3 4.6 11.1 2.1 2.8 2.3 4.9 4.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 17.2 21.9 18.1 27.1 14.9 11.7 18.4 13.8 12.7 17.9 ARHGAP35 "GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP" ENSG00000160007 "Rho GTPase activating protein 35" Q9NRY4 19 46918676-47005077 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, GTPase activation, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037311, HPA055184, HPA056470" Approved Supported "Nuclear bodies,Aggresome" "Nuclear bodies" Aggresome "CAB037311: AB_477435, HPA055184: , HPA056470: " "unprognostic (5.47e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (2.40e-2)" "unprognostic (2.01e-2)" "unprognostic (7.78e-3)" "unprognostic (9.82e-3)" "unprognostic (4.41e-2)" "unprognostic (2.71e-1)" "unprognostic (2.73e-2)" "unprognostic (3.25e-2)" "unprognostic (1.92e-1)" "prognostic favourable (5.55e-8)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" 4.0 3.1 11.9 1.9 9.0 0.8 5.4 6.1 11.7 4.5 4.4 3.9 3.9 3.3 5.3 4.3 2.6 8.7 10.7 9.9 6.7 7.7 4.8 2.1 8.4 6.2 4.2 17.3 4.4 2.0 4.4 3.9 4.8 5.6 9.0 3.4 5.1 4.2 4.6 2.2 3.1 13.8 7.0 2.4 4.5 2.2 1.1 1.4 0.9 1.2 1.0 3.1 1.1 20.0 22.8 15.4 13.6 14.1 11.8 2.6 10.9 15.7 11.1 12.8 12.2 7.2 10.8 7.8 44.7 12.3 14.2 14.2 15.4 7.4 5.9 14.6 16.0 9.4 13.2 8.6 12.4 11.9 14.3 12.6 13.5 10.0 9.7 3.9 12.7 11.8 8.3 13.5 8.0 8.4 9.3 10.5 3.3 9.3 40.2 15.5 14.7 20.2 19.0 8.1 17.9 10.5 12.5 9.8 7.8 10.6 12.9 4.1 7.4 8.8 22.0 9.0 23.9 0.9 1.0 0.9 2.8 0.8 2.9 0.8 2.6 3.1 1.3 1.1 1.0 1.2 0.4 1.0 1.2 1.4 0.8 1.1 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 62.9" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.5 7.5 3.5 5.5 0.7 0.6 6.8 1.9 0.6 2.4 1.6 4.8 4.5 0.7 5.1 0.8 6.4 1.7 1.9 0.5 0.0 6.7 0.1 4.9 3.0 1.2 0.0 0.7 0.5 3.1 3.2 1.3 0.8 6.9 0.0 1.0 12.1 4.1 0.0 3.7 10.7 3.8 2.8 2.8 1.9 3.8 10.3 7.3 5.7 2.0 3.4 8.4 1.1 1.9 1.8 0.1 6.2 4.1 0.0 0.1 0.3 3.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.8;lymphoid tissue: 48.4" "Cell line enhanced" "Detected in many" "Daudi: 25.7;Karpas-707: 26.4;MOLT-4: 24.8;RPMI-8226: 48.8;THP-1: 23.8;U-698: 22.7;U-937: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001012, HPA001083" Enhanced Approved "Nucleoplasm,Focal adhesion sites" "Focal adhesion sites" Nucleoplasm "HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favourable (3.94e-5)" "prognostic unfavourable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favourable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 7.0 4.8 5.3 24.3 5.8 44.8 5.0 4.5 3.2 3.1 6.5 5.2 2.1 6.0 3.9 7.0 4.4 5.2 6.5 4.2 4.5 3.2 7.4 4.9 13.4 29.1 5.2 0.9 2.6 2.3 0.9 3.5 9.0 4.8 4.2 3.0 5.7 7.5 1.8 1.6 1.8 18.0 3.9 5.9 48.4 4.9 3.6 4.2 43.2 4.2 1.6 29.0 7.1 3.6 10.8 17.7 18.7 30.5 8.5 15.7 12.6 0.4 0.1 0.2 1.7 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.1 12.3 25.7 1.5 0.0 0.2 1.3 0.0 0.0 6.9 1.0 9.9 0.1 0.4 1.0 18.2 16.9 0.0 0.1 0.0 0.1 2.6 0.0 26.4 0.1 1.3 24.8 0.3 0.8 0.0 11.8 3.5 48.8 0.1 0.2 2.4 3.5 0.2 0.6 0.2 5.7 23.8 0.5 0.1 0.3 0.2 0.1 16.0 13.6 22.7 0.2 21.3 0.0 5.1 14.1 18.7 15.7 23.1 10.9 10.8 11.2 12.4 14.1 10.4 10.1 10.1 12.0 8.5 30.5 17.7 12.6 12.6 5.3 5.8 4.5 3.2 4.5 3.2 5.2 0.9 4.8 4.2 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell line enhanced" "Detected in some" "BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.3 0.0 0.0 0.0 12.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 11.3 0.0 13.7 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: " "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.5 4.6 0.1 2.5 3.4 3.1 0.5 0.9 1.1 2.1 4.4 22.8 0.7 6.4 1.7 7.7 2.3 1.7 1.1 0.0 1.9 11.0 8.9 1.4 4.5 0.1 0.0 3.3 2.1 4.2 0.7 1.7 0.4 0.0 3.4 0.6 1.2 0.0 5.5 5.6 3.4 15.8 0.4 5.3 14.8 2.5 1.6 7.6 0.2 6.0 0.8 1.4 3.0 3.0 3.7 3.5 1.7 3.3 0.0 4.4 3.5 2.7 12.9 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 ARHGAP5 "GFI2, p190-B, p190BRhoGAP, RhoGAP5" ENSG00000100852 "Rho GTPase activating protein 5" Q13017 14 32076114-32159728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046993, HPA056507" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA046993: , HPA056507: " "unprognostic (1.79e-1)" "unprognostic (2.03e-1)" "unprognostic (2.66e-3)" "unprognostic (6.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (1.55e-2)" "unprognostic (6.23e-2)" "unprognostic (2.88e-1)" "unprognostic (2.18e-1)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "prognostic favourable (3.97e-8)" "unprognostic (9.79e-2)" "unprognostic (2.21e-1)" "unprognostic (2.13e-1)" "unprognostic (1.00e-2)" 11.3 13.1 29.8 8.4 26.1 4.0 13.0 39.1 29.2 14.2 14.6 11.5 7.9 16.0 13.2 11.9 31.5 11.1 15.3 28.0 29.5 19.6 20.8 14.5 12.8 5.9 26.8 23.4 23.3 13.5 21.8 27.6 16.9 24.2 14.7 12.3 9.2 26.0 14.5 11.5 14.0 17.3 13.4 26.6 18.7 13.3 20.4 30.6 8.8 32.5 7.7 8.0 15.6 25.8 7.3 9.0 1.5 1.8 6.8 7.4 2.3 18.6 15.2 15.2 22.2 20.0 14.1 8.7 11.6 14.4 7.1 10.7 19.3 18.3 5.5 10.4 14.7 19.9 14.5 12.5 13.9 5.5 8.4 8.3 9.4 28.2 13.6 5.0 5.0 15.6 25.5 6.6 25.0 8.7 7.3 16.5 11.5 9.8 10.9 0.2 7.5 18.3 11.9 18.7 1.0 15.6 49.9 23.6 9.2 31.3 16.8 23.7 17.4 0.3 13.9 13.2 19.9 10.9 8.5 6.3 12.3 0.8 6.6 5.4 35.9 1.5 1.8 0.0 4.0 0.8 4.8 7.3 7.0 3.7 6.1 7.1 7.4 4.3 0.6 6.8 1.3 9.0 5.7 2.3 29.8 26.1 39.1 29.2 29.5 19.6 26.8 23.4 24.2 30.6 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell line enhanced" "Detected in some" "HAP1: 5.1;HEK 293: 18.4;MCF7: 23.6;SCLC-21H: 8.3;SH-SY5Y: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA078260: " "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.6 0.4 0.1 5.1 0.0 0.0 0.0 18.4 0.0 0.3 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.2 0.2 0.0 23.6 0.0 0.3 2.5 0.0 0.0 0.0 0.4 0.0 0.0 8.3 10.3 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 ARHGEF1 "LBCL2, P115-RHOGEF, SUB1.5" ENSG00000076928 "Rho guanine nucleotide exchange factor 1" Q92888 19 41883161-41930150 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 61.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009502, HPA012924, HPA060784" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363" "prognostic favourable (5.92e-4)" "unprognostic (2.09e-1)" "unprognostic (8.29e-3)" "unprognostic (8.10e-3)" "unprognostic (7.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.99e-2)" "unprognostic (7.28e-2)" "unprognostic (5.88e-2)" "unprognostic (1.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.29e-3)" "prognostic unfavourable (3.36e-8)" "unprognostic (3.54e-1)" "unprognostic (1.95e-1)" "unprognostic (8.00e-2)" "unprognostic (4.65e-2)" 15.5 8.4 10.7 40.1 16.5 50.0 13.8 8.7 13.8 11.7 14.1 23.3 9.7 13.7 12.7 9.6 12.2 13.0 14.1 9.3 10.6 6.2 12.4 10.4 23.7 57.8 18.1 8.5 12.5 10.8 7.0 11.8 9.6 11.8 11.4 5.8 12.1 13.1 9.2 5.2 12.9 29.3 9.0 12.2 61.0 17.0 3.7 15.6 43.6 13.4 8.6 40.8 12.4 11.7 11.1 10.8 13.7 26.9 15.4 26.3 14.3 19.9 24.3 5.6 7.0 8.0 8.4 6.6 10.6 16.2 13.4 11.8 7.4 17.3 26.8 19.5 9.6 11.8 7.2 16.4 4.2 25.1 8.3 21.6 10.5 9.7 11.7 23.1 35.7 10.1 10.9 13.0 8.5 12.8 8.5 16.5 7.7 13.8 16.1 17.9 6.4 18.9 24.4 10.5 15.8 8.2 11.0 3.7 15.7 14.8 6.6 12.1 7.7 39.5 17.2 17.9 12.0 9.5 16.3 22.5 14.3 23.2 14.6 36.7 28.2 5.1 9.4 13.7 25.1 19.8 20.3 10.8 19.1 26.3 10.8 11.1 20.0 20.4 13.7 15.4 26.9 5.8 19.4 14.3 10.7 16.5 8.7 13.8 10.6 6.2 18.1 8.5 11.8 15.6 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539835-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.7" "Cell line enhanced" "Detected in many" "Hep G2: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 40 "classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 46 "dendritic cells: 9.7;monocytes: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favourable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favourable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 9.5 6.1 6.2 6.1 6.2 0.7 7.8 31.7 7.5 8.5 13.4 7.1 9.9 9.0 7.7 11.2 14.4 6.4 11.7 16.0 5.7 6.1 16.4 50.7 7.8 2.2 6.3 3.8 5.3 30.2 8.1 2.7 3.3 9.1 6.6 7.4 9.6 13.2 12.3 33.4 13.4 9.7 10.5 5.9 5.4 6.5 3.9 5.9 0.4 10.4 7.4 2.9 9.6 11.9 0.0 9.7 0.2 13.1 0.0 0.0 4.5 5.2 6.0 7.7 2.6 13.1 4.4 5.2 3.6 7.2 4.3 3.6 6.2 15.9 0.0 6.8 6.7 4.1 1.0 1.9 0.8 0.1 1.9 0.0 6.2 17.6 3.0 0.0 0.0 5.9 3.7 2.7 0.7 0.8 0.0 0.1 12.0 5.0 0.0 0.1 3.4 0.0 0.0 3.0 1.9 9.2 11.0 11.3 8.3 2.8 2.0 8.2 7.5 6.3 0.0 3.8 4.6 4.4 1.5 0.0 1.6 0.0 5.8 0.1 2.0 0.0 13.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 4.5 6.2 6.2 31.7 7.5 5.7 6.1 6.3 3.8 9.1 5.9 ARHGEF11 "GTRAP48, KIAA0380, PDZ-RHOGEF" ENSG00000132694 "Rho guanine nucleotide exchange factor 11" O15085 1 156934840-157045370 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011026, HPA012037, HPA014658" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428" "unprognostic (2.19e-1)" "unprognostic (9.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.17e-1)" "unprognostic (2.00e-1)" "unprognostic (4.94e-3)" "unprognostic (3.30e-2)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favourable (1.72e-4)" "unprognostic (3.38e-1)" "unprognostic (2.41e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-1)" "unprognostic (1.08e-1)" "unprognostic (4.73e-2)" 11.9 13.0 17.5 11.6 13.4 4.3 12.3 28.8 22.4 12.3 13.2 9.2 22.0 14.4 14.7 11.9 13.1 12.2 14.3 13.2 13.6 16.0 10.9 7.6 12.7 8.0 13.9 13.7 15.6 11.0 31.7 15.4 12.3 13.1 11.4 12.9 14.5 9.3 25.1 14.7 11.2 23.3 15.2 9.1 9.8 11.9 20.9 9.9 1.0 14.9 5.3 6.3 13.2 12.6 0.4 0.9 3.3 2.8 0.0 1.0 0.7 6.9 13.7 11.8 8.9 15.7 8.1 13.4 6.9 10.3 10.8 7.9 9.2 7.4 0.9 12.1 12.0 7.5 8.0 7.2 6.0 9.9 4.9 3.4 8.2 6.0 9.1 6.9 12.3 12.5 7.9 9.9 7.7 7.7 5.6 0.6 7.2 9.0 1.7 3.8 14.6 8.4 0.2 5.8 3.8 5.3 11.4 2.2 13.5 14.8 12.0 12.5 10.7 15.9 11.6 11.1 7.1 9.7 7.1 10.0 6.1 0.6 7.0 0.9 36.7 0.0 1.4 0.0 0.0 2.8 0.0 0.4 0.6 0.0 0.9 0.0 0.6 1.0 3.3 0.0 1.5 0.0 0.3 0.7 17.5 13.4 28.8 22.4 13.6 16.0 13.9 13.7 13.1 9.9 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favourable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 12.9 10.9 14.7 14.0 19.9 19.9 6.1 15.3 17.3 9.3 11.9 12.7 9.5 1.1 18.8 27.3 9.8 18.8 19.4 18.2 10.7 9.2 21.1 11.7 9.8 17.8 0.0 15.7 18.9 14.1 20.4 22.7 28.2 17.8 43.3 23.5 9.0 0.0 0.0 4.0 9.4 4.6 16.8 4.1 22.9 22.6 10.8 13.3 21.4 18.0 5.6 15.3 1.7 27.8 20.7 8.9 13.4 11.1 12.7 5.1 7.2 8.5 2.7 15.6 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 9.8;U-251 MG: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: " "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favourable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 11.2 4.0 9.1 5.8 8.7 1.0 9.8 5.6 17.8 9.2 20.0 6.5 3.3 10.3 5.9 3.1 12.0 8.3 17.6 4.1 8.7 4.6 3.1 22.0 18.6 1.0 5.4 6.3 5.3 27.1 13.9 2.9 4.7 12.2 5.3 3.7 4.4 4.1 5.5 1.5 7.0 11.5 12.7 9.7 1.6 12.3 7.4 5.5 0.0 4.1 2.5 2.0 7.4 11.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 5.2 3.0 6.0 4.1 2.7 0.4 0.1 0.3 0.0 1.5 1.7 2.4 0.4 2.4 0.4 0.1 6.2 3.0 1.5 2.8 0.0 7.9 0.0 2.2 0.8 2.5 0.8 0.1 0.9 0.1 1.9 0.3 0.1 0.0 0.0 1.0 6.0 1.0 0.1 3.8 2.6 0.0 9.8 0.0 0.5 3.5 2.2 0.7 0.7 8.6 1.3 5.2 0.4 0.0 0.9 3.9 0.0 17.7 2.5 0.4 0.0 1.6 0.0 6.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 8.7 5.6 10.1 8.7 4.6 5.4 6.3 12.2 5.5 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 37.8;LHCN-M2: 34.8;TIME: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favourable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favourable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favourable (8.98e-4)" 3.4 17.7 3.0 2.7 1.4 0.0 7.7 2.3 2.3 9.7 6.7 1.1 8.6 2.3 11.9 9.7 7.1 7.5 12.0 1.5 1.4 1.9 43.0 5.5 5.5 0.3 1.7 3.2 14.5 19.2 0.2 7.0 1.1 2.5 5.1 2.8 4.3 20.0 9.5 0.9 11.1 3.9 2.7 3.3 2.0 14.8 2.0 1.0 4.1 10.5 6.0 6.0 3.4 6.2 0.0 0.0 0.0 0.0 0.6 1.2 0.1 10.9 7.8 0.0 1.0 1.0 1.4 0.0 4.0 8.1 5.1 5.1 2.3 4.8 0.0 8.6 1.4 3.7 0.5 6.5 7.8 0.0 1.1 0.2 1.2 9.9 8.2 0.0 0.0 1.3 2.6 8.0 37.8 16.7 0.0 0.0 34.8 1.0 0.0 0.0 0.1 3.2 0.0 2.1 1.3 14.0 6.7 0.7 1.5 1.9 0.3 0.2 1.7 0.0 22.3 2.5 3.5 0.2 3.8 0.4 0.0 0.0 3.9 0.5 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.1 3.0 1.4 2.3 2.3 1.4 1.9 1.7 3.2 2.5 1.0 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Group enriched" "Detected in some" 8 "RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA036510: AB_10672357, HPA045484: " "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 16.0 0.0 0.0 0.0 0.0 8.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070270-21090240 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.4;ASC TERT1: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 2.8;neutrophil: 9.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 15.7 32.9 9.3 7.4 9.2 1.7 12.4 16.5 8.2 16.2 8.2 11.4 30.9 3.5 13.6 12.6 5.9 9.3 20.2 7.8 10.2 4.6 7.2 16.9 9.3 4.2 12.6 4.5 15.7 16.6 17.7 6.6 6.3 9.1 9.8 6.3 10.3 20.1 30.0 6.5 4.9 5.2 11.2 10.5 19.5 6.4 4.7 10.8 1.3 11.0 4.9 2.5 8.6 9.6 0.0 1.0 9.2 1.3 0.1 0.0 0.5 1.6 1.5 17.4 3.1 14.7 22.2 0.6 5.8 15.7 6.8 5.3 0.7 4.1 0.0 0.9 11.4 2.5 1.5 2.0 2.6 3.2 0.6 2.3 1.7 4.7 2.0 1.5 8.6 9.0 1.4 5.9 1.8 0.0 0.7 0.7 5.5 0.2 0.0 4.8 3.9 0.3 0.5 11.5 0.7 4.4 2.1 0.4 6.0 3.2 0.3 4.7 1.5 5.1 2.8 14.1 9.2 6.2 2.7 1.4 0.0 0.0 4.8 2.1 3.8 0.0 1.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.5 9.3 9.2 16.5 8.2 10.2 4.6 12.6 4.5 9.1 10.8 ARHGEF5 "GEF5, P60, TIM, TIM1" ENSG00000050327 "Rho guanine nucleotide exchange factor 5" Q12774 7 144355288-144380632 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.4;CAPAN-2: 13.9;hTCEpi: 15.3;WM-115: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA020980, HPA029504, HPA044188, HPA045619, HPA045699" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: , HPA045619: , HPA045699: " "unprognostic (1.45e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-2)" "unprognostic (1.94e-1)" "unprognostic (9.45e-2)" "unprognostic (2.69e-2)" "unprognostic (9.95e-3)" "unprognostic (9.21e-2)" "unprognostic (1.05e-2)" "unprognostic (2.27e-1)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "prognostic favourable (3.28e-7)" "unprognostic (4.67e-2)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "unprognostic (7.76e-2)" 2.3 1.0 1.2 5.2 1.8 0.9 7.6 1.2 1.2 4.6 7.7 1.2 7.4 8.5 3.4 7.8 16.6 2.5 8.4 1.3 1.2 0.4 9.0 6.7 4.8 3.2 1.2 1.2 3.0 8.8 7.7 4.3 14.3 2.6 6.6 4.6 4.0 17.7 9.4 1.2 21.1 16.7 2.2 1.7 2.4 6.5 1.4 1.2 1.5 11.6 10.0 4.5 3.4 6.9 3.1 0.2 1.1 0.1 0.0 4.2 0.4 20.4 1.9 0.0 0.0 0.0 0.0 7.0 2.2 1.4 1.0 1.2 6.9 13.9 0.0 6.7 0.9 9.5 0.8 9.5 1.0 0.0 2.9 0.0 3.1 1.0 2.3 0.0 0.0 3.6 15.3 0.7 7.1 0.2 0.0 0.0 0.8 8.4 0.0 0.0 4.5 3.8 0.8 0.0 0.2 11.3 7.0 0.0 0.0 8.6 8.5 3.7 5.2 1.3 0.2 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 15.0 0.0 0.0 0.0 0.8 0.1 1.3 1.8 2.7 2.1 0.1 3.1 2.7 0.7 1.1 0.0 0.0 0.2 4.2 0.4 1.2 1.8 1.2 1.2 1.2 0.4 1.2 1.2 2.6 1.2 ARID2 "BAF200, DKFZp686G052, FLJ30619, KIAA1557" ENSG00000189079 "AT-rich interaction domain 2" Q68CP9 12 45729665-45908040 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063044 Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA063044: " "unprognostic (8.41e-2)" "unprognostic (1.03e-1)" "unprognostic (4.02e-2)" "unprognostic (3.94e-2)" "unprognostic (4.15e-2)" "prognostic favourable (5.75e-4)" "unprognostic (1.26e-2)" "unprognostic (9.71e-2)" "unprognostic (9.04e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.47e-1)" "unprognostic (1.12e-2)" "unprognostic (9.21e-2)" "unprognostic (3.02e-1)" "unprognostic (2.00e-1)" "unprognostic (6.53e-2)" 9.0 7.9 7.1 14.6 7.2 14.0 11.8 15.7 8.8 10.2 11.4 8.2 17.9 6.4 12.2 10.7 11.5 8.8 10.6 8.2 7.4 5.8 8.7 6.9 10.2 13.0 9.6 3.8 12.2 10.7 18.4 15.1 10.3 7.5 9.9 8.1 10.1 9.7 20.6 8.6 13.5 12.6 12.5 7.3 10.2 9.0 30.9 11.0 33.3 11.5 8.2 11.2 10.0 10.0 2.1 5.3 10.5 4.9 3.1 4.4 1.3 5.4 7.8 14.0 6.1 6.0 4.2 7.6 3.8 5.4 5.3 5.0 11.1 5.6 10.5 7.0 5.2 6.6 11.3 6.4 7.7 4.6 5.4 13.9 8.6 5.4 4.1 10.9 6.4 3.4 4.9 6.7 10.7 5.4 11.7 10.9 4.7 7.1 15.6 7.8 8.3 4.2 12.1 10.0 10.1 5.1 9.0 7.6 9.7 6.2 7.2 6.0 10.9 21.9 6.4 5.7 6.9 3.8 4.9 7.3 6.0 29.3 4.4 28.7 4.0 10.5 1.7 4.2 4.1 2.2 4.3 1.7 3.7 4.4 2.4 2.1 3.6 3.3 2.4 3.1 4.9 5.3 3.1 1.3 7.1 7.2 15.7 8.8 7.4 5.8 9.6 3.8 7.5 11.0 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.3" "Cell line enhanced" "Detected in many" "BEWO: 62.8;CACO-2: 21.2;K-562: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favourable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 4.0 2.3 1.7 6.2 2.3 11.5 4.4 4.8 3.8 3.6 5.0 1.6 3.3 4.2 2.9 2.9 4.1 2.7 3.2 2.1 2.2 1.5 4.4 2.6 6.1 7.8 2.8 2.0 1.6 5.5 3.4 4.1 38.3 2.1 2.3 1.8 2.6 2.8 5.6 2.0 3.3 5.0 2.6 2.4 8.3 3.4 17.8 2.5 6.6 2.1 2.1 4.6 4.0 6.9 1.5 9.2 6.4 2.9 1.9 0.5 0.8 1.1 1.4 5.2 1.3 2.2 1.6 62.8 4.9 3.2 2.6 1.8 21.2 0.1 0.4 1.1 1.6 0.4 2.1 1.1 1.1 6.5 1.5 2.1 1.8 19.0 0.9 7.2 5.4 2.4 1.6 1.6 0.4 0.9 27.3 6.1 0.7 1.6 2.8 8.3 5.0 0.3 6.3 1.6 4.0 0.3 1.0 2.5 4.8 1.5 1.3 0.9 2.2 19.5 1.4 1.7 2.4 2.5 0.5 14.3 12.7 3.7 1.1 4.3 1.2 0.8 2.4 1.6 0.5 2.1 0.5 1.5 0.3 0.4 1.5 0.9 0.5 0.2 6.4 1.9 2.9 9.2 0.3 0.8 1.7 2.3 4.8 3.8 2.2 1.5 2.8 2.0 2.1 2.5 ARID4A "RBBP1, RBP-1, RBP1" ENSG00000032219 "AT-rich interaction domain 4A" P29374 14 58298385-58373887 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048899 Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA048899: " "unprognostic (1.57e-1)" "unprognostic (9.39e-2)" "unprognostic (5.17e-2)" "unprognostic (2.69e-1)" "unprognostic (3.70e-2)" "prognostic favourable (1.91e-4)" "unprognostic (2.71e-1)" "prognostic favourable (7.82e-4)" "unprognostic (2.08e-2)" "unprognostic (6.92e-2)" "unprognostic (3.27e-1)" "unprognostic (3.72e-2)" "unprognostic (9.32e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (4.11e-2)" "unprognostic (3.52e-2)" 15.1 8.5 17.3 15.1 22.2 34.5 13.4 45.9 27.0 12.8 12.0 7.9 12.7 10.2 11.6 9.7 10.1 10.7 10.7 10.0 13.3 11.5 11.3 21.7 12.0 15.8 9.6 18.7 15.3 11.4 17.2 22.9 11.3 17.3 10.8 10.6 6.4 10.8 13.5 10.6 13.2 12.3 12.5 11.0 15.3 10.2 7.9 15.0 15.0 12.6 4.5 12.8 13.8 11.9 15.1 7.5 42.7 14.1 10.7 11.1 3.6 6.6 5.6 15.7 7.7 7.8 9.5 7.9 7.9 6.8 5.4 8.6 6.5 10.5 16.0 8.5 6.6 7.7 6.9 3.8 8.0 11.2 4.4 7.2 6.3 6.3 4.7 15.2 10.5 7.1 4.2 5.2 5.4 8.5 8.2 13.2 5.7 8.9 11.0 13.7 3.1 6.8 11.3 13.5 4.7 5.8 11.8 13.5 11.7 13.4 6.8 9.4 11.6 14.0 12.1 9.2 7.2 7.4 3.6 4.3 3.2 14.7 5.5 9.7 4.6 19.3 7.6 21.7 8.5 7.8 9.5 11.6 10.3 8.8 5.6 15.1 11.1 10.8 42.7 10.7 14.1 7.5 7.2 3.6 17.3 22.2 45.9 27.0 13.3 11.5 9.6 18.7 17.3 15.0 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027333, HPA053692" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027333: AB_1845013, HPA053692: " "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.3 9.3 16.3 12.6 12.0 12.6 13.4 14.1 12.4 9.8 9.6 9.5 13.2 14.5 16.4 10.6 11.0 13.2 5.9 14.2 18.7 14.3 11.7 11.1 8.0 9.2 12.5 17.2 8.4 8.0 12.0 10.3 13.2 15.1 20.9 9.1 5.6 18.6 11.4 15.0 6.1 7.0 11.5 12.1 10.7 10.4 13.3 18.4 18.0 14.9 13.9 15.8 20.3 18.2 12.1 9.2 14.7 13.7 20.4 16.1 14.5 8.3 9.2 16.1 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552638 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 71.4;RPMI-8226: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favourable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 20.1 4.1 6.8 24.5 8.7 14.6 26.2 3.1 8.8 10.5 14.6 4.9 4.1 7.2 17.5 16.1 9.1 11.5 16.8 17.8 7.0 5.5 5.4 7.2 26.0 29.0 10.7 3.1 11.4 9.8 3.8 6.6 13.0 17.4 14.7 3.7 11.4 8.2 5.1 26.1 7.3 12.3 33.1 13.6 14.9 10.1 5.4 6.2 12.4 8.2 7.7 15.7 19.5 12.0 5.2 12.8 21.4 5.3 17.7 11.5 8.8 0.8 0.3 0.4 1.4 0.8 0.9 2.1 1.4 4.8 1.7 1.5 0.8 0.2 0.2 0.9 0.8 1.2 0.3 0.0 0.5 71.4 1.1 1.7 0.3 1.6 0.9 1.2 1.3 0.6 1.6 1.3 0.2 1.5 1.4 10.8 0.6 0.7 2.3 4.2 0.9 0.0 3.2 3.0 31.5 0.2 0.6 0.6 0.2 0.1 0.1 1.1 0.0 2.6 1.3 1.5 1.8 1.6 1.2 6.7 5.2 0.8 0.8 2.9 1.3 7.2 5.3 21.4 11.5 4.8 11.1 4.4 9.7 10.7 7.1 5.2 10.8 10.5 15.3 17.7 3.3 12.8 11.0 8.8 6.8 8.7 3.1 8.8 7.0 5.5 10.7 3.1 17.4 6.2 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.7 5.1 13.7 0.4 16.6 44.8 11.8 9.3 20.1 0.9 1.4 4.0 15.9 5.5 8.0 2.5 14.3 5.2 2.4 0.7 4.1 5.0 9.5 0.2 9.9 17.3 1.3 7.0 8.0 1.4 0.7 2.2 3.8 2.8 5.4 0.4 0.4 5.2 6.6 3.8 0.4 7.8 9.0 1.3 1.7 7.4 4.1 4.8 3.4 0.2 1.2 6.6 8.9 9.9 4.2 0.1 0.0 4.3 5.7 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474326-72602985 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003295, HPA073245" Approved Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA003295: AB_1845017, HPA073245: " "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 15.3 15.6 11.4 17.4 15.5 24.6 13.3 20.4 21.5 15.8 14.5 10.4 14.0 17.0 21.1 11.2 14.2 12.3 14.4 19.7 10.5 10.5 10.9 10.5 13.7 9.3 10.1 15.0 17.3 13.5 12.9 14.0 15.4 12.6 14.0 7.6 13.0 13.2 13.1 68.3 16.3 13.5 15.8 10.7 11.4 12.5 55.2 10.0 16.9 11.7 13.0 12.7 18.4 20.4 1.9 1.1 4.6 1.5 2.1 2.5 0.3 9.3 9.9 9.7 5.7 5.0 3.6 11.5 10.6 3.8 4.8 3.3 10.0 8.1 9.2 15.9 4.5 13.5 10.0 5.5 2.7 16.3 6.9 6.9 12.2 6.6 3.6 10.3 8.1 4.2 1.9 5.3 6.9 3.5 7.2 11.0 4.7 6.1 10.0 4.0 10.5 3.6 11.4 11.9 5.2 2.7 15.8 9.1 10.4 13.8 6.2 16.2 5.0 11.9 9.1 7.9 11.1 30.6 14.7 11.5 23.2 10.7 5.2 9.5 8.4 4.6 1.0 2.2 1.7 1.5 1.5 0.7 1.3 1.1 0.7 1.9 1.6 1.5 3.4 2.1 0.7 1.1 2.5 0.3 11.4 15.5 20.4 14.0 10.5 10.5 10.1 15.0 12.6 10.0 ARL13B "ARL2L1, DKFZp761H079, JBTS8" ENSG00000169379 "ADP ribosylation factor like GTPase 13B" Q3SXY8 3 93980139-94055668 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048926 Approved Uncertain Microtubules,Cytosol Microtubules Cytosol "HPA048926: " "unprognostic (2.29e-2)" "unprognostic (2.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.94e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.42e-3)" "unprognostic (8.86e-2)" "unprognostic (2.73e-1)" "unprognostic (5.41e-2)" "unprognostic (7.50e-2)" 10.0 6.3 6.6 6.0 9.0 2.4 8.4 6.2 9.0 10.7 6.6 6.5 3.8 3.8 12.5 10.2 6.8 11.8 10.6 7.6 8.9 6.3 10.9 8.2 10.7 5.1 9.0 5.9 10.4 6.0 11.6 17.1 7.8 10.3 6.8 4.4 10.2 5.9 7.3 3.1 6.5 6.7 9.4 9.3 8.3 6.2 10.7 9.4 7.3 14.2 7.8 4.3 8.7 7.4 5.8 7.7 5.6 7.4 5.3 6.5 2.8 5.6 8.4 5.2 3.6 6.9 2.5 2.7 6.0 3.3 9.1 11.7 4.9 2.7 3.9 8.0 5.1 3.2 5.0 3.7 11.6 8.7 5.8 8.2 4.4 3.9 5.0 9.4 4.5 3.7 2.4 10.3 13.0 3.5 8.1 4.2 5.2 3.4 8.3 0.4 2.5 7.2 6.4 19.3 1.5 5.0 0.8 14.1 4.2 12.3 0.5 6.9 1.8 3.0 3.6 8.9 9.6 3.8 5.0 1.6 1.5 7.6 6.5 6.3 5.1 5.6 6.5 4.8 6.5 6.8 6.1 5.8 5.9 5.4 5.2 4.5 5.8 5.0 3.2 5.3 7.4 7.7 4.3 2.8 6.6 9.0 6.2 9.0 8.9 6.3 9.0 5.9 10.3 9.4 ARL14EP "ARF7EP, C11orf46, FLJ38968" ENSG00000152219 "ADP ribosylation factor like GTPase 14 effector protein" Q8N8R7 11 30323051-30338227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039634, HPA048127" Approved Supported "Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol" "Vesicles, Focal adhesion sites, Cytosol" Nucleoplasm "HPA039634: , HPA048127: AB_2680277" "prognostic favourable (2.50e-5)" "unprognostic (8.93e-2)" "unprognostic (6.19e-3)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (3.09e-1)" "prognostic unfavourable (5.26e-4)" "unprognostic (2.50e-2)" "unprognostic (6.50e-3)" "unprognostic (5.76e-2)" "unprognostic (8.86e-2)" "unprognostic (1.04e-1)" "unprognostic (8.57e-3)" "unprognostic (1.60e-1)" "unprognostic (3.47e-1)" "unprognostic (4.50e-2)" "prognostic favourable (7.49e-4)" 13.9 21.5 24.5 12.9 29.1 6.3 18.7 22.7 23.4 17.0 14.5 8.0 22.4 8.7 18.1 22.7 11.1 15.8 12.4 20.5 17.7 15.5 16.5 17.6 10.3 23.5 15.5 20.5 20.1 15.0 33.4 28.6 10.6 15.1 19.0 10.3 9.0 17.0 19.9 28.0 11.6 12.5 18.3 16.0 18.2 14.4 14.5 15.0 11.6 23.3 13.9 19.1 16.1 15.1 17.6 12.7 5.5 9.6 24.4 28.7 11.2 5.7 8.3 9.3 8.2 15.3 16.6 4.7 11.2 14.2 10.2 11.3 4.6 2.2 23.4 7.7 8.1 9.7 13.5 9.5 14.5 18.5 16.8 7.0 6.6 8.0 24.1 12.6 8.1 17.2 19.2 4.8 18.3 11.2 11.1 12.8 17.8 5.4 11.3 10.4 10.8 11.6 10.0 22.8 9.5 13.7 8.0 10.6 11.3 8.8 11.7 13.8 12.5 7.1 9.8 11.7 6.2 23.0 10.6 20.0 11.3 15.2 11.2 7.9 11.1 5.5 9.6 3.0 12.1 9.4 28.7 17.6 14.8 13.4 12.7 14.0 13.7 13.1 1.7 24.4 7.0 9.1 9.5 11.2 24.5 29.1 22.7 23.4 17.7 15.5 15.5 20.5 15.1 15.0 ARL15 "ARFRP2, FLJ20051" ENSG00000185305 "ADP ribosylation factor like GTPase 15" Q9NXU5 5 53883945-54310582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044604, HPA063820" Uncertain Approved "Golgi apparatus,Plasma membrane,Cell Junctions" "Golgi apparatus" "Plasma membrane, Cell Junctions" "HPA044604: AB_10960542, HPA063820: " "unprognostic (2.18e-1)" "unprognostic (4.32e-2)" "unprognostic (1.82e-2)" "unprognostic (2.41e-2)" "unprognostic (1.08e-1)" "unprognostic (3.70e-1)" "unprognostic (8.52e-3)" "unprognostic (1.16e-2)" "unprognostic (3.05e-2)" "unprognostic (6.56e-2)" "unprognostic (4.26e-3)" "unprognostic (3.86e-1)" "unprognostic (2.48e-3)" "unprognostic (1.35e-1)" "unprognostic (9.15e-2)" "unprognostic (5.60e-2)" "unprognostic (1.08e-1)" 22.0 19.9 13.4 13.1 10.5 2.2 20.1 15.7 22.4 29.9 15.6 5.9 8.7 13.9 32.2 9.9 13.2 12.7 20.5 20.1 19.7 13.2 23.9 12.8 14.4 13.9 11.3 11.2 9.8 7.8 3.5 28.0 31.4 12.3 14.3 15.4 15.3 19.6 12.1 5.2 16.9 12.7 26.7 15.1 15.2 11.1 14.2 10.5 17.4 13.4 13.9 10.8 19.1 13.6 2.0 5.0 7.4 3.5 1.4 4.8 2.3 1.9 3.8 5.9 9.9 5.9 5.2 7.4 6.2 9.4 6.2 13.3 14.6 4.8 17.1 10.2 6.0 4.7 8.9 10.2 8.7 2.2 9.2 23.6 5.5 1.2 1.4 2.2 27.7 7.4 7.0 10.2 7.1 15.0 21.2 2.7 4.1 4.1 4.3 2.2 2.0 2.5 3.9 6.3 0.4 8.7 20.7 7.5 3.9 7.9 4.4 5.0 4.7 2.9 7.6 3.9 6.0 2.9 4.5 1.1 1.1 19.6 5.9 6.3 6.3 2.7 3.5 4.6 2.9 3.2 1.7 2.0 2.0 2.1 5.0 1.6 2.1 1.7 7.4 1.4 2.3 0.7 4.8 2.3 13.4 10.5 15.7 22.4 19.7 13.2 11.3 11.2 12.3 10.5 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014113-65022184 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favourable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 39.6 32.0 37.3 17.7 78.7 19.8 26.8 16.1 46.5 21.2 23.5 34.7 13.4 23.9 26.8 20.2 23.7 35.2 22.4 52.6 34.8 32.7 33.8 6.6 23.1 14.8 36.1 38.2 27.2 29.9 22.5 15.4 25.5 32.7 25.3 15.5 30.3 26.9 33.1 78.3 19.6 23.4 28.2 44.9 16.7 18.9 31.4 28.7 7.9 26.3 23.6 12.9 24.7 22.8 43.7 37.8 18.7 21.8 21.0 40.7 34.7 35.8 57.1 17.7 26.2 48.1 36.6 16.1 17.7 40.9 25.4 25.1 16.1 24.8 13.8 33.8 24.9 23.0 18.6 31.1 12.1 14.5 29.2 13.9 25.8 24.3 36.9 16.9 12.7 28.8 26.1 21.1 47.4 33.7 32.9 25.9 17.0 42.4 14.0 38.1 27.7 46.7 7.4 19.4 33.3 27.3 15.6 33.0 18.6 15.1 15.7 49.7 16.5 20.8 25.3 47.8 16.1 38.0 18.2 8.9 12.5 8.5 22.6 24.5 38.8 10.2 21.8 18.7 34.8 21.2 37.6 43.7 32.2 33.6 27.6 37.3 36.8 40.7 2.8 21.0 12.4 37.8 20.6 34.7 37.3 78.7 16.1 46.5 34.8 32.7 36.1 38.2 32.7 28.7 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714407 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome 17000 Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: " "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favourable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 8.8 13.8 24.8 6.6 29.4 2.9 11.4 24.1 32.9 14.1 8.9 9.6 8.2 6.8 17.1 16.7 10.2 23.0 8.3 29.9 19.9 21.4 22.7 8.1 9.6 5.5 20.2 16.0 25.2 9.9 18.9 21.0 7.7 17.6 12.1 7.7 21.5 8.8 14.5 7.9 7.9 6.4 13.4 14.2 5.3 9.0 13.6 9.3 4.1 17.3 5.5 7.2 16.0 13.8 5.0 7.8 14.9 8.1 4.5 11.1 5.8 8.5 14.8 20.4 14.9 9.5 14.2 3.6 6.8 10.4 8.3 9.1 5.1 4.4 3.6 6.6 11.0 6.4 7.7 9.1 10.4 9.3 8.0 5.8 10.6 4.8 10.3 2.7 5.8 7.2 7.7 11.5 6.8 9.5 2.6 3.6 13.8 8.8 5.4 4.3 7.8 5.9 4.6 15.1 3.1 11.0 4.6 7.2 15.7 5.2 1.1 8.0 27.2 2.7 5.4 5.7 8.0 11.5 9.3 2.6 5.1 6.6 15.0 8.0 4.9 2.3 8.1 2.7 4.5 6.5 11.1 5.0 7.8 6.5 7.8 3.5 4.8 5.7 14.9 4.5 5.5 5.7 5.2 5.8 24.8 29.4 24.1 25.6 19.9 21.4 20.2 16.0 17.6 9.3 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell line enhanced" "Detected in many" "AN3-CA: 61.3;K-562: 72.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064513: " "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 22.6 3.6 12.3 6.7 6.7 30.8 21.5 3.0 15.8 16.9 19.4 3.2 7.4 11.3 13.6 9.9 23.5 11.0 7.5 7.0 6.0 4.6 5.2 6.6 8.6 9.5 10.3 11.0 5.2 3.5 1.8 5.6 19.2 8.5 12.0 13.7 4.0 39.0 6.8 4.2 34.9 44.6 12.8 6.5 9.5 10.3 71.2 6.7 3.7 8.8 9.2 6.5 10.5 25.0 22.8 7.4 3.3 15.4 6.5 17.6 7.3 10.0 10.7 28.7 61.3 4.6 7.7 0.0 4.1 3.8 6.8 4.1 9.5 7.6 0.0 1.8 5.8 2.9 6.3 5.2 6.9 2.2 4.7 2.1 14.1 8.8 9.6 8.8 3.7 3.4 20.9 3.9 17.7 16.1 72.8 9.9 6.9 4.3 0.4 12.5 10.4 12.4 0.0 10.0 4.7 8.9 4.9 5.2 4.9 6.8 7.2 1.4 3.5 7.3 5.6 2.7 9.6 10.2 16.6 4.5 5.9 2.3 7.1 3.7 10.8 3.3 7.8 0.3 6.3 13.0 17.6 21.4 15.0 9.7 7.4 22.8 7.4 6.1 1.1 6.5 15.4 6.6 8.9 7.3 12.3 6.7 3.0 15.8 6.0 4.6 10.3 11.0 8.5 6.7 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497053 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 74.3;U-2197: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavourable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavourable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (6.99e-5)" 9.3 6.8 11.1 17.7 9.6 30.3 12.8 19.2 21.2 6.4 6.2 4.9 3.1 3.9 3.6 9.4 13.9 7.6 19.2 3.6 9.1 16.5 8.5 7.9 9.9 28.9 9.4 11.8 2.6 3.6 0.8 5.4 16.8 23.9 6.7 7.4 5.9 14.2 3.6 1.7 15.1 8.1 3.6 5.3 28.0 7.9 1.9 1.8 44.7 2.5 4.4 20.1 14.0 10.8 5.9 17.8 18.7 0.5 18.2 29.7 8.7 7.4 23.0 3.0 0.3 2.7 0.8 7.6 0.7 3.4 0.9 1.7 10.6 14.6 0.0 1.9 1.9 5.6 3.0 15.9 1.1 6.9 1.0 0.0 0.1 0.1 2.8 0.0 0.6 1.7 10.6 9.0 5.5 1.5 0.1 24.7 4.2 1.0 21.4 0.0 3.0 5.2 0.0 13.2 4.2 74.3 8.3 10.8 1.9 0.2 1.7 1.1 0.2 0.4 3.4 14.9 5.7 40.7 14.3 12.3 4.4 0.3 25.5 0.0 7.7 18.7 0.4 8.4 29.7 0.5 29.2 5.9 20.7 23.5 3.2 5.7 18.7 20.9 0.7 18.2 0.2 17.8 25.8 8.7 11.1 9.6 19.2 21.2 9.1 16.5 9.4 11.8 23.9 1.8 ARL4D ARF4L ENSG00000175906 "ADP ribosylation factor like GTPase 4D" P49703 17 43398959-43401137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 25.6;hTCEpi: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory B-cell: 18.5;myeloid DC: 4.9;naive B-cell: 18.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 9.7;cerebral cortex: 11.2;hippocampal formation: 7.5;olfactory region: 8.6" HPA060379 Uncertain Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA060379: " "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (2.34e-2)" "prognostic favourable (1.16e-5)" "unprognostic (7.71e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.47e-1)" "unprognostic (4.59e-2)" "unprognostic (4.45e-1)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (7.87e-2)" "unprognostic (2.00e-3)" "unprognostic (3.49e-2)" "unprognostic (6.48e-2)" "unprognostic (1.27e-3)" "prognostic unfavourable (9.25e-4)" 7.4 3.3 2.5 3.4 6.4 0.8 6.7 3.7 8.9 20.9 10.4 1.1 4.6 1.5 15.2 6.6 38.4 15.6 7.0 6.8 2.6 2.0 21.6 26.0 6.0 1.2 1.3 2.8 12.6 1.5 1.1 15.1 6.9 2.3 10.8 2.7 22.0 14.0 11.6 2.9 16.8 2.2 22.0 1.0 9.0 3.3 17.3 0.5 0.5 52.5 13.9 10.5 23.3 14.5 18.9 4.9 1.1 2.4 1.1 3.3 2.6 3.6 4.6 2.9 2.2 5.5 7.7 1.3 9.0 9.3 6.4 8.3 4.1 16.2 0.0 4.5 9.6 10.0 1.9 13.7 4.4 0.8 3.2 0.3 3.8 9.4 25.6 1.0 0.9 8.6 33.3 9.3 20.2 2.7 0.6 0.2 6.2 0.2 2.2 2.0 3.0 4.3 3.8 0.6 0.4 10.7 8.0 3.4 2.4 7.0 0.1 6.5 13.3 3.6 0.5 9.2 3.0 11.9 2.6 0.9 0.4 0.0 11.4 0.8 3.0 0.0 1.6 1.1 3.2 2.4 2.0 18.5 2.7 2.9 4.9 18.9 3.0 3.3 0.0 1.1 0.8 1.4 0.6 2.6 2.5 6.4 3.7 8.9 2.6 2.0 1.3 2.8 2.3 0.5 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801242 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 5.5 9.2 8.8 3.6 18.6 1.6 6.0 10.0 17.7 6.5 4.9 5.0 7.3 2.7 7.9 7.3 5.3 11.9 6.2 5.9 17.1 11.0 13.2 4.4 8.4 3.9 8.9 14.1 6.4 5.6 22.6 22.3 5.0 12.9 7.1 4.6 7.3 9.1 6.5 2.9 5.2 3.2 7.2 8.0 4.7 5.0 10.9 9.0 4.2 9.1 2.0 3.8 5.6 5.1 2.7 1.0 0.5 1.0 4.1 4.8 1.6 7.6 4.3 3.9 3.3 9.9 7.0 1.0 5.0 4.7 4.4 5.7 1.6 3.1 4.2 4.8 2.4 3.7 5.0 5.7 9.0 5.1 3.0 1.2 3.2 1.7 4.8 5.2 2.7 3.6 4.1 5.9 1.5 4.3 1.4 0.8 7.1 2.7 2.9 2.5 4.9 4.9 1.5 4.1 2.5 5.0 2.2 21.6 11.5 4.3 3.0 9.0 3.5 2.0 3.2 4.4 3.9 3.8 6.6 3.4 4.1 4.8 8.1 2.9 5.3 0.5 0.5 0.2 2.4 0.7 4.8 1.9 2.1 2.5 0.9 2.7 3.6 3.0 0.0 4.1 1.0 1.0 3.6 1.6 8.8 18.6 10.0 17.7 17.1 11.0 8.9 14.1 12.9 9.0 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152761253 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.7;eosinophil: 45.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavourable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavourable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 6.1 5.1 8.4 4.2 10.1 14.5 9.4 6.6 11.4 4.7 5.7 10.1 7.9 6.5 5.6 2.5 7.8 5.1 5.6 3.2 11.4 4.9 3.3 2.3 7.2 7.2 15.9 7.4 6.9 3.3 2.6 8.3 10.2 12.9 4.6 4.1 3.4 4.9 4.8 9.7 8.2 6.1 4.7 12.4 8.7 6.0 7.3 13.5 2.5 4.1 4.6 5.4 6.3 18.9 5.7 7.4 50.7 3.5 2.6 5.6 3.6 8.3 5.2 12.6 3.5 3.1 3.8 19.5 10.3 4.2 8.6 10.8 13.6 12.3 14.8 10.3 4.4 9.6 6.6 4.5 9.0 23.1 14.1 12.1 5.2 12.0 4.2 9.9 11.3 2.8 5.3 9.3 7.5 6.4 13.4 9.5 6.6 6.0 10.2 10.7 12.2 11.6 11.8 12.5 11.9 3.6 6.2 11.0 11.9 9.4 0.9 8.2 4.2 7.5 8.9 13.8 9.4 9.6 9.0 9.1 9.1 11.9 6.6 8.5 11.3 50.7 2.8 45.4 4.1 3.0 4.2 5.7 4.2 4.1 3.2 4.9 4.3 3.7 7.5 2.6 3.5 7.4 5.6 3.6 8.4 10.1 6.6 11.4 11.4 4.9 15.9 7.4 12.9 13.5 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.3;REH: 8.5;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA072942: " "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.5 0.5 1.1 2.8 0.1 0.9 0.5 2.1 2.1 0.4 0.7 0.7 0.0 1.4 0.2 0.4 0.2 1.1 0.1 0.1 0.3 0.0 0.1 2.7 0.2 0.7 4.3 0.6 1.8 0.4 2.0 0.2 0.9 2.0 0.0 0.3 0.1 2.2 1.3 8.5 0.0 0.1 0.1 0.3 9.0 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.3 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;HSkMC: 9.5;MOLT-4: 6.5;U-698: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.1 3.8 7.2 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.7 0.0 0.0 9.5 2.3 0.1 1.3 0.7 0.1 4.4 1.1 0.4 6.5 0.8 0.5 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.1 0.0 0.0 0.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.1 0.3 3.9 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: " "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favourable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 8.3 8.1 6.6 8.1 11.6 35.3 8.4 13.1 13.6 5.3 5.7 7.8 5.5 9.7 9.1 6.0 8.4 7.1 4.9 6.6 8.4 7.5 6.7 16.1 8.4 7.3 8.9 5.4 8.6 9.3 9.2 9.4 7.3 9.1 7.2 2.9 6.5 10.4 5.8 14.2 13.2 8.3 4.5 5.9 8.6 8.0 6.0 8.9 6.8 9.9 6.8 5.3 5.1 16.8 4.0 10.0 2.8 3.1 9.8 4.9 3.2 2.9 4.6 2.0 2.9 1.3 1.0 5.2 3.8 1.7 2.3 1.9 4.3 3.0 2.8 8.1 2.1 4.4 2.3 3.5 0.4 4.0 5.9 1.2 7.0 9.9 2.5 8.6 8.8 2.3 4.0 2.2 0.6 3.4 6.3 7.0 1.5 7.3 3.3 34.7 3.3 2.9 5.8 2.9 10.6 1.7 3.4 6.6 5.8 3.5 4.8 2.6 3.1 10.3 6.4 4.9 3.6 2.0 3.1 6.4 5.5 1.8 3.2 7.3 3.4 2.8 3.1 0.9 4.9 1.6 4.1 4.0 3.8 3.8 4.1 3.5 3.4 3.8 1.8 9.8 1.7 10.0 4.6 3.2 6.6 11.6 13.1 13.6 8.4 7.5 8.9 5.4 9.1 8.9 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: " "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavourable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.2 9.9 13.1 10.6 16.5 14.6 17.6 15.7 15.2 21.5 21.1 15.5 10.7 19.1 16.2 13.5 10.6 16.8 15.3 26.7 12.8 11.8 34.0 6.6 10.5 20.9 26.3 38.2 21.7 9.8 13.8 19.9 16.7 12.7 10.9 26.6 17.7 18.4 12.4 18.1 8.7 14.5 21.0 15.2 14.1 18.9 15.2 11.1 22.5 7.8 13.0 15.5 14.0 18.1 11.5 9.4 15.2 11.5 20.9 15.9 29.3 10.4 12.6 11.4 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;ASC TERT1: 23.8;BJ hTERT+ SV40 Large T+ RasG12V: 27.3;LHCN-M2: 24.0;RH-30: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005685, CAB020695" Supported Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "CAB020695: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favourable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.5 0.0 26.4 23.8 0.0 8.6 16.9 10.8 27.3 0.0 0.1 0.0 7.4 13.2 0.7 0.0 1.2 6.1 0.0 0.0 4.9 1.6 0.0 14.0 0.0 0.0 19.9 1.6 8.2 0.0 6.5 0.1 0.1 24.0 0.3 0.0 0.0 7.9 0.0 0.0 30.3 0.0 7.4 0.0 5.4 4.5 0.0 0.1 14.8 0.8 3.6 8.6 6.6 3.5 19.1 0.1 0.0 0.1 0.0 6.4 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favourable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 15.0 0.1 13.4 12.2 0.1 16.4 20.6 0.4 0.4 0.0 6.3 0.0 0.0 21.5 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.6 0.0 14.1 0.1 0.0 19.2 5.2 12.8 0.1 17.4 0.0 0.1 48.4 0.0 0.0 0.2 34.8 0.1 4.1 26.7 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 7.6 0.0 3.8 18.5 19.7 11.5 0.1 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: " "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favourable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.7 6.0 16.2 9.0 37.5 41.8 3.6 19.3 18.7 8.5 24.7 7.1 8.2 3.4 11.1 22.5 1.7 12.2 7.1 10.4 6.7 7.7 6.2 20.2 10.1 29.7 6.0 14.9 23.1 9.5 10.2 11.0 16.1 4.8 30.0 23.1 3.9 5.0 0.2 8.3 1.3 6.4 21.2 3.0 11.9 3.6 7.6 6.4 9.3 0.6 20.0 7.1 6.2 22.5 11.3 7.4 25.5 3.7 24.3 6.5 0.0 17.2 4.9 9.5 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: " "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favourable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.1 0.0 3.9 4.1 0.8 5.5 4.4 4.5 8.9 1.9 0.8 0.0 2.2 8.1 0.9 0.0 0.1 7.5 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 9.8 0.0 7.9 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.0 0.4 6.7 0.0 1.2 1.4 5.5 5.1 0.8 0.0 3.0 0.6 1.2 2.9 2.1 1.3 6.3 0.0 0.0 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 ARMCX5 "FLJ12969, GASP5" ENSG00000125962 "Armadillo repeat containing, X-linked 5" Q6P1M9 X 102599168-102604159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000996 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane" "HPA000996: AB_1078212" "unprognostic (7.71e-2)" "unprognostic (2.43e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (1.54e-1)" "unprognostic (5.05e-2)" "unprognostic (4.07e-2)" "prognostic favourable (6.58e-5)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (2.83e-1)" "unprognostic (3.28e-3)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (2.83e-1)" "unprognostic (5.24e-2)" 8.6 13.2 11.4 7.0 17.3 6.4 13.8 24.3 19.8 11.2 9.5 8.7 13.1 7.9 13.3 12.5 10.1 11.9 7.5 7.8 11.1 6.3 10.0 15.5 8.3 6.9 8.1 12.9 16.5 25.3 14.5 26.4 6.1 12.8 16.6 11.9 9.2 13.4 11.0 6.1 9.9 10.4 10.8 7.0 10.2 11.7 6.1 8.4 9.5 15.3 7.0 9.6 10.4 9.8 9.7 9.3 2.5 9.8 7.1 15.9 8.5 8.0 7.3 17.2 9.1 7.7 8.7 9.7 7.9 6.1 9.3 16.6 8.6 10.0 0.0 9.7 7.9 7.0 15.3 7.5 10.6 0.0 6.1 8.1 9.2 7.1 10.0 14.7 9.5 10.8 9.8 8.0 9.7 9.4 7.8 0.0 12.3 7.1 10.4 1.7 7.7 13.8 10.3 42.2 0.0 6.9 11.2 8.2 7.3 14.2 7.4 11.3 5.1 7.1 9.5 6.9 6.2 7.8 5.6 0.0 5.7 0.0 5.4 15.1 17.7 0.0 9.5 2.5 12.0 9.8 11.5 9.7 11.3 9.4 9.3 6.0 15.9 12.3 0.8 7.1 6.0 8.1 7.7 8.5 11.4 17.3 24.3 19.8 11.1 6.3 8.1 12.9 12.8 8.4 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: , HPA048125: " "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.8 12.3 7.0 25.2 15.0 2.4 13.9 13.6 12.5 24.5 4.7 6.4 7.1 14.3 13.0 6.9 11.9 5.6 9.8 6.1 7.3 6.6 10.9 6.2 11.6 6.4 8.4 9.3 5.8 7.7 4.0 12.7 5.4 9.1 18.7 16.3 9.4 0.0 8.8 1.6 9.7 16.5 2.6 9.0 0.9 6.8 6.4 8.2 0.0 10.4 5.7 3.1 9.8 15.3 6.9 21.2 3.2 11.3 6.0 0.0 4.5 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" 3200000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavourable (7.09e-4)" "prognostic favourable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 15.5 15.8 10.7 11.5 16.2 3.9 20.5 17.5 18.2 13.7 12.8 7.5 9.9 14.7 13.0 13.4 11.5 10.6 9.0 13.4 11.4 13.0 34.7 33.2 15.4 15.0 10.9 8.6 15.3 7.7 7.7 13.8 26.7 18.6 11.6 14.2 9.2 8.8 10.6 14.9 7.0 16.2 11.8 10.6 16.2 10.9 10.8 9.4 13.2 26.5 11.9 14.0 14.1 10.6 9.6 12.3 26.9 18.6 10.8 13.2 10.8 8.1 6.3 13.2 11.8 10.8 17.0 21.2 15.3 13.4 12.9 17.1 16.2 6.7 12.2 10.3 10.8 8.3 38.8 11.4 21.8 13.4 12.2 8.8 7.5 18.8 13.4 16.5 11.1 13.7 8.1 17.2 10.2 18.2 12.6 15.7 16.0 33.9 10.3 15.8 22.4 5.3 13.6 11.4 9.6 39.4 10.4 5.5 3.5 12.8 12.1 7.8 34.2 13.0 15.0 6.3 8.8 23.3 12.1 7.3 9.2 14.5 11.2 20.4 7.4 22.8 14.7 26.9 7.8 18.6 10.3 9.6 10.2 8.3 12.3 7.1 9.5 8.7 12.2 10.8 16.6 4.6 13.2 10.8 10.7 16.2 17.5 18.2 11.4 13.0 10.9 8.6 18.6 9.4 ARNT "bHLHe2, HIF-1beta" ENSG00000143437 "Aryl hydrocarbon receptor nuclear translocator" P27540 1 150809705-150876768 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "U-698: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001759, CAB004318" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB004318: AB_626698, HPA001759: AB_1078213" "unprognostic (1.81e-1)" "unprognostic (8.14e-2)" "unprognostic (6.87e-2)" "unprognostic (5.76e-2)" "unprognostic (1.86e-1)" "unprognostic (4.10e-2)" "unprognostic (9.43e-2)" "unprognostic (5.27e-3)" "unprognostic (5.05e-1)" "unprognostic (3.42e-2)" "unprognostic (1.22e-1)" "unprognostic (9.52e-2)" "unprognostic (1.85e-3)" "unprognostic (2.68e-1)" "unprognostic (4.67e-1)" "unprognostic (6.45e-2)" "unprognostic (6.92e-2)" 23.5 20.8 12.1 14.5 12.6 11.3 25.1 25.4 14.4 28.0 17.2 18.7 12.8 10.9 26.1 14.4 16.6 20.4 17.9 20.0 10.2 8.2 14.4 32.2 21.6 12.0 11.6 9.5 31.8 22.4 16.5 22.9 31.7 12.3 18.2 16.4 28.3 15.2 16.3 25.5 21.9 15.2 22.6 14.0 19.2 16.5 14.9 12.3 18.8 16.1 13.9 18.0 23.0 24.4 6.6 12.7 23.9 15.6 8.0 8.8 9.7 4.0 4.1 6.2 4.7 13.4 12.9 8.4 4.5 9.0 6.2 5.7 3.5 4.1 4.2 4.1 8.1 4.6 5.6 5.1 5.4 6.7 3.4 5.0 7.0 4.1 7.7 6.0 5.9 10.0 4.8 7.5 6.7 7.6 6.5 8.5 6.4 7.8 4.8 3.3 5.1 3.2 6.0 7.5 6.0 4.9 4.1 4.1 6.1 8.8 6.0 3.5 7.7 13.1 5.4 5.2 4.6 4.1 3.9 9.7 7.0 94.7 6.3 0.2 3.5 23.9 15.6 13.9 8.8 14.7 7.9 6.2 7.2 8.4 12.7 6.6 7.0 7.1 8.1 8.0 14.7 5.2 7.2 9.7 12.1 12.6 25.4 14.4 10.2 8.2 11.6 9.5 12.3 12.3 ARNTL "bHLHe5, BMAL1, JAP3, MOP3, PASD3" ENSG00000133794 "Aryl hydrocarbon receptor nuclear translocator like" O00327 11 13276652-13387266 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045962, HPA050938" Supported Supported Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "CAB045962: AB_11124144, HPA050938: " "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (9.00e-2)" "unprognostic (1.77e-1)" "unprognostic (3.72e-1)" "unprognostic (3.76e-2)" "unprognostic (8.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (2.10e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (7.08e-2)" 12.3 28.5 13.4 10.3 13.3 13.4 18.2 24.4 25.2 16.4 10.3 5.7 10.6 11.8 10.4 6.5 9.3 9.7 9.4 8.1 11.5 7.5 11.1 17.3 12.1 15.0 6.7 13.1 21.1 9.8 6.1 17.8 9.2 9.3 7.5 8.9 8.6 11.2 8.2 19.2 27.2 10.9 11.7 9.6 10.4 9.6 16.2 9.3 29.2 17.6 0.7 12.2 8.1 17.0 2.8 6.1 20.0 7.8 9.8 19.7 7.3 6.8 6.6 6.1 4.1 11.8 7.6 4.8 6.9 7.4 6.8 8.0 3.3 10.0 0.1 2.2 5.2 2.6 4.8 8.2 5.9 11.7 5.0 3.1 5.4 1.7 21.1 1.4 13.0 9.4 21.7 2.5 18.2 4.8 1.8 12.2 6.8 3.7 3.2 0.7 1.7 3.6 4.2 7.7 3.3 6.6 1.6 1.3 11.9 5.7 2.0 6.6 4.4 5.8 9.3 7.1 5.5 16.7 3.9 3.5 9.4 0.0 7.0 3.6 6.1 4.4 6.7 13.7 14.3 6.9 19.7 2.4 13.4 12.9 6.1 2.8 7.8 9.1 20.0 9.8 7.8 1.1 8.5 7.3 13.4 13.3 24.4 25.2 11.5 7.5 6.7 13.1 9.3 9.3 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0" "Cell line enhanced" "Detected in many" "HDLM-2: 34.6;U-2197: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059074: " "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.5 1.3 5.7 9.8 5.9 2.2 3.3 3.6 10.6 6.8 3.1 1.1 0.0 2.9 1.5 0.5 30.0 1.5 3.9 1.9 9.1 2.8 1.6 10.3 2.7 5.0 2.1 6.8 0.9 2.3 2.4 1.5 14.7 2.6 1.9 3.5 0.0 9.2 0.9 1.0 7.7 2.8 4.7 2.0 1.2 10.9 2.8 1.3 3.8 1.2 15.4 21.1 5.9 12.5 0.6 1.4 4.5 0.5 0.5 1.5 0.2 21.5 5.5 1.2 0.4 1.1 3.3 17.4 7.6 10.1 5.0 7.9 5.2 16.8 0.1 4.3 3.6 8.9 3.6 26.8 12.8 34.6 4.6 4.1 3.6 4.3 1.4 8.3 1.8 1.2 2.4 17.5 13.7 23.5 2.1 8.8 5.7 2.6 4.5 4.6 9.5 19.4 8.5 20.3 1.3 4.2 12.4 4.0 0.6 3.9 0.6 0.1 0.8 2.7 15.9 16.3 9.4 47.3 31.6 1.3 2.3 0.0 14.0 6.8 3.2 4.5 0.5 0.5 0.2 0.3 0.2 0.5 0.2 0.2 1.4 0.6 0.2 0.3 2.4 0.5 0.2 0.3 1.5 0.2 5.7 5.9 3.6 10.6 9.1 2.8 2.1 6.8 2.6 1.3 ARPC1A "Arc40, SOP2Hs, SOP2L" ENSG00000241685 "Actin related protein 2/3 complex subunit 1A" Q92747 7 99325910-99366262 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004334 Approved Approved "Cell Junctions,Cytosol" 2400000 "Cell Junctions" Cytosol "HPA004334: AB_1078215" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (6.22e-3)" "unprognostic (1.93e-2)" "unprognostic (8.38e-3)" "unprognostic (1.95e-2)" "prognostic unfavourable (4.70e-4)" "unprognostic (2.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.89e-2)" "unprognostic (7.88e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (7.07e-2)" "unprognostic (1.83e-1)" 36.6 39.8 40.2 25.2 41.0 18.7 49.1 32.3 55.9 40.0 43.6 32.3 37.9 50.1 30.4 45.9 58.3 43.3 32.1 65.3 45.9 43.5 30.6 41.2 29.6 32.2 38.6 39.7 47.2 41.9 30.9 31.4 31.8 40.6 28.2 44.2 33.9 31.7 36.7 20.9 46.1 55.0 31.9 27.9 26.8 53.1 28.6 25.1 23.7 44.4 41.8 31.6 31.5 33.9 11.1 16.1 33.2 29.1 10.9 12.6 9.9 45.4 24.8 28.2 12.9 26.3 44.8 24.0 32.7 38.4 33.4 33.3 27.8 52.5 15.9 48.4 39.7 19.3 36.9 47.5 40.4 7.9 31.1 8.5 18.5 22.4 29.0 10.0 11.2 41.6 26.6 43.0 46.0 54.6 21.3 18.5 51.2 66.5 16.7 13.4 26.4 56.1 9.9 19.5 19.5 24.8 27.6 29.1 24.9 32.0 46.0 43.6 23.0 14.8 42.3 42.8 38.4 75.4 52.1 7.2 13.2 22.6 37.0 22.5 56.1 33.2 18.9 31.9 9.8 28.6 7.6 11.0 9.3 12.6 16.1 11.1 12.1 9.1 23.8 10.9 29.1 11.7 12.1 9.9 40.2 41.0 32.3 55.9 45.9 43.5 38.6 39.7 40.6 25.1 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394814 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 213.6" "Cell line enhanced" "Detected in all" "SK-MEL-30: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Approved Supported Vesicles,Cytosol 53000000 "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavourable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 31.8 17.8 8.7 50.7 14.4 56.4 35.4 1.9 7.7 17.9 30.7 8.4 18.1 32.6 17.4 21.8 16.0 18.3 23.4 24.4 5.7 7.0 27.9 34.8 40.0 92.8 10.7 3.7 11.6 13.0 3.8 13.1 36.2 9.4 15.6 10.5 20.6 18.3 15.1 10.6 10.0 42.3 12.1 10.2 81.8 16.3 10.8 9.3 31.0 23.0 13.7 37.2 19.0 21.1 53.5 133.7 127.2 154.4 38.9 83.4 213.6 15.7 28.6 2.2 6.2 8.3 30.2 21.9 21.9 22.1 8.8 7.8 18.6 61.4 27.3 41.0 23.8 11.9 2.8 19.3 3.6 22.2 10.3 19.9 8.3 12.8 24.0 19.9 67.8 16.8 10.0 12.4 12.4 23.2 22.1 66.0 12.8 72.7 22.0 43.6 7.8 62.4 17.8 1.9 67.0 18.2 7.8 1.8 5.8 14.9 65.8 110.1 15.5 40.6 34.0 25.2 20.9 44.4 27.5 12.3 24.4 33.5 25.1 52.0 45.1 53.7 153.2 121.6 53.8 154.4 50.2 53.5 62.8 59.6 133.7 42.8 37.0 49.3 127.2 38.9 142.0 77.9 83.4 213.6 8.7 14.4 1.9 7.7 5.7 7.0 10.7 3.7 9.4 9.3 ARPC2 "ARC34, p34-Arc" ENSG00000163466 "Actin related protein 2/3 complex subunit 2" O15144 2 218217094-218254356 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001994, HPA008352" Approved Supported "Golgi apparatus,Cytosol" 24000000 Cytosol "Golgi apparatus" "CAB001994: , HPA008352: AB_1854887" "unprognostic (7.42e-2)" "unprognostic (4.07e-1)" "unprognostic (1.50e-1)" "unprognostic (3.28e-3)" "unprognostic (2.77e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (3.95e-3)" "unprognostic (6.25e-2)" "prognostic unfavourable (1.07e-7)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (7.41e-2)" 46.9 28.8 32.6 78.6 37.9 79.5 67.1 19.3 31.4 34.1 42.5 19.9 26.3 34.0 37.2 35.8 103.4 30.2 51.2 52.3 40.7 25.0 38.2 35.1 71.8 118.3 26.4 27.8 30.7 31.2 18.9 23.0 67.1 26.8 35.6 48.6 23.7 39.0 32.7 60.1 56.2 59.2 69.1 23.9 73.7 43.8 36.5 22.3 59.0 27.2 72.7 102.5 58.5 49.7 60.6 101.2 167.7 145.0 50.0 76.2 149.4 46.7 20.5 29.5 21.9 39.6 53.3 54.9 73.1 70.6 61.8 62.2 63.5 49.8 38.2 39.9 83.1 54.5 39.9 108.1 72.9 31.8 28.4 38.8 31.0 34.8 44.4 80.9 109.7 35.4 87.5 61.8 51.3 80.6 18.3 75.6 94.7 32.4 43.9 94.9 35.1 20.0 33.5 26.1 52.0 62.2 85.3 17.4 31.7 26.6 29.6 62.8 21.4 74.5 70.1 80.5 30.8 36.1 54.7 41.2 43.6 66.7 58.3 50.9 60.5 106.1 97.2 143.7 75.0 131.3 50.2 60.6 58.9 72.7 101.2 47.6 42.1 62.0 167.7 50.0 145.0 56.1 76.2 149.4 32.6 37.9 19.3 31.4 40.7 25.0 26.4 27.8 26.8 22.3 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 50.8 28.2 24.3 16.7 20.1 28.7 58.2 69.9 53.9 30.5 24.9 25.5 36.1 46.8 79.6 40.2 35.4 17.1 23.8 16.1 67.4 15.3 28.3 38.4 22.0 32.7 41.0 55.2 34.7 25.4 36.9 29.4 35.7 21.5 38.8 39.5 20.9 38.2 11.0 23.2 10.8 35.6 21.6 45.2 17.1 26.4 10.5 28.3 72.9 31.5 27.0 31.6 36.7 79.5 44.6 23.2 49.8 67.3 46.3 51.1 32.0 35.1 29.6 34.2 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6" "Group enriched" "Detected in some" 8 "MOLT-4: 34.9;REH: 19.4;RH-30: 11.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enriched" "Detected in all" 5 "basal ganglia: 146.9" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017303 Enhanced Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 1.2 1.3 12.3 1.5 146.9 4.6 1.1 27.8 67.9 1.1 1.4 0.3 0.0 1.3 1.1 1.1 3.2 1.1 1.1 1.1 6.8 2.8 2.0 2.9 1.2 1.2 3.9 11.5 1.1 1.1 1.1 1.9 1.1 6.7 2.0 1.5 0.0 1.1 1.3 43.6 1.1 1.4 1.1 0.8 1.2 1.1 1.1 14.8 41.2 1.5 3.5 1.5 1.1 0.1 0.1 12.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 34.9 0.0 0.0 1.4 19.4 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 12.3 146.9 27.8 14.7 6.8 2.8 3.9 11.5 6.7 14.8 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960698-97973838 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;BJ: 38.5;HSkMC: 21.7;hTCEpi: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 9.2 9.3 11.4 11.5 18.4 6.7 14.8 3.3 16.3 9.4 27.4 67.3 11.6 11.2 10.7 11.9 11.8 10.8 14.7 9.7 18.7 9.2 14.1 21.8 14.1 6.4 18.1 15.2 7.4 25.0 3.7 6.5 13.0 29.4 8.3 17.0 4.6 6.5 13.5 10.1 25.3 15.3 14.0 48.7 5.9 18.1 10.2 41.9 1.9 14.9 4.5 3.5 11.7 12.4 0.5 2.4 3.1 5.1 0.1 0.1 0.8 2.1 0.0 0.3 5.6 2.5 18.7 0.0 38.5 17.2 5.1 2.3 2.3 1.3 0.0 5.4 1.7 2.2 1.4 13.4 8.3 0.0 3.6 3.7 0.7 1.5 1.0 2.5 5.8 21.7 33.3 5.8 6.9 0.2 5.1 0.0 1.8 6.9 0.4 2.1 1.1 0.8 0.0 0.3 0.0 10.0 4.7 1.9 3.3 5.8 2.1 10.4 0.8 3.9 0.0 1.5 1.1 8.0 1.8 0.0 0.0 0.0 3.3 0.4 4.0 2.3 5.1 3.1 0.1 3.6 0.0 0.5 0.0 0.0 2.4 0.4 0.1 0.0 3.0 0.1 0.6 0.6 0.0 0.8 11.4 18.4 3.3 16.3 18.7 9.2 18.1 15.2 29.4 41.9 ARSA ENSG00000100299 "Arylsulfatase A" P15289 22 50622754-50628173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005554, CAB025183" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 4500000 "Golgi apparatus" Cytosol "CAB025183: , HPA005554: AB_1078220" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (4.07e-2)" "prognostic favourable (2.96e-5)" "unprognostic (4.66e-2)" "unprognostic (4.40e-1)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.61e-2)" "unprognostic (2.16e-1)" "unprognostic (4.47e-2)" "unprognostic (2.76e-1)" "unprognostic (9.90e-2)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (7.73e-3)" 19.0 15.2 14.0 15.2 15.7 16.6 15.2 11.9 17.9 12.0 20.3 21.4 26.4 30.2 13.3 21.4 15.6 18.5 23.3 18.8 13.4 8.8 17.5 24.1 15.7 16.8 19.1 10.3 9.3 45.4 13.1 20.4 18.5 17.3 15.8 8.8 14.0 36.8 21.9 6.3 11.1 23.4 8.7 13.2 25.6 23.6 27.2 17.9 10.6 18.7 7.5 16.5 14.8 13.3 5.6 15.7 30.1 19.8 3.9 8.9 7.7 4.0 5.7 2.8 5.3 20.5 11.2 6.9 6.6 8.0 2.9 4.9 1.6 6.3 2.7 4.0 10.7 6.3 0.6 6.0 0.4 1.2 4.3 1.6 6.4 5.7 14.2 2.4 16.8 13.3 11.8 4.7 3.0 6.4 1.7 38.4 5.8 4.6 2.1 2.7 0.8 5.6 1.9 0.2 12.6 4.8 6.3 1.3 4.2 9.3 8.3 4.7 3.7 3.0 11.3 2.0 7.8 7.4 1.9 9.1 0.8 2.1 5.9 2.1 6.7 4.3 13.7 17.1 8.9 16.0 7.9 5.6 6.5 7.3 11.2 5.6 3.9 5.3 30.1 3.9 19.8 15.7 8.5 7.7 14.0 15.7 11.9 17.9 13.4 8.8 19.1 10.3 17.3 17.9 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903970-2929351 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: " "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favourable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favourable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.1 5.6 3.7 10.1 3.5 2.3 14.2 3.2 5.0 14.7 15.4 5.8 27.4 11.9 8.9 19.2 9.3 16.6 16.8 8.7 5.7 3.6 34.1 23.8 13.1 11.3 3.1 3.3 13.0 48.1 8.5 3.9 16.2 8.7 11.5 8.5 7.8 15.8 30.9 1.6 5.9 22.3 12.0 4.5 5.7 19.5 5.2 3.3 1.8 12.9 5.6 7.1 12.4 6.9 2.1 6.3 5.7 8.5 3.0 2.6 3.2 4.5 8.1 2.2 10.5 9.5 5.5 0.1 2.6 4.8 1.2 0.8 0.5 15.7 0.0 16.9 5.3 0.0 0.4 1.3 1.1 0.1 0.0 0.0 0.0 2.6 5.2 0.0 6.3 8.6 4.3 2.3 2.5 7.8 0.0 0.0 5.2 11.0 0.0 1.1 1.8 3.4 1.9 0.0 0.1 8.4 0.1 0.0 5.9 3.6 4.3 2.7 11.6 8.7 7.1 0.0 0.3 0.8 1.2 0.1 0.0 0.0 7.7 5.5 5.9 2.1 8.5 5.7 2.6 7.1 1.0 2.1 1.3 2.0 6.3 1.4 0.3 1.5 1.5 3.0 2.7 4.4 0.4 3.2 3.7 3.5 3.2 5.0 5.7 3.6 3.1 3.3 8.7 3.3 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555074-95605064 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 8.5 10.2 6.9 4.8 7.6 4.7 7.6 14.2 12.3 8.9 8.6 4.3 9.6 5.1 8.5 9.6 6.7 7.4 6.9 8.5 7.9 7.1 11.5 9.7 7.4 5.6 8.4 9.9 12.8 11.7 29.3 14.5 11.2 7.2 10.7 5.9 7.3 6.7 11.2 5.5 8.4 5.4 6.7 8.8 5.5 9.7 4.5 7.5 10.6 15.8 2.8 4.5 9.2 14.0 6.7 2.7 10.0 1.6 3.9 9.2 2.3 3.3 2.1 4.6 4.6 22.8 11.9 6.6 10.7 6.2 4.2 8.7 2.7 5.3 4.6 5.6 3.6 3.2 4.0 6.8 9.3 4.9 5.8 3.7 5.5 4.4 6.6 2.0 3.0 8.7 6.1 6.4 4.1 6.8 3.7 5.0 9.3 1.6 5.5 3.9 5.9 10.4 3.4 7.3 7.2 9.7 0.8 3.2 3.3 6.6 2.2 6.4 6.1 2.1 12.2 6.7 5.4 10.3 6.5 4.3 7.3 5.5 6.6 5.4 24.8 10.0 1.6 2.5 5.3 1.5 6.1 5.3 6.0 6.7 0.8 6.7 9.2 6.9 1.5 3.9 1.0 2.7 4.5 2.3 6.9 7.6 14.2 12.3 7.9 7.1 8.4 9.9 7.2 7.5 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell line enhanced" "Detected in many" "K-562: 15.4;SCLC-21H: 14.7;SH-SY5Y: 11.3;U-2 OS: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: , HPA063675: " "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favourable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.2 0.3 4.4 5.7 0.0 0.0 4.6 0.8 0.3 0.2 0.5 0.9 0.7 1.3 3.6 0.4 3.0 0.7 1.4 0.0 0.4 5.5 0.4 0.3 3.4 1.3 0.4 1.0 0.1 0.5 0.2 0.2 3.6 15.4 0.4 0.0 2.9 0.2 2.0 4.5 1.8 8.2 0.2 0.4 0.8 0.7 14.7 11.3 0.9 1.4 2.2 1.2 0.3 1.3 0.1 12.9 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 ASAP1 "CENTB4, DDEF1, KIAA1249, PAP, ZG14P" ENSG00000153317 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 1" Q9ULH1 8 130052104-130443660 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 61.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 13.0;monocytes: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011136, CAB037292, HPA048565" Approved Approved "Plasma membrane,Centrosome,Cytosol" 25000 "Plasma membrane, Centrosome, Cytosol" "CAB037292: AB_476723, HPA011136: , HPA048565: " "unprognostic (1.20e-2)" "unprognostic (1.15e-2)" "unprognostic (7.68e-2)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.77e-1)" "unprognostic (3.33e-2)" "prognostic unfavourable (5.63e-8)" "prognostic unfavourable (3.56e-5)" "unprognostic (3.34e-1)" "unprognostic (5.27e-2)" "unprognostic (8.56e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.50e-7)" "unprognostic (3.79e-2)" "unprognostic (1.19e-1)" "unprognostic (7.38e-2)" "unprognostic (1.22e-3)" 34.1 17.2 10.5 9.5 12.5 29.7 19.8 6.4 21.8 19.3 8.9 9.1 6.6 4.4 15.6 18.9 10.5 11.8 14.5 17.5 10.0 11.0 7.9 7.6 26.2 12.9 11.3 8.0 15.2 6.8 21.7 8.2 27.3 15.2 9.9 7.2 13.9 6.2 13.9 13.0 12.1 8.4 16.6 11.9 26.1 8.0 21.7 9.7 5.6 12.3 10.6 14.5 12.9 21.2 1.5 4.1 13.0 6.6 0.7 1.6 1.1 15.3 11.5 16.8 9.5 14.6 21.7 13.5 16.4 28.7 20.1 21.5 5.8 5.8 3.5 11.7 23.8 3.9 8.6 14.4 28.1 5.5 5.2 6.1 6.7 7.4 37.6 2.6 1.9 20.4 4.8 10.6 17.7 21.0 3.1 14.1 17.5 4.6 3.5 2.7 4.2 10.5 4.9 3.0 2.4 5.1 8.3 4.8 15.7 12.1 7.4 8.7 6.2 6.0 61.6 16.1 7.8 6.3 24.1 13.0 3.0 2.5 11.9 3.8 17.9 0.0 2.4 1.6 0.7 2.4 0.4 1.5 1.2 1.0 4.1 1.3 1.6 1.0 13.0 0.7 6.6 0.4 0.8 1.1 10.5 12.5 6.4 14.6 10.0 11.0 11.3 8.0 15.2 9.7 ASAP3 "CENTB6, DDEFL1, FLJ20199, UPLC1" ENSG00000088280 "ArfGAP with SH3 domain, ankyrin repeat and PH domain 3" Q8TDY4 1 23428563-23484568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;ASC TERT1: 18.3;HSkMC: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Lineage enhanced" "Detected in single" "monocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020537, HPA020546" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA020537: , HPA020546: " "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (4.35e-3)" "prognostic unfavourable (5.56e-4)" "unprognostic (3.87e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "prognostic favourable (2.80e-4)" "unprognostic (1.88e-2)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.24e-1)" "unprognostic (1.18e-1)" "prognostic favourable (5.12e-5)" "unprognostic (3.39e-3)" "unprognostic (3.92e-2)" "unprognostic (2.02e-2)" "unprognostic (7.27e-2)" 10.6 15.5 8.7 5.9 9.9 0.7 15.2 2.6 8.3 11.0 8.9 6.6 13.5 2.4 7.9 7.7 12.9 8.7 7.8 20.7 6.9 5.1 10.7 7.4 7.9 2.3 9.2 6.1 29.6 13.7 13.7 7.4 12.4 16.3 12.0 6.8 8.2 14.6 25.5 24.2 32.5 3.7 9.9 15.4 1.9 8.9 9.4 6.7 0.2 12.0 12.0 6.2 7.0 17.7 0.1 0.0 0.0 1.6 0.0 0.4 0.4 1.0 1.0 10.4 6.8 19.3 18.3 12.9 1.9 2.2 2.9 3.8 0.7 0.0 5.3 2.2 3.6 4.9 7.2 1.7 1.7 0.2 0.9 0.3 2.8 6.6 10.4 0.0 0.5 23.3 2.6 4.7 4.2 2.2 3.6 0.0 1.8 2.2 0.7 0.0 1.8 2.4 2.7 1.1 0.0 2.0 2.1 0.3 3.5 8.2 2.0 2.0 7.8 0.0 0.8 1.2 3.1 3.5 0.1 2.3 2.3 0.6 0.5 0.0 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.4 8.7 9.9 2.6 8.3 6.9 5.1 9.2 6.1 16.3 6.7 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.7;RPMI-8226: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA048293: , HPA061742: " "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 7.7 14.0 5.8 5.8 7.3 2.7 10.8 12.2 18.2 7.4 23.7 7.3 6.9 21.6 6.5 11.0 7.5 11.8 9.6 7.9 5.3 5.8 18.4 28.5 5.4 14.7 5.8 5.5 13.6 8.4 2.8 5.9 3.3 8.7 6.7 5.9 41.1 6.1 6.3 8.1 8.1 26.4 5.1 5.1 7.0 6.9 4.7 4.9 2.1 4.6 7.0 11.7 9.3 8.6 2.3 10.8 0.4 9.5 0.8 3.5 5.2 4.6 6.1 2.7 11.7 11.4 3.1 4.6 0.8 2.2 2.7 3.5 5.1 9.1 29.7 7.3 1.8 7.4 6.1 6.1 0.5 1.4 10.4 4.2 3.7 4.0 7.3 3.8 0.4 5.0 9.9 1.6 2.3 2.4 5.2 0.6 0.8 3.4 4.6 3.5 5.6 3.7 1.9 0.2 31.6 3.8 7.6 5.3 12.3 5.8 3.8 9.3 12.2 5.0 0.6 1.6 2.9 7.0 2.4 1.4 3.6 19.9 5.2 10.0 1.3 0.0 9.5 0.2 1.2 6.7 2.1 1.5 3.5 1.5 10.8 2.3 3.5 1.6 0.4 0.8 5.0 0.3 0.9 5.2 5.8 7.3 12.2 18.2 5.3 5.8 5.8 5.5 8.7 4.9 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell line enhanced" "Detected in some" "Karpas-707: 8.6;RPMI-8226: 7.8;U-266/70: 23.4;U-266/84: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favourable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 23.4 5.2 0.8 0.2 2.4 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602534-100651705 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 8.6 8.9 8.9 15.5 11.9 20.2 10.2 12.7 10.2 10.3 12.1 8.1 13.5 8.3 11.6 12.5 10.0 10.9 9.5 7.0 10.4 8.3 12.5 12.1 8.8 12.9 10.6 6.7 11.2 11.0 13.7 11.8 14.0 9.4 10.1 11.8 7.6 10.3 11.3 8.0 9.5 15.5 11.2 9.7 10.4 8.3 13.8 9.2 21.2 11.5 9.6 11.1 11.6 9.2 6.6 7.0 13.6 8.0 5.5 9.4 6.3 6.2 13.9 6.4 7.6 8.5 9.2 7.4 6.9 12.5 11.6 12.1 8.3 12.7 10.2 6.4 8.8 13.9 8.9 9.0 12.1 7.2 9.5 13.6 9.2 8.2 12.9 7.9 12.0 8.8 10.1 9.4 15.6 10.6 8.0 8.6 6.5 6.7 6.1 8.0 6.1 6.8 8.5 13.9 8.5 11.4 14.1 6.4 9.1 10.6 10.4 14.3 7.3 10.0 8.0 10.2 9.5 7.0 9.6 10.4 21.4 9.8 7.8 7.3 8.0 1.7 8.0 13.6 7.6 6.5 6.1 6.3 6.7 9.3 7.0 6.6 9.4 6.7 7.3 5.5 4.1 4.5 7.7 6.3 8.9 11.9 12.7 10.2 10.4 8.3 10.6 6.7 9.4 9.2 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavourable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 17.2 23.3 23.2 13.3 25.9 10.9 20.9 27.4 23.8 21.2 12.4 25.7 19.6 9.5 16.9 21.3 16.4 17.2 16.0 26.4 24.7 21.6 18.6 24.3 12.7 19.8 35.2 14.9 21.9 24.8 19.3 22.0 14.5 28.2 15.4 12.9 13.1 11.9 19.5 25.7 14.8 12.5 18.0 35.4 16.9 13.7 20.9 34.5 20.8 17.8 9.4 20.9 18.0 15.7 24.9 22.9 25.4 14.9 19.7 24.2 14.6 13.2 17.4 13.3 25.1 18.4 19.3 10.2 8.1 17.3 13.8 17.0 18.9 47.8 17.9 16.6 11.7 17.2 10.6 16.2 14.9 12.6 9.4 11.3 14.4 17.4 16.6 12.3 11.9 18.1 35.6 14.8 20.8 16.8 15.5 22.4 14.7 12.6 16.1 17.0 7.0 4.2 9.1 10.7 13.1 23.7 8.9 12.6 9.0 11.2 28.9 21.8 9.9 8.4 16.0 7.0 13.3 5.5 8.5 13.9 17.9 21.7 11.3 28.1 5.4 16.5 14.9 25.4 14.5 14.7 14.4 24.3 17.2 15.2 15.1 24.9 24.2 21.9 9.4 19.7 11.5 22.9 21.6 14.6 23.2 25.9 27.4 23.8 24.7 21.6 35.2 14.9 28.2 34.5 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788608-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: " "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 19.5 24.2 13.1 22.1 15.1 32.3 23.1 13.4 14.0 16.8 16.9 17.9 22.5 16.5 17.1 17.7 31.1 14.6 19.0 17.7 10.8 8.2 15.8 35.3 19.2 20.2 15.4 9.1 16.2 18.4 17.5 20.6 23.2 12.5 20.1 17.8 17.6 22.2 30.9 50.0 21.7 22.3 14.2 12.9 22.7 25.8 41.0 13.0 28.9 21.9 25.0 26.6 19.1 21.2 11.3 21.1 28.5 27.6 17.3 18.8 10.9 19.6 11.5 12.5 16.9 18.7 16.7 17.9 20.5 15.8 21.4 21.4 13.3 10.7 19.7 14.8 19.8 24.0 16.0 23.3 18.1 25.1 27.9 16.9 14.6 15.9 23.6 30.2 51.3 17.9 21.2 24.3 22.3 18.7 17.3 19.1 19.3 24.3 18.5 15.9 9.1 15.7 22.3 15.3 20.6 13.1 32.6 19.4 17.0 19.1 21.1 15.3 14.9 15.9 18.4 29.9 5.0 18.1 20.3 22.9 17.5 23.3 17.4 17.0 21.5 18.2 16.7 28.5 18.8 27.6 16.8 11.3 14.2 15.8 21.1 8.9 14.7 14.8 5.1 17.3 22.5 12.0 16.4 10.9 13.1 15.1 13.4 14.0 10.8 8.2 15.4 9.1 12.5 13.0 ASCC3 "ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH" ENSG00000112249 "Activating signal cointegrator 1 complex subunit 3" Q8N3C0 6 100508194-100881372 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031608, HPA031609, HPA031610" Enhanced Supported "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526" "unprognostic (6.79e-2)" "unprognostic (1.46e-2)" "unprognostic (2.96e-3)" "unprognostic (1.12e-1)" "unprognostic (9.70e-3)" "unprognostic (4.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.14e-2)" "unprognostic (4.02e-1)" "unprognostic (3.34e-1)" "unprognostic (5.08e-3)" "unprognostic (1.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" 15.9 15.4 10.9 15.5 14.5 13.6 13.4 16.1 11.7 16.7 13.2 7.7 10.1 11.4 16.4 12.9 18.4 11.3 11.1 14.9 9.7 8.4 10.4 28.3 12.6 13.1 13.1 7.6 13.8 15.1 25.0 38.6 26.1 10.4 16.4 17.1 6.4 15.4 14.0 13.6 15.3 16.1 12.2 15.5 17.7 11.5 11.7 12.4 25.0 10.6 11.6 15.2 16.0 17.9 8.5 9.4 5.9 6.4 6.0 7.8 1.8 7.0 8.8 13.3 8.2 14.9 19.0 20.7 31.0 20.0 10.7 12.4 18.0 5.7 21.7 6.1 20.8 15.9 11.4 27.5 17.4 13.7 9.8 16.4 16.5 11.7 13.7 17.4 12.7 17.2 14.1 15.6 19.9 19.6 19.4 9.9 29.5 6.8 8.6 5.3 7.0 6.7 10.5 10.1 8.0 10.6 20.0 8.7 6.6 12.9 11.7 5.3 6.5 9.9 26.9 12.0 9.1 10.3 13.0 4.3 3.9 19.4 8.6 13.2 12.5 5.9 3.9 2.4 6.7 6.4 7.8 5.8 5.6 6.0 4.1 8.5 6.5 6.2 0.3 6.0 5.2 9.4 4.3 1.8 10.9 14.5 16.1 11.7 9.7 8.4 13.1 7.6 10.4 12.4 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Group enriched" "Detected in some" 22 "SCLC-21H: 32.6;SH-SY5Y: 17.6" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell line enriched" "Detected in some" 30 "Hep G2: 102.0" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.1 0.2 0.3 3.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.3 102.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 1.8 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell line enriched" "Detected in some" 8 "Hep G2: 105.4" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 ASH1L "ASH1, ASH1L1, huASH1, KMT2H" ENSG00000116539 "ASH1 like histone lysine methyltransferase" Q9NR48 1 155335268-155562807 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004806 Approved Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA004806: AB_1845087" "unprognostic (2.98e-1)" "unprognostic (3.15e-2)" "unprognostic (1.10e-1)" "unprognostic (1.70e-2)" "unprognostic (2.05e-2)" "unprognostic (4.75e-2)" "unprognostic (1.42e-1)" "unprognostic (1.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (6.84e-2)" "prognostic favourable (3.80e-4)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (2.45e-2)" "unprognostic (1.94e-1)" 20.1 10.1 12.1 17.7 14.5 12.3 14.5 23.6 15.5 15.4 17.7 15.5 20.4 8.2 18.7 12.5 12.5 12.2 10.0 11.0 11.8 10.6 13.0 8.9 10.6 9.4 16.6 11.5 23.5 10.0 24.4 22.6 12.9 13.2 18.9 10.7 10.7 11.8 22.2 21.8 12.8 12.8 17.4 14.5 8.6 10.4 7.8 14.3 15.6 16.8 7.1 10.6 17.8 19.9 11.0 5.7 16.5 5.3 8.6 10.7 1.7 13.6 11.8 7.7 6.7 17.4 18.8 8.7 11.1 11.7 7.6 6.4 8.7 9.2 6.1 11.3 14.5 14.2 12.1 9.8 12.1 6.0 7.8 7.5 11.6 4.7 8.5 8.4 5.9 11.5 10.9 12.7 12.5 9.0 10.7 9.2 12.7 10.7 5.7 4.5 7.3 11.4 5.2 16.0 7.0 8.4 15.1 7.9 11.8 17.5 15.9 8.6 12.7 18.2 13.9 11.8 12.6 11.1 13.7 8.6 4.9 9.8 9.2 6.3 10.1 16.5 5.3 11.0 8.3 3.2 7.9 10.0 7.8 6.3 2.5 11.0 10.7 5.5 12.8 8.6 3.5 5.7 8.6 1.7 12.1 14.5 23.6 15.2 11.8 10.6 16.6 11.5 13.2 14.3 ASH2L "ASH2, ASH2L1, ASH2L2, Bre2" ENSG00000129691 "ASH2 like histone lysine methyltransferase complex subunit" Q9UBL3 8 38105242-38144076 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042289 Approved Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA042289: AB_10795608" "unprognostic (9.39e-2)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (5.40e-3)" "unprognostic (2.87e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.10e-2)" "unprognostic (9.73e-3)" "prognostic favourable (4.25e-4)" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.54e-1)" 22.3 17.0 24.2 16.7 26.7 24.0 19.7 26.1 28.2 20.9 20.0 21.9 14.7 14.5 20.8 16.1 21.6 18.2 19.6 20.6 21.0 23.4 21.0 20.6 16.0 21.4 20.3 26.8 24.1 30.1 28.3 13.9 24.3 23.1 19.4 20.9 16.0 18.1 20.0 31.8 18.8 23.0 21.8 20.1 20.3 18.8 41.7 16.0 36.2 19.5 15.3 24.1 20.1 17.4 12.6 17.0 33.9 16.6 16.6 13.2 11.4 13.8 7.3 12.4 12.3 8.9 11.2 15.9 14.1 14.8 17.8 15.7 7.9 6.3 15.6 12.0 11.8 8.3 15.9 7.9 16.9 6.0 7.2 63.6 7.9 16.5 12.9 10.2 12.9 9.6 7.5 8.2 9.2 13.9 42.6 12.1 17.3 8.0 27.1 12.8 16.0 4.7 11.3 13.7 6.7 9.2 10.5 5.7 10.1 10.4 6.9 11.4 8.3 12.0 10.8 11.0 11.2 15.6 11.2 11.6 14.5 13.9 11.2 13.4 15.1 18.2 13.9 33.9 11.1 16.6 11.8 12.5 12.5 13.1 17.0 12.6 13.2 12.1 11.8 16.6 15.0 9.7 13.0 11.4 24.2 26.7 26.1 28.2 21.0 23.4 20.3 26.8 23.1 16.0 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell line enhanced" "Detected in many" "HEK 293: 16.8;SH-SY5Y: 19.4" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA058870: " "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.1 4.7 6.2 14.0 1.9 2.9 3.5 1.5 4.1 2.7 2.7 3.3 1.7 1.3 3.2 0.9 2.2 6.1 5.2 1.6 1.3 16.8 4.2 6.6 2.0 2.7 6.3 15.8 7.4 2.5 0.4 0.6 0.5 2.8 0.1 2.2 2.6 6.0 12.3 2.6 8.3 6.1 5.9 2.8 1.3 0.2 9.2 19.4 3.5 1.2 2.1 7.7 4.1 0.4 2.7 9.1 1.8 0.8 0.0 0.0 0.0 3.5 5.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell line enhanced" "Detected in many" "U-266/70: 16.9;U-266/84: 8.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049155: , HPA054805: " "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.5 1.6 2.4 3.3 0.0 7.2 0.4 0.0 0.3 0.4 0.7 1.6 0.8 0.4 0.2 2.2 0.9 0.0 0.7 7.7 4.1 1.6 2.6 0.0 0.0 0.1 3.8 0.5 0.5 0.2 0.0 0.1 3.8 6.3 0.5 5.9 0.3 0.4 1.7 2.8 2.9 1.6 0.5 0.3 1.3 2.1 8.4 0.6 0.4 4.1 1.7 0.4 0.1 1.5 2.2 4.0 1.0 16.9 8.9 0.1 2.0 5.6 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 30 "HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 ASNA1 "ARSA-I, GET3, TRC40" ENSG00000198356 "ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli 52000 Nucleoli Nucleoplasm "HPA045951: , HPA048087: " "unprognostic (2.87e-1)" "prognostic favourable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favourable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavourable (8.47e-4)" 22.3 33.9 32.3 23.1 32.8 35.1 22.2 28.2 51.9 23.5 27.2 26.1 23.6 24.7 24.8 30.3 33.3 30.7 28.9 48.0 30.5 27.9 46.9 28.5 21.2 26.6 29.2 26.5 24.2 30.3 23.8 25.2 32.0 27.3 21.8 18.3 30.9 26.7 21.5 35.7 28.9 24.7 21.3 24.5 26.5 24.2 30.9 18.5 25.8 40.7 28.0 23.5 28.7 20.6 12.5 27.1 16.0 26.9 9.3 20.2 19.4 33.2 27.5 14.8 31.8 29.4 18.1 18.2 17.3 23.9 33.6 26.5 21.5 16.6 15.4 27.1 22.4 17.9 20.4 23.1 16.1 23.6 31.9 13.2 20.8 24.4 31.4 19.5 25.8 20.9 20.4 27.1 16.1 23.7 16.4 20.9 26.2 74.5 25.8 15.7 37.3 51.8 19.2 22.9 30.0 31.3 28.5 27.4 23.3 23.4 31.6 27.7 26.0 18.9 20.2 47.5 16.1 52.6 40.2 37.6 63.2 14.1 33.4 32.1 26.2 16.0 26.9 15.0 16.1 20.4 13.7 12.5 14.4 14.2 27.1 10.6 10.4 12.8 9.6 9.3 23.7 17.8 20.2 19.4 32.3 32.8 28.2 51.9 30.5 27.9 29.2 26.5 27.3 18.5 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Cell line enhanced" "Detected in some" "HEK 293: 13.3;MOLT-4: 15.5;SH-SY5Y: 9.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042631, HPA042654" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" 51000 Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.3 0.0 0.5 3.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 1.6 15.5 0.1 0.0 0.3 0.3 0.3 1.0 0.0 0.2 1.7 9.2 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 1.9 0.2 2.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavourable (1.25e-4)" "prognostic unfavourable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavourable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 19.8 11.1 18.1 11.0 1.0 2.5 6.8 15.9 11.2 15.8 12.5 7.7 15.5 20.3 5.7 12.4 20.1 15.5 6.3 19.7 18.2 11.8 14.2 26.2 7.4 0.2 21.2 10.1 0.2 0.6 12.7 8.9 16.6 17.8 24.1 16.2 7.8 17.0 9.9 8.2 3.0 13.0 24.8 14.9 5.7 5.5 9.5 13.5 22.6 11.7 5.1 13.0 8.8 12.6 9.8 9.5 16.8 28.9 6.9 9.4 11.7 7.7 5.8 19.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 ASPSCR1 "ASPL, ASPS, TUG, UBXD9, UBXN9" ENSG00000169696 "ASPSCR1, UBX domain containing tether for SLC2A4" Q9BZE9 17 81976807-82017406 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "Hep G2: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026749 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA026749: AB_1845114" "unprognostic (5.01e-2)" "unprognostic (1.19e-3)" "unprognostic (7.61e-2)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "prognostic favourable (8.55e-4)" "unprognostic (2.02e-1)" "unprognostic (2.07e-2)" "unprognostic (3.43e-1)" "unprognostic (1.71e-3)" "prognostic favourable (2.67e-4)" "unprognostic (1.13e-1)" "prognostic unfavourable (1.26e-4)" "unprognostic (3.16e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (1.01e-2)" 10.3 12.6 14.3 12.6 14.5 16.8 10.6 16.5 20.8 9.9 12.9 16.7 11.8 17.5 10.1 15.8 11.9 9.3 15.1 11.5 13.1 12.6 15.8 31.9 14.1 14.8 18.9 12.9 8.8 17.8 17.0 19.7 21.8 14.8 13.2 7.1 14.4 22.6 9.9 25.1 15.5 14.4 9.1 12.6 13.2 13.0 16.9 14.6 9.8 16.4 12.9 13.0 9.7 8.3 8.1 14.6 15.7 11.3 7.2 10.5 5.2 4.9 8.8 3.4 5.0 2.2 2.7 14.9 4.7 3.6 5.7 5.6 5.1 5.8 5.1 4.9 3.4 2.4 3.7 3.6 1.8 3.5 11.2 5.7 7.2 80.8 7.1 5.0 8.3 3.1 3.9 2.9 2.0 5.5 5.7 7.3 3.2 17.0 4.6 10.9 4.3 6.4 5.1 5.0 10.4 5.6 4.6 9.2 9.4 3.9 12.3 8.8 7.4 12.0 4.5 9.9 6.8 7.2 5.9 5.3 3.2 5.7 5.3 5.1 5.9 15.7 11.3 8.0 6.7 7.6 4.0 7.9 10.5 9.0 14.6 8.1 8.0 6.0 2.9 7.2 9.3 9.1 4.9 5.2 14.3 14.5 16.5 20.8 13.1 12.6 18.9 12.9 14.8 14.6 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase like 1" Q7L266 11 62337448-62393412 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.4;cervix, uterine: 68.7;testis: 57.6" "Cell line enhanced" "Detected in many" "EFO-21: 30.0;HAP1: 28.9;RPTEC TERT1: 25.6;SCLC-21H: 39.5" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 51.4;eosinophil: 52.4" "Group enriched" "Detected in many" 4 "granulocytes: 52.4;monocytes: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "CAB070192: , HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favourable (6.14e-4)" "prognostic favourable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavourable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favourable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 3.6 2.6 27.8 3.8 37.0 7.1 4.6 12.3 22.3 68.7 7.9 9.9 2.0 4.1 15.3 7.9 1.4 36.8 9.5 1.7 19.5 19.0 23.8 2.4 6.6 3.3 30.8 11.8 1.6 5.1 1.5 5.7 2.3 16.4 8.6 9.9 4.9 6.4 4.8 2.3 1.2 3.1 3.0 9.6 2.4 5.6 57.6 11.3 2.8 3.7 0.0 3.0 2.9 1.0 0.5 8.2 52.4 14.2 2.5 0.7 4.9 0.8 6.6 7.3 9.4 0.0 0.0 5.8 0.8 0.2 1.3 1.2 10.8 2.9 0.6 30.0 0.1 0.6 28.9 0.3 1.5 1.1 11.9 0.4 9.0 7.8 0.2 8.0 10.8 0.3 0.1 0.6 0.1 13.6 8.0 7.5 0.3 12.6 21.5 5.3 9.9 5.2 8.7 4.4 4.0 25.6 2.0 39.5 5.6 5.6 9.8 4.8 5.2 4.1 0.7 0.1 5.5 0.4 3.2 11.5 10.9 1.0 0.3 4.1 3.3 51.4 14.2 52.4 0.6 10.3 0.4 0.5 0.2 0.7 8.2 0.4 0.5 0.7 3.3 2.5 7.2 1.4 0.1 4.9 27.8 37.0 12.3 22.3 19.5 19.0 30.8 11.8 16.4 11.3 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.6 1.1 1.3 2.2 8.8 22.5 4.2 13.9 86.6 2.7 8.4 4.9 3.2 0.0 9.4 28.6 82.0 5.7 0.5 1.9 2.0 2.6 0.0 1.8 12.7 30.7 1.7 0.1 14.8 79.7 4.4 8.0 0.1 0.4 51.7 2.7 57.6 0.6 24.3 1.8 2.5 0.1 1.5 132.8 7.6 5.8 33.4 0.5 49.5 52.2 3.9 35.8 99.5 0.0 1.1 6.9 0.2 1.2 8.6 8.2 2.9 21.8 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell line enhanced" "Detected in some" "Karpas-707: 5.9;NTERA-2: 4.5;SCLC-21H: 2.8;U-2 OS: 3.6;U-266/84: 20.1" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA074112: " "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.5" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favourable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.7 3.1 4.7 5.1 4.7 10.2 3.8 1.5 1.7 1.8 5.3 3.0 5.7 4.4 2.5 0.9 7.5 0.4 2.0 3.1 1.9 2.1 3.6 10.9 2.0 1.4 4.1 6.4 0.7 5.1 0.4 1.2 2.6 4.3 5.1 2.6 2.6 1.1 8.9 4.6 3.3 18.1 1.7 5.3 8.2 4.2 24.5 4.5 1.5 3.2 10.2 0.9 2.3 3.9 6.4 3.8 3.2 6.2 3.5 5.4 7.0 1.4 16.7 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 ASXL1 KIAA0978 ENSG00000171456 "Additional sex combs like 1, transcriptional regulator" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA064156: " "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavourable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favourable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 24.3 19.6 19.0 35.0 18.2 39.0 24.7 28.3 23.8 32.4 22.7 17.7 16.9 15.6 32.4 22.2 14.3 20.5 21.6 17.9 19.7 10.7 21.2 25.2 27.3 26.7 20.3 14.7 28.1 27.1 21.2 16.3 19.8 18.2 20.6 16.4 16.6 17.4 23.3 25.5 18.2 21.8 21.8 12.2 28.2 19.7 32.1 23.0 47.4 26.8 15.8 29.0 23.2 35.3 9.8 3.1 1.3 0.8 1.7 14.6 1.9 22.6 13.2 20.7 11.4 9.5 11.8 18.0 15.2 13.0 26.6 19.7 39.1 14.6 21.4 9.8 18.7 15.8 17.4 14.6 21.7 32.0 9.4 34.2 20.9 21.4 8.5 14.2 14.2 13.1 9.8 18.5 13.9 14.6 16.5 11.6 12.3 6.9 19.4 11.5 5.0 15.2 11.3 24.7 9.2 10.9 10.9 9.5 14.9 27.6 9.2 12.1 13.1 10.1 15.1 28.3 24.7 13.0 16.9 13.6 14.5 15.8 14.3 37.9 10.8 0.0 0.8 1.3 4.4 0.7 3.5 9.8 5.2 5.6 0.7 5.8 5.8 5.9 0.9 1.7 0.7 3.1 14.6 1.9 19.0 18.2 28.3 23.8 19.7 10.7 20.3 14.7 18.2 23.0 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Group enriched" "Detected in some" 24 "Daudi: 3.9;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA020558 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD1 FLJ14600 ENSG00000138138 "ATPase family, AAA domain containing 1" Q8NBU5 10 87751512-87841343 "Enzymes, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037569 Uncertain Approved Nucleoli,Mitochondria Nucleoli Mitochondria "HPA037569: AB_10672496" "unprognostic (9.92e-2)" "unprognostic (2.90e-1)" "unprognostic (4.05e-2)" "unprognostic (2.68e-1)" "unprognostic (3.24e-2)" "unprognostic (6.60e-3)" "unprognostic (3.38e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-1)" "unprognostic (8.45e-2)" "unprognostic (1.35e-3)" "unprognostic (1.67e-2)" "prognostic favourable (3.98e-6)" "unprognostic (2.35e-1)" "unprognostic (3.29e-1)" "unprognostic (3.45e-2)" "unprognostic (4.22e-2)" 16.2 21.3 20.4 15.1 26.2 8.0 19.4 22.4 29.8 19.2 15.9 14.4 16.0 13.5 19.6 17.0 17.3 14.8 13.3 39.9 20.4 22.2 20.6 22.1 14.1 14.2 20.4 17.1 19.1 12.6 25.6 24.9 30.2 31.2 24.3 18.4 19.8 15.8 20.4 32.1 14.4 14.1 18.4 18.2 12.5 14.0 19.8 14.7 18.0 20.1 18.5 15.7 18.9 15.2 9.0 7.3 6.7 7.6 9.8 13.5 7.4 9.8 9.3 11.9 11.3 14.4 12.7 9.0 10.0 16.6 10.3 11.6 8.4 28.6 9.5 7.7 8.3 16.4 9.9 8.5 12.1 8.5 13.4 7.8 13.0 10.3 17.1 21.2 5.4 12.6 23.8 10.9 27.1 6.8 7.6 12.4 11.4 6.0 13.6 14.4 8.8 6.5 9.3 7.6 10.4 15.8 7.6 7.6 16.6 8.8 6.3 20.1 16.5 10.0 8.4 9.4 8.4 6.3 13.0 16.7 15.3 12.2 10.4 14.8 7.2 6.7 3.8 5.7 9.2 5.9 13.5 9.0 10.3 11.4 7.3 7.6 11.8 11.6 2.2 9.8 7.6 5.5 9.3 7.4 20.4 26.2 22.4 29.8 20.4 22.2 20.4 17.1 31.2 14.7 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.5 9.0 0.2 1.0 3.8 4.2 2.1 4.7 6.8 4.4 3.4 12.9 4.1 1.9 8.8 6.1 3.2 8.6 2.9 5.3 7.8 5.2 3.0 0.1 15.1 6.3 0.4 0.4 6.9 2.4 2.4 12.1 10.8 3.1 2.8 16.8 7.5 5.6 1.9 11.6 18.1 6.1 1.2 5.1 5.6 5.0 4.7 2.7 2.5 5.1 6.7 1.9 5.9 7.9 8.2 7.5 3.6 3.7 16.2 2.5 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 ATAT1 "C6orf134, Em:AB023049.7, FLJ13158, MEC17" ENSG00000137343 "Alpha tubulin acetyltransferase 1" Q5SQI0 6 30626842-30646823 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 10.9;AN3-CA: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046816, HPA050999" Approved Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus, Cytosol" "HPA046816: , HPA050999: " "unprognostic (3.98e-1)" "unprognostic (3.18e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-2)" "unprognostic (8.86e-2)" "unprognostic (8.18e-3)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.49e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-2)" "unprognostic (1.29e-3)" "unprognostic (1.25e-2)" "prognostic unfavourable (7.78e-5)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.02e-1)" "prognostic favourable (1.35e-4)" 4.8 3.8 16.8 5.4 16.8 4.4 4.1 12.5 20.7 5.5 4.9 16.3 3.0 4.6 10.2 21.0 3.2 8.3 5.4 3.9 15.7 15.9 4.4 3.8 3.9 4.8 14.0 12.2 10.1 4.4 4.4 10.6 4.3 13.0 9.8 5.3 4.1 5.4 4.0 4.5 6.9 6.1 4.9 13.5 4.3 7.9 7.0 12.8 3.3 4.3 1.7 5.6 4.0 3.8 1.7 2.6 2.6 1.7 0.7 2.1 0.8 2.0 1.1 10.9 8.1 1.5 1.1 0.4 0.3 0.1 0.4 0.8 2.9 2.1 0.3 1.7 1.7 2.4 4.0 1.4 0.1 1.5 4.7 0.1 0.4 2.7 0.7 0.2 1.3 2.2 0.9 0.7 0.0 0.9 1.6 0.2 2.0 1.8 1.6 0.7 0.7 0.2 0.9 0.3 0.6 2.0 3.0 0.6 4.3 0.7 1.0 0.7 4.4 0.5 0.8 3.1 2.2 0.1 0.8 1.6 2.1 1.0 2.5 4.8 3.2 2.6 1.7 1.3 0.8 1.5 1.0 1.7 1.0 0.8 1.6 1.2 2.1 1.6 0.3 0.7 1.1 2.6 0.9 0.8 16.8 16.8 12.5 20.7 15.7 15.9 14.0 12.2 13.0 12.8 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell line enhanced" "Detected in many" "BEWO: 43.4;HDLM-2: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA001562 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.6 0.4 13.4 2.8 1.3 3.4 43.4 4.8 3.9 4.1 9.9 8.9 5.0 0.1 2.2 0.3 3.7 8.0 1.3 6.8 31.7 7.7 0.5 3.9 3.1 24.6 2.8 7.5 6.0 21.6 11.5 26.9 0.8 3.1 25.3 0.6 0.8 8.5 1.8 9.6 2.8 2.5 8.9 5.7 0.5 0.9 6.0 6.1 6.2 11.2 18.8 6.5 2.0 0.8 1.2 6.4 4.0 2.1 20.0 8.4 2.2 4.0 1.5 3.5 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 ATF4 "CREB-2, TAXREB67, TXREB" ENSG00000128272 "Activating transcription factor 4" P18848 22 39519695-39522685 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011596 Approved Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "CAB011596: AB_725569" "unprognostic (2.51e-2)" "unprognostic (7.36e-2)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (4.45e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (4.07e-4)" "unprognostic (4.43e-2)" "unprognostic (1.97e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.41e-1)" "prognostic unfavourable (9.77e-5)" "unprognostic (7.06e-2)" "unprognostic (9.78e-2)" "unprognostic (6.40e-2)" "unprognostic (1.95e-1)" 66.7 46.6 35.0 35.8 42.1 137.9 134.9 38.1 44.1 46.9 99.1 27.3 66.6 40.2 52.1 45.1 69.9 39.8 47.0 44.1 35.7 30.6 41.5 90.1 53.0 37.1 69.3 21.8 53.6 125.3 24.7 40.2 56.8 49.7 70.0 41.2 39.6 241.8 72.7 127.2 42.6 44.3 119.7 64.3 43.2 70.1 23.8 50.4 21.6 62.5 66.7 49.3 118.9 104.7 29.2 32.6 24.1 26.4 19.3 23.0 19.9 38.4 23.5 41.1 52.8 46.0 45.7 68.1 46.5 73.6 37.6 48.1 51.7 29.5 74.2 10.2 34.7 30.4 66.5 55.1 45.9 45.6 48.1 50.8 24.1 52.4 101.9 95.2 48.1 77.1 120.2 67.1 98.8 36.2 53.7 79.9 28.5 24.3 56.8 69.4 35.9 30.6 59.1 27.2 76.4 49.1 32.9 62.0 25.8 20.9 56.1 135.9 34.5 118.2 28.4 22.7 65.7 24.7 31.6 87.1 103.4 86.2 25.0 48.7 50.6 24.1 26.4 17.5 16.2 22.5 20.8 29.2 21.7 20.7 32.6 21.1 23.0 20.8 13.2 19.3 23.6 20.2 22.8 19.9 35.0 42.1 38.1 44.1 35.7 30.6 69.3 21.8 49.7 50.4 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 24 "liver: 470.7" "Cell line enhanced" "Detected in all" "Karpas-707: 78.3;THP-1: 65.2;U-266/84: 99.3;U-698: 46.7" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7" "Group enriched" "Detected in all" 7 "dendritic cells: 18.7;monocytes: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favourable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavourable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 4.6 6.6 2.1 5.0 2.7 2.9 7.0 1.3 2.2 2.4 2.9 2.4 3.9 4.6 2.3 4.0 3.4 2.6 3.1 4.2 2.1 2.1 3.0 470.7 2.8 5.0 2.2 1.4 2.6 3.8 1.4 1.9 4.4 2.1 2.8 1.6 2.6 3.1 2.5 4.3 2.1 4.2 2.5 2.6 3.3 2.8 5.3 1.9 3.8 20.0 3.3 5.5 5.6 7.1 1.1 18.7 2.2 11.9 1.5 1.3 2.5 9.8 6.9 2.6 1.8 2.8 2.4 2.7 7.2 6.0 7.4 4.6 5.2 5.4 8.8 3.7 4.1 3.6 3.3 2.9 3.5 45.0 3.3 6.0 2.1 3.9 1.9 23.3 17.2 16.6 4.7 5.4 1.3 3.2 5.4 78.3 3.6 9.2 3.3 5.1 1.3 9.3 27.9 2.9 3.6 8.4 13.4 4.3 3.0 16.7 7.2 5.0 5.8 65.2 5.4 14.5 9.2 1.7 7.3 2.1 99.3 46.7 11.3 9.3 5.4 0.3 11.9 0.7 0.7 11.7 1.3 1.1 0.9 0.9 7.5 0.7 0.7 0.9 2.2 1.5 3.0 18.7 0.9 2.5 2.1 2.7 1.3 2.2 2.1 2.1 2.2 1.4 2.1 1.9 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli 31000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 11.7 19.4 23.1 13.7 29.4 24.9 14.3 20.2 19.1 17.8 20.2 15.4 9.8 11.2 19.2 32.7 20.0 27.7 15.4 11.0 19.4 11.4 13.5 14.0 15.6 17.0 20.6 16.5 22.6 18.4 38.1 16.1 21.1 16.9 16.8 18.8 14.1 16.2 14.0 7.1 17.8 15.9 9.4 12.8 22.8 20.2 19.5 17.0 21.7 21.2 11.8 21.0 18.0 16.4 4.4 5.7 6.6 4.1 5.6 4.9 4.4 0.8 2.9 8.1 3.0 6.1 6.9 3.0 3.3 3.2 7.3 9.2 9.5 15.9 14.5 11.7 29.4 4.7 11.0 22.1 5.4 2.9 12.1 1.1 15.3 10.1 20.1 1.1 17.6 11.5 9.8 1.3 20.4 19.9 19.1 19.3 18.7 7.5 10.1 7.1 2.4 0.5 0.7 3.5 6.4 6.6 1.4 0.5 0.8 14.3 7.8 19.4 24.4 1.8 8.6 4.0 4.5 6.5 9.9 19.3 8.3 6.8 9.3 6.7 9.9 6.6 2.2 1.9 4.9 4.1 4.7 4.4 2.8 2.3 5.7 3.4 1.8 3.5 2.5 5.6 3.7 3.8 4.5 4.4 23.1 29.4 20.2 19.1 19.4 11.4 20.6 16.5 16.9 17.0 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.2 19.8 10.5 11.6 20.3 26.0 7.0 12.3 12.8 13.7 9.1 14.2 16.0 16.0 16.4 15.1 12.8 8.2 13.7 12.6 15.5 10.4 13.8 22.8 15.2 13.6 17.7 10.4 20.2 17.9 17.0 19.4 26.8 15.7 14.9 20.4 18.9 10.6 12.4 10.5 10.7 14.1 12.7 15.4 20.6 13.2 8.9 9.5 18.8 13.9 19.5 18.6 11.0 19.7 16.4 11.6 13.0 11.1 7.3 8.7 10.3 13.4 16.8 14.9 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 17.5 15.0 11.1 36.4 15.3 25.2 16.6 29.4 12.7 18.0 12.9 14.1 16.0 7.3 16.1 14.5 20.2 13.0 15.2 18.3 11.7 8.3 11.3 14.0 16.2 25.2 13.8 10.7 19.5 13.0 23.3 23.3 22.4 11.9 15.7 12.3 14.4 21.7 18.0 25.4 15.6 16.6 15.4 12.3 23.9 12.5 30.1 13.6 38.8 20.2 12.6 24.5 17.2 27.3 25.0 9.9 15.9 9.7 8.6 13.4 6.6 10.9 6.5 27.2 15.7 14.4 18.4 5.9 11.5 6.7 9.3 14.4 15.0 11.8 18.4 8.1 8.1 11.1 16.8 10.9 21.3 13.1 9.9 12.3 11.2 3.3 8.4 8.3 7.3 9.8 9.1 11.5 12.0 20.3 7.2 10.0 14.7 10.4 12.0 7.3 17.3 6.3 25.0 30.0 9.9 8.1 21.6 8.7 7.2 13.5 7.9 7.6 8.0 9.8 9.3 13.2 8.5 7.6 9.8 6.5 6.3 26.0 8.4 7.9 14.2 15.9 8.1 13.6 12.9 6.3 13.4 16.9 11.0 12.5 7.2 25.0 8.9 12.2 13.5 8.6 9.7 9.9 13.4 6.6 11.1 15.3 29.4 12.7 11.7 8.3 13.8 10.7 11.9 13.6 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972025-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044163: " "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 8.2 9.2 8.4 6.3 13.6 8.4 11.7 11.3 15.4 7.2 8.9 14.7 7.5 5.5 12.0 13.7 10.9 7.2 7.3 8.0 8.4 7.9 9.3 10.4 7.1 8.3 10.3 13.5 5.8 9.9 23.0 9.5 7.9 11.3 9.6 10.2 12.4 8.6 9.6 10.3 10.9 6.0 9.1 10.4 6.7 7.1 27.0 8.9 22.8 11.7 4.6 9.9 9.2 8.2 7.6 11.4 12.2 9.3 9.2 8.9 6.0 3.7 9.9 6.5 18.4 4.3 8.3 16.5 4.3 3.5 3.2 4.9 2.9 13.5 6.5 3.6 6.9 2.2 4.7 9.6 4.2 11.0 3.4 7.2 9.4 3.1 4.2 3.7 5.9 7.6 6.6 4.6 3.9 5.9 8.5 5.6 11.5 7.4 8.4 4.3 9.2 6.5 6.4 9.3 15.6 8.1 5.2 9.6 13.8 7.0 3.9 7.9 7.6 7.0 4.7 6.0 5.7 3.0 9.0 7.6 12.6 9.0 8.0 9.0 9.6 3.3 9.3 12.2 8.4 8.8 7.9 5.9 7.5 7.7 11.4 7.6 7.2 8.9 12.1 9.2 6.5 8.8 7.4 6.0 8.4 13.6 11.3 15.4 8.4 7.9 10.3 13.5 11.3 8.9 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavourable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.7 25.2 19.4 11.4 27.1 31.8 19.6 16.0 28.4 19.8 25.4 17.2 13.7 12.9 11.4 24.1 16.8 18.6 21.7 20.1 24.4 35.5 13.8 17.6 30.0 30.4 18.4 24.1 38.2 25.9 13.6 30.2 19.5 24.1 29.5 17.7 20.6 18.3 27.3 24.2 21.9 17.5 25.1 22.5 13.3 15.1 18.5 18.6 22.1 17.8 23.6 25.4 38.1 19.1 24.4 15.0 22.5 17.5 26.9 29.8 16.3 30.3 16.7 17.9 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" Cytosol "Nucleoplasm, Vesicles" "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favourable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.6 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.1 11.7 4.7 8.6 3.6 6.6 2.0 6.6 12.4 6.4 14.4 7.7 6.6 5.0 14.9 9.1 5.8 9.5 5.1 6.3 12.0 5.8 3.3 16.2 6.0 17.0 4.1 10.8 6.7 5.6 10.4 4.1 8.5 13.0 5.1 8.0 11.7 10.1 11.3 6.4 7.9 7.2 7.1 14.2 4.1 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 ATG3 "APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96" ENSG00000144848 "Autophagy related 3" Q9NT62 3 112532509-112562046 "Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037260, HPA040471" Enhanced Supported "Plasma membrane,Cytosol" 26000 "Plasma membrane, Cytosol" "CAB037260: AB_1078236, HPA040471: " "unprognostic (2.77e-2)" "prognostic favourable (6.82e-4)" "unprognostic (4.90e-3)" "unprognostic (1.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (9.35e-6)" "unprognostic (6.79e-2)" "unprognostic (6.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (7.52e-3)" "unprognostic (4.66e-2)" "unprognostic (6.02e-2)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" 24.2 27.7 30.8 30.3 34.2 51.6 23.1 19.5 26.8 20.0 24.3 29.9 16.6 24.5 18.0 17.0 23.6 15.7 17.4 20.9 31.4 27.1 32.2 36.2 23.2 31.0 38.9 17.9 21.1 29.0 24.5 27.7 24.5 33.3 18.5 26.9 13.1 20.3 22.3 18.7 19.6 27.9 19.6 53.3 40.1 23.5 51.7 34.8 33.8 28.2 23.4 28.6 21.6 19.7 12.3 34.5 35.6 61.9 9.7 15.0 24.0 31.2 17.1 16.1 16.3 21.2 17.6 18.1 27.6 20.2 27.3 25.0 23.9 18.7 39.4 21.0 23.8 22.7 26.2 23.9 38.5 6.7 12.7 24.7 17.0 15.3 33.1 43.2 21.1 16.2 18.3 26.8 41.3 25.4 21.1 33.9 28.8 27.4 25.5 20.4 17.6 34.0 22.3 14.4 33.2 22.7 17.1 27.7 10.9 22.9 22.0 32.2 24.7 32.5 20.4 29.3 23.9 12.3 24.1 22.1 21.1 60.9 26.7 40.3 21.4 10.8 34.3 23.9 8.6 51.6 10.7 12.3 10.6 10.6 34.5 11.5 10.4 10.2 35.6 9.7 61.9 7.4 15.0 24.0 30.8 34.2 19.5 26.8 31.4 27.1 38.9 17.9 33.3 34.8 ATG4A "APG4A, AUTL2" ENSG00000101844 "Autophagy related 4A cysteine peptidase" Q8WYN0 X 108091668-108154671 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036374, HPA064759" Uncertain Approved "Actin filaments,Microtubules" Microtubules "Actin filaments" "HPA036374: AB_10672354, HPA064759: " "prognostic unfavourable (1.36e-5)" "unprognostic (1.41e-2)" "unprognostic (3.65e-1)" "unprognostic (2.52e-1)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (1.18e-1)" "unprognostic (2.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.14e-1)" "unprognostic (2.62e-2)" "unprognostic (4.09e-1)" "unprognostic (1.03e-3)" "unprognostic (7.53e-2)" "unprognostic (2.98e-1)" "unprognostic (5.02e-3)" "unprognostic (1.20e-2)" 8.2 11.8 6.4 6.1 8.0 6.1 7.4 9.7 6.2 6.8 10.0 5.5 8.6 10.3 6.9 10.4 10.6 5.4 6.5 10.9 4.3 3.2 15.3 23.4 10.8 8.2 6.9 5.7 4.7 22.3 8.2 13.1 7.9 7.2 6.6 11.3 6.7 17.2 6.2 18.8 6.3 18.7 7.2 6.7 10.5 12.9 3.1 8.2 12.0 12.0 7.4 10.5 7.4 7.8 8.7 9.8 18.7 9.9 10.0 11.9 7.4 5.8 2.9 1.9 3.6 18.4 6.3 2.3 8.2 5.1 4.2 5.0 2.3 3.3 6.4 7.4 6.5 2.8 5.5 6.0 6.4 10.8 6.1 2.7 5.1 1.5 4.0 5.7 8.9 6.5 6.3 5.2 2.1 40.1 8.3 20.5 7.7 5.3 5.4 5.3 3.5 8.4 3.7 3.2 9.3 6.2 5.2 2.7 2.1 5.2 6.4 3.4 3.2 5.3 11.0 2.5 1.2 9.0 4.4 9.5 10.8 6.9 5.2 6.6 3.7 18.7 7.0 13.1 11.6 9.9 8.3 8.7 8.9 10.9 9.8 7.6 7.0 11.9 2.2 10.0 6.7 4.6 9.2 7.4 6.4 8.0 9.7 6.2 4.3 3.2 6.9 5.7 7.2 8.2 ATG4B "Apg4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: " "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favourable (9.64e-4)" 10.9 16.5 19.6 16.6 21.3 31.3 15.1 34.8 25.7 13.5 18.7 21.7 23.2 14.6 33.5 24.0 26.7 17.7 18.8 19.5 20.5 21.5 17.2 15.5 15.8 19.4 29.2 19.7 17.3 19.2 18.7 27.4 15.4 20.3 20.5 18.9 20.8 22.8 14.2 17.2 26.6 21.1 18.9 23.1 18.7 15.5 28.0 21.4 21.2 18.2 7.3 21.9 15.3 14.4 16.5 20.3 18.9 18.6 11.4 19.6 16.8 8.6 13.4 19.2 14.9 19.3 14.1 19.1 12.7 13.8 16.4 13.6 14.7 15.3 6.6 5.7 22.7 12.7 18.3 24.1 16.0 14.1 18.6 19.5 21.7 31.8 25.1 11.2 11.0 13.9 16.8 18.4 17.8 16.9 16.6 10.2 18.6 21.1 20.2 19.9 22.4 14.4 34.8 17.7 10.0 12.9 28.0 19.3 13.4 10.8 14.4 15.1 15.9 16.6 18.4 15.7 10.7 10.4 13.6 11.5 12.0 25.4 19.0 14.1 14.6 4.6 18.6 18.9 18.7 15.5 15.5 15.7 15.2 16.5 20.3 16.5 19.6 14.7 14.8 11.4 16.2 16.3 19.3 16.8 19.6 21.3 34.8 25.7 20.5 21.5 29.2 19.7 20.3 21.4 ATG4C "APG4C, AUTL1, AUTL3, FLJ14867" ENSG00000125703 "Autophagy related 4C cysteine peptidase" Q96DT6 1 62784135-62865513 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007049 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007049: AB_1845159" "unprognostic (1.28e-1)" "unprognostic (2.69e-1)" "prognostic favourable (9.83e-4)" "unprognostic (7.43e-2)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (3.76e-2)" "unprognostic (8.36e-2)" "unprognostic (1.83e-2)" "unprognostic (1.30e-1)" "unprognostic (3.77e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-2)" "unprognostic (1.81e-1)" "unprognostic (4.17e-2)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" 8.8 9.8 19.4 11.3 32.8 6.0 9.2 16.7 23.4 10.6 9.5 29.8 7.2 7.7 9.6 7.2 8.6 8.0 10.4 7.2 23.7 15.5 13.5 12.6 9.2 13.7 42.6 16.5 10.3 11.2 15.5 11.3 15.0 22.4 8.0 10.6 4.9 10.8 8.0 6.4 6.3 7.8 11.2 26.5 13.3 8.6 8.9 40.4 11.0 12.0 3.7 12.4 13.4 6.8 20.6 19.4 16.0 10.9 7.0 9.4 6.7 7.6 6.1 9.5 8.3 12.5 13.5 9.5 11.5 7.8 11.1 12.5 4.5 6.1 16.3 8.9 5.8 5.9 11.3 8.7 16.1 12.2 10.4 18.3 6.5 5.8 8.9 14.8 12.3 11.1 6.2 11.8 5.6 13.3 15.5 13.3 9.3 3.6 14.9 5.7 13.9 10.1 17.9 22.8 11.5 8.0 5.6 12.9 6.5 7.6 14.4 14.8 7.0 7.0 5.2 8.9 8.7 15.0 12.6 11.6 15.6 13.3 10.2 14.7 10.7 16.0 10.9 8.5 4.8 8.8 6.6 20.6 6.6 5.6 19.4 19.1 9.4 7.7 1.6 7.0 5.0 11.6 5.7 6.7 19.4 32.8 16.7 23.4 23.7 15.5 42.6 16.5 22.4 40.4 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA067683: " "unprognostic (2.85e-1)" "prognostic favourable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favourable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favourable (2.39e-7)" "prognostic favourable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 6.9 4.7 6.5 8.8 1.2 1.0 5.1 4.3 4.3 6.1 6.8 7.8 2.3 4.5 8.2 0.5 11.0 4.0 3.7 0.8 4.4 10.6 11.9 11.4 4.3 4.1 4.7 12.2 1.0 7.7 5.3 1.9 1.8 8.8 10.9 1.9 11.2 14.0 29.1 9.9 12.8 10.3 4.0 8.0 3.5 9.4 24.6 9.5 6.3 12.4 4.9 7.6 11.7 3.4 9.4 5.9 18.9 9.5 9.7 6.6 5.3 8.0 9.3 10.6 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favourable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavourable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favourable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.2 14.4 6.5 3.4 11.3 15.0 32.0 17.2 22.4 17.2 20.1 6.1 16.6 8.4 10.4 15.2 5.6 7.2 24.1 29.6 7.4 9.0 6.0 13.9 7.3 15.0 17.4 20.1 15.4 11.2 33.3 21.0 23.7 8.9 6.9 23.8 11.9 4.9 8.2 5.0 18.7 6.2 7.7 7.4 13.0 13.2 5.7 5.7 12.2 10.4 6.6 11.3 17.0 16.1 14.2 10.3 9.2 24.0 4.4 11.5 14.1 22.9 16.4 19.0 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311817-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Enhanced "Plasma membrane,Cytosol" 3400000 "Plasma membrane, Cytosol" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavourable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavourable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 19.4 27.4 21.1 23.0 28.4 16.9 24.8 12.1 32.3 20.6 26.7 29.1 18.1 23.4 27.9 15.6 19.1 21.9 19.1 18.2 20.3 21.1 23.1 35.6 17.3 36.1 29.7 19.9 23.4 32.9 25.1 21.1 31.1 24.4 21.9 35.9 19.5 14.4 29.4 35.5 17.0 20.6 26.7 21.7 29.0 20.4 15.0 28.0 46.3 16.1 13.5 35.3 27.6 18.0 21.7 13.4 2.9 8.9 19.6 22.8 10.0 20.2 30.7 17.1 29.1 23.0 23.3 8.6 20.7 18.0 23.7 27.2 59.1 31.8 29.5 25.7 21.6 21.3 37.6 31.2 34.0 21.9 36.4 35.9 26.3 53.0 29.8 44.9 18.4 19.7 24.0 31.6 38.2 15.8 46.3 24.6 32.5 29.9 39.1 21.8 65.9 17.2 36.4 24.7 26.4 25.1 32.7 26.9 18.6 16.6 20.5 23.4 33.6 16.0 13.9 20.1 20.8 25.9 13.0 31.1 40.6 61.2 17.5 25.1 29.0 2.9 6.0 0.1 13.2 8.9 22.8 21.7 18.6 20.0 13.4 13.2 18.9 17.5 0.7 19.6 7.4 11.7 17.7 10.0 21.1 28.4 12.1 32.3 20.3 21.1 29.7 19.9 24.4 28.0 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222484-108369102 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB000102: , HPA067142: " "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 8.3 10.9 12.7 26.5 19.3 16.8 9.4 17.7 14.4 10.9 8.5 10.9 8.8 6.0 11.2 11.4 6.9 9.5 9.2 9.6 12.4 8.5 7.7 9.5 10.1 33.4 19.6 6.7 20.5 20.7 15.7 29.2 8.8 14.5 9.1 7.9 7.2 15.1 9.8 6.2 8.4 16.5 10.6 23.4 22.6 8.9 6.1 17.9 19.5 10.7 5.1 26.9 10.7 10.7 13.7 6.1 13.5 12.5 7.6 18.5 4.4 2.6 3.8 7.5 4.0 9.8 14.3 1.9 6.0 6.7 3.5 5.8 4.7 6.3 9.4 8.9 4.8 4.0 5.7 5.0 5.4 7.5 3.3 8.5 4.7 4.7 5.1 10.2 9.2 9.2 3.1 5.2 10.2 7.2 8.2 6.4 6.8 1.9 7.0 9.4 6.1 3.8 5.5 5.2 14.8 3.9 5.4 5.1 6.3 6.9 3.2 10.3 4.9 5.8 11.3 8.6 4.8 4.9 5.6 4.3 4.5 47.4 5.7 11.3 9.6 13.5 5.7 3.8 14.9 5.3 10.4 11.1 10.5 11.3 2.7 13.7 18.5 17.9 10.8 7.6 12.5 6.1 5.3 4.4 12.7 19.3 17.7 14.4 12.4 8.5 19.6 6.7 14.5 17.9 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" 27000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favourable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 27.0 37.2 43.1 25.6 40.4 23.4 39.1 22.8 38.5 29.0 23.9 29.7 32.3 30.2 21.4 37.6 28.4 24.5 33.4 27.7 37.5 45.7 50.5 96.1 21.3 48.9 54.3 37.0 16.2 29.0 31.5 23.0 25.6 35.2 25.7 24.4 25.0 34.7 29.8 12.8 26.3 31.6 28.1 46.5 34.1 21.0 28.7 33.8 24.5 36.3 29.7 44.8 27.2 22.1 22.5 49.9 43.3 54.8 20.1 22.8 24.2 13.9 23.0 13.5 9.3 36.1 29.6 17.9 25.2 28.6 25.4 34.7 31.1 30.2 28.1 30.8 43.2 13.1 16.4 63.3 20.9 18.0 28.0 12.3 15.0 31.6 33.7 17.0 14.1 38.3 13.3 31.9 21.1 37.2 10.1 83.2 38.5 34.2 12.5 37.7 7.7 48.3 7.7 15.6 43.5 24.4 12.2 17.7 10.4 21.6 61.8 94.2 30.2 20.8 41.6 26.4 21.1 32.2 43.8 68.7 60.4 16.8 35.8 11.5 108.8 27.5 48.7 43.3 18.3 54.8 16.7 22.5 16.6 15.8 39.1 16.2 13.2 14.3 36.4 20.1 37.4 49.9 22.8 24.2 43.1 40.4 22.8 38.5 37.5 45.7 54.3 37.0 35.2 33.8 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell line enhanced" "Detected in many" "HAP1: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA050808: " "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favourable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.5 1.0 2.4 1.6 6.8 7.4 0.4 10.5 12.7 5.0 9.1 5.4 9.0 4.7 3.9 16.9 2.7 24.5 8.8 7.8 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.6 8.5 0.0 2.5 13.7 0.5 2.5 0.7 0.8 1.3 2.8 5.3 0.0 9.1 1.8 1.6 2.9 4.9 1.2 3.1 2.2 1.2 12.8 12.5 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 4.0 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793500-182921635 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 16.8 7.9 7.7 19.7 9.8 35.4 17.0 18.4 9.4 20.5 21.6 8.9 14.3 13.6 15.0 11.7 37.3 11.8 12.7 21.1 6.9 5.9 13.7 14.3 19.4 20.3 10.3 5.7 15.2 14.6 21.0 26.0 8.0 8.3 16.8 16.9 9.8 19.7 13.8 13.1 21.8 22.8 16.5 11.3 23.4 27.6 22.8 8.9 49.0 10.8 20.4 21.9 22.7 25.5 3.6 4.2 7.5 1.8 3.0 3.4 1.3 22.2 3.2 7.0 9.8 15.0 16.4 6.5 10.3 14.2 8.0 9.4 7.9 11.6 10.3 17.7 14.8 13.5 8.4 10.6 14.0 22.9 6.7 24.9 4.3 1.7 8.8 19.6 16.0 11.1 12.0 9.0 13.1 12.6 8.8 32.3 12.9 7.5 16.3 6.3 5.0 6.3 6.8 20.6 12.4 9.7 18.8 4.2 7.6 28.7 3.7 12.5 4.0 14.6 12.3 12.2 13.3 10.5 17.9 44.1 39.4 19.4 8.4 8.4 7.1 7.5 1.7 7.2 3.1 1.8 3.0 3.6 2.7 3.1 1.9 2.4 2.3 3.4 6.8 3.0 1.7 4.2 2.0 1.3 7.7 9.8 18.4 9.4 6.9 5.9 10.3 5.7 8.3 8.9 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.9 5.7 10.2 9.7 11.6 18.1 24.8 17.2 18.7 18.7 34.0 31.3 12.2 19.7 51.1 24.7 17.0 9.7 17.1 43.5 65.7 8.5 10.9 7.6 6.7 20.1 35.4 28.6 8.3 7.7 38.8 25.3 9.7 12.5 39.9 22.7 8.5 14.2 7.1 9.7 9.9 13.0 21.9 11.8 15.8 16.0 15.6 8.3 18.2 19.0 12.8 36.3 24.8 12.6 22.8 19.0 45.3 32.0 26.4 47.5 35.1 45.4 21.0 15.8 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57941541-57957269 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell line enhanced" "Detected in many" "NB-4: 14.8;RH-30: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: " "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.7 4.9 4.3 5.2 5.3 11.3 4.8 6.1 4.8 5.6 8.2 1.3 2.5 3.9 3.2 4.2 7.3 3.1 2.4 6.4 4.2 3.6 5.4 6.2 2.7 6.8 2.7 3.8 4.2 5.8 3.2 3.0 3.5 2.9 5.1 8.2 2.3 3.4 3.3 11.7 5.6 4.3 6.5 3.4 3.7 3.8 39.5 2.0 20.8 4.7 5.9 4.7 6.3 6.2 3.0 4.5 12.0 4.5 2.6 5.6 3.0 1.9 1.5 1.9 2.2 2.8 2.7 1.0 1.9 1.9 2.2 2.1 1.2 2.4 6.8 2.4 1.4 1.8 1.8 1.9 3.8 3.4 1.8 4.4 1.2 1.9 1.2 8.9 3.0 1.4 1.5 1.3 0.5 1.5 4.6 4.9 1.8 3.0 4.8 14.8 1.6 3.7 3.1 48.8 2.8 1.8 2.5 1.2 1.8 3.0 2.8 1.5 4.9 8.4 0.8 1.6 2.8 2.1 1.8 4.0 2.1 3.5 1.8 9.6 2.7 7.6 4.5 12.0 3.5 2.4 2.6 3.0 4.0 3.3 4.5 3.0 4.3 4.0 1.9 2.6 4.2 2.1 5.6 3.0 4.3 5.3 6.1 4.8 4.2 3.6 2.7 3.8 2.9 2.0 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.0;salivary gland: 35.8" "Cell line enhanced" "Detected in some" "HaCaT: 6.3;MCF7: 16.3;RT4: 12.9;SK-BR-3: 22.7;T-47d: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA052262: , HPA075812: " "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favourable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.3 0.0 2.1 8.0 1.5 6.1 2.5 0.2 2.0 3.5 23.0 0.5 1.9 16.3 1.8 1.9 2.7 4.0 18.8 0.4 1.8 1.9 2.6 0.2 21.9 0.2 1.3 0.7 1.3 0.5 0.0 2.9 4.8 0.7 7.9 21.9 1.0 35.8 0.2 0.9 15.2 14.5 0.5 0.6 0.2 3.4 0.4 0.4 0.3 8.2 2.2 8.1 4.8 7.8 0.0 0.0 2.7 0.0 0.0 0.1 0.0 4.1 0.3 0.5 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 3.9 3.6 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 12.9 3.3 0.0 0.0 22.7 0.2 7.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 2.0 1.8 1.9 1.3 0.7 0.7 0.4 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: , HPA060520: " "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favourable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 38.3 44.4 38.5 36.6 46.1 47.9 38.0 30.1 34.2 37.8 33.1 38.3 27.3 40.3 31.8 30.8 32.8 49.5 36.3 51.2 33.3 50.0 44.9 37.6 58.9 30.4 54.3 31.3 50.2 49.4 25.6 27.4 42.4 27.3 43.3 41.5 114.1 52.4 77.5 30.0 84.9 33.7 33.6 36.6 57.6 54.7 33.3 39.8 25.2 47.3 56.7 58.6 64.6 22.8 14.9 23.3 40.1 24.6 33.2 56.4 56.4 34.9 31.0 25.0 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 ATP5S "ATPW, HSU79253" ENSG00000125375 "ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)" Q99766 14 50312326-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046967, HPA062690" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA046967: , HPA062690: " "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favourable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favourable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 5.5 5.0 8.4 6.0 12.5 10.0 7.0 5.6 11.0 5.9 5.2 13.9 7.9 9.4 7.0 7.6 7.9 6.0 5.7 9.0 8.8 9.0 6.8 5.0 5.4 6.6 10.0 10.5 6.3 7.3 3.3 11.2 3.5 10.1 5.6 4.6 8.3 5.6 4.7 11.6 11.7 6.5 3.6 12.4 5.4 5.4 19.8 10.3 5.1 10.1 8.0 6.1 5.1 5.1 17.0 14.2 15.4 14.1 9.2 12.9 9.6 7.8 2.0 3.8 2.1 4.7 8.4 11.8 2.9 3.6 4.9 7.2 3.3 5.9 8.9 2.6 4.6 4.8 1.3 2.7 3.1 5.1 2.4 4.8 4.1 13.8 1.1 7.0 7.3 7.5 6.7 0.7 1.4 3.6 1.5 15.9 3.3 7.1 1.7 5.3 2.4 4.2 5.1 5.6 4.7 2.4 11.2 5.4 3.5 2.3 7.5 5.3 8.0 3.6 2.2 6.3 9.0 3.8 2.9 8.0 5.2 5.2 1.0 5.3 5.0 9.8 10.4 15.4 11.4 11.4 10.0 17.0 9.4 11.0 7.7 14.1 11.9 12.9 1.1 9.2 14.1 14.2 10.8 9.6 8.4 12.5 5.6 11.0 8.8 9.0 10.0 10.5 10.1 10.3 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428632-154436516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain Approved "Plasma membrane,Microtubules,Cytosol" 160000 "Plasma membrane, Microtubules, Cytosol" "CAB015218: " "prognostic unfavourable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favourable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 29.8 37.8 36.6 20.0 50.3 27.5 22.1 59.2 82.7 28.4 26.5 39.4 27.4 24.0 20.6 43.2 29.1 29.6 23.0 35.1 40.8 47.5 42.4 26.9 37.9 21.8 36.5 40.5 24.4 42.6 67.1 41.5 66.1 60.1 41.6 24.7 29.8 35.9 29.4 18.4 30.2 24.2 22.9 39.4 36.4 27.6 21.2 24.2 22.1 39.7 20.9 21.4 27.3 21.1 20.1 68.4 64.0 56.6 23.7 28.9 33.8 22.4 21.4 18.3 31.1 29.7 16.4 34.4 16.6 23.6 25.9 37.8 20.2 28.1 13.3 70.4 35.6 24.1 26.9 15.4 14.3 12.1 27.8 7.6 27.5 20.0 37.4 12.3 56.5 21.8 26.4 24.3 14.0 35.9 9.1 37.6 16.9 32.9 8.9 18.6 6.8 21.9 13.8 12.2 34.5 27.4 18.8 18.3 19.0 14.5 59.3 31.1 26.1 30.4 27.7 18.9 17.1 32.2 27.0 54.3 58.3 15.7 22.6 26.7 19.0 37.4 53.9 64.0 28.6 56.6 28.9 17.5 23.7 24.7 68.4 20.1 21.4 23.5 60.0 23.7 43.4 39.0 26.9 33.8 36.6 50.3 59.2 82.7 40.8 47.5 36.5 40.5 60.1 24.2 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" HPA053771 Approved Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA053771: " "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.3 2.8 0.0 1.2 0.6 0.5 0.2 0.3 2.2 0.2 0.0 2.0 1.1 0.0 2.6 0.5 0.7 1.2 0.0 0.2 15.3 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favourable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favourable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.5 13.5 8.3 14.8 14.0 12.1 4.8 4.6 8.6 9.9 13.0 8.6 14.7 1.2 8.5 9.5 14.2 12.7 7.8 11.5 10.1 13.4 10.5 10.2 6.8 8.6 4.5 19.2 9.0 11.3 15.8 6.8 7.0 38.1 41.4 14.7 5.6 1.8 4.0 5.3 0.1 0.1 8.6 18.2 11.4 5.2 22.9 12.2 7.2 6.6 13.7 15.9 6.8 4.1 8.4 0.3 12.3 5.5 16.9 22.9 2.5 11.3 0.1 9.8 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.2 8.3 8.6 11.6 5.1 4.9 5.3 3.9 4.6 5.1 5.6 6.1 2.6 12.5 2.8 5.3 7.0 11.2 4.1 3.8 8.5 6.3 18.0 6.6 3.5 8.1 11.4 37.1 4.4 3.6 6.0 6.5 4.4 10.9 2.3 5.6 9.0 10.8 14.1 9.0 5.5 10.4 7.5 4.0 4.9 8.1 5.2 8.8 6.6 4.6 5.8 4.8 8.4 6.4 6.5 2.5 7.9 6.5 7.5 8.2 11.7 5.4 6.9 5.5 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747019-113812056 "Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.6" "Group enriched" "Detected in all" 6 "dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035083, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol 2700000 "Nucleoplasm, Vesicles" Cytosol "CAB006910: , HPA035083: AB_2674453, HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favourable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 12.8 19.8 24.1 10.4 33.2 7.4 12.7 34.8 52.8 14.0 11.1 10.3 5.6 9.3 7.5 8.2 13.2 10.0 10.8 4.7 26.2 38.2 47.9 18.2 12.3 11.4 25.4 25.0 6.2 10.5 39.3 13.5 12.3 52.0 11.2 11.8 14.7 18.0 8.4 4.5 12.6 7.9 8.2 13.6 13.7 10.9 8.9 8.3 9.6 21.0 5.7 13.6 10.2 8.2 3.8 16.4 33.6 15.4 3.8 3.4 6.0 25.0 11.4 14.4 12.5 30.3 13.6 15.3 13.6 20.8 14.3 19.8 21.5 20.2 20.5 32.3 19.8 16.3 32.4 17.9 18.8 9.3 8.9 18.2 17.7 16.5 25.1 13.3 21.3 18.3 12.4 18.5 12.9 23.2 20.8 15.6 21.2 16.4 9.7 6.0 18.0 14.3 8.4 10.4 23.3 39.1 23.9 27.9 10.3 23.8 16.2 17.8 24.6 10.8 21.3 13.3 10.0 9.1 8.1 16.3 17.5 19.0 26.2 16.9 14.8 9.2 15.4 5.2 2.8 11.7 2.6 3.8 2.6 2.7 16.4 2.9 2.5 2.9 33.6 3.8 9.5 4.6 3.4 6.0 24.1 33.2 34.8 52.8 26.2 38.2 25.4 25.0 52.0 8.3 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Group enriched" "Detected in some" 9 "BEWO: 13.5;HaCaT: 12.4;SK-BR-3: 30.6" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: " "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.3 0.8 1.6 1.9 13.5 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.7 12.4 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 30.6 0.0 0.3 0.0 0.2 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 ATP6V1C1 "ATP6C, ATP6D, VATC, Vma5" ENSG00000155097 "ATPase H+ transporting V1 subunit C1" P21283 8 103021063-103073051 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023943, HPA057297" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023943: AB_1845197, HPA057297: " "unprognostic (5.73e-3)" "unprognostic (3.30e-1)" "unprognostic (1.09e-2)" "unprognostic (1.93e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-2)" "prognostic unfavourable (8.82e-4)" "unprognostic (3.29e-2)" "unprognostic (3.87e-1)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (3.98e-2)" "unprognostic (1.23e-1)" "unprognostic (3.85e-1)" "unprognostic (3.88e-1)" "unprognostic (2.83e-1)" 17.1 23.1 25.1 16.8 36.7 6.5 15.7 26.2 58.8 13.6 11.1 11.4 7.6 12.1 14.1 10.9 10.6 12.2 13.7 19.0 28.5 28.0 35.0 18.1 12.9 15.9 23.2 33.3 14.4 12.9 21.3 29.2 20.2 45.1 13.2 13.7 11.5 10.4 12.2 11.7 8.5 12.8 14.5 15.0 14.3 12.1 13.0 12.5 10.7 26.9 8.4 15.6 15.5 10.7 10.6 16.3 27.9 24.3 10.0 12.5 10.8 29.5 17.8 9.4 7.0 24.7 16.0 11.6 22.2 22.2 24.9 29.5 13.1 30.0 19.0 25.5 17.6 11.9 18.6 17.3 35.7 12.5 14.3 18.6 13.5 15.6 26.4 9.9 22.4 15.3 22.5 33.5 16.1 18.7 23.6 15.7 27.7 13.4 18.6 7.3 8.3 17.2 10.8 16.7 14.4 27.9 21.3 12.1 10.4 12.5 11.9 38.9 24.8 11.8 22.3 14.5 14.7 32.2 15.5 20.5 7.4 18.1 28.1 20.6 14.0 8.4 17.4 20.6 9.1 24.3 10.2 10.6 7.7 8.9 16.3 10.2 9.0 9.7 27.9 10.0 22.1 8.8 12.5 10.8 25.1 36.7 26.2 58.8 28.5 28.0 23.2 33.3 45.1 12.5 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587746-114598373 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli 150000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: " "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favourable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 34.8 66.4 41.5 36.7 38.0 56.6 56.6 37.5 49.4 45.2 34.2 23.4 42.3 26.7 43.7 91.0 57.5 32.3 39.2 45.4 40.8 52.5 84.9 65.9 45.3 50.0 52.2 39.5 49.2 55.9 39.5 79.4 77.8 44.7 65.3 33.2 49.2 63.2 45.1 54.9 40.8 33.2 31.7 35.6 66.5 52.7 58.3 25.6 51.7 65.2 53.5 53.4 45.8 40.1 99.9 81.6 96.6 67.9 50.0 85.1 121.6 17.9 17.3 35.7 8.7 29.6 21.5 33.1 28.1 22.3 23.3 16.7 23.2 21.7 17.4 24.6 20.0 40.8 26.6 21.2 19.6 13.8 18.3 16.7 21.9 33.7 41.5 37.2 31.0 27.4 57.1 18.6 23.2 22.0 32.0 37.0 31.8 39.0 35.9 23.5 42.2 32.7 34.9 22.9 27.9 47.6 30.9 26.9 34.4 37.8 66.1 99.7 53.6 44.2 29.3 19.0 15.1 29.5 31.4 49.9 97.9 30.4 24.5 22.4 26.0 78.3 67.9 96.6 46.7 63.9 57.9 99.9 65.6 56.0 50.9 94.2 85.1 67.1 87.3 50.0 65.8 81.6 76.5 121.6 41.5 38.0 37.5 49.4 40.8 52.5 52.2 39.5 44.7 25.6 ATP6V1H "CGI-11, SFD, SFDalpha, SFDbeta, VMA13" ENSG00000047249 "ATPase H+ transporting V1 subunit H" Q9UI12 8 53715557-53843558 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009532, HPA023421" Approved Approved "Actin filaments,Cytosol" 48000 "Actin filaments" Cytosol "CAB009532: AB_667834, HPA023421: AB_1845202" "unprognostic (1.67e-3)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (2.16e-2)" "unprognostic (2.38e-1)" "unprognostic (2.25e-2)" "prognostic unfavourable (7.81e-4)" "unprognostic (2.01e-1)" "unprognostic (1.95e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-1)" "unprognostic (5.30e-2)" "prognostic favourable (1.46e-7)" "unprognostic (1.06e-1)" "unprognostic (3.37e-2)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" 14.1 25.1 42.2 9.7 41.5 14.0 15.8 22.5 46.2 14.6 12.1 12.0 10.5 8.3 13.7 19.3 18.1 13.1 11.6 17.2 39.0 25.5 36.6 11.3 13.8 11.1 21.4 30.0 15.0 11.7 27.0 20.0 14.0 30.0 19.6 12.0 12.7 16.4 18.2 17.3 14.4 8.3 14.6 14.7 10.2 13.3 10.8 11.3 15.3 30.0 11.5 12.3 15.3 11.0 12.0 16.3 30.6 17.0 18.8 17.7 9.3 19.1 13.4 12.3 13.3 21.9 14.0 10.5 21.3 19.2 24.5 24.8 12.4 22.2 12.2 20.0 17.2 30.1 20.3 26.4 21.7 19.0 16.4 13.4 14.1 15.2 31.8 8.5 15.0 20.9 32.8 16.8 26.2 16.3 16.9 6.0 31.1 13.4 13.5 13.5 12.1 8.0 11.7 4.9 7.7 34.7 25.7 9.9 16.4 12.3 22.1 33.2 28.1 7.3 19.0 10.9 10.0 26.0 11.5 12.8 12.8 14.2 26.2 11.6 11.8 19.0 11.5 30.6 11.5 13.0 13.1 12.0 14.2 13.7 16.3 10.8 13.8 14.3 13.8 18.8 17.0 13.4 17.7 9.3 42.2 41.5 22.5 46.2 39.0 25.5 21.4 30.0 30.0 11.3 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012887: AB_1845205, HPA048107: " "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 9.8 7.4 2.6 8.6 4.6 6.4 8.5 2.3 2.9 8.2 7.7 5.9 9.6 4.8 9.5 7.6 10.0 5.7 4.5 5.1 2.9 2.8 9.0 3.3 9.3 9.3 4.1 1.7 7.3 6.3 13.2 15.9 5.0 4.3 8.2 4.4 5.2 12.3 10.3 6.1 15.9 8.5 7.8 6.3 10.8 7.0 2.7 6.0 15.6 6.0 7.1 11.7 11.8 7.0 2.3 1.4 10.7 2.4 1.7 3.0 1.2 2.5 6.7 4.5 4.6 4.3 4.5 0.8 3.9 5.4 2.3 4.8 0.9 3.0 3.7 5.8 3.8 3.1 5.8 3.1 4.4 5.5 4.0 1.9 6.5 0.7 5.4 3.3 3.5 4.8 1.3 5.0 1.5 6.1 15.3 14.4 4.3 2.2 3.5 1.1 1.3 1.4 2.9 7.5 12.6 3.9 7.2 1.4 17.1 9.6 2.4 4.9 1.8 1.1 7.7 3.1 3.1 4.3 1.5 4.7 8.3 4.3 5.1 2.0 4.7 8.3 2.0 5.5 2.4 1.9 1.2 2.0 1.7 1.7 1.3 2.3 2.1 3.0 10.7 1.7 2.4 1.4 0.6 1.2 2.6 4.6 2.3 2.9 2.9 2.8 4.1 1.7 4.3 6.0 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell line enriched" "Detected in some" 6 "HMC-1: 21.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: " "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;HBF TERT88: 24.3;RT4: 57.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favourable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favourable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.1 3.4 0.1 0.1 3.5 6.4 4.9 19.6 19.1 20.6 12.9 2.6 8.8 0.7 5.9 27.1 15.0 0.1 4.1 24.3 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.7 6.2 10.9 10.8 0.1 0.4 11.9 4.8 0.2 0.2 0.2 1.0 0.1 0.1 0.2 2.8 57.5 0.4 0.3 0.4 12.1 0.1 3.7 0.6 12.4 16.8 0.6 2.7 4.5 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Cell line enhanced" "Detected in some" "HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 3.0 0.6 0.0 0.0 5.2 18.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 12.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 37.6 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449235-142578826 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA054320: " "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavourable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 10.5 24.3 7.7 11.4 15.9 10.1 14.8 11.3 14.6 10.1 8.5 10.0 10.4 6.0 14.7 16.8 9.4 12.1 9.3 8.8 9.8 7.1 9.6 12.0 10.3 16.0 10.0 8.1 12.3 13.6 18.0 22.5 8.8 12.5 11.0 11.2 9.5 12.5 10.8 7.7 11.2 10.9 9.8 8.8 14.2 9.0 15.3 9.7 19.0 13.8 7.7 15.1 10.9 10.6 5.8 2.8 2.2 4.0 6.7 6.0 0.8 22.5 11.1 7.4 8.4 10.6 11.6 8.8 12.4 7.0 9.3 9.6 5.2 7.2 18.4 12.9 8.8 14.6 10.9 11.5 14.1 5.9 7.2 10.1 8.4 5.0 4.7 16.9 5.7 9.1 6.4 8.8 10.5 9.6 7.0 8.3 9.5 9.9 12.7 7.0 7.1 7.9 10.6 10.8 13.3 9.4 10.5 5.3 5.3 22.9 8.3 8.1 12.1 6.9 12.4 9.5 4.8 12.3 13.3 10.8 6.4 17.1 12.3 6.6 7.5 0.7 2.7 2.2 4.4 4.0 6.0 3.1 3.2 4.2 2.8 5.8 4.1 4.0 1.7 6.7 2.5 2.5 2.4 0.8 7.7 15.9 11.3 14.6 9.8 7.1 10.0 8.1 12.5 9.7 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;LHCN-M2: 9.3;RH-30: 13.7;SH-SY5Y: 9.8;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.4 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 6.9 9.3 0.2 8.0 0.0 6.6 0.1 5.9 13.7 8.8 3.1 0.0 3.4 9.8 0.0 0.0 0.2 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: " "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.3 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.6 2.2 2.6 2.1 2.1 0.1 5.0 7.1 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.6 3.1 5.5 3.7 4.4 4.7 4.0 4.6 0.0 4.1 1.9 1.7 0.2 3.6 0.7 3.3 0.2 4.5 3.0 3.1 5.8 0.2 1.9 3.4 4.3 7.0 2.8 5.4 7.0 3.2 4.9 3.7 3.3 24.1 13.8 0.1 2.0 3.2 7.7 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 ATXN10 "E46L, FLJ37990, SCA10" ENSG00000130638 "Ataxin 10" Q9UBB4 22 45671798-45845307 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049531 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA049531: " "unprognostic (5.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (3.01e-2)" "unprognostic (7.50e-2)" "unprognostic (1.19e-3)" "unprognostic (3.18e-1)" "unprognostic (2.15e-2)" "unprognostic (5.07e-2)" "unprognostic (8.38e-2)" "unprognostic (3.51e-1)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (7.48e-2)" "unprognostic (6.98e-2)" 18.1 33.3 40.2 20.6 40.5 20.9 38.5 31.7 75.3 28.5 20.6 20.9 22.0 13.8 28.8 23.9 27.5 33.6 23.3 42.3 44.5 42.4 32.0 37.0 30.5 38.8 35.6 41.2 35.4 33.5 39.7 32.6 28.1 38.1 28.3 21.8 18.0 22.6 30.1 47.5 18.3 13.6 29.7 38.3 18.3 18.5 31.5 22.3 34.0 37.2 21.8 28.7 26.8 21.8 23.3 52.2 28.1 40.4 25.2 31.0 33.3 40.8 21.2 41.2 24.9 18.9 28.5 22.2 46.8 50.0 33.5 36.8 10.6 27.5 42.2 19.3 46.8 24.5 29.7 31.2 36.2 7.7 30.6 19.8 40.8 20.3 27.3 52.8 14.8 29.3 21.7 17.4 27.4 24.4 14.4 23.5 50.7 17.4 28.7 23.8 27.2 16.4 41.5 15.8 34.2 42.6 39.1 22.8 35.8 29.1 17.5 31.6 26.4 28.3 22.2 33.9 12.6 12.1 15.3 23.1 13.9 34.0 21.1 22.2 35.9 19.0 31.7 28.1 23.4 37.6 31.0 23.3 23.3 28.3 52.2 22.6 25.7 24.8 1.5 25.2 40.4 18.5 21.9 33.3 40.2 40.5 31.7 75.3 44.5 42.4 35.6 41.2 38.1 22.3 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: " "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.0 9.3 14.6 14.3 19.6 6.4 10.4 8.2 11.4 8.0 15.7 11.5 12.8 10.5 9.8 7.7 14.0 18.1 13.1 2.3 4.9 5.4 11.7 12.1 8.6 8.8 11.6 12.5 14.3 15.0 12.6 6.5 8.6 12.4 21.9 9.0 7.8 7.1 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.5 6.6 8.8 12.3 6.0 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000163635 "Ataxin 7" O15265 3 63898399-64003453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in many" HPA034989 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favourable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 8.8 6.4 4.9 14.5 7.4 19.7 8.9 10.2 6.5 9.5 10.7 4.9 6.7 8.0 10.9 9.2 9.2 7.5 11.4 7.5 5.0 4.3 6.3 8.2 10.2 19.9 6.1 3.1 12.4 21.7 15.3 10.9 15.1 6.0 8.2 8.1 15.1 12.2 7.8 9.6 10.6 12.5 9.2 5.7 11.1 7.2 14.6 6.7 55.4 8.8 8.5 24.2 8.4 10.2 0.9 0.5 11.1 0.5 2.6 5.9 1.1 5.9 4.8 5.0 4.0 5.7 6.5 6.5 3.5 6.4 7.4 6.0 6.8 5.8 5.7 2.1 6.7 3.9 6.3 6.5 7.9 15.0 2.6 10.0 5.7 2.0 2.9 4.2 12.1 6.2 3.5 11.0 12.2 5.5 3.7 17.5 4.6 14.2 8.8 3.4 3.4 2.2 3.8 4.5 6.9 3.6 7.1 2.0 3.7 7.7 5.2 7.0 3.6 6.0 7.6 6.4 8.7 9.3 8.0 7.9 7.9 6.4 7.6 7.0 6.1 11.1 0.3 0.9 3.2 0.5 2.6 0.0 5.9 3.4 0.1 0.9 5.7 3.7 1.2 2.6 0.1 0.5 4.7 1.1 4.9 7.4 10.2 6.5 5.0 4.3 6.1 3.1 6.0 6.7 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000285258 "Ataxin 7" O15265 3 63864557-64003462 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.9" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034989: AB_10602596" 0.4 0.0 1.5 2.8 1.3 0.0 2.0 0.7 0.0 2.0 2.0 0.0 0.9 0.8 0.0 1.0 0.9 0.9 2.1 0.5 1.0 3.0 1.9 0.9 0.9 0.5 0.6 0.3 3.1 0.8 0.3 1.5 1.0 0.0 0.8 1.8 0.1 4.9 3.6 8.9 1.9 2.5 4.3 0.7 2.4 0.1 3.4 3.2 3.2 6.0 3.3 3.0 2.5 4.0 5.5 1.4 3.2 6.8 1.1 2.0 2.7 3.3 2.3 4.8 6.5 2.5 6.2 4.2 2.4 4.5 4.5 5.7 1.8 6.8 5.1 6.7 2.9 2.3 9.7 2.8 13.0 2.9 3.9 2.2 0.8 5.7 2.9 2.4 2.5 3.3 1.1 1.7 5.9 4.8 3.8 1.4 6.6 4.0 6.0 3.3 3.6 4.6 5.3 4.7 4.2 2.3 4.7 3.5 5.7 1.9 2.7 2.5 1.2 2.9 4.9 2.9 2.4 1.6 4.3 3.5 2.5 8.9 2.5 1.4 3.6 4.3 0.7 ATXN7L1 "ATXN7L4, KIAA1218, MGC33190" ENSG00000146776 "Ataxin 7 like 1" Q9ULK2 7 105605067-105876604 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021448 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021448: AB_1845213" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (4.36e-2)" "unprognostic (1.01e-2)" "unprognostic (2.84e-1)" "unprognostic (8.20e-3)" "unprognostic (3.69e-1)" "unprognostic (2.51e-2)" "unprognostic (8.71e-2)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-2)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 10.8 10.7 10.3 12.1 16.6 7.7 10.6 24.7 13.4 13.3 11.7 9.7 12.3 7.9 9.2 9.1 9.6 11.7 8.4 6.4 8.5 6.2 14.1 12.3 7.8 15.6 7.1 7.3 13.3 7.2 11.2 17.8 10.8 6.9 10.1 11.6 8.3 11.4 12.1 5.2 12.2 10.9 9.7 6.9 10.4 9.8 20.8 9.9 12.4 11.8 4.6 17.9 11.3 11.7 3.9 3.1 4.3 4.8 4.2 14.5 3.4 2.8 3.8 8.3 3.9 5.1 6.0 2.6 5.1 5.1 4.6 4.3 3.7 5.5 1.1 4.0 5.4 2.7 4.6 5.3 3.4 15.9 3.1 3.8 2.8 3.6 3.0 6.2 12.8 4.1 4.3 3.1 3.1 4.1 4.5 2.6 3.8 6.8 3.4 3.5 15.3 3.9 3.4 2.8 0.8 3.5 2.9 5.2 3.4 3.6 7.3 7.2 3.8 6.4 10.4 7.3 3.3 5.9 2.0 0.5 0.0 0.1 4.5 9.7 7.2 2.3 4.2 4.3 2.9 4.8 2.1 3.9 7.5 6.4 3.1 3.6 8.2 4.7 1.4 4.2 2.8 2.1 14.5 3.4 10.3 16.6 24.7 13.4 8.5 6.2 7.1 7.3 6.9 9.9 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved Nucleoli,Vesicles,Cytosol Nucleoli "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: " "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 4.2 5.2 7.5 4.0 9.2 10.2 2.6 15.2 10.9 2.8 2.8 5.1 1.2 2.7 4.4 1.8 2.8 3.3 3.8 2.0 6.5 3.3 3.4 3.0 3.4 3.8 5.7 7.0 7.3 2.4 1.6 9.9 2.5 4.7 2.2 1.4 5.7 1.8 3.2 13.3 3.5 3.1 2.0 3.1 5.4 2.9 8.8 4.8 2.7 4.2 1.0 2.6 3.2 2.4 2.4 1.3 2.4 2.4 2.7 5.6 2.2 2.2 1.7 1.2 4.5 1.6 2.9 3.2 1.6 2.1 3.4 2.2 3.6 1.5 5.8 2.6 2.0 2.5 2.4 2.2 0.4 5.3 3.4 3.2 3.6 1.6 1.0 4.8 7.6 3.1 1.2 3.5 0.0 0.8 5.3 3.3 0.6 7.0 8.4 6.3 7.0 2.5 5.9 2.9 4.1 1.2 2.3 10.6 4.3 1.7 5.7 2.6 1.0 5.0 0.3 2.4 7.0 2.2 6.4 2.1 1.4 5.5 2.8 4.0 6.0 0.0 1.9 2.4 5.4 2.4 5.0 2.3 4.3 5.6 1.3 2.4 4.0 3.8 1.9 2.7 1.6 1.0 3.8 2.2 7.5 9.2 15.2 10.9 6.5 3.3 5.7 7.0 4.7 4.8 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA064316: " "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 14.0 12.9 36.7 18.9 25.1 23.8 11.9 23.0 53.1 13.2 16.1 11.3 16.7 19.1 14.3 16.9 22.3 14.2 14.9 12.4 30.7 24.8 12.4 12.6 14.3 20.8 22.7 32.1 13.2 13.7 16.3 17.1 18.8 23.6 13.0 15.3 7.9 16.9 18.5 11.3 19.0 16.5 16.1 15.1 17.6 15.5 17.0 14.1 13.9 14.3 11.3 21.3 16.7 22.4 5.1 4.4 6.7 3.2 1.3 4.8 2.6 17.5 29.8 32.9 21.3 23.0 22.9 17.9 21.6 24.2 27.7 26.3 22.7 20.0 30.9 17.4 24.3 19.4 25.6 20.3 23.3 36.0 25.4 20.9 24.5 25.1 22.7 32.6 42.6 25.8 31.0 23.2 24.6 26.7 27.9 19.4 18.2 13.2 39.1 24.9 24.7 23.4 27.0 31.9 23.1 22.3 25.3 21.0 26.6 12.8 11.3 22.1 27.7 29.1 22.9 28.0 29.4 14.5 20.1 23.5 30.5 37.4 18.4 14.2 16.3 1.4 3.2 3.7 4.8 2.2 2.9 3.6 3.8 3.0 2.7 5.1 2.9 3.6 6.7 1.3 2.3 4.4 2.0 2.6 36.7 25.1 23.0 53.1 30.7 24.8 22.7 32.1 23.6 14.1 AUP1 ENSG00000115307 "AUP1, lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529939 "Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavourable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 18.8 21.7 13.9 15.5 16.9 9.4 24.2 18.0 16.7 25.7 28.2 14.6 18.4 14.0 14.6 17.8 25.6 15.4 12.5 14.1 11.8 11.2 19.2 44.5 14.4 21.1 18.4 8.0 11.8 44.2 26.4 14.1 20.6 15.1 13.6 25.9 13.5 29.8 17.6 34.6 25.2 31.3 18.0 12.2 18.2 26.0 10.6 14.4 13.5 19.0 11.7 19.9 16.7 13.5 26.3 38.0 30.6 46.3 20.7 31.6 36.4 16.0 24.2 6.2 10.5 36.8 18.4 17.0 11.7 26.8 21.7 11.4 37.6 11.6 16.5 8.3 22.7 19.8 26.6 20.5 15.4 14.2 25.3 24.4 12.3 31.3 38.9 12.7 12.7 24.3 45.3 32.7 30.3 22.7 32.2 22.8 23.1 23.1 13.2 15.3 16.0 20.7 17.1 25.5 48.4 24.2 13.7 9.9 11.1 11.6 35.8 27.7 15.7 20.3 8.6 17.6 10.9 4.2 18.5 5.8 9.2 20.2 21.0 17.3 31.0 28.4 39.3 30.6 25.0 46.3 30.2 24.3 26.4 27.3 38.0 26.3 22.1 24.7 19.1 20.7 40.4 35.8 31.6 36.4 13.9 16.9 18.0 16.7 11.8 11.2 18.4 8.0 15.1 14.4 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 32.5 24.0 16.1 11.3 0.9 2.1 20.4 26.7 12.5 64.7 27.3 67.2 22.8 10.7 18.4 10.9 26.3 28.5 17.9 69.0 9.6 10.9 19.0 24.6 41.8 0.5 25.4 26.8 1.0 1.9 22.4 20.1 15.1 21.5 8.5 27.5 33.2 15.2 19.7 14.7 24.8 11.6 31.1 11.8 10.3 8.6 13.9 7.5 37.3 43.0 17.9 25.5 15.9 8.6 28.1 27.9 15.5 37.6 11.9 13.8 18.5 15.2 14.8 23.2 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favourable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 26.6 29.3 30.3 19.6 30.5 20.9 16.3 17.8 40.5 14.1 27.9 18.7 18.3 33.5 14.3 18.3 25.0 14.5 22.9 55.2 25.3 23.4 35.0 59.1 14.4 17.6 29.0 23.0 14.8 41.2 16.8 18.7 23.6 21.9 17.2 13.6 20.0 35.8 20.4 115.9 20.2 29.5 15.9 18.5 16.9 24.7 73.8 12.6 16.0 27.1 41.4 20.7 18.2 15.2 53.4 81.9 82.5 67.5 36.1 61.6 59.2 38.7 23.6 12.9 23.2 11.5 14.5 23.9 23.6 15.7 37.4 26.6 41.3 36.0 20.5 35.2 15.9 28.7 17.7 31.2 10.8 24.5 50.1 16.5 30.9 38.1 22.6 21.3 22.5 19.0 14.1 26.2 10.6 20.2 32.5 28.4 21.7 29.6 26.1 76.1 24.4 67.2 30.5 15.9 44.0 29.5 10.3 41.5 31.1 16.9 59.1 56.0 25.6 49.9 15.2 23.2 29.8 27.6 34.7 37.1 33.8 43.0 32.3 31.5 15.6 60.8 67.5 70.6 51.1 53.6 48.4 53.1 53.9 53.7 58.0 53.4 50.7 49.3 82.5 36.1 46.0 81.9 61.6 59.2 30.3 30.5 17.8 40.5 25.3 23.4 29.0 23.0 21.9 12.6 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "CAB005862: AB_449204, HPA037708: " "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.0 28.2 42.0 20.2 0.9 1.4 16.1 19.7 10.6 40.8 37.7 36.5 12.4 41.0 10.2 7.8 30.2 30.5 13.5 33.8 18.0 50.1 24.4 16.1 30.8 0.1 12.9 24.0 0.7 0.6 23.9 15.0 18.8 15.2 15.9 17.9 19.5 46.8 18.3 26.1 12.6 31.7 38.7 17.0 8.9 8.1 9.1 13.0 17.5 7.9 13.4 13.8 8.7 7.3 16.4 16.9 14.7 51.2 11.6 7.7 30.8 7.9 19.6 33.1 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "AUTS2, activator of transcription and developmental regulator" Q8WXX7 7 69598296-70793495 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.5;REH: 26.9;SCLC-21H: 37.8;T-47d: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.6;naive B-cell: 11.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 10.3 7.3 29.3 11.6 30.3 9.3 20.3 14.3 19.1 10.5 14.0 17.3 4.1 8.9 10.5 12.4 13.7 8.0 16.6 5.6 22.2 12.9 14.6 19.7 14.7 6.1 14.8 12.3 17.2 6.0 9.9 17.4 5.7 18.9 14.6 13.1 9.9 52.1 8.3 14.9 23.3 18.8 13.6 10.2 8.2 11.3 10.0 20.6 10.5 6.7 7.9 8.9 13.0 10.8 11.6 3.2 0.8 0.2 1.5 2.2 0.7 0.1 2.4 27.5 1.4 1.8 1.1 0.3 1.7 0.0 0.1 0.1 9.3 0.1 4.0 0.6 1.6 8.9 3.3 3.7 0.7 18.3 7.4 2.0 2.6 0.1 0.8 0.0 0.1 2.9 5.1 4.1 1.0 0.0 0.1 2.2 2.3 1.5 0.4 0.7 19.6 0.0 26.9 13.4 11.4 0.0 4.1 37.8 20.6 1.7 3.0 0.0 25.9 0.0 0.0 0.1 9.3 2.9 16.9 0.0 0.0 13.9 0.0 0.0 0.0 0.8 0.2 0.2 1.6 0.1 2.2 8.6 1.1 1.5 0.7 11.6 0.2 0.9 0.5 1.5 0.1 3.2 0.2 0.7 29.3 30.3 14.3 19.1 22.2 12.9 14.8 12.3 18.9 20.6 AVEN PDCD12 ENSG00000169857 "Apoptosis and caspase activation inhibitor" Q9NQS1 15 33866227-34039176 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020863 Approved Approved "Plasma membrane,Actin filaments,Centrosome" "Plasma membrane, Actin filaments" Centrosome "HPA020863: AB_1845219" "unprognostic (1.54e-3)" "unprognostic (1.99e-1)" "unprognostic (8.93e-2)" "unprognostic (5.77e-2)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (6.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (4.14e-3)" "unprognostic (1.79e-1)" "prognostic unfavourable (5.29e-10)" "unprognostic (7.66e-3)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-3)" 11.0 11.1 7.1 8.7 7.7 5.2 16.1 14.4 8.8 9.6 12.4 6.8 8.6 9.0 13.4 9.5 11.5 8.9 10.6 35.0 6.9 8.7 5.8 16.7 8.0 6.0 8.6 6.8 10.3 41.0 3.6 9.0 15.0 8.3 10.6 12.2 5.4 9.8 11.8 25.7 9.3 9.9 15.3 8.1 7.3 10.9 14.1 6.1 9.9 5.4 11.6 9.4 11.6 15.0 1.2 6.1 0.2 1.7 1.2 2.3 0.3 8.3 13.6 14.1 4.6 11.5 13.1 8.4 21.3 19.1 17.1 11.0 3.7 5.9 7.8 13.2 17.9 5.7 6.4 13.9 14.1 7.6 4.2 13.5 8.9 10.4 17.2 13.5 9.9 10.9 27.5 10.0 24.4 18.3 13.3 11.5 23.7 8.9 5.3 23.3 6.6 4.7 8.1 7.9 16.7 13.9 11.0 7.5 9.1 11.8 6.2 5.8 6.7 15.0 12.9 15.1 5.2 6.4 17.6 11.3 8.9 16.5 7.2 15.9 8.0 0.0 0.8 0.0 1.6 1.7 2.0 1.2 1.7 0.6 0.6 0.6 0.8 1.1 0.2 1.2 0.7 6.1 2.3 0.3 7.1 7.7 14.4 8.8 6.9 8.7 8.6 6.8 8.3 6.1 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687323 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.4;HHSteC: 29.3;hTCEpi: 55.3;SK-MEL-30: 44.6;U-2197: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 21.5 27.4 5.1 4.7 8.5 3.3 11.0 6.3 17.7 13.0 18.6 3.6 4.8 10.7 5.8 8.2 16.3 6.5 19.9 8.5 5.5 5.8 5.6 29.9 17.1 1.7 7.3 5.6 43.3 10.8 4.1 7.2 19.3 8.0 15.3 15.0 13.6 10.7 13.8 8.3 35.5 15.3 8.5 12.6 11.9 12.7 8.4 2.5 1.3 8.2 9.7 7.6 22.0 16.6 3.5 12.4 2.3 7.1 2.0 5.0 3.0 8.9 23.4 0.1 3.4 4.9 2.2 4.8 4.4 23.9 6.0 9.1 4.3 11.2 0.2 3.1 2.4 9.4 1.8 7.6 2.2 0.2 2.1 0.6 28.4 12.0 29.3 0.5 0.7 3.6 55.3 4.5 11.9 0.8 1.3 0.4 3.3 7.6 0.4 0.7 0.8 2.2 0.3 2.7 0.3 5.8 4.8 0.4 0.9 15.1 5.4 44.6 4.1 0.7 1.3 1.4 2.8 32.3 1.0 1.0 0.7 0.1 5.4 1.8 0.9 0.0 7.1 2.3 5.0 6.1 2.3 3.5 3.3 3.7 12.4 2.2 3.6 4.4 0.7 2.0 0.5 2.4 2.9 3.0 5.1 8.5 6.3 17.7 5.5 5.8 7.3 5.6 8.0 2.5 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 10.8 8.3 13.7 18.9 17.1 28.1 21.0 26.4 13.6 10.4 15.8 12.7 9.4 17.3 12.6 8.5 14.1 10.7 12.7 11.0 11.5 7.7 9.8 9.6 13.6 13.4 15.6 10.6 13.3 17.7 11.1 11.9 8.4 13.9 11.4 10.2 9.6 13.9 9.5 17.7 16.9 17.6 18.9 9.6 15.1 15.2 9.6 14.6 17.5 12.7 7.5 14.5 11.9 22.9 1.8 1.4 5.5 1.1 3.6 10.4 2.4 9.4 13.8 7.3 12.9 5.5 5.1 15.5 6.4 5.9 8.9 7.7 20.2 11.1 14.7 9.9 6.6 13.7 11.5 10.0 4.0 14.4 18.8 9.5 11.5 14.7 9.4 10.9 10.6 5.0 17.5 9.2 11.3 5.8 23.7 8.1 4.0 25.4 11.7 7.6 16.8 8.4 22.2 6.7 20.4 6.7 5.6 16.8 10.3 12.2 13.7 20.1 9.0 13.9 6.6 8.9 9.5 10.2 9.2 9.4 9.2 18.0 4.2 7.3 8.7 1.4 1.1 5.5 10.4 0.9 9.5 1.8 3.0 7.0 0.8 1.6 3.2 4.3 3.2 3.6 0.7 1.4 3.0 2.4 13.7 17.1 26.4 13.6 11.5 7.7 15.6 10.6 13.9 14.6 AXIN2 "DKFZp781B0869, MGC126582" ENSG00000168646 "Axin 2" Q9Y2T1 17 65528563-65561647 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.3;CACO-2: 24.7;Hep G2: 36.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 33.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012283, CAB017783" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "CAB012283: AB_2290204, CAB017783: " "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.48e-1)" "unprognostic (9.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (4.57e-2)" "unprognostic (8.84e-3)" "prognostic favourable (6.58e-4)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (3.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.74e-1)" "unprognostic (1.25e-1)" 7.4 10.1 9.0 7.0 8.9 0.9 5.2 8.2 13.1 16.5 12.2 8.7 10.5 7.2 29.0 7.7 6.5 18.6 6.9 7.3 7.9 5.7 3.5 2.5 15.2 3.4 5.3 10.3 14.7 3.9 3.2 5.8 18.2 10.6 14.8 15.2 7.8 4.6 9.8 12.4 14.9 7.5 18.0 4.8 6.9 14.6 6.8 9.0 27.6 11.3 3.6 3.8 11.8 8.7 4.1 0.0 4.4 0.0 1.9 5.1 0.8 0.0 6.6 13.3 0.2 4.8 2.0 5.9 0.2 0.6 0.4 0.8 24.7 2.4 0.4 0.8 3.8 0.2 2.7 0.0 0.9 1.1 1.5 0.0 1.1 36.9 0.5 0.0 0.0 1.2 1.0 1.0 0.3 1.1 0.1 0.6 0.6 0.1 6.4 0.0 2.6 0.3 4.6 0.7 0.0 1.2 0.1 4.1 2.7 0.2 0.1 2.3 0.4 0.1 3.0 2.6 4.8 3.7 0.8 0.0 1.3 1.7 1.2 0.3 1.2 4.4 0.0 0.0 0.3 0.0 0.8 1.0 2.3 0.4 0.0 4.1 5.1 0.8 0.0 1.9 0.0 0.0 0.0 0.8 9.0 8.9 8.2 13.1 7.9 5.7 5.3 10.3 10.6 9.0 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 66.1;U-251 MG: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 52.5 21.2 1.3 0.1 4.8 4.8 0.0 41.8 37.6 61.4 38.1 1.1 24.7 0.0 17.0 66.1 4.4 0.0 28.1 52.9 0.0 0.0 0.0 14.0 0.8 17.4 0.0 0.0 3.6 0.5 36.2 56.2 22.7 2.0 0.0 38.0 0.0 0.0 0.0 0.5 10.2 0.0 22.4 0.0 27.4 0.0 0.0 0.0 10.8 0.0 0.2 0.1 0.9 46.6 43.5 29.7 41.5 70.8 0.0 0.1 0.1 29.0 0.0 32.3 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711477-44718877 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Immunity "Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" 3200000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 127.2 50.9 24.2 109.2 29.8 131.1 85.2 11.8 23.1 70.5 111.4 29.1 43.3 79.1 72.7 74.7 80.5 36.8 112.8 73.6 26.0 23.1 109.7 140.3 191.2 172.1 42.2 18.8 54.8 42.7 7.8 40.5 91.9 33.1 78.7 128.9 53.5 121.5 40.9 45.7 94.1 178.5 55.1 56.7 272.8 52.5 30.0 29.5 108.0 97.7 71.5 131.6 135.9 73.5 138.9 74.9 341.3 132.8 128.8 215.8 323.7 33.1 14.7 1.4 8.3 54.6 73.6 52.1 22.0 44.9 35.8 60.9 19.1 77.4 15.8 31.1 21.4 29.3 5.5 9.8 17.2 110.7 13.0 60.2 89.2 22.1 41.6 33.7 36.1 37.2 9.1 11.0 11.8 24.4 15.3 2.2 39.6 17.7 13.8 89.0 2.4 31.4 16.8 36.0 100.3 31.2 137.5 5.8 2.1 23.0 18.7 25.9 6.2 175.3 48.5 70.3 7.8 92.6 42.9 41.0 93.8 29.5 68.5 111.3 33.6 221.2 90.4 210.9 126.8 132.8 125.9 138.9 171.7 141.1 58.9 109.4 137.0 167.5 341.3 128.8 106.5 74.9 215.8 323.7 24.2 29.8 11.8 23.1 26.0 23.1 42.2 18.8 33.1 29.5 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235449923-235504481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 35.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012502, HPA050662" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA012502: AB_1845228, HPA050662: " "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 5.0 6.3 3.9 4.3 5.1 1.3 8.4 4.7 4.5 5.4 7.6 3.5 5.1 3.3 8.0 8.7 10.3 6.1 9.7 7.9 2.8 2.9 3.7 4.6 3.7 3.1 3.0 3.2 5.9 35.7 9.8 8.9 4.5 4.7 8.3 5.8 8.5 8.7 7.3 21.6 6.1 6.9 16.9 2.5 3.3 9.2 5.8 3.9 4.7 7.1 7.0 5.0 9.7 5.9 1.5 5.7 2.4 2.7 1.9 1.9 1.3 10.0 6.6 7.3 10.8 11.8 10.0 17.6 8.8 8.0 6.7 6.2 5.1 9.0 5.3 11.7 10.0 12.7 14.2 10.3 8.2 10.4 9.8 3.3 8.4 5.8 7.5 10.8 3.7 7.2 6.7 6.9 16.6 10.2 8.1 7.1 6.2 4.8 6.8 3.9 10.4 3.8 7.5 12.2 13.4 4.3 12.0 9.4 12.0 15.3 5.8 7.6 11.1 11.0 10.0 5.9 9.7 9.9 11.8 10.4 8.5 3.2 3.8 7.8 13.6 2.4 2.3 1.1 1.1 2.7 1.7 1.5 0.8 1.9 5.7 1.1 1.0 1.3 0.2 1.9 2.5 3.1 0.5 1.3 3.9 5.1 4.7 4.5 2.8 2.9 3.0 3.2 4.7 3.9 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Group enriched" "Detected in some" 4 "AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA078659: " "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.0 0.0 0.4 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 8.0;hTCEpi: 9.7;T-47d: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055261: " "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.4 1.0 0.3 2.1 0.2 0.1 1.0 0.1 0.0 0.3 0.6 3.4 0.4 0.5 0.9 0.0 2.0 2.6 2.1 0.1 8.0 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.7 0.1 0.4 0.0 1.5 0.6 0.2 4.8 0.0 0.7 0.6 2.0 0.4 0.6 1.0 1.4 0.6 1.3 1.7 1.5 1.0 0.5 7.5 0.1 0.1 0.5 2.8 0.5 0.3 0.6 4.9 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 B3GNT9 MGC4655 ENSG00000237172 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9" Q6UX72 16 67148105-67151214 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.5;T-cells: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052743, HPA062734" Approved Approved "Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "Nucleoli fibrillar center" "HPA052743: , HPA062734: " "unprognostic (2.56e-2)" "unprognostic (2.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.07e-1)" "unprognostic (6.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.28e-2)" "unprognostic (3.01e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (4.96e-3)" "unprognostic (7.56e-3)" 5.6 7.3 5.0 5.2 7.1 0.6 7.2 0.9 8.8 12.6 5.7 12.4 12.6 3.5 11.7 11.3 6.6 11.4 11.4 11.4 6.0 3.9 7.0 5.0 7.3 4.6 12.2 5.3 20.6 3.1 34.7 17.9 7.9 5.5 12.0 3.6 16.6 8.9 15.9 2.1 4.7 4.4 8.0 5.3 5.0 6.1 9.7 7.1 0.8 25.2 4.6 3.9 8.6 7.9 0.1 1.5 0.2 0.1 0.0 1.9 0.1 2.2 4.1 0.3 0.4 13.5 14.0 0.5 10.6 17.2 6.9 9.0 1.9 0.4 0.3 0.7 16.3 5.2 0.1 0.5 3.8 3.5 1.5 0.3 4.6 1.7 11.0 0.2 0.2 11.6 4.0 6.7 0.2 0.9 0.4 1.3 10.7 1.3 1.2 0.6 2.5 3.7 3.4 6.2 2.0 1.0 2.8 2.4 5.3 24.0 0.1 0.3 0.6 1.8 2.1 12.4 0.5 12.4 4.7 1.6 1.1 0.4 15.5 0.6 6.0 0.0 0.1 0.2 0.9 0.0 1.1 0.1 1.9 1.6 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.6 0.1 5.0 7.1 0.9 8.8 6.0 3.9 12.2 5.3 5.5 7.1 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 460364-563509 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 43.1" "Cell line enhanced" "Detected in some" "BEWO: 25.8;HDLM-2: 9.1;HEK 293: 9.1;NTERA-2: 11.4;U-937: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favourable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.3 5.7 1.4 2.1 3.8 1.5 1.1 0.3 8.2 6.1 12.8 0.6 0.4 0.8 8.5 2.9 6.0 3.4 9.6 16.8 5.6 0.9 4.1 0.3 6.2 0.2 0.9 1.7 2.1 7.9 2.5 14.7 0.1 2.0 1.6 9.8 1.5 3.8 1.1 2.7 11.0 1.7 1.9 0.5 0.4 43.1 8.0 0.1 1.0 2.1 9.1 4.1 1.8 4.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 25.8 0.0 0.0 0.0 0.0 6.4 5.0 0.0 0.6 0.0 2.8 6.4 0.7 0.0 9.1 9.1 0.0 0.0 1.3 0.0 0.0 3.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 0.5 0.4 3.5 0.0 6.2 5.5 3.1 2.0 0.6 0.2 0.7 0.6 2.0 0.0 0.0 2.0 0.2 0.6 0.0 0.1 0.1 0.0 11.1 4.3 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.3 8.2 5.6 0.9 0.9 1.7 2.0 0.1 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell line enhanced" "Detected in many" "AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053126 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" "Intracellular and membrane" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA053126: " "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 19.7 11.3 0.0 0.0 4.6 3.5 0.9 1.6 0.5 2.0 0.0 0.0 2.6 0.4 0.7 2.6 4.7 0.5 0.0 6.7 0.0 6.2 6.1 0.2 0.0 4.8 0.3 2.8 0.1 2.1 0.2 6.0 0.0 0.0 5.8 0.2 0.0 17.6 7.7 0.0 0.0 2.6 0.2 0.0 21.9 26.7 1.3 0.9 0.2 7.7 0.0 4.8 1.1 6.3 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" 12000 "Golgi apparatus, Vesicles" "HPA007620: , HPA047739: " "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavourable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 18.6 8.6 34.5 10.1 22.4 4.6 15.6 8.1 35.7 18.4 16.1 16.1 10.7 9.4 13.3 8.5 20.2 11.4 11.9 23.3 25.3 18.9 8.4 24.2 7.7 4.4 18.9 15.6 15.3 39.5 9.9 10.6 9.9 12.7 13.5 10.4 8.7 21.4 21.5 41.0 19.5 9.4 21.3 16.1 5.2 11.2 11.4 11.3 1.9 9.0 12.1 10.1 16.5 11.7 1.7 0.4 0.1 0.6 0.2 2.6 0.7 19.8 14.5 15.2 25.8 20.6 18.5 15.2 22.6 18.6 18.0 16.5 9.5 17.6 13.1 11.5 36.0 13.8 13.5 23.1 8.4 13.2 25.7 8.7 10.1 21.8 16.7 8.3 0.3 16.1 27.0 12.9 26.4 20.8 16.4 8.5 14.0 14.3 4.3 8.3 21.1 18.2 15.6 20.4 20.5 12.7 9.3 27.6 22.9 9.9 31.2 15.1 13.6 9.9 16.3 31.3 40.2 21.6 25.1 3.0 5.9 5.6 14.0 6.3 20.9 0.0 0.2 0.0 2.6 0.6 2.4 1.7 1.2 2.2 0.4 0.5 0.0 2.0 0.1 0.2 0.1 0.2 1.1 0.7 34.5 22.4 8.1 35.7 25.3 18.9 18.9 15.6 12.7 11.3 B4GALT3 beta4Gal-T3 ENSG00000158850 "Beta-1,4-galactosyltransferase 3" O60512 1 161171310-161177968 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010793 Approved Supported "Golgi apparatus,Cytosol" 74000 "Golgi apparatus" Cytosol "HPA010793: AB_1078256" "unprognostic (5.67e-3)" "unprognostic (7.68e-3)" "unprognostic (1.20e-2)" "unprognostic (8.15e-3)" "unprognostic (3.91e-1)" "unprognostic (1.10e-2)" "prognostic unfavourable (5.87e-5)" "unprognostic (3.11e-2)" "unprognostic (3.13e-1)" "unprognostic (4.64e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-1)" "prognostic unfavourable (7.12e-7)" "unprognostic (1.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-1)" 20.7 18.7 16.5 17.2 22.1 17.3 33.4 20.1 23.2 15.0 19.0 12.4 22.2 18.4 13.6 21.0 20.4 17.2 17.5 17.2 13.4 14.7 22.5 21.7 20.8 21.6 16.4 13.4 25.4 37.5 15.8 29.1 41.0 16.6 18.5 19.3 14.8 33.0 27.8 19.5 20.2 15.1 11.7 14.1 26.6 21.5 28.4 16.4 14.8 28.2 10.7 21.4 20.6 22.9 16.7 22.6 7.1 12.6 15.1 25.5 11.9 9.7 6.5 9.6 12.7 14.3 7.3 15.3 5.6 10.0 11.6 10.7 12.7 19.9 9.0 16.0 6.2 9.9 10.1 6.2 6.9 9.4 12.3 5.1 4.3 10.2 10.3 10.1 14.4 10.2 9.2 10.7 11.6 13.1 16.6 20.3 9.4 10.1 6.6 9.7 12.0 13.8 8.0 5.4 22.2 9.8 6.0 13.7 16.2 5.6 14.8 11.7 14.8 18.5 5.5 5.8 10.5 6.5 16.2 73.3 39.5 12.0 8.6 8.7 9.2 5.1 8.9 7.1 17.6 10.1 15.7 16.7 16.7 16.8 10.8 13.5 16.4 15.4 5.9 15.1 12.6 22.6 25.5 11.9 16.5 22.1 20.1 23.2 13.4 14.7 16.4 13.4 16.6 16.4 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell line enhanced" "Detected in some" "AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: " "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.4 0.2 0.2 7.3 0.0 1.2 8.5 0.0 0.1 0.2 0.0 0.1 0.2 4.6 0.4 0.4 0.0 0.0 0.0 1.4 0.2 0.3 0.0 0.5 0.0 0.5 1.4 1.4 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.4 0.1 0.1 0.5 0.0 0.0 13.3 9.8 0.2 0.0 0.0 0.1 0.1 1.4 7.7 0.5 0.2 0.5 0.0 0.1 0.1 36.2 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267350-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: , HPA068786: , HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 23.2 26.7 39.8 24.2 33.6 37.3 23.7 32.5 50.0 25.6 25.6 24.5 18.7 25.5 24.9 20.5 26.3 22.0 26.8 36.8 35.2 33.3 24.0 31.2 21.6 30.7 34.4 33.8 23.6 29.2 22.2 15.7 31.9 25.8 22.7 23.8 20.8 30.5 25.5 72.7 25.0 23.4 23.9 23.3 29.1 24.5 24.6 22.2 34.5 19.2 33.5 31.3 21.4 19.8 44.7 51.6 51.6 50.1 33.2 55.2 59.7 34.9 19.6 19.9 18.8 22.2 15.8 45.3 21.0 28.0 42.5 42.4 22.5 41.9 24.8 50.2 29.1 17.4 23.2 29.1 27.3 35.6 37.1 21.8 26.1 27.2 18.0 39.1 27.9 23.9 20.3 28.1 16.8 35.7 36.3 29.2 30.7 28.6 39.4 37.2 51.8 42.3 26.5 26.3 32.7 31.2 17.3 19.3 34.9 25.5 26.7 22.9 23.4 31.7 25.7 25.9 16.4 31.5 34.9 39.2 46.8 32.7 36.6 51.9 24.3 50.0 50.1 51.6 45.4 46.0 43.4 44.7 42.0 43.8 51.6 43.3 39.2 38.6 12.6 33.2 43.4 42.8 55.2 59.7 39.8 33.6 32.5 50.0 35.2 33.3 34.4 33.8 25.8 22.2 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.7" "Group enriched" "Detected in all" 4 "granulocytes: 46.7;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034949: " "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavourable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavourable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 23.3 7.8 7.9 15.5 13.1 44.7 10.3 4.7 8.8 13.5 12.8 9.6 6.7 9.9 16.0 10.0 18.6 8.9 15.6 10.7 8.0 5.8 11.7 17.6 25.2 21.9 10.8 5.5 9.5 12.5 5.3 9.2 28.8 11.1 14.9 7.8 9.2 12.2 5.3 30.7 22.9 17.9 15.9 16.0 22.9 9.5 20.6 11.1 14.3 11.3 12.6 14.0 19.4 15.8 4.0 7.6 46.7 15.2 2.1 4.4 4.0 7.4 3.0 9.5 2.4 7.5 21.8 5.9 8.2 19.7 8.0 9.0 6.3 10.4 8.9 6.6 7.5 3.9 5.7 11.0 14.2 7.4 4.7 27.5 6.4 6.5 10.0 7.9 10.3 11.2 16.9 15.6 23.3 4.2 13.9 47.2 10.9 2.6 6.7 4.6 14.7 3.1 6.9 22.6 11.5 4.2 5.9 3.9 4.6 4.5 8.5 10.4 6.2 9.6 10.5 7.8 10.9 8.5 4.1 27.4 17.5 9.6 6.4 9.8 23.4 17.9 15.2 11.3 1.6 12.4 1.3 3.2 2.7 1.4 7.6 4.0 3.9 1.9 46.7 2.1 13.3 1.8 4.4 4.0 7.9 13.1 4.7 8.8 8.0 5.8 10.8 5.5 11.1 11.1 BACH2 BTBD25 ENSG00000112182 "BTB domain and CNC homolog 2" Q9BYV9 6 89926529-90296908 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Group enriched" "Detected in some" 6 "Daudi: 51.5;U-698: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 15.4" "Lineage enriched" "Detected in many" 4 "B-cells: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051384, HPA058384" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051384: , HPA058384: " "unprognostic (4.00e-3)" "unprognostic (3.17e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-4)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.42e-2)" "unprognostic (8.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (3.12e-3)" "unprognostic (4.22e-1)" "unprognostic (9.87e-3)" "unprognostic (2.10e-2)" "unprognostic (1.83e-1)" "unprognostic (2.03e-1)" "unprognostic (3.87e-4)" 2.9 2.1 5.3 29.8 5.6 18.5 4.1 11.4 6.9 5.4 2.2 6.3 1.0 1.3 6.8 2.1 1.9 3.0 2.3 2.6 5.2 2.9 1.7 5.8 5.8 26.7 5.2 4.0 6.3 4.0 5.8 1.9 2.4 4.9 3.7 1.7 0.9 5.2 2.2 7.9 5.4 6.5 2.8 5.2 7.6 1.8 3.4 6.9 26.9 2.0 2.4 20.6 4.8 3.3 15.4 0.2 1.8 0.0 1.5 3.7 0.4 0.3 0.0 1.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 51.5 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 1.1 0.0 2.0 4.5 0.0 0.1 1.0 0.0 0.5 0.4 7.0 1.3 0.9 0.0 0.1 1.7 4.8 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.4 0.1 30.2 0.2 0.5 0.3 1.8 0.0 0.7 0.4 0.0 0.8 2.1 0.8 0.7 0.2 15.4 3.7 2.4 0.0 1.5 0.0 0.2 0.1 0.4 5.3 5.6 11.4 6.9 5.2 2.9 5.2 4.0 4.9 6.9 BAG3 ENSG00000151929 "BCL2 associated athanogene 3" O95817 10 119651370-119677819 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 115.2;vagina: 160.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.6" "Lineage enriched" "Detected in many" 7 "T-cells: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Enhanced "Plasma membrane,Cytosol" 890000 "Plasma membrane, Cytosol" "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 17.8 14.1 18.8 7.7 25.7 2.7 38.3 18.4 20.7 11.7 14.1 7.3 6.5 6.3 10.1 10.6 23.3 8.7 17.0 38.2 20.6 14.3 16.8 10.1 14.3 5.9 20.9 4.5 7.3 9.3 27.6 8.8 16.5 27.4 14.4 6.7 5.5 14.6 12.9 115.2 18.5 5.6 20.4 35.8 4.4 15.1 8.1 20.6 1.3 11.1 32.7 12.8 14.0 160.1 0.3 0.8 0.4 1.1 0.2 7.6 1.0 26.1 29.8 8.3 10.8 21.6 15.2 15.6 23.9 20.3 18.3 15.8 12.6 12.8 1.0 11.4 20.5 39.1 8.5 42.2 12.7 12.8 14.0 1.4 8.0 15.7 18.3 0.0 6.1 15.3 24.4 13.3 21.1 20.4 11.2 6.5 18.2 37.4 1.4 5.8 3.2 34.1 0.0 11.8 4.5 13.8 5.9 1.5 1.4 9.5 16.9 12.4 10.5 3.5 25.4 9.7 8.4 13.1 34.1 6.0 3.5 0.6 18.1 0.4 7.3 0.0 1.0 0.0 1.2 1.1 2.0 0.3 4.4 1.5 0.8 0.0 7.6 2.7 0.4 0.2 0.5 0.2 3.0 1.0 18.8 25.7 18.4 20.7 20.6 14.3 20.9 4.5 27.4 20.6 BAG6 "BAT3, D6S52E, G3" ENSG00000204463 "BCL2 associated athanogene 6" P46379 6 31639028-31652705 "Predicted intracellular proteins" "Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport" "Chaperone, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020704, HPA045116, HPA053291" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" 2000000 "Nucleoplasm, Cytosol" "CAB020704: , HPA045116: , HPA053291: " "unprognostic (7.32e-2)" "unprognostic (2.96e-2)" "unprognostic (3.43e-1)" "unprognostic (7.67e-3)" "unprognostic (2.61e-1)" "unprognostic (6.00e-2)" "unprognostic (1.07e-3)" "unprognostic (2.14e-1)" "unprognostic (4.46e-1)" "unprognostic (1.34e-1)" "unprognostic (2.88e-2)" "unprognostic (9.98e-2)" "unprognostic (1.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.82e-2)" "unprognostic (6.05e-2)" "unprognostic (8.16e-2)" 20.8 30.1 16.1 18.4 21.7 16.9 18.1 22.1 31.2 23.9 23.8 22.3 17.9 38.2 25.1 38.6 19.9 23.8 21.4 25.5 15.1 14.1 20.6 41.8 25.7 18.1 15.9 15.6 22.0 22.2 6.6 20.7 27.0 17.5 20.5 30.7 24.4 20.9 19.6 50.5 22.3 31.0 17.3 13.2 23.7 26.1 101.8 16.2 39.9 22.9 30.4 27.1 18.3 19.3 4.8 8.4 8.2 7.5 3.2 6.3 3.1 1.9 14.2 16.6 3.3 8.3 12.8 3.7 3.4 2.7 3.3 3.5 35.3 1.6 2.5 25.7 27.5 2.4 2.0 29.1 5.3 4.1 39.0 11.0 1.8 22.5 12.5 3.2 32.6 10.3 11.8 2.9 3.8 9.5 20.7 11.4 23.8 5.5 2.0 19.4 2.1 2.6 4.8 2.2 4.5 14.2 5.1 2.4 4.5 1.2 4.1 3.3 29.8 27.4 1.8 11.3 8.6 1.9 3.3 15.0 19.8 21.8 15.3 2.7 3.5 8.2 5.7 6.6 6.3 7.5 5.0 4.4 4.4 4.1 4.5 4.8 3.5 4.2 5.8 3.2 6.8 8.4 3.0 3.1 16.1 21.7 22.1 31.2 15.1 14.1 15.9 15.6 17.5 16.2 BAIAP2 "BAP2, IRSp53" ENSG00000175866 "BAI1 associated protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavourable (7.58e-6)" 10.1 10.9 29.0 4.1 37.4 1.7 11.5 19.6 45.3 14.6 11.8 11.4 18.0 4.3 10.1 26.0 45.9 20.6 17.6 8.7 22.1 10.6 20.6 26.3 20.0 3.6 7.3 24.3 5.1 7.6 8.4 19.2 17.0 9.8 25.7 7.1 11.8 17.0 17.1 3.9 52.6 4.9 10.8 5.4 6.2 20.1 9.2 12.3 2.1 10.2 20.1 20.2 11.1 20.5 0.1 15.4 4.8 7.8 1.3 2.7 2.3 29.9 13.8 8.9 11.5 7.1 9.5 10.3 12.4 8.1 11.2 5.0 18.7 15.2 0.1 9.0 10.9 29.2 8.1 14.2 4.3 0.1 10.2 6.1 12.2 13.9 6.6 0.0 8.9 4.0 16.8 9.2 4.9 6.0 7.8 0.2 6.4 15.9 1.2 6.7 3.7 12.2 1.8 2.2 24.6 34.3 10.5 11.7 12.8 19.8 28.7 33.3 25.2 6.9 7.3 26.2 24.9 4.3 13.1 0.4 0.1 0.4 22.8 1.0 5.6 0.0 5.9 0.4 2.7 7.8 0.9 0.1 1.0 0.9 8.3 0.1 1.2 1.5 4.8 1.3 7.2 15.4 0.4 2.3 29.0 37.4 19.6 45.3 22.1 10.6 7.3 24.3 9.8 12.3 BAIAP2L1 IRTKS ENSG00000006453 "BAI1 associated protein 2 like 1" Q9UHR4 7 98291651-98401068 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 4.7 11.2 1.3 16.9 1.1 0.0 10.3 0.3 0.9 6.1 27.3 1.1 10.8 16.2 3.6 4.7 17.9 6.8 29.6 2.1 0.7 0.6 8.9 31.0 15.4 0.9 0.8 0.2 2.6 47.4 4.7 16.9 17.0 1.2 15.2 12.5 6.5 14.7 12.3 3.3 11.3 34.0 3.4 0.7 1.4 33.0 11.6 0.4 2.1 18.0 11.2 14.1 18.9 12.9 1.3 2.7 0.1 0.2 0.0 0.9 0.1 16.0 12.8 0.3 0.3 0.0 0.6 21.5 4.1 2.7 2.2 1.6 17.7 24.2 0.7 6.2 1.5 14.3 6.0 17.6 2.0 0.0 7.7 0.0 5.5 10.1 2.7 0.0 5.8 0.6 23.9 1.2 17.6 0.0 9.5 0.0 1.8 13.5 0.0 0.0 10.1 6.9 0.0 0.2 2.6 13.7 14.2 9.2 1.8 9.6 28.0 4.9 7.8 0.4 0.5 3.2 15.6 0.6 1.9 0.3 4.8 8.1 0.3 2.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.3 0.9 0.2 0.1 0.0 0.2 2.7 0.1 0.1 1.3 1.1 0.3 0.9 0.7 0.6 0.8 0.2 1.2 0.4 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677342-28682939 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 46.8;seminal vesicle: 52.4" "Cell line enhanced" "Detected in many" "CACO-2: 42.8;SK-MEL-30: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: , HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favourable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 2.0 24.7 6.7 1.8 6.9 3.0 13.6 2.2 6.3 3.9 2.3 12.9 15.5 1.1 10.1 2.0 1.1 2.8 3.0 22.8 6.7 6.4 11.2 12.9 5.7 3.1 12.0 2.9 46.8 3.9 7.4 4.5 20.9 10.5 6.5 2.8 30.4 3.8 52.4 1.2 2.7 1.1 12.7 10.8 9.0 2.3 4.8 7.9 0.1 0.6 2.1 1.3 13.8 11.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 10.8 1.1 0.6 1.3 0.0 6.5 2.6 0.9 4.2 2.7 42.8 4.5 0.1 1.6 1.9 3.2 2.6 0.4 1.9 2.6 6.0 10.1 1.6 16.2 1.5 0.6 13.4 1.0 0.6 2.8 0.4 0.6 5.7 4.9 0.8 17.8 0.0 0.7 19.6 2.7 0.1 2.0 0.9 3.4 10.4 1.8 1.4 3.5 20.8 51.1 6.1 0.7 0.0 2.8 2.1 4.5 1.3 0.1 3.7 0.0 0.2 2.3 17.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.7 6.9 2.2 4.8 6.7 6.4 12.0 2.9 10.5 7.9 BANF1 BAF ENSG00000175334 "Barrier to autointegration factor 1" O75531 11 66002079-66004149 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB032896, HPA039242" Enhanced Supported Nucleoplasm,Cytosol 77000 Nucleoplasm Cytosol "CAB032896: AB_2061090, HPA039242: " "unprognostic (1.69e-1)" "unprognostic (4.46e-3)" "unprognostic (2.04e-1)" "unprognostic (9.59e-3)" "unprognostic (1.23e-1)" "unprognostic (3.70e-3)" "unprognostic (6.16e-3)" "unprognostic (8.39e-3)" "unprognostic (2.31e-1)" "unprognostic (5.07e-2)" "unprognostic (1.76e-2)" "unprognostic (4.57e-1)" "unprognostic (7.36e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" 31.2 39.7 38.2 31.6 33.9 24.0 33.5 30.8 38.1 40.7 32.4 33.2 26.5 25.0 38.8 44.4 43.8 58.4 33.4 51.0 35.4 32.5 38.6 61.0 24.6 35.7 33.8 24.7 60.0 40.8 33.5 27.3 40.1 27.5 52.6 33.1 31.1 38.0 38.8 112.7 25.5 29.9 38.9 35.8 39.7 26.8 44.2 27.8 57.6 71.5 54.5 43.8 36.4 45.8 40.0 44.6 14.7 42.8 32.5 30.4 43.8 62.7 63.5 42.8 41.5 21.9 29.1 21.6 34.9 32.6 65.2 41.3 36.8 50.6 54.4 64.5 46.1 44.2 56.2 58.2 47.9 42.7 33.6 63.2 40.2 45.7 26.8 45.7 48.8 27.0 37.5 41.6 36.7 47.5 50.3 43.7 62.9 101.7 51.2 89.9 48.4 44.5 48.1 42.4 123.3 58.6 31.9 34.6 44.6 37.8 62.6 43.3 69.7 35.3 32.9 50.0 55.5 56.5 48.7 32.1 57.9 68.1 43.9 39.1 45.4 14.7 41.6 13.9 29.2 41.7 27.6 40.0 24.5 28.3 44.6 37.8 28.3 30.4 4.4 32.5 42.8 40.0 20.6 43.8 38.2 33.9 30.8 38.1 35.4 32.5 33.8 24.7 27.5 27.8 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell line enhanced" "Detected in some" "Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.2 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.5 10.2 1.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.0 2.1 0.0 0.1 7.1 0.0 0.5 0.3 0.0 0.0 0.1 0.0 3.1 0.4 0.4 0.0 0.4 0.0 4.3 0.1 0.4 0.0 0.3 4.7 2.0 0.0 0.2 0.1 0.0 0.4 1.8 1.0 0.0 0.4 0.0 0.0 24.5 0.0 1.6 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 BANP "BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1" ENSG00000172530 "BTG3 associated nuclear protein" Q8N9N5 16 87949244-88077318 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047164 Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA047164: " "unprognostic (1.82e-1)" "unprognostic (7.84e-3)" "unprognostic (4.73e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.35e-2)" "unprognostic (4.95e-2)" "unprognostic (1.47e-1)" "unprognostic (1.19e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.68e-3)" "unprognostic (4.98e-2)" "unprognostic (2.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (5.89e-2)" 11.9 14.2 17.0 19.4 20.7 21.1 15.4 35.8 21.5 13.6 11.3 11.8 22.0 10.1 14.3 7.2 10.7 13.5 10.0 10.9 13.2 9.0 10.9 17.6 13.4 17.1 24.4 8.9 18.2 12.7 16.5 15.2 14.9 18.3 12.9 7.5 11.7 12.4 17.7 13.6 12.2 12.4 9.0 16.3 17.7 10.3 19.0 23.3 23.2 13.8 8.0 13.0 12.1 27.5 14.4 16.4 36.0 11.4 12.8 15.2 10.2 8.8 14.2 7.0 10.5 6.3 7.7 23.9 10.7 5.5 10.6 7.2 15.4 12.4 11.9 14.6 2.5 10.2 10.6 4.9 3.8 9.2 11.3 7.5 8.8 12.7 5.4 7.9 6.1 2.3 7.9 6.5 4.7 6.5 12.4 6.9 6.4 10.3 10.8 10.3 12.3 17.2 11.7 8.2 8.6 6.3 4.2 10.5 8.7 13.6 8.1 9.9 9.9 10.2 7.9 11.5 8.0 6.7 10.5 5.6 9.6 18.5 6.9 12.2 11.0 12.1 11.2 21.7 13.3 9.9 11.0 14.4 14.0 11.6 13.7 13.2 15.2 13.4 36.0 12.8 11.4 16.4 12.3 10.2 17.0 20.7 35.8 21.5 13.2 9.0 24.4 8.9 18.3 23.3 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401013-52410350 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: , HPA055560: " "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favourable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 13.8 17.6 35.6 14.7 33.3 37.3 13.5 21.8 50.4 12.5 17.0 16.3 11.5 12.4 14.7 14.6 21.2 12.1 15.7 16.4 41.5 15.5 16.6 19.0 14.9 15.2 19.4 27.6 16.9 16.3 30.0 11.1 14.8 19.6 14.4 14.9 15.6 17.9 14.6 24.8 40.5 13.9 14.5 10.0 16.1 13.3 37.3 14.7 18.6 15.3 12.9 16.0 14.1 11.7 5.5 8.4 11.3 5.0 3.0 8.5 3.9 15.3 17.5 21.2 18.0 20.5 13.2 23.9 15.2 19.7 24.7 19.2 21.1 14.4 22.0 7.6 21.2 12.5 22.3 24.5 15.8 21.8 21.1 27.3 37.0 21.8 19.1 25.6 24.3 19.7 32.9 27.3 14.7 19.7 23.3 19.5 18.6 13.3 30.3 35.1 23.9 21.3 13.1 17.2 21.7 15.2 24.9 8.1 26.1 18.7 5.4 22.2 15.3 35.4 21.1 22.4 20.6 26.8 28.2 29.6 38.9 31.5 24.4 27.0 26.4 3.4 5.0 7.4 8.5 3.9 4.0 5.0 6.8 6.9 3.3 5.5 4.9 6.4 11.3 3.0 3.1 8.4 6.0 3.9 35.6 33.3 21.8 50.4 41.5 15.5 19.4 27.6 19.6 14.7 BARD1 ENSG00000138376 "BRCA1 associated RING domain 1" Q99728 2 214725646-214809711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB034106, HPA035354, HPA044864" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "CAB034106: AB_2061237, HPA035354: , HPA044864: " "unprognostic (4.85e-2)" "unprognostic (1.87e-2)" "unprognostic (1.74e-2)" "unprognostic (8.37e-3)" "unprognostic (2.57e-2)" "unprognostic (1.03e-2)" "unprognostic (6.25e-4)" "unprognostic (1.99e-1)" "unprognostic (2.16e-2)" "unprognostic (3.92e-3)" "unprognostic (2.80e-2)" "unprognostic (7.41e-2)" "unprognostic (1.94e-8)" "unprognostic (3.94e-2)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" 4.4 1.9 3.2 11.8 4.8 16.1 4.9 1.2 5.8 7.3 5.4 5.4 3.6 3.7 6.8 5.0 10.0 4.1 3.9 3.6 3.4 2.8 2.2 2.1 5.3 8.2 5.1 1.9 5.8 3.7 3.6 6.3 3.8 4.5 5.7 6.1 1.9 4.7 6.5 12.4 16.3 4.5 7.5 5.3 4.7 3.8 9.5 3.9 25.8 4.0 8.0 9.9 8.3 7.8 9.7 6.6 6.0 3.4 6.1 16.0 2.0 7.7 4.3 11.7 6.0 1.6 2.0 8.0 9.4 5.5 9.3 10.7 5.4 7.7 8.3 4.5 3.9 8.5 8.4 5.5 13.3 6.6 4.4 8.3 7.9 5.7 0.6 9.2 8.4 2.7 0.8 8.2 4.5 3.1 4.6 23.5 8.9 6.4 16.5 9.6 9.2 2.2 14.3 11.8 7.5 2.7 6.5 3.7 5.9 8.6 9.9 3.4 10.2 9.2 2.7 12.0 8.4 7.0 8.5 7.1 7.9 16.9 4.8 7.0 8.0 2.9 1.7 6.0 4.8 3.4 3.1 8.9 5.3 5.2 3.0 9.7 2.5 3.6 0.5 6.1 2.9 6.6 16.0 2.0 3.2 4.8 1.2 5.8 3.4 2.8 5.1 1.9 4.5 3.9 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Group enriched" "Detected in some" 7 "AN3-CA: 15.2;HMC-1: 36.4;NTERA-2: 10.8;THP-1: 14.4" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA055858: " "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 10.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell line enriched" "Detected in some" 4 "HDLM-2: 59.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033311, HPA068414" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB033311: AB_781574, HPA068414: " "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 7.7 0.0 1.9 0.0 59.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 14.4 0.0 0.1 0.1 0.0 0.0 7.3 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616692 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 24.1;neutrophil: 54.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 54.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: " "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 16.7 20.7 22.1 12.7 37.7 23.5 16.5 30.3 28.5 25.8 18.3 30.0 19.4 12.4 25.4 17.7 16.6 19.2 19.3 13.4 26.1 13.1 13.3 12.3 18.1 9.8 37.2 20.4 33.4 16.4 27.1 45.4 14.9 29.5 17.1 12.4 13.0 19.0 24.6 19.2 12.7 14.5 20.0 42.3 14.4 14.4 18.6 48.9 6.5 19.0 9.1 9.6 18.6 19.2 2.4 5.9 54.6 7.0 4.7 2.7 1.4 3.6 7.3 25.2 15.2 7.6 12.2 4.4 7.8 9.6 4.3 5.1 11.1 10.2 6.3 13.4 7.6 8.5 10.0 10.6 6.8 2.1 5.7 11.5 12.7 1.5 5.0 7.8 8.0 9.5 11.7 10.7 11.8 22.1 12.5 1.2 6.8 4.3 2.7 4.8 8.3 6.4 6.4 8.1 4.3 8.7 13.3 16.7 14.6 15.4 1.9 9.2 2.9 21.6 21.8 7.8 15.8 3.2 5.2 4.7 0.4 7.0 7.2 8.5 4.9 24.1 7.0 8.8 2.7 3.0 2.2 1.5 1.6 2.7 4.4 2.4 1.1 1.7 54.6 4.7 2.6 5.9 1.7 1.4 22.1 37.7 30.3 28.5 26.1 13.1 37.2 20.4 29.5 48.9 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favourable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 1.5 2.5 0.9 3.1 3.8 7.4 1.2 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 139.4;liver: 39.3" "Group enriched" "Detected in some" 5 "hTCEpi: 15.9;RPTEC TERT1: 9.8" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" 25000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favourable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 0.9 0.5 9.2 0.5 7.1 0.5 8.2 3.9 7.5 1.5 0.6 4.9 0.1 0.5 0.6 3.6 5.7 3.8 3.6 0.5 7.9 6.3 139.4 39.3 0.6 0.6 10.9 4.3 0.5 0.8 0.5 8.3 1.3 9.2 0.7 0.5 0.0 2.2 2.0 0.6 16.4 0.5 0.5 7.1 0.5 0.6 0.6 5.8 0.0 8.9 1.6 0.7 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 15.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.1 3.9 7.5 7.9 6.3 10.9 4.3 9.2 5.8 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX, HMG-box containing" Q8WY36 3 107522936-107811324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006049: , HPA050646: " "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 10.6 22.6 13.1 11.0 20.6 11.2 10.8 12.8 15.1 14.3 13.2 15.4 27.8 6.7 15.1 28.3 10.2 13.2 12.7 11.5 14.8 11.6 14.9 7.3 10.8 10.4 24.5 9.0 21.0 9.0 35.7 39.6 17.8 17.5 17.4 7.3 9.1 11.8 25.1 8.5 7.5 9.4 14.0 26.7 14.1 9.6 43.9 25.5 13.5 19.3 8.0 10.1 15.9 15.6 33.7 16.3 25.2 17.5 25.2 26.1 11.4 18.7 17.4 15.0 22.5 13.4 19.5 12.2 17.8 18.4 16.2 18.0 1.9 15.3 9.7 22.3 11.3 13.0 16.8 21.7 24.5 12.6 7.8 14.6 14.1 4.1 15.9 20.0 9.0 16.3 15.9 16.3 32.8 13.6 6.7 14.7 13.7 6.2 11.3 2.0 7.3 14.8 16.0 14.2 11.0 10.3 14.2 10.8 11.0 31.5 3.1 15.5 12.5 4.5 17.8 19.9 14.8 7.3 12.7 6.3 4.2 11.0 18.0 10.4 11.5 25.2 9.1 21.6 22.6 9.2 26.1 32.8 20.3 22.8 12.7 33.7 25.7 21.1 14.9 25.2 17.5 16.3 13.4 11.4 13.1 20.6 12.8 15.1 14.8 11.6 24.5 9.0 17.5 25.5 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1, Cas family scaffolding protein" P56945 16 75228187-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB000443: , HPA042282: " "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavourable (9.11e-5)" "prognostic unfavourable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favourable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 16.6 12.3 14.3 8.4 19.5 1.8 11.5 29.1 26.7 16.7 22.7 31.5 9.1 28.6 17.5 11.0 9.6 10.8 20.4 17.8 14.2 9.4 21.3 17.3 15.9 4.9 18.9 13.5 11.3 31.0 9.2 13.2 28.1 13.9 10.9 7.9 14.6 25.7 12.5 37.4 7.2 25.7 8.6 10.4 28.9 28.7 17.3 20.1 0.2 11.8 9.7 6.3 13.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 16.2 7.9 2.6 3.0 2.8 15.2 12.8 7.4 9.4 7.4 20.7 13.9 0.8 17.0 14.2 7.9 2.6 14.6 2.7 0.0 9.1 0.0 9.8 17.2 7.7 0.0 6.6 8.6 7.3 11.1 5.5 25.4 8.2 0.4 5.5 22.0 0.0 0.5 10.4 10.8 0.3 3.5 3.3 8.6 12.0 9.7 13.9 12.2 2.8 4.9 6.6 2.2 22.8 15.8 13.7 3.9 18.8 3.5 1.9 0.2 9.9 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.5 29.1 26.7 14.2 9.4 18.9 13.5 13.9 20.1 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavourable (8.41e-4)" "prognostic unfavourable (5.42e-4)" "prognostic unfavourable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favourable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.1 6.5 12.2 0.9 5.3 4.2 10.5 15.6 27.3 12.9 8.0 1.1 11.3 2.4 5.4 24.1 9.4 0.3 20.2 11.3 1.0 0.3 0.0 4.7 2.8 9.5 0.1 0.0 4.9 22.4 13.3 45.4 14.2 0.4 0.0 34.9 2.3 0.2 0.0 3.8 22.5 1.0 17.6 0.3 33.8 19.2 0.4 1.0 7.6 8.1 9.7 9.1 0.6 16.7 19.2 5.0 8.2 20.6 1.3 0.5 0.3 2.8 0.0 7.0 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2, pre-mRNA processing factor" O75934 1 114567557-114581639 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" "Nuclear speckles, Centrosome" "HPA067881: " "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavourable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favourable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavourable (4.27e-4)" "prognostic favourable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavourable (5.24e-4)" "unprognostic (1.87e-1)" 23.2 28.0 36.7 17.6 34.1 43.0 25.0 30.4 40.6 21.3 19.7 16.5 17.3 16.7 22.9 33.2 26.0 16.6 20.7 24.5 31.6 41.8 28.7 32.9 17.5 22.4 37.0 28.8 26.8 18.2 22.9 32.5 17.4 39.0 24.1 21.0 13.9 19.5 26.7 38.4 19.0 19.0 20.1 26.9 20.8 18.3 21.2 24.6 20.0 27.8 24.5 22.1 31.1 19.5 30.4 24.8 30.9 22.6 35.4 40.1 32.9 18.9 6.9 14.4 13.6 7.7 9.0 21.6 14.3 11.0 19.0 19.6 9.7 7.8 16.9 19.8 9.2 9.3 16.7 14.1 26.5 15.2 15.0 8.8 13.8 14.0 13.9 22.2 9.6 8.1 15.5 19.6 24.3 12.4 16.9 12.7 15.6 116.3 19.8 16.6 24.9 15.8 14.2 25.4 11.8 13.3 16.6 18.8 12.5 17.8 13.8 21.9 12.2 17.6 10.8 11.6 15.5 23.3 26.8 13.8 14.2 27.3 22.7 18.6 43.9 21.6 18.5 30.9 29.3 21.9 40.1 30.4 36.7 35.7 19.4 26.7 38.2 37.2 17.6 35.4 22.6 24.8 35.8 32.9 36.7 34.1 30.4 40.6 31.6 41.8 37.0 28.8 39.0 24.6 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 31.6" "Cell line enhanced" "Detected in many" "Daudi: 38.1;U-698: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.9;naive B-cell: 28.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavourable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.8 2.3 7.3 29.1 12.9 3.9 4.5 6.2 12.8 4.8 4.2 2.3 4.2 2.4 5.4 7.2 4.7 3.6 3.8 3.1 13.8 7.5 7.0 1.4 3.8 28.5 7.1 9.2 3.0 3.6 9.2 5.4 5.0 5.2 7.7 1.9 8.8 4.9 7.1 2.1 2.1 8.6 6.0 2.0 12.2 4.5 5.1 2.2 9.2 5.9 0.0 31.6 7.6 5.3 28.9 7.0 0.6 0.1 6.9 12.9 5.3 4.8 8.7 0.7 3.8 1.4 3.6 1.5 6.3 5.7 4.6 3.2 4.1 2.9 38.1 2.4 2.6 7.2 4.3 9.1 2.6 2.4 3.8 0.2 3.4 3.4 1.9 0.0 0.2 1.2 5.3 3.5 1.7 0.2 0.1 0.2 1.6 17.0 1.4 0.1 3.1 7.1 11.9 1.1 0.3 2.1 4.4 3.9 4.1 9.8 9.4 0.2 18.6 0.4 0.2 4.9 7.2 4.9 1.5 0.6 2.8 33.9 2.0 0.3 0.4 0.6 0.1 0.1 6.2 0.1 3.5 28.9 3.8 7.5 0.1 28.7 12.9 10.3 0.6 6.9 0.1 7.0 3.1 5.3 7.3 12.9 6.2 12.8 13.8 7.5 7.1 9.2 5.2 2.2 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038011: " "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 24.0 25.0 27.9 28.8 28.0 32.3 33.4 28.0 30.2 20.8 23.0 15.0 27.8 19.7 21.1 35.9 27.6 21.3 17.9 28.7 28.7 21.3 35.0 45.9 19.0 27.6 23.6 22.0 28.0 29.2 19.8 27.6 19.8 33.5 27.3 26.3 14.4 34.7 26.7 132.7 19.3 23.5 29.7 35.6 27.2 28.2 28.6 24.1 24.6 26.0 32.0 28.7 24.0 47.9 30.9 30.7 16.1 35.4 26.0 33.8 19.0 53.9 28.1 31.9 35.3 18.2 20.1 26.7 29.1 27.8 36.0 33.4 45.9 36.3 38.0 18.3 26.5 30.0 54.4 41.2 50.4 34.9 37.0 38.2 24.3 50.6 23.1 52.4 24.3 20.6 24.9 42.9 45.4 34.1 42.2 19.5 30.4 32.3 33.8 53.0 24.6 42.4 32.4 33.6 22.8 31.8 26.0 17.0 17.3 21.7 35.6 35.6 19.2 23.3 22.8 16.8 29.7 24.7 52.3 20.0 22.3 56.5 33.0 27.3 12.9 12.4 28.7 16.1 24.6 34.7 33.8 30.9 28.2 26.8 30.7 28.9 31.9 28.6 4.7 26.0 35.4 26.5 29.7 19.0 27.9 28.0 28.0 30.2 28.7 21.3 23.6 22.0 33.5 24.1 BCDIN3D ENSG00000186666 "BCDIN3 domain containing RNA methyltransferase" Q7Z5W3 12 49836039-49843129 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039911 Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA039911: AB_10673021" "unprognostic (2.21e-2)" "unprognostic (6.64e-2)" "unprognostic (2.70e-3)" "unprognostic (1.73e-2)" "unprognostic (1.68e-1)" "unprognostic (2.84e-2)" "unprognostic (9.96e-3)" "prognostic favourable (3.24e-4)" "unprognostic (2.30e-3)" "unprognostic (1.62e-3)" "unprognostic (2.12e-3)" "unprognostic (1.84e-1)" "prognostic favourable (1.03e-5)" "unprognostic (2.31e-2)" "unprognostic (3.15e-2)" "unprognostic (1.06e-1)" "prognostic favourable (1.06e-4)" 5.6 9.3 6.9 6.0 8.4 2.6 7.8 8.9 9.0 6.1 6.0 7.2 6.9 4.9 8.3 7.5 9.1 7.7 4.9 5.3 5.9 4.5 7.3 10.5 4.5 8.3 9.8 4.8 8.5 11.9 8.4 12.7 6.5 6.6 8.7 5.7 5.2 15.4 6.9 32.8 7.6 8.4 5.3 7.6 9.3 8.4 5.3 7.7 15.2 9.9 4.2 10.8 7.4 6.0 9.9 5.0 5.9 6.6 6.2 10.3 4.6 3.3 4.8 4.6 7.2 9.7 5.7 4.8 4.7 6.1 4.9 5.2 2.5 8.9 3.0 5.3 2.0 4.5 4.6 2.7 2.7 10.2 6.2 4.1 3.7 1.6 7.7 4.7 4.1 3.1 11.0 3.4 4.9 2.2 7.4 8.2 3.0 8.5 5.2 7.6 4.6 8.6 5.5 4.4 5.9 4.8 3.1 6.4 8.9 5.5 9.0 6.6 11.2 5.2 2.6 4.1 3.2 6.2 2.5 7.8 6.7 5.6 4.5 3.5 2.8 5.9 5.4 2.8 7.6 6.5 10.1 9.9 9.4 7.2 5.0 9.1 10.3 9.7 4.6 6.2 6.6 3.0 7.8 4.6 6.9 8.4 8.9 9.0 5.9 4.5 9.8 4.8 6.6 7.7 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favourable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 6.9 2.6 9.9 13.2 10.0 8.8 7.9 4.9 10.3 8.1 11.2 4.2 9.6 19.7 5.3 11.8 7.0 5.5 6.5 11.5 24.5 8.1 9.7 6.8 5.7 11.2 13.9 4.4 8.4 6.8 5.6 7.0 9.7 8.2 17.7 18.2 3.8 5.0 8.1 7.3 3.4 12.8 30.7 16.8 22.6 10.6 6.6 9.3 8.4 7.0 4.9 9.0 10.7 4.1 4.9 3.4 4.5 6.6 12.6 12.3 6.5 6.0 10.4 7.3 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "B cell CLL/lymphoma 11A" Q9H165 2 60450520-60555154 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 107.1" "Cell line enhanced" "Detected in some" "Daudi: 20.3;MOLT-4: 18.7;REH: 19.1;U-698: 41.8;U-937: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1" "Group enriched" "Detected in many" 16 "B-cells: 53.7;dendritic cells: 107.1" "Group enriched" "Detected in all" 5 "amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8" "Group enriched" "Detected in all" 4 "basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9" "CAB014891, HPA029003" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 1.5 2.4 6.6 13.9 14.6 17.0 5.5 1.8 34.5 3.9 8.6 0.2 0.1 7.6 1.8 1.4 13.6 4.8 2.2 4.7 14.5 3.4 1.7 1.5 3.0 21.2 3.5 14.4 1.6 11.3 1.2 3.9 0.9 9.6 4.8 5.1 0.0 11.4 2.0 1.4 24.9 11.4 2.9 2.0 13.5 3.3 2.0 2.6 20.9 2.4 4.0 30.4 3.6 7.8 53.7 107.1 1.3 5.1 1.0 0.1 1.2 0.2 0.0 1.7 0.0 0.3 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 20.3 0.1 0.0 4.1 6.3 3.0 0.0 0.3 6.0 0.0 0.2 0.1 0.0 7.3 0.0 0.7 1.6 0.0 1.0 1.0 0.3 0.1 0.0 0.0 18.7 7.4 11.5 0.1 19.1 0.5 7.7 0.0 0.3 8.2 2.0 0.1 0.1 0.1 0.1 3.5 0.5 0.1 4.8 0.1 0.0 0.3 0.0 41.8 0.0 13.4 0.6 0.4 2.9 0.5 0.0 5.1 0.1 39.6 0.0 0.0 10.7 53.7 0.1 0.1 1.3 1.0 3.7 107.1 0.1 1.2 6.6 14.6 1.8 34.5 14.5 3.4 3.5 14.4 9.6 2.6 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "B cell CLL/lymphoma 11B" Q9C0K0 14 99169287-99271524 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6" "Cell line enriched" "Detected in some" 6 "MOLT-4: 32.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 13.7" "Group enriched" "Detected in many" 8 "gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 14 "T-cells: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favourable (7.48e-4)" 0.3 0.4 4.4 6.6 13.7 5.2 1.3 0.3 3.8 0.8 1.3 0.1 0.0 2.3 1.9 0.8 3.9 0.3 3.0 0.8 4.8 1.0 0.3 0.5 1.1 10.8 0.8 2.6 0.2 0.1 0.0 0.1 0.0 0.6 0.6 1.7 0.3 5.0 0.7 0.1 17.6 3.0 0.2 0.7 4.9 2.1 0.4 1.6 25.4 0.9 1.5 8.8 2.0 2.3 0.0 0.0 0.1 0.0 0.5 7.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 3.0 0.0 1.8 32.6 0.5 0.3 0.0 5.1 0.0 0.0 0.0 1.8 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 3.3 0.0 3.0 0.0 4.5 3.7 0.0 0.0 7.4 4.9 0.0 0.5 0.0 0.0 3.0 1.1 4.4 13.7 0.3 3.8 4.8 1.0 0.8 2.6 0.6 1.6 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2, apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 22.3;U-266/70: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7" "Group enriched" "Detected in many" 8 "B-cells: 5.2;T-cells: 7.6" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: " "unprognostic (1.11e-3)" "prognostic favourable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favourable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 3.0 10.1 15.7 9.4 5.3 24.6 4.7 8.4 14.8 7.8 7.4 9.1 5.0 17.1 9.3 4.7 12.2 9.2 6.5 10.0 8.1 8.5 2.3 5.0 14.6 10.8 5.6 18.2 2.9 19.6 7.0 22.4 9.2 8.4 5.9 10.8 5.4 15.7 20.0 6.3 10.5 8.6 9.3 17.8 5.4 3.5 10.5 21.0 35.6 2.9 13.4 7.9 16.4 5.2 0.3 0.7 0.2 0.7 7.6 1.9 0.4 0.1 2.3 1.8 2.7 0.4 0.8 0.2 0.2 0.7 0.5 1.1 0.1 0.0 0.4 0.2 0.1 2.0 0.3 0.4 13.3 0.4 0.0 0.6 0.2 0.5 12.1 1.8 0.5 0.2 0.9 1.9 0.2 0.2 22.3 0.4 0.4 2.5 5.2 0.5 0.4 11.4 0.5 8.6 3.8 1.8 1.9 1.8 0.0 0.0 2.7 0.1 10.2 0.1 3.0 1.0 0.3 1.5 77.6 10.2 0.8 0.5 8.6 1.7 0.7 0.0 0.0 2.3 0.0 7.6 5.2 6.3 3.8 0.1 4.1 5.1 4.5 0.1 0.7 0.2 0.3 6.7 1.9 10.1 9.4 4.7 8.4 10.0 8.1 10.8 5.6 9.2 10.5 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 6.7 6.5 2.8 15.3 3.3 12.6 7.9 1.2 3.2 8.8 11.8 2.9 9.3 8.3 8.2 9.1 14.0 7.2 11.3 9.5 3.3 1.8 8.1 15.3 12.0 15.5 3.7 2.2 9.2 18.0 3.2 2.6 21.5 3.8 9.0 5.8 6.3 10.6 9.4 12.5 6.5 9.0 8.1 3.4 14.8 8.9 10.0 3.8 29.8 6.6 18.1 15.1 8.4 7.0 13.9 22.4 13.4 9.8 12.0 13.6 5.6 32.9 20.0 16.2 30.4 4.2 4.1 19.0 18.7 7.6 18.8 20.1 27.8 18.0 18.6 9.0 6.3 16.4 14.7 12.3 10.3 23.2 32.3 17.1 13.6 19.3 3.7 17.6 20.9 4.9 6.0 21.0 6.0 12.5 43.7 24.0 9.9 18.7 21.1 30.5 20.8 26.0 27.4 17.3 20.1 8.2 16.2 0.3 9.5 19.1 25.9 13.3 10.8 22.6 7.5 21.3 25.3 14.9 30.7 20.2 31.2 35.4 9.1 25.0 21.1 9.6 6.8 13.4 11.4 9.8 13.6 13.9 12.3 11.0 6.0 11.6 11.9 11.6 9.2 12.0 7.1 22.4 12.4 5.6 2.8 3.3 1.2 3.2 3.3 1.8 3.7 2.2 3.8 3.8 BCL2L2-PABPN1 ENSG00000258643 "BCL2L2-PABPN1 readthrough" Q92843 14 23306835-23325369 "Cancer-related genes, Predicted intracellular proteins, Transporters" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 23.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000637, HPA048740" Approved Uncertain "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553, HPA048740: " "unprognostic (1.32e-2)" "unprognostic (8.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-3)" "unprognostic (9.82e-3)" "unprognostic (2.85e-2)" "unprognostic (1.05e-6)" "unprognostic (4.39e-2)" "unprognostic (1.67e-1)" "unprognostic (1.84e-3)" "unprognostic (7.61e-2)" "unprognostic (3.47e-2)" "unprognostic (1.72e-7)" "unprognostic (3.13e-2)" "unprognostic (8.77e-2)" "unprognostic (3.46e-3)" "unprognostic (4.95e-2)" 11.4 5.3 14.2 5.8 17.7 12.0 17.7 16.4 24.2 17.9 21.0 14.4 11.4 4.5 13.7 6.9 14.4 16.1 16.0 11.2 17.8 9.5 7.1 6.9 10.3 6.4 13.1 21.2 8.0 21.4 29.1 11.4 18.0 17.5 16.3 5.6 7.5 22.1 37.7 7.0 14.5 7.7 18.6 20.2 9.7 13.0 15.0 14.8 0.0 14.4 5.7 5.4 16.6 12.1 1.9 1.1 2.1 4.4 3.5 0.3 1.1 5.1 6.5 4.2 3.4 0.3 9.5 3.3 1.4 13.6 21.2 23.1 5.3 16.7 1.7 1.2 7.1 7.2 4.8 6.5 5.5 3.5 5.3 0.4 0.9 8.6 2.9 1.8 10.3 8.6 12.0 7.8 1.4 5.0 1.5 5.0 6.5 7.8 0.2 1.0 5.2 4.2 3.1 0.1 1.1 3.7 2.1 7.0 2.8 2.1 7.1 1.9 3.7 2.7 1.8 5.5 4.4 5.4 3.6 2.8 2.6 0.5 2.3 3.8 8.5 2.1 4.4 0.3 0.2 1.6 0.2 1.4 0.0 0.0 0.6 1.9 0.3 0.1 0.8 3.5 2.6 1.1 0.0 1.1 14.2 17.7 16.4 24.2 17.8 9.5 13.1 21.2 17.5 14.8 BCL3 "BCL4, D19S37" ENSG00000069399 "B cell CLL/lymphoma 3" P20749 19 44747705-44760044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.5;Karpas-707: 22.0;SiHa: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002051, HPA047514" Approved Supported Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "CAB002051: AB_563428, HPA047514: " "prognostic favourable (9.67e-4)" "unprognostic (8.82e-2)" "unprognostic (2.81e-1)" "unprognostic (7.54e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (3.49e-2)" "unprognostic (2.34e-3)" "unprognostic (2.79e-1)" "prognostic favourable (3.74e-4)" "unprognostic (2.09e-2)" "unprognostic (9.23e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.13e-14)" "unprognostic (8.24e-2)" "unprognostic (1.36e-1)" "unprognostic (3.77e-2)" "unprognostic (3.04e-2)" 17.7 13.0 4.0 21.1 5.6 35.2 18.7 1.4 4.7 11.7 14.9 2.4 5.9 24.5 10.4 9.7 27.1 12.5 22.7 20.1 3.9 2.0 17.8 52.1 36.4 20.5 4.3 0.5 26.5 13.2 2.4 9.2 9.5 5.6 16.0 8.0 8.8 13.7 13.7 20.2 9.0 35.5 11.5 6.5 41.6 15.0 8.3 4.0 6.5 13.9 22.9 37.0 18.7 11.9 1.3 2.6 16.5 2.4 1.8 1.5 0.7 3.8 13.4 0.3 7.1 2.6 5.4 0.6 2.4 2.6 1.5 2.2 2.8 7.1 3.8 5.5 4.7 4.3 0.9 4.0 0.9 26.5 0.2 0.4 7.0 3.6 6.2 0.3 11.4 9.4 3.2 3.3 4.2 4.0 0.5 22.0 0.9 3.2 0.0 2.9 0.3 5.6 1.7 2.7 1.4 6.8 8.1 0.0 0.4 28.2 14.4 0.7 5.0 2.9 6.7 4.8 5.0 7.5 0.9 20.9 8.2 3.9 8.9 0.5 3.6 0.2 2.4 4.2 0.7 1.6 1.0 1.3 0.9 1.1 2.1 1.1 0.5 0.6 16.5 1.8 0.9 2.6 1.5 0.7 4.0 5.6 1.4 4.7 3.9 2.0 4.3 0.5 5.6 4.0 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "B cell CLL/lymphoma 6" P41182 3 187721377-187745727 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 114.3" "Cell line enhanced" "Detected in many" "ASC diff: 26.8;Daudi: 42.1;HSkMC: 30.6;U-698: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: " "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 47.1 14.3 21.8 23.2 25.9 50.6 48.0 58.7 23.7 21.2 21.2 19.2 11.5 4.1 17.7 8.8 20.9 28.3 22.3 18.6 21.5 8.0 10.1 20.1 26.3 24.5 31.6 9.3 20.2 15.6 9.1 23.3 7.5 28.5 17.3 5.8 15.9 19.1 11.8 114.3 36.4 8.1 24.4 50.1 27.2 16.1 10.2 26.6 18.9 14.8 10.4 22.4 24.9 20.0 3.9 5.6 63.4 15.4 0.9 1.3 5.2 1.2 3.6 3.5 0.8 26.8 21.4 3.9 4.2 10.4 4.9 5.2 2.5 2.0 42.1 3.1 5.3 2.0 1.1 2.8 4.2 8.9 1.4 0.0 1.7 6.0 13.9 0.5 0.2 30.6 17.9 6.0 9.2 2.7 0.4 7.3 4.7 1.4 1.4 0.3 0.3 2.7 11.7 1.8 0.2 3.4 6.2 0.8 0.0 4.9 2.1 2.7 9.2 1.5 5.5 11.9 1.9 4.3 1.9 5.4 1.7 58.5 6.5 1.5 8.4 1.6 6.9 4.1 1.3 8.7 1.3 1.4 0.8 1.2 5.6 3.9 0.5 0.6 63.4 0.9 15.4 0.9 0.6 5.2 21.8 25.9 58.7 23.7 21.5 8.0 31.6 9.3 28.5 26.6 BCL7A BCL7 ENSG00000110987 "BCL tumor suppressor 7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.9;MOLT-4: 19.0;U-698: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 8.4;plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 10 "B-cells: 8.4;dendritic cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favourable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.8 3.7 13.0 9.8 14.5 9.9 6.5 19.8 18.2 6.7 4.2 6.8 3.3 3.6 6.0 7.4 3.3 10.3 4.3 9.4 9.5 7.5 10.7 5.3 5.1 19.4 6.6 15.9 4.9 11.7 8.3 6.1 2.8 6.8 6.3 3.8 3.8 8.2 7.2 12.8 8.2 3.4 4.1 5.1 6.5 4.4 3.1 7.9 26.4 11.1 3.5 15.8 6.9 5.4 8.4 9.7 0.1 0.1 0.5 0.9 0.6 1.7 2.4 7.9 5.6 0.5 0.3 1.7 1.0 1.0 1.7 1.5 1.0 0.7 25.9 2.9 0.8 2.3 5.7 5.5 1.4 0.0 9.4 1.3 0.2 1.4 1.7 4.0 2.3 1.2 5.2 1.2 7.1 2.1 5.8 0.0 1.0 3.6 19.0 0.3 2.8 4.0 10.5 2.7 0.3 3.1 4.4 7.9 8.9 1.3 0.3 3.3 5.3 3.3 1.9 0.3 1.7 2.9 1.7 2.7 1.8 29.9 0.5 2.5 1.8 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.2 0.2 2.2 8.4 0.9 0.6 0.1 0.5 0.1 9.7 0.0 0.6 13.0 14.5 19.8 18.0 9.5 7.5 6.6 15.9 6.8 7.9 BCL9 ENSG00000116128 "B cell CLL/lymphoma 9" O00512 1 147541412-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA020274: " "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 4.5 7.8 10.2 5.9 9.2 3.1 4.8 22.3 12.6 18.2 9.4 8.1 10.9 5.3 23.9 15.9 6.8 18.9 5.2 8.3 8.0 7.4 9.6 4.3 5.0 4.0 5.9 8.7 17.0 6.1 14.6 10.6 4.5 6.8 10.5 7.9 11.8 8.1 13.2 7.9 7.8 5.5 15.7 5.4 3.8 7.6 6.1 6.5 22.4 7.8 8.0 6.0 9.6 8.0 0.4 0.0 0.6 0.3 0.1 2.6 1.0 3.0 2.9 20.9 15.5 2.4 2.8 4.1 2.5 3.9 2.7 2.6 3.8 4.5 2.9 5.5 2.3 2.4 13.2 4.5 2.6 6.8 3.7 1.4 3.2 2.5 2.0 0.8 4.1 2.8 3.8 3.2 2.3 4.2 2.7 4.7 2.4 6.8 7.1 0.7 24.6 6.5 7.6 5.2 5.5 10.6 3.4 5.7 12.3 2.8 5.1 4.8 6.5 1.4 3.0 1.9 9.1 5.4 3.9 21.1 5.3 5.4 4.8 0.8 9.2 0.0 0.3 0.6 1.0 0.0 0.9 0.2 1.2 1.2 0.0 0.4 2.6 1.6 0.2 0.1 0.1 0.0 0.9 1.0 10.2 9.2 22.3 12.6 8.0 7.4 5.9 8.7 6.8 6.5 BCO1 "BCDO, BCDO1, BCMO, BCMO1, FLJ10730" ENSG00000135697 "Beta-carotene oxygenase 1" Q9HAY6 16 81238448-81291142 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 28.1;retina: 62.0" "Cell line enhanced" "Detected in some" "A549: 12.5;EFO-21: 9.5;HAP1: 3.6;NTERA-2: 5.1;RPTEC TERT1: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043811 Uncertain "Actin filaments,Centriolar satellite" "Actin filaments, Centriolar satellite" "HPA043811: AB_10962487" "unprognostic (2.78e-1)" "unprognostic (3.88e-3)" "unprognostic (2.61e-1)" "unprognostic (3.32e-1)" "unprognostic (4.05e-2)" "unprognostic (8.01e-4)" "unprognostic (1.65e-1)" "unprognostic (2.99e-2)" "unprognostic (1.58e-3)" "unprognostic (7.26e-2)" "unprognostic (2.97e-2)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.48e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 0.1 0.0 1.3 0.2 1.4 0.0 0.2 0.2 1.6 0.3 28.1 0.3 1.4 11.0 0.7 0.5 0.7 0.6 1.4 0.1 1.7 1.9 4.2 2.5 0.3 0.1 0.8 0.1 2.0 0.4 0.0 1.9 0.1 5.9 1.3 3.6 62.0 1.3 2.8 0.6 0.3 16.9 0.4 0.4 0.1 2.3 0.2 0.3 0.3 0.2 0.5 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 2.5 0.0 9.5 0.0 0.1 3.6 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 9.6 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.2 1.6 1.7 1.9 0.8 0.1 5.9 0.3 BCORL1 "CXorf10, FLJ11362" ENSG00000085185 "BCL6 corepressor like 1" Q5H9F3 X 129981107-130058083 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 20.0;HAP1: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031775, HPA031777, HPA068568" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: " "unprognostic (8.07e-2)" "unprognostic (2.78e-2)" "unprognostic (7.09e-2)" "prognostic unfavourable (2.20e-5)" "unprognostic (4.58e-1)" "unprognostic (1.68e-3)" "unprognostic (1.96e-3)" "unprognostic (5.56e-3)" "unprognostic (2.39e-1)" "unprognostic (8.02e-2)" "unprognostic (4.46e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (5.00e-4)" "unprognostic (9.18e-2)" "unprognostic (2.60e-2)" "unprognostic (3.09e-1)" "unprognostic (1.41e-2)" 7.5 7.9 7.7 5.2 9.1 9.8 9.1 19.8 10.5 8.7 8.3 10.7 8.1 5.4 9.2 5.4 5.8 9.3 4.2 6.9 8.4 4.5 7.5 4.7 6.7 5.3 7.6 5.9 11.4 8.9 13.4 15.0 28.9 7.5 8.1 4.5 6.0 6.5 8.4 6.0 6.5 6.0 8.8 5.3 7.7 6.6 26.1 8.1 6.8 10.3 2.2 5.1 6.7 8.5 1.2 1.6 3.5 1.3 0.8 1.3 0.7 2.2 5.4 12.7 20.0 7.5 5.4 3.5 2.9 3.5 3.8 4.4 6.5 1.4 1.0 6.6 5.9 1.3 30.1 1.2 3.6 2.2 4.4 10.3 2.6 2.2 3.7 2.5 3.0 3.3 2.5 7.5 0.4 4.6 4.9 10.6 2.5 1.3 3.8 7.8 3.5 3.8 8.1 5.1 1.4 2.1 0.3 2.1 7.2 1.6 0.4 1.9 4.4 3.9 3.8 3.1 4.0 3.8 2.8 3.4 6.2 1.6 2.1 5.3 1.4 0.1 1.3 2.8 1.3 0.2 1.0 1.2 0.9 0.8 1.6 1.0 0.6 0.7 3.5 0.8 0.5 0.7 0.2 0.7 7.7 9.1 19.8 10.5 8.4 4.5 7.6 5.9 7.5 8.1 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favourable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 18.6 8.1 12.4 12.7 7.4 5.1 18.8 6.8 6.3 6.3 5.1 14.1 7.5 13.0 12.6 5.7 19.2 1.3 18.8 1.8 24.9 12.9 11.4 11.1 11.2 9.7 10.5 6.0 4.3 12.7 9.4 8.2 21.8 43.5 6.1 2.8 12.3 9.8 8.2 10.5 7.9 12.9 5.0 8.6 9.7 11.8 11.4 10.8 12.4 10.7 5.1 6.7 8.6 24.6 3.8 0.4 6.1 5.5 1.4 5.6 4.6 9.7 8.0 5.8 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell line enhanced" "Detected in many" "BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" 19244000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: , HPA056104: " "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.6 0.2 0.0 2.3 1.9 0.0 22.4 4.3 17.2 13.1 0.0 2.6 0.0 2.1 8.1 1.0 0.1 0.2 16.5 0.1 0.1 0.0 2.2 0.0 10.0 0.1 0.1 5.8 2.2 3.8 2.2 0.7 0.0 0.0 2.7 0.0 0.0 0.0 2.1 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 0.1 0.0 7.4 24.1 4.0 9.3 5.0 0.3 0.0 0.0 9.3 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA053851: " "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 0.9 1.0 9.5 0.3 0.1 4.8 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.3 0.2 0.1 0.1 0.3 0.0 0.6 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 0.0 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.5 0.1 0.2 0.5 8.4 0.6 0.1 0.2 0.2 0.2 1.4 0.2 0.1 0.3 0.4 2.6 0.1 0.4 0.5 0.1 0.1 5.5 0.2 1.3 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Group enriched" "Detected in some" 7 "HeLa: 21.3;SH-SY5Y: 51.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002899 Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.4 1.9 21.3 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.2 0.0 0.0 1.6 0.1 0.6 0.5 0.7 0.0 0.1 2.6 0.0 0.0 1.1 51.9 1.1 0.0 1.2 0.3 5.3 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 3.7 0.9 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Cell line enhanced" "Detected in some" "HAP1: 24.1;HEK 293: 5.8;HEL: 14.7;MOLT-4: 9.0;U-698: 9.6" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 24.1 0.0 0.0 0.0 5.8 14.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.4 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 BEND5 "C1orf165, FLJ11588" ENSG00000162373 "BEN domain containing 5" Q7L4P6 1 48727523-48776969 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 4.2;HDLM-2: 13.5;MOLT-4: 5.5;NTERA-2: 3.2;REH: 7.7;SH-SY5Y: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 7.1;naive B-cell: 10.1" "Lineage enriched" "Detected in many" 5 "B-cells: 10.1" "Low region specificity" "Detected in many" "HPA054347, HPA058007" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA054347: , HPA058007: " "prognostic favourable (2.50e-5)" "unprognostic (1.36e-2)" "unprognostic (7.19e-3)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (4.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.32e-2)" "unprognostic (4.28e-2)" "unprognostic (2.37e-3)" "unprognostic (3.35e-2)" "unprognostic (9.68e-2)" "prognostic favourable (8.30e-6)" 2.7 5.4 6.5 5.6 7.7 3.0 3.1 2.1 15.5 4.8 5.0 2.8 3.5 1.6 5.0 4.9 2.3 4.3 6.0 4.0 6.0 5.1 6.5 0.8 3.0 5.9 5.4 9.7 12.8 2.8 1.9 5.9 1.4 14.7 3.9 1.6 3.3 2.5 4.3 6.6 1.9 2.6 2.6 3.2 6.4 2.9 2.6 1.9 11.3 4.3 0.5 4.1 4.4 2.9 10.1 1.9 0.2 0.0 1.1 2.0 0.6 0.0 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.2 3.2 0.0 7.7 1.4 0.0 0.1 1.5 1.4 3.8 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.2 1.9 10.1 2.0 1.2 0.2 1.1 0.0 1.9 0.0 0.6 6.5 7.7 2.1 15.5 6.0 5.1 5.4 9.7 14.7 1.9 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.0;fHDF/TERT166: 18.2" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: " "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.3 1.4 0.8 0.4 12.0 20.0 3.2 10.2 10.0 4.6 5.3 0.1 1.6 0.0 3.3 18.2 0.4 1.1 0.5 5.8 1.5 0.6 2.2 4.9 0.2 3.2 6.2 0.1 8.6 2.9 6.4 2.9 3.0 2.8 5.9 9.3 3.4 3.7 1.6 2.9 0.8 0.0 0.1 1.6 1.7 3.4 4.0 4.0 6.8 0.8 0.8 0.2 3.8 3.9 14.0 0.4 9.4 2.2 8.2 9.0 2.6 8.2 4.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.6" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.7 4.4 5.7 2.5 0.1 0.0 7.4 3.0 0.1 8.7 5.1 3.6 14.6 0.0 4.2 6.5 0.4 8.1 2.2 7.4 0.0 7.3 0.1 0.0 11.0 3.3 0.0 0.0 0.2 5.1 1.3 0.0 8.2 4.5 0.0 7.5 5.8 0.1 0.0 2.5 1.0 0.0 4.1 0.0 6.1 1.3 0.5 4.4 8.9 0.0 0.2 0.2 3.7 6.8 1.7 11.4 10.5 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 18.6 20.3 11.4 23.4 15.2 9.2 19.2 14.4 19.8 22.3 18.0 21.0 34.1 17.0 23.4 28.6 16.2 21.7 25.3 18.7 11.6 12.6 21.4 30.3 20.4 20.4 14.9 13.7 33.8 62.2 29.3 31.4 17.3 15.8 27.3 18.0 24.4 35.1 28.0 11.6 18.6 22.4 26.1 13.4 22.3 21.8 27.4 10.5 18.4 27.0 15.6 22.4 25.8 21.0 18.1 12.3 34.3 15.1 15.1 22.5 15.9 18.4 15.4 9.2 11.3 28.5 25.2 13.3 19.7 26.0 21.2 21.8 19.1 17.9 16.3 9.6 35.7 17.2 10.6 18.0 16.3 12.6 11.4 15.1 8.1 19.3 26.4 17.1 29.5 28.3 24.3 12.5 33.7 14.3 21.9 17.1 13.5 10.0 12.5 10.9 14.0 17.5 13.0 13.6 11.0 17.4 8.3 10.0 12.2 17.6 28.5 19.2 14.6 13.5 15.8 16.5 7.7 6.7 9.7 30.3 13.8 14.4 22.3 14.4 15.0 27.0 10.4 34.3 16.7 15.1 20.0 18.1 19.3 17.0 10.5 15.1 22.5 17.3 24.5 15.1 13.2 12.3 14.6 15.9 11.4 15.2 14.4 19.8 11.6 12.6 14.9 13.7 15.8 10.5 BEX4 "BEXL1, FLJ10097" ENSG00000102409 "Brain expressed X-linked 4" Q9NWD9 X 103215092-103217246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 37.4;HMC-1: 45.3;K-562: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045105, HPA051935" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045105: AB_10966792, HPA051935: " "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.55e-3)" "unprognostic (1.75e-3)" "unprognostic (3.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-3)" "unprognostic (3.03e-1)" "unprognostic (6.33e-2)" "prognostic favourable (9.41e-4)" "unprognostic (1.62e-2)" "prognostic favourable (2.54e-14)" "unprognostic (1.62e-3)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (5.33e-2)" 9.8 36.8 63.8 8.6 71.4 21.5 20.8 53.6 68.8 20.7 14.3 29.5 11.5 6.4 25.5 99.8 17.7 24.5 14.8 35.1 61.6 77.6 34.9 5.1 15.8 10.7 54.3 54.7 38.8 12.6 40.7 34.1 29.4 50.5 30.1 10.1 18.0 27.1 32.1 2.5 7.5 8.7 20.9 51.2 23.1 9.6 16.2 24.4 8.6 47.8 3.5 12.3 14.1 11.5 12.9 28.3 36.7 10.4 34.0 25.7 15.0 0.0 0.0 23.2 0.0 5.9 4.1 20.7 5.4 4.7 10.2 18.9 0.0 0.3 0.0 9.1 3.8 0.1 9.3 1.2 11.4 0.0 8.7 37.4 0.0 0.0 18.1 28.0 45.3 15.3 3.1 5.3 0.0 11.9 52.4 0.1 3.1 0.1 19.5 0.2 28.0 1.6 0.0 6.7 0.1 9.4 0.5 17.3 26.4 1.9 0.3 1.1 0.9 0.3 0.3 1.3 8.3 0.1 0.0 3.0 1.3 0.0 3.9 0.0 1.1 36.7 8.6 14.8 12.1 10.4 10.1 12.9 14.7 12.2 18.2 12.6 25.7 20.2 1.9 34.0 8.5 28.3 13.5 15.0 63.8 71.4 53.6 68.8 61.6 77.6 54.3 54.7 50.5 24.4 BFSP1 "CP115, CP94, filensin, LIFL-H" ENSG00000125864 "Beaded filament structural protein 1" Q12934 20 17493905-17569220 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.3;SK-BR-3: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.1" "Group enriched" "Detected in many" 5 "NK-cells: 1.5;T-cells: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040748, HPA042038" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040748: AB_10963786, HPA042038: AB_10964054" "unprognostic (2.24e-3)" "unprognostic (1.99e-1)" "unprognostic (1.63e-1)" "prognostic favourable (1.39e-4)" "unprognostic (1.07e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-6)" "unprognostic (5.11e-2)" "unprognostic (5.53e-1)" "unprognostic (2.10e-4)" "unprognostic (1.75e-1)" "unprognostic (8.81e-2)" "unprognostic (3.35e-4)" "unprognostic (4.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.78e-2)" "unprognostic (7.50e-2)" 2.5 1.8 3.5 2.5 5.6 0.8 2.6 2.8 4.4 3.5 1.8 0.9 5.5 0.8 10.7 5.4 5.1 2.2 4.8 2.4 3.2 3.7 6.1 1.1 4.1 0.6 3.3 1.7 5.3 2.7 4.8 1.3 4.5 3.0 3.3 1.2 2.3 2.0 4.0 3.0 1.8 0.9 2.7 6.9 0.8 1.1 8.0 0.7 0.6 5.3 2.3 1.5 5.1 1.1 0.0 0.0 0.7 0.0 1.5 6.1 0.5 0.7 7.5 2.4 0.3 0.6 2.5 0.4 1.9 8.7 1.2 1.2 3.3 6.4 0.0 1.5 1.0 1.1 2.6 1.5 1.0 1.6 2.0 0.5 1.1 1.0 1.4 0.4 0.8 3.0 4.6 0.7 2.1 5.2 0.2 0.4 3.9 1.4 0.0 1.0 5.7 2.1 0.0 1.7 0.4 18.3 1.3 2.5 0.3 2.2 9.9 3.8 4.8 1.6 5.9 0.3 0.6 0.6 1.8 0.0 0.1 0.0 1.3 0.0 1.5 0.1 0.0 0.0 6.1 0.0 0.2 0.0 1.7 1.0 0.0 0.0 0.1 0.5 0.7 1.5 0.0 0.0 0.0 0.5 3.5 5.6 2.8 4.4 3.2 3.7 3.3 1.7 3.0 0.7 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.5;U-698: 6.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BGN "DSPG1, SLRR1A" ENSG00000182492 Biglycan P21810 X 153494939-153509554 "Disease related genes, Predicted secreted proteins" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 45.5;BJ hTERT+: 58.9;fHDF/TERT166: 82.2;HSkMC: 43.2;hTEC/SVTERT24-B: 34.9;HUVEC TERT2: 82.4;U-138 MG: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003157, CAB003678" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" 2500000 "Golgi apparatus" "Endoplasmic reticulum" "CAB003678: AB_425325, HPA003157: AB_1078282" "unprognostic (1.74e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-3)" "unprognostic (3.60e-1)" "unprognostic (5.42e-2)" "unprognostic (3.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.22e-2)" "unprognostic (1.76e-3)" "unprognostic (1.30e-2)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (6.00e-8)" "unprognostic (7.05e-3)" "unprognostic (2.40e-2)" "unprognostic (5.66e-2)" "unprognostic (2.57e-3)" 41.1 39.7 8.1 23.2 14.6 0.4 20.2 5.6 14.3 76.7 12.0 18.7 16.7 6.0 63.4 31.7 21.1 23.6 86.7 133.0 8.9 5.2 67.6 78.1 77.6 29.4 8.9 16.3 39.6 16.8 5.1 26.7 131.1 15.0 33.6 7.0 48.3 20.4 38.2 17.0 31.0 8.6 56.9 5.9 101.3 10.0 28.0 15.8 3.9 45.3 29.9 14.6 34.5 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.7 10.8 0.1 45.5 58.9 8.4 2.8 5.7 0.0 0.0 8.4 82.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 43.2 0.3 34.9 1.6 82.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 17.4 37.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 14.6 5.6 14.3 8.9 5.2 8.9 16.3 15.0 15.8 BHLHA15 "bHLHa15, BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211427-98212979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "pancreas: 145.8;salivary gland: 95.2" "Group enriched" "Detected in some" 8 "Karpas-707: 16.7;RPMI-8226: 31.0;U-266/70: 37.1" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 7 "B-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.2 0.8 0.2 0.0 0.1 0.1 0.2 0.3 1.2 0.0 3.5 0.9 0.1 0.1 0.4 0.1 0.8 0.1 0.3 0.2 0.3 4.7 0.5 1.8 0.1 0.0 0.0 145.8 0.0 0.4 0.0 0.0 1.6 0.1 0.0 95.2 6.8 0.4 0.2 0.8 0.0 0.1 1.9 6.2 0.1 0.0 0.0 0.2 1.2 2.7 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 1.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 16.7 0.0 0.3 0.0 0.0 0.5 0.5 0.2 0.0 31.0 0.0 0.0 1.8 0.7 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 37.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000887: " "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.0 3.9 4.1 2.4 5.2 3.4 4.7 5.7 10.9 3.3 2.3 0.0 3.6 3.9 2.8 7.1 3.8 6.4 0.0 4.2 1.0 3.3 0.7 6.6 0.7 1.3 4.3 3.4 2.5 0.3 5.7 3.0 3.5 5.0 2.2 2.6 0.4 7.6 3.0 1.4 3.8 0.0 3.7 5.8 5.8 5.4 3.8 1.1 0.4 3.2 1.8 5.8 1.5 4.0 2.2 3.3 1.9 4.7 0.0 3.5 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 BHLHE41 "BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120026-26125127 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.9" "Cell line enhanced" "Detected in many" "Karpas-707: 15.1;RT4: 47.2;U-266/70: 20.2;U-87 MG: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 5.3;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 54 "B-cells: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA056035: , HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavourable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favourable (1.09e-4)" 7.0 11.7 23.8 5.8 32.3 1.2 10.7 22.9 26.9 30.6 7.6 33.3 3.0 2.8 6.9 15.6 3.2 34.5 14.1 14.7 25.9 19.6 3.8 1.4 9.1 6.0 38.9 14.0 10.9 6.4 6.2 11.2 8.3 28.3 8.2 9.1 19.0 13.4 11.7 58.9 3.8 4.3 4.3 49.6 6.2 4.4 4.0 44.0 0.9 43.6 6.4 13.3 16.5 6.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 8.0 3.7 1.8 0.8 1.4 0.1 0.5 0.0 5.0 0.0 0.7 1.6 4.2 0.1 0.7 0.4 0.0 0.6 0.3 0.0 0.0 0.3 2.1 0.1 0.6 0.4 2.9 5.8 0.0 0.0 15.1 0.9 0.4 0.0 1.4 3.9 2.9 0.0 0.7 11.5 1.9 47.2 0.0 0.1 0.5 0.2 10.6 0.0 0.0 2.5 2.7 3.2 0.3 2.2 20.2 11.6 0.0 17.4 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 32.3 22.9 26.9 25.9 19.6 38.9 14.0 28.3 44.0 BICD2 KIAA0699 ENSG00000185963 "BICD cargo adaptor 2" Q8TD16 9 92711363-92764812 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023013, HPA024452" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA023013: AB_1845352, HPA024452: AB_1845353" "unprognostic (9.99e-3)" "unprognostic (1.98e-1)" "unprognostic (7.84e-3)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "unprognostic (2.86e-1)" "unprognostic (2.37e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (6.54e-3)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.39e-4)" "unprognostic (1.25e-1)" "unprognostic (2.26e-1)" "unprognostic (3.95e-1)" "unprognostic (1.39e-2)" 10.4 7.8 13.9 8.9 12.5 7.2 7.1 13.2 13.1 13.1 9.9 7.7 7.9 3.2 9.7 4.5 27.2 7.2 6.7 15.6 11.8 5.8 7.5 5.2 9.1 9.3 13.4 9.8 8.4 7.2 21.7 3.8 9.8 11.9 7.4 3.7 6.6 9.1 10.0 13.9 40.3 5.9 9.7 9.2 11.3 5.9 5.9 11.0 8.5 6.2 16.3 18.2 10.6 17.2 3.3 5.2 10.5 7.5 1.5 2.4 2.0 14.1 11.7 8.7 8.9 17.0 11.7 12.3 13.7 9.9 7.8 6.2 6.8 6.4 15.9 9.0 15.2 44.3 9.7 21.8 8.9 7.6 10.6 8.4 11.4 9.4 10.1 11.5 13.6 12.0 30.5 13.0 10.0 11.6 8.2 12.4 17.0 9.2 10.9 7.2 6.0 14.4 12.1 18.9 8.4 12.5 11.9 6.1 9.4 9.6 9.0 6.2 3.7 5.4 15.5 14.6 9.7 24.4 14.8 10.2 7.4 14.1 12.3 7.1 12.7 2.2 4.4 5.6 1.8 5.2 1.8 2.7 2.0 2.4 5.2 3.3 1.9 1.7 10.5 1.5 7.5 4.5 1.2 2.0 13.9 12.5 13.2 13.1 11.8 5.8 13.4 9.8 11.9 11.0 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Cell line enhanced" "Detected in many" "hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA061116: " "unprognostic (2.17e-1)" "prognostic favourable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favourable (3.15e-4)" "prognostic unfavourable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favourable (3.93e-5)" "prognostic favourable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.7 0.0 1.1 9.5 0.0 27.3 0.0 0.3 0.0 0.3 1.1 0.0 14.7 6.4 0.1 11.7 2.7 0.7 0.5 2.4 3.5 4.5 17.2 1.2 2.0 5.4 1.4 12.3 4.4 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Cell line enhanced" "Detected in some" "A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favourable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.8 10.4 0.0 0.0 0.0 16.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 7.4 0.1 0.0 0.0 8.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 BIRC2 "API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48" ENSG00000110330 "Baculoviral IAP repeat containing 2" Q13490 11 102347211-102378670 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005513, CAB020661" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" Nucleoplasm "CAB020661: , HPA005513: AB_1846746" "unprognostic (1.36e-1)" "unprognostic (3.29e-1)" "unprognostic (9.52e-3)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (7.02e-2)" "unprognostic (2.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.05e-2)" "unprognostic (3.02e-2)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (5.00e-2)" "unprognostic (1.64e-2)" 20.9 25.8 19.1 23.3 24.1 25.9 57.0 20.5 28.5 25.1 22.2 18.4 18.7 19.3 24.6 31.1 18.6 17.0 21.1 39.2 19.1 18.3 24.3 36.8 34.0 47.2 23.3 15.8 21.5 40.8 22.0 27.3 24.3 22.3 19.6 22.2 14.3 21.9 22.1 38.8 17.3 24.4 23.8 26.3 27.6 19.0 19.7 15.5 51.2 18.9 17.3 21.9 22.2 20.2 5.8 12.6 37.5 16.6 12.2 12.0 9.8 9.6 7.2 11.1 8.7 14.1 19.5 7.1 37.5 14.4 21.5 13.1 8.9 24.1 10.6 37.2 17.2 10.7 7.2 9.9 25.9 14.2 3.7 10.7 5.3 10.8 14.4 6.4 6.9 12.4 19.3 12.3 15.8 14.7 9.6 0.0 38.7 3.1 6.8 5.7 5.3 7.0 3.4 14.4 7.1 16.6 11.2 4.6 6.1 13.1 8.0 11.2 12.6 7.8 24.1 45.6 10.3 13.7 24.2 4.4 6.0 7.3 9.8 8.2 33.2 31.7 16.6 37.5 9.1 15.2 7.5 5.8 8.7 8.4 12.6 5.6 11.3 11.3 25.5 12.2 16.3 7.6 12.0 9.8 19.1 24.1 20.5 28.5 19.1 18.3 23.3 15.8 22.3 15.5 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.0;lymphoid tissue: 46.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 32.9;naive B-cell: 32.9" "Group enriched" "Detected in many" 10 "B-cells: 32.9;T-cells: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favourable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favourable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavourable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavourable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 6.9 3.3 1.4 43.9 2.3 5.1 5.4 0.5 2.0 5.3 13.1 0.5 2.8 6.8 2.9 3.7 8.4 3.9 13.9 6.0 2.2 1.3 10.8 12.5 21.8 46.3 2.8 1.2 3.4 7.0 1.1 14.5 0.9 2.2 8.7 6.2 1.1 9.2 4.7 2.2 5.5 46.0 7.3 3.0 34.9 15.9 3.2 2.7 34.2 3.0 4.1 34.0 12.6 6.2 32.9 0.8 2.0 2.6 2.5 17.1 2.8 6.3 5.1 0.0 0.1 0.1 0.7 0.6 0.5 4.3 0.6 0.7 0.9 37.5 33.0 17.0 0.3 3.6 0.0 0.9 2.1 31.2 0.1 0.1 1.5 0.2 6.5 0.5 0.7 0.7 4.6 2.1 32.8 0.1 0.1 0.0 0.8 0.0 2.2 0.3 0.1 0.2 0.0 0.3 1.6 8.5 3.3 0.0 0.1 0.5 0.5 0.3 1.6 0.3 1.7 7.2 0.7 0.4 6.5 22.0 18.8 11.6 1.3 1.8 0.8 2.0 0.9 0.4 1.4 2.2 2.5 32.9 10.7 3.5 0.8 32.9 7.5 2.2 0.5 2.5 2.6 0.3 17.1 2.8 1.4 2.3 0.5 2.0 2.2 1.3 2.8 1.2 2.2 2.7 BIRC6 BRUCE ENSG00000115760 "Baculoviral IAP repeat containing 6" Q9NR09 2 32357028-32618899 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074409, HPA074738" Supported "Golgi apparatus,Vesicles,Mitotic spindle" "Golgi apparatus, Vesicles" "Mitotic spindle" "HPA074409: , HPA074738: " "unprognostic (3.38e-2)" "unprognostic (8.13e-3)" "unprognostic (8.88e-2)" "unprognostic (7.06e-3)" "unprognostic (6.69e-3)" "unprognostic (9.01e-2)" "unprognostic (4.51e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (4.49e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-2)" "unprognostic (1.30e-1)" "unprognostic (4.61e-1)" "unprognostic (7.32e-2)" "unprognostic (3.37e-1)" 15.0 16.7 10.3 20.7 14.4 18.4 16.1 21.9 13.7 16.2 13.0 15.3 15.6 8.7 17.2 13.9 13.2 13.1 11.7 11.4 9.8 7.3 14.1 14.8 12.5 16.1 13.9 11.8 23.6 24.8 32.5 17.4 14.1 14.8 11.3 13.6 11.5 14.7 17.1 20.9 14.9 16.0 12.5 13.3 16.1 13.9 13.0 14.4 23.1 21.5 9.2 17.2 16.2 12.0 3.8 2.8 10.6 2.4 2.3 3.4 0.7 15.1 12.7 11.8 5.1 9.3 13.2 7.1 6.7 9.5 8.3 7.9 8.7 3.6 16.3 5.4 12.6 7.0 16.5 10.0 10.3 13.0 7.5 22.0 8.0 7.2 5.1 20.4 7.8 8.8 4.9 13.0 11.6 12.3 17.8 7.0 7.7 5.8 10.2 4.7 7.9 7.5 10.4 19.0 5.5 6.0 15.6 8.8 13.5 13.3 6.9 6.1 4.6 7.3 19.2 8.7 9.8 5.9 10.2 9.4 13.1 21.8 6.3 10.1 5.7 10.6 1.6 0.9 2.7 1.2 3.4 1.7 2.1 2.3 1.3 3.8 2.3 2.6 2.7 2.3 2.4 2.8 1.6 0.7 10.3 14.4 21.9 13.7 9.8 7.3 13.9 11.8 14.8 14.4 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 62.2" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA047850: , HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.1 0.4 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.2 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.4 7.8 8.7 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.8 3.8 14.1 2.6 1.1 9.1 13.4 3.7 6.1 8.5 9.9 14.7 8.4 2.2 0.0 14.1 7.3 0.0 0.0 4.7 2.4 3.3 12.7 4.4 4.9 3.4 10.6 7.8 9.3 1.7 10.8 16.4 5.4 1.1 9.8 6.5 6.1 3.3 4.4 2.6 3.1 11.6 1.8 3.4 6.3 3.5 8.7 3.2 13.1 14.7 1.9 10.0 5.8 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.1 16.1 15.6 10.8 10.7 11.5 7.5 9.5 5.9 15.0 13.0 23.6 3.0 30.3 17.0 7.6 7.1 33.7 13.0 12.7 8.0 26.5 18.6 14.5 20.0 15.6 33.8 11.5 13.5 0.9 11.7 6.8 22.0 39.6 12.4 6.2 7.7 41.8 24.7 14.9 7.5 36.3 40.5 20.0 12.0 9.1 36.0 12.9 8.4 16.4 10.3 11.2 17.5 14.0 9.3 18.7 4.1 16.8 15.0 30.8 40.9 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96191702-96271587 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7;lymphoid tissue: 47.1" "Group enriched" "Detected in some" 6 "Daudi: 17.9;REH: 43.3;RPMI-8226: 23.9;U-698: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7" "Group enriched" "Detected in many" 117 "B-cells: 35.9;dendritic cells: 50.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Plasma membrane,Cytoplasmic bodies" "Plasma membrane, Cytoplasmic bodies" "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: " "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favourable (2.67e-6)" 2.3 2.0 6.9 22.1 8.9 4.2 3.0 1.3 4.8 6.2 15.0 13.7 9.8 17.7 1.9 15.3 31.1 2.7 9.9 1.5 6.4 3.6 18.9 29.5 3.2 24.4 8.9 4.4 1.4 10.4 9.3 2.4 5.0 9.2 5.4 8.5 2.4 9.5 11.5 1.2 6.3 20.6 1.2 16.7 41.7 13.3 1.4 8.7 3.6 6.4 12.8 47.1 6.8 11.8 35.9 50.7 0.2 0.3 0.3 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.1 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 43.3 0.0 23.9 0.2 3.3 0.0 0.0 0.0 4.1 0.0 6.1 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 65.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 35.9 0.0 0.0 4.4 31.0 0.0 0.0 0.2 0.3 0.0 50.7 0.0 1.8 6.9 8.9 1.3 4.8 6.4 3.6 8.9 4.4 9.2 8.7 BLOC1S4 "BCAS4L, CNO, FLJ11230" ENSG00000186222 "Biogenesis of lysosomal organelles complex 1 subunit 4" Q9NUP1 4 6716055-6717671 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043840 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA043840: AB_10965701" "unprognostic (3.09e-1)" "unprognostic (8.40e-2)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (1.06e-4)" "unprognostic (3.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.80e-1)" "unprognostic (3.53e-1)" "unprognostic (1.76e-1)" "unprognostic (9.24e-3)" "unprognostic (5.62e-3)" 14.6 15.5 9.2 11.8 11.5 13.6 11.4 10.7 14.4 15.4 15.2 9.5 10.1 14.6 13.8 14.3 14.1 12.3 15.7 9.6 9.3 7.7 13.6 13.8 8.7 16.9 8.6 9.4 19.1 18.4 8.4 9.8 23.2 9.8 13.7 9.4 13.3 10.8 11.2 16.6 10.7 15.8 8.2 7.4 17.7 13.3 14.0 8.9 20.9 16.8 10.1 15.5 12.3 10.9 6.1 3.8 13.7 4.8 2.5 9.6 1.8 9.9 6.8 10.4 10.6 8.1 10.5 21.0 8.1 8.9 7.6 6.7 6.1 10.8 9.5 8.8 7.2 6.8 5.8 9.3 5.9 7.6 9.5 14.5 6.5 15.0 10.0 7.0 13.6 9.9 9.3 6.0 5.2 6.9 19.0 8.7 7.8 9.9 11.4 24.4 13.6 13.7 11.9 11.5 8.5 10.4 8.9 9.0 12.1 6.8 4.9 14.4 15.4 13.7 7.7 7.1 6.2 8.1 10.2 13.0 12.6 12.6 7.8 12.9 11.1 2.5 3.1 13.7 5.1 4.8 5.2 6.1 6.2 5.5 3.8 4.9 9.6 5.3 1.8 2.5 3.1 3.7 5.1 1.8 9.2 11.5 10.7 14.4 9.3 7.7 8.6 9.4 9.8 8.9 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465840 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 137.6" "Cell line enhanced" "Detected in many" "A549: 82.6;K-562: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 73.4" "Group enriched" "Detected in all" 7 "dendritic cells: 54.8;monocytes: 73.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 440000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 36.9 17.9 10.9 12.8 12.2 137.6 28.9 3.5 10.9 17.0 26.7 7.7 18.5 20.9 14.1 19.6 45.3 14.6 19.0 31.0 8.2 8.6 31.8 72.4 37.3 30.0 11.7 9.6 21.3 19.4 5.7 5.6 32.2 13.8 22.9 7.7 17.5 27.1 22.1 43.4 16.7 26.4 22.1 9.7 47.1 31.1 7.6 7.9 6.6 24.3 42.9 24.4 29.9 22.1 8.6 54.8 9.1 73.4 4.0 5.3 34.4 34.8 82.6 1.1 12.3 11.5 11.1 9.8 4.4 12.9 6.0 11.7 16.2 31.7 11.7 34.0 7.9 11.1 4.2 9.6 1.2 19.8 3.6 17.8 12.5 9.8 26.5 0.2 5.2 10.8 18.2 8.0 4.4 6.3 75.0 21.3 7.0 54.2 0.9 1.0 0.3 23.1 8.2 3.9 18.9 7.5 23.5 0.0 1.8 13.4 35.2 13.5 34.3 2.7 6.8 16.0 17.2 24.6 2.3 11.6 13.6 4.4 41.8 7.0 6.2 5.0 73.4 2.6 4.6 33.7 4.4 8.6 4.0 4.0 54.8 5.4 4.2 3.3 9.1 4.0 16.9 11.5 5.3 34.4 10.9 12.2 3.5 10.9 8.2 8.6 11.7 9.6 13.8 7.9 BLZF1 JEM-1 ENSG00000117475 "Basic leucine zipper nuclear factor 1" Q9H2G9 1 169367970-169396540 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025703, HPA027331, HPA067113" Supported Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA025703: AB_1845379, HPA027331: AB_1845380, HPA067113: " "unprognostic (5.25e-2)" "unprognostic (9.03e-2)" "unprognostic (9.31e-3)" "unprognostic (1.48e-2)" "unprognostic (4.66e-1)" "unprognostic (4.00e-1)" "unprognostic (2.34e-2)" "unprognostic (4.52e-3)" "unprognostic (1.07e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-3)" "unprognostic (4.86e-2)" "prognostic unfavourable (2.33e-4)" "unprognostic (3.28e-1)" "unprognostic (3.06e-2)" "unprognostic (7.53e-2)" "unprognostic (2.18e-1)" 17.5 13.5 15.7 12.2 18.6 19.7 17.3 21.0 24.1 19.6 14.3 7.8 12.7 10.5 14.4 13.2 29.3 11.8 14.5 14.7 13.8 11.6 19.6 13.1 11.3 9.4 14.0 18.0 17.4 12.0 15.5 30.3 16.9 20.5 19.9 14.1 7.5 16.0 15.2 13.5 15.7 17.3 18.8 16.7 10.9 12.4 35.6 15.8 19.1 19.1 17.5 13.6 22.1 20.8 5.2 5.1 31.4 7.5 8.9 10.9 5.1 24.5 7.9 7.9 6.7 12.0 18.5 12.7 21.9 15.4 23.3 25.8 9.2 16.1 3.7 12.4 14.5 18.0 7.7 13.6 18.4 7.6 7.5 6.6 9.7 6.4 12.6 12.6 9.4 13.6 17.6 17.5 15.8 12.2 11.4 9.9 21.4 5.2 5.5 5.8 9.5 11.8 3.2 12.4 7.6 22.4 8.3 4.9 14.8 14.3 19.5 16.4 21.7 9.0 14.6 13.9 10.9 12.9 17.7 10.0 11.9 9.2 10.8 5.8 21.4 31.4 5.9 23.2 6.2 7.5 7.9 5.2 7.7 7.0 5.1 4.8 6.9 7.4 12.0 8.9 7.0 3.9 10.9 5.1 15.7 18.6 21.0 24.1 13.8 11.6 14.0 18.0 20.5 15.8 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321211-22331484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 87.1;U-937: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: , HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavourable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 19.7 23.5 28.0 17.0 35.0 13.3 26.5 26.1 33.7 21.6 22.3 26.3 11.6 14.1 23.9 22.8 16.0 17.0 17.4 15.1 28.3 24.2 19.2 25.5 16.7 17.9 42.3 27.7 18.8 18.6 40.0 37.6 20.6 24.8 25.5 16.0 16.5 15.7 20.3 28.5 10.3 14.6 26.3 34.8 24.6 16.5 24.3 40.7 12.9 17.6 10.6 18.8 21.5 25.9 5.0 1.8 13.0 3.4 6.2 8.4 2.4 12.7 6.2 7.1 2.2 12.5 10.1 7.2 8.6 3.9 6.6 7.8 6.5 16.0 6.5 5.9 7.8 4.5 10.3 6.1 8.2 87.1 12.8 18.0 5.3 7.3 7.5 6.6 10.0 6.5 10.6 7.2 8.0 4.6 17.8 11.1 8.7 5.1 17.8 1.9 1.6 14.8 13.3 10.2 6.2 6.2 4.2 6.0 11.9 5.7 7.5 9.6 6.7 26.7 9.8 7.4 22.2 17.7 11.6 13.7 17.8 14.4 10.5 102.3 4.8 13.0 1.5 2.5 6.1 3.4 8.4 5.0 6.4 5.8 1.0 2.6 5.5 5.2 0.6 6.2 2.1 1.8 4.3 2.4 28.0 35.0 26.1 33.7 28.3 24.2 42.3 27.7 24.8 40.7 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell line enhanced" "Detected in some" "Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" 247500 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: " "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 1.6 41.5 10.6 0.0 12.0 1.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.0 0.0 0.0 0.0 18.4 0.0 0.0 0.1 4.5 1.3 31.3 0.1 0.2 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 56.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: " "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.5 8.7 13.9 13.4 10.7 11.9 12.0 10.4 10.4 4.7 8.7 2.0 13.9 24.0 10.8 7.2 9.2 16.3 5.9 4.9 6.0 5.7 7.3 9.6 1.7 4.7 9.8 8.7 7.6 10.2 30.0 3.9 9.9 12.8 10.7 1.4 1.5 3.0 4.9 3.9 10.9 3.0 8.9 12.2 5.6 5.6 12.6 7.6 14.0 5.8 4.0 33.0 21.2 11.3 7.2 7.2 1.4 1.7 0.6 5.1 3.8 6.1 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1, ribosome biogenesis factor" Q14692 10 42782801-42834937 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA036589: AB_10601460, HPA043081: " "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavourable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 17.8 15.3 10.4 15.8 19.7 17.4 16.2 22.5 20.6 15.5 12.9 13.7 11.2 11.8 23.1 13.4 17.8 14.0 10.0 14.4 10.8 13.3 17.8 16.8 14.1 17.2 12.6 15.4 17.5 16.2 24.7 28.0 15.3 22.8 14.1 15.4 12.3 18.8 14.0 29.9 18.1 13.8 14.7 15.0 18.3 13.5 14.8 13.4 20.7 14.0 17.2 19.2 14.4 15.9 9.8 8.4 3.4 9.1 6.2 11.6 5.6 16.6 14.2 13.8 15.7 10.5 8.7 13.4 14.0 14.8 16.5 14.3 19.5 13.1 8.8 10.0 12.0 14.6 22.5 18.0 21.8 12.9 15.7 11.8 11.0 16.6 9.0 31.9 11.2 7.7 9.2 17.8 17.4 12.5 20.7 9.6 11.7 14.0 17.7 10.6 17.5 15.1 16.3 14.5 9.5 9.2 14.7 10.6 11.3 12.2 13.6 11.5 16.5 9.2 15.1 7.8 27.9 15.5 22.7 7.7 9.5 26.0 11.3 23.7 5.9 3.4 5.1 2.9 8.6 9.1 10.2 9.8 10.6 9.3 8.4 7.4 11.6 10.0 0.7 6.2 7.4 4.4 7.5 5.6 10.4 19.7 22.5 20.6 10.8 13.3 12.6 15.4 22.8 13.4 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavourable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 18.1 6.9 16.6 11.2 46.3 29.2 14.0 18.4 54.1 17.3 38.3 3.1 8.8 5.6 17.4 34.6 9.3 8.2 23.6 57.6 3.6 4.5 23.2 7.2 5.4 25.8 2.0 40.3 35.0 18.6 19.6 11.8 22.1 10.4 13.6 36.2 7.9 14.3 7.6 5.3 7.6 7.7 21.1 11.0 17.9 11.8 17.7 15.8 8.9 1.8 13.9 9.1 4.4 28.9 32.5 14.1 20.3 4.1 20.0 9.0 7.5 49.4 4.2 7.3 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 30.7;ASC diff: 45.3;BJ hTERT+: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025806, HPA060778, HPA061787" Uncertain Enhanced "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 4500000 "Nucleoplasm, Plasma membrane" "CAB025806: , HPA060778: , HPA061787: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favourable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 10.7 30.7 45.3 2.4 0.3 4.9 16.2 1.2 1.0 0.0 0.0 0.0 3.0 8.3 0.0 2.1 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 7.8 0.7 0.6 0.1 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.7 2.6 0.0 4.8 0.0 0.2 0.0 3.2 4.6 0.0 0.2 0.1 1.3 0.1 0.0 1.7 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135398-74147994 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: " "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavourable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 18.5 16.1 23.2 11.7 26.0 18.0 20.4 15.6 29.8 11.0 24.0 7.5 12.1 18.4 10.0 13.8 12.6 11.2 12.5 56.8 18.9 21.0 22.0 15.7 14.1 14.7 24.1 18.1 6.9 27.8 12.8 12.3 7.7 17.6 11.5 19.7 11.9 21.5 14.2 57.2 5.9 15.3 14.4 15.8 8.8 16.8 8.2 10.6 7.7 12.1 27.9 11.1 8.9 9.1 14.3 20.7 3.4 9.7 15.2 32.0 13.9 23.5 30.7 11.2 11.0 20.7 19.6 27.6 22.0 13.0 24.5 16.8 39.9 11.0 15.6 20.2 19.0 12.5 25.6 31.4 22.0 30.5 42.2 19.8 21.3 60.8 18.5 38.8 9.7 15.6 24.1 23.8 29.6 18.2 41.4 18.5 26.5 36.3 32.4 29.0 16.4 47.1 21.3 29.1 32.0 32.4 23.9 16.9 10.1 15.6 25.7 27.1 14.7 24.7 10.0 20.3 34.7 22.7 43.6 17.0 29.9 21.4 21.4 31.2 18.2 3.4 4.8 1.1 23.2 9.1 25.3 14.3 32.0 24.5 12.1 12.4 28.0 24.1 0.9 15.2 9.7 20.7 27.8 13.9 23.2 26.0 15.6 29.8 18.9 21.0 24.1 18.1 17.6 10.6 BOP1 KIAA0124 ENSG00000261236 "Block of proliferation 1" Q14137 8 144262102-144291370 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 66.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA047869: , HPA066764: " "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavourable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavourable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 4.8 4.3 5.7 7.7 5.9 7.8 6.4 6.3 6.9 2.0 3.9 1.6 2.0 5.1 2.7 1.5 6.8 2.6 4.8 5.1 5.5 2.8 6.2 2.3 6.6 4.1 6.7 2.7 17.5 5.1 2.2 3.2 4.3 2.9 1.5 1.5 5.8 3.0 19.0 7.4 4.5 4.9 2.0 4.8 4.4 8.3 3.3 6.3 3.9 6.7 4.5 3.5 6.9 5.2 6.4 2.5 4.7 3.5 5.7 2.5 12.4 24.3 3.3 14.3 1.9 2.2 12.4 8.6 1.8 8.7 5.5 18.4 7.2 15.1 14.7 3.3 10.0 6.1 10.2 2.0 13.3 24.5 19.0 14.7 13.9 4.6 8.4 10.5 4.5 5.1 7.3 6.6 5.4 19.1 5.1 3.3 31.5 22.5 10.7 8.2 66.9 17.3 5.0 23.0 3.6 8.3 18.8 7.5 9.2 11.9 5.8 8.8 8.0 10.2 8.0 24.7 10.7 24.6 4.8 3.0 12.6 5.9 13.6 10.5 0.0 4.7 2.5 4.4 4.7 4.8 5.2 4.9 5.7 6.4 4.5 4.4 4.1 0.2 3.5 4.0 4.1 4.2 2.5 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.6 3.9 12.9 8.7 1.6 1.6 9.1 7.6 6.8 12.0 13.1 10.4 13.1 14.8 4.3 4.3 9.7 11.6 7.5 15.9 13.7 6.4 18.2 6.3 8.5 1.5 34.4 11.8 1.3 1.9 5.3 11.7 9.9 8.3 6.4 8.6 5.3 15.4 10.0 5.7 4.7 11.3 7.6 6.5 4.0 5.9 3.4 4.1 7.6 7.4 5.5 5.0 12.6 3.6 3.3 7.6 5.8 9.7 5.5 5.0 10.6 9.4 16.3 8.3 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 BORCS6 "C17orf59, FLJ20014" ENSG00000196544 "BLOC-1 related complex subunit 6" Q96GS4 17 8188333-8190907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 27.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045415, HPA060791" Uncertain Supported Centrosome,Cytosol Cytosol Centrosome "HPA045415: AB_10964575, HPA060791: " "unprognostic (2.11e-1)" "unprognostic (7.22e-3)" "unprognostic (3.25e-2)" "prognostic favourable (2.78e-4)" "unprognostic (3.84e-2)" "unprognostic (9.91e-3)" "unprognostic (7.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" "unprognostic (6.93e-2)" "prognostic favourable (2.60e-4)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (2.18e-2)" "unprognostic (4.38e-2)" "unprognostic (3.28e-1)" "unprognostic (3.10e-2)" 3.1 4.5 3.5 3.8 3.4 2.8 2.6 3.2 3.9 2.3 4.4 6.3 3.7 2.9 5.5 2.3 1.6 4.4 3.4 2.6 3.9 3.7 3.7 4.8 3.7 2.3 8.4 4.7 2.1 3.0 2.9 1.9 4.3 4.3 11.5 6.2 5.5 2.1 2.8 6.8 3.9 2.1 2.7 3.7 3.3 2.9 13.4 11.3 27.0 12.0 14.5 17.4 10.5 4.7 5.4 1.9 3.9 4.0 3.0 7.6 3.5 3.8 3.3 3.6 3.0 3.3 4.2 7.7 2.7 6.8 2.9 3.9 1.1 12.7 11.9 3.3 5.3 4.7 4.6 1.9 7.2 3.1 4.2 3.0 3.4 5.2 3.5 9.0 2.0 5.2 6.4 5.5 1.3 6.3 7.8 2.4 6.4 4.5 2.7 2.3 5.2 3.6 2.7 2.9 4.0 3.0 4.3 2.1 1.8 3.4 3.6 13.8 6.1 2.0 3.0 6.9 2.5 21.4 10.1 27.0 16.2 10.3 13.1 12.8 13.7 17.4 11.3 13.4 13.2 14.6 9.5 14.5 12.0 9.9 12.4 10.5 BORCS7 "C10orf32, FLJ40752" ENSG00000166275 "BLOC-1 related complex subunit 7" Q96B45 10 102854223-102864961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA037648 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA037648: AB_10673634" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (1.35e-2)" "unprognostic (7.46e-3)" "unprognostic (3.16e-2)" "unprognostic (1.77e-1)" "prognostic favourable (9.08e-8)" "unprognostic (9.85e-2)" "unprognostic (1.77e-1)" "unprognostic (1.06e-1)" "unprognostic (1.67e-3)" 16.0 40.4 22.7 8.1 26.5 13.2 20.2 14.3 22.1 15.6 11.9 16.4 15.2 15.2 15.2 19.4 9.7 20.2 17.7 15.1 19.7 20.9 26.0 42.7 15.7 10.4 18.0 22.5 15.4 15.2 32.8 23.2 21.2 20.1 18.7 10.3 15.0 11.2 12.6 17.2 9.1 17.7 11.8 17.8 18.1 13.7 18.0 17.3 8.9 36.9 14.2 7.9 11.3 10.9 16.2 29.7 16.8 21.6 16.4 13.5 8.6 7.6 10.4 12.8 11.0 14.1 19.4 10.5 11.4 23.4 8.8 8.4 6.9 8.7 4.9 6.0 18.1 6.4 4.2 5.8 6.5 6.1 8.9 11.2 7.1 14.3 16.2 20.2 19.4 24.2 16.1 5.9 9.5 15.3 6.5 5.1 14.0 5.6 5.5 8.3 4.2 9.9 10.2 16.9 7.0 7.3 8.5 3.6 13.9 4.2 7.6 17.4 14.4 11.6 11.4 7.4 7.9 7.5 8.0 13.5 20.5 5.8 15.7 11.8 2.6 16.8 19.5 13.6 11.8 21.6 12.9 16.2 12.1 11.9 13.8 14.4 13.5 12.4 6.0 16.4 19.3 29.7 11.8 8.6 22.7 26.5 14.3 22.1 19.7 20.9 18.0 22.5 20.1 17.3 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favourable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 11.3 17.0 25.0 12.9 26.8 12.2 13.3 19.3 31.0 10.1 13.5 17.3 14.5 15.5 12.9 15.8 13.8 14.0 14.8 17.9 23.9 30.0 16.0 14.1 12.0 14.0 26.3 12.2 10.5 10.1 11.7 20.1 11.3 15.6 10.9 15.3 13.6 12.4 15.5 12.0 9.6 9.5 13.0 13.9 11.9 11.2 11.1 12.9 12.4 13.0 11.1 13.8 10.9 8.5 8.7 9.8 25.6 14.6 5.0 7.1 6.7 9.6 5.4 8.9 7.3 9.8 5.3 8.9 10.1 8.5 16.0 14.8 9.4 9.4 7.1 14.1 11.7 6.4 9.7 12.4 7.6 3.9 12.3 5.4 12.3 10.1 8.0 3.9 7.6 6.4 9.3 12.2 6.1 14.0 9.5 10.3 16.9 17.4 14.6 9.0 4.8 11.9 6.9 3.6 8.1 13.8 5.9 18.3 10.1 9.2 6.1 7.5 6.7 7.5 7.1 5.5 8.1 18.7 15.3 6.5 7.7 8.2 10.9 6.6 11.2 10.6 9.6 16.0 4.9 13.7 4.8 8.7 5.7 5.6 7.4 6.3 4.7 5.2 25.6 5.0 14.6 9.8 7.1 6.7 25.0 26.8 19.3 31.0 23.9 30.0 26.3 12.2 15.6 12.9 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 10.9;U-266/70: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.4 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.3 0.5 0.0 0.6 0.6 0.6 0.3 0.4 2.4 1.1 0.1 0.3 2.2 0.0 0.2 0.0 2.3 0.7 3.7 0.4 0.2 1.9 0.6 3.1 0.7 0.4 0.0 10.9 3.3 0.9 0.9 0.0 0.2 0.0 1.1 1.9 0.0 0.9 0.3 0.5 0.3 0.7 1.2 5.6 0.4 11.1 1.7 5.5 2.3 2.6 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Cell line enhanced" "Detected in all" "HDLM-2: 37.1;RT4: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved Nucleoplasm,Nucleoli 69000000 Nucleoli Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favourable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favourable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.4 5.4 7.2 9.7 8.3 4.9 7.2 13.4 16.2 5.2 7.8 2.1 6.0 5.4 4.0 7.5 3.6 7.6 7.4 9.2 37.1 6.7 3.1 5.0 2.5 5.7 5.9 4.1 4.8 6.7 9.8 5.3 18.9 9.0 6.8 12.3 2.1 9.6 8.2 7.4 5.2 7.3 5.1 3.9 11.8 59.6 6.2 10.4 6.2 7.5 6.7 4.9 3.8 14.3 8.3 2.0 11.1 10.8 11.3 12.9 6.8 14.4 5.7 14.2 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 BRAF BRAF1 ENSG00000157764 "B-Raf proto-oncogene, serine/threonine kinase" P15056 7 140719327-140924928 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001328, CAB004552, HPA071048" Approved Approved Vesicles,Cytosol Vesicles Cytosol "CAB004552: AB_626760, HPA001328: AB_1078296, HPA071048: " "unprognostic (2.98e-3)" "unprognostic (5.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.66e-3)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.07e-2)" "unprognostic (4.23e-2)" "unprognostic (4.07e-2)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (1.91e-2)" "unprognostic (3.79e-3)" "unprognostic (2.08e-1)" "unprognostic (1.76e-1)" "unprognostic (8.01e-2)" "unprognostic (5.46e-2)" 13.1 12.1 20.1 16.5 20.4 27.8 14.2 29.9 21.5 12.4 12.3 9.5 12.5 9.3 15.3 17.0 11.8 11.5 12.0 13.6 13.2 12.2 13.7 12.8 15.9 13.3 9.9 17.8 16.8 13.2 28.9 24.8 13.7 15.3 14.5 11.0 10.7 11.6 16.6 12.9 15.6 10.5 13.0 10.9 12.3 12.0 24.9 12.2 13.5 16.6 7.5 12.1 18.6 18.1 2.6 1.9 7.5 2.4 7.0 5.6 1.1 5.4 4.6 6.8 8.1 8.3 10.7 10.9 6.1 6.5 4.9 7.1 5.0 5.9 9.3 4.7 6.2 3.0 6.0 4.8 9.0 8.6 4.9 6.0 4.5 4.6 7.0 9.8 6.1 7.1 5.4 5.2 10.8 5.7 9.5 16.7 8.7 2.9 13.0 10.3 6.3 2.9 8.5 5.8 7.6 4.8 10.4 7.9 6.6 7.0 4.3 6.3 4.0 6.7 8.4 5.3 4.1 11.5 4.9 19.4 11.0 14.8 8.7 9.9 5.7 3.3 2.0 7.5 3.1 1.7 2.1 2.6 3.0 2.4 1.6 2.6 5.6 2.8 4.1 7.0 2.4 1.9 2.7 1.1 20.1 20.4 29.9 21.5 13.2 12.2 9.9 17.8 15.3 12.2 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685986 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: " "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 9.8 9.9 9.8 7.2 11.6 26.5 9.6 10.0 12.8 8.3 9.3 10.0 8.0 8.6 10.1 7.0 9.4 8.4 7.3 8.8 8.6 8.7 8.4 9.3 7.9 9.7 9.2 8.5 9.7 7.8 9.4 10.4 9.8 12.0 8.3 9.0 6.7 8.9 9.7 19.1 12.7 9.3 9.1 11.1 9.6 7.9 55.9 10.1 12.4 9.5 5.6 10.4 10.2 11.8 12.7 11.7 25.7 13.5 16.6 18.5 11.6 9.7 14.4 11.8 13.5 12.6 10.7 19.7 13.7 11.6 16.0 12.3 19.3 6.8 18.8 8.2 13.0 12.0 16.4 11.2 17.1 12.0 10.6 23.3 9.0 13.0 15.9 20.4 15.8 12.0 16.0 13.8 22.4 13.8 24.1 6.2 13.1 12.3 16.9 19.7 15.9 15.2 15.8 12.9 16.8 10.5 20.6 14.7 10.9 16.1 13.7 13.4 15.0 13.0 12.7 10.3 9.6 9.2 9.7 15.9 20.0 20.8 9.7 11.3 11.2 16.1 13.0 24.0 14.7 13.5 14.3 12.7 15.4 14.7 11.7 12.5 14.6 14.8 25.7 16.6 10.6 8.4 18.5 11.6 9.8 11.6 10.0 12.8 8.6 8.7 9.2 8.5 12.0 10.1 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1, DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: " "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 4.8 4.3 6.0 9.6 11.3 15.3 5.1 12.9 10.6 5.4 9.2 3.4 6.8 4.3 5.4 5.5 9.1 5.5 3.3 6.5 6.6 5.3 4.2 7.7 4.9 13.0 7.5 5.9 5.1 4.7 4.2 11.0 5.3 10.5 4.1 10.4 3.7 5.4 7.4 7.3 8.3 6.7 5.5 9.2 5.9 5.1 17.6 7.0 10.9 15.6 7.3 14.6 5.5 5.6 2.0 9.1 9.7 12.7 1.4 1.3 10.7 15.5 25.2 13.9 11.1 2.3 5.2 13.6 18.3 7.9 15.4 14.7 15.3 12.1 35.9 3.4 7.0 18.0 18.9 10.2 25.9 16.4 13.8 16.9 19.8 13.2 0.5 30.1 14.7 1.4 1.7 23.2 7.4 7.9 25.4 15.4 14.5 10.3 25.2 9.9 7.6 6.7 17.4 29.3 14.7 5.7 15.1 9.6 10.3 14.1 4.7 6.9 12.4 13.9 5.2 13.8 11.2 17.8 19.1 7.2 17.6 27.6 11.1 17.9 14.4 4.6 12.7 1.8 1.3 4.0 1.3 1.1 1.3 1.0 9.1 2.0 1.2 1.3 9.7 1.4 1.5 1.4 0.4 10.7 6.0 11.3 12.9 10.6 6.6 5.3 7.5 5.9 10.5 7.0 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026815 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 3.9 3.5 6.0 4.5 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.2 5.3 14.0 2.8 2.1 5.4 4.9 2.5 9.6 9.1 2.6 8.9 2.2 3.2 0.2 12.7 4.4 0.3 0.3 9.1 6.3 4.0 5.8 4.9 5.7 4.5 10.1 7.5 7.2 1.9 10.0 15.5 2.7 1.3 4.3 2.3 4.3 5.2 2.2 2.1 2.6 6.3 3.1 5.7 6.1 6.3 5.9 1.9 2.9 7.2 2.9 5.1 5.4 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 BRD7 "BP75, CELTIX1" ENSG00000166164 "Bromodomain containing 7" Q9NPI1 16 50313487-50368934 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042389, CAB046458, HPA060171" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB046458: AB_2066024, HPA042389: , HPA060171: " "unprognostic (2.10e-2)" "unprognostic (9.52e-3)" "unprognostic (7.06e-2)" "unprognostic (3.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (4.85e-3)" "unprognostic (1.08e-1)" "prognostic unfavourable (5.38e-4)" "unprognostic (2.15e-1)" "unprognostic (8.97e-2)" "unprognostic (9.46e-2)" "prognostic favourable (1.55e-4)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (3.59e-2)" "unprognostic (6.34e-2)" 23.5 26.9 38.8 33.7 39.0 42.2 39.1 34.5 35.9 24.5 30.7 32.4 26.4 23.4 29.0 38.1 37.3 27.1 24.4 41.2 35.3 31.9 29.9 22.9 27.9 32.1 38.4 26.9 26.8 36.5 53.3 35.1 37.9 42.6 29.5 30.3 22.2 26.9 30.7 37.9 31.2 31.1 27.2 48.1 32.1 29.0 41.5 36.4 46.1 31.2 26.5 36.4 24.5 40.0 8.8 11.2 9.6 6.8 12.3 12.1 3.7 21.9 19.4 34.2 20.3 14.5 14.3 22.5 18.1 17.9 28.6 13.0 32.6 22.4 32.9 19.0 16.0 20.4 31.2 18.2 33.1 14.9 25.9 22.3 15.6 45.0 17.1 30.7 24.6 10.5 27.5 14.7 25.4 19.0 32.1 10.6 17.4 14.3 34.7 41.4 26.8 18.5 42.8 32.1 23.9 25.1 15.6 26.6 21.6 22.0 21.4 14.8 12.8 27.9 19.1 18.2 22.2 14.9 17.5 5.0 1.9 56.3 14.3 22.4 18.0 8.2 6.8 9.6 8.8 5.7 6.8 8.0 8.9 8.1 5.4 8.8 10.1 12.1 4.0 12.3 5.1 11.2 8.5 3.7 38.8 39.0 34.5 35.9 35.3 31.9 38.4 26.9 42.6 36.4 BRD8 "p120, SMAP" ENSG00000112983 "Bromodomain containing 8" Q9H0E9 5 138139766-138178986 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001841 Supported Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA001841: AB_1845438" "unprognostic (1.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.81e-3)" "unprognostic (2.31e-2)" "unprognostic (9.01e-2)" "unprognostic (3.56e-2)" "prognostic unfavourable (1.09e-6)" "unprognostic (1.73e-1)" "unprognostic (7.01e-2)" "unprognostic (6.06e-2)" "unprognostic (1.51e-2)" "unprognostic (4.87e-2)" "prognostic unfavourable (7.80e-4)" "unprognostic (4.29e-1)" "unprognostic (1.28e-1)" "unprognostic (2.22e-1)" "unprognostic (2.07e-2)" 11.9 14.1 21.0 10.4 22.1 14.0 18.2 28.9 24.8 17.1 15.7 21.1 14.4 11.1 20.0 31.2 13.8 18.9 12.0 11.6 16.5 16.6 15.5 14.2 14.0 13.5 18.5 16.8 24.9 17.8 19.8 37.0 17.7 22.1 17.2 18.4 15.4 14.7 18.5 15.3 16.8 12.8 18.7 16.6 16.4 14.3 54.6 20.7 25.5 20.5 7.7 15.3 14.3 14.0 9.7 10.6 17.8 9.6 20.7 15.3 8.3 11.7 15.4 27.1 43.4 19.8 18.6 24.5 18.2 20.3 26.5 28.0 23.0 26.4 11.7 18.3 16.8 13.9 28.5 17.6 28.7 20.6 21.2 15.9 36.5 15.6 11.0 9.6 16.9 13.8 11.7 20.9 19.1 16.8 14.2 15.3 17.6 13.1 19.5 15.4 12.2 8.0 19.1 22.4 14.3 17.8 17.3 24.0 12.1 21.8 9.5 16.6 16.4 17.9 10.5 13.1 15.2 9.0 15.8 13.6 15.0 16.3 10.0 14.3 12.0 12.7 9.6 11.9 14.1 6.9 14.8 9.7 12.0 12.4 10.6 9.6 15.3 15.1 17.8 20.7 7.1 7.4 11.0 8.3 21.0 22.1 28.9 24.8 16.5 16.6 18.5 16.8 22.1 20.7 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1, RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA051918: , HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favourable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favourable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 12.1 11.8 15.2 11.0 15.9 9.2 8.2 21.7 25.9 10.4 9.6 24.7 11.0 11.8 11.0 7.0 9.1 15.4 10.5 10.6 16.4 19.1 10.0 9.8 11.3 11.2 19.1 14.5 14.4 20.8 18.0 16.6 9.3 18.3 12.1 6.9 13.2 15.8 11.0 21.8 12.4 12.3 12.5 21.2 12.0 10.5 11.1 14.8 9.9 9.7 6.1 9.5 8.9 7.6 3.3 6.4 4.0 7.4 4.9 3.6 2.8 7.2 16.5 7.0 15.5 6.4 7.2 7.4 11.1 6.8 9.4 7.6 11.6 11.2 5.7 10.8 7.1 14.9 8.5 7.0 5.1 15.6 9.4 6.7 8.6 5.3 7.1 8.0 14.9 6.8 5.9 5.6 6.9 6.7 8.1 4.3 4.5 22.8 9.5 10.2 5.3 17.8 17.0 4.9 5.7 4.7 17.8 23.0 17.1 11.0 8.7 9.3 20.1 11.2 10.0 7.3 6.4 13.8 8.5 8.9 6.6 5.3 8.8 6.6 9.9 0.7 2.3 4.0 3.6 2.2 2.5 3.2 2.5 3.5 2.5 3.3 3.4 2.9 1.0 4.9 7.4 6.4 3.1 2.8 15.2 15.9 21.7 25.9 16.4 19.1 19.1 14.5 18.3 14.8 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.6;U-698: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.3 12.3 4.6 4.2 3.9 2.0 5.0 6.6 1.4 4.0 1.9 7.8 6.4 37.6 7.8 1.7 11.5 10.7 6.0 3.9 6.9 5.8 17.2 5.5 7.0 0.7 25.0 21.6 0.9 3.5 4.6 2.5 1.7 5.9 2.2 4.2 10.0 12.8 11.2 2.5 4.8 8.1 7.6 8.2 6.1 14.3 6.1 4.0 8.1 8.9 2.9 15.7 20.7 2.0 3.5 3.8 3.7 6.6 7.3 13.1 46.1 3.8 9.4 9.6 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA063522 Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA063522: " "prognostic favourable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favourable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favourable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.7 5.5 7.6 4.3 1.2 1.3 13.9 2.7 0.5 1.5 2.3 7.0 6.9 1.5 1.8 0.5 7.4 1.0 1.0 1.1 5.1 3.3 1.7 13.2 1.8 0.7 0.7 4.3 1.5 2.0 2.2 0.5 0.9 1.8 3.9 0.6 7.4 4.7 10.7 7.4 3.1 14.6 5.7 4.9 1.7 2.2 5.3 4.8 2.7 3.3 2.6 3.4 3.9 2.2 7.3 5.9 6.3 2.3 11.9 5.1 3.9 1.3 4.4 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61681266-61863521 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Cell line enhanced" "Detected in many" "MCF7: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favourable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favourable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 1.0 0.9 0.7 6.3 3.5 9.1 1.1 0.6 1.4 1.4 2.6 0.2 0.6 2.8 1.5 1.2 3.7 0.8 1.8 0.4 0.5 0.5 0.6 2.3 1.3 4.0 0.5 0.9 2.1 1.3 0.1 0.4 1.7 0.7 1.0 2.8 0.4 1.4 0.0 0.4 2.7 5.5 1.0 0.5 2.3 1.3 10.8 0.4 30.1 0.4 2.0 6.6 1.3 1.7 2.2 0.5 2.1 0.3 0.6 3.7 0.5 12.3 4.2 12.2 6.9 0.4 1.1 2.7 11.4 6.7 12.2 15.8 4.3 3.9 7.3 2.6 2.4 4.5 6.3 2.3 16.4 1.8 7.7 7.5 6.7 5.3 0.1 9.6 4.4 0.2 0.1 9.7 2.6 2.6 5.2 5.0 7.6 41.4 15.2 3.3 2.6 3.6 9.5 23.4 3.5 1.6 5.6 4.9 12.7 4.4 1.5 1.8 4.1 3.7 2.2 18.0 13.1 6.6 13.1 3.1 6.0 7.9 3.7 4.6 4.5 2.1 0.3 1.5 0.5 0.2 0.6 2.2 1.2 0.6 0.4 1.8 1.8 0.9 1.0 0.6 0.2 0.5 3.7 0.5 0.7 3.5 0.6 1.4 0.5 0.5 0.5 0.9 0.7 0.4 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "BRX1, biogenesis of ribosomes" Q8TDN6 5 34915376-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039614: AB_10963698" "prognostic unfavourable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favourable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavourable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.9 18.4 20.4 15.6 24.0 30.6 23.7 24.9 24.1 16.4 14.4 10.7 18.9 11.9 18.1 18.2 23.4 17.6 11.9 16.4 15.8 15.2 17.0 18.6 14.0 22.2 21.1 15.6 19.4 13.4 15.6 19.1 24.5 20.9 15.9 16.5 7.7 15.7 14.5 19.7 15.9 13.3 22.9 18.6 17.0 14.7 13.4 21.9 17.0 16.6 14.2 23.1 21.6 21.7 22.9 14.0 4.1 10.4 15.0 22.1 16.2 14.7 14.5 14.9 20.5 6.5 9.2 29.4 18.2 12.9 24.6 15.7 19.8 19.5 32.5 9.4 10.8 12.3 26.0 18.8 28.0 17.4 25.7 21.7 34.9 17.7 17.8 34.5 15.0 11.1 12.2 22.7 20.5 11.3 37.9 10.0 16.0 16.0 23.9 37.8 24.0 21.4 21.5 27.0 13.9 14.1 17.2 18.0 16.1 37.7 26.4 16.9 16.5 21.3 6.7 18.9 20.7 13.6 34.8 9.0 19.2 41.3 16.4 39.7 23.5 4.1 8.5 4.0 14.4 7.9 20.4 22.9 17.7 18.1 10.7 18.0 22.1 19.6 0.5 15.0 10.4 14.0 16.4 16.2 20.4 24.0 24.9 24.1 15.8 15.2 21.1 15.6 20.9 21.9 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1, SCAR/WAVE actin nucleating complex subunit" Q8WUW1 3 10115592-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" 130000 "Nuclear speckles" "Cell Junctions" "HPA060391: " "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 67.1 47.6 53.4 40.4 57.1 52.4 62.9 33.4 69.5 52.8 58.6 36.1 47.3 37.9 63.2 68.3 73.0 59.4 70.8 54.4 42.6 45.3 66.8 57.3 49.3 53.2 43.3 53.6 62.7 57.8 38.8 39.2 44.4 40.7 60.8 51.8 41.5 84.2 53.1 62.7 57.0 46.5 74.3 37.2 47.0 57.2 65.2 34.2 50.2 83.3 62.4 64.8 63.0 61.0 67.4 89.7 76.1 75.4 47.2 61.0 89.1 30.1 36.2 38.6 20.0 64.6 70.6 91.4 44.9 44.8 42.2 42.0 24.8 35.5 34.8 21.4 51.6 15.8 27.7 45.5 46.3 38.3 38.4 48.0 41.8 36.9 36.8 45.6 36.4 46.3 44.1 47.2 34.4 58.8 31.1 40.8 63.6 66.3 29.5 36.5 44.4 45.9 28.6 39.7 37.8 55.5 50.1 15.0 26.1 36.1 31.5 36.3 51.2 40.0 53.1 42.5 32.6 49.7 40.0 23.5 63.0 78.5 61.5 62.7 34.9 54.1 75.4 75.9 56.5 72.4 50.3 67.4 55.0 53.1 84.3 67.4 50.1 54.4 76.1 47.2 70.9 89.7 61.0 89.1 53.4 57.1 33.4 69.5 42.6 45.3 43.3 53.6 40.7 34.2 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" 190000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 24.0 21.1 22.7 15.7 25.3 33.0 22.2 21.6 24.9 17.8 23.6 22.0 13.8 19.8 18.2 15.6 30.1 17.7 18.3 14.9 22.5 20.2 22.6 21.0 18.5 22.7 30.2 22.7 21.4 16.2 28.3 21.8 28.1 29.6 17.0 23.7 11.8 21.3 17.9 23.7 23.5 33.0 16.8 27.5 22.9 23.2 12.6 30.1 24.4 25.0 22.5 19.7 21.1 19.8 8.8 13.4 30.9 21.7 14.2 15.3 8.5 25.6 15.4 9.6 8.3 13.9 14.8 18.5 17.6 22.2 14.6 16.8 8.6 33.7 8.6 21.3 21.8 22.7 10.7 16.9 22.2 10.6 9.5 12.7 17.3 8.5 15.7 14.5 12.2 13.0 16.7 18.1 21.6 13.1 19.2 11.8 17.9 7.7 6.1 7.6 12.0 18.4 6.5 29.0 19.1 17.2 25.6 10.8 17.0 19.4 22.2 13.1 27.0 14.9 18.9 20.1 11.6 20.7 19.9 8.8 14.8 7.7 16.3 12.3 18.3 30.9 15.8 18.3 12.0 21.7 13.3 8.8 15.3 12.0 13.4 8.3 10.3 13.0 27.3 14.2 21.0 7.5 13.8 8.5 22.7 25.3 21.6 24.9 22.5 20.2 30.2 22.7 29.6 30.1 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748018 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 42.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavourable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavourable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 10.5 7.7 6.2 10.4 8.1 29.2 10.7 16.5 13.1 10.7 9.5 10.4 5.0 6.8 14.4 8.9 10.7 12.9 10.7 7.0 5.4 4.2 8.2 5.3 10.7 12.3 8.3 7.0 12.5 9.2 11.3 9.5 9.9 7.5 9.0 6.3 9.6 12.1 8.5 11.1 14.2 10.5 8.3 5.1 12.2 9.2 23.7 11.4 24.3 12.0 7.8 11.4 11.5 9.4 1.2 3.5 2.3 1.8 9.3 4.2 1.3 5.3 8.3 8.3 4.0 5.2 4.4 42.4 6.6 4.4 7.8 5.8 7.4 4.6 9.2 3.1 6.6 4.5 8.4 6.7 5.6 9.7 8.9 11.9 16.6 4.9 6.1 16.9 11.1 5.6 5.6 11.5 6.9 6.0 12.6 9.3 4.9 12.9 10.5 13.9 10.5 7.8 14.2 5.8 6.4 4.1 8.5 4.9 7.6 7.1 5.2 6.0 5.2 16.4 7.6 9.2 7.8 7.9 12.1 7.5 8.4 17.1 7.2 13.9 7.9 2.2 1.8 2.3 2.7 1.6 4.2 1.1 2.1 2.5 1.5 1.2 2.5 2.9 1.3 9.3 1.5 3.5 1.3 1.3 6.2 8.1 16.5 13.1 5.4 4.2 8.3 7.0 7.5 11.4 BRPF3 KIAA1286 ENSG00000096070 "Bromodomain and PHD finger containing 3" Q9ULD4 6 36196744-36232790 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022787 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA022787: AB_1845454" "unprognostic (1.44e-1)" "unprognostic (2.24e-1)" "unprognostic (5.52e-2)" "unprognostic (2.15e-2)" "unprognostic (2.98e-1)" "unprognostic (9.51e-2)" "unprognostic (5.33e-2)" "unprognostic (3.78e-1)" "unprognostic (3.02e-2)" "unprognostic (1.07e-1)" "unprognostic (7.98e-2)" "unprognostic (3.74e-1)" "unprognostic (3.59e-2)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.28e-1)" 9.6 21.8 11.9 12.3 11.7 12.3 25.8 22.4 16.7 11.9 15.2 10.9 28.3 13.5 16.0 13.4 9.5 10.8 10.6 10.9 10.3 9.1 15.9 16.5 9.6 7.7 10.4 11.7 15.2 20.8 18.1 18.8 8.7 7.4 15.2 15.3 8.0 16.5 31.0 22.9 14.5 17.0 12.2 9.8 9.8 12.4 22.9 11.8 11.8 18.3 4.4 7.1 13.9 22.3 0.8 0.5 3.0 0.2 0.1 2.0 0.6 6.7 6.5 16.3 12.8 9.0 7.7 14.0 10.2 10.8 14.4 11.4 19.0 6.4 10.5 11.0 9.9 6.6 14.3 7.3 12.6 9.9 8.9 7.4 6.0 11.2 9.6 5.7 10.3 9.8 6.3 17.1 8.6 10.7 15.3 9.6 7.8 9.6 6.5 2.5 8.2 5.6 19.0 6.7 3.2 4.7 13.9 23.4 7.3 8.3 9.1 8.7 10.2 15.8 11.2 15.0 12.9 4.1 11.7 8.0 10.3 7.9 2.5 9.1 17.7 3.0 0.2 1.4 1.9 0.2 2.0 0.8 0.5 0.6 0.2 0.4 0.9 0.6 1.5 0.1 0.1 0.5 1.2 0.6 11.9 11.7 22.4 16.7 10.3 9.1 10.4 11.7 7.4 11.8 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 7.0 4.6 5.4 3.9 7.0 33.0 6.2 8.0 5.1 9.4 6.8 7.3 7.6 7.8 22.4 7.2 7.1 8.2 12.3 6.3 6.7 11.3 6.3 16.0 6.8 16.5 16.6 6.4 7.9 8.4 14.6 10.6 5.8 14.9 7.9 10.4 5.6 6.6 8.0 10.3 12.6 15.3 8.8 12.9 17.3 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.1 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80670854-80809688 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 7.7 5.7 7.5 9.1 7.7 10.5 13.0 20.9 8.5 9.3 8.2 5.6 8.6 8.5 8.0 6.2 10.8 8.1 6.3 5.0 7.4 4.6 5.6 7.5 12.7 9.3 5.3 5.5 11.9 7.8 7.3 12.5 8.6 6.5 6.7 8.1 7.7 8.2 11.3 3.7 14.0 10.3 5.8 12.7 8.9 7.3 9.3 7.1 10.1 9.0 6.0 9.1 10.7 12.7 1.1 0.7 2.8 1.1 0.5 1.2 0.5 4.7 5.2 7.9 5.2 3.2 4.0 5.8 2.8 2.4 3.6 4.9 2.3 6.6 5.1 6.5 2.6 8.5 12.0 4.7 4.8 4.4 4.9 10.4 8.4 3.6 2.3 6.0 7.1 2.7 3.2 4.1 5.7 5.4 7.6 13.0 4.1 0.8 3.4 5.5 12.1 2.2 3.1 13.8 3.0 4.1 4.1 1.8 4.5 6.8 3.7 3.0 1.7 5.9 4.9 4.2 5.3 3.9 3.0 5.8 6.0 6.1 3.4 12.1 2.8 0.5 1.1 0.7 0.8 0.9 0.8 0.7 0.8 0.7 0.6 1.1 0.6 1.2 2.8 0.5 0.8 0.7 0.6 0.5 7.5 7.7 20.9 8.5 7.4 4.6 5.3 5.5 6.5 7.1 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32365103-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 36.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favourable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 21.9 34.7 30.5 16.8 33.9 45.6 22.8 44.0 41.2 20.7 20.5 34.4 30.8 20.7 25.9 36.8 19.9 22.5 23.4 19.6 27.7 27.1 20.1 41.4 19.6 16.6 27.8 27.2 32.0 37.1 44.5 26.4 28.1 32.5 24.8 24.3 22.2 30.4 21.2 19.0 25.1 23.9 22.8 28.9 20.1 21.4 40.4 27.3 16.2 23.9 16.1 20.3 19.5 19.8 8.4 6.8 36.4 5.8 5.2 6.8 5.4 17.8 9.6 19.9 18.5 28.4 23.8 16.1 20.4 27.8 26.0 26.2 14.1 16.4 12.9 23.4 29.5 16.4 15.7 15.3 20.8 24.5 19.8 10.4 18.1 16.1 26.5 13.0 17.9 24.0 34.3 23.6 16.4 22.4 27.8 22.2 18.7 9.3 15.1 11.7 17.4 15.6 12.5 15.1 17.3 18.9 13.8 29.1 16.1 19.1 19.9 19.5 16.0 11.5 22.2 16.3 13.8 22.7 17.1 25.2 29.9 9.4 21.0 14.2 12.2 36.4 4.9 17.2 6.5 5.8 6.8 5.9 5.8 5.4 4.6 8.4 6.8 5.9 8.1 5.2 5.1 6.8 6.1 5.4 30.5 33.9 44.0 41.2 27.7 27.1 27.8 27.2 32.5 27.3 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell line enhanced" "Detected in some" "A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favourable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 19.7 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 4.1 12.7 0.0 0.2 0.0 1.8 0.2 0.0 0.0 2.1 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 29.4 0.3 0.0 0.5 0.0 0.4 0.0 15.4 1.9 4.3 6.8 0.0 0.0 14.8 0.0 14.9 2.1 0.0 0.0 0.0 0.0 0.0 4.8 6.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405648 "CD markers, Plasma proteins, Predicted membrane proteins" "Antiviral defense, B-cell activation, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 101.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA017060 Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017060: AB_1845467" "prognostic favourable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 29.6 72.2 8.4 31.1 9.8 13.6 27.9 2.5 7.6 14.4 12.0 5.6 24.8 6.9 13.4 36.7 8.6 26.8 30.1 13.9 7.9 4.9 24.7 30.8 44.9 16.6 10.0 5.2 101.0 6.9 0.3 8.6 31.5 8.8 15.6 4.8 8.4 11.4 17.5 6.0 3.2 14.0 11.3 9.0 32.9 12.3 8.5 9.4 10.3 10.3 5.9 12.3 14.0 42.4 26.2 74.1 35.8 66.4 57.9 32.6 54.5 39.2 0.0 0.1 18.1 0.0 0.1 6.2 0.1 3.0 58.0 78.1 18.4 35.4 30.4 42.9 24.2 0.1 26.4 2.9 1.8 33.5 0.2 0.4 63.6 17.9 33.2 14.3 38.6 0.1 0.0 19.1 0.0 14.7 17.3 75.8 0.0 10.7 6.8 25.1 19.9 50.8 12.8 0.1 63.5 13.8 0.1 0.0 0.1 40.1 1.5 48.2 30.4 20.3 0.1 0.2 1.4 0.0 0.4 39.1 51.0 20.1 0.1 56.7 0.2 35.8 61.6 21.0 32.6 66.4 30.8 21.0 27.5 30.2 50.7 26.2 22.5 25.6 20.3 57.9 59.3 74.1 24.8 54.5 8.4 9.8 2.5 7.6 7.9 4.9 10.0 5.2 8.8 9.4 BTAF1 "MOT1, TAF-172, TAF(II)170, TAF172, TAFII170" ENSG00000095564 "B-TFIID TATA-box binding protein associated factor 1" O14981 10 91923769-92030325 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070682 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070682: " "unprognostic (2.41e-1)" "unprognostic (1.29e-1)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-1)" "prognostic favourable (5.07e-4)" "unprognostic (2.72e-1)" "unprognostic (9.28e-2)" "unprognostic (1.16e-1)" "unprognostic (7.34e-2)" "unprognostic (9.70e-3)" "unprognostic (4.27e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.45e-2)" "unprognostic (1.10e-1)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" 21.8 13.7 15.1 20.2 23.1 26.7 20.8 19.9 21.6 20.8 19.7 18.3 17.4 15.9 24.3 22.0 19.4 26.2 15.5 15.9 16.0 7.0 13.8 15.5 20.1 29.3 22.2 13.4 30.4 19.7 21.1 22.3 13.8 16.5 18.2 16.4 18.1 21.0 18.3 15.8 48.6 23.4 22.1 22.4 22.4 19.6 21.2 23.8 29.0 19.5 10.8 25.8 24.3 21.2 6.9 9.6 6.8 6.3 4.4 5.3 2.6 17.0 8.3 19.6 23.8 10.4 16.5 9.8 10.0 11.9 9.9 14.9 11.4 10.5 18.4 6.5 9.8 18.5 13.1 8.9 14.9 12.5 14.2 13.0 19.5 11.9 10.7 19.5 13.7 11.6 11.5 15.1 22.0 9.5 10.6 21.2 10.1 7.4 15.0 12.4 8.9 6.6 12.2 12.2 8.5 9.3 10.6 7.6 8.9 9.6 4.9 12.3 9.9 13.1 10.2 9.0 7.2 12.0 14.2 24.7 11.3 15.2 14.1 18.1 2.3 6.8 5.5 2.9 5.3 3.7 4.6 5.1 3.9 3.6 4.0 6.9 4.9 3.7 3.9 4.4 6.3 9.6 3.1 2.6 15.1 23.1 19.9 21.6 16.0 7.0 22.2 13.4 16.5 23.8 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016422-83067354 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Uncertain "Nucleoplasm,Cytoplasmic bodies,Rods & Rings" Nucleoplasm "Cytoplasmic bodies, Rods & Rings" "HPA024263: , HPA067671: " "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favourable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 11.6 9.4 17.6 7.9 17.3 10.4 10.0 11.9 22.5 9.2 11.0 13.8 4.7 10.8 8.5 9.8 10.4 10.9 9.8 35.0 17.0 14.3 13.0 11.3 8.1 11.1 17.0 11.5 8.5 6.1 12.8 10.0 8.0 18.0 10.6 12.3 6.9 8.7 8.7 96.2 6.6 10.6 9.3 18.2 9.2 7.9 18.4 11.5 10.5 12.7 21.3 11.0 9.8 7.4 4.6 8.8 9.3 6.7 3.9 7.2 2.1 15.2 14.8 13.1 12.8 20.6 35.6 6.8 22.3 30.5 19.3 21.5 9.3 16.0 30.8 27.8 25.0 19.4 28.6 17.8 22.9 24.6 23.3 26.2 22.1 13.3 24.3 24.7 29.3 28.9 16.1 13.1 19.6 28.4 23.2 17.3 40.6 8.0 18.7 12.9 18.2 16.3 19.1 33.2 15.3 19.4 36.4 22.9 16.4 25.9 21.5 36.6 16.2 20.8 28.5 21.9 16.4 30.1 30.8 17.8 27.5 30.0 23.7 41.9 15.2 2.2 4.9 9.3 5.5 5.4 4.9 4.5 5.2 7.2 8.8 4.6 5.9 5.8 2.9 3.9 6.7 3.8 4.8 2.1 17.6 17.3 11.9 22.5 17.0 14.3 17.0 11.5 18.0 11.5 BTBD10 "GMRP-1, GMRP1, MGC13007" ENSG00000148925 "BTB domain containing 10" Q9BSF8 11 13388001-13463297 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046777 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA046777: " "unprognostic (2.38e-1)" "unprognostic (4.25e-1)" "unprognostic (1.75e-1)" "unprognostic (9.76e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (1.07e-1)" "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (1.29e-3)" "unprognostic (1.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (1.27e-1)" 11.0 10.3 18.7 10.5 36.3 9.3 11.0 17.7 33.2 13.0 14.2 9.4 12.7 10.5 13.5 9.8 23.3 9.8 12.1 13.6 17.0 18.8 9.2 7.7 10.2 11.0 14.6 17.4 11.8 7.1 16.4 13.3 19.1 23.7 12.5 16.8 7.1 9.2 14.9 10.5 10.4 9.1 17.2 13.3 9.4 13.8 28.8 12.4 8.9 10.8 10.2 13.4 18.6 16.3 9.4 14.5 33.1 23.3 12.1 11.5 8.4 21.7 15.5 14.0 9.4 12.7 12.5 17.8 23.0 13.4 17.9 16.3 14.9 25.7 15.1 11.0 17.1 17.8 10.6 24.6 21.1 15.0 11.2 8.0 5.9 8.8 19.8 10.8 18.7 10.8 27.5 10.3 23.8 36.0 4.5 15.5 18.3 13.2 10.9 5.9 6.0 14.1 9.8 12.0 9.2 28.2 17.7 6.0 8.5 13.7 11.2 7.7 7.9 5.8 32.5 18.3 15.1 17.7 13.2 5.8 20.2 10.1 12.7 9.3 15.6 18.1 12.6 18.4 9.7 19.3 11.5 9.4 9.2 10.6 14.5 9.0 10.5 10.4 33.1 12.1 23.3 6.3 11.3 8.4 18.7 36.3 17.7 33.2 17.0 18.8 14.6 17.4 23.7 12.4 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318413-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 61.8" "Cell line enhanced" "Detected in many" "A549: 19.0;Hep G2: 10.0;MOLT-4: 12.7;PC-3: 9.0;RT4: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA055898: , HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.9 1.1 3.7 2.4 6.6 3.3 2.7 4.6 10.2 6.8 1.0 2.2 3.2 1.1 1.3 1.5 24.1 0.8 1.2 1.0 2.9 9.4 3.7 1.4 1.0 4.0 8.3 3.0 0.6 1.2 61.8 3.2 2.0 19.0 3.1 1.0 1.7 6.2 1.6 0.9 8.4 1.6 1.0 4.9 1.5 1.0 1.1 1.2 24.8 14.4 9.5 9.0 2.3 7.9 0.3 1.3 2.8 0.8 0.3 7.2 1.2 0.1 19.0 3.9 0.0 1.4 0.4 0.0 0.4 0.0 0.2 0.0 0.2 3.1 0.0 4.7 0.1 6.9 3.9 7.2 0.2 0.0 1.2 0.0 0.1 10.0 0.0 0.1 0.0 1.5 3.0 0.0 2.3 0.5 0.0 0.0 0.1 0.6 12.7 1.5 4.0 9.0 0.0 6.1 0.0 0.0 8.6 5.0 1.9 0.0 0.2 0.0 0.4 0.5 0.8 0.0 0.2 0.0 1.5 0.0 0.0 0.0 5.0 1.9 0.0 1.3 0.8 1.1 2.1 0.3 7.2 0.1 2.4 1.4 1.3 0.3 3.0 2.7 2.8 0.3 0.6 0.2 1.1 1.2 3.7 6.6 4.6 10.2 2.9 9.4 8.3 3.0 19.0 1.2 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Cell line enriched" "Detected in some" 8 "RT4: 26.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Nucleoli Cytosol "HPA040529: , HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 26.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056125-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA067026: " "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 22.3 29.1 20.6 14.8 22.1 26.7 26.2 25.5 52.3 17.5 12.8 17.2 8.4 7.1 19.5 16.7 20.3 19.6 12.5 28.4 23.7 22.4 18.5 20.8 19.6 38.8 20.4 23.8 29.2 47.6 21.0 24.3 19.1 16.7 15.7 12.6 16.5 26.4 13.5 36.9 19.3 9.8 22.4 23.1 14.1 14.2 19.2 14.6 20.7 22.9 13.6 20.4 19.0 16.2 23.2 34.1 32.2 36.0 21.3 28.2 27.9 27.7 6.8 33.1 17.3 17.9 23.1 34.3 27.5 27.7 31.6 34.0 12.3 14.6 25.9 27.6 19.3 16.2 31.9 21.4 40.5 17.9 22.4 29.7 12.4 18.3 49.1 32.8 20.5 23.7 29.7 29.2 41.2 25.0 22.4 16.6 28.3 11.9 22.7 19.5 59.0 14.8 15.0 38.6 30.4 30.5 22.3 26.1 29.6 32.2 29.8 39.5 26.9 35.2 18.2 17.8 19.3 22.9 32.3 29.0 47.8 25.3 15.4 25.6 22.4 24.1 35.4 32.2 15.0 36.0 20.1 23.2 21.7 15.4 34.1 22.1 25.4 19.4 15.1 21.3 31.0 16.1 28.2 27.9 20.6 22.1 25.5 52.3 23.7 22.4 20.4 23.8 16.7 14.6 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145897 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 190.7" "Cell line enhanced" "Detected in all" "ASC TERT1: 49.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favourable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavourable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 52.0 22.1 11.5 58.3 13.4 126.9 114.4 66.8 10.4 41.7 40.1 5.5 21.9 15.5 30.1 22.0 28.7 27.9 39.9 49.2 11.9 8.1 22.2 58.1 85.6 190.7 10.4 8.2 29.1 64.2 17.6 17.1 23.4 13.3 28.7 18.1 21.0 19.0 25.9 31.6 70.6 34.3 26.0 24.6 77.1 26.4 19.0 8.9 148.9 15.7 14.3 58.2 54.2 35.2 58.3 6.6 94.3 14.0 47.1 95.2 26.1 6.8 8.6 9.5 1.1 35.7 49.6 4.1 7.7 17.1 5.2 5.2 5.1 2.4 7.4 1.6 8.2 4.7 3.1 8.7 9.7 8.9 6.7 1.4 6.0 2.6 36.2 5.4 2.5 42.3 26.2 11.9 36.9 10.4 5.1 9.8 5.9 7.1 3.8 17.4 2.3 9.9 13.1 5.3 2.3 16.0 14.3 5.3 10.6 9.7 7.5 25.0 31.4 12.6 3.3 5.9 1.8 4.5 4.7 13.6 7.2 12.3 4.6 4.3 6.6 22.3 13.6 94.3 17.0 10.6 20.1 44.5 34.3 29.8 6.6 58.3 95.2 39.1 52.3 47.1 14.0 6.2 39.2 26.1 11.5 13.4 66.8 10.4 11.9 8.1 10.4 8.2 13.3 8.9 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.9;HMC-1: 38.6;U-266/70: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favourable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 61.6 45.9 10.1 61.4 20.6 46.9 27.8 13.0 10.4 23.0 53.3 27.8 27.0 15.2 27.1 24.6 55.7 103.7 76.1 65.3 10.4 10.0 22.3 4.3 40.7 20.0 12.2 5.5 102.0 117.6 7.0 52.2 42.7 28.3 61.0 38.5 30.4 18.1 104.1 98.9 30.5 36.6 50.8 22.7 32.7 67.1 11.5 9.9 82.9 36.7 45.2 49.0 64.7 21.5 14.1 17.3 34.5 14.2 5.7 8.5 7.1 0.9 1.4 2.6 1.0 3.3 2.4 21.7 2.5 5.0 0.6 2.5 1.9 0.4 36.9 1.8 0.8 16.2 9.4 9.9 1.2 2.4 4.6 19.3 2.7 4.2 7.2 0.1 38.6 2.4 18.4 2.4 4.5 13.5 8.9 25.6 6.7 0.8 4.0 1.2 1.1 0.2 2.5 8.7 18.5 1.2 30.1 0.4 2.7 2.0 0.8 0.3 2.1 2.3 3.3 0.0 4.3 0.6 0.1 59.8 30.2 23.6 0.5 0.9 1.5 3.2 8.1 9.9 4.7 12.1 7.1 14.1 5.3 4.8 5.1 13.1 8.5 5.9 34.5 5.7 14.2 17.3 4.9 7.1 10.1 20.6 13.0 10.4 10.4 10.0 12.2 5.5 28.3 9.9 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;Karpas-707: 8.4;U-266/70: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: " "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.2 0.4 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.7 1.6 0.1 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.4 5.8 2.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 BTK "AGMX1, ATK, IMD1, PSCTK1, XLA" ENSG00000010671 "Bruton tyrosine kinase" Q06187 X 101349447-101390796 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 77.5;lymphoid tissue: 37.0" "Cell line enhanced" "Detected in some" "Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 77.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001198, HPA002028, CAB016689" Enhanced Supported "Plasma membrane,Cytosol" 610000 "Plasma membrane, Cytosol" "CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306" "unprognostic (3.19e-2)" "unprognostic (2.51e-3)" "unprognostic (1.06e-2)" "unprognostic (3.66e-2)" "unprognostic (5.69e-2)" "unprognostic (3.76e-3)" "unprognostic (6.55e-2)" "unprognostic (3.58e-3)" "unprognostic (6.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (2.08e-3)" "unprognostic (7.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (8.14e-2)" 7.3 2.4 3.3 23.5 5.6 14.0 2.6 0.8 3.6 2.3 3.0 4.7 0.3 2.2 1.9 2.6 2.4 2.0 3.7 3.3 3.3 2.5 2.2 2.5 10.7 25.1 5.4 1.2 1.2 1.5 0.2 1.4 3.2 4.1 2.5 4.5 1.5 3.2 1.0 1.0 2.5 12.9 3.3 10.8 37.0 3.1 1.3 6.3 4.0 1.7 1.8 36.7 5.8 2.0 13.7 13.2 77.5 20.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 16.0 144.1 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.0 0.0 0.0 11.2 0.2 0.0 12.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 13.7 0.0 20.9 0.0 77.5 11.3 19.3 0.0 18.1 0.0 13.7 0.0 0.0 13.2 13.7 0.0 0.0 4.5 0.0 20.7 6.0 0.0 6.1 3.3 5.6 0.8 3.6 3.3 2.5 5.4 1.2 4.1 6.3 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell line enriched" "Detected in some" 6 "U-698: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favourable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.0 0.2 1.1 0.0 0.2 0.5 0.0 0.0 0.2 2.8 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.1 0.1 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 4.3 0.1 0.0 0.2 0.1 28.0 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: " "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.5 10.1 14.2 16.3 13.9 12.1 5.1 9.5 15.3 9.9 8.3 7.0 5.2 10.7 9.6 8.0 10.2 11.6 10.3 10.8 7.0 9.2 7.8 6.3 9.1 7.4 11.3 4.2 7.4 12.0 8.5 15.2 12.2 8.4 3.6 9.5 5.6 7.6 5.7 6.6 7.9 9.6 19.9 2.2 9.1 4.3 10.5 9.0 6.2 2.8 8.8 7.7 4.0 10.3 5.2 8.3 6.8 6.6 6.0 13.0 6.8 5.2 5.7 3.5 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell line enhanced" "Detected in many" "HEL: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavourable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavourable (1.03e-5)" "prognostic unfavourable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 29.9 8.8 23.1 14.5 1.0 1.7 12.3 15.6 10.3 27.2 20.5 18.4 17.2 20.3 9.7 9.0 13.1 29.5 11.3 33.8 16.1 14.4 67.2 9.4 14.7 0.2 19.3 19.0 0.4 0.7 20.9 10.4 15.8 29.4 42.4 22.2 9.8 32.3 16.2 22.3 16.6 21.5 19.8 31.0 5.5 9.5 15.5 6.7 11.1 9.4 8.4 7.4 16.4 6.5 12.4 20.2 9.3 21.6 22.2 20.8 25.0 8.3 15.0 21.7 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23, rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA052185: " "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavourable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavourable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 16.6 23.4 16.3 15.0 18.8 19.6 18.3 12.3 20.6 17.5 19.3 17.9 19.5 18.3 19.1 30.6 17.5 24.1 23.1 34.2 16.0 17.5 28.1 36.3 16.1 18.3 25.3 17.5 19.3 27.9 14.3 21.8 22.1 16.4 16.5 19.8 20.3 25.1 25.6 52.2 19.3 21.6 21.2 18.7 18.7 18.9 97.0 16.5 22.1 25.8 22.6 22.7 18.7 14.8 43.9 49.0 14.4 18.3 30.1 37.6 31.4 22.1 24.4 8.9 71.0 12.4 11.0 14.9 15.3 13.8 19.8 16.2 33.9 29.9 25.9 8.1 16.5 15.9 20.6 14.9 18.3 18.1 23.9 11.3 28.6 13.6 15.6 31.5 16.5 9.9 17.1 17.4 15.8 12.7 44.4 47.9 17.1 34.9 19.8 43.3 21.4 28.1 17.7 17.5 112.7 21.9 16.0 27.1 20.4 20.5 54.6 22.6 34.4 25.3 13.7 17.1 21.8 21.5 32.7 16.6 29.0 43.4 39.2 24.1 35.7 11.5 17.1 14.4 30.7 18.3 34.3 43.9 35.5 33.6 31.5 38.0 37.6 34.4 3.2 30.1 16.2 49.0 37.3 31.4 16.3 18.8 12.3 20.6 16.0 17.5 25.3 17.5 16.4 16.5 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 26.4 31.9 43.6 26.1 44.8 66.6 29.5 28.3 36.4 25.6 31.3 25.6 31.6 27.0 25.1 32.2 35.2 35.7 28.1 30.8 39.2 36.3 37.9 33.2 26.2 34.5 39.5 27.4 28.8 31.4 21.0 35.2 33.7 32.3 27.3 22.7 22.0 31.5 28.9 20.7 23.5 31.2 25.4 34.5 29.1 26.7 51.2 27.0 24.1 40.1 29.0 31.6 35.3 26.5 39.1 32.2 91.2 42.7 34.1 37.6 56.6 25.0 29.6 16.6 37.1 16.6 18.7 16.1 24.1 23.1 27.7 30.4 34.5 25.0 19.2 29.5 23.2 15.0 18.2 22.0 23.2 23.2 24.7 14.0 21.1 22.6 34.7 23.8 18.5 18.3 27.3 25.2 47.6 21.5 34.3 44.1 25.4 65.8 31.2 64.6 36.4 37.1 16.4 16.7 33.2 24.1 20.0 29.1 35.0 23.8 27.5 50.0 17.3 30.1 17.5 26.4 33.6 52.2 37.6 27.7 46.5 51.3 23.3 35.6 47.7 59.1 39.3 91.2 34.1 40.5 31.9 39.1 32.8 33.0 32.2 36.6 27.9 29.2 83.0 34.1 42.7 31.1 37.6 56.6 43.6 44.8 28.3 36.4 39.2 36.3 39.5 27.4 32.3 27.0 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137174 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.3;skeletal muscle: 37.1" "Cell line enhanced" "Detected in many" "RH-30: 18.4;WM-115: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;granulocytes: 2.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 1.0 2.3 2.4 7.6 0.6 8.9 0.7 4.1 2.6 11.5 6.7 6.7 1.7 5.3 2.8 5.3 2.5 2.1 29.3 2.8 2.5 1.5 0.7 2.3 0.9 10.4 1.3 1.2 1.0 0.8 3.5 3.5 6.1 5.4 3.5 3.6 1.6 10.0 37.1 0.8 2.7 19.4 10.7 0.7 5.9 10.0 6.3 0.0 1.6 8.6 0.8 10.3 8.6 0.5 1.2 2.9 0.3 0.4 0.4 0.1 0.8 1.2 4.7 0.8 6.9 9.5 2.1 3.5 2.5 5.5 7.3 0.3 0.0 0.0 0.0 6.6 0.0 2.0 1.2 5.1 0.0 1.7 0.0 0.6 0.2 1.5 0.0 0.3 5.5 4.3 8.5 0.7 2.4 0.0 11.9 12.1 0.1 0.1 0.6 1.0 0.0 3.4 18.4 0.0 0.0 0.0 6.2 10.7 2.2 0.0 4.7 0.0 12.0 5.4 8.8 0.0 0.0 9.2 1.1 0.4 0.0 5.2 0.0 18.5 2.9 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.7 0.4 0.1 1.2 0.1 0.1 2.3 7.6 0.7 4.1 2.8 2.5 10.4 1.3 6.1 6.3 BYSL Enp1 ENSG00000112578 "Bystin like" Q13895 6 41921188-41933046 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031217, HPA031219" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA031217: AB_10599488, HPA031219: AB_10601989" "unprognostic (6.12e-3)" "unprognostic (6.97e-2)" "unprognostic (2.90e-1)" "unprognostic (2.33e-3)" "unprognostic (4.38e-2)" "unprognostic (2.73e-3)" "prognostic unfavourable (6.43e-4)" "unprognostic (2.09e-2)" "unprognostic (2.51e-1)" "unprognostic (6.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-1)" "prognostic unfavourable (2.15e-8)" "unprognostic (4.39e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-3)" "unprognostic (5.99e-2)" 11.5 13.4 6.0 11.5 7.2 6.0 17.5 5.0 8.9 7.8 7.9 4.6 5.3 4.0 11.0 5.4 11.7 9.3 10.0 17.6 5.9 6.8 8.0 18.6 7.1 7.4 5.8 6.5 11.8 15.9 10.6 5.4 11.3 7.4 8.0 6.8 4.8 9.6 7.9 31.7 9.2 5.0 12.6 6.3 9.9 7.3 8.9 4.6 20.1 7.1 11.9 12.9 7.3 10.1 4.0 9.3 0.9 3.4 4.5 5.5 2.2 12.2 15.2 8.4 11.9 6.3 7.1 17.2 12.5 6.6 19.8 14.5 21.0 3.2 22.6 11.4 9.4 8.2 25.6 18.3 15.6 8.1 27.9 21.1 10.7 23.6 10.9 15.0 9.3 9.1 11.9 18.5 16.9 13.6 26.8 5.0 13.1 20.9 15.8 15.2 6.5 16.0 18.8 11.5 14.4 11.0 10.4 16.9 10.3 8.4 7.6 14.6 8.8 13.2 10.5 11.6 13.6 7.9 18.2 5.9 7.6 49.0 3.9 15.3 12.0 0.0 3.4 0.9 3.9 3.4 5.5 3.8 2.5 3.1 5.4 4.0 1.3 3.0 0.3 4.5 3.1 9.3 3.1 2.2 6.0 7.2 5.0 8.9 5.9 6.8 5.8 6.5 7.4 4.6 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 104.4;skeletal muscle: 89.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Approved Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavourable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavourable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 10.6 7.2 4.2 7.8 8.5 10.1 13.5 3.4 8.9 7.9 13.6 3.4 22.0 7.7 7.6 7.6 17.9 7.1 6.1 70.8 4.4 2.8 8.4 10.2 8.1 11.4 3.5 5.8 6.4 12.3 1.8 5.7 104.4 2.5 9.8 16.2 13.2 10.1 25.3 89.7 16.8 8.0 16.6 2.8 8.4 15.6 3.5 3.4 14.5 13.6 41.1 11.1 16.8 10.3 17.2 37.3 1.7 20.3 20.1 23.6 16.3 16.8 16.4 27.9 40.2 13.6 24.2 25.0 24.1 31.7 23.9 25.4 39.7 25.7 39.4 28.7 18.7 35.2 32.8 27.5 31.6 5.2 18.9 24.5 18.5 22.3 14.2 33.5 15.4 18.5 14.9 20.8 38.5 34.0 46.9 8.5 19.3 19.8 17.0 38.9 28.4 33.9 20.4 18.2 41.4 22.5 30.8 35.7 21.0 9.5 85.1 12.6 37.5 29.1 19.3 18.9 23.9 27.7 26.5 16.4 17.1 55.5 9.2 42.2 67.6 0.9 17.4 1.7 11.0 20.3 17.9 17.2 16.1 14.9 37.3 15.8 23.6 19.5 0.7 20.1 14.5 14.4 11.9 16.3 4.2 8.5 3.4 8.9 4.4 2.8 3.5 5.8 2.5 3.4 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;SiHa: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "HPA038130, HPA038131" Approved Approved "Nucleoplasm,Nucleoli,Nuclear speckles" Nucleoplasm "Nucleoli, Nuclear speckles" "HPA038130: , HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.6 0.1 2.4 0.2 0.2 1.5 5.2 0.2 0.7 1.6 0.5 0.4 0.1 0.7 0.3 1.0 0.1 0.0 0.6 1.7 0.6 1.0 0.0 0.2 0.7 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.2 0.4 1.7 0.3 0.9 0.4 8.4 0.3 0.1 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.0 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299193-49327487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 104.2;tongue: 35.0" "Group enriched" "Detected in some" 21 "K-562: 8.9;RH-30: 13.6" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA057556: " "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 2.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.0 1.7 0.1 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 3.3 15.3 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 104.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.5 35.0 3.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Cell line enhanced" "Detected in some" "SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 48.4 0.0 0.1 0.0 1.9 0.0 14.8 0.2 0.0 10.4 0.0 15.4 0.0 12.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell line enhanced" "Detected in some" "HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA037607 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 30.1 0.0 0.1 0.3 11.4 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 12.8 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell line enhanced" "Detected in all" "SK-MEL-30: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA012748 Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavourable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavourable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.3 12.8 7.6 14.8 18.4 18.7 8.8 29.9 19.4 15.1 15.6 27.0 7.6 5.6 9.3 37.0 14.0 11.2 13.4 9.7 6.1 6.6 5.9 13.0 18.0 14.9 5.0 20.0 15.4 10.0 22.8 9.4 6.0 10.4 9.2 12.7 15.4 1.2 7.3 12.7 15.6 2.3 13.0 28.9 6.8 5.9 5.0 9.3 9.7 7.8 62.4 7.3 4.2 6.6 23.7 14.7 29.9 13.1 11.4 11.2 5.2 19.0 3.9 22.8 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 123.3;liver: 55.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" 640000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favourable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 6.0 10.2 5.0 4.3 7.6 1.8 7.2 6.7 6.0 5.9 12.0 7.7 7.8 12.2 6.4 7.3 6.8 7.5 10.6 8.5 5.3 5.0 123.3 55.9 8.0 4.6 8.4 5.1 8.5 13.9 5.6 11.6 5.7 7.3 9.7 10.0 8.9 8.3 6.5 14.2 5.2 20.0 6.7 9.3 5.2 8.4 5.1 7.8 8.9 11.3 5.3 5.3 6.9 4.9 10.6 12.4 37.6 11.7 9.3 11.9 7.2 3.8 5.5 12.7 7.8 10.0 11.4 14.8 5.3 8.8 5.4 7.5 2.1 21.6 15.7 35.4 10.2 9.0 14.6 3.9 7.5 15.8 5.0 8.6 12.8 10.1 11.3 7.2 4.6 10.6 7.5 10.0 7.2 8.7 11.3 11.0 5.5 3.0 13.1 10.0 4.7 8.8 12.6 16.5 24.8 30.9 7.4 6.5 8.3 9.7 12.2 11.7 27.1 5.7 5.7 5.5 4.4 9.6 2.8 4.9 14.4 15.5 4.2 12.0 9.4 23.7 11.7 27.3 9.0 8.5 9.3 10.6 9.3 10.2 8.9 9.5 11.5 10.1 37.6 9.3 7.4 12.4 11.9 7.2 5.0 7.6 6.7 6.0 5.3 5.0 8.4 5.1 7.3 7.8 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16756881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: " "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavourable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 44.5 47.1 34.7 37.8 49.0 34.7 40.5 59.7 43.0 40.3 42.1 32.3 29.7 27.3 54.1 35.3 51.6 36.3 34.0 55.1 32.4 33.3 42.6 56.4 41.6 43.0 36.5 38.9 54.2 39.6 35.8 53.7 58.9 35.7 42.0 23.6 30.6 40.1 36.3 69.5 36.4 28.4 43.0 38.9 41.1 35.1 27.5 33.9 50.6 47.6 32.6 36.5 52.0 39.2 97.7 91.8 87.4 74.8 67.4 91.1 123.2 65.4 52.8 63.1 31.1 35.2 32.1 44.4 65.2 33.9 43.4 39.8 49.9 62.2 56.6 52.4 39.5 38.3 42.4 30.7 47.1 74.3 45.4 50.0 45.6 45.0 43.6 71.5 45.0 31.7 43.1 25.8 57.0 30.3 62.5 39.5 37.3 38.3 76.6 34.8 46.7 30.1 62.5 63.7 29.8 33.7 37.6 43.4 44.4 57.0 43.3 77.5 38.5 49.7 56.5 54.6 44.6 65.2 61.5 26.5 97.8 78.7 47.5 41.7 49.8 78.3 65.8 87.4 72.2 72.9 83.0 97.7 80.2 75.8 71.4 89.3 91.1 78.9 31.3 67.4 74.8 91.8 81.5 123.2 34.7 49.0 59.7 43.0 32.4 33.3 36.5 38.9 35.7 33.9 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favourable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.3 19.7 4.9 16.4 25.2 21.1 12.9 3.4 23.4 4.2 11.5 24.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.2 4.0 6.7 18.1 15.2 15.2 16.9 15.7 6.6 10.6 38.1 9.3 5.2 9.6 5.7 46.4 7.8 6.5 11.8 11.1 4.0 3.9 6.1 6.3 8.4 15.9 10.9 3.8 16.9 33.7 16.5 45.7 8.3 7.1 3.1 3.5 19.9 3.0 26.2 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 C11orf74 "FLJ38678, HEPIS, NWC" ENSG00000166352 "Chromosome 11 open reading frame 74" Q86VG3 11 36594493-36659290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 66.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 10.7 13.1 16.0 4.2 18.8 8.6 11.5 15.5 20.8 10.5 15.4 8.7 8.3 5.5 11.8 18.5 9.5 25.3 10.1 28.1 14.3 15.4 17.1 13.1 8.1 4.1 17.2 16.5 17.8 10.2 12.5 23.1 7.9 19.6 13.3 8.3 9.0 8.6 8.2 26.5 3.8 7.5 13.1 15.5 5.7 9.7 33.1 14.5 3.5 66.1 10.8 4.0 12.5 7.3 0.3 18.6 7.5 12.5 8.5 8.2 5.8 5.3 9.0 20.0 15.5 16.4 28.1 7.9 11.1 12.6 11.5 20.3 0.3 8.5 0.0 8.8 11.3 2.2 13.5 15.2 22.8 0.0 21.8 8.7 5.1 9.9 13.7 12.0 2.1 17.7 11.8 7.6 10.8 18.8 11.7 0.0 12.7 9.0 2.0 9.8 12.7 13.8 8.6 24.3 5.1 16.0 1.8 0.5 23.7 11.4 3.0 18.2 18.2 6.5 12.0 15.8 11.3 20.9 9.4 3.3 6.1 0.0 13.8 14.3 8.1 7.5 12.5 0.7 1.1 9.7 3.7 0.0 3.3 2.8 13.7 0.3 8.2 2.0 0.7 8.5 9.1 18.6 0.4 5.8 16.0 18.8 15.5 20.8 14.3 15.4 17.2 16.5 19.6 14.5 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavourable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.3 3.2 0.2 1.4 0.0 0.0 0.7 63.8 0.0 0.0 5.9 0.0 0.6 0.8 3.1 1.2 0.7 0.0 7.4 0.0 0.9 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 26.4" "Cell line enriched" "Detected in some" 8 "K-562: 7.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039032 Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA039032: " "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf43 FLJ12448 ENSG00000157895 "Chromosome 12 open reading frame 43" Q96C57 12 121000486-121016502 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046148, HPA061739" Uncertain Supported "Nucleoli,Golgi apparatus" Nucleoli "Golgi apparatus" "HPA046148: AB_10965169, HPA061739: " "unprognostic (1.51e-1)" "unprognostic (5.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.75e-2)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "prognostic unfavourable (1.29e-6)" "prognostic unfavourable (6.44e-4)" "unprognostic (3.53e-1)" "unprognostic (5.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.95e-1)" "unprognostic (2.45e-3)" "unprognostic (9.70e-2)" "unprognostic (2.49e-1)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" 10.0 8.6 12.1 7.5 12.9 7.5 8.7 15.2 19.6 7.4 10.2 8.5 3.1 5.7 11.4 5.3 7.2 11.2 5.8 8.7 8.4 8.5 7.2 12.0 7.8 9.2 8.3 11.1 14.3 8.8 9.3 6.8 8.3 13.1 7.3 6.4 8.0 10.0 8.0 7.2 6.4 5.8 10.0 7.1 7.3 7.2 7.1 6.7 7.5 7.6 4.0 8.4 9.6 6.9 16.2 10.7 5.8 13.7 11.0 19.9 13.4 9.8 22.2 11.6 9.1 10.4 8.2 12.9 12.2 12.6 20.5 13.0 15.9 9.3 18.3 12.6 11.8 11.2 13.7 18.6 12.3 21.9 15.3 14.6 9.4 11.8 12.3 19.3 11.8 9.6 9.9 18.8 11.9 11.7 17.3 4.9 10.8 16.1 21.0 15.2 20.8 16.6 19.0 13.8 13.7 12.6 14.7 15.9 10.2 16.3 7.1 13.1 19.4 9.1 11.2 11.4 13.7 9.1 12.8 8.9 12.8 14.3 14.9 11.6 16.8 3.7 10.3 5.8 16.9 13.7 15.4 16.2 16.7 16.4 10.7 13.0 19.9 16.9 1.6 11.0 11.4 8.6 15.1 13.4 12.1 12.9 15.2 19.6 8.4 8.5 8.3 11.1 13.1 6.7 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986310-105074197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 82.3" "Lineage enriched" "Detected in all" 13 "dendritic cells: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 12.1 11.4 14.1 14.4 14.4 15.9 10.8 6.5 15.4 9.0 13.6 9.4 12.4 14.9 9.6 10.0 11.1 7.3 7.1 9.2 12.3 11.5 8.0 18.8 7.7 14.6 11.4 11.0 10.2 35.3 2.7 10.8 7.9 16.0 10.3 11.7 7.5 21.6 13.8 7.7 10.6 10.6 9.7 9.6 12.3 14.1 8.1 9.7 11.0 12.1 8.5 15.4 9.0 11.1 5.9 82.3 1.2 6.2 4.7 5.5 3.5 9.2 13.2 6.4 16.3 5.4 5.5 29.6 8.4 2.1 5.1 2.8 13.3 4.7 17.7 8.4 3.7 6.2 5.3 12.7 5.7 5.0 9.5 11.7 6.7 18.1 7.9 17.5 9.3 8.1 5.4 7.7 8.3 8.2 9.7 4.6 4.9 15.5 11.5 30.0 12.4 19.1 15.6 7.7 39.9 6.8 12.1 8.2 6.0 8.1 17.4 12.4 14.4 7.1 3.9 12.8 8.4 10.9 12.6 9.7 11.0 18.7 5.9 12.4 12.0 1.2 6.2 0.1 2.6 5.2 3.2 5.9 3.5 3.2 18.7 4.4 3.6 3.4 0.7 4.7 2.9 82.3 5.5 3.5 14.1 14.4 6.5 15.4 12.3 11.5 11.4 11.0 16.0 9.7 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.6 2.8 2.8 8.2 3.1 2.2 2.6 1.9 1.0 2.0 2.4 1.2 2.9 2.3 2.3 0.7 3.0 3.2 6.3 2.7 5.1 3.2 1.8 0.8 1.9 2.6 2.6 1.0 1.2 3.9 2.1 4.3 3.9 2.9 0.5 2.7 0.8 1.0 1.6 9.8 1.6 3.1 4.9 3.3 3.7 0.8 2.1 2.5 4.2 1.0 3.7 3.2 1.2 3.0 1.8 2.0 1.4 2.1 1.4 1.0 7.5 2.3 2.4 2.6 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavourable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favourable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.5 10.0 11.4 22.3 5.7 6.1 6.9 12.1 7.7 12.3 9.1 10.8 8.6 18.1 10.5 3.9 10.7 12.3 6.6 11.8 13.6 11.0 21.3 9.9 9.4 12.8 9.9 10.8 6.4 16.1 8.9 18.5 8.0 22.5 7.5 8.2 6.3 23.7 18.3 8.7 15.5 17.7 13.6 16.8 11.5 8.3 24.3 10.5 13.5 6.9 12.6 11.0 11.6 9.0 13.4 16.1 12.1 12.2 12.4 14.3 16.6 8.7 13.1 17.5 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 C12orf66 FLJ32549 ENSG00000174206 "Chromosome 12 open reading frame 66" Q96MD2 12 64186316-64222296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046743, HPA052855" Uncertain Supported "Lysosomes,Cytokinetic bridge" Lysosomes "Cytokinetic bridge" "HPA046743: , HPA052855: " "unprognostic (7.44e-3)" "unprognostic (2.38e-1)" "unprognostic (6.20e-2)" "unprognostic (2.70e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (7.46e-2)" "unprognostic (4.07e-2)" 6.0 9.7 6.9 6.0 14.5 2.9 10.2 4.4 11.5 5.7 5.1 15.7 4.5 5.8 4.9 9.4 7.9 7.5 4.7 4.2 7.5 6.8 10.2 15.3 5.2 9.4 21.7 6.8 7.6 13.9 14.8 5.6 3.9 9.4 4.6 6.0 4.3 6.4 6.0 9.1 10.3 5.2 4.5 12.3 8.6 5.5 6.0 11.7 5.7 10.5 6.0 8.6 6.3 6.0 8.4 4.4 0.4 2.7 3.7 10.3 4.4 4.9 7.9 1.5 4.3 4.1 6.9 4.2 2.7 3.4 4.1 2.6 2.4 3.9 15.6 3.8 2.1 5.7 6.3 4.9 4.4 11.8 4.2 5.6 1.9 2.2 5.4 6.1 3.3 5.3 8.3 5.3 9.7 2.9 7.8 10.4 4.1 9.4 6.9 5.3 7.1 6.2 3.5 4.6 11.8 6.1 5.8 3.6 3.5 4.4 6.2 4.4 10.0 3.9 2.2 4.1 2.7 4.0 2.6 13.9 11.4 8.8 6.3 5.4 4.6 0.4 2.7 0.2 3.7 2.5 6.2 8.4 6.9 5.4 4.4 7.5 9.8 9.1 0.3 3.7 1.7 3.1 10.3 4.4 6.9 14.5 4.4 11.5 7.5 6.8 21.7 6.8 9.4 11.7 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favourable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.2 16.9 10.4 4.9 6.5 11.0 6.5 3.9 7.2 5.9 11.9 5.2 7.1 8.6 3.9 9.6 10.1 8.2 5.5 10.1 20.4 10.7 16.3 14.9 7.2 15.7 9.8 5.7 9.5 3.6 6.4 6.6 13.7 4.9 6.6 6.8 17.4 23.7 8.2 19.1 10.1 6.3 7.0 9.5 8.1 27.8 9.5 6.5 11.4 15.0 19.4 8.5 3.4 8.9 5.0 6.6 6.6 13.2 20.2 14.8 10.1 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: " "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favourable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.4 9.5 11.6 10.4 8.3 17.1 12.7 5.7 3.2 5.5 4.1 7.8 6.3 7.9 6.8 2.5 12.8 4.7 4.7 4.1 11.7 10.1 7.9 14.5 15.7 7.8 12.8 15.4 13.7 15.6 4.8 8.8 8.5 11.7 20.7 5.6 6.9 6.5 21.1 9.0 8.7 12.4 7.1 12.8 9.9 6.2 23.2 12.6 7.1 5.3 12.7 11.5 6.7 10.9 8.4 6.1 6.3 3.3 9.5 10.9 6.5 9.3 7.4 4.8 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 C14orf119 FLJ20671 ENSG00000179933 "Chromosome 14 open reading frame 119" Q9NWQ9 14 23094765-23100462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003638 Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA003638: AB_2243669" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (2.91e-1)" "unprognostic (2.33e-2)" "unprognostic (5.26e-3)" "prognostic unfavourable (5.42e-5)" "unprognostic (1.23e-1)" "unprognostic (3.36e-2)" "unprognostic (1.65e-2)" "unprognostic (4.08e-3)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-2)" "unprognostic (3.61e-2)" "prognostic favourable (3.30e-5)" "unprognostic (1.63e-1)" 28.2 35.0 16.3 22.0 18.5 9.2 38.9 11.6 17.3 30.4 28.4 17.0 23.9 22.6 29.9 30.3 32.0 23.5 22.4 29.6 16.3 19.9 36.3 24.6 30.4 37.3 22.4 15.1 25.2 39.4 16.7 28.1 32.2 23.1 27.9 35.8 27.1 28.0 28.1 21.2 20.7 27.4 33.5 20.1 33.8 28.2 33.0 16.7 27.2 40.0 26.3 33.1 25.8 24.0 34.6 37.4 72.7 40.2 30.2 45.0 43.7 13.6 13.6 20.5 12.4 45.3 39.5 16.5 23.0 34.1 30.4 36.2 10.7 21.3 10.4 12.0 37.3 23.5 19.5 30.6 42.3 16.6 9.5 15.7 11.3 45.8 35.7 23.5 24.6 48.0 27.6 25.6 18.9 33.2 10.4 11.7 33.3 19.7 11.0 18.2 12.8 20.8 9.8 15.3 12.0 34.5 22.1 9.9 9.0 19.2 18.1 19.9 12.2 13.7 26.7 14.5 12.7 21.7 10.3 11.0 12.9 12.8 13.3 14.9 12.9 63.7 40.2 72.7 32.6 25.7 37.1 34.6 37.2 36.2 37.4 28.5 39.1 38.3 23.8 30.2 17.3 25.2 45.0 43.7 16.3 18.5 11.6 17.3 16.3 19.9 22.4 15.1 23.1 16.7 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell line enhanced" "Detected in some" "HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059518: " "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.3 4.2 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 20.4 0.2 2.7 1.3 0.0 5.6 0.0 0.3 1.5 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985908-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted - unknown location" "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favourable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 10.4 6.1 10.2 11.8 7.3 12.4 9.8 14.3 7.9 12.0 12.2 8.3 16.7 8.1 10.8 13.5 10.3 11.1 10.3 7.2 9.6 4.6 10.3 9.7 8.7 10.3 6.8 5.9 12.2 15.9 12.9 18.9 5.4 7.4 11.0 10.9 9.1 9.8 10.2 7.3 20.3 9.4 8.4 11.0 12.9 9.5 5.8 9.0 22.7 16.3 7.8 14.6 11.6 9.5 9.7 8.8 21.3 11.3 8.8 12.4 6.6 3.8 7.3 6.2 8.7 10.1 22.5 8.7 4.6 7.1 3.7 4.8 4.5 11.5 10.9 4.4 4.2 8.3 3.8 11.5 3.5 4.2 2.6 6.9 8.8 10.4 8.8 5.0 5.9 16.3 9.0 5.4 6.9 6.7 7.4 2.4 3.7 11.0 6.3 9.3 2.1 5.1 10.3 6.0 6.6 4.8 6.0 22.7 9.9 6.1 5.9 6.2 9.1 8.8 3.8 6.9 9.2 3.1 4.5 8.5 2.3 7.5 4.8 6.2 7.0 11.7 7.5 21.3 8.3 6.9 7.3 9.7 6.8 8.6 8.8 9.4 10.2 9.8 10.7 8.8 11.3 6.2 12.4 6.6 10.2 7.3 14.3 7.9 9.6 4.6 6.8 5.9 7.4 9.0 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042980 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favourable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.5 16.3 14.3 11.1 15.4 15.1 13.5 15.9 15.8 10.9 13.9 15.0 16.3 16.3 9.6 24.2 10.8 10.6 10.1 9.0 13.1 9.1 17.2 16.3 9.2 16.0 13.2 13.8 13.9 16.7 12.3 14.1 9.0 12.7 10.3 10.0 11.9 13.8 12.1 13.4 18.2 16.8 10.6 10.5 13.8 11.3 14.3 10.3 14.3 16.0 11.9 12.5 9.9 10.4 27.9 18.8 27.0 14.1 26.5 24.7 12.2 9.3 11.9 7.8 10.7 9.9 9.2 7.5 6.2 10.0 6.1 6.9 8.6 16.7 10.2 8.5 4.8 18.2 17.2 12.8 6.9 19.4 12.0 9.7 15.9 9.8 9.8 15.9 10.2 8.1 18.0 10.2 11.6 10.6 13.1 17.0 5.8 9.6 13.6 8.7 13.7 8.1 18.3 11.0 13.6 10.4 14.7 19.1 11.7 16.4 11.8 23.1 14.8 9.5 6.7 13.2 18.5 9.9 11.0 15.8 23.9 19.3 16.6 16.4 14.4 27.0 14.1 18.8 19.3 13.6 21.1 27.9 20.5 19.9 13.2 24.4 24.1 20.7 15.1 26.5 12.6 18.8 24.7 12.2 14.3 15.4 15.9 15.8 13.1 9.1 13.2 13.8 12.7 10.3 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Cell line enhanced" "Detected in some" "ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favourable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.8 1.8 11.3 0.2 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.1 0.9 7.5 2.9 2.4 0.0 0.0 0.0 7.8 0.4 0.0 0.0 0.8 0.0 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.7 0.7 3.1 0.2 0.1 1.8 6.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" "Nucleoli, Vesicles" Cytosol "HPA062820: " "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favourable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.3 4.6 1.2 5.1 5.4 7.9 3.3 1.9 3.4 3.6 2.8 3.5 3.1 3.6 4.1 2.1 5.1 4.6 1.3 2.9 2.1 10.9 3.9 3.5 4.6 3.5 4.7 3.2 8.1 3.6 1.2 4.3 1.6 4.3 8.1 1.1 2.4 3.8 7.7 2.0 5.9 5.2 2.6 13.2 2.5 3.0 6.9 5.2 3.3 3.2 5.8 2.8 7.3 1.7 4.8 7.3 5.9 4.9 7.7 11.1 8.8 2.0 9.3 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA067189: " "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favourable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.6 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.1 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.0 0.4 8.7 2.8 1.6 2.8 14.7 4.1 1.2 2.6 2.3 4.3 6.1 2.2 0.1 9.2 0.9 3.3 0.5 0.0 11.1 7.6 0.0 7.8 4.7 2.0 3.3 12.7 6.8 2.7 1.9 2.4 0.9 2.5 0.9 1.9 4.9 1.2 6.1 7.2 1.1 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 32.5;U-2197: 23.6;U-87 MG: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favourable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.5 4.4 0.4 19.8 16.9 0.0 5.7 19.7 5.1 2.8 0.0 0.2 0.0 1.3 32.5 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.5 0.0 4.3 8.2 1.7 11.4 0.1 7.8 0.1 0.1 7.6 6.3 1.4 0.1 5.6 4.0 0.3 6.0 0.0 2.8 1.8 8.7 8.6 0.3 2.9 1.7 0.1 0.1 4.5 11.5 5.9 23.6 2.8 1.9 4.5 0.0 40.5 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.4 1.1 0.5 5.1 1.0 2.6 0.5 3.5 1.9 1.1 0.6 4.0 0.7 1.8 0.7 1.0 1.1 1.9 3.5 0.6 0.7 0.8 2.3 2.7 3.0 1.0 2.1 2.1 1.5 4.6 2.8 1.7 1.7 1.4 1.5 1.9 0.3 5.4 1.2 0.6 2.1 0.3 0.4 3.4 1.6 1.5 1.3 3.9 1.3 0.7 1.2 1.4 1.3 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 0.9 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.4 15.2 9.5 16.5 22.1 14.8 17.6 13.7 23.5 10.7 12.8 4.6 20.2 9.8 29.2 20.2 16.0 9.5 12.7 5.0 14.3 9.4 10.0 8.6 11.4 32.1 11.7 12.0 17.8 13.8 14.1 29.0 10.3 14.7 17.0 10.4 21.6 5.4 7.8 7.4 10.0 12.4 14.3 29.7 12.2 7.1 10.4 16.0 10.3 27.2 21.4 23.5 17.3 8.9 18.7 10.5 12.0 8.9 24.8 14.4 7.4 23.9 18.0 25.7 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 C16orf70 "C16orf6, FLJ12076, lin-10, LIN10" ENSG00000125149 "Chromosome 16 open reading frame 70" Q9BSU1 16 67109958-67148539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041131, HPA041214" Approved Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA041131: AB_10795487, HPA041214: AB_10794267" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (3.74e-3)" "unprognostic (1.81e-2)" "unprognostic (6.29e-2)" "unprognostic (1.07e-1)" "unprognostic (4.38e-2)" "unprognostic (1.68e-1)" "unprognostic (2.15e-2)" 8.0 7.7 11.3 6.7 14.6 14.2 10.5 14.0 22.4 8.4 7.9 24.2 8.6 6.7 8.9 8.8 12.5 10.1 8.2 8.0 12.6 8.9 11.8 43.2 7.9 7.6 18.2 13.1 10.1 6.2 19.5 8.3 10.6 15.5 12.9 9.4 7.7 8.9 8.4 20.1 22.0 7.1 10.0 18.0 11.2 6.9 10.6 16.0 7.0 7.1 5.8 10.3 8.4 10.3 7.2 14.1 6.3 15.9 5.2 8.3 7.3 6.7 10.1 9.7 10.1 12.3 7.4 22.9 7.7 8.4 15.7 17.3 11.2 6.0 6.8 6.8 9.1 9.1 12.0 7.6 20.4 3.6 11.0 5.4 6.4 23.4 7.6 5.2 30.0 7.3 10.6 15.3 7.2 8.8 8.7 2.9 9.6 6.8 10.2 8.2 10.7 16.5 14.3 16.8 10.7 6.9 4.1 12.6 6.8 23.9 5.5 5.8 11.0 4.5 6.7 11.2 9.5 7.9 6.6 4.5 8.1 20.4 10.1 5.5 8.8 2.9 15.9 5.4 4.7 11.8 6.2 7.2 7.0 8.3 14.1 4.9 7.1 6.6 6.3 5.2 11.8 4.6 6.7 7.3 11.3 14.6 14.0 22.4 12.6 8.9 18.2 13.1 15.5 16.0 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091648-9121640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: " "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.1 16.5 15.4 15.8 22.5 80.1 17.7 15.2 25.5 20.1 19.5 18.3 17.4 13.5 17.3 16.7 24.0 14.9 22.6 24.9 13.6 14.4 17.2 23.7 19.3 20.1 14.3 19.3 17.3 16.8 31.3 14.0 20.5 19.0 16.5 14.3 17.8 16.6 16.3 34.5 19.2 17.3 16.7 14.1 19.4 16.6 20.2 12.6 20.1 17.5 20.6 21.2 17.7 21.5 4.1 3.8 14.3 4.1 3.0 5.8 1.9 9.0 10.1 16.2 14.7 19.4 15.1 8.5 17.9 14.9 10.3 10.7 8.4 11.8 16.2 10.3 20.6 10.7 14.9 15.8 21.8 10.6 8.3 10.9 14.0 17.7 25.0 13.7 12.8 22.9 24.9 17.3 24.9 17.9 16.4 24.9 18.3 13.1 12.1 12.2 19.7 8.9 20.8 19.8 17.4 13.5 16.7 10.5 11.8 21.4 15.2 18.0 17.5 14.0 20.5 20.3 13.4 26.0 11.4 28.4 24.4 23.1 18.1 12.3 16.4 5.5 3.8 4.0 5.1 4.0 5.8 3.5 4.4 3.6 2.8 4.1 5.1 4.5 14.3 3.0 4.1 3.8 3.4 1.9 15.4 22.5 15.2 25.5 13.6 14.4 14.3 19.3 19.0 12.6 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 33.7;hTCEpi: 28.8;T-47d: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" "Plasma membrane" Centrosome "HPA049367: " "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavourable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavourable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.0 4.0 0.1 1.6 1.8 2.0 5.0 1.5 1.9 4.7 1.3 3.1 11.3 0.1 17.1 1.1 17.4 0.7 33.7 2.7 0.0 2.7 0.0 1.8 0.3 5.1 0.3 0.0 4.5 28.8 4.5 19.8 15.3 0.0 0.0 0.1 10.1 0.0 18.4 1.1 11.6 0.5 0.0 1.0 0.0 13.7 3.8 1.0 6.1 3.1 3.1 30.0 5.1 15.6 3.0 7.9 1.3 4.3 4.2 3.0 13.2 0.0 4.3 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell line enhanced" "Detected in many" "Hep G2: 11.7;SH-SY5Y: 11.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: " "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.6 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.9 1.1 2.6 2.5 6.6 7.6 1.4 2.6 11.7 2.0 0.2 3.9 2.3 2.5 0.8 1.8 1.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.6 3.4 0.4 3.9 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 C17orf49 "BAP18, HEPIS, MGC49942" ENSG00000258315 "Chromosome 17 open reading frame 49" Q8IXM2 17 7014495-7017525 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022961, HPA024457" Supported Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (1.48e-2)" "unprognostic (1.67e-3)" "unprognostic (9.09e-2)" "unprognostic (5.15e-2)" "unprognostic (4.54e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (7.62e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-2)" "unprognostic (2.25e-2)" "unprognostic (1.49e-2)" "unprognostic (1.06e-9)" "unprognostic (5.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.41e-2)" "unprognostic (4.62e-2)" 28.3 21.9 32.7 30.7 29.1 55.4 25.8 24.9 32.1 21.4 20.7 20.9 13.9 18.5 19.1 29.9 29.7 27.2 25.6 25.6 28.4 24.5 23.3 34.3 30.4 45.2 25.9 21.1 19.0 25.1 20.8 20.9 29.7 19.7 20.4 23.2 22.5 22.7 16.8 32.7 30.2 19.2 18.4 23.1 44.6 18.4 21.8 17.9 60.4 31.4 30.7 53.7 25.7 18.8 52.3 78.9 48.8 49.8 82.3 48.3 40.4 18.1 24.1 38.2 29.5 27.3 38.8 13.2 9.9 16.2 19.8 16.3 11.9 15.0 17.4 27.3 23.6 15.1 9.5 19.1 15.2 60.9 25.2 15.7 7.7 22.7 20.5 10.0 21.0 24.4 25.8 14.8 29.9 30.9 5.7 49.9 24.2 20.7 16.4 33.4 12.8 14.1 10.2 11.2 25.2 22.4 12.1 10.4 29.6 17.4 8.9 17.5 11.3 12.9 16.8 11.5 14.2 19.4 25.0 17.9 10.2 5.8 18.0 14.9 16.5 48.8 37.6 34.4 47.0 49.8 29.8 52.3 48.3 47.0 57.6 50.6 32.3 35.7 34.3 82.3 37.1 78.9 47.9 40.4 32.7 29.1 24.9 32.1 28.4 24.5 25.9 21.1 19.7 17.9 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: " "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.1 2.3 7.9 7.3 6.9 2.1 7.1 3.5 5.2 5.9 12.1 0.4 3.5 4.0 3.9 0.3 9.8 3.7 8.6 11.0 15.2 0.7 5.6 5.0 13.6 0.9 3.9 6.5 3.4 10.5 11.4 3.7 1.9 0.8 4.4 0.0 7.6 0.3 4.3 5.2 7.4 4.8 0.5 1.9 0.5 5.1 0.9 6.6 0.2 5.2 0.1 0.3 6.6 6.1 6.3 14.5 8.5 2.3 2.8 13.5 7.3 1.3 7.1 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavourable (3.46e-4)" "prognostic unfavourable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 6.0 5.2 11.5 12.7 9.7 4.7 8.1 5.3 5.2 6.6 9.7 9.4 10.2 9.1 12.3 5.2 8.7 6.5 0.3 5.7 6.6 1.8 1.4 14.3 7.1 4.8 11.8 10.7 5.6 5.6 13.5 8.5 5.1 9.4 8.6 12.0 10.0 2.7 6.1 4.7 2.8 3.6 3.6 2.9 7.2 6.6 2.2 11.2 8.8 7.5 8.6 6.1 10.3 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991101-67996431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 110.1" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavourable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavourable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.1 6.8 10.7 6.2 9.3 3.5 17.3 8.8 11.5 29.0 8.3 5.7 8.3 4.1 15.4 8.1 6.5 8.1 6.6 8.9 7.7 6.3 6.3 9.1 6.2 3.1 7.4 5.0 6.3 10.4 5.2 3.6 33.3 5.2 7.8 7.5 5.7 5.3 4.0 6.9 3.7 6.1 11.8 5.5 5.1 6.6 4.8 4.4 1.1 6.9 4.5 6.8 11.0 11.7 3.6 5.2 9.5 6.3 3.2 3.0 2.2 5.2 5.2 5.2 6.4 3.8 9.6 4.1 2.2 6.2 3.9 6.3 3.0 6.9 7.0 5.0 1.8 2.7 11.8 4.7 9.4 12.6 11.9 4.5 1.9 9.6 6.0 3.8 8.4 5.2 5.7 3.7 8.7 18.1 9.6 10.9 3.7 7.0 0.7 5.1 5.9 5.5 1.7 5.7 9.3 4.9 3.5 3.9 7.0 3.3 30.9 11.3 8.8 4.5 3.3 3.3 3.4 2.3 4.6 21.9 16.0 6.2 8.4 6.8 5.8 9.5 3.8 6.3 3.0 3.6 1.0 3.6 1.1 2.4 5.2 0.8 0.5 1.2 1.5 3.2 6.3 0.2 0.5 2.2 10.7 9.3 8.8 11.5 7.7 6.3 7.4 5.0 5.2 4.4 C17orf62 "FLJ90469, MGC4368" ENSG00000178927 "Chromosome 17 open reading frame 62" Q9BQA9 17 82442589-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA045696: " "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavourable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 19.9 17.3 16.8 35.8 25.2 16.4 20.0 8.6 20.4 16.2 16.2 20.8 10.5 12.1 16.5 13.1 17.1 16.0 22.9 12.1 15.2 12.1 17.5 29.1 20.2 48.3 26.8 12.4 17.6 21.3 12.9 15.7 14.9 20.6 19.5 13.6 12.2 14.7 12.7 6.5 13.9 21.1 20.2 19.0 53.7 16.4 8.3 20.9 26.0 13.8 8.2 42.3 29.2 13.3 30.6 33.0 74.9 44.2 24.2 25.9 34.6 14.0 20.5 11.3 18.6 17.9 18.8 11.0 12.7 15.4 18.7 22.3 7.6 14.3 35.7 11.7 17.9 14.2 7.7 9.5 12.9 25.4 6.3 9.7 6.7 8.9 18.6 10.9 28.7 21.7 13.8 16.0 9.0 24.2 8.1 26.8 15.7 15.6 45.2 9.2 8.6 11.0 34.6 6.8 27.4 13.8 17.9 9.7 18.4 22.9 26.8 16.3 27.5 43.9 8.3 14.6 14.3 23.9 13.4 49.0 16.3 26.3 19.0 17.8 12.8 43.8 34.1 44.0 25.9 44.2 20.0 30.2 23.9 25.0 31.4 30.6 20.2 19.6 74.9 24.2 39.6 33.0 24.8 34.6 16.8 25.2 8.6 20.4 15.2 12.1 26.8 12.4 20.6 20.9 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell line enhanced" "Detected in some" "MCF7: 10.8;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.0 0.0 0.6 0.7 1.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 10.8 0.3 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 2.7 0.3 0.0 0.1 0.0 0.0 1.7 1.3 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 C17orf75 "NJMU-R1, SRI2" ENSG00000108666 "Chromosome 17 open reading frame 75" Q9HAS0 17 32324565-32350023 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004061, HPA075333" Approved Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA004061: AB_1078337, HPA075333: " "unprognostic (4.21e-2)" "unprognostic (2.49e-2)" "unprognostic (3.32e-2)" "unprognostic (2.28e-1)" "unprognostic (1.51e-1)" "unprognostic (4.73e-2)" "unprognostic (1.07e-3)" "unprognostic (6.36e-2)" "unprognostic (3.29e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.92e-2)" "unprognostic (7.80e-2)" "prognostic favourable (1.33e-4)" "unprognostic (3.09e-1)" "unprognostic (1.29e-1)" "unprognostic (4.27e-2)" "unprognostic (5.60e-2)" 6.9 17.3 16.6 8.2 21.2 5.7 13.1 25.8 23.9 8.7 10.1 12.7 10.9 10.5 12.7 15.6 9.9 14.7 6.9 18.6 13.4 14.8 19.6 12.7 8.0 10.8 13.8 14.1 16.0 11.3 16.6 17.2 9.3 21.1 11.8 11.3 11.7 11.8 11.8 15.0 8.0 9.2 11.0 11.3 10.8 10.9 20.4 13.3 11.7 16.4 8.3 11.3 9.7 8.9 15.0 13.7 18.4 12.3 13.7 16.4 13.0 13.2 14.4 20.9 7.4 6.1 8.1 10.9 9.6 10.6 15.5 13.8 7.2 5.2 9.1 11.2 8.8 14.9 17.2 13.1 22.2 6.4 16.7 7.3 13.3 13.3 13.2 10.4 6.1 6.4 15.9 11.1 8.0 11.7 14.3 13.2 10.1 10.9 29.1 9.0 13.3 7.9 18.4 13.8 15.9 9.2 7.4 20.4 16.8 8.5 7.5 20.2 19.1 6.4 7.3 8.1 12.8 3.8 14.9 15.8 17.8 31.4 6.2 9.1 2.4 18.4 10.6 13.2 16.0 8.8 16.4 14.5 14.6 15.4 13.7 15.0 16.1 15.1 3.5 13.7 12.3 10.4 15.0 13.0 16.6 21.2 25.8 23.9 13.4 14.8 13.8 14.1 21.1 13.3 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.8 10.4 14.5 8.8 10.7 9.2 14.1 13.0 11.3 18.5 17.6 9.9 8.2 18.8 9.3 6.6 9.9 20.1 7.5 21.7 6.8 13.7 17.3 11.0 11.5 9.3 18.1 10.2 7.1 9.4 12.3 10.2 15.8 18.6 11.3 12.3 5.6 21.0 8.6 11.5 11.3 12.7 39.9 9.6 9.6 7.5 17.8 16.0 6.9 12.7 15.1 13.9 11.5 8.6 19.4 17.9 6.2 12.3 12.8 15.2 18.1 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410327-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.2" "Cell line enhanced" "Detected in many" "HaCaT: 9.0;U-2197: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.7" "Low lineage specificity" "Detected in many" HPA023583 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 4.9 6.0 2.4 10.6 1.9 2.7 5.2 8.7 3.9 3.6 4.2 4.4 2.2 3.5 4.5 2.4 13.6 6.6 3.8 5.2 6.1 7.6 1.9 3.8 2.8 4.0 7.6 3.8 3.8 3.4 8.2 1.4 6.2 3.3 2.9 4.2 3.5 5.8 4.3 2.5 4.7 1.9 2.8 2.1 2.4 53.2 2.9 5.0 6.9 1.8 1.9 3.1 1.8 0.4 0.9 2.7 0.4 0.8 1.4 0.2 2.6 3.9 1.8 2.2 1.0 0.8 0.9 2.0 1.4 1.5 1.0 0.1 4.0 0.7 1.5 4.3 9.0 4.9 1.0 1.5 0.3 0.6 1.9 3.4 0.3 3.4 0.4 0.8 1.0 2.5 3.4 0.4 1.5 0.3 0.1 1.0 2.3 6.5 3.5 2.8 1.2 0.7 0.4 2.4 6.3 2.3 0.6 2.1 2.4 3.4 0.5 2.0 2.9 1.5 1.9 0.9 12.0 0.8 0.2 0.2 0.0 2.3 0.9 1.1 0.4 0.4 2.7 0.3 0.2 0.0 0.2 0.2 0.8 0.5 0.4 1.4 1.3 0.2 0.8 0.4 0.9 0.0 0.2 6.0 10.6 5.2 8.7 5.2 6.1 4.0 7.6 6.2 2.9 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835088-38841455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 10.7" "Cell line enriched" "Detected in some" 6 "hTCEpi: 7.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" "Intermediate filaments" Nucleoli "HPA051696: " "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.0 7.7 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 1.0 0.5 0.0 1.3 0.3 0.5 0.0 0.2 0.2 0.5 0.7 0.0 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972083-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" "Nucleoli, Plasma membrane" "HPA065505: , HPA067322: " "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favourable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 14.1 16.1 13.4 16.7 12.5 53.0 18.4 23.1 25.8 13.0 12.8 7.9 17.6 15.2 15.0 17.7 15.0 12.9 11.7 15.2 12.4 12.5 14.0 14.5 11.3 17.1 11.7 14.7 16.4 22.0 12.9 16.9 14.8 13.0 13.4 12.3 8.1 16.5 17.8 28.7 13.6 14.1 15.8 10.6 17.2 16.7 28.7 11.7 22.9 14.8 21.4 15.7 17.8 14.8 18.5 15.1 40.6 16.5 16.5 21.7 10.6 13.3 9.0 19.7 13.6 12.7 19.2 13.3 18.3 17.4 22.0 22.4 7.7 9.1 10.7 19.6 13.4 13.6 13.7 14.1 24.4 16.1 14.0 11.1 10.8 17.2 18.3 33.8 13.9 18.6 22.9 19.4 19.7 17.9 18.0 17.3 14.4 14.8 22.3 23.4 16.5 9.9 15.1 16.8 20.7 14.9 14.6 12.6 18.9 12.2 9.8 29.2 14.3 15.3 12.7 21.7 10.4 8.0 16.1 24.3 21.5 23.4 11.1 17.6 11.4 40.6 16.5 18.3 14.6 16.5 14.6 18.5 15.9 13.7 15.1 16.1 12.3 16.0 14.9 16.5 15.3 14.6 21.7 10.6 13.4 12.5 23.1 25.8 12.4 12.5 11.7 14.7 13.0 11.7 C18orf25 "ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051314: , HPA051899: " "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 5.3 4.9 5.8 6.4 8.2 18.6 6.5 10.1 10.1 6.1 4.9 5.5 6.5 4.4 7.7 5.3 54.0 6.2 3.8 11.4 4.8 4.9 5.4 6.2 5.9 6.8 5.3 6.5 5.9 5.0 15.3 6.3 7.3 8.3 5.2 5.7 9.5 11.3 4.8 13.1 6.2 5.5 5.7 4.7 6.3 5.1 7.8 5.7 8.2 7.4 10.2 11.8 7.2 12.7 8.1 11.0 19.0 11.0 2.8 11.1 5.5 11.2 11.3 9.5 10.7 6.8 6.2 12.2 16.4 8.7 17.6 15.0 8.6 13.0 8.7 15.6 11.0 25.7 17.5 11.1 19.1 14.4 5.6 7.6 9.6 6.5 11.8 14.2 10.3 5.7 13.0 20.4 17.0 6.9 8.5 10.4 9.7 8.5 10.8 7.3 8.4 4.4 9.8 11.3 12.7 16.8 20.3 13.3 6.9 12.0 8.5 8.5 5.6 8.8 10.0 16.0 11.5 3.9 15.0 13.7 11.6 14.0 8.3 15.1 17.1 4.2 7.5 15.4 5.7 8.4 9.9 5.9 11.1 8.6 7.4 8.1 8.0 6.3 19.0 2.8 11.0 11.0 7.1 5.5 5.8 8.2 10.1 10.1 4.8 4.9 5.3 6.5 8.3 5.7 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477250-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favourable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 17.1 16.5 67.0 7.1 59.0 19.1 25.5 27.4 48.4 22.2 24.2 29.5 16.1 10.7 12.7 35.0 13.6 17.2 19.4 25.1 57.5 49.8 42.2 38.6 19.6 14.8 67.8 28.3 16.5 20.1 23.8 20.5 15.7 47.0 21.3 22.4 17.0 21.6 18.9 10.8 10.2 14.2 14.9 78.5 13.6 23.4 15.5 25.2 8.3 28.8 8.0 12.7 19.4 9.6 16.1 21.4 57.2 22.1 9.8 15.4 21.0 7.6 8.8 16.7 10.4 15.2 13.5 19.2 11.6 12.8 11.3 9.6 1.6 3.5 6.9 29.3 9.8 8.9 3.8 13.1 9.7 22.1 7.8 6.2 5.9 10.6 24.2 12.2 13.3 11.7 29.1 7.6 11.3 15.1 7.1 13.3 23.4 4.8 7.7 6.3 4.6 8.8 7.3 5.8 13.9 30.1 15.0 19.2 33.1 7.6 6.0 15.7 8.6 4.5 16.1 11.7 9.9 3.3 12.5 40.6 24.1 7.5 9.2 8.2 10.9 36.3 17.1 43.2 13.9 19.3 15.4 16.1 13.7 14.3 14.1 12.8 11.7 15.4 57.2 9.8 22.1 21.4 14.6 21.0 67.0 59.0 27.4 48.4 57.5 49.8 67.8 28.3 47.0 25.2 C19orf24 FLJ20640 ENSG00000228300 "Chromosome 19 open reading frame 24" Q9BVV8 19 1275438-1279249 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 20.2 25.3 13.4 20.9 14.9 17.1 65.7 11.3 15.8 11.7 15.6 9.1 17.5 21.8 13.8 22.0 18.7 13.0 26.5 14.3 13.3 10.9 22.6 48.6 17.0 55.0 13.4 7.0 16.6 41.6 5.9 16.9 18.4 9.7 17.6 6.0 11.1 29.6 22.5 6.9 16.6 19.6 10.5 10.9 22.8 16.6 16.8 10.0 23.1 25.7 19.0 15.8 15.5 21.9 40.9 44.8 9.5 27.5 19.0 33.8 21.3 25.6 24.5 2.3 20.2 3.9 9.3 9.4 12.5 6.7 13.3 11.7 28.0 14.4 7.4 17.5 4.4 13.7 4.1 13.2 1.5 27.0 21.1 8.0 21.9 16.2 16.6 16.9 17.8 11.1 17.1 10.1 4.4 9.7 15.2 42.9 5.3 25.7 20.3 25.1 11.9 24.8 15.1 4.7 46.1 7.4 13.7 16.6 10.8 7.9 19.4 28.9 14.1 28.6 6.1 24.5 7.8 29.8 29.6 28.2 36.6 9.2 26.5 21.2 21.9 9.5 26.8 9.2 31.2 27.5 30.9 40.9 33.8 32.9 26.7 36.0 31.9 32.3 4.7 19.0 23.1 44.8 31.9 21.3 13.4 14.9 11.3 15.8 13.3 10.9 13.4 7.0 9.7 10.0 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell line enhanced" "Detected in some" "A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: , HPA059696: " "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 69.7 107.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.4 0.0 39.9 0.0 26.2 0.0 64.5 0.0 0.0 0.0 0.0 22.6 1.8 0.5 0.0 0.0 0.0 67.5 0.0 43.3 1.1 0.0 0.0 0.0 18.0 0.0 0.1 0.1 61.5 0.0 0.0 0.0 40.8 20.7 0.1 0.0 40.7 29.5 0.0 9.2 0.2 14.6 0.0 20.3 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell line enriched" "Detected in some" 4 "U-937: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favourable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavourable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.4 0.8 0.1 0.2 0.0 0.2 0.6 0.1 0.2 3.7 0.3 0.0 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.4 0.4 4.0 0.4 0.7 0.2 0.1 0.2 7.9 0.1 1.3 0.1 5.7 0.3 0.2 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.7 0.0 0.5 0.1 5.5 0.0 0.0 0.0 0.7 0.0 4.8 2.2 1.1 0.0 32.0 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 C19orf44 FLJ21742 ENSG00000105072 "Chromosome 19 open reading frame 44" Q9H6X5 19 16496311-16521352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041683, HPA049414" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA041683: AB_10793929, HPA049414: " "unprognostic (2.16e-1)" "unprognostic (2.16e-2)" "unprognostic (1.25e-1)" "unprognostic (8.52e-2)" "unprognostic (2.05e-1)" "unprognostic (8.38e-3)" "unprognostic (1.83e-1)" "unprognostic (4.19e-2)" "unprognostic (6.45e-2)" "unprognostic (1.36e-1)" "unprognostic (2.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.04e-1)" "unprognostic (7.02e-2)" "unprognostic (7.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.90e-1)" 5.0 4.6 8.1 3.6 8.1 6.1 5.6 11.2 8.8 9.9 7.7 7.4 10.2 3.9 12.7 5.8 5.1 11.5 7.6 5.9 6.3 5.1 6.9 4.3 4.5 3.8 4.0 3.8 13.2 8.1 14.9 19.7 4.1 5.9 11.0 2.9 11.2 10.6 9.9 6.9 7.7 3.8 8.2 5.9 3.9 5.3 19.7 5.8 4.1 9.1 3.1 4.3 6.4 6.1 3.5 1.6 5.7 1.7 1.5 2.7 1.0 5.5 6.3 5.4 7.7 3.6 8.8 7.3 4.7 4.5 5.9 8.6 3.8 6.9 4.8 8.5 3.7 3.9 4.6 4.1 4.7 2.8 11.3 2.3 9.0 4.9 6.3 2.6 2.5 4.5 4.1 7.9 5.8 3.2 6.7 1.5 3.2 7.6 4.2 6.8 3.5 8.3 3.1 2.7 6.6 6.2 2.5 6.4 3.9 4.6 6.8 4.1 5.9 2.8 6.4 8.0 3.8 5.6 6.4 4.8 3.4 2.7 5.7 2.5 6.7 5.7 1.5 0.5 1.6 0.7 0.4 3.5 1.5 0.7 0.6 3.4 1.7 2.7 3.3 1.5 1.7 1.6 0.6 1.0 8.1 8.1 11.2 8.8 6.3 5.1 4.0 3.8 5.9 5.8 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774168-13778462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059928: , HPA061291: " "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 37.3 41.5 55.6 31.1 53.7 42.1 33.1 22.0 41.7 40.4 35.7 27.0 34.2 28.0 33.9 55.6 43.1 44.0 39.3 67.0 46.2 44.8 42.8 68.4 35.5 42.4 47.2 34.7 49.9 46.9 27.4 41.8 27.2 37.3 39.2 26.4 30.1 45.9 35.7 90.7 31.5 29.2 39.6 37.0 34.8 31.3 34.1 30.0 59.6 53.5 47.7 41.6 43.1 43.1 67.9 63.0 57.3 49.6 36.3 75.8 92.4 34.8 49.7 24.8 20.6 35.2 39.9 16.4 32.9 29.2 40.9 40.8 46.1 17.1 18.6 41.0 39.7 18.7 22.9 49.6 21.2 22.2 72.3 17.4 53.8 50.0 36.4 27.2 23.1 48.6 35.9 37.8 21.4 35.0 26.9 32.1 31.8 78.5 38.4 28.3 31.6 88.2 21.1 18.9 32.1 36.3 43.2 22.6 27.3 23.0 27.3 33.3 24.8 28.0 23.3 46.5 18.6 49.7 45.0 35.9 45.6 27.8 28.3 31.0 25.1 48.1 48.8 57.3 49.0 49.6 55.5 67.9 63.4 57.0 44.2 63.3 75.8 68.0 23.7 36.3 43.1 63.0 69.4 92.4 55.6 53.7 22.0 41.7 46.2 44.8 47.2 34.7 37.3 30.0 C19orf66 "FLJ11286, IRAV, RyDEN" ENSG00000130813 "Chromosome 19 open reading frame 66" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favourable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavourable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favourable (1.35e-4)" 9.8 13.8 13.7 17.6 12.1 9.0 9.9 10.6 16.9 14.5 11.2 8.4 10.3 9.6 12.6 14.1 8.9 16.4 15.5 6.9 11.0 13.9 11.5 55.8 11.6 14.4 9.0 13.5 14.5 10.0 14.1 12.8 9.8 10.0 12.4 6.1 11.6 13.0 15.8 3.7 7.6 14.2 9.7 8.6 14.0 8.3 3.7 8.6 9.8 11.9 5.4 13.0 12.9 10.1 8.8 6.7 11.6 12.0 17.5 21.2 10.0 2.7 1.6 1.7 1.2 6.5 8.8 0.7 3.3 18.0 24.5 26.0 0.2 2.4 1.7 1.0 8.5 1.2 0.8 6.0 0.4 11.8 0.0 5.1 1.1 4.1 12.7 1.7 2.9 15.8 4.5 3.8 0.6 7.0 0.7 6.8 4.9 2.2 5.8 3.4 0.4 2.5 5.3 0.0 3.2 3.6 4.3 0.2 1.5 4.7 0.4 13.8 0.2 4.6 5.1 2.1 1.0 2.8 0.4 8.3 2.6 0.4 5.6 1.6 4.1 11.1 8.3 11.6 15.9 7.4 21.2 8.8 13.5 17.1 6.7 6.9 11.5 12.1 10.8 17.5 12.0 1.3 13.9 10.0 13.7 12.1 10.6 16.9 11.0 13.9 9.0 13.5 10.0 8.6 C19orf70 "MIC13, P117, QIL1" ENSG00000174917 "Chromosome 19 open reading frame 70" Q5XKP0 19 5678421-5680896 "Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favourable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 20.2 23.6 32.9 14.5 28.4 13.2 16.0 11.0 29.8 13.0 22.2 13.5 17.8 25.4 12.2 26.8 22.7 16.7 24.0 70.2 27.2 26.5 30.5 38.4 12.7 21.1 32.1 21.1 13.5 24.2 13.2 15.6 12.4 16.9 16.6 11.7 13.6 28.7 22.7 79.1 17.6 20.7 14.7 20.9 14.1 18.2 33.4 12.3 11.6 20.3 45.0 12.6 15.4 11.8 43.6 48.2 11.6 42.2 27.4 39.5 40.7 23.9 19.9 6.9 13.2 16.3 16.9 9.0 15.9 15.1 18.4 15.2 15.8 12.5 10.4 25.9 13.9 17.9 3.6 22.5 5.3 17.2 37.9 10.2 13.8 17.5 23.0 13.9 12.8 19.8 20.4 9.9 13.8 13.1 15.7 32.7 13.8 21.7 21.0 16.6 7.3 63.6 11.5 8.3 38.2 20.0 15.1 16.2 20.7 4.9 31.4 22.2 19.2 17.1 13.4 18.1 7.7 33.0 22.5 49.4 32.6 8.3 26.9 22.3 18.3 8.9 35.5 11.6 33.6 42.2 39.5 43.6 38.6 37.2 41.2 35.6 38.1 35.9 5.6 27.4 35.6 48.2 30.9 40.7 32.9 28.4 11.0 29.8 27.2 26.5 32.1 21.1 16.9 12.3 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 88.8" "Group enriched" "Detected in many" 4 "HeLa: 26.7;SK-MEL-30: 16.3;WM-115: 58.2" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Region enriched" "Detected in all" 4 "cerebellum: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: " "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favourable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favourable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favourable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 1.6 2.3 1.6 4.1 2.2 5.1 1.6 9.8 2.2 1.7 1.6 2.0 1.6 4.7 2.5 1.9 1.6 2.6 1.6 1.6 1.6 1.3 3.5 1.6 2.1 4.9 1.8 1.9 2.8 4.2 0.0 4.5 1.6 1.7 2.2 0.0 1.6 7.6 1.6 1.6 7.4 3.9 1.6 1.6 5.2 3.2 88.8 1.8 1.6 6.3 1.6 1.6 1.7 1.6 0.3 0.5 0.0 0.2 0.0 0.7 0.1 5.2 4.3 1.4 1.9 0.0 0.0 2.9 3.3 0.0 0.0 0.0 2.7 1.6 0.9 2.5 0.0 4.7 0.0 0.2 0.0 5.3 2.5 0.7 26.7 0.8 0.0 0.7 3.3 0.0 0.0 0.1 0.0 0.0 3.6 4.8 0.0 3.7 1.1 1.7 1.2 1.3 1.7 2.1 4.9 0.0 2.1 3.4 3.1 5.8 2.9 16.3 3.3 1.7 4.4 2.6 3.5 8.0 3.0 3.8 1.0 1.3 7.9 3.1 58.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.2 0.5 0.0 0.1 1.6 2.2 9.8 2.2 1.6 1.3 1.8 1.9 1.7 1.8 C19orf73 FLJ10490 ENSG00000221916 "Chromosome 19 open reading frame 73" Q9NVV2 19 49118397-49119140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA062719 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA062719: " "unprognostic (3.02e-1)" "unprognostic (3.75e-2)" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (2.04e-2)" "unprognostic (4.39e-3)" "unprognostic (2.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.92e-1)" "unprognostic (1.97e-3)" "prognostic favourable (1.58e-4)" "unprognostic (3.05e-1)" "unprognostic (9.00e-5)" "unprognostic (1.19e-1)" "unprognostic (6.70e-2)" "unprognostic (1.91e-1)" "unprognostic (5.13e-3)" 2.5 3.4 5.0 2.3 6.7 1.0 3.7 10.2 8.7 1.4 3.9 4.1 3.1 7.7 1.3 5.6 2.6 1.4 2.1 3.5 4.9 4.5 2.5 4.8 1.5 2.3 9.2 4.9 0.7 12.9 3.3 5.4 1.4 5.0 2.5 2.9 1.8 6.3 2.1 3.6 4.1 4.4 1.3 4.7 3.6 2.9 2.1 5.6 1.1 3.1 1.2 1.7 1.5 1.4 6.2 5.5 0.7 4.1 7.9 4.6 2.3 2.4 3.1 1.2 6.0 2.0 0.4 1.3 0.7 0.4 1.3 0.9 0.2 1.4 1.8 0.7 0.5 1.6 1.6 0.2 0.2 3.5 12.7 1.5 1.9 2.0 2.0 0.0 0.7 0.2 4.1 0.9 3.4 0.4 2.8 2.9 0.6 2.5 1.9 1.8 0.9 0.6 1.8 2.4 2.3 2.3 1.0 6.3 2.9 1.1 1.5 2.3 1.5 0.6 1.2 1.6 2.7 0.5 0.6 1.8 3.4 2.0 1.1 2.1 1.8 0.0 3.3 0.7 2.9 1.9 4.6 2.7 2.2 2.6 5.5 6.2 4.3 3.2 0.1 7.9 4.1 4.2 1.9 2.3 5.0 6.7 10.2 8.7 4.9 4.5 9.2 4.9 5.0 5.6 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 10.7" "Cell line enhanced" "Detected in some" "HEK 293: 9.2;HMC-1: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome "Vesicles, Aggresome" "HPA060238: " "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.4 0.0 0.0 0.7 0.0 0.0 1.2 9.2 0.9 0.0 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.4 2.1 1.8 0.0 0.0 0.5 1.5 0.5 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.1 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037413: , HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 17.1 20.1 15.9 13.3 17.9 31.5 17.2 13.9 26.5 15.4 16.3 12.4 15.4 14.7 14.9 14.6 13.8 13.9 12.4 15.8 14.9 15.6 28.4 29.8 14.4 21.0 14.8 16.8 14.9 27.3 12.5 25.3 18.6 17.0 14.8 13.9 8.6 13.5 14.0 29.4 11.7 19.2 12.2 17.2 16.4 15.1 13.8 18.6 17.4 18.0 16.4 14.7 13.2 20.0 20.0 16.1 32.1 19.6 22.6 19.7 9.4 21.4 12.1 15.1 12.6 15.3 19.4 20.1 27.9 19.3 19.6 16.2 21.0 24.2 27.2 17.0 18.7 10.6 17.8 13.0 30.6 28.9 21.4 31.9 10.2 24.1 15.5 39.5 33.9 16.0 21.9 14.7 14.1 15.0 25.3 23.7 18.0 10.9 26.2 34.2 16.2 15.0 16.6 18.0 21.4 17.7 15.6 13.2 15.1 10.2 17.8 27.6 13.0 26.8 16.6 16.9 19.5 20.6 24.5 22.8 25.3 34.3 21.6 24.6 19.2 28.1 14.3 32.1 15.9 18.5 18.7 20.0 18.0 13.2 16.1 17.2 19.6 19.7 29.0 22.6 19.6 15.0 19.0 9.4 15.9 17.9 13.9 26.5 14.9 15.6 14.8 16.8 17.0 18.6 C1GALT1 "C1GALT, T-synthase" ENSG00000106392 "Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1" Q9NS00 7 7156934-7248651 "Enzymes, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011294, HPA012819" Enhanced Approved "Nuclear bodies,Cytosol" 10000 "Nuclear bodies, Cytosol" "HPA011294: AB_1845623, HPA012819: AB_1845624" "unprognostic (1.52e-1)" "prognostic unfavourable (1.04e-4)" "unprognostic (7.38e-2)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.04e-2)" "prognostic unfavourable (1.42e-5)" "unprognostic (2.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-1)" "unprognostic (3.28e-1)" "unprognostic (8.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-1)" 11.4 7.7 10.1 12.4 14.1 23.1 11.0 10.6 14.9 13.9 10.7 21.5 4.0 19.3 5.4 7.1 24.7 12.7 16.1 11.6 12.8 10.8 21.5 14.7 10.9 11.7 23.7 8.9 6.2 6.2 42.3 11.0 30.2 19.2 5.7 12.2 8.1 17.6 5.7 8.1 8.6 15.8 5.3 31.0 13.8 15.3 5.4 21.4 12.9 10.6 6.2 11.6 10.3 8.4 15.9 13.5 33.2 26.0 16.6 17.4 12.2 18.7 8.1 2.5 4.3 7.4 15.5 8.7 21.5 16.1 10.0 14.9 5.5 19.4 8.7 5.5 8.5 6.0 3.6 8.0 15.8 5.2 3.0 8.2 4.8 15.3 8.1 8.6 3.6 12.7 5.7 24.6 19.0 8.1 17.7 5.5 80.7 3.2 2.3 4.2 15.6 8.7 7.9 14.7 5.3 11.4 8.3 3.0 8.1 13.6 15.3 14.6 4.8 4.5 8.6 16.1 24.9 22.9 8.7 10.5 8.9 9.9 10.6 11.7 17.8 33.2 11.1 31.2 16.1 16.5 16.9 15.9 15.0 17.4 12.2 13.7 15.7 17.0 24.3 16.6 26.0 13.5 13.0 12.2 10.1 14.1 10.6 14.9 12.8 10.8 23.7 8.9 19.2 21.4 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Cell line enriched" "Detected in single" 51 "K-562: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavourable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.2 9.5 8.2 13.4 7.2 5.2 18.7 9.9 7.1 15.0 11.1 14.4 10.0 11.7 12.0 4.3 12.0 15.1 10.1 15.4 18.7 17.0 13.4 9.6 9.0 13.9 14.5 8.8 7.0 12.5 14.8 19.3 7.5 26.2 14.3 8.5 5.7 14.1 6.4 25.6 18.3 14.0 17.2 32.2 7.9 7.1 24.8 11.9 8.7 13.5 20.1 7.6 6.6 5.0 15.1 9.5 12.1 20.1 11.7 13.0 24.0 7.5 14.3 15.8 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell line enhanced" "Detected in some" "A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favourable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 17.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 31.8 0.0 2.1 0.0 39.2 0.0 37.7 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.0 0.0 11.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 18.4 4.7 0.0 0.1 0.3 3.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 C1orf123 FLJ20580 ENSG00000162384 "Chromosome 1 open reading frame 123" Q9NWV4 1 53214099-53220617 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043835 Uncertain Approved "Vesicles,Mitotic spindle,Cytosol" 380000 Cytosol "Vesicles, Mitotic spindle" "HPA043835: AB_10796797" "unprognostic (1.09e-2)" "unprognostic (5.91e-2)" "unprognostic (2.03e-2)" "unprognostic (4.55e-2)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (9.20e-3)" "unprognostic (2.27e-1)" "unprognostic (5.52e-2)" "unprognostic (9.37e-3)" "unprognostic (1.46e-1)" "unprognostic (3.05e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (6.31e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (2.43e-1)" 32.6 21.4 27.8 19.1 29.4 12.9 26.3 16.4 25.4 29.2 33.2 25.0 22.7 15.4 34.0 28.9 25.7 32.2 22.7 28.8 24.3 22.3 26.9 29.3 20.3 18.3 24.7 26.3 33.5 17.5 21.0 20.1 22.5 23.7 31.7 24.7 24.0 16.6 33.5 44.4 14.3 16.9 48.4 22.5 18.4 23.4 26.0 23.8 18.9 26.0 18.0 19.4 28.9 26.0 25.5 38.4 31.5 39.1 30.5 36.5 26.4 11.6 12.7 16.8 15.3 39.0 50.0 14.9 17.5 18.7 17.8 19.3 10.8 10.1 18.1 14.7 21.2 4.6 10.3 17.2 21.6 23.3 17.6 18.4 9.8 16.2 38.4 21.1 12.2 32.4 18.8 19.0 20.2 29.0 19.0 5.1 22.2 19.6 25.9 19.9 27.9 20.2 19.0 21.3 14.2 20.6 11.9 14.2 13.7 16.6 15.2 16.5 10.8 21.7 18.1 20.7 12.2 14.3 17.0 7.4 10.7 20.4 16.6 21.2 15.9 28.3 32.1 31.5 30.4 39.1 27.7 25.5 30.2 31.7 38.4 23.6 33.7 33.4 13.0 30.5 31.8 25.9 36.5 26.4 27.8 29.4 16.4 25.4 24.3 22.3 24.7 26.3 23.7 23.8 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Cell line enhanced" "Detected in some" "AF22: 4.4;RPTEC TERT1: 1.0;SCLC-21H: 6.1;U-87 MG: 1.7" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: " "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favourable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.1 0.3 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387058-184629020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.9;Karpas-707: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5" "Group enriched" "Detected in many" 12 "NK-cells: 7.5;T-cells: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 12.0 15.9 16.8 7.5 9.5 2.1 25.2 17.5 18.8 20.2 18.5 4.4 16.7 8.7 17.3 14.2 14.1 10.1 9.2 20.0 12.5 8.8 4.1 7.5 12.2 3.5 8.3 13.3 13.9 4.7 12.6 7.6 5.7 11.8 17.8 13.1 10.7 5.1 18.9 51.7 30.1 15.8 25.2 7.6 8.2 10.7 4.1 5.4 1.5 4.4 13.6 3.9 22.0 23.5 0.0 0.7 0.2 0.1 7.5 11.4 2.1 0.6 0.1 3.6 0.3 11.2 9.2 6.0 3.1 3.1 2.0 1.8 0.0 0.3 0.0 0.0 3.5 2.0 2.3 2.6 1.9 22.9 3.6 0.1 1.0 0.0 4.4 1.9 1.0 11.1 7.6 2.3 2.0 2.3 0.0 17.4 3.0 2.4 2.3 0.5 5.3 0.6 3.0 3.7 3.4 0.0 1.2 2.0 5.3 1.6 1.4 6.5 0.2 0.2 2.3 4.0 2.1 6.1 3.8 10.8 5.0 0.0 4.0 3.3 4.6 0.0 0.1 0.0 11.4 0.0 1.1 0.0 1.9 5.9 0.7 0.0 0.6 5.9 0.2 7.5 0.0 0.2 0.0 2.1 16.8 9.5 17.5 15.9 12.5 8.8 8.3 13.3 11.8 5.4 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: " "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavourable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.3 7.9 4.4 5.7 19.9 14.6 2.9 9.7 11.4 14.4 13.8 4.7 7.2 4.3 7.0 14.2 3.2 10.8 6.4 12.4 13.9 5.1 25.5 11.6 1.3 7.6 12.6 16.8 15.0 8.1 10.3 3.3 9.4 10.1 11.5 15.4 5.5 5.1 10.8 6.3 6.7 3.4 5.8 3.5 4.9 4.0 5.9 5.8 9.2 1.9 18.9 3.6 5.7 11.1 11.7 9.3 8.7 10.1 3.5 8.7 3.2 11.7 12.2 18.2 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 C1orf35 "MGC4174, MMTAG2" ENSG00000143793 "Chromosome 1 open reading frame 35" Q9BU76 1 228100726-228105411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046175 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Plasma membrane" Cytosol "HPA046175: AB_10959459" "unprognostic (1.12e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (7.71e-4)" "unprognostic (6.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.64e-2)" "unprognostic (5.44e-3)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "prognostic favourable (7.38e-4)" "unprognostic (6.12e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.70e-1)" "unprognostic (8.58e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" 10.1 12.7 14.3 15.6 17.0 12.7 12.0 23.9 15.7 12.5 11.2 11.6 16.1 12.5 13.7 10.6 17.3 14.9 8.1 8.0 13.8 10.0 10.6 10.2 11.0 12.5 17.7 13.6 19.0 21.0 12.5 10.0 12.4 15.0 13.2 6.4 10.4 19.1 16.1 14.0 24.1 11.3 13.3 9.2 12.6 13.2 8.8 13.2 14.6 12.4 6.9 12.0 12.8 13.9 20.2 26.7 21.9 18.4 17.6 21.5 10.3 9.5 10.7 6.8 4.1 3.7 3.8 16.0 7.4 3.4 6.6 4.8 9.6 9.1 9.3 16.0 2.5 10.7 6.4 7.1 2.4 10.6 34.1 5.8 7.4 9.4 6.2 12.9 7.3 3.3 8.5 6.3 6.1 7.2 14.7 5.2 4.9 11.3 17.2 16.5 13.4 24.8 12.2 10.8 15.4 5.7 7.2 12.0 11.3 6.9 11.1 9.5 13.2 12.1 6.3 5.2 7.7 13.7 15.6 9.6 4.9 8.7 6.3 7.6 8.1 6.3 16.3 21.9 16.2 18.4 20.9 20.2 18.1 17.7 20.4 16.7 21.5 18.1 2.2 17.6 17.5 26.7 18.0 10.3 14.3 17.0 23.9 15.7 13.8 10.0 17.7 13.6 15.0 13.2 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902647-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.5" "Lineage enriched" "Detected in many" 4 "monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065352 Approved Vesicles,Aggresome Vesicles Aggresome "HPA065352: " "prognostic favourable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 3.3 10.8 6.5 1.5 3.2 1.7 2.1 1.0 6.6 3.1 5.6 2.8 4.0 4.2 1.6 6.2 3.2 1.7 4.7 7.5 4.8 4.0 8.6 20.9 5.0 2.4 2.7 2.9 2.9 8.2 0.5 6.0 2.9 3.7 2.7 3.0 4.5 4.8 1.5 6.6 1.2 4.3 2.2 1.6 2.2 3.5 4.7 3.5 0.1 4.6 2.1 1.4 1.6 1.5 0.1 2.6 0.0 10.5 0.0 0.8 1.1 4.3 5.2 0.4 2.0 2.6 8.0 2.9 6.6 4.4 5.3 2.7 4.6 3.1 7.1 10.5 7.0 1.7 1.7 1.2 0.5 2.3 13.4 4.2 3.8 7.8 1.1 9.4 6.2 4.6 3.9 1.9 0.7 1.9 1.2 1.6 3.1 6.4 0.5 8.3 4.3 7.6 1.0 2.8 2.8 8.2 6.2 15.8 11.8 8.2 1.5 2.4 3.6 3.6 4.5 6.3 7.2 8.8 3.8 3.2 2.4 1.7 4.1 2.8 6.4 0.0 3.6 0.0 0.4 10.5 0.0 0.0 0.2 0.8 2.6 0.1 0.4 0.4 0.0 0.0 5.1 0.7 0.1 1.1 6.5 3.2 1.0 6.6 4.8 4.0 2.7 2.9 3.7 3.5 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavourable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 2.5 3.9 5.7 5.5 8.5 2.3 5.8 10.4 8.9 2.7 3.8 5.8 4.0 3.3 2.3 5.2 10.4 2.8 2.3 4.1 3.7 2.9 4.9 4.1 2.2 9.8 5.1 4.6 2.5 4.5 4.5 6.5 3.4 4.8 4.6 5.2 3.9 5.1 2.7 2.3 15.0 4.1 2.4 4.9 4.9 3.9 3.9 5.0 4.9 3.2 0.0 5.7 3.9 4.7 6.3 5.5 5.9 1.9 2.8 2.9 1.9 5.6 3.0 1.9 1.1 2.6 2.9 4.4 3.2 4.2 3.9 4.1 5.9 4.4 5.9 1.9 2.1 11.4 1.2 9.3 4.6 5.9 3.8 3.9 2.2 0.5 3.6 5.5 1.8 1.7 8.3 4.8 8.0 2.3 7.7 4.3 3.4 2.8 4.6 5.7 7.9 5.1 4.9 9.0 8.3 3.3 4.9 7.6 8.2 4.4 3.4 4.8 5.3 2.9 2.1 3.4 3.9 3.4 5.1 4.0 4.0 6.6 3.0 4.6 4.7 5.9 1.6 1.4 2.9 1.9 2.1 3.8 1.4 2.3 3.2 6.3 2.4 2.8 1.1 2.8 1.0 5.5 1.2 1.9 5.7 8.5 10.4 8.9 3.7 2.9 5.1 4.6 4.8 5.0 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Group enriched" "Detected in some" 7 "NTERA-2: 11.2;U-87 MG: 32.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 C1QBP "gC1Q-R, gC1qR, HABP1, p32, SF2p32" ENSG00000108561 "Complement C1q binding protein" Q07021 17 5432777-5448830 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026483 Supported Approved "Plasma membrane,Mitochondria" "Intracellular and membrane" 930000 "Plasma membrane" Mitochondria "HPA026483: AB_1847108" "unprognostic (2.18e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (6.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.76e-2)" "unprognostic (7.47e-2)" "unprognostic (4.62e-2)" "unprognostic (2.40e-3)" "unprognostic (6.03e-2)" "unprognostic (4.60e-3)" "unprognostic (3.08e-2)" "unprognostic (7.80e-3)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-1)" "unprognostic (3.97e-1)" 24.1 51.6 34.0 51.0 31.4 36.3 42.3 25.8 46.2 22.0 48.8 21.1 22.5 33.9 25.8 25.7 51.1 27.1 33.0 47.1 34.8 35.4 48.4 69.0 26.6 81.1 35.4 25.1 25.2 51.9 32.7 31.2 26.7 36.6 23.8 52.2 24.9 25.1 28.0 55.0 27.3 30.0 29.2 27.8 43.8 26.4 21.3 17.2 55.4 28.1 71.9 46.0 25.5 25.4 59.5 68.1 9.9 35.8 39.0 55.6 65.7 48.8 76.0 26.9 43.4 20.1 24.8 36.4 37.5 30.7 87.4 53.8 72.7 16.4 105.0 37.1 28.3 43.8 86.4 50.9 80.9 24.0 148.7 48.3 39.5 84.5 32.1 58.9 38.5 27.4 46.8 48.0 69.5 44.5 57.4 26.9 33.9 34.1 83.6 42.6 60.6 45.5 66.7 38.1 57.3 50.4 37.0 21.6 40.5 30.8 39.6 52.2 25.0 29.8 26.1 28.1 25.6 31.9 81.4 14.1 21.5 46.2 26.8 56.7 43.0 9.9 34.7 8.3 40.1 35.8 52.5 59.5 45.0 39.9 68.1 49.4 55.6 46.3 2.8 39.0 26.9 56.9 34.3 65.7 34.0 31.4 25.8 46.2 34.8 35.4 35.4 25.1 36.6 17.2 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Cell line enhanced" "Detected in many" "ASC diff: 82.7;BJ hTERT+: 19.4;HHSteC: 31.3;HSkMC: 16.6;U-87 MG: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" 313900000 30000 Nucleoplasm Cytosol "CAB025429: , HPA051101: " "unprognostic (2.58e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavourable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.0 0.0 0.0 82.7 7.4 0.0 4.1 19.4 1.7 3.4 0.6 3.9 0.0 0.4 1.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.0 0.3 31.3 0.0 0.0 16.6 0.0 3.7 0.2 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 8.4 0.0 5.4 0.0 0.0 0.1 0.3 1.5 2.6 0.4 7.7 0.0 0.0 0.3 8.8 0.2 0.9 1.2 0.0 0.0 0.0 19.5 0.0 0.7 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 C1QTNF2 CTRP2 ENSG00000145861 "C1q and TNF related 2" Q9BXJ5 5 160347751-160370641 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 26.0;U-138 MG: 11.6;U-2 OS: 6.3;WM-115: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061290 Uncertain Approved "Golgi apparatus,Centrosome" "Secreted to blood" "Golgi apparatus, Centrosome" "HPA061290: " "unprognostic (2.28e-2)" "unprognostic (5.61e-2)" "unprognostic (4.09e-2)" "unprognostic (4.53e-2)" "unprognostic (8.92e-3)" "unprognostic (6.20e-2)" "unprognostic (1.46e-1)" "unprognostic (1.94e-1)" "unprognostic (5.91e-2)" "unprognostic (8.33e-2)" "unprognostic (3.23e-2)" "unprognostic (8.32e-2)" "unprognostic (2.11e-5)" "unprognostic (5.40e-5)" "unprognostic (1.14e-1)" "unprognostic (6.75e-2)" "unprognostic (1.10e-2)" 5.5 2.1 2.1 1.9 5.2 0.6 5.6 4.4 4.9 9.5 4.9 1.1 1.3 3.4 10.9 6.9 6.8 4.9 9.3 8.5 2.0 1.8 1.3 1.0 5.0 1.1 1.4 3.0 2.9 0.9 0.6 1.2 2.4 1.0 7.7 3.4 14.3 3.4 9.6 4.8 3.0 4.6 6.4 1.3 1.7 4.3 5.8 1.5 0.0 4.3 12.1 1.3 6.0 5.8 0.6 0.4 3.7 0.1 1.0 0.2 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.0 2.9 3.9 0.7 2.5 0.1 0.6 0.0 0.1 1.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 26.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.2 11.6 6.3 1.1 3.1 0.1 0.0 0.0 0.4 0.0 5.1 3.7 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.6 0.2 0.2 1.1 1.0 0.1 0.4 0.1 0.1 2.1 5.2 4.4 4.9 2.0 1.8 1.4 3.0 1.0 1.5 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Cell line enhanced" "Detected in many" "ASC diff: 177.7;ASC TERT1: 90.7;BJ hTERT+: 78.2;BJ hTERT+ SV40 Large T+ RasG12V: 48.2;HSkMC: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" 14000000000 "Nucleoplasm, Cytosol" "HPA001251: , HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavourable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 177.7 90.7 0.1 19.9 78.2 23.7 48.2 0.2 0.3 0.0 0.6 15.6 0.2 1.7 0.8 3.3 1.8 0.1 0.0 0.6 0.6 34.2 0.1 0.2 105.0 0.5 10.8 0.8 0.4 0.0 2.5 3.1 0.0 0.8 0.1 0.8 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.4 0.4 0.4 0.0 0.0 0.0 5.6 0.9 26.1 0.1 0.1 0.4 0.0 8.1 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 C1RL "C1r-LP, C1RL1" ENSG00000139178 "Complement C1r subcomponent like" Q9NZP8 12 7089587-7109273 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.6;HSkMC: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA011338, CAB026172" Supported Approved Microtubules,Cytosol "Secreted to blood" 5500000000 20000000000 Microtubules Cytosol "CAB026172: , HPA011338: AB_1847111" "prognostic favourable (7.92e-4)" "unprognostic (7.76e-2)" "unprognostic (3.91e-3)" "unprognostic (5.25e-3)" "unprognostic (2.92e-3)" "unprognostic (9.60e-2)" "unprognostic (2.75e-3)" "unprognostic (7.76e-2)" "unprognostic (1.22e-1)" "unprognostic (4.34e-1)" "unprognostic (9.58e-3)" "unprognostic (1.57e-1)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.75e-1)" "unprognostic (5.74e-2)" "unprognostic (2.52e-1)" "unprognostic (2.26e-3)" 16.5 31.2 3.8 10.0 5.5 6.1 14.2 1.2 4.9 12.1 13.5 3.2 10.5 6.0 12.4 14.9 13.3 14.5 14.7 10.0 2.5 1.6 21.4 96.1 14.2 13.1 4.5 2.7 21.3 23.8 5.2 15.7 4.2 6.4 16.5 7.2 11.3 16.9 11.5 11.1 7.8 9.5 15.4 9.3 12.7 11.1 7.2 4.7 2.8 14.4 8.1 7.0 15.5 16.4 2.2 1.7 11.7 2.5 0.6 1.4 0.9 2.2 5.9 0.6 5.9 18.4 31.6 4.2 3.7 17.2 3.6 11.3 3.8 10.3 0.9 3.2 2.9 5.0 1.6 6.4 1.5 9.3 0.3 3.5 5.9 8.8 14.9 0.7 17.2 35.0 12.0 2.3 7.4 3.9 2.8 2.2 2.3 0.1 0.5 0.7 1.1 0.1 2.0 0.0 0.7 10.5 10.0 0.4 1.3 12.6 1.5 2.2 1.5 3.1 3.3 3.4 6.3 3.9 0.6 1.7 0.7 0.1 6.4 2.5 1.5 7.2 1.5 8.0 1.4 2.3 0.6 2.2 1.4 1.0 1.7 1.1 0.9 0.8 11.7 0.6 2.5 0.9 0.8 0.9 3.8 5.5 1.2 4.9 2.5 1.6 4.5 2.7 6.4 4.7 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 351.6" "Cell line enhanced" "Detected in some" "ASC diff: 97.0;ASC TERT1: 129.2;BJ hTERT+: 41.1;HSkMC: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 17 "granulocytes: 6.2" "Low region specificity" "Detected in all" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" 93000000000 13000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favourable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 48.7 16.6 3.3 18.7 4.1 0.0 55.7 1.9 3.1 35.3 31.1 2.9 12.7 6.8 32.2 50.0 38.3 46.4 47.2 34.4 2.5 1.1 18.0 351.6 31.4 21.1 6.3 3.2 98.8 15.5 1.9 6.0 8.5 6.5 52.1 18.6 26.1 14.6 12.4 18.2 14.7 19.2 47.6 8.8 32.5 24.6 37.2 2.3 3.2 30.5 22.7 18.8 48.6 73.0 0.2 0.1 6.2 0.3 0.2 0.1 0.0 0.0 2.2 0.1 1.2 97.0 129.2 0.4 17.5 41.1 9.3 17.0 0.0 0.2 0.0 2.4 21.7 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.6 4.6 29.2 0.2 0.1 68.6 0.3 7.5 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 10.6 0.2 0.2 0.0 0.0 0.0 4.3 0.3 16.5 0.0 0.0 0.0 0.1 9.3 0.1 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 6.2 0.2 0.1 0.1 0.0 0.0 3.3 4.1 1.9 3.1 2.5 1.1 6.3 3.2 6.5 2.3 C20orf194 DKFZp434N061 ENSG00000088854 "Chromosome 20 open reading frame 194" Q5TEA3 20 3249305-3407625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052103, HPA067418" Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA052103: , HPA067418: " "unprognostic (9.77e-2)" "unprognostic (8.39e-2)" "unprognostic (5.03e-3)" "unprognostic (1.83e-1)" "unprognostic (1.18e-1)" "unprognostic (4.26e-2)" "unprognostic (1.66e-2)" "unprognostic (7.64e-2)" "unprognostic (6.41e-2)" "unprognostic (1.68e-1)" "prognostic favourable (1.68e-4)" "unprognostic (2.97e-1)" "prognostic favourable (7.68e-4)" "unprognostic (9.58e-3)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (7.52e-2)" 15.2 13.4 18.5 6.9 20.1 4.6 11.9 20.3 21.9 12.6 11.8 25.3 7.3 5.8 12.5 9.7 11.7 12.8 11.3 19.4 16.3 17.2 14.2 3.7 13.3 5.7 16.5 20.3 17.2 7.5 8.5 10.4 12.2 17.4 12.2 6.4 10.9 6.0 16.5 36.8 7.5 6.0 17.2 23.0 9.5 9.1 13.5 16.9 4.6 13.2 4.0 4.3 12.2 11.0 1.6 3.5 1.0 3.0 0.0 1.7 0.7 2.8 2.6 7.3 3.5 15.2 16.9 0.8 6.8 7.7 4.6 5.8 0.0 3.2 0.0 1.9 9.0 3.4 2.7 6.7 6.3 0.6 1.4 0.8 1.0 7.2 7.1 0.9 0.4 13.7 5.3 6.0 5.2 9.1 1.4 0.0 6.6 1.3 1.8 4.7 2.2 1.7 2.1 6.6 0.0 5.9 5.9 1.5 4.3 3.0 5.4 8.8 5.1 8.3 10.1 5.7 2.5 3.5 3.3 0.0 0.0 0.0 1.8 0.8 4.3 1.0 3.0 0.0 1.7 1.5 1.0 1.0 1.3 1.7 3.1 1.6 0.5 1.3 0.0 0.0 1.4 3.5 1.4 0.7 18.5 20.1 20.3 21.9 16.3 17.2 16.5 20.3 17.4 16.9 C20orf196 FLJ25067 ENSG00000171984 "Chromosome 20 open reading frame 196" Q8IYI0 20 5750393-5863912 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 30.4;U-698: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040749 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" "HPA040749: AB_10673093" "unprognostic (2.03e-1)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "unprognostic (4.20e-3)" "unprognostic (6.15e-2)" "unprognostic (1.66e-1)" "unprognostic (1.72e-3)" "unprognostic (6.66e-2)" "unprognostic (9.04e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-2)" "unprognostic (7.59e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "prognostic favourable (4.05e-5)" 5.4 13.9 7.1 15.5 7.3 17.8 8.1 10.6 8.7 6.8 7.9 9.2 12.6 11.9 7.7 8.7 7.4 6.7 8.0 12.3 7.0 7.0 6.9 4.1 9.3 17.6 8.9 6.7 7.7 11.1 2.8 10.6 5.1 6.9 8.7 7.4 10.9 19.1 12.9 15.1 5.6 13.7 6.7 7.1 14.2 6.2 4.2 7.8 20.4 9.6 9.4 16.8 6.4 6.6 21.7 10.9 15.6 10.8 16.2 22.7 10.2 4.7 6.0 3.0 1.3 1.9 1.5 1.3 1.4 2.4 1.9 2.8 2.7 5.4 18.7 3.6 1.4 2.2 1.9 3.5 2.2 5.6 2.3 6.8 0.9 10.1 4.2 8.2 3.2 2.4 5.1 2.9 1.9 3.8 9.5 7.5 3.4 2.1 11.4 30.4 3.6 3.2 9.4 4.0 8.4 2.8 2.4 4.8 4.5 2.8 2.7 5.5 2.1 8.7 2.2 2.1 3.0 1.9 3.0 5.2 8.7 24.8 1.0 8.6 3.6 11.2 8.7 15.6 17.0 10.4 13.2 19.7 19.5 16.7 9.2 21.7 18.8 13.4 3.9 16.2 10.8 10.9 22.7 10.2 7.1 7.3 10.6 8.7 7.0 7.0 8.9 6.7 6.9 7.8 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol 87000 "Nucleoplasm, Cytosol" "HPA047483: " "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.0 36.1 5.7 24.0 11.7 6.5 8.9 8.8 5.8 16.3 12.0 24.7 13.0 21.4 8.6 10.3 29.4 15.1 22.1 6.2 4.9 27.1 12.1 7.3 44.0 8.4 17.3 5.3 9.1 9.3 20.8 10.4 11.0 21.4 13.5 8.4 48.2 22.9 41.3 24.4 48.9 17.7 13.9 25.3 10.2 12.4 25.4 11.6 8.0 35.8 17.6 7.9 21.8 6.7 22.9 15.8 36.2 26.9 10.4 17.3 15.9 6.8 32.9 11.1 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favourable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 7.8 3.3 3.2 4.1 2.1 1.4 12.6 4.1 2.4 1.6 0.9 6.0 2.4 5.7 8.2 1.4 3.8 0.6 0.7 0.4 8.6 8.2 5.9 2.6 7.0 2.8 6.3 6.4 1.9 1.4 0.7 1.4 1.0 7.2 9.8 1.0 9.8 6.9 15.6 8.0 5.1 17.8 4.1 12.7 1.9 11.6 8.4 7.8 5.7 1.3 6.8 6.1 14.0 4.6 3.6 4.6 3.8 3.0 16.1 8.4 3.9 8.8 12.8 6.4 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 C21orf33 "D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI" ENSG00000160221 "Chromosome 21 open reading frame 33" P30042 21 44133605-44210114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.0;U-266/70: 36.5;U-266/84: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018517 Supported Approved Centrosome,Mitochondria "Intracellular and membrane" 1800000 Mitochondria Centrosome "HPA018517: " "unprognostic (9.61e-3)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-3)" "unprognostic (6.57e-2)" "unprognostic (8.19e-2)" "unprognostic (1.36e-2)" "unprognostic (8.61e-3)" "unprognostic (9.43e-2)" "unprognostic (4.60e-3)" "unprognostic (1.97e-3)" "unprognostic (1.40e-1)" "unprognostic (6.96e-2)" "unprognostic (1.30e-2)" 16.0 9.6 9.1 6.1 11.4 2.2 7.2 7.9 16.6 5.1 11.7 11.6 12.4 3.0 6.6 22.8 7.6 7.3 5.2 29.2 8.4 8.7 31.6 36.8 8.5 9.9 10.9 9.2 6.7 15.7 2.0 6.5 5.6 8.3 11.0 1.9 6.6 8.8 8.0 45.9 13.4 7.7 7.6 7.3 8.9 13.7 11.8 5.1 5.8 7.1 21.0 15.2 5.1 4.7 22.5 12.3 8.9 20.7 14.7 15.6 23.9 0.4 1.6 0.9 0.2 9.3 8.9 13.9 18.1 10.3 14.3 10.9 21.7 0.2 43.0 0.3 0.1 0.2 0.1 8.6 6.4 9.5 20.9 1.2 3.5 11.6 10.4 0.6 0.3 0.1 0.9 3.9 0.7 0.7 8.1 13.6 5.0 1.6 0.4 1.2 0.4 0.6 0.4 0.1 15.2 0.9 0.3 14.3 0.2 0.2 0.5 14.0 1.0 1.5 8.8 5.5 0.3 10.8 0.1 36.5 30.4 0.9 0.5 2.8 6.5 8.9 11.3 6.8 13.0 13.3 11.3 22.5 15.5 15.6 4.6 21.6 14.8 12.8 5.1 14.7 20.7 12.3 14.6 23.9 9.1 11.4 7.9 16.6 8.4 8.7 10.9 9.2 8.3 5.1 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1" "Cell line enhanced" "Detected in many" "REH: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.2" "Low lineage specificity" "Detected in many" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: " "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favourable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavourable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favourable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.3 1.8 2.2 4.3 5.0 11.1 5.2 3.6 3.1 3.2 3.5 4.6 3.3 4.7 2.2 9.7 3.1 27.2 3.2 2.6 2.9 2.9 1.3 1.3 9.1 5.9 2.9 1.8 8.0 3.2 1.4 25.1 2.1 5.8 2.3 2.7 1.9 2.5 1.7 1.6 5.3 4.3 1.5 1.8 2.8 3.7 5.7 2.2 22.7 1.8 2.1 4.6 1.7 2.1 2.1 1.8 8.2 0.5 0.7 1.8 0.9 12.2 5.6 14.9 9.3 1.5 2.0 8.3 7.6 2.8 5.3 5.2 2.6 9.0 8.9 1.9 2.1 9.9 4.0 3.2 1.6 9.2 8.7 14.3 14.7 1.4 0.3 4.0 8.2 0.9 0.7 3.8 0.9 3.3 8.1 23.7 4.3 5.0 19.9 5.5 6.4 2.8 29.6 6.7 7.9 1.6 2.3 12.3 7.7 5.7 4.1 1.8 10.0 8.1 2.3 3.3 9.4 3.2 4.5 9.6 4.2 4.2 5.8 17.7 8.5 8.2 0.5 1.1 0.9 0.3 0.5 0.2 1.1 1.2 0.1 2.1 1.8 1.4 0.7 0.7 0.2 1.8 1.3 0.9 2.2 5.0 3.6 3.1 2.9 2.9 2.9 1.8 5.8 2.2 C21orf91 "C21orf14, C21orf38, CSSG1, EURL, YG81" ENSG00000154642 "Chromosome 21 open reading frame 91" Q9NYK6 21 17788967-17819386 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018288, HPA049030" Approved Approved "Microtubules,Cytokinetic bridge" Microtubules "Cytokinetic bridge" "HPA018288: AB_1845710, HPA049030: " "unprognostic (3.28e-1)" "unprognostic (3.41e-2)" "unprognostic (3.12e-2)" "unprognostic (4.51e-2)" "unprognostic (6.19e-2)" "unprognostic (1.11e-3)" "unprognostic (2.42e-1)" "unprognostic (8.81e-3)" "unprognostic (2.79e-1)" "unprognostic (1.97e-1)" "unprognostic (3.25e-1)" "unprognostic (5.49e-2)" "unprognostic (1.24e-2)" "unprognostic (6.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.49e-2)" "unprognostic (9.90e-3)" 7.2 5.6 9.6 9.3 21.7 7.4 8.3 2.9 14.1 6.9 5.2 31.7 2.0 5.1 9.7 4.6 9.4 7.0 6.1 5.4 15.7 8.8 5.5 8.8 8.8 14.3 27.3 8.0 8.6 4.0 6.9 5.3 19.1 23.6 5.6 5.4 2.0 8.1 4.2 4.6 19.0 5.9 7.7 34.2 9.4 6.2 23.9 25.8 22.2 5.8 5.2 12.8 9.9 6.5 6.0 5.8 34.2 5.0 8.8 15.1 4.9 2.9 0.4 6.6 0.0 1.7 3.2 2.9 4.3 7.7 4.3 3.8 2.5 1.5 10.2 2.1 1.7 2.3 7.1 5.6 3.7 11.1 3.8 6.7 5.9 1.6 3.8 8.2 3.9 2.3 6.1 5.6 9.1 1.1 4.7 45.8 3.1 1.8 11.4 2.5 6.9 2.4 8.9 12.7 4.1 2.8 5.0 2.6 6.0 4.9 4.3 19.4 2.5 4.6 2.0 19.0 5.9 0.1 2.7 12.1 14.8 8.8 1.5 7.7 7.2 34.2 4.8 23.4 9.6 5.0 13.7 6.0 8.9 10.2 5.8 5.1 7.0 9.2 10.7 8.8 4.9 1.4 15.1 4.9 9.6 21.7 2.9 14.1 15.7 8.8 27.3 8.0 23.6 25.8 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoplasm Nucleoli "HPA052741: " "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favourable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.7 4.5 11.0 6.7 8.1 8.6 9.9 7.4 8.0 6.3 8.5 4.5 5.7 5.5 5.4 6.1 4.1 5.6 5.7 7.6 19.5 5.3 6.0 9.3 3.7 4.7 4.4 11.9 6.8 7.7 10.5 7.5 1.6 9.8 8.1 5.5 14.4 3.5 5.4 4.5 3.5 5.1 9.1 6.0 5.4 6.0 2.7 4.2 8.6 7.8 11.1 9.0 5.5 4.3 8.3 14.2 4.4 3.9 17.3 17.6 5.1 5.0 5.4 11.2 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 C2CD3 DKFZP586P0123 ENSG00000168014 "C2 calcium dependent domain containing 3" Q4AC94 11 74012714-74171210 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 14.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038552, HPA038553, HPA040433" Approved Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA038552: AB_10669542, HPA038553: , HPA040433: " "unprognostic (3.94e-1)" "unprognostic (7.89e-2)" "unprognostic (3.68e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (8.48e-5)" "unprognostic (1.99e-1)" "unprognostic (4.96e-3)" "unprognostic (2.20e-1)" "unprognostic (1.74e-1)" "unprognostic (5.86e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "unprognostic (3.11e-1)" "unprognostic (1.18e-1)" "unprognostic (2.92e-1)" 7.4 11.9 10.5 13.5 11.2 17.3 8.4 14.9 11.8 8.1 6.8 14.3 4.4 6.3 10.9 10.3 7.8 12.5 6.4 8.3 9.6 6.5 8.5 8.4 9.7 8.5 12.0 8.1 10.2 6.9 17.5 15.0 13.5 11.4 8.6 9.0 10.4 8.5 7.9 6.9 9.7 7.3 7.2 11.3 10.0 7.7 19.9 13.2 16.7 13.1 4.2 12.1 8.1 9.7 5.3 2.0 14.8 3.2 3.3 2.6 0.5 5.6 11.1 8.2 9.9 4.8 4.3 3.8 8.2 5.9 10.8 9.4 15.5 4.5 5.8 6.1 5.0 10.0 9.1 3.9 12.7 9.6 4.6 8.4 12.5 6.1 5.2 9.5 13.2 3.1 3.7 11.3 6.6 6.7 8.4 11.4 9.5 5.4 10.2 5.1 5.7 5.4 8.7 38.6 6.3 3.2 9.0 9.9 6.4 15.6 5.5 12.3 9.6 5.2 7.3 7.7 11.9 8.1 7.3 8.9 6.1 18.0 2.7 5.6 8.5 14.8 1.9 2.2 2.6 2.2 2.2 2.3 1.5 2.1 1.0 5.3 2.0 1.9 13.1 3.3 3.2 2.0 1.0 0.5 10.5 11.2 14.9 11.8 9.6 6.5 12.0 8.1 11.4 13.2 C2CD5 "CDP138, KIAA0528" ENSG00000111731 "C2 calcium dependent domain containing 5" Q86YS7 12 22448583-22544546 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046194 Approved Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA046194: AB_10965327" "unprognostic (2.59e-1)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.17e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-3)" "unprognostic (1.17e-2)" "unprognostic (8.47e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (2.05e-1)" "unprognostic (1.87e-3)" 10.2 11.2 18.9 16.3 26.6 11.8 13.6 48.5 30.7 13.1 18.5 10.0 10.0 17.8 15.6 12.3 10.4 15.8 15.4 8.8 14.6 16.5 15.7 7.8 11.2 13.8 13.5 22.8 17.4 12.3 23.3 26.2 9.3 26.9 10.3 20.0 13.3 12.7 10.0 8.0 11.7 14.8 12.7 10.8 15.0 19.2 12.9 12.9 18.7 15.5 4.9 14.3 11.7 11.8 7.3 6.1 15.3 14.1 12.8 8.0 4.3 8.6 8.6 19.2 10.4 12.7 16.9 12.2 9.6 10.4 18.0 21.5 9.4 11.6 9.9 4.3 9.0 7.8 12.2 7.9 25.2 15.9 12.7 12.2 9.4 8.4 11.7 16.4 14.7 9.6 5.7 11.5 20.3 13.0 7.9 6.4 11.6 9.3 15.4 25.2 38.1 6.5 13.5 21.2 13.3 10.6 7.1 8.9 7.7 8.7 8.5 9.1 11.3 11.0 11.2 10.8 8.8 9.7 10.1 5.2 4.0 15.9 6.7 12.5 7.9 15.3 6.1 2.9 5.5 13.5 7.2 7.3 8.0 5.4 6.1 5.0 7.2 5.7 6.2 12.8 14.1 3.5 8.0 4.3 18.9 26.6 48.5 30.7 14.6 16.5 13.5 22.8 26.9 12.9 C2orf49 "asw, MGC5509" ENSG00000135974 "Chromosome 2 open reading frame 49" Q9BVC5 2 105337359-105349211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043846, HPA060814" Approved Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA043846: , HPA060814: " "unprognostic (4.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.06e-1)" "unprognostic (6.16e-3)" "unprognostic (2.57e-3)" "unprognostic (8.75e-3)" "unprognostic (1.89e-3)" "unprognostic (6.51e-2)" "unprognostic (5.01e-2)" "unprognostic (2.07e-1)" "unprognostic (2.56e-1)" "unprognostic (5.94e-2)" "prognostic unfavourable (5.06e-5)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.04e-2)" 15.9 14.8 17.2 15.8 20.4 24.3 17.3 25.6 22.4 19.7 15.0 21.9 19.9 13.4 22.0 13.5 18.6 19.0 14.2 21.3 20.0 16.0 13.4 15.0 14.0 16.9 25.3 19.9 30.7 19.3 13.0 12.0 19.2 18.1 17.2 15.1 12.4 15.9 17.2 28.2 14.3 14.8 18.3 22.9 15.3 19.7 19.2 22.1 26.5 18.8 13.1 18.8 18.1 21.2 16.7 18.4 17.9 13.5 8.2 11.7 6.4 14.9 10.7 13.5 13.6 15.2 18.7 24.1 15.1 15.7 13.3 18.4 23.3 15.0 17.6 18.9 12.8 14.4 18.4 12.8 17.4 22.9 14.1 19.1 9.2 17.9 18.8 15.8 15.8 13.5 22.3 18.8 17.1 11.9 26.5 14.6 18.7 11.6 19.2 18.3 17.6 12.9 12.8 19.9 20.1 14.9 14.4 16.0 12.8 13.3 12.1 17.5 11.8 17.9 19.5 14.2 19.9 10.1 12.2 18.6 15.0 18.6 14.2 16.1 13.7 10.2 13.5 11.1 9.4 7.9 9.2 14.3 10.5 9.1 8.8 16.7 11.7 9.8 17.9 8.2 10.6 18.4 11.6 6.4 17.2 20.4 25.6 22.4 20.0 16.0 25.3 19.9 18.1 22.1 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Group enriched" "Detected in some" 6 "CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.1 1.3 0.1 0.1 0.0 15.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 3.1 1.0 0.0 0.0 56.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: " "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavourable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.5 8.0 13.1 9.9 13.5 6.7 8.9 3.9 5.2 6.5 8.8 7.1 10.4 11.6 6.0 7.2 9.5 7.2 7.9 7.1 6.1 15.0 19.9 11.7 7.4 11.1 10.7 10.5 10.2 9.1 4.9 13.1 10.7 10.0 13.1 6.3 9.7 12.1 10.4 6.2 6.9 13.6 25.0 11.4 8.4 9.1 16.8 12.1 6.1 8.1 7.9 9.2 5.4 6.3 4.7 13.1 5.3 3.7 16.9 11.8 10.8 7.0 10.8 5.7 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 C2orf70 LOC339778 ENSG00000173557 "Chromosome 2 open reading frame 70" A6NJV1 2 26562582-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.5;testis: 44.9" "Cell line enhanced" "Detected in some" "A-431: 7.3;CAPAN-2: 5.6;EFO-21: 3.6;RPTEC TERT1: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA062453: " "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favourable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.3 1.1 0.3 2.2 0.0 0.3 0.1 0.8 0.5 1.0 3.1 2.3 0.3 0.4 5.2 0.2 11.5 0.6 1.4 1.1 2.7 0.7 0.1 1.0 0.1 0.8 0.7 2.7 4.5 0.0 1.2 0.1 4.4 0.4 0.6 0.0 3.1 1.7 0.2 0.1 0.2 0.1 0.7 0.1 7.6 44.9 0.5 0.0 3.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.0 3.6 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 1.7 0.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.1 0.8 1.1 2.7 0.8 0.7 4.4 0.5 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;SH-SY5Y: 2.2" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favourable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavourable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.9;testis: 20.0" "Cell line enhanced" "Detected in many" "MCF7: 11.9;RPMI-8226: 11.3;SCLC-21H: 14.8;SH-SY5Y: 16.2" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.2" "Low lineage specificity" "Detected in many" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: " 0.4 0.9 2.2 1.2 5.5 0.5 0.9 1.2 3.4 1.3 0.8 2.6 8.2 0.9 2.2 4.9 1.6 17.9 2.0 0.7 2.1 1.9 0.0 2.5 3.0 0.0 2.8 3.2 1.6 4.9 13.7 1.0 1.9 1.8 0.2 3.2 1.3 3.5 0.8 0.3 1.1 0.7 0.0 2.1 1.7 20.0 0.8 5.3 2.1 0.7 1.9 1.9 0.0 6.5 13.2 0.2 1.8 3.1 3.4 1.3 3.5 6.5 2.0 7.2 2.2 1.9 0.7 0.6 2.1 0.6 0.7 0.4 4.0 8.4 1.6 1.0 1.3 0.1 1.7 0.7 4.7 0.5 0.9 0.5 0.1 1.1 1.7 1.9 1.1 4.3 0.8 0.8 0.0 0.3 1.3 1.1 11.9 2.2 4.4 3.9 1.4 1.1 0.7 11.3 2.6 1.5 14.8 16.2 2.0 3.2 0.9 3.0 1.6 0.1 0.7 3.2 2.2 1.8 3.1 5.5 2.7 4.5 1.7 1.5 0.1 1.8 0.0 0.6 1.8 0.3 5.7 0.7 0.8 6.2 6.5 3.4 1.5 0.2 3.1 1.4 13.2 0.6 1.3 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62318973-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA048286: " "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favourable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 3.8 14.7 28.2 5.6 23.6 1.0 35.0 16.4 31.2 5.0 3.9 7.7 2.5 3.3 5.5 6.8 11.0 4.1 6.8 4.6 20.9 22.0 9.6 2.9 6.4 5.0 19.9 20.5 8.2 6.3 2.3 19.0 4.8 25.9 17.8 4.1 4.1 5.0 5.6 1.0 12.0 2.7 6.8 15.2 3.0 6.1 20.9 8.1 1.2 9.2 3.8 8.2 13.5 3.4 3.7 6.7 5.2 21.0 0.7 6.1 2.1 0.0 5.7 6.9 0.0 5.0 7.3 5.3 9.3 5.6 11.8 11.7 0.0 8.4 0.0 0.0 6.3 1.5 0.0 5.9 9.1 0.0 3.9 5.1 0.0 0.0 3.4 0.0 11.0 3.3 8.0 13.3 10.9 5.7 0.6 0.0 11.6 105.2 0.0 0.0 8.7 11.8 0.0 0.0 2.8 9.6 16.0 12.1 10.2 6.2 22.3 8.6 9.0 5.7 0.1 5.8 0.0 26.9 9.3 5.7 0.0 0.0 5.6 0.0 20.2 5.2 4.3 0.4 0.2 14.3 0.1 3.7 3.6 2.8 4.6 1.1 1.0 0.7 0.3 0.7 21.0 6.7 6.1 2.1 28.2 23.6 16.4 31.2 20.9 22.0 19.9 20.5 25.9 8.1 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 4 "Daudi: 5.6;HEL: 11.9;U-698: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 11.9 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.5 0.8 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806351 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037663 Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favourable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 4.3 16.9 6.7 3.1 7.9 2.3 6.8 9.2 9.5 5.0 3.6 6.5 5.0 4.1 6.1 9.7 2.5 5.4 3.5 9.3 7.6 7.9 9.4 4.1 5.2 2.8 5.6 11.0 6.9 19.4 11.7 8.6 2.1 7.9 7.2 3.4 5.5 4.5 6.6 5.6 1.6 2.8 11.1 5.0 2.8 4.3 6.2 6.9 1.7 13.4 2.4 1.7 4.0 6.3 2.3 3.0 3.0 1.8 6.1 7.7 3.4 5.9 8.4 4.0 5.5 0.3 5.0 1.7 2.5 3.9 2.5 6.0 2.9 7.6 1.1 6.1 2.5 0.9 4.0 0.1 4.5 2.9 5.9 3.6 1.3 7.6 7.0 4.9 1.2 3.9 4.4 2.6 5.2 4.2 5.7 2.8 4.3 4.3 5.2 4.4 5.3 1.8 5.3 2.1 5.8 13.9 2.8 3.0 4.1 5.7 7.6 5.1 10.5 6.4 2.7 2.8 2.1 6.0 6.3 4.8 4.5 0.0 2.0 4.6 2.9 3.0 1.8 0.2 6.2 1.6 7.7 2.3 4.9 5.5 3.0 2.2 6.2 6.4 0.1 6.1 1.1 2.4 3.2 3.4 6.7 7.9 9.2 9.5 7.6 7.9 5.6 11.0 7.9 6.9 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Group enriched" "Detected in some" 5 "EFO-21: 6.4;HeLa: 1.6;TIME: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA046432 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: " "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: , HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favourable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavourable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.3 6.6 12.9 6.9 8.6 7.8 5.9 10.3 12.3 15.3 20.8 7.5 8.7 8.5 9.2 9.4 4.6 9.3 7.5 13.2 15.2 4.4 10.4 5.1 6.4 12.3 14.2 9.0 11.2 7.6 10.3 8.8 8.8 6.6 9.7 16.6 7.3 14.3 6.0 15.6 7.4 9.0 4.5 8.0 10.1 8.6 3.9 5.7 9.4 5.1 15.4 9.9 10.8 8.0 9.6 10.4 58.0 11.3 9.0 13.3 12.6 7.4 11.3 8.9 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell line enhanced" "Detected in some" "A-431: 3.5;ASC TERT1: 2.1;BJ: 4.5;LHCN-M2: 2.7;SCLC-21H: 3.0;U-251 MG: 2.9;U-87 MG: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.3 2.1 0.0 4.5 0.8 0.1 0.2 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.9 0.0 0.0 1.2 2.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 C4orf33 FLJ33703 ENSG00000151470 "Chromosome 4 open reading frame 33" Q8N1A6 4 129093317-129116640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 23.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061199 Uncertain Approved "Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nuclear bodies" "HPA061199: " "unprognostic (7.27e-2)" "unprognostic (8.84e-2)" "unprognostic (3.50e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.07e-2)" "unprognostic (5.82e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (1.34e-2)" "unprognostic (3.55e-2)" "unprognostic (5.14e-2)" "prognostic favourable (3.04e-4)" "unprognostic (2.09e-2)" "unprognostic (2.54e-1)" "unprognostic (9.89e-2)" "prognostic favourable (2.49e-5)" 7.5 12.2 12.7 7.4 15.9 17.7 9.4 24.2 27.9 5.8 18.1 8.2 4.7 17.7 5.8 12.0 10.7 8.9 10.8 6.7 15.8 14.8 14.5 10.7 11.4 8.3 17.0 16.5 12.8 10.8 13.1 25.8 9.9 26.7 5.5 17.4 5.8 7.2 5.2 3.0 9.0 23.9 5.9 32.4 9.4 17.7 5.6 10.7 8.8 14.0 6.7 6.5 9.7 6.7 3.5 7.5 23.5 8.1 5.2 3.3 3.4 5.5 2.6 7.8 8.6 4.7 6.0 9.8 5.3 6.2 6.7 8.0 2.4 21.7 5.3 10.2 6.0 3.9 8.5 7.3 6.2 26.3 6.3 8.8 8.3 2.1 7.3 6.2 10.5 5.1 6.5 5.9 2.4 4.6 12.3 23.5 5.8 2.1 9.7 6.1 0.4 3.5 4.0 6.5 5.3 18.0 4.7 11.1 2.2 3.4 9.3 6.3 8.1 5.5 3.2 6.0 1.9 3.9 4.4 11.5 4.5 9.0 10.3 14.6 4.7 9.5 8.1 23.5 2.3 7.8 1.9 3.5 2.0 2.7 7.5 2.0 2.0 3.3 3.8 5.2 8.1 4.2 3.2 3.4 12.7 15.9 24.2 27.9 15.8 14.8 17.0 16.5 26.7 10.7 C5orf38 "CEI, IRX2NB" ENSG00000186493 "Chromosome 5 open reading frame 38" Q86SI9 5 2752131-2755397 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.9" "Cell line enhanced" "Detected in many" "BEWO: 37.4;HaCaT: 12.8;hTCEpi: 20.5;MCF7: 10.9;SiHa: 15.7;SK-BR-3: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073667 Approved "Golgi apparatus,Vesicles" "Secreted - unknown location" "Golgi apparatus, Vesicles" "HPA073667: " "unprognostic (5.00e-3)" "unprognostic (4.10e-2)" "unprognostic (1.71e-2)" "unprognostic (3.72e-5)" "unprognostic (4.08e-2)" "unprognostic (2.24e-2)" "unprognostic (2.67e-2)" "unprognostic (8.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-2)" "unprognostic (7.60e-2)" "unprognostic (3.84e-7)" "unprognostic (2.60e-2)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (5.60e-2)" 8.3 0.5 4.5 0.6 7.6 0.5 16.3 10.4 3.0 0.6 1.1 1.5 9.8 0.7 0.7 6.8 4.1 0.6 0.6 2.4 6.0 7.0 6.6 0.5 19.4 1.1 10.5 2.0 0.5 3.8 5.0 2.6 4.3 14.8 5.9 0.7 3.4 34.9 3.9 0.9 10.6 0.5 0.5 12.2 0.7 11.2 1.5 4.7 0.0 5.0 1.6 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 6.7 0.0 2.9 2.1 37.4 4.8 3.8 3.2 2.8 1.9 0.0 0.0 0.0 0.9 12.8 0.7 3.7 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 20.5 0.8 2.6 0.0 0.0 0.0 0.8 10.9 0.0 0.1 1.0 0.0 0.0 1.3 0.0 4.2 0.0 1.0 0.0 15.7 14.7 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.6 10.4 0.3 6.0 7.0 10.5 2.0 14.8 4.7 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Cell line enhanced" "Detected in some" "PC-3: 40.1;SiHa: 9.0;U-2 OS: 26.2;U-251 MG: 10.2" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058999 Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" "Nuclear speckles" Mitochondria "HPA058999: " "unprognostic (1.72e-1)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.1 0.0 0.0 0.0 4.7 26.2 0.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 C5orf51 LOC285636 ENSG00000205765 "Chromosome 5 open reading frame 51" A6NDU8 5 41904188-41921636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043779, HPA063816" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043779: , HPA063816: " "unprognostic (6.64e-2)" "unprognostic (2.24e-2)" "unprognostic (9.92e-2)" "unprognostic (6.92e-3)" "unprognostic (3.93e-2)" "unprognostic (3.41e-2)" "prognostic unfavourable (1.90e-4)" "unprognostic (4.98e-2)" "unprognostic (1.59e-1)" "unprognostic (4.90e-3)" "unprognostic (2.10e-2)" "unprognostic (4.58e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-1)" "unprognostic (3.75e-1)" "unprognostic (2.30e-2)" "unprognostic (1.67e-2)" 16.6 12.4 15.9 12.7 21.5 3.4 15.9 20.5 21.3 14.7 12.5 23.5 12.6 10.5 14.9 21.9 16.2 11.4 12.2 12.8 16.0 17.5 15.3 14.0 10.7 13.1 20.6 12.3 22.1 11.9 24.1 18.6 17.2 25.1 16.5 12.6 13.2 12.9 15.4 7.2 14.1 11.9 16.8 22.1 12.8 11.5 9.4 18.5 16.2 19.0 6.9 14.0 18.9 13.5 5.6 6.8 21.0 7.4 5.6 7.4 7.9 7.4 5.7 11.7 24.3 23.9 18.9 12.7 8.8 15.3 12.5 13.3 5.7 7.6 8.0 10.9 9.8 4.8 15.4 8.3 18.1 10.7 4.7 7.7 17.2 8.5 29.0 9.8 5.9 18.3 12.1 14.6 16.9 10.7 13.7 13.8 13.1 7.7 9.2 10.1 11.6 3.1 8.1 16.2 12.4 8.3 7.2 7.1 11.1 28.1 13.5 14.5 15.0 10.1 7.7 14.8 8.9 11.2 8.5 7.0 11.3 8.2 16.5 17.2 10.5 21.0 6.9 6.6 4.7 5.6 6.0 5.1 5.5 5.0 6.8 5.6 7.4 4.9 4.7 5.6 7.4 4.1 3.9 7.9 15.9 21.5 20.5 21.3 16.0 17.5 20.6 12.3 25.1 18.5 C6orf106 "dJ391O22.4, FLJ22195" ENSG00000196821 "Chromosome 6 open reading frame 106" Q9H6K1 6 34587288-34696859 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034489, HPA034490" Approved Approved "Nuclear speckles,Centrosome" "Nuclear speckles" Centrosome "HPA034489: AB_10669991, HPA034490: AB_2674186" "unprognostic (3.76e-2)" "unprognostic (2.51e-1)" "unprognostic (7.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (8.40e-2)" "unprognostic (9.94e-2)" "unprognostic (7.57e-2)" "unprognostic (5.68e-2)" "unprognostic (3.55e-2)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" 16.5 10.7 12.5 13.7 12.7 7.5 15.2 22.5 18.7 9.5 22.4 6.3 6.7 9.1 9.0 15.5 13.7 8.6 15.9 60.4 11.2 10.0 23.9 35.2 16.9 10.1 14.4 6.8 11.6 12.0 14.1 7.3 11.1 9.0 9.0 9.5 10.3 12.6 16.1 66.3 10.4 14.9 12.3 7.8 9.1 10.0 20.7 8.2 5.8 15.7 26.6 13.3 13.4 11.4 8.6 4.1 18.2 7.3 5.7 9.2 4.7 29.5 13.4 13.5 19.6 32.1 17.7 15.8 20.1 23.6 24.0 30.1 26.3 13.9 33.8 15.2 19.9 29.4 38.9 16.9 30.6 47.6 15.2 28.3 15.7 25.1 31.4 23.7 31.6 11.9 35.4 24.1 22.0 18.9 31.8 14.4 13.5 17.6 16.6 16.4 12.3 12.1 13.1 17.1 18.0 18.8 29.6 16.0 12.5 30.0 14.7 29.5 18.6 20.0 19.1 19.9 15.3 20.7 19.9 20.6 46.7 26.3 7.1 21.1 23.1 18.2 3.5 7.3 9.1 6.3 4.8 6.7 6.6 7.2 4.1 8.6 3.6 5.7 4.5 5.7 7.3 2.2 9.2 4.7 12.5 12.7 22.5 18.7 11.2 10.0 14.4 6.8 9.0 8.2 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101118-42142619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3" "Cell line enhanced" "Detected in many" "A-431: 27.2;CACO-2: 24.8;CAPAN-2: 20.6;HaCaT: 18.4;SK-BR-3: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavourable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 1.3 0.5 0.2 3.7 0.2 0.2 4.2 0.3 0.3 13.3 20.9 0.2 1.4 15.7 0.7 1.2 66.1 2.6 15.5 0.5 0.2 0.1 6.2 0.6 5.9 0.2 0.2 0.2 1.4 20.8 1.1 2.2 3.1 0.2 6.8 5.3 0.2 16.6 4.0 1.2 24.8 37.2 0.7 0.2 0.2 16.2 0.4 0.2 0.6 12.5 49.3 54.3 4.8 17.5 2.1 1.9 3.5 1.3 0.9 1.2 0.7 27.2 0.3 0.0 0.1 0.1 3.2 13.5 1.6 2.0 3.8 4.0 24.8 20.6 0.0 2.9 2.7 18.4 0.0 8.3 2.5 2.2 3.8 1.3 2.4 5.5 1.0 0.0 0.1 1.9 15.4 2.9 4.3 0.0 0.7 0.2 0.7 9.5 0.3 0.1 1.8 0.7 0.1 0.0 0.1 2.9 12.3 1.5 0.0 2.4 16.6 0.0 12.1 0.1 0.4 0.2 1.8 6.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.9 1.3 1.7 0.8 0.8 0.6 1.0 0.8 0.8 1.4 2.1 0.9 1.2 3.5 0.9 0.5 1.9 0.5 0.7 0.2 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.2 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell line enhanced" "Detected in many" "MCF7: 8.5;NB-4: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA051142: " "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favourable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.1 0.9 0.0 4.3 0.2 0.1 0.3 0.6 2.9 2.3 0.1 3.9 0.0 0.2 2.4 0.0 1.0 1.3 4.1 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.8 1.0 1.5 0.0 4.6 0.3 1.0 8.5 1.8 7.5 2.3 3.0 1.5 0.2 1.0 1.2 0.6 4.9 3.0 0.9 0.6 4.8 0.2 1.5 0.4 2.0 0.6 1.5 1.7 3.5 7.4 1.5 3.4 1.0 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 C7orf25 MGC2821 ENSG00000136197 "Chromosome 7 open reading frame 25" Q9BPX7 7 42908726-42912305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020120, HPA049635" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA020120: AB_1845755, HPA049635: " "unprognostic (6.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-2)" "unprognostic (4.83e-2)" "unprognostic (1.13e-3)" "unprognostic (2.23e-2)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (1.66e-2)" "unprognostic (1.73e-1)" "unprognostic (5.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.26e-1)" "unprognostic (2.66e-1)" "unprognostic (3.87e-2)" "unprognostic (3.05e-3)" 4.8 6.5 7.6 3.8 7.6 2.4 6.1 7.1 11.0 5.0 5.2 6.3 2.6 2.1 5.3 11.0 5.2 6.5 5.9 5.8 9.2 8.6 7.7 5.9 4.8 5.2 10.0 9.1 7.2 5.1 12.6 6.5 5.8 12.2 8.2 3.4 4.0 5.0 9.2 5.7 3.9 5.3 5.8 9.6 5.2 5.3 11.0 5.3 5.8 7.7 4.5 3.8 5.3 4.4 2.1 1.4 20.9 1.9 1.6 2.2 1.1 3.4 9.0 3.2 4.8 4.6 2.5 3.6 6.9 2.6 4.5 4.1 5.9 4.5 9.1 5.3 6.6 5.9 3.4 6.1 5.2 4.3 8.6 4.8 9.2 3.5 8.3 3.6 3.1 5.0 4.1 4.5 4.6 3.5 6.0 2.1 3.8 6.5 1.9 3.5 3.9 11.6 2.2 3.5 3.8 2.6 8.6 4.0 4.6 10.1 3.0 3.6 4.0 3.5 9.2 4.6 5.2 4.9 4.3 4.8 10.7 2.8 4.2 4.6 9.8 20.9 1.9 12.3 1.5 1.8 2.2 2.1 1.1 1.4 1.4 1.7 1.6 1.6 6.4 1.6 1.7 0.6 0.8 1.1 7.6 7.6 7.1 11.0 9.2 8.6 10.0 9.1 12.2 5.3 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: , HPA052175: " "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favourable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.3 6.5 15.4 10.7 6.0 8.6 6.7 5.9 9.7 6.0 8.7 4.7 13.2 8.8 4.9 12.4 8.7 6.1 4.4 5.1 12.5 4.9 5.8 9.1 12.6 11.7 15.9 6.9 9.3 5.8 6.1 10.5 12.9 10.1 5.7 18.7 10.2 24.3 13.0 12.5 20.9 5.2 11.2 6.3 9.8 8.6 15.9 6.5 21.6 9.0 9.8 17.7 7.5 8.1 26.5 8.8 14.6 12.3 12.0 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Cell line enhanced" "Detected in many" "U-266/70: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020346 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavourable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.9 2.1 4.7 5.3 1.8 1.0 2.6 1.2 5.1 3.8 5.8 4.0 2.8 7.4 1.9 2.3 1.2 5.2 1.4 4.1 3.5 5.0 3.5 0.2 5.4 4.4 5.6 8.5 3.2 4.0 3.1 0.7 0.7 5.2 4.1 1.0 0.0 5.7 7.2 1.9 1.9 7.2 5.4 1.1 2.6 3.7 1.4 3.9 1.2 5.0 4.8 0.8 9.5 1.0 2.4 6.4 0.0 1.8 18.5 5.9 10.6 0.7 5.4 10.8 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 C7orf43 FLJ10925 ENSG00000146826 "Chromosome 7 open reading frame 43" Q8WVR3 7 100154420-100158715 "Predicted intracellular proteins" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019359, HPA029463, HPA029464" Approved Enhanced "Vesicles,Plasma membrane,Centriolar satellite" Vesicles "Plasma membrane, Centriolar satellite" "HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205" "unprognostic (1.57e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-3)" "unprognostic (2.59e-1)" "unprognostic (5.23e-2)" "unprognostic (1.06e-1)" "unprognostic (9.36e-3)" "unprognostic (5.68e-3)" "unprognostic (6.97e-3)" "unprognostic (1.25e-1)" "prognostic favourable (6.19e-5)" "unprognostic (2.42e-2)" "unprognostic (1.85e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-1)" "unprognostic (3.26e-1)" "unprognostic (6.54e-3)" 7.0 10.4 10.6 23.0 11.3 12.2 12.2 24.8 23.2 6.7 14.0 9.4 13.6 16.2 9.6 10.8 12.1 8.4 10.5 6.4 12.8 13.9 12.3 12.9 19.0 21.4 10.8 10.6 5.7 11.6 18.7 14.5 21.6 14.6 10.2 13.5 8.8 13.5 10.8 10.1 28.1 16.4 6.9 6.0 25.8 14.9 26.8 6.9 17.6 12.2 7.4 14.0 8.5 7.8 2.1 0.7 5.2 1.7 0.5 2.6 1.0 4.8 6.2 7.3 12.3 4.6 2.5 8.2 9.0 7.1 6.2 4.6 4.8 5.7 6.1 8.3 6.8 9.3 3.5 7.1 2.4 11.4 6.7 4.5 7.8 4.2 5.5 5.7 21.4 5.1 4.9 6.1 4.7 5.4 9.9 11.1 8.1 14.9 12.8 12.2 8.2 9.0 7.7 3.3 6.8 5.4 5.5 9.3 9.9 8.0 23.5 4.8 4.8 6.9 7.5 12.4 10.6 16.5 6.9 16.6 15.6 6.1 7.0 7.8 13.2 1.7 1.0 3.5 2.0 1.6 1.4 0.9 2.6 1.8 0.7 2.1 1.5 2.2 5.2 0.5 1.7 0.6 0.2 1.0 10.6 11.3 24.8 23.2 12.8 13.9 10.8 10.6 14.6 6.9 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA052281: " "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favourable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 22.5 14.2 37.7 14.9 29.4 9.7 14.9 16.4 32.8 17.0 17.5 15.5 19.4 12.8 20.1 18.8 14.8 21.0 20.3 28.7 28.1 21.4 21.7 14.2 16.1 21.2 22.4 23.0 21.6 79.5 12.3 39.3 13.9 17.3 21.7 7.9 25.9 25.1 28.8 68.4 8.2 13.8 34.5 19.1 19.5 25.1 19.5 9.8 6.0 20.8 18.0 16.6 17.2 10.9 32.3 41.5 76.3 27.0 8.1 20.6 22.7 41.1 26.4 8.8 26.8 4.8 6.8 18.6 18.5 9.1 16.5 14.0 18.6 17.7 12.3 12.2 11.9 26.1 10.6 22.3 3.3 11.7 21.3 11.3 18.7 25.2 19.5 14.4 7.8 9.7 17.9 15.3 14.1 11.2 20.0 11.9 7.3 59.4 6.6 38.4 21.6 39.2 19.6 3.3 20.4 7.7 11.4 20.3 29.2 15.2 18.0 24.9 43.3 26.4 12.9 9.6 42.7 28.5 24.2 10.1 13.6 11.2 19.3 23.9 30.2 3.2 27.0 76.3 20.6 26.2 14.6 23.6 16.9 17.4 41.5 32.3 13.2 15.3 3.0 8.1 25.0 12.0 19.7 22.7 37.7 29.4 16.4 32.8 28.1 21.4 22.4 23.0 17.3 9.8 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052378-145056030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavourable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavourable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 14.3 41.8 14.4 8.8 13.5 5.5 23.2 10.7 17.3 25.3 19.3 13.4 11.3 11.3 11.9 15.0 12.1 14.4 13.1 15.0 15.3 12.1 15.5 11.8 9.4 12.4 14.3 12.0 24.3 13.5 32.4 8.5 12.9 18.1 13.9 24.9 11.9 12.5 24.4 21.7 11.5 7.6 9.5 21.8 9.3 10.2 9.3 13.5 9.1 16.6 10.5 8.5 10.1 9.4 8.7 13.7 4.9 12.0 17.9 13.0 11.3 8.2 8.4 2.9 1.4 17.4 6.1 5.7 5.7 11.9 11.1 8.0 1.7 0.7 9.7 19.1 6.7 2.8 12.0 12.7 8.0 4.4 21.8 12.6 5.1 2.7 16.6 6.5 2.8 13.1 21.5 6.1 11.3 8.6 23.8 2.0 5.2 12.0 13.6 3.7 7.1 22.5 8.4 3.7 11.4 7.3 2.9 6.9 10.5 16.2 1.8 7.4 1.9 2.5 4.4 2.8 8.5 4.2 7.3 6.9 4.8 20.4 9.4 15.1 4.9 0.3 10.0 4.9 10.3 12.0 13.0 8.7 10.9 11.5 13.7 8.6 12.9 10.3 0.6 17.9 9.4 12.6 7.8 11.3 14.4 13.5 10.7 17.3 15.3 12.1 14.3 12.0 18.1 13.5 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: " "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.2 0.2 1.4 4.4 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.3 0.3 0.8 0.2 0.1 5.7 0.7 1.0 0.4 0.2 0.1 0.5 0.1 0.6 0.8 1.5 0.1 0.3 1.0 4.9 0.6 0.1 0.5 2.5 0.1 0.2 5.3 0.1 0.6 0.4 1.1 0.1 0.3 0.3 0.0 2.5 0.2 0.1 1.0 0.6 3.3 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 C8orf37 "BBS21, CORD16, FLJ30600, RP64" ENSG00000156172 "Chromosome 8 open reading frame 37" Q96NL8 8 95244919-95269201 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024198 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" Cytosol "Plasma membrane, Cell Junctions" "HPA024198: AB_1845775" "unprognostic (7.90e-2)" "unprognostic (1.98e-2)" "unprognostic (5.68e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (2.72e-3)" "unprognostic (4.20e-3)" "unprognostic (2.04e-2)" "unprognostic (8.94e-2)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (6.11e-3)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (6.72e-3)" "unprognostic (2.02e-1)" "unprognostic (1.33e-2)" "unprognostic (3.29e-1)" 4.8 5.6 7.9 5.8 9.9 2.4 6.4 9.8 8.0 6.7 3.1 10.5 2.9 2.6 6.5 8.6 3.3 10.5 4.0 7.0 8.7 7.1 6.6 4.9 4.3 5.6 7.4 6.9 13.0 3.8 10.1 9.9 4.9 7.9 5.6 2.8 4.6 4.3 7.1 2.9 4.2 3.3 6.2 9.2 4.4 3.2 4.5 9.5 3.8 6.7 1.6 5.1 4.0 4.4 3.9 1.9 2.3 1.4 2.7 2.3 0.8 4.1 6.7 5.6 2.9 2.0 5.2 1.6 1.8 4.1 2.4 3.1 1.0 9.1 8.3 4.4 3.0 3.4 2.3 4.6 5.2 2.6 2.1 6.5 4.1 3.0 2.2 1.4 3.6 5.2 2.2 2.8 7.8 3.5 3.3 4.9 3.0 3.2 6.9 1.6 1.8 4.6 3.6 3.0 2.1 5.2 1.8 5.4 5.3 3.7 0.8 3.1 6.5 1.3 3.0 2.9 3.8 2.5 1.8 4.5 4.3 5.6 5.6 3.1 3.6 1.3 1.4 0.6 1.2 0.9 2.1 1.9 1.4 1.3 1.9 3.9 1.4 2.3 2.3 2.7 0.7 0.9 0.5 0.8 7.9 9.9 9.8 8.0 8.7 7.1 7.4 6.9 7.9 9.5 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell line enhanced" "Detected in many" "U-87 MG: 11.7;WM-115: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.8 0.0 6.2 6.2 0.0 5.4 6.0 2.9 5.0 0.0 0.0 0.0 0.0 2.8 0.6 0.2 1.0 5.7 0.0 0.6 0.5 0.0 0.0 2.2 0.0 0.9 1.9 3.7 3.9 1.0 3.7 0.1 0.0 7.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.2 0.0 3.2 0.0 0.2 6.0 0.0 0.0 1.7 5.1 5.0 6.0 4.8 0.0 0.0 0.0 11.7 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA044805: , HPA071903: " "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 43.6 22.3 33.1 21.5 20.6 39.9 25.9 29.0 27.9 34.0 33.6 25.9 37.8 10.9 24.1 19.2 30.4 23.0 31.9 38.4 30.7 25.1 64.4 21.1 38.3 24.4 24.2 29.2 33.8 37.9 21.9 27.8 28.8 28.9 26.8 28.2 34.4 53.3 45.5 9.5 38.9 22.8 27.7 49.5 33.0 28.0 11.2 24.0 22.0 36.2 40.0 41.8 36.1 22.0 21.7 45.5 24.0 27.5 31.3 36.6 51.2 43.3 31.0 24.1 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219957-123241398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavourable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavourable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 11.9 15.4 13.5 11.4 21.8 13.8 14.5 18.5 15.2 12.0 13.5 11.5 27.0 11.8 9.2 16.1 16.4 9.5 11.2 11.1 11.5 11.8 10.1 19.3 10.2 15.9 11.8 10.6 9.8 12.3 8.5 24.0 15.5 10.9 11.5 15.8 12.5 13.9 23.7 16.9 10.0 12.5 10.8 9.4 15.9 10.4 7.4 14.4 18.8 13.9 9.9 18.3 10.3 10.7 12.7 17.2 24.4 18.9 13.4 18.6 11.0 8.4 7.8 7.3 5.1 7.2 6.6 5.0 8.0 7.8 9.4 9.5 7.1 6.2 5.8 8.8 7.6 6.5 8.3 4.3 10.7 9.2 11.8 6.8 3.6 10.0 12.9 3.5 5.6 4.8 8.5 8.4 7.1 8.3 9.7 4.5 7.8 24.7 10.3 8.1 5.9 13.6 5.5 3.7 6.6 8.0 7.0 9.6 9.0 8.0 59.1 8.4 7.2 8.7 4.5 5.4 10.2 5.8 6.5 6.0 6.6 6.3 5.8 8.1 5.7 15.9 16.7 24.4 13.3 18.9 13.9 11.2 14.5 16.8 17.2 12.7 13.9 13.7 9.8 13.4 15.3 14.9 18.6 11.0 13.5 21.8 18.5 15.2 11.5 11.8 11.8 10.6 10.9 14.4 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 63.3;testis: 47.8" "Cell line enhanced" "Detected in many" "MCF7: 22.2;T-47d: 23.0;U-2197: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: " "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favourable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 1.5 7.2 8.0 1.0 9.2 1.0 2.2 1.5 6.2 4.1 1.1 6.2 8.2 1.1 3.3 22.1 1.0 63.3 2.7 1.5 9.6 9.3 7.8 1.5 9.8 0.9 4.9 4.9 9.3 4.5 3.3 7.6 1.5 19.9 2.0 1.3 1.7 2.0 5.0 1.4 1.2 1.0 1.3 2.6 1.0 1.8 47.8 2.6 0.1 6.7 0.2 1.2 2.2 0.3 1.7 0.9 0.1 2.6 1.8 4.2 1.1 5.8 10.1 4.5 6.9 1.9 4.2 0.9 4.0 2.8 4.8 3.3 3.8 5.9 1.0 5.3 2.6 4.0 4.9 2.2 4.1 0.3 4.5 0.0 11.2 11.6 5.4 0.8 2.8 2.9 1.7 2.4 0.7 2.3 5.4 0.8 2.3 22.2 3.0 1.0 9.4 11.9 4.6 2.2 3.6 11.4 4.2 4.3 4.6 5.5 2.4 0.6 23.0 0.9 1.1 2.7 3.7 23.7 1.5 2.6 6.4 0.9 8.2 0.3 0.8 0.1 2.6 0.0 1.9 1.6 4.2 0.7 1.3 1.4 0.9 1.7 2.4 1.8 0.0 1.8 0.4 0.4 1.6 1.1 8.0 9.2 1.5 6.2 9.6 9.3 4.9 4.9 19.9 2.6 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavourable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.7 3.7 9.6 3.9 3.9 5.0 17.9 13.4 4.2 9.3 10.1 1.0 5.2 15.1 4.0 3.3 5.0 7.5 0.7 15.0 20.4 11.6 8.0 6.7 6.4 3.1 9.6 12.8 2.4 5.1 5.2 3.7 2.8 11.3 10.3 12.1 4.7 16.9 11.3 11.3 11.3 15.9 7.6 3.6 3.9 4.1 10.5 4.6 5.8 5.0 4.0 6.0 7.4 3.7 8.5 9.5 11.5 11.6 19.8 14.8 9.6 6.4 10.8 9.0 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Cell line enriched" "Detected in some" 5 "U-2 OS: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA032108 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 1.1 0.4 0.0 0.2 0.0 0.0 21.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: , HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.6 5.1 9.0 7.3 9.4 17.1 9.1 9.9 15.3 7.9 7.8 1.1 4.6 12.5 5.0 8.5 14.0 9.4 9.3 11.0 8.8 4.6 7.6 7.4 6.3 10.1 11.2 6.3 13.8 12.8 8.0 17.5 9.7 9.0 8.4 10.1 3.9 13.5 7.9 8.4 12.4 8.0 15.5 0.3 11.3 11.1 7.4 9.8 4.9 12.5 16.2 4.4 6.5 8.5 7.3 9.4 16.7 7.2 8.5 13.9 5.7 10.0 8.6 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637942-48646312 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Cell line enhanced" "Detected in many" "AN3-CA: 24.6;SCLC-21H: 17.6;U-266/84: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favourable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favourable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favourable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 2.3 9.6 60.2 2.3 58.2 1.5 4.1 54.1 87.7 3.8 2.5 4.5 1.7 5.3 17.7 16.0 3.5 10.5 3.5 2.9 44.1 12.2 4.2 1.2 3.2 3.0 18.5 31.6 24.6 3.3 16.7 5.4 1.3 8.9 4.6 2.0 2.7 4.0 8.4 5.0 6.6 4.0 10.7 11.0 2.8 3.1 2.7 17.8 0.1 4.3 0.8 3.4 2.1 1.8 3.4 4.5 0.0 1.1 2.6 3.7 1.4 1.0 6.7 12.2 24.6 1.7 0.7 0.3 0.8 7.8 0.8 1.8 1.6 8.5 4.0 1.0 0.8 2.7 5.0 2.5 0.7 0.8 7.1 1.7 3.6 0.1 1.6 0.1 5.5 3.0 5.0 0.7 1.1 0.9 3.1 11.3 0.4 2.5 2.1 0.7 5.4 2.6 1.4 0.5 8.3 5.4 0.2 17.6 10.2 0.9 0.9 1.5 3.5 0.4 0.1 2.2 8.2 0.0 0.2 10.7 17.9 0.7 3.1 2.3 1.1 0.0 0.9 0.0 3.7 1.1 3.1 2.4 2.9 2.8 1.6 3.4 3.6 3.3 0.0 2.6 0.0 4.5 3.0 1.4 60.2 58.2 54.1 63.8 44.1 12.2 18.5 31.6 8.9 17.8 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell line enhanced" "Detected in many" "A549: 38.2;ASC TERT1: 40.3;RT4: 40.5;SK-BR-3: 32.5;T-47d: 52.3;U-138 MG: 55.8;U-87 MG: 67.0" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced Approved Nucleoplasm,Vesicles 29000 Nucleoplasm Vesicles "CAB025181: , CAB062549: , CAB068179: , HPA008773: AB_1078394, HPA073203: " "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 38.2 0.6 0.0 5.1 40.3 2.0 2.7 2.5 0.4 0.7 0.2 0.0 0.0 9.4 2.2 0.2 0.0 1.8 1.1 0.0 1.3 0.0 2.6 0.0 0.1 0.0 0.0 15.2 2.1 11.6 3.7 0.4 0.0 0.0 0.5 22.0 0.0 0.0 0.6 6.0 0.0 0.0 0.0 0.0 40.5 0.3 0.0 0.1 32.5 0.0 52.3 0.0 0.0 55.8 3.0 1.8 0.0 0.0 0.0 0.0 67.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell line enhanced" "Detected in many" "HEL: 16.1;RPTEC TERT1: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Uncertain Nucleoplasm,Nucleoli,Vesicles 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favourable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.3 0.4 0.9 0.1 0.6 0.7 0.4 1.1 1.1 0.1 3.1 7.5 5.8 0.4 0.5 1.3 2.4 2.3 3.0 0.2 1.6 1.0 16.1 2.1 6.9 1.6 0.2 0.7 2.4 0.5 0.2 1.3 1.7 4.1 3.2 2.7 0.1 0.3 0.2 0.5 0.5 0.2 2.4 0.2 8.7 0.3 0.3 0.1 0.5 0.0 1.6 0.6 0.8 1.6 3.0 4.3 0.1 1.6 1.3 0.6 2.0 6.3 2.3 2.8 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell line enhanced" "Detected in some" "A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in all" "CAB005100, CAB017107, HPA055207" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB005100: AB_2066539, CAB017107: , HPA055207: " "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favourable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 CAB39 "CGI-66, MO25" ENSG00000135932 "Calcium binding protein 39" Q9Y376 2 230712845-230821075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037112 Supported Approved "Nucleoli fibrillar center,Cytosol" 130000 "Nucleoli fibrillar center" Cytosol "CAB037112: AB_1078367" "unprognostic (4.36e-3)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" "unprognostic (1.71e-1)" "unprognostic (3.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.50e-2)" "unprognostic (2.84e-2)" "unprognostic (9.16e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (8.33e-4)" "unprognostic (1.04e-1)" "prognostic favourable (9.05e-6)" "unprognostic (1.59e-1)" "unprognostic (2.92e-1)" "unprognostic (8.93e-2)" "unprognostic (1.36e-1)" 28.8 16.7 24.5 25.8 24.0 22.1 22.2 22.4 35.0 16.5 26.1 16.8 14.0 23.4 19.3 18.3 28.3 15.5 20.8 34.2 25.4 26.0 27.4 18.9 20.9 25.8 28.4 27.6 17.0 16.3 22.3 15.2 21.0 32.8 20.9 28.4 13.9 22.4 16.7 82.2 21.8 28.8 26.3 28.0 21.5 22.6 19.6 17.8 20.9 22.0 26.6 28.1 22.9 30.8 3.6 3.6 12.4 5.1 11.6 8.4 2.6 37.4 8.7 11.9 10.1 14.7 18.5 13.6 21.6 27.1 13.6 14.3 10.6 41.2 9.7 17.0 18.7 17.3 13.2 40.5 27.8 40.5 10.4 26.0 11.2 11.3 12.5 35.9 30.3 13.0 23.7 17.5 38.8 16.8 43.3 9.0 12.9 13.0 16.6 22.2 11.8 15.4 19.4 17.7 9.5 25.3 30.5 13.0 7.9 16.1 20.3 17.2 5.0 20.9 21.3 19.3 7.3 20.3 17.6 11.7 8.8 15.7 13.7 20.9 15.7 4.5 4.5 6.9 6.0 5.1 6.2 3.6 7.5 7.7 3.6 3.1 6.0 8.4 12.4 11.6 4.7 2.7 7.1 2.6 24.5 24.0 22.4 35.0 25.4 26.0 28.4 27.6 32.8 17.8 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell line enriched" "Detected in some" 4 "MOLT-4: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favourable (1.79e-4)" "prognostic unfavourable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 CABIN1 "KIAA0330, PPP3IN" ENSG00000099991 "Calcineurin binding protein 1" Q9Y6J0 22 24011192-24178628 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043296 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043296: AB_10794657" "unprognostic (8.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.74e-2)" "prognostic favourable (9.57e-5)" "unprognostic (3.43e-2)" "unprognostic (3.06e-3)" "unprognostic (1.04e-2)" "unprognostic (2.92e-2)" "unprognostic (6.21e-2)" "unprognostic (3.75e-1)" "unprognostic (3.46e-3)" "unprognostic (1.01e-1)" "prognostic favourable (2.94e-4)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-3)" "unprognostic (7.79e-2)" 14.4 14.6 15.9 18.5 22.9 34.2 13.4 47.2 29.2 17.5 17.3 23.3 22.6 17.6 24.9 17.2 12.4 23.7 16.9 15.4 14.7 13.2 18.2 13.7 19.7 22.4 12.7 17.4 16.6 18.2 24.4 24.9 12.0 17.8 17.6 11.4 19.0 18.6 24.2 10.2 20.7 16.7 18.0 10.9 21.2 18.6 24.4 10.8 22.5 27.0 10.6 19.3 14.1 14.2 4.1 2.7 15.9 3.7 4.8 7.0 2.0 12.3 9.0 12.3 10.8 11.2 13.0 17.3 10.4 9.1 8.4 9.6 11.1 6.1 14.4 5.8 10.4 11.8 14.6 9.5 7.5 24.0 14.3 12.4 10.2 23.2 5.3 28.4 13.4 11.0 6.2 10.3 7.8 14.0 25.6 7.9 4.8 15.9 13.4 30.9 7.6 6.5 13.1 9.1 18.0 7.6 12.6 15.9 13.6 12.9 9.1 13.2 8.1 12.9 11.4 19.6 15.3 7.5 7.5 13.9 8.3 8.7 9.1 13.7 8.1 5.9 3.7 12.9 5.5 2.5 6.2 2.5 4.2 7.0 2.3 4.1 5.0 4.6 15.9 4.8 1.7 2.7 3.2 2.0 15.9 22.9 47.2 29.2 14.7 13.2 12.7 17.4 17.8 10.8 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 40.6" "Cell line enhanced" "Detected in many" "SK-MEL-30: 42.2;U-266/70: 61.0" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" "HPA073649: " "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favourable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 12.0 2.9 22.3 1.6 31.5 1.8 40.6 8.6 23.4 4.7 4.1 3.0 0.0 6.0 7.7 2.7 5.6 9.2 4.2 3.2 13.9 11.9 10.8 8.0 17.0 2.0 17.2 12.9 3.3 2.0 31.3 2.6 8.4 13.6 2.8 4.2 17.1 17.0 3.9 1.1 13.5 5.1 5.7 3.8 2.6 11.6 2.8 9.2 0.3 12.2 0.2 1.8 5.4 7.1 0.3 0.5 0.0 0.2 4.2 0.4 0.0 3.5 3.9 3.3 0.2 2.0 0.1 5.7 0.8 4.8 1.1 0.7 2.6 6.3 0.1 3.7 4.0 3.1 2.5 0.6 0.9 0.1 5.4 0.2 10.8 10.0 1.7 0.6 0.2 1.2 0.5 1.4 1.7 13.1 0.1 4.5 3.2 8.1 0.0 2.3 2.1 13.0 0.8 11.8 13.4 5.9 8.6 3.1 2.3 7.2 9.1 42.2 14.6 1.9 21.8 13.6 0.1 0.4 1.0 61.0 23.2 7.4 0.0 5.2 4.6 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.3 0.3 0.0 0.4 0.0 4.2 0.2 0.5 0.1 0.0 22.3 31.5 8.6 23.4 13.9 11.9 17.2 12.9 13.6 9.2 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: " "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavourable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.5 7.2 12.5 12.7 1.9 2.7 1.7 5.4 5.4 15.2 7.1 25.9 5.5 9.6 4.7 3.5 6.1 7.6 3.6 6.0 4.3 4.2 11.2 3.7 6.2 3.4 4.5 5.8 1.7 4.1 4.3 1.6 3.5 2.8 8.4 3.4 11.7 11.8 3.6 4.1 8.3 16.5 10.5 4.2 2.2 6.3 6.8 10.3 8.0 10.6 2.1 7.2 6.9 3.6 14.1 4.3 18.5 5.6 8.1 6.6 11.4 12.6 5.2 7.3 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138956-24161603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 91.1" "Cell line enhanced" "Detected in many" "SiHa: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9" "Group enriched" "Detected in many" 5 "B-cells: 7.1;granulocytes: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040703: , HPA047801: " "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 0.8 1.2 3.9 0.7 3.2 0.7 2.3 0.7 4.8 3.0 0.7 3.5 0.0 0.7 1.5 1.2 1.0 1.8 1.0 0.5 3.6 2.1 0.6 0.5 0.6 0.8 3.1 3.0 0.9 0.7 0.4 9.5 0.7 5.4 1.0 0.8 0.6 0.9 1.0 0.6 1.1 0.7 1.7 2.3 0.7 0.8 91.1 2.9 0.0 0.7 0.0 0.7 1.5 0.6 7.1 0.7 6.3 0.5 1.3 1.0 0.4 3.3 9.0 2.5 1.3 2.8 7.0 10.7 6.0 3.9 7.4 8.1 1.7 6.7 0.1 4.9 8.9 3.3 2.5 5.2 7.9 0.4 4.0 0.2 4.9 2.0 4.0 0.2 0.4 8.4 8.4 9.6 2.5 2.2 0.0 0.2 2.0 1.0 0.1 0.3 8.0 5.2 0.5 0.3 0.1 3.2 4.2 5.3 6.5 18.4 3.8 0.3 8.4 0.9 1.2 0.6 1.8 2.5 0.1 0.2 0.2 0.0 3.6 0.6 0.3 6.3 0.5 1.0 0.4 0.3 0.2 6.6 0.5 0.5 0.2 7.1 0.4 1.0 2.9 1.3 0.5 0.7 0.2 0.4 3.9 3.2 0.7 4.8 3.6 2.1 3.1 3.0 5.4 2.9 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.6;NTERA-2: 29.6;U-2197: 15.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.9 21.6 3.2 8.6 3.0 0.0 3.0 4.0 5.1 4.9 12.5 0.1 0.0 8.9 4.9 1.6 12.0 2.5 5.2 2.3 6.5 4.5 1.3 0.0 0.0 1.9 0.0 2.6 1.8 0.6 3.3 2.8 0.0 0.0 0.0 0.3 0.3 0.0 29.6 2.2 2.3 2.2 0.0 0.0 0.6 0.5 11.3 6.6 0.0 2.6 0.8 0.3 1.9 0.5 3.8 15.2 2.7 0.0 0.0 0.0 0.4 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.0 0.0 0.0 1.0 1.3 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell line enhanced" "Detected in some" "A549: 10.8;AN3-CA: 15.6;MCF7: 28.6;T-47d: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favourable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.8 1.8 15.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 28.6 0.0 0.0 5.8 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 8.5 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 CACNB2 "CACNLB2, MYSB" ENSG00000165995 "Calcium voltage-gated channel auxiliary subunit beta 2" Q08289 10 18140677-18543557 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 10.5;HSkMC: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035326 Enhanced Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA035326: AB_10669903" "unprognostic (3.03e-3)" "unprognostic (3.04e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (4.58e-3)" "unprognostic (4.67e-4)" "unprognostic (8.03e-2)" "unprognostic (3.76e-2)" "unprognostic (8.10e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-4)" "unprognostic (1.40e-1)" "prognostic favourable (3.56e-5)" "unprognostic (3.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.03e-1)" "unprognostic (8.16e-2)" 2.7 15.6 10.5 4.2 16.4 2.1 2.8 27.0 25.8 7.0 11.6 1.9 7.4 3.4 9.6 5.8 9.7 7.8 4.6 15.8 8.8 9.7 4.6 4.0 2.7 1.8 4.3 11.8 18.1 8.6 2.7 16.9 1.3 9.2 9.7 8.7 10.0 7.1 18.0 2.1 5.6 9.4 31.1 2.4 1.7 6.5 2.0 3.2 0.1 2.5 0.0 1.0 13.4 12.8 1.9 0.8 4.0 0.7 1.0 3.7 0.2 0.2 1.4 0.9 0.7 0.7 0.4 0.6 0.4 0.0 0.1 0.4 0.6 0.6 1.1 0.2 0.3 0.9 10.5 0.0 0.0 0.4 3.2 1.0 1.8 1.9 2.7 0.8 1.9 13.2 0.0 0.0 0.0 0.0 1.1 2.2 0.0 0.8 1.1 1.2 3.8 0.1 0.9 1.0 1.0 0.0 1.1 5.3 1.5 0.1 0.1 0.4 0.2 1.1 0.2 0.7 2.4 0.4 0.7 2.4 2.3 2.2 0.3 1.5 0.5 4.0 0.5 0.6 1.0 0.7 1.4 1.3 1.1 0.5 0.1 1.9 1.8 2.6 0.7 1.0 0.7 0.8 3.7 0.2 10.5 16.4 27.0 18.3 8.8 9.7 4.3 11.8 9.2 3.2 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in many" "U-937: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.7" "Lineage enriched" "Detected in single" 9 "T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA059515: " "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 3.8 3.7 27.4 2.9 22.4 1.2 4.2 18.5 42.9 11.9 9.1 1.5 3.0 3.8 22.6 8.1 11.6 16.1 6.7 2.6 16.4 12.2 3.9 1.3 6.1 1.7 10.0 14.5 24.1 2.1 2.8 4.2 5.3 4.4 5.7 7.8 3.4 4.5 9.1 2.1 7.8 5.8 20.4 2.4 2.2 4.7 4.7 2.3 4.6 6.1 3.4 3.6 7.5 6.9 0.2 0.5 0.0 0.3 0.0 4.7 0.5 6.8 5.4 9.1 18.5 11.1 7.9 5.5 7.0 14.8 10.4 6.2 1.7 5.6 0.8 9.2 11.7 7.3 8.2 7.6 3.9 7.9 2.5 3.6 4.4 0.2 4.4 0.6 3.9 5.0 4.6 4.3 2.1 11.8 0.5 2.9 6.7 17.0 8.4 0.9 5.6 4.6 9.7 2.0 2.7 7.5 12.9 12.9 12.8 2.1 15.5 5.1 10.6 3.0 11.3 6.6 9.4 3.2 3.8 3.3 1.3 0.2 5.5 45.1 2.0 0.0 0.3 0.0 0.9 0.1 0.4 0.2 1.8 1.8 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.4 4.7 0.5 27.4 22.4 18.5 42.9 16.4 12.2 10.0 14.5 4.4 2.3 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell line enhanced" "Detected in some" "A549: 12.4;EFO-21: 21.8;HHSteC: 5.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA056615: " "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.0 0.0 21.8 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 2.5 0.0 0.0 0.0 3.0 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACTIN "C19orf29, cactin, fSAPc, NY-REN-24" ENSG00000105298 "Cactin, spliceosome C complex subunit" Q8WUQ7 19 3610641-3626815 "Predicted intracellular proteins" "Immunity, Innate immunity, mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042504, HPA042548" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA042504: AB_10797501, HPA042548: AB_10794760" "unprognostic (1.18e-1)" "unprognostic (7.90e-3)" "unprognostic (1.09e-1)" "prognostic favourable (3.69e-5)" "unprognostic (5.93e-2)" "unprognostic (2.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (7.22e-3)" "unprognostic (3.88e-2)" "unprognostic (4.98e-3)" "unprognostic (5.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.55e-3)" 16.1 14.4 18.3 19.4 17.8 19.8 16.2 19.2 19.9 11.8 12.4 13.1 12.3 14.5 14.2 9.6 11.9 13.0 13.0 10.3 14.2 10.9 11.9 14.8 11.7 16.5 14.3 9.9 21.4 14.9 8.9 11.1 11.3 13.4 13.4 8.5 10.3 15.5 12.8 28.6 22.0 16.2 12.2 9.8 23.0 15.7 14.4 15.0 13.9 12.6 11.9 12.7 11.3 18.5 2.1 4.3 0.8 2.9 0.9 3.7 1.3 14.4 8.4 7.1 12.1 5.2 5.1 10.8 10.4 4.2 6.3 7.0 8.3 6.5 12.2 8.9 6.5 13.5 7.4 8.7 3.8 12.2 9.7 7.5 11.4 9.9 7.2 10.2 11.0 5.0 8.5 5.8 4.0 9.0 16.7 13.6 3.3 8.7 18.2 8.9 15.1 9.8 19.3 9.2 11.4 5.8 7.4 9.8 13.7 11.7 8.3 8.4 6.6 11.8 11.6 8.4 10.7 18.4 18.1 20.9 13.9 13.4 10.4 16.4 11.3 0.0 1.2 0.0 3.7 2.9 1.3 2.0 1.8 1.7 1.0 2.1 2.0 2.5 0.8 0.9 0.4 4.3 1.4 1.3 18.3 17.8 19.2 19.1 14.2 10.9 14.3 9.9 13.4 15.0 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175011715 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 117.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Approved Enhanced Nucleoplasm,Cytosol 360000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: " "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavourable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favourable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 15.1 15.9 38.3 20.3 39.7 24.6 36.2 36.1 46.5 16.0 16.7 10.7 12.5 13.3 14.0 22.5 13.9 15.6 12.7 13.0 36.9 39.1 23.4 18.5 13.3 25.2 33.8 22.8 26.5 10.1 21.4 17.2 19.1 33.1 17.0 18.6 7.9 11.8 17.2 29.8 12.6 14.0 14.4 29.0 13.3 11.7 23.3 27.5 16.2 19.1 12.6 23.9 16.6 117.2 26.7 20.1 17.3 30.2 25.3 29.0 25.8 30.4 21.1 31.1 13.3 10.4 11.7 20.0 23.4 13.9 30.4 22.2 21.7 19.1 32.2 24.5 16.6 16.7 38.7 17.1 31.5 17.0 23.6 24.1 20.8 23.3 7.9 32.4 15.1 7.8 10.6 24.9 15.1 21.3 48.3 18.1 21.8 11.3 49.8 29.6 29.5 9.8 22.5 22.1 37.1 21.6 24.4 21.4 20.6 15.9 27.9 24.1 21.6 28.4 11.0 17.3 18.5 24.1 37.5 17.5 50.2 71.4 14.5 28.5 20.1 17.3 16.1 15.9 19.0 24.4 22.1 26.7 27.5 23.0 20.1 20.4 29.0 25.7 8.7 25.3 30.2 16.6 28.5 25.8 38.3 39.7 36.1 46.5 36.9 39.1 33.8 22.8 33.1 27.5 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell line enriched" "Detected in many" 5 "WM-115: 109.8" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favourable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.5 2.5 13.4 17.5 0.0 0.2 0.7 0.4 0.7 1.2 1.8 3.7 1.5 0.0 3.2 0.1 2.0 2.9 1.7 1.5 0.1 2.3 0.0 0.5 5.4 1.6 0.0 1.3 0.5 3.9 6.4 0.2 0.8 0.8 0.1 0.1 1.2 1.2 0.1 1.4 0.8 6.9 0.1 0.8 1.7 1.8 1.5 8.6 0.9 2.7 3.4 2.0 0.4 0.3 0.1 20.7 0.1 0.8 1.2 0.8 0.0 0.9 0.1 109.8 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 21.6;Karpas-707: 28.2;MCF7: 14.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056398: " "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 2.7 0.1 0.2 6.7 1.5 6.8 0.0 6.2 0.0 0.0 3.1 0.0 0.2 0.9 0.6 0.0 5.5 2.1 0.0 12.1 8.7 0.0 0.1 2.8 1.2 1.1 0.9 21.6 0.0 28.2 0.1 14.8 0.0 0.0 6.3 10.7 0.0 0.0 11.1 0.3 7.0 10.9 0.0 0.3 12.2 0.5 4.7 0.0 6.1 2.4 1.6 0.0 4.3 8.4 0.3 0.0 9.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 CALCOCO1 "calphoglin, Cocoa, KIAA1536" ENSG00000012822 "Calcium binding and coiled-coil domain 1" Q9P1Z2 12 53708517-53727745 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 45.2;HSkMC: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038313, HPA038314" Approved Enhanced Vesicles,Cytosol 11000 Cytosol Vesicles "HPA038313: AB_10675794, HPA038314: AB_10672587" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" "unprognostic (3.11e-2)" "unprognostic (8.42e-2)" "unprognostic (3.03e-1)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (9.66e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-3)" "unprognostic (8.01e-2)" "unprognostic (2.80e-1)" "unprognostic (5.63e-3)" "unprognostic (9.88e-3)" 31.6 18.9 30.9 13.6 45.6 14.2 27.7 88.2 46.5 22.5 34.9 27.7 23.5 13.7 27.3 29.7 24.0 25.5 28.0 44.8 32.1 15.4 19.7 14.6 35.0 13.6 28.8 25.3 29.1 26.0 36.9 28.1 23.2 30.3 26.1 15.6 27.1 33.0 33.8 59.2 54.4 20.3 35.8 20.5 22.1 30.7 14.4 38.7 11.1 22.5 20.4 16.3 34.6 23.0 8.1 5.4 34.7 10.3 8.3 14.7 10.1 5.0 5.1 7.3 9.1 45.2 30.1 5.0 9.5 22.5 8.2 10.5 2.2 17.9 2.0 10.2 25.3 5.4 3.4 9.6 7.2 8.3 6.2 3.6 10.3 1.7 23.3 1.4 8.3 43.2 22.1 8.2 7.1 14.9 3.0 16.7 14.3 2.1 4.1 5.1 1.6 5.5 5.0 4.3 6.6 12.3 3.1 4.5 8.0 7.1 2.7 9.7 8.0 4.6 16.4 3.3 4.9 3.8 1.5 16.6 5.3 0.7 16.1 1.7 4.6 34.7 9.2 33.4 12.7 10.2 9.3 6.7 9.0 10.1 5.4 8.1 8.0 8.6 32.6 8.3 10.3 4.0 14.7 10.1 30.9 45.6 88.2 46.5 32.1 15.4 28.8 25.3 30.3 38.7 CALCOCO2 "MGC17318, NDP52" ENSG00000136436 "Calcium binding and coiled-coil domain 2" Q13137 17 48830988-48866522 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022989, HPA023019, HPA023195" Enhanced Supported Vesicles,Cytosol Cytosol Vesicles "HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916" "unprognostic (3.71e-1)" "unprognostic (2.87e-1)" "unprognostic (3.84e-2)" "unprognostic (3.37e-2)" "unprognostic (4.90e-2)" "unprognostic (4.46e-2)" "unprognostic (2.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.88e-1)" "unprognostic (2.15e-1)" "unprognostic (2.41e-1)" "unprognostic (4.03e-2)" "unprognostic (3.52e-2)" "unprognostic (1.06e-1)" "unprognostic (3.80e-2)" "unprognostic (7.57e-2)" "unprognostic (5.65e-2)" 70.5 30.8 20.6 21.0 29.5 22.2 50.8 22.1 28.1 38.5 40.2 26.8 32.7 27.0 39.4 35.6 41.3 36.1 28.4 55.5 24.8 16.6 36.6 48.7 42.6 28.2 36.8 24.8 37.7 22.7 24.6 46.3 26.5 32.3 37.3 42.1 46.9 30.0 31.8 70.1 31.3 35.2 47.8 42.8 29.5 35.5 51.8 37.3 25.0 48.4 32.3 26.0 46.4 74.2 18.0 22.0 44.4 40.7 33.2 34.2 24.7 26.3 17.1 7.2 13.9 53.9 39.1 20.9 25.6 34.5 29.7 33.4 31.9 17.3 8.9 25.8 31.1 14.7 17.5 21.7 35.8 40.8 14.5 8.4 10.7 12.4 62.0 28.5 43.2 57.5 32.4 31.4 22.9 21.7 15.4 27.1 25.7 7.7 24.5 15.2 2.2 21.1 16.3 35.4 16.8 11.4 8.4 2.9 6.2 8.0 5.2 22.8 33.5 16.0 21.0 32.5 9.9 19.8 18.1 24.1 33.4 6.3 19.7 14.5 13.3 30.2 36.2 36.3 19.8 39.5 18.9 18.0 17.7 20.3 22.0 16.6 18.1 19.6 44.4 33.2 40.7 11.1 34.2 24.7 20.6 29.5 22.1 28.1 24.8 16.6 36.8 24.8 32.3 37.3 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970728 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 224.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 78.6;fHDF/TERT166: 127.8;U-138 MG: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" 110000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 38.6 17.4 6.7 33.4 11.1 0.0 26.6 11.9 9.1 83.1 141.0 6.0 111.4 12.6 82.3 59.8 122.8 45.8 46.3 20.1 7.7 5.0 33.5 39.6 26.1 12.9 8.7 8.5 76.3 6.9 4.1 17.8 57.4 8.9 87.8 25.1 10.9 12.4 133.3 15.3 12.9 39.2 224.5 8.5 35.9 64.5 29.7 9.7 2.1 20.3 14.1 5.3 205.3 70.4 0.1 0.2 4.3 0.2 0.4 0.2 5.9 12.0 7.9 17.9 15.7 62.2 50.4 17.7 70.9 78.6 24.4 27.1 14.4 0.3 0.0 16.9 127.8 2.8 11.4 21.1 33.2 0.1 3.8 0.4 9.4 9.7 40.9 0.0 0.0 38.7 15.7 27.3 15.4 20.5 0.0 0.1 36.4 0.0 0.0 0.2 21.4 2.7 0.1 15.9 0.0 5.0 3.2 3.1 7.8 24.9 3.3 9.5 0.7 0.1 54.7 82.0 14.3 15.5 24.1 0.0 0.0 0.0 28.5 0.0 61.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 4.3 0.4 0.0 0.0 0.0 5.9 6.7 11.1 11.9 9.1 7.7 5.0 8.7 8.5 8.9 9.7 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.4;BJ: 18.5;BJ hTERT+: 18.8;fHDF/TERT166: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.2 3.7 0.9 1.2 14.1 23.4 4.5 18.5 18.8 5.7 8.1 1.6 2.6 1.6 2.1 21.2 2.5 1.9 0.0 1.1 0.2 10.7 3.8 1.1 0.3 6.4 0.6 0.3 8.0 0.0 1.7 0.0 6.7 0.8 9.9 3.7 12.1 1.4 1.7 2.3 3.4 4.4 1.5 3.5 0.5 0.4 2.6 1.1 0.7 3.1 1.0 0.6 1.2 11.9 1.8 2.2 6.3 1.3 1.5 3.5 1.9 15.7 11.6 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: " "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.7 5.7 3.4 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.0 2.5 2.0 1.1 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.2 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.9 3.8 2.9 0.6 7.2 5.6 7.7 4.9 2.3 8.4 5.6 5.1 0.9 4.3 2.9 3.3 2.5 2.3 6.7 1.7 3.4 2.4 3.8 3.5 6.6 6.3 10.6 6.2 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499555 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "salivary gland: 129.5;skin 1: 212.5" "Cell line enriched" "Detected in some" 21 "A-431: 92.9" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" 75000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favourable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 8.0 0.3 0.2 6.7 0.2 0.2 0.2 0.0 1.0 0.2 4.8 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 129.5 0.2 1.8 212.5 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.1 0.2 10.9 8.2 0.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell line enriched" "Detected in some" 6 "Karpas-707: 30.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 30.7 0.0 0.0 0.0 0.0 4.1 0.0 4.7 0.0 0.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 4.9 4.7 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349482-12835545 "Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 46.7;U-266/70: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favourable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 5.1 5.3 20.9 10.5 22.1 6.6 4.0 23.4 33.5 8.3 11.5 4.6 10.0 3.8 3.3 3.3 8.7 4.3 6.8 13.8 18.6 7.2 2.2 11.5 7.6 9.3 5.8 17.8 2.6 17.0 1.3 2.5 3.2 5.0 4.9 12.9 11.9 4.5 15.4 1.7 18.5 5.5 5.6 4.9 10.5 3.4 6.2 6.8 20.8 13.6 2.9 12.5 8.1 7.0 7.1 4.2 31.8 3.7 1.4 2.3 1.3 0.1 2.5 2.9 0.1 1.8 0.6 0.2 0.4 0.9 0.6 0.9 3.5 2.0 1.4 0.3 0.2 1.3 3.5 0.5 0.5 46.7 1.8 5.6 8.3 0.2 0.5 0.1 5.1 0.1 2.3 1.2 0.1 0.3 0.1 0.2 0.7 2.9 10.9 2.2 1.9 1.1 8.3 1.6 2.6 0.1 2.7 4.5 2.0 5.5 2.0 0.0 1.5 1.3 0.1 2.4 3.6 7.7 1.6 21.5 6.7 4.7 3.6 3.6 0.0 8.3 2.2 31.8 1.8 3.1 1.9 5.6 1.6 2.3 4.2 7.1 1.9 1.3 13.9 1.4 3.7 1.4 0.5 1.3 20.9 22.1 23.4 33.5 18.6 7.2 5.8 17.8 5.0 6.8 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: " "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 2.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: " "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.7 0.0 1.0 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 5.2 0.0 0.2 0.1 2.3 0.1 0.9 0.1 0.0 0.0 41.0 2.2 0.2 0.0 0.0 1.9 0.1 0.2 0.2 0.3 0.2 0.0 0.5 0.4 0.1 0.1 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: " "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.3 15.8 5.3 34.6 66.2 5.6 33.5 22.4 13.2 11.4 9.6 4.0 20.5 4.9 23.3 0.5 9.8 5.2 13.5 7.8 2.5 0.0 5.2 11.0 17.5 0.0 0.0 42.3 7.2 10.2 25.3 11.7 0.8 9.2 24.8 3.8 2.0 0.8 2.2 5.3 4.0 18.5 0.1 13.5 9.7 4.3 4.3 4.5 6.8 4.5 0.1 5.5 7.0 34.9 8.2 14.8 6.6 7.1 3.6 17.6 18.0 1.2 16.4 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell line enhanced" "Detected in all" "PC-3: 45.4;SK-BR-3: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: , HPA051783: , HPA051785: , HPA053973: " "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 10.9 7.9 7.1 13.6 5.2 8.6 8.4 7.5 12.9 10.4 8.5 12.2 11.8 8.1 7.9 9.7 17.0 5.6 6.4 8.3 7.3 6.7 5.5 6.1 5.5 2.6 7.5 9.3 4.5 5.8 10.3 7.2 8.8 6.0 12.1 5.7 7.6 12.5 11.2 5.2 45.4 11.4 7.5 4.3 5.4 15.9 3.7 8.6 4.3 57.2 3.7 10.7 4.7 10.8 7.7 12.4 4.2 10.1 3.7 4.4 7.5 8.3 21.5 2.7 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell line enhanced" "Detected in many" "REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA050835: , HPA075200: " "unprognostic (7.28e-2)" "prognostic favourable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.1 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.1 2.6 2.7 0.4 0.5 0.4 2.7 0.2 1.4 0.7 0.4 1.5 9.1 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.6 0.4 1.9 0.0 0.0 3.3 0.4 5.9 0.1 0.1 7.9 3.6 18.7 5.4 1.5 0.6 2.1 19.6 4.2 1.8 0.5 0.1 6.0 0.1 0.0 20.4 8.9 1.9 3.3 2.2 3.3 2.7 4.7 1.1 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 CAMK4 CaMK-GR ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.9;lymphoid tissue: 71.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3" "Lineage enriched" "Detected in single" 26 "T-cells: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 1.1 6.5 9.5 6.4 34.2 4.6 1.0 48.9 16.5 1.8 2.3 1.0 0.0 2.4 1.3 0.8 1.4 0.9 2.7 0.9 5.9 3.2 1.4 2.5 1.9 12.0 2.3 6.8 1.4 0.9 0.3 1.3 0.6 3.4 5.8 2.5 0.1 1.7 2.6 0.8 0.9 3.8 1.5 2.0 4.2 2.6 13.8 6.6 71.7 1.0 0.0 8.1 2.8 1.1 0.7 0.0 0.4 0.0 0.6 19.8 3.4 0.0 0.0 1.4 1.0 0.3 1.1 0.0 0.3 3.2 3.8 3.7 0.0 0.0 0.0 2.0 0.1 0.1 3.1 0.3 2.8 41.2 2.6 0.6 1.3 0.0 0.1 0.2 0.1 0.1 0.0 8.0 0.8 0.6 0.0 1.5 0.2 0.0 12.6 0.0 1.9 0.1 1.9 2.4 0.1 1.4 0.0 9.1 16.1 0.5 0.0 2.7 0.0 0.2 0.0 7.8 4.6 0.0 6.9 1.3 0.1 0.0 3.8 0.0 3.0 0.0 0.0 0.0 2.8 0.0 14.1 0.7 10.3 7.8 0.0 0.2 19.8 10.9 0.4 0.6 0.0 0.0 11.3 3.4 9.5 34.2 48.9 15.1 5.9 3.2 2.3 6.8 3.4 6.6 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell line enhanced" "Detected in some" "AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.1 24.6 0.1 0.7 0.0 4.7 0.0 0.0 8.4 5.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA052636: , HPA056472: " "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.5 7.4 12.8 23.7 28.4 44.0 5.7 13.6 19.8 10.2 19.3 13.6 14.6 39.1 20.0 9.5 12.4 10.5 16.6 14.5 18.2 19.4 10.4 13.6 11.1 20.9 5.5 32.9 35.6 18.1 12.5 21.6 19.2 6.5 18.2 15.1 10.7 14.5 23.2 6.5 7.5 16.3 16.9 15.1 17.5 9.4 18.9 13.3 9.8 6.2 32.6 17.2 11.5 18.4 9.9 6.1 15.1 12.3 17.2 18.5 15.0 16.7 17.3 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 CAMSAP1 "DKFZp434F195, FLJ31228" ENSG00000130559 "Calmodulin regulated spectrin associated protein 1" Q5T5Y3 9 135808487-135907228 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020527, HPA024161" Approved Supported "Mitotic spindle,Cytosol" "Mitotic spindle, Cytosol" "HPA020527: , HPA024161: AB_1845967" "unprognostic (3.18e-3)" "unprognostic (4.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.57e-2)" "unprognostic (6.00e-2)" "unprognostic (1.43e-2)" "unprognostic (1.79e-3)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-2)" "prognostic favourable (3.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (2.66e-3)" 8.0 8.6 12.4 6.5 15.7 10.5 8.3 23.9 21.7 7.6 6.3 14.3 7.2 4.1 9.5 6.9 22.0 9.8 6.5 9.2 11.2 10.8 5.2 4.8 8.2 6.6 10.4 9.9 13.5 9.5 8.9 9.4 6.5 12.2 8.0 4.7 24.2 7.3 8.6 32.7 10.4 4.3 8.6 10.3 6.2 6.2 20.8 9.2 10.0 5.7 14.4 11.4 7.6 10.0 2.4 1.1 3.8 1.6 1.0 2.1 1.2 9.1 13.5 22.2 15.6 5.2 4.6 10.9 7.4 6.2 8.1 6.1 11.8 8.0 4.2 10.7 9.3 18.8 11.7 8.0 6.2 14.3 6.5 6.1 15.1 5.9 7.9 10.6 9.2 6.0 10.2 10.3 14.2 9.0 12.6 9.2 10.5 16.3 9.8 6.6 12.7 9.8 19.3 18.5 10.3 8.1 11.2 24.3 23.9 9.5 6.9 10.3 9.7 8.8 11.1 15.4 12.1 11.3 12.5 4.6 8.6 11.6 10.0 7.2 8.8 3.8 1.5 0.3 1.1 1.6 2.1 2.4 1.8 1.7 0.9 0.5 1.3 1.9 0.5 1.0 1.3 1.1 1.4 1.2 12.4 15.7 23.9 21.5 11.2 10.8 10.4 9.9 12.2 9.2 CAMSAP2 "CAMSAP1L1, KIAA1078" ENSG00000118200 "Calmodulin regulated spectrin associated protein family member 2" Q08AD1 1 200739558-200860704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026304, HPA026511, HPA027302" Enhanced Supported "Microtubule ends,Cytosol" "Microtubule ends" Cytosol "HPA026304: AB_1852376, HPA026511: AB_1852378, HPA027302: AB_1852380" "unprognostic (1.19e-1)" "unprognostic (9.98e-3)" "unprognostic (1.44e-1)" "unprognostic (9.52e-2)" "unprognostic (7.96e-3)" "unprognostic (4.82e-2)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.34e-2)" "unprognostic (5.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "unprognostic (1.56e-1)" "unprognostic (2.92e-2)" "unprognostic (1.38e-3)" "unprognostic (1.95e-1)" "unprognostic (8.23e-3)" "unprognostic (9.56e-2)" 11.6 11.9 12.8 4.5 15.2 0.1 7.4 16.8 29.7 11.3 5.8 16.6 5.9 2.7 14.4 7.7 8.1 6.6 8.9 7.7 13.0 11.9 8.9 5.0 10.5 2.3 10.3 11.1 14.5 3.9 20.7 6.1 13.0 17.4 8.2 4.7 8.6 5.0 10.0 5.4 9.0 2.7 11.6 10.2 5.6 5.0 10.1 7.0 1.8 13.8 5.3 4.1 13.1 7.4 0.1 0.5 0.7 0.6 0.0 1.4 0.1 11.2 7.6 10.5 9.5 8.5 11.3 12.1 11.4 9.9 9.2 7.7 5.5 6.8 0.0 6.5 12.6 10.2 10.8 16.8 11.1 6.7 5.5 0.5 11.5 2.5 9.5 0.7 2.9 8.2 25.9 14.7 57.9 14.0 1.4 3.6 14.9 5.9 0.1 0.2 9.8 10.8 4.5 11.6 5.1 7.9 8.3 5.5 9.8 16.8 10.4 9.4 9.9 0.6 16.7 15.1 9.0 9.4 14.1 7.2 11.9 6.0 11.0 1.7 11.4 0.7 0.6 0.0 0.3 0.1 0.4 0.1 1.4 0.0 0.5 0.0 1.4 0.4 0.0 0.0 0.1 0.2 0.8 0.1 12.8 15.2 16.8 16.3 13.0 11.9 10.3 11.1 17.4 7.0 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595902-7618304 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell line enhanced" "Detected in many" "CACO-2: 19.7;Hep G2: 11.2;SK-BR-3: 9.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: " "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favourable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.8 2.8 8.0 1.9 9.2 0.9 4.1 12.0 15.5 4.5 11.4 0.8 13.5 20.9 1.5 8.0 14.7 4.8 7.6 0.9 5.2 4.8 9.7 14.2 4.5 1.1 2.6 6.5 1.0 15.7 4.2 6.2 3.6 7.0 6.7 4.1 8.8 22.1 16.0 1.1 33.9 17.7 1.0 1.0 1.1 14.5 9.1 1.1 0.9 9.6 2.5 5.7 4.1 6.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 8.3 1.3 0.2 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 19.7 4.4 2.3 3.6 0.0 7.4 3.2 2.1 0.0 1.5 7.6 0.0 0.3 11.2 0.0 0.0 3.4 0.0 4.2 0.0 0.3 0.0 0.7 0.0 0.0 9.4 0.1 0.1 5.1 3.6 0.5 0.0 2.7 1.5 4.4 6.4 6.8 1.0 9.7 0.0 8.0 1.3 0.0 0.0 1.6 0.0 0.3 3.9 0.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.0 9.2 12.0 15.5 5.2 4.8 2.6 6.5 7.0 1.1 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051147 Approved "Nucleoplasm,Actin filaments,Mitochondria" Nucleoplasm "Actin filaments, Mitochondria" "HPA051147: " "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favourable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 7.8 14.1 2.6 3.7 17.7 12.4 5.4 7.7 8.5 7.2 6.4 3.5 2.1 9.3 7.5 11.9 8.0 10.0 11.9 4.1 13.0 12.9 5.9 7.6 3.9 10.2 3.4 25.2 8.5 15.0 6.8 10.8 12.1 9.5 8.5 6.8 5.2 6.0 2.2 0.4 5.8 5.3 3.0 3.6 8.2 8.3 3.7 3.2 4.8 8.8 2.3 7.8 3.4 16.0 5.8 3.4 6.0 12.4 4.3 4.6 3.3 14.1 6.9 5.6 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 CAND1 "DKFZp434M1414, KIAA0829, TIP120, TIP120A" ENSG00000111530 "Cullin associated and neddylation dissociated 1" Q86VP6 12 67269281-67319951 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055748, HPA062833, HPA069053" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" 4200000 "Nucleoplasm, Golgi apparatus, Cytosol" "HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074" "unprognostic (1.50e-2)" "unprognostic (1.60e-1)" "unprognostic (1.39e-3)" "unprognostic (2.31e-1)" "unprognostic (2.19e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (2.02e-2)" "unprognostic (2.17e-2)" "unprognostic (3.02e-1)" "unprognostic (3.38e-3)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" "unprognostic (2.88e-1)" "unprognostic (1.58e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" 21.3 26.7 28.7 19.1 38.3 19.6 27.0 34.6 32.6 23.9 20.0 17.5 17.0 19.7 22.8 29.9 26.6 20.6 19.0 15.2 24.8 27.0 25.4 27.7 18.7 25.4 23.3 29.0 29.0 22.1 33.2 27.1 23.3 33.2 24.1 21.7 15.8 19.6 22.0 11.1 29.5 19.5 22.4 21.5 20.2 19.3 26.9 23.8 39.4 27.0 17.0 30.2 21.1 22.1 11.9 7.8 6.1 10.1 14.7 15.2 4.3 22.2 23.0 35.1 24.9 26.9 21.1 23.5 22.2 19.2 23.4 20.7 21.3 12.8 48.2 19.4 22.2 21.4 37.6 25.2 26.9 18.3 22.5 27.2 18.5 20.1 17.7 31.9 15.5 19.8 19.2 21.4 19.8 21.8 21.4 27.1 25.2 21.9 28.9 21.7 37.1 16.1 28.3 30.0 20.4 21.6 38.1 36.0 17.9 27.6 25.5 17.9 27.3 14.7 18.5 18.7 12.1 12.8 16.7 8.9 10.9 41.1 22.2 19.0 19.1 6.1 5.0 5.5 11.6 5.9 14.1 8.6 14.2 12.7 7.8 11.9 15.2 12.7 2.2 14.7 10.1 6.6 14.7 4.3 28.7 38.3 34.6 31.8 24.8 27.0 23.3 29.0 33.2 23.8 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 76.2" "Cell line enhanced" "Detected in many" "HEK 293: 18.2;REH: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA005777: " "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 2.9 2.8 6.4 1.4 7.6 1.4 1.4 7.2 11.8 2.3 3.2 3.7 0.5 1.5 3.7 2.6 2.6 3.6 2.1 17.8 4.7 4.3 1.7 1.7 1.9 1.4 2.7 5.5 3.3 2.5 6.4 4.9 1.4 3.1 3.0 1.4 4.2 2.2 3.4 76.2 1.6 1.7 5.2 2.2 2.2 2.1 11.4 2.6 0.1 2.4 11.1 1.2 3.0 5.0 1.2 0.2 0.7 0.5 0.0 2.2 0.6 0.7 1.5 5.8 0.2 0.2 0.1 0.3 1.6 0.6 3.1 4.2 0.8 0.3 0.9 1.7 0.8 0.2 6.4 0.1 2.8 1.6 18.2 1.3 2.2 1.2 4.9 0.1 0.1 1.3 0.3 3.0 0.1 0.7 4.7 0.9 0.9 2.9 2.3 0.7 4.0 1.8 11.2 1.1 0.9 0.2 1.3 3.9 5.2 0.1 0.8 1.0 1.7 5.5 0.4 0.9 1.0 0.9 1.2 1.5 8.9 8.6 0.5 1.1 1.9 0.0 0.5 0.0 1.2 0.2 0.6 1.2 0.6 2.2 0.1 0.5 1.3 0.9 0.7 0.0 0.1 0.2 1.6 0.6 6.4 7.6 7.2 11.8 4.7 4.3 2.7 5.5 3.1 2.6 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.4 8.4 16.3 19.6 0.1 0.0 3.5 19.3 14.1 15.9 14.5 2.8 2.4 0.0 18.2 20.7 2.8 7.2 7.2 23.0 0.0 2.7 0.0 5.4 9.2 1.5 0.0 0.0 1.2 3.5 8.0 3.5 0.7 0.0 0.0 33.5 8.7 0.0 0.0 6.2 4.8 1.8 21.7 0.3 8.3 2.2 2.1 4.1 6.5 21.0 11.4 23.2 3.9 0.0 12.9 12.3 0.3 16.9 0.0 0.0 0.0 4.2 0.0 17.5 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 CAPN10 ENSG00000142330 "Calpain 10" Q9HC96 2 240586716-240617705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004170, HPA056098" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA004170: AB_1078381, HPA056098: " "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (9.29e-3)" "unprognostic (6.09e-2)" "unprognostic (5.44e-3)" "prognostic favourable (8.47e-5)" "prognostic unfavourable (4.78e-6)" "unprognostic (7.48e-3)" "unprognostic (7.94e-2)" "unprognostic (1.31e-2)" "prognostic favourable (7.94e-5)" "unprognostic (1.46e-1)" "unprognostic (1.11e-2)" "unprognostic (1.19e-1)" "unprognostic (6.88e-2)" "unprognostic (5.76e-2)" "unprognostic (5.58e-3)" 9.2 11.8 16.8 12.9 15.1 10.9 6.6 20.5 15.7 8.3 13.6 12.8 10.0 20.8 11.3 8.0 9.7 9.8 10.2 11.5 15.9 10.7 14.2 9.3 8.4 15.3 11.2 18.1 10.0 13.0 8.6 13.2 7.3 11.1 10.6 12.2 12.4 14.6 10.7 6.5 19.5 16.2 8.3 8.1 21.0 15.0 10.7 13.7 15.1 9.3 5.6 13.2 8.3 7.0 1.5 2.0 7.7 1.8 5.8 2.2 0.8 5.1 7.8 7.7 6.0 3.0 2.5 13.4 6.6 2.8 4.4 4.3 5.7 12.4 3.9 2.3 2.3 8.8 1.9 4.4 2.3 14.9 13.6 7.2 12.9 10.0 4.9 4.6 10.2 2.2 3.1 4.6 1.9 3.3 8.0 4.9 1.8 4.5 10.3 17.7 11.5 5.5 9.8 5.4 8.3 6.9 6.2 19.4 15.2 4.2 6.0 8.3 3.0 5.7 5.7 7.6 6.5 6.1 7.9 12.2 2.7 7.0 7.2 8.5 7.1 1.7 1.8 3.3 2.0 1.0 0.5 1.5 1.3 2.0 0.8 1.5 1.2 1.8 7.7 5.8 1.1 2.0 2.2 0.8 16.8 15.1 20.5 15.7 15.9 10.7 11.2 18.1 11.1 13.7 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" "Focal adhesion sites" Nucleoplasm "HPA053322: " "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavourable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.2 0.8 2.5 0.3 0.0 0.0 0.4 0.5 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.8 0.0 0.1 0.0 0.1 0.4 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.6 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066932-77126155 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.5;intestine: 47.8" "Cell line enhanced" "Detected in many" "U-2197: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.8" "Lineage enriched" "Detected in single" 5 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: " "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 3.9 7.1 5.6 19.5 5.4 1.5 3.9 6.3 10.8 7.4 34.1 6.0 4.8 32.7 6.3 8.3 18.3 6.6 49.5 4.4 5.4 4.6 8.7 26.8 2.8 1.2 3.7 7.0 15.4 3.2 0.7 3.3 2.6 10.2 9.3 27.9 7.4 4.7 7.5 1.8 1.9 47.8 9.3 4.1 2.2 29.3 22.0 2.3 0.6 3.1 4.6 7.3 9.8 6.3 0.2 0.7 0.0 0.9 0.0 4.8 2.1 0.4 6.7 4.5 4.4 17.0 16.4 0.4 6.8 11.8 7.0 5.1 3.9 2.0 0.2 4.9 11.7 0.3 1.8 0.5 3.0 0.4 0.4 1.3 0.2 0.4 4.2 0.1 0.4 8.1 0.7 11.2 2.7 8.1 0.1 0.1 12.9 9.4 1.1 0.2 3.8 5.3 1.0 15.2 0.2 2.3 8.5 0.3 8.1 1.6 1.3 3.0 1.0 0.0 16.7 13.6 8.0 18.7 0.8 0.4 0.9 0.0 7.0 0.2 3.1 0.0 0.7 0.0 4.8 0.9 0.4 0.0 0.5 1.6 0.7 0.2 2.4 2.5 0.0 0.0 0.2 0.3 0.0 2.1 5.6 5.4 6.3 10.8 5.4 4.6 3.7 7.0 10.2 2.3 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell line enriched" "Detected in some" 9 "RT4: 41.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: " "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 2.4 0.0 0.0 0.0 4.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.9 41.1 0.6 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139575-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol 50000000 "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 67.8 59.4 58.7 49.6 53.1 47.1 54.4 29.9 92.0 74.8 87.8 50.8 45.3 61.3 50.1 48.8 111.9 74.9 70.6 137.2 55.7 61.0 104.0 67.5 70.7 74.0 56.6 52.0 63.0 45.1 72.3 48.6 48.1 71.5 59.8 69.6 62.8 61.4 71.8 95.7 30.9 95.6 69.2 47.4 63.6 50.4 49.2 27.8 45.4 71.4 65.9 87.3 56.7 57.9 13.4 25.7 11.3 33.2 9.6 20.3 8.1 40.5 101.8 25.5 36.4 61.6 75.5 5.1 33.2 71.0 67.8 52.6 23.0 60.3 14.6 49.3 110.6 21.7 30.5 81.4 57.6 61.4 15.0 16.9 30.7 38.8 71.6 16.8 42.8 80.7 50.8 43.8 62.3 73.6 20.4 58.9 103.0 53.3 30.0 30.5 14.7 51.6 15.9 20.7 27.0 127.2 40.9 17.3 21.8 40.0 56.8 15.8 33.1 27.6 47.5 60.2 45.8 20.1 33.3 21.0 27.9 13.0 68.3 23.0 51.5 8.8 22.5 9.3 20.3 31.4 13.0 12.9 14.3 16.2 19.8 13.4 8.8 11.8 11.3 9.6 33.2 25.7 14.0 8.1 58.7 53.1 29.9 92.0 55.7 61.0 56.6 52.0 71.5 27.8 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavourable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favourable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.6 3.2 6.1 5.2 6.1 6.5 3.7 8.6 7.3 3.7 5.1 1.7 3.0 2.7 7.6 9.0 3.7 3.2 14.0 6.8 4.0 3.6 11.3 5.3 6.5 3.4 1.7 1.1 7.4 5.6 12.0 9.7 8.4 0.7 2.7 8.8 0.9 2.2 2.9 7.2 9.9 1.0 9.2 1.3 1.6 16.7 7.7 4.7 3.2 2.3 3.7 2.1 0.5 11.4 7.2 4.0 22.0 15.8 5.3 3.7 2.4 8.8 0.5 4.7 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.0;U-266/70: 10.0" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favourable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favourable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.0 1.1 0.7 3.4 1.3 1.8 2.1 0.5 0.4 0.2 0.3 0.8 7.4 0.8 2.2 0.9 1.3 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.2 2.1 0.2 0.5 0.5 0.5 2.9 0.4 2.1 1.4 2.0 0.6 5.6 1.7 0.3 2.3 1.0 3.1 0.7 2.5 0.5 36.0 3.6 2.2 2.3 1.0 0.6 0.4 2.6 9.5 10.0 3.4 0.6 4.2 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell line enhanced" "Detected in many" "A549: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040004 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome Centrosome "Nucleoplasm, Nucleoli" "HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.8 5.0 1.4 0.4 2.5 1.9 0.2 1.0 0.2 2.7 2.9 0.0 2.3 0.5 4.4 0.7 1.1 0.0 2.2 1.9 1.7 0.8 2.1 0.8 0.0 0.0 0.3 0.0 0.8 1.3 2.3 0.5 0.3 0.4 0.8 3.5 0.1 2.4 2.0 0.7 0.7 0.0 0.0 0.2 3.5 0.0 2.9 1.4 0.2 0.1 1.6 1.7 0.7 1.1 2.5 1.1 0.6 0.4 0.2 0.0 0.0 2.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.1 0.0 0.9 0.0 0.1 0.0 4.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 1.2 2.2 0.0 0.5 0.0 0.0 18.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line alpha subunit 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved "Endoplasmic reticulum,Cytosol" 19000000 "Endoplasmic reticulum" Cytosol "HPA007470: AB_1845985, HPA007643: " "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavourable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favourable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 32.4 17.7 23.6 15.8 22.6 33.6 18.5 17.6 30.2 17.7 26.3 10.7 13.5 16.9 20.6 16.4 25.9 14.9 17.6 36.4 26.7 20.6 40.9 29.2 23.2 16.6 22.1 15.9 17.3 13.8 12.9 16.4 26.1 27.1 21.8 20.6 11.8 14.4 18.3 47.1 11.6 30.6 30.3 19.6 26.0 17.8 12.4 13.7 17.7 24.5 21.0 14.0 31.5 15.0 6.6 14.8 32.0 22.8 7.1 7.8 17.7 12.9 8.8 8.5 11.1 16.3 17.3 4.7 12.8 18.1 12.9 14.8 6.4 16.6 8.8 21.0 18.1 8.1 8.8 10.5 20.0 9.6 7.0 13.2 8.7 10.7 10.1 8.8 17.9 13.9 11.8 10.5 9.9 27.1 8.8 15.3 25.3 6.3 11.4 14.8 12.6 7.6 8.1 11.5 17.4 30.0 11.1 9.1 10.4 11.9 44.9 12.2 6.3 10.2 10.0 20.7 6.6 16.3 12.0 12.1 8.8 16.8 12.3 12.5 14.7 19.9 16.4 19.2 5.5 20.1 6.1 6.6 6.5 5.7 14.8 6.0 6.4 6.5 32.0 7.1 22.8 8.2 7.8 17.7 23.6 22.6 17.6 30.2 26.7 20.6 22.1 15.9 27.1 13.7 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavourable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 47.7 28.4 51.2 36.8 70.3 90.5 36.0 81.3 84.9 72.1 74.2 35.4 67.4 33.0 35.5 101.6 40.6 43.9 56.1 81.2 51.9 31.1 64.6 38.1 55.2 72.1 42.8 106.8 83.4 46.7 61.7 58.4 65.6 22.9 47.2 72.0 33.9 47.4 49.8 38.4 30.8 42.9 36.0 43.3 90.9 27.5 31.1 24.1 47.8 40.0 53.8 43.9 37.5 67.6 48.6 39.9 79.5 38.7 29.2 35.1 41.6 63.7 56.4 52.3 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.6;U-2197: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: " "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favourable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 8.1 6.8 3.5 4.5 2.3 0.0 10.2 1.5 2.7 5.7 16.4 2.4 4.1 23.7 9.8 6.4 6.8 5.9 14.1 7.6 1.7 1.1 14.0 10.5 7.0 2.4 1.6 1.3 6.8 8.9 1.6 1.7 4.9 3.8 5.6 6.2 5.6 12.6 3.2 8.0 7.3 33.6 4.1 1.3 3.3 7.0 11.1 1.3 0.7 5.6 13.5 3.9 4.9 9.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 12.8 9.4 1.7 1.3 0.0 3.8 8.5 1.2 2.8 5.5 4.3 5.8 9.2 0.0 4.6 2.2 18.2 2.1 23.6 1.7 0.0 5.1 0.3 5.9 9.0 2.3 0.2 0.8 1.3 4.9 10.5 13.5 11.0 1.3 0.0 4.1 4.4 0.0 0.8 3.1 5.7 0.0 16.9 1.3 8.2 2.2 0.6 1.0 9.0 4.0 0.9 4.3 0.7 14.6 4.1 12.1 35.4 6.7 0.0 0.0 0.0 13.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 3.5 2.3 1.5 2.7 1.7 1.1 1.6 1.3 3.8 1.3 CARF "ALS2CR8, CaRF, FLJ21579, NYD-SP24" ENSG00000138380 "Calcium responsive transcription factor" Q8N187 2 202912214-202987063 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034557, HPA043191" Approved Approved "Nucleoli fibrillar center,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA034557: AB_10601663, HPA043191: " "unprognostic (4.63e-2)" "unprognostic (3.11e-1)" "unprognostic (1.30e-1)" "unprognostic (1.93e-2)" "unprognostic (6.09e-2)" "unprognostic (8.65e-3)" "unprognostic (1.12e-1)" "unprognostic (2.13e-3)" "unprognostic (4.39e-2)" "unprognostic (1.10e-1)" "unprognostic (7.58e-3)" "unprognostic (1.08e-1)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" 8.3 8.7 9.8 7.9 15.0 7.1 11.5 10.7 18.2 9.4 8.8 18.3 9.3 6.7 15.4 15.4 8.2 11.1 8.8 7.4 12.1 8.7 10.5 6.5 7.6 11.8 18.4 14.5 13.9 8.1 12.0 18.8 7.4 19.1 10.3 9.0 10.7 8.9 11.1 7.9 11.4 9.4 10.2 15.8 10.5 8.8 27.3 16.3 16.4 15.4 3.8 11.1 12.8 9.7 4.1 2.4 1.7 2.6 11.9 6.0 1.0 2.5 2.4 6.5 5.6 4.7 9.3 4.9 4.0 4.6 4.1 3.7 3.3 6.4 3.9 1.7 4.6 4.6 3.2 2.6 4.4 3.0 1.9 6.9 3.0 1.7 4.1 3.5 3.1 8.5 5.6 3.4 8.8 2.4 2.7 16.1 6.1 5.0 7.2 5.7 2.8 3.5 4.9 4.5 3.1 7.1 2.7 4.6 5.0 4.3 2.4 1.9 3.6 6.9 2.9 7.5 1.9 4.8 2.5 14.4 8.0 4.3 6.4 4.1 4.6 1.7 1.4 1.1 3.2 2.6 3.6 2.9 3.3 2.9 1.5 4.1 4.7 3.2 0.6 11.9 1.6 2.4 6.0 1.0 9.8 15.0 10.7 18.2 12.1 8.7 18.4 14.5 19.1 16.3 CARS2 FLJ12118 ENSG00000134905 "Cysteinyl-tRNA synthetase 2, mitochondrial" Q9HA77 13 110641412-110713603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041776 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA041776: " "unprognostic (2.34e-3)" "unprognostic (9.50e-2)" "unprognostic (6.62e-2)" "prognostic favourable (1.84e-4)" "unprognostic (1.98e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (7.82e-2)" "unprognostic (2.11e-3)" "unprognostic (5.75e-2)" "prognostic unfavourable (2.49e-5)" "unprognostic (4.73e-2)" "unprognostic (3.42e-1)" "unprognostic (3.21e-1)" "unprognostic (1.71e-2)" 19.6 28.1 11.9 24.8 13.0 25.6 37.1 18.2 14.5 21.8 20.2 17.6 21.2 17.8 18.5 23.0 20.2 16.8 26.9 26.0 9.9 10.3 17.0 21.4 19.9 26.7 11.3 14.1 17.6 31.7 11.5 19.7 12.5 11.7 17.5 15.0 16.6 19.0 21.3 39.7 16.1 20.1 22.1 11.7 19.7 17.9 11.2 11.4 21.8 19.2 18.5 21.9 16.9 16.7 3.4 4.0 3.1 6.8 0.6 2.2 1.7 35.1 11.7 6.7 16.4 18.0 16.9 9.1 15.7 14.3 15.9 19.6 16.4 15.9 16.4 22.0 17.1 18.7 11.5 19.6 13.0 15.0 19.2 10.2 24.8 18.7 18.4 25.0 12.5 21.0 15.7 13.8 16.7 11.3 7.0 5.2 22.4 8.2 11.1 8.1 5.7 11.6 16.4 4.9 6.7 17.0 10.3 12.0 9.1 12.6 19.5 18.1 9.4 27.8 10.1 13.3 5.0 16.7 15.7 9.3 10.6 9.5 65.0 15.0 13.1 0.0 4.7 0.7 2.0 5.1 2.2 3.4 0.6 0.8 4.0 1.4 2.0 1.0 3.1 0.6 6.8 3.4 0.7 1.7 11.9 13.0 18.2 14.5 9.9 10.3 11.3 14.1 11.7 11.4 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.8 13.9 13.3 7.9 9.0 7.4 4.3 9.5 7.9 5.6 5.1 29.9 17.7 0.1 4.9 11.8 21.8 14.7 9.7 9.4 9.6 8.2 0.0 12.5 10.6 9.3 1.7 1.4 8.4 26.7 10.6 13.6 4.5 0.8 8.5 12.1 12.7 3.1 0.7 12.2 9.1 5.1 32.8 5.2 12.6 23.7 12.2 6.5 17.9 7.1 5.4 7.7 0.3 5.3 10.5 10.6 8.9 5.2 3.3 2.0 3.6 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB079050: , HPA055990: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 1.2 0.3 0.0 16.6 3.7 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.9 0.7 0.0 0.9 0.0 0.4 0.2 0.0 7.7 3.7 0.1 0.2 0.2 1.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.2;lymphoid tissue: 40.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 37.8;HBEC3-KT: 17.9;HHSteC: 20.3;U-937: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in many" "olfactory region: 22.8" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 7.4 3.9 6.6 15.1 17.0 8.2 6.9 3.5 7.0 4.1 12.8 2.2 2.9 34.0 3.0 4.2 10.6 4.3 7.3 4.9 9.3 3.0 6.4 5.8 20.5 16.2 16.7 2.6 4.4 3.4 0.2 3.7 8.7 13.3 6.1 13.9 3.7 7.0 3.2 1.6 9.9 37.2 5.2 17.4 40.7 5.6 1.5 11.0 4.1 3.7 5.6 9.0 9.7 13.2 7.3 39.6 40.5 64.2 11.1 34.3 31.2 0.4 0.1 0.0 1.8 2.0 4.2 0.3 1.9 37.8 4.8 13.2 0.0 0.2 6.1 0.7 2.1 2.7 0.0 17.9 1.1 4.0 0.0 0.3 0.2 0.4 20.3 7.1 0.0 7.2 12.7 3.9 10.4 2.0 0.0 0.0 1.1 0.0 0.2 9.9 0.0 0.1 5.9 0.1 4.8 0.1 2.9 0.1 0.1 5.6 0.3 8.3 0.4 16.4 2.4 4.4 0.2 0.4 0.5 0.0 1.7 0.0 2.7 44.7 0.9 12.3 42.8 23.2 25.4 64.2 34.3 7.3 18.1 22.0 39.6 6.0 9.9 16.4 40.5 11.1 64.0 1.4 22.2 31.2 6.6 17.0 3.5 7.0 9.3 3.0 16.7 2.6 13.3 11.0 CASP10 MCH4 ENSG00000003400 "Caspase 10" Q92851 2 201182881-201229406 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 16.0 3.3 3.4 10.1 3.4 14.9 7.6 1.9 3.3 7.0 17.7 4.4 4.3 18.6 8.3 8.2 10.4 4.9 7.2 4.8 3.6 3.0 10.3 7.8 14.2 10.4 4.1 1.4 3.4 6.1 1.4 2.1 8.5 4.7 5.0 11.9 4.1 6.9 6.9 3.6 5.4 42.4 4.8 5.6 26.1 8.7 2.1 2.5 17.1 6.8 8.2 17.9 9.4 6.1 7.8 6.0 4.7 15.4 7.1 7.1 5.8 2.9 2.3 0.1 0.2 0.1 0.2 5.1 0.5 3.4 0.3 1.3 3.1 6.8 0.2 4.9 1.7 1.9 0.1 1.6 0.9 1.4 3.3 8.2 2.4 10.2 1.1 5.4 8.9 0.3 1.4 3.7 0.3 17.7 9.8 12.1 0.3 0.1 10.5 5.1 0.3 1.5 5.7 0.3 12.1 6.2 4.1 0.1 0.1 2.8 0.1 1.3 0.0 5.2 7.1 0.2 0.5 2.3 0.1 13.2 7.8 0.3 3.3 4.2 0.1 4.7 9.6 0.6 6.2 13.5 5.2 7.8 5.2 3.4 5.3 5.0 7.1 6.0 1.9 7.1 15.4 6.0 1.0 5.8 3.4 3.4 1.9 3.3 3.6 3.0 4.1 1.4 4.7 2.5 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell line enriched" "Detected in some" 7 "hTCEpi: 32.4" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: " "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavourable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Supported Nucleoplasm,Mitochondria 310000 "Nucleoplasm, Mitochondria" "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favourable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.2 4.6 18.3 8.7 11.4 15.2 10.6 24.8 18.8 17.4 10.1 8.3 6.9 11.5 3.9 12.1 7.0 14.5 8.8 19.9 29.4 7.9 18.3 3.6 19.3 13.6 14.9 17.5 20.7 10.8 11.0 9.0 21.5 15.1 72.7 17.9 3.5 23.5 13.9 18.1 5.8 17.0 8.6 11.0 15.0 13.5 10.5 11.4 10.7 9.8 13.9 5.3 9.7 14.6 8.0 7.3 5.9 11.4 33.8 31.7 7.9 9.7 10.4 11.3 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavourable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.3 2.1 0.0 2.8 13.7 31.2 5.3 11.0 21.5 17.7 24.8 5.3 29.0 3.3 23.7 14.2 10.6 0.0 19.0 16.9 3.7 0.1 8.6 1.6 13.8 33.6 8.6 4.2 28.3 28.5 21.1 29.5 30.7 0.2 0.0 13.5 0.6 5.0 10.2 0.0 6.3 3.8 4.1 2.9 14.8 10.1 0.1 0.0 10.1 7.2 10.0 2.9 12.6 15.9 18.7 6.5 16.4 7.7 0.0 0.0 0.0 9.5 19.7 13.0 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.8" "Cell line enhanced" "Detected in all" "Karpas-707: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favourable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favourable (9.93e-4)" 8.1 6.1 3.6 6.7 4.3 5.3 14.3 2.8 3.8 6.9 25.5 2.8 4.5 23.4 5.9 4.3 8.7 5.3 11.7 4.9 4.0 2.0 11.0 14.3 5.6 8.5 5.0 1.6 7.0 13.0 2.3 6.4 4.3 4.5 8.1 19.5 3.4 8.0 10.3 3.4 6.5 42.8 14.0 6.6 9.1 9.2 2.7 4.3 14.5 11.2 3.3 8.4 8.2 12.7 4.4 8.0 8.5 7.0 5.6 21.3 8.0 12.4 4.0 8.3 7.5 6.1 6.0 12.3 7.0 4.8 6.2 6.8 6.7 25.6 1.3 8.1 7.1 5.8 9.9 11.0 5.0 19.7 6.5 10.9 3.6 5.9 4.9 10.9 7.7 6.6 8.2 6.0 1.5 11.8 14.1 38.8 10.1 7.0 28.1 6.9 6.3 7.3 9.8 5.3 6.8 20.6 11.8 8.8 6.6 7.4 13.3 4.1 5.7 4.0 10.0 6.9 7.4 3.3 7.9 5.7 10.3 1.4 9.0 13.1 3.5 8.5 5.3 6.3 4.9 4.8 5.3 4.1 17.8 9.3 6.0 4.4 21.3 11.8 1.1 5.6 7.0 8.0 16.4 8.0 3.6 4.3 2.8 3.8 4.0 2.0 5.0 1.6 4.5 4.3 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: " "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favourable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavourable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 14.1 10.6 2.0 31.6 2.6 27.1 10.2 1.4 1.8 7.9 18.5 3.9 7.0 9.6 9.6 12.0 11.7 9.1 12.1 4.4 2.1 2.3 16.4 14.8 17.1 28.3 3.9 1.1 8.2 7.6 1.8 5.9 12.3 3.2 9.8 8.7 4.4 9.6 8.4 2.7 7.4 34.7 5.1 5.0 37.7 7.4 3.8 2.7 43.7 6.7 10.7 43.4 9.6 7.3 13.8 13.7 52.5 17.0 22.2 26.4 12.0 14.3 12.2 3.6 9.9 10.0 14.6 5.5 6.3 6.2 7.5 12.4 16.4 25.0 1.6 13.9 4.9 7.3 7.8 7.5 14.8 9.3 7.1 14.0 9.9 15.6 8.1 10.8 15.2 12.7 18.5 14.2 11.1 7.1 12.5 31.2 6.8 5.9 14.1 11.5 5.8 10.9 10.6 7.4 25.5 14.1 16.0 1.0 0.5 8.2 13.6 8.1 3.6 8.5 8.8 8.1 8.4 4.2 4.9 28.3 12.6 9.7 12.2 14.6 7.6 20.7 13.0 24.9 25.0 17.0 23.1 13.8 20.5 26.4 13.7 7.8 13.3 16.9 52.5 22.2 15.6 6.1 24.0 12.0 2.0 2.6 1.4 1.8 2.1 2.3 3.9 1.1 3.2 2.7 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" "Nucleoli, Nuclear bodies" "HPA053573: " "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 3.8 3.1 5.4 8.0 7.3 4.8 6.0 9.7 7.8 7.4 4.7 3.3 3.8 3.5 5.0 3.4 4.5 3.7 3.5 3.9 6.5 3.1 3.4 3.9 8.8 6.1 5.0 6.6 3.8 5.7 7.0 5.9 6.6 7.2 4.3 3.5 4.0 5.2 3.2 2.6 4.7 5.3 5.7 5.4 4.0 5.0 5.9 9.1 4.5 2.1 5.9 6.5 3.2 9.9 7.8 17.7 4.1 17.8 12.3 3.6 4.2 4.2 13.6 9.4 4.6 4.7 5.5 10.5 4.0 7.5 9.8 4.9 3.4 12.5 5.5 5.4 6.4 12.2 5.2 8.7 12.7 10.4 15.6 10.1 1.7 2.0 14.6 8.2 2.3 2.5 9.8 4.6 5.4 16.7 7.5 5.1 3.7 8.2 2.6 3.9 4.0 16.2 17.0 4.8 1.4 9.2 9.0 6.2 8.7 1.9 3.8 4.2 7.5 7.3 4.8 4.2 8.4 9.5 4.5 11.1 7.4 5.0 8.3 7.6 17.7 2.5 8.2 10.7 4.1 10.3 8.3 12.3 11.2 3.1 9.9 9.9 9.5 4.4 17.8 3.5 7.8 10.2 3.6 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190556-160201886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 320.9;tongue: 83.5" "Group enriched" "Detected in some" 9 "BEWO: 10.4;HDLM-2: 19.8;RT4: 35.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA007845, CAB015170, HPA026823" Enhanced Uncertain Nucleoplasm,Mitochondria "Intracellular and membrane" "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favourable (8.93e-5)" 6.1 0.1 0.5 0.0 0.3 0.1 0.2 0.3 2.0 0.1 0.1 0.0 0.1 0.0 0.1 11.9 3.9 0.2 0.1 4.0 0.4 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.0 1.3 0.0 0.2 4.5 0.4 320.9 0.1 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.0 0.9 83.5 4.7 0.4 0.1 0.9 0.0 0.9 0.7 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.2 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.1 0.0 35.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.1 0.1 0.0 0.0 0.9 0.7 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.9 0.1 0.1 0.9 0.2 0.1 0.0 0.3 0.0 0.5 0.3 0.3 2.0 0.4 0.3 0.2 0.0 0.0 0.0 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 201.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882" Approved Enhanced "Endoplasmic reticulum,Cytosol" 18000000 "Endoplasmic reticulum, Cytosol" "CAB009491: AB_2259755, HPA036881: , HPA036882: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (4.98e-4)" 38.3 20.7 10.4 25.0 16.3 22.1 32.0 8.7 21.7 38.0 44.6 10.5 18.6 25.6 24.8 25.9 87.4 19.5 25.5 98.5 11.9 10.6 27.2 38.2 29.5 21.1 14.3 12.5 26.9 14.8 22.3 25.3 52.6 24.8 30.0 34.5 12.7 38.7 23.2 201.9 40.7 56.3 36.2 18.7 21.7 22.2 21.2 15.6 10.1 25.6 51.2 34.1 42.2 57.0 24.5 32.7 12.4 48.0 18.3 26.6 27.2 47.9 39.6 6.7 17.5 40.6 75.7 23.7 34.2 48.4 27.4 35.7 9.7 29.3 6.9 32.4 46.3 81.7 12.7 46.5 33.2 44.6 12.0 8.9 41.9 11.6 31.2 5.8 15.5 34.2 43.1 39.3 64.1 30.6 7.5 22.4 33.3 15.1 2.8 0.2 5.2 14.7 2.7 22.7 11.8 54.4 20.3 28.4 6.8 34.9 19.2 22.3 11.7 6.3 40.6 37.4 15.9 24.9 34.5 7.5 20.0 3.2 42.4 3.1 10.3 2.5 48.0 7.0 26.6 29.0 25.2 24.5 23.9 26.5 32.7 22.7 12.2 16.3 12.4 18.3 32.2 9.0 24.2 27.2 10.4 16.3 8.7 21.7 11.9 10.6 14.3 12.5 24.8 15.6 CASZ1 "castor, cst, FLJ20321, SRG, ZNF693" ENSG00000130940 "Castor zinc finger 1" Q86V15 1 10636604-10796650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 9.5;HDLM-2: 10.3;SCLC-21H: 16.0;SK-BR-3: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028222, HPA029927" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028222: AB_10600106, HPA029927: AB_10601564" "unprognostic (1.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.67e-2)" "unprognostic (7.49e-3)" "unprognostic (4.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-4)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (1.03e-5)" "unprognostic (3.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-2)" "unprognostic (1.56e-1)" 3.4 0.9 0.3 2.5 1.5 2.8 6.0 0.3 0.7 6.1 20.7 0.5 14.7 8.8 11.0 2.4 9.9 3.4 13.8 9.9 0.2 0.2 4.5 1.4 7.4 0.8 0.8 0.3 1.7 4.4 0.0 4.0 1.2 0.9 12.1 2.4 19.8 17.0 17.4 29.9 25.3 27.1 8.0 0.2 1.2 9.2 1.0 0.8 0.2 1.9 14.4 6.2 7.2 7.2 0.5 3.5 1.9 2.2 1.6 1.6 0.4 9.5 0.8 1.8 1.7 0.0 0.0 0.4 0.3 0.1 0.3 0.3 2.0 2.2 0.4 2.0 0.4 8.3 1.8 1.9 0.1 10.3 3.3 0.6 1.6 2.2 0.3 1.1 3.1 0.1 7.1 0.1 0.6 0.3 0.0 0.0 0.0 5.1 0.5 6.8 0.2 0.5 0.8 1.2 0.1 1.6 3.9 16.0 1.4 2.5 15.2 0.2 8.1 1.0 0.1 0.0 1.3 0.8 0.2 0.0 0.0 1.0 0.0 2.9 0.1 1.9 0.2 1.2 1.6 0.4 0.7 0.4 0.6 1.1 0.6 0.5 0.0 0.5 0.4 1.6 2.2 3.5 0.3 0.4 0.3 1.5 0.3 0.7 0.2 0.2 0.8 0.3 0.9 0.8 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.4 0.2 1.8 0.8 0.0 4.1 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.2 0.0 0.8 0.0 0.5 0.1 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.8 1.9 0.1 0.4 0.5 0.4 0.9 0.2 0.4 0.0 0.3 0.0 1.0 0.6 0.0 0.7 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell line enriched" "Detected in some" 4 "RH-30: 45.1" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: " "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402452-42423517 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 110.3;TIME: 91.5;U-138 MG: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" 29000 "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: " "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavourable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavourable (5.87e-4)" 105.6 12.7 4.7 26.4 5.4 0.7 111.2 4.5 7.6 68.6 52.0 15.3 31.9 7.1 65.6 45.6 60.3 37.1 74.0 37.3 6.4 4.6 12.1 6.6 47.0 15.6 7.7 6.1 57.8 6.8 7.5 6.9 47.7 13.6 51.8 12.4 34.0 17.4 53.8 45.4 28.6 18.6 115.4 14.7 23.9 27.0 24.3 5.2 3.3 30.4 47.9 12.6 80.6 57.9 0.9 0.6 2.7 0.5 0.7 1.2 0.2 30.6 26.3 0.5 7.0 35.6 42.9 0.7 110.3 48.1 44.1 35.0 13.2 2.0 0.0 22.1 78.8 50.7 4.7 33.0 36.1 0.1 0.9 13.4 16.1 6.4 22.5 0.0 0.1 29.4 12.2 34.6 11.9 59.4 9.1 0.1 18.8 0.4 0.7 0.1 2.6 0.1 0.0 17.6 0.0 18.8 0.1 0.0 0.2 37.0 0.6 8.8 3.0 0.2 91.5 93.8 44.1 33.5 40.0 0.0 0.0 0.1 27.8 0.0 10.5 2.7 0.5 0.3 0.5 0.4 0.3 0.3 1.2 0.3 0.2 0.9 0.6 0.3 2.3 0.7 0.4 0.6 0.3 0.2 4.7 5.4 4.5 7.6 6.4 4.6 7.7 6.1 13.6 5.2 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834302-191847255 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 27.6;HEL: 20.1;HUVEC TERT2: 62.5;LHCN-M2: 96.9;TIME: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 9.9;neutrophil: 8.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" 160000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: " "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favourable (8.45e-5)" "prognostic unfavourable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 60.3 8.9 4.9 10.1 8.3 1.8 37.8 2.8 6.1 26.1 32.6 2.8 14.5 3.9 23.9 17.4 18.2 19.5 45.3 46.5 7.1 5.3 15.9 10.4 57.9 20.1 8.9 5.6 20.4 7.6 3.2 4.3 11.6 5.8 19.3 8.9 9.8 6.9 11.2 35.7 3.8 10.6 39.3 7.1 52.9 8.8 7.2 4.4 0.3 34.5 20.1 2.8 33.2 34.5 0.1 1.0 9.9 0.8 0.4 0.1 39.0 0.0 3.4 1.2 0.0 0.1 0.6 0.0 0.7 0.6 0.1 0.2 0.0 0.0 0.0 4.4 27.6 0.6 0.0 5.4 0.4 0.0 0.0 20.1 0.2 7.6 7.8 0.0 0.0 1.5 3.6 0.5 1.7 62.5 7.2 0.0 96.9 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 8.9 0.4 0.4 1.0 0.1 39.0 4.9 8.3 2.8 6.1 7.1 5.3 8.9 5.6 5.8 4.4 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100587906 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 83.8;tongue: 52.4" "Cell line enhanced" "Detected in many" "AF22: 7.2;NTERA-2: 10.1;SCLC-21H: 15.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 3.5 0.0 0.3 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.2 2.7 1.9 0.0 0.1 16.4 0.5 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.8 0.0 83.8 0.1 0.0 0.1 0.7 0.0 0.1 1.4 0.0 0.1 0.2 52.4 1.6 0.0 0.0 0.4 0.3 1.4 0.4 0.7 0.7 0.0 0.5 0.4 7.2 2.7 1.6 2.4 5.2 1.3 1.0 1.0 1.2 0.0 0.5 0.3 0.3 0.6 0.3 3.4 0.1 2.1 1.7 2.4 0.0 1.1 0.0 0.5 0.3 0.4 5.8 0.3 1.0 0.6 1.2 0.2 0.3 4.5 0.1 2.0 0.3 10.1 0.8 2.9 6.8 0.0 0.8 0.4 15.5 4.1 0.2 0.3 1.4 0.2 0.2 1.3 1.8 1.4 1.3 1.1 0.4 1.3 0.7 1.9 0.1 1.3 0.6 0.3 0.2 0.5 0.4 0.2 0.2 0.7 0.5 0.1 0.4 0.5 0.5 1.4 0.7 0.3 0.3 0.2 0.0 0.3 0.6 0.5 0.3 0.5 0.3 0.5 0.1 0.0 0.0 CBFB PEBP2B ENSG00000067955 "Core-binding factor beta subunit" Q13951 16 67029116-67101058 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038852 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038852: AB_10795358" "unprognostic (1.05e-1)" "unprognostic (1.18e-2)" "unprognostic (1.30e-1)" "unprognostic (3.22e-2)" "unprognostic (4.66e-2)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.83e-4)" "unprognostic (1.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-3)" "unprognostic (1.88e-2)" "prognostic unfavourable (2.89e-8)" "unprognostic (1.03e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" 15.9 10.9 15.9 26.4 25.1 20.5 15.0 9.5 14.3 15.4 10.6 23.3 11.8 8.8 15.3 10.2 20.5 14.3 16.3 21.5 16.2 13.2 12.1 14.4 16.1 32.6 23.6 12.4 17.3 13.6 40.4 18.8 13.2 17.5 14.6 11.1 13.7 19.6 10.3 33.3 14.8 12.2 11.7 22.4 18.2 17.1 7.3 24.2 42.2 17.0 14.8 31.0 15.9 18.8 6.5 9.1 20.5 9.2 14.8 7.0 5.1 15.4 10.3 9.0 14.7 6.6 8.5 14.5 17.9 10.7 16.9 15.0 20.7 17.7 34.2 17.1 15.2 15.4 16.1 10.1 22.8 11.7 9.2 23.7 8.8 16.4 9.4 30.9 51.1 8.5 6.9 18.9 14.6 13.7 25.2 12.2 17.5 11.7 31.8 16.6 8.8 14.6 64.5 39.1 29.0 11.9 13.8 13.3 11.9 45.9 7.0 18.3 6.3 22.2 18.9 26.3 18.0 14.9 24.0 16.7 29.7 99.9 20.0 21.2 23.6 20.5 7.4 7.4 6.7 9.2 7.0 6.5 6.6 7.0 9.1 6.4 6.3 5.3 4.6 14.8 6.1 3.3 7.0 5.1 15.9 25.1 9.5 14.3 16.2 13.2 23.6 12.4 17.5 24.2 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 38.4 9.0 3.7 19.5 4.9 15.5 16.3 24.4 3.8 13.7 18.7 5.9 7.7 9.3 13.8 12.2 8.3 12.5 13.4 27.5 3.8 4.8 7.4 6.7 16.3 19.1 4.4 1.9 17.7 6.8 3.4 13.5 25.4 7.9 12.9 8.0 11.6 9.1 6.3 10.3 8.5 13.8 25.6 5.7 16.4 12.4 9.2 5.2 11.6 13.5 7.0 18.0 24.9 24.1 5.1 3.1 2.8 2.1 10.3 9.9 1.6 1.6 2.2 7.6 3.7 8.7 8.8 4.9 5.6 2.8 1.6 2.7 2.9 1.9 3.6 4.0 3.0 2.8 1.0 1.0 2.0 2.7 2.9 1.9 11.7 1.8 12.8 1.3 1.4 8.4 3.0 4.4 12.0 5.5 2.0 11.5 3.5 2.0 1.9 0.9 2.7 3.2 4.1 2.3 0.6 4.0 7.2 5.8 6.4 6.7 0.8 8.8 1.6 2.9 3.1 23.4 2.0 3.2 1.3 6.5 0.5 5.6 6.2 1.2 1.5 0.7 1.5 2.8 9.9 0.9 8.8 2.2 5.1 5.6 1.3 5.1 4.4 8.0 1.0 10.3 2.1 3.1 5.6 1.6 3.7 4.9 24.4 3.8 3.8 4.8 4.4 1.9 7.9 5.2 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 176.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018433 Enhanced Approved Nucleoplasm,Cytosol 12000000 Nucleoplasm Cytosol "HPA018433: AB_1846109" "prognostic favourable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favourable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 9.6 22.9 31.7 8.4 41.6 3.7 8.5 12.0 35.8 14.6 63.4 75.9 6.5 176.1 9.3 17.1 40.2 9.6 15.1 7.8 37.7 24.7 35.2 77.2 11.7 8.5 57.3 25.2 10.4 8.0 8.9 7.9 11.7 51.6 16.7 16.8 10.4 23.1 15.0 8.7 34.4 118.1 11.6 48.1 10.0 41.4 5.7 41.9 3.6 11.3 29.8 14.3 12.4 17.1 17.0 29.9 17.1 51.4 19.1 29.2 37.0 25.4 39.2 4.8 12.4 25.2 25.5 0.2 28.5 20.5 15.6 18.7 14.4 15.0 6.4 18.8 26.6 18.7 9.8 28.0 12.0 31.6 23.2 19.2 22.8 9.8 14.4 10.6 17.7 12.4 35.3 15.1 6.6 16.6 0.0 4.7 14.3 25.2 5.3 11.1 0.0 28.6 0.0 0.1 17.7 41.5 12.7 14.0 12.6 27.6 40.1 32.4 19.0 14.8 16.7 17.5 7.4 44.5 20.6 32.1 58.1 0.1 32.2 10.6 25.4 1.8 36.6 17.1 18.1 51.4 15.3 17.0 22.7 16.9 29.9 15.6 29.2 21.4 2.5 19.1 38.6 10.4 22.7 37.0 31.7 41.6 12.0 35.8 37.7 24.7 57.3 25.2 51.6 41.9 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavourable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.0 3.4 1.5 3.0 11.8 18.3 2.3 13.2 15.6 15.1 12.1 0.1 2.6 0.0 3.9 13.5 5.6 2.0 2.6 6.1 16.4 6.3 0.5 3.6 0.1 1.0 0.0 0.0 2.6 0.3 10.5 1.3 9.1 0.0 0.1 4.4 9.0 1.1 5.3 1.2 15.3 2.5 2.9 23.4 5.0 5.1 0.8 1.1 10.1 12.3 19.2 3.6 1.4 6.2 9.8 0.8 11.0 12.7 0.5 0.2 0.0 10.2 0.3 17.6 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 CBS HIP4 ENSG00000160200 Cystathionine-beta-synthase P35520 21 43053191-43076943 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.7;pancreas: 43.0" "Cell line enhanced" "Detected in many" "BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 84 "neutrophil: 8.3" "Lineage enriched" "Detected in single" 84 "granulocytes: 8.3" HPA001223 Supported Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 1.3 1.5 6.5 2.4 5.1 0.4 1.0 12.3 6.7 4.8 1.3 2.0 0.8 1.6 0.9 0.8 0.8 2.0 2.1 2.0 5.6 5.5 1.3 55.7 1.7 1.4 4.8 2.8 13.9 43.0 0.3 1.4 1.4 2.3 4.0 0.7 2.8 9.3 3.4 0.8 0.6 2.9 1.4 3.7 0.8 2.7 2.2 3.3 0.8 5.0 0.8 0.9 2.6 0.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.3 3.8 5.0 19.6 11.3 7.3 40.2 7.8 2.0 3.2 3.3 11.8 0.3 0.0 4.2 14.7 0.4 38.3 2.7 0.6 0.0 4.8 2.6 15.3 14.2 51.8 1.6 3.8 4.4 0.4 3.5 3.1 8.6 29.6 22.3 2.4 44.3 2.7 0.0 4.7 6.7 0.0 0.0 42.4 0.1 3.5 10.4 15.3 17.2 1.0 7.4 6.1 20.0 1.1 0.2 9.9 0.1 0.8 7.8 6.2 8.8 3.6 2.3 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 6.5 5.1 12.3 5.2 5.6 5.5 4.8 2.8 2.3 3.3 CBSL ENSG00000274276 "Cystathionine-beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;liver: 21.2;pancreas: 18.5" "Cell line enhanced" "Detected in many" "AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" HPA001223 Supported Approved Nucleoli,Vesicles 190000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 21.2 0.0 0.0 1.6 18.5 0.0 0.0 1.8 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 35.7 0.0 0.0 0.4 7.4 4.3 2.7 8.3 0.1 4.8 0.0 0.0 0.0 3.1 0.0 3.8 1.7 0.0 9.4 0.0 0.0 0.0 0.2 0.0 5.1 4.2 13.9 0.0 7.0 0.0 0.2 16.5 0.1 0.0 5.6 0.6 66.2 0.0 0.0 0.0 0.0 10.8 0.0 13.8 21.1 0.0 1.1 14.4 0.0 0.0 0.0 0.7 0.0 4.6 1.4 20.9 7.7 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 CBX1 "CBX, HP1-BETA, HP1Hs-beta, M31, MOD1" ENSG00000108468 "Chromobox 1" P83916 17 48070052-48101521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012265 Supported Supported "Nucleoplasm,Nuclear bodies" 35000 "Nucleoplasm, Nuclear bodies" "CAB012265: AB_297216" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (2.02e-1)" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (3.04e-1)" "prognostic unfavourable (2.70e-4)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" "unprognostic (6.55e-2)" "unprognostic (2.78e-1)" "unprognostic (2.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.48e-3)" "unprognostic (3.82e-1)" "unprognostic (3.65e-1)" "unprognostic (6.73e-2)" 17.4 19.1 39.4 19.5 40.5 8.6 25.5 40.0 39.7 31.3 18.8 22.0 15.4 11.1 39.6 29.3 18.7 22.5 16.4 18.3 35.0 33.4 22.9 12.5 15.6 18.6 32.2 38.0 47.6 12.4 27.8 20.7 19.9 30.8 23.1 19.9 13.5 15.5 29.3 35.4 16.7 11.8 32.8 41.8 18.5 14.2 39.6 31.8 30.9 23.5 12.9 26.1 20.2 19.6 12.7 7.6 25.0 9.1 6.3 9.5 4.1 38.1 21.9 72.1 33.9 14.6 13.1 39.9 35.5 17.2 34.7 37.3 57.1 15.3 26.3 38.1 27.9 15.4 26.5 22.4 61.3 48.8 21.3 21.3 21.9 21.0 8.9 20.3 13.3 9.3 12.5 25.8 33.1 28.3 26.5 12.3 27.8 23.9 56.7 13.9 27.4 28.3 42.7 59.7 16.8 20.1 22.0 25.6 63.8 24.5 8.1 12.8 38.4 14.5 19.7 48.5 44.8 20.6 35.7 17.3 39.2 25.3 13.3 9.0 21.5 2.8 9.1 11.2 9.5 9.1 7.9 11.4 8.6 7.8 7.1 12.7 9.1 7.5 25.0 6.3 6.4 7.6 8.4 4.1 39.4 40.5 40.0 35.1 35.0 33.4 32.2 38.0 30.8 31.8 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213356 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" 40000 Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavourable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavourable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavourable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 40.7 49.4 41.2 54.3 38.8 65.8 69.4 37.4 45.9 33.9 38.4 20.3 39.0 49.8 39.5 42.1 36.4 33.9 28.6 43.3 39.0 40.8 51.1 45.8 37.0 68.6 44.9 37.2 45.3 31.8 22.4 27.5 45.4 51.1 30.7 43.7 23.7 35.0 45.6 60.4 27.1 56.4 46.7 66.9 54.0 29.3 45.1 33.7 92.3 32.1 38.2 65.0 39.8 38.1 38.8 37.4 55.2 48.4 39.5 60.7 35.1 49.3 21.8 46.7 46.2 16.8 30.6 36.8 38.8 29.6 29.6 30.1 25.8 41.7 75.1 31.3 25.6 39.5 39.0 32.4 48.5 20.7 29.1 42.8 28.8 28.7 18.5 67.6 41.6 22.4 28.4 23.4 33.5 39.9 68.5 37.2 50.0 28.2 65.1 81.6 59.5 31.6 42.7 43.5 61.9 43.1 27.7 57.2 63.5 32.1 68.4 35.6 58.1 61.4 29.6 26.9 48.9 31.4 51.4 55.2 79.5 127.7 23.5 58.3 121.5 47.8 38.4 55.2 34.6 47.6 42.8 38.8 51.7 42.7 37.4 35.8 55.0 54.0 39.3 39.5 48.4 30.5 60.7 35.1 41.2 38.8 37.4 45.9 39.0 40.8 44.9 37.2 51.1 33.7 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839429 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 38.4;SK-MEL-30: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: " "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavourable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 7.1 9.9 11.6 11.3 14.8 109.1 7.0 9.0 22.5 5.9 6.2 20.4 6.3 8.3 5.9 6.3 14.8 6.7 10.3 12.0 12.9 12.9 6.5 15.3 9.0 13.9 15.4 10.8 9.3 16.8 16.2 14.8 17.0 13.9 8.9 4.8 14.5 12.9 6.9 3.8 20.6 8.5 5.2 12.6 16.3 10.8 5.5 13.1 29.2 8.3 6.7 19.2 8.6 7.1 3.6 4.2 5.2 1.7 1.0 3.8 1.3 10.6 9.6 2.9 12.5 1.8 1.7 8.2 4.8 2.9 1.8 1.9 6.9 6.0 4.1 6.9 1.9 5.5 3.2 3.2 1.3 4.4 6.1 2.3 9.1 12.8 9.0 12.2 18.3 2.3 19.0 1.6 2.9 1.5 7.1 23.3 1.9 7.6 16.7 12.5 1.6 9.7 17.4 2.9 18.5 2.5 5.1 3.0 5.8 7.3 38.4 42.7 9.1 19.6 3.8 10.4 9.2 6.4 6.2 20.2 10.3 11.6 6.5 10.6 13.8 3.9 1.4 4.1 2.4 1.5 1.8 3.3 3.1 3.3 0.9 3.6 3.8 3.5 5.2 1.0 1.7 4.2 0.5 1.3 11.6 14.8 9.0 22.5 12.9 12.9 15.4 10.8 13.9 13.1 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861450-38872314 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA048653: " "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favourable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 15.0 15.0 44.7 14.5 35.1 21.7 7.4 27.8 53.8 14.0 19.5 15.3 9.8 6.5 19.3 14.2 12.9 18.8 10.9 14.0 40.6 18.3 12.1 5.9 13.0 12.0 15.8 21.8 23.4 13.1 62.2 15.5 4.7 19.3 16.1 7.4 17.0 12.5 25.4 5.5 7.7 9.2 23.8 12.1 11.2 12.0 5.0 12.0 11.3 13.4 4.5 13.8 16.6 9.5 4.7 26.9 2.6 7.4 5.2 11.7 9.2 16.5 17.5 3.9 13.4 30.2 17.0 1.2 18.1 10.5 9.4 8.8 8.7 15.5 27.2 13.6 12.3 19.8 7.2 7.7 5.2 26.1 22.7 2.7 7.6 3.0 16.5 13.3 13.5 25.2 3.9 21.5 10.3 10.6 6.1 13.8 6.4 18.7 8.2 3.9 3.5 13.6 12.4 13.1 10.7 13.4 15.7 19.2 4.2 11.6 15.5 9.7 10.6 8.0 13.8 8.2 25.4 14.2 12.3 14.2 13.6 9.9 16.1 14.0 17.0 1.1 5.5 2.6 11.7 7.4 9.7 4.2 8.1 8.2 5.4 4.7 6.7 8.2 2.3 5.2 6.8 26.9 4.6 9.2 44.7 35.1 27.8 53.8 40.6 18.3 15.8 21.8 19.3 12.0 CBX7 ENSG00000100307 "Chromobox 7" O95931 22 39120167-39152674 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.5;U-266/70: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011574, HPA048677, HPA056480" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB011574: AB_726005, HPA048677: , HPA056480: " "prognostic favourable (6.18e-4)" "prognostic favourable (3.63e-4)" "prognostic unfavourable (3.73e-4)" "unprognostic (9.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.48e-3)" "unprognostic (4.76e-3)" "unprognostic (1.45e-2)" "unprognostic (3.86e-2)" "unprognostic (1.11e-3)" "prognostic favourable (1.04e-4)" "unprognostic (3.03e-3)" "prognostic favourable (2.45e-5)" "unprognostic (3.90e-1)" "unprognostic (1.26e-1)" "unprognostic (3.10e-1)" "unprognostic (1.63e-2)" 17.6 23.1 26.1 14.2 34.3 4.0 14.0 45.0 44.7 20.1 29.3 17.2 24.1 12.3 27.8 21.9 18.0 24.7 19.1 36.5 23.9 19.5 17.6 6.4 19.1 17.2 18.7 29.5 36.9 15.0 33.4 17.1 6.2 19.7 27.1 10.6 21.1 24.0 44.0 38.6 15.4 15.8 35.9 12.9 22.0 18.8 6.5 19.9 4.5 16.9 10.8 15.1 26.2 21.1 3.7 0.7 5.5 0.9 1.7 5.1 1.6 4.4 1.9 0.9 7.2 8.9 3.4 2.4 4.2 5.2 2.3 2.8 0.9 3.0 0.7 5.0 3.1 1.6 0.6 1.9 1.7 23.5 2.3 0.1 3.0 0.4 3.1 1.0 9.3 1.7 2.9 1.1 0.4 0.6 1.1 11.9 1.8 4.2 1.5 0.5 0.5 3.2 1.7 1.5 6.3 1.1 1.8 2.4 0.5 2.1 3.1 4.8 3.8 1.7 1.7 3.9 7.4 3.9 1.8 20.4 11.4 2.7 7.9 1.7 1.6 0.6 0.5 4.8 3.7 0.1 3.8 2.9 4.0 4.0 0.1 3.7 5.1 4.8 5.5 1.7 0.9 0.7 3.8 1.6 26.1 34.3 45.0 44.7 23.9 19.5 18.7 29.5 19.7 19.9 CC2D1A "FLJ20241, MRT3" ENSG00000132024 "Coiled-coil and C2 domain containing 1A" Q6P1N0 19 13906201-13930879 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005436, CAB015220" Supported Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB015220: , HPA005436: AB_1078884" "unprognostic (8.66e-2)" "unprognostic (1.31e-2)" "unprognostic (2.55e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "prognostic favourable (7.02e-4)" "unprognostic (7.00e-2)" "unprognostic (1.59e-3)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (2.61e-3)" "unprognostic (4.07e-2)" "unprognostic (1.23e-3)" "unprognostic (6.67e-3)" "unprognostic (1.97e-1)" "unprognostic (9.22e-2)" "unprognostic (1.71e-2)" 11.2 9.5 19.1 14.5 18.7 9.1 12.0 30.5 22.2 11.4 28.7 13.6 15.3 43.2 10.1 10.0 18.2 16.9 16.6 10.4 17.8 21.3 12.6 16.2 11.9 9.5 15.8 20.1 11.5 30.0 17.3 18.7 12.2 16.1 14.2 14.7 13.3 32.7 16.9 18.7 28.6 35.3 11.1 12.6 11.3 21.0 10.1 13.7 10.6 12.0 13.6 13.7 13.1 14.1 2.4 3.0 4.1 5.2 1.6 4.8 2.0 22.0 9.3 3.1 12.8 6.3 5.2 9.9 7.7 9.5 12.5 12.0 12.8 6.7 11.6 12.6 7.7 16.2 5.8 11.7 4.3 16.9 32.0 5.7 11.4 8.0 10.5 4.7 16.9 6.3 14.3 7.7 5.1 8.4 5.9 9.5 4.0 23.4 11.1 12.9 7.0 16.7 11.5 6.9 9.2 8.5 16.8 11.5 6.7 10.2 15.5 11.6 11.4 9.0 7.9 9.6 4.8 21.2 9.3 16.2 7.2 6.0 12.2 15.9 8.7 3.9 3.2 4.1 4.8 5.2 1.9 2.4 2.3 2.1 3.0 1.3 1.2 2.7 2.8 1.6 4.8 2.5 1.9 2.0 19.1 18.7 30.5 22.2 17.8 21.3 15.8 20.1 16.1 13.7 CC2D1B KIAA1836 ENSG00000154222 "Coiled-coil and C2 domain containing 1B" Q5T0F9 1 52345723-52366193 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027500, HPA031426" Uncertain Supported Nucleoplasm,Vesicles 140000 Nucleoplasm Vesicles "HPA027500: AB_10600693, HPA031426: " "unprognostic (1.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.38e-2)" "unprognostic (2.50e-2)" "unprognostic (5.85e-2)" "unprognostic (2.04e-2)" "prognostic unfavourable (1.45e-5)" "unprognostic (3.39e-2)" "unprognostic (4.75e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-2)" "unprognostic (2.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-2)" "unprognostic (1.87e-1)" 14.6 16.0 12.6 14.5 20.0 7.4 11.5 12.9 18.8 9.6 13.0 22.5 10.8 14.3 11.1 15.2 16.5 9.6 13.6 14.9 14.3 14.9 17.7 15.5 17.9 18.7 21.0 17.2 14.1 17.2 15.3 20.0 16.2 20.6 12.7 11.0 17.3 16.1 14.0 25.6 15.6 14.9 11.3 29.2 16.9 14.4 24.3 19.2 17.9 17.1 17.1 15.7 12.8 10.8 2.9 1.7 11.2 1.8 2.7 4.0 1.9 10.0 14.2 6.4 9.3 22.0 8.2 15.5 13.3 20.1 16.1 12.7 9.9 7.9 7.2 11.3 13.9 7.2 7.8 15.7 6.7 11.8 9.2 7.9 12.0 7.6 16.3 9.0 17.6 12.8 14.6 18.4 13.0 10.1 12.1 7.2 16.0 7.6 9.9 7.3 11.7 14.0 6.6 12.9 8.4 14.9 14.7 7.6 6.5 12.4 18.4 16.7 6.6 11.9 13.6 20.6 11.5 10.9 14.7 10.5 9.9 7.8 22.9 10.4 20.7 11.2 1.8 4.0 4.0 1.0 3.0 2.9 3.2 2.9 1.7 2.2 2.5 3.4 2.6 2.7 0.8 1.7 2.3 1.9 12.6 20.0 12.9 18.8 14.3 14.9 21.0 17.2 20.6 19.2 CCAR1 "CARP-1, CARP1, FLJ10590" ENSG00000060339 "Cell division cycle and apoptosis regulator 1" Q8IX12 10 68721012-68792377 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007856, HPA048513" Supported Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA007856: AB_1078415, HPA048513: " "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (2.34e-2)" "unprognostic (1.86e-1)" "unprognostic (5.15e-3)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.41e-5)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "prognostic favourable (4.05e-5)" "unprognostic (2.89e-2)" "unprognostic (3.21e-3)" "prognostic unfavourable (1.37e-4)" "unprognostic (1.67e-1)" "unprognostic (2.36e-1)" "unprognostic (2.24e-1)" "unprognostic (1.41e-2)" 24.2 28.0 22.6 38.7 27.9 27.8 24.6 36.9 31.7 26.0 28.7 21.5 24.7 22.7 23.9 23.7 26.5 19.7 23.2 21.6 21.3 20.5 27.4 22.3 23.4 37.5 31.7 17.9 32.1 22.9 28.6 44.3 29.2 23.6 25.0 31.1 26.0 26.7 37.9 47.0 32.3 25.4 24.5 30.4 28.6 23.5 18.9 29.9 42.1 28.5 20.6 37.4 28.8 25.0 12.4 18.6 12.3 12.8 8.8 16.0 9.1 26.4 27.7 32.0 21.4 13.9 13.4 24.9 23.7 20.4 25.9 17.8 36.5 21.6 31.2 13.1 16.3 20.9 33.4 18.8 28.4 21.3 21.0 25.0 19.1 22.6 15.8 39.4 29.4 13.4 23.4 21.8 26.9 20.7 34.0 20.2 24.9 19.1 26.2 25.0 31.9 25.9 30.7 19.1 18.6 22.6 20.2 18.5 16.1 23.3 38.4 23.3 26.0 24.2 20.2 16.1 20.3 17.3 25.5 14.0 18.4 33.5 13.5 26.6 15.2 4.9 12.8 12.3 15.5 11.5 13.8 12.3 11.0 14.9 18.6 12.4 13.3 14.0 3.1 8.8 12.8 11.8 16.0 9.1 22.6 27.9 36.9 31.7 21.3 20.5 31.7 17.9 23.6 29.9 CCAR2 "DBC-1, DBC1, KIAA1967, NET35" ENSG00000158941 "Cell cycle and apoptosis regulator 2" Q8N163 8 22604632-22621514 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Metalloenzyme inhibitor, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019907, HPA019943, CAB072827, CAB072828" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" 5300 "Nucleoplasm, Nuclear bodies" "CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454" "unprognostic (3.42e-2)" "unprognostic (5.78e-3)" "unprognostic (2.46e-3)" "unprognostic (1.33e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-2)" "unprognostic (5.13e-2)" "unprognostic (8.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (1.54e-2)" "prognostic favourable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (2.46e-1)" "unprognostic (7.54e-2)" "unprognostic (1.77e-1)" 28.6 32.7 27.8 35.4 38.3 63.1 29.9 45.0 59.1 26.7 33.0 38.4 28.0 25.7 37.3 24.6 31.7 32.8 30.0 21.9 24.6 25.0 25.2 28.1 29.7 39.7 24.8 36.3 37.8 28.0 34.5 31.5 32.3 33.2 28.8 23.4 27.2 29.1 25.4 44.4 39.8 30.9 25.2 22.4 41.2 29.7 62.4 25.0 63.5 29.4 23.3 37.0 30.6 26.2 13.3 10.7 14.4 21.0 12.2 24.3 14.3 26.2 49.2 47.6 24.8 18.9 15.9 31.7 25.8 25.5 38.2 34.2 44.1 21.8 43.5 32.6 28.2 33.0 43.7 30.7 27.7 17.6 26.1 51.4 38.0 34.2 17.5 28.1 44.0 16.4 27.6 30.4 18.8 27.4 53.6 27.7 28.1 31.4 84.5 29.7 69.3 18.0 56.7 39.3 23.3 19.8 62.6 23.8 55.6 29.1 33.5 22.3 30.5 26.6 44.2 28.4 37.6 34.1 34.0 20.4 25.3 51.2 31.9 24.7 44.0 12.9 10.1 14.4 24.3 17.4 20.7 13.3 18.2 18.3 10.7 13.2 18.3 19.0 3.7 12.2 21.0 10.1 20.9 14.3 27.8 38.3 45.0 59.1 24.6 25.0 24.8 36.3 33.2 25.0 CCBE1 "FLJ30681, KIAA1983" ENSG00000183287 "Collagen and calcium binding EGF domains 1" Q6UXH8 18 59430940-59697380 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 28.0" "Cell line enhanced" "Detected in some" "BJ: 26.2;BJ hTERT+: 26.9;BJ hTERT+ SV40 Large T+ RasG12V: 25.2;HBF TERT88: 30.2;hTERT-HME1: 40.9;LHCN-M2: 45.9;TIME: 24.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "hippocampal formation: 10.0" "Group enriched" "Detected in some" 7 "basophil: 9.6;neutrophil: 2.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041361, HPA041374" Uncertain Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" "Plasma membrane, Cytosol" "HPA041361: AB_10796667, HPA041374: AB_10794515" "unprognostic (3.09e-1)" "unprognostic (5.01e-2)" "unprognostic (9.54e-5)" "unprognostic (1.66e-2)" "unprognostic (2.40e-2)" "unprognostic (5.68e-5)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (2.17e-2)" "unprognostic (3.62e-3)" "unprognostic (4.04e-3)" "unprognostic (1.64e-1)" "unprognostic (7.45e-2)" "unprognostic (2.02e-2)" 10.0 12.6 2.4 3.8 1.1 0.4 3.5 0.4 2.0 16.8 15.8 0.6 8.2 0.8 12.1 2.8 2.3 6.9 6.9 2.1 10.0 0.5 3.1 4.3 16.5 3.6 0.4 2.1 28.0 0.8 0.4 2.6 0.3 1.7 3.0 2.3 9.1 1.0 3.5 10.6 3.3 3.0 4.9 0.3 0.3 1.7 2.1 1.3 0.2 1.0 0.0 0.7 2.9 5.1 0.8 0.4 9.6 0.3 0.8 0.3 0.2 5.1 0.4 0.0 0.0 4.1 12.9 8.0 26.2 26.9 19.1 25.2 0.0 0.1 0.1 0.0 10.4 0.5 0.0 16.9 30.2 0.1 0.1 0.0 0.1 0.1 9.5 0.1 0.0 8.6 0.7 14.9 40.9 0.9 0.0 0.1 45.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.5 0.1 0.2 0.0 0.0 0.2 0.0 0.1 24.7 0.0 2.6 3.9 0.0 0.1 0.0 0.0 1.3 0.1 0.6 9.6 0.3 0.8 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.8 0.3 0.3 2.7 0.8 0.2 0.4 0.2 0.2 2.4 1.1 0.4 2.0 10.0 0.5 0.4 2.1 1.7 1.3 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512178-57536599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 5.0 3.7 1.9 7.4 2.1 0.8 12.1 2.0 2.4 12.1 9.7 1.8 8.1 4.5 11.1 7.2 5.5 7.9 8.4 6.4 1.6 1.5 5.6 2.2 9.9 6.2 2.0 2.8 8.2 4.6 3.6 2.4 5.0 4.2 13.5 0.9 5.5 4.6 8.6 2.6 4.3 4.3 17.2 2.9 5.8 4.7 2.9 2.2 7.7 7.2 3.9 5.2 10.6 21.2 2.4 1.0 0.3 0.0 1.6 3.5 0.7 5.6 6.9 2.7 3.8 0.9 1.3 5.6 3.7 2.1 2.1 1.1 2.8 6.7 5.2 15.0 1.1 4.3 1.4 2.0 0.8 4.2 6.1 0.7 3.2 1.1 3.5 0.4 7.0 3.2 1.3 1.8 0.4 1.7 3.9 0.0 0.7 2.2 4.6 4.6 6.4 13.1 4.2 3.1 2.1 2.8 0.8 0.5 7.1 5.8 1.9 2.6 4.0 2.5 4.6 4.0 13.4 0.3 3.3 6.3 2.3 2.0 2.3 1.9 6.6 0.0 0.0 0.0 3.1 0.0 2.6 2.4 0.8 3.5 0.0 1.3 1.4 2.4 0.3 1.6 0.0 1.0 0.1 0.7 1.9 2.1 2.0 2.4 1.6 1.5 2.0 2.8 4.2 2.2 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 33.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.5;BJ hTERT+: 20.4;fHDF/TERT166: 18.3;HSkMC: 11.3;Karpas-707: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Not detected" "Not detected" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: " "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavourable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 8.7 4.2 6.4 4.7 7.1 1.3 4.4 3.2 8.0 4.2 4.8 4.9 2.9 2.3 4.0 6.4 4.7 2.9 16.9 4.7 6.0 5.4 5.9 3.3 16.4 11.5 7.0 5.0 3.3 3.1 3.2 5.0 33.7 8.7 4.0 6.1 4.0 3.2 2.2 2.1 2.9 3.9 6.4 9.3 3.3 4.7 4.3 7.0 1.7 6.8 5.0 2.9 16.9 4.0 0.9 11.5 0.4 0.3 1.3 2.6 0.3 0.0 0.0 2.9 0.2 2.6 10.5 0.1 0.5 20.4 0.2 0.3 0.1 0.2 0.1 0.4 18.3 0.2 0.1 0.2 0.3 0.8 0.2 0.6 0.0 0.9 5.1 0.1 0.3 11.3 0.4 0.3 2.5 0.1 0.0 7.2 1.7 0.0 0.4 0.2 0.6 0.3 0.9 0.2 0.3 0.1 0.0 1.2 1.1 0.1 0.0 0.0 0.2 0.9 2.8 0.4 0.2 0.1 0.2 3.1 0.2 0.5 1.5 1.2 1.8 0.0 0.1 0.4 1.4 0.3 1.3 0.6 0.8 1.1 0.3 0.9 2.6 1.6 0.0 1.3 0.2 11.5 0.3 0.3 6.4 7.1 3.2 8.0 6.0 5.4 7.0 5.0 8.7 7.0 CCDC106 HSU79303 ENSG00000173581 "Coiled-coil domain containing 106" Q9BWC9 19 55641062-55653161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041925, HPA043219" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041925: , HPA043219: " "unprognostic (5.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "unprognostic (5.16e-2)" "unprognostic (9.19e-2)" "unprognostic (2.82e-1)" "unprognostic (8.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.88e-2)" "unprognostic (8.74e-2)" "prognostic favourable (2.23e-6)" "unprognostic (2.28e-1)" "prognostic favourable (7.54e-11)" "unprognostic (5.03e-2)" "unprognostic (7.88e-2)" "unprognostic (3.26e-1)" "unprognostic (8.69e-2)" 15.9 18.7 31.6 8.7 43.9 4.4 14.5 27.2 29.8 13.9 10.4 14.3 10.5 7.2 13.2 11.2 13.0 12.5 14.2 18.0 32.3 21.2 23.5 19.2 10.4 14.8 20.3 14.4 20.9 13.8 19.2 17.5 8.8 15.2 14.7 5.2 12.4 18.0 19.6 34.1 9.3 8.3 20.0 15.1 15.6 13.0 15.9 10.8 13.7 18.0 6.5 14.1 16.9 10.0 11.1 9.0 0.0 2.4 0.6 3.4 1.5 3.8 15.3 6.7 11.7 4.8 4.6 0.9 3.3 6.0 11.7 9.9 3.3 6.1 11.3 2.6 6.3 3.4 11.3 7.2 3.3 0.6 38.9 12.0 10.3 5.8 14.5 0.8 6.9 7.4 0.9 2.7 0.6 3.7 8.7 7.3 5.7 1.0 7.2 4.8 3.2 8.5 11.4 3.4 7.8 12.1 0.3 7.4 13.8 2.7 19.1 6.6 8.3 7.8 4.1 3.6 3.7 0.3 2.4 4.3 1.5 14.7 9.7 3.9 0.2 0.0 2.4 0.0 0.5 1.6 1.5 7.8 0.5 0.7 3.0 11.1 3.4 2.0 0.0 0.6 0.1 9.0 0.3 1.5 31.6 43.9 27.2 29.4 32.3 21.2 20.3 14.4 15.2 10.8 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: " "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.3 19.5 3.5 13.5 12.2 8.7 8.1 3.3 2.4 5.2 6.0 17.7 2.7 4.4 6.5 6.4 15.3 7.1 2.4 11.0 8.1 7.2 3.8 9.5 11.5 7.8 9.2 7.2 6.0 3.2 10.1 10.8 5.1 4.2 5.6 4.4 22.3 6.1 1.4 4.1 28.7 4.3 3.9 6.6 7.0 9.8 6.6 5.1 4.7 7.5 13.9 7.7 10.0 12.3 4.5 6.7 10.4 25.7 6.1 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell line enhanced" "Detected in all" "RPMI-8226: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: , HPA050621: " "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavourable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.3 2.6 5.4 8.5 3.5 6.7 1.3 4.8 2.5 3.6 4.2 1.1 3.1 6.6 4.0 3.3 3.4 5.6 2.7 7.6 5.2 4.3 4.3 4.0 1.7 4.6 5.6 2.2 3.0 3.3 4.7 6.2 5.5 1.8 5.4 4.8 4.1 8.5 4.9 5.8 4.7 9.1 6.7 49.2 3.5 1.9 8.1 10.6 5.2 3.3 14.3 5.6 8.3 5.5 4.8 3.2 9.1 6.6 5.9 5.7 1.3 3.2 4.5 2.8 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 CCDC115 "ccp1, FLJ30131, MGC12981" ENSG00000136710 "Coiled-coil domain containing 115" Q96NT0 2 130338241-130342349 "Disease related genes, Predicted intracellular proteins" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034598 Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA034598: AB_10601697" "prognostic favourable (7.59e-4)" "unprognostic (1.28e-2)" "unprognostic (1.10e-3)" "unprognostic (6.80e-3)" "unprognostic (3.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (8.13e-3)" "unprognostic (2.63e-1)" "unprognostic (4.29e-1)" "unprognostic (2.87e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (7.83e-2)" "unprognostic (2.16e-1)" "unprognostic (3.16e-2)" 18.7 18.4 25.1 14.7 25.9 17.2 21.5 23.4 39.8 27.1 22.3 24.6 17.9 18.1 22.3 28.9 24.2 25.6 19.9 15.0 25.2 24.1 24.9 14.9 21.8 22.6 26.1 22.5 36.1 24.0 25.3 17.1 23.2 28.1 21.3 17.2 19.1 23.8 25.4 9.4 26.5 19.1 17.7 24.1 19.5 16.9 13.0 16.8 17.1 25.3 14.2 28.4 20.3 20.1 34.0 32.8 51.5 56.2 26.7 34.4 38.7 12.6 6.7 8.2 5.2 16.8 17.8 10.4 6.6 16.0 13.2 15.3 14.9 28.2 16.7 22.6 10.1 13.3 6.9 10.9 10.4 19.9 12.6 12.1 3.8 18.5 14.2 13.8 24.1 15.2 25.9 8.3 4.8 13.6 11.9 14.0 15.8 12.1 21.1 22.8 11.3 17.2 16.9 9.4 14.0 11.5 12.2 9.4 14.4 8.6 15.1 14.6 15.0 14.8 10.9 7.4 8.0 11.9 5.0 7.7 8.0 15.7 13.8 13.4 8.8 36.8 33.1 51.5 29.7 45.3 26.6 33.8 32.1 31.7 32.8 34.0 30.9 28.8 11.4 26.7 56.2 25.8 34.4 38.7 25.1 25.9 23.4 39.8 25.2 24.1 26.1 22.5 28.1 16.8 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 10.7 14.2 12.3 13.6 13.6 19.2 25.2 19.3 12.7 15.9 13.1 9.6 16.6 12.1 15.3 8.9 11.5 10.7 10.0 9.0 12.2 10.6 10.3 26.1 12.5 17.0 14.6 8.3 14.9 13.3 12.4 14.1 20.7 11.9 13.0 11.9 9.5 21.0 16.5 20.2 9.1 10.9 15.2 13.1 13.8 12.3 35.9 15.4 24.2 18.1 7.4 20.1 12.3 31.3 13.4 13.9 14.0 13.9 23.3 15.2 12.6 8.6 7.2 14.8 14.3 9.6 8.4 11.6 8.8 10.8 15.3 13.5 10.9 4.2 27.1 3.9 8.0 9.1 21.5 3.5 14.6 14.7 14.2 11.0 8.2 16.0 6.6 17.7 14.2 5.7 7.6 8.8 5.5 10.5 15.4 12.1 6.8 11.1 10.3 14.4 12.0 3.5 21.0 23.2 11.8 6.8 3.4 5.6 7.5 13.5 12.7 5.4 15.8 7.6 6.1 19.2 13.2 6.0 6.7 28.3 29.3 22.8 6.7 9.6 8.1 10.7 13.9 14.0 10.2 12.3 10.5 10.0 8.6 9.9 13.9 13.4 15.2 12.2 6.7 23.3 11.7 12.2 10.7 12.6 12.3 13.6 19.3 12.7 12.2 10.6 14.6 8.3 11.9 15.4 CCDC121 "FLJ13646, FLJ43364" ENSG00000176714 "Coiled-coil domain containing 121" Q6ZUS5 2 27625639-27629012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 12.5" "Low lineage specificity" "Detected in all" HPA051791 Uncertain Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA051791: " "unprognostic (1.52e-1)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (3.93e-1)" "unprognostic (1.28e-1)" "unprognostic (4.71e-3)" "prognostic favourable (4.12e-4)" "unprognostic (4.03e-2)" "unprognostic (1.23e-1)" "unprognostic (5.65e-4)" "unprognostic (7.78e-2)" "prognostic favourable (1.87e-5)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (7.86e-2)" "unprognostic (5.42e-2)" 4.4 3.6 7.4 2.0 12.2 1.4 5.9 7.0 10.3 5.8 3.6 5.5 6.7 2.6 5.5 5.3 5.9 8.3 3.0 6.3 9.0 5.2 6.2 3.2 4.5 2.3 13.3 6.0 11.7 3.9 8.3 7.3 3.8 9.3 7.3 3.5 3.4 5.7 8.5 3.6 3.3 3.0 4.6 10.8 4.3 3.8 27.5 11.2 1.0 8.1 1.7 2.5 4.4 3.0 3.1 1.7 12.5 4.0 2.6 3.0 1.3 3.6 4.2 5.8 6.4 10.5 4.7 7.2 1.9 0.9 1.9 0.9 3.2 3.3 1.8 3.0 1.2 3.4 4.2 1.5 2.1 2.6 4.6 1.1 2.5 4.0 2.0 1.7 3.4 1.6 5.1 1.0 2.7 3.9 4.9 2.6 2.7 3.0 1.2 1.7 6.0 2.1 6.2 14.1 3.2 4.0 2.9 7.5 8.6 1.5 7.1 2.3 5.8 3.9 2.0 1.7 6.3 1.4 5.1 1.6 1.6 2.8 4.1 2.3 2.0 2.0 2.4 12.5 0.6 3.4 1.7 3.1 1.9 0.7 1.7 2.7 3.0 2.2 5.1 2.6 4.0 0.5 0.3 1.3 7.4 12.2 7.0 10.3 9.0 5.2 13.3 6.0 9.3 11.2 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 11.2;hTERT-HME1: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: , HPA061456: " "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 4.3 6.7 5.0 8.5 9.5 1.8 7.5 2.4 5.6 5.5 5.5 7.2 8.8 3.3 8.0 10.7 4.5 8.6 5.9 8.3 6.1 5.0 10.4 5.7 5.5 4.6 9.8 5.8 12.2 6.9 8.4 15.6 8.2 6.0 9.8 6.9 3.6 5.7 4.8 3.3 7.8 7.3 9.8 6.4 7.7 5.8 9.7 11.0 5.2 10.9 4.5 4.7 6.2 11.8 3.6 3.0 6.4 2.6 3.6 1.9 1.0 2.1 1.8 0.8 0.0 0.7 4.5 2.3 5.8 6.4 3.0 3.4 3.1 7.9 3.6 3.3 3.5 3.5 0.8 0.9 4.3 5.7 2.7 1.5 1.0 1.7 8.4 0.8 0.4 11.2 7.1 4.4 11.6 1.5 0.0 1.1 4.1 2.6 0.5 0.5 1.0 1.8 0.8 0.0 1.9 4.7 1.2 2.1 3.1 3.9 0.1 3.5 0.7 0.6 6.8 0.2 0.8 5.2 0.0 0.0 0.0 1.6 2.9 0.1 3.0 6.4 1.6 2.4 1.3 1.4 1.6 2.4 1.9 1.4 1.2 3.6 1.3 1.4 3.9 3.6 2.6 3.0 1.7 1.0 5.0 9.5 2.4 5.6 6.1 5.0 9.8 5.8 6.0 11.0 CCDC124 ENSG00000007080 "Coiled-coil domain containing 124" Q96CT7 19 17933016-17943991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041708, HPA046765" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041708: AB_2677628, HPA046765: " "unprognostic (9.39e-2)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.68e-4)" "unprognostic (4.32e-2)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.19e-1)" "unprognostic (3.71e-2)" "unprognostic (3.22e-1)" 32.2 21.8 28.8 23.1 25.7 28.1 16.3 16.8 34.4 15.0 22.3 16.8 16.5 20.0 29.0 17.8 22.0 13.6 20.0 34.8 26.5 22.3 18.1 24.4 15.5 16.2 26.4 23.8 15.5 29.4 14.0 12.3 16.3 18.5 17.6 7.6 16.1 34.7 19.9 96.8 20.6 21.2 20.5 20.2 20.7 26.7 14.0 13.3 13.6 19.1 29.0 14.1 17.0 33.2 30.2 39.1 31.9 42.4 32.4 42.2 28.7 48.3 34.5 11.8 23.3 7.9 6.1 38.8 24.3 8.0 13.0 11.0 25.9 20.3 37.1 35.3 10.1 18.6 13.0 23.2 3.8 38.8 71.2 30.7 27.0 29.9 15.3 34.4 21.2 9.7 15.5 13.1 12.6 13.6 39.2 15.7 6.6 47.7 33.6 43.7 26.7 59.1 33.2 21.5 40.4 10.6 17.5 23.5 33.9 16.9 19.7 24.2 18.0 12.9 28.7 22.0 27.4 42.2 37.5 22.1 23.4 35.6 27.4 41.7 27.7 27.4 39.0 31.9 42.2 42.4 33.5 28.2 32.8 38.8 39.1 30.2 26.1 31.6 9.5 32.4 30.2 34.5 36.9 28.7 28.8 25.7 16.8 30.4 26.5 22.3 26.4 23.8 18.5 13.3 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 5.8;eosinophil: 13.0;neutrophil: 10.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavourable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favourable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favourable (2.51e-4)" 4.3 6.1 4.9 6.1 5.6 13.6 10.0 4.9 4.7 4.1 7.9 5.8 7.8 6.7 5.9 4.0 6.6 5.5 10.0 3.0 4.8 4.9 5.0 17.6 5.8 6.2 6.4 4.9 4.8 14.9 4.2 10.4 5.5 6.7 10.1 7.9 3.6 15.9 12.3 2.8 5.3 10.6 4.5 4.7 5.2 8.3 3.4 4.1 3.1 5.5 4.7 5.5 7.3 5.6 0.9 1.5 13.0 2.3 1.1 1.1 0.8 2.1 3.5 0.7 10.0 1.2 0.7 12.8 1.3 1.9 0.8 0.5 3.1 10.7 3.9 7.4 1.4 2.7 7.3 3.7 0.8 13.4 5.8 2.4 5.7 6.0 3.1 2.6 1.4 4.1 1.9 4.1 1.3 1.4 7.1 1.7 0.7 8.6 3.4 4.2 0.1 2.3 4.9 0.0 5.2 4.9 2.4 4.1 2.6 2.6 5.9 1.9 19.1 2.7 1.6 0.8 1.4 2.5 2.0 7.8 11.9 1.4 2.5 14.3 0.4 5.8 1.1 13.0 1.1 0.9 0.9 0.9 1.0 0.8 1.5 0.9 0.9 0.5 10.9 1.1 2.3 1.2 0.7 0.8 4.9 5.6 4.9 4.7 4.8 4.9 6.4 4.9 6.7 4.1 CCDC127 FLJ25701 ENSG00000164366 "Coiled-coil domain containing 127" Q96BQ5 5 196871-218215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045052 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA045052: AB_10960630" "prognostic unfavourable (7.01e-4)" "unprognostic (4.26e-2)" "unprognostic (1.93e-2)" "unprognostic (9.18e-2)" "unprognostic (2.78e-3)" "unprognostic (2.65e-2)" "prognostic unfavourable (4.04e-6)" "unprognostic (2.41e-1)" "unprognostic (1.57e-1)" "unprognostic (9.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (5.95e-5)" "unprognostic (2.42e-1)" "unprognostic (9.06e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-1)" 10.3 14.3 10.3 7.3 13.0 3.8 9.7 14.0 16.2 10.7 10.0 10.6 8.2 8.7 11.6 7.7 13.4 10.5 12.7 16.3 9.8 11.8 8.1 6.8 6.9 12.4 12.0 9.8 15.3 8.6 5.0 14.9 10.2 13.9 10.5 4.1 10.5 8.1 6.1 18.4 12.4 10.1 8.1 9.5 7.2 9.4 11.1 12.2 9.6 23.5 7.4 5.2 9.9 7.9 9.0 8.1 7.2 5.3 8.6 11.0 5.3 4.0 5.2 5.9 10.7 7.2 5.5 5.8 7.7 4.0 3.5 3.4 5.5 8.4 8.4 11.2 3.5 5.3 3.7 3.0 3.3 21.2 6.5 2.9 24.6 4.8 4.2 2.3 5.4 4.5 4.8 3.2 2.3 2.8 4.8 2.9 3.7 3.2 4.2 4.7 5.0 6.8 4.9 4.3 6.8 6.5 4.0 6.5 10.3 10.7 7.4 7.0 9.7 4.4 6.5 8.8 5.2 3.5 3.1 4.9 4.1 5.7 5.7 4.1 5.5 4.6 4.5 7.2 8.1 5.3 8.7 9.0 8.3 9.6 4.5 8.8 9.8 11.0 2.9 8.6 4.7 8.1 6.2 5.3 10.3 13.0 14.0 14.7 9.8 11.8 12.0 9.8 13.9 12.2 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049899: , HPA054223: " "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 2.6 2.5 5.7 5.0 7.0 6.1 4.8 13.5 8.2 3.1 3.9 4.9 1.6 2.1 6.0 2.8 5.5 8.6 3.8 2.3 6.8 5.0 3.6 5.5 2.8 8.1 4.3 5.1 3.7 3.5 2.3 7.4 2.8 8.0 3.1 4.8 1.9 3.3 2.1 2.1 4.8 3.4 3.3 6.4 3.2 3.7 19.4 6.5 19.5 2.3 2.9 7.2 4.3 6.1 5.4 8.1 3.1 2.1 3.2 4.8 2.4 8.1 3.8 13.0 6.7 1.0 1.2 8.3 3.6 1.1 8.5 6.3 12.3 4.8 19.7 5.4 1.1 7.0 9.4 4.9 7.7 4.5 12.1 9.1 7.1 10.1 1.3 12.4 1.3 0.8 1.4 10.0 3.0 4.4 17.2 9.1 4.3 4.6 17.7 8.4 19.3 3.9 11.7 12.3 12.1 4.7 6.5 9.2 9.0 7.8 4.2 6.2 4.5 6.0 2.8 5.4 9.5 3.4 7.5 2.9 6.6 20.6 2.2 9.7 5.3 3.1 0.9 1.3 2.1 2.1 3.9 5.1 2.8 4.0 0.9 5.4 4.1 4.8 0.5 3.2 0.8 8.1 4.1 2.4 5.7 7.0 13.5 8.2 6.8 5.0 4.3 5.1 8.0 6.5 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;TIME: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022996, HPA047220, HPA047851" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: , HPA047851: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.5 3.8 0.9 2.4 3.4 10.9 0.4 0.2 0.0 0.2 0.2 4.8 0.1 0.5 3.3 6.7 5.9 4.9 0.3 0.3 3.4 0.3 0.5 0.5 0.3 0.2 0.7 3.1 2.0 0.1 2.3 0.2 0.1 0.5 0.3 2.2 0.2 0.1 1.2 0.8 0.4 1.5 0.2 0.1 0.1 4.6 1.2 1.3 0.7 0.2 1.4 4.0 0.2 9.3 0.8 0.5 5.2 1.5 6.6 6.8 0.2 0.4 6.8 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 2.3 0.0 0.0 26.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 CCDC146 KIAA1505 ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7;fallopian tube: 27.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons and medulla: 32.7" "Cell type enhanced" "Detected in many" "eosinophil: 12.5;neutrophil: 14.0" "Group enriched" "Detected in many" 4 "granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020082, HPA020105" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favourable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 1.8 0.8 6.5 1.9 7.2 1.3 1.9 1.8 8.3 4.3 3.2 4.5 2.7 1.9 3.7 9.1 3.5 27.9 2.6 1.4 7.4 3.4 4.2 1.3 4.9 2.2 1.6 4.2 6.4 1.8 2.9 10.9 1.5 32.7 3.4 2.2 4.4 3.9 1.8 1.6 7.4 2.2 2.4 2.8 2.8 2.5 22.2 2.9 0.5 6.3 0.9 2.0 3.1 3.4 1.0 1.8 14.0 0.7 5.0 4.4 0.6 1.0 1.5 4.4 2.4 2.9 3.0 0.5 1.1 1.0 1.1 1.9 0.0 7.5 2.5 0.2 0.3 1.5 0.6 1.4 1.9 3.0 0.5 2.9 2.0 1.3 0.9 3.2 2.4 1.7 2.2 2.0 0.3 1.0 0.0 2.8 0.3 0.3 2.6 4.7 0.5 1.1 6.9 0.7 0.3 4.6 0.8 3.4 2.2 1.6 1.5 0.9 1.4 1.1 1.4 1.7 0.6 2.4 0.7 4.4 6.8 2.1 3.9 4.9 4.0 0.6 0.5 12.5 4.4 0.7 3.1 1.0 1.9 3.0 0.8 0.2 1.2 1.9 14.0 5.0 0.3 1.8 1.4 0.6 6.5 7.2 1.8 8.3 7.4 3.4 1.6 4.2 32.7 2.9 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HBF TERT88: 4.2;hTEC/SVTERT24-B: 2.7;RPTEC TERT1: 3.3;SCLC-21H: 4.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favourable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.2 1.1 6.0 0.1 0.1 0.9 0.5 0.0 0.3 4.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.1 0.4 1.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.3 0.4 4.1 0.2 0.3 0.4 0.5 2.3 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 0.9 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 3.7 4.6 5.8 10.3 1.0 4.2 2.3 1.5 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell line enhanced" "Detected in some" "HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.9 0.1 2.8 3.5 0.0 4.7 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.1 3.7 0.0 0.0 0.4 0.0 0.3 0.2 10.8 4.5 2.8 0.1 0.0 4.5 0.0 1.9 0.0 1.4 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.4 0.0 0.1 0.0 0.4 0.1 0.1 0.2 19.5 4.5 0.1 0.1 13.0 0.1 5.7 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell line enhanced" "Detected in some" "A-431: 7.3;SCLC-21H: 26.0;U-266/70: 4.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: , HPA048237: " "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.3 0.3 0.2 0.5 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.9 0.4 0.0 0.5 0.0 3.7 0.2 0.1 2.1 0.1 0.1 0.0 0.1 26.0 0.4 0.1 0.1 1.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.7 1.2 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: " "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favourable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favourable (9.46e-4)" "prognostic favourable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favourable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 1.9 1.6 5.1 6.7 9.7 1.7 3.6 3.8 4.3 5.8 0.6 2.4 1.8 9.4 6.8 1.8 1.0 5.8 2.7 9.0 1.4 4.4 1.6 2.3 11.7 1.7 6.6 11.6 15.4 3.1 4.2 12.1 3.9 21.4 2.1 2.7 2.6 3.5 0.9 7.3 3.0 0.0 12.0 3.9 3.2 0.7 2.7 3.7 4.2 6.7 6.2 7.4 8.0 3.4 1.0 5.9 3.3 19.7 4.7 3.8 4.6 9.0 4.9 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494030-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.4;fallopian tube: 33.0" "Group enriched" "Detected in some" 5 "MCF7: 13.8;T-47d: 8.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.1" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favourable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 6.2 2.1 1.4 6.7 0.3 4.0 0.4 2.4 3.9 0.9 6.5 0.3 2.6 5.2 19.4 0.6 33.0 1.5 3.3 3.7 3.6 1.6 1.5 9.7 3.6 1.3 1.4 14.4 0.5 0.3 1.5 1.6 16.1 1.2 0.7 3.9 0.5 0.6 0.8 0.6 1.2 1.5 1.2 2.9 1.8 5.9 1.5 0.7 5.7 0.6 0.8 1.7 1.2 0.1 1.8 8.6 4.1 0.1 0.1 0.9 0.0 0.2 0.5 0.0 0.5 0.4 0.0 0.1 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 8.1 0.1 0.8 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 3.1 8.6 0.1 4.1 0.1 0.1 0.0 0.0 1.8 0.1 0.1 0.1 2.9 0.1 3.7 0.1 0.1 0.9 2.1 6.7 0.4 2.4 3.7 3.6 1.3 1.4 16.1 1.5 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553086-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 9.4;HEL: 14.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Uncertain Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 2.5 2.5 5.8 5.5 7.5 4.0 3.6 8.2 7.8 4.1 2.4 1.1 6.9 1.9 11.6 5.8 2.4 4.6 3.4 2.6 4.9 4.1 2.8 1.3 2.5 2.4 3.4 7.6 6.3 3.4 4.2 7.8 7.3 6.6 3.4 2.5 2.0 1.9 7.4 2.4 4.9 2.2 7.1 6.1 1.5 3.1 20.4 3.3 20.2 4.3 1.4 2.2 2.5 2.8 1.6 0.7 5.1 0.6 0.4 1.8 0.2 1.7 0.9 2.1 2.1 1.2 2.6 1.4 1.4 1.1 1.4 1.5 0.6 0.8 9.4 0.7 0.8 0.4 0.9 1.3 1.5 2.0 0.9 14.6 1.5 1.3 1.8 2.1 1.9 1.5 2.6 1.1 2.1 0.6 0.4 2.6 1.6 0.7 4.0 1.9 1.7 2.1 4.8 1.6 0.3 1.0 1.4 3.1 1.5 2.8 1.0 3.5 1.1 1.5 1.1 2.8 1.6 0.8 0.9 1.4 1.7 6.2 1.2 1.2 2.0 5.1 0.6 0.0 0.8 0.6 1.8 0.7 0.7 0.7 0.7 1.6 0.5 0.9 0.5 0.4 0.4 0.7 0.6 0.2 5.8 7.5 8.2 7.8 4.9 4.1 3.4 7.6 6.6 3.3 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;SCLC-21H: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 3.8 2.3 2.7 20.0 4.3 13.4 4.6 3.7 2.7 2.2 3.2 0.4 2.9 2.5 1.8 4.0 3.2 1.8 1.7 2.6 3.4 1.9 2.0 3.0 3.8 11.9 1.7 1.8 2.8 1.5 0.7 4.8 1.9 2.6 1.9 4.1 1.3 2.0 3.1 6.2 3.1 3.4 2.3 3.8 6.0 2.3 12.6 2.5 15.8 2.1 2.8 8.2 2.9 3.3 12.2 11.9 6.0 3.9 1.1 2.7 0.5 15.5 5.2 12.2 3.8 3.0 3.1 6.4 9.7 5.1 10.0 10.1 2.7 5.4 20.2 5.4 5.2 7.4 5.3 7.6 14.5 9.9 7.0 13.8 11.1 4.7 1.1 14.3 6.4 2.1 0.6 7.5 7.4 6.4 14.7 15.6 13.2 2.2 6.8 5.8 11.2 6.5 8.8 14.6 5.9 4.9 7.0 5.4 3.4 13.7 7.0 4.0 3.3 8.4 4.9 11.7 8.3 7.5 11.0 6.7 8.7 12.1 2.4 12.8 3.1 3.4 3.8 5.3 2.4 3.9 2.7 8.8 2.2 2.1 1.6 12.2 1.7 2.0 6.0 1.1 3.5 11.9 2.2 0.5 2.7 4.3 3.7 2.7 3.4 1.9 1.7 1.8 2.6 2.5 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183584-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell line enhanced" "Detected in some" "A549: 4.2;AF22: 9.8;NTERA-2: 3.3;SH-SY5Y: 6.7;U-2 OS: 3.9;U-87 MG: 4.9" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA039947: , HPA041715: " "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 2.0 11.4 9.0 2.3 14.4 0.8 1.3 14.9 30.5 3.0 1.8 2.2 0.1 1.1 6.1 1.3 1.7 1.3 3.3 1.9 9.3 17.6 1.3 1.3 1.5 1.0 11.5 10.6 8.8 1.3 8.7 7.3 5.1 23.7 1.6 1.5 0.8 0.9 2.3 2.2 1.5 2.1 3.6 3.6 1.4 1.5 5.1 0.4 0.0 1.2 0.5 0.8 2.1 1.8 0.0 0.3 0.6 0.2 0.0 1.2 0.3 0.0 4.2 9.8 0.4 0.8 0.8 0.0 0.3 1.8 0.5 0.8 0.5 0.1 0.0 0.2 0.3 0.1 1.0 0.2 0.1 2.3 0.2 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 2.0 6.7 0.8 0.1 0.2 0.0 0.0 0.2 1.1 3.9 0.0 0.2 0.0 0.0 0.0 4.9 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.2 0.4 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 9.0 14.4 14.9 30.5 9.3 17.6 11.5 10.6 23.7 0.4 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148427-20151065 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.1;testis: 23.1" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 7.8;SH-SY5Y: 10.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 47 "dendritic cells: 4.7" "Low region specificity" "Detected in single" HPA049901 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA049901: " "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.1 0.9 0.4 0.5 0.6 0.5 0.5 1.4 1.2 0.4 0.4 0.4 0.4 1.0 0.6 0.4 0.4 0.4 0.4 0.4 0.4 1.9 0.4 0.4 0.6 0.7 0.5 0.4 0.4 0.4 0.0 6.1 0.8 0.4 0.4 0.0 0.4 0.4 0.4 0.7 1.5 0.5 0.4 0.4 1.8 0.8 23.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.7 0.3 0.0 0.7 0.0 1.6 0.8 1.3 0.9 0.1 0.1 0.0 0.2 0.8 0.3 0.0 0.0 0.1 0.2 0.0 1.4 0.2 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.5 0.1 0.2 3.7 1.2 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.0 0.0 0.1 7.8 10.2 0.5 0.0 0.6 0.0 0.1 4.1 2.4 4.4 3.0 0.2 0.6 0.1 0.2 3.8 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.6 1.4 0.6 0.4 1.9 0.5 0.4 0.4 0.4 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 7 "A549: 9.1;RPTEC TERT1: 27.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavourable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favourable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.1 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.1 0.2 0.1 0.0 0.2 27.1 0.4 0.3 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235467-49250526 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888" Uncertain Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000229: , HPA000888: AB_1078420" "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 11.5 15.4 12.1 18.2 14.9 26.0 16.3 20.7 16.5 12.5 11.8 13.7 17.2 16.3 14.8 12.3 15.8 13.7 11.9 12.9 12.2 9.8 13.9 14.2 19.8 24.7 12.2 15.9 13.7 20.3 12.1 13.5 11.0 11.8 15.2 8.6 12.8 19.2 21.3 23.0 15.1 15.3 14.6 12.4 23.9 14.2 4.5 14.1 25.0 13.0 15.5 17.9 12.6 12.3 12.4 23.5 13.9 22.1 6.1 13.9 15.1 10.5 9.2 5.6 19.5 5.2 5.4 12.0 6.3 4.6 7.0 8.1 9.2 9.2 3.9 9.3 5.5 8.6 6.1 10.3 2.9 10.1 13.6 4.1 8.7 8.7 8.8 11.6 7.3 5.0 8.9 9.3 5.1 6.9 8.1 6.9 5.0 32.7 8.4 13.6 6.5 13.5 12.3 9.1 16.9 5.5 5.4 6.7 5.1 9.6 11.3 8.4 17.6 11.4 7.6 9.1 9.9 11.2 6.5 12.5 6.8 7.0 9.9 21.7 7.1 5.1 22.1 13.9 12.0 19.2 13.1 12.4 12.5 13.9 23.5 11.6 11.4 12.9 1.8 6.1 15.7 9.3 12.9 15.1 12.1 14.9 20.7 16.5 12.2 9.8 12.2 15.9 11.8 14.1 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: " "prognostic favourable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favourable (3.18e-4)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.0 1.4 1.5 1.4 0.9 3.1 0.2 2.1 1.6 2.8 2.0 14.8 4.1 5.8 0.6 5.2 0.8 7.3 1.5 4.3 1.8 2.1 1.8 0.6 1.6 0.7 3.6 0.3 0.7 5.2 0.5 1.3 0.9 1.5 2.2 4.4 0.2 1.5 3.1 2.6 1.3 0.0 0.8 6.1 2.0 3.4 3.0 4.5 2.6 2.8 7.6 0.1 0.4 2.4 6.9 1.7 0.7 0.6 1.9 0.9 6.2 0.6 1.9 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733311-27772653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favourable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 12.7 25.4 16.8 10.6 22.4 4.0 16.7 14.2 26.1 10.3 26.0 13.1 12.0 32.5 13.2 14.2 13.7 14.6 11.3 11.1 16.5 14.0 21.5 30.4 8.5 12.8 19.9 15.8 10.9 16.0 15.6 12.7 9.9 29.4 11.4 15.1 9.8 14.1 12.4 23.3 10.9 39.7 10.5 19.0 12.1 18.0 12.0 17.2 9.7 17.8 13.8 12.8 13.2 10.5 19.2 18.9 14.9 13.2 13.8 21.8 9.1 23.8 12.9 13.1 12.2 11.7 17.0 8.8 20.1 19.5 12.4 12.1 5.3 8.6 25.8 13.9 10.1 11.3 11.6 19.5 17.9 9.6 7.8 32.1 12.2 9.3 19.7 11.2 10.4 18.9 13.0 13.3 18.8 26.6 15.1 12.4 13.8 8.7 27.3 9.5 18.8 7.2 8.9 22.2 13.6 16.2 14.0 7.5 21.0 13.5 10.4 20.4 11.9 6.3 21.4 11.4 18.0 19.4 10.5 13.5 15.7 9.4 17.7 15.0 11.7 14.9 10.4 7.3 14.6 13.2 19.8 19.2 21.2 17.8 12.1 14.0 18.8 20.9 4.0 13.8 12.5 18.9 21.8 9.1 16.8 22.4 14.2 26.1 16.5 14.0 19.9 15.8 29.4 17.2 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" Q8IWP9 6 138773509-138793319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA055125: " "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favourable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 12.9 30.8 25.4 19.8 28.7 20.9 17.9 22.6 27.9 15.6 17.4 13.3 18.7 18.5 11.5 24.8 12.4 22.6 16.8 11.0 31.4 32.2 36.5 40.5 17.4 19.2 22.2 21.7 14.2 22.2 25.5 19.2 19.3 28.3 16.1 15.4 16.4 31.6 20.8 17.4 11.0 21.3 13.9 16.1 18.3 16.5 15.0 13.4 18.2 33.9 9.3 19.8 19.3 12.5 30.0 29.3 73.5 27.3 30.6 44.5 24.5 3.3 6.2 4.7 8.5 8.9 12.4 9.6 5.7 10.0 7.4 12.3 5.3 6.8 14.7 11.0 5.6 6.0 7.6 7.9 12.2 16.9 17.1 11.9 7.6 10.5 14.0 20.6 12.6 8.0 10.0 5.4 16.0 12.2 12.0 20.7 8.4 7.5 16.8 27.2 4.3 6.4 10.2 4.7 13.6 8.9 5.1 5.8 9.0 7.5 6.8 16.3 3.3 22.8 9.3 5.9 6.8 10.9 8.5 27.7 24.5 10.8 6.3 12.8 5.2 33.2 27.3 33.7 26.0 27.0 23.2 30.0 27.6 28.3 29.3 29.7 32.1 29.5 73.5 30.6 22.9 25.8 44.5 24.5 25.4 28.7 22.6 27.9 31.4 32.2 22.2 21.7 28.3 13.4 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;HAP1: 13.7;HDLM-2: 22.5;U-2 OS: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" Nucleoplasm Cytosol "HPA062425: " "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.5 0.0 1.3 13.7 2.5 0.4 22.5 5.8 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.7 0.3 0.0 0.7 0.0 0.1 0.7 0.1 0.0 3.8 1.1 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 0.0 0.0 0.0 0.0 14.9 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 22.7 23.5 17.9 17.2 24.3 19.0 17.9 17.6 24.0 17.1 18.4 17.6 17.4 18.4 24.5 20.0 12.6 20.3 19.4 21.4 20.7 21.9 25.9 15.3 16.6 27.8 17.6 21.0 28.2 32.6 15.8 26.5 22.6 20.8 16.5 22.0 20.5 20.7 17.4 22.4 11.5 18.5 18.5 16.7 25.2 18.9 9.2 16.1 16.2 24.4 9.4 26.8 26.9 22.2 50.6 16.3 12.7 9.6 7.7 13.8 11.6 7.8 5.7 7.5 12.1 15.3 16.1 4.5 6.3 9.4 11.2 11.8 8.5 11.1 2.9 17.7 9.3 14.8 7.4 7.1 8.1 17.8 8.5 32.2 9.6 10.6 10.4 12.1 17.0 13.9 7.6 8.8 5.9 14.1 17.6 19.6 8.5 6.8 5.5 10.5 3.0 7.3 9.7 9.5 9.7 20.7 19.1 8.3 8.5 9.4 9.8 4.6 10.4 22.4 15.5 10.5 9.2 18.4 9.0 10.7 10.5 9.4 11.1 19.1 14.7 12.7 9.4 9.3 9.8 9.6 7.9 40.9 11.0 10.6 12.2 50.6 11.2 9.5 9.9 7.7 9.4 16.3 13.8 11.6 17.9 24.3 17.6 24.0 20.7 21.9 17.6 21.0 20.8 16.1 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363868 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.5" "Cell line enhanced" "Detected in many" "RH-30: 37.0;U-266/70: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavourable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favourable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 2.7 4.7 9.3 6.8 17.1 8.3 8.4 3.8 11.7 4.2 6.6 2.1 3.8 7.9 4.1 8.6 5.9 9.7 4.0 3.2 9.0 7.5 4.1 3.4 2.8 4.3 5.6 6.2 7.7 4.8 7.2 12.5 3.9 11.1 5.4 7.4 3.3 3.6 3.8 2.8 4.7 6.3 2.8 4.5 3.3 6.9 31.5 4.4 14.8 6.7 5.3 6.0 3.3 3.9 4.8 2.4 0.4 3.6 4.1 7.1 1.3 10.1 11.6 9.9 9.9 1.8 4.0 7.1 6.4 2.6 7.4 7.2 6.5 1.9 11.3 4.7 3.6 9.3 9.6 4.2 13.2 4.3 14.0 8.9 14.7 16.2 0.9 8.7 3.5 1.4 3.0 6.1 2.7 5.2 8.9 3.7 7.3 7.3 16.9 14.0 10.4 10.6 17.2 37.0 1.6 2.7 3.3 7.5 10.0 10.2 4.5 4.4 12.1 4.7 2.6 11.1 10.5 21.0 15.3 36.9 33.5 7.9 10.3 0.4 9.5 0.0 0.2 0.4 3.6 1.0 4.5 3.5 4.5 4.8 1.0 4.8 5.4 3.3 0.0 4.1 3.6 2.4 7.1 1.3 9.3 17.1 3.8 11.7 9.0 7.5 5.6 6.2 11.1 4.4 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.6 11.8 7.1 8.3 10.5 11.1 19.5 6.4 5.9 12.9 10.6 18.6 16.2 21.0 9.2 5.1 14.1 17.4 21.0 7.9 9.8 11.4 17.9 18.7 13.9 16.2 8.7 8.2 8.4 47.7 16.0 17.5 7.3 9.9 6.1 12.2 9.2 10.1 11.3 15.5 19.1 7.0 8.3 16.2 17.5 12.1 5.9 12.3 10.6 11.6 17.2 12.5 13.5 5.5 7.5 10.2 18.6 12.3 9.9 14.5 10.9 10.0 18.9 7.0 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 CCDC57 "FLJ00130, FLJ23754" ENSG00000176155 "Coiled-coil domain containing 57" Q2TAC2 17 82101460-82212830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7" "Lineage enriched" "Detected in many" 6 "T-cells: 10.7" "HPA023315, HPA023326, HPA023342, HPA023344" Approved Approved "Microtubules,Centriolar satellite,Cytosol" Microtubules "Centriolar satellite, Cytosol" "HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162" "unprognostic (2.51e-3)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (9.92e-3)" "unprognostic (1.25e-1)" "unprognostic (2.11e-3)" "unprognostic (1.33e-1)" "unprognostic (1.56e-2)" "unprognostic (3.19e-2)" "unprognostic (2.16e-1)" "prognostic favourable (5.55e-5)" "unprognostic (2.07e-1)" "prognostic unfavourable (2.28e-6)" "unprognostic (5.19e-2)" "unprognostic (1.53e-1)" "unprognostic (2.04e-1)" "unprognostic (3.80e-3)" 5.5 9.0 12.9 10.4 14.1 12.1 14.1 20.3 16.6 9.9 8.5 7.6 17.1 11.8 14.2 13.7 4.2 14.9 11.2 4.7 9.3 6.8 13.0 6.8 8.8 7.9 5.4 13.7 14.0 13.7 15.9 22.7 5.8 8.9 14.9 5.2 16.7 13.6 13.8 6.2 8.9 8.9 11.3 3.8 7.7 11.4 23.7 8.8 10.6 19.8 5.2 9.6 7.9 7.2 0.6 1.6 1.9 0.6 0.4 10.7 1.5 4.3 9.0 4.7 6.2 2.8 5.2 5.6 3.4 3.4 2.5 2.2 2.7 6.9 2.3 3.2 2.8 10.5 1.3 6.2 1.4 2.4 9.3 3.8 15.0 5.7 3.7 3.7 4.9 5.2 4.9 4.8 6.3 3.0 5.0 1.3 1.6 6.5 7.1 7.2 1.6 3.6 4.0 2.0 3.2 4.8 5.5 16.2 10.1 3.1 14.7 5.8 8.6 4.3 3.1 9.9 9.1 4.2 6.8 9.6 0.9 0.7 7.7 4.3 3.9 0.5 0.6 0.7 0.9 0.2 0.4 0.6 0.8 1.2 0.5 0.6 5.2 10.7 1.9 0.4 0.1 1.6 0.3 1.5 12.9 14.1 20.3 16.6 9.3 6.8 5.4 13.7 8.9 8.8 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved "Nucleoli,Intermediate filaments,Mitochondria" Mitochondria "Nucleoli, Intermediate filaments" "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favourable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.5 11.0 21.0 13.4 7.8 11.0 27.0 13.3 14.4 32.2 31.8 30.9 17.6 25.4 23.0 10.1 24.2 34.0 22.7 38.7 8.7 12.0 29.9 7.8 37.4 13.1 44.4 10.7 9.0 11.8 19.7 21.7 14.8 33.8 11.1 16.9 17.2 28.3 31.8 40.2 20.8 18.8 24.9 31.2 22.2 18.4 21.2 10.4 15.4 16.4 36.9 16.3 29.3 8.5 18.1 23.2 7.6 26.4 8.8 11.7 54.8 20.6 21.6 15.9 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.4 10.8 9.0 6.4 10.0 8.7 14.0 10.4 12.0 18.3 15.0 21.8 6.5 13.4 5.3 10.3 7.3 40.9 19.8 15.6 14.1 21.8 13.2 6.4 14.4 29.5 17.4 7.6 15.1 16.8 19.3 24.4 15.0 24.9 6.9 11.2 20.7 16.0 23.8 14.2 25.2 12.1 13.4 10.9 9.7 11.4 15.3 7.4 11.9 6.4 15.1 13.8 23.1 7.0 9.1 7.0 6.5 19.0 11.0 12.3 25.7 6.5 13.9 12.3 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Cell line enhanced" "Detected in some" "U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: " "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 0.9 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.1 0.9 0.8 1.1 0.3 0.2 3.3 0.4 1.9 2.0 0.8 0.3 0.5 0.3 1.5 0.0 0.3 0.9 1.2 0.1 1.6 0.4 0.9 7.6 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Cell line enriched" "Detected in single" 18 "MCF7: 9.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: " "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.5;testis: 53.2" "Cell line enhanced" "Detected in many" "HeLa: 7.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 13.7" "Group enriched" "Detected in many" 11 "gdT-cell: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1" "Lineage enriched" "Detected in single" 15 "T-cells: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: " "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.3 0.4 2.2 0.6 5.1 1.1 0.5 0.6 2.2 1.6 0.3 4.5 0.5 0.4 1.3 5.1 0.3 22.5 1.1 0.3 2.9 3.2 2.0 0.2 5.0 0.8 0.6 2.0 2.7 0.7 1.1 3.9 0.2 13.7 0.3 0.1 2.1 0.4 0.5 0.3 1.3 0.5 0.2 0.7 1.0 0.3 53.2 1.0 0.0 2.2 0.0 0.3 0.3 0.2 0.3 0.0 0.1 0.0 0.6 9.5 2.2 1.2 4.8 2.2 4.2 0.1 0.0 2.1 1.1 0.1 0.6 2.0 5.8 2.9 1.6 1.6 0.0 1.4 0.0 0.1 0.9 2.6 2.3 2.6 7.3 2.1 0.3 2.1 2.4 0.0 0.1 1.2 0.0 0.0 1.1 0.6 0.1 2.7 0.6 2.8 4.7 1.2 1.5 1.0 1.8 3.5 3.1 1.2 2.0 1.3 1.7 1.6 4.5 1.8 1.9 1.6 1.6 1.8 0.9 2.1 2.1 1.5 1.7 1.7 0.4 0.0 0.0 0.0 8.9 0.0 9.5 0.3 7.6 7.1 0.0 0.3 4.7 6.3 0.1 0.6 0.0 0.0 4.1 2.2 2.2 5.1 0.6 2.2 2.9 3.2 0.6 2.0 13.7 1.0 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621818 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 8.4 7.5 9.3 7.6 11.7 6.5 12.0 31.0 15.1 11.7 11.0 9.6 7.6 5.9 12.7 12.7 6.7 12.9 7.6 8.4 9.8 6.4 9.2 4.6 7.7 10.1 10.8 10.6 14.7 7.1 10.1 32.9 7.6 11.0 9.7 9.4 7.8 9.1 10.9 11.9 5.7 7.7 11.1 11.2 8.7 8.0 8.6 12.9 11.9 12.1 5.7 10.2 11.0 9.7 2.6 1.1 7.0 2.2 5.0 14.1 2.7 5.4 1.9 6.1 3.6 9.2 5.4 4.8 7.0 6.4 9.2 8.1 4.2 4.3 15.2 1.6 3.7 3.0 3.4 6.4 10.3 5.4 4.1 9.5 8.4 4.8 6.5 12.1 3.6 5.3 9.3 7.6 5.4 5.8 8.8 2.4 7.1 4.4 9.7 7.7 9.9 7.5 3.3 5.2 8.2 5.5 1.9 2.3 4.2 8.4 5.4 5.1 1.9 5.3 3.1 6.9 5.4 6.4 9.5 4.9 5.2 8.1 5.1 13.9 5.4 7.0 1.5 3.3 4.3 1.9 5.6 2.6 7.4 5.3 1.1 1.7 8.6 6.2 0.3 5.0 2.2 1.0 14.1 2.7 9.3 11.7 31.0 15.1 9.8 6.4 10.8 10.6 11.0 12.9 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.1" "Cell line enhanced" "Detected in some" "A-431: 7.9;HHSteC: 10.7;HSkMC: 11.7;RT4: 7.9;TIME: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA040865: , HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavourable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favourable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.6 3.0 1.2 7.7 2.4 0.3 5.8 0.6 4.7 5.5 20.7 0.8 3.1 14.8 4.5 2.5 2.1 2.6 9.1 5.7 1.7 1.7 5.6 9.9 15.2 2.3 2.0 4.7 15.4 2.8 0.5 15.7 23.9 4.4 5.2 13.9 9.3 2.2 13.0 7.7 1.0 40.1 2.1 1.6 5.8 10.5 7.4 0.1 0.0 3.5 2.1 1.0 3.0 4.2 0.8 0.6 1.1 2.2 0.5 1.0 0.5 7.9 2.5 0.0 0.0 2.3 6.6 0.0 0.2 3.2 0.5 0.5 4.4 4.7 0.0 5.9 0.0 0.1 0.5 5.1 0.4 0.0 1.2 0.6 2.9 0.9 10.7 0.0 0.0 11.7 0.0 2.4 0.1 3.7 0.0 0.1 0.3 0.6 0.0 0.1 0.0 2.7 0.2 0.0 0.2 0.9 7.9 0.0 1.9 2.5 0.8 0.1 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.7 0.7 0.4 0.8 0.6 0.6 0.6 0.5 0.4 0.8 0.9 1.0 0.7 0.5 2.2 0.6 0.5 0.5 1.2 2.4 0.6 4.7 1.7 1.7 2.0 4.7 4.4 0.1 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 99.8" "Cell line enhanced" "Detected in many" "ASC diff: 34.2;Daudi: 52.8;U-266/70: 33.8;U-698: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: " "prognostic favourable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 31.6 33.7 2.1 33.4 3.2 10.9 99.8 1.7 4.7 7.3 43.4 2.5 6.6 5.7 12.2 7.3 28.1 12.7 14.0 57.6 2.2 2.5 3.8 12.6 23.7 23.2 4.3 0.9 11.4 15.3 5.3 6.1 21.4 8.4 17.2 5.8 9.0 5.5 8.7 87.1 4.5 14.9 53.0 5.1 21.7 15.6 6.7 2.2 13.3 5.1 18.8 17.7 37.2 58.4 11.4 20.4 18.0 10.7 11.9 11.7 8.3 2.1 0.2 0.1 1.8 34.2 3.6 1.2 0.3 3.3 0.6 0.5 0.4 0.2 52.8 1.9 0.1 0.1 0.8 0.6 0.2 0.0 0.7 6.7 0.0 3.2 5.6 2.4 9.7 8.7 0.0 0.2 0.0 3.3 6.3 11.9 0.0 0.0 11.2 6.2 2.0 4.3 9.6 0.2 3.2 0.1 1.4 0.0 0.2 0.6 0.9 0.4 0.5 6.2 8.2 0.2 1.7 0.1 0.4 33.8 15.7 34.1 0.4 5.9 0.0 18.0 10.7 12.3 11.7 8.6 10.2 5.9 9.1 11.0 9.3 11.4 7.3 6.7 9.2 11.9 8.2 20.4 6.6 8.3 2.1 3.2 1.7 4.7 2.2 2.5 4.3 0.9 8.4 2.2 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Nucleoli "Mitotic spindle, Cytosol" "HPA075536: " "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.5 2.8 0.8 3.5 2.4 1.9 1.3 2.3 0.8 0.8 2.5 0.6 3.8 1.9 1.2 1.6 1.3 1.3 1.4 3.1 6.6 0.3 1.0 2.0 0.7 4.3 1.0 1.9 1.7 0.7 1.7 0.6 1.0 1.5 6.5 3.2 0.4 0.8 0.6 0.7 2.8 1.6 3.6 0.3 2.3 0.5 1.9 1.9 0.4 0.4 1.5 1.9 1.5 3.8 2.0 2.3 2.6 1.3 2.1 1.4 1.9 2.5 7.3 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 CCDC71L "C7orf74, FLJ36031" ENSG00000253276 "Coiled-coil domain containing 71 like" Q8N9Z2 7 106656765-106660996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067925 Approved Approved "Golgi apparatus,Actin filaments,Cytosol" "Golgi apparatus, Actin filaments" Cytosol "HPA067925: " "unprognostic (1.51e-1)" "prognostic unfavourable (9.08e-4)" "unprognostic (7.26e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-2)" "unprognostic (1.95e-3)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (2.38e-3)" "unprognostic (6.03e-2)" "unprognostic (2.83e-1)" "prognostic unfavourable (2.53e-6)" "unprognostic (3.34e-2)" "unprognostic (3.72e-1)" "unprognostic (2.26e-1)" "unprognostic (6.35e-2)" 19.5 5.2 2.4 13.2 2.2 8.8 10.6 0.6 3.8 7.8 8.4 2.5 5.8 4.3 10.3 6.5 6.3 19.7 9.2 6.3 3.5 2.3 9.0 42.9 11.2 10.8 1.8 2.7 13.4 6.3 3.2 3.7 4.0 2.3 9.3 4.0 8.1 16.5 4.9 6.7 3.2 8.3 7.0 2.4 17.0 9.0 12.7 2.2 35.3 9.1 2.9 6.8 12.5 10.8 2.3 2.4 7.3 1.2 1.6 2.9 0.8 10.2 2.1 3.2 3.8 7.2 6.9 0.0 16.0 20.4 6.2 6.7 0.3 6.5 7.0 5.5 26.7 1.1 1.5 4.5 5.1 16.2 3.7 0.8 0.4 0.0 11.3 3.5 8.4 5.8 2.7 2.8 1.6 21.4 23.1 17.2 7.3 2.9 4.7 5.5 6.9 7.6 6.4 0.9 1.3 3.1 0.6 1.4 9.6 10.2 3.7 22.1 1.7 4.2 9.4 13.8 1.2 1.6 6.1 16.7 1.5 5.6 10.6 4.5 15.1 7.2 1.0 3.0 2.0 0.8 1.5 2.3 1.6 1.5 0.7 1.7 0.8 1.2 7.3 1.6 1.2 2.4 2.9 0.8 2.4 2.2 0.6 3.8 3.5 2.3 1.8 2.7 2.3 2.2 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell line enhanced" "Detected in many" "AF22: 11.9;AN3-CA: 14.2;HSkMC: 13.0;K-562: 12.4;RH-30: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favourable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.1 0.1 11.9 14.2 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.1 4.8 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.6 0.0 0.1 13.0 0.0 3.3 9.9 0.0 12.4 0.0 4.3 0.0 0.0 0.8 8.6 0.0 0.4 16.1 0.0 10.4 0.0 1.9 0.1 0.0 0.0 0.0 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96352769-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 19.4 12.5 22.8 14.6 32.7 12.1 15.3 34.5 29.6 13.6 12.7 18.3 6.7 9.8 18.4 12.2 9.0 14.9 13.9 10.4 23.7 9.0 13.7 17.8 15.7 17.4 31.9 20.3 16.5 13.5 11.7 22.3 14.3 25.6 12.2 11.6 8.1 11.9 13.7 10.8 10.5 15.5 14.1 26.0 16.5 13.6 19.4 35.5 7.5 15.9 6.2 15.8 15.4 16.9 14.3 12.2 28.6 10.8 22.7 19.2 11.0 5.3 8.1 25.1 9.7 16.7 14.3 9.3 21.0 12.9 13.8 20.2 13.3 18.9 11.2 19.8 10.9 12.7 8.9 7.6 20.5 19.1 5.4 22.9 17.4 11.3 12.0 17.9 15.3 8.8 4.1 27.8 10.4 16.4 13.7 12.2 18.5 0.2 15.1 17.5 5.0 5.9 10.4 21.4 9.9 10.5 14.1 4.0 10.7 11.6 1.2 10.3 1.9 8.9 19.0 24.5 13.5 20.4 11.1 4.1 12.5 16.3 7.3 14.1 17.4 28.6 8.3 15.5 16.5 10.2 17.2 14.3 17.6 16.1 8.9 12.1 19.2 18.2 11.6 22.7 10.8 12.2 18.4 11.0 22.8 32.7 34.5 29.6 23.7 9.0 31.9 20.3 25.6 35.5 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Cell line enriched" "Detected in single" 10 "MCF7: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.1 0.3 7.7 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500180-99604026 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058346 Uncertain Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA058346: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favourable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 3.5 12.0 13.9 3.3 15.5 7.2 6.1 45.2 11.8 11.3 15.3 11.7 16.6 15.4 8.7 12.6 24.0 10.0 13.9 11.4 11.6 7.6 7.8 32.3 6.7 1.9 10.3 5.9 6.9 15.3 10.4 10.0 7.1 9.1 15.8 9.5 19.9 20.8 14.8 15.2 13.6 27.0 15.4 8.4 3.0 10.5 8.1 8.1 2.7 9.5 9.3 8.7 13.7 17.9 0.3 0.1 0.7 0.0 0.4 2.0 0.6 17.3 15.9 19.8 11.8 0.2 0.0 18.4 5.9 6.0 11.9 6.9 19.3 18.4 0.1 23.4 6.6 23.4 14.6 14.1 7.4 28.5 8.6 0.9 15.8 13.0 1.6 0.2 1.8 0.0 7.5 3.4 9.8 3.7 4.2 2.6 1.4 29.0 7.7 2.3 7.2 16.6 11.6 8.3 3.9 8.4 6.9 9.8 12.3 15.0 8.0 3.6 17.5 3.5 8.3 2.3 19.8 8.4 5.8 4.2 5.5 0.1 0.4 1.5 1.6 0.7 0.0 0.0 0.6 0.0 0.8 0.2 1.9 1.3 0.0 0.3 2.0 1.1 0.6 0.4 0.0 0.1 2.0 0.6 13.9 15.5 45.2 11.8 11.6 7.6 10.3 5.9 9.1 8.1 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavourable (7.36e-5)" "prognostic unfavourable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 20.9 28.6 7.1 20.4 5.7 9.5 9.7 14.1 11.0 26.0 14.0 24.3 14.1 25.7 27.0 7.6 19.7 23.9 17.0 12.0 9.0 26.4 13.1 12.7 33.9 19.1 20.4 22.4 10.9 13.0 24.0 15.2 19.2 41.7 13.2 12.7 24.8 30.6 31.1 28.6 41.1 21.0 10.6 64.6 9.0 8.9 16.0 10.3 9.1 21.0 16.5 21.2 8.2 12.5 25.9 15.9 35.1 30.5 11.2 16.5 27.8 21.2 22.1 31.3 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Cell line enhanced" "Detected in some" "HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favourable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavourable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.5 9.0 1.4 0.5 0.7 0.0 0.2 0.0 9.8 0.0 6.8 1.8 0.5 0.4 4.2 39.8 0.0 0.0 0.1 0.0 0.2 0.2 10.4 0.3 0.4 5.7 3.5 0.3 0.2 5.4 0.1 8.4 0.1 0.1 2.2 0.0 0.0 0.2 0.4 1.2 15.8 0.0 0.0 0.3 0.0 0.1 2.2 0.7 7.3 0.5 11.5 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 23.9;U-266/70: 21.0;U-266/84: 29.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 18.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favourable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favourable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 3.6 0.9 2.7 31.1 18.7 15.0 6.9 0.9 2.3 3.0 8.9 1.8 15.5 9.6 4.7 4.0 8.9 9.7 11.8 2.2 2.0 2.4 5.0 2.6 11.1 34.5 2.0 0.3 2.0 14.8 6.7 4.0 1.8 1.6 6.4 4.7 4.1 12.1 11.7 1.5 4.5 9.6 6.0 2.9 14.5 8.1 4.8 3.7 18.5 2.5 6.0 27.6 7.1 5.3 2.3 1.8 5.2 3.2 3.1 11.0 2.8 3.1 2.9 3.4 3.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 3.0 4.7 13.5 2.5 0.0 0.1 4.8 2.7 0.0 11.4 1.8 3.6 2.0 4.2 0.3 7.0 3.0 0.0 4.0 0.0 0.0 3.7 4.1 17.0 0.0 10.3 7.1 9.3 3.3 4.4 5.9 0.1 4.5 0.8 4.5 23.9 5.3 2.0 6.9 1.6 3.8 6.5 1.1 0.0 0.0 0.0 0.0 21.0 29.5 6.9 0.0 6.4 0.0 5.2 3.2 1.3 9.0 1.8 8.7 2.3 6.1 9.3 1.8 1.9 3.9 5.8 2.6 3.1 2.5 1.5 11.0 2.8 2.7 18.7 0.9 2.3 2.0 2.4 2.0 0.3 1.6 3.7 CCDC91 "DKFZp779L1558, FLJ11088, p56" ENSG00000123106 "Coiled-coil domain containing 91" Q7Z6B0 12 28133249-28581511 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038169 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038169: AB_10672506" "unprognostic (6.25e-2)" "unprognostic (4.25e-2)" "unprognostic (3.67e-2)" "unprognostic (1.91e-2)" "unprognostic (6.71e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (1.05e-4)" "unprognostic (4.98e-2)" "unprognostic (2.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (7.69e-4)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.85e-2)" "unprognostic (2.38e-1)" 14.3 16.8 16.3 14.5 20.6 9.4 14.6 14.8 22.5 11.3 12.9 10.8 14.4 10.5 16.3 16.6 14.5 11.3 13.4 26.5 16.1 19.8 18.2 13.4 11.3 13.1 18.2 17.1 16.8 22.9 23.3 26.2 10.6 32.3 14.0 11.5 11.5 14.2 15.6 32.7 9.1 11.9 21.2 21.6 13.9 14.8 36.3 15.3 23.3 22.3 9.7 11.6 21.0 16.1 6.5 4.2 16.0 5.4 7.1 8.5 3.6 10.2 7.4 6.8 0.3 7.1 6.6 12.8 8.8 9.3 7.7 9.9 5.1 13.9 5.4 7.6 10.4 11.9 6.3 14.1 11.7 15.7 5.1 17.8 14.2 4.1 11.0 16.9 8.9 6.5 14.2 7.7 22.6 6.1 16.1 18.1 7.3 3.7 16.7 14.5 14.0 7.0 10.3 19.8 9.2 12.5 7.1 5.8 10.5 16.6 5.6 26.4 10.8 13.5 4.6 16.5 11.4 16.2 5.0 22.8 24.7 14.8 14.2 13.9 9.3 16.0 2.4 3.4 5.5 4.6 7.3 6.5 7.1 7.9 3.4 5.5 8.5 7.7 0.8 7.1 5.4 4.2 8.1 3.6 16.3 20.6 14.8 22.5 16.1 19.8 18.2 17.1 32.3 15.3 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: " "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favourable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favourable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 19.3 11.1 35.2 9.4 24.6 3.8 16.3 17.0 34.5 11.4 11.7 16.4 6.0 14.4 11.8 18.6 8.9 12.6 10.6 23.6 33.6 26.5 11.5 11.0 20.1 8.2 27.2 23.0 13.0 11.8 18.3 14.9 17.3 34.2 11.2 7.8 13.6 9.0 12.9 22.3 7.7 14.2 14.2 22.4 9.4 11.1 24.0 13.0 8.0 15.3 4.9 6.6 10.7 12.7 1.7 1.3 4.6 1.3 1.3 3.7 1.8 4.0 4.5 2.3 4.0 15.2 8.4 4.1 6.8 12.9 3.8 4.1 2.4 1.2 1.9 2.4 8.5 2.8 2.5 1.7 2.6 12.6 5.9 2.5 1.6 1.5 8.1 0.4 9.7 4.7 7.8 4.8 3.0 10.6 2.5 0.9 3.4 2.7 2.4 4.4 1.0 10.1 3.1 1.3 0.5 5.2 4.2 4.4 6.3 3.3 1.7 4.6 4.8 2.2 10.5 7.7 1.7 4.9 2.3 3.2 1.7 0.6 6.1 3.4 3.2 4.6 1.3 1.9 2.3 0.7 3.7 1.6 3.0 3.5 1.0 1.7 2.3 2.8 1.2 1.3 0.1 1.3 0.5 1.8 35.2 24.6 17.0 34.5 33.6 26.5 27.2 23.0 34.2 13.0 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA054183: " "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavourable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (9.66e-4)" "unprognostic (2.40e-2)" 23.0 20.6 12.9 21.9 14.3 27.2 14.5 23.9 15.6 12.3 18.1 12.8 16.0 17.3 16.8 16.9 10.9 12.3 14.9 23.4 13.1 13.0 14.6 11.0 15.9 16.0 11.8 11.5 20.3 18.0 24.0 26.8 18.6 13.3 11.4 16.0 14.6 13.6 24.9 20.6 16.0 18.1 17.2 15.1 17.1 12.1 15.9 12.0 17.4 17.1 10.2 20.4 11.9 19.2 4.2 3.0 6.3 5.5 3.9 5.7 2.3 13.5 6.0 16.6 14.6 24.1 16.6 14.1 16.1 10.6 10.6 10.9 13.0 8.7 11.6 11.1 12.6 11.8 9.6 8.3 13.9 15.0 9.8 14.6 10.5 17.4 10.7 15.8 16.7 11.3 8.7 16.6 19.8 11.2 8.0 8.2 11.8 5.8 10.0 17.2 7.5 9.8 12.8 13.0 7.8 8.8 14.5 13.3 7.9 10.5 8.0 11.3 6.7 9.8 15.7 18.3 15.4 15.4 11.1 10.9 11.3 18.4 10.6 11.8 10.6 6.3 4.2 4.5 5.7 5.5 5.6 4.2 4.1 4.7 3.0 4.1 5.6 4.8 4.4 3.9 3.4 1.5 1.8 2.3 12.9 14.3 23.9 15.6 13.1 13.0 11.8 11.5 13.3 12.0 CCDC97 "FLJ40267, MGC20255" ENSG00000142039 "Coiled-coil domain containing 97" Q96F63 19 41310189-41324883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043320, HPA043572" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA043320: AB_10964344, HPA043572: AB_10962488" "unprognostic (9.25e-3)" "unprognostic (7.26e-2)" "unprognostic (1.68e-1)" "unprognostic (5.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "prognostic unfavourable (1.09e-4)" "unprognostic (8.40e-2)" "unprognostic (1.91e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (4.51e-2)" "unprognostic (2.16e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-1)" "unprognostic (7.92e-2)" "unprognostic (1.65e-2)" 20.4 15.3 15.5 20.7 18.8 21.5 16.8 16.1 24.7 21.3 16.7 26.7 17.8 15.1 21.3 26.6 22.9 24.5 15.8 16.4 14.6 14.1 16.5 13.3 15.4 23.2 16.0 16.2 27.4 20.6 20.8 21.9 22.9 18.6 19.0 12.6 20.9 21.1 17.2 28.8 21.5 18.4 15.6 21.0 24.2 17.3 39.9 16.8 27.7 17.9 20.4 27.2 17.7 19.7 13.6 7.6 14.6 13.3 11.5 16.8 8.3 12.9 28.4 15.1 17.5 19.9 15.9 10.9 8.7 7.1 13.9 11.9 16.8 12.5 12.3 9.4 7.2 8.8 20.6 17.4 10.6 22.6 20.0 11.3 12.8 11.0 15.2 18.7 24.5 15.4 22.4 16.1 13.5 9.5 14.4 23.7 13.2 9.4 17.0 4.5 7.0 10.3 19.3 12.0 9.0 12.7 24.7 13.5 12.0 19.5 21.5 8.5 14.7 14.3 11.3 12.0 12.1 6.2 14.4 24.4 20.8 11.9 11.4 13.8 15.9 9.0 8.3 9.7 15.3 9.2 16.8 11.3 10.3 10.9 6.8 13.6 11.4 10.0 14.6 11.5 13.3 7.6 8.5 8.3 15.5 18.8 16.1 24.7 14.6 14.1 16.0 16.2 18.6 16.8 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 39.2;WM-115: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 2.8 4.8 3.6 9.4 5.8 1.5 4.5 3.4 6.2 9.4 29.6 6.3 38.1 5.7 11.5 14.1 19.8 5.0 12.3 30.5 5.8 3.2 5.1 2.1 6.8 1.7 6.7 4.7 2.6 12.0 9.7 4.8 2.3 5.7 10.3 7.6 12.9 13.9 40.6 35.0 7.7 8.3 16.2 3.6 2.5 11.0 5.3 6.3 0.3 21.3 16.1 6.1 13.0 7.2 0.5 0.5 6.7 0.6 0.9 0.3 0.4 15.4 2.2 0.0 0.1 0.3 1.5 0.8 4.7 4.7 5.2 5.1 0.1 14.3 0.1 6.6 15.1 39.2 0.0 12.8 4.9 0.0 0.1 4.6 18.3 1.5 2.8 0.0 0.9 1.9 2.9 2.2 6.7 3.7 0.0 0.2 8.9 0.0 0.1 0.0 0.1 4.1 0.0 1.3 0.0 15.8 0.8 0.0 1.1 2.8 6.2 2.7 0.6 0.7 19.7 9.8 15.8 2.6 12.3 0.0 0.0 0.1 11.9 0.8 44.6 6.7 0.6 0.6 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.3 0.2 1.2 0.9 0.2 0.5 0.0 0.4 3.6 5.8 3.4 5.3 5.8 3.2 6.7 4.7 5.7 6.3 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36002038 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 36.4;liver: 17.9" "Cell line enriched" "Detected in some" 14 "Hep G2: 26.6" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" 7900000 "Golgi apparatus" Vesicles "HPA058608: " "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favourable (3.02e-4)" 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.1 18.0 0.0 0.0 11.6 0.0 0.4 0.0 1.1 7.4 0.8 0.0 6.4 17.9 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 15.8 0.0 0.0 0.0 0.0 0.4 36.4 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 1.0 2.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.7 0.4 0.2 2.2 0.9 0.1 1.0 0.3 0.0 CCL2 "GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF" ENSG00000108691 "C-C motif chemokine ligand 2" P13500 17 34255218-34257203 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "BJ hTERT+: 159.2;HMC-1: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 10.3;eosinophil: 3.9" "Group enriched" "Detected in many" 6 "granulocytes: 3.9;monocytes: 10.3" "Low region specificity" "Detected in many" "CAB013676, HPA019163" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 342420 "Golgi apparatus" Vesicles "CAB013676: , HPA019163: AB_1846179" "unprognostic (6.43e-2)" "unprognostic (4.14e-2)" "unprognostic (4.78e-2)" "unprognostic (5.57e-2)" "unprognostic (2.37e-3)" "unprognostic (8.64e-2)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.19e-1)" "unprognostic (9.33e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (4.51e-4)" "unprognostic (1.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.81e-1)" "unprognostic (4.92e-2)" 78.1 31.2 10.3 52.3 50.6 19.1 19.0 1.5 23.3 9.7 41.9 28.6 3.0 9.4 7.2 7.6 14.4 25.8 62.0 76.9 45.1 6.7 32.5 38.4 105.2 16.9 16.0 2.0 28.6 32.8 15.2 17.3 22.8 63.6 42.0 25.3 22.3 13.5 13.4 17.8 10.5 16.7 34.6 85.4 16.1 30.2 4.6 8.6 4.8 20.8 21.6 19.1 27.2 9.0 0.0 1.1 3.9 10.3 0.0 0.1 2.3 0.0 1.2 3.4 0.0 9.6 8.2 0.0 9.7 159.2 20.7 44.4 0.5 0.0 0.0 7.7 2.2 5.3 0.3 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.3 0.0 207.5 9.1 0.0 4.3 0.2 9.4 0.5 1.7 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.2 1.7 29.6 0.0 0.0 0.6 0.0 0.5 0.2 0.3 0.2 0.5 11.1 0.4 0.3 0.0 0.1 0.0 0.0 6.5 3.0 7.0 0.0 10.3 3.9 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 2.3 10.3 50.6 1.5 23.3 45.1 6.7 16.0 2.0 63.6 8.6 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442882 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;parathyroid gland: 24.2;testis: 50.4" "Cell line enriched" "Detected in some" 4 "HMC-1: 85.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 20.7;ovarian cancer: 18.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 108 "basophil: 24.5" "Lineage enriched" "Detected in single" 233 "granulocytes: 24.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA060646: , HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.8 7.3 0.4 6.2 1.3 0.6 0.2 4.7 4.0 0.3 1.6 0.0 0.4 2.6 4.7 0.3 11.1 0.6 0.3 4.5 5.9 0.3 0.2 1.0 1.0 1.9 5.5 1.2 0.5 24.2 4.8 0.2 3.1 0.3 0.3 0.1 0.4 0.2 1.3 0.2 0.3 5.1 1.0 0.3 0.4 50.4 0.4 0.2 0.4 0.0 0.5 0.4 0.6 0.1 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 3.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.7 85.1 0.0 8.3 0.1 0.7 0.2 0.0 0.1 0.0 1.0 0.1 16.6 0.5 2.1 0.0 2.0 0.0 0.5 0.0 0.6 1.4 0.0 2.0 0.0 0.0 16.6 1.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 21.0 0.1 24.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.2 0.2 4.7 4.5 5.9 1.9 5.5 3.1 0.4 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavourable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavourable (9.17e-5)" "prognostic unfavourable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavourable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.1 9.9 27.3 11.6 1.4 3.8 22.3 26.6 11.7 35.5 26.4 21.6 23.7 35.1 7.2 14.0 12.9 34.3 15.7 29.2 16.8 15.8 28.2 13.2 21.0 0.3 42.4 20.0 0.9 1.2 14.6 8.8 21.2 40.0 35.3 28.1 13.7 54.0 24.6 21.5 11.1 24.8 52.8 17.1 10.0 7.6 11.6 12.3 14.0 17.1 7.4 14.3 18.0 12.4 16.6 25.2 17.5 25.4 22.4 23.7 40.2 9.5 43.2 18.4 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105078-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.2;testis: 73.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "T-reg: 17.8" "Lineage enriched" "Detected in many" 6 "T-cells: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavourable (2.83e-4)" "prognostic unfavourable (4.63e-4)" "prognostic unfavourable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 2.0 1.1 0.4 21.0 0.4 24.7 2.5 0.3 0.6 1.8 5.5 0.5 0.2 5.2 1.0 1.5 11.3 0.5 1.6 1.2 0.4 0.4 1.0 1.0 1.9 12.0 0.4 0.3 0.8 0.7 0.0 0.4 6.7 0.4 1.1 6.3 0.4 2.1 0.6 0.4 3.6 5.1 2.0 1.3 5.2 3.0 73.9 0.2 70.2 0.8 10.3 16.0 1.8 3.4 1.8 2.3 0.7 0.1 3.0 17.8 1.8 28.4 25.1 41.3 10.2 1.8 3.8 21.9 23.6 15.2 36.6 30.1 40.6 17.6 26.5 17.1 15.2 35.2 39.0 20.1 34.6 27.5 20.9 34.3 29.4 23.0 0.5 25.5 22.1 1.4 2.7 15.7 20.1 24.8 34.6 42.6 27.6 20.7 29.1 37.2 30.5 14.9 34.0 58.4 26.9 11.5 20.2 25.7 17.4 32.4 17.6 21.3 30.5 25.5 12.9 18.2 31.0 20.1 44.9 19.0 28.4 47.1 11.9 58.4 25.7 0.0 0.1 0.6 0.1 0.0 0.2 1.8 3.9 4.1 2.3 0.9 0.0 0.1 0.7 3.0 0.0 0.1 17.8 1.8 0.4 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.2 CCNC CycC ENSG00000112237 "Cyclin C" P24863 6 99542380-99568973 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Cyclin, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010499, HPA069322" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB010499: AB_2244021, HPA069322: " "unprognostic (1.48e-2)" "unprognostic (1.21e-2)" "unprognostic (1.85e-3)" "unprognostic (6.34e-2)" "unprognostic (1.92e-2)" "unprognostic (1.95e-3)" "unprognostic (2.09e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-2)" "unprognostic (1.92e-1)" "unprognostic (7.10e-2)" "prognostic favourable (8.12e-4)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (3.83e-2)" 18.0 21.1 14.5 16.8 20.4 13.7 23.8 23.2 24.3 15.6 17.3 8.7 21.8 19.8 13.5 28.1 26.5 11.7 24.7 12.0 14.9 16.9 31.5 47.4 16.2 23.4 13.6 12.6 13.5 35.6 20.8 31.8 24.4 17.6 18.2 15.9 12.4 37.0 20.9 13.1 15.4 22.6 17.3 12.1 21.1 20.2 8.6 10.0 27.3 30.7 16.8 21.9 17.5 15.5 20.1 15.0 21.5 13.9 17.7 26.6 18.8 26.8 8.0 15.4 30.0 11.5 15.8 38.7 19.5 23.5 23.7 30.3 30.7 15.8 52.6 21.0 16.1 17.5 23.5 26.4 37.5 13.2 25.3 32.6 13.4 26.8 20.9 36.4 10.7 15.6 16.1 16.7 21.0 23.5 44.2 19.7 20.7 13.6 13.3 26.9 20.6 13.3 22.8 25.9 20.9 30.6 30.4 23.1 14.1 9.8 22.2 22.7 13.0 34.9 18.7 13.0 17.4 13.6 28.6 14.0 21.4 45.2 22.0 26.0 16.0 21.5 12.9 10.7 14.2 13.9 26.6 20.1 17.9 14.5 15.0 16.0 20.1 15.7 2.5 17.7 10.4 15.0 18.0 18.8 14.5 20.4 23.2 24.3 14.9 16.9 13.6 12.6 17.6 10.0 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934933-42050357 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 129.2;lymphoid tissue: 142.5" "Cell line enhanced" "Detected in all" "MOLT-4: 92.5;REH: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA071369" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "CAB000116: , HPA071369: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favourable (8.08e-6)" "unprognostic (2.11e-1)" 20.2 39.8 16.1 28.9 17.5 74.7 36.0 13.3 19.8 13.3 17.3 11.3 14.1 16.0 10.8 10.4 13.5 13.4 19.0 16.3 15.4 14.5 13.7 8.0 32.1 83.8 14.1 15.5 11.1 10.9 5.0 10.1 21.9 9.3 14.2 11.4 10.2 18.1 14.4 6.5 14.6 22.0 11.7 11.5 51.2 18.0 7.4 10.0 142.5 26.8 9.3 32.8 13.0 16.6 24.1 42.4 129.2 45.8 39.0 52.8 66.2 9.0 33.1 3.5 7.7 6.3 12.9 40.2 10.6 6.1 11.0 8.1 6.2 4.1 39.0 18.0 7.1 5.6 9.2 13.0 5.7 6.6 6.0 61.8 14.8 5.0 13.9 10.1 54.6 12.3 8.5 10.6 4.0 13.5 31.1 3.8 15.7 12.2 92.5 48.5 1.5 7.1 87.9 13.5 4.3 25.4 6.1 11.8 3.1 9.0 11.6 5.2 7.1 39.5 22.5 12.2 6.7 10.6 11.9 2.5 1.9 60.9 7.1 21.3 7.4 129.2 30.5 87.7 52.8 35.1 37.0 16.4 36.4 42.5 42.4 24.1 42.8 45.0 42.8 39.0 45.8 27.8 23.2 66.2 16.1 17.5 13.3 19.8 15.4 14.5 14.1 15.5 9.3 10.0 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197176 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.4" "Cell line enriched" "Detected in many" 8 "HEL: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: " "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favourable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 15.6 10.9 3.4 12.6 5.3 55.4 17.5 10.8 9.5 8.8 9.4 5.6 11.5 7.6 11.3 10.7 18.3 10.4 9.6 14.1 3.9 6.9 8.2 8.4 11.6 23.6 6.1 5.6 5.6 13.4 5.2 9.6 24.1 9.3 8.8 9.0 7.7 11.3 12.8 21.1 12.0 12.9 8.2 6.0 12.8 11.8 5.9 5.4 8.3 15.6 5.9 11.0 15.9 11.7 5.4 2.9 16.9 8.0 4.6 7.6 1.6 0.3 0.3 0.6 0.3 1.6 1.1 0.6 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.5 1.3 0.6 1.4 0.6 0.2 0.9 1.4 16.6 0.8 0.6 1.2 0.8 1.0 1.9 1.6 0.2 0.6 1.2 1.0 0.6 0.5 0.0 0.5 1.9 1.2 0.4 0.5 0.6 1.4 2.1 0.7 0.8 1.3 0.6 0.5 0.4 0.1 1.6 1.6 0.5 0.2 1.2 0.3 1.9 0.7 0.3 1.7 1.8 0.5 16.9 1.9 4.9 5.2 3.3 5.4 4.4 5.6 5.1 1.6 5.4 5.9 6.1 6.1 4.6 8.0 2.9 7.6 1.6 3.4 5.3 10.8 9.5 3.9 6.9 6.1 5.6 9.3 5.4 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157151-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 99.1" HPA034684 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favourable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 18.4 8.1 11.3 13.5 15.1 25.9 26.7 53.0 17.2 15.1 12.3 8.9 9.6 8.6 16.4 10.7 45.2 8.0 10.4 6.3 9.6 5.4 23.0 3.4 12.8 21.4 7.3 10.6 12.5 7.2 8.8 7.7 20.0 7.3 26.1 11.0 12.2 18.4 10.5 7.5 12.8 9.8 13.5 7.4 14.2 7.7 8.0 7.8 25.3 17.3 7.2 22.6 20.3 18.6 4.8 2.2 16.0 2.3 1.6 4.6 0.6 10.2 1.3 23.1 12.2 15.3 19.7 15.7 8.6 24.9 6.7 12.6 1.5 14.9 20.7 14.0 8.0 7.4 6.0 28.5 13.1 14.3 4.0 1.7 6.0 3.0 8.0 3.0 21.6 16.6 14.2 3.1 7.0 10.1 0.9 12.7 12.4 4.0 14.0 6.5 2.3 1.4 8.1 22.5 1.3 42.5 28.5 6.1 19.6 10.2 16.2 6.0 12.0 4.6 9.3 9.2 9.4 6.6 1.4 9.3 7.1 14.6 6.4 4.8 4.6 11.4 1.5 16.0 0.8 2.0 1.9 2.7 1.2 0.8 1.5 4.8 0.9 0.5 6.5 1.6 2.3 2.2 4.6 0.6 11.3 15.1 53.0 17.2 9.6 5.4 7.3 10.6 7.3 7.8 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: , HPA061470: " "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favourable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 25.1 15.1 49.3 43.1 74.2 67.9 18.9 19.4 47.7 30.8 29.7 18.5 38.3 46.5 29.9 48.7 13.2 33.7 68.1 49.2 33.0 13.2 27.8 17.6 17.6 72.9 47.7 56.3 53.1 81.5 28.4 69.7 43.1 23.8 50.7 43.7 29.0 62.0 45.1 21.6 9.4 38.9 46.6 19.6 45.8 28.8 62.6 34.2 25.8 39.7 31.4 22.5 20.4 29.1 37.8 22.6 40.1 26.5 28.1 12.7 49.1 32.0 33.0 24.4 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 23.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: " "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favourable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 23.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 1.7 3.6 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: " "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 7.1 10.5 5.0 8.9 9.2 18.1 7.7 11.4 8.2 6.9 8.6 6.4 9.3 8.1 10.8 8.3 6.7 8.7 8.0 5.3 4.9 5.5 11.4 6.4 8.2 8.2 5.0 3.7 8.7 9.3 11.3 11.0 7.4 6.6 7.1 7.1 9.2 7.6 7.3 7.3 5.3 11.7 7.7 5.0 13.4 7.4 9.9 5.7 16.3 7.2 5.8 8.3 6.8 5.0 1.9 6.9 1.1 4.0 1.2 3.1 2.1 5.0 4.1 25.1 24.9 2.5 2.0 3.6 3.2 3.8 4.9 4.4 10.4 2.2 7.0 3.7 3.1 3.1 16.6 3.5 6.3 3.4 6.7 6.8 3.0 14.7 6.0 6.8 3.3 3.8 4.7 4.5 10.8 11.2 9.9 0.1 2.9 4.9 11.5 7.7 13.9 3.4 13.8 1.1 0.5 5.5 4.8 3.8 13.3 3.7 0.9 6.9 5.8 7.5 5.6 3.1 6.7 3.4 7.5 1.4 0.5 6.5 3.5 12.0 2.0 0.3 4.0 1.1 2.3 3.3 3.1 1.8 2.0 1.2 6.9 1.9 2.9 2.6 0.5 1.2 3.2 1.4 1.5 2.1 5.0 9.2 11.4 8.2 4.9 5.5 5.0 3.7 6.6 5.7 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" "HPA057911: " "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavourable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favourable (6.96e-7)" 32.0 23.2 12.4 36.1 18.7 60.9 26.5 17.1 15.0 16.8 24.3 13.6 17.0 19.8 15.2 20.0 16.7 21.5 25.8 15.6 11.7 8.7 20.4 29.5 23.2 20.6 20.9 9.8 23.3 24.2 13.5 25.3 17.5 18.7 18.0 10.4 15.9 14.9 26.5 16.1 18.5 28.0 19.2 24.6 27.7 19.8 8.6 18.0 25.9 18.5 17.7 20.8 20.2 22.4 12.3 11.3 24.0 8.5 13.1 15.0 6.7 13.1 8.6 11.6 8.5 11.9 7.9 12.1 8.4 9.8 10.0 9.2 14.9 10.3 14.9 7.6 6.2 11.2 8.8 10.0 9.1 13.1 10.8 9.9 9.2 12.4 9.8 6.5 5.6 9.4 18.4 9.5 12.6 7.8 6.3 8.8 7.2 10.9 11.9 11.9 10.4 10.4 11.3 10.3 21.4 6.3 8.0 6.8 12.8 7.0 6.0 16.7 6.1 17.8 6.5 9.2 5.4 10.1 10.8 18.3 15.0 18.9 9.4 9.1 8.7 4.3 8.5 12.5 11.6 7.1 12.2 11.2 10.8 11.9 10.6 12.3 15.0 12.1 24.0 13.1 8.2 11.3 11.9 6.7 12.4 18.7 17.1 15.0 11.7 8.7 20.9 9.8 18.7 18.0 CCNQ FAM58A ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587919-153600045 "Disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050137: , HPA059843: " "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 3.1 5.7 4.2 6.1 12.8 4.2 9.7 3.7 11.1 4.5 5.2 6.4 4.2 6.1 3.7 10.5 5.1 5.1 4.0 14.7 7.9 6.5 6.3 5.0 10.9 9.5 6.1 4.1 9.5 3.0 6.4 6.4 7.3 5.7 6.1 3.5 8.0 6.8 10.3 4.0 5.0 4.9 6.7 7.3 5.4 2.7 7.4 3.9 4.9 4.2 8.7 5.2 4.5 7.4 1.9 6.8 2.3 1.1 4.8 1.4 19.9 15.6 6.0 21.4 11.1 5.7 9.5 12.0 10.5 11.5 11.8 14.9 7.1 16.2 23.3 12.8 12.9 19.9 11.4 11.9 9.9 20.2 3.9 9.4 11.4 9.8 13.6 9.4 7.5 10.3 7.8 8.6 9.7 4.8 7.8 9.8 23.2 9.6 16.7 7.6 26.3 10.9 9.7 8.4 8.7 8.6 8.0 10.5 6.2 9.8 14.1 3.6 12.5 7.0 10.2 14.3 22.4 18.2 11.3 10.7 20.5 9.1 21.3 7.5 0.0 2.3 6.8 4.0 2.1 1.8 7.4 3.7 2.8 1.9 6.2 4.0 2.8 1.4 1.1 1.0 1.9 4.8 1.4 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.44e-4)" "prognostic unfavourable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favourable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.8 3.4 22.3 8.3 11.1 11.3 17.0 9.4 7.8 8.9 11.2 9.1 7.9 11.2 7.1 7.7 8.9 13.3 7.1 13.1 6.0 9.0 12.0 8.7 12.9 10.8 10.8 10.7 10.3 14.1 8.8 10.9 13.1 10.0 11.5 10.3 4.6 11.9 16.2 18.1 7.1 11.6 8.0 8.9 13.9 18.9 15.3 12.6 6.9 8.1 10.7 8.5 13.2 11.9 11.6 12.8 4.9 6.9 8.1 5.0 11.7 7.2 8.6 9.8 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.7;Karpas-707: 72.4;U-266/84: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 52.9;neutrophil: 59.9" "Group enriched" "Detected in all" 7 "granulocytes: 59.9;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: , HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavourable (5.07e-4)" "prognostic unfavourable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 22.4 20.3 21.1 11.2 34.8 29.5 20.2 27.6 27.7 32.1 16.0 9.9 28.2 11.9 16.0 19.4 12.7 11.7 26.6 29.7 21.2 26.1 27.5 56.2 23.3 19.8 21.8 18.5 17.4 41.6 37.7 56.3 13.4 21.7 21.0 16.5 13.5 33.1 27.4 44.2 7.8 16.9 16.7 23.2 19.5 22.2 13.8 19.7 5.2 41.9 12.9 11.3 20.0 16.7 3.7 5.5 59.9 15.4 4.9 5.6 5.6 2.8 10.4 2.3 5.2 38.3 13.0 3.3 6.2 11.9 3.7 5.7 3.0 5.0 4.3 21.5 20.6 3.9 2.0 5.3 3.1 11.4 3.1 5.8 13.2 2.7 49.7 8.0 18.1 10.9 12.8 7.8 7.6 13.6 9.7 72.4 11.7 3.9 0.0 4.0 1.4 2.7 1.3 3.7 17.2 7.8 2.1 3.0 4.6 7.4 4.1 31.6 6.6 17.7 13.7 11.0 2.4 8.3 4.2 14.0 51.1 2.7 20.7 16.1 8.7 34.6 11.5 52.9 5.6 10.1 4.8 3.7 3.6 4.3 5.5 2.8 3.1 4.3 59.9 4.9 15.4 0.9 4.4 5.6 21.1 34.8 27.6 27.7 21.2 26.1 21.8 18.5 21.7 19.7 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328558-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 14.9 8.7 18.5 7.9 18.2 7.3 16.7 22.1 21.8 16.4 18.3 17.9 11.4 9.4 15.7 13.1 22.7 9.2 10.3 42.9 19.6 18.2 9.9 10.5 13.3 9.0 21.7 15.9 11.8 9.9 11.8 8.8 15.3 28.3 12.6 10.4 9.4 10.3 13.5 46.2 13.0 15.5 24.2 22.2 8.2 10.6 45.7 15.2 11.8 19.9 14.6 9.1 17.1 11.9 5.2 4.4 5.2 3.0 14.6 15.0 5.4 8.0 6.2 7.4 16.4 11.0 17.9 5.3 9.7 16.1 6.0 11.8 3.5 8.6 5.3 6.3 17.9 6.9 5.5 6.2 9.1 17.7 3.4 1.9 3.0 4.3 10.1 2.8 4.1 8.7 8.9 9.8 31.5 16.5 2.5 16.4 10.9 5.0 4.9 2.0 3.2 5.0 5.0 3.8 1.9 5.4 8.5 2.3 4.1 5.3 3.5 16.6 6.5 1.4 14.7 18.2 8.3 8.9 10.2 16.6 5.5 4.3 11.7 3.7 7.8 2.7 3.0 5.2 14.9 2.8 15.0 5.2 11.1 13.7 2.9 5.0 10.0 10.5 4.2 14.6 2.2 4.4 6.7 5.4 18.5 18.2 22.1 21.8 19.6 18.2 21.7 15.9 28.3 15.2 CCT3 "Cctg, TRIC5" ENSG00000163468 "Chaperonin containing TCP1 subunit 3" P49368 1 156308968-156367873 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006543 Approved Supported "Plasma membrane,Cytosol" 4000000 "Plasma membrane, Cytosol" "HPA006543: AB_1078426" "unprognostic (2.14e-2)" "unprognostic (3.20e-3)" "unprognostic (1.66e-1)" "unprognostic (6.00e-3)" "unprognostic (8.39e-3)" "unprognostic (3.14e-3)" "prognostic unfavourable (3.87e-7)" "unprognostic (4.43e-3)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (5.44e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.34e-4)" "unprognostic (7.16e-2)" "unprognostic (5.76e-2)" "unprognostic (5.67e-2)" "unprognostic (1.10e-1)" 38.8 68.8 37.6 41.8 43.2 26.9 51.2 54.5 51.4 35.1 42.1 46.2 33.8 37.9 50.4 34.8 56.1 52.2 29.2 41.5 36.7 41.6 60.8 61.9 30.9 48.1 43.5 32.8 53.0 59.0 56.7 55.9 39.2 43.0 38.1 50.0 35.3 34.4 41.4 66.4 38.2 39.5 59.7 41.2 41.6 41.9 49.8 47.6 62.1 60.0 49.9 60.7 44.8 82.4 34.8 39.3 14.2 30.5 30.8 45.1 43.9 50.2 57.4 39.2 37.5 43.5 32.4 51.1 47.1 37.4 74.5 45.8 56.8 46.7 83.1 54.8 39.4 47.4 124.0 61.2 63.7 44.5 78.0 52.7 46.7 44.8 32.1 65.1 44.4 41.1 36.7 66.8 62.3 63.0 90.4 30.0 44.2 46.8 85.7 40.0 79.3 83.2 69.0 39.7 89.9 54.6 31.8 53.1 54.8 43.3 76.4 41.9 67.6 79.8 43.5 30.3 45.2 31.7 83.8 55.9 99.2 123.6 35.3 41.6 49.1 14.2 25.3 11.2 31.2 30.5 41.6 34.1 34.7 34.2 39.3 34.8 45.1 37.8 3.6 30.8 30.2 25.5 35.5 43.9 37.6 43.2 54.5 51.4 36.7 41.6 43.5 32.8 43.0 47.6 CCT4 Cctd ENSG00000115484 "Chaperonin containing TCP1 subunit 4" P50991 2 61868089-61888804 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029349 Supported Supported Nucleoplasm,Cytosol 3400000 Cytosol Nucleoplasm "HPA029349: AB_10600800" "prognostic unfavourable (2.03e-4)" "unprognostic (2.80e-2)" "unprognostic (6.46e-2)" "unprognostic (1.74e-3)" "unprognostic (5.03e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (9.37e-12)" "unprognostic (1.28e-3)" "unprognostic (2.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-2)" "unprognostic (5.18e-2)" "unprognostic (2.00e-1)" "unprognostic (3.96e-1)" "unprognostic (2.14e-2)" 35.1 42.3 34.8 33.3 38.7 32.4 63.3 41.2 40.6 37.7 36.2 26.0 34.4 26.7 43.1 32.6 47.9 44.6 25.3 49.0 31.4 33.7 43.1 37.6 28.7 54.1 42.1 33.9 66.4 65.9 39.7 32.8 37.7 40.0 37.6 35.4 21.5 32.1 35.9 52.5 37.5 28.1 42.5 39.7 36.2 38.1 49.4 37.7 55.6 50.0 40.8 50.9 39.3 93.4 30.3 31.4 13.7 29.8 31.6 39.1 34.6 41.7 48.7 32.6 30.1 27.1 41.3 54.7 38.2 27.4 55.3 37.1 84.8 30.4 67.3 38.9 27.3 30.2 63.8 49.0 58.4 33.0 62.7 43.0 25.2 53.2 24.4 52.8 28.8 35.0 34.2 44.5 46.3 46.1 61.0 21.8 47.0 37.5 45.5 72.6 58.5 43.5 51.7 50.9 45.5 38.4 28.8 28.4 23.9 27.7 35.4 49.3 25.6 39.1 28.9 30.7 44.7 22.8 61.9 33.3 44.5 114.2 30.4 61.1 40.2 13.7 19.0 7.5 27.8 27.2 35.7 30.3 29.6 33.3 31.4 27.5 39.1 38.0 2.7 31.6 29.8 20.3 30.7 34.6 34.8 38.7 41.2 40.6 31.4 33.7 42.1 33.9 40.0 37.7 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 49.0 27.9 35.7 25.7 26.4 36.4 39.8 39.4 25.1 44.7 37.4 59.1 30.4 97.1 26.5 27.2 19.9 73.6 45.5 50.9 41.0 38.3 134.3 33.6 26.4 27.4 66.3 37.6 27.7 28.1 52.6 43.8 42.7 103.5 56.8 45.6 25.5 49.9 26.0 64.3 34.8 44.9 70.3 60.3 45.7 25.8 35.8 25.8 38.6 40.8 33.8 36.5 58.1 30.8 25.4 71.9 23.9 49.0 36.9 71.3 76.5 29.8 75.5 38.8 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 8.8 0.1 4.7 5.2 0.0 0.0 6.5 0.2 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.5 4.3 6.8 0.0 0.0 5.4 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.5;HaCaT: 3.5;HBEC3-KT: 3.9;hTCEpi: 5.3;SK-BR-3: 4.8;T-47d: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA062915: " "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favourable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 3.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.3 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.1 1.0 0.0 0.9 0.0 0.0 4.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell line enhanced" "Detected in some" "ASC diff: 66.6;ASC TERT1: 65.7;BJ hTERT+: 43.3;fHDF/TERT166: 58.0;HSkMC: 70.0;U-2197: 104.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" 27000000 "Plasma membrane" Nucleoplasm "HPA051856: " "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavourable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 66.6 65.7 0.0 28.8 43.3 2.1 2.0 0.0 0.0 0.0 0.7 58.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.2 0.0 0.0 70.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 CD2AP CMS ENSG00000198087 "CD2 associated protein" Q9Y5K6 6 47477789-47627263 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003267, HPA003326, CAB004352" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" 160000 "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457" "unprognostic (5.98e-2)" "unprognostic (1.08e-2)" "unprognostic (1.75e-2)" "unprognostic (1.74e-1)" "unprognostic (1.31e-1)" "unprognostic (1.77e-2)" "unprognostic (1.74e-3)" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (5.53e-5)" "unprognostic (2.21e-1)" "unprognostic (3.09e-3)" "unprognostic (6.12e-3)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "prognostic favourable (7.57e-5)" 15.2 9.9 5.3 18.0 7.6 6.6 11.9 13.6 6.1 13.2 23.5 6.2 19.0 31.0 13.2 12.9 20.1 8.0 14.7 7.3 4.9 5.3 31.3 19.2 17.3 8.0 5.8 4.0 9.9 19.3 24.0 14.4 17.2 7.3 15.0 20.9 6.6 17.5 19.4 8.7 13.0 31.9 9.5 7.7 17.0 22.3 8.7 6.4 55.1 13.3 13.3 13.8 16.9 15.5 1.3 12.2 3.7 0.7 3.8 2.4 0.7 20.4 8.1 2.5 5.2 3.5 5.2 20.3 5.0 6.2 6.8 8.7 13.3 14.5 26.5 21.2 6.5 7.7 8.4 12.6 11.2 10.5 13.6 14.7 6.8 11.9 4.7 8.2 5.7 3.6 11.9 6.5 9.5 11.0 25.7 8.5 6.2 6.4 15.5 3.0 7.5 2.9 8.3 6.5 12.1 43.1 36.6 7.7 3.0 10.1 13.6 9.8 12.8 5.2 13.1 13.8 11.6 4.4 14.2 6.5 10.8 19.0 14.7 4.4 7.0 1.9 0.7 3.7 1.5 0.5 2.4 1.2 1.4 1.5 1.5 1.3 1.3 2.0 0.1 3.8 0.4 12.2 1.1 0.7 5.3 7.6 13.6 6.1 4.9 5.3 5.8 4.0 7.3 6.4 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350766-30355361 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041508: , HPA061309: " "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 24.6 33.0 23.6 27.8 24.4 17.8 22.5 27.6 43.4 24.2 25.4 27.4 31.8 25.8 32.3 29.0 23.1 30.0 35.6 27.4 23.1 23.7 24.8 18.2 22.3 30.2 23.2 27.3 29.7 30.9 46.3 30.3 22.3 20.3 25.8 21.3 20.8 27.4 40.7 31.7 22.0 22.6 28.1 20.6 32.0 24.5 23.4 19.8 26.8 29.8 25.9 36.5 22.9 19.9 38.2 28.1 51.3 39.0 29.2 37.6 29.9 21.3 26.1 22.0 19.9 18.4 17.6 18.7 23.9 28.8 27.2 29.3 19.9 26.0 33.1 29.6 25.9 23.6 22.5 28.0 21.9 19.6 26.5 14.0 24.7 23.4 26.5 19.8 25.9 18.8 23.7 30.2 19.4 28.2 15.8 25.5 27.1 51.5 27.3 16.8 29.6 15.4 40.5 18.3 24.9 22.1 21.6 18.1 34.7 16.0 28.3 16.0 26.8 16.1 20.1 31.4 21.9 15.7 20.8 42.8 31.1 30.5 21.5 18.4 25.6 36.3 26.3 46.2 31.7 30.8 25.1 36.2 25.8 29.4 23.3 38.2 21.8 26.9 51.3 29.2 39.0 28.1 37.6 29.9 23.6 24.4 27.6 43.4 23.1 23.7 23.2 27.3 20.3 19.8 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.2;HMC-1: 25.6;THP-1: 4.8;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavourable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.4 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.1 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Cell line enhanced" "Detected in some" "HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "CAB011442, HPA035832, HPA064807" Approved Supported "Nucleoplasm,Plasma membrane" 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: , HPA064807: " "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 37.1 27.8 0.0 0.0 0.0 0.0 0.0 5.1 7.0 0.0 0.0 0.0 17.7 0.0 8.5 0.0 1.4 20.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.2 4.8 0.4 0.6 0.0 0.1 2.4 0.0 3.2 27.4 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 31.8;MOLT-4: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: , HPA036723: " "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 1.1 0.3 0.9 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 31.8 0.0 0.0 0.8 0.0 31.4 0.1 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 4.8 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 CD3EAP "ASE-1, CAST, PAF49" ENSG00000117877 "CD3e molecule associated protein" O15446 19 45406209-45410766 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-251 MG: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 7.3 5.9 7.7 8.4 9.7 4.0 7.1 14.9 9.0 5.6 5.5 6.5 2.9 4.9 6.4 3.0 9.9 7.1 6.4 6.7 7.1 6.4 5.2 6.8 4.5 7.2 8.1 6.0 8.7 18.3 6.6 7.3 5.1 8.0 5.2 4.9 3.1 7.2 4.6 14.2 8.4 4.3 6.6 5.6 5.8 4.3 5.2 9.3 3.6 6.1 7.8 8.5 5.5 5.8 3.5 15.9 1.3 3.7 3.2 4.1 2.1 10.2 10.6 1.7 7.8 2.5 2.1 6.9 4.9 1.7 8.7 5.1 10.4 7.4 16.0 5.2 3.7 9.9 15.3 14.0 6.2 7.8 9.9 8.9 4.0 7.6 4.3 8.9 3.1 3.2 9.1 12.7 6.9 6.3 20.2 3.2 8.4 12.1 6.8 2.6 12.4 8.9 9.2 6.8 10.5 3.5 7.6 10.6 3.9 10.5 14.0 2.2 7.0 5.4 6.1 12.5 13.0 7.1 64.5 5.8 23.0 17.0 6.2 12.8 9.0 0.9 2.8 0.3 1.7 3.7 3.4 2.8 2.2 2.4 5.0 3.5 3.1 4.1 1.3 3.2 3.3 15.9 1.2 2.1 7.7 9.7 14.9 9.0 7.1 6.4 8.1 6.0 8.0 9.3 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell line enriched" "Detected in single" 78 "MOLT-4: 64.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: " "prognostic favourable (6.33e-4)" "prognostic favourable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favourable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.2 64.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138870-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000112, CAB000316, HPA005785" Enhanced Enhanced "Golgi apparatus,Plasma membrane" "Secreted - unknown location" 2400000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavourable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 45.5 9.0 10.5 42.5 21.7 53.0 35.6 4.7 13.4 43.2 19.5 26.3 8.3 10.6 80.5 20.3 66.5 18.6 48.0 11.7 14.9 9.3 12.4 9.1 43.4 48.4 31.5 6.1 12.8 83.9 0.8 3.8 19.4 40.7 30.1 24.5 30.2 148.2 22.4 15.9 107.7 18.9 44.5 100.5 30.9 19.9 7.2 20.3 17.9 20.6 53.9 53.7 55.0 54.2 22.7 41.0 19.1 65.2 54.6 53.1 59.9 41.5 37.6 0.3 0.1 22.7 62.8 0.1 81.5 63.8 45.4 25.3 2.5 13.1 0.0 10.9 115.5 71.7 0.8 88.6 62.4 8.9 0.4 1.5 18.5 0.0 22.4 21.1 97.8 28.3 70.0 61.1 49.6 15.9 0.3 13.6 43.5 0.2 1.9 13.9 0.8 11.1 0.1 7.7 0.6 66.5 12.0 0.1 0.1 15.4 0.4 36.9 2.2 1.2 45.6 56.6 10.2 69.4 83.7 23.6 25.4 0.2 85.9 11.9 82.2 19.1 65.2 6.0 26.2 45.7 37.0 22.7 39.8 34.9 41.0 16.2 34.5 28.7 16.4 54.6 59.3 14.2 53.1 59.9 10.5 21.7 4.7 13.4 14.9 9.3 31.5 6.1 40.7 20.3 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043094-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" 2000000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favourable (7.29e-5)" "unprognostic (1.83e-1)" 16.2 24.3 23.0 28.8 46.5 58.0 29.0 44.0 55.5 20.5 25.7 42.5 13.4 19.8 16.2 30.4 46.7 31.7 26.0 26.7 24.1 24.4 19.1 22.1 49.6 35.1 27.4 28.8 16.2 25.7 11.5 34.8 23.3 43.6 40.2 29.0 15.7 43.8 18.9 18.1 19.3 21.2 21.0 37.7 29.0 33.4 20.6 25.0 34.4 30.1 22.0 42.5 25.1 29.1 40.1 35.6 44.1 64.4 45.1 65.3 51.7 45.4 8.2 16.4 9.3 23.6 25.4 21.7 17.2 26.9 13.4 22.9 0.4 25.7 20.9 27.9 16.5 31.2 9.1 17.3 17.5 12.3 6.3 53.1 7.6 0.7 13.7 37.8 71.8 16.3 10.6 12.8 10.3 13.2 12.5 49.6 19.9 23.3 45.9 14.2 6.8 20.9 24.5 12.1 29.5 34.0 18.1 12.5 7.8 10.2 20.4 17.4 36.9 12.4 12.7 34.7 6.4 19.4 11.6 19.2 13.0 29.3 25.3 19.0 9.5 31.7 24.7 44.1 40.2 48.1 35.0 40.1 47.0 42.0 35.6 39.2 35.4 38.3 30.1 45.1 64.4 27.7 65.3 51.7 23.0 46.5 44.0 55.5 24.1 24.4 27.4 28.8 43.6 25.0 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Cell line enhanced" "Detected in some" "Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: " "prognostic favourable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favourable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.5 42.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 13.2 6.5 0.0 0.0 0.8 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.0 60.1 15.4 0.0 11.4 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell line enhanced" "Detected in many" "TIME: 213.3;U-2197: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavourable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavourable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavourable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favourable (1.39e-10)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.5 15.5 4.6 13.5 107.8 84.5 2.7 94.2 105.1 23.6 27.7 7.2 49.8 1.2 16.8 101.4 18.7 8.5 93.9 33.2 26.3 12.9 1.7 54.9 10.8 29.4 9.9 5.7 39.2 23.8 20.0 96.4 144.0 11.6 38.3 148.6 15.1 4.6 4.1 2.5 80.9 1.7 14.4 13.3 71.3 28.3 3.2 4.3 32.8 15.2 17.3 11.6 1.0 213.3 54.3 13.0 176.7 32.6 17.0 33.2 1.6 46.7 0.0 94.3 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579467-7582113 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 179.1;lymphoid tissue: 139.1" "Cell line enhanced" "Detected in many" "ASC diff: 73.3;U-87 MG: 115.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1" "Group enriched" "Detected in many" 11 "dendritic cells: 68.4;monocytes: 179.1" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: , CAB072862: , HPA048982: " "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 118.4 28.5 12.5 46.8 21.6 46.8 40.9 2.9 11.2 27.1 38.1 15.5 2.1 57.0 9.6 24.1 26.9 17.3 33.7 39.0 10.1 6.9 20.9 43.1 84.4 102.5 21.1 4.4 15.8 7.5 2.1 8.5 34.7 15.7 12.1 18.5 12.8 22.2 4.4 16.1 9.4 58.3 15.6 26.0 139.1 17.6 9.4 16.3 13.3 8.8 12.3 21.1 31.4 19.1 3.7 68.4 11.0 179.1 0.9 0.5 125.6 35.1 7.1 0.4 0.5 73.3 28.0 0.3 11.2 30.7 14.9 17.4 1.5 10.6 0.4 12.8 32.6 1.5 0.1 7.1 10.1 0.3 1.3 5.6 1.7 8.5 6.2 2.7 31.7 8.8 1.4 31.2 23.0 3.9 2.2 3.6 14.4 0.2 0.2 2.4 0.4 5.2 0.4 0.6 20.7 3.0 1.5 0.2 0.4 9.3 4.7 10.9 0.2 21.6 12.2 19.0 1.1 19.0 14.6 0.2 0.2 0.2 115.5 6.9 9.6 10.1 155.1 0.9 0.4 179.1 0.5 3.7 0.2 0.3 40.9 2.0 0.3 0.2 11.0 0.9 170.1 68.4 0.3 125.6 12.5 21.6 2.9 11.2 10.1 6.9 21.1 4.4 15.7 16.3 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell line enhanced" "Detected in some" "Daudi: 12.4;Karpas-707: 8.0;REH: 5.2;U-698: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in all" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: " "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.8 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.4 0.0 0.2 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.0 0.0 8.0 0.7 0.0 0.2 1.6 0.1 0.1 5.2 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.0 0.1 0.2 27.7 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: " "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 6.7 27.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 6.6 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 57.0;TIME: 72.2;U-937: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 72.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.6 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavourable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 6.5 9.0 8.4 9.8 8.1 14.4 9.8 16.2 9.7 11.8 6.8 8.7 9.4 6.0 11.0 9.6 7.1 9.1 7.2 5.2 6.4 4.4 6.3 6.7 6.6 8.0 8.3 7.4 21.7 9.6 9.1 9.5 6.7 5.8 11.4 5.5 9.3 10.6 10.1 6.6 10.1 6.9 9.3 5.1 8.1 8.0 14.7 8.6 14.7 9.0 3.3 8.2 10.2 12.2 0.3 0.8 3.7 0.3 0.0 0.6 0.1 6.8 4.7 6.4 9.2 5.7 4.9 7.7 9.1 3.8 8.9 6.5 11.7 3.6 3.3 10.1 5.0 13.6 6.8 4.1 2.6 8.4 6.3 12.4 8.4 4.5 4.2 9.1 11.7 6.7 4.6 5.6 4.1 6.7 15.8 5.0 7.2 3.8 7.0 12.1 3.2 7.5 10.1 8.0 2.9 2.8 6.8 5.2 6.1 7.1 10.0 1.5 7.6 13.7 4.8 9.3 8.4 7.6 10.3 10.0 10.4 7.5 4.9 13.6 7.6 3.7 0.3 1.7 0.5 0.1 0.6 0.1 0.4 0.5 0.0 0.3 0.4 0.3 0.4 0.0 0.0 0.8 0.1 0.1 8.4 8.1 16.2 9.7 6.4 4.4 8.3 7.4 5.8 8.6 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: " "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavourable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavourable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 26.1 28.0 30.8 28.8 50.8 35.7 25.5 24.6 35.0 25.8 32.0 24.2 16.3 21.5 26.1 27.2 34.1 25.3 18.4 36.5 28.5 25.1 33.2 45.1 21.5 34.7 25.9 27.6 19.5 26.0 18.4 26.9 28.8 36.6 20.7 31.8 16.1 22.4 22.9 29.2 29.8 24.7 30.2 24.9 36.2 21.8 22.5 24.6 39.0 24.4 20.5 41.9 29.2 23.4 43.7 40.7 66.4 34.0 32.3 38.8 40.6 32.0 43.0 30.7 37.2 29.5 29.2 25.2 27.9 19.4 40.3 43.4 59.4 41.1 55.4 29.4 35.2 36.2 55.8 51.1 33.7 38.8 43.9 43.2 34.7 54.4 36.4 33.7 37.5 31.1 26.6 50.9 30.2 44.0 44.5 26.7 35.1 29.7 43.0 28.3 54.0 16.1 44.7 25.7 49.2 36.9 18.7 15.8 31.2 29.8 38.8 34.6 40.5 38.0 47.2 24.8 30.5 37.8 35.2 26.2 48.1 67.9 31.1 32.2 16.1 28.6 28.7 66.4 31.4 32.4 32.4 43.7 35.3 34.6 40.7 42.1 29.0 30.9 64.6 32.3 34.0 33.2 38.8 40.6 30.8 50.8 24.6 35.0 28.5 25.1 25.9 27.6 36.6 24.6 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell line enhanced" "Detected in many" "K-562: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 6.2 2.4 5.8 6.5 5.5 13.7 12.2 1.8 6.2 7.7 11.8 4.8 2.2 7.2 15.1 4.8 3.4 13.7 3.6 4.1 8.8 3.5 6.6 2.4 12.3 15.4 3.8 5.4 5.8 6.7 9.8 8.1 7.6 4.6 10.0 6.3 8.3 7.7 3.9 4.3 5.6 22.6 5.0 3.2 9.6 6.0 38.2 4.7 12.0 6.1 3.4 11.3 5.8 8.4 4.8 6.1 11.6 3.7 3.9 13.0 4.1 2.2 1.8 5.8 6.5 2.1 1.6 4.0 2.8 1.9 2.8 2.3 6.1 1.9 1.1 2.1 1.7 1.7 3.9 1.6 2.9 2.2 9.7 3.9 1.7 1.9 0.8 5.2 7.0 1.3 0.4 3.0 1.0 4.9 30.0 3.4 4.1 0.9 4.2 5.9 3.5 2.3 4.6 7.5 1.1 1.9 5.0 1.0 1.8 3.0 2.9 3.9 1.3 6.8 2.1 1.6 3.5 2.6 1.6 1.7 0.6 1.7 1.9 4.9 0.9 11.6 3.7 8.4 7.3 3.3 13.0 4.8 11.3 8.4 3.5 3.1 11.0 5.8 5.5 3.9 2.3 6.1 5.6 4.1 5.8 5.5 1.8 6.2 8.8 3.5 3.8 5.4 4.6 4.7 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: , HPA055288: " "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavourable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 51.7 25.3 35.3 23.0 1.2 3.1 33.9 24.0 21.6 70.1 37.4 39.6 43.2 30.0 14.1 22.0 36.5 38.6 45.8 58.5 23.5 28.5 43.9 25.0 24.5 0.3 30.6 16.0 1.0 2.1 48.6 44.1 29.7 19.8 20.6 31.7 20.0 29.4 18.8 44.7 34.1 42.8 48.5 19.0 17.1 13.8 20.9 10.3 42.5 28.7 13.3 20.1 38.8 15.4 21.0 49.2 23.3 74.5 15.9 14.0 31.1 15.0 38.2 31.2 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188402 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005855 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA005855: AB_1846364" "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.8 1.2 1.1 5.5 1.1 13.0 0.8 0.7 1.2 1.1 3.3 0.6 1.0 1.8 0.6 0.9 3.9 0.4 2.2 0.7 1.3 2.4 1.2 0.9 0.7 4.1 1.4 0.2 2.1 3.6 0.4 2.3 4.2 1.2 1.0 4.0 1.5 1.8 0.5 0.7 0.8 2.1 0.8 0.7 3.6 1.3 19.4 0.2 23.0 1.6 8.8 7.4 0.8 1.3 1.7 0.9 0.5 0.1 0.0 1.0 0.1 7.5 3.7 17.8 9.6 0.6 1.2 12.3 10.5 4.0 13.2 10.7 16.1 3.9 22.4 4.1 2.7 5.7 30.5 7.2 13.9 7.3 16.0 28.7 6.8 7.9 0.6 20.2 8.3 0.6 1.1 16.4 7.1 5.0 22.8 11.9 7.1 4.0 25.2 15.7 26.0 8.5 11.3 11.7 12.2 3.3 7.1 8.4 10.4 6.5 7.6 3.3 4.0 14.3 2.5 6.5 10.0 7.2 14.2 6.0 17.9 35.2 4.8 22.5 5.4 0.0 0.0 0.5 0.4 0.0 0.0 1.7 0.6 0.2 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.1 1.1 1.1 0.7 1.2 1.3 2.4 1.4 0.2 1.2 0.2 CDC25B ENSG00000101224 "Cell division cycle 25B" P30305 20 3786772-3806121 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038892, HPA038893, HPA075215" Enhanced Supported "Vesicles,Mitotic spindle" Vesicles "Mitotic spindle" "HPA038892: , HPA038893: , HPA075215: " "unprognostic (4.69e-2)" "unprognostic (5.74e-2)" "unprognostic (2.93e-2)" "prognostic unfavourable (4.76e-4)" "unprognostic (1.13e-1)" "unprognostic (4.23e-1)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.31e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.03e-2)" "prognostic unfavourable (2.94e-13)" "unprognostic (1.15e-1)" "unprognostic (2.38e-1)" "unprognostic (3.94e-1)" "unprognostic (9.46e-2)" 12.1 8.7 15.1 27.7 23.3 26.0 28.8 49.6 21.1 13.0 14.7 12.8 4.6 14.9 17.0 10.3 11.7 13.0 18.6 7.5 15.7 12.5 13.3 11.0 33.0 42.8 21.9 12.5 17.3 5.7 7.5 21.0 30.3 13.8 11.0 12.0 7.7 7.4 10.2 6.2 19.8 16.8 14.8 14.7 24.5 14.1 6.3 22.3 33.3 18.7 20.8 31.6 15.3 16.3 4.5 1.3 1.5 1.8 9.3 15.5 5.9 29.8 64.5 8.6 14.3 10.6 10.4 4.3 14.8 22.2 24.8 18.5 11.2 43.3 20.8 6.4 15.1 43.7 11.7 24.6 11.7 8.0 12.6 11.2 20.7 13.5 42.3 8.7 5.8 10.2 19.8 23.0 27.2 13.7 7.2 55.1 14.6 24.0 27.1 12.7 6.4 27.6 14.2 24.4 14.9 16.9 2.8 6.2 13.5 35.1 33.5 17.2 11.3 4.5 11.3 13.3 16.1 24.1 19.6 13.4 21.2 8.4 6.8 8.6 12.8 1.5 1.4 0.0 13.6 1.8 12.7 3.5 13.6 13.7 1.3 4.5 11.4 13.2 0.1 9.3 0.9 0.7 15.5 5.9 15.1 23.3 49.6 21.1 15.7 12.5 21.9 12.5 13.8 22.3 CDC34 "E2-CDC34, UBC3, UBE2R1" ENSG00000099804 "Cell division cycle 34" P49427 19 531712-542092 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002382, CAB005109, CAB047311" Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB005109: AB_2276050, CAB047311: , HPA002382: AB_1846370" "unprognostic (4.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (2.84e-1)" "unprognostic (5.73e-2)" "prognostic unfavourable (7.57e-4)" "unprognostic (2.20e-1)" "unprognostic (3.11e-1)" "unprognostic (3.83e-2)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (3.02e-2)" "unprognostic (8.87e-3)" "unprognostic (9.68e-2)" "unprognostic (7.82e-3)" "unprognostic (3.33e-2)" 16.5 15.9 21.3 11.3 19.1 24.7 20.4 25.7 30.9 16.0 20.5 19.5 10.5 15.4 13.3 13.4 15.6 14.5 13.6 35.6 21.1 18.2 12.1 36.0 13.0 9.9 18.5 19.8 17.0 37.4 11.3 17.0 24.9 16.2 17.2 10.6 15.3 26.4 18.5 63.9 19.0 13.2 18.6 14.3 12.7 15.7 43.6 15.0 12.2 13.1 17.0 8.7 19.2 16.4 2.9 2.8 11.5 4.5 1.5 4.1 1.3 18.4 18.4 23.7 19.5 10.8 10.3 23.7 16.6 12.7 17.9 18.7 28.6 11.3 10.2 17.4 11.8 12.8 18.6 14.0 9.2 16.6 50.0 9.4 12.2 30.9 26.9 13.2 11.4 13.3 21.0 15.1 15.8 21.3 40.2 20.4 11.8 26.4 18.0 17.6 29.9 17.9 16.7 12.2 17.1 13.5 11.0 30.9 22.9 14.4 15.0 27.6 12.0 19.4 17.4 13.1 15.6 30.4 22.1 20.4 15.6 13.6 17.9 18.7 13.5 4.5 3.5 6.2 2.3 3.4 1.7 2.9 3.2 4.1 2.8 1.7 2.5 2.4 11.5 1.5 4.5 2.3 3.1 1.3 21.3 19.1 25.7 30.9 21.1 18.2 18.5 19.8 16.2 15.0 CDC42 "CDC42Hs, G25K" ENSG00000070831 "Cell division cycle 42" P60953 1 22052627-22092946 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004360, HPA069590" Approved Supported "Microtubules,Cytokinetic bridge" 42000000 "Microtubules, Cytokinetic bridge" "CAB004360: AB_627233, HPA069590: " "unprognostic (9.40e-2)" "unprognostic (1.37e-1)" "unprognostic (9.45e-3)" "unprognostic (5.11e-2)" "unprognostic (1.73e-1)" "unprognostic (9.72e-2)" "prognostic unfavourable (5.28e-5)" "unprognostic (1.09e-1)" "unprognostic (7.92e-3)" "unprognostic (1.86e-2)" "unprognostic (3.90e-2)" "unprognostic (9.41e-2)" "unprognostic (9.72e-3)" "unprognostic (2.71e-1)" "unprognostic (3.88e-2)" "unprognostic (6.38e-2)" "unprognostic (2.09e-1)" 76.4 42.0 42.2 45.8 45.9 103.1 44.1 48.8 51.3 46.4 56.1 63.0 27.7 42.1 93.6 33.5 62.0 40.5 42.9 36.3 43.7 56.8 66.3 67.2 55.0 60.3 48.5 33.9 59.0 35.2 30.7 33.0 83.6 55.7 44.1 56.6 40.5 72.9 35.3 38.8 50.1 61.7 52.0 61.7 66.9 45.4 34.6 24.8 60.3 44.4 48.8 60.1 50.8 45.8 25.3 36.0 67.9 71.4 29.4 36.3 48.6 54.8 26.2 45.9 39.7 54.8 57.9 49.2 59.3 56.8 66.1 61.5 31.4 66.9 44.5 46.7 73.2 35.8 42.9 65.6 79.5 58.9 33.1 77.2 35.9 37.0 48.2 66.2 64.1 53.3 71.7 61.5 36.1 95.7 43.1 49.2 77.5 23.1 41.5 53.2 30.3 32.2 34.9 53.7 41.5 57.4 51.1 33.4 30.4 53.0 41.3 43.9 43.7 38.2 83.4 48.8 46.2 62.8 35.2 27.3 54.8 50.9 42.9 72.3 49.8 46.3 45.6 52.3 33.9 60.0 33.0 25.3 36.3 34.5 36.0 24.1 26.6 35.0 67.9 29.4 71.4 23.5 33.7 48.6 42.2 45.9 48.8 51.3 43.7 56.8 48.5 33.9 55.7 24.8 CDC42EP1 "Borg5, CEP1, MSE55" ENSG00000128283 "CDC42 effector protein 1" Q00587 22 37560447-37569405 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;monocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006379 Approved Supported "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA006379: AB_1078486" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.44e-1)" "unprognostic (3.79e-3)" "unprognostic (5.82e-2)" "unprognostic (4.06e-2)" "unprognostic (4.38e-2)" "unprognostic (5.57e-2)" "unprognostic (9.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.09e-3)" 19.1 26.2 12.1 10.6 29.4 1.9 21.9 2.9 27.3 17.2 13.0 68.7 7.2 19.7 21.0 6.2 25.0 20.4 31.9 12.2 18.3 10.1 14.6 57.4 18.6 6.9 41.4 13.1 31.7 80.8 7.4 5.7 24.9 28.7 11.5 9.9 12.0 36.5 16.9 7.2 22.4 13.8 13.2 34.5 9.7 69.5 8.8 34.2 0.4 9.7 14.2 14.2 10.3 19.2 0.6 3.5 0.4 9.4 0.6 0.3 3.5 30.2 8.8 3.8 17.1 6.1 10.5 18.6 17.4 10.3 20.1 13.9 21.5 3.9 0.0 6.1 20.1 23.6 4.5 8.7 6.7 3.7 15.2 0.1 8.5 12.9 43.8 0.0 0.1 19.5 13.2 16.5 15.8 14.9 18.9 0.1 8.2 10.3 0.0 0.1 3.4 19.9 0.1 6.9 0.6 7.0 0.4 0.1 0.7 12.7 28.4 27.2 12.6 2.7 22.7 42.2 25.2 20.2 24.0 0.0 0.1 0.0 16.7 0.1 33.9 0.4 9.4 0.0 0.2 2.9 0.2 0.0 0.1 0.1 3.5 0.6 0.1 0.3 0.3 0.6 0.2 0.4 0.0 3.5 12.1 29.4 2.9 27.3 18.3 10.1 41.4 13.1 28.7 34.2 CDC42EP2 "BORG1, CEP2" ENSG00000149798 "CDC42 effector protein 2" O14613 11 65314818-65322429 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 28.3;U-2197: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 13.3;intermediate monocyte: 29.8;neutrophil: 46.1;non-classical monocyte: 21.7" "Group enriched" "Detected in many" 13 "granulocytes: 46.1;monocytes: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038562 Approved Supported Microtubules,Cytosol "Microtubules, Cytosol" "HPA038562: AB_10671745" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (9.91e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (4.73e-3)" "prognostic unfavourable (2.89e-5)" "prognostic unfavourable (6.66e-4)" "unprognostic (1.01e-1)" "unprognostic (5.36e-2)" "unprognostic (8.57e-3)" "unprognostic (3.81e-1)" "unprognostic (1.68e-1)" "unprognostic (2.66e-2)" "unprognostic (3.67e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-2)" 47.2 5.1 7.7 11.8 37.7 2.1 32.1 3.2 15.4 15.9 11.2 39.1 4.7 12.6 13.9 6.3 11.5 12.7 20.5 11.4 10.7 6.6 9.9 6.5 15.0 8.8 31.4 8.9 10.5 7.9 2.2 4.3 16.9 19.7 8.5 4.5 2.5 4.1 8.3 7.0 4.6 10.6 11.6 24.4 15.3 12.0 2.4 24.7 0.0 17.3 7.0 3.2 18.6 16.2 0.2 2.8 46.1 29.8 0.0 0.1 3.9 5.0 6.1 2.2 3.5 8.3 13.3 0.7 5.2 19.0 5.8 7.1 10.2 9.8 0.9 13.0 11.6 6.0 2.4 13.9 1.8 1.9 3.2 1.2 8.3 7.0 22.4 0.3 0.6 6.0 1.8 16.0 14.7 14.4 2.3 3.1 5.3 8.1 0.8 0.8 3.5 28.3 1.3 1.2 1.7 11.1 2.8 0.7 2.3 11.0 9.3 1.0 1.8 0.4 15.9 4.2 4.2 30.8 2.1 1.1 1.7 1.7 6.7 0.4 3.3 0.0 13.3 0.5 0.1 29.8 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 46.1 0.0 21.7 0.2 0.0 3.9 7.7 37.7 3.2 15.4 10.7 6.6 31.4 8.9 19.7 24.7 CDC42EP3 "BORG2, CEP3, UB1" ENSG00000163171 "CDC42 effector protein 3" Q9UKI2 2 37641882-37738468 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034986, HPA061792" Approved Supported "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA034986: AB_10602207, HPA061792: " "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-2)" "unprognostic (4.11e-3)" "unprognostic (2.38e-2)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (1.72e-1)" "unprognostic (1.84e-1)" "unprognostic (3.81e-1)" "unprognostic (3.14e-3)" "unprognostic (7.30e-3)" "unprognostic (1.97e-1)" "unprognostic (2.97e-1)" "unprognostic (4.53e-2)" 19.7 2.1 5.1 5.7 5.8 18.9 14.0 2.4 6.6 13.6 14.4 2.9 1.8 0.9 33.3 6.6 5.0 8.6 4.9 14.3 2.6 1.8 8.4 3.0 10.6 5.7 3.2 2.3 7.7 7.4 1.1 5.5 6.0 3.8 24.9 4.9 7.9 5.8 28.5 27.8 5.3 6.3 25.4 3.2 6.9 5.4 60.2 2.7 14.8 6.4 3.5 5.2 14.9 8.2 7.2 8.4 51.9 30.3 10.1 21.8 13.8 16.7 6.5 3.8 0.2 14.6 7.7 5.8 14.5 38.6 22.6 16.5 11.9 6.8 3.1 11.5 34.2 8.1 4.6 17.3 23.2 11.2 1.3 5.3 6.6 0.0 28.3 1.2 0.3 23.2 16.2 19.5 43.5 13.1 0.8 2.4 106.2 0.1 0.7 9.4 7.5 3.9 0.4 28.0 1.5 16.3 8.1 4.1 11.3 7.1 5.1 8.7 1.7 10.0 9.7 27.1 7.0 7.1 14.7 4.4 5.9 1.0 11.2 8.1 37.5 11.0 21.8 1.7 20.2 15.3 21.8 7.2 13.1 17.3 8.4 2.9 4.4 11.1 51.9 10.1 30.3 0.2 9.4 13.8 5.1 5.8 2.4 6.6 2.6 1.8 3.2 2.3 3.8 2.7 CDC42EP4 "BORG4, CEP4, KAIA1777, MGC17125, MGC3740" ENSG00000179604 "CDC42 effector protein 4" Q9H3Q1 17 73283624-73312175 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 15.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023335, HPA024797" Approved Supported Supported "Plasma membrane,Actin filaments,Microtubules" "Actin filaments, Microtubules" "Plasma membrane" "HPA023335: AB_10603783, HPA024797: AB_10600696" "unprognostic (8.76e-2)" "unprognostic (4.38e-3)" "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (6.29e-2)" "unprognostic (9.01e-3)" "unprognostic (2.44e-3)" "unprognostic (1.08e-1)" "unprognostic (8.00e-2)" "unprognostic (2.41e-1)" "unprognostic (4.16e-2)" "unprognostic (6.73e-2)" "unprognostic (3.97e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" 36.0 27.7 24.4 15.2 31.2 8.8 65.2 35.5 45.4 23.5 21.6 28.7 33.4 24.3 23.9 44.5 19.7 41.8 25.2 27.6 28.9 18.4 12.0 15.4 15.9 12.2 20.8 21.1 50.3 50.8 19.9 20.8 15.8 30.7 18.0 13.0 21.8 22.0 38.5 16.7 16.4 22.0 18.9 30.6 11.9 21.6 13.7 24.2 5.9 26.5 14.2 18.9 14.1 46.1 0.1 3.6 4.7 15.6 0.2 0.1 1.4 11.3 26.5 9.9 8.1 20.2 16.9 25.0 10.1 12.7 9.7 7.1 5.6 16.2 0.0 9.0 12.4 8.1 6.9 6.8 6.0 0.5 6.4 2.5 13.7 13.3 10.0 0.4 2.8 21.0 5.9 8.2 4.3 10.9 6.9 0.5 6.0 8.5 0.4 3.3 5.4 18.4 0.3 4.4 1.2 11.6 13.0 6.5 9.8 7.3 21.4 7.1 24.9 3.7 11.0 9.2 18.9 7.1 7.3 0.5 0.4 0.0 14.7 1.8 23.5 2.8 2.6 4.7 0.1 7.0 0.1 0.1 0.0 0.0 3.6 0.0 0.1 0.0 4.6 0.2 15.6 0.1 0.0 1.4 24.4 31.2 35.5 25.1 28.9 18.4 20.8 21.1 30.7 24.2 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell line enhanced" "Detected in many" "K-562: 86.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavourable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavourable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.1 11.0 13.7 10.7 0.6 1.3 5.8 16.2 7.6 18.7 18.6 8.4 7.3 14.6 5.7 4.8 12.6 14.6 10.7 16.8 17.8 24.7 19.5 12.4 9.2 0.7 28.3 10.7 0.4 0.5 14.3 6.4 9.4 86.6 18.4 10.9 17.5 22.9 13.4 4.1 8.3 19.1 22.8 6.4 4.3 12.6 17.7 9.3 8.8 9.7 2.8 6.3 12.6 3.6 14.6 23.4 11.0 14.7 6.3 11.6 17.0 7.7 14.2 19.5 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 85.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: , HPA065070: " "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.0 17.3 21.0 14.9 1.1 2.3 19.1 27.3 8.2 23.9 29.0 19.6 11.2 20.2 17.1 5.8 36.4 18.1 12.4 23.8 10.7 14.2 16.4 20.7 17.6 0.7 22.4 10.1 0.5 0.9 27.7 16.7 7.2 29.9 19.0 11.6 13.1 32.5 5.4 17.2 6.4 24.0 51.0 19.1 4.0 28.2 14.4 12.9 24.8 85.2 8.4 17.3 19.4 6.0 17.3 24.7 28.3 32.3 7.9 17.2 39.0 15.0 14.8 18.9 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 CDC7 "CDC7L1, HsCdc7, Hsk1, huCdc7" ENSG00000097046 "Cell division cycle 7" O00311 1 91500893-91525764 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002669, HPA035831" Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "CAB002669: , HPA035831: " "unprognostic (6.84e-2)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (7.02e-3)" "unprognostic (5.57e-2)" "unprognostic (3.57e-3)" "prognostic unfavourable (3.15e-6)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (1.36e-3)" "unprognostic (2.04e-2)" "unprognostic (1.75e-2)" "prognostic unfavourable (1.89e-15)" "unprognostic (9.44e-3)" "unprognostic (2.49e-2)" "unprognostic (1.09e-1)" "unprognostic (5.39e-2)" 2.5 3.7 5.7 7.6 8.9 15.4 4.3 19.4 10.3 2.5 4.2 1.4 0.9 4.2 2.8 2.6 4.7 1.7 2.6 1.9 6.8 5.2 3.6 2.3 5.1 11.7 4.0 4.7 3.7 2.4 2.2 12.3 7.9 5.2 2.7 6.8 2.3 2.5 2.3 1.0 6.8 4.9 3.3 5.9 15.1 2.6 21.2 4.7 18.7 2.5 4.5 12.0 4.2 3.0 1.6 3.5 0.1 1.6 2.4 6.5 2.1 14.0 4.2 27.1 7.7 0.6 3.6 8.6 5.3 4.2 10.5 11.5 8.7 5.0 9.7 7.5 3.3 6.1 17.8 6.0 14.6 16.1 15.3 14.8 12.0 4.1 1.0 16.1 5.4 1.9 1.8 9.6 5.5 4.0 19.5 14.2 7.2 5.1 13.7 14.4 22.5 9.9 17.1 22.5 6.2 4.6 10.6 21.6 8.5 16.9 4.7 9.4 4.4 7.9 3.3 12.0 10.6 9.2 8.0 5.2 6.6 26.1 4.3 15.6 4.4 0.0 1.6 0.0 5.9 1.2 5.2 1.5 4.5 5.6 3.5 1.6 2.5 5.1 0.1 2.4 0.3 2.1 6.5 2.1 5.7 8.9 19.4 10.3 6.8 5.2 4.0 4.7 5.2 4.7 CDC73 "C1orf28, FIHP, HRPT1, HRPT2, parafibromin" ENSG00000134371 "Cell division cycle 73" Q6P1J9 1 193121997-193253901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016359, HPA030772" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016359: AB_628102, HPA030772: " "unprognostic (4.41e-2)" "unprognostic (6.22e-2)" "unprognostic (1.90e-2)" "unprognostic (5.30e-2)" "unprognostic (2.88e-3)" "unprognostic (3.53e-2)" "unprognostic (2.48e-3)" "unprognostic (5.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.40e-1)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (5.44e-3)" "unprognostic (3.47e-1)" "unprognostic (2.49e-1)" "unprognostic (6.73e-3)" "unprognostic (2.98e-3)" 23.4 20.0 18.1 16.8 22.9 21.0 20.1 25.6 22.6 20.4 20.1 14.5 16.3 12.0 26.8 15.2 20.6 14.9 16.4 21.4 18.4 15.0 18.8 17.1 17.2 16.6 19.7 15.9 23.3 14.5 27.1 24.8 17.3 19.4 26.9 16.2 13.6 17.3 19.0 44.5 15.0 14.5 25.6 23.9 16.0 15.7 16.3 22.1 20.6 27.1 14.1 15.8 26.8 35.0 6.6 6.7 10.2 7.0 9.0 12.5 5.2 13.3 12.0 15.9 10.2 14.9 14.5 12.2 14.4 14.0 17.4 15.3 8.2 15.9 17.4 10.2 17.7 13.1 14.4 13.6 21.3 11.0 6.8 12.6 10.9 8.0 14.0 17.1 12.6 11.8 13.2 16.3 15.6 14.8 19.1 14.1 23.3 12.3 13.9 8.5 15.3 4.5 12.5 9.6 16.6 20.4 9.3 4.8 13.1 18.0 22.2 20.5 19.1 12.4 16.5 17.0 3.9 14.4 14.7 13.2 9.8 14.3 10.2 10.5 29.6 6.6 7.0 10.2 9.3 6.8 12.5 6.6 9.2 9.2 6.7 5.4 8.4 8.7 7.4 9.0 5.7 4.9 9.3 5.2 18.1 22.9 25.6 22.6 18.4 15.0 19.7 15.9 19.4 22.1 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059416, HPA064971" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA059416: , HPA064971: " "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavourable (4.19e-4)" "prognostic unfavourable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavourable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavourable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.0 15.7 18.2 13.7 3.1 5.2 23.8 22.5 6.9 17.7 15.5 19.2 19.3 19.8 12.3 7.9 24.2 12.7 25.9 10.4 21.6 10.0 12.5 13.4 16.0 3.8 22.1 10.5 3.7 8.1 13.6 12.8 11.9 13.7 20.5 12.2 36.9 20.6 14.9 13.5 36.0 20.0 26.5 7.3 6.0 17.5 10.6 13.1 21.5 8.6 17.3 17.0 14.9 18.5 15.7 19.9 21.5 29.9 7.6 9.4 20.2 13.1 11.2 25.9 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavourable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 5.9 2.1 14.2 16.0 11.7 12.5 27.6 7.6 3.6 10.3 28.3 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.3 5.9 2.7 0.9 7.7 6.4 6.4 14.9 6.3 4.1 7.9 61.8 40.7 21.1 5.3 43.7 13.6 17.5 6.8 8.7 5.2 9.2 9.3 3.1 5.0 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.7 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "olfactory region: 22.0" HPA027169 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058" "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.6 6.7 6.3 0.1 3.5 4.4 0.0 16.1 13.9 12.5 17.8 2.5 17.9 41.0 5.3 13.8 12.1 10.0 16.5 25.4 0.0 6.6 9.8 20.0 1.6 4.5 25.8 0.1 8.3 3.0 9.7 28.4 24.7 13.5 0.0 9.7 7.3 32.5 9.3 36.3 8.4 32.7 22.8 27.4 3.5 3.7 23.3 19.0 7.3 4.5 7.3 10.9 11.7 10.4 13.7 16.9 23.8 19.4 21.1 14.5 53.0 13.1 34.8 13.4 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Enhanced "Nucleoplasm,Nucleoli,Cytokinetic bridge" Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavourable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavourable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.0 12.3 23.2 16.7 1.0 2.0 15.6 21.2 10.7 37.5 26.6 19.1 21.1 34.1 8.6 13.5 16.0 26.6 14.1 39.9 22.7 11.9 30.7 13.1 15.1 0.2 29.5 15.9 0.7 1.0 21.1 18.7 16.5 25.9 36.7 27.0 12.5 27.2 18.1 26.8 17.0 26.5 31.7 19.5 8.5 11.8 20.7 9.1 23.3 11.0 14.3 16.1 11.2 9.9 18.5 19.6 10.5 33.1 25.0 32.4 46.5 8.7 27.5 21.1 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737225-68835548 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 125.5" "Cell line enhanced" "Detected in some" "BEWO: 105.6;CACO-2: 35.5;CAPAN-2: 49.6;HaCaT: 47.9;hTCEpi: 33.8;MCF7: 29.3;RT4: 36.5;T-47d: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "myeloid DC: 2.8;plasmacytoid DC: 8.5" "Lineage enriched" "Detected in single" 18 "dendritic cells: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" 22000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: , CAB072856: , CAB072857: , HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favourable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.1 0.7 1.3 14.8 1.5 0.5 15.3 0.8 1.1 14.4 63.8 1.8 42.4 25.5 4.7 18.6 48.5 9.7 48.9 0.8 1.5 1.0 24.2 64.9 24.4 0.5 1.8 0.9 5.6 71.5 62.2 13.2 55.2 2.8 28.9 25.9 11.8 66.6 43.7 0.8 30.5 125.5 1.5 1.1 3.5 21.6 2.1 1.8 11.7 83.0 26.2 32.6 16.8 21.7 0.0 8.5 0.0 0.0 0.3 0.4 0.1 21.3 2.2 0.0 0.0 0.0 0.0 105.6 0.0 0.0 0.0 0.0 35.5 49.6 0.0 0.4 0.0 47.9 0.0 23.8 0.0 4.1 0.6 0.0 0.1 7.6 0.0 0.0 0.2 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.1 0.8 0.1 0.0 0.0 0.3 8.7 36.5 1.3 0.1 0.2 0.0 9.0 31.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.8 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.1 0.1 1.3 1.5 0.8 1.1 1.5 1.0 1.8 0.9 2.8 1.8 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell line enriched" "Detected in some" 5 "RH-30: 56.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in many" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: " "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.0 0.0 0.0 0.1 0.0 56.6 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 7 "CACO-2: 33.3;U-266/70: 55.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Enhanced "Nucleoplasm,Cell Junctions" 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.1 6.1 0.3 0.4 0.0 0.1 0.5 0.1 0.1 0.0 0.1 33.3 1.5 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.1 0.6 0.2 0.1 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.4 0.2 0.5 0.2 0.2 0.4 0.1 1.0 0.1 0.1 0.6 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.5 0.2 55.3 0.1 0.1 0.1 0.2 0.3 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27950966-28177446 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.6;parathyroid gland: 35.4" "Cell line enhanced" "Detected in many" "AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.4;neutrophil: 4.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: , HPA058574: " "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 29.6 9.8 1.5 9.4 0.5 0.5 5.7 16.1 3.2 2.0 8.0 0.2 0.8 3.1 1.9 0.6 4.7 1.7 77.6 9.9 9.6 9.2 23.3 0.7 1.1 6.0 9.1 3.4 0.7 35.4 5.4 0.5 5.9 1.4 0.8 6.8 0.5 4.6 0.4 0.5 0.9 3.2 6.7 5.9 2.5 19.6 7.4 0.9 2.8 0.0 1.0 1.0 1.3 0.0 0.0 4.4 0.0 0.7 0.9 0.0 0.0 4.5 56.4 0.0 8.9 1.8 0.0 40.7 12.4 16.6 15.2 0.0 0.0 0.0 21.9 84.2 6.0 9.2 0.0 23.6 0.1 5.9 0.0 15.2 14.0 8.5 0.0 0.0 0.8 0.1 38.1 6.7 14.5 0.0 0.0 12.9 0.0 10.2 0.0 7.5 4.9 0.0 6.7 7.7 0.0 1.8 14.7 25.5 0.0 0.0 4.5 0.0 0.0 2.2 36.0 11.5 0.5 29.4 0.0 0.0 0.0 6.9 0.0 27.7 4.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 9.8 9.4 5.7 10.1 9.9 9.6 6.0 9.1 5.9 7.4 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065233 Approved "Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite" "Cell Junctions, Cytosol" "HPA065233: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 5.8 4.7 8.0 4.3 9.3 2.9 5.0 13.0 12.6 6.2 4.5 4.0 6.1 3.0 13.4 3.2 5.8 5.8 10.1 3.8 10.5 5.1 4.6 1.1 4.7 3.4 4.4 4.8 3.8 3.5 8.3 3.1 5.7 5.3 4.6 4.5 7.9 4.7 4.5 1.8 7.2 5.0 10.2 4.0 5.2 4.1 3.4 6.6 7.8 6.8 3.8 4.1 7.3 6.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.5 2.5 10.6 12.0 2.6 1.3 5.9 4.8 3.1 4.0 5.2 3.2 3.5 0.2 3.9 5.2 14.6 4.5 4.0 3.3 3.9 3.8 0.5 6.5 1.0 2.9 7.3 0.2 10.2 1.3 4.4 2.9 6.6 1.5 6.3 3.5 7.2 0.5 4.9 2.6 5.9 12.7 3.5 4.7 1.1 2.1 30.8 8.2 11.2 6.0 0.6 5.3 1.0 6.1 4.0 15.5 1.6 3.5 2.0 0.6 0.1 4.2 2.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 9.3 13.0 12.6 10.5 5.1 4.4 4.8 5.3 6.6 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell line enriched" "Detected in some" 6 "RT4: 33.9" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: " "unprognostic (2.42e-1)" "prognostic favourable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favourable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.1 0.0 0.0 0.6 0.0 33.9 0.7 0.1 0.3 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell line enhanced" "Detected in some" "A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavourable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavourable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.4 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.6 9.1 0.0 0.1 0.0 67.7 0.6 32.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.1 0.0 19.9 0.0 0.0 0.0 0.0 12.7 0.0 0.0 1.2 2.0 0.0 0.0 0.0 29.3 11.0 0.1 0.0 0.2 0.0 11.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 111.2;TIME: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavourable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 111.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 95.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510675-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA049352: " "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favourable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favourable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 17.7 14.2 36.8 6.9 41.6 5.1 8.2 36.4 54.6 13.6 9.5 16.3 2.7 30.0 13.4 4.4 8.0 10.9 9.5 25.0 33.8 37.1 23.7 13.2 9.6 8.2 34.2 38.9 18.7 22.9 10.4 19.3 8.5 26.3 13.2 4.1 7.8 10.8 14.7 34.0 9.1 24.2 8.7 20.7 12.0 9.2 10.1 15.7 13.0 10.6 6.7 6.9 7.8 6.3 8.7 9.2 19.3 19.2 14.3 15.9 7.2 3.8 1.6 5.4 1.6 0.4 0.0 0.1 5.9 0.9 5.8 5.0 9.3 1.5 0.2 6.0 4.8 0.1 4.9 20.8 1.0 13.1 9.3 17.6 6.2 24.1 3.9 8.5 11.0 5.7 10.8 5.2 0.8 4.6 0.3 4.8 6.5 0.4 6.6 11.1 12.0 4.6 25.0 4.8 48.1 1.2 0.1 16.3 7.0 11.8 0.5 7.3 2.1 4.7 0.2 3.0 8.9 2.0 0.2 12.9 11.9 17.8 0.1 8.6 2.0 3.2 7.9 19.3 15.9 12.5 8.6 8.7 5.7 8.9 7.6 8.3 11.4 9.7 6.2 14.3 19.2 9.2 9.1 7.2 36.8 41.6 36.4 50.3 33.8 37.1 34.2 38.9 26.3 15.7 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Approved Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: " "unprognostic (7.81e-2)" "prognostic favourable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.3 26.8 7.5 15.1 41.3 28.6 22.4 21.7 24.3 15.4 15.4 15.6 23.8 8.3 41.1 25.0 19.5 12.2 14.0 7.1 20.7 24.5 5.9 20.0 22.8 28.8 8.8 15.4 48.3 24.8 20.7 9.5 19.3 8.8 21.5 13.9 39.4 11.9 17.4 18.0 20.0 23.3 9.4 24.1 20.3 11.9 31.2 17.5 11.5 24.5 17.1 18.3 23.9 16.7 22.9 7.2 18.6 11.1 16.0 18.1 5.9 25.0 14.2 13.8 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favourable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavourable (1.10e-6)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.2 18.4 48.9 19.3 3.2 4.9 20.1 36.5 26.6 44.5 42.9 43.0 42.7 44.2 14.2 10.0 30.0 33.2 21.2 46.4 31.4 24.2 23.2 18.1 24.9 0.5 35.5 24.0 0.9 2.1 28.8 28.1 26.7 35.3 54.5 49.5 12.8 44.6 25.5 21.5 38.7 38.8 45.5 21.7 17.0 16.0 22.9 20.1 24.5 37.3 18.9 40.2 21.8 11.0 19.0 40.6 20.0 49.8 21.4 34.3 39.9 16.4 39.8 23.6 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Nucleoplasm "Midbody, Midbody ring" "HPA007451: , HPA059634: , HPA067060: " "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favourable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favourable (3.63e-4)" 12.3 19.9 16.8 16.4 23.8 17.3 10.1 14.8 21.9 11.1 18.3 8.1 16.4 23.4 12.1 21.7 14.4 14.4 19.4 8.7 15.3 12.6 22.2 33.9 11.8 14.0 13.3 19.4 11.3 22.2 21.6 27.7 13.6 15.8 13.6 12.6 8.1 17.2 8.9 17.5 14.1 20.7 9.0 10.7 15.9 19.0 8.7 13.6 8.0 27.1 10.1 12.1 10.8 14.5 7.8 14.5 3.4 15.3 15.2 13.3 8.8 14.5 9.5 7.7 3.1 3.2 6.1 8.0 12.0 6.8 8.6 2.9 7.3 11.1 12.9 6.2 10.4 10.2 3.3 16.8 5.4 2.8 8.0 5.1 10.6 0.8 13.2 8.2 9.3 7.4 5.6 5.4 8.2 15.0 13.3 1.7 9.8 19.0 9.9 23.5 15.6 7.2 14.4 10.4 18.1 15.4 11.6 7.5 16.3 15.1 7.0 3.5 16.5 13.0 13.2 5.9 15.1 6.1 8.2 6.6 3.6 4.0 8.9 14.2 8.3 3.2 11.7 3.4 12.9 15.3 10.9 6.8 11.4 8.9 14.5 7.8 13.3 10.9 1.5 15.2 11.2 10.0 8.8 8.8 16.8 23.8 14.8 21.9 15.3 12.6 13.3 19.4 15.8 13.6 CDK11A "CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, p58GTA, PITSLRE" ENSG00000008128 "Cyclin dependent kinase 11A" Q9UQ88 1 1702730-1724324 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.5" "Low lineage specificity" "Detected in all" "CAB010467, HPA025061, HPA073626" Supported Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB010467: AB_631212, HPA025061: AB_1846407, HPA073626: " "unprognostic (6.25e-2)" "unprognostic (8.32e-2)" "unprognostic (1.47e-2)" "unprognostic (2.74e-1)" "unprognostic (9.32e-3)" "unprognostic (3.54e-2)" "unprognostic (2.25e-3)" "unprognostic (7.97e-2)" "prognostic unfavourable (5.06e-4)" "unprognostic (1.28e-1)" "unprognostic (5.58e-3)" "unprognostic (3.07e-2)" "prognostic unfavourable (1.15e-6)" "unprognostic (1.97e-1)" "unprognostic (5.98e-2)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" 14.3 14.9 17.2 23.7 26.9 39.7 13.0 35.2 32.7 12.5 16.4 14.3 6.1 29.2 16.5 8.5 12.1 12.6 10.2 10.2 19.4 8.4 11.7 12.5 19.0 20.3 22.6 9.0 16.2 12.9 12.2 27.5 12.9 17.1 14.4 14.6 11.6 12.7 10.3 21.5 15.1 34.9 13.1 26.0 24.2 15.7 16.4 25.1 14.9 14.6 7.6 22.4 13.5 15.2 7.4 11.8 33.5 6.3 4.4 5.5 1.4 16.1 9.7 7.0 6.4 9.2 7.4 6.9 15.9 7.1 7.9 9.2 12.2 14.8 17.2 9.7 4.6 12.0 6.5 8.2 6.3 13.1 10.4 15.3 18.3 10.9 6.1 17.1 22.1 8.5 5.6 6.9 4.5 13.6 17.9 14.4 6.6 9.1 7.9 13.4 9.7 8.3 14.5 10.7 8.3 6.4 7.3 7.8 11.3 13.9 16.4 19.1 11.0 7.1 13.8 12.5 12.1 5.6 8.8 20.1 14.6 21.6 4.2 13.9 3.9 16.7 6.3 7.7 5.5 3.4 4.2 6.2 4.7 4.2 2.0 7.4 4.7 4.0 33.5 4.4 3.7 11.8 4.5 1.4 17.2 26.9 35.2 32.7 19.4 8.4 22.6 9.0 17.1 25.1 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461511-39564907 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 16.0 13.1 12.4 17.4 9.2 32.4 14.0 23.4 17.8 18.2 17.6 9.6 15.7 11.1 15.7 12.0 16.9 12.2 12.5 11.0 10.1 6.7 10.2 18.5 13.5 15.2 10.9 14.3 17.4 11.3 19.0 12.2 18.4 9.5 12.7 11.7 10.4 15.6 11.1 11.1 17.0 16.5 11.0 10.6 16.3 11.8 18.9 8.3 29.0 15.0 5.4 17.3 16.3 20.5 5.1 4.0 10.4 2.9 6.6 4.0 0.9 8.7 10.8 6.5 6.1 4.8 5.4 6.1 7.9 6.7 10.9 8.1 13.3 5.4 12.4 7.0 8.3 14.2 13.0 10.0 10.5 8.1 11.2 13.4 7.4 10.3 4.7 18.3 9.4 5.8 6.9 13.2 10.5 6.6 22.7 8.2 6.2 4.1 14.9 4.7 6.8 4.9 9.9 14.1 7.0 4.1 10.5 7.0 4.5 10.1 85.6 6.9 11.0 7.9 7.1 9.9 7.9 6.9 10.2 6.7 4.8 17.5 7.0 7.8 6.4 10.4 2.9 4.1 4.0 2.2 3.0 2.9 2.5 2.7 1.8 5.1 2.9 2.7 9.7 6.6 1.8 4.0 2.0 0.9 12.4 9.2 23.4 17.8 10.1 6.7 10.9 14.3 9.5 8.3 CDK14 "PFTAIRE1, PFTK1" ENSG00000058091 "Cyclin dependent kinase 14" O94921 7 90466424-91210590 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.5;memory B-cell: 9.8;naive B-cell: 5.3;neutrophil: 5.6" "Group enriched" "Detected in many" 9 "B-cells: 9.8;granulocytes: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015267 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015267: AB_1855249" "prognostic favourable (5.86e-4)" "unprognostic (3.96e-1)" "unprognostic (1.91e-2)" "unprognostic (2.09e-3)" "unprognostic (1.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-1)" "unprognostic (4.48e-2)" "unprognostic (3.60e-2)" "unprognostic (3.09e-2)" "unprognostic (2.77e-3)" "unprognostic (2.91e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (7.79e-4)" "unprognostic (2.46e-1)" "unprognostic (2.86e-1)" "unprognostic (4.39e-3)" 8.2 4.7 19.8 7.1 19.4 6.1 8.3 28.6 34.9 10.6 5.2 3.7 0.6 2.7 8.6 3.2 3.1 12.0 11.9 11.5 25.8 15.5 19.8 12.7 9.2 10.9 17.3 17.4 14.9 14.2 3.8 14.2 5.9 22.8 11.3 3.4 4.3 7.7 7.0 5.4 2.7 3.8 7.4 7.0 7.5 7.4 7.2 4.5 0.9 13.1 1.6 11.9 6.9 6.7 9.8 0.9 7.5 0.7 0.1 0.2 0.6 7.0 0.0 14.1 1.8 13.2 13.4 3.2 5.9 5.6 3.6 3.9 0.1 3.4 25.0 0.7 5.8 2.1 0.7 8.3 7.0 0.0 3.3 0.0 4.7 0.1 6.1 7.1 0.1 9.5 2.1 10.8 3.9 4.6 0.1 30.8 7.3 0.0 0.0 2.7 8.9 3.8 19.2 19.4 19.0 1.9 1.9 3.1 9.1 15.0 0.0 0.3 1.9 3.6 11.3 15.7 20.1 13.1 9.0 17.4 13.3 17.9 5.9 9.4 15.3 7.5 0.3 0.5 0.0 0.7 0.0 9.8 0.0 0.0 0.9 5.3 0.0 0.0 5.6 0.1 0.5 0.1 0.2 0.6 19.8 19.4 28.6 34.9 25.8 15.5 17.3 17.4 22.8 4.5 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.2;ovary: 9.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HBF TERT88: 18.2;HMC-1: 34.4;LHCN-M2: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "basophil: 3.5;eosinophil: 6.9" "Lineage enriched" "Detected in single" 69 "granulocytes: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 1.3 0.2 0.1 5.2 0.1 0.0 3.7 0.3 0.1 3.4 2.3 0.1 0.1 0.3 4.1 20.2 1.1 1.0 4.2 0.3 0.1 0.0 0.4 0.1 3.3 0.1 0.1 0.1 9.8 0.2 0.0 0.5 0.1 0.1 2.0 0.7 1.4 0.6 0.3 0.7 1.1 3.0 3.9 0.1 0.1 1.1 2.5 0.1 0.1 0.2 1.2 1.2 1.6 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.7 0.0 3.1 14.6 5.5 11.9 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.2 0.0 34.4 2.0 0.0 1.5 0.7 0.0 0.0 0.0 10.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Uncertain "Plasma membrane,Microtubules,Cytosol" "Plasma membrane, Microtubules, Cytosol" "CAB016535: AB_785112, HPA000974: , HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavourable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 22.0 20.1 32.3 13.9 25.0 26.6 17.6 51.5 49.0 17.2 19.3 15.5 17.0 16.4 14.8 12.8 23.8 18.8 14.1 47.3 29.2 18.0 19.9 12.7 14.0 10.8 22.0 21.1 16.7 18.6 22.8 14.9 18.6 28.5 12.7 14.7 13.7 20.1 16.1 91.2 17.0 15.3 18.2 14.8 12.0 14.7 28.7 12.1 10.4 20.9 36.3 12.6 12.9 12.1 8.5 13.5 8.5 10.7 6.3 7.7 5.7 41.2 31.7 30.4 44.9 22.3 19.2 30.4 19.6 24.2 29.9 22.3 35.6 20.0 9.9 12.5 35.2 23.4 32.3 41.8 20.2 11.9 51.3 10.8 44.5 27.7 29.0 11.3 25.2 23.9 26.8 42.4 51.2 26.7 16.0 16.9 26.1 35.9 9.8 26.0 23.8 34.2 10.5 24.1 17.4 22.5 32.7 25.7 19.4 53.3 41.3 20.2 36.8 13.9 26.8 20.0 32.8 30.5 23.4 13.3 13.0 9.7 17.6 52.7 22.4 3.1 8.8 8.5 4.8 10.7 6.2 3.8 6.2 7.7 11.6 8.5 5.6 5.8 4.2 6.3 9.6 13.5 6.0 5.7 32.3 25.0 51.5 49.0 29.2 18.0 22.0 21.1 28.5 12.1 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 43.7;TIME: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.8 4.1 10.8 2.9 5.3 14.0 7.7 10.9 15.4 9.6 9.1 2.4 2.8 7.2 7.6 7.9 4.4 6.4 6.7 13.2 7.6 4.9 10.4 2.8 3.4 11.5 5.5 6.0 10.2 7.0 14.2 25.7 43.7 7.6 5.9 21.7 3.0 5.2 8.7 4.7 7.2 9.1 5.8 6.2 11.4 4.1 5.6 3.8 6.4 6.0 7.9 4.6 5.0 52.4 8.6 3.3 4.6 5.9 8.3 6.3 7.8 3.2 2.4 6.3 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007053: AB_1846369" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavourable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.8 13.4 16.2 7.3 10.5 7.0 11.6 12.4 4.4 5.8 4.8 4.0 9.1 4.2 8.2 2.1 5.1 2.5 10.1 11.3 3.0 15.6 5.7 5.6 4.4 6.3 11.7 7.2 5.5 6.0 9.3 4.3 4.7 12.8 9.4 5.8 8.4 9.4 1.3 2.6 9.1 6.9 3.5 5.1 6.6 6.9 12.8 8.9 7.2 10.4 2.4 23.2 4.8 9.2 4.9 18.6 7.1 1.4 1.8 7.9 9.7 8.5 9.5 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 CDK2 ENSG00000123374 "Cyclin dependent kinase 2" P24941 12 55966769-55972784 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 105.5" "Cancer enhanced" "Detected in all" "melanoma: 88.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013115, HPA066915" Enhanced Enhanced Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB013115: AB_2536375, HPA066915: " "unprognostic (2.36e-2)" "unprognostic (2.60e-1)" "unprognostic (3.71e-2)" "unprognostic (1.83e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (9.94e-4)" "prognostic unfavourable (8.61e-5)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (4.67e-2)" "unprognostic (5.38e-3)" "unprognostic (4.69e-3)" "prognostic unfavourable (1.46e-10)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (6.75e-2)" 10.7 7.6 4.5 20.8 6.5 18.7 11.5 4.2 4.3 12.6 11.6 3.5 6.0 6.1 10.7 6.4 13.6 10.8 12.6 10.1 5.4 2.2 8.3 16.7 19.5 12.2 6.0 2.0 14.2 8.3 5.2 4.2 49.0 7.3 10.8 9.1 51.2 9.3 9.9 10.8 14.6 9.3 11.8 5.0 12.5 10.1 7.8 5.1 39.3 9.5 10.7 14.7 16.7 10.1 9.3 10.8 5.2 3.9 4.5 7.6 4.3 16.5 8.9 19.6 10.9 4.0 5.2 36.2 20.6 10.8 25.6 24.0 18.7 15.9 15.7 15.5 7.6 10.6 14.9 9.0 26.1 18.5 14.6 18.1 14.8 7.1 1.3 14.3 13.1 2.7 2.3 17.3 6.0 12.9 17.2 14.3 17.8 12.7 29.6 12.1 7.8 13.3 29.0 18.9 11.8 7.4 16.2 8.1 10.5 23.5 8.6 105.5 18.6 10.5 7.2 17.7 17.2 13.6 15.0 8.2 9.4 19.6 10.0 10.5 15.2 5.2 3.6 3.1 7.0 3.9 7.0 9.3 3.2 5.0 2.7 6.1 3.0 5.3 1.7 4.5 1.6 10.8 7.6 4.3 4.5 6.5 4.2 4.3 5.4 2.2 6.0 2.0 7.3 5.1 CDK4 PSK-J3 ENSG00000135446 "Cyclin dependent kinase 4" P11802 12 57747727-57756013 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 10 "HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006024, CAB013116, CAB069405" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" Cytosol "Nucleoplasm, Nuclear membrane, Nucleoli" "CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: " "unprognostic (8.88e-2)" "unprognostic (2.53e-1)" "unprognostic (5.27e-2)" "unprognostic (9.01e-2)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.09e-7)" "unprognostic (7.39e-2)" "unprognostic (3.23e-3)" "unprognostic (2.93e-2)" "unprognostic (3.19e-2)" "unprognostic (9.10e-2)" "prognostic unfavourable (3.15e-5)" "unprognostic (3.32e-1)" "unprognostic (1.67e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-2)" 32.2 43.1 13.8 22.2 15.7 24.0 45.0 13.1 17.9 36.3 28.2 20.1 22.8 15.2 51.4 28.1 29.9 31.0 32.3 27.4 14.5 12.1 24.0 36.9 26.8 26.4 18.3 13.7 61.4 54.4 18.9 34.2 25.0 16.0 37.2 26.9 26.2 29.3 24.1 27.8 25.6 20.7 34.1 13.5 27.2 23.9 24.6 17.5 29.2 54.3 32.1 27.5 33.6 30.9 29.6 25.5 2.6 19.9 15.8 32.1 22.2 9.3 10.8 14.3 12.7 13.1 11.5 9.5 5.4 17.6 23.8 19.8 15.4 8.9 13.6 9.7 8.4 7.2 19.7 125.1 18.1 6.7 9.1 12.7 7.3 10.8 15.4 14.4 8.8 11.3 9.2 14.6 16.8 15.3 13.5 11.7 138.1 13.5 13.7 11.7 16.8 11.0 12.4 434.6 12.6 7.4 14.7 12.9 12.1 9.5 7.2 14.4 9.6 17.5 6.9 11.2 10.5 12.6 10.9 5.8 9.5 20.9 10.3 13.3 13.4 1.7 14.3 2.6 26.2 19.9 27.0 29.6 23.1 23.7 21.0 28.1 32.1 28.5 1.2 15.8 12.0 25.5 16.6 22.2 13.8 15.7 13.1 17.9 14.5 12.1 18.3 13.7 16.0 17.5 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB008909: , HPA064535: " "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.6 14.0 13.1 21.3 14.5 10.7 6.5 7.7 12.8 15.2 12.6 9.9 10.9 11.5 27.7 9.5 8.3 21.0 11.8 7.0 9.1 12.5 12.6 12.3 9.8 9.6 10.2 23.7 11.5 8.8 12.5 3.9 10.2 12.8 8.4 15.2 22.6 27.4 20.8 14.4 22.1 13.4 5.4 12.8 13.2 8.8 8.3 35.7 11.1 13.7 14.6 6.4 9.0 8.6 15.0 3.9 11.2 14.4 19.6 21.4 4.5 23.6 14.7 26.8 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.5;SK-MEL-30: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000252: " "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.1 5.2 1.6 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.0 0.5 1.0 1.2 1.0 0.9 2.0 1.2 2.1 0.3 3.9 0.3 0.5 1.1 0.2 0.6 1.1 0.6 3.1 1.6 1.3 1.1 2.0 1.2 3.2 0.8 1.7 0.8 3.3 1.1 1.5 3.1 3.6 0.7 0.9 31.5 8.5 1.2 0.7 22.6 1.3 2.4 1.1 2.1 3.2 0.8 3.2 0.6 0.8 1.0 1.8 2.9 5.1 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA066301: " "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavourable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 13.9 12.8 15.1 13.0 23.0 20.8 14.8 29.2 22.4 11.1 12.2 18.3 12.3 11.3 15.4 15.4 13.2 12.8 8.3 15.0 11.2 9.5 11.8 14.6 12.5 14.7 12.2 16.2 14.0 12.4 16.6 17.9 13.1 15.5 11.5 16.2 15.5 19.7 12.0 29.2 19.0 14.5 14.1 10.1 15.8 13.0 14.8 15.9 14.4 15.8 11.2 18.7 13.4 12.5 16.0 14.2 8.5 16.3 15.6 17.4 10.8 10.9 11.3 7.9 7.1 7.4 5.8 17.4 6.6 9.5 19.2 20.2 47.8 9.8 19.3 8.9 7.1 16.2 13.4 18.8 14.9 3.5 7.1 23.3 11.7 18.1 8.9 14.7 7.4 7.6 8.1 12.8 15.4 10.6 14.7 8.1 8.3 10.9 15.0 11.1 5.8 16.7 11.1 18.0 14.8 10.5 9.6 10.8 6.0 21.0 10.1 13.9 14.6 7.1 7.8 14.2 11.6 9.6 11.0 7.0 7.9 14.2 8.5 15.9 6.7 3.3 12.7 8.5 14.7 16.3 17.4 16.0 14.5 14.0 14.2 9.8 13.1 11.3 0.7 15.6 13.0 9.9 12.4 10.8 15.1 23.0 29.2 22.4 11.2 9.5 12.2 16.2 15.5 15.9 CDK5RAP2 "C48, CEP215, FLJ10867, MCPH3" ENSG00000136861 "CDK5 regulatory subunit associated protein 2" Q96SN8 9 120388869-120580170 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035820, HPA046529, CAB079753" Approved Enhanced "Cell Junctions,Centrosome" Centrosome "Cell Junctions" "CAB079753: , HPA035820: AB_10671939, HPA046529: " "unprognostic (7.72e-2)" "unprognostic (2.04e-2)" "unprognostic (2.84e-2)" "unprognostic (4.48e-2)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" "unprognostic (6.70e-3)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (1.00e-1)" "unprognostic (7.36e-2)" "unprognostic (2.26e-2)" "unprognostic (1.88e-1)" "unprognostic (4.94e-2)" "unprognostic (2.36e-1)" "unprognostic (3.33e-2)" "unprognostic (7.41e-2)" 10.3 12.0 12.3 13.0 23.2 21.3 15.2 20.0 19.9 15.7 13.0 22.0 9.1 5.8 11.9 8.4 12.8 11.2 10.2 18.3 14.9 7.9 7.8 20.1 10.9 14.0 21.6 9.8 18.6 9.3 17.0 20.3 8.8 15.1 14.5 9.2 10.6 21.3 11.6 41.7 16.0 10.2 15.6 14.2 11.2 12.3 19.8 25.7 23.4 11.9 8.5 14.9 12.8 16.5 7.4 2.7 13.7 5.2 4.7 4.5 1.9 9.5 16.8 23.3 14.0 10.1 14.9 12.5 12.3 9.5 14.0 13.1 13.2 12.6 17.8 5.7 12.0 21.0 18.4 14.1 13.5 14.2 7.4 15.2 30.8 23.3 9.5 18.7 10.2 26.8 9.4 12.4 16.4 12.1 14.0 15.5 18.3 21.5 20.0 12.0 21.6 12.7 19.7 27.9 8.4 10.0 7.6 15.3 17.6 21.4 11.8 14.2 27.6 12.9 8.1 12.2 13.3 14.2 13.9 11.3 15.7 20.0 12.7 12.0 25.5 13.7 2.2 3.5 4.5 2.1 4.4 5.7 4.2 4.1 1.3 7.4 3.5 3.5 2.9 4.7 5.2 2.7 3.3 1.9 12.3 23.2 20.0 19.9 14.9 7.9 21.6 9.8 15.1 25.7 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavourable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favourable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 22.3 36.0 19.9 35.6 16.7 16.8 35.7 16.3 19.8 16.5 15.2 28.2 21.7 26.9 33.8 17.0 21.9 12.9 18.3 18.5 39.7 17.0 12.8 42.9 38.2 18.7 15.1 14.3 19.1 15.5 14.8 29.1 15.9 15.1 25.0 16.7 42.8 41.1 24.5 12.0 15.6 22.0 33.5 30.5 16.4 28.1 13.6 32.6 12.6 11.3 16.4 25.7 19.8 12.7 13.7 12.2 16.5 20.8 32.9 31.0 16.6 17.1 21.0 16.6 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.6" "Cell line enhanced" "Detected in many" "MOLT-4: 91.7;REH: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavourable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavourable (2.33e-5)" 6.6 11.3 6.0 9.1 7.5 22.5 5.9 2.4 6.0 7.8 10.0 9.6 5.7 7.5 6.0 5.9 8.5 4.6 7.8 6.6 6.9 4.2 6.5 7.5 7.3 7.4 7.0 5.2 5.0 10.0 25.7 4.2 20.5 7.5 6.1 9.2 4.4 10.9 6.1 2.0 11.6 9.4 9.8 7.5 6.3 10.8 5.4 8.0 74.6 4.3 9.2 10.3 6.7 9.0 3.6 5.6 6.5 4.8 3.9 7.1 2.3 6.0 2.8 7.8 5.0 2.3 2.6 1.6 6.3 3.9 3.1 3.0 7.7 4.7 4.7 3.6 4.2 3.8 4.3 9.0 7.4 10.3 3.0 11.8 5.4 7.4 1.4 7.3 0.5 2.5 4.9 4.2 20.0 1.2 11.2 13.0 5.6 1.2 91.7 0.7 2.4 2.6 44.8 27.6 7.9 4.3 0.1 4.1 26.8 0.7 2.1 3.7 0.1 12.0 4.6 10.3 16.1 4.0 12.6 7.0 0.1 6.3 1.5 25.0 13.6 4.9 1.9 6.5 5.2 3.9 5.9 2.0 5.5 5.6 4.0 3.6 7.1 4.0 1.1 3.9 4.8 5.6 2.8 2.3 6.0 7.5 2.4 6.0 6.9 4.2 7.0 5.2 7.5 8.0 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 26.2 27.0 22.8 18.9 22.4 33.9 17.4 31.0 26.8 23.1 21.9 22.9 24.7 16.6 22.5 20.1 22.7 29.1 21.5 22.9 26.3 23.4 18.5 48.7 23.3 26.6 23.4 18.8 43.7 29.1 15.5 28.4 19.8 20.6 20.7 10.8 18.7 20.6 21.6 14.6 26.6 21.4 21.0 17.9 29.0 17.7 22.3 16.1 29.3 25.8 18.3 24.2 17.0 17.6 6.0 8.9 5.1 6.4 18.6 9.9 2.9 8.8 16.1 10.1 11.1 11.5 9.0 13.2 9.1 13.4 9.5 8.6 11.9 10.0 15.5 10.7 10.3 17.9 6.6 14.9 3.6 13.9 8.0 14.5 17.4 9.8 16.8 14.0 23.3 15.8 18.2 10.1 11.4 19.6 12.5 20.9 8.5 23.3 15.3 21.1 22.3 17.2 44.3 8.6 22.3 13.8 9.9 10.0 11.9 13.7 14.5 8.2 18.2 13.3 22.4 11.4 12.9 9.8 8.8 38.1 29.2 13.9 10.7 9.6 10.4 3.7 3.4 4.9 9.9 4.5 9.9 3.5 5.6 7.9 4.4 6.0 6.3 7.7 5.1 18.6 6.4 8.9 3.8 2.9 22.8 22.4 31.0 26.8 26.3 23.4 23.4 18.8 20.6 16.1 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50329404-50416461 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 16.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059605: , HPA065919: " "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 7.1 2.1 7.5 1.8 5.1 0.9 3.0 2.7 20.2 14.1 5.9 1.6 2.5 8.4 12.1 2.3 2.6 16.4 2.6 2.9 7.1 2.4 18.8 1.1 4.3 3.0 2.0 12.3 10.5 2.0 1.4 1.4 4.9 2.9 4.0 5.7 1.6 2.5 8.4 1.7 3.0 3.0 7.7 3.1 3.7 2.0 1.9 1.4 1.3 5.0 6.1 2.1 7.0 5.6 5.7 1.3 6.0 2.5 3.8 6.7 2.6 6.0 4.8 0.6 2.4 6.5 7.8 0.3 2.1 3.8 2.2 2.5 1.9 5.7 0.4 2.6 4.6 4.2 0.9 0.6 2.5 6.6 2.3 6.4 2.1 1.7 7.3 5.8 3.5 1.7 3.5 4.5 10.0 8.4 2.6 2.6 1.0 0.3 1.9 3.1 0.7 2.3 0.7 2.8 1.8 6.9 2.3 1.1 1.3 2.4 16.5 0.6 0.2 4.9 2.6 5.7 2.9 5.6 4.7 0.8 0.4 0.4 0.9 6.1 6.9 6.0 2.5 4.4 6.3 2.3 6.2 4.6 4.4 6.7 1.3 5.7 3.4 3.7 1.4 3.8 0.3 1.2 4.1 2.6 7.5 5.1 2.7 20.2 7.1 2.4 2.0 12.3 2.9 1.4 CDKL2 "KKIAMRE, P56" ENSG00000138769 "Cyclin dependent kinase like 2" Q92772 4 75578005-75630716 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.7" "Cell line enhanced" "Detected in some" "A-431: 5.6;HEK 293: 3.7;HHSteC: 4.3;RPTEC TERT1: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040672 Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA040672: AB_10794744" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (6.91e-2)" "unprognostic (3.80e-5)" "unprognostic (3.43e-2)" "unprognostic (2.71e-2)" "unprognostic (1.59e-1)" "unprognostic (8.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.88e-15)" "unprognostic (5.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-1)" "unprognostic (7.52e-2)" 0.7 2.4 7.1 1.2 11.1 0.7 1.2 7.7 13.2 1.7 2.0 6.2 0.0 1.0 1.7 2.3 2.3 4.1 1.4 1.3 5.1 6.7 11.8 0.7 9.2 1.3 7.1 7.0 3.8 1.6 5.7 8.9 0.7 12.5 2.0 2.4 3.4 1.2 2.0 0.7 0.9 0.9 1.5 7.4 0.9 1.5 27.7 6.1 0.0 6.9 0.0 2.0 1.1 0.9 0.4 0.0 0.2 0.0 0.0 1.6 0.1 5.6 0.7 0.3 0.0 0.3 0.3 0.0 0.3 1.7 2.4 1.9 0.5 1.2 0.1 0.9 0.1 0.8 0.0 0.5 2.2 0.2 3.7 0.0 0.2 0.0 4.3 0.0 0.1 1.4 2.1 0.4 0.8 0.1 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.1 0.3 3.0 2.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.4 1.6 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 1.2 0.1 7.1 11.1 7.7 13.2 5.1 6.7 7.1 7.0 12.5 6.1 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027751 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 2.5 2.7 7.0 2.2 7.1 1.6 2.5 7.0 8.5 2.6 2.4 5.9 5.5 2.3 3.9 5.3 2.6 3.7 2.6 6.6 6.1 6.5 4.5 2.8 2.2 2.5 8.0 4.3 3.0 2.4 3.2 6.5 2.2 8.6 2.8 2.6 3.9 2.0 3.2 7.5 2.7 2.5 4.6 8.4 2.7 2.2 33.4 9.3 1.3 3.9 2.1 3.0 2.8 2.2 1.5 2.7 1.0 1.1 1.4 4.0 1.3 1.0 2.2 3.3 2.2 5.6 4.8 1.4 3.0 2.7 1.4 3.3 2.0 1.5 2.8 1.9 1.9 0.9 2.7 1.9 2.7 3.0 2.1 1.5 2.4 3.4 3.4 0.6 1.0 2.2 4.9 4.1 1.3 1.3 1.5 1.2 3.6 1.1 2.1 8.3 2.2 1.0 3.6 1.4 0.8 1.8 1.0 5.0 1.5 2.2 0.6 3.6 1.9 1.7 1.0 2.7 0.6 3.6 1.0 3.4 4.5 5.4 4.1 2.2 2.1 0.0 0.9 1.0 0.9 1.1 4.0 1.5 1.4 2.5 2.7 1.0 3.8 3.8 0.2 1.4 0.4 1.6 2.3 1.3 7.0 7.1 7.0 8.5 6.1 6.5 8.0 4.3 8.6 9.3 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687339 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 97.4;HSkMC: 71.6;hTCEpi: 92.6;LHCN-M2: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 21.0;non-classical monocyte: 27.7" "Group enriched" "Detected in many" 8 "B-cells: 8.8;dendritic cells: 8.5;monocytes: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: " "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favourable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favourable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 81.2 27.0 8.2 21.9 29.8 22.0 38.0 4.8 13.7 25.2 60.8 13.9 10.2 39.8 17.5 17.7 63.5 49.4 47.3 35.9 22.2 8.4 29.1 102.2 55.8 6.3 16.6 4.9 59.1 45.5 12.8 22.8 38.6 44.1 42.0 40.7 8.8 18.0 11.4 98.6 43.5 144.9 40.2 29.6 13.6 25.2 25.3 10.3 6.6 22.7 42.2 27.4 50.5 44.4 8.8 8.5 1.8 27.7 0.2 1.1 13.3 3.0 12.4 9.6 0.2 33.8 60.5 17.6 50.3 40.8 6.2 24.5 1.1 2.9 2.0 1.8 31.5 6.9 0.4 55.5 10.1 4.0 2.5 0.3 10.3 15.4 97.4 0.0 15.1 71.6 92.6 57.1 18.0 32.4 0.5 14.2 72.2 6.4 0.4 1.2 1.2 1.8 6.1 7.9 3.5 11.0 23.1 4.3 4.2 11.6 1.0 2.3 3.8 12.6 17.9 10.9 10.3 0.7 4.1 23.9 4.6 6.1 14.1 1.1 30.3 0.0 9.3 0.2 0.2 21.0 0.3 8.8 0.4 0.3 8.0 5.7 0.1 0.1 1.8 0.2 27.7 8.5 1.1 13.3 8.2 29.8 4.8 13.7 22.2 8.4 16.6 4.9 44.1 10.3 CDKN1B "KIP1, P27KIP1" ENSG00000111276 "Cyclin dependent kinase inhibitor 1B" P46527 12 12715058-12722371 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003691, CAB021888, HPA059086" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB003691: AB_425362, CAB021888: , HPA059086: " "unprognostic (5.67e-2)" "unprognostic (9.76e-2)" "prognostic favourable (5.15e-4)" "unprognostic (6.90e-3)" "unprognostic (5.84e-3)" "unprognostic (1.03e-2)" "prognostic unfavourable (3.25e-4)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (2.85e-3)" "unprognostic (9.23e-3)" "unprognostic (2.96e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.23e-1)" "unprognostic (8.68e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" 29.8 30.9 30.2 25.0 30.0 40.2 45.3 64.5 50.6 31.6 34.4 35.6 19.9 29.2 33.1 19.8 26.0 24.3 24.3 21.2 33.0 29.5 20.8 23.3 29.2 38.5 42.9 25.1 46.2 15.1 22.2 15.9 26.8 26.3 25.1 22.2 31.4 23.5 24.2 48.8 26.1 26.4 19.4 46.0 34.3 19.4 19.2 39.0 43.0 29.4 21.4 25.5 34.1 29.1 6.2 3.3 19.2 4.5 6.2 10.6 2.9 12.8 6.4 34.3 5.9 11.8 6.7 16.8 12.1 19.2 16.7 20.6 18.3 14.6 0.1 4.6 6.9 12.3 16.0 5.9 15.0 21.8 11.3 10.0 17.6 18.4 15.8 8.5 7.1 7.4 12.8 5.5 16.1 9.9 10.7 36.7 5.9 16.5 11.9 12.2 13.7 6.0 8.8 11.2 21.5 8.0 13.9 13.0 21.4 17.3 12.5 22.6 6.6 19.1 6.7 8.3 13.2 7.5 11.7 31.8 21.0 11.6 10.3 12.8 8.0 4.5 3.1 6.8 5.4 3.1 5.6 6.2 6.9 6.5 3.2 4.8 7.4 5.2 19.2 6.2 4.5 3.3 10.6 2.9 30.2 30.0 64.5 50.6 33.0 29.5 42.9 25.1 26.3 39.0 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Cell line enhanced" "Detected in many" "EFO-21: 8.3;HeLa: 8.5;RPMI-8226: 11.2;SH-SY5Y: 22.8;SiHa: 15.9;SK-MEL-30: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.3 0.1 0.3 0.2 0.2 0.1 3.7 0.8 0.1 8.5 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.2 1.8 0.6 0.3 0.0 0.0 3.9 7.4 2.7 1.4 0.0 11.2 0.4 0.0 2.4 22.8 15.9 0.2 8.7 0.1 1.8 0.3 0.0 1.5 0.0 0.0 4.8 0.0 0.0 0.0 1.2 4.5 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974633 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 42.1 12.6 5.9 10.7 7.9 14.9 31.7 4.3 5.7 13.1 13.0 8.7 7.7 6.6 17.1 13.9 11.5 8.4 13.7 20.1 5.7 3.1 7.4 3.3 7.9 11.0 13.7 5.3 22.5 9.4 23.1 5.7 3.1 3.9 10.3 5.7 6.0 5.4 12.2 9.2 8.5 7.9 15.1 7.5 8.5 5.3 5.3 8.9 54.2 8.0 4.9 9.8 17.4 21.7 3.4 7.4 12.2 2.5 6.0 14.1 3.8 13.8 5.7 1.0 19.1 19.7 2.8 0.2 13.2 13.4 22.2 19.5 0.3 4.7 27.2 11.9 11.2 1.7 12.9 1.7 10.9 16.4 17.3 20.6 43.6 3.5 1.0 14.3 9.4 1.0 0.3 6.0 2.6 5.8 9.2 0.0 12.9 3.4 18.4 6.9 0.0 14.0 22.0 18.0 0.0 7.0 5.8 9.7 22.7 18.0 12.7 4.2 6.3 48.6 4.6 25.5 9.8 15.4 0.2 27.9 26.5 22.4 0.0 52.3 22.4 12.2 2.5 11.0 5.2 1.4 6.0 3.4 7.7 6.8 6.1 1.9 4.3 4.1 0.2 6.0 0.6 7.4 14.1 3.8 5.9 7.9 4.3 5.7 5.7 3.1 13.7 5.3 3.9 8.9 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566462-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;bone marrow: 119.4" "Cell line enhanced" "Detected in many" "HEL: 32.4;MOLT-4: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: " "unprognostic (3.08e-1)" "prognostic favourable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavourable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 5.5 4.7 27.9 6.8 24.2 119.4 4.1 14.3 28.7 2.6 3.9 4.2 0.5 3.9 2.4 2.5 3.8 3.0 4.0 8.4 22.9 17.9 2.7 2.1 6.6 11.1 14.3 14.3 2.8 2.8 2.6 3.4 4.8 11.8 2.5 3.6 2.4 3.2 3.0 6.3 6.0 3.5 4.6 5.7 9.7 2.8 10.9 3.6 18.6 1.8 2.8 8.4 4.2 2.4 17.3 16.0 44.1 10.7 11.9 11.3 9.5 10.9 1.7 5.6 3.7 3.0 4.7 1.4 7.2 8.5 8.0 7.0 2.2 2.6 3.0 2.4 7.6 2.3 1.9 1.8 2.9 12.2 4.6 32.4 2.0 3.6 3.5 3.2 26.3 1.9 6.0 4.1 3.0 2.2 1.3 26.7 7.9 1.5 39.9 17.1 1.1 8.4 6.5 5.5 1.8 3.6 0.9 7.9 4.2 5.1 3.8 5.5 3.4 8.6 1.7 9.5 4.9 15.6 10.7 16.8 5.7 5.6 10.0 5.5 6.7 35.9 5.6 23.5 10.0 6.8 8.0 17.3 8.3 11.3 5.4 15.9 7.9 9.4 44.1 11.9 10.7 16.0 6.7 9.5 27.9 24.2 14.3 28.7 22.9 17.9 14.3 14.3 11.8 3.6 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816954 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 142.1;seminal vesicle: 53.7" "Cell line enhanced" "Detected in some" "AF22: 22.6;ASC diff: 27.9;ASC TERT1: 10.8;HAP1: 8.0;NTERA-2: 8.4" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "memory CD4 T-cell: 4.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 41 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favourable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 31.9 6.2 9.3 1.7 11.2 0.8 9.9 7.6 9.4 3.4 1.5 3.7 36.4 1.0 3.1 42.6 1.8 4.9 3.7 7.6 7.3 9.0 1.7 142.1 3.9 2.3 6.5 5.5 8.7 4.7 1.0 6.5 17.7 14.5 4.0 1.3 19.2 2.8 53.7 3.5 1.1 1.1 2.6 5.3 1.8 1.2 5.0 4.3 0.0 2.8 2.5 1.6 2.4 2.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 22.6 0.0 27.9 10.8 0.1 0.6 0.2 2.2 2.1 0.0 0.0 0.0 0.0 0.2 0.0 8.0 0.0 3.1 0.0 3.9 0.7 0.0 0.6 0.1 0.0 0.0 4.1 0.0 0.3 0.0 2.9 0.0 0.0 2.5 0.0 0.5 0.1 8.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 9.3 11.2 7.6 9.4 7.3 9.0 6.5 5.5 14.5 4.3 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favourable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 7.3 12.7 10.4 9.4 10.9 5.3 7.8 10.6 12.4 10.1 11.4 11.4 5.3 7.0 12.4 11.8 6.0 11.9 8.3 14.1 10.4 6.8 9.4 8.5 9.4 9.0 10.7 9.5 11.2 8.5 8.0 11.1 7.9 10.9 11.0 6.0 10.3 15.5 11.8 12.3 7.7 9.4 8.2 8.7 11.6 9.9 4.0 10.9 12.9 11.2 5.2 9.6 8.1 12.2 8.9 11.6 11.0 8.5 8.3 11.6 7.3 5.5 4.1 6.6 9.6 4.2 7.4 5.5 3.0 4.4 6.1 5.7 0.7 5.7 5.7 3.2 2.2 6.5 3.0 1.0 3.7 5.3 10.5 3.0 6.2 6.2 7.7 8.1 4.6 7.9 5.9 4.5 5.6 4.5 5.8 7.1 4.3 4.0 10.0 5.8 5.1 4.0 6.4 2.7 12.1 4.6 1.8 3.3 8.0 3.7 6.6 6.3 7.1 3.4 3.5 11.5 7.3 6.4 3.7 7.0 3.3 4.4 5.3 5.9 11.3 1.5 6.5 11.0 10.1 8.0 9.5 7.3 9.9 8.9 5.5 8.9 11.6 8.4 1.7 8.3 8.5 11.6 7.4 7.3 10.4 10.9 10.6 12.4 10.4 6.8 10.7 9.5 10.9 10.9 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell line enhanced" "Detected in some" "AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: " "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.3;HaCaT: 28.1;HeLa: 9.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.3 6.7 0.2 1.9 0.2 0.7 0.1 0.5 1.5 0.2 0.7 5.0 15.3 0.1 0.4 1.3 28.1 0.4 0.3 0.4 2.3 0.3 0.1 9.5 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.0 1.2 0.8 0.1 0.4 0.2 0.2 0.8 0.0 0.4 0.0 1.8 3.7 0.1 0.2 2.2 2.0 0.1 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.6;hTCEpi: 25.8;SK-BR-3: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: " "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favourable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favourable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.5 0.2 0.6 0.1 0.0 0.0 12.1 0.0 0.1 0.3 0.2 4.9 20.6 0.0 0.9 0.0 12.1 3.8 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.8 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.1 0.0 1.7 0.8 0.0 0.0 2.4 5.8 8.8 4.8 0.1 1.3 28.0 0.0 8.5 0.2 0.0 0.0 0.7 1.3 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 CDS2 ENSG00000101290 "CDP-diacylglycerol synthase 2" O95674 20 5126786-5197887 "Enzymes, Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/84: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019698 Approved Approved "Endoplasmic reticulum,Cytosol" 200000 "Endoplasmic reticulum" Cytosol "HPA019698: AB_1846464" "unprognostic (4.59e-2)" "unprognostic (1.98e-1)" "unprognostic (2.39e-1)" "unprognostic (3.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.48e-1)" "unprognostic (3.35e-3)" "unprognostic (1.65e-1)" "prognostic favourable (3.53e-9)" "unprognostic (8.89e-2)" "unprognostic (3.53e-1)" "unprognostic (1.38e-1)" "unprognostic (2.44e-1)" 14.8 16.1 22.2 9.9 25.5 12.1 12.1 36.0 34.5 12.7 11.8 21.4 6.7 5.9 12.9 9.8 10.5 12.5 10.0 26.6 22.0 34.0 16.9 14.2 14.5 10.9 26.7 24.0 10.9 7.2 20.6 15.6 11.1 28.3 15.9 12.3 19.8 8.0 19.7 9.4 6.2 9.9 20.2 16.2 9.8 10.6 13.0 12.5 8.1 14.2 4.6 13.6 11.6 8.2 7.6 7.9 28.3 9.7 6.5 11.1 11.7 9.4 10.6 10.6 5.5 6.3 5.8 4.9 5.2 10.7 8.6 12.5 6.5 9.3 7.2 2.6 9.7 13.6 8.6 10.9 9.2 7.6 3.0 8.3 3.0 10.0 5.9 5.4 3.1 5.0 6.1 11.3 4.4 11.5 4.0 9.3 8.0 1.6 10.6 2.0 5.1 3.2 9.2 8.6 3.3 5.5 9.2 4.4 6.2 5.8 9.9 13.4 6.1 2.5 8.4 6.2 4.9 5.5 5.2 8.1 59.6 6.0 2.8 4.2 3.7 24.1 9.7 11.5 10.0 8.0 10.6 7.6 10.2 11.1 7.9 7.4 8.0 7.8 28.3 6.5 7.3 6.3 11.1 11.7 22.2 25.5 36.0 31.6 22.0 34.0 26.7 24.0 28.3 12.5 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803213-88809258 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.2;esophagus: 7.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavourable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.4 0.4 0.7 2.7 0.9 25.2 0.4 0.0 1.2 1.2 2.5 2.9 0.3 0.0 7.1 0.3 0.0 0.1 0.6 2.2 0.5 0.6 0.9 3.2 1.7 0.0 0.4 0.9 2.1 2.0 0.3 1.0 0.8 0.1 0.0 3.3 3.2 0.3 0.8 3.1 1.7 3.3 0.1 2.1 0.2 1.9 3.7 2.1 3.5 0.9 1.7 4.0 0.7 9.6 10.1 4.4 7.4 0.2 0.9 17.8 6.6 1.8 5.2 3.3 20.6 10.0 14.3 7.3 1.4 12.5 5.5 4.4 1.7 5.1 23.8 13.4 8.9 17.2 0.0 7.6 5.9 0.4 0.3 5.3 1.1 1.6 21.8 4.8 1.9 23.9 31.0 39.3 11.4 8.1 33.3 6.0 12.6 1.1 7.3 10.6 7.9 11.4 3.6 5.0 11.3 15.6 1.7 7.3 11.6 10.9 9.7 17.8 15.4 19.6 5.3 19.4 8.7 0.5 0.9 3.5 2.7 0.5 1.1 1.2 2.7 2.7 1.0 3.7 4.0 2.4 2.1 1.7 0.7 2.1 3.0 0.7 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 49.7 11.6 20.5 13.5 23.7 29.3 24.3 27.5 35.9 27.6 27.4 28.7 20.1 63.7 41.9 30.8 21.5 29.3 27.5 51.8 40.7 11.0 37.6 12.8 17.6 36.9 41.8 24.2 27.8 28.9 24.6 66.5 34.8 27.0 42.8 39.9 14.3 34.2 24.2 20.7 14.9 20.9 27.3 51.0 29.0 20.3 16.3 12.3 26.1 19.5 32.7 63.0 25.7 43.1 29.5 27.9 23.4 27.2 62.5 46.8 150.0 16.5 25.4 17.1 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.8;TIME: 17.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: , HPA052865: " "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.3 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.3 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.7 1.4 3.2 0.2 0.8 1.1 8.8 2.2 5.4 2.1 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.0 0.0 1.6 0.2 13.8 1.0 1.7 0.4 0.9 0.9 0.8 1.2 0.3 17.8 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT/enhancer binding protein alpha" P49715 19 33299934-33302564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.3;liver: 44.3" "Cell line enhanced" "Detected in some" "BEWO: 42.6;Hep G2: 22.8;NB-4: 23.5;THP-1: 85.0;U-937: 27.2" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 13 "dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA052734: , HPA065037: , HPA067937: " "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 40.7 1.5 2.3 7.6 4.6 8.4 52.3 2.1 4.0 3.5 9.0 5.2 1.1 9.0 2.2 2.1 6.1 2.4 6.4 6.6 3.9 2.4 2.0 44.3 39.9 10.3 4.1 3.1 1.3 9.0 4.5 1.7 17.4 2.7 3.8 5.1 1.9 5.6 1.6 15.4 23.7 12.7 2.9 6.6 3.0 3.5 1.2 2.6 2.2 2.5 10.7 3.5 5.4 7.9 0.1 4.1 11.0 11.8 0.0 0.6 1.5 0.5 1.0 0.0 1.5 12.3 0.0 42.6 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.6 0.0 1.9 1.2 0.1 0.0 7.3 1.5 0.0 0.0 22.8 0.2 7.5 9.1 0.4 5.5 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 23.5 1.0 0.5 0.0 0.0 0.2 0.0 3.7 0.0 0.3 0.1 0.1 0.1 2.9 85.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 27.2 0.0 11.0 6.0 0.0 0.6 9.4 0.6 0.0 0.1 0.4 4.1 0.1 0.2 0.4 2.1 0.0 11.8 0.2 0.0 1.5 2.3 4.6 2.1 4.0 3.9 2.4 4.1 3.1 2.7 2.6 CEBPE CRP1 ENSG00000092067 "CCAAT/enhancer binding protein epsilon" Q15744 14 23117304-23119616 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 87.1;bone marrow: 29.4" "Group enriched" "Detected in some" 4 "HL-60: 58.0;NB-4: 30.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 201 "eosinophil: 87.1" "Lineage enriched" "Detected in single" 237 "granulocytes: 87.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.3 0.0 0.1 0.8 0.2 29.4 0.1 0.1 1.3 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.1 0.2 2.7 0.2 0.3 0.1 0.1 0.1 0.0 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.9 0.1 0.3 7.7 0.4 0.1 0.1 2.6 0.1 0.1 0.8 0.2 0.1 0.0 0.1 87.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 30.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.3 87.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 1.3 0.1 0.1 0.3 0.1 0.1 0.1 CEBPZ "CBF2, CTF2" ENSG00000115816 "CCAAT/enhancer binding protein zeta" Q03701 2 37201612-37231713 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052065 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052065: " "unprognostic (1.64e-2)" "unprognostic (1.20e-1)" "unprognostic (3.00e-3)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.88e-1)" "unprognostic (1.72e-2)" "prognostic unfavourable (2.94e-5)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (2.66e-1)" "prognostic unfavourable (8.13e-4)" "unprognostic (2.65e-2)" "unprognostic (5.36e-2)" "unprognostic (4.19e-2)" "unprognostic (8.76e-2)" "unprognostic (2.05e-1)" "unprognostic (8.01e-2)" 21.3 23.0 13.1 23.7 14.4 20.0 21.7 17.0 16.4 22.4 17.8 8.4 17.2 12.8 17.2 16.6 18.6 17.4 12.6 19.4 12.0 12.9 30.5 22.6 15.4 16.7 13.2 12.9 24.2 17.2 18.8 27.3 18.2 16.5 20.4 15.5 8.2 15.5 17.9 88.0 14.0 19.1 19.5 15.4 23.1 15.5 27.3 14.1 19.5 22.5 18.7 17.5 30.1 41.0 20.8 17.4 17.2 14.7 17.0 23.1 9.2 19.7 15.3 15.8 8.7 15.7 17.0 13.5 18.9 13.1 16.0 17.3 24.3 15.0 36.3 16.8 11.1 16.9 41.0 19.3 20.7 23.2 18.1 33.8 15.9 19.7 12.4 33.9 15.3 12.9 19.1 21.2 21.7 14.4 36.7 16.8 16.3 10.2 19.6 26.6 51.6 14.5 15.7 25.8 27.4 15.4 18.7 17.0 27.5 15.7 19.3 21.2 14.0 14.9 11.7 15.7 17.9 13.9 25.8 18.8 19.8 29.5 13.9 31.3 17.1 17.2 11.7 10.6 17.2 14.7 21.7 20.3 18.2 16.6 11.8 20.8 23.1 19.1 4.2 17.0 14.3 17.4 14.0 9.2 13.1 14.4 17.0 16.4 12.0 12.9 13.2 12.9 16.5 14.1 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Cell line enhanced" "Detected in some" "AF22: 12.6;HAP1: 11.6;HEK 293: 5.8;K-562: 6.4;NTERA-2: 18.5;SCLC-21H: 8.3" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.6 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 11.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.4 18.5 0.0 1.4 0.8 0.0 0.0 4.0 8.3 0.0 0.0 0.1 0.7 1.3 1.9 0.1 0.1 2.8 0.0 0.0 4.7 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 CELF2 "BRUNOL3, CUGBP2, Etr-3, NAPOR-2" ENSG00000048740 "CUGBP Elav-like family member 2" O95319 10 10798397-11336675 "Predicted intracellular proteins" "mRNA processing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 52.0;HMC-1: 50.7;REH: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016395, HPA035813, HPA065098" Enhanced Uncertain "Nucleoplasm,Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" Nucleoplasm "CAB016395: AB_2086271, HPA035813: , HPA065098: " "unprognostic (1.62e-2)" "unprognostic (1.52e-2)" "unprognostic (1.90e-2)" "unprognostic (3.55e-2)" "unprognostic (9.00e-2)" "prognostic favourable (7.61e-4)" "unprognostic (1.57e-1)" "unprognostic (3.77e-2)" "unprognostic (4.20e-2)" "unprognostic (5.22e-2)" "unprognostic (2.60e-3)" "unprognostic (2.83e-2)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.45e-1)" 27.0 4.9 26.5 21.0 35.2 49.5 14.6 23.6 35.7 11.7 12.2 10.1 4.5 7.1 11.6 5.1 16.3 10.6 12.9 26.8 24.0 14.9 3.8 3.6 20.8 31.4 11.0 20.0 35.7 3.8 2.2 6.7 6.6 11.6 11.2 13.8 8.5 9.1 10.0 14.8 6.5 18.9 17.3 15.8 22.7 9.4 5.9 15.0 36.9 6.8 6.3 20.9 13.0 11.0 22.7 23.1 51.0 27.2 30.6 31.9 22.9 0.0 0.0 12.8 0.0 2.0 0.7 1.4 1.8 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.0 1.8 0.0 0.1 10.4 3.1 52.0 0.2 0.0 0.4 14.9 50.7 0.8 0.1 0.1 0.0 1.8 2.3 21.7 15.9 0.0 18.3 10.8 5.2 0.0 22.5 13.7 4.6 0.9 0.0 1.9 0.1 0.0 0.0 13.6 0.0 10.2 0.0 2.4 0.7 8.0 0.0 8.3 7.5 2.4 0.8 18.0 5.7 25.4 18.1 37.8 25.3 24.9 31.9 21.5 25.2 27.7 23.1 22.7 26.6 24.7 51.0 30.6 27.2 16.4 25.8 22.9 26.5 35.2 23.6 33.9 24.0 14.9 11.0 20.0 11.6 15.0 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786690 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: , HPA054405: " "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 30.4 18.9 41.2 18.0 41.6 11.9 22.9 13.0 28.9 22.4 23.0 41.1 18.7 19.6 18.4 19.8 22.3 18.1 27.3 26.9 41.9 29.1 19.8 20.3 20.0 16.0 48.0 14.7 25.0 23.9 22.7 12.1 15.2 22.0 18.6 12.3 13.0 27.6 24.3 58.3 32.6 19.9 20.1 55.8 19.8 21.9 9.0 21.9 19.6 21.7 26.4 14.9 20.7 28.0 3.7 4.2 1.4 4.5 3.9 5.0 2.5 31.6 40.8 8.0 17.1 17.1 13.6 5.1 22.8 16.6 14.7 11.9 16.6 22.9 11.1 7.2 21.1 25.6 6.4 25.9 7.4 15.7 10.9 23.5 14.7 14.6 19.9 7.6 7.9 15.4 14.0 21.0 13.5 12.5 15.1 7.0 12.4 52.2 22.7 17.5 10.1 48.8 19.0 1.0 8.0 15.3 19.6 19.8 14.7 18.9 26.6 17.7 16.7 17.0 21.3 25.6 13.8 22.0 34.7 8.5 12.2 6.5 8.9 27.4 16.7 0.1 4.5 1.4 5.0 4.0 3.5 2.5 3.6 3.1 3.2 3.7 3.3 3.8 0.6 3.9 2.6 4.2 1.0 2.5 41.2 41.6 13.0 28.9 41.9 29.1 48.0 14.7 22.0 21.9 CENPBD1 MGC16385 ENSG00000177946 "CENPB DNA-binding domain containing 1" B2RD01 16 89969773-89972832 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEK 293: 7.6;K-562: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA052759, HPA060522" Uncertain Approved Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA052759: , HPA060522: " "unprognostic (2.63e-2)" "unprognostic (2.22e-3)" "unprognostic (4.43e-2)" "unprognostic (3.48e-3)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.37e-2)" "unprognostic (1.86e-3)" "unprognostic (1.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-2)" "unprognostic (6.44e-2)" "prognostic favourable (5.27e-11)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-2)" 7.2 5.9 6.6 2.6 7.3 4.5 6.3 6.1 9.5 3.3 4.0 4.9 10.5 5.9 3.6 5.0 4.0 3.6 4.6 4.2 6.6 6.1 7.6 5.6 6.7 7.1 7.9 7.0 7.6 8.9 3.9 7.1 4.4 6.2 4.9 6.0 3.8 6.0 4.8 4.2 5.1 2.9 3.8 5.6 6.6 4.7 8.2 6.3 2.5 3.5 1.8 2.5 4.8 2.7 3.7 3.6 1.4 1.6 1.4 2.7 1.3 1.2 0.0 0.2 0.4 0.5 0.9 2.1 0.8 0.3 0.0 0.0 0.6 0.0 1.3 1.2 0.9 2.0 0.0 0.0 0.3 0.0 7.6 0.0 0.3 0.5 0.4 0.4 1.2 0.0 1.3 0.0 0.0 0.0 4.6 0.9 0.0 1.1 1.4 0.5 0.6 0.5 3.1 1.6 0.0 0.0 0.0 2.7 1.9 2.8 0.3 0.1 0.7 0.0 0.0 0.2 1.8 0.2 1.2 0.8 1.3 1.0 0.5 1.2 0.5 0.6 1.6 1.4 2.4 0.7 2.1 1.2 1.9 0.8 3.6 3.7 2.7 2.3 0.5 1.4 1.4 3.1 1.1 1.3 6.6 7.3 6.1 9.5 6.6 6.1 7.9 7.0 6.2 6.3 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468748-67545606 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Enhanced "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA049740: , HPA058252: " "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favourable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favourable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 9.4 8.6 9.3 11.9 14.6 12.9 13.5 26.9 12.2 12.6 7.3 4.6 6.2 5.6 12.6 10.1 9.1 10.1 6.6 6.9 8.0 5.8 9.0 6.6 8.7 7.7 11.8 7.7 20.9 16.4 8.0 21.2 6.3 9.1 12.3 6.0 5.0 10.2 13.4 5.3 9.8 9.1 10.3 13.4 10.5 9.5 7.5 12.6 17.7 13.0 9.1 6.8 10.2 10.4 5.1 2.4 2.8 1.5 1.6 5.0 1.2 0.8 1.0 2.8 1.6 3.3 2.0 1.5 1.0 0.9 1.3 1.1 1.2 2.2 4.4 1.5 1.3 1.5 3.7 1.7 2.0 1.7 0.7 3.5 1.8 1.6 1.2 6.2 1.5 2.5 0.6 1.0 2.2 0.7 4.9 3.0 1.9 1.5 8.4 5.7 3.0 0.6 4.1 6.9 1.5 1.7 1.5 4.7 2.3 2.1 4.2 1.2 1.3 2.3 1.0 1.8 1.2 1.3 0.9 2.3 1.0 4.7 2.0 3.6 1.1 2.7 1.3 2.8 3.2 1.5 1.9 3.3 3.6 3.4 1.1 5.1 5.0 3.7 1.0 1.6 1.1 2.4 2.0 1.2 9.3 14.6 26.9 12.2 8.0 5.8 11.8 7.7 9.1 12.6 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.6 5.9 21.6 10.4 1.5 3.3 4.2 18.8 9.4 14.0 9.4 9.3 11.2 14.0 4.8 6.9 9.2 15.4 7.6 22.2 17.5 5.7 16.5 12.4 6.7 0.2 19.5 9.6 1.0 0.5 11.3 9.5 11.8 17.0 16.8 18.1 7.5 15.3 8.8 6.9 9.3 10.3 20.2 4.6 3.9 4.1 10.0 5.9 16.7 11.6 4.5 6.6 6.9 12.8 13.6 14.3 14.1 19.2 8.2 14.0 14.5 7.5 10.9 14.4 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189548-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.8;testis: 37.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA036494 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favourable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favourable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavourable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 4.0 1.9 2.9 15.2 3.1 19.1 5.5 2.1 3.0 3.9 4.7 1.2 0.7 4.2 2.9 3.1 7.7 2.5 2.8 4.4 2.7 2.1 1.9 2.2 3.6 11.1 2.6 3.7 3.6 1.6 1.6 2.7 6.8 1.8 2.4 5.5 1.6 3.0 1.5 3.6 6.0 4.0 2.4 2.6 6.2 2.5 37.3 1.8 31.8 1.8 10.2 12.2 3.1 4.3 12.1 6.1 2.5 3.6 7.5 9.8 4.2 18.1 5.6 26.4 20.6 1.7 5.5 14.0 8.9 9.6 20.0 21.7 7.7 23.2 39.1 10.8 5.3 13.6 17.2 20.7 25.7 11.8 11.9 9.1 9.6 7.6 0.6 13.1 9.4 2.1 4.3 13.0 14.4 6.7 16.1 15.6 15.4 10.1 42.2 18.8 22.9 4.9 26.3 34.8 30.1 6.3 6.7 18.2 24.3 9.8 6.7 7.9 9.3 8.9 3.2 10.0 16.8 13.2 22.2 19.3 29.1 31.3 15.3 26.6 18.8 0.6 1.8 2.5 4.5 3.0 7.3 11.8 7.6 5.7 2.8 12.1 9.8 8.3 0.4 7.5 3.6 6.1 8.7 4.2 2.9 3.1 2.1 3.0 2.7 2.1 2.6 3.7 1.8 1.8 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA061297: " "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 2.6 1.8 1.5 10.8 4.7 9.1 4.0 1.7 2.9 3.7 3.9 3.6 0.0 4.0 4.1 2.2 7.1 2.7 2.8 1.7 1.8 1.4 1.5 1.6 2.9 7.7 3.3 1.8 4.5 1.2 0.3 1.3 3.6 2.6 1.8 5.3 1.2 2.0 0.8 1.5 4.5 3.8 4.3 4.3 4.0 3.3 4.6 2.7 18.3 1.3 4.1 11.0 3.1 3.7 2.6 2.9 4.8 2.8 3.2 3.3 1.2 16.9 11.7 14.5 11.1 1.8 3.3 6.4 18.3 9.8 18.6 37.8 15.6 10.8 12.4 6.6 7.2 9.9 21.1 9.7 26.1 7.7 5.4 7.6 16.7 5.9 0.2 10.0 8.4 1.3 0.8 24.7 3.1 15.8 5.4 22.9 18.0 11.9 9.9 3.6 11.1 14.4 9.3 20.9 8.0 4.6 10.1 9.2 4.9 22.5 6.4 3.8 6.3 3.3 6.4 17.5 14.7 16.3 14.6 3.7 8.5 14.0 6.9 13.4 13.5 2.2 2.1 2.3 2.0 2.8 1.3 2.6 2.0 2.6 1.0 2.1 1.6 1.7 4.8 3.2 2.6 2.9 3.3 1.2 1.5 4.7 1.7 2.9 1.8 1.4 3.3 1.8 2.6 2.7 CENPJ "BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4" ENSG00000151849 "Centromere protein J" Q9HC77 13 24882284-24922889 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060426 Approved "Nucleoplasm,Plasma membrane,Centrosome" "Nucleoplasm, Plasma membrane, Centrosome" "HPA060426: " "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (2.68e-1)" "unprognostic (1.01e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-2)" "unprognostic (2.15e-5)" "unprognostic (7.41e-2)" "unprognostic (1.50e-2)" "unprognostic (9.83e-2)" "unprognostic (2.44e-1)" "unprognostic (3.48e-2)" "prognostic unfavourable (1.75e-5)" "unprognostic (7.36e-2)" "unprognostic (5.51e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" 5.0 3.5 6.6 6.7 11.9 10.2 6.2 18.4 6.4 10.3 7.6 5.0 7.2 7.5 8.8 4.8 6.6 6.0 3.3 4.2 5.4 4.4 3.9 2.9 4.9 8.5 9.7 3.8 8.1 3.2 2.1 4.6 7.6 7.2 6.3 8.8 2.4 4.6 12.0 3.6 7.6 9.0 9.1 11.6 7.4 4.6 24.3 10.1 14.6 20.8 5.7 7.8 7.9 7.8 4.3 2.4 3.8 1.3 2.2 2.1 0.7 5.2 5.1 17.6 16.3 2.5 3.6 9.9 12.4 5.6 7.7 7.2 6.7 9.4 9.7 3.7 4.5 12.9 13.2 7.0 11.9 8.8 6.6 34.9 12.2 5.6 1.2 16.0 11.5 2.1 2.0 6.8 3.8 5.8 9.8 18.0 8.0 5.1 10.9 21.8 9.9 3.9 12.2 12.2 4.9 3.0 6.0 8.9 8.3 6.3 6.8 5.0 3.4 10.9 5.5 9.1 6.2 12.6 8.1 5.0 9.1 10.4 4.2 11.7 14.1 1.9 0.8 3.8 2.1 1.3 0.9 4.3 1.4 1.6 0.9 4.1 1.8 0.9 0.4 2.2 0.9 2.4 1.5 0.7 6.6 11.9 18.4 6.4 5.4 4.4 9.7 3.8 7.2 10.1 CENPO "CENP-O, MGC11266" ENSG00000138092 "Centromere protein O" Q9BU64 2 24793136-24822376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.7;testis: 28.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046189 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA046189: " "unprognostic (1.67e-2)" "unprognostic (2.42e-1)" "unprognostic (1.98e-2)" "prognostic unfavourable (3.54e-4)" "unprognostic (1.79e-1)" "unprognostic (7.48e-3)" "prognostic unfavourable (1.73e-6)" "unprognostic (5.56e-2)" "unprognostic (4.02e-1)" "unprognostic (4.81e-2)" "unprognostic (5.93e-2)" "unprognostic (1.63e-2)" "prognostic unfavourable (5.71e-13)" "unprognostic (4.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" 6.9 6.0 6.6 7.6 7.8 15.4 6.3 6.2 11.9 4.4 6.6 8.3 2.6 6.5 4.6 3.9 6.3 3.6 3.4 3.3 8.4 6.4 5.3 3.5 4.9 9.2 6.2 6.5 6.6 4.9 4.2 5.2 6.7 7.9 4.4 7.9 3.6 4.1 2.8 5.6 7.9 6.0 4.6 6.3 6.6 4.8 28.9 5.7 28.7 5.0 6.5 11.4 4.7 4.9 1.6 4.1 0.3 1.2 2.1 3.5 1.3 13.7 16.3 19.0 10.0 2.3 3.5 10.6 16.7 10.0 23.7 18.2 20.7 7.0 9.6 1.9 10.3 7.4 18.6 6.3 15.9 12.4 9.7 15.0 10.3 13.8 1.1 12.5 11.4 1.7 1.1 23.6 5.2 10.9 17.5 10.9 14.6 9.6 17.1 9.2 13.6 10.4 13.9 24.6 5.1 6.0 8.4 12.5 13.6 9.9 7.8 3.6 7.5 5.3 7.0 21.9 20.0 7.2 18.5 6.7 8.8 19.4 6.8 12.2 16.7 0.0 1.2 0.0 3.5 0.9 1.5 1.6 1.6 2.0 1.9 1.3 1.2 2.7 0.3 2.1 1.1 4.1 2.7 1.3 6.6 7.8 6.2 11.9 8.4 6.4 6.2 6.5 7.9 5.7 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325484-92620533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: " "unprognostic (5.48e-2)" "prognostic favourable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favourable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 5.0 5.1 6.8 8.9 8.8 15.5 4.9 14.9 7.4 6.0 3.8 3.5 1.4 4.5 6.4 4.1 8.4 3.6 4.6 4.3 5.4 4.6 3.5 3.2 3.5 7.8 6.1 4.5 4.6 7.5 7.8 9.4 5.3 6.8 4.8 4.5 5.5 5.0 2.8 11.8 30.0 3.2 4.8 4.4 5.4 3.0 8.7 6.5 14.8 3.0 7.4 9.1 4.4 8.0 6.7 4.8 4.1 10.3 5.1 8.2 4.0 7.9 5.0 7.0 5.1 2.9 3.2 6.7 8.4 4.7 10.4 8.4 2.3 4.5 10.0 3.9 2.6 9.5 6.8 4.6 9.8 14.3 8.0 10.3 4.5 3.2 1.5 20.9 9.9 3.4 2.6 10.1 6.5 5.2 11.0 14.6 7.9 5.0 29.4 6.3 5.7 9.4 10.0 11.5 11.2 1.6 8.0 15.7 5.5 9.5 6.1 3.0 3.2 6.5 2.5 10.2 5.0 15.4 11.9 9.7 11.4 13.2 11.4 10.5 9.2 3.0 3.2 4.1 4.9 10.3 8.2 6.7 5.3 4.1 3.6 5.7 5.0 4.8 0.8 5.1 5.1 4.8 5.7 4.0 6.8 8.8 14.9 7.4 5.4 4.6 6.1 4.5 6.8 6.5 CENPU "CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1" ENSG00000151725 "Centromere protein U" Q71F23 4 184694618-184734133 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2" "Cell line enhanced" "Detected in many" "Karpas-707: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 14.1;eosinophil: 14.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022048 Supported "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA022048: AB_1853985" "unprognostic (1.47e-1)" "unprognostic (9.88e-2)" "unprognostic (5.02e-2)" "unprognostic (2.37e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (4.39e-3)" "prognostic unfavourable (7.51e-4)" "unprognostic (1.67e-3)" "unprognostic (3.34e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.11e-9)" "unprognostic (2.19e-2)" "unprognostic (7.40e-3)" "unprognostic (4.46e-2)" "unprognostic (2.74e-1)" 2.7 1.7 1.4 7.8 1.0 30.7 3.1 1.2 1.3 2.8 4.4 1.2 2.9 2.8 1.4 3.2 11.2 0.9 1.7 1.0 1.2 0.6 1.4 2.3 2.0 9.5 1.3 0.2 1.1 1.3 0.7 0.6 7.0 1.0 2.0 5.1 0.9 3.5 0.5 1.2 7.1 5.2 1.5 1.0 5.8 2.3 50.2 0.6 30.0 0.9 7.3 9.1 1.6 4.5 0.8 1.7 14.3 2.8 3.0 2.5 0.7 23.0 6.5 28.0 14.1 1.5 2.4 14.8 13.9 6.2 11.4 7.9 7.7 13.3 19.2 1.3 6.5 9.2 23.0 14.2 11.7 9.3 9.2 16.5 5.9 3.9 0.2 29.1 11.5 1.2 0.7 14.0 2.6 11.9 18.1 57.7 21.3 15.3 37.4 18.6 14.8 8.7 29.7 9.1 5.6 6.3 8.9 19.8 21.1 10.1 12.9 10.5 17.7 16.0 7.1 10.2 13.3 10.5 16.0 8.5 8.6 15.7 14.3 22.6 33.4 14.1 0.7 14.3 0.6 1.9 0.4 0.8 1.0 1.0 0.5 0.8 0.6 0.8 0.1 3.0 2.8 1.7 2.5 0.7 1.4 1.0 1.2 1.3 1.2 0.6 1.3 0.2 1.0 0.6 CENPV "CENP-V, p30, PRR6" ENSG00000166582 "Centromere protein V" Q7Z7K6 17 16342534-16353656 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 34.1;HEK 293: 28.0;NTERA-2: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6;memory B-cell: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042529, HPA042616" Enhanced Approved Nucleoplasm,Midbody,Cytosol Nucleoplasm "Midbody, Cytosol" "HPA042529: AB_10793882, HPA042616: AB_10794050" "unprognostic (7.64e-2)" "unprognostic (4.41e-2)" "unprognostic (5.92e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (6.47e-2)" "unprognostic (1.21e-1)" "unprognostic (4.00e-2)" "unprognostic (7.73e-3)" "unprognostic (7.93e-2)" "unprognostic (4.09e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-2)" "unprognostic (2.54e-2)" "unprognostic (3.60e-3)" 4.6 5.6 13.7 4.0 14.7 6.2 6.6 12.0 17.3 4.2 19.5 6.7 2.8 13.6 8.0 5.5 1.3 9.1 3.5 5.7 10.2 10.1 5.2 14.6 2.5 2.3 7.8 11.8 9.1 5.9 3.7 7.3 2.2 5.8 4.6 11.5 2.4 1.6 6.4 25.4 0.9 29.1 6.1 7.3 1.5 18.0 10.6 6.1 22.5 4.0 2.9 2.1 3.2 2.3 3.3 1.0 3.6 0.0 0.0 1.0 0.3 3.2 6.4 34.1 17.2 0.9 0.9 5.9 2.7 2.7 8.6 6.6 6.4 1.4 13.1 5.5 2.0 0.9 22.0 0.2 5.4 0.0 28.0 3.0 1.7 12.6 9.6 3.1 0.0 2.4 0.9 10.3 6.1 4.8 5.3 0.0 2.5 0.5 24.4 10.4 33.5 0.0 17.6 1.3 1.5 1.9 4.8 18.3 13.9 6.9 0.1 1.5 0.1 7.7 0.3 0.0 2.7 0.3 0.0 0.0 0.0 7.6 0.0 4.3 0.2 0.0 0.0 3.6 0.3 0.0 0.1 3.3 0.1 0.1 0.7 0.3 1.0 0.9 0.0 0.0 0.0 1.0 0.2 0.3 13.7 14.7 12.0 17.3 10.2 10.1 7.8 11.8 5.8 6.1 CEP112 "CCDC46, MGC33887" ENSG00000154240 "Centrosomal protein 112" Q8N8E3 17 65635538-66192084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell line enhanced" "Detected in many" "LHCN-M2: 16.7;RH-30: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024481 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA024481: AB_1846153" "unprognostic (9.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.11e-3)" "unprognostic (1.43e-2)" "unprognostic (7.99e-2)" "unprognostic (4.48e-3)" "unprognostic (3.37e-2)" "unprognostic (1.39e-3)" "unprognostic (3.50e-2)" "unprognostic (4.46e-3)" "unprognostic (1.02e-2)" "unprognostic (1.26e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" 10.0 3.8 6.0 9.0 8.3 1.7 9.6 2.9 6.5 11.5 6.7 1.9 14.9 1.9 8.8 10.2 4.3 6.9 6.6 7.4 5.9 4.3 5.2 2.9 6.9 2.2 4.3 3.4 7.7 4.3 8.4 28.3 6.6 6.8 8.6 3.2 7.2 2.9 13.9 9.5 3.1 2.9 9.8 7.4 7.9 4.5 39.5 4.3 4.2 6.8 6.9 1.8 6.6 13.6 3.0 4.1 4.3 1.3 2.9 2.7 0.5 2.5 5.2 6.9 2.0 3.7 7.7 0.2 2.3 4.0 2.9 2.6 0.7 1.1 0.9 2.2 5.0 0.3 1.5 1.5 4.2 1.3 2.4 0.1 2.3 0.9 1.7 0.3 0.1 4.5 2.5 2.7 0.8 8.8 0.1 2.6 16.7 0.3 2.6 0.2 0.7 2.2 0.7 39.5 0.2 3.1 0.1 1.9 3.9 2.4 0.2 1.8 1.9 0.2 3.9 7.7 4.3 2.0 3.4 1.2 1.0 0.1 2.3 0.1 2.8 2.9 1.3 1.1 1.1 0.6 1.9 1.0 2.7 1.2 0.7 3.0 1.7 1.4 4.3 2.9 0.8 4.1 1.7 0.5 6.0 8.3 2.9 6.5 5.9 4.3 4.3 3.4 6.8 4.3 CEP120 "CCDC100, FLJ36090" ENSG00000168944 "Centrosomal protein 120" Q8N960 5 123344885-123423592 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028823, HPA051556" Uncertain Approved Microtubules,Cytosol Microtubules Cytosol "HPA028823: AB_10601355, HPA051556: " "unprognostic (3.65e-1)" "unprognostic (9.94e-2)" "unprognostic (3.69e-2)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (2.97e-2)" "unprognostic (4.41e-1)" "unprognostic (1.15e-1)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (1.82e-2)" "unprognostic (1.51e-1)" "unprognostic (4.94e-3)" "unprognostic (1.05e-1)" "unprognostic (1.69e-1)" "unprognostic (9.44e-3)" "unprognostic (1.58e-1)" 13.3 12.9 8.6 15.2 12.8 9.2 12.1 22.9 10.8 13.1 11.1 12.5 14.4 7.9 15.7 11.3 9.3 13.5 11.6 9.5 10.0 11.6 10.7 12.7 11.4 16.1 11.2 9.8 24.3 11.0 9.8 18.1 8.9 11.4 11.7 9.6 13.9 9.8 12.0 7.3 6.9 11.8 12.0 12.0 13.9 8.6 19.4 10.9 28.4 11.7 6.0 15.6 13.0 14.2 3.6 1.6 5.5 2.4 1.6 5.4 1.7 7.7 8.7 9.6 14.3 9.7 12.3 9.8 9.2 12.0 10.3 17.2 7.3 7.0 10.9 8.5 7.1 6.2 9.4 9.9 16.6 21.8 6.0 5.4 7.2 6.3 10.1 6.9 9.4 9.3 10.5 13.8 16.5 8.7 5.5 19.5 9.9 3.6 12.1 11.6 4.6 6.5 7.1 13.3 6.8 5.7 4.5 10.5 8.7 8.1 4.3 13.4 6.3 15.3 6.4 10.8 8.8 6.0 11.6 13.0 9.9 10.7 9.3 12.6 10.5 5.5 1.2 2.6 2.0 2.4 2.7 3.6 3.4 2.7 1.5 3.1 2.9 4.9 0.8 1.6 0.8 1.6 5.4 1.7 8.6 12.8 22.9 10.8 10.0 11.6 11.2 9.8 11.4 10.9 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915015-102001058 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 47.3" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;EFO-21: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavourable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 7.6 11.1 9.0 2.4 20.2 2.4 8.3 16.8 14.8 7.9 4.2 5.0 4.2 2.0 9.1 6.7 5.3 17.5 4.9 4.5 9.6 8.3 3.8 1.4 6.1 3.3 7.5 10.2 11.4 5.0 6.4 47.3 2.6 12.4 6.6 4.8 3.2 3.2 7.6 2.3 8.5 2.7 7.3 9.2 3.1 4.0 19.2 8.9 0.5 7.4 1.5 2.5 3.9 9.7 2.5 4.8 1.4 0.5 3.3 2.0 0.5 0.9 2.2 1.0 1.3 10.0 5.5 0.4 2.1 1.8 1.0 0.9 0.6 3.0 1.3 9.5 1.9 0.9 1.2 2.3 0.9 3.0 1.4 0.3 3.7 1.1 1.1 0.2 0.3 1.9 4.7 1.3 2.8 2.9 0.3 0.4 2.5 1.1 1.0 0.3 0.8 1.6 0.2 1.1 0.2 1.9 1.2 2.7 4.2 1.3 1.9 0.3 3.7 0.4 1.7 3.3 1.9 1.0 2.2 2.2 1.2 0.2 3.2 0.3 1.3 0.7 0.5 1.0 2.0 0.1 0.9 1.8 1.2 1.6 0.4 2.5 1.7 1.7 1.4 3.3 0.2 4.8 0.3 0.5 9.0 20.2 16.8 14.8 9.6 8.3 7.5 10.2 12.4 8.9 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 61.2" "Cell line enhanced" "Detected in many" "Karpas-707: 25.2;MOLT-4: 21.6;U-266/70: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.6;T-cells: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000602, HPA001116, HPA018498" Uncertain Supported "Centriolar satellite,Cytosol" "Centriolar satellite" Cytosol "HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560" "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 3.8 2.0 5.2 6.5 7.6 10.5 7.5 13.6 5.4 3.4 3.6 4.2 2.7 3.2 4.0 2.2 4.4 4.8 2.0 3.1 3.8 2.5 2.4 2.0 3.8 8.1 6.9 3.1 4.4 2.1 4.2 8.6 2.3 4.5 2.9 3.3 2.3 4.5 3.2 3.1 5.1 3.0 4.0 5.5 6.3 3.1 9.0 6.8 61.2 5.7 3.1 9.1 6.0 4.4 2.2 8.6 1.7 0.8 1.1 9.6 0.8 5.9 3.1 2.8 2.3 0.6 1.1 1.5 6.7 2.0 3.9 3.9 2.1 3.4 13.7 1.2 1.9 3.2 3.0 1.9 7.5 7.7 1.9 2.6 3.9 1.1 0.3 2.7 3.5 0.2 0.5 5.6 3.0 2.9 3.3 25.2 3.7 3.7 21.6 1.4 2.1 3.9 3.9 6.9 10.7 0.8 3.1 3.6 1.7 5.4 2.2 1.1 2.5 2.0 2.7 8.6 4.7 2.3 6.5 45.6 1.8 6.1 2.4 3.6 2.9 0.0 0.8 1.7 2.9 0.3 2.3 2.2 3.2 2.2 2.5 0.9 2.8 1.3 0.1 1.1 0.5 8.6 9.6 0.8 5.2 7.6 13.6 5.4 3.8 2.5 6.9 3.1 4.5 6.8 CEP131 "AZ1, AZI1, KIAA1118" ENSG00000141577 "Centrosomal protein 131" Q9UPN4 17 81189593-81222999 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024019 Approved Supported "Microtubules,Cytokinetic bridge,Centriolar satellite" "Microtubules, Cytokinetic bridge, Centriolar satellite" "HPA024019: AB_1845227" "unprognostic (1.56e-2)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (2.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.26e-2)" "prognostic unfavourable (9.68e-5)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.33e-3)" "unprognostic (7.04e-2)" "unprognostic (8.82e-3)" "unprognostic (1.36e-2)" "unprognostic (8.48e-2)" "unprognostic (2.66e-1)" "unprognostic (7.32e-3)" 8.4 8.3 8.9 15.7 9.2 18.8 7.7 23.5 11.7 7.0 6.1 10.7 5.6 10.4 10.6 9.0 7.2 7.9 11.1 8.5 9.0 7.8 8.0 4.4 8.9 15.2 6.9 8.4 10.0 9.1 4.6 11.6 9.4 8.3 8.1 2.7 9.7 12.5 5.7 18.0 15.4 9.1 9.5 7.8 18.2 10.7 23.7 9.3 15.6 9.0 4.5 10.4 7.0 7.8 5.1 3.8 4.0 7.4 1.9 2.6 1.3 11.0 10.8 5.8 10.5 1.0 1.5 18.4 7.7 1.3 5.7 4.4 12.7 5.6 7.9 4.4 1.9 8.0 1.7 3.8 1.3 3.2 14.8 7.6 16.6 21.6 1.6 6.5 16.9 1.3 2.6 4.1 1.1 4.0 5.4 4.7 1.4 12.5 15.0 12.7 5.1 9.6 15.3 6.7 3.3 2.1 9.8 13.3 15.0 9.9 6.2 9.4 9.4 6.5 5.3 10.3 17.9 9.1 10.1 12.1 2.0 5.9 5.3 5.7 7.3 4.0 1.6 1.0 2.6 4.3 0.8 5.1 1.5 2.1 3.5 3.7 2.2 1.6 2.5 1.9 7.4 3.8 0.2 1.3 8.9 9.2 23.5 11.7 9.0 7.8 6.9 8.4 8.3 9.3 CEP162 "C6orf84, KIAA1009, QN1" ENSG00000135315 "Centrosomal protein 162" Q5TB80 6 84124241-84227635 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030170, HPA030171, HPA030172, HPA030173" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206" "unprognostic (1.75e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.95e-4)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.21e-3)" "unprognostic (1.57e-3)" "unprognostic (3.98e-2)" "unprognostic (2.87e-3)" "unprognostic (3.27e-2)" "unprognostic (6.32e-2)" "unprognostic (3.58e-1)" "unprognostic (1.44e-3)" 5.9 4.3 4.2 5.3 6.0 3.8 5.4 9.4 7.8 6.4 6.3 4.8 6.6 2.1 9.1 4.4 4.1 7.2 5.2 4.0 4.5 2.6 7.7 2.6 5.3 4.6 4.8 3.2 7.9 4.1 9.6 19.1 4.5 5.8 4.7 4.9 2.7 5.5 4.6 4.1 4.1 4.2 6.4 7.6 5.8 4.9 14.4 6.4 11.6 7.7 2.1 4.2 7.3 5.4 2.5 1.8 2.2 1.3 0.1 2.6 0.8 2.9 1.3 8.7 9.5 5.2 7.8 5.5 3.3 3.2 4.7 5.8 3.8 4.0 3.2 3.2 2.6 4.6 5.1 3.1 7.5 8.0 3.5 5.8 5.9 2.8 2.9 6.2 5.6 3.6 2.3 4.8 1.8 5.2 11.7 3.7 3.4 1.5 1.6 4.0 5.7 2.0 8.9 11.2 1.7 3.5 2.7 6.0 7.5 2.3 1.4 2.5 3.1 4.6 4.2 4.7 4.2 4.1 3.7 2.9 3.9 1.9 2.9 3.4 5.8 0.0 1.3 1.5 1.9 1.2 2.6 2.5 1.5 1.7 0.7 1.6 1.2 2.0 2.2 0.1 1.0 1.8 0.3 0.8 4.2 6.0 9.4 7.8 4.5 2.6 4.8 3.2 5.8 6.4 CEP164 "KIAA1052, NPHP15" ENSG00000110274 "Centrosomal protein 164" Q9UPV0 11 117314557-117413268 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, DNA damage, DNA repair, Mitosis" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037605, HPA037606, HPA061504" Uncertain Enhanced Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA037605: AB_10672908, HPA037606: AB_10672498, HPA061504: " "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (7.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.47e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (2.40e-5)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (1.90e-1)" "prognostic favourable (5.93e-4)" "unprognostic (6.54e-2)" "prognostic unfavourable (2.89e-5)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (7.93e-2)" 7.1 6.8 7.8 11.2 10.4 7.0 7.2 17.4 7.8 10.5 6.8 9.1 11.2 4.7 17.4 9.4 9.7 12.9 12.1 4.6 6.9 6.8 7.1 7.2 7.3 7.7 7.4 8.3 13.9 28.1 10.8 19.1 5.1 8.2 7.4 5.8 16.4 6.9 7.6 3.1 8.3 6.2 11.5 10.4 9.7 6.3 29.7 8.3 10.8 9.6 5.0 14.4 8.0 8.0 18.0 21.1 36.5 16.6 11.8 21.4 4.3 8.8 12.4 9.1 18.2 9.2 15.8 2.9 17.7 9.9 12.7 12.5 15.3 14.5 17.6 12.8 10.9 11.8 10.1 10.4 10.9 17.4 8.4 5.3 12.2 4.8 13.6 7.6 11.9 10.9 8.9 19.3 18.8 16.4 14.4 11.6 9.9 7.7 7.0 6.9 6.5 13.5 9.4 10.9 6.9 5.6 7.7 10.7 15.5 14.0 8.6 10.1 11.8 8.9 17.7 15.2 9.5 14.6 16.1 4.1 5.0 10.5 7.4 8.7 10.0 30.7 15.7 9.4 15.9 12.9 10.1 15.2 20.0 17.9 5.8 18.0 18.9 15.1 36.5 11.8 16.6 21.1 21.4 4.3 7.8 10.4 17.4 7.8 6.9 6.8 7.4 8.3 8.2 8.3 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Cell line enhanced" "Detected in many" "WM-115: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Centrosome "Mitotic spindle, Cytosol" "HPA042151: , HPA045597: , HPA045787: " "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavourable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.1 11.1 8.2 15.9 2.8 16.1 9.5 12.1 11.4 3.1 5.9 4.5 9.8 13.6 3.0 11.3 6.9 17.2 10.0 6.5 4.6 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.5 16.9 28.1 11.3 4.7 15.3 1.3 5.0 4.3 16.5 14.5 9.0 9.4 1.5 2.5 1.0 19.0 25.7 8.2 0.7 7.7 2.8 11.1 31.1 22.6 6.7 12.1 18.4 4.6 5.9 9.0 12.0 7.5 51.8 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 CEP170B "Cep170R, FAM68C, KIAA0284" ENSG00000099814 "Centrosomal protein 170B" Q9Y4F5 14 104865280-104896770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000871, HPA059017" Enhanced Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA000871: , HPA059017: " "unprognostic (1.09e-1)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.38e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.12e-4)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (4.96e-2)" "unprognostic (2.68e-1)" "prognostic unfavourable (4.41e-4)" "prognostic favourable (3.26e-4)" "unprognostic (1.62e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (1.17e-2)" 10.3 8.8 19.9 7.3 26.3 1.3 10.9 25.9 39.7 6.6 18.0 5.3 9.1 24.7 7.4 5.0 14.7 8.5 15.1 4.9 18.5 12.4 9.9 9.4 8.0 2.1 8.9 19.7 4.6 25.4 9.0 10.5 4.8 13.5 10.3 8.9 5.3 17.5 12.5 4.6 35.0 24.6 6.7 6.5 3.8 23.2 10.9 6.0 0.2 10.1 6.2 5.6 8.8 11.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 10.8 9.0 0.7 8.6 3.6 2.7 20.1 8.6 3.4 4.3 2.9 9.5 6.7 0.0 10.5 6.5 24.1 2.0 10.0 1.1 4.0 4.2 0.0 9.6 6.2 7.4 0.0 8.9 2.6 12.8 4.5 6.6 4.3 2.7 0.1 3.6 22.9 0.0 0.1 2.8 7.8 3.6 0.0 2.6 4.3 18.5 2.3 2.4 12.7 7.5 11.4 13.1 1.6 9.5 6.9 7.6 18.9 5.7 0.4 0.0 0.0 5.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 19.9 26.3 25.9 39.7 18.5 12.4 8.9 19.7 13.5 6.0 CEP192 "FLJ10352, KIAA1569, PPP1R62" ENSG00000101639 "Centrosomal protein 192" Q8TEP8 18 12991362-13125052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039392, HPA040503" Uncertain Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA039392: AB_10697549, HPA040503: AB_10670919" "unprognostic (6.94e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-3)" "unprognostic (6.87e-3)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (9.00e-2)" "unprognostic (6.61e-2)" "unprognostic (1.28e-1)" "unprognostic (7.89e-2)" "unprognostic (2.39e-1)" "unprognostic (4.54e-2)" "unprognostic (1.66e-3)" 7.6 6.5 7.9 14.9 11.8 16.3 8.3 14.5 11.8 8.8 7.7 11.1 7.1 6.7 13.6 9.3 7.6 8.8 9.9 7.1 8.1 4.7 6.9 6.1 8.7 11.0 8.7 11.8 17.4 9.5 10.4 11.1 7.8 11.8 8.0 9.4 7.9 10.4 6.6 6.2 8.2 9.6 9.5 7.6 8.4 8.2 16.4 9.8 18.3 11.1 6.0 12.2 12.1 8.6 3.9 1.8 2.1 4.9 0.9 3.5 1.0 9.9 5.4 14.8 7.7 6.5 10.1 4.8 7.0 9.3 11.1 11.8 7.4 4.4 11.3 4.7 7.1 4.9 12.8 6.6 13.2 4.4 4.6 10.3 8.3 3.9 3.4 16.3 7.9 6.9 2.5 9.3 8.5 9.1 14.1 7.6 8.6 5.0 14.0 7.1 4.7 3.4 12.1 11.6 5.8 3.8 10.2 10.8 6.1 11.2 5.6 3.5 4.4 8.4 9.1 8.8 20.8 10.0 9.6 5.1 7.3 12.9 5.6 7.4 8.4 1.5 2.1 1.5 3.2 1.5 2.4 1.8 2.1 2.0 0.9 3.9 2.3 3.5 2.1 0.9 4.9 1.8 1.8 1.0 7.9 11.8 14.5 11.8 8.1 4.7 8.7 11.8 11.8 9.8 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661639-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038595: , HPA038596: AB_10672720, HPA038597: " "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 8.4 7.4 15.8 12.1 15.4 19.6 11.7 30.6 20.5 10.0 10.0 6.1 9.4 8.6 10.5 11.2 8.4 7.7 7.6 6.5 12.1 8.1 7.6 6.3 8.6 14.1 10.7 14.7 12.2 8.1 8.5 24.5 8.5 12.1 10.6 9.8 5.1 7.9 9.4 13.4 12.5 9.2 7.8 13.8 11.7 8.0 15.5 15.0 11.6 12.3 5.2 9.9 10.7 8.9 6.3 3.0 9.1 3.1 2.7 3.0 0.6 7.1 6.6 17.0 14.6 7.9 7.8 8.3 9.2 6.8 8.8 10.3 12.1 13.8 2.2 13.8 5.8 13.4 8.5 6.8 9.0 10.2 6.6 13.0 19.0 6.0 4.8 11.7 12.8 5.6 4.0 8.3 7.4 7.3 14.7 13.8 11.1 6.1 6.0 19.3 5.7 6.8 12.1 16.1 8.7 7.2 12.6 10.2 9.6 14.6 9.8 2.6 16.1 6.4 7.4 8.3 10.8 14.8 7.1 5.1 11.1 14.4 4.9 13.8 11.3 4.1 3.1 5.7 2.8 1.5 2.2 5.0 2.5 1.9 1.3 6.3 3.0 2.5 9.1 2.7 2.0 3.0 1.7 0.6 15.8 15.4 30.6 20.5 12.1 8.1 10.7 14.7 12.1 15.0 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavourable (3.20e-9)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavourable (0.00e+0)" "prognostic favourable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.0 20.4 13.6 17.2 1.5 3.1 7.6 28.1 19.9 26.7 27.7 21.6 27.5 13.6 12.4 18.2 29.2 16.4 13.8 32.1 41.0 8.5 5.1 12.6 7.3 0.1 8.8 11.9 0.7 1.0 28.4 34.7 24.6 4.6 25.9 30.1 11.8 23.2 13.4 5.3 14.9 10.1 22.2 7.5 12.0 6.3 5.6 7.9 21.6 6.7 17.0 17.5 9.0 15.3 16.9 23.7 23.2 46.1 11.6 15.7 16.7 13.2 33.4 15.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 CEP57 "KIAA0092, Translokin, TSP57" ENSG00000166037 "Centrosomal protein 57" Q86XR8 11 95789965-95832693 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018315 Approved Supported Microtubules,Cytosol "Intracellular and membrane" Microtubules Cytosol "HPA018315: AB_1846537" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (1.45e-2)" "unprognostic (2.66e-1)" "prognostic favourable (7.24e-4)" "unprognostic (1.69e-1)" "unprognostic (2.25e-2)" "unprognostic (8.10e-2)" "unprognostic (9.04e-3)" "unprognostic (7.93e-2)" "unprognostic (2.38e-3)" "unprognostic (7.81e-2)" "unprognostic (1.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.35e-1)" "unprognostic (6.69e-3)" "unprognostic (3.25e-1)" 16.8 13.7 12.9 25.9 20.6 21.6 17.4 27.9 16.2 25.6 33.8 6.9 19.2 27.0 18.5 18.8 18.2 16.5 22.9 14.0 13.3 14.1 14.9 34.4 19.0 28.9 12.6 15.2 27.2 24.5 13.6 26.1 13.3 15.0 21.5 15.6 10.5 14.1 22.3 12.6 15.8 28.8 22.2 14.6 19.8 15.3 24.3 12.7 46.5 23.4 15.7 23.9 27.5 18.3 17.2 15.5 17.6 11.0 18.6 25.3 13.0 11.2 5.6 19.4 14.4 8.3 17.1 15.4 12.8 20.6 17.7 20.1 20.1 24.2 20.3 17.9 9.5 19.0 14.6 12.7 18.8 15.9 9.7 27.9 16.3 16.7 15.3 28.3 16.9 11.5 18.1 18.1 34.9 14.7 18.0 11.2 14.1 5.5 30.6 37.4 9.9 12.8 19.1 23.2 17.0 14.9 12.5 9.3 13.5 15.2 15.1 16.1 15.4 18.4 8.2 15.5 12.5 22.7 12.2 8.2 16.0 22.7 6.4 31.6 13.4 11.3 9.1 17.6 16.5 11.0 21.2 17.2 21.0 18.8 11.9 16.2 20.2 19.2 8.5 18.6 9.1 15.5 25.3 13.0 12.9 20.6 27.9 16.2 13.3 14.1 12.6 15.2 15.0 12.7 CEP57L1 "bA487F23.2, C6orf182, MGC21731" ENSG00000183137 "Centrosomal protein 57 like 1" Q8IYX8 6 109095110-109163932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040378 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040378: AB_10794028" "unprognostic (5.93e-3)" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-2)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (4.69e-3)" "unprognostic (3.63e-2)" "unprognostic (7.25e-2)" "unprognostic (1.27e-1)" "unprognostic (2.33e-1)" "unprognostic (9.97e-2)" "unprognostic (2.42e-5)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (8.48e-2)" "unprognostic (1.72e-1)" 11.9 9.3 10.6 7.3 13.5 8.9 11.4 13.9 16.1 11.3 8.8 8.1 8.6 8.4 9.6 10.9 8.0 7.1 9.3 10.4 8.9 6.9 8.1 11.8 8.4 8.1 10.2 10.5 9.3 7.5 18.5 13.5 9.7 13.5 7.1 11.1 7.0 7.4 7.3 7.8 6.8 7.6 10.7 12.8 7.2 7.8 24.6 11.8 6.3 8.7 6.1 6.9 7.6 9.1 7.4 6.9 14.6 10.3 13.4 8.2 5.2 8.3 3.6 11.0 11.2 10.6 17.5 8.9 19.4 10.6 17.2 19.7 5.5 7.3 7.4 8.9 9.9 4.4 7.7 7.1 27.2 9.5 7.5 16.0 8.8 5.8 9.7 13.1 7.1 10.0 5.5 14.7 14.6 15.0 28.9 25.9 15.7 5.6 14.5 11.4 3.6 7.1 12.0 8.4 7.5 8.2 3.5 8.6 7.0 9.4 7.1 6.3 9.0 20.9 7.2 11.4 6.8 12.0 20.2 7.6 8.6 11.8 10.8 20.2 9.1 14.6 6.3 7.4 6.1 7.1 6.2 4.0 6.0 8.2 6.7 7.4 5.8 8.2 3.6 13.4 10.3 6.9 8.0 5.2 10.6 13.5 13.9 16.1 8.9 6.9 10.2 10.5 13.5 11.8 CEP68 KIAA0582 ENSG00000011523 "Centrosomal protein 68" Q76N32 2 65056366-65087004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040493, HPA040620" Enhanced Supported "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA040493: AB_10673411, HPA040620: AB_10794144" "unprognostic (7.99e-2)" "unprognostic (6.15e-2)" "unprognostic (5.09e-2)" "unprognostic (4.90e-3)" "unprognostic (1.31e-2)" "unprognostic (1.75e-2)" "unprognostic (4.84e-3)" "unprognostic (8.25e-3)" "unprognostic (9.94e-2)" "unprognostic (5.09e-2)" "unprognostic (9.22e-2)" "unprognostic (1.77e-1)" "prognostic favourable (3.93e-4)" "unprognostic (2.25e-1)" "unprognostic (2.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.71e-1)" 18.4 7.3 12.7 9.2 17.0 5.0 16.2 24.8 22.2 19.2 13.2 11.9 8.5 6.6 20.0 10.4 11.7 16.9 12.7 15.7 12.5 11.9 8.4 3.3 9.2 10.6 11.3 17.6 26.4 10.6 13.2 7.5 11.8 15.0 14.2 8.6 11.6 12.0 15.4 28.2 13.6 8.7 17.3 10.3 10.2 9.7 7.6 7.8 10.3 11.6 12.9 9.9 13.4 13.0 5.1 8.7 1.5 5.5 5.2 11.1 3.0 2.7 5.0 9.7 7.1 8.8 9.9 17.9 2.6 4.8 4.1 3.6 3.8 2.5 4.7 3.4 4.8 3.9 6.3 4.1 4.4 5.7 5.4 6.4 1.8 4.6 2.4 3.6 4.6 9.3 5.8 3.8 5.3 11.7 5.8 15.2 5.2 3.2 6.0 6.6 9.8 4.0 6.3 11.8 5.5 3.7 3.7 17.2 11.7 5.3 3.9 5.6 2.3 2.3 4.6 3.9 5.4 6.1 2.6 16.6 4.6 11.1 2.1 2.8 4.7 1.0 1.7 0.4 3.0 3.1 3.4 3.4 7.0 5.6 4.3 5.1 11.1 6.6 1.5 5.2 5.5 8.7 5.1 3.0 12.7 17.0 24.8 22.2 12.5 11.9 11.3 17.6 15.0 7.8 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favourable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavourable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.5 4.5 10.6 13.0 6.6 7.5 10.0 4.2 8.1 5.9 8.8 6.3 11.7 5.1 10.2 8.0 9.5 9.7 8.5 13.5 8.9 6.3 14.6 10.5 8.2 10.5 0.7 5.4 40.2 5.0 4.5 11.2 8.6 10.6 17.1 9.7 8.1 15.3 0.8 6.3 10.2 16.9 13.8 13.1 11.4 9.6 13.0 8.4 22.5 5.4 25.4 27.0 7.0 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.3 9.8 1.4 14.9 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" 12 94306449-94459988 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (4.98e-4)" "prognostic unfavourable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 6.8 9.8 10.1 11.3 10.5 8.4 9.7 11.8 10.1 8.7 7.4 7.6 7.0 5.5 12.3 12.7 6.7 16.2 6.1 19.0 9.0 6.6 8.2 6.3 7.1 7.7 6.2 7.7 11.0 12.2 9.3 12.1 6.3 8.9 6.8 10.3 7.8 10.0 8.5 7.3 6.3 5.4 11.0 6.3 6.9 6.3 22.3 7.3 10.6 9.7 9.4 8.0 6.7 9.2 7.6 8.5 1.9 3.5 5.7 6.6 2.0 5.6 6.3 10.8 10.2 4.8 6.4 9.3 10.0 3.2 7.2 7.5 7.8 4.7 14.8 2.2 3.0 8.0 12.9 7.6 11.3 8.5 9.4 8.7 6.7 7.9 4.8 14.2 6.0 4.1 6.4 6.0 18.6 6.8 11.2 6.1 7.5 5.7 9.7 23.7 12.3 11.7 13.3 10.2 14.8 6.6 7.1 11.2 4.7 8.4 10.0 6.8 6.7 9.0 4.0 8.6 5.3 4.2 7.8 8.0 8.9 13.5 3.6 15.1 8.1 0.6 3.5 1.9 5.8 3.5 5.2 6.6 5.8 4.4 7.7 7.6 6.1 5.4 1.4 5.7 1.5 8.5 6.6 2.0 10.1 10.5 11.8 10.1 9.0 6.6 6.2 7.7 8.9 7.3 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Supported "Nucleoli,Golgi apparatus,Centrosome,Cytosol" Nucleoli "Golgi apparatus, Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavourable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.4 6.7 10.8 11.4 3.0 2.8 21.1 6.8 3.2 9.5 10.1 8.6 12.6 12.8 9.3 2.8 11.9 12.0 5.7 9.5 9.4 10.4 18.1 13.1 9.0 3.1 16.5 20.0 1.4 5.6 7.9 5.8 4.2 24.3 17.9 6.9 4.8 15.8 20.0 10.4 11.1 16.1 12.5 11.9 4.7 2.0 18.3 8.4 9.6 8.0 8.0 7.3 11.8 4.9 7.7 12.9 9.0 10.5 14.1 20.6 16.0 4.8 29.1 14.6 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane" "HPA039382: , HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 10.1 9.5 8.5 8.3 12.1 6.8 11.6 16.4 14.4 12.9 10.5 12.5 9.7 6.4 17.0 11.3 10.1 14.8 8.3 8.8 8.1 6.4 9.8 5.6 9.4 8.9 7.9 8.4 17.1 9.0 11.3 20.2 8.8 9.1 15.0 7.4 10.2 10.3 10.2 10.5 10.7 7.4 11.4 6.6 7.7 8.1 8.4 8.4 10.1 11.8 5.0 7.6 10.2 11.4 7.7 5.1 12.7 6.1 2.8 6.9 2.1 13.1 18.1 12.6 10.8 6.8 8.0 7.3 10.7 7.1 18.9 14.5 6.5 8.2 5.4 5.8 10.8 7.6 12.3 8.6 13.1 14.2 7.5 4.2 12.6 6.2 5.4 5.8 4.2 9.6 12.0 17.8 11.7 14.1 6.4 8.1 8.7 10.0 6.6 4.5 5.4 5.8 7.3 6.8 4.7 8.6 7.4 17.8 13.1 10.9 7.6 6.1 5.7 4.8 9.0 13.7 12.2 11.7 10.8 4.0 6.2 4.9 11.8 5.5 10.2 12.7 4.4 2.1 4.0 6.1 6.9 4.7 4.2 3.4 2.4 7.7 4.1 4.7 5.3 2.8 3.0 5.1 4.4 2.1 8.5 12.1 16.4 14.4 8.1 6.4 7.9 8.4 9.1 8.4 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: " "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favourable (5.78e-4)" "prognostic unfavourable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavourable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 10.0 6.4 13.1 11.3 3.5 9.0 13.1 5.1 5.2 6.4 9.7 7.7 5.8 16.1 3.4 7.2 12.8 11.2 9.9 13.2 4.2 8.6 14.3 12.4 14.8 11.6 15.5 7.7 10.2 10.4 7.1 15.9 5.4 16.4 11.8 7.0 11.8 19.6 9.9 8.1 8.0 14.1 23.7 11.9 7.4 16.1 8.3 15.0 7.0 10.3 13.3 11.4 10.4 8.0 14.6 11.4 6.7 6.9 12.0 9.6 17.1 6.3 11.9 8.9 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 CEP97 "FLJ23047, LRRIQ2" ENSG00000182504 "Centrosomal protein 97" Q8IW35 3 101723925-101770562 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002980 Uncertain Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA002980: AB_1848820" "unprognostic (7.36e-2)" "unprognostic (4.70e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (2.01e-3)" "unprognostic (1.00e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.79e-1)" "unprognostic (1.05e-1)" 3.8 4.3 7.5 5.2 11.8 6.6 4.1 15.2 11.8 4.5 3.9 12.1 3.6 2.5 5.7 4.1 3.8 8.7 3.5 3.5 7.9 4.9 3.5 2.9 3.7 6.5 15.3 7.0 5.4 3.1 10.2 9.9 4.1 12.8 3.9 3.7 3.0 4.1 3.6 4.8 4.1 3.9 6.6 8.1 4.3 3.5 20.0 14.8 10.8 5.3 1.7 6.8 4.7 4.1 2.7 1.3 5.1 1.1 0.9 2.5 0.8 9.3 5.6 9.5 6.9 5.3 4.2 2.9 10.1 7.1 7.8 9.7 2.4 4.4 8.1 4.6 5.6 6.3 7.1 5.5 13.2 8.9 3.4 4.7 6.1 1.7 2.6 5.8 7.2 2.5 4.4 6.7 5.7 4.3 3.7 14.6 9.5 2.8 9.5 3.0 3.3 7.3 7.0 13.2 5.5 2.5 3.6 18.2 7.4 5.4 3.5 4.8 6.0 5.0 4.3 10.6 7.9 3.1 7.3 9.2 8.4 14.6 4.3 5.3 10.4 5.1 0.4 1.9 2.2 0.1 1.8 2.7 1.9 1.3 0.5 1.7 1.3 1.1 3.1 0.9 1.1 1.3 2.5 0.8 7.5 11.8 15.2 11.8 7.9 4.9 15.3 7.0 12.8 14.8 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: " "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.4 6.1 6.8 7.3 55.3 59.0 5.9 30.7 29.0 8.0 6.0 2.2 0.4 0.0 12.6 50.1 6.5 3.0 4.0 3.1 2.4 4.8 0.5 5.5 3.3 16.9 1.1 17.2 32.7 2.1 8.7 2.1 9.1 2.7 7.5 10.4 18.0 0.4 11.6 0.4 4.6 0.9 4.8 1.3 3.7 3.6 1.0 1.9 6.9 8.4 3.5 6.8 2.3 10.0 21.4 5.8 29.4 4.7 8.8 6.9 0.1 20.3 3.3 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536676-181680665 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell line enhanced" "Detected in some" "HEL: 26.2;HL-60: 14.5;MOLT-4: 35.2;NB-4: 30.9;SCLC-21H: 23.7;THP-1: 14.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "cerebellum: 49.5;pons and medulla: 13.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 31.8" "HPA035443, HPA035444, HPA043203" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035443: , HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.6 1.2 9.2 2.0 14.4 1.1 49.5 2.5 3.7 1.7 4.2 0.4 3.1 1.0 5.3 0.6 5.8 4.1 0.5 2.9 1.3 8.1 1.3 5.0 13.8 0.6 1.4 2.9 0.8 0.1 2.1 2.0 13.7 1.0 0.0 6.8 1.0 0.4 0.5 0.5 6.4 0.4 1.0 17.9 2.8 1.1 1.1 0.4 0.9 0.4 1.1 4.3 1.3 4.0 5.2 12.6 12.7 4.7 6.9 4.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 4.1 0.1 0.1 0.1 0.0 0.1 4.4 0.0 0.1 2.6 0.1 0.1 0.1 0.0 0.4 26.2 0.3 0.0 0.1 14.5 0.7 0.1 0.3 0.1 0.2 0.0 0.0 4.6 0.0 0.0 35.2 30.9 0.6 0.2 7.5 2.2 0.6 0.3 0.0 23.7 0.7 0.0 0.0 0.1 0.0 14.6 2.4 1.2 0.6 0.1 1.0 11.3 6.3 2.0 0.9 9.8 10.7 2.0 4.7 12.6 4.5 12.7 3.7 4.0 6.4 6.9 5.2 3.4 3.5 4.5 0.7 4.7 10.9 2.9 1.4 4.2 1.2 2.0 49.5 2.5 2.9 1.3 0.6 1.4 13.7 1.1 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027262 Approved Supported "Nuclear membrane,Endoplasmic reticulum" 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717" "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.7 28.2 23.8 51.0 71.1 43.7 17.8 26.4 38.8 50.3 34.6 29.5 45.7 22.7 44.1 41.4 29.4 33.0 28.1 41.4 30.8 26.9 31.3 19.8 35.8 51.5 35.5 38.8 39.7 36.3 44.4 55.4 31.3 33.5 52.0 62.8 38.8 23.2 20.5 36.5 50.5 26.5 16.2 36.2 54.5 21.9 22.0 34.3 29.1 51.7 30.1 61.6 53.9 24.3 36.5 16.4 32.9 46.4 33.7 37.8 142.5 41.0 15.2 36.9 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.2;NB-4: 38.2;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favourable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favourable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favourable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.0 0.3 0.0 0.7 1.3 3.3 1.5 0.7 7.5 0.8 15.6 11.1 0.0 5.3 6.5 0.1 0.7 13.7 5.1 3.0 0.1 21.2 12.9 0.0 8.5 5.0 8.4 3.5 7.6 0.1 2.2 0.5 0.0 0.3 1.2 38.2 10.2 3.7 18.8 0.2 1.2 2.5 0.0 3.8 5.1 1.6 0.3 5.4 7.4 3.5 0.0 1.1 3.2 7.5 0.0 9.8 7.8 11.9 0.0 23.9 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavourable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavourable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favourable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.3 10.4 23.0 6.5 12.9 10.8 19.5 20.6 17.8 19.8 18.8 24.5 14.7 14.1 17.2 29.1 8.7 10.1 7.9 19.6 22.1 10.3 11.8 8.8 14.8 25.6 11.9 16.0 18.6 12.0 16.3 15.2 18.0 8.8 13.1 24.8 16.2 10.4 32.5 14.8 10.1 13.6 15.1 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 11.2 13.8 17.1 17.0 11.4 12.8 8.9 12.8 12.1 11.3 13.5 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "esophagus: 46.7;intestine: 146.9;liver: 78.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018897 Enhanced Approved "Golgi apparatus,Cytosol" 7500000 "Golgi apparatus, Cytosol" "HPA018897: AB_1846558" "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favourable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 5.8 15.3 8.5 8.8 11.7 2.4 5.1 13.0 15.9 9.5 42.3 12.1 11.2 146.9 7.0 11.9 46.7 6.1 14.5 15.2 7.4 6.6 22.5 78.6 6.7 4.6 8.2 10.7 8.4 12.0 10.0 6.8 7.3 10.3 9.7 42.6 13.0 12.7 7.9 11.6 8.9 117.3 10.4 5.6 7.8 10.9 8.5 8.2 9.0 11.7 14.1 12.1 7.6 11.6 6.9 8.9 5.0 10.6 7.9 10.7 5.2 6.8 9.0 9.5 12.7 9.4 8.8 7.2 7.8 12.6 9.2 11.7 9.7 11.4 8.0 7.8 10.2 17.8 6.9 19.7 7.2 7.1 9.6 7.9 5.1 18.2 13.3 10.3 13.8 12.7 37.3 13.0 21.9 6.8 11.0 5.9 15.5 4.3 9.1 8.6 5.1 9.1 10.8 9.6 9.4 26.1 12.0 6.2 8.1 25.5 6.4 6.6 11.1 12.8 8.4 12.1 6.5 7.5 5.9 11.9 14.2 9.5 18.7 8.1 9.1 4.7 10.4 4.7 10.1 7.8 9.2 6.1 7.7 10.7 8.9 6.9 9.5 8.6 5.0 7.9 10.6 7.7 6.8 5.2 8.5 11.7 13.0 15.9 7.4 6.6 8.2 10.7 10.3 8.2 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961237-66975148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8;liver: 26.7" "Cell line enhanced" "Detected in many" "AN3-CA: 8.9;Daudi: 9.8;U-937: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" 1200000 "Nuclear membrane, Endoplasmic reticulum" "HPA041008: , HPA041307: " "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favourable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.5 0.1 0.8 13.3 1.3 0.2 1.0 1.6 1.3 0.6 40.7 0.7 1.4 16.8 0.4 0.7 2.2 1.5 3.0 0.7 1.5 1.0 6.8 26.7 0.9 0.2 0.8 1.1 0.5 7.8 0.0 1.1 0.4 2.2 0.4 17.9 1.1 5.9 0.6 12.9 0.5 41.8 0.5 0.9 0.2 4.6 0.9 0.6 0.5 0.4 2.4 0.5 0.4 0.3 0.7 0.6 2.7 0.6 0.3 0.9 0.2 0.5 3.5 0.4 8.9 0.3 0.2 1.4 0.3 0.2 0.4 0.6 0.5 4.4 9.8 3.0 0.0 0.7 1.4 0.7 0.2 1.6 6.5 4.9 1.4 2.9 0.1 1.1 0.7 0.4 1.1 1.0 0.2 0.0 3.1 2.1 0.4 1.4 1.6 1.7 1.5 0.6 1.5 0.8 1.5 0.1 0.5 0.5 1.0 0.3 6.7 0.2 5.9 7.5 0.4 0.5 2.8 0.8 0.2 1.1 4.0 1.4 0.3 8.3 0.3 0.6 0.6 2.7 0.3 0.3 0.5 0.5 0.6 0.4 0.6 0.7 0.9 0.6 2.0 0.3 0.4 0.3 0.9 0.2 0.8 1.3 1.6 1.3 1.5 1.0 0.8 1.1 2.2 0.6 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell line enhanced" "Detected in many" "A549: 9.1;HeLa: 7.4;MCF7: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favourable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.1 0.9 1.2 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 4.5 0.0 0.0 0.0 3.4 1.0 0.9 7.4 2.2 0.0 0.7 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 6.5 1.3 0.5 0.8 4.9 2.0 0.9 1.5 0.0 0.4 6.3 1.1 1.9 3.6 0.7 3.2 0.3 1.7 1.9 1.5 4.9 0.8 1.0 2.5 1.1 0.7 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407983-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.7;testis: 60.5" "Cell line enhanced" "Detected in some" "MCF7: 4.4;RPTEC TERT1: 5.3;T-47d: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: " "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.2 0.5 1.3 0.3 3.0 0.2 0.5 0.3 2.2 0.9 0.3 3.0 0.2 0.3 0.7 3.4 0.2 17.7 0.4 0.3 2.1 2.0 1.5 0.3 2.4 0.2 0.7 1.4 2.7 0.3 0.8 2.6 0.4 8.1 0.5 0.2 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.2 60.5 0.6 0.0 1.4 0.0 0.2 0.4 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.9 0.5 2.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 1.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.9 0.0 0.2 0.0 0.1 0.8 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 1.2 1.1 0.6 0.4 0.5 0.3 9.0 0.2 0.0 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 3.0 0.3 2.2 2.1 2.0 0.7 1.4 8.1 0.6 CFAP36 "BARTL1, CCDC104, MGC15407" ENSG00000163001 "Cilia and flagella associated protein 36" Q96G28 2 55519604-55545879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008994, HPA017061" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA008994: AB_2275429, HPA017061: AB_1846129" "unprognostic (8.11e-2)" "unprognostic (3.21e-3)" "unprognostic (1.24e-1)" "unprognostic (3.36e-2)" "unprognostic (7.98e-2)" "unprognostic (3.68e-1)" "unprognostic (4.65e-3)" "unprognostic (7.79e-2)" "unprognostic (1.51e-2)" "unprognostic (1.58e-2)" "unprognostic (3.66e-3)" "unprognostic (7.63e-2)" "unprognostic (8.57e-3)" "unprognostic (4.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.56e-3)" "unprognostic (2.96e-1)" 13.0 22.7 34.6 9.9 46.6 7.3 25.3 16.7 39.4 23.3 16.7 10.2 18.1 7.8 24.4 39.1 12.3 32.7 21.1 15.4 28.6 34.9 32.4 9.1 15.1 11.0 27.7 29.5 29.3 15.8 32.8 47.1 10.6 36.7 22.1 12.1 13.5 10.6 24.6 6.5 8.1 8.4 19.7 19.3 8.8 16.6 66.4 14.4 8.9 39.9 7.7 9.8 21.7 13.3 8.0 6.2 6.3 2.9 5.5 25.2 8.3 18.9 15.0 16.3 21.3 21.5 41.7 9.9 11.9 24.5 18.4 15.4 11.3 7.0 6.8 28.0 15.6 12.6 12.6 16.6 23.8 16.5 24.9 10.0 14.7 11.7 23.7 18.4 12.4 20.5 27.1 24.9 29.5 20.4 12.5 5.6 23.2 14.2 11.1 20.5 8.3 15.0 8.7 19.3 7.1 37.4 10.7 24.5 12.3 16.2 8.3 22.0 13.6 6.4 10.5 18.8 11.5 19.4 16.1 10.1 4.6 2.3 31.9 8.4 8.6 6.3 2.1 6.2 9.1 2.3 17.5 8.0 25.2 14.5 2.7 5.2 21.0 12.8 2.4 5.5 2.9 6.2 13.7 8.3 34.6 46.6 16.7 39.4 28.6 34.9 27.7 29.5 36.7 14.4 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.5;TIME: 12.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.3 1.8 0.8 1.1 1.1 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 0.7 0.4 0.5 2.2 1.0 1.4 3.0 0.8 0.2 2.6 1.7 0.4 0.5 1.9 0.7 10.5 0.7 4.9 1.3 0.7 1.2 2.4 2.4 1.4 1.5 1.5 1.7 3.0 1.8 2.3 1.7 1.3 0.7 1.5 2.3 0.7 12.7 2.4 2.9 2.2 2.4 5.4 2.3 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353764-104455090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.9;testis: 17.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.1;U-2 OS: 10.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 6.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036555, HPA071938" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.3 0.5 0.8 0.6 2.0 0.4 0.3 0.7 1.0 3.0 0.3 2.9 0.3 0.1 2.3 0.3 0.3 10.9 0.3 3.0 1.4 1.5 0.3 0.3 2.1 0.3 0.3 0.3 2.0 0.3 1.5 1.9 0.4 6.8 0.4 0.0 0.6 0.3 0.4 1.4 0.2 0.3 0.8 0.3 0.3 0.1 17.5 0.7 0.3 0.8 0.3 0.4 0.3 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.2 0.6 0.2 1.7 5.1 1.0 2.8 0.0 0.0 3.9 0.4 0.6 0.3 0.0 0.3 3.1 0.4 0.2 0.9 1.2 0.0 0.6 0.5 0.7 0.6 2.2 0.8 2.7 1.6 1.0 1.2 1.3 0.0 0.0 1.1 0.3 0.0 0.4 0.3 0.5 0.6 0.0 0.6 0.4 0.0 0.2 0.9 0.3 0.6 3.3 1.1 10.7 0.6 3.0 0.3 0.1 0.2 1.2 1.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.7 1.0 1.4 1.5 0.3 0.3 6.8 0.7 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Cell line enhanced" "Detected in some" "Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: " "unprognostic (2.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favourable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.0 6.3 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.1 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.3 1.1 0.4 0.2 3.2 0.0 0.5 0.8 0.7 0.6 0.1 0.0 0.9 0.0 3.8 0.0 0.1 0.1 1.0 0.3 0.2 0.6 0.2 12.7 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Cell line enhanced" "Detected in some" "ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" 878700000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favourable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.0 5.8 0.0 0.0 0.3 1.5 0.6 0.0 6.9 0.1 5.1 11.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.5 0.0 0.7 0.1 18.7 0.1 0.9 0.6 0.2 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.1 0.2 0.4 0.2 1.6 0.0 0.0 0.0 0.5 1.2 0.2 0.0 0.2 0.0 0.2 0.5 0.3 0.3 0.5 1.9 0.5 3.1 0.5 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433485 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: " "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavourable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 21.3 33.0 38.3 23.3 32.9 18.7 28.5 31.8 35.4 35.6 24.3 19.5 24.6 18.9 37.4 40.9 21.3 36.1 18.8 19.2 33.7 40.5 40.2 26.6 20.6 16.9 33.6 28.4 54.5 26.9 20.9 53.0 38.5 32.7 28.4 25.8 21.1 23.8 25.6 25.9 20.8 22.2 33.8 38.6 18.0 19.1 38.5 29.7 27.2 28.7 12.6 21.4 26.0 41.1 20.1 28.2 33.7 27.6 15.1 37.8 15.0 16.4 12.2 41.7 15.4 38.0 42.5 12.5 16.5 19.2 21.9 31.7 21.0 22.5 15.8 24.5 20.3 18.5 32.0 26.2 44.0 6.8 15.2 16.5 11.8 44.7 26.2 17.3 14.4 26.4 22.5 26.4 32.3 23.8 22.9 7.4 24.4 37.4 25.4 38.3 20.4 6.4 46.1 17.1 27.3 24.3 9.1 25.0 21.1 27.6 5.8 22.6 24.0 30.8 14.1 15.7 17.0 16.5 10.4 14.4 22.4 59.4 15.7 23.0 13.8 28.7 27.3 33.7 19.4 27.6 27.3 19.8 26.7 21.3 28.2 20.1 24.5 23.1 22.4 15.1 25.0 28.1 37.8 15.0 38.3 32.9 31.8 35.4 33.7 40.5 33.6 28.4 32.7 29.7 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: " "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.6 15.9 10.2 6.6 10.4 39.0 5.8 30.8 35.5 29.5 31.5 11.9 7.6 6.3 12.6 49.1 3.5 21.8 6.5 52.0 0.8 9.0 1.3 18.8 28.2 17.0 1.6 1.0 29.5 2.3 25.1 13.9 29.2 1.9 5.0 36.2 5.0 1.2 0.8 3.3 24.4 1.1 32.5 0.9 10.7 3.6 2.1 8.8 20.1 4.3 10.4 9.6 1.5 25.6 29.4 19.6 13.8 14.7 7.0 4.5 2.4 10.8 2.3 6.9 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116104-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 79.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 79.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favourable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 35.4 17.6 13.7 29.8 17.4 66.8 31.6 26.9 12.6 20.5 25.7 13.5 31.3 17.5 24.7 27.6 21.0 19.2 22.1 58.1 14.7 7.7 24.9 18.9 58.5 34.3 16.8 8.9 14.6 14.3 9.1 18.7 28.3 12.6 23.2 17.7 20.9 21.8 27.4 113.7 16.7 26.8 30.5 13.8 35.7 19.4 10.9 14.8 17.2 31.2 26.2 31.4 24.1 33.7 5.3 6.6 79.2 12.6 8.7 11.8 7.8 5.1 10.6 7.6 4.5 23.6 18.1 9.4 13.1 22.9 8.7 10.6 12.2 19.4 1.4 12.5 15.2 3.8 2.4 9.9 13.9 38.8 7.4 7.8 9.1 19.8 16.5 5.8 25.9 19.7 9.8 14.6 12.9 44.0 26.3 32.7 15.7 4.3 2.7 23.2 2.6 8.0 2.8 1.8 11.1 10.8 10.7 1.7 3.0 8.8 7.8 10.3 5.5 10.9 47.7 18.2 7.6 6.7 6.4 54.5 17.9 8.7 12.9 4.7 9.0 16.3 12.1 13.5 11.7 12.3 10.3 5.3 10.1 11.0 6.6 4.0 6.4 8.3 79.2 8.7 12.6 4.6 11.8 7.8 13.7 17.4 26.9 12.6 14.7 7.7 16.8 8.9 12.6 14.8 CGAS "C6orf150, cGAS, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452276 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 32.0" "Cell line enhanced" "Detected in many" "RH-30: 21.2;RPMI-8226: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Approved "Centriolar satellite,Cytosol" "Centriolar satellite" Cytosol "HPA031700: AB_10601693, HPA031702: " "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavourable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 6.5 2.0 2.9 10.5 4.5 18.5 8.1 1.2 3.9 4.7 3.7 3.4 2.1 4.1 5.5 2.8 5.3 3.9 4.3 3.2 2.8 2.9 2.5 1.9 9.6 11.8 7.2 0.6 3.4 3.8 2.3 1.8 4.8 4.4 6.6 3.1 2.2 4.2 2.9 1.9 1.8 5.2 3.6 4.7 12.8 3.5 1.7 4.3 6.2 3.9 4.2 15.5 6.6 32.0 6.3 12.5 13.3 12.9 3.0 6.0 3.9 8.8 3.0 0.0 0.1 0.6 1.3 0.0 4.4 1.9 5.8 6.4 9.8 6.7 0.1 9.7 2.1 4.6 4.9 0.0 6.2 14.7 0.0 7.7 3.8 0.0 2.1 5.9 5.4 0.8 1.6 5.7 0.0 1.7 0.0 18.4 4.2 3.6 0.0 13.4 2.9 5.4 11.5 21.2 22.3 0.0 3.7 0.1 0.0 7.8 0.2 4.6 0.0 16.0 2.0 0.0 4.3 3.9 0.1 4.0 8.7 0.1 0.0 8.5 5.8 13.3 9.2 13.2 4.6 12.9 3.6 6.3 6.0 4.6 5.4 4.8 1.4 2.6 5.8 3.0 7.8 12.5 5.8 3.9 2.9 4.5 1.2 3.9 2.8 2.9 7.2 0.6 4.4 4.3 CGN KIAA1319 ENSG00000143375 Cingulin Q9P2M7 1 151510510-151538692 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.1" "Cell line enhanced" "Detected in many" "BEWO: 15.0;CACO-2: 37.3;CAPAN-2: 24.6;RT4: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB017193, HPA027586, HPA027587, HPA027657" Enhanced Supported "Plasma membrane,Cell Junctions" 24000000 "Plasma membrane, Cell Junctions" "CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527" "unprognostic (1.57e-1)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (8.74e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (8.38e-2)" "unprognostic (4.61e-1)" "unprognostic (2.11e-2)" "unprognostic (2.96e-3)" "unprognostic (7.10e-2)" "prognostic favourable (5.84e-10)" "unprognostic (2.66e-1)" "unprognostic (3.00e-1)" "unprognostic (8.28e-2)" "unprognostic (2.10e-2)" 3.9 0.3 2.1 8.5 5.1 0.0 4.1 11.9 3.5 2.2 18.0 3.7 15.5 23.9 1.0 3.5 5.9 6.1 11.9 0.5 1.4 1.4 10.7 15.0 12.4 0.2 5.0 1.0 1.4 25.3 22.1 4.7 1.9 4.8 4.6 11.6 1.8 19.8 14.4 0.2 11.6 44.1 1.8 1.9 0.2 13.6 6.4 4.3 0.9 3.6 2.3 4.3 6.9 3.8 1.2 0.9 2.6 1.0 1.6 2.4 0.1 11.7 1.3 1.1 1.9 0.0 0.0 15.0 0.0 0.0 0.3 0.4 37.3 24.6 0.5 4.0 0.0 11.2 3.6 2.1 0.2 7.0 2.5 1.0 0.5 0.8 0.0 0.2 1.6 0.0 0.4 0.5 0.3 0.1 0.5 3.6 0.0 10.8 2.0 0.2 9.6 1.0 2.2 1.2 1.7 7.9 18.1 3.8 1.9 0.7 11.4 0.4 14.1 0.1 0.2 0.1 3.6 0.2 0.5 3.3 3.3 2.1 0.1 1.3 0.9 1.1 1.0 0.4 2.4 0.4 0.7 0.7 0.7 0.5 0.1 1.2 0.8 1.4 2.6 1.6 0.5 0.9 0.7 0.1 2.1 5.1 11.9 3.5 1.4 1.4 5.0 1.0 4.8 4.3 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550727 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.8" "Cell line enhanced" "Detected in some" "AF22: 7.8;HUVEC TERT2: 31.0;TIME: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: , HPA069214: " "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favourable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favourable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favourable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 3.1 8.7 10.8 1.7 9.8 0.6 14.6 3.2 12.2 25.7 2.0 7.3 8.9 1.4 14.9 4.9 7.7 7.0 2.7 13.6 11.2 7.8 54.8 26.2 15.3 1.3 8.3 5.9 8.1 13.6 12.5 2.9 20.8 10.9 27.6 2.3 11.1 32.0 12.7 1.0 7.4 1.7 10.6 5.3 0.8 9.0 5.2 9.7 1.3 15.0 4.2 8.0 10.0 14.6 0.5 0.2 1.1 0.1 0.3 0.2 0.0 0.0 0.7 7.8 0.0 0.0 0.0 0.1 0.1 1.7 0.6 1.4 4.8 0.0 0.0 6.9 1.0 0.0 3.7 0.0 1.0 0.0 0.6 0.0 0.1 3.3 0.1 0.0 0.0 0.3 0.2 0.8 0.0 31.0 0.0 0.0 1.2 1.3 0.0 0.1 3.8 0.3 0.0 3.9 0.1 2.6 0.0 0.2 0.4 0.0 3.0 0.0 0.3 0.3 18.9 0.0 2.0 0.0 1.0 0.0 0.0 0.0 0.1 3.5 0.0 0.9 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.2 0.1 0.0 10.8 9.8 3.2 12.2 11.2 7.8 8.3 5.9 10.9 9.7 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favourable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.3 7.5 7.8 7.1 13.6 8.5 6.0 8.2 7.4 11.9 11.7 6.9 9.4 4.6 10.3 6.7 7.4 8.3 6.9 14.1 9.6 7.1 6.4 1.9 8.7 16.9 3.7 3.7 8.4 13.4 8.9 14.6 8.3 2.6 5.7 10.8 14.8 3.8 5.7 5.2 11.9 8.5 9.5 2.7 9.2 11.0 5.7 4.7 6.5 3.5 12.3 9.2 3.3 7.1 14.7 12.5 6.2 6.8 4.2 4.9 6.6 9.1 4.5 9.7 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 CHAF1A "CAF-1, CAF1, CAF1B, CAF1P150, MGC71229, P150" ENSG00000167670 "Chromatin assembly factor 1 subunit A" Q13111 19 4402662-4445018 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 4 "dendritic cells: 15.2;granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015186 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB015186: AB_628065" "unprognostic (1.91e-1)" "prognostic favourable (8.22e-5)" "unprognostic (2.49e-1)" "unprognostic (4.71e-2)" "unprognostic (2.06e-1)" "unprognostic (1.89e-3)" "unprognostic (5.30e-3)" "unprognostic (8.78e-2)" "unprognostic (2.06e-2)" "unprognostic (2.12e-2)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.54e-2)" "prognostic favourable (4.15e-6)" "unprognostic (1.71e-1)" "unprognostic (2.11e-3)" "unprognostic (4.03e-2)" 5.3 5.3 6.3 14.6 7.3 28.2 5.3 12.6 8.8 4.7 7.2 4.9 8.6 6.9 4.7 5.1 11.5 4.7 5.2 4.0 6.1 3.9 3.0 4.5 4.6 13.3 5.5 5.6 4.6 4.4 3.3 4.3 7.5 5.4 6.5 7.2 4.1 7.8 8.1 12.2 11.3 7.0 6.8 4.8 8.2 5.6 20.4 4.9 27.8 3.3 9.8 11.5 6.7 5.9 1.7 15.2 4.3 2.4 1.0 0.8 0.9 21.2 14.5 24.2 15.2 2.4 3.0 12.5 20.2 8.3 17.1 19.4 17.6 7.6 32.7 8.4 6.4 16.7 20.6 13.8 20.3 18.8 22.7 20.3 21.7 13.8 1.2 23.5 16.6 1.6 2.9 14.0 6.0 8.0 24.5 29.7 10.4 12.2 38.0 13.2 27.0 12.1 28.3 19.1 18.7 4.4 25.3 17.2 13.3 13.8 9.8 8.0 8.6 17.6 5.8 14.1 12.4 24.0 24.4 14.9 22.0 31.4 11.9 30.4 16.7 2.9 2.3 4.3 0.5 2.4 0.4 1.7 0.6 0.1 2.0 0.8 0.6 0.4 1.2 1.0 0.4 15.2 0.8 0.9 6.3 7.3 12.6 8.8 6.1 3.9 5.5 5.6 5.4 4.9 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314335-114337626 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 13.7 16.8 11.8 12.7 18.5 16.5 13.3 25.2 19.8 12.4 13.3 15.9 10.9 13.7 16.7 11.7 12.6 16.7 10.7 10.3 11.6 12.2 12.7 20.6 12.3 19.9 12.5 12.4 17.8 20.8 12.8 9.5 13.5 16.6 14.5 14.3 12.4 13.2 14.7 16.1 12.6 16.4 14.2 11.4 16.8 16.3 11.6 11.9 35.0 15.2 9.8 23.1 14.3 11.2 7.9 14.5 7.0 6.8 3.7 5.7 2.5 15.2 6.7 24.7 10.4 8.9 13.7 10.5 16.2 13.7 15.4 17.3 9.8 9.3 31.6 6.6 12.7 9.8 18.0 13.0 23.1 12.2 22.0 20.7 9.6 8.6 10.0 30.1 12.4 13.5 8.1 12.2 12.0 7.4 13.1 8.7 19.7 6.1 20.0 8.8 18.5 8.7 20.1 11.6 10.9 11.7 9.5 12.0 14.2 9.3 21.2 15.4 12.1 25.5 8.1 8.5 13.6 9.0 9.9 11.2 11.4 34.3 16.9 17.8 16.3 7.0 4.0 5.2 4.7 4.6 5.7 6.8 4.3 4.5 4.5 7.9 3.5 3.9 1.0 3.7 6.8 14.5 2.8 2.5 11.8 18.5 25.2 19.8 11.6 12.2 12.5 12.4 16.6 11.9 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favourable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.0 16.8 14.1 20.0 11.7 11.5 14.3 11.5 13.5 11.6 15.7 15.1 20.1 11.0 12.8 10.2 15.6 13.8 14.9 9.7 16.7 26.3 8.4 14.1 23.1 13.8 12.8 13.5 10.6 18.7 9.9 6.7 16.1 12.8 12.5 15.3 22.3 15.7 28.3 13.5 111.5 15.1 11.0 14.2 19.0 12.4 7.0 13.8 7.2 50.3 23.6 28.2 17.9 9.5 7.4 16.2 12.2 19.8 12.5 13.0 17.3 17.3 26.0 5.7 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 CHCHD7 "COX23, MGC2217" ENSG00000170791 "Coiled-coil-helix-coiled-coil-helix domain containing 7" Q9BUK0 8 56211686-56218798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050783 Approved Approved "Cell Junctions,Aggresome" "Cell Junctions" Aggresome "HPA050783: " "unprognostic (1.64e-2)" "unprognostic (3.23e-2)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (4.46e-2)" "unprognostic (2.43e-1)" "unprognostic (5.04e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "prognostic favourable (9.47e-5)" "unprognostic (1.94e-1)" "unprognostic (5.07e-1)" "unprognostic (1.77e-2)" "unprognostic (2.50e-1)" 16.6 14.8 24.1 19.6 29.4 17.6 18.9 27.1 23.3 17.6 20.7 18.3 22.8 22.5 13.1 34.3 15.7 17.6 12.3 27.0 21.0 19.5 23.4 18.0 19.4 24.4 27.0 16.0 36.3 20.0 22.5 48.3 13.3 26.7 19.2 21.3 19.2 34.5 18.0 23.2 14.6 26.2 14.8 32.0 33.0 17.7 7.6 24.8 27.4 19.8 18.3 24.9 15.5 16.4 31.0 33.6 26.2 20.6 24.2 31.1 17.3 18.8 6.0 13.5 4.4 36.0 25.6 14.0 13.5 12.7 10.8 8.1 15.4 23.1 17.8 11.9 7.9 10.6 14.0 20.7 13.4 7.7 26.9 27.2 14.4 21.3 18.3 23.2 17.5 30.5 19.1 7.6 34.2 11.2 13.3 11.7 25.3 9.4 23.1 34.4 11.9 8.7 26.6 4.1 14.8 19.8 20.4 3.5 2.3 7.1 11.0 10.0 11.5 13.0 16.2 5.7 12.1 18.3 12.6 12.4 12.6 29.7 16.0 34.5 9.7 21.5 20.6 26.2 23.2 19.0 22.5 31.0 26.0 23.6 22.8 26.4 31.1 27.8 7.9 24.2 16.6 33.6 29.7 17.3 24.1 29.4 27.1 23.3 21.0 19.5 27.0 16.0 26.7 24.8 CHD1 ENSG00000153922 "Chromodomain helicase DNA binding protein 1" O14646 5 98853985-98928957 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022236 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA022236: " "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (1.09e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (7.15e-2)" "unprognostic (6.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-1)" "unprognostic (4.94e-2)" "unprognostic (3.15e-1)" "prognostic unfavourable (7.25e-6)" "unprognostic (2.69e-1)" "unprognostic (3.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.17e-1)" 13.0 7.4 5.5 15.8 7.5 41.7 10.2 14.9 5.5 9.4 9.3 4.7 7.9 6.6 11.3 7.5 7.6 10.8 10.6 6.8 4.9 3.1 7.3 10.1 12.1 8.8 8.8 3.2 18.1 8.3 9.3 12.0 11.1 6.4 7.7 7.4 5.6 8.1 11.5 13.2 8.2 12.3 8.3 7.2 17.2 8.6 12.0 7.4 70.1 8.1 5.5 9.3 10.4 11.3 10.1 7.1 16.7 8.2 8.1 8.4 2.2 11.4 10.5 24.8 16.8 8.4 8.7 21.7 11.9 7.8 9.7 12.6 13.1 8.9 9.7 11.6 6.9 9.6 19.4 13.1 20.3 15.2 14.6 17.2 12.6 9.9 9.3 16.5 13.4 7.5 5.4 16.8 17.0 11.7 20.7 15.0 9.7 9.2 32.8 7.2 16.7 12.8 27.9 17.4 14.6 8.5 11.0 11.6 9.9 15.3 8.0 19.3 7.7 11.4 13.1 20.8 11.2 13.0 21.0 10.5 11.0 20.7 11.4 16.6 12.5 11.4 8.2 10.7 6.5 7.5 8.2 10.1 6.1 6.1 7.1 9.4 8.4 6.6 16.7 8.1 7.1 5.2 6.3 2.2 5.5 7.5 14.9 5.5 4.9 3.1 8.8 3.2 6.4 7.4 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: , HPA076524: " "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavourable (2.43e-4)" "prognostic favourable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favourable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.1 30.4 17.8 23.6 21.7 18.2 9.5 14.2 19.1 12.1 12.9 5.9 10.3 34.3 10.8 20.9 16.5 33.4 15.0 15.2 17.4 19.4 16.6 39.4 0.7 11.6 4.7 32.7 24.0 8.0 16.2 10.9 22.3 11.1 0.5 11.2 12.0 13.1 5.5 2.8 11.2 38.4 21.7 5.2 12.0 29.7 12.1 16.4 35.3 13.8 6.9 15.8 7.8 27.9 26.2 20.6 6.3 20.4 2.5 0.4 19.4 13.3 13.5 22.3 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Group enriched" "Detected in some" 4 "SCLC-21H: 16.6;U-2 OS: 7.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.3 1.3 0.0 0.0 0.0 0.0 16.6 0.2 0.1 0.0 0.0 2.8 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell line enhanced" "Detected in many" "AF22: 25.8;SCLC-21H: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA053075: " "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavourable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.8 1.9 25.8 4.5 0.0 0.0 8.1 0.2 0.0 0.9 0.8 4.8 3.6 7.5 0.4 0.0 2.3 13.2 3.8 0.8 2.8 7.1 17.6 3.2 6.3 1.1 5.3 3.3 0.5 2.9 0.0 4.3 3.8 1.3 6.7 0.6 3.9 8.3 6.0 17.7 0.9 17.3 6.1 2.4 2.0 4.4 23.6 11.7 0.7 2.9 7.2 5.2 5.0 4.4 0.2 4.2 0.2 2.1 7.1 4.1 11.7 1.5 0.6 6.6 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 CHD8 "DUPLIN, HELSNF1, KIAA1564" ENSG00000100888 "Chromodomain helicase DNA binding protein 8" Q9HCK8 14 21385194-21456126 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052186, HPA076133" Enhanced "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA052186: , HPA076133: " "unprognostic (3.45e-1)" "unprognostic (9.71e-2)" "unprognostic (3.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.14e-1)" "unprognostic (3.43e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (7.31e-2)" "unprognostic (9.22e-2)" "prognostic favourable (8.35e-4)" "unprognostic (1.64e-1)" "unprognostic (2.63e-2)" "unprognostic (2.54e-3)" "unprognostic (2.88e-1)" "unprognostic (9.24e-2)" "unprognostic (2.51e-1)" "unprognostic (8.07e-3)" 13.9 14.5 13.0 14.8 21.5 34.8 17.0 28.9 25.7 15.8 14.4 26.6 14.1 11.1 18.3 13.4 17.4 15.9 11.7 12.3 13.5 13.3 14.0 11.2 15.5 18.5 15.4 15.2 20.7 19.0 34.7 25.3 15.2 20.3 16.3 14.6 19.3 15.7 14.9 16.9 24.5 16.4 17.2 13.1 19.2 16.1 15.2 18.1 29.9 17.4 10.4 24.8 16.6 14.5 12.3 7.8 12.8 7.4 8.7 8.6 3.0 16.2 21.3 23.6 11.0 15.1 13.1 13.4 12.9 14.9 19.7 19.7 18.5 14.1 26.9 8.2 17.3 20.0 28.9 18.2 25.0 20.6 13.2 23.6 14.3 22.4 14.0 32.6 22.5 17.6 14.8 22.1 15.9 17.5 16.4 14.4 14.9 17.5 23.4 13.3 18.0 18.1 22.0 17.9 9.1 14.6 30.1 17.3 16.6 20.3 15.8 11.2 11.1 15.8 20.5 16.4 12.6 9.6 15.3 16.4 19.5 26.9 6.6 12.1 16.3 12.8 4.8 12.1 7.7 5.0 8.6 5.8 6.8 7.5 3.3 12.3 7.4 6.4 11.0 8.7 7.4 7.8 5.7 3.0 13.0 21.5 28.9 25.7 13.5 13.3 15.4 15.2 20.3 18.1 CHD9 "BC022889, FLJ12178, KIAA0308" ENSG00000177200 "Chromodomain helicase DNA binding protein 9" Q3L8U1 16 53055033-53329150 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 42.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042053, HPA049420" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042053: , HPA049420: " "unprognostic (3.57e-2)" "unprognostic (3.73e-2)" "unprognostic (3.44e-3)" "unprognostic (2.42e-1)" "unprognostic (4.34e-2)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "unprognostic (7.75e-3)" "unprognostic (2.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.35e-2)" "prognostic favourable (1.84e-4)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (5.09e-2)" "unprognostic (2.87e-1)" 18.0 12.6 14.5 12.5 17.3 30.3 15.7 49.3 19.6 18.5 13.8 6.6 17.4 8.0 14.2 15.0 14.4 13.5 11.6 12.2 15.9 8.2 16.8 12.3 12.3 9.2 16.0 12.3 18.8 12.9 28.1 39.9 12.3 15.1 13.7 11.5 8.9 17.8 15.3 17.1 14.4 11.1 11.6 20.1 11.6 13.4 7.0 18.7 15.6 17.7 11.2 9.4 13.9 15.1 16.4 42.9 23.7 12.7 12.1 8.8 1.7 5.7 6.7 15.0 12.2 11.2 16.4 2.6 10.6 7.8 5.6 2.5 3.7 5.2 7.7 6.9 8.7 7.0 7.8 5.5 7.9 2.7 5.8 10.9 6.4 2.3 7.8 15.1 9.1 11.3 5.6 8.2 10.4 8.3 12.7 2.6 7.0 2.2 7.5 3.4 5.4 5.1 26.5 18.0 3.3 3.4 5.4 6.4 7.1 9.4 3.1 7.8 3.4 7.0 16.0 10.6 5.4 3.9 7.1 8.0 5.5 13.5 7.5 6.5 10.4 23.7 9.2 8.9 5.7 7.6 8.8 12.5 3.9 6.2 5.4 16.4 3.1 4.4 3.0 12.1 12.7 42.9 1.9 1.7 14.5 17.3 49.3 19.6 15.9 8.2 16.0 12.3 15.1 18.7 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625136-125676255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 80.0;seminal vesicle: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.7" "Lineage enriched" "Detected in many" 6 "T-cells: 11.7" "Low region specificity" "Detected in single" HPA044364 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044364: " "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favourable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavourable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavourable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 3.0 2.5 2.5 9.0 2.8 14.9 2.1 1.1 2.2 2.5 5.2 1.3 80.0 5.0 1.9 10.2 6.5 1.7 3.6 1.5 2.4 2.4 3.7 2.0 1.8 9.6 3.0 1.2 3.8 4.0 25.5 3.5 3.8 1.5 2.9 6.3 1.6 2.6 66.8 1.2 2.9 5.2 2.3 3.0 3.6 2.8 7.2 1.5 22.4 1.8 4.5 8.8 3.8 3.3 1.9 1.8 1.9 0.7 1.2 11.7 1.0 12.7 10.4 23.4 14.2 4.8 10.3 10.2 17.9 8.6 11.5 12.4 25.4 28.3 33.4 18.5 7.0 15.4 14.3 9.4 14.2 20.9 6.6 61.9 8.7 13.0 1.5 31.6 11.8 5.3 2.0 14.5 10.3 13.6 31.3 29.4 15.1 6.6 46.9 15.5 23.7 9.4 28.6 21.9 17.5 10.6 17.0 14.8 15.7 14.7 10.2 4.3 27.5 10.3 9.1 16.6 14.1 8.0 16.4 6.6 11.8 47.6 6.1 23.8 19.4 1.9 0.5 0.3 1.3 0.7 1.2 1.9 3.5 1.6 1.1 1.5 3.3 2.0 0.4 1.2 0.4 1.8 11.7 1.0 2.5 2.8 1.1 2.2 2.4 2.4 3.0 1.2 1.5 1.5 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 5.6 8.3 2.5 13.0 7.0 13.7 5.6 0.7 5.6 6.6 9.8 2.5 4.8 6.8 4.8 10.9 10.0 4.3 6.0 6.0 4.1 2.3 5.3 6.5 7.9 10.1 6.7 1.6 12.9 6.7 1.2 4.2 10.1 5.1 8.3 10.6 8.7 7.0 5.8 2.2 6.3 8.5 5.4 5.0 9.8 5.8 9.7 3.6 13.1 7.5 4.8 13.7 6.2 6.7 11.8 8.7 6.5 8.4 2.9 4.4 3.7 14.7 4.7 13.5 16.7 3.8 19.2 8.7 7.3 8.6 9.7 14.2 12.0 10.1 17.4 6.2 5.1 14.2 20.5 13.4 11.3 12.4 15.7 22.9 9.0 19.8 3.8 14.5 16.8 8.1 6.2 12.4 11.0 10.7 13.8 15.2 9.0 20.7 11.6 23.3 19.0 12.0 25.3 9.2 20.3 6.0 6.1 7.9 4.5 8.1 14.5 8.0 9.9 13.4 3.7 7.8 9.3 6.8 3.8 9.2 16.2 34.0 7.4 15.2 9.9 6.5 3.7 1.2 1.1 8.4 2.3 11.8 2.2 2.1 8.7 8.4 4.4 2.8 0.3 2.9 4.1 7.0 2.8 3.7 2.5 7.0 0.7 5.6 4.1 2.3 6.7 1.6 5.1 3.6 CHFR "FLJ10796, RNF196" ENSG00000072609 "Checkpoint with forkhead and ring finger domains" Q96EP1 12 132822187-132956304 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045768, HPA073826" Approved Uncertain "Nuclear bodies,Microtubules" "Nuclear bodies, Microtubules" "HPA045768: , HPA073826: " "unprognostic (1.46e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-1)" "unprognostic (2.14e-3)" "unprognostic (6.56e-4)" "unprognostic (1.94e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.00e-2)" "unprognostic (3.98e-3)" "prognostic unfavourable (4.21e-9)" "unprognostic (5.03e-1)" "unprognostic (8.46e-2)" "unprognostic (6.71e-2)" "unprognostic (1.11e-2)" 13.7 11.4 14.1 19.0 15.0 25.8 12.5 20.0 16.9 12.1 15.2 16.5 13.4 19.0 15.6 16.7 21.6 12.6 14.3 13.7 12.5 9.8 12.8 13.4 17.0 21.7 15.1 12.6 9.6 16.8 9.6 20.6 22.9 13.0 14.3 12.8 15.5 13.9 14.7 21.0 16.7 18.7 17.8 15.1 24.9 16.8 19.2 14.2 22.3 13.5 12.7 18.4 18.6 14.2 6.6 12.1 19.7 17.0 12.3 12.5 10.1 4.4 10.8 9.1 0.8 8.0 10.7 17.0 9.1 7.6 9.7 10.1 8.5 3.8 0.1 8.8 10.6 7.1 1.1 9.2 5.6 0.6 9.6 14.4 7.4 8.6 17.5 0.6 25.0 14.4 8.4 8.8 6.6 11.8 6.1 0.0 6.7 14.8 10.4 11.2 10.9 8.6 1.4 1.3 4.4 6.4 20.9 8.9 11.4 7.5 7.7 7.0 13.8 14.9 13.2 0.6 2.2 5.0 3.3 15.9 0.0 2.1 0.0 3.0 8.7 17.6 14.2 19.7 10.8 16.9 10.0 6.6 8.7 11.6 12.1 4.5 8.3 9.1 18.9 12.3 17.0 6.6 12.5 10.1 14.1 15.0 20.0 16.9 12.5 9.8 15.1 12.6 13.0 14.2 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: " "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.1 2.1 2.7 6.0 8.2 0.0 4.5 6.1 3.7 4.5 2.7 5.1 1.9 6.3 4.0 1.2 3.0 2.2 8.3 4.6 3.7 2.7 3.4 0.0 3.9 0.0 5.5 5.6 2.7 7.0 3.8 5.3 0.7 18.3 7.2 0.6 1.6 0.0 6.6 4.1 1.6 5.3 1.2 4.7 2.0 1.2 1.7 5.1 2.4 5.4 2.0 1.1 6.1 4.3 4.2 8.5 2.7 5.2 12.9 0.0 6.3 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: , HPA076603: " "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.5 2.1 6.4 5.6 10.7 8.2 6.3 16.0 17.0 9.6 9.7 8.3 10.4 9.8 14.4 10.3 3.5 8.6 11.7 10.4 5.4 4.4 5.3 2.0 6.2 32.1 8.7 11.1 11.1 9.6 14.5 22.2 14.0 5.7 7.4 19.1 3.1 10.2 14.0 4.2 7.9 6.6 3.5 3.8 11.0 3.9 9.3 8.8 3.8 5.6 11.7 3.0 13.0 23.9 12.3 9.6 17.6 10.3 8.8 4.2 8.0 9.1 8.7 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 CHID1 "FLJ42707, MGC3234" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867860-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" 1700000 "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favourable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 18.2 26.6 19.3 17.8 22.2 16.5 19.7 13.4 25.2 20.4 18.3 14.1 23.3 12.9 18.1 40.1 18.5 27.8 25.9 22.0 16.0 19.3 21.0 47.5 14.2 19.6 17.1 17.8 26.1 63.0 20.1 26.8 27.8 13.7 19.5 12.8 21.0 36.8 23.0 14.5 12.8 14.3 22.4 16.5 29.7 16.8 36.4 12.9 10.9 20.3 21.9 13.8 15.6 15.7 20.5 33.6 8.3 23.1 18.4 17.9 18.8 19.3 19.0 14.4 35.2 55.9 29.7 24.4 21.8 25.9 21.4 20.9 20.7 57.3 15.9 20.4 31.9 38.4 14.3 25.4 15.7 13.9 35.3 11.4 7.0 19.0 25.8 26.4 10.2 28.7 16.1 14.5 21.2 18.0 20.7 41.0 14.8 13.7 14.8 34.7 12.8 28.9 12.8 13.9 28.7 15.7 5.6 27.7 22.8 23.7 33.4 20.2 13.5 40.7 17.5 24.5 10.7 6.8 17.5 24.2 20.4 9.6 27.4 23.2 19.1 7.6 23.1 8.3 16.9 20.4 17.9 20.5 16.4 17.6 33.6 15.1 17.4 17.4 3.0 18.4 19.2 31.4 14.1 18.8 19.3 22.2 13.4 25.2 16.0 19.3 17.1 17.8 13.7 12.9 CHM "DXS540, REP-1, TCD" ENSG00000188419 "CHM, Rab escort protein 1" P24386 X 85861180-86047562 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003231, CAB016171" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016171: AB_2229397, HPA003231: AB_1078518" "unprognostic (6.50e-3)" "unprognostic (1.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.40e-1)" "unprognostic (6.20e-3)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-2)" "unprognostic (6.15e-2)" "unprognostic (2.44e-1)" "unprognostic (7.60e-3)" 12.6 18.8 13.9 9.7 23.2 3.2 11.2 17.8 22.9 14.3 9.3 9.0 8.3 6.6 14.5 7.1 9.7 15.9 10.4 9.9 12.6 11.0 17.7 10.9 9.9 9.2 9.3 12.1 11.8 8.3 20.2 31.9 13.2 17.9 11.3 9.3 7.5 10.4 10.8 16.3 8.1 8.0 12.5 12.1 10.8 10.2 6.6 11.9 14.6 15.6 8.4 8.7 12.1 10.4 7.4 4.6 6.2 7.1 4.9 6.0 3.9 9.3 6.2 6.3 4.3 10.4 11.1 4.0 11.1 9.3 7.7 8.5 5.0 8.7 3.2 14.3 7.9 5.4 13.8 6.2 13.3 6.4 6.6 1.9 9.0 5.1 8.3 7.9 14.0 8.4 5.9 12.5 15.9 13.2 6.6 11.1 12.0 2.7 4.8 2.9 9.5 10.2 5.1 11.4 4.8 7.3 5.5 5.6 8.7 13.3 4.7 10.4 3.4 3.8 9.4 9.9 7.0 34.4 5.5 4.1 15.2 4.5 10.6 6.7 8.6 6.2 5.8 4.0 5.5 7.1 5.0 6.6 4.4 5.6 4.6 7.4 5.8 6.0 3.2 4.9 5.6 4.6 5.5 3.9 13.9 23.2 17.8 22.9 12.6 11.0 9.3 12.1 17.9 11.9 CHML REP-2 ENSG00000203668 "CHM like, Rab escort protein 2" P26374 1 241628853-241640254 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: " "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavourable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 6.5 3.8 6.0 5.7 10.5 10.8 7.7 3.6 18.0 6.0 6.4 3.1 1.4 3.8 7.6 5.0 6.1 7.2 5.6 5.1 5.3 5.1 6.5 21.1 12.5 10.0 4.9 13.1 13.3 5.6 8.5 8.2 30.7 4.2 3.7 6.1 2.0 5.8 3.0 7.1 6.5 6.5 5.6 3.7 9.3 5.6 9.9 2.2 14.8 11.0 2.2 5.1 5.2 6.6 1.6 2.9 3.0 1.3 0.5 1.4 0.2 17.4 5.4 8.5 6.7 2.6 7.7 16.6 6.9 3.5 6.0 4.2 9.9 3.2 4.8 10.6 4.6 3.6 11.9 7.5 11.3 9.2 10.9 6.3 22.1 6.9 5.2 15.0 8.2 6.4 3.4 8.0 8.3 4.7 17.0 6.0 7.1 6.8 9.9 10.1 11.3 17.6 15.1 10.5 16.1 6.1 10.9 10.9 18.0 8.7 6.7 7.5 7.8 9.8 9.5 12.4 24.0 6.2 13.1 6.9 16.9 5.2 12.0 9.1 19.1 3.0 0.9 0.6 0.5 1.3 0.8 1.3 0.3 0.4 0.8 1.6 1.4 1.1 0.1 0.5 0.8 2.9 0.1 0.2 6.0 10.5 3.6 18.0 5.3 5.1 4.9 13.1 4.2 2.2 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA061997: , HPA062896: " "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favourable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.8 12.6 16.4 13.8 21.5 15.1 23.8 13.8 23.3 9.4 12.6 16.3 13.0 8.0 20.7 14.9 11.0 7.4 19.2 8.4 7.4 9.2 5.8 19.2 13.4 15.9 22.1 10.0 21.9 41.6 10.5 24.5 13.6 9.8 10.4 14.8 15.9 15.3 17.0 6.8 6.3 7.9 8.4 13.7 25.2 17.7 16.0 16.0 23.4 11.0 21.1 9.0 20.4 19.8 21.2 11.2 16.7 14.7 12.5 14.3 10.2 19.6 10.3 10.0 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 CHMP2A "BC-2, CHMP2, VPS2, VPS2A" ENSG00000130724 "Charged multivesicular body protein 2A" O43633 19 58551566-58555124 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 104.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041153, HPA042031" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 49000 Cytosol "Nucleoplasm, Plasma membrane" "HPA041153: AB_10964358, HPA042031: AB_10961727" "unprognostic (1.80e-1)" "unprognostic (4.70e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (2.54e-1)" "unprognostic (3.86e-2)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (2.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.98e-1)" "unprognostic (2.21e-1)" "unprognostic (3.09e-2)" "unprognostic (4.23e-2)" "unprognostic (2.71e-2)" 40.7 59.6 52.5 37.3 56.7 55.1 41.2 36.3 44.8 39.0 53.2 37.8 50.4 43.5 36.9 61.7 57.4 41.9 60.4 80.6 45.0 40.1 64.8 66.5 36.4 55.8 48.2 38.7 36.9 59.8 46.9 39.1 79.2 38.5 35.2 49.2 33.0 62.4 64.8 75.7 54.9 72.0 42.4 48.5 43.4 45.2 29.4 35.1 34.0 49.8 53.9 44.4 42.5 34.0 17.5 30.5 117.2 34.7 17.0 29.4 24.9 17.7 48.1 15.5 14.2 24.0 30.1 19.1 16.5 34.2 8.8 9.6 14.1 26.6 4.7 24.4 27.6 14.6 12.8 31.5 7.5 15.9 104.7 11.6 35.2 21.7 46.5 19.3 18.3 34.9 44.7 13.8 44.2 25.5 13.8 22.8 26.5 30.1 24.4 17.9 6.5 36.9 10.6 13.4 35.7 38.4 40.5 18.3 31.0 26.9 35.9 19.7 27.6 19.8 28.7 45.1 6.5 13.1 19.1 58.2 63.6 15.5 31.7 22.9 29.5 33.5 34.7 46.6 20.2 31.7 17.0 17.5 22.3 22.7 30.5 15.8 15.7 17.7 117.2 17.0 31.6 27.8 29.4 24.9 52.5 56.7 36.3 44.8 45.0 40.1 48.2 38.7 38.5 35.1 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282069 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favourable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 29.7 37.5 48.0 24.3 48.6 18.8 36.2 39.9 49.4 28.3 39.0 28.1 28.4 38.1 28.2 36.3 39.2 31.4 30.6 35.1 45.1 45.2 55.6 39.2 35.6 26.1 44.1 47.5 26.5 19.9 36.4 34.8 55.7 47.4 40.8 40.9 19.8 26.0 30.2 27.1 25.6 51.9 27.5 49.2 33.0 37.3 21.2 37.0 24.9 42.0 26.1 26.0 33.7 33.5 12.4 27.8 51.2 24.6 18.1 16.6 18.1 30.8 23.0 23.4 15.1 35.9 32.7 21.9 30.9 35.0 49.3 54.8 17.5 19.6 16.7 34.2 29.0 13.4 24.5 25.2 40.1 34.5 17.3 14.0 46.5 19.0 31.2 17.7 27.6 34.7 46.7 33.1 30.9 25.6 15.0 22.1 38.8 14.1 18.4 54.9 21.5 28.4 11.3 20.8 11.0 40.5 16.9 11.5 29.6 31.4 18.5 28.3 18.9 28.0 25.5 24.7 25.8 21.1 27.3 14.7 29.1 19.2 35.6 12.3 15.8 31.5 20.1 40.2 10.7 21.6 11.5 12.4 14.3 14.0 18.3 10.6 13.2 12.5 51.2 18.1 24.6 27.8 16.6 18.1 48.0 48.6 39.9 49.4 45.1 45.2 44.1 47.5 47.4 37.0 CHMP7 MGC29816 ENSG00000147457 "Charged multivesicular body protein 7" Q8WUX9 8 23243637-23262000 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.1" "Cell line enhanced" "Detected in all" "Daudi: 24.5;U-698: 29.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 31.7" "Group enriched" "Detected in all" 12 "B-cells: 15.2;T-cells: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036119 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036119: AB_10673000" "unprognostic (2.94e-3)" "unprognostic (1.64e-1)" "unprognostic (7.59e-3)" "unprognostic (4.51e-2)" "unprognostic (2.47e-1)" "unprognostic (2.83e-3)" "unprognostic (9.00e-2)" "unprognostic (1.84e-1)" "unprognostic (6.44e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (8.98e-3)" "unprognostic (1.88e-2)" "unprognostic (6.80e-3)" "unprognostic (2.06e-1)" "unprognostic (7.54e-2)" "unprognostic (2.30e-1)" 6.4 12.7 7.3 29.2 7.4 15.4 11.0 10.5 9.2 7.5 9.2 5.6 6.4 8.1 10.0 4.5 7.5 7.3 7.6 9.8 6.3 8.0 6.9 7.4 7.2 48.8 7.8 5.8 8.1 12.4 4.4 7.0 5.3 7.3 7.4 7.3 4.1 12.5 7.9 13.8 7.5 13.7 9.8 6.5 26.2 10.5 7.0 6.8 76.1 7.7 5.9 43.3 9.3 13.7 15.2 1.3 1.8 1.9 1.8 31.7 11.8 3.8 5.3 2.8 4.8 2.6 2.7 3.3 3.2 2.3 4.7 3.9 6.0 3.0 24.5 3.8 2.3 3.7 2.7 3.9 1.8 6.6 4.9 5.1 6.8 3.1 2.4 1.3 7.4 2.2 2.7 4.5 1.3 3.8 5.7 3.3 2.6 3.8 4.3 5.7 4.7 4.1 1.8 2.3 3.4 2.4 5.0 3.7 3.5 2.4 3.6 1.4 4.0 2.7 4.2 5.7 3.8 4.1 2.5 9.7 5.1 29.4 4.4 4.1 4.3 0.4 1.9 1.8 2.5 1.7 5.2 14.6 16.6 7.7 1.3 15.2 31.7 17.9 1.7 1.8 1.2 1.1 17.3 11.8 7.3 7.4 10.5 9.2 6.3 8.0 7.8 5.8 7.3 6.8 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538947-219543787 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavourable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavourable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (2.96e-4)" 8.6 14.1 9.7 8.4 11.8 1.4 6.8 8.5 19.4 22.1 8.6 11.3 23.0 18.4 17.0 24.6 7.9 9.2 17.1 36.3 12.2 10.7 11.3 52.1 11.6 5.4 9.0 10.5 38.1 60.7 16.3 36.9 62.7 10.4 19.3 3.8 27.4 31.6 19.9 4.3 9.0 13.3 9.1 8.3 4.5 15.6 34.2 7.0 3.8 17.9 7.4 10.6 11.9 8.5 1.3 11.1 6.9 0.1 2.1 3.0 0.8 18.5 3.7 2.7 23.2 10.6 16.6 31.8 18.9 16.0 5.4 4.9 10.3 16.4 5.8 40.7 18.2 23.8 1.8 11.4 0.8 8.9 6.4 2.0 5.2 44.5 14.8 1.8 12.2 22.3 20.1 5.4 5.2 0.0 12.9 14.2 5.1 29.2 0.2 4.8 11.5 14.3 0.0 8.8 11.3 6.4 8.4 6.8 10.4 9.1 8.8 25.8 3.0 6.3 0.4 19.9 10.9 23.7 9.8 17.1 5.3 2.6 18.2 1.8 20.0 2.1 0.0 6.9 2.4 0.1 3.0 1.3 1.9 1.6 0.0 0.1 2.2 0.8 0.0 2.1 0.0 11.1 1.2 0.8 9.7 11.8 8.5 19.4 12.2 10.7 9.0 10.5 10.4 7.0 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavourable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favourable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 29.3 13.4 19.0 12.9 22.6 19.1 13.1 20.2 15.3 14.4 11.4 20.7 14.9 19.5 16.9 13.3 14.9 17.6 18.8 13.7 12.5 14.9 20.7 17.4 23.4 11.4 17.4 14.4 23.7 16.7 41.5 18.6 11.8 18.5 10.8 12.2 25.4 19.8 7.9 14.2 17.1 17.3 9.4 28.1 20.1 12.9 11.1 16.2 17.5 7.4 13.7 18.9 12.8 2.7 9.5 9.9 5.6 2.6 5.7 3.7 8.9 7.3 4.9 14.4 17.2 17.1 7.5 18.9 29.6 10.3 12.6 4.8 15.3 2.7 33.5 30.0 11.3 2.2 13.5 4.5 10.3 6.7 2.8 8.0 6.7 16.2 5.8 24.0 26.2 7.6 9.7 3.5 16.2 2.7 7.9 16.3 14.7 5.4 22.7 6.6 8.5 5.1 2.9 9.0 10.0 7.1 5.4 9.5 10.1 10.0 4.8 3.8 9.6 22.0 11.5 1.9 15.2 16.0 14.6 2.1 3.9 41.7 7.8 15.5 1.2 5.6 7.9 5.7 5.1 5.4 2.7 3.1 5.1 6.3 2.7 2.2 2.3 9.9 2.6 5.0 9.5 3.4 3.7 13.4 12.9 13.1 20.2 13.7 12.5 11.4 17.4 11.8 11.1 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Cell line enhanced" "Detected in some" "MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.7 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Cell line enhanced" "Detected in some" "RH-30: 4.9;SCLC-21H: 14.2;U-2 OS: 4.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.4 0.2 0.3 0.3 0.0 0.1 1.8 0.1 0.0 2.1 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.1 0.6 0.2 0.0 1.0 0.2 0.2 0.6 0.2 0.0 4.9 0.0 0.0 0.1 14.2 0.3 0.4 0.1 0.1 0.1 2.4 0.0 0.4 4.1 0.0 0.1 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 33.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" "Focal adhesion sites" "Plasma membrane" "HPA054381: " "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavourable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 2.9 3.3 1.7 4.4 1.7 0.6 4.9 1.8 1.7 2.7 6.4 0.4 1.6 7.8 4.7 1.9 4.0 1.1 16.3 2.4 1.7 1.8 0.9 1.8 1.4 2.0 1.9 0.3 1.7 11.8 0.0 0.7 2.1 1.2 3.6 7.1 3.5 1.7 0.7 5.8 1.0 6.8 6.1 1.3 1.9 5.3 9.8 0.6 4.5 1.6 2.9 4.4 5.7 33.9 0.9 1.1 3.4 1.6 1.6 1.4 0.7 6.6 17.1 9.3 5.2 1.1 0.8 3.8 4.9 2.4 5.4 9.9 6.5 31.6 3.9 12.1 1.0 5.9 17.9 7.2 5.6 8.0 21.4 7.3 13.4 6.5 0.6 4.9 10.4 0.3 1.3 1.4 2.0 10.1 7.1 5.2 3.4 14.5 6.2 1.7 7.5 4.7 8.0 10.8 4.0 6.5 15.9 15.8 23.2 11.7 11.4 5.4 25.4 1.2 2.2 7.4 8.9 5.4 15.3 6.0 24.7 4.4 4.5 8.0 6.8 3.0 1.6 2.5 0.8 1.6 0.4 0.3 0.8 0.5 0.9 0.9 1.4 1.4 3.4 1.6 1.3 1.1 0.3 0.7 1.7 1.7 1.8 1.7 1.7 1.8 1.9 0.3 1.2 0.6 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624119-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7" "Group enriched" "Detected in some" 16 "SCLC-21H: 20.2;SH-SY5Y: 26.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6" "Not detected" "Not detected" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.2 6.6 2.7 3.9 0.8 0.7 0.2 0.5 0.4 0.6 2.3 0.2 0.0 0.2 0.8 0.7 1.4 0.1 0.1 0.8 1.0 0.3 0.5 0.1 0.1 2.9 0.2 0.0 0.3 0.2 0.0 1.6 0.0 1.3 0.2 1.1 10.6 2.2 2.4 0.6 0.3 1.0 0.9 1.0 1.0 0.8 10.7 0.1 18.5 0.4 0.3 1.1 0.5 0.5 1.5 0.4 1.4 0.8 1.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 26.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.3 0.5 0.2 0.6 0.9 0.5 0.6 0.2 1.5 0.8 0.8 1.4 1.0 0.4 0.4 0.3 0.0 2.7 0.8 0.5 0.4 1.0 0.3 0.2 0.0 1.3 0.1 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell line enriched" "Detected in single" 72 "RH-30: 42.8" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: , HPA065404: " "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007666-124093607 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.1;REH: 35.6;U-266/70: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.4" "Group enriched" "Detected in many" 10 "granulocytes: 29.4;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol 560000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavourable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 16.4 10.0 8.7 17.0 20.6 5.7 10.7 3.4 17.9 9.8 15.4 6.6 4.0 8.8 8.6 10.8 11.3 13.1 11.7 6.4 11.3 5.3 9.0 11.9 13.9 35.4 6.5 9.6 35.0 12.6 2.9 7.7 5.9 9.2 8.5 8.3 14.4 8.2 13.4 11.0 8.3 12.5 9.5 9.0 31.5 11.4 4.8 8.7 2.8 19.3 6.1 12.6 12.5 12.0 2.1 2.0 29.4 15.4 0.0 0.1 3.2 12.6 8.5 3.2 0.7 3.1 1.7 0.0 2.6 3.5 1.4 2.0 0.2 6.9 0.0 8.3 10.5 14.4 0.6 8.3 1.2 0.0 2.4 0.0 3.9 6.3 1.0 0.0 16.3 1.0 9.6 3.9 3.3 2.8 0.0 27.1 6.9 7.0 0.0 0.0 2.8 0.0 35.6 4.3 8.4 7.0 1.2 0.3 0.7 6.8 3.9 0.0 2.8 0.0 3.3 0.3 0.1 10.0 0.4 24.6 5.9 6.8 0.1 0.0 0.0 0.0 8.8 6.2 0.0 14.0 0.0 2.0 0.0 0.0 1.8 2.1 0.1 0.0 29.4 0.0 15.4 2.0 0.1 3.2 8.7 20.6 3.4 17.9 11.3 5.3 6.5 9.6 9.2 8.7 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Cell line enhanced" "Detected in many" "ASC diff: 20.0;ASC TERT1: 20.6;HEL: 15.9;HHSteC: 41.3;HMC-1: 19.0;HSkMC: 21.7;U-266/70: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: " "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.0 20.6 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 0.0 0.7 2.7 0.4 0.2 0.5 15.9 0.0 0.0 41.3 0.4 19.0 21.7 3.3 1.0 3.4 1.2 1.8 1.0 5.2 0.0 2.9 4.0 5.6 2.7 0.1 0.3 0.0 0.5 0.7 1.3 0.0 0.2 0.0 1.8 0.0 0.6 4.1 2.4 1.4 3.2 4.6 18.2 0.2 1.1 4.7 3.0 12.6 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964365-72013564 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-251 MG: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" 510000 "Golgi apparatus, Cytosol" "HPA047523: , HPA055704: " "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 22.2 11.6 9.2 7.0 19.4 0.7 12.0 2.9 11.6 10.4 9.0 19.4 4.8 1.7 13.7 7.4 8.4 13.6 6.2 11.9 11.3 5.1 8.6 1.8 6.3 2.2 30.1 5.5 25.0 6.1 1.9 4.0 10.0 15.6 10.7 3.3 5.7 6.3 19.5 13.6 7.1 4.0 21.0 16.2 2.9 11.6 19.4 25.2 0.5 7.3 4.8 2.2 7.5 18.5 0.2 0.3 0.8 0.1 0.1 0.2 0.0 6.7 7.3 3.8 9.3 17.3 6.8 0.1 14.4 13.9 8.9 5.9 6.4 13.7 0.0 10.0 17.0 8.9 3.3 9.9 7.1 0.2 2.5 0.0 12.8 6.1 8.8 0.0 0.0 9.4 11.5 8.8 12.1 2.6 2.0 0.0 9.4 0.2 0.0 0.0 1.6 2.4 0.0 4.5 0.0 12.5 7.0 0.2 3.7 10.9 0.2 10.6 0.8 1.4 5.4 11.0 12.7 18.2 28.8 0.0 0.0 0.0 8.0 0.0 7.7 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.3 0.1 0.0 9.2 19.4 2.9 11.6 11.3 5.1 30.1 5.5 15.6 25.2 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573784-46598408 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 17.8;HHSteC: 13.2;NTERA-2: 15.8;PC-3: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 15.4" "Group enriched" "Detected in many" 10 "granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favourable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.1 7.5 4.9 3.8 6.6 4.7 12.1 4.7 10.3 10.5 4.4 3.6 2.5 2.2 5.0 4.1 4.2 3.2 10.7 25.6 4.1 4.0 3.6 11.0 5.4 3.7 4.5 4.7 27.0 3.4 2.4 3.4 5.9 3.6 3.9 2.2 1.4 2.7 3.7 4.3 5.4 3.3 3.5 1.9 17.1 3.4 3.6 1.8 2.4 4.2 1.4 2.0 4.1 8.7 1.0 1.0 9.4 8.0 0.4 15.4 1.6 4.1 3.4 2.9 2.7 8.5 6.0 0.1 5.7 4.1 1.5 2.0 0.9 1.6 0.0 17.8 2.3 3.1 2.8 1.0 1.3 2.4 6.2 0.8 0.3 3.0 13.2 1.4 0.1 2.0 0.8 2.9 2.4 4.7 0.0 3.6 1.1 1.9 0.5 1.8 15.8 13.2 2.7 2.5 7.4 4.2 0.1 6.8 2.6 0.8 0.2 0.6 1.0 0.3 1.1 4.8 0.5 2.5 2.6 8.5 1.7 1.2 5.3 0.0 0.3 1.2 1.9 0.6 1.4 5.9 1.3 1.0 5.3 2.5 1.0 0.6 1.1 1.0 9.4 0.4 8.0 0.6 15.4 1.6 4.9 6.6 4.7 10.3 4.1 4.0 4.5 4.7 3.6 1.8 CHUK "IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16" ENSG00000213341 "Conserved helix-loop-helix ubiquitous kinase" O15111 10 100188298-100229619 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001402, CAB004240, CAB018564" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (3.74e-2)" "unprognostic (3.01e-1)" "unprognostic (3.02e-2)" "unprognostic (5.93e-2)" "unprognostic (4.02e-2)" "unprognostic (2.09e-1)" "unprognostic (8.58e-2)" "unprognostic (8.39e-2)" "unprognostic (6.73e-2)" "unprognostic (1.49e-1)" "prognostic favourable (1.27e-4)" "unprognostic (2.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-3)" "unprognostic (2.22e-1)" 16.6 16.6 14.0 14.3 18.9 21.3 14.2 16.0 15.8 11.8 15.0 13.0 13.9 16.1 14.7 12.4 13.5 12.0 11.7 14.5 13.3 17.6 27.2 35.8 14.0 20.8 17.9 6.9 11.4 14.5 19.6 18.2 14.2 16.4 12.9 17.6 9.5 13.9 12.5 23.6 11.0 20.6 16.1 18.6 18.7 15.1 12.5 15.6 22.5 14.5 11.7 15.5 13.8 13.6 3.7 3.4 7.2 4.8 4.0 4.3 1.4 15.6 13.2 13.6 20.2 13.1 11.8 10.5 19.9 19.6 18.6 22.8 14.8 9.3 21.2 11.8 13.5 15.5 22.6 10.6 21.0 22.5 19.5 14.1 10.5 16.3 11.2 26.0 20.7 9.4 11.3 21.5 21.0 13.2 15.9 17.6 20.3 9.5 20.5 16.1 8.8 9.7 13.4 15.1 9.7 11.8 10.1 8.1 12.1 10.8 8.4 17.3 16.7 15.9 13.9 11.7 13.2 12.7 22.6 20.8 18.7 20.7 12.8 21.2 9.2 2.6 3.0 5.1 2.4 4.8 4.0 3.7 3.0 4.3 3.4 2.1 3.3 4.2 7.2 4.0 3.2 2.1 2.8 1.4 14.0 18.9 16.0 15.8 13.3 17.6 17.9 6.9 16.4 15.6 CIAO1 "CIA1, WDR39" ENSG00000144021 "Cytosolic iron-sulfur assembly component 1" O76071 2 96266132-96273349 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017882 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017882: AB_1846738" "unprognostic (2.34e-1)" "unprognostic (4.68e-2)" "unprognostic (5.32e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.55e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.14e-4)" "unprognostic (9.86e-2)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.26e-2)" "unprognostic (2.15e-2)" 19.8 39.7 23.6 22.2 27.6 11.1 21.4 17.9 31.9 22.1 18.4 19.9 22.3 20.4 19.4 16.5 24.0 22.3 18.3 26.1 18.3 18.2 25.4 32.5 17.7 17.7 19.2 22.7 20.4 22.2 30.6 17.8 22.2 24.5 16.4 21.1 19.2 22.0 23.5 26.1 16.3 18.5 21.5 19.7 21.8 19.3 19.1 19.0 21.6 19.4 12.2 26.0 19.9 16.9 29.6 39.8 33.1 39.7 25.9 35.2 38.5 20.5 20.6 15.7 14.6 20.2 16.4 25.6 15.8 16.8 25.6 25.3 35.1 15.2 21.7 33.6 19.5 15.7 24.2 23.4 18.4 11.5 39.9 16.7 15.3 37.9 13.1 19.4 15.2 16.4 18.8 21.3 26.7 28.5 21.3 14.9 17.2 32.6 19.3 18.2 22.0 41.8 19.4 13.9 25.2 16.8 19.3 16.9 19.4 9.9 26.9 18.9 13.5 14.2 14.7 16.0 22.8 19.0 20.9 20.3 21.4 19.3 20.8 18.9 15.7 30.6 35.3 33.1 32.7 29.3 35.2 25.3 28.7 34.9 39.8 29.6 28.5 34.2 32.4 25.9 39.7 24.0 27.6 38.5 23.6 27.6 17.9 31.9 18.3 18.2 19.2 22.7 24.5 19.0 CIB1 "CIB, KIP, SIP2-28" ENSG00000185043 "Calcium and integrin binding 1" Q99828 15 90229975-90234047 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012991, HPA042413, HPA048825" Approved Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "CAB012991: AB_2533205, HPA042413: , HPA048825: " "unprognostic (1.20e-1)" "unprognostic (1.59e-1)" "unprognostic (1.73e-2)" "prognostic favourable (2.26e-5)" "unprognostic (7.56e-2)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (8.29e-3)" "unprognostic (1.77e-1)" "unprognostic (4.09e-2)" "unprognostic (5.25e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (1.85e-1)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" 16.5 40.1 15.0 31.1 14.7 42.5 21.8 4.1 13.8 24.1 51.6 15.4 31.0 31.6 12.2 37.2 39.9 37.2 43.3 47.7 14.8 14.0 49.8 74.5 27.9 27.6 17.5 13.8 17.8 67.8 20.2 24.0 20.6 18.3 30.3 34.0 16.7 40.4 44.5 21.2 10.0 67.5 13.9 13.6 29.3 23.8 25.7 11.0 21.5 37.8 27.8 44.3 38.0 16.3 87.9 43.0 49.4 45.4 35.9 55.2 64.9 24.5 55.6 4.9 17.7 21.8 22.8 8.1 26.0 22.8 21.5 19.3 21.7 43.9 7.1 28.2 30.6 25.5 10.5 30.0 11.7 16.8 23.9 15.9 38.3 36.0 21.5 31.9 15.5 16.2 18.1 20.1 13.9 27.5 21.4 11.3 16.3 48.2 24.0 37.1 7.9 28.6 13.6 13.5 28.9 54.9 42.0 4.1 4.9 35.6 28.9 27.8 22.4 19.3 17.3 23.8 17.0 28.7 31.8 15.4 24.1 8.3 38.5 36.5 10.2 25.3 39.3 49.4 46.0 45.4 37.7 87.9 55.2 50.2 43.0 70.7 46.0 45.5 22.8 35.9 41.0 28.5 44.3 64.9 15.0 14.7 4.1 13.8 14.8 14.0 17.5 13.8 18.3 11.0 CIC KIAA0306 ENSG00000079432 "Capicua transcriptional repressor" Q96RK0 19 42268537-42295797 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026388, HPA044341, HPA064725" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB026388: , HPA044341: , HPA064725: " "unprognostic (2.02e-2)" "unprognostic (4.08e-1)" "unprognostic (1.41e-2)" "unprognostic (3.54e-3)" "unprognostic (3.67e-1)" "unprognostic (4.17e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-1)" "unprognostic (4.87e-1)" "unprognostic (1.85e-2)" "unprognostic (1.72e-3)" "unprognostic (3.10e-1)" "unprognostic (4.23e-2)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (1.88e-2)" "unprognostic (1.56e-1)" 18.6 15.7 30.5 22.8 29.9 28.1 20.3 46.8 31.6 17.5 14.7 24.7 13.0 16.5 28.6 12.3 12.3 22.1 17.4 12.1 25.5 15.2 14.9 15.1 15.8 21.5 25.2 20.1 31.5 22.6 16.6 22.6 13.2 20.4 14.4 6.2 19.0 23.8 20.8 21.0 34.1 16.1 16.3 16.5 24.7 14.5 31.5 25.6 13.6 16.8 10.6 13.4 13.6 17.4 2.3 2.0 5.0 2.6 0.6 2.5 1.6 17.6 32.0 12.3 16.9 8.0 15.1 6.0 13.5 11.3 11.4 10.6 9.0 10.9 12.3 12.9 10.6 8.6 6.8 20.4 3.7 29.8 9.2 10.3 20.2 10.7 10.1 5.8 29.4 18.0 12.0 12.9 7.6 10.4 10.1 25.9 6.4 16.8 11.4 11.1 7.7 18.2 9.8 10.5 7.3 9.5 16.6 15.9 13.1 12.8 8.0 10.1 9.5 12.5 19.9 27.3 22.2 9.3 16.4 21.5 14.8 8.4 21.2 9.2 16.1 3.4 1.8 1.0 2.5 2.6 1.9 1.7 1.3 1.6 1.7 2.3 0.9 1.5 5.0 0.6 1.9 2.0 0.5 1.6 30.5 29.9 46.8 31.6 25.5 15.2 25.2 20.1 20.4 25.6 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavourable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.6 5.6 15.7 10.0 0.7 1.5 6.4 14.2 6.7 16.8 19.8 6.7 8.4 12.6 4.9 5.1 9.5 5.3 5.0 30.7 4.0 5.2 15.1 7.6 5.0 0.2 9.7 10.8 0.6 1.0 13.1 5.4 7.5 9.3 20.4 16.5 3.8 11.6 8.6 16.1 9.6 13.3 14.6 6.9 5.1 5.2 7.6 10.0 10.4 4.1 5.8 7.0 6.9 5.5 17.3 19.6 5.2 17.0 4.7 5.2 20.9 7.6 10.5 17.6 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 CISH "CIS, CIS-1, G18, SOCS" ENSG00000114737 "Cytokine inducible SH2 containing protein" Q9NSE2 3 50606490-50611831 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HDLM-2: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB034039, HPA040812" Approved Approved "Microtubules,Cytokinetic bridge" Microtubules "Cytokinetic bridge" "CAB034039: AB_2080282, HPA040812: " "unprognostic (2.36e-3)" "unprognostic (7.60e-3)" "unprognostic (2.89e-2)" "prognostic favourable (1.13e-5)" "unprognostic (8.54e-2)" "unprognostic (9.38e-2)" "prognostic favourable (6.98e-4)" "unprognostic (6.97e-3)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "prognostic favourable (9.65e-4)" "unprognostic (1.30e-2)" "prognostic favourable (3.53e-12)" "unprognostic (2.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" 11.8 2.8 0.8 9.7 1.9 3.7 38.0 0.6 1.1 5.2 7.5 0.7 15.6 5.9 6.8 5.9 7.4 4.5 6.4 20.8 1.3 1.0 26.1 36.2 20.5 6.4 1.2 0.2 10.6 11.3 1.9 8.6 47.6 3.8 5.6 5.3 2.8 18.4 19.6 54.0 7.0 6.3 2.8 3.5 7.6 5.5 2.5 1.4 13.8 31.3 7.1 7.0 5.9 5.4 0.4 2.8 7.3 4.0 0.8 23.3 8.1 0.6 0.2 0.7 1.5 0.1 0.9 0.6 0.1 0.1 0.1 0.1 0.6 0.1 0.0 0.5 0.2 0.7 1.2 0.9 0.0 80.1 0.2 4.8 0.4 0.6 0.5 0.6 5.8 3.8 0.4 0.1 0.3 0.1 18.8 0.1 0.1 3.6 1.0 4.3 0.7 0.7 0.4 0.3 4.9 1.6 0.7 0.3 1.2 0.2 9.8 0.1 5.5 3.9 0.1 0.2 0.6 0.7 0.3 0.0 0.1 0.0 0.1 5.7 0.1 7.3 4.0 5.3 14.3 2.4 22.2 0.4 23.3 17.8 2.8 0.1 18.3 17.5 3.5 0.8 1.5 1.8 13.9 8.1 0.8 1.9 0.6 1.1 1.3 1.0 1.2 0.2 3.8 1.4 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 247.1;pituitary gland: 62.8;testis: 89.9" "Group enriched" "Detected in some" 5 "AN3-CA: 17.5;SK-MEL-30: 69.6" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Region enriched" "Detected in many" 5 "hypothalamus: 18.9" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049051: " "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favourable (6.10e-4)" "prognostic favourable (3.95e-4)" "unprognostic (2.99e-2)" 0.5 0.6 3.5 0.5 2.2 0.4 6.0 0.9 2.8 1.3 0.5 0.3 5.3 0.5 1.0 247.1 0.4 0.5 0.4 0.4 2.4 18.9 0.6 0.4 0.5 0.4 1.1 0.9 0.5 0.6 0.4 62.8 0.4 2.7 2.1 0.4 27.8 0.4 1.2 0.4 0.4 0.5 1.7 0.5 0.4 0.4 89.9 0.0 0.0 1.7 0.0 0.4 0.4 0.0 0.0 0.8 2.2 0.5 0.0 1.1 1.1 0.1 0.1 0.7 17.5 0.8 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 6.3 0.4 0.0 1.8 2.5 0.3 0.1 0.0 0.0 0.1 3.4 0.3 0.2 0.2 0.3 0.0 0.7 0.1 0.1 0.2 0.0 1.3 1.0 1.2 0.0 1.2 0.9 0.0 0.2 7.9 4.1 0.1 1.5 69.6 0.5 0.4 0.0 0.1 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.2 1.6 0.0 0.5 2.2 0.4 0.0 1.1 0.0 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 3.5 2.2 0.9 2.8 2.4 18.9 1.1 0.9 2.7 0.0 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3;lymphoid tissue: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008410, HPA027821" Enhanced Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavourable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavourable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 4.6 9.2 7.1 12.1 12.2 42.3 4.4 16.4 9.9 4.3 6.7 1.9 2.3 9.0 4.2 5.2 14.7 3.0 4.1 5.3 5.8 7.8 5.0 3.2 5.0 13.5 5.9 5.8 3.5 2.4 3.4 10.9 10.2 16.1 4.6 7.4 1.4 6.7 3.6 5.8 10.4 7.0 6.5 5.5 12.4 4.2 22.1 5.2 49.2 5.0 10.3 14.8 8.1 6.6 15.2 16.1 30.4 12.8 2.5 15.7 4.2 19.2 10.4 41.8 20.6 5.4 5.4 10.5 31.7 18.7 37.0 23.9 15.0 24.4 36.9 5.1 23.6 22.6 28.8 16.1 51.7 25.0 23.7 33.3 11.7 10.6 2.3 33.1 13.6 3.9 6.7 17.3 22.8 22.4 14.0 15.3 40.8 9.0 22.7 16.3 24.7 11.0 21.9 23.9 16.1 11.3 10.5 12.8 16.7 17.9 13.2 9.8 14.5 15.9 14.7 10.7 16.6 16.7 31.7 9.0 13.3 45.6 7.5 17.3 28.2 30.4 7.2 10.4 5.4 10.4 4.8 12.2 8.2 6.4 7.5 15.2 6.5 5.5 2.2 2.5 12.8 16.1 15.7 4.2 7.1 12.2 16.4 9.9 5.8 7.8 5.9 5.8 16.1 5.2 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736607-112764677 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 38.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Mitotic spindle,Cytosol" "Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: " "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavourable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 1.5 0.7 0.6 9.2 0.6 13.4 1.3 0.7 0.6 0.6 1.8 0.0 0.3 1.5 0.5 1.4 3.8 0.7 0.1 2.3 0.6 0.5 0.7 0.7 1.2 5.3 0.6 0.2 0.6 0.6 0.0 0.5 3.2 0.2 0.6 2.4 0.0 1.0 0.0 0.6 1.5 2.4 0.9 0.6 2.2 0.9 9.0 0.1 38.3 0.6 5.9 6.0 0.9 0.7 1.0 0.8 1.8 0.7 1.6 1.8 0.4 19.9 4.0 15.8 7.1 0.9 1.5 3.2 16.5 13.7 17.2 16.4 3.7 5.8 13.7 6.9 6.5 7.7 9.1 8.7 29.0 19.0 4.0 22.8 5.6 3.2 0.0 10.7 13.7 0.4 0.8 21.6 12.3 7.8 6.0 20.0 14.0 2.9 12.9 4.1 6.7 13.0 9.4 16.6 3.6 2.9 7.8 8.7 5.5 6.7 5.6 5.7 5.4 5.0 5.5 19.1 14.9 15.2 12.1 4.3 8.3 11.7 8.2 7.7 29.9 0.8 0.5 0.7 0.5 0.7 0.4 0.9 1.2 1.1 0.5 1.0 0.5 0.7 1.8 1.6 0.7 0.8 1.8 0.4 0.6 0.6 0.7 0.6 0.6 0.5 0.6 0.2 0.2 0.1 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237877-106304279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 73.6;BJ hTERT+: 92.9;fHDF/TERT166: 110.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 34.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792, HPA001225" Enhanced Uncertain "Nuclear speckles,Cytosol,Cytoplasmic bodies" 11000 "Nuclear speckles, Cytosol" "Cytoplasmic bodies" "HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavourable (6.61e-5)" "prognostic unfavourable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 13.0 23.8 7.1 15.3 4.9 39.5 27.2 6.9 8.4 42.3 19.2 6.5 24.8 8.1 23.7 35.2 47.3 17.2 26.6 32.9 5.7 8.0 18.3 42.1 22.2 28.5 6.3 5.4 28.6 55.2 12.7 12.0 30.6 6.8 23.9 20.5 13.2 34.4 28.0 11.1 20.8 10.7 20.4 5.8 16.7 23.0 10.3 4.2 4.0 18.6 30.0 27.8 25.8 21.4 4.2 2.3 34.6 7.5 0.1 1.0 2.4 11.2 14.2 17.2 18.7 33.6 30.0 10.0 73.6 92.9 36.0 41.5 6.0 2.6 0.7 13.4 110.9 20.5 12.6 11.1 25.9 0.3 7.3 0.0 8.2 11.8 25.1 0.1 0.2 28.7 15.3 30.5 22.1 42.1 0.0 1.4 34.1 3.8 0.5 0.4 10.0 17.3 5.2 12.4 0.9 10.9 10.2 5.7 6.3 13.1 8.9 7.0 10.0 5.1 35.9 28.4 15.7 11.7 20.8 3.9 0.0 8.0 20.5 1.4 24.8 34.6 7.5 8.7 0.5 2.7 0.7 4.2 0.7 0.4 2.3 1.6 1.0 0.9 12.7 0.1 4.1 0.0 0.2 2.4 7.1 4.9 6.9 8.4 5.7 8.0 6.3 5.4 6.8 4.2 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Plasma membrane,Centrosome" 460000 "Plasma membrane, Centrosome" Nucleoli "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 25.9 25.1 53.9 23.1 12.8 20.1 12.5 29.8 18.1 28.4 30.2 20.4 8.8 28.3 10.5 20.0 29.5 38.6 16.9 35.7 25.5 29.5 47.2 20.1 19.6 9.5 36.0 19.8 10.2 9.0 15.9 34.5 21.4 33.3 26.6 23.4 17.9 30.6 9.3 29.0 20.2 32.5 57.4 24.8 9.1 16.0 25.1 21.4 40.5 14.5 14.8 26.7 9.8 18.4 27.6 24.4 46.7 43.9 15.1 32.6 40.8 17.3 17.1 27.0 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavourable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavourable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.4 82.1 61.5 33.3 8.9 9.1 49.2 27.7 21.5 60.1 48.2 79.3 88.0 56.7 47.4 18.3 55.2 61.0 39.7 56.5 50.9 39.5 38.3 36.5 55.7 2.7 46.1 35.3 5.3 17.2 51.4 71.3 30.1 62.2 77.1 45.2 59.2 43.2 35.6 78.0 74.1 43.5 50.7 72.6 21.4 21.8 25.1 63.4 41.9 39.7 45.8 53.1 64.6 16.8 39.1 40.5 32.2 65.9 47.6 92.3 80.0 24.8 39.3 53.9 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 86.6 74.3 45.5 30.4 13.4 12.2 33.2 51.6 27.9 57.2 45.8 30.5 43.0 64.9 30.6 19.3 61.0 54.5 39.7 65.8 50.6 44.1 32.9 54.4 80.9 5.8 67.0 37.5 4.4 9.2 40.9 36.2 52.9 39.2 56.9 73.2 65.0 52.6 118.1 66.4 68.6 45.6 50.0 38.7 44.9 19.9 38.5 22.9 42.8 41.6 41.6 50.1 39.0 30.0 24.7 47.0 59.7 75.0 46.1 93.5 52.4 36.5 38.8 35.2 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA067071: " "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favourable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 7.9 14.5 20.6 6.5 31.6 6.0 9.0 45.4 67.1 13.0 8.9 50.7 3.4 5.6 11.7 6.7 10.2 9.4 10.0 22.0 19.1 16.8 10.4 6.1 8.6 7.9 33.4 22.1 16.1 6.5 11.6 16.1 8.7 44.7 9.8 7.7 13.4 6.5 12.4 31.7 7.3 6.7 11.2 29.7 7.7 6.8 6.5 37.3 4.1 8.1 4.9 8.6 8.0 7.5 8.4 8.7 4.7 8.4 12.3 7.2 5.6 7.2 16.0 18.4 15.4 12.0 11.8 13.2 13.6 12.8 16.0 17.3 9.3 7.6 23.9 7.9 10.6 6.3 23.7 10.8 19.5 19.2 16.9 23.5 14.1 8.2 5.7 23.1 20.1 7.2 10.8 17.3 16.5 15.4 22.8 13.7 17.2 4.0 17.1 9.9 13.6 10.2 18.5 17.3 12.9 10.2 8.3 15.4 26.1 15.7 12.3 13.5 11.6 20.6 14.7 12.6 11.0 9.4 14.9 9.7 18.1 19.8 11.4 16.0 15.9 4.7 5.9 3.3 4.8 6.3 7.2 8.4 4.2 4.5 8.7 5.6 5.7 5.2 1.2 12.3 8.4 8.3 4.5 5.6 20.6 31.6 45.4 38.7 19.1 16.8 33.4 22.1 44.7 37.3 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: , HPA061117: " "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.2 2.2 6.7 2.2 3.3 3.4 3.3 3.0 3.9 1.7 0.7 7.1 0.4 6.9 3.2 8.6 0.8 4.8 2.5 3.3 2.5 0.2 6.1 0.3 7.7 1.7 1.8 2.0 11.2 4.2 8.3 2.2 2.3 1.1 2.3 13.6 0.7 5.2 2.8 6.9 2.5 1.2 2.2 8.4 2.3 14.1 7.4 4.6 2.1 3.8 14.7 2.5 2.4 4.9 2.3 9.9 2.5 1.4 0.9 0.3 6.3 0.5 3.4 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell line enriched" "Detected in some" 5 "hTCEpi: 67.0" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: " "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 12.3 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 67.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell line enriched" "Detected in single" 964 "RT4: 96.4" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favourable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favourable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavourable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 10.5 2.9 1.2 11.6 1.5 10.2 7.5 0.8 1.8 11.2 7.6 2.0 3.5 1.1 18.9 5.9 3.9 12.2 16.5 5.7 1.1 0.7 17.3 2.6 6.0 4.3 0.9 1.3 12.1 5.8 0.1 4.3 11.6 3.1 4.7 1.4 3.9 5.9 1.5 4.6 1.4 5.5 7.5 1.9 7.2 7.7 3.8 1.5 1.1 6.3 9.8 11.6 5.6 5.1 11.9 1.0 11.1 8.0 0.2 8.8 2.1 6.8 14.4 1.0 4.6 1.9 2.7 0.0 9.6 5.3 6.7 3.3 2.3 19.0 4.2 8.2 12.0 4.8 0.2 4.8 2.9 0.2 0.1 0.0 9.7 1.8 6.4 0.8 1.1 3.6 1.2 6.9 3.1 1.4 1.6 0.2 6.8 5.5 0.0 3.1 3.8 13.2 0.4 2.3 0.2 10.4 0.3 0.0 0.7 26.3 1.0 0.5 0.6 1.1 5.8 13.2 5.7 16.6 14.1 0.9 0.0 0.5 16.7 0.8 5.2 0.0 0.7 11.1 8.8 2.6 5.1 8.2 4.1 6.8 1.0 11.9 0.1 3.0 0.2 0.2 8.0 0.0 0.7 2.1 1.2 1.5 0.8 1.6 1.1 0.7 0.9 1.3 3.1 1.5 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell line enhanced" "Detected in many" "CACO-2: 24.9;RH-30: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: " "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favourable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favourable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.7 2.8 2.1 3.3 8.3 5.2 4.6 1.5 0.7 0.9 1.2 24.9 1.7 1.8 0.8 1.7 1.4 6.7 0.8 1.5 0.7 4.6 1.7 1.4 6.5 3.9 2.3 3.3 3.1 1.1 2.5 3.7 3.6 2.7 2.7 2.9 1.8 0.8 0.6 3.1 1.3 1.0 38.6 2.7 3.7 2.8 3.7 2.7 2.1 2.1 3.1 1.9 1.1 1.8 1.0 2.1 7.6 0.9 2.2 6.7 4.1 1.6 3.7 5.0 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.7 5.3 12.1 10.1 13.0 13.5 3.8 4.8 9.2 6.6 10.4 8.2 13.9 8.1 4.0 4.4 8.5 7.9 8.9 5.9 3.6 4.3 8.4 10.6 10.8 16.8 4.7 7.9 9.2 5.3 12.5 7.0 5.9 10.7 11.8 6.7 3.1 4.9 12.8 8.1 4.2 6.1 6.6 7.4 8.8 4.7 5.3 8.4 3.2 5.1 11.1 4.5 8.5 7.2 6.2 7.0 10.6 3.3 7.1 4.3 21.0 7.7 9.5 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418865-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.9;ovary: 47.7;testis: 86.1" "Cell line enhanced" "Detected in some" "ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favourable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 8.2 1.9 14.1 2.0 40.6 1.7 6.3 3.5 50.3 1.9 3.4 85.9 0.5 2.2 2.7 4.6 4.6 4.2 18.9 4.0 28.7 13.0 3.2 2.8 2.8 2.1 59.5 17.1 47.7 2.1 1.8 5.5 4.2 37.3 5.1 2.5 0.6 4.7 4.2 1.7 3.6 2.6 2.8 80.6 2.6 2.5 86.1 47.9 0.0 2.0 0.9 2.0 6.3 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 56.4 71.2 0.0 0.7 3.6 4.6 7.7 0.0 9.4 0.0 42.2 5.7 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 3.2 17.4 0.0 0.0 26.0 0.0 25.3 0.0 60.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.1 40.6 3.5 25.0 28.7 13.0 59.5 17.1 37.3 47.9 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Group enriched" "Detected in some" 20 "A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: " "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favourable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.6;Daudi: 7.6;RT4: 8.1;SK-BR-3: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Uncertain "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favourable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favourable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.1 0.0 0.2 0.9 0.1 9.6 2.4 1.9 2.5 3.9 1.8 5.1 7.6 0.0 0.1 3.0 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.5 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.1 0.0 0.3 3.9 0.1 0.2 2.4 1.6 0.0 0.0 0.0 1.2 8.1 0.4 1.1 3.1 8.3 0.1 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 166.7" "Cell line enhanced" "Detected in some" "BEWO: 26.6;CACO-2: 27.7;CAPAN-2: 53.9;HaCaT: 113.3;MCF7: 39.4;SK-BR-3: 47.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favourable (8.96e-11)" "prognostic favourable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favourable (1.85e-4)" "unprognostic (1.62e-1)" 1.6 2.0 0.4 28.0 0.4 0.0 9.5 0.4 0.4 9.9 71.4 0.4 47.6 47.2 2.4 49.3 73.4 13.4 47.2 0.7 0.4 0.3 30.0 12.1 32.3 0.8 0.4 0.4 3.4 70.9 12.3 7.3 25.0 0.4 9.8 42.5 0.7 40.9 42.2 0.9 2.9 166.7 1.8 0.5 1.4 1.2 1.8 0.4 1.5 40.5 28.3 45.6 12.2 19.3 3.8 1.6 0.0 3.0 2.2 6.7 2.3 3.2 0.3 0.0 0.0 0.0 0.2 26.6 0.0 0.0 0.0 0.0 27.7 53.9 0.0 1.0 0.1 113.3 0.0 3.4 0.0 0.0 0.6 0.0 0.7 0.0 2.1 0.0 0.2 0.5 5.4 0.0 0.2 2.5 0.3 0.1 0.0 39.4 0.0 0.3 0.1 1.0 0.0 0.0 0.7 0.0 0.0 6.5 0.1 0.3 47.2 0.0 17.2 0.4 5.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 2.2 3.0 4.8 0.5 1.5 3.3 1.6 3.8 3.7 6.7 0.0 2.2 0.1 0.2 0.9 2.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA076613: " "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.5 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 19.1 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.2 0.1 15.0 0.1 0.7 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.0;HUVEC TERT2: 92.2;TIME: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: " "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favourable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 92.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944488-11182189 "Disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: " "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favourable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 9.2 9.7 11.1 12.7 13.7 15.8 8.3 17.2 19.5 8.7 9.4 14.2 9.5 11.0 9.4 10.8 11.5 9.7 6.9 10.7 11.0 10.7 11.2 12.9 12.0 11.4 12.4 10.1 7.7 7.3 22.5 21.8 9.6 13.6 8.6 8.6 12.2 9.4 9.2 14.0 15.9 10.8 9.7 14.4 9.5 8.5 43.1 11.6 15.4 11.5 5.2 12.9 8.3 8.7 7.7 5.0 6.6 6.7 4.0 5.6 2.4 5.2 5.5 4.3 5.6 7.2 5.1 3.8 5.4 5.4 4.6 6.1 6.1 9.9 10.4 12.8 6.7 4.7 5.5 10.2 6.0 50.7 5.8 4.7 7.6 6.5 5.1 5.1 10.3 6.0 5.0 7.6 6.5 6.3 7.8 6.5 5.5 8.6 8.1 4.1 3.4 4.4 11.1 3.6 6.1 9.6 3.9 5.5 7.3 7.8 8.1 4.2 5.7 8.2 6.6 5.9 7.8 8.7 4.8 4.6 4.0 8.7 7.5 7.6 6.1 5.5 4.5 3.2 5.5 3.7 3.4 4.4 4.7 3.7 3.6 7.7 5.6 4.8 6.6 4.0 6.7 5.0 3.3 2.4 11.1 13.7 17.2 19.5 11.0 10.7 12.4 10.1 13.6 11.6 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699555 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 45.6;lymphoid tissue: 47.5" "Group enriched" "Detected in some" 4 "Daudi: 27.2;HDLM-2: 21.2;Karpas-707: 12.9;U-698: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5" "Group enriched" "Detected in many" 11 "B-cells: 24.6;T-cells: 45.6" "HPA017649, HPA047584" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favourable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favourable (1.68e-7)" 3.8 1.0 1.1 47.5 1.1 7.8 3.7 0.8 1.0 2.9 6.0 0.6 1.4 1.7 3.0 7.0 3.6 3.2 3.0 3.3 1.2 1.1 2.6 1.3 10.4 28.3 1.7 1.2 4.0 1.5 0.2 1.3 1.7 1.1 4.5 2.1 2.5 9.8 3.2 1.2 2.4 11.2 3.2 2.5 21.3 2.7 5.7 1.0 44.7 2.8 2.7 29.4 8.2 2.5 24.6 0.4 1.1 0.4 3.1 45.6 19.2 0.4 1.0 1.5 0.1 0.2 0.6 1.6 0.7 1.0 0.3 0.9 0.7 0.9 27.2 0.1 0.7 0.3 0.5 0.0 0.5 21.2 0.4 0.8 0.6 1.2 2.4 0.6 0.7 0.9 0.7 0.2 0.9 0.0 0.2 12.9 0.6 1.8 0.3 2.4 1.3 0.2 5.9 0.6 0.8 1.4 1.5 0.2 0.5 0.3 1.1 1.1 0.2 0.7 0.2 0.5 0.7 0.4 0.4 1.8 0.4 41.8 1.2 1.2 0.8 1.1 0.4 0.2 37.8 0.2 23.0 15.9 37.3 41.3 0.4 24.6 39.4 45.6 1.1 3.1 0.2 0.3 31.5 19.2 1.1 1.1 0.8 1.0 1.2 1.1 1.7 1.2 1.1 1.0 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 23 "HL-60: 14.8;U-937: 57.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054137: " "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 5 "HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" HPA063928 Supported "Plasma membrane,Centriolar satellite" "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 55.5 0.0 30.5 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 CLHC1 "C2orf63, FLJ31438" ENSG00000162994 "Clathrin heavy chain linker domain containing 1" Q8NHS4 2 55174791-55232563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045418, HPA053557" Uncertain Approved "Nucleoli fibrillar center,Centrosome" "Nucleoli fibrillar center, Centrosome" "HPA045418: AB_10962144, HPA053557: " "unprognostic (1.60e-1)" "unprognostic (2.86e-1)" "unprognostic (3.43e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.91e-2)" "unprognostic (6.41e-3)" "unprognostic (1.03e-3)" "unprognostic (1.39e-1)" "unprognostic (3.54e-4)" "unprognostic (6.36e-2)" "unprognostic (1.05e-4)" "unprognostic (1.84e-1)" "unprognostic (1.47e-1)" "unprognostic (1.19e-2)" "prognostic favourable (2.15e-4)" 4.8 5.7 10.4 3.6 8.7 3.5 6.7 15.7 11.9 6.0 5.3 12.9 9.3 3.9 8.5 9.8 5.5 9.5 6.2 4.6 8.2 5.1 5.2 3.5 5.3 6.6 6.0 8.3 7.4 5.5 8.4 23.6 6.9 8.9 9.1 6.6 8.9 5.8 8.9 3.0 9.6 5.6 7.1 12.0 7.2 4.9 23.2 8.8 10.1 8.3 1.6 5.2 6.6 6.1 1.3 2.9 4.0 2.0 3.2 2.1 1.0 4.3 3.2 8.3 4.9 3.4 4.7 7.2 5.7 5.4 2.9 2.7 6.3 4.0 6.4 3.4 2.6 6.6 3.5 4.9 6.0 5.7 4.1 9.3 9.7 5.7 3.7 5.6 4.6 6.6 4.0 3.6 8.4 2.9 4.7 3.8 3.3 3.5 4.1 6.3 3.0 1.3 5.0 4.7 4.0 4.6 5.1 9.5 5.8 3.3 5.4 5.4 4.1 3.1 8.4 7.3 4.9 3.4 4.0 7.6 1.9 3.7 5.4 5.7 1.8 1.2 0.6 4.0 0.9 2.0 0.1 1.2 1.7 0.9 1.0 1.3 2.1 1.0 0.4 3.2 1.6 2.9 1.1 1.0 10.4 8.7 15.7 11.9 8.2 5.1 6.0 8.3 8.9 8.8 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Group enriched" "Detected in some" 5 "HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane" 290000 "Plasma membrane" Nucleoplasm "HPA047381: , HPA060101: " "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavourable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 36.5 0.2 5.1 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 19.7 18.2 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 31.1 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.4 0.0 1.7 0.5 0.7 0.3 1.1 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9" "Group enriched" "Detected in some" 8 "CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.8" "Lineage enriched" "Detected in single" 23 "T-cells: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA074371 Supported "Nuclear speckles,Plasma membrane" 1000000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 7.4 0.6 0.8 3.2 1.5 0.0 2.3 0.6 1.1 6.0 10.2 0.3 0.4 5.6 0.8 2.5 2.2 1.2 2.1 65.6 0.9 1.2 17.5 0.5 32.8 0.4 1.1 1.4 0.7 0.7 0.4 1.3 22.0 0.8 0.9 7.5 7.8 2.0 0.4 99.9 0.7 46.2 1.4 0.9 16.1 0.9 1.0 0.0 0.2 4.8 18.8 1.5 1.0 4.3 0.3 0.0 0.0 0.0 0.3 8.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.3 0.0 9.4 0.0 0.3 0.0 0.1 0.0 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.3 0.0 11.4 0.3 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 8.8 0.3 3.6 2.2 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 1.6 0.8 0.8 1.5 0.6 1.1 0.9 1.2 1.1 1.4 0.8 0.0 CLINT1 "CLINT, ENTH, EPNR, KIAA0171" ENSG00000113282 "Clathrin interactor 1" Q14677 5 157785743-157859175 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 95.0;eosinophil: 27.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 95.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043280, HPA056947" Supported Supported Nucleoplasm,Vesicles 340000 Vesicles Nucleoplasm "HPA043280: AB_10793944, HPA056947: AB_2683283" "unprognostic (1.92e-2)" "unprognostic (6.93e-2)" "prognostic favourable (2.95e-4)" "unprognostic (7.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (2.53e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-2)" "unprognostic (4.89e-3)" "unprognostic (1.04e-1)" "prognostic favourable (8.88e-5)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (6.77e-4)" "unprognostic (3.56e-1)" 22.0 23.3 12.6 27.1 18.8 38.1 18.8 13.6 14.7 22.0 27.9 10.0 43.8 28.8 19.1 30.3 56.4 17.1 40.3 23.4 14.0 12.7 40.8 48.6 22.3 19.2 11.7 11.7 20.1 25.3 47.9 25.9 30.1 14.3 21.5 23.7 11.3 39.9 47.1 38.7 26.0 34.6 30.9 13.0 19.0 29.4 12.1 13.0 23.6 30.3 23.3 32.8 37.1 33.8 7.8 9.9 95.0 7.8 8.8 12.7 7.5 22.7 32.9 23.5 21.8 32.7 27.6 33.7 32.1 33.3 31.8 44.9 45.8 36.0 42.9 36.9 30.5 34.4 31.8 37.1 45.4 20.2 25.7 28.6 29.6 22.9 33.4 39.0 38.8 20.5 27.9 35.6 40.2 29.7 24.4 23.9 25.5 20.0 30.6 21.7 24.6 34.1 27.6 35.2 36.2 31.8 41.0 20.7 22.5 23.2 40.2 31.6 27.7 27.6 29.8 27.8 20.6 25.3 31.4 27.9 26.5 55.0 22.5 44.7 24.3 95.0 7.4 27.6 7.4 7.8 12.7 7.8 7.1 7.3 9.9 7.0 6.2 6.6 2.8 8.8 7.8 7.8 10.1 7.5 12.6 18.8 13.6 14.7 14.0 12.7 11.7 11.7 14.3 13.0 CLIP1 "CLIP, CLIP-170, CLIP170, CYLN1, RSN" ENSG00000130779 "CAP-Gly domain containing linker protein 1" P30622 12 122271432-122422632 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004399, HPA026678" Approved Supported "Microtubule ends,Cytosol" 7700 "Microtubule ends, Cytosol" "CAB004399: AB_671001, HPA026678: AB_1846954" "unprognostic (1.18e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (2.51e-1)" "unprognostic (7.62e-2)" "unprognostic (2.31e-2)" "unprognostic (8.97e-2)" "unprognostic (3.26e-2)" "unprognostic (5.50e-2)" "unprognostic (2.63e-1)" "unprognostic (3.37e-1)" "unprognostic (2.52e-3)" 14.4 12.6 9.8 9.1 10.9 6.4 11.7 44.5 11.5 11.6 19.5 4.3 13.9 5.7 14.3 10.1 24.8 7.5 7.7 11.8 9.3 7.5 10.0 15.2 10.0 5.8 6.5 9.5 6.3 9.1 37.8 10.9 36.5 8.7 13.2 7.1 6.7 11.8 15.1 96.5 16.8 9.1 31.1 7.2 5.9 9.6 6.1 6.9 3.7 24.1 25.9 10.1 22.2 16.6 5.3 5.4 18.2 10.6 3.9 7.2 3.7 15.3 19.4 12.0 12.1 10.3 15.9 20.9 21.9 20.9 14.9 9.3 9.0 7.6 6.9 14.8 28.4 19.7 7.6 9.0 16.9 28.9 5.5 2.3 12.9 9.5 20.5 7.9 12.7 10.5 31.0 17.1 25.9 14.9 8.6 4.7 14.9 8.9 4.9 2.8 4.5 17.2 4.6 9.3 3.4 13.4 17.6 4.6 2.9 47.0 11.5 19.2 9.9 4.7 28.8 11.3 12.2 26.5 14.3 5.3 4.1 4.1 19.4 4.0 7.8 3.6 6.5 5.2 7.2 10.6 5.4 5.3 6.7 6.5 5.4 3.6 5.0 3.7 18.2 3.9 8.6 3.5 5.8 3.7 9.8 10.9 44.5 11.5 9.3 7.5 6.5 9.5 8.7 6.9 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: " "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favourable (2.28e-4)" 26.3 55.1 27.8 30.5 43.4 97.6 40.2 40.1 40.7 42.2 23.0 19.9 39.1 12.9 29.1 34.5 26.3 19.1 35.8 26.7 31.0 21.9 21.8 35.3 28.2 30.1 56.0 23.1 48.1 20.9 36.6 41.5 40.0 34.4 34.3 16.5 13.7 25.6 37.1 27.3 32.1 14.9 36.8 55.2 32.4 15.1 12.4 52.6 25.0 30.4 20.2 25.6 51.2 71.8 13.2 9.8 26.2 6.2 6.5 14.4 7.4 8.1 6.1 10.3 3.1 11.7 12.9 8.1 8.8 12.6 9.0 12.0 11.4 5.3 2.8 6.0 5.5 8.8 13.0 4.1 18.5 12.4 11.4 8.3 15.5 14.1 7.0 8.7 14.2 5.9 18.6 11.3 19.9 5.2 10.0 36.8 12.8 5.5 10.2 26.4 6.5 14.0 10.4 12.2 14.6 6.2 5.3 10.4 8.2 7.7 2.9 12.8 2.4 6.0 8.0 10.1 6.9 9.7 9.7 21.7 9.0 6.5 6.5 7.1 6.8 26.2 6.2 13.3 13.6 4.4 13.1 13.2 12.8 12.1 4.1 10.1 14.4 11.4 12.7 6.5 4.2 9.8 13.0 7.4 27.8 43.4 40.1 40.7 31.0 21.9 56.0 23.1 34.4 52.6 CLK2 clk2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA055366: , HPA059507: " "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favourable (5.43e-4)" 15.3 16.6 14.6 15.0 19.0 12.9 17.1 33.1 20.2 22.3 18.0 18.7 18.1 14.5 22.6 19.9 15.5 18.2 13.9 11.8 17.1 7.3 17.3 18.2 14.7 22.2 16.9 16.9 24.7 15.9 29.2 21.6 19.2 13.5 22.1 13.5 16.1 16.4 18.2 10.4 21.4 15.6 17.0 13.5 27.0 13.7 13.7 20.3 18.1 22.9 8.0 22.2 16.7 20.1 2.8 1.9 4.8 1.7 0.7 4.1 1.1 6.0 5.2 18.9 5.8 9.5 5.1 16.1 5.4 6.6 4.2 4.2 5.5 4.3 13.1 7.5 3.7 8.7 9.4 7.0 4.0 9.5 7.4 10.4 5.4 7.0 8.2 12.9 10.5 4.1 6.4 6.1 12.3 7.3 14.6 9.1 6.3 10.4 8.8 7.7 12.3 7.4 9.8 11.4 14.1 10.6 13.5 9.0 12.8 2.0 6.5 5.0 9.9 15.9 4.8 2.6 6.9 4.7 4.5 17.4 14.8 11.9 5.1 9.3 2.9 4.8 1.7 3.4 2.0 0.8 2.9 2.8 3.4 1.8 1.8 2.4 3.4 4.1 2.1 0.7 0.8 1.9 1.7 1.1 14.6 19.0 33.1 20.2 17.1 7.3 16.9 16.9 13.5 20.3 CLK3 clk3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavourable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavourable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 20.9 17.2 15.7 24.7 22.5 62.7 31.1 23.4 18.8 24.9 24.6 23.1 16.4 18.6 24.1 17.7 25.3 17.3 21.2 16.4 17.8 13.5 17.2 16.0 19.6 21.9 29.3 14.5 23.7 21.8 19.0 19.9 27.9 16.7 20.6 14.4 19.9 24.8 20.9 28.4 24.1 20.7 19.8 19.2 23.8 19.6 31.5 23.3 28.8 21.0 12.0 23.7 23.2 19.8 38.9 36.0 60.7 46.0 43.6 43.4 39.7 22.3 14.2 18.8 10.5 24.2 18.5 14.8 15.3 24.2 21.9 26.9 19.2 14.8 20.4 11.3 13.6 15.8 35.0 14.7 14.3 28.9 19.1 25.0 21.1 13.3 38.5 6.7 19.4 23.2 29.3 28.7 24.0 23.9 12.1 14.9 12.7 15.8 19.8 22.7 12.0 10.0 16.1 9.0 13.3 17.0 16.2 10.6 12.4 12.2 13.6 13.5 12.9 13.5 11.0 13.0 10.0 8.1 20.0 24.4 19.6 16.7 11.4 33.0 16.3 32.9 34.4 45.0 38.5 37.4 37.4 37.7 41.1 39.7 31.9 38.9 42.1 40.1 60.7 43.6 46.0 36.0 43.4 39.7 15.7 22.5 23.4 18.8 17.8 13.5 29.3 14.5 16.7 23.3 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 13.9;T-47d: 11.6;WM-115: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favourable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.1 1.1 0.2 4.4 2.0 0.4 0.1 0.0 0.3 0.2 0.6 9.0 0.0 0.8 0.0 4.7 0.5 3.2 0.0 3.6 1.3 0.1 0.2 4.2 0.4 0.0 0.1 2.1 3.2 1.4 5.1 3.6 0.0 1.0 2.6 4.6 0.2 0.4 0.4 1.7 4.0 3.8 2.3 3.4 8.7 1.4 1.4 1.8 13.9 7.1 11.6 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.9 2.5 2.1 13.2 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: , HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.4 28.7 7.5 10.5 4.6 3.8 18.1 11.0 5.3 13.5 11.1 22.1 18.7 17.9 5.4 6.5 21.4 21.5 10.6 5.4 11.8 26.3 25.7 20.9 16.4 9.5 28.9 18.4 6.7 3.5 10.8 7.5 9.0 16.9 36.3 10.3 31.4 13.1 20.7 17.9 12.2 12.8 22.9 24.3 11.3 30.0 15.4 6.3 12.3 19.3 10.5 10.3 28.9 5.9 15.2 18.1 11.2 38.7 26.6 28.9 14.6 9.5 35.2 14.7 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637805 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Cytosol" Microtubules "CAB017840: , HPA031707: , HPA031708: , HPA032045: " "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 22.6 44.7 43.0 31.3 37.3 27.8 36.4 24.5 45.6 30.0 31.9 41.8 26.2 22.1 29.3 47.4 41.5 34.5 29.9 33.2 37.2 39.5 26.8 90.9 20.8 41.2 45.3 31.2 49.2 44.9 26.5 28.9 29.0 38.5 28.7 35.7 29.6 28.2 27.4 43.1 24.4 26.3 26.1 48.5 32.5 28.5 21.7 31.7 47.0 40.5 36.8 45.1 31.9 28.8 33.4 45.9 12.8 34.1 31.8 32.7 30.6 24.4 24.1 40.3 29.9 30.2 43.4 16.3 21.6 33.4 35.3 31.9 58.9 35.1 55.3 36.0 26.3 29.8 48.7 44.9 43.3 30.9 29.7 54.3 30.4 33.9 25.4 80.2 25.2 34.8 52.5 31.1 59.1 40.0 71.2 17.1 34.6 36.4 52.7 65.4 38.0 45.3 28.5 78.4 59.3 25.5 34.4 41.1 46.8 29.1 33.1 20.0 44.9 35.1 26.3 26.4 32.3 51.4 20.8 34.4 47.9 59.3 10.4 30.2 21.1 12.8 33.1 12.2 21.0 34.1 24.0 32.1 26.8 23.1 45.9 33.4 32.7 27.5 2.3 31.8 28.7 28.2 23.0 30.6 43.0 37.3 24.5 45.6 37.2 39.5 45.3 31.2 38.5 31.7 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55547138 "Enzymes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 9.3 9.2 7.8 5.8 11.7 1.7 8.4 16.2 14.3 12.5 9.5 5.2 9.2 7.1 10.5 8.4 13.9 8.1 6.7 10.5 7.9 7.9 12.4 9.1 8.2 9.4 7.0 9.8 11.7 8.6 18.7 21.9 8.5 8.4 9.7 8.4 5.6 8.2 9.2 16.1 9.4 12.6 13.8 8.3 9.1 9.6 18.5 5.0 4.0 14.7 5.9 5.2 8.4 17.1 2.5 3.6 0.6 3.0 2.9 4.7 1.4 13.4 5.9 5.3 8.3 8.0 8.1 2.6 13.9 11.4 9.7 9.0 3.7 10.7 3.6 7.2 16.1 11.3 6.8 10.8 16.5 4.4 2.4 2.9 6.2 4.6 7.1 4.7 3.4 4.7 10.7 13.4 13.2 9.1 6.6 7.4 14.6 7.4 2.6 2.6 3.8 6.8 1.7 6.1 2.4 7.5 7.3 5.2 4.7 10.0 12.4 6.3 4.2 2.6 12.5 13.2 14.1 4.3 18.7 6.7 4.8 2.3 11.7 4.2 10.4 0.0 3.0 0.6 2.8 3.0 4.7 1.4 3.2 2.5 3.6 2.5 1.9 2.4 0.6 2.9 2.7 2.1 3.1 1.4 7.8 11.7 16.2 14.3 7.9 7.9 7.0 9.8 8.4 5.0 CLPTM1 ENSG00000104853 "CLPTM1, transmembrane protein" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068702, HPA068767" Approved Approved "Nuclear membrane,Centriolar satellite" "Nuclear membrane, Centriolar satellite" "HPA068702: , HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 29.7 53.4 39.4 20.3 56.2 14.7 20.2 26.7 66.4 25.8 26.6 36.8 17.3 31.5 20.3 24.0 23.7 25.6 22.1 32.2 35.7 35.7 40.6 62.5 23.1 19.1 36.0 33.7 26.9 36.2 53.8 21.1 34.3 37.7 27.1 21.3 30.2 38.0 29.6 37.6 32.9 27.6 23.7 27.2 22.6 25.1 26.7 30.7 13.9 27.3 16.1 26.3 19.5 18.6 18.4 24.1 25.5 28.8 12.5 24.4 11.8 26.4 59.8 13.9 27.5 46.4 18.7 14.8 26.2 28.9 30.9 33.3 25.9 26.8 26.3 29.3 34.6 31.3 24.7 23.7 21.0 19.3 34.2 20.4 22.6 21.7 32.8 16.2 23.9 29.3 25.2 29.5 19.1 21.5 21.1 36.9 27.3 23.8 17.0 9.5 12.5 19.9 17.7 15.1 25.5 28.7 37.1 16.4 18.1 32.4 48.2 14.2 26.3 13.0 19.9 34.8 21.7 18.2 32.4 25.9 56.6 20.5 28.8 16.1 31.8 10.4 16.7 25.5 17.0 23.6 14.3 17.5 18.3 24.4 15.4 18.4 14.5 12.2 15.7 12.5 28.8 24.1 15.1 11.8 39.4 56.2 26.7 66.4 35.7 35.7 36.0 33.7 37.7 30.7 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: " "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favourable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.2 9.0 7.8 9.9 8.4 10.8 8.5 6.0 6.8 6.6 7.0 8.9 7.4 16.3 5.1 8.1 11.3 28.7 8.0 7.1 6.4 5.2 12.2 8.7 11.3 12.0 15.6 7.1 12.8 11.0 6.1 11.7 8.4 11.2 5.8 7.7 6.6 7.3 13.8 8.8 4.0 14.5 9.4 16.8 12.5 12.2 6.8 5.5 8.1 13.1 8.8 5.9 13.2 7.4 6.7 5.9 5.4 5.6 6.2 9.4 8.6 6.6 19.8 5.2 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA026305: , HPA026312: " "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favourable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.5 7.1 15.7 8.2 1.1 2.0 5.9 17.7 5.0 13.0 17.4 11.4 8.0 18.4 5.8 4.7 8.7 15.2 6.1 20.4 12.6 6.9 25.9 15.7 5.0 0.0 21.2 15.3 0.4 0.2 22.4 1.6 7.0 17.4 12.8 12.4 5.6 22.2 4.8 14.8 5.1 14.2 23.7 5.5 2.7 14.3 5.8 6.8 15.4 4.7 3.1 4.1 8.3 5.0 18.7 14.2 11.5 19.7 4.6 11.3 19.4 5.9 15.2 15.1 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: " "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.0 2.5 0.6 0.1 0.7 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 2.3 0.0 0.0 0.0 2.4 10.1 0.0 1.2 0.5 1.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 CLTA Lca ENSG00000122705 "Clathrin light chain A" P09496 9 36190856-36304781 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002665, HPA050918, HPA054667" Enhanced Enhanced Vesicles,Endosomes,Lysosomes 2100000 "Vesicles, Endosomes, Lysosomes" "CAB002665: , HPA050918: , HPA054667: " "prognostic favourable (5.64e-4)" "unprognostic (7.62e-2)" "unprognostic (9.22e-2)" "unprognostic (8.45e-3)" "unprognostic (1.71e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (9.46e-5)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-3)" "unprognostic (7.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.98e-2)" 60.0 64.8 65.0 46.9 60.8 35.4 55.5 68.6 86.3 58.1 71.4 55.5 35.8 65.6 58.1 64.5 63.8 65.2 56.4 31.4 62.6 62.0 72.2 60.0 48.7 53.1 67.1 67.0 78.1 52.8 42.8 47.0 78.2 67.9 53.3 67.6 48.1 58.8 47.6 33.2 47.5 58.3 52.4 71.5 59.6 56.3 48.3 41.9 58.2 77.1 49.4 54.5 46.2 60.5 31.3 57.3 29.1 59.5 22.6 40.5 45.9 60.3 48.5 36.6 27.8 53.5 53.9 59.0 62.7 47.8 50.5 59.5 36.3 27.2 45.7 34.8 41.7 25.8 45.8 43.6 46.5 30.9 37.0 35.0 49.4 37.1 71.9 37.1 32.5 59.2 48.4 57.9 46.0 62.3 30.4 24.1 76.0 21.0 33.3 47.3 58.4 69.5 32.2 24.3 25.9 68.2 43.3 28.4 47.8 26.2 30.8 51.5 27.8 45.9 79.6 40.8 45.9 46.6 65.2 16.2 38.0 48.5 50.3 52.2 35.9 29.1 56.6 28.0 26.5 59.5 27.8 31.3 28.9 27.2 57.3 30.6 26.4 22.8 22.2 22.6 45.6 49.5 40.5 45.9 65.0 60.8 68.6 86.3 62.6 62.0 67.1 67.0 67.9 41.9 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392455-176416569 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 103.7;MCF7: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" 350000 Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 20.4 24.1 29.7 18.7 26.7 13.5 16.0 27.5 47.9 27.7 34.7 14.2 11.4 35.4 15.0 15.7 94.2 12.7 28.4 65.7 26.4 26.9 20.3 15.0 15.6 12.2 25.9 22.7 24.3 19.7 17.9 19.8 61.2 28.7 16.8 18.1 19.4 22.2 19.3 93.7 81.8 41.1 27.1 15.4 14.2 39.6 9.9 10.1 14.3 17.2 55.4 31.2 26.1 45.3 4.3 9.9 28.0 9.9 7.4 11.6 3.6 32.8 15.8 4.5 19.1 10.1 7.6 36.8 42.4 16.5 26.9 19.3 20.3 15.4 7.2 25.0 19.0 31.4 7.6 103.7 10.5 49.2 14.1 4.8 23.4 12.5 15.9 7.6 12.9 8.0 36.1 14.7 17.4 12.6 9.2 18.5 14.8 92.2 12.0 11.6 3.6 23.5 13.1 7.9 23.6 14.2 13.4 19.3 6.6 20.1 22.2 14.4 9.0 14.8 27.2 9.7 14.5 17.6 23.9 14.7 10.1 9.7 7.8 16.3 11.0 2.8 9.9 28.0 7.2 7.5 3.7 3.1 6.4 7.0 9.9 4.3 5.2 5.5 18.7 7.4 9.7 8.0 11.6 3.6 29.7 26.7 27.5 47.9 26.4 26.9 25.9 22.7 28.7 10.1 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" 51000000 "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: " "unprognostic (1.56e-1)" "prognostic unfavourable (7.35e-4)" "prognostic favourable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavourable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.02e-4)" 39.5 45.7 47.4 35.1 57.6 30.7 57.9 59.1 83.6 38.1 45.0 25.1 47.7 27.9 38.7 52.3 32.1 30.9 34.1 39.9 47.1 53.7 48.6 46.0 46.5 60.7 53.9 59.3 29.8 23.3 96.1 30.0 51.5 57.0 38.9 48.9 22.7 28.6 54.4 44.2 30.5 27.7 45.8 47.8 28.0 34.2 29.4 28.8 28.0 43.7 26.6 31.2 37.1 40.6 10.0 24.6 13.9 24.6 12.3 15.6 13.1 46.9 71.1 35.1 34.7 59.3 48.3 40.1 50.5 53.3 45.3 47.3 43.5 28.9 32.7 58.0 71.7 31.0 52.2 42.0 60.5 35.1 28.1 53.6 45.0 67.5 45.2 36.6 31.0 45.7 25.7 68.8 44.4 50.0 53.3 46.3 70.5 83.7 21.7 10.9 30.2 41.5 19.3 58.8 39.6 50.7 66.7 31.5 37.5 31.3 20.5 29.9 48.7 23.1 63.9 83.1 49.6 39.6 51.7 36.5 51.2 30.2 60.9 24.8 50.7 10.5 20.9 13.9 12.7 24.6 15.6 10.0 11.7 13.7 24.6 9.1 10.0 11.0 13.4 12.3 20.7 16.1 14.5 13.1 47.4 57.6 59.1 83.6 47.1 53.7 53.9 59.3 57.0 28.8 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell line enhanced" "Detected in many" "HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA048543: " "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favourable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.2 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 10.7 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.0 0.7 0.6 0.3 3.5 0.2 0.4 3.6 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.6 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 CLUAP1 "CFAP22, FAP22, FLJ13297, IFT38, KIAA0643" ENSG00000103351 "Clusterin associated protein 1" Q96AJ1 16 3500924-3539048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036976, HPA044191" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA036976: AB_10602209, HPA044191: " "unprognostic (1.78e-1)" "unprognostic (9.28e-3)" "unprognostic (1.21e-1)" "prognostic favourable (3.01e-4)" "unprognostic (1.57e-1)" "unprognostic (3.67e-1)" "unprognostic (4.53e-2)" "unprognostic (3.63e-2)" "unprognostic (2.04e-1)" "unprognostic (8.44e-2)" "unprognostic (3.13e-1)" "unprognostic (6.94e-3)" "unprognostic (5.11e-3)" "unprognostic (8.43e-2)" "unprognostic (2.07e-1)" "unprognostic (8.94e-3)" "unprognostic (1.12e-2)" 8.3 10.4 12.3 6.8 22.3 3.3 12.7 13.6 18.8 19.2 11.7 12.1 15.7 4.0 23.0 14.7 10.2 27.6 9.5 9.4 11.4 12.5 16.5 6.8 10.5 6.7 11.9 17.8 22.7 10.7 30.5 22.1 9.3 15.8 15.4 8.9 12.0 10.0 18.3 8.8 6.0 6.0 17.6 11.7 5.7 8.8 34.6 10.3 8.2 19.5 6.2 5.2 12.7 9.1 4.7 4.5 2.7 2.7 5.5 19.8 4.1 8.2 10.0 11.5 15.4 17.5 18.2 6.0 10.5 14.1 17.1 12.8 2.7 16.9 4.0 9.2 17.0 8.7 7.5 12.3 14.7 3.3 7.1 3.7 5.7 5.4 20.5 6.6 4.1 11.7 13.7 16.0 15.9 9.3 10.8 0.6 12.6 9.9 6.1 7.3 11.9 5.8 13.7 8.0 8.1 25.7 2.5 12.8 11.0 6.2 4.9 7.6 10.2 15.3 6.1 11.7 7.9 9.0 8.1 6.9 5.6 1.1 4.5 3.9 8.1 2.7 2.5 0.7 4.5 2.7 8.5 4.7 13.0 7.7 4.5 4.0 19.8 13.4 1.0 5.5 1.6 4.5 6.7 4.1 12.3 22.3 13.6 18.8 11.4 12.5 11.9 17.8 15.8 10.3 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.2" "Cell line enhanced" "Detected in all" "CACO-2: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" Vesicles "Nuclear bodies" "HPA031505: , HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favourable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 14.1 21.0 9.6 10.4 12.4 7.8 10.2 16.0 20.9 7.6 17.5 10.6 7.4 29.4 8.4 6.9 28.7 7.6 11.2 31.8 8.5 6.9 28.6 75.2 7.4 8.2 7.0 9.7 8.3 20.3 7.0 8.2 6.2 12.5 9.4 8.1 9.9 18.9 8.4 65.6 20.0 20.9 9.9 6.5 9.9 13.6 11.4 7.5 6.8 10.1 22.1 15.9 12.4 10.0 4.5 5.0 0.4 5.9 1.1 4.7 1.5 18.6 33.3 2.4 8.4 5.0 3.6 27.8 10.0 3.5 10.8 7.8 67.1 7.6 34.1 12.0 4.7 34.2 11.1 13.0 3.6 12.2 24.6 18.7 25.8 23.2 4.6 14.8 12.2 6.0 7.8 12.2 6.3 5.5 22.8 10.3 3.2 20.1 16.6 14.5 7.6 19.2 27.2 10.4 18.0 6.8 28.9 11.2 8.9 11.4 31.5 11.7 18.9 7.7 10.5 9.0 12.4 24.6 21.9 5.2 5.9 12.9 9.3 19.8 10.6 0.0 4.3 0.0 3.4 5.9 2.6 4.1 2.0 1.8 4.4 4.5 4.7 4.1 0.4 1.1 3.6 5.0 2.6 1.5 9.6 12.4 16.0 20.9 8.5 6.9 7.0 9.7 12.5 7.5 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell line enhanced" "Detected in many" "Hep G2: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: " "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.5 3.9 7.4 5.0 0.0 0.0 4.4 2.8 0.2 0.0 0.0 3.0 1.5 3.1 0.7 0.0 1.1 0.0 0.4 0.0 2.5 6.8 5.2 2.1 24.3 0.0 1.7 1.0 0.2 0.0 0.0 0.0 0.3 7.2 9.0 0.0 0.8 3.0 5.5 0.5 1.7 6.2 3.5 10.8 0.8 0.7 6.5 4.5 2.9 1.8 2.2 2.4 0.7 0.6 3.0 4.3 2.1 1.4 5.1 8.9 6.4 2.4 3.3 2.5 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046174-22065674 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavourable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 8.1 28.2 28.1 9.6 31.6 17.6 14.9 16.3 39.3 12.1 34.3 14.5 17.1 29.4 12.8 32.0 33.2 10.0 11.0 18.1 28.8 33.4 12.8 31.9 7.9 9.8 33.9 27.3 11.9 18.6 14.6 14.3 20.2 34.3 17.0 33.1 10.2 14.8 12.9 18.2 12.9 32.9 13.3 18.0 8.5 12.9 30.2 14.8 6.4 10.9 11.9 12.4 11.8 17.2 12.2 19.5 19.4 18.9 22.8 19.9 15.0 19.5 15.8 19.5 9.2 15.3 19.2 28.4 13.7 15.0 14.9 15.7 35.4 22.7 17.4 13.4 11.7 16.0 11.5 19.0 20.1 22.9 14.4 52.4 12.9 17.8 14.3 13.8 27.8 12.9 18.1 18.9 28.3 19.7 32.9 8.9 26.3 25.8 15.8 32.1 47.1 22.1 11.3 20.4 16.5 17.7 21.5 7.8 13.7 10.8 19.1 15.3 26.3 18.9 14.3 16.8 13.9 14.7 25.1 6.1 7.8 23.1 27.3 10.8 16.9 10.3 17.9 19.4 13.7 18.9 17.8 12.2 18.6 18.1 19.5 12.1 16.8 17.4 1.8 22.8 16.5 12.3 19.9 15.0 28.1 31.6 16.3 39.3 28.8 33.4 33.9 27.3 34.3 14.8 CMIP ENSG00000153815 "C-Maf inducing protein" Q8IY22 16 81445170-81711762 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054424, HPA066710" Approved Supported Nucleoplasm,Cytosol 360000 "Nucleoplasm, Cytosol" "HPA054424: AB_2682484, HPA066710: AB_2685708" "unprognostic (6.84e-2)" "unprognostic (1.99e-1)" "unprognostic (2.89e-2)" "unprognostic (3.76e-1)" "unprognostic (3.02e-2)" "unprognostic (9.83e-3)" "unprognostic (2.28e-2)" "prognostic unfavourable (9.47e-7)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (3.10e-2)" "unprognostic (6.04e-2)" "unprognostic (4.12e-2)" "unprognostic (3.42e-2)" "unprognostic (9.08e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (1.59e-1)" 19.1 19.7 34.3 25.6 27.9 19.6 15.4 13.1 46.5 28.5 26.5 13.0 7.1 33.5 15.5 14.1 26.5 20.3 27.8 9.3 28.1 35.7 15.8 11.4 18.8 17.2 19.4 30.6 17.7 16.5 8.9 26.4 23.8 19.4 13.4 20.0 7.8 15.5 14.0 6.3 24.5 40.5 19.1 15.7 18.0 28.2 11.0 13.2 20.8 11.3 10.2 16.1 22.2 37.2 0.8 0.5 5.7 1.7 0.5 1.0 0.9 11.2 37.8 7.5 3.8 3.9 3.2 15.3 8.2 5.6 5.2 2.3 12.7 23.2 5.0 7.0 6.8 11.6 4.8 27.3 5.0 3.2 3.5 24.3 7.1 22.1 3.9 7.4 52.7 3.1 11.6 9.6 12.4 14.3 21.2 4.4 3.1 11.3 13.0 9.3 5.9 8.0 23.6 2.4 4.9 6.5 11.2 39.3 7.9 19.1 7.1 2.4 5.5 10.0 9.8 8.3 8.9 8.0 7.4 5.6 4.3 22.0 9.8 8.8 3.3 4.8 1.7 2.1 1.0 1.2 0.5 0.1 0.2 0.3 0.5 0.8 0.1 0.5 5.7 0.5 0.3 0.5 0.2 0.9 34.3 27.9 13.1 33.7 28.1 35.7 19.4 30.6 19.4 13.2 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog (yeast)" Q9BQ75 3 99817834-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavourable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavourable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 21.4 34.1 23.7 15.1 24.5 17.7 20.6 24.1 27.4 13.4 12.9 9.4 8.2 8.3 19.6 10.7 12.0 13.3 10.5 16.6 24.0 22.2 17.1 17.5 10.8 15.8 15.3 22.3 21.1 26.4 20.7 25.9 11.7 19.2 15.1 12.4 9.3 12.4 14.5 58.2 11.5 9.3 13.8 15.7 12.9 11.0 28.1 13.5 13.6 14.9 14.4 14.7 18.8 15.7 23.5 26.1 1.6 10.9 11.2 19.0 7.9 28.5 12.9 12.8 18.4 9.1 10.7 13.2 13.3 7.2 24.0 20.0 16.0 9.6 30.9 23.4 7.1 17.3 17.7 15.1 31.7 16.0 16.9 24.4 9.2 13.0 16.3 33.3 13.4 7.3 14.7 17.9 29.9 16.5 15.0 20.1 17.3 19.7 26.6 31.1 18.7 32.5 12.0 20.7 33.1 14.8 7.0 36.1 15.2 13.3 10.9 30.3 13.1 20.8 4.7 19.0 54.0 11.0 27.0 14.4 28.6 60.1 12.3 36.9 31.7 0.3 4.7 0.8 10.0 10.9 14.2 23.2 14.8 13.5 9.9 23.5 18.7 19.0 1.6 11.2 9.7 26.1 13.7 7.9 23.7 24.5 24.1 27.4 24.0 22.2 15.3 22.3 19.2 13.5 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696707 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favourable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 2.7 4.8 18.9 3.3 18.2 2.9 6.6 8.3 22.1 4.8 16.1 13.5 8.7 12.6 3.2 21.8 4.5 11.5 4.8 3.3 20.0 16.2 18.3 2.5 6.5 1.3 17.0 13.0 2.5 15.1 31.7 9.4 4.3 12.5 6.8 13.4 5.2 10.7 6.9 2.7 7.2 15.8 4.2 13.3 1.8 18.5 6.3 10.3 0.0 39.3 0.5 2.1 4.3 2.6 0.2 1.3 0.1 1.2 0.2 0.9 0.2 9.7 8.3 4.9 12.0 1.6 2.5 20.4 4.1 3.6 2.2 3.6 14.7 11.1 0.4 7.1 2.4 12.4 11.9 4.6 3.3 0.8 10.9 0.9 3.0 8.9 3.5 0.8 1.9 4.0 8.3 2.6 5.2 1.2 4.9 2.7 3.2 10.7 0.1 1.9 5.7 5.5 2.1 6.4 3.0 9.6 8.8 11.6 4.5 16.8 9.2 5.8 9.9 2.0 2.5 4.1 4.7 1.1 4.2 0.9 2.0 0.5 5.0 2.0 4.9 0.0 1.2 0.0 0.3 0.3 0.0 0.0 0.1 0.9 1.3 0.2 0.1 0.2 0.1 0.2 0.7 1.3 0.7 0.2 18.9 18.2 8.3 22.1 20.0 16.2 17.0 13.0 12.5 10.3 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell line enriched" "Detected in some" 6 "HEL: 41.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 14.4 17.4 23.1 17.3 17.7 22.4 14.6 25.0 25.0 14.5 18.0 15.5 21.3 15.0 19.5 19.4 12.6 16.9 15.0 18.8 17.6 16.1 13.9 16.6 15.2 19.2 16.0 22.7 22.6 18.4 24.4 20.2 20.6 16.9 16.3 13.1 17.1 17.6 17.9 28.9 16.6 16.5 17.6 12.5 21.7 15.9 63.9 17.8 18.4 15.7 14.1 20.7 16.2 14.8 11.1 9.8 8.1 13.2 9.7 11.5 7.8 6.9 6.6 9.5 15.5 10.8 9.9 11.5 8.3 11.5 21.1 23.7 9.9 4.6 14.4 9.4 12.2 7.8 12.1 8.6 16.2 9.9 10.7 7.9 7.7 11.0 8.3 11.4 5.4 8.5 6.4 11.6 8.3 9.8 17.6 10.6 11.0 11.3 14.4 10.2 4.8 6.3 11.5 11.3 8.2 6.8 8.4 10.5 7.9 9.3 7.2 11.9 12.2 8.8 9.0 12.7 9.5 5.0 9.3 12.1 6.3 76.3 5.0 12.0 13.9 8.1 10.2 6.4 10.1 13.2 8.5 11.1 8.9 10.7 9.8 8.1 9.9 8.0 6.6 9.7 9.9 8.2 11.5 7.8 23.1 17.7 25.0 25.0 17.6 16.1 16.0 22.7 16.9 17.8 CMTR2 "AFT, FLJ11171, FTSJD1, MTr2" ENSG00000180917 "Cap methyltransferase 2" Q8IYT2 16 71281389-71289715 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041700, HPA048265" Uncertain Approved "Nuclear speckles,Cell Junctions" "Cell Junctions" "Nuclear speckles" "HPA041700: , HPA048265: " "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (2.94e-3)" "unprognostic (1.43e-1)" "unprognostic (6.30e-2)" "unprognostic (3.82e-2)" "unprognostic (1.93e-3)" "unprognostic (2.86e-2)" "unprognostic (7.93e-2)" "unprognostic (3.41e-1)" "unprognostic (1.85e-2)" "unprognostic (7.39e-2)" "prognostic favourable (4.97e-5)" "unprognostic (9.55e-2)" "unprognostic (5.99e-2)" "unprognostic (1.54e-1)" "unprognostic (5.34e-2)" 10.4 14.9 7.1 11.7 9.0 5.4 15.9 5.3 9.1 10.6 13.4 11.5 15.6 14.1 12.5 16.4 20.4 8.8 11.0 9.0 8.5 6.9 13.5 18.2 10.7 14.7 12.4 3.4 16.2 12.2 12.7 24.3 17.4 9.0 11.9 10.5 10.6 13.6 14.1 8.4 9.9 16.1 9.4 9.5 17.5 8.9 16.0 9.3 20.9 14.3 7.6 15.4 9.6 14.2 11.2 10.3 11.0 8.0 13.1 11.2 8.6 11.3 7.9 11.4 11.3 12.9 11.2 6.4 9.3 9.1 10.5 10.1 4.7 15.8 6.1 11.2 7.3 11.2 7.0 8.3 12.9 6.3 4.7 17.0 4.6 5.9 16.1 10.0 23.3 8.1 15.9 7.7 10.4 11.9 7.3 4.6 17.4 10.1 12.1 16.9 7.1 4.7 16.4 7.3 13.2 12.9 7.7 7.5 8.5 10.5 9.2 10.2 13.7 7.3 11.4 11.9 11.0 12.1 7.2 8.6 8.9 10.9 8.9 10.2 10.2 11.0 7.2 7.1 9.8 8.0 11.2 11.2 9.2 10.3 10.3 10.2 10.5 10.3 0.4 13.1 5.2 3.6 8.0 8.6 7.1 9.0 5.3 9.1 8.5 6.9 12.4 3.4 9.0 9.3 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129169484-129183922 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Supported Nucleoplasm,Cytosol 43000 "Nucleoplasm, Cytosol" "HPA063097: " "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavourable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 54.2 52.8 36.4 33.6 33.7 35.9 46.6 43.5 35.6 58.1 47.1 34.5 40.5 32.4 54.5 49.4 55.6 40.9 48.5 78.2 33.0 32.0 38.0 71.6 47.5 40.6 39.7 30.3 67.4 65.4 39.3 33.5 41.5 33.3 62.3 37.1 41.3 48.9 50.9 182.1 46.7 40.6 71.9 38.0 43.2 43.1 32.1 33.1 39.0 67.3 81.1 41.2 76.1 63.5 74.3 60.3 120.1 84.1 61.7 83.4 172.9 61.2 36.3 53.0 42.0 53.0 45.5 41.8 48.2 76.5 52.6 60.5 53.2 43.2 81.5 41.4 44.8 46.1 69.2 55.9 71.3 54.7 50.4 78.7 37.5 57.2 52.8 84.4 45.3 43.9 65.6 36.8 133.0 46.4 58.9 56.1 55.0 73.3 78.2 62.1 64.6 61.4 68.8 49.2 97.1 54.4 59.1 72.2 57.8 38.0 37.6 102.2 43.3 58.1 48.8 39.0 38.4 53.5 48.7 52.8 48.0 128.2 40.1 57.9 51.4 93.4 84.1 96.8 64.1 63.8 80.6 74.3 77.4 68.9 60.3 62.7 83.4 72.0 120.1 61.7 48.9 35.1 73.9 172.9 36.4 33.7 43.5 35.6 33.0 32.0 39.7 30.3 33.3 33.1 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 75.1;RPMI-8226: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol 2400000 "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favourable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 19.0 11.5 31.0 19.1 36.0 6.1 16.9 10.4 33.0 39.4 37.6 45.2 27.0 51.3 12.5 35.3 20.4 38.9 25.9 11.6 31.1 26.4 89.0 66.4 22.1 23.0 36.1 24.1 11.4 27.6 15.7 13.7 28.8 27.2 34.7 22.2 14.1 16.9 32.7 7.5 11.8 71.1 10.4 39.4 39.2 27.2 6.5 32.5 10.9 43.9 11.6 21.4 28.4 12.0 29.6 49.0 12.5 44.4 31.4 23.9 30.3 10.0 13.6 9.9 9.3 12.1 7.2 41.6 10.6 10.0 14.5 14.5 7.9 10.8 12.7 13.5 11.5 15.3 15.0 20.1 10.4 19.0 5.9 12.6 6.9 12.5 17.6 24.7 19.7 10.8 15.5 12.5 22.7 12.7 13.3 75.1 9.6 11.3 13.1 11.8 14.9 8.1 14.3 11.4 96.6 57.1 42.2 10.7 5.6 8.3 59.0 14.1 24.7 10.2 13.2 15.6 13.3 3.4 7.1 14.1 57.6 17.0 10.5 18.1 13.0 7.8 30.0 12.5 21.8 44.4 23.8 28.9 17.6 20.3 49.0 29.6 19.1 20.7 4.4 31.4 43.1 43.0 23.9 30.3 31.0 36.0 10.4 33.0 31.1 26.4 36.1 24.1 27.2 32.5 CNFN PLAC8L2 ENSG00000105427 Cornifelin Q9BYD5 19 42387019-42390287 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7" "Cell line enhanced" "Detected in many" "A549: 14.4;HEK 293: 20.7;MCF7: 9.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 367.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 25.1;naive B-cell: 27.5" "Lineage enriched" "Detected in many" 11 "B-cells: 27.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA049073, HPA053997" Enhanced Approved "Microtubules,Cytokinetic bridge" Microtubules "Cytokinetic bridge" "HPA049073: , HPA053997: " "unprognostic (5.08e-2)" "unprognostic (4.21e-3)" "unprognostic (2.52e-1)" "unprognostic (7.22e-2)" "unprognostic (3.15e-2)" "unprognostic (8.35e-3)" "unprognostic (6.04e-2)" "unprognostic (2.06e-3)" "unprognostic (3.52e-1)" "unprognostic (9.44e-2)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (8.42e-2)" "unprognostic (4.83e-2)" "unprognostic (7.77e-3)" "prognostic favourable (4.02e-5)" "unprognostic (2.45e-1)" 0.4 0.3 0.2 0.2 0.8 0.2 2.5 0.2 0.2 58.9 0.5 0.2 0.2 0.2 4.4 1.4 268.7 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.6 0.3 0.2 39.0 0.3 0.5 37.3 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.9 0.2 323.6 276.3 0.2 85.7 27.5 2.4 0.5 2.0 0.0 0.7 1.0 4.6 14.4 0.3 1.3 0.7 0.7 0.2 0.8 0.3 0.3 0.3 0.8 1.2 4.0 6.5 0.2 1.9 1.2 1.8 0.1 0.0 20.7 0.3 5.4 1.5 0.0 0.0 0.0 1.5 3.2 0.8 0.0 0.0 0.8 0.2 0.0 9.8 0.0 0.1 5.3 4.3 1.7 0.2 2.2 1.4 1.8 2.2 6.3 2.7 4.0 1.9 4.9 2.0 0.0 0.0 4.4 0.1 0.0 4.7 5.6 2.6 0.0 1.7 0.2 0.0 2.0 0.0 0.7 1.5 0.2 25.1 0.5 0.5 2.4 27.5 0.2 0.4 0.5 0.0 0.3 0.5 0.0 1.0 0.2 0.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: " "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.1 0.1 0.7 0.0 2.0 0.3 0.4 0.1 0.0 0.8 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 0.0 0.8 0.7 0.2 1.3 0.1 0.2 0.6 3.0 0.1 0.0 0.1 0.6 10.5 0.3 0.1 0.2 0.6 0.2 1.1 0.0 0.6 0.3 4.1 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.3 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel beta 1" Q14028 16 57882340-57971116 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 79.8" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA039159, HPA060355" Approved Vesicles,Cytosol Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.2 7.2 13.1 3.0 3.0 0.7 0.2 0.2 6.3 0.2 1.7 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.8 0.2 7.1 11.0 0.2 0.2 0.4 0.7 1.3 4.0 0.1 1.5 0.0 0.5 1.2 4.2 0.2 1.2 79.8 0.3 0.4 0.1 0.5 1.8 0.2 0.7 0.2 0.2 1.3 0.0 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 2.6 0.3 0.3 0.4 0.0 0.6 1.2 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.6 1.7 0.9 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.0 3.3 0.0 1.2 9.4 0.1 5.4 2.7 0.0 0.1 0.1 0.7 0.3 0.4 0.4 0.1 0.2 0.5 0.1 0.1 0.3 0.1 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.2 2.6 0.3 0.3 0.3 0.0 0.0 13.1 3.0 0.2 6.3 7.1 11.0 1.3 4.0 4.2 0.0 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell line enhanced" "Detected in some" "A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.7 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.1 10.8 5.5 0.0 10.1 0.0 0.0 0.0 4.6 1.8 0.0 0.1 0.2 0.0 0.6 0.0 0.1 2.1 0.0 6.7 3.5 0.0 3.5 0.9 0.0 2.6 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 CNKSR3 "FLJ31349, MAGI1" ENSG00000153721 "CNKSR family member 3" Q6P9H4 6 154387504-154510659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in many" "CAB037133, HPA049651" Approved Approved Mitochondria,Cytosol Mitochondria Cytosol "CAB037133: AB_477217, HPA049651: " "unprognostic (3.07e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-1)" "unprognostic (2.34e-1)" "unprognostic (5.62e-2)" "unprognostic (1.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.78e-2)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (4.67e-3)" "unprognostic (4.90e-2)" "prognostic favourable (6.00e-4)" "unprognostic (4.23e-2)" "unprognostic (8.79e-2)" "unprognostic (1.57e-3)" "unprognostic (3.38e-1)" 9.4 2.2 4.2 5.5 5.8 1.6 5.8 1.8 5.0 7.6 12.5 11.6 6.0 8.7 15.8 8.3 19.4 6.5 9.2 8.9 5.3 3.4 17.0 20.0 6.3 3.5 8.0 2.5 10.0 26.6 1.5 4.5 8.2 8.3 8.3 5.5 12.6 7.5 7.7 2.2 6.7 13.5 15.3 8.2 7.6 6.7 8.6 7.7 0.6 4.1 8.7 6.6 9.8 10.2 0.9 1.4 3.6 0.6 0.9 0.5 0.2 0.3 3.9 2.7 5.5 4.9 3.7 0.3 4.8 3.0 8.4 7.0 17.1 0.4 0.1 5.3 5.2 1.7 8.1 0.5 4.4 0.0 5.0 13.0 0.8 9.4 2.2 0.0 2.9 5.0 2.6 3.2 3.4 2.6 1.7 0.1 2.3 1.0 0.1 0.3 2.0 5.1 3.8 4.8 6.3 9.8 2.7 1.7 10.5 2.2 1.2 1.0 0.0 1.1 3.0 0.8 2.5 6.3 3.1 0.1 0.0 0.1 0.1 0.3 3.7 2.1 0.6 1.2 0.5 0.4 0.4 0.5 0.4 0.4 0.4 0.9 0.5 0.5 3.6 0.9 0.4 1.4 0.3 0.2 4.2 5.8 1.8 5.0 5.3 3.4 8.0 2.5 8.3 7.7 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026581-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" 39000000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: " "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavourable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 36.6 6.5 1.3 46.2 2.5 44.2 29.2 2.0 3.0 38.2 16.9 5.4 22.2 5.5 35.5 24.5 39.4 25.0 40.1 18.7 1.5 1.5 24.6 15.8 54.7 61.5 3.5 1.5 81.1 26.8 1.9 6.9 21.5 4.8 35.6 7.8 26.3 40.9 34.4 6.1 21.3 17.7 28.2 2.9 59.4 21.1 15.9 2.1 37.0 68.1 27.3 78.6 37.9 51.2 33.6 29.3 115.7 26.3 27.1 57.0 43.1 37.2 12.6 35.1 43.7 18.1 34.5 27.3 33.7 37.4 42.6 33.1 43.3 32.2 24.5 34.6 60.9 36.7 20.8 53.9 28.4 17.0 1.7 17.0 20.2 33.8 72.6 15.9 39.2 58.7 25.7 26.9 20.4 23.9 10.1 38.2 34.6 7.1 1.4 14.6 43.3 5.5 8.4 12.4 27.7 41.8 44.8 0.0 2.5 42.7 5.8 4.8 42.4 26.8 58.7 23.3 24.2 35.6 34.3 17.8 13.5 48.9 13.7 19.1 37.2 61.3 18.6 81.0 34.8 24.2 57.0 33.6 43.7 46.4 29.3 30.8 37.3 36.3 115.7 27.1 26.3 13.0 45.6 43.1 1.3 2.5 2.0 3.0 1.5 1.5 3.5 1.5 4.8 2.1 CNN3 ENSG00000117519 "Calponin 3" Q15417 1 94896949-94927278 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 9.7;naive CD4 T-cell: 11.1" "Group enriched" "Detected in many" 14 "B-cells: 9.7;T-cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009849, HPA051237" Enhanced Enhanced "Actin filaments,Cytosol" 320000 "Actin filaments" Cytosol "CAB009849: AB_2276410, HPA051237: " "unprognostic (8.47e-2)" "unprognostic (5.19e-2)" "unprognostic (5.22e-2)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-2)" "unprognostic (8.87e-2)" "unprognostic (5.20e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-3)" "unprognostic (2.33e-2)" "unprognostic (8.71e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (1.99e-4)" 49.3 78.5 53.4 27.9 53.9 1.2 82.7 25.3 44.7 55.1 36.3 30.8 20.8 45.4 74.0 31.4 53.6 39.4 55.3 33.0 46.8 40.3 74.2 50.6 59.0 28.6 45.3 27.0 61.5 28.0 21.6 33.5 88.5 67.8 38.8 30.2 47.5 32.9 48.9 16.1 16.6 33.4 68.6 78.2 30.8 30.6 21.1 41.9 9.3 44.3 18.4 17.2 48.7 74.5 9.7 0.1 0.4 0.1 0.7 11.1 2.6 44.8 8.7 49.6 43.7 35.5 31.9 22.0 21.7 43.0 36.6 58.1 40.2 4.0 0.0 50.1 28.0 12.9 36.2 19.3 53.0 0.1 12.8 2.0 6.1 30.4 66.0 0.0 0.0 29.8 3.0 45.2 10.5 32.8 0.4 4.1 95.4 0.0 2.1 0.1 38.1 4.7 0.0 59.2 0.2 47.7 18.7 3.0 30.4 18.1 7.7 30.6 13.9 4.5 20.1 24.5 42.0 9.0 70.6 5.0 2.9 0.1 5.3 0.0 36.7 0.1 0.0 0.0 1.9 0.1 3.1 3.9 2.0 1.1 0.1 9.7 11.1 7.6 0.4 0.7 0.1 0.0 0.0 2.6 53.4 53.9 25.3 43.6 46.8 40.3 45.3 27.0 67.8 41.9 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Cell line enhanced" "Detected in some" "A549: 17.3;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.0 10.4 0.0 3.9 0.0 0.0 1.2 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.2 0.0 0.8 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.5 1.8 0.4 0.8 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811891 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavourable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavourable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 3.7 4.0 4.8 17.0 9.6 4.5 7.4 24.1 11.1 6.8 31.2 11.3 8.3 6.3 10.4 5.2 7.7 10.8 7.3 11.5 5.4 5.0 5.9 4.9 8.1 4.3 6.0 6.6 6.1 11.4 9.0 10.6 17.1 5.5 7.4 33.5 13.9 10.8 11.3 21.3 7.4 11.1 5.7 5.2 6.1 12.6 11.8 6.1 4.6 9.7 6.1 9.3 6.5 7.4 3.7 2.2 2.8 2.3 0.8 3.2 1.1 6.8 4.5 3.7 6.7 3.8 2.6 10.1 3.0 4.3 4.4 6.1 8.2 7.5 5.0 8.8 3.1 8.9 9.5 5.1 4.1 10.0 7.5 4.0 3.0 4.4 5.4 1.9 4.0 2.5 6.5 7.1 4.3 2.4 2.0 14.3 2.3 9.7 4.0 2.7 4.8 6.2 6.0 1.7 5.8 4.5 5.4 17.3 5.2 5.7 29.3 4.3 14.3 3.3 2.2 2.6 5.9 5.6 3.3 5.0 4.0 2.5 3.8 3.8 4.6 2.8 1.6 0.5 3.2 1.8 1.1 3.7 1.7 1.7 2.2 2.1 1.1 2.1 0.7 0.8 2.3 1.7 0.8 1.1 4.8 9.6 24.1 11.1 5.4 5.0 6.0 6.6 5.5 6.1 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: " "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.2 9.3 9.7 9.1 4.7 5.4 64.7 7.0 7.0 10.0 11.3 7.0 7.2 13.6 4.7 4.9 7.3 11.4 9.2 10.0 11.7 11.7 17.4 8.4 6.8 13.7 14.3 6.7 4.0 8.3 11.0 14.6 8.1 18.1 10.6 5.8 6.8 12.7 6.9 14.6 8.9 12.9 6.6 13.6 6.4 9.7 5.5 10.7 10.3 14.5 8.4 14.1 16.2 5.0 6.2 8.8 8.1 11.5 11.0 22.5 13.6 6.3 10.9 7.5 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70242994-70354993 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA067711: " "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavourable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 27.8 19.9 18.9 24.6 23.8 44.5 24.9 53.3 24.7 24.0 21.7 21.9 21.6 20.1 37.5 25.8 22.5 20.6 18.8 20.1 18.7 16.2 21.8 24.1 25.9 24.8 23.8 21.2 26.8 20.5 25.0 41.2 30.1 19.8 24.3 24.9 20.5 21.6 21.9 27.6 36.7 24.4 25.5 23.4 26.8 18.8 16.3 24.8 46.1 22.7 20.9 28.8 24.8 24.5 28.8 33.1 37.1 36.5 32.2 41.3 27.2 19.9 19.0 32.3 20.4 17.8 20.2 26.9 22.2 26.8 24.6 21.2 24.4 19.5 42.9 20.5 25.3 19.8 22.4 21.8 27.7 20.5 20.3 28.2 17.6 22.8 19.0 36.4 25.2 22.0 24.5 23.2 28.2 26.1 25.6 24.9 21.4 21.6 41.5 26.0 27.5 20.3 32.3 26.7 26.0 22.8 40.3 21.6 25.5 26.1 21.1 18.7 27.0 30.2 19.0 23.0 15.9 21.0 17.9 22.7 26.0 34.0 23.6 17.9 18.0 37.1 26.0 28.3 29.4 36.5 32.8 28.8 31.9 32.9 33.1 27.6 38.0 41.3 15.1 32.2 29.3 23.0 29.7 27.2 18.9 23.8 53.3 24.7 18.7 16.2 23.8 21.2 19.8 24.8 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966741-41977731 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 211.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 49.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Enhanced Nucleoplasm,Cytosol 730000 Nucleoplasm Cytosol "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 9.1 8.9 51.4 9.5 72.8 6.7 8.1 13.4 125.3 10.3 7.5 211.7 2.3 7.1 8.0 12.7 15.0 9.3 10.8 7.6 78.4 40.7 14.7 9.6 6.7 10.5 86.7 49.0 11.2 9.2 5.8 4.4 7.8 66.7 11.7 6.4 3.6 15.1 13.2 7.6 11.1 6.4 10.1 160.2 7.1 7.4 4.6 63.5 2.1 7.2 2.2 11.2 9.8 5.7 9.9 49.1 7.3 13.1 7.3 7.5 9.1 13.7 23.5 22.3 27.5 19.1 18.0 9.6 17.2 26.5 44.8 50.6 18.4 12.6 14.6 13.9 22.4 23.7 15.0 11.4 15.6 14.5 19.0 14.2 16.2 31.9 20.6 13.8 12.9 29.7 8.2 24.5 6.0 20.4 10.0 12.0 15.6 8.7 35.4 12.5 5.2 16.8 22.1 32.8 14.2 11.9 14.1 13.1 17.7 21.8 32.9 38.3 14.7 20.7 20.4 17.5 19.2 23.7 20.3 13.5 15.3 11.7 17.3 10.7 68.2 4.9 12.1 7.3 7.5 13.1 5.9 9.9 6.5 6.0 11.1 7.0 5.9 6.9 2.6 7.3 10.3 49.1 7.2 9.1 51.4 72.8 13.4 93.8 78.4 40.7 86.7 49.0 66.7 63.5 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Group enriched" "Detected in some" 7 "ASC diff: 39.4;HSkMC: 26.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA042256: , HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 39.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.8 1.3 0.0 2.6 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Cell line enhanced" "Detected in some" "A-431: 6.1;ASC diff: 4.2;SiHa: 3.3;T-47d: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Uncertain "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.1 0.7 0.4 1.3 4.2 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.0 3.3 0.3 0.8 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 CNTLN "bA340N12.1, C9orf101, C9orf39, FLJ20276" ENSG00000044459 Centlein Q9NXG0 9 17134982-17503923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.9" "Lineage enriched" "Detected in many" 4 "monocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007201, HPA036728, HPA036729" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA007201: , HPA036728: AB_10670847, HPA036729: AB_10670240" "unprognostic (1.97e-2)" "unprognostic (2.81e-3)" "unprognostic (1.81e-1)" "unprognostic (2.48e-1)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (7.71e-2)" "unprognostic (1.68e-1)" "unprognostic (7.71e-3)" "unprognostic (5.07e-3)" "unprognostic (1.06e-1)" "unprognostic (6.65e-2)" "unprognostic (2.47e-1)" "unprognostic (5.38e-2)" "unprognostic (3.35e-2)" "unprognostic (1.37e-1)" "unprognostic (5.80e-2)" 13.2 5.6 4.3 5.2 5.1 12.5 7.4 15.5 4.5 16.6 8.6 4.2 6.7 2.2 22.6 6.0 6.0 8.0 7.4 4.9 4.2 3.8 5.0 20.0 5.4 4.8 4.9 2.6 15.2 3.6 10.0 13.2 6.1 6.3 9.8 4.0 7.0 3.8 6.3 5.9 3.5 4.4 11.9 8.1 8.6 4.4 8.2 6.8 4.4 5.5 5.8 2.8 11.7 13.5 0.3 1.5 0.8 6.9 1.2 0.2 0.5 5.8 4.0 8.9 5.0 4.4 10.3 0.3 6.9 4.6 5.1 7.0 0.3 2.0 4.3 1.1 4.7 0.3 10.2 2.8 8.1 0.2 3.6 25.0 8.6 1.4 4.8 3.4 5.5 6.5 1.5 4.3 4.2 7.3 0.9 1.0 8.2 0.5 2.8 5.5 6.9 7.5 4.1 8.2 2.1 3.0 1.4 5.6 5.8 8.4 0.2 2.1 1.7 8.7 5.3 7.1 2.8 7.7 5.9 3.5 4.2 0.1 3.3 4.3 3.2 0.6 2.7 0.1 0.1 3.3 0.0 0.3 0.2 0.1 1.5 0.3 0.1 0.1 0.8 1.2 6.9 1.5 0.2 0.5 4.3 5.1 15.5 4.5 4.2 3.8 4.9 2.6 6.3 6.8 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 CNTRL "CEP1, CEP110" ENSG00000119397 Centriolin Q7Z7A1 9 121074863-121177610 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020468, HPA020480, HPA051583" Approved Supported Centrosome,Cytosol Centrosome Cytosol "HPA020468: , HPA020480: , HPA051583: " "unprognostic (4.33e-3)" "unprognostic (2.89e-3)" "unprognostic (2.09e-2)" "unprognostic (7.97e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.21e-5)" "unprognostic (1.05e-2)" "unprognostic (3.22e-3)" "unprognostic (3.74e-3)" "unprognostic (2.02e-1)" "unprognostic (1.78e-2)" "unprognostic (5.47e-2)" "unprognostic (3.60e-3)" "unprognostic (9.83e-3)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" "unprognostic (1.13e-2)" 7.7 4.7 5.5 22.2 11.7 24.0 6.8 10.9 8.7 8.4 5.5 4.9 5.9 3.8 7.3 6.4 5.6 8.4 5.1 4.4 6.6 4.3 4.0 3.8 9.3 20.3 8.1 4.1 10.6 5.2 4.0 17.3 5.8 7.0 7.2 5.5 4.4 6.3 8.6 2.8 5.2 8.8 5.7 9.7 14.8 7.1 30.2 9.8 26.7 6.2 4.2 19.2 8.6 7.1 12.7 10.5 15.0 6.9 4.8 10.4 2.5 5.3 3.6 10.0 7.2 1.5 2.3 1.7 3.7 2.8 2.9 2.5 2.1 5.9 24.6 1.4 2.7 11.3 3.3 2.2 4.8 14.9 2.6 12.8 6.5 2.5 2.1 34.8 15.6 1.4 1.7 3.1 7.5 6.4 8.3 14.1 2.8 3.4 13.6 11.9 3.4 2.9 12.9 15.1 7.0 1.4 2.5 3.8 5.7 12.7 2.3 2.9 4.9 16.7 4.7 3.1 5.4 4.8 6.8 9.8 10.7 16.7 2.6 14.4 7.1 12.2 6.9 15.0 7.5 4.5 5.7 10.8 7.7 5.5 3.4 12.7 9.3 6.6 2.7 4.8 5.8 10.5 10.4 2.5 5.5 11.7 10.9 8.7 6.6 4.3 8.1 4.1 7.0 9.8 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949918 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 9.0 7.4 7.5 9.2 10.1 18.4 9.3 11.2 12.7 13.0 10.9 9.8 9.9 6.8 21.3 12.6 11.0 10.4 9.0 7.1 9.5 8.0 9.2 8.7 15.0 8.4 9.3 9.9 11.4 11.0 16.5 9.6 9.9 9.9 9.9 12.5 10.3 9.6 8.6 6.8 16.9 9.1 16.3 7.0 9.9 8.4 51.2 6.4 16.0 10.4 6.2 11.2 9.3 10.0 2.1 7.6 9.4 3.4 3.4 3.5 2.6 22.1 14.5 21.8 12.0 9.2 12.7 7.1 19.3 18.1 27.1 20.8 12.3 8.3 22.8 10.3 16.9 17.9 16.8 13.5 30.3 22.4 13.2 15.1 23.8 9.7 13.6 14.0 23.4 11.6 10.0 19.0 19.2 16.7 10.9 11.2 18.7 7.2 21.2 13.5 4.8 11.4 22.6 14.9 8.5 12.5 6.8 7.1 12.8 15.6 8.0 6.2 10.9 8.9 13.6 15.1 12.8 20.5 26.6 17.2 11.5 15.8 13.0 17.9 21.5 9.4 2.5 1.0 2.9 3.4 2.6 2.1 2.2 3.5 1.7 1.5 1.4 2.4 0.4 3.4 1.4 7.6 2.9 2.6 7.5 10.1 11.2 12.7 9.5 8.0 9.3 9.9 9.9 6.4 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876988 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favourable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 19.0 46.2 18.9 17.0 17.3 10.8 18.1 12.2 20.2 17.5 23.9 25.7 27.0 24.7 18.0 22.4 24.9 20.1 31.5 35.3 17.7 17.0 33.2 74.7 14.7 20.2 20.5 16.3 23.2 37.1 17.6 17.2 18.3 19.4 21.5 21.1 17.6 21.2 28.0 33.2 14.4 31.2 16.2 21.5 20.1 19.2 13.5 19.4 16.3 38.7 27.6 18.2 21.5 18.9 23.4 32.3 5.3 20.6 16.7 21.2 15.0 22.9 42.8 17.7 25.7 15.7 19.6 17.8 23.4 16.3 27.9 23.6 31.2 28.6 19.6 47.5 19.3 23.1 27.0 31.4 21.7 25.5 24.6 32.8 26.7 29.3 29.8 22.2 25.7 24.7 30.1 46.5 30.3 25.5 28.2 19.3 24.9 43.7 17.5 34.8 23.2 44.4 20.5 38.0 51.7 29.4 21.3 16.0 26.9 21.7 24.9 63.0 34.9 22.6 17.4 23.0 20.5 46.3 30.6 23.9 25.9 66.3 12.6 27.8 26.0 5.3 20.5 4.7 15.9 20.6 20.2 23.4 18.7 16.5 24.6 20.4 20.1 21.2 1.4 16.7 19.1 32.3 19.0 15.0 18.9 17.3 12.2 20.2 17.7 17.0 20.5 16.3 19.4 19.4 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favourable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.8 17.3 26.5 13.1 8.0 13.8 13.0 17.6 23.9 17.9 24.4 7.5 22.8 12.9 16.2 11.0 22.1 55.2 8.0 26.1 46.6 33.7 19.7 15.6 11.4 21.8 18.1 14.0 17.0 38.9 16.1 15.0 9.5 18.6 38.1 20.4 10.9 11.1 10.0 35.1 17.2 17.0 14.8 10.8 12.8 22.6 40.4 20.1 34.0 12.8 16.4 13.6 22.0 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 COA7 "C1orf163, FLJ12439, RESA1, SELRC1" ENSG00000162377 "Cytochrome c oxidase assembly factor 7 (putative)" Q96BR5 1 52684451-52698366 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028154, HPA029926" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA028154: AB_10600656, HPA029926: AB_10602173" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.55e-4)" "unprognostic (2.30e-2)" "unprognostic (5.12e-2)" "prognostic unfavourable (7.01e-5)" "unprognostic (1.14e-1)" "unprognostic (2.27e-2)" "unprognostic (1.24e-1)" "unprognostic (4.07e-2)" "unprognostic (7.42e-2)" "unprognostic (2.49e-1)" "prognostic favourable (4.35e-4)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 8.8 8.5 9.0 6.9 10.6 4.6 9.7 7.9 16.6 6.6 10.1 7.0 4.1 10.1 8.5 6.0 9.5 6.6 5.2 8.6 7.6 9.2 12.8 15.7 5.5 4.9 8.4 12.4 6.7 19.1 7.2 7.7 7.4 10.0 4.9 10.3 4.2 6.7 5.2 26.3 8.6 7.2 8.0 7.6 6.1 7.0 4.3 7.8 2.3 9.6 9.9 5.8 6.9 7.9 3.7 5.9 3.3 8.4 2.3 3.4 2.7 12.2 7.0 6.4 10.5 10.4 9.1 14.2 9.3 7.7 11.5 9.7 8.6 4.4 28.2 6.3 5.4 9.4 15.5 13.0 15.1 8.6 15.5 23.7 11.0 9.9 12.9 23.2 8.1 10.0 11.6 13.1 16.5 7.9 21.5 5.0 8.7 8.1 7.8 12.0 28.3 19.9 15.5 22.0 20.4 10.2 12.4 14.4 7.6 13.4 17.3 17.1 10.1 15.9 8.7 9.1 12.0 12.5 12.7 10.5 26.2 13.1 4.2 16.9 7.4 3.1 5.9 1.8 2.5 8.4 3.4 3.7 2.6 2.5 5.9 1.8 2.4 2.6 3.3 2.3 4.0 2.8 1.5 2.7 9.0 10.6 7.9 16.6 7.6 9.2 8.4 12.4 10.0 7.8 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell line enhanced" "Detected in many" "BEWO: 15.9;HeLa: 28.3;RPMI-8226: 21.8;SK-BR-3: 12.7;U-266/84: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Low region specificity" "Detected in many" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favourable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 1.8 1.3 27.5 1.8 26.1 0.7 9.5 12.5 23.8 3.9 11.6 27.9 2.2 11.6 2.0 4.4 9.5 12.7 5.8 32.8 27.7 14.5 8.3 12.3 8.8 0.7 23.8 13.8 2.6 11.4 24.7 5.2 3.4 10.8 9.4 7.3 2.8 26.9 3.7 68.7 10.7 20.7 2.2 25.0 0.8 7.4 2.5 16.8 0.0 5.5 12.2 3.1 1.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 5.8 4.3 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 10.4 9.4 0.0 0.4 0.0 10.9 6.0 0.0 0.0 0.0 4.6 0.0 28.3 2.2 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 3.0 0.1 0.0 3.6 0.0 0.0 4.2 3.6 0.0 0.2 21.8 8.5 0.0 5.7 0.1 2.0 12.7 1.8 9.1 0.0 0.0 0.0 5.2 0.1 0.4 0.0 16.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 27.5 26.1 12.5 19.0 27.7 14.5 23.8 13.8 10.8 16.8 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536630 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: " "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 12.5 17.4 8.7 17.1 14.0 10.9 17.0 19.7 14.5 16.9 17.1 13.0 22.4 13.2 16.9 20.6 14.4 14.0 12.8 12.5 8.9 9.4 16.5 46.2 12.1 11.7 9.3 10.0 17.9 29.4 10.9 22.6 32.9 11.5 20.9 20.7 12.9 28.3 25.2 12.5 14.7 18.8 13.3 10.1 14.8 15.6 9.9 11.2 17.4 18.5 8.7 18.5 14.8 14.8 5.1 7.2 7.4 4.6 4.9 8.0 3.8 5.8 5.3 10.2 9.1 13.4 15.4 9.7 9.7 13.8 11.4 9.5 7.7 10.8 8.0 4.3 11.5 12.8 8.4 9.8 17.3 6.2 6.8 9.0 6.4 13.5 16.6 13.1 8.6 11.5 14.9 7.5 26.8 11.0 5.8 4.9 13.5 9.0 7.2 12.4 8.3 6.4 8.5 5.9 7.4 10.6 9.5 5.1 9.2 6.3 12.4 12.9 8.5 13.6 10.3 5.5 4.3 10.2 6.1 6.9 3.7 8.3 10.5 6.7 9.7 7.4 4.1 7.3 7.5 4.6 8.0 5.1 5.8 6.4 3.1 4.9 6.6 6.1 3.7 4.9 2.9 7.2 6.2 3.8 8.7 14.0 19.7 14.5 8.9 9.4 9.3 10.0 11.5 11.2 COG4 "COD1, DKFZP586E1519" ENSG00000103051 "Component of oligomeric golgi complex 4" 16 70480568-70523565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040924, HPA042539" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA040924: , HPA042539: " "unprognostic (1.30e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (6.08e-2)" "unprognostic (1.41e-2)" "prognostic unfavourable (1.64e-5)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "unprognostic (3.02e-1)" "unprognostic (3.35e-1)" "unprognostic (1.99e-2)" "unprognostic (1.79e-1)" 15.1 19.0 16.7 15.0 17.6 10.9 11.9 19.4 19.2 19.1 17.3 23.2 18.2 8.9 14.7 11.9 23.3 17.8 12.7 18.5 13.8 13.7 15.0 16.6 15.8 11.6 19.0 14.0 16.9 9.9 28.1 19.1 18.0 15.1 14.2 14.8 16.4 13.7 15.8 51.3 16.9 15.6 16.9 17.0 15.2 15.2 16.8 16.7 20.3 18.1 11.8 20.7 16.2 15.6 10.8 23.9 16.7 23.0 9.5 17.1 16.5 14.5 23.9 19.0 12.6 26.0 18.2 21.7 16.3 21.6 20.7 18.0 19.2 26.8 9.8 23.7 25.7 21.4 24.3 26.0 29.2 8.3 14.9 8.9 23.1 18.4 15.3 5.9 6.1 21.6 17.0 26.9 16.6 20.7 21.4 7.3 23.1 29.5 9.6 9.0 18.4 12.6 18.2 12.6 22.2 17.0 12.3 17.8 18.5 31.9 12.4 9.6 31.4 10.3 19.5 19.1 12.1 14.3 11.7 7.6 9.4 30.2 20.8 6.2 18.5 14.4 19.2 16.7 15.4 20.9 11.2 8.5 15.1 13.8 23.9 10.8 13.5 12.5 10.1 9.5 23.0 11.0 17.1 16.5 16.7 17.6 19.4 19.2 13.8 13.7 19.0 14.0 15.1 16.7 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201555-107564514 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: " "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavourable (1.48e-4)" "unprognostic (1.15e-1)" 17.2 15.8 15.2 13.7 14.9 16.5 13.9 16.1 17.7 24.8 12.1 15.0 18.3 8.8 28.4 14.0 16.4 10.9 20.3 25.7 13.3 10.3 12.7 8.9 12.9 9.5 14.7 12.5 16.7 18.9 40.3 28.4 14.4 13.4 25.6 14.1 10.5 34.0 20.6 16.5 15.8 12.5 23.8 17.5 10.8 13.1 12.6 15.3 14.0 26.3 11.5 17.3 13.9 21.4 9.8 8.6 10.1 12.9 7.0 12.3 8.9 16.2 7.5 6.8 2.6 2.0 1.8 6.7 12.0 14.3 6.4 10.2 4.8 7.5 2.3 4.6 11.8 8.4 2.8 2.1 9.3 11.3 2.1 1.8 3.1 8.0 1.5 4.6 10.7 6.1 1.1 12.5 14.0 18.4 5.2 8.9 12.3 8.0 4.8 0.0 0.9 8.1 2.1 3.0 4.2 5.5 7.8 1.5 10.1 4.1 12.4 13.1 1.2 3.0 20.9 3.9 6.6 19.8 7.0 2.9 6.7 5.0 10.5 6.4 18.9 9.9 10.8 10.1 9.6 12.5 12.3 9.8 12.0 10.3 8.6 8.2 10.2 10.1 5.1 7.0 12.9 5.5 9.5 8.9 15.2 14.9 16.1 17.7 13.3 10.3 14.7 12.5 13.4 15.3 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favourable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 11.7 16.1 16.3 9.5 18.8 2.6 13.6 23.8 18.7 17.1 12.0 11.4 9.6 13.1 12.6 8.5 13.8 13.2 13.8 19.6 13.3 12.9 13.7 11.8 8.9 9.9 13.3 17.9 19.1 23.4 18.6 37.7 19.4 17.9 17.6 11.4 8.8 16.4 15.7 10.2 13.0 13.3 14.6 15.4 9.9 15.4 24.0 14.1 10.3 18.5 7.9 10.1 14.2 11.5 7.6 6.4 5.6 7.2 10.0 10.3 5.6 7.1 4.7 8.1 5.5 15.5 19.5 14.4 11.4 16.7 10.1 12.5 5.7 11.8 12.3 6.7 17.6 9.7 8.6 9.0 11.4 14.1 10.9 11.8 5.1 8.7 9.1 11.8 12.8 8.2 11.1 6.4 7.5 9.9 4.9 4.7 16.8 7.2 8.5 11.4 7.4 6.2 8.5 20.5 6.0 7.6 9.2 4.4 5.8 10.5 9.0 9.0 10.4 7.5 14.1 5.5 6.6 12.1 5.8 3.8 3.6 9.1 16.6 6.6 16.4 4.4 4.7 5.6 6.1 7.2 10.3 7.6 7.8 8.2 6.4 6.6 6.6 8.5 1.1 10.0 4.2 3.6 8.9 5.6 16.3 18.8 23.8 18.7 13.3 12.9 13.3 17.9 17.9 14.1 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938187-56961054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA068537, CAB069400" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoplasm "Nucleoli, Nuclear bodies" "CAB017524: AB_1121780, CAB069400: , HPA027885: , HPA068537: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favourable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavourable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 8.7 5.6 7.3 5.5 8.1 10.9 8.2 12.6 8.9 8.9 6.4 7.6 4.9 6.7 8.1 8.1 8.5 6.8 4.9 5.3 5.8 5.7 7.0 8.5 5.3 7.7 7.1 6.5 8.6 9.1 8.5 9.7 9.5 8.2 7.8 7.3 5.8 7.5 9.1 7.9 7.8 7.0 5.9 7.2 8.1 6.4 58.8 6.0 12.3 8.7 5.3 8.5 7.7 7.3 22.5 13.7 14.0 13.4 12.7 17.8 8.6 13.0 9.9 20.5 7.9 7.0 8.4 14.2 9.4 8.9 14.4 15.4 13.6 11.3 15.8 19.1 7.5 7.6 13.8 10.9 20.6 18.9 17.5 25.7 9.5 15.3 7.6 21.6 15.7 7.8 13.6 10.8 11.7 12.2 22.2 13.2 13.4 16.5 17.0 13.8 12.0 10.0 8.1 25.2 12.6 9.8 13.2 17.4 17.2 6.3 6.3 15.7 22.7 21.2 8.6 16.8 12.7 8.1 12.1 19.6 24.4 18.5 8.7 12.0 10.2 14.0 11.5 13.9 13.9 10.4 15.6 22.5 15.4 14.6 11.3 21.6 17.8 17.2 6.8 12.7 13.4 13.7 15.2 8.6 7.3 8.1 12.6 8.9 5.8 5.7 7.1 6.5 8.2 6.0 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652247-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 38.1;ASC TERT1: 29.5;BJ hTERT+: 32.3;fHDF/TERT166: 29.4;HSkMC: 27.8;U-2197: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027235, HPA027237" Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 530000 "Golgi apparatus, Plasma membrane, Cytosol" "HPA027235: AB_1847101, HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavourable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 18.0 7.3 7.0 12.7 9.0 0.2 10.8 2.8 8.2 63.1 17.3 10.2 12.5 6.1 31.0 15.2 9.3 8.3 15.9 9.1 9.6 6.2 3.4 1.0 7.2 3.1 9.9 10.2 62.6 2.6 1.3 7.3 8.2 8.8 29.3 4.6 12.5 15.3 38.1 4.2 26.9 8.6 45.2 15.7 3.9 10.5 10.0 10.3 1.5 11.8 7.9 5.0 26.1 28.3 0.2 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 38.1 29.5 4.0 17.5 32.3 4.2 4.5 0.1 3.0 0.0 0.5 29.4 13.6 0.0 18.0 1.0 0.0 0.0 0.0 2.0 5.9 12.7 0.0 0.1 27.8 12.4 12.1 6.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.7 2.1 0.3 2.6 0.3 0.0 0.0 15.7 15.7 27.0 0.3 0.0 0.0 0.0 10.7 0.0 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.1 0.1 0.0 0.0 0.0 7.0 9.0 2.8 7.1 9.6 6.2 9.9 10.2 8.8 10.3 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell line enhanced" "Detected in some" "HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: " "prognostic favourable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavourable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.7 0.0 55.3 0.0 88.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.1 0.0 98.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 5.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50183289-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 415.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 89.7;BJ: 172.4;fHDF/TERT166: 260.2;HSkMC: 131.8;U-138 MG: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA011795 Approved Approved Vesicles,Cytosol "Secreted to extracellular matrix" 58000000 Cytosol Vesicles "HPA011795: AB_1847088" "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavourable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 30.2 5.7 0.7 28.2 4.0 0.1 31.7 0.6 0.9 415.7 25.7 1.6 23.9 3.0 121.8 70.9 17.4 33.0 110.3 43.9 0.7 0.1 7.5 4.6 18.8 38.5 0.7 1.2 73.6 10.5 1.0 10.7 89.1 2.2 31.5 4.0 9.2 9.1 21.0 11.0 35.5 10.6 88.0 1.3 13.7 15.0 44.6 0.7 7.7 6.7 15.5 8.7 67.3 49.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.2 0.9 0.1 36.9 89.7 1.5 172.4 46.8 43.0 27.0 3.4 0.8 0.0 0.4 260.2 0.5 0.4 0.1 7.7 0.2 0.3 0.0 4.3 0.2 70.3 0.0 0.0 131.8 2.5 52.5 0.2 0.0 0.1 0.0 21.6 0.4 0.0 0.0 0.9 0.5 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.3 0.2 0.0 2.2 0.0 0.0 140.1 30.6 20.9 0.8 0.1 0.3 0.0 10.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 0.6 0.9 0.7 0.1 0.7 1.2 2.2 0.7 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Cell line enhanced" "Detected in some" "HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavourable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.9 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Cell line enriched" "Detected in some" 8 "HeLa: 30.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.1 0.0 2.3 4.1 30.8 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.2 3.9 0.0 0.5 0.0 1.1 0.1 0.0 2.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535853 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.2;U-266/70: 13.9;U-266/84: 3.7;WM-115: 6.7" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 8 "olfactory region: 4.5" "Not detected" "Not detected" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" "Nucleoplasm, Cytosol" "HPA043844: , HPA060468: " "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 2.7 3.7 1.0 7.0 1.1 0.3 3.1 2.4 1.6 10.2 11.8 0.6 11.5 1.3 2.9 16.2 14.7 5.5 5.7 7.0 1.3 2.2 2.8 1.9 1.3 1.0 9.8 0.2 2.9 5.8 0.1 12.2 0.5 6.1 5.8 4.7 12.8 19.3 6.2 5.6 2.1 6.6 16.0 7.9 0.3 5.7 3.2 0.2 0.2 1.4 10.2 0.9 8.4 14.2 0.6 0.3 1.6 0.2 2.1 1.0 0.0 2.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.6 0.0 0.0 1.6 0.6 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.3 2.0 0.2 0.3 0.0 0.9 0.5 0.0 0.1 0.0 3.2 0.1 0.2 0.0 0.1 1.0 0.0 0.1 0.8 1.0 0.0 0.7 1.8 0.0 13.9 3.7 0.0 0.2 0.8 6.7 0.5 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.6 0.4 1.0 1.6 2.1 0.1 0.3 0.0 0.0 1.0 1.1 2.4 1.3 1.3 2.2 9.8 0.2 6.1 0.2 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164565-227314792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.9" "Cell line enhanced" "Detected in some" "HeLa: 16.1;Karpas-707: 9.5;RPTEC TERT1: 10.7;U-266/70: 8.8" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 3.8;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 7 "B-cells: 3.8" "Not detected" "Not detected" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favourable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.7 9.5 0.9 5.4 2.9 0.3 0.9 1.4 2.9 0.7 0.7 1.7 12.0 0.7 1.5 15.3 1.1 1.5 5.3 6.7 1.6 1.2 27.9 0.7 15.0 3.6 2.4 0.0 3.6 4.4 0.2 16.7 0.2 7.5 4.9 1.0 20.9 1.1 11.2 17.8 0.6 5.0 2.9 3.1 6.1 1.5 1.5 3.4 0.0 16.2 9.4 5.8 1.8 1.2 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 2.9 10.7 2.1 0.5 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 8.8 3.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.9 1.4 2.9 1.6 1.2 2.4 0.0 7.5 3.4 COL4A3BP "CERT, GPBP, STARD11" ENSG00000113163 "Collagen type IV alpha 3 binding protein" Q9Y5P4 5 75356345-75512138 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 51.1;WM-115: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035645, HPA042608" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035645: AB_10600700, HPA042608: " "unprognostic (2.45e-1)" "unprognostic (7.16e-2)" "unprognostic (6.56e-3)" "unprognostic (1.53e-2)" "unprognostic (2.44e-1)" "unprognostic (9.29e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-1)" "unprognostic (2.51e-1)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (4.29e-2)" "prognostic favourable (1.24e-5)" "unprognostic (9.12e-2)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (2.91e-1)" 30.0 25.5 16.5 17.1 21.9 17.9 21.4 34.4 21.2 26.9 19.9 14.9 21.5 13.5 20.5 11.6 21.9 17.1 17.4 14.9 15.2 16.3 21.1 22.7 19.6 13.4 22.5 12.4 17.9 12.4 24.6 25.9 17.8 18.2 19.0 14.6 14.8 17.5 16.1 33.4 14.2 19.3 18.9 16.6 17.2 17.0 21.3 20.7 17.8 37.4 14.3 15.9 21.8 19.1 6.4 9.8 20.9 16.6 5.1 8.8 5.7 16.3 8.5 8.2 7.1 51.1 14.3 10.9 9.2 11.4 7.1 9.5 12.7 9.4 7.9 20.0 9.8 10.0 12.4 12.7 10.9 9.7 5.8 6.6 9.3 6.7 13.0 6.5 7.6 10.7 9.0 8.3 9.5 8.2 11.9 12.0 9.3 8.6 7.7 4.9 10.5 6.3 6.6 10.8 7.3 11.6 19.9 6.3 6.3 11.6 8.2 11.4 7.9 11.2 11.1 4.8 5.8 8.6 7.5 11.2 14.6 9.3 8.4 11.2 44.2 5.0 13.9 10.6 6.0 15.6 5.6 6.0 6.2 5.6 9.8 6.4 5.9 5.8 20.9 5.1 16.6 5.7 8.8 5.7 16.5 21.9 34.4 21.2 15.2 16.3 22.5 12.4 18.2 20.7 COL6A2 ENSG00000142173 "Collagen type VI alpha 2 chain" P12110 21 46098097-46132849 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.7;ASC TERT1: 173.4;BJ: 83.4;BJ hTERT+: 77.6;HHSteC: 92.0;HSkMC: 123.8;U-138 MG: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 14 "T-cells: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA007029, HPA030920, HPA038799" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 8900000 Cytosol "Plasma membrane" "HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214" "unprognostic (3.53e-1)" "unprognostic (3.76e-2)" "unprognostic (3.20e-2)" "unprognostic (4.87e-2)" "unprognostic (2.92e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-1)" "unprognostic (5.28e-3)" "unprognostic (2.11e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-1)" "unprognostic (2.01e-1)" "prognostic unfavourable (8.72e-14)" "unprognostic (2.13e-2)" "unprognostic (7.61e-2)" "unprognostic (2.31e-2)" "unprognostic (2.22e-3)" 81.2 8.7 1.5 65.0 2.7 0.2 116.7 1.8 2.7 103.5 112.6 4.7 75.0 15.3 127.2 160.3 55.5 66.5 179.8 90.6 2.1 1.3 9.6 9.1 38.7 38.3 3.2 3.8 76.1 14.8 2.7 11.8 52.6 8.8 81.0 9.8 23.5 33.4 81.4 30.6 37.8 38.1 231.3 5.8 23.6 49.0 33.2 1.8 9.8 19.9 58.5 17.2 107.2 76.1 0.0 0.0 0.0 0.0 0.5 7.6 0.7 0.7 0.9 2.7 2.4 93.7 173.4 0.7 83.4 77.6 21.1 9.7 0.1 3.3 0.0 6.3 59.8 0.0 0.6 0.0 1.7 0.0 0.9 0.0 0.0 0.0 92.0 0.0 0.3 123.8 0.0 39.9 0.8 0.0 0.0 0.0 8.5 0.3 0.0 0.1 1.5 10.2 0.0 5.3 0.1 0.0 0.0 0.0 4.3 3.2 0.0 0.0 0.0 0.5 0.0 90.5 10.6 33.3 20.6 0.0 0.0 0.0 46.3 0.0 12.8 0.0 0.0 0.0 7.6 0.0 5.1 0.0 0.7 3.8 0.0 0.0 0.8 2.1 0.0 0.5 0.0 0.0 0.1 0.7 1.5 2.7 1.8 2.7 2.1 1.3 3.2 3.8 8.8 1.8 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell line enhanced" "Detected in some" "HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA056316: , HPA075286: " "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.2 0.1 0.6 0.3 0.9 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.4 1.2 3.7 0.1 0.7 0.0 0.0 0.1 34.6 0.5 0.7 0.3 9.7 0.6 0.3 33.4 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.9 0.4 0.7 0.8 0.4 0.8 0.0 2.4 0.0 5.1 0.5 0.8 0.0 4.3 0.4 5.4 37.4 0.0 0.0 4.4 0.0 0.1 0.5 0.0 1.1 0.3 4.4 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in some" 6 "BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: " "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 52.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.4 20.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 2.3 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.2 0.0 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;BJ: 8.4;HSkMC: 14.3;U-2197: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: , HPA071056: " "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.6 17.3 0.6 8.4 2.9 1.2 2.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 4.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 17.0" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 0.0 4.1 5.4 4.6 0.1 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 17.0 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Group enriched" "Detected in some" 5 "BEWO: 16.9;HDLM-2: 5.5;U-937: 8.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" "Plasma membrane" "Cell Junctions" "HPA045876: " "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.1 1.4 1.0 16.9 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.2 0.2 0.3 0.4 0.5 5.5 1.2 0.6 0.7 0.1 0.2 0.4 1.1 0.8 0.4 0.8 0.3 0.3 0.0 0.5 0.8 0.3 0.6 1.8 0.2 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.7 0.2 0.1 0.4 1.2 0.8 0.1 0.1 1.0 1.8 0.6 1.6 1.5 0.1 0.1 8.5 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 COMMD1 "C2orf5, MGC27155, MURR1" ENSG00000173163 "Copper metabolism domain containing 1" Q8N668 2 61888724-62147247 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034633, HPA049223" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034633: AB_10601800, HPA049223: " "unprognostic (6.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.83e-1)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.22e-2)" "unprognostic (5.58e-2)" "unprognostic (1.07e-1)" "unprognostic (4.93e-1)" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (2.07e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (1.27e-1)" "unprognostic (5.51e-2)" "unprognostic (2.77e-1)" 19.6 26.2 18.6 23.2 22.3 14.2 22.8 26.7 21.4 20.1 16.6 16.7 21.2 18.2 21.0 26.2 25.3 18.0 16.8 41.7 16.1 15.2 25.4 28.8 15.6 17.3 17.8 22.4 19.9 32.8 15.0 30.0 21.2 16.8 19.0 19.0 17.9 26.6 24.3 32.1 21.0 14.4 24.7 19.9 16.1 19.5 26.8 19.0 16.3 23.6 20.3 19.7 17.6 19.5 33.0 42.7 17.1 36.5 31.2 31.8 35.7 10.0 13.0 14.9 11.5 19.2 22.3 12.7 12.1 20.5 24.6 18.0 22.1 9.2 17.8 10.4 22.6 7.9 8.1 14.8 26.6 19.1 9.9 13.8 7.6 24.4 16.5 21.4 10.9 16.2 17.2 11.9 14.2 24.7 8.4 29.1 26.0 18.9 16.5 38.1 12.6 17.8 11.8 19.4 20.3 22.3 11.1 8.9 10.1 13.7 23.1 12.3 14.6 9.4 11.6 22.2 19.1 13.8 18.5 12.8 10.0 22.1 13.0 19.1 19.2 16.5 36.5 17.1 25.1 30.8 24.6 33.0 28.4 27.7 42.7 30.7 27.2 29.0 3.0 31.2 26.2 39.6 31.8 35.7 18.6 22.3 26.7 21.4 16.1 15.2 17.8 22.4 16.8 19.0 COMMD2 HSPC042 ENSG00000114744 "COMM domain containing 2" Q86X83 3 149738470-149752499 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044190 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044190: AB_10966289" "unprognostic (2.17e-1)" "unprognostic (8.34e-3)" "unprognostic (6.28e-2)" "unprognostic (1.55e-3)" "unprognostic (1.53e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" "unprognostic (4.93e-2)" "prognostic unfavourable (3.69e-6)" "unprognostic (1.31e-1)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (4.86e-2)" 14.1 11.2 13.3 9.6 16.1 10.3 20.9 22.0 18.3 17.2 10.9 21.1 4.8 10.6 18.8 10.5 14.6 13.2 10.6 11.2 13.4 12.3 21.9 17.2 17.0 13.2 16.0 12.5 18.1 11.3 14.4 14.2 22.3 18.7 14.0 11.7 14.1 14.6 12.2 9.4 13.3 15.8 17.0 19.6 15.2 10.4 9.6 14.4 20.5 19.3 9.6 14.6 12.4 12.8 8.7 10.0 16.4 14.2 11.7 11.4 9.4 16.6 4.9 15.9 9.2 14.0 16.1 10.6 10.4 11.0 16.3 16.5 8.5 10.4 13.4 12.0 10.2 10.7 15.2 12.8 19.0 9.9 14.5 12.0 6.7 5.7 15.0 17.3 5.5 12.1 14.1 8.0 14.4 11.4 5.9 7.6 11.6 5.2 11.9 8.5 17.6 6.6 11.1 16.1 17.9 15.4 4.4 7.3 11.3 12.2 9.8 22.5 18.2 11.5 9.9 9.6 3.9 9.5 12.4 13.8 5.4 22.1 9.3 15.6 3.9 16.4 8.2 13.9 8.0 12.0 11.4 8.7 9.8 9.5 10.0 8.0 10.4 10.9 6.4 11.7 14.2 6.2 7.8 9.4 13.3 16.1 22.0 18.3 13.4 12.3 16.0 12.5 18.7 14.4 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: , HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 8.5 12.4 4.5 6.6 9.1 2.8 6.9 5.1 8.5 9.7 11.9 4.7 8.3 4.9 4.0 5.9 9.4 8.3 4.3 14.3 4.7 4.1 5.5 6.9 8.0 5.0 6.6 4.7 4.3 11.4 5.7 8.7 4.7 5.7 5.0 2.8 4.2 8.3 14.6 22.8 4.8 7.6 7.0 7.3 7.3 7.6 23.4 6.6 12.3 3.7 7.6 6.4 12.0 5.4 25.0 30.3 25.7 25.8 18.8 21.6 26.6 3.8 13.8 4.8 0.5 5.6 3.8 0.7 3.9 4.3 2.1 5.5 7.6 1.5 1.9 5.7 13.0 1.8 5.1 8.4 0.7 15.2 1.7 5.2 2.9 3.3 17.1 0.4 2.4 6.7 4.8 7.6 4.0 5.3 1.0 5.4 0.6 3.7 15.6 0.5 0.5 4.3 4.4 5.3 4.2 2.1 4.7 0.5 1.7 7.4 1.8 1.6 3.4 3.8 7.0 1.7 5.4 0.3 1.0 11.6 14.0 6.1 2.6 11.6 1.7 25.7 25.8 17.2 15.1 23.5 16.6 25.0 16.1 14.7 30.3 21.9 11.0 12.2 3.8 18.8 17.8 29.2 21.6 26.6 4.5 9.1 5.1 8.5 4.7 4.1 6.6 4.7 5.7 6.6 COMMD4 FLJ20452 ENSG00000140365 "COMM domain containing 4" Q9H0A8 15 75335891-75343224 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066957 Uncertain Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA066957: " "unprognostic (7.77e-2)" "unprognostic (3.07e-3)" "unprognostic (1.03e-1)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (1.49e-1)" "unprognostic (2.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.78e-3)" "unprognostic (2.01e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-3)" "unprognostic (2.51e-1)" "unprognostic (2.27e-1)" "unprognostic (1.96e-1)" "unprognostic (5.07e-2)" 15.9 35.2 16.1 20.7 17.5 20.4 16.2 12.6 23.1 14.4 19.5 21.7 22.2 21.9 20.7 26.2 17.7 15.7 30.1 16.6 13.9 12.9 25.1 28.1 24.3 17.4 15.6 15.4 13.7 15.2 14.9 16.2 23.7 14.1 15.2 15.9 20.9 30.8 16.6 13.2 15.2 20.1 16.7 16.6 19.3 18.3 32.7 14.7 30.4 20.3 27.4 17.3 16.4 14.5 17.3 26.0 14.6 22.3 26.9 33.4 13.8 33.1 51.5 23.7 30.7 10.4 15.0 23.3 25.7 24.0 44.3 44.9 29.7 44.4 21.2 24.3 19.4 34.9 45.1 26.9 22.3 15.5 57.7 25.2 41.4 32.7 18.4 19.6 24.7 16.7 14.3 28.7 5.5 22.0 25.9 30.9 34.1 39.4 16.9 21.8 33.3 30.3 29.9 38.4 27.9 22.6 29.4 19.1 28.0 33.4 25.2 39.3 38.9 35.0 20.3 31.4 29.9 31.6 45.1 22.1 50.5 24.3 34.6 40.6 30.2 10.8 17.3 14.6 33.4 22.3 20.8 17.3 20.9 24.6 19.0 15.8 12.6 19.7 3.6 26.9 18.7 26.0 30.9 13.8 16.1 17.5 12.6 23.1 13.9 12.9 15.6 15.4 14.1 14.7 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA046905: " "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 24.7 22.3 18.2 16.7 18.1 27.6 14.6 26.0 22.9 15.2 19.1 18.1 17.7 17.8 16.6 15.3 18.9 15.9 17.0 20.9 18.4 17.1 18.0 21.8 20.0 21.0 23.8 12.2 13.4 20.3 11.0 18.3 16.3 15.9 15.8 10.5 16.4 22.4 17.4 16.0 17.5 15.5 17.9 18.5 22.2 16.9 11.7 16.8 17.7 23.6 14.3 19.0 20.2 15.1 29.3 36.6 36.3 42.6 32.0 33.8 31.8 16.0 18.9 9.2 12.3 11.4 9.1 8.2 9.4 10.0 16.0 12.6 11.5 12.7 11.1 20.8 11.3 10.9 11.4 15.4 6.9 14.5 16.1 23.3 18.1 19.2 15.3 7.9 20.3 12.0 14.1 10.9 8.2 12.2 16.6 20.6 12.8 29.3 7.0 8.2 14.0 38.4 9.2 10.6 17.0 15.4 14.4 21.6 18.8 15.6 9.5 13.4 18.4 14.8 11.2 12.1 23.8 16.9 18.2 8.6 9.1 10.2 16.7 14.7 15.5 28.5 42.6 36.3 29.3 34.6 26.1 29.3 22.8 28.7 36.6 26.1 22.8 25.3 25.7 32.0 21.8 13.4 33.8 31.8 18.2 18.1 26.0 22.9 18.4 17.1 23.8 12.2 15.9 16.8 COMMD8 FLJ20502 ENSG00000169019 "COMM domain containing 8" Q9NX08 4 47450796-47463719 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035887 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035887: AB_10600702" "unprognostic (9.04e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (5.13e-2)" "unprognostic (2.51e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.07e-2)" "unprognostic (4.24e-2)" "unprognostic (3.47e-2)" "unprognostic (1.78e-1)" "unprognostic (3.78e-2)" "prognostic favourable (2.71e-5)" "unprognostic (1.06e-1)" "unprognostic (2.10e-1)" "unprognostic (7.76e-2)" "unprognostic (7.13e-2)" 11.4 14.0 14.7 13.9 21.3 13.1 10.9 9.5 18.8 9.7 12.5 5.7 7.7 13.1 9.7 17.3 21.1 8.3 10.0 19.1 14.1 14.0 32.5 16.1 15.1 21.4 13.9 15.0 8.4 10.4 15.5 20.5 20.0 11.3 9.2 13.4 6.5 9.8 9.2 7.7 12.5 17.1 12.8 11.6 14.5 10.0 16.9 10.9 15.2 15.7 19.7 17.5 15.5 12.7 21.1 32.7 39.8 36.4 23.9 22.9 27.9 12.4 6.9 6.1 3.1 13.0 18.6 8.5 18.8 12.5 12.4 16.9 11.6 14.8 20.0 15.8 17.7 6.7 19.5 15.3 22.4 11.8 8.8 11.5 7.7 8.9 17.7 28.0 14.8 15.9 20.7 11.7 13.1 15.6 8.5 8.2 30.1 6.9 16.6 22.7 4.2 9.0 8.4 13.9 4.3 35.5 10.2 12.0 6.1 7.8 6.4 14.9 11.7 18.6 12.8 17.7 17.0 15.7 22.3 8.7 10.4 16.1 19.2 36.8 12.7 39.8 26.2 29.5 21.3 34.9 22.9 21.1 19.6 21.1 32.7 18.8 18.5 21.0 12.9 23.9 36.4 15.3 22.0 27.9 14.7 21.3 9.5 18.8 14.1 14.0 13.9 15.0 11.3 10.9 COMMD9 "FLJ31106, HSPC166" ENSG00000110442 "COMM domain containing 9" Q9P000 11 36269284-36289449 "Predicted intracellular proteins" "Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009142 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA009142: AB_1847105" "unprognostic (1.56e-2)" "unprognostic (4.75e-3)" "unprognostic (7.57e-2)" "unprognostic (4.40e-3)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-3)" "unprognostic (2.62e-1)" "unprognostic (6.15e-2)" "prognostic favourable (8.54e-4)" "unprognostic (4.94e-2)" "unprognostic (2.40e-1)" "unprognostic (6.08e-3)" "unprognostic (7.24e-2)" "unprognostic (1.71e-1)" "unprognostic (7.31e-3)" "unprognostic (1.88e-1)" 26.9 25.4 28.0 15.8 25.4 32.6 18.5 18.1 36.9 14.3 15.0 26.5 9.5 16.2 12.4 20.4 18.4 16.2 15.8 23.1 25.4 25.7 34.5 28.0 20.4 24.8 27.7 23.8 15.8 23.3 19.4 18.9 18.9 22.8 12.6 19.1 16.0 16.7 11.1 43.6 19.6 16.4 17.0 28.4 26.0 14.8 14.6 17.2 24.7 19.8 21.1 23.6 16.6 12.2 22.5 66.3 28.8 66.2 14.8 18.9 46.4 10.6 12.7 14.0 14.7 21.7 15.2 7.8 12.8 16.6 29.2 27.5 10.4 9.2 12.4 12.8 25.4 15.8 24.6 17.2 27.6 14.8 29.0 6.8 23.9 17.9 20.4 26.4 20.5 19.1 19.3 15.9 9.8 23.9 16.7 13.4 22.9 13.8 17.6 18.4 14.9 27.1 19.4 31.8 14.6 30.4 10.1 17.2 19.3 18.3 18.2 16.3 39.7 10.1 15.9 17.7 13.6 42.0 18.6 9.4 19.2 13.9 20.4 24.9 16.9 12.2 66.2 28.8 16.8 59.6 15.7 21.8 16.2 16.1 66.3 22.5 18.7 15.7 7.4 14.8 47.5 25.0 18.9 46.4 28.0 25.4 18.1 36.9 25.4 25.7 27.7 23.8 22.8 17.2 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell line enhanced" "Detected in many" "MCF7: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Supported "Endoplasmic reticulum,Vesicles" 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favourable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favourable (5.67e-4)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.0 19.6 2.2 19.4 22.1 19.7 0.8 21.6 27.3 18.5 21.3 16.6 22.2 7.7 9.6 30.9 26.1 3.7 23.2 4.9 16.6 24.7 13.7 10.5 38.7 41.3 22.8 5.5 25.0 28.7 16.1 16.0 17.4 55.4 16.4 15.0 118.0 8.9 41.0 4.8 6.6 13.5 19.4 10.6 19.6 60.5 9.5 8.3 7.2 61.3 17.8 13.2 64.3 20.8 33.2 12.7 10.9 16.2 6.0 2.5 6.3 35.8 30.9 22.8 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233969-75236030 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.2" "Cell line enhanced" "Detected in many" "HEK 293: 22.5;PC-3: 31.2;RPMI-8226: 17.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favourable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 2.5 5.2 1.3 5.8 1.4 2.9 5.7 3.6 2.2 4.8 14.1 0.5 9.7 17.9 2.0 5.9 20.0 1.6 6.4 8.0 1.2 1.6 12.6 14.9 4.4 4.1 1.9 1.7 2.2 57.2 3.2 5.3 7.8 2.2 3.1 2.1 3.2 21.2 9.1 19.6 7.3 22.9 1.9 1.0 3.4 16.1 1.5 0.6 2.7 7.0 14.4 6.0 2.4 7.5 6.6 15.7 3.8 9.3 7.3 12.5 7.1 4.8 0.9 0.2 0.9 0.1 0.4 14.6 1.4 0.4 0.1 0.3 1.2 4.3 13.7 2.8 0.3 6.9 0.4 1.2 0.0 2.1 22.5 0.5 1.3 2.3 0.7 2.6 2.3 0.3 1.9 0.0 1.1 0.0 5.5 2.7 0.0 3.2 3.8 8.1 0.7 31.2 7.1 0.7 17.5 1.0 0.2 5.3 1.3 1.5 11.3 3.0 6.6 0.3 1.2 0.3 4.3 0.4 1.6 15.0 3.1 6.6 0.3 2.3 0.3 0.0 8.9 3.8 12.1 9.3 12.5 6.6 11.7 12.2 10.1 4.7 3.8 6.7 1.8 7.3 8.9 15.7 9.0 7.1 1.3 1.4 3.6 1.7 1.2 1.6 1.9 1.7 2.2 0.6 COPA HEP-COP ENSG00000122218 "Coatomer protein complex subunit alpha" P53621 1 160289273-160343400 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" 260000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavourable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavourable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 38.3 32.7 29.2 28.9 41.0 22.9 32.4 43.1 48.4 46.3 34.3 53.2 24.5 38.4 37.0 33.1 28.4 31.5 28.6 38.4 33.3 35.2 36.3 64.3 33.8 26.6 42.7 29.3 36.8 47.8 49.1 57.4 45.1 56.2 35.3 39.9 28.8 42.1 33.9 40.5 28.7 50.3 40.4 42.8 36.6 32.8 21.2 35.8 36.0 42.8 21.0 34.1 30.3 27.5 15.4 31.4 25.1 29.1 18.1 21.2 25.3 28.1 22.1 23.4 22.7 60.4 49.8 27.5 38.7 46.0 33.0 39.0 28.8 19.2 20.7 25.1 58.7 28.3 27.1 27.9 38.0 23.5 18.3 23.8 30.4 30.2 45.4 28.9 24.9 46.5 17.0 44.0 41.1 38.6 21.9 23.2 39.3 20.6 18.6 12.6 25.7 25.8 16.7 27.0 31.8 27.0 26.6 19.5 24.6 43.7 38.4 40.9 42.8 39.1 45.5 24.9 19.4 33.3 25.4 38.2 26.5 31.8 32.4 15.1 37.0 25.1 29.1 20.1 17.1 27.3 21.2 15.4 14.3 18.3 31.4 12.1 13.2 15.2 10.8 18.1 27.9 13.3 17.5 25.3 29.2 41.0 43.1 48.4 33.3 35.2 42.7 29.3 56.2 35.8 COPB1 COPB ENSG00000129083 "Coatomer protein complex subunit beta 1" P53618 11 14443440-14500027 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" 400000 "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: , HPA064403: " "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (6.91e-4)" "prognostic unfavourable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavourable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 30.9 33.0 18.4 23.5 20.8 31.2 55.4 23.7 23.6 32.5 26.6 15.5 42.0 25.9 32.2 33.0 32.2 28.3 25.1 34.8 18.9 16.8 37.6 56.6 38.4 53.9 22.6 15.5 31.3 52.2 40.1 43.5 52.3 22.2 31.9 31.3 17.2 43.4 41.7 21.9 24.7 33.1 39.7 26.1 29.8 30.2 21.7 20.6 46.0 37.7 26.7 28.0 28.2 27.3 26.7 33.9 27.9 30.4 28.0 39.6 24.8 31.2 26.8 28.7 21.5 48.0 55.7 23.2 47.4 49.8 42.3 49.7 20.7 48.7 30.4 21.3 59.8 34.5 32.3 31.8 52.3 28.4 26.8 32.3 19.2 31.5 42.6 29.6 32.8 38.8 42.0 28.2 53.6 44.2 23.9 25.0 53.2 23.5 26.9 18.2 14.9 29.2 22.1 39.6 20.7 38.1 28.9 18.4 19.8 36.7 29.7 24.3 27.0 25.9 44.8 40.7 21.1 43.8 25.7 13.4 22.6 33.5 30.7 18.5 37.9 27.3 24.9 27.9 32.2 30.4 39.6 26.7 27.5 32.9 33.9 22.6 27.6 28.6 20.5 28.0 30.3 20.4 29.3 24.8 18.4 20.8 23.7 23.6 18.9 16.8 22.6 15.5 22.2 20.6 COPG1 COPG ENSG00000181789 "Coatomer protein complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" 110000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: " "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 25.2 39.4 21.1 22.2 28.0 20.1 37.3 23.6 50.3 43.3 42.1 24.3 50.6 34.2 27.6 66.5 29.5 24.4 34.5 33.4 24.2 26.7 32.4 72.1 36.5 39.4 23.0 21.6 28.6 75.6 47.6 49.7 49.3 34.9 45.1 45.1 22.4 59.9 45.5 24.1 24.3 32.4 29.1 20.7 29.0 36.3 23.6 16.2 26.9 33.0 22.0 27.7 19.9 24.1 15.7 31.9 34.9 33.0 31.1 31.8 26.0 32.4 16.5 24.1 20.9 56.6 45.9 25.8 52.9 50.6 36.5 46.2 30.3 20.2 17.8 30.8 75.2 19.6 19.9 31.2 39.8 21.7 8.2 29.6 21.8 48.9 51.6 22.4 31.8 47.9 27.5 29.2 48.2 32.8 10.3 43.1 43.9 49.3 13.1 22.8 14.4 20.2 14.2 22.7 34.5 45.5 27.0 15.1 17.6 40.6 30.4 48.5 33.6 32.8 44.4 19.9 18.9 42.0 20.4 33.7 16.1 31.2 48.6 17.1 38.1 34.9 26.8 20.2 26.2 33.0 31.8 15.0 23.7 25.7 31.9 15.7 18.5 21.6 21.3 31.1 29.7 29.4 23.6 26.0 21.1 28.0 23.6 50.3 24.2 26.7 23.0 21.6 34.9 16.2 COPRS "C17orf79, COPR5, HSA272196, TTP1" ENSG00000172301 "Coordinator of PRMT5 and differentiation stimulator" Q9NQ92 17 31851864-31859337 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA052552 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA052552: " "unprognostic (1.65e-2)" "unprognostic (4.88e-2)" "unprognostic (2.46e-1)" "unprognostic (4.01e-3)" "unprognostic (3.12e-2)" "unprognostic (1.12e-2)" "prognostic unfavourable (3.69e-4)" "unprognostic (6.88e-2)" "unprognostic (3.10e-1)" "unprognostic (4.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.01e-2)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (3.11e-2)" 20.9 19.0 32.6 9.7 31.0 6.3 30.3 23.0 37.6 15.3 24.2 11.8 15.6 8.0 15.2 57.3 10.5 24.9 14.9 24.7 28.2 35.5 22.7 31.0 12.3 9.2 29.7 31.3 24.3 20.7 12.2 18.9 9.4 23.9 27.5 13.6 16.0 14.6 23.5 19.9 7.8 7.9 21.2 16.0 8.1 14.1 75.0 14.4 2.6 28.1 11.2 12.7 16.1 18.5 5.8 4.5 3.5 3.5 0.0 3.0 0.4 21.5 28.4 14.3 14.6 23.4 22.5 10.0 24.2 30.3 27.7 28.4 17.7 5.8 12.2 13.5 28.8 12.9 25.1 14.5 31.5 4.1 37.6 3.3 16.3 20.8 23.8 11.4 9.8 14.4 19.1 37.3 20.5 14.8 16.6 10.2 30.1 18.6 16.9 36.3 10.8 14.3 13.5 26.5 22.1 16.2 13.3 12.9 10.0 14.3 6.9 22.1 22.8 12.3 8.3 73.0 19.8 26.0 33.5 17.5 16.2 12.4 38.2 10.6 9.8 3.5 3.5 0.0 1.1 3.3 3.0 3.8 1.1 0.2 4.5 5.8 0.6 0.7 1.2 0.0 1.6 1.8 1.5 0.4 32.6 31.0 23.0 37.6 28.2 35.5 29.7 31.3 23.9 14.4 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" 190000 Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: " "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 36.6 26.7 23.3 15.6 34.3 48.9 30.1 29.7 35.7 35.1 27.9 10.6 26.4 19.2 26.8 21.5 34.1 20.3 24.3 27.0 21.4 21.6 27.8 33.0 25.7 18.3 28.7 20.4 36.4 25.4 26.6 30.4 25.6 41.4 30.1 19.2 8.1 19.1 22.6 59.8 20.6 27.9 34.8 37.5 22.5 21.7 26.6 27.3 22.1 33.4 27.8 20.9 56.8 33.6 11.7 15.7 8.9 17.8 11.6 20.8 11.5 22.1 13.1 28.1 23.6 34.6 49.4 19.4 38.9 37.3 34.2 31.5 27.6 12.2 36.7 26.7 37.3 32.7 39.8 32.3 37.8 24.9 16.0 34.1 28.3 22.2 26.5 32.2 17.9 41.5 26.4 27.8 49.3 35.8 43.8 19.7 37.2 11.9 17.1 16.1 18.2 17.2 18.8 26.5 54.9 36.3 33.5 27.4 19.9 22.4 24.1 31.0 23.9 32.5 23.0 33.7 18.0 62.9 40.8 17.9 45.8 46.3 31.4 52.4 27.2 8.0 13.8 8.9 10.6 17.8 19.5 11.7 16.1 15.3 15.7 10.1 20.8 13.1 5.6 11.6 15.7 10.2 20.8 11.5 23.3 34.3 29.7 35.7 21.4 21.6 28.7 20.4 41.4 27.3 COPS3 "CSN3, SGN3" ENSG00000141030 "COP9 signalosome subunit 3" Q9UNS2 17 17246820-17281293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021997, HPA050557" Approved Supported Nucleoplasm,Cytosol 29000 Nucleoplasm Cytosol "HPA021997: AB_1847152, HPA050557: " "unprognostic (3.35e-2)" "unprognostic (3.98e-3)" "unprognostic (1.84e-2)" "unprognostic (6.29e-2)" "unprognostic (6.39e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.91e-3)" "unprognostic (2.11e-2)" "unprognostic (6.37e-3)" "prognostic unfavourable (1.56e-4)" "prognostic unfavourable (8.65e-5)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.40e-1)" "unprognostic (3.03e-3)" 15.2 15.2 16.3 15.7 21.9 51.9 16.3 20.8 24.7 15.4 15.4 15.7 14.9 13.9 14.3 14.1 21.0 12.1 10.0 22.7 17.5 18.8 16.1 21.0 11.7 18.7 17.4 15.2 16.0 26.2 17.6 21.8 21.7 26.7 16.5 17.1 11.9 17.1 15.7 69.4 15.7 13.3 16.9 15.9 14.3 15.8 39.5 11.8 31.4 15.2 24.4 21.9 16.1 14.0 28.1 45.2 37.7 35.8 32.3 33.0 38.2 37.8 35.6 27.9 24.2 13.4 18.4 17.1 29.6 18.1 42.8 34.5 58.3 14.2 52.5 24.0 23.5 27.8 37.9 29.3 48.6 20.9 53.9 36.6 27.6 25.0 22.9 31.3 41.7 16.6 22.3 29.6 29.7 24.7 29.8 19.5 27.0 38.0 57.7 39.8 25.0 22.9 43.5 49.9 27.3 17.1 16.7 21.9 19.1 25.9 12.1 23.4 18.1 21.1 17.7 26.1 29.2 47.0 50.4 15.6 20.2 28.1 22.6 31.2 26.2 20.8 30.5 29.4 27.6 35.8 31.9 27.2 32.2 31.6 45.2 28.1 32.2 30.5 37.7 32.3 34.6 21.8 33.0 38.2 16.3 21.9 20.8 24.7 17.5 18.8 17.4 15.2 26.7 11.8 COPS7A CSN7A ENSG00000111652 "COP9 signalosome subunit 7A" Q9UBW8 12 6723741-6731875 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026915 Supported Supported Nucleoplasm,Cytosol 66000 Nucleoplasm Cytosol "HPA026915: AB_1847156" "unprognostic (3.50e-1)" "unprognostic (1.33e-2)" "unprognostic (3.95e-3)" "unprognostic (3.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.96e-3)" "unprognostic (3.91e-2)" "unprognostic (4.26e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" 24.1 26.0 31.6 16.6 38.1 8.8 20.5 29.6 59.5 18.2 18.5 25.0 14.1 15.8 20.1 27.9 29.1 25.8 20.1 42.2 29.6 27.9 26.2 29.6 18.8 14.6 31.6 36.9 20.1 23.1 33.9 24.3 25.4 45.3 24.7 17.5 23.8 22.1 24.5 44.6 20.9 14.1 24.2 22.5 16.2 18.1 14.9 13.9 9.2 26.1 29.6 17.6 22.7 17.6 13.7 27.1 35.9 28.4 11.5 16.5 17.8 18.8 20.0 9.6 9.4 28.6 34.2 23.5 23.3 30.5 23.6 24.0 13.9 26.4 13.1 10.1 31.1 15.3 13.0 23.8 22.6 17.9 14.5 12.2 13.7 17.6 24.7 12.8 7.6 31.7 23.1 27.8 55.4 18.3 8.7 5.3 33.1 15.3 7.4 8.1 25.9 18.4 5.1 19.7 12.9 20.0 19.0 5.5 13.0 15.3 19.5 25.6 8.3 18.6 18.8 25.2 13.2 22.1 22.4 6.1 6.5 10.5 42.9 16.6 27.5 29.4 23.1 35.9 15.9 28.4 16.5 11.3 13.7 14.2 27.1 13.7 14.2 14.0 18.7 11.5 22.5 16.8 12.1 17.8 31.6 38.1 29.6 59.5 29.6 27.9 31.6 36.9 45.3 13.9 COPS8 "COP9, CSN8, MGC1297, SGN8" ENSG00000198612 "COP9 signalosome subunit 8" Q99627 2 237085312-237100466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 77.7;U-138 MG: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036485 Uncertain Supported Nucleoplasm,Cytosol 110000 Nucleoplasm Cytosol "HPA036485: AB_10670720" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (8.74e-2)" "unprognostic (1.07e-3)" "unprognostic (1.20e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (4.70e-5)" "unprognostic (1.34e-2)" "unprognostic (8.03e-2)" "unprognostic (2.04e-1)" "unprognostic (6.85e-2)" "unprognostic (2.70e-1)" "unprognostic (2.41e-2)" "unprognostic (7.36e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" 20.1 23.1 25.2 15.6 37.0 15.7 17.9 15.2 33.8 20.6 14.0 16.7 8.6 7.7 20.9 18.3 12.5 18.0 19.9 37.8 31.7 27.9 24.2 15.6 12.3 13.5 23.6 25.8 23.7 10.8 18.2 15.0 19.8 28.1 16.6 11.7 18.6 12.7 18.1 64.5 12.3 9.7 25.4 21.3 10.4 13.5 20.8 15.4 14.8 17.5 20.3 14.5 18.0 13.2 32.4 26.9 26.1 25.9 32.2 36.2 31.7 9.4 8.0 17.6 8.7 50.5 40.0 11.7 16.7 16.6 17.2 19.1 5.2 9.6 6.5 6.4 18.1 7.2 17.2 22.7 24.0 15.3 11.1 9.5 10.3 18.5 34.9 12.3 5.6 65.8 26.3 17.2 77.7 20.0 13.1 6.3 54.2 9.0 15.1 12.6 15.5 11.8 11.6 20.9 13.0 21.2 7.7 8.6 14.9 10.0 8.6 24.8 9.9 10.1 21.0 92.0 15.5 18.0 18.0 12.1 10.0 20.9 28.7 7.5 23.2 21.9 22.8 26.1 29.7 25.0 36.2 32.4 31.7 33.8 26.9 26.9 30.8 32.1 7.0 32.2 25.9 19.4 33.1 31.7 25.2 37.0 15.2 32.3 31.7 27.9 23.6 25.8 28.1 15.4 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 31.9 29.1 81.6 20.6 73.2 24.0 40.9 22.6 61.6 29.1 27.6 22.7 20.5 25.6 17.2 53.2 34.5 23.5 25.4 62.3 75.8 44.7 30.5 23.5 17.8 26.7 64.3 24.3 23.2 64.3 8.9 27.6 17.6 32.9 25.9 18.9 19.0 43.3 26.5 86.9 20.6 24.5 21.1 52.6 22.6 25.8 18.8 25.9 26.5 34.7 41.6 19.8 23.5 20.9 68.2 79.9 90.7 67.7 52.4 82.0 79.9 26.6 36.2 28.6 29.8 39.5 32.3 26.3 38.6 27.0 25.4 32.5 26.2 24.0 7.4 11.7 35.2 21.5 25.2 35.8 17.6 31.3 93.1 22.2 37.3 81.1 31.5 22.2 20.9 37.9 29.6 18.9 23.6 37.2 25.5 16.0 36.8 57.7 35.5 69.3 43.4 79.1 28.0 38.3 23.0 31.4 46.1 33.1 33.2 20.3 27.7 41.3 25.5 43.4 30.0 33.6 37.6 42.7 36.7 32.9 27.9 37.3 41.9 26.4 33.0 90.7 67.2 87.6 68.6 66.6 68.0 68.2 71.2 70.1 62.6 52.8 62.6 70.5 24.1 52.4 67.7 79.9 82.0 79.9 81.6 73.2 22.6 61.6 75.8 44.7 64.3 24.3 32.9 25.9 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266858-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: " "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavourable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favourable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favourable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 2.9 12.4 5.0 2.3 6.8 2.2 3.1 7.6 7.3 3.7 2.9 4.8 5.9 1.9 3.6 7.7 4.3 5.2 3.2 43.5 4.5 5.4 7.2 12.8 3.5 3.4 5.6 3.9 4.5 5.5 6.0 9.9 1.7 4.8 4.1 2.7 14.0 6.5 5.6 103.7 2.2 2.9 3.7 3.6 3.8 2.6 2.4 3.0 4.9 5.4 46.1 6.2 2.7 3.3 11.7 6.8 8.0 1.1 5.0 8.6 3.6 2.4 10.2 9.9 6.4 5.7 5.7 4.2 3.5 8.5 12.6 12.6 7.9 3.8 14.6 8.1 8.9 2.3 11.4 2.0 7.5 2.2 12.7 6.8 9.3 8.2 7.8 5.3 4.1 5.9 3.3 9.3 3.7 6.6 4.5 6.0 11.6 3.3 7.6 19.1 8.4 5.9 16.4 10.8 9.6 6.9 1.5 14.3 15.5 12.2 2.5 3.8 3.9 5.9 4.6 2.4 7.0 6.7 3.6 12.6 13.5 7.1 7.0 5.0 1.8 8.0 1.0 0.9 7.7 1.1 7.9 11.7 7.1 8.2 1.7 6.7 8.6 8.4 0.4 5.0 0.8 6.8 4.6 3.6 5.0 6.8 7.6 7.3 4.5 5.4 5.6 3.9 4.8 3.0 COQ3 bA9819.1 ENSG00000132423 "Coenzyme Q3, methyltransferase" Q9NZJ6 6 99369400-99394204 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031273, HPA031274" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031273: AB_10611107, HPA031274: AB_10602176" "unprognostic (1.81e-2)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (4.62e-2)" "unprognostic (2.41e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.40e-1)" "unprognostic (8.77e-2)" "unprognostic (9.78e-2)" "unprognostic (1.09e-1)" "prognostic favourable (6.86e-5)" "unprognostic (4.61e-2)" "unprognostic (1.81e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" 5.2 7.8 8.6 4.2 10.8 3.2 7.5 13.6 16.3 4.5 8.9 4.5 4.3 6.9 4.3 6.8 8.2 4.5 3.0 21.7 8.2 7.5 10.2 12.4 2.9 7.1 6.9 12.0 6.0 5.7 11.6 7.4 2.5 9.8 6.8 11.0 7.3 11.7 7.6 28.0 5.8 6.3 6.6 4.6 4.8 5.2 2.3 6.0 4.1 4.3 16.8 7.0 7.5 4.6 6.6 8.0 9.4 7.4 9.7 12.5 5.3 11.9 6.9 8.4 11.8 5.4 6.1 11.5 10.4 6.4 15.7 18.2 9.6 5.2 11.8 6.9 7.7 11.2 13.9 16.2 19.2 12.4 17.8 14.3 9.4 10.2 7.2 20.6 5.6 3.9 9.9 9.2 9.4 9.5 21.7 8.9 8.3 11.9 9.0 17.3 10.1 13.3 4.4 8.6 15.6 12.3 10.5 13.1 7.0 7.2 11.1 13.5 13.6 13.7 3.4 6.9 10.1 10.5 15.7 3.1 5.8 18.4 8.8 20.1 10.1 9.4 3.3 2.4 6.0 7.4 6.8 6.6 7.6 9.5 8.0 3.1 12.5 9.5 0.5 9.7 6.3 5.2 5.5 5.3 8.6 10.8 13.6 16.3 8.2 7.5 6.9 12.0 9.8 6.0 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503274-120534434 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria Nucleoli Mitochondria "HPA049487: " "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 14.6 21.7 15.8 16.1 16.7 7.0 29.5 15.6 21.3 12.5 16.4 13.5 21.8 15.7 12.6 16.4 14.0 15.5 13.5 31.9 14.8 13.1 26.0 39.8 17.6 19.1 17.5 15.4 15.1 28.6 14.2 13.4 18.6 19.4 12.7 17.1 11.6 17.9 17.8 58.4 11.1 13.2 14.0 18.5 14.6 12.4 16.9 15.0 17.2 17.7 30.4 15.2 10.1 17.0 21.3 27.4 9.7 19.6 25.1 28.2 22.4 16.3 26.2 23.7 6.8 31.2 24.1 16.3 20.0 13.1 20.5 13.0 10.5 13.8 16.5 23.7 20.9 17.7 21.0 22.2 21.1 20.6 12.4 22.0 16.1 17.3 25.6 23.9 13.8 23.0 24.1 19.1 22.5 18.0 21.5 12.1 23.6 21.5 13.8 27.5 20.8 20.4 25.6 24.0 23.9 26.4 12.5 17.9 14.4 14.5 7.4 27.2 37.2 19.7 17.9 14.2 16.3 10.5 13.2 26.2 22.0 18.8 16.2 22.7 17.0 9.4 19.6 9.7 18.8 19.2 18.2 21.1 20.4 19.9 27.4 21.3 28.2 22.3 2.1 25.1 17.9 18.0 24.4 22.4 15.8 16.7 15.6 21.3 14.8 13.1 17.5 15.4 19.4 15.0 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA067252: , HPA071922: " "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favourable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.4 13.4 11.6 6.8 6.6 7.0 9.8 7.3 6.0 10.0 10.4 8.5 10.4 9.5 35.6 5.6 13.2 16.2 9.1 7.2 8.0 16.3 5.0 12.3 26.0 8.1 12.0 11.2 5.8 8.1 9.3 6.8 8.1 13.8 8.9 7.0 22.4 12.5 9.7 8.8 7.2 15.3 12.9 12.1 8.7 8.4 16.9 9.7 6.8 15.1 8.5 13.8 16.4 8.8 10.7 6.2 7.7 10.5 8.3 13.4 10.4 11.4 7.0 6.8 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: " "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.3 31.8 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Enhanced "Plasma membrane,Cytosol" 200000000 "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: , HPA070456: " "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favourable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 26.0 24.0 12.6 20.6 16.1 9.7 21.6 9.7 19.0 25.8 37.0 20.3 23.1 35.0 28.7 34.0 31.2 25.6 35.3 15.2 12.6 11.0 27.5 36.4 21.6 23.3 15.9 10.7 21.2 24.2 15.4 16.1 29.2 14.3 31.4 19.1 20.5 42.5 27.4 9.2 16.7 44.7 20.5 14.8 34.7 29.8 13.9 16.5 16.1 31.6 23.3 20.0 25.8 20.8 4.2 17.5 10.9 47.1 2.4 12.3 11.7 18.9 18.6 9.0 18.4 23.4 20.4 13.5 13.4 28.5 23.1 17.5 31.1 28.1 0.6 28.1 19.0 16.4 10.1 17.9 4.1 4.3 8.8 13.3 12.2 13.3 37.3 0.2 28.7 27.6 16.0 19.5 9.0 29.1 9.8 2.0 13.1 54.0 2.9 1.5 11.6 17.6 2.6 9.4 3.3 15.5 23.7 10.2 12.7 12.7 34.6 41.7 43.3 15.2 23.0 15.8 11.4 21.3 8.3 0.3 0.6 3.0 25.4 1.8 15.9 10.9 22.9 1.7 1.9 47.1 1.4 4.2 9.3 3.0 17.5 1.4 5.3 2.3 10.9 2.4 45.8 13.5 12.3 11.7 12.6 16.1 9.7 19.0 12.6 11.0 15.9 10.7 14.3 16.5 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192640 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 36.1" "Cell line enhanced" "Detected in many" "BEWO: 33.9;SK-BR-3: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavourable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 0.8 1.2 6.9 1.8 8.1 2.9 9.3 2.4 3.9 22.0 0.7 1.3 20.8 2.0 2.2 13.6 2.7 27.7 1.5 1.3 3.0 1.4 2.9 7.5 1.6 2.6 1.3 1.5 1.4 2.8 5.2 3.5 3.3 9.0 7.9 1.2 5.4 1.9 0.9 6.3 36.1 1.9 0.6 3.8 6.6 11.4 0.6 5.6 1.1 3.6 6.6 7.7 6.2 0.6 0.7 10.9 7.0 1.5 11.1 1.4 4.1 1.4 0.3 1.0 0.6 0.7 33.9 0.3 0.3 1.0 1.6 9.4 0.7 0.0 4.8 0.6 11.5 3.8 6.3 0.7 3.3 0.9 0.1 5.8 8.3 1.4 3.8 0.3 0.2 7.8 0.5 9.5 0.3 3.2 1.9 0.1 3.1 0.7 3.8 4.3 1.1 2.9 0.0 0.1 0.7 11.6 0.8 1.2 2.1 22.8 0.8 2.7 6.3 0.3 0.1 5.0 0.1 1.2 0.3 1.9 0.3 0.2 1.2 1.4 7.7 1.5 10.9 2.4 3.0 5.5 0.6 4.1 3.8 0.5 0.6 2.7 3.5 1.1 1.5 7.0 0.7 11.1 1.4 1.2 1.8 9.3 2.4 1.3 3.0 2.6 1.3 3.3 0.6 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578969-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.5;fallopian tube: 27.4" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;ASC TERT1: 27.4;HSkMC: 19.7;hTEC/SVTERT24-B: 16.0;U-87 MG: 27.3" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.2;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 21 "B-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 4.4 15.7 3.2 30.1 1.9 4.8 33.7 53.5 6.5 3.4 27.3 0.8 2.4 7.5 3.9 2.7 27.4 6.3 7.2 23.0 15.1 5.5 2.0 5.8 3.5 20.9 18.8 18.4 2.9 1.6 1.5 4.7 23.6 3.2 2.9 11.8 3.4 6.9 3.8 5.6 3.3 8.4 35.0 3.6 2.0 2.2 17.5 0.0 4.6 0.6 1.9 3.0 1.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 12.1 1.0 12.7 27.4 0.0 6.1 6.8 1.0 1.5 0.1 1.3 1.4 0.7 1.0 0.0 0.4 0.1 4.4 0.0 0.5 0.0 0.0 0.6 4.6 0.0 0.1 19.7 0.1 16.0 0.9 0.4 0.0 0.0 11.2 0.0 0.0 0.0 2.9 0.0 0.9 0.0 0.5 1.7 0.0 7.0 0.1 0.1 0.0 3.6 0.0 1.4 0.1 3.6 4.1 0.7 8.1 0.0 0.0 1.4 27.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 30.1 33.7 29.3 23.0 15.1 20.9 18.8 23.6 17.5 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;HDLM-2: 2.4;THP-1: 1.8;TIME: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: , HPA062721: " "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.6 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.5 0.0 1.3 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.5 0.1 0.6 1.1 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favourable (4.32e-6)" "prognostic favourable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 8.6 16.6 6.9 9.9 6.9 6.3 15.7 10.5 7.4 19.2 13.3 14.5 6.4 20.4 8.3 10.5 16.7 14.1 13.5 15.5 11.0 14.1 12.1 13.4 16.0 12.2 12.5 11.4 9.1 17.0 12.0 15.3 10.1 16.4 7.0 8.4 10.7 10.6 8.2 10.5 8.6 8.9 23.4 14.4 12.1 16.2 5.2 8.8 10.8 14.4 13.0 8.1 7.1 8.3 8.4 7.0 8.5 13.2 8.5 11.9 9.2 12.6 13.0 10.3 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.1;SCLC-21H: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavourable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.1 0.1 0.2 0.2 1.7 0.7 0.2 0.2 0.8 0.6 0.0 1.7 0.1 0.3 0.1 1.7 0.2 2.4 0.4 0.5 0.0 0.4 0.2 0.0 0.4 0.1 0.2 0.6 0.5 0.1 0.0 0.2 0.0 0.4 9.5 0.3 0.3 0.1 0.0 0.4 0.0 0.3 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria Mitochondria Nucleoli "CAB073545: , HPA059124: " "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 37.5 24.1 26.8 29.0 46.0 65.6 32.0 31.2 45.6 28.5 36.4 26.4 27.2 33.3 31.3 35.7 16.9 31.9 33.0 41.8 51.2 24.5 22.5 17.3 46.8 54.2 33.8 25.1 64.3 66.6 27.9 67.4 40.1 32.8 57.2 44.1 30.6 40.3 56.3 26.2 25.1 22.0 46.5 28.3 40.8 30.5 31.8 36.4 13.1 32.9 89.4 23.6 39.5 30.2 25.9 33.9 31.3 30.4 47.0 52.5 25.0 36.6 36.8 21.9 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865256-148897196 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 111.7" "Cell line enriched" "Detected in some" 43 "HEL: 79.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1118 "basophil: 111.7" "Lineage enriched" "Detected in single" 1118 "granulocytes: 111.7" "Low region specificity" "Detected in single" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 12.4 0.6 0.4 12.0 0.4 5.6 6.2 0.4 0.5 25.4 14.1 0.8 4.4 7.1 14.1 21.2 16.5 3.7 50.9 4.5 0.4 0.2 5.8 2.8 37.3 15.2 0.4 0.4 2.0 7.2 0.7 0.8 1.3 0.5 37.3 16.4 8.5 8.8 5.8 1.4 12.7 20.2 24.3 0.4 1.0 13.7 7.1 0.4 3.6 1.4 9.9 7.1 14.0 8.9 0.0 0.0 111.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 79.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.5 0.4 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavourable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 20.2 1.1 0.0 0.0 0.1 0.3 0.0 16.2 30.8 16.6 4.1 0.1 1.7 0.0 3.2 6.9 1.2 0.0 8.9 17.2 0.1 0.0 0.0 6.5 0.4 0.4 0.0 0.0 0.2 14.5 1.5 2.1 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.1 2.4 0.0 16.7 0.0 7.8 0.8 0.0 0.0 10.7 5.1 0.1 0.1 0.0 12.4 4.0 34.2 1.3 1.6 0.0 0.0 0.0 61.4 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HSkMC: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: , HPA055465: " "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.1 18.5 16.1 16.5 16.8 32.0 5.8 16.8 24.6 11.7 14.4 21.7 7.9 1.5 21.4 19.2 8.7 10.4 21.2 19.7 5.7 14.9 3.4 11.4 13.4 20.4 22.6 9.1 57.0 9.5 14.9 14.5 23.6 6.7 18.0 9.3 2.3 7.2 6.2 4.5 4.2 7.0 18.7 4.7 21.8 13.9 4.0 10.2 20.0 17.3 8.7 16.4 15.7 28.1 11.7 7.7 18.1 16.0 7.2 15.1 5.1 14.9 14.8 9.8 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Cell line enhanced" "Detected in many" "Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: " "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavourable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 9.0 1.7 7.2 0.8 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.2 3.4 0.7 0.8 0.0 13.2 0.0 3.7 49.9 0.5 0.0 0.0 17.6 3.7 0.0 0.0 0.0 0.0 0.3 1.8 2.5 0.0 0.4 5.7 2.0 0.0 0.0 0.1 0.1 0.5 70.2 23.2 103.0 12.9 0.0 7.7 0.3 0.0 2.8 7.2 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.0" "Cell line enhanced" "Detected in many" "SK-MEL-30: 15.8;U-2197: 45.7;U-87 MG: 16.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 27 "B-cells: 1.8;T-cells: 3.5" HPA040396 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040396: " "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.1 5.6 7.5 1.6 10.8 0.5 2.1 11.9 15.7 5.2 5.3 9.4 0.2 1.6 4.2 8.7 4.0 9.2 4.3 2.9 6.2 6.2 1.6 0.8 1.9 0.8 12.4 9.0 15.4 1.6 1.4 8.3 0.6 13.0 2.7 2.9 3.9 1.4 4.4 2.2 1.5 2.2 3.9 7.7 0.9 2.6 32.0 8.1 0.0 2.7 0.0 0.8 5.5 3.8 1.8 0.0 0.0 0.0 0.0 3.5 0.6 0.0 1.5 0.1 0.1 1.1 0.0 0.0 1.2 0.1 0.7 0.6 0.0 0.0 0.0 2.7 0.4 0.0 2.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.8 0.0 1.0 0.6 0.0 1.5 0.0 0.0 3.6 0.0 0.5 0.0 0.2 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 4.5 1.0 3.9 0.2 15.8 0.0 0.5 0.0 8.3 3.3 45.7 2.5 2.3 5.8 0.6 16.6 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.3 1.8 0.0 0.5 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 7.5 10.8 11.9 15.7 6.2 6.2 12.4 9.0 13.0 8.1 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Cell line enhanced" "Detected in many" "Karpas-707: 15.8;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059056 Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA059056: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favourable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favourable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.1 0.3 0.4 2.6 0.7 0.7 1.1 1.1 0.8 1.6 1.3 0.8 2.6 1.4 1.3 0.5 3.3 1.1 0.9 0.9 1.6 1.4 1.8 1.8 0.9 2.0 0.9 1.9 0.6 2.0 1.0 3.1 1.5 1.3 15.8 0.6 0.9 1.2 1.0 0.2 1.2 1.5 2.3 2.7 1.6 0.5 2.0 0.6 1.0 3.0 1.9 3.8 2.0 1.2 0.8 0.8 0.6 1.0 8.8 2.3 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell line enhanced" "Detected in many" "U-266/70: 38.3;U-266/84: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favourable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 3.9 5.4 2.7 1.5 4.9 2.8 5.4 7.1 6.6 2.4 2.9 5.1 2.6 4.9 5.0 3.9 0.3 2.4 3.7 4.0 9.8 2.7 3.3 13.0 3.0 10.5 1.1 6.4 4.4 8.5 6.3 9.8 2.3 10.7 12.0 5.6 2.8 0.9 1.0 1.5 5.4 0.8 2.2 16.3 3.5 7.1 3.0 3.4 0.8 9.9 12.7 6.9 2.2 7.0 4.1 2.0 2.0 4.5 38.3 55.0 2.5 9.9 2.3 5.1 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 CPNE1 CPN1 ENSG00000214078 "Copine 1" Q99829 20 35626031-35664956 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047259, HPA072634" Approved Supported "Nucleoplasm,Nuclear membrane" 160000 "Nucleoplasm, Nuclear membrane" "HPA047259: , HPA072634: " "unprognostic (5.94e-2)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (6.06e-2)" "prognostic unfavourable (2.74e-10)" "unprognostic (3.10e-1)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" 32.0 25.3 23.1 32.9 25.6 36.5 31.8 34.0 24.7 35.5 31.5 23.9 26.3 18.4 38.8 35.1 30.8 34.3 27.8 22.1 22.1 16.0 25.4 23.2 33.3 28.7 22.0 24.8 41.6 27.5 21.5 33.3 39.3 19.4 30.0 27.6 27.4 27.9 25.9 23.9 32.9 31.9 40.5 19.2 42.4 26.3 25.6 23.1 64.8 36.3 27.1 44.4 34.9 33.7 39.4 43.9 52.1 31.0 60.1 53.8 44.7 41.0 32.5 18.5 7.7 2.3 3.1 14.1 19.9 35.6 48.4 32.0 97.7 18.1 28.9 19.2 29.5 15.9 14.3 37.6 30.0 5.4 10.9 72.9 25.6 70.7 22.3 23.6 10.2 20.7 38.8 19.5 23.2 30.5 9.5 14.8 23.5 22.6 35.0 31.7 4.5 31.5 25.0 55.4 19.7 19.7 29.7 13.0 14.6 44.9 21.4 30.4 22.2 23.6 19.9 51.4 9.4 16.7 20.9 10.0 10.1 20.0 37.0 13.0 11.3 13.6 31.0 52.1 39.6 30.4 53.8 39.4 38.0 36.6 43.9 37.0 37.7 37.4 42.9 60.1 28.9 24.0 46.0 44.7 23.1 25.6 34.0 24.7 22.1 16.0 22.0 24.8 19.4 23.1 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: " "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.2 16.0 24.8 13.7 4.5 4.3 4.1 9.1 14.3 20.8 14.6 4.5 9.7 5.0 8.3 13.7 13.1 9.7 5.4 11.3 6.1 5.7 2.0 6.4 3.7 8.1 1.6 0.2 4.1 6.1 8.1 4.0 30.5 5.5 0.1 5.2 3.8 2.4 24.3 5.6 3.4 31.0 7.8 4.1 13.8 3.2 0.5 10.1 11.5 2.5 6.9 2.7 33.2 21.5 19.0 10.4 4.7 11.7 1.2 1.0 11.1 12.3 7.2 13.3 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514427-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol 52000 "Nucleoplasm, Cytosol" "Nucleoli, Mitochondria" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favourable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 26.5 16.6 21.3 9.8 18.0 35.1 20.6 18.8 13.5 26.0 16.4 20.9 13.2 15.1 28.6 12.6 40.5 15.9 14.6 24.4 17.6 19.7 29.8 25.5 16.9 22.6 19.7 10.5 26.7 24.1 25.4 28.9 16.1 17.0 22.4 16.5 21.0 20.6 15.3 10.4 18.7 19.5 20.9 18.7 18.3 16.9 9.7 14.1 30.5 33.6 21.8 29.7 25.4 20.0 14.6 31.4 28.2 24.3 15.0 18.3 14.4 34.3 12.1 8.4 10.9 32.4 25.3 6.9 16.5 24.6 13.8 15.7 7.8 11.8 9.4 11.0 20.1 26.6 18.0 17.6 24.9 10.0 14.1 1.5 8.9 9.3 11.2 0.8 0.8 17.1 19.0 15.3 20.4 16.9 8.4 18.2 17.1 13.3 16.5 0.5 3.2 17.6 7.9 7.7 44.0 17.9 24.7 17.8 14.0 14.4 66.0 10.4 25.1 2.6 18.0 12.4 12.1 16.4 12.8 13.0 15.6 2.6 17.8 3.5 11.4 10.8 16.7 26.4 18.3 19.1 14.2 14.6 14.8 12.8 30.8 14.1 13.3 14.3 28.2 15.0 24.3 31.4 10.5 14.4 21.3 18.0 18.8 13.5 17.6 19.7 19.7 10.5 17.0 14.1 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell line enhanced" "Detected in some" "A549: 9.7;AF22: 9.1;Karpas-707: 2.7;RT4: 3.1" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: " "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.7 9.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 2.7 1.3 0.6 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.6 3.1 1.3 0.6 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.3 0.3 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12804017 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.6" "Cell line enhanced" "Detected in many" "Hep G2: 44.4;HMC-1: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 93.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" 380000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: " "prognostic unfavourable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favourable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 10.9 11.5 8.3 14.3 14.3 9.5 8.5 2.7 11.8 9.2 13.8 20.8 7.4 16.3 8.2 6.2 23.1 7.2 8.9 10.7 11.2 9.5 26.2 31.4 10.4 21.2 20.7 7.7 6.4 4.1 4.3 6.5 36.6 17.6 9.1 11.9 10.2 15.1 7.3 6.4 6.8 20.5 10.0 22.1 27.4 8.1 18.2 13.1 5.8 11.1 8.4 16.9 9.8 9.6 1.5 23.1 93.6 43.7 1.9 1.8 14.6 1.5 9.3 1.0 2.4 3.9 8.4 0.1 17.0 4.6 9.2 7.5 4.5 4.8 2.2 17.7 12.4 0.1 0.0 4.2 9.5 5.2 2.6 19.3 1.4 44.4 2.4 0.0 42.0 8.4 0.9 0.8 6.6 13.7 6.7 1.4 22.4 1.9 1.7 8.9 2.8 1.3 3.6 6.0 4.8 13.8 2.9 4.9 3.2 0.0 15.5 6.1 3.3 4.2 20.4 13.2 2.7 0.0 0.0 0.0 0.3 3.5 2.9 9.8 2.8 6.1 30.6 19.3 1.3 43.7 1.1 1.5 1.1 1.4 23.1 1.0 0.3 0.8 93.6 1.9 40.6 5.6 1.8 14.6 8.3 14.3 2.7 11.8 11.2 9.5 20.7 7.7 17.6 13.1 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645227-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 94.4" "Cell line enhanced" "Detected in many" "ASC diff: 37.7;ASC TERT1: 43.3;Karpas-707: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 51000000 "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favourable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 17.4 12.6 12.5 10.1 18.3 9.5 15.4 8.3 11.3 26.3 16.5 19.4 21.1 9.4 24.5 19.5 9.1 16.8 20.0 24.1 14.0 9.2 26.4 22.1 13.9 12.3 27.6 8.8 35.3 18.8 20.7 14.2 12.4 16.6 18.1 10.9 19.8 10.9 18.6 5.0 9.1 14.1 30.8 15.3 12.9 14.5 7.3 24.5 1.3 94.4 8.1 7.2 16.9 19.3 1.8 12.8 62.6 17.5 6.3 7.3 8.4 0.6 1.9 1.6 0.4 37.7 43.3 0.5 11.5 17.5 4.1 8.5 1.3 0.8 1.1 9.4 18.2 0.6 0.7 0.8 3.9 10.4 1.5 9.8 1.8 5.7 8.3 2.3 12.7 22.6 2.1 4.7 1.2 1.8 9.5 31.5 9.2 0.6 0.3 4.8 1.2 1.9 2.2 0.3 0.5 8.5 4.4 1.2 0.8 4.1 0.4 8.9 4.4 9.5 8.2 18.0 2.1 0.8 4.2 3.1 0.7 0.4 11.4 7.8 11.9 5.4 17.5 10.8 7.3 12.0 7.3 1.5 5.5 6.3 12.8 1.8 5.0 6.7 62.6 6.3 11.0 3.7 5.7 8.4 12.5 18.3 8.3 11.3 14.0 9.2 27.6 8.8 16.6 24.5 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121937-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 20.5 24.0 14.6 24.1 16.3 10.6 16.7 14.5 16.5 18.3 16.4 19.3 21.5 15.1 19.3 16.5 25.7 15.4 15.9 16.3 14.9 13.6 16.8 22.2 17.3 20.1 20.8 11.8 21.5 16.5 24.9 28.9 19.6 16.0 17.1 18.1 14.7 18.5 25.3 36.6 14.9 19.0 18.8 19.7 23.8 17.8 25.7 18.1 44.0 22.6 19.4 25.0 19.7 17.7 9.3 13.0 15.0 14.4 12.8 13.4 9.7 18.4 18.4 18.8 19.4 9.8 8.7 28.0 23.9 23.4 22.2 22.1 15.9 25.7 19.8 15.7 25.4 27.4 25.9 21.7 32.2 32.0 8.9 29.0 19.0 15.3 29.1 29.1 24.5 14.2 18.6 21.1 38.1 20.7 26.0 25.1 24.7 26.9 33.5 10.3 21.3 16.8 33.1 29.2 17.8 15.1 26.2 20.8 14.0 28.1 15.9 20.3 33.0 18.3 22.1 17.9 11.3 13.4 20.3 15.2 24.7 40.4 21.5 23.0 27.7 15.0 14.4 10.4 9.6 13.6 12.9 9.3 8.6 10.2 13.0 5.3 7.8 10.5 5.2 12.8 10.7 8.4 13.4 9.7 14.6 16.3 14.5 16.5 14.9 13.6 20.8 11.8 16.0 18.1 CPSF6 "CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7" ENSG00000111605 "Cleavage and polyadenylation specific factor 6" Q16630 12 69239537-69274358 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039973 Supported Enhanced "Nucleoplasm,Nuclear speckles" 500000 "Nucleoplasm, Nuclear speckles" "HPA039973: AB_10795242" "unprognostic (1.50e-1)" "unprognostic (3.33e-2)" "unprognostic (4.37e-3)" "unprognostic (5.47e-2)" "unprognostic (4.24e-2)" "unprognostic (7.74e-2)" "prognostic unfavourable (1.91e-6)" "unprognostic (6.82e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (2.11e-4)" "unprognostic (2.20e-1)" "unprognostic (7.63e-2)" "unprognostic (2.05e-1)" "unprognostic (7.41e-2)" 22.3 26.4 29.4 28.1 32.6 52.0 23.1 49.1 32.2 24.8 20.7 24.3 21.3 21.8 27.4 34.5 27.1 23.2 17.0 21.8 24.3 16.4 20.0 19.7 21.6 36.1 23.6 26.8 42.2 23.5 28.6 36.4 21.0 24.9 21.5 21.5 22.2 25.6 21.4 25.4 23.3 23.1 22.3 20.7 24.7 21.9 22.1 25.8 42.8 25.5 10.5 32.9 21.3 24.2 22.0 25.5 21.0 21.5 19.3 30.2 12.4 28.4 24.0 35.5 24.8 13.8 15.7 26.7 18.8 22.4 26.8 25.4 24.9 19.6 45.4 19.3 19.0 26.9 34.7 22.2 28.7 29.6 23.7 36.6 24.8 28.5 20.6 49.4 26.8 18.8 17.6 21.6 8.9 20.6 37.6 48.8 22.2 33.1 46.2 32.3 34.2 20.5 46.9 28.0 31.8 21.1 33.9 29.9 26.3 25.2 23.7 25.6 28.4 35.0 23.6 20.3 24.9 19.1 30.7 31.4 25.3 56.8 16.4 28.9 26.0 21.0 17.1 18.7 19.7 21.5 20.9 22.0 22.0 20.2 25.5 19.0 17.0 20.1 5.2 19.3 17.8 18.3 30.2 12.4 29.4 32.6 49.1 32.2 24.3 16.4 23.6 26.8 24.9 25.8 CPSF7 "CFIM59, FLJ12529" ENSG00000149532 "Cleavage and polyadenylation specific factor 7" Q8N684 11 61402641-61430031 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041094 Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041094: AB_10794187" "unprognostic (6.87e-3)" "unprognostic (8.31e-2)" "unprognostic (1.94e-1)" "unprognostic (4.79e-3)" "unprognostic (1.07e-1)" "unprognostic (9.41e-3)" "prognostic unfavourable (9.83e-4)" "unprognostic (5.35e-2)" "unprognostic (2.07e-3)" "unprognostic (7.95e-2)" "unprognostic (2.59e-1)" "unprognostic (3.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.71e-1)" "unprognostic (2.38e-1)" "unprognostic (6.18e-2)" 23.3 25.6 23.2 24.3 39.0 34.5 25.6 31.6 49.5 26.9 25.4 35.4 34.9 22.6 41.6 33.5 27.0 31.6 19.9 20.9 25.0 19.9 25.2 33.6 24.0 28.5 24.3 24.9 40.5 29.0 36.1 47.8 26.9 29.2 27.6 25.5 33.2 28.4 28.4 36.7 33.9 27.6 32.5 27.2 33.9 26.9 31.3 28.5 45.6 36.0 19.8 32.3 27.1 26.3 10.4 10.5 14.2 8.3 8.5 12.9 7.4 26.3 26.5 37.1 29.4 20.1 17.9 26.2 21.9 21.1 29.2 22.4 30.9 22.7 39.6 23.6 23.4 32.7 35.6 25.1 35.7 26.2 18.2 33.4 34.2 24.8 20.4 40.4 29.7 18.9 20.6 31.0 45.3 19.7 40.0 25.5 21.0 31.9 39.9 32.9 36.5 20.9 37.6 29.3 32.6 21.8 32.7 25.3 25.8 29.2 25.8 27.0 35.7 17.3 19.8 32.4 27.7 30.3 22.6 35.2 41.4 45.6 18.9 19.5 23.7 14.2 7.4 9.2 12.2 8.3 12.9 10.4 9.7 12.3 10.5 10.0 10.7 10.8 14.0 8.5 6.1 8.9 6.6 7.4 23.2 39.0 31.6 49.5 25.0 19.9 24.3 24.9 29.2 28.5 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favourable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.8 3.3 7.7 7.5 6.6 3.9 8.8 4.9 5.0 7.1 6.6 1.6 6.7 13.5 7.5 2.3 7.9 14.3 11.3 6.0 7.4 8.4 7.7 4.5 1.3 9.8 7.3 7.4 8.4 9.7 5.1 4.4 4.8 9.8 4.8 4.4 4.6 5.7 6.0 14.4 8.8 6.6 7.3 14.3 8.8 7.4 11.5 7.7 9.8 12.5 18.5 14.5 15.6 4.7 4.0 3.2 7.0 4.0 14.9 9.1 8.3 5.1 8.4 5.8 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 154.2;tongue: 80.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 160.3;MCF7: 61.1;T-47d: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004135 Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavourable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavourable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 4.9 1.1 1.0 1.7 3.2 0.7 16.8 1.3 2.1 66.8 1.3 1.2 38.5 0.0 13.9 2.8 154.2 13.1 2.8 1.2 0.9 2.1 1.4 0.2 0.7 0.4 0.8 2.9 5.9 0.8 2.7 5.0 7.0 3.7 6.7 0.7 7.9 10.6 28.0 0.5 25.7 0.9 8.8 1.1 0.8 0.5 1.1 0.9 2.1 2.2 80.5 33.5 10.0 66.6 0.1 0.0 0.4 0.0 0.0 1.3 0.5 10.2 0.5 11.7 0.1 15.3 22.9 0.0 21.8 160.3 1.7 2.2 18.2 37.8 0.1 10.8 23.1 13.3 2.8 0.0 0.5 0.2 0.8 0.0 1.4 0.1 3.0 0.0 0.2 7.2 1.0 2.5 0.0 0.0 0.0 0.2 0.1 61.1 0.1 0.1 14.1 5.7 0.1 0.0 0.3 0.2 0.4 29.2 2.1 0.3 37.8 0.1 124.2 0.0 0.0 0.4 6.7 3.6 1.3 0.9 2.2 0.1 3.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 0.0 0.1 1.3 1.2 0.4 0.0 0.0 0.0 0.0 0.5 1.0 3.2 1.3 2.1 0.9 2.1 0.8 2.9 3.7 0.9 CRADD RAIDD ENSG00000169372 "CASP2 and RIPK1 domain containing adaptor with death domain" P78560 12 93677375-93894840 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005337 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005337: AB_2085481" "unprognostic (1.07e-2)" "prognostic favourable (9.06e-5)" "unprognostic (9.65e-3)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (3.10e-1)" "unprognostic (3.79e-2)" "unprognostic (8.99e-2)" "unprognostic (1.54e-1)" "unprognostic (7.89e-2)" "unprognostic (6.06e-2)" "unprognostic (3.18e-2)" "prognostic favourable (4.04e-9)" "unprognostic (2.57e-2)" "unprognostic (6.86e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" 7.8 15.9 11.0 4.4 14.2 7.1 10.4 12.5 10.4 8.8 9.3 11.5 16.7 14.8 10.6 11.9 9.9 8.3 9.6 35.7 12.3 8.9 14.8 31.4 7.5 7.1 9.8 9.7 8.5 9.7 18.7 21.2 6.5 13.3 9.4 7.5 11.3 10.3 8.8 22.1 8.0 15.4 12.2 11.5 8.3 9.5 15.0 13.2 9.7 8.6 15.5 5.5 10.2 8.4 8.6 7.6 25.3 12.2 10.8 15.0 6.8 6.1 13.9 6.9 7.8 10.0 18.1 8.7 7.0 8.7 6.2 7.3 13.0 2.5 10.9 4.4 8.1 6.3 7.4 9.3 8.1 11.5 10.0 5.8 5.9 9.5 10.3 5.3 5.6 16.4 14.2 10.0 7.9 7.5 16.4 5.2 7.3 9.8 7.7 9.5 8.8 10.7 13.1 3.5 15.1 6.0 4.5 10.6 10.2 9.5 9.4 16.8 16.6 10.4 7.9 14.5 7.2 6.9 7.1 12.3 6.7 10.1 6.8 7.9 6.8 24.9 6.9 25.3 14.7 8.3 13.0 8.6 10.3 15.0 5.6 7.2 11.1 8.2 19.4 10.8 12.2 7.6 11.5 6.8 11.0 14.2 12.5 10.4 12.3 8.9 9.8 9.7 13.3 13.2 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favourable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.2 8.6 10.9 10.3 7.3 7.3 12.6 6.2 5.4 8.4 6.0 7.9 9.0 5.3 5.9 7.1 8.9 13.0 6.3 7.7 6.4 13.5 8.3 9.9 4.9 5.3 11.7 13.5 6.3 8.6 10.0 8.1 8.3 11.1 4.1 4.6 8.7 7.7 7.2 8.7 5.3 30.0 5.2 9.2 5.5 5.4 11.4 8.1 9.2 7.6 4.9 6.1 16.2 9.4 8.0 7.8 6.8 7.8 7.0 10.1 13.5 2.7 7.8 7.1 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094810-129111189 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6;testis: 71.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" 13000 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_1847209" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favourable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favourable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 11.6 13.4 8.4 4.6 9.2 5.9 10.7 7.5 15.9 8.3 15.4 8.6 6.2 24.3 6.5 9.5 9.4 5.4 10.0 17.3 7.7 7.9 12.9 50.0 4.2 3.1 8.3 9.1 7.3 33.1 16.8 3.2 7.9 9.3 10.5 4.4 8.1 14.7 7.9 98.6 7.0 22.8 8.3 5.2 4.6 8.1 71.7 4.4 2.4 8.0 20.2 4.4 9.3 6.8 2.6 11.3 6.0 11.3 6.0 10.0 8.1 0.1 18.3 6.4 13.2 12.0 16.1 9.4 7.8 8.7 9.5 6.0 3.8 7.4 0.7 4.7 13.1 3.3 1.7 2.8 3.4 11.8 0.4 3.6 9.2 14.8 17.1 0.1 14.0 14.7 0.0 8.0 0.2 12.4 1.7 3.8 9.8 3.7 0.3 8.1 1.5 8.2 9.1 12.3 6.1 9.2 0.3 2.1 6.6 0.0 4.2 2.7 26.7 4.0 11.2 14.3 1.0 17.9 7.7 13.0 11.0 0.0 16.9 2.2 9.1 2.5 11.3 6.0 5.0 7.4 10.0 2.4 6.9 6.6 11.3 2.6 4.3 4.7 2.9 6.0 7.3 5.3 6.4 8.1 8.4 9.2 7.5 15.9 7.7 7.9 8.3 9.1 9.3 4.4 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: " "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.2 11.8 0.2 20.2 20.1 8.9 20.0 32.5 14.1 14.2 8.5 3.6 0.8 5.4 21.7 2.1 6.9 14.7 27.6 5.8 3.4 25.3 8.5 20.2 13.4 7.6 36.3 8.3 9.4 17.7 20.8 18.5 13.0 11.8 16.4 7.2 2.4 9.4 4.2 4.4 5.3 6.4 6.7 11.0 4.1 3.0 7.1 6.5 16.9 8.9 2.4 5.7 19.7 18.9 2.9 22.7 7.3 14.0 4.8 5.3 22.7 21.5 41.9 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Group enriched" "Detected in many" 4 "MCF7: 24.8;SK-BR-3: 54.8;T-47d: 44.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favourable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.2 3.3 3.1 3.4 2.2 3.2 7.8 1.9 2.2 2.6 2.3 1.5 9.6 4.2 10.1 0.8 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.5 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.3 2.4 5.3 1.2 24.8 2.7 1.1 2.1 4.0 6.1 3.2 7.8 2.8 1.6 5.8 6.3 2.0 54.8 5.2 44.0 4.5 1.4 0.8 2.4 1.6 1.5 9.9 5.1 3.1 1.7 2.5 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell line enhanced" "Detected in many" "HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050020: , HPA061622: " "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.6 0.1 0.3 0.8 2.3 3.5 2.2 1.4 9.7 0.7 0.9 0.4 0.1 3.3 7.4 0.0 2.6 10.5 2.0 0.2 0.2 31.6 0.4 0.7 0.7 10.0 10.8 1.5 1.2 13.2 0.8 0.0 0.0 0.0 4.8 3.9 0.2 3.6 0.2 4.8 1.0 0.4 2.8 0.1 0.2 1.1 0.1 0.7 0.4 4.6 13.9 15.2 4.4 0.8 2.2 0.1 5.1 0.2 7.8 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880726 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: " "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favourable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 18.5 10.9 17.2 22.8 17.5 37.0 17.4 42.6 18.8 20.1 17.2 16.8 17.1 9.9 25.1 15.2 14.1 18.9 21.3 14.5 17.1 8.7 11.1 12.3 16.9 14.4 20.5 12.0 31.6 23.4 24.3 13.0 13.3 15.8 18.4 11.6 14.6 14.9 16.7 28.2 20.4 16.4 17.0 13.6 17.4 14.7 29.1 20.2 29.6 19.5 13.8 16.1 19.0 29.9 4.7 2.3 10.6 3.8 2.0 2.7 1.1 5.5 14.3 18.6 8.2 11.4 11.3 9.6 8.0 13.5 13.9 13.5 12.9 10.5 15.4 9.6 15.3 10.8 21.4 6.6 15.8 26.0 8.6 12.1 13.2 8.2 12.6 12.1 17.4 10.0 6.7 15.4 18.6 10.4 13.7 21.1 7.5 19.1 8.0 5.8 15.2 5.9 37.8 14.7 11.8 5.4 7.5 15.5 10.2 13.7 13.5 8.1 12.0 11.9 16.1 17.0 16.9 8.7 7.3 9.9 10.6 29.9 3.4 7.3 11.9 2.9 1.7 1.3 2.7 2.2 1.4 4.7 1.3 2.0 1.0 3.3 1.4 1.7 10.6 2.0 3.8 2.3 1.3 1.1 17.2 17.5 42.6 18.8 17.1 8.7 20.5 12.0 15.8 20.2 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favourable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.8 7.6 6.7 7.6 23.7 24.0 12.9 11.6 19.6 8.5 11.8 5.5 8.7 5.1 4.5 14.0 5.0 10.1 8.9 14.6 28.5 6.1 4.0 7.7 6.7 15.5 5.7 7.5 15.5 15.9 10.0 16.5 12.5 4.0 8.1 14.3 9.5 2.9 4.7 20.0 7.0 4.1 11.6 3.2 16.4 17.1 7.9 9.0 11.7 5.7 20.2 3.2 6.5 10.0 11.8 7.6 11.6 11.4 6.8 9.0 1.3 14.0 4.9 12.1 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85659708-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA021526: , HPA063652: " "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 15.4 18.7 16.6 19.5 23.3 13.2 19.8 31.4 21.7 23.1 18.1 23.7 18.5 22.0 29.0 19.9 15.0 22.3 18.2 13.3 16.9 10.5 14.9 16.2 17.5 25.0 34.0 18.7 31.5 27.2 30.0 23.8 18.3 20.2 21.2 20.6 20.0 19.3 17.0 13.1 18.2 24.4 20.0 21.3 26.1 20.2 12.7 24.8 21.6 27.1 11.7 21.3 19.1 21.3 3.1 2.4 2.3 2.8 1.9 3.8 0.8 3.6 11.2 9.4 3.1 3.9 4.3 11.4 5.8 3.4 5.0 6.6 11.2 17.9 9.3 5.9 3.3 13.4 7.5 3.9 7.5 7.5 9.3 9.6 32.2 3.4 3.1 9.7 5.6 4.5 9.3 5.5 8.2 2.9 8.3 15.8 4.5 5.9 8.6 13.9 3.7 5.8 17.6 10.8 6.8 4.4 7.0 9.8 9.3 9.3 13.1 2.3 15.6 15.7 4.3 10.7 8.7 17.3 8.0 6.0 5.2 12.9 3.0 7.0 8.7 1.9 1.6 1.4 2.3 1.4 3.8 3.1 1.5 1.9 2.0 2.9 2.5 2.3 2.3 1.9 2.8 2.4 1.1 0.8 16.6 23.3 31.4 21.7 16.9 10.5 34.0 18.7 20.2 24.8 CREG1 CREG ENSG00000143162 "Cellular repressor of E1A stimulated genes 1" O75629 1 167529677-167553767 "Predicted secreted proteins" "Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 155.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.1;classical monocyte: 36.8;eosinophil: 21.7;intermediate monocyte: 21.5;myeloid DC: 26.9;neutrophil: 13.0;non-classical monocyte: 19.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.9;granulocytes: 21.7;monocytes: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056390 Approved Vesicles,Microtubules "Secreted to blood" 550000 Microtubules Vesicles "HPA056390: " "unprognostic (3.25e-1)" "unprognostic (2.00e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-3)" "unprognostic (4.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.55e-1)" "unprognostic (5.02e-2)" "unprognostic (2.07e-3)" "unprognostic (8.54e-2)" "unprognostic (8.65e-2)" "unprognostic (1.21e-1)" "unprognostic (8.24e-3)" "unprognostic (2.99e-1)" "unprognostic (4.63e-2)" "unprognostic (3.78e-3)" "unprognostic (3.16e-1)" 50.9 52.6 15.7 21.0 17.9 29.6 56.7 11.8 15.0 23.0 32.8 21.7 21.3 16.5 22.0 46.8 41.9 25.0 40.8 48.9 15.5 13.6 39.8 81.3 68.5 83.8 16.4 9.6 43.3 41.6 19.1 36.2 46.8 14.7 41.4 23.7 28.7 39.0 22.6 33.0 37.1 30.4 40.9 21.0 98.2 22.7 27.6 15.1 12.6 53.1 32.7 23.7 50.8 40.9 1.3 26.9 21.7 36.8 3.3 5.3 13.9 11.8 5.3 2.7 5.7 43.9 12.2 7.0 5.1 2.3 4.0 5.3 8.7 13.6 13.0 14.9 5.6 18.7 3.1 10.9 2.8 17.6 10.7 5.3 4.4 4.8 15.1 11.7 39.3 12.8 33.1 4.7 5.1 1.3 27.3 53.4 5.5 4.9 2.4 12.1 3.0 8.4 4.1 7.8 155.2 7.2 8.3 1.8 3.4 12.7 17.5 14.1 23.1 32.2 2.5 1.0 5.3 16.7 3.3 10.5 20.8 8.6 17.6 12.2 2.1 15.1 36.8 21.7 1.6 21.5 2.5 1.3 2.4 2.0 26.9 0.6 5.3 2.6 13.0 3.3 19.9 1.8 1.1 13.9 15.7 17.9 11.8 15.0 15.5 13.6 16.4 9.6 14.7 15.1 CRELD1 AVSD2 ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933822-9945413 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" 16000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 21.8 22.9 31.6 15.3 32.4 7.3 27.3 52.2 45.1 9.9 22.4 12.0 17.1 12.5 15.1 17.8 13.1 20.1 15.8 50.2 25.6 24.9 16.6 23.5 15.8 11.0 17.2 30.7 19.7 15.2 21.9 32.4 15.1 27.2 25.4 11.4 10.0 19.4 32.2 24.4 11.6 13.1 19.5 19.4 11.9 14.8 11.1 22.3 5.9 45.7 7.4 8.2 17.8 15.6 10.5 13.7 11.5 12.5 13.4 14.3 10.4 2.8 5.3 8.7 4.5 14.7 9.6 48.1 10.6 3.2 2.6 5.0 5.1 8.7 3.5 23.4 7.4 1.9 4.2 7.7 1.8 6.9 3.9 3.2 6.9 12.0 29.4 1.1 12.3 9.8 14.2 6.6 6.0 12.1 3.8 4.2 2.5 6.9 2.0 8.6 2.3 3.6 2.1 1.3 8.3 11.3 5.0 3.5 11.2 4.9 4.6 9.5 11.7 6.9 8.4 5.1 8.2 6.7 2.5 4.8 6.2 6.5 11.4 3.6 5.4 11.5 11.4 9.4 14.2 11.6 14.3 8.9 10.5 13.7 8.2 10.5 14.2 12.7 1.8 13.4 12.5 13.7 8.0 10.4 31.6 32.4 52.2 45.1 25.6 24.9 17.2 30.7 27.2 22.3 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 21.9 61.4 14.3 21.3 15.1 8.1 15.4 6.2 13.8 10.6 8.0 8.4 10.2 4.1 13.3 10.8 8.2 9.9 19.7 19.5 14.5 15.2 15.4 26.1 19.6 7.1 12.7 8.3 21.4 8.2 8.3 24.2 42.0 20.1 12.2 6.4 9.6 5.7 19.2 10.0 3.2 7.0 11.0 15.5 21.8 7.5 74.9 7.7 8.1 10.8 6.8 7.3 18.1 11.7 6.4 11.2 10.1 4.9 8.6 14.6 8.2 9.0 14.5 12.3 12.6 8.6 9.0 12.3 11.9 9.3 7.5 10.4 1.7 3.8 15.4 11.6 6.9 2.1 10.5 7.8 11.0 37.8 7.7 5.4 10.0 6.8 10.3 1.3 5.8 7.9 9.8 14.6 4.5 20.8 15.9 6.4 11.4 7.3 9.4 3.9 3.6 33.4 5.8 6.4 2.8 13.2 3.6 2.9 7.8 5.6 4.9 31.5 2.7 4.0 27.6 5.7 7.4 15.7 7.8 2.8 3.8 5.3 13.7 12.2 4.9 4.7 3.3 10.1 11.5 4.9 14.2 6.4 12.7 10.1 3.8 5.5 9.0 10.4 9.0 8.6 3.6 11.2 14.6 8.2 14.3 15.1 6.2 13.8 14.5 15.2 12.7 8.3 20.1 7.7 CRIP1 CRIP ENSG00000213145 "Cysteine rich protein 1" P50238 14 105486317-105488947 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042462 Approved Approved "Nuclear speckles,Plasma membrane,Centrosome,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane, Centrosome" "HPA042462: AB_10794277" "unprognostic (2.97e-3)" "unprognostic (1.27e-3)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.39e-1)" "unprognostic (2.93e-3)" "unprognostic (4.33e-1)" "unprognostic (3.33e-1)" "unprognostic (3.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (3.26e-3)" "unprognostic (5.10e-2)" "unprognostic (2.66e-1)" "unprognostic (7.51e-3)" "unprognostic (2.14e-1)" 44.3 3.3 3.8 37.5 4.9 5.5 97.2 3.2 4.0 37.7 44.0 4.5 65.3 25.7 20.0 83.0 28.4 23.7 33.8 45.5 4.5 4.7 20.4 2.6 56.7 53.0 4.7 4.5 11.2 4.2 1.1 7.3 38.5 4.8 11.7 13.2 9.9 21.8 71.0 12.9 48.8 106.3 25.9 5.1 16.6 20.3 7.5 1.9 24.2 32.0 83.4 58.3 18.4 18.9 111.4 79.3 56.3 49.4 56.9 121.1 75.8 0.0 129.0 0.8 0.1 2.3 1.6 12.0 0.2 0.0 1.7 0.0 4.0 71.9 38.9 0.7 34.4 77.9 0.0 0.0 0.1 55.1 0.0 3.0 63.2 21.7 0.4 0.0 0.0 0.7 0.0 4.2 0.0 0.1 0.1 0.1 0.0 1.0 1.9 0.3 1.2 6.7 30.5 0.0 8.1 0.0 0.0 3.4 0.2 0.4 0.2 0.0 101.1 18.5 0.2 0.0 0.1 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.1 19.4 43.3 56.3 47.7 38.5 32.7 111.4 92.1 51.4 79.3 43.6 21.9 25.7 2.9 56.9 49.4 62.1 121.1 75.8 3.8 4.9 3.2 4.0 4.5 4.7 4.7 4.5 4.8 1.9 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell line enhanced" "Detected in many" "A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 37.7 5.5 15.0 0.9 3.9 1.6 1.7 0.4 0.5 0.1 1.1 7.0 0.0 38.6 12.3 21.6 0.7 9.2 0.0 0.2 0.2 0.0 23.7 14.3 4.0 0.0 3.2 1.9 0.8 0.9 5.1 36.1 0.0 0.3 5.4 55.4 0.1 0.1 1.5 22.7 0.0 0.7 1.6 25.4 0.1 8.4 20.9 2.4 43.4 0.3 37.2 0.0 14.0 12.5 5.9 0.3 7.0 0.1 0.1 0.1 3.6 0.0 25.2 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 CRIPT HSPC139 ENSG00000119878 "CXXC repeat containing interactor of PDZ3 domain" Q9P021 2 46616416-46625742 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046080 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA046080: " "unprognostic (3.38e-2)" "unprognostic (4.08e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.54e-2)" "unprognostic (3.38e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (5.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-2)" "unprognostic (4.42e-2)" 13.8 17.1 29.3 9.4 26.2 10.0 18.9 24.3 23.9 12.2 11.4 28.7 10.8 15.5 18.2 17.5 12.6 14.6 10.5 22.1 26.5 23.1 19.8 18.8 9.3 11.9 27.6 18.1 17.5 9.8 12.7 21.9 14.3 23.2 14.9 13.4 13.6 16.8 12.5 18.4 13.6 14.2 12.1 36.6 10.1 11.3 12.3 26.2 13.4 14.0 8.8 13.2 14.4 10.8 13.3 14.0 20.9 9.4 11.5 15.5 9.0 15.8 9.4 10.0 8.7 12.3 13.2 12.7 11.1 8.4 9.6 10.1 12.1 12.1 8.6 30.4 12.4 8.5 10.1 10.8 14.9 18.5 11.9 9.1 11.9 15.6 14.2 8.7 8.7 10.2 14.3 12.4 8.8 14.4 13.2 12.9 11.3 8.5 9.0 17.5 10.3 13.1 8.3 19.2 16.7 13.5 10.3 14.3 20.8 11.6 9.7 16.0 7.3 8.2 10.0 13.8 12.0 11.2 14.8 10.0 10.7 11.0 18.1 10.4 12.4 20.9 9.4 17.8 8.8 8.4 8.6 13.3 9.8 8.5 9.9 11.2 9.9 9.0 19.1 11.5 6.8 14.0 15.5 9.0 29.3 26.2 24.3 23.3 26.5 23.1 27.6 18.1 23.2 26.2 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;BEWO: 23.2;HHSteC: 55.4;HSkMC: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" 219300000000 "Nucleoplasm, Nucleoli" "HPA030054: , HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavourable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 14.9 5.6 23.2 11.3 10.0 9.1 6.4 1.5 0.9 0.0 1.0 9.9 0.3 0.0 0.0 9.2 0.0 0.0 0.1 0.2 0.0 55.4 0.0 0.1 23.3 0.0 2.6 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 0.6 0.0 0.1 0.1 0.1 1.7 2.2 0.1 2.6 1.2 0.2 4.5 0.3 1.3 0.1 0.6 9.5 0.3 0.1 0.0 1.9 0.0 0.2 1.3 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 CRKL ENSG00000099942 "CRK like proto-oncogene, adaptor protein" P46109 22 20917426-20953749 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 87.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000532, HPA001100" Uncertain Enhanced Nucleoplasm,Cytosol 1500000 Nucleoplasm Cytosol "HPA000532: , HPA001100: AB_1078569" "unprognostic (5.54e-2)" "unprognostic (2.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.92e-2)" "unprognostic (6.51e-2)" "unprognostic (2.35e-2)" "unprognostic (4.60e-1)" "unprognostic (2.71e-1)" "unprognostic (5.99e-2)" "prognostic unfavourable (8.82e-6)" "unprognostic (8.40e-2)" "unprognostic (1.43e-1)" "unprognostic (9.52e-2)" "unprognostic (1.61e-2)" 16.4 15.2 25.0 18.1 24.1 41.9 18.4 34.0 31.7 17.8 19.9 26.4 12.3 20.2 18.9 12.8 25.2 19.9 13.6 22.6 22.6 23.8 16.4 24.9 19.0 21.3 24.6 26.1 26.9 21.7 22.2 17.9 25.1 20.7 18.8 18.7 16.7 14.5 19.1 48.1 22.7 19.1 18.6 23.6 19.6 14.3 12.6 19.8 35.7 16.6 17.8 24.7 17.7 24.6 11.7 14.8 19.2 21.5 11.0 19.7 16.8 11.2 6.7 15.2 11.9 10.3 6.6 16.4 7.6 9.4 11.8 13.4 11.1 5.1 14.5 6.2 8.0 14.5 17.8 12.2 14.1 12.3 17.4 20.1 7.4 12.2 10.3 21.3 10.3 6.7 16.3 10.2 17.6 10.4 87.6 12.0 9.5 10.6 12.4 10.0 12.0 7.4 16.2 24.2 3.5 7.9 9.9 9.9 12.7 12.8 11.3 9.3 9.7 11.9 8.4 18.8 21.4 7.0 9.6 11.5 11.1 16.9 13.9 9.1 11.5 13.4 13.0 19.2 17.5 12.5 18.9 11.6 15.8 17.5 14.8 11.7 19.7 18.4 14.1 11.0 21.5 7.4 12.8 16.8 25.0 24.1 34.0 31.7 22.6 23.8 24.6 26.1 20.7 19.8 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 43.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Supported "Plasma membrane,Cytosol" 830000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 8.7 4.8 8.8 22.7 8.3 16.7 7.3 12.4 9.4 6.9 7.0 5.9 3.9 5.5 6.3 3.6 15.4 6.1 7.0 5.8 7.5 6.6 5.3 5.4 9.7 28.6 6.6 9.3 5.8 5.5 5.1 6.9 12.3 7.3 6.6 7.4 4.4 7.5 3.9 3.8 10.7 11.3 6.1 8.7 22.0 5.9 9.6 6.7 26.7 5.7 4.5 27.8 10.3 9.3 15.9 13.9 43.6 21.8 12.9 35.7 25.2 6.2 6.9 4.3 9.0 7.9 6.2 6.5 5.9 5.8 11.5 12.1 9.1 4.3 20.9 8.9 7.3 11.0 7.3 4.9 13.9 9.7 13.4 8.7 6.1 6.0 4.4 11.5 6.5 3.6 6.9 9.3 7.9 11.2 22.1 22.2 7.2 3.8 25.4 12.7 8.6 4.6 11.3 14.0 12.2 7.6 5.3 3.1 7.3 6.3 9.4 6.5 7.2 5.8 5.9 6.7 8.3 10.7 14.4 9.3 7.7 14.0 6.4 9.4 7.4 15.5 18.8 43.6 13.0 19.2 13.7 15.9 18.3 14.6 13.9 14.9 35.7 26.4 38.3 12.9 21.8 7.2 20.1 25.2 8.8 8.3 12.4 9.4 7.5 6.6 6.6 9.3 7.3 6.7 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.1;pituitary gland: 23.0" "Cell line enhanced" "Detected in some" "AF22: 20.4;HAP1: 29.2;NTERA-2: 21.2;REH: 55.5;RH-30: 32.7;SCLC-21H: 42.4;SH-SY5Y: 26.8" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favourable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 8.2 24.2 2.5 21.7 0.7 1.0 32.0 63.1 3.3 2.0 5.9 0.1 1.5 11.7 0.7 2.7 4.3 4.3 2.6 22.2 23.9 2.4 0.9 4.2 1.8 9.9 18.1 6.9 4.8 0.9 23.0 4.6 12.3 3.0 1.9 4.6 2.6 3.1 1.0 3.3 2.5 11.6 4.7 1.4 3.5 2.8 4.5 0.0 2.4 0.9 1.3 2.9 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 20.4 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 29.2 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 21.2 0.6 55.5 32.7 4.9 0.0 0.0 42.4 26.8 0.0 0.1 0.3 0.2 0.0 1.7 1.0 7.1 0.6 0.6 3.7 0.5 0.0 2.5 0.2 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 21.7 32.0 34.2 22.2 23.9 9.9 18.1 12.3 4.5 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favourable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favourable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavourable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 4.9 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.6 0.7 2.8 0.3 3.5 3.3 1.2 11.6 2.7 3.1 4.2 3.7 0.7 1.1 9.8 10.6 3.2 2.1 9.7 4.2 1.4 4.3 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.7 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" 1832500000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.1 0.9 0.0 12.8 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33113979-33147773 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 121.2;ASC TERT1: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 67.8" "Group enriched" "Detected in all" 5 "dendritic cells: 55.8;monocytes: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 59.2 33.4 16.3 13.4 22.2 13.6 63.2 5.4 14.1 57.5 39.4 23.3 32.7 12.8 54.2 41.1 42.8 35.1 43.5 37.0 16.8 13.1 25.7 16.8 35.9 37.8 24.2 13.0 48.5 13.3 14.6 7.6 25.4 13.8 54.5 19.7 35.4 16.4 42.2 23.9 24.6 18.8 66.1 22.8 17.6 25.2 26.1 19.0 5.1 34.1 25.8 18.3 62.4 59.7 7.6 55.8 5.5 67.8 6.9 12.9 30.8 9.0 17.9 5.6 17.6 121.2 79.4 32.6 19.8 43.2 24.0 22.9 6.0 5.1 6.3 22.1 37.5 11.7 9.9 15.1 17.4 15.6 15.6 9.9 14.0 6.2 36.3 6.4 8.1 63.3 31.0 21.6 27.6 25.2 8.4 12.1 24.2 7.7 2.3 6.5 6.7 24.4 8.4 16.5 12.1 18.8 6.1 1.1 9.1 13.4 11.8 28.5 12.6 15.7 16.4 31.5 13.5 17.1 20.9 8.8 29.7 0.9 24.7 12.9 17.2 2.1 67.8 4.9 6.9 26.3 10.0 7.6 10.1 7.7 55.8 6.8 5.8 5.4 5.5 6.9 7.8 15.0 12.9 30.8 16.3 22.2 5.4 14.1 16.8 13.1 24.2 13.0 13.8 19.0 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022035 Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255" "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favourable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favourable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.3 8.0 5.8 9.3 5.4 4.6 16.5 4.8 3.2 4.6 4.5 5.4 5.7 6.1 10.2 4.6 4.7 1.7 3.0 1.1 2.7 13.9 5.1 7.1 8.8 5.2 7.0 14.5 7.4 2.9 4.0 1.2 2.6 4.0 5.6 2.6 16.0 4.5 8.1 7.5 11.8 7.2 2.5 6.7 2.9 7.8 10.7 9.6 5.4 5.2 5.8 5.8 4.3 4.6 5.3 8.1 9.6 5.5 3.8 3.0 4.0 6.1 7.6 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529925-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: " "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 22.3 14.0 13.7 17.0 20.9 11.4 26.6 15.0 16.2 21.2 22.2 27.5 15.3 8.9 23.9 14.5 15.1 19.4 21.5 17.2 14.0 9.7 10.7 11.7 19.2 21.7 24.1 10.9 45.9 13.9 17.1 9.6 20.2 15.7 18.2 11.7 17.4 19.9 22.0 16.1 15.8 13.7 31.8 20.3 13.1 14.2 15.3 23.6 12.8 22.7 9.2 18.1 24.0 29.6 5.3 2.1 16.0 2.5 3.3 6.6 3.0 4.7 7.9 5.4 8.8 11.7 8.7 24.7 6.1 8.9 9.6 9.1 6.5 4.8 0.1 4.4 12.6 8.0 8.6 5.3 7.6 8.2 10.0 12.1 39.3 3.0 13.3 3.1 20.7 9.7 8.5 7.9 10.7 6.9 6.4 2.8 7.1 5.5 1.3 4.5 1.9 3.7 4.1 8.6 0.2 3.4 10.1 9.9 8.8 17.8 5.9 9.9 5.9 5.9 8.5 10.7 7.9 9.9 7.0 3.7 5.0 3.6 4.4 6.3 5.1 16.0 2.5 1.4 3.7 0.8 4.2 3.1 4.5 4.0 1.6 5.3 6.6 4.1 0.5 3.3 0.3 2.1 4.2 3.0 13.7 20.9 15.0 16.2 14.0 9.7 24.1 10.9 15.7 23.6 CRY1 PHLL1 ENSG00000008405 "Cryptochrome circadian regulator 1" Q16526 12 106991364-107093829 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018762 Approved Supported "Nucleoplasm,Nuclear membrane,Microtubules" "Nucleoplasm, Nuclear membrane, Microtubules" "CAB018762: AB_2083970" "unprognostic (1.21e-3)" "unprognostic (4.74e-2)" "unprognostic (6.50e-2)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.84e-1)" "unprognostic (3.48e-2)" "unprognostic (3.61e-1)" "unprognostic (4.29e-3)" "unprognostic (1.34e-2)" "unprognostic (6.85e-3)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.82e-2)" "unprognostic (5.08e-1)" "unprognostic (1.85e-1)" "unprognostic (2.25e-1)" 12.2 12.2 8.7 8.5 12.6 9.5 18.3 29.2 10.3 12.4 14.3 12.4 5.0 10.7 14.3 12.9 10.7 15.8 16.3 12.2 10.5 8.7 16.0 13.7 18.0 5.0 17.4 7.3 10.7 12.9 8.6 10.0 13.4 13.1 11.2 8.3 8.7 9.4 11.8 10.8 8.7 17.6 15.9 15.4 10.1 14.6 37.6 15.1 26.5 20.1 6.2 7.5 9.5 18.4 1.7 3.5 6.8 6.4 4.7 13.9 4.7 8.5 8.7 10.7 11.8 7.7 4.9 19.2 9.2 9.8 18.7 12.7 10.0 5.2 0.0 5.8 8.5 5.9 13.7 4.7 20.5 8.6 8.5 8.4 7.8 6.9 9.9 8.6 7.4 4.6 4.9 13.7 13.0 15.5 9.4 7.5 11.5 6.0 19.2 9.7 13.1 12.7 17.2 27.1 3.0 13.1 10.1 19.4 10.0 17.3 11.3 5.5 8.0 4.8 6.8 11.0 11.8 7.5 8.1 13.9 13.0 4.0 5.3 8.2 8.9 6.8 2.5 4.4 11.2 3.8 13.9 1.6 8.5 7.0 3.5 1.7 8.0 7.8 1.1 4.7 6.4 2.3 11.0 4.7 8.7 12.6 29.2 10.3 10.5 8.7 17.4 7.3 13.1 15.1 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavourable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favourable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favourable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 17.4 13.3 18.2 8.8 27.4 17.2 16.7 29.8 36.5 17.7 12.1 15.4 10.5 7.6 16.2 12.4 11.2 20.8 18.7 39.5 15.6 13.1 15.7 27.8 15.7 6.7 12.7 15.0 26.3 23.4 20.6 16.4 9.3 11.5 15.0 7.3 35.5 14.4 17.1 58.2 24.3 8.5 18.7 10.4 9.2 12.2 17.4 9.6 5.9 23.6 22.4 10.3 17.4 10.6 7.8 5.2 7.6 10.6 10.4 10.4 7.1 1.2 3.6 5.6 6.6 15.3 7.7 12.3 4.3 7.8 5.5 4.1 5.9 2.9 8.4 3.4 9.1 7.4 5.3 4.5 3.8 8.9 4.8 5.5 6.3 8.0 5.8 6.7 7.6 9.0 6.7 4.3 6.8 3.8 10.7 14.4 5.0 4.5 5.7 8.0 15.2 4.4 9.8 8.1 3.9 4.0 6.8 9.0 3.4 7.3 6.6 3.7 8.8 4.8 4.8 7.9 4.8 12.0 3.0 13.4 9.2 6.9 4.8 3.0 4.7 5.7 5.0 7.6 8.7 7.1 7.2 7.8 8.4 9.3 5.2 7.7 10.3 10.4 2.6 10.4 10.6 3.8 6.9 7.1 18.2 27.4 29.8 36.5 15.6 13.1 12.7 15.0 11.5 9.6 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA037737: , HPA038430: " "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA037737: , HPA038430: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Group enriched" "Detected in some" 5 "ASC diff: 230.1;fHDF/TERT166: 75.0" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: " "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.3 230.1 10.1 1.6 6.4 0.2 0.1 0.2 0.1 0.0 0.0 3.8 75.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 1.9 0.0 0.0 8.1 1.0 0.0 0.5 0.0 0.5 0.2 18.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.8 3.4 0.5 0.0 0.1 29.8 10.7 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Not detected" "Not detected" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: , HPA030949: " "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.4 0.0 0.0 0.0 8.8 31.7 3.2 1.5 11.6 3.4 3.2 0.7 3.7 16.4 0.7 7.2 16.9 0.1 39.6 1.6 22.3 0.7 0.0 0.4 5.1 4.2 10.0 0.0 15.8 23.1 6.4 30.7 14.4 0.5 2.3 9.1 1.2 2.8 4.0 0.1 6.9 4.9 0.1 0.1 5.3 24.9 0.7 0.0 6.4 11.0 0.1 5.4 7.6 4.2 3.8 0.5 0.0 10.5 1.8 1.4 17.9 18.1 12.6 8.2 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822040-97944963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 6 "dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0" "Low region specificity" "Detected in all" HPA044122 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044122: AB_10960490" "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favourable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 19.9 5.1 6.4 13.4 20.9 1.9 13.1 1.6 13.0 14.6 19.2 8.2 12.1 6.0 10.4 7.4 13.9 9.0 8.6 14.9 9.1 5.3 8.2 5.3 11.3 6.5 28.4 5.1 8.7 8.5 10.2 7.4 15.8 15.0 12.9 11.9 4.7 10.6 9.0 21.5 19.5 8.4 10.1 20.3 7.8 11.1 19.2 20.5 2.0 39.7 12.3 7.0 11.2 16.9 0.5 7.1 1.9 3.0 0.1 0.6 0.5 11.1 4.2 2.5 3.0 7.8 8.5 4.4 4.0 3.6 2.9 4.4 0.3 3.7 0.1 1.3 6.8 7.3 4.8 3.3 5.6 13.7 2.6 2.8 1.8 1.3 4.1 4.1 0.7 5.5 3.4 3.6 4.1 5.6 0.2 2.1 5.0 0.1 1.4 0.4 2.1 3.9 0.0 8.7 1.4 4.3 7.4 27.7 2.0 8.4 3.2 2.8 3.0 4.6 7.6 6.4 4.9 3.6 4.8 3.5 0.1 2.6 6.7 2.5 4.1 1.9 3.0 0.1 0.3 1.8 0.5 0.2 0.6 0.4 2.6 0.5 0.2 0.4 0.0 0.1 1.9 7.1 0.1 0.5 6.4 20.9 1.6 13.0 9.1 5.3 28.4 5.1 15.0 20.5 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124501 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 17.7" "Cell line enriched" "Detected in single" 19 "HEL: 15.0" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved "Plasma membrane,Intermediate filaments,Cytokinetic bridge" "Plasma membrane, Intermediate filaments" "Cytokinetic bridge" "HPA041269: , HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.2 0.2 4.2 0.2 2.0 2.3 0.2 0.0 2.5 0.2 0.2 0.3 0.0 0.4 0.2 0.2 0.3 0.3 0.2 0.6 2.1 4.3 0.2 0.2 0.2 0.2 4.0 1.6 17.7 0.2 0.2 0.4 0.5 1.9 2.0 0.2 2.1 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.2 0.5 1.4 0.5 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.2 2.0 0.0 2.5 2.1 4.3 4.0 1.6 1.9 0.5 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favourable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favourable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.4 3.0 2.6 19.0 14.5 16.8 2.6 4.9 8.8 2.1 1.7 1.1 3.2 0.0 9.3 6.7 0.8 2.5 4.4 2.2 8.3 2.1 6.1 0.3 23.7 8.3 1.9 5.5 9.9 2.8 1.6 10.0 23.0 0.4 2.4 5.6 12.5 5.2 3.1 0.1 4.6 2.7 1.7 0.4 18.3 7.4 1.8 2.2 2.9 1.4 21.8 9.4 7.8 22.0 2.7 1.2 6.5 3.0 3.4 0.7 0.0 5.1 3.4 10.9 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 18.9 17.6 32.6 14.1 27.6 18.4 19.4 36.6 32.4 20.5 21.5 24.8 13.2 13.4 26.9 18.0 17.6 17.2 15.1 17.9 26.4 23.0 21.6 16.0 14.5 14.7 30.8 19.4 20.4 13.6 18.5 27.7 19.3 25.2 17.3 18.8 17.2 15.2 21.7 15.5 20.9 13.3 19.8 29.9 13.2 15.6 28.9 27.0 18.2 22.6 9.7 13.4 20.8 15.6 27.5 30.7 24.8 26.1 31.5 33.8 18.2 21.0 9.4 26.7 19.6 14.4 20.9 13.5 15.0 21.6 19.3 17.3 13.6 16.7 14.9 13.6 18.4 11.7 14.0 15.5 17.6 13.7 14.8 27.3 19.9 12.4 22.7 17.1 17.5 19.6 13.6 20.3 16.0 24.2 20.2 15.4 17.9 10.7 16.5 17.7 18.6 12.7 15.9 21.4 20.4 27.1 18.9 11.6 18.4 19.7 10.0 21.4 19.7 12.7 25.4 15.6 14.9 12.8 11.6 25.4 34.9 16.1 20.3 12.8 17.4 21.7 25.2 24.8 24.2 26.1 25.9 26.5 25.9 22.5 30.7 27.5 33.8 27.4 14.4 31.5 23.7 24.2 20.3 18.2 32.6 27.6 36.6 32.4 26.4 23.0 30.8 19.4 25.2 27.0 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41560763-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 84.8;ovary: 48.5" "Group enriched" "Detected in some" 6 "HeLa: 7.9;U-2 OS: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: " "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favourable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 2.5 39.0 4.7 2.1 9.6 1.1 1.2 30.5 15.3 16.8 2.6 2.7 5.5 1.6 18.4 2.0 2.2 4.1 2.6 84.8 6.0 8.5 9.9 1.2 2.8 1.1 9.0 6.0 48.5 25.5 1.1 4.1 1.3 17.7 5.3 1.4 5.6 1.4 11.7 1.5 1.1 1.5 9.1 10.5 1.2 1.6 11.1 3.4 0.0 1.1 0.3 1.0 5.8 6.2 1.0 1.0 1.7 1.1 0.4 1.6 0.7 0.0 0.1 1.0 0.1 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.0 2.0 0.0 7.9 0.9 2.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.7 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 29.0 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 1.0 1.0 1.7 1.3 1.1 0.5 1.0 0.8 0.7 1.0 1.0 1.5 0.7 1.0 0.4 0.9 0.2 1.6 0.7 4.7 9.6 30.5 14.7 6.0 8.5 9.0 6.0 17.7 3.4 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 266.5" "Cell line enhanced" "Detected in all" "MCF7: 222.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" 13000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: " "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 71.2 31.4 33.5 25.8 33.2 37.9 42.1 29.6 35.4 39.0 64.7 29.6 35.9 29.5 46.4 38.9 58.8 30.3 29.4 64.2 33.2 31.7 37.4 39.5 34.2 31.4 41.6 31.4 43.9 37.2 50.3 38.4 38.8 44.4 52.6 32.9 32.0 43.2 42.0 266.5 33.8 46.5 88.3 42.4 32.2 39.9 41.5 35.1 39.6 55.7 73.9 31.9 75.4 45.5 43.9 59.0 57.9 65.2 48.1 62.3 80.5 60.6 21.4 38.1 38.0 43.5 56.6 53.3 53.6 40.1 36.1 29.4 31.3 18.4 47.8 45.3 51.1 25.8 42.2 41.6 52.7 58.4 28.8 46.9 39.0 27.7 38.5 34.8 28.0 41.0 45.3 43.2 57.1 41.3 47.5 31.4 44.1 222.4 46.7 22.2 72.6 28.9 35.0 118.0 22.5 28.7 47.8 47.1 31.3 52.5 43.8 40.6 22.5 55.7 49.7 42.7 58.9 56.0 58.8 48.0 52.2 53.6 55.2 39.6 130.2 46.4 57.7 57.9 40.9 60.8 55.5 43.9 52.2 49.7 59.0 34.7 62.3 52.3 40.9 48.1 65.2 23.0 56.7 80.5 33.5 33.2 29.6 35.4 33.2 31.7 41.6 31.4 44.4 35.1 CSE1L "CAS, CSE1, XPO2" ENSG00000124207 "Chromosome segregation 1 like" P55060 20 49046246-49096960 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002140, HPA038059, HPA038060" Enhanced Enhanced Nucleoplasm,Cytosol 64000 "Nucleoplasm, Cytosol" "CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812" "unprognostic (4.01e-2)" "unprognostic (3.15e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.91e-5)" "unprognostic (4.86e-1)" "unprognostic (4.91e-2)" "prognostic unfavourable (2.42e-8)" "unprognostic (3.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.63e-2)" "unprognostic (2.72e-3)" "unprognostic (2.54e-2)" "prognostic unfavourable (1.89e-4)" "unprognostic (2.59e-1)" "unprognostic (4.84e-1)" "unprognostic (5.71e-1)" "prognostic unfavourable (6.91e-4)" 15.7 18.9 19.5 18.7 23.7 13.7 21.2 24.9 31.3 17.5 14.2 13.4 14.0 12.0 19.5 15.5 25.5 17.3 11.8 17.8 20.0 17.7 18.8 18.7 12.8 24.0 27.3 19.4 18.7 17.3 23.2 16.8 23.1 24.2 16.7 18.4 8.4 15.5 17.0 34.3 20.9 12.4 21.7 31.3 12.6 17.1 50.9 21.0 27.0 14.7 28.1 25.3 18.3 17.5 12.8 14.8 9.4 15.9 16.8 18.0 12.8 35.5 24.8 30.3 23.3 11.8 15.2 32.9 28.1 14.9 88.5 37.5 81.0 28.8 36.5 37.7 17.8 41.3 44.5 52.8 84.5 5.9 21.6 25.3 29.1 39.2 7.2 27.8 13.9 8.5 19.8 43.2 25.1 29.2 35.7 14.4 33.1 12.2 33.5 14.4 25.5 37.0 21.4 49.9 28.4 19.4 24.9 26.7 15.5 44.9 48.7 16.0 40.6 18.2 18.8 47.1 39.6 27.7 39.8 8.4 20.4 34.2 28.1 22.5 25.0 9.4 11.8 2.7 11.0 15.2 16.5 12.8 16.8 13.4 14.8 10.4 18.0 15.3 3.3 16.8 15.9 6.6 14.4 12.8 19.5 23.7 24.9 31.3 20.0 17.7 27.3 19.4 24.2 21.0 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 46.6;ASC TERT1: 29.3;BJ hTERT+: 30.7;HHSteC: 70.9;HSkMC: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 7.0;eosinophil: 16.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" 423300 17000000 "Plasma membrane" "Nuclear bodies" "HPA076624: " "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavourable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 38.1 21.4 11.5 14.6 16.7 10.1 36.5 4.3 14.6 13.8 12.8 28.2 3.6 8.5 12.0 10.1 11.3 15.7 20.6 16.0 11.4 5.8 10.7 10.3 23.5 16.9 24.3 5.4 16.9 11.3 6.7 5.2 26.0 19.2 16.3 11.0 12.2 12.4 11.6 12.7 10.4 12.7 16.0 21.9 25.8 11.9 7.5 20.3 2.9 12.4 7.8 11.0 20.6 29.2 0.0 0.0 16.5 0.0 0.0 1.0 0.1 1.5 5.7 2.9 1.1 46.6 29.3 1.0 6.7 30.7 5.3 4.9 0.2 0.8 0.0 8.4 16.4 1.2 1.2 2.2 2.0 18.6 0.9 2.0 3.3 1.9 70.9 0.0 2.6 45.3 0.6 11.7 7.1 1.0 0.4 1.1 6.3 0.1 0.0 0.3 1.0 0.5 0.2 1.5 0.1 2.2 1.5 0.1 0.3 1.9 0.5 2.3 0.4 0.2 3.5 5.6 1.9 24.5 3.7 0.5 0.2 0.0 14.1 0.0 20.7 7.0 0.0 16.5 0.2 0.0 0.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 11.5 16.7 4.3 14.6 11.4 5.8 24.3 5.4 19.2 20.3 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in some" 5 "BEWO: 50.6;SK-BR-3: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 50.6 0.1 0.0 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 7.2 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Approved Vesicles,Cytosol 1500000 "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favourable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favourable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (1.74e-4)" "prognostic favourable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 9.3 8.0 9.5 39.3 11.0 19.9 12.6 18.7 13.4 12.1 13.5 11.8 7.3 16.1 13.9 6.4 33.3 10.6 11.2 14.0 9.8 8.5 8.0 20.9 15.6 67.2 11.1 7.4 10.5 6.7 6.6 10.4 8.8 12.2 9.8 8.9 9.8 13.2 7.0 8.7 14.9 26.2 8.5 10.9 62.7 13.1 8.1 10.6 62.7 8.1 9.5 47.4 17.4 13.2 35.6 22.8 49.6 46.8 16.3 30.7 19.9 12.7 18.0 8.8 14.5 8.4 6.5 7.6 8.6 8.2 16.3 11.6 16.4 11.8 57.1 11.4 7.7 13.3 18.5 17.3 4.6 27.6 22.8 48.3 6.6 16.5 11.7 25.2 61.6 9.2 8.5 11.6 10.4 12.3 13.9 19.9 9.7 21.5 18.1 14.9 10.9 12.9 20.1 7.6 41.6 7.5 28.4 14.7 10.2 11.1 23.4 14.8 16.1 37.2 10.6 19.8 10.4 15.5 14.8 10.7 21.5 58.3 10.2 48.2 13.3 20.7 19.7 49.6 23.4 42.4 20.0 29.4 20.3 23.1 22.8 35.6 15.7 18.4 39.1 16.3 46.8 13.2 30.7 19.9 9.5 11.0 18.7 13.4 9.8 8.5 11.1 7.4 12.2 10.6 CSNK1D "CKID, CKIdelta, HCKID" ENSG00000141551 "Casein kinase 1 delta" P48730 17 82239023-82273731 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015410 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "CAB015410: AB_831049" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (7.04e-4)" "unprognostic (2.38e-2)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.38e-6)" "unprognostic (8.05e-2)" "unprognostic (1.09e-1)" "unprognostic (5.00e-2)" "prognostic favourable (9.62e-5)" "unprognostic (2.23e-3)" "prognostic unfavourable (8.34e-4)" "unprognostic (3.54e-1)" "unprognostic (2.52e-1)" "unprognostic (5.52e-3)" "unprognostic (4.74e-2)" 30.1 36.3 30.8 25.9 30.8 21.0 26.3 36.3 42.8 30.9 33.0 27.7 32.9 32.6 37.9 29.8 31.3 38.0 34.9 28.5 26.2 26.9 32.0 33.5 30.1 25.8 27.2 27.8 31.4 42.8 34.2 35.9 32.8 30.3 35.3 19.3 28.4 38.0 37.7 52.3 26.7 42.3 34.1 21.4 36.4 32.5 48.3 24.6 29.2 33.0 31.8 33.7 31.4 26.1 6.4 11.4 29.6 12.1 8.7 7.6 7.1 21.3 25.4 14.5 19.9 19.1 20.4 29.1 31.4 19.8 22.5 21.1 20.8 18.4 19.5 24.8 22.3 20.7 13.6 31.8 18.2 16.5 32.9 24.2 20.2 22.3 55.5 19.9 18.5 30.9 22.6 15.3 22.8 32.8 27.2 10.4 21.2 24.9 25.5 20.8 15.5 40.0 22.0 17.9 17.3 23.7 33.5 17.9 32.3 37.5 31.3 35.1 22.4 26.1 34.5 32.4 29.1 28.1 23.8 22.7 11.0 20.9 26.0 17.1 23.5 4.7 11.0 14.6 7.6 12.1 7.4 6.4 5.9 7.3 11.4 5.6 5.0 5.3 29.6 8.7 11.1 5.5 5.2 7.1 30.8 30.8 36.3 42.8 26.2 26.9 27.2 27.8 30.3 24.6 CSNK1E "CKIE, CKIepsilon, HCKIE" ENSG00000213923 "Casein kinase 1 epsilon" P49674 22 38290691-38318084 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in all" "CAB009626, HPA026288" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009626: AB_2084517, HPA026288: AB_1847276" "unprognostic (2.32e-1)" "unprognostic (8.41e-2)" "unprognostic (5.14e-2)" "unprognostic (5.01e-3)" "unprognostic (1.95e-2)" "unprognostic (4.50e-3)" "prognostic unfavourable (8.20e-5)" "unprognostic (2.08e-3)" "unprognostic (3.69e-1)" "unprognostic (1.22e-1)" "unprognostic (9.63e-2)" "unprognostic (4.16e-3)" "prognostic unfavourable (4.67e-6)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-1)" "unprognostic (3.25e-3)" 28.5 22.9 30.7 18.3 32.5 21.4 28.6 40.1 42.6 26.4 21.5 32.3 15.7 19.0 37.3 27.3 23.4 28.0 22.1 28.8 31.7 22.3 17.3 11.8 28.4 17.3 28.6 30.1 38.1 25.4 56.2 29.2 33.1 28.7 26.2 17.4 30.5 23.9 23.1 26.3 35.3 17.1 24.0 23.2 20.9 21.8 13.0 33.9 13.3 21.4 14.2 17.4 25.5 28.8 3.7 15.7 4.8 1.8 5.9 4.0 1.2 23.3 11.4 31.0 29.7 15.5 23.8 23.3 30.5 39.1 27.8 27.0 14.6 18.3 17.6 13.3 28.8 20.0 23.5 42.2 20.2 28.1 51.1 5.6 37.7 11.2 32.0 12.3 15.0 22.7 35.8 42.3 57.3 29.5 12.4 36.4 26.8 15.6 17.1 15.1 22.7 16.5 32.0 22.2 27.6 25.5 19.6 45.9 18.0 26.0 27.0 30.5 13.8 17.9 33.5 25.2 27.5 14.5 24.3 16.3 23.3 24.8 37.4 13.9 42.2 3.8 1.8 3.4 3.4 0.8 4.0 2.5 3.8 3.4 1.8 3.7 2.1 3.1 4.8 5.9 0.6 15.7 1.7 1.2 30.7 32.5 40.1 38.8 31.7 22.3 28.6 30.1 28.7 33.9 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 19.7;SK-MEL-30: 44.8;U-138 MG: 28.9;WM-115: 42.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: " "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.5 0.0 0.3 2.2 0.5 3.1 0.0 19.7 8.8 13.8 9.0 0.0 13.7 0.0 0.4 13.7 0.1 0.0 0.1 4.3 0.1 0.0 0.0 5.7 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 44.8 0.3 0.3 0.0 28.9 5.7 1.1 0.2 0.0 0.0 0.0 6.3 0.1 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell line enhanced" "Detected in many" "AF22: 26.2;HEK 293: 7.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049529: , HPA067818: , HPA071779: " "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favourable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.2 4.6 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.0 0.0 0.4 2.2 0.2 0.2 0.0 7.2 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.0 5.1 0.2 0.1 1.2 0.2 0.3 2.5 2.7 0.4 0.2 0.5 1.1 0.9 2.8 1.3 1.6 3.3 0.1 1.2 2.4 0.2 0.0 5.4 0.0 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: " "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favourable (1.07e-4)" "prognostic unfavourable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 33.5 24.9 5.9 16.4 11.5 70.1 20.4 4.9 8.6 16.2 14.4 11.4 13.9 5.1 12.9 9.6 25.9 35.8 28.7 19.7 5.4 5.3 9.6 33.3 35.7 7.9 8.8 3.3 24.9 16.3 11.7 17.6 30.9 15.3 15.8 6.8 9.7 10.9 50.1 22.4 19.9 21.0 26.9 11.9 9.2 20.3 11.4 7.5 8.9 14.5 14.6 7.8 21.4 16.9 3.6 3.9 15.9 9.2 2.2 2.5 1.9 2.3 5.2 1.3 2.6 2.6 2.8 4.3 8.6 12.0 7.2 5.9 7.3 2.1 7.7 1.8 6.5 2.6 1.6 11.3 3.5 11.4 2.1 8.7 4.2 5.5 3.3 2.1 8.7 1.3 6.2 11.2 1.8 9.7 6.6 13.6 5.8 7.4 0.4 3.5 6.2 4.4 3.6 5.7 12.5 5.7 8.5 3.8 0.6 4.7 35.4 2.9 3.9 4.0 4.8 3.7 15.7 3.1 6.3 3.5 2.9 3.5 8.0 2.7 4.6 0.1 2.7 3.2 1.7 5.6 2.1 3.6 1.6 1.9 3.0 3.6 2.0 1.3 15.9 2.2 9.2 3.9 2.5 1.9 5.9 11.5 4.9 8.6 5.4 5.3 8.8 3.3 15.3 7.5 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Supported Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.0 0.9 0.6 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.7 0.7 0.0 9.3 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 CST3 ENSG00000101439 "Cystatin C" P01034 20 23626706-23638473 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 160.1;ASC TERT1: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5" "Group enriched" "Detected in many" 9 "dendritic cells: 269.6;monocytes: 211.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000118, HPA013143" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 4100000000 "Golgi apparatus, Vesicles" "CAB000118: , HPA013143: AB_1847417" "unprognostic (3.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.53e-2)" "unprognostic (4.06e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.46e-2)" "unprognostic (3.72e-1)" "unprognostic (2.29e-3)" "unprognostic (3.51e-2)" "unprognostic (1.85e-1)" "unprognostic (1.16e-1)" "unprognostic (2.97e-1)" "unprognostic (5.01e-2)" "prognostic favourable (8.77e-4)" 95.8 72.6 229.0 37.9 254.7 22.2 68.6 61.4 196.7 76.6 78.2 75.4 39.5 59.4 47.6 143.6 73.8 64.9 89.4 79.7 157.4 96.2 35.9 67.3 58.0 91.2 148.3 90.6 51.4 142.1 34.5 45.6 25.8 69.9 55.2 66.1 195.0 338.2 74.2 44.2 44.9 77.9 57.3 73.3 85.5 105.5 57.4 68.4 40.7 43.2 40.1 31.9 49.4 50.2 0.6 269.6 27.4 211.0 6.4 2.4 106.7 12.6 28.8 6.7 15.5 160.1 109.6 12.6 22.1 30.8 15.2 12.3 54.7 19.6 0.0 20.8 30.1 43.0 6.2 44.1 4.7 0.0 21.3 13.0 5.7 93.0 57.3 0.6 21.9 84.8 37.2 20.4 21.9 23.7 11.8 0.3 21.1 20.2 0.1 13.8 9.0 63.2 0.4 8.2 17.5 62.4 28.7 7.4 8.5 16.1 4.8 27.4 13.6 47.7 59.8 14.4 10.4 20.1 8.2 13.6 0.4 0.1 12.3 28.6 16.2 1.4 163.9 1.0 2.4 211.0 0.9 0.6 0.6 1.6 269.6 0.5 0.6 1.2 27.4 6.4 135.1 153.5 0.4 106.7 229.0 254.7 61.4 196.7 157.4 96.2 148.3 90.6 69.9 68.4 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Group enriched" "Detected in some" 6 "A-431: 26.2;CAPAN-2: 73.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: " "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.2 0.0 0.0 0.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.1 73.1 0.0 0.4 0.9 0.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favourable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.6 0.1 0.0 0.3 3.8 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.6 10.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.7 0.8 13.3 0.2 3.7 146.6 0.3 14.4 0.0 0.0 3.5 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 1.6 0.8 1.1 0.1 91.6 0.0 0.2 2.4 0.0 0.1 0.0 0.1 58.3 3.2 29.1 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776445 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8" "Cell line enhanced" "Detected in all" "RT4: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol 6100000 Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: " "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavourable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 21.1 7.5 5.6 6.1 5.9 3.2 13.6 3.0 5.3 57.8 8.8 4.4 3.9 5.6 6.1 6.4 365.3 6.0 7.2 6.5 4.6 5.0 9.6 17.3 17.2 11.2 5.3 4.9 7.8 5.0 3.2 7.6 5.2 5.8 7.1 7.2 7.8 65.2 6.2 4.8 9.4 7.5 6.3 5.1 7.4 10.4 4.1 4.1 8.6 11.6 138.8 130.6 14.0 81.5 11.4 43.2 25.4 69.1 7.7 22.3 21.3 57.8 17.5 5.8 7.3 30.9 25.4 14.4 12.5 14.5 7.9 7.9 13.5 32.5 4.7 9.7 19.5 10.4 13.3 14.0 5.0 19.4 15.8 13.1 13.5 15.6 27.6 3.2 10.9 26.9 14.6 21.8 10.8 11.0 9.7 25.8 11.6 14.6 4.1 10.1 14.0 30.2 6.8 3.3 53.1 22.7 90.4 5.5 4.9 16.5 8.8 35.2 8.2 8.1 16.9 13.2 6.9 12.3 7.9 6.4 11.2 8.7 57.4 15.2 9.2 16.8 28.2 16.9 14.5 45.9 13.3 11.4 18.6 15.0 43.2 9.7 13.2 13.0 25.4 7.7 69.1 5.3 22.3 21.3 5.6 5.9 3.0 5.3 4.6 5.0 5.3 4.9 5.8 4.1 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100840932 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavourable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favourable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 8.6 11.1 10.1 14.1 14.6 12.2 10.5 18.8 14.5 10.0 14.9 9.1 15.8 11.4 11.9 11.8 30.1 11.3 8.8 7.8 12.7 10.5 10.3 7.9 9.1 14.7 11.2 11.6 9.8 8.1 11.9 12.7 9.5 10.8 10.3 16.5 9.7 13.0 16.8 7.2 11.8 12.7 10.7 12.5 11.8 9.1 18.9 11.2 20.6 9.0 9.4 24.2 11.3 12.8 15.8 19.6 14.6 20.9 19.1 21.2 12.7 17.1 20.2 12.8 12.6 7.4 6.3 18.8 13.7 12.2 22.8 34.2 22.2 15.2 16.8 16.9 8.8 17.6 31.6 17.3 26.0 15.8 20.4 15.3 19.2 15.2 10.5 20.2 17.1 6.0 8.5 24.6 15.4 13.7 24.4 16.9 13.4 20.7 16.8 15.4 37.2 19.9 17.5 22.2 20.2 8.9 15.7 11.7 15.0 21.9 10.2 9.6 10.3 11.3 11.3 13.5 22.0 17.4 17.6 10.9 22.2 20.8 11.5 24.4 16.3 14.6 14.6 10.1 21.2 16.5 16.6 15.8 18.7 20.0 19.6 13.4 16.4 16.2 2.4 19.1 20.9 13.5 20.3 12.7 10.1 14.6 18.8 14.5 12.7 10.5 11.2 11.6 10.8 11.2 CSTF2T "CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64" ENSG00000177613 "Cleavage stimulation factor subunit 2 tau variant" Q9H0L4 10 51695487-51699591 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039216, HPA062021" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039216: AB_10795462, HPA062021: " "unprognostic (2.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.93e-2)" "unprognostic (2.17e-1)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (5.92e-2)" "unprognostic (5.36e-2)" "unprognostic (7.63e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.31e-1)" "unprognostic (1.96e-1)" 20.2 23.5 16.5 20.0 21.6 14.0 15.2 16.2 24.0 14.8 13.5 29.6 9.9 14.3 16.8 13.4 13.1 19.0 12.7 17.4 18.4 16.6 15.5 15.4 11.9 21.7 21.3 16.5 23.3 16.3 30.2 14.1 14.6 23.5 15.8 13.5 12.6 13.4 12.5 25.0 13.3 16.8 16.8 28.0 24.6 17.7 11.6 20.1 31.9 17.0 12.6 22.9 17.0 13.2 4.6 5.5 5.5 5.1 13.9 6.8 3.2 8.3 10.0 15.1 15.8 21.3 14.6 1.0 11.9 11.1 13.8 13.5 13.2 12.3 24.2 6.9 10.4 13.2 11.3 12.5 12.6 14.0 12.8 13.9 10.6 2.4 10.3 5.3 12.8 21.0 9.7 12.1 14.1 10.3 14.9 13.8 11.9 7.1 21.8 8.6 5.5 21.6 17.4 30.4 5.1 10.6 7.0 12.7 16.3 9.9 10.4 10.6 19.4 10.0 10.9 8.8 12.1 8.1 14.8 17.6 6.5 17.4 18.4 12.6 7.6 3.7 5.0 5.5 4.9 5.1 6.8 2.3 3.6 3.8 5.5 4.6 6.2 5.3 1.5 13.9 3.4 3.5 5.7 3.2 16.5 21.6 16.2 24.0 18.4 16.6 21.3 16.5 23.5 20.1 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Group enriched" "Detected in some" 7 "HMC-1: 68.4;Karpas-707: 31.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.5 31.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.4 0.0 0.0 0.5 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell line enhanced" "Detected in some" "AN3-CA: 32.5;K-562: 9.7;Karpas-707: 36.1;U-266/84: 30.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 9.7 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 7.1 30.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Cell line enhanced" "Detected in some" "HMC-1: 29.2;T-47d: 17.1;U-266/84: 88.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 88.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Cell line enhanced" "Detected in some" "HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 1.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.9 64.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Cell line enriched" "Detected in some" 9 "U-266/84: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Group enriched" "Detected in some" 5 "AN3-CA: 13.8;HMC-1: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 54.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Group enriched" "Detected in some" 37 "K-562: 28.2;RPMI-8226: 62.9;SK-BR-3: 41.1;U-266/84: 71.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: , HPA076586: " "prognostic unfavourable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 33 "HMC-1: 32.5;K-562: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 32.5 0.0 0.0 0.0 0.0 0.0 44.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.1 0.1 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679801-79756623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: " "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favourable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favourable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 10.6 8.2 6.2 12.8 9.5 21.8 9.5 7.5 12.2 7.9 12.0 14.4 5.3 13.4 11.9 9.3 11.4 9.8 10.0 6.6 6.8 5.7 8.9 13.4 10.2 14.4 12.3 5.1 7.7 13.4 4.6 7.9 10.6 9.1 9.1 6.2 8.4 10.6 8.3 12.1 20.9 13.8 8.2 6.8 15.3 12.2 27.2 10.6 26.2 9.4 8.8 14.8 11.4 8.9 0.7 1.5 6.4 1.0 2.4 2.0 0.5 8.0 9.0 5.0 7.2 4.0 3.4 16.7 5.4 4.0 5.0 4.9 5.9 5.1 10.3 2.5 3.5 9.9 4.3 5.7 2.1 9.5 7.7 5.3 4.5 8.0 5.9 23.4 13.2 5.6 5.4 5.3 2.5 6.0 6.5 5.3 1.9 7.2 15.7 18.4 7.9 12.1 12.2 6.6 12.4 3.7 8.4 7.8 8.1 6.4 6.4 8.6 5.2 13.8 8.1 8.6 12.5 3.4 5.8 4.4 16.5 10.2 7.3 11.8 6.0 0.0 1.0 6.4 1.3 0.9 1.1 0.7 1.0 2.0 1.5 0.4 1.3 0.7 2.7 2.4 0.9 0.2 0.3 0.5 6.2 9.5 7.5 12.2 6.8 5.7 12.3 5.1 9.1 10.6 CTDSP2 "OS4, PSR2, SCP2" ENSG00000175215 "CTD small phosphatase 2" O14595 12 57819927-57846739 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "RH-30: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052607 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA052607: " "unprognostic (7.09e-2)" "unprognostic (2.45e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (4.39e-1)" "unprognostic (5.57e-2)" "unprognostic (1.05e-3)" "unprognostic (2.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" "unprognostic (1.12e-1)" "unprognostic (4.15e-1)" "unprognostic (7.38e-3)" "unprognostic (5.50e-2)" "unprognostic (6.50e-2)" "unprognostic (2.18e-1)" "unprognostic (3.11e-1)" 44.5 43.6 28.2 31.6 34.8 17.6 39.6 57.1 33.4 49.0 48.4 36.7 47.7 24.4 50.4 32.9 38.0 41.9 37.7 34.6 31.2 16.5 32.8 32.6 51.3 31.3 37.1 19.9 52.5 53.9 33.7 25.4 42.9 31.0 40.5 38.6 29.3 45.8 60.9 48.8 39.9 36.1 44.1 25.7 38.1 43.1 21.0 40.9 62.9 40.1 32.8 33.9 46.1 63.0 7.3 9.3 18.7 9.7 8.2 11.5 7.1 10.8 4.7 22.6 14.4 20.4 35.2 7.5 11.7 22.3 11.7 10.4 6.0 17.7 13.3 13.5 25.0 8.7 9.4 11.4 12.3 4.5 4.0 18.4 7.2 4.8 19.0 8.3 10.7 33.6 12.2 10.6 9.0 18.2 9.6 23.6 5.8 5.0 8.9 5.0 11.5 6.0 11.9 165.7 17.4 9.1 15.8 4.2 9.4 16.4 9.4 14.1 17.1 14.6 14.6 10.4 11.4 11.7 4.1 7.0 7.5 16.0 11.7 7.7 8.0 11.5 9.7 14.7 6.9 9.0 8.2 7.3 9.9 8.0 9.3 6.5 11.5 8.7 18.7 8.2 7.7 7.7 6.4 7.1 28.2 34.8 57.1 33.4 31.2 16.5 37.1 19.9 31.0 40.9 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861960-37984469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles 10000 Vesicles Nucleoplasm "HPA048325: " "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favourable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 12.8 6.3 11.1 7.8 12.4 5.6 22.0 30.2 14.1 15.5 19.9 8.0 25.7 9.3 14.5 18.3 16.8 12.2 37.2 18.9 13.1 5.9 26.7 13.3 19.0 4.9 7.8 9.9 13.7 10.2 8.3 9.4 20.6 6.9 17.5 20.3 15.6 45.5 22.4 12.5 34.8 11.2 21.3 8.1 11.3 19.7 8.1 8.3 2.9 10.0 13.9 6.9 19.6 21.7 0.0 0.2 1.1 0.5 0.0 0.5 5.6 15.5 6.8 2.8 8.8 11.0 15.9 20.9 10.7 13.5 7.4 8.8 9.8 12.8 0.0 6.6 13.2 13.0 6.9 20.3 6.0 0.0 5.4 9.5 7.2 22.1 10.1 0.0 2.3 8.2 49.9 7.8 9.4 10.4 3.0 0.0 12.3 4.9 3.9 0.0 11.5 1.0 4.3 5.4 0.1 23.8 10.4 2.3 7.4 5.9 10.6 11.9 10.2 2.6 8.2 5.4 7.5 10.0 6.7 0.2 0.0 0.0 6.0 5.3 9.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.0 0.0 0.0 5.6 11.1 12.4 30.2 14.1 13.1 5.9 7.8 9.9 6.9 8.3 CTGF "CCN2, IGFBP8" ENSG00000118523 "Connective tissue growth factor" P29279 6 131948176-131951373 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, DNA synthesis" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 128.3;HUVEC TERT2: 107.9;TIME: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "naive B-cell: 11.6" "Lineage enriched" "Detected in single" 117 "B-cells: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB005123, HPA031074, HPA031075" Approved Approved "Golgi apparatus,Vesicles" "Secreted in other tissues" 5200000 "Golgi apparatus, Vesicles" "CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248" "unprognostic (2.87e-1)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (5.68e-2)" "unprognostic (9.79e-2)" "unprognostic (1.82e-2)" "unprognostic (3.38e-1)" "unprognostic (4.96e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.27e-3)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.62e-1)" "unprognostic (1.77e-2)" "unprognostic (3.84e-3)" 51.9 15.5 3.5 48.2 7.6 0.0 39.2 1.6 7.1 84.0 26.9 7.2 27.5 5.8 84.9 50.1 38.9 56.3 82.5 73.6 8.8 3.6 83.5 18.8 45.8 53.3 4.7 9.4 30.7 26.3 4.7 9.7 44.0 13.8 54.5 19.7 55.0 28.2 45.3 29.4 30.1 28.7 123.4 12.0 169.8 41.6 24.4 2.3 5.9 66.9 46.9 9.8 48.5 23.3 11.6 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 10.0 0.2 22.7 12.9 0.1 29.0 13.9 18.0 9.6 0.0 0.9 0.0 128.3 37.2 0.4 0.3 2.0 17.0 0.1 0.2 0.0 4.1 10.4 8.9 0.0 0.0 18.8 0.4 13.0 3.2 107.9 0.0 0.0 51.0 0.1 0.0 0.0 4.8 1.7 2.4 0.4 0.0 6.5 0.0 0.0 0.0 2.9 4.9 1.3 0.4 0.2 222.6 25.0 19.5 31.4 53.4 0.9 0.1 0.2 3.4 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.5 7.6 1.6 7.1 8.8 3.6 4.7 9.4 13.8 2.3 CTNNA1 CAP102 ENSG00000044115 "Catenin alpha 1" P35221 5 138610967-138935034 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021089, HPA046119, HPA063535" Approved Enhanced "Plasma membrane,Cell Junctions" 5400 "Plasma membrane, Cell Junctions" "CAB021089: AB_10123543, HPA046119: , HPA063535: " "unprognostic (2.25e-3)" "unprognostic (3.32e-2)" "unprognostic (2.82e-3)" "unprognostic (1.80e-1)" "unprognostic (8.40e-2)" "unprognostic (2.35e-1)" "unprognostic (1.66e-3)" "unprognostic (4.83e-2)" "unprognostic (2.28e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (6.18e-2)" "prognostic favourable (7.34e-7)" "unprognostic (1.54e-1)" "unprognostic (2.31e-1)" "unprognostic (7.62e-2)" "unprognostic (1.04e-1)" 55.9 54.0 39.6 24.4 50.2 10.9 55.1 16.5 39.5 43.4 58.9 68.5 33.9 44.2 53.0 47.5 76.9 45.8 41.1 68.6 38.8 32.3 62.2 37.7 49.8 27.0 57.3 29.3 42.7 38.1 55.5 25.6 54.0 45.5 39.4 49.0 35.6 48.8 43.5 30.5 49.8 53.9 59.6 49.7 30.9 48.2 18.7 56.6 8.1 51.2 46.4 44.1 48.4 45.1 3.8 15.2 9.8 21.8 0.3 5.0 7.1 32.5 23.8 36.0 53.3 31.4 34.5 54.9 33.0 41.6 31.6 40.1 49.5 44.3 0.1 28.0 49.2 25.0 24.7 54.3 36.8 18.7 21.5 13.7 39.1 30.0 37.9 0.2 13.4 21.7 43.5 37.7 41.5 59.5 7.5 14.2 34.0 28.8 0.3 4.2 14.5 0.5 12.9 21.0 19.6 66.7 43.6 14.4 19.0 60.9 85.7 49.8 30.3 9.4 50.4 33.3 18.0 20.6 22.8 5.1 9.6 1.9 31.7 5.9 42.9 2.2 17.1 1.5 2.9 21.8 1.9 3.8 2.1 2.1 15.2 3.2 0.1 1.1 9.8 0.3 20.2 3.7 5.0 7.1 39.6 50.2 16.5 39.5 38.8 32.3 57.3 29.3 45.5 56.6 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: , HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favourable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 25.8 3.8 23.8 18.1 3.6 6.0 7.6 5.1 9.0 7.6 4.9 1.8 33.0 8.0 14.9 6.6 13.2 2.7 30.5 3.5 20.1 4.2 5.2 1.2 24.1 7.5 3.8 3.0 6.7 30.2 9.6 9.9 20.4 9.1 3.8 4.6 15.8 8.6 14.4 12.6 6.7 9.8 7.0 5.1 3.9 8.9 26.2 16.5 11.7 10.6 15.5 13.0 9.5 13.3 4.9 6.0 7.4 11.2 8.3 10.8 9.3 1.8 19.8 19.5 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 CTNNBL1 "C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L" ENSG00000132792 "Catenin beta like 1" Q8WYA6 20 37693955-37872129 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004742, HPA027906, HPA027907" Approved Enhanced Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362" "unprognostic (2.81e-1)" "unprognostic (3.42e-1)" "unprognostic (8.80e-2)" "unprognostic (1.88e-3)" "unprognostic (1.93e-1)" "unprognostic (2.55e-2)" "unprognostic (1.44e-1)" "unprognostic (5.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (2.81e-1)" "unprognostic (5.31e-2)" 21.0 14.7 19.6 25.8 21.4 27.3 18.9 20.9 21.3 20.3 23.5 18.4 31.7 16.1 25.4 25.2 18.9 21.0 17.7 25.6 17.5 15.8 19.3 35.3 19.3 26.9 17.9 14.7 21.7 14.6 14.5 22.6 22.4 17.5 19.4 18.1 16.1 15.5 34.3 27.3 20.1 19.7 23.8 16.6 49.5 25.9 35.5 20.6 31.0 15.9 15.5 29.7 22.2 29.3 24.9 31.4 60.3 29.1 21.7 18.2 18.4 15.3 14.2 13.6 10.6 9.8 8.1 21.5 9.8 10.3 23.6 20.9 52.9 12.4 17.1 14.4 9.9 16.5 18.2 23.2 25.5 8.2 9.1 56.1 7.8 25.8 10.2 17.7 74.6 8.6 13.8 13.3 13.3 14.1 15.1 7.0 12.6 12.7 28.7 23.6 12.2 20.6 20.2 26.3 12.9 10.3 12.9 10.9 13.0 17.0 24.5 17.2 12.0 14.3 10.4 23.7 14.1 15.5 15.9 8.2 10.4 19.9 16.6 11.1 12.5 60.3 22.3 27.9 15.8 29.1 15.0 24.9 15.4 16.2 31.4 23.4 15.5 16.6 4.9 21.7 28.7 24.7 18.2 18.4 19.6 21.4 20.9 21.3 17.5 15.8 17.9 14.7 17.5 20.6 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell line enhanced" "Detected in some" "AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus, Cell Junctions" "CAB037339: , HPA015077: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA046947: " "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favourable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.1 13.8 8.1 6.9 13.2 6.7 5.1 6.0 10.1 6.9 8.7 7.7 6.1 3.7 6.4 4.0 15.8 7.1 4.1 5.3 46.0 12.5 4.2 10.4 6.2 17.8 2.8 28.8 8.3 5.2 7.3 5.9 7.6 4.3 5.8 6.5 5.6 2.8 2.7 3.6 6.1 6.2 3.3 8.7 6.2 6.3 1.6 5.9 7.0 9.4 7.0 6.6 2.8 8.9 6.8 4.3 15.4 4.9 4.7 6.0 1.7 10.5 3.0 4.6 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 CTPS1 "CTPS, GATD5" ENSG00000171793 "CTP synthase 1" P17812 1 40979335-41012565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017111, HPA051322" Enhanced Supported "Actin filaments,Cytosol" "Actin filaments, Cytosol" "CAB017111: , HPA051322: " "unprognostic (6.60e-2)" "unprognostic (4.44e-2)" "unprognostic (3.21e-2)" "unprognostic (2.00e-3)" "unprognostic (2.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.42e-2)" "unprognostic (9.72e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (2.04e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-1)" "unprognostic (8.21e-3)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" "unprognostic (1.89e-2)" 7.1 10.0 4.5 10.8 7.8 9.7 5.1 5.9 9.8 14.4 23.6 5.8 16.3 4.3 25.9 8.4 11.3 21.9 13.4 6.7 4.7 5.1 8.6 26.4 7.0 9.4 7.9 4.7 10.1 6.3 16.8 5.4 7.7 6.2 14.4 9.8 9.1 56.5 19.6 13.2 5.8 13.5 35.8 5.1 7.5 9.0 11.8 6.7 14.6 4.5 11.3 13.2 21.3 9.5 6.0 12.8 0.0 7.3 6.6 7.0 3.8 21.1 19.4 27.5 22.1 7.6 9.5 43.2 37.2 16.0 40.9 27.6 38.1 18.8 39.7 16.9 17.0 15.0 29.4 27.8 40.9 16.6 22.3 24.3 25.9 12.0 24.9 32.4 19.1 10.4 15.1 42.3 30.4 18.6 24.4 17.5 28.6 11.9 35.0 12.1 37.5 23.1 27.0 33.4 25.7 20.7 19.3 36.9 18.0 23.2 25.0 9.2 8.7 44.8 15.2 27.1 35.4 18.2 46.2 11.3 13.2 35.3 17.7 25.8 28.1 0.0 4.0 0.0 4.6 7.3 6.6 6.0 5.3 4.8 12.0 3.9 4.4 7.0 0.0 6.6 6.1 12.8 6.6 3.8 4.5 7.8 5.9 9.8 4.7 5.1 7.9 4.7 6.2 6.7 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16588003-16712936 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017437 Uncertain Approved Nucleoplasm,Cytosol 14000 "Nucleoplasm, Cytosol" "HPA017437: AB_1847326" "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favourable (4.56e-4)" 10.0 12.0 7.8 11.5 11.9 7.8 13.5 14.3 9.9 17.5 13.3 14.8 10.8 15.6 22.0 10.2 9.6 12.1 11.9 7.2 8.6 7.1 8.1 13.4 8.3 7.9 9.1 6.1 17.9 14.9 22.9 8.5 8.3 9.3 12.8 12.6 14.1 11.8 9.7 5.5 9.2 12.8 14.0 12.3 7.1 11.3 4.4 10.8 11.5 11.8 8.4 10.6 11.8 11.2 1.6 3.3 1.1 6.1 3.8 2.4 1.4 7.5 6.9 11.3 9.4 5.8 4.4 0.1 4.2 3.5 6.8 6.2 7.0 7.9 0.2 13.3 4.3 6.1 15.9 7.6 8.1 0.0 10.5 4.3 9.7 10.1 3.0 3.0 0.1 4.8 2.6 6.3 5.4 9.0 6.1 0.3 6.1 10.0 0.1 2.4 19.4 8.1 0.1 6.5 2.3 7.2 8.5 7.1 13.0 13.2 1.0 7.6 18.3 8.8 5.8 3.5 1.9 9.3 3.6 0.2 0.1 25.1 2.8 2.7 3.9 0.4 1.5 1.1 1.3 0.8 2.4 1.6 2.2 1.4 3.3 1.4 1.7 1.7 0.1 3.8 6.1 2.2 2.0 1.4 7.8 11.9 14.3 9.9 8.6 7.1 9.1 6.1 9.3 10.8 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869448 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 297.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 237.0;fHDF/TERT166: 137.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4" "Group enriched" "Detected in all" 5 "dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" 130000000 Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favourable (5.76e-4)" "prognostic unfavourable (9.02e-4)" 227.9 42.1 19.6 67.2 24.4 14.7 67.6 14.9 31.4 76.7 49.1 30.1 22.7 29.9 53.2 44.8 54.2 52.4 43.6 120.7 18.3 23.7 95.6 167.8 94.3 175.1 29.1 16.5 44.2 31.6 13.8 21.6 68.7 24.8 42.6 27.9 33.8 63.7 33.6 41.3 22.8 51.2 51.1 35.9 116.4 26.7 21.5 20.4 18.1 297.0 25.9 38.4 56.8 62.2 7.9 95.4 53.1 127.4 5.3 17.1 108.5 6.4 29.1 3.7 16.0 65.8 74.1 11.6 121.4 237.0 42.5 50.4 13.9 37.9 0.1 17.6 137.7 35.4 5.1 33.5 26.9 3.1 5.0 9.4 3.4 34.1 67.0 2.1 7.0 81.1 45.7 38.4 34.4 83.1 7.8 21.5 35.3 5.1 0.8 3.4 3.1 9.8 3.3 3.8 16.4 12.9 10.1 1.6 9.5 14.0 7.6 63.3 12.3 6.3 115.1 72.3 24.5 23.1 22.6 21.4 15.5 0.5 82.9 8.1 33.8 53.1 127.4 16.3 5.2 97.0 7.2 7.9 17.1 5.8 68.0 6.1 9.6 4.1 18.5 5.3 54.7 95.4 13.4 108.5 19.6 24.4 14.9 28.0 18.3 23.7 29.1 16.5 24.8 20.4 CTSF "CATSF, CLN13" ENSG00000174080 "Cathepsin F" Q9UBX1 11 66563463-66568841 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 28.2;SK-MEL-30: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 7.5;T-cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002141, HPA031431, HPA055610" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" 3600000 Cytosol "Vesicles, Plasma membrane" "CAB002141: AB_563471, HPA031431: , HPA055610: " "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (7.22e-3)" "unprognostic (2.25e-2)" "unprognostic (6.72e-2)" "unprognostic (2.67e-2)" "unprognostic (2.76e-2)" "unprognostic (3.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.69e-2)" "unprognostic (9.12e-2)" "prognostic favourable (8.92e-7)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (2.42e-1)" 28.1 29.4 24.7 8.0 29.0 1.8 31.1 38.4 47.1 37.3 23.8 32.6 25.2 5.8 38.1 29.8 12.9 34.3 37.3 34.5 25.3 20.5 29.8 45.4 17.3 8.5 28.0 26.0 68.2 23.1 42.6 15.9 20.2 25.4 32.3 8.1 35.0 35.5 37.8 35.8 19.7 9.4 34.6 22.4 10.4 17.8 37.1 30.1 0.8 18.6 14.2 6.3 22.2 21.5 2.1 1.1 0.5 0.7 7.5 9.7 2.4 0.1 9.2 5.0 12.9 21.3 8.6 3.6 6.5 16.5 6.8 4.8 0.0 8.2 0.0 11.0 14.2 0.9 8.5 2.8 3.6 2.2 0.0 0.3 3.8 0.0 11.9 0.1 5.0 28.2 9.6 1.5 1.1 4.3 2.8 1.5 8.5 1.9 0.1 1.1 0.6 3.4 0.0 1.9 1.6 6.1 0.2 6.0 6.4 17.4 2.0 52.3 13.2 0.8 2.8 2.7 2.7 3.2 0.6 8.8 0.1 0.0 6.5 0.1 4.1 0.0 0.7 0.4 6.5 0.7 7.0 2.0 5.6 7.3 0.8 2.1 9.7 5.5 0.5 7.5 0.3 1.1 1.7 2.4 24.7 29.0 38.4 47.1 25.3 20.5 28.0 26.0 25.4 30.1 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 82.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 42.8" "Group enriched" "Detected in all" 5 "B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" 10000000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favourable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 16.7 10.6 9.5 24.2 7.0 5.4 23.9 4.5 9.8 25.1 11.4 17.7 14.7 10.6 10.3 17.1 7.8 13.1 29.2 16.5 14.8 6.7 66.7 18.7 82.6 65.4 12.1 11.6 14.6 25.8 12.3 6.5 7.7 9.4 18.6 6.6 6.7 15.4 15.9 7.0 13.5 16.6 9.8 10.8 20.3 15.6 6.7 15.7 6.6 8.5 4.8 34.8 39.6 13.5 20.6 41.2 1.4 42.8 1.3 7.6 27.3 16.0 1.1 0.4 4.7 1.1 0.0 5.2 1.6 0.6 2.8 1.5 7.0 42.5 5.6 1.7 0.1 31.0 2.0 7.7 2.3 23.6 0.1 0.1 0.2 16.2 1.6 0.0 1.0 0.8 2.2 0.0 0.0 0.2 11.4 0.0 3.8 1.7 3.6 9.8 1.2 0.3 0.0 0.3 0.9 9.8 118.0 0.5 1.1 6.9 3.9 9.6 1.5 5.3 2.2 0.0 1.0 0.0 0.7 0.1 12.2 3.1 0.0 10.3 1.7 0.0 42.8 0.4 1.4 28.3 7.6 20.6 4.1 2.1 41.2 12.0 0.4 0.7 1.4 1.3 17.0 4.2 3.1 27.3 9.5 7.0 4.5 9.8 14.8 6.7 12.1 11.6 9.4 15.7 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87725519-87731393 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 237.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 198.5;HSkMC: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 31.0;non-classical monocyte: 44.3" "Lineage enriched" "Detected in many" 10 "monocytes: 44.3" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 17000000 "Golgi apparatus" Vesicles "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavourable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favourable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 60.3 21.5 10.4 27.2 24.6 18.4 23.3 6.9 12.3 14.8 23.2 14.1 13.7 9.0 24.1 22.3 11.4 25.7 20.7 37.7 10.7 11.4 65.4 98.0 53.1 80.5 18.9 7.7 25.0 14.3 18.8 18.0 237.0 18.4 19.4 13.0 23.2 22.0 23.5 29.3 9.1 12.0 36.6 16.1 108.1 17.5 14.1 15.7 6.8 19.2 9.4 10.1 41.3 26.5 0.0 1.7 0.1 44.3 0.0 4.3 2.4 6.3 36.8 2.5 4.3 46.3 198.5 15.4 20.5 59.7 17.6 22.1 3.5 5.9 0.0 9.6 26.5 5.4 3.3 6.6 14.5 0.1 3.2 1.1 10.4 8.6 30.0 0.0 4.4 91.8 11.2 28.8 11.2 13.8 11.9 0.0 25.3 10.6 0.0 0.7 4.9 7.0 1.5 1.5 0.0 12.3 3.3 3.7 4.5 4.3 9.6 23.5 1.1 7.3 21.7 15.8 8.6 57.5 8.6 1.6 5.9 0.0 57.8 0.0 5.2 0.1 3.5 0.1 0.0 31.0 0.0 0.0 1.8 0.0 1.7 0.0 4.3 0.3 0.1 0.0 44.3 0.1 0.3 2.4 10.4 24.6 6.9 11.7 10.7 11.4 18.9 7.7 18.4 15.7 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell line enriched" "Detected in many" 8 "BEWO: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favourable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavourable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavourable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 7.3 2.2 2.5 6.5 0.1 0.0 113.4 0.0 0.0 1.6 1.3 14.9 7.3 0.1 0.6 0.1 14.0 12.1 8.9 2.3 0.0 1.6 0.3 0.7 2.3 0.0 0.0 1.0 0.0 3.0 0.4 0.3 0.5 0.2 0.0 2.9 2.7 0.2 0.1 15.0 2.1 0.0 5.4 0.1 2.2 0.9 0.6 1.1 7.4 2.6 2.6 4.6 0.8 0.0 0.4 7.4 0.1 0.8 1.5 4.0 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 CTTN EMS1 ENSG00000085733 Cortactin Q14247 11 70398404-70436584 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 128.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011235, HPA057242" Supported Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" 34000000 "Plasma membrane, Cytosol" "Golgi apparatus, Vesicles" "CAB011235: , HPA057242: " "unprognostic (6.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.05e-1)" "unprognostic (3.13e-2)" "unprognostic (5.81e-2)" "prognostic unfavourable (2.19e-6)" "prognostic unfavourable (4.45e-4)" "unprognostic (6.10e-2)" "unprognostic (2.39e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-3)" "unprognostic (1.20e-1)" "unprognostic (1.50e-2)" "unprognostic (6.97e-2)" "unprognostic (2.79e-1)" "unprognostic (3.72e-3)" "unprognostic (1.94e-1)" 37.5 53.6 33.0 19.7 36.7 5.7 32.0 33.3 41.1 41.3 35.3 42.3 33.7 37.1 48.8 40.2 49.4 35.5 56.2 37.3 28.5 23.5 47.2 24.9 30.5 13.7 45.0 32.0 46.3 40.0 28.9 38.3 32.3 37.2 38.9 32.4 24.4 38.0 38.5 31.5 52.9 39.2 43.1 36.0 21.4 51.3 30.2 38.6 7.7 36.0 44.5 26.7 33.2 38.2 0.1 0.8 4.6 0.2 0.0 0.4 13.9 128.4 28.3 9.6 11.0 16.2 25.3 15.8 27.5 27.5 24.3 19.2 37.4 32.4 5.0 27.3 35.2 28.6 11.4 28.9 17.8 10.1 11.5 0.5 21.1 17.5 35.0 0.1 6.8 35.7 20.4 26.8 15.2 20.3 14.4 0.9 23.9 35.1 0.2 1.8 10.4 17.3 0.0 11.8 4.0 27.1 41.9 7.9 13.5 20.1 27.6 45.7 22.5 0.5 25.3 21.4 13.7 33.2 18.3 2.2 1.4 0.3 42.7 0.1 29.2 1.4 0.2 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.0 4.6 0.0 0.2 0.8 0.0 13.9 33.0 36.7 33.3 41.1 28.5 23.5 45.0 32.0 37.2 38.6 CTTNBP2 "C7orf8, CORTBP2, KIAA1758, Orf4" ENSG00000077063 "Cortactin binding protein 2" Q8WZ74 7 117710651-117874139 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HEL: 26.9;HMC-1: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "non-classical monocyte: 9.6" "Lineage enriched" "Detected in single" 22 "monocytes: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009151, HPA044654" Enhanced Approved "Midbody ring,Cytosol" "Midbody ring, Cytosol" "CAB009151: AB_2088281, HPA044654: " "unprognostic (6.28e-2)" "unprognostic (2.90e-1)" "unprognostic (5.11e-2)" "unprognostic (1.81e-3)" "unprognostic (1.21e-1)" "unprognostic (3.64e-1)" "unprognostic (7.38e-2)" "unprognostic (3.28e-4)" "unprognostic (3.83e-1)" "unprognostic (7.98e-2)" "unprognostic (7.93e-3)" "unprognostic (1.20e-1)" "prognostic favourable (3.71e-5)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.45e-3)" 11.2 3.9 10.7 1.8 17.6 0.7 4.7 8.3 15.5 10.7 3.9 22.1 2.0 3.3 11.4 9.4 14.0 7.2 6.6 2.4 13.5 9.1 11.5 3.8 3.2 1.0 16.2 9.9 5.4 13.1 21.9 5.8 3.4 15.5 6.6 5.0 5.0 5.2 4.0 1.1 2.5 3.3 9.5 14.3 4.2 1.8 2.2 16.8 0.0 9.8 1.7 2.1 4.8 4.9 0.0 0.4 0.0 9.6 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 3.8 0.0 0.0 0.0 1.0 26.9 0.2 0.0 0.1 0.0 35.8 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.1 5.1 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.5 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 10.7 17.6 8.3 15.3 13.5 9.1 16.2 9.9 15.5 16.8 CTTNBP2NL DKFZp547A023 ENSG00000143079 "CTTNBP2 N-terminal like" Q9P2B4 1 112396181-112463456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 10.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007301 Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA007301: AB_1847693" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "prognostic favourable (1.14e-4)" "unprognostic (4.21e-3)" "unprognostic (4.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (1.05e-1)" "prognostic favourable (8.08e-4)" "unprognostic (1.38e-1)" "unprognostic (1.63e-1)" "unprognostic (9.99e-2)" "unprognostic (5.12e-2)" 18.8 5.3 10.0 9.8 13.0 0.5 15.0 10.6 12.4 12.9 15.3 14.4 5.0 7.5 18.3 7.6 20.0 8.8 17.0 8.9 10.1 7.9 10.3 5.5 16.5 5.7 10.8 7.8 10.1 4.7 9.6 9.3 20.1 10.2 9.5 15.2 9.7 10.8 10.0 4.4 20.0 12.3 13.9 18.7 10.1 8.5 5.8 11.0 2.6 8.9 7.2 9.5 13.6 15.6 0.5 10.6 0.1 3.3 0.0 2.3 0.5 9.4 3.5 11.7 5.5 7.9 10.4 3.9 15.0 14.1 9.7 9.7 2.6 4.8 1.5 6.1 11.2 7.8 7.6 10.3 11.4 3.1 3.6 2.0 6.1 2.1 9.2 0.7 3.5 12.3 6.3 12.0 10.6 23.6 1.8 1.4 13.4 2.8 1.2 0.2 7.5 5.5 2.3 10.9 0.0 14.8 7.0 5.7 6.0 11.6 2.4 6.0 1.9 0.8 30.5 9.8 11.5 10.0 7.0 0.1 1.3 0.0 10.2 0.8 25.6 0.0 3.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 10.6 0.5 0.0 0.0 0.1 0.0 0.5 4.6 2.3 0.5 10.0 13.0 10.6 12.4 10.1 7.9 10.8 7.8 10.2 11.0 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 CUEDC1 ENSG00000180891 "CUE domain containing 1" Q9NWM3 17 57861243-57955323 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 17.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023050, HPA024836" Approved Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" Centrosome "HPA023050: AB_1847332, HPA024836: AB_1847333" "unprognostic (4.46e-1)" "unprognostic (3.76e-3)" "unprognostic (4.77e-2)" "unprognostic (4.87e-3)" "unprognostic (4.04e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (2.65e-5)" "unprognostic (6.69e-2)" "unprognostic (1.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "prognostic favourable (8.46e-4)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (2.52e-2)" "unprognostic (2.65e-2)" 9.8 10.6 11.7 8.6 19.3 5.2 9.3 8.5 16.6 22.3 18.5 39.1 11.8 5.0 13.4 13.9 21.2 21.6 12.9 24.2 12.6 12.1 12.0 3.7 13.7 4.4 30.0 8.0 6.4 11.6 7.1 11.5 7.8 18.5 13.0 7.2 19.3 19.1 18.4 48.9 5.5 7.3 19.2 18.7 6.6 12.2 2.9 28.3 2.5 11.2 15.8 4.7 15.4 10.4 0.0 17.6 1.8 1.3 0.1 0.0 0.1 8.2 25.4 26.6 4.7 4.3 8.0 0.9 5.8 11.8 12.2 8.9 4.6 31.6 0.1 23.7 11.2 6.6 2.9 12.5 4.4 16.0 4.9 0.2 16.5 3.8 10.5 0.1 2.0 8.1 7.6 7.1 6.0 5.9 0.3 0.1 11.2 4.6 0.4 0.2 0.9 7.0 0.8 6.9 1.2 8.3 5.4 11.0 6.0 2.4 2.6 10.0 36.8 0.9 7.4 32.7 20.7 8.9 12.9 0.0 0.1 0.1 14.2 1.1 26.1 0.6 0.4 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 1.3 17.6 0.0 0.1 11.7 19.3 8.5 15.4 12.6 12.1 30.0 8.0 18.5 28.3 CUEDC2 "C10orf66, MGC2491" ENSG00000107874 "CUE domain containing 2" Q9H467 10 102423245-102432661 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036544, HPA041829" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036544: AB_10670111, HPA041829: " "unprognostic (2.10e-1)" "unprognostic (2.80e-2)" "unprognostic (7.31e-2)" "unprognostic (4.24e-2)" "unprognostic (9.78e-2)" "unprognostic (3.09e-1)" "prognostic unfavourable (2.75e-4)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (3.48e-3)" "unprognostic (4.34e-1)" "unprognostic (1.67e-1)" "unprognostic (8.38e-2)" "unprognostic (1.58e-2)" 18.8 26.2 29.9 14.9 28.5 13.0 16.2 22.0 49.7 19.8 20.3 19.0 18.5 10.8 19.6 20.8 17.1 25.1 22.7 38.7 25.5 22.3 20.1 18.2 14.9 15.3 27.5 29.5 27.9 23.3 24.4 16.7 14.6 25.4 20.7 12.6 17.5 21.5 22.4 61.6 13.2 11.2 23.6 23.6 15.1 16.3 13.5 18.2 16.5 20.0 25.5 15.8 17.1 14.9 37.4 50.1 35.5 50.5 38.2 36.1 36.0 15.7 18.0 28.2 33.2 23.5 30.3 10.6 13.3 42.9 28.5 21.8 5.6 15.9 26.2 28.3 22.2 15.5 18.3 28.7 14.1 23.4 18.6 16.1 15.3 5.6 39.9 12.4 11.0 35.6 26.7 27.8 27.7 29.4 12.5 26.2 31.9 16.9 28.8 27.6 9.7 11.3 33.4 34.6 13.5 29.0 7.3 14.0 33.5 8.9 8.8 27.1 26.9 19.7 16.8 14.2 13.5 18.1 17.7 32.5 26.3 17.4 25.7 43.3 11.3 34.1 50.5 35.5 32.3 39.7 36.1 34.8 32.1 33.7 50.1 37.4 32.0 30.7 19.2 38.2 24.6 43.3 35.7 36.0 29.9 28.5 22.0 49.7 25.5 22.3 27.5 29.5 25.4 18.2 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli 190000 Nucleoplasm Nucleoli "CAB002676: , HPA064584: " "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 26.0 20.9 21.2 20.4 22.4 22.3 27.5 27.5 26.2 23.9 25.8 19.5 22.5 16.7 30.2 23.7 22.7 21.2 18.7 25.7 21.1 21.8 16.9 35.2 20.5 26.5 21.7 16.7 25.0 17.9 24.9 30.7 32.0 21.0 23.9 18.8 22.7 19.6 25.0 58.9 20.5 21.2 37.7 26.3 21.9 22.4 65.6 23.7 16.9 24.5 24.6 24.5 26.1 28.8 16.8 24.1 13.4 17.1 22.1 20.8 16.1 30.7 23.9 23.5 36.3 18.5 20.8 29.8 25.4 30.0 25.7 24.5 25.4 21.5 42.2 20.4 25.1 20.8 33.5 23.7 30.3 27.5 28.5 24.9 16.9 24.6 21.7 28.2 23.7 17.0 23.3 18.8 19.1 28.0 38.4 32.6 28.0 29.4 24.5 32.3 44.0 22.9 29.8 20.7 40.6 21.1 22.5 33.8 24.8 29.6 35.3 20.0 11.6 22.4 21.5 18.4 6.4 37.2 29.2 30.6 21.2 41.8 37.4 31.5 27.1 13.4 15.2 12.0 16.1 17.1 18.6 16.8 16.7 18.6 24.1 14.4 20.8 16.7 2.1 22.1 14.5 5.5 15.9 16.1 21.2 22.4 27.5 26.2 21.1 21.8 21.7 16.7 21.0 23.7 CUL5 VACM-1 ENSG00000166266 "Cullin 5" Q93034 11 108008733-108107776 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002185, CAB017787" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "CAB017787: , HPA002185: AB_1078587" "unprognostic (5.66e-2)" "unprognostic (6.58e-2)" "unprognostic (7.16e-3)" "unprognostic (1.30e-1)" "unprognostic (5.54e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" "unprognostic (2.80e-1)" "unprognostic (5.97e-3)" "unprognostic (1.78e-1)" "unprognostic (9.17e-2)" "unprognostic (1.77e-2)" "prognostic favourable (1.06e-5)" "unprognostic (3.83e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 11.6 13.2 10.8 9.0 14.8 25.0 13.4 17.1 19.3 13.1 10.8 12.7 11.0 9.0 13.6 10.7 11.2 10.9 8.7 14.8 11.3 10.6 16.7 15.3 9.7 10.2 12.5 12.3 13.2 11.2 17.8 14.6 12.6 19.5 12.9 9.5 11.2 11.4 10.9 41.6 11.5 11.2 11.8 13.1 12.5 10.3 6.5 12.7 23.1 14.6 15.1 10.0 10.8 13.6 6.4 5.9 4.1 6.7 4.0 6.2 3.6 9.7 4.6 13.8 10.6 9.1 14.6 6.9 10.3 11.4 9.5 10.7 14.6 11.5 13.7 19.3 12.9 12.5 12.8 8.6 13.9 8.8 7.8 12.9 4.4 10.8 15.6 14.5 10.5 11.5 11.8 9.9 13.2 13.0 16.5 5.1 14.9 5.4 13.9 12.6 7.2 8.1 10.1 10.3 14.9 12.0 14.8 10.0 14.2 14.0 14.9 8.4 21.7 12.0 13.5 17.6 8.2 12.4 11.0 5.2 4.0 17.9 6.9 16.6 11.1 1.9 6.7 4.1 5.4 5.2 4.9 4.4 5.6 5.3 5.9 6.4 6.1 6.2 1.2 4.0 6.0 5.9 4.0 3.6 10.8 14.8 17.1 19.3 11.3 10.6 12.5 12.3 19.5 12.7 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" 35000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: " "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favourable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 26.6 65.6 47.9 28.3 60.1 33.5 47.6 37.7 73.7 47.7 37.9 36.8 53.9 42.1 40.1 78.5 30.5 46.0 48.8 49.6 45.2 44.9 46.3 61.6 39.0 77.4 46.5 37.8 57.7 66.6 43.8 86.1 45.7 39.8 38.8 28.9 34.2 74.3 69.7 34.6 32.7 37.2 32.4 47.0 36.0 38.7 27.3 31.6 52.2 69.7 30.3 31.3 42.6 28.9 56.5 31.4 27.1 32.0 49.9 69.8 60.8 43.2 25.9 41.5 52.6 31.3 30.8 20.1 39.6 74.0 76.5 81.6 25.8 27.0 30.6 30.7 45.3 26.5 27.0 40.3 43.2 25.9 59.7 31.9 43.0 67.6 40.7 24.8 24.3 40.8 34.0 36.7 31.1 20.5 39.1 62.2 55.9 33.6 37.5 52.8 37.2 34.3 41.2 24.8 80.8 52.6 18.8 81.3 41.4 23.7 41.2 71.8 30.3 52.1 22.6 41.4 35.2 29.4 41.2 61.2 60.8 33.4 35.8 54.9 33.6 27.1 32.0 16.5 45.7 22.9 63.2 56.5 67.6 52.7 31.4 44.2 68.5 53.2 4.6 49.9 16.8 27.1 69.8 60.8 47.9 60.1 37.7 73.7 45.2 44.9 46.5 37.8 39.8 31.6 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038619 Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649" "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.3 20.2 7.1 21.6 26.4 12.1 3.9 7.7 9.9 7.8 8.8 9.3 7.2 34.2 6.9 13.1 8.1 14.5 12.8 8.7 10.1 13.8 11.3 9.1 14.6 12.2 21.0 5.6 12.5 8.0 12.4 25.8 13.3 10.0 7.6 5.8 6.5 18.8 21.7 7.1 7.6 12.8 8.3 13.1 8.1 3.9 2.3 5.3 3.5 5.6 9.7 9.0 12.0 7.4 3.2 4.4 3.5 10.1 12.5 16.2 24.0 10.6 45.1 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "Q13948, P39880" 7 101815904-102283958 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: " "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavourable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favourable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 19.3 12.7 22.9 19.2 24.4 19.5 12.3 48.6 29.9 31.6 26.4 23.1 17.3 22.2 52.1 17.4 23.9 24.5 23.2 53.8 18.8 18.3 27.4 16.0 22.0 11.8 20.4 11.7 33.0 41.4 34.4 30.2 24.4 16.9 22.8 17.2 26.8 26.3 16.9 31.0 15.9 25.3 27.5 31.6 15.0 23.4 8.3 17.1 44.0 33.5 23.2 24.1 31.8 21.9 2.0 12.1 4.7 21.0 3.0 2.2 4.5 14.3 15.4 10.9 13.4 8.8 18.3 6.8 14.4 15.3 6.1 4.0 9.1 9.2 18.5 23.2 14.2 11.8 6.9 11.6 3.7 8.9 7.7 6.5 11.4 7.6 23.5 8.4 3.6 12.7 23.7 4.7 10.7 7.9 15.1 15.8 5.7 29.5 27.3 10.3 4.4 16.1 18.1 9.0 22.0 10.1 16.4 10.0 29.8 12.6 31.6 12.3 6.2 10.1 11.7 25.9 17.5 19.5 8.2 10.3 4.9 40.1 23.9 7.8 18.0 2.1 8.6 1.5 2.1 8.8 2.2 2.0 1.6 2.2 7.0 1.7 1.6 2.2 4.7 3.0 21.0 12.1 1.5 4.5 22.9 24.4 48.6 29.9 18.8 18.3 20.4 11.7 16.9 17.1 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.1;LHCN-M2: 7.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: " "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.6 1.7 0.0 0.4 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.6 0.9 0.7 1.0 1.7 0.0 1.5 2.6 2.2 2.2 3.5 4.6 0.8 0.3 0.0 3.7 1.1 0.3 1.5 7.1 1.7 1.3 1.5 7.9 0.4 1.9 2.7 1.7 1.3 0.0 4.0 0.6 1.3 1.3 1.8 0.7 0.8 0.4 1.1 1.3 1.9 3.5 0.0 2.4 0.9 0.0 1.9 1.4 3.1 1.2 5.8 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CWC15 "AD002, C11orf5, Cwf15, HSPC148" ENSG00000150316 "CWC15 spliceosome associated protein homolog" Q9P013 11 94962622-94973612 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039878 Supported Approved "Nuclear speckles,Mitochondria" "Nuclear speckles, Mitochondria" "HPA039878: " "unprognostic (1.97e-1)" "unprognostic (5.51e-2)" "unprognostic (1.66e-2)" "unprognostic (8.64e-2)" "unprognostic (3.81e-1)" "unprognostic (6.85e-2)" "unprognostic (1.29e-1)" "unprognostic (1.52e-1)" "unprognostic (4.84e-3)" "prognostic favourable (9.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (1.44e-1)" "unprognostic (1.34e-1)" "prognostic favourable (7.17e-4)" "unprognostic (5.23e-2)" 9.5 9.6 9.9 7.9 12.0 10.6 13.5 12.4 11.9 10.1 9.2 7.2 7.7 5.8 8.6 14.9 10.0 9.2 5.5 14.1 9.8 9.6 14.0 15.6 8.8 8.7 10.3 10.1 11.8 8.6 7.5 12.1 11.1 12.6 9.5 8.1 6.4 10.2 9.1 24.4 9.0 10.1 7.3 11.7 10.7 9.5 17.2 12.4 11.2 11.2 14.7 9.6 9.8 10.6 31.8 31.3 36.8 33.0 26.1 35.8 25.7 10.7 8.7 26.0 12.4 24.7 22.6 13.6 16.1 22.7 27.1 22.4 38.8 24.5 16.6 32.8 22.8 11.3 15.7 20.4 29.1 21.0 13.8 20.8 10.4 17.5 21.2 26.0 13.0 22.4 23.4 18.1 24.2 26.3 24.5 14.4 24.3 14.2 25.0 35.2 12.5 21.9 17.0 15.8 17.5 26.9 12.9 14.8 11.5 17.8 17.5 13.9 28.3 21.0 14.4 17.8 14.2 24.7 16.0 6.9 17.4 22.9 10.0 30.1 17.3 36.8 25.1 34.5 26.8 27.3 35.8 31.8 34.6 32.8 31.3 27.6 34.4 34.7 29.5 26.1 33.0 29.7 35.4 25.7 9.9 12.0 12.4 11.9 9.8 9.6 10.3 10.1 12.6 12.4 CWC22 "EIF4GL, fSAPb, KIAA1604, NCM" ENSG00000163510 "CWC22 spliceosome associated protein homolog" Q9HCG8 2 179944876-180007113 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036748 Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA036748: AB_10669913" "unprognostic (1.90e-1)" "unprognostic (7.10e-2)" "unprognostic (7.30e-2)" "unprognostic (6.14e-2)" "unprognostic (4.96e-2)" "unprognostic (4.33e-2)" "prognostic unfavourable (7.42e-4)" "unprognostic (3.15e-1)" "unprognostic (1.31e-2)" "unprognostic (3.30e-2)" "unprognostic (3.84e-2)" "unprognostic (4.80e-2)" "prognostic unfavourable (7.76e-5)" "unprognostic (1.74e-1)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-3)" 20.4 14.2 15.8 17.3 16.8 18.1 19.2 33.5 24.6 21.1 17.0 10.5 13.5 12.4 21.5 14.3 18.4 17.6 15.5 14.8 17.5 11.9 17.2 20.7 14.7 21.3 14.4 19.6 25.4 14.7 21.8 25.0 17.8 17.0 20.4 15.2 9.1 15.4 14.7 20.2 15.9 17.4 23.6 19.0 20.5 15.4 10.9 16.3 26.5 20.7 17.6 21.7 21.8 23.8 12.4 9.9 26.4 11.9 10.9 16.4 8.2 9.4 5.9 16.5 11.0 11.9 14.3 12.6 12.6 14.8 15.5 15.1 13.3 12.0 18.7 11.3 9.1 10.4 15.6 11.7 23.5 16.4 13.8 25.0 7.7 18.0 11.8 34.7 13.9 9.3 14.2 19.5 26.4 11.5 27.1 11.5 10.1 9.5 18.1 18.1 25.3 9.5 16.7 20.4 14.0 10.7 12.0 11.3 15.3 10.3 8.3 14.3 6.2 22.0 9.8 13.2 11.3 8.7 13.0 10.1 10.6 22.8 11.9 14.1 13.3 26.4 9.5 21.5 12.3 11.9 12.4 12.4 13.3 14.5 9.9 11.3 16.4 12.8 15.9 10.9 8.9 6.3 11.3 8.2 15.8 16.8 33.5 24.6 17.5 11.9 14.4 19.6 17.0 16.3 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like 1, cell cycle control (S. pombe)" Q69YN2 10 100232298-100267680 "Disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 13.8 9.8 8.6 13.6 12.5 20.5 15.8 18.3 18.6 11.8 9.9 15.4 6.1 7.9 13.8 9.0 11.0 12.9 8.7 10.6 9.0 10.3 11.2 14.8 11.6 19.1 11.5 8.6 14.3 14.1 12.4 12.4 12.2 12.4 10.5 11.5 12.3 11.0 10.6 14.1 14.7 11.8 14.4 11.2 19.1 10.1 19.7 10.8 22.3 13.8 11.2 22.6 12.5 10.1 12.2 12.2 18.6 13.9 13.9 15.4 11.1 14.2 10.8 9.7 14.1 4.8 6.5 10.1 9.4 14.0 22.2 19.0 10.7 11.1 16.6 9.8 8.4 13.2 22.5 12.9 23.6 11.5 9.1 9.4 9.6 8.7 8.0 23.3 9.0 8.1 5.4 16.1 15.2 14.6 10.9 13.7 11.8 8.4 18.1 7.7 6.9 9.6 6.2 18.4 9.7 6.8 7.9 4.4 8.4 12.3 4.8 12.2 19.2 6.4 11.7 7.8 10.3 8.7 15.6 11.3 15.1 10.0 10.3 18.3 5.0 9.8 13.9 18.6 12.1 13.2 15.4 12.2 12.7 13.0 12.2 12.0 14.1 13.8 7.2 13.9 11.7 4.8 15.2 11.1 8.6 12.5 18.3 18.6 9.0 10.3 11.5 8.6 12.4 10.8 CWF19L2 FLJ32343 ENSG00000152404 "CWF19 like 2, cell cycle control (S. pombe)" Q2TBE0 11 107326345-107457844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038166 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA038166: AB_10669518" "unprognostic (1.38e-1)" "unprognostic (9.41e-2)" "unprognostic (1.37e-1)" "unprognostic (7.35e-2)" "unprognostic (7.17e-2)" "unprognostic (6.42e-2)" "unprognostic (8.78e-2)" "unprognostic (1.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (4.48e-2)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (1.76e-2)" 16.5 9.9 19.0 18.2 24.4 11.5 18.4 43.7 25.1 23.0 13.6 5.6 14.9 8.0 17.7 13.9 11.5 13.2 9.8 11.3 16.2 10.7 18.2 13.3 11.4 14.8 16.3 16.9 23.8 9.6 17.7 27.9 13.2 17.9 16.6 10.3 5.1 11.4 14.6 29.1 13.0 11.3 14.9 23.5 18.0 11.1 9.0 21.7 15.8 15.8 9.2 16.8 21.0 47.4 19.4 12.5 22.2 6.8 11.2 13.9 2.8 6.1 5.0 10.9 5.2 9.0 10.2 8.1 8.0 7.6 6.4 8.5 11.6 14.5 10.7 15.5 5.6 15.0 12.0 6.2 11.1 11.9 6.7 11.9 5.7 7.6 5.9 13.9 10.0 5.2 10.9 7.3 11.1 8.6 17.9 6.2 9.2 4.5 10.7 12.7 10.2 7.2 9.4 10.3 14.3 7.5 7.6 6.3 5.2 11.8 8.8 4.5 11.9 6.7 7.7 10.6 8.5 5.5 7.2 3.3 6.1 10.5 3.1 13.7 9.7 22.2 6.8 11.8 9.8 6.0 10.8 17.6 11.4 9.7 2.9 19.4 13.9 10.6 13.0 11.2 6.3 12.5 9.7 2.8 19.0 24.4 43.7 25.1 16.2 10.7 16.3 16.9 17.9 21.7 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell line enhanced" "Detected in many" "CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favourable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.5 3.1 15.2 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.9 31.7 4.9 2.0 6.8 0.0 9.6 7.6 2.0 0.3 3.1 6.5 0.0 9.1 20.5 0.9 0.6 0.0 0.0 8.3 0.4 0.1 3.0 0.1 0.1 0.0 0.3 1.2 0.0 36.7 0.0 0.0 5.1 3.9 12.7 35.4 6.1 4.1 3.6 4.1 2.1 8.4 0.1 0.1 0.0 9.1 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733526-4739922 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 34.3;CACO-2: 23.6;CAPAN-2: 18.7;HaCaT: 38.5;T-47d: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7" "Group enriched" "Detected in many" 7 "dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 1103333 4000000 "Golgi apparatus" Vesicles "HPA053253: , HPA066315: " "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 32.5 9.5 8.2 18.7 9.7 16.3 9.7 2.0 6.6 8.0 17.2 15.8 3.4 19.1 4.8 10.5 13.1 9.5 23.0 5.2 9.9 6.9 12.5 34.8 41.9 28.8 13.3 5.1 10.6 11.0 34.6 8.6 9.7 10.0 9.8 8.3 12.7 26.6 5.9 3.3 11.3 29.5 5.2 16.5 34.1 18.7 51.9 10.0 4.5 8.1 8.5 10.1 9.7 7.4 3.4 10.7 25.9 37.7 0.0 0.3 6.9 34.3 4.7 0.0 11.1 0.1 0.9 4.4 0.4 3.3 3.3 4.5 23.6 18.7 0.0 4.2 0.2 38.5 5.5 4.0 1.1 3.5 6.3 0.0 0.5 10.4 2.3 0.0 5.1 0.2 6.6 1.7 0.2 0.9 0.0 0.2 0.2 7.2 0.1 0.6 0.0 2.9 0.4 0.0 5.1 7.0 5.7 0.0 0.3 7.0 2.8 1.8 18.5 0.4 0.1 0.5 2.5 0.8 2.0 1.2 1.5 0.0 0.1 0.1 0.8 0.0 18.3 4.0 0.1 29.3 0.1 2.9 0.3 0.2 10.7 3.4 0.1 0.3 25.9 0.0 37.7 4.6 0.0 6.9 8.2 9.7 2.0 6.6 9.9 6.9 13.3 5.1 10.0 10.0 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 14.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.2 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell line enriched" "Detected in some" 7 "THP-1: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 7.4 0.0 0.0 7.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 0.0 5.4 0.5 2.6 0.0 8.3 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 CXorf56 FLJ22965 ENSG00000018610 "Chromosome X open reading frame 56" Q9H5V9 X 119538149-119565408 "Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038245, HPA038617, HPA064831" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: " "prognostic unfavourable (3.45e-4)" "unprognostic (3.88e-3)" "unprognostic (7.82e-2)" "unprognostic (1.03e-3)" "unprognostic (8.92e-2)" "unprognostic (7.74e-3)" "unprognostic (6.38e-3)" "unprognostic (3.89e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-2)" "unprognostic (9.63e-3)" "unprognostic (1.68e-3)" "unprognostic (9.26e-3)" "unprognostic (4.68e-3)" "unprognostic (1.45e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-1)" 15.9 14.5 18.7 12.7 29.1 19.1 21.1 21.0 24.2 15.0 15.6 18.3 15.1 12.3 17.6 14.5 13.6 17.6 12.4 16.3 16.0 20.5 18.2 14.3 14.6 15.7 18.0 21.3 24.0 16.3 20.5 12.6 29.0 20.2 15.3 15.0 18.6 14.6 16.1 16.4 17.4 12.5 16.2 17.8 15.0 13.0 12.7 17.6 12.8 20.2 13.2 19.0 14.4 13.1 19.4 12.0 16.8 15.4 7.7 12.9 10.9 17.0 20.0 12.1 13.8 13.8 10.1 15.5 11.8 12.1 18.5 16.7 17.3 17.3 27.0 29.6 13.7 11.4 30.5 15.6 26.0 16.2 23.0 9.6 18.2 11.6 11.0 26.6 15.5 11.1 13.5 22.6 19.4 12.9 21.6 17.3 9.0 29.9 16.7 14.0 18.1 20.8 16.3 12.5 20.3 11.1 13.4 8.3 14.6 22.8 12.7 15.8 10.5 11.6 12.4 11.2 7.8 20.6 24.8 15.0 26.5 27.5 10.1 26.1 14.2 5.7 12.8 16.8 12.4 15.4 11.4 13.5 10.8 12.9 12.0 19.4 11.1 10.5 6.5 7.7 14.1 11.3 12.4 10.9 18.7 29.1 21.0 24.2 16.0 20.5 18.0 21.3 20.2 17.6 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468312-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.4;pituitary gland: 17.2" "Cell line enhanced" "Detected in some" "AF22: 7.1;AN3-CA: 9.8;Karpas-707: 9.1;RPMI-8226: 5.3;SCLC-21H: 12.3;U-266/70: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 2.2 4.3 10.3 0.9 12.0 0.6 4.3 17.5 19.4 2.4 2.5 7.4 0.8 5.4 1.9 5.3 1.0 6.7 1.5 5.3 9.9 14.4 1.7 2.7 2.3 0.7 7.9 9.9 5.6 5.8 3.2 17.2 1.4 10.2 2.1 2.9 7.9 7.5 2.1 1.3 0.8 5.5 1.8 5.3 1.4 4.3 4.9 13.3 0.0 7.1 0.1 0.7 1.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 7.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.5 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 2.6 0.0 2.5 0.1 0.0 0.0 5.3 0.0 0.1 12.3 2.2 0.0 0.6 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 10.0 2.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.0 17.5 19.4 9.9 14.4 7.9 9.9 10.2 13.3 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell line enhanced" "Detected in many" "SK-BR-3: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: " "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favourable (2.40e-4)" "prognostic unfavourable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.3 7.9 8.8 3.3 12.3 16.9 3.4 6.1 9.4 2.6 5.3 17.4 9.6 12.4 27.4 16.4 10.8 1.8 4.7 1.3 1.3 3.0 18.5 7.0 12.2 5.3 4.0 0.6 6.0 1.0 4.5 1.3 0.7 17.2 2.0 19.3 24.5 4.4 13.1 10.6 2.2 8.0 17.9 18.9 20.2 6.8 28.0 28.8 2.2 56.6 4.6 30.9 19.3 3.8 22.0 4.3 10.4 5.5 7.4 15.5 23.4 33.1 1.4 12.1 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol "Nucleoli, Vesicles" "Nucleoplasm, Cytosol" "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.0 30.5 4.9 14.1 23.2 15.4 4.1 9.1 13.9 11.0 11.0 8.3 20.2 35.2 16.4 16.0 25.3 4.6 25.4 6.7 23.5 10.4 6.0 20.6 5.6 10.9 8.3 15.8 21.6 35.9 23.9 11.0 16.3 19.8 21.1 18.5 19.4 15.7 3.6 9.1 17.5 19.0 4.7 26.3 12.7 17.9 6.0 10.0 18.6 26.9 21.0 21.8 9.7 10.9 13.0 6.7 12.6 13.1 13.2 17.4 19.7 17.8 14.6 16.3 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell line enhanced" "Detected in many" "ASC diff: 151.3;RT4: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: , HPA058547: " "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favourable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favourable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 9.8 16.8 8.8 0.0 151.3 26.9 11.7 6.8 14.7 14.5 21.8 19.8 10.7 12.0 4.8 12.4 22.0 0.0 9.3 11.6 22.4 11.7 4.4 9.2 52.5 23.5 8.4 5.8 45.0 7.4 8.2 4.2 7.9 7.1 4.5 12.1 17.7 4.7 10.0 3.9 10.9 11.7 2.8 0.2 14.4 66.0 25.1 10.4 6.6 18.0 8.0 35.6 8.0 7.4 0.0 11.4 3.5 8.6 3.2 13.0 3.7 8.9 2.3 8.4 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424525-69466266 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" 1600000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favourable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 21.3 130.7 29.6 15.4 33.1 5.9 17.1 12.0 37.9 16.6 29.0 22.8 12.6 21.9 20.5 24.6 21.4 19.2 14.7 18.0 23.1 22.0 26.9 26.5 18.3 20.1 21.6 24.4 19.9 12.8 26.3 16.2 24.6 34.3 17.1 38.2 20.2 14.8 16.7 19.9 16.0 31.2 19.9 20.8 20.7 15.4 14.0 16.0 26.0 19.9 17.6 23.5 24.3 16.0 24.8 44.2 35.8 28.3 32.3 46.0 32.4 29.0 92.5 38.1 23.5 17.6 23.6 16.3 26.0 36.3 43.7 41.3 64.5 35.7 26.5 26.3 25.2 34.6 36.3 37.7 49.7 14.1 13.8 12.8 16.7 75.1 26.0 26.2 28.4 20.2 19.1 51.8 24.8 41.2 20.6 12.8 26.7 37.8 43.0 32.0 28.2 12.7 40.8 21.1 29.1 58.3 33.3 22.3 11.4 69.4 13.3 22.0 25.8 21.1 18.5 25.2 20.8 16.7 22.9 15.6 34.4 81.3 26.0 21.9 29.1 35.8 20.3 24.3 39.3 28.3 32.2 24.8 29.6 30.8 24.8 22.6 24.6 29.2 6.1 32.3 20.1 44.2 46.0 32.4 29.6 33.1 12.0 37.9 23.1 22.0 21.6 24.4 34.3 16.0 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 14.0 13.0 13.2 5.5 22.5 7.2 13.1 14.1 16.8 10.5 7.9 14.0 12.8 6.5 10.9 17.0 7.9 28.2 9.4 13.9 14.4 12.0 19.2 13.0 8.8 4.7 9.4 13.5 14.6 13.1 9.7 18.1 7.0 16.5 11.0 7.8 11.7 10.5 13.2 9.9 10.1 6.0 9.4 6.5 5.9 8.4 14.5 11.7 6.9 22.8 8.6 5.6 7.4 7.5 3.4 3.1 2.7 2.3 1.6 5.9 1.8 16.1 12.0 5.8 15.4 10.4 9.3 3.5 8.3 8.3 9.0 8.6 7.6 3.1 7.0 5.9 6.7 14.5 12.8 10.9 13.5 4.6 14.7 4.6 15.7 10.8 4.7 8.1 3.3 7.8 13.8 15.6 14.2 9.5 3.3 4.8 4.9 7.0 12.6 3.3 7.3 12.5 8.7 2.7 7.0 14.1 3.1 7.9 5.3 13.2 7.4 7.6 8.7 3.3 6.6 7.0 6.1 12.2 10.5 2.5 6.1 3.9 14.6 4.5 4.4 0.5 2.3 0.1 2.7 1.9 3.3 3.4 2.4 1.4 3.1 1.5 5.9 3.1 2.7 1.6 1.1 1.4 2.2 1.8 13.2 22.5 14.1 16.8 14.4 12.0 9.4 13.5 16.5 11.7 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042299 Approved Approved "Nuclear membrane,Nucleoli,Centrosome" "Secreted - unknown location" "Nuclear membrane" "Nucleoli, Centrosome" "HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favourable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favourable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favourable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favourable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.8 10.5 6.1 6.4 39.3 11.6 2.5 7.6 16.4 5.5 5.7 3.1 5.2 2.5 6.9 8.8 11.1 2.5 3.5 2.2 8.3 12.6 2.4 6.6 5.2 7.1 1.0 4.8 15.1 8.4 3.0 6.0 10.0 2.5 15.5 4.2 9.6 3.6 1.6 2.2 5.7 4.4 5.4 6.2 12.8 4.1 4.9 4.1 8.5 5.0 11.2 13.2 1.5 13.5 8.1 2.1 7.5 3.9 3.0 2.2 1.9 10.0 2.2 3.1 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Uncertain Nucleoli,Mitochondria,Cytosol 860000 "Nucleoli, Mitochondria, Cytosol" "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favourable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.3 5.2 4.6 9.4 42.9 9.9 45.1 16.8 15.8 10.9 9.8 4.3 9.9 5.2 14.3 16.7 46.3 3.7 14.4 7.2 7.5 9.5 2.9 6.3 4.9 15.5 2.5 7.4 15.8 47.6 12.0 6.6 7.2 8.8 9.4 39.4 9.8 3.2 2.2 3.0 10.0 5.3 22.2 11.1 10.3 10.0 3.9 4.8 9.4 31.4 13.6 14.5 5.7 7.0 12.5 5.3 4.7 9.3 8.8 10.4 2.4 13.8 3.9 9.3 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 41.6;BJ hTERT+ SV40 Large T+: 22.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 17.8;NTERA-2: 23.4;WM-115: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: " "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.2 1.1 0.5 0.0 0.1 0.6 7.7 14.5 41.6 22.3 20.2 0.2 3.1 0.0 3.5 7.4 0.2 0.0 0.1 17.8 0.0 0.0 0.0 1.2 0.3 12.1 0.1 2.2 6.1 0.4 0.0 1.2 1.8 2.2 0.0 0.1 0.0 0.0 0.0 23.4 1.1 11.0 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.3 0.6 1.6 3.0 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.4 0.1 0.0 32.0 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 CYBRD1 "CYB561A2, DCYTB, FLJ23462, FRRS3" ENSG00000071967 "Cytochrome b reductase 1" Q53TN4 2 171522247-171558133 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 141.9;ASC TERT1: 61.7;BJ hTERT+: 53.4;HSkMC: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 4 "dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014757, HPA056736" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA014757: AB_1847374, HPA056736: " "unprognostic (1.35e-1)" "unprognostic (1.57e-1)" "unprognostic (2.89e-2)" "unprognostic (4.87e-2)" "unprognostic (2.97e-2)" "unprognostic (3.11e-2)" "unprognostic (2.86e-1)" "unprognostic (5.44e-3)" "unprognostic (8.90e-3)" "unprognostic (3.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (1.02e-3)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-2)" 75.2 26.0 10.1 9.3 13.2 4.0 78.9 6.1 8.0 44.5 56.3 14.7 16.3 49.5 44.3 28.5 29.6 26.1 38.8 43.1 12.1 5.5 8.6 6.2 35.6 10.6 11.0 11.2 49.5 5.4 2.0 9.5 9.5 11.4 41.7 10.2 32.0 21.5 21.1 17.5 26.7 111.3 41.1 12.8 7.3 18.1 20.1 11.7 2.1 103.8 23.9 10.0 43.8 56.0 0.0 11.7 6.7 12.4 2.5 1.2 4.4 3.1 2.3 1.3 2.5 141.9 61.7 0.1 11.6 53.4 6.1 7.7 0.1 4.4 0.0 2.0 27.2 1.6 1.1 0.9 7.2 2.4 0.3 2.6 3.6 0.0 29.8 2.8 0.2 43.7 9.0 9.4 1.8 3.8 0.8 0.0 16.6 0.0 0.9 2.5 0.6 0.6 0.3 16.8 0.1 0.9 0.1 0.1 0.6 13.5 0.0 7.2 4.7 1.7 7.6 13.7 1.9 12.7 4.9 0.0 0.0 0.0 6.5 2.3 7.3 0.0 12.0 0.5 1.2 12.4 0.2 0.0 0.2 0.1 11.7 0.0 0.0 0.0 6.7 2.5 9.4 0.5 0.0 4.4 10.1 13.2 6.1 8.0 12.1 5.5 11.0 11.2 11.4 11.7 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell line enhanced" "Detected in all" "PC-3: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favourable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.4 13.4 28.0 11.1 12.3 25.8 12.8 15.6 32.7 21.5 35.2 27.8 31.5 28.9 17.1 33.0 29.2 25.4 12.3 19.3 38.7 33.8 42.5 32.2 19.9 19.9 22.1 17.9 31.8 20.8 41.3 18.9 30.7 28.2 17.0 79.8 37.3 18.5 15.5 151.2 33.0 17.9 55.2 26.8 35.8 36.0 15.9 35.7 49.4 26.2 40.6 30.6 14.4 20.8 44.4 23.0 38.9 31.3 22.7 23.4 26.5 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;brain: 44.2;kidney: 69.7" "Cell line enhanced" "Detected in many" "Daudi: 52.2;MOLT-4: 49.5;U-266/70: 38.6;U-698: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: , HPA071459: " "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavourable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favourable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favourable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 1.9 6.6 28.6 13.4 31.7 22.8 1.7 39.1 44.2 1.8 4.3 7.7 1.6 3.1 3.5 12.3 2.1 4.9 4.7 5.1 28.7 20.4 69.7 8.2 5.9 25.9 16.2 27.2 2.7 3.6 30.6 13.2 4.4 15.8 3.2 5.0 4.7 2.2 3.5 3.1 1.8 6.4 2.9 7.9 15.8 9.5 2.6 8.9 28.5 5.4 0.0 25.7 6.0 1.7 13.7 15.6 30.1 42.8 17.4 32.1 22.9 0.0 8.1 12.5 7.1 0.2 0.3 20.1 1.4 2.5 0.6 1.8 1.5 0.1 52.2 3.6 0.8 0.1 9.9 6.7 1.5 11.8 15.6 6.6 10.6 6.1 1.0 7.0 18.4 1.4 2.7 2.0 0.1 2.2 0.1 21.0 1.7 1.9 49.5 1.3 5.5 2.1 12.2 0.3 24.9 6.6 7.4 18.2 7.2 0.1 7.1 1.1 4.9 0.2 2.9 0.4 5.4 1.7 1.3 38.6 9.6 36.7 5.5 8.3 3.0 17.4 4.3 30.1 32.1 20.0 22.9 13.7 23.3 27.7 6.2 13.4 24.7 28.1 14.4 17.4 42.8 15.6 18.4 22.9 28.6 31.7 39.1 38.3 28.7 20.4 16.2 27.2 15.8 8.9 CYGB "HGB, STAP" ENSG00000161544 Cytoglobin Q8WWM9 17 76527356-76551175 "Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 24.4;Hep G2: 18.6;HHSteC: 37.2;HSkMC: 30.3;SH-SY5Y: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017757, HPA061642" Approved Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA017757: AB_1847410, HPA061642: " "unprognostic (6.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.97e-2)" "prognostic favourable (2.55e-5)" "prognostic unfavourable (1.85e-4)" "unprognostic (3.36e-2)" "unprognostic (3.31e-3)" "unprognostic (2.01e-1)" "unprognostic (7.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.08e-2)" "unprognostic (4.14e-2)" "prognostic unfavourable (2.13e-4)" "unprognostic (3.34e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (7.76e-2)" 48.1 16.1 6.2 9.5 8.3 1.1 34.4 10.9 11.6 13.3 19.0 1.5 8.4 15.2 8.8 8.4 12.5 8.8 24.1 43.4 4.2 11.2 6.9 13.6 17.8 9.5 6.3 5.5 11.2 7.6 8.5 5.0 10.0 17.7 22.8 7.0 23.7 10.4 9.4 17.1 8.2 17.8 17.6 3.5 8.0 13.1 9.3 2.2 1.1 22.0 11.4 3.4 35.1 41.5 4.4 0.4 2.4 0.3 2.5 1.3 0.5 0.0 0.3 0.6 0.1 24.4 7.2 8.2 0.2 0.6 0.1 0.2 0.0 0.1 0.0 7.9 0.7 0.2 0.0 10.5 0.0 0.0 0.0 0.1 0.1 18.6 37.2 0.0 0.0 30.3 2.3 0.8 0.8 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.2 40.6 0.0 0.0 0.8 0.0 0.2 0.0 1.0 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.1 3.1 0.0 0.3 0.4 0.5 0.2 0.3 3.4 0.4 0.2 0.4 4.4 0.7 1.3 2.4 2.5 0.2 0.0 0.5 0.5 6.2 8.3 10.9 11.6 4.2 11.2 6.3 5.5 17.7 2.2 CYLD "CYLD1, KIAA0849, USPL2" ENSG00000083799 "CYLD lysine 63 deubiquitinase" Q9NQC7 16 50742050-50801935 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011713, HPA050095" Approved Supported "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "CAB011713: AB_731794, HPA050095: " "unprognostic (9.83e-2)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" "unprognostic (2.83e-2)" "unprognostic (3.84e-1)" "unprognostic (5.06e-2)" "unprognostic (3.87e-2)" "unprognostic (3.24e-2)" "unprognostic (9.46e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (3.43e-2)" "unprognostic (6.83e-2)" "unprognostic (8.42e-2)" 9.3 16.2 13.9 22.9 26.4 51.1 9.1 14.2 20.9 9.2 10.3 18.8 12.8 10.2 16.1 8.1 15.3 8.5 13.3 12.7 15.7 17.0 9.4 13.2 15.6 30.7 16.3 14.3 11.5 12.2 20.3 27.8 9.8 20.0 11.0 12.7 13.3 12.6 10.9 31.7 12.4 14.2 12.5 16.3 23.4 12.4 22.6 13.7 16.9 16.2 8.0 29.3 14.1 12.6 9.2 10.2 31.4 9.8 13.6 19.1 10.2 9.1 2.9 3.3 3.7 5.3 7.7 3.0 13.6 19.9 14.2 8.4 2.4 4.3 10.6 4.9 13.2 3.6 3.9 8.2 21.1 46.4 6.0 5.3 5.1 1.9 10.6 5.2 24.9 8.4 6.7 17.1 17.9 5.7 2.2 9.2 19.8 1.3 5.1 7.6 3.5 4.8 4.6 6.8 10.1 4.6 3.2 4.3 3.3 11.5 3.9 3.3 3.9 6.6 6.4 24.3 5.5 8.5 5.5 24.3 23.1 11.8 17.8 5.9 5.1 31.4 8.6 20.8 10.7 9.8 12.9 9.2 15.8 14.4 10.2 6.2 14.7 11.4 19.4 13.6 9.5 6.2 19.1 10.2 13.9 26.4 14.2 20.9 15.7 17.0 16.3 14.3 20.0 13.7 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238940-203305611 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: , HPA058461: " "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 11.1 14.9 5.0 9.1 6.4 2.8 7.6 6.8 6.1 9.3 8.6 8.6 9.2 6.0 10.8 7.1 8.0 8.0 9.1 7.0 4.5 4.8 13.5 12.5 8.4 7.8 8.1 2.1 13.4 17.3 9.1 13.6 9.4 6.5 9.0 7.8 10.9 9.8 8.8 5.3 6.3 10.5 9.0 6.5 10.1 8.8 10.8 8.1 13.8 16.9 4.3 9.1 7.7 9.7 13.0 13.6 6.8 11.3 8.8 15.5 9.1 5.2 4.8 2.5 4.8 14.4 3.0 5.1 8.8 4.5 3.7 3.9 13.9 7.5 3.8 7.2 5.5 5.7 3.2 4.0 5.2 5.0 3.7 8.1 3.1 6.4 11.2 8.8 5.1 6.8 3.1 6.0 6.3 7.4 12.5 12.9 6.8 7.0 7.4 4.7 9.5 10.7 5.0 5.6 7.3 4.4 10.3 3.7 5.0 0.3 4.6 7.2 2.8 4.8 8.4 12.2 4.7 6.0 5.5 8.8 9.5 4.6 7.5 3.5 5.6 5.2 10.4 6.8 14.4 11.3 15.5 11.1 14.9 12.7 7.8 13.0 12.5 9.2 2.2 8.8 10.5 13.6 13.4 9.1 5.0 6.4 6.8 6.1 4.5 4.8 8.1 2.1 6.5 8.1 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Group enriched" "Detected in some" 16 "A549: 92.9;Hep G2: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: " "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 92.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.4" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: , HPA062973: " "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.4 0.0 0.2 1.6 0.0 0.4 0.3 0.3 7.4 0.4 0.1 0.1 0.3 0.6 0.4 0.8 0.5 0.4 0.4 0.4 0.0 0.5 0.3 0.1 0.6 0.4 0.1 0.2 0.1 0.8 1.9 0.7 0.5 0.2 0.5 0.5 1.8 0.1 0.9 0.2 0.3 0.1 0.5 0.8 1.1 0.9 0.6 0.3 0.8 0.6 0.3 0.8 0.9 0.2 1.2 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell line enhanced" "Detected in many" "ASC diff: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: , HPA046754: , HPA064827: " "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favourable (2.75e-5)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 2.5 0.1 3.3 5.5 1.8 7.4 0.0 3.5 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell line enhanced" "Detected in many" "A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 9.8 1.2 1.0 2.1 0.0 0.0 2.7 0.3 0.3 0.3 0.1 0.7 12.4 0.7 0.7 0.2 13.8 0.3 3.1 0.0 1.3 1.0 0.2 12.2 6.5 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.1 0.4 2.1 0.8 19.1 0.4 0.7 0.5 1.5 1.5 1.3 1.7 0.4 0.7 0.3 1.0 2.0 1.8 0.5 3.9 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.7 0.5 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favourable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 17.4 12.4 20.7 28.5 36.0 34.4 12.0 17.7 27.5 10.1 17.4 64.1 5.0 13.2 7.7 6.5 25.9 10.2 15.5 10.3 21.5 16.0 11.5 16.0 25.7 42.3 44.4 27.4 5.9 16.0 7.5 8.4 15.8 32.1 15.2 19.9 10.1 17.3 5.3 17.5 15.9 21.4 10.0 31.2 31.8 24.8 7.9 45.2 19.3 15.2 9.2 50.1 14.4 12.1 24.7 19.1 45.9 20.0 21.8 39.4 31.3 9.1 6.4 6.4 5.5 4.4 5.6 6.2 4.3 3.8 5.3 6.2 4.0 10.2 6.8 4.3 5.6 8.1 3.1 11.2 4.3 14.2 8.6 2.7 8.1 7.3 3.1 5.6 27.5 2.7 9.3 6.0 6.2 17.0 4.5 26.3 6.2 4.6 36.2 5.0 1.6 5.7 9.6 7.1 23.8 5.8 6.4 3.7 13.5 7.6 14.8 6.0 7.2 6.6 8.0 4.2 6.2 6.6 4.4 30.6 14.0 24.9 3.1 5.6 4.4 45.9 16.2 31.4 39.4 20.0 28.6 24.7 32.8 31.8 13.7 23.0 36.5 30.7 33.8 21.8 17.6 19.1 24.5 31.3 20.7 36.0 17.7 27.5 21.5 16.0 44.4 27.4 32.1 45.2 CYTH2 "ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like" ENSG00000105443 "Cytohesin 2" Q99418 19 48469032-48482314 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014872, HPA060662" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" 11000 Cytosol "Golgi apparatus, Plasma membrane" "CAB014872: , HPA060662: " "unprognostic (2.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (4.10e-2)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.66e-1)" "unprognostic (2.83e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (2.33e-2)" "unprognostic (9.19e-2)" "unprognostic (3.14e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-1)" "prognostic favourable (3.21e-4)" 13.5 14.2 12.7 14.1 13.6 8.0 19.5 11.4 24.4 21.9 11.7 12.9 14.8 23.2 15.4 15.9 18.8 15.0 25.5 8.3 12.4 7.4 19.2 8.9 15.2 10.0 13.2 18.9 14.4 17.3 35.1 21.0 21.1 12.4 18.0 9.7 13.5 24.2 14.4 7.4 19.9 23.0 12.2 8.7 13.0 19.2 42.0 13.5 18.4 46.2 15.1 10.6 15.6 15.9 4.1 5.6 11.1 4.0 1.8 6.1 3.2 9.2 14.1 42.8 9.6 6.5 5.6 7.8 7.3 6.7 7.8 7.4 7.7 12.7 6.1 7.7 6.3 11.7 8.2 8.9 5.0 9.3 11.2 8.6 17.6 8.3 5.8 5.2 11.8 7.2 15.3 9.7 6.2 10.1 8.6 21.5 10.3 7.5 8.7 38.3 4.6 5.8 11.2 6.4 4.2 13.3 20.3 12.6 12.4 8.0 22.5 6.2 10.6 7.0 10.9 17.0 8.6 4.0 10.4 21.4 11.3 4.0 6.2 10.4 11.8 4.1 4.0 3.3 4.1 3.0 2.7 4.1 5.3 6.1 3.3 2.7 4.9 3.4 11.1 1.8 3.9 5.6 5.3 3.2 12.7 13.6 11.4 24.4 12.4 7.4 13.2 18.9 12.4 13.5 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell line enhanced" "Detected in many" "WM-115: 35.0" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavourable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.2 5.4 5.1 3.5 24.1 28.5 7.3 12.6 11.0 12.5 11.9 8.3 10.6 2.9 7.7 25.4 20.1 3.5 9.1 8.3 0.2 5.1 0.8 6.4 1.0 11.5 0.8 1.3 20.1 4.2 6.6 9.6 2.1 3.3 0.4 9.1 3.5 0.7 3.8 3.6 7.3 3.8 13.8 1.6 9.6 2.6 3.3 6.4 7.8 27.4 22.1 1.6 6.0 7.8 8.6 22.8 9.2 7.7 1.0 0.3 3.0 2.7 2.3 35.0 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.4;lymphoid tissue: 92.9" "Cell line enhanced" "Detected in some" "Daudi: 14.3;Karpas-707: 39.0;RPMI-8226: 11.9;U-266/70: 66.4;U-266/84: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Low region specificity" "Detected in single" HPA007191 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favourable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.4 1.4 1.4 33.3 1.6 32.3 3.9 0.8 1.0 4.4 9.7 1.6 0.8 9.3 3.1 4.2 6.6 2.8 5.8 3.8 1.5 1.5 4.1 3.9 26.8 92.9 3.1 0.6 2.9 3.1 0.0 1.5 1.3 2.0 2.4 5.0 3.1 11.5 3.1 1.4 2.1 17.4 2.1 4.3 48.3 14.4 3.3 1.3 40.5 3.2 3.8 61.8 24.1 3.2 21.9 13.0 48.5 53.3 19.9 53.4 31.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 11.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 66.4 24.9 6.4 0.6 1.7 0.0 48.5 8.4 24.5 30.6 27.8 30.9 21.9 32.4 28.9 13.0 21.1 53.4 40.7 48.2 19.9 53.3 6.7 31.3 31.6 1.4 1.6 0.8 1.0 1.5 1.5 3.1 0.6 2.0 1.3 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell line enhanced" "Detected in some" "HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" "Nuclear membrane, Endoplasmic reticulum" "HPA067201: " "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavourable (7.43e-4)" "prognostic unfavourable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavourable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 33.5 0.0 1.7 0.0 0.0 0.0 81.5 0.1 0.0 1.2 1.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 5.1 0.0 0.0 11.4 0.0 7.9 0.0 0.0 0.2 0.0 0.0 0.0 1.0 19.7 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 18.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" 450000 "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: " "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favourable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 13.8 8.0 13.8 9.4 9.3 3.7 9.3 17.3 13.3 14.6 11.4 6.3 7.4 4.5 16.9 7.0 19.2 8.4 6.0 17.3 10.2 6.7 6.0 10.7 9.7 8.8 5.6 13.6 8.6 8.2 25.6 9.6 12.4 8.7 10.9 7.8 16.9 12.0 10.5 6.0 25.6 7.7 19.5 10.0 10.2 9.1 5.8 7.2 4.1 7.1 14.1 13.8 15.3 13.1 10.7 18.3 4.9 3.1 6.9 3.8 1.9 12.8 1.3 8.8 2.3 5.8 4.1 11.6 1.6 1.6 3.4 3.6 6.6 10.7 13.3 3.4 4.0 26.5 8.3 6.4 2.8 5.8 2.9 5.0 3.3 7.9 3.6 5.6 2.6 2.7 6.5 2.9 2.9 7.5 8.1 6.6 2.1 11.0 4.7 2.7 4.8 3.8 4.4 7.5 1.3 4.4 10.1 13.8 3.1 11.2 16.4 10.0 21.8 1.2 7.5 2.6 5.1 5.9 1.5 1.4 1.6 15.6 3.6 1.0 6.3 4.9 2.1 2.5 2.6 2.4 3.1 10.7 3.3 2.4 2.4 4.7 2.7 2.7 2.6 6.9 3.1 18.3 3.8 1.9 13.8 9.3 17.3 13.3 10.2 6.7 5.6 13.6 8.7 7.2 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell line enhanced" "Detected in some" "HSkMC: 25.6;LHCN-M2: 25.1;SK-MEL-30: 31.0;U-138 MG: 9.6;WM-115: 12.1" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA051300: , HPA054630: " "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.5 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.6 0.0 0.1 0.0 0.0 0.0 0.0 25.1 0.0 0.6 0.0 0.7 0.0 0.0 4.5 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.0 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 DAB2 DOC-2 ENSG00000153071 "DAB2, clathrin adaptor protein" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 194.4" "Cell line enhanced" "Detected in many" "ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "plasmacytoid DC: 26.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: " "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavourable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 51.6 44.2 2.6 12.2 3.5 0.6 21.8 6.1 2.6 16.6 14.0 4.1 4.5 3.3 16.6 34.8 10.8 9.6 13.3 25.1 2.9 3.0 75.2 6.9 22.4 31.8 4.0 2.1 12.7 11.3 3.2 3.9 194.4 4.7 11.6 14.6 14.6 12.9 5.3 12.7 9.3 10.4 16.0 5.2 21.1 7.2 8.7 2.5 7.3 10.9 8.4 7.4 17.8 14.7 0.1 26.6 2.2 2.5 0.9 1.3 7.0 0.0 1.5 2.4 5.3 42.2 45.4 3.0 27.2 27.9 10.7 17.7 19.9 0.0 0.0 1.7 65.6 0.0 0.3 0.9 15.1 0.0 0.8 3.6 36.2 6.5 10.2 0.0 4.7 28.2 0.0 17.5 3.1 32.2 0.0 0.9 17.7 0.1 0.3 0.0 1.6 3.0 0.9 6.2 0.0 7.1 0.5 0.0 0.0 3.2 1.7 15.2 0.1 0.9 39.5 46.0 5.1 5.3 2.2 0.0 0.0 0.0 16.0 3.4 5.9 2.2 1.2 0.2 1.3 2.5 0.0 0.1 0.2 0.7 3.4 0.1 0.1 1.0 1.8 0.9 0.6 26.6 0.2 7.0 2.6 3.5 6.1 2.6 2.9 3.0 4.0 2.1 4.7 2.5 DACH1 DACH ENSG00000276644 "Dachshund family transcription factor 1" Q9UI36 13 71437966-71867192 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 8.0;HAP1: 12.5;HEK 293: 9.3;HL-60: 20.3;NB-4: 9.0;SCLC-21H: 20.9;SH-SY5Y: 16.7;THP-1: 14.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 15 "basophil: 4.7;eosinophil: 9.2;NK-cell: 4.9;plasmacytoid DC: 7.5" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 9.2;NK-cells: 4.9" "Region enriched" "Detected in many" 5 "basal ganglia: 34.7" "Region enriched" "Detected in all" 5 "basal ganglia: 34.0" HPA012672 Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012672: AB_1847466" "unprognostic (3.16e-1)" "unprognostic (5.26e-2)" "unprognostic (1.41e-2)" "unprognostic (2.36e-1)" "unprognostic (4.21e-2)" "unprognostic (5.63e-2)" "unprognostic (2.22e-2)" "unprognostic (8.08e-3)" "unprognostic (2.12e-2)" "unprognostic (2.50e-1)" "unprognostic (3.04e-3)" "unprognostic (4.37e-1)" "unprognostic (2.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-1)" "unprognostic (5.17e-2)" 4.9 12.2 0.6 3.8 15.5 5.7 9.2 1.8 2.9 11.4 5.4 0.0 3.5 5.4 6.3 4.1 0.9 2.9 15.8 3.0 0.2 10.2 1.9 10.2 0.3 0.0 1.5 0.9 1.8 7.3 24.4 7.3 4.9 7.9 3.5 19.6 1.9 6.9 3.6 0.6 9.6 2.1 2.9 7.8 1.8 6.1 6.6 6.1 0.0 1.2 0.2 2.1 10.2 0.0 7.5 9.2 0.2 4.9 0.0 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.2 20.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 9.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 20.9 16.7 0.0 0.0 0.0 0.5 14.7 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 4.7 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 4.9 0.0 7.5 0.0 0.1 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647612-46661138 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 9.3;SH-SY5Y: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavourable (6.66e-4)" 5.2 3.8 21.0 5.8 15.9 1.7 1.6 3.7 32.3 10.7 17.3 24.6 3.5 4.2 21.6 14.8 7.8 10.9 7.4 10.5 21.7 13.9 3.9 2.2 5.6 1.5 17.4 13.6 8.8 1.5 1.4 1.2 2.1 14.1 11.7 7.2 13.7 1.7 25.1 1.7 2.8 4.7 30.3 17.0 4.8 7.4 5.7 9.4 0.0 1.6 1.5 1.3 13.2 6.0 1.6 1.2 5.9 0.9 2.0 0.7 0.3 0.2 0.3 5.1 4.8 1.7 1.4 0.5 2.8 4.7 0.9 1.4 0.3 0.3 0.4 1.9 9.3 0.3 3.2 0.1 1.0 0.4 1.7 1.2 0.7 0.2 2.6 0.2 2.1 4.6 0.1 1.2 0.0 0.4 1.6 1.7 0.8 0.4 0.2 1.2 2.0 0.7 4.1 1.4 0.3 0.3 0.4 2.0 22.7 0.5 0.2 0.4 0.4 0.4 0.5 2.4 2.9 2.5 0.5 1.5 0.5 0.7 0.6 0.8 1.8 5.9 0.9 1.0 0.7 0.5 0.5 0.7 0.7 0.5 0.2 1.6 0.7 0.7 4.6 2.0 0.7 1.2 0.5 0.3 21.0 15.9 3.7 32.3 21.7 13.9 17.4 13.6 14.1 9.4 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA069377: " "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 20.1 28.2 12.6 12.7 20.3 25.8 29.8 18.4 26.1 19.1 18.0 11.4 19.4 15.1 14.3 17.5 16.2 12.5 26.6 18.9 12.4 13.8 24.0 88.0 18.4 25.2 11.6 5.8 22.5 47.0 14.2 19.0 45.7 7.5 14.6 10.6 14.6 34.1 22.3 22.0 22.1 31.3 16.0 13.2 15.1 14.0 27.1 7.9 7.2 23.1 15.1 16.8 15.6 20.8 5.6 18.9 13.6 14.7 2.4 8.4 7.5 11.5 13.3 5.7 7.5 8.7 6.8 4.6 16.3 11.1 14.1 15.3 7.0 12.7 6.2 7.1 7.9 17.1 9.3 8.6 8.1 2.8 6.5 3.3 15.2 4.8 9.4 9.4 5.3 6.0 14.3 9.4 9.3 6.0 9.4 3.1 8.3 8.1 3.3 13.4 20.8 10.1 29.0 6.6 13.5 8.8 4.3 7.4 4.4 9.2 14.1 2.7 9.9 17.7 7.4 12.2 23.2 15.2 7.6 3.3 5.9 5.3 6.0 14.8 14.7 6.2 14.7 13.6 4.4 13.9 3.9 5.6 3.5 2.9 18.9 3.6 8.4 4.8 7.3 2.4 12.2 3.2 2.9 7.5 12.6 20.3 18.4 23.4 12.4 13.8 11.6 5.8 7.5 7.9 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favourable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favourable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 9.4 14.1 9.3 13.9 9.0 4.4 21.6 10.2 11.9 11.3 9.5 7.7 14.9 7.2 7.7 14.7 13.1 34.3 14.2 8.6 8.6 7.3 16.0 9.3 10.8 9.1 7.2 9.4 13.5 29.3 12.6 11.1 8.7 6.3 8.4 7.5 8.4 13.2 18.5 7.5 13.0 10.2 6.5 5.1 8.5 9.9 32.0 6.8 21.1 21.1 13.5 12.7 9.5 14.1 17.7 8.2 7.3 9.3 14.5 19.2 9.3 6.2 8.6 5.4 10.6 15.4 20.6 6.6 5.3 14.3 8.8 8.5 6.0 7.8 2.5 7.6 14.0 4.2 7.0 13.5 6.2 3.8 4.7 2.7 7.9 11.2 10.1 7.6 5.4 13.9 14.1 11.1 24.6 13.6 2.1 6.2 8.6 10.6 3.4 5.1 8.9 8.1 1.7 0.7 18.0 23.4 9.8 3.4 11.4 5.8 15.9 11.9 11.2 8.4 8.4 3.4 5.5 12.2 4.7 20.0 10.9 1.3 13.0 3.5 6.8 7.1 7.7 3.7 10.2 9.3 18.8 17.7 17.0 12.7 8.2 15.5 14.4 9.3 7.3 14.5 8.6 5.6 19.2 9.3 9.3 9.0 10.2 11.9 8.6 7.3 7.2 9.4 6.3 6.8 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 18.9 13.8 17.2 15.8 32.2 39.0 19.1 46.6 72.4 35.3 41.0 9.8 16.2 8.3 30.6 57.5 3.7 10.7 27.6 39.3 43.5 7.8 11.1 26.8 24.1 30.4 20.7 8.3 20.0 9.6 23.1 41.9 65.7 12.8 28.1 34.5 15.0 11.1 13.2 6.2 31.8 15.3 7.6 13.6 46.5 35.3 11.7 15.7 47.5 19.4 12.4 15.3 30.5 32.2 21.9 23.8 14.4 24.6 15.8 20.4 12.2 21.7 40.5 32.8 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.3 21.0 17.2 27.2 25.4 32.1 42.3 27.3 28.9 28.1 24.6 38.7 39.8 46.2 55.7 22.2 33.1 25.5 23.8 30.7 28.9 18.6 28.1 18.8 35.1 34.8 38.4 25.1 26.9 34.2 35.8 47.4 27.6 60.7 32.9 29.2 43.0 33.7 45.0 30.4 34.4 27.9 21.6 49.0 33.4 31.0 20.0 35.5 26.2 77.4 47.1 48.0 63.3 23.6 23.9 25.2 29.5 45.8 36.0 53.7 53.2 23.8 34.5 30.7 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;skeletal muscle: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4" "Lineage enriched" "Detected in many" 23 "granulocytes: 51.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA071581: " "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favourable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 8.2 1.6 2.6 6.8 5.0 10.3 5.2 1.4 3.9 3.6 16.6 12.0 8.3 14.2 1.7 1.5 2.1 1.2 1.7 17.6 3.6 2.0 2.2 1.4 14.0 2.5 6.8 3.0 0.7 1.7 1.1 1.1 0.3 4.7 3.1 4.7 1.9 4.8 4.8 46.1 4.6 25.8 1.2 3.4 4.7 6.9 2.0 6.5 1.1 22.3 8.7 3.3 2.1 9.6 0.3 2.2 51.8 0.0 0.7 0.6 0.3 2.8 2.0 5.6 1.4 10.0 0.4 0.1 1.9 6.0 1.0 1.1 0.8 1.4 0.2 0.6 6.0 8.3 3.5 0.1 0.6 0.2 0.1 1.1 3.9 0.1 0.1 0.1 17.0 1.0 7.2 0.3 0.2 0.6 0.4 0.1 0.7 8.6 0.0 0.3 0.6 2.0 2.6 0.0 0.3 0.0 2.8 0.4 0.3 0.4 1.1 0.0 4.8 0.4 0.4 0.8 1.0 1.3 1.6 0.6 0.2 0.0 0.0 2.7 0.2 19.1 0.0 51.8 0.6 0.0 0.2 0.3 0.1 0.5 0.0 0.1 0.0 0.4 16.4 0.7 0.0 2.2 0.0 0.3 2.6 5.0 1.4 3.9 3.6 2.0 6.8 3.0 4.7 6.5 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: , HPA058635: " "unprognostic (3.95e-5)" "prognostic favourable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.8 0.0 0.0 0.3 5.5 0.0 0.0 0.0 0.6 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favourable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.2 19.6 12.2 7.6 9.3 13.3 15.6 12.9 10.7 18.7 14.3 18.3 26.4 15.9 17.7 10.3 30.1 33.7 21.8 25.6 18.1 16.5 13.7 9.8 12.8 9.1 11.6 12.5 9.6 10.0 18.9 19.3 18.6 27.7 12.5 15.5 8.1 14.7 6.5 23.6 17.6 17.4 15.6 29.2 17.0 9.8 16.0 14.7 14.2 31.6 20.3 33.1 15.3 8.2 9.6 15.2 13.2 20.6 9.8 24.8 18.4 5.6 12.9 20.7 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 14.9;U-2197: 28.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.5 0.3 0.6 0.4 3.6 0.3 0.2 0.0 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 14.9 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.3 1.5 0.1 1.4 28.1 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: , HPA065779: " "prognostic favourable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavourable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 10.4 14.3 10.7 13.5 11.9 8.8 10.8 11.3 14.8 11.8 12.2 9.4 7.3 11.2 13.2 43.7 13.5 12.6 12.1 9.1 9.7 7.3 9.2 12.0 10.3 18.3 10.2 8.5 13.8 18.6 24.4 10.4 11.6 11.6 13.0 14.1 7.3 10.7 15.2 14.8 11.6 12.7 15.5 8.1 20.4 10.5 20.2 11.5 25.0 16.1 6.8 30.9 11.5 10.9 17.0 5.9 12.6 11.2 15.3 18.2 21.8 2.2 0.0 7.1 2.9 1.2 2.3 4.7 7.0 23.1 18.0 13.3 0.8 2.4 7.0 2.5 5.4 1.3 0.1 5.7 16.7 8.3 15.7 9.1 12.5 11.2 3.9 9.6 2.6 6.1 8.5 2.0 5.4 0.5 5.0 4.5 5.6 5.3 3.8 21.5 0.4 3.3 5.9 0.1 7.8 1.4 0.7 8.6 2.2 0.0 0.4 3.7 2.2 0.2 5.9 4.5 5.6 0.2 0.1 7.8 16.3 15.1 3.3 4.4 4.7 7.8 7.5 12.6 16.3 8.0 18.2 16.6 15.4 15.8 5.9 17.0 13.9 14.1 7.4 15.3 11.2 5.9 17.1 21.8 10.7 11.9 11.3 14.8 9.7 7.3 10.2 8.5 11.6 11.5 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol 1700000 Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavourable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 22.1 15.0 11.4 33.1 14.2 37.1 32.9 16.1 19.4 15.2 21.4 22.2 17.2 28.3 17.8 11.0 30.9 16.0 13.5 26.7 11.5 9.2 17.1 38.1 18.7 29.2 16.8 12.4 20.7 28.3 11.9 11.4 22.2 13.3 15.9 15.6 16.8 17.0 12.0 31.4 20.2 28.7 17.7 10.9 28.5 22.0 46.8 15.0 43.8 15.9 22.6 21.0 21.4 27.7 7.1 6.1 4.3 7.5 6.5 7.1 3.1 52.7 19.2 12.9 23.5 5.7 7.0 37.0 23.8 11.9 19.5 16.1 19.1 26.2 62.2 14.6 11.5 29.8 17.0 22.7 16.5 43.5 27.0 32.0 18.4 19.4 13.3 38.7 27.5 7.0 15.0 13.2 24.3 17.0 47.6 32.8 12.1 21.6 67.8 34.5 39.8 19.4 49.0 20.6 38.3 14.6 17.9 25.7 23.0 15.7 24.8 28.7 22.5 51.7 18.4 16.1 21.8 28.0 51.9 38.9 39.9 49.4 19.4 37.8 24.5 3.2 5.5 4.3 6.5 7.5 7.1 7.1 6.0 6.9 4.9 5.5 6.0 6.4 2.4 6.5 5.2 6.1 6.1 3.1 11.4 14.2 16.1 19.4 11.5 9.2 16.8 12.4 13.3 15.0 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA042923: " "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavourable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavourable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavourable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 2.9 3.8 0.7 0.6 0.9 1.4 0.3 1.5 2.9 2.2 0.9 3.1 1.1 0.8 1.3 3.0 0.8 1.6 2.2 2.0 1.9 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 1.3 1.7 6.4 2.0 2.3 4.1 2.9 3.0 2.8 1.1 4.6 3.6 1.2 0.2 4.3 2.8 1.9 3.2 1.5 1.3 2.5 0.5 1.8 2.1 4.6 3.0 3.7 7.6 3.0 1.2 4.3 3.8 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 201.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 37 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 201.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 DBN1 D0S117E ENSG00000113758 "Drebrin 1" Q16643 5 177456608-177474401 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.7" "Group enriched" "Detected in many" 8 "dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051452, HPA056940" Enhanced Supported Supported "Plasma membrane,Actin filaments" 17000000 "Plasma membrane, Actin filaments" "HPA051452: AB_2681489, HPA056940: AB_2683279" "unprognostic (3.81e-2)" "unprognostic (6.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.57e-3)" "unprognostic (9.32e-2)" "unprognostic (5.68e-2)" "unprognostic (2.01e-3)" "unprognostic (4.29e-2)" "unprognostic (1.73e-2)" "unprognostic (7.92e-2)" "unprognostic (2.94e-2)" "unprognostic (3.64e-1)" "prognostic favourable (8.28e-4)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-3)" 21.4 9.0 21.7 15.0 42.4 5.4 13.5 12.0 46.0 25.7 21.7 8.8 8.7 8.6 37.4 15.0 19.2 16.2 21.5 13.9 24.2 20.9 15.1 2.7 12.1 7.3 11.9 22.1 20.2 13.2 9.1 17.1 6.7 20.3 14.9 5.8 9.3 24.8 23.0 21.3 12.7 10.0 29.5 8.6 7.8 17.0 14.4 9.4 19.8 20.0 11.0 4.4 20.6 12.0 0.2 5.1 6.0 0.9 0.1 12.7 1.5 2.9 10.1 33.8 58.9 8.0 12.7 10.5 36.1 9.3 21.2 17.8 34.9 10.6 0.0 25.8 28.0 4.7 14.9 26.2 10.0 0.8 12.9 19.6 13.2 14.5 28.5 7.3 3.6 16.6 6.9 23.7 7.1 34.9 9.0 4.7 15.4 4.2 20.1 11.2 48.9 22.7 60.2 36.6 5.9 15.8 4.2 39.8 54.1 11.8 5.2 20.0 14.4 7.6 53.9 23.7 32.2 5.2 16.7 1.1 0.5 31.6 9.9 6.9 14.5 6.0 0.9 0.7 9.2 0.5 12.7 0.1 0.2 6.6 1.4 0.2 0.3 4.5 2.5 0.1 0.4 5.1 0.0 1.5 21.7 42.4 12.0 40.8 24.2 20.9 11.9 22.1 20.3 9.4 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell line enhanced" "Detected in many" "MCF7: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favourable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.7 11.8 1.1 14.2 0.3 0.1 8.4 1.7 2.1 3.5 1.7 11.4 6.3 0.0 0.9 0.3 8.0 12.4 0.3 3.3 0.0 22.7 0.0 1.6 18.7 0.5 0.1 1.3 0.3 1.0 5.9 0.0 14.9 2.2 0.1 1.2 46.7 0.0 9.7 19.8 5.0 4.7 10.8 0.2 19.4 1.4 17.1 18.3 1.9 1.7 14.6 11.0 1.3 12.0 2.7 5.3 0.1 7.7 0.0 0.1 0.0 1.1 0.9 6.8 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.4 3.8 3.1 21.7 2.0 0.9 4.3 12.6 13.8 10.6 7.2 10.4 29.4 0.3 2.2 12.4 31.8 21.2 1.1 6.5 0.1 12.5 17.9 16.6 9.4 12.7 0.9 27.3 0.3 3.6 4.0 3.7 7.2 1.2 0.4 0.8 27.2 1.5 1.3 4.0 22.9 0.0 0.3 0.2 30.2 0.4 7.1 3.6 4.4 2.4 27.2 29.8 5.5 11.6 0.4 21.1 14.0 13.8 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported Nucleoplasm,Cytosol 15000000 Cytosol Nucleoplasm "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 23.9 19.6 21.2 45.4 17.4 34.1 20.5 11.4 24.0 23.9 21.0 19.6 23.5 17.9 22.0 21.8 65.6 19.1 32.7 18.0 18.3 18.8 18.9 18.4 23.6 49.8 19.1 23.8 15.2 19.2 16.7 18.5 25.8 16.1 21.0 15.2 17.2 23.4 22.3 15.9 26.2 23.2 25.2 19.8 46.8 24.7 13.0 15.8 31.0 18.2 32.0 52.3 23.6 31.6 46.7 66.0 64.1 73.7 31.6 35.4 80.5 19.4 28.4 17.8 19.3 22.2 14.3 16.5 32.1 26.8 32.0 26.9 28.4 27.2 43.7 23.3 34.9 34.6 10.3 37.5 12.0 23.3 12.0 14.8 21.3 16.2 22.5 22.1 27.6 13.5 15.0 30.4 10.6 21.9 18.6 15.2 30.3 28.3 39.6 24.9 14.5 24.0 22.0 14.5 21.7 20.7 27.2 21.6 28.7 21.9 43.0 6.8 31.7 30.9 35.1 26.3 23.8 15.2 37.1 35.6 15.3 24.5 24.7 25.1 62.2 39.2 66.3 50.2 35.4 73.7 28.0 46.7 26.7 28.8 63.9 45.8 27.0 28.2 64.1 31.6 71.0 66.0 31.3 80.5 21.2 17.4 11.4 24.0 18.3 18.8 19.1 23.8 16.1 15.8 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: , HPA053203: " "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favourable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 13.3 12.5 11.5 16.3 12.3 12.9 12.2 17.9 12.5 9.6 10.3 11.0 12.5 7.6 13.1 10.1 11.3 9.2 8.4 8.8 9.6 6.8 11.0 11.1 10.9 13.0 11.1 9.1 11.9 11.1 24.8 12.9 15.4 10.3 10.1 10.9 8.6 12.5 11.8 28.1 14.1 11.8 10.4 9.1 11.9 10.7 50.7 10.9 18.5 14.2 7.6 16.7 12.5 16.5 7.3 6.4 3.3 6.0 7.3 10.7 6.2 10.7 13.2 12.9 11.6 11.6 9.3 12.2 12.1 9.1 13.1 12.9 14.4 10.5 26.2 6.7 9.5 9.5 24.2 10.8 17.0 18.2 12.0 22.4 18.1 12.4 8.5 29.2 16.3 6.1 12.6 16.9 12.4 10.1 13.1 17.1 10.2 10.9 22.3 11.9 13.5 14.6 9.5 13.8 17.3 10.2 16.8 6.7 11.9 13.3 12.4 7.3 8.4 12.4 12.6 10.8 14.5 17.7 18.5 11.6 15.7 27.0 12.5 20.1 8.8 3.2 4.0 3.3 9.4 4.5 10.7 7.1 8.1 8.0 6.4 7.3 8.9 7.3 1.0 7.3 6.0 5.2 8.7 6.2 11.5 12.3 17.9 12.5 9.6 6.8 11.1 9.1 10.3 10.9 DCAF13 "DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1" ENSG00000164934 "DDB1 and CUL4 associated factor 13" Q9NV06 8 103414714-103443453 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Ubl conjugation pathway" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044504 Uncertain Supported "Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol" "Nucleoplasm, Nucleoli" "Cell Junctions, Centrosome, Cytosol" "HPA044504: " "prognostic unfavourable (4.06e-4)" "unprognostic (4.39e-2)" "unprognostic (1.70e-1)" "unprognostic (4.46e-3)" "unprognostic (3.57e-2)" "unprognostic (7.86e-3)" "prognostic unfavourable (8.05e-6)" "unprognostic (5.92e-3)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.54e-3)" "unprognostic (2.31e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (8.63e-2)" 18.4 20.5 13.8 18.1 15.7 10.6 20.2 11.3 14.3 16.0 16.7 13.0 12.9 13.1 18.1 16.7 24.0 15.3 10.7 15.9 12.4 11.8 35.2 26.5 12.4 18.4 16.5 12.1 20.9 28.9 15.7 34.6 21.2 16.2 16.4 18.5 7.4 15.9 11.3 21.1 13.7 16.8 15.3 13.9 20.4 14.7 25.3 15.0 26.4 17.1 22.6 24.3 16.9 15.5 28.6 26.4 10.3 22.1 24.0 27.2 20.2 27.5 24.8 23.2 23.6 16.9 19.6 17.4 20.6 15.8 19.6 20.1 24.4 27.0 38.4 35.3 21.5 20.8 31.4 26.3 38.0 36.6 22.3 53.1 14.9 27.7 19.3 21.7 22.9 15.9 18.2 28.8 48.0 27.2 35.6 16.9 29.8 22.5 41.1 22.8 35.5 38.8 26.8 28.2 39.6 28.5 23.1 29.6 28.1 12.9 20.2 23.3 31.1 14.9 17.8 20.0 32.1 25.7 27.5 18.7 32.5 54.3 26.9 47.5 25.5 8.6 18.6 10.3 18.4 22.1 25.2 28.6 19.8 19.7 26.4 22.1 19.8 20.2 2.0 24.0 16.0 13.7 27.2 20.2 13.8 15.7 11.3 14.3 12.4 11.8 16.5 12.1 16.2 15.0 DCAF15 "C19orf72, MGC99481" ENSG00000132017 "DDB1 and CUL4 associated factor 15" Q66K64 19 13952492-13961449 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068351 Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA068351: " "unprognostic (6.91e-2)" "unprognostic (6.55e-3)" "unprognostic (3.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.95e-1)" "unprognostic (1.89e-2)" "unprognostic (1.83e-3)" "unprognostic (9.72e-2)" "unprognostic (8.03e-2)" "unprognostic (1.21e-1)" "prognostic favourable (7.97e-4)" "unprognostic (1.98e-2)" "prognostic unfavourable (1.34e-5)" "unprognostic (7.97e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" 10.3 6.5 10.4 15.1 8.5 27.5 11.1 20.1 13.3 13.9 12.7 8.7 8.9 10.7 11.4 8.4 14.7 11.3 10.0 11.0 12.1 7.0 11.1 13.1 14.8 19.4 9.0 8.5 10.3 8.4 11.0 10.7 18.6 8.8 10.4 8.4 9.8 10.0 9.1 13.3 21.0 13.8 8.2 7.4 21.4 9.9 41.0 6.5 29.2 10.7 16.5 23.4 9.9 12.8 2.2 2.8 5.1 2.2 0.8 3.6 1.3 15.4 9.6 25.3 13.9 2.7 4.0 11.6 10.7 7.5 22.5 22.5 17.0 6.6 14.3 12.4 10.2 14.1 16.1 10.1 8.0 17.2 28.6 17.6 16.1 17.6 5.7 14.5 26.0 5.2 9.5 16.6 7.5 11.2 18.5 21.2 9.8 23.6 25.9 27.1 30.1 15.1 24.0 8.9 9.8 12.0 12.0 16.2 16.7 9.6 7.0 8.7 8.9 18.8 7.7 15.4 11.4 24.3 19.9 15.0 16.4 14.9 9.9 21.3 13.2 1.2 2.0 5.1 2.1 2.2 1.6 2.1 1.7 2.4 1.2 2.2 0.9 2.4 4.1 0.8 1.4 2.8 3.6 1.3 10.4 8.5 20.1 13.3 12.1 7.0 9.0 8.5 8.8 6.5 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (6.40e-4)" "prognostic favourable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favourable (7.67e-4)" 13.0 13.1 12.7 12.1 20.5 23.3 19.8 19.4 19.7 18.5 13.1 22.5 9.9 12.0 26.9 16.5 11.5 16.1 11.3 11.8 13.9 15.7 11.3 6.8 12.6 16.7 14.4 16.2 29.6 16.0 17.8 25.8 14.8 19.0 16.9 14.8 17.1 15.2 13.0 16.2 22.4 14.0 17.2 16.0 13.3 13.6 19.2 16.3 30.6 15.7 7.0 18.3 16.3 14.6 4.8 3.0 9.7 2.8 3.6 6.3 2.2 12.1 2.6 14.2 14.8 4.1 7.2 7.8 8.0 9.4 9.5 11.3 7.4 9.9 13.7 6.4 7.3 6.2 8.3 8.4 14.2 4.6 7.6 19.2 8.7 12.1 9.8 16.8 7.9 9.3 7.0 12.0 12.0 6.5 20.6 22.9 5.5 4.5 18.5 16.2 11.7 7.7 19.6 16.2 8.8 4.1 9.6 21.2 17.0 8.4 2.3 9.1 8.3 4.6 8.2 11.1 8.7 12.2 10.0 10.2 4.0 17.2 9.1 11.7 7.4 9.7 2.4 3.4 4.5 2.8 5.9 3.7 5.0 4.9 1.5 4.8 6.3 5.9 1.8 3.6 1.9 3.0 3.4 2.2 12.7 20.5 19.4 19.7 13.9 15.7 14.4 16.2 19.0 16.3 DCAF6 "IQWD1, PC326" ENSG00000143164 "DDB1 and CUL4 associated factor 6" Q58WW2 1 167935783-168075843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054305 Supported "Nucleoplasm,Focal adhesion sites" "Nucleoplasm, Focal adhesion sites" "HPA054305: " "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.19e-1)" "unprognostic (5.42e-2)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.74e-1)" "unprognostic (3.20e-2)" "unprognostic (9.21e-2)" "unprognostic (7.06e-2)" "unprognostic (6.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 10.6 17.0 10.9 7.8 12.2 6.2 8.8 10.5 17.8 10.2 11.5 3.9 8.4 6.2 9.5 11.4 9.3 7.7 8.2 43.8 7.6 5.5 9.5 26.2 7.3 4.8 5.2 11.5 8.3 6.1 10.8 11.3 7.8 6.5 10.5 8.7 5.7 10.3 11.9 155.9 6.4 7.8 10.2 4.8 5.9 9.8 21.5 4.8 7.8 8.2 27.3 7.3 9.1 7.3 6.2 7.7 12.5 13.9 4.4 7.2 5.0 22.9 11.0 6.1 9.9 20.2 28.8 21.5 23.5 35.3 16.7 24.9 18.2 19.4 19.0 13.7 30.3 17.3 9.5 17.6 23.7 10.7 10.2 20.2 16.7 13.1 16.3 9.0 9.7 20.4 17.8 15.8 13.2 18.2 22.8 15.7 24.5 5.3 10.0 8.3 3.9 12.2 7.8 12.6 14.7 41.7 11.2 9.0 7.1 18.8 17.3 12.9 29.6 11.1 25.6 16.7 10.4 16.1 9.7 16.9 13.7 14.8 22.3 7.8 6.8 6.0 7.0 12.5 6.7 9.6 7.2 6.2 5.4 5.8 7.7 4.5 5.0 6.4 7.2 4.4 13.9 4.6 6.1 5.0 10.9 12.2 10.5 17.8 7.6 5.5 5.2 11.5 6.5 4.8 DCAF7 "HAN11, SWAN-1, WDR68" ENSG00000136485 "DDB1 and CUL4 associated factor 7" P61962 17 63550461-63594266 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022948, HPA022962" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA022948: AB_1858820, HPA022962: AB_1858821" "unprognostic (7.75e-2)" "unprognostic (3.31e-1)" "unprognostic (1.37e-3)" "unprognostic (3.78e-2)" "unprognostic (1.03e-1)" "unprognostic (7.24e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (1.86e-1)" "unprognostic (2.28e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic favourable (3.49e-4)" "unprognostic (2.40e-2)" "unprognostic (1.97e-1)" "unprognostic (9.95e-2)" "unprognostic (4.18e-2)" 17.0 18.4 27.6 25.8 24.8 7.9 15.6 20.8 27.3 21.1 22.9 27.1 22.5 24.9 19.4 19.4 20.5 19.6 20.1 17.1 24.9 22.3 26.7 20.9 23.5 25.5 22.2 16.5 17.1 20.0 39.2 19.0 25.7 19.4 22.4 25.7 21.1 18.0 24.5 11.5 15.8 26.7 18.8 24.4 28.8 19.8 32.5 22.2 47.1 21.9 13.0 30.3 20.7 16.2 10.2 12.1 13.6 17.3 10.0 13.6 8.4 11.1 15.9 27.9 17.8 9.7 8.0 7.4 11.2 9.9 12.4 10.6 11.6 12.1 20.7 9.1 11.1 12.0 23.2 15.7 16.0 7.9 14.8 26.9 10.2 13.6 10.0 29.9 15.7 6.7 10.4 7.2 16.6 19.3 28.3 9.7 15.7 13.7 32.3 14.4 9.0 21.5 25.9 33.2 11.7 18.2 17.0 26.9 49.8 10.1 19.6 13.2 14.5 24.4 20.3 20.6 9.5 10.3 18.4 10.1 13.0 11.1 11.7 19.5 12.2 11.5 12.6 13.6 13.6 15.0 11.0 9.4 9.5 10.5 12.1 10.2 8.7 9.2 5.5 10.0 17.3 9.0 6.6 8.4 27.6 24.8 20.8 27.3 24.9 22.3 22.2 16.5 19.4 22.2 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262531 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favourable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavourable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 26.6 28.7 26.3 21.6 29.5 21.2 26.4 37.6 38.3 22.2 28.0 39.6 31.6 25.0 28.7 38.2 24.6 27.6 29.0 35.8 25.9 20.0 25.6 42.2 23.0 25.5 30.1 29.2 29.8 34.6 45.3 33.1 21.5 31.7 23.8 19.0 29.3 29.0 44.9 86.4 28.8 26.1 26.8 23.8 28.6 28.6 20.8 32.5 25.7 36.9 27.2 22.7 28.0 21.6 26.6 17.8 22.4 21.6 24.9 26.6 14.4 16.8 21.2 24.0 21.6 30.2 22.9 20.9 20.0 28.4 16.8 15.1 22.2 29.3 18.6 37.7 22.7 20.9 11.6 18.9 10.6 42.7 22.8 20.7 29.6 17.5 24.6 17.4 26.6 27.1 20.0 15.0 21.8 25.9 18.7 34.4 15.5 16.0 22.3 17.3 17.2 21.1 21.9 14.2 36.5 19.3 30.1 16.3 15.7 33.6 37.6 22.5 35.3 26.3 31.1 20.7 10.7 12.7 18.5 56.6 38.6 30.4 23.1 16.3 16.9 22.4 17.5 18.1 26.6 16.9 26.1 23.7 23.6 25.0 14.8 26.6 26.2 23.8 19.9 24.9 21.6 17.8 24.3 14.4 26.3 29.5 37.6 38.3 25.9 20.0 30.1 29.2 31.7 32.5 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 61.3;LHCN-M2: 102.3;RPTEC TERT1: 64.1;U-87 MG: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" 1800000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavourable (3.32e-5)" "prognostic unfavourable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 13.1 14.6 4.5 6.4 7.2 1.1 19.3 9.7 9.6 12.0 13.1 5.1 8.1 2.7 16.8 9.2 8.8 13.9 11.7 24.2 4.5 6.2 11.3 9.2 13.1 3.2 6.7 3.5 19.0 6.4 17.6 12.7 9.9 6.5 11.2 6.8 19.3 11.1 14.7 6.6 7.7 5.2 16.7 7.1 2.1 8.6 33.8 7.3 8.1 18.7 6.3 3.6 15.1 6.8 0.6 1.2 1.7 0.5 0.1 1.1 0.2 7.0 51.5 6.9 5.4 9.2 22.0 3.0 15.9 7.6 10.8 12.4 4.3 22.5 0.0 50.1 27.3 6.5 3.1 25.9 25.1 0.1 1.1 2.4 1.6 6.5 5.6 1.1 1.1 8.7 4.0 31.2 61.3 7.1 0.5 0.6 102.3 1.8 0.9 0.7 4.8 17.8 1.0 13.0 0.6 64.1 1.8 1.8 3.2 4.3 0.9 18.6 3.4 0.9 11.7 28.0 22.5 7.1 55.7 0.8 1.2 0.9 78.2 0.4 12.2 1.2 0.5 1.7 0.0 0.1 0.0 0.6 0.1 0.1 0.5 0.2 1.1 0.1 0.9 0.1 0.3 1.2 0.0 0.2 4.5 7.2 9.7 9.6 4.5 6.2 6.7 3.5 6.5 7.3 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171756-24358052 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 37.0;kidney: 46.4;pancreas: 22.7" "Cell line enhanced" "Detected in some" "CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Enhanced "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" "Mitotic spindle, Cytosol" "Microtubules, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: , HPA031584: " "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.1 0.9 1.1 0.2 1.5 0.0 3.5 0.3 0.9 1.6 0.3 0.2 1.0 0.3 3.4 37.0 0.2 5.8 7.7 0.2 1.3 1.7 46.4 1.8 3.9 0.0 0.6 0.5 2.1 22.7 7.6 4.3 1.7 1.8 1.5 0.3 2.8 0.9 3.7 0.5 0.2 0.2 0.4 0.5 0.1 1.1 3.7 0.2 0.2 8.4 0.0 0.2 1.0 0.1 1.2 0.5 1.3 0.4 1.0 0.5 0.2 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 1.5 0.1 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.4 0.3 0.5 0.2 0.2 0.5 0.5 0.3 0.3 1.2 0.4 0.4 1.3 1.0 0.2 0.5 0.2 0.2 1.1 1.5 0.3 0.9 1.3 1.7 0.6 0.5 1.8 0.2 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Cell line enriched" "Detected in some" 6 "U-2 OS: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA064159: " "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell line enhanced" "Detected in some" "ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: , HPA015655: " "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 17.3 16.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 13.3 0.0 10.3 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 15.1 7.5 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 21.4 0.2 0.0 1.2 0.0 0.6 0.0 4.3 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.5 4.4 0.7 0.1 0.0 0.0 1.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 DCLRE1A "hSNM1, KIAA0086, PSO2, SNM1" ENSG00000198924 "DNA cross-link repair 1A" Q6PJP8 10 113834725-113854383 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036907 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036907: AB_10673626" "unprognostic (1.22e-1)" "unprognostic (7.55e-2)" "unprognostic (4.84e-2)" "unprognostic (3.82e-2)" "unprognostic (1.09e-2)" "unprognostic (1.30e-2)" "prognostic unfavourable (5.74e-5)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (4.05e-2)" "unprognostic (2.85e-1)" "unprognostic (3.07e-1)" "unprognostic (6.34e-2)" 3.4 7.1 7.0 4.1 8.1 4.5 6.1 10.2 9.9 5.0 5.3 3.7 4.5 4.7 5.9 6.9 6.5 5.0 4.0 4.8 6.0 6.4 7.3 15.6 7.0 7.5 6.0 2.6 6.5 9.4 10.7 16.9 4.8 8.4 7.4 6.3 5.6 5.4 5.0 6.8 4.2 5.2 4.8 5.5 6.8 5.9 5.2 5.2 8.2 6.1 2.8 6.0 5.1 3.4 1.4 2.1 1.8 0.8 1.9 6.0 2.5 10.5 8.9 13.6 13.7 1.8 3.0 7.8 6.4 6.6 8.8 10.2 6.9 14.6 8.2 7.3 3.2 8.9 12.9 5.6 11.5 16.2 11.1 14.0 5.9 8.8 5.9 14.6 13.3 2.0 6.9 7.4 13.1 5.3 16.0 9.0 4.9 6.3 7.0 5.9 6.6 4.8 4.1 16.1 5.4 5.8 5.0 5.9 9.8 3.7 6.4 9.6 7.7 7.1 4.6 5.1 10.1 6.9 10.6 10.5 11.9 12.8 7.6 21.4 7.3 1.8 0.6 1.4 5.8 0.4 3.8 1.4 2.6 3.9 2.1 0.7 1.9 3.2 0.3 1.9 0.8 0.9 6.0 2.5 7.0 8.1 10.2 9.9 6.0 6.4 6.0 2.6 8.4 5.2 DCLRE1B "FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905141-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA064934: " "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavourable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavourable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavourable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 8.7 4.9 6.7 8.3 6.8 13.1 7.3 15.4 7.8 6.7 6.8 8.3 0.4 4.3 6.9 4.3 8.4 7.0 5.8 5.4 7.0 5.6 5.3 4.2 8.0 15.1 6.7 4.5 7.7 3.8 3.4 3.1 8.7 6.5 4.4 7.8 6.1 4.6 5.0 3.4 7.0 5.5 8.7 8.5 12.8 4.7 7.2 6.4 20.9 5.1 8.2 9.6 5.9 5.9 2.3 4.2 2.4 7.0 8.7 4.4 3.5 8.1 3.0 5.8 6.5 4.3 3.1 3.6 6.5 4.8 8.9 9.8 3.6 2.7 7.8 4.4 5.0 4.3 8.0 7.1 11.7 6.7 5.6 6.4 4.8 3.2 1.1 7.3 6.5 3.8 2.4 12.9 7.0 4.7 9.6 6.6 9.6 33.4 11.2 5.5 4.5 7.2 9.1 17.5 3.7 3.1 3.0 5.1 4.5 6.3 5.3 4.3 3.4 7.4 2.8 10.9 11.6 17.7 9.1 3.1 3.3 8.7 9.1 7.6 18.0 2.4 7.0 1.9 3.4 6.4 4.3 1.4 4.4 3.1 4.2 2.3 2.6 3.6 0.3 8.7 3.7 1.5 2.4 3.5 6.7 6.8 15.4 7.8 7.0 5.6 6.7 4.5 6.5 6.4 DCLRE1C "A-SCID, ARTEMIS, FLJ11360, SCIDA, SNM1C" ENSG00000152457 "DNA cross-link repair 1C" Q96SD1 10 14897359-14954432 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA recombination, DNA repair, Immunity" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069295 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA069295: " "unprognostic (8.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.66e-2)" "unprognostic (2.40e-2)" "unprognostic (1.36e-2)" "prognostic favourable (1.30e-4)" "unprognostic (8.02e-4)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic favourable (7.98e-4)" "unprognostic (1.91e-1)" "unprognostic (4.20e-2)" "prognostic unfavourable (9.03e-8)" "unprognostic (2.43e-2)" "unprognostic (2.32e-1)" "unprognostic (2.51e-1)" "unprognostic (5.45e-3)" 7.0 5.1 4.8 13.8 9.9 15.2 6.9 6.8 5.9 6.2 6.0 6.0 6.2 6.0 5.7 4.8 9.5 5.8 4.6 4.8 5.4 3.5 5.9 3.3 5.9 14.8 6.9 3.4 6.1 4.4 5.3 7.2 5.0 6.3 7.0 6.2 5.0 6.8 9.2 3.7 7.8 7.8 8.2 8.2 13.3 6.9 2.8 8.3 23.3 7.1 5.6 16.5 9.7 8.0 23.5 17.2 19.3 14.5 8.0 12.2 6.7 11.8 5.8 4.8 10.4 5.0 6.5 5.1 7.4 3.9 10.1 10.2 6.4 10.0 16.0 3.0 5.7 9.9 5.5 3.9 8.4 9.3 5.8 11.9 5.3 4.2 4.0 7.4 14.0 5.2 3.6 9.8 4.0 5.6 7.6 13.5 6.1 5.4 10.8 7.2 3.4 2.7 12.3 6.8 8.9 5.2 4.6 2.7 5.1 7.9 8.3 20.6 9.7 13.6 4.6 6.2 9.1 12.8 7.8 7.7 13.5 16.3 6.3 7.9 8.7 19.3 11.1 14.9 10.1 14.5 12.1 19.3 11.7 12.2 16.2 23.5 10.2 11.3 10.7 8.0 12.7 17.2 9.0 6.7 4.8 9.9 6.8 5.9 5.4 3.5 6.9 3.4 6.3 8.3 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946054-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 19.1" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 7.3 14.3 8.6 7.1 9.9 2.4 7.4 10.7 8.4 11.0 17.9 6.7 5.6 4.8 18.1 9.8 6.1 11.5 9.2 3.2 10.3 4.9 6.5 7.2 6.4 7.0 7.6 8.2 12.9 8.5 8.5 19.8 6.0 6.1 11.7 8.4 7.5 7.2 11.6 8.7 6.2 7.7 29.1 8.5 7.5 9.9 15.8 7.5 10.0 8.0 1.7 7.1 14.4 8.2 3.8 3.9 2.6 3.4 4.0 19.1 3.8 0.1 3.4 6.2 4.8 7.9 10.0 10.4 4.2 8.3 5.3 6.6 0.2 5.3 8.2 1.5 6.1 0.0 4.2 4.4 4.6 13.9 4.6 3.5 2.6 4.9 10.6 4.8 4.0 7.6 7.3 4.8 4.1 8.6 2.1 3.4 6.4 4.2 6.7 4.1 13.6 1.5 3.9 2.9 1.5 6.2 0.0 0.9 4.5 3.6 3.0 3.0 3.0 4.5 5.0 2.5 9.3 5.8 4.2 2.9 2.1 5.6 6.1 3.2 6.4 2.6 2.1 0.2 7.9 3.1 9.7 3.8 8.0 7.6 3.9 3.8 6.3 8.0 0.4 4.0 3.4 2.0 19.1 3.8 8.6 9.9 10.7 8.4 10.3 4.9 7.6 8.2 6.1 7.5 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: " "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavourable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavourable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 4.5 16.2 4.5 5.1 5.1 7.1 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 7.1 13.2 7.5 3.8 4.6 16.0 11.6 12.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 DCPS "HINT-5, HSL1, HSPC015" ENSG00000110063 "Decapping enzyme, scavenger" Q96C86 11 126303752-126345749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039632, HPA058597" Supported Supported Nucleoplasm,Cytosol 1400000 Nucleoplasm Cytosol "HPA039632: AB_10794200, HPA058597: " "unprognostic (1.45e-1)" "unprognostic (5.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.55e-2)" "unprognostic (5.22e-2)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (5.57e-2)" "unprognostic (1.91e-2)" "unprognostic (4.83e-2)" "unprognostic (5.00e-2)" "unprognostic (5.25e-2)" "unprognostic (2.24e-2)" "unprognostic (8.04e-2)" "unprognostic (7.67e-2)" "unprognostic (3.40e-2)" 11.1 13.1 6.8 14.4 8.2 13.5 9.2 8.5 14.5 12.1 10.6 6.8 8.0 7.8 12.4 9.6 14.4 9.9 13.9 10.9 5.5 6.1 13.3 39.6 9.9 18.5 6.3 5.8 11.8 17.2 7.0 9.5 14.1 6.8 12.7 11.7 13.3 17.4 9.4 21.8 11.3 9.7 11.3 7.1 21.9 9.6 13.4 6.5 22.0 12.7 18.5 22.1 15.1 9.8 13.2 39.5 3.2 14.3 7.8 14.6 7.1 10.5 6.6 8.3 13.7 6.4 8.6 6.9 5.6 8.3 8.6 8.7 12.5 21.7 14.4 21.2 8.9 12.4 11.7 17.6 5.7 27.2 6.3 21.1 7.6 10.8 14.0 22.6 19.1 8.7 11.1 10.9 14.9 11.5 8.5 24.7 9.4 15.2 14.4 25.9 5.8 22.7 10.0 12.1 27.4 8.3 11.8 10.7 8.2 17.0 13.9 10.3 23.6 14.2 7.3 13.5 6.3 6.4 10.5 9.9 9.2 14.9 3.9 39.2 33.8 1.7 9.2 3.2 8.8 14.3 8.2 13.2 8.5 9.0 15.4 9.0 6.0 6.8 0.5 7.8 12.6 39.5 14.6 7.1 6.8 8.2 8.5 14.5 5.5 6.1 6.3 5.8 6.8 6.5 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 75.0" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 DCTD ENSG00000129187 "DCMP deaminase" P32321 4 182890060-182917936 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035894 Approved Approved Nucleoplasm,Cytosol 13000 "Nucleoplasm, Cytosol" "HPA035894: AB_10673488" "unprognostic (1.26e-1)" "unprognostic (9.80e-3)" "unprognostic (3.15e-2)" "unprognostic (3.78e-3)" "unprognostic (3.13e-3)" "unprognostic (2.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.59e-3)" "unprognostic (2.62e-2)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.20e-1)" "prognostic favourable (1.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-1)" 24.8 46.2 24.7 19.9 23.8 12.9 27.3 11.6 28.3 27.1 20.4 17.3 22.6 16.4 26.0 20.1 30.9 25.9 40.9 25.8 22.5 22.2 25.7 47.6 25.8 29.4 21.1 20.3 35.9 51.7 28.3 25.3 18.9 21.3 23.7 21.5 30.0 26.4 22.8 24.8 19.4 19.1 27.4 25.6 24.9 27.2 11.8 16.7 15.0 52.9 21.3 26.0 24.5 25.1 31.9 24.8 23.7 25.7 30.8 36.8 22.7 22.4 20.7 21.2 19.5 32.0 43.7 27.7 43.3 38.7 31.1 19.3 21.0 43.7 7.8 10.7 42.2 11.2 15.4 27.0 28.6 37.8 11.7 36.1 12.0 25.0 34.3 35.1 22.6 36.3 28.9 27.3 28.5 26.6 35.8 78.2 41.3 16.3 22.7 21.5 16.8 18.1 24.8 15.1 15.1 25.0 27.0 20.9 13.0 20.5 17.7 20.2 13.6 18.4 30.9 25.9 19.9 12.5 33.0 30.1 16.2 10.0 28.6 23.0 30.4 23.7 22.0 19.7 29.2 25.7 36.8 31.9 25.6 29.7 24.8 21.7 25.5 26.7 1.6 30.8 24.9 19.1 21.9 22.7 24.7 23.8 11.6 28.3 22.5 22.2 21.1 20.3 21.3 16.7 DCTN1 ENSG00000204843 "Dynactin subunit 1" Q14203 2 74361154-74392087 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009108, HPA034635, HPA071875" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" 220000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB009108: AB_2090601, HPA034635: , HPA071875: " "unprognostic (1.14e-1)" "unprognostic (7.19e-2)" "unprognostic (1.33e-3)" "unprognostic (4.08e-2)" "unprognostic (1.20e-1)" "unprognostic (2.67e-1)" "unprognostic (4.61e-3)" "unprognostic (2.11e-2)" "unprognostic (2.79e-1)" "unprognostic (3.73e-3)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "prognostic favourable (2.34e-7)" "unprognostic (5.41e-2)" "unprognostic (3.11e-1)" "unprognostic (7.86e-3)" "unprognostic (1.12e-3)" 20.7 21.1 36.0 13.7 54.6 11.1 14.0 45.9 70.9 23.5 17.1 37.8 8.9 11.8 18.5 9.8 22.9 19.7 15.1 37.7 39.5 35.8 13.5 10.0 18.9 10.9 37.7 40.3 21.9 15.2 70.2 21.6 17.2 54.6 16.5 14.0 13.2 23.5 21.7 39.5 19.9 13.7 26.5 32.2 12.4 16.0 25.5 26.7 9.4 17.0 9.5 12.8 17.2 18.0 11.6 12.1 12.9 15.8 9.8 16.7 15.5 18.7 22.0 20.7 21.6 38.0 28.3 16.7 30.3 31.6 38.6 27.6 29.2 14.5 25.9 12.4 62.8 18.8 25.2 38.4 29.5 32.1 25.4 26.8 17.7 24.5 29.3 14.6 33.2 34.0 18.8 41.9 25.1 33.0 11.5 18.5 29.1 16.1 26.5 15.1 22.3 23.4 23.8 36.4 18.5 21.4 11.6 25.5 22.6 16.9 20.4 18.2 13.1 10.6 24.9 35.2 25.6 15.1 22.4 11.5 9.1 23.5 32.9 23.8 24.6 7.3 11.4 12.9 16.7 14.2 13.5 11.6 9.5 12.4 12.1 8.6 6.8 7.5 9.8 9.8 15.8 9.6 8.1 15.5 36.0 54.6 45.9 70.9 39.5 35.8 37.7 40.3 54.6 26.7 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favourable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favourable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 26.4 32.5 42.4 16.2 49.1 46.5 30.4 33.7 58.3 25.7 23.3 20.7 22.2 21.4 24.6 25.5 33.7 31.7 23.1 42.8 36.3 37.4 32.8 32.4 21.1 21.9 35.8 48.4 32.6 33.7 29.8 36.3 23.0 37.4 27.4 20.6 27.5 32.4 28.6 69.1 37.9 18.3 28.0 26.2 19.4 23.7 16.2 22.0 42.6 32.4 37.1 29.2 22.5 24.9 28.5 44.6 62.3 45.9 29.9 56.0 46.8 34.0 28.6 26.6 27.8 23.7 33.1 11.0 29.1 27.2 40.6 32.0 18.3 12.8 15.7 18.3 38.3 13.6 24.1 30.5 26.0 49.2 30.3 10.4 50.6 15.7 25.6 27.4 31.9 29.1 26.4 28.0 18.4 26.7 12.4 32.6 35.3 28.0 34.5 74.0 8.0 46.2 17.4 14.4 21.5 19.5 12.1 8.8 22.7 21.6 19.9 11.1 26.6 31.5 24.2 25.6 20.7 29.0 28.2 22.0 28.5 10.4 40.3 16.0 52.0 62.3 44.0 59.3 35.2 44.2 32.0 28.5 37.8 37.2 44.0 28.3 29.9 35.7 38.4 29.9 45.9 44.6 56.0 46.8 42.4 49.1 33.7 58.3 36.3 37.4 35.8 48.4 37.4 22.0 DCTN4 ENSG00000132912 "Dynactin subunit 4" Q9UJW0 5 150708440-150759109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017532, HPA038026" Uncertain Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "CAB017532: AB_1122152, HPA038026: " "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.87e-3)" "unprognostic (7.82e-3)" "unprognostic (1.37e-2)" "unprognostic (2.08e-1)" "unprognostic (8.41e-2)" "unprognostic (1.38e-1)" "unprognostic (5.86e-2)" "unprognostic (9.68e-3)" "unprognostic (1.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.83e-1)" 26.1 27.9 27.9 13.3 27.3 41.0 25.7 30.3 36.5 19.8 15.9 32.4 17.7 15.9 20.6 27.6 20.0 18.4 16.5 20.6 27.3 29.0 20.0 22.0 17.8 13.3 30.8 24.0 26.3 32.5 23.9 27.7 25.9 33.2 24.1 18.6 21.3 15.7 22.4 42.0 19.0 15.4 21.3 34.7 13.9 18.0 22.9 25.4 18.8 24.8 15.3 14.5 23.3 16.2 5.0 10.9 16.4 10.7 3.0 6.9 5.2 9.4 11.3 20.5 34.2 25.1 24.3 16.9 16.7 16.8 20.2 20.4 21.1 11.9 9.2 23.4 19.8 11.5 25.2 19.6 24.8 18.5 19.8 11.9 13.1 13.2 22.9 14.3 17.0 24.5 17.5 18.1 31.8 14.3 18.1 11.9 26.1 9.9 8.8 7.7 10.3 17.8 7.8 12.4 10.2 15.0 16.2 46.6 19.6 17.7 24.2 24.8 23.4 19.2 15.9 22.6 12.7 14.7 17.6 10.6 13.5 5.5 26.0 19.3 18.4 3.2 10.7 10.5 5.5 7.8 5.6 5.0 6.2 5.4 10.9 4.4 5.9 6.9 16.4 3.0 6.4 5.1 4.3 5.2 27.9 27.3 30.3 33.3 27.3 29.0 30.8 24.0 33.2 25.4 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641392-23677455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: " "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavourable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favourable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 16.9 16.4 26.6 17.5 38.8 36.9 15.9 19.0 47.1 15.3 19.3 26.9 13.3 20.9 19.2 13.1 30.4 14.6 14.7 17.3 19.4 17.2 22.0 15.4 17.4 20.7 19.1 23.8 14.7 18.6 23.2 17.6 21.1 29.0 18.4 26.1 17.4 19.7 15.5 21.0 23.8 22.2 22.3 19.7 21.5 19.4 20.1 19.9 16.2 19.6 10.5 31.6 20.9 18.7 14.5 17.0 19.0 19.3 20.2 17.9 16.0 11.7 23.5 23.0 19.2 16.4 12.3 16.2 20.9 13.1 13.6 16.4 26.3 16.3 16.6 17.1 21.9 12.4 38.0 20.2 16.9 18.9 15.0 20.5 28.2 37.0 11.2 24.9 15.9 10.2 14.6 16.7 17.8 21.3 39.0 12.9 21.7 32.6 19.1 7.2 27.2 10.4 23.5 19.9 18.1 11.0 25.0 19.3 20.0 18.4 15.0 12.4 20.9 21.2 28.8 18.3 8.4 14.3 14.6 17.6 26.2 26.7 17.5 12.5 19.8 11.2 16.1 19.0 16.2 13.5 17.9 14.5 15.0 17.5 17.0 11.2 12.8 15.1 7.0 20.2 19.3 11.8 17.3 16.0 26.6 38.8 19.0 47.1 19.4 17.2 19.1 23.8 29.0 19.9 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156297-30183640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavourable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favourable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 29.5 34.6 41.4 15.6 39.4 23.3 32.6 23.6 43.6 21.0 20.6 27.4 15.4 14.2 24.1 27.2 24.1 18.0 20.0 44.5 37.7 35.2 32.8 27.5 20.3 15.3 42.3 36.3 26.3 19.5 31.0 27.7 32.7 41.4 21.9 22.5 16.5 20.3 23.7 20.4 17.5 15.6 26.0 46.2 16.8 19.3 13.9 30.3 15.4 33.7 18.2 17.9 25.7 18.8 7.4 19.8 9.5 15.9 10.2 11.2 6.9 18.9 18.2 23.0 12.1 21.0 28.9 14.8 25.8 29.9 25.2 26.4 11.8 12.6 14.1 27.7 27.0 14.1 15.9 21.8 29.7 11.3 12.4 20.2 15.6 18.5 16.2 11.4 17.2 24.4 31.2 18.0 19.3 22.5 22.6 15.6 26.7 14.4 21.1 16.4 18.8 11.6 11.3 17.3 12.3 35.8 18.6 37.8 21.4 15.0 18.5 25.6 17.8 16.2 21.6 13.7 47.8 11.2 18.3 6.6 7.4 18.2 25.2 13.1 23.8 9.5 14.1 4.9 8.6 15.9 9.8 7.4 7.8 10.1 16.8 5.5 9.0 11.2 4.5 10.2 15.1 19.8 8.7 6.9 41.4 39.4 23.6 43.6 37.7 35.2 42.3 36.3 41.4 30.3 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423619-30430075 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Approved Nucleoplasm,Cytosol 270000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavourable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favourable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 15.3 15.8 14.8 25.0 13.2 12.5 20.7 15.5 19.2 12.1 37.4 10.3 11.3 20.7 14.1 14.4 19.7 18.9 28.1 23.3 12.1 12.6 27.0 25.3 11.2 27.6 13.3 16.6 16.6 25.2 16.4 7.7 16.3 11.4 15.4 40.3 10.6 20.5 21.1 28.3 16.1 22.9 13.9 11.3 22.5 16.4 9.9 7.8 21.3 22.6 26.0 25.0 13.2 13.0 47.3 30.9 19.0 24.5 23.1 26.2 25.3 26.3 32.4 14.8 19.0 4.2 5.7 13.7 12.7 7.6 19.2 19.6 24.3 22.5 35.7 26.7 7.9 20.7 30.6 24.9 24.0 18.8 48.3 20.8 14.9 31.6 5.4 37.1 32.4 6.5 14.2 21.4 12.3 19.7 26.1 12.6 13.6 46.0 44.1 41.6 19.5 26.2 62.6 16.4 46.5 22.2 17.2 31.5 17.8 8.4 30.2 11.9 26.1 16.0 9.9 14.9 13.3 19.1 22.8 8.3 24.7 45.5 9.8 30.8 17.3 19.0 12.4 11.7 18.8 22.1 26.2 47.3 24.2 21.3 28.7 40.2 21.8 21.0 1.5 23.1 24.5 30.9 24.1 25.3 14.8 13.2 15.5 19.2 12.1 12.6 13.3 16.6 11.4 7.8 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.0 10.2 13.7 5.9 14.6 14.3 11.6 14.8 16.7 16.7 16.4 15.1 17.2 27.0 32.6 13.8 13.0 11.5 11.9 22.2 22.1 6.2 26.0 8.0 6.3 9.2 15.3 19.7 10.2 14.5 9.3 8.8 11.4 8.7 14.2 12.2 12.4 15.0 8.2 11.2 9.4 11.8 14.5 17.9 12.0 16.3 10.0 9.9 25.9 18.7 13.9 38.2 12.4 11.1 10.4 10.0 14.1 17.4 11.7 21.8 27.5 13.0 14.5 14.9 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell line enhanced" "Detected in all" "SCLC-21H: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favourable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.7 4.2 7.1 5.4 5.2 4.6 5.5 5.3 6.5 5.0 5.7 15.0 4.1 4.9 1.7 6.1 9.8 7.6 4.0 7.2 3.2 12.8 8.3 19.2 4.1 2.7 12.6 6.2 6.8 6.7 5.6 4.5 4.2 4.6 4.7 4.8 4.8 8.6 20.8 4.5 6.6 9.0 11.7 6.5 3.7 4.5 31.6 7.0 4.1 14.2 3.9 8.1 5.9 7.0 6.6 9.0 5.0 7.6 14.0 5.9 9.8 15.0 5.6 4.4 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 38.4" "Cell line enhanced" "Detected in all" "ASC diff: 30.1;ASC TERT1: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: " "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavourable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 19.2 9.9 4.3 6.0 4.6 2.7 17.2 7.9 5.6 7.5 6.0 5.5 3.2 3.4 7.7 5.9 8.5 6.6 9.6 8.9 2.5 2.8 10.0 17.4 9.7 3.1 5.2 3.0 5.3 6.6 6.4 9.5 9.4 6.7 6.6 4.1 6.3 3.9 4.5 38.4 7.1 4.9 11.9 3.9 4.5 6.4 7.9 3.8 1.5 4.8 11.5 4.5 6.7 15.8 1.4 1.6 4.8 2.5 2.6 2.7 1.0 2.6 4.7 2.4 5.1 30.1 22.7 3.2 8.9 7.7 4.5 6.1 5.9 5.1 1.7 7.3 8.7 3.7 2.7 3.7 6.0 2.3 1.9 1.4 3.7 8.5 7.9 2.2 13.7 14.9 5.1 8.6 4.9 12.3 1.6 4.6 9.2 3.6 2.0 3.1 5.6 1.6 3.4 2.7 1.6 4.0 2.8 2.2 2.9 3.5 3.9 2.0 2.6 1.0 6.0 9.6 3.4 4.0 2.4 3.9 2.3 1.2 10.2 2.3 4.9 4.8 1.4 1.2 1.7 2.5 1.7 1.0 1.2 2.7 1.6 1.4 1.5 2.7 1.9 2.6 2.2 1.2 1.0 1.0 4.3 4.6 7.9 5.6 2.5 2.8 5.2 3.0 6.7 3.8 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 16.9 22.9 15.9 9.9 26.1 3.5 13.5 15.4 24.8 15.9 14.3 12.8 15.5 7.6 17.8 17.3 13.4 13.6 14.2 14.9 29.8 22.3 19.4 36.5 10.4 10.7 17.7 22.0 20.8 9.8 9.9 19.8 9.3 24.6 16.6 12.0 9.4 15.9 22.9 14.3 10.2 9.8 31.4 24.0 11.4 14.6 20.4 13.4 3.9 16.8 8.6 8.2 20.3 13.7 4.6 2.9 10.2 4.2 4.4 10.7 5.3 5.6 10.2 13.8 19.9 14.1 14.2 5.3 17.6 13.1 10.1 9.1 6.5 6.1 4.2 11.4 19.9 5.7 17.5 11.0 13.9 2.7 5.1 7.5 7.9 15.7 29.8 10.4 10.1 14.6 13.1 11.5 10.1 10.1 8.3 3.1 17.4 8.3 12.7 7.3 8.1 8.3 6.1 7.1 2.4 13.1 6.7 8.1 8.8 7.6 9.4 14.6 9.7 6.6 16.4 13.4 11.0 10.7 14.0 5.8 8.2 3.9 9.4 9.9 7.6 5.5 4.2 10.2 7.2 3.7 10.7 4.6 8.1 8.0 2.9 3.3 7.8 8.5 1.7 4.4 2.6 1.9 3.7 5.3 15.9 26.1 15.4 24.8 29.8 22.3 17.7 22.0 24.6 13.4 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103062076-103092215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA050863: " "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavourable (4.62e-4)" "prognostic unfavourable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favourable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavourable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 20.9 18.3 18.9 17.2 24.5 13.4 19.1 22.5 28.8 12.9 13.5 15.9 11.5 11.4 15.9 13.7 26.5 12.9 10.6 24.2 20.3 16.6 14.4 19.0 13.9 21.5 15.6 21.0 12.2 17.7 14.5 17.0 17.3 23.6 15.4 13.9 9.9 15.6 13.5 38.7 14.0 11.3 18.4 17.5 15.7 16.0 24.0 21.0 19.4 13.2 24.2 21.3 14.4 14.7 14.4 17.3 11.8 13.1 20.5 17.0 13.4 22.0 12.2 13.5 20.7 11.0 14.0 15.0 21.9 11.9 18.1 18.6 46.9 25.8 10.6 38.7 15.5 21.0 28.4 27.7 18.6 18.7 19.1 28.5 10.5 18.2 18.7 40.8 14.8 12.2 24.6 24.2 25.1 22.3 46.5 0.0 17.1 19.9 26.9 31.9 26.3 31.3 11.5 21.6 27.0 13.7 22.7 18.3 19.5 20.4 20.9 18.2 24.5 17.1 18.1 14.7 17.8 26.0 19.5 9.0 14.2 35.5 10.4 40.1 15.2 11.8 11.1 10.2 13.8 13.1 16.3 14.4 16.3 14.2 13.7 14.1 14.0 16.3 4.0 20.5 10.0 17.3 17.0 13.4 18.9 24.5 22.5 28.8 20.3 16.6 15.6 21.0 23.6 21.0 DCXR "DCR, KIDCR, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037732 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 293.8" "Cell line enhanced" "Detected in all" "Hep G2: 64.9;MCF7: 79.8" "Cancer enhanced" "Detected in all" "liver cancer: 305.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules 2700000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favourable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favourable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 12.7 6.1 12.8 4.3 12.1 5.7 12.2 9.0 15.1 9.9 9.5 8.4 18.1 7.8 4.4 62.7 11.7 6.1 4.8 11.8 9.8 9.7 50.8 293.8 10.5 5.3 14.4 7.3 8.1 13.0 6.7 7.2 9.0 13.4 22.3 5.4 7.8 19.3 14.0 22.5 8.6 6.8 3.6 8.4 4.4 14.9 8.7 9.7 8.3 15.6 12.6 9.1 7.5 6.4 32.8 52.7 25.3 33.1 35.2 43.7 35.8 8.9 12.3 5.7 10.3 23.0 5.8 15.2 4.6 6.0 12.7 8.7 21.8 3.9 18.5 9.0 6.4 10.6 10.4 9.2 4.4 3.9 26.7 17.7 9.2 64.9 24.7 13.6 21.8 8.4 11.5 4.0 14.6 7.1 20.2 13.5 6.7 79.8 11.4 32.7 6.6 13.1 10.5 7.7 24.2 9.4 12.7 15.9 9.4 6.4 55.0 8.0 41.2 13.5 3.6 6.7 8.4 9.0 8.6 13.9 10.2 8.7 5.7 15.0 4.9 13.9 33.1 25.3 24.7 30.6 23.6 28.6 30.8 23.6 52.7 32.8 43.7 31.9 16.5 35.2 28.0 42.5 33.1 35.8 12.8 12.1 9.0 15.1 9.8 9.7 14.4 7.3 13.4 9.7 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323301 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: " "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 11.6 15.5 24.5 12.7 26.6 16.1 9.9 14.6 36.2 10.8 14.6 13.5 9.6 15.4 11.6 9.9 13.4 13.5 11.8 16.4 18.9 19.8 12.9 17.9 14.6 14.7 19.0 24.4 12.9 13.4 10.9 10.9 26.4 23.0 12.9 13.1 10.8 13.6 15.9 17.8 20.8 16.9 11.5 13.2 13.4 17.4 29.6 12.0 15.9 10.5 10.9 13.7 12.4 9.9 7.1 12.7 11.5 8.0 6.5 8.8 5.7 12.4 11.1 8.4 6.7 8.8 6.3 13.1 8.5 10.8 13.0 12.0 9.8 11.0 4.9 11.8 8.7 10.6 6.2 12.3 6.3 8.1 16.4 6.0 8.8 9.2 10.7 6.8 11.8 9.7 14.2 7.8 7.2 7.5 7.1 8.6 6.8 6.2 13.6 10.1 9.6 19.0 8.7 6.6 8.2 10.2 9.3 8.6 12.9 6.2 14.3 7.4 7.2 9.1 11.3 8.7 7.3 22.4 11.7 10.7 14.4 6.9 19.2 11.7 8.6 5.0 7.3 11.5 8.6 8.0 7.4 7.1 7.2 8.5 5.9 6.6 8.3 8.0 8.2 6.5 6.9 12.7 8.8 5.7 24.5 26.6 14.6 36.2 18.9 19.8 19.0 24.4 23.0 12.0 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell line enhanced" "Detected in many" "SH-SY5Y: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006308 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favourable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favourable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.7 2.3 6.6 1.2 11.1 9.4 0.8 22.1 13.4 7.9 8.4 26.6 5.0 0.0 9.2 25.0 5.4 23.9 4.6 10.1 0.0 9.2 0.0 6.3 9.2 4.0 17.0 1.0 7.8 0.4 6.6 4.2 12.5 0.0 1.9 20.2 1.5 0.9 0.0 7.9 6.9 0.0 15.5 0.2 33.7 14.0 18.7 36.3 2.9 16.8 2.7 9.1 1.3 24.4 6.9 5.6 1.7 15.4 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;ASC TERT1: 13.2;EFO-21: 16.9;fHDF/TERT166: 10.5;SK-MEL-30: 10.6;U-2 OS: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012509 Uncertain Supported "Centriolar satellite,Cytosol" 1800000 Cytosol "Centriolar satellite" "HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 24.3 7.8 12.5 11.1 10.3 5.5 22.7 3.1 7.8 32.1 17.0 7.9 12.9 2.6 34.6 22.0 18.4 18.1 26.7 20.7 11.8 10.8 16.9 12.9 37.4 16.5 10.6 6.6 22.5 4.3 3.0 6.2 13.7 13.1 19.8 5.4 13.0 18.1 13.2 6.8 15.1 22.3 27.1 18.9 21.4 11.4 7.3 9.9 14.1 35.4 17.1 8.9 16.3 23.4 2.9 5.5 8.0 2.7 2.3 0.5 0.3 0.4 6.6 0.2 1.4 10.6 13.2 0.7 0.6 0.3 0.4 0.1 4.3 0.7 0.2 16.9 10.5 0.8 0.0 6.2 0.0 0.1 8.9 0.5 0.5 0.1 0.3 0.9 0.0 8.5 0.1 0.8 0.1 0.1 0.2 2.2 0.0 3.6 0.5 2.5 0.1 0.2 0.3 0.5 0.0 7.5 0.7 0.4 0.9 0.3 0.0 10.6 0.7 0.9 1.1 0.8 12.6 0.2 0.1 2.7 9.2 2.5 7.3 1.5 0.2 8.0 0.8 7.7 0.5 2.6 0.3 2.9 0.2 0.3 1.5 2.5 0.1 0.1 1.3 2.3 2.7 5.5 0.4 0.3 12.5 10.3 3.1 7.8 11.8 10.8 10.6 6.6 13.1 9.9 DDB2 "DDBB, FLJ34321, UV-DDB2, XPE" ENSG00000134574 "Damage specific DNA binding protein 2" Q92466 11 47214465-47239240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025912, HPA058406" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB025912: , HPA058406: " "prognostic favourable (7.29e-4)" "prognostic favourable (1.58e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.20e-4)" "unprognostic (4.29e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-2)" "unprognostic (6.18e-2)" "unprognostic (2.25e-1)" "unprognostic (3.58e-3)" "unprognostic (3.53e-1)" "unprognostic (1.94e-1)" "unprognostic (4.57e-3)" "unprognostic (1.21e-2)" "unprognostic (4.25e-2)" "unprognostic (9.82e-3)" "unprognostic (1.07e-1)" 12.2 22.2 5.3 13.3 8.6 8.1 11.3 11.0 8.2 16.8 13.5 7.3 13.4 6.0 18.2 14.1 25.4 14.3 13.0 6.1 4.7 2.9 6.6 20.8 11.3 16.1 15.0 5.0 9.8 15.6 6.1 8.6 5.5 6.3 20.9 12.3 8.1 17.6 14.8 6.3 36.9 11.0 19.0 17.6 15.1 9.1 7.6 7.6 23.3 6.6 16.7 26.0 17.3 15.2 11.4 6.1 11.5 11.0 7.4 27.0 9.0 8.2 22.3 9.3 7.0 6.0 12.2 11.0 9.1 21.3 11.6 13.7 3.6 4.8 19.9 1.9 8.3 14.6 5.3 18.5 5.8 4.9 10.0 4.7 21.3 16.5 5.9 5.4 12.4 16.3 21.0 5.8 13.0 34.0 1.2 9.7 19.0 15.6 20.7 2.6 3.0 8.1 10.4 2.3 10.7 4.9 8.2 4.9 6.1 11.1 3.2 2.9 20.4 1.8 14.6 35.7 16.3 7.8 4.2 10.2 7.7 4.4 13.4 6.9 12.8 5.9 8.1 11.5 12.1 11.0 11.7 11.4 12.7 11.7 6.1 7.4 9.4 10.1 2.2 7.4 9.2 0.1 27.0 9.0 5.3 8.6 11.0 8.2 4.7 2.9 15.0 5.0 6.3 7.6 DDHD2 "KIAA0725, SAMWD1, SPG54" ENSG00000085788 "DDHD domain containing 2" O94830 8 38225218-38275558 "Disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015202, HPA023143, HPA023147" Supported Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "CAB015202: , HPA023143: AB_1847534, HPA023147: AB_1847535" "unprognostic (1.49e-3)" "unprognostic (2.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" "unprognostic (2.64e-1)" "prognostic favourable (7.72e-4)" "unprognostic (4.54e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.49e-2)" "unprognostic (3.01e-3)" "unprognostic (3.21e-2)" "unprognostic (2.46e-1)" "unprognostic (7.88e-2)" "unprognostic (1.49e-1)" 20.1 14.3 24.5 13.5 27.1 9.4 14.9 34.4 48.1 18.9 13.5 23.2 10.6 15.3 16.6 18.7 16.9 15.5 13.9 21.3 26.6 25.1 17.4 9.1 13.0 13.8 28.6 24.9 24.3 16.4 17.3 15.4 11.8 27.5 18.6 13.4 20.0 13.6 23.8 21.4 12.5 17.1 16.7 37.3 12.5 11.0 16.8 17.9 8.8 15.0 9.3 16.4 14.9 13.3 13.3 5.5 3.7 4.0 13.2 12.3 5.9 25.0 11.4 25.9 12.7 10.4 14.0 8.4 7.9 14.2 18.9 17.0 13.7 9.9 10.0 11.1 13.7 9.7 14.6 14.6 28.9 8.5 10.0 35.6 15.7 13.0 9.0 4.2 5.6 7.2 11.7 11.7 12.2 22.3 25.2 10.9 11.9 5.3 28.1 6.3 5.8 6.8 15.0 22.4 6.8 10.3 15.0 9.4 14.6 19.2 10.2 9.7 11.7 11.2 20.3 10.8 14.4 10.7 12.5 11.6 10.4 22.7 17.7 8.1 15.3 2.1 3.1 3.7 9.6 4.0 10.7 8.3 8.6 10.6 5.5 13.3 9.5 6.7 0.3 13.2 2.8 3.0 12.3 5.9 24.5 27.1 34.4 48.1 26.6 25.1 28.6 24.9 27.5 17.9 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617500-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol 170000 "Nucleoplasm, Cytosol" "HPA043119: , HPA043225: " "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 14.8 8.1 5.1 10.5 7.1 10.5 15.0 8.7 8.4 8.7 10.8 8.2 9.8 9.0 12.3 9.6 19.4 7.7 8.3 12.5 5.8 4.7 10.4 24.9 10.2 9.1 6.7 5.2 8.3 9.4 14.8 8.0 11.5 7.5 12.1 7.9 11.5 13.5 13.8 54.8 13.3 9.2 8.0 6.5 9.9 6.9 4.3 6.0 11.1 7.6 11.7 16.4 12.1 12.3 3.8 5.4 0.8 2.3 2.0 3.5 1.4 7.4 4.3 7.9 8.2 10.9 8.6 7.7 4.7 3.6 4.1 3.6 10.6 6.8 18.8 5.5 5.1 8.0 17.2 7.6 7.0 8.6 11.5 14.7 7.3 10.4 4.7 19.4 7.4 8.5 9.0 7.7 8.3 8.4 23.5 7.0 5.0 5.0 11.2 6.4 7.6 3.6 10.6 11.2 11.1 5.8 6.2 9.7 5.4 8.8 14.2 13.0 7.4 5.1 7.3 6.0 5.1 6.7 5.7 6.6 7.9 15.2 4.7 14.2 4.6 0.7 2.3 0.4 3.3 2.1 2.9 2.6 2.5 2.6 2.3 3.8 2.8 3.5 0.8 2.0 1.6 5.4 2.3 1.4 5.1 7.1 8.7 8.4 5.8 4.7 6.7 5.2 7.5 6.0 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: " "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.5 9.8 7.1 1.0 1.5 7.2 11.4 4.8 12.6 14.7 9.3 7.5 7.3 17.1 2.6 11.5 16.6 7.2 17.5 13.2 8.9 10.4 4.9 4.1 0.1 12.7 9.2 0.3 0.7 15.9 7.3 5.9 10.4 12.7 11.1 8.7 12.0 10.4 11.7 10.9 8.9 19.0 9.4 2.7 10.0 7.4 9.9 7.0 7.1 2.7 7.7 5.3 2.8 12.7 17.2 33.3 13.8 7.2 18.9 25.5 4.0 9.2 12.0 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 13.8;BJ: 20.2;fHDF/TERT166: 10.9;HSkMC: 10.5;RPTEC TERT1: 14.4" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favourable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.5 5.9 0.0 2.7 13.8 0.8 20.2 1.7 0.3 0.1 0.1 0.6 0.0 0.5 10.9 0.0 4.2 0.3 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 10.5 0.1 0.2 1.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 6.7 0.0 0.4 0.0 0.0 14.4 0.0 0.0 0.0 0.4 0.8 2.7 0.0 0.1 0.1 0.0 0.0 0.0 1.5 2.7 0.0 0.0 5.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999309 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 40.8;skeletal muscle: 73.8" "Cell line enhanced" "Detected in some" "HAP1: 10.3;RPMI-8226: 19.7;SCLC-21H: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1" HPA060952 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA060952: " "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.7 0.7 40.5 0.8 40.8 1.3 0.7 0.0 38.5 0.7 0.7 0.2 0.0 0.7 0.7 3.8 1.0 0.7 0.7 0.9 30.5 2.0 4.8 0.7 0.7 0.9 2.9 9.3 0.7 0.8 0.8 0.0 0.7 0.0 1.6 0.7 0.0 0.7 0.7 73.8 0.8 0.8 0.7 0.0 0.8 0.8 0.8 1.2 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 4.4 0.4 0.0 0.2 0.0 1.5 10.3 0.0 0.1 0.5 4.7 2.3 0.5 1.0 0.0 5.3 0.2 0.0 0.1 0.1 0.0 0.1 0.0 3.5 0.2 0.1 5.2 5.8 0.1 1.4 4.8 0.3 19.7 0.0 0.1 10.3 1.0 0.2 0.5 0.2 0.2 0.7 0.1 0.2 0.5 0.2 0.0 1.2 2.3 4.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 40.5 40.8 0.0 31.9 30.5 2.0 2.9 9.3 0.0 1.2 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favourable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.3 6.4 9.1 1.9 0.6 0.8 5.6 0.5 0.1 0.2 0.0 8.6 10.3 0.1 10.8 1.7 31.2 1.9 24.0 0.1 10.7 3.4 0.0 5.8 2.2 1.8 0.0 0.4 1.2 12.4 0.1 0.2 0.7 5.6 0.2 1.3 12.2 0.6 0.0 1.5 1.3 1.3 6.8 0.7 4.6 31.9 1.6 0.8 1.8 14.4 7.0 35.8 0.2 1.4 4.5 4.2 0.4 4.5 0.2 0.0 0.8 2.9 0.0 3.9 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787400 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 60.6;ASC TERT1: 59.9;BJ hTERT+: 44.3;fHDF/TERT166: 31.7;HSkMC: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Supported "Plasma membrane,Actin filaments" 850000 "Plasma membrane, Actin filaments" "HPA070112: " "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 42.1 43.5 4.7 10.9 6.9 0.2 15.6 7.9 7.1 30.3 30.4 9.0 18.6 3.3 24.2 17.7 25.0 13.4 16.6 15.4 7.9 4.7 4.0 3.3 8.9 5.1 12.9 3.4 26.4 2.2 2.1 4.0 6.6 12.7 21.8 9.1 30.7 6.4 19.3 5.2 6.1 10.1 34.3 19.7 3.4 14.1 8.3 7.5 0.0 8.6 12.8 4.1 29.0 18.3 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 16.0 60.6 59.9 0.2 23.6 44.3 10.3 14.9 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.1 14.1 12.7 0.1 0.0 0.0 0.0 26.3 0.0 0.0 42.5 0.1 18.2 0.4 11.8 0.1 5.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 6.7 0.1 0.0 0.0 0.0 9.7 0.0 0.0 0.8 0.0 0.0 0.6 16.5 3.6 8.3 3.2 0.7 1.3 0.0 14.9 0.0 16.7 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.7 6.9 7.9 7.1 7.9 4.7 12.9 3.4 12.7 7.5 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: " "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favourable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 29.5 47.3 28.5 18.6 45.7 17.8 20.5 33.4 38.2 22.1 23.9 29.8 23.7 35.3 21.5 17.8 21.1 21.0 24.3 17.7 27.0 21.8 28.5 54.0 27.0 17.5 47.9 22.9 23.9 43.6 37.5 17.7 31.3 30.9 27.3 16.6 20.6 48.5 29.3 29.5 22.2 31.9 17.1 36.8 20.2 31.5 14.7 39.3 12.6 34.0 14.2 16.2 20.8 29.4 15.1 32.0 24.4 20.2 12.3 21.0 12.9 29.5 37.3 9.2 17.2 21.0 8.0 13.3 18.9 9.1 11.7 12.8 29.3 21.6 17.7 15.4 10.4 33.2 9.5 28.2 4.3 12.0 17.7 15.0 12.4 50.8 28.8 16.9 16.3 12.5 27.7 22.3 16.0 10.6 20.7 21.3 7.4 16.2 11.5 31.5 11.4 17.2 15.3 8.2 26.9 18.9 27.8 20.5 12.6 19.4 54.9 17.5 23.3 10.4 16.0 18.8 8.4 13.2 28.7 16.0 18.0 7.5 5.2 14.3 10.9 11.7 20.2 24.4 19.6 13.3 19.5 15.1 20.9 21.0 20.5 15.1 18.7 18.2 5.4 12.3 12.1 32.0 18.6 12.9 28.5 45.7 33.4 38.2 27.0 21.8 47.9 22.9 30.9 39.3 DDX1 DBP-RB ENSG00000079785 "DEAD-box helicase 1" Q92499 2 15591178-15631111 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing" "Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012280, HPA034502, HPA034503" Enhanced Enhanced Nucleoplasm,Cytosol 46000 Nucleoplasm Cytosol "CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025" "unprognostic (9.94e-2)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (8.36e-3)" "unprognostic (9.28e-3)" "unprognostic (1.56e-2)" "prognostic unfavourable (9.09e-9)" "unprognostic (2.55e-1)" "unprognostic (2.05e-1)" "unprognostic (4.81e-3)" "unprognostic (3.89e-2)" "unprognostic (2.03e-1)" "prognostic favourable (9.69e-4)" "unprognostic (3.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.94e-2)" "unprognostic (1.20e-3)" 23.8 28.2 29.3 17.6 35.0 17.1 30.1 35.3 37.2 25.1 24.5 15.0 20.5 21.0 24.3 25.6 27.7 21.0 15.8 47.6 34.7 25.3 35.8 35.2 17.8 16.0 24.5 36.9 23.6 27.6 42.1 41.2 28.1 35.1 22.2 28.1 14.8 23.9 24.5 67.5 24.5 25.9 31.0 21.0 17.1 24.1 19.2 23.0 23.0 29.6 24.8 21.5 26.1 19.8 18.7 22.8 19.2 25.1 23.0 26.6 19.9 19.1 29.4 41.8 31.2 36.3 31.9 48.2 40.3 33.8 39.7 33.4 46.9 19.8 49.7 19.6 46.4 29.2 57.1 38.6 42.0 21.1 37.1 54.5 39.3 59.1 27.3 44.5 25.7 24.7 26.7 33.0 31.8 35.7 55.5 16.4 39.1 26.8 24.3 33.6 53.8 24.8 29.4 63.3 36.0 45.4 38.6 33.7 42.2 27.5 29.0 36.6 20.2 18.9 28.8 33.3 34.5 20.9 45.4 21.5 37.3 67.1 30.0 35.7 31.0 19.2 20.0 11.5 20.2 25.1 21.3 18.7 23.4 23.4 22.8 18.0 26.6 23.6 3.1 23.0 23.2 19.5 21.6 19.9 29.3 35.0 35.3 37.2 34.7 25.3 24.5 36.9 35.1 23.0 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073845-31104791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065197 Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Centrosome" Nucleoplasm "Nucleoli fibrillar center, Centrosome" "HPA065197: " "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavourable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 6.3 5.3 6.4 8.0 8.7 21.0 5.9 18.1 10.5 7.6 6.1 6.0 8.8 7.1 11.0 3.7 7.6 7.5 5.1 4.0 7.0 2.7 6.5 7.0 4.9 14.9 8.4 4.6 9.6 19.0 7.7 9.3 5.6 7.1 8.0 8.6 5.0 11.3 7.1 8.8 14.2 12.1 8.0 6.7 10.9 8.0 8.2 9.4 33.2 7.2 6.4 11.1 5.8 7.8 5.8 4.9 1.3 7.3 4.3 5.5 1.9 12.4 12.2 14.1 12.6 2.2 4.7 20.8 7.7 3.9 9.1 9.7 14.4 21.2 16.3 10.8 4.1 12.3 11.1 10.6 7.3 14.9 22.8 19.4 20.2 8.9 0.8 13.6 12.6 4.5 4.7 11.5 9.0 4.4 9.5 36.5 6.5 10.3 23.3 20.4 29.7 6.5 18.8 22.1 22.7 4.8 14.2 10.2 7.5 7.9 12.2 3.9 10.3 8.7 3.6 7.9 15.6 15.3 14.0 14.8 11.4 39.0 9.4 10.9 7.2 0.0 2.3 1.3 4.2 2.5 3.3 5.2 4.0 3.1 3.1 5.8 4.1 5.5 1.1 4.3 7.3 4.9 3.4 1.9 6.4 8.7 18.1 10.5 7.0 2.7 8.4 4.6 7.1 9.4 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favourable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavourable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 11.1 12.4 9.8 12.2 10.8 15.7 13.0 15.3 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 DDX21 "GURDB, RH-II/GU" ENSG00000165732 "DExD-box helicase 21" Q9NR30 10 68956128-68985073 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036592, HPA036593" Enhanced Enhanced Nucleoplasm,Nucleoli 14000 Nucleoli Nucleoplasm "HPA036592: AB_10673625, HPA036593: AB_2675208" "unprognostic (3.04e-1)" "unprognostic (6.81e-3)" "unprognostic (1.13e-2)" "unprognostic (1.21e-2)" "unprognostic (1.75e-2)" "unprognostic (6.71e-3)" "unprognostic (1.34e-2)" "unprognostic (1.99e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (3.12e-4)" "unprognostic (1.64e-1)" "unprognostic (1.39e-2)" "unprognostic (9.33e-2)" "unprognostic (5.41e-2)" "unprognostic (1.24e-2)" "unprognostic (5.74e-3)" 37.5 16.0 10.0 26.6 13.3 46.8 24.4 8.0 11.8 18.5 20.1 7.2 16.2 13.3 18.7 13.7 28.3 20.1 17.6 19.1 11.4 8.0 25.1 48.0 25.9 24.4 14.9 7.2 30.2 27.9 15.6 20.7 22.8 18.3 14.0 17.6 5.9 18.0 17.8 61.2 22.5 18.5 19.0 20.4 43.5 19.0 12.9 13.3 27.1 18.1 24.1 25.8 33.2 22.4 12.6 11.5 17.1 17.3 7.7 15.0 6.2 32.8 19.5 11.4 35.2 10.3 13.6 24.1 22.6 18.3 29.2 24.9 63.1 22.5 49.6 13.9 18.7 29.3 43.9 28.2 39.2 15.4 30.9 34.7 13.9 26.2 22.1 82.5 33.0 14.0 36.7 34.9 58.4 21.2 66.0 24.8 20.5 15.0 32.3 18.0 31.2 41.7 28.9 18.7 24.3 19.4 17.7 23.6 25.3 20.3 45.1 26.3 25.5 17.3 21.8 17.2 24.3 23.0 39.6 28.6 37.8 73.2 14.3 62.6 11.6 5.0 9.7 17.1 8.4 15.0 15.0 12.6 10.9 11.0 11.5 10.4 10.3 11.3 4.5 7.7 17.3 10.8 7.9 6.2 10.0 13.3 8.0 11.8 11.4 8.0 14.9 7.2 18.3 13.3 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829764-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: " "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 26.1 26.5 29.5 35.6 34.2 19.4 27.2 32.8 35.6 26.7 32.8 23.3 27.5 27.9 31.0 22.3 31.0 31.1 25.2 25.1 29.8 20.3 25.2 37.7 27.7 35.2 26.5 25.3 36.2 30.4 32.2 28.1 34.4 25.0 29.9 32.6 24.7 31.1 27.0 44.4 30.6 32.3 29.4 24.1 40.0 30.6 24.9 32.0 46.8 28.2 29.8 38.9 28.9 47.9 12.0 11.5 19.6 13.3 11.2 19.8 10.6 21.6 49.4 23.5 24.9 23.5 16.3 25.0 26.8 20.6 30.5 19.4 48.1 28.9 27.3 29.5 22.2 19.6 50.9 24.4 26.1 42.8 27.0 36.2 42.1 21.7 12.7 36.5 33.0 15.7 22.0 32.3 19.4 24.9 47.9 24.5 22.1 30.0 34.6 34.7 34.9 23.5 37.0 27.8 21.7 18.0 30.5 29.0 16.9 26.9 30.8 11.2 30.1 33.6 22.3 23.1 16.9 11.3 21.2 18.5 25.8 33.0 19.6 25.8 12.6 17.1 11.1 19.6 19.5 13.3 19.8 12.0 14.5 17.6 10.8 11.4 14.0 16.9 11.9 11.2 8.9 11.5 13.1 10.6 29.5 34.2 32.8 35.6 29.8 20.3 26.5 25.3 25.0 32.0 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048291-94081245 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 103.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favourable (3.06e-9)" "prognostic unfavourable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 18.0 45.5 19.7 13.7 41.3 53.3 18.5 31.4 40.8 17.4 20.9 21.9 14.3 13.6 23.2 103.0 20.1 18.9 21.3 28.6 25.0 31.3 36.3 30.1 16.4 27.4 22.0 29.0 21.4 12.5 8.3 32.0 11.2 38.7 16.0 14.6 17.4 15.9 17.7 28.5 23.4 12.6 17.9 21.8 18.1 15.0 38.5 17.4 14.3 25.3 11.8 25.8 21.7 14.9 4.1 3.1 10.6 3.3 6.2 5.3 5.0 3.8 1.0 7.1 4.6 4.3 5.6 1.7 10.7 8.9 13.9 12.5 1.3 2.4 17.7 4.0 2.3 2.5 7.3 0.6 15.2 7.7 0.4 9.4 2.0 5.7 3.5 13.5 4.2 0.9 4.0 2.5 2.4 2.3 4.9 5.2 5.9 10.6 4.0 11.5 4.7 0.1 5.4 16.5 2.0 10.1 1.4 5.6 5.2 10.5 2.6 4.9 4.1 4.8 6.8 4.0 2.6 5.1 3.2 2.1 13.6 19.0 5.7 7.4 3.1 10.6 3.3 2.5 5.0 2.6 1.4 2.9 2.9 3.0 2.0 4.1 5.3 5.3 2.6 6.2 2.5 3.1 3.3 5.0 19.7 41.3 31.4 40.8 25.0 31.3 22.0 29.0 38.7 17.4 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: " "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favourable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.1 4.5 5.4 6.3 3.5 10.5 4.2 6.2 10.6 7.6 8.8 9.8 23.0 6.5 5.2 11.1 6.4 10.2 6.3 3.1 10.5 8.3 4.8 9.1 8.5 13.0 9.0 6.8 11.1 8.7 8.0 5.9 14.8 3.6 4.7 13.7 13.6 18.3 11.0 6.8 13.4 4.2 24.6 7.4 7.1 9.4 6.3 17.1 4.9 9.3 9.4 14.3 4.2 4.7 4.0 6.7 6.9 8.1 9.8 22.1 5.8 10.1 6.3 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavourable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 6.8 6.9 8.2 15.3 11.2 6.0 12.3 18.4 8.5 7.5 6.6 9.4 12.6 5.0 8.9 8.8 9.8 8.8 7.5 5.4 6.3 6.3 8.4 9.2 12.0 15.1 9.1 5.7 16.9 17.3 10.0 8.8 5.8 9.8 9.2 8.0 7.4 12.7 12.6 12.9 14.0 7.2 12.7 12.9 8.7 6.8 15.2 8.3 6.8 22.7 10.8 13.8 7.2 12.6 5.0 4.5 1.9 2.7 3.1 6.9 3.0 7.1 13.2 6.5 8.9 7.9 7.2 12.7 7.6 7.5 12.1 9.2 14.7 14.7 17.8 7.0 7.1 20.0 20.3 8.9 9.7 10.9 7.5 9.6 11.8 7.7 9.6 17.1 7.9 6.3 12.2 12.3 17.4 7.9 17.7 7.0 10.0 15.3 11.9 9.3 16.0 13.6 12.6 11.5 20.5 11.0 6.8 11.7 8.3 14.0 12.4 10.6 26.0 5.0 6.6 20.5 9.3 11.6 11.8 3.4 10.7 13.9 7.4 10.9 15.4 0.0 1.9 1.9 5.7 2.7 4.7 4.2 5.5 4.4 4.5 5.0 6.9 5.1 0.3 3.1 1.9 2.8 3.6 3.0 8.2 11.2 18.4 8.5 6.3 6.3 9.1 5.7 9.8 8.3 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: " "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.4 50.5 47.2 25.9 55.6 47.2 28.8 33.1 46.6 34.0 27.4 51.9 30.6 0.5 23.7 37.1 30.7 57.7 46.6 56.7 26.9 45.0 28.9 50.3 31.2 28.9 54.1 52.0 34.1 33.1 57.3 55.4 53.3 53.0 28.6 31.6 34.4 34.1 16.9 45.4 20.4 40.0 50.3 37.0 32.0 61.2 32.3 48.9 75.0 38.5 39.7 34.6 36.8 48.1 35.1 37.6 37.5 39.3 33.4 39.6 44.9 35.4 32.8 33.2 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 DDX3Y DBY ENSG00000067048 "DEAD-box helicase 3, Y-linked" O15523 Y 12904108-12920478 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059583" Enhanced Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: " "unprognostic (3.89e-2)" "unprognostic (1.70e-1)" "prognostic favourable (4.70e-5)" "unprognostic (6.50e-2)" "unprognostic (4.74e-2)" "unprognostic (2.22e-2)" "unprognostic (4.17e-2)" "unprognostic (3.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (7.87e-2)" 12.0 10.5 4.9 29.5 14.1 46.1 8.7 17.0 16.3 0.4 24.4 12.6 31.5 7.6 0.4 29.7 12.2 0.4 14.2 10.8 5.6 7.1 8.9 26.5 20.0 17.7 5.7 0.0 0.4 14.5 0.4 12.2 14.0 20.2 26.7 15.8 15.1 20.4 32.6 17.7 8.4 16.0 40.7 6.2 34.3 8.9 41.9 0.0 26.9 10.8 21.4 19.3 14.4 0.0 6.1 8.8 6.5 7.1 6.5 8.4 3.8 0.1 7.5 0.0 0.0 0.0 0.0 5.5 18.6 13.3 9.8 12.1 0.0 0.0 40.6 0.0 18.3 0.0 0.0 0.0 17.3 10.2 0.0 41.4 0.0 12.2 9.7 0.0 0.0 10.3 11.6 0.0 0.0 0.0 0.0 0.0 11.6 0.0 16.0 0.0 7.4 0.0 0.0 4.9 7.4 10.5 11.2 12.2 0.0 0.0 0.0 13.6 0.0 9.7 13.3 15.3 0.0 0.0 12.2 21.9 34.4 30.2 1.8 0.0 0.0 1.6 6.2 5.7 8.4 7.1 7.7 6.1 6.4 7.1 8.8 5.9 7.8 6.5 6.5 6.5 4.6 2.5 5.7 3.8 4.9 14.1 17.0 16.3 5.6 7.1 5.7 0.0 20.2 0.0 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177517469 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: " "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 17.9 22.7 27.0 25.1 30.7 17.2 16.5 22.8 39.2 19.1 21.2 16.9 18.5 25.5 19.5 16.5 23.0 22.1 17.1 15.3 29.3 20.1 23.7 29.3 16.8 19.9 22.1 24.8 21.2 18.0 22.2 15.1 22.1 27.4 16.3 15.4 19.0 19.0 17.5 36.6 21.7 26.8 16.7 14.8 21.9 19.7 16.8 15.4 24.9 22.9 18.2 23.5 19.6 18.4 15.9 22.5 16.4 22.8 18.6 20.6 18.0 21.0 24.1 13.2 15.5 13.6 16.1 44.5 18.9 11.5 13.9 10.3 39.2 19.7 23.6 28.8 17.8 17.3 17.2 43.3 9.5 56.4 21.6 30.0 24.5 23.2 18.0 31.0 31.9 15.8 15.3 13.2 17.8 17.7 26.0 16.9 16.4 45.4 25.8 15.2 23.2 19.5 28.1 16.0 27.8 15.5 24.5 15.7 17.2 20.1 26.8 22.6 18.7 45.3 18.9 25.5 15.1 16.2 29.4 20.3 23.8 40.3 27.9 34.2 16.7 10.6 22.8 16.4 16.1 21.5 20.6 15.9 16.0 15.3 22.5 14.1 14.8 15.5 7.7 18.6 21.4 10.2 15.6 18.0 27.0 30.7 22.8 39.2 29.3 20.1 22.1 24.8 27.4 15.4 DDX49 "Dbp8, FLJ10432" ENSG00000105671 "DEAD-box helicase 49" Q9Y6V7 19 18919675-18928633 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041870, HPA048093" Enhanced Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA041870: , HPA048093: " "unprognostic (3.51e-1)" "prognostic favourable (2.01e-6)" "unprognostic (2.28e-2)" "unprognostic (1.28e-1)" "unprognostic (8.56e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (7.05e-4)" "unprognostic (4.12e-2)" "unprognostic (2.41e-3)" "unprognostic (8.67e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "prognostic unfavourable (7.44e-5)" "unprognostic (3.93e-2)" "unprognostic (2.99e-2)" "unprognostic (4.97e-2)" "unprognostic (3.24e-1)" 14.8 16.8 17.6 17.3 16.9 28.3 18.0 17.0 30.7 15.3 15.8 19.0 14.8 19.5 15.6 13.2 23.4 16.5 12.2 18.2 19.2 12.9 15.5 25.6 13.0 19.3 15.7 14.8 15.7 26.8 13.0 11.1 23.3 16.2 15.5 10.3 13.5 24.3 15.8 27.2 23.6 18.7 12.7 16.8 16.7 15.7 19.7 16.3 23.4 18.8 16.6 18.7 16.4 15.6 8.2 25.0 13.5 19.5 14.1 14.0 9.7 15.8 16.5 6.7 21.0 9.8 7.9 25.2 10.1 6.9 17.9 14.5 18.8 16.1 20.8 30.9 10.0 13.7 14.9 13.9 5.1 6.3 39.6 10.2 17.9 16.3 23.3 26.2 14.2 15.8 13.4 14.2 15.1 8.1 19.2 14.9 6.3 35.5 18.9 12.2 21.8 40.3 21.0 11.2 22.5 9.6 10.0 23.6 24.3 13.3 13.2 16.1 13.6 12.6 10.4 8.7 9.9 31.5 16.5 19.6 23.4 19.0 11.1 30.2 13.6 10.5 17.7 13.5 12.8 19.5 10.6 8.1 9.7 9.6 25.0 8.2 9.7 10.2 7.9 14.1 12.6 11.2 14.0 9.7 17.6 16.9 17.0 30.7 19.2 12.9 15.7 14.8 16.2 16.3 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.1 3.0 6.2 3.1 10.9 4.2 2.9 6.6 10.4 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.8 9.0 7.5 3.4 5.7 4.0 3.6 3.8 9.5 3.6 2.1 6.1 10.9 18.4 7.4 17.3 13.0 5.7 12.1 4.8 4.9 10.3 5.4 5.2 7.5 5.3 6.6 8.3 6.6 2.7 8.2 6.6 11.0 10.1 5.9 12.7 5.6 6.8 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643464 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA056173: " "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favourable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavourable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 6.4 4.5 4.3 5.3 5.5 9.1 4.6 8.1 6.5 6.9 6.1 4.8 5.0 5.9 7.8 10.7 6.7 3.5 5.0 3.0 4.5 9.4 7.1 4.2 5.1 5.4 3.1 6.3 4.4 6.2 8.8 5.8 6.5 6.1 6.0 4.0 4.1 4.8 6.7 6.0 10.6 4.8 6.2 5.7 4.8 4.8 4.9 8.7 5.7 5.8 6.1 6.0 6.9 4.0 5.7 3.5 4.2 3.5 4.7 1.5 4.7 9.8 1.0 9.7 5.5 4.9 4.2 6.5 5.8 8.5 8.3 5.0 1.8 2.7 4.5 4.3 4.4 10.8 7.1 11.4 6.5 12.2 6.0 6.2 4.0 5.4 7.7 3.2 5.1 7.2 5.5 6.9 9.8 0.8 1.8 5.0 1.5 11.7 4.0 5.5 0.4 7.5 8.5 5.0 9.7 5.4 7.2 5.8 7.7 1.8 4.7 3.4 6.0 6.5 7.0 4.3 3.5 7.3 2.3 3.8 5.4 5.7 4.9 5.5 3.4 3.2 3.5 4.2 4.2 3.3 3.6 4.0 3.5 2.3 4.0 3.4 4.7 2.8 3.5 2.4 5.7 3.1 1.5 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell line enhanced" "Detected in some" "K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: " "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.4 27.7 10.3 19.0 6.9 8.3 26.7 14.4 13.4 19.7 10.8 28.5 12.9 34.3 16.9 12.0 19.7 18.3 18.7 7.5 19.7 22.5 20.6 14.9 19.4 12.2 34.3 24.4 13.7 14.8 19.0 11.8 16.1 29.8 12.3 10.1 24.5 29.5 49.0 24.1 19.7 21.9 15.3 35.0 10.7 27.7 13.4 12.2 20.4 31.3 13.0 26.8 26.9 11.9 16.7 18.7 19.8 30.0 18.0 20.5 38.6 14.7 19.2 17.5 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 DDX55 KIAA1595 ENSG00000111364 "DEAD-box helicase 55" Q8NHQ9 12 123602077-123620941 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039962, HPA044101" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039962: , HPA044101: " "unprognostic (1.14e-1)" "unprognostic (2.30e-2)" "unprognostic (2.29e-1)" "unprognostic (3.71e-3)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (2.11e-9)" "unprognostic (1.60e-1)" "unprognostic (4.49e-2)" "unprognostic (7.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-3)" "prognostic unfavourable (8.97e-12)" "unprognostic (9.15e-3)" "unprognostic (2.94e-1)" "unprognostic (3.47e-2)" "unprognostic (1.23e-3)" 15.0 13.5 12.3 16.4 14.0 27.7 16.3 21.4 13.9 13.0 13.2 15.7 16.2 12.0 14.7 13.2 14.2 15.0 11.8 8.8 11.4 10.9 10.2 17.8 11.2 19.9 15.6 10.3 17.5 25.9 13.8 20.3 12.3 14.4 14.4 14.5 11.9 15.2 12.6 12.6 21.4 12.9 11.9 10.5 18.8 11.6 11.2 14.8 16.9 12.2 12.5 16.5 11.9 23.1 13.4 12.8 7.3 10.0 12.2 15.7 8.5 10.0 14.2 10.9 11.0 9.4 7.5 16.5 12.4 4.6 11.1 7.7 16.1 7.3 14.8 10.0 5.4 12.3 16.6 9.2 13.0 11.1 15.1 20.0 15.7 11.9 7.1 24.6 15.8 6.2 9.8 13.1 15.3 7.9 20.4 7.9 7.8 10.3 24.1 33.5 16.9 14.2 18.2 11.7 9.7 7.8 17.4 13.0 10.8 10.1 13.1 16.9 23.4 16.0 8.1 9.6 12.6 15.6 15.3 14.6 18.0 26.9 9.1 17.7 16.3 2.8 9.2 7.3 12.0 10.0 12.7 13.4 11.6 12.5 7.5 11.3 15.7 14.7 5.6 12.2 5.9 12.8 9.1 8.5 12.3 14.0 21.4 13.9 11.4 10.9 15.6 10.3 14.4 14.8 DDX58 "DKFZp434J1111, FLJ13599, RIG-I" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455705-32526324 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 44.8;BJ hTERT+ SV40 Large T+ RasG12V: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012643, HPA047193" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB012643: , HPA047193: " "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavourable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 27.7 8.2 5.7 14.5 7.9 5.6 11.3 4.2 5.7 9.9 9.5 5.2 9.1 7.2 12.7 11.7 10.8 7.6 10.3 7.1 6.0 5.1 14.7 8.5 13.7 14.3 6.3 4.5 9.2 7.7 6.6 10.2 14.8 7.5 12.1 8.1 5.5 12.4 5.8 8.3 10.7 16.1 10.8 7.7 13.8 8.0 4.5 6.4 35.4 13.0 7.4 9.7 9.9 9.4 4.9 2.0 24.8 5.7 6.1 6.5 3.0 2.9 1.1 1.6 0.9 3.8 4.0 2.5 1.8 8.8 44.8 46.8 1.2 2.6 0.8 3.2 1.6 2.4 1.7 1.9 6.3 7.2 0.6 2.8 2.5 2.0 3.1 1.8 2.2 2.8 0.7 5.2 1.5 8.1 0.6 0.6 5.9 0.4 2.5 4.6 1.3 1.2 2.4 1.2 0.3 6.8 1.6 1.2 0.7 2.6 1.1 4.9 1.9 1.5 9.3 1.3 1.3 1.1 0.9 0.1 0.5 0.5 2.0 0.8 0.9 8.5 3.8 10.3 6.2 5.7 5.5 4.8 5.6 5.6 2.0 4.9 5.1 5.6 24.8 6.1 3.9 0.1 6.5 3.0 5.7 7.9 4.2 5.7 6.0 5.1 6.3 4.5 7.5 6.4 DDX59 "DKFZP564B1023, ZNHIT5" ENSG00000118197 "DEAD-box helicase 59" Q5T1V6 1 200623896-200669969 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047166 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA047166: AB_2679966" "unprognostic (1.99e-1)" "unprognostic (1.60e-1)" "unprognostic (3.44e-2)" "unprognostic (4.87e-2)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (4.83e-2)" "unprognostic (3.40e-3)" "unprognostic (2.43e-3)" "unprognostic (4.16e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (9.02e-4)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (6.66e-2)" "unprognostic (5.98e-2)" 14.0 14.4 12.1 16.4 14.8 23.7 22.7 16.7 11.2 14.5 11.6 10.8 12.6 8.1 15.8 17.6 12.0 13.8 11.4 18.0 12.0 9.9 13.6 15.1 11.8 15.1 15.1 6.7 17.1 21.6 13.9 10.7 46.5 12.8 14.1 12.5 15.0 19.4 12.9 28.6 21.5 12.4 14.0 17.2 20.9 10.4 9.9 14.5 18.5 15.1 10.1 13.2 12.8 12.7 12.2 9.5 23.1 16.2 12.4 15.6 7.9 9.2 10.8 12.5 10.5 5.7 9.8 28.0 10.5 9.4 11.2 9.1 3.4 11.0 9.5 5.3 8.3 8.9 7.0 10.7 8.0 29.9 7.2 7.2 13.8 10.0 11.4 10.4 13.4 10.6 16.2 8.5 23.2 8.6 9.1 14.1 10.9 10.7 6.2 15.6 13.2 8.8 5.3 8.7 18.2 12.0 10.9 7.6 19.8 16.6 17.3 18.4 14.9 14.6 7.7 9.5 5.4 9.3 10.8 10.8 14.0 12.6 9.1 6.6 16.2 23.1 10.3 19.0 13.0 8.9 10.6 12.2 10.9 11.7 8.5 11.5 11.3 10.3 18.2 12.4 16.2 9.5 15.6 7.9 12.1 14.8 16.7 11.2 12.0 9.9 15.1 6.7 12.8 14.5 DDX6 "HLR2, RCK" ENSG00000110367 "DEAD-box helicase 6" P26196 11 118747766-118791149 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004668, HPA024201, HPA026644" Approved Supported "Cytosol,Cytoplasmic bodies" "Cytoplasmic bodies" Cytosol "CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582" "unprognostic (1.26e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-1)" "unprognostic (3.40e-2)" "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "prognostic unfavourable (6.56e-4)" "unprognostic (3.43e-1)" "unprognostic (1.48e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (7.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.91e-3)" "unprognostic (1.88e-1)" "unprognostic (9.58e-2)" "unprognostic (4.55e-2)" 29.8 23.0 25.0 24.1 41.0 43.3 25.1 41.9 39.2 26.9 23.2 29.4 14.5 17.1 30.1 22.9 31.8 23.4 17.5 26.8 25.5 25.1 22.8 24.6 23.4 32.2 21.9 27.1 38.2 27.9 30.9 43.2 26.1 29.6 24.9 20.8 25.4 26.8 22.9 43.8 23.9 24.1 27.8 30.4 30.6 21.2 19.9 24.0 46.0 27.9 19.4 42.8 33.0 25.7 12.2 6.5 17.8 10.3 7.2 12.6 5.7 11.7 16.0 25.8 25.4 22.6 23.3 16.9 15.9 20.9 14.8 14.1 23.3 18.1 26.9 16.7 26.0 18.8 30.1 23.2 23.9 20.2 6.0 51.8 10.3 18.9 15.0 37.1 20.0 24.6 17.1 21.9 35.7 23.6 23.8 39.1 20.9 32.0 27.0 17.2 18.3 11.8 29.8 20.8 21.5 17.3 30.4 17.1 23.6 30.0 24.1 9.5 28.2 14.6 26.9 24.6 13.5 14.0 16.0 12.2 15.8 32.1 9.8 17.9 21.0 10.5 4.1 11.6 10.1 5.7 12.6 11.4 9.9 10.4 4.7 12.2 12.4 10.8 17.8 7.2 10.3 6.5 8.9 5.7 25.0 41.0 41.9 39.2 25.5 25.1 21.9 27.1 29.6 24.0 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216293-168318807 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 22.5;BJ hTERT+ SV40 Large T+ RasG12V: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA046952 Approved Supported "Intermediate filaments,Cytosol" Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 18.0 8.3 4.1 18.5 5.0 4.4 9.0 1.3 3.8 11.4 14.8 4.3 5.1 8.8 10.8 15.2 10.7 8.1 11.5 8.5 3.7 3.5 10.0 8.8 21.6 18.7 4.2 3.2 20.3 5.5 8.8 6.7 25.5 5.6 11.6 14.3 9.0 15.6 6.2 5.6 7.9 16.7 11.2 6.1 18.9 29.2 5.7 3.9 23.2 14.5 6.0 9.3 8.2 7.2 4.1 2.5 3.2 6.3 7.6 10.0 3.5 5.5 1.2 2.8 1.1 2.1 7.7 3.1 1.8 13.5 22.5 21.8 0.0 12.2 0.0 1.1 3.0 4.6 0.3 4.5 6.5 4.3 0.5 8.7 4.8 0.0 10.1 3.2 2.2 6.9 1.9 5.7 1.3 8.4 0.0 1.6 2.8 0.3 4.9 2.4 0.5 1.6 3.3 1.4 0.1 6.6 3.4 0.6 0.6 3.5 0.9 13.6 0.9 4.1 5.6 1.4 1.4 0.5 1.4 1.0 0.2 0.0 4.3 3.8 3.9 3.2 2.8 2.6 8.5 5.1 10.0 4.1 6.7 8.0 2.5 3.3 6.8 8.5 2.8 7.6 6.3 0.2 5.5 3.5 4.1 5.0 1.3 3.8 3.7 3.5 4.2 3.2 5.6 3.9 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.5" "Group enriched" "Detected in all" 4 "granulocytes: 22.5;monocytes: 7.8" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: " "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavourable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 12.7 5.0 2.8 13.1 3.1 33.0 9.9 1.4 3.2 7.2 8.4 3.2 2.7 6.0 9.2 7.9 3.8 6.9 6.7 6.0 2.4 2.4 4.5 6.0 25.8 17.7 3.8 1.4 7.3 5.1 4.4 5.2 32.6 3.4 5.0 6.5 6.8 7.0 5.7 3.3 4.3 14.0 5.3 4.2 11.9 9.5 2.7 3.1 25.3 5.8 3.5 8.1 4.9 6.8 1.6 2.4 22.5 7.8 1.7 3.7 1.6 6.0 3.6 1.4 0.6 3.7 10.7 7.0 6.1 13.0 23.1 16.1 0.0 14.4 0.1 0.3 6.2 2.4 0.6 3.7 6.7 3.5 0.5 13.4 4.0 0.3 4.5 5.5 3.4 3.0 1.1 8.3 0.7 16.2 0.2 0.1 14.8 0.1 4.9 3.5 0.3 3.0 2.7 3.1 0.0 2.2 3.6 0.2 1.9 10.9 1.3 6.1 1.0 7.7 17.3 1.2 8.2 2.9 2.1 5.9 0.9 0.0 4.1 16.3 1.7 1.6 4.0 3.5 2.7 6.3 3.7 0.9 2.7 2.7 2.4 1.6 2.2 2.3 22.5 1.7 7.8 0.0 3.6 1.6 2.8 3.1 1.4 3.2 2.4 2.4 3.8 1.4 3.4 3.1 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1, transcription factor" O75398 11 644233-706715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell line enhanced" "Detected in many" "HEK 293: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" Nucleoplasm "Nucleoli fibrillar center" "HPA030302: " "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 4.8 5.9 36.1 6.5 19.9 4.5 16.9 19.4 26.2 5.4 4.3 5.3 5.2 4.8 7.5 6.3 6.8 9.8 6.0 8.3 30.2 15.7 4.5 2.8 5.3 4.4 18.3 3.4 6.0 13.2 5.9 14.5 5.2 9.7 6.7 2.2 3.6 11.8 4.7 7.8 6.6 4.0 7.2 8.1 4.0 7.2 5.7 9.8 15.2 12.0 2.7 5.3 7.0 20.3 1.2 4.4 3.3 3.0 3.5 5.9 1.6 7.3 4.5 7.3 3.9 7.1 9.4 5.7 5.4 7.1 11.7 8.5 4.8 6.3 2.1 6.0 5.4 4.9 7.0 5.0 1.7 9.0 41.4 4.9 2.5 3.7 12.9 10.8 8.0 7.9 6.9 2.1 5.9 9.2 10.9 8.7 4.4 3.7 4.0 9.9 17.0 9.5 9.9 2.5 8.1 8.2 0.9 10.4 10.9 4.0 5.9 3.9 3.6 3.1 10.6 3.8 2.1 1.6 4.7 9.6 3.5 3.8 4.4 7.2 7.5 0.0 3.0 3.3 2.4 1.7 2.6 1.2 4.7 2.7 4.4 0.8 5.9 3.2 1.8 3.5 1.9 0.5 1.7 1.6 36.1 19.9 19.4 26.2 30.2 15.7 18.3 3.4 9.7 9.8 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavourable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favourable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favourable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.3 5.9 17.4 19.7 12.2 19.9 3.7 9.1 15.7 5.9 9.3 2.3 10.3 7.9 7.2 10.9 7.8 6.4 9.2 9.9 11.9 0.7 19.0 5.3 9.4 15.3 4.1 3.9 15.7 7.1 4.7 8.0 17.7 19.7 15.7 28.5 11.9 11.8 6.1 1.1 17.8 10.0 4.6 14.1 29.2 26.0 0.7 6.6 13.8 129.9 10.9 16.6 10.7 15.9 10.1 4.8 13.3 5.4 7.9 6.0 9.3 9.6 9.4 12.8 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89947925-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041745: , HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favourable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favourable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 18.0 15.9 25.4 22.4 23.0 25.3 15.6 42.4 30.6 12.6 16.4 15.4 19.4 12.0 17.1 14.1 22.5 14.3 16.3 23.7 23.7 24.8 14.9 12.2 15.4 42.8 28.0 29.0 18.2 22.5 19.0 18.0 11.5 20.5 14.5 9.2 13.9 21.4 18.9 19.5 27.4 13.6 17.6 23.6 16.6 15.2 8.8 15.0 4.8 14.5 13.6 32.4 15.5 23.8 23.0 27.4 32.0 16.7 5.3 11.5 11.1 15.0 30.9 14.0 19.0 14.5 15.4 16.0 23.5 20.0 34.8 16.2 32.7 18.3 18.3 17.7 16.0 10.0 16.6 27.9 15.5 4.4 47.2 8.2 16.5 46.8 15.7 5.9 13.1 17.3 23.1 24.9 14.7 25.9 26.9 6.2 20.6 55.2 11.6 18.0 17.8 31.6 24.2 10.3 15.7 18.6 14.6 20.8 21.4 37.8 14.1 13.2 13.1 19.3 26.0 20.1 22.0 10.7 24.9 12.2 8.6 23.0 21.5 15.4 23.5 2.3 16.7 32.0 11.5 13.4 10.5 19.6 9.6 8.4 10.7 23.0 6.6 6.4 22.5 5.3 7.6 27.4 11.4 11.1 25.4 23.0 42.4 30.6 23.7 24.8 28.0 29.0 20.5 15.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056734 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 231 "intestine: 574.2" "Group enriched" "Detected in some" 8 "BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favourable (9.44e-5)" "unprognostic (3.91e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 408.9 0.0 0.0 249.9 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 574.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 1.7 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell line enriched" "Detected in some" 20 "T-47d: 48.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA046644: " "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favourable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.7 2.4 0.0 0.0 1.4 0.0 48.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favourable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.7 8.7 7.9 14.9 5.4 8.5 36.6 14.4 21.7 12.3 10.6 11.9 6.6 11.9 3.0 11.6 8.4 6.7 10.4 12.0 5.0 5.1 5.6 21.2 8.7 7.2 6.7 3.8 7.8 9.4 10.1 17.4 10.9 15.3 9.1 9.9 8.4 8.0 9.7 15.7 13.3 12.4 7.7 10.1 6.1 5.2 16.8 13.6 11.6 7.7 8.9 10.5 17.0 5.0 13.3 5.1 15.4 7.5 14.0 10.8 8.2 11.1 13.4 8.7 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA042586: " "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 5.9 1.5 1.7 2.9 0.8 4.4 2.7 4.6 3.2 2.8 1.7 1.6 3.8 10.9 2.4 7.0 3.1 2.7 3.3 2.5 8.2 2.9 3.9 3.0 0.7 2.4 12.8 4.9 1.5 4.5 1.1 3.2 1.2 3.0 16.9 2.8 1.1 6.8 6.6 0.6 1.5 4.2 1.5 8.5 7.0 5.6 2.9 4.6 7.1 4.8 1.2 2.0 11.2 3.4 0.3 2.8 0.1 2.7 8.6 0.0 5.5 3.0 5.2 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell line enhanced" "Detected in some" "Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favourable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (8.95e-4)" "prognostic favourable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favourable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 12.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.6 0.0 0.8 0.0 4.2 26.9 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 8.3 6.5 0.0 0.0 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.0 0.0 17.9 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell line enhanced" "Detected in many" "HDLM-2: 20.7;MOLT-4: 51.9;SK-BR-3: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043630: , HPA048642: " "unprognostic (1.72e-3)" "prognostic favourable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favourable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favourable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.2 0.4 0.0 0.0 2.5 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.0 10.9 3.7 1.5 3.2 0.0 0.5 1.1 20.7 0.0 3.2 0.7 0.0 3.8 0.0 3.4 3.0 2.3 0.3 0.0 0.1 0.0 3.4 0.3 8.7 51.9 0.3 0.0 1.4 1.2 0.0 15.8 3.6 11.1 3.7 0.0 3.7 33.7 1.2 9.9 10.3 0.0 0.0 0.0 0.0 0.0 3.1 1.2 8.2 0.0 9.2 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.9" "Cell line enhanced" "Detected in many" "HDLM-2: 26.8;HeLa: 33.1;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.0;neutrophil: 22.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA024491: , HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 21.8 6.2 12.2 21.7 15.2 75.9 17.6 1.7 12.3 10.4 17.0 11.5 2.3 5.5 10.3 6.1 6.8 8.3 12.0 8.8 12.1 8.5 12.2 3.9 30.1 27.8 15.9 7.7 8.9 4.7 4.5 5.8 13.0 13.7 9.0 7.4 7.1 10.2 8.3 12.9 8.3 12.7 7.8 21.9 24.7 9.1 4.6 11.8 3.4 11.4 3.5 20.6 9.5 9.8 2.4 2.2 22.2 5.4 1.4 0.4 1.6 6.8 6.2 0.4 1.3 1.9 2.8 1.0 3.9 11.5 1.6 1.3 1.9 6.4 1.8 10.2 7.3 3.5 1.7 4.2 1.1 26.8 1.6 7.1 33.1 0.6 1.7 7.0 1.1 0.2 2.1 1.8 2.3 9.0 0.0 17.3 1.2 2.1 1.0 9.8 0.4 8.1 1.2 0.3 6.7 6.4 2.3 2.0 1.2 0.7 0.5 0.4 2.8 11.3 7.1 0.3 3.1 4.5 0.1 3.5 15.4 0.5 1.1 24.3 0.4 9.3 2.9 18.0 0.4 4.5 0.4 2.4 0.3 0.1 2.2 2.3 0.0 0.1 22.2 1.4 5.4 0.0 0.1 1.6 12.2 15.2 1.7 12.3 12.1 8.5 15.9 7.7 13.7 11.8 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA065343: " "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 13.7 15.7 9.5 13.9 11.3 32.9 9.5 26.7 12.6 10.0 9.6 12.2 6.8 6.9 11.5 6.6 8.0 9.3 13.2 8.2 10.7 8.5 9.8 19.1 12.8 20.8 12.1 9.7 16.3 19.9 17.9 21.2 9.9 11.6 8.1 8.2 14.6 9.5 7.2 15.3 7.6 10.2 12.5 16.6 13.6 10.2 9.0 11.9 16.9 12.7 5.6 20.1 13.4 10.1 9.3 3.1 6.8 3.6 4.4 8.0 1.9 4.8 4.6 2.4 2.4 7.2 8.0 3.0 5.0 6.7 3.3 5.0 2.6 3.8 24.8 3.5 7.3 9.0 4.7 4.4 5.9 27.5 5.4 23.6 5.9 4.9 4.2 8.0 8.4 5.3 5.0 4.6 9.8 9.0 7.1 15.4 3.8 2.6 3.7 4.3 0.7 3.4 1.8 8.5 21.4 3.9 9.3 3.9 3.6 4.9 3.4 4.4 3.3 20.4 9.6 4.7 5.2 8.4 6.9 8.4 9.3 9.3 6.6 17.4 3.8 3.1 3.6 6.8 5.3 1.5 8.0 7.8 4.6 6.7 3.1 9.3 4.9 4.7 1.9 4.4 1.2 1.2 4.2 1.9 9.5 11.3 26.7 12.6 10.7 8.5 12.1 9.7 11.6 11.9 DENND4B KIAA0476 ENSG00000198837 "DENN domain containing 4B" O75064 1 153929501-153946696 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040188, HPA071133" Approved Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA040188: AB_10671168, HPA071133: " "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (1.59e-2)" "unprognostic (9.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-3)" "prognostic unfavourable (4.14e-4)" "unprognostic (1.58e-1)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "prognostic favourable (3.18e-5)" "unprognostic (2.21e-1)" "prognostic unfavourable (9.27e-9)" "unprognostic (4.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.56e-3)" 14.5 9.6 14.4 21.5 13.6 30.7 9.9 23.5 19.7 8.6 8.3 11.9 3.1 9.2 10.3 7.9 7.7 8.8 9.9 12.4 10.5 9.8 8.6 7.9 14.2 25.8 12.5 8.5 12.4 11.0 8.5 8.3 10.1 12.6 7.9 6.3 8.0 10.2 7.6 40.6 8.6 12.7 8.8 9.3 25.9 9.2 5.5 12.9 15.7 9.4 5.9 21.1 10.7 7.7 3.0 4.8 3.9 6.2 2.0 3.9 3.0 5.8 11.3 8.8 8.8 5.3 5.1 9.1 5.8 6.3 9.2 8.6 6.8 6.8 14.8 9.9 3.9 10.5 7.9 5.3 4.1 13.4 7.1 13.0 11.8 6.5 7.3 13.6 26.5 4.6 9.4 8.5 9.2 6.5 13.8 8.3 5.2 12.1 16.5 12.6 12.2 11.1 17.7 5.9 8.4 4.4 8.8 10.4 12.8 6.1 14.5 8.2 10.4 33.7 6.7 9.9 9.7 8.2 9.2 25.3 17.8 19.5 6.8 10.8 11.8 2.5 3.8 1.1 3.3 6.2 3.9 2.9 2.6 1.9 3.7 3.0 1.3 2.8 3.9 2.0 4.9 4.8 1.7 3.0 14.4 13.6 23.5 19.7 10.5 9.8 12.5 8.5 12.6 12.9 DENND4C "bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF" ENSG00000137145 "DENN domain containing 4C" Q5VZ89 9 19230435-19373545 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014917, HPA015096" Approved Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA014917: AB_2261659, HPA015096: AB_1845831" "unprognostic (4.57e-2)" "unprognostic (1.73e-2)" "unprognostic (6.81e-2)" "unprognostic (1.71e-1)" "unprognostic (1.87e-2)" "unprognostic (1.48e-1)" "unprognostic (2.43e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "prognostic favourable (3.51e-5)" "unprognostic (3.27e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" 31.5 14.0 7.4 11.2 9.4 5.8 17.8 17.7 10.4 18.8 17.9 7.3 17.5 17.4 15.0 12.7 15.8 12.5 9.9 13.7 8.0 5.7 10.2 10.1 16.3 7.2 9.1 6.7 16.3 16.0 16.9 18.2 14.6 8.4 14.9 14.5 10.4 16.9 12.2 11.5 20.5 18.4 19.1 8.9 9.8 13.8 9.0 9.6 14.3 12.9 8.3 11.0 22.3 17.7 3.0 4.0 8.5 2.1 8.1 10.2 3.4 11.6 10.9 7.9 10.2 17.3 21.0 14.4 6.7 10.1 7.1 9.5 5.4 7.7 4.9 5.6 8.8 6.3 9.2 5.6 8.7 32.5 5.2 22.6 12.6 6.3 8.6 5.2 12.9 8.2 12.8 6.2 10.6 13.2 6.1 5.7 9.0 4.4 9.2 11.6 5.9 5.5 8.3 4.6 7.1 18.7 22.4 8.0 5.9 6.0 13.5 4.7 8.3 7.1 12.3 6.3 3.5 6.9 6.9 3.9 9.4 2.6 5.2 5.1 3.5 8.5 2.1 2.5 7.8 1.1 10.2 2.5 6.7 7.8 4.0 3.0 6.1 7.3 1.1 8.1 1.1 4.0 4.8 3.4 7.4 9.4 17.7 10.4 8.0 5.7 9.1 6.7 8.4 9.6 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265390 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052923: , HPA055009: " "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavourable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavourable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 26.7 13.0 36.6 18.6 37.2 22.9 15.8 23.7 43.8 20.0 16.8 56.8 9.3 4.4 23.2 16.7 13.8 18.1 19.8 35.2 36.3 31.6 13.1 11.4 22.8 13.4 44.4 20.4 18.2 17.5 18.1 9.2 22.1 35.3 14.5 10.2 13.6 9.0 26.6 12.1 7.3 8.0 32.8 51.0 21.9 10.5 10.4 34.9 7.3 11.5 5.9 12.4 17.9 20.3 1.8 5.1 14.7 9.9 1.7 5.5 2.0 6.4 8.8 24.2 21.6 35.2 32.3 24.1 21.1 31.1 29.2 34.4 8.2 4.9 0.0 9.1 38.8 5.4 21.5 7.1 35.9 22.3 11.7 2.3 13.5 11.9 20.0 11.1 4.8 25.1 4.8 17.4 25.0 26.1 10.6 0.2 30.5 4.9 6.2 7.6 6.8 9.4 10.6 14.4 0.1 13.9 5.0 5.5 11.3 19.8 9.5 10.6 5.1 7.2 18.5 23.0 13.7 27.6 15.5 0.5 0.1 5.5 22.4 5.7 17.3 5.3 5.2 6.1 0.3 7.8 0.8 1.8 1.9 1.6 5.1 0.5 5.5 2.6 14.7 1.7 9.9 1.6 0.0 2.0 36.6 37.2 23.7 33.9 36.3 31.6 44.4 20.4 35.3 34.9 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382223-31591097 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 5 "B-cells: 4.1;dendritic cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules Microtubules Nucleoli "HPA038865: " "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 6.0 9.5 9.9 9.3 16.6 3.1 5.9 24.5 17.8 6.5 8.1 7.9 2.7 12.4 9.7 3.4 3.9 6.0 6.2 14.4 9.3 12.4 10.7 17.0 4.6 9.3 8.7 10.9 30.5 7.9 6.0 12.8 6.9 16.0 4.7 6.3 7.7 3.2 5.0 10.9 2.8 14.6 10.2 6.4 8.9 6.8 20.3 8.4 0.4 4.6 3.2 11.1 6.6 7.3 4.1 2.2 0.6 0.3 0.4 0.2 0.2 1.7 17.6 13.0 4.9 4.7 5.9 2.0 4.3 4.7 10.9 7.9 11.8 7.1 6.5 7.2 9.3 0.5 2.5 1.2 11.0 0.0 5.5 0.1 13.8 7.0 4.3 5.8 0.1 3.6 3.9 7.3 12.1 10.0 2.5 13.3 6.8 1.6 3.4 6.2 13.2 3.1 3.3 18.0 0.1 9.3 2.3 4.1 6.3 10.8 1.2 9.4 1.8 3.3 10.4 4.1 10.5 7.3 9.0 7.1 7.8 6.6 7.0 0.7 6.9 0.3 0.3 0.3 0.2 0.1 0.1 4.0 0.1 0.1 0.6 4.1 0.1 0.1 0.6 0.4 0.2 2.2 0.0 0.2 9.9 16.6 24.5 17.8 9.3 12.4 8.7 10.9 16.0 8.4 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6;testis: 19.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favourable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 1.3 0.8 0.7 12.1 0.5 5.1 1.9 0.3 0.7 1.2 3.3 0.1 0.5 2.9 0.5 0.7 6.5 0.6 0.3 1.3 2.1 0.6 0.7 0.8 2.0 5.5 0.5 0.2 0.6 0.5 0.3 0.4 7.4 0.3 2.5 4.3 0.5 1.3 0.0 0.4 1.7 3.7 1.5 0.4 3.1 1.4 19.5 0.0 28.6 0.5 5.4 5.7 1.5 2.0 0.3 0.0 0.0 0.0 0.8 2.6 0.3 15.5 7.2 13.8 6.3 0.9 2.0 10.8 20.0 9.2 17.0 14.8 5.9 6.5 0.0 14.9 8.2 10.5 20.0 10.4 28.9 13.6 13.1 12.7 12.8 3.4 0.2 10.9 0.0 0.7 0.5 19.5 10.9 12.3 8.6 12.4 30.3 3.5 0.0 4.1 11.8 9.8 0.0 41.1 5.1 6.9 4.2 15.5 7.2 20.0 8.5 10.4 7.7 5.5 7.2 11.0 12.6 19.4 23.1 7.8 16.7 0.1 10.4 3.8 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.6 0.3 0.7 0.5 0.3 0.7 2.1 0.6 0.5 0.2 0.3 0.0 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: " "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favourable (2.42e-4)" "prognostic unfavourable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavourable (3.08e-4)" "prognostic unfavourable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 23.7 8.1 24.7 15.1 0.5 0.8 27.1 6.4 4.4 11.4 14.8 13.4 15.1 13.6 15.9 1.9 8.0 19.8 14.5 15.3 19.3 14.3 16.9 9.3 16.7 0.4 14.2 16.6 0.5 1.5 3.7 5.3 10.5 12.1 18.6 10.0 14.9 23.0 12.4 18.2 13.2 25.6 20.1 11.6 9.2 11.9 13.8 6.3 15.1 5.4 7.1 10.1 11.3 4.8 4.8 14.3 3.9 16.3 9.4 16.5 26.8 6.0 21.0 13.4 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favourable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 1.9 1.9 2.4 8.0 2.7 4.9 6.6 6.5 0.4 0.0 1.8 7.9 4.6 5.3 1.9 5.8 0.0 7.4 1.2 7.8 9.2 1.6 4.3 5.5 2.3 2.9 2.8 2.1 0.0 2.9 0.0 26.7 0.5 0.0 7.0 2.4 0.0 0.0 20.2 0.0 1.6 0.6 0.8 2.1 18.4 3.3 15.9 0.8 2.3 0.0 3.2 5.3 17.1 5.1 0.0 0.0 0.0 1.1 0.0 15.6 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell line enhanced" "Detected in many" "ASC diff: 34.4;HDLM-2: 23.9;HHSteC: 62.2;HSkMC: 48.4;HUVEC TERT2: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: " "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavourable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.7 0.0 0.1 0.0 34.4 16.8 1.7 0.0 2.3 0.1 0.4 0.2 2.5 0.0 0.3 3.0 0.2 0.2 2.0 0.1 23.9 0.9 0.0 0.0 2.4 62.2 0.0 0.0 48.4 0.1 0.0 0.3 38.3 0.0 14.7 0.1 0.0 0.0 0.3 0.0 0.2 1.1 0.4 5.6 0.1 2.4 1.3 0.0 0.0 0.3 1.3 0.0 1.6 0.3 1.8 1.3 0.1 1.6 0.4 0.6 0.0 10.4 0.6 0.9 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell line enhanced" "Detected in many" "Daudi: 29.8;RPMI-8226: 53.0;RPTEC TERT1: 43.9;U-698: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.3 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 29.8 0.7 0.3 0.1 1.6 0.0 0.1 0.6 0.8 4.0 0.2 0.1 3.8 0.8 6.9 1.7 2.8 0.2 0.1 0.0 0.0 4.9 0.1 2.0 0.0 0.7 0.4 1.0 0.1 1.4 53.0 43.9 1.2 0.9 0.2 0.5 3.2 0.9 2.8 0.1 0.0 0.1 0.2 6.3 0.1 13.2 3.1 15.6 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 DESI1 "D15Wsu75e, FAM152B, PPPDE2" ENSG00000100418 "Desumoylating isopeptidase 1" Q6ICB0 22 41598028-41621096 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053415 Approved Approved "Cytokinetic bridge,Cytosol" Cytosol "Cytokinetic bridge" "HPA053415: " "unprognostic (1.07e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-2)" "prognostic favourable (7.70e-4)" "unprognostic (2.31e-2)" "unprognostic (6.16e-3)" "unprognostic (8.75e-3)" "unprognostic (9.27e-2)" "unprognostic (3.97e-2)" "unprognostic (6.27e-2)" "unprognostic (1.80e-2)" "unprognostic (1.42e-1)" "unprognostic (2.31e-3)" "unprognostic (2.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" 12.9 14.5 24.6 12.6 25.4 8.4 13.4 17.0 33.3 11.7 11.9 22.8 9.5 14.5 10.4 15.1 19.7 11.3 11.5 30.3 24.3 19.7 19.5 69.2 14.0 13.2 23.5 16.3 12.7 13.2 15.7 10.0 11.8 18.3 13.4 14.0 9.7 13.2 14.4 14.6 15.9 16.1 14.5 22.4 11.3 12.6 29.2 19.0 9.7 9.7 14.6 16.8 10.8 9.2 6.2 7.4 10.6 12.5 2.8 7.3 5.5 7.1 7.6 7.6 10.4 10.8 12.9 4.3 14.4 9.3 13.4 9.9 10.0 4.6 27.2 10.0 16.6 10.4 20.1 16.1 14.1 12.2 15.4 6.1 14.1 8.4 13.2 24.0 8.3 11.0 18.9 16.5 15.4 20.2 17.7 31.0 10.6 9.0 5.4 7.3 7.5 11.5 7.4 3.2 27.8 16.9 4.6 5.4 2.8 13.9 15.3 9.8 5.0 7.9 20.4 10.0 7.2 10.5 7.0 11.4 8.8 13.0 24.6 10.6 13.1 9.5 9.3 10.6 5.0 12.5 6.4 6.2 6.2 5.9 7.4 5.4 5.6 6.5 5.5 2.8 8.2 4.4 7.3 5.5 24.6 25.4 17.0 33.3 24.3 19.7 23.5 16.3 18.3 19.0 DET1 FLJ10103 ENSG00000140543 "DET1, COP1 ubiquitin ligase partner" Q7L5Y6 15 88494440-88546675 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Cytosol" "HPA048873: " "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 6.0 9.3 5.5 4.3 7.0 1.9 6.4 5.5 6.8 9.5 6.3 8.2 7.0 5.5 15.9 9.1 3.8 9.6 7.8 8.8 4.3 4.2 5.4 4.5 4.3 4.2 5.0 6.1 17.9 10.1 7.1 6.4 5.6 5.9 8.5 5.6 12.6 6.7 7.4 13.8 4.4 5.9 11.4 5.1 4.4 5.5 3.6 4.6 10.7 6.8 4.1 6.4 7.7 6.0 5.3 7.6 2.9 7.4 3.4 6.6 3.8 2.0 6.7 9.5 6.9 4.7 7.1 1.8 6.5 7.0 5.7 6.0 1.4 6.3 3.9 5.0 8.3 3.1 10.7 2.0 4.9 0.3 6.9 7.4 3.7 2.3 7.4 2.8 1.5 6.1 7.2 2.7 7.8 4.4 9.4 4.7 7.1 3.2 4.0 3.1 4.3 2.1 4.7 7.8 4.8 3.0 5.9 3.7 5.8 7.3 2.5 16.2 3.6 5.9 3.6 5.8 4.5 5.9 6.0 2.7 1.9 2.6 6.5 4.8 5.1 0.0 4.8 2.9 5.3 7.4 3.9 4.8 4.6 4.7 7.6 5.3 6.6 5.4 0.7 3.4 4.6 4.1 5.1 3.8 5.5 7.0 5.5 6.8 4.3 4.2 5.0 6.1 5.9 4.6 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favourable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.3 13.7 7.4 13.0 30.2 16.6 6.8 14.5 15.1 9.5 9.1 6.4 9.9 11.2 21.9 16.4 12.2 8.7 15.6 8.2 26.2 19.5 5.5 9.0 27.1 17.3 9.5 10.5 16.9 18.0 9.3 10.8 13.7 12.6 11.2 10.5 16.5 11.8 10.3 10.3 14.3 11.0 9.8 17.1 11.8 7.0 15.3 13.5 13.8 15.3 11.5 12.1 16.5 14.9 9.6 10.4 22.7 9.4 14.9 11.4 3.2 8.4 20.4 10.8 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 DFFA "DFF-45, DFF1, DFF45, ICAD" ENSG00000160049 "DNA fragmentation factor subunit alpha" O00273 1 10456522-10472526 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002679, HPA018859, HPA019938, HPA025230" Supported Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623" "unprognostic (1.23e-1)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" "unprognostic (3.59e-2)" "unprognostic (1.57e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (9.46e-4)" "unprognostic (1.55e-1)" "unprognostic (9.24e-3)" "unprognostic (3.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "prognostic favourable (1.57e-9)" "unprognostic (1.21e-2)" "unprognostic (3.46e-2)" "unprognostic (3.89e-2)" "unprognostic (1.88e-1)" 17.8 19.9 22.9 15.6 23.0 7.9 20.9 20.4 20.7 16.6 15.1 22.5 19.1 16.5 18.4 14.4 24.2 18.6 15.3 17.2 20.7 19.9 23.7 18.9 15.5 15.6 26.4 18.9 22.5 19.8 25.7 17.2 27.2 26.1 17.0 17.3 15.0 16.3 18.4 16.8 14.8 14.7 22.4 24.1 14.8 16.8 13.4 21.9 16.7 18.0 13.0 21.4 18.7 26.1 14.1 10.7 7.2 9.9 14.1 14.4 8.9 14.3 14.4 12.4 14.1 10.5 10.0 6.0 20.6 13.3 21.5 16.0 34.3 19.1 30.8 13.3 17.3 11.9 23.9 24.4 21.8 12.2 16.5 15.3 14.9 13.7 17.2 18.7 10.2 12.5 12.3 33.8 27.3 16.3 27.4 7.0 15.2 18.3 18.4 8.5 10.9 16.8 15.9 14.8 15.5 19.3 11.1 14.7 14.3 19.1 16.8 22.6 10.7 6.5 17.0 10.1 13.8 18.5 13.5 8.7 12.1 44.9 10.7 17.8 15.2 1.3 9.9 7.2 14.4 8.0 10.9 14.1 9.7 12.4 9.2 13.7 10.2 12.3 1.5 14.1 9.7 10.7 13.5 8.9 22.9 23.0 20.4 20.7 20.7 19.9 26.4 18.9 26.1 21.9 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: " "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favourable (6.29e-5)" 4.7 4.1 6.0 5.0 7.8 3.8 4.0 13.2 7.8 3.8 4.3 4.2 2.0 12.5 5.9 1.5 3.1 4.9 4.2 4.1 4.1 1.8 2.9 2.0 3.5 2.9 5.4 4.1 6.7 9.3 1.3 8.7 4.8 2.9 3.0 1.6 4.3 3.3 3.3 1.9 2.3 5.6 2.6 3.0 5.6 4.1 1.7 6.3 2.8 3.2 1.0 5.6 4.7 3.4 3.1 6.3 6.9 8.2 2.7 6.4 3.7 3.1 2.8 1.3 3.9 0.9 1.0 0.9 2.7 0.8 2.9 2.9 1.7 1.3 1.2 1.7 0.6 0.9 0.4 1.7 0.2 7.3 7.4 11.0 1.2 1.6 2.6 6.0 8.5 0.5 0.3 2.7 0.1 3.3 6.0 1.3 0.6 0.9 6.6 3.5 2.2 6.3 5.4 2.3 2.4 0.6 0.4 2.8 5.0 2.0 3.0 8.3 0.7 3.6 4.9 1.2 1.0 5.7 2.3 2.4 3.5 3.4 1.4 9.3 1.7 5.3 5.5 6.9 4.7 5.1 2.9 3.1 3.0 3.8 6.3 1.2 2.8 4.5 1.7 2.7 8.2 0.1 6.4 3.7 6.0 7.8 13.2 7.8 4.1 1.8 5.4 4.1 2.9 6.3 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.1 1.9 3.6 3.2 1.3 2.3 2.7 2.7 2.6 1.8 9.7 2.6 1.5 10.6 1.7 3.3 1.6 3.7 0.5 2.8 4.0 2.8 3.3 15.8 2.3 0.7 2.9 1.8 2.9 1.6 1.9 2.0 2.2 3.5 1.7 3.2 4.8 3.1 0.9 17.6 6.2 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.0 0.4 0.6 1.4 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria Vesicles "Nucleoplasm, Mitochondria" "HPA041645: , HPA045462: " "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.7 8.3 44.8 12.2 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 42.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favourable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.6 1.6 1.5 0.1 0.2 0.5 0.7 2.8 2.3 1.9 2.3 3.7 2.0 2.4 3.5 1.5 2.0 3.6 1.5 4.0 7.8 4.6 3.1 3.9 2.4 1.7 6.0 4.5 0.9 2.0 2.0 4.1 2.6 2.5 42.7 2.4 2.4 14.2 3.4 1.1 4.8 4.4 6.2 5.8 1.9 3.7 2.3 1.6 2.3 1.2 0.1 2.6 2.9 2.4 0.5 2.7 0.8 0.4 5.6 11.5 1.6 1.7 3.5 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.6 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 19.8 0.0 2.6 0.0 2.9 0.0 6.3 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.3 0.1 0.1 2.2 0.4 1.2 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.8 0.0 1.6 0.1 4.1 0.0 0.0 0.7 2.0 2.4 0.0 7.5 0.0 12.5 5.9 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favourable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavourable (5.67e-4)" 8.0 40.1 12.1 5.6 14.5 19.0 16.8 5.3 22.8 5.5 9.3 27.9 8.8 20.8 4.0 27.3 14.6 5.2 5.8 10.7 13.7 13.2 7.1 64.8 12.0 2.7 20.6 12.3 21.5 7.3 14.0 7.0 3.7 23.4 10.0 6.6 16.6 10.0 3.9 5.4 22.9 15.8 4.5 20.5 5.9 8.5 17.7 15.5 2.8 5.4 12.1 7.7 4.3 7.4 6.3 6.2 3.5 1.9 4.6 12.1 5.7 21.6 19.6 19.2 21.2 9.0 14.0 6.0 8.9 23.8 7.6 20.8 73.0 71.1 15.1 14.3 8.5 41.6 22.8 48.3 8.1 5.7 17.1 5.7 16.6 31.2 23.1 10.8 2.8 16.2 21.4 28.6 19.7 11.2 27.0 32.3 7.6 58.1 8.9 12.2 27.5 11.7 8.1 27.0 65.0 28.6 32.7 26.1 9.7 8.5 28.2 20.3 27.3 5.9 10.6 2.1 11.6 0.6 10.7 10.7 12.9 16.1 6.1 19.2 8.6 3.5 1.9 1.7 9.7 1.2 11.8 6.3 8.2 9.0 2.5 5.4 10.5 12.1 1.0 4.6 1.2 6.2 5.1 5.7 12.1 14.5 5.3 22.8 13.7 13.2 20.6 12.3 23.4 15.5 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933682-48944969 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 32.4;kidney: 18.0" "Cell line enhanced" "Detected in many" "U-266/70: 6.7;U-266/84: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.8;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 31 "granulocytes: 5.8;T-cells: 4.8" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favourable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.3 0.5 1.5 0.1 2.1 0.1 0.2 1.8 1.5 0.1 8.2 0.2 0.1 10.6 0.2 0.4 0.8 0.3 0.8 0.1 2.7 2.0 18.0 0.7 1.9 0.2 0.4 0.4 0.5 0.4 0.2 2.1 1.3 0.6 3.5 0.1 1.2 0.8 0.2 0.3 0.2 32.4 0.1 0.9 1.8 0.7 2.8 0.1 0.4 0.1 0.5 0.7 1.1 0.3 0.1 0.0 5.8 0.0 0.0 4.8 0.5 2.9 0.0 0.2 1.5 0.8 0.7 1.2 0.0 0.4 0.5 1.4 2.8 2.3 0.0 0.6 0.0 0.8 1.0 2.1 1.0 1.1 2.3 4.1 0.9 1.1 0.0 0.0 1.0 0.6 0.2 1.1 0.0 0.0 1.3 0.4 0.0 0.6 0.0 0.3 0.6 1.9 1.5 0.2 2.1 0.4 0.9 4.5 2.4 0.5 0.3 0.9 2.0 0.1 0.0 0.0 1.8 0.7 0.1 6.7 5.3 1.7 1.4 0.0 0.4 5.8 0.0 0.9 1.6 0.0 0.8 0.0 1.6 0.7 0.0 0.1 4.8 3.1 0.1 0.0 0.0 0.0 1.2 0.5 1.5 2.1 1.8 1.5 2.7 2.0 0.4 0.4 0.6 0.1 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.7 15.3 24.9 13.2 11.2 18.5 5.8 13.3 19.6 25.5 25.7 10.9 10.1 21.5 15.1 14.5 12.6 17.0 18.9 17.6 18.8 12.0 14.3 16.7 14.3 13.8 17.1 22.9 14.9 23.3 15.4 26.6 17.8 13.0 15.3 18.6 41.2 30.5 24.8 19.5 26.1 20.3 9.3 31.0 19.6 11.2 32.4 44.0 13.4 19.5 22.6 18.1 28.7 8.9 30.0 12.2 29.3 20.2 48.9 52.7 14.6 18.4 21.1 28.3 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000599 Approved Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655" "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favourable (1.18e-5)" "prognostic favourable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.0 2.6 2.9 1.1 6.7 7.1 0.7 3.9 8.7 9.4 10.2 1.0 10.7 5.2 1.7 6.1 9.0 2.1 18.3 4.5 3.5 2.3 1.5 6.4 17.4 3.1 3.1 1.2 6.4 10.7 2.3 1.7 7.0 3.2 4.9 7.6 4.4 1.1 1.1 0.5 4.0 3.9 2.0 7.1 7.2 4.1 2.5 1.8 5.6 7.6 1.9 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.3 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591798-36600806 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "intestine: 88.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 11000 Cytosol "Golgi apparatus" "HPA041226: , HPA048236: , HPA053623: " "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favourable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 1.3 0.6 1.2 4.1 2.4 0.4 0.7 0.5 5.7 0.4 38.7 0.4 0.4 42.7 0.4 0.1 1.2 1.1 1.4 2.0 0.5 2.5 1.7 0.1 0.0 0.0 2.4 0.1 2.8 1.5 0.2 0.0 1.6 0.5 12.4 2.8 2.1 0.8 2.0 0.8 88.0 0.9 0.1 0.0 1.1 2.2 0.3 0.0 1.3 1.3 1.0 0.4 0.0 0.9 0.2 0.9 0.7 0.1 2.7 0.1 6.5 5.9 2.8 7.4 0.6 1.7 5.5 2.0 1.4 6.4 5.8 9.6 5.3 0.7 1.4 2.0 6.9 6.0 4.1 6.5 3.4 11.4 1.7 5.7 18.6 3.1 1.9 0.6 0.9 3.9 4.4 3.3 4.9 15.6 5.8 3.5 5.8 6.4 3.5 2.2 2.3 8.0 7.0 11.0 6.5 5.6 6.0 2.6 7.0 7.3 16.4 10.0 1.8 1.8 0.9 9.1 4.8 5.0 9.5 8.0 2.3 3.3 4.7 2.8 0.4 0.5 0.9 1.0 0.7 0.1 0.4 1.0 0.6 0.1 0.9 1.3 0.9 0.5 0.1 0.1 0.2 2.7 0.1 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804157 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034238, HPA057028, HPA058315" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: , HPA058315: " "prognostic favourable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favourable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 15.6 6.4 6.9 4.1 7.1 3.9 11.1 5.2 10.9 9.5 7.6 13.8 7.1 5.5 8.4 16.0 7.7 7.5 7.4 8.3 6.0 6.0 14.2 15.8 8.7 4.8 5.8 6.2 10.4 37.6 11.1 10.0 7.3 8.0 7.7 4.7 14.0 11.5 13.0 10.4 10.1 12.2 8.3 7.2 8.3 7.3 3.9 6.5 4.4 10.2 6.9 9.2 6.4 5.7 6.0 4.5 36.3 7.3 1.6 11.6 5.7 0.9 3.1 5.6 7.6 2.5 5.3 5.2 1.7 3.9 2.2 1.2 3.5 15.6 3.9 1.2 3.2 1.9 0.1 0.8 0.3 3.6 2.7 1.2 1.0 3.2 6.7 0.7 1.1 3.4 6.0 0.7 3.2 5.2 1.6 4.4 2.5 4.5 1.5 3.2 6.7 0.5 0.5 0.7 6.4 8.8 2.6 3.4 7.1 2.6 5.7 6.8 5.9 3.9 9.1 1.3 1.9 0.3 1.8 2.1 1.5 1.9 4.0 2.1 4.9 2.9 7.3 0.2 6.4 6.2 11.6 6.0 9.9 8.0 4.0 5.6 8.8 6.2 36.3 1.6 7.0 4.5 8.6 5.7 6.9 7.1 5.2 10.9 6.0 6.0 5.8 6.2 8.0 6.5 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell line enhanced" "Detected in some" "Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053915: , HPA069551: " "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favourable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 19.7 1.5 0.1 0.0 48.8 0.0 0.2 1.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 2.2 0.1 0.4 0.1 0.0 58.4 0.2 0.3 0.4 285.8 0.3 0.2 0.0 0.0 0.1 93.6 0.5 0.2 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.0;CAPAN-2: 59.3;SK-BR-3: 31.8;WM-115: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favourable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 5.1 29.0 0.0 12.8 16.8 1.4 3.3 1.7 0.0 0.0 0.1 3.4 59.3 0.0 1.4 17.0 23.4 6.2 3.2 0.0 0.0 10.4 4.5 3.0 16.1 2.5 0.0 0.0 8.5 3.9 0.1 0.1 5.4 6.8 0.0 0.1 0.9 1.2 0.2 1.9 11.7 0.1 0.0 5.9 0.0 9.9 0.3 0.5 9.8 31.8 1.8 3.1 1.2 3.9 0.1 0.6 8.9 0.1 0.9 0.0 0.0 6.7 0.4 55.1 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953586-23969279 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favourable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 15.8 18.5 8.3 10.3 13.7 5.9 15.4 4.4 9.6 11.0 22.2 10.2 12.1 30.3 13.7 11.7 17.2 8.3 16.3 16.3 9.0 6.6 65.8 40.3 12.6 13.6 14.0 7.7 12.6 20.6 7.3 9.7 8.9 9.3 17.0 12.4 12.0 17.5 14.4 25.3 16.6 35.2 14.4 9.6 12.4 12.9 13.5 12.6 6.9 17.1 16.1 11.1 10.0 14.8 9.7 22.0 2.6 25.5 7.9 10.6 14.9 7.5 15.5 5.3 8.7 8.5 9.4 0.1 14.4 7.6 5.7 4.6 3.2 8.2 6.5 7.7 7.1 9.1 4.3 5.9 5.2 17.5 8.8 3.9 13.0 18.1 5.2 5.6 24.2 9.4 7.4 4.8 10.4 7.1 5.8 15.5 7.8 26.0 10.3 5.3 5.2 15.6 16.7 9.4 21.5 5.9 8.9 10.3 8.7 13.8 9.0 6.8 8.3 7.6 13.2 7.1 7.5 7.3 4.6 11.9 11.1 1.7 6.2 6.4 7.1 2.4 25.5 2.6 8.9 21.0 10.6 9.7 10.1 8.9 22.0 8.3 10.3 9.9 1.1 7.9 11.1 18.5 8.6 14.9 8.3 13.7 4.4 9.6 9.0 6.6 14.0 7.7 9.3 12.6 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023972 Uncertain Uncertain "Nuclear membrane,Vesicles" "Secreted - unknown location" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favourable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 6.3 11.2 6.9 12.8 7.9 3.0 11.4 14.6 9.6 7.2 9.9 3.4 2.6 12.1 5.6 10.4 25.5 5.4 4.3 8.9 5.0 4.1 42.0 33.0 16.7 7.2 4.6 2.4 7.1 28.4 6.0 5.2 3.1 7.6 8.3 9.5 5.4 14.2 10.9 18.7 9.8 14.9 6.4 5.6 8.1 7.1 28.2 4.5 13.8 5.9 32.8 14.5 5.3 7.1 10.4 22.3 3.2 27.2 7.9 11.5 14.7 8.5 12.8 2.2 10.9 21.3 22.3 0.2 7.7 15.2 11.2 8.4 3.7 10.1 5.5 5.3 15.4 9.3 9.9 12.8 9.4 18.1 5.9 1.3 11.1 22.9 15.7 7.1 22.1 23.0 16.3 7.3 10.8 13.1 4.3 19.8 12.0 26.7 17.6 7.3 4.4 14.2 27.8 9.0 17.3 16.1 11.3 11.9 7.2 10.5 9.7 6.4 11.8 10.6 9.2 5.9 6.2 7.0 3.8 11.6 9.1 1.6 5.1 10.3 8.4 2.3 27.2 3.2 10.1 22.5 10.4 10.4 10.8 11.5 22.3 8.2 11.1 10.1 1.3 7.9 13.2 18.3 10.3 14.7 6.9 7.9 14.6 9.6 5.0 4.1 4.6 2.4 7.6 4.5 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031121 Approved Approved Nucleoplasm,Mitochondria 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803" "prognostic favourable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favourable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 51.8 15.7 9.1 19.9 47.0 18.4 11.5 16.7 43.2 6.1 13.6 8.6 35.1 5.4 10.1 15.6 22.4 11.8 23.6 8.9 37.7 11.0 13.3 7.7 14.2 24.7 15.8 0.4 13.6 28.3 9.7 32.8 11.7 4.0 11.7 15.3 15.6 9.2 15.1 4.3 15.9 9.5 12.2 6.3 27.3 17.7 19.5 24.4 17.0 25.7 37.1 18.0 7.0 8.2 30.5 10.3 8.3 9.6 4.2 1.9 9.6 16.6 15.3 20.8 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favourable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favourable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 10.0 11.9 4.4 9.5 11.6 8.0 7.6 9.6 5.4 7.0 12.9 15.0 10.6 4.2 14.7 8.2 14.3 6.4 15.7 10.0 8.1 20.6 5.8 8.8 12.8 6.4 3.2 4.3 6.2 10.5 9.0 13.7 6.8 3.5 5.3 8.2 20.7 3.5 12.7 6.0 5.1 5.9 11.5 7.4 23.4 12.2 2.4 5.1 11.9 10.6 10.3 7.1 6.7 3.4 5.9 4.1 17.6 10.8 2.9 4.5 7.9 9.2 12.0 8.7 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219516-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003035 Approved Approved "Actin filaments,Cytosol" "Secreted to blood" "Actin filaments, Cytosol" "HPA003035: AB_1080631" "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 7.3 9.5 21.5 3.1 26.7 2.9 55.7 21.5 25.3 32.1 7.3 1.2 1.2 4.6 25.1 6.4 3.2 7.5 6.7 37.8 23.7 3.4 34.6 18.9 5.8 3.2 21.8 16.9 25.0 15.2 5.5 24.2 32.7 28.3 7.7 6.5 1.2 10.8 5.7 6.3 4.9 6.5 5.3 26.5 5.9 8.6 3.4 23.6 1.2 8.1 1.2 2.7 6.1 27.4 12.2 18.3 30.0 21.1 8.7 9.1 10.0 4.5 20.8 14.0 6.5 17.6 11.0 10.6 10.4 17.6 8.0 10.8 15.5 9.9 7.2 13.4 12.3 2.2 9.7 8.4 5.6 13.3 15.0 7.0 10.9 11.6 20.2 3.8 5.6 13.6 10.4 6.9 6.9 6.3 7.6 3.6 12.8 5.2 13.9 5.3 3.4 5.8 5.4 7.4 2.0 8.6 11.1 13.4 13.4 9.9 11.8 7.7 5.1 6.0 8.5 8.7 2.1 4.9 6.1 4.2 0.0 18.8 5.8 5.0 3.9 6.5 21.1 17.1 8.4 15.7 8.9 12.2 7.6 7.0 18.3 10.6 7.2 6.0 30.0 8.7 9.5 14.8 9.1 10.0 21.5 26.7 21.5 25.3 23.7 3.4 21.8 16.9 28.3 23.6 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favourable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 18.4 18.7 22.1 18.5 31.1 23.6 18.3 31.2 43.5 22.3 17.8 26.9 15.5 17.3 23.3 14.8 21.0 24.8 17.9 21.3 19.1 19.8 18.6 19.3 16.7 22.0 20.4 28.0 27.1 21.2 37.3 24.8 20.6 23.6 20.4 13.0 22.0 20.4 23.6 27.1 26.2 16.1 18.8 15.3 21.2 18.7 54.4 18.4 23.8 20.1 15.2 16.9 18.6 17.6 9.9 13.0 9.8 10.5 8.2 16.1 11.6 8.1 20.7 20.5 21.1 9.5 7.9 14.0 15.4 13.2 26.6 19.2 23.8 17.4 26.5 12.1 15.0 12.5 30.3 21.5 9.5 18.0 36.3 23.1 30.5 23.2 16.5 21.5 24.0 13.8 13.7 28.1 19.8 17.3 32.5 17.1 12.4 22.0 27.3 23.6 22.8 35.4 18.2 11.0 23.5 13.3 20.7 16.9 22.5 15.0 21.4 11.1 15.0 22.6 12.0 16.1 20.9 18.1 28.2 20.7 25.8 24.1 16.7 18.8 19.9 9.8 10.1 7.2 15.0 10.3 13.0 9.9 12.7 16.1 13.0 9.3 12.1 13.0 1.5 8.2 10.5 7.8 14.3 11.6 22.1 31.1 31.2 43.5 19.1 19.8 20.4 28.0 23.6 18.4 DHX34 "DDX34, KIAA0134" ENSG00000134815 "DExH-box helicase 34" Q14147 19 47349281-47382704 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042159, HPA043558" Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA042159: AB_10963066, HPA043558: AB_10961262" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-3)" "prognostic unfavourable (8.63e-6)" "unprognostic (9.14e-2)" "unprognostic (4.74e-2)" "unprognostic (5.11e-2)" "unprognostic (4.76e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (3.16e-6)" "unprognostic (7.38e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (7.21e-3)" 6.8 6.9 12.6 11.0 11.5 20.3 6.6 18.7 13.3 8.2 5.9 9.1 8.9 7.7 10.4 5.3 8.3 9.0 5.7 6.0 11.2 6.4 7.2 10.9 8.9 7.9 12.3 8.4 13.3 12.9 7.8 14.2 7.8 11.4 8.9 4.6 8.5 9.9 8.3 7.8 11.8 7.0 6.6 10.5 13.5 6.7 21.8 12.5 5.6 9.6 4.6 9.6 7.3 11.2 1.5 1.9 13.5 2.2 0.8 1.8 1.1 7.1 18.8 4.6 9.1 4.1 2.8 8.8 5.7 1.9 5.9 5.3 12.0 7.0 11.0 5.8 3.2 10.5 6.4 7.5 3.0 9.1 17.4 11.5 10.2 9.1 4.5 8.9 4.9 3.5 6.1 10.0 5.6 3.9 19.1 4.8 3.9 8.4 8.8 22.2 9.6 11.3 9.7 3.7 6.6 3.2 9.7 8.3 5.1 7.0 7.0 4.6 6.3 5.7 4.4 6.9 9.0 4.3 10.0 7.3 10.0 10.3 5.6 6.5 8.1 1.0 2.0 0.8 1.3 2.2 1.2 1.2 1.0 1.8 1.9 1.5 1.6 0.7 13.5 0.8 1.7 1.5 0.6 1.1 12.6 11.5 18.7 13.3 11.2 6.4 12.3 8.4 11.4 12.5 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: , HPA062700: " "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavourable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavourable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 10.4 7.3 9.7 6.9 14.6 13.9 9.8 9.7 14.3 12.2 23.2 14.8 10.7 9.9 19.7 13.9 13.9 12.5 9.2 16.9 9.0 5.8 10.4 7.5 8.7 12.6 8.2 6.7 13.9 6.5 12.1 13.5 8.4 10.9 13.3 14.3 12.4 10.4 12.6 12.5 11.1 12.4 14.7 9.9 8.4 13.4 12.5 9.4 12.1 8.5 7.6 11.2 15.9 11.8 4.6 6.7 2.0 4.9 5.8 8.2 4.4 7.3 4.4 11.9 4.9 4.6 6.0 8.4 4.4 7.8 10.1 7.8 21.0 7.2 8.4 7.8 8.4 11.7 8.2 12.9 10.1 2.1 4.0 11.2 10.0 11.9 5.5 13.0 5.9 7.0 8.3 8.9 8.4 4.5 11.3 4.8 5.4 6.0 21.3 10.0 6.8 9.9 10.4 17.4 6.8 3.7 8.4 10.5 8.2 12.1 7.3 11.1 9.9 10.8 4.4 14.6 8.0 5.7 9.1 4.8 6.4 8.8 8.6 5.9 7.6 0.0 4.9 2.0 5.3 4.5 5.2 4.6 4.5 5.6 6.7 4.3 8.2 4.3 1.0 5.8 3.8 2.4 2.8 4.4 9.7 14.6 9.7 14.3 9.0 5.8 8.2 6.7 10.9 9.4 DHX36 "DDX36, KIAA1488, MLEL1" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324497 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035399 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 16.3 14.0 11.5 14.1 27.5 12.6 15.7 19.0 21.3 17.9 14.7 10.3 12.4 10.7 20.4 10.6 14.5 14.3 13.7 23.9 13.4 12.7 16.7 17.1 14.6 17.0 12.2 15.0 20.0 13.7 34.0 36.2 16.4 20.1 15.7 12.2 9.3 15.5 20.5 53.4 14.7 14.3 15.1 13.7 18.9 13.4 28.3 11.3 24.3 20.4 13.4 17.1 20.7 15.6 6.3 5.9 3.1 5.7 4.8 6.9 1.1 26.7 18.3 24.9 14.3 11.7 16.5 12.4 17.5 17.6 20.0 23.9 18.6 21.5 26.0 28.4 15.3 17.3 23.4 14.8 31.5 24.9 15.5 18.8 15.7 10.5 19.9 26.1 16.5 18.6 12.6 21.4 26.3 17.1 17.7 15.0 18.4 13.0 21.6 5.7 33.0 17.6 22.5 20.9 37.4 14.3 19.0 23.3 24.8 18.2 19.4 25.4 19.9 13.3 19.3 21.0 13.2 19.6 34.9 28.1 18.1 37.5 17.0 13.7 22.2 1.9 2.7 3.1 6.9 2.8 4.4 4.7 6.1 4.7 2.3 6.3 5.8 6.0 1.1 4.8 5.7 5.9 5.4 1.1 11.5 27.5 19.0 21.3 13.4 12.7 12.2 15.0 20.1 11.3 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavourable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 9.6 11.2 9.7 8.5 16.7 7.0 10.4 11.9 16.4 14.1 9.4 9.9 9.8 4.2 13.9 17.1 8.4 11.2 9.5 9.3 9.6 11.0 11.2 7.2 7.9 9.2 8.9 9.5 13.2 9.5 18.9 17.9 11.2 13.1 10.5 9.2 11.6 7.8 14.2 11.5 11.1 6.9 11.8 7.7 9.9 7.9 27.7 8.3 13.9 11.8 8.1 11.1 10.5 8.3 7.1 5.2 1.7 10.1 3.3 6.0 4.2 16.9 13.6 15.2 11.4 10.0 12.4 12.5 11.8 11.6 11.2 11.0 10.9 5.2 4.9 11.9 12.0 8.8 17.2 13.0 18.4 20.4 12.7 9.6 9.1 14.8 9.1 10.1 5.6 11.8 7.9 14.5 9.1 14.9 12.3 7.0 12.1 12.3 10.1 9.3 19.0 8.1 5.0 20.2 9.7 10.3 6.5 12.6 18.5 11.8 12.2 13.8 8.5 5.6 11.4 11.1 12.9 8.5 12.6 7.4 8.2 2.1 8.7 7.1 7.4 1.7 10.1 1.7 4.5 6.9 6.0 5.7 4.0 3.5 5.2 7.1 4.8 3.0 0.5 3.3 8.0 1.7 3.3 4.2 9.7 16.7 11.9 16.4 9.6 11.0 8.9 9.5 13.1 8.3 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112733 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.5;SK-MEL-30: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favourable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 12.7 16.3 6.7 15.3 7.8 11.1 9.8 2.8 8.4 7.9 9.8 9.6 15.0 8.2 9.6 16.2 8.7 12.0 12.6 5.3 6.5 5.3 11.0 20.9 21.7 14.4 5.9 9.0 12.9 7.4 4.3 9.6 7.0 8.2 10.6 5.0 13.4 18.0 17.1 6.9 7.8 10.5 9.2 7.9 17.1 9.1 10.7 5.1 17.2 7.5 5.6 12.9 10.9 7.6 6.4 7.6 8.6 12.0 7.6 7.1 5.9 1.2 0.0 0.0 0.7 6.2 5.3 0.2 1.7 11.8 24.4 28.5 0.1 7.6 0.1 1.8 2.8 1.0 0.1 1.9 0.9 4.7 0.1 2.0 1.1 0.4 6.9 1.8 4.6 8.6 3.2 2.1 2.1 2.9 0.0 6.7 1.3 0.0 10.9 2.2 0.2 0.0 3.9 0.0 0.5 2.7 4.4 0.2 0.0 0.7 3.1 13.9 4.2 1.9 1.2 1.2 0.0 0.4 0.6 2.3 1.9 0.1 2.4 1.7 1.3 3.1 9.9 8.6 4.5 12.0 6.5 6.4 6.4 4.0 7.6 4.9 7.1 5.3 4.0 7.6 10.5 2.5 5.5 5.9 6.7 7.8 2.8 8.4 6.5 5.3 5.9 9.0 8.2 5.1 DHX8 "DDX8, Dhr2, HRH1, PRP22, PRPF22" ENSG00000067596 "DEAH-box helicase 8" Q14562 17 43483865-43544463 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049285 Approved Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" Nucleoplasm "Nuclear bodies" "HPA049285: " "unprognostic (2.99e-1)" "unprognostic (4.42e-2)" "unprognostic (5.64e-2)" "unprognostic (9.02e-2)" "unprognostic (1.25e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-3)" "unprognostic (9.43e-2)" "unprognostic (2.58e-1)" "unprognostic (3.40e-2)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (4.04e-1)" "unprognostic (5.08e-3)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" 21.9 18.6 17.5 17.0 22.9 47.8 22.3 21.6 29.8 20.3 21.0 25.3 17.2 17.1 26.1 28.4 26.6 17.9 16.7 18.5 18.1 18.7 18.5 20.1 19.8 21.0 20.8 19.7 19.5 17.4 35.4 23.0 21.7 22.7 22.1 24.6 20.1 21.7 21.7 25.2 32.9 22.0 24.6 19.2 27.3 19.5 34.6 20.6 40.8 20.5 17.8 28.9 19.4 22.6 11.5 16.3 23.3 20.4 9.5 14.9 9.8 12.3 35.1 19.1 23.7 19.0 19.5 10.6 13.0 27.5 28.8 27.7 16.0 12.6 17.1 12.1 25.5 16.8 28.6 22.9 33.8 17.9 22.6 14.5 26.8 24.7 16.3 25.1 22.0 9.7 19.4 23.6 26.0 25.4 16.1 16.9 22.2 13.4 31.8 22.4 15.5 13.4 19.4 36.4 17.6 19.5 25.9 16.5 24.9 14.6 8.4 11.7 19.5 24.8 17.3 22.4 12.2 16.1 19.4 12.7 15.1 19.4 18.6 15.7 17.9 23.3 15.2 17.2 13.7 20.4 13.6 11.5 11.4 14.9 16.3 10.6 11.2 10.9 19.2 9.5 19.6 8.4 11.7 9.8 17.5 22.9 21.6 29.8 18.1 18.7 20.8 19.7 22.7 20.6 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.0 18.4 0.0 6.9 7.3 3.7 7.9 3.3 7.6 11.3 5.5 5.9 0.0 10.3 1.1 4.9 0.3 5.9 0.0 4.8 3.5 9.2 14.5 5.2 9.2 3.7 5.0 15.7 7.2 0.0 9.3 6.9 3.2 5.4 5.9 15.3 5.9 0.0 10.4 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.5 1.7 8.0 9.1 8.1 3.7 6.6 4.4 0.1 0.0 9.5 6.8 14.8 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163987 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.2;testis: 19.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA032151 Supported "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA032151: " "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favourable (9.04e-4)" "prognostic unfavourable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavourable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 1.8 0.4 1.7 11.5 1.8 6.7 1.6 0.1 1.4 0.9 4.7 0.2 0.4 2.0 1.4 1.1 7.1 0.3 2.5 1.1 1.0 1.6 1.7 0.4 4.1 2.9 1.0 0.0 0.4 0.4 0.5 0.2 9.4 0.2 0.4 2.3 0.0 1.6 0.0 0.1 1.8 4.3 2.7 0.3 2.5 3.1 19.6 0.0 35.2 0.2 5.3 5.9 0.8 1.5 0.4 2.0 0.4 0.2 0.0 0.5 0.2 17.9 6.0 6.2 3.5 1.1 2.9 10.6 25.2 11.2 25.5 22.3 15.9 12.2 6.0 2.0 12.9 12.3 10.1 9.9 38.9 6.8 7.0 8.6 15.4 3.6 1.6 11.7 6.9 1.1 0.2 15.5 10.5 11.4 6.6 8.6 24.2 2.6 10.4 5.0 5.8 3.5 7.1 15.4 4.9 8.3 3.7 3.3 5.7 12.8 8.9 3.9 6.5 6.4 11.3 16.2 10.4 5.4 20.8 5.8 6.3 9.4 4.3 5.8 12.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 2.0 0.5 0.2 1.7 1.8 0.1 1.4 1.0 1.6 1.0 0.0 0.2 0.0 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: " "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favourable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favourable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.6 9.0 15.2 8.6 7.8 9.6 8.1 8.8 7.5 32.9 9.5 38.6 12.1 11.5 12.2 10.8 18.3 13.8 17.1 21.4 6.3 9.3 16.6 14.9 27.5 9.9 14.8 17.2 9.8 23.6 11.4 6.4 9.0 16.2 10.6 8.3 11.3 30.0 13.1 12.1 13.2 21.3 19.4 7.3 5.4 10.4 18.7 11.1 17.7 17.2 11.6 17.1 17.0 11.2 26.9 18.8 8.9 12.5 7.1 4.6 15.4 12.2 7.5 9.7 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA042944: " "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavourable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.4 8.7 15.9 20.8 11.8 15.7 15.9 18.6 7.0 14.4 15.3 14.1 15.5 29.8 17.0 13.8 11.3 10.7 11.0 18.3 21.2 18.7 20.5 11.4 11.7 14.2 16.8 15.8 13.6 8.9 14.0 13.7 12.5 20.7 13.8 14.6 14.5 24.7 25.9 15.4 18.4 16.0 16.1 41.1 13.0 13.4 17.9 15.6 15.9 14.9 15.9 12.0 15.8 13.8 9.9 10.4 14.0 25.4 18.2 18.9 26.9 15.1 30.2 14.6 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Cell line enhanced" "Detected in some" "BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029544, HPA048002" Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029544: AB_10600804, HPA048002: " "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favourable (1.67e-4)" "prognostic favourable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.4 0.0 26.1 5.5 2.3 0.3 0.0 0.1 0.0 0.1 14.3 0.5 0.9 0.0 1.9 0.0 0.0 0.0 29.9 0.0 14.9 0.0 0.0 1.6 0.0 0.5 0.0 0.5 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 54.7 11.4 0.1 0.0 0.0 0.3 0.1 2.4 5.5 6.6 0.8 0.0 0.0 2.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: " "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favourable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.4 3.9 12.6 13.7 6.1 8.8 5.5 6.8 5.6 1.1 1.2 0.3 2.4 14.1 0.1 4.5 0.7 4.2 0.2 4.0 0.1 2.7 1.2 6.1 0.0 5.5 11.1 3.6 4.3 0.0 1.5 0.0 0.7 5.1 10.8 0.4 0.0 1.9 1.6 6.1 3.1 1.2 4.8 4.5 3.7 5.3 1.5 3.2 12.7 4.2 0.0 0.1 7.2 1.9 21.5 2.9 0.5 8.5 4.6 9.1 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045896-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 33.2;pituitary gland: 35.2" "Cell line enhanced" "Detected in some" "HHSteC: 7.3;HSkMC: 15.3;TIME: 9.5;U-251 MG: 7.7;U-87 MG: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 49.9" "Group enriched" "Detected in some" 18 "plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 20 "dendritic cells: 2.1;T-cells: 1.8" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favourable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favourable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.0 10.2 2.0 0.2 49.9 0.0 2.4 0.9 2.9 2.3 1.6 1.0 0.0 3.4 1.2 5.4 1.3 1.3 5.9 5.7 1.3 8.7 3.2 4.5 2.3 0.0 1.3 1.1 33.2 9.9 8.8 35.2 0.0 17.3 2.3 0.1 2.4 1.3 1.1 1.0 1.1 1.2 0.3 1.7 1.2 1.9 2.4 0.5 0.0 1.6 0.3 0.1 1.2 1.9 0.0 2.1 0.0 0.0 0.0 1.8 0.0 0.0 1.3 1.4 0.0 4.7 3.5 0.5 4.0 1.4 0.3 1.1 0.0 0.7 0.0 0.2 4.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 7.3 0.0 0.0 15.3 0.1 0.6 0.0 0.9 0.2 0.0 4.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.1 0.1 0.0 9.5 0.0 0.4 0.2 7.7 2.4 0.0 0.0 14.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 2.0 49.9 0.9 2.9 1.3 8.7 1.3 1.1 17.3 0.5 DIS3 "dis3p, EXOSC11, KIAA1008, RRP44" ENSG00000083520 "DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease" Q9Y2L1 13 72752169-72782096 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039281, HPA058762" Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039281: AB_10795583, HPA058762: " "unprognostic (1.61e-1)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" "unprognostic (8.97e-2)" "unprognostic (8.14e-2)" "unprognostic (1.51e-2)" "unprognostic (1.49e-1)" "unprognostic (2.84e-1)" "unprognostic (6.38e-2)" "unprognostic (8.68e-2)" "unprognostic (1.32e-3)" "unprognostic (3.35e-3)" "unprognostic (1.02e-1)" "unprognostic (2.37e-2)" "unprognostic (3.69e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-1)" 25.5 14.7 11.7 17.6 24.8 23.8 22.4 23.4 19.4 20.3 18.8 11.6 17.0 11.8 18.0 19.3 23.1 17.8 16.0 21.6 12.4 13.6 20.2 25.6 19.3 22.2 13.9 17.0 23.4 15.3 15.8 22.8 26.3 18.7 18.0 15.6 9.8 17.4 19.3 19.9 17.3 17.9 17.5 12.9 22.8 16.2 27.7 14.6 23.7 21.3 19.1 23.0 26.7 19.3 6.9 6.8 11.1 9.7 10.3 10.0 5.0 15.6 7.3 14.4 12.1 15.4 18.4 9.5 14.0 17.1 14.3 17.6 11.2 13.1 19.1 12.2 14.3 13.1 19.7 16.1 23.2 15.6 14.5 22.4 15.7 10.1 19.2 37.8 13.0 19.1 11.3 16.2 21.4 15.3 14.9 8.0 17.4 5.5 16.0 18.6 13.5 8.6 13.0 11.0 8.6 14.4 12.6 13.1 17.2 11.5 9.6 13.5 9.3 17.3 14.3 8.7 7.0 9.7 14.8 15.5 17.4 15.3 24.2 18.0 12.5 11.1 5.5 7.8 6.5 9.7 9.4 6.9 8.5 7.3 6.8 6.0 8.1 7.6 3.4 10.3 7.6 4.3 10.0 5.0 11.7 24.8 23.4 19.4 12.4 13.6 13.9 17.0 18.7 14.6 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 13.7 15.4 18.7 14.7 16.6 11.8 14.5 15.7 16.4 13.7 11.8 20.7 19.1 9.0 14.7 15.5 10.6 15.5 10.0 20.1 17.3 17.0 14.2 15.2 10.8 14.0 19.4 10.8 16.2 24.4 24.9 18.9 9.0 17.7 14.7 10.3 15.4 14.4 16.3 29.4 9.4 9.0 15.2 19.6 11.1 10.5 15.4 14.0 19.3 18.0 9.4 12.8 12.5 9.7 9.1 10.5 7.8 13.1 14.1 13.2 8.0 8.4 19.2 5.8 7.7 7.3 9.9 8.2 6.3 6.9 9.3 7.8 9.4 5.7 30.0 6.9 7.5 14.4 14.3 5.0 6.9 7.9 13.2 17.6 12.5 10.7 5.5 17.1 6.2 4.0 5.7 2.5 8.3 7.2 10.2 7.3 8.3 6.2 7.6 10.0 9.2 10.6 11.5 25.0 17.5 3.1 9.6 9.9 9.7 12.8 4.2 7.0 6.3 11.4 9.3 10.8 10.2 4.5 10.8 6.4 19.9 14.5 3.7 22.6 4.3 7.8 5.9 5.1 9.9 7.1 12.8 8.5 9.5 13.2 10.5 9.1 11.6 9.6 0.7 14.1 13.1 7.5 8.8 8.0 18.7 16.6 15.7 16.4 17.3 17.0 19.4 10.8 17.7 14.0 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Group enriched" "Detected in some" 5 "HaCaT: 8.0;SCLC-21H: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059903: " "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 8.0 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.4 0.4 1.1 0.2 0.4 0.5 0.3 2.1 16.6 2.4 0.3 0.2 0.2 0.4 0.2 0.5 1.1 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Cell line enhanced" "Detected in some" "AF22: 7.8;NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 10.8" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054579: " "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.8 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.3 0.0 0.8 0.0 2.0 0.0 0.2 3.2 10.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 DKC1 "Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101" ENSG00000130826 "Dyskerin pseudouridine synthase 1" O60832 X 154762742-154777689 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Isomerase, Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000166, HPA000447, HPA001022, CAB033086" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" 40000 "Nucleoli fibrillar center" Nucleoplasm "CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: " "unprognostic (9.87e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (2.66e-5)" "unprognostic (2.86e-1)" "prognostic unfavourable (2.94e-4)" "prognostic unfavourable (1.39e-5)" "unprognostic (7.02e-2)" "prognostic unfavourable (9.13e-4)" "unprognostic (2.53e-2)" "unprognostic (2.35e-2)" "unprognostic (2.63e-2)" "prognostic unfavourable (1.46e-9)" "unprognostic (5.28e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-1)" "unprognostic (2.55e-1)" 17.6 18.1 17.2 22.5 17.3 42.3 25.8 19.6 20.7 16.6 20.3 14.8 20.7 17.4 19.7 17.1 33.6 18.5 15.9 16.9 15.4 16.3 15.2 22.5 15.2 26.8 15.6 16.6 23.9 38.7 22.6 24.6 19.1 17.0 17.1 26.2 13.7 20.8 18.7 40.8 25.5 18.5 18.3 20.9 25.8 17.6 33.1 16.7 31.3 26.6 28.7 33.2 16.4 20.8 23.5 18.5 16.7 15.5 20.8 26.8 14.8 36.1 20.2 12.5 17.8 7.8 8.0 18.5 13.8 9.8 20.7 19.6 25.4 18.1 69.3 36.4 11.6 19.5 38.0 22.8 31.2 16.7 21.1 35.3 21.2 22.0 11.0 46.4 21.3 7.6 21.9 22.8 52.1 14.3 31.8 17.4 14.0 21.0 31.2 35.7 20.8 25.3 27.2 28.0 35.8 13.0 20.6 27.5 13.6 12.2 21.4 18.8 10.8 18.7 11.4 14.9 22.4 19.1 45.6 32.2 44.5 113.1 10.2 49.2 16.1 4.8 13.1 16.7 21.4 15.5 26.8 23.5 17.6 22.7 18.5 17.1 23.3 22.2 4.0 20.8 14.9 13.4 13.4 14.8 17.2 17.3 19.6 20.7 15.4 16.3 15.6 16.6 17.0 16.7 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Cell line enhanced" "Detected in many" "BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavourable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.0 92.8 26.6 30.2 1.3 0.4 0.0 6.6 86.9 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 16.9 0.0 0.0 6.7 8.7 9.0 22.2 28.1 0.0 0.0 36.7 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 9.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 49.8 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.7;hTERT-HME1: 13.8;HUVEC TERT2: 18.8;U-2197: 18.6;WM-115: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 33.9 8.0 8.5 8.8 15.4 4.9 31.9 3.1 11.4 13.6 13.1 16.0 2.0 6.1 12.4 7.4 8.6 10.4 13.1 15.1 10.0 7.3 9.2 24.1 32.4 5.6 18.0 6.8 8.0 6.3 6.3 4.4 22.3 16.2 5.7 4.5 13.6 4.9 4.1 7.6 5.4 8.5 18.7 15.0 16.6 11.1 5.5 16.5 0.0 12.0 6.1 2.9 17.1 17.2 0.0 0.2 6.5 1.3 0.0 0.1 0.0 0.0 0.1 1.6 0.0 12.3 7.0 5.9 0.6 0.1 0.2 0.5 3.9 2.4 0.0 0.2 11.7 2.0 1.0 1.6 1.1 0.0 0.9 0.3 0.0 4.1 6.4 0.0 3.5 5.4 0.1 18.7 13.8 18.8 1.0 0.0 5.6 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.9 0.0 0.8 0.0 0.2 6.2 0.0 0.0 1.9 13.5 7.3 18.6 4.4 0.0 0.0 0.0 10.4 0.0 13.7 6.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.5 15.4 3.1 11.0 10.0 7.3 18.0 6.8 16.2 16.5 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299300 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 12.3 12.6 30.0 10.2 34.5 9.6 14.2 42.1 37.7 19.9 17.8 32.3 17.0 16.1 15.4 8.8 30.2 12.7 12.9 13.8 26.9 19.2 21.0 18.6 12.9 10.6 32.9 27.3 18.7 11.9 28.2 19.8 15.1 29.1 12.1 20.2 10.4 16.5 14.7 18.7 13.7 18.4 15.3 32.2 8.8 16.7 11.1 39.4 14.7 34.6 13.9 14.8 13.8 15.7 3.7 2.9 2.9 1.0 1.4 3.9 1.5 46.9 7.4 14.8 26.8 12.2 11.5 15.1 16.8 15.4 16.9 19.9 21.7 20.3 13.7 48.2 16.6 31.0 13.5 26.1 32.6 3.7 9.0 12.0 11.5 15.8 12.1 11.9 11.9 10.3 14.2 15.5 34.0 21.2 9.7 16.7 40.6 18.2 17.7 4.6 11.6 14.3 9.5 17.9 9.8 17.6 19.9 7.3 12.3 26.3 17.5 19.1 40.0 9.2 20.1 45.9 12.1 12.6 28.3 26.5 19.0 17.8 16.9 18.2 14.3 0.0 0.9 2.9 1.5 1.0 3.9 3.7 2.9 2.7 2.2 2.0 3.0 3.1 1.1 1.4 0.4 2.9 2.9 1.5 30.0 34.5 42.1 37.7 26.9 19.2 32.9 27.3 29.1 39.4 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.6;NTERA-2: 5.1;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.6;T-47d: 19.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: " "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.1 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.6 0.0 19.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444861-70505490 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 20.6;SK-BR-3: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: " "prognostic unfavourable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favourable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 2.7 3.3 12.5 6.5 17.6 0.7 10.8 16.4 25.2 9.2 16.0 4.3 14.7 11.7 7.6 23.7 14.5 17.4 16.3 6.0 15.2 10.0 10.8 1.4 7.8 3.1 6.5 10.2 11.2 27.1 21.2 8.9 5.5 8.0 9.6 17.1 10.2 21.0 10.4 1.1 8.4 20.8 11.3 3.4 14.6 13.8 1.9 3.5 3.2 13.8 2.6 8.0 11.2 9.9 0.4 0.0 0.0 0.0 1.7 2.4 0.3 3.6 1.7 10.6 4.5 2.7 3.4 7.4 2.2 2.5 1.2 1.2 10.5 8.7 0.0 5.1 2.2 8.0 20.6 4.8 0.8 4.3 6.2 0.0 9.4 5.7 5.4 0.1 1.4 3.5 3.2 1.5 3.4 0.4 2.0 14.7 1.1 12.9 8.3 0.0 17.8 12.4 7.8 5.2 1.6 7.2 11.3 5.0 0.3 1.7 20.6 3.9 10.8 0.0 0.8 1.4 1.4 1.3 1.6 9.7 7.3 4.6 2.1 0.0 2.0 0.0 0.0 0.0 2.1 0.0 1.8 0.4 1.7 2.4 0.0 0.0 1.1 1.8 0.0 1.7 0.0 0.0 2.4 0.3 12.5 17.6 16.4 25.2 15.2 10.0 6.5 10.2 8.0 3.5 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA054105: , HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavourable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favourable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 18.8 16.6 25.7 14.3 32.9 4.5 18.0 16.2 31.9 19.0 20.1 9.0 14.9 13.5 23.1 13.1 16.8 18.5 17.0 25.9 23.7 12.7 10.2 11.0 21.6 9.8 9.5 20.7 18.9 30.2 7.7 10.2 16.9 8.8 15.7 10.1 15.4 19.3 21.2 58.0 27.1 13.6 27.2 6.8 14.5 12.2 12.6 10.9 8.3 13.8 16.8 10.8 29.0 15.0 16.1 13.5 19.5 13.1 6.9 12.5 9.1 13.9 12.6 15.5 12.8 14.7 24.1 15.6 21.0 19.3 20.6 14.3 19.1 8.9 3.9 11.3 29.4 13.4 4.1 21.5 15.4 6.3 1.5 8.9 6.5 12.9 21.3 3.6 7.8 15.8 16.7 24.3 17.0 20.2 6.2 10.8 15.5 10.4 7.2 13.7 6.7 27.1 7.3 4.1 5.4 9.6 6.9 10.2 14.1 13.7 28.0 17.3 16.0 6.3 20.3 62.8 19.2 27.0 11.5 3.7 2.7 4.2 25.1 4.5 24.6 2.1 12.8 19.5 12.5 13.1 9.8 16.1 11.3 8.7 11.3 14.9 8.8 7.0 18.5 6.9 12.6 13.5 8.7 9.1 25.7 32.9 16.2 31.9 23.7 12.7 9.5 20.7 8.8 10.9 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.52e-6)" "prognostic unfavourable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavourable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.0 14.7 38.8 17.4 0.9 3.9 12.0 21.5 14.2 31.9 30.4 12.0 20.5 21.6 11.9 12.5 23.1 24.8 17.3 41.9 25.9 12.2 22.1 13.8 10.3 0.1 21.6 13.6 0.7 0.6 14.9 7.2 35.1 17.9 21.6 29.6 17.8 27.3 11.1 20.0 15.4 21.3 37.5 9.9 10.4 12.1 19.8 11.1 22.9 8.6 8.5 19.3 8.1 13.6 14.3 37.4 13.8 24.7 5.3 11.5 28.6 10.0 15.4 22.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA061223: , HPA068672: , HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.1 1.8 0.5 7.7 0.0 0.4 1.7 1.9 2.1 2.1 1.0 1.8 0.2 0.9 1.2 0.3 16.2 5.4 8.8 0.4 1.0 2.0 0.4 0.9 2.7 0.5 0.3 1.1 0.9 26.6 0.6 5.0 0.0 0.4 0.7 0.8 1.9 0.4 0.4 0.7 1.9 1.0 0.9 0.5 0.3 1.8 5.7 0.5 0.6 0.2 0.3 0.5 1.6 0.5 0.8 2.5 0.6 3.7 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 41.1" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA056533 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 1.9 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 1.9 0.0 0.0 1.2 0.5 0.1 0.5 3.0 0.1 0.0 0.1 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.4 3.1 0.3 0.1 0.1 0.1 0.1 7.3 7.4 1.4 0.0 41.1 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 DMAP1 "DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4" ENSG00000178028 "DNA methyltransferase 1 associated protein 1" Q9NPF5 1 44213455-44220681 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028419, CAB033018" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB033018: AB_2230431, HPA028419: " "unprognostic (1.91e-3)" "unprognostic (2.79e-3)" "unprognostic (4.90e-2)" "unprognostic (6.52e-2)" "unprognostic (4.80e-2)" "unprognostic (1.43e-3)" "prognostic unfavourable (1.44e-4)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" "unprognostic (1.86e-2)" "unprognostic (2.29e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" 12.7 31.7 21.5 17.6 22.4 12.5 12.6 21.3 31.5 12.8 13.8 20.4 15.6 13.5 14.0 14.9 12.9 19.8 11.7 20.3 20.7 18.3 14.9 16.1 12.9 17.2 18.0 19.4 23.3 19.9 25.3 15.7 14.3 17.9 13.9 11.9 19.2 21.1 15.2 30.5 18.0 12.7 17.0 15.8 16.7 13.8 13.8 17.0 15.2 18.1 14.3 13.6 12.7 11.4 18.6 15.4 23.2 14.8 26.5 23.1 15.0 12.4 13.3 18.8 9.9 9.8 9.3 21.7 11.1 14.9 26.8 23.2 21.7 15.7 18.7 15.1 17.8 10.3 16.7 14.3 14.3 15.0 27.0 17.2 23.7 21.4 17.7 16.8 13.1 14.5 15.9 22.1 12.8 17.2 11.9 17.2 15.6 14.5 23.5 21.2 26.7 17.0 23.9 19.0 20.4 14.1 15.8 17.5 14.4 20.8 14.9 21.1 12.3 19.5 16.5 7.6 23.0 17.4 22.3 21.0 12.5 15.0 14.4 16.8 12.5 23.2 14.8 14.1 21.2 13.1 21.6 18.6 21.4 21.8 15.4 18.6 19.6 19.3 6.4 26.5 10.5 12.4 23.1 15.0 21.5 22.4 21.3 31.5 20.7 18.3 18.0 19.4 17.9 17.0 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell line enhanced" "Detected in many" "A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favourable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 31.5 5.1 0.0 0.0 1.2 1.9 8.9 0.1 4.2 0.2 0.3 39.0 33.5 0.0 12.8 0.3 17.7 9.6 51.1 0.4 0.1 9.3 0.0 0.0 8.7 1.5 0.0 0.1 17.5 13.8 0.9 29.7 0.0 0.1 0.0 0.1 27.6 0.0 0.0 28.3 2.1 0.0 0.0 1.2 50.5 20.9 0.1 0.0 7.7 0.0 3.1 12.8 0.0 0.0 4.9 15.0 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769717-45782552 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Cell line enhanced" "Detected in many" "RH-30: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favourable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 9.0 18.7 5.1 9.7 6.3 1.7 4.9 8.8 6.2 16.5 23.4 4.4 15.6 8.7 21.2 15.0 31.2 13.7 20.3 56.7 5.0 5.3 4.9 2.2 6.5 4.1 4.8 6.5 8.4 33.3 3.1 10.7 6.8 5.6 16.3 3.8 22.0 6.1 19.7 79.6 5.1 11.3 65.1 4.2 5.3 12.0 5.9 4.0 1.1 6.1 36.6 5.0 44.9 8.2 1.5 0.0 0.0 0.8 0.3 2.2 0.0 7.2 10.1 12.0 7.4 8.1 11.3 7.2 16.2 12.0 6.5 6.3 1.2 3.9 2.3 2.4 18.5 10.6 3.4 1.6 2.4 11.3 10.6 0.9 12.6 1.7 7.9 0.1 4.1 16.5 5.7 5.6 2.7 3.0 7.1 5.8 9.4 8.0 1.1 2.7 7.1 2.2 3.7 44.2 3.7 3.5 8.3 6.5 10.3 8.8 18.5 5.2 15.2 3.5 9.1 7.6 7.5 7.2 11.8 11.2 9.6 2.3 6.9 1.0 10.6 0.0 0.0 0.0 2.2 0.8 0.5 0.3 0.7 0.2 0.0 1.5 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.1 6.3 8.8 6.2 5.0 5.3 4.8 6.5 5.6 4.0 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: " "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 1.2 4.2 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.2 3.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 DMWD "D19S593E, DMR-N9, gene59" ENSG00000185800 "DM1 locus, WD repeat containing" Q09019 19 45782947-45792802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068172, HPA069843" Approved Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA068172: , HPA069843: " "unprognostic (6.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.03e-2)" "unprognostic (1.65e-3)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.47e-4)" "unprognostic (5.11e-3)" "unprognostic (7.61e-2)" "unprognostic (7.26e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (1.18e-2)" "unprognostic (4.59e-2)" 20.1 15.5 24.2 12.9 29.4 7.3 11.0 17.1 34.2 12.1 17.7 19.2 6.6 10.8 21.7 9.0 13.2 14.5 16.6 29.0 20.2 16.2 9.6 5.8 13.6 11.5 17.8 19.1 17.0 13.4 13.7 20.3 16.7 18.8 14.7 8.7 14.8 13.6 14.9 31.8 13.1 10.4 16.9 9.9 15.0 13.1 17.8 16.7 11.2 11.8 6.7 8.5 14.6 11.8 4.3 0.7 1.8 1.9 4.8 3.8 0.9 16.9 19.0 17.2 11.9 10.5 13.4 13.2 14.9 10.5 13.3 12.1 11.2 9.5 7.2 8.8 16.7 12.9 9.0 7.4 7.0 21.0 16.7 6.1 18.8 9.7 13.1 0.7 10.0 12.5 9.2 12.4 17.7 11.4 15.0 16.2 10.5 13.9 8.5 4.8 7.8 12.4 8.8 6.2 7.9 8.2 16.3 17.2 19.2 16.0 12.5 10.7 10.8 4.2 23.9 15.4 15.3 10.2 22.1 23.4 14.4 8.2 16.0 1.1 17.9 1.3 0.7 0.5 3.8 1.6 3.0 1.7 3.2 3.0 0.7 4.3 1.2 2.4 1.8 4.8 1.9 0.6 1.9 0.9 24.2 29.4 17.1 34.2 20.2 16.2 17.8 19.1 18.8 16.7 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: " "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favourable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 17.8 10.4 9.3 14.0 14.1 29.3 16.1 14.2 15.4 12.0 11.6 15.4 9.6 8.3 15.7 8.5 13.0 12.0 10.3 10.2 8.9 5.6 18.8 9.6 13.9 12.5 11.5 11.4 17.4 20.1 21.3 14.1 9.5 18.9 35.9 9.8 13.3 13.6 10.9 10.9 21.4 13.1 13.0 10.9 11.5 12.4 9.2 13.1 18.1 17.9 6.8 13.8 14.3 12.4 11.2 9.5 4.6 9.0 1.5 3.8 2.6 9.5 7.4 8.4 8.6 9.1 12.1 9.0 7.9 7.9 7.9 9.4 8.9 5.9 18.6 8.2 10.1 5.8 9.3 9.4 10.4 14.3 9.3 13.1 12.9 3.1 7.6 8.5 11.4 9.6 5.3 9.2 7.7 10.4 11.0 12.6 6.4 6.0 11.4 4.9 4.6 4.5 9.0 15.6 7.2 6.2 11.1 7.9 8.0 13.6 4.9 12.2 8.2 9.9 10.0 9.5 8.0 9.5 8.3 11.9 8.4 16.2 11.8 8.4 7.6 4.6 5.5 3.9 2.9 4.9 3.6 9.7 2.3 2.4 3.8 11.2 3.8 2.1 4.5 1.5 9.0 9.5 2.8 2.6 9.3 14.1 14.2 15.4 8.9 5.6 11.5 11.4 18.9 13.1 DNAAF1 "CILD13, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.3;testis: 49.6" "Cell line enhanced" "Detected in some" "Hep G2: 3.4;Karpas-707: 8.6;PC-3: 2.6;SK-BR-3: 2.4;U-266/70: 7.2;U-266/84: 4.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.1" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1" "Cell type enhanced" "Detected in some" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: " "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favourable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.8 1.2 3.5 0.6 9.4 1.5 0.5 0.1 1.5 2.1 0.6 5.3 1.5 0.4 1.0 13.3 0.9 21.3 0.5 0.4 4.6 6.5 0.7 2.0 3.7 0.9 0.5 1.5 4.2 0.4 0.7 6.1 1.5 11.1 0.4 0.4 0.9 0.5 0.6 0.6 0.5 0.6 0.4 1.0 7.2 0.5 49.6 1.2 0.0 1.2 0.0 0.4 0.8 0.0 0.5 1.0 5.5 0.8 0.9 2.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.0 2.4 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 7.2 4.7 0.7 0.2 0.4 0.0 3.6 0.8 0.4 0.4 0.6 0.1 0.0 0.2 0.1 0.4 0.5 0.8 0.8 5.5 0.9 0.4 1.0 2.1 0.9 3.5 9.4 0.1 1.5 4.6 6.5 0.5 1.5 11.1 1.2 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" 19 55158661-55166722 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 12 "fallopian tube: 29.7;testis: 60.1" "Cell line enhanced" "Detected in many" "HEK 293: 16.9;HEL: 19.7;K-562: 15.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA056220 Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA056220: " "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavourable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.2 1.0 0.7 0.1 1.7 0.0 0.4 0.1 0.5 1.9 0.3 2.5 1.8 0.0 0.9 3.8 0.3 29.7 0.6 2.9 1.2 1.5 2.5 1.7 3.3 0.1 0.5 0.1 3.1 0.8 1.0 0.3 0.1 2.7 0.2 0.0 0.4 0.8 0.6 0.2 0.3 0.1 0.1 0.2 0.2 0.2 60.1 0.8 0.2 1.5 0.1 0.4 0.1 0.1 0.0 0.9 0.5 0.4 0.0 0.0 1.6 5.4 4.5 0.4 4.4 0.0 0.0 0.5 0.1 0.0 0.6 0.5 0.2 2.6 6.6 1.6 0.2 6.5 0.9 1.9 0.2 0.0 16.9 19.7 0.2 0.3 0.1 8.4 2.0 0.1 2.7 1.1 1.4 0.3 15.4 9.0 0.2 3.5 0.2 0.2 0.3 9.8 10.2 0.6 2.0 3.4 0.1 0.6 1.7 0.7 0.7 1.0 5.5 0.3 0.6 0.5 2.6 2.5 0.1 0.2 1.5 0.3 3.1 11.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.7 1.7 0.1 0.5 1.2 1.5 0.5 0.1 2.7 0.8 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.6" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051048 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA051048: " "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.8 3.0 11.4 1.8 14.7 1.6 4.9 1.8 8.0 4.3 2.1 3.2 5.9 1.1 7.0 15.3 1.8 15.7 3.4 1.6 9.2 7.8 7.2 1.0 6.2 1.5 4.2 8.9 4.8 3.5 13.6 26.6 1.2 9.1 3.2 1.5 6.9 2.4 3.2 1.3 2.4 1.3 3.1 3.7 2.0 1.7 14.6 4.5 0.1 14.3 0.9 1.3 2.8 2.0 2.9 4.2 4.3 1.8 0.7 1.1 0.4 6.5 4.3 4.7 10.0 1.9 3.3 1.5 0.8 2.4 3.1 3.6 0.9 2.6 0.5 4.2 2.0 1.8 1.8 2.6 3.7 2.0 2.1 2.3 2.8 1.5 1.8 5.0 4.1 2.0 5.5 7.5 2.8 7.0 0.7 0.3 4.6 2.3 0.9 4.3 2.6 3.6 0.8 2.3 0.8 17.1 2.3 4.8 10.5 4.3 1.1 5.8 6.0 1.2 2.3 5.0 2.5 4.1 4.8 1.8 4.8 1.4 8.2 1.0 1.1 0.0 1.8 1.3 0.6 1.2 0.4 2.9 0.9 0.7 1.2 2.6 1.1 0.8 4.3 0.7 1.2 4.2 0.9 0.4 11.4 14.7 1.8 8.0 9.2 7.8 4.2 8.9 9.1 4.5 DNAAF5 "CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2" ENSG00000164818 "Dynein axonemal assembly factor 5" Q86Y56 7 726701-786475 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020243 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA020243: AB_1848750" "unprognostic (9.77e-2)" "unprognostic (9.53e-3)" "unprognostic (2.55e-1)" "unprognostic (2.57e-1)" "unprognostic (8.22e-3)" "prognostic unfavourable (8.42e-4)" "prognostic unfavourable (3.83e-4)" "unprognostic (8.07e-3)" "unprognostic (2.02e-1)" "unprognostic (7.59e-2)" "unprognostic (8.26e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-3)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "unprognostic (8.70e-3)" 11.5 13.0 9.3 13.5 11.4 10.7 12.3 17.4 14.2 15.5 16.3 14.7 10.3 12.0 18.4 13.9 16.7 23.4 15.4 18.8 11.6 8.6 15.0 18.2 9.9 11.8 9.5 7.6 20.6 22.5 14.4 21.1 12.1 10.4 16.1 9.9 14.0 17.6 14.3 33.9 12.0 13.6 13.9 9.2 12.5 13.0 14.8 9.4 20.7 15.9 11.2 14.2 15.6 12.4 3.3 4.6 1.4 2.8 3.0 4.7 1.9 30.3 24.0 7.2 16.7 4.7 5.2 18.1 6.3 6.1 7.9 7.5 23.9 16.1 18.6 9.2 6.6 18.5 13.3 15.8 6.1 3.1 22.5 4.6 14.3 17.3 6.5 13.8 8.3 6.3 6.8 9.9 7.3 10.7 28.9 3.9 5.7 29.8 8.2 12.4 26.4 19.1 15.2 2.3 12.8 9.2 12.9 15.1 25.1 10.3 25.5 7.3 22.5 11.6 8.8 4.4 15.7 15.0 14.1 7.6 9.1 10.8 9.7 14.6 23.0 0.0 1.9 1.4 2.2 2.8 3.3 1.6 3.5 4.7 2.7 3.3 3.3 2.5 0.0 3.0 2.0 4.6 0.8 1.9 9.3 11.4 17.4 14.2 11.6 8.6 9.5 7.6 10.4 9.4 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Group enriched" "Detected in some" 5 "HeLa: 9.8;MOLT-4: 4.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: " "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 9.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 6.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.1;hTEC/SVTERT24-B: 1.3;U-698: 1.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.5 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.0 1.1 0.1 0.4 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.3 1.3 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025211-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 189.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001306 Approved Supported Microtubules,Cytosol Cytosol Microtubules "HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favourable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favourable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 29.0 46.7 46.5 26.1 47.2 42.7 57.2 31.6 53.3 30.4 18.7 20.7 25.5 14.4 27.6 27.9 17.1 34.8 28.2 22.2 42.5 51.7 36.0 71.9 30.7 23.8 56.5 30.8 30.7 19.5 47.3 40.2 35.0 49.6 29.8 21.7 9.0 18.9 23.0 14.5 13.1 15.9 29.0 42.4 22.3 20.8 42.2 51.5 24.1 47.0 15.3 28.1 27.9 189.5 36.6 60.0 50.0 69.0 31.6 37.2 49.5 38.0 68.3 55.3 19.2 38.5 25.0 31.7 39.4 31.8 70.9 55.2 45.3 17.7 39.1 30.2 26.7 17.4 79.6 23.7 61.2 55.0 23.2 31.3 84.1 57.3 18.5 36.0 36.8 15.4 24.4 26.7 8.5 42.2 48.7 17.1 40.5 31.1 60.0 79.2 53.8 47.7 44.2 19.8 20.0 39.7 22.6 35.2 38.4 53.0 34.3 17.5 16.0 35.0 36.1 25.3 43.3 28.8 52.2 11.0 34.0 41.3 33.2 31.4 21.7 33.3 40.1 43.3 28.5 56.0 33.3 36.6 35.6 31.4 35.7 32.7 37.2 34.7 50.0 31.6 69.0 60.0 30.1 49.5 46.5 47.2 31.6 53.3 42.5 51.7 56.5 30.8 49.6 51.5 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: , HPA060538: " "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favourable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 10.9 13.1 13.2 11.2 18.1 17.5 20.1 14.3 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 17.1 21.0 14.8 25.1 4.2 17.6 13.0 6.4 24.0 21.7 19.7 18.2 18.6 17.2 12.5 11.9 14.9 14.9 6.0 18.2 12.0 14.1 27.5 20.1 19.5 16.4 24.2 21.0 26.0 11.7 18.1 11.6 17.0 25.8 15.6 10.0 15.4 15.3 12.8 8.1 9.2 12.0 14.8 10.1 23.7 13.5 17.0 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 DNAJA3 "hTid-1, TID1" ENSG00000103423 "DnaJ heat shock protein family (Hsp40) member A3" Q96EY1 16 4425805-4456775 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016095, HPA040875, HPA044229" Approved Enhanced Vesicles,Mitochondria Mitochondria Vesicles "CAB016095: AB_668801, HPA040875: , HPA044229: " "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (2.86e-3)" "unprognostic (2.91e-2)" "unprognostic (4.17e-1)" "unprognostic (5.18e-2)" "unprognostic (1.60e-1)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (3.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.27e-2)" "prognostic favourable (1.79e-4)" "unprognostic (4.17e-2)" "unprognostic (1.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.92e-1)" 10.8 26.6 10.7 11.3 15.5 6.2 13.0 15.3 20.8 10.0 14.0 13.9 11.1 17.3 11.3 8.7 15.6 12.6 12.5 28.8 13.9 12.6 19.0 44.8 9.1 13.4 13.0 13.0 13.2 18.1 21.6 12.1 13.7 14.2 11.5 13.4 10.6 14.4 13.4 46.7 12.8 13.2 11.4 12.6 11.4 12.8 15.1 11.1 13.6 16.1 16.2 13.3 13.4 11.2 10.4 6.5 2.2 7.0 7.8 11.9 7.9 8.9 17.9 6.3 11.8 7.9 6.9 11.7 11.8 8.9 16.5 13.6 14.9 12.6 17.6 11.0 7.6 13.6 20.4 14.0 9.6 12.1 17.6 9.0 15.5 14.3 19.5 15.6 8.6 8.4 16.8 14.5 24.3 7.9 23.1 14.6 9.3 20.4 14.6 11.3 13.7 16.6 18.2 10.0 32.9 12.3 9.6 15.5 6.7 12.9 29.6 19.5 16.9 13.1 7.4 12.3 8.4 29.6 14.7 15.1 20.2 24.0 6.6 15.1 14.4 0.7 4.6 2.2 9.5 7.0 11.0 10.4 9.1 8.9 6.5 8.9 11.9 9.2 0.5 7.8 5.2 4.6 7.4 7.9 10.7 15.5 15.3 20.8 13.9 12.6 13.0 13.0 14.2 11.1 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.2;skeletal muscle: 69.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.4;HeLa: 18.2;RT4: 33.9;SCLC-21H: 21.8;SiHa: 17.0;THP-1: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: " "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favourable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 7.3 10.1 29.6 7.6 33.7 28.6 7.6 20.1 25.8 8.6 8.7 10.5 10.4 7.8 5.1 25.3 9.1 21.7 6.6 63.2 22.3 33.8 7.7 1.9 7.0 6.0 26.0 28.1 3.6 3.2 9.5 11.9 5.5 29.2 15.4 10.6 7.2 6.8 9.6 69.0 15.5 9.0 10.7 16.0 5.1 10.8 26.8 14.9 2.0 6.3 15.2 6.9 12.6 62.3 1.9 1.1 2.7 1.0 0.4 4.7 1.6 13.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.2 0.0 17.4 0.0 0.1 1.2 12.5 0.0 0.0 0.0 0.0 0.0 7.8 18.2 0.0 3.9 0.0 8.4 1.5 1.7 1.0 0.0 2.6 0.0 0.0 0.1 13.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.9 21.8 0.0 17.0 3.4 1.5 13.1 15.7 0.2 0.0 3.6 1.6 0.1 0.2 0.9 0.0 0.0 1.6 0.0 0.0 0.8 2.7 1.8 0.9 2.6 1.9 2.5 2.5 1.1 0.4 4.7 3.9 0.0 0.4 1.0 0.6 1.4 1.6 29.6 33.7 20.1 25.8 22.3 33.8 26.0 28.1 29.2 14.9 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355230 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.9 31.7 18.6 20.1 20.6 27.2 32.6 24.0 28.3 24.1 21.8 29.9 26.4 25.0 26.8 31.0 23.8 21.1 28.7 25.3 18.0 17.3 25.6 34.3 26.8 27.5 19.9 19.4 25.4 33.1 38.4 26.2 36.0 20.2 24.5 17.5 27.5 32.4 44.8 40.3 28.6 27.4 22.8 22.3 26.9 24.3 29.2 18.2 20.8 25.5 25.8 23.5 21.1 21.2 7.6 15.5 23.3 19.8 8.3 8.7 9.9 15.5 16.1 10.2 17.0 13.4 13.6 12.9 15.6 27.1 21.5 20.1 18.9 27.1 11.5 12.6 18.8 26.1 9.4 14.0 11.4 12.5 12.8 6.1 9.6 12.2 29.5 12.4 23.5 17.5 29.1 19.0 24.1 14.9 9.6 17.3 17.8 15.0 10.6 10.6 4.7 4.7 9.8 7.7 7.9 15.8 9.1 7.0 10.1 8.5 31.6 15.2 12.1 14.3 16.7 10.8 14.8 12.0 19.5 14.7 10.9 6.7 17.8 13.7 7.3 9.1 18.1 11.0 8.7 19.8 7.8 7.6 8.6 6.5 15.5 7.3 7.2 7.1 23.3 8.3 16.8 10.5 8.7 9.9 18.6 20.6 24.0 28.3 18.0 17.3 19.9 19.4 20.2 18.2 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.5;LHCN-M2: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.7 3.5 2.0 15.0 28.0 1.6 27.2 6.9 12.1 13.7 0.9 1.8 2.0 4.6 12.9 2.1 4.4 2.4 20.7 2.3 1.2 1.0 8.2 6.6 20.3 0.5 0.5 11.6 6.6 15.7 4.5 42.5 4.4 1.4 72.3 0.1 0.6 1.5 2.1 1.3 1.1 6.0 1.3 2.9 0.7 2.5 0.8 3.1 2.3 2.6 0.9 0.8 20.3 17.1 4.2 12.1 3.5 1.2 0.4 1.8 2.3 1.2 2.9 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 99.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 7.7;neutrophil: 7.6" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: " "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 7.2 6.3 5.9 5.1 7.2 0.9 2.6 8.6 13.0 6.5 19.1 6.2 9.2 3.8 18.5 9.7 15.7 9.6 8.7 29.3 6.6 6.3 3.7 2.0 3.7 2.2 4.7 3.4 6.5 3.1 2.2 8.6 1.4 6.0 13.8 6.2 5.7 3.7 26.2 99.4 1.5 6.1 29.9 4.5 5.6 11.3 8.1 3.5 1.6 4.4 38.0 2.9 23.0 3.6 0.7 7.7 7.6 1.5 0.5 1.3 0.7 2.6 2.1 13.6 7.2 8.0 6.2 1.5 11.3 8.3 17.5 15.6 1.6 0.6 2.5 2.8 12.4 0.3 5.2 8.9 14.9 3.5 1.6 0.9 3.1 0.7 9.2 0.3 8.2 9.0 0.6 10.3 5.2 11.1 0.2 5.3 14.1 1.8 4.2 3.6 6.4 4.6 3.3 14.1 1.4 2.5 0.2 5.8 9.5 6.1 0.3 1.3 2.2 0.8 4.9 8.4 18.5 4.3 3.5 2.0 1.3 1.8 9.6 1.0 9.0 0.1 1.5 0.0 0.4 0.4 1.3 0.7 0.3 0.1 7.7 0.3 0.5 1.1 7.6 0.5 0.1 0.2 1.3 0.7 5.9 7.2 8.6 8.5 6.6 6.3 4.7 3.4 6.0 3.5 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: " "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavourable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 24.0 23.1 38.0 17.9 35.0 51.3 40.5 42.2 41.3 17.1 25.5 21.7 19.1 14.5 23.3 38.8 33.2 20.9 17.3 37.0 31.7 32.2 24.5 16.7 19.4 16.4 37.6 32.2 22.8 18.8 17.2 20.2 24.4 37.7 19.5 17.2 15.3 20.1 25.6 96.9 34.2 15.6 31.7 33.9 17.2 16.8 38.3 35.2 12.2 17.9 23.5 21.9 23.4 51.9 32.7 30.4 74.3 48.1 35.5 42.1 55.0 38.0 23.1 28.2 28.5 28.6 26.0 26.1 42.8 35.1 39.9 43.8 31.4 38.5 14.6 80.7 31.6 24.4 19.1 29.9 62.0 29.4 26.1 26.2 13.9 22.2 26.3 19.4 22.1 22.7 29.1 30.2 14.4 29.6 42.5 14.7 51.0 25.8 48.4 38.2 56.3 30.9 26.1 20.3 20.4 32.9 23.4 17.0 44.9 33.4 26.2 31.3 19.1 27.6 36.9 25.2 19.2 60.0 36.8 28.2 40.1 17.2 35.8 44.7 31.8 70.6 41.5 48.8 36.2 41.6 36.1 32.7 33.2 37.2 30.4 28.1 42.1 39.3 74.3 35.5 48.1 27.6 38.9 55.0 38.0 35.0 42.2 41.3 31.7 32.2 37.6 32.2 37.7 35.2 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569568-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 33.6;Karpas-707: 30.6;U-266/70: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 13.7 28.9 11.6 9.7 14.1 16.7 14.6 8.6 15.4 18.2 11.1 10.0 33.7 11.1 12.6 31.4 8.7 12.8 10.8 24.2 11.6 18.7 29.2 54.3 16.1 13.3 14.0 11.4 14.6 47.9 6.9 31.0 51.2 15.7 14.2 9.6 10.1 32.2 29.5 29.4 7.6 10.8 10.7 14.7 10.8 11.9 18.5 10.6 5.4 37.4 7.2 14.2 18.1 13.5 10.0 30.1 25.8 7.7 9.9 24.0 11.4 2.5 2.9 4.0 4.5 11.1 8.0 8.8 9.3 11.3 5.1 6.2 2.9 4.9 3.3 10.4 2.9 3.0 4.4 2.2 5.3 3.6 2.4 1.7 2.0 8.9 33.6 2.6 3.5 5.6 17.8 3.0 16.7 5.3 2.5 30.6 8.0 3.7 2.4 3.1 4.0 1.6 1.6 4.0 17.4 4.2 1.6 2.7 5.8 3.4 15.6 17.0 2.9 3.7 6.1 5.4 2.5 6.7 3.2 54.0 17.2 3.8 4.8 3.4 4.9 25.8 7.7 3.5 14.1 5.8 24.0 10.0 15.4 14.1 5.7 8.1 8.9 10.2 2.1 9.9 6.2 30.1 8.9 11.4 11.6 14.1 8.6 15.4 11.6 18.7 14.0 11.4 15.7 10.6 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417526-132539032 "Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: " "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavourable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 23.3 17.8 20.4 15.1 14.4 20.5 16.2 18.0 19.9 20.8 23.1 8.1 23.3 14.5 25.0 18.7 22.3 16.8 13.1 20.5 19.9 11.0 23.6 12.1 17.7 14.9 11.5 17.8 20.1 12.2 21.1 12.3 22.9 17.3 17.8 18.8 10.2 16.1 24.6 20.0 13.7 20.1 26.3 12.5 19.4 16.0 10.3 16.4 13.0 20.6 13.8 13.6 24.5 32.4 2.2 5.7 3.4 7.0 1.7 2.1 1.6 14.6 8.4 11.5 5.8 26.8 23.9 7.0 15.9 29.9 15.5 17.2 9.4 9.3 7.7 10.2 21.6 12.0 10.7 11.6 21.6 8.7 3.0 9.5 8.4 6.2 14.1 9.5 9.3 17.4 8.5 14.0 17.4 21.6 5.3 12.8 21.9 11.2 7.8 4.5 6.7 7.6 7.6 8.2 6.1 14.0 15.5 4.1 6.8 15.2 8.0 17.2 12.5 9.0 20.1 17.5 9.0 17.0 6.8 7.3 7.1 10.4 18.3 6.7 12.8 3.4 5.2 0.7 1.9 4.3 1.8 2.2 2.0 1.7 5.7 1.4 1.5 2.1 1.2 1.7 7.0 2.7 1.1 1.6 20.4 14.4 18.0 19.9 19.9 11.0 11.5 17.8 17.3 16.4 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favourable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.3 14.5 6.5 5.3 10.1 4.8 4.0 3.9 3.8 1.6 2.2 4.0 6.9 8.4 1.5 2.9 3.8 1.9 2.0 2.2 0.0 7.8 4.7 4.2 3.3 5.6 8.2 3.0 5.8 3.3 4.6 2.0 5.0 2.8 1.3 0.2 2.5 4.7 2.2 7.4 2.1 8.2 2.9 2.3 1.2 5.6 7.9 3.5 4.1 1.1 6.3 4.9 2.2 12.8 5.7 3.6 5.5 1.3 8.2 2.1 4.2 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell line enhanced" "Detected in many" "HDLM-2: 20.9;HEL: 55.8;K-562: 21.7" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: " "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favourable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 0.9 0.0 1.6 0.7 0.2 8.3 7.0 11.4 11.5 11.3 0.9 0.1 3.3 0.6 2.9 0.8 5.0 1.1 9.1 20.9 2.4 55.8 1.9 0.2 0.0 1.8 1.4 1.0 0.8 1.1 4.9 0.2 21.7 0.4 2.3 0.6 0.7 0.0 2.3 0.7 0.0 1.7 0.1 8.7 0.0 13.9 9.6 4.1 5.5 1.9 2.6 0.1 2.1 1.7 1.2 0.2 2.0 2.1 1.3 1.0 4.7 1.4 2.8 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 DNAJC7 "TPR2, TTC2" ENSG00000168259 "DnaJ heat shock protein family (Hsp40) member C7" Q99615 17 41976433-42021376 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023015, HPA052395" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023015: AB_1847804, HPA052395: " "unprognostic (3.21e-2)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (8.40e-2)" "unprognostic (1.16e-1)" "unprognostic (5.31e-3)" "prognostic unfavourable (3.35e-4)" "unprognostic (7.71e-2)" "unprognostic (2.58e-2)" "unprognostic (1.90e-2)" "unprognostic (2.48e-2)" "unprognostic (8.37e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (2.32e-2)" "unprognostic (8.93e-3)" 22.9 24.2 42.0 27.6 49.3 24.7 28.3 36.6 44.1 22.2 30.5 25.0 21.0 21.5 18.6 32.3 31.4 19.3 19.9 30.6 36.5 38.6 36.9 30.8 21.8 30.1 38.1 30.5 26.4 29.0 37.7 38.2 24.4 48.2 20.4 29.0 21.0 21.0 22.1 44.3 28.0 22.4 18.9 28.9 23.7 22.0 25.2 32.9 31.8 26.5 29.0 40.9 24.3 33.5 15.8 48.1 14.0 21.2 17.8 16.2 13.2 19.4 33.3 31.2 23.3 19.1 32.2 26.6 20.0 28.5 38.0 30.5 38.4 19.8 30.1 23.9 29.1 29.3 49.1 36.0 45.4 26.8 68.8 24.2 28.4 53.3 27.4 35.1 22.0 26.8 21.2 35.0 32.8 29.9 37.1 21.3 32.1 16.3 37.9 29.1 30.5 24.3 26.5 35.6 26.5 28.5 25.5 30.4 23.9 16.9 49.9 24.5 28.0 29.3 23.5 20.9 19.7 21.8 33.2 15.6 35.2 27.8 22.6 25.7 22.1 14.0 20.6 13.6 13.2 21.2 14.6 15.8 14.6 15.1 21.6 15.0 14.4 13.8 8.9 17.8 20.4 48.1 16.2 13.2 42.0 49.3 36.6 44.1 36.5 38.6 38.1 30.5 48.2 32.9 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73248862 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavourable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavourable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 3.1 4.0 4.0 5.0 4.3 24.2 4.6 12.9 5.8 3.0 4.6 4.2 4.0 3.9 6.8 2.9 1.7 2.7 4.2 5.2 2.8 3.5 2.9 7.7 3.5 5.2 2.6 3.6 4.3 5.4 3.6 5.8 3.6 3.9 3.4 5.3 4.1 3.8 3.1 5.9 3.4 4.3 2.9 9.9 3.1 4.4 15.6 9.4 13.2 4.9 10.6 16.5 8.8 26.2 16.3 21.0 17.4 5.0 4.9 9.2 21.3 12.6 21.5 22.5 27.8 18.4 18.2 7.0 9.4 17.9 21.0 14.2 24.3 21.0 14.5 38.6 16.6 18.4 3.5 33.9 15.6 4.0 7.8 22.5 19.7 14.1 34.5 21.2 16.9 24.4 32.8 25.7 7.7 45.5 24.4 18.4 9.9 10.6 12.7 10.1 17.0 15.6 25.7 11.2 13.4 15.9 10.3 14.4 25.5 15.3 32.6 9.9 14.9 29.2 14.4 33.8 9.2 7.3 1.8 13.2 13.0 4.9 14.4 15.6 15.9 14.1 3.0 12.7 15.6 13.8 2.1 10.6 4.7 9.4 16.5 8.8 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA053129: , HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favourable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 6.2 6.3 9.9 5.2 15.0 5.2 4.7 9.2 15.6 5.6 4.7 10.6 7.2 2.4 9.8 11.2 4.1 20.2 8.6 7.6 16.0 9.6 9.9 3.9 6.7 4.3 7.3 14.2 7.1 5.7 11.8 15.0 4.2 18.8 5.5 5.0 7.6 5.5 7.7 4.4 2.9 3.1 8.2 8.5 4.1 5.0 42.4 7.6 3.5 14.2 2.9 3.9 4.8 4.4 6.8 10.9 6.3 4.7 3.8 7.5 2.4 9.0 6.7 8.2 7.5 5.9 7.4 6.8 9.1 7.0 12.1 12.4 6.9 14.4 3.6 6.9 9.6 5.5 7.7 7.0 17.4 5.4 3.2 3.0 9.8 2.5 6.1 3.4 3.7 5.6 5.6 13.1 9.4 7.6 3.3 8.3 14.4 14.8 8.8 4.2 3.8 6.6 6.4 12.4 1.5 9.9 9.6 12.8 6.0 15.2 2.9 7.1 16.3 2.3 7.2 15.0 27.1 11.1 8.4 4.9 10.2 7.8 12.3 1.8 10.4 6.3 4.3 4.5 5.2 4.7 7.5 4.9 5.1 5.3 3.9 6.8 4.8 5.2 4.1 3.8 3.7 10.9 4.3 2.4 9.9 15.0 9.2 15.6 16.0 9.6 7.3 14.2 18.8 7.6 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favourable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.8 4.5 9.1 8.1 11.6 11.7 0.0 3.7 7.3 5.8 6.4 2.8 10.5 2.2 8.2 5.5 4.3 5.7 10.1 4.1 5.5 7.4 1.2 1.3 3.1 18.5 7.1 1.9 9.4 33.0 7.8 14.1 8.4 2.6 4.5 7.2 11.0 6.6 7.0 3.5 3.6 6.4 3.9 2.9 12.3 5.3 12.8 6.9 7.8 6.0 15.3 10.9 6.8 5.1 5.3 5.4 8.1 3.8 2.8 0.8 1.0 16.0 2.4 5.1 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: , HPA057639: " "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.2 4.0 3.5 5.0 4.2 2.0 1.9 2.3 1.5 3.5 3.8 3.7 0.9 1.6 7.3 2.1 1.7 2.6 2.3 3.8 3.0 5.9 2.7 2.2 4.2 1.9 3.4 2.9 4.2 6.2 1.0 3.7 4.4 1.6 0.9 1.4 4.7 4.2 3.4 2.2 1.8 2.7 2.3 2.5 2.3 4.4 1.3 4.1 3.1 2.2 4.5 1.8 2.3 2.4 5.0 2.9 10.6 8.3 5.6 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA062738: " "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.5 2.6 7.6 1.3 2.7 6.7 6.8 3.7 5.5 2.4 9.0 4.4 9.7 25.0 4.9 9.0 1.6 3.9 0.6 39.6 9.9 3.5 3.7 3.7 5.1 7.8 6.6 3.4 4.0 4.0 2.5 2.9 5.6 7.0 3.5 31.1 9.2 13.0 11.4 19.8 28.2 3.7 11.2 6.7 4.3 11.5 16.7 6.9 6.4 6.1 7.9 7.2 6.3 9.2 8.4 6.4 10.3 6.1 8.7 8.6 6.8 3.8 8.5 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Supported Enhanced Vesicles,Cytosol 10000000 Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: " "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavourable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 15.4 16.2 24.9 14.8 34.4 22.3 14.3 40.5 37.8 13.0 14.5 12.4 14.9 12.3 16.5 16.5 19.8 13.3 11.9 25.4 26.1 28.1 19.4 12.8 11.2 13.8 23.4 23.2 14.1 9.8 28.7 18.8 16.0 27.9 19.3 16.0 12.1 11.1 21.1 25.6 11.8 11.0 21.7 21.7 11.6 12.2 23.1 14.9 13.4 15.2 17.4 15.8 16.9 12.2 5.9 17.0 5.0 14.6 7.2 7.9 7.1 22.1 22.1 23.2 23.8 18.8 19.3 44.9 24.9 19.2 23.5 21.8 31.0 17.0 29.8 17.5 22.5 19.9 24.4 28.6 28.3 15.7 19.9 33.9 21.3 17.0 15.5 24.0 17.9 17.4 14.5 24.9 25.7 28.4 24.5 12.9 26.9 8.6 9.6 20.2 48.9 10.8 16.2 43.7 20.3 19.8 30.5 20.3 20.8 26.5 18.2 19.4 20.9 16.4 25.6 20.1 20.2 47.1 23.1 9.1 24.6 31.1 19.5 16.1 15.2 5.0 9.7 3.1 5.6 14.6 6.8 5.9 6.0 5.9 17.0 5.2 7.3 7.9 1.7 7.2 13.6 5.4 6.1 7.1 24.9 34.4 40.5 37.8 26.1 28.1 23.4 23.2 27.9 14.9 DNM2 "CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII" ENSG00000079805 "Dynamin 2" P50570 19 10718079-10833488 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Phagocytosis" "Hydrolase, Motor protein" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054246 Supported Approved "Golgi apparatus,Cytosol" 500000 "Golgi apparatus, Cytosol" "HPA054246: " "unprognostic (2.30e-1)" "unprognostic (5.23e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "prognostic favourable (8.91e-4)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.03e-1)" "unprognostic (3.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.75e-2)" "unprognostic (5.35e-2)" "unprognostic (5.47e-2)" "unprognostic (5.40e-3)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" 23.8 32.6 18.5 29.3 31.2 53.4 20.4 25.7 29.7 20.1 51.4 57.5 46.0 32.1 20.4 16.8 29.9 19.7 27.0 35.0 20.8 18.0 38.5 25.1 39.2 28.2 48.3 18.0 17.9 32.2 19.5 20.0 32.3 32.2 24.0 42.5 24.5 24.7 37.7 46.6 40.6 50.8 18.6 43.1 37.6 48.2 23.3 36.4 39.1 23.5 21.1 41.5 35.7 31.5 3.4 11.1 8.6 9.8 10.1 5.8 4.6 34.9 28.9 21.2 16.9 21.9 21.5 27.2 23.4 22.2 34.7 29.5 28.8 23.1 25.4 42.2 25.2 30.7 28.9 25.4 29.1 31.1 23.0 48.7 25.8 32.2 27.0 26.7 46.3 22.0 19.6 26.5 25.0 33.7 39.1 43.7 21.3 42.3 37.2 25.5 24.1 35.0 37.8 23.0 28.6 22.8 52.7 30.6 20.0 26.7 22.9 16.7 18.4 31.8 30.5 38.1 12.9 53.5 30.9 36.2 36.9 23.4 28.5 40.9 18.8 3.0 4.5 8.6 5.6 8.2 5.1 3.4 4.2 5.8 5.3 3.1 2.4 4.1 8.5 10.1 9.8 11.1 4.8 4.6 18.5 31.2 25.7 29.7 20.8 18.0 48.3 18.0 32.2 36.4 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: " "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favourable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favourable (6.15e-4)" 11.0 4.8 3.7 8.3 3.6 5.8 8.4 9.2 4.4 13.0 24.9 3.2 23.0 14.5 15.6 11.1 8.2 9.2 10.2 6.0 3.1 2.6 11.1 8.6 6.6 4.5 2.3 3.0 13.8 22.3 24.6 5.0 8.5 3.5 11.6 13.8 8.5 7.2 23.3 10.2 20.0 38.3 15.9 3.1 6.2 15.3 8.6 2.3 30.4 7.1 8.8 7.7 17.4 16.8 4.3 0.8 1.6 2.7 5.3 1.7 1.2 10.8 8.9 8.1 12.8 14.9 12.5 1.9 19.6 19.0 9.5 9.2 6.0 16.5 11.3 8.4 15.0 8.6 9.4 11.3 13.4 0.6 2.9 1.6 10.1 4.2 7.7 1.1 0.8 5.9 2.5 11.7 10.4 22.7 1.5 0.0 19.2 1.3 1.9 2.1 7.8 5.4 2.3 8.3 0.5 16.2 9.4 1.4 1.8 3.2 0.8 2.4 0.7 1.0 27.4 7.1 6.8 5.7 12.8 0.9 0.7 15.9 6.8 3.6 5.3 0.0 1.8 0.4 1.7 2.7 1.6 3.0 0.4 1.2 0.8 4.3 0.4 0.8 1.6 5.3 2.7 0.6 0.0 1.2 3.7 3.6 9.2 4.4 3.1 2.6 2.3 3.0 3.5 2.3 DNPH1 "C6orf108, dJ330M21.3, rcl" ENSG00000112667 "2'-deoxynucleoside 5'-phosphate N-hydrolase 1" O43598 6 43225629-43229484 "Predicted intracellular proteins" "Nucleotide metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029675, HPA029676" Enhanced Approved Nucleoplasm,Cytosol 370000 Nucleoplasm Cytosol "HPA029675: AB_10599998, HPA029676: AB_10599424" "unprognostic (1.12e-2)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (8.24e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (2.61e-1)" "unprognostic (7.72e-2)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (2.25e-2)" "unprognostic (1.49e-1)" "unprognostic (1.74e-1)" "unprognostic (5.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (5.10e-2)" 17.4 25.5 24.1 16.2 27.5 10.1 8.4 7.0 18.7 11.9 39.3 15.0 10.2 53.1 12.3 13.2 19.3 19.5 18.5 12.0 17.3 16.7 48.7 34.7 10.0 14.8 17.2 14.0 13.7 38.8 17.2 9.3 7.3 13.4 13.1 9.7 16.9 22.4 11.8 40.8 10.7 51.0 10.4 10.4 18.8 22.2 5.4 10.8 14.6 14.2 19.2 19.3 12.2 8.9 44.1 36.2 0.9 46.7 7.5 52.6 19.5 35.6 26.2 4.1 16.9 2.9 9.0 12.7 8.7 3.1 5.9 7.7 10.7 13.0 25.7 13.8 2.9 18.3 3.1 6.9 1.7 13.6 62.2 12.1 24.0 30.3 6.9 10.2 7.9 5.6 8.8 1.7 5.3 7.7 27.3 45.6 4.7 59.0 9.7 25.5 8.1 15.9 16.5 5.4 65.0 10.1 12.2 15.8 19.0 8.0 21.3 17.5 29.2 33.9 9.6 4.5 7.8 10.2 17.1 31.9 14.6 20.0 2.8 13.6 7.0 0.1 23.3 0.9 9.2 46.7 16.7 44.1 30.4 16.2 36.2 38.2 27.2 18.3 0.8 7.5 33.2 27.4 52.6 19.5 24.1 27.5 7.0 18.7 17.3 16.7 17.2 14.0 13.4 10.8 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304396-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 171.0" "Group enriched" "Detected in some" 420 "MOLT-4: 48.7;REH: 168.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "naive B-cell: 1.2;naive CD4 T-cell: 4.5" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.1 0.1 0.3 24.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.7 0.0 171.0 0.6 0.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 168.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 DNTTIP1 "C20orf167, dJ447F3.4, Tdif1" ENSG00000101457 "Deoxynucleotidyltransferase terminal interacting protein 1" Q9H147 20 45791937-45811427 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Group enriched" "Detected in all" 7 "dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045496 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045496: " "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (2.07e-1)" "unprognostic (4.52e-2)" "unprognostic (2.50e-1)" "unprognostic (3.05e-2)" "prognostic unfavourable (1.79e-5)" "unprognostic (6.29e-2)" "unprognostic (7.16e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-3)" "unprognostic (5.63e-2)" "prognostic unfavourable (1.90e-6)" "unprognostic (3.18e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" 15.2 16.3 15.8 19.0 18.0 31.6 16.0 15.5 19.9 16.4 24.2 15.4 20.5 14.0 23.3 21.3 18.8 20.6 18.6 20.6 14.6 15.3 15.6 18.7 18.2 17.7 14.5 17.6 20.1 24.1 18.2 17.8 18.3 15.1 23.5 32.0 16.1 21.0 21.6 45.0 21.8 19.6 32.6 13.8 21.2 20.7 36.9 11.8 25.2 21.1 19.4 21.7 30.1 16.1 3.2 14.2 41.0 16.6 1.0 3.4 4.5 20.4 10.9 11.3 10.7 8.7 9.4 11.8 7.7 12.5 25.0 22.7 34.6 33.6 8.5 25.3 11.2 15.5 9.9 16.5 16.7 4.6 12.4 9.2 11.5 22.0 17.7 18.0 15.4 9.4 15.6 16.3 15.8 14.6 8.5 8.7 14.8 27.2 14.7 27.9 7.6 74.6 11.9 14.0 8.8 12.5 9.8 10.6 9.6 15.7 12.8 16.1 12.7 28.9 8.5 15.0 11.2 14.5 18.4 9.5 6.1 10.5 32.8 11.6 12.8 4.8 16.6 21.6 1.4 6.9 1.4 3.2 1.9 2.4 14.2 2.7 3.4 1.6 41.0 1.0 4.2 5.5 2.7 4.5 15.8 18.0 15.5 19.9 14.6 15.3 14.5 17.6 15.1 11.8 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Cell line enhanced" "Detected in many" "BEWO: 9.6;REH: 7.8;SCLC-21H: 26.1;U-937: 12.5" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: " "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.0 0.8 0.3 0.0 9.6 0.4 0.7 0.5 0.3 3.9 2.7 0.0 0.9 0.4 0.2 4.9 2.0 0.2 0.1 0.5 0.7 0.5 0.3 0.7 0.9 2.8 1.1 0.8 0.1 1.1 0.0 0.3 0.0 0.0 7.6 2.0 3.5 1.5 4.1 7.8 0.1 0.4 0.5 0.8 26.1 2.0 0.5 2.7 0.2 2.6 1.6 0.8 0.3 1.5 0.3 0.3 0.4 0.1 0.1 0.3 12.5 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042445 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;lymphoid tissue: 27.6" "Cell line enhanced" "Detected in many" "BJ: 20.0;HDLM-2: 22.7;TIME: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA058106: " "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.2 7.6 17.1 16.7 28.8 8.8 4.0 3.0 18.4 9.5 5.9 27.6 0.0 4.1 3.4 1.4 3.4 2.5 6.4 1.8 24.3 14.7 2.9 5.4 7.3 23.9 33.3 9.6 15.9 1.8 1.9 1.4 2.5 23.2 2.0 6.7 1.1 4.1 2.0 1.3 5.0 8.5 4.4 37.7 26.5 6.1 2.3 35.5 27.6 2.7 1.3 18.4 6.6 3.7 6.8 6.2 2.6 9.6 12.8 10.5 4.0 0.0 9.4 3.0 0.0 3.9 8.3 0.0 20.0 16.4 9.6 7.2 0.0 0.0 0.2 0.0 12.6 0.2 0.0 0.0 7.7 22.7 0.0 0.2 2.0 0.0 0.1 1.9 0.9 1.9 0.2 13.9 5.4 9.5 0.0 18.8 16.2 0.9 3.4 2.6 1.1 2.2 4.5 4.4 2.7 0.5 0.0 0.1 2.5 0.0 0.0 2.0 0.6 8.7 21.2 10.4 2.5 4.9 6.8 0.0 0.0 0.0 14.7 12.9 4.5 2.6 2.8 0.2 6.2 8.2 6.4 6.8 10.5 8.8 6.2 3.8 10.4 9.0 0.1 12.8 9.6 2.6 7.5 4.0 17.1 28.8 3.0 18.4 24.3 14.7 33.3 9.6 23.2 35.5 DOCK11 "ACG, FLJ32122, FLJ43653, ZIZ2" ENSG00000147251 "Dedicator of cytokinesis 11" Q5JSL3 X 118495898-118686163 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.2;HMC-1: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059695 Uncertain Approved "Nuclear membrane,Nucleoli" "Nuclear membrane, Nucleoli" "HPA059695: " "unprognostic (4.09e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.56e-1)" "unprognostic (1.32e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.50e-1)" "unprognostic (5.56e-2)" "unprognostic (1.76e-1)" "unprognostic (6.37e-3)" "unprognostic (3.06e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.11e-2)" "unprognostic (8.16e-3)" 27.3 6.9 5.0 15.9 15.0 23.5 30.6 1.4 3.1 7.6 11.6 1.5 4.2 2.5 7.9 8.2 7.8 7.0 7.3 6.7 4.4 3.3 7.4 2.6 11.7 27.5 5.4 2.0 3.5 1.7 2.4 15.9 10.0 3.9 6.0 4.8 1.4 4.4 4.1 2.5 4.4 9.7 9.6 7.8 13.8 7.3 3.7 5.3 19.7 9.4 3.6 13.8 9.3 13.3 5.2 4.6 13.1 7.3 7.6 11.3 2.1 0.0 2.4 2.0 1.8 27.2 11.6 5.3 2.8 6.0 2.3 6.0 0.3 0.0 7.4 0.2 10.0 0.1 3.5 0.0 2.0 9.1 3.1 16.1 2.6 0.0 8.8 9.7 39.1 8.1 0.1 2.4 2.7 0.0 4.9 13.4 1.4 1.6 5.8 12.9 2.1 3.8 3.9 5.2 0.2 0.0 0.5 0.7 4.8 8.4 7.8 2.7 0.9 8.2 0.1 1.8 0.6 10.7 1.2 4.1 6.2 6.9 4.0 15.6 0.9 6.3 4.2 7.5 8.8 6.1 5.5 4.9 7.4 7.0 4.6 5.2 6.7 8.3 13.1 7.6 7.3 3.7 11.3 2.1 5.0 15.0 1.4 3.1 4.4 3.3 5.4 2.0 3.9 5.3 DOCK4 "FLJ34238, KIAA0716" ENSG00000128512 "Dedicator of cytokinesis 4" Q8N1I0 7 111726110-112206411 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.7;HUVEC TERT2: 35.6;TIME: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071516 Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" "Nucleoli, Plasma membrane" "Golgi apparatus, Cytosol" "HPA071516: " "unprognostic (1.37e-1)" "unprognostic (4.18e-1)" "unprognostic (1.53e-1)" "unprognostic (2.48e-2)" "unprognostic (7.10e-2)" "unprognostic (2.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" "unprognostic (5.78e-2)" "unprognostic (7.06e-2)" "unprognostic (3.66e-1)" "unprognostic (5.71e-2)" "unprognostic (1.89e-2)" "unprognostic (9.48e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" 10.7 6.5 16.5 10.0 28.2 2.3 6.8 11.7 28.2 9.1 4.4 21.0 2.0 2.8 7.9 4.4 4.4 8.7 7.9 6.9 22.2 10.1 7.3 13.9 25.5 3.7 18.2 12.4 14.2 5.0 4.7 4.0 10.8 12.2 6.5 4.9 1.7 4.4 3.9 6.7 3.5 3.2 10.7 20.3 3.2 3.1 3.5 21.8 0.0 5.8 2.7 3.6 5.7 5.2 0.2 0.3 6.4 1.2 0.1 0.1 0.2 0.0 1.6 4.0 3.2 3.3 4.9 2.3 0.4 4.4 0.8 1.3 0.0 0.0 0.3 3.3 1.0 0.1 0.6 3.8 3.4 1.2 6.6 0.1 2.7 5.6 2.4 0.5 0.2 2.6 0.4 18.7 9.7 35.6 0.0 10.1 1.7 0.4 0.8 0.2 2.1 6.9 0.2 2.9 1.6 2.7 0.1 0.9 3.1 2.5 2.0 2.4 0.3 0.1 30.7 3.1 1.5 6.0 1.3 0.4 0.1 0.3 0.3 0.7 6.9 0.2 0.7 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 6.4 0.1 0.2 0.3 0.0 0.2 16.5 28.2 11.7 18.2 22.2 10.1 18.2 12.4 12.2 21.8 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell line enhanced" "Detected in some" "Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003218 Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695" "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favourable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.5 0.4 17.0 1.2 0.0 0.7 0.2 0.1 0.0 5.8 0.6 0.0 0.0 0.0 0.0 16.8 2.3 0.0 3.1 0.0 0.0 0.0 3.7 8.6 0.0 1.0 15.7 26.6 0.0 0.2 19.8 0.0 6.5 0.0 17.5 0.0 0.0 0.0 0.2 1.1 0.4 50.6 3.3 0.0 0.1 0.2 0.0 3.4 0.0 0.0 0.0 10.6 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favourable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favourable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.1 11.0 1.7 3.6 0.9 1.0 7.3 8.7 1.8 4.3 3.4 15.2 3.8 7.2 6.8 1.3 9.5 2.7 3.0 0.9 10.5 12.3 7.5 6.2 18.1 3.5 9.9 10.4 1.2 3.0 4.1 1.8 2.2 16.2 8.5 1.7 10.4 10.8 11.3 9.7 14.8 12.2 4.0 10.3 2.6 5.1 10.4 7.7 6.1 5.4 8.7 7.5 5.5 5.0 5.4 7.4 14.2 15.9 11.3 8.1 9.5 6.4 22.6 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 DOK4 FLJ10488 ENSG00000125170 "Docking protein 4" Q8TEW6 16 57471922-57487327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.6;CACO-2: 29.1;SH-SY5Y: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "gdT-cell: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055849 Supported Uncertain "Vesicles,Microtubules,Cytokinetic bridge" Microtubules "Vesicles, Cytokinetic bridge" "HPA055849: " "unprognostic (3.44e-2)" "unprognostic (2.04e-2)" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (3.66e-1)" "unprognostic (9.71e-2)" "unprognostic (5.35e-2)" "unprognostic (1.39e-1)" "unprognostic (1.13e-2)" "unprognostic (3.00e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-1)" "unprognostic (2.58e-3)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "unprognostic (4.42e-3)" "unprognostic (1.18e-3)" 5.0 4.6 7.8 9.5 4.5 0.7 13.6 15.6 6.9 14.2 29.2 2.0 17.7 24.4 9.9 11.8 15.5 8.1 21.0 7.3 5.0 6.9 27.1 25.8 12.3 1.9 3.4 4.7 12.8 14.8 7.2 10.1 6.6 5.2 12.9 16.9 8.4 7.5 15.0 3.1 22.7 51.5 9.6 2.1 5.1 19.9 8.4 2.9 1.9 8.6 12.9 6.3 8.8 14.1 0.5 0.1 4.3 0.0 0.1 1.4 0.2 2.7 25.6 4.1 7.4 5.8 6.5 4.6 4.8 6.4 3.4 1.0 29.1 14.5 0.2 21.1 10.0 5.7 2.5 1.3 1.5 0.7 1.9 5.9 7.5 16.7 8.3 0.0 0.6 4.5 3.9 4.5 0.5 5.2 1.9 1.2 4.1 2.6 0.3 1.1 2.6 1.1 2.3 2.1 0.3 18.0 1.0 20.5 67.0 3.9 1.7 1.2 1.5 1.1 5.5 0.6 4.3 1.7 0.2 0.8 1.0 0.2 1.9 1.2 2.5 0.0 0.0 0.0 1.4 0.0 0.6 0.1 0.3 0.2 0.1 0.5 0.4 0.3 4.3 0.1 0.0 0.0 0.1 0.2 7.8 4.5 15.6 6.9 5.0 6.9 3.4 4.7 5.2 2.9 DOK6 "DOK5L, HsT3226, MGC20785" ENSG00000206052 "Docking protein 6" Q6PKX4 18 69401055-69849087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.6;SCLC-21H: 4.8;SH-SY5Y: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041099, HPA063534" Approved Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "HPA041099: , HPA063534: " "unprognostic (5.83e-2)" "unprognostic (1.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (2.77e-2)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (1.90e-2)" "unprognostic (8.62e-2)" "unprognostic (5.99e-2)" "unprognostic (1.04e-2)" "unprognostic (4.60e-3)" "unprognostic (2.13e-4)" "unprognostic (2.30e-3)" "unprognostic (2.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.09e-3)" 2.1 1.6 21.3 1.6 11.3 0.6 1.3 6.8 22.1 3.8 1.5 0.9 0.3 1.0 3.0 1.4 1.7 1.7 5.8 10.2 19.2 9.2 8.7 4.4 4.2 1.2 13.7 13.1 4.2 0.7 3.4 1.1 9.9 14.0 3.5 1.3 5.5 1.7 4.2 0.6 1.2 1.3 6.6 2.7 1.8 1.3 2.8 2.7 0.0 4.1 0.0 1.2 5.2 6.6 0.0 0.0 0.0 0.0 0.9 0.9 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 10.9 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 10.6 0.0 0.0 4.8 10.9 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 1.5 0.3 0.0 0.0 3.1 0.0 3.2 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.3 0.4 21.3 11.3 6.8 17.1 19.2 9.2 13.7 13.1 14.0 2.7 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell line enriched" "Detected in some" 4 "MCF7: 27.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA059449: , HPA062780: " "prognostic favourable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favourable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favourable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 1.0 0.0 3.4 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.3 27.1 0.0 1.1 0.2 0.1 0.0 5.3 0.2 1.8 2.3 0.4 0.1 2.2 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA066767: , HPA068706: " "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favourable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.1 6.8 10.0 20.1 10.6 9.2 10.7 17.4 13.2 9.8 15.0 8.1 2.8 5.7 15.5 36.4 9.2 13.4 6.8 4.7 8.1 3.5 13.1 10.8 20.3 3.8 6.3 14.6 12.4 14.2 7.8 12.8 8.5 4.5 14.2 25.2 3.1 3.2 8.7 11.9 3.1 9.0 11.1 11.8 7.7 6.2 7.0 14.2 11.7 6.3 20.5 5.0 10.6 11.9 4.3 14.9 8.8 4.3 10.7 2.8 11.2 3.5 9.0 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081100-129090438 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 6.4 12.8 10.0 6.8 10.6 7.7 6.8 11.7 19.3 8.3 17.1 17.7 8.6 28.6 6.0 7.4 18.8 6.6 9.2 4.1 10.1 10.7 9.4 21.8 6.7 6.6 13.2 10.6 7.7 10.5 10.4 6.9 11.6 12.5 10.0 14.2 6.1 10.3 5.8 5.2 10.3 27.7 6.3 15.2 8.5 11.8 12.2 11.0 9.4 6.3 8.5 9.1 7.8 8.0 8.8 12.5 9.8 8.3 7.9 21.7 7.2 4.3 16.6 16.3 14.9 5.5 4.7 18.9 10.7 6.2 20.3 11.3 21.3 14.4 8.3 9.4 6.6 31.3 16.7 8.9 8.6 9.8 10.3 11.0 11.2 16.3 9.7 11.3 13.7 5.0 12.5 13.3 10.6 9.0 18.1 8.4 5.7 21.8 13.0 11.8 14.0 13.5 15.3 13.2 15.0 7.4 7.0 18.6 12.2 13.4 12.3 4.5 22.5 7.5 7.4 17.5 8.4 16.4 14.4 10.5 20.0 12.7 7.7 2.3 11.5 4.4 6.8 9.8 8.9 8.1 21.7 8.8 10.9 10.8 8.5 6.0 11.1 10.5 1.4 7.9 8.3 12.5 10.1 7.2 10.0 10.6 11.7 19.3 10.1 10.7 13.2 10.6 12.5 11.0 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: , HPA049033: " "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favourable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.0 6.3 13.3 11.6 4.2 7.7 10.4 21.6 9.3 16.6 18.8 17.8 7.4 14.7 5.6 10.7 8.1 17.9 7.7 18.2 14.7 15.5 27.6 13.9 16.1 3.0 14.6 6.7 5.5 2.5 18.7 4.6 10.6 26.3 25.7 14.2 5.5 13.3 5.2 13.8 7.8 12.0 27.6 15.7 7.4 7.3 14.5 6.0 32.4 10.4 9.5 13.6 7.4 6.1 15.8 11.0 11.5 15.2 23.3 22.9 24.2 8.8 19.5 17.8 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favourable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.0 8.1 8.2 8.6 4.3 6.3 5.3 4.3 6.3 5.7 0.9 7.2 4.5 6.8 5.0 9.1 6.9 5.5 6.3 10.2 6.0 3.7 2.1 4.4 8.8 6.3 6.8 9.7 6.0 15.8 6.4 12.5 5.4 4.7 3.5 2.6 4.0 1.8 5.5 7.2 6.8 2.6 5.8 10.4 16.2 3.0 4.7 3.0 1.2 4.8 5.0 10.6 5.5 2.0 5.5 4.9 6.7 4.7 4.2 2.9 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell line enhanced" "Detected in many" "BEWO: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034922, HPA072065" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "CAB034922: AB_2277578, HPA072065: " "prognostic unfavourable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 15.0 3.2 2.4 4.1 2.7 5.3 23.3 7.2 8.5 10.2 6.4 2.2 1.2 2.8 1.1 5.3 3.1 4.6 1.6 8.3 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.4 6.6 1.7 4.2 2.0 4.6 3.0 16.8 5.0 6.4 2.0 3.3 8.9 1.4 13.7 5.4 6.0 6.5 3.7 4.8 21.6 6.1 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.5 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 161.7;kidney: 52.2;pancreas: 100.5" "Cell line enhanced" "Detected in some" "CACO-2: 5.1;Hep G2: 19.9;HHSteC: 9.0;U-937: 28.3" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" 270000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 53.6 0.1 0.4 16.1 0.2 3.4 0.3 0.1 0.9 0.1 0.1 0.1 52.2 0.1 0.3 0.9 0.1 0.1 0.2 100.5 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.3 0.4 0.1 0.4 161.7 0.1 0.1 0.9 0.2 9.8 0.1 0.2 0.1 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.1 2.8 0.0 0.0 0.0 0.0 5.1 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 19.9 9.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA049148: " "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.4 2.9 12.5 9.1 0.9 0.6 1.2 3.7 2.1 6.3 5.4 2.1 0.3 5.7 2.5 2.8 2.2 15.4 2.1 2.8 5.4 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 1.1 4.2 0.3 6.0 4.8 3.0 0.3 2.2 3.5 5.7 6.3 1.2 0.6 1.0 18.2 6.3 4.2 0.4 0.8 1.9 0.3 1.4 9.2 2.9 2.2 3.3 2.3 7.5 7.6 4.8 2.0 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 DPH1 "DPH2L, DPH2L1, OVCA1" ENSG00000108963 "Diphthamide biosynthesis 1" Q9BZG8 17 2030110-2043430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069750, HPA073864" Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA069750: , HPA073864: " "unprognostic (5.54e-2)" "unprognostic (1.99e-1)" "unprognostic (1.62e-1)" "unprognostic (1.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "prognostic favourable (1.78e-5)" "unprognostic (2.74e-3)" "unprognostic (2.10e-2)" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (7.30e-2)" "unprognostic (1.41e-1)" 16.6 22.9 17.6 19.0 22.7 10.3 17.0 38.6 26.5 17.8 17.1 17.2 21.1 17.0 22.2 17.0 17.9 29.0 22.6 20.2 14.1 13.1 21.4 32.7 15.7 22.7 17.0 21.6 25.2 29.4 28.4 42.9 17.3 15.4 26.1 13.3 21.3 25.7 23.9 33.3 29.0 17.3 18.9 11.4 17.8 18.4 19.5 19.9 17.5 21.0 25.8 19.0 17.2 16.0 11.3 9.3 0.7 6.8 5.6 12.0 5.5 9.0 15.8 4.3 10.6 13.6 9.9 11.9 11.9 17.9 20.3 13.2 15.1 7.4 17.6 15.4 35.2 7.2 14.5 13.4 11.0 4.6 33.3 4.1 7.4 9.0 12.9 5.1 6.7 14.9 13.7 16.2 13.2 9.1 13.8 7.2 7.9 11.9 9.0 3.3 4.0 16.2 10.4 3.1 13.6 9.0 5.6 8.2 9.5 10.8 12.2 11.9 17.8 4.2 6.3 14.2 6.5 17.4 10.7 7.2 5.0 4.3 13.9 7.0 4.9 0.0 4.6 0.7 9.5 6.8 10.4 11.3 7.8 8.6 9.3 9.5 12.0 8.7 0.3 5.6 4.6 6.7 10.4 5.5 17.6 22.7 38.6 26.5 14.1 13.1 17.0 21.6 15.4 19.9 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257978-16264972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 17.6 13.9 15.7 10.6 14.8 8.0 21.3 10.7 15.0 12.6 15.3 8.9 8.2 12.4 13.2 13.0 12.6 11.5 12.1 15.4 14.2 17.3 17.9 27.4 12.5 10.0 19.3 6.9 15.8 9.1 7.6 19.3 17.3 18.6 11.0 10.4 5.6 7.2 13.6 33.2 5.4 32.8 17.3 17.4 15.3 12.0 13.2 12.6 12.8 14.4 10.1 9.0 15.3 12.8 7.3 11.3 25.6 15.6 7.2 10.6 8.7 5.2 7.7 16.6 10.2 30.7 22.4 13.3 15.2 12.2 14.4 16.9 9.5 3.3 5.0 5.1 18.8 3.3 15.2 9.7 17.3 25.2 10.4 8.4 6.2 10.6 19.3 12.3 8.3 15.5 12.9 19.6 8.5 13.1 14.3 8.7 20.4 6.9 9.2 8.1 13.4 8.1 6.5 10.9 7.7 12.8 4.2 3.6 10.6 7.1 3.5 17.4 6.8 12.2 15.3 12.4 7.7 21.8 12.6 6.7 22.4 6.6 17.8 13.9 10.7 15.3 12.0 17.8 8.6 15.6 10.6 7.3 9.2 10.4 11.3 6.6 7.8 9.1 25.6 7.2 14.4 4.5 8.1 8.7 15.7 14.8 10.7 15.0 14.2 17.3 19.3 6.9 18.6 12.6 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA042976: AB_10964890, HPA055496: " "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 13.3 12.7 8.0 6.8 16.1 6.4 15.3 11.6 15.8 14.7 9.2 15.5 10.8 8.5 23.9 17.1 14.7 11.5 10.5 14.4 7.8 7.2 14.7 11.2 8.7 9.3 9.7 12.0 16.7 19.5 15.8 31.7 11.1 13.4 8.5 10.2 14.6 11.5 14.7 24.9 15.2 8.7 16.8 11.1 8.3 9.6 11.3 10.6 7.1 15.3 16.5 10.0 11.0 11.3 8.4 6.3 0.3 6.5 13.2 10.8 4.4 10.5 5.6 9.5 8.1 1.7 7.9 9.3 4.0 7.0 9.7 5.0 7.6 9.9 3.2 9.7 3.6 12.1 11.0 11.4 11.6 2.5 6.9 12.2 6.5 11.9 10.2 6.5 7.9 6.6 14.5 3.8 18.7 9.2 13.4 13.3 8.8 4.1 8.0 6.1 8.4 5.2 9.9 8.9 4.5 8.3 13.4 7.0 6.8 7.4 8.4 6.4 28.8 9.1 2.8 9.4 9.2 9.4 6.3 12.0 18.8 8.2 8.1 11.2 8.9 0.0 6.5 0.3 6.2 6.0 7.7 8.4 8.3 8.6 6.3 6.5 10.8 9.5 0.3 13.2 5.6 5.4 5.4 4.4 8.0 16.1 11.6 15.8 7.8 7.2 9.7 12.0 13.4 10.6 DPP7 "DPP2, DPPII" ENSG00000176978 "Dipeptidyl peptidase 7" Q9UHL4 9 137110542-137115177 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 56.7;THP-1: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021282, CAB025541, HPA059381" Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 1300000 "Golgi apparatus, Vesicles" "CAB025541: , HPA021282: AB_1847673, HPA059381: " "unprognostic (1.15e-1)" "unprognostic (5.54e-2)" "prognostic unfavourable (6.07e-6)" "unprognostic (6.78e-3)" "unprognostic (1.25e-1)" "unprognostic (8.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.10e-2)" "unprognostic (2.28e-2)" "unprognostic (5.71e-3)" "prognostic favourable (8.31e-5)" "unprognostic (7.99e-2)" "unprognostic (1.46e-2)" "unprognostic (2.56e-2)" "unprognostic (1.72e-1)" "unprognostic (2.15e-1)" "unprognostic (1.02e-1)" 28.1 45.2 23.7 23.4 35.3 31.8 20.8 23.5 27.5 21.5 22.0 24.9 40.7 23.2 17.5 35.8 19.1 27.0 30.2 44.7 24.6 29.2 21.0 29.9 25.6 34.8 29.7 25.9 14.3 55.4 23.3 42.5 21.9 24.2 28.8 6.9 32.8 73.1 41.6 25.3 26.9 17.8 22.8 21.7 29.1 24.4 30.9 26.8 18.9 41.2 17.5 24.7 21.3 16.6 20.0 60.8 12.2 43.1 19.2 36.8 38.2 6.8 10.9 0.9 0.9 13.5 10.8 1.4 10.4 17.0 6.9 4.5 10.3 5.7 13.6 11.4 6.8 14.9 8.0 2.0 0.3 13.3 0.5 6.2 15.0 0.3 30.2 16.8 34.9 13.3 8.3 3.0 6.2 9.0 13.6 10.6 4.6 19.0 8.4 16.0 3.7 10.7 12.4 0.1 56.7 11.0 7.7 17.4 12.1 12.0 31.6 29.4 11.3 54.5 10.9 17.7 6.0 11.2 7.2 13.0 7.4 3.6 21.2 10.2 7.9 6.8 43.1 12.2 34.4 37.6 35.5 19.7 31.1 29.6 41.7 20.0 28.1 25.1 2.6 19.2 22.6 60.8 36.8 38.2 23.7 35.3 23.5 27.5 24.6 29.2 29.7 25.9 24.2 26.8 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 5 "HAP1: 22.7;NTERA-2: 83.5" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB020678: , HPA035249: , HPA035250: " "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA071264: , HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 0.8 2.2 3.4 4.7 2.1 0.2 1.6 2.5 2.5 0.1 2.2 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30, histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039812 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavourable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 20.3 41.8 38.2 22.6 34.8 14.6 34.2 30.1 36.0 30.5 25.8 19.4 28.9 23.1 25.6 44.3 31.8 49.7 23.8 23.9 35.4 44.2 42.1 44.7 23.6 24.6 40.4 33.1 24.5 25.8 21.4 39.4 23.4 38.6 32.0 25.6 17.6 34.7 35.1 24.5 26.2 24.6 26.8 41.4 19.8 24.2 13.4 31.0 22.1 49.1 26.9 25.3 26.4 25.4 57.8 35.2 50.6 37.2 34.4 67.7 43.5 52.5 36.4 27.5 21.2 24.2 36.1 36.9 27.3 24.5 22.2 21.9 52.2 42.6 32.5 28.0 24.0 21.4 25.1 31.7 24.2 37.9 40.3 29.2 26.6 58.5 21.4 29.5 18.3 24.3 37.0 23.8 21.1 35.0 34.0 23.2 33.7 57.1 33.1 59.8 37.9 38.0 27.1 32.5 40.8 38.7 36.3 44.5 31.8 27.1 38.2 36.6 26.6 21.7 26.8 20.4 32.9 18.8 33.0 27.4 40.4 42.5 21.4 32.3 24.7 46.0 37.2 50.6 36.3 34.0 43.8 57.8 51.0 44.4 35.2 46.1 45.8 43.0 41.4 34.4 37.0 32.1 67.7 43.5 38.2 34.8 30.1 36.0 35.4 44.2 40.4 33.1 38.6 31.0 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell line enhanced" "Detected in many" "ASC diff: 60.4;Karpas-707: 62.2" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavourable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 22.7 22.4 11.9 60.4 27.9 2.2 9.2 21.4 8.8 11.5 8.8 6.8 7.0 6.7 28.7 4.6 23.5 9.2 8.4 15.8 2.0 7.9 8.6 12.4 38.7 1.7 3.2 34.5 13.3 24.0 14.0 17.6 0.2 62.2 8.8 3.0 13.5 1.7 17.5 4.4 18.0 9.0 4.6 14.7 5.4 10.2 21.5 11.2 0.1 6.0 1.7 3.2 31.7 20.0 8.1 16.5 4.0 8.8 9.0 5.5 28.9 10.4 10.1 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 DPYSL4 "DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186900-132205776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;heart muscle: 19.0" "Cell line enhanced" "Detected in many" "AF22: 23.2;AN3-CA: 30.4;SH-SY5Y: 31.6" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA049066: " "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavourable (3.11e-4)" 1.5 4.4 11.8 2.0 12.3 1.1 1.5 8.9 32.0 1.7 1.4 6.5 0.2 1.1 6.4 2.2 1.4 1.4 2.1 19.0 13.6 9.6 1.0 1.0 1.5 1.4 9.0 9.1 3.0 1.9 1.0 5.0 1.3 6.0 4.8 1.0 4.6 1.5 4.2 2.5 1.6 1.2 2.7 8.1 2.5 1.8 6.7 4.8 0.0 1.0 0.0 1.3 1.4 0.4 0.7 0.0 0.0 0.6 1.1 2.5 0.8 0.0 6.5 23.2 30.4 0.0 0.2 0.0 1.9 0.2 1.2 0.3 0.0 0.2 0.0 0.8 1.0 0.0 4.5 4.4 0.1 0.0 0.8 0.0 0.0 2.4 4.1 0.0 4.6 2.1 2.1 0.7 0.1 2.3 0.0 0.2 3.3 1.9 0.0 0.0 4.0 2.2 0.0 0.0 3.6 0.0 0.4 3.6 31.6 0.7 0.0 4.0 0.1 0.0 3.8 5.8 9.7 0.0 5.4 0.0 1.5 0.0 9.7 0.0 0.6 0.0 0.1 0.0 1.4 0.6 0.0 0.0 1.1 0.1 0.0 0.7 2.5 0.7 0.0 1.1 0.5 0.0 0.0 0.8 11.8 12.3 8.9 18.7 13.6 9.6 9.0 9.1 6.0 4.8 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: " "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 34.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 48.9 28.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Group enriched" "Detected in some" 4 "HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.0 0.7 0.1 6.4 0.1 0.0 0.3 0.4 0.1 18.0 0.0 0.2 0.3 0.0 6.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.1 0.0 2.5 0.0 0.6 0.0 0.0 0.8 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117333-111140216 "Predicted membrane proteins" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 17.6;THP-1: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: " "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavourable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 21.8 10.1 5.9 14.4 6.6 7.9 18.4 13.5 6.9 8.4 12.0 7.5 5.7 10.6 8.6 11.1 10.0 12.7 9.1 11.7 5.3 6.0 13.0 9.2 11.5 19.9 9.3 4.2 12.3 8.2 5.7 9.9 14.1 8.4 10.1 8.7 8.8 10.7 7.1 10.6 7.0 15.2 10.1 15.1 24.9 9.5 6.1 8.3 15.0 10.6 6.7 14.7 16.8 7.7 16.1 11.2 3.0 10.9 6.2 10.4 11.4 2.0 0.1 3.4 2.0 8.5 7.2 6.0 8.1 3.1 2.0 4.6 2.5 1.1 7.3 5.4 4.0 2.3 4.8 1.3 3.9 8.8 3.4 4.1 2.5 1.2 6.4 0.6 1.8 5.0 6.1 3.3 1.3 1.0 2.3 3.3 2.4 1.4 3.9 5.3 6.5 4.1 3.8 3.8 3.1 7.3 2.1 6.5 2.4 0.9 2.7 17.6 4.7 19.3 3.5 0.6 0.8 4.1 5.4 4.2 1.2 12.5 1.5 8.1 1.3 2.7 10.3 3.0 6.5 10.9 10.4 13.6 9.0 8.1 11.2 16.1 9.5 7.9 2.1 6.2 7.6 11.2 5.4 11.4 5.9 6.6 13.5 5.4 5.3 6.0 9.3 4.2 8.4 8.3 DRG1 NEDD3 ENSG00000185721 "Developmentally regulated GTP binding protein 1" Q9Y295 22 31399523-31530634 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 86.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001218 Enhanced Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA001218: AB_1078704" "unprognostic (4.94e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (5.26e-2)" "unprognostic (4.66e-2)" "unprognostic (3.49e-3)" "prognostic unfavourable (7.71e-4)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" "unprognostic (2.32e-3)" "unprognostic (8.69e-3)" "unprognostic (1.55e-3)" "unprognostic (4.80e-2)" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (2.25e-1)" 14.5 18.1 12.3 10.6 18.1 11.9 15.3 14.1 20.9 12.7 10.5 13.3 11.7 9.3 13.6 17.6 13.4 14.7 8.4 18.5 11.2 12.7 15.3 15.7 9.4 11.1 12.6 14.9 15.7 16.4 14.2 11.9 19.6 17.2 13.5 13.3 14.3 17.0 13.3 47.0 11.9 10.1 14.9 10.9 11.7 12.4 86.8 9.9 23.6 17.8 12.1 15.7 15.0 10.5 29.4 25.2 25.1 27.1 25.0 27.6 24.8 22.0 18.2 22.6 18.6 20.3 24.0 18.1 20.7 25.2 38.9 32.7 29.7 11.3 32.5 11.2 25.9 18.9 38.9 25.1 42.5 15.1 47.2 20.9 20.9 29.9 29.2 50.3 19.7 20.4 18.8 31.5 47.8 26.9 26.9 14.0 29.8 25.9 20.1 25.8 18.0 20.3 27.7 36.0 28.4 25.5 20.3 24.1 15.1 23.2 23.2 29.5 17.4 22.2 15.0 17.5 23.3 17.6 23.2 19.0 21.4 31.3 17.1 22.2 22.5 13.7 23.9 25.1 20.5 27.1 23.8 29.4 22.1 25.2 25.2 21.7 24.7 23.9 5.4 25.0 19.9 22.1 27.6 24.8 12.3 18.1 14.1 20.9 11.2 12.7 12.6 14.9 17.2 9.9 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favourable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 16.8 24.1 8.2 8.1 15.3 16.3 15.7 11.9 11.8 19.3 18.0 25.5 10.1 16.3 15.5 13.7 17.8 13.5 16.5 13.1 14.4 36.9 7.1 12.8 14.2 16.6 6.5 11.4 18.1 14.7 19.3 16.3 18.4 12.5 6.4 11.2 19.0 17.3 11.0 6.1 17.7 18.6 19.9 30.2 11.5 9.9 4.7 13.3 11.8 7.0 14.6 13.9 9.9 13.8 9.3 8.9 10.9 19.5 7.3 8.9 9.2 13.4 11.9 17.1 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell line enhanced" "Detected in some" "RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" HPA020446 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.8 2.1 0.6 2.6 0.6 1.9 0.0 0.0 0.1 0.1 15.3 0.6 1.0 0.1 0.6 1.5 3.0 0.1 0.4 0.2 1.4 0.5 1.2 0.6 0.9 0.3 2.3 1.2 1.3 0.4 0.0 0.4 1.2 0.3 0.2 0.7 0.2 0.7 0.2 0.8 1.6 0.1 0.0 0.4 1.6 0.9 0.7 0.0 1.3 1.1 0.2 0.1 0.4 0.0 2.7 2.4 0.2 1.0 1.4 0.1 2.5 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell line enhanced" "Detected in some" "RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 2.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 1.0 0.0 0.4 0.3 0.3 0.1 0.0 0.3 0.0 0.7 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.4 1.5 0.0 0.7 0.0 1.4 0.0 0.9 1.6 0.0 1.3 0.5 0.1 0.1 0.3 11.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 18.5 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Cell line enhanced" "Detected in some" "HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Not detected" "Not detected" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: , HPA073937: " "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavourable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.4 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.4 0.0 16.0 0.0 0.0 3.8 0.2 1.3 0.1 2.6 0.0 0.0 2.7 41.1 0.0 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019324 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA019324: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 DSE "DS-Epi1, DSEPI, SART2" ENSG00000111817 "Dermatan sulfate epimerase" Q9UL01 6 116254173-116444860 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 8.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014764, HPA052151" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA014764: AB_1856587, HPA052151: " "unprognostic (1.28e-1)" "prognostic unfavourable (3.36e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-3)" "unprognostic (1.21e-1)" "unprognostic (1.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.02e-2)" "unprognostic (7.81e-2)" "prognostic unfavourable (6.34e-4)" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (6.19e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "unprognostic (1.10e-2)" 32.3 10.6 7.4 22.3 10.7 13.1 34.8 5.4 7.7 16.0 12.8 4.9 9.9 5.3 11.7 18.5 13.5 15.3 12.9 16.1 8.1 4.3 11.2 10.4 17.7 13.1 9.8 4.5 21.0 4.0 15.4 20.9 21.7 13.1 13.0 7.1 14.3 9.3 9.4 8.5 16.9 10.7 12.8 16.1 24.9 7.6 10.9 9.0 8.3 8.7 10.9 8.3 14.6 29.4 3.6 8.9 2.5 3.9 0.2 1.1 1.2 10.4 2.2 7.8 7.3 21.1 14.0 8.8 12.3 29.0 15.5 22.7 0.0 2.9 0.2 1.1 21.4 19.9 1.1 28.9 20.3 10.7 4.8 0.7 3.3 0.1 23.6 0.4 0.5 29.6 12.5 17.1 16.8 9.1 0.2 4.8 7.3 0.3 1.3 0.6 4.2 0.6 1.8 7.2 4.9 10.2 0.7 2.6 2.0 11.9 0.0 0.2 0.1 1.2 3.4 15.6 4.6 3.9 9.8 1.0 0.3 0.5 8.3 1.3 1.8 0.7 3.1 0.1 1.0 3.9 0.6 3.2 0.9 0.4 8.9 3.6 1.1 0.4 2.5 0.2 2.2 4.2 0.2 1.2 7.4 10.7 5.4 7.7 8.1 4.3 9.8 4.5 13.1 9.0 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 19.5;BJ hTERT+: 11.3;LHCN-M2: 24.3;U-138 MG: 25.3" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060942 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA060942: " "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.3 0.0 4.6 6.8 0.3 19.5 11.3 5.0 2.1 0.0 0.0 0.0 0.0 9.8 0.1 0.4 0.8 4.8 0.0 0.0 0.0 2.2 0.0 3.9 0.0 0.0 6.9 1.3 3.0 7.2 0.9 0.0 0.2 24.3 0.0 0.0 0.0 0.3 2.0 0.2 5.1 0.0 2.2 0.0 0.9 1.1 1.8 0.0 0.0 0.0 0.0 1.7 25.3 0.7 1.8 2.2 0.1 0.0 0.0 5.3 0.0 2.1 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 homolog, MIS12 kinetochore complex component" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Cytosol" "HPA002813: AB_1078343, HPA030627: " "unprognostic (3.60e-2)" "prognostic favourable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavourable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavourable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 6.7 10.4 5.6 15.6 7.4 11.6 8.2 5.4 7.2 5.1 8.6 4.1 9.5 6.3 9.5 12.0 9.1 5.0 8.1 6.2 5.1 4.7 5.8 8.6 6.1 11.0 4.8 3.9 5.3 5.4 3.6 7.6 12.9 5.1 6.5 10.3 10.1 9.7 8.1 4.6 7.3 8.8 5.9 4.1 11.6 7.0 27.2 4.1 21.2 6.3 11.4 13.8 5.8 5.5 10.9 25.4 21.7 5.9 5.6 6.5 3.7 13.1 11.9 14.0 11.1 5.5 7.2 9.2 16.1 13.6 24.7 27.9 20.6 17.0 15.1 10.7 8.7 17.3 13.0 12.6 23.6 6.7 8.3 29.5 11.4 13.8 1.2 16.9 13.0 2.8 3.6 17.1 5.4 12.0 11.5 12.6 16.2 9.4 21.6 13.0 6.5 21.0 17.0 42.6 10.1 6.2 7.8 14.3 6.5 20.0 20.6 9.7 21.0 11.4 6.3 22.6 13.8 22.1 17.3 10.6 14.2 17.2 19.0 15.3 16.1 21.7 3.6 7.5 4.4 5.9 4.9 8.8 4.8 5.8 3.9 10.9 5.9 5.5 6.5 5.6 5.0 25.4 6.5 3.7 5.6 7.4 5.4 7.2 5.1 4.7 4.8 3.9 5.1 4.1 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 92.5;hTERT-HME1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 11.9 5.7 7.7 4.4 12.8 20.2 4.4 16.1 15.4 6.7 7.5 3.3 3.2 1.8 6.7 36.4 8.4 6.5 28.4 13.2 11.4 9.7 3.4 10.4 6.1 11.5 3.2 0.0 8.9 92.5 16.2 68.5 12.6 2.7 7.9 17.3 3.3 0.9 1.3 5.9 4.2 0.0 6.0 2.7 20.2 15.4 10.3 7.7 6.9 2.4 11.0 3.7 5.2 33.8 14.8 12.4 7.0 13.3 8.9 6.3 0.9 10.5 1.7 7.0 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 DSTYK "DustyPK, KIAA0472, RIP5, RIPK5" ENSG00000133059 "Dual serine/threonine and tyrosine protein kinase" Q6XUX3 1 205142505-205211566 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044140 Uncertain Uncertain "Nuclear speckles,Intermediate filaments" "Nuclear speckles, Intermediate filaments" "HPA044140: AB_10965031" "unprognostic (1.42e-2)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.66e-1)" "unprognostic (1.43e-2)" "unprognostic (9.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (3.26e-2)" "unprognostic (7.80e-2)" "unprognostic (1.93e-1)" "unprognostic (1.55e-1)" "prognostic unfavourable (8.73e-5)" 6.4 9.2 13.8 4.4 13.3 19.6 8.2 20.4 16.4 8.4 6.5 6.8 4.2 3.3 10.5 7.4 6.7 9.2 5.4 5.7 10.7 9.0 9.3 2.5 7.3 5.4 8.1 11.8 14.0 5.9 22.0 11.0 7.1 12.2 7.2 4.6 9.2 6.2 8.8 14.6 14.0 4.8 8.8 11.0 7.0 5.3 11.5 9.2 7.1 8.4 3.6 5.3 7.6 6.4 3.5 3.1 9.8 3.5 4.8 5.1 1.6 6.8 4.5 4.8 5.8 7.0 11.9 3.4 8.6 8.6 9.0 6.2 2.0 3.8 5.1 2.6 14.5 4.9 5.2 5.5 9.2 2.4 5.7 9.2 5.9 2.1 6.3 2.6 4.9 7.0 8.4 9.2 8.8 6.6 11.9 3.4 7.1 4.7 2.0 2.3 5.2 5.4 1.8 8.7 4.4 6.0 4.3 2.7 5.2 7.3 7.6 24.1 5.6 3.4 6.5 5.6 5.7 8.5 5.7 3.5 2.5 3.0 6.6 3.6 20.1 9.8 3.5 6.0 4.6 2.5 4.3 2.7 3.4 3.8 3.1 3.5 5.1 3.7 5.1 4.8 1.8 2.3 2.0 1.6 13.8 13.3 20.4 16.4 10.7 9.0 8.1 11.8 12.2 9.2 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-tyrosyl-tRNA deacylase 1" Q8TEA8 20 18587893-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol 180000 "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 14.9 17.7 25.2 13.6 26.5 13.6 19.7 22.4 35.4 13.5 13.7 22.2 10.5 10.6 14.4 17.2 18.8 14.5 11.1 16.7 24.7 29.5 20.1 9.4 13.7 15.5 25.2 30.4 19.1 19.7 20.3 23.7 12.7 27.3 13.6 16.0 17.1 17.6 12.4 22.5 17.6 9.8 15.0 30.9 12.7 16.3 20.6 14.4 4.8 29.5 24.9 17.4 13.4 12.6 20.9 27.5 29.9 20.6 16.4 22.5 12.6 18.5 20.9 20.6 20.2 8.8 16.4 11.5 16.4 15.2 13.1 14.4 13.6 14.5 0.0 11.2 15.3 10.5 16.4 34.8 13.8 9.0 11.8 20.7 4.8 22.7 27.9 16.0 11.2 13.0 28.0 14.7 54.4 22.2 12.9 24.1 19.0 27.2 3.4 29.2 19.1 46.0 0.0 30.7 15.6 19.9 10.0 28.2 21.3 8.8 24.4 42.4 13.9 10.0 21.8 17.3 9.4 22.1 22.2 19.4 19.2 10.3 11.9 18.8 14.3 29.9 14.5 10.4 22.2 20.6 22.2 20.9 21.7 22.5 27.5 17.8 16.0 16.7 17.1 16.4 20.5 6.4 16.1 12.6 25.2 26.5 22.4 35.4 24.7 29.5 25.2 30.4 27.3 14.4 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: , HPA032031: " "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavourable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.5 10.7 18.4 9.2 1.1 2.3 9.0 15.8 9.8 14.9 22.3 6.6 11.1 9.5 5.9 6.0 9.8 24.2 13.3 21.6 11.5 11.6 15.2 14.1 8.1 0.0 19.9 9.5 1.0 0.4 24.2 12.9 6.8 18.1 19.4 17.2 5.0 26.6 9.1 21.2 12.4 21.1 32.4 18.4 4.2 8.7 11.5 18.0 15.0 14.4 6.5 12.2 9.1 3.7 15.0 11.2 15.4 17.7 7.1 11.1 22.0 7.6 13.2 14.5 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell line enhanced" "Detected in many" "MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" "Nucleoplasm, Cell Junctions, Intermediate filaments" "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favourable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.2 0.1 7.5 0.0 4.8 13.4 1.2 2.0 7.3 0.3 0.9 1.7 0.0 0.0 4.4 0.8 0.6 0.9 3.9 0.7 0.0 5.2 0.0 0.4 3.5 3.9 0.1 0.1 10.2 0.8 6.3 2.2 3.2 1.1 0.9 2.1 17.5 0.1 0.0 19.5 4.0 0.0 3.7 11.9 0.3 0.1 27.5 3.2 0.0 0.7 2.0 10.7 2.6 0.1 8.7 4.7 0.1 2.7 0.6 0.9 0.4 28.1 0.0 3.7 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522801-15663058 "Disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favourable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.72e-4)" "prognostic favourable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 7.2 5.0 22.8 10.5 91.0 9.3 7.7 6.7 18.4 6.8 10.5 7.8 4.5 7.2 8.0 12.5 7.2 6.9 7.9 12.0 15.0 18.0 11.3 5.0 8.4 16.9 18.5 10.3 7.3 6.7 13.1 8.5 9.3 13.7 8.1 10.9 13.4 6.7 10.1 15.4 7.1 7.6 11.9 9.4 10.2 7.6 5.5 17.2 9.3 7.8 2.7 19.4 8.6 8.1 17.8 17.9 8.1 7.1 26.9 12.1 6.6 15.5 6.8 5.8 12.5 8.5 9.7 8.9 8.0 10.5 19.4 17.5 8.9 7.2 22.0 21.7 11.3 5.4 11.4 8.5 17.6 14.1 15.2 15.4 8.9 13.2 14.9 15.5 13.2 9.2 13.1 9.8 14.6 17.0 14.6 5.5 11.6 18.3 16.2 24.8 4.1 9.8 19.2 11.4 17.2 18.0 16.3 11.9 5.0 6.3 15.1 18.9 10.9 10.0 7.8 10.9 7.2 11.3 14.7 14.9 28.3 15.5 5.1 13.8 20.7 5.9 5.9 8.1 12.1 7.1 8.0 13.7 10.3 10.4 6.4 17.8 9.8 7.9 6.8 26.9 4.9 17.9 6.9 6.6 22.8 91.0 6.7 18.4 15.0 18.0 18.5 10.3 13.7 17.2 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA042214: " "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.4 5.2 9.6 5.1 19.1 37.4 7.6 12.9 12.9 17.2 12.7 1.6 3.6 7.0 9.7 16.1 8.0 6.8 6.8 16.7 4.7 4.8 6.1 10.6 6.2 12.8 7.9 5.3 18.0 9.1 10.7 13.2 7.0 11.3 7.5 18.0 8.9 5.3 6.4 6.0 7.1 7.7 19.8 27.7 5.5 3.1 8.6 6.5 15.6 5.3 12.0 5.3 11.5 4.6 20.4 8.1 11.4 14.3 6.0 9.1 4.2 17.9 22.7 12.6 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.7;lymphoid tissue: 13.3" "Group enriched" "Detected in some" 12 "Daudi: 40.0;REH: 16.4;U-698: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: " "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.7 2.3 6.1 8.9 7.0 3.2 3.9 7.3 8.3 0.8 0.7 1.1 0.5 1.6 2.0 0.5 1.2 1.7 1.0 2.7 5.4 5.9 1.7 6.4 0.5 13.3 3.7 4.2 0.5 2.0 0.0 2.2 0.9 4.6 0.8 0.2 1.4 3.2 0.5 0.5 0.5 2.2 0.5 1.1 9.8 1.0 4.9 0.5 0.5 1.3 0.5 8.1 0.5 0.5 2.3 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.7 0.0 16.4 0.0 0.9 0.0 0.0 1.0 2.7 0.1 0.1 0.9 0.0 0.1 0.4 0.0 1.5 0.0 0.0 0.2 0.0 40.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.2 6.1 7.0 7.3 7.1 5.4 5.9 3.7 4.2 4.6 0.5 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell line enhanced" "Detected in all" "A549: 28.0;CAPAN-2: 46.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA042931: " "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavourable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.7 28.0 4.2 6.1 2.4 2.3 9.0 2.7 2.4 3.1 4.2 7.8 46.2 4.0 2.0 2.7 9.6 2.2 13.3 1.9 8.9 4.7 2.3 5.7 6.8 3.2 3.3 5.8 4.1 8.1 7.9 4.3 2.3 6.9 6.0 3.7 6.2 5.0 11.5 6.0 4.2 5.6 3.8 7.1 1.4 10.0 1.6 3.4 4.5 7.7 3.7 7.7 8.8 2.4 17.3 8.2 5.8 11.0 4.5 5.3 4.5 3.7 3.5 8.8 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: " "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favourable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favourable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.4 25.0 0.0 0.0 0.0 0.1 5.1 13.3 11.3 11.5 4.3 13.6 4.5 7.9 11.1 5.2 0.0 0.6 8.0 11.3 1.5 2.6 13.0 4.5 19.3 0.0 0.0 9.5 6.3 8.6 0.1 12.6 0.0 15.4 8.6 7.0 13.7 0.1 19.7 0.7 0.0 20.9 0.2 1.0 8.4 18.2 28.8 4.0 1.2 2.4 14.4 6.9 0.0 14.8 5.9 6.8 7.3 25.2 18.9 0.0 9.5 0.0 7.7 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 DTX3L "BBAP, RNF143" ENSG00000163840 "Deltex E3 ubiquitin ligase 3L" Q8TDB6 3 122564238-122575203 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.3;BJ hTERT+ SV40 Large T+ RasG12V: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010570 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA010570: AB_1847877" "unprognostic (8.15e-2)" "unprognostic (7.36e-3)" "unprognostic (5.04e-2)" "unprognostic (3.74e-3)" "unprognostic (9.51e-2)" "unprognostic (9.22e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (9.23e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (8.99e-4)" "unprognostic (2.76e-2)" "unprognostic (2.33e-2)" "unprognostic (7.77e-2)" "unprognostic (9.28e-2)" "unprognostic (3.33e-2)" "unprognostic (2.61e-2)" 32.3 13.0 5.9 22.7 8.4 8.1 11.2 2.0 6.8 14.2 18.5 5.9 6.0 14.8 14.0 12.8 17.9 12.0 15.1 21.5 5.0 5.1 17.3 39.2 21.3 18.3 6.4 3.3 21.7 18.5 10.3 13.9 22.2 6.5 20.9 12.1 7.6 13.9 9.8 14.6 6.2 31.8 10.8 9.7 35.2 12.4 4.9 6.9 24.8 23.9 8.0 18.3 17.0 22.1 6.4 6.5 21.9 13.6 7.8 10.2 6.7 11.4 3.5 1.0 3.0 4.7 10.9 3.9 3.0 11.1 35.3 43.7 3.4 11.8 1.3 5.9 4.9 11.6 3.5 4.8 7.8 9.7 1.3 10.0 2.6 3.6 9.3 5.1 7.9 9.4 5.7 5.3 3.0 6.6 1.2 7.2 2.6 3.5 12.4 3.6 0.6 6.5 13.8 8.1 2.2 9.0 7.4 1.5 1.6 6.2 2.8 22.3 3.2 6.5 8.1 4.0 5.7 0.4 3.8 2.6 1.4 6.1 7.0 6.7 4.1 12.5 8.5 8.7 9.3 13.6 10.2 5.9 7.8 10.0 6.5 6.4 7.1 7.6 21.9 7.8 13.5 0.7 7.4 6.7 5.9 8.4 2.0 6.8 5.0 5.1 6.4 3.3 6.5 6.9 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791238 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: " "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 9.1 9.4 7.4 11.4 9.4 25.4 9.5 7.1 13.2 8.9 12.4 13.7 8.7 16.6 13.1 7.7 12.3 11.1 11.1 7.8 6.0 5.0 9.9 17.5 7.9 12.6 8.3 6.7 11.8 17.6 4.7 8.6 11.1 7.8 11.8 4.6 12.4 12.4 10.1 14.3 17.5 14.4 7.6 7.5 12.5 12.3 42.5 8.1 15.6 11.7 10.3 11.1 8.8 9.7 13.5 19.2 4.3 18.6 15.8 16.6 9.9 10.8 10.7 3.1 10.9 0.8 1.4 10.2 3.6 2.1 3.8 2.9 16.7 5.1 11.1 13.9 1.4 7.1 2.6 3.5 0.6 8.1 24.6 7.3 5.6 6.3 5.5 16.2 21.3 3.3 3.8 4.3 3.0 2.5 19.4 0.0 2.0 14.2 13.6 16.5 11.1 29.2 7.1 6.4 13.6 1.6 7.8 10.8 10.9 3.8 6.4 7.1 4.4 13.3 3.3 5.4 9.6 16.1 15.6 31.9 23.4 10.6 5.3 16.8 6.1 4.3 13.2 3.4 14.8 18.6 16.6 10.2 11.0 13.5 18.7 13.5 15.1 14.4 1.5 15.8 14.4 19.2 12.5 9.9 7.4 9.4 7.1 13.2 6.0 5.0 8.3 6.7 7.8 8.1 DUSP1 "CL100, HVH1, MKP-1, PTPN10" ENSG00000120129 "Dual specificity phosphatase 1" P28562 5 172768090-172771195 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 43.1;hTCEpi: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 326.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 326.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069577 Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA069577: " "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (9.73e-2)" "unprognostic (8.17e-2)" "unprognostic (4.64e-1)" "unprognostic (1.58e-3)" "unprognostic (4.18e-2)" "unprognostic (6.94e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (3.11e-5)" "unprognostic (2.69e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-3)" 158.4 78.0 12.4 68.5 14.0 89.7 91.8 17.4 14.9 81.4 37.1 32.4 48.5 9.4 55.4 71.6 82.7 94.8 138.8 49.2 12.5 11.4 29.8 115.4 135.0 43.5 30.6 9.7 69.4 34.4 26.6 40.8 93.7 29.3 67.1 34.2 61.0 38.1 192.8 54.8 116.1 27.6 65.0 29.5 36.1 53.6 45.9 18.7 10.8 90.4 104.1 46.9 69.0 109.7 2.4 11.5 326.0 31.8 4.5 9.8 14.0 2.1 5.4 1.7 2.3 37.5 22.0 2.9 34.9 10.2 23.5 9.5 5.9 2.5 0.7 10.2 24.5 0.9 1.6 8.6 11.0 19.1 4.6 0.4 11.9 2.5 43.1 0.2 0.8 21.0 75.3 10.6 17.3 7.3 1.7 13.7 15.1 2.5 1.1 1.0 1.5 1.6 40.5 3.2 6.3 16.7 1.1 7.4 3.1 9.4 16.1 1.2 1.3 0.4 19.2 16.7 8.3 16.2 2.6 2.8 1.6 0.6 14.8 0.3 0.6 33.3 24.6 69.8 3.9 25.0 9.8 2.4 3.5 4.0 11.5 2.1 1.7 1.9 326.0 4.5 31.8 0.6 2.8 14.0 12.4 14.0 17.4 14.9 12.5 11.4 30.6 9.7 29.3 18.7 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell line enhanced" "Detected in many" "HaCaT: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favourable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.0 2.6 0.2 0.1 18.8 9.7 0.2 4.0 10.6 6.7 5.2 0.1 1.6 4.7 1.4 10.4 41.5 0.9 3.9 5.8 12.0 0.5 8.1 1.1 0.7 4.4 3.6 5.5 13.5 2.9 7.2 7.3 0.2 0.8 1.6 6.4 0.1 0.7 2.7 0.6 0.2 0.4 11.5 0.3 2.3 3.7 15.5 1.2 0.5 0.5 17.2 0.9 2.1 1.4 3.4 0.9 5.1 4.9 2.8 2.0 2.5 5.3 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: " "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavourable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 19.6 16.1 15.1 15.1 17.9 29.5 21.4 31.8 21.5 23.1 16.8 16.4 16.2 16.3 29.9 19.8 38.7 37.4 15.2 15.2 17.2 13.9 19.3 16.5 17.2 21.5 12.7 15.8 26.4 14.9 11.6 28.2 19.1 14.0 18.2 16.8 16.5 22.3 20.3 16.2 27.9 19.7 18.9 13.4 21.5 15.4 19.7 13.8 28.7 16.8 16.2 29.3 20.4 27.3 29.9 20.9 42.6 19.1 28.0 37.6 29.2 19.0 8.3 8.9 9.4 16.2 20.3 16.0 14.0 18.4 18.3 18.7 11.9 14.5 24.8 9.1 15.1 13.4 11.0 28.2 17.7 17.1 11.5 15.2 6.3 18.1 17.0 17.1 14.3 16.4 34.3 16.3 22.7 20.2 16.1 14.6 20.2 10.5 16.4 18.2 14.4 11.4 6.6 24.0 22.3 14.8 15.9 13.3 7.2 13.0 15.5 16.5 8.2 9.1 11.4 13.1 16.1 15.0 16.5 15.6 12.3 32.8 12.1 17.4 12.7 24.7 19.1 42.6 26.8 16.9 34.6 29.9 31.7 31.6 20.9 28.1 33.9 31.8 29.1 28.0 16.9 15.9 37.6 29.2 15.1 17.9 31.8 21.5 17.2 13.9 12.7 15.8 14.0 13.8 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489831-37513501 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 12.5;HBF TERT88: 17.9;WM-115: 10.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol 44000 "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavourable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 4.7 3.7 3.3 2.1 6.6 1.1 3.9 1.8 8.0 3.3 1.0 1.5 0.1 0.7 2.7 1.2 7.2 11.7 5.1 2.6 2.3 2.1 6.5 2.4 1.0 1.9 2.5 3.0 2.9 1.7 3.3 11.6 2.6 1.4 1.4 1.6 2.8 1.1 1.7 8.4 0.9 3.5 2.7 1.7 1.0 3.5 0.8 2.3 8.3 6.1 4.3 1.9 1.0 0.5 0.0 3.2 0.0 0.4 0.4 0.5 1.7 0.1 0.4 0.8 0.0 0.5 1.5 8.0 6.1 10.7 12.5 0.9 1.8 0.1 0.7 5.8 1.3 0.1 4.7 17.9 0.1 0.5 0.0 1.0 2.0 0.8 0.4 1.2 4.7 2.9 3.8 2.0 0.2 0.4 0.0 7.9 0.3 0.8 0.2 0.2 0.0 0.7 0.5 0.2 2.6 0.7 1.3 0.1 0.4 0.7 1.1 0.6 1.0 0.7 8.6 2.0 0.1 4.0 0.0 0.2 0.1 0.0 0.0 10.3 0.0 0.0 0.9 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.3 0.2 3.2 0.4 0.0 0.0 0.0 0.5 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Cell line enhanced" "Detected in some" "CACO-2: 5.3;REH: 17.4;SH-SY5Y: 5.0;SK-MEL-30: 4.3;U-2 OS: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA076649: " "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favourable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.3 0.1 1.0 2.2 0.3 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.7 0.0 17.4 2.0 0.1 0.0 0.0 2.4 5.0 2.8 0.0 4.3 1.3 1.0 0.0 0.0 4.2 0.0 0.0 1.8 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143166-96145440 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 151.1" "Cell line enhanced" "Detected in many" "Daudi: 15.3;HeLa: 13.9;Karpas-707: 17.4;NB-4: 14.4;RT4: 17.3;SCLC-21H: 15.5;U-698: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 46.1" "Group enriched" "Detected in all" 10 "NK-cells: 29.6;T-cells: 46.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071920 Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA071920: " "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavourable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 6.4 3.1 2.0 13.1 4.3 51.3 2.9 1.3 4.3 4.8 3.9 1.9 7.9 0.8 4.3 18.3 4.1 3.0 8.8 7.4 3.0 1.4 5.5 3.4 15.9 19.0 1.8 0.8 3.0 1.7 0.4 14.6 0.6 2.0 10.7 1.1 2.8 2.0 151.1 1.8 9.8 4.7 3.7 1.6 16.4 2.1 3.3 0.7 43.4 2.4 2.6 12.2 24.6 14.1 3.9 2.3 1.4 2.2 29.6 46.1 7.5 1.5 0.0 0.1 0.1 0.2 0.3 2.2 1.9 0.0 2.8 2.7 4.4 0.3 15.3 5.5 2.1 1.1 3.8 0.0 0.5 0.2 0.0 0.3 13.9 0.0 1.0 6.3 1.3 0.5 1.0 0.4 0.0 0.0 0.0 17.4 0.1 2.6 12.4 14.4 3.4 5.4 0.0 0.2 12.1 0.1 17.3 15.5 0.8 0.7 0.2 2.8 1.0 7.2 0.0 0.0 4.1 0.0 0.8 1.2 1.8 21.0 0.0 6.9 0.1 0.5 0.9 0.2 46.1 2.2 22.6 3.9 11.4 41.4 2.3 2.6 7.8 23.9 1.4 29.6 1.8 0.6 3.4 7.5 2.0 4.3 1.3 4.3 3.0 1.4 1.8 0.8 2.0 0.7 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 70.3;U-266/70: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 24.8 13.1 22.0 24.6 31.3 19.4 28.7 12.1 27.5 18.1 29.0 29.8 18.8 21.2 20.6 25.2 29.8 15.0 20.4 31.0 22.6 17.4 16.0 20.3 24.6 27.4 33.5 16.1 13.9 27.9 10.8 14.8 25.9 25.5 16.1 15.9 16.9 20.9 15.5 32.0 30.6 21.8 23.4 29.2 30.0 21.4 41.3 30.0 9.2 19.9 19.0 27.9 22.8 27.4 21.6 18.0 16.3 17.5 2.9 8.2 9.8 3.5 2.2 4.7 7.0 5.4 6.1 6.2 2.6 2.1 2.3 2.8 2.3 4.0 7.5 6.4 2.7 2.5 5.9 4.9 1.7 17.9 6.8 5.1 1.7 6.4 2.8 1.8 6.7 4.5 14.8 1.7 3.1 6.7 4.7 25.2 1.9 2.1 2.6 6.5 2.8 5.1 5.3 3.2 70.3 4.4 1.5 8.1 3.2 2.2 0.9 7.7 4.7 2.3 9.1 2.1 2.8 2.1 1.6 35.8 25.2 10.4 0.8 5.0 4.7 16.3 17.5 6.9 5.0 14.0 3.5 21.6 3.9 5.1 18.0 17.5 3.6 5.1 12.0 2.9 12.6 15.4 8.2 9.8 22.0 31.3 12.1 27.5 22.6 17.4 33.5 16.1 25.5 30.0 DUSP28 "DUSP26, VHP" ENSG00000188542 "Dual specificity phosphatase 28" Q4G0W2 2 240560054-240564014 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047456, CAB069448" Uncertain Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB069448: , HPA047456: AB_10961145" "unprognostic (1.88e-2)" "unprognostic (9.29e-2)" "unprognostic (4.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (7.56e-3)" "unprognostic (4.13e-3)" "unprognostic (3.71e-2)" "prognostic favourable (1.84e-4)" "unprognostic (9.85e-2)" "unprognostic (1.80e-3)" "unprognostic (6.99e-2)" "unprognostic (2.52e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-3)" 1.8 2.8 2.7 3.0 3.4 7.9 3.5 6.3 3.7 3.1 2.6 3.3 6.5 2.9 2.6 5.0 3.5 3.1 4.4 16.3 2.8 2.7 3.2 3.4 2.5 6.1 3.5 2.4 2.6 10.2 2.6 5.0 3.2 2.8 4.3 2.8 2.7 3.7 2.4 21.2 4.9 4.2 4.3 2.2 5.9 4.2 8.2 2.3 2.6 4.4 13.4 4.2 2.8 4.5 3.8 3.3 10.7 2.1 2.7 3.3 2.0 1.7 1.6 2.2 2.5 1.4 0.7 2.3 1.9 1.1 1.5 1.1 0.9 4.4 2.7 1.0 1.2 4.9 1.7 0.6 1.6 3.3 6.2 3.8 3.3 2.4 1.0 2.5 6.6 1.6 1.7 1.0 1.3 0.7 2.7 3.2 1.3 1.8 3.1 4.0 1.4 1.4 3.8 4.7 3.6 1.1 2.9 4.8 2.7 1.8 1.9 2.1 2.3 4.3 1.7 3.5 2.8 2.2 1.7 12.9 3.7 4.3 2.1 1.9 2.7 10.7 2.1 0.7 2.7 1.4 3.0 2.1 2.8 2.8 1.2 3.8 3.3 3.0 3.6 2.7 1.5 3.3 2.2 2.0 2.7 3.4 6.3 3.6 2.8 2.7 3.5 2.4 2.8 2.3 DUSP3 VHR ENSG00000108861 "Dual specificity phosphatase 3" P51452 17 43766121-43778988 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063616 Supported Nucleoplasm,Cytosol 1300000 Nucleoplasm Cytosol "HPA063616: " "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (1.04e-3)" "prognostic unfavourable (3.00e-4)" "unprognostic (4.83e-2)" "unprognostic (8.98e-2)" "unprognostic (5.13e-1)" "unprognostic (6.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.40e-3)" "prognostic favourable (5.49e-5)" "unprognostic (2.67e-3)" "unprognostic (5.45e-2)" "unprognostic (1.94e-1)" "unprognostic (1.37e-2)" 17.1 17.8 23.1 10.2 20.8 4.6 22.0 14.3 28.6 12.8 28.4 11.1 16.7 13.4 17.5 18.7 23.6 10.6 19.3 64.0 21.5 18.1 27.1 39.9 17.2 9.0 17.6 19.1 9.1 19.2 27.5 11.4 15.0 17.1 22.6 13.1 14.3 11.1 36.6 106.9 8.9 15.2 31.1 12.7 14.5 19.6 8.0 10.8 1.2 13.9 22.8 6.5 20.7 24.1 1.7 19.5 5.2 17.0 0.9 1.7 5.8 10.9 19.8 7.6 8.1 22.3 12.0 6.5 8.3 19.9 19.4 23.5 19.0 7.4 1.7 13.2 15.5 9.5 11.8 10.2 20.5 3.7 9.0 5.5 9.1 15.5 27.3 0.6 5.7 11.1 18.4 14.9 13.1 13.5 4.9 1.9 22.6 7.8 2.8 2.8 3.5 14.5 3.6 23.0 4.1 26.9 11.5 4.3 7.7 9.7 6.5 24.4 29.1 15.4 14.0 22.0 14.9 31.2 13.7 10.2 13.4 0.4 26.1 7.7 7.3 5.2 17.0 3.5 1.0 8.9 1.7 1.7 1.5 1.2 19.5 1.6 1.2 1.1 4.1 0.9 10.8 8.2 0.9 5.8 23.1 20.8 14.3 28.6 21.5 18.1 17.6 19.1 17.1 10.8 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347232-89353271 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.0" "Cell line enhanced" "Detected in many" "AN3-CA: 80.6;NB-4: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Group enriched" "Detected in many" 11 "granulocytes: 125.0;monocytes: 79.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favourable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 37.7 7.5 7.2 15.9 11.7 41.3 24.1 3.4 14.7 11.6 12.4 6.2 5.8 6.1 9.8 8.7 12.0 15.4 25.1 16.2 10.5 6.5 17.1 38.4 28.2 13.3 6.9 7.4 7.5 12.2 15.0 13.7 19.7 7.9 17.4 15.3 44.4 64.3 6.3 12.0 8.5 14.6 11.3 7.1 28.4 10.3 4.8 6.4 6.1 21.0 13.3 17.8 15.2 6.9 1.2 9.2 125.0 79.7 1.2 0.9 32.4 1.1 1.1 24.0 80.6 20.8 17.7 0.0 8.7 11.1 1.7 1.3 7.0 1.2 0.0 2.0 3.7 9.3 0.1 21.6 2.5 0.1 0.1 3.6 0.2 11.2 14.7 15.5 39.5 3.4 7.6 15.3 14.3 40.1 0.0 3.8 5.5 0.5 0.5 57.8 14.6 19.7 39.3 3.0 1.5 24.8 23.3 0.4 17.1 0.2 0.1 45.9 1.2 8.6 10.7 5.9 0.1 1.1 4.1 0.6 3.1 0.0 24.5 10.9 37.4 125.0 49.5 22.4 0.9 79.7 0.4 0.2 0.2 0.3 9.2 1.2 0.1 0.3 22.5 1.2 74.4 1.2 0.6 32.4 7.2 11.7 3.4 14.7 10.5 6.5 6.9 7.4 7.9 6.4 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Cell line enhanced" "Detected in some" "A549: 2.4;U-2 OS: 3.6;U-266/70: 7.8;U-266/84: 10.1;U-698: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: " 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.4 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.6 0.0 0.0 0.0 3.6 0.7 0.0 7.8 10.1 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225341-7234545 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: , HPA022914: AB_1847683, HPA064732: " "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favourable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 14.6 16.7 16.9 11.0 24.6 12.5 14.2 22.3 16.2 20.2 15.7 20.0 12.3 12.6 24.3 12.3 22.6 18.0 15.3 12.8 14.5 8.2 13.2 7.8 12.2 14.8 16.7 12.3 30.6 12.7 15.7 26.3 14.9 12.5 18.9 8.6 18.9 14.4 19.3 11.9 21.2 12.9 18.2 10.9 12.7 11.4 14.5 17.0 24.6 16.1 9.5 16.3 16.7 19.7 11.7 7.8 11.6 5.4 7.2 12.1 6.9 12.9 18.9 22.8 22.7 17.5 15.8 9.9 9.1 16.6 22.0 28.3 16.1 11.0 18.5 13.8 10.0 18.7 18.9 12.3 8.4 18.3 21.6 12.0 20.1 16.9 30.7 6.7 10.4 23.6 21.1 20.8 11.4 9.1 10.2 8.8 13.2 12.2 25.6 6.7 7.8 7.3 37.7 14.8 11.3 12.1 11.6 10.1 20.5 16.5 8.3 19.8 11.9 9.3 7.5 12.4 11.3 23.1 16.8 13.7 11.4 8.5 14.5 10.1 19.2 11.6 4.7 10.7 12.1 5.4 10.1 10.4 8.3 10.7 5.6 11.7 9.9 10.1 2.1 7.2 5.1 7.8 5.0 6.9 16.9 24.6 22.3 16.2 14.5 8.2 16.7 12.3 12.5 17.0 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155388-184173610 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: " "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (4.77e-5)" "prognostic unfavourable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 22.8 18.5 18.0 16.8 19.4 15.3 25.1 18.3 23.2 22.6 27.6 24.7 23.9 16.2 32.1 16.4 20.0 22.2 22.2 27.9 19.9 12.3 16.8 13.1 20.6 12.1 21.4 16.0 30.0 22.7 17.2 17.8 56.0 17.4 19.7 15.8 31.1 18.7 26.2 26.3 27.6 19.1 30.3 16.4 17.8 19.4 15.6 20.1 7.3 20.9 13.3 14.6 24.5 26.3 2.5 2.7 4.1 4.0 1.5 3.1 1.2 19.8 6.5 15.8 17.9 16.4 16.4 40.7 11.8 12.1 14.3 11.9 19.1 8.0 13.9 31.7 15.4 17.0 12.9 9.4 10.0 21.9 13.5 15.5 9.8 11.5 24.6 8.6 12.1 16.5 16.9 10.4 11.9 10.4 15.5 19.3 15.0 19.0 12.7 10.2 13.9 9.4 20.3 18.3 12.1 13.3 16.4 17.1 21.7 14.7 17.0 28.8 42.5 11.0 10.2 13.0 12.7 13.6 18.3 20.7 15.3 15.5 12.9 9.2 10.0 0.2 2.4 4.1 2.3 4.0 3.1 2.5 1.5 2.4 2.3 2.0 2.0 1.3 3.6 1.5 2.8 2.7 1.1 1.2 18.0 19.4 18.3 23.2 19.9 12.3 21.4 16.0 17.4 20.1 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Cell line enhanced" "Detected in many" "AN3-CA: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: " "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favourable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavourable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.4 14.1 1.7 1.0 1.5 1.6 2.6 4.4 3.6 2.2 2.9 1.0 3.1 5.8 4.1 1.5 3.2 1.6 1.9 4.4 1.9 2.9 2.8 3.9 0.0 2.7 2.2 2.9 1.8 3.0 6.6 2.4 3.2 1.8 4.4 0.1 2.3 0.7 0.1 0.1 2.0 1.8 5.2 0.7 7.3 5.5 3.3 1.4 3.7 0.0 4.4 0.9 0.8 4.8 2.8 3.6 1.9 3.4 2.4 2.6 4.6 2.1 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 DYNC1H1 "CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22" ENSG00000197102 "Dynein cytoplasmic 1 heavy chain 1" Q14204 14 101964510-102056443 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" "Motor protein" "Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003742, CAB010443" Enhanced Supported Centrosome,Cytosol 120000 "Centrosome, Cytosol" "CAB010443: AB_2093483, HPA003742: AB_1078713" "unprognostic (2.58e-1)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (4.65e-2)" "unprognostic (4.66e-2)" "unprognostic (5.49e-2)" "prognostic unfavourable (3.03e-7)" "unprognostic (8.93e-2)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "prognostic favourable (1.09e-6)" "unprognostic (1.63e-2)" "unprognostic (8.73e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-3)" 23.3 17.2 24.3 13.9 42.9 21.1 12.7 43.9 53.4 16.9 18.4 35.0 10.2 13.9 18.6 12.5 18.3 15.5 16.1 26.6 26.1 26.6 11.2 9.4 14.6 14.0 29.1 23.4 24.7 15.4 28.1 16.4 14.8 51.5 16.7 11.9 15.5 18.0 18.6 44.5 42.0 13.8 17.7 30.3 15.4 15.5 17.2 12.6 15.1 18.1 11.1 12.9 19.1 12.8 2.7 6.3 4.5 6.0 7.8 4.7 3.3 23.8 35.7 19.7 15.1 44.1 28.8 12.0 20.7 19.3 24.4 21.5 15.2 12.1 13.7 17.0 28.2 21.8 19.2 23.1 8.9 11.8 11.6 9.8 23.3 24.6 20.1 14.4 10.2 18.7 12.2 57.6 43.0 26.7 8.4 15.7 27.7 23.4 9.4 3.6 11.9 44.2 8.9 20.7 7.8 19.7 38.0 22.4 18.1 27.3 13.9 18.0 11.5 6.1 58.6 29.0 12.4 40.0 28.2 10.8 10.9 9.2 39.9 8.6 17.8 3.6 3.4 2.5 4.6 6.0 4.7 2.2 3.0 4.0 6.3 2.7 3.6 4.2 4.5 7.8 3.9 3.3 3.0 3.3 24.3 42.9 43.9 53.4 26.1 26.6 29.1 23.4 51.5 12.6 DYNC1I2 "DIC74, DNCI2" ENSG00000077380 "Dynein cytoplasmic 1 intermediate chain 2" Q13409 2 171687409-171748420 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Motor protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033836, HPA040619, HPA053987" Supported Supported "Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol" 33000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Microtubules" "CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-2)" "unprognostic (8.15e-2)" "unprognostic (8.90e-2)" "unprognostic (1.37e-3)" "unprognostic (2.51e-3)" "unprognostic (6.30e-3)" "unprognostic (1.23e-1)" "unprognostic (1.89e-2)" "unprognostic (1.40e-2)" "unprognostic (4.19e-1)" "prognostic favourable (8.04e-4)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (1.35e-3)" "unprognostic (6.42e-2)" 33.4 32.9 39.6 22.5 53.2 10.8 35.5 30.1 50.0 36.1 33.0 50.0 20.1 28.8 43.1 29.3 37.5 26.5 32.0 34.3 45.2 38.3 43.5 21.8 27.3 18.5 59.3 37.9 40.6 23.3 35.8 29.9 40.2 58.7 33.7 35.8 15.1 28.3 34.7 41.3 27.9 27.7 43.7 92.7 25.8 26.5 28.6 49.2 27.9 31.2 23.5 24.3 36.7 31.8 23.5 35.3 51.7 30.8 18.9 19.9 11.5 19.9 12.8 39.9 14.6 36.9 35.6 22.6 35.0 27.3 29.5 32.2 22.3 19.9 18.3 30.8 41.6 20.2 31.3 33.6 38.7 6.9 14.1 16.0 16.5 25.1 18.5 18.2 17.2 27.6 32.0 36.4 23.5 51.6 25.2 5.0 58.2 12.5 15.5 14.8 18.3 13.1 15.7 35.9 13.2 39.2 32.1 25.0 28.1 19.4 15.6 20.7 15.2 17.8 55.9 45.0 22.3 17.9 20.9 6.3 12.0 14.8 30.6 14.8 32.9 51.7 30.8 14.7 16.9 30.1 18.0 23.1 19.5 19.6 21.4 23.5 17.6 16.7 1.8 18.9 29.4 35.3 19.9 11.5 39.6 53.2 30.1 45.7 45.2 38.3 59.3 37.9 58.7 49.2 DYNC1LI1 DNCLI1 ENSG00000144635 "Dynein cytoplasmic 1 light intermediate chain 1" Q9Y6G9 3 32525971-32570874 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035013 Approved Supported Centrosome,Cytosol "Centrosome, Cytosol" "HPA035013: AB_10600807" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.78e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (5.38e-2)" "prognostic unfavourable (9.19e-9)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (7.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (2.21e-2)" "unprognostic (2.14e-2)" "unprognostic (5.51e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-2)" 16.1 11.6 15.8 14.8 18.6 27.5 18.9 24.5 28.0 13.4 13.8 12.7 9.2 11.6 17.0 11.6 13.9 14.7 14.1 40.1 16.3 23.4 18.4 15.9 16.3 15.8 18.3 16.4 15.2 18.6 16.8 18.9 14.9 26.5 18.6 14.2 14.1 12.0 12.9 41.1 32.1 13.0 19.7 16.6 18.1 13.8 34.0 11.7 19.3 12.8 16.6 17.2 15.5 13.5 6.2 15.3 29.8 25.1 7.5 6.1 10.7 13.1 14.2 22.1 13.8 12.7 15.0 61.0 20.3 28.0 36.7 30.2 15.0 11.3 16.4 13.8 20.5 6.8 22.1 15.9 35.1 15.5 15.3 21.7 10.4 13.4 15.6 24.6 12.8 12.1 12.7 25.8 20.3 23.6 25.1 15.2 19.6 10.5 18.8 10.9 22.8 19.1 16.6 11.8 17.1 14.9 12.0 9.5 14.0 14.3 17.7 15.3 14.7 14.4 17.5 20.2 17.0 17.5 20.3 11.0 27.7 26.6 11.3 21.3 15.7 11.3 13.3 11.7 5.2 16.8 5.4 6.1 5.6 5.7 15.3 6.2 3.9 5.0 29.8 7.5 25.1 8.4 6.1 10.7 15.8 18.6 24.5 28.0 16.3 23.4 18.3 16.4 26.5 11.7 DYNC1LI2 DNCLI2 ENSG00000135720 "Dynein cytoplasmic 1 light intermediate chain 2" O43237 16 66720893-66751798 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057201 Approved Centrosome,Cytosol Centrosome Cytosol "HPA057201: " "unprognostic (6.03e-2)" "unprognostic (2.40e-2)" "unprognostic (8.28e-2)" "unprognostic (1.57e-2)" "unprognostic (5.35e-2)" "unprognostic (2.80e-1)" "unprognostic (7.58e-2)" "unprognostic (3.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (4.77e-2)" "unprognostic (1.92e-1)" "unprognostic (7.70e-3)" "unprognostic (1.34e-1)" 26.5 21.4 63.8 16.8 63.5 16.7 19.0 28.8 43.3 23.0 24.4 61.2 17.6 19.5 23.9 19.5 23.7 17.9 22.5 26.6 68.3 48.3 20.3 13.0 20.8 11.0 75.0 28.9 22.1 20.2 44.7 19.3 21.1 51.1 25.3 28.7 13.6 20.8 24.5 17.2 23.1 19.8 30.1 89.5 15.5 22.6 14.9 55.0 6.7 28.8 7.9 12.6 20.4 20.0 9.0 12.1 16.3 17.1 8.2 14.9 7.9 15.0 15.8 23.5 21.0 30.4 30.2 21.4 24.6 19.7 20.2 26.3 21.4 14.8 6.3 19.6 24.1 21.8 18.0 17.6 29.6 4.2 13.0 7.7 18.3 20.2 16.9 8.1 11.5 19.7 24.2 23.2 16.1 28.3 12.5 8.3 26.1 10.7 5.1 10.7 14.1 27.5 11.2 49.7 7.5 20.1 21.2 23.6 16.5 44.4 9.6 28.5 11.7 8.2 35.9 26.2 13.1 12.8 16.7 10.6 7.7 12.5 22.5 7.9 16.4 10.1 17.1 16.1 13.4 9.8 14.9 5.2 11.3 10.7 12.1 9.0 9.6 9.1 16.3 8.2 13.1 7.6 10.9 7.9 63.8 63.5 28.8 43.3 68.3 48.3 75.0 28.9 51.1 55.0 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: " "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavourable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavourable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.4 89.7 89.0 68.2 78.2 83.0 28.6 108.6 50.2 88.7 53.2 84.5 52.9 44.0 58.7 103.7 70.8 105.7 90.8 88.7 58.3 69.2 43.0 64.3 114.3 79.0 44.8 71.5 50.4 97.2 66.5 54.6 92.1 53.9 50.7 117.0 103.9 58.5 97.6 73.0 104.7 59.8 46.1 54.6 126.7 72.7 61.2 45.2 88.5 76.9 98.6 76.2 65.6 70.8 68.3 58.3 60.2 93.5 30.6 58.7 43.7 75.7 70.1 87.4 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083415-58095536 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: " "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favourable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favourable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 15.4 28.3 38.6 11.1 55.2 9.9 11.6 41.1 41.1 12.9 14.5 22.6 16.3 16.2 12.0 15.6 11.9 13.5 13.3 43.8 32.2 40.2 28.1 23.1 11.8 9.4 48.3 28.7 14.4 11.8 36.2 15.0 19.7 40.6 20.6 13.7 15.5 19.2 18.8 64.8 12.6 15.6 14.3 32.5 11.2 12.7 19.0 27.2 7.6 22.0 15.1 11.8 9.9 16.4 1.5 0.8 3.5 3.0 1.5 3.1 0.8 20.3 13.9 28.5 12.9 17.8 9.8 45.3 20.6 8.2 10.0 7.9 30.7 9.9 18.2 23.4 12.7 11.0 13.1 16.3 17.3 18.0 9.5 19.7 8.1 18.0 14.1 21.0 12.3 9.8 11.2 11.6 9.2 6.6 19.6 11.1 9.6 30.8 23.8 8.7 19.6 14.2 22.0 16.8 7.5 8.6 22.2 19.5 15.6 18.4 7.4 15.6 22.0 9.9 11.9 19.7 24.8 13.1 15.1 20.8 25.2 22.2 10.1 17.0 13.7 3.5 1.1 2.0 2.6 0.6 2.9 1.3 2.1 2.3 0.5 1.5 2.2 3.1 1.7 1.5 3.0 0.8 1.4 0.8 38.6 55.2 41.1 41.1 32.2 40.2 48.3 28.7 40.6 27.2 DYRK1A "DYRK, DYRK1, MNBH" ENSG00000157540 "Dual specificity tyrosine phosphorylation regulated kinase 1A" Q13627 21 37365573-37526358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015323, HPA015810" Approved Approved "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA015323: AB_1847922, HPA015810: AB_1847921" "unprognostic (2.71e-1)" "unprognostic (3.35e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-2)" "unprognostic (4.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (9.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (9.95e-2)" "unprognostic (7.39e-2)" "unprognostic (9.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (3.14e-1)" "unprognostic (1.40e-2)" 20.0 18.5 19.2 23.4 20.0 49.7 19.9 31.6 24.6 23.7 23.0 16.3 17.6 15.4 24.4 18.7 16.8 19.4 19.0 23.2 18.8 17.9 16.9 16.1 24.8 27.3 15.5 17.8 25.7 17.8 31.0 25.1 25.0 14.0 17.6 18.1 18.5 18.7 22.7 39.8 20.1 18.7 22.7 13.8 24.1 18.5 23.5 16.3 60.9 22.7 17.4 22.1 22.7 29.3 3.0 3.3 6.0 2.5 1.3 3.8 0.8 10.2 8.0 16.3 11.5 7.8 8.5 14.5 9.1 11.7 9.3 9.8 11.4 9.0 13.8 6.2 16.0 7.0 11.9 8.9 10.9 21.1 5.1 40.8 13.3 6.9 11.7 16.1 15.0 8.6 10.6 12.0 18.5 9.6 15.4 32.0 9.6 10.3 21.1 11.0 17.3 4.8 27.4 9.0 12.7 9.7 13.4 16.9 9.4 20.8 14.3 14.3 13.4 15.0 12.3 12.7 3.8 7.9 7.6 21.8 16.9 19.8 10.1 18.2 13.8 5.5 1.5 2.0 3.4 2.1 2.1 2.8 3.6 2.6 1.8 3.0 3.8 3.7 6.0 1.3 2.5 3.3 3.1 0.8 19.2 20.0 31.6 24.6 18.8 17.9 15.5 17.8 14.0 16.3 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: " "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 12.2 5.3 4.5 20.1 4.8 8.6 8.1 4.4 6.6 10.1 21.3 4.1 8.3 13.7 14.6 9.6 9.6 9.1 16.9 26.1 4.7 3.2 6.3 4.6 10.1 17.9 4.0 3.3 7.6 8.5 3.6 4.4 13.0 5.0 7.1 15.3 6.6 7.2 6.6 23.7 9.4 26.0 11.2 5.3 10.3 14.0 4.4 3.9 34.3 7.6 12.5 17.2 11.1 12.2 2.7 1.9 5.9 1.3 6.9 6.8 1.6 13.5 7.7 11.5 8.3 5.8 7.9 9.2 13.8 9.0 6.8 3.9 10.1 7.5 25.4 17.1 20.0 15.9 9.2 5.4 7.3 10.9 12.0 4.1 5.1 3.8 2.2 9.2 8.9 6.5 7.8 18.2 14.6 3.8 5.0 13.3 8.6 7.8 7.9 4.5 10.0 12.4 21.1 11.4 11.2 7.9 17.1 15.2 18.0 5.8 7.8 8.0 5.3 7.8 5.6 10.8 10.2 7.4 10.9 6.3 1.0 14.1 10.4 6.3 11.1 3.2 0.5 5.9 5.2 1.3 4.0 2.7 3.9 6.8 1.9 2.7 3.3 6.1 0.7 6.9 1.3 0.8 3.1 1.6 4.5 4.8 4.4 6.6 4.7 3.2 4.0 3.3 5.0 3.9 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA075041 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA075041: " "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.1 2.7 4.2 4.2 3.5 6.2 7.7 1.3 2.7 5.6 2.7 2.6 3.7 1.2 7.6 5.1 2.7 6.2 12.8 16.3 6.0 3.4 3.4 7.4 5.0 1.6 2.6 2.0 7.6 5.2 2.8 11.2 1.2 4.6 4.5 1.5 4.1 5.5 3.0 2.1 2.0 2.1 7.5 2.7 1.8 3.7 38.2 3.1 5.1 11.9 3.0 1.7 5.4 7.6 0.0 6.1 0.0 0.1 0.0 0.3 0.0 2.5 3.4 0.8 4.8 8.6 7.7 0.1 8.1 17.9 7.4 9.6 0.2 1.2 3.7 1.2 9.5 0.7 4.2 6.5 7.9 0.0 2.8 5.4 4.4 0.8 13.7 3.7 3.5 5.4 4.2 12.8 35.2 5.7 10.3 0.7 11.4 0.9 8.1 2.1 6.8 6.4 20.2 2.6 0.0 2.3 0.1 4.9 3.6 7.3 0.3 9.9 0.9 0.9 4.3 15.5 5.9 7.5 6.7 2.9 1.0 4.4 9.2 4.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.2 3.5 1.3 2.7 6.0 3.4 2.6 2.0 4.6 3.1 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.8 0.6 0.1 0.3 0.0 4.8 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 32.4 3.1 0.0 29.4 0.0 0.0 2.1 3.2 0.3 0.0 31.1 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 0.1 0.3 21.2 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 DZIP1 "DZIP, KIAA0996" ENSG00000134874 "DAZ interacting zinc finger protein 1" Q86YF9 13 95578202-95644703 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054891, HPA057272, HPA070194" Uncertain Supported "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Cytosol" "Centriolar satellite" "HPA054891: , HPA057272: , HPA070194: " "unprognostic (6.74e-3)" "unprognostic (7.65e-2)" "unprognostic (1.94e-1)" "unprognostic (4.64e-3)" "unprognostic (4.82e-2)" "unprognostic (5.52e-3)" "unprognostic (6.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.34e-2)" "unprognostic (8.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.41e-3)" "unprognostic (1.48e-1)" "unprognostic (3.64e-2)" "unprognostic (3.89e-3)" 5.0 6.3 17.2 4.4 17.4 0.4 3.7 13.9 16.1 11.5 6.7 4.1 3.8 2.2 16.2 10.7 6.2 10.7 8.5 3.8 13.1 18.1 16.2 1.7 4.0 3.6 8.7 13.5 24.2 9.6 0.9 8.9 4.6 8.8 7.7 3.7 5.8 3.2 13.3 1.7 1.1 2.6 12.3 5.6 2.8 3.6 27.3 4.5 0.6 1.7 1.8 3.5 5.0 5.2 0.4 0.2 1.2 0.2 0.3 0.3 0.0 1.4 5.2 17.5 17.8 13.6 16.9 3.5 12.6 14.6 14.1 17.0 0.1 0.0 0.0 2.9 10.1 0.0 11.6 4.6 16.0 0.9 10.3 16.1 4.0 10.9 9.4 0.0 0.1 11.9 0.4 4.3 5.8 9.5 0.0 0.0 10.3 0.0 0.0 0.0 7.9 0.4 0.0 12.0 0.0 13.6 1.8 4.3 11.4 9.6 0.0 0.5 0.0 6.0 0.7 14.1 6.8 1.9 10.3 0.0 0.0 0.0 3.7 0.0 2.5 1.2 0.2 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.4 0.1 0.3 1.1 0.3 0.1 0.2 0.1 0.0 17.2 17.4 13.9 16.1 13.1 18.1 8.7 13.5 8.8 4.5 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5" "Group enriched" "Detected in many" 17 "dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 5.3 2.0 2.2 6.1 2.5 10.9 5.5 12.1 3.3 17.4 5.1 5.3 3.1 2.9 14.8 6.5 4.3 15.2 7.9 3.8 2.4 2.1 5.1 1.2 6.4 2.0 2.6 1.6 12.4 8.3 6.2 5.6 2.7 6.1 9.3 2.1 10.9 2.5 5.0 1.7 10.4 2.3 11.3 3.4 3.1 10.0 4.2 3.4 0.1 4.2 4.2 2.5 8.0 17.8 0.0 1.5 1.7 1.8 0.0 0.0 0.4 5.2 3.0 6.2 5.1 3.9 5.3 1.4 8.5 5.1 5.1 6.4 2.0 0.4 0.0 4.4 7.8 1.7 4.5 2.0 2.4 1.1 4.4 2.3 6.3 0.3 3.2 1.7 4.0 5.6 2.1 5.5 2.7 2.8 1.7 0.0 6.9 0.3 0.0 0.7 7.4 1.0 0.0 7.1 0.0 2.3 8.3 2.2 4.9 8.7 0.0 4.4 2.3 3.6 2.1 12.6 5.7 6.0 4.4 0.0 0.0 0.1 5.0 2.5 4.8 0.0 1.8 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.2 2.5 12.1 3.3 2.4 2.1 2.6 1.6 6.1 3.4 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675683-33686404 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 21.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Enhanced Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: " "unprognostic (7.46e-2)" "prognostic favourable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavourable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavourable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavourable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavourable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favourable (1.62e-4)" "unprognostic (1.91e-1)" 2.4 5.3 6.8 12.7 9.7 32.5 2.1 1.1 6.4 1.2 4.4 5.1 0.7 3.9 1.4 0.8 5.1 1.5 4.1 2.0 7.1 3.6 0.9 1.7 8.1 9.3 6.2 2.9 3.4 1.2 2.3 0.3 3.3 5.9 1.7 4.8 0.3 1.6 1.4 1.4 5.4 4.9 3.3 6.2 4.8 3.4 12.1 6.0 21.9 1.0 4.9 7.7 1.9 3.1 2.2 0.6 0.7 3.7 1.4 1.2 0.6 15.9 15.5 18.0 14.0 1.8 1.3 13.7 15.3 7.4 19.6 16.5 27.4 16.5 29.4 15.5 6.8 12.0 8.7 8.1 8.8 8.8 12.5 24.0 23.1 15.9 0.1 11.2 15.2 1.0 0.5 10.7 1.9 5.0 6.3 20.8 12.1 14.1 23.8 23.8 5.4 22.3 23.8 49.1 12.1 3.3 9.8 26.9 18.9 18.6 13.0 7.6 16.3 14.2 2.7 22.9 13.4 15.8 21.7 20.3 13.7 24.2 19.0 6.7 13.5 0.0 0.0 0.7 0.1 0.9 0.0 2.2 0.6 0.4 0.2 0.2 0.2 1.2 0.3 1.4 3.7 0.6 0.8 0.6 6.8 9.7 1.1 6.4 7.1 3.6 6.2 2.9 5.9 6.0 E2F3 ENSG00000112242 "E2F transcription factor 3" O00716 6 20401906-20493715 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029779, HPA065012" Supported "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA029779: , HPA065012: " "unprognostic (4.10e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.80e-3)" "unprognostic (2.96e-1)" "unprognostic (9.14e-2)" "unprognostic (8.99e-3)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "prognostic favourable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (5.64e-2)" "prognostic unfavourable (1.63e-8)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (3.50e-1)" "unprognostic (5.99e-3)" 9.5 8.4 7.6 12.2 13.4 22.1 10.8 1.7 10.1 4.8 7.1 2.9 3.2 6.8 6.3 6.9 8.0 4.9 9.9 11.1 8.3 6.8 14.6 6.1 7.8 19.7 5.8 7.3 4.0 3.6 2.9 3.2 7.4 7.9 5.0 8.6 5.1 4.7 4.5 15.1 4.3 8.0 7.9 5.0 16.9 5.0 8.9 3.1 17.7 11.4 10.2 12.0 9.2 4.8 0.7 3.7 10.3 3.1 4.8 3.6 1.5 6.7 5.5 15.9 17.0 5.3 5.9 11.0 9.1 7.9 8.8 9.7 6.8 4.2 15.1 17.7 8.5 7.1 18.1 8.2 14.8 5.9 12.8 27.5 9.1 7.5 5.7 18.0 16.5 4.7 6.1 8.6 10.5 6.0 30.4 9.4 9.9 6.9 20.4 20.1 11.9 5.7 22.2 14.0 17.4 10.5 11.8 11.5 21.0 8.5 11.7 12.0 6.0 10.9 8.0 14.2 8.9 7.0 14.5 5.9 18.7 19.0 3.5 11.2 20.1 6.9 3.1 1.4 2.3 2.3 3.1 0.7 1.5 3.6 3.7 0.7 1.3 2.8 10.3 4.8 1.5 1.6 2.2 1.5 7.6 13.4 1.7 10.1 8.3 6.8 5.8 7.3 7.9 3.1 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.0;Daudi: 53.1;U-698: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Enhanced Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA055723: , HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.8 5.2 27.0 10.0 0.5 0.7 8.7 0.9 2.1 0.8 2.3 3.1 5.7 53.1 3.8 1.1 1.0 15.7 1.3 1.0 5.5 7.2 5.3 2.9 7.3 4.3 1.6 0.0 1.0 2.1 1.0 3.8 0.8 11.2 0.4 1.4 3.1 5.4 3.5 8.7 4.6 4.3 1.1 5.7 8.7 3.4 3.3 10.4 0.6 1.8 8.0 11.3 1.7 0.0 1.3 1.0 1.5 3.5 10.0 6.7 25.4 1.5 1.3 2.6 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA064882: , HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.3 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 12.6 10.8 1.0 8.5 9.5 8.7 4.9 2.4 4.0 0.0 7.5 11.9 0.2 0.0 1.9 0.6 13.1 10.3 13.7 3.7 6.9 14.6 9.3 4.1 6.0 15.9 8.3 9.6 4.0 9.7 3.8 4.3 3.5 7.0 0.8 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Cell line enhanced" "Detected in all" "BEWO: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge" "Nucleoplasm, Nuclear bodies, Vesicles" "Cytokinetic bridge" "HPA059516: , HPA060569: , HPA069538: " "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 3.9 6.4 6.8 7.0 4.0 3.4 55.0 5.8 4.1 6.7 6.5 8.8 4.4 11.0 3.7 4.2 3.3 8.9 5.1 7.7 9.0 6.4 9.5 5.8 8.0 9.0 8.9 7.7 4.5 9.1 9.6 6.5 6.6 10.1 8.2 5.5 8.1 8.8 5.0 12.2 6.7 8.1 5.6 6.1 5.8 6.9 7.0 12.3 7.1 6.6 6.7 9.9 7.1 6.4 7.0 5.2 6.2 8.3 10.8 21.6 11.6 6.8 10.7 8.3 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515929-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favourable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favourable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favourable (2.96e-4)" "unprognostic (3.24e-2)" 30.1 32.8 24.4 23.1 23.5 53.4 36.5 32.4 30.1 30.0 35.0 20.6 25.3 24.7 27.9 33.0 26.3 28.5 19.9 19.9 22.8 26.4 30.1 34.4 20.5 23.2 21.8 25.3 37.3 22.5 31.1 28.1 33.8 27.8 29.4 36.8 21.6 27.3 27.8 41.3 39.1 43.2 23.8 20.9 26.5 23.5 21.6 24.2 34.8 34.1 22.6 24.8 27.7 31.2 36.8 19.3 50.2 26.2 33.6 42.3 24.8 15.0 18.5 17.3 10.2 20.5 21.1 27.0 13.9 21.4 17.4 18.3 8.7 20.1 15.8 19.7 16.9 14.2 12.7 18.5 20.6 19.7 11.3 11.6 14.5 36.9 28.1 20.5 12.8 24.1 23.9 10.0 25.8 17.3 11.4 17.6 16.2 35.3 28.3 16.6 10.1 20.7 18.0 20.8 15.8 21.0 20.5 14.0 15.4 19.7 19.1 29.7 33.2 13.1 18.7 9.1 7.7 11.8 8.9 22.2 24.9 16.8 8.5 11.4 11.4 40.7 22.0 45.2 24.8 20.1 29.7 36.8 31.1 28.0 19.3 33.7 31.8 28.8 50.2 33.6 26.2 16.9 42.3 24.8 24.4 23.5 32.4 30.1 22.8 26.4 21.8 25.3 27.8 24.2 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favourable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.1 16.4 7.7 12.4 5.4 7.8 9.4 9.0 6.9 11.2 9.4 11.9 8.2 11.3 9.3 8.3 9.1 29.1 16.6 10.7 4.5 14.1 6.5 10.1 20.2 8.7 7.2 8.2 8.3 9.9 10.0 14.2 5.0 20.3 6.0 7.9 17.1 7.2 5.2 20.4 5.7 12.9 8.9 21.7 14.1 7.0 13.8 10.1 7.1 13.4 7.2 18.1 8.2 4.0 8.8 7.8 9.7 11.4 11.0 10.4 9.1 9.0 10.1 13.0 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 EBF1 "EBF, OLF1" ENSG00000164330 "Early B cell factor 1" Q9UH73 5 158695916-159099761 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;HSkMC: 14.8;REH: 39.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 23.6" "Group enriched" "Detected in some" 62 "memory B-cell: 11.8;naive B-cell: 10.4" "Lineage enriched" "Detected in single" 66 "B-cells: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (9.62e-7)" "prognostic unfavourable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 33.7 3.3 1.9 9.7 2.5 3.1 25.0 23.6 2.0 15.9 5.8 1.1 9.0 1.2 19.7 13.0 5.0 8.5 9.4 15.5 2.0 2.4 3.3 0.9 5.2 12.7 3.2 1.2 7.4 3.7 1.8 2.6 10.7 4.7 8.5 3.4 10.4 4.7 10.8 15.5 4.8 4.5 25.7 6.6 5.4 3.4 8.4 1.0 0.1 6.8 13.2 9.1 11.7 12.5 11.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 6.1 0.0 19.0 8.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 5.4 0.0 2.2 0.0 0.2 0.0 0.1 1.2 0.0 0.0 1.6 0.0 0.3 0.0 0.0 14.8 0.0 5.8 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 39.7 0.2 0.0 0.0 0.0 3.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.8 8.3 0.1 0.0 0.0 5.5 4.8 0.4 6.6 0.1 0.0 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 2.5 23.6 1.6 2.0 2.4 3.2 1.2 4.7 1.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "Early B cell factor 3" Q9H4W6 10 129835283-129963841 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.8;lymphoid tissue: 29.9" "Cell line enhanced" "Detected in some" "ASC diff: 9.9;HAP1: 11.6;LHCN-M2: 18.5;NB-4: 23.3;RH-30: 10.1;SCLC-21H: 23.9;THP-1: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.0 0.9 0.3 3.4 0.4 0.1 25.8 0.7 0.5 7.3 3.6 0.2 2.5 0.2 5.4 4.9 4.3 3.8 4.3 10.5 0.3 2.5 0.6 0.4 1.0 29.9 5.0 0.3 1.0 1.2 3.6 0.9 3.8 4.8 4.6 0.8 2.0 3.6 2.2 10.9 2.8 1.0 6.3 9.3 0.2 1.6 4.6 0.1 0.5 6.7 6.3 2.4 4.7 16.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 9.9 7.6 0.1 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 11.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 2.3 0.0 0.0 0.0 0.0 18.5 0.1 0.0 23.3 0.1 0.0 0.3 10.1 0.0 0.0 0.1 23.9 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 1.2 6.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 2.5 5.0 0.3 4.8 0.1 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA062510: , HPA068795: " "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.0 2.1 0.0 15.3 2.6 0.5 0.3 2.4 1.5 1.0 2.6 2.5 1.8 3.1 1.1 2.1 0.1 0.0 0.8 1.8 3.1 1.7 0.1 5.1 2.6 1.2 1.2 1.9 1.6 2.4 3.1 0.5 1.3 2.2 2.1 1.4 1.0 2.1 1.8 0.9 2.4 1.5 2.4 2.9 2.6 2.2 6.3 1.5 1.1 3.8 0.2 1.3 0.9 5.2 4.6 1.4 2.9 3.9 2.1 0.4 1.3 1.0 2.6 4.3 3.2 0.8 2.7 1.8 2.0 2.2 2.6 1.3 1.2 2.2 5.0 2.2 0.8 4.1 4.8 2.9 1.6 2.6 2.6 1.8 1.6 5.0 1.4 2.8 2.0 5.8 3.3 1.4 5.2 1.3 2.0 1.4 5.4 1.2 2.5 1.3 2.3 0.7 3.5 1.6 3.4 1.5 2.9 4.0 3.1 5.0 2.4 2.6 1.5 4.6 2.5 0.3 1.5 6.3 3.6 0.5 3.0 1.5 3.2 3.1 0.5 2.6 2.7 3.8 3.3 1.1 0.6 2.2 3.7 0.2 ECD "GCR2, hSGT1" ENSG00000122882 "Ecdysoneless cell cycle regulator" O95905 10 73130155-73169055 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006465 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA006465: " "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (2.19e-1)" "unprognostic (2.75e-2)" "unprognostic (4.71e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (1.22e-1)" "unprognostic (3.55e-2)" "unprognostic (6.61e-2)" "unprognostic (3.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (7.05e-2)" "unprognostic (3.84e-2)" 23.2 22.3 22.2 22.4 23.8 34.8 23.2 34.7 27.0 20.4 18.6 21.8 20.0 15.6 23.7 20.9 21.2 17.0 20.6 18.8 17.9 16.9 22.4 23.6 17.7 21.4 23.4 16.7 24.1 21.1 32.5 32.1 23.4 25.5 21.8 18.1 16.7 21.4 21.3 19.9 23.3 16.8 19.9 19.4 20.5 18.5 25.4 23.1 32.7 24.2 18.7 22.4 22.1 20.7 20.4 16.8 23.3 26.3 25.4 27.2 15.7 18.5 13.4 15.2 23.1 14.0 13.9 12.5 14.5 22.8 23.7 27.8 24.3 19.5 14.6 14.3 14.1 15.6 16.2 17.2 24.4 11.8 15.8 18.4 11.0 17.3 21.2 21.9 12.3 15.5 14.4 19.9 25.0 25.2 19.0 10.2 22.3 15.7 19.6 12.2 15.6 38.8 14.6 16.9 7.9 19.0 13.8 6.7 12.6 13.1 29.9 18.6 17.1 10.6 15.5 10.3 20.9 11.1 16.6 11.9 8.1 24.9 19.3 18.4 8.8 15.0 19.3 20.9 21.8 20.5 23.2 20.4 20.6 21.4 16.8 18.6 27.2 19.4 23.3 25.4 26.3 11.5 19.7 15.7 22.2 23.8 34.7 27.0 17.9 16.9 23.4 16.7 25.5 23.1 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 6 "AN3-CA: 29.4;HeLa: 15.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favourable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.4 20.5 30.5 2.0 25.3 26.0 27.7 24.8 7.3 2.7 0.7 31.9 27.5 9.4 18.5 14.7 40.3 6.7 21.2 9.4 13.8 39.3 11.9 8.5 4.7 21.0 9.1 23.5 13.2 57.6 30.8 6.9 26.2 7.1 24.0 21.2 11.0 34.9 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.4 24.5 4.0 58.1 20.9 11.5 18.4 15.0 10.6 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA027241 Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976" "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavourable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.1 0.6 2.3 0.0 13.8 76.4 2.1 22.4 53.2 14.0 18.3 0.3 3.4 0.1 0.2 50.1 12.9 0.0 2.6 14.7 0.1 0.1 0.9 0.7 0.1 3.8 0.0 23.2 6.7 0.1 36.0 1.3 3.9 4.8 0.1 39.0 0.0 0.0 0.7 0.2 0.7 0.3 16.8 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.1 0.0 5.9 1.0 29.7 4.4 3.3 4.8 0.1 0.1 0.2 15.6 2.0 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 121 "EFO-21: 48.5;HUVEC TERT2: 122.6;TIME: 90.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: " "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.6 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 90.6 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 ECSIT SITPEC ENSG00000130159 "ECSIT signalling integrator" Q9BQ95 19 11505916-11529174 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042979 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042979: AB_10964063" "unprognostic (9.88e-2)" "unprognostic (3.57e-3)" "unprognostic (2.93e-1)" "unprognostic (3.55e-3)" "unprognostic (2.27e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "unprognostic (1.24e-1)" "unprognostic (2.92e-1)" "unprognostic (2.18e-1)" "unprognostic (1.01e-2)" "unprognostic (4.08e-2)" "prognostic favourable (1.48e-9)" "unprognostic (2.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (5.95e-2)" 15.3 16.8 13.8 10.7 15.5 12.9 12.8 20.0 24.5 13.5 21.0 9.5 11.1 24.2 13.1 6.8 19.7 16.2 13.8 49.5 12.9 11.6 15.6 27.7 8.4 9.9 13.5 10.8 27.2 28.5 14.7 10.5 6.4 12.5 16.3 12.0 13.2 26.8 11.0 64.2 11.8 17.9 12.9 9.1 10.1 18.4 8.2 11.9 13.8 21.4 29.5 12.7 14.1 14.2 21.4 22.3 6.2 20.9 13.1 18.6 15.2 14.9 13.6 8.2 12.0 12.7 14.6 9.2 8.0 10.9 17.5 14.2 20.2 10.5 22.4 17.2 10.4 20.3 20.8 17.1 6.2 12.8 17.0 20.9 8.8 18.3 12.4 11.9 17.5 15.2 18.7 14.3 15.9 12.9 22.6 23.4 6.5 20.7 20.8 17.8 22.3 36.5 20.9 8.8 29.9 9.5 9.7 31.6 19.9 9.6 16.1 16.1 18.3 18.2 6.6 18.3 12.7 25.9 14.9 20.9 40.3 11.2 15.3 17.9 13.0 2.1 17.2 6.2 15.2 20.9 17.3 21.4 16.5 14.1 22.3 20.3 18.6 16.9 3.5 13.1 18.6 12.6 18.1 15.2 13.8 15.5 20.0 24.5 12.9 11.6 13.5 10.8 12.5 11.9 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036363: , HPA053261: " "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavourable (6.82e-6)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavourable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.0 32.9 25.9 13.4 2.7 5.6 13.0 20.4 16.8 30.7 29.8 18.2 48.9 11.4 31.1 11.9 20.3 20.9 13.1 42.0 16.3 11.5 7.1 18.0 9.3 1.1 11.0 8.3 1.8 2.2 18.2 18.7 13.2 7.4 16.8 24.2 16.3 11.2 8.3 21.2 17.9 8.1 25.5 14.7 23.3 10.8 17.4 11.1 25.8 29.4 10.4 48.9 8.2 11.4 14.9 14.3 20.0 42.4 8.3 11.1 21.6 13.2 9.7 19.4 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Group enriched" "Detected in many" 6 "monocytes: 3.0;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Intracellular and membrane" Vesicles "Lipid droplets" "HPA037972: , HPA037973: " "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favourable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 6.8 11.7 2.2 3.1 3.0 0.3 3.9 0.9 2.4 10.3 3.4 3.9 7.4 0.9 6.3 5.7 5.0 4.4 7.0 13.3 2.6 2.1 6.9 3.1 4.3 5.8 4.3 2.0 7.9 6.3 18.4 1.9 2.7 2.9 8.3 1.7 5.0 5.4 10.4 3.3 5.4 1.6 5.4 4.6 2.0 4.7 2.7 2.3 0.8 8.9 5.0 1.2 4.4 8.1 0.0 0.0 0.0 3.0 0.6 4.0 0.3 0.0 0.6 0.3 2.9 0.6 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.3 5.6 0.2 0.4 4.0 1.5 0.0 0.0 4.6 0.0 0.1 18.2 1.1 0.0 1.2 2.4 1.4 0.0 1.0 0.5 0.0 5.1 0.0 1.2 0.0 0.0 3.0 0.4 0.0 1.3 6.1 0.1 0.0 1.6 0.0 0.1 0.4 0.1 0.3 0.1 0.5 1.9 2.4 2.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 3.0 4.0 0.0 1.8 0.9 0.0 0.0 1.1 0.2 0.0 0.6 2.0 0.0 0.0 0.3 2.2 3.0 0.9 2.4 2.6 2.1 4.3 2.0 2.9 2.3 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.6" "Group enriched" "Detected in some" 4 "HMC-1: 36.7;RT4: 29.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 24.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 24.6" "Group enriched" "Detected in some" 5 "olfactory region: 0.7;thalamus: 0.8" "Low region specificity" "Detected in many" HPA018836 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.9 0.4 0.5 2.4 0.5 0.2 5.8 0.3 0.4 1.1 1.1 0.1 13.7 0.2 0.9 13.0 7.2 1.0 1.3 2.2 0.4 0.4 2.5 0.6 1.7 1.2 0.5 0.0 0.7 5.5 0.0 0.4 6.4 0.1 11.3 0.2 1.7 3.6 16.6 0.3 5.7 0.7 3.6 0.4 2.9 6.4 4.0 0.2 4.5 6.4 5.3 6.8 15.6 9.9 0.1 0.3 24.6 0.2 2.9 4.0 1.1 0.0 1.7 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.7 0.4 0.4 0.0 0.0 0.0 0.1 4.1 3.0 4.4 0.7 5.9 3.5 0.0 0.0 0.6 0.0 0.1 36.7 0.0 1.3 0.5 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.8 0.0 1.5 0.0 0.0 0.0 29.7 0.2 0.1 0.0 0.6 0.1 7.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.6 0.2 0.0 2.1 0.2 2.7 0.1 3.2 4.0 0.3 0.1 0.3 2.1 0.2 2.9 0.1 0.0 2.9 1.1 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.0 0.1 0.2 EDC4 "Ge-1, HEDLS, RCD-8" ENSG00000038358 "Enhancer of mRNA decapping 4" Q6P2E9 16 67873023-67884503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041164, HPA043038" Supported Enhanced "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "HPA041164: , HPA043038: " "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (7.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.87e-1)" "unprognostic (7.93e-2)" "unprognostic (3.75e-3)" "unprognostic (1.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.48e-1)" "unprognostic (3.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.17e-1)" 11.3 12.6 14.4 13.2 20.2 25.2 12.1 33.3 27.0 11.9 18.5 17.5 11.2 16.5 15.5 13.0 14.3 15.4 15.2 11.9 12.8 11.9 12.8 10.8 12.9 18.0 14.4 15.2 19.7 18.6 23.6 18.4 13.1 15.6 13.2 14.3 15.0 13.4 13.4 22.0 19.1 15.0 13.5 10.7 15.4 15.8 18.1 15.1 25.6 12.9 6.8 19.2 15.9 11.4 6.2 6.6 4.4 11.0 9.1 12.2 6.4 9.3 13.1 9.1 8.2 8.6 6.3 17.9 8.7 7.2 17.5 14.1 21.4 8.9 15.4 9.5 11.8 13.1 18.0 6.8 9.2 5.9 22.8 11.0 8.3 11.3 10.1 13.0 12.3 8.5 9.4 17.7 8.5 13.2 19.1 2.8 10.4 14.2 17.1 33.9 9.0 7.6 26.2 11.0 16.5 6.8 6.9 15.7 8.5 22.9 6.4 6.3 11.8 18.1 8.7 7.1 10.4 6.6 11.5 14.8 8.5 37.7 5.5 16.0 6.6 0.7 5.9 4.4 10.2 7.0 9.5 6.2 9.0 9.8 6.6 5.4 9.0 6.4 2.9 9.1 11.0 4.8 12.2 6.4 14.4 20.2 33.3 27.0 12.8 11.9 14.4 15.2 15.6 15.1 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9;U-698: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 3.8 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 10.7 2.2 35.3 6.6 2.8 20.5 3.9 1.5 3.6 29.9 5.4 23.5 6.2 10.0 0.4 4.0 5.6 8.1 11.5 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 EDF1 "CFAP280, EDF-1" ENSG00000107223 "Endothelial differentiation related factor 1" O60869 9 136862119-136866286 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035642 Approved Supported Nucleoplasm,Cytosol 140000 "Nucleoplasm, Cytosol" "HPA035642: AB_10611959" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-3)" "unprognostic (4.49e-2)" "unprognostic (2.32e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (4.03e-2)" "unprognostic (2.65e-2)" "unprognostic (9.76e-2)" "unprognostic (1.83e-1)" "unprognostic (2.08e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" 49.5 68.5 77.7 58.3 67.3 55.6 71.0 68.2 75.2 51.6 68.7 35.1 75.3 106.6 55.0 60.9 68.4 57.3 66.7 83.2 66.5 61.8 65.4 107.5 47.2 75.3 64.9 64.2 72.1 273.4 44.5 64.4 47.7 62.3 64.1 46.5 38.2 123.3 96.5 175.4 69.4 102.3 64.3 71.9 48.8 61.9 49.5 44.8 43.6 64.5 75.1 51.5 51.9 57.7 78.2 116.5 58.0 70.5 68.6 83.6 85.4 63.5 85.6 47.7 48.4 47.6 50.2 93.9 73.5 49.8 59.6 46.6 69.2 44.6 55.9 68.5 63.9 77.0 37.1 56.3 22.0 60.4 45.2 38.9 107.7 94.0 94.7 66.3 53.3 49.6 72.5 46.7 54.4 57.3 56.3 72.6 51.0 139.4 59.0 105.5 50.3 73.5 52.0 69.7 113.0 79.1 68.0 61.2 58.8 76.7 108.1 74.4 104.4 93.2 69.4 65.2 49.3 70.5 68.3 41.9 69.9 47.1 85.2 39.9 59.6 45.7 70.5 58.0 69.9 59.9 77.2 78.2 74.8 72.1 70.8 71.9 66.9 68.8 28.2 68.6 48.9 116.5 83.6 85.4 77.7 67.3 68.2 75.2 66.5 61.8 64.9 64.2 62.3 44.8 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 107.5;HUVEC TERT2: 71.2;T-47d: 22.0;TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" 1085 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.5 9.0 0.1 0.0 0.0 0.0 0.0 2.8 2.5 2.4 2.0 11.6 1.3 0.0 107.5 1.1 0.8 0.0 1.6 1.7 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 71.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 5.6 1.4 0.1 0.0 0.2 8.5 0.0 22.0 0.1 52.7 6.0 4.8 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;ASC TERT1: 14.2;HHSteC: 7.3;LHCN-M2: 16.8;SH-SY5Y: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavourable (1.50e-7)" "prognostic unfavourable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.1 0.0 7.2 14.2 0.0 2.1 2.8 0.3 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 1.5 0.0 2.4 0.0 7.3 0.0 0.0 5.5 0.4 0.4 0.0 0.0 0.0 1.1 16.8 0.2 0.0 0.1 1.2 0.8 0.0 0.7 0.1 1.1 0.8 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.6 0.0 0.0 1.1 0.3 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell line enhanced" "Detected in some" "AF22: 24.6;ASC diff: 18.7;SK-MEL-30: 22.6;U-266/70: 14.8;WM-115: 47.1" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB017842: , HPA027546: " "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favourable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 1.9 0.0 24.6 0.0 18.7 0.7 0.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 22.6 0.0 0.1 0.1 0.2 0.0 0.0 0.1 14.8 8.3 0.0 0.4 0.0 47.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavourable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 8.9 8.7 10.9 11.9 5.1 8.5 5.7 11.2 11.0 13.0 14.8 11.0 7.6 12.0 5.6 7.1 11.3 17.2 2.7 14.8 7.9 13.7 8.4 7.4 6.4 8.6 12.6 8.7 5.2 4.3 12.4 5.6 6.1 7.9 9.2 7.3 3.6 12.5 8.7 16.1 7.9 10.0 10.5 7.8 4.5 4.1 5.9 11.6 8.3 4.2 7.6 7.7 4.8 3.9 6.9 7.1 9.0 12.7 12.0 8.0 18.9 7.4 6.2 3.8 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773958 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA040417: , HPA042543: " "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favourable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 12.1 14.1 15.2 8.9 13.8 3.9 13.4 20.9 14.1 12.2 9.4 9.5 8.6 5.9 14.8 19.9 8.0 15.2 8.4 12.4 12.2 14.7 11.5 17.3 7.8 8.1 14.3 14.7 14.5 10.3 9.1 19.1 8.5 11.7 14.1 8.1 10.6 12.8 12.7 15.5 7.2 5.9 12.5 16.2 8.1 8.1 8.2 14.0 11.3 12.9 8.2 8.6 8.9 8.6 10.7 8.8 0.7 4.4 13.1 11.2 5.7 5.7 4.5 3.7 6.1 15.7 16.3 9.2 7.6 5.8 6.7 3.5 6.2 6.5 9.4 5.7 8.3 4.7 5.0 6.5 7.0 6.0 4.4 12.0 2.1 11.8 8.7 23.7 2.4 11.1 5.8 5.0 11.2 12.0 6.9 1.3 19.0 15.9 7.9 21.1 6.4 3.3 9.9 4.0 1.8 9.5 6.7 8.6 5.1 6.5 3.3 8.5 3.4 21.9 7.0 4.6 0.0 10.3 3.3 1.8 3.3 10.1 4.0 16.4 3.3 0.0 4.4 0.7 7.7 3.3 8.1 10.7 9.0 7.6 7.2 4.9 11.2 9.8 0.6 13.1 3.4 8.8 9.5 5.7 15.2 13.8 20.9 14.1 12.2 14.7 14.3 14.7 11.7 14.0 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791870 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050138 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA050138: " "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (9.09e-2)" 11.5 11.8 17.6 13.2 19.0 13.0 17.3 25.2 18.0 11.1 12.0 12.5 17.3 6.2 11.8 18.3 10.1 11.7 10.7 14.0 13.8 12.6 16.5 17.8 9.0 9.8 12.3 14.2 16.4 11.3 15.7 15.4 10.2 12.1 12.5 13.3 9.6 15.0 12.2 28.4 10.5 11.2 13.0 14.8 9.6 12.5 28.6 13.3 8.3 17.7 12.1 12.0 9.3 12.5 9.8 6.7 6.0 5.2 10.4 10.8 5.7 18.6 4.9 7.8 10.4 4.9 12.1 6.0 8.7 15.0 12.2 11.4 5.5 13.5 11.3 5.0 7.7 6.2 7.1 5.7 18.0 11.7 3.8 7.3 5.8 5.8 10.4 11.4 5.4 6.7 7.3 6.1 14.2 8.2 11.3 14.2 14.7 6.8 7.1 11.4 7.9 7.7 3.2 7.6 4.3 5.8 3.7 2.1 7.7 4.7 6.1 14.4 8.0 12.4 8.3 5.1 6.4 5.7 14.0 6.7 5.9 11.7 7.0 5.3 6.3 6.0 5.0 3.5 8.1 5.0 10.5 9.8 8.8 8.5 6.2 6.6 10.8 8.5 1.5 10.4 5.2 6.7 9.9 5.7 17.6 19.0 25.2 18.0 13.8 12.6 12.3 14.2 12.1 13.3 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell line enriched" "Detected in many" 7 "RH-30: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA043020: , HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.4 1.8 2.1 5.2 4.9 1.5 2.1 4.3 3.6 3.6 2.0 3.2 1.1 2.4 2.9 1.9 1.3 1.3 3.6 1.1 2.0 5.5 1.9 3.5 4.6 1.3 2.4 5.2 3.4 3.7 3.9 3.8 3.3 8.7 2.1 1.4 1.6 3.9 1.3 3.2 3.2 58.0 3.7 2.4 2.2 1.7 2.3 3.8 2.8 2.3 4.6 3.6 3.6 5.4 3.0 2.2 2.2 1.9 0.8 1.4 4.1 5.8 3.6 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" O60344 3 184249650-184259585 "Predicted intracellular proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.5" "Low cell line specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062215 Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA062215: " 2.1 1.7 0.2 3.3 0.8 1.8 1.9 0.3 0.5 1.3 4.2 0.0 2.5 2.5 0.6 0.5 4.1 0.4 1.4 2.4 0.4 4.2 29.5 2.3 2.5 0.2 0.0 1.7 8.3 1.0 3.1 8.4 0.8 1.6 2.3 0.8 5.7 2.7 5.4 2.4 4.3 1.1 0.1 3.7 1.6 13.0 0.6 4.8 6.9 4.5 3.7 1.3 1.6 4.9 10.1 1.2 12.0 3.4 7.6 5.6 13.1 6.9 1.6 4.4 2.4 1.6 10.1 1.5 2.9 2.3 2.2 12.9 2.0 15.6 10.3 1.7 4.9 7.4 7.5 1.3 6.1 8.7 4.1 4.4 8.2 2.9 10.8 3.5 2.0 9.1 2.6 4.5 1.9 7.4 14.5 1.1 20.6 4.4 13.1 3.3 13.0 9.2 2.2 12.6 2.7 3.2 8.0 2.7 3.0 23.6 5.8 19.9 5.0 1.4 2.6 3.5 6.1 7.6 8.7 17.5 15.4 2.1 17.8 2.7 0.0 12.0 1.2 4.3 9.7 4.8 4.9 4.6 4.2 10.1 3.2 3.3 5.2 0.2 3.4 6.2 9.0 7.6 5.6 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Cell line enriched" "Detected in single" 10 "REH: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043346, HPA062215" Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043346: AB_10794181, HPA062215: " 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1B2 ENSG00000114942 "Eukaryotic translation elongation factor 1 beta 2" P24534 2 206159585-206162928 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012477, HPA035029" Supported Approved "Nucleoli fibrillar center,Cytosol" 640000 "Nucleoli fibrillar center, Cytosol" "CAB012477: AB_732078, HPA035029: " "prognostic favourable (2.60e-4)" "unprognostic (3.12e-1)" "unprognostic (4.22e-2)" "unprognostic (6.44e-2)" "unprognostic (4.74e-2)" "unprognostic (2.70e-1)" "unprognostic (1.49e-3)" "unprognostic (1.33e-1)" "prognostic unfavourable (9.95e-4)" "unprognostic (2.70e-1)" "unprognostic (5.37e-3)" "unprognostic (1.29e-1)" "prognostic unfavourable (3.62e-6)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-2)" 42.9 33.9 37.6 72.1 32.6 93.8 78.8 18.8 37.1 46.7 80.3 23.3 37.8 55.8 41.4 43.9 71.7 42.1 54.1 40.7 30.2 26.4 36.9 72.4 41.9 171.3 35.9 20.7 73.2 252.4 9.1 19.4 34.6 35.3 41.6 49.1 19.3 93.2 60.0 122.3 59.4 58.3 59.7 36.1 58.7 40.4 27.3 22.4 58.3 44.2 101.5 69.2 63.1 79.0 88.9 55.0 6.2 29.4 46.5 95.3 121.3 27.3 34.0 40.0 37.3 57.1 96.7 85.1 55.0 56.5 58.2 38.7 74.9 46.8 78.3 37.0 64.9 35.5 53.0 65.5 53.0 24.2 48.7 55.6 48.1 101.0 76.2 110.1 49.7 97.6 77.8 43.2 98.2 61.1 76.5 65.3 64.4 56.9 97.7 91.5 55.5 57.9 73.1 78.0 99.2 63.0 53.8 40.3 41.2 22.0 47.9 53.5 29.3 136.3 43.1 30.7 41.0 40.0 52.1 70.5 57.8 89.2 35.7 74.9 23.3 6.2 28.2 3.5 37.2 29.4 68.4 88.9 66.4 49.4 55.0 69.7 95.3 76.8 4.1 46.5 23.1 53.5 35.1 121.3 37.6 32.6 18.8 37.1 30.2 26.4 35.9 20.7 35.3 22.4 EEF1D "EF-1D, FLJ20897" ENSG00000104529 "Eukaryotic translation elongation factor 1 delta" P29692 8 143579697-143599541 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "DNA-binding, Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045101, HPA051002" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" 900000 "Nucleoplasm, Nucleoli fibrillar center" "HPA045101: AB_10963077, HPA051002: " "unprognostic (9.34e-2)" "unprognostic (2.37e-2)" "unprognostic (9.92e-2)" "unprognostic (1.63e-3)" "unprognostic (5.25e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (3.82e-4)" "unprognostic (8.56e-2)" "unprognostic (3.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.58e-5)" "unprognostic (3.99e-2)" "unprognostic (2.06e-1)" "unprognostic (2.67e-2)" "unprognostic (2.14e-1)" 58.0 47.7 25.2 48.0 23.6 67.6 61.7 20.1 25.9 56.4 54.7 35.0 50.8 33.8 57.2 50.8 63.0 39.5 68.6 58.5 24.5 20.5 43.0 89.4 49.1 123.8 27.3 18.7 95.0 258.8 23.3 27.8 34.6 22.3 70.7 25.3 50.2 98.6 48.3 95.1 56.2 45.4 65.7 31.2 60.1 49.9 33.4 23.3 73.4 76.4 82.3 77.4 57.8 94.6 122.6 75.1 35.9 46.3 69.1 128.4 143.7 46.8 68.5 30.6 26.4 27.7 34.2 34.0 36.4 46.9 58.1 46.3 93.5 44.7 36.0 38.5 40.6 46.8 31.6 58.8 25.3 28.4 52.0 35.3 120.8 91.0 41.4 21.9 30.0 65.6 86.0 35.1 40.0 38.8 33.0 53.5 32.9 151.4 85.4 55.8 32.3 90.9 38.0 22.0 70.5 49.7 79.7 30.4 32.9 31.8 78.1 76.2 58.4 56.2 30.1 33.9 99.6 50.3 78.3 36.4 14.0 37.5 38.1 44.9 29.4 19.5 46.3 21.3 80.0 41.6 103.1 114.0 102.4 83.8 53.3 122.6 128.4 103.5 35.9 69.1 36.6 75.1 96.2 143.7 25.2 23.6 20.1 25.9 24.5 20.5 27.3 18.7 22.3 23.3 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102578 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: " "unprognostic (9.39e-3)" "prognostic favourable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favourable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 10.5 21.8 20.1 14.2 26.9 34.0 18.5 20.0 24.6 10.8 12.2 13.5 12.3 8.2 13.6 19.2 15.9 10.3 9.5 12.5 19.4 27.0 34.9 19.2 9.9 19.7 26.9 16.2 10.8 26.6 19.8 28.6 11.7 41.2 12.5 15.2 9.6 13.5 13.4 14.4 8.4 8.4 13.3 21.3 11.8 14.8 36.3 19.4 9.9 13.9 15.8 20.3 11.6 9.3 20.9 29.6 6.8 15.0 14.0 21.3 13.5 27.7 14.7 23.7 16.3 7.8 13.1 14.4 23.4 14.8 21.1 21.8 24.0 11.6 30.5 51.6 15.2 11.6 26.7 26.9 35.6 17.0 34.8 24.6 19.4 41.6 14.5 48.6 18.1 10.9 25.4 25.1 26.1 29.8 58.7 8.5 20.2 11.6 20.8 39.5 21.3 23.6 25.6 13.9 47.8 34.5 21.5 35.2 10.9 9.9 22.5 27.8 17.9 16.7 15.3 17.7 17.5 16.0 33.9 13.3 60.2 43.3 9.9 20.6 28.0 6.2 11.0 6.8 13.5 15.0 19.1 20.9 18.1 17.8 29.6 20.5 20.3 20.6 1.1 14.0 11.2 13.0 21.3 13.5 20.1 26.9 20.0 24.6 19.4 27.0 26.9 16.2 41.2 19.4 EEF2 "EEF-2, EF2" ENSG00000167658 "Eukaryotic translation elongation factor 2" P13639 19 3976056-3985469 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007795, HPA040534, HPA057351" Enhanced Enhanced "Plasma membrane,Cytosol" 9700000 "Plasma membrane, Cytosol" "CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417" "unprognostic (5.47e-2)" "unprognostic (9.59e-2)" "unprognostic (3.75e-1)" "prognostic favourable (1.81e-6)" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.11e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.42e-1)" "prognostic favourable (1.25e-5)" "unprognostic (4.46e-2)" "unprognostic (5.60e-2)" "unprognostic (6.82e-2)" "unprognostic (9.86e-2)" 104.2 84.9 64.0 66.7 57.1 92.7 77.5 55.7 96.2 93.4 91.3 55.8 80.8 95.4 100.1 75.1 115.1 83.4 88.6 104.1 51.6 44.4 65.5 161.0 67.7 108.9 51.4 38.3 167.1 395.7 45.1 72.3 63.7 47.5 105.6 41.3 67.7 191.3 64.4 260.8 87.2 100.9 112.3 46.8 85.4 98.5 70.9 32.4 123.4 127.1 112.5 108.3 111.8 94.7 84.9 60.0 10.0 58.4 48.3 76.3 83.7 95.2 68.4 39.8 105.1 106.7 192.3 57.3 74.9 101.4 71.7 70.6 107.8 44.2 199.0 44.6 69.1 72.3 62.8 116.0 38.0 49.6 104.2 50.8 65.7 110.7 156.0 109.1 88.4 248.2 122.7 63.1 97.7 74.2 99.1 146.7 43.6 138.2 97.9 83.7 105.3 69.2 109.1 59.2 126.5 59.0 85.2 109.0 101.3 47.1 94.3 135.0 91.9 132.7 88.9 51.4 53.7 104.4 115.2 157.4 105.6 99.0 76.6 137.2 67.0 10.0 58.4 8.3 38.6 45.8 68.7 84.9 67.7 50.8 60.0 70.7 76.3 59.4 6.1 48.3 43.8 50.5 58.4 83.7 64.0 57.1 55.7 96.2 51.6 44.4 51.4 38.3 47.5 32.4 EEFSEC "eEFSec, EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153454-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.5;SH-SY5Y: 8.8;SK-BR-3: 14.8;SK-MEL-30: 12.7;T-47d: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favourable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 8.2 6.8 5.6 7.9 7.9 3.1 7.9 8.4 9.8 11.6 8.6 9.3 7.3 2.5 10.8 5.4 8.0 9.4 7.1 18.7 7.6 6.4 9.4 18.1 7.1 15.5 5.4 4.2 11.5 8.4 23.9 9.2 9.7 6.9 9.0 4.9 7.2 10.7 11.2 20.3 15.9 15.7 10.0 5.0 9.2 6.9 11.5 6.2 17.2 8.4 6.7 10.5 7.7 7.9 7.1 10.9 7.3 7.8 9.7 7.0 3.8 0.4 0.1 3.4 1.4 0.1 0.2 0.4 0.0 0.2 0.2 0.2 0.3 5.7 12.5 0.1 3.1 0.9 0.3 0.1 0.1 0.3 0.3 0.0 0.1 0.1 4.9 0.2 0.3 0.1 0.1 3.4 0.1 0.2 0.0 0.2 2.9 0.1 6.2 0.3 0.4 0.1 0.2 0.2 0.8 0.0 0.0 0.3 8.8 0.0 14.8 12.7 8.0 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.2 0.5 7.5 7.3 6.7 7.8 5.6 7.1 5.9 5.8 10.9 5.8 5.6 6.5 0.0 9.7 6.2 4.6 7.0 3.8 5.6 7.9 8.4 9.8 7.6 6.4 5.4 4.2 6.9 6.2 EEPD1 KIAA1706 ENSG00000122547 "Endonuclease/exonuclease/phosphatase family domain containing 1" Q7L9B9 7 36153149-36301543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 13.3;HDLM-2: 14.0;PC-3: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.2;neutrophil: 21.9" "Group enriched" "Detected in many" 6 "granulocytes: 23.2;T-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053668 Approved "Nuclear speckles,Vesicles,Plasma membrane" "Nuclear speckles" "Vesicles, Plasma membrane" "HPA053668: " "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-3)" "unprognostic (5.21e-3)" "unprognostic (1.14e-1)" "unprognostic (4.76e-1)" "unprognostic (1.19e-2)" "unprognostic (3.75e-2)" "unprognostic (7.89e-2)" "unprognostic (8.77e-2)" "unprognostic (7.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (6.52e-2)" "unprognostic (2.23e-2)" "unprognostic (4.59e-2)" 20.3 5.1 4.9 6.4 8.6 8.1 22.5 3.3 19.3 9.6 15.2 11.8 6.5 11.0 12.5 5.6 6.5 5.4 18.4 6.2 6.4 5.4 3.7 15.2 8.7 4.6 13.3 3.5 6.9 8.1 2.4 3.3 4.6 5.6 8.2 4.5 5.7 3.8 4.3 39.7 10.2 23.6 9.1 10.2 7.5 10.5 3.4 7.7 11.5 2.2 4.4 3.6 6.1 10.9 0.1 1.5 23.2 2.8 1.7 11.5 2.0 1.6 4.6 1.4 4.5 13.3 2.9 0.1 1.1 5.7 0.9 1.6 0.9 3.5 4.5 1.5 1.7 1.9 1.9 2.2 0.8 14.0 3.2 0.6 0.4 8.4 1.2 0.7 4.4 5.9 1.4 0.5 0.4 0.1 5.5 0.5 1.0 1.8 4.6 11.2 6.5 17.8 1.2 1.6 1.0 2.8 3.7 3.5 2.5 0.4 0.6 1.7 1.4 5.4 0.4 1.8 5.3 1.2 1.3 3.5 3.8 0.0 4.4 3.0 1.1 10.0 2.8 23.2 1.5 1.7 2.6 0.1 11.5 3.3 1.5 0.0 2.6 0.7 21.9 1.7 0.7 1.3 5.1 2.0 4.9 8.6 3.3 7.5 6.4 5.4 13.3 3.5 5.6 7.7 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Cell line enhanced" "Detected in some" "A-431: 8.9;ASC diff: 3.9;ASC TERT1: 9.1;CAPAN-2: 4.4;hTEC/SVTERT24-B: 3.7;SCLC-21H: 7.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: " "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 8.9 0.0 1.1 0.0 3.9 9.1 0.0 0.1 0.9 0.0 0.3 0.0 4.4 0.0 0.0 0.2 2.4 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.2 0.3 3.7 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.3 0.1 0.0 0.0 0.0 2.1 7.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA051209: " "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 4.7 5.8 10.2 6.2 8.1 5.3 9.3 5.7 7.6 5.6 5.2 10.4 6.7 5.1 4.9 6.9 6.2 11.0 4.9 3.7 7.8 6.6 7.6 5.8 3.2 3.3 8.6 5.7 5.2 4.8 8.3 8.2 8.4 7.7 5.4 5.6 6.1 5.6 5.4 2.4 3.7 3.6 6.3 8.4 6.7 4.4 36.9 6.2 2.5 7.9 3.3 6.3 5.2 4.1 2.6 2.1 12.8 5.3 3.3 1.6 0.8 4.9 7.6 6.6 8.2 4.1 4.4 18.7 7.2 6.6 9.9 6.9 8.9 17.5 7.7 13.8 4.8 10.8 5.7 14.4 14.3 8.6 3.6 5.5 6.5 14.5 0.9 7.0 13.4 3.0 3.6 6.4 7.4 8.2 5.8 7.6 11.7 25.5 5.2 9.5 2.8 13.7 6.0 10.5 5.5 9.1 13.7 2.8 4.7 9.1 17.0 8.5 13.8 5.1 6.9 5.4 7.4 5.6 7.0 4.6 13.1 13.3 7.8 3.3 9.7 12.8 1.3 3.4 0.6 3.0 0.3 2.6 1.0 1.0 2.1 2.6 1.6 1.4 4.0 3.3 5.3 1.8 1.3 0.8 10.2 8.1 5.7 7.6 7.8 6.6 8.6 5.7 7.7 6.2 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell line enhanced" "Detected in some" "Hep G2: 4.6;RPTEC TERT1: 3.7;SCLC-21H: 2.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.4 0.4 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.5 0.6 4.6 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.0 1.3 0.9 0.0 0.3 0.1 1.6 0.3 0.1 0.8 0.0 0.5 3.7 0.0 2.9 0.1 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.5 1.0 0.2 1.4 1.8 2.1 0.5 0.7 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 3.9 1.7 0.2 2.1 7.2 3.0 2.2 0.5 0.6 1.1 1.7 5.6 0.3 6.5 0.8 1.0 0.0 0.4 3.9 0.2 0.6 5.1 3.2 0.5 2.0 3.9 0.6 1.3 1.9 2.7 0.0 4.4 1.5 9.7 2.4 0.1 1.7 2.2 0.9 3.1 4.6 1.2 1.8 9.1 3.2 1.2 0.6 1.2 0.1 2.6 6.5 4.7 1.6 0.2 1.3 0.4 1.0 10.0 6.9 0.9 6.2 7.7 4.2 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.3 8.2 7.0 11.1 33.5 21.1 16.1 15.5 23.0 17.2 17.8 9.8 9.7 11.5 16.3 21.1 17.4 12.0 17.2 23.5 21.9 7.7 14.4 9.1 4.0 11.5 18.6 28.4 18.6 28.7 13.7 11.4 21.0 8.9 16.5 17.8 5.6 12.2 8.4 10.0 9.3 9.3 19.6 10.1 18.2 29.1 3.6 5.0 19.2 27.2 14.6 12.2 16.2 19.3 14.8 7.2 17.1 15.7 16.9 23.5 9.3 18.9 16.0 10.9 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 34.2;THP-1: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavourable (6.51e-4)" "unprognostic (4.88e-2)" 11.0 12.5 16.7 5.6 18.6 10.8 14.7 20.1 15.5 11.6 7.3 23.6 13.9 3.0 18.7 19.5 9.6 32.1 13.1 13.7 18.0 14.3 12.5 6.5 11.2 7.8 22.3 12.3 10.6 12.1 14.6 20.6 14.7 16.3 9.2 11.3 11.8 7.4 16.0 15.5 6.1 6.5 13.2 20.9 6.4 10.5 24.4 21.9 5.4 23.7 13.5 9.1 11.5 16.0 3.6 10.8 4.9 1.8 2.9 0.8 1.2 3.1 3.9 8.9 2.3 3.2 7.6 10.9 3.9 4.2 5.1 4.7 10.0 8.5 10.8 8.5 4.9 2.5 3.6 2.3 3.2 1.1 2.1 5.2 15.6 4.4 6.9 5.3 34.2 6.6 4.8 6.8 6.4 7.8 19.9 8.8 4.4 3.2 1.1 14.6 11.4 3.0 20.5 1.3 2.8 13.0 5.3 7.0 9.5 6.9 2.6 5.7 2.6 30.1 1.2 6.3 2.3 3.4 14.2 3.0 5.0 7.2 5.0 15.3 5.1 1.2 1.7 2.8 0.5 1.8 0.8 3.6 0.7 0.4 5.5 3.3 0.6 0.6 4.9 2.9 1.3 10.8 0.8 1.2 16.7 18.6 20.1 15.5 18.0 14.3 22.3 12.3 16.3 21.9 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favourable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.2 5.2 6.9 4.4 7.3 10.9 3.5 4.1 4.4 7.0 8.7 1.7 4.9 4.4 9.7 2.3 5.8 5.9 3.9 8.4 8.1 4.1 3.5 9.8 3.6 4.7 4.9 3.2 5.9 9.5 8.2 5.6 5.9 4.4 7.2 4.6 1.3 9.3 3.3 3.0 5.3 6.0 10.4 4.3 10.8 3.4 14.8 5.7 7.7 4.4 9.9 4.5 3.5 1.6 3.9 3.5 11.7 3.8 4.8 8.3 5.1 7.3 3.5 5.8 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034492, HPA057359" Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227, HPA057359: " "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 5.3 0.0 0.0 0.0 0.0 17.6 0.3 0.3 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.3 0.0 0.0 1.4 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.0;breast: 83.4;kidney: 75.9" "Cell line enhanced" "Detected in some" "BEWO: 29.7;RPTEC TERT1: 16.0;SK-BR-3: 70.9;T-47d: 55.5" "Cancer enhanced" "Detected in all" "breast cancer: 100.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.1" "Group enriched" "Detected in many" 5 "granulocytes: 6.1;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: , HPA056959: " "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favourable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 16.1 4.0 32.0 2.3 71.3 1.1 83.4 4.1 39.1 37.2 3.9 85.0 0.8 2.7 22.2 16.5 5.1 16.7 6.0 13.5 42.0 24.5 75.9 24.2 4.0 2.3 85.0 25.2 32.1 39.3 4.8 3.5 55.2 43.2 8.0 3.4 12.9 10.1 13.8 13.5 5.9 3.8 10.3 66.0 20.7 3.7 7.3 80.1 0.0 6.8 3.6 1.8 5.0 9.3 0.8 0.7 6.1 0.7 0.3 1.6 0.3 0.0 0.8 1.3 0.3 0.5 0.0 29.7 6.2 0.4 0.5 0.4 0.2 0.1 0.0 0.4 2.6 0.0 4.4 0.0 0.0 0.1 2.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.1 0.1 0.5 0.1 0.0 1.9 0.0 0.1 1.7 0.1 16.0 0.1 0.0 0.7 2.1 70.9 4.2 55.5 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.1 1.9 0.7 0.4 0.7 0.3 1.2 0.8 1.0 1.0 0.3 0.3 1.6 1.6 6.1 0.3 0.2 0.7 0.3 0.3 32.0 71.3 4.1 35.5 42.0 24.5 85.0 25.2 43.2 80.1 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1286154-1300237 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.0;intestine: 30.3;liver: 14.2" "Cell line enhanced" "Detected in some" "AF22: 4.8;BEWO: 4.9;Hep G2: 9.3;NTERA-2: 5.4;REH: 7.1;SH-SY5Y: 16.8;U-2 OS: 5.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA067567: " "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.2 0.1 1.5 3.4 2.2 0.2 0.1 1.5 2.0 0.1 10.7 2.0 0.0 12.0 0.2 0.1 0.4 0.1 10.0 0.1 1.0 1.6 0.3 14.2 0.1 0.1 1.2 0.5 0.1 0.1 0.1 0.3 0.2 1.1 0.1 2.3 1.9 0.1 0.2 0.2 0.1 30.3 0.2 0.9 0.2 0.6 0.6 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 1.7 0.0 0.0 4.9 0.2 0.0 0.0 0.0 3.5 0.0 0.0 2.3 0.0 0.0 2.2 0.0 0.0 0.1 2.1 0.0 0.0 9.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.4 0.0 7.1 0.6 0.0 0.0 0.1 0.0 16.8 0.2 0.0 0.1 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 1.5 2.0 1.0 1.6 1.2 0.5 1.1 0.7 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376889-107670895 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.3;RPTEC TERT1: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;memory CD8 T-cell: 3.0" "Group enriched" "Detected in many" 7 "NK-cells: 2.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: " "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.92e-7)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 5.3 1.9 1.9 2.3 6.0 0.0 7.3 10.1 22.2 15.0 4.2 0.9 2.5 1.2 1.6 2.8 9.1 3.9 3.6 8.3 2.5 5.3 5.3 0.6 7.0 3.2 2.1 8.9 5.5 0.7 6.9 18.5 3.1 4.8 6.2 3.6 3.3 11.2 6.8 1.1 13.3 2.3 2.8 3.5 6.3 3.1 1.8 1.1 0.1 2.5 6.0 3.3 4.0 8.1 0.0 0.0 0.4 0.1 2.5 3.5 0.4 6.2 11.1 19.3 0.0 9.3 8.1 1.8 0.2 3.3 2.4 6.0 0.1 7.0 0.0 10.6 1.2 6.5 10.7 9.2 2.3 0.0 6.5 0.0 6.1 0.0 1.8 0.3 0.0 8.6 8.8 0.0 7.8 7.6 0.0 0.0 4.6 6.0 0.0 0.0 2.3 0.9 0.0 8.7 0.2 29.4 8.1 2.9 7.7 3.0 4.5 1.9 1.9 1.2 0.1 14.6 2.6 8.9 3.5 0.5 0.0 4.0 6.4 0.4 15.7 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.3 1.4 0.4 2.5 0.1 0.0 0.1 0.4 1.9 6.0 10.1 22.2 2.5 5.3 2.1 8.9 4.8 1.1 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489731-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 49.4;SH-SY5Y: 24.8;U-87 MG: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Lineage enhanced" "Detected in single" "NK-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol 760000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavourable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavourable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 15.7 4.9 11.2 8.2 11.0 0.8 21.8 8.3 14.0 13.2 23.1 5.8 13.1 13.9 10.8 5.2 11.4 13.6 11.2 11.8 10.4 6.5 9.3 11.8 50.1 7.8 6.2 11.5 8.4 3.7 5.7 6.1 27.7 5.2 11.8 18.4 15.2 12.7 20.6 6.6 14.3 20.6 10.5 5.0 9.3 21.3 7.2 5.9 7.3 11.2 8.8 5.9 7.7 12.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 11.8 1.1 49.4 0.0 0.1 0.4 0.2 5.4 3.4 5.3 3.1 11.9 18.1 0.0 5.2 1.6 14.1 1.8 6.9 5.8 0.0 10.6 0.0 4.1 0.0 1.0 3.9 0.3 2.3 12.4 0.2 10.6 6.7 0.0 0.0 5.8 2.0 0.1 0.0 2.6 2.4 9.9 2.0 0.0 7.6 1.5 3.5 24.8 2.0 1.0 0.0 0.6 0.1 5.2 10.6 0.0 0.3 12.1 0.1 0.0 0.0 22.2 0.2 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 11.2 11.0 8.3 14.0 10.4 6.5 6.2 11.5 5.2 5.9 EFR3A KIAA0143 ENSG00000132294 "EFR3 homolog A" Q14156 8 131904088-132013642 "Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022859, HPA023092, HPA023402" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031" "unprognostic (4.79e-2)" "unprognostic (6.54e-2)" "unprognostic (6.42e-2)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (3.44e-2)" "unprognostic (3.04e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-1)" "unprognostic (8.11e-2)" "unprognostic (5.89e-3)" "unprognostic (5.22e-2)" "unprognostic (3.46e-1)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.29e-1)" "unprognostic (2.21e-3)" 14.7 16.0 21.6 13.6 21.4 8.0 46.8 48.6 52.2 20.4 19.2 7.1 15.0 15.0 18.0 26.5 18.6 16.5 14.6 22.7 28.2 18.5 20.2 28.9 18.8 22.4 20.7 24.4 13.6 13.8 29.2 12.9 13.3 63.3 18.7 12.5 13.9 14.6 20.8 37.1 13.8 15.2 28.1 11.9 14.5 14.8 13.8 7.6 18.7 25.4 9.8 17.7 18.1 14.1 9.5 12.0 11.8 25.8 10.0 12.1 9.5 20.9 18.9 5.9 4.9 24.3 28.1 11.9 15.0 21.1 12.5 16.6 4.1 15.7 12.9 14.2 33.7 6.9 9.3 20.5 15.4 29.6 5.1 12.8 9.4 8.3 23.3 4.9 13.6 23.7 11.7 12.3 19.6 15.7 7.0 17.4 22.1 13.7 13.6 4.5 3.3 11.9 5.5 11.6 6.1 15.1 13.1 4.0 13.8 29.8 4.2 11.6 13.5 8.4 21.8 22.3 20.5 10.8 15.6 12.4 10.6 8.1 16.5 11.9 11.3 5.4 11.7 11.8 12.1 16.4 10.8 9.5 9.8 9.8 12.0 8.3 9.0 9.1 7.2 10.0 25.8 2.8 7.7 9.5 21.6 21.4 48.6 52.2 28.2 18.5 20.7 24.4 63.3 7.6 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042130-25159137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;retina: 21.1;skeletal muscle: 25.1" "Cell line enhanced" "Detected in many" "AN3-CA: 8.9;BEWO: 10.4;SH-SY5Y: 9.3;SK-BR-3: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 1.9 3.2 13.1 1.7 22.9 1.3 1.3 15.5 30.5 1.4 1.7 9.4 0.0 1.4 1.8 8.4 1.3 1.8 1.5 6.9 11.4 8.7 1.4 1.1 4.4 1.3 8.7 13.5 1.4 1.3 2.4 4.1 3.2 29.9 1.5 1.8 21.1 1.1 2.0 25.1 1.7 1.3 2.6 7.8 4.3 2.2 3.5 9.0 0.0 4.5 0.2 1.1 1.4 0.7 1.0 0.6 4.4 0.5 1.0 0.7 0.1 0.1 7.0 8.2 8.9 0.5 0.1 10.4 0.8 0.2 0.4 0.1 5.6 0.3 0.1 0.5 1.2 0.5 6.5 0.0 0.1 1.3 1.6 1.3 0.3 0.5 0.0 0.1 0.7 0.1 0.0 2.0 0.1 0.2 0.1 0.4 0.2 0.8 0.2 0.4 1.6 5.6 0.6 7.9 0.2 0.1 0.2 3.5 9.3 1.0 15.6 5.0 0.8 0.1 0.5 0.5 2.4 3.6 1.7 0.6 0.7 0.1 6.4 0.1 1.7 4.4 0.4 1.1 0.7 0.3 0.5 0.6 0.4 0.6 0.3 1.0 0.4 0.7 1.7 1.0 0.5 0.6 0.2 0.1 13.1 22.9 15.5 22.7 11.4 8.7 8.7 13.5 29.9 9.0 EFS "CASS3, EFS1, EFS2, HEFS, SIN" ENSG00000100842 "Embryonal Fyn-associated substrate" O43281 14 23356402-23365752 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 27.7;AN3-CA: 15.1;BEWO: 23.2;SH-SY5Y: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001581, HPA001790" Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001581: , HPA001790: " "unprognostic (9.58e-3)" "unprognostic (1.10e-2)" "unprognostic (3.68e-2)" "unprognostic (1.78e-1)" "unprognostic (6.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-1)" "unprognostic (3.85e-2)" "unprognostic (7.36e-2)" "unprognostic (2.15e-1)" "unprognostic (2.75e-1)" "unprognostic (1.00e-2)" "prognostic unfavourable (4.09e-5)" "unprognostic (3.44e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" 12.0 10.2 11.7 4.4 15.7 0.6 13.1 9.4 21.2 17.9 8.5 29.4 8.0 2.8 17.0 9.8 18.3 10.0 6.7 5.5 14.3 8.3 3.2 1.2 5.7 2.8 14.9 8.2 23.7 1.5 25.0 3.2 33.1 15.6 17.9 3.1 8.3 15.6 18.6 3.8 42.3 3.9 13.0 25.7 4.5 4.7 4.4 16.0 0.4 6.8 15.5 10.0 11.8 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 27.7 15.1 6.9 8.0 23.2 2.0 4.2 0.7 0.3 0.0 0.0 0.0 0.0 11.4 10.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 4.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 8.8 0.0 0.0 8.8 3.0 26.5 5.9 0.9 0.0 6.6 0.0 0.0 2.9 0.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 15.7 9.4 11.8 14.3 8.3 14.9 8.2 15.6 16.0 EFTUD2 "SNRNP116, Snrp116, Snu114, U5-116KD" ENSG00000108883 "Elongation factor Tu GTP binding domain containing 2" Q15029 17 44849943-44899662 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022021 Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA022021: AB_1848032" "unprognostic (4.28e-2)" "unprognostic (4.12e-2)" "unprognostic (1.98e-3)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (4.98e-2)" "prognostic unfavourable (2.71e-6)" "unprognostic (6.94e-2)" "unprognostic (4.52e-1)" "unprognostic (2.37e-1)" "unprognostic (4.11e-3)" "unprognostic (5.19e-2)" "unprognostic (5.48e-3)" "unprognostic (1.62e-2)" "unprognostic (5.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" 22.5 26.5 16.0 23.1 27.0 25.0 17.7 13.4 34.9 14.8 20.3 22.0 10.4 16.6 22.1 15.4 27.0 20.2 12.7 22.6 16.6 16.7 21.5 27.7 17.3 25.2 15.8 19.8 15.3 20.0 21.2 15.3 27.5 22.6 14.9 23.2 19.1 27.2 15.7 49.6 22.0 20.3 18.5 15.7 25.9 18.5 30.2 13.1 36.9 18.6 17.9 34.9 18.6 16.0 12.8 31.8 31.6 31.5 15.6 16.9 23.3 22.8 45.8 22.3 36.2 17.1 17.0 26.3 18.2 24.4 46.0 40.0 35.2 19.6 39.6 21.5 22.9 26.2 48.5 31.8 53.8 39.7 40.2 39.2 28.6 37.4 18.9 46.2 29.2 18.4 18.2 42.5 23.2 39.8 48.3 15.4 26.1 22.8 46.2 30.5 23.0 38.3 32.6 45.4 34.3 26.2 25.7 36.8 22.0 17.9 13.3 18.8 35.2 29.2 24.1 34.6 26.7 20.9 45.8 16.3 20.5 39.8 27.8 25.7 35.2 12.3 31.5 31.6 15.2 31.0 16.9 12.8 13.5 14.6 31.8 12.5 12.0 13.3 5.1 15.6 29.7 13.7 13.2 23.3 16.0 27.0 13.4 34.9 16.6 16.7 15.8 19.8 22.6 13.1 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" Vesicles "Nuclear speckles" "HPA061173: " "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 0.9 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.7 0.3 0.0 0.0 1.7 0.9 3.0 0.0 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell line enriched" "Detected in many" 12 "A-431: 337.7" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavourable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 337.7 4.3 1.1 1.5 6.9 4.3 1.1 3.3 4.5 2.0 1.6 0.8 3.7 0.2 0.8 2.8 13.5 0.0 14.9 2.5 0.1 0.2 0.0 1.8 0.2 1.8 0.0 0.0 2.1 13.7 5.2 27.9 0.2 0.0 0.0 4.4 0.2 0.0 0.0 0.3 2.2 0.0 0.6 0.0 2.5 3.6 0.0 1.3 2.8 3.4 0.6 0.3 0.7 1.0 1.9 0.5 14.6 3.1 0.0 0.3 0.1 2.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;HMC-1: 7.3;MCF7: 23.9;SK-MEL-30: 16.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favourable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favourable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.4 4.5 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.3 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.0 23.9 0.0 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.0 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 EHBP1 "KIAA0903, NACSIN" ENSG00000115504 "EH domain binding protein 1" Q8NDI1 2 62673851-63046487 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035468, HPA035469" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA035468: AB_10671513, HPA035469: AB_10601365" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (8.78e-2)" "unprognostic (3.83e-3)" "unprognostic (1.43e-1)" "unprognostic (1.57e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.78e-1)" "unprognostic (1.95e-1)" "unprognostic (3.33e-2)" "unprognostic (3.14e-1)" "unprognostic (3.13e-3)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-2)" "prognostic unfavourable (1.95e-8)" 19.6 12.6 19.8 10.2 15.4 4.0 12.0 27.5 22.5 22.5 22.3 8.0 7.5 6.8 22.3 6.0 20.9 12.7 18.2 7.8 16.0 15.9 12.3 36.9 8.1 5.7 17.1 13.0 35.1 10.9 9.7 14.5 8.2 12.8 12.6 10.4 8.6 10.2 14.0 5.4 7.4 8.5 21.4 9.3 5.4 11.1 24.1 9.8 5.4 10.4 7.5 7.0 12.3 12.7 8.4 5.4 3.5 3.6 4.7 6.8 2.8 18.3 25.4 10.4 6.2 18.2 35.2 10.5 16.4 16.1 12.1 10.0 30.2 13.8 12.7 6.0 30.0 11.2 13.4 11.6 20.1 13.5 6.3 10.9 9.0 35.6 12.5 6.3 8.4 16.2 21.0 12.3 24.1 7.7 7.5 7.3 19.4 7.1 7.3 4.0 10.1 9.9 6.6 13.0 5.4 8.1 6.0 11.3 9.2 13.5 10.0 16.3 4.8 6.3 5.6 13.1 13.6 21.5 8.6 8.4 5.7 12.1 13.0 9.9 26.1 0.2 3.4 3.5 6.3 3.6 6.3 8.4 6.8 6.0 5.4 7.3 6.7 5.7 1.3 4.7 1.9 3.5 3.7 2.8 19.8 15.4 27.5 22.5 16.0 15.9 17.1 13.0 12.8 9.8 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34661057 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 34.7;HaCaT: 23.9;HBEC3-KT: 26.3;RT4: 53.1;T-47d: 53.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "myeloid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA050923: , HPA060734: " "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favourable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.8 1.0 0.8 9.3 0.9 0.0 32.1 0.7 0.7 19.3 16.0 0.5 152.4 6.9 4.5 21.4 69.0 23.0 22.1 0.7 0.9 0.9 11.6 1.6 9.9 0.1 1.5 0.3 4.7 10.5 0.2 0.9 0.5 1.4 20.7 22.3 0.2 118.0 161.8 0.7 12.8 10.1 1.7 3.3 0.7 10.1 1.4 0.5 0.4 1.2 50.3 59.7 13.7 30.3 0.0 4.9 0.0 0.4 0.0 0.0 0.2 11.4 6.6 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 34.7 0.0 4.4 0.0 23.9 0.0 26.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 4.7 53.1 0.0 0.0 0.1 3.6 0.0 53.8 0.1 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.7 0.7 0.9 0.9 1.5 0.3 1.4 0.5 EHMT1 "bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D" ENSG00000181090 "Euchromatic histone lysine methyltransferase 1" Q9H9B1 9 137618963-137870016 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060022 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA060022: " "unprognostic (1.18e-1)" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "prognostic favourable (6.56e-4)" "unprognostic (1.03e-1)" "prognostic favourable (8.91e-4)" "unprognostic (5.87e-2)" "unprognostic (1.74e-2)" "unprognostic (4.18e-3)" "unprognostic (2.34e-1)" "unprognostic (2.26e-2)" "unprognostic (7.55e-3)" "unprognostic (2.01e-2)" "unprognostic (6.58e-3)" "unprognostic (4.24e-1)" "unprognostic (7.12e-3)" "unprognostic (7.75e-2)" 16.6 18.3 16.4 23.2 22.3 24.9 17.1 23.7 20.4 16.3 20.7 21.6 20.4 17.1 22.0 13.0 17.9 18.5 20.0 12.1 12.8 9.6 12.7 14.9 14.9 25.0 27.8 12.1 21.4 13.6 15.1 16.2 17.9 18.6 16.9 12.4 19.1 16.5 18.0 23.1 17.3 17.9 21.5 12.5 22.1 16.4 30.8 21.5 22.3 18.9 11.0 22.2 19.2 15.7 20.0 19.0 25.0 13.7 13.1 15.6 6.9 11.0 22.1 24.8 22.9 10.5 10.9 20.7 14.6 9.2 10.7 8.7 14.4 13.8 33.8 14.2 11.0 23.7 14.8 15.9 8.5 18.9 10.5 14.3 22.1 9.2 9.2 21.7 17.1 9.8 11.2 12.9 12.6 17.5 21.4 11.7 7.6 25.5 25.4 10.8 24.1 14.7 32.7 21.3 19.5 8.9 20.3 21.9 17.8 27.7 19.5 6.3 21.9 17.5 16.4 12.6 13.1 19.3 13.8 7.5 20.8 27.8 9.3 11.6 13.6 13.6 13.7 16.3 15.6 11.7 10.0 13.3 13.5 13.3 10.4 20.0 13.3 11.8 25.0 13.1 12.0 19.0 11.1 6.9 16.4 22.3 23.7 20.4 12.8 9.6 27.8 12.1 18.6 21.5 EHMT2 "BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a" ENSG00000204371 "Euchromatic histone lysine methyltransferase 2" Q96KQ7 6 31879759-31897687 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 10.2;NTERA-2: 15.5;U-266/84: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050550, HPA060259" Supported Supported "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" "Nuclear speckles" Nucleoplasm "HPA050550: , HPA060259: " "unprognostic (3.11e-2)" "unprognostic (2.72e-1)" "unprognostic (4.39e-2)" "unprognostic (1.92e-2)" "unprognostic (5.44e-2)" "unprognostic (3.51e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (3.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.89e-2)" "unprognostic (1.88e-1)" "unprognostic (9.78e-3)" "unprognostic (8.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.25e-1)" "unprognostic (9.03e-2)" 9.4 12.2 13.1 9.6 21.4 7.6 6.3 17.1 17.5 8.0 7.7 12.3 8.4 14.6 15.0 11.7 18.0 7.6 8.1 7.6 12.3 12.4 5.3 4.4 8.5 6.9 12.6 10.6 10.6 13.2 2.2 8.1 6.0 10.3 10.4 4.3 7.2 5.6 9.6 5.2 5.5 10.1 9.6 8.4 9.1 9.8 7.6 14.9 14.6 9.5 4.8 7.2 8.7 7.6 0.3 0.6 0.0 0.7 0.1 1.1 1.3 0.0 3.5 6.3 0.0 2.8 1.5 4.0 2.7 2.2 3.1 2.6 0.0 0.0 0.0 6.2 4.5 0.0 0.0 6.8 1.5 4.1 9.4 0.0 0.0 0.0 0.0 10.2 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 15.5 0.0 6.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 5.2 0.0 0.0 3.0 3.3 2.6 5.6 0.0 9.0 12.2 2.9 3.8 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.2 0.1 0.8 0.6 0.3 0.3 1.1 1.1 0.0 0.1 0.7 0.6 0.2 1.3 13.1 21.4 17.1 16.5 12.3 12.4 12.6 10.6 10.3 14.9 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell line enhanced" "Detected in all" "HEL: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.6 24.7 42.9 23.7 28.4 32.5 53.0 22.6 6.5 20.6 117.8 13.4 26.6 26.2 26.5 12.8 25.0 48.6 26.1 38.6 36.7 53.4 10.1 24.4 17.3 12.1 13.6 28.2 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 71.9 26.5 30.5 22.4 15.2 15.6 20.3 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 69.1" "Cell line enhanced" "Detected in many" "A549: 10.0;BJ: 9.3;BJ hTERT+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;HeLa: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5" "Low region specificity" "Detected in single" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059367: " "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 1.7 1.7 2.0 2.9 2.7 3.0 1.7 4.0 2.6 1.6 1.8 1.5 0.2 0.6 2.1 1.9 1.3 1.8 1.8 1.2 1.9 1.9 1.2 0.9 1.8 3.7 1.2 2.3 3.4 1.7 0.9 5.3 1.1 2.2 2.7 0.6 1.7 1.3 4.1 1.5 1.6 1.6 1.6 1.2 1.9 1.4 69.1 1.6 2.3 1.0 0.4 2.5 1.5 1.3 2.9 0.5 0.7 1.5 6.6 9.5 2.6 0.3 10.0 0.3 1.0 2.2 2.3 1.9 9.3 7.6 4.5 7.7 0.2 0.5 0.1 0.1 2.1 0.2 0.3 0.8 6.6 0.6 0.1 1.8 8.4 1.5 3.3 0.1 0.5 3.1 0.0 2.8 0.6 0.7 0.1 0.6 2.8 0.1 3.3 1.4 0.5 2.0 0.2 0.0 0.1 2.5 0.3 0.1 0.0 6.2 0.4 0.2 0.0 0.0 1.4 0.1 0.3 2.2 0.4 0.4 0.2 0.1 0.2 0.0 0.9 0.0 0.3 0.5 5.2 1.5 5.5 2.7 6.6 6.2 0.3 2.9 9.5 5.7 0.7 6.6 0.9 0.5 7.6 2.6 2.0 2.7 4.0 2.6 1.9 1.9 1.2 2.3 2.2 1.6 EIF1AD "haponin, MGC11102" ENSG00000175376 "Eukaryotic translation initiation factor 1A domain containing" Q8N9N8 11 65996545-66002176 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054991, HPA058735" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA054991: , HPA058735: " "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (3.03e-1)" "prognostic unfavourable (3.59e-5)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (8.63e-5)" "unprognostic (1.86e-2)" "unprognostic (1.17e-1)" "unprognostic (8.76e-2)" "unprognostic (1.36e-3)" "unprognostic (2.31e-1)" "unprognostic (1.59e-3)" "unprognostic (7.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.28e-3)" "unprognostic (3.96e-1)" 16.8 18.4 15.5 17.9 18.8 38.7 16.3 21.8 23.7 16.0 15.3 15.4 19.9 15.0 18.3 16.4 22.1 16.0 15.3 15.6 15.1 16.1 15.2 18.5 16.2 21.1 18.8 11.1 21.5 23.7 22.0 24.0 25.5 17.7 15.8 14.8 17.5 17.8 16.2 27.1 23.4 17.6 14.9 18.2 22.2 16.6 22.3 19.9 21.2 16.0 18.1 27.0 15.5 23.8 14.8 16.1 28.2 15.5 11.6 14.7 9.4 22.3 19.5 16.4 16.4 13.2 13.8 15.5 16.4 16.2 21.0 17.9 18.8 21.5 17.0 28.8 18.8 15.5 19.5 21.9 19.5 15.7 10.2 24.1 22.4 20.2 16.5 21.9 18.9 11.5 19.2 31.5 21.5 14.0 35.8 24.8 29.8 29.8 20.3 24.4 12.4 21.4 22.4 16.7 33.3 11.8 14.0 12.1 14.9 18.5 25.3 19.1 24.6 13.7 16.7 27.4 18.6 22.4 15.8 30.4 35.8 35.7 19.9 15.4 18.2 28.2 15.5 10.0 14.7 12.7 11.3 14.8 12.6 10.7 16.1 14.5 12.0 11.0 10.6 11.6 15.3 9.7 11.3 9.4 15.5 18.8 21.8 23.7 15.1 16.1 18.8 11.1 17.7 19.9 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150584242 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavourable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 33.5 23.7 12.6 21.4 22.8 27.2 34.3 38.3 23.8 35.1 29.4 12.6 17.3 23.1 31.5 19.9 37.2 20.6 19.0 24.9 11.3 11.9 27.0 44.5 24.7 32.8 16.5 11.7 35.6 39.4 22.6 36.4 26.2 22.7 32.9 23.8 15.4 29.8 23.9 53.3 26.8 33.1 25.0 16.9 28.9 26.5 16.3 17.9 38.5 41.8 33.8 25.8 44.0 26.1 17.0 27.7 7.9 24.6 20.5 26.9 19.0 38.1 13.9 19.5 20.6 25.1 50.0 27.0 23.6 32.7 30.3 32.8 38.5 42.2 50.4 36.2 28.1 31.1 32.4 32.7 43.1 19.0 21.7 29.6 16.7 29.7 24.1 36.8 28.3 33.3 37.2 22.2 49.6 37.5 24.3 30.0 24.4 26.9 26.8 19.5 27.7 22.0 23.6 25.6 58.5 31.7 23.7 24.8 26.5 14.2 22.7 36.9 33.3 34.3 21.9 19.2 18.3 27.1 45.3 52.1 27.4 46.4 24.3 32.3 9.5 7.9 22.6 4.7 14.9 23.5 23.3 17.0 21.2 18.2 27.7 14.9 26.9 21.0 1.8 20.5 24.6 13.1 17.3 19.0 12.6 22.8 38.3 23.8 11.3 11.9 16.5 11.7 22.7 17.9 EIF2AK1 "HRI, KIAA1369" ENSG00000086232 "Eukaryotic translation initiation factor 2 alpha kinase 1" Q9BQI3 7 6022244-6059230 "Enzymes, Predicted intracellular proteins" "Kinase, Protein synthesis inhibitor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016496, CAB022082, HPA061675" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB022082: , HPA016496: AB_1848057, HPA061675: " "unprognostic (7.15e-3)" "unprognostic (2.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.91e-1)" "unprognostic (6.70e-2)" "unprognostic (9.69e-3)" "prognostic unfavourable (6.99e-4)" "unprognostic (2.36e-1)" "unprognostic (2.54e-1)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (1.99e-1)" "unprognostic (5.45e-2)" "unprognostic (9.02e-2)" "unprognostic (1.06e-2)" 21.0 38.2 31.7 25.4 32.7 62.8 26.9 23.9 41.1 22.8 34.5 31.0 20.8 26.5 22.6 28.6 28.4 23.4 21.5 40.0 29.9 30.0 32.0 46.3 22.1 23.3 33.3 30.3 23.0 32.4 61.9 25.4 43.9 33.4 26.4 34.9 23.4 46.4 26.3 31.6 28.9 29.9 17.8 35.6 25.4 34.7 16.3 22.6 37.1 29.0 17.4 29.6 22.4 20.1 11.7 7.5 17.4 7.4 10.4 10.6 4.8 41.1 25.9 20.8 31.6 20.0 18.0 27.4 21.2 19.4 19.0 24.1 23.7 27.8 32.2 23.3 23.3 29.1 27.0 19.3 24.5 19.9 41.5 33.2 28.2 35.7 16.4 28.2 30.3 14.5 24.4 17.9 19.3 20.1 53.1 31.2 17.8 41.1 15.4 36.0 26.1 29.3 34.0 21.9 37.8 24.1 20.1 25.9 46.6 40.8 54.5 18.1 41.0 34.6 19.2 10.9 40.7 19.2 22.4 31.7 31.6 32.8 22.0 37.2 31.6 10.6 7.4 17.4 9.5 5.9 6.4 11.7 7.4 10.6 7.5 7.7 8.6 7.7 4.1 10.4 6.5 6.6 8.8 4.8 31.7 32.7 23.9 41.1 29.9 30.0 33.3 30.3 33.4 22.6 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002911-75012366 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: " "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favourable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 11.8 20.1 11.6 9.2 12.3 9.1 11.6 11.0 16.4 13.2 13.9 13.2 9.2 9.8 11.6 15.8 14.3 10.4 12.6 15.0 11.5 12.0 19.6 18.8 10.3 11.6 13.6 11.4 12.3 12.9 32.3 11.9 20.4 15.7 13.6 12.2 11.7 11.1 14.8 29.0 12.5 13.1 11.0 14.8 12.1 10.9 20.1 11.0 17.7 33.4 11.2 12.7 14.9 9.7 4.2 5.1 7.7 3.9 6.5 8.1 4.8 5.0 6.1 5.0 5.7 5.8 4.8 6.6 3.3 5.4 6.4 7.4 7.7 5.2 4.5 2.1 5.1 3.9 7.7 7.6 9.6 2.7 5.8 3.9 5.4 5.3 7.5 2.9 4.7 4.4 7.3 8.1 8.4 21.8 3.5 4.4 13.6 14.9 4.6 3.6 3.6 9.1 2.9 5.9 3.7 9.0 6.1 5.4 4.3 3.4 4.9 7.2 7.9 2.8 5.6 4.9 4.8 2.2 4.1 7.6 6.2 5.3 5.4 3.7 3.7 7.7 3.9 2.8 6.7 3.9 5.6 4.2 5.9 5.4 5.1 4.1 4.4 4.6 2.2 6.5 3.7 4.2 8.1 4.8 11.6 12.3 11.0 16.4 11.5 12.0 13.6 11.4 15.7 11.0 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 16.5 18.3 12.9 9.2 14.6 7.1 16.1 22.2 16.5 11.6 10.1 13.1 11.2 6.6 13.1 10.1 11.8 9.6 7.5 22.5 10.7 11.1 11.9 20.7 8.8 9.9 13.7 11.1 12.3 18.5 23.3 26.7 7.3 16.0 10.6 10.6 12.3 17.9 11.9 52.1 10.5 6.6 14.8 12.1 9.8 9.1 13.7 12.3 11.1 9.8 13.7 12.4 12.2 10.9 11.3 21.9 2.3 21.4 14.1 15.4 12.5 13.8 11.3 12.5 10.6 15.3 18.4 15.0 22.4 17.1 23.0 21.8 16.3 8.3 36.2 16.5 16.9 8.2 26.3 19.0 28.2 12.5 24.1 17.9 12.5 15.6 19.5 27.5 10.2 12.7 10.4 25.1 28.7 21.1 41.1 12.6 24.9 9.5 26.4 12.0 17.4 22.5 21.4 20.9 25.8 11.8 6.5 22.6 8.2 22.6 26.0 14.3 10.1 12.8 11.3 15.0 17.9 21.9 29.0 13.1 14.7 27.0 11.6 23.1 17.8 1.0 14.3 2.3 12.2 21.4 14.4 9.5 12.0 13.5 21.9 11.3 15.2 15.4 1.2 14.1 18.5 15.4 9.9 12.5 12.9 14.6 22.2 16.5 10.7 11.1 13.7 11.1 16.0 12.3 EIF2B4 "DKFZP586J0119, EIF-2B, EIF2B, EIF2Bdelta" ENSG00000115211 "Eukaryotic translation initiation factor 2B subunit delta" Q9UI10 2 27364352-27370486 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032234, HPA039993" Uncertain Approved "Nuclear membrane,Actin filaments" "Nuclear membrane" "Actin filaments" "CAB032234: AB_668909, HPA039993: " "unprognostic (2.26e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" "unprognostic (7.55e-2)" "unprognostic (2.37e-1)" "unprognostic (4.63e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (3.64e-2)" "unprognostic (2.18e-1)" "unprognostic (3.56e-3)" "unprognostic (1.11e-1)" "unprognostic (2.68e-1)" "prognostic unfavourable (5.46e-8)" "unprognostic (1.79e-1)" "unprognostic (1.70e-1)" "unprognostic (8.76e-2)" "unprognostic (1.67e-2)" 18.5 20.6 22.0 18.0 21.6 9.1 18.8 21.8 20.6 19.7 23.8 17.4 20.0 13.6 20.3 16.4 25.5 17.6 14.0 29.2 20.4 14.4 20.3 24.1 15.0 14.2 19.0 17.8 17.5 27.4 21.1 21.0 18.1 19.3 23.3 17.9 16.3 25.8 22.1 52.7 27.1 14.6 22.5 19.6 15.7 20.1 28.5 19.9 14.0 15.8 13.7 21.2 20.6 24.1 17.7 28.3 22.7 29.7 15.1 25.4 21.1 15.4 23.6 18.4 13.8 25.3 18.8 20.1 17.0 18.3 23.7 16.1 36.1 6.4 19.6 15.7 20.2 9.8 26.3 21.0 15.8 15.1 17.1 25.1 15.1 39.5 22.0 23.2 9.1 17.6 21.9 29.5 22.2 22.4 23.0 9.3 22.5 13.6 10.9 21.5 19.2 16.3 20.0 29.2 16.7 21.1 12.2 13.9 15.1 13.3 19.7 16.3 12.0 8.4 20.9 16.3 19.7 14.0 18.6 20.4 25.3 29.7 13.6 19.2 15.1 22.7 29.7 20.4 18.2 25.7 25.4 17.7 18.3 18.4 28.3 14.5 17.5 19.3 4.4 15.1 25.4 20.9 22.4 21.1 22.0 21.6 21.8 20.6 20.4 14.4 19.0 17.8 19.3 19.9 EIF2D LGTN ENSG00000143486 "Eukaryotic translation initiation factor 2D" P41214 1 206571292-206612463 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028220 Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA028220: AB_10602022" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (4.09e-3)" "unprognostic (2.39e-1)" "unprognostic (2.20e-3)" "unprognostic (6.60e-2)" "unprognostic (1.45e-1)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "prognostic unfavourable (1.74e-4)" "unprognostic (3.54e-1)" "unprognostic (1.97e-1)" "unprognostic (8.32e-2)" "unprognostic (2.13e-2)" 19.4 22.3 12.3 14.6 17.0 15.7 25.0 16.7 14.5 23.6 22.2 19.4 23.7 12.1 24.5 21.1 22.3 25.2 19.0 15.2 13.5 9.0 19.6 20.0 15.4 19.9 19.7 10.0 36.2 38.1 19.7 17.3 15.2 14.9 22.8 18.9 18.1 26.9 18.3 27.7 19.2 15.2 22.6 14.5 16.0 21.9 13.1 18.5 29.3 29.3 20.0 21.7 21.0 21.1 19.2 16.6 5.6 13.1 16.4 21.3 10.5 20.1 12.5 10.2 8.8 30.2 39.8 12.4 11.4 23.7 20.7 20.4 10.1 17.7 34.3 8.9 23.2 14.3 16.6 25.8 18.4 11.2 21.3 12.0 14.9 19.1 33.3 21.7 12.4 36.2 34.5 16.4 32.8 26.2 27.9 16.1 18.0 15.8 19.4 10.1 8.3 19.1 15.8 21.9 37.8 21.0 7.5 9.6 8.8 10.0 26.9 24.3 20.6 17.1 18.3 11.5 11.5 5.3 15.2 14.8 8.2 23.9 15.4 14.8 8.5 5.6 10.3 1.6 11.8 9.2 15.9 19.2 16.4 14.5 16.6 15.5 21.3 15.3 0.2 16.4 13.1 8.8 14.5 10.5 12.3 17.0 16.7 14.5 13.5 9.0 19.7 10.0 14.9 18.5 EIF2S2 "EIF2, EIF2beta, PPP1R67" ENSG00000125977 "Eukaryotic translation initiation factor 2 subunit beta" P20042 20 34088298-34112332 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034415, HPA041262, HPA041332" Approved Supported "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB034415: AB_2095998, HPA041262: , HPA041332: " "unprognostic (5.76e-3)" "unprognostic (7.12e-2)" "unprognostic (2.66e-2)" "prognostic unfavourable (8.74e-4)" "unprognostic (1.02e-1)" "unprognostic (1.47e-3)" "prognostic unfavourable (3.23e-5)" "unprognostic (9.36e-3)" "unprognostic (2.39e-1)" "unprognostic (6.55e-3)" "unprognostic (3.04e-3)" "unprognostic (1.25e-2)" "prognostic unfavourable (9.64e-10)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-2)" 25.9 30.1 32.8 23.3 40.7 21.4 38.1 20.2 37.7 21.1 24.3 10.9 27.1 21.2 21.2 22.4 36.3 17.0 18.3 36.3 30.1 20.4 22.0 40.1 27.2 37.7 40.0 26.2 19.9 45.4 18.7 22.4 29.9 35.8 20.4 24.7 7.4 26.3 25.5 101.8 21.2 20.4 37.0 50.2 23.0 28.1 19.6 35.6 18.2 24.1 32.7 30.1 25.0 30.7 38.8 48.5 28.1 39.3 32.4 42.4 27.3 38.9 26.2 19.9 24.0 19.5 29.7 38.0 35.7 34.3 35.6 36.0 92.0 27.4 35.0 26.3 32.2 36.9 32.3 58.7 43.3 11.2 17.6 69.3 21.6 47.0 50.4 44.3 22.6 30.3 50.1 35.2 52.7 37.2 40.6 33.5 29.2 25.0 41.0 37.0 19.3 47.9 23.7 33.9 32.3 28.1 32.7 20.3 13.8 39.5 24.0 73.2 36.3 52.5 25.0 40.8 25.1 25.5 33.4 31.5 27.7 36.5 38.3 34.5 29.5 21.2 37.0 28.1 26.9 39.3 32.9 38.8 38.2 37.6 34.7 31.8 36.4 36.5 21.9 32.4 35.6 48.5 42.4 27.3 32.8 40.7 20.2 37.7 30.1 20.4 40.0 26.2 35.8 35.6 EIF3A "EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 36.7 27.4 19.6 29.4 20.2 41.4 42.4 22.4 22.3 27.8 29.2 21.7 32.3 26.0 33.4 26.0 35.7 22.7 25.0 36.7 19.9 18.6 28.2 41.5 24.6 39.0 24.2 20.1 29.2 61.9 35.8 33.2 33.7 25.5 26.9 26.4 14.4 31.4 31.6 92.3 36.0 29.2 49.3 29.8 29.8 34.1 18.6 22.6 45.8 28.6 33.6 28.7 40.5 38.9 15.0 20.2 21.6 29.7 14.2 27.6 13.9 50.8 38.5 31.8 43.4 34.6 50.2 24.7 46.4 48.2 29.9 30.1 36.2 33.7 59.7 17.3 38.2 51.2 41.3 35.6 42.6 32.8 34.0 51.3 29.8 40.2 39.5 75.0 38.2 43.3 40.1 44.0 75.9 33.8 52.5 39.4 38.6 30.1 31.0 35.5 30.4 19.7 32.1 68.7 28.5 28.6 43.0 14.8 31.5 36.5 34.3 48.0 22.0 48.0 49.6 29.0 26.8 30.3 67.0 34.2 37.5 58.8 30.8 74.0 19.9 21.6 21.2 12.6 16.5 23.9 19.1 15.0 19.9 14.9 20.2 13.3 13.9 15.0 5.7 14.2 29.7 11.6 27.6 13.9 19.6 20.2 22.4 22.3 19.9 18.6 24.2 20.1 25.5 22.6 EIF3B "eIF3b, EIF3S9, PRT1" ENSG00000106263 "Eukaryotic translation initiation factor 3 subunit B" P55884 7 2354086-2380745 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017562, HPA048983" Approved Approved Nucleoplasm,Cytosol 22000 Nucleoplasm Cytosol "CAB017562: AB_2246341, HPA048983: " "unprognostic (1.50e-3)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (3.92e-2)" "unprognostic (9.45e-3)" "prognostic unfavourable (2.20e-4)" "prognostic unfavourable (4.41e-9)" "unprognostic (4.64e-3)" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (3.47e-1)" "prognostic unfavourable (9.66e-6)" "unprognostic (2.38e-1)" "unprognostic (7.54e-2)" "unprognostic (9.00e-2)" "unprognostic (6.18e-3)" 27.5 27.3 16.5 28.9 21.8 38.7 28.8 20.0 26.2 23.5 33.3 22.4 25.7 20.3 29.6 24.1 38.8 28.6 26.2 32.1 15.8 16.5 24.3 51.4 21.7 29.6 22.2 19.4 31.2 66.6 24.2 20.3 34.6 21.1 26.0 24.0 18.0 34.1 24.2 72.3 39.8 23.9 33.0 16.5 31.6 29.7 45.2 19.0 44.9 23.1 34.3 35.9 32.9 29.7 6.5 8.0 3.7 7.3 16.5 9.5 4.4 85.0 43.5 18.0 48.8 20.4 18.5 44.7 29.9 22.5 34.1 32.0 56.8 33.3 49.7 24.7 31.7 46.4 49.6 39.4 37.7 14.8 58.2 37.8 42.2 38.3 28.8 46.0 28.1 23.0 26.0 36.9 38.9 27.4 96.1 23.2 31.1 60.4 22.2 51.8 56.3 39.2 27.4 36.5 51.2 21.8 39.0 41.2 30.8 31.6 70.5 17.1 46.9 51.1 28.9 26.4 58.3 40.4 54.0 25.6 34.4 50.4 29.9 51.7 64.4 1.8 7.3 3.7 7.6 6.8 9.5 6.3 7.4 8.4 7.8 6.5 8.8 8.9 0.6 16.5 5.8 8.0 8.7 4.4 16.5 21.8 20.0 26.2 15.8 16.5 22.2 19.4 21.1 19.0 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli 22000000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favourable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 30.9 18.4 17.4 17.5 19.8 26.4 55.1 34.4 19.3 40.7 29.1 16.1 16.7 20.8 36.1 18.9 33.4 24.2 14.0 15.5 15.0 15.6 23.7 36.1 18.4 31.3 14.0 13.4 63.4 78.8 20.2 26.8 27.9 17.7 38.7 23.8 21.5 39.6 31.0 40.3 30.6 25.2 35.8 15.6 24.7 22.7 19.6 11.4 44.0 54.8 32.3 31.0 38.6 22.0 33.6 58.1 9.8 35.9 25.0 42.5 55.2 16.8 9.6 27.1 19.6 26.2 58.7 19.5 16.2 39.0 26.1 35.8 15.9 12.5 58.1 4.5 18.9 10.8 29.8 22.4 30.8 7.6 49.7 20.5 14.0 7.5 16.4 54.3 17.6 31.6 25.6 19.3 29.2 32.4 17.0 15.9 30.2 6.6 14.4 25.2 15.4 25.3 16.6 37.2 17.0 19.9 10.2 19.7 30.6 16.0 18.8 21.8 14.3 21.9 15.6 16.3 19.8 9.9 12.9 9.5 15.5 23.7 15.3 24.1 13.3 9.8 35.9 9.6 20.7 35.4 34.6 33.6 30.0 25.0 58.1 27.5 42.5 31.8 4.8 25.0 29.1 28.4 29.1 55.2 17.4 19.8 34.4 19.3 15.0 15.6 14.0 13.4 17.7 11.4 EIF4E "EIF4E1, EIF4EL1, EIF4F" ENSG00000151247 "Eukaryotic translation initiation factor 4E" P06730 4 98871684-98930637 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Autism, Autism spectrum disorder, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004077, CAB016316, HPA051311" Supported Enhanced "Cytosol,Cytoplasmic bodies" 580000 "Cytosol, Cytoplasmic bodies" "CAB004077: AB_823488, CAB016316: AB_627502, HPA051311: " "unprognostic (3.07e-3)" "unprognostic (1.43e-1)" "unprognostic (6.53e-3)" "unprognostic (7.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-3)" "unprognostic (2.03e-5)" "unprognostic (6.55e-3)" "unprognostic (1.09e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (5.40e-2)" "unprognostic (1.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" 22.3 26.8 25.7 20.1 35.3 25.2 23.1 40.8 38.4 21.4 27.2 23.3 19.1 19.8 21.7 21.4 39.6 19.9 18.8 23.0 26.0 29.9 29.3 26.2 18.8 24.4 27.7 28.4 18.8 16.1 24.7 25.6 21.8 35.3 19.9 33.2 15.4 23.2 21.0 29.8 19.1 19.5 24.8 31.0 19.4 20.6 39.1 23.4 22.4 33.4 27.1 34.2 22.1 24.2 31.3 25.4 36.6 32.0 32.6 32.2 30.0 25.6 22.5 38.4 25.5 21.9 23.0 23.0 48.9 30.7 40.5 30.5 30.2 32.5 52.0 15.8 30.0 13.0 52.8 36.8 49.5 34.3 15.3 35.4 15.7 27.5 18.8 50.8 26.8 16.4 23.5 31.2 24.7 31.1 58.8 24.3 35.8 22.0 47.0 19.7 30.2 21.0 29.7 26.0 23.1 35.7 22.9 32.5 21.4 22.8 48.4 15.8 23.6 20.1 22.8 29.3 31.5 26.3 39.4 18.2 46.1 47.0 26.1 26.1 33.1 23.3 22.3 36.6 26.3 25.9 30.5 31.3 29.2 27.0 25.4 26.9 32.2 31.9 16.2 32.6 32.0 21.4 28.7 30.0 25.7 35.3 40.8 38.4 26.0 29.9 27.7 28.4 35.3 23.4 EIF4E2 "4EHP, EIF4EL3, IF4e" ENSG00000135930 "Eukaryotic translation initiation factor 4E family member 2" O60573 2 232550052-232583644 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019253, HPA077074" Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA019253: AB_1848092, HPA077074: " "unprognostic (3.44e-2)" "unprognostic (2.70e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-2)" "unprognostic (1.63e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.38e-4)" "unprognostic (1.42e-1)" "unprognostic (5.62e-3)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" "unprognostic (1.21e-2)" "unprognostic (1.36e-2)" "unprognostic (7.74e-2)" "unprognostic (3.34e-3)" "unprognostic (1.88e-1)" "unprognostic (9.38e-2)" 19.0 22.9 27.9 24.0 24.4 25.4 19.4 27.1 38.1 17.6 30.7 18.4 17.0 24.4 26.2 18.2 32.1 18.5 20.0 21.3 25.8 14.8 29.8 43.2 20.4 21.0 18.6 27.2 22.0 26.2 16.3 25.0 26.8 26.3 19.9 35.7 16.1 27.3 15.9 77.6 23.8 25.2 25.3 27.0 25.4 26.7 25.2 21.5 18.1 19.1 24.8 27.1 20.0 21.2 13.5 38.9 49.6 46.8 14.1 24.1 29.7 27.6 22.9 28.1 20.7 20.6 28.2 43.3 37.2 20.2 25.6 26.3 25.2 26.1 27.1 10.6 36.2 23.5 31.6 32.3 32.3 24.2 26.0 37.0 24.7 33.5 25.1 51.6 35.0 24.2 24.3 26.9 19.5 41.6 34.7 9.2 28.9 44.5 21.0 43.9 44.7 19.1 18.2 62.4 17.7 51.4 32.9 27.3 37.4 19.8 23.0 23.7 21.9 36.3 38.0 24.0 31.7 25.1 27.4 17.3 16.3 35.6 26.9 28.5 20.8 49.6 45.1 40.7 14.8 46.8 11.8 13.5 15.1 15.4 38.9 12.2 12.9 13.1 29.5 14.1 41.7 15.2 24.1 29.7 27.9 24.4 27.1 38.1 25.8 14.8 18.6 27.2 26.3 21.5 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030341-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7;salivary gland: 109.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 17.7 3.4 2.5 4.9 3.6 9.2 21.7 1.8 3.2 5.5 15.4 2.0 7.7 6.2 5.3 2.1 22.2 5.0 7.0 9.4 2.2 1.8 6.0 39.6 6.9 7.4 4.3 1.4 9.3 94.7 1.7 2.2 8.7 2.8 7.4 4.6 2.8 109.8 8.0 38.4 4.9 9.0 7.1 4.2 9.3 10.6 3.0 2.7 2.7 3.7 12.6 9.2 11.3 11.1 16.3 41.3 31.3 53.5 4.0 7.6 28.0 20.4 10.6 3.1 18.4 4.0 3.5 13.6 22.7 10.6 12.3 19.7 7.0 5.3 8.0 15.9 11.3 10.9 10.3 18.5 7.3 6.1 33.5 46.8 4.7 9.6 41.8 15.1 7.5 9.8 30.2 13.6 25.5 19.7 25.5 21.4 5.1 12.8 13.2 36.8 22.9 42.7 11.6 13.0 28.2 4.6 2.0 43.2 32.8 4.6 7.5 53.4 10.0 17.8 18.5 7.4 24.3 21.9 17.2 30.8 16.7 9.2 17.3 26.8 16.0 5.1 53.5 31.3 3.9 41.2 3.5 16.3 4.5 4.0 41.3 13.5 3.6 3.6 4.7 4.0 31.4 31.3 7.6 28.0 2.5 3.6 1.8 3.2 2.2 1.8 4.3 1.4 2.8 2.7 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404379-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: , HPA061665: " "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favourable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 57.3 27.2 22.1 28.2 21.8 20.2 77.1 22.7 23.0 28.7 47.9 16.7 25.9 30.8 24.8 18.3 28.3 22.7 37.9 52.4 18.0 15.8 44.4 40.1 31.8 21.6 19.0 14.7 33.4 28.4 23.2 13.3 36.2 18.6 33.2 31.6 34.8 25.5 50.2 54.5 27.6 51.2 32.4 17.8 30.5 28.7 17.9 16.2 34.8 23.5 29.2 22.1 39.8 64.3 7.0 14.0 20.6 17.5 9.3 14.2 14.2 16.8 5.6 30.1 29.4 58.4 22.2 16.3 10.3 12.9 7.7 8.4 24.1 15.2 17.6 6.3 15.2 11.0 14.7 9.6 8.8 18.7 7.6 12.7 6.7 9.5 13.7 22.5 9.0 24.7 9.9 9.4 8.6 11.7 20.6 16.2 11.9 9.7 19.1 23.2 25.3 10.1 19.8 12.1 11.4 9.9 17.6 16.4 24.7 14.3 32.9 13.6 15.0 20.1 12.7 5.0 6.3 8.2 9.2 10.8 21.2 20.8 5.8 33.7 5.1 13.8 15.5 20.6 14.2 13.8 11.6 7.0 11.5 11.7 14.0 6.1 9.8 10.1 17.0 9.3 17.5 4.7 12.5 14.2 22.1 21.8 22.7 23.0 18.0 15.8 19.0 14.7 18.6 16.2 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174245-74197101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 520000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavourable (3.89e-4)" "prognostic unfavourable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 46.8 42.7 47.6 37.6 52.8 82.3 42.8 56.0 89.5 39.8 44.5 46.6 36.2 43.1 48.1 37.9 58.6 44.4 40.7 47.4 45.6 41.4 34.5 50.7 37.4 42.8 45.4 54.6 54.2 74.3 54.3 30.1 72.2 47.6 44.8 35.1 35.6 60.3 45.4 89.6 53.0 41.5 43.4 59.9 34.6 45.4 52.5 32.1 46.8 43.5 57.9 44.2 43.4 41.4 38.4 57.6 60.2 64.2 46.7 52.0 80.6 86.2 57.5 43.9 53.2 39.1 41.7 49.9 61.7 46.9 51.1 50.3 70.4 66.5 74.1 16.9 56.9 45.8 48.3 82.0 48.4 49.8 56.6 41.3 54.0 56.5 44.8 69.6 41.7 48.7 52.1 56.7 80.8 55.9 72.5 32.2 52.3 73.6 54.9 82.6 58.5 56.9 64.4 58.8 66.9 42.5 55.2 44.6 56.4 57.5 72.7 48.9 82.2 45.1 58.2 73.3 49.8 61.2 77.5 38.3 45.7 126.5 57.3 73.1 75.2 45.7 58.4 60.2 43.5 64.2 44.9 38.4 44.7 43.0 57.6 35.3 52.0 42.4 39.0 46.7 63.6 24.4 47.6 80.6 47.6 52.8 56.0 89.5 45.6 41.4 45.4 54.6 47.6 32.1 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 123.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000867, CAB004226" Supported Enhanced "Plasma membrane,Cytosol" 21000 Cytosol "Plasma membrane" "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favourable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 35.7 31.9 36.5 20.8 41.1 67.7 34.4 31.5 47.2 21.3 32.5 25.5 18.8 31.7 27.6 23.5 34.0 27.6 26.2 34.1 37.9 34.2 37.9 78.4 27.3 37.2 37.1 33.3 24.7 32.1 30.1 26.7 31.9 39.3 23.4 32.5 19.2 28.5 32.8 59.4 22.7 31.5 39.5 36.9 31.1 28.2 39.1 27.0 29.6 40.1 30.5 31.1 29.1 37.9 96.7 96.6 90.1 74.3 86.8 90.5 102.2 21.4 25.2 29.3 13.3 25.5 22.6 31.0 31.7 34.4 32.7 24.9 37.1 22.9 22.3 20.1 28.4 28.9 36.9 32.1 55.9 18.2 14.7 19.9 13.3 19.5 26.6 35.8 17.1 24.2 21.6 28.9 39.6 32.8 41.1 21.4 27.0 30.8 24.4 11.9 15.3 48.1 20.7 38.2 13.9 19.3 70.0 26.2 18.4 31.7 23.8 25.7 22.8 16.5 24.9 26.2 17.9 33.4 33.0 64.1 123.4 46.8 25.8 25.2 30.5 83.4 74.3 90.1 74.1 73.2 82.6 95.9 76.0 69.3 70.7 96.7 90.5 76.1 80.3 86.8 73.8 96.6 62.3 102.2 36.5 41.1 31.5 47.2 37.9 34.2 37.1 33.3 39.3 27.0 EIF5A "EIF-5A, EIF5A1, MGC104255, MGC99547" ENSG00000132507 "Eukaryotic translation initiation factor 5A" P63241 17 7306999-7312463 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005042, HPA061298" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005042: AB_562281, HPA061298: " "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (8.10e-2)" "unprognostic (2.80e-1)" "unprognostic (6.95e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-2)" "prognostic unfavourable (9.04e-4)" "unprognostic (4.10e-1)" "unprognostic (4.11e-2)" "unprognostic (1.64e-2)" "unprognostic (8.25e-2)" "prognostic unfavourable (1.63e-5)" "unprognostic (3.53e-1)" "unprognostic (2.79e-1)" "unprognostic (6.01e-2)" "unprognostic (7.65e-2)" 69.0 55.6 37.9 57.0 40.4 83.1 44.5 35.0 59.8 44.6 54.8 37.5 39.8 47.4 47.2 45.5 107.0 38.1 52.9 55.8 35.6 33.6 58.5 192.9 46.6 67.2 34.3 35.9 50.3 126.0 26.0 34.1 73.9 34.0 38.0 57.2 40.7 87.7 40.7 100.6 71.1 49.0 45.4 29.5 65.5 42.9 56.8 24.2 77.9 57.9 105.4 79.0 48.6 50.7 64.7 87.7 44.4 75.7 75.2 79.3 64.3 133.0 166.1 51.2 102.5 39.6 51.0 72.0 100.5 66.3 135.9 95.1 99.3 56.8 129.0 65.1 77.2 91.0 111.3 129.5 123.7 71.7 161.6 77.6 137.6 127.2 70.2 58.9 80.3 54.1 68.0 100.3 136.3 87.2 106.7 36.1 91.9 82.5 69.2 85.2 97.2 82.0 68.5 62.3 118.9 82.0 74.0 59.6 77.5 64.4 78.5 62.2 62.1 45.4 81.7 95.8 69.0 63.6 158.7 30.4 41.5 83.4 90.6 88.7 109.1 44.4 56.0 38.9 65.1 75.7 79.3 64.7 67.1 57.7 85.8 62.6 62.3 62.6 25.1 75.2 68.6 87.7 58.9 64.3 37.9 40.4 35.0 59.8 35.6 33.6 34.3 35.9 34.0 24.2 EIF5B "DKFZp434I036, FLJ10524, IF2, KIAA0741" ENSG00000158417 "Eukaryotic translation initiation factor 5B" O60841 2 99337353-99401326 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034648, HPA040095" Approved Approved "Plasma membrane,Cytosol" 11000 Cytosol "Plasma membrane" "HPA034648: AB_10601902, HPA040095: " "unprognostic (1.23e-1)" "unprognostic (6.94e-2)" "unprognostic (2.01e-1)" "unprognostic (5.03e-2)" "unprognostic (4.65e-2)" "unprognostic (5.88e-3)" "prognostic unfavourable (7.15e-10)" "unprognostic (6.80e-2)" "unprognostic (9.84e-3)" "prognostic favourable (8.99e-4)" "unprognostic (1.68e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (1.42e-6)" "unprognostic (6.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.43e-1)" "unprognostic (7.93e-3)" 24.5 16.0 25.2 22.4 32.6 11.5 22.6 27.7 26.0 23.7 25.1 10.5 19.9 14.8 19.4 28.7 30.8 14.5 15.0 61.7 26.0 22.3 28.8 32.1 17.9 19.2 26.9 23.0 22.3 24.6 26.8 27.5 26.4 28.5 26.0 20.3 7.1 22.3 29.1 105.8 25.3 19.3 31.5 37.6 27.0 20.7 22.6 33.8 17.8 18.2 29.2 22.8 40.1 31.9 15.9 20.2 11.6 12.1 14.1 14.9 4.5 33.7 16.9 19.3 25.1 23.4 27.8 32.0 29.8 18.8 19.9 19.8 38.9 24.2 38.7 25.9 22.2 19.4 33.7 28.9 35.2 23.4 20.2 46.5 17.3 51.1 18.6 45.5 28.8 18.7 20.4 27.6 28.3 28.9 51.3 19.4 28.5 27.4 28.8 42.2 30.1 24.9 25.2 28.7 31.6 40.7 28.4 16.4 15.5 16.2 37.4 24.0 15.2 30.1 31.7 30.9 30.3 16.1 26.5 14.4 20.4 31.6 22.5 50.5 22.7 11.6 8.8 9.8 12.7 9.5 14.9 15.3 13.4 12.5 6.4 15.9 13.2 14.0 2.3 14.1 12.1 20.2 9.0 4.5 25.2 32.6 27.7 26.0 26.0 22.3 26.9 23.0 28.5 33.8 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: " "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 11.1 20.9 11.2 12.6 7.1 9.6 25.3 11.7 12.1 14.1 10.8 13.9 14.1 19.4 20.7 11.8 11.4 8.7 16.8 7.8 15.1 16.5 17.2 13.0 32.2 13.5 16.8 21.5 8.7 15.3 14.2 18.5 17.8 19.1 13.5 12.9 20.7 15.5 24.5 12.9 16.7 18.2 11.8 26.1 17.4 15.4 24.4 28.3 8.2 13.8 12.7 12.8 15.7 12.4 11.3 5.9 9.3 15.6 15.5 37.5 16.1 13.4 17.5 10.4 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 ELAC1 D29 ENSG00000141642 "ElaC ribonuclease Z 1" Q9H777 18 50967991-50988121 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040867, HPA066483" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040867: AB_10697716, HPA066483: " "unprognostic (1.05e-2)" "unprognostic (1.65e-1)" "unprognostic (6.95e-3)" "unprognostic (1.75e-2)" "unprognostic (8.61e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (3.03e-3)" "unprognostic (5.87e-2)" "unprognostic (2.82e-3)" "unprognostic (3.67e-3)" "unprognostic (6.36e-2)" "prognostic favourable (8.43e-8)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" 8.7 15.0 7.7 7.7 9.7 3.3 9.4 7.1 11.9 8.0 9.1 12.8 12.1 7.6 11.3 20.1 7.5 10.0 9.6 7.2 7.3 8.3 12.4 15.2 7.6 11.2 7.6 7.2 8.8 19.5 17.1 15.7 12.3 8.7 9.9 10.8 13.7 20.1 12.2 6.8 7.7 11.7 8.3 7.1 10.8 10.1 16.7 3.9 10.1 15.6 7.0 9.9 8.7 6.6 14.2 12.4 7.8 9.1 16.1 15.7 8.1 6.9 4.8 12.7 10.8 14.3 6.1 5.4 7.6 10.1 7.2 5.1 1.8 6.6 5.4 5.3 7.0 7.0 3.9 8.0 4.9 11.7 1.0 6.6 1.8 1.2 8.4 16.7 4.8 7.6 6.4 3.8 8.9 7.4 6.7 13.5 12.6 3.1 5.7 5.0 6.3 2.1 6.6 4.5 10.0 8.3 3.0 7.5 8.6 6.3 1.1 12.1 5.9 12.8 6.5 9.4 4.9 2.7 5.1 12.7 10.6 7.2 8.7 5.6 11.8 4.1 7.8 7.8 13.2 9.1 14.6 14.2 12.7 12.9 12.4 13.6 12.4 15.7 0.9 16.1 8.7 10.4 10.0 8.1 7.7 9.7 7.1 11.9 7.3 8.3 7.6 7.2 8.7 3.9 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: " "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favourable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 35.6 23.7 39.8 29.9 15.6 15.7 22.4 26.6 22.4 39.7 31.1 34.2 20.8 43.0 37.5 29.2 24.9 44.3 30.5 33.6 38.4 41.2 37.7 17.4 31.8 22.9 35.7 30.2 19.4 18.3 27.6 16.8 30.3 38.7 32.3 27.3 26.5 59.6 28.8 35.5 30.2 67.1 26.0 28.3 25.2 26.4 28.6 20.9 25.2 25.5 20.1 29.1 28.2 22.7 37.2 26.1 34.4 45.8 33.0 31.8 45.2 20.8 43.0 32.0 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell line enhanced" "Detected in some" "A-431: 9.9;AF22: 15.2;SCLC-21H: 51.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB022222: , HPA063001: " "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 9.9 0.1 15.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 4.1 6.4 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.9 0.0 4.6 0.1 0.3 0.5 2.1 0.0 0.0 0.0 4.0 4.8 0.0 5.5 0.0 0.0 0.0 51.0 4.8 0.1 0.1 0.1 0.2 0.7 0.0 0.1 3.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 52.5" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: " "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 ELF2 "EU32, NERF, NERF-1A, NERF-1B, NERF-2" ENSG00000109381 "E74 like ETS transcription factor 2" Q15723 4 139028112-139177218 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006057, HPA071166" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA006057: AB_1078733, HPA071166: AB_2686351" "unprognostic (7.21e-2)" "unprognostic (3.84e-2)" "unprognostic (7.41e-2)" "unprognostic (3.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-2)" "unprognostic (7.05e-3)" "unprognostic (1.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.21e-2)" "unprognostic (2.48e-2)" "unprognostic (3.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.97e-3)" 35.3 12.6 13.2 17.4 24.9 34.3 24.2 29.7 21.6 23.4 22.4 15.2 25.7 12.7 22.9 17.5 18.8 19.0 15.7 20.3 16.1 11.6 15.6 17.4 18.6 19.8 29.3 10.2 25.5 19.5 19.5 23.6 22.8 17.7 23.4 16.9 14.2 21.0 22.4 27.6 19.1 17.9 30.0 23.4 22.8 16.2 30.1 25.1 31.1 21.6 22.4 17.6 25.2 35.0 19.3 19.1 12.5 8.0 10.6 14.8 4.8 9.2 6.8 17.1 12.3 17.2 20.9 16.2 11.1 19.3 12.0 13.8 12.8 18.3 18.6 11.2 14.8 9.6 25.3 14.9 12.5 11.6 10.9 17.0 15.8 10.9 13.2 18.6 13.5 18.5 15.1 11.4 13.9 17.7 27.2 10.8 10.1 15.4 20.9 15.7 10.6 7.5 20.6 22.2 16.9 14.5 16.1 17.2 19.3 13.5 16.8 10.0 11.4 21.3 14.8 11.0 9.6 10.0 7.2 24.2 27.0 16.4 8.2 19.0 9.9 8.6 8.0 12.5 12.4 6.4 12.9 15.3 11.8 10.5 8.8 19.3 14.8 13.4 8.0 10.6 6.4 19.1 9.3 4.8 13.2 24.9 29.7 21.6 16.1 11.6 29.3 10.2 17.7 25.1 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130064874-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA058595: , HPA060277: " "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavourable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favourable (1.42e-4)" 16.9 3.6 2.0 18.1 2.5 27.6 16.9 0.5 3.0 7.7 10.8 3.1 7.0 8.4 10.5 8.1 10.5 9.5 11.0 7.3 3.1 1.2 5.9 2.5 21.9 33.3 3.8 0.9 12.7 4.5 3.8 4.2 23.5 3.0 6.6 10.9 3.6 5.4 7.9 5.7 9.1 16.3 6.4 4.2 18.9 12.3 3.5 2.9 18.1 3.9 7.4 11.5 11.7 14.4 3.9 6.1 9.4 10.3 8.4 10.3 5.1 22.5 8.4 1.5 0.1 3.9 8.4 22.0 10.5 13.4 12.8 14.2 11.6 16.1 11.6 21.1 14.2 14.7 8.4 12.4 12.6 12.4 7.0 22.7 11.2 5.4 8.7 19.8 29.1 8.7 13.9 20.5 20.3 12.3 8.7 3.2 6.9 13.1 3.2 11.3 1.0 8.3 7.0 2.7 4.9 7.8 26.1 5.8 2.5 9.4 9.1 2.9 4.5 19.1 11.4 9.0 7.1 16.7 19.4 1.7 0.7 9.3 10.6 18.2 2.0 1.6 5.4 7.8 10.3 10.3 8.3 3.9 6.2 8.8 6.1 3.5 6.2 7.2 9.4 8.4 7.0 3.7 6.3 5.1 2.0 2.5 0.5 3.0 3.1 1.2 3.8 0.9 3.0 2.9 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell line enhanced" "Detected in some" "REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066382 Approved "Nucleoplasm,Cell Junctions" 11000 "Nucleoplasm, Cell Junctions" "HPA066382: " "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favourable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 2.9 6.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.5 0.0 2.8 1.2 0.7 19.1 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.0 0.2 0.0 12.0 17.6 20.5 0.0 0.0 0.2 5.1 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELK3 "ERP, NET, SAP2" ENSG00000111145 "ELK3, ETS transcription factor" P41970 12 96194382-96269835 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001600 Approved Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA001600: AB_1078752" "unprognostic (3.11e-1)" "unprognostic (8.81e-3)" "unprognostic (6.38e-2)" "unprognostic (5.77e-2)" "unprognostic (7.18e-3)" "unprognostic (1.12e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-3)" "unprognostic (7.39e-2)" "prognostic unfavourable (4.93e-4)" "unprognostic (2.29e-2)" "unprognostic (1.13e-1)" "unprognostic (1.20e-3)" "unprognostic (2.90e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (2.05e-2)" 36.9 9.3 5.0 20.9 6.7 8.3 23.5 12.9 4.5 29.2 12.6 7.3 12.0 4.6 45.2 15.6 25.7 15.0 16.3 15.5 4.8 5.1 13.3 8.2 17.1 20.6 6.1 2.8 13.3 5.8 6.6 6.0 15.9 8.9 18.1 7.5 15.7 14.1 8.6 10.5 8.7 11.1 20.8 13.1 32.7 9.1 8.6 6.3 17.4 19.7 25.1 32.1 15.9 20.9 11.3 9.4 4.1 12.8 10.5 24.1 6.3 12.8 7.7 7.9 4.2 20.2 38.0 2.0 16.4 31.4 13.1 10.1 0.4 9.6 2.0 5.6 18.3 4.6 0.8 26.2 23.1 5.6 3.0 0.6 3.2 2.9 6.1 6.2 1.5 22.3 4.9 26.9 20.4 31.2 1.5 8.6 44.1 1.9 1.2 4.2 9.7 10.3 10.2 13.4 2.3 11.2 3.4 0.4 8.4 5.3 2.4 8.2 1.3 3.4 19.2 36.0 14.1 22.1 14.2 16.6 13.7 0.5 12.7 7.3 24.9 3.3 12.8 0.3 6.2 6.9 24.1 11.3 14.7 8.4 9.4 9.9 8.9 6.5 4.1 10.5 5.9 3.8 23.4 6.3 5.0 6.7 12.9 4.5 4.8 5.1 6.1 2.8 8.9 6.3 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell line enhanced" "Detected in some" "Daudi: 7.8;U-698: 18.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Low region specificity" "Detected in all" HPA028938 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028938: AB_10795352" "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.2 0.1 0.5 7.8 0.1 0.7 2.8 0.3 0.0 0.5 0.7 3.3 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.3 0.3 0.0 0.0 1.2 0.2 0.8 0.0 0.8 0.8 0.1 0.1 0.2 0.0 3.5 0.2 0.3 1.5 0.3 3.5 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 18.8 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 24.5;HaCaT: 23.2;T-47d: 22.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favourable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 1.1 0.8 0.6 7.8 1.8 2.5 4.6 6.7 1.4 2.8 30.3 0.5 32.0 18.9 2.6 9.8 13.1 4.8 16.0 0.9 0.7 0.8 13.3 3.9 6.9 1.4 0.5 0.5 1.2 26.6 6.5 28.7 13.7 1.0 13.2 5.1 0.9 25.1 28.8 0.5 19.1 37.7 1.7 0.5 2.8 12.8 8.7 0.6 1.1 18.2 9.7 9.2 6.8 6.0 1.2 0.8 2.1 0.4 0.4 1.0 0.1 10.6 1.2 1.2 1.5 0.2 0.3 16.7 0.6 0.3 0.8 0.7 7.0 24.5 1.5 0.8 0.3 23.2 1.1 10.7 0.1 0.7 1.4 1.5 1.9 2.3 0.5 0.9 3.8 0.2 7.9 0.6 0.6 0.8 1.4 0.7 0.4 8.9 0.9 4.5 1.6 0.9 2.2 1.1 2.3 1.0 1.4 8.2 1.8 1.5 7.3 0.7 22.9 1.6 1.4 1.9 2.3 1.1 1.1 2.5 0.8 2.8 0.9 2.1 0.9 0.0 0.4 1.0 1.0 0.0 0.1 1.2 0.8 0.1 0.5 1.1 0.6 0.2 2.1 0.4 0.1 0.8 0.5 0.1 0.6 1.8 6.7 1.4 0.7 0.8 0.5 0.5 1.0 0.6 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.6;RH-30: 26.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.3 0.4 0.0 1.8 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.0 11.6 0.0 0.1 0.8 0.0 0.0 0.1 0.5 1.7 0.0 26.5 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.6 0.1 0.0 0.0 3.5 0.0 2.0 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA047600: " "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favourable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.5 7.3 14.9 11.4 15.7 18.1 9.6 15.5 14.8 8.6 10.4 7.1 14.0 10.7 6.9 9.7 6.0 14.1 9.8 10.7 10.4 8.4 8.8 5.8 9.3 14.2 13.4 7.8 12.4 16.4 7.3 7.6 9.4 11.3 17.7 14.8 4.8 14.5 4.6 7.9 6.0 17.1 11.5 6.9 12.5 10.5 7.1 26.4 10.2 10.4 11.1 10.2 5.6 9.4 19.9 7.2 9.3 16.0 18.6 26.4 13.6 14.5 10.6 15.0 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favourable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavourable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favourable (2.85e-5)" 18.5 14.5 11.0 10.5 17.4 4.9 15.0 15.4 14.7 13.4 12.0 18.4 18.6 9.5 12.7 11.6 8.7 13.8 11.5 9.2 13.2 8.6 10.7 14.4 8.4 9.0 20.2 8.8 12.0 11.4 14.4 15.6 11.7 14.2 13.7 9.7 13.0 11.6 14.5 18.8 9.7 10.6 13.4 11.1 11.1 12.1 12.3 17.4 7.6 13.0 6.8 10.2 11.9 10.7 4.5 4.5 10.8 6.6 6.1 7.6 3.9 4.0 5.2 6.0 8.8 18.7 8.4 3.5 7.5 5.8 11.2 10.3 4.3 2.1 3.2 5.8 6.0 4.3 8.3 10.3 10.2 11.0 5.8 5.4 2.9 3.0 9.8 4.1 7.2 8.6 9.2 10.6 12.2 7.9 5.5 3.7 10.3 3.1 6.0 2.4 2.8 5.5 4.3 12.2 2.9 5.1 2.5 5.6 2.9 4.6 6.4 6.9 3.5 3.1 4.4 8.0 4.3 6.9 6.8 4.7 8.3 4.2 8.0 4.8 8.1 9.1 3.9 10.8 7.6 2.6 4.0 4.5 4.9 3.0 4.5 4.1 4.2 7.3 3.5 6.1 6.6 1.2 7.3 3.9 11.0 17.4 15.4 14.7 13.2 8.6 20.2 8.8 14.2 17.4 ELOA "SIII, TCEB3, TCEB3A" ENSG00000011007 "Elongin A" Q14241 1 23743155-23762059 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005910 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA005910: AB_1080227" "unprognostic (6.90e-2)" "unprognostic (5.99e-3)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.99e-1)" "unprognostic (3.93e-2)" "prognostic unfavourable (1.44e-5)" "unprognostic (1.72e-1)" "unprognostic (8.84e-3)" "unprognostic (6.00e-2)" "unprognostic (4.94e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-3)" "unprognostic (2.90e-1)" "unprognostic (4.27e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 25.6 13.7 10.0 14.2 16.1 22.9 16.3 16.0 17.2 13.7 12.2 15.2 15.1 9.8 15.0 9.0 23.6 13.3 15.7 12.9 9.9 9.8 18.1 41.7 20.3 24.1 10.3 12.5 16.0 41.5 19.1 17.1 19.6 12.7 13.6 13.5 13.0 18.6 13.4 26.0 18.3 14.1 14.0 10.9 20.5 24.6 14.4 10.0 19.3 18.4 22.4 21.8 15.6 14.5 20.7 18.8 18.3 20.9 11.0 14.8 13.2 20.0 11.2 16.2 13.9 19.2 12.0 10.3 20.8 18.8 31.0 27.1 13.7 17.6 10.5 25.6 21.0 19.3 33.2 21.9 34.7 30.1 16.4 23.7 17.6 15.9 17.0 24.8 14.4 12.7 17.7 33.8 25.9 18.5 35.1 18.3 24.7 15.2 12.8 10.1 18.8 17.0 19.3 20.6 20.0 14.6 13.7 31.0 17.5 18.9 19.1 23.1 13.8 9.2 19.6 24.4 21.6 43.2 24.4 19.0 21.2 23.2 21.4 24.8 24.3 18.3 19.8 15.4 14.8 20.9 14.6 20.7 12.4 13.3 18.8 16.6 10.2 13.4 5.5 11.0 18.4 15.5 14.0 13.2 10.0 16.1 16.0 17.2 9.9 9.8 10.3 12.5 12.7 10.0 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: " "prognostic unfavourable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 44.6 36.6 33.6 24.3 25.7 33.6 24.1 44.4 36.3 43.6 44.8 32.5 39.0 22.8 36.0 39.3 32.1 37.0 44.3 57.7 26.2 30.7 39.7 39.1 51.5 33.6 25.4 29.8 34.0 35.6 39.4 51.0 40.5 34.9 30.6 57.2 33.1 65.3 45.7 30.5 59.3 23.8 21.1 21.6 47.5 39.2 31.7 30.0 18.6 101.5 41.4 37.4 27.4 30.9 31.7 35.8 34.6 44.5 34.8 42.4 42.0 38.1 27.8 38.4 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226328-102229589 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.6" "Cell line enhanced" "Detected in some" "ASC diff: 8.2;ASC TERT1: 8.1;HSkMC: 11.9;NB-4: 9.2;SiHa: 18.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6" "Group enriched" "Detected in many" 12 "dendritic cells: 2.6;monocytes: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036236 Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 6.3 1.1 1.2 2.1 2.4 3.6 7.3 0.4 0.9 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.3 2.5 2.5 0.6 0.2 0.5 0.2 1.8 0.1 0.7 0.0 0.2 0.2 0.0 1.8 2.4 1.1 0.3 0.2 1.6 3.4 1.7 1.7 24.6 0.3 0.0 0.2 0.8 0.2 6.8 0.0 0.0 0.2 2.8 0.0 0.6 2.6 0.0 2.6 0.5 9.4 0.0 0.0 1.9 2.6 0.2 0.1 6.5 8.2 8.1 2.3 0.1 0.2 0.3 0.4 0.4 2.5 0.0 0.3 0.0 0.0 4.9 0.0 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.1 11.9 1.4 3.0 0.0 0.0 0.1 2.9 0.7 0.0 0.0 9.2 0.1 0.9 0.0 4.3 0.0 1.6 0.0 0.0 0.3 18.5 0.8 0.6 6.7 2.2 0.0 1.3 0.0 0.3 0.2 0.4 5.7 0.0 2.9 5.3 0.0 0.0 9.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 6.6 0.0 0.0 1.9 1.2 2.4 0.4 0.9 0.6 0.2 0.7 0.0 1.1 0.0 ELP1 "DYS, IKAP, IKBKAP, IKI3, TOT1" ENSG00000070061 "Elongator complex protein 1" O95163 9 108867517-108934116 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 26.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 26.9" "Low region specificity" "Detected in all" "CAB021340, HPA049677, HPA050686" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB021340: , HPA049677: , HPA050686: " "prognostic unfavourable (1.57e-4)" "unprognostic (8.71e-2)" "unprognostic (5.13e-2)" "unprognostic (4.21e-2)" "unprognostic (6.44e-2)" "unprognostic (4.49e-2)" "unprognostic (2.76e-2)" "unprognostic (1.55e-1)" "unprognostic (1.67e-1)" "unprognostic (4.02e-2)" "unprognostic (1.10e-2)" "unprognostic (2.80e-2)" "unprognostic (1.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.57e-1)" "unprognostic (2.27e-2)" "unprognostic (4.98e-2)" 10.4 33.0 18.7 10.6 22.9 10.8 13.1 37.6 19.9 13.0 11.5 17.2 11.4 8.2 15.7 17.3 9.8 15.1 10.3 15.3 14.8 15.2 13.0 14.7 11.2 12.8 20.9 17.3 26.4 12.9 41.3 42.3 11.2 20.5 13.1 12.6 15.0 12.0 12.8 11.6 15.7 11.2 14.4 16.7 13.3 11.3 11.7 19.3 12.1 15.4 8.3 13.2 10.4 13.4 2.1 2.7 26.9 2.6 4.0 4.2 1.9 9.1 17.6 15.2 9.8 16.7 16.1 12.5 15.0 10.4 15.3 12.2 16.6 6.7 16.8 6.8 13.4 23.6 23.3 18.7 16.9 15.8 14.6 9.8 27.4 44.9 12.5 19.1 8.8 12.3 13.2 21.3 20.1 13.1 23.1 11.8 14.0 15.6 16.3 11.8 19.4 17.7 14.2 20.5 10.5 11.6 11.8 18.4 14.8 16.5 16.5 10.2 21.4 8.6 12.5 8.8 10.1 19.6 14.9 11.2 25.2 8.5 14.7 12.7 11.9 26.9 1.7 2.5 3.1 2.0 4.2 2.1 3.0 4.0 2.7 1.4 2.9 3.6 0.3 4.0 2.6 1.3 2.4 1.9 18.7 22.9 37.6 19.9 14.8 15.2 20.9 17.3 20.5 19.3 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180556 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favourable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 21.3 19.8 16.5 21.0 22.4 10.5 32.9 23.2 23.6 23.2 19.8 21.6 29.6 14.0 32.3 29.7 15.0 27.2 18.7 21.0 15.8 16.2 17.8 41.0 16.1 17.1 18.6 18.0 46.3 26.7 22.0 43.6 18.7 21.3 28.0 15.4 22.5 19.7 27.4 34.7 23.7 15.6 22.5 18.0 18.1 18.3 19.4 21.7 23.5 20.2 14.1 20.5 25.2 19.5 17.1 14.2 13.4 18.2 17.3 18.8 11.1 10.1 7.3 13.8 12.4 19.6 29.6 15.3 21.1 30.7 17.8 23.9 7.7 9.5 21.4 14.8 17.6 14.5 17.6 15.7 25.4 9.7 9.5 8.3 12.7 13.3 21.5 26.8 8.9 24.0 18.1 17.7 28.9 19.9 13.9 11.4 18.9 12.3 12.9 11.6 16.4 5.6 21.1 16.6 14.9 16.2 23.8 11.0 21.0 19.8 7.8 30.9 10.0 13.6 11.7 16.2 9.4 5.9 10.8 13.7 10.8 19.9 13.6 14.4 13.9 13.4 9.7 7.7 10.9 14.3 15.3 17.1 14.7 12.8 14.1 14.3 18.8 16.4 1.6 17.3 18.2 14.2 14.4 11.1 16.5 22.4 23.2 23.6 15.8 16.2 18.6 18.0 21.3 21.7 ELP5 "C17orf81, DERP6" ENSG00000170291 "Elongator acetyltransferase complex subunit 5" Q8TE02 17 7251416-7259940 "Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023279, HPA052411" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023279: AB_1847613, HPA052411: " "unprognostic (3.73e-2)" "unprognostic (9.21e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-3)" "unprognostic (7.72e-2)" "unprognostic (1.22e-1)" "unprognostic (7.70e-2)" "unprognostic (1.53e-1)" "unprognostic (7.83e-3)" "unprognostic (1.60e-2)" "prognostic favourable (2.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.83e-1)" "unprognostic (8.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.62e-1)" "unprognostic (2.30e-2)" 12.4 18.2 14.0 13.6 14.0 11.8 10.4 14.1 17.8 11.1 15.5 12.2 13.3 11.4 13.1 13.5 10.9 12.6 11.9 23.0 13.2 12.0 16.5 21.3 9.1 15.0 13.6 12.8 15.2 10.6 9.6 15.9 12.6 12.5 14.0 11.0 16.4 20.9 12.7 28.3 7.8 14.6 18.0 11.2 14.1 10.7 103.3 12.4 23.6 15.7 17.2 16.1 11.6 11.0 31.1 36.7 16.3 29.3 27.6 34.7 21.5 12.3 35.1 15.8 14.3 27.8 22.0 6.9 11.1 13.2 17.9 16.6 35.0 8.2 24.6 12.3 17.6 9.3 39.9 26.2 12.9 15.2 56.3 22.7 11.8 31.8 13.8 16.0 9.0 15.5 19.7 12.2 24.1 15.2 15.6 6.6 27.7 20.9 40.7 30.7 13.0 24.4 35.0 17.8 13.3 19.8 11.7 7.7 15.4 21.6 6.6 17.1 9.4 11.7 17.2 10.3 12.1 19.7 17.6 7.7 10.3 28.6 18.8 15.7 13.3 16.3 25.3 12.4 27.9 29.3 34.7 31.1 24.9 25.5 30.0 31.0 26.4 31.2 4.4 27.6 19.3 36.7 33.8 21.5 14.0 14.0 14.1 17.8 13.2 12.0 13.6 12.8 12.5 12.4 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: " "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favourable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.7 15.9 21.3 21.5 17.1 15.8 12.1 20.3 14.1 26.0 23.6 15.5 17.8 31.6 12.7 17.5 10.4 20.6 29.6 15.9 17.6 16.0 28.6 24.6 17.2 18.8 21.6 17.8 17.1 16.0 29.6 18.9 22.3 29.9 9.9 25.8 18.5 25.8 24.5 25.5 27.3 12.9 10.3 19.3 18.2 14.9 19.0 18.5 17.3 14.0 10.5 19.1 17.5 14.5 26.6 19.0 13.8 25.3 20.9 27.4 29.0 13.8 26.4 27.1 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved Approved Microtubules,Cytosol Cytosol Microtubules "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favourable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 41.8 31.5 19.8 17.2 27.1 35.4 24.7 17.2 28.0 17.6 25.0 18.6 23.5 23.2 19.4 19.6 31.3 18.8 17.7 28.3 18.6 21.5 33.0 47.2 22.3 12.7 23.6 20.6 16.3 27.2 25.5 15.9 19.6 27.9 20.8 23.2 16.3 26.0 21.9 54.7 25.4 24.8 20.2 21.9 17.1 23.1 52.6 19.2 15.0 37.7 22.4 20.3 27.3 25.4 25.0 35.1 41.6 46.1 28.1 40.2 51.4 13.4 28.6 10.7 6.4 68.6 27.0 36.0 27.7 24.0 17.3 18.8 19.5 21.5 10.7 20.2 31.4 18.9 18.2 16.4 17.9 29.1 18.3 17.5 21.7 12.7 29.6 19.7 19.8 31.6 29.6 30.3 17.5 21.5 22.3 31.5 25.6 33.1 10.4 9.8 11.9 19.6 13.5 15.1 31.9 21.1 24.4 7.6 15.4 19.7 29.7 17.7 25.1 16.2 24.6 17.4 14.6 18.8 28.0 16.9 44.0 21.7 36.7 14.5 21.8 38.4 46.1 41.3 27.4 36.2 28.3 24.9 27.2 31.2 35.1 25.0 19.9 26.8 41.6 28.1 34.7 31.5 40.2 51.4 19.8 27.1 17.2 27.9 18.6 21.5 23.6 20.6 27.9 19.2 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA062681: " "unprognostic (2.21e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavourable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 30.6 30.2 13.2 13.8 9.5 7.7 25.5 22.0 10.8 18.1 16.7 18.2 11.5 19.3 32.1 10.2 29.6 15.3 15.5 13.1 18.6 57.1 14.0 21.2 25.3 13.8 9.7 14.4 9.6 17.7 16.6 11.7 13.7 17.5 14.0 13.2 18.6 19.8 28.6 19.0 34.1 18.5 12.3 18.3 25.3 8.7 10.9 19.8 18.1 14.2 23.4 16.5 10.5 15.0 15.2 18.9 22.9 32.2 13.7 15.1 12.7 23.8 12.7 18.2 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" 520000 "Nuclear membrane, Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: , CAB062552: , HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 31.2 11.8 8.2 9.0 7.4 14.9 14.7 15.4 16.5 19.7 20.7 10.5 6.1 24.9 23.5 15.8 17.4 15.6 19.1 8.4 14.6 34.1 11.7 17.4 6.2 20.2 11.2 12.9 13.0 15.2 17.6 21.9 13.7 9.6 10.8 13.4 13.3 19.6 20.6 13.7 37.0 16.3 12.2 23.7 10.6 6.0 10.4 12.9 8.0 13.4 18.8 9.3 8.4 12.3 9.8 18.7 22.1 22.1 35.1 26.0 44.9 11.9 19.0 10.6 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.3;epididymis: 10.6;testis: 21.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 29 "basophil: 15.3" "Lineage enriched" "Detected in single" 29 "granulocytes: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 1.0 0.9 1.6 2.5 2.0 6.0 0.8 0.8 1.8 1.3 1.9 3.0 0.0 1.1 0.9 10.6 2.6 0.7 1.6 0.7 0.9 0.6 0.7 0.8 1.1 3.3 1.4 0.9 1.3 0.6 0.2 0.5 2.4 1.5 0.7 2.0 1.0 1.6 0.1 1.4 1.5 2.1 0.8 1.9 2.2 1.1 21.9 2.8 5.7 0.5 0.9 3.9 1.0 1.2 0.1 0.5 15.3 0.0 0.0 0.1 0.2 7.4 11.0 14.7 7.6 0.7 1.5 10.6 7.8 3.0 10.9 10.1 17.3 6.1 5.9 10.4 3.1 5.9 13.6 6.2 15.6 11.6 10.7 14.3 12.7 8.0 0.0 5.8 4.7 0.3 0.4 12.5 5.2 2.5 8.6 14.4 6.4 8.1 13.3 7.5 8.5 7.6 13.8 28.5 8.3 2.4 3.0 5.7 11.4 4.8 2.6 4.5 9.4 6.7 1.7 14.2 8.5 9.3 10.7 9.0 9.1 5.8 4.5 6.6 8.7 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.6 2.0 0.8 1.8 0.9 0.6 1.4 0.9 1.5 2.8 EMG1 ENSG00000126749 "EMG1, N1-specific pseudouridine methyltransferase" Q92979 12 6970893-6979941 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039304: , HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 8.1 10.1 4.9 12.4 6.6 7.3 8.8 3.6 6.3 5.8 7.5 4.8 11.5 7.5 6.9 9.9 8.1 5.8 7.4 11.6 5.0 7.2 8.3 6.4 8.8 6.4 4.2 8.9 9.4 2.7 5.6 12.6 6.2 7.2 6.8 5.1 8.6 11.4 14.9 5.6 6.7 6.3 5.5 7.7 6.0 4.8 6.1 9.0 8.7 9.5 10.8 7.5 8.7 33.3 20.5 7.7 29.6 20.8 30.1 28.5 16.8 16.8 6.5 8.0 5.1 3.7 27.1 12.6 5.6 10.0 6.8 33.0 18.1 17.0 4.7 7.7 12.4 5.9 14.4 11.3 12.3 9.6 23.6 16.6 30.4 6.6 23.9 15.3 6.0 8.6 14.5 16.6 4.3 11.6 3.8 9.4 19.9 12.4 14.7 53.9 8.8 17.2 13.2 13.5 6.3 21.4 3.8 11.4 13.2 13.9 12.0 3.8 17.8 9.1 10.5 13.6 8.5 28.5 4.6 5.2 29.6 11.2 10.4 16.6 4.4 16.6 7.7 24.0 23.8 24.8 30.7 25.5 26.3 18.8 33.3 30.1 27.7 2.3 20.8 29.6 20.5 24.1 28.5 EML4 "C2orf2, ELP120, ROPP120" ENSG00000143924 "Echinoderm microtubule associated protein like 4" Q9HC35 2 42169350-42332548 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036687, HPA036688, HPA065337" Enhanced Supported "Intermediate filaments,Microtubules,Cytosol" 41000 Microtubules "Intermediate filaments, Cytosol" "HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.79e-2)" "unprognostic (9.19e-2)" "unprognostic (8.61e-3)" "unprognostic (1.61e-2)" "unprognostic (2.96e-3)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" 11.3 17.3 5.8 29.3 6.8 19.2 10.5 4.6 5.2 9.4 21.6 6.7 6.8 20.3 13.6 11.6 10.7 8.7 20.3 6.5 5.1 3.9 11.7 26.4 19.3 27.7 4.6 4.0 12.5 37.8 10.8 11.6 26.9 6.5 8.5 12.8 12.1 17.7 8.9 4.3 17.9 33.5 9.2 5.0 30.9 11.7 14.2 5.3 17.4 13.2 6.9 30.0 14.0 9.0 11.5 4.2 10.0 11.0 9.4 17.5 5.9 14.4 25.1 14.6 11.6 5.3 8.8 16.0 9.0 7.1 10.0 9.7 26.2 18.2 13.2 6.2 8.8 7.5 12.6 8.6 17.5 25.8 10.5 12.1 7.8 60.0 6.8 9.1 12.5 9.6 3.3 13.2 9.0 6.9 12.0 13.4 10.7 8.5 8.6 2.4 14.9 7.2 8.9 23.2 7.8 8.2 21.0 14.5 29.2 8.8 9.2 6.8 4.8 3.7 8.0 10.2 13.7 8.1 8.1 15.1 10.5 11.4 8.9 8.8 7.1 4.4 3.9 7.7 7.8 10.9 16.3 11.5 13.0 12.7 3.3 7.9 11.4 8.3 10.0 9.4 11.0 4.2 17.5 5.9 5.8 6.8 4.6 5.2 5.1 3.9 4.6 4.0 6.5 5.3 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell line enhanced" "Detected in some" "Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA062808: , HPA068759: " "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.2 0.1 0.4 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.5 2.7 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.0 1.1 0.0 0.7 1.4 0.2 0.3 1.1 0.6 0.5 0.6 0.0 0.7 20.1 2.7 0.3 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 4.9 1.2 22.8 1.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Cell line enhanced" "Detected in many" "MCF7: 58.3;RT4: 40.1;SK-BR-3: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014711 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA014711: AB_1848147" "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.2 8.6 3.6 4.2 8.1 7.0 7.1 8.9 8.2 5.4 8.2 28.2 21.9 0.0 2.8 10.6 27.8 9.2 11.0 7.1 0.0 5.8 0.0 18.1 15.4 1.4 0.0 0.0 4.2 2.9 7.2 0.7 2.2 2.0 0.5 14.9 58.3 0.1 0.1 4.1 2.1 1.6 4.1 13.6 1.2 40.1 5.0 5.7 11.0 57.6 3.3 35.2 1.3 1.2 17.3 7.5 5.7 4.9 0.1 0.2 0.0 7.6 0.1 16.9 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell line enhanced" "Detected in many" "NB-4: 114.2" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.31e-7)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.5 62.3 3.4 10.0 55.3 86.4 0.1 38.4 70.0 50.9 45.1 6.0 20.1 0.7 8.7 85.3 1.0 3.7 4.2 31.3 18.3 1.6 26.6 16.4 3.6 46.4 13.1 27.8 46.8 0.8 52.2 36.0 21.8 17.5 45.7 77.8 0.9 1.9 114.2 4.7 15.8 1.6 12.0 27.0 43.6 0.0 0.1 0.2 17.4 0.1 9.9 0.2 20.1 35.8 46.0 20.0 36.4 30.1 24.1 29.9 1.7 27.2 17.3 31.2 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB014884: , HPA073141: " "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.2 14.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 8.6 0.8 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA045646: , HPA069809: " "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavourable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.4 26.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.0 0.0 5.8 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 3.4 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 1.9 0.0 7.9 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH, actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" 18000 "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 19.2 17.4 15.8 11.9 17.0 0.6 11.1 7.6 17.6 17.8 24.4 15.3 39.9 9.3 21.9 19.9 16.7 11.8 29.0 18.2 16.7 15.3 5.8 5.9 13.8 3.5 13.7 11.3 24.3 16.7 22.5 10.3 13.5 12.7 26.4 8.0 3.3 14.5 44.9 20.2 8.2 8.0 61.4 13.4 17.3 21.0 18.5 17.2 5.3 6.8 11.4 3.5 35.3 21.9 2.1 0.4 1.0 0.3 0.5 0.4 0.0 20.2 16.2 20.1 18.2 7.9 10.4 26.0 22.5 10.8 13.6 10.3 10.4 7.5 8.6 60.0 34.7 17.9 23.5 8.5 12.9 0.1 14.5 8.9 14.4 14.0 23.6 1.0 0.3 16.1 10.3 17.6 22.6 10.7 0.6 0.4 13.4 3.9 4.0 1.0 33.9 14.7 6.1 28.5 0.2 6.2 15.7 19.8 16.0 44.2 16.9 14.9 20.1 1.3 20.8 35.3 26.0 29.3 44.6 0.9 2.5 5.8 19.4 1.1 18.0 1.0 0.3 0.2 0.4 0.1 0.3 0.6 0.4 0.3 0.0 2.1 0.4 0.4 1.0 0.5 0.2 0.4 0.2 0.0 15.8 17.0 7.6 13.7 16.7 15.3 13.7 11.3 12.7 17.2 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 66.9;TIME: 136.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: , HPA011862: AB_1846217, HPA067440: " "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favourable (6.61e-4)" "prognostic favourable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavourable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 0.9 0.0 16.8 11.5 29.6 19.5 14.0 10.4 6.1 0.0 0.1 0.1 9.5 35.8 0.3 0.0 3.1 3.4 0.0 0.0 5.5 11.0 0.6 13.1 2.6 0.0 19.7 0.7 13.5 4.9 66.9 0.0 0.1 12.1 0.1 0.0 0.2 0.2 0.5 8.7 1.7 0.1 0.0 0.0 0.1 0.2 10.3 9.0 2.6 1.8 3.9 136.5 34.1 1.8 22.2 0.0 0.7 0.1 0.1 9.2 6.8 11.2 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074939-79088599 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 51.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Approved Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favourable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavourable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favourable (8.73e-5)" 10.0 10.1 9.5 20.7 18.4 8.9 11.4 7.0 13.9 10.9 15.1 12.4 8.8 20.3 11.4 6.8 6.5 10.6 8.6 10.3 9.3 5.8 9.2 10.2 10.1 10.7 16.8 8.5 16.3 9.3 11.3 9.8 8.1 13.6 12.3 12.5 10.7 12.1 9.6 35.4 11.9 17.3 7.3 11.9 24.9 11.4 3.9 14.0 8.1 13.6 7.0 9.1 17.5 51.4 0.2 0.7 0.0 1.1 0.0 2.1 0.6 4.5 9.6 3.4 6.2 3.6 1.5 6.5 3.4 1.7 2.8 2.0 5.1 4.9 0.0 4.2 3.5 6.7 5.4 3.7 1.6 2.7 7.2 4.0 9.8 3.0 2.7 4.6 7.7 4.0 5.2 2.4 2.7 2.9 5.8 2.8 1.8 3.8 0.4 4.4 1.5 8.7 8.5 11.6 2.9 1.5 12.7 2.8 5.7 5.5 25.5 2.5 9.0 4.4 3.8 5.5 4.1 4.8 3.4 6.8 1.2 1.9 2.3 8.5 4.0 0.0 0.7 0.0 0.0 1.1 0.9 0.0 0.1 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.6 2.1 0.6 9.5 18.4 7.0 13.9 9.3 5.8 16.8 8.5 13.6 14.0 ENKD1 "C16orf48, DKFZP434A1319" ENSG00000124074 "Enkurin domain containing 1" Q9H0I2 16 67662945-67667265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041163, HPA041478" Approved Supported "Plasma membrane,Centrosome,Cytosol" "Plasma membrane" "Centrosome, Cytosol" "HPA041163: AB_10794986, HPA041478: AB_10794668" "unprognostic (6.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-3)" "prognostic favourable (1.68e-4)" "unprognostic (4.41e-1)" "unprognostic (1.06e-1)" "unprognostic (3.78e-3)" "unprognostic (1.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (5.69e-2)" "unprognostic (6.58e-2)" "unprognostic (1.67e-1)" "unprognostic (2.44e-1)" "unprognostic (3.31e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" 8.5 7.7 4.9 5.9 7.0 3.8 6.6 5.0 6.9 10.4 11.7 6.1 18.6 4.7 11.2 14.2 8.2 14.5 11.0 6.1 5.4 5.2 10.9 4.7 8.9 2.9 4.5 4.4 10.9 38.8 23.7 12.0 4.8 8.3 12.7 3.6 7.9 11.7 12.6 6.0 7.2 5.1 12.9 4.3 6.1 7.3 19.6 6.4 7.1 20.4 5.2 4.9 12.9 6.4 0.6 4.2 3.0 1.3 0.7 1.5 0.5 6.9 4.8 11.3 5.2 3.8 3.9 5.6 5.5 3.3 4.3 5.4 3.4 10.7 2.6 9.4 3.4 8.1 2.9 6.5 5.4 4.0 6.6 2.5 14.4 8.1 6.0 4.6 3.6 3.4 4.7 6.0 5.4 3.5 4.2 1.6 2.2 3.5 5.0 19.2 5.3 1.9 17.8 1.2 19.1 4.6 0.7 11.4 12.4 11.6 1.1 5.9 10.2 6.5 9.2 5.4 7.5 10.0 0.0 12.5 5.6 2.7 8.1 6.8 1.6 0.0 1.3 0.0 0.3 0.5 1.5 0.6 1.2 0.7 0.5 0.0 0.8 1.1 3.0 0.7 0.7 4.2 0.0 0.5 4.9 7.0 5.0 6.9 5.4 5.2 4.5 4.4 8.3 6.4 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879250 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394" Supported Enhanced "Plasma membrane,Cytosol" 490000000 "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: " "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavourable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 68.6 57.7 92.7 94.9 109.6 121.8 73.4 46.6 119.4 47.3 63.8 74.6 21.7 71.3 44.9 24.2 138.2 52.2 55.0 45.2 79.1 70.7 180.4 165.4 64.8 80.3 74.9 62.7 58.2 31.6 52.7 35.5 70.5 88.6 38.6 66.4 62.6 106.1 69.1 45.0 74.6 70.3 84.0 56.4 80.0 44.3 31.7 48.8 98.8 55.4 91.0 119.3 73.5 62.9 38.7 114.1 22.1 105.4 55.5 63.7 159.3 180.7 158.0 76.2 65.2 63.8 71.3 69.1 98.3 109.0 211.8 199.1 101.1 105.0 130.3 131.2 118.2 89.2 129.4 262.3 216.0 88.9 136.7 110.0 160.5 125.6 95.9 219.2 67.8 73.6 79.6 167.7 255.0 135.6 120.5 51.0 137.3 89.5 82.6 117.4 83.1 158.6 85.6 113.6 212.8 250.7 43.1 103.1 63.7 115.3 167.9 121.2 84.1 65.7 123.9 146.7 129.9 125.1 167.1 145.5 103.2 197.7 227.8 179.8 123.1 13.9 105.4 20.8 52.3 75.8 59.1 38.7 55.8 53.8 114.1 32.7 45.6 47.8 22.1 55.5 72.4 31.2 63.7 159.3 92.7 109.6 46.6 119.4 79.1 70.7 74.9 62.7 88.6 48.8 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Cell line enhanced" "Detected in many" "U-87 MG: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: " "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavourable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 14.0 8.9 3.2 0.1 4.8 5.2 0.2 10.9 7.0 16.2 25.0 1.7 1.1 19.8 1.8 4.7 2.1 33.7 3.0 24.6 39.6 3.1 27.3 9.1 11.8 3.5 1.6 32.9 2.6 0.1 11.9 2.4 3.4 1.8 0.2 10.8 1.9 12.8 1.7 17.1 5.0 14.2 2.7 4.3 7.9 1.9 25.9 18.2 2.8 0.2 18.6 0.9 0.8 4.3 14.2 15.0 19.1 14.1 14.5 14.5 2.9 81.3 0.0 2.9 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 638.2;tongue: 320.3" "Group enriched" "Detected in many" 4 "HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" 100000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: " "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavourable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.6 0.3 0.2 0.6 0.2 0.7 0.5 0.6 0.2 0.2 0.4 0.0 0.1 0.8 0.4 8.5 8.6 0.4 0.1 38.3 0.2 0.1 0.5 5.0 0.4 0.5 0.2 0.0 0.4 0.3 0.3 0.5 0.2 0.1 2.1 0.1 1.2 11.8 0.1 638.2 0.3 0.7 0.4 0.2 0.8 0.4 0.5 0.0 0.6 4.8 320.3 10.5 0.3 0.3 13.3 21.0 27.1 24.8 18.5 23.3 36.0 2.8 6.2 2.8 2.6 2.4 0.6 6.8 5.0 0.6 0.3 0.3 3.0 1.9 5.2 6.8 0.4 3.6 1.0 0.4 0.2 70.1 5.7 5.1 30.0 4.4 0.9 1.5 29.6 4.1 1.0 0.5 1.0 0.3 2.3 9.7 1.5 1.5 1.8 6.2 3.6 2.6 8.3 48.2 25.2 0.7 1.9 1.8 6.8 3.2 2.8 3.6 2.5 1.6 1.5 3.0 5.5 1.3 3.7 6.9 3.8 4.3 1.7 5.0 2.9 13.5 15.6 27.1 21.8 22.5 14.7 13.3 18.7 20.3 21.0 11.1 12.3 19.7 19.7 18.5 24.8 16.6 23.3 36.0 0.2 0.2 0.6 0.2 0.2 0.1 0.2 0.0 0.1 0.0 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: " "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.4 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.0 2.6 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.7 8.2 0.0 0.0 1.4 0.2 0.0 0.0 0.0 1.1 0.6 0.9 0.0 2.1 0.1 0.0 5.1 0.0 0.5 0.0 0.7 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430562-82461091 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" 140000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavourable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 10.2 15.4 43.4 12.1 37.1 14.3 16.3 22.9 38.8 13.8 12.7 34.7 5.1 12.2 10.5 23.3 13.5 10.4 9.0 11.1 44.2 34.9 20.8 13.3 11.1 16.0 47.5 26.4 12.9 14.6 17.8 11.7 17.7 31.0 17.2 15.3 8.9 11.4 11.9 9.8 13.1 11.0 11.1 66.2 12.8 13.2 6.1 29.4 14.2 18.0 8.2 18.6 10.7 9.5 13.0 14.1 4.3 10.4 14.4 20.2 12.2 18.8 12.5 22.4 13.9 13.7 13.5 24.6 22.0 14.7 20.1 18.0 22.7 21.1 37.5 23.1 16.6 10.2 29.6 27.8 36.4 22.6 13.8 22.7 12.2 30.2 22.3 37.6 19.7 13.0 29.6 21.0 24.9 20.3 29.3 20.7 26.2 24.3 41.4 22.4 20.6 10.1 29.6 34.4 20.4 32.8 18.7 31.8 19.4 12.5 37.8 27.9 17.1 18.2 14.9 25.0 18.5 24.7 28.9 23.8 20.4 46.8 16.1 23.4 33.5 3.4 8.7 4.3 14.4 10.4 18.0 13.0 17.3 16.5 12.7 11.0 20.2 16.2 0.7 14.4 8.8 14.1 18.4 12.2 43.4 37.1 22.9 38.4 44.2 34.9 47.5 26.4 31.0 29.4 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell line enhanced" "Detected in some" "AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: " "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favourable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 24.7 0.0 33.8 72.2 0.0 22.7 41.5 9.8 9.4 0.0 0.0 0.0 0.3 26.8 0.0 0.5 0.0 6.9 1.8 0.7 0.0 0.0 0.6 15.1 0.0 0.1 33.1 0.2 20.0 1.0 0.1 0.0 4.0 0.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.4 23.9 0.1 0.2 0.0 0.0 16.8 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favourable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favourable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favourable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.8 1.9 3.9 0.3 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.5 2.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 9.3 0.0 0.0 0.0 1.4 0.0 0.1 5.8 8.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "U-698: 419.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol 22000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: " "unprognostic (6.27e-2)" "prognostic favourable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 30.3 26.4 48.9 26.9 48.9 46.8 33.0 33.8 69.3 31.7 31.8 28.0 26.8 34.4 29.7 45.4 66.3 26.3 28.5 30.0 42.4 37.9 31.7 32.3 28.6 30.0 42.0 39.0 27.7 30.5 33.0 25.2 37.5 34.6 23.9 30.4 28.5 29.4 22.8 67.7 49.8 34.0 27.3 38.3 23.8 28.7 12.8 27.3 25.8 35.2 42.9 35.5 31.7 36.3 34.4 39.5 49.5 33.6 33.0 33.2 38.4 14.3 7.6 10.5 10.1 6.7 5.6 11.4 6.5 6.6 9.7 8.2 8.5 10.9 12.9 10.8 5.2 11.6 8.5 14.4 7.2 22.3 11.9 18.5 10.7 6.4 4.5 14.9 23.9 4.4 8.9 10.0 12.8 9.1 14.1 27.2 6.5 31.1 14.6 12.1 21.1 9.3 14.3 8.7 16.1 12.7 12.6 15.8 10.0 9.2 19.4 10.0 26.5 21.9 9.6 7.2 13.4 8.6 16.7 15.3 22.2 419.6 10.0 17.3 9.5 28.7 30.7 49.5 32.2 33.6 28.9 34.4 27.0 33.2 39.5 31.8 22.3 32.9 29.0 33.0 31.9 30.2 29.8 38.4 48.9 48.9 33.8 69.3 42.4 37.9 42.0 39.0 34.6 27.3 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favourable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.6 0.0 0.2 0.1 0.4 0.0 0.0 8.7 1.4 0.0 0.3 0.9 0.2 0.0 0.1 4.7 0.2 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2, transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345953 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavourable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 31.9 35.0 28.7 28.1 34.3 44.4 34.8 20.6 31.4 28.2 34.5 18.7 28.3 31.8 24.6 33.8 30.1 22.9 19.1 34.0 31.8 26.2 44.1 58.8 24.7 26.6 27.6 28.3 19.6 27.8 16.5 35.8 30.6 29.1 24.0 33.7 19.9 27.2 25.9 66.7 20.3 31.6 28.4 31.9 30.6 29.0 21.3 24.3 26.1 24.3 29.5 30.3 29.6 23.3 14.0 32.1 30.3 38.9 13.0 14.6 22.6 42.1 35.3 52.5 23.6 20.0 25.7 15.1 33.7 21.8 34.6 43.8 26.1 26.3 27.5 31.7 26.2 21.6 23.5 23.9 42.3 43.5 27.8 52.7 26.5 53.6 21.4 18.1 32.9 19.4 16.4 22.8 21.6 52.0 50.1 15.5 39.3 68.7 54.7 41.2 38.1 34.5 34.9 22.8 34.0 46.7 32.4 31.7 34.2 21.1 26.6 28.8 33.8 31.4 35.3 23.3 39.3 24.0 34.1 26.6 28.3 52.0 23.5 30.6 27.1 16.3 35.6 30.3 10.7 37.1 13.2 14.0 14.6 13.0 32.1 9.6 12.1 13.3 19.4 13.0 38.9 26.5 14.2 22.6 28.7 34.3 20.6 31.4 31.8 26.2 27.6 28.3 29.1 24.3 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavourable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.1 2.7 5.4 6.5 7.6 14.9 3.9 11.0 13.5 7.0 9.3 3.7 4.6 0.4 1.7 11.9 2.7 3.7 14.3 8.8 26.3 2.6 8.4 6.2 5.2 8.4 4.7 3.5 12.4 12.2 9.0 11.5 38.4 2.3 5.0 23.4 2.1 0.7 1.5 6.2 1.3 0.3 5.6 3.5 6.0 18.7 0.5 3.0 12.6 1.0 10.0 2.8 6.5 20.3 19.7 6.0 2.2 10.6 2.5 8.3 4.0 7.8 7.3 11.0 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell line enhanced" "Detected in many" "BEWO: 45.9;HHSteC: 57.5;RT4: 56.9;TIME: 56.7;U-138 MG: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031200: , HPA069697: " "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favourable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.2 5.6 0.3 0.4 27.0 17.4 45.9 16.6 45.2 9.5 10.4 0.9 0.9 0.0 4.1 31.5 2.5 0.1 13.3 7.1 0.1 0.2 0.0 1.8 11.7 57.5 0.0 3.4 25.5 18.3 18.6 13.1 32.7 0.5 0.0 5.8 4.5 0.1 0.1 0.2 3.1 0.1 0.6 1.7 5.9 56.9 0.2 11.8 13.0 29.9 3.6 2.0 2.3 56.7 49.3 1.4 6.5 1.3 0.0 0.0 0.0 36.0 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell line enhanced" "Detected in many" "HEL: 39.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavourable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favourable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavourable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.3 1.7 18.3 8.6 1.5 0.2 6.1 1.8 2.8 2.3 2.9 4.9 8.8 13.6 4.9 2.5 3.3 22.8 1.7 2.5 24.5 7.0 39.0 5.5 7.9 2.8 13.2 26.0 0.5 5.4 2.2 3.9 4.0 36.7 10.8 0.0 2.5 21.4 8.6 19.2 2.8 32.9 8.0 19.5 2.2 9.3 24.7 18.3 5.7 5.4 12.4 4.1 5.1 0.3 0.1 3.8 3.6 3.8 16.3 21.1 24.3 3.5 13.6 2.0 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 EPB41L2 4.1-G ENSG00000079819 "Erythrocyte membrane protein band 4.1 like 2" O43491 6 130839347-131063322 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005730, HPA006642" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" 170000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA005730: AB_1848195, HPA006642: AB_1848194" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (8.34e-3)" "unprognostic (3.40e-3)" "unprognostic (1.41e-1)" "unprognostic (5.17e-2)" "prognostic unfavourable (2.41e-5)" "unprognostic (1.25e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.16e-4)" "unprognostic (3.24e-1)" "unprognostic (1.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.64e-2)" "unprognostic (3.82e-1)" "unprognostic (3.48e-2)" "unprognostic (9.19e-2)" 50.2 16.5 29.6 17.3 42.8 3.9 21.1 6.5 40.1 20.5 23.1 32.3 7.2 12.3 23.0 13.7 13.2 25.6 18.0 22.8 33.4 24.6 11.5 12.1 24.4 15.4 50.5 33.1 44.4 9.1 8.2 8.4 26.2 34.8 11.2 23.2 52.0 10.1 15.8 16.0 7.1 21.4 20.6 59.5 25.3 11.7 32.2 51.9 6.8 15.2 14.6 11.6 15.2 16.6 10.5 8.6 0.5 8.8 1.0 2.5 1.3 8.3 8.7 19.8 27.2 13.8 22.1 6.1 14.1 17.8 14.4 20.1 16.6 11.8 10.1 26.5 19.3 4.3 7.6 13.0 28.8 43.0 17.5 18.1 10.4 9.5 8.1 0.0 22.2 10.8 0.2 25.4 9.8 22.1 49.1 29.1 9.1 2.1 14.1 3.1 18.3 9.5 22.1 23.8 0.9 24.2 7.9 2.1 0.0 5.9 0.1 11.4 3.0 18.9 26.7 17.0 32.0 28.6 42.3 24.1 0.4 9.5 11.6 0.1 25.8 0.1 3.1 0.5 1.0 8.8 0.9 2.9 1.0 1.2 8.6 10.5 1.7 0.7 0.0 1.0 3.3 2.3 2.5 1.3 29.6 42.8 6.5 39.6 33.4 24.6 50.5 33.1 34.8 51.9 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.0 0.3 1.2 0.0 17.6 20.5 13.8 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 12.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 1.4 10.7 0.0 3.8 0.0 18.5 0.1 0.1 0.0 0.0 0.1 0.2 2.5 3.9 0.0 0.0 0.0 0.1 1.4 20.7 0.1 0.0 0.1 8.2 0.2 1.4 50.8 0.1 18.5 18.0 21.8 0.0 0.0 0.0 0.0 1.6 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 19.6;HeLa: 22.2;RT4: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favourable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 21.4 3.7 3.5 5.0 4.0 2.1 19.0 2.1 6.1 7.3 3.0 1.7 22.1 1.9 6.1 11.3 13.6 6.2 11.7 9.3 4.0 3.1 10.0 4.8 21.9 6.9 3.7 2.0 4.9 4.2 14.3 4.3 8.9 3.7 5.3 3.8 10.5 7.7 22.0 6.8 7.2 3.2 5.9 4.3 6.7 4.3 4.8 1.9 2.1 15.7 8.2 6.9 5.5 12.2 3.6 0.5 1.3 1.2 0.4 4.8 0.9 0.5 3.4 9.1 0.9 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.8 7.7 3.8 19.6 0.0 4.6 0.6 4.3 0.0 0.6 3.2 6.0 22.2 1.2 0.1 1.6 2.0 0.0 1.9 0.0 0.0 5.7 1.1 3.5 0.0 1.1 2.7 2.1 1.7 0.6 1.4 6.9 0.8 5.3 13.4 7.6 3.9 6.7 3.3 2.6 10.0 0.8 9.8 0.4 1.5 1.2 2.7 3.5 0.7 2.9 0.9 3.2 0.5 1.3 0.4 0.2 4.8 0.6 2.7 3.6 1.5 1.4 0.5 3.3 2.4 4.7 0.5 0.4 1.2 0.3 1.4 0.9 3.5 4.0 2.1 3.9 4.0 3.1 3.7 2.0 3.7 1.9 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell line enhanced" "Detected in many" "BEWO: 17.4;hTCEpi: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavourable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.5 5.7 0.4 0.4 0.4 0.0 17.4 0.6 0.2 2.0 1.0 9.8 4.5 0.0 1.2 0.5 7.5 11.6 6.1 2.1 4.8 2.7 0.0 1.8 13.9 1.2 0.2 0.0 0.1 27.3 0.8 9.4 0.1 0.1 0.0 2.8 11.6 0.2 0.1 7.5 8.5 0.0 0.0 0.3 7.0 6.9 7.2 0.7 1.8 12.1 0.0 2.8 0.0 0.2 4.1 4.2 1.3 1.6 0.0 0.0 0.0 3.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell line enriched" "Detected in single" 92 "HEL: 42.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 EPC1 Epl1 ENSG00000120616 "Enhancer of polycomb homolog 1" Q9H2F5 10 32267751-32378798 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005811 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA005811: " "unprognostic (6.94e-2)" "unprognostic (3.03e-2)" "unprognostic (9.93e-2)" "unprognostic (9.43e-2)" "unprognostic (5.73e-2)" "prognostic favourable (6.40e-4)" "unprognostic (1.80e-2)" "unprognostic (3.83e-3)" "unprognostic (7.43e-2)" "unprognostic (5.55e-2)" "prognostic favourable (6.02e-4)" "unprognostic (4.40e-2)" "unprognostic (1.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-3)" 17.3 10.0 13.2 19.9 14.3 35.0 19.4 45.3 16.3 20.1 18.0 15.6 13.6 10.6 21.4 15.1 11.7 17.3 12.4 13.5 13.0 10.5 12.3 13.9 13.7 20.5 14.1 10.1 25.4 19.9 20.4 35.7 12.5 12.6 17.2 16.1 15.8 15.1 14.7 22.0 16.8 15.5 21.5 14.3 18.9 13.2 10.2 17.8 41.2 17.9 14.4 19.9 19.1 17.8 12.7 11.1 16.1 6.1 6.6 9.1 3.1 7.8 8.2 16.8 14.1 8.0 11.4 6.6 9.3 5.6 10.1 9.9 5.6 9.4 14.5 6.2 9.3 7.6 8.9 7.3 7.5 11.9 8.4 12.5 6.9 6.8 8.8 8.4 14.2 9.5 12.2 6.7 4.9 9.3 10.4 18.1 9.6 7.8 15.7 6.1 3.7 3.2 17.7 13.7 6.9 8.3 7.5 12.9 13.3 8.2 6.1 12.4 5.9 14.1 9.5 7.3 10.5 5.1 7.5 7.8 5.9 15.3 7.1 13.6 6.7 14.6 6.1 10.9 8.6 4.0 9.1 10.7 8.6 7.8 3.9 12.7 8.9 8.1 16.1 6.6 5.8 11.1 8.7 3.1 13.2 14.3 45.3 16.3 13.0 10.5 14.1 10.1 12.6 17.8 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Group enriched" "Detected in some" 6 "hTCEpi: 61.2;U-2197: 27.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.1 0.0 61.2 1.0 4.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 1.1 0.0 0.1 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.4 31.3 8.7 4.2 0.6 0.7 5.1 9.3 13.3 17.0 10.8 13.0 41.9 0.0 40.4 5.3 6.3 2.0 21.6 5.9 0.0 1.4 0.0 9.1 8.3 11.1 0.0 0.0 1.0 8.1 9.2 20.5 18.1 0.0 0.0 10.7 4.9 0.0 0.0 4.2 48.0 0.0 7.9 0.0 18.0 8.0 0.0 1.3 18.2 4.4 1.2 0.6 0.1 22.3 6.1 16.3 0.4 49.2 0.0 0.1 0.1 4.7 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Cell line enriched" "Detected in some" 6 "AF22: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Group enriched" "Detected in some" 4 "HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 3.1 0.0 0.6 33.9 0.4 2.5 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.1 0.1 0.1 1.3 0.0 0.0 0.5 0.1 9.2 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.6 2.0 0.3 4.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: " "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favourable (4.98e-4)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 16.7 7.1 6.8 10.9 0.6 0.6 0.0 3.9 0.2 11.8 2.5 2.4 6.7 0.2 8.4 1.7 15.8 4.6 22.8 3.1 0.0 1.6 0.0 0.7 0.0 7.1 0.0 1.7 2.3 7.3 21.1 0.1 31.1 0.6 0.0 2.3 2.5 0.3 0.1 1.6 4.6 2.0 7.0 0.3 5.8 1.6 7.4 7.8 6.8 0.2 0.1 0.4 0.2 30.7 4.7 12.4 11.9 26.8 0.0 0.1 0.0 8.8 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 EPN1 ENSG00000063245 "Epsin 1" Q9Y6I3 19 55675226-55709858 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009729, HPA061136" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB009729: AB_2277865, HPA061136: " "unprognostic (6.93e-2)" "unprognostic (2.47e-1)" "unprognostic (5.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.94e-2)" "unprognostic (8.76e-2)" "unprognostic (1.23e-2)" "unprognostic (7.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (6.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (2.78e-3)" "unprognostic (7.92e-3)" 26.7 23.4 34.2 20.6 31.4 15.7 31.4 26.3 47.1 13.5 32.7 17.2 18.1 67.7 13.7 19.8 21.3 15.4 28.2 56.0 28.0 18.6 23.1 36.0 16.5 25.5 17.5 25.9 23.2 54.5 12.1 14.3 15.0 15.8 19.3 13.8 13.5 24.8 22.7 84.7 22.2 59.7 12.2 14.3 26.9 55.1 20.2 13.1 11.2 15.3 26.3 14.6 13.1 16.2 2.2 3.6 4.6 6.9 0.7 2.0 2.4 24.6 34.1 8.5 17.4 9.8 9.4 17.5 18.4 10.5 13.1 13.1 14.2 15.6 15.2 12.5 14.7 18.9 7.4 14.0 4.7 5.2 70.5 11.1 18.2 16.8 13.6 7.1 10.7 12.2 12.4 11.3 8.2 12.5 16.5 12.9 8.6 13.9 11.3 11.7 19.5 48.2 7.6 11.6 26.6 9.9 14.6 12.3 29.9 17.0 18.5 12.1 13.9 25.0 20.8 36.5 17.6 13.1 26.5 14.2 12.9 10.9 26.8 14.4 18.0 2.4 3.5 4.4 1.4 4.5 1.0 2.2 1.4 1.3 2.4 2.0 1.4 1.3 4.6 0.7 6.9 3.6 2.0 2.4 34.2 31.4 26.3 47.1 28.0 18.6 17.5 25.9 15.8 13.1 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532543-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 12.4;HBEC3-KT: 17.2;hTCEpi: 9.7;MCF7: 27.5;RT4: 21.6;SK-BR-3: 11.2;T-47d: 24.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 6.8;pons and medulla: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055546: , HPA063224: " "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favourable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.4 7.7 0.5 1.9 0.7 0.4 1.9 1.1 6.8 5.3 7.8 1.5 24.0 5.1 0.7 3.8 26.2 6.0 12.6 6.6 0.5 0.7 10.9 0.4 0.7 0.0 2.0 1.4 10.3 18.3 9.6 0.9 8.4 17.8 9.3 3.4 0.3 16.7 18.7 0.4 19.7 5.1 0.5 0.6 0.3 23.8 2.2 0.0 3.4 1.2 15.9 21.9 8.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 6.3 5.4 0.0 0.1 0.0 12.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 27.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 21.6 0.2 0.0 0.0 11.2 0.0 24.9 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.1 6.8 0.5 0.7 2.0 1.4 17.8 0.0 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;Hep G2: 18.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: , HPA056555: " "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.4 2.2 15.7 0.5 0.1 3.8 0.6 0.2 0.6 1.1 3.4 1.1 5.5 3.8 0.4 2.3 7.3 1.5 1.2 5.7 5.6 1.2 0.6 18.0 1.0 0.6 3.0 0.3 2.6 0.7 1.5 0.5 3.7 8.5 0.4 4.6 4.9 1.6 0.5 3.1 11.8 1.3 12.0 0.4 0.7 3.4 5.3 1.9 2.6 0.6 3.7 2.3 0.8 0.6 0.7 0.7 0.6 4.5 4.9 7.0 1.3 8.1 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favourable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.4 1.1 3.5 4.1 5.3 3.4 2.1 2.2 6.8 3.5 4.5 1.2 1.3 2.4 3.9 3.9 0.9 2.7 1.3 4.1 1.9 1.6 13.0 1.1 2.0 3.8 2.7 5.4 2.5 0.5 4.7 3.3 8.2 11.4 11.6 3.9 3.1 2.5 3.2 1.9 9.3 6.7 5.9 5.2 3.3 1.8 1.4 10.9 1.4 2.0 6.0 3.5 4.7 3.4 1.9 2.6 6.5 1.9 5.9 4.3 2.6 10.3 2.6 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519328 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" 67000 "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: " "unprognostic (1.45e-2)" "prognostic unfavourable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 39.0 26.9 35.5 25.3 27.8 13.2 19.3 22.2 41.0 25.7 16.7 35.7 16.2 11.4 21.8 21.3 19.6 14.1 19.3 18.9 40.7 26.0 21.0 19.1 24.4 30.7 36.2 11.2 22.4 10.9 17.0 14.6 22.8 20.3 22.5 15.5 25.7 24.3 16.4 30.9 18.1 19.3 18.2 36.8 33.8 15.2 32.4 33.1 25.0 20.3 23.4 32.1 25.3 17.0 16.1 10.8 14.9 12.2 10.7 18.7 8.0 14.7 4.4 9.6 9.0 22.2 22.2 23.9 10.3 16.4 8.5 12.6 6.0 8.2 30.2 10.7 16.2 14.1 12.4 9.9 12.9 34.1 7.8 26.9 7.6 7.2 20.9 15.2 24.8 18.0 9.2 14.8 20.2 15.8 16.6 13.8 12.9 7.2 12.2 8.3 13.1 7.2 10.0 14.5 6.6 11.2 18.4 6.6 9.2 12.3 21.9 17.9 8.9 10.8 21.8 7.9 8.5 15.8 8.6 16.5 16.7 20.4 11.7 17.3 6.9 14.9 10.1 11.6 10.1 10.7 15.3 16.1 12.2 15.6 10.8 10.0 7.3 10.5 7.8 10.7 12.2 7.1 18.7 8.0 35.5 27.8 22.2 41.0 40.7 26.0 36.2 11.2 20.3 33.1 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 73.3" "Cell line enhanced" "Detected in many" "A-431: 45.8;BEWO: 45.3;CAPAN-2: 43.2;SK-BR-3: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 6.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 13.6" HPA041143 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavourable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 1.7 3.0 2.0 6.4 3.3 0.0 12.4 6.9 2.5 11.6 31.5 1.2 23.9 38.7 4.6 10.1 53.3 5.3 21.7 1.0 1.3 1.6 30.4 38.3 18.0 0.4 1.7 0.5 3.9 11.6 1.8 4.3 39.6 3.6 8.4 6.0 2.7 26.2 17.6 0.7 22.8 73.3 2.4 2.4 0.5 18.0 7.2 1.5 0.9 29.5 29.4 33.7 6.9 19.2 0.2 6.4 0.7 0.1 0.1 0.1 0.1 45.8 14.0 0.0 0.3 0.5 3.1 45.3 4.0 4.2 6.0 2.6 10.5 43.2 0.1 16.8 4.3 24.3 0.1 24.3 1.4 0.1 0.9 0.0 5.2 18.8 3.4 0.0 0.0 1.6 16.3 1.7 4.2 0.0 0.3 0.2 0.6 14.7 0.1 0.2 0.5 4.5 0.1 0.1 0.3 21.2 11.4 0.1 0.1 14.3 53.0 0.1 20.0 0.0 0.3 2.4 5.7 1.5 0.3 0.1 0.2 0.1 1.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.1 2.0 3.3 6.9 2.5 1.3 1.6 1.7 0.5 3.6 1.5 ERAL1 HERA-B ENSG00000132591 "Era like 12S mitochondrial rRNA chaperone 1" O75616 17 28854938-28861067 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021425, HPA024423" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA021425: AB_1848228, HPA024423: AB_1848229" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (5.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.55e-1)" "unprognostic (8.37e-3)" "prognostic unfavourable (3.59e-4)" "unprognostic (8.20e-2)" "unprognostic (7.04e-2)" "unprognostic (2.70e-1)" "unprognostic (8.57e-3)" "unprognostic (5.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.49e-1)" "unprognostic (2.62e-1)" "unprognostic (5.79e-2)" 16.2 24.8 24.1 13.3 31.6 12.7 19.4 25.1 47.9 18.4 20.9 27.1 15.8 18.0 21.5 19.2 20.6 22.2 17.2 24.5 23.0 22.0 24.9 33.7 14.8 16.0 21.3 20.2 22.0 18.1 29.3 15.4 24.7 27.6 18.0 23.4 17.3 28.2 21.2 34.1 18.3 19.7 21.8 18.4 17.0 18.2 17.3 15.5 20.4 20.3 21.5 23.8 16.1 14.8 20.1 29.0 11.1 23.1 20.8 18.2 14.9 15.9 31.1 18.2 20.6 20.1 13.8 17.8 12.8 18.3 38.9 32.0 30.3 10.3 20.6 15.6 22.0 17.8 33.3 29.2 32.5 20.3 39.0 16.5 20.7 30.6 25.8 19.6 15.1 18.0 26.0 31.5 29.9 31.7 32.8 13.0 21.6 25.1 20.4 30.4 16.8 14.9 18.9 28.9 26.6 23.5 18.2 19.4 15.6 20.9 51.5 16.5 36.2 23.1 12.7 15.9 17.9 17.5 26.9 10.5 19.0 22.0 17.2 17.2 16.1 11.1 17.9 7.1 17.8 23.1 13.4 20.1 15.2 13.0 29.0 18.6 17.6 18.2 1.4 20.8 15.6 15.0 16.3 14.9 24.1 31.6 25.1 47.9 23.0 22.0 21.3 20.2 27.6 15.5 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: " "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.3 4.7 6.3 5.9 35.0 34.3 18.4 5.4 17.5 13.1 23.0 5.9 26.7 22.0 11.3 10.4 7.6 5.2 11.1 8.2 39.8 2.2 7.1 3.1 4.0 40.1 3.4 13.2 14.2 4.8 15.0 4.6 18.0 3.7 21.4 7.8 3.4 31.6 3.5 3.1 3.0 23.5 8.6 10.9 9.8 11.4 2.3 1.6 8.6 5.8 8.4 5.1 16.4 14.3 11.3 3.8 1.9 8.9 8.0 15.0 17.1 12.1 11.6 6.6 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 27 "SK-BR-3: 263.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.8" "Lineage enriched" "Detected in many" 4 "T-cells: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Supported "Plasma membrane,Cytosol" 430000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavourable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavourable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favourable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 5.8 2.4 5.2 10.4 7.0 0.1 20.1 4.2 7.0 19.1 46.5 9.1 55.2 21.6 14.9 18.7 40.9 22.7 26.6 24.8 6.3 3.1 37.5 21.5 17.6 3.7 5.1 5.6 19.3 16.2 27.7 8.1 60.8 7.5 23.6 16.6 15.9 28.7 58.1 8.9 35.3 47.2 10.9 4.5 4.0 17.1 6.5 3.7 2.8 35.7 20.8 22.9 19.7 20.3 1.3 0.3 2.1 0.4 0.9 8.8 2.2 3.1 3.8 4.2 2.7 5.1 3.6 5.7 2.2 3.7 4.9 4.2 2.8 8.6 0.2 4.6 5.1 9.8 0.2 5.1 2.3 0.4 3.2 0.1 3.0 4.5 3.0 0.0 0.0 3.5 4.8 3.0 1.8 2.0 0.4 0.1 3.6 4.8 0.5 0.2 7.6 0.9 0.3 1.7 0.4 5.0 9.8 0.8 0.2 4.2 263.9 1.3 7.4 0.1 0.2 2.5 3.3 3.2 1.4 0.4 0.2 0.2 0.2 0.0 8.2 1.6 0.4 0.8 8.8 0.3 0.7 0.9 0.5 2.5 0.3 1.3 1.0 2.5 2.1 0.9 0.2 0.2 0.4 2.2 5.2 7.0 4.2 7.0 6.3 3.1 5.1 5.6 7.5 3.7 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 31.1;MCF7: 20.3;RT4: 24.3;SK-BR-3: 28.6;SK-MEL-30: 38.1;T-47d: 31.7;WM-115: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.3" "Low region specificity" "Detected in many" "CAB025331, HPA045396" Uncertain Approved "Plasma membrane,Actin filaments" "Secreted - unknown location" 420000 "Actin filaments" "Plasma membrane" "CAB025331: , HPA045396: " "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 1.1 1.4 11.6 12.6 16.5 0.6 26.8 2.0 16.7 6.8 40.5 40.3 12.0 37.7 2.8 7.5 29.4 5.7 22.9 3.4 18.6 9.0 16.5 33.9 13.4 0.5 23.5 9.3 0.9 21.5 11.4 1.0 15.4 14.9 16.8 29.7 5.5 36.8 22.3 1.1 30.7 41.3 3.2 27.4 0.5 32.9 1.2 23.8 0.0 4.5 7.4 8.5 11.8 14.4 0.9 0.7 5.3 0.6 1.2 1.2 0.2 10.1 0.6 0.8 0.3 0.0 0.0 16.5 0.8 1.9 1.1 1.1 5.5 18.3 0.0 0.2 0.2 8.6 1.2 1.9 0.6 0.2 0.8 0.0 0.3 31.1 0.0 0.0 0.1 0.4 2.5 0.2 0.0 0.0 0.7 0.3 0.1 20.3 0.1 0.3 2.8 0.4 0.1 1.9 0.5 2.1 24.3 0.9 0.3 0.7 28.6 38.1 31.7 0.1 0.0 0.1 1.1 0.6 0.1 0.3 0.1 0.1 0.1 0.0 40.5 5.3 0.4 0.8 0.9 0.4 0.4 0.4 0.7 0.3 0.3 0.9 0.6 1.2 3.3 1.2 0.6 0.7 0.8 0.2 11.6 16.5 2.0 16.7 18.6 9.0 23.5 9.3 14.9 23.8 ERBIN "ERBB2IP, LAP2" ENSG00000112851 "Erbb2 interacting protein" Q96RT1 5 65926475-66082549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048606, HPA059863" Approved Supported "Nuclear speckles,Plasma membrane" 250000 "Nuclear speckles, Plasma membrane" "HPA048606: , HPA059863: " "unprognostic (4.34e-1)" "unprognostic (5.56e-2)" "unprognostic (9.88e-2)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (4.23e-3)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" "unprognostic (6.52e-2)" "unprognostic (5.45e-3)" "unprognostic (7.98e-2)" "unprognostic (5.62e-3)" "unprognostic (7.21e-3)" "unprognostic (3.08e-1)" "unprognostic (6.86e-2)" "unprognostic (7.81e-2)" 20.1 8.7 33.2 28.5 32.7 13.3 13.0 5.4 15.9 16.1 21.1 10.6 16.3 12.1 14.5 22.1 17.2 10.5 17.2 12.6 29.5 22.5 15.8 24.1 20.1 21.1 32.5 7.4 11.1 13.7 15.4 6.9 10.4 16.0 18.2 13.8 11.1 17.3 26.0 16.4 16.9 37.4 15.3 31.0 27.6 20.3 13.3 17.6 40.2 19.6 16.3 19.6 20.7 14.9 6.2 4.5 13.5 7.6 5.0 7.1 3.6 30.2 10.2 13.3 15.9 10.0 12.1 10.1 19.5 20.0 27.8 31.1 9.6 36.2 25.5 19.0 30.1 10.1 8.5 14.2 49.3 11.2 3.8 8.8 12.9 7.6 13.2 6.8 8.6 13.1 9.5 15.2 22.3 10.3 8.9 17.6 18.7 10.3 17.9 7.8 3.3 2.9 16.5 10.7 14.1 16.3 20.7 6.5 6.0 20.7 7.0 14.7 12.1 16.7 9.4 15.8 28.1 9.5 25.0 15.2 9.4 21.9 10.4 11.3 9.0 13.5 5.2 6.7 7.1 7.6 6.5 6.2 5.5 6.3 4.5 4.9 6.5 6.7 11.9 5.0 6.0 2.9 4.8 3.6 33.2 32.7 5.4 15.3 29.5 22.5 32.5 7.4 16.0 17.6 ERC1 "CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2" ENSG00000082805 "ELKS/RAB6-interacting/CAST family member 1" Q8IUD2 12 990509-1495933 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019513, HPA019523, HPA024130" Approved Supported "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014" "unprognostic (2.41e-1)" "unprognostic (4.00e-2)" "unprognostic (2.14e-1)" "unprognostic (5.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (5.50e-2)" "unprognostic (8.49e-2)" "unprognostic (2.53e-1)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (6.79e-2)" "unprognostic (3.75e-3)" "unprognostic (4.19e-2)" "unprognostic (3.01e-1)" "unprognostic (7.37e-2)" "prognostic unfavourable (7.01e-4)" 12.6 11.4 10.3 12.5 14.7 7.4 15.1 41.7 10.4 11.2 11.9 8.5 9.2 4.3 17.1 11.0 13.7 9.8 9.9 14.7 10.0 11.2 11.2 8.0 8.8 5.4 9.0 6.4 12.5 8.6 24.3 19.4 13.2 10.7 11.4 7.5 10.1 9.3 14.4 9.2 9.9 6.4 22.1 8.5 7.3 8.6 11.0 9.9 9.8 15.3 7.2 8.6 15.7 15.3 8.6 2.9 2.1 3.8 1.1 3.5 0.5 2.9 7.3 3.9 2.6 10.4 8.8 5.4 9.2 7.4 6.3 5.8 6.4 3.6 4.5 1.3 11.9 5.0 8.3 7.1 8.8 9.5 4.2 11.1 7.3 3.2 7.9 5.7 2.6 7.1 6.2 11.1 20.8 8.1 3.3 9.0 4.7 3.2 1.8 1.2 6.2 3.5 3.6 14.8 1.4 6.2 5.3 2.3 4.6 14.4 3.3 5.2 3.4 2.4 15.0 10.9 11.1 8.0 8.6 2.4 4.5 6.7 7.1 3.4 4.8 1.4 2.8 2.1 1.6 1.0 2.2 8.6 2.4 2.4 2.4 5.6 3.5 2.6 2.1 1.1 3.8 2.9 2.2 0.5 10.3 14.7 41.7 10.4 10.0 11.2 9.0 6.4 10.7 9.9 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: , HPA069266: " "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favourable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 7.4 15.6 11.4 10.6 17.7 6.7 7.1 9.5 23.8 9.4 8.1 11.7 7.8 7.9 11.7 6.0 6.7 10.0 10.1 7.9 9.4 9.1 8.7 13.2 6.5 9.9 8.2 10.5 9.5 13.1 12.9 10.9 7.2 14.0 8.2 6.4 12.5 9.5 11.8 15.9 10.7 7.1 11.2 5.3 9.7 8.3 17.2 7.8 10.8 10.2 5.1 8.3 9.3 6.6 7.8 17.2 5.0 13.9 11.3 9.8 8.7 12.3 6.0 12.6 17.7 7.5 8.9 6.7 17.6 12.1 22.8 17.5 14.0 8.5 4.4 10.1 17.1 6.4 8.8 14.8 8.7 10.6 14.5 7.5 11.5 14.7 15.9 11.9 13.3 10.2 2.3 26.0 14.8 13.2 18.2 5.0 15.7 6.0 7.0 7.9 5.8 10.6 13.5 8.9 3.7 6.5 10.9 7.4 8.0 15.6 11.1 6.2 10.5 15.8 17.1 21.8 11.9 9.2 39.1 11.6 6.7 6.4 6.4 7.3 9.6 0.0 13.3 5.0 7.7 13.9 9.8 7.8 7.4 7.4 17.2 5.8 7.1 7.4 0.4 11.3 10.9 8.3 7.4 8.7 11.4 17.7 9.5 23.8 9.4 9.1 8.2 10.5 14.0 7.8 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "CAB000156: , HPA045828: " "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.0 5.1 7.6 6.9 8.6 7.3 8.6 7.0 10.7 9.1 4.5 8.0 4.1 4.7 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.1 6.3 9.2 7.3 9.7 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "Q03468, P0DP91, Q8N328" 10 49455368-49539538 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 34.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA071297: " "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 7.9 6.9 11.5 6.0 12.3 13.9 11.1 21.0 13.9 9.8 7.0 8.9 10.6 6.4 9.3 8.6 13.5 8.1 7.7 9.1 12.7 6.5 10.1 10.0 8.0 7.9 9.2 11.4 12.5 13.1 20.3 14.2 9.7 10.1 10.5 8.8 9.2 10.5 13.7 9.6 14.4 9.1 7.9 11.8 9.2 7.6 7.8 12.4 7.8 13.6 8.2 9.6 9.9 11.6 7.9 5.1 10.9 8.1 1.6 5.3 2.1 6.6 3.5 2.6 1.6 4.5 7.6 2.1 11.9 16.5 8.2 5.8 3.6 4.1 2.9 2.2 10.7 6.2 3.7 9.4 8.3 4.6 2.4 2.2 13.1 2.0 2.6 3.0 2.3 2.6 12.9 8.0 34.2 11.9 4.3 0.8 10.6 4.9 2.1 1.7 2.4 6.2 2.0 3.8 1.7 2.8 4.7 3.5 3.6 8.8 3.2 5.3 5.8 1.7 22.8 4.6 3.8 5.5 3.0 3.2 3.0 2.8 5.6 3.3 3.4 10.9 4.1 9.7 5.3 3.7 4.2 7.9 3.1 2.9 5.1 6.3 3.8 1.8 9.8 1.6 8.1 2.8 4.0 2.1 11.5 12.3 21.0 13.9 12.7 6.5 9.2 11.4 10.1 12.4 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Supported Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA050492: " "prognostic unfavourable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 10.9 9.6 8.9 5.6 0.6 1.1 4.9 11.8 5.4 10.4 10.9 7.8 6.9 17.8 4.5 4.2 9.1 16.6 8.8 18.5 10.1 12.1 6.1 3.3 4.6 0.0 11.9 8.6 0.1 0.5 14.4 2.7 5.7 8.0 4.4 10.5 8.6 11.3 7.0 16.1 14.9 9.5 15.9 3.1 2.6 6.8 7.3 5.2 8.7 5.9 2.2 4.5 2.6 3.5 7.0 11.3 13.2 7.7 3.4 5.3 15.3 4.9 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 ERCC6L2 "C9orf102, FLJ37706, RAD26L" ENSG00000182150 "ERCC excision repair 6 like 2" Q5T890 9 95875701-96014571 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021260, HPA022422" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021260: AB_1859544, HPA022422: " "unprognostic (6.70e-2)" "unprognostic (2.40e-1)" "unprognostic (2.68e-1)" "unprognostic (1.28e-1)" "unprognostic (8.30e-2)" "unprognostic (3.62e-2)" "unprognostic (4.64e-2)" "unprognostic (3.92e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.32e-1)" "prognostic favourable (8.70e-5)" "unprognostic (3.63e-1)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (7.39e-2)" 13.5 13.9 14.6 12.7 17.4 7.6 13.6 21.8 19.3 17.7 12.9 13.2 13.9 10.4 18.7 11.8 11.6 11.4 11.8 13.3 14.0 9.7 12.4 11.7 12.7 15.0 15.3 12.2 21.7 10.6 26.2 22.0 11.7 16.1 15.5 11.5 11.0 11.2 12.7 13.9 10.1 13.5 16.1 12.1 15.8 13.4 12.5 15.4 29.7 20.3 7.1 12.4 17.4 13.8 7.3 12.7 4.3 5.3 5.1 12.9 4.0 11.3 14.3 17.0 12.2 6.7 11.4 8.2 10.1 10.3 10.2 11.7 11.0 5.0 12.8 5.6 14.3 14.0 16.4 7.0 15.2 9.1 7.9 11.5 10.9 7.1 6.5 14.6 11.5 10.1 7.2 12.6 10.0 9.5 14.9 7.2 10.6 9.1 12.2 5.5 12.7 8.7 11.4 22.2 4.5 8.7 10.3 15.9 12.2 7.1 7.4 7.2 7.0 7.6 10.1 11.5 14.7 14.2 11.9 4.8 7.3 6.2 11.1 7.0 16.6 3.2 4.4 4.3 8.7 5.3 8.4 5.7 8.3 9.3 4.8 7.3 12.9 9.4 2.7 5.1 4.2 12.7 9.9 4.0 14.6 17.4 21.8 19.3 14.0 9.7 15.3 12.2 16.1 15.4 ERG "erg-3, p55" ENSG00000157554 "ERG, ETS transcription factor" P11308 21 38380027-38661780 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 42.7;MOLT-4: 14.0;REH: 45.3;TIME: 34.6" "Cancer enhanced" "Detected in all" "prostate cancer: 18.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.7;NK-cell: 1.0" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018377, HPA046598" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB018377: AB_675518, HPA046598: " "unprognostic (2.14e-1)" "prognostic unfavourable (6.18e-6)" "unprognostic (6.44e-3)" "unprognostic (8.64e-3)" "unprognostic (5.65e-2)" "unprognostic (1.91e-1)" "unprognostic (9.03e-4)" "unprognostic (4.30e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (2.89e-1)" "prognostic unfavourable (3.94e-4)" "unprognostic (4.31e-3)" "unprognostic (3.88e-2)" "unprognostic (2.64e-2)" "unprognostic (5.63e-3)" 39.1 4.2 5.7 6.5 8.5 6.6 20.5 3.6 7.0 17.9 5.2 2.3 5.6 3.3 16.9 9.0 6.2 9.2 11.6 10.1 6.2 3.6 10.8 6.0 19.9 7.4 8.0 1.8 7.7 4.8 2.3 3.9 23.2 8.0 8.1 3.6 7.8 4.2 5.6 13.5 5.3 6.2 11.8 4.7 32.5 5.0 4.8 5.0 2.4 10.8 9.1 3.6 9.6 15.8 0.0 1.7 0.0 0.2 1.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.0 0.0 0.0 0.3 0.0 42.7 0.0 0.0 0.0 0.3 14.0 0.0 0.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 34.6 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 5.7 8.5 3.6 7.0 6.2 3.6 8.0 1.8 8.0 5.0 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75661189 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043172, HPA063568" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043172: AB_10793942, HPA063568: " "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favourable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 6.4 20.0 14.2 6.3 16.3 8.1 12.6 9.2 25.5 11.8 11.7 16.3 10.5 14.9 11.3 29.6 23.7 12.4 11.8 9.4 13.6 15.5 17.6 48.3 19.3 9.4 11.9 10.4 15.0 12.4 16.5 13.2 15.6 17.9 15.5 11.2 26.2 15.4 10.6 6.6 15.6 16.9 10.5 18.2 7.1 9.5 52.2 9.6 7.5 24.3 21.3 15.6 9.2 13.5 18.1 18.2 11.8 6.0 14.2 22.0 13.9 14.1 8.0 16.2 12.6 11.0 20.5 10.0 5.8 17.9 11.3 19.4 12.3 33.9 6.0 8.5 7.2 15.7 14.3 24.6 12.9 11.2 9.5 6.5 8.1 17.3 16.0 7.1 9.7 25.6 21.3 16.1 9.0 13.1 5.7 14.8 7.7 27.8 10.8 7.9 15.7 12.9 8.7 11.0 11.9 36.9 18.4 13.9 7.7 14.6 12.5 8.6 20.9 10.5 9.4 6.2 12.4 5.9 5.7 9.6 11.3 13.0 9.9 10.4 10.4 11.8 6.0 8.9 20.1 5.9 19.8 18.1 22.0 20.9 14.2 15.3 20.2 20.1 3.2 14.2 5.9 18.2 19.4 13.9 14.2 16.3 9.2 25.5 13.6 15.5 11.9 10.4 17.9 9.6 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834275-172952685 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 30.2 56.5 14.2 20.6 13.8 12.0 44.6 25.5 18.1 42.9 30.5 12.3 35.6 24.6 26.4 24.9 22.6 23.7 30.3 20.7 14.2 11.4 36.4 120.8 28.6 29.3 14.5 11.4 22.5 55.5 15.6 18.9 25.5 13.5 48.1 32.9 19.2 51.5 29.3 27.1 16.7 32.6 22.0 10.8 30.8 36.5 15.8 13.2 29.1 41.5 20.9 25.8 21.3 45.8 6.6 4.2 20.8 9.2 8.5 3.8 3.0 20.3 19.5 16.8 37.3 64.3 48.1 9.3 41.6 31.5 18.8 17.6 27.7 21.0 19.7 29.8 70.2 7.5 12.3 55.2 22.1 15.6 12.1 12.1 28.7 14.8 47.1 5.6 3.9 40.8 23.1 27.7 26.0 30.1 7.2 27.6 31.1 25.5 16.1 9.7 10.0 18.1 55.6 11.2 60.4 43.9 11.9 9.5 17.1 14.5 41.5 20.8 17.2 6.4 22.9 30.7 12.6 29.4 16.9 44.0 49.0 8.2 42.7 13.5 13.4 2.1 4.9 12.1 2.3 7.1 3.8 6.6 1.2 1.5 4.2 4.9 1.0 1.6 20.8 8.5 9.2 2.1 0.7 3.0 14.2 13.8 25.5 18.1 14.2 11.4 14.5 11.4 13.5 13.2 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA049695: " "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavourable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favourable (8.18e-4)" "prognostic unfavourable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavourable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 26.6 21.0 24.4 21.9 32.8 5.5 29.9 28.1 36.1 25.4 22.7 14.6 25.8 21.2 23.1 33.1 32.5 16.6 21.2 33.7 25.3 22.6 27.7 36.2 18.6 18.9 29.8 24.2 24.9 32.6 27.3 40.1 40.9 31.2 29.5 21.4 12.1 28.8 23.8 29.2 15.6 24.3 31.4 31.0 25.6 21.1 32.8 30.7 25.7 28.6 21.6 25.8 33.4 20.6 27.0 39.0 59.2 30.1 22.1 40.8 27.5 24.6 22.7 18.6 12.5 26.9 31.7 45.4 40.2 33.9 25.2 27.3 29.9 41.7 13.6 40.1 31.9 25.9 17.7 26.6 40.4 29.1 19.1 22.1 32.5 17.3 15.8 30.7 18.7 22.4 21.4 31.8 32.2 19.5 18.0 38.7 33.6 13.3 15.3 33.3 26.2 64.2 14.2 51.3 27.6 21.4 36.2 7.1 11.6 20.5 23.3 23.8 45.0 25.2 21.6 34.4 29.3 45.4 43.3 28.5 36.0 27.2 28.7 23.0 27.8 24.2 17.0 22.1 29.7 25.3 35.8 27.0 38.1 34.8 17.8 22.3 38.4 32.3 59.2 22.1 30.1 39.0 40.8 27.5 24.4 32.8 28.1 36.1 25.3 22.6 29.8 24.2 31.2 30.7 ERH DROER ENSG00000100632 "ERH, mRNA splicing and mitosis factor" P84090 14 69380123-69398627 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavourable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 42.6 45.4 54.9 43.9 46.7 47.0 51.3 45.1 48.4 46.6 43.5 31.1 39.4 42.1 53.3 63.3 44.8 46.4 35.9 40.6 47.6 51.1 56.1 62.2 34.5 52.5 43.5 48.5 47.8 38.7 23.9 45.5 55.2 45.4 40.4 50.3 41.3 58.5 40.3 43.3 31.0 47.3 46.9 43.6 55.2 35.6 54.6 28.4 72.2 55.2 37.5 64.4 47.7 36.8 38.7 37.3 24.2 32.4 34.1 35.3 38.8 89.6 58.2 58.3 38.8 29.3 21.6 35.3 47.0 27.1 42.5 39.8 59.3 37.3 85.1 20.7 31.4 26.3 58.9 39.1 50.6 44.4 36.0 42.7 38.6 66.1 45.2 37.1 31.0 24.6 21.0 38.0 34.2 34.7 41.1 28.6 34.7 102.5 56.1 52.9 45.4 55.2 45.4 57.8 29.1 42.8 61.4 44.8 41.8 44.9 41.2 25.7 50.6 52.0 37.0 41.6 61.7 27.6 46.8 32.2 30.5 95.1 30.9 39.5 40.1 15.3 32.4 24.2 26.1 30.1 25.7 38.7 32.5 28.6 34.0 30.6 30.7 27.2 15.4 34.1 27.1 37.3 35.3 38.8 54.9 46.7 45.1 48.4 47.6 51.1 43.5 48.5 45.4 28.4 ERI1 "3'HEXO, THEX1" ENSG00000104626 "Exoribonuclease 1" Q8IV48 8 9002147-9116746 "Predicted intracellular proteins" "RNA-mediated gene silencing, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033838, HPA055548, HPA056074" Uncertain Approved Vesicles,Microtubules Microtubules Vesicles "CAB033838: AB_2098575, HPA055548: , HPA056074: " "unprognostic (2.49e-1)" "unprognostic (1.13e-1)" "prognostic favourable (8.05e-5)" "unprognostic (1.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.61e-3)" "unprognostic (1.08e-3)" "unprognostic (2.90e-1)" "unprognostic (5.50e-2)" "unprognostic (1.49e-1)" "unprognostic (1.25e-3)" "unprognostic (4.23e-1)" "prognostic unfavourable (1.42e-4)" "unprognostic (4.27e-2)" "unprognostic (3.57e-1)" "unprognostic (8.75e-2)" "unprognostic (2.36e-2)" 11.9 6.9 6.6 12.2 8.6 20.0 15.4 10.8 8.0 8.8 9.3 7.9 6.6 8.8 15.3 7.1 10.0 10.0 7.5 6.9 6.4 6.3 10.1 9.9 10.9 12.6 8.4 4.9 9.1 7.4 9.1 11.9 32.2 6.3 8.5 9.2 9.2 9.0 7.4 6.8 6.4 8.8 9.7 9.0 13.0 7.9 18.7 8.0 17.8 7.6 4.6 13.2 11.4 15.6 7.5 5.4 7.6 7.3 8.3 13.5 5.0 17.0 11.1 9.9 7.4 7.8 12.9 13.3 14.8 8.1 11.4 14.1 8.2 8.2 19.0 3.8 8.8 6.1 8.6 10.2 15.9 7.9 5.3 10.7 9.3 6.4 8.0 8.3 16.2 7.5 3.5 9.2 8.4 14.8 11.9 13.1 12.9 5.7 24.5 10.4 11.0 7.0 10.7 14.0 7.2 14.4 25.7 1.4 10.5 8.8 7.0 7.4 5.3 7.5 12.7 11.9 11.9 22.9 11.7 2.6 9.3 17.2 8.9 12.0 9.4 7.6 6.5 4.7 6.2 7.3 6.4 7.5 7.5 6.6 5.4 5.8 6.1 5.6 4.9 8.3 4.6 4.1 13.5 5.0 6.6 8.6 10.8 8.0 6.4 6.3 8.4 4.9 6.3 8.0 ERI2 "EXOD1, KIAA1504, MGC16943, ZGRF5" ENSG00000196678 "ERI1 exoribonuclease family member 2" A8K979 16 20780193-20900349 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 11.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.8" "Low region specificity" "Detected in all" "HPA035384, HPA035385" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA035384: AB_10602316, HPA035385: " "unprognostic (1.25e-1)" "unprognostic (1.47e-1)" "unprognostic (2.01e-3)" "unprognostic (4.36e-2)" "unprognostic (8.64e-2)" "unprognostic (2.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (5.99e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-2)" "unprognostic (1.08e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.05e-2)" "unprognostic (9.28e-3)" 18.5 14.3 9.2 7.5 10.4 8.5 15.0 7.8 11.9 8.3 11.2 12.0 9.3 12.2 8.2 12.1 12.4 9.1 8.9 8.4 9.0 7.9 12.7 19.4 8.2 5.3 11.7 7.4 9.9 14.4 19.2 14.9 10.1 11.1 12.0 15.7 8.1 10.3 11.0 7.0 10.7 12.1 11.8 12.2 6.4 12.7 21.3 9.7 10.8 9.7 12.1 6.6 9.6 15.1 0.6 2.4 11.8 2.9 0.7 0.9 0.6 10.8 5.2 14.3 6.2 4.4 5.6 8.6 8.5 5.1 7.8 9.9 6.5 11.3 3.0 9.9 4.7 8.2 14.2 8.9 14.6 9.6 7.5 7.4 6.1 11.2 4.0 14.1 6.2 5.1 11.1 10.5 8.8 4.7 23.3 9.0 13.1 9.6 2.0 12.6 8.8 2.9 16.2 11.7 6.7 7.2 8.5 7.3 8.9 5.5 10.6 6.5 22.2 15.7 3.5 8.4 4.7 8.1 11.4 5.5 8.4 1.8 7.9 11.5 11.5 11.8 2.3 2.0 0.6 1.7 0.4 0.6 0.5 0.6 2.4 0.1 0.4 0.3 0.1 0.7 2.9 0.8 0.9 0.6 9.2 10.4 7.8 11.9 9.0 7.9 11.7 7.4 11.1 9.7 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: " "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavourable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 12.6 15.4 30.7 8.3 32.0 12.4 15.2 19.7 43.7 15.1 13.4 23.2 10.8 12.3 14.7 22.2 13.4 23.4 12.7 21.1 28.9 25.1 25.3 15.5 11.7 10.0 23.9 26.8 18.6 15.7 24.0 17.2 13.5 22.9 16.7 14.1 14.8 14.7 16.9 35.7 13.3 8.6 17.7 17.9 9.5 10.6 24.4 21.9 9.7 17.6 11.9 11.0 12.5 12.1 18.8 25.3 9.6 22.2 14.8 18.2 15.2 28.1 21.8 27.7 30.6 18.2 22.9 17.4 18.4 24.6 32.8 30.6 14.1 30.1 20.1 31.2 22.6 16.3 24.8 31.4 23.2 22.5 47.7 22.5 36.8 19.8 26.6 22.6 12.9 23.3 29.5 24.8 34.2 22.5 21.9 16.4 21.5 18.9 25.1 21.2 32.7 34.6 24.3 25.4 29.4 25.4 14.9 47.2 22.3 20.1 27.6 32.6 18.1 18.8 13.6 21.7 22.7 23.5 27.8 15.6 18.1 21.6 26.9 19.7 27.3 9.4 16.3 9.6 16.7 22.2 18.2 18.8 14.0 16.2 25.3 18.3 16.7 17.2 1.5 14.8 21.3 18.9 18.1 15.2 30.7 32.0 19.7 43.7 28.9 25.1 23.9 26.8 22.9 21.9 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 20.2 11.7 12.3 35.7 16.9 30.5 18.1 9.0 15.6 13.6 16.0 13.9 13.7 13.1 21.7 25.6 15.3 13.7 17.1 14.7 15.1 11.4 17.6 15.3 19.4 29.3 14.5 14.0 16.9 12.2 13.8 16.1 16.9 16.9 15.4 11.7 14.0 13.5 19.4 17.2 17.0 15.8 16.2 17.0 22.2 14.9 11.8 14.0 21.8 18.2 13.3 25.0 17.1 15.3 11.7 10.2 18.5 20.9 7.2 6.2 6.0 9.1 13.2 7.1 8.4 7.6 9.3 14.7 8.8 4.7 8.0 8.9 8.4 5.9 20.9 4.2 7.4 15.4 12.9 13.5 5.7 9.0 16.8 14.6 8.5 12.0 8.6 8.9 13.7 10.7 8.8 6.1 7.9 8.7 14.9 12.1 8.0 7.6 17.1 15.8 11.2 5.9 15.5 4.6 14.3 8.9 16.9 3.2 9.1 6.4 8.3 11.7 3.4 10.7 13.9 5.9 2.8 0.3 9.3 7.9 20.6 22.6 12.1 14.3 6.2 11.4 20.9 7.2 5.4 19.0 4.8 9.7 6.2 5.3 10.2 11.7 5.3 4.7 18.5 7.2 16.8 7.8 4.4 6.0 12.3 16.9 9.0 15.6 15.1 11.4 14.5 14.0 16.9 14.0 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 61.2" "Cell line enriched" "Detected in many" 4 "hTCEpi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in all" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favourable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavourable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 0.6 0.3 1.4 0.6 1.1 0.0 1.3 0.6 0.8 2.1 0.6 0.6 0.6 0.0 1.5 1.0 0.6 3.3 0.6 0.9 1.0 1.5 0.9 1.6 4.2 0.6 1.1 0.6 0.6 0.7 0.8 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.1 0.6 0.6 0.6 0.6 1.0 61.2 0.6 0.6 6.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.3 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.9 1.8 4.5 1.0 0.0 0.1 0.0 0.1 1.1 0.4 0.0 0.7 1.2 2.3 0.0 0.1 4.7 0.2 0.2 0.7 36.1 0.0 8.4 0.0 5.0 0.0 0.0 1.8 0.0 0.4 5.5 0.9 0.0 0.9 0.0 2.6 0.1 0.6 1.2 3.2 0.0 1.3 0.7 0.7 0.0 1.2 1.0 0.0 0.5 0.0 0.0 0.0 4.5 2.1 3.5 0.0 0.0 0.0 2.7 0.0 0.9 0.0 0.5 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.6 0.8 1.0 1.5 1.1 0.6 0.6 0.6 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Group enriched" "Detected in some" 12 "CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042632: , HPA048484: " "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell line enhanced" "Detected in some" "A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favourable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favourable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.8 0.0 0.0 0.1 0.0 4.0 3.6 1.3 1.9 1.4 0.1 2.0 0.0 5.2 0.9 0.3 6.3 0.1 2.3 0.0 9.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 1.4 2.7 0.0 0.0 0.1 6.1 15.9 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817088-42844993 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 10.0 14.1 9.3 6.7 10.4 25.7 8.4 2.5 9.3 9.3 7.9 12.4 12.2 6.4 9.4 16.7 8.3 10.2 7.4 4.7 9.3 6.3 7.8 13.1 9.8 4.4 10.4 8.3 6.2 11.7 9.8 12.3 12.0 10.8 9.4 8.3 11.8 10.2 8.0 4.0 9.2 9.4 6.5 14.6 8.6 7.8 4.2 11.9 4.8 13.1 3.2 8.1 9.7 8.0 2.4 8.1 3.0 7.1 3.5 5.0 2.9 3.4 4.6 1.5 4.6 5.2 15.3 1.3 6.9 11.6 6.1 6.2 1.8 6.3 3.1 2.5 7.2 4.4 1.6 2.1 5.6 5.1 5.6 24.7 3.4 1.5 6.5 3.5 12.7 9.3 7.9 2.8 6.7 4.0 16.7 3.1 5.6 2.3 1.7 1.2 3.5 2.5 1.7 2.1 2.9 5.3 5.3 3.2 2.4 5.9 2.2 2.6 4.3 13.1 6.3 4.7 2.8 3.9 3.2 1.4 2.7 1.3 3.8 3.8 2.9 0.5 6.8 3.0 2.1 7.1 1.2 2.4 2.3 2.2 8.1 1.3 2.0 2.3 2.1 3.5 4.5 2.3 5.0 2.9 9.3 10.4 2.5 9.3 9.3 6.3 10.4 8.3 10.8 11.9 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell line enriched" "Detected in some" 6 "HAP1: 20.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favourable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 1.9 0.3 20.8 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.0 0.2 2.8 0.4 0.2 0.7 2.3 0.3 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.7 1.2 0.0 0.2 0.1 0.2 0.6 3.4 1.9 0.5 1.8 0.9 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 ERP29 "C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013316-112023451 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" 4900000 Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favourable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 19.1 37.1 20.2 32.4 19.8 55.1 39.7 29.5 30.8 23.3 45.8 16.8 66.5 32.0 23.1 38.3 30.6 24.6 39.0 24.2 18.6 24.9 34.9 67.5 33.8 61.2 22.5 19.7 28.5 111.2 33.3 35.9 46.1 23.4 30.9 29.6 23.2 61.5 58.8 13.0 37.0 35.6 27.2 21.4 41.6 39.5 31.7 16.3 35.8 53.8 28.3 37.6 24.4 30.9 49.2 83.9 60.6 43.3 14.8 37.7 46.6 20.3 19.9 14.7 28.5 55.6 22.3 31.3 20.1 24.7 16.4 21.1 31.0 23.8 21.9 15.8 34.9 25.5 27.3 26.0 13.4 18.7 15.2 24.8 22.7 34.8 37.7 60.5 24.3 31.7 34.1 26.4 30.8 22.7 28.2 40.8 12.3 23.6 19.8 110.0 23.8 15.0 16.5 17.8 70.3 33.5 31.5 13.3 17.9 25.0 20.7 60.3 26.0 83.5 16.9 13.8 21.5 13.2 14.9 45.3 51.9 18.4 23.4 38.2 10.7 14.8 43.3 60.6 25.5 32.0 27.6 47.9 33.8 31.6 41.9 49.2 37.7 30.7 8.7 14.8 29.0 83.9 31.5 46.6 20.2 19.8 29.5 30.8 18.6 24.9 22.5 19.7 23.4 16.3 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Cell line enhanced" "Detected in some" "CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" 5000000 Nucleoplasm Cytosol "HPA011423: , HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.4 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 27.6 5.9 0.0 0.6 0.1 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 19.9 0.0 2.9 0.0 1.5 0.0 0.1 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 14.7 0.4 1.2 0.2 1.8 0.8 0.0 2.4 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: , HPA053679: " "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favourable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 24.8 18.9 8.5 10.3 1.1 1.8 4.7 15.0 6.3 13.9 15.9 6.7 4.9 9.2 7.9 3.9 13.8 10.3 4.1 21.2 7.1 4.4 10.9 8.5 7.0 0.1 5.5 10.2 0.3 0.4 8.1 2.0 5.1 8.7 14.1 8.0 4.8 22.3 2.5 5.7 6.4 9.9 25.4 6.7 4.5 15.1 3.7 5.4 7.5 9.1 3.8 6.2 6.1 2.2 8.6 17.8 17.3 11.7 1.9 5.0 11.4 4.7 9.3 11.9 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 ESD ENSG00000139684 "Esterase D" P10768 13 46771256-46797232 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039700 Approved Approved "Golgi apparatus,Cytosol" 16000000 "Golgi apparatus" Cytosol "HPA039700: AB_10697553" "unprognostic (3.05e-1)" "prognostic unfavourable (5.01e-4)" "unprognostic (7.66e-2)" "unprognostic (1.75e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.16e-4)" "unprognostic (1.73e-2)" "unprognostic (3.31e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (2.91e-2)" "unprognostic (2.71e-2)" "unprognostic (2.18e-1)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" 58.5 30.9 32.0 28.6 29.8 24.2 44.5 23.7 32.0 54.4 37.3 29.0 34.2 31.8 53.2 50.4 54.1 40.6 30.3 45.6 30.7 29.3 58.8 82.2 28.2 31.4 31.7 32.1 61.3 24.9 27.5 47.5 26.4 28.6 55.2 41.7 32.5 31.5 45.2 47.4 29.7 38.4 50.8 37.4 31.1 32.1 32.4 26.7 65.5 78.9 50.9 31.7 62.5 36.9 30.1 48.7 15.1 37.1 29.8 35.7 26.4 21.8 12.7 38.6 26.5 45.3 74.8 10.3 31.5 45.7 43.9 34.2 21.5 26.8 24.9 9.5 37.7 22.4 42.4 37.2 56.2 28.4 44.0 32.1 12.8 33.1 37.1 62.8 13.8 51.1 34.6 28.3 38.1 41.1 31.4 6.7 72.6 21.4 55.6 41.7 10.0 24.2 44.3 22.7 16.8 62.3 8.9 19.1 21.7 14.0 11.9 25.2 22.9 36.0 27.4 16.2 19.1 31.0 29.0 4.6 9.7 21.5 35.0 36.0 21.6 7.7 37.1 15.1 15.0 31.5 24.6 30.1 30.0 23.0 40.8 25.3 35.7 27.9 4.3 29.8 28.0 48.7 24.9 26.4 32.0 29.8 23.7 32.0 30.7 29.3 31.7 32.1 28.6 26.7 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784886 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047083: , HPA050396: " "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.4 10.5 13.5 9.7 19.7 7.1 11.9 17.0 17.4 10.8 8.8 6.9 9.2 7.7 11.2 11.5 11.9 9.2 9.1 9.7 17.2 11.6 10.8 14.6 7.0 10.3 16.8 17.5 14.1 8.7 12.9 20.0 11.9 17.2 12.2 10.7 4.2 8.9 8.6 29.9 11.3 7.5 12.9 28.9 10.7 8.1 14.3 17.9 9.2 11.5 12.1 10.1 11.2 9.2 13.8 14.6 2.0 10.6 11.5 12.4 3.7 13.2 12.6 11.7 5.9 9.0 10.8 6.5 14.2 8.7 10.3 8.8 13.4 12.5 17.4 7.2 6.7 20.4 17.4 14.2 18.4 4.6 8.2 22.9 5.1 31.4 12.5 27.5 6.3 8.7 10.1 17.0 13.8 7.8 31.8 7.9 11.7 11.7 20.8 16.5 11.2 7.6 13.6 29.1 12.7 7.2 11.7 11.5 7.1 11.4 18.0 17.6 9.1 12.1 10.5 15.9 11.0 11.6 26.1 8.0 19.4 21.4 6.7 12.1 14.5 1.8 6.9 2.0 8.7 8.6 10.0 13.6 10.0 9.3 6.9 13.8 12.4 11.3 0.4 11.5 10.6 14.6 7.5 3.7 13.5 19.7 17.0 17.4 17.2 11.6 16.8 17.5 17.2 17.9 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.01e-5)" "prognostic unfavourable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favourable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.4 12.7 13.7 11.2 0.3 1.2 8.4 8.2 4.2 14.1 9.0 6.9 11.0 22.5 4.6 3.3 10.4 15.8 4.8 7.4 7.0 16.0 15.1 11.5 5.3 0.0 9.4 12.5 0.4 0.3 8.2 4.0 7.2 20.2 20.4 4.2 13.0 14.8 8.1 11.0 6.9 13.9 14.6 9.3 2.0 5.2 9.8 7.6 6.9 10.2 5.3 16.8 6.3 3.3 7.1 13.8 6.0 11.2 15.1 14.0 15.2 4.1 8.9 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 68.9" "Group enriched" "Detected in some" 9 "MCF7: 24.3;T-47d: 31.5" "Group enriched" "Detected in many" 9 "breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: , HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favourable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 3.0 0.9 0.5 1.6 0.5 0.2 16.2 0.8 0.4 64.5 1.5 0.2 2.2 0.1 68.9 27.7 1.1 26.7 1.9 1.1 0.5 0.8 1.5 6.6 3.6 1.6 0.4 0.1 14.2 0.4 0.0 9.3 0.9 0.6 3.6 0.1 2.6 1.6 4.1 2.0 0.6 0.5 20.8 0.4 1.6 0.3 1.9 0.4 1.9 1.3 2.2 2.5 3.8 23.7 0.6 1.0 0.0 0.8 0.3 2.5 1.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.0 24.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 31.5 0.0 0.0 0.1 0.1 0.3 0.0 2.9 0.5 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.3 0.2 1.0 0.6 1.3 0.4 1.0 0.4 2.5 0.9 0.0 0.3 0.0 0.0 0.3 1.0 0.5 0.5 0.8 0.4 0.5 0.8 0.4 0.1 0.6 0.4 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 65.1" "Cell line enhanced" "Detected in some" "A-431: 33.5;BEWO: 25.7;CAPAN-2: 35.3;HaCaT: 20.5;hTCEpi: 57.7;RT4: 24.5;T-47d: 27.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: " "prognostic unfavourable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favourable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.6 0.5 0.5 15.1 0.5 0.0 7.6 0.5 0.6 9.7 18.1 0.2 18.7 7.7 3.3 21.3 43.1 6.6 14.5 0.6 0.5 0.5 6.4 0.7 15.5 0.8 0.5 0.2 1.8 65.1 11.8 10.1 18.5 0.3 8.9 20.8 0.2 38.2 15.1 0.5 24.8 12.7 1.9 0.5 0.5 12.1 1.0 0.2 1.4 20.2 30.4 28.9 9.0 16.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 33.5 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 10.9 35.3 0.0 0.9 0.0 20.5 0.9 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.7 0.0 0.3 0.0 0.0 0.0 0.0 16.3 0.4 0.1 3.1 0.8 0.0 0.0 4.4 4.4 24.5 9.0 0.0 0.0 5.3 3.4 27.3 0.2 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.2 0.3 0.2 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305572-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053785 Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favourable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 8.2 9.6 6.0 8.9 7.7 7.9 17.8 9.8 9.4 4.3 32.4 4.9 18.3 43.1 4.6 6.2 17.1 4.1 15.7 45.2 6.8 5.0 21.4 26.9 8.7 9.2 10.4 5.2 2.5 20.5 10.1 4.6 11.0 8.0 7.5 12.6 6.0 28.7 14.9 78.3 10.5 46.4 7.1 7.4 9.3 14.1 2.2 6.0 6.0 8.2 27.1 10.0 8.5 12.0 4.1 4.2 8.5 8.4 2.6 5.4 2.4 9.7 15.6 3.9 9.4 5.3 5.1 21.2 9.6 4.7 3.6 3.6 14.4 11.9 13.4 18.0 5.1 25.1 6.5 12.9 1.4 9.0 8.4 8.6 18.5 11.3 7.3 14.6 21.8 7.2 19.7 8.1 10.7 5.0 14.5 7.4 5.9 21.9 7.1 20.8 10.8 29.7 7.7 7.6 29.9 12.0 20.6 8.2 10.1 4.9 32.7 30.9 10.1 14.5 10.8 6.6 7.9 18.5 9.7 11.4 9.4 8.8 10.7 14.4 5.2 0.3 4.7 7.1 4.4 8.4 4.4 2.9 3.8 3.1 4.2 4.1 4.1 5.4 8.5 2.6 7.5 3.2 5.1 2.4 6.0 7.7 9.8 9.4 6.8 5.0 10.4 5.2 8.0 6.0 ETAA1 ETAA16 ENSG00000143971 "ETAA1, ATR kinase activator" Q9NY74 2 67397319-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 9.3 23.4 6.4 11.0 11.3 6.6 14.7 14.0 10.6 15.4 11.7 6.3 9.4 7.2 14.6 13.9 12.0 13.9 15.7 9.4 8.7 5.5 17.5 11.1 11.3 14.8 9.7 10.4 15.6 16.2 14.2 13.9 8.8 10.7 11.6 9.2 6.1 12.4 13.7 11.4 12.4 11.1 10.6 8.5 11.8 10.5 11.3 10.3 19.2 15.9 9.7 9.8 11.6 12.7 7.5 4.4 3.4 5.2 4.2 7.4 3.1 9.1 7.1 12.0 10.8 9.4 13.0 9.9 9.8 13.0 10.5 10.1 5.7 11.1 17.1 5.4 8.0 11.2 10.2 11.9 15.0 10.0 8.1 9.5 17.1 8.3 9.0 9.5 9.0 10.2 17.0 7.7 12.1 16.6 7.7 7.4 14.3 4.1 14.0 10.5 12.2 7.7 10.1 19.1 7.9 12.7 6.0 10.1 20.1 9.9 9.1 9.3 7.9 4.6 11.4 14.3 11.0 6.7 11.5 8.3 7.4 13.8 13.3 10.1 10.8 3.4 2.5 2.0 5.5 4.1 6.0 7.5 5.1 3.2 3.1 7.0 7.0 6.2 0.2 4.2 5.2 4.4 7.4 3.1 6.4 11.3 14.0 10.6 8.7 5.5 9.7 10.4 10.7 10.3 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA010712: , HPA029407: " "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favourable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.5 14.3 11.2 11.4 11.6 8.0 6.0 8.3 8.5 10.8 17.0 20.0 7.2 5.2 5.1 13.6 3.8 14.9 16.6 11.0 16.5 6.1 9.2 10.7 15.8 15.2 7.4 3.7 11.1 9.5 10.2 19.8 8.5 10.9 4.6 17.2 32.2 30.0 9.1 15.6 13.8 16.1 13.7 9.1 5.0 8.8 8.7 7.5 12.5 11.8 15.3 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.5 8.4 10.3 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 ETS2 ENSG00000157557 "ETS proto-oncogene 2, transcription factor" P15036 21 38805307-38824955 "Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 59.3;hTCEpi: 54.3;hTERT-HME1: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003176 Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA003176: " "unprognostic (2.06e-1)" "unprognostic (5.91e-2)" "unprognostic (9.16e-3)" "unprognostic (5.33e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.88e-3)" "unprognostic (7.36e-2)" "unprognostic (8.99e-3)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.89e-1)" "unprognostic (8.10e-2)" "unprognostic (7.10e-2)" 33.6 10.4 25.8 29.6 12.8 44.7 28.5 5.5 36.5 28.4 38.1 7.3 13.7 39.7 27.0 20.3 30.1 21.8 42.6 42.9 16.2 10.8 21.2 75.5 58.3 56.9 13.8 18.2 23.6 11.7 20.0 19.7 23.2 14.2 31.4 50.6 12.9 17.6 17.4 64.2 72.4 59.0 43.3 13.6 68.7 25.8 8.3 11.0 7.2 21.5 28.4 13.7 40.8 35.5 0.2 16.5 18.5 14.9 0.1 2.5 3.6 22.9 4.9 3.4 1.1 3.9 13.3 9.2 5.4 31.4 7.2 9.5 4.4 6.5 5.0 2.6 4.8 6.8 5.8 14.5 13.7 4.6 2.3 59.3 29.8 10.8 40.4 3.6 5.8 7.9 54.3 10.1 44.3 5.7 6.0 0.0 3.1 3.4 11.0 3.9 11.1 3.3 36.1 2.2 4.6 10.1 14.9 2.7 3.6 15.3 6.3 1.2 0.3 6.7 6.1 17.2 2.5 11.0 11.8 0.1 0.0 5.0 4.1 12.3 14.3 10.1 9.2 3.3 1.7 12.3 2.0 0.2 1.6 2.5 16.5 0.2 1.6 1.6 18.5 0.1 14.9 4.0 0.1 3.6 25.8 12.8 5.5 36.5 16.2 10.8 13.8 18.2 14.2 11.0 ETV6 TEL ENSG00000139083 "ETS variant 6" P41212 12 11649854-11895402 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 38.9;NB-4: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000264 Enhanced Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA000264: AB_1078763" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavourable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavourable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favourable (1.54e-5)" 17.2 8.9 5.1 20.0 7.6 32.8 20.4 1.6 9.1 10.5 14.5 6.0 9.8 7.2 10.8 14.2 11.3 8.9 15.3 6.7 5.6 3.8 9.2 9.6 16.0 13.4 6.0 3.1 10.5 10.4 8.4 8.7 7.7 7.4 14.9 11.0 8.0 41.9 12.4 6.9 23.9 14.6 25.0 9.4 17.8 9.7 4.7 5.7 30.6 10.0 10.0 19.9 19.0 15.8 2.9 6.2 11.4 7.1 2.4 2.2 1.3 2.5 3.5 3.2 5.5 2.4 2.3 3.8 1.9 3.2 2.5 3.0 0.2 12.2 2.1 1.9 3.2 3.3 1.4 5.8 3.0 38.9 0.7 13.7 1.9 1.3 3.0 14.4 15.0 4.5 3.6 2.4 5.1 7.5 1.0 7.3 2.2 1.6 8.1 20.7 5.1 0.9 2.3 3.0 5.6 5.7 16.2 0.6 3.2 3.8 3.7 3.5 1.2 9.1 8.5 5.6 4.8 1.8 4.0 3.2 2.4 1.2 3.6 0.1 6.4 5.6 5.7 6.6 1.5 6.6 2.0 2.9 2.2 1.4 4.1 2.3 1.3 0.8 11.4 2.4 7.1 6.2 1.4 1.3 5.1 7.6 1.6 9.1 5.6 3.8 6.0 3.1 7.4 5.7 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;U-138 MG: 36.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favourable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favourable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.3 9.9 0.1 0.4 0.0 2.0 27.1 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.3 0.7 0.0 0.0 5.0 2.7 23.8 11.0 12.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.5 0.0 0.1 9.8 36.4 15.3 0.6 22.6 0.2 0.0 0.0 20.6 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.1;BJ hTERT+: 26.9;hTERT-HME1: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favourable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavourable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.1 4.0 2.2 5.8 14.6 21.1 0.8 7.0 26.9 8.1 10.6 0.0 0.0 0.0 2.2 11.1 3.7 2.3 5.8 6.7 5.1 1.6 0.0 2.3 1.0 10.8 0.0 0.6 10.4 8.5 10.8 26.8 5.6 0.0 0.0 18.8 0.0 0.0 0.0 2.4 3.7 4.7 6.2 0.0 2.8 0.5 1.2 3.8 0.0 0.0 2.8 1.4 0.2 9.8 7.0 1.3 4.9 6.1 4.3 3.5 0.3 20.0 0.0 6.5 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Cell line enhanced" "Detected in many" "HHSteC: 19.8;Karpas-707: 32.7;RPMI-8226: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA045033: , HPA057051: " "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.6 10.4 0.0 1.3 2.2 1.7 6.0 0.0 0.4 8.8 0.0 1.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 19.8 10.2 11.1 12.8 0.0 2.4 6.8 0.6 0.3 32.7 12.9 0.1 7.3 11.2 0.0 0.0 7.6 1.3 50.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.1 4.2 7.2 0.2 0.3 4.7 14.8 0.0 9.9 5.8 7.4 5.9 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 98.2" "Cell line enhanced" "Detected in many" "MOLT-4: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favourable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavourable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 14.5 15.0 50.9 37.0 57.8 19.9 28.5 57.4 66.2 11.8 12.4 20.7 10.7 12.7 23.6 25.1 11.2 18.0 20.1 19.7 42.4 43.3 12.4 24.4 28.4 63.5 34.8 31.4 23.3 17.1 9.8 28.6 13.5 26.2 16.4 12.0 24.2 20.0 16.5 12.8 15.6 18.7 29.4 23.1 44.2 15.2 13.2 20.3 98.2 11.0 7.5 55.8 18.3 9.3 7.8 2.5 14.2 8.7 9.3 20.6 5.4 4.0 3.6 27.4 8.2 5.5 15.9 15.8 5.4 6.8 3.5 4.8 0.2 2.8 7.7 7.1 4.9 0.1 12.9 9.3 4.4 8.3 8.2 12.7 2.9 2.1 4.6 3.8 30.2 8.4 4.8 2.4 9.3 9.5 6.3 0.5 3.8 5.6 70.9 20.3 5.7 5.4 17.1 14.2 1.3 4.5 0.1 33.3 19.5 3.8 5.9 1.6 4.5 11.2 5.8 2.9 4.6 17.9 2.9 14.5 10.9 21.8 3.8 6.4 4.7 1.5 1.5 14.2 11.6 7.6 8.9 6.2 13.6 11.0 2.5 7.8 16.5 14.6 0.3 9.3 8.7 0.4 20.6 5.4 50.9 57.8 57.4 66.2 42.4 43.3 34.8 31.4 26.2 20.3 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027452 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1" "Cell line enhanced" "Detected in some" "HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: " "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 0.2 0.0 0.0 2.3 0.1 1.1 1.2 0.0 0.3 11.6 5.7 0.1 2.8 4.8 1.9 1.3 69.9 0.9 4.1 0.0 0.0 0.0 4.8 0.0 5.7 0.2 0.0 0.0 0.4 2.4 1.8 1.1 2.3 0.1 3.2 0.7 0.7 10.9 4.5 0.5 43.7 7.8 2.1 0.2 0.1 1.9 0.3 0.1 0.4 6.3 43.1 46.1 5.0 21.6 0.4 1.7 1.9 0.3 1.6 1.4 0.0 11.0 9.3 0.0 0.1 0.1 0.0 3.9 0.1 0.0 0.0 0.0 1.2 6.7 0.0 0.0 0.0 24.1 0.0 3.1 0.0 0.0 0.0 0.2 6.9 7.0 0.0 0.0 1.7 0.0 5.0 0.1 0.0 0.0 0.0 0.4 0.0 15.8 0.4 1.5 0.0 4.2 4.5 0.0 0.1 7.3 34.9 0.4 0.0 4.6 17.4 0.0 22.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 1.0 0.3 0.7 0.6 0.3 0.7 0.2 0.2 0.5 0.1 0.4 1.4 0.6 1.9 1.6 0.2 1.7 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell line enhanced" "Detected in some" "A-431: 1.9;HeLa: 3.2;hTCEpi: 11.3;RT4: 3.9;SiHa: 2.1;T-47d: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 2.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EWSR1 EWS ENSG00000182944 "EWS RNA binding protein 1" Q01844 22 29268009-29300525 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Calmodulin-binding, Repressor, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004230, HPA051771, HPA062953" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910" "unprognostic (1.96e-1)" "unprognostic (6.39e-3)" "unprognostic (1.32e-1)" "unprognostic (3.93e-2)" "unprognostic (3.59e-1)" "unprognostic (3.15e-2)" "prognostic unfavourable (1.27e-6)" "unprognostic (1.33e-1)" "unprognostic (1.09e-2)" "unprognostic (2.71e-2)" "unprognostic (7.04e-2)" "unprognostic (9.30e-2)" "prognostic unfavourable (1.21e-5)" "unprognostic (7.33e-3)" "unprognostic (1.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.50e-3)" 35.3 43.2 45.3 41.3 51.3 67.5 32.1 58.2 48.6 32.4 39.8 43.2 31.3 41.0 45.1 38.5 40.8 37.6 25.9 40.7 40.1 32.8 33.0 48.5 33.4 50.5 32.7 49.9 38.4 32.0 47.2 44.3 34.0 41.7 35.0 39.9 41.5 32.3 38.2 52.8 34.8 36.6 40.5 33.8 44.1 34.5 85.6 32.5 39.9 32.5 30.9 55.4 36.4 34.5 52.0 65.8 50.6 81.1 58.4 67.8 76.1 56.4 44.0 60.5 47.0 30.9 25.6 41.6 34.4 55.0 57.1 49.0 50.1 29.3 77.2 21.8 52.7 44.4 86.2 70.4 58.8 52.5 61.5 58.3 39.0 47.9 46.2 89.6 41.7 39.1 29.7 47.6 77.3 44.1 43.6 34.9 42.2 56.7 90.0 34.4 42.5 33.5 63.2 58.3 46.6 52.5 60.0 49.6 47.4 42.8 50.2 37.1 32.2 48.8 45.0 34.9 38.8 21.9 49.9 45.4 36.4 71.6 33.2 39.9 42.4 48.4 57.9 50.6 60.2 81.1 60.7 50.4 56.6 59.6 65.8 52.0 55.8 53.6 43.3 58.4 78.6 35.3 67.8 76.1 45.3 51.3 58.2 48.6 40.1 32.8 32.7 49.9 41.7 32.5 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favourable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 18.8 8.9 6.9 10.1 4.2 5.1 8.7 9.4 8.0 8.8 11.7 7.5 13.3 0.0 7.0 9.8 10.7 7.6 9.5 10.0 4.7 9.1 5.5 3.3 4.4 16.6 4.0 5.3 10.3 15.8 9.0 5.9 12.4 3.4 7.3 8.3 9.5 2.3 6.1 7.4 8.9 0.0 6.6 6.6 13.0 7.0 13.4 12.0 7.0 14.8 6.9 19.7 3.5 9.8 8.2 5.8 6.6 4.8 5.6 7.4 0.0 0.0 4.4 6.1 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 EXD3 "FLJ20433, LOC54932, mut-7" ENSG00000187609 "Exonuclease 3'-5' domain containing 3" Q8N9H8 9 137306896-137423262 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047395 Approved Approved "Actin filaments,Focal adhesion sites" "Focal adhesion sites" "Actin filaments" "HPA047395: AB_10962864" "unprognostic (2.91e-1)" "unprognostic (5.67e-2)" "unprognostic (1.75e-3)" "prognostic favourable (4.30e-4)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (1.37e-1)" "unprognostic (2.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "unprognostic (7.99e-3)" "unprognostic (2.05e-1)" "unprognostic (8.67e-2)" "unprognostic (5.05e-2)" 9.7 10.9 8.0 10.1 11.1 8.4 10.4 11.9 12.4 11.2 15.5 16.5 14.9 22.8 10.2 17.5 11.1 11.5 14.1 10.5 8.7 7.9 11.8 7.3 12.3 8.0 9.5 11.2 11.1 13.3 8.3 13.8 8.3 11.0 14.0 8.9 13.9 17.5 11.4 15.9 17.4 20.6 15.8 7.4 16.3 14.3 5.1 9.1 1.7 11.4 6.8 7.8 10.0 10.8 4.0 5.3 10.8 6.0 5.3 8.5 3.6 5.7 4.9 2.4 6.8 2.0 3.0 5.7 2.8 3.3 2.5 3.9 3.3 12.3 2.5 7.9 2.1 10.7 0.7 3.1 0.8 5.8 5.9 2.0 8.7 5.1 6.2 1.4 21.5 3.4 4.3 2.2 1.9 8.6 4.7 4.6 2.1 15.4 0.1 4.9 2.8 3.4 4.4 2.0 17.2 5.1 3.3 3.3 5.9 2.8 6.0 2.7 9.7 6.4 10.7 3.5 3.4 5.5 4.3 6.1 2.7 2.1 6.7 4.5 6.6 10.8 5.0 10.6 3.5 6.0 4.0 3.9 6.0 3.3 5.3 4.0 4.8 3.7 1.2 5.3 5.8 3.4 8.5 3.6 8.0 11.1 11.9 12.4 8.7 7.9 9.5 11.2 11.0 9.1 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA053079: , HPA069738: " "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavourable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavourable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 2.1 1.0 0.9 10.3 1.0 15.6 1.0 0.3 1.3 1.3 3.1 0.3 0.1 2.9 0.7 0.8 6.2 0.4 1.3 1.5 0.7 0.6 0.9 1.3 1.5 5.6 0.6 0.3 1.3 1.3 1.8 0.4 4.6 0.7 0.7 3.9 0.3 1.4 0.1 1.0 1.7 4.2 1.0 0.6 5.7 1.5 14.8 0.1 31.3 0.6 4.0 8.1 1.6 2.0 1.4 0.6 2.9 0.7 0.9 3.3 1.0 15.0 10.0 16.5 10.9 1.0 2.7 14.0 20.0 6.7 17.9 19.6 12.5 8.5 16.4 9.8 4.6 15.0 20.9 8.3 21.3 25.4 18.3 15.2 10.7 6.3 0.3 21.7 11.3 0.6 0.4 17.9 4.8 5.5 30.5 21.7 14.3 6.9 23.4 12.3 22.6 9.9 17.0 15.5 17.5 3.7 9.6 18.5 23.5 13.1 10.6 7.1 9.8 13.5 2.0 17.4 15.3 16.3 27.0 16.0 21.1 26.4 6.0 17.7 20.8 2.9 0.7 0.0 1.1 0.0 0.0 1.4 1.1 1.1 0.6 1.3 0.6 0.2 0.3 0.9 0.0 0.1 3.3 1.0 0.9 1.0 0.3 1.3 0.7 0.6 0.6 0.3 0.7 0.1 EXO5 "C1orf176, DEM1, FLJ21144" ENSG00000164002 "Exonuclease 5" Q9H790 1 40508741-40516556 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028429 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028429: AB_2092105" "unprognostic (9.44e-2)" "unprognostic (7.36e-2)" "unprognostic (3.69e-2)" "unprognostic (6.65e-2)" "unprognostic (1.66e-1)" "unprognostic (3.23e-2)" "prognostic unfavourable (9.16e-6)" "unprognostic (4.65e-2)" "unprognostic (2.24e-3)" "unprognostic (1.91e-3)" "unprognostic (4.78e-2)" "prognostic unfavourable (2.93e-4)" "unprognostic (9.95e-3)" "unprognostic (4.36e-2)" "unprognostic (4.13e-1)" "unprognostic (9.85e-3)" "unprognostic (2.53e-1)" 8.6 9.1 9.9 8.6 12.4 6.5 16.9 13.9 10.4 8.6 8.4 5.5 11.1 6.9 11.7 8.9 8.5 8.4 7.5 10.3 8.5 5.9 9.9 10.7 8.3 12.3 6.4 10.2 7.5 8.1 8.4 6.9 8.1 6.5 8.9 8.4 7.3 9.0 11.8 6.2 8.2 10.0 12.5 6.1 13.8 7.2 10.1 7.5 15.7 7.3 5.8 16.9 8.6 10.8 11.8 7.9 16.4 9.8 8.6 14.9 7.0 5.4 1.9 4.9 8.1 3.3 3.0 3.4 7.4 1.9 6.7 8.1 3.5 6.6 7.3 4.6 4.7 6.8 4.7 4.9 8.0 2.4 3.0 6.4 9.3 4.8 4.0 0.0 6.4 3.1 3.1 9.2 3.4 4.2 7.3 0.0 9.5 2.3 10.0 5.0 7.3 0.7 7.7 16.6 2.9 3.3 8.4 5.9 5.2 9.5 3.4 6.0 4.8 56.5 4.6 4.6 13.8 10.3 7.1 2.2 6.8 0.0 0.6 2.0 9.1 7.5 6.6 16.4 14.9 9.8 12.3 11.8 10.4 10.7 7.9 9.8 12.8 12.4 11.3 8.6 7.2 6.4 13.4 7.0 9.9 12.4 13.9 10.4 8.5 5.9 6.4 10.2 6.5 7.5 EXOC1 "BM-102, FLJ10893, SEC3, SEC3L1, Sec3p" ENSG00000090989 "Exocyst complex component 1" Q9NV70 4 55853616-55905034 "Predicted intracellular proteins, Transporters" "Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037706, HPA044873" Uncertain Approved "Plasma membrane,Microtubules,Cytosol" "Plasma membrane" "Microtubules, Cytosol" "HPA037706: AB_10670525, HPA044873: " "unprognostic (7.10e-3)" "unprognostic (4.48e-2)" "unprognostic (8.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.81e-2)" "unprognostic (2.63e-1)" "prognostic unfavourable (2.63e-4)" "unprognostic (2.84e-3)" "unprognostic (4.65e-2)" "unprognostic (2.04e-2)" "unprognostic (4.03e-3)" "unprognostic (1.55e-1)" "unprognostic (1.94e-1)" "unprognostic (3.11e-1)" "unprognostic (2.93e-2)" "unprognostic (6.24e-2)" "prognostic favourable (5.50e-5)" 21.2 19.7 20.7 21.0 24.0 12.9 25.3 22.8 40.7 18.4 20.2 18.2 14.6 18.9 20.8 24.6 32.7 18.3 17.9 19.8 26.9 23.6 18.7 11.4 26.2 29.2 24.7 22.8 18.2 14.9 29.7 20.0 23.4 30.7 16.8 22.4 12.9 20.3 19.2 14.6 31.6 20.5 18.4 29.1 23.7 17.5 18.5 21.5 19.1 19.0 15.8 21.9 18.8 21.4 7.3 11.7 16.4 18.1 10.1 9.2 6.3 11.3 6.6 11.9 13.7 20.5 25.8 8.0 16.1 16.2 13.2 13.9 4.6 19.9 11.0 11.3 17.3 13.6 9.7 12.8 19.0 5.8 6.7 10.2 8.2 5.3 19.4 11.0 14.5 20.8 17.5 13.7 15.2 21.4 14.6 10.9 28.6 7.2 8.0 11.2 7.5 12.6 9.4 8.9 8.9 14.7 12.5 8.9 15.8 9.6 15.9 13.3 10.1 11.9 25.8 16.4 13.4 14.0 13.8 13.1 6.5 9.8 21.3 12.4 15.4 15.2 12.1 10.4 5.8 15.7 7.5 7.3 8.2 8.2 11.7 6.7 7.4 5.4 16.4 10.1 18.1 5.3 9.2 6.3 20.7 24.0 22.8 40.7 26.9 23.6 24.7 22.8 30.7 21.5 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443158-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA037880: " "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favourable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 18.7 15.6 22.0 20.7 22.4 19.1 16.5 20.1 28.6 18.1 22.4 22.5 22.3 18.3 22.2 14.9 26.3 19.0 20.9 20.8 22.5 17.3 15.9 14.1 15.6 18.8 23.3 29.5 21.6 23.5 20.8 18.0 17.9 22.7 17.6 13.3 14.5 23.9 20.2 47.5 24.9 17.1 26.7 16.2 18.2 20.8 40.7 21.0 13.3 19.8 20.7 17.4 20.8 17.6 3.6 3.5 31.0 6.2 9.8 6.4 4.4 12.5 21.2 7.1 15.9 12.3 10.6 17.8 11.2 11.6 11.3 13.7 10.6 18.6 10.7 17.4 14.0 14.3 5.7 9.7 8.3 39.3 9.9 11.5 44.4 8.0 11.5 17.2 29.2 10.8 7.2 12.6 11.1 12.6 8.7 7.0 8.7 14.9 12.3 20.5 5.9 12.7 10.1 8.2 13.7 9.5 15.8 7.2 9.1 27.9 15.8 10.8 21.4 19.9 9.4 11.2 13.9 8.6 9.0 11.9 8.6 7.6 11.8 20.9 10.1 5.4 5.7 31.0 6.4 6.2 5.4 3.3 5.0 5.1 3.5 3.6 6.4 5.9 7.9 9.8 4.4 2.6 6.4 4.4 22.0 22.4 20.1 28.6 22.5 17.3 23.3 29.5 22.7 21.0 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.0;TIME: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.8 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.6 1.3 1.2 0.2 0.0 0.2 11.0 1.3 1.4 0.3 0.1 1.0 0.1 3.9 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 17.8;K-562: 16.4" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: " 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.1 0.0 1.1 0.0 0.1 0.0 0.1 0.0 17.8 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 16.4 0.3 0.0 0.2 0.0 0.0 0.2 0.5 1.2 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: " "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favourable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.7 14.6 20.2 19.9 23.7 24.7 7.0 13.0 21.7 11.8 15.6 8.4 25.0 13.3 9.4 24.4 11.3 10.8 17.7 19.7 20.2 12.9 10.7 15.4 8.9 26.1 14.0 11.7 24.0 22.2 16.8 31.2 20.1 15.4 13.3 21.9 11.6 25.5 15.5 15.1 13.7 11.4 17.9 23.9 19.1 15.9 15.8 24.9 19.5 18.0 20.8 11.9 13.2 21.8 13.2 6.9 13.9 14.1 21.1 12.8 12.8 38.9 16.5 20.1 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92834713-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: " "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favourable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 9.7 19.4 15.3 8.5 16.9 11.6 9.4 18.9 16.2 7.4 9.6 4.5 5.1 8.3 7.3 7.5 4.9 6.3 10.3 7.0 15.5 8.6 7.0 10.8 12.0 16.7 6.1 12.8 5.4 12.5 8.2 17.8 34.6 8.1 9.4 10.8 3.5 7.2 5.0 29.3 6.2 9.8 12.8 6.7 12.6 7.6 10.0 8.1 13.5 29.1 10.2 8.2 9.5 8.2 4.9 7.6 21.2 3.4 1.8 2.5 1.7 8.4 10.6 11.3 7.4 0.6 0.7 4.0 3.9 10.8 3.5 4.4 3.9 7.2 9.6 8.2 1.8 5.4 9.1 2.4 4.5 8.5 9.2 13.9 3.7 5.0 4.4 15.1 12.5 1.0 1.3 3.2 2.1 46.2 11.7 6.4 1.7 4.5 6.3 9.8 1.5 3.1 9.6 4.9 5.0 7.7 5.7 3.8 5.3 4.0 4.1 5.0 8.0 8.0 9.4 0.2 3.7 3.3 6.3 4.8 5.1 7.8 1.2 17.0 4.0 3.7 3.4 10.1 2.2 2.7 2.2 4.7 2.5 2.1 3.4 4.9 2.1 2.4 21.2 1.8 2.6 7.6 2.3 1.7 15.3 16.9 18.9 16.2 15.5 8.6 6.1 12.8 8.1 8.1 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: , HPA063991: " "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 10.8 8.3 7.6 9.2 22.0 9.1 13.2 8.0 11.3 6.9 4.5 11.2 1.7 2.8 5.0 13.3 18.2 6.4 13.1 10.0 2.1 5.2 8.4 5.8 6.4 11.8 1.2 2.9 7.7 19.1 7.7 12.1 11.2 0.9 0.0 9.0 3.7 3.1 1.4 7.9 4.6 1.7 13.7 1.1 6.6 25.5 3.8 3.3 13.6 4.2 5.5 2.9 1.1 12.3 8.0 6.8 6.8 4.8 2.9 2.8 0.0 9.3 0.6 6.3 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 EXOC7 "BLOM4, EXO70, Exo70p, KIAA1067, YJL085W" ENSG00000182473 "Exocyst complex component 7" Q9UPT5 17 76081017-76121576 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022840, HPA022842" Supported Approved "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA022840: AB_1848316, HPA022842: AB_1848317" "unprognostic (5.20e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (3.49e-2)" "unprognostic (2.37e-2)" "unprognostic (1.88e-1)" "unprognostic (1.30e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (7.39e-3)" "unprognostic (1.53e-2)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (1.05e-1)" "unprognostic (1.18e-1)" 23.2 22.2 30.5 18.2 37.1 27.5 20.4 27.8 46.2 23.8 24.4 33.0 20.8 19.1 28.7 20.8 31.8 32.6 21.3 27.5 29.2 23.5 21.0 22.6 21.2 17.6 20.9 28.2 31.5 24.1 40.5 29.3 24.0 34.6 30.0 17.0 27.0 29.2 27.9 24.0 21.8 21.6 31.1 21.7 21.4 19.6 14.5 23.0 23.7 29.5 14.1 26.4 30.2 20.5 12.8 13.7 29.6 34.4 15.5 17.9 19.0 21.2 26.4 24.4 19.7 23.2 16.5 25.4 19.5 26.1 35.4 25.7 22.2 14.4 11.0 14.3 34.1 17.5 14.7 19.0 23.8 9.5 19.9 18.3 20.7 23.4 16.2 20.3 19.0 23.0 15.0 27.4 13.4 39.2 12.2 11.3 22.0 19.5 32.6 9.0 12.8 28.2 17.6 41.8 11.2 20.4 44.1 13.3 31.1 22.1 16.4 15.1 26.9 16.8 25.6 38.0 22.9 25.0 21.4 15.6 5.7 10.2 22.7 9.2 19.6 21.1 19.2 29.6 17.9 26.6 12.3 12.4 13.7 15.3 13.7 12.8 14.5 12.2 22.2 15.5 34.4 5.9 14.8 19.0 30.5 37.1 27.8 46.2 29.2 23.5 20.9 28.2 34.6 23.0 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97436142-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 18.2 23.3 22.3 28.8 26.2 24.8 23.4 22.8 26.6 19.9 21.9 21.4 23.4 21.9 22.9 45.6 25.1 20.2 19.2 19.4 21.6 23.2 20.5 24.6 18.3 30.1 24.2 19.8 22.3 35.0 21.0 33.6 22.8 21.8 21.5 26.2 20.6 32.5 27.7 23.6 22.1 20.7 24.2 22.4 27.4 26.2 15.6 20.8 36.6 23.4 21.1 34.1 23.5 19.9 37.3 32.2 30.9 43.0 18.5 47.2 28.4 18.8 19.0 12.1 20.1 16.9 18.1 15.9 16.8 29.0 22.7 26.5 30.7 20.8 21.1 16.8 18.7 21.1 19.2 22.6 22.3 22.4 23.6 13.0 16.4 23.2 29.5 29.0 14.3 18.6 29.8 25.8 39.1 26.4 15.7 35.1 17.6 24.0 27.5 48.2 18.8 16.4 20.0 14.2 36.4 15.1 10.8 6.9 12.1 11.8 9.9 25.0 23.4 32.9 13.0 11.3 12.9 17.1 35.0 22.1 27.0 36.8 18.5 36.8 8.6 24.3 31.6 30.9 28.1 43.0 35.3 37.3 35.5 31.9 32.2 29.4 34.2 29.6 13.0 18.5 39.0 28.1 47.2 28.4 22.3 26.2 22.8 26.6 21.6 23.2 24.2 19.8 21.8 20.8 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favourable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.1 14.8 31.1 12.0 16.6 18.4 17.8 22.9 16.9 40.4 36.8 21.8 33.9 23.4 14.9 21.7 23.1 34.3 25.5 37.2 26.2 34.4 34.0 29.1 22.2 16.3 27.6 27.1 14.4 22.1 39.6 23.4 25.1 35.6 21.6 22.2 13.1 27.1 25.5 20.6 17.8 28.0 26.5 20.4 23.7 11.9 20.1 19.6 24.7 21.4 27.4 18.7 25.5 22.7 21.6 22.5 19.3 26.8 13.1 20.5 46.3 22.0 41.2 25.8 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA021756: , HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavourable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 13.0 14.2 14.4 18.6 17.0 12.7 17.9 22.7 18.0 16.1 14.3 15.8 13.6 11.0 18.7 10.1 16.6 19.0 11.7 12.5 15.8 12.5 14.3 18.4 11.1 16.7 18.5 17.3 22.1 25.0 19.6 12.6 13.1 13.9 13.9 17.4 14.6 14.1 13.7 22.3 13.1 11.5 18.7 12.3 14.0 13.4 8.4 17.6 17.3 14.2 15.7 21.3 15.8 13.9 11.0 10.4 5.6 7.9 16.8 11.7 7.7 13.7 28.2 16.9 14.9 6.1 6.9 12.3 20.7 10.0 20.8 16.1 22.7 12.0 27.4 11.4 11.1 25.2 26.9 20.7 23.0 16.2 13.1 21.9 27.6 15.8 11.5 33.0 14.5 8.8 7.8 29.1 34.1 14.7 23.8 11.9 14.4 24.5 23.2 9.2 20.9 18.3 18.3 31.0 29.9 9.7 12.8 10.4 11.6 24.2 18.5 10.9 19.2 11.9 8.9 20.5 15.9 18.2 29.2 6.1 24.0 41.6 14.6 19.3 16.0 1.5 7.7 5.6 10.9 7.9 11.2 11.0 11.0 9.2 10.4 10.4 11.7 10.0 2.0 16.8 5.4 6.8 9.9 7.7 14.4 17.0 22.7 18.0 15.8 12.5 18.5 17.3 13.9 17.6 EXOSC4 "FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p" ENSG00000178896 "Exosome component 4" Q9NPD3 8 144078626-144080647 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024792 Approved Supported "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA024792: AB_1848325" "unprognostic (2.32e-1)" "unprognostic (1.55e-2)" "unprognostic (3.06e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.58e-3)" "unprognostic (1.26e-1)" "unprognostic (8.36e-2)" "prognostic favourable (2.23e-4)" "unprognostic (4.32e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (2.71e-1)" "unprognostic (5.11e-2)" 12.3 16.7 12.8 11.4 17.6 13.8 8.9 13.9 20.6 8.1 12.0 10.5 13.6 15.8 9.8 10.4 14.5 10.0 9.3 16.5 11.4 11.2 14.9 21.5 8.7 11.4 11.5 13.0 10.3 15.0 8.0 10.2 11.5 12.0 12.1 6.5 11.6 28.0 14.7 12.1 12.7 11.1 6.7 9.3 13.4 13.9 45.0 9.7 14.8 10.8 10.4 11.1 8.7 7.8 24.7 38.2 19.0 31.8 17.1 16.1 18.8 10.2 22.5 4.0 9.6 3.5 2.6 11.0 8.0 3.3 6.3 6.4 15.7 7.2 6.2 11.7 3.3 8.4 7.4 8.8 1.8 8.1 25.0 8.9 16.8 17.4 5.8 6.6 10.6 3.8 9.0 7.3 5.8 3.2 13.9 4.2 5.1 37.2 10.2 13.1 10.4 90.3 4.5 6.6 16.0 6.0 10.4 12.6 16.7 10.0 13.0 18.5 14.7 10.0 3.2 6.5 14.2 15.5 13.6 11.2 13.4 7.7 9.4 10.6 10.1 19.0 31.8 12.5 15.9 29.4 16.1 22.0 12.4 15.4 29.8 24.7 15.9 15.4 9.2 17.1 16.1 38.2 13.7 18.8 12.8 17.6 13.9 20.6 11.4 11.2 11.5 13.0 12.0 9.7 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397479 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA053150: , HPA055677: " "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavourable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 9.1 14.3 12.6 12.3 16.6 13.1 11.1 7.6 21.3 8.8 12.1 10.8 9.0 10.0 8.1 6.0 14.6 13.6 6.4 11.6 12.0 10.3 7.9 25.1 5.7 17.0 13.4 9.9 13.2 46.9 3.2 4.9 6.5 10.3 9.5 6.6 6.3 14.0 8.1 30.9 18.5 9.5 6.6 14.0 12.7 9.8 7.5 11.8 16.8 15.1 15.7 12.2 11.3 8.6 22.9 36.8 3.3 23.7 17.1 21.1 13.5 17.8 33.5 4.7 13.8 3.0 3.8 11.0 7.6 3.6 12.4 10.3 19.5 13.2 27.9 19.7 3.7 6.8 9.3 8.5 3.9 17.8 32.1 12.4 12.6 14.8 9.6 22.4 12.3 4.7 19.1 10.0 9.6 5.8 16.6 20.1 4.1 23.4 19.3 15.8 16.6 16.6 18.3 12.9 25.1 5.0 12.8 18.1 13.6 10.9 18.3 18.5 8.5 27.7 4.6 13.1 11.0 8.3 23.3 31.7 40.5 30.3 10.2 32.3 11.1 3.3 21.7 0.6 13.2 23.7 15.8 21.1 14.4 13.3 34.1 22.9 21.1 18.5 1.5 17.1 14.0 36.8 11.1 13.5 12.6 16.6 7.6 21.3 12.0 10.3 13.4 9.9 10.3 11.8 EXOSC8 "bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p" ENSG00000120699 "Exosome component 8" Q96B26 13 36998816-37009613 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034240, HPA039702, HPA043942, HPA075230" Uncertain Supported "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: , HPA075230: " "unprognostic (8.67e-2)" "unprognostic (9.39e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.01e-2)" "unprognostic (3.24e-3)" "unprognostic (2.45e-2)" "unprognostic (2.35e-2)" "unprognostic (7.32e-3)" "prognostic unfavourable (8.39e-7)" "unprognostic (9.58e-3)" "unprognostic (7.42e-2)" "unprognostic (1.10e-1)" "unprognostic (4.51e-1)" 15.1 14.5 16.0 18.0 15.7 24.5 20.1 15.4 16.3 17.3 17.1 16.7 13.5 13.0 15.6 15.2 18.8 16.3 10.1 16.8 14.9 12.7 16.5 22.9 15.5 22.8 19.8 15.5 19.4 14.5 6.9 15.3 21.6 15.2 18.3 19.8 12.6 13.1 14.4 22.5 16.2 20.0 19.3 18.5 20.0 14.9 30.4 19.6 31.5 18.9 21.1 24.6 20.4 14.5 27.6 23.5 9.3 16.0 18.0 30.7 21.3 12.8 9.8 28.0 18.9 8.6 9.1 21.4 20.1 14.1 27.7 22.6 21.3 26.4 18.7 8.8 11.2 18.1 27.3 19.6 32.7 27.2 23.0 50.9 10.8 25.8 11.1 41.0 17.5 5.4 14.9 18.8 30.3 21.0 24.1 11.8 19.4 16.7 20.8 33.4 29.2 12.9 13.6 28.6 15.2 15.4 9.2 7.2 13.8 10.9 12.5 17.8 9.6 32.8 10.4 10.1 14.5 12.3 26.5 6.9 8.2 39.8 16.0 29.3 18.6 9.3 13.0 9.2 19.2 16.0 19.9 27.6 24.6 22.7 14.3 22.9 30.7 28.5 2.8 18.0 15.7 23.5 22.2 21.3 16.0 15.7 15.4 16.3 14.9 12.7 19.8 15.5 15.2 19.6 EXOSC9 "p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p" ENSG00000123737 "Exosome component 9" Q06265 4 121801317-121817021 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041838, HPA048257, CAB070171" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: " "unprognostic (7.36e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-2)" "unprognostic (2.23e-1)" "unprognostic (2.78e-1)" "unprognostic (3.36e-2)" "prognostic unfavourable (1.04e-4)" "unprognostic (7.89e-2)" "unprognostic (3.73e-2)" "unprognostic (1.66e-2)" "unprognostic (9.25e-2)" "unprognostic (9.85e-3)" "prognostic unfavourable (6.49e-4)" "unprognostic (3.28e-2)" "unprognostic (6.66e-2)" "unprognostic (1.68e-1)" "unprognostic (7.21e-2)" 12.5 12.7 10.1 18.9 14.7 29.7 13.9 16.8 18.6 11.2 9.7 8.1 12.5 7.5 12.5 12.4 13.3 11.8 7.8 13.1 13.5 11.3 11.3 14.0 11.9 19.8 11.3 12.2 12.6 10.4 14.2 15.5 12.1 12.9 10.3 12.0 9.6 10.9 8.9 17.6 12.1 10.3 10.6 11.7 14.2 10.4 36.7 10.0 33.7 9.2 15.4 18.9 12.2 10.5 19.9 15.9 20.1 17.7 11.6 23.6 14.0 19.2 9.1 24.6 14.6 3.9 7.9 12.0 25.1 14.5 36.0 27.8 9.8 16.2 33.9 6.2 15.6 6.9 26.5 11.7 32.1 15.0 12.2 17.0 14.0 12.6 8.1 28.8 15.8 6.0 6.1 25.1 7.2 17.7 29.1 13.4 33.6 11.3 44.0 22.2 12.9 10.7 24.6 41.2 15.2 12.3 6.3 15.7 16.5 9.2 13.7 15.2 11.7 18.6 10.7 16.1 23.8 13.5 24.2 19.6 14.8 40.7 16.7 20.1 10.6 12.0 13.3 20.1 18.7 17.7 18.4 19.9 20.5 23.6 15.9 19.9 23.3 20.7 3.3 11.6 17.0 15.7 21.6 14.0 10.1 14.7 16.8 18.6 13.5 11.3 11.3 12.2 12.9 10.0 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895998 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 83000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: " "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 7.5 23.0 9.8 4.1 19.9 1.7 10.4 14.7 22.8 13.4 8.7 8.1 9.9 4.5 16.7 13.1 6.0 10.1 10.3 8.2 9.5 13.3 11.2 10.0 7.6 3.4 14.0 12.0 18.8 7.7 17.5 18.7 21.8 20.1 12.3 7.1 8.6 6.0 11.4 5.3 5.9 4.6 15.4 11.4 5.4 6.2 9.7 16.3 6.4 9.3 5.0 3.4 9.0 6.2 2.1 7.4 3.3 1.1 5.3 5.6 1.9 5.1 2.7 19.8 20.7 22.0 16.2 12.6 8.9 14.6 7.0 15.7 2.5 3.9 5.7 8.6 8.1 5.0 7.2 7.6 14.2 11.6 5.0 7.0 9.6 7.1 7.2 10.9 3.7 19.2 2.7 14.0 2.7 25.5 8.8 0.7 17.6 2.6 5.7 6.0 24.9 6.0 4.2 20.4 4.7 7.5 3.9 8.2 23.3 6.8 1.7 15.9 4.3 4.9 10.7 17.5 10.3 11.2 9.3 6.1 5.4 3.5 27.9 11.3 5.7 3.3 0.8 0.0 5.6 1.1 2.8 1.9 1.9 3.7 2.5 2.1 2.1 4.8 0.2 5.3 0.9 7.4 0.0 1.9 9.8 19.9 14.7 22.8 9.5 13.3 14.0 12.0 20.1 16.3 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 45.5;pituitary gland: 30.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.4;RH-30: 12.7;SH-SY5Y: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "NK-cell: 9.8" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028917 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA028917: " "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 1.0 1.1 2.8 0.6 16.8 0.5 0.6 0.2 6.8 4.0 0.6 1.9 0.0 0.7 0.6 2.2 1.0 2.5 0.8 4.6 2.8 2.2 0.6 0.5 1.0 0.6 2.9 2.8 0.8 0.6 45.5 30.8 0.6 4.2 12.4 0.7 15.3 1.2 4.6 3.2 0.6 0.7 3.9 0.4 0.7 0.9 1.3 5.1 4.4 0.9 2.9 0.6 3.5 5.7 0.8 1.9 1.8 2.3 9.8 2.3 0.2 0.1 0.0 3.7 16.4 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 1.2 0.9 0.0 12.7 5.4 0.0 0.0 1.3 31.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.2 1.8 0.3 0.6 0.9 0.9 1.9 0.8 0.7 1.9 0.7 0.8 1.3 1.4 1.6 9.8 2.3 1.9 2.3 0.2 2.8 16.8 0.2 2.8 2.8 2.2 2.9 2.8 4.2 5.1 F11R "CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1" ENSG00000158769 "F11 receptor" Q9Y624 1 160995211-161021348 "CD markers, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;HaCaT: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 44.5;neutrophil: 32.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004671, HPA043616, HPA061700" Enhanced Supported "Cell Junctions,Microtubules" 41000000 Microtubules "Cell Junctions" "CAB004671: AB_425964, HPA043616: , HPA061700: " "unprognostic (1.60e-2)" "unprognostic (5.78e-3)" "unprognostic (1.78e-3)" "unprognostic (2.24e-1)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (2.28e-1)" "unprognostic (2.55e-1)" "unprognostic (6.35e-2)" "unprognostic (1.98e-3)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (1.59e-1)" "unprognostic (9.72e-3)" "unprognostic (5.01e-2)" 20.7 13.3 3.0 9.6 3.6 6.4 11.8 2.0 3.5 14.5 36.3 3.9 21.4 20.5 8.6 11.2 41.5 12.3 30.5 10.0 3.4 3.2 35.9 69.8 55.0 10.4 3.6 1.8 10.9 37.9 18.5 16.3 61.8 5.3 17.8 19.5 5.7 59.3 23.7 9.0 22.0 59.8 4.9 4.0 27.0 18.8 11.0 3.3 8.1 52.2 25.8 29.9 16.8 19.7 1.3 7.0 44.5 8.9 2.2 3.8 6.6 28.5 3.7 1.1 0.3 0.8 0.0 23.3 0.1 0.0 1.0 1.0 26.4 37.7 2.1 19.4 0.0 49.4 5.8 24.5 1.5 1.6 4.3 6.0 1.5 12.0 1.1 5.6 17.8 0.3 31.0 0.1 8.2 23.2 8.1 0.6 0.1 12.3 1.7 3.2 19.7 5.3 2.6 0.0 9.2 16.6 21.7 8.2 2.1 6.9 29.7 6.1 32.3 10.0 13.9 0.1 0.7 0.1 0.2 6.9 13.6 0.7 4.4 5.5 1.8 7.6 8.9 44.5 3.8 4.5 2.0 1.3 3.5 2.3 7.0 0.9 3.4 2.7 32.2 2.2 3.4 5.3 1.5 6.6 3.0 3.6 2.0 3.5 3.4 3.2 3.6 1.8 5.3 3.3 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 7 "HEL: 24.3;HMC-1: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favourable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.0 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.6 0.1 0.2 0.2 0.3 0.3 24.3 0.9 0.4 0.2 0.3 9.8 0.0 0.1 0.3 0.2 0.8 1.9 1.0 0.1 0.3 0.3 2.4 0.3 0.2 0.2 0.2 0.7 0.2 0.5 0.4 0.2 0.2 0.1 0.1 0.5 1.6 0.9 0.5 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "Fanconi anemia core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavourable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favourable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 33.1 18.8 15.4 14.3 12.1 15.2 20.5 15.4 16.4 17.8 19.1 13.8 19.1 14.6 17.8 17.7 20.3 12.6 14.2 17.0 15.4 14.8 27.7 20.9 15.0 22.5 14.9 10.3 16.9 17.2 8.0 26.4 11.7 13.3 21.8 7.3 20.9 21.4 23.9 27.3 28.1 14.9 15.0 14.3 24.4 30.5 20.2 11.5 35.1 30.5 11.4 16.5 17.1 19.3 13.2 22.0 31.0 8.7 5.1 12.6 5.6 10.2 1.6 2.3 2.8 1.4 1.9 13.7 11.7 4.3 3.8 5.1 2.5 6.8 12.0 17.3 1.8 5.0 1.6 1.7 1.9 25.7 23.7 10.0 2.7 5.2 5.4 6.9 9.7 3.2 3.8 2.3 2.5 4.6 13.7 2.8 2.6 4.2 10.0 21.6 8.1 21.6 13.5 7.1 11.2 1.8 1.6 18.7 25.0 7.6 3.3 20.0 3.2 2.8 9.8 5.9 14.1 7.3 6.6 27.1 14.4 17.6 11.1 4.3 2.4 3.6 8.7 31.0 10.1 8.1 10.0 13.2 9.2 10.9 8.8 13.1 12.6 10.4 11.2 5.1 7.5 22.0 7.8 5.6 15.4 12.1 15.4 14.1 15.4 14.8 14.9 10.3 13.3 11.5 FAAP24 "C19orf40, FLJ46828, MGC32020" ENSG00000131944 "Fanconi anemia core complex associated protein 24" Q9BTP7 19 32972209-32978222 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041168 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041168: AB_10960496" "unprognostic (1.18e-2)" "unprognostic (1.22e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (6.52e-2)" "unprognostic (2.73e-1)" "unprognostic (2.58e-3)" "unprognostic (3.76e-2)" "unprognostic (1.88e-2)" "unprognostic (3.98e-2)" "unprognostic (2.82e-3)" "unprognostic (3.54e-2)" "prognostic unfavourable (4.00e-7)" "unprognostic (4.37e-3)" "unprognostic (5.30e-1)" "unprognostic (2.31e-3)" "unprognostic (2.15e-1)" 3.7 3.5 1.8 4.1 2.1 5.3 3.9 2.3 2.9 3.0 2.9 2.4 3.3 2.8 3.3 4.6 4.8 2.6 6.7 1.9 1.5 1.7 4.3 2.5 2.3 4.6 3.8 0.9 4.2 2.4 0.2 2.0 6.1 3.1 9.6 4.0 3.3 3.2 1.9 1.0 4.6 5.1 2.2 2.6 6.1 2.8 16.9 2.0 8.7 3.0 3.1 8.6 3.6 2.7 7.2 7.7 16.0 8.0 7.7 6.2 3.7 5.0 12.6 5.2 8.1 2.6 5.5 4.2 6.5 6.8 12.5 16.4 8.9 8.3 6.0 9.6 2.7 3.6 9.9 4.8 10.0 16.1 5.1 12.9 5.7 6.7 1.5 4.5 6.6 3.1 3.1 7.8 4.8 5.0 6.7 6.1 9.1 5.7 9.4 5.9 2.3 5.7 8.5 4.7 3.2 2.5 3.1 5.5 4.3 7.3 8.5 5.3 5.9 11.2 3.0 12.5 6.0 5.2 5.9 4.9 9.9 8.1 8.9 9.8 8.1 10.8 6.4 8.7 3.9 7.3 4.4 6.6 4.7 5.6 4.0 7.2 4.3 6.2 16.0 7.7 8.0 7.7 6.0 3.7 1.8 2.1 2.3 2.9 1.5 1.7 3.8 0.9 3.1 2.0 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in some" 7 "CACO-2: 25.6;Hep G2: 81.3" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 25.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 81.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.0 1.4 7.5 0.0 0.1 0.8 5.6 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322390 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "intestine: 358.6" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.1;neutrophil: 7.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" 46000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.1 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 47.0 0.0 0.0 50.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.9 0.1 0.1 0.0 0.1 0.1 358.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.5 7.6 0.7 0.9 0.5 0.0 0.2 0.3 0.2 0.4 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.4 0.3 0.4 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.3 0.1 0.4 2.4 0.0 0.5 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.5 0.0 0.1 0.4 3.8 0.2 0.5 0.3 0.2 3.2 0.0 0.5 1.0 2.6 0.1 0.4 0.0 0.3 0.1 0.9 0.4 0.4 1.4 0.1 0.7 0.2 0.6 0.3 0.2 0.1 2.1 0.7 0.7 0.4 0.3 0.4 0.2 0.4 0.3 0.2 0.5 0.5 0.5 7.6 0.9 0.2 0.5 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365625-31376850 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "heart muscle: 420.9;skeletal muscle: 129.4" "Cell line enriched" "Detected in some" 5 "ASC TERT1: 117.9" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" 4400000 "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: " "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favourable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 2.3 5.2 8.1 0.7 6.0 0.5 22.7 1.4 14.6 3.9 1.3 0.8 3.4 0.7 6.8 5.3 3.1 2.8 1.1 420.9 11.0 5.3 21.3 1.9 4.3 1.3 9.8 6.0 2.2 0.4 0.3 0.7 1.1 13.7 5.0 1.5 3.0 4.4 14.0 129.4 0.9 0.6 13.0 3.4 3.9 3.6 2.0 1.3 0.1 1.7 31.6 2.2 2.5 2.5 1.4 0.5 0.0 0.9 0.2 0.9 0.6 0.1 0.0 3.2 0.2 22.6 117.9 1.1 0.9 8.7 0.1 3.1 0.2 0.8 0.2 12.5 2.4 0.3 0.9 0.0 0.1 0.1 0.5 0.3 1.1 2.3 1.5 0.2 0.0 10.4 0.0 2.3 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.2 6.0 0.4 0.1 1.2 0.0 2.8 0.0 0.3 0.0 0.5 0.0 13.5 0.1 1.4 0.3 0.2 0.1 2.1 0.1 0.1 0.4 0.1 0.5 0.1 0.2 0.0 0.4 0.0 0.9 0.9 0.6 0.2 0.5 0.5 0.5 1.4 0.0 0.9 0.0 0.2 0.1 0.4 0.6 0.6 8.1 6.0 1.4 13.3 11.0 5.3 9.8 6.0 13.7 1.3 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell line enhanced" "Detected in many" "Daudi: 92.9;MOLT-4: 90.8" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: " "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavourable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.7 16.5 10.1 0.0 48.4 4.5 0.0 11.8 0.6 9.2 11.7 0.1 7.9 92.9 6.8 2.9 5.4 24.6 18.9 7.9 47.2 53.4 33.5 11.8 25.0 4.3 32.0 8.7 3.5 38.9 11.4 23.5 53.0 9.6 10.1 5.5 5.6 90.8 16.4 13.4 64.3 40.5 0.0 9.8 14.8 71.8 42.0 15.9 5.7 1.9 4.4 0.0 16.5 7.5 0.0 26.3 0.1 0.1 12.5 4.9 66.2 4.2 30.7 14.8 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Group enriched" "Detected in some" 8 "AF22: 37.8;U-251 MG: 10.2;WM-115: 22.7" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: , HPA028825: AB_10602130" "prognostic favourable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavourable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 37.8 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.2 0.0 0.0 0.0 0.4 0.0 22.7 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 FADD "GIG3, MORT1" ENSG00000168040 "Fas associated via death domain" Q13158 11 70203163-70207390 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 81.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001464, CAB010209" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB010209: AB_2100622, HPA001464: AB_1848348" "unprognostic (2.08e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (6.91e-2)" "unprognostic (9.51e-2)" "unprognostic (3.89e-1)" "prognostic unfavourable (8.22e-5)" "unprognostic (7.25e-3)" "prognostic unfavourable (2.21e-5)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" "unprognostic (2.45e-3)" "unprognostic (2.78e-3)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "prognostic favourable (3.45e-4)" "unprognostic (7.29e-2)" 16.1 20.2 7.9 13.3 8.9 7.1 13.5 10.9 11.8 13.7 16.2 10.9 20.8 13.5 18.0 18.7 18.8 13.3 19.7 11.4 7.8 8.0 17.9 17.4 11.0 19.2 10.5 6.6 12.9 24.9 9.1 9.3 26.3 7.9 12.5 12.7 10.1 14.4 14.5 10.3 13.7 16.9 10.1 8.3 18.8 14.0 8.7 7.4 33.5 16.9 12.4 19.8 14.6 15.1 18.6 17.6 42.7 19.5 16.6 24.6 16.0 81.8 13.8 6.9 6.2 8.4 6.8 6.2 14.1 11.1 12.3 8.3 11.8 13.4 12.2 13.6 9.3 12.1 6.7 12.5 9.6 11.3 7.4 5.5 7.9 6.0 7.5 6.9 7.4 6.7 8.9 13.3 16.9 11.6 9.0 6.3 10.8 12.0 8.4 12.2 10.9 22.9 6.5 16.7 11.6 12.1 6.0 6.1 5.8 10.4 9.8 28.9 10.6 7.7 12.9 9.6 9.4 14.7 13.4 8.8 6.7 7.1 14.0 7.0 13.5 15.0 17.1 12.7 21.0 17.7 24.1 18.6 22.3 24.6 17.6 16.4 23.2 20.9 42.7 16.6 19.5 16.0 20.7 16.0 7.9 8.9 10.9 11.8 7.8 8.0 10.5 6.6 7.9 7.4 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" "Lipid droplets" "Endoplasmic reticulum" "HPA065968: , HPA071246: , HPA073828: " "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (1.79e-4)" "prognostic unfavourable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 21.1 27.7 17.5 16.5 28.5 21.7 20.8 25.4 28.3 21.5 19.2 24.4 17.4 17.2 22.3 21.5 23.0 21.0 18.0 15.1 16.8 18.9 20.5 34.2 17.8 17.2 16.4 15.9 29.3 25.9 32.4 31.5 32.0 25.5 22.3 23.1 24.6 20.1 18.6 15.3 25.5 22.6 22.2 14.5 21.0 18.8 31.9 14.2 30.0 23.1 15.2 24.3 20.7 17.5 7.2 10.9 10.0 14.9 12.4 13.1 7.5 13.9 15.9 15.8 17.5 22.4 17.9 21.6 18.3 21.0 20.9 22.7 20.6 25.3 12.2 20.7 19.3 21.6 22.6 46.4 29.0 48.6 12.4 8.0 16.2 10.0 22.9 17.3 10.5 23.5 20.5 25.5 21.3 17.3 11.4 16.7 19.9 23.2 15.1 9.2 12.7 13.5 15.0 13.7 13.6 17.7 18.5 14.0 15.0 22.3 19.4 20.2 22.8 13.8 19.3 28.8 15.6 15.8 24.4 14.4 15.3 16.0 18.2 12.4 25.1 10.0 9.2 6.1 10.0 7.6 12.2 7.2 8.2 10.5 10.9 7.0 10.7 9.5 7.8 12.4 14.9 7.5 13.1 7.5 17.5 28.5 25.4 28.3 16.8 18.9 16.4 15.9 25.5 14.2 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favourable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favourable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 10.4 17.0 10.4 6.7 9.9 6.5 9.2 8.6 12.7 6.8 21.7 9.3 8.2 26.7 9.8 10.9 14.8 5.8 10.2 15.8 10.9 11.4 46.8 43.6 5.6 5.2 10.1 9.4 7.9 17.4 9.0 11.1 10.4 9.9 8.1 11.1 8.5 9.1 9.8 20.2 12.4 24.8 6.9 8.8 6.3 14.9 6.9 9.5 4.7 12.5 19.0 5.7 9.9 7.9 18.5 23.1 8.6 27.5 19.6 16.0 13.7 8.3 18.8 9.0 15.8 12.0 8.7 5.6 13.7 6.8 9.2 10.1 12.0 8.7 5.3 11.6 8.5 17.2 7.0 11.0 8.3 8.0 16.6 4.8 16.2 27.6 11.7 8.2 9.2 11.4 14.5 8.4 5.6 11.9 4.9 5.6 11.5 38.2 4.4 12.5 5.3 14.1 10.2 12.2 15.0 32.9 10.5 17.6 14.6 17.9 14.4 21.5 21.2 5.6 17.4 15.1 10.8 8.8 7.4 8.1 17.0 6.3 9.6 6.0 6.4 6.5 23.5 8.6 14.4 27.5 13.0 18.5 14.5 15.7 23.1 16.9 16.0 14.9 2.0 19.6 19.1 17.9 14.7 13.7 10.4 9.9 8.6 12.7 10.9 11.4 10.1 9.4 9.9 9.5 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 61.9" "Cell line enhanced" "Detected in many" "U-698: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042440: , HPA052209: " "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavourable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favourable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 13.7 6.6 12.3 6.7 11.6 2.6 19.0 7.8 9.9 24.5 6.8 10.2 38.5 4.7 9.6 15.1 8.8 28.5 9.0 4.7 12.2 12.5 15.4 6.0 7.6 7.2 13.9 7.1 8.4 27.5 7.2 15.4 6.1 10.7 11.4 6.0 9.1 7.2 61.9 6.1 6.2 4.2 7.2 19.6 3.7 6.7 5.4 9.1 13.2 15.2 9.3 9.6 10.3 13.2 13.9 5.0 11.1 2.6 13.9 9.1 3.4 26.5 5.2 0.5 4.7 5.1 9.6 19.1 8.2 5.0 8.7 7.5 8.9 7.8 0.0 7.3 10.7 7.0 22.7 4.7 9.8 21.8 23.7 5.0 14.4 12.9 5.7 0.0 1.6 13.5 9.1 3.2 5.0 9.4 3.2 6.8 5.4 10.1 0.1 22.5 10.3 5.2 26.8 6.2 0.7 13.8 13.2 9.0 7.6 14.6 8.1 20.5 13.7 6.6 5.7 1.8 4.1 8.9 3.9 0.0 0.1 44.7 7.2 0.0 7.1 11.1 2.4 1.7 9.1 2.6 8.5 13.9 5.0 7.2 5.0 7.9 3.4 8.5 0.3 13.9 1.7 3.5 5.4 3.4 12.3 11.6 7.8 8.2 12.2 12.5 13.9 7.1 10.7 9.1 FAM102B "DKFZp779B126, SYM-3B" ENSG00000162636 "Family with sequence similarity 102 member B" Q5T8I3 1 108560089-108644900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028451 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA028451: AB_10602497" "unprognostic (1.30e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (3.87e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-3)" "unprognostic (3.10e-1)" "unprognostic (2.62e-2)" "unprognostic (1.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.11e-2)" "prognostic unfavourable (3.47e-6)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" 11.6 5.2 11.8 10.4 11.4 19.0 11.3 23.3 20.0 8.5 13.8 3.8 6.6 11.4 7.5 8.2 6.5 6.7 15.7 9.2 15.6 14.3 4.6 5.1 8.1 8.8 12.6 19.0 10.5 5.8 12.1 7.3 6.0 11.4 8.5 15.7 5.5 13.5 9.6 2.3 4.2 11.5 11.4 10.2 8.6 7.9 8.8 5.0 9.4 6.7 4.3 8.4 16.4 18.0 0.9 2.7 5.7 2.3 0.7 1.4 0.5 3.6 2.6 5.2 2.8 9.5 5.7 3.4 2.1 2.9 3.3 5.7 0.9 3.6 4.0 2.0 5.5 7.1 17.8 0.7 4.3 2.6 2.6 5.6 20.1 0.4 2.4 7.2 10.7 3.0 0.8 4.9 0.3 2.1 13.5 22.3 7.8 14.7 4.6 5.2 4.1 13.1 10.6 13.3 0.8 0.9 4.2 17.1 5.0 8.5 14.8 4.4 3.1 11.8 0.4 5.4 10.2 4.6 8.1 4.0 0.9 3.7 7.9 5.7 2.8 5.7 1.1 1.0 1.0 2.3 0.6 0.9 1.0 1.4 2.7 0.9 0.7 0.5 1.0 0.7 0.9 0.5 0.8 0.5 11.8 11.4 23.3 20.0 15.6 14.3 12.6 19.0 11.4 5.0 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021459 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021459: AB_1848361" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavourable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 9.3 7.2 8.7 9.1 9.0 23.2 12.4 10.8 7.9 9.9 9.1 6.9 7.4 7.8 8.4 8.4 10.4 6.6 8.5 11.6 8.1 7.0 6.4 10.0 8.2 10.1 6.9 8.3 8.2 11.4 8.4 11.2 14.2 6.4 9.3 8.1 8.4 8.3 8.0 11.9 11.7 10.1 7.3 7.1 11.8 13.3 74.8 6.5 14.6 9.2 7.1 11.2 9.9 11.6 21.3 19.7 34.3 20.3 26.7 49.5 29.9 22.6 18.6 9.4 17.4 14.4 13.6 30.8 18.5 19.5 20.5 21.2 15.6 14.7 13.3 15.3 17.8 14.5 12.0 13.5 22.3 15.5 16.2 19.3 16.0 23.6 19.2 16.8 33.2 14.3 18.0 18.1 13.3 23.9 14.9 22.2 24.5 15.4 29.8 11.6 12.9 23.9 16.4 26.2 12.8 15.6 18.6 15.5 20.6 10.8 15.8 19.9 22.2 17.4 16.6 24.3 28.1 16.5 21.6 22.0 21.7 16.1 21.7 18.4 17.9 24.5 20.3 34.3 24.7 17.6 23.7 21.3 30.3 28.1 19.7 20.2 22.2 26.7 33.3 26.7 18.6 12.8 49.5 29.9 8.7 9.0 10.8 7.9 8.1 7.0 6.9 8.3 6.4 6.5 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell line enhanced" "Detected in many" "HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA046638: " "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavourable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.2 1.5 1.4 0.4 0.7 1.9 1.3 0.0 0.8 0.7 0.1 2.6 1.2 0.6 0.8 3.6 3.4 13.8 0.3 1.3 0.0 43.3 0.1 0.3 0.2 0.0 0.0 0.0 5.4 0.1 1.0 0.0 1.2 1.9 9.2 0.3 0.5 1.5 0.0 10.4 4.5 5.0 0.7 0.4 0.0 0.4 12.0 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.7 20.5 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 FAM107B "C10orf45, FLJ45505, HITS, MGC11034" ENSG00000065809 "Family with sequence similarity 107 member B" Q9H098 10 14518557-14774897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 63.7;HDLM-2: 76.1;Karpas-707: 54.6;THP-1: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 6 "granulocytes: 17.3;NK-cells: 14.5;T-cells: 32.4" "HPA039661, HPA058814, HPA073195" Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA039661: AB_10794751, HPA058814: , HPA073195: " "unprognostic (1.24e-1)" "unprognostic (1.91e-2)" "unprognostic (1.15e-1)" "unprognostic (1.80e-2)" "unprognostic (8.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.67e-1)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.82e-2)" "unprognostic (5.60e-2)" "unprognostic (4.63e-1)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (6.93e-2)" "unprognostic (7.01e-2)" "unprognostic (3.53e-2)" 15.0 15.2 30.0 27.5 44.7 48.7 19.3 13.1 21.7 15.0 20.2 56.3 85.8 10.4 15.7 7.0 8.3 7.0 21.8 5.9 44.1 23.8 40.1 47.4 20.8 45.7 49.7 14.6 3.5 40.7 16.4 10.7 17.2 38.5 10.0 14.0 3.9 27.7 85.7 2.1 8.4 17.8 10.5 66.3 15.4 37.9 11.6 44.7 7.5 6.2 4.1 41.9 15.5 9.8 3.5 1.4 17.3 3.7 14.5 32.4 19.2 10.2 22.3 8.9 0.5 1.3 0.3 3.7 10.3 15.0 6.4 4.6 13.7 8.7 63.7 9.4 4.7 3.2 2.8 6.3 11.4 76.1 2.4 1.7 10.1 16.1 4.8 22.9 4.1 0.7 4.9 2.6 1.3 27.0 0.1 54.6 4.9 2.6 5.6 6.7 2.2 4.9 40.8 6.9 23.4 14.6 6.7 3.3 9.5 4.1 2.1 6.7 8.1 50.5 8.8 6.6 5.5 20.9 3.4 24.2 21.5 41.2 1.1 20.1 1.7 11.5 1.7 17.3 29.8 2.0 29.1 3.5 24.0 25.1 1.4 3.1 32.4 32.0 7.2 14.5 3.7 1.0 21.1 19.2 30.0 44.7 13.1 21.7 44.1 23.8 49.7 14.6 38.5 44.7 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "CAB034110: AB_1562838, HPA069240: " "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.4 3.4 1.9 3.5 2.1 0.9 13.2 3.9 2.2 2.5 2.2 7.3 7.9 4.1 1.7 2.4 20.3 1.5 10.3 2.1 3.3 1.1 8.4 2.1 1.9 0.9 2.3 3.0 0.5 12.8 3.4 3.4 1.7 4.5 10.1 2.3 7.5 6.4 6.2 2.5 5.8 6.4 3.3 5.3 1.9 9.1 3.6 4.3 3.3 39.7 1.7 16.4 3.4 2.2 6.0 4.4 5.4 4.3 3.7 3.2 1.7 0.9 6.0 4.3 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 FAM110B "C8orf72, MGC39325" ENSG00000169122 "Family with sequence similarity 110 member B" Q8TC76 8 57994509-58204279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.0;RPTEC TERT1: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 13.1;intermediate monocyte: 3.6;non-classical monocyte: 6.4" "Group enriched" "Detected in many" 11 "granulocytes: 13.1;monocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008318, HPA011781" Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA008318: AB_1853892, HPA011781: AB_1853891" "unprognostic (2.07e-1)" "unprognostic (6.91e-2)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.88e-8)" "unprognostic (4.09e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "unprognostic (8.72e-2)" "prognostic favourable (1.44e-4)" "unprognostic (1.06e-2)" "prognostic favourable (4.31e-8)" "unprognostic (2.23e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.15e-4)" 6.5 3.1 15.7 4.1 12.2 4.1 9.9 23.7 18.4 8.8 6.1 5.0 24.3 2.3 8.9 6.8 3.0 9.1 7.9 21.7 10.3 14.4 6.6 6.0 4.1 2.0 8.0 5.9 8.2 3.0 16.7 4.1 5.0 7.9 10.0 3.2 9.5 8.5 19.8 17.1 3.0 3.3 10.4 11.5 30.8 5.5 14.7 4.9 0.0 8.6 3.4 2.1 7.9 9.4 0.3 0.9 13.1 6.4 0.0 0.2 0.5 0.0 1.1 4.1 0.1 1.8 0.7 1.6 7.7 9.0 5.4 2.5 0.0 0.1 0.0 1.5 5.5 0.0 3.6 0.0 4.2 0.0 3.8 0.7 1.2 4.5 6.2 1.0 0.2 6.6 1.5 0.2 3.4 0.0 0.0 0.1 4.1 0.1 0.0 2.7 3.9 1.7 0.0 4.6 0.0 13.4 0.8 3.9 4.3 0.0 0.5 0.2 3.6 0.4 0.0 3.8 2.5 0.0 2.6 1.7 0.0 0.0 1.8 0.0 4.4 0.0 1.4 13.1 0.0 3.6 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.2 0.5 0.0 6.4 0.0 0.1 0.5 15.7 12.2 23.7 11.8 10.3 14.4 8.0 5.9 7.9 4.9 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, DNA replication, Host-virus interaction" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavourable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favourable (4.39e-4)" 16.3 13.7 4.8 28.1 6.7 9.9 14.5 3.3 4.8 14.7 14.2 8.3 13.2 12.8 18.1 16.8 10.2 11.3 15.9 6.7 5.5 3.9 14.5 11.7 17.5 19.6 7.4 3.8 11.2 10.7 17.8 17.4 10.8 8.1 22.5 11.7 13.2 13.4 13.0 5.6 11.0 19.3 14.0 12.3 29.5 12.9 5.9 6.5 73.4 19.5 12.9 21.3 10.9 13.2 4.6 6.5 7.7 6.3 6.9 8.6 2.4 21.0 5.5 2.7 2.5 6.0 7.3 1.8 30.2 16.4 13.0 19.2 8.2 19.8 30.9 12.7 9.7 7.4 9.0 13.1 16.4 27.5 0.4 11.6 6.9 2.5 6.2 18.5 15.8 5.1 3.3 12.1 3.9 12.0 1.4 25.5 14.0 6.0 27.8 12.4 1.2 5.9 19.2 9.7 7.2 8.7 18.8 0.0 0.7 15.5 13.0 5.9 26.6 8.3 11.6 21.2 19.1 14.4 14.0 13.1 13.6 5.0 11.6 13.2 25.5 6.2 6.3 6.7 6.6 5.4 8.6 4.2 4.5 4.8 6.5 4.6 4.4 3.7 7.7 6.9 2.6 1.8 4.6 2.4 4.8 6.7 3.3 4.8 5.5 3.9 7.4 3.8 8.1 6.5 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.0 6.2 9.3 0.1 1.0 1.8 0.1 18.3 9.2 10.9 16.2 13.1 9.6 30.0 12.4 5.3 18.7 13.5 12.3 19.5 15.6 3.3 3.2 11.8 5.7 0.0 0.1 3.9 0.4 0.4 10.5 0.8 5.8 0.9 28.3 12.8 9.1 18.9 0.2 0.1 7.3 20.0 13.8 11.7 5.8 20.8 1.8 5.9 15.1 17.5 3.0 19.4 1.7 3.2 8.5 18.5 25.5 16.6 21.8 15.7 0.2 12.3 0.1 12.1 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 FAM114A1 Noxp20 ENSG00000197712 "Family with sequence similarity 114 member A1" Q8IWE2 4 38867677-38945739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 42.2;ASC TERT1: 44.2;BJ hTERT+: 50.5;fHDF/TERT166: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA067948, HPA069104, HPA069701" Uncertain Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA067948: , HPA069104: , HPA069701: " "unprognostic (2.13e-3)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (4.66e-2)" "unprognostic (9.40e-3)" "unprognostic (6.77e-2)" "unprognostic (2.54e-1)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (3.63e-6)" "unprognostic (1.31e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (3.44e-3)" 15.8 27.3 4.4 11.8 7.3 0.3 17.9 2.5 5.1 23.3 18.9 8.0 17.1 9.0 34.1 23.5 19.9 11.4 24.1 14.1 7.0 4.2 9.6 31.8 14.5 6.1 5.8 5.0 21.7 33.4 8.8 18.7 19.1 6.5 22.0 14.0 13.0 59.9 12.6 9.3 10.1 15.8 36.7 6.2 6.3 13.9 10.8 5.8 1.5 11.5 16.7 15.1 29.1 17.8 0.7 4.3 3.8 6.3 0.1 0.2 1.3 8.6 6.2 3.8 4.5 42.2 44.2 1.2 34.4 50.5 14.6 22.4 1.6 6.8 0.0 4.8 55.7 2.4 0.0 11.0 17.0 0.0 0.9 0.6 6.6 8.1 15.1 0.0 1.2 26.1 3.5 21.2 4.9 20.9 0.6 0.0 21.3 2.2 0.0 0.4 0.8 3.2 0.1 19.0 0.6 4.9 1.7 0.1 1.9 6.9 0.1 7.0 4.3 0.7 31.9 15.9 7.4 19.9 8.0 0.1 0.0 0.0 26.1 0.6 13.0 0.8 5.1 0.1 0.2 6.3 0.1 0.7 0.2 0.1 4.3 0.3 0.2 0.2 3.8 0.1 2.2 0.5 0.1 1.3 4.4 7.3 2.5 5.1 7.0 4.2 5.8 5.0 6.5 5.8 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202635188-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: " "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 5.8 12.5 10.1 11.1 10.3 4.3 10.0 20.8 18.1 5.5 7.9 3.2 7.1 7.0 5.0 7.5 9.6 6.6 6.2 4.3 8.6 10.8 8.3 3.6 6.2 13.0 5.9 9.1 8.8 11.6 24.7 7.5 11.0 4.7 8.6 7.9 3.7 8.6 9.3 5.8 9.0 6.0 7.3 5.7 8.2 6.6 12.6 5.8 22.4 5.5 4.8 11.7 7.2 12.7 9.0 4.8 2.3 8.9 4.5 9.9 3.3 1.5 2.0 8.8 6.0 3.0 1.7 8.5 0.5 0.8 0.5 1.0 2.5 3.4 6.6 5.4 0.9 1.5 7.5 3.8 1.4 0.1 6.0 5.5 3.8 9.3 2.4 4.7 2.5 2.3 5.3 1.1 1.6 2.3 7.9 1.3 0.5 3.2 12.6 9.8 8.9 3.8 10.0 1.8 7.8 4.7 4.2 14.9 12.9 6.6 4.4 3.1 1.8 6.5 1.4 1.1 2.0 1.5 0.9 4.9 2.8 8.8 2.0 3.6 1.1 0.3 4.5 1.6 1.6 8.9 4.0 9.0 3.6 3.1 4.8 8.5 9.9 6.8 2.3 4.5 8.8 1.7 1.3 3.3 10.1 10.3 20.8 18.1 8.6 10.8 5.9 9.1 4.7 5.8 FAM118A "bK268H5.C22.4, C22orf8, FLJ20635" ENSG00000100376 "Family with sequence similarity 118 member A" Q9NWS6 22 45308968-45341955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003902 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA003902: AB_1848368" "unprognostic (6.22e-3)" "unprognostic (1.19e-2)" "unprognostic (9.92e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (3.72e-2)" "unprognostic (7.61e-3)" "unprognostic (9.42e-2)" "unprognostic (6.11e-2)" "unprognostic (5.02e-3)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.87e-6)" "unprognostic (9.76e-2)" "unprognostic (1.28e-1)" "unprognostic (4.50e-1)" "unprognostic (1.16e-3)" 8.4 7.9 9.8 14.3 17.3 11.7 14.7 14.6 12.0 10.5 13.9 9.6 10.3 12.2 15.5 41.7 10.8 6.5 15.3 13.9 12.1 7.7 8.4 8.8 10.0 29.0 10.2 5.0 13.8 8.2 32.9 22.7 11.4 11.7 23.7 7.6 12.1 14.6 18.6 20.0 23.9 16.0 14.5 8.1 14.5 12.5 22.1 10.7 14.0 14.4 6.6 17.9 17.3 13.3 8.3 15.7 6.5 8.6 5.9 13.9 4.7 5.5 4.0 4.6 5.9 4.0 4.2 12.9 4.1 6.1 5.9 5.2 11.6 5.2 24.8 3.2 3.7 19.5 6.2 5.4 5.6 5.5 16.3 13.3 5.9 7.8 6.0 12.1 3.5 4.8 5.5 7.9 5.2 3.5 19.9 26.3 2.5 12.3 7.6 23.1 3.9 5.9 9.2 3.4 8.6 2.9 13.9 10.5 13.2 4.7 8.8 11.0 4.3 6.1 4.0 4.4 15.0 5.4 5.2 14.5 2.8 12.8 5.4 8.0 8.1 4.5 8.6 2.5 7.0 7.1 5.6 5.3 8.6 8.6 10.9 8.3 13.9 10.0 6.5 5.9 5.6 15.7 11.4 4.7 9.8 17.3 14.6 12.0 12.1 7.7 10.2 5.0 11.7 10.7 FAM120B "CCPG, KIAA1838, PGCC1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407065 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavourable (1.60e-4)" "prognostic favourable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 18.4 20.6 18.5 21.1 28.7 10.7 20.5 28.4 27.7 20.5 16.6 28.5 16.3 15.8 28.3 24.1 16.5 26.8 18.1 18.4 18.1 22.8 17.3 15.6 18.3 16.7 20.6 19.5 23.4 17.0 24.7 32.0 19.5 26.1 22.4 18.6 19.1 21.4 21.2 25.7 18.4 16.2 20.1 21.1 16.9 16.9 20.7 20.4 24.7 22.3 15.3 22.0 19.8 16.3 7.4 9.2 14.7 13.6 15.9 10.2 8.5 5.9 6.1 9.3 11.1 13.4 13.0 5.5 10.0 11.7 8.9 8.9 5.4 4.6 8.4 6.0 14.3 7.2 9.6 11.5 11.7 12.1 5.9 9.0 5.7 7.1 12.0 8.8 7.2 15.7 12.3 8.2 10.9 13.7 9.8 6.9 14.9 12.2 6.4 7.9 4.6 4.2 5.5 8.7 8.7 9.3 5.3 6.6 10.1 8.6 7.7 3.0 7.6 17.6 11.6 3.8 6.3 10.0 7.0 8.6 7.1 8.9 10.4 7.3 13.9 14.7 8.1 10.0 8.3 9.0 9.5 6.6 7.9 8.9 9.2 7.4 10.2 8.1 13.9 15.9 13.6 5.3 8.4 8.5 18.5 28.7 28.4 27.7 18.1 22.8 20.6 19.5 26.1 20.4 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780034-68784608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA056646: " "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favourable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 21.0 21.3 13.9 12.0 20.2 9.8 21.4 22.5 24.6 23.1 15.5 17.0 12.4 10.0 20.3 15.6 17.6 19.7 14.4 24.2 13.8 14.3 21.5 21.2 14.1 14.7 16.8 14.2 24.2 17.9 25.3 20.8 21.8 18.0 20.6 14.9 22.4 17.0 19.8 20.0 15.1 15.0 17.6 13.9 17.7 15.0 16.2 14.6 18.1 19.1 14.8 15.4 15.7 16.5 5.8 6.7 4.3 5.1 4.5 9.8 2.5 5.3 3.6 5.0 4.4 17.5 11.4 6.9 7.7 7.3 6.8 5.5 1.3 2.7 11.3 3.9 8.1 10.1 5.6 5.2 8.5 12.2 6.0 6.2 6.0 4.5 10.8 11.3 4.5 9.2 11.9 6.2 4.9 6.7 6.6 12.9 7.3 2.9 6.3 3.0 6.4 6.6 7.7 7.0 3.5 6.1 4.4 8.1 3.7 5.7 4.8 3.9 2.9 5.0 8.4 6.4 4.5 11.8 5.6 15.2 6.1 4.7 6.8 7.2 7.1 4.3 5.1 3.7 4.5 4.9 4.0 3.6 4.5 4.9 5.7 5.8 9.8 5.5 2.9 4.5 4.8 6.7 4.9 2.5 13.9 20.2 22.5 24.6 13.8 14.3 16.8 14.2 18.0 14.6 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in some" 4 "HAP1: 13.0;HUVEC TERT2: 7.7;NTERA-2: 25.5;SH-SY5Y: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA048182: " "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 0.1 13.0 0.1 0.1 0.0 1.9 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 7.7 0.1 0.0 0.0 0.2 3.1 0.2 25.5 2.0 0.7 0.0 1.8 0.0 0.1 1.8 9.8 0.4 1.6 1.5 0.2 0.7 0.1 0.0 0.9 0.6 0.9 0.2 0.0 0.0 1.2 2.2 1.0 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;blood: 18.0" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 48.1" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 18.0;eosinophil: 11.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA070240: " "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 28.8 0.6 1.6 1.4 1.9 5.9 16.0 0.6 1.8 4.2 2.1 1.6 0.7 1.3 2.4 2.5 2.6 1.8 1.7 2.4 2.2 2.2 1.4 2.6 5.8 0.8 2.0 0.6 2.5 0.5 9.4 0.8 12.5 1.8 3.9 1.5 4.0 1.7 0.6 4.3 2.6 1.5 3.5 2.1 0.8 1.2 2.3 0.2 1.0 2.9 0.8 1.0 3.4 2.6 0.0 5.6 18.0 2.1 3.8 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 48.1 2.1 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 2.1 11.6 0.1 1.6 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.1 3.8 0.5 0.0 1.7 0.7 1.6 1.9 0.6 1.8 2.2 2.2 2.0 0.6 1.8 0.2 FAM126A "DRCTNNB1A, HCC, HYCC1, hyccin" ENSG00000122591 "Family with sequence similarity 126 member A" Q9BYI3 7 22889371-23014130 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042873 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042873: AB_2678207" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (1.96e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-4)" "unprognostic (1.35e-1)" "unprognostic (9.76e-3)" "unprognostic (1.30e-2)" "unprognostic (7.23e-2)" "unprognostic (6.19e-2)" "prognostic unfavourable (6.04e-7)" "prognostic unfavourable (5.99e-4)" "unprognostic (1.87e-1)" "unprognostic (2.40e-2)" "prognostic unfavourable (9.03e-4)" 15.6 6.1 12.4 13.6 16.9 4.6 14.3 1.7 10.2 10.5 10.5 9.3 1.5 9.6 10.9 4.7 16.1 7.3 12.3 12.2 11.9 6.4 6.1 8.6 15.0 16.8 12.0 5.2 8.6 7.9 1.5 13.2 16.6 10.0 9.7 5.2 11.3 8.4 6.0 28.4 6.0 10.7 13.1 8.6 14.7 6.0 22.3 11.4 12.8 8.1 10.3 14.3 10.6 15.0 9.5 5.9 16.3 12.1 3.6 5.3 3.3 9.5 4.0 19.6 7.9 18.6 29.6 3.0 28.9 29.4 12.8 19.2 6.3 3.6 8.7 5.2 23.5 3.7 19.8 6.5 21.1 4.2 7.0 7.5 6.7 4.4 16.1 12.9 8.8 12.9 4.8 26.3 25.8 14.9 16.1 26.3 23.1 2.7 7.9 10.2 19.2 8.5 8.6 19.4 4.5 3.7 3.3 6.5 0.0 11.7 0.2 12.0 5.7 9.3 14.6 44.0 5.9 22.7 15.5 36.1 14.0 30.4 28.4 6.9 38.4 3.9 4.6 16.3 2.3 9.5 1.8 7.6 3.3 2.1 5.9 9.5 1.8 2.4 0.9 3.6 12.1 2.2 5.3 3.3 12.4 16.9 1.7 9.4 11.9 6.4 12.0 5.2 10.0 11.4 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: , HPA067307: " "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 10.5 6.9 9.8 8.7 17.2 22.1 7.3 28.7 21.1 5.9 10.3 6.5 5.9 9.8 6.8 6.3 12.1 5.8 6.4 6.5 9.3 9.2 12.0 10.9 9.4 7.9 7.3 11.6 7.8 7.1 9.8 16.6 7.2 15.1 5.8 9.6 8.8 7.0 4.9 5.6 10.2 9.3 5.8 8.1 10.6 11.0 6.3 6.4 8.3 10.3 2.9 8.7 5.5 8.1 2.1 1.2 20.3 1.9 2.3 3.4 1.5 3.2 1.7 2.5 2.6 2.6 3.5 5.4 3.1 1.8 2.5 2.4 4.4 3.9 3.0 3.1 3.1 4.0 5.0 1.9 3.9 4.3 3.1 8.7 4.6 4.1 2.1 10.5 7.6 1.5 2.4 3.4 2.1 2.4 8.0 11.2 2.5 2.0 6.3 6.9 1.7 2.9 3.7 3.7 2.7 2.4 3.6 4.9 2.5 3.3 3.8 2.8 2.6 4.6 4.8 4.7 3.4 2.3 2.8 8.3 34.6 6.4 2.8 4.1 3.2 1.7 1.4 5.1 3.1 1.8 3.4 2.1 2.6 2.4 1.2 2.0 2.6 3.1 20.3 2.3 1.9 0.9 1.7 1.5 9.8 17.2 28.7 21.1 9.3 9.2 7.3 11.6 15.1 6.4 FAM129A "C1orf24, GIG39, NIBAN" ENSG00000135842 "Family with sequence similarity 129 member A" Q9BZQ8 1 184790724-184974550 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 129.1;urinary bladder: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 32.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" 40000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavourable (4.52e-4)" 10.1 3.5 1.1 16.9 1.8 2.3 7.8 0.8 1.3 13.0 39.3 1.0 14.9 2.5 14.6 11.0 32.3 10.7 30.4 52.2 1.1 1.1 1.8 1.2 6.1 10.7 3.0 0.5 8.0 27.3 0.8 1.9 2.9 1.7 34.6 5.1 13.8 59.3 14.7 21.4 4.1 8.3 129.1 2.1 6.5 30.0 4.1 1.3 4.9 4.7 14.7 8.7 90.3 20.3 0.5 2.3 32.7 1.5 2.6 5.3 0.8 13.6 0.1 0.0 0.0 9.8 14.9 0.5 7.0 14.4 6.1 7.7 0.0 5.8 0.0 4.6 18.0 15.4 0.8 0.5 9.8 27.2 1.1 5.7 2.9 0.0 22.8 18.5 6.5 13.6 22.3 17.7 21.5 0.0 1.3 28.9 0.1 0.0 0.6 3.2 3.7 1.4 4.3 3.3 0.2 8.4 0.2 0.7 0.7 0.1 0.0 10.0 3.0 5.9 1.1 12.1 0.0 2.1 14.4 24.3 9.6 2.9 23.7 7.7 11.8 7.1 1.5 4.7 2.5 0.9 2.1 0.5 2.2 2.3 2.3 0.1 0.2 0.9 32.7 2.6 0.3 0.2 5.3 0.8 1.1 1.8 0.8 1.3 1.1 1.1 3.0 0.5 1.7 1.3 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.5 30.3 24.0 44.0 40.9 24.3 15.1 8.0 24.5 0.0 17.5 49.7 36.9 4.4 32.6 8.0 4.2 4.7 3.7 37.5 8.3 30.7 0.1 10.8 33.2 20.5 40.0 14.1 36.6 7.1 0.2 46.1 26.1 0.2 6.2 5.3 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 35.9 25.6 15.6 16.8 1.2 47.3 25.0 10.9 31.4 36.3 0.4 0.8 0.0 70.5 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 FAM129C "BCNP1, FLJ39802" ENSG00000167483 "Family with sequence similarity 129 member C" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9" "Group enriched" "Detected in some" 22 "Daudi: 29.1;REH: 14.6;U-698: 18.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 226 "memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2" "Group enriched" "Detected in many" 284 "B-cells: 19.5;dendritic cells: 37.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043277 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.5 0.2 0.2 37.9 0.2 12.1 0.2 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.6 0.2 0.2 0.5 0.3 0.9 17.4 0.2 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.4 9.9 0.2 0.1 0.2 12.3 0.0 0.3 28.5 0.4 0.5 0.0 2.5 0.5 0.4 35.4 3.0 0.4 19.5 37.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.7 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 4.9 0.0 4.0 5.1 0.0 0.2 1.2 0.8 0.2 10.1 0.0 0.0 0.0 0.3 0.2 2.0 0.4 0.7 2.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.3 16.5 15.9 0.0 0.0 0.0 0.0 0.0 16.2 0.5 0.2 1.1 0.0 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.2 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell line enhanced" "Detected in some" "A549: 10.7;HEK 293: 6.9;PC-3: 7.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: " "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favourable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.2 10.7 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.3 0.0 0.4 0.5 1.2 1.4 0.3 0.3 0.0 6.9 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 0.7 0.0 0.0 0.1 2.2 0.0 0.0 0.4 7.9 0.0 0.0 4.5 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Cell line enhanced" "Detected in some" "Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA066175: , HPA069513: " "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 21.8 0.0 0.0 0.0 0.0 0.5 5.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.5 11.3 0.4 17.0 37.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560793-92590394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA066175: , HPA069513: " "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 10.5 11.7 18.5 11.1 23.6 32.1 15.1 25.7 23.3 13.6 10.4 8.2 12.0 11.9 13.0 22.5 11.4 10.4 9.2 9.2 13.8 9.1 11.2 14.3 11.2 14.1 15.3 13.2 15.1 13.6 13.4 21.3 12.9 18.0 12.0 11.7 7.5 11.4 10.5 17.1 12.8 10.8 15.7 18.5 12.1 10.6 7.3 17.3 15.9 12.5 7.5 12.8 10.6 12.0 22.5 23.2 9.8 11.7 10.7 17.0 5.9 12.8 6.7 18.8 28.8 11.0 11.8 11.3 14.6 15.8 14.3 17.5 10.7 14.4 21.1 14.2 9.9 10.4 14.8 9.2 22.0 11.8 19.4 17.1 9.8 21.4 11.6 18.8 14.8 7.8 9.8 11.0 13.7 8.4 22.4 26.8 15.3 15.7 29.5 29.3 25.7 8.6 21.4 18.9 17.5 14.3 13.8 18.3 17.7 12.6 16.0 17.0 14.9 13.8 9.7 16.5 26.2 19.2 16.3 7.0 7.4 37.8 9.9 24.8 21.2 9.5 11.7 9.8 10.7 10.5 13.9 22.5 13.6 13.2 9.6 18.8 17.0 14.4 4.9 10.7 7.8 23.2 14.3 5.9 18.5 23.6 25.7 23.3 13.8 9.1 15.3 13.2 18.0 17.3 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favourable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favourable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 5.8 4.3 6.4 9.2 6.8 1.7 5.3 14.0 10.7 9.6 13.3 4.0 5.3 14.9 7.7 4.9 33.8 5.4 8.8 5.2 5.4 5.2 9.6 5.5 5.5 4.1 6.1 7.1 8.0 6.9 16.4 13.8 22.7 8.5 18.9 13.0 4.2 10.4 6.7 5.7 14.2 27.9 4.8 8.9 4.5 12.3 11.0 6.0 4.1 4.8 13.1 10.6 7.6 14.4 3.9 6.3 3.3 5.3 5.4 2.2 1.5 5.8 3.4 7.6 4.7 3.5 2.6 6.8 1.9 3.8 2.1 3.5 6.6 4.8 10.5 13.7 1.4 5.7 7.5 4.7 3.6 5.0 6.2 4.8 3.7 5.8 4.3 8.8 5.0 2.2 11.0 4.0 10.9 5.4 7.5 5.5 2.3 0.6 1.6 4.1 4.9 2.8 5.1 23.9 5.0 7.8 3.2 8.0 2.4 2.3 2.0 2.3 1.4 4.0 2.6 1.8 4.6 1.7 4.3 6.5 7.4 4.2 1.2 8.0 3.2 3.3 4.3 0.2 1.5 3.5 1.9 3.0 1.4 0.6 6.3 3.9 2.2 1.3 1.2 5.4 5.3 1.0 1.7 1.5 6.4 6.8 14.0 10.7 5.4 5.2 6.1 7.1 8.5 6.0 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell line enriched" "Detected in some" 11 "RH-30: 13.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 13.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" Nucleoli "HPA038108: , HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favourable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.5 7.2 32.2 13.3 9.1 5.7 6.9 2.2 2.1 3.1 5.7 0.1 2.3 4.0 1.5 8.1 4.1 5.1 0.3 5.6 4.0 5.1 0.4 9.4 3.3 0.5 12.7 3.3 5.7 2.1 3.8 10.5 0.4 4.9 0.1 0.3 1.5 6.8 3.8 5.5 9.4 2.1 4.2 12.0 14.0 3.7 1.4 4.4 5.4 3.1 0.1 1.4 6.4 3.5 3.1 3.2 1.9 1.1 0.0 9.5 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246129-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.2;HSkMC: 6.8;NTERA-2: 5.7;SCLC-21H: 11.3;SH-SY5Y: 6.6" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 11.8 17.0 16.1 3.8 22.3 0.3 7.7 12.4 24.9 9.4 6.4 36.6 3.2 4.5 9.0 8.7 14.4 15.3 11.6 7.8 18.9 15.9 3.8 2.3 10.0 4.5 23.8 18.8 22.2 2.5 4.0 8.3 2.9 21.2 17.9 6.7 16.5 4.9 8.7 15.3 7.3 5.0 12.5 33.2 5.0 3.9 5.2 28.9 0.0 6.0 7.6 2.5 7.4 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 1.7 0.3 0.1 0.0 1.6 0.0 5.2 2.4 0.2 0.0 0.0 6.8 0.8 0.3 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 5.7 0.5 0.0 1.1 0.0 0.0 1.7 11.3 6.6 0.0 0.3 0.0 0.9 0.0 0.0 3.3 3.0 0.1 2.6 0.0 0.0 0.1 4.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 22.3 12.4 23.4 18.9 15.9 23.8 18.8 21.2 28.9 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: " "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 2.4 0.1 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.2 0.0 11.6 1.9 7.1 16.1 0.0 0.0 0.0 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.2 0.0 3.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 FAM160B1 "bA106M7.3, KIAA1600" ENSG00000151553 "Family with sequence similarity 160 member B1" Q5W0V3 10 114821744-114899832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043624 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA043624: AB_10797145" "unprognostic (2.61e-1)" "unprognostic (2.47e-2)" "unprognostic (2.62e-1)" "unprognostic (8.45e-3)" "unprognostic (6.43e-2)" "unprognostic (9.87e-3)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (2.29e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (4.02e-6)" "unprognostic (3.41e-3)" "unprognostic (3.35e-1)" "unprognostic (2.10e-1)" "unprognostic (1.25e-2)" 15.9 13.3 9.9 12.1 13.1 40.9 31.0 10.2 15.7 11.7 10.8 6.1 11.8 11.2 18.4 10.6 9.8 13.4 11.0 18.1 7.7 5.9 7.4 16.8 13.4 18.7 5.9 8.5 15.1 10.8 13.6 11.4 14.4 7.0 10.0 7.6 8.5 9.6 11.0 42.6 9.4 13.4 18.7 6.7 12.1 10.9 16.0 5.2 17.7 12.9 7.2 8.8 13.6 19.7 3.4 3.2 15.0 2.7 3.9 8.7 2.0 9.2 5.2 5.7 8.5 14.0 16.0 6.6 16.8 17.0 10.1 8.1 1.8 3.7 5.6 5.0 15.8 6.3 2.7 7.0 12.0 18.9 5.3 2.2 9.1 4.1 10.2 5.9 7.7 12.4 6.8 7.5 12.2 13.5 3.0 14.5 18.7 4.4 10.2 5.9 3.7 3.6 8.9 9.4 3.8 6.8 5.7 1.2 5.1 7.4 8.1 8.7 3.2 3.5 13.4 6.2 4.0 18.1 5.9 5.5 1.6 6.5 8.1 15.1 5.8 15.0 2.7 3.9 5.0 2.1 3.7 3.4 6.8 8.5 3.1 3.2 3.8 5.0 13.6 3.9 2.3 3.2 8.7 2.0 9.9 13.1 10.2 15.7 7.7 5.9 5.9 8.5 7.0 5.2 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089159-22104898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favourable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 15.8 11.8 9.6 13.1 10.0 6.6 14.3 14.3 14.8 12.9 13.2 12.9 20.8 12.0 13.2 16.9 13.7 14.1 14.5 26.0 8.5 6.9 12.3 9.8 11.0 11.2 12.5 10.5 11.4 22.1 15.3 14.1 22.4 10.9 14.4 6.0 13.4 18.8 25.1 15.1 24.4 13.4 25.3 10.4 12.3 16.1 6.4 10.3 6.5 16.0 11.6 13.2 19.9 11.2 2.7 0.9 0.5 1.4 1.7 3.2 2.1 3.7 9.2 4.4 6.8 8.9 8.3 6.8 5.7 12.5 8.5 5.9 3.8 4.5 3.8 6.3 17.9 5.2 3.2 10.3 1.8 3.3 3.5 5.7 2.4 2.6 12.1 1.5 5.3 13.9 7.0 6.2 4.2 8.7 3.8 3.3 8.0 7.7 4.1 2.2 1.8 3.2 4.3 3.2 2.2 7.1 9.1 1.5 4.8 3.5 7.4 4.8 4.4 3.4 8.3 8.6 6.6 7.7 3.9 2.6 0.8 0.7 9.1 2.8 9.2 0.0 1.2 0.5 3.2 0.7 1.9 2.7 2.1 2.6 0.8 2.3 1.9 2.7 0.3 1.7 1.4 0.9 0.3 2.1 9.6 10.0 14.3 14.8 8.5 6.9 12.5 10.5 10.9 10.3 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favourable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 30.4 6.5 9.7 18.1 17.9 16.6 5.0 12.5 11.2 11.9 30.5 16.3 14.0 33.2 21.8 4.3 21.4 17.6 30.4 31.9 17.1 13.2 26.9 11.3 29.1 11.8 26.2 9.6 19.2 16.0 11.3 24.0 15.8 18.1 13.3 17.0 11.9 26.7 31.9 14.3 34.7 16.1 13.9 43.2 34.5 74.4 14.6 11.7 9.3 22.2 25.5 13.9 13.0 11.1 11.8 8.5 6.9 12.9 26.5 9.0 33.7 35.1 25.7 5.4 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 39.0" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Supported Approved "Nuclear bodies,Plasma membrane,Cytosol" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: " "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 1.8 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Cell line enhanced" "Detected in many" "BEWO: 23.1;Hep G2: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.2 4.7 3.3 4.5 0.0 0.0 23.1 0.7 1.7 3.5 3.6 2.1 3.5 0.0 2.4 0.0 3.7 6.9 10.4 3.7 3.9 7.9 1.4 0.8 15.7 0.1 0.0 0.0 0.1 11.0 0.8 5.2 0.0 0.0 0.0 2.1 1.5 4.9 0.0 8.4 2.6 7.2 2.1 0.3 3.3 8.3 2.0 2.7 8.7 3.9 0.6 3.7 1.0 0.0 0.2 3.4 0.0 3.8 12.8 11.9 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell line enhanced" "Detected in many" "TIME: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" 96000 "Plasma membrane" Nucleoplasm "HPA051345: " "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favourable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavourable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.2 12.9 4.9 5.2 9.9 0.1 7.8 1.5 3.9 3.4 1.1 7.3 0.0 9.4 20.2 0.6 9.1 0.1 4.5 2.5 14.4 18.1 2.0 17.9 5.7 0.0 14.7 7.8 1.9 10.7 1.5 19.7 7.1 0.0 12.5 0.5 3.1 0.0 12.3 3.5 12.2 6.8 1.9 4.9 0.0 8.9 11.4 4.3 0.1 0.0 0.0 0.2 42.0 5.4 22.9 19.6 8.2 2.6 0.7 0.0 12.0 0.0 4.1 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell line enhanced" "Detected in many" "Karpas-707: 24.9;U-138 MG: 17.3" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.7 4.1 12.8 12.3 9.3 0.1 2.5 4.5 3.1 4.5 7.5 12.3 0.0 0.9 7.2 0.3 5.6 2.4 4.5 0.0 3.2 2.8 1.3 0.0 1.0 0.8 1.0 11.8 1.0 2.4 1.9 6.8 0.0 24.9 5.9 1.6 1.6 0.0 5.4 2.8 0.0 8.0 0.5 4.9 8.8 12.9 7.0 1.3 0.8 3.4 1.0 0.6 4.0 17.3 2.3 0.3 1.6 6.6 6.4 0.0 5.3 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 FAM172A "C5orf21, DKFZP564D172" ENSG00000113391 "Family with sequence similarity 172 member A" Q8WUF8 5 93618069-94111699 "Predicted intracellular proteins, Predicted secreted proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012299, HPA045505" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA012299: AB_1845724, HPA045505: " "unprognostic (1.12e-2)" "unprognostic (2.17e-1)" "unprognostic (3.10e-2)" "unprognostic (7.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (1.51e-1)" "unprognostic (1.57e-2)" "unprognostic (2.52e-3)" "unprognostic (1.91e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.38e-1)" "unprognostic (6.56e-2)" "unprognostic (1.72e-2)" "unprognostic (1.03e-2)" 18.4 15.4 24.2 17.8 21.8 9.8 19.3 28.8 20.8 19.9 14.4 15.5 13.9 11.2 19.1 16.1 17.7 18.8 14.3 14.0 21.0 19.9 18.5 8.0 14.9 22.4 18.9 13.0 23.0 18.2 20.7 28.4 15.1 15.6 19.4 12.3 12.6 14.3 22.6 6.2 11.8 12.9 26.2 20.8 13.6 13.7 8.3 16.6 16.1 22.8 9.5 16.1 19.0 15.7 9.8 7.1 13.1 7.3 12.3 11.9 6.4 4.5 5.3 13.1 14.7 15.8 19.1 6.8 9.8 7.6 4.2 4.2 3.6 6.4 6.6 7.4 11.5 4.0 3.9 13.8 10.0 4.5 4.7 8.7 11.2 2.4 6.7 6.7 10.2 16.7 7.9 3.9 7.5 9.7 1.7 2.0 17.4 5.0 5.6 5.1 2.0 4.4 6.3 13.8 6.2 6.7 8.9 11.7 20.9 7.9 3.3 7.2 8.1 8.2 9.5 10.2 9.2 6.6 11.5 8.5 12.3 7.5 16.0 7.5 18.6 13.1 5.4 7.0 11.9 7.3 11.9 9.4 8.9 8.7 7.1 9.8 10.1 10.2 13.0 12.3 5.1 6.8 9.2 6.4 24.2 21.8 28.8 20.8 21.0 19.9 18.9 13.0 15.6 16.6 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074513: " "prognostic unfavourable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.0 7.9 7.5 8.7 6.6 2.7 11.3 5.7 6.0 4.7 8.4 12.1 9.4 20.3 8.0 5.5 12.1 10.3 9.8 15.6 7.4 7.8 27.3 6.3 5.9 12.0 9.4 6.1 11.4 9.9 3.4 11.6 10.9 9.6 17.0 6.8 5.9 10.7 4.8 9.7 8.2 5.5 8.3 15.4 9.6 6.3 6.3 39.7 14.0 6.3 14.3 12.6 6.4 12.9 7.6 7.8 8.2 6.5 7.2 10.5 8.1 13.8 5.2 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535305-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "neutrophil: 28.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavourable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favourable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 15.6 24.6 18.8 8.3 21.0 3.0 15.3 14.2 26.8 11.1 12.0 16.5 14.0 11.8 11.3 15.2 18.0 35.9 9.5 17.3 22.0 25.0 18.3 15.2 17.6 5.5 19.3 18.2 9.1 26.8 23.6 21.9 15.6 24.1 19.5 9.1 16.6 16.5 13.7 38.8 20.4 10.7 9.6 19.4 10.1 15.5 37.3 12.2 4.4 14.3 17.0 9.6 9.9 11.7 1.5 2.2 28.0 2.7 2.5 2.7 1.6 4.9 5.3 2.1 6.8 5.3 4.2 7.6 11.5 6.4 4.7 6.4 1.0 6.5 0.9 23.4 4.9 4.3 1.8 7.4 3.4 6.0 5.4 0.6 9.1 3.0 7.2 2.5 6.3 5.5 17.7 3.6 2.7 7.0 1.8 6.9 7.8 10.0 0.7 5.4 1.1 14.3 1.7 8.2 8.6 8.2 6.0 4.3 11.6 8.0 7.2 6.3 7.0 5.6 8.0 6.0 3.7 9.5 9.0 21.7 28.4 1.1 7.4 3.4 5.2 3.6 2.5 3.4 1.8 2.7 2.7 1.4 1.8 2.2 2.2 1.5 1.6 2.1 28.0 2.5 2.7 2.2 2.2 1.6 18.8 21.0 14.2 26.8 22.0 25.0 19.3 18.2 24.1 12.2 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" 180000 Vesicles Nucleoplasm "HPA053222: , HPA055440: " "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favourable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 20.8 25.6 29.5 17.5 29.2 24.9 20.6 14.1 25.9 27.2 45.8 29.2 19.6 32.6 16.3 17.9 22.2 12.7 22.0 44.2 31.6 35.3 35.5 49.1 36.0 10.4 41.1 24.2 14.4 21.5 14.2 43.8 17.7 39.6 37.9 41.6 13.6 19.5 22.3 33.8 17.4 34.0 25.5 45.4 15.7 24.1 42.6 22.2 13.3 31.0 19.0 12.8 27.6 18.2 14.1 16.8 56.7 15.1 9.4 18.5 9.7 20.1 16.3 12.4 10.0 21.5 21.6 16.8 32.9 17.9 17.1 18.8 16.5 26.6 8.3 23.6 31.2 21.1 15.1 18.6 21.9 23.5 11.5 6.4 20.7 56.2 26.6 9.8 15.0 19.4 24.5 20.7 16.3 19.5 15.2 25.9 32.9 28.9 12.0 9.1 10.1 23.2 7.0 17.5 11.6 30.9 21.8 17.4 15.6 38.8 30.6 25.3 28.3 7.5 22.9 22.4 19.9 24.9 16.8 20.1 24.1 9.9 13.9 6.6 21.8 20.9 15.1 24.9 10.7 11.4 12.6 14.1 14.2 12.2 10.9 11.3 11.3 11.0 56.7 9.4 9.7 16.8 18.5 9.7 29.5 29.2 14.1 25.9 31.6 35.3 41.1 24.2 39.6 22.2 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5" "Cell line enhanced" "Detected in some" "K-562: 17.1;RH-30: 4.7;RPMI-8226: 18.7;WM-115: 18.8" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD4 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 0.8 0.0 2.4 0.6 3.8 18.2 0.6 1.0 1.5 0.6 1.0 0.6 0.6 0.1 0.7 6.8 0.6 1.5 0.6 0.6 3.4 1.9 0.6 0.6 0.6 0.6 5.3 0.6 0.6 0.6 0.0 0.6 1.1 0.6 0.6 0.2 1.0 0.6 1.0 0.6 1.2 0.6 0.6 8.5 13.3 0.0 29.5 0.6 0.6 0.6 0.6 0.6 1.0 0.6 0.0 0.8 0.0 0.0 0.1 2.6 0.6 4.1 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 4.7 18.7 0.0 0.0 0.6 0.0 0.0 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 18.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 1.7 0.0 0.1 0.0 0.8 0.0 0.6 2.4 3.8 1.0 1.5 3.4 1.9 5.3 0.6 0.6 0.6 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell line enhanced" "Detected in some" "RT4: 6.6;SH-SY5Y: 3.5;U-2 OS: 3.4" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Approved Approved "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA066861: " "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favourable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.1 0.1 1.2 0.1 0.0 0.0 0.0 0.2 6.6 1.0 3.5 0.0 0.0 0.1 0.1 0.4 0.0 0.1 3.4 0.1 0.1 0.3 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell line enhanced" "Detected in many" "AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.3 16.4 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.3 1.1 0.0 0.2 0.0 5.0 0.0 0.2 1.3 9.6 0.5 1.5 7.2 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.0 13.4 0.6 0.2 0.3 0.3 0.0 5.5 1.2 0.0 0.0 0.0 0.1 0.1 10.7 7.9 0.5 0.5 1.6 2.2 1.9 0.2 0.8 0.5 0.2 4.1 4.1 4.4 0.3 1.3 0.0 2.1 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 FAM192A "C16orf94, NIP30" ENSG00000172775 "Family with sequence similarity 192 member A" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: " "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 21.2 23.1 39.3 31.3 42.5 60.4 31.0 38.0 45.6 22.4 33.4 41.8 19.1 30.3 25.2 31.0 28.0 25.4 21.9 25.8 37.2 36.3 26.9 27.0 25.3 39.6 44.8 32.5 26.1 33.9 52.1 31.1 28.4 36.7 28.1 41.1 24.7 24.8 24.6 31.8 40.7 32.4 25.4 40.8 42.0 27.5 41.4 40.0 47.2 33.2 21.9 42.6 23.1 23.9 26.6 30.4 48.5 38.1 17.9 22.2 20.8 31.0 39.8 44.4 29.8 19.5 24.2 41.9 36.7 27.6 45.5 29.5 37.6 33.0 47.1 41.4 28.0 41.8 30.8 36.9 46.2 20.9 24.8 32.8 35.7 38.9 28.2 40.1 46.8 24.1 36.9 43.2 35.0 32.5 43.8 15.2 29.9 23.1 43.6 37.5 28.6 30.0 53.7 64.8 45.6 30.7 25.7 32.0 36.8 67.1 28.6 24.7 23.7 27.9 32.1 33.8 28.3 24.6 27.3 36.5 28.6 60.6 34.5 29.1 32.2 48.5 26.6 40.1 17.3 30.6 16.8 26.6 16.7 16.0 30.4 23.9 17.4 18.0 36.8 17.9 38.1 21.0 22.2 20.8 39.3 42.5 38.0 45.6 37.2 36.3 44.8 32.5 36.7 40.0 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536631-2732565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favourable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 17.1 14.1 17.8 25.5 17.7 22.4 19.7 33.0 23.2 17.4 14.5 18.2 21.3 15.3 23.5 16.0 12.1 16.4 17.2 11.9 16.7 14.3 12.4 13.7 20.2 17.3 18.0 11.8 23.7 17.4 20.4 21.5 15.3 16.1 16.4 11.9 18.8 16.4 19.3 18.1 16.6 15.8 16.0 13.9 17.0 14.7 29.1 17.2 26.3 15.4 13.7 16.0 14.6 30.7 2.5 3.9 5.7 6.3 3.2 2.9 1.0 7.0 8.8 16.5 9.4 10.0 10.3 9.0 10.8 9.2 10.6 9.0 9.0 11.5 13.9 6.7 11.8 6.1 11.4 7.7 8.7 8.6 7.5 20.7 10.9 9.3 12.2 12.4 14.6 11.3 8.2 10.4 10.7 10.5 14.5 15.3 8.7 7.4 20.3 20.2 13.5 10.0 20.0 8.7 6.8 7.1 9.2 14.5 12.5 9.2 6.4 9.3 11.8 12.8 14.1 16.3 9.7 8.8 14.0 15.5 11.4 13.4 9.2 10.4 11.5 5.7 2.2 1.8 2.2 1.5 1.5 1.5 1.9 2.9 1.4 2.5 1.9 2.7 4.2 3.2 6.3 3.9 1.4 1.0 17.8 17.7 33.0 23.2 16.7 14.3 18.0 11.8 16.1 17.2 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519788-177554541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavourable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favourable (1.30e-5)" 13.5 9.5 18.5 16.5 17.2 35.6 15.8 37.9 20.4 18.1 13.5 13.6 17.2 15.4 19.8 11.6 13.8 13.3 12.3 9.1 18.4 8.0 16.3 18.5 17.0 20.5 17.3 18.3 22.1 22.1 10.3 15.2 15.2 17.0 19.0 11.6 17.1 14.3 14.6 11.6 34.9 18.7 12.7 10.9 27.8 14.9 14.0 16.2 11.7 16.9 9.5 15.3 13.7 23.1 1.3 1.6 2.9 1.8 2.0 2.8 0.9 5.2 7.1 15.7 13.6 7.8 7.5 33.9 4.8 5.2 8.0 7.6 18.9 10.3 10.1 7.5 4.6 9.2 7.1 10.1 5.9 22.2 7.4 7.1 11.1 9.0 4.5 6.9 14.7 7.4 11.3 6.7 7.4 8.0 6.8 10.0 5.7 17.7 12.6 20.2 10.9 5.6 20.6 3.5 8.5 7.6 15.1 14.6 9.3 5.6 16.1 4.7 15.7 9.6 9.9 8.9 7.4 5.7 5.7 10.9 4.5 8.1 7.1 11.3 7.3 0.0 1.8 0.7 2.8 0.2 1.8 0.7 1.4 2.0 1.1 1.3 0.7 1.0 2.9 2.0 1.1 1.6 0.9 0.9 18.5 17.2 37.9 20.4 18.4 8.0 17.3 18.3 17.0 16.2 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;ASC TERT1: 39.8;HSkMC: 45.6;HUVEC TERT2: 50.9;WM-115: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.1 39.8 3.0 0.8 0.6 0.1 1.0 3.4 1.2 0.0 0.1 1.3 0.0 18.6 4.9 0.5 0.0 0.0 0.2 0.0 9.5 14.1 0.1 0.0 45.6 1.2 6.5 0.7 50.9 3.3 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 7.4 2.1 1.4 0.0 2.4 4.3 4.7 2.5 1.6 0.0 0.0 11.6 0.6 0.0 19.6 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166620-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.5 13.4 19.6 7.5 24.4 13.0 13.1 17.1 25.9 11.1 9.3 14.2 21.0 8.7 13.0 39.2 9.0 10.5 7.8 8.0 17.4 19.2 17.1 8.6 9.0 8.7 19.3 17.9 13.9 13.1 24.9 11.8 9.9 22.6 11.8 9.7 8.7 10.8 16.6 10.7 10.4 8.2 9.9 16.9 9.2 8.9 10.9 12.9 6.5 19.4 5.6 8.5 9.5 12.8 3.8 2.3 2.6 2.0 1.5 3.9 1.3 16.9 10.8 9.8 10.7 7.3 8.8 9.9 9.0 8.5 11.8 11.1 8.3 14.2 9.4 11.2 8.3 12.9 17.6 13.3 19.4 4.5 9.8 7.4 13.8 9.4 10.4 14.0 10.5 6.8 17.0 11.6 11.7 11.9 8.0 21.2 13.1 12.1 7.5 10.0 9.7 12.6 8.0 6.4 11.7 20.1 11.4 5.3 6.5 21.8 14.6 15.6 7.3 7.0 14.6 13.2 4.8 10.2 9.6 10.0 8.3 10.5 14.9 15.2 9.6 2.2 2.0 1.1 2.8 1.5 3.2 1.6 2.6 3.4 2.3 3.8 3.9 2.3 2.6 1.5 2.0 1.2 2.9 1.3 19.6 24.4 17.1 23.3 17.4 19.2 19.3 17.9 22.6 12.9 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297930-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: " "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 31.2 17.5 30.0 18.5 31.6 40.3 28.1 18.9 37.8 24.9 26.8 20.0 19.6 17.9 27.4 29.5 26.1 19.2 19.2 29.5 25.4 21.7 25.0 24.8 21.4 22.4 23.4 25.9 26.2 21.4 19.1 31.3 19.1 30.4 21.1 21.6 19.4 21.9 20.7 36.3 17.1 18.5 34.0 31.2 24.1 20.8 39.9 20.9 19.8 26.0 21.9 23.0 32.8 18.4 27.4 32.4 36.6 35.1 17.5 27.2 28.7 21.4 9.7 16.0 22.3 16.0 17.5 9.1 17.0 32.1 24.7 22.4 11.4 20.1 15.3 10.6 18.3 18.6 13.4 17.8 22.5 24.0 16.6 12.7 10.0 10.0 23.9 32.8 18.1 12.0 21.8 18.1 38.1 21.0 13.2 18.1 20.4 12.0 20.1 30.6 11.3 8.7 17.3 31.0 11.2 22.3 11.0 10.3 16.3 11.7 10.9 25.0 17.4 23.8 14.6 13.0 12.2 11.5 25.8 13.0 11.5 22.0 25.4 35.6 13.1 29.8 31.7 36.6 21.7 34.4 22.7 27.4 24.6 19.8 32.4 20.2 21.3 24.7 17.6 17.5 35.1 23.5 27.2 28.7 30.0 31.6 18.9 37.8 25.4 21.7 23.4 25.9 30.4 20.9 FAM206A "C9orf6, CG-8, FLJ20457, Simiate" ENSG00000119328 "Family with sequence similarity 206 member A" Q9NX38 9 108934181-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cytosol" "Cytokinetic bridge" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 12.0 11.4 16.8 9.0 28.8 12.9 17.8 12.3 19.2 11.6 13.3 12.8 10.3 13.8 12.6 22.9 16.0 18.9 9.9 13.3 16.2 16.0 14.1 12.6 12.0 9.9 16.7 20.0 13.7 13.7 23.3 28.5 10.6 16.0 11.9 15.1 7.6 16.9 13.5 12.2 22.9 15.1 14.4 16.6 7.5 13.0 16.7 14.8 8.4 20.9 10.2 10.6 10.5 11.7 10.6 23.6 24.4 20.7 12.4 16.1 11.9 8.7 9.5 10.4 11.4 18.5 25.7 13.9 9.0 9.7 8.4 6.9 14.1 4.8 8.6 5.0 8.0 21.4 8.3 8.7 8.4 5.2 8.6 5.2 12.9 13.2 15.5 18.8 7.4 13.5 16.6 10.2 23.6 11.4 18.4 8.9 9.9 24.8 13.4 7.6 11.7 13.9 6.7 16.8 9.0 10.9 9.8 13.4 7.3 12.9 11.3 14.1 15.4 10.2 7.4 4.7 8.6 20.8 10.6 7.3 18.9 6.3 15.0 7.5 6.8 19.9 20.6 19.0 9.9 20.6 15.2 10.6 15.8 13.1 22.6 6.9 16.1 12.1 24.4 12.4 20.7 23.6 13.0 11.9 16.8 28.8 12.3 19.2 16.2 16.0 16.7 20.0 16.0 14.8 FAM207A "C21orf70, PRED56" ENSG00000160256 "Family with sequence similarity 207 member A" Q9NSI2 21 44940010-44976989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034178, HPA036354" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB034178: AB_1564323, HPA036354: AB_10672242" "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "unprognostic (4.99e-3)" "unprognostic (1.05e-2)" "unprognostic (1.37e-2)" "unprognostic (1.14e-3)" "prognostic unfavourable (7.04e-4)" "unprognostic (3.23e-2)" "unprognostic (4.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.84e-2)" "unprognostic (7.94e-2)" "prognostic unfavourable (7.80e-4)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (4.12e-1)" "unprognostic (5.77e-2)" 15.5 12.4 9.3 15.3 13.1 15.6 10.0 13.1 15.3 7.6 12.3 7.7 9.2 15.8 9.3 8.4 10.2 8.3 13.9 33.0 8.2 8.0 11.0 19.5 8.2 12.1 9.9 12.4 8.1 15.9 6.4 5.8 8.1 9.5 8.8 6.0 7.2 16.5 10.5 35.5 11.4 11.8 7.5 6.7 18.3 13.3 25.2 8.0 15.3 10.0 15.3 10.7 10.9 13.1 9.7 12.3 5.5 6.2 6.0 6.5 3.0 14.9 16.3 5.6 7.1 2.8 3.8 13.4 10.4 2.9 7.9 6.4 27.6 4.7 15.4 22.6 3.7 10.1 7.7 11.3 3.3 11.2 23.3 45.6 11.2 23.2 11.1 14.7 5.9 6.6 6.7 7.2 6.7 8.5 25.7 10.9 6.2 26.4 13.9 23.2 19.0 23.4 13.7 6.0 26.6 7.6 6.0 27.4 11.7 13.7 16.5 15.5 11.4 10.7 11.2 6.7 13.9 9.0 22.1 22.9 19.8 15.0 5.3 25.4 9.3 4.3 5.6 5.5 2.8 5.8 2.6 9.7 4.8 6.5 5.4 6.2 5.1 5.2 3.7 6.0 6.2 12.3 5.1 3.0 9.3 13.1 13.1 15.3 8.2 8.0 9.9 12.4 9.5 8.0 FAM208B "bA318E3.2, C10orf18, FLJ20360, KIAA2006" ENSG00000108021 "Family with sequence similarity 208 member B" Q5VWN6 10 5684838-5763740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038042, HPA038043, HPA061547" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: " "unprognostic (3.69e-2)" "unprognostic (3.13e-2)" "unprognostic (9.25e-2)" "unprognostic (8.83e-2)" "unprognostic (8.12e-3)" "unprognostic (4.84e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.39e-1)" "unprognostic (9.21e-2)" "unprognostic (8.36e-2)" "unprognostic (8.85e-2)" "unprognostic (4.88e-3)" "unprognostic (2.90e-3)" "unprognostic (2.98e-1)" "unprognostic (3.50e-1)" "unprognostic (7.79e-3)" "unprognostic (5.23e-2)" 15.4 15.5 10.1 22.9 13.6 16.1 16.4 18.9 13.4 18.7 15.0 11.8 13.6 8.6 21.2 20.7 14.6 19.6 13.4 16.9 12.0 9.3 13.6 15.9 15.1 20.5 15.0 10.6 23.8 19.4 26.2 24.3 16.0 12.6 15.9 15.8 12.9 15.6 17.0 26.9 12.7 16.4 17.4 12.8 16.7 15.7 29.7 14.0 19.5 22.6 14.1 21.1 17.4 22.0 4.3 2.2 1.8 2.4 8.6 3.2 0.8 17.2 14.7 9.5 16.0 12.2 14.6 13.3 14.8 9.4 12.7 16.2 15.5 10.3 35.4 9.5 14.5 13.7 27.0 15.1 20.7 6.9 18.2 16.5 11.4 10.4 12.2 12.1 9.9 11.1 17.0 20.7 17.7 14.7 26.5 8.3 14.2 11.7 15.7 4.3 11.5 9.5 11.7 13.2 12.4 7.7 15.8 11.7 13.2 14.7 13.4 10.5 17.5 9.6 14.7 16.2 17.5 31.1 20.1 10.2 9.6 31.6 8.0 12.0 8.5 1.4 2.4 0.5 2.4 2.3 2.2 2.1 1.8 2.3 1.4 4.3 1.8 3.2 1.8 8.6 0.9 2.2 2.4 0.8 10.1 13.6 18.9 13.4 12.0 9.3 15.0 10.6 12.6 14.0 FAM20B "GXK1, KIAA0475" ENSG00000116199 "FAM20B, glycosaminoglycan xylosylkinase" O75063 1 179025804-179076562 "Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007409 Approved Supported "Nucleoplasm,Golgi apparatus" 280000 "Golgi apparatus" Nucleoplasm "HPA007409: AB_10601649" "unprognostic (7.58e-2)" "unprognostic (1.12e-1)" "unprognostic (4.97e-2)" "unprognostic (6.23e-3)" "unprognostic (3.29e-1)" "unprognostic (3.07e-1)" "unprognostic (4.76e-2)" "unprognostic (7.70e-3)" "unprognostic (7.85e-2)" "unprognostic (3.93e-2)" "unprognostic (5.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.76e-1)" "unprognostic (2.03e-1)" "unprognostic (1.76e-1)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" 18.2 21.3 17.7 12.8 20.9 8.8 26.0 16.1 26.4 15.8 20.8 10.8 13.3 8.7 18.5 14.7 17.5 14.7 17.3 32.9 17.1 17.2 16.2 14.8 14.6 9.1 16.1 19.9 19.0 10.1 22.5 16.9 15.2 15.2 15.6 13.4 14.5 9.9 18.8 19.0 11.4 10.6 25.9 13.6 10.5 14.4 6.8 9.4 7.3 16.5 7.7 9.4 17.6 28.7 4.9 3.6 2.3 2.3 4.4 4.1 1.5 17.7 16.2 12.6 13.3 22.5 23.8 14.0 14.8 17.0 10.4 9.4 8.1 17.7 9.1 19.5 26.0 13.0 12.8 10.9 15.3 11.6 8.6 29.2 15.3 10.3 11.3 19.3 18.5 13.8 11.9 14.2 11.1 12.8 32.5 13.5 16.6 9.9 8.4 7.0 16.6 3.5 10.3 13.3 12.2 8.7 20.1 16.9 41.4 15.6 17.7 15.1 15.3 14.2 13.5 16.7 14.7 22.9 19.9 11.0 20.1 8.0 16.5 9.4 16.5 2.3 2.0 0.6 3.8 1.7 4.1 4.2 2.4 3.5 2.2 4.9 3.5 3.2 1.9 4.4 2.3 3.6 2.7 1.5 17.7 20.9 16.1 26.4 17.1 17.2 16.1 19.9 15.2 9.4 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell line enhanced" "Detected in many" "HSkMC: 52.0;U-87 MG: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavourable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavourable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.8 6.7 0.2 9.6 12.3 20.4 0.0 12.3 20.9 6.7 5.4 0.8 8.5 0.0 6.8 18.4 12.0 1.0 0.6 1.7 2.9 0.6 0.0 3.2 3.7 9.3 0.0 0.9 52.0 1.5 0.2 0.7 4.6 0.0 0.1 1.7 1.8 0.0 0.7 6.5 0.4 1.5 0.4 0.0 5.0 0.0 3.2 0.1 12.8 0.0 1.9 9.1 6.3 12.9 8.4 4.2 7.1 3.7 0.0 0.0 0.0 32.0 0.8 23.8 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavourable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.4 7.1 5.0 4.7 5.9 6.2 7.3 8.6 8.1 9.8 11.4 9.5 6.1 13.0 10.9 6.1 6.0 9.5 10.8 16.0 8.8 4.4 9.0 5.2 7.0 7.0 15.4 8.5 5.3 8.5 9.4 33.2 6.2 12.2 7.1 11.2 8.6 9.5 9.9 5.6 7.1 7.7 11.9 15.0 8.1 7.9 3.2 5.6 7.6 11.2 20.6 5.9 7.3 6.8 25.0 24.6 15.5 10.6 8.0 10.0 14.9 13.3 8.0 10.0 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358915-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042652: " "unprognostic (3.29e-1)" "prognostic favourable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favourable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favourable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 19.8 47.7 13.2 9.3 22.8 30.5 29.0 13.4 12.3 23.4 18.1 10.9 24.0 10.7 22.3 24.7 24.4 18.5 29.5 48.1 13.0 12.9 15.2 43.2 16.3 11.8 15.2 9.3 50.5 21.8 13.1 15.1 17.6 13.7 30.9 13.8 21.4 29.0 33.5 54.2 17.5 15.0 19.9 11.1 12.2 16.3 11.1 9.7 5.9 19.8 25.7 12.3 22.8 30.9 1.9 2.8 10.3 5.6 2.2 4.0 1.5 4.7 1.8 7.3 17.8 21.3 24.1 14.3 5.8 13.2 10.7 12.4 3.3 2.3 0.4 3.0 10.0 13.8 3.9 16.9 18.0 0.7 6.1 2.9 4.4 31.8 14.0 0.3 1.8 20.6 18.9 6.0 8.6 17.1 22.1 3.1 13.1 4.9 2.4 1.3 6.2 11.6 0.0 15.2 3.8 5.5 5.6 10.2 18.4 14.2 31.0 71.6 13.7 2.7 11.8 9.6 6.4 15.2 3.5 2.5 2.5 0.1 7.6 1.8 6.2 3.3 3.8 10.3 2.9 5.6 2.2 1.9 3.4 4.0 2.8 1.8 3.6 3.4 1.7 2.2 2.4 2.4 3.7 1.5 13.2 22.8 13.4 12.3 13.0 12.9 15.2 9.3 13.7 9.7 FAM212A "C3orf54, INKA1" ENSG00000185614 "Family with sequence similarity 212 member A" Q96EL1 3 49803254-49805030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.8;skin 1: 30.0" "Cell line enhanced" "Detected in many" "HEL: 31.3;HMC-1: 21.5;NB-4: 17.4;THP-1: 19.3;U-937: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4" "Group enriched" "Detected in many" 6 "B-cells: 25.8;granulocytes: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041879 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favourable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 6.0 4.1 5.8 3.2 4.7 5.0 3.5 8.0 6.3 6.8 2.6 4.9 1.4 1.7 5.5 2.8 16.3 2.9 4.8 7.6 4.4 4.3 3.4 1.2 7.3 5.9 6.3 4.8 3.6 2.3 0.8 2.0 5.2 5.6 5.4 1.4 3.2 4.5 3.9 15.3 30.0 3.5 5.3 8.3 6.9 2.2 2.4 4.3 1.8 1.9 10.4 8.4 4.8 8.5 25.8 3.6 19.0 2.9 0.0 1.5 2.8 0.6 0.5 0.7 0.5 0.9 2.0 0.0 1.4 0.9 0.6 0.8 0.0 0.0 6.8 0.2 1.0 4.0 0.2 4.8 0.0 1.2 0.0 31.3 0.3 0.1 1.2 4.7 21.5 2.6 6.9 1.4 1.2 2.9 2.1 0.5 0.5 0.3 0.4 17.4 0.5 2.7 6.3 0.3 1.5 0.0 7.8 0.3 2.5 1.2 0.2 0.6 0.1 19.3 1.7 3.5 0.4 1.6 0.6 0.8 0.7 0.5 1.5 16.0 0.8 19.0 0.9 4.3 0.6 2.2 0.1 25.8 0.6 0.7 0.2 23.4 0.9 1.5 0.5 0.0 2.9 3.6 0.6 2.8 5.8 4.7 8.0 6.3 4.4 4.3 6.3 4.8 5.6 4.3 FAM214B "bA182N22.6, FLJ11560, KIAA1539" ENSG00000005238 "Family with sequence similarity 214 member B" Q7L5A3 9 35104112-35116341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.8;TIME: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.6" "Group enriched" "Detected in many" 4 "dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048831, HPA055751" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA048831: , HPA055751: " "unprognostic (2.91e-3)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.06e-1)" "unprognostic (7.72e-3)" "unprognostic (2.38e-2)" "unprognostic (1.70e-2)" "unprognostic (1.02e-2)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (8.15e-2)" 13.0 10.3 14.1 12.4 14.9 35.0 6.7 10.4 18.9 7.3 12.0 25.9 10.7 10.9 7.7 7.9 22.4 6.1 12.5 16.5 15.4 14.4 12.5 7.7 13.6 7.4 17.0 11.4 7.5 5.6 10.4 10.9 26.3 20.8 8.6 11.5 9.3 8.6 11.1 8.9 10.9 10.6 11.8 20.5 19.1 10.7 5.8 8.4 3.7 9.1 12.2 12.0 10.4 8.8 0.5 4.4 14.6 8.5 1.7 2.1 2.5 2.9 2.4 6.9 4.9 5.4 8.4 1.4 14.8 13.4 8.2 5.3 1.7 2.1 0.7 4.4 23.8 1.3 1.2 4.7 5.4 3.8 0.3 3.7 5.3 1.5 5.5 1.0 16.3 5.9 8.5 9.6 6.1 15.8 2.0 3.0 17.1 0.8 1.4 4.5 1.3 3.7 1.6 1.2 0.8 10.7 0.6 0.5 4.5 2.4 1.7 7.9 2.1 2.4 26.8 11.6 5.6 5.5 5.4 1.9 1.8 0.4 18.2 1.9 12.8 4.7 5.2 4.7 2.1 6.9 0.7 0.5 1.3 1.4 4.4 0.2 0.5 0.9 14.6 1.7 8.5 1.1 0.7 2.5 14.1 14.9 10.4 18.9 15.4 14.4 17.0 11.4 20.8 8.4 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell line enhanced" "Detected in all" "HDLM-2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: " "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favourable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavourable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.4 4.8 11.4 6.5 10.7 4.1 11.2 7.6 5.7 6.6 8.4 3.3 2.9 2.7 7.8 7.3 5.2 9.0 4.8 6.6 43.0 5.2 1.1 6.2 3.6 6.0 2.7 6.4 4.3 4.9 9.8 5.5 10.8 2.7 13.8 5.1 2.5 4.2 3.8 7.4 7.2 5.4 1.9 2.4 4.7 2.7 3.6 11.6 6.5 4.8 3.8 2.4 2.7 12.8 7.3 5.7 15.1 10.4 3.6 5.2 2.4 20.9 6.3 12.8 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899987-74907121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA048929: , HPA058064: " "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 16.5 14.4 12.5 10.0 16.5 5.9 28.7 18.5 20.0 11.3 11.6 10.1 10.3 11.2 11.1 22.9 16.6 14.6 12.1 22.7 13.0 13.6 11.7 4.7 13.4 10.6 13.8 12.5 13.0 11.0 22.3 21.5 9.1 15.1 18.6 9.8 13.8 15.9 13.7 12.0 18.1 10.1 12.8 10.2 18.2 11.2 5.2 11.0 4.4 13.7 8.1 11.8 16.8 11.2 3.7 1.4 6.9 1.5 2.1 3.7 1.1 2.5 5.6 10.9 5.3 15.7 9.8 5.7 8.0 4.1 6.7 5.2 2.3 6.3 7.1 5.2 5.2 9.0 11.9 4.9 3.6 13.6 12.1 2.9 9.7 1.2 5.8 4.2 7.6 5.5 16.3 2.5 6.3 5.4 4.4 5.6 6.4 0.6 3.9 5.2 6.4 9.8 9.4 3.6 4.0 12.8 5.5 9.5 5.0 7.1 6.2 10.7 9.9 2.7 10.8 4.5 4.0 3.7 6.3 6.5 4.7 3.4 6.8 10.4 5.2 3.8 1.0 6.9 2.2 1.4 3.7 3.7 2.8 0.9 1.4 2.9 2.3 1.8 2.4 2.1 1.5 0.3 0.3 1.1 12.5 16.5 18.5 20.0 13.0 13.6 13.8 12.5 15.1 11.0 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favourable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favourable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favourable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.8 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 11.7 0.2 0.1 1.0 0.3 0.5 0.8 0.0 0.2 7.5 1.7 1.4 0.3 2.6 0.1 1.1 1.5 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 4.7 0.3 1.5 1.3 2.3 0.9 3.4 0.5 1.5 0.6 8.3 50.2 1.0 1.6 3.3 1.9 1.2 0.1 0.2 1.4 0.6 1.0 1.3 1.6 1.0 0.1 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favourable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.5 8.5 15.4 15.4 0.8 6.4 24.6 9.3 19.6 0.7 4.1 1.3 19.1 11.8 1.0 3.6 9.3 14.8 0.4 12.0 1.5 2.0 6.6 9.6 3.4 0.8 9.3 6.3 15.3 2.6 9.0 2.0 3.4 11.3 0.4 6.2 5.4 4.5 10.1 9.7 4.4 1.4 13.6 0.2 16.3 6.8 5.1 0.6 9.9 8.3 3.1 5.1 7.7 3.3 29.5 8.5 2.6 0.1 11.8 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: " "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 8.9 18.6 23.3 53.8 36.1 21.6 12.3 21.8 27.7 13.3 17.1 18.8 25.9 8.1 35.6 27.4 18.2 7.3 13.1 11.1 11.2 13.0 11.4 11.6 15.1 22.1 6.0 6.8 22.3 20.4 18.8 15.4 21.4 12.6 2.1 14.4 37.0 6.9 6.8 29.3 9.4 20.7 16.3 40.5 23.0 8.7 29.4 23.8 35.3 20.7 18.5 26.5 10.5 21.3 28.1 8.3 15.0 6.6 4.9 2.0 10.7 19.8 9.7 38.2 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell line enhanced" "Detected in many" "EFO-21: 20.5;PC-3: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavourable (8.64e-4)" "prognostic unfavourable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favourable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.6 1.8 15.0 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.1 0.0 20.5 0.3 5.5 7.8 4.5 3.4 13.3 10.7 0.0 3.2 4.0 4.0 0.0 4.8 0.0 4.4 0.1 2.3 0.0 4.9 0.0 0.2 17.9 0.1 0.0 9.0 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 9.6 2.4 0.6 0.4 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051712: " "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 37.2 42.9 56.2 34.0 37.6 53.1 43.9 33.4 56.2 29.0 39.9 18.7 33.1 50.5 37.2 35.1 41.2 30.9 35.4 32.5 51.6 35.7 39.8 54.9 31.7 35.5 34.9 45.9 30.3 32.5 25.1 24.8 51.1 41.5 30.4 38.8 18.6 34.6 33.4 52.0 42.7 56.7 35.2 45.8 43.2 40.4 24.1 34.3 32.8 33.5 29.8 37.5 40.3 38.9 27.9 41.5 94.9 65.7 27.6 32.2 51.5 29.1 22.4 35.3 22.7 41.7 32.1 33.4 28.4 32.3 35.1 38.8 30.7 35.4 19.4 49.7 36.6 22.6 36.0 31.0 31.0 25.5 39.6 36.0 20.2 27.2 33.8 45.2 42.3 37.1 32.6 28.1 25.9 37.8 28.1 28.7 34.6 38.8 34.9 47.3 50.7 55.5 36.9 24.4 32.0 38.4 29.3 30.5 46.3 24.0 22.9 30.4 19.5 51.8 35.1 27.4 16.2 49.9 35.5 34.3 56.6 30.6 39.8 55.1 23.6 41.0 47.8 94.9 24.7 60.1 26.1 27.9 23.7 26.7 41.5 27.8 28.8 31.4 41.0 27.6 65.7 28.5 32.2 51.5 56.2 37.6 33.4 56.2 51.6 35.7 34.9 45.9 41.5 34.3 FAM35A "bA163M19.1, FAM35A1, MGC5560" ENSG00000122376 "Family with sequence similarity 35 member A" Q86V20 10 87094161-87191468 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favourable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favourable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 17.3 16.9 5.4 14.4 7.2 5.4 15.4 6.4 4.9 12.6 20.2 4.7 9.1 15.0 10.8 10.6 12.6 9.3 7.4 11.5 6.0 6.1 31.2 35.3 12.5 16.4 9.0 3.5 12.7 10.2 3.6 19.4 7.4 6.8 14.0 11.6 7.4 11.4 14.0 9.3 9.1 33.1 14.8 6.9 15.6 8.7 7.1 7.9 12.0 30.7 12.6 9.4 12.3 13.6 9.0 10.7 4.9 11.1 11.2 13.7 8.5 15.9 12.9 7.4 17.0 8.3 8.1 10.8 10.8 15.2 14.5 16.0 14.8 12.3 11.7 6.0 14.6 10.7 18.2 8.2 15.0 16.6 12.0 16.2 12.3 13.9 12.9 25.2 14.2 7.4 15.2 13.2 22.9 9.6 20.5 21.2 13.4 9.1 20.5 18.0 8.5 9.0 12.7 14.7 12.9 13.3 13.4 3.7 15.3 8.3 9.8 14.3 21.7 14.2 9.4 8.3 7.5 12.3 21.4 11.9 26.0 28.4 14.0 31.6 4.4 4.9 7.0 2.3 6.8 11.1 13.7 9.0 10.3 10.0 10.7 7.2 10.5 10.5 0.1 11.2 8.4 3.7 9.7 8.5 5.4 7.2 6.4 4.9 6.0 6.1 9.0 3.5 6.8 7.9 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoli Nucleoplasm "CAB025016: , HPA035268: , HPA056991: " "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.3 15.8 4.0 13.3 12.0 6.1 11.2 8.4 5.8 5.8 6.9 7.2 10.0 10.7 42.8 14.0 12.0 6.2 7.4 1.4 8.7 8.4 4.2 13.8 5.1 18.9 2.8 6.7 7.5 6.7 12.0 8.4 4.0 7.9 7.9 6.6 17.1 5.1 12.1 1.7 19.9 6.4 4.0 29.3 6.3 6.8 7.9 6.0 3.8 9.4 13.8 7.1 4.3 4.5 7.8 4.7 21.1 11.3 30.3 16.6 13.0 14.4 7.3 7.9 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 FAM45A ENSG00000119979 "Family with sequence similarity 45 member A" Q8TCE6 10 119104086-119137984 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041159 Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Centrosome, Cytosol" "HPA041159: AB_10793871" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (1.90e-1)" "unprognostic (3.12e-1)" "unprognostic (1.88e-2)" "unprognostic (2.13e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-2)" "unprognostic (4.46e-2)" "unprognostic (2.64e-2)" "unprognostic (6.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.20e-2)" 12.2 13.2 16.2 8.5 20.0 17.0 9.5 10.2 17.6 11.6 12.5 10.2 6.5 7.6 9.4 10.7 16.0 9.0 8.5 10.8 13.5 10.4 16.6 18.9 8.6 6.8 10.6 17.6 17.3 8.8 11.6 5.4 10.8 18.4 8.9 11.0 7.7 10.7 8.3 14.0 12.0 9.7 9.8 13.5 8.4 9.7 7.1 11.5 10.1 14.8 10.8 9.9 13.1 14.7 2.3 9.9 30.2 19.2 3.8 10.0 6.0 8.3 9.8 12.5 14.4 21.4 21.4 5.5 11.9 29.8 10.7 10.3 9.5 11.2 5.9 4.5 14.6 12.6 10.6 10.4 9.3 10.0 6.0 1.3 3.4 8.3 24.4 3.5 2.8 22.2 8.9 7.8 11.0 14.4 2.8 6.7 13.4 6.7 4.4 6.0 7.5 4.0 4.8 15.7 4.3 10.3 8.9 2.1 8.3 8.5 8.9 17.4 8.6 12.3 14.6 7.6 3.9 7.8 6.0 7.3 2.7 6.5 12.3 15.3 3.4 23.0 15.1 30.2 4.2 18.3 3.4 2.3 6.3 5.5 9.9 1.9 3.1 4.1 20.1 3.8 19.2 2.5 10.0 6.0 16.2 20.0 10.2 17.6 13.5 10.4 10.6 17.6 18.4 11.5 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.8;fHDF/TERT166: 25.0;HeLa: 24.7;HL-60: 28.3;THP-1: 48.8;U-937: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051067: , HPA067140: " "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 21.8 9.6 1.9 8.2 5.9 4.9 7.5 15.4 0.8 0.1 0.3 25.0 0.9 0.7 1.3 3.6 0.0 1.9 0.0 24.7 2.4 6.8 28.3 2.2 4.2 0.7 3.8 0.6 0.6 0.4 0.0 3.2 4.4 0.0 20.1 0.2 1.1 0.0 9.0 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.4 0.3 48.8 1.3 5.6 1.2 2.4 2.2 0.1 0.1 0.1 8.0 21.9 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283780 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 3.1;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 3.1;dendritic cells: 2.3" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA053331: " "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 5.5 6.8 12.5 0.8 8.5 1.2 8.9 2.4 14.8 3.7 3.2 9.2 4.4 4.3 2.4 15.5 1.6 23.5 5.1 3.2 10.1 13.7 9.1 11.2 4.8 0.9 10.7 15.5 1.2 9.7 9.9 10.3 10.0 12.1 5.2 3.8 2.7 5.4 4.0 9.5 2.0 4.2 3.0 13.3 1.8 6.0 9.2 6.2 0.0 13.2 1.5 0.9 2.6 1.1 3.1 2.3 0.1 0.4 0.1 0.5 0.1 0.8 3.6 3.3 0.9 2.5 0.4 0.7 0.4 2.3 0.7 0.8 4.2 3.2 0.2 1.0 1.2 1.1 1.5 0.8 1.3 3.4 0.2 0.2 2.0 5.9 1.5 0.8 0.6 1.5 0.9 1.0 0.9 0.5 0.3 2.1 1.1 5.2 0.3 0.4 0.7 1.8 0.5 0.9 0.5 4.5 3.0 5.6 4.1 1.5 1.9 0.6 1.9 0.4 0.9 0.7 0.7 2.1 0.6 8.0 1.9 0.3 2.4 0.3 1.1 0.0 0.4 0.1 0.2 0.0 0.5 0.2 0.2 0.1 0.2 3.1 0.4 0.1 0.1 0.1 0.4 2.3 0.0 0.1 12.5 8.5 2.4 14.8 10.1 13.7 10.7 15.5 12.1 6.2 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 38.2;skeletal muscle: 41.3" "Cell line enhanced" "Detected in many" "ASC diff: 17.5;Karpas-707: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA053331: " "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 17.4 2.3 7.8 1.6 8.0 4.0 7.6 1.9 13.9 2.5 8.2 8.6 4.1 2.1 3.0 7.3 3.5 5.0 4.2 16.5 9.4 3.9 4.2 38.2 7.5 0.6 5.4 14.6 2.6 4.6 2.8 9.2 9.4 11.4 6.3 9.0 2.5 5.0 5.0 41.3 1.6 10.7 6.5 9.6 1.6 3.7 6.1 5.8 0.0 8.1 1.3 0.9 4.9 2.5 0.2 1.0 2.2 1.5 3.4 1.6 0.4 2.0 2.4 1.0 2.2 17.5 5.9 2.3 3.4 7.2 3.0 3.1 4.1 2.3 0.0 2.1 8.3 1.2 3.6 1.5 2.7 2.7 0.5 0.8 4.9 5.8 1.9 1.8 2.5 2.5 9.2 2.8 3.7 0.3 0.2 24.4 7.2 3.8 0.0 1.8 1.0 1.7 0.0 0.5 1.5 3.4 6.1 1.0 4.3 1.5 4.8 0.1 1.0 1.0 0.9 1.5 0.7 3.9 3.0 5.8 2.7 0.0 4.3 1.9 1.3 0.0 0.5 2.2 1.1 1.5 0.6 0.2 1.1 1.2 0.9 0.1 0.9 1.3 1.3 3.4 0.1 1.0 1.6 0.4 7.8 8.0 1.9 13.9 9.4 3.9 5.4 14.6 11.4 5.8 FAM49B BM-009 ENSG00000153310 "Family with sequence similarity 49 member B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.5;bone marrow: 80.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Approved Approved Nucleoplasm,Cytosol 990000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavourable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavourable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 19.2 14.5 23.2 42.8 33.1 80.1 20.6 28.0 36.9 7.2 14.3 18.2 5.5 14.2 8.0 10.6 17.9 7.9 14.9 9.8 25.5 25.2 11.8 12.3 19.1 49.6 28.5 19.6 6.4 10.0 7.5 16.1 19.4 21.2 7.6 17.4 7.3 12.0 7.9 16.8 9.0 19.3 13.5 38.8 41.3 12.9 13.6 21.2 28.2 13.8 9.7 46.4 20.6 8.4 21.0 47.3 93.5 42.2 30.8 29.3 43.4 31.6 17.0 18.5 10.4 1.6 2.4 24.7 9.6 9.3 13.4 14.3 9.7 21.8 31.6 21.2 6.3 15.8 15.3 25.4 20.1 66.2 10.7 31.7 9.5 10.9 6.5 20.5 27.3 3.9 11.9 9.0 18.8 11.8 22.7 36.7 14.6 14.1 69.6 15.2 15.7 23.5 30.4 12.5 53.1 27.4 13.0 12.4 16.2 19.3 12.2 28.5 14.2 26.6 7.2 4.9 31.8 10.4 20.4 12.2 36.0 52.5 7.8 44.7 12.7 45.5 35.3 65.6 29.3 42.2 22.4 21.0 16.7 23.9 47.3 15.1 15.0 24.6 93.5 30.8 36.5 30.4 22.5 43.4 23.2 33.1 28.0 36.9 25.5 25.2 28.5 19.6 21.2 21.2 FAM50B "D6S2654E, X5L" ENSG00000145945 "Family with sequence similarity 50 member B" Q9Y247 6 3849386-3851317 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 41.7;MCF7: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067817 Approved Supported "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA067817: " "unprognostic (1.15e-1)" "unprognostic (7.76e-2)" "unprognostic (4.28e-2)" "unprognostic (4.43e-2)" "unprognostic (2.12e-3)" "unprognostic (2.69e-1)" "unprognostic (2.38e-2)" "unprognostic (7.13e-2)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (2.15e-1)" "unprognostic (2.90e-1)" "prognostic favourable (4.01e-6)" "unprognostic (1.60e-1)" "unprognostic (3.22e-1)" "unprognostic (1.34e-1)" "unprognostic (9.39e-2)" 7.2 9.5 13.4 5.7 20.6 3.1 5.7 18.7 16.7 6.7 6.8 11.0 8.4 10.1 8.3 6.7 5.5 11.2 8.1 16.0 12.8 14.2 12.9 12.0 6.2 7.1 11.4 14.9 14.4 12.7 5.8 7.7 3.4 9.7 8.2 3.0 5.9 15.2 9.8 41.1 7.9 6.9 10.2 10.8 7.7 7.9 10.2 9.9 5.8 11.8 5.7 5.5 7.5 13.3 14.9 10.1 3.4 9.1 19.4 20.5 5.6 3.1 4.2 0.0 0.0 2.5 2.4 0.2 3.7 1.8 2.5 3.2 0.0 5.7 3.3 4.0 2.7 2.4 0.0 1.5 1.9 41.7 2.2 0.0 10.0 0.0 2.6 0.0 0.0 2.6 2.9 2.0 0.5 2.5 0.0 0.0 2.2 13.1 0.0 4.6 0.9 2.0 0.0 0.0 0.0 1.2 0.0 5.9 5.2 6.0 3.8 0.2 4.1 3.7 3.5 0.0 0.4 5.0 0.0 0.0 9.0 0.0 1.4 0.3 6.9 3.4 4.7 2.4 7.1 6.1 16.8 14.9 13.6 9.2 6.1 12.9 11.3 7.1 1.9 19.4 9.1 10.1 20.5 5.6 13.4 20.6 18.7 16.7 12.8 14.2 11.4 14.9 9.7 9.9 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favourable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavourable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.2 4.7 1.9 4.7 7.4 13.9 2.4 13.4 27.7 7.6 15.5 2.7 0.9 14.5 2.4 24.7 5.5 0.3 10.1 12.7 5.8 4.8 0.5 3.7 6.8 2.6 1.3 0.9 8.2 8.1 16.7 3.8 0.1 5.1 15.5 9.6 1.6 4.8 1.2 3.5 1.9 4.3 14.3 4.5 1.1 4.5 4.9 3.8 3.7 3.7 4.9 1.8 0.4 0.5 9.0 6.9 17.5 4.7 23.4 22.3 17.0 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.1;HEK 293: 25.1;HUVEC TERT2: 31.2;REH: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046812, HPA054443" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA046812: , HPA054443: " "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favourable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.3 9.4 9.2 0.0 0.0 8.4 0.3 0.0 0.3 0.4 9.5 1.5 0.8 28.1 0.0 2.9 4.8 0.1 0.0 1.3 25.1 5.3 0.4 0.3 0.1 0.8 2.8 0.1 0.0 0.1 0.0 31.2 6.2 0.9 0.0 4.1 3.6 8.4 14.5 2.1 20.0 0.2 9.4 0.5 1.0 16.0 17.3 0.4 1.8 7.0 5.2 4.9 16.0 0.8 7.0 1.3 0.5 5.5 0.5 2.4 0.6 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 FAM72A "LMPIP, MGC57827, RP11-312O7.1, UGENE" ENSG00000196550 "Family with sequence similarity 72 member A" Q5TYM5 1 206186179-206204414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (3.61e-2)" "unprognostic (1.58e-1)" "unprognostic (1.80e-1)" "unprognostic (5.20e-5)" "unprognostic (3.61e-1)" "unprognostic (1.19e-3)" "unprognostic (1.01e-5)" "unprognostic (7.70e-3)" "unprognostic (1.45e-2)" "unprognostic (5.58e-3)" "unprognostic (2.87e-2)" "unprognostic (1.03e-1)" "unprognostic (4.44e-16)" "unprognostic (1.82e-1)" "unprognostic (1.94e-2)" "unprognostic (4.83e-2)" "unprognostic (3.89e-1)" 3.4 2.5 1.9 4.7 1.6 6.3 3.2 8.0 1.3 0.8 1.5 2.4 0.6 0.0 2.5 1.8 2.2 0.9 2.4 1.8 1.0 1.3 2.4 8.9 2.6 0.8 0.7 2.3 0.4 2.8 0.5 1.7 0.7 0.2 0.2 5.0 2.2 1.3 3.1 6.3 0.8 6.3 0.5 6.2 1.1 1.2 2.1 5.6 1.2 9.2 0.6 3.6 2.4 9.7 8.0 8.4 3.6 1.2 1.5 10.1 7.0 3.0 8.1 6.1 4.7 14.6 25.1 6.0 1.8 11.7 9.7 3.8 9.7 13.8 8.0 11.3 7.3 6.3 0.8 19.5 12.8 2.1 0.7 7.2 12.8 5.0 22.5 17.3 5.0 5.7 12.1 17.5 15.2 10.7 13.4 14.6 18.9 4.5 1.5 8.4 4.9 5.0 4.6 4.1 9.7 10.6 2.6 6.5 7.5 8.4 11.5 14.0 20.5 22.5 5.3 16.0 8.9 0.0 7.5 0.0 0.9 9.2 0.2 2.1 1.8 1.8 5.6 0.8 0.2 0.4 1.2 0.6 5.4 2.3 3.6 2.4 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 11.9 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 19.9 10.3 0.6 0.4 5.9 12.0 4.5 15.0 16.4 5.4 5.0 10.0 16.4 13.9 9.1 15.0 15.8 12.1 2.9 1.4 8.0 4.6 4.8 3.7 3.7 5.0 15.6 1.5 6.2 10.5 12.0 11.2 14.6 18.1 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell line enhanced" "Detected in many" "U-266/84: 29.0" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.5 5.0 6.1 2.7 0.3 0.8 5.8 4.3 1.4 5.7 4.4 0.7 10.3 20.4 5.6 0.5 8.3 8.1 2.6 6.3 7.0 4.8 8.8 4.4 1.5 0.3 17.9 8.0 0.1 0.0 4.5 11.8 2.5 15.4 9.6 0.3 0.6 10.6 13.9 4.8 3.2 13.5 4.3 14.5 1.0 1.1 3.0 5.5 4.1 2.4 2.3 5.9 15.4 1.7 4.6 7.6 6.0 9.3 20.1 29.0 12.1 2.4 11.2 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA043271: , HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.3 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.7 4.9 0.7 8.9 7.3 1.4 7.2 11.0 7.3 6.8 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 2.7 13.6 19.2 4.0 6.3 8.2 11.9 11.4 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.6 3.3 2.2 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.5 22.8 21.3 0.0 9.7 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: " "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favourable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.6 7.0 8.0 8.2 10.1 8.8 14.4 8.1 8.6 12.1 11.9 8.0 11.7 15.9 5.3 9.0 11.5 10.0 9.0 9.4 8.2 7.6 4.9 9.9 9.4 8.1 7.8 7.7 9.0 9.8 13.2 13.3 6.0 9.3 15.0 8.6 8.4 18.4 7.2 12.6 7.0 11.2 9.5 9.0 9.6 12.5 11.6 5.2 9.3 10.1 9.7 7.3 3.1 6.4 14.3 6.2 16.5 5.6 13.7 14.9 13.0 8.9 10.2 6.1 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768942-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036608: " "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavourable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favourable (2.72e-4)" 10.1 6.2 5.3 12.1 9.3 35.7 9.3 12.3 9.7 8.5 10.8 6.2 6.1 9.5 8.2 7.5 7.8 7.3 10.1 4.9 6.1 4.4 5.2 13.6 8.2 16.8 10.5 5.6 8.3 6.7 6.3 9.5 8.2 7.1 9.0 5.7 6.3 9.1 8.2 5.6 8.7 9.0 9.8 8.9 8.8 6.6 28.2 10.1 12.0 8.4 4.1 17.8 8.6 7.9 3.0 7.3 8.7 3.0 4.5 7.6 2.8 4.4 3.4 12.9 7.0 2.1 2.2 10.8 7.6 3.7 5.7 6.5 12.7 8.7 16.8 9.7 3.7 8.5 7.5 2.6 6.0 9.0 5.5 19.7 6.2 6.6 5.5 13.8 11.3 2.8 4.3 6.5 5.8 5.3 11.6 9.4 3.1 3.3 15.5 16.2 7.2 3.1 16.8 9.6 9.8 4.2 5.0 5.4 15.5 9.4 5.3 5.7 7.0 6.0 5.4 7.8 8.4 9.2 6.9 5.1 10.8 25.9 1.8 13.5 11.0 0.1 2.9 5.2 5.4 3.0 4.4 3.0 4.9 5.4 2.0 2.6 4.5 6.7 8.7 4.5 2.8 7.3 7.6 2.8 5.3 9.3 12.3 9.7 6.1 4.4 10.5 5.6 7.1 10.1 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell line enhanced" "Detected in many" "BEWO: 18.1;HEL: 17.1;HL-60: 16.9;NB-4: 26.6;THP-1: 23.8;U-937: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favourable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favourable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.5 0.8 0.2 18.1 0.2 0.1 0.2 0.1 0.1 0.1 7.5 0.1 0.1 0.0 7.3 0.1 0.0 1.9 0.6 17.1 0.2 0.1 0.3 16.9 0.7 0.2 0.3 0.0 0.0 10.0 6.0 2.1 0.2 2.6 0.7 26.6 1.2 0.2 1.8 1.0 10.5 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.6 23.8 0.2 1.0 1.1 0.6 0.0 1.6 0.8 4.4 0.1 15.9 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 FAM78B ENSG00000188859 "Family with sequence similarity 78 member B" Q5VT40 1 166057426-166166969 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 12.2;SK-MEL-30: 10.9;U-2 OS: 3.0;WM-115: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052789, HPA073246" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052789: , HPA073246: " "unprognostic (7.38e-3)" "unprognostic (1.14e-3)" "unprognostic (7.96e-2)" "unprognostic (3.16e-2)" "unprognostic (3.77e-2)" "unprognostic (3.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-3)" "unprognostic (3.25e-2)" "unprognostic (1.69e-3)" "unprognostic (3.87e-2)" "unprognostic (1.87e-11)" "unprognostic (7.41e-2)" "unprognostic (2.09e-1)" "unprognostic (5.41e-2)" "unprognostic (2.69e-2)" 3.3 1.5 5.1 2.7 6.4 1.4 3.1 8.6 10.5 3.6 2.8 1.0 0.3 3.5 3.6 1.1 1.6 1.1 2.3 3.2 2.4 1.1 2.7 2.8 1.6 1.8 1.1 3.1 2.1 5.2 1.1 3.5 1.4 2.1 1.8 1.1 5.7 2.2 1.3 3.1 2.0 1.6 1.1 1.2 2.2 3.6 3.7 1.5 0.0 1.7 1.7 1.3 2.7 2.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 12.2 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.3 0.1 0.6 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.8 0.5 0.0 0.2 10.9 0.3 0.4 0.2 0.7 3.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 6.4 8.6 10.5 2.4 1.1 1.1 3.1 2.1 1.5 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell line enriched" "Detected in many" 4 "Daudi: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001847: , HPA065797: " "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.7 8.4 0.6 0.1 0.2 0.1 3.4 0.3 0.0 0.5 1.6 1.0 1.0 36.7 0.2 0.1 4.4 4.7 1.4 1.1 0.4 2.4 0.0 5.6 0.3 0.0 3.1 0.7 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.5 1.9 0.0 0.1 0.5 3.0 0.8 8.5 0.9 1.9 2.1 1.7 0.5 3.3 0.1 5.4 1.4 1.9 0.2 1.4 4.3 1.6 6.2 0.0 0.0 0.4 1.4 1.2 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: , HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (5.44e-6)" "prognostic unfavourable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavourable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.2 19.3 15.3 12.8 1.7 1.9 27.4 14.1 8.8 27.9 17.1 29.4 14.4 7.9 14.0 9.2 26.9 20.8 24.1 26.2 2.6 8.2 9.2 14.8 21.2 1.4 4.0 4.8 1.0 1.2 16.0 9.3 15.3 8.1 11.5 15.8 16.8 6.2 5.9 12.6 24.6 6.0 28.1 4.4 8.0 8.0 7.1 11.8 41.1 34.3 6.1 21.4 4.2 7.3 18.5 22.7 21.0 30.9 3.5 5.3 8.2 8.3 6.0 13.5 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994949-40043529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.4;seminal vesicle: 33.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 22.8;hTERT-HME1: 7.2;RT4: 10.9;SCLC-21H: 24.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: " "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favourable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favourable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.1 0.2 0.1 2.8 0.2 0.8 4.7 0.2 0.3 2.6 6.9 0.1 29.4 3.0 0.2 7.5 15.4 1.1 4.0 1.5 0.2 0.1 4.8 2.1 1.0 0.1 0.2 0.1 0.5 14.4 2.6 2.6 0.5 0.1 6.3 3.1 0.4 7.8 33.3 0.1 13.8 12.5 0.8 0.2 0.1 5.9 24.9 0.1 1.3 12.6 12.8 8.1 3.0 4.1 0.7 0.5 2.7 0.4 0.6 0.3 0.1 4.7 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 7.0 1.4 0.0 0.0 0.0 7.6 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 22.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 10.9 24.1 0.0 0.2 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.3 2.2 0.6 0.3 0.5 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell line enhanced" "Detected in many" "BEWO: 51.1;SK-MEL-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: , HPA059578: " "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.7 2.2 4.6 5.4 1.1 51.1 2.6 2.0 1.0 1.8 7.1 4.2 0.0 0.6 1.7 2.8 4.1 0.6 0.8 14.2 10.0 2.2 0.1 0.3 20.7 1.6 12.4 18.0 9.3 0.0 4.7 2.5 17.6 3.0 0.9 1.6 1.0 2.9 3.3 1.5 5.5 7.1 5.3 3.5 5.0 2.0 5.6 0.9 0.4 26.7 0.2 9.9 0.3 8.0 0.0 0.1 4.9 6.4 7.7 3.9 2.3 3.3 15.8 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768456-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 21.9 15.3 12.2 16.1 14.3 39.1 17.3 17.2 15.2 17.3 18.7 11.8 26.7 15.3 16.4 15.5 20.0 13.6 17.3 14.6 12.6 14.4 20.0 30.6 18.4 17.9 15.4 11.6 18.8 15.4 25.2 20.3 26.9 15.6 14.0 16.3 16.1 18.0 24.2 9.2 17.1 23.0 12.8 18.4 31.3 14.4 11.9 14.0 24.4 19.8 12.0 20.0 15.3 16.2 5.7 8.9 12.0 10.4 6.6 4.3 4.2 25.4 17.1 5.4 9.3 10.3 11.2 8.6 14.7 16.1 14.0 17.9 8.4 10.5 12.0 16.5 12.1 12.5 12.6 15.9 25.1 22.8 12.2 18.8 9.0 10.1 16.2 8.6 24.5 10.5 12.9 18.3 22.9 12.6 6.7 17.1 12.5 29.9 14.7 5.6 5.2 15.4 8.1 8.8 8.8 11.8 26.1 6.4 9.0 19.5 42.1 19.6 13.0 9.1 12.6 13.4 24.2 14.8 21.4 13.4 25.5 11.5 21.0 15.5 16.2 6.9 8.3 12.0 3.8 10.4 3.4 5.7 3.8 3.2 8.9 5.0 3.3 4.3 11.4 6.6 9.1 3.5 3.3 4.2 12.2 14.3 17.2 15.2 12.6 14.4 15.4 11.6 15.6 14.0 FAM96A "CIA2A, FLJ22875" ENSG00000166797 "Family with sequence similarity 96 member A" Q9H5X1 15 64072559-64094018 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: " "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 13.6 32.3 11.2 19.1 12.8 17.0 13.9 9.0 10.3 8.5 24.3 13.6 17.7 31.3 8.1 14.9 13.6 8.3 14.0 20.6 11.2 10.8 39.4 89.7 18.1 22.7 15.2 8.0 7.8 27.0 10.6 15.4 25.2 11.2 17.2 20.2 10.7 16.5 15.7 28.2 7.6 45.5 6.4 14.9 25.2 17.9 8.9 13.8 20.5 30.1 18.3 19.3 14.6 9.0 51.8 63.7 23.7 48.6 11.8 21.3 38.2 19.5 28.7 17.6 10.9 14.9 18.3 11.6 15.4 17.2 20.6 21.8 28.3 31.7 32.5 27.1 9.7 21.6 34.3 15.1 17.5 26.5 18.5 26.5 26.0 26.6 11.8 42.9 22.9 14.4 15.2 13.4 12.0 20.8 36.2 25.2 14.5 33.1 16.3 37.1 25.4 15.2 26.2 23.2 72.0 26.5 23.0 18.8 14.2 12.3 28.1 29.8 20.6 44.8 12.5 16.3 23.2 18.6 33.1 24.4 57.5 29.2 19.8 77.6 15.5 16.2 48.6 16.9 10.1 44.1 12.4 51.8 15.3 13.5 42.6 48.8 12.3 11.6 23.7 11.8 36.7 63.7 21.3 38.2 11.2 12.8 9.0 10.3 11.2 10.8 15.2 8.0 11.2 13.8 FAM96B "CGI-128, CIA2B, MIP18" ENSG00000166595 "Family with sequence similarity 96 member B" Q9Y3D0 16 66932055-66934423 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041501, HPA041736" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041501: AB_10795123, HPA041736: AB_10793932" "unprognostic (2.49e-1)" "unprognostic (3.79e-2)" "unprognostic (8.06e-2)" "unprognostic (5.42e-3)" "unprognostic (3.93e-2)" "unprognostic (4.91e-2)" "unprognostic (4.98e-2)" "unprognostic (8.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-2)" "unprognostic (5.10e-2)" "unprognostic (1.50e-1)" "unprognostic (9.84e-2)" "unprognostic (6.48e-2)" "unprognostic (1.12e-2)" 22.5 34.2 38.7 26.5 38.2 17.7 31.9 26.8 34.5 19.6 28.8 30.3 19.8 26.3 20.4 27.5 43.5 28.6 25.0 58.0 36.7 33.6 41.6 57.8 27.4 30.6 39.4 27.4 29.5 38.3 23.2 30.0 27.3 30.7 22.0 25.6 16.6 21.9 22.2 89.6 14.2 29.4 22.3 41.4 25.3 24.3 32.2 28.5 24.1 41.2 40.8 25.3 25.7 37.0 51.8 92.7 46.3 52.7 40.7 61.2 44.8 25.3 57.5 19.5 24.4 24.7 23.5 23.8 23.2 26.1 35.6 44.8 60.6 29.5 23.0 30.2 27.4 33.6 27.9 28.0 25.5 28.5 39.3 14.0 17.1 70.6 47.0 20.7 55.9 23.1 27.2 42.0 36.9 24.0 23.5 15.4 28.8 48.7 35.2 49.9 26.0 70.0 30.1 20.9 44.2 52.6 22.9 34.4 38.5 49.8 13.5 35.2 14.8 34.6 20.4 26.8 31.8 15.0 32.1 33.8 27.1 58.4 47.4 21.5 34.7 41.5 47.0 46.3 43.2 51.2 42.3 51.8 46.3 46.9 51.7 44.4 37.3 41.5 23.0 40.7 52.7 92.7 61.2 44.8 38.7 38.2 26.8 34.5 36.7 33.6 39.4 27.4 30.7 28.5 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 15.6 15.6 20.4 16.9 21.0 10.8 17.0 27.3 24.4 13.7 19.3 12.7 8.7 12.5 17.9 12.9 14.9 14.5 11.0 15.8 20.1 19.6 17.7 10.1 10.6 16.3 18.6 20.3 15.6 10.6 27.5 18.3 20.1 17.7 16.5 15.7 9.3 11.2 14.2 16.2 11.5 12.8 17.4 21.0 13.8 12.0 13.0 14.0 27.4 15.7 12.3 16.8 14.8 13.4 3.5 2.5 3.7 1.1 3.8 6.6 0.7 13.5 7.2 35.8 18.3 6.6 12.2 17.5 17.4 12.8 17.2 17.4 16.0 6.6 9.4 19.3 14.4 14.4 21.5 17.8 24.3 9.6 11.7 27.6 16.7 12.3 9.6 26.1 16.0 11.2 11.2 15.4 17.9 17.7 19.8 11.8 16.4 6.1 22.0 14.0 19.2 10.1 23.5 19.3 7.8 14.9 17.9 22.1 22.7 19.2 12.3 8.4 15.1 16.2 14.7 19.7 24.0 13.0 19.5 22.0 19.7 34.1 10.7 17.3 20.4 3.7 0.9 2.5 5.3 0.8 4.6 2.8 5.4 4.4 1.1 3.5 6.6 5.1 0.8 3.8 1.1 2.5 3.3 0.7 20.4 21.0 27.3 24.4 20.1 19.6 18.6 20.3 17.7 14.0 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favourable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 11.7 12.8 1.5 7.4 1.6 5.6 6.5 6.8 5.8 6.8 7.2 2.1 8.6 10.7 7.7 4.0 5.7 2.9 4.9 1.1 17.2 6.0 3.5 2.1 4.9 7.3 3.0 6.4 5.3 10.3 3.4 6.3 4.0 9.6 11.8 4.0 13.0 4.3 2.3 1.1 13.8 8.9 3.1 6.3 8.2 6.2 2.6 7.6 6.9 12.2 4.0 9.3 9.4 5.1 3.1 8.3 9.4 8.2 12.7 6.4 4.5 7.9 7.0 4.9 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30903852-30943108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: " "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favourable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 5.9 8.9 11.6 6.9 17.4 6.3 12.7 19.6 18.4 15.0 11.4 17.7 11.9 4.6 11.6 22.9 6.5 8.5 8.5 13.0 12.6 11.0 14.7 14.4 6.9 5.5 18.5 11.8 12.5 18.2 7.2 17.0 10.6 15.4 16.4 9.7 8.6 17.3 8.3 16.8 9.3 6.7 11.5 13.0 7.3 8.5 9.4 15.0 5.1 14.3 6.3 5.8 9.0 9.1 4.0 3.6 0.6 1.7 4.5 5.4 1.6 6.4 11.0 3.6 2.0 13.0 11.6 2.4 4.5 1.9 4.8 5.1 7.5 3.3 1.5 8.1 4.9 13.0 6.1 9.5 4.7 5.1 2.9 1.1 11.2 1.3 5.6 0.9 6.1 3.5 7.0 2.9 7.7 2.3 5.5 10.1 7.8 1.4 10.0 4.4 2.8 2.5 8.5 11.9 2.8 7.1 5.1 8.3 5.8 9.9 6.8 3.5 6.1 7.6 8.3 15.1 3.6 4.2 5.8 13.9 9.7 1.7 6.6 4.8 1.3 0.1 0.8 0.6 3.7 1.3 4.7 2.8 3.5 1.7 2.7 4.0 5.4 2.8 0.3 4.5 1.7 3.6 3.2 1.6 11.6 17.4 19.6 18.4 12.6 11.0 18.5 11.8 15.4 15.0 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell line enhanced" "Detected in many" "BEWO: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: " "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavourable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.5 9.1 17.5 4.9 0.9 1.3 45.3 7.9 3.5 11.4 9.3 6.8 8.5 16.8 3.7 2.6 7.5 18.0 6.1 11.4 8.0 12.2 23.0 14.0 6.5 0.1 17.0 14.4 0.4 1.0 12.8 7.1 6.8 14.0 19.3 8.5 9.9 14.2 6.5 21.1 6.4 15.5 14.2 11.9 3.9 9.7 4.9 9.6 9.7 7.6 3.1 11.6 10.8 3.9 9.4 10.8 5.7 11.4 8.2 16.0 28.5 5.4 17.5 16.1 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: " "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavourable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavourable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.5 14.3 13.2 3.2 5.1 12.0 11.1 8.0 21.8 20.9 9.3 9.9 15.6 7.7 3.5 9.7 11.9 10.2 8.3 18.2 7.2 11.1 20.9 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 11.1 7.3 21.0 10.9 14.0 19.1 15.5 14.9 15.1 19.8 16.9 11.0 5.1 6.7 6.9 12.6 7.3 10.4 4.1 13.5 8.1 6.7 10.3 20.7 13.2 14.9 5.7 10.8 9.4 9.2 8.4 14.1 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "Fanconi anemia complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 62.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavourable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavourable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favourable (7.80e-5)" 6.3 29.2 16.0 11.2 22.9 10.6 16.2 7.1 18.1 11.6 9.6 30.7 7.9 9.2 16.6 15.7 8.6 11.7 9.8 10.2 17.0 23.5 7.1 16.7 7.7 10.9 25.0 15.2 21.3 10.8 16.8 62.5 10.0 33.5 11.6 12.4 13.7 14.8 9.1 6.5 14.4 10.1 11.3 23.4 12.0 10.5 14.7 28.2 8.6 14.2 6.9 12.0 10.1 12.7 10.8 7.1 5.6 6.9 8.8 5.5 2.7 18.4 13.5 27.6 13.5 4.9 6.5 14.7 13.6 8.5 13.5 17.6 11.9 23.3 12.8 17.7 4.4 10.8 15.3 10.3 22.6 30.0 24.2 21.0 19.0 16.1 5.3 20.2 11.6 4.8 4.9 9.8 3.9 10.5 19.5 11.7 9.1 9.4 7.1 25.1 29.8 2.8 13.5 20.9 10.0 11.8 18.3 31.3 15.7 19.4 8.0 12.7 7.3 13.6 6.2 12.1 18.2 8.8 14.9 12.1 7.6 7.5 25.7 13.7 18.3 2.7 3.7 5.6 4.9 6.9 3.8 10.8 4.1 5.4 7.1 10.0 1.4 3.1 1.1 8.8 4.9 6.5 5.5 2.7 16.0 22.9 7.1 18.1 17.0 23.5 25.0 15.2 33.5 28.2 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.8;HUVEC TERT2: 30.2;NB-4: 25.9;SK-BR-3: 31.9;TIME: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavourable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 9.4 7.2 9.8 6.9 17.4 12.0 7.6 5.1 18.2 4.6 25.7 3.2 6.1 13.3 6.2 29.4 6.0 3.7 4.2 5.4 12.8 10.9 4.0 3.1 8.6 6.7 9.4 10.4 2.1 2.6 1.0 2.9 19.2 6.6 2.8 22.3 4.1 4.8 1.7 4.5 8.7 14.0 6.0 5.1 12.3 3.7 8.4 5.9 7.2 3.5 4.5 2.3 6.6 4.3 0.9 4.0 23.7 11.5 1.8 7.6 4.4 0.9 1.7 1.7 0.4 2.5 9.9 0.7 7.5 8.8 2.1 2.0 2.9 10.1 1.3 2.0 1.0 0.5 4.6 0.0 0.5 0.6 11.5 25.8 4.1 0.9 5.3 10.3 8.6 2.8 0.0 3.2 4.0 30.2 2.2 1.0 0.3 0.3 6.6 25.9 7.0 19.7 5.5 2.9 1.1 9.3 2.6 3.0 2.7 1.7 31.9 12.7 1.5 9.7 24.5 5.6 1.7 2.0 3.3 1.6 1.6 0.6 8.9 13.6 4.8 1.3 11.5 23.7 2.7 6.9 1.8 0.9 4.5 3.2 4.0 0.7 1.5 1.7 20.7 1.8 3.7 1.5 7.6 4.4 9.8 17.4 5.1 18.2 12.8 10.9 9.4 10.4 6.6 5.9 FARSB "FARSLB, FRSB, PheHB" ENSG00000116120 "Phenylalanyl-tRNA synthetase beta subunit" Q9NSD9 2 222570536-222656337 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036677, HPA036678, HPA061398" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036677: , HPA036678: AB_10673504, HPA061398: " "unprognostic (9.95e-3)" "unprognostic (1.86e-3)" "unprognostic (7.02e-2)" "unprognostic (7.42e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (6.45e-10)" "unprognostic (8.89e-3)" "unprognostic (4.51e-2)" "unprognostic (3.63e-2)" "unprognostic (5.25e-3)" "unprognostic (6.25e-2)" "prognostic unfavourable (3.21e-5)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (1.25e-4)" 15.7 10.8 11.9 12.6 23.5 11.5 16.0 15.1 28.5 11.6 17.3 13.7 5.9 15.9 14.2 11.7 19.1 10.8 7.2 13.4 13.7 15.1 11.7 18.3 9.0 12.0 11.6 18.0 16.7 18.6 15.0 15.7 8.8 29.4 11.2 20.7 9.6 12.3 11.5 33.2 14.1 11.5 14.9 9.7 10.3 13.9 15.6 11.2 15.6 11.9 17.1 14.2 11.8 12.0 16.3 16.0 1.2 11.4 18.5 20.0 14.6 22.0 13.0 15.1 19.7 13.8 19.9 23.3 22.5 14.2 22.2 18.2 32.8 12.2 10.8 17.1 16.4 18.6 29.1 25.2 32.8 16.2 15.1 24.8 14.7 20.9 21.6 36.1 10.3 13.3 19.8 25.4 39.0 21.0 37.3 22.3 27.0 20.6 21.6 20.4 19.3 16.2 21.3 36.4 35.0 18.2 14.4 24.6 8.0 9.4 16.5 19.4 15.3 15.2 11.4 19.1 15.7 27.3 27.1 10.7 10.7 39.5 14.9 24.3 19.9 0.2 8.5 1.2 11.4 10.3 16.8 16.3 15.4 14.0 16.0 14.0 20.0 17.2 0.9 18.5 11.4 8.0 13.3 14.6 11.9 23.5 15.1 28.5 13.7 15.1 11.6 18.0 29.4 11.2 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990582-89015785 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 40.1" "Group enriched" "Detected in all" 5 "granulocytes: 40.1;T-cells: 30.9" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" 450000 "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 13.5 26.3 6.1 17.3 7.7 12.4 10.6 2.1 7.2 15.6 14.2 6.1 7.0 5.9 15.7 16.6 14.1 14.2 14.5 8.9 8.2 2.7 11.7 21.9 28.6 15.6 6.0 3.9 24.7 4.1 4.5 4.6 9.0 7.5 22.3 21.3 4.4 7.1 8.5 4.3 9.6 16.3 12.5 10.2 15.3 5.0 7.3 5.1 12.5 10.0 15.8 14.4 14.8 21.4 3.0 4.0 40.1 6.8 1.2 30.9 3.9 8.5 3.3 1.7 5.5 14.2 21.0 0.0 18.9 19.1 0.7 3.7 0.0 9.3 1.7 7.3 17.7 1.3 0.3 15.8 1.3 27.5 2.7 0.1 1.8 5.6 13.6 0.9 0.4 26.0 14.2 11.8 25.5 1.6 0.0 43.8 19.2 0.7 2.7 1.4 0.2 0.9 0.1 0.1 1.7 26.5 2.7 0.1 0.1 2.7 0.0 0.3 6.0 0.3 4.1 6.0 3.4 5.6 4.3 17.2 1.7 0.1 5.0 3.4 1.8 11.3 3.2 9.4 3.3 3.9 4.8 3.0 10.4 7.2 4.0 0.7 1.2 3.4 40.1 1.2 6.8 0.0 30.9 3.9 6.1 7.7 2.1 7.2 8.2 2.7 6.0 3.9 7.5 5.1 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell line enhanced" "Detected in many" "SK-BR-3: 152.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavourable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.1 24.3 11.3 7.8 18.3 12.4 24.2 4.6 6.0 4.9 9.0 25.4 15.8 7.7 3.8 3.5 19.4 10.9 21.3 0.9 3.6 47.4 16.0 18.2 33.9 5.2 8.6 2.4 11.9 5.6 12.5 2.9 5.5 24.1 6.9 1.7 40.1 9.4 13.7 21.9 14.2 8.3 6.4 15.3 5.5 29.7 28.1 15.6 6.8 152.8 12.4 27.2 16.5 9.6 7.2 14.8 5.9 11.0 9.3 2.0 8.0 4.3 9.4 10.6 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Approved "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favourable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.7 18.4 5.9 14.1 22.0 9.9 9.8 12.7 17.3 10.8 13.0 12.7 13.7 3.7 17.3 17.1 10.3 5.6 15.2 2.9 10.8 10.1 4.6 4.6 10.8 27.9 3.2 10.4 13.0 22.3 12.5 9.2 12.7 6.7 7.9 12.5 31.7 7.7 9.2 9.9 21.7 5.1 7.1 11.8 14.7 10.9 7.0 7.3 16.7 26.0 16.9 14.0 12.6 10.4 13.8 3.0 12.9 11.2 21.2 12.9 2.4 27.5 7.2 15.8 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA068525: , HPA074462: " "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavourable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favourable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.0 6.2 6.1 7.9 3.8 4.9 12.0 6.0 5.1 9.3 7.2 9.3 7.6 24.6 12.0 6.2 7.5 14.9 8.3 13.3 6.7 7.7 8.5 20.3 7.3 5.2 14.0 7.1 5.5 3.6 8.7 5.4 5.1 11.6 4.3 7.0 5.1 9.4 8.2 5.6 8.8 11.0 7.5 5.6 7.6 7.6 4.3 4.0 17.8 7.9 8.7 7.1 6.5 3.5 9.3 9.4 9.6 9.7 5.0 4.7 15.7 6.2 13.0 7.5 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: " "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.1 51.5 45.5 72.1 44.6 66.6 62.4 44.6 43.5 62.6 39.7 58.2 78.5 93.1 121.2 38.4 69.1 42.2 59.5 26.1 68.3 64.6 75.1 54.1 79.9 82.0 89.0 82.8 82.1 99.1 53.7 73.2 48.2 70.0 110.4 33.1 97.7 102.7 179.6 125.2 85.8 100.0 36.4 182.7 57.6 44.2 63.4 63.6 34.7 100.3 139.4 89.7 123.4 45.6 56.6 65.3 87.3 71.3 120.1 114.1 158.5 68.6 69.3 64.0 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 FBLIM1 "CAL, FBLP-1, migfilin" ENSG00000162458 "Filamin binding LIM protein 1" Q8WUP2 1 15756607-15786594 "Predicted intracellular proteins" "Cell adhesion, Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 53.1;TIME: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025287, HPA072750" Approved Enhanced "Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites" "Cell Junctions, Focal adhesion sites" "Nucleoli fibrillar center" "HPA025287: AB_1848443, HPA072750: " "unprognostic (4.10e-2)" "prognostic unfavourable (4.07e-4)" "unprognostic (2.26e-1)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.33e-2)" "unprognostic (8.77e-3)" "prognostic unfavourable (6.15e-4)" "unprognostic (2.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (8.64e-4)" "unprognostic (8.33e-2)" "unprognostic (3.01e-1)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 11.6 6.0 1.7 12.8 1.4 0.0 10.1 0.8 1.3 21.5 36.6 1.4 26.8 24.6 30.3 15.8 17.8 16.5 60.2 21.7 1.2 1.0 18.2 3.0 14.7 16.1 1.8 1.6 36.0 13.0 13.9 3.8 21.5 2.3 26.7 15.7 9.0 13.0 26.5 4.1 6.2 62.8 18.7 1.3 22.7 18.9 22.3 0.9 1.3 10.3 7.4 6.3 24.7 16.9 1.8 1.3 4.6 1.2 1.6 1.2 0.3 6.4 3.6 3.2 0.1 0.8 1.7 4.4 11.0 17.6 8.2 6.5 1.2 9.7 0.0 23.9 17.6 12.5 2.3 25.2 4.0 0.0 1.2 0.0 0.9 6.2 21.1 0.0 0.1 8.4 16.8 6.8 16.1 53.1 0.2 1.6 2.7 0.1 0.1 0.1 3.3 4.7 0.0 0.0 0.2 10.2 4.5 0.0 7.8 5.8 0.7 1.2 1.3 0.1 82.8 10.8 1.4 0.1 5.0 0.1 0.2 0.1 1.6 0.0 0.1 4.6 1.2 1.0 0.7 0.5 0.6 1.0 0.7 0.7 0.4 1.8 1.1 1.2 3.5 1.6 0.7 1.3 0.4 0.3 1.7 1.4 0.8 1.3 1.2 1.0 1.8 1.6 2.3 0.9 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529116-168530634 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 18.9;SH-SY5Y: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049546 Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA049546: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.8 6.2 10.3 0.9 12.1 0.7 1.1 10.6 24.9 1.0 0.9 0.9 0.0 1.4 0.8 0.8 0.8 1.4 1.1 1.3 11.0 18.4 1.1 0.9 0.9 0.7 9.7 8.5 1.2 2.1 1.8 7.4 1.0 7.9 1.4 0.9 0.5 1.4 1.3 0.9 1.5 1.6 1.1 3.0 0.8 1.4 5.1 1.7 0.0 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.4 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.4 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 15.8 1.6 0.0 0.8 0.0 1.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.1 10.6 16.9 11.0 18.4 9.7 8.5 7.9 1.7 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188216 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 17.4;BJ hTERT+: 12.4;SCLC-21H: 11.2;SH-SY5Y: 9.0;U-2197: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4" "Lineage enriched" "Detected in single" 36 "T-cells: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" 27000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 7.5 5.8 2.9 9.0 3.4 1.1 10.4 10.3 16.4 12.4 2.3 1.6 4.1 1.7 6.5 8.2 2.9 10.5 7.1 3.3 4.0 3.8 2.5 6.6 3.7 11.8 6.9 4.2 2.8 3.4 16.7 27.4 13.6 10.5 4.7 2.0 14.7 3.9 9.0 1.9 7.1 3.8 3.2 2.2 7.3 4.1 2.0 1.1 8.7 14.9 5.5 9.5 3.6 10.4 0.0 0.5 0.0 0.0 0.0 18.5 3.5 0.0 0.1 17.4 0.0 1.9 1.4 0.0 3.8 12.4 4.2 6.6 0.0 0.1 0.0 0.1 5.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.8 0.9 0.0 0.0 1.3 0.1 7.0 0.0 1.0 0.0 0.0 1.4 0.0 0.4 0.0 0.4 0.3 0.0 0.0 4.4 0.2 0.0 11.2 9.0 0.0 0.0 0.5 0.4 0.1 3.6 0.6 0.5 18.0 0.5 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 18.5 0.2 0.0 0.0 16.2 0.5 0.0 0.0 0.0 0.5 17.4 3.5 2.9 3.4 10.3 16.4 4.0 3.8 6.9 4.2 10.5 1.1 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Cell line enhanced" "Detected in many" "HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.4 16.1 0.0 2.6 4.6 3.3 17.6 0.0 15.6 11.7 0.0 0.0 0.0 0.0 23.5 2.6 10.4 2.6 14.7 0.0 4.2 0.0 7.4 0.0 37.3 2.3 0.0 26.6 1.4 6.6 58.9 33.1 0.0 0.0 9.6 0.0 0.0 0.8 6.9 5.3 5.1 5.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 4.9 0.0 6.3 12.0 17.9 0.0 0.0 0.0 0.0 1.8 0.0 6.6 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell line enhanced" "Detected in some" "BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA012513, HPA055286, HPA077371" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA012513: AB_1848446, HPA055286: , HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.2 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 5.0 1.2 0.0 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: " "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavourable (9.82e-4)" "prognostic favourable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favourable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.5 7.3 3.4 5.9 1.4 1.7 25.7 4.3 1.1 2.8 1.7 13.4 2.6 6.9 7.6 1.3 8.6 3.6 2.2 0.9 6.0 18.2 8.8 4.2 10.1 2.9 9.2 9.7 1.6 4.1 2.8 1.8 2.6 19.2 1.5 1.1 11.7 12.0 34.2 9.2 13.0 19.0 3.8 4.8 2.2 4.3 13.7 10.6 4.1 6.5 5.2 7.1 9.6 4.2 3.1 7.8 5.8 5.4 9.3 4.8 4.5 3.4 9.3 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594165 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: " "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favourable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 6.0 6.0 12.5 8.1 13.0 7.4 4.9 10.2 15.8 5.9 11.7 9.3 4.2 7.3 5.1 3.4 7.2 9.2 7.5 5.7 11.4 9.3 5.4 4.8 6.2 10.4 9.7 7.2 6.8 17.4 9.9 11.3 6.2 7.9 5.2 5.3 6.2 8.2 6.8 3.4 3.6 8.0 3.7 10.5 8.9 14.1 20.1 9.9 21.2 9.4 1.8 6.2 6.3 19.4 3.8 0.6 2.2 0.5 2.4 4.6 0.5 7.6 11.4 3.4 5.9 2.9 3.0 9.9 1.7 3.3 1.7 1.9 11.9 10.2 10.6 2.1 2.0 5.5 2.7 4.2 0.3 17.5 12.8 13.1 3.2 3.8 3.8 9.9 9.6 4.7 2.0 3.1 2.6 3.0 5.3 30.3 2.0 8.5 9.9 4.9 14.1 4.7 8.7 5.4 6.7 2.7 7.2 6.4 6.3 4.2 6.7 6.6 5.2 8.2 4.2 3.8 11.8 4.7 6.2 3.6 3.8 13.1 8.0 5.9 5.7 2.2 0.5 0.0 0.4 0.4 0.4 0.9 1.4 1.5 0.6 3.8 1.5 0.7 1.1 2.4 0.5 0.6 4.6 0.5 12.5 13.0 10.2 15.8 11.4 9.3 9.7 7.2 7.9 9.9 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513798 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036049: " "unprognostic (2.86e-3)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 6.4 6.2 11.0 7.2 15.0 8.5 3.7 10.8 17.7 3.0 4.6 8.1 4.3 5.6 5.1 3.4 6.1 4.4 3.3 5.0 10.2 8.0 4.3 3.6 4.4 5.7 6.6 12.3 4.3 8.0 6.2 4.8 4.2 7.6 5.0 3.2 5.6 5.3 3.8 10.8 10.2 5.0 4.3 5.4 5.4 4.6 5.7 7.7 4.3 4.8 2.8 5.6 4.8 3.2 3.4 2.5 8.9 4.0 3.9 2.7 1.8 9.2 12.2 3.5 7.4 3.2 3.4 6.0 5.5 2.9 3.4 3.7 9.2 5.9 4.2 6.7 2.7 14.6 4.0 9.7 2.6 3.2 5.1 2.2 9.2 3.0 2.3 4.7 3.6 2.8 5.2 5.3 2.5 4.1 6.7 3.8 2.3 9.7 2.5 3.0 11.2 10.1 6.2 6.7 2.3 2.2 4.8 7.5 10.5 8.6 14.6 2.9 14.3 2.9 9.3 11.3 16.2 8.3 8.4 5.0 6.2 3.2 5.8 5.8 13.4 7.9 3.5 1.3 2.7 3.2 2.7 2.1 1.7 2.5 2.5 3.4 1.9 2.4 8.9 3.9 4.0 2.5 2.0 1.8 11.0 15.0 10.8 17.7 10.2 8.0 6.6 12.3 7.6 7.7 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: " "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favourable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 4.0 1.1 1.7 1.9 2.4 4.0 0.6 3.2 2.6 2.9 4.3 0.8 4.9 0.2 1.0 2.1 1.1 1.4 3.6 2.0 0.4 2.0 0.7 3.4 0.8 2.9 0.3 0.8 1.6 2.6 1.8 1.4 5.2 1.0 0.4 9.9 0.4 0.8 0.7 1.2 1.0 0.1 1.0 0.1 7.4 1.2 2.1 2.1 1.4 0.8 2.4 2.3 1.2 4.0 1.5 1.4 1.1 1.8 0.4 0.2 0.2 1.3 0.3 1.0 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 65.9;smooth muscle: 68.0" "Cell line enhanced" "Detected in many" "MCF7: 7.9;SCLC-21H: 9.0;U-937: 5.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA047624: , HPA054627: " "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 1.9 0.4 0.4 5.5 0.4 0.0 1.1 0.6 0.7 31.4 26.0 0.0 20.8 1.4 65.9 7.6 11.9 10.5 31.1 10.3 0.4 0.4 0.6 0.4 0.7 0.2 0.4 0.3 7.1 0.4 0.0 0.4 1.0 0.2 20.1 2.9 1.9 3.3 24.0 2.2 0.7 4.1 68.0 0.4 0.4 6.3 4.2 0.0 0.0 0.6 1.0 0.4 38.2 4.8 1.5 4.3 0.5 0.2 2.0 2.9 0.5 1.2 2.1 0.3 1.3 0.7 0.9 0.1 0.4 0.1 0.5 0.0 1.4 1.6 0.5 1.1 0.2 1.3 0.7 0.4 0.0 1.3 0.9 0.4 1.5 3.5 0.2 0.5 0.2 0.5 0.3 0.1 0.7 0.2 0.0 1.9 0.0 7.9 1.2 1.0 2.5 0.8 1.1 0.0 3.8 0.3 0.4 9.0 0.3 1.0 1.8 0.3 3.2 0.9 1.3 0.6 1.7 0.8 0.4 1.2 2.0 1.3 0.9 5.6 1.3 0.4 0.1 0.0 1.2 0.1 1.6 1.5 1.3 1.4 0.0 1.2 2.9 1.0 0.5 2.0 0.2 4.3 0.1 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.3 0.2 0.0 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavourable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 5.4 2.2 5.4 0.9 7.0 3.2 7.9 1.4 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 3.4 3.7 5.9 1.5 14.1 5.2 1.9 2.6 7.9 6.3 2.2 12.4 5.3 2.6 2.9 2.9 4.7 7.2 6.9 11.9 3.3 2.9 1.9 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 FBXO10 FBX10 ENSG00000147912 "F-box protein 10" Q9UK96 9 37510892-37576349 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.7;HHSteC: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.9" "Lineage enriched" "Detected in many" 5 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002863, HPA072721" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002863: AB_10965996, HPA072721: " "unprognostic (2.40e-1)" "unprognostic (2.43e-2)" "unprognostic (5.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.98e-1)" "unprognostic (3.44e-3)" "unprognostic (1.96e-2)" "unprognostic (1.80e-1)" "unprognostic (5.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.93e-5)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-1)" "unprognostic (2.74e-1)" "unprognostic (1.99e-1)" 3.8 7.5 4.8 7.5 8.3 1.2 3.4 4.4 12.1 3.6 6.7 4.9 6.3 2.8 5.0 16.9 4.7 2.8 4.5 4.3 6.3 5.9 3.9 4.0 3.5 7.7 4.0 6.7 3.1 7.4 6.4 20.8 3.1 3.9 4.0 2.9 5.3 15.0 5.2 27.0 2.9 4.8 5.0 3.1 10.1 3.6 12.2 3.3 2.9 11.7 6.0 7.7 4.5 2.9 5.9 0.8 0.0 0.2 0.2 1.1 0.5 1.6 4.0 17.7 4.5 8.3 3.0 1.4 3.1 5.5 3.8 5.8 2.3 1.1 10.3 1.0 3.3 0.1 6.4 1.5 2.8 5.7 5.1 2.0 3.8 1.9 25.4 5.4 0.7 6.7 1.2 3.5 2.3 5.4 7.1 2.9 6.8 1.4 2.1 1.8 8.1 1.5 4.0 7.7 1.3 2.2 1.1 3.7 9.4 2.0 2.4 2.2 1.0 5.6 4.3 2.8 4.8 2.4 2.1 3.5 2.8 1.7 2.3 2.1 2.6 0.0 0.1 0.0 0.7 0.2 0.7 5.9 1.1 0.7 0.0 3.2 0.1 0.1 0.0 0.2 0.2 0.8 0.2 0.5 4.8 8.3 4.4 12.1 6.3 5.9 4.0 6.7 3.9 3.3 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell line enhanced" "Detected in many" "AF22: 15.4;Karpas-707: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: , HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favourable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.0 2.5 15.4 6.0 0.4 0.0 0.4 0.1 0.6 2.4 4.5 2.4 3.6 4.6 5.6 0.1 4.1 1.7 2.5 2.3 1.8 2.9 2.2 0.2 1.3 0.3 2.6 1.6 0.2 8.3 0.6 2.5 0.0 0.8 17.8 1.0 4.1 0.3 3.6 3.3 3.5 0.1 3.6 7.1 3.2 2.1 10.0 4.2 0.3 2.5 6.7 10.7 4.5 0.5 1.3 4.7 2.7 2.2 3.9 3.4 3.9 5.2 0.6 2.7 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell line enhanced" "Detected in some" "CACO-2: 20.6;HBEC3-KT: 18.1;Hep G2: 43.2;SiHa: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005472: " "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favourable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.7 2.0 0.0 6.6 0.1 0.0 1.0 0.3 0.6 0.1 0.0 20.6 2.0 0.0 8.5 0.0 0.0 0.7 18.1 0.0 0.1 0.2 0.0 0.2 43.2 0.9 0.0 0.0 0.6 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.5 0.7 0.9 81.5 0.0 0.8 4.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114087-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Supported "Nucleoplasm,Focal adhesion sites" Nucleoplasm "Focal adhesion sites" "HPA003289: " "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 17.4 13.1 16.4 14.9 19.7 12.1 19.6 22.5 21.6 18.7 15.9 15.0 13.1 13.3 16.2 13.3 22.2 14.1 15.1 15.0 15.3 15.6 21.4 26.6 14.0 14.9 15.9 13.6 18.7 13.4 25.7 16.2 15.8 20.2 16.5 17.1 11.9 16.6 14.9 24.6 32.3 14.4 15.7 15.6 16.1 13.7 11.9 15.5 19.4 15.7 13.1 16.1 17.5 20.0 10.3 10.0 14.7 8.9 10.9 11.0 5.7 14.0 6.2 9.7 10.4 10.2 11.8 16.0 14.2 11.7 9.7 9.2 8.6 11.1 6.8 14.8 13.0 12.4 14.3 13.8 16.7 9.6 16.0 8.6 7.9 6.2 12.7 16.2 11.4 11.4 16.7 14.0 25.5 16.0 14.0 9.8 17.3 4.6 8.4 8.2 23.2 13.4 9.0 13.9 12.8 18.2 9.4 15.8 17.0 14.8 22.8 15.8 12.0 16.3 18.3 12.0 9.1 15.0 26.8 10.6 12.5 10.6 14.9 7.9 23.3 8.9 8.7 14.7 7.8 8.1 10.1 10.3 8.2 9.6 10.0 10.2 8.3 9.1 5.3 10.9 8.9 4.7 11.0 5.7 16.4 19.7 22.5 21.6 15.3 15.6 15.9 13.6 20.2 15.5 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002467: " "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favourable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 18.2 16.0 18.4 8.7 33.9 14.1 17.4 27.7 30.3 16.1 13.3 17.1 11.5 11.2 16.4 15.8 21.1 15.0 13.5 28.1 17.3 19.3 29.3 25.3 12.2 10.3 15.2 15.4 18.8 16.5 35.9 21.8 15.3 27.8 16.6 15.0 16.7 17.0 16.9 67.6 18.4 16.3 19.0 12.4 12.6 14.6 15.1 15.2 18.6 21.6 24.2 16.6 15.9 16.6 11.1 8.4 13.0 9.2 15.7 22.8 10.4 11.6 10.5 14.3 15.2 17.3 13.6 8.6 14.0 14.1 11.4 14.3 11.9 11.8 7.8 9.9 15.2 20.3 19.1 18.5 19.2 7.8 26.4 4.0 16.4 9.7 11.0 9.2 9.4 13.8 18.8 7.8 12.5 15.0 13.6 15.7 12.8 7.9 6.8 5.4 7.2 16.1 5.2 32.0 11.0 16.5 14.8 20.3 11.2 19.8 13.7 10.3 19.7 7.1 13.7 14.1 12.4 19.9 11.7 8.8 11.4 13.3 12.6 7.2 13.9 13.0 7.8 11.1 15.1 7.5 16.6 10.9 17.9 17.0 8.4 11.1 22.8 15.9 8.4 15.7 9.2 4.3 21.4 10.4 18.4 33.9 27.7 30.3 17.3 19.3 15.2 15.4 27.8 15.2 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favourable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.8 9.3 3.1 8.4 16.1 9.7 9.1 8.5 8.6 8.5 4.5 8.4 4.1 11.4 9.4 9.0 7.5 6.0 7.1 5.7 5.2 11.0 3.8 5.7 23.6 9.0 3.7 3.2 11.5 6.0 11.0 10.5 5.2 10.9 4.5 4.5 7.0 8.6 5.0 6.0 8.3 11.1 3.7 4.8 3.8 3.5 14.5 7.1 19.0 3.9 5.8 6.1 3.2 7.1 8.2 6.2 7.8 6.7 10.4 8.0 14.1 6.5 6.8 5.0 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Group enriched" "Detected in some" 5 "HDLM-2: 59.7;U-251 MG: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: " "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavourable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.8 0.3 0.0 0.0 3.8 0.9 0.6 0.3 4.0 0.2 0.4 0.0 1.0 0.0 1.1 2.9 0.1 0.0 0.3 0.3 59.7 1.4 0.0 2.1 0.0 5.2 0.0 0.2 7.7 2.6 0.9 1.1 0.2 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.6 0.6 0.1 0.4 0.4 6.8 6.9 6.6 0.1 0.2 1.1 0.3 0.4 17.9 6.2 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013109 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053865: " "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favourable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 4.0 7.8 8.9 1.9 12.6 1.9 7.3 4.1 12.2 6.7 2.8 11.9 4.7 3.2 5.4 8.9 3.8 21.7 3.9 2.9 8.3 9.1 10.3 3.7 4.9 2.1 8.1 6.9 6.8 3.7 11.7 11.7 3.6 10.1 6.4 3.0 9.3 5.0 5.8 2.0 6.1 3.2 3.9 8.9 2.1 3.7 14.0 5.2 2.7 14.8 2.8 2.7 2.9 3.3 2.8 3.6 0.8 1.7 2.7 4.5 1.2 1.2 2.5 3.0 1.2 1.5 9.2 6.0 1.6 4.2 2.2 3.9 0.8 4.0 0.1 0.8 2.8 1.0 1.4 0.8 3.9 0.3 0.9 0.5 0.9 1.5 5.9 1.0 0.4 9.7 6.8 4.3 3.3 2.3 1.7 0.7 2.6 5.1 2.1 2.4 7.9 2.9 2.6 0.8 0.6 4.0 1.0 2.9 3.7 2.6 2.1 1.0 4.4 1.8 1.7 3.7 1.4 6.0 0.6 2.7 2.2 0.9 4.6 0.5 2.7 0.1 1.7 0.1 2.5 1.3 2.1 2.8 1.9 1.7 3.6 2.0 4.5 2.5 0.8 2.7 0.9 1.7 3.5 1.2 8.9 12.6 4.1 12.2 8.3 9.1 8.1 6.9 10.1 5.2 FBXO38 "Fbx38, FLJ13962, MOKA, SP329" ENSG00000145868 "F-box protein 38" Q6PIJ6 5 148383935-148442836 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034821, HPA041444" Approved Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA034821: AB_10669897, HPA041444: " "unprognostic (7.72e-2)" "unprognostic (5.75e-3)" "unprognostic (1.95e-2)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-2)" "unprognostic (7.06e-2)" "unprognostic (5.43e-3)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (2.03e-1)" "unprognostic (6.29e-2)" "unprognostic (2.21e-3)" "unprognostic (1.31e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (4.70e-3)" 23.2 19.3 13.8 17.7 21.2 12.6 20.6 20.8 21.1 22.3 18.4 20.0 20.4 13.8 25.2 18.2 17.6 16.7 16.9 24.1 18.8 13.8 19.2 25.7 20.7 19.0 16.3 18.8 19.2 16.9 29.2 34.1 19.7 24.6 22.2 19.3 16.4 19.4 18.7 28.5 19.3 18.4 18.2 17.8 24.8 18.8 20.0 18.9 26.9 18.1 17.1 21.7 21.7 18.0 5.5 8.1 13.7 14.8 8.0 7.9 4.9 8.4 9.0 14.1 10.3 15.9 17.9 7.4 11.1 21.3 15.9 21.8 13.3 10.5 12.4 11.0 18.0 12.0 14.7 14.0 19.2 13.5 9.4 7.3 13.3 9.0 15.9 19.8 12.1 17.3 12.0 15.2 15.0 21.3 8.1 13.4 15.5 3.4 12.4 9.3 6.6 13.8 11.2 20.6 12.3 15.4 9.9 12.6 12.3 14.8 9.9 14.3 10.5 14.4 13.9 14.5 5.3 7.6 12.3 16.5 16.6 10.6 14.5 11.3 11.0 13.7 6.3 9.0 5.9 8.6 6.3 5.5 5.5 5.7 8.1 4.8 5.7 7.2 12.0 8.0 14.8 3.9 7.9 4.9 13.8 21.2 20.8 21.1 18.8 13.8 16.3 18.8 24.6 18.9 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "Daudi: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: , HPA058386: " "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavourable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.5 1.7 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.0 2.1 26.5 0.1 0.1 2.9 3.7 2.3 1.2 11.0 0.3 8.1 4.0 1.6 0.9 12.2 6.2 1.5 0.9 0.0 0.9 0.2 1.6 4.4 1.2 0.9 4.2 11.4 2.7 1.6 14.9 6.8 12.9 0.7 1.2 9.2 3.4 4.5 1.9 2.8 2.6 5.1 0.2 4.1 3.6 3.7 0.7 5.2 2.2 12.6 1.0 13.4 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA049390: " "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favourable (5.44e-4)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favourable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 6.9 10.8 8.4 9.8 2.2 3.9 9.6 3.7 2.0 2.9 3.4 9.0 9.2 12.1 5.0 2.0 10.1 6.2 4.6 2.2 14.9 13.1 9.8 36.6 4.8 3.3 4.4 12.7 3.3 4.2 4.9 3.1 4.3 7.7 14.8 2.4 6.6 10.0 5.1 5.3 3.8 13.6 4.7 11.2 3.4 8.4 8.4 7.4 5.8 12.3 4.8 10.4 5.4 4.9 6.2 5.6 3.4 6.0 14.2 19.6 8.1 6.9 6.2 5.0 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 FBXO7 "Fbx, FBX7, PARK15" ENSG00000100225 "F-box protein 7" Q9Y3I1 22 32474676-32498829 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032113, HPA032114, CAB034296" Uncertain Supported Nucleoplasm,Cytosol 430000 "Nucleoplasm, Cytosol" "CAB034296: AB_2102563, HPA032113: , HPA032114: AB_10696202" "unprognostic (3.99e-2)" "unprognostic (1.53e-1)" "prognostic favourable (1.08e-5)" "unprognostic (1.36e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.45e-2)" "unprognostic (2.28e-1)" "unprognostic (2.53e-1)" "prognostic favourable (2.66e-10)" "unprognostic (3.33e-2)" "unprognostic (1.65e-1)" "unprognostic (7.02e-2)" "unprognostic (1.79e-3)" 22.9 27.8 25.5 16.2 28.6 92.9 27.7 14.5 30.6 23.7 22.5 55.9 17.0 20.1 22.5 29.6 18.5 28.3 18.8 16.3 29.3 26.2 43.3 51.2 24.9 26.0 39.9 18.2 27.7 26.9 27.6 23.2 31.8 33.4 23.0 22.7 35.9 18.6 23.6 12.4 20.7 28.4 24.0 52.7 29.5 20.6 42.1 24.4 33.3 77.6 16.4 24.4 19.7 26.3 22.0 25.4 60.4 21.7 28.6 33.0 24.9 21.3 15.0 19.6 22.1 30.3 28.9 14.2 18.3 33.1 29.0 34.6 14.8 14.6 19.6 15.3 31.3 14.3 28.5 23.4 29.8 33.7 25.8 27.0 16.4 22.9 36.9 35.3 24.1 24.1 37.9 25.5 19.6 31.2 21.4 25.5 31.4 15.7 17.5 22.1 7.7 11.2 17.3 20.8 23.6 33.2 22.3 28.7 18.8 22.8 18.4 64.7 10.2 18.7 21.8 15.2 21.7 14.7 14.3 18.0 19.1 18.8 28.5 18.0 60.6 60.4 18.9 39.8 27.6 21.7 33.0 22.0 25.3 27.0 25.4 19.6 22.4 24.3 7.2 28.6 20.7 16.7 30.7 24.9 25.5 28.6 14.5 30.6 29.3 26.2 39.9 18.2 33.4 24.4 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174284264 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favourable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 16.8 18.5 13.5 9.2 14.1 7.3 16.4 19.4 14.0 15.6 17.3 14.0 10.7 13.4 13.1 19.5 16.4 15.1 13.1 19.1 13.3 12.0 20.2 43.5 11.8 9.5 14.6 10.1 15.7 22.6 16.5 26.9 27.1 14.3 16.8 15.3 14.7 13.3 13.1 7.4 16.0 18.9 18.8 14.7 13.9 14.7 10.0 14.0 18.2 19.9 6.5 12.4 20.6 18.2 12.6 8.6 19.2 8.9 9.8 15.5 7.8 4.7 3.2 6.5 2.2 14.6 16.0 5.1 9.7 8.9 6.4 6.5 2.5 8.4 3.6 9.2 6.3 3.0 4.3 5.6 6.8 10.8 9.8 3.2 5.3 3.9 11.1 4.3 3.5 9.2 13.9 5.9 7.8 6.4 6.7 18.8 8.4 4.7 4.5 4.5 1.8 3.4 2.6 4.3 5.7 10.0 2.0 6.0 39.3 4.3 7.6 10.7 4.3 4.7 7.3 3.8 3.6 10.7 5.4 9.7 4.6 3.1 12.7 3.1 5.2 19.2 6.2 12.7 12.3 7.8 15.5 12.6 14.2 12.1 8.5 10.7 13.5 11.8 6.2 9.8 8.9 8.6 15.0 7.8 13.5 14.1 19.4 14.0 13.3 12.0 14.6 10.1 14.3 14.0 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062578, HPA072204" Approved Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA062578: , HPA072204: " "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 15.0 17.1 28.1 11.5 29.4 7.9 17.2 29.7 34.4 17.5 11.2 24.7 9.4 10.2 19.2 10.7 20.0 22.7 14.5 30.3 28.9 26.3 19.5 16.5 14.0 14.0 28.8 20.1 21.8 24.1 37.8 15.8 11.2 23.3 16.2 13.3 12.4 11.6 18.1 24.5 11.0 10.3 21.6 30.6 13.6 15.8 11.3 21.2 12.0 17.5 7.0 17.0 12.9 16.0 9.0 8.2 19.1 7.0 12.9 6.2 5.5 16.2 16.7 24.9 21.7 19.6 19.9 12.7 17.5 25.1 21.9 27.6 17.0 11.0 14.9 21.6 22.4 10.7 17.9 26.4 36.6 19.7 17.7 12.1 17.4 13.1 17.8 13.4 17.3 14.4 18.4 17.6 28.9 18.3 7.5 15.1 26.6 12.2 9.3 7.0 9.5 18.6 13.8 20.9 10.1 16.9 13.8 10.4 18.4 15.4 13.1 32.3 16.4 14.4 15.8 21.7 10.8 13.1 17.2 15.4 17.4 10.4 15.2 12.9 16.5 19.1 7.0 6.5 5.7 4.7 6.2 8.7 4.9 5.7 6.9 9.0 4.7 5.8 6.7 12.9 5.1 8.2 5.3 5.5 28.1 29.4 29.7 29.9 28.9 26.3 28.8 20.1 23.3 21.2 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell line enhanced" "Detected in all" "U-266/70: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 3.9 10.2 7.4 7.1 5.1 8.4 7.1 6.5 4.4 4.2 7.9 6.3 12.7 2.0 6.8 2.9 8.7 16.0 6.2 7.2 4.1 5.9 4.8 5.6 7.2 14.4 5.4 8.1 25.3 7.6 12.9 7.7 9.3 13.6 5.5 6.9 16.5 5.7 5.0 3.1 16.6 4.3 2.5 5.4 8.5 6.5 5.6 4.5 6.2 3.9 3.4 6.8 8.1 6.0 6.8 3.1 4.0 37.4 21.3 12.4 4.8 4.7 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 FCGBP FC(GAMMA)BP ENSG00000275395 "Fc fragment of IgG binding protein" 19 39863323-39934626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9" "Cell line enhanced" "Detected in some" "A549: 9.7;Daudi: 3.0;RH-30: 10.9;RPMI-8226: 3.8;U-266/70: 3.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003517, HPA003564" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytokinetic bridge" "Plasma membrane" "Golgi apparatus, Cytokinetic bridge" "HPA003517: AB_1078838, HPA003564: AB_2231648" "unprognostic (1.65e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-3)" "unprognostic (1.77e-2)" "unprognostic (2.04e-2)" "prognostic favourable (1.28e-5)" "prognostic unfavourable (4.74e-5)" "unprognostic (1.36e-2)" "unprognostic (1.83e-1)" "prognostic unfavourable (9.70e-6)" "unprognostic (9.44e-2)" "unprognostic (3.03e-2)" "unprognostic (5.92e-3)" "unprognostic (8.60e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (4.27e-4)" "unprognostic (2.08e-1)" 1.7 0.6 1.7 5.9 1.8 0.0 2.7 0.2 1.6 13.9 43.3 0.8 0.7 15.2 0.2 0.4 0.2 0.0 46.6 0.7 0.6 0.6 0.2 0.6 0.2 0.9 0.6 0.6 0.2 0.0 1.2 1.5 1.1 0.4 16.7 0.3 1.3 1.2 0.2 2.8 16.9 0.2 2.1 0.2 17.0 0.4 0.9 0.5 20.9 0.2 0.5 0.2 0.2 0.6 2.3 0.0 0.9 1.3 3.2 0.6 0.0 9.7 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.3 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.4 2.8 1.2 0.3 0.7 0.2 10.9 3.8 0.2 1.3 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.6 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.9 0.3 0.0 0.7 1.4 2.3 0.6 0.9 3.2 0.0 1.3 0.5 0.0 0.2 0.6 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 182.8" "Cell line enhanced" "Detected in some" "HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 182.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 182.8" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" 55000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: " "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavourable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 36.8 12.6 13.2 44.6 19.2 18.6 8.2 2.2 10.1 9.1 7.1 10.0 0.0 3.8 4.7 6.6 5.5 11.6 17.0 11.3 17.0 8.9 11.5 7.1 44.1 50.0 25.9 1.7 8.0 5.8 2.8 6.1 47.5 19.6 7.0 9.9 10.8 8.3 4.8 7.3 3.0 7.3 17.6 30.9 43.4 5.9 4.8 19.2 3.2 6.3 2.5 4.4 19.3 4.5 0.2 7.0 182.8 27.2 0.0 0.0 10.6 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.2 0.0 0.3 4.0 28.2 0.3 0.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.2 7.9 0.0 0.6 0.1 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 30.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 12.9 3.5 0.1 27.2 31.6 0.0 20.7 0.0 0.2 0.0 0.0 7.0 0.1 0.0 0.0 182.8 0.0 16.7 0.2 0.0 10.6 13.2 19.2 2.2 10.1 17.0 8.9 25.9 1.7 19.6 19.2 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell line enhanced" "Detected in many" "Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: " "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 27.9 8.0 0.2 1.1 1.7 1.0 0.1 12.3 0.9 2.2 0.7 2.8 0.3 6.9 4.7 0.0 0.1 0.1 0.2 0.7 10.9 13.4 0.0 7.7 15.8 12.4 1.7 13.3 13.5 0.1 19.2 0.1 0.5 0.6 1.3 0.1 2.8 0.4 2.7 6.9 0.5 0.1 2.0 0.5 0.2 8.5 3.8 15.1 0.4 17.2 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 FCHO2 ENSG00000157107 "FCH domain only 2" Q0JRZ9 5 72955981-73090522 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.9" "Group enriched" "Detected in many" 8 "granulocytes: 15.9;monocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037685, HPA037686, HPA077850" Enhanced Approved Vesicles,Centrosome,Cytosol Centrosome "Vesicles, Cytosol" "HPA037685: AB_2675610, HPA037686: AB_10673636, HPA077850: " "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "unprognostic (1.01e-2)" "unprognostic (1.10e-1)" "unprognostic (6.59e-2)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (6.25e-2)" "unprognostic (1.31e-1)" "unprognostic (5.67e-2)" "unprognostic (6.56e-3)" "unprognostic (1.21e-1)" "prognostic favourable (7.00e-5)" "unprognostic (1.43e-1)" "unprognostic (3.27e-3)" "unprognostic (9.59e-2)" "unprognostic (1.76e-1)" 32.2 9.6 10.7 10.0 12.2 8.3 18.0 23.1 18.3 16.2 18.3 8.9 15.3 15.5 23.7 13.0 30.2 14.6 15.7 12.5 11.2 7.0 18.6 16.0 22.8 18.5 10.8 9.5 16.1 11.1 17.5 11.4 19.2 10.9 12.6 16.1 9.9 17.1 12.6 17.7 15.2 20.8 16.6 11.9 18.9 12.2 10.5 12.4 3.2 22.4 11.7 11.8 14.6 22.5 0.7 1.1 15.9 4.5 0.7 1.3 0.5 9.0 7.4 7.1 6.2 10.0 13.3 20.9 8.0 11.9 6.1 9.6 3.7 15.9 2.2 11.3 11.1 6.9 6.0 14.1 8.3 2.3 7.0 4.4 6.1 4.6 5.0 0.9 4.6 8.9 7.3 8.2 13.1 13.8 5.0 3.9 12.5 4.2 0.0 4.4 2.2 3.7 2.0 6.9 2.6 14.8 12.9 2.8 4.5 11.0 7.8 5.0 9.5 6.3 14.3 8.0 3.8 8.8 5.6 1.4 2.5 0.4 5.2 0.6 9.8 11.5 2.6 6.4 1.3 3.5 0.8 0.3 0.4 0.5 1.1 0.7 0.2 0.4 15.9 0.7 4.5 0.4 0.3 0.5 10.7 12.2 23.1 18.3 11.2 7.0 10.8 9.5 10.9 12.4 FCHSD1 FLJ00007 ENSG00000197948 "FCH and double SH3 domains 1" Q86WN1 5 141639302-141651419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043795 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043795: AB_10963435" "prognostic favourable (8.62e-4)" "unprognostic (4.08e-2)" "unprognostic (6.17e-2)" "unprognostic (5.28e-2)" "unprognostic (3.50e-3)" "unprognostic (8.56e-3)" "unprognostic (5.34e-2)" "unprognostic (9.61e-3)" "unprognostic (2.17e-2)" "unprognostic (2.66e-2)" "unprognostic (1.88e-3)" "unprognostic (1.50e-2)" "prognostic unfavourable (6.19e-6)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.77e-4)" "unprognostic (4.12e-3)" "prognostic favourable (1.21e-4)" 7.5 6.6 9.2 16.1 14.1 15.2 8.6 3.0 12.5 11.7 9.9 11.1 4.9 9.7 12.5 8.6 8.6 8.5 13.7 5.4 8.8 6.6 6.8 2.9 9.6 18.6 18.8 4.3 17.7 7.5 23.8 12.6 7.9 14.5 10.0 4.8 5.6 10.3 6.1 2.6 18.5 15.3 8.8 14.5 18.4 10.5 7.4 15.4 7.4 10.6 8.8 23.2 12.1 13.8 5.3 1.9 9.8 3.0 2.3 7.2 2.9 7.3 4.6 6.2 13.0 5.3 6.7 11.0 15.9 8.2 14.3 22.6 8.6 15.7 3.0 8.0 12.2 4.2 2.0 8.8 6.4 12.9 3.3 6.4 6.1 3.1 4.1 2.0 21.7 8.2 7.0 11.2 3.7 8.2 3.9 5.8 1.6 6.5 1.6 3.9 1.8 4.3 0.0 0.0 2.9 4.9 11.0 0.7 7.0 0.3 6.0 9.1 7.3 6.1 16.5 0.2 4.0 5.8 6.6 7.0 2.3 1.6 12.5 7.2 6.8 6.3 1.7 5.6 7.0 2.0 5.2 5.3 3.8 7.2 1.9 3.0 3.6 4.9 9.8 2.3 3.0 1.7 5.0 2.9 9.2 14.1 3.0 12.5 8.8 6.6 18.8 4.3 14.5 15.4 FCHSD2 "KIAA0769, SH3MD3" ENSG00000137478 "FCH and double SH3 domains 2" O94868 11 72836745-73142261 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038545, HPA038546" Uncertain Approved "Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites" "Nuclear speckles, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA038545: , HPA038546: AB_10673013" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "prognostic favourable (1.71e-4)" "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.62e-3)" "unprognostic (1.41e-2)" "unprognostic (2.62e-1)" "unprognostic (1.27e-2)" "unprognostic (2.56e-1)" "unprognostic (3.69e-2)" "unprognostic (6.16e-2)" "unprognostic (2.89e-3)" "unprognostic (2.02e-1)" "unprognostic (4.70e-1)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" 18.5 15.1 28.4 41.5 27.8 19.0 26.5 16.9 25.2 13.2 11.4 17.0 6.8 7.0 12.7 10.2 9.7 11.5 18.1 19.2 24.8 21.4 10.6 13.3 26.2 31.7 19.7 12.1 26.3 9.2 10.2 7.6 24.1 17.6 11.2 11.2 12.5 11.1 11.7 7.4 7.0 14.4 16.4 15.6 30.8 10.1 17.4 26.3 19.2 11.9 4.8 33.0 17.9 11.3 16.8 19.0 11.6 4.8 1.1 2.4 2.0 5.1 4.4 9.1 11.9 3.7 9.3 8.5 9.1 19.5 5.6 4.7 3.4 7.5 27.9 11.2 11.7 7.4 5.3 5.3 7.5 9.6 2.7 22.5 5.0 11.2 9.6 11.0 2.9 5.6 5.8 5.5 6.7 13.4 4.9 18.2 7.2 5.5 13.3 18.9 2.0 5.4 20.3 14.2 53.2 8.8 6.9 4.6 6.5 3.3 6.2 11.9 4.5 8.1 17.2 18.0 6.9 12.5 2.8 17.5 9.7 24.8 3.1 18.3 5.2 11.0 4.8 10.5 1.7 3.1 1.2 13.0 1.8 2.0 4.8 16.8 2.1 2.4 11.6 1.1 1.6 19.0 1.8 2.0 28.4 27.8 16.9 20.2 24.8 21.4 19.7 12.1 17.6 26.3 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in some" 5 "RPMI-8226: 51.7;U-266/70: 26.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favourable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 7.2 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.2 51.7 0.0 0.1 0.0 0.0 1.0 0.2 4.8 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.1 1.9 7.2 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 35.6 19.4 71.3 25.7 16.7 61.3 25.4 17.0 33.7 27.2 44.3 31.4 84.9 27.2 41.4 14.9 39.8 42.4 147.8 25.5 14.8 30.4 15.8 34.6 37.8 27.5 25.5 18.1 43.6 23.4 43.2 21.7 47.3 28.1 73.3 28.3 38.3 32.6 24.8 42.8 28.4 28.2 30.9 75.4 71.6 23.8 27.7 23.7 17.5 31.9 29.4 23.0 69.4 34.4 15.2 18.7 9.4 31.1 31.1 23.9 48.5 14.8 27.2 23.9 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 FDXACB1 "hCG_2033039, LOC91893" ENSG00000255561 "Ferredoxin-fold anticodon binding domain containing 1" Q9BRP7 11 111874056-111881243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039012, HPA061375" Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039012: AB_10670916, HPA061375: " "unprognostic (2.91e-2)" "unprognostic (3.32e-3)" "unprognostic (1.32e-2)" "unprognostic (6.81e-7)" "unprognostic (1.32e-1)" "unprognostic (9.64e-2)" "unprognostic (2.05e-1)" "unprognostic (7.11e-3)" "unprognostic (3.95e-2)" "unprognostic (7.42e-2)" "unprognostic (3.67e-1)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (6.57e-2)" "unprognostic (4.42e-1)" "unprognostic (4.61e-2)" "unprognostic (1.79e-2)" 3.7 6.7 4.4 6.2 5.2 4.0 5.8 2.2 6.1 4.4 3.2 4.7 3.1 4.0 3.9 6.0 3.9 3.7 5.0 2.8 6.6 4.7 3.4 4.3 5.2 8.5 3.6 3.4 4.3 5.1 5.3 3.6 3.0 5.2 3.4 4.2 4.1 6.2 2.2 1.6 6.6 4.3 3.0 5.3 7.6 3.2 11.1 4.0 11.2 3.4 2.6 7.9 4.2 2.7 6.5 4.8 1.8 4.6 5.6 10.4 4.5 1.6 2.1 3.0 6.0 2.2 2.0 1.4 1.2 1.3 1.3 1.6 2.6 3.6 5.8 3.3 1.1 4.8 2.7 2.7 2.9 7.4 1.3 6.7 1.1 2.1 1.3 6.7 5.9 1.7 1.6 1.9 2.4 2.3 4.6 7.8 2.5 2.2 6.4 6.5 1.6 3.1 4.0 1.9 7.2 3.0 2.9 1.4 2.0 1.8 3.5 1.8 5.1 4.1 1.8 3.2 3.2 3.6 2.8 3.9 5.7 16.0 1.8 9.9 4.1 0.2 3.2 1.8 6.8 4.6 9.0 6.5 6.1 6.2 4.8 5.2 9.4 10.4 0.9 5.6 3.8 4.6 3.2 4.5 4.4 5.2 2.2 6.1 6.6 4.7 3.6 3.4 5.2 4.0 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: " "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.2 5.3 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.4 8.2 4.5 5.4 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 5.0 11.7 15.8 4.8 7.3 11.0 4.9 14.5 12.2 10.3 6.1 8.7 6.3 9.3 15.3 10.9 5.7 10.8 8.1 8.3 11.5 7.0 6.5 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.6 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 FEM1B ENSG00000169018 "Fem-1 homolog B" Q9UK73 15 68277803-68295865 "Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041920, HPA042192" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041920: AB_10796788, HPA042192: AB_10796574" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-1)" "unprognostic (6.84e-2)" "unprognostic (1.89e-2)" "unprognostic (3.49e-3)" "unprognostic (1.35e-1)" "unprognostic (2.89e-2)" "unprognostic (4.67e-2)" 13.4 10.5 13.1 11.2 17.0 38.1 17.7 23.0 22.9 14.8 14.6 14.1 13.6 11.1 23.2 12.6 18.5 14.1 11.1 16.9 13.7 13.7 10.4 14.6 11.9 14.2 17.8 16.1 17.4 8.5 14.0 12.9 13.7 17.2 15.0 12.4 12.4 12.3 16.6 42.9 18.7 14.2 22.3 14.3 11.9 10.4 55.4 15.4 12.9 12.9 11.4 13.1 18.7 17.8 4.4 4.4 4.0 7.9 6.5 6.9 3.0 7.2 13.4 13.8 13.0 12.6 11.7 9.3 10.4 10.9 10.7 9.9 9.0 9.8 16.8 7.6 14.1 26.5 28.7 13.1 9.0 8.0 11.4 18.4 15.9 5.7 10.9 14.9 11.5 10.7 28.8 13.0 31.6 8.4 15.4 20.6 9.1 8.5 10.7 7.7 14.1 4.3 15.5 15.6 21.6 6.9 26.5 18.6 11.7 10.7 11.2 28.8 10.0 14.0 10.9 18.8 16.5 6.5 9.5 13.5 28.9 17.9 10.7 16.4 11.1 0.0 5.1 3.6 5.7 7.9 5.8 3.7 5.7 6.2 4.4 4.4 6.9 5.0 4.0 6.5 6.3 3.2 3.0 3.0 13.1 17.0 23.0 22.9 13.7 13.7 17.8 16.1 17.2 15.4 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavourable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favourable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavourable (5.73e-6)" "prognostic favourable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.0 28.6 31.4 16.9 3.1 3.9 20.0 27.5 15.7 33.7 38.4 25.0 23.4 44.9 21.5 11.7 32.9 44.2 24.1 34.6 23.6 24.3 23.7 39.1 25.4 2.4 36.8 24.5 2.7 3.3 31.1 8.3 13.1 35.8 32.5 28.0 39.1 51.2 33.1 34.5 28.1 35.2 36.4 46.3 13.4 29.5 35.8 29.7 18.3 24.1 15.8 34.9 25.9 8.8 30.0 37.9 38.2 27.7 25.7 39.9 46.6 20.9 24.7 25.8 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 FERMT2 "KIND2, mig-2, PLEKHC1, UNC112B" ENSG00000073712 "Fermitin family member 2" Q96AC1 14 52857268-52952435 "Predicted intracellular proteins" "Cell adhesion, Cell shape, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "MAIT T-cell: 3.8" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040505 Uncertain Supported "Nucleoplasm,Focal adhesion sites" 58000 "Nucleoplasm, Focal adhesion sites" "HPA040505: AB_10673300" "unprognostic (4.38e-2)" "unprognostic (4.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "unprognostic (4.89e-3)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.58e-1)" "unprognostic (1.99e-1)" "unprognostic (3.87e-2)" "unprognostic (3.96e-3)" "unprognostic (7.69e-2)" "unprognostic (3.14e-1)" "unprognostic (1.73e-3)" 45.9 7.2 15.5 12.3 14.3 0.1 24.4 7.9 12.8 24.1 36.6 12.7 16.0 4.2 41.6 14.2 20.6 22.2 22.2 21.8 18.3 7.5 18.4 35.3 18.1 5.4 15.0 9.1 23.3 6.7 5.8 7.2 37.9 10.7 24.1 11.5 11.0 7.1 41.3 14.5 5.0 11.0 56.7 12.9 11.7 21.4 10.2 15.5 0.6 13.3 6.2 2.1 49.5 16.5 0.0 0.0 0.0 0.0 0.0 3.8 0.0 4.8 4.2 22.5 10.3 36.8 30.3 18.7 32.2 20.9 38.3 24.2 7.2 3.8 0.0 11.0 32.9 2.0 17.5 2.4 28.8 0.0 4.9 6.7 19.3 8.5 47.3 0.1 2.8 29.1 5.1 21.0 28.0 19.8 0.1 33.9 28.6 5.8 1.6 0.1 14.2 11.1 0.8 22.9 0.0 13.4 4.4 1.3 28.9 34.1 7.6 7.9 6.6 0.2 24.6 30.2 20.7 23.9 11.9 5.0 6.0 0.1 6.9 0.0 7.2 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 14.3 7.9 12.4 18.3 7.5 15.0 9.1 10.7 15.5 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell line enhanced" "Detected in many" "HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.5 1.0 3.1 6.0 0.9 0.0 1.7 1.0 0.8 0.0 2.2 0.1 2.0 0.5 0.6 0.1 0.5 1.1 0.3 20.9 0.0 3.7 2.0 18.6 39.8 3.0 0.0 2.6 0.0 10.5 0.6 0.0 0.0 6.8 0.5 24.4 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 0.0 36.6 8.3 0.0 3.6 0.1 0.0 0.0 2.6 0.8 0.1 15.8 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125445745-125496317 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.4" "Cell line enhanced" "Detected in many" "AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Supported Microtubules,Cytosol Microtubules Cytosol "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavourable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 6.6 5.6 48.3 4.4 50.1 1.3 4.3 28.2 121.4 6.4 5.1 58.8 0.2 2.9 6.9 4.0 5.9 4.1 9.4 12.4 54.2 38.2 2.7 7.4 10.0 3.5 68.2 29.8 6.0 1.4 5.0 2.3 6.0 43.4 6.6 5.3 1.4 2.4 12.9 1.7 3.5 3.5 13.0 123.4 3.9 2.5 7.2 51.4 0.0 2.2 0.0 2.9 16.8 2.1 0.0 0.4 2.1 0.5 1.0 30.8 5.0 0.0 0.0 39.9 0.0 26.3 24.0 0.0 6.2 8.0 1.5 0.3 0.0 0.0 0.0 7.3 11.7 0.1 18.1 38.6 0.8 3.2 0.2 18.3 0.0 0.0 22.2 0.0 0.1 19.6 8.9 7.2 19.1 17.6 2.4 0.2 1.9 0.9 0.1 0.0 36.5 0.4 0.0 0.0 0.0 0.0 14.0 39.0 4.1 0.1 0.0 0.6 2.9 17.9 15.8 0.1 1.0 0.0 5.2 0.4 0.1 0.0 4.3 0.0 16.8 2.1 0.5 0.0 30.8 0.1 18.0 0.0 1.1 8.9 0.4 0.0 0.4 7.7 0.6 1.0 0.0 0.0 0.0 5.0 48.3 50.1 28.2 97.4 54.2 38.2 68.2 29.8 43.4 51.4 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavourable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 31.7 23.4 28.7 12.0 25.3 8.1 18.6 20.1 31.2 18.3 17.2 28.0 6.0 13.1 20.4 13.1 20.4 13.1 14.6 28.5 26.1 22.6 21.4 18.4 16.5 13.1 27.6 21.6 18.3 6.8 14.2 8.5 29.6 29.3 15.6 18.4 19.0 9.7 22.1 51.0 9.1 18.7 26.9 33.8 17.8 12.2 12.6 25.4 9.4 14.8 12.2 12.1 15.5 13.5 1.7 13.6 4.7 3.5 3.1 1.5 0.7 15.3 9.2 12.6 5.3 24.9 33.0 9.9 39.1 20.0 24.0 15.2 6.4 5.0 9.5 24.0 50.6 6.1 10.6 13.5 26.2 2.2 5.8 7.7 3.3 10.6 11.9 7.7 1.9 31.6 11.6 14.8 17.8 34.2 8.3 3.0 44.2 5.4 4.7 6.7 6.6 14.5 3.1 11.4 3.2 19.0 15.0 0.3 11.4 9.6 7.9 9.3 2.8 9.7 39.7 15.0 8.0 8.2 22.7 2.2 2.6 6.5 14.9 5.4 21.1 2.4 3.5 4.7 1.5 3.3 1.0 1.7 1.1 0.8 3.6 1.0 1.3 0.5 4.0 3.1 1.9 13.6 1.3 0.7 28.7 25.3 20.1 28.8 26.1 22.6 27.6 21.6 29.3 25.4 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Group enriched" "Detected in some" 10 "NTERA-2: 57.4;SCLC-21H: 25.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in single" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064639: , HPA073693: " "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 57.4 1.0 0.0 0.0 0.0 0.0 0.1 25.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496166 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000911 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA000911: AB_1078853" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 5.9 7.7 15.6 5.9 10.9 1.6 7.1 16.3 15.6 12.3 7.2 3.7 3.4 4.5 12.4 4.4 9.3 7.6 7.8 9.2 9.6 7.1 5.1 1.9 4.6 4.0 4.8 11.2 13.7 6.9 6.9 5.4 9.4 5.7 6.5 3.8 6.8 7.7 7.9 3.3 11.8 5.5 11.9 3.7 5.8 5.2 4.6 4.8 0.0 5.6 7.3 4.3 7.6 7.8 1.6 0.6 0.5 2.6 1.2 3.2 1.1 13.8 5.9 11.4 14.9 5.3 9.5 5.5 8.3 8.4 7.0 5.7 1.8 1.2 0.8 6.8 12.8 5.4 9.6 5.9 3.9 1.4 8.4 0.5 4.5 2.1 5.7 0.7 0.5 7.7 3.7 10.7 5.1 6.3 2.2 0.5 5.5 2.9 1.6 1.5 11.2 9.3 8.0 6.5 0.5 6.0 0.8 10.6 10.0 9.1 0.8 13.7 10.0 1.2 6.1 8.8 7.8 19.3 7.6 1.0 2.0 1.5 9.7 1.6 4.8 0.0 0.6 0.5 2.0 1.3 2.0 1.5 1.6 2.2 0.6 1.6 3.2 1.8 0.0 1.2 2.6 0.2 1.4 1.1 15.6 10.9 16.3 15.6 9.6 7.1 4.8 11.2 5.7 4.8 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947451-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.2;lymphoid tissue: 48.1" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;Karpas-707: 28.7;RT4: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA020963: , HPA021018: " "unprognostic (5.66e-3)" "prognostic favourable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favourable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 3.1 1.5 2.3 20.5 2.5 23.4 3.5 0.5 1.6 1.8 3.1 3.1 1.6 1.9 2.8 2.5 2.8 2.5 3.1 1.5 2.2 2.0 4.6 2.1 7.5 30.5 3.3 1.0 1.1 5.7 0.1 1.0 2.6 2.6 3.2 1.4 2.2 6.6 1.0 0.7 3.1 10.1 1.5 6.3 28.1 2.6 3.9 2.5 48.1 3.5 2.1 25.8 7.7 3.2 11.3 10.3 49.2 24.7 10.5 15.7 17.1 6.3 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.9 4.4 5.1 0.2 0.0 4.1 0.3 0.0 0.0 8.8 0.0 8.1 0.0 0.3 0.0 2.1 20.7 0.0 0.1 0.0 0.0 0.0 0.3 28.7 0.0 10.6 9.4 9.0 0.2 0.5 9.4 0.0 7.2 0.0 16.3 0.6 0.2 0.0 7.0 0.2 2.7 9.5 0.0 0.0 0.3 0.0 0.0 2.9 2.9 2.4 1.5 4.5 0.0 34.0 13.4 36.7 15.1 17.3 15.5 8.5 15.6 14.1 10.3 11.3 15.7 13.3 49.2 10.5 24.7 4.7 13.5 17.1 2.3 2.5 0.5 1.6 2.2 2.0 3.3 1.0 2.6 2.5 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell line enhanced" "Detected in some" "AF22: 11.6;NTERA-2: 7.9;SCLC-21H: 18.6;U-251 MG: 11.1;WM-115: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA071557: " "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.6 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.6 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 4.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 3.2 0.0 0.0 7.9 0.2 0.0 0.1 0.0 3.6 1.3 18.6 0.0 0.0 0.4 0.0 0.8 0.1 0.3 4.8 2.5 0.0 11.1 0.1 1.8 0.0 1.0 0.0 13.4 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 FGF2 FGFB ENSG00000138685 "Fibroblast growth factor 2" P09038 4 122826708-122898236 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 56.5;BJ hTERT+: 33.1;fHDF/TERT166: 61.3;hTERT-HME1: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000125, HPA065502" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Secreted in other tissues" "Nucleoplasm, Nuclear bodies" "CAB000125: , HPA065502: " "unprognostic (1.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-1)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (2.82e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (9.85e-4)" "unprognostic (3.37e-1)" "unprognostic (4.61e-3)" "unprognostic (2.36e-1)" "unprognostic (1.81e-1)" "unprognostic (4.45e-2)" "unprognostic (3.45e-3)" 28.1 3.8 19.4 6.9 21.3 0.7 12.1 6.5 15.3 10.2 14.2 10.3 1.9 2.6 17.9 6.3 6.4 10.1 9.4 5.6 17.1 11.0 5.5 2.9 8.3 2.5 9.9 10.7 16.8 2.4 10.1 4.0 8.1 18.6 10.3 5.6 7.5 4.6 11.9 2.0 2.3 4.1 16.2 17.3 1.9 7.6 3.0 12.3 0.0 3.1 3.8 2.7 7.5 14.5 0.8 0.8 0.5 0.5 0.3 1.0 0.0 1.2 3.1 1.7 6.8 4.3 7.2 0.0 56.5 33.1 23.7 13.8 0.0 0.1 0.0 6.6 61.3 0.2 1.8 0.1 23.9 4.4 0.8 0.0 6.4 0.0 12.8 0.3 0.0 3.9 0.3 23.4 33.8 2.6 1.7 1.9 6.1 0.0 0.0 0.0 5.1 1.3 0.0 0.9 0.0 7.5 0.0 1.0 0.9 10.9 0.0 0.4 0.0 0.1 2.3 19.6 3.8 7.2 4.8 3.3 3.6 0.0 5.6 0.0 2.0 0.5 0.5 0.4 0.3 0.4 0.2 0.4 0.5 0.4 0.2 0.8 0.7 1.0 0.4 0.3 0.4 0.8 0.7 0.0 19.4 21.3 6.5 15.3 17.1 11.0 9.9 10.7 18.6 12.3 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell line enhanced" "Detected in some" "BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: " "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 1.9 7.1 0.0 19.7 37.4 5.2 3.8 0.0 0.0 0.0 0.0 26.9 0.0 0.0 6.9 28.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 2.0 0.0 15.3 7.3 1.7 0.0 0.1 25.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 6.4 34.9 1.4 1.7 16.7 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423096-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 23.7;ASC TERT1: 21.8;fHDF/TERT166: 9.8;HSkMC: 22.2;RH-30: 17.6;U-138 MG: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 9 "cerebellum: 9.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 39.7 2.7 0.6 9.9 0.6 0.0 16.5 0.6 2.4 73.3 22.2 0.0 10.1 1.1 13.1 16.1 25.2 14.1 25.4 19.1 0.6 0.6 5.9 1.2 44.8 5.5 2.1 0.0 43.7 2.5 2.9 2.8 9.1 0.8 42.5 4.5 2.7 6.4 8.1 25.6 3.6 4.2 38.3 1.4 1.0 6.6 12.7 0.0 0.0 23.2 24.7 2.9 72.2 32.4 0.2 0.1 1.6 0.2 0.3 0.5 0.0 0.1 0.0 0.1 0.1 23.7 21.8 0.0 7.2 4.4 0.0 0.0 0.0 0.1 0.0 0.1 9.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.0 0.1 0.0 22.2 0.4 1.9 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.1 0.0 17.6 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.1 0.1 0.1 12.0 0.2 0.4 0.0 0.2 0.1 0.0 3.3 0.0 0.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.1 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.6 2.1 0.0 0.8 0.0 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell line enhanced" "Detected in some" "AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favourable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.0 57.8 0.0 0.0 19.4 0.1 0.0 0.0 0.0 15.1 0.3 0.0 4.1 0.9 17.4 18.7 4.0 0.0 0.0 4.0 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.5 0.0 0.0 0.0 2.2 5.6 4.9 0.1 0.1 0.1 10.6 0.0 15.5 0.0 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.4" "Cell line enhanced" "Detected in many" "HDLM-2: 26.2;RH-30: 18.2" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054971 Approved "Nucleoplasm,Nuclear bodies" 110000 "Nucleoplasm, Nuclear bodies" "HPA054971: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.5 10.3 5.4 6.5 5.7 1.4 4.6 23.2 5.5 4.9 5.1 4.4 10.1 4.9 9.6 26.1 4.5 7.0 8.6 7.6 3.7 5.0 13.0 45.4 7.8 5.2 6.2 3.3 3.8 8.4 9.9 7.4 2.7 4.4 5.7 4.7 6.8 7.6 8.8 26.0 3.7 7.6 6.3 3.0 3.4 3.8 2.9 3.4 4.5 5.4 4.3 6.9 6.2 3.7 8.2 3.6 3.9 4.8 4.7 8.0 3.0 2.8 0.8 6.0 2.4 3.0 10.6 0.5 2.5 4.2 1.4 2.2 0.0 2.2 3.3 8.1 6.7 1.2 1.0 7.4 3.1 26.2 0.7 2.3 1.9 5.3 7.8 1.3 1.5 14.9 6.3 3.1 4.9 2.8 1.6 2.1 9.5 3.2 1.7 1.9 3.7 3.2 4.0 18.2 1.2 8.0 5.4 4.6 2.0 3.5 2.0 7.2 1.7 1.4 2.7 2.4 1.8 2.8 1.7 4.8 1.7 2.8 8.2 5.5 2.2 2.6 2.2 2.2 5.4 2.3 5.0 8.2 2.6 6.6 3.6 6.8 4.8 8.0 3.9 4.7 4.8 1.8 4.5 3.0 5.4 5.7 23.2 5.5 3.7 5.0 6.2 3.3 4.4 3.4 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Group enriched" "Detected in some" 4 "Daudi: 29.4;U-266/70: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 54.6 0.7 2.2 0.0 6.7 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad" P49789 3 59749310-61251459 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 11.9;U-266/70: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "naive CD4 T-cell: 38.3" "Lineage enriched" "Detected in all" 14 "T-cells: 38.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favourable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 6.4 24.0 13.7 8.0 17.5 9.0 12.1 4.7 13.3 7.9 8.0 21.0 12.4 8.2 6.2 9.5 5.1 9.2 13.0 14.9 15.3 13.8 30.9 10.7 5.2 9.3 19.5 9.3 8.9 11.8 16.3 15.2 4.1 14.4 5.8 7.8 14.0 11.4 9.9 11.6 7.0 7.6 9.1 17.1 6.0 8.1 10.5 18.2 3.7 15.6 5.7 6.9 7.3 6.1 1.6 2.4 1.8 1.8 2.6 38.3 4.7 0.0 0.0 1.0 0.0 0.6 0.0 1.6 0.1 0.1 0.0 0.0 1.8 3.0 2.6 0.5 0.1 0.0 10.0 2.1 0.0 1.4 3.4 2.2 1.3 4.1 2.6 5.6 0.1 6.8 4.1 0.1 5.1 0.0 1.6 8.3 0.1 2.5 10.1 4.5 0.8 0.6 7.5 0.0 11.9 11.2 1.3 2.1 2.8 1.0 6.9 6.5 0.4 0.1 0.0 1.2 0.4 0.1 1.5 24.4 7.4 0.0 2.7 0.0 1.4 1.8 1.8 0.2 0.9 1.2 0.5 1.6 6.9 0.7 2.2 1.4 38.3 6.7 0.3 2.6 0.4 2.4 7.4 4.7 13.7 17.5 4.7 13.3 15.3 13.8 19.5 9.3 14.4 18.2 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 57.7;fHDF/TERT166: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavourable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.4 13.1 12.3 28.5 11.5 0.2 36.7 57.7 7.3 17.8 0.0 2.7 0.1 12.8 52.2 0.1 25.3 31.3 6.2 0.1 29.2 0.1 7.8 0.0 26.7 0.0 6.1 21.4 5.1 8.9 28.1 7.7 0.0 5.5 17.2 0.4 5.1 0.3 4.0 11.1 14.4 0.5 7.8 0.2 0.0 9.2 13.8 1.3 0.0 2.6 0.0 0.5 21.6 34.1 15.8 1.3 9.2 1.4 3.2 0.2 2.5 0.2 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 FHL2 "DRAL, SLIM3" ENSG00000115641 "Four and a half LIM domains 2" Q14192 2 105357712-105438513 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "heart muscle: 312.0;ovary: 80.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 79.9;RPTEC TERT1: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;T-cells: 4.6" "Group enriched" "Detected in many" 4 "amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3" "Low region specificity" "Detected in all" "HPA005922, HPA006028, CAB008368" Enhanced Enhanced "Actin filaments,Focal adhesion sites" "Actin filaments, Focal adhesion sites" "CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858" "unprognostic (1.04e-1)" "unprognostic (1.63e-3)" "unprognostic (3.30e-1)" "unprognostic (3.42e-2)" "unprognostic (5.89e-2)" "prognostic unfavourable (2.01e-4)" "unprognostic (2.80e-2)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.42e-2)" "unprognostic (3.34e-2)" "unprognostic (8.11e-2)" "prognostic unfavourable (6.42e-5)" "unprognostic (2.06e-1)" "unprognostic (3.49e-1)" "unprognostic (9.92e-3)" "unprognostic (4.73e-2)" 8.3 9.8 1.5 5.7 3.6 1.5 8.9 0.8 5.6 16.3 10.5 1.4 5.1 6.0 14.8 12.1 9.2 6.8 16.5 312.0 2.5 0.4 5.5 7.8 2.1 2.7 0.9 3.0 80.7 1.6 0.2 4.1 16.7 1.1 12.8 7.4 18.5 6.2 8.7 9.4 5.6 16.9 11.9 0.8 3.9 12.7 13.4 0.7 3.1 6.6 16.9 5.1 18.1 7.6 1.4 1.3 7.8 0.8 1.5 4.6 2.6 22.5 5.3 3.1 0.1 10.1 12.8 29.6 42.8 11.3 27.5 33.1 9.5 35.3 0.0 3.6 52.1 7.0 4.6 38.9 31.4 0.9 3.5 15.8 6.5 7.1 40.0 0.0 3.5 26.6 21.4 43.3 28.8 56.0 4.1 1.3 79.9 0.8 3.6 0.1 6.5 16.7 0.0 4.8 0.6 73.7 16.0 0.1 1.0 16.0 7.2 11.1 9.0 0.5 26.9 20.0 20.3 22.1 34.4 0.4 0.0 0.1 31.9 0.0 20.6 7.8 0.8 1.0 2.2 0.4 1.5 1.1 1.8 3.6 0.7 1.4 1.4 2.9 4.5 1.5 0.3 1.3 4.6 2.6 1.5 3.6 0.8 5.6 2.5 0.4 0.9 3.0 1.1 0.7 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109691312-109825428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "CAB017823: , HPA068859: " "prognostic unfavourable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favourable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favourable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 11.0 13.5 14.5 12.2 30.3 14.0 14.4 13.5 35.3 12.4 13.2 11.0 5.0 8.3 11.3 17.0 11.7 10.5 13.4 10.1 14.5 18.5 13.2 8.7 19.2 16.6 17.6 17.7 12.2 9.9 25.4 15.4 12.6 19.0 11.6 14.6 9.7 17.0 12.0 12.1 9.2 10.7 14.7 16.0 17.3 11.4 12.6 12.9 18.1 12.6 8.5 15.0 12.5 10.5 15.5 15.9 12.8 20.0 8.0 7.7 9.8 6.2 6.5 9.8 11.7 10.4 14.4 6.2 8.1 11.7 6.7 18.0 4.8 6.6 16.8 5.2 13.1 4.7 9.6 6.4 15.6 10.2 11.7 9.4 6.5 4.8 9.6 8.8 8.4 7.4 8.4 11.4 7.9 13.6 5.5 7.2 9.4 5.8 9.0 7.6 5.1 3.2 6.3 4.5 5.8 11.3 15.5 10.9 10.2 5.3 7.8 16.4 5.6 14.7 9.5 4.2 3.6 6.1 6.9 3.4 2.4 8.1 22.3 6.3 3.8 11.5 20.0 12.8 7.7 19.7 6.0 14.6 5.7 7.3 15.9 15.5 7.0 6.8 8.7 8.0 13.5 6.9 6.6 9.8 14.5 30.3 13.5 35.3 14.5 18.5 17.6 17.7 19.0 12.9 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.7 2.1 17.3 0.0 0.0 0.0 6.4 2.2 1.5 1.6 3.0 0.0 2.1 0.0 6.2 2.4 0.8 5.7 2.4 1.3 0.0 4.3 0.0 4.0 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.5 3.7 0.0 0.0 4.7 1.4 0.0 0.0 7.3 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 1.8 0.0 0.3 7.2 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.6;smooth muscle: 44.7" "Cell line enhanced" "Detected in some" "EFO-21: 10.5;HUVEC TERT2: 2.6;RPTEC TERT1: 2.9;U-266/70: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA053564: " "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 11.0 1.3 2.0 6.3 3.0 0.2 2.5 0.6 2.5 8.2 10.9 0.0 4.1 1.3 8.8 4.1 10.5 4.5 5.9 37.6 3.7 1.2 2.7 2.4 7.5 1.2 1.1 0.7 4.4 1.4 5.4 5.1 3.7 0.8 14.9 2.6 4.3 1.5 2.8 29.4 0.9 4.1 44.7 1.4 0.6 3.9 2.8 0.0 0.0 2.3 10.8 0.7 30.7 6.0 1.4 0.9 1.8 0.8 0.6 0.9 0.0 0.1 1.9 0.3 0.1 0.1 0.3 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.2 10.5 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.2 0.1 0.0 0.2 0.2 1.4 0.1 0.2 0.0 2.6 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 2.9 0.6 0.2 0.2 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 10.4 1.0 0.1 0.1 0.5 0.1 1.2 0.6 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.2 1.4 0.9 0.6 1.8 0.6 0.8 0.9 0.3 0.0 2.0 3.0 0.6 1.9 3.7 1.2 1.1 0.7 0.8 0.0 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FK506 binding protein 14" Q9NWM8 7 30010587-30026684 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavourable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavourable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavourable (4.25e-4)" 8.8 7.4 8.7 9.2 7.3 5.1 8.8 17.6 7.7 14.9 7.8 4.1 6.9 4.2 12.1 14.2 8.0 8.1 8.5 9.8 7.1 5.2 5.4 9.2 7.6 8.1 9.2 5.2 13.0 9.8 8.6 27.8 10.7 7.1 9.8 6.9 8.4 7.6 10.9 3.3 6.4 5.3 18.8 8.1 6.7 7.2 4.2 7.1 2.6 5.6 5.9 7.7 13.4 8.7 1.6 3.3 2.7 1.2 1.0 1.6 0.6 3.4 2.6 7.3 17.0 19.1 24.5 3.4 17.5 16.4 6.1 12.0 2.2 2.2 1.2 8.3 15.3 7.5 4.1 6.4 12.3 0.6 5.8 2.7 4.9 6.4 9.7 1.9 4.8 15.3 6.7 10.6 12.6 13.5 4.4 2.5 11.0 1.4 1.0 2.4 3.8 4.7 0.0 4.9 4.0 6.1 3.0 1.9 6.4 6.2 14.0 4.3 3.2 2.6 10.9 6.6 7.7 11.2 6.9 3.9 4.0 2.1 9.3 1.9 20.3 1.9 1.2 1.2 1.3 0.8 1.0 1.1 1.6 1.1 2.2 1.6 1.5 1.3 2.7 1.0 0.5 3.3 1.4 0.6 8.7 7.3 17.6 7.7 7.1 5.2 9.2 5.2 7.1 7.1 FKBP15 "FKBP133, KIAA0674, PPP1R76, WAFL" ENSG00000119321 "FK506 binding protein 15" Q5T1M5 9 113161006-113221361 "Predicted intracellular proteins" "Endocytosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007979 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA007979: AB_1848615" "unprognostic (2.81e-1)" "unprognostic (2.51e-1)" "unprognostic (2.55e-3)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (2.67e-1)" "unprognostic (2.16e-3)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-3)" "unprognostic (1.02e-1)" "unprognostic (6.45e-2)" "unprognostic (4.28e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (3.44e-2)" "unprognostic (5.62e-3)" 19.8 17.8 16.7 25.3 21.9 19.2 19.4 18.6 21.6 16.9 15.3 25.4 14.2 15.1 18.1 17.0 18.8 16.7 14.4 16.4 16.2 13.1 15.7 17.2 26.7 30.9 22.6 15.4 18.6 17.5 34.7 22.1 24.4 19.2 17.2 18.7 17.6 20.0 22.3 19.2 22.3 18.2 20.5 23.5 36.5 15.9 6.8 20.9 25.1 18.7 13.4 23.3 18.6 18.3 2.8 8.5 5.7 20.5 3.7 3.4 4.5 12.3 12.7 8.5 8.3 18.5 16.4 11.6 15.4 23.4 17.3 15.5 8.0 12.9 20.6 7.5 19.5 27.0 10.3 15.1 16.0 15.7 6.9 7.9 13.8 7.6 15.0 16.8 20.8 16.4 15.3 19.1 19.9 16.9 9.7 12.6 17.7 18.9 12.6 8.9 8.9 10.1 11.4 18.0 7.4 12.6 11.4 7.6 7.5 18.7 14.3 9.0 17.2 6.3 19.6 18.7 7.0 18.5 15.9 10.9 11.9 9.5 19.5 9.7 15.2 1.8 11.6 1.6 3.4 14.6 2.8 2.0 2.1 2.1 8.5 2.8 2.5 1.9 5.7 3.7 20.5 3.5 2.2 4.5 16.7 21.9 18.6 21.6 16.2 13.1 22.6 15.4 19.2 20.9 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Approved Enhanced Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: " "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (6.12e-5)" "prognostic unfavourable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.5 34.6 10.0 16.8 12.5 7.4 48.1 15.3 5.5 25.3 17.2 34.4 19.0 20.8 4.4 9.8 21.3 62.3 20.7 30.5 38.0 39.9 22.9 25.5 12.2 9.6 17.9 6.2 6.7 19.0 29.9 30.0 14.7 21.0 29.7 10.1 44.7 31.3 16.2 85.5 25.0 18.8 17.6 12.4 21.3 19.9 14.5 20.8 17.7 48.4 7.7 65.3 12.1 7.8 12.5 39.3 14.0 38.5 7.4 11.3 30.7 11.1 26.7 12.7 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: " "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favourable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.6 26.3 20.6 39.1 21.3 33.5 51.7 29.7 31.6 22.7 31.5 24.9 50.0 21.0 48.3 36.4 19.9 12.7 41.3 6.4 25.6 60.3 19.6 34.3 29.9 36.7 19.4 43.2 43.7 39.9 20.4 13.0 23.3 41.1 50.0 19.7 61.0 35.2 58.1 42.1 38.2 37.0 17.1 71.8 30.5 24.0 22.9 41.7 20.8 17.2 37.0 20.2 56.7 27.1 28.4 26.0 55.4 22.5 38.3 21.9 24.4 64.3 31.2 25.2 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FK506 binding protein 9" O95302 7 32957404-33006931 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;fHDF/TERT166: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: " "unprognostic (1.23e-2)" "prognostic unfavourable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavourable (5.80e-4)" "prognostic unfavourable (2.02e-4)" "prognostic unfavourable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavourable (7.02e-6)" 35.4 21.1 9.7 12.5 13.6 0.9 43.7 4.5 16.3 33.6 18.3 9.3 16.8 8.8 31.3 30.9 23.7 24.1 28.8 44.4 9.7 11.9 18.2 10.1 30.6 17.5 10.8 9.7 25.9 26.0 12.9 16.0 35.2 13.2 23.7 21.2 30.4 16.0 25.6 17.1 28.0 13.4 37.0 12.8 10.7 17.4 16.3 6.4 2.9 18.9 19.4 11.1 23.7 23.6 0.4 1.4 7.4 4.1 0.3 0.1 0.9 7.0 13.4 5.2 21.6 49.7 57.5 7.0 38.1 39.7 12.6 20.1 5.8 16.8 0.0 15.6 70.8 13.8 7.7 18.6 14.5 0.0 2.3 1.2 14.4 5.8 20.7 0.0 2.0 37.3 11.3 11.2 10.9 15.8 2.7 1.4 25.6 6.8 0.0 3.5 1.1 7.1 0.0 14.1 0.0 14.1 2.4 4.9 12.0 21.7 11.1 13.5 7.8 3.4 21.2 20.7 19.9 12.8 8.7 4.6 8.8 0.0 20.2 0.0 41.1 1.5 4.1 0.9 0.1 2.6 0.1 0.4 0.1 0.0 1.4 0.3 0.1 0.1 7.4 0.3 0.7 0.3 0.0 0.9 9.7 13.6 4.5 16.3 9.7 11.9 10.8 9.7 13.2 6.4 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FK506 binding protein like" Q9UIM3 6 32128707-32130291 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA043478: , HPA060158: " "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favourable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.6 5.6 4.1 2.7 4.7 4.6 7.1 12.1 6.2 4.4 4.5 3.9 8.9 6.0 4.1 8.7 12.7 7.0 4.5 6.0 4.1 3.5 5.9 6.7 4.5 7.7 7.1 2.4 7.0 13.2 6.2 5.0 6.9 5.8 3.8 4.9 3.7 8.0 3.6 5.1 11.5 4.4 5.1 3.6 7.8 6.6 7.6 6.8 10.5 11.6 2.8 6.8 4.7 6.3 3.4 3.7 8.3 4.8 3.3 4.6 1.5 0.0 2.0 4.4 11.9 6.6 4.7 3.8 2.9 3.3 5.5 5.3 9.5 4.0 3.3 3.4 5.0 2.2 6.2 5.7 3.8 5.9 7.6 0.0 6.6 5.3 3.7 0.0 3.6 4.6 5.8 10.7 6.7 5.8 11.1 8.2 5.6 3.2 3.6 4.1 3.3 1.7 3.0 5.8 7.2 5.7 0.7 8.4 2.0 2.9 5.3 6.3 9.2 6.4 2.5 8.0 6.6 4.1 7.0 4.4 7.7 3.0 3.1 5.4 4.9 4.9 3.4 2.3 4.6 4.8 4.4 2.8 2.6 3.3 3.7 3.4 3.0 2.9 8.3 3.3 2.5 2.9 1.1 1.5 4.1 4.7 12.1 6.2 4.1 3.5 7.1 2.4 5.8 6.8 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: , HPA060454: " "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favourable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.0 12.4 8.6 10.9 12.2 11.0 21.5 14.5 8.8 14.0 11.4 14.7 7.5 12.1 12.3 8.9 4.6 10.0 8.1 14.9 15.3 8.0 8.7 7.2 9.7 6.2 13.7 13.5 8.7 10.9 10.7 11.5 7.9 7.7 8.9 3.8 4.5 15.1 12.1 4.5 12.2 7.6 2.8 5.6 18.1 8.5 16.1 10.8 5.2 7.0 6.4 4.9 11.9 13.2 13.9 4.8 17.2 8.2 9.8 7.2 10.7 5.0 17.5 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 FLAD1 "FAD1, PP591" ENSG00000160688 "Flavin adenine dinucleotide synthetase 1" Q8NFF5 1 154983338-154993111 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028476, HPA028486, HPA028563" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286" "unprognostic (2.64e-1)" "unprognostic (2.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.84e-2)" "unprognostic (7.34e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (1.31e-1)" "unprognostic (2.32e-1)" "unprognostic (8.08e-2)" "unprognostic (6.51e-2)" "unprognostic (9.74e-2)" "prognostic unfavourable (2.55e-6)" "unprognostic (1.67e-2)" "unprognostic (5.06e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-2)" 16.5 16.5 20.3 15.5 18.9 12.1 17.4 15.9 20.8 14.1 16.4 19.3 14.7 19.6 15.9 21.2 19.8 16.7 11.8 16.1 18.2 10.4 19.0 36.5 13.5 20.0 20.8 15.6 14.5 19.0 13.6 12.0 18.5 15.9 18.7 19.0 16.1 16.2 16.3 26.3 23.3 23.9 17.6 12.4 22.9 16.1 19.1 18.9 15.7 20.8 18.4 22.0 15.5 15.4 25.1 24.5 15.2 24.1 14.9 26.4 22.7 13.1 21.2 13.5 23.0 11.8 8.7 25.7 10.0 8.3 14.6 12.5 18.8 16.3 15.4 20.2 9.2 17.3 25.8 20.7 9.5 16.0 19.4 12.5 16.8 13.2 16.1 18.0 16.3 12.4 27.2 16.6 17.8 16.9 20.0 12.5 12.3 28.4 12.4 12.6 29.4 22.0 20.9 6.7 35.3 13.9 18.4 22.8 31.3 15.6 35.4 19.7 30.3 27.4 10.7 9.2 12.7 11.8 15.7 19.6 24.3 26.5 11.1 14.7 14.7 15.2 23.0 14.8 24.0 20.9 26.4 25.1 22.1 22.7 24.1 20.5 20.5 20.2 5.2 14.9 24.1 24.5 23.3 22.7 20.3 18.9 15.9 20.8 18.2 10.4 20.8 15.6 15.9 18.9 FLCN "BHD, MGC17998, MGC23445" ENSG00000154803 Folliculin Q8NFG4 17 17212212-17237188 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB015158, HPA028760" Supported Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB015158: AB_2231645, HPA028760: AB_10601323" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.74e-1)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.73e-2)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (3.90e-1)" "prognostic favourable (4.49e-4)" "unprognostic (6.45e-3)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.65e-1)" 11.9 15.3 23.6 10.8 41.6 15.6 13.9 49.4 26.9 18.0 21.3 18.5 10.4 25.0 22.1 15.8 11.0 14.5 17.6 17.2 17.2 8.6 9.6 15.5 15.6 11.6 24.2 13.5 25.2 13.7 6.1 20.3 13.3 18.1 15.4 10.7 14.8 10.5 14.8 22.7 12.6 20.2 15.4 14.8 16.5 15.3 12.5 29.1 6.6 15.8 3.9 8.0 15.0 14.8 6.0 2.4 10.5 6.8 4.5 5.0 3.1 6.4 15.7 5.8 7.5 18.9 10.8 8.5 5.8 9.7 9.2 12.8 11.9 5.4 3.2 8.1 7.0 7.5 7.0 3.6 4.8 6.1 5.9 6.5 4.6 6.8 17.5 2.4 18.3 15.8 12.4 14.4 10.7 7.5 8.9 8.3 8.8 8.3 4.3 4.1 5.9 3.9 8.6 26.8 3.7 5.5 7.1 7.0 4.5 6.1 3.7 10.1 5.6 4.5 8.8 21.7 9.4 29.9 7.6 4.1 3.9 3.0 13.7 5.5 8.5 3.6 4.7 2.8 2.9 6.8 4.1 5.3 3.5 2.5 2.4 6.0 3.9 3.4 10.5 4.5 2.2 2.4 5.0 3.1 23.6 41.6 49.4 26.9 17.2 8.6 24.2 13.5 18.1 29.1 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.2" "Cell line enhanced" "Detected in many" "HEL: 40.2;HUVEC TERT2: 22.3;REH: 18.8;TIME: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073099 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA073099: " "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 14.7 2.5 3.5 15.8 4.4 10.6 9.9 1.4 3.2 6.7 5.1 3.8 2.1 3.3 7.8 6.5 4.8 5.3 6.0 7.5 3.8 3.1 4.2 3.6 17.4 24.4 6.2 1.6 4.0 3.2 2.5 2.0 11.4 3.8 4.3 3.1 4.8 4.2 3.3 5.2 3.2 6.9 5.7 6.6 40.2 4.1 2.7 4.6 26.8 5.7 2.8 17.9 6.2 6.7 4.5 13.1 20.1 12.0 7.8 8.8 11.6 0.0 0.0 2.0 0.0 0.2 0.4 0.0 1.2 3.4 1.4 1.2 0.0 0.0 6.8 12.2 4.0 0.0 0.3 5.0 1.6 3.2 0.1 40.2 0.2 0.0 2.4 4.8 5.7 0.3 0.4 2.9 6.8 22.3 0.0 8.8 0.3 0.0 4.8 2.7 0.6 1.2 18.8 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.8 23.1 0.2 0.0 0.1 1.2 2.8 5.9 5.9 0.0 11.7 1.8 20.1 9.5 16.1 7.2 10.3 8.8 4.5 6.2 5.8 13.1 3.6 2.6 5.6 7.8 7.8 12.0 2.2 7.4 11.6 3.5 4.4 1.4 3.2 3.8 3.1 6.2 1.6 3.8 4.6 FLII "FLI, Fli1, FLIL, MGC39265" ENSG00000177731 "FLII, actin remodeling protein" Q13045 17 18244836-18258916 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007084, HPA008903, CAB016132" Approved Enhanced "Nucleoplasm,Centriolar satellite,Cytosol" 1800000 "Nucleoplasm, Centriolar satellite, Cytosol" "CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640" "unprognostic (8.09e-2)" "unprognostic (1.09e-2)" "unprognostic (6.89e-2)" "unprognostic (2.53e-2)" "unprognostic (4.22e-2)" "unprognostic (4.78e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-3)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" 21.2 16.8 8.6 16.9 12.4 16.6 21.7 11.7 11.4 17.5 18.5 12.8 14.3 14.6 17.3 16.3 25.9 13.7 15.6 28.3 9.3 7.4 19.0 18.8 17.3 13.4 15.0 6.1 15.3 20.0 15.4 13.5 15.8 13.6 17.2 10.7 11.0 21.3 17.0 78.4 14.4 18.9 19.1 11.1 20.0 15.4 15.6 11.9 21.2 15.1 25.4 17.5 21.5 16.3 5.3 16.0 12.9 24.9 5.2 7.2 10.3 58.9 21.3 6.0 9.3 14.0 12.7 9.1 16.4 19.9 18.5 11.5 27.1 13.5 11.5 17.2 18.8 26.3 8.1 27.3 10.9 9.6 12.6 6.3 15.7 10.7 15.8 7.0 13.4 11.4 16.7 15.1 22.8 17.9 5.1 4.7 10.8 17.6 10.3 5.8 6.3 11.2 10.1 27.2 14.3 13.8 16.7 2.1 3.2 19.1 16.3 8.8 27.7 5.5 21.9 16.5 17.0 31.7 19.3 4.9 3.6 3.5 15.6 6.8 8.9 4.8 13.6 12.9 7.0 21.4 7.2 5.3 5.8 7.2 16.0 3.6 4.3 4.6 12.0 5.2 24.9 4.7 6.6 10.3 8.6 12.4 11.7 11.4 9.3 7.4 15.0 6.1 13.6 11.9 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374638 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 396.7;urinary bladder: 276.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" 2900000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavourable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (3.88e-4)" 42.8 8.8 2.9 46.4 3.9 22.9 30.7 2.0 5.2 106.5 204.2 6.3 86.0 13.1 158.9 54.4 140.2 79.9 121.0 18.8 3.2 2.2 17.2 5.5 29.1 21.1 3.4 5.9 77.4 7.3 1.6 4.8 20.0 9.4 129.3 13.4 19.0 12.6 98.8 13.7 15.0 50.2 396.7 3.6 25.5 82.7 29.9 2.9 12.1 11.7 16.3 15.1 276.1 64.5 6.3 13.1 7.1 19.7 5.9 22.6 24.1 87.2 67.8 23.9 30.8 20.9 27.7 39.4 58.4 65.1 53.6 47.7 43.9 16.2 7.5 151.6 90.7 50.1 21.5 51.2 15.1 30.8 7.5 24.2 88.7 15.2 38.5 28.6 31.8 26.5 12.4 79.8 31.9 39.8 6.8 52.3 38.3 20.0 13.6 9.9 25.2 45.1 13.7 21.7 6.7 20.8 18.2 5.3 12.1 48.8 7.9 39.3 7.6 9.0 95.2 61.2 59.0 62.0 107.6 32.8 19.2 15.2 56.9 19.2 61.2 4.1 11.5 7.1 22.6 15.2 14.3 6.3 10.5 18.7 13.1 3.0 4.0 9.1 2.6 5.9 19.7 1.7 12.8 24.1 2.9 3.9 2.0 5.2 3.2 2.2 3.4 5.9 9.4 2.9 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 70.2;TIME: 79.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" 37000000 "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavourable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favourable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 24.7 17.8 7.8 25.3 10.6 2.2 30.0 12.6 7.4 21.3 33.5 17.2 49.6 19.4 36.1 47.4 18.6 17.3 16.0 7.7 10.6 8.5 20.6 29.2 14.1 9.4 16.1 5.3 22.9 22.4 25.6 7.8 36.0 13.2 35.8 28.5 20.1 25.5 44.0 7.7 28.9 50.2 39.7 24.3 12.1 21.2 11.7 13.5 49.3 28.2 12.0 13.0 32.8 34.7 3.8 15.9 7.4 1.2 5.9 4.9 1.2 19.8 34.0 3.4 5.0 2.3 4.0 59.9 7.4 6.0 16.5 16.9 34.0 34.0 3.2 2.8 26.0 32.7 6.4 47.2 16.1 17.9 3.1 2.7 28.9 16.5 17.1 2.3 9.8 6.3 20.5 22.9 70.2 55.8 4.5 1.0 10.2 4.3 7.2 5.7 5.3 29.4 3.2 0.9 2.8 22.1 33.9 3.8 3.6 37.5 20.6 4.1 17.0 6.6 79.1 4.3 13.5 51.5 26.3 0.7 0.2 2.6 16.0 4.3 4.5 7.4 0.3 4.2 0.5 0.8 2.6 3.8 1.6 0.7 1.2 1.6 4.9 3.5 0.1 5.9 1.2 15.9 1.7 1.2 7.8 10.6 12.6 7.4 10.6 8.5 16.1 5.3 13.2 13.5 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell line enhanced" "Detected in many" "BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006135 Enhanced Supported "Plasma membrane,Cytosol" 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavourable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.1 8.6 0.8 78.6 14.9 22.4 10.8 24.4 0.2 0.0 13.3 35.8 0.0 4.8 0.1 13.3 0.0 2.6 0.0 4.0 0.0 9.0 0.0 0.0 16.3 0.0 38.9 0.0 13.9 9.4 0.0 15.2 0.0 0.0 0.3 13.1 4.5 0.0 26.0 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 0.1 0.3 28.8 7.8 33.6 2.0 0.0 0.0 0.0 0.0 26.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 FLOT1 ENSG00000137312 "Flotillin 1" O75955 6 30727709-30742733 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001393, CAB007766" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" 1500000 "Golgi apparatus" "Vesicles, Plasma membrane" "CAB007766: AB_562116, HPA001393: AB_1078892" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (5.78e-4)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (3.41e-3)" "unprognostic (2.68e-3)" "unprognostic (1.86e-1)" "unprognostic (2.65e-1)" "prognostic favourable (3.06e-4)" "unprognostic (1.81e-2)" "unprognostic (9.36e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (6.43e-3)" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (2.46e-2)" 25.7 43.8 32.1 22.6 26.1 22.4 45.9 27.8 37.4 32.9 23.3 14.3 18.8 16.7 19.3 16.7 15.8 27.6 18.8 46.4 29.5 25.7 26.6 26.0 22.9 34.1 29.2 31.9 16.5 24.7 28.7 17.9 25.9 27.2 23.1 18.4 13.0 25.5 32.9 46.1 8.2 16.7 29.0 30.4 22.8 16.7 11.7 18.7 7.8 28.7 13.8 17.1 21.3 36.9 2.9 6.0 29.1 7.3 7.2 3.5 4.7 7.2 2.9 7.0 8.3 7.2 11.1 3.7 7.4 10.1 13.1 11.7 3.8 3.6 4.9 8.1 16.8 5.4 6.9 2.8 8.0 15.1 6.6 6.4 2.8 3.8 17.1 1.2 8.4 11.9 4.2 7.8 15.1 9.1 4.6 7.9 13.7 2.4 4.2 1.7 2.3 8.4 5.4 7.9 6.7 5.1 2.1 6.7 6.4 5.5 3.9 27.8 6.3 1.3 6.1 25.1 8.2 4.4 20.7 5.4 5.3 4.9 3.4 5.3 15.9 12.8 7.3 12.2 3.5 3.4 2.3 2.9 2.2 2.9 5.5 2.2 2.5 2.9 29.1 7.2 2.2 6.0 0.3 4.7 32.1 26.1 27.8 37.4 29.5 25.7 29.2 31.9 27.2 18.7 FLOT2 "ECS-1, ECS1, ESA, ESA1, M17S1" ENSG00000132589 "Flotillin 2" Q14254 17 28879335-28897679 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001396, CAB004395, HPA071038" Supported Supported "Vesicles,Plasma membrane" 1900000 "Plasma membrane" Vesicles "CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: " "unprognostic (6.04e-2)" "unprognostic (8.76e-3)" "unprognostic (3.01e-1)" "unprognostic (8.92e-2)" "unprognostic (4.15e-3)" "unprognostic (2.17e-2)" "unprognostic (4.36e-3)" "unprognostic (2.12e-1)" "unprognostic (5.21e-2)" "unprognostic (1.20e-1)" "unprognostic (9.98e-2)" "unprognostic (2.80e-1)" "unprognostic (4.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (2.20e-2)" 26.1 19.5 21.5 28.3 21.9 47.8 21.1 17.3 35.9 17.3 20.7 14.4 13.7 11.1 15.7 14.3 25.9 21.0 15.0 24.5 17.3 18.7 36.4 52.5 24.7 40.1 15.3 17.8 19.8 18.5 18.8 9.1 30.4 31.9 27.6 14.8 20.9 24.3 29.5 21.1 17.7 19.2 25.5 12.8 49.6 17.5 8.4 12.3 17.4 21.8 14.5 33.1 36.7 34.4 25.7 29.4 84.8 21.3 14.8 21.4 24.1 14.7 25.2 19.6 16.8 10.0 12.7 21.2 11.5 15.9 17.0 20.1 26.0 12.7 20.6 22.4 12.8 17.5 21.1 19.1 7.3 65.3 24.9 25.0 23.7 18.7 13.2 20.3 4.2 15.4 14.8 14.1 18.9 26.9 23.5 18.1 7.8 22.3 5.6 15.3 17.2 6.7 8.7 19.7 50.4 30.0 46.3 17.3 29.0 27.0 19.3 20.9 20.1 36.6 21.9 6.1 11.0 9.8 17.4 10.3 17.7 10.6 17.0 19.6 11.3 28.0 21.3 41.2 21.4 19.5 15.8 21.4 16.4 18.1 29.4 25.7 12.3 15.2 84.8 14.8 20.8 8.0 19.3 24.1 21.5 21.9 17.3 35.9 17.3 18.7 15.3 17.8 31.9 12.3 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell line enhanced" "Detected in some" "AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: " "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favourable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 15.3 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.4 3.1 0.0 0.5 0.3 4.3 0.0 4.5 0.1 0.0 0.9 0.0 0.2 0.1 1.3 0.0 0.0 2.7 28.9 0.0 5.4 0.0 0.0 0.1 2.9 0.2 1.9 0.0 5.0 0.0 0.0 0.1 0.0 9.7 1.8 0.3 3.1 0.0 0.0 4.8 0.2 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell line enhanced" "Detected in some" "BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" 875697 54000 "Plasma membrane, Actin filaments" "CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.0 13.5 6.2 3.6 0.0 0.0 0.0 0.0 2.2 0.0 1.6 0.0 11.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 84.6 0.1 0.0 0.0 0.2 15.3 0.4 0.0 0.0 0.0 1.0 0.8 9.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 30.3 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Secreted to blood" 270000000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "CAB000099: , HPA046519: , HPA067906: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.2 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.3 2.8 0.1 0.2 0.1 12.6 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 8.1 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 12.0 0.2 12.7 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911937-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 15.6 16.6 13.1 12.6 17.2 12.5 10.2 24.4 27.4 13.6 12.2 17.7 9.5 14.7 14.3 13.4 11.8 11.9 15.0 16.7 12.1 15.9 10.1 5.9 10.7 11.6 15.8 18.5 21.4 12.2 22.6 12.2 9.5 18.8 13.9 4.7 25.3 14.4 15.6 28.1 22.8 14.4 14.1 16.2 19.9 11.0 5.1 10.9 8.5 11.5 8.4 10.3 17.1 15.7 4.6 1.6 2.3 1.6 0.9 5.5 2.1 5.0 17.9 4.1 12.1 6.7 6.8 12.5 9.4 7.4 4.8 4.9 2.9 16.5 12.4 25.1 7.2 10.6 3.4 6.3 0.9 20.6 10.2 4.1 15.1 9.9 15.0 5.5 14.5 6.1 20.1 10.0 7.4 6.7 9.2 13.2 3.6 12.1 12.5 6.6 6.7 12.3 22.0 6.1 22.2 5.6 3.4 8.9 8.2 9.9 10.8 12.6 8.4 10.0 12.6 8.0 7.3 15.5 6.3 19.6 16.7 11.1 8.8 9.0 9.3 2.3 1.6 0.6 3.0 0.7 4.9 2.0 4.5 5.5 1.6 4.6 3.9 3.4 0.2 0.9 0.8 1.0 2.2 2.1 13.1 17.2 24.4 27.4 12.1 15.9 15.8 18.5 18.8 10.9 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765545-33194733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 21.9" "Cell line enhanced" "Detected in many" "Karpas-707: 9.3;RH-30: 12.5;SK-MEL-30: 13.0;T-47d: 11.4;U-138 MG: 7.3" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 7.0 2.1 3.7 3.9 5.3 2.2 4.9 0.6 12.1 8.9 8.5 1.8 2.6 2.6 2.2 4.8 3.9 5.1 4.0 2.4 3.3 2.0 4.7 1.4 7.7 3.3 5.9 7.3 1.1 2.5 2.6 8.0 5.1 4.6 3.8 6.9 21.9 6.4 2.5 2.2 9.2 4.3 3.7 6.4 3.0 11.7 12.4 4.6 1.8 4.7 1.5 2.0 2.7 6.8 0.6 1.8 2.8 0.7 0.1 0.7 0.1 1.6 1.8 0.3 0.2 0.0 0.2 2.0 2.3 1.8 0.6 1.7 0.2 2.2 0.2 0.8 2.7 1.4 0.0 1.5 1.7 0.0 0.1 1.2 0.3 0.1 0.1 0.0 0.1 0.7 0.0 2.7 0.0 0.0 0.0 9.3 4.1 1.7 0.0 0.0 0.5 0.1 0.2 12.5 2.2 0.8 0.6 0.1 0.3 0.0 1.5 13.0 11.4 0.0 1.6 7.3 1.2 6.6 0.6 0.0 0.0 0.4 3.5 0.0 4.5 2.8 0.7 0.0 0.3 0.0 0.5 0.0 0.7 0.6 1.4 0.6 0.4 0.0 0.1 0.1 0.0 1.8 0.1 0.1 3.7 5.3 0.6 12.1 3.3 2.0 5.9 7.3 4.6 4.6 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475189 "Disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.0;parathyroid gland: 26.6" "Cell line enhanced" "Detected in some" "BJ: 26.5;fHDF/TERT166: 26.1;LHCN-M2: 28.7;U-138 MG: 19.0;WM-115: 29.6" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA050649: " "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 7.3 17.1 1.3 14.5 0.9 1.3 17.2 41.0 1.1 3.2 9.4 0.0 1.4 2.5 2.1 2.1 3.7 2.0 0.9 16.2 11.8 2.9 0.9 1.4 0.9 9.9 15.5 3.9 2.1 26.6 5.6 1.2 12.2 2.9 3.0 1.4 1.3 3.6 0.9 1.0 1.3 2.7 12.3 1.2 1.2 3.4 12.3 0.0 1.3 0.0 1.0 1.2 0.4 0.5 0.4 0.6 0.3 0.4 2.3 0.0 0.0 0.8 2.8 0.0 7.2 5.5 0.0 26.5 14.0 10.5 5.7 0.0 0.0 0.0 0.0 26.1 0.0 0.4 0.0 10.3 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.6 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.9 0.8 0.0 0.1 0.0 0.0 0.0 4.4 3.9 0.0 0.1 0.1 1.1 0.0 0.1 19.0 0.1 7.1 6.9 0.0 0.0 0.0 3.7 0.0 29.6 0.6 0.3 0.1 0.3 0.2 0.2 0.1 0.9 0.1 0.1 0.5 2.3 1.4 0.5 0.4 0.1 0.4 0.3 0.0 17.1 14.5 17.2 19.3 16.2 11.8 9.9 15.5 12.2 12.3 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335237-152649834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Cell line enhanced" "Detected in many" "BEWO: 56.7;hTERT-HME1: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7;non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 5 "monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavourable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 15.1 13.6 26.2 7.0 44.6 0.8 9.4 18.3 55.0 8.5 6.6 55.0 1.4 5.8 13.6 10.2 4.6 6.7 11.1 4.8 32.0 20.6 9.7 5.3 17.9 8.2 63.4 27.9 35.9 7.4 17.8 10.2 35.9 39.2 8.9 8.4 5.4 20.1 8.2 31.0 4.0 5.5 10.7 74.1 12.0 8.2 5.8 56.7 1.3 14.5 3.2 5.4 9.1 11.6 0.0 0.9 0.0 4.2 0.0 0.1 0.0 4.0 4.3 13.6 7.5 16.5 17.8 56.7 4.1 8.5 7.4 10.4 4.6 0.2 0.0 8.9 3.6 4.7 6.5 13.2 11.8 0.0 6.8 0.0 2.8 19.9 4.7 1.1 0.2 11.6 8.2 14.3 36.9 13.0 0.1 0.1 4.0 1.1 0.2 1.2 8.7 8.8 7.3 2.9 5.9 21.6 2.8 13.9 11.3 3.5 1.3 14.4 0.3 0.4 14.4 11.2 0.3 3.7 7.1 0.3 0.1 0.0 10.4 0.9 22.7 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.1 0.0 26.2 44.6 18.3 36.7 32.0 20.6 63.4 27.9 39.2 56.7 FMNL3 "DKFZp762B245, MGC45819, WBP3" ENSG00000161791 "Formin like 3" Q8IVF7 12 49636499-49708165 "Predicted intracellular proteins" Angiogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002552, HPA023201" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane,Cytosol" "Golgi apparatus, Vesicles, Plasma membrane" Cytosol "HPA002552: AB_1078862, HPA023201: AB_1848575" "unprognostic (2.97e-1)" "unprognostic (2.77e-3)" "unprognostic (4.97e-3)" "unprognostic (7.19e-2)" "unprognostic (5.42e-2)" "unprognostic (2.33e-3)" "unprognostic (5.37e-3)" "unprognostic (1.52e-2)" "unprognostic (2.83e-1)" "unprognostic (1.54e-1)" "unprognostic (6.67e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (1.04e-1)" "unprognostic (2.31e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" 18.3 6.4 10.1 19.9 10.7 5.0 13.8 8.5 11.2 9.3 8.0 23.2 6.3 6.0 13.5 20.8 5.1 7.5 13.0 12.6 10.6 9.0 10.1 3.1 18.0 22.5 14.0 7.7 18.9 3.8 3.7 5.0 14.4 12.9 7.5 6.2 9.8 5.0 5.1 6.3 4.8 10.7 12.3 14.2 13.0 6.7 10.5 11.3 16.2 15.0 5.1 27.9 9.6 7.7 1.7 8.6 3.6 0.7 1.1 1.5 0.7 4.4 1.3 10.0 3.3 2.8 11.3 0.1 5.5 11.3 7.6 6.7 5.1 1.2 9.6 10.7 6.6 0.2 5.1 2.3 7.0 8.4 1.9 10.5 1.5 0.2 4.9 2.1 13.8 7.1 0.3 11.8 5.0 20.0 2.3 7.1 11.1 3.3 8.5 3.1 3.3 2.9 4.1 12.5 1.4 7.1 0.6 1.7 4.7 3.2 0.4 6.5 0.8 3.1 25.2 18.9 6.6 0.3 9.5 3.7 0.2 5.2 11.7 6.5 7.9 3.6 0.3 1.2 1.5 0.7 0.7 0.4 0.5 0.9 0.4 1.7 0.8 0.9 0.0 1.1 0.6 8.6 0.3 0.7 10.1 10.7 8.5 11.2 10.6 9.0 14.0 7.7 12.9 11.3 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA049100: , HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favourable (1.09e-4)" "prognostic favourable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favourable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.4 4.9 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.1 0.6 1.3 0.3 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.6 0.4 0.4 2.5 3.5 0.0 0.2 0.0 1.4 1.5 3.0 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.4 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell line enhanced" "Detected in some" "Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favourable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.0 1.9 0.5 0.6 0.4 0.3 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.3 0.0 0.0 0.0 1.0 0.1 1.1 0.0 28.4 0.6 0.9 6.4 0.9 0.1 0.3 0.0 0.4 0.1 0.1 1.1 0.9 0.2 0.5 2.0 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 1.9 0.9 1.4 7.2 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 4.9;HaCaT: 2.7;SH-SY5Y: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.4 0.5 4.9 0.1 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.9 0.7 0.0 0.0 1.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 5.9 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell line enhanced" "Detected in many" "AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" Nucleoplasm "Aggresome, Cytosol" "HPA051804: , HPA063581: " "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavourable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavourable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 16.9 17.3 10.6 0.1 3.8 7.7 2.8 2.4 0.7 0.2 0.0 0.4 12.2 0.0 6.4 2.3 2.4 0.0 1.0 0.8 0.0 8.7 6.4 0.0 0.1 9.0 1.1 4.8 0.9 20.7 0.9 0.0 10.2 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 0.0 18.9 2.6 1.2 1.0 2.9 0.0 0.0 0.0 14.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;PC-3: 1.1;U-87 MG: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: " "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.0 0.0 1.2 0.5 0.0 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 FNIP2 "FNIPL, KIAA1450, MAPO1" ENSG00000052795 "Folliculin interacting protein 2" Q9P278 4 158769138-158908049 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 60.9;U-266/70: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.8;myeloid DC: 3.1;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.1;monocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042779, HPA052758, HPA072420" Approved Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA042779: AB_10794386, HPA052758: , HPA072420: " "unprognostic (3.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "unprognostic (4.02e-1)" "unprognostic (1.46e-1)" "unprognostic (3.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (7.93e-2)" "unprognostic (1.77e-1)" "prognostic favourable (3.96e-11)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (7.10e-2)" 23.6 8.6 12.5 7.4 15.5 5.8 11.3 10.9 16.0 10.4 15.7 17.5 11.4 5.6 9.3 9.8 11.0 7.6 15.3 20.9 15.1 9.1 35.5 44.0 21.8 12.0 14.1 14.4 8.5 14.2 13.0 5.2 21.7 11.1 8.5 16.8 8.0 10.0 14.7 15.3 11.4 8.1 13.3 12.9 9.6 16.3 7.2 15.0 5.5 13.9 8.3 4.1 9.3 9.5 0.0 3.1 0.6 9.4 0.9 1.0 0.5 1.3 1.5 6.8 3.5 5.1 3.2 7.5 3.0 3.2 3.1 3.4 1.8 1.4 0.0 0.7 10.8 1.3 6.4 3.1 3.8 60.9 2.3 6.4 0.8 2.5 3.2 2.6 12.8 2.3 2.6 2.1 2.7 3.4 3.8 0.2 5.1 0.4 6.2 0.3 2.1 1.6 3.6 3.3 1.7 2.5 3.5 4.4 3.9 1.6 1.1 6.8 1.4 1.5 4.3 5.0 3.1 3.4 2.2 20.6 8.6 1.3 5.0 3.3 3.5 0.6 1.1 0.3 0.7 4.8 0.4 0.0 0.4 0.3 3.1 0.0 0.4 1.0 0.2 0.9 9.4 0.6 0.1 0.5 12.5 15.5 10.9 16.0 15.1 9.1 14.1 14.4 11.1 15.0 FOSB "AP-1, DKFZp686C0818, G0S3, GOS3, GOSB, MGC42291" ENSG00000125740 "FosB proto-oncogene, AP-1 transcription factor subunit" P53539 19 45467995-45475179 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 14.6;hTCEpi: 9.1;Karpas-707: 7.5;SK-BR-3: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.0" "Group enriched" "Detected in many" 4 "amygdala: 4.1;basal ganglia: 4.2;cerebral cortex: 5.3;hippocampal formation: 4.5;olfactory region: 8.8" "Low region specificity" "Detected in many" "CAB010267, HPA054663" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB010267: AB_640583, HPA054663: " "unprognostic (7.22e-2)" "unprognostic (9.74e-2)" "unprognostic (2.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.30e-3)" "unprognostic (9.43e-2)" "unprognostic (2.04e-2)" "unprognostic (2.99e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (3.51e-2)" "unprognostic (4.99e-3)" "unprognostic (8.72e-2)" "unprognostic (4.45e-2)" "unprognostic (4.04e-2)" 72.7 13.0 2.3 111.4 7.4 39.2 10.0 5.5 7.7 62.9 9.0 14.9 2.2 1.7 32.1 6.1 18.9 135.1 102.6 14.1 2.5 2.9 3.4 8.6 22.9 6.0 2.0 1.2 29.1 12.2 8.1 8.1 129.0 8.5 12.2 7.9 38.6 8.7 59.1 2.2 59.5 10.8 36.3 2.5 2.6 30.5 21.7 1.3 4.0 33.6 114.5 8.2 16.7 4.4 0.2 1.7 9.0 1.6 0.2 0.7 0.2 0.4 0.8 0.2 0.3 1.3 0.3 2.4 2.5 1.1 0.8 0.7 0.5 1.0 2.1 0.4 1.6 0.9 0.5 1.7 0.5 0.3 0.8 0.6 0.8 0.4 0.9 1.2 14.6 0.5 9.1 1.9 2.1 1.0 0.8 7.5 0.2 0.2 0.2 1.2 0.5 0.4 0.6 0.1 1.4 0.7 1.4 3.4 0.4 1.5 10.7 1.3 0.6 0.8 0.2 0.6 0.7 1.2 0.8 5.6 0.7 0.6 1.2 0.8 1.4 1.5 1.6 1.7 0.3 0.2 0.7 0.1 0.4 0.3 1.7 0.2 0.0 0.0 9.0 0.2 0.1 0.1 0.1 0.2 2.3 7.4 5.5 7.7 2.5 2.9 2.0 1.2 8.5 1.3 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589984-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 47.0;prostate: 44.4" "Cell line enhanced" "Detected in some" "Hep G2: 16.3;MCF7: 35.4;PC-3: 24.7;RT4: 33.1;SK-BR-3: 33.5;T-47d: 47.5" "Cancer enhanced" "Detected in many" "prostate cancer: 127.0" "Region enriched" "Detected in single" 6 "midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1" "Region enriched" "Detected in some" 6 "midbrain: 6.1" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: " "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favourable (1.00e-4)" 0.1 0.0 0.1 6.1 0.1 0.0 23.5 0.1 0.3 1.5 9.4 0.1 0.1 4.6 0.1 0.5 7.2 1.3 6.5 0.1 0.1 0.3 0.4 47.0 13.2 0.1 2.0 0.1 0.6 0.2 0.0 1.1 0.1 0.2 44.4 6.0 0.2 9.4 0.7 0.1 0.7 5.1 2.4 0.1 0.1 13.0 0.6 0.1 0.2 0.1 4.4 9.9 12.5 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.3 0.9 0.0 0.5 0.0 8.2 4.6 1.1 0.0 0.0 8.1 0.0 1.4 16.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 35.4 0.0 0.1 0.0 24.7 0.0 0.3 0.1 3.4 33.1 4.2 0.0 1.6 33.5 0.0 47.5 0.1 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 2.0 0.1 0.2 0.1 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22581005-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.4;pancreas: 47.9;stomach 1: 20.7" "Cell line enhanced" "Detected in some" "A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Region enriched" "Detected in single" 7 "midbrain: 4.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: " "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favourable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favourable (6.28e-4)" "prognostic favourable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.2 0.0 0.2 1.3 0.2 0.0 0.2 0.2 0.3 9.7 4.5 0.2 0.2 2.2 1.8 0.2 0.2 3.8 13.1 0.2 0.2 0.1 0.2 44.4 15.9 0.2 1.4 0.2 3.4 47.9 0.0 0.4 0.3 0.4 0.5 6.0 0.2 0.2 0.2 0.2 0.0 1.8 0.2 0.2 0.2 20.7 0.3 0.2 0.2 2.2 0.2 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 0.0 0.0 0.0 11.7 0.0 0.0 0.7 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.3 0.0 7.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.5 0.0 26.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 1.4 0.2 0.4 0.2 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Group enriched" "Detected in some" 4 "AF22: 7.0;HDLM-2: 15.2;HEK 293: 11.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073369: " "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 11.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609972-1613897 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "retina: 32.7;salivary gland: 86.6" "Cell line enhanced" "Detected in many" "AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040670 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 7.7 4.4 2.6 1.3 3.4 1.0 9.4 2.3 3.4 6.6 1.4 2.8 3.2 1.2 2.4 3.8 3.8 3.4 9.8 9.5 3.2 2.1 12.9 1.4 3.8 1.6 4.5 2.3 4.8 2.8 2.2 6.5 3.1 6.5 6.0 1.3 32.7 86.6 4.9 3.6 7.1 1.2 2.1 3.9 0.9 1.1 4.6 2.6 2.8 3.7 4.2 2.9 5.7 4.6 0.0 0.0 0.2 0.1 1.4 0.0 0.0 7.2 0.8 0.2 38.9 1.8 2.0 1.2 3.6 4.3 2.3 1.8 2.7 1.5 0.0 4.2 2.1 8.2 3.7 2.7 1.9 2.2 37.9 1.5 2.2 1.3 1.2 0.5 2.5 6.8 3.7 3.1 3.6 3.3 1.0 0.0 0.9 1.5 0.0 0.8 0.1 3.1 0.0 1.6 0.2 15.2 5.5 1.4 3.4 4.5 0.0 2.6 1.1 0.6 0.8 4.9 3.0 2.5 3.8 0.1 0.3 0.0 1.4 1.8 4.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 2.6 3.4 2.3 3.4 3.2 2.1 4.5 2.3 6.5 2.6 FOXC2 "FKHL14, MFH-1" ENSG00000176692 "Forkhead box C2" Q99958 16 86567251-86569728 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 17.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 15.7;HUVEC TERT2: 12.0;LHCN-M2: 19.3;TIME: 21.4;U-138 MG: 11.5;U-2197: 19.3;U-87 MG: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA056302 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA056302: " "unprognostic (3.17e-2)" "unprognostic (1.76e-3)" "unprognostic (4.87e-2)" "unprognostic (4.32e-1)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (4.49e-2)" "unprognostic (1.15e-2)" "unprognostic (4.71e-2)" "unprognostic (8.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.57e-7)" "unprognostic (1.12e-2)" "unprognostic (3.47e-2)" "unprognostic (2.43e-1)" "unprognostic (1.84e-4)" 4.8 5.7 1.1 1.6 1.4 0.5 6.4 1.1 3.4 6.2 2.0 2.2 0.1 1.1 1.6 5.3 3.0 3.9 5.6 8.8 1.1 1.1 9.1 0.9 4.9 5.4 4.3 2.6 4.0 1.3 0.6 3.7 0.9 9.9 2.1 1.0 17.6 4.2 2.9 3.2 1.5 0.9 2.1 8.5 0.5 1.1 7.7 0.7 0.0 3.3 1.0 0.9 4.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.0 0.0 6.4 8.8 5.0 0.9 0.0 0.0 0.0 0.9 0.8 0.0 0.1 2.0 4.4 0.0 0.3 0.0 4.8 0.0 1.7 0.0 0.0 0.8 2.1 15.7 5.0 12.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 21.4 11.5 0.0 19.3 0.0 0.0 0.0 0.0 15.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.1 3.4 1.1 1.1 4.3 2.6 9.9 0.7 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA071469: " "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 1.4 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXJ2 FHX ENSG00000065970 "Forkhead box J2" Q9P0K8 12 8032703-8055503 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008723 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA008723: AB_1078903" "unprognostic (1.68e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-2)" "unprognostic (1.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (9.65e-2)" "unprognostic (3.08e-1)" "unprognostic (2.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (4.63e-4)" "unprognostic (9.01e-2)" "unprognostic (2.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.02e-2)" 19.6 9.7 7.6 9.2 8.6 14.8 14.2 23.7 14.6 20.8 14.7 11.7 17.3 8.1 20.5 11.6 12.3 14.7 13.3 17.3 9.4 5.8 8.5 6.5 12.9 8.4 8.8 8.4 19.9 11.0 21.0 10.2 12.1 7.3 15.4 9.0 11.7 12.4 19.7 25.7 18.1 10.8 17.9 8.4 11.7 12.5 6.7 9.8 13.0 12.0 13.5 13.2 17.0 14.7 4.2 4.5 6.9 3.5 7.3 5.0 2.4 7.3 6.3 6.9 8.7 8.1 8.9 15.2 10.7 11.0 10.5 7.8 8.9 8.2 0.1 2.0 12.9 8.1 6.2 7.1 11.3 12.8 4.2 9.8 7.2 3.0 10.1 4.4 27.6 7.8 10.8 13.5 19.9 7.5 7.1 5.0 8.4 5.8 6.2 4.0 7.9 4.2 6.7 10.7 3.6 4.4 5.0 2.9 3.9 13.4 9.4 4.7 2.1 5.3 6.7 12.8 15.8 9.0 6.4 4.0 4.0 5.0 8.3 3.6 7.6 6.3 3.4 5.1 4.0 2.7 5.0 2.3 4.0 4.6 4.3 4.2 4.7 4.1 6.9 7.3 3.5 4.5 3.1 2.4 7.6 8.6 23.7 14.6 9.4 5.8 8.8 8.4 7.3 9.8 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: " "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavourable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.6 11.5 12.7 13.2 13.7 17.0 18.4 10.4 15.4 14.0 15.6 10.6 16.4 21.0 11.1 14.5 13.1 17.7 17.1 23.8 15.7 10.0 23.1 14.7 9.0 11.9 21.2 15.9 12.6 17.0 20.9 26.0 15.2 13.9 15.3 16.7 7.8 21.4 12.2 19.8 10.6 20.1 33.4 14.3 11.9 19.9 17.7 16.7 18.7 21.7 18.8 10.9 31.7 14.1 14.7 19.7 14.8 17.1 15.1 18.6 17.2 13.2 17.7 11.7 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 FOXK1 IMAGE:5164497 ENSG00000164916 "Forkhead box K1" P85037 7 4682309-4771443 "Predicted intracellular proteins, Transcription factors" "Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017998, HPA018864" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA017998: AB_1849077, HPA018864: AB_1849079" "unprognostic (3.05e-2)" "unprognostic (5.01e-2)" "unprognostic (1.54e-1)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (3.03e-1)" "prognostic unfavourable (2.54e-6)" "unprognostic (2.34e-2)" "unprognostic (2.62e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-3)" "unprognostic (4.96e-2)" "unprognostic (3.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (4.34e-2)" "unprognostic (3.72e-1)" 13.0 16.7 15.5 12.7 16.0 24.7 10.3 18.1 23.8 14.1 15.4 18.4 9.5 10.1 16.9 8.3 12.4 14.4 11.7 13.6 14.4 13.7 10.7 8.4 14.3 11.9 19.3 13.9 15.5 17.6 10.6 22.2 9.9 14.2 11.7 9.3 13.8 12.6 14.0 27.4 21.0 11.3 15.5 12.1 15.6 11.9 14.7 19.9 12.5 9.2 9.5 11.0 14.9 19.0 3.2 2.8 1.9 4.0 3.7 6.5 2.9 8.7 11.2 7.2 14.3 7.2 5.4 9.0 4.0 3.5 2.9 3.3 11.1 9.9 14.8 4.7 6.4 14.3 7.8 9.8 2.9 4.3 4.8 6.9 11.6 6.2 7.0 8.6 8.0 10.3 5.5 6.9 9.6 5.5 14.9 3.3 3.4 10.0 3.3 15.5 10.9 5.7 12.4 7.2 9.4 4.2 13.0 6.5 8.2 6.1 13.3 4.7 7.3 11.5 16.9 5.0 15.9 7.7 8.5 9.2 7.5 9.8 6.8 10.1 7.9 1.9 2.4 1.0 4.6 4.0 6.5 3.2 4.5 4.3 2.8 3.2 5.1 4.7 1.4 3.7 3.7 2.3 2.2 2.9 15.5 16.0 18.1 21.4 14.4 13.7 19.3 13.9 14.2 19.9 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.4 22.9 21.5 23.4 12.4 13.7 14.3 12.6 14.5 22.1 22.5 22.2 13.8 18.3 9.2 15.6 12.5 22.9 14.5 21.0 12.5 21.9 18.9 15.1 21.9 19.6 21.0 12.7 12.9 26.7 23.4 26.7 22.3 25.2 18.8 12.1 12.8 35.8 13.4 12.3 17.6 23.5 18.4 15.1 10.1 18.1 35.6 26.3 12.5 31.9 29.7 22.4 24.4 17.4 29.2 20.5 19.5 25.4 21.7 19.2 23.7 15.8 17.6 15.3 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947140 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3" "Cell line enhanced" "Detected in some" "A-431: 5.4;fHDF/TERT166: 6.3;HEL: 9.0;hTCEpi: 8.3;K-562: 9.2;SiHa: 6.4;THP-1: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069613 Enhanced Supported "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA069613: " "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 1.5 0.3 0.0 1.2 0.0 0.0 0.3 1.0 13.9 0.0 0.6 0.0 0.0 10.0 0.4 0.1 6.4 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.4 55.5 0.6 15.3 13.1 1.4 0.8 0.2 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 2.1 0.3 3.9 0.1 0.0 1.7 0.2 0.0 0.4 0.1 0.0 0.4 0.0 2.6 6.3 1.2 0.0 0.0 0.1 0.0 0.0 9.0 1.1 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 9.2 0.0 3.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 6.4 0.0 0.0 0.0 6.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.3 1.0 0.4 0.2 0.3 0.4 0.8 0.2 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB017832 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavourable (1.95e-6)" "prognostic unfavourable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.6 29.1 22.6 20.7 3.4 4.5 28.8 18.7 18.5 38.1 34.5 36.7 25.7 18.5 4.0 26.8 22.3 33.8 17.2 37.3 34.6 18.1 20.9 27.9 15.7 0.5 16.8 17.1 2.3 1.9 35.3 24.9 26.8 11.7 41.7 29.9 26.9 22.8 8.0 49.8 21.7 16.6 34.3 9.7 9.0 18.4 12.7 20.2 24.0 20.1 11.0 19.7 18.8 10.7 30.9 47.0 36.1 65.0 5.5 9.1 26.8 14.3 16.1 32.7 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favourable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavourable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.7 6.2 12.7 13.9 17.4 45.5 13.6 23.6 13.8 8.1 7.4 25.0 3.2 8.2 8.2 4.6 9.1 6.5 9.8 8.3 16.1 9.5 6.8 18.7 10.6 17.4 23.3 12.8 6.2 8.4 9.8 7.0 12.6 19.0 6.2 8.0 2.9 7.1 4.7 8.0 5.9 10.1 9.5 23.6 17.2 7.4 6.1 26.0 17.8 7.9 6.9 15.7 10.9 8.2 7.6 11.3 42.3 11.3 8.3 9.9 5.6 6.9 10.6 12.2 10.8 9.7 7.2 13.5 7.7 8.5 6.5 7.4 9.3 8.7 15.1 10.4 9.1 8.8 7.4 8.8 9.6 11.7 6.5 29.6 7.6 9.3 17.0 16.2 23.5 6.4 3.8 7.0 12.4 6.9 14.0 18.1 10.6 5.3 17.9 10.7 9.3 5.5 9.0 25.6 12.4 5.7 8.8 6.9 7.0 3.8 7.2 13.7 3.2 9.6 8.0 9.0 9.0 8.5 8.2 9.8 7.3 21.9 7.9 14.9 12.1 35.1 11.1 42.3 8.7 8.9 9.9 7.5 8.3 7.9 11.3 7.6 6.4 6.4 14.1 8.3 11.3 7.0 9.5 5.6 12.7 17.4 23.6 13.8 16.1 9.5 23.3 12.8 19.0 26.0 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA059209: " "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favourable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 26.8 14.5 12.6 23.2 11.3 33.9 35.2 46.9 10.7 17.2 28.4 15.3 12.2 18.2 19.3 11.2 21.0 17.4 11.9 20.2 12.8 7.8 7.5 15.4 14.1 20.1 11.3 7.4 28.8 15.1 35.0 10.1 11.3 13.2 15.7 11.1 17.8 13.4 12.6 44.3 29.5 31.1 25.1 14.0 13.2 15.9 12.6 13.2 34.0 8.8 18.4 19.9 25.7 31.7 9.6 19.3 21.4 14.2 17.3 24.3 15.2 0.1 2.6 7.2 4.3 29.5 9.5 4.9 5.5 5.8 5.1 8.4 2.6 2.1 8.6 2.9 8.7 1.9 12.4 8.0 7.6 36.9 2.3 2.8 5.3 8.9 9.5 5.6 5.1 22.4 4.6 0.4 3.5 10.9 3.3 24.5 8.6 3.3 11.0 5.6 7.6 4.8 17.4 24.6 7.9 0.5 8.8 3.8 12.9 8.1 8.1 2.2 4.4 16.1 19.1 8.8 11.8 8.6 8.3 21.8 37.1 15.4 3.0 9.9 5.1 21.4 13.0 18.8 24.3 14.2 19.5 7.8 16.4 20.8 19.3 9.6 21.5 20.5 5.4 17.3 8.7 4.3 19.2 15.2 12.6 11.3 46.9 10.7 12.8 7.8 11.3 7.4 13.2 13.2 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.3;SH-SY5Y: 6.5;U-266/70: 8.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA050018: " "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.5 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40469953-40666597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.9" "Cell line enhanced" "Detected in many" "ASC diff: 18.9;Daudi: 20.0;HSkMC: 25.2;U-698: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favourable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favourable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 41.6 6.9 7.0 18.4 11.2 8.0 35.5 2.3 5.0 21.4 13.4 8.4 7.7 3.5 27.4 9.8 9.5 17.2 13.3 9.9 7.8 3.9 8.3 25.6 15.3 22.4 8.3 3.9 46.0 12.2 3.8 6.2 9.5 6.5 7.9 6.8 5.7 7.5 9.3 85.9 12.3 7.6 18.6 9.7 10.8 7.4 12.3 9.0 9.4 13.1 9.0 15.6 14.4 16.2 6.1 0.5 2.8 1.6 1.1 7.1 1.0 0.3 0.6 5.6 0.1 18.9 3.7 5.4 0.8 1.1 0.2 0.1 1.4 1.3 20.0 3.7 0.5 4.8 4.4 2.4 0.3 9.1 4.6 0.0 0.6 4.4 9.0 0.1 0.5 25.2 16.4 0.1 3.1 14.2 0.3 6.4 1.4 0.7 0.0 0.2 8.2 1.4 14.2 6.5 1.5 10.5 2.5 1.2 0.3 0.7 3.8 0.8 0.6 0.5 8.3 0.1 1.1 0.0 0.5 3.6 1.3 25.9 0.5 0.9 2.6 0.9 0.8 0.5 1.5 1.0 2.3 3.2 3.9 2.2 0.5 6.1 7.1 5.3 2.8 1.1 1.6 0.0 5.5 1.0 7.0 11.2 2.3 5.0 7.8 3.9 8.3 3.9 6.5 9.0 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71096197-71103535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 98.6" "Cell line enriched" "Detected in many" 5 "BEWO: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039560: , HPA040232: " "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favourable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favourable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 8.5 13.2 21.7 3.8 21.5 9.9 5.1 9.1 15.6 4.8 8.4 9.1 11.9 6.3 6.8 10.2 7.3 7.7 5.8 9.7 21.4 14.5 5.2 3.6 5.5 3.6 22.8 8.4 13.4 6.8 8.7 3.0 98.6 9.2 7.0 4.7 4.9 8.5 11.3 33.8 5.5 6.6 9.4 17.3 6.0 5.2 13.9 13.1 4.4 5.9 7.5 4.2 7.5 11.0 0.9 0.2 3.4 0.6 1.0 1.8 0.9 1.7 0.5 1.4 1.8 3.3 2.3 60.0 1.4 1.6 0.7 1.7 1.2 2.4 2.3 1.8 1.8 0.8 3.6 1.6 0.8 2.3 5.5 3.4 11.2 1.9 1.9 1.9 2.7 1.9 3.8 0.6 0.4 1.8 6.9 4.6 0.3 0.3 3.0 3.1 6.5 2.1 2.1 3.5 3.6 1.2 1.0 1.0 2.9 2.9 0.4 3.1 0.7 1.2 1.7 0.4 0.9 3.1 0.3 3.0 1.6 0.4 1.6 5.2 0.5 0.2 0.6 3.2 0.9 0.6 0.3 0.8 0.5 0.9 0.2 0.9 0.4 1.8 3.4 1.0 0.3 0.0 1.3 0.9 21.7 21.5 9.1 15.6 21.4 14.5 22.8 8.4 9.2 13.1 FOXP4 FLJ40908 ENSG00000137166 "Forkhead box P4" Q8IVH2 6 41546426-41602384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007176 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007176: AB_1078911" "unprognostic (8.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.17e-6)" "unprognostic (3.20e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (9.72e-4)" "unprognostic (2.13e-2)" "unprognostic (7.86e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-3)" "unprognostic (9.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-2)" 12.1 7.8 6.3 13.7 12.6 4.4 15.5 12.3 10.0 28.2 15.8 14.0 16.4 18.7 20.7 8.4 10.5 10.1 29.5 12.9 6.6 7.3 16.4 18.9 14.4 9.1 12.9 4.9 17.1 24.8 5.9 12.6 5.5 9.4 21.7 7.2 21.2 30.1 13.0 7.9 7.1 19.3 11.7 7.9 5.8 37.0 15.4 10.9 12.0 23.9 6.3 14.0 11.7 27.6 2.0 1.0 0.3 0.9 0.6 1.5 0.4 10.1 13.9 17.6 18.8 3.4 1.1 18.0 5.6 3.0 5.0 3.4 43.4 3.2 11.7 10.5 3.4 7.8 5.1 5.3 2.1 9.2 8.1 9.3 7.7 29.1 6.4 5.9 7.7 2.8 6.6 4.4 2.7 4.8 11.5 4.8 2.3 27.4 6.9 10.1 4.4 4.9 7.5 5.6 7.9 4.3 8.4 4.9 7.1 6.0 14.3 9.9 8.1 14.4 6.8 6.3 15.7 9.8 9.4 3.8 2.4 16.3 5.2 9.9 5.9 0.3 0.7 0.3 0.7 0.9 1.2 1.0 0.6 1.5 0.6 2.0 0.1 0.3 0.3 0.6 0.3 1.0 1.1 0.4 6.3 12.6 12.3 9.2 6.6 7.3 12.9 4.9 9.4 10.9 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844301-31845619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;RH-30: 11.9;U-2 OS: 15.9;U-251 MG: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavourable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 5.9 3.1 2.7 3.0 4.7 0.3 11.7 2.7 4.9 9.7 2.6 4.8 1.8 0.9 15.5 6.2 2.8 3.6 11.7 14.0 3.2 2.6 5.5 0.9 6.5 4.6 4.1 4.8 4.0 1.1 0.8 3.2 14.4 5.2 5.0 1.6 7.0 2.0 7.0 4.5 1.8 1.8 3.7 2.6 5.5 1.6 9.7 0.6 3.0 4.9 7.0 3.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.0 15.9 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.7 2.7 4.9 3.2 2.6 4.1 4.8 5.2 0.6 FP565260.1 ENSG00000275464 21 5130871-5154734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 17.2" "Cell line enhanced" "Detected in many" "HEL: 37.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA024573 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 3.0 3.0 1.1 3.0 2.2 3.3 1.4 1.1 6.8 1.7 1.9 7.2 1.1 2.8 1.6 2.6 1.9 2.4 4.8 2.9 3.2 1.8 1.1 1.8 4.2 2.4 1.1 1.9 2.0 2.5 1.1 2.3 2.9 1.8 2.7 1.1 1.7 1.1 6.8 1.8 2.2 3.4 1.1 2.8 1.4 1.4 1.1 1.1 1.7 1.1 2.3 2.4 1.1 8.9 6.6 5.0 12.9 7.4 17.2 7.5 11.6 8.7 5.9 9.1 2.6 1.9 3.5 0.0 0.0 0.0 0.0 0.0 7.5 0.0 5.4 3.9 7.7 16.4 7.2 0.0 2.5 5.3 37.5 4.6 4.5 4.1 17.2 11.2 7.1 8.8 10.1 7.9 7.7 20.9 4.1 2.5 10.3 12.6 11.8 23.3 11.0 19.8 5.5 10.3 5.3 9.3 5.7 10.3 9.6 14.6 5.5 12.2 9.3 3.7 4.5 11.4 0.1 12.1 4.9 5.3 23.6 8.0 22.7 6.2 2.6 5.5 5.0 15.0 9.7 17.2 8.7 9.1 11.0 6.6 8.9 9.2 12.6 3.3 7.4 12.9 4.4 6.0 7.5 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" "Plasma membrane, Cytoplasmic bodies" "HPA029179: " "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.9 1.0 0.3 0.1 2.2 0.0 4.0 0.6 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.7 0.1 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 FP565260.6 ENSG00000280071 21 5079294-5128425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018517 Uncertain Approved Centrosome,Mitochondria "Intracellular and membrane" Mitochondria Centrosome "HPA018517: " "unprognostic (4.87e-2)" "unprognostic (2.69e-3)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (2.96e-1)" "unprognostic (6.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.39e-2)" "unprognostic (7.65e-2)" "unprognostic (1.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.33e-2)" "unprognostic (6.67e-4)" "unprognostic (1.88e-2)" "unprognostic (6.80e-2)" "unprognostic (4.25e-1)" "unprognostic (2.84e-2)" 3.9 6.7 2.8 2.0 6.6 1.3 3.4 8.2 7.0 3.0 5.7 5.2 2.5 5.7 2.2 5.0 3.9 3.3 2.8 15.5 3.2 12.9 14.4 4.8 10.5 6.7 4.7 5.6 2.7 4.0 0.9 6.4 4.2 3.0 4.7 4.4 4.9 2.3 17.1 1.3 3.6 2.4 3.0 2.6 2.2 1.4 3.9 1.1 4.2 11.1 2.4 3.9 2.0 47.1 43.8 19.9 46.4 37.1 41.4 46.1 13.1 12.4 13.8 24.2 13.2 12.6 6.7 0.0 2.6 0.8 1.2 2.0 13.5 1.2 15.3 16.2 9.5 19.9 10.4 1.2 9.0 8.9 51.0 13.2 12.6 12.0 21.9 9.7 20.1 17.4 8.0 14.6 16.0 20.0 15.2 9.5 27.5 21.9 24.0 26.9 20.3 44.9 10.4 47.8 18.1 12.2 13.9 23.5 18.3 34.4 12.8 35.3 30.8 5.7 7.9 9.8 0.8 8.0 20.5 20.9 8.6 16.3 45.4 6.6 19.9 33.6 16.9 31.6 36.0 31.6 43.9 41.4 32.9 43.8 47.1 39.7 30.2 6.8 37.1 46.4 28.9 40.0 46.1 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 34.2" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: , HPA061744: " "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.6 2.7 0.2 0.4 2.4 0.1 0.8 0.8 0.0 0.1 0.3 6.9 0.5 0.1 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.0 0.3 0.6 0.6 0.5 1.1 0.2 0.0 1.6 0.1 0.0 0.3 34.2 0.8 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 FRAT1 ENSG00000165879 "FRAT1, WNT signaling pathway regulator" Q92837 10 97319267-97321915 "Predicted intracellular proteins" "Wnt signaling pathway" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 9.0;neutrophil: 11.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.2" "Low region specificity" "Detected in all" "CAB046472, HPA055258" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB046472: AB_1849131, HPA055258: " "unprognostic (1.48e-2)" "prognostic favourable (5.92e-4)" "unprognostic (3.54e-1)" "unprognostic (1.13e-2)" "unprognostic (1.45e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.11e-2)" "unprognostic (4.44e-3)" "unprognostic (5.73e-2)" "unprognostic (2.50e-2)" "unprognostic (6.36e-3)" "unprognostic (1.89e-1)" "prognostic favourable (6.36e-5)" "unprognostic (6.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.43e-2)" 5.2 3.7 3.0 8.0 4.0 14.9 3.9 5.8 5.8 3.9 6.9 3.4 5.0 7.4 3.6 2.0 3.8 4.0 6.8 3.5 3.3 4.5 2.9 12.6 6.6 18.7 4.4 3.1 3.4 6.7 4.1 2.8 6.5 4.9 4.9 3.3 2.8 6.1 5.9 5.7 4.9 9.9 2.6 2.7 16.2 8.2 21.6 3.3 9.7 2.7 3.3 4.3 3.5 4.7 0.6 1.1 11.2 2.2 0.2 0.8 0.5 0.9 1.5 1.8 8.1 2.3 1.1 1.8 0.9 3.5 0.7 0.7 0.2 1.0 5.3 1.8 0.6 2.4 1.3 1.7 0.1 4.6 2.5 4.5 0.8 2.1 0.8 1.7 4.9 1.0 2.5 0.3 1.1 1.4 1.9 3.8 0.5 4.9 4.6 9.2 2.3 6.6 3.9 0.4 3.4 0.6 1.1 0.9 2.7 1.2 2.5 1.7 9.4 6.4 1.3 0.4 0.5 1.3 0.4 3.5 2.0 1.8 0.6 8.3 0.0 1.0 2.2 9.0 0.6 1.4 0.4 0.5 0.5 0.8 1.1 0.6 0.8 0.6 11.2 0.2 1.6 0.7 0.3 0.5 3.0 4.0 5.8 5.8 3.3 4.5 4.4 3.1 4.9 3.3 FRAT2 ENSG00000181274 "FRAT2, WNT signaling pathway regulator" O75474 10 97332497-97334709 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 70.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 29.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049763: " "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favourable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.0 3.8 5.7 8.7 7.5 23.8 9.7 8.6 9.4 5.7 18.8 4.8 10.2 21.9 6.0 5.9 13.2 6.4 7.2 7.7 6.1 4.9 5.8 15.6 12.0 22.4 5.6 2.0 3.0 16.5 4.8 3.2 9.6 7.7 8.8 14.0 5.4 22.4 4.9 8.7 17.8 20.3 3.7 5.9 28.0 11.5 14.9 7.3 9.0 8.1 8.3 11.1 7.9 13.2 1.2 1.9 29.3 3.7 0.6 1.1 1.1 5.3 2.1 3.5 15.7 2.5 2.1 13.1 1.2 4.4 1.9 1.9 3.3 6.3 6.5 4.3 1.2 10.1 9.2 4.7 1.5 9.7 14.0 8.7 4.6 7.2 1.5 13.9 10.5 1.6 10.2 1.8 5.9 4.7 7.6 2.1 0.9 8.7 6.0 17.7 21.8 8.8 6.2 1.4 9.2 4.5 4.8 6.4 5.2 1.5 9.6 6.0 14.5 22.1 2.1 1.1 1.4 0.8 3.1 5.8 5.9 3.2 1.3 24.2 0.4 3.3 3.7 7.1 0.6 2.3 0.3 0.5 0.7 0.9 1.9 1.2 1.1 0.7 29.3 0.6 3.5 0.4 0.3 1.1 5.7 7.5 8.6 9.4 6.1 4.9 5.6 2.0 7.7 7.3 FRK "GTK, PTK5, RAK" ENSG00000111816 "Fyn related Src family tyrosine kinase" P42685 6 115931149-116060758 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell line enhanced" "Detected in many" "RT4: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025217, HPA030479" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB025217: , HPA030479: " "unprognostic (7.70e-3)" "unprognostic (1.99e-2)" "unprognostic (1.11e-1)" "unprognostic (4.68e-3)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (4.23e-2)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (7.54e-2)" "prognostic favourable (9.66e-7)" "unprognostic (1.52e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.10e-1)" 1.5 2.2 0.8 3.0 1.3 1.3 2.6 0.5 0.8 6.4 21.4 0.2 10.2 6.8 1.6 9.0 10.5 2.8 7.3 3.3 1.2 0.8 23.7 19.6 5.6 0.6 1.5 0.5 2.4 5.9 0.3 3.8 2.7 0.8 4.1 5.5 0.8 9.2 6.1 2.9 2.0 41.4 2.5 2.4 1.0 5.5 1.8 0.5 1.2 1.0 5.2 7.4 5.0 3.6 2.2 1.2 3.8 1.2 1.4 2.3 0.3 3.2 5.3 0.8 1.3 0.4 0.4 1.0 0.8 0.2 0.1 0.1 4.1 5.1 1.3 4.9 0.8 7.7 0.4 1.5 0.2 4.4 0.5 1.8 4.6 3.5 0.3 1.2 1.1 0.3 2.2 0.5 0.6 0.3 0.9 3.3 1.3 1.8 1.0 0.8 1.4 0.9 1.5 4.6 1.6 6.5 10.1 1.1 1.2 1.1 6.8 0.7 2.1 1.0 1.3 1.5 1.6 1.2 0.8 5.0 3.5 2.3 1.5 0.8 1.0 3.2 1.0 1.0 1.9 0.6 2.3 1.1 1.4 1.7 0.4 2.2 1.1 1.4 3.8 1.4 1.2 1.2 1.0 0.3 0.8 1.3 0.5 0.7 1.2 0.8 1.5 0.5 0.8 0.5 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell line enhanced" "Detected in some" "HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: " "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favourable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favourable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.2 1.9 0.1 0.4 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.6 0.4 2.4 0.9 0.1 0.1 0.0 0.0 0.1 0.1 11.6 2.5 1.4 0.1 0.0 0.1 0.5 0.0 0.0 0.1 1.3 0.0 0.0 2.5 0.3 0.0 0.0 0.2 3.6 0.0 1.5 39.2 3.2 5.1 14.5 7.0 0.7 0.1 0.4 0.8 0.4 2.2 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.8 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 28.0;TIME: 34.1;WM-115: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 20.5 2.9 8.2 4.6 13.6 2.6 5.6 4.2 22.4 5.3 3.6 2.0 5.9 2.5 4.3 3.4 4.6 4.4 4.9 5.8 10.3 9.5 5.6 6.0 6.1 5.0 7.3 10.3 3.8 8.5 1.1 9.3 12.3 4.3 5.4 2.9 7.8 7.5 9.6 3.8 18.5 3.4 3.3 5.0 17.1 3.3 7.6 1.5 2.6 3.7 2.0 4.5 4.1 3.6 1.9 2.1 2.0 0.9 1.4 2.0 0.2 1.8 1.2 21.1 0.1 1.9 5.4 5.3 5.4 11.3 7.9 13.0 3.7 0.6 0.0 6.2 5.4 4.1 0.1 1.0 6.9 0.1 3.1 0.4 0.2 0.0 2.6 0.1 0.3 3.7 1.0 28.0 4.0 22.4 4.0 0.1 15.6 2.5 1.3 0.2 3.7 0.8 0.1 4.7 0.0 5.2 1.7 0.7 3.6 0.0 10.2 17.0 5.7 0.7 34.1 12.9 3.0 8.4 8.1 0.1 0.0 0.0 10.0 0.3 48.4 0.4 0.5 0.5 0.4 0.9 0.7 1.9 1.8 0.6 0.4 0.8 0.8 0.5 2.0 1.4 0.6 2.1 2.0 0.2 8.2 13.6 4.2 22.4 10.3 9.5 7.3 10.3 4.3 1.5 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002861, HPA005506" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA002861: AB_1078878, HPA005506: " "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.8 8.8 3.6 8.3 9.6 5.1 6.3 7.7 7.3 6.7 5.3 8.4 11.5 8.5 16.8 11.0 12.1 4.5 6.8 2.9 14.1 4.1 11.7 8.0 4.6 5.2 6.5 18.3 6.3 5.4 6.4 3.4 10.8 9.7 9.5 7.4 9.3 9.9 9.6 3.9 11.5 13.2 6.6 9.6 5.5 8.6 7.6 5.3 6.0 24.4 18.6 8.9 5.4 9.4 7.6 7.9 10.2 4.8 16.4 8.4 8.0 6.6 4.1 52.2 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 FRYL "AF4p12, DKFZp686E205, KIAA0826, MOR2" ENSG00000075539 "FRY like transcription coactivator" O94915 4 48497361-48780322 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031106, HPA031107" Supported Approved "Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Microtubules, Cytokinetic bridge" "HPA031106: AB_10600660, HPA031107: AB_10600536" "unprognostic (7.50e-2)" "unprognostic (9.72e-3)" "unprognostic (6.68e-3)" "unprognostic (3.22e-2)" "unprognostic (5.37e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (4.80e-2)" "unprognostic (4.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.62e-2)" "unprognostic (3.32e-2)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" 9.6 7.5 13.4 13.1 27.4 12.4 8.3 10.1 20.2 7.3 30.5 23.4 7.1 8.6 8.5 3.7 6.3 6.5 7.1 7.7 13.8 8.6 7.6 4.8 9.0 10.6 30.2 7.9 7.1 5.8 28.4 12.5 9.0 17.6 5.9 30.8 5.5 6.1 6.2 9.1 8.8 13.4 8.1 25.8 8.8 9.1 5.2 30.1 11.8 6.9 3.9 10.9 8.8 6.0 2.1 2.2 12.6 2.0 3.3 2.8 0.9 10.2 6.3 14.8 9.4 6.2 8.7 8.0 9.4 9.6 10.0 11.9 4.9 8.3 12.9 8.0 10.1 6.6 9.6 16.0 21.3 7.3 3.3 24.1 6.4 2.3 4.1 16.5 9.6 6.7 6.1 13.7 14.3 14.4 7.4 5.2 12.5 5.2 16.9 5.8 2.5 5.8 13.5 18.8 2.6 9.1 11.2 13.1 5.8 9.8 2.5 5.3 3.9 10.8 21.4 10.8 14.5 5.7 18.8 7.0 9.1 11.7 9.1 11.0 10.8 12.6 1.2 2.3 2.8 2.0 2.2 2.1 2.5 2.2 1.1 1.8 2.8 2.7 3.7 3.3 1.2 2.2 1.8 0.9 13.4 27.4 10.1 20.2 13.8 8.6 30.2 7.9 17.6 30.1 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell line enhanced" "Detected in many" "BEWO: 80.6;K-562: 67.5;NB-4: 76.7;PC-3: 67.5;SH-SY5Y: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: " "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavourable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavourable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 7.8 18.3 12.2 43.7 4.7 9.1 80.6 18.9 8.4 3.2 3.5 12.7 2.0 0.1 23.2 8.3 30.0 7.0 30.4 0.2 9.0 3.8 0.5 19.4 59.7 2.5 0.0 1.5 5.6 9.0 6.1 5.0 15.9 67.5 0.1 4.2 0.8 0.2 76.7 31.9 67.5 17.8 2.9 0.3 4.7 0.7 9.8 64.8 15.9 0.2 0.6 0.4 4.8 32.3 22.5 39.6 13.0 19.4 0.1 0.1 0.0 14.5 0.0 42.2 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 FSD1L "CCDC10, CSDUFD1, FSD1CL, FSD1NL" ENSG00000106701 "Fibronectin type III and SPRY domain containing 1 like" Q9BXM9 9 105447796-105552433 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035138 Approved Approved "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA035138: AB_10601324" "unprognostic (9.28e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.88e-3)" "unprognostic (3.93e-2)" "unprognostic (1.82e-2)" "unprognostic (3.17e-5)" "unprognostic (4.20e-2)" "unprognostic (5.65e-2)" "unprognostic (9.64e-3)" "unprognostic (2.66e-3)" "unprognostic (3.32e-2)" "unprognostic (8.28e-2)" "unprognostic (2.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.07e-2)" "unprognostic (1.22e-3)" 2.5 6.9 9.5 3.9 15.2 4.1 3.2 11.1 19.6 3.6 4.9 8.3 6.7 8.6 4.3 6.3 2.2 14.5 3.0 7.4 10.0 13.0 4.2 1.8 4.3 3.0 11.3 8.7 2.8 3.2 7.6 18.9 2.0 20.6 3.2 4.8 7.6 2.3 3.8 11.1 2.4 6.7 3.3 15.5 2.8 4.2 12.2 7.4 2.0 4.1 6.0 3.1 2.4 2.3 5.5 2.1 1.2 2.9 1.7 2.5 0.9 3.5 4.0 6.3 3.7 1.7 3.5 2.1 3.1 2.1 3.1 2.7 2.0 1.3 9.4 1.3 3.1 1.4 4.8 1.8 4.3 11.3 1.5 1.6 5.2 2.4 2.3 5.5 3.6 1.8 1.6 4.2 6.6 2.4 1.9 5.5 2.2 1.2 8.8 2.9 4.0 2.5 11.2 4.2 0.7 2.5 0.8 13.0 6.2 3.6 0.9 2.6 4.2 1.6 2.7 4.9 3.1 4.1 4.4 3.0 10.2 2.5 3.2 3.0 1.6 1.2 2.9 0.1 1.7 1.6 0.8 5.5 2.5 1.8 1.8 2.3 0.3 1.1 1.2 1.7 1.5 2.1 0.6 0.9 9.5 15.2 11.1 14.8 10.0 13.0 11.3 8.7 20.6 7.4 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738895-185833290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 27.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;RT4: 4.7;U-266/70: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.4 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.3 0.3 2.7 0.1 0.1 0.0 0.6 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.6 0.5 0.5 0.3 1.4 0.3 0.2 0.1 0.1 0.3 0.6 0.6 0.1 0.5 3.6 27.6 0.1 0.1 0.4 0.1 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120451253 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 127.1;BJ: 147.5;fHDF/TERT166: 182.0;HBF TERT88: 121.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 10.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" 32000000 "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: " "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavourable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 72.3 28.6 4.8 23.1 5.8 0.0 104.0 2.5 6.7 52.1 39.1 7.3 28.7 5.8 41.6 58.1 39.2 42.6 45.6 69.4 5.9 3.2 15.1 5.5 33.6 44.4 4.3 4.3 26.9 8.7 5.5 7.9 110.0 13.2 36.3 15.4 26.2 17.5 32.5 23.6 18.4 18.6 90.2 9.4 16.7 22.1 19.8 4.9 4.7 23.8 29.1 11.1 67.1 65.8 0.1 1.2 10.2 0.1 0.0 0.0 3.6 5.3 1.4 15.3 6.3 92.4 127.1 0.0 147.5 82.8 95.5 84.8 0.0 12.3 0.0 12.5 182.0 1.4 4.7 18.3 121.8 0.0 2.2 0.0 11.6 0.0 20.3 0.0 0.0 96.6 0.5 61.7 13.5 55.3 0.0 0.0 15.5 0.0 1.4 0.1 12.6 12.3 0.0 6.4 0.0 10.2 0.1 2.7 6.5 52.4 0.9 5.3 1.6 0.4 67.5 35.9 34.5 18.7 21.8 0.0 0.0 0.1 12.5 0.0 4.6 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 3.6 4.8 5.8 2.5 6.7 5.9 3.2 4.3 4.3 13.2 4.9 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 32.7;U-266/70: 11.7;U-266/84: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.3 7.5 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.7 0.9 0.3 6.1 0.0 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.3 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.0 3.4 4.0 0.0 7.1 0.8 0.3 8.0 0.8 0.3 0.7 7.6 0.0 8.3 32.7 0.7 1.6 1.4 0.1 2.8 0.3 0.2 0.3 1.3 0.4 0.2 11.7 11.7 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell line enriched" "Detected in some" 29 "Hep G2: 44.4" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favourable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favourable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favourable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 44.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO, alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Approved Vesicles,Cytosol 130000 "Vesicles, Cytosol" "CAB017123: , HPA041086: , HPA068695: " "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 17.5 25.4 19.7 8.7 37.4 5.6 27.1 29.7 37.5 20.2 13.5 30.1 11.4 5.8 22.7 16.8 13.2 19.5 16.2 19.5 19.9 25.9 19.0 13.0 27.3 10.1 21.8 19.6 21.2 15.2 42.0 31.6 14.7 28.9 15.8 10.9 18.9 13.4 19.1 19.9 13.6 8.1 22.6 23.8 11.5 10.1 6.2 22.2 10.0 20.7 7.8 10.6 16.1 12.5 12.3 15.3 8.1 14.8 16.3 22.1 14.0 6.6 12.0 16.0 16.4 31.6 23.9 5.3 16.0 14.6 13.5 3.9 7.5 8.8 15.1 17.7 20.6 9.8 14.8 15.7 19.8 7.0 11.6 6.8 16.3 13.9 21.8 5.4 7.8 26.2 16.7 12.2 15.1 19.9 6.6 3.8 21.7 5.2 12.0 8.3 8.3 7.9 18.5 24.3 14.2 20.4 5.6 19.8 13.7 18.2 10.8 4.9 14.2 13.0 18.9 16.9 11.3 9.0 9.8 7.3 5.9 15.6 15.7 10.1 12.9 8.1 11.6 6.0 17.7 14.8 22.1 12.3 17.0 17.7 15.3 11.7 16.0 17.2 2.0 16.3 10.0 6.1 16.5 14.0 19.7 37.4 29.7 37.5 19.9 25.9 21.8 19.6 28.9 22.2 FUBP3 FBP3 ENSG00000107164 "Far upstream element binding protein 3" Q96I24 9 130578965-130638352 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047658, HPA058392" Uncertain Approved Nucleoplasm,Cytosol 6200 Nucleoplasm Cytosol "HPA047658: , HPA058392: " "unprognostic (1.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.91e-1)" "unprognostic (2.51e-1)" "unprognostic (5.67e-3)" "unprognostic (2.12e-2)" "unprognostic (2.29e-2)" "prognostic unfavourable (2.38e-4)" "unprognostic (3.12e-2)" "unprognostic (7.27e-2)" "unprognostic (4.66e-1)" "unprognostic (4.23e-2)" "prognostic favourable (4.39e-5)" "unprognostic (2.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.23e-2)" 26.6 24.1 24.3 18.5 24.3 10.5 21.8 23.9 30.3 22.8 24.0 37.7 22.9 19.9 32.7 20.7 24.2 22.1 25.4 24.3 24.6 20.0 22.4 37.6 19.9 18.7 27.4 22.8 25.2 27.7 36.6 23.8 33.8 23.9 26.1 20.4 21.9 26.1 25.3 15.2 22.0 20.5 26.9 30.0 20.2 22.0 30.0 27.5 26.4 39.9 18.1 20.1 23.2 22.9 4.5 5.6 2.1 4.5 7.3 6.9 3.0 20.6 19.1 27.9 22.9 20.1 23.0 35.4 29.7 26.6 24.0 18.7 27.5 19.2 20.1 15.7 28.1 36.2 23.4 25.2 28.6 22.1 20.1 22.2 30.4 20.1 27.6 33.3 25.2 22.1 20.3 25.2 23.9 19.6 35.3 12.5 24.8 27.8 25.7 17.0 35.8 24.4 23.0 34.8 26.9 21.0 21.9 18.5 30.7 31.5 23.5 19.4 32.2 25.4 24.8 43.5 20.7 29.3 34.3 11.5 18.9 26.1 24.3 14.5 31.0 0.0 3.7 2.1 4.7 4.5 6.9 4.5 5.1 5.6 5.6 3.3 5.9 5.1 1.0 7.3 3.5 4.9 4.0 3.0 24.3 24.3 23.9 23.7 24.6 20.0 27.4 22.8 23.9 27.5 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009499 Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095" "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.1 8.6 1.9 8.7 14.3 9.2 22.2 17.8 13.6 7.4 5.2 12.6 15.5 0.5 45.9 12.9 25.5 3.9 9.2 1.6 40.7 10.1 24.8 15.5 16.5 7.6 3.4 40.9 10.4 10.4 8.4 3.8 23.6 18.9 2.5 4.9 9.7 1.3 11.2 6.2 2.5 2.2 7.5 3.2 11.5 10.8 3.9 2.6 15.1 8.2 12.6 2.9 9.1 34.7 8.3 17.8 12.7 26.1 4.4 25.1 1.1 15.9 11.2 16.8 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: , HPA058655: " "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.1 4.4 7.0 8.4 11.1 11.3 3.7 4.5 7.2 4.3 5.9 6.6 3.9 2.5 5.4 5.6 6.1 10.2 4.1 4.4 5.7 3.9 8.3 3.7 7.3 5.1 1.8 3.0 7.8 7.4 1.1 5.4 8.7 7.6 3.4 4.1 1.3 6.5 2.7 9.9 2.9 4.8 5.4 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 3.7 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 FUT11 MGC33202 ENSG00000196968 "Fucosyltransferase 11" Q495W5 10 73772291-73780251 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014033 Approved Approved "Nuclear membrane,Golgi apparatus" "Intracellular and membrane" 840000 "Nuclear membrane" "Golgi apparatus" "HPA014033: AB_1849192" "prognostic unfavourable (6.78e-4)" "prognostic unfavourable (2.39e-6)" "unprognostic (1.47e-2)" "unprognostic (2.42e-3)" "unprognostic (3.27e-1)" "unprognostic (7.64e-2)" "unprognostic (2.29e-2)" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (9.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (3.67e-4)" "unprognostic (2.59e-2)" "unprognostic (1.71e-1)" "unprognostic (3.61e-1)" "unprognostic (2.66e-2)" 16.2 9.5 8.9 9.0 9.2 7.8 13.9 7.9 11.8 13.8 7.0 8.2 9.8 4.4 12.5 7.8 14.6 9.0 12.8 14.5 7.3 6.3 9.2 7.4 16.1 18.2 10.4 7.2 13.4 7.9 8.9 7.7 24.0 9.7 9.7 5.6 9.7 9.1 9.8 7.5 6.9 7.9 11.9 8.7 14.2 6.9 18.8 7.4 4.5 10.0 6.8 8.6 10.8 11.1 1.7 2.6 3.9 1.3 7.8 16.0 4.4 14.4 8.0 5.7 11.8 11.3 13.1 1.7 7.4 17.9 9.5 18.5 2.6 7.8 3.3 5.4 12.1 6.2 2.9 7.4 10.5 7.9 6.2 4.5 6.4 4.2 4.4 6.3 14.2 8.7 1.7 9.0 9.3 17.2 4.4 6.0 9.3 1.7 1.1 3.3 2.6 20.1 1.5 3.5 3.9 3.4 2.6 1.7 5.5 6.5 6.9 4.2 4.6 2.8 17.5 12.3 5.3 6.1 9.1 8.0 2.7 0.7 17.3 5.6 4.0 3.9 1.0 1.0 16.0 1.2 11.4 1.7 4.8 11.2 1.3 1.5 3.5 7.4 0.2 7.8 1.3 2.6 1.9 4.4 8.9 9.2 7.9 11.8 7.3 6.3 10.4 7.2 9.7 7.4 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 40.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favourable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 1.1 1.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.8 40.9 0.3 0.3 0.0 7.2 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.9 0.3 0.3 0.3 0.1 1.8 0.0 0.3 2.2 0.3 0.1 0.3 0.0 6.1 0.0 0.1 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA040863, HPA043410" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA040863: , HPA043410: " "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.9 6.9 3.3 30.7 14.8 11.2 20.8 11.2 17.2 7.8 8.7 5.4 12.9 9.3 9.6 11.1 2.6 7.9 3.1 12.0 34.5 3.4 9.4 2.5 7.0 7.6 2.1 7.7 28.1 2.0 10.8 5.1 19.8 3.4 7.9 5.6 18.0 9.9 5.1 4.5 24.2 6.8 2.9 5.3 14.0 9.8 7.1 5.3 6.0 2.8 2.4 2.8 3.4 43.1 10.3 11.0 4.5 9.1 15.9 6.0 22.2 20.8 3.7 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell line enhanced" "Detected in some" "MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: " "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.4 9.6 0.2 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 FXN "CyaY, FA, FARR, FRDA, X25" ENSG00000165060 Frataxin Q16595 9 69035259-69120427 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022164, HPA068304" Supported Supported Mitochondria,Cytosol Mitochondria Cytosol "CAB022164: , HPA068304: " "unprognostic (3.38e-2)" "unprognostic (1.54e-1)" "unprognostic (7.47e-2)" "unprognostic (2.37e-3)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.71e-3)" "unprognostic (1.10e-1)" "unprognostic (9.06e-2)" "unprognostic (1.67e-1)" "unprognostic (4.74e-2)" 8.7 19.9 10.8 9.1 9.8 21.9 11.8 13.9 11.0 8.3 9.3 12.3 11.6 6.6 12.4 11.7 9.2 9.6 7.2 20.2 8.7 10.1 10.2 40.2 9.5 12.8 11.7 8.5 16.8 25.9 18.8 8.6 8.4 10.5 9.9 11.6 12.1 11.9 13.6 25.1 5.2 7.2 16.6 8.9 12.9 9.2 13.3 9.7 3.7 11.1 9.5 9.6 10.5 7.9 15.8 17.7 2.0 18.5 24.2 28.3 19.1 11.2 9.6 15.7 7.5 7.2 10.7 15.2 8.2 7.2 12.5 9.7 5.1 7.3 20.2 6.3 8.5 12.4 18.5 18.7 15.8 23.6 21.1 28.5 6.3 37.5 12.3 20.8 12.4 11.8 15.1 12.5 13.6 16.7 21.3 19.8 11.6 11.0 5.9 9.1 21.2 19.1 14.0 10.8 13.8 14.4 9.4 12.1 5.4 8.4 5.5 8.5 6.2 6.4 9.9 8.2 14.3 10.7 11.8 5.6 4.8 12.0 3.8 17.2 8.2 2.0 16.7 0.1 21.5 18.5 16.3 15.8 22.0 21.2 17.7 10.3 28.3 27.1 0.8 24.2 14.1 15.0 17.0 19.1 10.8 9.8 13.9 11.0 8.7 10.1 11.7 8.5 10.5 9.7 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Cell line enhanced" "Detected in some" "ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 30.3 8.8 0.8 3.6 0.1 0.0 0.0 0.0 0.2 2.4 0.9 0.0 0.6 0.7 0.4 0.0 2.1 0.8 0.4 0.0 1.1 3.5 0.2 0.2 12.5 0.0 0.1 0.3 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.1 3.9 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.6 0.4 5.0 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell line enhanced" "Detected in some" "HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 15.9 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.5 23.2 0.0 0.0 0.0 88.3 0.0 33.3 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 160.7 0.0 0.0 0.0 0.0 0.1 0.0 29.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 83.9 19.7 0.2 0.1 82.6 6.1 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 59.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell line enhanced" "Detected in some" "AF22: 37.1;HAP1: 24.5;RH-30: 15.4;SCLC-21H: 56.2;SH-SY5Y: 32.1" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: " "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favourable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favourable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 24.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.6 0.1 7.4 0.0 0.0 15.4 0.2 0.9 0.0 56.2 32.1 0.0 0.1 1.2 0.6 0.6 0.0 0.0 9.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 9.5;RPTEC TERT1: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in many" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA068838: , HPA075209: " 2.8 2.7 7.4 1.8 12.4 1.8 2.7 4.2 22.2 6.0 4.5 7.9 1.4 1.8 11.4 5.2 2.5 3.9 6.6 3.0 4.8 2.9 23.0 2.8 3.1 2.1 2.5 16.5 10.2 9.6 2.4 4.2 2.5 4.6 9.4 2.0 2.2 19.5 2.2 2.9 2.5 3.0 13.7 2.5 4.2 2.9 3.6 4.3 0.0 2.9 0.5 2.3 10.1 2.8 0.0 0.5 0.0 1.1 0.8 1.3 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.7 0.0 0.0 0.4 0.0 10.9 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 0.4 0.3 0.0 0.8 0.0 0.5 0.0 0.7 7.4 12.4 4.2 22.2 4.8 2.9 2.5 16.5 4.6 4.3 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Group enriched" "Detected in some" 4 "HEL: 18.4;MOLT-4: 62.6;REH: 18.4;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796" Enhanced Approved "Nucleoplasm,Plasma membrane" 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126" "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.3 0.0 0.0 0.1 0.0 7.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 18.4 0.0 0.0 0.0 6.9 5.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 62.6 3.9 0.0 0.0 18.4 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.1 1.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 24.3 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "NK-cells: 15.3;T-cells: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" 2000000 "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: " "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favourable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favourable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 29.1 7.2 49.2 29.0 38.4 16.3 18.1 33.9 62.1 25.7 12.1 33.7 4.1 10.1 21.8 21.4 10.2 32.0 19.4 21.2 39.4 34.0 9.5 12.2 25.2 57.2 35.7 23.1 18.6 4.4 15.0 12.5 17.7 25.6 9.6 10.0 11.0 6.4 8.4 7.0 16.5 19.0 24.2 30.9 39.8 15.4 10.1 31.3 34.8 27.5 5.6 38.5 22.6 19.3 1.6 1.7 0.7 1.5 15.3 43.2 10.7 1.9 0.2 34.2 5.7 26.2 16.1 0.6 5.4 17.1 4.6 8.3 0.2 0.3 3.8 3.5 10.4 0.2 4.8 7.5 9.1 0.1 12.6 10.5 2.5 0.5 15.5 3.5 3.6 15.4 11.3 17.4 14.9 18.8 0.8 26.8 16.4 0.2 16.7 3.2 4.9 3.4 5.3 4.6 0.2 0.0 1.7 24.0 9.7 1.0 0.4 22.8 0.2 10.6 11.9 14.0 2.6 103.1 3.4 3.8 3.5 5.9 26.4 8.2 24.3 0.2 1.5 0.0 34.1 1.2 43.2 1.1 21.2 37.5 1.7 1.6 7.0 18.7 0.7 15.3 0.9 1.0 17.6 10.7 49.2 38.4 33.9 35.3 39.4 34.0 35.7 23.1 25.6 31.3 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.7;BJ hTERT+ SV40 Large T+: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: " "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.5 25.7 14.7 8.4 3.3 2.9 0.3 21.3 13.0 25.5 18.4 19.8 4.4 0.0 6.7 5.3 3.5 1.7 1.8 6.1 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 1.0 1.6 0.2 6.4 4.0 3.4 1.9 16.1 4.8 9.8 4.4 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 8.2 3.6 0.4 13.8 12.2 2.6 12.5 0.6 0.4 1.8 2.5 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;Hep G2: 31.8;HSkMC: 18.3;HUVEC TERT2: 36.0;TIME: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: " "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favourable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.0 2.0 25.4 6.6 1.4 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.0 1.2 0.5 1.0 0.1 0.8 1.0 0.8 31.8 7.5 0.0 0.0 18.3 0.2 1.1 0.2 36.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 7.2 0.0 1.9 0.0 3.5 5.2 0.2 0.3 1.3 0.3 0.5 4.6 0.0 17.6 3.0 2.0 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 FZR1 "CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242" ENSG00000105325 "Fizzy and cell division cycle 20 related 1" Q9UM11 19 3506273-3538330 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043536 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA043536: AB_10968058" "unprognostic (2.78e-1)" "prognostic favourable (1.75e-4)" "unprognostic (1.15e-1)" "prognostic favourable (2.57e-4)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (9.20e-2)" "unprognostic (1.61e-1)" "unprognostic (9.70e-2)" "unprognostic (1.18e-1)" "unprognostic (4.15e-3)" "unprognostic (1.41e-2)" "unprognostic (3.75e-1)" "unprognostic (5.41e-3)" "unprognostic (1.75e-1)" "unprognostic (9.04e-2)" "unprognostic (1.04e-1)" 10.3 16.9 15.4 12.0 19.9 37.2 10.6 39.1 23.1 13.3 13.8 17.7 11.0 29.0 14.6 10.1 14.6 12.3 14.5 10.3 13.0 16.6 12.0 13.8 10.7 12.6 11.7 14.3 16.4 20.6 13.2 22.5 15.4 16.1 12.3 5.0 14.9 24.6 15.1 18.1 15.7 18.0 12.0 10.7 15.3 16.3 29.7 14.1 18.9 15.6 9.3 15.8 10.6 12.9 3.0 1.7 5.7 2.1 3.3 3.5 1.5 23.2 14.2 12.1 11.8 3.4 5.6 10.5 14.7 7.6 14.3 11.3 14.3 11.5 12.9 7.6 9.5 13.9 6.7 12.3 2.9 17.6 13.0 6.2 10.0 13.9 7.5 11.1 13.1 5.0 6.5 8.8 5.1 9.2 11.0 20.7 7.7 12.2 19.6 7.9 11.3 11.1 14.6 11.5 12.6 7.2 11.8 11.5 14.0 13.1 9.3 7.2 9.7 8.7 13.9 9.8 12.1 23.7 25.1 24.1 5.6 9.9 13.4 21.7 11.9 3.5 1.9 5.7 3.5 2.1 2.0 3.0 3.4 2.4 1.7 2.6 1.8 2.7 3.7 3.3 1.5 1.4 2.4 1.5 15.4 19.9 39.1 23.1 13.0 16.6 11.7 14.3 16.1 14.1 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559123-30620063 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Approved Approved "Golgi apparatus,Vesicles,Cytosol" Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 7.6 5.1 5.6 7.6 14.2 8.5 6.6 10.8 10.4 8.1 5.8 5.8 4.2 5.9 8.5 4.8 7.0 5.4 4.5 4.9 6.7 5.2 5.4 5.5 5.4 8.6 7.3 4.9 7.1 5.7 6.0 10.9 6.9 7.6 6.0 6.1 5.3 5.9 7.1 5.2 6.1 5.8 6.7 7.1 7.9 5.4 39.6 8.8 20.9 7.3 4.8 9.5 6.0 8.3 11.5 8.1 16.5 12.5 7.9 12.4 5.0 20.8 9.5 21.3 9.8 6.9 8.5 18.0 19.6 7.1 11.9 13.4 9.2 12.7 17.5 6.3 10.7 17.6 20.4 11.2 24.2 14.4 8.3 9.6 10.4 16.9 6.2 18.5 12.2 5.3 4.5 9.5 21.7 14.0 11.8 14.6 16.6 12.1 12.4 4.6 17.8 16.7 11.4 0.0 4.8 7.0 13.0 18.1 12.2 15.8 10.7 4.5 12.2 6.3 10.4 12.7 13.6 9.3 12.8 8.4 24.6 21.0 3.8 9.3 18.8 16.5 7.5 14.1 9.6 9.7 12.4 10.8 9.4 7.7 6.4 11.5 12.0 10.1 6.8 7.9 12.5 8.1 7.3 5.0 5.6 14.2 10.8 10.4 6.7 5.2 7.3 4.9 7.6 8.8 G6PD G6PD1 ENSG00000160211 "Glucose-6-phosphate dehydrogenase" P11413 X 154531391-154547572 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.1" "Cell line enhanced" "Detected in all" "A549: 225.5;MCF7: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 77.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 77.3" "Low region specificity" "Detected in all" "HPA000247, HPA000834" Enhanced Enhanced "Centriolar satellite,Cytosol" 12000000 Cytosol "Centriolar satellite" "HPA000247: AB_1078978, HPA000834: AB_1078977" "unprognostic (1.73e-2)" "unprognostic (1.53e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (7.78e-2)" "unprognostic (4.34e-2)" "prognostic unfavourable (9.45e-13)" "unprognostic (2.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.66e-1)" "unprognostic (2.89e-3)" "unprognostic (2.83e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (7.25e-2)" 21.9 29.4 10.4 15.6 10.7 51.4 18.2 8.4 14.7 12.2 7.5 13.6 4.8 7.2 14.0 13.2 29.0 11.0 24.7 10.1 8.8 10.1 15.4 3.7 20.8 31.0 10.3 8.0 19.8 7.9 5.9 20.7 9.2 10.9 11.3 7.3 17.8 13.9 8.6 4.4 11.3 7.3 17.5 11.1 20.3 9.9 83.1 9.5 22.5 24.6 44.8 25.7 24.1 19.0 3.6 7.6 77.3 16.2 12.7 10.3 11.8 15.4 225.5 4.6 17.8 19.5 26.7 4.1 10.8 31.0 11.0 19.1 10.3 5.8 10.0 16.8 24.7 13.8 7.2 18.3 5.7 10.2 5.0 10.6 51.0 23.2 38.2 10.6 36.4 12.9 5.4 21.6 4.6 22.9 6.3 4.4 19.9 85.5 6.8 7.6 3.3 16.7 6.7 2.6 10.9 33.2 19.3 4.7 5.9 10.8 42.1 9.0 6.3 8.9 27.2 7.0 24.7 9.7 16.6 5.3 6.9 17.1 19.4 7.0 14.3 29.3 16.2 77.3 10.3 13.6 6.6 3.4 2.7 7.4 7.6 3.6 3.5 5.9 27.1 12.7 11.1 3.5 3.5 11.8 10.4 10.7 8.4 14.7 8.8 10.1 10.3 8.0 10.9 9.5 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell line enhanced" "Detected in many" "REH: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favourable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.3 0.7 8.7 6.3 4.4 4.3 11.4 2.3 7.8 2.8 5.0 6.5 5.7 0.1 0.7 3.3 1.9 8.3 2.7 3.2 0.4 2.0 6.1 1.9 3.0 3.0 0.8 1.2 5.2 4.9 3.4 2.3 3.7 2.0 11.2 1.9 4.9 0.5 0.0 2.5 2.7 37.3 4.3 4.3 4.4 4.1 2.0 6.2 1.6 6.8 2.9 4.4 0.8 2.8 3.6 2.9 1.7 1.7 18.1 8.8 13.4 2.4 2.4 2.9 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566351-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavourable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favourable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 29.6 47.4 69.0 18.0 70.5 24.7 33.8 52.3 61.4 29.4 23.9 54.2 26.0 18.7 25.7 47.1 21.7 30.9 23.7 76.6 59.6 69.5 42.0 31.4 25.4 23.4 73.4 52.5 28.9 25.8 46.2 33.6 31.8 52.4 33.4 23.6 30.8 27.3 31.0 52.7 24.3 19.4 28.2 72.0 25.7 21.8 20.2 45.4 17.5 35.7 22.4 26.8 22.6 19.3 38.2 47.0 87.8 25.4 18.9 35.1 35.9 23.4 19.9 34.1 16.1 53.1 46.8 17.3 27.6 40.0 37.8 42.6 18.3 30.4 33.9 34.1 31.4 20.2 25.3 25.9 46.9 14.6 48.3 20.0 18.4 27.1 28.9 19.1 36.1 32.3 36.7 31.9 23.8 30.7 29.2 13.9 37.8 33.2 28.2 36.6 20.4 22.4 31.8 16.5 40.8 39.6 15.4 40.2 42.1 43.1 10.4 39.7 33.3 30.2 28.0 16.5 25.1 23.9 14.8 39.6 37.5 70.9 39.6 18.6 24.2 47.8 25.3 61.1 23.9 23.4 30.6 38.2 25.6 27.3 30.4 32.1 23.3 21.8 87.8 18.9 25.4 47.0 35.1 35.9 69.0 70.5 52.3 61.4 59.6 69.5 73.4 52.5 52.4 45.4 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor beta subunit 1" Q06547 15 50275392-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: " "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavourable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 15.4 12.6 8.1 13.8 16.8 31.7 14.3 16.0 14.0 12.7 9.5 8.4 8.6 8.1 14.1 10.8 13.8 12.0 12.6 10.3 8.8 7.2 9.1 16.2 15.2 25.7 9.1 8.7 12.1 10.6 8.7 11.5 15.1 7.3 11.4 11.8 10.7 12.1 8.1 15.2 10.4 12.8 13.9 7.3 17.1 11.2 17.3 9.9 35.7 16.2 12.5 20.8 13.4 11.9 23.1 16.8 26.8 15.0 19.1 21.1 14.3 11.7 13.5 19.8 15.4 5.2 7.4 26.4 15.4 12.2 18.3 16.1 22.9 9.7 15.4 9.4 12.6 19.3 17.7 13.2 23.3 21.3 10.6 18.2 14.1 15.6 12.6 17.4 14.1 9.7 13.0 17.1 22.3 31.9 16.7 19.4 12.1 26.6 25.7 15.7 13.5 9.2 31.8 14.4 14.6 11.0 14.9 18.7 15.5 13.7 13.0 15.6 11.3 17.3 15.1 16.7 13.9 29.2 27.5 13.9 18.9 27.1 10.3 16.1 16.8 26.8 12.2 23.6 15.9 15.0 21.1 23.1 15.7 16.9 16.8 21.3 14.6 16.8 12.4 19.1 11.1 13.3 20.4 14.3 8.1 16.8 16.0 14.0 8.8 7.2 9.1 8.7 7.3 9.9 GABPB2 MGC29891 ENSG00000143458 "GA binding protein transcription factor beta subunit 2" Q8TAK5 1 151070578-151125542 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028471, HPA058483" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028471: AB_10602319, HPA058483: " "unprognostic (1.21e-1)" "unprognostic (7.03e-3)" "unprognostic (2.76e-2)" "unprognostic (9.95e-2)" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" "unprognostic (4.65e-2)" "unprognostic (7.71e-2)" "unprognostic (1.98e-2)" "unprognostic (8.02e-2)" "unprognostic (1.75e-2)" "unprognostic (1.61e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.90e-3)" 9.9 8.3 9.5 9.3 13.3 12.2 10.9 12.3 12.2 10.0 8.5 14.8 10.7 7.0 10.1 8.0 8.7 10.2 10.7 11.0 11.6 5.8 7.9 6.4 7.7 9.9 14.4 9.7 17.6 7.8 15.1 12.8 6.5 11.4 9.4 9.8 11.0 7.6 12.6 10.0 13.9 8.1 12.0 10.2 10.1 9.8 20.2 15.2 15.7 10.0 11.6 9.8 9.9 16.6 4.7 5.0 4.7 5.1 2.6 4.8 2.6 6.8 2.4 1.7 2.1 6.0 8.9 2.2 6.3 3.9 3.7 2.6 0.7 5.1 7.1 2.4 6.0 6.0 3.6 3.2 5.4 2.6 1.4 1.9 3.7 0.1 4.0 7.7 4.0 4.8 3.8 5.1 7.5 1.3 4.7 5.0 4.4 9.7 10.6 1.4 0.8 2.7 3.2 2.8 3.3 3.1 1.9 3.0 1.2 8.0 2.8 2.4 7.1 8.5 4.0 0.9 3.2 6.5 5.1 2.7 1.3 26.0 3.0 5.9 4.3 3.6 2.8 1.6 4.4 3.3 2.7 3.1 4.8 3.9 2.5 4.7 4.3 4.7 4.7 2.6 5.1 5.0 1.7 2.6 9.5 13.3 12.3 12.2 11.6 5.8 14.4 9.7 11.4 15.2 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044371: " "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 5.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029816 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 50.5 37.3 10.3 24.6 33.8 142.2 34.2 6.7 26.4 20.0 29.2 17.9 4.1 9.7 14.2 10.7 17.6 34.3 44.6 59.0 22.5 15.6 26.2 143.6 49.8 14.7 17.1 3.9 36.3 45.5 16.7 27.5 22.6 32.4 27.2 6.6 26.6 28.1 36.9 38.4 22.1 12.3 14.5 32.8 14.7 27.1 12.4 13.1 6.7 53.9 29.5 13.7 35.0 15.0 12.2 13.5 45.1 14.9 14.9 22.6 10.1 21.2 4.2 0.5 2.8 16.2 12.5 1.3 21.7 6.3 17.1 8.9 5.9 8.2 10.1 14.7 10.7 11.8 1.1 7.2 4.2 7.7 3.9 1.1 4.7 2.2 27.4 2.3 7.1 20.2 4.7 5.1 25.5 6.8 0.5 27.6 17.6 6.8 2.6 11.3 2.6 9.2 9.8 7.9 15.9 7.7 3.8 0.2 0.2 24.2 18.2 7.0 9.6 17.0 27.6 17.1 15.8 12.2 27.0 12.4 9.2 4.1 4.1 6.9 5.5 11.7 11.8 45.1 22.6 14.9 20.4 7.4 15.8 17.3 11.9 12.2 14.1 18.5 34.5 14.9 11.6 13.5 19.1 10.1 10.3 33.8 6.7 26.4 22.5 15.6 17.1 3.9 32.4 13.1 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell line enhanced" "Detected in many" "HAP1: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.5 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.9 9.7 0.3 0.4 1.7 0.5 1.6 1.5 0.5 0.4 0.9 3.3 0.4 0.5 0.7 0.3 0.6 1.2 4.0 0.9 1.1 0.6 1.3 1.8 0.5 1.9 2.1 1.0 1.0 1.5 1.1 0.9 1.1 0.7 2.9 1.1 0.8 5.0 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" Q13068 X 49589496-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 36.8" "Cell line enriched" "Detected in some" 4 "AN3-CA: 243.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.8 0.1 0.7 0.0 0.0 0.0 0.0 243.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.1 0.3 0.3 0.7 0.0 0.2 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.8 1.0 0.1 0.0 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 3.9;pituitary gland: 3.1;testis: 2.9" "Cell line enhanced" "Detected in some" "AN3-CA: 7.0;BJ hTERT+: 1.4;T-47d: 1.3;WM-115: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 0.6 0.0 1.8 0.1 0.8 0.5 0.3 0.0 0.2 0.0 0.5 2.0 0.0 1.7 0.1 0.5 0.5 0.5 0.0 0.0 0.0 0.6 0.4 3.9 0.0 0.0 3.1 0.0 0.4 0.3 0.2 1.1 0.2 0.0 0.0 1.4 0.2 0.3 0.0 2.9 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.5 0.1 0.5 0.3 0.0 0.0 0.6 7.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.7 0.3 0.3 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Group enriched" "Detected in some" 11 "U-2 OS: 7.6;U-266/84: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 7.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Group enriched" "Detected in some" 11 "U-2 OS: 7.6;U-266/84: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 7.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 9.6" "Cell line enhanced" "Detected in some" "AN3-CA: 7.3;HeLa: 4.0;Karpas-707: 1.9;T-47d: 1.7;U-266/84: 4.3;WM-115: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.5 0.8 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.5 0.3 0.0 0.0 0.7 4.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, P0CL82, O76087" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 16.2;testis: 58.6" "Group enriched" "Detected in some" 4 "AN3-CA: 133.5;K-562: 130.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 58.6 0.0 0.0 0.0 0.0 7.0 8.5 3.1 9.1 9.6 14.7 16.2 1.1 0.0 0.0 133.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 130.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.5 6.7 0.8 0.0 0.1 0.0 7.7 0.0 0.0 0.0 16.7 0.9 9.1 3.1 3.9 7.5 2.5 7.0 10.3 7.2 0.0 6.2 8.5 7.5 0.9 9.6 6.3 8.5 14.7 16.2 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "blood: 7.4;stomach 1: 14.0" "Cell line enriched" "Detected in some" 7 "AN3-CA: 145.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 7.4" "Low lineage specificity" "Detected in many" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 1.3 2.5 0.4 7.4 6.2 0.0 0.0 0.0 145.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.4 2.5 1.3 0.8 2.2 1.3 1.5 3.6 0.5 0.0 2.6 0.6 3.2 0.0 0.4 1.8 1.4 7.4 6.2 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 223 "testis: 22.3" "Group enriched" "Detected in some" 52 "A-431: 19.2;U-266/84: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 20.2" "Group enriched" "Detected in some" 5 "AN3-CA: 47.2;K-562: 47.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.2 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.7 0.8 1.6 0.0 0.0 0.0 0.0 47.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.4 0.8 0.7 0.9 0.0 0.7 1.6 0.4 0.4 0.8 0.5 0.6 1.4 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.8" "Cell line enriched" "Detected in some" 6 "AN3-CA: 126.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 126.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.6 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 46.7" "Group enriched" "Detected in some" 5 "Karpas-707: 19.2;T-47d: 66.1;WM-115: 72.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.7 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 66.1 0.0 0.0 10.7 2.3 0.0 0.0 0.2 2.8 0.0 0.6 0.0 72.7 0.4 0.6 0.1 0.1 0.7 0.0 1.0 0.5 0.6 0.0 0.4 0.5 0.2 0.0 0.5 0.6 0.7 0.6 1.3 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" X 49341192-49345922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 52 "blood: 5.8;stomach 1: 18.4;testis: 4.9" "Cell line enhanced" "Detected in some" "AN3-CA: 141.3;K-562: 67.6;T-47d: 34.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.4 4.9 0.0 0.0 0.0 2.5 2.6 0.7 1.2 0.7 5.8 0.2 0.0 0.0 0.0 141.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 67.6 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 34.2 0.0 0.4 8.7 0.3 0.0 0.0 0.1 2.6 0.0 0.1 0.0 14.8 0.7 1.2 0.3 1.0 0.0 0.0 1.5 0.4 2.2 0.0 2.5 4.9 0.0 0.7 0.7 0.0 2.6 5.8 0.2 GAK DNAJC26 ENSG00000178950 "Cyclin G associated kinase" O14976 4 849276-932373 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027405, HPA027459, HPA027463" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027405: AB_10611111, HPA027459: AB_10599948, HPA027463: AB_10601959" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.24e-3)" "unprognostic (1.07e-1)" "unprognostic (3.50e-3)" "unprognostic (1.68e-1)" "unprognostic (7.07e-2)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (3.33e-3)" "prognostic favourable (1.70e-6)" "unprognostic (1.09e-3)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "prognostic favourable (7.41e-4)" 16.5 18.9 16.8 42.2 22.7 29.9 16.7 32.4 27.7 18.0 32.5 19.7 18.6 48.2 22.4 18.6 23.7 20.5 26.8 11.4 16.2 13.9 25.0 22.1 22.2 22.4 17.6 19.4 21.1 33.0 19.5 18.9 16.6 17.9 20.3 15.2 16.9 70.8 20.6 26.2 25.6 41.1 15.2 14.3 30.9 39.2 28.6 18.5 23.6 19.7 19.2 22.3 18.9 18.9 4.7 7.1 10.8 19.3 4.0 8.5 6.9 15.7 12.7 7.8 13.2 7.8 6.7 20.1 15.0 9.0 10.3 8.6 16.0 22.6 13.5 10.2 9.0 13.8 8.0 12.4 4.9 13.7 14.1 15.6 12.8 12.0 14.7 15.8 24.5 9.7 10.7 10.4 5.1 11.2 16.8 17.1 6.9 15.2 26.8 40.9 13.9 23.3 22.2 9.0 12.0 8.3 12.9 13.4 14.5 8.7 11.1 10.4 17.8 13.6 18.4 14.4 8.4 14.6 20.0 27.8 18.6 15.0 16.2 19.4 13.1 2.6 9.0 10.8 8.5 8.9 7.4 4.7 5.6 5.7 6.0 4.0 3.2 4.7 6.7 4.0 19.3 7.1 5.0 6.9 16.8 22.7 32.4 27.7 16.2 13.9 17.6 19.4 17.9 18.5 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 149.9" "Cell line enhanced" "Detected in some" "CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "hypothalamus: 18.8" "Cell type enriched" "Detected in single" 15 "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Region enhanced" "Detected in many" "hypothalamus: 111.6" "Low region specificity" "Detected in all" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" 60030 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: " "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 2.8 0.2 0.1 14.8 0.5 0.4 4.5 0.6 2.0 0.2 6.0 0.1 0.4 1.7 0.2 0.7 0.7 0.2 0.3 0.6 1.3 18.8 0.3 0.2 0.2 0.1 0.2 0.6 0.2 2.9 0.0 149.9 0.9 2.2 0.7 4.1 0.6 0.5 1.8 0.3 4.5 2.2 9.7 0.3 0.2 1.5 0.5 0.4 0.7 0.2 0.4 0.3 1.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 4.4 6.6 0.0 0.1 0.0 46.9 1.7 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 21.9 1.1 14.1 0.0 0.2 0.6 0.0 0.3 0.7 0.0 0.0 1.1 24.3 0.0 0.0 13.3 0.0 86.7 11.2 4.2 0.0 0.0 8.9 0.1 0.0 9.1 35.0 4.6 0.2 0.0 0.2 10.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.7 1.3 18.8 0.2 0.6 2.2 0.4 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell line enhanced" "Detected in many" "HaCaT: 8.5;HSkMC: 8.6;WM-115: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: " "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.0 7.5 2.1 2.2 1.3 1.7 0.4 0.2 0.7 0.5 7.3 8.5 0.2 1.2 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.6 3.3 3.9 0.4 2.5 1.1 0.1 2.3 0.2 2.7 0.1 1.3 0.9 2.1 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.5 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.6 1.4 0.4 29.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800804 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007340 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA007340: AB_1078934" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favourable (2.68e-4)" "unprognostic (1.41e-2)" 4.4 5.5 4.8 5.6 6.1 1.8 5.0 4.3 8.7 9.1 22.3 3.2 12.4 20.0 3.0 6.0 26.2 6.4 34.7 3.7 4.0 4.1 18.2 26.1 7.7 3.9 3.7 5.2 2.4 15.9 7.7 3.5 29.4 3.5 4.8 23.8 5.5 32.1 6.9 1.7 3.9 30.4 4.1 3.6 8.6 46.7 3.4 2.6 3.7 2.3 9.8 19.6 8.1 8.4 3.1 10.6 2.0 18.6 19.4 5.2 4.7 16.2 19.5 7.8 12.4 2.9 4.1 7.6 11.1 15.0 19.7 14.7 17.8 54.5 3.8 15.6 6.5 18.0 6.9 28.4 15.0 8.2 4.5 10.9 9.9 19.3 29.8 4.7 3.2 8.8 15.0 18.1 45.5 16.9 12.1 1.0 14.0 17.3 7.7 5.0 2.2 19.0 9.2 7.6 4.9 31.9 10.9 3.0 6.9 20.1 18.3 19.7 13.4 3.9 9.2 14.4 21.4 14.8 13.6 5.0 12.1 5.0 15.2 20.0 7.7 1.1 7.7 1.7 5.1 15.5 5.2 3.1 3.1 4.1 10.6 1.0 3.6 2.5 2.0 19.4 18.6 3.0 5.1 4.7 4.8 6.1 4.3 8.7 4.0 4.1 3.7 5.2 3.5 2.6 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765711 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 36.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" 8600 Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavourable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavourable (1.62e-5)" 6.4 3.3 3.8 6.2 4.4 3.6 14.2 4.6 5.1 4.7 9.3 3.7 3.5 15.9 4.7 5.0 9.0 4.8 3.8 7.2 3.6 3.6 12.3 31.6 4.7 11.7 4.3 3.8 5.2 16.0 1.9 2.6 4.6 3.2 4.7 1.3 3.6 14.9 4.7 5.4 6.2 17.3 3.7 4.0 7.2 5.3 5.7 3.3 7.6 3.3 5.1 4.8 3.6 5.0 10.6 36.7 20.7 30.2 5.7 9.4 14.6 8.0 30.3 1.8 8.5 2.7 6.8 7.1 6.5 5.4 6.7 6.3 16.8 1.6 12.5 8.2 3.4 4.7 2.0 1.9 0.7 5.4 19.0 7.8 11.5 28.1 9.2 5.2 17.3 6.0 2.6 3.3 1.4 15.6 6.2 7.7 4.1 34.4 14.4 19.7 2.1 15.7 17.3 21.1 20.8 3.7 3.3 4.1 11.4 5.6 14.4 14.2 11.7 8.6 13.7 10.0 9.6 9.5 5.7 19.5 4.8 3.2 11.2 12.2 7.7 2.6 30.2 8.3 9.4 25.5 8.5 10.6 7.8 8.6 27.2 6.8 4.2 6.2 20.7 5.7 20.2 36.7 8.7 14.6 3.8 4.4 4.6 5.1 3.6 3.6 4.3 3.8 3.2 3.3 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: " "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favourable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favourable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 12.7 24.9 10.2 9.2 15.3 6.5 12.4 15.7 15.3 14.7 16.3 15.3 25.6 21.5 16.0 9.9 11.5 13.5 9.9 14.2 11.3 10.3 32.3 28.4 12.7 8.0 16.2 9.4 11.5 18.5 19.4 34.2 10.8 15.3 11.1 17.9 13.2 12.2 16.3 12.5 11.6 17.9 11.8 13.9 12.8 13.9 9.2 14.8 14.6 16.7 10.9 11.5 10.3 11.6 9.6 10.4 24.2 11.3 12.8 23.1 8.7 6.2 7.3 3.4 4.5 8.7 13.6 9.9 6.5 8.7 6.5 7.7 9.3 6.6 2.0 5.2 6.8 9.1 13.4 9.3 9.2 11.2 3.9 11.7 7.0 7.8 9.5 8.0 3.7 7.0 17.1 6.9 17.3 13.1 11.6 11.4 7.0 6.7 5.8 6.4 1.4 7.0 7.1 4.1 30.3 12.0 5.9 4.1 2.7 7.2 15.0 12.3 7.4 7.8 7.2 6.4 4.4 25.9 6.1 9.4 32.3 3.8 9.9 30.7 8.7 24.2 10.6 18.6 12.8 11.3 13.6 9.6 13.1 12.6 10.4 6.7 10.5 10.7 5.4 12.8 10.8 9.2 23.1 8.7 10.2 15.3 15.7 15.3 11.3 10.3 16.2 9.4 15.3 14.8 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell line enhanced" "Detected in many" "TIME: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavourable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 7.4 25.4 6.2 5.4 13.2 11.8 4.8 21.5 12.0 8.6 8.2 3.5 17.1 4.8 15.2 36.1 1.3 2.8 16.8 7.9 12.6 2.0 13.3 4.8 4.8 10.2 2.8 13.0 14.6 3.9 6.9 10.3 16.4 3.0 15.4 14.6 7.7 0.3 2.0 2.4 5.2 1.5 3.3 4.8 11.9 5.1 0.8 2.0 9.5 35.6 2.8 13.8 2.2 48.2 20.9 5.0 5.1 22.8 4.4 4.3 2.6 13.7 5.7 6.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell line enhanced" "Detected in many" "A549: 12.9;RPMI-8226: 14.9;RPTEC TERT1: 22.0;RT4: 16.3" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" 9400 "Golgi apparatus" Nucleoplasm "HPA030138: " "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 10.9 12.9 0.0 0.0 0.0 0.0 0.0 3.6 1.9 2.4 0.3 0.0 0.0 10.2 3.7 0.2 0.0 0.4 0.5 0.4 0.3 1.3 5.7 0.0 0.0 0.0 8.2 0.0 0.0 2.3 0.0 8.5 0.0 0.0 9.1 0.0 5.0 0.0 0.0 6.1 0.0 7.1 0.0 14.9 22.0 16.3 12.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.9 2.8 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Group enriched" "Detected in some" 5 "ASC diff: 43.8;ASC TERT1: 43.2;HSkMC: 32.9" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 43.8 43.2 0.0 0.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 32.9 0.0 0.4 0.5 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 7.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell line enhanced" "Detected in some" "AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favourable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favourable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.9 0.0 0.0 0.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell line enhanced" "Detected in some" "A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" 630000 "Nucleoli, Golgi apparatus, Cytosol" Vesicles "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.1 2.5 0.0 0.0 1.0 8.1 0.0 15.2 27.2 0.2 0.6 1.0 13.4 0.0 0.0 31.7 27.1 0.4 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.5 0.0 15.7 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;SK-BR-3: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favourable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favourable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.4 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 11.1 0.6 8.4 5.3 2.6 1.2 7.4 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 20.4 1.6 0.3 0.0 22.6 12.5 2.9 1.6 21.0 0.0 0.0 3.3 6.5 0.8 0.1 7.5 0.1 33.9 0.0 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favourable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.1 10.6 10.4 3.3 5.6 8.3 14.9 5.3 6.0 5.0 6.9 3.3 32.0 11.2 3.9 4.7 17.2 4.4 9.3 6.8 43.5 8.5 13.6 21.9 0.1 3.7 20.1 9.7 5.3 8.5 11.1 5.6 32.9 9.1 17.5 25.2 6.6 14.7 11.1 10.2 7.0 14.8 9.6 2.9 36.6 9.5 8.4 6.4 2.5 14.8 7.3 5.9 6.0 39.3 3.6 15.9 0.1 11.4 5.1 0.0 6.0 14.6 12.1 12.8 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 4 "Karpas-707: 26.3;NTERA-2: 9.3;U-266/84: 7.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: " "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.3 0.0 0.0 0.2 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016949 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA016949: AB_1849465" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favourable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 13.3 14.0 12.5 17.3 20.7 17.6 14.4 16.6 14.2 15.8 14.3 25.6 15.4 11.7 17.9 26.0 20.7 12.9 13.0 12.4 13.4 10.4 13.5 18.0 30.5 13.8 25.0 13.7 18.8 13.1 17.4 20.5 10.8 19.8 13.1 17.8 18.3 20.4 13.7 23.9 13.9 15.4 15.9 25.1 15.5 13.1 24.5 22.6 17.4 16.8 12.3 18.3 16.2 16.3 17.6 12.2 9.3 10.1 4.0 7.4 4.7 6.1 3.2 7.9 8.5 9.6 13.5 5.0 13.6 14.7 15.0 12.6 4.7 4.4 3.4 7.4 13.7 12.9 9.4 14.5 10.4 8.4 4.3 8.4 8.5 9.1 8.1 8.1 7.3 9.1 8.7 6.1 10.4 10.1 8.7 9.5 11.8 1.3 5.4 9.0 4.8 4.1 10.5 9.2 11.7 11.3 5.8 5.9 8.4 7.6 6.7 4.8 2.5 19.3 9.2 15.8 4.2 13.0 8.1 10.3 13.6 6.9 7.4 15.0 8.7 9.3 9.3 7.4 3.7 10.1 5.0 16.2 5.7 6.9 12.2 17.6 7.4 4.4 5.0 4.0 8.1 9.6 5.5 4.7 12.5 20.7 16.6 14.2 13.4 10.4 25.0 13.7 19.8 22.6 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavourable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavourable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 196.0 345.9 99.8 155.5 97.4 160.6 217.5 149.0 212.2 218.1 227.7 244.1 134.6 229.2 29.5 175.6 111.7 92.7 345.6 151.4 201.0 100.7 126.8 217.1 207.3 131.3 204.9 102.1 134.3 112.9 214.3 242.1 240.0 68.1 48.3 247.7 391.1 233.5 107.9 368.8 115.3 189.9 177.7 109.1 248.1 239.9 70.7 113.5 131.5 343.1 197.9 53.6 144.8 149.7 170.2 205.7 87.8 257.4 109.8 79.8 295.4 360.8 129.9 266.3 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell line enhanced" "Detected in many" "A549: 16.2" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA042666: " "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.4 16.2 4.5 6.8 0.0 0.0 3.8 1.3 0.0 0.0 0.0 9.8 7.4 7.4 2.1 0.0 5.4 0.0 0.0 0.0 7.2 7.9 4.9 10.3 5.0 0.1 4.4 5.9 0.0 0.0 0.0 0.0 0.0 11.8 4.4 0.0 13.8 1.7 2.1 6.1 2.2 5.2 3.2 5.7 0.0 4.4 8.1 3.7 1.6 4.1 4.8 3.4 1.9 1.5 5.2 5.8 1.3 1.8 12.1 3.2 4.3 2.8 8.0 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 GAPVD1 "DKFZP434C212, KIAA1521" ENSG00000165219 "GTPase activating protein and VPS9 domains 1" Q14C86 9 125261794-125367207 "Predicted intracellular proteins" Endocytosis "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029386, HPA029387" Uncertain Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA029386: AB_10599604, HPA029387: AB_10600311" "unprognostic (8.43e-3)" "unprognostic (3.84e-2)" "unprognostic (3.53e-1)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (4.04e-2)" "unprognostic (7.08e-2)" "unprognostic (1.31e-2)" "unprognostic (7.56e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "unprognostic (2.54e-3)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (1.67e-2)" "unprognostic (5.82e-2)" 17.6 16.2 16.0 14.9 18.6 26.6 16.9 25.7 21.3 17.5 16.1 20.9 18.0 10.8 19.1 14.0 24.3 16.0 13.7 15.4 15.5 14.1 17.6 14.5 20.5 15.1 21.1 15.6 18.9 14.1 30.3 20.2 23.3 20.1 14.7 13.2 16.4 15.9 17.2 31.6 23.5 14.6 17.4 15.3 17.3 14.6 32.1 20.2 18.6 24.8 12.2 19.9 16.2 17.7 10.4 14.8 19.2 17.8 13.6 14.8 10.0 11.5 12.0 11.4 10.6 13.8 15.1 16.6 12.9 14.8 15.0 12.6 19.1 8.3 15.4 7.0 16.2 23.5 23.6 13.5 16.0 14.1 14.1 17.5 29.5 9.4 16.3 20.8 29.6 10.8 13.2 17.8 14.4 17.8 33.9 8.5 12.5 16.9 15.5 9.1 11.5 13.7 13.6 24.9 14.9 8.6 11.9 15.2 10.2 18.8 17.4 10.3 21.4 10.8 18.6 10.6 7.8 18.9 13.8 11.0 20.7 15.8 13.0 11.8 13.6 18.6 15.0 18.0 13.7 15.6 13.4 10.2 14.2 14.8 14.8 10.4 14.2 14.7 19.2 13.6 17.8 5.6 10.9 10.0 16.0 18.6 25.7 21.3 15.5 14.1 21.1 15.6 20.1 20.2 GAR1 NOLA1 ENSG00000109534 "GAR1 ribonucleoprotein" Q9NY12 4 109815510-109824740 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059098 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA059098: " "unprognostic (9.72e-2)" "unprognostic (6.94e-2)" "unprognostic (3.04e-2)" "unprognostic (4.47e-2)" "unprognostic (2.40e-1)" "unprognostic (1.24e-2)" "prognostic unfavourable (2.64e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (4.17e-3)" "unprognostic (2.14e-2)" "unprognostic (2.45e-3)" "unprognostic (1.17e-1)" "unprognostic (5.11e-2)" "unprognostic (1.11e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-3)" 16.6 18.9 15.2 19.5 19.9 34.7 22.4 11.0 16.5 14.6 20.9 12.4 15.5 17.0 24.3 14.8 26.6 17.2 17.8 11.6 14.2 13.3 15.6 20.0 13.7 17.2 15.5 17.1 20.2 24.1 15.7 19.1 24.8 13.8 17.3 21.0 14.5 23.3 17.5 13.8 25.4 16.3 19.0 18.1 18.8 15.1 27.7 16.3 29.5 17.3 27.6 22.4 15.5 15.5 11.3 9.3 7.4 9.3 9.5 10.7 4.3 15.6 18.2 12.5 16.9 6.7 9.6 10.9 16.3 8.8 13.5 10.9 28.4 19.9 38.3 10.7 12.3 7.5 23.0 16.2 22.5 11.3 22.6 22.8 16.4 31.0 16.3 48.8 12.1 8.7 17.0 16.7 12.0 16.3 54.4 11.7 16.6 33.5 30.1 33.7 20.4 22.1 20.4 20.5 14.2 17.8 22.1 18.5 18.9 10.3 26.8 14.5 9.5 14.5 14.1 13.5 18.9 9.9 20.8 14.9 24.2 47.3 9.6 23.9 14.6 7.4 5.9 3.3 9.7 9.3 10.3 11.3 9.2 9.8 9.3 10.0 10.7 9.9 1.0 9.5 8.0 9.2 9.6 4.3 15.2 19.9 11.0 16.5 14.2 13.3 15.5 17.1 13.8 16.3 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470484 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.5" "Cell line enhanced" "Detected in many" "hTCEpi: 12.0;hTERT-HME1: 20.8;RT4: 17.7;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040709: , HPA042046: " "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavourable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favourable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 11.1 8.7 9.7 2.9 10.9 8.0 6.0 17.6 11.1 6.0 7.2 19.5 0.3 6.5 4.2 3.4 11.0 4.8 4.9 8.9 11.8 5.8 15.3 12.5 5.2 1.3 16.3 10.1 4.4 43.5 1.9 5.1 4.8 13.2 4.3 6.3 3.0 11.2 5.1 7.7 13.9 7.8 4.6 12.9 3.1 12.7 6.7 16.4 0.0 3.5 3.1 2.9 9.3 9.1 1.9 5.0 2.6 1.0 3.1 1.4 0.0 1.0 1.5 1.7 0.3 4.6 3.2 4.7 0.3 0.0 0.0 0.0 0.3 2.6 3.0 2.5 0.2 3.3 2.6 4.9 0.0 0.9 1.6 0.0 3.0 1.0 2.3 0.3 0.2 3.8 12.0 0.2 20.8 0.1 0.1 0.6 1.8 2.4 0.8 0.1 1.8 0.8 1.2 6.8 5.2 6.0 17.7 5.6 14.7 3.9 5.0 0.2 1.0 2.5 0.2 1.2 1.4 0.0 0.4 2.1 0.2 0.7 1.9 0.0 1.4 0.0 1.0 0.2 0.5 0.1 0.2 0.3 0.8 0.5 0.1 1.9 1.0 1.4 2.6 3.1 0.1 5.0 0.1 0.0 9.7 10.9 17.6 11.1 11.8 5.8 16.3 10.1 13.2 16.4 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 5.9;SH-SY5Y: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: " "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.6 0.3 1.8 1.9 0.6 0.0 1.7 0.1 0.9 3.3 0.0 0.3 0.0 1.4 0.0 2.9 1.9 0.8 0.7 0.3 0.2 2.6 0.0 0.0 1.3 1.4 1.1 0.1 1.0 0.0 0.6 0.7 2.7 0.2 2.0 5.9 3.2 4.1 2.1 6.5 1.3 4.7 0.5 1.6 0.1 0.0 0.4 1.9 0.0 0.6 4.1 3.9 2.0 0.9 1.0 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 GART "GARS-AIRS-GART, PGFT, PRGS" ENSG00000159131 "Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase" P22102 21 33503931-33543491 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Ligase, Multifunctional enzyme, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002119, HPA005779" Approved Uncertain Nucleoplasm,Mitochondria,Cytosol 1300000 "Nucleoplasm, Mitochondria, Cytosol" "HPA002119: AB_1849482, HPA005779: AB_1849484" "unprognostic (3.77e-2)" "unprognostic (2.25e-2)" "unprognostic (4.51e-3)" "unprognostic (1.72e-2)" "unprognostic (2.30e-2)" "prognostic unfavourable (5.05e-5)" "prognostic unfavourable (9.82e-5)" "unprognostic (2.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.92e-1)" "prognostic unfavourable (2.19e-4)" "unprognostic (1.98e-3)" "prognostic unfavourable (3.95e-6)" "unprognostic (1.36e-2)" "unprognostic (2.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" 24.9 24.7 16.0 20.0 22.3 14.2 22.2 14.5 20.3 16.2 20.1 20.5 13.3 18.9 21.7 15.9 28.1 19.9 14.3 19.3 16.4 14.9 19.2 33.6 18.3 24.4 21.9 14.6 21.0 30.6 21.6 22.9 23.1 21.0 16.4 26.9 19.5 18.6 16.1 33.2 17.6 19.1 23.5 17.9 21.4 21.9 47.0 21.7 40.8 20.0 19.4 32.8 21.6 17.6 18.7 19.5 9.7 20.9 27.1 21.1 13.3 30.0 14.3 21.2 23.5 15.6 16.1 23.8 19.5 16.5 22.8 24.2 27.1 25.6 40.0 11.6 13.0 15.9 44.4 30.6 33.3 21.0 26.4 60.3 17.1 17.7 21.3 33.5 15.9 14.2 21.4 26.9 39.6 21.5 70.1 25.7 20.6 14.4 35.3 22.5 46.2 16.9 29.5 39.5 56.6 18.3 16.1 22.6 20.3 27.0 21.3 25.2 27.0 21.5 15.8 15.5 18.6 13.4 20.8 25.6 35.4 43.7 16.3 39.5 22.9 5.3 15.2 9.7 17.3 20.9 21.1 18.7 16.9 17.9 19.5 14.4 17.7 17.4 7.0 27.1 17.7 14.7 20.6 13.3 16.0 22.3 14.5 20.3 16.4 14.9 21.9 14.6 21.0 21.7 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Group enriched" "Detected in some" 10 "Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: " "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favourable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 40.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.2 2.0 0.0 0.5 11.7 0.6 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.4 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.5" "Cell line enhanced" "Detected in many" "U-138 MG: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.1" "Group enriched" "Detected in many" 10 "dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favourable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 15.1 10.7 15.2 5.3 13.4 5.4 7.6 10.5 19.8 4.5 5.6 6.8 40.5 17.9 5.1 8.4 8.6 4.6 4.3 7.0 12.9 8.1 6.0 6.6 7.5 2.2 11.3 10.2 2.9 10.0 4.6 6.8 4.3 9.5 7.1 2.2 3.2 12.7 22.9 4.9 22.4 13.0 4.5 10.0 11.5 8.3 16.6 8.8 0.0 4.5 9.2 3.5 3.9 4.7 0.0 1.1 3.1 2.0 0.0 0.2 1.2 8.2 9.6 1.5 6.1 2.4 2.3 9.6 12.3 3.8 5.2 2.7 4.3 5.9 0.0 5.6 6.5 25.1 2.5 7.0 0.9 11.2 1.2 10.8 7.6 3.0 3.0 0.1 7.6 2.4 4.8 5.0 2.0 6.9 5.1 1.7 3.7 7.0 0.2 6.0 2.2 21.7 0.2 4.3 0.7 3.1 5.3 0.5 8.1 9.5 12.8 6.8 12.7 1.7 14.7 33.1 22.8 14.7 12.3 0.1 0.1 0.1 14.6 0.4 8.1 0.0 2.0 3.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.5 0.0 1.4 0.0 0.0 1.2 15.2 13.4 10.5 19.8 12.9 8.1 11.3 10.2 9.5 8.8 GAS6 "AXLLG, AXSF, DKFZp666G247, FLJ34709" ENSG00000183087 "Growth arrest specific 6" Q14393 13 113820549-113864067 "Predicted secreted proteins" "Growth regulation, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 55.7;BJ hTERT+: 80.6;HSkMC: 47.2;RPMI-8226: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in single" 51 "dendritic cells: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008275, HPA056080" Approved Approved "Centriolar satellite,Cytosol" "Secreted to blood" 8904000 920000 Cytosol "Centriolar satellite" "HPA008275: AB_1849497, HPA056080: " "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.97e-3)" "unprognostic (1.37e-1)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (2.09e-2)" "unprognostic (2.92e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.55e-1)" "unprognostic (4.81e-3)" "unprognostic (1.97e-1)" "unprognostic (2.16e-2)" "unprognostic (9.00e-2)" "prognostic unfavourable (8.93e-6)" 25.6 12.6 10.6 6.8 10.7 1.0 35.3 8.0 13.2 52.9 17.1 7.9 35.7 17.9 48.6 20.1 27.0 45.8 24.3 45.9 10.6 8.3 14.7 13.9 27.9 14.4 9.2 9.5 33.0 18.4 7.3 15.8 19.1 13.9 34.2 9.5 20.3 26.8 35.9 27.1 27.9 17.0 53.4 8.8 7.7 16.5 25.2 9.5 10.0 29.2 13.1 6.5 31.8 44.7 0.0 31.7 0.0 0.6 0.0 0.1 0.5 23.6 1.0 0.7 0.6 28.4 15.9 3.0 55.7 80.6 23.3 27.9 1.5 11.4 0.2 1.8 25.1 22.3 0.3 12.4 5.9 0.0 3.2 0.1 1.7 0.1 20.3 0.1 0.2 47.2 7.3 6.4 6.4 0.8 0.4 13.0 37.5 1.1 0.1 0.2 1.5 1.6 0.7 0.0 76.5 8.4 0.3 3.8 3.5 6.1 0.2 0.0 7.4 18.9 13.1 6.1 7.6 0.7 15.7 0.0 1.2 0.2 6.9 0.5 0.9 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 31.7 0.0 0.5 10.6 10.7 8.0 13.2 10.6 8.3 9.2 9.5 13.9 9.5 GAS7 "KIAA0394, MGC1348" ENSG00000007237 "Growth arrest specific 7" O60861 17 9910609-10198551 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2" "Cell line enriched" "Detected in some" 9 "WM-115: 107.7" "Cancer enhanced" "Detected in all" "melanoma: 54.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004838, HPA064678" Enhanced Approved "Plasma membrane,Actin filaments,Focal adhesion sites" "Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA004838: AB_2667263, HPA064678: " "unprognostic (1.68e-2)" "unprognostic (2.84e-3)" "unprognostic (1.80e-1)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-2)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-2)" "unprognostic (2.48e-1)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" "unprognostic (6.48e-2)" "unprognostic (8.78e-2)" "unprognostic (3.08e-2)" "prognostic unfavourable (6.89e-4)" 19.1 6.5 22.1 15.4 40.3 18.7 10.8 86.2 64.7 22.6 9.3 33.4 1.7 5.2 9.7 4.4 17.0 12.6 11.5 23.1 25.8 15.0 1.5 2.1 9.9 5.9 28.1 25.0 5.9 2.8 1.4 1.7 11.0 14.2 3.7 8.7 7.7 4.0 8.2 3.9 21.2 7.4 16.3 33.8 10.0 4.2 11.8 22.2 2.7 2.5 2.7 7.2 11.7 7.8 0.4 3.6 11.0 17.6 2.8 2.1 4.4 0.0 0.1 0.1 0.2 3.4 4.8 0.0 0.1 0.0 0.5 0.2 0.0 0.0 1.3 0.3 1.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.1 1.1 0.3 9.9 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 10.4 3.1 0.5 0.0 2.7 0.0 9.6 0.0 0.0 0.0 0.6 0.0 0.0 12.4 0.5 4.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 7.0 107.7 0.4 17.6 10.8 2.1 4.7 0.7 0.3 0.2 1.0 3.6 0.4 0.2 1.0 11.0 2.8 3.1 0.6 0.0 4.4 22.1 40.3 86.2 38.8 25.8 15.0 28.1 25.0 14.2 22.2 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041311: , HPA048238: " "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favourable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favourable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favourable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 7.1 11.1 8.5 6.5 13.2 2.3 7.6 13.5 12.2 11.7 6.8 10.0 10.8 4.1 12.7 16.2 7.8 26.5 11.6 21.0 8.7 9.8 12.4 6.3 9.9 4.0 8.9 8.9 12.8 12.9 23.2 22.0 3.5 10.1 8.9 4.6 11.0 16.2 12.6 18.8 4.2 4.2 8.4 7.5 4.2 7.6 16.1 6.4 1.7 15.5 5.5 5.2 6.6 5.1 2.5 4.8 4.3 5.0 0.0 3.7 2.3 10.6 8.6 1.1 5.4 5.1 3.9 9.2 2.1 5.4 8.8 2.6 8.6 8.1 0.6 5.9 4.4 10.6 3.6 6.3 1.9 0.0 6.4 2.2 5.5 9.8 5.7 1.2 1.8 5.2 3.6 6.6 3.0 5.2 8.5 1.2 3.7 25.6 1.5 5.4 7.2 4.5 0.4 10.1 0.6 11.0 5.2 9.1 6.6 11.3 6.1 12.9 11.5 5.0 3.6 5.4 6.3 2.9 5.1 2.0 3.2 0.0 13.8 1.7 9.4 4.3 3.1 3.7 1.8 5.0 1.8 1.2 2.8 3.7 4.4 2.5 2.3 2.0 4.0 0.0 3.1 4.8 3.5 2.3 8.5 13.2 13.5 12.2 8.7 9.8 8.9 8.9 10.1 6.4 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475970 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.1;intestine: 23.6" "Cell line enhanced" "Detected in some" "EFO-21: 2.5;HEL: 4.9;K-562: 7.7;SiHa: 3.4;T-47d: 8.2" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067583 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA067583: " "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.9 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.4 15.9 0.0 5.2 14.8 3.8 1.7 0.3 9.1 22.1 6.8 0.0 0.0 3.3 0.7 1.6 0.0 0.0 0.0 3.1 0.0 0.3 0.6 0.6 0.0 11.3 0.0 1.0 0.4 0.8 0.1 0.3 23.6 18.3 0.2 0.1 10.3 16.8 0.0 0.0 1.2 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 3.4 0.0 0.0 8.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favourable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favourable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favourable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 8.1 13.5 18.7 18.1 9.1 5.6 19.0 11.1 8.8 11.4 12.0 15.0 6.5 8.8 8.1 6.7 8.6 17.9 7.5 5.7 12.4 12.2 9.4 35.4 16.1 10.1 14.0 23.5 9.6 14.1 9.6 10.1 29.7 9.2 16.9 10.5 8.1 3.8 14.5 19.4 21.5 7.0 7.5 7.4 15.8 19.3 15.3 20.5 6.2 15.7 11.0 10.7 12.7 20.6 12.3 14.9 10.5 13.5 11.5 7.3 7.3 15.5 5.1 9.5 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489699-81762161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Cell line enhanced" "Detected in all" "ASC diff: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Nucleoplasm,Cytosol 5900000 "Nucleoplasm, Cytosol" "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 23.1 22.4 2.2 7.8 4.2 5.6 19.2 4.2 4.6 6.4 7.7 5.2 5.2 4.1 8.4 4.9 7.5 4.9 11.5 19.7 3.6 4.3 14.0 36.3 11.3 7.5 7.9 3.4 8.2 5.7 8.2 11.6 11.4 8.4 5.7 4.5 9.9 8.0 10.1 56.9 5.9 6.3 7.2 6.1 8.0 4.5 4.6 4.1 5.4 6.5 11.2 4.5 9.6 10.0 11.6 13.6 14.5 11.4 13.0 7.2 6.1 12.0 7.3 2.4 34.6 60.9 46.3 4.4 20.0 28.6 12.0 20.4 1.4 3.1 13.5 8.8 24.6 1.4 2.0 9.2 28.3 6.3 1.1 4.2 15.1 4.5 41.9 14.1 3.7 34.1 6.9 19.3 19.9 26.6 3.2 7.8 39.0 3.5 2.3 16.8 2.4 11.1 4.4 11.0 15.8 8.5 4.1 1.2 1.6 13.0 3.8 4.1 2.7 11.7 37.0 24.9 5.8 17.4 18.5 35.7 4.1 4.9 40.5 9.5 10.1 6.3 11.4 14.5 5.6 10.4 5.4 11.0 6.0 5.9 13.6 11.6 7.0 7.2 11.0 13.0 10.8 4.5 5.0 6.1 2.2 4.2 4.2 4.6 3.6 4.3 7.9 3.4 8.4 4.1 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.5;HDLM-2: 25.9;RT4: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042682, CAB045975" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" Nucleoplasm "Actin filaments, Cytosol" "CAB045975: AB_10584474, HPA042682: " "prognostic favourable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavourable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavourable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favourable (1.10e-5)" 40.1 39.4 4.7 24.4 14.3 8.9 31.9 2.3 11.0 38.2 35.7 3.3 9.5 11.0 29.0 20.6 39.0 17.5 18.5 12.6 4.6 4.1 21.6 17.9 42.8 21.3 14.3 2.9 35.5 4.9 39.8 5.9 17.3 12.2 48.7 13.8 12.4 14.2 15.4 20.1 19.5 39.6 48.1 26.7 27.5 20.2 13.0 6.0 7.7 22.0 18.2 15.3 63.1 40.3 3.1 8.5 78.9 44.2 20.1 61.2 22.2 6.0 0.5 0.0 0.0 17.4 15.2 4.5 1.5 15.7 2.6 6.0 0.1 9.6 0.0 23.5 10.4 1.1 0.0 0.2 1.4 25.9 0.0 0.1 4.4 1.3 4.6 0.7 1.1 15.8 0.1 3.9 0.0 17.7 0.3 0.9 7.2 0.0 0.0 5.7 0.0 0.4 0.1 6.6 0.0 4.9 32.4 0.0 0.2 7.6 2.2 0.2 0.2 1.0 12.0 1.9 0.4 2.8 1.6 18.8 0.0 0.0 6.0 0.1 0.3 12.2 20.5 6.6 24.6 31.2 32.6 3.1 26.3 27.1 8.5 2.7 18.0 18.9 78.9 20.1 44.2 0.5 61.2 22.2 4.7 14.3 2.3 11.0 4.6 4.1 14.3 2.9 12.2 6.0 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181148-89198932 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.8;HDLM-2: 7.9;HEL: 10.4;REH: 8.8;RT4: 14.8;U-266/70: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favourable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavourable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 25.4 4.4 3.9 18.4 5.9 3.6 9.4 2.1 5.0 7.8 5.8 4.4 2.9 8.0 10.5 7.4 7.9 6.3 5.7 9.2 4.6 4.4 8.5 9.8 34.7 20.5 5.8 4.4 12.8 2.4 9.3 4.8 9.1 6.9 12.7 4.8 17.4 4.8 4.8 12.0 3.2 11.0 5.1 7.4 23.4 7.4 2.6 2.7 8.1 23.3 5.7 15.2 9.3 7.7 3.3 2.0 5.1 12.6 12.2 7.6 4.4 0.6 0.0 0.1 0.2 0.1 0.1 0.5 1.5 6.2 6.7 6.1 0.1 9.8 0.5 0.8 1.8 0.7 0.0 0.3 0.3 7.9 0.1 10.4 0.3 0.3 0.9 0.2 0.3 0.3 0.0 0.1 0.0 1.5 0.3 1.9 0.0 0.1 5.1 0.3 0.4 0.1 8.8 0.2 0.3 0.1 14.8 0.2 0.5 0.2 0.5 0.2 0.5 1.1 0.4 0.2 1.4 0.2 0.1 13.3 0.2 0.3 0.3 0.1 1.8 0.4 3.8 0.4 6.6 12.6 5.8 2.3 7.3 7.3 2.0 3.3 5.5 5.1 5.1 12.2 11.5 0.7 7.6 4.4 3.9 5.9 2.1 5.0 4.6 4.4 5.8 4.4 6.9 2.7 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.3 2.1 5.8 0.0 1.4 1.2 0.2 2.1 6.1 3.4 6.2 4.8 16.3 1.9 15.0 0.1 0.8 2.2 6.9 4.2 9.1 9.2 17.1 1.5 9.1 1.7 21.4 5.0 1.5 2.4 3.1 0.7 0.4 0.3 6.6 0.2 16.8 0.4 12.4 3.7 8.3 7.4 1.4 9.6 17.9 9.6 3.8 6.5 2.8 12.6 10.6 8.6 9.6 0.4 0.8 6.2 9.7 3.2 6.3 11.7 0.3 5.3 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020460 Uncertain Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548" "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.7 2.3 5.9 33.6 12.2 9.9 4.1 12.6 13.3 9.6 8.2 5.1 1.0 2.7 5.9 5.6 5.1 5.9 8.9 2.2 1.2 10.7 6.1 7.3 20.1 19.9 10.8 8.0 11.6 5.4 6.3 14.0 7.8 15.6 3.2 4.5 7.7 11.3 20.0 2.5 9.4 11.9 1.2 16.1 12.1 6.9 12.2 8.3 9.8 15.9 6.7 12.8 5.3 5.9 9.7 5.3 6.4 4.3 10.7 5.2 5.7 6.7 10.1 10.1 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580618-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 11.5 14.1 13.4 11.0 13.7 17.7 14.2 13.9 12.8 11.6 10.2 12.8 8.6 9.6 13.2 10.3 14.1 10.7 12.2 9.0 10.2 7.9 9.8 17.8 10.4 12.3 19.8 7.6 13.6 12.7 14.8 14.5 13.6 13.0 11.5 9.6 8.4 13.8 11.0 12.5 14.5 12.9 8.4 12.1 15.5 12.7 20.7 17.9 15.7 11.8 9.5 14.4 10.3 29.2 8.4 7.9 15.6 9.1 10.2 11.6 8.8 8.2 11.2 5.0 10.7 11.1 7.7 6.9 7.3 8.5 7.3 9.2 9.3 5.7 7.6 4.4 6.7 9.2 7.1 8.0 7.9 10.7 6.5 5.6 6.1 4.9 16.5 9.7 9.4 7.2 21.9 7.8 15.5 6.9 9.1 8.8 8.2 8.3 9.3 8.4 10.3 8.8 6.7 5.4 8.7 6.3 6.4 7.9 11.4 7.8 37.2 14.5 6.3 7.0 8.8 10.9 3.5 9.4 8.3 24.2 10.5 4.9 10.7 9.9 11.0 5.8 8.1 15.0 9.1 8.2 11.6 8.4 8.2 8.9 7.9 8.0 6.8 6.7 15.6 10.2 9.1 4.6 7.6 8.8 13.4 13.7 13.9 12.8 10.2 7.9 19.8 7.6 13.0 17.9 GCC2 "GCC185, KIAA0336" ENSG00000135968 "GRIP and coiled-coil domain containing 2" Q8IWJ2 2 108448561-108509415 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035849, HPA035850" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035849: AB_10671941, HPA035850: " "unprognostic (1.35e-1)" "unprognostic (1.29e-2)" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (1.59e-1)" "unprognostic (3.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.53e-2)" "unprognostic (6.53e-3)" "unprognostic (3.99e-1)" "unprognostic (4.71e-1)" "unprognostic (9.61e-2)" "unprognostic (1.64e-2)" 10.9 10.6 12.0 15.2 21.6 20.5 13.1 5.0 16.8 11.9 13.6 3.9 26.7 13.4 10.9 32.0 9.5 12.4 13.2 8.0 9.3 5.8 12.8 8.3 14.2 13.0 7.8 15.6 17.6 13.1 11.5 24.3 8.6 15.0 14.6 13.6 4.3 14.9 32.3 9.6 9.3 18.1 8.4 11.4 11.7 18.1 15.5 10.5 11.1 13.8 6.1 10.0 16.3 11.3 14.3 17.6 20.3 8.8 7.9 23.0 4.5 7.5 5.8 7.6 2.7 5.6 13.5 13.2 10.5 12.4 4.0 6.7 11.2 9.3 8.8 12.5 7.2 6.2 4.3 7.4 8.5 10.7 7.5 11.9 9.8 7.4 6.2 15.4 8.7 14.2 7.1 10.4 8.8 6.9 15.2 7.2 7.5 4.6 6.4 8.0 12.2 7.6 6.5 8.9 8.2 4.6 12.6 7.9 9.0 11.8 8.7 9.0 4.4 5.0 11.9 8.2 12.4 7.8 4.0 9.5 16.7 10.5 9.2 3.9 5.1 20.1 5.2 13.7 15.4 4.6 14.9 14.3 16.9 16.0 4.0 13.6 23.0 19.7 20.3 7.9 8.8 17.6 12.3 4.5 12.0 21.6 5.0 16.8 9.3 5.8 7.8 15.6 15.0 10.5 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142873-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "pancreas: 202.8" "Group enriched" "Detected in some" 5 "EFO-21: 37.1;U-2 OS: 52.8" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "pons and medulla: 3.7" "Region enhanced" "Detected in single" "midbrain: 2.0" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" 77950 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 1.0 0.1 0.2 0.6 0.2 1.1 0.2 0.2 1.8 0.2 6.6 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 3.4 0.2 0.2 0.2 0.2 0.2 0.2 202.8 0.0 0.2 0.2 0.5 0.2 12.6 0.2 0.2 0.2 0.2 2.5 11.0 0.2 0.2 0.2 2.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 2.9 0.0 1.4 8.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.5 0.2 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell line enhanced" "Detected in many" "BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favourable (8.69e-4)" "prognostic favourable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favourable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.6 0.0 1.2 0.8 2.2 0.9 0.6 13.2 3.3 0.1 2.0 5.7 0.9 0.0 5.1 4.9 0.3 0.2 1.9 5.6 0.0 1.2 1.4 1.6 1.9 0.0 0.4 0.8 0.0 0.0 6.8 7.1 0.2 1.1 4.5 5.8 1.4 0.0 1.6 2.7 5.8 29.3 2.4 1.5 0.7 5.6 1.6 0.2 0.1 1.9 3.7 2.3 5.6 4.2 3.2 2.4 4.5 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44144271-44198170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 46.8" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.0" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 17 "B-cells: 4.4;T-cells: 4.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 1.1 0.5 3.2 0.7 2.8 0.0 0.7 9.5 3.7 1.4 1.4 1.3 0.7 0.3 1.5 1.5 0.7 2.3 0.9 7.1 2.1 7.5 0.7 8.7 0.7 0.7 2.9 1.2 2.2 2.9 0.0 46.8 3.3 1.6 0.8 0.5 0.8 0.7 1.6 0.7 1.2 0.7 0.7 1.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.9 4.4 0.2 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 4.4 1.6 0.4 0.2 0.7 4.8 0.9 0.0 0.0 0.0 0.0 0.0 0.7 3.2 2.8 9.5 2.4 2.1 7.5 2.9 1.2 1.6 0.7 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell line enhanced" "Detected in all" "A549: 54.7;Hep G2: 46.7;RT4: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favourable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavourable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 8.1 54.7 4.5 10.6 5.4 2.4 6.0 4.1 6.7 3.1 3.7 8.0 19.0 15.5 7.9 3.7 11.6 13.7 30.1 4.2 12.2 8.4 10.4 10.6 46.7 6.2 13.6 6.4 3.8 12.8 3.5 15.7 4.7 5.7 4.9 1.5 8.6 11.7 5.4 8.3 5.1 3.9 2.7 13.7 10.1 50.4 13.0 6.4 6.9 11.1 7.2 7.6 6.5 6.5 2.8 9.8 7.1 6.1 6.6 10.1 9.0 7.0 9.8 4.7 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavourable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 14.0 22.2 2.4 4.8 8.3 5.2 9.5 16.8 10.5 12.8 9.6 3.7 8.3 5.3 33.7 10.8 14.2 3.6 6.8 10.3 14.4 4.9 37.1 15.2 16.0 15.6 13.6 5.9 6.4 2.6 26.0 4.2 13.9 14.7 7.9 9.2 2.7 9.8 3.1 8.4 10.6 4.6 7.4 7.8 9.1 16.4 5.8 2.4 15.8 12.5 5.8 2.8 8.5 14.6 13.4 7.9 25.2 25.1 7.1 9.1 5.5 11.1 7.7 4.7 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell line enriched" "Detected in some" 5 "A549: 55.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favourable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 55.8 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 2.3 2.3 0.2 9.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 11.2 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.1 0.2 3.5 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell line enriched" "Detected in some" 5 "RT4: 26.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favourable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.3 0.0 0.0 0.3 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.0 2.6 0.2 26.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favourable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavourable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 11.9 2.7 1.0 0.9 1.1 1.0 5.6 6.0 6.9 4.0 2.7 9.1 1.4 1.3 3.9 6.4 3.9 11.8 7.9 2.0 4.8 4.3 7.8 1.3 3.9 9.8 2.8 1.3 2.9 6.1 0.7 2.3 0.1 3.6 2.9 7.9 0.6 13.7 10.5 4.0 5.6 1.7 2.0 7.2 11.7 28.7 7.0 2.6 5.9 11.8 1.3 0.1 8.8 4.1 2.0 2.8 6.0 5.6 4.4 4.0 0.2 9.2 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074747 Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA074747: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favourable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favourable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.6 17.6 9.7 11.5 46.8 17.4 13.9 15.1 26.0 11.8 14.7 10.0 26.2 11.0 19.5 22.0 12.7 13.5 17.8 14.4 11.9 20.8 9.2 17.3 21.6 28.4 12.1 8.6 18.3 28.9 12.6 14.8 15.8 5.1 11.4 12.8 26.4 10.5 11.2 11.3 13.7 15.2 17.8 15.9 29.2 22.5 11.3 10.3 14.7 17.6 13.9 18.0 14.5 16.6 10.0 9.0 13.2 9.2 10.7 10.1 7.6 15.4 18.0 8.9 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell line enriched" "Detected in some" 8 "LHCN-M2: 26.8" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavourable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.5 3.2 2.1 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 26.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 24.6;U-87 MG: 7.4;WM-115: 27.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: " "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.3 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 1.0 0.1 24.6 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.6 0.0 0.0 0.0 3.3 0.0 0.8 3.8 2.3 0.0 0.0 7.4 0.0 27.0 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Group enriched" "Detected in many" 6 "MCF7: 13.7;SK-BR-3: 48.5" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Not detected" "Not detected" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.8 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 2.1 0.4 0.9 0.7 13.7 0.4 0.9 1.1 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: , HPA057114: " "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.4 16.5 16.3 11.9 5.7 6.7 8.4 5.5 4.4 14.7 14.7 14.4 13.6 17.0 11.5 4.7 8.8 21.8 9.3 15.5 8.7 12.7 9.9 10.1 35.8 11.7 15.0 6.5 3.6 8.9 9.3 13.4 12.8 11.8 12.5 8.2 22.8 16.4 14.5 11.4 18.6 15.4 17.8 10.7 8.2 7.6 16.0 3.2 11.5 8.9 6.0 20.3 6.6 5.2 6.8 10.1 6.6 8.9 13.1 20.3 24.9 3.3 16.0 9.5 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744414-753999 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA065699: , HPA067891: " "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 10.8 6.5 6.4 5.9 5.1 10.5 10.1 15.0 7.2 11.1 6.9 5.4 11.3 6.1 10.5 5.9 12.0 9.5 9.9 9.1 5.5 3.3 5.4 9.9 8.0 12.8 5.8 4.0 13.5 8.5 4.1 5.2 7.6 5.4 11.2 5.0 6.8 9.1 8.8 10.5 29.5 7.6 8.7 4.2 11.4 10.7 36.7 6.5 20.5 20.1 8.7 11.4 10.4 9.9 11.7 8.3 1.5 9.6 6.9 13.4 8.4 18.6 33.1 11.1 16.6 7.1 8.9 13.8 10.7 7.5 19.4 17.3 18.8 10.1 32.8 14.3 9.2 23.7 20.9 20.1 15.6 12.3 31.1 11.8 17.6 10.5 5.0 12.4 16.2 8.6 10.2 15.9 11.3 10.9 16.3 13.8 10.3 13.2 20.4 7.0 10.7 14.3 22.2 5.3 15.4 8.3 13.8 11.5 9.3 11.0 11.3 5.0 12.0 9.1 8.6 12.0 10.9 15.5 25.8 2.3 5.0 18.8 10.3 17.6 13.7 1.5 6.1 0.3 7.6 8.5 13.4 11.6 8.2 8.0 8.3 11.7 10.0 9.8 0.8 6.9 9.6 4.8 5.5 8.4 6.4 5.1 15.0 7.2 5.5 3.3 5.8 4.0 5.4 6.5 GEMIN5 ENSG00000082516 "Gem nuclear organelle associated protein 5" Q8TEQ6 5 154887416-154938209 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037392, HPA037393" Uncertain Enhanced "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA037392: , HPA037393: AB_10672489" "unprognostic (1.14e-2)" "unprognostic (2.81e-3)" "unprognostic (5.41e-3)" "prognostic unfavourable (6.23e-5)" "unprognostic (5.44e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (9.91e-2)" "unprognostic (8.70e-2)" "unprognostic (3.61e-2)" "unprognostic (9.38e-2)" "unprognostic (5.11e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (9.40e-3)" "unprognostic (5.01e-2)" 17.7 10.5 9.4 13.8 13.2 6.4 17.0 11.2 11.7 12.9 10.8 16.5 12.1 7.0 14.4 10.2 11.3 13.2 8.6 14.8 9.5 10.4 10.3 12.3 9.5 14.9 14.0 10.5 18.3 15.4 17.1 15.1 9.9 10.4 12.8 10.1 9.1 10.4 13.3 23.0 15.3 8.6 14.6 11.4 11.0 9.6 13.8 12.5 19.7 11.9 11.0 14.5 12.4 10.9 6.1 4.6 2.9 4.0 4.5 7.3 3.4 8.6 12.9 8.4 19.3 9.0 7.7 10.8 8.4 5.1 14.8 11.0 21.2 7.8 22.8 10.7 8.0 9.2 24.8 15.4 20.3 4.5 11.6 13.8 8.4 12.7 5.0 24.0 8.1 5.8 7.2 20.5 12.3 12.0 21.8 5.6 11.0 11.8 12.9 9.6 11.7 10.1 16.8 16.4 19.0 6.2 5.9 11.0 7.6 9.7 10.9 6.8 12.8 5.5 7.3 13.4 9.6 10.0 18.9 5.6 8.6 17.9 5.7 19.8 11.7 0.0 3.1 2.9 4.5 4.0 7.3 6.1 4.2 4.3 4.6 5.0 6.3 6.6 0.3 4.5 3.9 3.4 3.9 3.4 9.4 13.2 11.2 11.7 9.5 10.4 14.0 10.5 10.4 12.5 GEMIN6 FLJ23459 ENSG00000152147 "Gem nuclear organelle associated protein 6" Q8WXD5 2 38751534-38785000 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035726, HPA035727" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035726: AB_10669528, HPA035727: " "unprognostic (1.97e-2)" "unprognostic (3.83e-1)" "unprognostic (2.32e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (2.10e-2)" "unprognostic (3.82e-3)" "unprognostic (3.10e-2)" "unprognostic (8.13e-2)" "unprognostic (3.53e-3)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.94e-4)" "unprognostic (2.47e-1)" "unprognostic (2.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-2)" 9.2 17.0 10.8 12.8 11.7 4.8 12.0 8.2 13.1 9.3 10.2 8.4 8.1 12.7 12.0 15.5 11.8 13.2 8.1 8.1 9.6 10.5 17.7 21.0 8.1 13.9 9.9 11.0 14.8 18.8 9.2 11.7 10.5 9.7 9.2 12.6 8.5 11.0 8.0 15.8 7.7 10.7 12.5 11.9 12.9 11.1 29.2 13.1 12.7 13.5 11.0 16.9 10.6 9.3 20.5 14.8 4.6 17.1 15.0 18.4 12.9 18.2 14.9 10.5 12.2 13.7 12.1 18.0 15.6 7.9 13.9 11.6 15.8 8.8 25.1 18.1 8.0 8.7 16.3 15.2 20.3 21.5 20.6 16.3 8.9 25.7 9.4 13.5 8.5 8.2 11.2 18.5 9.3 14.5 16.6 8.8 13.8 12.9 16.3 17.4 18.0 18.0 11.3 18.5 13.7 12.5 6.5 13.2 20.8 4.0 15.2 11.7 7.8 4.7 7.9 13.5 17.2 10.5 23.3 18.1 35.3 24.4 10.9 20.6 13.4 1.6 15.5 4.6 13.0 17.1 14.2 20.5 13.4 13.2 14.8 18.9 16.5 17.0 2.4 15.0 15.2 10.9 18.4 12.9 10.8 11.7 8.2 13.1 9.6 10.5 9.9 11.0 9.7 13.1 GEMIN7 FLJ13956 ENSG00000142252 "Gem nuclear organelle associated protein 7" Q9H840 19 45079195-45091524 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052075 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA052075: " "unprognostic (3.32e-1)" "unprognostic (1.48e-2)" "unprognostic (3.84e-1)" "unprognostic (3.17e-2)" "unprognostic (1.60e-1)" "unprognostic (7.00e-2)" "prognostic unfavourable (5.86e-5)" "unprognostic (7.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.95e-1)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "prognostic unfavourable (9.64e-11)" "unprognostic (7.01e-2)" "unprognostic (4.54e-1)" "unprognostic (1.83e-1)" "prognostic favourable (8.00e-4)" 9.7 10.6 8.9 13.0 12.2 18.3 12.3 22.1 19.0 8.1 13.6 10.0 8.2 18.9 10.0 8.7 18.5 9.0 9.6 13.3 9.8 9.7 12.4 20.2 10.3 21.6 10.0 9.0 8.5 24.1 6.1 20.4 12.9 12.8 11.9 13.2 12.7 16.8 9.5 20.7 14.7 16.5 9.7 6.9 24.3 17.4 5.3 10.5 12.8 12.5 14.7 17.1 13.1 11.7 28.4 22.9 15.2 14.3 29.6 32.0 18.9 20.7 27.7 16.2 19.9 12.4 13.0 12.6 16.0 11.8 24.6 27.4 16.8 13.4 20.9 11.1 13.8 13.0 23.5 19.0 14.9 16.6 30.6 23.0 12.7 21.8 17.4 18.3 13.8 19.4 15.7 13.7 9.9 23.9 24.0 21.9 9.6 30.7 17.5 19.0 15.2 14.4 21.1 7.5 27.0 18.6 15.4 16.2 11.3 12.5 27.2 14.1 18.3 19.7 12.8 9.1 17.4 5.9 21.0 22.8 33.6 33.3 14.6 18.5 14.6 10.7 14.3 15.2 32.0 11.5 30.2 28.4 23.6 29.4 20.1 23.7 18.3 23.8 7.9 29.6 8.3 22.9 19.8 18.9 8.9 12.2 22.1 19.0 9.8 9.7 10.0 9.0 12.8 10.5 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14008279-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favourable (7.73e-5)" 13.4 13.5 14.5 12.9 17.0 12.0 19.9 12.3 20.0 16.5 13.9 24.0 27.3 9.0 21.5 16.9 13.2 22.8 16.4 15.5 14.8 14.0 16.7 12.9 14.5 16.0 16.6 14.7 28.9 22.2 18.7 27.4 10.3 21.0 13.1 11.9 16.8 24.7 30.2 7.6 15.7 10.0 17.1 23.3 12.5 13.6 8.2 12.7 14.6 21.3 7.9 13.2 12.7 13.0 11.3 15.4 0.8 6.9 9.9 15.2 7.5 6.3 6.3 7.5 1.8 12.2 18.7 3.7 5.9 6.6 5.2 3.6 3.3 11.0 14.8 14.2 4.8 8.5 4.6 10.4 5.0 7.9 9.5 3.8 4.7 7.4 7.1 9.0 8.0 15.0 17.2 9.0 15.7 11.2 6.6 13.1 7.8 8.5 9.0 14.1 8.1 3.7 13.8 5.2 26.3 8.7 6.2 7.4 20.5 6.3 11.9 7.0 16.3 9.0 8.5 3.8 2.2 11.1 2.4 8.9 4.4 9.3 8.8 5.5 2.2 0.6 6.7 0.2 9.4 6.4 11.6 11.3 15.2 8.9 12.2 9.8 13.1 9.8 0.8 9.9 6.9 15.4 8.4 7.5 14.5 17.0 12.3 20.0 14.8 14.0 16.6 14.7 21.0 12.7 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.0 12.8 9.0 13.3 4.6 3.2 28.5 7.3 5.1 9.3 9.3 34.9 32.6 9.6 7.6 4.1 16.6 10.1 7.9 4.0 3.9 17.3 5.3 10.1 19.7 10.3 9.0 9.8 4.9 9.5 8.1 5.3 7.3 34.1 8.9 5.2 19.8 6.8 21.7 32.3 19.3 14.4 1.5 10.3 8.2 15.4 16.3 17.6 6.7 24.6 10.5 18.7 16.0 7.3 6.9 15.4 15.8 9.9 13.5 8.4 12.4 7.1 15.5 17.3 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984207-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: " "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favourable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 9.7 12.2 9.7 15.2 9.9 10.7 14.8 15.2 12.5 8.1 24.8 10.8 15.2 29.6 10.1 10.2 11.0 10.2 16.1 17.8 9.8 9.7 13.7 33.5 17.1 18.1 10.7 9.7 9.4 43.8 19.2 10.9 18.0 8.0 11.9 18.0 10.5 22.5 12.5 27.5 8.3 33.2 9.2 9.6 15.2 12.8 20.0 7.8 7.7 15.1 15.0 11.4 12.4 17.1 16.1 9.1 9.8 12.7 7.8 17.7 7.7 11.3 18.1 14.9 12.1 6.3 12.6 19.3 13.2 12.9 18.6 15.2 26.0 19.0 6.4 18.0 9.8 17.1 11.3 17.4 11.8 19.7 23.1 8.8 17.8 29.5 11.4 12.7 16.6 8.1 13.5 16.2 14.6 8.7 13.7 21.4 13.5 26.7 14.5 13.8 23.8 18.1 31.8 11.4 20.7 18.9 8.9 13.1 12.5 17.8 38.0 14.1 18.1 13.6 8.1 18.1 20.2 10.1 22.6 36.3 19.6 18.3 6.0 8.7 15.2 3.1 12.6 9.8 9.2 10.5 9.9 16.1 12.6 15.6 9.1 13.4 11.5 7.9 1.1 7.8 12.7 4.0 17.7 7.7 9.7 9.9 15.2 12.5 9.8 9.7 10.7 9.7 8.0 7.8 GFM1 "EFGM, EGF1, GFM" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644278-158692575 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavourable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favourable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 20.1 23.3 17.6 14.1 18.6 14.7 19.8 32.8 23.4 11.4 20.7 17.8 19.1 18.8 15.4 17.9 16.2 14.3 12.6 27.9 18.0 17.9 34.1 42.2 13.5 13.2 18.9 19.5 13.2 17.0 30.9 16.4 17.4 22.6 15.3 23.3 13.8 16.3 15.4 46.5 15.4 16.0 16.0 18.5 14.2 17.1 19.8 17.8 14.5 21.4 17.6 13.6 15.0 13.2 13.2 16.5 10.8 19.8 16.0 21.1 11.5 30.4 17.5 8.5 10.2 13.6 8.9 11.4 15.7 13.8 22.0 17.2 23.3 18.8 26.1 19.9 11.7 18.5 19.0 14.6 24.6 14.5 12.8 21.7 11.9 12.9 15.5 27.8 11.8 12.3 17.3 14.2 13.2 14.7 22.5 16.0 20.0 16.8 16.3 11.1 19.2 11.8 15.9 10.2 42.0 17.5 12.8 15.4 14.9 24.8 33.6 26.7 41.4 22.7 10.8 14.7 7.3 23.0 24.8 30.9 19.4 47.5 13.9 23.4 16.4 10.8 13.2 9.1 16.1 19.8 21.1 13.2 15.0 16.9 16.5 11.9 17.6 18.5 1.9 16.0 14.0 8.6 11.9 11.5 17.6 18.6 32.8 23.4 18.0 17.9 18.9 19.5 22.6 17.8 GFM2 "EFG2, FLJ21661" ENSG00000164347 "G elongation factor mitochondrial 2" Q969S9 5 74721204-74767371 "Predicted intracellular proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036863, HPA069871" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036863: , HPA069871: " "unprognostic (2.58e-3)" "unprognostic (7.04e-2)" "unprognostic (8.54e-3)" "unprognostic (1.98e-1)" "unprognostic (4.49e-2)" "unprognostic (2.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.64e-1)" "unprognostic (1.40e-1)" "unprognostic (3.80e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.33e-5)" "unprognostic (9.55e-2)" "unprognostic (4.15e-1)" "unprognostic (8.52e-3)" "unprognostic (9.82e-2)" 9.7 23.8 14.7 8.7 22.4 12.1 13.1 14.2 24.8 10.7 12.8 12.7 17.8 8.3 12.3 16.8 13.0 21.6 8.7 29.5 18.5 15.6 21.9 30.8 9.1 10.3 13.8 18.1 11.6 12.9 19.8 24.9 12.9 20.4 12.5 15.3 11.6 15.7 11.2 26.4 10.5 10.3 10.4 11.7 10.3 16.3 13.7 10.4 18.0 12.3 12.8 14.2 12.3 12.6 8.3 6.1 17.1 9.8 15.6 7.4 4.6 19.9 17.1 14.4 27.3 11.0 14.9 14.7 22.0 13.4 22.5 24.1 18.7 13.0 20.7 23.5 11.6 16.7 29.0 30.7 29.3 18.2 17.0 12.2 17.3 12.8 14.0 11.9 13.5 16.7 13.7 17.8 21.4 15.2 20.5 17.2 25.5 11.2 16.4 7.3 5.9 15.5 20.6 23.6 23.5 16.4 12.8 24.3 13.1 25.4 19.6 21.7 17.0 20.7 12.1 8.6 14.8 10.9 13.9 10.0 19.3 20.9 13.2 17.0 13.1 17.1 6.3 8.0 6.6 6.5 6.4 8.3 5.4 7.2 6.1 7.0 7.4 7.2 3.3 15.6 9.8 4.0 6.2 4.6 14.7 22.4 14.2 24.8 18.5 15.6 13.8 18.1 20.4 10.4 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.4;HMC-1: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.2 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 9.9 10.4 0.7 6.5 2.0 3.1 0.4 0.7 3.7 18.4 3.8 3.8 1.5 5.2 28.5 0.6 2.5 0.9 2.7 5.6 0.5 0.9 0.8 2.3 1.2 3.2 1.0 2.1 4.0 1.3 5.1 0.3 1.4 3.4 0.6 2.4 0.4 2.3 0.6 0.5 7.5 0.9 2.0 2.1 3.3 8.3 4.7 11.9 0.8 3.1 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 GFOD2 "FLJ23802, MGC11335" ENSG00000141098 "Glucose-fructose oxidoreductase domain containing 2" Q3B7J2 16 67674531-67719421 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040939, HPA041112" Uncertain Supported Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA040939: AB_10796564, HPA041112: AB_10794541" "unprognostic (9.80e-2)" "unprognostic (2.20e-1)" "unprognostic (2.06e-2)" "unprognostic (3.16e-3)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (2.93e-2)" "unprognostic (5.61e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-2)" "prognostic favourable (5.95e-4)" "unprognostic (1.17e-1)" "prognostic favourable (8.66e-4)" "unprognostic (1.90e-1)" "unprognostic (1.76e-1)" "unprognostic (7.87e-2)" "unprognostic (9.64e-2)" 9.0 9.4 9.6 7.7 13.8 13.4 8.6 42.9 18.9 10.7 10.6 5.0 9.4 10.7 8.1 5.9 21.8 12.2 8.4 6.8 10.1 12.4 9.8 24.4 7.9 6.9 8.2 11.1 5.6 9.0 14.1 11.7 19.4 10.8 7.4 8.7 6.4 8.7 7.2 6.5 14.1 8.1 8.6 5.7 12.8 7.5 8.3 5.1 6.1 9.7 13.2 12.8 9.0 16.4 9.1 6.5 10.6 5.5 6.4 10.2 4.1 9.3 15.1 9.3 19.1 9.4 7.1 10.9 7.8 10.0 14.6 14.9 12.8 8.5 15.7 7.3 9.0 11.8 9.5 8.9 12.4 9.4 11.7 4.0 8.0 18.3 7.2 6.5 7.8 5.9 10.4 19.2 5.8 20.9 8.2 3.1 8.1 19.8 10.5 7.7 12.6 8.2 17.0 5.4 12.2 8.9 13.2 19.0 11.1 19.2 6.5 5.9 9.8 4.3 16.1 11.3 11.3 10.0 7.6 8.0 11.2 17.1 7.0 9.5 8.1 0.7 5.5 5.7 5.6 3.5 9.0 8.0 9.5 9.6 5.6 9.1 8.4 6.6 10.6 6.4 3.4 6.5 10.2 4.1 9.6 13.8 42.9 18.9 10.1 12.4 8.2 11.1 10.8 5.1 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favourable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.5 6.6 8.5 5.3 24.0 16.5 18.5 18.2 17.0 8.6 11.0 21.2 8.7 8.6 6.7 16.9 4.6 10.7 5.6 14.3 7.8 4.1 10.0 4.9 21.8 28.4 6.8 4.0 10.4 27.3 16.7 32.0 8.0 8.3 14.0 16.8 5.6 7.2 7.1 11.1 5.5 7.2 17.8 4.4 14.0 7.6 5.3 3.0 6.8 12.6 24.4 5.0 4.3 12.2 7.7 10.3 13.2 8.7 10.0 6.7 6.5 12.5 4.6 8.8 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273467 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 16.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.2;EFO-21: 17.8;fHDF/TERT166: 32.3;HBF TERT88: 24.4;MCF7: 21.3;U-251 MG: 19.9" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" 89000 "Golgi apparatus" Nucleoplasm "HPA043829: " "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 24.0 4.3 6.3 9.5 13.8 0.3 26.8 0.8 8.4 12.5 14.9 1.8 5.9 2.2 6.7 23.4 11.1 12.7 11.5 6.4 4.8 6.7 7.0 21.9 3.2 7.4 9.5 2.7 10.0 7.3 2.2 3.9 0.3 2.9 12.1 4.8 3.4 5.4 6.6 7.5 6.8 7.2 9.8 3.4 5.8 7.8 5.3 1.9 2.6 2.6 10.7 8.1 10.5 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 0.0 0.0 0.0 0.0 2.9 0.1 16.7 29.2 0.0 0.0 0.0 17.8 32.3 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 4.2 0.0 0.0 0.0 0.0 2.2 21.3 2.6 0.0 1.8 0.0 0.0 0.7 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 19.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 13.8 0.8 4.6 4.8 6.7 9.5 2.7 2.9 1.9 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252379-138274671 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 17 "SH-SY5Y: 26.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 2.4 2.4 0.3 7.1 1.0 0.0 1.8 7.0 0.6 7.9 13.0 0.1 11.0 3.8 3.0 6.1 9.3 1.2 9.4 6.2 0.3 0.3 0.9 0.4 2.9 0.1 0.6 0.1 4.7 7.0 0.0 2.3 0.1 1.3 4.4 5.8 10.0 7.5 10.9 1.3 3.6 4.7 8.6 1.4 0.1 6.9 8.4 0.5 0.4 1.0 2.8 0.8 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 26.4 0.4 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 7.0 0.6 0.3 0.3 0.6 0.1 1.3 0.5 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: , HPA051016: " "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favourable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.2 12.8 16.0 15.6 14.1 11.6 17.6 15.1 12.1 13.3 14.8 11.3 10.4 28.0 10.3 10.8 17.0 14.2 16.8 12.2 23.9 23.6 11.1 22.9 12.1 13.7 27.2 21.6 14.0 15.0 18.9 12.0 12.5 22.3 18.2 13.7 17.4 12.1 29.2 12.6 13.2 13.4 12.9 12.0 13.7 14.8 14.8 26.2 9.6 20.2 23.3 21.0 19.8 14.9 18.2 17.8 16.4 12.0 39.3 15.7 29.0 20.4 16.5 15.9 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872860 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles 1500000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: " "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 6.8 6.7 21.6 6.7 23.7 2.9 8.5 42.6 29.1 9.5 11.5 9.7 14.3 9.8 12.3 19.5 6.4 10.5 11.4 13.8 19.7 17.0 9.9 7.2 9.0 10.3 11.2 32.1 13.4 19.5 20.8 18.3 8.5 19.2 11.4 9.6 6.9 18.8 15.3 31.6 11.1 9.0 9.6 11.0 8.3 12.9 5.0 15.6 4.9 16.3 4.3 8.2 9.3 8.5 6.1 2.6 1.5 3.0 3.2 12.8 1.8 2.2 3.3 17.0 17.4 13.4 12.0 15.1 9.4 9.6 7.8 11.6 17.4 11.1 0.0 11.2 7.3 1.5 7.3 4.1 5.1 0.7 13.1 6.7 5.9 9.1 12.0 0.3 11.1 17.4 4.7 8.7 4.0 0.6 5.0 1.2 5.3 3.8 1.7 3.4 3.9 1.7 0.0 11.6 10.7 11.3 3.3 9.9 11.6 4.8 7.7 12.1 5.9 6.1 0.2 26.8 10.7 2.5 5.3 13.1 1.7 0.8 31.5 0.6 9.8 1.5 3.0 1.4 7.4 2.0 2.1 5.6 6.3 2.8 2.6 6.1 12.8 8.9 0.3 3.2 0.7 1.4 4.8 1.8 21.6 23.7 42.6 29.1 19.7 17.0 11.2 32.1 19.2 15.6 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423777-42721878 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4" "Group enriched" "Detected in some" 5 "HSkMC: 13.3;T-47d: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" 2200000 21000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: , HPA057705: " "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favourable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 44.4 2.8 0.7 5.4 1.3 0.3 31.5 0.4 1.4 4.0 6.9 0.5 1.7 0.6 5.7 3.9 2.4 2.5 3.9 6.0 1.3 1.6 5.3 82.4 2.3 2.2 1.2 1.4 5.0 1.3 3.6 2.0 4.0 2.0 8.7 2.5 2.4 2.3 7.4 23.4 3.0 2.4 5.2 1.0 2.6 3.5 1.6 0.2 0.1 2.9 4.3 0.5 3.8 8.4 0.6 0.3 1.8 0.5 0.4 0.3 0.1 0.0 0.0 0.3 3.0 2.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 13.3 4.3 0.0 0.6 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.1 33.9 0.0 1.8 3.0 1.3 1.6 0.3 0.3 0.0 0.0 0.3 0.0 1.5 1.8 0.3 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.3 1.7 0.4 0.5 0.3 0.2 0.1 0.7 1.3 0.4 1.4 1.3 1.6 1.2 1.4 2.0 0.2 GID8 "bA305P22.1, C20orf11, FLJ20602, TWA1" ENSG00000101193 "GID complex subunit 8 homolog" Q9NWU2 20 62938119-62948475 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049929, HPA055047" Approved Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA049929: , HPA055047: " "unprognostic (1.35e-1)" "unprognostic (4.06e-2)" "unprognostic (5.90e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.19e-1)" "unprognostic (8.25e-2)" "unprognostic (3.88e-2)" "unprognostic (4.58e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-1)" "unprognostic (2.72e-2)" "unprognostic (1.43e-1)" "prognostic favourable (3.22e-4)" "unprognostic (3.97e-1)" "unprognostic (1.43e-1)" "unprognostic (2.01e-1)" "unprognostic (6.87e-2)" 14.0 14.1 23.0 15.4 18.7 35.5 21.5 20.7 23.5 20.8 18.6 14.3 21.0 15.1 18.2 19.5 55.9 23.0 19.0 15.9 17.4 10.9 15.6 29.6 15.2 24.2 15.5 22.9 30.6 30.0 22.2 15.7 15.1 14.7 17.8 16.1 17.7 21.2 17.7 19.7 34.0 17.1 19.8 14.1 19.6 20.1 22.4 17.2 23.6 20.6 26.0 24.6 22.8 28.7 9.3 9.8 16.0 10.4 12.9 15.0 8.3 15.6 10.0 15.0 13.5 12.4 9.8 14.7 8.8 7.3 25.2 11.4 48.2 15.3 19.7 15.1 11.3 18.2 13.7 18.2 15.3 5.2 6.7 18.3 13.0 23.0 9.8 21.2 15.5 10.7 20.3 10.8 12.6 12.2 14.0 8.5 8.6 22.0 25.2 19.0 15.1 15.0 20.0 28.2 11.7 9.2 22.1 15.6 12.8 20.7 20.4 12.7 28.3 20.5 12.2 15.1 18.9 11.8 11.8 9.0 10.3 20.5 10.2 10.4 9.5 5.8 10.4 16.0 11.7 8.7 13.7 8.4 12.3 13.0 9.8 9.3 13.6 15.0 15.2 12.9 8.1 7.4 10.6 8.3 23.0 18.7 20.7 23.5 17.4 10.9 15.5 22.9 14.7 17.2 GIGYF1 "GYF1, PERQ1" ENSG00000146830 "GRB10 interacting GYF protein 1" O75420 7 100679507-100694037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020999, HPA023995" Enhanced Approved Vesicles,Microtubules Vesicles Microtubules "HPA020999: AB_2111744, HPA023995: AB_1855221" "unprognostic (3.82e-3)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (2.67e-2)" "unprognostic (7.46e-2)" "prognostic favourable (7.42e-4)" "prognostic unfavourable (2.30e-4)" "unprognostic (1.43e-2)" "unprognostic (8.06e-2)" "unprognostic (1.65e-2)" "prognostic favourable (1.35e-5)" "unprognostic (3.66e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (1.89e-1)" "unprognostic (2.79e-1)" "unprognostic (2.67e-3)" 15.5 17.3 22.1 15.9 23.0 28.2 16.3 66.8 32.4 20.6 14.0 18.9 27.3 17.1 25.1 20.2 11.5 18.3 16.4 13.2 20.3 9.4 14.4 13.3 13.5 18.5 14.1 16.3 29.8 23.8 17.8 26.3 16.2 15.7 17.1 9.3 19.6 26.5 25.7 25.5 31.7 17.6 12.9 9.3 24.0 17.0 18.9 20.4 11.8 20.5 10.4 14.2 14.3 14.0 4.1 3.9 8.8 2.6 2.5 5.1 0.9 6.9 7.2 11.6 17.0 5.6 4.4 20.7 6.6 5.4 4.1 4.8 4.2 12.1 9.8 8.6 4.8 8.4 5.7 6.7 2.6 10.4 11.6 6.8 17.8 6.0 5.5 7.7 11.7 6.9 5.4 5.3 7.6 4.1 18.7 9.7 3.7 15.8 13.6 42.7 14.2 8.8 21.9 6.1 9.8 3.0 6.4 10.5 16.5 8.6 13.9 7.6 6.3 13.0 6.4 12.1 15.0 19.7 6.0 7.9 3.5 5.3 7.0 15.5 7.1 3.3 2.6 2.2 5.1 2.3 3.8 2.7 3.4 3.2 1.0 4.1 3.1 3.2 8.8 2.5 2.5 3.9 1.8 0.9 22.1 23.0 66.8 32.4 20.3 9.4 14.1 16.3 15.7 20.4 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514830-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 155.1" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 39.0;MOLT-4: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1" "Low region specificity" "Detected in many" "HPA020266, HPA020268" Enhanced Supported Vesicles,Cytosol Vesicles Cytosol "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favourable (7.43e-4)" "prognostic favourable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 32.2 7.3 6.2 30.1 9.8 1.9 19.7 4.3 8.0 19.9 9.5 2.1 5.3 7.6 13.4 11.9 12.2 10.2 9.4 14.6 9.3 6.4 20.1 10.5 22.8 54.7 10.0 3.3 7.0 4.7 3.3 4.9 12.5 7.2 13.5 8.8 6.2 10.7 4.6 17.0 4.6 20.5 12.4 8.1 51.5 7.7 6.7 8.2 18.7 16.7 11.3 34.9 13.4 11.0 0.4 18.0 3.4 41.1 65.0 155.1 131.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 41.1 0.5 79.6 36.9 77.6 0.4 118.6 95.4 18.0 0.3 155.1 108.0 3.4 65.0 38.6 1.0 64.7 131.0 6.2 9.8 4.3 8.0 9.3 6.4 10.0 3.3 7.2 8.2 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: " "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favourable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 6.0 9.3 5.0 5.7 9.5 1.4 8.0 15.0 9.6 9.0 7.0 6.5 6.1 4.9 7.0 5.6 7.2 6.4 3.7 12.7 5.8 5.1 7.9 8.3 5.6 6.6 14.0 4.2 11.0 6.0 8.4 17.4 5.1 9.4 8.3 6.7 3.6 6.1 7.6 14.6 4.5 5.9 5.8 11.4 6.9 6.3 9.3 10.8 8.6 9.1 6.1 6.7 9.4 9.5 4.6 3.3 4.8 7.1 3.7 8.3 2.8 5.4 5.8 7.4 5.4 3.5 9.1 6.0 7.3 5.0 5.5 4.9 3.5 7.0 3.3 6.9 2.8 6.4 6.9 10.2 7.4 4.1 5.5 4.7 5.7 3.9 7.3 4.2 3.1 3.6 11.4 5.0 10.3 4.3 4.2 4.8 8.6 3.9 5.8 2.8 6.3 9.2 5.2 8.5 8.4 7.2 4.5 6.0 4.4 4.8 4.0 6.9 11.8 6.4 3.5 5.6 3.4 6.0 5.5 5.8 4.7 4.7 7.1 6.7 4.5 0.4 2.7 4.8 3.4 3.4 3.9 4.6 4.6 5.0 3.3 3.8 5.6 5.6 3.8 3.7 7.1 3.2 8.3 2.8 5.0 9.5 15.0 9.6 5.8 5.1 14.0 4.2 9.4 10.8 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: " "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.7 5.6 9.1 12.3 49.3 29.6 14.9 26.8 31.4 20.3 25.5 7.3 10.5 5.8 14.8 25.2 16.1 5.9 13.3 26.7 9.6 13.1 5.5 5.4 8.7 18.8 10.8 5.3 32.8 11.6 17.2 11.9 21.8 7.1 9.6 19.1 10.0 6.8 8.1 3.2 6.0 7.2 16.4 4.3 28.9 6.9 5.8 5.6 26.6 15.8 5.5 9.9 11.0 15.2 11.0 11.6 28.0 17.6 9.5 11.0 7.2 20.4 9.8 10.1 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 GINS4 "MGC14799, SLD5" ENSG00000147536 "GINS complex subunit 4" Q9BRT9 8 41529206-41545046 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024663, HPA026580" Uncertain Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA024663: AB_1857224, HPA026580: AB_1857225" "unprognostic (7.74e-2)" "unprognostic (3.72e-2)" "unprognostic (2.25e-3)" "prognostic unfavourable (2.30e-5)" "unprognostic (1.70e-1)" "unprognostic (4.01e-2)" "unprognostic (1.71e-3)" "unprognostic (8.01e-3)" "unprognostic (4.03e-3)" "unprognostic (1.50e-2)" "unprognostic (4.34e-4)" "unprognostic (1.79e-1)" "unprognostic (3.67e-5)" "unprognostic (2.40e-3)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (3.22e-1)" 2.0 3.0 2.3 6.2 4.7 9.0 2.7 1.6 3.7 2.7 3.4 6.8 0.0 2.5 2.4 3.0 6.0 1.6 2.4 5.7 3.7 1.8 2.2 2.2 2.5 7.9 5.9 3.3 2.6 1.3 1.6 1.2 4.8 2.8 1.8 5.1 1.9 2.6 0.8 3.7 3.4 3.7 2.4 4.7 5.0 2.1 8.6 5.6 14.0 2.1 5.7 9.6 2.1 3.0 5.8 5.2 3.9 1.4 2.7 6.7 1.7 9.5 13.8 19.6 8.7 1.2 1.5 8.1 13.7 8.3 14.2 16.7 12.7 8.4 13.3 5.6 6.9 7.3 15.7 11.3 21.0 4.9 8.7 19.3 10.2 8.6 0.3 4.2 10.0 0.8 0.5 23.5 5.3 7.0 9.5 4.5 9.9 6.6 17.4 4.8 10.8 7.6 16.3 18.2 5.6 5.1 9.1 6.0 4.7 9.7 4.3 3.9 11.2 4.7 4.8 9.7 14.7 17.8 13.7 5.3 7.7 15.9 6.9 9.9 23.4 2.4 1.4 0.5 3.0 1.3 1.7 2.4 4.8 2.0 0.7 5.8 3.1 2.0 3.9 2.7 0.7 5.2 6.7 1.7 2.3 4.7 1.6 3.7 3.7 1.8 5.9 3.3 2.8 5.6 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 65.4 30.4 9.3 14.6 8.6 8.7 7.4 24.6 12.4 20.3 18.4 16.3 24.8 0.9 46.3 17.3 37.6 8.0 20.6 6.9 6.8 14.2 12.8 20.8 15.8 26.5 1.3 15.8 10.0 20.6 12.3 10.8 13.6 5.9 11.3 10.2 48.8 4.2 2.6 10.1 30.5 4.3 7.8 8.7 25.0 57.4 8.7 9.7 13.7 33.9 31.5 21.3 7.1 23.5 28.7 15.8 40.0 26.2 10.6 13.4 3.3 24.0 10.4 30.1 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.1;HaCaT: 4.8;Hep G2: 17.9;HUVEC TERT2: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 17 "T-cells: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051212: , HPA062684: " "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favourable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favourable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 6.4 17.0 0.8 3.2 0.9 0.0 4.0 0.4 1.0 2.6 27.0 0.3 0.2 19.6 5.4 4.5 5.7 1.4 8.1 3.1 0.5 0.5 21.3 10.4 3.2 2.2 0.5 0.3 3.7 24.7 3.3 2.5 1.6 1.3 2.1 7.8 1.5 6.9 1.0 1.8 2.7 64.0 1.4 0.6 22.7 3.0 2.2 0.4 0.1 1.5 4.9 1.4 2.5 5.1 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 5.1 0.0 0.8 0.0 0.4 0.9 4.0 2.6 1.2 0.0 0.4 4.8 0.0 0.0 2.6 0.1 0.0 0.6 0.0 17.9 1.0 0.0 0.0 0.8 0.0 2.8 0.1 18.9 0.0 0.1 2.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 1.0 0.6 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 0.5 0.5 0.5 0.3 1.3 0.4 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585553-3593541 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 12.0;HMC-1: 7.8;THP-1: 14.5;WM-115: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enriched" "Detected in single" 9 "T-cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" 13000 Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 5.5 2.4 1.3 1.3 1.3 0.0 3.0 1.3 1.3 3.4 1.5 1.9 5.0 1.0 4.5 3.2 6.0 2.2 2.1 2.7 1.3 0.6 4.1 1.6 4.5 2.0 1.3 1.3 1.3 1.3 4.6 1.3 1.3 1.3 4.3 1.3 1.9 1.3 5.2 1.3 1.1 5.4 9.3 1.3 4.8 2.0 1.3 2.2 2.0 3.8 1.3 1.4 1.3 13.0 0.1 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 1.0 0.0 0.1 4.3 12.0 0.0 0.4 0.0 7.8 0.1 0.0 0.7 0.0 1.3 1.9 0.0 0.2 0.0 0.0 0.7 0.4 0.7 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 3.0 0.0 14.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.3 1.3 1.3 1.3 1.3 0.6 1.3 1.3 1.3 2.2 GIT1 ENSG00000108262 "GIT ArfGAP 1" Q9Y2X7 17 29573469-29594054 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004059, HPA004186" Enhanced Supported "Focal adhesion sites,Mitochondria,Cytosol" 53000 "Focal adhesion sites, Cytosol" Mitochondria "HPA004059: AB_1078966, HPA004186: AB_1078967" "unprognostic (3.66e-1)" "unprognostic (4.46e-2)" "unprognostic (3.24e-2)" "unprognostic (6.30e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.54e-6)" "unprognostic (3.00e-3)" "unprognostic (2.79e-1)" "unprognostic (5.23e-2)" "unprognostic (2.12e-2)" "unprognostic (3.08e-1)" "unprognostic (8.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.30e-2)" "unprognostic (2.10e-1)" "unprognostic (1.69e-1)" 13.0 8.5 34.0 11.1 38.1 8.0 9.4 18.9 43.4 7.8 9.8 15.6 2.2 11.6 10.0 5.3 13.2 14.0 10.2 12.2 41.5 16.4 7.0 3.7 12.0 12.6 19.2 21.8 13.6 14.3 10.2 8.1 13.8 15.0 8.4 6.9 7.8 11.9 10.3 10.0 20.2 10.9 8.7 11.9 11.1 9.5 42.9 19.8 10.8 11.0 4.5 9.7 9.8 7.5 1.8 4.7 3.0 6.0 5.6 4.9 3.6 17.1 28.8 14.2 25.2 11.3 7.2 16.5 8.5 8.4 10.3 9.2 11.6 6.4 13.0 13.7 11.1 28.4 14.9 21.9 5.3 16.8 17.8 9.4 14.1 10.4 13.8 11.8 7.7 8.7 25.2 11.8 18.5 19.0 7.6 11.3 7.3 17.7 37.3 16.0 10.5 6.9 28.4 19.0 19.5 9.3 9.5 29.9 25.6 12.0 28.0 42.0 13.7 15.8 23.5 9.8 14.2 21.5 17.1 9.4 12.9 14.2 16.1 10.2 16.5 0.3 3.6 3.0 4.7 6.0 2.2 1.8 4.5 4.9 4.7 1.7 3.7 2.7 1.2 5.6 3.7 4.0 2.9 3.6 34.0 38.1 18.9 43.4 41.5 16.4 19.2 21.8 15.0 19.8 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.8;HUVEC TERT2: 61.6;NTERA-2: 62.7;TIME: 45.3;U-87 MG: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: , HPA047551: , HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavourable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 7.2 32.1 0.0 17.5 10.9 0.0 24.0 48.8 8.1 19.8 0.1 0.0 0.0 2.7 9.3 3.1 0.8 14.7 26.4 0.0 8.8 0.3 2.9 0.0 21.9 0.0 0.0 29.0 15.9 29.6 10.7 61.6 0.0 0.7 1.6 1.3 0.0 12.9 62.7 8.0 0.0 0.0 0.6 32.4 3.5 0.0 0.5 0.0 0.0 0.0 2.5 0.0 45.3 25.0 6.9 21.1 15.5 0.0 0.0 0.0 61.0 0.0 3.5 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781189-34786369 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1" "Cell line enhanced" "Detected in some" "A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA074472: " "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavourable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.1 0.1 1.0 2.4 0.4 0.0 3.4 1.4 1.2 6.3 2.2 0.0 0.6 0.0 0.7 3.0 40.1 0.5 4.1 0.1 0.2 0.1 0.5 0.8 0.6 0.4 0.1 0.1 0.2 0.2 0.0 0.1 11.3 0.0 3.7 2.8 0.0 3.7 0.9 0.2 49.3 0.6 0.2 0.1 0.1 3.2 0.5 0.0 0.7 0.2 32.1 25.0 4.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 3.5 0.0 30.0 0.0 25.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 42.1 0.0 10.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 6.7 0.0 0.0 0.0 12.5 9.9 0.0 0.0 3.9 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.4 1.2 0.2 0.1 0.1 0.1 0.0 0.0 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" "Nucleoli, Cytosol" "Cell Junctions" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavourable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.6 9.1 23.0 7.9 3.0 4.7 9.0 19.6 15.5 21.1 22.7 5.3 9.8 0.1 1.0 18.3 4.6 11.9 6.1 29.8 0.1 8.9 0.1 4.9 0.6 1.9 0.1 0.8 3.3 0.6 16.1 5.3 7.2 0.8 0.2 12.2 0.1 2.8 1.8 10.3 7.8 16.7 29.2 0.1 5.1 7.4 4.4 10.0 2.2 0.1 6.6 4.8 2.8 6.0 18.7 18.1 8.5 16.6 0.1 4.6 13.1 6.5 0.1 17.5 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;SCLC-21H: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.5 1.3 0.7 1.8 1.4 0.4 0.6 0.7 0.9 1.2 0.2 9.7 2.6 0.9 0.3 0.3 0.3 0.3 1.5 0.3 2.4 2.1 2.5 0.0 0.0 0.4 0.2 0.8 0.5 0.2 1.0 0.3 0.4 0.5 1.8 0.6 0.6 1.9 0.4 0.3 0.1 0.8 0.0 5.1 3.0 0.4 0.1 0.3 0.1 0.3 4.5 1.3 3.7 4.4 1.5 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5 (putative)" Q6ZS86 3 142157527-142225607 "Enzymes, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: " "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 6.1 12.2 5.6 5.7 7.2 10.8 10.9 9.0 9.4 11.5 10.9 8.4 11.5 14.4 10.9 14.8 7.9 7.2 8.3 5.4 5.5 4.1 5.7 3.1 6.2 3.5 9.3 6.0 11.5 4.8 5.4 20.3 3.7 12.6 13.5 11.8 6.7 14.8 14.7 5.0 8.8 14.0 9.4 11.6 3.5 8.1 6.2 5.3 4.6 7.4 4.2 6.1 8.5 6.7 1.3 1.1 3.6 5.3 3.8 3.8 0.5 10.9 2.7 4.0 2.7 8.3 15.8 6.9 3.6 2.5 4.0 2.5 4.2 6.1 7.9 3.3 3.5 4.7 4.5 3.5 5.3 2.8 4.4 5.1 6.6 3.1 4.5 5.8 6.9 6.5 3.1 2.6 3.5 2.3 4.5 4.8 7.3 7.0 5.1 4.9 2.6 3.2 4.9 4.2 2.9 4.2 6.9 3.9 2.9 10.1 10.7 3.2 14.9 3.9 2.5 3.2 2.7 7.0 4.0 5.1 4.8 8.1 5.8 3.7 5.4 3.6 1.1 0.7 3.8 0.9 1.9 0.5 1.3 1.4 0.8 1.3 1.0 1.7 3.2 3.8 5.3 1.1 0.6 0.5 5.6 7.2 9.0 9.4 5.5 4.1 9.3 6.0 12.6 5.3 GKAP1 "FKSG21, GKAP42" ENSG00000165113 "G kinase anchoring protein 1" Q5VSY0 9 83739421-83829516 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 98.8" "Cell line enhanced" "Detected in many" "U-266/84: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035117, HPA035118, HPA066173" Enhanced Supported Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA035117: , HPA035118: AB_10671100, HPA066173: AB_2732740" "unprognostic (1.91e-1)" "unprognostic (2.94e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (9.62e-2)" "unprognostic (2.50e-1)" "unprognostic (2.52e-3)" "unprognostic (7.66e-3)" "unprognostic (3.04e-1)" "unprognostic (1.86e-2)" "prognostic favourable (6.96e-5)" "unprognostic (4.18e-1)" "prognostic favourable (1.05e-6)" "unprognostic (9.73e-2)" "unprognostic (1.38e-2)" "unprognostic (2.06e-1)" "unprognostic (6.24e-3)" 4.4 4.2 6.0 2.8 6.1 2.5 9.2 15.6 6.1 4.7 5.0 4.1 6.6 3.0 5.5 4.5 3.2 3.9 3.4 9.0 6.1 6.8 4.2 5.1 2.9 2.6 6.5 3.1 7.0 5.2 6.2 7.9 2.0 6.1 6.6 2.7 3.2 4.2 5.9 25.0 1.7 3.0 8.1 8.0 2.4 3.5 98.8 7.2 8.4 8.1 5.2 2.7 6.0 14.7 1.9 0.6 3.0 0.8 5.3 1.9 0.1 4.8 6.0 4.4 5.8 0.6 0.0 6.2 1.9 1.5 3.0 3.1 0.8 2.7 7.5 1.9 0.8 1.0 4.3 0.5 5.1 8.9 3.9 4.3 3.0 4.3 6.5 2.0 0.4 0.2 3.5 1.5 1.6 2.7 3.5 6.3 0.9 4.5 10.5 6.9 3.6 3.0 7.4 9.9 2.6 3.1 0.8 14.7 8.7 4.3 2.0 3.4 0.8 4.1 0.9 1.0 7.1 0.7 3.3 10.3 22.6 2.9 2.2 1.4 1.2 3.0 0.8 0.6 1.4 0.0 1.3 1.7 1.3 1.5 0.6 1.9 1.0 1.9 2.5 5.3 0.3 0.3 1.5 0.1 6.0 6.1 15.6 6.1 6.1 6.8 6.5 3.1 6.1 7.2 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996608-33097230 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 1700000 Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: , HPA069503: " "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favourable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 17.3 33.1 9.6 14.9 14.7 9.5 18.4 8.9 19.8 18.3 21.9 12.1 19.8 21.2 18.3 55.0 12.7 15.2 25.8 13.7 9.7 10.0 35.0 33.2 24.3 25.0 9.2 9.7 18.3 25.3 28.4 16.4 26.5 14.0 13.6 23.7 23.5 21.1 17.7 6.1 12.9 28.3 15.6 9.8 21.4 22.7 10.0 8.0 8.3 26.9 7.7 19.5 18.4 13.6 11.1 45.2 22.7 39.2 6.8 20.9 20.9 5.6 9.8 6.3 7.6 39.1 20.3 136.7 9.1 24.7 11.7 15.1 13.9 13.6 2.8 8.1 18.6 5.5 6.0 11.6 8.7 16.0 5.0 10.9 5.9 7.1 20.1 7.6 11.2 23.4 11.2 10.6 6.3 18.0 9.8 10.6 12.8 6.6 4.5 5.0 4.3 4.3 3.9 4.2 13.0 12.6 8.4 1.9 6.6 11.7 19.0 11.4 12.6 19.9 10.5 7.5 5.2 10.3 7.7 8.4 13.4 0.9 15.9 11.0 5.7 10.5 39.2 22.7 8.3 34.6 11.8 11.1 10.2 9.1 45.2 10.0 5.4 6.5 15.5 6.8 23.7 9.5 20.9 20.9 9.6 14.7 8.9 19.8 9.7 10.0 9.2 9.7 14.0 8.0 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell line enhanced" "Detected in some" "BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: " "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavourable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favourable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.5 7.0 0.0 0.1 65.3 0.0 0.0 0.0 0.0 15.5 0.1 0.1 1.5 0.0 0.1 0.0 0.1 0.0 0.3 3.7 0.0 0.0 10.3 0.0 0.0 14.2 0.0 0.0 0.5 0.0 2.7 0.0 0.1 0.3 0.3 0.2 0.0 7.6 1.2 0.3 0.0 0.1 27.0 0.3 6.2 3.2 0.0 6.0 0.0 1.4 0.0 0.9 0.1 0.2 0.7 0.3 0.3 8.9 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1, RNA export mediator" Q53GS7 9 128504700-128542288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" "Nuclear membrane" Nucleoli "HPA041689: , HPA043538: , HPA061560: " "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favourable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favourable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 12.5 17.0 11.1 13.5 13.2 12.2 14.7 22.1 13.8 13.1 15.7 16.5 17.6 14.6 13.8 11.4 18.5 13.5 12.6 13.2 10.5 8.9 13.1 20.4 11.3 23.0 11.2 9.9 15.7 21.1 20.8 16.3 16.4 10.6 13.4 17.2 13.1 13.6 16.7 23.3 18.3 14.9 12.0 9.8 17.5 12.1 42.8 11.8 27.2 12.4 14.6 20.0 14.3 13.5 16.0 19.2 26.2 22.5 22.6 20.5 15.8 10.8 20.4 10.0 17.0 9.9 10.1 13.3 11.0 9.4 15.4 11.0 13.6 7.6 22.0 8.9 12.3 38.3 17.3 15.6 13.4 20.8 11.3 11.2 22.4 12.7 11.2 18.1 14.9 7.1 15.2 17.5 18.8 8.7 16.1 19.4 17.7 25.1 17.8 12.8 8.4 17.7 18.3 24.6 29.0 10.4 9.7 11.9 8.9 26.8 16.2 9.6 30.0 12.8 6.3 16.4 11.0 19.2 15.2 19.6 47.0 17.2 15.4 13.9 17.7 26.2 18.1 20.3 20.5 22.5 16.7 12.0 16.0 18.1 19.2 16.0 14.4 16.6 15.4 22.6 22.0 11.4 18.3 15.8 11.1 13.2 22.1 13.8 10.5 8.9 11.2 9.9 10.6 11.8 GLI1 GLI ENSG00000111087 "GLI family zinc finger 1" P08151 12 57460135-57472262 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.9;BJ hTERT+: 7.6;NTERA-2: 7.7;RH-30: 35.1;U-266/70: 9.7" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009460, HPA065172, HPA068903" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009460: AB_2111764, HPA065172: , HPA068903: " "unprognostic (4.97e-4)" "unprognostic (5.53e-2)" "unprognostic (1.26e-1)" "unprognostic (5.58e-3)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.00e-2)" "unprognostic (1.88e-1)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-8)" "unprognostic (4.59e-3)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-2)" 3.2 1.7 4.0 2.1 2.5 0.6 2.1 8.2 4.4 14.4 3.5 0.0 3.0 3.7 12.8 8.3 0.7 4.7 8.3 2.7 2.9 1.9 3.2 1.8 2.0 1.3 1.5 2.0 4.7 1.0 0.1 1.2 0.6 3.3 5.6 4.9 9.6 2.9 4.3 3.1 2.4 3.7 3.8 2.8 1.2 2.4 6.2 2.5 0.6 3.3 3.4 1.4 4.8 4.6 0.9 0.4 5.2 0.2 0.1 0.5 0.1 0.0 5.5 1.6 11.9 0.2 0.0 0.2 0.7 7.6 1.3 1.3 0.2 0.4 1.9 0.0 0.3 1.0 0.9 0.7 0.2 2.1 0.1 0.0 0.6 0.1 1.2 0.3 0.6 0.5 0.2 1.3 0.4 0.2 0.4 4.0 0.6 0.0 0.3 0.2 7.7 0.5 0.6 35.1 0.8 1.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 1.3 4.4 0.4 0.2 9.7 0.4 3.2 1.2 0.8 2.1 2.2 0.2 0.9 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.4 0.4 0.3 5.2 0.1 0.1 0.4 0.5 0.1 4.0 2.5 8.2 4.4 2.9 1.9 1.5 2.0 3.3 2.5 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.3" "Cell line enhanced" "Detected in many" "AF22: 19.2;NTERA-2: 11.7;U-2 OS: 19.9;WM-115: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: " "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 2.1 1.6 3.6 2.9 5.3 0.2 2.3 3.1 3.4 8.0 4.4 1.9 1.5 0.9 8.6 2.6 3.9 5.8 8.8 3.3 3.7 1.0 1.7 0.8 2.9 0.7 1.3 1.5 23.3 0.8 0.7 2.6 1.7 3.6 6.2 1.4 5.9 1.8 2.4 1.6 3.7 3.2 4.5 1.6 2.0 3.9 5.4 2.1 1.7 1.6 4.7 2.6 4.3 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 19.2 3.8 2.1 4.1 0.0 7.3 1.6 3.2 2.1 0.0 0.6 0.0 0.8 3.6 0.3 5.3 0.0 1.6 0.0 3.4 0.5 4.7 0.0 4.6 0.0 1.5 2.1 0.0 10.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 11.7 5.9 0.0 2.1 1.2 0.0 0.0 0.8 3.3 3.4 0.0 0.5 0.0 0.2 5.8 0.0 19.9 2.0 0.0 0.0 0.0 0.0 7.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.3 3.1 3.4 3.7 1.0 1.3 1.5 3.6 2.1 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA023131: " "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 13.5 5.7 14.9 15.7 17.6 11.6 10.6 12.8 12.0 10.0 12.0 13.7 13.7 14.2 10.0 6.9 10.7 8.3 8.9 8.5 16.4 12.4 9.6 11.2 9.6 13.9 10.3 11.6 11.0 18.4 8.0 7.4 5.0 8.5 9.7 8.6 13.5 20.0 14.0 10.3 13.8 13.4 11.8 9.7 13.4 11.6 11.6 6.9 12.0 10.6 12.8 17.1 9.0 8.2 1.5 3.5 0.9 1.1 3.4 2.2 0.6 4.8 10.0 4.7 7.4 7.8 3.2 5.3 2.9 1.8 2.2 2.6 2.8 14.3 6.3 5.5 4.8 6.4 2.6 3.2 1.5 11.1 7.6 9.7 4.7 3.3 5.5 3.0 3.3 10.0 1.7 3.0 6.5 4.7 5.1 10.7 6.0 13.2 14.0 2.5 4.3 14.1 8.5 2.2 6.4 5.2 11.1 4.5 5.4 8.7 3.8 5.9 16.6 1.4 2.7 3.3 9.3 4.7 3.0 14.2 6.6 5.0 5.4 5.8 5.4 0.0 1.1 0.0 1.4 1.0 2.2 1.5 1.6 0.9 0.6 1.4 2.0 1.0 0.9 3.4 0.0 3.5 2.1 0.6 14.9 17.6 12.8 12.0 16.4 12.4 10.3 11.6 8.5 6.9 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.5 0.3 0.5 4.3 2.5 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.7 3.2 0.5 0.1 0.8 1.3 0.6 2.3 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.4 2.4 2.5 0.2 1.2 1.0 11.1 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.9" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HDLM-2: 25.2;TIME: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules 18000000 Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavourable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 28.5 10.8 8.1 25.5 12.1 32.5 15.6 5.7 11.2 19.9 32.4 23.3 9.1 7.5 40.3 16.8 16.3 18.7 13.0 11.7 9.4 7.1 4.9 3.5 31.2 26.5 14.7 6.5 13.4 2.8 0.4 2.9 4.7 12.3 20.1 17.1 11.6 7.9 21.3 4.8 6.1 14.9 35.5 21.8 21.1 13.8 5.0 13.2 10.1 10.6 7.4 9.4 19.2 14.2 3.3 28.8 92.9 48.6 15.8 24.8 45.5 1.2 1.0 7.5 7.9 26.4 12.6 0.8 12.0 7.2 2.8 5.1 0.4 0.1 0.0 3.7 10.8 0.0 2.7 0.4 1.7 25.2 2.3 3.0 2.4 0.1 10.5 1.9 10.3 8.5 0.3 16.1 2.8 22.2 0.1 1.8 6.4 2.8 9.4 5.2 7.2 3.8 6.5 15.9 0.3 0.6 0.6 2.0 4.1 1.5 0.7 1.2 0.8 8.3 44.7 3.9 9.1 3.5 9.7 2.8 0.7 4.3 4.0 12.2 0.9 30.1 48.6 71.9 24.8 22.3 13.1 3.2 17.2 15.8 28.8 3.3 7.3 11.5 92.9 15.8 16.2 2.5 17.6 45.5 8.1 12.1 5.7 9.8 9.4 7.1 14.7 6.5 12.3 13.2 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 27.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056976 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA056976: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favourable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 3.6 6.0 1.5 2.3 1.6 0.0 2.4 4.3 2.4 5.0 4.4 1.2 5.8 1.0 1.2 4.3 7.4 8.4 0.9 1.2 11.5 0.3 7.8 1.4 1.4 8.0 3.2 2.2 5.3 5.7 5.6 0.2 3.0 5.8 1.1 1.5 1.2 4.3 0.2 0.8 2.7 1.9 5.3 0.5 5.6 2.7 0.3 0.0 0.2 0.0 0.0 0.1 0.0 4.0 10.4 1.7 3.8 1.4 5.6 3.5 4.4 4.2 1.6 1.2 2.8 2.9 0.0 7.7 4.8 2.5 1.0 4.5 0.1 4.6 0.0 0.0 7.9 1.4 6.1 0.0 0.8 3.3 1.1 1.4 0.7 1.5 0.3 1.8 1.1 2.6 0.1 0.8 3.7 1.8 6.7 2.3 4.7 0.0 0.1 0.7 3.6 5.1 2.2 1.0 6.1 0.7 3.4 2.3 3.9 27.5 1.3 0.8 0.5 1.2 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GLMN "FAP48, FKBPAP, GLML, GVM, VMGLOM" ENSG00000174842 "Glomulin, FKBP associated protein" Q92990 1 92246402-92298987 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031446, HPA031448" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA031446: , HPA031448: " "unprognostic (4.20e-2)" "unprognostic (3.47e-2)" "prognostic favourable (1.71e-4)" "unprognostic (7.37e-2)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "prognostic unfavourable (2.42e-5)" "unprognostic (7.32e-2)" "unprognostic (2.07e-3)" "unprognostic (4.59e-2)" "unprognostic (9.88e-2)" "unprognostic (1.81e-2)" "prognostic unfavourable (5.89e-8)" "unprognostic (7.33e-2)" "unprognostic (5.21e-2)" "unprognostic (1.89e-1)" "unprognostic (3.58e-1)" 4.9 6.6 12.5 8.1 14.8 9.0 10.3 21.3 19.5 7.4 6.8 6.6 5.1 5.1 11.5 8.6 10.1 6.3 5.7 7.2 9.4 6.9 6.4 5.2 5.3 10.6 6.8 13.2 8.3 4.7 8.5 13.6 7.9 8.6 7.6 7.3 13.9 4.9 6.9 7.5 13.5 6.6 6.9 8.0 7.6 5.8 11.2 5.7 13.3 9.0 4.8 12.1 7.9 6.9 2.5 2.0 1.4 1.4 9.0 5.5 1.9 12.1 4.7 15.7 8.6 5.6 8.8 14.5 8.5 7.0 10.6 9.5 9.6 4.8 12.3 13.7 5.0 9.3 8.2 7.7 15.3 8.7 11.6 16.4 9.3 9.5 5.5 20.7 8.6 6.8 4.5 12.4 5.6 11.4 13.6 7.6 13.9 2.8 12.7 15.8 23.9 8.5 11.0 21.6 8.5 12.0 11.8 14.5 7.5 14.7 14.0 8.8 6.7 20.0 7.1 7.7 7.5 13.2 12.7 6.7 9.1 15.5 2.9 21.0 4.5 0.0 0.7 1.4 3.2 1.4 5.5 2.5 3.5 3.9 2.0 1.5 3.1 3.6 0.2 9.0 0.8 1.4 2.7 1.9 12.5 14.8 21.3 19.5 9.4 6.9 6.8 13.2 8.6 5.7 GLO1 GLOD1 ENSG00000124767 "Glyoxalase I" Q04760 6 38675925-38703141 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HMC-1: 244.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040541, CAB040542, HPA059791" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 1600000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB040541: , CAB040542: , HPA059791: " "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (1.08e-2)" "unprognostic (3.96e-3)" "unprognostic (2.51e-1)" "prognostic unfavourable (5.21e-4)" "unprognostic (5.09e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (8.71e-2)" "unprognostic (1.20e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (6.21e-2)" 22.2 30.5 42.1 19.5 42.3 11.4 32.0 25.4 42.3 27.1 42.1 19.7 22.9 48.1 25.3 49.2 28.2 31.5 17.8 39.2 37.8 37.7 37.1 65.3 30.7 31.6 38.9 29.7 37.6 25.9 33.2 12.6 26.7 40.6 74.0 22.7 21.7 21.7 28.2 57.5 31.3 64.3 28.9 37.6 25.6 21.3 12.9 21.4 19.8 32.6 42.5 24.3 28.6 24.7 25.9 28.6 8.5 15.6 10.8 24.4 14.7 18.1 8.4 24.2 24.0 11.5 20.8 21.4 15.8 15.0 22.3 23.2 20.5 7.0 20.2 12.5 12.6 12.0 20.7 20.4 28.3 18.3 32.0 29.9 10.9 19.1 17.3 11.3 244.2 17.7 12.6 21.1 15.1 24.0 23.5 13.4 20.8 15.3 17.7 14.4 17.4 16.5 15.4 29.3 13.2 20.3 13.7 18.9 19.1 11.1 15.5 29.8 18.0 57.1 9.9 17.4 16.0 15.0 25.0 10.6 20.0 55.5 6.3 29.4 27.9 8.5 9.8 6.9 18.0 15.6 24.4 24.7 18.1 18.3 18.3 25.9 17.1 17.9 1.2 10.8 12.1 28.6 15.7 14.7 42.1 42.3 25.4 42.3 37.8 37.7 38.9 29.7 40.6 21.4 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol 3800000 Cytosol "Nucleoplasm, Nucleoli" "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favourable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 21.7 29.5 31.3 16.7 35.6 10.2 19.1 26.0 36.2 17.8 37.1 21.5 16.5 43.0 22.3 23.3 23.6 24.9 20.9 19.7 26.1 38.5 41.6 40.4 16.8 22.8 23.0 34.8 22.9 32.3 13.9 19.4 28.1 28.6 21.1 26.6 21.9 29.2 20.9 21.4 27.5 42.5 24.7 18.2 23.8 43.4 17.9 18.2 22.7 26.0 19.2 24.0 25.2 17.5 27.5 17.9 17.8 24.6 22.8 36.7 26.0 40.3 36.6 42.2 23.3 18.6 18.5 25.8 32.4 19.9 26.3 20.0 29.6 29.0 48.2 35.3 14.5 29.3 36.8 20.5 27.5 35.3 31.4 23.2 20.3 38.7 18.5 23.9 30.7 12.9 28.6 26.4 23.2 24.2 37.9 31.4 27.7 24.9 41.0 18.4 30.9 12.5 41.1 17.1 22.1 25.9 27.6 19.3 32.4 25.7 18.6 41.5 23.1 25.4 31.5 25.1 20.1 35.1 40.5 17.7 32.2 29.6 29.8 26.9 26.2 9.2 19.8 17.8 27.7 24.2 30.2 27.0 33.6 33.3 17.5 27.5 28.7 31.3 2.7 22.8 24.6 17.9 36.7 26.0 31.3 35.6 26.0 36.2 26.1 38.5 23.0 34.8 28.6 18.2 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95823005 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 94.4;skeletal muscle: 141.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 83.5;U-87 MG: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Approved "Plasma membrane,Cytosol" 13000000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: " "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 17.7 20.7 6.2 15.0 6.6 30.6 10.5 15.5 15.5 5.4 22.6 3.1 4.0 40.2 2.9 4.6 3.1 3.7 9.5 25.2 12.1 7.8 45.9 46.9 23.1 21.5 7.8 5.9 3.5 2.6 9.5 6.4 63.9 7.6 5.7 8.8 2.4 17.9 5.5 141.6 7.3 42.5 4.5 7.3 15.2 8.2 2.2 4.0 14.4 6.3 6.4 14.3 11.6 5.8 16.0 52.2 94.4 81.6 11.2 48.9 71.1 3.2 14.7 1.1 2.4 31.8 45.8 0.2 49.2 83.5 5.3 8.9 3.6 1.5 12.8 7.0 14.8 1.2 1.8 23.4 14.8 11.1 3.7 9.3 9.7 33.8 60.6 9.8 27.5 28.5 2.8 33.7 3.3 10.1 1.2 7.7 33.4 1.1 16.9 17.4 3.2 16.8 27.4 10.1 15.8 63.9 2.4 3.3 1.8 12.9 6.4 5.6 1.7 9.7 11.7 14.0 15.8 11.1 2.0 5.5 28.2 10.2 68.6 24.7 2.9 3.8 81.6 94.4 26.2 51.0 35.7 16.0 24.1 19.5 52.2 10.7 24.1 22.1 85.7 11.2 40.5 18.0 48.9 71.1 6.2 6.6 15.5 15.5 12.1 7.8 7.8 5.9 7.6 4.0 GLRX2 "bA101E13.1, GRX2" ENSG00000023572 "Glutaredoxin 2" Q9NS18 1 193090866-193106114 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023087, HPA057224" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA023087: AB_1849778, HPA057224: " "unprognostic (4.80e-2)" "unprognostic (3.77e-2)" "unprognostic (8.04e-2)" "unprognostic (2.33e-1)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "unprognostic (2.40e-3)" "unprognostic (5.11e-2)" "unprognostic (3.21e-2)" "unprognostic (2.38e-2)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (3.30e-7)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (6.21e-2)" "unprognostic (4.48e-2)" 14.1 17.9 13.8 9.7 12.2 10.7 16.3 7.4 22.0 7.8 14.9 6.6 7.4 14.7 6.7 14.5 13.1 5.1 8.8 23.5 13.0 13.3 14.3 28.2 7.8 6.1 16.5 13.1 5.4 10.4 4.6 9.9 9.5 22.3 21.8 11.7 7.4 8.6 11.6 28.5 8.9 12.7 10.9 12.3 7.6 10.3 27.9 8.7 2.3 7.7 11.6 9.0 9.6 10.2 10.8 17.4 19.6 21.4 11.6 14.1 10.9 13.8 17.0 4.3 9.7 16.1 10.5 7.8 20.4 8.8 16.8 14.0 10.5 13.2 6.2 11.4 8.4 13.5 5.1 11.6 17.3 13.6 9.6 11.9 11.5 12.2 17.3 9.7 12.0 7.1 10.1 23.1 11.6 10.6 17.6 6.5 20.3 19.1 7.7 17.9 5.1 12.5 7.1 7.0 14.0 16.2 9.1 4.2 3.7 8.2 24.4 68.9 10.6 11.0 6.4 13.2 3.3 28.6 20.9 13.2 13.6 11.8 12.6 11.2 18.3 7.8 15.2 19.6 10.8 17.9 11.9 10.8 11.3 9.7 17.4 8.2 10.2 11.4 7.6 11.6 21.4 7.3 14.1 10.9 13.8 12.2 7.4 22.0 13.0 13.3 16.5 13.1 22.3 8.7 GLT8D2 FLJ31494 ENSG00000120820 "Glycosyltransferase 8 domain containing 2" Q9H1C3 12 103988984-104064183 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;RPTEC TERT1: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6" "Low region specificity" "Detected in many" "HPA012740, HPA026904, HPA070791" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012740: , HPA026904: AB_1849731, HPA070791: " "unprognostic (4.02e-1)" "prognostic unfavourable (7.37e-4)" "unprognostic (9.53e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-3)" "unprognostic (2.57e-1)" "unprognostic (1.25e-1)" "unprognostic (7.55e-2)" "unprognostic (5.03e-2)" "unprognostic (8.87e-2)" "prognostic unfavourable (1.58e-6)" "prognostic unfavourable (7.92e-4)" "unprognostic (7.15e-2)" "unprognostic (7.70e-3)" "unprognostic (7.03e-3)" 10.2 5.2 2.2 9.9 3.3 0.2 12.0 0.7 2.4 32.8 10.3 1.4 8.8 2.5 24.5 23.1 13.5 13.3 19.1 18.8 2.2 1.8 3.4 2.8 6.9 2.2 2.1 2.1 25.5 2.5 5.9 12.5 6.9 3.5 19.6 5.3 21.8 6.7 8.3 4.0 2.7 6.7 17.3 2.2 1.0 5.5 7.8 0.8 1.0 26.0 10.9 5.7 11.2 13.1 0.8 0.9 0.2 0.6 0.0 2.1 0.0 0.1 0.2 0.2 8.7 11.4 27.9 0.2 12.5 34.4 3.2 4.2 0.1 0.0 0.3 0.7 14.3 0.0 0.1 4.6 2.8 0.6 3.9 0.2 4.6 0.0 5.1 0.3 0.2 25.8 0.2 3.9 5.5 1.7 0.1 0.5 14.1 0.1 0.2 0.1 1.0 2.6 0.3 13.4 0.1 17.6 0.1 0.5 0.7 13.1 0.3 0.1 2.3 0.2 0.2 5.3 2.5 0.5 0.7 1.5 0.3 0.1 0.4 0.2 0.4 0.0 0.0 0.0 2.1 0.6 0.7 0.8 0.3 1.3 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.9 0.0 0.0 2.2 3.3 0.7 2.4 2.2 1.8 2.1 2.1 3.5 0.8 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182381704-182392206 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 92.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 92.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported Mitochondria,Cytosol 28000 "Mitochondria, Cytosol" "CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980" "prognostic favourable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 173.3 19.2 83.7 37.2 91.0 47.6 63.1 48.5 80.7 41.9 20.4 49.9 9.4 6.2 20.5 29.7 54.0 31.6 26.2 23.5 74.0 48.7 15.6 64.9 39.5 36.9 71.0 48.8 66.2 49.0 7.4 8.9 41.8 70.6 17.4 23.3 39.3 30.4 25.5 159.8 27.9 16.4 30.5 51.3 36.1 71.4 24.0 55.2 8.6 63.9 15.5 24.2 34.7 32.2 2.5 11.0 92.2 21.1 3.4 6.3 18.6 2.9 1.2 13.7 0.0 138.5 97.9 10.1 5.0 16.2 3.0 2.7 7.2 3.0 2.5 5.4 9.7 6.8 5.9 35.6 2.5 6.8 16.6 33.5 5.7 14.0 7.3 14.7 26.8 84.6 42.8 3.8 45.4 6.1 28.2 1.5 10.7 1.6 22.9 14.1 10.1 6.4 8.3 3.6 4.3 5.3 13.0 9.4 6.2 1.4 18.3 1.9 17.8 18.7 4.5 0.1 0.2 0.0 1.1 0.5 0.3 0.0 2.6 8.4 0.5 43.6 21.1 54.9 6.3 20.5 2.6 1.6 4.5 5.2 11.0 2.5 2.3 3.9 92.2 3.4 17.1 6.1 1.7 18.6 83.7 91.0 48.5 80.7 74.0 48.7 71.0 48.8 70.6 55.2 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 113.8" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;Daudi: 9.6;RPTEC TERT1: 3.2;U-2197: 2.5" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA039501: " "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favourable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 27.7 113.8 0.1 0.0 0.2 0.0 0.2 0.2 0.9 0.1 0.0 0.5 2.1 0.0 0.5 1.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 1.3 0.0 0.5 0.2 1.1 0.8 3.9 0.0 9.6 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.4 3.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.1 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" 11 59086307-59094786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 4.9;breast: 12.5;lymphoid tissue: 4.1" "Cell line enhanced" "Detected in some" "Daudi: 4.8;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 4.9" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Group enriched" "Detected in some" 17 "memory B-cell: 1.9;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 24 "B-cells: 4.9" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA039501: " "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 1.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.0 0.3 0.4 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.5 2.5 0.2 4.9 1.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52293476 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 108.4" "Cell line enhanced" "Detected in many" "CACO-2: 18.9;Hep G2: 25.1" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favourable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 6.4 4.9 1.9 8.4 5.0 5.2 4.8 2.7 6.2 2.3 7.9 7.1 4.2 23.8 4.3 4.8 2.8 2.5 7.2 2.7 1.9 2.2 10.7 108.4 3.1 6.5 2.5 4.9 2.3 3.6 1.9 2.5 3.1 3.9 2.8 3.5 4.7 3.2 3.0 7.0 1.9 17.8 1.9 1.8 5.5 6.0 2.7 1.8 3.3 3.1 2.4 5.9 2.7 2.2 8.3 9.1 10.9 9.5 5.7 11.8 6.3 2.2 5.5 3.0 1.1 16.0 2.2 1.8 2.5 2.6 4.7 3.5 18.9 1.9 5.9 1.5 2.2 1.5 1.7 6.2 0.9 1.6 1.9 8.3 6.7 25.1 1.5 2.7 5.0 2.1 3.1 6.9 2.7 9.0 2.2 4.3 3.6 1.7 4.6 2.2 1.6 4.6 1.5 2.7 8.9 4.8 3.1 2.2 2.2 2.4 1.3 2.5 3.1 1.3 3.8 3.7 4.4 2.4 4.8 4.5 3.1 3.8 2.5 4.5 2.8 3.0 9.5 10.9 11.8 5.1 6.1 8.3 9.0 10.3 9.1 5.7 6.8 10.1 7.8 5.7 6.1 5.6 11.7 6.3 1.9 5.0 2.7 6.2 1.9 2.2 2.5 4.9 3.9 1.8 GLYR1 "BM045, HIBDL, N-PAC, NP60" ENSG00000140632 "Glyoxylate reductase 1 homolog" Q49A26 16 4803203-4847342 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017022, HPA048226, HPA050136" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028" "unprognostic (4.72e-1)" "unprognostic (1.65e-1)" "unprognostic (3.19e-2)" "unprognostic (8.20e-2)" "unprognostic (2.77e-1)" "unprognostic (1.97e-2)" "unprognostic (3.86e-2)" "unprognostic (3.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (1.41e-1)" "unprognostic (8.47e-3)" "prognostic favourable (8.74e-7)" "unprognostic (3.34e-1)" "unprognostic (4.38e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-1)" 24.1 33.2 39.1 29.4 37.4 27.5 22.5 26.3 44.8 24.8 32.6 31.0 32.8 30.7 30.0 20.6 32.1 33.9 26.1 28.3 29.8 24.8 39.0 30.5 24.5 27.6 27.0 33.1 22.2 27.4 53.4 34.7 24.1 37.1 30.4 32.3 28.5 29.9 29.4 41.6 24.3 29.9 30.1 27.3 30.7 33.9 17.4 26.0 27.6 29.6 17.2 30.0 35.3 22.7 7.6 8.3 22.2 14.5 5.2 7.5 5.5 12.9 14.4 23.8 14.8 21.0 16.9 22.9 24.4 18.3 18.8 16.1 20.3 23.1 21.1 23.3 22.5 14.3 29.8 20.5 16.9 34.2 17.9 21.7 17.4 14.2 11.9 35.0 40.4 16.0 16.3 17.6 13.1 23.8 36.2 18.2 20.3 21.0 28.4 19.4 28.3 10.9 36.8 18.7 25.9 23.0 19.4 29.2 14.8 26.5 24.8 11.3 27.8 37.1 26.3 12.9 14.5 57.9 15.2 15.2 21.1 44.1 9.2 17.4 26.2 6.3 10.9 5.7 7.5 9.8 6.5 5.1 4.9 7.1 7.3 7.6 5.2 4.6 22.2 5.2 14.5 8.3 4.9 5.5 39.1 37.4 26.3 44.8 29.8 24.8 27.0 33.1 37.1 26.0 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: " "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 9.3 8.2 7.4 9.0 9.8 29.8 8.4 13.5 11.5 8.7 10.5 7.7 6.9 9.6 10.6 6.1 10.0 11.0 9.5 7.4 8.1 6.2 7.7 9.3 8.7 11.5 6.0 6.5 11.5 17.6 9.6 9.5 14.5 7.2 9.9 5.1 9.8 16.0 7.5 10.1 10.0 11.0 10.3 7.1 12.1 8.8 18.8 5.7 24.7 18.0 9.5 10.4 9.2 13.8 3.0 2.6 4.4 5.6 1.9 4.5 2.2 10.7 6.6 8.1 7.0 3.9 3.6 10.8 7.5 4.8 12.1 6.4 20.4 8.0 8.6 7.9 6.5 15.4 6.3 11.0 5.4 4.6 7.1 6.6 9.6 9.8 5.3 6.3 11.0 5.2 10.5 7.8 9.8 5.3 9.7 6.2 4.2 11.6 15.3 13.8 5.8 10.7 16.7 8.3 7.9 4.9 9.6 12.2 10.0 13.5 12.0 7.8 14.6 10.4 6.5 13.3 7.3 7.9 8.2 11.9 9.8 13.6 8.0 5.9 8.6 0.0 1.9 3.2 4.5 2.6 4.3 2.1 4.0 3.9 2.1 3.0 4.5 3.9 4.4 1.9 5.6 2.6 2.7 2.2 7.4 9.8 13.5 11.5 8.1 6.2 6.0 6.5 7.2 5.7 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favourable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.4 12.3 24.7 18.0 26.7 33.4 18.5 31.2 23.0 22.7 28.4 14.2 27.0 28.0 14.8 30.7 11.3 24.9 21.6 36.0 10.1 8.6 14.0 13.9 13.1 22.8 19.5 12.3 25.3 20.3 19.7 19.5 20.4 10.2 9.9 35.9 15.1 11.9 7.6 15.9 13.1 12.1 29.0 8.1 29.0 29.0 14.7 22.8 21.7 18.5 23.6 20.4 15.5 16.1 33.0 25.1 16.7 19.3 3.5 6.2 17.5 27.8 12.1 20.8 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favourable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.5 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 2.0 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell line enhanced" "Detected in many" "HMC-1: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: , HPA045481: " "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavourable (3.97e-5)" "prognostic favourable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favourable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.0 2.7 3.0 3.0 1.6 11.0 2.8 2.4 1.7 1.6 1.6 5.9 10.8 5.7 1.9 5.3 1.7 3.0 1.1 3.7 2.8 3.4 3.2 1.7 0.9 9.6 43.0 2.0 2.1 1.8 0.9 3.8 2.3 3.9 1.8 6.5 6.0 15.9 1.6 3.7 10.4 1.2 6.2 3.2 10.5 2.3 7.1 3.8 4.0 1.6 3.7 13.8 6.8 3.1 1.8 3.5 2.0 2.0 0.8 8.9 2.0 12.6 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Uncertain Approved Nucleoplasm,Nucleoli 160000 Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: , HPA068782: " "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 18.9 44.2 19.6 14.6 24.2 11.5 26.2 13.6 31.7 22.5 21.1 25.1 20.3 21.3 18.8 26.3 17.8 28.7 23.4 15.0 20.1 21.9 39.1 26.3 19.0 18.1 23.0 21.2 26.1 26.9 49.1 22.4 22.7 26.0 20.3 21.6 21.9 22.6 23.7 16.1 14.4 21.7 18.2 20.3 25.5 21.2 10.6 19.1 21.6 43.0 11.2 21.0 21.8 17.6 7.5 14.4 32.3 14.0 7.6 14.9 11.0 9.0 10.4 14.1 9.2 16.3 23.1 12.8 10.7 19.1 15.1 19.3 12.2 7.2 12.1 9.8 15.7 12.6 15.5 23.2 21.5 11.4 11.4 9.5 6.5 44.5 15.3 15.6 15.0 21.7 16.7 7.9 16.5 24.4 5.5 11.5 15.2 16.9 15.4 14.0 10.9 13.5 11.7 9.5 10.0 20.7 15.0 10.0 14.1 7.7 16.9 14.4 14.7 12.5 12.5 7.1 5.7 9.4 7.8 25.5 24.4 7.9 5.9 11.9 6.9 9.0 14.0 7.2 10.1 11.2 10.7 7.5 10.2 11.2 14.4 7.1 9.1 10.2 32.3 7.6 11.3 6.5 14.9 11.0 19.6 24.2 13.6 31.7 20.1 21.9 23.0 21.2 26.0 19.1 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: " "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavourable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavourable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.5 18.8 0.1 23.4 15.0 8.6 12.5 15.1 11.1 13.7 0.0 3.2 0.1 4.0 13.4 3.0 10.4 12.8 14.7 0.1 9.6 17.6 18.1 1.2 23.7 2.2 3.8 16.1 32.4 5.9 17.1 7.4 1.4 0.0 20.7 0.5 0.1 0.1 5.4 7.4 8.2 7.2 8.8 33.1 9.9 13.8 9.5 13.4 0.2 10.6 2.5 0.4 13.1 24.8 17.5 5.7 4.7 0.1 0.0 0.1 6.5 1.3 11.0 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259355 "Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 53000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favourable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 81.9 37.8 50.8 69.5 47.2 102.5 53.4 17.7 45.3 56.2 47.9 67.2 34.5 22.6 51.4 41.1 44.4 47.1 55.5 57.0 44.6 48.0 34.1 50.9 72.8 78.7 53.3 34.3 54.0 21.4 24.9 42.1 81.3 46.8 44.3 22.5 38.5 25.8 60.0 29.6 29.0 35.7 53.6 81.8 96.7 30.1 28.5 45.9 70.0 37.7 32.4 55.5 60.7 49.8 5.3 14.2 35.8 19.4 6.1 8.4 5.6 15.1 8.2 24.8 24.8 30.5 38.3 4.5 33.0 53.3 47.6 49.1 9.2 21.4 18.1 14.5 74.4 12.1 17.7 46.1 30.5 38.5 6.2 45.5 22.3 14.3 30.1 41.5 60.6 37.1 20.6 43.1 17.7 111.5 3.0 39.3 47.5 19.6 35.1 44.9 13.3 32.1 22.0 11.9 26.4 30.6 17.1 6.1 10.4 24.1 7.3 15.2 11.5 43.1 97.0 41.1 24.1 38.7 33.0 24.9 31.7 15.9 46.3 56.7 49.2 2.6 16.5 23.4 8.4 19.4 4.9 5.0 6.3 7.6 14.2 5.3 5.0 5.7 35.8 6.1 15.0 11.7 6.6 5.6 50.8 47.2 17.7 45.3 44.6 48.0 53.3 34.3 46.8 45.9 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: " "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favourable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavourable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favourable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 13.9 4.9 9.5 5.6 9.1 10.9 7.8 10.6 8.5 10.8 10.8 7.5 4.9 7.5 7.1 11.3 7.4 8.9 10.8 15.1 8.4 5.5 6.5 8.5 6.4 7.8 10.2 6.0 8.1 9.2 12.4 8.6 12.9 8.5 7.4 10.7 9.5 7.8 8.3 9.5 5.8 5.6 22.4 4.8 12.0 10.7 6.1 10.7 7.4 8.4 11.6 6.5 9.0 11.7 9.1 12.5 13.6 12.0 7.9 8.9 8.7 15.1 10.1 14.1 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell line enhanced" "Detected in many" "Daudi: 18.0;HeLa: 18.5;U-2 OS: 9.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: " "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 5.9 7.3 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.4 1.1 18.0 1.2 0.1 0.3 6.8 5.7 0.0 3.8 6.2 0.1 18.5 3.6 0.0 0.2 0.4 0.8 8.6 0.0 0.1 0.0 1.6 0.2 0.2 0.2 0.2 0.5 6.0 0.1 0.1 1.0 0.2 0.4 0.2 6.7 0.1 8.5 0.4 2.1 0.2 0.2 1.0 0.7 9.5 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 GNAQ "G-ALPHA-q, GAQ" ENSG00000156052 "G protein subunit alpha q" P50148 9 77716087-78031458 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 18.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010036, HPA048886" Uncertain Approved "Nuclear speckles,Plasma membrane,Cytosol" 28000000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB010036: AB_631536, HPA048886: " "unprognostic (2.10e-1)" "unprognostic (8.53e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (1.87e-1)" "unprognostic (6.83e-3)" "unprognostic (1.05e-1)" "unprognostic (3.84e-2)" "unprognostic (2.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.11e-7)" "unprognostic (1.90e-1)" "unprognostic (3.13e-1)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" 12.7 12.6 24.3 9.9 20.8 21.8 11.6 12.5 29.6 13.1 16.6 17.1 9.1 7.9 13.7 11.2 13.1 10.0 11.6 5.6 24.2 18.3 12.1 12.3 23.1 11.8 19.1 14.6 13.5 8.5 12.7 7.6 12.1 14.3 13.0 16.0 10.4 9.8 15.9 5.9 5.1 9.0 18.2 23.9 5.8 15.5 6.0 14.8 18.6 13.3 4.0 4.8 14.5 13.1 0.8 2.8 18.4 3.5 3.3 2.0 1.2 12.1 13.9 12.3 13.5 15.6 16.0 17.8 16.5 12.5 7.3 8.8 4.2 10.0 0.0 13.4 15.1 20.0 9.1 10.0 9.1 0.4 5.3 33.3 12.1 8.5 14.1 20.3 12.5 10.9 12.3 14.1 14.4 17.8 5.8 0.1 12.8 15.4 23.4 12.9 10.0 2.0 8.7 15.1 0.1 16.5 26.1 13.8 21.1 11.9 10.1 12.4 9.1 7.6 22.3 12.8 0.8 17.4 9.6 0.1 0.0 0.1 8.8 12.0 13.2 18.4 2.2 4.6 0.8 1.9 1.6 0.8 1.8 1.0 2.4 0.8 2.0 1.6 7.7 3.3 3.5 2.8 1.9 1.2 24.3 20.8 12.5 24.0 24.2 18.3 19.1 14.6 14.3 14.8 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favourable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.6 32.5 54.8 25.5 93.1 42.6 49.2 55.8 51.0 63.9 45.8 94.7 50.1 31.7 86.9 72.5 41.8 50.2 74.3 43.3 20.9 30.2 35.2 49.4 62.0 43.1 20.4 22.2 50.7 37.8 31.0 41.7 48.3 30.9 43.3 42.0 132.2 104.3 50.1 17.4 34.4 64.2 48.0 55.9 51.2 38.2 68.0 155.7 77.6 77.0 62.2 58.9 56.1 53.1 84.8 76.2 30.5 52.5 75.9 49.0 66.9 37.2 10.0 43.2 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" 60000000 "Plasma membrane" "Golgi apparatus" "HPA040736: " "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavourable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 55.2 42.1 84.7 55.1 82.3 41.7 37.8 78.8 112.5 44.0 52.1 46.4 26.0 55.4 44.3 31.2 41.7 38.8 36.6 39.6 74.7 65.7 43.9 38.7 47.1 47.1 68.5 52.1 45.0 33.9 48.9 36.9 45.3 56.6 40.1 41.0 70.7 37.6 41.7 19.7 35.5 65.3 51.2 61.0 51.0 40.8 31.4 39.2 44.5 37.6 19.5 45.6 42.2 54.1 7.7 18.8 18.4 13.2 10.6 9.9 6.0 54.0 51.2 60.8 42.4 34.8 38.3 23.5 76.8 51.3 69.8 54.8 41.7 54.2 56.5 56.6 77.4 28.6 60.9 55.7 63.8 86.6 30.0 54.8 48.5 47.4 43.8 32.9 60.2 33.8 39.3 66.6 62.0 56.6 33.9 51.1 66.5 33.7 72.1 25.9 35.0 41.5 70.4 47.0 44.6 47.8 33.7 74.8 85.3 71.2 46.4 62.3 32.4 45.2 86.2 61.5 41.3 47.8 55.7 34.7 60.4 129.3 52.6 69.5 34.6 7.4 11.1 17.1 8.7 13.2 8.0 7.4 8.7 9.7 10.9 7.7 5.9 6.5 18.4 10.6 13.2 18.8 9.9 6.0 84.7 82.3 78.8 112.5 74.7 65.7 68.5 52.1 56.6 39.2 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pituitary gland: 27.0;retina: 79.9" "Cell line enhanced" "Detected in many" "Daudi: 8.4;NTERA-2: 10.1;U-698: 25.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA040736: " "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.8 1.6 0.9 1.4 2.0 0.5 0.8 6.9 1.6 1.1 1.0 0.8 0.8 2.3 2.7 0.8 0.8 1.0 1.1 5.4 1.0 1.3 0.8 0.8 0.8 1.4 1.1 0.8 3.5 0.8 3.2 27.0 0.8 1.6 1.6 0.4 79.9 2.6 1.8 1.5 0.6 1.6 4.1 0.9 0.9 0.9 0.8 0.8 0.8 1.2 1.0 1.8 2.1 0.8 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 4.9 0.8 0.6 0.8 0.5 2.9 0.6 1.6 1.1 1.0 0.2 8.4 0.0 3.1 0.3 4.8 0.2 1.5 0.7 1.1 2.1 2.6 0.7 0.5 0.6 1.4 1.2 0.2 1.5 2.1 1.3 0.8 0.7 0.4 0.4 0.4 0.4 10.1 0.3 0.3 1.7 0.5 0.3 0.2 0.8 1.2 0.2 0.0 0.6 0.0 0.5 2.6 1.3 2.0 2.4 3.8 0.7 0.5 25.4 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 6.9 1.5 1.0 1.3 1.1 0.8 1.6 0.8 GNB5 GB5 ENSG00000069966 "G protein subunit beta 5" O14775 15 52115105-52191369 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032353, HPA041942, HPA044198" Uncertain Approved "Nuclear speckles,Centrosome,Rods & Rings" 11000 "Nuclear speckles" "Centrosome, Rods & Rings" "CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: " "unprognostic (2.38e-2)" "unprognostic (3.58e-1)" "unprognostic (1.97e-3)" "prognostic favourable (1.47e-6)" "unprognostic (6.15e-2)" "unprognostic (1.37e-2)" "unprognostic (2.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-3)" "unprognostic (2.10e-1)" "prognostic favourable (3.32e-11)" "unprognostic (1.40e-3)" "unprognostic (8.12e-3)" "unprognostic (3.55e-3)" "unprognostic (1.52e-1)" 6.2 11.2 17.7 8.2 25.6 3.7 8.9 42.5 30.7 15.2 9.2 4.0 9.6 4.6 21.2 13.4 9.0 20.4 15.4 17.3 13.0 18.6 26.9 10.3 5.8 14.7 13.6 21.9 38.1 13.7 35.5 14.7 4.4 21.3 12.9 4.5 20.4 6.5 20.3 1.7 4.8 7.0 13.3 5.9 8.3 7.5 11.7 9.2 7.0 16.2 1.9 14.1 14.6 14.0 21.6 9.9 3.6 1.9 10.8 19.7 9.3 8.0 20.8 5.8 10.2 9.9 12.4 5.6 15.8 15.4 14.1 15.4 5.8 6.1 14.1 5.0 12.9 11.9 10.2 15.0 10.7 10.9 7.7 9.4 28.1 6.7 11.8 4.7 34.1 11.4 12.7 11.3 4.2 8.8 0.7 13.3 15.4 14.4 7.4 13.4 5.3 9.2 10.0 20.1 17.1 10.0 24.7 9.3 8.1 15.1 1.4 12.3 4.9 14.7 21.6 12.7 13.9 14.4 15.9 8.5 16.3 15.4 26.7 11.5 20.4 3.6 1.9 0.2 10.7 1.7 8.9 21.0 14.0 12.8 4.8 21.6 13.2 11.3 1.0 10.8 1.4 9.9 19.7 9.3 17.7 25.6 42.5 30.7 13.0 18.6 13.6 21.9 21.3 9.2 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Cell line enhanced" "Detected in many" "AF22: 20.5;fHDF/TERT166: 36.3;MOLT-4: 28.2;SH-SY5Y: 23.9;WM-115: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favourable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavourable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.5 12.8 3.1 4.1 0.3 3.3 4.2 1.6 1.3 1.6 0.0 0.0 0.4 36.3 0.0 2.7 0.0 1.1 9.2 0.3 0.0 0.2 0.0 1.6 1.8 0.1 6.8 0.0 1.6 0.1 0.0 0.0 1.7 10.4 0.0 28.2 3.0 10.9 2.5 10.0 1.6 0.5 1.7 0.0 3.0 23.9 0.0 0.0 8.8 0.0 0.0 0.0 5.0 0.8 0.1 2.5 0.0 0.0 1.4 4.1 10.0 65.4 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694492 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli,Nuclear bodies" Nucleoli "Nuclear bodies" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavourable (6.11e-4)" "prognostic unfavourable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 27.7 28.0 14.8 21.8 17.5 13.0 40.5 17.2 25.4 25.0 27.0 10.0 22.8 21.6 22.2 17.5 41.8 17.4 16.1 20.5 21.6 15.9 19.3 50.4 19.5 26.6 18.4 15.7 27.2 45.1 14.1 43.3 24.7 23.4 28.3 27.0 8.8 30.3 27.3 52.2 24.1 21.2 19.5 19.6 32.0 22.7 15.0 16.9 18.3 18.1 34.3 35.8 44.3 24.9 16.2 21.6 1.8 8.9 13.6 19.4 10.0 21.2 15.9 23.4 25.0 22.3 22.7 35.8 26.3 20.9 28.1 21.1 24.0 15.6 49.8 8.7 20.2 15.5 38.4 25.1 37.8 31.1 27.4 38.0 27.2 36.8 46.4 54.1 28.3 20.1 44.7 30.4 47.5 22.1 41.8 26.6 19.1 15.2 32.4 30.2 40.2 31.3 19.3 19.0 61.6 22.1 29.8 16.7 21.4 16.4 37.7 36.8 14.9 30.7 17.0 18.8 20.0 27.4 54.9 29.4 47.5 75.5 20.1 39.5 29.7 0.6 8.0 1.8 11.3 8.9 19.4 16.2 15.3 13.4 13.9 13.5 17.7 16.6 1.0 13.6 6.4 21.6 9.7 10.0 14.8 17.5 17.2 25.4 21.6 15.9 18.4 15.7 23.4 16.9 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.1 27.7 5.7 11.8 5.9 4.0 10.6 6.7 4.9 7.5 6.0 23.4 9.2 15.7 12.9 9.6 10.9 19.2 8.4 10.4 10.8 9.9 15.7 22.2 11.0 4.5 24.4 15.5 5.8 4.0 17.6 10.6 8.1 10.3 15.8 7.5 21.7 13.8 5.1 16.6 15.6 14.9 13.1 15.2 5.7 17.7 9.4 5.6 21.8 13.5 6.3 17.8 6.2 11.5 13.7 13.7 13.2 11.3 11.9 15.2 20.2 7.1 20.2 15.2 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 GNPDA1 "GNPDA, GNPI, GPI, HLN, KIAA0060" ENSG00000113552 "Glucosamine-6-phosphate deaminase 1" P46926 5 141991749-142013041 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" 970000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: " "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (6.79e-2)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (8.89e-3)" "prognostic unfavourable (2.60e-6)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.09e-1)" "unprognostic (1.58e-1)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (9.66e-2)" "unprognostic (2.05e-3)" 15.6 28.2 13.9 10.0 19.1 4.3 18.7 12.6 22.5 16.5 13.7 13.2 11.7 18.0 24.8 34.0 10.7 11.9 13.7 10.6 12.3 16.1 46.2 10.2 11.0 21.8 14.1 16.5 20.7 7.7 15.1 19.9 18.9 13.4 17.8 14.0 17.1 10.6 18.9 16.5 9.0 18.8 18.4 10.9 18.2 9.5 16.3 10.8 12.4 18.2 9.2 11.8 23.6 11.2 7.9 20.6 5.0 22.7 5.6 32.7 14.7 11.7 17.2 6.8 33.2 23.1 15.7 15.7 9.3 22.5 24.8 28.3 25.7 14.0 0.0 21.4 6.7 12.5 31.2 27.8 22.0 9.0 13.4 8.6 10.1 18.3 41.1 23.8 11.4 18.7 16.5 15.8 42.2 26.0 10.2 31.8 26.5 7.4 18.1 2.7 25.2 34.8 7.1 21.8 26.2 23.9 32.5 6.0 15.7 18.5 19.3 35.4 15.8 7.5 12.4 14.5 9.9 22.3 13.1 17.9 34.2 13.2 21.3 8.2 12.6 0.0 19.4 2.6 15.7 22.7 32.7 7.9 12.8 14.4 20.6 3.7 15.5 16.5 5.0 5.6 20.4 11.6 10.6 14.7 13.9 19.1 12.6 22.5 12.3 16.1 14.1 16.5 13.4 10.8 GNPDA2 SB52 ENSG00000163281 "Glucosamine-6-phosphate deaminase 2" Q8TDQ7 4 44682200-44726595 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000499, HPA046891" Uncertain Approved "Golgi apparatus,Vesicles" 710000 Vesicles "Golgi apparatus" "HPA000499: AB_1079005, HPA046891: " "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (3.29e-1)" "unprognostic (1.55e-3)" "unprognostic (1.02e-1)" "unprognostic (1.33e-1)" "unprognostic (9.57e-2)" "unprognostic (9.75e-3)" "unprognostic (1.03e-1)" "unprognostic (1.28e-3)" "unprognostic (4.18e-2)" "unprognostic (6.86e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" 12.3 13.7 14.8 11.2 21.5 7.3 14.9 47.5 24.5 15.2 12.3 7.3 8.7 8.0 17.5 15.3 11.2 13.3 10.8 17.8 14.5 13.9 14.3 4.3 10.0 11.7 13.7 17.6 24.2 8.1 13.0 29.9 6.6 16.5 15.7 8.5 11.5 9.8 16.2 10.9 10.2 8.7 16.6 12.7 11.4 9.9 11.1 11.3 10.0 18.9 8.4 10.2 13.5 11.0 11.6 3.3 5.8 4.1 8.4 11.4 4.4 9.0 6.3 6.8 5.7 10.6 14.8 2.2 16.1 17.5 10.3 9.7 3.2 11.1 7.8 9.3 13.7 3.1 6.2 15.0 11.7 10.4 7.1 11.2 10.3 5.6 11.8 11.7 10.4 17.4 10.6 10.6 7.9 15.4 6.7 10.4 19.5 0.4 14.0 6.6 3.2 11.7 9.3 14.5 4.4 10.3 5.4 11.7 9.5 7.0 4.1 15.2 8.8 6.9 15.8 14.2 13.3 22.8 18.2 13.5 21.3 11.3 23.2 8.3 12.6 5.8 2.3 4.5 9.7 3.3 11.3 11.6 9.1 9.0 3.3 10.4 11.4 10.9 1.1 8.4 4.1 2.6 9.6 4.4 14.8 21.5 47.5 24.5 14.5 13.9 13.7 17.6 16.5 11.3 GNPTG "C16orf27, c316G12.3, CAB56184, GNPTAG" ENSG00000090581 "N-acetylglucosamine-1-phosphate transferase gamma subunit" Q9UJJ9 16 1351923-1364113 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004055 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 420000000 "Endoplasmic reticulum" Cytosol "HPA004055: AB_1079006" "unprognostic (4.37e-2)" "unprognostic (2.20e-2)" "unprognostic (1.84e-1)" "unprognostic (9.57e-3)" "unprognostic (2.70e-3)" "unprognostic (2.09e-1)" "unprognostic (3.03e-2)" "unprognostic (3.66e-1)" "unprognostic (1.69e-1)" "unprognostic (3.29e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.14e-2)" "unprognostic (2.20e-1)" "unprognostic (2.31e-1)" "unprognostic (4.85e-2)" "unprognostic (2.07e-2)" 23.1 67.3 38.0 16.9 35.7 19.9 20.2 22.0 38.8 19.6 23.5 41.7 22.2 16.5 18.9 28.4 17.3 19.1 22.2 17.8 38.5 31.7 29.9 41.1 21.7 22.6 39.3 28.6 22.3 34.6 33.7 25.1 27.2 28.9 21.1 15.6 20.5 37.8 22.2 28.1 33.4 19.5 15.1 43.3 26.3 21.2 18.0 31.0 11.1 24.0 13.2 13.2 20.0 17.8 15.5 29.3 25.8 37.1 14.6 21.7 20.9 4.7 7.6 5.6 9.8 51.7 19.2 7.2 13.9 18.2 5.5 10.6 6.8 13.4 3.0 16.1 18.7 8.7 3.4 8.1 2.8 9.5 7.4 3.9 23.7 11.6 21.9 6.4 16.0 25.6 14.2 5.3 7.6 10.1 4.7 17.9 9.1 10.8 3.0 6.4 5.2 4.3 10.8 4.8 13.6 13.7 6.2 4.4 5.8 14.0 14.5 10.0 13.4 9.7 9.8 11.1 9.5 9.1 6.7 18.9 13.7 6.2 9.1 5.6 7.3 25.8 37.1 22.2 21.7 34.0 19.9 15.5 18.7 20.5 29.3 14.6 17.3 15.8 15.0 14.6 31.9 24.7 21.3 20.9 38.0 35.7 22.0 38.8 38.5 31.7 39.3 28.6 28.9 31.0 GOLGA3 "GCP170, golgin-160, MEA-2" ENSG00000090615 "Golgin A3" Q08378 12 132768909-132828858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039809, HPA040044" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039809: AB_10962348, HPA040044: AB_10981600" "unprognostic (1.93e-1)" "unprognostic (7.91e-2)" "unprognostic (6.80e-2)" "unprognostic (1.41e-1)" "unprognostic (2.56e-2)" "unprognostic (4.08e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (1.10e-1)" "unprognostic (7.69e-2)" "unprognostic (1.55e-2)" "prognostic favourable (3.87e-4)" "unprognostic (2.99e-1)" "prognostic unfavourable (6.47e-5)" "unprognostic (1.40e-2)" "unprognostic (1.45e-1)" "unprognostic (2.01e-2)" "unprognostic (1.20e-1)" 17.5 14.2 14.7 17.6 17.0 13.8 14.5 23.7 21.4 20.1 19.9 17.6 20.6 12.3 18.2 20.0 18.3 14.3 20.7 17.0 14.6 16.7 11.2 18.7 15.5 16.0 15.8 13.2 20.5 39.1 16.1 32.1 18.8 16.2 18.0 16.8 14.3 26.9 19.8 20.5 21.4 15.5 24.6 12.9 18.2 22.2 13.9 14.1 9.8 15.3 15.4 18.2 17.1 16.1 7.3 8.0 5.1 4.6 7.3 7.5 3.5 9.7 19.8 7.1 11.9 25.0 16.9 13.1 16.7 12.7 10.5 9.2 18.8 4.4 13.2 9.0 24.6 10.2 7.7 10.1 7.2 3.5 8.9 13.3 20.0 12.2 14.6 14.6 19.6 12.7 12.3 14.2 14.4 10.2 12.9 5.2 10.9 15.0 12.6 13.5 7.3 13.4 10.1 7.9 4.7 6.7 23.2 9.0 5.7 13.8 12.4 7.9 16.1 10.8 20.8 12.4 9.2 13.9 10.7 16.2 13.5 18.0 15.6 8.7 15.8 5.1 4.2 3.6 7.5 4.5 6.6 4.6 5.5 5.9 4.1 7.3 6.3 6.6 3.2 7.3 4.6 8.0 4.5 3.5 14.7 17.0 23.7 21.4 14.6 16.7 15.8 13.2 16.2 14.1 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favourable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 22.3 20.6 16.7 14.0 29.0 11.4 30.6 26.9 27.1 19.1 25.1 14.5 29.1 23.9 12.8 18.4 22.0 11.3 16.7 34.3 18.1 12.3 22.1 32.7 15.2 12.2 30.5 12.8 14.8 27.7 27.1 42.8 34.5 18.9 21.1 18.1 20.2 24.8 24.4 64.6 29.8 29.1 19.0 23.9 14.8 21.2 26.0 24.9 10.3 29.9 22.6 11.8 20.5 24.8 10.0 9.9 19.8 11.0 13.0 14.9 3.2 23.4 16.2 8.4 10.6 22.2 19.2 21.4 30.2 25.3 11.9 14.4 13.9 13.1 8.1 7.9 25.6 13.8 13.3 21.4 24.8 10.3 9.8 10.9 14.4 22.1 22.3 11.5 8.0 10.2 20.5 18.8 36.6 17.2 13.3 12.7 19.1 10.0 8.8 5.0 9.1 15.5 2.0 25.5 8.5 14.8 24.7 5.4 7.1 18.7 20.2 23.1 29.7 8.4 20.7 12.2 14.2 23.5 21.5 15.7 11.0 7.1 21.7 10.1 14.3 19.8 5.5 12.0 14.9 6.4 12.5 8.1 9.2 10.3 4.5 10.0 9.6 7.2 7.7 13.0 11.0 9.9 6.0 3.2 16.7 29.0 26.9 27.1 18.1 12.3 30.5 12.8 18.9 24.9 GOLGA8A "GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 30.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.7" "Low lineage specificity" "Detected in single" HPA051808 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA051808: " "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favourable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favourable (5.68e-6)" 2.6 4.7 3.6 5.1 4.4 3.1 5.8 20.1 3.5 6.3 3.5 5.8 5.3 18.0 4.1 3.7 3.6 2.9 3.9 3.7 2.6 0.4 2.3 6.5 3.3 7.4 3.3 8.0 2.4 0.7 4.6 0.8 6.7 5.3 2.6 18.4 4.0 1.2 3.8 8.3 3.3 8.3 5.7 0.6 2.6 5.3 0.7 0.0 0.8 0.0 2.7 0.2 0.0 1.0 5.9 1.7 5.9 0.0 0.0 1.2 9.2 0.0 1.5 0.7 10.3 0.0 0.0 1.7 1.1 9.7 4.3 3.1 2.4 8.9 3.6 21.7 30.0 6.5 0.6 8.3 5.8 0.0 8.9 1.0 0.2 0.1 19.7 18.4 4.1 1.8 2.2 15.1 3.1 3.2 8.8 5.2 7.3 3.4 6.1 8.0 3.7 6.1 4.2 1.0 1.6 5.0 4.8 7.4 1.7 0.0 1.6 17.7 5.8 2.5 2.3 17.7 1.6 0.0 0.0 0.8 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 25.2" "Cell line enhanced" "Detected in many" "HeLa: 14.3;Hep G2: 12.7;NB-4: 19.7" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "basophil: 2.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.2" HPA051808 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA051808: " "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavourable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favourable (5.79e-4)" 2.6 3.4 0.0 2.8 0.6 6.8 4.3 2.5 2.7 2.5 2.0 0.0 4.1 6.1 0.8 3.8 2.8 1.6 0.0 0.7 3.0 2.3 4.5 8.0 0.0 9.0 25.2 0.1 4.9 0.9 5.4 0.1 4.6 5.2 1.8 3.3 5.4 0.5 0.0 5.2 4.0 5.3 16.4 3.1 3.0 1.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 2.0 2.2 0.2 4.2 2.3 4.6 6.0 1.8 0.5 2.1 3.5 2.2 2.8 0.0 4.0 1.9 1.7 0.8 1.9 1.7 2.9 7.0 0.3 14.3 12.7 3.4 1.7 2.3 6.6 2.6 1.2 3.8 2.1 0.7 0.2 1.9 1.0 0.8 19.7 2.6 3.8 0.1 0.0 0.3 1.7 4.0 3.2 4.8 1.0 0.3 2.2 1.9 3.9 0.0 3.1 7.3 0.9 3.2 1.4 1.3 2.9 1.0 0.9 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLPH3 "GOPP1, GPP34, MIDAS, Vps74" ENSG00000113384 "Golgi phosphoprotein 3" Q9H4A6 5 32124704-32174350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044564, HPA055841" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044564: AB_10795169, HPA055841: " "unprognostic (1.64e-2)" "unprognostic (1.66e-1)" "unprognostic (9.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (9.34e-2)" "unprognostic (1.89e-2)" "unprognostic (8.19e-2)" "unprognostic (2.95e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" 26.7 22.0 17.9 21.8 17.4 7.9 24.9 19.9 20.6 27.9 40.5 22.1 25.0 20.9 24.3 28.3 24.6 19.4 36.0 23.1 17.7 17.8 30.7 75.0 24.3 22.6 20.9 12.6 26.6 37.2 27.2 22.9 35.6 19.0 36.0 28.2 22.3 35.8 24.9 20.6 19.0 34.0 33.0 19.6 21.3 28.1 16.0 19.1 26.4 30.0 19.3 26.0 25.4 27.9 11.9 9.5 18.9 11.1 8.7 13.2 4.2 15.6 10.5 17.0 18.4 32.3 31.0 48.8 21.6 28.9 20.3 19.4 14.2 28.3 14.1 21.4 29.1 14.7 21.0 15.2 25.7 18.3 12.5 15.5 35.9 27.0 26.0 23.9 18.2 23.6 21.9 19.9 23.0 16.2 16.1 34.4 22.5 15.7 15.2 31.2 14.6 10.8 14.3 24.5 14.5 25.3 19.9 13.0 14.5 50.2 52.7 21.2 21.5 26.6 15.6 18.0 16.8 14.1 15.1 38.7 47.4 17.1 16.1 34.4 21.3 7.3 8.4 18.9 8.9 11.1 7.8 10.8 9.7 11.5 9.5 11.9 11.1 8.4 8.6 8.7 10.8 7.3 13.2 4.2 17.9 17.4 19.9 20.6 17.7 17.8 20.9 12.6 19.0 19.1 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646225-150697144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028558 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA028558: AB_10601656" "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 16.5 19.4 16.0 10.2 14.6 4.9 18.6 20.7 16.7 21.6 26.5 10.5 26.2 15.7 19.3 30.0 36.6 24.6 14.8 11.7 10.6 15.5 21.3 13.0 14.5 10.5 12.2 11.0 22.7 30.4 16.8 30.8 14.1 15.9 19.2 32.6 16.5 25.4 22.4 16.1 17.3 20.2 14.9 11.0 15.0 19.5 14.9 12.1 21.1 30.7 11.7 20.8 21.6 22.2 10.6 11.7 7.1 3.1 16.2 13.1 4.9 6.9 6.8 3.8 2.2 9.7 7.0 6.3 6.4 9.9 7.1 10.2 3.0 12.5 8.8 9.3 4.6 6.1 6.3 5.5 8.6 5.9 6.9 9.8 3.7 4.0 8.5 8.0 7.8 4.7 9.4 7.4 16.0 10.4 7.9 5.7 4.1 7.1 6.7 3.4 7.2 6.7 4.7 4.4 10.0 8.2 4.7 5.9 5.5 3.3 9.4 4.6 7.1 8.9 8.2 2.4 3.9 3.1 5.4 7.2 6.2 98.2 6.8 8.3 3.1 7.1 1.5 2.7 9.7 1.3 13.1 10.6 9.8 9.5 8.1 8.8 12.9 9.6 1.3 16.2 3.1 11.7 10.3 4.9 16.0 14.6 20.7 16.7 10.6 15.5 12.2 11.0 15.9 12.1 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055909: , HPA066383: " "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavourable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.5 12.3 10.1 13.1 20.4 32.0 17.2 45.7 17.5 14.5 23.8 16.0 17.2 7.0 11.8 23.7 11.3 8.4 9.5 25.4 10.2 8.0 10.2 8.0 11.2 22.9 13.2 13.2 16.2 18.4 17.4 32.0 13.1 6.4 7.8 22.2 10.9 5.9 21.9 28.0 8.8 5.0 24.8 14.7 12.0 7.1 2.7 8.5 18.7 7.3 24.9 10.1 14.9 14.6 17.1 18.7 21.1 24.8 7.6 16.5 18.6 23.5 12.7 23.0 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749662-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: , HPA074504: " "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavourable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 17.4 12.5 13.5 16.1 18.9 13.6 18.3 30.1 21.6 17.6 15.7 14.4 18.7 11.8 25.8 18.3 13.7 15.9 12.0 14.0 14.8 10.2 14.9 12.7 16.7 18.3 14.8 13.0 17.2 16.3 26.0 22.3 15.9 15.3 16.1 15.4 16.3 15.2 15.8 18.8 17.8 17.5 18.3 16.5 21.1 15.1 14.1 16.0 25.1 18.8 11.4 24.8 16.9 16.0 7.0 5.2 10.2 4.7 8.4 6.6 2.5 11.5 9.6 18.6 11.4 11.7 14.8 11.7 10.4 13.0 13.6 13.3 11.4 10.5 13.3 11.5 13.8 13.4 13.7 12.2 15.8 12.4 9.7 13.3 11.8 6.4 11.1 15.6 12.4 13.1 10.8 15.0 14.3 16.1 16.9 5.2 11.4 11.8 13.5 9.4 20.5 11.0 12.5 11.8 14.8 10.0 14.0 10.4 17.5 12.8 13.0 10.1 14.2 18.8 18.0 11.1 9.2 11.2 13.0 20.9 13.9 22.4 9.7 9.4 12.2 5.0 4.7 4.0 6.6 3.7 4.4 3.7 4.3 4.6 4.7 7.0 4.5 4.1 10.2 8.4 3.1 5.2 4.2 2.5 13.5 18.9 30.1 21.6 14.8 10.2 14.8 13.0 15.3 16.0 GON7 C14orf142 ENSG00000170270 "GON7, KEOPS complex subunit" Q9BXV9 14 93202894-93207094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051832 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051832: " "unprognostic (2.28e-2)" "unprognostic (1.96e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.53e-5)" "unprognostic (3.40e-3)" "unprognostic (8.82e-2)" "unprognostic (1.45e-3)" "unprognostic (2.47e-3)" "unprognostic (7.37e-2)" "prognostic favourable (3.08e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-1)" "unprognostic (2.67e-1)" "unprognostic (2.77e-1)" 7.3 15.5 11.4 8.7 13.2 5.4 11.0 11.3 13.4 14.6 14.2 4.9 21.5 12.5 6.8 20.5 7.5 33.8 9.8 18.6 10.9 13.6 21.1 14.7 10.1 13.7 10.4 11.3 7.6 11.5 9.5 14.8 6.1 13.2 8.7 12.9 7.6 9.4 12.1 13.2 5.1 17.4 6.4 8.2 10.3 9.3 8.9 9.5 13.6 14.6 9.5 11.8 8.3 8.8 14.2 14.8 10.7 10.8 10.6 17.6 8.8 5.0 6.9 7.2 7.4 6.4 7.7 5.7 6.4 6.0 9.4 10.8 4.4 7.9 15.8 4.9 4.1 7.2 7.9 5.7 11.2 9.2 6.2 4.1 10.0 10.5 4.8 15.7 7.8 4.7 5.3 7.2 5.9 7.0 9.7 10.6 8.4 17.0 10.6 13.7 4.7 13.5 15.2 9.2 8.2 9.2 6.6 11.8 8.0 5.8 7.5 10.6 9.7 11.1 4.6 4.8 5.8 8.5 5.1 11.7 26.2 14.9 10.0 9.6 5.8 10.7 9.7 8.1 9.6 10.8 12.5 14.2 11.0 10.1 12.3 9.8 10.4 11.4 3.5 10.6 9.8 14.8 17.6 8.8 11.4 13.2 11.3 13.4 10.9 13.6 10.4 11.3 13.2 9.5 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532129-170553446 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027208, HPA027250, HPA027746" Approved Enhanced "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favourable (1.39e-4)" "prognostic unfavourable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavourable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 7.7 14.7 8.4 9.4 9.2 0.5 10.6 8.7 9.5 10.7 9.4 4.8 7.0 4.8 8.8 10.5 6.3 6.8 6.7 8.2 7.4 7.8 7.2 11.1 6.8 9.6 6.3 8.1 12.6 9.7 6.5 20.6 9.4 8.7 11.1 10.4 6.3 8.8 13.1 3.3 6.5 7.0 6.4 11.1 10.4 5.6 8.6 7.3 8.7 10.5 4.2 9.7 10.4 10.0 6.2 7.3 1.2 7.4 7.9 9.4 5.5 5.1 5.0 9.6 3.6 12.8 9.5 6.3 7.8 12.0 6.9 7.1 3.2 8.7 7.5 8.9 7.8 6.5 9.5 4.6 9.2 8.0 2.9 5.0 6.5 4.0 8.6 6.6 5.1 8.3 4.5 7.3 6.9 5.4 6.8 3.7 7.3 1.2 9.4 6.0 8.5 6.3 5.7 6.4 9.9 6.2 3.8 2.4 5.3 6.4 7.8 18.1 5.0 11.6 6.8 10.9 5.8 4.3 10.7 6.7 7.2 6.6 9.1 6.0 9.8 1.0 7.4 0.0 4.7 7.4 7.4 6.1 8.3 7.2 7.3 6.2 7.3 6.2 1.2 7.9 5.7 4.6 9.4 5.5 8.4 9.2 8.7 9.5 7.4 7.8 6.3 8.1 8.7 7.3 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: , HPA054472: " "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 22.4 24.6 27.9 18.7 27.8 12.5 22.6 22.2 31.1 24.1 25.3 28.9 38.0 43.9 25.9 30.0 19.7 19.6 21.4 28.7 25.2 26.5 37.4 39.7 21.0 23.8 27.0 22.8 27.5 33.6 26.8 40.6 27.6 23.5 22.0 25.1 25.8 28.4 29.8 34.4 19.2 38.2 27.1 27.8 31.5 20.6 38.8 18.4 23.6 24.9 15.2 30.7 20.9 21.0 16.9 15.5 15.1 37.0 13.9 17.6 15.5 18.1 20.5 14.6 17.8 25.0 17.9 17.0 26.1 25.8 28.5 25.8 26.0 11.4 16.2 14.9 32.9 13.2 19.0 21.2 35.3 34.6 14.5 24.5 16.9 25.4 27.6 19.0 19.7 18.7 20.9 23.2 33.2 23.3 23.9 22.0 20.6 20.1 20.6 10.3 13.6 29.2 17.7 28.5 18.8 18.0 15.6 12.9 27.3 14.3 8.6 20.2 24.0 13.2 27.2 27.0 17.4 21.0 24.9 28.5 16.0 25.6 25.5 12.2 29.5 15.1 15.5 13.1 16.8 28.9 15.5 14.8 15.0 13.8 15.5 16.9 14.9 13.0 1.8 13.9 37.0 14.0 17.6 15.5 27.9 27.8 22.2 31.1 25.2 26.5 27.0 22.8 23.5 18.4 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol 130000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favourable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favourable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 3.3 14.0 15.7 3.6 32.1 2.0 5.9 22.9 56.4 13.5 12.0 9.7 5.9 14.7 3.4 7.0 10.3 4.6 12.2 116.9 19.4 19.0 34.6 82.9 3.5 3.4 17.8 16.4 3.8 8.2 15.9 4.9 3.7 49.9 5.9 14.7 9.0 12.4 7.2 102.1 4.5 12.7 5.4 7.7 3.6 10.1 9.3 4.7 3.3 11.7 31.3 7.1 4.9 4.0 10.6 21.4 3.9 16.8 11.4 15.6 8.8 16.9 9.4 11.1 28.0 8.6 7.4 31.4 13.9 25.6 24.3 26.5 21.3 13.8 16.6 4.8 11.7 21.3 25.3 18.3 26.8 5.7 10.8 6.3 12.1 27.7 45.6 18.0 10.8 11.6 19.8 20.6 55.9 11.7 16.2 26.0 15.5 15.3 9.6 13.5 7.1 13.1 10.5 10.6 17.3 42.4 9.3 4.8 7.1 10.5 14.9 51.9 28.5 6.2 5.4 6.2 13.8 6.7 15.9 18.6 21.9 16.9 16.3 9.4 8.2 2.4 5.3 3.9 12.4 14.7 11.4 10.6 13.5 12.9 12.9 10.2 10.2 14.5 0.5 11.4 16.8 21.4 15.6 8.8 15.7 32.1 22.9 56.4 19.4 19.0 17.8 16.4 49.9 4.7 GPALPP1 "AD029, bA245H20.2, KIAA1704, LSR7" ENSG00000133114 "GPALPP motifs containing 1" Q8IXQ4 13 44989529-45037669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038966, HPA058739" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038966: AB_10672656, HPA058739: " "unprognostic (4.99e-2)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (8.81e-2)" "unprognostic (3.65e-2)" "unprognostic (2.63e-2)" "unprognostic (8.86e-2)" "unprognostic (6.08e-2)" "unprognostic (2.72e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" "unprognostic (4.56e-2)" "unprognostic (1.41e-3)" "unprognostic (3.37e-2)" "unprognostic (6.38e-2)" "unprognostic (5.88e-2)" "unprognostic (3.94e-2)" 15.6 17.9 19.8 13.8 28.1 16.4 15.0 27.6 24.9 18.1 15.0 15.0 14.5 13.7 18.3 15.5 14.4 13.8 12.5 14.4 19.4 15.3 13.9 13.7 12.7 19.1 14.2 23.3 20.9 12.2 9.1 17.8 19.7 16.8 14.9 15.0 10.8 12.7 16.0 15.0 10.3 14.4 17.6 14.3 16.1 15.3 13.9 19.9 19.4 19.6 12.6 18.8 15.6 15.8 10.4 13.0 11.1 8.5 10.1 10.6 5.1 8.8 7.6 14.3 8.9 6.8 11.3 10.0 12.7 10.4 14.7 14.1 13.2 16.3 20.2 8.5 10.2 14.8 14.1 10.2 16.6 17.3 16.6 15.2 9.8 9.4 11.0 21.6 7.5 8.9 7.3 9.6 8.7 11.7 13.2 4.4 10.8 9.8 20.5 14.9 9.8 7.1 20.0 11.8 8.6 8.3 8.8 5.8 10.0 10.7 6.3 8.1 6.6 17.2 13.4 7.9 5.7 9.3 9.5 6.0 7.4 20.3 8.5 13.3 10.2 2.6 8.5 11.1 9.0 7.1 7.6 8.7 9.5 7.6 10.7 10.4 10.6 9.6 4.0 10.1 6.5 13.0 7.8 5.1 19.8 28.1 27.6 24.9 19.4 15.3 14.2 23.3 16.8 19.9 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 54.5;HMC-1: 20.0;U-87 MG: 23.8;WM-115: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favourable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavourable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 10.4 10.3 0.0 0.1 0.5 1.3 0.2 0.8 1.5 0.2 0.2 0.7 54.5 0.0 1.1 2.0 2.3 4.9 0.9 0.1 0.7 2.3 0.0 3.2 10.0 1.4 2.9 20.0 0.7 0.0 0.4 1.2 5.1 8.3 8.2 0.2 1.0 0.7 0.7 0.2 4.4 0.1 2.3 3.9 10.3 0.7 0.2 0.0 2.0 2.1 5.7 0.4 0.5 0.2 2.5 4.4 2.4 9.8 0.4 0.7 0.0 23.8 5.9 18.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 GPATCH1 "ECGP, FLJ10206, FLJ38686, GPATC1" ENSG00000076650 "G-patch domain containing 1" Q9BRR8 19 33080880-33130542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043430, HPA043604" Approved Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA043430: AB_10960493, HPA043604: AB_10960499" "unprognostic (2.38e-2)" "unprognostic (1.71e-2)" "unprognostic (9.95e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (2.41e-1)" "unprognostic (1.28e-2)" "unprognostic (4.60e-3)" "unprognostic (3.54e-2)" "unprognostic (5.17e-2)" "unprognostic (3.56e-2)" "unprognostic (6.53e-2)" "unprognostic (5.37e-3)" "unprognostic (8.10e-2)" "unprognostic (4.57e-2)" "unprognostic (1.25e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-3)" 8.8 8.0 11.0 10.0 12.2 6.9 9.8 21.2 15.7 9.7 9.9 13.8 8.3 11.0 13.0 9.6 9.1 8.9 8.2 7.8 11.1 7.9 9.6 7.3 7.1 9.4 10.5 7.1 15.9 8.8 13.5 11.8 12.9 10.3 10.1 9.7 8.6 9.6 10.8 10.3 11.4 10.6 9.7 7.5 9.6 10.2 8.9 11.1 13.6 10.0 5.6 13.1 10.3 11.4 6.5 5.7 17.4 6.4 3.0 9.7 4.4 7.3 15.6 7.4 7.8 4.9 5.7 6.2 6.7 4.7 10.3 8.6 11.1 6.9 10.4 8.7 5.3 6.5 9.3 5.5 9.0 18.0 5.7 9.8 5.8 8.1 6.5 17.0 6.6 4.8 6.5 7.0 6.4 5.7 10.4 6.6 5.1 9.4 9.8 5.6 5.1 6.6 10.0 9.4 4.6 4.7 4.6 8.2 5.5 10.6 6.7 3.7 5.6 12.3 6.4 9.0 6.7 4.9 9.6 5.6 9.1 9.1 5.6 8.7 8.2 17.4 6.0 6.5 6.1 6.4 4.2 6.2 5.7 7.6 5.7 6.5 9.7 6.1 4.4 3.0 3.3 5.0 8.4 4.4 11.0 12.2 21.2 15.7 11.1 7.9 10.5 7.1 10.3 11.1 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 15.3 12.4 15.5 14.6 20.6 40.1 14.3 17.9 22.4 12.8 14.1 18.1 9.0 10.5 17.0 12.9 14.8 12.3 16.0 20.6 11.2 9.3 12.2 11.2 16.2 14.5 14.3 12.7 16.2 12.4 14.0 20.2 14.1 16.7 14.4 13.9 17.9 13.4 13.8 18.2 13.9 14.0 19.1 12.2 13.0 12.8 19.7 14.4 18.1 14.4 8.7 16.2 15.5 15.0 8.7 10.6 11.5 10.9 7.6 8.1 5.1 12.2 16.2 12.8 10.5 7.7 13.5 10.8 14.5 10.3 14.4 14.1 10.8 20.6 14.8 8.7 11.1 14.8 15.6 9.7 25.1 16.4 8.9 13.4 16.3 6.9 9.9 8.8 19.1 12.3 9.2 12.1 15.7 14.4 13.4 20.7 12.6 20.3 11.8 11.8 16.4 11.8 13.4 16.0 7.6 9.9 24.9 10.6 13.6 16.5 14.6 8.3 17.0 14.1 16.0 18.5 10.8 10.3 11.0 20.7 19.6 19.2 14.8 12.3 18.9 6.9 10.9 11.5 5.7 9.3 4.8 8.7 3.1 8.1 10.6 6.8 6.7 4.8 8.3 7.6 6.7 8.2 6.4 5.1 15.5 20.6 17.9 22.4 11.2 9.3 14.3 12.7 16.7 14.4 GPATCH3 "FLJ12455, GPATC3" ENSG00000198746 "G-patch domain containing 3" Q96I76 1 26890488-26900466 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032078, HPA054973" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA032078: AB_10603671, HPA054973: " "unprognostic (2.93e-2)" "unprognostic (1.33e-2)" "unprognostic (7.34e-2)" "unprognostic (9.63e-2)" "unprognostic (1.42e-1)" "unprognostic (9.44e-2)" "prognostic unfavourable (1.23e-7)" "unprognostic (4.37e-2)" "unprognostic (7.75e-2)" "unprognostic (6.46e-2)" "prognostic favourable (6.42e-4)" "unprognostic (3.77e-1)" "unprognostic (3.22e-3)" "unprognostic (2.31e-2)" "unprognostic (3.81e-2)" "unprognostic (2.59e-1)" "unprognostic (6.82e-2)" 11.7 14.5 13.1 10.2 13.6 31.8 13.0 19.5 20.9 9.4 11.7 15.8 11.8 13.0 11.8 14.5 11.6 10.3 12.0 9.6 11.6 10.9 10.9 14.8 10.5 12.4 12.6 10.8 11.8 11.8 12.0 10.1 13.3 13.6 10.3 10.1 10.1 10.4 10.5 21.5 16.0 11.7 10.4 12.1 15.4 12.0 17.2 16.2 16.9 10.1 10.5 11.7 10.5 12.2 12.4 17.4 22.4 16.8 8.1 16.0 12.8 8.8 7.3 6.9 11.0 6.7 6.4 9.4 7.0 7.9 13.9 12.2 9.7 10.6 8.2 7.7 6.8 9.3 11.4 12.7 7.3 9.2 17.2 15.8 16.0 20.6 9.3 10.9 11.1 9.9 11.8 14.0 7.4 9.0 18.6 10.8 5.7 8.1 9.3 21.3 16.1 11.0 11.8 9.8 13.1 7.0 4.8 9.1 11.2 13.4 11.9 20.7 10.5 11.5 9.2 9.0 10.4 12.1 7.8 14.0 19.2 10.9 8.1 15.8 7.8 22.4 16.8 19.7 16.0 13.7 12.9 12.4 13.3 14.0 17.4 12.1 14.0 13.2 7.1 8.1 15.8 13.3 11.4 12.8 13.1 13.6 19.5 20.9 11.6 10.9 12.6 10.8 13.6 16.2 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594487-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: " "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavourable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 18.2 13.3 14.7 16.9 27.7 9.4 15.1 6.9 22.5 10.0 12.1 8.3 3.9 9.7 13.8 10.0 14.0 11.6 7.2 11.9 12.6 12.1 18.0 23.1 10.0 15.7 15.3 12.4 15.3 12.9 19.6 16.2 10.0 24.2 12.6 14.6 5.7 11.5 11.9 47.1 10.9 10.0 15.1 10.2 16.6 12.5 8.8 13.2 8.0 10.3 19.0 19.1 12.5 10.1 16.6 10.1 0.3 11.2 10.7 15.9 7.6 17.1 23.6 10.0 14.3 9.2 7.0 12.9 21.2 8.5 16.6 9.7 24.1 13.0 41.2 17.6 14.8 12.0 22.6 18.7 18.4 12.2 22.4 24.6 23.1 18.4 8.3 54.8 15.9 8.0 15.8 31.4 27.8 11.6 40.2 10.4 13.4 31.9 22.5 13.3 43.6 24.9 22.5 17.0 28.5 11.4 20.3 15.7 23.7 20.3 44.7 13.1 14.6 26.7 17.7 15.8 21.5 16.4 37.9 19.0 20.9 53.2 14.3 28.5 23.9 0.0 5.4 0.1 13.3 10.5 13.4 16.6 13.5 14.7 10.1 16.6 15.4 15.9 0.3 10.7 11.2 6.4 8.5 7.6 14.7 27.7 6.9 22.5 12.6 12.1 15.3 12.4 24.2 13.2 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395284-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 8.6 8.5 7.1 12.0 9.3 11.9 7.7 22.2 11.7 8.3 6.5 9.9 6.4 6.9 10.2 4.7 8.5 7.4 6.7 8.1 7.8 5.6 6.4 4.8 7.5 10.0 8.7 6.8 11.2 7.7 14.7 18.1 11.0 9.0 7.1 7.5 9.2 9.1 5.8 21.0 8.3 8.6 8.0 8.3 9.3 6.5 7.6 10.1 9.6 7.7 3.8 9.5 11.6 12.8 10.1 9.6 10.3 16.0 12.4 13.2 6.1 10.2 7.3 8.8 8.5 5.7 7.8 8.7 8.5 10.1 10.6 11.2 10.2 6.9 12.9 5.0 10.5 6.8 11.8 8.0 13.0 15.2 7.6 15.2 6.9 5.6 4.1 12.5 10.3 8.0 4.4 11.1 10.5 8.6 10.4 11.0 6.3 3.2 16.0 1.1 5.9 7.3 14.3 11.4 9.1 1.4 7.5 8.2 6.4 9.9 4.3 5.8 6.1 6.9 6.9 6.6 6.0 9.8 10.0 11.3 10.0 14.0 7.3 4.9 6.6 10.3 8.2 6.7 13.2 7.9 12.4 10.1 10.4 9.4 7.9 9.7 9.7 9.7 6.4 12.4 16.0 9.6 5.2 6.1 7.1 9.3 22.2 11.7 7.8 5.6 8.7 6.8 9.0 10.1 GPBP1 "DKFZp761C169, vasculin" ENSG00000062194 "GC-rich promoter binding protein 1" Q86WP2 5 57173948-57264679 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037773 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Cytosol" "Plasma membrane" "HPA037773: AB_10671721" "unprognostic (1.53e-1)" "unprognostic (2.23e-2)" "unprognostic (1.57e-1)" "unprognostic (3.49e-1)" "unprognostic (8.30e-2)" "unprognostic (9.68e-3)" "unprognostic (1.24e-2)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (3.70e-1)" "unprognostic (5.93e-2)" "unprognostic (5.48e-2)" "unprognostic (3.75e-2)" "unprognostic (1.65e-1)" "unprognostic (4.89e-2)" "unprognostic (2.57e-1)" "prognostic favourable (4.15e-5)" 25.6 33.1 33.8 27.0 37.8 38.0 37.2 53.9 34.0 30.6 23.5 29.7 20.3 20.8 29.0 33.1 25.5 32.4 24.5 25.4 32.5 28.4 27.1 28.4 29.9 34.0 41.5 34.0 46.7 23.5 37.6 43.9 35.6 33.2 27.6 24.9 19.7 27.2 26.9 37.3 24.6 25.8 22.0 42.4 31.5 24.0 46.9 37.2 49.9 35.1 20.3 33.7 29.4 50.2 31.7 18.9 35.5 18.9 33.5 37.7 27.1 21.7 17.4 33.4 28.1 21.9 21.8 30.8 16.6 28.3 27.6 35.6 28.2 25.3 28.9 19.5 17.0 15.0 28.5 19.2 34.9 16.4 19.6 23.7 19.9 23.4 25.5 17.1 24.6 17.7 29.8 22.4 31.5 22.2 24.1 47.6 22.0 27.3 27.0 30.0 20.8 12.2 29.2 27.4 28.4 21.2 22.7 30.1 23.3 24.3 21.8 26.5 42.6 29.3 14.7 10.1 20.6 14.6 24.0 36.3 30.3 32.2 16.9 25.9 18.8 35.5 17.1 32.3 28.1 17.7 35.2 31.7 34.0 33.1 18.9 26.8 37.7 34.9 33.2 33.5 18.9 13.4 35.3 27.1 33.8 37.8 53.9 34.0 32.5 28.4 41.5 34.0 33.2 37.2 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 29.9 20.5 16.9 21.2 23.7 24.9 25.2 24.4 18.6 27.4 36.9 33.3 29.7 31.6 26.3 23.8 34.8 22.5 19.7 23.9 17.3 17.0 30.2 38.9 28.3 29.1 33.2 12.4 24.7 46.9 24.4 36.6 25.7 22.1 26.4 37.2 29.8 33.5 35.3 29.6 31.0 58.0 25.7 28.2 30.6 26.2 33.2 27.2 40.5 37.7 30.3 35.4 32.5 27.5 13.5 17.8 29.8 22.1 20.0 20.0 15.4 15.8 9.8 17.1 18.1 20.2 19.7 23.4 12.6 21.0 18.3 23.1 9.8 17.8 22.0 16.5 17.3 16.6 18.7 19.0 23.3 25.1 13.3 28.6 11.4 15.2 27.9 28.4 26.5 14.3 41.7 14.3 41.0 23.1 24.3 19.6 20.8 8.5 25.2 25.7 24.3 11.2 16.6 22.3 16.2 21.0 15.7 21.1 14.1 20.8 30.8 32.1 14.0 33.6 19.6 13.2 13.9 14.2 19.1 19.2 17.8 16.3 13.9 23.8 13.8 16.4 16.6 29.8 17.8 21.2 18.9 13.5 17.6 17.4 17.8 11.5 19.4 18.9 17.7 20.0 22.1 10.2 20.0 15.4 16.9 23.7 24.4 18.6 17.3 17.0 33.2 12.4 22.1 27.2 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435671-240468078 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 142.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030571 Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" 6500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322" "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavourable (5.78e-5)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavourable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 13.6 22.8 32.4 7.2 21.0 1.9 8.1 42.7 33.6 11.5 8.1 10.1 9.5 5.4 9.6 9.8 26.3 7.8 7.1 40.7 26.5 11.9 8.5 11.0 7.4 4.0 8.8 22.5 14.1 18.1 5.8 14.4 20.2 13.6 29.5 4.0 6.3 16.3 17.6 62.9 142.6 4.9 12.0 8.3 5.2 6.5 20.0 10.5 1.7 4.5 24.3 10.7 10.5 15.2 0.9 0.1 0.0 0.0 0.1 0.8 0.3 16.0 22.1 5.2 13.7 16.0 15.4 21.3 38.6 19.2 4.5 5.2 7.9 18.0 0.4 5.3 40.8 44.4 2.8 27.4 0.9 7.7 2.3 0.0 20.3 9.7 23.0 0.3 1.5 13.5 17.9 10.0 5.2 2.3 0.1 0.8 11.4 8.4 0.2 0.1 8.2 4.9 2.8 23.9 3.7 3.6 26.0 5.2 3.5 25.2 22.3 2.3 7.0 1.6 10.8 24.0 40.7 11.4 15.9 0.1 0.1 0.1 17.1 0.4 26.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.3 32.4 21.0 42.7 33.6 26.5 11.9 8.8 22.5 13.6 10.5 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favourable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favourable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 50.7 2.0 2.2 0.3 6.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 17.4 0.2 0.0 29.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 26.6 0.7 0.1 4.6 0.0 66.9 1.9 0.0 0.3 0.2 0.0 0.0 0.7 0.7 0.0 5.2 6.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Group enriched" "Detected in some" 11 "CACO-2: 30.6;HeLa: 17.5" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA040152: , HPA044081: " "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavourable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 17.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 GPC6 ENSG00000183098 "Glypican 6" Q9Y625 13 93226842-94407401 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;HHSteC: 18.2;HSkMC: 31.0;U-87 MG: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 23 "NK-cells: 2.3" "Low region specificity" "Detected in all" HPA017671 Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 360000 "Golgi apparatus, Vesicles" "HPA017671: AB_1849833" "unprognostic (5.24e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" "unprognostic (9.76e-2)" "unprognostic (1.72e-1)" "unprognostic (5.50e-2)" "unprognostic (1.28e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.33e-2)" "unprognostic (3.71e-2)" "unprognostic (2.53e-3)" "unprognostic (6.21e-3)" "unprognostic (7.42e-2)" "unprognostic (3.36e-1)" "unprognostic (3.35e-3)" 11.0 3.2 3.7 9.7 6.8 0.4 6.5 3.2 7.3 7.6 10.6 3.7 2.6 3.1 5.7 9.9 6.3 6.9 19.9 7.9 3.0 3.0 9.5 21.3 6.6 4.9 2.5 4.7 11.1 2.3 1.2 7.5 1.8 5.1 12.8 8.2 20.8 3.6 19.2 1.8 3.0 7.1 13.7 19.8 3.4 8.1 2.4 2.1 0.2 4.4 1.5 1.4 14.3 15.6 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.9 4.3 1.9 27.3 9.2 0.0 3.0 0.0 2.1 2.9 0.0 0.0 0.1 0.0 6.6 0.0 2.4 0.5 3.9 0.0 1.8 0.0 0.0 8.3 18.2 0.0 0.0 31.0 0.2 5.0 3.5 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.8 1.4 0.0 0.7 0.0 2.4 0.0 1.7 7.3 0.0 0.8 0.0 5.9 0.0 0.0 11.6 9.9 10.8 5.0 6.8 0.0 0.0 22.8 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 3.7 6.8 3.2 7.3 3.0 3.0 2.5 4.7 5.1 2.1 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.1 107.4 9.4 73.5 30.9 23.0 22.5 29.4 23.2 37.1 44.8 60.5 27.0 50.2 43.7 28.8 53.1 56.8 63.9 42.2 55.8 22.9 64.5 51.8 63.6 20.0 83.5 42.0 31.5 26.4 43.9 22.8 34.6 32.8 39.8 26.1 64.6 36.3 29.2 25.4 38.0 34.0 24.9 94.8 46.5 51.3 51.4 29.9 59.3 104.6 21.4 23.7 26.6 29.8 14.0 30.9 39.8 45.3 73.5 41.7 45.5 46.8 63.5 28.4 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651508 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavourable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavourable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 24.3 24.3 18.8 18.7 23.2 28.1 26.3 22.9 27.2 18.3 21.6 20.7 13.7 19.3 21.3 21.2 26.7 21.0 18.2 21.5 17.2 22.1 29.7 29.2 18.2 29.2 20.0 16.1 24.6 35.4 19.8 18.5 31.1 23.3 18.8 25.6 14.3 23.0 17.6 30.9 25.0 25.3 22.1 16.4 26.6 20.8 30.2 15.9 29.0 26.9 22.5 28.3 21.5 24.3 29.1 35.8 28.5 28.2 39.6 38.6 29.7 32.1 18.3 17.2 12.5 16.3 16.7 17.5 18.0 17.9 25.5 18.9 19.9 16.9 20.1 17.5 19.6 14.0 23.9 22.3 25.9 18.7 16.7 23.0 14.7 24.2 21.2 33.6 12.1 17.1 19.7 26.2 24.6 26.6 28.5 18.9 30.1 18.7 20.3 25.2 29.8 18.0 20.5 51.1 21.0 20.6 18.6 15.4 24.4 19.7 22.2 20.0 13.3 19.5 21.6 22.3 32.9 11.0 42.1 21.9 23.5 54.1 32.0 29.2 18.3 28.5 24.7 21.1 33.4 28.2 36.0 29.1 31.1 38.6 35.8 25.2 27.7 34.1 3.7 39.6 26.3 18.5 30.3 29.7 18.8 23.2 22.9 27.2 17.2 22.1 20.0 16.1 23.3 15.9 GPN3 "ATPBD1C, MGC14560" ENSG00000111231 "GPN-loop GTPase 3" Q9UHW5 12 110452484-110469268 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039764, HPA047793" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039764: , HPA047793: " "unprognostic (1.68e-3)" "unprognostic (1.11e-2)" "unprognostic (9.82e-2)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.27e-3)" "prognostic unfavourable (3.98e-5)" "unprognostic (5.50e-2)" "unprognostic (4.45e-2)" "unprognostic (2.70e-1)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" "prognostic favourable (2.65e-6)" "unprognostic (5.81e-2)" "unprognostic (2.85e-1)" "unprognostic (1.62e-1)" "unprognostic (2.27e-1)" 17.8 15.1 14.1 11.2 17.3 9.6 26.7 18.4 14.2 13.0 12.5 11.9 10.1 5.9 14.9 11.8 15.6 15.1 10.2 24.8 11.4 10.9 23.3 23.2 13.6 14.8 26.6 11.4 19.4 14.5 19.6 12.2 15.4 18.6 17.0 10.0 11.0 16.6 14.3 35.1 9.6 8.7 17.5 20.0 16.0 13.6 28.3 19.4 11.8 20.1 22.0 12.6 16.5 13.1 20.2 28.0 34.4 31.4 11.8 18.9 16.8 15.2 23.5 16.4 16.0 18.4 11.7 21.7 20.9 12.7 23.6 19.2 21.9 9.1 29.3 14.6 11.4 14.0 20.2 18.8 32.2 16.7 18.8 17.3 12.7 18.0 12.8 27.0 16.0 12.4 11.9 23.1 15.0 17.0 29.1 6.7 16.5 10.3 24.7 51.5 20.0 24.1 8.5 22.6 22.4 14.8 13.7 12.6 13.0 21.4 14.6 17.7 24.9 31.9 9.3 19.7 14.5 19.1 24.1 9.2 23.8 30.5 14.5 25.0 22.4 15.3 24.5 34.4 14.0 31.4 15.5 20.2 15.0 15.8 22.6 19.9 18.9 12.6 12.6 11.8 31.1 28.0 12.3 16.8 14.1 17.3 18.4 14.2 11.4 10.9 26.6 11.4 18.6 19.4 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 4 "HHSteC: 52.5;hTCEpi: 23.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 2.9 0.2 5.4 9.3 3.3 2.8 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 52.5 0.0 0.0 2.1 23.7 4.8 7.7 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.0 0.0 0.0 0.1 4.1 1.8 4.7 0.4 0.0 0.0 0.0 1.4 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavourable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favourable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 21.0 21.6 24.2 16.6 26.8 12.5 23.7 28.1 28.0 25.0 24.0 35.9 20.5 13.3 24.0 19.1 22.5 26.2 20.9 20.6 22.3 26.6 24.4 22.9 23.0 17.4 29.5 23.1 21.8 26.6 34.4 21.6 40.7 29.9 28.4 26.3 29.3 23.0 24.4 20.5 25.6 15.4 26.7 28.8 17.2 18.9 23.9 22.9 17.3 40.0 15.4 19.7 19.4 17.3 2.0 3.4 6.3 6.3 1.4 2.4 2.3 12.7 18.7 17.8 14.1 19.1 20.3 17.9 20.4 22.9 17.2 17.2 17.8 17.3 7.1 15.1 22.4 32.1 13.6 12.5 14.8 10.9 9.1 7.4 23.0 10.2 18.6 15.6 11.0 16.9 19.6 17.1 17.4 15.9 10.6 7.1 14.7 15.7 8.3 6.3 12.0 14.1 7.9 26.2 11.2 14.4 17.7 6.2 13.8 26.6 19.0 14.3 33.2 8.2 18.6 21.9 11.8 17.9 15.4 4.5 14.9 6.8 19.5 7.4 20.7 2.8 5.7 3.4 1.5 6.1 2.1 1.8 1.6 1.7 3.4 2.0 1.0 2.4 6.3 1.4 6.3 2.1 1.5 2.3 24.2 26.8 28.1 27.6 22.3 26.6 29.5 23.1 29.9 22.9 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: " "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favourable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favourable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.5 12.6 7.8 15.2 30.6 16.6 8.8 9.0 27.4 12.5 13.4 7.7 13.3 5.5 16.8 18.4 9.9 8.8 18.8 6.5 22.1 10.1 8.9 13.3 10.2 30.1 5.7 12.2 18.0 36.0 12.1 24.5 14.7 8.9 36.9 12.6 8.0 10.0 8.3 5.6 11.2 8.2 8.9 20.8 26.1 11.4 0.0 8.5 9.1 14.9 13.8 14.3 13.9 12.1 7.2 4.6 22.8 9.5 23.9 12.9 3.8 24.7 18.4 7.7 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: " "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favourable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 8.9 20.0 6.9 20.0 13.5 7.2 29.3 10.7 9.0 10.7 6.9 14.7 12.6 9.2 18.6 6.7 18.0 9.6 5.9 3.1 29.1 12.1 8.7 20.5 9.4 7.7 5.8 17.0 9.0 9.4 9.3 7.1 5.7 7.8 22.5 6.4 22.7 6.5 15.6 9.4 20.0 13.0 7.4 14.9 7.4 12.2 11.0 13.4 13.0 17.7 11.5 19.4 2.4 9.2 29.6 20.5 22.3 7.7 18.0 33.1 7.7 21.2 4.9 18.0 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell line enhanced" "Detected in many" "U-266/70: 16.0;WM-115: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: " "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.4 5.6 3.1 0.6 4.2 1.4 0.7 2.4 0.3 0.3 2.4 1.3 2.9 0.4 1.4 1.3 2.3 0.9 1.6 2.5 1.4 0.2 1.0 0.9 1.3 4.5 3.6 2.1 0.7 1.1 0.4 6.0 4.7 0.7 1.7 1.1 0.5 1.7 2.0 6.1 1.1 2.4 1.5 6.5 5.5 1.3 1.0 2.1 0.4 0.4 3.0 3.1 1.2 4.4 0.6 16.0 2.3 0.4 3.5 0.8 10.5 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Plasma membrane,Cell Junctions" Nucleoli "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.6 2.6 0.8 2.1 0.7 0.7 4.3 1.4 0.9 1.2 1.6 2.1 1.8 0.6 1.8 1.5 9.9 2.4 0.9 1.8 12.8 3.9 0.0 7.7 3.1 2.6 0.0 1.0 0.7 2.0 2.1 1.3 0.9 0.7 16.9 0.5 3.4 1.9 0.9 0.9 3.3 0.3 0.7 2.2 0.8 3.1 1.2 3.2 5.7 33.2 2.8 4.7 0.5 7.0 4.2 1.1 10.9 0.6 16.3 2.6 0.0 3.1 6.6 1.7 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell line enhanced" "Detected in many" "CACO-2: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: " "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.3 9.8 3.7 6.6 0.0 5.9 6.4 5.0 5.4 23.8 1.0 0.0 3.3 8.8 18.2 3.7 5.8 2.9 2.3 4.7 2.2 3.0 0.1 1.5 0.6 1.5 2.3 3.7 4.3 7.0 10.1 2.0 0.1 7.6 0.5 0.7 0.1 6.3 6.0 1.8 6.6 0.0 2.6 1.6 3.1 13.5 6.4 0.2 17.6 3.4 0.7 13.5 10.5 5.4 14.0 6.6 0.0 0.0 0.0 2.8 0.0 2.6 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell line enhanced" "Detected in many" "HAP1: 10.3" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavourable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favourable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.2 0.5 4.7 2.8 0.0 1.3 3.0 2.2 2.6 0.8 0.1 0.2 2.0 2.8 0.7 10.3 0.0 1.9 0.6 1.0 0.5 8.4 0.3 6.8 0.5 0.1 6.6 0.0 3.3 4.7 3.5 0.0 5.7 3.2 4.2 0.0 0.0 6.3 3.6 0.1 2.5 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 1.1 0.1 6.5 3.6 5.2 2.3 1.1 0.2 0.3 0.7 2.5 0.0 2.0 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294530-99307405 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.7" "Group enriched" "Detected in some" 47 "HDLM-2: 52.5;HL-60: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028847, CAB033690" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "CAB033690: AB_2114269, HPA028847: AB_10603672" "unprognostic (3.28e-3)" "prognostic favourable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 27.0 5.5 3.1 33.8 5.0 40.8 7.6 1.1 2.9 5.9 11.2 7.5 4.5 3.2 3.8 9.2 9.3 6.4 17.3 11.7 4.8 6.1 5.4 7.2 26.5 53.7 7.5 2.6 4.4 2.1 2.1 4.8 11.1 9.3 7.4 9.2 4.8 6.6 2.0 4.1 5.3 19.2 9.0 31.3 46.5 6.0 3.7 7.4 13.2 6.5 8.3 38.9 34.9 5.2 46.8 30.6 101.7 1.2 55.0 60.2 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 52.5 0.0 0.4 0.1 0.0 0.0 35.9 0.1 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 101.7 1.2 46.1 5.7 0.4 34.0 46.8 60.2 30.9 9.3 19.1 38.1 5.2 1.2 55.0 0.4 30.6 47.3 27.8 3.1 5.0 1.1 2.9 4.8 6.1 7.5 2.6 9.3 7.4 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356500-141367267 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "EFO-21: 6.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 3.7;non-classical monocyte: 5.4" "Lineage enriched" "Detected in single" 14 "monocytes: 5.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA071337 Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 2.8 0.5 0.7 2.7 1.4 0.1 2.5 0.2 2.0 10.6 9.1 1.0 4.3 2.2 6.7 1.9 3.4 3.9 6.1 2.1 0.8 0.4 1.1 0.4 3.5 0.3 1.4 0.9 3.7 0.5 0.5 0.5 3.2 2.1 2.2 1.0 1.1 0.5 3.0 2.1 1.0 10.5 4.5 0.5 0.8 4.3 1.6 0.7 0.0 1.4 1.5 0.5 1.7 3.4 0.0 0.3 0.3 5.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.1 0.7 1.4 0.2 2.0 0.8 0.4 1.4 0.9 2.1 0.7 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell line enhanced" "Detected in some" "EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favourable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favourable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 12.8 0.0 0.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 12.2 0.7 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 10.5 0.8 0.2 21.1 0.0 0.0 0.0 0.0 10.1 5.7 2.2 8.0 2.8 0.0 0.0 7.4 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.1;U-937: 1.4" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.3 0.5 0.1 1.1 0.0 0.3 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.4 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 21.9;hTCEpi: 9.7;SK-BR-3: 8.5;TIME: 15.3" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" 48000 "Nuclear membrane, Cytosol" "HPA042903: , HPA068009: " "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favourable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 21.9 0.2 2.7 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.7 0.0 0.1 4.5 0.0 4.3 0.0 0.5 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Cell line enriched" "Detected in some" 8 "HEK 293: 10.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in single" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA049862: , HPA054678: " "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 GPR63 "PSP24(beta), PSP24B" ENSG00000112218 "G protein-coupled receptor 63" Q9BZJ6 6 96794126-96837463 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.8;HHSteC: 12.7;Karpas-707: 19.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039103 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039103: AB_10672841" "unprognostic (8.22e-2)" "unprognostic (2.77e-1)" "unprognostic (1.71e-2)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (1.33e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (3.39e-1)" "unprognostic (2.53e-2)" "unprognostic (7.29e-3)" "unprognostic (3.00e-1)" "unprognostic (2.03e-3)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-2)" 1.8 3.4 3.8 3.1 11.0 0.8 1.6 7.5 10.7 3.3 3.9 1.6 1.0 5.1 1.9 1.5 2.0 2.8 2.7 1.9 3.2 2.2 1.4 0.5 1.4 0.9 2.2 6.4 4.0 5.0 3.9 4.3 2.5 10.1 3.3 6.2 2.5 1.7 2.2 1.0 1.7 3.6 3.6 1.4 1.3 4.1 8.0 5.2 2.5 2.3 0.0 0.9 2.2 4.8 0.8 0.9 2.6 0.6 1.4 1.1 0.1 0.0 0.1 1.5 0.3 2.1 0.8 0.4 0.9 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.1 1.1 4.9 2.2 0.0 7.8 3.7 4.6 0.4 0.0 12.7 2.9 0.5 2.4 0.4 0.0 3.4 0.0 3.3 19.0 0.4 0.4 2.2 0.0 4.9 0.7 0.0 1.7 3.8 0.3 0.2 2.2 1.4 0.3 3.0 0.5 1.2 0.6 0.0 1.3 1.9 0.2 1.7 1.5 0.8 0.1 0.8 1.8 1.0 0.8 0.6 0.2 0.6 0.2 0.3 0.7 1.1 0.6 0.1 0.8 1.0 0.9 2.6 1.4 0.2 0.9 0.3 0.1 3.8 11.0 7.5 10.7 3.2 2.2 2.2 6.4 10.1 5.2 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell line enhanced" "Detected in some" "Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.3 7.9 10.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell line enhanced" "Detected in some" "A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: " "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 11.3 0.0 0.0 0.0 24.6 0.0 32.8 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 43.8 0.0 18.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.7 0.0 0.0 0.0 1.1 12.9 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favourable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavourable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.4 5.0 13.5 10.4 4.3 5.1 1.0 7.7 6.9 6.6 12.9 1.7 2.3 0.0 2.6 7.9 1.8 16.1 4.1 8.4 0.0 6.2 0.7 1.5 0.4 3.1 1.2 1.0 5.3 4.4 7.3 0.3 4.7 1.9 0.5 7.9 2.3 3.5 0.5 6.7 7.0 4.7 2.2 0.0 4.1 1.8 3.0 9.3 7.7 1.5 1.0 4.3 2.6 4.1 4.7 9.9 9.5 7.3 0.2 0.3 0.0 6.3 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell line enhanced" "Detected in many" "A-431: 41.8;CAPAN-2: 161.0;HaCaT: 42.2;SiHa: 59.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: " "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavourable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavourable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 41.8 33.5 0.0 0.1 0.4 0.2 2.1 12.6 4.8 8.2 6.3 5.8 161.0 0.0 1.0 10.0 42.2 0.1 6.1 12.6 0.0 0.5 0.0 13.8 0.2 3.0 0.0 0.0 0.2 8.2 3.4 0.8 5.0 0.0 0.0 0.3 29.3 0.0 0.0 0.1 5.2 0.0 0.9 0.0 16.3 8.3 0.0 0.0 59.2 4.5 1.9 1.3 0.1 0.5 0.3 10.7 19.2 0.5 0.0 0.0 0.0 4.3 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell line enhanced" "Detected in many" "Hep G2: 23.9;HMC-1: 42.1;RPTEC TERT1: 56.7;RT4: 26.2;T-47d: 31.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favourable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.6 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 21.4 0.0 13.2 0.1 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 23.9 4.9 0.0 42.1 0.4 7.6 0.0 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 19.4 0.0 0.0 1.0 56.7 26.2 8.0 0.7 0.8 1.8 0.0 31.9 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.0 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.3;SCLC-21H: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA036478: , HPA070892: " "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavourable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 4.9 7.1 1.1 2.4 4.2 4.9 2.5 3.8 4.9 4.7 2.4 8.3 10.0 2.6 3.2 3.1 3.4 3.3 27.3 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.1 2.6 4.1 0.6 2.7 4.3 12.1 3.1 9.5 0.8 0.0 5.0 7.7 15.4 5.5 4.9 4.3 3.8 30.3 17.4 5.6 1.6 8.5 3.7 3.1 3.3 7.1 8.2 2.7 7.1 0.2 1.0 2.3 6.1 0.4 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell line enhanced" "Detected in some" "Karpas-707: 46.0;RPMI-8226: 11.8;SCLC-21H: 12.3;U-266/70: 7.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043148: , HPA057666: , HPA059092: " "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favourable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favourable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 11.8 0.1 0.0 12.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 5.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 GPS1 "COPS1, CSN1" ENSG00000169727 "G protein pathway suppressor 1" Q13098 17 82050691-82057470 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047448, HPA052848" Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA047448: , HPA052848: " "unprognostic (1.96e-1)" "unprognostic (5.89e-2)" "unprognostic (1.50e-1)" "unprognostic (9.65e-2)" "unprognostic (3.41e-1)" "unprognostic (2.19e-1)" "unprognostic (4.75e-3)" "unprognostic (2.18e-2)" "unprognostic (3.17e-1)" "prognostic favourable (3.06e-4)" "unprognostic (1.18e-3)" "unprognostic (1.92e-1)" "unprognostic (4.96e-3)" "unprognostic (4.07e-1)" "unprognostic (8.90e-2)" "unprognostic (1.45e-1)" "unprognostic (2.15e-1)" 23.5 23.9 27.2 19.3 28.2 23.6 18.8 27.7 47.2 20.5 18.7 33.3 19.8 22.4 21.5 21.1 22.2 24.5 19.2 33.4 28.7 26.7 29.6 39.9 17.2 21.6 28.7 25.9 25.3 34.4 23.2 22.3 20.8 28.0 23.2 12.0 25.1 37.1 28.9 67.1 26.5 19.7 16.8 23.7 20.7 21.9 36.0 18.2 32.3 25.3 29.8 20.6 19.5 17.0 26.1 37.3 25.2 34.5 29.7 44.0 36.0 26.7 50.1 18.7 24.3 13.2 12.8 26.4 18.0 14.5 28.7 23.8 43.8 16.7 13.3 16.2 18.0 20.4 17.7 23.1 9.8 8.8 63.3 22.4 28.1 48.5 21.9 24.4 21.8 18.2 16.9 25.3 15.1 29.8 21.0 15.4 15.8 52.9 41.6 27.7 23.7 37.5 25.6 25.6 21.5 17.6 27.9 32.0 50.2 18.3 34.0 26.6 38.5 22.1 16.9 28.7 34.0 22.1 28.9 28.3 11.8 14.0 22.4 15.8 25.7 19.6 34.5 25.2 33.0 31.7 34.5 26.1 34.8 33.0 37.3 24.5 25.0 31.2 5.4 29.7 28.6 25.7 44.0 36.0 27.2 28.2 27.7 47.2 28.7 26.7 28.7 25.9 28.0 18.2 GPSM1 "AGS3, DKFZP727I051" ENSG00000160360 "G protein signaling modulator 1" Q86YR5 9 136327476-136359605 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042199, HPA060736" Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA042199: AB_10959329, HPA060736: " "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.07e-3)" "unprognostic (3.44e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-2)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (5.96e-3)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (4.66e-2)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.48e-2)" 7.8 10.2 15.2 5.6 8.3 5.6 4.2 38.6 23.0 10.5 5.3 12.8 4.8 4.7 13.4 10.1 2.6 7.1 8.3 25.5 8.8 11.6 5.5 1.8 13.8 3.2 8.8 14.2 16.4 28.1 4.4 6.6 8.8 10.5 12.7 2.2 20.4 7.7 8.6 2.8 12.0 4.6 9.0 9.1 8.0 6.1 12.0 9.9 2.8 3.9 3.7 2.0 5.0 8.2 0.4 0.7 0.0 2.0 0.0 2.1 0.3 1.6 2.7 6.6 11.5 3.8 6.6 5.5 19.0 7.9 5.4 2.9 5.5 1.8 0.0 8.0 11.5 1.2 1.0 3.9 1.2 14.9 11.2 2.2 8.9 1.0 16.2 0.1 2.8 10.7 2.6 4.9 2.8 5.4 5.7 0.1 3.5 6.2 1.0 2.1 6.9 10.0 35.4 11.8 5.5 1.4 1.2 16.1 20.0 3.5 0.4 5.9 8.0 3.8 8.7 10.0 8.0 11.6 3.8 3.4 0.1 0.0 6.0 0.0 9.4 0.0 0.3 0.0 0.7 2.0 0.8 0.0 1.2 0.1 0.7 0.4 0.5 0.3 0.0 0.0 0.0 0.0 2.1 0.3 15.2 8.3 38.6 18.8 8.8 11.6 8.8 14.2 10.5 9.9 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 126.9;liver: 195.2" "Group enriched" "Detected in some" 20 "A549: 120.7;HaCaT: 33.4;Hep G2: 112.0;RT4: 79.8;SCLC-21H: 36.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.4" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Low region specificity" "Detected in single" HPA003545 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavourable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 0.1 0.0 0.1 23.8 0.2 0.0 0.8 0.2 0.1 5.5 50.4 0.5 2.0 14.4 0.3 1.0 53.0 0.6 126.9 0.2 0.1 0.2 29.4 195.2 2.0 0.1 0.1 0.1 0.9 7.0 0.0 0.2 0.1 0.2 16.8 71.6 0.1 59.7 4.1 0.3 3.9 35.4 5.6 0.2 0.1 57.8 0.4 0.1 0.5 0.2 44.0 7.4 56.3 15.0 0.2 0.0 0.5 0.8 2.4 0.1 0.0 0.0 120.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.0 0.0 0.7 0.0 33.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 112.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 79.8 36.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" 220000 "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: , HPA058546: " "unprognostic (8.42e-3)" "prognostic favourable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favourable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favourable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favourable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 163.0 76.4 63.3 27.1 73.7 33.3 102.3 33.5 83.7 53.3 49.1 42.4 33.8 56.9 27.2 74.7 35.6 38.4 46.9 64.4 54.2 60.2 75.3 119.0 44.7 41.7 74.6 47.3 47.1 35.1 33.1 54.7 46.4 49.3 44.7 25.5 82.3 61.6 46.9 98.2 36.3 58.5 43.6 46.5 32.4 27.7 170.4 36.5 29.9 52.8 49.8 39.2 51.2 47.0 56.7 64.0 85.2 85.2 28.4 58.5 110.5 28.3 32.3 46.7 98.7 141.7 84.0 52.0 22.5 81.3 42.9 43.8 65.9 38.5 10.3 24.6 45.5 32.0 27.3 32.6 21.0 57.6 49.3 19.4 29.0 92.9 82.4 22.7 31.1 83.3 49.7 21.7 36.6 60.0 27.1 25.9 35.4 72.9 38.4 39.0 44.2 52.1 53.3 6.3 29.7 46.6 70.6 40.3 25.5 44.1 41.9 45.8 40.9 55.6 50.8 45.7 30.4 78.3 28.2 91.1 61.7 24.0 43.0 45.6 26.2 75.6 85.2 85.2 37.0 62.0 43.0 56.7 54.3 38.6 64.0 47.8 58.5 41.7 42.4 28.4 68.3 44.1 46.8 110.5 63.3 73.7 33.5 83.7 54.2 60.2 74.6 47.3 49.3 36.5 GPX8 "EPLA847, UNQ847" ENSG00000164294 "Glutathione peroxidase 8 (putative)" Q8TED1 5 55160118-55167071 "Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 51.7;fHDF/TERT166: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA036720 Enhanced Supported "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA036720: " "unprognostic (4.85e-2)" "unprognostic (1.23e-2)" "unprognostic (6.53e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-2)" "unprognostic (9.74e-3)" "unprognostic (1.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.07e-2)" "unprognostic (4.34e-2)" "unprognostic (4.31e-2)" "unprognostic (8.68e-2)" "prognostic unfavourable (5.13e-9)" "prognostic unfavourable (7.96e-4)" "unprognostic (8.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.63e-2)" 12.6 7.1 0.8 5.8 1.0 0.0 12.2 0.5 0.7 31.4 6.8 1.7 17.3 1.3 23.6 34.5 13.3 13.2 11.2 12.1 1.0 0.9 13.7 2.6 7.3 5.6 1.1 0.9 31.5 5.0 4.5 3.2 40.9 4.0 24.2 4.7 17.8 7.3 16.7 5.0 5.1 4.4 14.1 3.3 7.5 4.9 10.2 0.5 0.7 28.4 11.0 5.4 15.8 19.7 1.0 0.7 2.4 0.5 0.6 0.9 0.2 6.9 5.9 12.7 12.4 33.7 38.4 7.0 35.6 51.7 20.0 40.1 0.6 15.9 0.0 38.0 48.4 6.0 7.6 10.3 27.5 0.0 3.2 0.3 10.4 1.2 10.7 0.0 0.0 27.1 10.3 12.2 6.4 23.3 0.2 0.0 22.7 2.2 0.0 0.0 5.8 8.2 0.0 7.3 0.0 12.3 0.2 0.0 0.3 12.0 0.8 12.6 11.4 0.7 20.9 10.7 11.8 15.9 19.1 0.0 0.0 0.0 17.0 0.0 23.2 1.4 0.5 0.3 0.5 0.3 0.5 0.6 0.5 0.5 0.2 1.0 0.9 0.9 2.4 0.6 0.3 0.7 0.2 0.2 0.8 1.0 0.5 0.7 1.0 0.9 1.1 0.9 4.0 0.5 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavourable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 15.6 19.1 14.6 21.4 14.0 17.1 19.4 13.8 18.1 16.8 13.2 10.4 17.4 13.0 16.9 12.9 7.8 17.2 13.8 17.2 15.9 12.0 13.3 11.0 27.5 42.0 13.7 12.2 21.8 44.1 11.5 14.9 14.1 16.6 15.6 7.5 11.5 45.3 17.2 35.7 6.8 10.9 21.3 12.8 21.1 16.1 11.7 12.1 17.9 12.7 11.5 12.1 17.3 21.4 1.1 4.1 13.1 14.9 3.8 5.5 2.5 5.4 42.3 8.3 16.4 9.7 11.1 6.9 6.6 10.9 8.9 8.8 16.0 4.7 3.1 13.2 9.9 3.6 8.6 13.0 3.4 13.1 15.0 9.1 10.5 14.7 19.5 6.4 14.5 19.6 8.1 6.3 10.8 28.8 9.9 2.1 6.1 5.2 14.6 7.9 13.0 4.7 13.9 2.6 3.8 9.5 1.0 12.5 25.2 6.7 5.1 10.9 7.7 7.1 15.6 14.3 7.4 2.9 9.4 2.3 7.8 7.5 9.4 7.1 10.5 13.1 4.5 3.6 2.9 7.3 5.5 0.5 3.9 2.1 4.1 1.1 2.9 4.2 9.8 3.8 14.9 1.4 3.1 2.5 14.6 14.0 13.8 18.1 15.9 12.0 13.7 12.2 16.6 12.1 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favourable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 11.2 0.0 0.2 1.1 0.4 1.6 0.2 0.3 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Group enriched" "Detected in some" 12 "BEWO: 58.1;SK-BR-3: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 26.5 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.8;CAPAN-2: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.1 1.2 1.0 4.7 21.3 7.4 6.4 22.1 38.8 10.5 14.3 1.0 26.0 0.0 9.5 24.8 5.4 0.3 8.9 11.2 1.8 1.5 1.0 2.4 1.3 5.0 0.0 0.7 12.4 4.0 9.6 3.2 0.0 0.0 0.0 18.2 2.1 0.0 0.3 1.1 1.5 0.4 6.3 5.0 14.1 23.4 0.4 0.0 4.0 2.3 6.9 8.0 1.3 1.8 2.1 0.7 3.8 4.1 1.4 1.1 0.0 0.4 0.0 6.3 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Cell line enhanced" "Detected in some" "HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 18.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 47.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 GRASP Tamalin ENSG00000161835 "General receptor for phosphoinositides 1 associated scaffold protein" Q7Z6J2 12 52006940-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 20.1;TIME: 14.5;WM-115: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "amygdala: 31.9;basal ganglia: 22.2;cerebral cortex: 27.5;hippocampal formation: 25.8;olfactory region: 21.0" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: " "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 29.3 5.1 6.4 9.9 16.4 28.6 17.3 2.1 21.0 17.8 7.3 6.3 5.2 3.8 16.2 7.8 6.8 14.5 17.2 10.8 5.2 3.9 8.7 6.9 38.1 6.3 5.3 9.1 12.1 8.4 3.5 4.5 13.0 8.0 8.9 4.0 14.7 4.7 12.8 16.3 7.1 6.8 9.9 4.5 16.9 6.0 2.8 4.5 3.5 11.3 13.5 6.6 9.0 26.3 0.3 0.8 0.0 0.1 0.1 1.2 0.0 0.0 0.0 2.6 0.1 1.2 2.1 0.6 0.1 0.7 0.0 0.7 0.0 0.0 0.0 5.7 0.0 0.1 0.8 0.0 0.2 0.1 0.7 0.2 0.0 3.6 4.5 0.2 2.0 4.4 0.0 0.2 0.0 20.1 0.9 0.0 0.5 0.1 1.8 4.9 2.3 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.1 3.4 0.0 0.2 14.5 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.4 0.0 26.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.3 0.8 0.1 0.2 0.2 0.0 0.1 0.1 0.8 1.2 0.0 6.4 16.4 2.1 20.9 5.2 3.9 5.3 9.1 8.0 4.5 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492812-164621848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 17.7" "Cell line enhanced" "Detected in some" "A549: 5.5;HUVEC TERT2: 10.5;RPTEC TERT1: 8.7;TIME: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: " "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 1.6 2.9 1.0 1.2 1.5 0.0 6.0 0.7 3.6 0.8 1.2 0.0 1.1 1.2 0.6 7.5 1.7 0.5 0.3 10.8 5.7 1.1 8.3 17.7 0.7 0.1 0.9 2.0 2.4 6.0 0.0 1.8 2.2 1.4 0.8 0.4 1.2 1.0 0.5 3.2 0.5 0.8 0.6 0.6 0.6 1.1 3.1 0.4 0.0 5.5 3.0 0.1 0.6 1.1 0.0 0.0 0.4 0.1 0.0 0.0 3.0 0.9 5.5 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.6 0.0 3.4 0.0 0.4 0.9 1.6 0.3 0.0 4.8 0.0 0.3 1.3 0.1 0.0 0.0 0.4 1.0 2.0 0.0 10.5 0.0 0.1 1.7 2.2 0.0 0.0 2.1 1.4 0.0 0.0 0.1 8.7 0.4 3.3 0.4 0.0 0.3 0.0 0.6 0.0 13.2 0.2 1.4 0.0 0.1 0.5 0.1 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 1.0 1.5 0.7 3.6 5.7 1.1 0.9 2.0 1.4 0.4 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 89.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 7.4" "Cell type enriched" "Detected in single" 20 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Region enhanced" "Detected in some" "cerebellum: 9.3" "Low region specificity" "Detected in all" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: " "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavourable (3.10e-4)" "prognostic unfavourable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favourable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 2.9 0.1 0.1 2.8 0.6 0.0 16.1 7.4 1.2 6.7 12.7 0.3 25.0 6.7 2.6 8.1 53.9 14.5 16.3 0.8 0.2 0.1 23.4 5.2 12.3 0.1 0.1 0.4 3.1 20.5 5.8 3.7 42.6 1.6 10.2 6.4 0.7 14.0 25.5 0.5 19.1 12.4 2.0 0.1 0.3 7.2 2.3 0.3 0.5 8.5 6.5 17.2 7.2 11.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 10.4 5.9 0.0 0.9 0.1 5.6 0.0 3.9 0.0 0.0 0.5 0.0 1.3 9.0 0.0 0.0 0.0 0.0 3.4 0.0 0.9 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.2 0.8 0.0 0.0 4.1 4.6 3.3 2.3 0.0 4.5 89.5 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 7.4 1.2 0.2 0.1 0.1 0.4 1.6 0.3 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell line enhanced" "Detected in some" "AF22: 14.8;Hep G2: 14.0;MCF7: 21.9;SH-SY5Y: 14.9;T-47d: 50.6" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favourable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.3 14.8 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 0.1 1.1 0.0 0.0 1.7 1.3 0.0 0.1 14.0 0.1 0.1 0.7 0.2 0.8 0.2 0.1 0.0 0.1 0.3 0.1 21.9 0.4 0.7 4.8 0.0 10.2 0.0 0.6 0.0 0.0 4.3 14.9 0.3 0.4 10.9 50.6 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.6 2.5 4.2 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Group enriched" "Detected in some" 4 "BEWO: 64.8;SK-BR-3: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.1 0.0 0.3 0.9 0.1 0.1 64.8 0.3 0.4 0.2 0.3 0.2 2.2 0.4 0.1 0.0 1.9 3.9 0.4 0.9 0.9 1.7 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.8 0.0 0.3 0.6 1.2 0.0 4.1 0.6 0.5 0.2 0.7 0.2 0.3 0.5 0.4 12.3 0.7 0.5 0.6 34.1 0.7 4.1 0.1 0.3 0.2 0.8 1.0 0.3 0.8 0.4 0.4 0.1 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022971 Uncertain Approved Nucleoplasm,Cytosol 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975" "prognostic favourable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favourable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.3 45.2 25.6 23.4 23.6 26.2 26.0 25.1 33.3 34.2 37.2 17.1 13.6 30.1 14.8 29.4 14.2 14.7 32.7 20.5 40.2 18.4 17.6 42.1 30.3 37.3 16.7 18.3 31.3 28.7 19.8 25.5 29.6 32.2 12.4 30.0 24.0 16.3 17.2 15.6 19.7 16.1 18.8 16.7 45.6 17.8 10.7 19.2 21.6 41.2 23.4 23.2 21.6 32.2 18.8 30.2 13.0 21.6 9.8 7.6 20.1 26.7 9.6 27.5 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in some" "HEL: 9.1;NTERA-2: 9.0;REH: 24.8;SCLC-21H: 7.1;SH-SY5Y: 15.8" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA074001: " "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favourable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavourable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 9.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 9.0 0.0 24.8 0.0 0.1 4.1 0.0 7.1 15.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.6 24.8 12.7 21.5 67.7 34.2 18.8 18.1 42.9 30.9 28.6 15.0 10.6 9.1 20.0 40.8 11.4 22.6 26.8 12.7 12.9 15.5 9.4 14.4 17.8 71.7 1.9 15.2 44.0 74.2 22.4 32.7 14.9 8.8 12.8 26.5 76.4 5.3 5.1 8.9 37.5 7.2 6.4 17.5 15.8 35.9 8.6 14.0 26.4 29.7 35.2 57.1 12.5 15.0 19.6 21.5 26.1 13.1 20.8 11.9 6.8 24.8 12.5 11.1 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 GRIPAP1 "DKFZp434P0630, GRASP-1, GRASP1, KIAA1167, MPMGp800B12492Q3" ENSG00000068400 "GRIP1 associated protein 1" Q4V328 X 48973720-49002264 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000282, HPA000615" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA000282: AB_1079022, HPA000615: AB_1079023" "unprognostic (3.34e-1)" "unprognostic (2.86e-3)" "unprognostic (3.24e-3)" "unprognostic (3.93e-3)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" "unprognostic (3.97e-3)" "unprognostic (1.01e-2)" "unprognostic (5.26e-2)" "unprognostic (3.65e-1)" "unprognostic (1.69e-3)" "unprognostic (1.06e-2)" "prognostic unfavourable (3.92e-7)" "unprognostic (4.24e-3)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "prognostic favourable (4.63e-7)" 7.3 10.1 12.4 10.0 19.5 14.0 7.1 24.8 20.6 7.3 7.3 7.4 6.8 8.3 7.5 12.0 7.0 9.9 6.4 7.8 9.4 8.6 6.6 8.5 9.0 10.5 9.7 20.8 8.8 7.7 11.7 12.9 7.0 12.9 7.5 6.9 8.7 7.7 7.4 7.0 10.9 11.1 7.0 10.7 13.1 8.5 8.0 9.0 7.4 8.6 3.2 10.6 7.5 8.6 11.5 10.0 21.2 12.2 12.9 9.1 7.0 12.7 20.3 14.6 30.5 8.8 6.8 13.1 10.4 13.0 13.5 12.9 11.0 11.2 19.3 6.0 10.3 18.3 18.1 11.4 10.9 22.5 9.2 15.5 25.8 11.5 15.2 16.6 27.9 7.0 16.5 18.0 13.4 12.3 11.3 25.5 12.4 23.5 14.4 22.4 17.2 11.1 16.1 22.0 15.4 13.5 15.8 12.9 14.4 22.1 8.9 13.0 20.2 33.4 14.5 7.1 11.3 14.6 8.5 15.5 12.1 13.5 12.5 25.3 12.2 18.8 12.2 16.9 8.9 10.9 7.5 9.4 9.1 8.4 9.8 11.5 8.0 8.3 21.2 12.9 9.9 10.0 7.2 7.0 12.4 19.5 24.8 16.8 9.4 8.6 9.7 20.8 12.9 9.0 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell line enhanced" "Detected in many" "HDLM-2: 22.6;SH-SY5Y: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favourable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 2.1 6.5 2.1 4.5 0.6 9.4 0.7 2.0 2.0 3.5 3.4 3.7 11.8 0.2 0.1 0.1 6.4 4.8 6.1 22.6 4.2 5.4 0.7 7.4 0.2 17.5 9.2 1.1 3.3 1.4 2.5 0.3 0.5 0.0 2.4 2.9 12.5 1.2 4.6 0.0 5.6 10.3 2.0 0.0 3.5 15.1 20.5 1.1 0.0 4.9 1.8 7.0 0.2 0.0 13.3 0.1 2.5 1.4 4.6 9.2 8.7 6.2 2.0 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 GRK5 GPRK5 ENSG00000198873 "G protein-coupled receptor kinase 5" P34947 10 119207589-119459742 "Enzymes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 36.5;HUVEC TERT2: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025579, HPA046838" Approved Supported "Nuclear membrane,Nuclear speckles,Plasma membrane" "Nuclear membrane, Nuclear speckles" "Plasma membrane" "CAB025579: , HPA046838: " "unprognostic (1.09e-1)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.02e-2)" "unprognostic (6.56e-2)" "unprognostic (3.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.69e-1)" "unprognostic (4.11e-1)" "unprognostic (1.06e-1)" "unprognostic (3.70e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (2.38e-7)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" 15.9 8.3 3.4 16.8 7.8 2.7 10.2 6.5 5.0 12.5 18.8 3.9 4.5 12.4 13.4 12.2 8.1 7.7 19.5 45.4 4.2 4.2 4.3 5.7 27.6 8.8 3.7 2.5 16.5 3.5 26.2 6.3 24.0 4.5 7.5 6.4 5.6 5.0 6.7 12.8 4.7 10.4 10.8 4.8 17.0 13.9 3.5 4.7 9.8 8.9 10.7 8.6 9.5 13.6 9.3 2.2 6.5 3.7 0.2 11.3 4.2 4.0 2.3 6.0 6.1 13.8 13.3 1.8 7.8 36.5 4.9 2.7 1.9 5.9 4.3 1.8 12.2 1.0 2.6 8.6 3.2 17.1 2.1 0.7 5.0 7.7 9.5 0.2 2.2 1.8 1.3 9.8 1.4 28.8 0.4 4.2 1.7 0.6 4.0 3.9 0.9 6.0 1.4 0.8 1.0 0.8 1.6 2.0 5.5 2.7 1.2 7.5 0.1 1.0 8.7 2.6 1.9 15.8 3.0 0.9 4.6 2.6 5.5 4.8 2.5 0.9 3.7 6.5 5.3 3.2 0.4 9.3 7.7 3.8 2.2 9.1 11.3 5.0 5.0 0.2 0.9 0.0 9.2 4.2 3.4 7.8 6.5 5.0 4.2 4.2 3.7 2.5 4.5 4.7 GRN "CLN11, PCDGF, PGRN" ENSG00000030582 "Granulin precursor" P28799 17 44345086-44353102 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 138.4;intermediate monocyte: 80.4;myeloid DC: 109.8;neutrophil: 61.8;non-classical monocyte: 36.4;plasmacytoid DC: 95.5" "Group enriched" "Detected in all" 8 "dendritic cells: 109.8;granulocytes: 61.8;monocytes: 138.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008763, CAB019394, HPA028747" Uncertain Enhanced "Endoplasmic reticulum,Endosomes,Lysosomes" "Secreted to blood" 91000000 "Endoplasmic reticulum, Endosomes, Lysosomes" "CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "unprognostic (8.38e-3)" "unprognostic (2.82e-1)" "prognostic unfavourable (8.78e-4)" "unprognostic (7.41e-2)" "unprognostic (3.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-1)" "unprognostic (6.34e-2)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" 66.8 27.1 8.2 31.2 10.2 76.4 30.1 5.2 13.9 29.1 45.0 16.6 46.2 23.2 29.8 76.5 104.7 18.8 51.4 46.9 7.8 9.5 39.3 43.2 74.9 81.1 10.5 9.3 20.7 21.6 11.6 18.0 116.4 11.4 28.7 25.1 23.8 54.5 42.1 15.2 37.3 42.9 21.1 13.4 76.3 25.6 21.0 9.7 23.5 31.4 46.3 52.1 34.8 38.5 13.0 109.8 61.8 138.4 2.1 3.8 83.8 17.2 28.2 8.6 23.2 70.5 37.1 26.4 21.2 67.6 35.0 46.5 12.2 42.6 51.1 45.5 34.2 26.9 12.3 49.5 15.8 8.4 26.6 5.4 14.8 25.7 35.8 8.8 72.0 49.1 65.7 29.1 19.2 39.8 10.4 7.7 23.7 25.6 5.0 25.4 6.5 47.7 14.3 26.9 60.1 39.1 20.6 8.2 10.9 28.4 13.4 52.3 30.6 33.4 47.7 65.6 15.8 44.8 14.6 17.0 46.4 17.4 39.6 20.9 18.1 12.5 138.4 11.9 2.7 80.4 2.1 13.0 2.9 2.4 109.8 8.2 2.2 2.1 61.8 2.1 36.4 95.5 3.8 83.8 8.2 10.2 5.2 13.9 7.8 9.5 10.5 9.3 11.4 9.7 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445773-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavourable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.9 15.5 9.2 15.7 11.1 14.8 15.5 12.9 14.1 13.6 14.1 10.4 11.9 15.6 18.7 12.8 20.0 15.0 16.2 16.9 7.8 8.6 13.0 26.3 12.5 17.5 11.0 10.3 19.3 35.5 16.5 10.3 14.7 9.5 13.8 8.0 12.0 18.6 14.4 29.1 18.3 11.5 13.3 8.2 19.4 14.7 13.1 10.9 18.6 17.3 19.0 17.3 14.1 18.0 21.1 18.4 1.4 17.8 17.4 22.6 16.5 16.8 44.7 7.6 14.3 6.2 6.2 6.5 13.2 6.3 19.1 15.9 25.1 12.5 24.1 11.5 8.2 14.4 18.9 20.4 7.5 18.1 25.6 22.0 15.2 17.8 7.2 20.7 14.1 7.4 11.3 18.0 9.1 9.4 30.7 15.2 7.9 17.5 21.8 52.1 20.7 13.1 27.1 8.6 17.3 7.9 20.9 17.2 9.5 14.9 21.1 6.6 10.4 10.5 10.0 17.8 15.0 7.8 31.3 15.5 35.5 22.6 5.9 18.7 20.6 0.1 11.0 1.4 19.6 17.8 22.6 21.1 18.1 19.5 18.4 20.4 21.3 19.7 0.8 17.4 13.5 13.6 15.6 16.5 9.2 11.1 12.9 14.1 7.8 8.6 11.0 10.3 9.5 10.9 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977766 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 35.7;tongue: 19.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.1;hTCEpi: 4.9;hTERT-HME1: 9.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 5.6" "Not detected" "Not detected" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" 7100 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 2.1 0.4 0.2 0.4 0.1 0.0 2.2 0.1 0.1 1.1 0.6 0.0 0.0 0.1 0.4 8.6 1.9 0.3 0.3 2.0 0.2 0.2 0.4 0.2 0.7 8.5 0.2 0.7 0.2 0.2 1.0 0.9 0.9 0.1 0.2 0.6 0.0 0.6 0.0 0.9 35.7 0.3 0.5 0.2 0.3 0.2 0.9 0.0 0.8 0.2 19.4 7.8 0.8 1.1 0.6 0.5 1.9 0.4 0.6 5.6 1.0 0.4 0.1 0.0 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.0 7.1 0.0 0.1 0.5 0.9 0.6 0.4 0.0 0.3 1.6 0.0 4.9 0.8 9.6 0.0 0.2 2.3 0.0 1.0 0.0 0.2 0.1 0.1 0.6 0.0 0.8 0.2 0.6 0.0 0.2 0.2 0.3 0.0 0.5 0.1 0.1 0.3 0.7 0.1 0.1 0.3 0.1 0.6 0.4 0.1 0.0 1.7 0.4 0.4 4.8 0.2 5.6 0.3 3.1 1.8 0.2 0.6 1.6 2.5 1.9 0.6 0.3 0.5 1.1 1.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.7 0.1 0.0 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.3" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.8" "Low lineage specificity" "Detected in many" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: " "unprognostic (5.78e-2)" "prognostic favourable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favourable (5.91e-9)" 4.0 0.0 1.3 13.3 2.0 1.3 2.8 4.8 1.7 2.1 33.1 1.4 2.0 25.2 1.3 1.7 1.3 1.3 14.4 1.3 1.3 0.6 2.2 17.1 2.4 3.5 1.3 1.3 2.0 2.8 0.0 1.3 1.8 1.3 3.5 22.4 1.3 1.3 2.7 1.3 2.8 71.3 3.9 1.3 4.7 18.1 1.4 1.5 1.6 2.9 1.3 2.8 4.1 4.5 0.8 0.0 1.8 0.0 0.1 2.8 0.4 0.4 0.3 0.6 0.1 1.5 0.9 0.5 0.3 0.2 0.1 0.4 0.3 12.0 0.6 0.5 0.3 1.6 0.3 0.3 0.8 2.4 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.6 2.0 0.5 0.7 0.2 0.2 0.7 0.1 0.1 0.6 1.3 0.1 0.4 0.6 0.1 0.9 0.0 0.3 0.2 0.3 0.1 100.5 0.3 0.5 0.3 0.3 0.4 0.6 1.1 0.2 2.2 1.8 0.5 0.1 0.4 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.8 2.8 1.4 0.0 0.0 2.6 0.6 0.7 0.1 0.0 0.0 0.4 0.4 1.3 2.0 4.8 1.7 1.3 0.6 1.3 1.3 1.3 1.5 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell line enhanced" "Detected in many" "BEWO: 42.8;K-562: 47.5;T-47d: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036365 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036365: AB_10601762" "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favourable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.4 8.1 5.4 13.5 3.5 3.2 42.8 6.1 4.2 3.4 1.2 6.9 6.2 2.6 7.3 6.9 4.2 8.5 2.3 1.7 4.9 7.2 19.4 7.6 8.5 4.5 8.9 11.1 5.9 5.6 3.6 1.7 0.9 47.5 0.4 1.1 30.2 32.0 7.9 9.4 2.4 21.1 1.8 6.8 3.1 1.7 35.2 24.4 12.0 22.5 1.1 48.9 22.4 1.5 7.0 8.8 1.9 1.6 7.4 4.4 15.6 4.0 5.6 6.1 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: , HPA046782: " "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.4 13.6 15.2 10.3 11.5 13.4 25.8 17.7 13.5 11.7 13.0 10.0 16.1 9.1 10.8 13.4 10.5 9.9 10.6 17.1 21.6 9.4 3.8 7.8 7.6 10.7 9.7 6.6 10.8 16.9 15.0 15.1 15.2 8.2 8.3 14.8 23.5 7.1 7.9 16.9 17.2 7.2 14.2 8.2 27.5 35.5 5.4 17.4 20.0 18.9 15.4 14.2 6.3 16.7 5.4 7.0 11.5 5.5 9.8 27.9 7.7 13.9 7.0 8.6 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol 150000 Cytosol Vesicles "HPA052488: , HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favourable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favourable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 28.5 36.5 27.0 31.2 25.0 30.1 52.5 18.1 33.9 21.7 25.8 18.5 23.3 15.6 20.8 23.1 42.8 18.7 20.1 35.6 22.4 15.3 26.2 46.0 31.3 38.1 26.4 21.6 20.8 48.2 40.9 18.5 23.1 24.1 24.3 29.1 12.6 26.4 30.8 74.1 25.3 20.5 25.6 27.4 26.3 28.1 30.6 23.2 34.8 27.7 24.8 37.0 23.9 30.1 8.8 7.8 7.9 12.0 7.3 11.4 4.6 45.1 44.8 25.0 34.4 36.2 37.7 36.2 50.3 52.3 40.5 40.5 31.9 42.0 61.3 66.1 43.5 34.8 63.3 46.5 68.3 29.3 32.8 41.8 36.4 67.3 30.5 52.9 22.4 29.4 36.7 45.7 62.9 44.7 67.4 31.8 46.9 43.5 44.6 27.5 49.9 25.6 52.9 43.2 71.6 40.0 39.7 40.4 21.6 72.2 54.9 29.4 47.6 25.5 34.4 45.1 28.4 32.6 39.5 31.7 46.8 53.5 31.7 54.0 27.3 1.5 6.5 7.9 7.6 12.0 10.6 8.8 9.8 9.0 7.8 6.4 9.9 9.5 2.2 7.3 10.1 4.3 11.4 4.6 27.0 25.0 18.1 33.9 22.4 15.3 26.4 21.6 24.1 23.2 GSR ENSG00000104687 "Glutathione-disulfide reductase" P00390 8 30678061-30727999 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001538, CAB008632" Approved Supported "Plasma membrane,Cytosol" 110000000 Cytosol "Plasma membrane" "CAB008632: AB_1616690, HPA001538: AB_1078986" "unprognostic (1.23e-1)" "prognostic favourable (3.37e-4)" "prognostic favourable (4.08e-5)" "unprognostic (2.89e-3)" "unprognostic (1.62e-1)" "unprognostic (3.50e-1)" "prognostic unfavourable (3.26e-5)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (4.15e-2)" "unprognostic (2.83e-2)" "unprognostic (6.92e-3)" "prognostic favourable (1.80e-4)" "unprognostic (2.31e-3)" "unprognostic (2.26e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 8.9 14.4 6.8 10.7 9.1 7.9 6.2 9.1 11.8 18.6 18.7 7.1 18.4 20.4 13.2 12.0 19.4 8.8 17.3 11.9 5.0 5.7 27.9 17.8 10.8 9.7 4.9 6.0 11.8 17.6 22.9 7.2 8.9 6.8 16.4 17.2 10.9 12.0 17.4 14.7 6.5 31.8 9.3 4.5 13.6 17.7 7.9 4.2 17.0 9.2 11.8 12.0 23.9 14.5 2.5 4.7 19.0 5.7 2.6 7.3 2.1 12.0 51.0 8.3 6.4 8.9 10.0 8.0 5.4 11.8 7.7 10.3 15.0 6.4 23.6 26.7 6.9 13.6 12.5 11.7 8.4 6.1 11.6 23.7 17.6 50.1 24.0 7.2 38.3 16.6 7.4 11.5 4.6 10.9 19.6 10.5 17.3 11.0 25.5 8.5 14.7 9.1 9.8 9.5 11.4 15.2 30.6 6.3 8.1 7.4 17.3 12.9 7.5 8.2 14.7 3.2 8.9 7.6 8.0 5.8 6.4 15.1 10.2 10.2 10.5 19.0 4.6 11.5 4.2 4.2 7.3 2.5 3.8 4.6 4.7 2.0 2.4 3.1 6.5 2.6 5.7 2.9 3.2 2.1 6.8 9.1 9.1 11.8 5.0 5.7 4.9 6.0 6.8 4.2 GSTM2 GST4 ENSG00000213366 "Glutathione S-transferase mu 2" P28161 1 109668022-109709551 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 41.0;HSkMC: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB040547, HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" 930000 Cytosol "Cytokinetic bridge" "CAB040547: , HPA055972: , HPA055973: " "unprognostic (2.51e-3)" "unprognostic (1.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.57e-2)" "unprognostic (2.20e-1)" "unprognostic (5.04e-2)" "unprognostic (7.31e-2)" "prognostic favourable (9.70e-5)" "unprognostic (1.51e-2)" "unprognostic (7.43e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-1)" "unprognostic (1.48e-3)" "unprognostic (1.07e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (2.14e-1)" 23.8 27.3 30.7 14.7 48.3 5.7 31.7 13.7 25.0 36.4 20.9 19.9 54.3 14.5 24.0 37.1 15.4 31.4 15.7 35.2 32.5 21.7 15.9 6.0 11.1 7.5 17.0 21.1 90.1 17.8 20.4 40.2 5.8 22.4 30.7 10.7 36.0 26.6 87.5 88.5 39.2 13.6 22.0 24.9 10.7 16.4 9.2 28.9 6.7 20.4 25.6 8.7 20.2 31.0 5.2 16.5 16.0 3.5 8.9 20.9 5.8 0.0 1.2 12.9 13.1 15.4 41.0 2.4 8.1 14.3 7.5 9.6 2.3 0.0 0.2 8.7 20.3 0.0 1.0 0.0 9.8 0.4 0.2 4.6 0.1 3.0 10.4 0.4 8.6 40.5 0.3 11.2 0.0 5.3 1.3 0.2 16.3 0.1 6.3 8.0 2.3 10.9 7.8 0.0 0.0 2.3 0.2 2.8 6.4 0.0 0.3 4.2 13.1 2.3 0.1 8.4 0.4 12.0 0.6 4.0 5.9 0.4 12.6 0.1 0.1 1.0 2.2 16.0 1.9 3.5 1.8 5.2 5.3 2.0 12.7 3.7 20.9 8.9 1.3 8.9 2.1 16.5 4.5 5.8 30.7 48.3 13.7 25.0 32.5 21.7 17.0 21.1 22.4 28.9 GSTM4 ENSG00000168765 "Glutathione S-transferase mu 4" Q03013 1 109656081-109674836 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 85.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "eosinophil: 69.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 69.8" "Low region specificity" "Detected in all" "HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" 660000 Cytosol "Cytokinetic bridge" "HPA048652: , HPA055972: , HPA055973: " "prognostic favourable (9.96e-5)" "unprognostic (1.96e-3)" "unprognostic (7.49e-2)" "unprognostic (9.92e-3)" "unprognostic (1.48e-1)" "unprognostic (1.08e-2)" "unprognostic (8.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.76e-2)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" 12.5 17.6 14.0 12.3 20.2 3.6 10.9 12.9 24.7 12.6 33.2 18.0 9.4 85.3 12.1 15.3 15.9 11.0 14.5 14.7 13.7 12.3 27.2 22.0 7.4 10.1 14.8 16.9 31.4 12.2 23.1 9.9 5.1 15.8 14.7 23.2 20.5 15.4 26.3 47.4 10.6 77.2 19.0 16.1 16.2 14.7 11.8 14.0 4.0 14.9 14.5 12.8 22.2 14.2 3.6 7.8 69.8 3.0 2.5 3.1 2.3 5.3 2.4 4.3 32.5 9.7 15.0 5.5 1.7 14.0 4.1 5.4 17.1 0.6 5.0 6.7 7.7 5.5 11.1 5.8 2.6 7.4 0.0 10.8 10.0 15.3 15.8 3.7 13.2 9.4 5.8 5.2 0.0 3.3 5.0 7.5 2.8 4.9 3.1 16.4 3.3 12.9 6.6 2.4 7.3 16.0 3.8 3.0 7.2 0.0 28.1 21.7 7.6 8.0 1.4 4.7 18.7 5.2 2.5 11.2 19.6 0.4 15.5 5.5 13.3 2.0 2.9 69.8 2.7 3.0 1.6 3.6 2.0 3.1 7.8 2.8 2.0 2.3 0.4 2.5 0.7 2.7 2.8 2.3 14.0 20.2 12.9 24.7 13.7 12.3 14.8 16.9 15.8 14.0 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109712255-109775428 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "breast: 237.6;ovary: 66.1" "Group enriched" "Detected in some" 7 "fHDF/TERT166: 17.6;HHSteC: 7.6;HSkMC: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;T-cells: 1.9" "HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" Cytosol "Cytokinetic bridge" "HPA048652: , HPA055972: , HPA055973: " "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 5.8 3.5 25.7 2.6 23.4 1.6 237.6 15.8 24.6 27.2 4.2 14.0 4.7 2.1 14.0 12.0 4.8 19.8 9.0 4.8 24.9 6.2 2.9 2.1 5.7 2.6 4.9 17.9 66.1 2.7 1.6 2.7 1.6 8.9 12.8 4.0 23.0 3.9 11.9 2.4 3.7 3.5 9.8 11.0 3.5 3.9 5.1 11.9 0.0 2.6 2.1 3.2 10.5 16.1 0.0 5.7 0.6 0.2 0.7 1.9 0.9 0.0 0.0 0.0 0.0 1.5 1.5 0.2 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.2 0.0 0.7 0.0 5.7 1.9 0.9 25.7 23.4 15.8 24.6 24.9 6.2 4.9 17.9 8.9 11.9 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced Approved Nucleoplasm,Cytosol 200000000 Cytosol Nucleoplasm "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favourable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 29.6 31.9 19.9 21.8 24.4 35.8 20.0 15.0 24.3 17.8 29.7 16.8 17.8 36.3 16.5 21.4 22.6 15.2 24.7 67.9 19.7 21.5 32.7 137.3 32.0 35.7 23.2 23.1 19.7 21.2 18.6 23.2 26.3 17.0 18.2 20.8 18.0 25.3 21.2 42.7 13.3 41.0 21.4 18.9 26.8 19.8 7.0 14.2 30.8 32.9 24.0 16.8 28.0 18.8 18.7 55.4 85.5 68.3 21.8 25.5 68.0 31.0 21.3 16.5 28.2 23.2 44.3 7.2 40.6 72.1 26.9 29.4 26.7 33.2 27.7 17.6 26.9 17.9 10.8 36.0 28.4 13.8 25.9 20.4 15.2 58.3 41.5 26.1 34.3 33.6 15.4 39.1 47.3 51.5 41.9 17.3 56.4 16.9 20.3 36.8 15.2 14.9 14.9 10.8 11.7 40.0 20.0 8.2 10.3 13.1 9.4 121.1 10.3 21.1 47.5 32.0 16.8 49.7 36.1 0.3 0.4 0.2 59.9 45.5 12.6 85.5 68.3 19.2 18.3 57.2 22.0 18.7 22.6 23.4 55.4 15.0 19.7 19.8 19.5 21.8 43.9 25.7 25.5 68.0 19.9 24.4 15.0 24.3 19.7 21.5 23.2 23.1 17.0 14.2 GSTP1 "FAEES3, GST3, GSTP" ENSG00000084207 "Glutathione S-transferase pi 1" P09211 11 67583595-67586656 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019779, HPA019869" Enhanced Supported Mitochondria,Cytosol 120000000 "Mitochondria, Cytosol" "HPA019779: AB_1849799, HPA019869: AB_1849801" "unprognostic (9.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.24e-2)" "unprognostic (2.72e-2)" "unprognostic (1.06e-2)" "unprognostic (1.30e-3)" "unprognostic (3.27e-1)" "unprognostic (4.98e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-3)" "unprognostic (2.14e-3)" "unprognostic (9.37e-2)" "unprognostic (5.72e-2)" "unprognostic (7.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.72e-3)" "unprognostic (1.48e-1)" 24.2 25.3 20.2 23.8 21.7 46.2 39.5 15.5 19.8 51.8 51.9 23.5 125.4 35.2 43.5 41.9 181.6 60.8 51.1 45.3 18.3 23.5 44.2 5.9 61.0 39.4 25.5 19.9 33.4 60.7 44.1 33.8 57.9 46.0 37.0 17.9 59.9 50.2 110.8 33.7 58.5 34.0 30.1 22.8 25.1 48.5 15.4 15.4 29.8 91.6 131.5 75.6 40.8 79.5 25.3 191.4 12.4 168.2 70.1 40.7 167.2 68.1 93.0 45.3 70.5 35.1 39.6 41.9 29.8 40.0 45.6 35.5 170.8 71.7 0.1 68.4 47.1 99.7 122.4 131.2 12.9 47.5 44.5 3.3 67.7 0.0 52.1 22.4 39.9 49.1 298.4 36.3 35.1 68.3 73.9 19.0 35.6 0.2 51.3 62.5 86.7 39.9 47.9 7.6 0.2 72.5 0.2 15.4 44.0 41.8 13.6 135.0 0.2 37.7 36.8 21.0 53.4 44.0 21.6 11.8 73.8 25.0 23.9 37.1 43.6 2.3 168.2 12.4 40.7 125.7 15.0 25.3 18.4 33.3 191.4 24.3 15.3 27.3 7.0 70.1 79.4 76.2 18.3 167.2 20.2 21.7 15.5 19.8 18.3 23.5 25.5 19.9 46.0 15.4 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell line enhanced" "Detected in many" "AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA000750 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favourable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.4 0.3 0.0 22.4 0.4 0.5 0.9 3.1 1.8 4.6 4.8 9.6 0.0 0.0 5.1 7.8 9.4 0.0 9.9 2.1 0.0 0.8 0.3 12.6 1.5 33.0 0.0 3.6 13.6 1.6 13.1 2.7 3.6 0.0 0.0 2.7 0.1 0.0 0.0 0.1 4.7 0.0 16.7 0.0 10.1 0.0 0.4 9.4 3.1 0.0 22.8 25.2 0.3 12.2 3.8 2.5 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell line enhanced" "Detected in all" "MCF7: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favourable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favourable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.4 12.4 9.8 6.9 6.2 8.6 16.6 4.1 4.1 7.6 10.8 4.2 16.4 14.4 5.8 4.8 8.3 6.7 7.8 7.3 7.6 6.6 7.0 4.7 8.8 9.8 2.6 5.8 8.1 8.5 4.4 7.5 6.5 5.8 13.3 5.1 60.2 4.0 5.5 2.9 9.9 6.9 10.3 11.2 11.6 8.0 10.8 9.8 9.0 18.0 12.7 29.4 3.8 4.4 5.9 20.2 6.7 3.0 10.0 10.7 12.7 15.5 3.9 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 GTF2A1 TFIIA ENSG00000165417 "General transcription factor IIA subunit 1" P52655 14 81175452-81221377 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000869 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000869: AB_1080253" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (7.98e-3)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (6.04e-3)" "unprognostic (1.65e-1)" "unprognostic (1.14e-1)" "unprognostic (1.85e-1)" "unprognostic (7.49e-2)" "unprognostic (2.76e-1)" "unprognostic (3.87e-2)" "unprognostic (4.04e-2)" "unprognostic (2.44e-1)" "unprognostic (2.11e-1)" "unprognostic (5.88e-2)" 16.9 14.9 18.2 15.7 23.3 8.7 17.1 32.6 23.4 15.7 12.9 17.7 12.7 12.2 16.0 20.1 17.9 12.5 13.1 12.7 17.0 17.8 15.3 18.4 11.6 18.9 16.2 17.0 17.6 14.7 21.0 20.6 24.5 19.9 14.8 14.7 14.0 14.5 13.1 20.3 14.7 12.4 16.2 18.5 17.2 13.4 23.9 16.7 36.3 30.4 11.3 18.5 15.9 15.0 1.3 3.2 9.3 3.9 1.5 2.3 0.8 10.5 10.6 22.3 14.9 12.7 10.7 8.1 12.8 13.3 11.8 10.7 15.7 10.7 17.3 10.4 10.6 8.0 15.3 9.7 21.0 14.6 4.6 15.7 12.2 9.3 12.5 11.0 16.3 9.9 7.5 16.2 21.2 12.0 9.6 23.9 15.1 17.7 28.0 6.5 12.1 10.2 15.1 19.5 10.7 7.9 21.7 21.1 12.5 30.2 12.4 13.5 18.5 9.4 15.0 12.0 9.2 16.6 13.3 19.2 20.5 18.0 9.6 12.9 19.0 9.3 1.2 2.1 2.3 0.9 2.0 1.3 2.1 1.3 0.7 1.2 1.9 2.1 2.0 1.5 3.9 3.2 1.1 0.8 18.2 23.3 32.6 23.4 17.0 17.8 16.2 17.0 19.9 16.7 GTF2B TFIIB ENSG00000137947 "General transcription factor IIB" Q00403 1 88852932-88891944 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061626 Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA061626: " "prognostic favourable (4.81e-4)" "unprognostic (5.21e-2)" "unprognostic (3.94e-3)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "unprognostic (2.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.37e-3)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (3.13e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.06e-3)" "unprognostic (3.74e-2)" 23.7 27.0 22.2 27.1 29.8 54.9 30.2 25.7 30.0 24.2 21.9 12.5 19.2 18.8 23.4 32.9 26.4 23.0 24.6 16.0 22.0 21.7 23.7 34.8 22.8 30.6 24.3 17.9 28.2 23.8 21.6 25.9 30.2 23.8 19.2 24.7 13.8 24.9 20.8 21.6 26.4 29.3 21.6 20.6 30.0 22.5 15.2 23.5 44.4 27.6 24.0 30.8 22.6 22.7 28.6 31.6 51.1 28.2 25.8 34.4 23.8 19.6 7.4 18.9 9.3 28.6 20.1 22.8 16.6 22.0 24.9 26.6 9.7 13.6 22.7 18.9 15.5 11.8 20.0 17.8 21.9 22.4 18.7 23.9 12.2 16.2 18.6 27.6 14.7 17.7 18.2 21.8 12.6 13.1 21.3 19.7 26.1 6.9 28.1 25.0 14.5 16.1 18.0 23.2 17.3 26.5 21.9 14.2 12.5 15.8 19.7 29.0 8.4 27.3 11.6 10.6 13.0 18.4 19.9 19.3 13.3 30.2 7.0 23.4 8.9 37.9 25.5 39.3 25.6 28.2 29.1 28.6 28.5 27.2 31.6 24.2 34.4 29.5 51.1 25.8 28.1 21.3 34.2 23.8 22.2 29.8 25.7 30.0 22.0 21.7 24.3 17.9 23.8 23.5 GTF2E2 "FE, TF2E2, TFIIE-B" ENSG00000197265 "General transcription factor IIE subunit 2" P29084 8 30578318-30658251 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004816, CAB009603, HPA025065" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009603: AB_2114537, HPA004816: , HPA025065: AB_10601658" "unprognostic (4.84e-2)" "unprognostic (7.38e-3)" "unprognostic (6.20e-3)" "unprognostic (9.09e-2)" "unprognostic (6.30e-2)" "unprognostic (4.38e-1)" "unprognostic (6.05e-3)" "unprognostic (8.69e-2)" "unprognostic (2.29e-1)" "unprognostic (4.72e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "prognostic unfavourable (5.82e-7)" "unprognostic (8.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.05e-3)" "unprognostic (1.24e-1)" 19.0 21.9 11.4 16.2 17.0 7.5 26.7 21.2 13.1 16.4 19.1 10.7 15.1 16.8 17.7 15.8 20.0 12.3 11.7 12.7 11.1 10.9 14.7 21.1 13.4 20.3 11.6 12.2 24.2 44.6 14.1 22.5 14.5 11.9 14.2 14.4 12.1 12.6 13.8 9.9 14.8 26.2 16.3 11.6 17.2 20.9 31.0 11.7 21.4 17.2 10.6 22.0 16.9 27.5 16.4 8.0 5.6 4.2 8.7 7.9 2.6 21.4 17.4 12.0 12.7 32.5 29.1 9.1 23.4 21.2 19.2 24.5 10.4 15.4 27.8 19.9 20.8 15.2 19.8 21.8 25.6 12.4 11.7 13.8 12.2 24.6 31.6 6.6 12.2 21.2 28.9 20.6 21.0 26.4 26.6 17.1 30.1 14.5 32.5 16.7 13.6 21.0 17.1 13.0 13.8 20.7 14.7 9.3 12.0 12.9 8.7 18.2 8.4 8.2 20.1 12.7 13.2 10.7 15.9 17.5 23.8 30.1 20.0 11.4 16.7 3.0 4.2 5.6 3.9 3.3 4.2 16.4 6.0 7.9 7.2 9.3 5.9 5.9 2.2 8.7 3.3 8.0 6.7 2.6 11.4 17.0 21.2 13.1 11.1 10.9 11.6 12.2 11.9 11.7 GTF2F1 "BTF4, RAP74, TF2F1, TFIIF" ENSG00000125651 "General transcription factor IIF subunit 1" P35269 19 6379569-6393981 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022793, HPA028707, HPA070752" Supported Enhanced "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA022793: AB_1857946, HPA028707: , HPA070752: " "unprognostic (1.30e-2)" "unprognostic (6.05e-3)" "unprognostic (2.00e-1)" "prognostic favourable (8.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.46e-2)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.99e-2)" "unprognostic (6.45e-3)" "unprognostic (6.96e-2)" "prognostic favourable (9.80e-4)" "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.92e-2)" "unprognostic (4.25e-1)" 24.9 26.0 32.5 26.6 33.1 41.1 22.6 60.7 47.3 25.5 24.7 18.8 26.1 35.2 31.7 22.6 30.8 29.9 26.5 22.9 28.9 25.9 24.4 21.7 19.8 34.9 23.9 36.3 59.8 40.7 31.8 33.4 19.9 26.6 24.6 16.3 22.3 33.9 24.4 25.6 21.8 31.9 27.6 26.4 26.7 26.4 39.4 23.1 23.6 36.4 19.7 22.2 26.0 39.8 24.4 21.5 28.4 21.4 19.0 23.8 14.1 38.0 28.1 20.4 32.5 13.8 22.4 16.1 26.8 25.2 33.5 32.0 29.4 15.1 23.3 37.7 17.5 34.7 19.2 17.0 16.4 35.4 24.4 32.2 20.9 26.1 24.0 37.4 26.2 23.5 22.8 23.9 18.2 19.7 39.4 31.6 18.5 26.5 37.1 21.3 37.0 35.8 34.3 22.7 29.7 18.6 21.9 25.1 34.5 27.7 21.3 29.5 27.0 29.8 27.8 26.3 22.2 45.3 37.7 56.1 63.0 25.1 32.7 39.2 29.4 7.0 21.4 14.0 20.5 20.6 23.8 24.4 18.4 19.5 16.9 23.3 21.7 18.8 28.4 19.0 19.1 21.5 17.6 14.1 32.5 33.1 60.7 47.3 28.9 25.9 23.9 36.3 26.6 23.1 GTF2F2 "BTF4, RAP30, TFIIF" ENSG00000188342 "General transcription factor IIF subunit 2" P13984 13 45120515-45284909 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006912 Supported Supported Nucleoplasm,Microtubules Nucleoplasm Microtubules "HPA006912: AB_1080256" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (4.51e-2)" "prognostic unfavourable (1.65e-5)" "unprognostic (3.67e-2)" "unprognostic (3.17e-1)" "unprognostic (3.36e-2)" "unprognostic (2.53e-3)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.53e-3)" "unprognostic (3.94e-2)" "unprognostic (6.44e-3)" 15.1 24.7 23.5 21.1 23.6 22.5 20.9 12.0 21.0 16.3 21.8 14.8 18.5 14.9 16.8 23.4 21.8 12.0 15.9 27.5 21.4 21.1 18.3 16.0 15.1 17.5 22.9 19.0 17.3 14.6 16.5 27.5 23.9 18.2 16.7 21.2 18.2 20.8 20.2 32.0 31.5 12.9 28.2 19.5 17.8 15.2 22.2 24.2 22.6 19.2 27.7 19.9 20.5 19.0 15.4 16.3 24.9 15.3 16.1 12.9 8.5 15.4 5.8 11.0 8.1 6.7 9.9 9.1 17.0 11.2 17.3 17.0 9.7 24.2 15.5 9.6 12.4 17.2 16.4 13.6 25.4 11.7 14.2 18.3 7.8 12.6 10.8 20.2 10.5 8.3 21.0 12.9 21.9 11.0 12.9 5.9 46.6 8.6 14.8 23.4 13.0 14.2 14.0 8.3 8.9 37.7 5.4 5.9 9.8 8.6 8.5 14.1 6.9 16.6 8.7 14.6 12.4 11.5 28.9 3.8 5.1 15.5 17.0 13.1 15.2 12.0 14.2 24.9 9.7 14.1 11.5 15.3 11.3 11.5 16.3 15.4 12.9 12.6 19.8 16.1 15.3 12.7 12.3 8.5 23.5 23.6 12.0 21.0 21.4 21.1 22.9 19.0 18.2 24.2 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell line enhanced" "Detected in many" "HHSteC: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.5 2.4 3.0 8.0 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.5 33.4 0.1 0.3 7.1 19.2 5.5 22.7 4.0 6.9 0.0 8.7 11.8 1.2 8.2 10.3 6.1 12.6 7.5 8.8 14.9 6.5 10.7 14.5 9.8 17.9 8.7 10.6 9.4 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "gdT-cell: 20.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051617 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA051617: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavourable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favourable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favourable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 13.6 18.4 19.4 12.1 25.9 17.3 10.6 25.3 31.2 17.3 12.8 21.0 18.8 11.0 19.0 12.0 39.3 19.9 16.5 23.7 15.8 16.2 16.9 13.2 14.1 13.5 14.3 19.1 20.7 24.0 33.8 33.2 13.5 15.8 35.4 12.4 22.3 15.3 16.9 29.5 41.5 11.7 19.3 12.8 14.2 15.7 24.4 17.1 25.2 35.8 18.8 21.0 12.3 20.7 1.9 4.2 2.1 2.1 7.8 20.6 3.6 12.7 28.2 20.8 24.2 18.7 15.1 11.8 13.9 15.7 19.4 16.6 21.1 12.1 14.1 20.6 17.0 14.4 26.3 17.7 16.0 6.3 25.2 11.6 23.9 30.0 10.5 13.3 15.5 18.5 13.5 23.8 10.5 19.2 14.3 11.6 15.2 31.5 14.7 16.0 27.9 13.5 27.5 25.7 14.4 12.2 13.4 26.3 17.6 14.0 11.9 8.6 21.4 10.1 20.3 19.6 11.8 12.3 14.2 12.4 11.1 14.3 8.1 14.8 14.3 1.0 2.1 2.1 20.6 1.9 15.2 1.9 2.4 10.3 2.7 1.6 2.5 6.7 1.6 7.8 2.0 4.2 2.5 3.6 19.4 25.9 25.3 31.2 15.8 16.2 14.3 19.1 15.8 17.1 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763032-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA069179: " "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavourable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 19.3 20.3 14.9 14.3 20.0 34.6 23.4 17.3 21.2 17.3 15.3 16.3 14.1 13.1 19.7 18.7 18.1 17.5 21.5 16.1 12.6 11.7 16.2 16.6 15.1 20.0 20.9 16.4 20.3 23.5 21.5 30.8 20.4 23.4 17.2 18.3 11.8 17.7 15.0 22.6 23.9 20.1 18.3 22.3 19.4 18.0 17.5 20.3 29.8 18.6 19.1 18.7 19.5 25.4 14.3 11.8 16.3 15.0 12.6 14.3 7.4 11.1 12.0 21.6 16.4 10.5 14.4 23.9 18.6 12.5 18.6 17.6 26.4 17.6 23.1 14.6 11.9 16.3 21.6 18.1 24.0 26.1 20.5 29.0 33.6 24.0 18.1 25.0 22.2 20.1 18.9 15.6 21.2 17.5 32.9 33.7 10.1 20.5 24.7 20.6 14.1 22.3 20.1 17.9 15.8 13.9 26.8 16.0 17.1 14.4 11.9 15.5 11.3 19.1 15.2 15.9 13.2 12.8 16.5 20.5 25.0 17.0 17.9 18.6 14.6 16.3 11.0 10.8 11.2 10.5 13.4 12.6 11.5 12.2 11.8 14.3 14.3 12.9 7.1 12.6 15.0 10.4 12.4 7.4 14.9 20.0 17.3 21.2 12.6 11.7 20.9 16.4 23.4 20.3 GTF3C4 "KAT12, TFIIIC90" ENSG00000125484 "General transcription factor IIIC subunit 4" Q9UKN8 9 132670035-132694955 "Enzymes, Predicted intracellular proteins" Transcription "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069369 Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA069369: " "unprognostic (7.02e-2)" "unprognostic (9.01e-2)" "unprognostic (1.31e-1)" "unprognostic (4.10e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-2)" "unprognostic (1.58e-1)" "unprognostic (1.76e-1)" "unprognostic (4.77e-1)" "unprognostic (1.92e-2)" "prognostic favourable (2.99e-4)" "unprognostic (1.65e-1)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" 6.9 8.5 12.3 6.6 11.6 7.8 11.6 23.8 13.9 10.8 8.0 7.0 5.6 5.3 10.2 9.3 11.4 9.5 7.4 7.8 8.7 8.1 8.7 7.4 8.9 10.9 9.4 11.6 15.0 8.4 16.6 10.1 9.7 8.9 8.9 7.7 7.6 11.3 8.4 11.6 14.5 6.6 8.6 5.6 6.3 8.1 16.9 6.4 11.6 13.3 5.3 9.3 8.8 7.9 2.3 2.1 1.5 1.5 2.1 3.1 0.9 8.3 12.0 15.3 13.0 7.6 8.9 11.0 8.1 10.7 11.5 8.5 14.6 6.3 13.1 5.5 10.5 19.5 23.3 13.2 12.8 7.9 9.6 11.0 17.3 6.2 7.4 16.2 7.0 6.9 10.1 11.7 15.4 9.8 17.9 6.7 8.3 13.7 9.9 7.6 19.3 11.7 9.8 18.5 11.5 8.5 7.1 21.2 14.4 14.5 14.8 9.0 20.6 6.7 10.2 19.1 10.7 8.7 12.1 2.8 6.3 14.6 8.1 10.3 11.7 0.1 1.5 1.2 2.5 1.3 2.0 2.3 2.2 3.1 1.2 2.2 2.3 2.4 1.5 2.1 1.2 2.1 2.0 0.9 12.3 11.6 23.8 13.9 8.7 8.1 9.4 11.6 8.9 6.4 GTF3C6 "bA397G5.3, C6orf51, TFIIIC35" ENSG00000155115 "General transcription factor IIIC subunit 6" Q969F1 6 110958560-110967890 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056179, HPA061345" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA056179: , HPA061345: " "unprognostic (6.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (3.04e-1)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (7.27e-6)" "unprognostic (2.08e-2)" "unprognostic (9.79e-3)" "unprognostic (2.89e-1)" "unprognostic (5.42e-2)" "unprognostic (7.75e-2)" "unprognostic (1.42e-3)" "unprognostic (9.31e-2)" "unprognostic (1.69e-1)" "unprognostic (2.39e-2)" "unprognostic (1.14e-2)" 17.0 21.6 26.4 14.3 25.3 12.8 14.6 10.9 17.4 15.8 22.1 14.2 12.7 17.4 12.3 12.9 17.3 16.4 23.0 32.1 21.2 20.1 31.1 23.5 10.9 15.6 24.8 17.8 15.6 14.7 21.6 15.5 11.0 18.1 32.7 18.4 12.1 14.7 16.1 95.8 10.4 17.5 15.7 21.4 19.7 18.1 20.3 20.3 17.9 13.2 30.7 18.7 17.2 13.1 36.2 38.8 19.0 37.6 23.4 63.5 33.3 14.7 27.7 19.5 20.5 9.7 19.1 26.7 24.9 18.2 24.0 19.5 40.1 11.0 20.9 23.9 22.2 6.3 21.8 21.3 18.1 31.5 36.7 39.3 25.7 51.6 19.6 55.7 32.1 19.3 17.2 18.3 17.5 26.5 47.2 11.3 34.8 28.6 27.4 57.8 26.9 22.3 27.5 14.9 17.5 31.2 32.5 17.3 24.5 18.0 2.4 18.6 9.0 30.0 28.1 6.0 18.2 43.9 37.7 10.0 20.3 35.8 6.3 33.5 29.8 19.0 26.9 14.9 25.1 37.6 27.9 36.2 31.6 30.9 35.6 26.3 24.8 29.2 4.3 23.4 29.9 38.8 63.5 33.3 26.4 25.3 10.9 17.4 21.2 20.1 24.8 17.8 18.1 20.3 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705723-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: " "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavourable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.0 17.1 16.0 22.1 20.6 86.0 16.5 24.9 24.9 16.2 17.4 26.8 20.8 20.6 19.6 15.6 19.3 22.7 20.6 19.5 17.2 14.1 15.9 14.7 24.8 20.9 20.6 21.7 25.9 21.0 23.1 23.1 15.6 17.2 20.8 17.9 28.8 18.7 19.9 28.5 23.0 21.2 20.3 16.1 25.5 18.8 17.2 22.7 18.3 23.1 12.6 23.6 23.6 16.5 7.2 5.0 12.1 7.3 3.4 7.7 4.3 13.5 4.9 18.0 14.5 6.3 9.4 8.9 12.3 13.9 19.2 16.4 10.3 7.1 12.7 4.8 12.8 12.2 21.2 13.7 10.6 21.6 15.4 22.4 16.0 7.3 11.8 26.4 11.3 10.0 10.4 15.4 24.0 10.3 13.4 26.8 10.5 5.5 14.8 11.5 13.0 9.5 28.8 18.3 15.7 6.6 10.7 24.6 8.6 15.3 10.1 9.3 9.2 11.2 12.4 10.3 10.5 7.6 9.8 24.8 8.5 17.7 9.9 13.4 8.2 3.6 4.3 5.5 7.5 7.0 6.6 7.2 5.5 7.7 5.0 6.6 4.1 5.7 12.1 3.4 7.3 2.6 4.9 4.3 16.0 20.6 24.9 24.9 17.2 14.1 20.6 21.7 17.2 22.7 GTPBP4 "CRFG, FLJ10686, FLJ10690, NGB, NOG1" ENSG00000107937 "GTP binding protein 4" Q9BZE4 10 988019-1019936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039618, HPA056468" Uncertain Supported "Nuclear membrane,Nucleoli" Nucleoli "Nuclear membrane" "HPA039618: AB_10795292, HPA056468: " "unprognostic (2.11e-3)" "unprognostic (3.10e-3)" "unprognostic (7.77e-3)" "prognostic unfavourable (4.57e-4)" "unprognostic (3.72e-2)" "unprognostic (8.91e-3)" "prognostic unfavourable (8.85e-12)" "unprognostic (9.06e-2)" "unprognostic (1.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (2.38e-5)" "unprognostic (7.90e-2)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (3.67e-2)" 19.0 24.6 11.3 13.9 14.9 24.8 14.2 11.6 15.0 11.0 10.5 12.2 10.3 9.6 14.8 10.1 12.2 15.8 8.9 11.9 14.1 11.8 11.8 14.0 9.5 13.8 14.0 10.1 16.3 22.8 12.7 18.3 13.8 15.3 11.1 12.2 8.9 10.3 9.9 24.8 11.4 11.0 14.4 18.1 13.5 12.7 22.9 12.2 14.2 11.9 16.3 16.3 11.6 10.4 10.5 11.3 10.7 14.2 15.8 14.2 7.7 21.0 17.2 14.5 12.7 10.2 12.3 10.4 19.8 6.9 24.3 20.7 25.4 16.4 30.5 6.0 15.7 16.7 28.6 18.1 28.4 15.0 17.8 33.5 12.4 15.4 16.2 14.5 18.1 15.9 15.4 26.6 18.6 13.2 34.2 12.7 22.2 19.4 22.2 13.7 21.1 11.8 22.1 12.7 21.1 14.4 13.4 7.3 21.9 13.0 16.7 22.9 23.9 14.5 11.4 11.5 6.4 27.7 23.9 16.4 31.5 38.4 13.0 15.4 9.5 10.7 8.4 3.0 11.6 14.2 13.6 10.5 11.0 11.7 11.3 9.9 12.2 11.8 1.4 15.8 10.8 7.4 14.2 7.7 11.3 14.9 11.6 15.0 14.1 11.8 14.0 10.1 15.3 12.2 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavourable (1.90e-10)" "prognostic unfavourable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.5 10.2 20.2 15.9 0.4 1.2 9.7 18.7 8.8 27.4 22.6 10.7 8.2 20.4 5.0 7.2 11.3 18.1 4.7 17.6 12.2 19.5 13.6 14.4 8.2 0.0 24.4 16.7 0.2 0.3 11.7 6.0 11.8 10.4 25.7 16.3 12.0 21.8 12.0 14.1 11.6 21.7 22.7 13.4 4.5 3.9 10.5 14.3 17.9 11.7 8.2 9.9 9.4 9.3 15.6 29.6 12.7 19.6 14.7 7.0 20.7 9.9 11.8 22.7 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 GUF1 FLJ13220 ENSG00000151806 "GUF1 homolog, GTPase" Q8N442 4 44678427-44700926 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003934, HPA024222" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003934: AB_1079034, HPA024222: " "unprognostic (1.32e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-2)" "unprognostic (3.65e-3)" "unprognostic (7.56e-2)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.37e-2)" "unprognostic (3.03e-2)" "unprognostic (1.56e-3)" "unprognostic (7.38e-3)" "prognostic favourable (2.66e-6)" "unprognostic (4.98e-3)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.65e-5)" "unprognostic (5.40e-2)" 10.0 11.3 12.7 7.5 16.6 11.4 10.8 9.7 17.7 7.6 11.5 9.4 8.7 9.4 10.2 9.1 13.2 8.9 7.9 12.3 12.6 9.9 15.1 16.0 6.6 10.8 10.4 11.6 10.6 9.3 11.5 11.3 7.8 13.0 10.6 12.4 7.4 10.4 8.0 31.1 11.5 12.5 7.6 11.8 9.7 15.4 11.7 11.1 13.9 11.2 13.1 9.3 11.7 9.2 4.8 4.7 4.6 6.1 5.2 7.0 3.9 7.6 3.9 7.2 9.2 3.1 6.3 16.1 10.4 5.5 10.9 8.4 6.8 5.5 16.6 8.3 5.1 6.1 12.4 12.1 12.5 5.6 8.0 19.8 3.3 4.7 9.8 21.5 8.5 6.2 5.5 8.1 7.1 7.8 20.0 3.3 8.8 3.7 12.0 4.5 4.7 9.1 8.7 15.0 7.0 3.2 3.0 10.0 7.5 6.7 2.8 7.4 4.5 6.3 7.7 7.5 8.6 10.0 12.5 12.0 10.9 12.2 8.1 12.9 6.3 1.1 4.6 4.6 4.7 6.1 6.1 4.8 4.7 4.2 4.3 4.4 4.5 4.6 0.1 5.2 4.0 4.7 7.0 3.9 12.7 16.6 9.7 17.7 12.6 9.9 10.4 11.6 13.0 11.1 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587" Approved Uncertain Nucleoplasm,Cytosol 240000 "Nucleoplasm, Cytosol" "HPA028118: AB_2756308, HPA048587: AB_2680453" "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavourable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 44.6 38.2 106.4 32.5 76.0 76.7 43.0 25.2 74.4 31.5 33.3 30.1 27.3 41.5 26.3 34.1 77.0 28.0 42.5 61.6 93.1 43.9 31.9 43.5 34.6 39.0 60.0 52.9 24.7 62.2 12.8 26.0 29.2 40.1 25.5 12.1 37.4 66.5 29.4 35.8 59.6 42.1 34.8 49.6 36.1 44.3 22.2 34.9 27.5 31.6 29.3 24.1 45.9 44.5 43.9 97.7 110.1 62.9 55.8 83.7 84.5 57.4 20.3 8.9 27.7 27.0 32.6 45.0 38.3 19.7 22.4 17.6 11.6 40.0 21.7 45.5 25.0 38.2 7.7 42.1 2.4 33.0 59.7 12.9 50.1 25.2 49.2 14.5 22.7 45.2 25.6 15.6 12.6 30.2 34.7 34.6 18.3 48.0 65.7 31.5 28.1 88.0 25.2 16.9 57.5 21.0 27.1 29.6 53.1 24.7 42.3 49.6 31.2 31.5 52.6 40.9 27.0 59.8 63.0 32.0 34.6 23.9 51.5 23.8 41.2 55.5 57.1 110.1 77.3 59.8 75.2 43.9 64.8 83.7 48.9 36.6 48.7 61.1 74.9 55.8 62.9 97.7 64.6 84.5 106.4 76.0 25.2 74.4 93.1 43.9 60.0 52.9 40.1 34.9 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381313-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: " "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 3.3 5.8 7.0 4.7 11.8 3.5 5.8 13.9 14.3 5.0 3.2 5.0 2.2 4.5 6.7 4.0 1.8 7.1 2.5 3.2 6.2 5.2 5.1 2.5 2.9 6.0 4.0 7.2 8.4 16.0 3.2 15.9 3.0 8.7 3.5 4.9 7.6 9.1 3.3 2.9 4.5 3.6 3.5 4.2 5.0 4.2 9.6 4.6 5.5 5.5 0.4 5.7 2.8 4.0 3.1 1.7 5.1 1.2 3.8 4.1 1.2 1.7 2.2 9.4 5.0 2.3 4.7 2.5 1.2 1.0 2.2 2.1 6.5 4.0 7.4 3.3 1.2 5.3 5.1 1.3 3.0 5.2 3.0 3.8 8.4 2.1 1.2 3.4 2.0 1.1 1.5 3.4 1.3 1.4 2.4 4.5 0.7 2.1 4.7 5.6 1.5 3.4 7.0 5.5 4.7 0.7 1.8 12.3 4.3 2.9 1.3 0.8 3.8 1.0 0.8 3.9 3.9 6.1 1.4 4.8 2.3 6.9 1.2 3.0 2.2 3.5 1.2 1.2 3.7 0.7 2.5 3.1 3.8 1.7 1.7 3.1 4.1 4.1 5.1 3.8 0.8 1.2 3.3 1.2 7.0 11.8 13.9 14.3 6.2 5.2 4.0 7.2 8.7 4.6 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.5;HSkMC: 12.9;MOLT-4: 23.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: " "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavourable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.2 0.0 7.5 6.9 13.5 1.1 1.2 2.8 2.7 6.6 0.3 0.8 0.0 2.1 3.2 0.1 0.7 1.5 2.6 0.0 0.9 0.0 5.0 7.9 8.7 3.1 0.0 12.9 0.7 6.5 1.0 0.0 3.7 0.1 1.6 1.7 23.1 0.1 4.4 1.5 0.1 6.4 0.0 0.8 1.1 0.7 3.4 6.4 0.3 0.8 2.5 1.0 0.0 2.9 9.3 9.0 4.2 0.7 0.1 0.1 7.6 1.5 5.1 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell line enhanced" "Detected in many" "AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: " "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favourable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.4 17.7 0.0 10.6 0.0 12.8 0.5 3.1 3.1 3.9 13.1 0.3 0.0 1.4 2.2 0.0 10.0 0.2 3.0 0.1 2.8 0.0 0.2 14.2 3.1 0.0 4.3 3.8 0.1 0.3 0.0 0.0 0.1 0.0 3.2 0.8 0.0 0.4 17.4 0.1 2.9 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 37.7 1.7 10.7 0.0 0.0 3.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell line enriched" "Detected in some" 4 "HEL: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968125-48993310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol 10000 "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: " "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavourable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 9.7 7.3 5.1 6.1 6.5 16.0 10.6 11.3 6.2 5.3 7.3 6.2 5.8 6.1 6.2 6.9 11.5 5.9 6.1 37.3 6.8 4.0 7.2 4.3 5.0 6.3 5.3 5.5 6.8 4.4 6.4 5.1 5.0 5.9 8.7 6.1 12.4 7.2 7.6 106.1 8.1 6.1 6.8 6.0 5.8 7.3 2.2 5.5 6.4 5.2 42.6 9.0 7.9 6.9 6.7 15.9 8.2 10.5 12.8 10.9 7.3 28.3 11.3 8.4 11.5 19.6 7.7 16.7 19.7 13.9 20.8 24.4 11.0 9.3 11.8 12.0 19.2 20.3 14.0 25.0 18.2 7.3 20.3 9.8 14.5 9.7 11.0 10.7 7.3 19.0 12.0 13.4 11.4 17.4 6.8 15.9 26.0 10.8 13.2 9.3 4.5 13.1 11.2 14.7 11.6 20.6 30.4 5.2 7.3 17.5 22.9 4.6 12.1 11.1 13.4 25.6 9.9 11.5 21.3 13.2 13.6 5.8 26.1 9.4 5.7 8.2 10.5 7.5 8.8 6.3 10.9 6.7 7.6 8.2 15.9 5.5 6.3 5.6 4.4 12.8 8.5 8.6 10.1 7.3 5.1 6.5 11.3 6.2 6.8 4.0 5.3 5.5 5.9 5.5 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373063 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavourable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 7.6 25.8 12.3 7.1 12.5 35.7 6.6 14.1 17.2 8.8 7.1 14.9 8.0 5.4 9.0 7.6 6.1 8.2 7.5 15.6 11.5 10.6 9.2 8.7 7.1 6.5 13.0 10.4 11.4 7.8 12.0 9.8 8.4 12.9 8.3 5.9 7.1 7.7 11.2 10.0 5.8 5.6 10.7 12.4 6.7 6.6 16.5 13.0 7.4 9.6 5.3 6.3 9.3 9.8 3.2 4.4 3.4 4.5 1.3 3.2 2.4 5.5 9.8 6.3 6.3 7.4 7.3 5.1 6.8 6.3 7.0 6.6 7.4 4.5 11.3 6.0 5.8 9.9 7.2 9.2 8.0 1.9 4.7 10.5 4.0 10.0 9.7 6.2 6.4 7.3 6.8 7.5 11.6 4.7 7.1 17.7 10.0 7.3 9.6 7.8 4.7 13.5 6.4 15.1 7.8 5.3 5.6 9.7 5.6 6.0 10.8 14.2 7.1 9.1 6.0 11.4 6.6 8.6 7.2 14.5 5.9 10.0 3.3 28.6 6.1 0.0 4.5 2.0 2.0 2.7 1.5 3.2 3.0 3.1 4.4 1.6 3.0 3.2 3.4 1.3 3.2 3.7 0.9 2.4 12.3 12.5 14.1 17.2 11.5 10.6 13.0 10.4 12.9 13.0 H1F0 "H10, H1FV" ENSG00000189060 "H1 histone family member 0" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 158.1" "Cell line enhanced" "Detected in many" "U-2 OS: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favourable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 21.7 13.6 27.5 14.7 24.9 158.1 32.3 35.7 41.7 48.2 37.9 20.4 11.3 35.8 42.7 18.5 66.0 31.7 38.5 30.3 23.5 17.6 33.2 90.6 22.8 15.0 16.0 23.8 48.5 43.5 20.2 25.6 33.6 23.5 43.7 34.0 28.3 43.2 12.4 53.5 53.2 59.2 28.0 18.6 16.3 34.6 15.2 18.8 56.3 36.1 33.4 32.0 24.9 45.2 0.1 6.3 12.5 9.0 0.1 2.4 4.7 20.7 9.0 28.0 12.4 7.4 6.8 39.8 16.9 35.3 49.5 70.7 36.6 33.1 0.0 4.2 14.0 40.6 0.0 11.6 35.3 0.1 2.0 35.1 3.3 24.4 25.9 0.0 0.1 6.3 20.8 24.8 28.0 13.1 0.0 0.0 3.8 34.3 5.8 3.4 10.8 44.5 9.7 16.7 7.1 7.8 5.6 6.4 36.1 46.6 31.8 61.5 24.8 21.9 8.7 3.7 113.0 16.6 3.4 0.0 2.3 0.1 4.6 12.6 10.7 12.5 7.6 11.3 0.1 9.0 0.1 0.0 0.8 0.2 6.3 0.1 2.4 0.3 4.2 0.1 7.7 5.7 0.2 4.7 27.5 24.9 35.7 41.7 23.5 17.6 16.0 23.8 23.5 18.8 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell line enhanced" "Detected in all" "U-266/70: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099" Supported Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB012235: , HPA040099: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.6 10.4 19.8 8.5 2.0 2.4 18.8 8.6 6.3 10.3 10.9 6.2 10.8 2.5 9.6 3.0 19.8 8.3 5.5 1.6 18.0 16.1 7.5 8.1 8.5 8.5 8.6 2.0 4.8 7.6 4.1 9.5 5.9 11.5 44.8 1.4 20.6 40.1 17.2 18.5 11.8 28.9 8.4 23.4 3.1 4.1 31.6 36.6 9.1 4.6 26.2 17.9 17.6 5.8 8.0 41.9 7.8 7.2 137.4 52.5 21.2 6.5 8.2 8.7 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: , HPA051647: " "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavourable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.1 15.8 25.0 14.9 2.3 1.7 26.4 29.8 9.1 16.8 14.8 25.0 11.3 18.0 18.0 6.8 27.2 11.8 8.5 4.5 26.5 33.1 36.4 4.3 25.7 2.4 17.9 22.7 1.4 1.8 7.1 4.4 8.4 29.4 29.6 8.0 66.7 40.9 53.6 18.2 33.5 40.0 29.5 8.4 7.6 11.4 26.7 31.7 23.6 13.8 4.1 20.6 13.6 10.3 16.3 43.1 13.2 22.1 8.1 7.9 18.2 3.7 29.2 31.8 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell line enhanced" "Detected in many" "K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.0 3.2 0.6 0.9 2.2 0.8 2.3 2.5 1.3 3.2 1.9 4.5 1.0 0.5 8.6 0.8 2.4 0.2 0.7 0.9 2.1 3.5 0.5 4.9 0.2 0.3 0.9 4.4 2.4 0.4 0.6 0.0 0.3 23.2 2.7 0.8 6.0 1.0 2.2 0.3 2.6 0.8 0.5 8.5 0.6 0.7 3.4 2.4 10.2 3.1 2.0 10.9 1.4 0.9 1.7 22.9 1.1 0.6 7.4 23.3 4.9 1.1 11.6 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 H2BFS ENSG00000274559 "H2B histone family member S" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 16.0" "Cell line enhanced" "Detected in many" "K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.5 1.0 0.0 0.0 1.0 0.9 1.4 1.3 2.9 3.3 2.8 2.8 0.0 0.0 2.2 0.3 2.3 0.2 1.2 0.0 0.8 3.7 0.9 1.9 0.0 0.0 0.0 1.8 0.7 0.6 1.1 0.9 1.6 1.0 1.2 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.0 3.2 0.6 0.9 2.2 0.8 2.3 2.5 1.3 3.2 1.9 4.5 1.0 0.5 8.6 0.8 2.4 0.2 0.7 0.9 2.1 3.5 0.5 4.9 0.2 0.3 0.9 4.4 2.4 0.4 0.6 0.0 0.3 23.2 2.7 0.8 6.0 1.0 2.2 0.3 2.6 0.8 0.5 8.5 0.6 0.7 3.4 2.4 10.2 3.1 2.0 10.9 1.4 0.9 1.7 22.9 1.1 0.6 7.4 23.3 4.9 1.1 11.6 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055969 Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favourable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.4 8.5 10.8 11.6 24.1 20.6 7.7 10.1 11.3 7.6 8.4 12.7 12.5 3.8 5.0 15.1 5.5 9.0 1.9 6.2 4.6 5.4 1.5 4.0 21.1 12.2 0.3 1.6 8.3 3.5 8.7 6.9 5.4 1.7 11.3 13.7 7.6 0.1 2.3 5.0 8.3 3.9 9.5 0.1 13.0 3.3 6.9 4.7 5.4 3.3 16.1 2.3 1.6 9.2 10.6 2.4 19.3 8.5 7.1 7.0 1.6 8.4 3.0 15.5 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728093-104859919 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 41.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: " "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.50e-4)" "unprognostic (1.75e-1)" 6.4 5.4 12.7 3.7 16.1 4.3 6.1 15.5 13.1 6.6 4.8 6.8 2.5 3.6 8.5 2.9 8.1 5.4 5.0 5.2 7.5 8.6 9.4 2.9 5.7 3.5 8.8 9.6 6.4 3.8 12.0 7.4 41.9 10.2 6.1 3.3 7.7 6.2 6.9 4.4 4.8 3.6 6.5 9.5 4.1 3.9 14.1 8.9 5.4 7.1 2.7 3.9 6.4 5.8 2.9 2.4 2.2 2.9 2.2 3.9 1.6 3.5 2.5 10.7 13.4 6.4 8.5 12.7 7.2 11.1 4.6 6.9 2.3 2.1 2.0 3.2 5.4 2.4 2.7 4.9 9.7 8.2 6.8 7.1 2.3 3.1 6.4 6.1 2.3 5.7 4.5 5.9 5.0 7.5 6.8 2.3 9.0 2.6 4.5 3.6 4.7 2.4 7.2 12.2 0.8 3.7 6.1 5.8 8.7 3.9 4.1 2.1 2.6 8.4 7.9 3.7 3.1 9.9 6.8 3.3 3.6 6.9 3.9 5.8 6.7 0.0 1.9 2.2 3.7 2.9 3.9 2.9 3.7 3.6 1.9 2.7 3.9 3.0 0.4 2.2 1.5 2.4 1.2 1.6 12.7 16.1 15.5 13.1 7.5 8.6 8.8 9.6 10.2 8.9 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560704-15601852 "Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 34.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035496: AB_10601328, HPA035497: , HPA073760: " "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 12.9 12.1 9.1 7.3 12.5 7.6 11.6 20.7 14.1 9.0 22.4 13.5 5.8 39.6 13.1 13.2 6.7 7.9 6.6 7.9 6.7 6.0 18.8 38.1 7.5 9.0 9.1 8.3 7.9 14.3 12.9 16.8 6.4 10.1 8.2 9.0 10.9 8.5 6.9 15.7 9.9 31.6 7.2 8.2 11.0 11.5 18.4 10.3 16.6 15.1 6.1 10.7 8.2 6.5 8.5 6.5 34.1 9.1 9.1 9.3 5.0 6.0 12.3 4.0 13.7 6.9 5.5 38.9 5.8 9.5 12.5 12.3 12.8 5.9 6.1 4.2 7.9 4.4 9.1 11.3 11.2 5.1 17.3 12.1 9.4 12.3 10.4 13.1 10.5 6.3 8.3 17.7 7.4 15.7 9.9 10.3 10.7 13.2 6.4 6.2 9.0 14.4 5.9 9.7 8.1 13.4 9.4 4.2 5.5 8.7 9.5 11.5 3.1 12.3 9.6 6.8 6.7 8.4 10.7 12.7 21.4 12.1 12.8 12.0 7.7 34.1 6.5 7.0 6.0 8.2 9.3 6.4 6.5 7.5 6.5 8.5 6.4 7.1 1.4 9.1 9.1 4.0 7.8 5.0 9.1 12.5 20.7 14.1 6.7 6.0 9.1 8.3 10.1 10.3 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell line enriched" "Detected in some" 7 "SH-SY5Y: 50.8" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Approved Uncertain "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.4;placenta: 62.9" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 117.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "hippocampal formation: 0.3" "HPA019591, CAB025576" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB025576: , HPA019591: " "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.2 24.2 0.2 10.9 0.2 0.0 4.7 0.4 0.2 34.3 42.7 0.2 7.5 1.9 42.7 7.9 16.6 9.7 61.4 54.1 0.2 0.2 0.2 8.2 0.2 0.1 0.2 0.0 13.4 3.8 0.0 0.3 62.9 0.0 13.1 3.6 5.2 1.1 4.2 0.6 1.7 13.5 37.5 0.2 1.8 19.9 5.4 0.0 0.0 1.5 2.7 2.2 25.7 12.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.7 3.4 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 0.0 0.0 0.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.8 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell line enriched" "Detected in some" 7 "REH: 45.1" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076992 Enhanced Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA076992: " "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favourable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 6.2 3.2 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 0.4 45.1 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell line enhanced" "Detected in many" "HDLM-2: 20.6;U-2 OS: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavourable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.3 0.9 9.6 2.7 3.0 3.0 2.6 0.6 1.0 1.3 2.7 4.0 0.0 7.6 3.3 1.0 9.1 1.2 0.0 20.6 8.0 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 1.9 0.1 4.5 0.0 5.9 0.4 0.1 0.0 0.0 7.1 0.1 0.0 0.4 7.2 1.8 0.1 0.1 2.6 0.5 0.5 3.6 0.0 0.3 0.8 6.9 20.6 5.2 0.4 0.9 0.0 0.0 2.5 0.0 5.9 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: " "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 3.3 5.9 6.3 3.3 13.9 7.5 3.7 2.6 8.5 3.8 4.4 11.8 5.4 4.0 3.6 5.4 4.4 3.3 3.7 3.7 6.0 4.4 4.6 4.9 3.2 4.6 16.6 4.2 2.6 4.8 5.4 8.3 5.9 9.2 3.6 5.3 3.4 4.5 3.0 4.9 5.0 4.1 4.5 7.7 4.3 6.2 19.2 13.0 4.8 4.1 0.6 5.0 4.4 3.1 6.7 8.2 20.3 10.2 6.0 10.1 4.5 3.7 6.1 5.1 4.8 10.1 6.2 6.0 5.4 5.2 7.5 9.4 4.2 4.3 6.5 3.5 4.4 7.3 5.4 4.7 7.0 7.6 6.4 6.6 4.7 4.7 11.7 6.1 9.0 7.7 12.7 4.9 9.7 4.6 10.3 8.2 6.1 7.9 7.5 2.6 13.7 7.4 5.1 7.1 11.5 5.8 4.4 4.8 4.0 6.4 6.9 7.7 11.5 5.4 4.4 7.5 5.8 9.8 4.8 7.8 8.3 7.0 5.7 3.7 7.6 20.3 7.5 10.2 10.1 10.2 7.1 5.0 8.3 7.5 6.2 6.7 8.1 8.9 11.1 6.0 9.2 8.2 9.8 4.5 6.3 13.9 2.6 8.5 6.0 4.4 16.6 4.2 9.2 13.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell line enriched" "Detected in some" 4 "U-87 MG: 49.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA067602: " "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 11.7 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 49.8 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 HAUS1 "CCDC5, FLJ40084, HEI-C, HsT1461" ENSG00000152240 "HAUS augmin like complex subunit 1" Q96CS2 18 46104332-46128333 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040601, HPA040652" Supported Supported Centrosome,Cytosol Cytosol Centrosome "HPA040601: AB_10794743, HPA040652: AB_10793966" "unprognostic (1.74e-2)" "unprognostic (1.89e-2)" "unprognostic (8.13e-3)" "unprognostic (1.92e-1)" "unprognostic (2.29e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (1.39e-1)" "unprognostic (4.76e-3)" "prognostic favourable (1.55e-4)" "unprognostic (3.75e-1)" "prognostic unfavourable (6.76e-4)" "unprognostic (5.97e-3)" "unprognostic (5.40e-2)" "unprognostic (9.79e-3)" "unprognostic (3.66e-2)" "unprognostic (7.96e-2)" 15.2 11.8 10.3 14.6 13.1 23.1 14.5 15.8 12.2 14.3 13.4 6.2 13.1 9.9 15.5 28.4 15.9 13.8 11.6 9.3 10.3 8.0 14.4 12.1 10.9 22.9 13.6 6.8 20.4 12.0 6.5 18.1 13.0 12.0 14.8 16.3 7.3 11.4 14.4 7.1 8.6 13.4 12.2 14.4 17.9 12.2 11.8 15.4 38.4 14.3 14.4 26.1 13.9 12.3 28.1 23.4 13.0 18.2 19.3 34.9 19.3 18.4 11.2 42.5 22.9 10.9 16.9 11.4 18.1 18.1 28.9 28.8 10.9 10.5 35.3 10.9 12.9 19.7 25.4 15.3 31.9 19.8 17.0 25.9 12.0 20.6 9.2 47.2 15.9 8.2 6.1 17.8 9.2 31.5 18.4 10.1 25.8 10.8 37.4 22.6 27.1 6.6 37.5 30.5 25.2 22.8 13.0 20.0 20.8 16.8 5.8 13.6 8.5 23.0 17.8 17.0 11.5 7.3 18.8 11.8 17.9 32.7 10.8 40.1 19.4 4.4 18.2 13.0 16.0 16.4 17.7 28.1 21.6 18.9 21.6 23.7 15.4 18.1 2.0 19.3 12.7 23.4 34.9 19.3 10.3 13.1 15.8 12.2 10.3 8.0 13.6 6.8 12.0 15.4 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.3 6.0 11.0 7.0 5.6 6.3 10.7 11.5 6.9 10.9 9.1 12.2 7.2 7.3 5.7 6.3 19.0 11.7 7.4 10.9 9.4 6.8 10.0 10.6 9.5 8.0 17.5 9.1 5.5 5.6 8.6 8.9 10.9 17.3 9.0 10.5 7.1 12.8 14.1 9.6 7.9 14.4 13.4 9.4 6.9 8.1 9.0 7.4 11.5 11.1 6.8 11.1 13.0 8.6 16.7 12.2 25.8 21.3 13.7 38.3 21.9 10.4 19.2 12.7 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 HAUS3 "C4orf15, dgt3, IT1, MGC4701" ENSG00000214367 "HAUS augmin like complex subunit 3" Q68CZ6 4 2227464-2242164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040649, HPA048190" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Mitochondria" "Microtubules, Mitochondria" "Cytokinetic bridge, Mitotic spindle" "HPA040649: , HPA048190: " "unprognostic (4.22e-2)" "unprognostic (1.50e-1)" "unprognostic (6.30e-2)" "unprognostic (2.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.57e-3)" "unprognostic (7.63e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.79e-2)" "unprognostic (2.15e-2)" "unprognostic (2.79e-1)" "unprognostic (4.40e-2)" "prognostic favourable (4.78e-5)" 11.7 10.8 15.5 10.9 14.7 44.4 11.5 26.3 14.3 8.6 9.5 10.0 8.6 9.6 11.0 9.1 10.3 8.8 6.9 6.3 11.8 5.9 7.8 8.8 11.1 15.0 11.7 11.0 10.8 13.6 7.3 18.9 10.3 10.5 10.7 8.8 6.0 10.8 8.5 9.0 10.4 11.2 9.6 14.5 15.2 10.5 12.5 13.7 20.7 9.8 4.3 13.0 9.3 9.6 11.0 8.6 14.9 7.8 12.2 15.6 7.6 9.7 4.9 14.3 14.1 6.8 9.6 14.1 15.6 6.8 14.2 13.1 8.6 12.6 18.3 6.7 5.9 9.0 11.5 7.8 18.2 7.0 7.6 10.9 11.6 7.1 5.5 11.4 12.4 5.4 10.5 12.7 6.5 11.5 20.8 22.2 14.2 5.0 16.6 19.8 12.2 11.9 13.2 12.8 11.0 7.2 7.0 17.8 9.8 9.6 7.0 8.9 15.2 7.5 8.1 17.6 9.5 10.7 16.4 11.2 11.2 17.1 9.4 17.1 13.2 10.1 5.5 14.9 10.9 7.4 14.4 7.7 11.5 12.2 5.0 11.0 13.4 12.1 6.4 12.2 7.8 8.6 15.6 7.6 15.5 14.7 26.3 14.3 11.8 5.9 11.7 11.0 10.5 13.7 HAUS4 "C14orf94, FLJ20424" ENSG00000092036 "HAUS augmin like complex subunit 4" Q9H6D7 14 22946228-22957161 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA029803, HPA071195" Approved Supported "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA029803: AB_10601428, HPA071195: " "unprognostic (8.47e-3)" "unprognostic (3.52e-1)" "unprognostic (6.47e-2)" "unprognostic (7.59e-2)" "unprognostic (3.08e-2)" "unprognostic (1.73e-1)" "unprognostic (7.54e-2)" "unprognostic (4.32e-3)" "unprognostic (2.92e-2)" "unprognostic (2.87e-2)" "unprognostic (7.70e-2)" "unprognostic (8.66e-2)" "unprognostic (3.00e-2)" "unprognostic (6.94e-2)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "prognostic unfavourable (2.24e-4)" 17.2 16.7 11.0 28.8 15.0 29.8 22.3 9.9 15.6 20.3 24.0 13.8 22.3 15.3 17.8 20.7 25.4 16.9 30.6 19.5 12.3 8.3 16.8 17.9 24.0 30.6 17.7 9.2 33.8 29.1 17.5 9.8 12.1 13.4 19.1 16.9 14.2 22.0 19.2 14.4 21.7 24.9 23.3 17.6 24.5 19.3 12.2 17.4 33.7 23.2 17.2 21.2 18.9 19.5 14.0 35.3 34.5 28.2 7.8 15.4 15.3 25.6 17.5 20.2 20.0 14.9 18.7 30.4 12.9 17.2 14.1 19.9 12.5 30.7 49.6 6.2 7.7 26.0 10.7 15.4 11.9 13.4 8.1 16.7 12.3 30.5 13.6 21.4 27.8 12.7 29.9 6.0 18.4 24.5 11.6 24.8 15.1 19.8 23.3 19.0 10.6 17.8 22.4 24.3 19.1 12.2 14.1 8.1 13.2 18.5 19.2 11.3 16.7 17.3 13.5 12.9 16.7 9.3 11.3 26.3 22.6 23.0 6.1 24.2 7.3 2.1 28.2 5.8 5.8 18.3 7.8 14.0 10.9 8.3 35.3 11.6 15.4 11.8 34.5 7.8 11.3 9.9 14.6 15.3 11.0 15.0 9.9 15.6 12.3 8.3 17.7 9.2 13.4 17.4 HAUS6 "dgt6, FAM29A, FLJ20060, KIAA1574" ENSG00000147874 "HAUS augmin like complex subunit 6" Q7Z4H7 9 19053143-19103119 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020960, HPA020965" Approved Supported "Nuclear speckles,Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "Nuclear speckles" "HPA020960: AB_1848393, HPA020965: AB_1848394" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (6.04e-3)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.21e-1)" "unprognostic (2.15e-1)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (1.48e-2)" "prognostic unfavourable (3.13e-5)" "unprognostic (2.52e-1)" "unprognostic (1.68e-1)" "unprognostic (3.13e-2)" "unprognostic (2.03e-1)" 8.7 9.6 10.9 9.2 13.1 17.5 11.1 10.8 10.3 7.7 7.0 9.9 5.6 4.9 8.9 8.0 7.0 7.4 6.4 7.1 10.5 7.3 5.2 11.0 7.1 12.8 15.0 8.9 11.1 6.3 5.8 8.5 8.4 12.4 7.6 7.9 5.6 7.1 7.4 7.2 9.8 7.2 8.9 13.5 10.0 5.8 27.1 13.6 27.3 6.6 3.8 12.7 7.0 7.1 3.6 2.6 10.9 2.2 7.2 6.1 2.5 10.8 7.4 15.3 11.9 5.9 7.1 8.3 11.7 8.3 10.8 16.7 3.8 5.0 12.7 4.3 6.7 4.5 14.0 6.8 16.8 11.6 6.7 67.7 13.5 8.7 3.9 8.9 15.5 4.4 7.1 10.2 22.3 7.8 9.2 8.4 12.4 3.5 17.4 15.2 16.3 7.5 13.6 10.4 5.2 5.8 6.3 8.9 12.3 5.2 4.8 7.4 3.8 11.3 7.7 9.7 5.9 8.3 13.4 3.3 7.3 12.6 9.1 7.6 4.2 10.9 2.2 2.2 4.5 2.2 6.1 3.5 4.3 5.6 2.2 3.6 5.2 4.6 3.5 7.2 2.0 2.6 5.4 2.5 10.9 13.1 10.8 10.3 10.5 7.3 15.0 8.9 12.4 13.6 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Nucleoli,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Centrosome, Cytosol" Nucleoli "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favourable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavourable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 13.1 9.4 16.1 10.3 16.4 9.4 7.9 9.1 19.3 12.7 9.3 8.9 20.3 7.9 10.8 17.1 7.0 9.9 15.1 11.9 20.3 9.1 13.3 11.9 9.4 12.1 12.0 16.5 9.3 4.3 3.1 6.4 12.6 11.1 11.8 6.2 7.8 8.5 17.4 7.2 46.9 7.4 12.1 8.9 16.4 8.8 6.1 18.4 14.2 10.8 8.8 9.8 7.5 11.8 20.2 22.3 10.1 31.1 16.7 18.5 15.8 13.7 22.2 9.8 19.1 3.5 4.8 13.7 9.5 5.4 11.0 19.7 16.1 7.7 13.2 30.7 6.5 11.7 14.1 9.6 8.6 15.8 23.2 9.6 20.6 12.0 3.1 15.8 13.9 7.3 2.5 9.8 6.2 7.8 12.0 6.8 6.5 26.5 14.8 19.1 6.1 22.2 13.9 16.2 19.9 3.5 8.7 10.9 8.3 5.2 11.3 3.9 4.5 7.6 5.0 9.5 19.0 22.2 17.4 9.9 26.2 51.5 5.1 28.4 13.1 4.7 26.2 10.1 17.0 31.1 17.8 20.2 18.5 17.1 22.3 16.6 18.4 16.7 3.4 16.7 27.1 12.6 15.5 15.8 16.1 16.4 9.1 19.3 20.3 9.1 12.0 16.5 11.1 18.4 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favourable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 16.9 18.6 17.5 13.0 27.3 31.8 18.0 23.2 34.7 16.7 14.9 18.2 9.2 10.1 15.6 10.8 20.0 13.8 12.0 22.3 18.4 18.8 17.4 28.4 11.7 16.3 21.1 16.0 15.6 20.4 19.5 25.4 18.7 33.6 14.2 13.5 11.0 17.1 14.1 66.4 14.7 15.3 18.6 25.0 14.4 14.2 14.0 17.1 42.5 17.5 19.9 18.5 16.3 13.6 25.2 28.4 38.4 24.6 32.9 38.4 28.3 14.8 10.0 20.9 30.3 19.2 17.1 16.0 30.1 26.0 28.7 35.6 16.7 11.2 25.8 13.6 26.6 11.2 29.2 22.1 44.9 26.2 20.0 78.9 28.4 22.4 23.1 48.7 21.6 16.9 16.9 27.2 33.4 23.7 42.1 21.8 30.3 14.1 29.9 12.3 13.5 10.9 28.1 23.3 17.6 17.7 14.2 20.7 14.1 20.6 21.6 21.4 18.0 29.4 22.4 20.4 21.3 25.2 31.8 49.7 35.8 43.8 31.1 25.4 25.3 38.4 24.6 25.4 23.4 22.1 26.3 25.2 28.1 23.8 28.4 22.6 38.4 31.6 11.2 32.9 21.1 22.6 32.9 28.3 17.5 27.3 23.2 34.7 18.4 18.8 21.1 16.0 33.6 17.1 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 152687-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.9;placenta: 5.0;testis: 9.9" "Cell line enriched" "Detected in some" 79 "K-562: 222.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol 160000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: " "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.8 0.0 0.8 0.1 0.5 8.9 0.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.6 3.3 0.7 0.3 0.1 1.1 0.6 0.1 1.1 0.1 0.7 0.1 0.0 0.1 5.0 0.1 1.2 0.0 0.1 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.8 0.1 9.9 0.1 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.6 0.6 0.7 0.3 1.1 0.1 0.1 0.1 HCFC1 "CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF" ENSG00000172534 "Host cell factor C1" P51610 X 153947553-153971807 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Chromatin regulator" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018312 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA018312: AB_1850522" "unprognostic (2.05e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (2.64e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (4.31e-6)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "prognostic favourable (9.62e-5)" "unprognostic (1.45e-1)" "unprognostic (1.29e-3)" "unprognostic (1.99e-2)" "unprognostic (2.12e-1)" "unprognostic (1.73e-2)" "unprognostic (2.80e-1)" 16.0 19.2 18.2 23.7 18.5 48.3 14.2 24.4 23.3 13.9 20.0 17.3 14.1 16.8 26.3 13.6 18.2 18.8 20.8 14.7 17.0 12.7 15.6 17.2 19.0 24.9 14.6 16.1 20.4 15.6 21.9 26.4 13.8 15.8 17.7 11.2 13.8 21.5 20.6 27.8 18.2 18.3 19.7 20.0 25.2 18.0 15.3 17.9 52.3 16.4 15.6 17.6 17.4 18.3 4.8 8.0 1.7 5.6 2.8 6.7 3.5 15.2 19.9 13.5 17.1 5.7 4.1 19.9 6.3 4.9 7.5 6.8 21.0 10.3 27.8 16.2 8.1 12.6 14.6 10.3 3.9 14.7 17.2 16.6 15.9 16.5 3.9 20.4 27.6 6.3 6.7 13.0 5.7 7.9 23.1 17.6 5.2 21.4 28.2 26.4 17.6 12.2 33.0 11.1 16.8 5.6 14.2 15.1 16.4 11.6 12.1 6.4 11.1 18.5 10.4 14.3 17.6 12.3 20.2 28.1 38.3 34.8 11.6 19.9 13.4 1.7 4.0 1.7 6.0 5.6 4.3 4.8 4.8 4.6 4.5 4.4 4.9 6.7 0.8 2.8 4.0 8.0 3.2 3.5 18.2 18.5 24.4 23.3 17.0 12.7 14.6 16.1 15.8 17.9 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064457-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 11.5 10.0 11.9 4.7 13.2 3.2 12.9 3.8 11.1 11.5 14.4 9.1 8.7 7.2 12.6 7.5 9.1 8.5 8.1 7.7 9.3 5.8 8.5 10.2 9.1 5.9 12.5 8.1 11.8 9.1 10.4 14.3 10.6 10.0 10.8 6.3 6.8 8.0 14.6 17.5 7.4 7.5 19.0 10.2 6.8 9.9 19.2 11.0 9.1 10.1 5.1 5.0 12.8 10.3 1.8 2.2 2.8 5.0 2.5 3.2 1.7 1.9 2.1 2.2 1.9 12.4 12.4 1.6 8.5 3.9 6.5 3.8 1.0 0.9 1.9 3.0 6.6 2.1 2.7 1.5 7.1 3.2 2.6 1.9 2.0 0.9 8.4 1.6 3.1 7.7 4.2 4.1 3.4 5.0 2.2 4.0 11.6 1.7 2.8 3.7 0.4 4.4 2.3 7.3 1.2 2.9 1.3 3.2 2.4 4.2 3.0 3.2 4.8 1.7 7.5 10.4 1.4 5.3 2.8 5.1 1.5 1.7 4.9 2.1 4.1 1.3 2.0 2.8 2.6 3.7 3.1 1.6 2.5 3.2 2.2 1.8 3.0 3.2 0.5 2.5 5.0 1.2 2.8 1.7 11.9 13.2 3.8 11.1 9.3 5.8 12.5 8.1 10.0 11.0 HCK JTK9 ENSG00000101336 "HCK proto-oncogene, Src family tyrosine kinase" P08631 20 32052188-32101856 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 107.1;lymphoid tissue: 72.6" "Group enriched" "Detected in some" 8 "THP-1: 22.6;U-937: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1" "Group enriched" "Detected in many" 15 "dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005195, HPA063768" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB005195: AB_631619, HPA063768: " "unprognostic (6.22e-2)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "unprognostic (7.98e-2)" "unprognostic (8.83e-2)" "unprognostic (5.50e-2)" "unprognostic (4.09e-2)" "unprognostic (1.72e-2)" "unprognostic (4.34e-2)" "unprognostic (1.59e-1)" "unprognostic (4.08e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.66e-4)" "unprognostic (4.92e-2)" "unprognostic (4.42e-2)" "unprognostic (6.95e-2)" "unprognostic (1.12e-1)" 12.3 5.8 5.9 40.8 13.1 20.8 4.0 1.8 5.3 3.0 5.8 6.1 0.9 5.9 2.5 5.7 3.1 5.9 6.5 8.8 6.0 3.7 4.0 7.9 20.9 50.3 11.2 1.2 3.4 2.8 0.7 2.9 8.8 8.0 3.8 5.9 3.1 4.1 1.9 3.1 2.8 7.8 10.2 9.1 72.6 3.7 2.6 8.2 5.8 3.3 1.2 16.4 9.4 3.5 4.7 31.6 73.0 107.1 1.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 22.6 0.0 0.0 0.1 0.0 0.0 0.6 0.1 3.3 0.0 64.8 0.0 0.5 50.8 62.5 0.1 96.5 0.1 4.7 0.1 0.1 31.6 3.7 0.1 0.0 73.0 1.1 107.1 2.8 0.1 40.2 5.9 13.1 1.8 5.3 6.0 3.7 11.2 1.2 8.0 8.2 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.7;lymphoid tissue: 110.1" "Cell line enhanced" "Detected in many" "Daudi: 42.3;HMC-1: 60.1;THP-1: 41.9;U-266/70: 59.5;U-698: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" 200000 "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 24.7 10.7 7.8 44.9 14.7 35.5 9.1 1.3 7.4 6.3 10.4 8.5 2.2 5.5 5.6 8.2 4.8 9.1 10.1 7.5 6.7 5.0 10.5 10.1 18.7 59.4 12.9 3.2 4.6 5.1 1.4 6.1 15.4 10.9 6.1 8.6 4.9 7.4 3.1 7.0 4.6 23.0 8.9 15.1 110.1 7.1 3.6 11.6 41.0 6.1 4.4 61.5 12.5 5.6 33.4 59.6 149.7 84.9 24.3 44.1 103.5 0.1 0.0 0.0 0.0 3.5 1.9 0.9 0.6 0.6 0.1 0.2 0.0 0.0 42.3 20.6 0.0 0.0 1.1 1.6 0.1 18.8 0.0 27.4 0.0 0.0 1.9 30.1 60.1 0.3 0.0 0.0 0.3 24.9 5.4 39.1 0.0 0.0 21.3 25.4 0.0 0.7 21.6 0.0 40.2 0.0 11.0 0.0 0.0 0.0 0.0 0.1 0.0 41.9 32.5 0.0 0.3 0.0 0.1 59.5 18.1 59.5 0.3 29.0 0.0 26.6 64.1 104.2 40.2 80.6 32.9 33.4 33.3 36.8 59.6 29.4 28.5 33.0 149.7 24.3 84.9 18.5 44.1 103.5 7.8 14.7 1.3 7.4 6.7 5.0 12.9 3.2 10.9 11.6 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902480-35904377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1" "Cell line enhanced" "Detected in some" "HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" "Plasma membrane" "Vesicles, Centriolar satellite" "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favourable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 29.4 4.0 6.5 19.9 5.2 84.0 5.9 1.4 3.1 3.9 4.9 4.8 0.5 4.5 5.4 6.0 3.0 4.5 6.3 7.3 5.7 5.9 5.6 6.9 38.4 79.1 7.7 2.2 3.4 2.9 0.7 4.3 10.6 4.9 5.5 3.6 7.1 6.2 3.7 2.4 2.8 10.9 4.5 12.7 49.5 5.6 1.7 4.4 56.8 3.4 3.3 26.7 5.2 3.6 6.1 66.6 15.9 57.0 96.4 134.0 89.5 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.2 5.6 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 51.7 0.1 0.1 0.1 29.8 34.5 0.3 0.0 0.0 0.0 0.0 0.4 7.4 0.1 0.0 3.4 11.6 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 39.1 0.1 0.3 0.4 0.0 0.0 0.3 0.2 8.5 0.3 58.7 0.0 7.3 57.0 7.9 134.0 42.0 99.3 6.1 57.4 108.5 32.6 3.7 48.3 96.4 15.9 96.4 23.0 66.6 48.5 89.5 6.5 5.2 1.4 3.1 5.7 5.9 7.7 2.2 4.9 4.4 HDAC3 "HD3, RPD3, RPD3-2" ENSG00000171720 "Histone deacetylase 3" O15379 5 141620876-141636870 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005583, HPA052052, CAB072336" Supported Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB005583: AB_562296, CAB072336: , HPA052052: " "unprognostic (6.65e-2)" "unprognostic (1.96e-1)" "prognostic favourable (3.39e-4)" "unprognostic (1.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (5.56e-2)" "unprognostic (2.45e-2)" "prognostic favourable (3.95e-4)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.65e-6)" "unprognostic (1.85e-1)" "unprognostic (1.63e-2)" "unprognostic (2.28e-3)" "unprognostic (2.17e-1)" 15.9 28.8 19.6 12.2 17.6 18.1 18.6 22.6 20.8 15.6 14.1 11.2 13.1 10.6 17.3 17.6 22.8 16.3 14.0 16.8 18.0 8.9 14.5 23.3 24.4 36.4 13.4 14.2 17.3 24.7 20.9 17.3 14.3 18.8 13.6 14.4 13.6 17.5 13.7 24.5 26.7 15.2 17.2 10.8 20.1 15.5 11.9 12.6 18.5 14.4 9.6 23.7 17.5 17.0 22.1 46.7 16.4 22.6 14.1 23.1 16.9 21.1 14.3 26.6 40.4 25.8 20.6 17.3 15.4 33.9 35.0 50.2 30.7 18.1 30.7 20.0 20.0 18.3 26.8 36.1 43.4 26.2 28.8 24.0 13.2 17.4 18.2 28.9 22.0 17.5 23.3 20.3 26.4 22.5 23.4 16.4 22.1 20.0 32.0 25.0 23.5 11.4 23.2 27.9 22.1 18.7 21.3 22.3 18.1 20.4 21.2 25.4 22.6 18.3 11.3 21.7 13.6 16.6 25.2 13.4 16.4 28.9 18.3 27.5 18.6 13.2 22.4 16.4 15.9 22.6 20.8 22.1 19.8 19.2 46.7 20.1 21.7 18.0 9.5 14.1 19.0 23.9 23.1 16.9 19.6 17.6 22.6 20.8 18.0 8.9 13.4 14.2 18.8 12.6 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.6" "Cell line enhanced" "Detected in many" "MOLT-4: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3" "Group enriched" "Detected in many" 8 "granulocytes: 28.3;monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004431, HPA048723" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoplasm, Cytosol" "CAB004431: AB_627706, HPA048723: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (6.33e-4)" "prognostic favourable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 7.9 6.8 6.1 6.8 5.2 17.1 4.6 6.4 12.3 11.3 21.4 4.6 4.3 2.5 10.2 6.4 8.8 9.0 24.6 5.2 5.0 6.0 3.2 3.1 4.2 4.3 6.1 5.4 8.5 5.8 4.9 8.3 2.5 5.2 7.5 4.8 8.3 3.7 7.3 54.6 6.9 6.5 15.8 4.2 5.4 7.0 8.1 4.3 6.5 4.8 13.2 5.6 10.2 4.6 0.5 1.7 28.3 7.4 2.1 1.2 0.4 4.3 4.3 5.5 6.6 3.1 5.3 6.5 4.5 3.1 3.6 3.4 2.0 7.8 2.0 1.8 3.9 4.3 3.8 1.8 1.8 12.0 2.0 3.2 5.3 6.3 4.2 4.9 2.9 3.6 4.6 6.6 5.3 3.8 4.5 4.6 1.7 5.3 31.6 6.7 4.3 2.2 8.2 10.4 3.2 4.1 5.5 4.4 7.8 6.3 2.8 11.1 1.5 13.4 6.1 4.2 0.3 7.2 6.1 3.3 3.1 3.9 6.1 6.8 8.3 10.5 7.4 1.1 0.9 2.4 1.1 0.5 0.9 0.8 0.8 0.5 0.5 1.0 28.3 2.1 1.0 1.7 1.2 0.4 6.1 5.2 6.4 7.5 5.0 6.0 6.1 5.4 5.2 4.3 HDAC5 "FLJ90614, KIAA0600, NY-CO-9" ENSG00000108840 "Histone deacetylase 5" Q9UQL6 17 44076746-44123702 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019400, HPA030991" Approved Supported "Nuclear speckles,Golgi apparatus,Cytosol" "Nuclear speckles" "Golgi apparatus, Cytosol" "CAB019400: AB_2116626, HPA030991: AB_10795286" "unprognostic (1.30e-2)" "prognostic favourable (6.14e-4)" "unprognostic (6.65e-2)" "unprognostic (8.06e-2)" "unprognostic (3.49e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (8.80e-3)" "unprognostic (3.80e-2)" "unprognostic (2.37e-2)" "unprognostic (4.91e-3)" "unprognostic (4.30e-1)" "prognostic favourable (3.30e-5)" "unprognostic (1.51e-2)" "unprognostic (3.11e-1)" "unprognostic (6.00e-2)" "unprognostic (1.76e-2)" 15.6 17.6 24.9 7.9 15.8 13.2 18.1 35.9 25.8 16.5 8.8 19.6 9.5 8.4 15.0 11.9 20.1 16.9 11.3 24.4 22.1 24.2 8.6 6.3 13.6 8.8 24.7 22.1 24.5 16.1 28.2 17.5 23.0 19.3 13.6 5.5 11.7 14.2 11.9 42.6 34.0 9.7 12.4 20.5 13.8 9.3 10.3 18.1 7.6 15.0 9.8 8.2 14.9 20.4 7.6 9.4 17.9 13.6 3.5 4.9 5.0 3.5 2.3 6.4 1.5 12.4 9.7 23.1 9.6 24.0 4.8 7.9 5.1 3.8 5.6 3.9 22.8 2.9 7.5 4.1 2.0 8.7 12.2 10.9 7.7 11.7 5.3 3.5 15.4 13.7 7.1 5.5 6.9 3.9 8.1 11.4 27.8 2.7 5.8 10.7 7.0 5.5 22.5 17.9 14.4 0.5 1.6 16.7 8.8 2.8 11.8 13.0 16.8 20.7 2.1 12.1 7.8 2.8 4.8 18.8 15.7 6.7 7.0 4.4 5.7 7.1 7.3 7.7 4.9 11.6 3.5 6.6 3.9 4.9 9.4 7.6 4.1 3.5 17.9 3.5 13.6 8.3 3.5 5.0 24.9 15.8 35.9 25.8 22.1 24.2 24.7 22.1 19.3 18.1 HDAC8 "HDACL1, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573103 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease mutation, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048560 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA048560: " "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.6 22.5 14.7 9.9 16.2 10.2 12.4 31.4 20.6 12.6 10.4 13.9 11.5 8.6 12.3 28.2 11.0 9.4 9.4 12.6 15.0 15.2 16.8 18.6 10.2 9.6 14.9 9.4 12.8 15.9 13.6 22.0 11.2 19.3 13.3 12.8 14.3 12.2 10.3 10.4 9.3 8.4 13.1 12.2 9.5 10.7 3.6 14.0 8.0 15.0 8.2 11.9 10.4 10.1 9.4 12.8 19.7 13.2 7.7 11.4 7.7 12.3 16.9 12.4 17.2 17.0 12.7 8.6 7.1 13.9 11.0 12.5 12.2 12.7 8.6 22.7 9.8 9.0 23.1 13.9 14.7 14.1 16.4 11.3 21.7 14.2 9.3 18.8 20.1 13.3 10.3 13.5 10.1 16.9 12.6 24.1 14.7 15.5 8.8 24.7 17.2 24.4 12.1 16.0 15.4 19.2 13.0 8.9 19.4 16.9 13.5 17.3 6.8 16.1 12.7 9.1 13.1 13.0 8.0 9.2 14.7 10.9 12.3 20.8 11.7 7.2 13.2 19.7 8.8 11.8 6.9 9.4 9.5 7.3 12.8 9.1 7.6 7.1 0.7 7.7 10.5 4.8 11.4 7.7 14.7 16.2 31.4 20.6 15.0 15.2 14.9 9.4 19.3 14.0 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli 19000 Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 17.5 29.8 50.5 12.0 36.1 11.3 21.1 26.4 31.7 14.8 15.2 11.1 31.6 12.4 12.9 25.2 19.6 17.2 12.4 34.7 41.1 37.0 31.3 8.9 13.4 18.8 45.0 18.9 18.3 22.9 16.3 15.6 11.5 23.4 15.7 16.9 19.3 54.8 42.0 42.8 13.5 16.1 19.0 25.8 12.2 14.4 25.7 16.8 12.9 24.3 35.4 18.2 17.7 11.2 27.3 15.4 4.4 14.2 23.6 33.9 17.7 8.4 23.6 14.7 60.2 11.9 16.5 20.5 11.4 17.4 12.4 12.8 37.1 10.2 39.2 24.6 21.6 8.4 20.6 16.7 15.8 15.4 48.3 18.1 13.2 36.4 27.3 23.4 13.4 23.0 25.7 17.6 40.5 8.8 68.4 16.9 26.6 47.0 18.1 24.7 17.3 19.2 27.3 11.7 8.2 28.8 10.8 28.8 14.0 13.9 27.1 24.9 15.9 39.8 5.4 12.5 13.7 19.1 22.9 20.2 13.9 32.4 17.9 42.4 25.4 4.4 14.2 2.5 22.9 12.2 18.7 27.3 25.3 31.0 14.7 22.0 31.4 33.9 3.2 23.6 11.1 15.4 21.5 17.7 50.5 36.1 26.4 31.7 41.1 37.0 45.0 18.9 23.4 16.8 HDDC3 MGC45386 ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929964-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 14.3 18.8 16.3 8.9 17.1 10.7 11.3 10.3 17.6 8.2 13.1 9.3 12.6 12.4 5.4 12.8 7.7 12.7 7.1 15.2 12.9 12.3 14.7 18.3 7.8 9.0 14.6 12.5 10.3 30.3 15.1 10.4 10.4 11.0 8.7 11.1 9.7 24.8 14.0 14.2 9.3 17.1 6.1 11.4 13.1 11.2 4.5 8.2 11.8 12.0 10.1 10.7 7.5 7.5 19.9 25.3 5.6 15.6 16.4 21.5 14.3 6.9 8.5 3.0 3.6 6.9 7.0 5.0 4.6 6.4 4.4 6.5 4.3 14.4 13.0 4.9 3.9 10.8 6.3 10.9 3.7 16.5 13.2 16.5 3.3 9.6 14.1 6.2 8.1 6.1 17.2 8.0 14.4 9.6 13.1 11.8 3.9 10.1 8.5 5.4 2.4 8.8 7.2 1.1 20.8 9.0 7.3 7.6 4.9 3.9 11.0 11.7 16.6 17.0 5.5 2.7 6.1 4.6 6.0 19.4 21.7 9.0 10.1 12.3 8.1 5.6 11.8 4.7 14.0 15.6 18.4 19.9 18.4 16.2 15.9 17.5 21.5 15.7 2.8 16.4 14.2 25.3 17.4 14.3 16.3 17.1 10.3 17.6 12.9 12.3 14.6 12.5 11.0 8.2 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472287-4502211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favourable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 10.3 9.6 15.4 10.0 13.6 8.1 10.3 15.3 21.0 9.7 8.8 9.0 8.0 10.1 12.3 10.4 6.6 10.2 9.9 8.5 16.6 13.5 9.8 9.9 7.3 10.2 11.9 13.2 15.9 10.6 8.3 10.2 9.6 10.5 10.1 5.0 7.8 11.3 16.8 39.4 10.9 9.2 12.0 8.8 10.3 9.2 49.1 9.5 13.6 7.3 6.2 7.4 7.7 9.0 7.0 2.2 3.6 1.8 2.3 2.4 0.8 27.4 16.2 28.2 26.1 12.3 12.6 19.7 22.2 12.0 24.4 21.8 18.5 12.0 24.2 13.0 16.3 15.8 18.7 20.2 14.4 27.1 29.7 14.9 12.2 24.4 15.9 14.6 21.3 17.9 11.0 16.8 8.2 22.3 17.1 30.6 11.8 19.5 33.1 29.4 32.2 29.2 33.0 23.2 15.6 15.2 14.1 31.2 30.8 21.6 12.4 17.9 12.2 23.3 29.4 15.5 21.1 29.0 20.9 38.0 19.8 17.0 21.7 23.6 16.3 0.0 1.8 3.6 1.4 1.1 0.4 1.1 1.5 1.1 1.6 7.0 2.4 0.9 0.5 2.3 0.6 2.2 1.8 0.8 15.4 13.6 15.3 21.0 16.6 13.5 11.9 13.2 10.5 9.5 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 54.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favourable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favourable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 4.9 54.7 5.1 10.1 8.4 3.3 12.7 6.2 8.5 6.0 29.8 5.6 10.6 38.2 6.4 15.5 13.8 5.8 18.1 9.1 4.6 5.3 17.7 36.6 4.4 6.3 4.5 9.4 7.2 23.7 20.5 9.1 6.5 7.3 10.6 16.8 8.3 24.4 12.5 2.8 11.4 47.1 8.0 4.8 6.0 17.7 4.5 4.0 8.0 18.2 6.1 6.8 7.0 6.9 12.1 10.6 5.9 2.9 5.6 12.3 5.8 3.6 10.5 2.3 6.3 5.7 2.5 19.2 2.7 5.2 4.4 4.9 19.2 18.4 8.1 3.4 1.5 14.4 3.6 4.2 1.5 11.3 8.2 11.2 5.7 11.9 6.6 0.6 8.6 3.9 9.0 3.6 10.3 2.3 8.8 2.0 2.1 23.9 5.1 3.2 5.1 8.2 4.2 0.0 6.5 5.6 7.7 5.7 3.6 4.7 20.3 6.8 12.7 2.3 2.3 0.9 0.0 0.7 0.9 5.0 9.7 3.3 1.1 0.0 0.6 0.1 2.9 5.9 9.9 1.6 11.2 11.3 11.5 9.0 4.5 12.1 12.0 8.9 1.9 5.6 0.2 10.6 12.3 5.8 5.1 8.4 6.2 8.5 4.6 5.3 4.5 9.4 7.3 4.0 HEATR1 "BAP28, FLJ10359, UTP10" ENSG00000119285 "HEAT repeat containing 1" Q9H583 1 236549005-236604504 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046917, HPA062200" Approved Enhanced "Nucleoli fibrillar center,Mitochondria" 120000 "Nucleoli fibrillar center" Mitochondria "HPA046917: , HPA062200: " "unprognostic (2.61e-1)" "unprognostic (1.44e-3)" "unprognostic (6.26e-2)" "unprognostic (1.34e-3)" "unprognostic (7.18e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (5.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.80e-1)" "unprognostic (4.67e-3)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (8.08e-2)" "unprognostic (3.38e-1)" "unprognostic (3.27e-2)" "unprognostic (4.00e-2)" 14.1 11.0 9.2 14.7 11.3 15.2 13.8 15.0 13.9 10.7 10.6 8.6 8.3 7.6 15.9 9.4 14.7 12.5 8.1 9.4 10.0 5.8 9.9 13.2 10.6 16.5 12.9 6.9 15.8 17.2 13.5 12.8 10.5 11.6 11.1 10.8 8.2 12.6 9.5 12.7 14.5 11.6 13.1 6.6 16.1 11.5 20.3 13.2 18.3 12.0 12.8 17.9 12.7 12.8 9.9 5.9 1.8 4.5 6.4 10.0 2.4 14.5 17.5 9.2 13.8 12.9 14.5 20.6 11.7 7.6 13.5 12.1 17.5 12.4 23.9 13.3 10.8 17.7 20.8 12.6 18.4 12.0 24.0 16.9 12.4 14.9 11.6 30.2 11.0 11.8 11.4 20.5 17.7 15.5 38.3 8.1 13.4 7.8 14.3 8.3 36.6 7.2 16.0 13.3 22.4 8.7 14.7 8.6 19.2 14.2 10.2 12.1 12.1 11.4 14.7 13.6 12.9 17.5 29.0 15.4 19.1 28.3 12.2 17.0 20.3 1.8 3.6 1.1 7.3 4.5 6.6 9.9 7.2 7.9 4.3 8.1 10.0 9.4 0.5 6.4 4.3 5.9 5.9 2.4 9.2 11.3 15.0 13.9 10.0 5.8 12.9 6.9 11.6 13.2 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: " "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavourable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.7 11.1 10.2 16.2 6.4 8.6 11.0 13.2 8.7 13.2 5.3 13.5 8.2 20.4 9.6 12.5 13.0 12.3 9.8 15.4 5.2 13.3 10.1 7.7 17.1 9.1 17.4 20.5 6.7 6.8 9.3 5.7 10.6 12.8 3.5 12.9 6.6 13.3 21.8 12.1 11.5 14.8 13.9 16.5 7.3 8.9 13.3 7.0 12.7 16.6 8.3 7.5 12.8 13.8 10.6 7.2 8.1 10.0 8.7 6.8 18.3 10.5 17.6 10.4 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA042025: AB_10959880, HPA055639: " "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 14.7 13.6 13.5 14.1 23.8 21.8 15.0 23.3 22.8 11.1 10.2 15.4 10.1 10.9 16.5 18.0 14.9 9.7 10.9 10.7 11.4 12.1 9.9 12.9 12.5 29.6 13.0 16.6 12.3 23.8 17.9 16.6 10.3 21.6 12.2 14.0 12.4 18.0 9.6 7.1 18.0 14.9 9.4 16.1 18.0 12.8 9.6 14.5 16.0 13.6 8.4 30.0 11.3 12.9 15.2 10.7 15.8 4.9 7.0 9.1 5.0 10.2 5.2 7.7 11.7 8.0 8.0 9.8 6.5 4.8 5.9 6.1 5.9 7.1 22.0 4.7 5.5 8.7 7.6 5.3 7.8 10.7 8.2 14.3 6.9 8.3 5.0 15.3 18.9 7.3 7.4 8.6 8.2 9.9 13.5 19.5 7.1 6.1 13.3 11.0 5.0 3.7 12.9 7.9 16.4 7.0 8.9 9.5 8.4 6.7 10.9 5.1 7.8 5.0 11.1 9.1 5.2 6.5 5.0 12.2 10.0 24.2 7.4 9.2 5.9 15.8 4.9 11.3 7.9 2.6 7.2 9.9 8.8 8.8 8.6 15.2 9.1 7.9 5.1 7.0 3.8 10.7 8.9 5.0 13.5 23.8 23.3 22.8 11.4 12.1 13.0 16.6 21.6 14.5 HEBP1 "HBP, HEBP" ENSG00000013583 "Heme binding protein 1" Q9NRV9 12 12974864-13000273 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056417, HPA075277" Approved Approved Nucleoplasm,Vesicles 130000 Vesicles Nucleoplasm "HPA056417: , HPA075277: " "unprognostic (1.65e-1)" "unprognostic (2.31e-2)" "unprognostic (9.28e-2)" "unprognostic (5.67e-3)" "unprognostic (4.45e-3)" "unprognostic (5.42e-3)" "unprognostic (2.70e-1)" "unprognostic (2.44e-1)" "unprognostic (6.04e-2)" "unprognostic (3.50e-2)" "unprognostic (1.94e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.71e-2)" "unprognostic (1.64e-1)" "unprognostic (4.02e-2)" "unprognostic (4.43e-2)" 23.4 36.0 12.3 7.6 21.1 16.0 24.5 7.7 14.0 17.7 46.8 18.0 20.0 79.8 14.2 13.9 13.9 13.6 25.4 18.3 11.8 11.7 20.4 48.5 16.2 11.2 16.7 8.0 27.8 27.6 13.3 9.0 13.9 17.2 17.8 7.6 20.0 18.2 16.4 12.8 19.1 79.1 22.9 22.2 19.3 13.4 11.2 15.1 5.5 52.8 13.9 8.7 18.2 23.9 5.3 21.4 9.0 27.4 7.1 9.4 9.9 17.3 10.4 7.3 12.8 55.2 43.0 5.0 15.7 22.4 15.1 20.2 6.6 6.3 5.1 6.3 30.7 15.7 9.0 12.5 17.6 0.7 7.4 2.8 12.5 16.7 39.6 5.0 2.7 33.0 11.8 20.0 24.8 30.8 3.1 4.3 25.5 10.8 4.0 8.2 10.1 7.4 9.4 20.7 5.2 12.1 16.6 4.0 3.7 20.9 9.7 19.5 5.1 7.5 33.7 11.1 13.5 17.6 8.1 4.1 3.3 1.8 17.7 9.1 4.4 4.6 27.4 6.8 4.3 19.8 6.0 4.9 7.3 4.7 21.4 5.3 9.4 5.4 9.0 7.1 26.5 10.7 4.1 9.9 12.3 21.1 7.7 14.0 11.8 11.7 16.7 8.0 17.2 15.1 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: " "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favourable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 22.0 22.3 14.2 21.0 16.8 22.0 18.5 22.3 18.9 19.4 17.9 15.2 20.2 11.5 17.6 15.7 30.4 16.1 15.2 26.2 13.5 14.3 18.0 35.2 15.0 14.1 14.5 14.5 18.2 15.1 34.8 20.5 27.0 18.8 16.8 15.5 16.8 18.9 16.4 88.5 24.3 16.3 15.6 13.7 16.4 18.8 18.9 14.4 16.7 24.8 23.0 18.6 18.6 22.3 10.6 9.3 12.6 8.6 8.9 8.1 3.3 28.4 17.8 15.7 9.8 49.6 26.0 15.0 17.4 17.6 15.6 13.5 13.3 15.4 22.3 18.5 31.8 19.3 20.8 15.7 23.7 13.6 8.5 22.8 14.7 53.1 23.1 23.7 16.8 22.8 21.8 17.5 27.5 28.6 16.4 10.4 24.2 23.3 9.2 10.1 11.9 16.2 17.0 18.1 9.7 24.3 29.5 11.6 13.6 25.5 17.7 15.4 18.6 15.3 28.6 18.1 14.2 13.0 14.7 11.4 16.1 25.2 8.6 12.0 15.2 12.6 8.6 11.3 7.1 7.1 8.1 7.2 8.0 6.3 9.3 10.6 6.7 6.6 4.4 8.9 5.3 7.8 8.0 3.3 14.2 16.8 22.3 18.9 13.5 14.3 14.5 14.5 18.8 14.4 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA041062: , HPA045473: " "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.6 8.5 7.5 11.6 7.9 4.9 4.1 3.9 5.3 4.5 10.3 1.9 5.9 3.8 6.7 5.7 11.1 5.4 4.0 7.6 10.0 8.4 11.2 5.7 4.1 5.9 8.2 6.5 6.6 8.2 5.4 8.1 10.4 4.6 5.1 6.2 7.0 12.5 4.0 7.9 9.5 4.3 3.8 4.3 8.9 13.9 9.5 9.6 9.4 3.6 7.1 8.4 11.7 6.3 4.6 6.5 5.5 15.7 5.9 6.6 5.1 3.9 3.9 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: " "unprognostic (1.94e-1)" "prognostic favourable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.7 19.5 25.2 31.9 1.0 2.3 13.7 15.1 9.7 12.6 20.0 25.7 16.0 24.4 6.0 5.0 19.9 14.4 12.1 18.1 23.6 16.6 13.0 19.8 20.6 0.6 24.4 11.7 1.3 0.7 15.1 7.2 8.7 7.0 15.6 14.9 19.8 25.7 12.2 26.1 8.7 24.0 22.5 5.6 8.6 25.5 10.1 8.2 17.9 5.1 2.6 21.9 7.9 6.1 13.9 7.0 12.6 18.1 8.1 15.4 26.1 6.9 15.1 6.3 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455856 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA036852: , HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favourable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 10.5 20.8 6.3 12.2 7.8 7.2 10.4 12.6 9.2 10.7 9.8 9.3 8.2 5.6 9.9 8.7 8.2 9.1 9.0 10.5 6.2 5.7 11.9 10.0 8.0 15.3 6.8 5.7 17.4 8.1 13.3 20.7 11.7 9.0 11.4 7.2 11.0 10.0 10.4 14.6 8.7 9.8 8.0 8.4 14.4 8.4 10.7 7.4 18.5 14.3 8.3 13.4 10.2 9.2 10.1 4.6 6.8 4.7 5.5 9.7 2.9 4.2 3.2 7.0 4.5 8.5 9.0 3.6 6.3 9.5 8.3 8.2 3.1 4.4 11.9 5.1 5.5 4.3 8.4 4.7 8.7 6.9 3.7 7.1 5.3 4.1 5.5 8.6 17.6 7.0 6.3 6.6 6.8 6.6 9.3 10.5 8.4 5.0 7.8 6.2 3.6 2.4 6.1 8.0 4.2 6.8 2.7 5.7 4.7 6.2 6.8 6.9 4.2 9.3 5.0 6.2 5.5 8.0 4.9 9.6 4.1 10.1 5.2 6.5 6.9 5.4 3.7 6.8 5.7 4.0 5.4 5.8 6.3 6.4 4.6 10.1 9.7 8.7 2.3 5.5 4.7 4.5 7.8 2.9 6.3 7.8 12.6 9.2 6.2 5.7 6.8 5.7 9.0 7.4 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Plasma membrane,Actin filaments" Nucleoli "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.5 7.6 9.2 9.5 11.7 6.5 14.2 6.7 6.7 8.8 9.7 11.0 6.0 15.6 5.6 9.0 8.0 17.6 8.5 14.2 6.0 5.5 19.9 8.3 9.0 5.6 16.4 12.2 7.7 8.2 8.7 11.1 13.6 13.8 10.0 7.4 9.6 21.1 5.7 5.6 7.3 14.3 16.8 6.8 7.1 10.7 9.3 8.5 10.6 8.9 11.6 10.5 10.2 12.2 11.4 13.1 6.2 6.0 8.2 9.6 11.8 5.6 10.2 11.8 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;testis: 45.2" "Cell line enhanced" "Detected in many" "MOLT-4: 23.9;NB-4: 26.7;THP-1: 20.0;U-937: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 18.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favourable (2.56e-4)" "prognostic favourable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 3.5 2.2 6.7 5.1 10.2 7.7 5.5 3.6 11.6 6.1 4.4 4.2 1.4 3.4 2.8 3.4 1.9 1.8 4.5 3.1 9.5 10.1 1.8 1.4 4.9 9.8 8.2 5.6 3.8 1.5 0.6 3.9 3.8 10.7 2.7 6.6 1.3 2.4 2.6 2.0 2.6 5.2 2.5 6.9 8.0 3.2 45.2 2.5 10.3 1.7 1.2 7.3 5.5 1.6 5.4 10.6 18.2 12.0 22.9 28.8 15.9 5.9 3.0 0.2 0.0 0.2 0.2 0.0 1.4 0.5 3.5 0.5 8.9 9.4 0.0 3.3 2.7 0.0 0.0 0.0 2.2 1.9 0.0 15.1 11.5 0.0 3.1 8.9 13.5 2.9 0.1 0.7 0.0 0.7 0.0 6.8 0.1 15.1 23.9 26.7 8.8 1.3 10.4 0.0 0.5 0.0 6.5 14.9 0.0 12.8 3.6 0.0 0.0 20.0 0.1 0.0 11.8 6.4 0.0 4.1 5.2 0.0 0.0 35.2 0.1 16.0 8.8 18.2 28.8 10.1 26.0 5.4 14.2 26.0 10.6 2.9 11.8 21.7 8.6 22.9 12.0 8.5 13.1 15.9 6.7 10.2 3.6 11.6 9.5 10.1 8.2 5.6 10.7 2.5 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 61.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favourable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Predicted intracellular proteins, Predicted membrane proteins" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.7" "Cell line enhanced" "Detected in some" "AF22: 14.0;HEL: 12.0;HSkMC: 18.2;K-562: 33.7;LHCN-M2: 13.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA000553, HPA005824" Approved Approved "Nucleoplasm,Nuclear bodies" 1200000 "Nucleoplasm, Nuclear bodies" "HPA000553: , HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavourable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 4.0 12.2 8.3 10.9 9.3 0.0 3.9 3.7 10.1 11.6 38.4 9.7 8.9 32.9 18.3 9.0 7.5 8.7 21.4 14.8 8.1 5.0 3.7 1.4 7.1 1.3 9.2 10.2 10.2 1.0 0.9 2.5 0.9 8.5 11.0 33.5 11.4 3.0 14.5 0.5 2.8 68.7 34.8 6.7 4.4 8.6 3.2 8.8 0.0 3.2 2.7 1.1 11.2 6.4 0.0 0.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 14.0 1.1 0.0 0.0 0.4 3.5 0.1 0.0 0.0 8.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.9 0.0 12.0 0.0 0.0 0.1 0.1 0.0 18.2 0.0 0.0 0.0 0.0 33.7 0.3 13.9 0.0 0.0 0.3 6.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 8.1 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.3 9.3 3.7 10.1 8.1 5.0 9.2 10.2 8.5 8.8 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB017188: , HPA048389: , HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favourable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 2.5 3.3 3.2 2.2 4.5 3.9 3.1 7.0 5.7 3.2 4.6 2.7 4.4 1.7 2.8 4.1 2.1 4.6 3.5 3.6 3.3 1.6 2.5 2.1 3.8 8.5 3.6 9.2 3.5 2.7 3.0 3.0 2.3 3.3 8.2 3.1 3.1 4.1 4.1 2.3 3.4 3.2 5.6 2.4 3.3 2.3 1.0 1.1 0.5 0.4 0.2 1.1 0.4 5.1 10.1 7.0 2.9 5.9 4.4 2.0 3.7 4.4 4.8 4.6 5.2 0.6 5.1 4.5 6.3 5.2 7.4 3.6 3.5 3.1 4.8 32.6 11.7 1.7 2.2 7.6 2.6 3.7 2.9 5.7 7.1 6.3 12.5 2.1 4.5 2.3 1.7 2.5 2.1 4.4 6.1 10.0 0.4 1.6 11.1 7.8 4.5 8.9 2.5 2.9 3.0 9.0 9.4 8.9 5.8 3.4 5.5 1.4 1.9 4.8 4.1 3.6 4.7 0.0 0.4 0.5 1.1 0.1 0.6 0.5 0.2 0.5 1.1 1.0 0.9 0.5 0.0 0.2 0.3 0.9 0.4 0.4 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075348 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 55.1;fHDF/TERT166: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: " "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavourable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 25.3 29.4 21.9 28.0 28.4 14.6 22.7 30.5 24.9 24.2 20.5 22.2 26.7 20.0 28.1 24.3 22.2 19.2 20.2 20.5 21.9 22.7 20.6 24.5 20.6 30.2 30.9 14.8 24.5 17.1 25.2 35.6 23.8 26.8 19.4 23.9 17.8 17.7 24.1 19.6 20.9 25.8 23.0 28.7 27.0 17.3 22.2 33.6 23.6 19.5 13.8 28.3 24.7 47.9 7.7 10.4 13.5 9.3 9.9 11.5 6.5 22.4 8.0 5.1 8.5 13.2 18.1 4.6 55.1 34.1 20.7 13.4 4.5 10.6 7.9 4.3 61.8 11.9 5.6 8.1 28.0 5.2 2.7 3.6 13.3 3.5 7.0 4.4 6.5 8.9 9.5 11.0 9.8 12.8 3.8 4.0 31.9 9.6 3.1 5.2 3.0 14.0 4.2 2.1 2.8 9.4 6.4 2.4 2.8 17.9 7.7 7.8 4.8 5.6 17.4 10.9 6.1 26.8 9.4 2.8 3.3 5.0 20.0 8.6 3.7 13.5 9.3 11.1 8.2 7.9 11.5 7.7 9.1 9.8 10.4 7.5 8.8 9.0 11.7 9.9 7.6 2.7 10.6 6.5 21.9 28.4 30.5 24.9 21.9 22.7 30.9 14.8 26.8 33.6 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 46.0;BJ hTERT+ SV40 Large T+ RasG12V: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favourable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.5 1.7 0.1 0.3 0.1 1.5 0.5 0.3 8.6 46.0 34.3 0.1 3.2 0.0 0.6 0.8 0.9 4.2 2.2 3.0 5.2 0.8 2.4 1.4 0.2 1.5 4.2 1.6 2.1 0.5 3.5 0.1 1.3 0.0 0.5 1.0 1.5 1.9 1.3 0.6 0.8 1.3 0.0 0.1 3.1 3.1 0.1 1.1 3.2 1.0 5.1 1.9 0.7 0.4 0.6 0.8 0.1 0.8 0.1 0.0 0.0 2.1 0.9 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 61.2;RPMI-8226: 76.8;U-266/70: 87.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favourable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.4 4.9 4.8 10.0 11.2 14.6 17.2 10.6 16.9 13.7 10.7 6.8 10.2 18.1 13.6 10.2 7.7 8.2 3.7 13.6 10.4 4.9 1.5 8.2 24.5 61.2 3.2 8.1 17.7 35.8 6.2 19.7 10.4 2.4 25.9 38.2 3.7 6.1 6.7 3.1 11.1 4.2 12.2 76.8 29.4 5.0 5.3 6.1 9.2 45.4 46.9 5.0 12.2 6.3 5.7 5.7 5.0 4.2 87.6 28.5 28.3 8.1 4.5 7.4 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEK 293: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA062465: " "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favourable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavourable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.5 0.5 0.5 0.0 0.0 0.0 5.8 2.7 0.3 1.7 1.8 0.7 1.4 0.0 6.6 0.2 8.0 0.7 0.1 0.0 0.0 65.3 0.0 0.7 0.9 0.5 0.0 0.5 0.0 0.6 0.1 0.1 0.2 1.2 0.1 0.0 2.4 3.6 0.2 0.0 6.3 0.0 0.6 1.3 0.6 0.0 0.3 1.5 1.9 4.6 8.2 3.4 0.0 0.3 0.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: , HPA076164: " "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in many" "NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061763 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nucleoli, Nuclear bodies" "Nucleoplasm, Cytosol" "HPA061763: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (2.79e-4)" "prognostic favourable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.4 6.4 7.2 0.4 0.2 4.1 0.4 0.4 0.6 0.9 1.1 0.8 0.0 1.0 0.1 0.8 6.5 0.4 0.2 2.8 7.8 1.4 1.0 13.1 1.0 10.5 8.8 0.6 4.0 0.9 1.3 0.4 13.3 0.1 0.4 3.2 1.6 50.4 10.2 1.1 7.1 16.2 3.0 0.8 0.6 33.4 14.6 1.9 2.9 48.2 2.5 22.4 0.6 0.6 1.3 3.5 3.7 3.0 0.5 2.2 2.2 25.7 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell line enhanced" "Detected in some" "A-431: 6.6;Daudi: 7.0;HAP1: 9.0;HDLM-2: 7.1;HeLa: 13.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA072105: " "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.6 0.5 0.5 2.2 0.2 0.3 0.3 0.3 0.5 0.8 2.4 0.1 0.4 7.0 0.1 0.0 0.7 9.0 0.6 0.0 7.1 4.3 0.3 13.4 0.1 0.8 0.7 0.9 0.2 1.2 1.9 5.1 0.1 0.2 3.2 0.1 0.1 0.1 0.3 0.2 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.2 0.4 0.0 0.4 0.1 0.0 0.6 0.0 1.5 1.5 2.3 4.4 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 HEXDC FLJ23825 ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 30.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favourable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favourable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favourable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favourable (2.52e-5)" 12.7 8.5 7.1 16.6 9.3 14.3 8.7 13.2 7.3 10.1 7.6 8.8 12.8 8.0 10.0 11.1 7.9 10.3 9.4 5.7 7.2 4.6 9.9 11.6 12.4 11.6 12.8 5.5 13.6 72.9 10.2 14.6 5.7 7.4 14.1 4.2 7.0 13.3 9.2 20.4 11.3 12.3 6.0 6.1 15.6 8.8 4.7 11.4 8.6 11.7 8.6 10.7 8.3 8.8 5.9 30.3 3.3 11.5 11.9 9.8 4.4 3.0 7.6 3.4 5.2 10.2 8.9 10.4 3.8 4.7 4.1 4.6 2.6 10.3 7.9 4.2 1.6 4.2 2.0 2.3 1.9 5.5 12.9 3.6 6.7 4.5 9.2 2.4 9.2 6.3 2.3 1.1 4.1 5.2 4.5 2.7 1.1 6.9 8.3 8.9 3.1 4.6 9.8 2.8 15.5 3.1 4.5 4.7 10.1 8.0 5.2 7.2 8.4 9.1 5.2 2.6 5.0 2.0 2.6 12.5 2.3 5.9 2.1 6.8 2.7 3.3 1.7 2.7 9.8 11.5 6.5 4.6 2.2 3.4 2.0 5.9 3.5 5.1 3.0 11.9 4.9 30.3 1.4 4.4 7.1 9.3 13.2 7.3 7.2 4.6 12.8 5.5 7.4 11.4 HEXIM1 "CLP-1, EDG1, HIS1, MAQ1" ENSG00000186834 "Hexamethylene bisacetamide inducible 1" O94992 17 45148502-45152101 "Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008926, CAB011625" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB011625: AB_2233058, HPA008926: AB_1079048" "unprognostic (2.82e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (2.39e-1)" "unprognostic (2.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (2.89e-3)" "unprognostic (1.26e-2)" 14.8 25.3 30.0 12.6 25.3 30.4 13.7 41.4 37.4 16.2 21.0 10.7 18.5 17.8 17.0 17.2 18.6 18.2 18.6 16.0 31.1 15.6 20.9 19.0 15.8 11.8 24.9 19.2 14.8 15.6 12.2 24.4 56.7 27.5 19.9 10.8 12.6 16.4 25.2 29.7 22.6 20.2 19.5 31.4 20.7 17.3 17.1 21.7 8.9 17.2 14.3 12.3 17.8 30.6 3.7 3.4 15.9 6.7 3.8 4.6 2.3 12.9 41.2 8.6 12.4 14.3 7.7 21.1 11.5 10.4 9.5 10.7 19.3 18.4 5.6 35.6 12.1 10.5 5.2 11.3 7.7 11.6 12.3 17.6 22.7 23.5 12.5 10.9 23.4 8.9 9.7 7.0 3.1 4.7 7.7 13.8 7.1 17.3 11.4 12.7 7.9 12.5 4.8 7.5 6.9 25.0 23.0 4.6 3.5 17.3 19.6 18.6 20.4 8.6 9.0 9.6 13.3 5.5 21.3 12.6 4.0 3.7 8.8 10.3 10.9 15.9 4.3 6.6 4.5 6.1 2.7 3.3 4.6 4.0 3.3 3.7 4.2 4.4 10.5 3.8 6.7 3.4 3.9 2.3 30.0 25.3 41.4 37.4 31.1 15.6 24.9 19.2 27.5 21.7 HEXIM2 FLJ32384 ENSG00000168517 "Hexamethylene bisacetamide inducible 2" Q96MH2 17 45160700-45170040 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Cell line enhanced" "Detected in all" "Hep G2: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023323, HPA028455" Enhanced Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA023323: AB_1850651, HPA028455: AB_10602603" "unprognostic (9.03e-3)" "unprognostic (2.18e-2)" "unprognostic (4.01e-2)" "prognostic favourable (2.53e-4)" "unprognostic (2.36e-1)" "unprognostic (6.35e-3)" "unprognostic (9.70e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "prognostic favourable (9.85e-4)" "unprognostic (2.34e-3)" "unprognostic (1.93e-1)" "unprognostic (1.29e-2)" "unprognostic (2.32e-3)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.90e-2)" 4.0 7.7 8.3 4.2 8.0 3.6 3.4 9.0 11.8 4.3 4.8 5.0 6.5 8.8 4.3 5.6 4.2 5.1 7.9 6.3 6.7 6.2 9.3 9.6 4.1 5.6 7.8 6.7 5.7 9.3 7.5 6.1 3.0 6.6 5.1 2.5 6.9 9.9 5.5 36.4 5.6 6.4 4.3 5.4 5.2 6.9 27.7 6.4 6.4 9.1 6.6 3.0 4.7 4.7 9.7 13.2 10.0 12.2 7.3 8.6 13.3 4.9 17.9 4.0 8.8 4.4 7.3 7.6 2.8 3.4 4.5 5.0 6.7 13.3 3.1 14.5 1.9 8.2 3.9 3.4 1.4 7.1 6.2 2.3 16.7 30.4 3.2 2.0 5.1 6.3 3.2 3.9 1.4 2.2 2.5 7.7 2.0 8.6 3.1 4.2 4.3 7.9 4.2 6.0 9.3 5.7 4.9 4.8 4.1 2.5 5.0 11.5 13.3 3.4 2.1 8.2 4.4 5.4 6.5 12.0 12.6 2.9 6.4 3.6 6.1 8.4 12.2 10.0 5.4 9.7 8.6 9.7 3.8 6.1 10.3 6.5 3.0 5.3 8.3 7.3 3.0 13.2 4.6 13.3 8.3 8.0 9.0 11.8 6.7 6.2 7.8 6.7 6.6 6.4 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell line enhanced" "Detected in many" "HEK 293: 48.4;PC-3: 11.0;SK-MEL-30: 33.1;WM-115: 11.3" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA055599: AB_2682858, HPA063472: " "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.4 0.3 0.2 8.8 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.8 0.3 2.2 1.8 0.1 0.2 0.1 48.4 0.0 1.5 0.8 0.5 0.0 0.3 0.4 1.4 0.0 6.1 1.6 3.1 1.4 0.5 0.1 0.0 0.2 0.1 11.0 0.0 1.8 1.4 0.1 1.5 2.0 5.6 0.0 1.0 33.1 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.5" "Cell line enhanced" "Detected in some" "AN3-CA: 5.1;HEK 293: 6.5;SK-MEL-30: 6.0;TIME: 13.6;U-266/70: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 20 "T-cells: 2.6" "Region enriched" "Detected in all" 4 "olfactory region: 34.5" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: " "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.0 1.8 7.4 1.8 9.2 0.7 5.5 5.7 11.8 10.4 2.9 13.1 0.7 2.2 11.3 24.0 2.8 19.3 7.6 28.5 8.2 6.2 3.6 7.8 3.7 1.2 8.2 11.4 10.7 4.1 7.1 5.4 5.4 12.8 2.3 2.4 10.4 3.0 4.5 19.1 2.1 2.2 2.9 11.3 2.9 2.0 6.5 7.2 0.0 3.6 4.9 1.4 3.5 4.9 0.0 0.0 0.0 0.1 0.0 2.6 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.2 0.2 0.1 0.0 0.4 6.5 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.4 0.0 0.0 3.0 0.3 0.5 0.6 0.8 0.0 0.1 2.1 0.0 0.0 0.0 6.0 1.8 0.0 13.6 0.3 0.0 0.1 0.7 16.6 0.3 0.1 0.6 0.0 1.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 0.0 0.4 7.4 9.2 5.7 5.9 8.2 6.2 8.2 11.4 12.8 7.2 HEYL "bHLHb33, HESR3, HEY3" ENSG00000163909 "Hes related family bHLH transcription factor with YRPW motif-like" Q9NQ87 1 39624153-39639945 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 66.3" "Cell line enhanced" "Detected in some" "LHCN-M2: 17.3;RH-30: 21.4;THP-1: 4.9;U-266/84: 5.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001438, HPA076960" Approved Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA001438: AB_1079052, HPA076960: " "unprognostic (1.98e-2)" "unprognostic (7.92e-2)" "unprognostic (4.19e-3)" "unprognostic (3.49e-1)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (7.20e-2)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (2.35e-1)" "unprognostic (8.50e-2)" "prognostic unfavourable (2.26e-6)" "prognostic unfavourable (3.57e-4)" "unprognostic (2.67e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (2.63e-5)" 10.0 8.3 2.9 4.7 6.2 0.5 6.5 1.8 4.0 14.7 4.4 2.9 5.1 1.9 21.7 13.2 4.0 11.2 13.9 28.2 3.2 4.8 12.3 3.3 12.5 2.0 6.8 2.9 14.4 66.3 1.7 8.2 22.1 7.1 8.1 2.9 10.9 2.3 11.4 8.9 1.9 2.7 18.9 2.4 4.5 3.4 25.4 4.4 0.0 11.0 6.8 1.9 6.0 8.8 1.1 0.5 0.0 0.3 0.0 0.1 0.0 0.0 2.4 3.9 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 1.6 0.2 0.0 1.4 0.4 0.0 2.2 0.0 0.2 0.0 2.6 4.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.5 17.3 1.4 0.0 0.0 0.0 0.1 1.1 21.4 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.6 5.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.2 1.8 4.0 3.2 4.8 6.8 2.9 7.1 4.4 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: " "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.1 18.7 0.3 9.1 13.8 10.6 0.0 5.8 14.0 7.5 11.9 1.5 16.6 0.8 15.9 9.6 5.2 0.0 6.9 9.6 2.1 0.1 0.2 4.4 1.2 2.7 0.0 0.3 11.0 2.0 8.2 0.7 5.1 0.3 0.2 6.4 3.3 0.0 0.1 0.4 0.0 1.1 0.0 0.1 6.2 5.4 0.0 0.0 3.5 0.0 5.0 26.6 0.8 3.9 5.3 0.5 5.3 5.1 0.1 0.1 0.1 7.9 0.1 11.4 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "HFM1, ATP dependent DNA helicase homolog" A2PYH4 1 91260766-91404869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;testis: 19.9" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 4.8;K-562: 4.9;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035036: , HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.8 0.7 2.6 0.3 4.1 0.4 0.8 11.3 4.4 1.7 0.9 1.5 2.7 0.6 3.7 2.5 0.4 1.2 0.6 1.0 2.3 0.9 1.3 0.4 0.5 1.6 0.7 1.4 6.4 1.2 0.1 7.8 0.9 3.9 1.1 0.7 2.7 1.0 2.0 2.3 0.4 0.5 1.7 4.7 0.7 0.6 19.9 1.5 0.0 2.7 0.5 0.4 0.7 2.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.1 4.8 0.0 0.2 0.1 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.1 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.2 2.4 0.0 0.3 1.4 0.1 0.0 0.0 3.1 3.8 0.0 0.0 1.2 0.0 0.8 0.1 0.0 1.0 0.9 0.1 4.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 4.1 11.3 4.4 2.3 0.9 0.7 1.4 3.9 1.5 HGF "DFNB39, F-TCF, HGFB, HPTA, SF" ENSG00000019991 "Hepatocyte growth factor" P14210 7 81699008-81770438 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Serine protease homolog" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 116.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "basophil: 33.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 33.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010333, HPA040360, HPA044088" Approved Approved Centrosome,Cytosol "Secreted to blood" Cytosol Centrosome "CAB010333: AB_647965, HPA040360: , HPA044088: " "unprognostic (5.24e-2)" "unprognostic (6.77e-2)" "unprognostic (1.72e-2)" "unprognostic (5.12e-2)" "unprognostic (1.85e-2)" "unprognostic (7.45e-5)" "unprognostic (1.66e-1)" "unprognostic (9.28e-3)" "unprognostic (3.28e-2)" "unprognostic (2.97e-2)" "unprognostic (2.74e-1)" "unprognostic (5.29e-2)" "prognostic unfavourable (5.59e-4)" "unprognostic (7.90e-3)" "unprognostic (2.92e-2)" "unprognostic (1.14e-2)" "unprognostic (2.06e-2)" 6.2 10.6 1.4 2.9 1.2 4.6 4.8 0.5 4.5 5.1 4.0 0.4 2.9 1.5 5.2 3.1 2.9 4.0 7.1 9.3 3.6 1.3 7.3 27.5 15.8 2.0 1.3 1.4 3.2 1.4 1.6 4.3 116.9 1.9 10.8 1.9 2.0 2.2 3.2 1.4 0.9 1.8 15.1 6.0 6.6 2.3 2.0 0.9 0.5 5.3 1.4 1.4 10.5 21.5 0.0 2.0 33.5 7.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 44.8 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 35.1 19.6 0.1 10.6 0.0 22.0 0.0 0.5 0.0 60.7 0.1 0.0 0.0 13.6 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 16.1 4.1 0.0 33.5 6.6 1.6 0.0 7.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 6.7 0.4 0.0 1.5 1.4 1.2 0.5 4.5 3.6 1.3 1.3 1.4 1.9 0.9 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137769-144140843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: " "unprognostic (2.13e-2)" "prognostic unfavourable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 13.4 12.3 6.3 7.7 5.5 4.6 7.6 7.3 8.6 5.5 11.8 5.2 4.9 5.0 6.5 3.8 8.7 5.1 5.5 5.1 5.2 3.6 8.2 15.1 5.1 9.5 5.7 7.3 9.7 12.8 6.8 4.4 3.8 6.1 8.6 4.5 5.9 10.5 6.4 13.2 8.9 5.9 5.8 3.8 8.8 15.7 7.9 4.7 11.3 11.0 4.7 8.6 4.9 7.7 2.1 0.9 0.0 0.9 2.2 2.9 0.6 4.7 1.6 1.2 2.1 1.6 1.1 2.9 8.2 0.6 1.7 1.2 2.1 1.2 14.0 11.3 1.5 5.0 2.3 1.1 0.5 6.7 8.7 5.3 1.3 1.0 1.6 2.9 3.5 0.7 3.5 1.9 1.2 0.8 15.1 0.5 1.1 4.0 10.1 2.7 3.3 27.9 12.6 1.0 2.1 1.0 1.1 2.5 2.6 3.8 2.0 2.7 1.7 1.1 2.9 1.0 8.6 3.0 9.7 8.4 5.4 3.4 1.0 5.0 1.7 0.0 0.6 0.0 1.5 0.9 0.9 0.5 1.9 2.9 0.9 2.1 1.8 1.3 0.0 2.2 0.7 0.7 0.6 0.6 6.3 5.5 7.3 8.6 5.2 3.6 5.7 7.3 6.1 4.7 HGS "Hrs, Vps27, ZFYVE8" ENSG00000185359 "Hepatocyte growth factor-regulated tyrosine kinase substrate" O14964 17 81683326-81703138 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004872, HPA007728" Uncertain Enhanced Endosomes,Lysosomes,Cytosol 250000 "Endosomes, Lysosomes" Cytosol "HPA004872: AB_1079053, HPA007728: AB_1850681" "unprognostic (6.52e-2)" "prognostic unfavourable (4.22e-4)" "unprognostic (4.29e-1)" "unprognostic (1.31e-2)" "unprognostic (4.91e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (5.61e-5)" "unprognostic (5.54e-3)" "unprognostic (1.09e-1)" "unprognostic (9.27e-2)" "unprognostic (5.30e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (4.31e-7)" "unprognostic (3.69e-1)" "unprognostic (2.27e-1)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" 26.8 33.5 34.7 31.9 44.7 66.5 28.9 35.7 45.6 25.4 31.1 35.2 24.5 33.2 27.3 37.2 42.1 32.8 29.1 25.4 32.7 30.4 34.2 31.3 29.4 34.3 39.8 44.2 33.2 39.7 21.8 31.7 32.4 40.7 31.9 31.1 23.6 38.2 27.9 36.3 57.5 32.5 32.6 28.5 38.5 35.6 53.1 38.1 22.2 26.2 25.9 32.5 24.9 34.6 12.2 14.6 28.9 20.2 17.2 18.7 18.8 33.2 27.1 20.5 25.4 18.5 20.9 22.5 25.0 24.3 29.3 22.6 22.8 23.8 9.3 17.1 33.8 28.3 17.3 27.4 20.7 7.9 28.9 20.0 34.1 28.7 27.9 17.2 26.4 23.3 30.0 32.7 46.6 36.7 21.8 17.1 30.8 20.1 18.9 39.8 14.8 28.8 20.6 16.4 14.7 28.7 25.2 29.3 34.9 19.0 48.4 22.2 29.7 33.4 30.5 57.1 33.6 28.2 46.4 21.9 7.7 11.8 35.1 22.5 30.0 25.2 17.4 22.3 18.7 20.2 12.4 11.4 13.5 13.0 14.6 12.2 10.1 11.7 28.9 17.2 19.1 12.4 14.9 18.8 34.7 44.7 35.7 45.6 32.7 30.4 39.8 44.2 40.7 38.1 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689951-92695646 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 71.4" "Cell line enhanced" "Detected in many" "EFO-21: 25.5;HEL: 27.7;HMC-1: 30.7;HUVEC TERT2: 30.3;K-562: 42.1;NB-4: 28.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051894, HPA055460" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051894: , HPA055460: " "prognostic favourable (8.83e-4)" "prognostic favourable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavourable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 6.3 8.2 2.8 12.0 3.6 28.1 13.7 0.9 2.2 4.5 3.2 3.0 1.1 2.3 3.6 3.8 2.9 2.7 18.0 7.3 2.8 2.1 2.8 33.1 15.3 29.7 3.6 0.9 1.9 15.6 0.7 1.5 6.4 2.8 4.3 2.4 2.3 1.9 1.6 2.8 2.2 8.4 9.3 2.9 18.3 2.7 1.9 2.8 1.8 71.4 2.0 11.3 6.5 7.1 25.0 13.5 21.4 17.8 0.3 0.3 4.9 3.0 5.8 3.0 0.0 0.2 0.2 0.0 1.6 13.2 2.1 1.9 1.1 0.7 3.0 25.5 0.2 0.6 2.7 0.0 2.6 0.0 3.1 27.7 2.4 18.6 6.2 16.0 30.7 0.0 0.0 1.9 0.0 30.3 42.1 0.0 0.1 0.9 0.1 28.1 0.0 3.4 9.4 0.8 0.0 0.2 1.2 1.4 0.3 1.7 0.0 0.0 0.9 8.5 10.5 0.0 0.1 0.0 0.0 0.7 0.5 5.8 0.0 22.2 14.6 7.9 14.7 21.4 0.3 16.4 0.1 21.4 0.0 0.0 11.3 25.0 0.0 0.0 11.8 0.3 17.8 13.5 0.1 4.9 2.8 3.6 0.9 2.2 2.8 2.1 3.6 0.9 2.8 2.8 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Cell line enhanced" "Detected in some" "A549: 3.9;Hep G2: 5.4;RH-30: 20.3;U-87 MG: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" Mitochondria Cytosol "HPA059673: " "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavourable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.3 0.0 20.3 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.1 0.0 10.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 HHLA3 ENSG00000197568 "HERV-H LTR-associating 3" Q9XRX5 1 70354805-70385339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA031323 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031323: AB_10601477" "unprognostic (2.31e-3)" "unprognostic (8.35e-2)" "unprognostic (3.29e-2)" "unprognostic (6.61e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (8.24e-3)" "unprognostic (9.87e-2)" "unprognostic (2.07e-1)" "unprognostic (3.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (1.75e-1)" "unprognostic (3.92e-2)" "unprognostic (5.16e-1)" "unprognostic (3.60e-2)" 6.9 20.0 18.2 4.1 19.5 7.6 8.5 6.9 19.3 8.9 6.4 20.1 7.2 4.6 8.2 25.7 8.0 15.8 6.8 5.1 15.8 16.5 16.8 17.6 4.6 9.7 17.5 14.6 18.0 15.5 15.8 14.1 6.8 13.4 11.4 6.1 13.1 14.4 8.6 2.8 11.0 4.3 7.9 17.0 7.3 5.2 8.9 15.4 5.8 13.6 3.2 9.0 7.6 13.2 13.4 8.5 4.5 3.0 5.2 11.2 3.9 7.8 3.6 14.1 8.0 12.2 9.9 2.1 2.2 5.2 3.7 4.8 1.2 9.1 7.5 9.7 9.4 4.9 13.8 6.4 6.6 21.3 7.9 5.0 7.5 3.5 11.9 2.4 4.0 12.9 7.6 8.0 9.4 1.2 9.2 21.3 5.4 5.9 5.0 8.6 13.9 4.9 10.4 1.0 3.6 17.2 1.3 5.1 4.0 16.9 5.3 9.9 3.1 5.5 3.1 4.0 2.3 8.3 2.7 10.7 8.6 20.3 8.1 7.6 7.7 4.5 2.5 1.4 6.5 3.0 6.5 10.5 6.7 7.0 3.7 13.4 11.2 9.9 0.7 5.2 2.2 8.5 10.8 3.9 18.2 19.5 6.9 19.3 15.8 16.5 17.5 14.6 13.4 15.4 HIBCH ENSG00000198130 "3-hydroxyisobutyryl-CoA hydrolase" Q6NVY1 2 190189735-190344193 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036540, HPA036541" Enhanced Approved Nucleoplasm,Mitochondria 90000 "Nucleoplasm, Mitochondria" "HPA036540: AB_10673355, HPA036541: AB_2675182" "unprognostic (3.60e-3)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.36e-3)" "unprognostic (3.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.96e-1)" "unprognostic (1.89e-1)" "unprognostic (2.88e-1)" "prognostic favourable (1.22e-4)" "unprognostic (7.32e-2)" "unprognostic (1.37e-2)" "prognostic favourable (1.04e-10)" "unprognostic (1.34e-1)" "unprognostic (3.73e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-3)" 13.7 38.6 18.1 10.1 19.5 5.0 15.8 16.4 18.7 16.3 15.8 14.5 13.0 24.7 17.0 13.0 20.2 10.2 10.0 13.7 18.5 12.7 65.7 56.8 7.6 8.2 20.1 10.8 9.5 29.5 35.8 24.7 7.8 21.0 11.7 18.7 15.0 10.6 12.2 17.5 23.7 16.5 11.3 18.2 9.0 10.4 10.6 22.2 10.5 17.4 15.4 9.3 12.5 49.2 24.2 15.1 14.6 7.6 17.3 20.0 7.3 9.8 7.5 16.2 10.2 15.2 13.5 8.9 10.6 5.7 10.0 10.9 23.3 8.7 14.8 15.1 9.1 18.7 17.1 14.5 15.1 21.3 13.3 19.8 15.8 20.4 5.2 14.1 7.4 10.9 7.9 11.7 2.1 16.2 24.0 13.0 10.9 9.0 14.3 16.2 5.1 15.4 17.9 11.6 37.7 22.6 29.7 12.3 11.6 9.2 13.1 29.9 14.8 11.0 11.5 10.6 9.9 7.1 7.4 8.3 17.7 12.4 9.7 12.3 8.3 12.9 6.7 14.6 11.9 7.6 12.8 24.2 13.3 12.5 11.1 18.7 14.2 18.2 3.5 17.3 5.7 15.1 20.0 7.3 18.1 19.5 16.4 18.7 18.5 12.7 20.1 10.8 21.0 22.2 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950743-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.3" "Cell line enhanced" "Detected in some" "MCF7: 34.7;SH-SY5Y: 18.0;SK-BR-3: 53.2;T-47d: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 34 "B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA031406: " "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favourable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favourable (1.34e-4)" 5.4 3.8 10.1 3.9 21.2 1.3 8.9 62.3 22.2 12.2 9.2 19.9 21.3 21.9 7.1 17.3 2.4 11.3 16.7 5.4 12.8 13.3 4.7 2.0 7.5 3.0 21.3 12.2 1.3 49.4 9.0 16.9 11.4 15.8 19.7 10.4 4.1 46.7 20.0 2.6 2.9 15.3 4.0 10.5 6.4 31.2 2.6 17.1 0.7 8.5 1.4 3.7 7.4 3.8 1.5 5.8 0.0 0.0 0.0 2.8 1.3 1.5 3.4 0.4 4.8 0.0 0.0 0.8 0.0 0.2 0.3 0.3 3.1 1.8 0.0 0.3 0.0 1.6 4.4 0.3 0.2 0.0 3.5 0.0 0.1 3.0 0.8 0.0 0.3 0.0 1.8 0.0 0.7 7.9 0.2 1.2 0.0 34.7 0.2 0.0 0.1 2.1 0.0 0.0 6.5 4.5 13.5 6.5 18.0 0.0 53.2 0.0 31.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 1.5 2.3 1.8 0.0 0.4 2.5 2.8 0.0 0.0 0.0 5.8 0.0 1.3 10.1 21.2 62.3 22.2 12.8 13.3 21.3 12.2 15.8 17.1 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 alpha subunit" Q16665 14 61695513-61748259 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 47.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Supported Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB017442: AB_10621732, HPA000907: , HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 31.9 62.0 15.6 45.2 17.8 125.2 24.9 22.7 18.5 45.7 15.3 12.3 23.5 10.8 17.7 31.3 31.2 21.7 50.0 19.4 17.5 16.5 76.4 42.7 42.8 27.3 18.3 11.0 34.5 12.7 13.7 26.8 24.2 25.1 17.6 13.9 14.0 24.6 36.2 8.0 17.4 16.9 18.7 27.2 57.3 16.0 21.1 12.4 24.7 26.9 18.4 28.8 37.8 21.5 6.6 6.0 47.8 6.8 6.2 7.9 5.1 37.6 15.0 15.1 43.2 24.0 38.7 20.5 31.3 37.8 39.5 35.6 6.5 12.5 9.2 23.6 38.7 8.9 9.7 51.5 49.4 4.0 5.0 5.6 13.8 11.2 53.6 2.3 6.2 67.6 16.3 28.9 31.0 24.8 3.8 0.0 117.8 7.8 7.3 2.9 13.6 19.8 0.5 34.0 2.7 50.9 25.1 12.7 14.1 58.8 8.4 20.7 8.8 4.5 14.7 89.7 20.1 29.7 26.3 4.9 7.2 10.4 47.3 4.7 24.2 11.2 6.8 47.8 3.8 5.5 4.9 6.5 5.0 4.4 6.0 6.6 7.9 5.1 18.2 6.2 5.6 2.9 3.4 5.1 15.6 17.8 22.7 13.2 17.5 16.5 18.3 11.0 25.1 12.4 HIF1AN "DKFZp762F1811, FIH1, FLJ20615, FLJ22027" ENSG00000166135 "Hypoxia inducible factor 1 alpha subunit inhibitor" Q9NWT6 10 100529072-100559998 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048742, HPA065302, CAB069903" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB069903: AB_10000508, HPA048742: , HPA065302: " "unprognostic (4.07e-2)" "unprognostic (7.75e-2)" "unprognostic (2.35e-2)" "unprognostic (3.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.54e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-2)" "unprognostic (3.09e-2)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (3.24e-2)" 8.8 12.7 11.6 11.9 10.8 7.6 12.9 9.5 14.1 9.2 10.7 11.5 8.8 9.7 11.6 10.4 11.1 9.6 12.5 16.0 10.2 9.4 10.3 8.8 9.3 12.3 13.0 9.5 14.5 14.3 17.1 10.6 10.2 10.8 10.7 9.3 9.2 10.6 12.1 46.8 13.3 10.6 14.9 9.7 11.1 10.0 17.9 10.3 13.5 8.1 14.8 12.3 10.8 10.8 9.7 8.5 16.9 14.0 10.1 11.3 9.3 9.2 9.8 13.2 13.2 20.5 8.5 11.5 9.8 23.8 14.6 17.3 15.1 7.9 9.9 9.0 14.7 10.8 11.6 8.8 16.0 10.9 7.0 9.5 8.6 11.5 10.6 11.3 12.6 8.3 9.0 14.2 15.6 8.2 4.1 5.6 16.4 9.7 12.1 7.4 4.3 4.7 8.8 16.3 4.8 10.2 12.3 5.1 8.3 8.5 5.2 9.2 17.8 6.2 6.9 7.5 9.8 7.3 9.8 7.7 7.7 7.7 12.4 9.3 5.6 13.1 8.8 16.9 9.8 12.4 9.6 9.7 10.1 9.0 8.5 7.5 9.8 9.9 9.3 10.1 14.0 3.1 11.3 9.3 11.6 10.8 9.5 14.1 10.2 9.4 13.0 9.5 10.8 10.3 HIF3A "bHLHe17, IPAS, MOP7, PASD7" ENSG00000124440 "Hypoxia inducible factor 3 alpha subunit" Q9Y2N7 19 46297046-46343433 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Apoptosis, Stress response, Transcription, Transcription regulation" "Developmental protein, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.1;HHSteC: 16.5;HSkMC: 14.5;TIME: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041141 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041141: AB_10803997" "unprognostic (9.20e-2)" "unprognostic (2.99e-1)" "unprognostic (5.48e-2)" "prognostic unfavourable (6.90e-9)" "unprognostic (4.12e-2)" "unprognostic (2.35e-2)" "unprognostic (3.57e-3)" "unprognostic (1.30e-1)" "unprognostic (3.32e-2)" "unprognostic (1.38e-2)" "unprognostic (3.76e-2)" "unprognostic (7.07e-2)" "unprognostic (3.41e-4)" "unprognostic (1.55e-2)" "unprognostic (1.61e-1)" "unprognostic (4.45e-4)" "unprognostic (5.98e-2)" 15.8 7.7 17.9 4.9 9.8 2.5 8.7 10.6 11.1 15.8 16.1 4.7 6.7 3.1 8.1 10.3 11.6 9.8 9.2 31.2 21.4 6.8 4.5 2.1 13.5 5.2 10.8 8.3 17.7 5.1 2.1 12.1 42.4 9.8 9.7 4.5 10.0 4.3 13.1 12.3 3.6 7.0 26.9 11.2 21.7 14.1 3.3 11.4 0.0 3.2 5.6 2.0 18.8 14.6 1.0 1.3 3.3 1.1 0.5 0.7 0.1 0.0 0.0 1.3 0.3 3.8 8.1 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 16.5 0.1 0.6 14.5 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.0 0.1 13.3 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.0 3.3 0.4 0.8 0.4 0.4 0.4 0.5 0.4 0.4 0.2 1.0 0.6 0.7 3.1 0.5 1.1 1.3 0.2 0.1 17.9 9.8 10.6 11.1 21.4 6.8 10.8 8.3 9.8 11.4 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42784298-42804531 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 89.9" "Low lineage specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favourable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favourable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 27.7 30.4 50.1 15.5 43.4 9.6 20.4 20.3 56.4 18.3 63.8 25.2 10.8 35.2 15.7 24.8 36.7 13.5 18.8 68.6 43.2 43.3 45.9 78.4 15.3 16.0 54.4 35.9 12.8 12.8 14.7 29.2 17.2 50.9 24.4 67.3 21.8 16.6 26.8 34.9 15.0 28.4 22.8 58.8 13.0 31.6 14.7 20.7 8.9 28.1 30.6 16.9 20.1 25.0 11.9 89.9 25.9 26.6 12.3 18.8 30.1 26.9 15.2 33.7 27.6 86.3 51.6 32.8 36.4 29.9 35.7 32.8 26.7 27.5 16.5 21.9 31.8 16.3 27.0 40.2 44.7 23.7 29.8 51.0 27.2 49.4 39.4 29.2 24.0 53.5 44.2 27.4 38.2 31.3 50.3 17.7 49.8 11.0 16.1 10.7 28.2 36.9 13.2 23.9 11.7 88.2 67.0 14.2 18.5 32.0 24.2 34.4 24.3 22.1 27.4 21.1 19.2 59.1 37.6 16.5 34.0 34.1 27.8 31.2 16.3 16.9 14.7 25.9 15.4 22.7 13.7 11.9 15.1 15.1 16.3 8.5 12.9 15.3 14.9 12.3 26.6 89.9 18.8 30.1 50.1 43.4 20.3 56.4 43.2 43.3 54.4 35.9 50.9 20.7 HIGD2A "MGC2198, RCF1B" ENSG00000146066 "HIG1 hypoxia inducible domain family member 2A" Q9BW72 5 176388747-176389771 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042715 Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA042715: " "unprognostic (9.24e-2)" "unprognostic (6.31e-3)" "unprognostic (7.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.94e-2)" "prognostic unfavourable (9.47e-4)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (1.98e-2)" "unprognostic (3.11e-3)" "unprognostic (9.56e-2)" "unprognostic (2.39e-2)" "unprognostic (1.45e-1)" "unprognostic (8.09e-2)" "unprognostic (1.78e-1)" "unprognostic (9.65e-2)" 37.2 38.5 31.4 33.5 36.0 34.9 37.5 21.4 33.2 26.8 43.8 22.5 29.7 36.7 25.7 31.1 47.0 31.5 39.4 80.0 28.5 26.6 46.3 56.1 30.1 54.1 30.3 20.0 33.2 42.6 36.6 28.8 26.4 21.0 41.2 30.9 31.2 64.0 32.6 115.9 27.8 38.1 43.3 25.9 37.3 31.6 28.8 15.0 63.1 42.3 53.8 34.3 42.1 28.7 70.4 104.6 25.5 107.7 31.1 67.6 88.9 17.6 31.2 18.6 31.6 19.6 37.4 48.9 11.1 21.2 32.4 40.8 32.5 37.3 32.1 27.1 20.2 22.7 28.2 49.8 13.0 75.2 44.3 15.8 32.1 44.5 27.5 24.6 43.1 47.4 41.4 18.2 22.2 27.2 17.5 64.7 23.7 58.2 28.0 31.4 22.0 34.2 27.2 13.9 58.1 50.6 29.4 19.6 26.2 12.7 53.6 54.5 32.0 41.6 17.0 22.1 22.9 20.3 23.1 30.1 35.9 26.1 28.6 44.2 13.8 25.5 84.5 23.8 46.3 106.5 45.8 70.4 64.9 53.5 104.6 52.2 59.6 55.6 14.4 31.1 107.7 68.6 67.6 88.9 31.4 36.0 21.4 33.2 28.5 26.6 30.3 20.0 21.0 15.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: " "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.8 0.7 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Hikeshi, heat shock protein nuclear import factor" Q53FT3 11 86302211-86345931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: " "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavourable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 23.4 24.1 25.7 16.0 23.3 15.5 31.1 19.1 24.0 21.1 23.5 20.1 14.5 10.2 27.4 24.9 24.6 18.2 15.5 36.1 23.9 23.8 11.7 20.0 16.9 22.0 30.2 18.9 26.2 22.6 18.7 32.0 26.6 25.9 18.1 19.2 15.7 15.4 29.2 46.9 20.2 13.0 30.0 25.1 18.1 15.9 15.3 26.6 23.8 20.8 23.6 28.1 21.6 24.0 30.0 33.3 20.6 26.7 25.9 39.5 20.7 9.8 10.6 26.0 14.3 22.0 27.5 13.7 15.2 18.4 15.9 19.0 31.6 27.4 10.0 35.1 20.0 21.1 19.2 33.4 17.0 21.3 16.9 16.1 17.6 23.4 29.7 19.7 13.2 19.3 34.0 19.0 22.6 30.4 17.3 23.0 32.4 26.8 23.5 46.9 21.2 7.2 18.1 12.8 22.4 27.2 18.6 16.1 13.9 18.9 14.2 10.3 22.7 13.3 15.4 18.9 13.3 37.8 11.2 9.9 22.4 19.3 9.6 18.7 18.5 19.6 26.7 20.6 25.2 24.7 27.7 30.0 30.9 27.3 33.3 24.9 27.2 27.6 5.5 25.9 24.3 25.9 39.5 20.7 25.7 23.3 19.1 24.0 23.9 23.8 30.2 18.9 25.9 26.6 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavourable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.0 23.2 12.7 13.8 17.4 6.4 23.9 4.0 5.0 8.5 9.4 5.8 10.1 7.5 3.2 6.0 7.1 7.1 8.6 10.9 4.1 6.5 4.6 4.9 5.2 3.9 7.2 6.3 10.6 7.5 6.7 4.5 6.9 6.6 3.1 8.4 13.5 21.7 13.2 15.7 10.3 16.4 5.9 11.7 4.7 16.4 12.2 11.2 6.3 44.1 7.8 35.9 7.1 5.0 10.9 5.4 8.2 5.0 3.1 2.2 9.6 20.6 11.2 9.4 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 HINT1 "HINT, PKCI-1, PRKCNH1" ENSG00000169567 "Histidine triad nucleotide binding protein 1" P49773 5 131159027-131171735 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044577 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 3600000 Cytosol "Nucleoplasm, Plasma membrane" "HPA044577: AB_10795618" "unprognostic (2.00e-1)" "unprognostic (9.27e-2)" "unprognostic (2.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (8.30e-3)" "unprognostic (2.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.49e-2)" "unprognostic (6.50e-3)" "unprognostic (4.43e-2)" "unprognostic (4.39e-3)" "unprognostic (2.08e-1)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (3.68e-1)" 28.5 46.5 56.6 46.2 51.6 50.5 64.7 42.9 78.4 29.8 53.3 20.4 49.1 36.5 30.6 43.8 44.3 42.3 36.7 61.4 47.3 43.9 65.4 124.4 38.9 54.7 48.7 50.6 32.2 62.9 43.9 39.6 24.6 40.8 41.3 50.0 22.6 44.4 41.8 84.0 38.3 41.3 37.9 37.5 32.5 32.5 30.5 25.1 29.4 47.5 56.6 39.4 29.1 45.1 26.6 46.5 19.2 25.3 20.9 40.3 52.9 37.5 55.0 43.2 88.5 30.8 33.4 39.9 28.6 26.8 28.9 33.6 53.7 52.7 51.7 57.1 36.7 23.2 34.4 75.4 26.8 45.2 63.3 19.9 77.9 68.7 64.5 31.0 6.4 44.6 66.6 34.7 58.3 36.2 30.2 113.2 37.1 41.4 52.4 78.1 41.9 43.9 37.9 43.2 93.5 54.3 48.5 53.0 33.2 37.9 25.9 45.1 31.4 45.4 39.7 38.2 21.7 30.3 58.1 32.6 41.6 44.9 53.6 50.2 35.2 19.2 25.3 9.6 21.7 12.8 29.7 26.6 40.3 28.6 39.2 25.7 32.0 25.3 5.0 20.9 12.9 46.5 27.0 52.9 56.6 51.6 42.9 78.4 47.3 43.9 48.7 50.6 40.8 25.1 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavourable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favourable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 6.9 5.5 7.7 15.9 3.0 8.3 9.5 7.5 10.9 5.8 6.0 13.5 3.8 15.1 14.0 5.0 10.4 9.8 6.3 6.8 14.2 12.6 6.3 8.3 11.3 14.2 9.9 10.7 6.5 14.1 5.8 14.8 8.7 19.6 10.2 5.7 10.5 7.9 7.2 2.6 5.3 6.7 5.3 5.0 12.0 12.7 15.4 9.5 6.8 9.8 35.1 9.9 15.3 6.1 4.0 5.6 18.9 10.6 14.8 16.9 9.6 11.2 9.5 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 HIP1R "FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655" ENSG00000130787 "Huntingtin interacting protein 1 related" O75146 12 122834453-122862960 "Cancer-related genes, Predicted intracellular proteins" Endocytosis Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.5;naive B-cell: 12.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017187, HPA038135, HPA038136" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852" "unprognostic (4.52e-1)" "unprognostic (6.39e-2)" "unprognostic (7.07e-2)" "unprognostic (6.55e-3)" "unprognostic (8.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.02e-2)" "unprognostic (8.11e-2)" "unprognostic (6.37e-2)" "unprognostic (1.76e-1)" "unprognostic (1.39e-2)" "unprognostic (6.72e-2)" "prognostic favourable (6.50e-7)" "unprognostic (2.18e-2)" "unprognostic (2.84e-1)" "unprognostic (2.54e-3)" "prognostic favourable (7.26e-4)" 9.8 14.5 24.6 13.2 26.5 11.6 8.0 11.5 31.6 4.6 11.6 40.5 19.7 29.2 4.0 9.1 7.0 4.0 7.8 10.8 29.5 21.7 16.2 9.0 6.3 15.3 31.4 20.6 3.2 27.7 7.4 15.6 5.2 18.0 8.6 5.4 2.9 52.0 24.1 5.7 26.5 21.3 3.0 27.4 11.1 30.4 4.0 30.6 8.1 8.1 5.9 12.6 7.4 6.5 12.3 0.0 2.7 0.0 0.6 3.2 1.6 17.3 5.0 3.8 15.6 1.1 3.0 18.7 2.7 4.5 2.8 2.2 7.7 5.2 16.5 9.2 2.0 15.0 4.6 10.0 0.2 2.6 6.6 0.3 5.7 8.1 3.5 1.3 11.8 1.8 7.1 3.8 6.4 19.3 4.3 0.9 1.6 24.9 7.8 4.0 3.5 6.0 4.1 4.8 5.7 9.4 21.0 3.8 8.5 3.2 8.5 4.5 17.4 0.7 15.2 1.8 13.4 5.5 2.6 11.9 6.3 9.8 2.9 2.8 1.5 0.0 0.0 2.7 2.9 0.0 1.7 9.5 1.8 2.2 0.0 12.3 3.2 2.0 0.2 0.6 0.0 0.0 0.4 1.6 24.6 26.5 11.5 19.8 29.5 21.7 31.4 20.6 18.0 30.6 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Cell line enhanced" "Detected in all" "MCF7: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome, Cytosol" "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.1 6.6 9.2 7.0 10.8 5.7 6.2 5.6 6.8 8.0 7.7 7.6 3.1 10.9 7.7 8.9 5.5 11.8 6.6 11.6 7.9 6.0 15.9 8.3 8.0 9.0 12.7 19.7 6.1 9.6 10.2 10.5 11.8 10.8 11.8 11.5 61.5 16.6 7.2 9.4 5.9 10.1 27.0 3.8 7.2 7.0 4.1 5.4 10.2 11.0 7.2 6.4 18.3 11.5 7.9 10.7 12.8 8.5 7.4 5.8 9.5 8.8 10.3 17.9 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 46.3 13.4 12.7 15.9 15.9 12.7 49.2 11.7 13.7 23.6 24.8 11.9 15.9 9.9 28.3 22.8 22.9 24.1 18.8 69.0 13.4 11.8 23.4 21.1 20.2 20.9 15.5 8.2 23.6 15.4 49.7 21.2 20.5 15.2 23.2 12.8 15.6 18.8 18.1 45.9 18.7 25.0 32.9 15.9 20.1 20.5 14.7 14.2 15.2 37.9 26.0 14.4 33.6 34.6 3.1 11.3 17.6 10.1 3.3 4.4 3.7 9.4 9.0 6.8 7.7 31.6 20.0 6.8 10.0 11.6 8.1 6.9 9.9 6.9 10.2 8.5 12.2 12.1 5.1 11.2 11.5 14.8 8.0 10.3 10.2 7.5 13.1 11.0 6.5 18.7 22.0 3.1 9.2 9.9 3.2 20.5 13.1 4.9 9.1 7.7 1.7 5.5 12.3 24.2 10.2 13.4 14.8 1.0 5.7 13.6 15.6 9.3 17.5 20.4 12.7 12.8 8.8 14.7 7.1 11.3 17.7 10.8 6.2 11.7 11.9 6.6 10.1 4.8 3.5 7.6 4.4 2.4 3.2 3.7 11.3 3.1 2.9 3.5 17.6 3.3 8.6 1.4 3.2 3.7 12.7 15.9 11.7 13.7 13.4 11.8 15.5 8.2 15.2 14.2 HIST1H1C "H1.2, H1c, H1F2, H1s-1" ENSG00000187837 "Histone cluster 1 H1 family member c" P16403 6 26055787-26056428 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 353.5" "Cell line enhanced" "Detected in many" "K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 79.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 79.7" "Low region specificity" "Detected in all" "CAB011507, HPA055907" Supported Supported Nucleoplasm,Nucleoli 1800000 "Nucleoplasm, Nucleoli" "CAB011507: AB_2117984, HPA055907: " "unprognostic (4.43e-2)" "unprognostic (1.57e-3)" "unprognostic (1.31e-2)" "unprognostic (2.96e-2)" "unprognostic (5.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.96e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (1.12e-4)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.85e-1)" "unprognostic (8.93e-2)" "unprognostic (3.08e-1)" "prognostic favourable (8.06e-5)" 25.1 17.4 10.1 32.1 10.2 94.7 36.0 23.8 12.8 29.8 23.3 8.1 14.3 15.0 24.7 21.0 48.6 16.6 27.4 37.6 9.3 7.3 23.8 43.1 31.4 37.2 8.2 8.7 34.4 46.6 2.3 5.8 29.1 6.9 44.3 21.2 26.5 22.0 9.5 69.1 21.0 21.1 22.9 12.5 28.4 25.6 33.7 5.4 353.5 21.7 28.5 39.7 38.8 28.0 14.9 5.9 79.7 3.2 3.3 8.6 4.2 5.7 4.2 3.1 3.3 8.0 1.6 0.1 2.9 4.8 13.8 14.7 2.2 4.2 0.4 16.8 3.8 2.5 1.0 2.2 3.9 5.6 3.6 2.4 4.6 2.5 2.3 1.1 5.8 11.2 3.1 1.8 3.0 2.1 48.9 36.8 6.8 2.6 2.9 2.6 1.7 6.4 1.5 1.4 18.7 8.1 4.2 8.0 2.7 46.5 8.0 3.2 9.9 1.7 0.9 6.3 91.7 1.8 1.3 101.7 96.6 4.4 4.6 38.1 2.1 35.8 2.6 79.7 3.8 2.6 4.8 9.8 6.3 4.1 5.6 14.9 5.8 4.4 43.0 3.3 3.2 5.9 8.6 4.2 10.1 10.2 23.8 12.8 9.3 7.3 8.2 8.7 6.9 5.4 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell line enhanced" "Detected in some" "K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.1 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.0 1.4 3.6 3.5 0.0 0.0 4.4 4.8 2.1 2.0 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.3 5.4 0.0 0.3 0.3 0.3 0.9 0.8 5.9 0.0 0.7 1.7 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 HIST1H2BC "H2B.1, H2B/l, H2BFL" ENSG00000180596 "Histone cluster 1 H2B family member c" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 115.7;lymphoid tissue: 143.2" "Cell line enhanced" "Detected in many" "SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 20 "neutrophil: 115.7" "Lineage enriched" "Detected in all" 26 "granulocytes: 115.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavourable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 7.8 5.8 5.5 21.3 7.1 31.3 10.7 2.1 5.9 12.9 11.5 5.9 12.8 5.2 4.1 13.1 20.9 10.8 8.1 5.8 6.5 4.6 8.4 20.2 15.3 11.4 5.4 4.1 5.6 9.6 1.7 9.9 17.5 3.8 31.7 4.1 5.9 12.4 18.6 20.0 10.0 6.0 4.3 10.4 11.7 10.6 9.4 4.5 143.2 6.4 8.7 23.4 12.9 14.3 4.3 2.8 115.7 1.3 1.2 1.8 2.7 2.9 1.7 0.9 0.9 0.9 0.5 1.1 2.9 1.1 2.0 1.6 2.4 1.8 1.1 5.6 1.0 2.2 1.2 1.2 1.0 2.6 1.0 0.9 2.7 4.1 1.1 1.4 3.7 12.3 0.7 0.8 0.5 0.7 16.6 9.3 3.8 3.3 3.1 3.0 0.9 5.4 1.4 1.3 6.9 3.4 0.7 4.2 1.3 32.9 2.5 1.1 14.0 1.3 2.4 2.4 23.0 1.5 1.2 19.0 23.3 5.5 1.0 3.6 1.6 4.5 1.1 5.8 1.2 1.3 1.6 2.3 1.8 1.7 0.8 4.3 1.4 1.0 115.7 1.2 1.2 2.8 1.1 2.7 5.5 7.1 2.1 5.9 6.5 4.6 5.4 4.1 3.8 4.5 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell line enhanced" "Detected in many" "U-266/70: 36.8;U-266/84: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.1 3.7 2.1 29.0 2.6 1.1 4.7 2.7 6.1 3.8 4.0 4.4 2.4 29.8 5.6 8.5 2.0 2.0 2.9 10.9 5.2 1.6 9.7 4.2 3.1 2.1 4.6 19.0 3.2 1.7 2.4 1.5 16.7 13.4 1.1 19.1 4.8 5.4 3.9 5.6 1.9 2.3 15.8 5.8 3.8 11.9 5.0 29.6 7.8 4.6 19.6 0.7 0.9 7.7 19.9 3.1 1.0 36.8 38.8 6.1 0.9 9.9 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell line enhanced" "Detected in many" "NB-4: 8.0;REH: 7.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.6 2.9 0.9 2.9 0.4 0.4 3.0 1.0 0.5 0.3 0.8 2.1 0.6 1.4 0.5 4.2 0.5 1.1 0.6 1.5 0.9 0.5 1.4 0.1 0.2 0.3 2.4 0.6 0.2 0.6 0.2 0.3 2.3 1.8 0.1 1.6 4.5 8.0 2.4 0.9 7.8 0.2 2.5 1.4 1.8 2.7 3.6 3.9 1.4 0.9 2.7 1.6 0.8 1.5 2.6 1.0 1.9 2.3 4.4 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Group enriched" "Detected in some" 4 "U-266/70: 21.3;U-266/84: 15.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.2 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.8 0.4 0.1 0.3 0.6 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.1 1.6 3.8 0.0 0.1 3.2 1.3 0.5 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.1 0.8 0.0 3.7 0.2 0.1 0.3 1.9 0.0 0.5 21.3 15.0 1.2 0.1 0.9 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 HIST1H2BG "H2B.1A, H2B/a, H2BFA" ENSG00000273802 "Histone cluster 1 H2B family member g" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.2" "Cell line enhanced" "Detected in many" "SiHa: 8.8;T-47d: 17.8;U-266/70: 16.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavourable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 0.4 1.5 0.7 16.5 1.2 8.9 20.2 5.1 3.4 4.3 2.9 0.5 5.1 1.8 2.8 4.0 6.6 2.1 1.8 1.7 0.2 1.2 0.6 2.0 7.2 0.1 2.0 1.3 1.9 0.4 0.5 1.6 0.7 10.3 3.0 1.2 5.0 5.8 0.3 1.6 2.2 2.8 4.7 3.1 2.9 6.7 0.3 75.2 1.0 6.9 8.3 4.3 0.0 5.8 14.6 12.0 1.6 1.3 6.2 2.0 2.4 0.1 1.2 0.0 3.8 0.2 0.3 3.1 0.2 2.0 0.8 0.3 2.1 0.0 3.1 0.3 2.6 1.1 1.0 1.1 2.1 1.3 0.7 1.2 1.1 0.6 0.2 2.0 1.4 0.5 0.6 0.0 0.4 7.6 0.1 0.0 1.8 2.2 1.7 1.2 1.6 1.4 0.7 4.3 1.1 0.6 7.2 1.1 8.8 3.2 1.0 17.8 0.8 0.2 0.0 1.0 0.3 0.4 16.7 0.1 0.0 0.3 1.0 0.5 12.0 1.2 2.5 2.0 0.9 6.2 3.7 3.1 3.8 4.4 5.8 1.5 1.3 5.6 1.3 1.6 14.6 2.7 2.0 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell line enhanced" "Detected in many" "U-266/70: 17.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavourable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.3 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.4 1.1 0.0 1.8 0.1 3.6 0.0 0.6 1.8 0.9 0.1 1.3 5.5 0.4 0.0 0.0 4.2 0.3 0.3 0.5 0.5 0.3 2.6 6.5 0.1 2.0 3.8 2.7 1.7 1.9 4.0 0.0 0.9 0.0 2.8 3.4 3.0 4.3 1.4 0.6 2.1 3.3 0.0 0.6 0.0 0.8 3.2 17.7 4.4 0.0 0.5 1.5 3.9 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.8 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.3 0.8 0.0 0.9 0.4 0.4 0.9 1.8 0.5 0.8 2.6 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 3.8 0.0 0.7 14.8 2.5 2.8 0.0 4.0 0.0 4.9 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.0 6.2 0.9 0.8 0.0 0.6 3.0 3.1 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell line enhanced" "Detected in many" "K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (4.02e-2)" "prognostic favourable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.7 4.7 1.4 1.3 7.1 0.5 1.8 2.1 1.2 8.3 3.6 4.0 2.2 0.6 6.7 2.2 2.7 2.0 1.8 4.6 4.4 3.5 1.1 5.3 0.2 0.6 0.4 3.0 3.4 0.2 1.7 0.8 0.4 41.2 24.3 2.2 2.0 1.7 2.4 1.7 4.4 0.9 1.2 3.7 1.0 1.4 9.2 1.0 37.1 2.5 1.0 0.1 1.5 1.0 2.1 41.1 1.6 0.9 35.0 43.1 9.9 0.5 11.6 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell line enhanced" "Detected in many" "K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavourable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.1 15.9 2.5 4.4 11.5 4.3 8.8 10.1 7.3 14.7 9.5 14.4 8.1 2.0 34.4 5.8 8.1 3.1 3.1 2.2 9.1 15.4 3.4 10.0 0.4 5.0 2.7 20.9 20.6 2.7 2.5 2.8 3.0 115.0 23.3 6.6 16.8 4.9 4.9 2.3 6.9 3.2 1.7 25.9 5.5 2.7 12.9 7.4 60.5 20.8 5.5 53.7 3.1 3.3 6.6 104.9 6.1 1.7 32.0 137.9 18.3 3.8 27.4 3.7 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell line enhanced" "Detected in many" "MOLT-4: 12.9;U-266/84: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.2 3.2 1.0 1.7 0.9 0.5 0.3 1.5 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.3 1.0 0.0 0.0 0.0 0.7 2.2 5.7 0.0 6.0 12.9 4.8 2.1 3.3 3.0 0.0 1.4 0.0 2.2 3.0 1.1 3.9 1.6 0.2 1.4 0.9 0.5 0.1 1.6 1.3 1.0 3.3 12.7 4.2 0.4 5.0 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.2 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.2 17.3 0.0 0.5 4.5 11.1 3.3 0.8 7.2 0.0 0.4 0.0 0.0 0.1 1.9 0.7 1.1 0.0 1.0 3.3 0.0 0.0 2.0 1.2 0.1 13.4 0.5 6.8 1.1 1.2 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell line enhanced" "Detected in many" "K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 1.9 0.9 0.7 1.1 0.7 0.8 0.5 0.8 0.7 3.0 0.7 2.1 1.3 0.4 0.3 1.5 4.4 0.7 3.6 1.3 1.4 0.9 3.6 1.2 0.3 0.1 1.3 0.2 8.7 6.8 0.8 1.8 2.9 4.4 1.3 1.0 2.0 0.9 5.1 0.4 0.9 9.6 1.9 3.5 1.3 2.9 2.4 0.8 1.5 2.1 2.1 1.1 0.6 6.0 9.0 3.5 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Cell line enhanced" "Detected in many" "U-266/84: 28.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favourable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.4 4.3 0.7 0.0 2.6 0.8 0.1 5.3 5.3 1.1 1.3 2.5 1.9 0.2 2.2 2.4 0.5 0.7 1.7 1.9 1.6 4.4 1.7 0.0 0.2 1.0 0.3 0.0 0.4 0.5 1.4 6.4 7.2 0.2 0.5 10.9 9.3 1.6 2.1 6.4 1.5 4.8 0.9 0.3 6.1 1.3 4.6 1.2 0.7 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.0 28.8 7.4 0.9 9.3 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell line enhanced" "Detected in many" "Karpas-707: 23.8;U-266/70: 39.7;U-266/84: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.1 2.7 0.9 4.0 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.5 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.5 0.8 3.2 0.3 5.3 9.2 3.3 0.7 2.8 0.5 4.8 23.8 2.1 6.8 1.2 2.0 1.2 2.4 1.4 0.7 5.4 1.6 0.9 12.8 2.0 13.8 1.9 1.0 9.8 0.9 0.7 1.3 14.4 0.9 0.3 39.7 21.2 1.0 1.7 1.4 0.7 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell line enhanced" "Detected in many" "U-266/70: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: , HPA043013: , HPA048671: " "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.5 0.6 4.5 3.0 0.3 7.7 4.0 5.9 5.2 0.3 2.2 0.4 0.6 4.4 1.3 0.1 0.5 4.6 1.2 0.9 0.4 1.5 0.0 6.6 0.2 1.7 5.4 0.0 7.6 1.9 3.3 1.2 2.3 0.8 0.9 3.1 3.7 0.4 1.0 0.3 1.1 0.7 2.8 0.4 2.6 7.2 4.1 3.5 0.3 1.3 9.6 1.4 1.5 0.0 11.2 2.0 31.4 1.0 1.3 5.2 0.3 3.3 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 2.5 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.4 0.2 0.0 0.0 0.8 0.0 0.2 1.4 0.5 0.9 0.4 0.3 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.1 4.3 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "Human immunodeficiency virus type I enhancer binding protein 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050724 Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria" Nucleoplasm "Nuclear bodies, Mitochondria" "HPA050724: AB_2616457" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 22.3 5.5 6.4 20.1 5.6 20.5 13.1 8.0 10.0 11.5 12.6 5.4 13.9 7.0 10.0 10.6 12.9 9.2 10.6 8.8 5.6 7.1 7.3 17.1 13.3 12.4 5.3 6.7 11.6 11.7 23.3 12.2 8.7 7.8 10.5 9.5 7.7 10.9 17.6 8.2 14.1 11.8 12.9 5.9 15.2 7.2 7.3 5.0 23.8 7.7 14.2 16.2 17.3 23.1 5.6 9.6 12.9 4.9 3.6 4.6 0.7 5.2 3.9 5.1 2.8 4.0 5.1 4.9 4.2 3.7 3.5 3.9 2.5 2.8 4.4 9.3 5.1 5.0 4.9 6.1 4.9 9.4 2.9 2.0 3.7 2.4 3.2 2.3 1.7 3.5 6.2 7.2 11.1 10.3 20.9 5.0 7.7 3.9 3.8 2.1 4.3 2.0 2.0 6.6 6.9 2.1 5.7 4.8 3.5 10.5 8.6 2.9 5.1 3.1 16.7 8.9 4.0 8.3 4.8 20.3 16.9 7.8 2.7 3.1 3.7 2.4 2.2 2.2 1.4 2.2 1.0 3.4 2.3 0.9 1.3 5.6 4.0 2.3 12.9 3.6 4.9 9.6 4.6 0.7 6.4 5.6 8.0 10.0 5.6 7.1 5.3 6.7 7.8 5.0 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli" Mitochondria "HPA008436: AB_1850757, HPA027261: " "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (3.37e-5)" "prognostic unfavourable (2.46e-4)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavourable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.0 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.6 5.3 2.9 10.1 19.9 18.0 13.2 24.4 12.5 6.7 20.5 18.5 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 11.4 17.4 13.3 33.6 17.2 23.7 18.6 19.2 16.0 18.3 33.8 9.4 9.4 10.3 13.0 8.1 14.7 11.2 10.5 8.4 13.1 8.3 19.8 21.5 14.5 27.6 12.7 10.0 21.4 11.8 12.5 49.2 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 HKR1 ZNF875 ENSG00000181666 "HKR1, GLI-Kruppel zinc finger family member" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: " "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favourable (4.41e-4)" "prognostic unfavourable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 13.0 25.8 14.6 13.2 22.4 12.6 24.9 29.8 27.2 20.5 14.5 22.9 21.5 7.7 24.8 24.1 12.4 22.9 17.9 26.9 14.6 15.6 19.3 12.3 12.9 14.3 14.9 17.4 22.6 14.2 31.0 35.5 17.2 21.2 27.5 13.8 49.4 18.7 19.3 18.1 27.1 13.4 17.0 13.3 20.2 14.2 22.6 15.5 16.4 30.9 13.7 20.1 15.0 15.6 12.4 7.9 10.0 5.1 9.9 14.8 5.7 4.1 10.4 13.4 17.8 9.8 8.6 9.4 7.0 10.6 13.0 14.1 5.2 4.9 14.5 17.0 7.3 3.4 8.8 9.3 13.5 7.6 15.0 5.1 12.6 5.5 12.9 4.7 12.4 12.7 11.6 8.8 19.3 7.9 0.9 0.9 9.4 8.4 10.4 9.3 27.0 5.9 7.1 5.9 5.6 11.4 16.7 16.7 22.8 7.0 8.9 8.8 12.8 9.0 7.1 10.3 7.5 7.8 10.8 18.7 19.7 15.0 1.1 5.8 11.6 10.0 4.2 6.6 8.0 5.1 14.8 10.7 10.6 11.4 6.3 12.4 14.4 12.0 4.0 9.9 3.6 7.9 12.2 5.7 14.6 22.4 29.8 27.2 14.6 15.6 14.9 17.4 21.2 15.5 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" "P16188, P04439, P13746" 6 29941260-29945884 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 154.8;fHDF/TERT166: 41.4;HBEC3-KT: 42.5;RPMI-8226: 40.3;U-266/70: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB078470 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favourable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favourable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 69.4 57.5 16.0 69.1 18.2 41.2 40.8 9.1 20.7 54.4 92.6 20.4 28.6 105.7 38.4 76.2 48.4 27.8 92.3 59.1 14.6 16.6 80.5 47.6 112.0 90.5 19.5 8.9 57.2 30.0 22.5 33.3 38.7 22.7 64.1 38.5 52.4 28.3 19.2 44.0 110.4 129.4 30.3 22.8 150.0 115.9 26.6 12.3 71.1 62.3 38.5 97.7 86.4 41.0 23.0 10.9 65.8 25.2 25.9 46.7 45.4 154.8 3.9 0.0 0.0 25.0 23.6 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.4 0.0 41.4 3.8 0.0 42.5 0.0 0.3 1.5 27.0 1.2 0.8 1.4 0.0 1.8 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 2.4 0.3 0.4 3.3 0.3 40.3 29.0 31.8 0.0 1.4 3.5 0.0 1.4 0.1 3.6 0.5 2.3 0.1 0.7 0.4 41.3 10.5 8.7 0.0 22.8 0.0 65.8 25.2 35.4 38.3 17.9 28.8 23.0 29.6 34.4 4.1 14.9 21.7 29.7 47.9 25.9 19.8 10.9 46.7 45.4 16.0 18.2 9.1 20.7 14.6 16.6 19.5 8.9 22.7 12.3 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Group enriched" "Detected in some" 6 "HDLM-2: 46.1;REH: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "HPA011078, HPA058509" Approved Approved "Nucleoplasm,Cell Junctions" 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: " "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favourable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 46.1 2.1 1.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 22.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 5.8 0.1 3.8 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 74.6" "Cell line enriched" "Detected in some" 6 "HDLM-2: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4" "Group enriched" "Detected in all" 6 "B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 23.9 10.0 3.5 40.4 3.0 9.0 17.0 1.0 4.9 11.0 18.8 8.8 4.5 0.0 9.9 42.6 9.6 8.0 21.7 12.7 4.1 5.3 35.4 9.9 61.2 61.1 6.1 4.2 6.3 4.0 0.0 9.2 4.0 7.9 11.3 10.7 13.5 11.8 5.6 7.8 12.4 27.6 4.6 15.5 74.5 32.7 4.6 2.9 63.5 13.3 7.9 74.6 37.9 7.4 35.6 68.2 4.6 27.8 1.5 7.1 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.4 0.0 3.6 0.0 3.6 0.0 111.8 2.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.6 2.0 0.0 0.0 0.1 0.1 0.0 13.4 0.3 12.3 9.3 0.0 0.0 0.0 27.8 4.6 2.4 24.1 1.1 30.9 1.2 3.7 68.2 35.6 0.0 1.1 1.9 1.5 6.6 21.4 7.1 31.9 3.5 3.0 1.0 4.9 4.1 5.3 6.1 4.2 7.9 2.9 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879400-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.2;THP-1: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 25.8;neutrophil: 28.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 28.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA005968 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 27.7 3.0 2.7 8.8 3.0 54.0 18.4 0.9 2.3 5.7 24.3 2.0 3.8 4.5 7.4 3.6 8.7 5.0 7.5 15.2 3.3 0.9 4.0 11.5 14.3 10.5 6.2 0.3 4.9 4.9 1.8 2.0 14.0 2.5 6.9 2.4 4.2 2.3 3.8 10.4 5.7 11.1 4.2 6.4 10.9 3.1 3.9 3.1 1.4 6.3 3.0 3.2 10.4 12.9 2.2 5.5 28.5 6.3 0.2 0.1 1.8 0.0 1.8 0.0 1.4 4.2 6.8 3.5 5.1 8.5 5.8 4.9 0.4 0.1 0.0 0.1 3.2 0.0 1.1 0.0 2.4 1.3 3.7 0.0 2.1 0.2 7.4 1.7 0.3 7.8 0.2 6.6 0.3 2.5 2.2 0.0 0.8 0.0 0.0 6.1 0.2 3.5 0.1 4.0 0.0 0.6 0.0 0.0 2.0 0.7 0.1 13.2 0.0 46.4 0.7 4.0 0.0 0.6 4.0 0.0 0.0 0.0 6.4 5.3 1.6 25.8 6.3 10.7 0.0 1.8 0.0 2.2 0.0 0.0 5.5 1.1 0.0 0.0 28.5 0.2 0.3 3.5 0.1 1.8 2.7 3.0 0.9 2.3 3.3 0.9 6.2 0.3 2.5 3.1 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890394-29064764 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: , HPA058586: " "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 10.8 23.1 16.4 10.5 15.5 21.2 10.4 18.6 15.8 9.2 8.4 13.9 8.5 6.7 14.9 8.6 9.6 8.7 9.4 12.7 14.6 8.2 10.1 10.0 15.9 11.0 16.6 10.1 13.9 10.9 13.5 13.6 14.6 15.9 7.6 8.8 9.9 11.7 12.5 9.7 12.1 10.2 11.6 20.0 11.8 9.3 16.8 18.2 13.0 13.7 5.6 12.6 10.4 14.3 6.6 4.8 5.0 9.0 2.2 5.5 2.6 5.0 5.5 6.1 7.0 5.7 6.0 5.1 2.2 2.9 3.4 3.9 2.5 3.2 12.3 5.4 3.8 4.3 11.8 4.4 4.8 4.5 2.1 12.8 10.3 3.4 4.5 4.3 8.6 2.9 6.3 4.5 8.5 7.6 18.1 12.3 4.8 2.9 7.9 2.2 4.2 1.3 6.5 6.0 2.9 2.4 9.3 2.6 7.8 4.2 3.2 4.6 3.2 3.9 10.9 3.1 14.6 3.3 3.0 3.7 3.8 4.8 4.2 5.3 4.5 5.0 4.8 2.0 4.0 4.9 5.5 6.6 3.9 3.5 4.8 5.7 5.0 4.8 2.7 2.2 9.0 3.8 1.7 2.6 16.4 15.5 18.6 15.8 14.6 8.2 16.6 10.1 15.9 18.2 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Approved Nucleoplasm,Nucleoli 18000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.29e-6)" "prognostic unfavourable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 15.8 3.5 14.8 35.7 13.5 55.4 13.0 13.8 19.0 26.1 22.0 5.9 7.7 42.3 8.6 7.2 79.4 15.1 17.8 13.0 11.7 12.6 14.6 6.9 16.0 46.1 10.7 8.7 3.9 13.0 4.1 5.1 31.8 12.5 8.7 21.2 9.9 22.0 6.9 33.7 38.3 36.0 3.8 8.4 31.6 24.2 32.6 7.2 107.3 12.5 39.6 72.7 13.0 29.6 26.6 33.4 12.8 10.1 7.3 22.4 11.0 120.4 47.7 24.5 17.1 11.4 84.6 107.0 48.7 55.7 37.8 21.1 31.2 84.5 56.8 24.6 19.9 25.9 28.8 86.9 30.1 12.4 19.3 17.4 16.1 41.7 24.2 62.2 20.1 36.2 9.7 68.4 35.8 114.1 70.1 2.9 52.6 12.2 53.9 76.6 119.2 80.9 80.2 0.5 62.7 25.6 11.1 42.8 18.1 5.1 24.7 45.0 9.9 66.8 98.9 19.7 62.2 28.6 45.6 23.4 36.2 73.4 41.7 26.0 98.3 6.2 10.1 12.8 10.2 10.1 13.3 26.6 18.7 16.0 30.7 16.4 22.4 17.7 2.6 7.3 9.4 33.4 21.0 11.0 14.8 13.5 13.8 19.0 11.7 12.6 10.7 8.7 12.5 7.2 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell line enhanced" "Detected in many" "AF22: 66.0;NTERA-2: 38.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB017809: , HPA039076: " "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavourable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.5 4.2 66.0 9.4 3.1 17.3 0.0 30.5 13.9 5.4 5.4 5.4 4.0 0.0 19.8 1.4 4.2 10.9 26.2 25.7 0.0 11.4 0.0 0.1 33.0 1.7 0.9 0.1 13.1 1.6 11.5 20.8 21.1 0.0 0.1 30.5 0.0 0.1 5.4 38.7 19.0 2.6 3.2 0.0 14.2 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.1 24.6 19.4 5.8 14.8 9.1 0.0 0.0 0.0 23.4 0.0 4.4 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331695-173335125 "Plasma proteins, Predicted intracellular proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1" "Cell line enhanced" "Detected in all" "MOLT-4: 168.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" 380000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: " "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavourable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavourable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavourable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavourable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 18.8 5.9 10.3 48.9 13.2 325.8 19.9 6.6 9.5 17.1 24.0 8.6 7.9 15.7 18.6 16.2 28.6 15.4 13.8 23.4 9.5 10.2 13.2 6.9 25.4 59.8 12.5 8.2 29.0 5.8 2.9 8.0 18.5 9.3 19.0 21.2 12.2 13.8 8.6 46.2 15.5 21.5 25.3 13.3 36.7 13.0 26.7 10.6 187.1 18.7 23.0 61.6 27.1 18.5 11.6 16.8 95.9 20.5 11.9 39.9 14.3 34.3 8.2 70.9 31.6 8.8 8.8 27.2 25.6 19.5 28.2 25.3 23.3 48.0 116.2 5.8 14.3 13.4 46.5 14.0 44.2 71.1 21.7 127.7 20.9 34.1 8.6 112.9 49.3 8.5 4.3 14.1 32.2 29.0 48.1 163.7 25.9 28.7 168.3 104.8 25.8 14.3 85.1 36.4 43.1 16.3 14.7 61.4 55.4 25.9 15.0 11.5 20.8 82.4 16.6 12.7 37.6 15.7 38.4 52.9 29.6 133.0 10.8 82.6 33.0 95.9 20.5 57.6 15.6 8.5 14.1 11.6 22.7 21.2 16.8 8.8 15.0 14.3 47.8 11.9 6.8 6.8 39.9 14.3 10.3 13.2 6.6 9.5 9.5 10.2 12.5 8.2 9.3 10.6 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell line enhanced" "Detected in all" "HBEC3-KT: 107.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA062583: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favourable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favourable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.1 16.5 52.0 27.0 2.2 6.5 64.7 16.3 10.8 19.0 9.9 13.0 15.4 26.0 52.6 12.5 17.9 47.3 107.0 21.4 17.7 13.8 22.6 15.9 20.4 3.2 34.0 11.5 5.1 25.3 7.7 19.6 24.5 11.7 15.5 22.5 28.5 37.5 26.2 30.8 20.2 46.0 42.3 14.7 13.9 17.8 37.5 24.5 24.2 26.2 8.1 23.1 22.6 18.4 7.9 18.7 25.1 35.9 14.1 17.5 96.4 9.4 17.4 16.0 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell line enhanced" "Detected in all" "AF22: 123.5;HBEC3-KT: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: , HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favourable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 15.3 7.4 123.5 14.2 7.2 28.7 8.4 2.4 9.7 3.5 7.0 12.8 22.2 16.3 5.5 3.5 12.1 30.7 71.2 3.7 3.4 36.9 6.0 6.8 17.3 11.3 13.1 4.3 15.6 8.6 18.5 7.4 3.6 10.7 44.6 2.9 7.1 11.8 16.0 22.1 3.9 8.5 17.3 18.0 54.7 23.8 10.6 5.1 12.6 6.3 3.7 9.9 17.5 4.3 2.6 13.3 2.8 2.3 6.0 9.1 22.2 2.3 15.8 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472450-26475972 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB018371: , HPA077364: " "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavourable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 30.6 34.9 36.0 52.4 32.3 169.1 37.6 30.8 39.1 51.3 43.4 30.3 53.6 30.0 46.1 60.6 44.1 50.1 51.6 37.6 30.5 32.0 35.9 37.1 62.9 100.2 32.7 30.5 64.7 59.4 16.7 52.7 49.6 26.0 48.0 49.9 42.5 58.9 51.9 41.1 33.9 41.3 68.1 40.4 50.0 33.2 29.9 31.1 104.6 48.6 52.5 83.2 43.7 38.7 60.4 81.4 157.4 73.6 38.6 83.4 103.5 82.5 28.7 83.1 34.9 7.7 17.9 32.4 40.9 23.6 80.1 61.8 29.5 77.4 93.0 39.1 33.2 47.7 104.7 40.6 68.2 57.2 74.2 99.8 34.0 28.8 14.5 211.2 58.3 18.8 21.3 43.8 25.9 37.2 78.9 44.7 41.9 60.9 150.6 96.0 69.5 53.3 104.8 130.4 56.9 25.2 22.6 82.9 51.4 122.9 34.6 45.2 56.7 100.2 27.7 40.0 74.7 76.5 68.1 54.6 74.1 103.5 25.7 222.3 79.2 30.3 59.9 157.4 34.2 69.0 32.0 60.4 46.8 41.4 60.9 59.1 51.5 41.7 53.1 38.6 73.6 81.4 83.4 103.5 36.0 32.3 30.8 39.1 30.5 32.0 32.7 30.5 26.0 31.1 HMGN3 TRIP7 ENSG00000118418 "High mobility group nucleosomal binding domain 3" Q15651 6 79201245-79234738 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018370, HPA027971, HPA063572" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB018370: , HPA027971: AB_1850808, HPA063572: " "unprognostic (1.02e-1)" "unprognostic (2.04e-2)" "unprognostic (5.92e-2)" "unprognostic (5.26e-2)" "unprognostic (3.48e-1)" "unprognostic (3.88e-2)" "unprognostic (5.24e-2)" "prognostic favourable (2.76e-4)" "unprognostic (8.78e-2)" "unprognostic (5.31e-3)" "unprognostic (1.47e-3)" "unprognostic (5.81e-2)" "prognostic unfavourable (1.02e-7)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.69e-1)" "unprognostic (6.43e-3)" 26.6 57.2 53.6 22.9 52.7 18.8 37.2 73.1 84.6 26.1 28.3 22.6 28.4 27.7 29.9 55.4 29.0 66.8 26.4 68.6 53.3 33.4 52.5 44.6 34.4 35.5 70.8 36.1 34.9 27.8 38.7 66.8 35.4 53.0 27.4 23.5 28.0 47.4 30.6 41.8 24.8 22.3 33.0 53.2 27.7 31.0 24.8 63.5 21.9 36.1 37.9 32.8 26.1 25.6 28.0 52.3 7.7 38.3 32.8 29.4 36.4 14.1 12.9 45.2 19.5 18.2 15.0 10.2 9.8 10.6 11.1 16.3 72.1 12.0 0.1 18.3 8.0 9.1 29.3 11.2 10.9 41.7 24.6 49.9 40.4 37.5 11.7 40.8 7.6 18.1 12.5 7.3 4.0 24.6 29.2 40.0 17.9 12.9 18.7 78.8 33.1 32.4 32.1 69.1 14.5 75.9 20.6 18.5 24.8 18.8 21.7 13.8 12.3 68.9 10.7 3.0 13.5 10.7 21.7 34.5 50.8 0.2 1.7 0.1 14.8 7.7 38.3 3.2 29.4 36.2 25.5 28.0 20.6 24.6 44.8 23.2 24.3 29.2 1.8 32.8 33.3 52.3 21.9 36.4 53.6 52.7 73.1 84.6 53.3 33.4 70.8 36.1 53.0 63.5 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113701-81201942 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Cell line enhanced" "Detected in many" "Daudi: 44.5;Karpas-707: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favourable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 5.2 11.4 14.7 3.1 15.6 12.5 6.5 6.0 12.0 8.6 10.6 5.1 12.3 10.2 7.7 30.9 9.8 7.5 4.8 5.4 16.1 14.3 16.2 9.9 3.9 2.0 13.2 10.1 9.5 5.6 11.9 39.8 2.0 10.4 7.0 7.9 3.5 5.6 9.3 3.6 5.2 10.8 7.3 22.1 8.2 5.9 48.6 19.6 10.9 8.1 8.6 2.7 7.8 6.0 6.5 11.0 2.8 3.1 3.4 10.2 3.4 0.2 2.2 5.8 28.5 5.0 1.5 1.2 1.6 2.5 0.4 0.7 0.7 10.8 44.5 5.0 0.7 1.9 34.4 4.1 1.0 26.0 13.7 18.6 21.0 0.3 0.5 30.9 18.4 1.2 1.1 1.7 1.7 2.2 24.5 65.6 2.9 1.0 28.1 11.0 25.9 7.5 1.0 24.3 21.0 7.0 0.8 0.2 0.6 0.2 0.6 1.9 3.5 7.3 2.6 0.9 7.6 4.5 6.0 4.6 1.9 7.2 2.7 12.2 1.6 2.0 3.1 1.4 8.5 1.6 7.7 3.6 5.2 4.6 5.3 6.5 10.2 8.7 2.8 3.4 2.5 11.0 1.7 3.4 14.7 15.6 6.0 12.0 16.1 14.3 13.2 10.1 10.4 19.6 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: , HPA043926: , HPA061524: " "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavourable (5.52e-4)" "prognostic unfavourable (1.93e-7)" "prognostic unfavourable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.1 14.5 1.4 2.6 20.2 20.1 9.8 25.2 22.9 27.0 40.8 35.1 19.2 6.2 24.4 31.3 19.0 43.0 31.8 9.7 21.0 9.5 13.1 0.4 18.6 19.4 0.7 1.1 23.6 18.5 14.3 19.8 28.8 26.2 7.7 19.6 10.6 23.4 14.5 21.4 36.3 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 27.6 14.9 9.3 18.1 15.3 14.4 26.9 15.5 25.9 28.3 11.9 28.8 17.3 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell line enhanced" "Detected in many" "BEWO: 110.9;U-138 MG: 64.7;U-87 MG: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.6 0.2 4.6 18.5 5.4 110.9 10.4 6.2 4.9 5.3 10.0 1.4 0.0 2.3 8.5 1.2 1.3 0.2 1.5 37.3 1.1 0.5 6.9 20.4 25.7 1.4 7.0 17.0 0.4 32.3 2.1 14.7 0.0 10.8 15.6 1.1 0.0 0.5 2.2 2.5 0.1 1.9 3.4 3.5 12.1 0.3 0.3 26.9 2.4 1.8 1.0 0.3 5.5 64.7 2.9 10.5 10.1 6.8 8.7 1.0 62.8 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol 1200000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favourable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 19.4 19.2 32.1 15.7 50.7 13.6 16.6 19.7 38.6 13.3 17.9 22.9 12.2 23.5 11.9 18.7 36.6 15.6 19.7 57.2 29.3 22.0 32.2 39.7 15.8 20.8 27.3 35.1 12.5 22.4 20.6 14.7 12.5 36.5 12.1 19.9 8.6 16.0 10.0 20.1 16.6 19.3 16.6 27.2 23.3 29.7 48.1 28.2 8.7 13.8 16.7 25.3 16.5 15.0 14.5 14.5 48.7 8.9 18.7 35.8 25.8 24.6 10.5 6.3 13.6 18.8 9.7 10.5 17.0 8.4 14.5 12.6 13.3 16.8 11.4 19.2 15.6 14.9 19.7 36.5 16.5 14.6 13.4 8.3 10.1 18.0 12.7 18.0 14.2 15.1 12.3 16.8 12.3 26.6 13.4 5.8 13.3 30.5 14.8 14.1 9.6 10.0 15.7 11.0 24.0 20.1 16.2 10.6 6.2 13.6 28.9 18.3 18.0 10.1 25.9 8.2 12.2 35.1 8.7 7.2 8.9 25.2 5.2 14.9 10.4 13.7 7.4 48.7 35.2 8.9 29.9 14.5 32.7 35.8 14.5 13.0 31.7 32.7 26.1 18.7 6.5 8.2 30.0 25.8 32.1 50.7 19.7 38.6 29.3 22.0 27.3 35.1 36.5 28.2 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.4;HEL: 5.4;HeLa: 5.0;K-562: 17.9;NB-4: 6.1;SiHa: 5.0" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA069659: " "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.4 5.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 6.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 2.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686432-37745247 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.7;kidney: 66.2;pancreas: 18.6" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 52.0" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Group enriched" "Detected in some" 5 "basal ganglia: 0.7;hypothalamus: 2.3" "Low region specificity" "Detected in some" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB068192: , HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favourable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favourable (2.51e-6)" 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.1 4.5 0.0 4.8 3.8 0.9 7.8 0.0 2.8 34.7 0.0 0.0 66.2 7.7 3.7 0.0 0.0 0.0 0.8 18.6 1.6 0.0 0.6 0.0 1.6 3.4 0.0 0.0 3.8 0.0 0.0 5.5 0.3 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.8 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 52.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell line enhanced" "Detected in some" "A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005438: AB_1850822, HPA010610: " "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 17.3 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.3 0.3 5.3 0.0 0.0 0.3 3.0 0.1 0.3 1.7 0.4 0.1 0.0 0.3 5.8 0.0 0.4 0.2 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 HNMT ENSG00000150540 "Histamine N-methyltransferase" P50135 2 137964020-138016364 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 61.3;HSkMC: 25.1;RT4: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6" "Group enriched" "Detected in many" 22 "dendritic cells: 20.9;monocytes: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035480, HPA035481, HPA073754" Approved Approved Nucleoplasm,Centrosome,Cytosol 64000 "Nucleoplasm, Cytosol" Centrosome "HPA035480: , HPA035481: AB_10672094, HPA073754: " "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" "unprognostic (5.44e-2)" "unprognostic (2.09e-2)" "unprognostic (2.81e-1)" "unprognostic (2.33e-1)" "unprognostic (2.29e-2)" "unprognostic (6.02e-2)" "unprognostic (5.69e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.41e-4)" "unprognostic (5.24e-2)" "unprognostic (1.34e-2)" "unprognostic (1.76e-2)" "unprognostic (5.34e-2)" "unprognostic (1.21e-1)" "prognostic favourable (4.68e-4)" 41.4 5.8 12.2 12.3 11.1 3.3 28.8 10.7 11.3 27.6 16.3 8.6 13.9 8.7 22.2 21.4 11.6 14.6 21.6 14.7 12.7 7.8 33.4 74.2 21.9 17.0 13.7 9.2 33.1 14.1 24.5 5.5 14.3 11.2 22.3 17.7 8.7 14.1 20.1 4.9 8.1 11.1 13.2 14.8 18.5 11.5 11.7 14.6 1.0 7.3 8.5 6.5 21.3 12.0 0.5 20.9 1.2 34.6 0.1 0.2 9.2 0.2 0.3 1.5 4.1 17.6 18.9 0.1 1.1 1.7 0.1 0.7 7.8 4.4 0.2 13.9 4.6 0.4 3.2 0.0 0.0 0.2 1.6 0.1 13.1 61.3 7.9 0.0 0.2 25.1 0.0 6.2 0.0 4.4 0.2 0.3 13.2 1.0 0.0 0.2 7.8 1.6 0.1 0.5 0.0 18.9 31.8 0.1 0.4 6.0 7.7 0.0 0.2 14.4 1.3 1.3 3.4 1.8 4.4 0.1 0.0 0.2 6.0 7.5 0.9 0.8 34.6 0.2 0.2 26.7 0.1 0.5 0.1 0.1 20.9 0.3 0.1 0.2 1.2 0.1 14.6 0.6 0.2 9.2 12.2 11.1 10.7 11.3 12.7 7.8 13.7 9.2 11.2 14.6 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.4 7.7 22.7 13.3 11.0 10.4 14.1 15.6 12.8 13.6 11.5 8.7 9.6 0.2 14.0 13.9 10.5 14.2 11.7 14.1 24.5 12.4 12.0 14.5 21.9 10.4 22.4 12.4 8.2 9.3 11.3 12.6 14.2 20.4 37.3 16.0 7.7 24.4 12.2 22.8 14.2 4.8 15.9 8.1 11.7 21.7 15.5 17.4 13.7 12.1 11.4 10.1 9.7 14.7 10.2 15.4 11.2 12.7 20.5 20.4 0.1 8.8 5.5 12.4 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 HOMER3 HOMER-3 ENSG00000051128 "Homer scaffolding protein 3" Q9NSC5 19 18929201-18941261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.8" "Cell line enhanced" "Detected in many" "NB-4: 61.2;THP-1: 73.6;U-266/84: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 14.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.1;monocytes: 14.7" "Region enriched" "Detected in many" 6 "cerebellum: 212.2" "Low region specificity" "Detected in all" "CAB032656, HPA040999, CAB079015" Enhanced Supported Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" Cytosol "Plasma membrane, Cytoplasmic bodies" "CAB032656: AB_2120801, CAB079015: , HPA040999: " "unprognostic (3.41e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (4.24e-5)" "unprognostic (1.19e-1)" "unprognostic (2.06e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (4.93e-5)" "unprognostic (1.07e-1)" "unprognostic (8.88e-2)" "unprognostic (5.78e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (5.99e-2)" "unprognostic (3.76e-2)" "unprognostic (2.33e-1)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" 11.4 8.3 11.1 6.5 16.0 12.4 31.0 42.3 12.2 8.7 6.7 17.6 2.1 4.9 8.2 5.2 7.6 4.8 10.9 11.9 15.8 9.0 21.2 4.1 7.0 5.5 19.4 7.2 8.2 5.3 13.6 2.4 9.7 15.5 8.1 4.5 15.4 8.4 7.0 49.2 10.9 5.5 7.6 24.2 64.8 6.5 3.4 14.6 2.2 19.6 7.8 3.3 12.3 16.8 2.4 1.2 5.1 14.7 0.0 0.7 3.6 19.3 5.0 9.6 7.9 8.9 9.0 4.7 19.2 17.0 19.3 9.8 2.5 7.4 0.1 9.1 21.5 12.1 3.3 24.9 10.8 0.6 2.0 0.0 1.6 4.7 8.3 3.7 0.3 7.3 16.1 10.7 14.5 23.4 0.5 5.1 14.0 5.2 0.3 61.2 4.9 20.7 9.5 2.9 9.0 6.9 5.0 0.0 8.1 4.7 5.6 13.5 2.5 73.6 18.6 17.2 7.7 20.7 23.0 49.9 63.2 16.1 27.1 47.3 12.4 0.1 14.7 2.6 0.1 5.1 0.0 2.4 0.7 0.3 1.2 1.7 0.1 0.0 5.1 0.0 1.4 0.2 0.7 3.6 11.1 16.0 42.3 12.2 15.8 9.0 19.4 7.2 15.5 14.6 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favourable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favourable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favourable (1.75e-4)" "unprognostic (3.23e-1)" 7.6 8.3 6.6 7.2 6.8 1.7 9.2 4.6 6.6 9.3 8.5 12.1 18.5 8.1 8.4 11.2 14.4 9.1 12.7 8.9 6.4 5.1 11.6 8.8 7.2 6.4 6.5 5.4 12.5 11.0 8.0 7.0 6.6 7.2 11.1 7.6 12.2 13.6 22.0 12.0 9.1 8.4 8.6 7.6 8.1 9.9 39.9 7.4 16.0 14.7 6.3 11.3 12.9 8.3 4.3 7.4 10.8 7.2 3.6 6.3 3.9 4.3 4.5 8.6 8.3 13.5 5.9 9.6 4.9 6.2 4.6 5.7 1.9 9.6 9.6 3.9 4.4 14.8 11.5 11.8 5.7 5.2 3.9 3.3 3.6 8.9 16.9 4.8 2.9 9.3 12.1 3.4 7.8 8.7 9.3 4.0 8.0 9.9 3.7 3.4 3.4 2.6 5.8 6.5 4.2 8.7 18.5 2.8 3.5 4.5 13.1 5.1 7.9 6.0 9.2 3.2 1.4 3.9 2.1 16.2 6.9 3.3 1.7 3.6 4.7 4.1 7.2 10.8 5.7 7.1 4.6 4.3 4.9 4.8 7.4 3.9 5.4 6.3 1.4 3.6 4.9 4.7 6.2 3.9 6.6 6.8 4.6 6.6 6.4 5.1 6.5 5.4 7.2 7.4 HOOK2 HK2 ENSG00000095066 "Hook microtubule tethering protein 2" Q96ED9 19 12763003-12872740 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4;RT4: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043519, HPA050351" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA043519: , HPA050351: " "unprognostic (4.26e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "unprognostic (1.16e-1)" "unprognostic (4.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.25e-3)" "unprognostic (3.06e-2)" "unprognostic (2.52e-2)" "unprognostic (1.75e-3)" "prognostic unfavourable (7.59e-5)" "prognostic favourable (3.28e-4)" "unprognostic (3.27e-3)" "unprognostic (5.74e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-2)" 18.6 6.6 14.9 5.7 13.5 1.9 15.5 21.9 17.5 8.5 14.5 4.2 32.7 25.5 8.0 24.9 18.5 8.9 16.8 15.5 12.2 6.9 16.0 15.0 8.1 4.1 10.2 8.4 8.7 31.9 28.4 49.1 11.3 12.9 17.3 12.2 6.6 22.9 35.9 29.8 26.4 27.1 5.3 10.8 6.0 18.1 7.4 12.1 3.5 33.5 15.8 11.4 10.1 12.0 3.9 3.7 2.2 2.7 2.6 6.8 2.4 15.3 3.8 4.7 3.2 5.0 4.8 16.6 4.6 2.2 2.6 3.4 12.8 18.3 2.8 8.7 4.6 20.4 4.8 14.0 2.7 8.8 3.4 3.0 7.1 4.3 2.9 1.5 4.8 5.8 13.4 3.7 5.4 1.5 5.0 2.5 5.3 34.4 1.6 2.9 2.2 4.0 5.1 2.8 7.0 5.5 39.8 12.5 6.0 3.3 10.4 3.1 15.1 4.0 3.1 6.0 3.5 8.8 1.7 9.7 9.5 1.8 5.6 5.8 3.9 0.8 1.6 0.0 3.4 2.7 2.1 3.9 4.0 1.5 3.7 3.1 6.8 4.4 2.2 2.6 1.6 1.3 1.0 2.4 14.9 13.5 21.9 17.5 12.2 6.9 10.2 8.4 12.9 12.1 HOOK3 HK3 ENSG00000168172 "Hook microtubule tethering protein 3" Q86VS8 8 42896932-43030539 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024756 Approved Supported "Golgi apparatus,Centriolar satellite,Cytosol" "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA024756: AB_1850913" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.73e-1)" "unprognostic (8.61e-3)" "unprognostic (6.05e-2)" "unprognostic (1.77e-3)" "unprognostic (2.36e-1)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.13e-1)" "prognostic unfavourable (1.32e-4)" "unprognostic (1.63e-1)" "unprognostic (3.78e-1)" "unprognostic (2.55e-1)" "unprognostic (7.12e-2)" 15.5 9.3 11.3 10.1 15.1 13.1 16.3 16.0 19.2 13.5 11.3 10.3 14.1 10.2 13.7 12.0 14.8 11.7 20.0 9.5 11.2 11.3 9.9 10.7 14.6 10.3 14.7 11.7 13.4 13.9 13.4 14.4 12.0 13.1 17.7 10.9 6.8 17.1 15.2 24.1 11.0 11.9 19.3 17.5 11.6 12.8 14.5 14.3 7.4 37.5 8.9 10.1 19.2 17.6 1.8 3.8 10.2 3.2 2.0 2.0 1.8 7.3 7.3 17.8 9.6 13.2 11.7 6.8 9.3 7.8 7.8 7.3 9.6 8.6 9.1 9.6 12.4 4.1 14.7 6.3 12.7 6.2 4.2 17.2 6.0 6.6 7.4 1.8 10.2 9.5 4.6 10.5 9.1 11.2 9.4 10.7 9.4 1.8 13.9 3.4 6.4 2.2 8.2 18.6 2.3 5.8 10.9 4.5 7.2 10.6 4.5 4.9 8.2 6.2 20.0 11.7 9.2 14.1 5.9 10.6 11.5 12.0 9.9 6.6 17.3 10.2 3.2 3.1 2.0 3.2 0.8 1.6 1.9 1.5 3.8 1.8 1.1 1.5 3.8 2.0 3.1 2.4 1.4 1.8 11.3 15.1 16.0 13.1 11.2 11.3 14.7 11.7 13.1 14.3 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.8;skin 1: 154.6" "Cell line enhanced" "Detected in some" "HDLM-2: 13.1;HUVEC TERT2: 29.0;RT4: 21.6;TIME: 32.8;U-266/70: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 68.6;NK-cell: 90.9" "Group enriched" "Detected in many" 14 "NK-cells: 90.9;T-cells: 68.6" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 1.7 5.0 24.1 5.2 13.0 2.0 23.1 4.0 28.2 26.4 3.1 3.6 3.0 3.4 2.5 106.2 90.3 2.3 6.7 5.7 20.0 8.2 2.3 0.7 112.4 3.4 12.1 12.9 1.4 1.1 2.3 1.2 128.8 15.0 4.5 1.6 1.0 19.0 12.9 3.4 154.6 3.4 20.9 11.2 2.3 3.2 9.6 1.9 1.8 65.9 93.2 66.3 6.8 37.8 5.6 0.4 1.5 0.5 90.9 68.6 38.2 0.0 0.0 0.0 0.0 2.2 7.1 2.6 0.0 0.0 0.6 0.4 0.0 0.0 5.3 0.3 0.1 0.9 0.6 0.0 0.8 13.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.3 1.6 0.0 29.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 21.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.1 0.2 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.2 68.6 0.4 37.4 5.6 17.1 30.1 0.3 4.3 3.1 21.0 1.5 90.9 0.5 0.4 1.0 38.2 24.1 13.0 4.0 28.2 20.0 8.2 12.1 12.9 15.0 1.9 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.4;hTCEpi: 19.3;SiHa: 5.9;THP-1: 11.1;U-2 OS: 3.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA028346: , HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 0.0 11.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HOXA10 "HOX1, HOX1H" ENSG00000253293 "Homeobox A10" P31260 7 27170591-27180261 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 48.2;endometrium 1: 45.6" "Cell line enhanced" "Detected in many" "HEK 293: 54.8;THP-1: 28.8;U-937: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 7.8;NK-cell: 12.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;NK-cells: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB019384 Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB019384: " "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.73e-3)" "unprognostic (2.61e-2)" "unprognostic (1.41e-2)" "unprognostic (8.05e-2)" "unprognostic (2.71e-2)" "unprognostic (3.83e-3)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (8.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-2)" 5.9 2.7 0.3 4.6 0.4 1.2 2.5 0.3 0.3 48.2 15.9 0.3 4.0 0.0 45.6 5.4 0.3 3.4 0.5 0.3 0.3 0.0 7.9 0.3 0.3 0.5 0.3 0.3 1.3 0.3 0.0 0.3 7.7 0.3 22.2 5.3 0.3 0.6 6.6 28.0 2.4 3.1 19.2 0.4 0.3 0.0 3.4 0.3 2.2 0.3 0.3 0.3 19.0 7.6 0.2 1.2 7.8 0.1 12.7 2.3 0.3 6.0 1.3 0.0 18.3 9.3 8.9 0.0 12.1 8.3 5.6 5.2 1.8 5.4 0.0 3.4 9.5 6.8 4.7 0.0 4.1 2.8 54.8 6.4 4.7 0.1 0.2 2.8 9.7 5.6 0.3 0.4 0.0 8.4 0.2 0.0 4.0 0.0 0.0 18.6 0.0 5.7 0.5 1.2 0.0 10.7 2.9 14.5 0.0 4.2 0.0 0.0 0.0 28.8 0.0 0.0 5.0 6.5 0.0 0.1 0.0 0.0 0.0 29.9 0.1 7.8 0.1 0.3 2.3 0.0 0.0 0.1 0.0 0.2 1.2 0.2 0.0 0.0 0.0 12.7 0.0 0.4 0.0 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Cell line enhanced" "Detected in many" "HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA069061 Supported "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.4 8.2 2.9 1.9 1.5 0.1 0.0 0.9 3.5 0.0 15.2 0.0 2.5 0.0 21.1 1.0 4.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 10.5 1.5 0.3 0.0 0.0 23.5 0.4 0.0 1.8 0.0 0.1 0.0 10.0 0.0 0.2 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;HaCaT: 6.8;RPTEC TERT1: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA078220: " "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.1 4.0 0.2 1.9 0.2 6.8 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.3 1.9 0.1 0.3 1.0 0.0 3.5 3.3 2.7 0.1 0.0 0.1 0.0 0.0 0.3 0.0 1.0 1.0 0.7 0.0 5.4 0.7 1.2 0.0 0.2 0.0 1.1 0.0 0.0 2.7 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.6 2.9 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.4" "Group enriched" "Detected in some" 9 "AN3-CA: 28.6;HEK 293: 39.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 5.9;NK-cell: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 5.9;NK-cells: 2.0" "Region enriched" "Detected in single" 34 "pons and medulla: 3.5" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favourable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.2 2.9 0.0 1.2 0.0 0.0 2.3 0.0 0.0 1.6 5.4 0.0 6.7 4.6 0.1 10.4 0.0 0.0 0.0 0.0 5.9 0.0 2.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 2.5 1.5 0.0 2.2 1.0 3.2 4.2 1.4 1.0 0.0 1.2 0.0 0.0 0.0 4.3 1.3 0.1 0.5 5.9 0.1 2.0 0.2 0.0 0.5 0.9 0.0 28.6 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.6 3.3 0.6 1.0 0.2 1.3 0.7 0.0 0.0 0.8 39.0 0.4 0.5 0.3 0.0 0.6 1.0 2.3 0.0 0.0 0.3 1.3 0.2 0.0 0.3 0.3 0.0 0.1 0.0 1.0 3.7 0.0 0.0 2.8 1.8 3.0 0.0 1.3 0.1 0.6 0.3 0.3 0.0 0.0 0.4 1.5 1.0 0.0 0.0 0.6 0.0 2.8 2.8 5.9 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.8" "Cell line enhanced" "Detected in many" "HAP1: 19.4;RPTEC TERT1: 24.0;SCLC-21H: 19.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 14 "pons and medulla: 9.2" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.7" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.7" "Region enriched" "Detected in single" 12 "pons and medulla: 1.4" "Region enriched" "Detected in single" 10 "pons and medulla: 2.9" HPA074048 Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA074048: " "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 6.5 14.5 0.2 4.8 0.2 0.0 11.2 0.3 0.6 7.3 10.0 0.2 7.9 0.0 5.0 15.4 3.0 12.2 0.5 0.2 0.2 0.0 25.4 0.4 2.6 3.5 0.2 0.2 6.2 0.2 0.3 0.2 1.3 9.2 8.2 7.2 0.2 0.2 8.9 27.8 8.2 6.1 8.1 14.3 3.7 3.2 2.7 0.2 1.6 0.9 0.2 1.1 11.4 6.7 0.2 0.9 0.0 0.0 7.7 1.6 0.2 6.8 2.4 0.0 7.4 0.0 0.0 0.4 2.4 4.2 5.1 5.9 3.6 2.7 4.7 6.8 1.9 4.8 19.4 0.0 3.1 0.0 12.2 0.3 2.7 0.1 0.5 0.4 0.2 4.1 0.2 0.6 6.9 9.7 0.0 0.0 1.9 1.2 0.0 1.0 0.2 0.7 2.4 4.5 0.0 24.0 4.7 19.4 0.0 13.3 0.0 0.0 0.2 1.9 0.8 0.0 4.6 13.8 2.3 0.0 0.1 0.1 0.0 9.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 7.7 0.0 0.6 0.4 0.2 0.2 0.2 0.3 0.6 0.2 0.0 0.2 0.2 9.2 0.2 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575513-48580111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.3" "Cell line enhanced" "Detected in many" "EFO-21: 23.0;HEK 293: 11.1;HMC-1: 14.1;K-562: 11.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 36 "pons and medulla: 3.7" "Region enriched" "Detected in single" 61 "pons and medulla: 7.5" HPA057432 Uncertain Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA057432: " "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 4.4 2.4 0.0 1.5 0.0 0.0 2.9 0.0 0.0 4.2 8.1 1.2 2.3 13.3 2.7 8.5 1.5 0.4 0.0 0.0 5.7 0.7 3.6 0.6 0.0 0.0 0.7 1.8 0.0 1.0 0.6 1.1 0.0 4.8 0.8 0.9 4.3 2.0 2.4 3.0 3.9 0.5 0.6 0.2 1.3 1.7 0.3 2.4 0.0 0.1 0.6 0.7 0.1 0.1 0.3 0.0 0.1 4.8 3.8 1.8 0.0 0.0 0.2 0.1 2.1 1.9 3.1 23.0 1.4 0.1 4.0 0.0 0.0 7.9 11.1 7.5 0.6 0.0 4.9 0.0 14.1 3.7 0.0 5.6 0.0 6.4 11.2 0.2 5.5 0.0 1.8 0.0 0.0 0.0 0.0 4.3 1.5 4.5 1.9 0.0 0.0 0.6 0.0 2.8 0.4 1.4 2.5 0.3 0.2 0.8 0.2 1.9 3.9 0.7 1.5 0.0 2.1 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.6 0.0 2.4 0.0 0.1 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell line enhanced" "Detected in many" "HEK 293: 21.1;RPTEC TERT1: 15.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 100 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: , HPA074454: " "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favourable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavourable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favourable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.7 0.0 2.4 2.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.1 2.6 0.0 0.2 0.0 0.0 0.0 21.1 0.9 5.4 0.0 4.1 0.0 1.2 1.3 0.0 2.8 0.0 1.4 1.6 0.0 3.2 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 15.7 1.6 0.0 0.0 0.1 0.0 2.3 0.4 0.0 5.2 0.7 2.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 73.7;seminal vesicle: 56.7" "Cell line enhanced" "Detected in many" "EFO-21: 13.1;HEK 293: 36.2;RPTEC TERT1: 24.6;TIME: 13.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.5" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.0" "Region enriched" "Detected in single" 60 "pons and medulla: 10.6" "Region enriched" "Detected in single" 62 "pons and medulla: 14.6" HPA042063 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favourable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 5.2 4.3 0.3 18.1 0.3 0.0 3.8 0.3 0.3 12.0 8.5 0.3 73.7 0.5 7.2 30.5 0.4 8.7 0.3 0.3 0.3 0.0 26.6 0.4 3.4 0.3 0.3 0.3 0.6 0.6 1.9 0.3 1.5 0.9 4.3 3.8 0.3 0.3 56.7 1.0 0.6 8.2 1.8 10.0 1.7 5.9 1.8 0.3 0.3 0.3 0.3 0.3 4.2 10.0 1.5 0.2 0.0 0.0 0.0 1.0 0.3 2.3 5.4 0.0 2.8 2.5 2.7 0.0 0.0 0.0 0.0 0.0 2.9 3.5 0.0 13.1 6.4 0.0 0.6 0.2 0.0 0.1 36.2 3.2 9.0 0.0 3.8 0.2 8.4 3.2 0.1 5.2 0.1 2.4 2.0 0.0 7.2 0.1 0.0 0.1 0.0 2.1 0.0 6.1 0.3 24.6 1.1 0.0 0.0 1.9 0.0 3.5 0.9 1.1 13.6 0.5 2.8 2.2 10.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.0 0.0 0.7 0.0 0.2 1.4 0.4 1.0 0.2 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.9 0.3 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell line enhanced" "Detected in many" "EFO-21: 30.8;RPTEC TERT1: 24.5;SK-MEL-30: 29.2;WM-115: 21.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 13 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favourable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 17.1 7.5 0.0 0.2 5.4 8.1 0.0 0.0 0.0 0.1 0.3 11.4 0.3 0.3 30.8 7.2 2.5 0.0 0.0 0.0 7.9 5.5 2.6 5.9 0.0 4.5 0.0 5.5 5.3 2.3 5.3 0.0 16.2 2.8 0.1 17.0 4.4 0.3 0.1 0.0 0.0 0.0 14.6 2.0 24.5 5.7 0.0 0.0 5.8 0.0 29.2 1.4 1.7 13.9 0.0 9.4 7.6 13.2 0.9 2.2 0.0 0.1 0.0 21.5 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell line enhanced" "Detected in some" "HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031463 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031463: AB_10601577" "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavourable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.0 1.3 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.6 0.0 8.3 0.2 0.0 1.3 0.0 0.0 77.4 29.8 13.5 0.5 0.0 0.5 0.2 30.6 0.0 0.0 0.0 0.8 0.0 32.8 0.0 1.3 0.0 0.0 0.1 0.0 1.2 0.0 5.2 0.4 13.5 0.0 0.0 0.0 1.0 0.0 8.5 0.1 0.0 0.1 0.0 7.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 16.2;skeletal muscle: 53.2" "Cell line enhanced" "Detected in many" "AN3-CA: 76.4;ASC diff: 22.6;ASC TERT1: 20.8;fHDF/TERT166: 17.6;T-47d: 26.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA053919: " "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 8.0 0.7 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.5 0.3 0.0 0.4 0.0 1.6 6.8 0.1 2.5 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.3 53.2 6.8 0.8 0.5 0.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 76.4 22.6 20.8 0.1 2.6 6.4 3.6 3.4 0.1 0.2 0.1 0.7 17.6 8.2 1.1 0.0 1.7 3.8 1.4 0.7 9.5 0.0 0.1 0.0 0.9 9.8 0.1 0.2 0.0 0.0 0.5 0.0 2.5 0.4 0.0 1.9 0.0 0.3 0.0 0.1 0.0 8.1 0.0 0.0 1.0 1.8 2.6 3.9 26.0 0.5 0.0 2.1 2.7 0.0 3.4 0.3 0.0 0.0 0.0 0.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.0;skin 1: 9.2" "Cell line enhanced" "Detected in some" "AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038291 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 4.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 0.1 2.5 0.1 0.1 0.1 0.8 2.0 1.0 0.1 0.7 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.7 0.1 0.1 0.5 0.1 0.0 0.1 0.6 0.3 0.5 0.0 0.1 0.1 2.0 7.0 9.2 2.7 0.4 0.1 0.1 0.0 1.6 0.1 0.5 0.1 0.1 0.1 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.7 0.0 23.0 2.2 3.3 0.0 3.3 11.6 4.9 3.6 0.2 0.9 0.0 0.2 3.1 10.1 4.4 0.0 2.2 0.6 0.1 0.1 7.5 0.0 0.0 0.1 0.1 0.6 0.9 0.0 0.3 0.0 0.9 0.0 3.1 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.1 2.1 5.2 2.0 18.1 0.0 0.0 0.0 4.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.1 0.0 8.3 5.0 6.1 0.0 0.5 0.4 0.9 0.7 3.5 0.4 0.0 0.6 2.5 1.3 0.1 0.0 0.3 2.6 2.9 0.0 1.0 0.1 0.2 0.0 0.1 5.7 0.6 4.1 0.4 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.1 0.6 0.2 4.3 1.7 0.1 0.0 1.4 0.9 3.1 0.3 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell line enhanced" "Detected in many" "AN3-CA: 37.3;fHDF/TERT166: 18.6;HDLM-2: 31.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054981: " "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavourable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.4 1.7 0.0 37.3 13.7 13.0 0.3 1.9 1.9 3.1 2.8 1.5 2.8 1.1 2.5 18.6 4.2 1.4 0.2 2.8 31.2 10.8 1.9 4.8 0.0 1.5 0.2 4.7 12.3 2.0 6.1 2.2 0.1 1.3 0.0 10.8 0.5 0.0 1.2 0.0 1.6 0.0 1.4 0.0 9.4 0.1 0.0 4.6 2.8 2.7 7.6 6.6 0.5 0.0 3.9 8.4 4.2 2.6 0.3 0.3 0.0 1.4 0.3 7.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54009106-54012362 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8" "Cell line enhanced" "Detected in many" "ASC diff: 23.7;ASC TERT1: 15.5;fHDF/TERT166: 27.6;HSkMC: 18.9;LHCN-M2: 20.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavourable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.4 0.4 0.7 0.2 0.0 7.1 0.2 0.3 0.5 0.5 0.2 0.2 0.0 0.3 16.7 0.4 6.3 0.6 0.6 0.2 0.0 7.0 0.2 0.2 2.2 0.2 0.5 25.2 0.2 0.0 0.2 1.9 0.4 0.3 0.0 0.2 0.2 0.2 12.8 2.6 4.8 7.9 2.5 0.2 0.0 2.6 0.2 0.3 0.7 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 8.3 23.7 15.5 0.1 1.5 0.0 2.8 1.8 2.5 1.2 0.0 0.2 27.6 1.0 2.2 0.7 3.2 2.8 3.0 0.4 1.0 0.0 2.9 0.0 3.2 18.9 2.1 8.9 5.2 0.2 0.3 0.0 20.6 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 3.1 0.0 0.0 1.1 2.8 0.5 7.2 0.8 0.0 0.0 0.5 4.4 3.8 0.9 0.0 0.0 0.0 0.5 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.0 0.2 0.5 0.4 0.2 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;HEK 293: 25.4;RPTEC TERT1: 18.2;SCLC-21H: 7.1;SiHa: 10.6;U-251 MG: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: " "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 18.2 0.0 7.1 1.9 10.6 0.0 0.0 0.0 0.0 1.6 0.0 1.3 0.5 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6" "Cell line enhanced" "Detected in some" "EFO-21: 7.9;HSkMC: 9.3;RPTEC TERT1: 9.7;SCLC-21H: 13.8;SH-SY5Y: 9.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 36 "pons and medulla: 3.8" "Region enriched" "Detected in single" 30 "pons and medulla: 6.7" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: " "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 6.2 1.1 0.4 3.2 0.4 0.2 19.6 0.2 0.2 8.7 3.6 0.0 22.5 0.3 25.9 36.4 1.1 4.8 2.0 0.4 0.8 0.5 8.5 0.2 0.3 0.8 1.5 0.0 7.0 0.3 0.2 0.2 0.2 0.5 2.1 0.4 0.0 0.6 22.6 0.7 0.7 0.4 4.0 7.2 1.9 0.3 3.6 0.0 0.0 0.4 0.2 0.3 1.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.9 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 9.3 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 9.7 0.5 13.8 9.3 0.1 0.1 3.9 0.0 0.0 0.6 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.8 0.5 1.5 0.0 0.5 0.0 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell line enhanced" "Detected in some" "EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 31 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA054383: , HPA070349: " "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.7 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.1 1.6 0.1 1.5 0.0 0.2 0.0 21.6 0.2 0.0 0.0 0.3 0.0 0.0 4.9 1.4 0.0 0.2 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 16.0 2.5 1.3 2.1 0.3 0.0 6.0 0.0 0.0 2.7 0.2 0.1 1.4 1.1 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122720-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 26.2" "Cell line enhanced" "Detected in some" "EFO-21: 8.6;HEK 293: 12.0;RPTEC TERT1: 14.1;SH-SY5Y: 16.4;SK-MEL-30: 9.0;TIME: 12.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA068683 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA068683: " "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavourable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favourable (9.58e-4)" "prognostic unfavourable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 4.1 2.7 0.2 1.7 0.4 0.0 11.4 0.2 0.2 13.1 10.8 0.2 10.4 0.0 26.2 12.0 1.6 5.1 2.6 0.5 0.2 0.0 19.7 0.2 0.7 2.4 0.2 0.2 8.9 0.2 0.0 0.2 1.6 0.4 13.0 2.2 0.2 0.4 16.0 3.8 3.9 1.1 12.6 0.6 3.7 0.1 9.8 0.2 0.3 2.2 2.2 1.3 2.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 1.2 0.8 1.0 0.8 0.0 0.0 0.0 8.6 1.1 5.6 0.0 0.0 0.6 0.0 12.0 0.0 0.6 0.0 0.1 0.0 0.0 2.8 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 14.1 5.2 3.2 16.4 4.1 0.0 9.0 0.0 0.0 12.4 0.0 2.8 4.0 4.3 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 HPF1 "C4orf27, FLJ20534" ENSG00000056050 "Histone PARylation factor 1" Q9NWY4 4 169729465-169757953 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043467 Uncertain Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Microtubules, Cytokinetic bridge" "HPA043467: AB_10793949" "unprognostic (1.09e-1)" "unprognostic (1.15e-2)" "unprognostic (1.72e-2)" "unprognostic (1.47e-1)" "unprognostic (2.70e-1)" "unprognostic (1.09e-1)" "unprognostic (8.68e-3)" "unprognostic (2.74e-2)" "prognostic unfavourable (5.63e-4)" "prognostic favourable (7.47e-4)" "unprognostic (6.34e-2)" "unprognostic (4.55e-1)" "unprognostic (3.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.32e-1)" "unprognostic (5.51e-2)" "unprognostic (1.09e-1)" 16.5 18.6 27.3 14.9 26.3 13.7 20.9 22.9 31.7 17.6 17.5 17.6 10.0 11.5 23.2 25.2 17.2 16.9 12.7 20.9 27.3 24.0 17.5 20.8 13.5 18.0 24.9 22.6 23.1 13.1 13.9 22.9 16.0 33.4 17.4 17.6 15.1 12.2 16.0 17.4 18.6 11.3 24.2 23.8 16.4 14.0 12.9 19.8 20.8 18.5 14.9 19.3 19.0 14.8 13.6 15.6 12.8 14.1 14.9 22.2 13.3 12.4 7.9 27.6 14.4 16.9 20.9 11.7 22.7 22.5 28.3 30.1 5.3 13.5 6.5 6.1 14.7 5.6 18.9 16.5 30.0 20.4 12.9 21.2 11.6 7.5 11.9 17.9 7.8 13.5 16.8 18.2 5.6 24.5 15.9 25.5 24.6 10.1 37.5 15.6 11.2 10.3 16.6 13.1 7.8 16.1 8.2 6.6 24.6 15.0 6.6 20.5 13.0 16.1 11.8 9.7 15.4 22.6 20.2 12.2 18.1 19.4 26.8 17.5 15.4 8.9 12.3 12.8 18.5 14.1 21.9 13.6 21.5 22.2 15.6 11.1 21.2 21.7 3.3 14.9 13.1 10.7 22.0 13.3 27.3 26.3 22.9 31.7 27.3 24.0 24.9 22.6 33.4 19.8 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell line enhanced" "Detected in some" "A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favourable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.3 0.0 0.0 16.9 1.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 59.7 2.0 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 2.8 0.0 0.2 5.6 92.8 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in some" 8 "HEL: 31.6;HMC-1: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 2.4 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3, biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129584-149173732 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: " "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 14.4 17.6 10.5 16.1 11.5 6.3 18.8 8.1 11.8 13.0 11.7 12.8 6.2 13.7 17.1 10.3 10.2 12.4 11.5 8.9 9.9 8.7 15.3 10.1 12.1 25.1 11.5 10.4 18.7 13.8 10.1 11.8 13.3 11.9 13.4 11.8 13.9 13.4 11.5 5.9 8.9 16.3 13.4 17.1 19.8 12.5 8.5 12.6 23.8 13.7 4.5 19.9 16.3 17.9 16.3 19.9 16.1 15.4 9.3 16.0 10.7 24.8 13.9 8.3 8.6 11.7 15.1 6.2 10.2 20.3 13.5 17.5 4.7 16.6 6.4 13.2 12.3 8.6 9.1 7.0 17.6 15.6 7.3 2.9 6.7 5.1 10.4 7.9 4.8 9.8 7.2 13.0 5.4 13.8 3.3 15.5 17.2 15.4 5.6 11.2 20.0 11.2 6.8 5.5 17.1 7.4 12.6 2.5 6.6 8.8 9.4 19.0 10.1 10.5 6.9 13.6 2.4 13.7 14.9 12.8 5.0 15.8 20.2 15.6 3.3 16.1 12.8 11.9 13.4 15.4 16.0 16.3 12.2 13.8 19.9 13.3 9.5 12.5 5.8 9.3 10.1 11.3 10.5 10.7 10.5 11.5 8.1 11.8 9.9 8.7 11.5 10.4 11.9 12.6 HPSE "HPA, HPSE1, HSE1" ENSG00000173083 Heparanase Q9Y251 4 83292461-83335153 "Enzymes, Predicted secreted proteins" "Cell adhesion" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.8;neutrophil: 12.8" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;monocytes: 17.8" "Region enhanced" "Detected in some" "olfactory region: 4.5" "Low region specificity" "Detected in all" "CAB009813, HPA055344" Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" 9700000 Nucleoplasm Vesicles "CAB009813: AB_2120854, HPA055344: " "unprognostic (6.57e-2)" "unprognostic (1.22e-2)" "unprognostic (9.13e-2)" "unprognostic (5.92e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.24e-2)" "unprognostic (5.65e-2)" "unprognostic (7.06e-2)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (9.62e-3)" "unprognostic (3.27e-1)" "unprognostic (2.78e-1)" "unprognostic (3.04e-3)" "unprognostic (4.15e-2)" "unprognostic (3.70e-3)" 4.9 5.1 3.0 6.8 3.5 2.2 1.2 0.8 2.4 3.6 6.2 7.1 0.0 2.3 2.9 2.8 14.5 5.7 3.0 5.8 3.2 1.5 3.0 5.6 8.2 16.1 7.1 1.4 7.5 1.1 15.5 2.3 11.3 3.4 1.1 7.0 0.7 12.5 2.1 0.7 6.9 3.6 2.1 7.0 19.0 2.4 6.0 2.8 1.6 1.4 16.9 9.7 2.4 4.9 0.3 1.9 12.8 17.8 1.4 3.4 4.8 8.1 0.4 0.0 1.1 1.9 0.6 0.0 1.0 4.5 2.0 8.7 0.2 6.1 0.2 1.4 2.2 7.9 10.3 1.4 3.6 0.8 0.9 2.2 5.8 0.1 1.1 1.4 4.9 0.8 3.1 1.4 9.8 10.8 0.0 24.7 0.9 1.7 0.1 0.1 0.4 1.5 0.0 0.3 0.3 5.7 0.2 5.8 0.0 11.3 6.2 0.9 0.8 1.9 12.6 0.9 2.8 0.8 1.0 0.3 3.8 0.1 6.5 6.6 1.5 0.2 17.8 0.0 1.0 6.7 0.7 0.2 1.9 0.7 1.9 0.3 1.4 1.2 12.8 1.4 0.9 0.1 3.4 4.8 3.0 3.5 0.8 2.4 3.2 1.5 7.1 1.4 3.4 2.8 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: , HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavourable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 12.3 11.4 25.2 9.1 34.5 5.0 16.2 16.1 25.3 7.9 9.5 8.1 10.8 8.9 6.2 9.2 22.3 8.3 10.9 28.7 22.2 22.4 8.2 6.5 8.9 8.0 23.2 12.9 7.7 9.7 11.7 10.3 10.1 15.0 10.0 6.2 8.2 10.1 12.7 51.8 32.0 8.2 8.4 17.0 6.5 7.2 6.1 11.0 5.9 8.1 24.5 9.3 9.9 19.8 2.1 1.1 0.7 4.6 0.1 2.0 0.3 21.8 19.4 9.3 8.3 5.8 4.1 12.0 10.9 5.8 17.1 14.6 9.8 8.7 8.4 3.4 14.8 17.4 9.9 26.5 4.8 6.9 22.1 4.3 7.8 8.5 8.8 3.4 3.3 6.2 29.6 9.2 10.0 8.5 8.8 12.3 9.6 17.9 12.7 12.1 9.4 19.3 10.2 11.8 7.5 9.6 5.4 36.3 14.4 10.1 18.1 7.8 14.8 6.7 13.5 15.3 12.1 5.6 14.0 4.6 6.1 6.5 14.4 6.3 14.3 0.0 0.6 0.7 1.4 1.2 1.6 0.8 1.4 1.3 0.7 2.1 2.0 0.6 0.0 0.1 4.6 1.1 2.0 0.3 25.2 34.5 16.1 21.1 22.2 22.4 23.2 12.9 15.0 11.0 HRASLS "H-REV107, HRASLS1" ENSG00000127252 "HRAS like suppressor" 3 193241125-193277738 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 40.9;testis: 42.1" "Cell line enhanced" "Detected in some" "HAP1: 8.5;NTERA-2: 7.4;PC-3: 16.5;RH-30: 7.2;SCLC-21H: 15.0;U-2 OS: 9.1;U-251 MG: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites" Cytosol "HPA051179: " "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favourable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.6 1.1 1.8 0.2 3.1 0.1 1.0 0.6 3.3 0.5 0.6 1.7 0.0 0.1 0.6 3.1 2.4 0.5 0.2 4.3 2.0 1.1 0.6 0.6 0.5 0.1 1.5 2.1 0.6 0.8 0.5 0.7 0.1 2.4 0.5 0.1 3.1 6.1 0.5 40.9 1.7 0.6 0.7 0.6 0.6 0.6 42.1 1.7 0.2 3.7 6.2 0.2 0.5 0.6 0.0 0.2 1.7 0.1 0.0 0.0 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 8.5 0.2 0.4 0.0 3.8 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.4 16.5 0.0 7.2 0.0 2.4 0.0 15.0 2.8 1.0 2.2 0.0 4.3 0.0 0.1 0.0 9.1 0.0 11.5 0.0 0.0 0.0 4.7 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.2 1.8 3.1 0.6 3.3 2.0 1.1 1.5 2.1 2.4 1.7 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.4;hTEC/SVTERT24-B: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.5" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 9.1 4.4 7.3 4.6 4.4 0.2 9.6 0.5 10.6 8.0 13.5 1.3 2.4 3.8 6.2 7.2 5.7 10.6 9.9 7.0 5.1 4.0 3.3 1.1 8.2 1.8 2.2 2.1 8.7 2.1 1.7 1.2 5.5 3.2 7.2 7.2 2.0 3.4 6.1 3.0 8.0 10.5 9.2 8.6 1.4 3.3 2.4 2.0 0.1 2.5 7.2 3.1 11.2 16.2 0.1 0.3 1.2 0.2 0.1 3.5 0.1 1.5 3.4 0.0 0.0 1.6 17.4 2.4 2.6 8.7 7.8 5.3 0.6 12.5 0.0 7.8 6.0 9.8 0.0 3.5 10.6 5.5 0.0 0.8 5.6 0.0 5.2 2.4 1.4 6.0 2.2 17.5 6.2 10.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 3.2 0.2 0.9 0.3 13.9 2.0 0.1 0.0 3.7 2.7 0.0 0.0 1.9 16.1 8.8 5.5 8.9 13.0 0.0 0.9 0.0 13.4 2.2 7.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 1.3 0.5 0.3 0.1 0.1 0.1 1.2 0.1 0.0 0.1 3.5 0.1 7.3 4.4 0.5 8.4 5.1 4.0 2.2 2.1 3.2 2.0 HS1BP3 "FLJ14249, HS1-BP3" ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651089 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol 32000 Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavourable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favourable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 17.9 23.1 10.4 8.8 15.7 10.7 11.8 6.7 17.6 17.6 22.6 21.3 14.3 11.7 17.6 18.6 22.6 13.9 28.4 17.5 11.0 9.1 18.5 47.8 14.2 11.7 16.7 9.4 14.8 13.9 10.6 14.3 22.3 13.5 20.3 11.7 17.0 12.9 17.3 9.6 17.0 16.0 27.3 13.8 14.5 16.4 9.7 14.1 6.6 18.5 8.0 9.9 20.8 17.1 6.0 8.0 14.6 13.3 2.9 5.3 6.1 8.8 10.3 5.2 6.3 27.7 18.6 10.4 3.4 15.7 8.0 10.6 8.0 10.7 5.9 2.7 4.9 5.6 10.3 10.6 3.9 7.6 8.5 3.2 5.2 26.7 26.1 2.3 13.9 19.7 24.9 9.1 16.9 15.2 2.0 12.8 9.1 7.6 1.0 4.0 4.3 7.5 5.7 10.6 5.8 17.8 10.7 4.9 7.6 2.4 10.5 20.1 6.6 4.9 9.8 8.0 8.6 12.2 5.1 9.2 10.2 5.4 17.2 11.3 8.4 11.4 11.3 11.0 5.3 11.2 3.7 6.0 3.2 4.0 8.0 4.0 2.7 2.8 14.6 2.9 13.3 3.0 2.9 6.1 10.4 15.7 6.7 17.6 11.0 9.1 16.7 9.4 13.5 14.1 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 38.8;HMC-1: 61.6;SCLC-21H: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044586, HPA075890" Approved "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" 27000 Nucleoplasm "Nuclear speckles" "HPA044586: AB_10963057, HPA075890: " "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.1 13.7 7.8 5.3 10.0 7.4 4.3 5.6 4.4 2.4 2.6 2.3 3.4 38.8 5.6 9.4 5.2 8.5 1.6 5.6 5.3 3.0 1.9 25.1 6.5 5.2 61.6 13.5 10.1 3.5 1.1 2.3 1.9 3.6 1.6 7.4 13.8 23.0 16.3 3.1 4.5 3.7 17.7 4.0 10.6 33.8 8.4 3.5 8.9 1.9 3.6 2.0 2.8 3.9 8.7 14.5 3.5 2.1 2.0 0.7 2.4 3.7 2.8 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell line enriched" "Detected in some" 6 "RT4: 19.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: " "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favourable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.2 1.0 0.8 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: " "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favourable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favourable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.2 6.3 2.6 3.4 10.5 3.3 3.8 6.6 4.8 4.5 4.9 10.0 19.4 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 7.8 5.6 9.3 4.0 13.5 3.0 6.1 6.0 14.8 5.9 7.7 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 6.0 4.0 4.1 14.1 7.3 13.3 6.2 13.1 10.6 9.1 9.8 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322906 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 158.8" "Cell line enhanced" "Detected in some" "NB-4: 4.8" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favourable (2.94e-4)" "prognostic favourable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 8.0 0.1 0.1 0.2 0.1 0.3 1.8 1.0 0.1 1.3 0.3 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.9 0.1 0.0 0.1 158.8 0.8 0.1 0.1 0.1 0.1 2.4 0.0 0.1 0.3 0.1 2.4 0.1 0.1 0.2 0.1 0.1 1.4 0.1 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.3 2.7 1.8 0.6 3.7 0.7 0.8 0.8 0.1 0.2 0.3 0.8 0.9 1.1 0.8 0.6 0.1 0.3 0.0 0.1 0.0 1.8 0.6 0.6 0.3 0.4 0.2 0.2 0.2 0.5 0.3 0.9 1.1 1.7 0.8 2.6 1.0 0.4 0.0 0.0 0.1 0.3 0.8 0.9 0.3 0.3 0.4 4.8 0.4 0.5 0.8 1.0 0.3 0.3 0.5 0.5 2.0 0.6 0.4 0.2 0.2 1.6 1.0 0.5 2.7 0.7 0.4 0.5 0.3 0.5 0.2 2.0 1.0 3.7 0.7 1.5 0.4 0.2 0.4 1.8 0.4 0.4 0.1 1.1 0.8 0.7 2.8 0.8 0.3 0.6 0.4 0.1 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell line enhanced" "Detected in many" "Karpas-707: 11.7;U-266/84: 14.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059141: " "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favourable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.6 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.0 0.9 11.7 0.8 2.1 4.6 1.0 6.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.8 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Cell line enriched" "Detected in some" 9 "CACO-2: 37.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favourable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.1 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Approved "Vesicles,Intermediate filaments,Mitochondria" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: " "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favourable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.5 30.2 10.3 11.0 7.9 7.6 7.3 6.8 9.1 4.8 7.3 9.7 11.6 13.0 6.4 3.9 16.3 6.3 14.5 2.4 10.0 5.6 4.3 16.5 11.5 8.6 10.1 6.1 10.6 12.7 8.3 10.8 11.5 14.6 17.9 13.9 18.7 8.6 15.3 6.8 18.4 10.6 4.3 8.7 6.2 14.2 10.8 18.0 2.9 19.7 18.0 5.1 9.2 10.3 12.4 7.4 5.7 23.3 18.4 18.9 12.0 6.3 9.3 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314722 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavourable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavourable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 24.7 22.9 17.4 21.0 20.9 20.8 30.8 24.4 23.6 21.3 26.9 18.3 17.7 18.9 23.3 16.7 25.5 28.5 22.9 42.8 17.0 17.5 21.2 19.5 20.3 23.6 17.4 15.9 32.4 36.8 25.8 21.8 22.8 17.8 26.7 15.2 20.7 26.4 24.6 55.2 20.3 17.8 35.1 14.4 20.3 23.6 42.6 17.8 23.2 29.9 24.2 19.8 30.3 33.9 16.9 20.3 20.3 24.2 12.9 18.4 14.2 14.6 19.9 8.6 7.3 14.5 13.6 14.3 11.0 10.0 10.9 9.5 13.3 12.9 16.9 16.2 15.2 10.7 13.1 15.8 7.0 10.7 15.1 21.2 20.4 18.1 22.9 6.1 16.4 13.2 14.9 15.3 28.3 14.7 14.0 10.2 10.9 29.7 20.6 9.4 11.0 57.4 13.4 7.5 21.4 7.8 14.9 13.0 10.5 16.8 13.5 19.4 15.2 12.6 14.8 11.2 25.4 17.6 18.0 7.1 5.4 14.5 16.0 11.5 10.7 10.6 18.9 20.3 14.5 19.9 15.2 16.9 15.7 18.4 20.3 15.5 15.6 13.9 8.1 12.9 24.2 10.3 18.1 14.2 17.4 20.9 24.4 23.6 17.0 17.5 17.4 15.9 17.8 17.8 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.9;hTCEpi: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.2 1.1 1.4 0.6 0.3 1.4 1.3 1.8 1.1 1.9 1.7 7.1 5.2 4.0 2.9 1.1 2.1 0.7 14.9 0.6 1.0 1.3 0.7 2.2 0.4 1.8 1.7 0.5 0.9 9.8 0.8 4.6 0.5 1.5 1.3 4.6 0.9 2.3 1.6 4.6 2.2 3.4 1.4 0.5 2.3 1.0 1.5 1.1 3.9 1.9 2.1 2.1 1.9 3.0 1.0 3.6 0.2 2.7 1.4 1.0 3.2 1.0 3.5 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 HSH2D "ALX, FLJ14886, HSH2" ENSG00000196684 "Hematopoietic SH2 domain containing" Q96JZ2 19 16134028-16158575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.4;lymphoid tissue: 33.8" "Cell line enhanced" "Detected in some" "HL-60: 13.4;HMC-1: 18.5;NB-4: 43.6;RPMI-8226: 19.6;U-937: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 47.4" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036616 Approved "Plasma membrane,Focal adhesion sites,Cytosol" "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA036616: AB_10671962" "unprognostic (1.69e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (9.46e-6)" "unprognostic (1.06e-1)" "unprognostic (5.50e-3)" "unprognostic (5.21e-3)" "unprognostic (9.35e-2)" "unprognostic (4.78e-2)" "unprognostic (4.21e-3)" "unprognostic (9.96e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "prognostic unfavourable (6.49e-6)" "unprognostic (9.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.21e-2)" "prognostic favourable (3.47e-5)" 1.2 1.1 1.2 31.5 1.1 19.2 1.2 1.1 1.1 1.4 8.9 0.0 5.2 5.5 1.1 6.2 2.0 1.5 10.3 1.2 1.1 1.1 1.3 1.5 6.0 16.7 1.0 0.0 1.1 4.8 0.9 3.7 2.3 0.3 2.2 4.0 1.0 8.8 5.2 1.1 1.1 12.1 0.7 1.1 21.8 5.4 1.1 0.0 8.5 1.7 2.4 33.8 4.7 1.1 14.5 6.0 47.4 8.4 19.0 4.3 3.6 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 6.8 12.9 0.2 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.8 0.0 13.4 18.5 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 2.8 0.0 43.6 0.0 0.0 0.9 0.0 19.6 0.1 1.8 0.0 0.0 0.0 0.4 0.1 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.9 12.6 7.1 0.0 42.8 0.0 47.4 3.7 23.0 4.3 5.0 3.9 14.5 1.9 2.8 6.0 8.6 1.8 2.3 43.7 19.0 8.4 1.8 2.9 3.6 1.2 1.1 1.1 1.1 1.1 1.1 1.0 0.0 0.3 0.0 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 3.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: " "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavourable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 21.2 24.9 15.4 4.0 21.8 1.1 7.5 10.2 47.7 7.6 6.3 6.8 3.3 2.1 9.4 8.0 5.3 9.1 5.9 6.4 17.1 15.5 23.5 1.9 2.8 2.0 17.1 17.8 23.5 3.0 4.0 17.2 4.2 23.3 4.1 4.9 7.4 3.6 9.1 4.9 9.5 2.9 8.6 8.2 3.6 2.8 8.2 8.6 0.0 6.8 1.2 1.6 4.1 6.6 0.0 0.0 3.1 0.0 0.0 0.4 0.0 2.3 8.9 0.9 7.8 9.0 6.5 0.4 4.5 9.0 2.2 1.2 8.3 0.1 0.0 2.4 5.5 5.9 5.8 0.7 7.4 0.0 3.1 0.0 3.1 8.7 1.2 0.0 0.7 2.7 3.6 6.7 0.6 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.7 0.0 0.0 2.7 0.1 33.9 0.1 2.0 11.7 2.6 2.2 3.1 1.7 0.0 0.0 2.1 3.6 11.9 4.4 0.1 0.0 0.0 3.6 0.0 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 21.8 10.2 32.4 17.1 15.5 17.1 17.8 23.3 8.6 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell line enriched" "Detected in some" 10 "HEK 293: 302.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: " "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 30.5 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.7 0.0 0.0 2.3 0.0 0.2 302.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Group enriched" "Detected in some" 4 "A549: 23.9;Karpas-707: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: " "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 23.9 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.5 1.3 1.0 0.0 0.0 0.0 0.5 7.4 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 71.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.4 0.0 0.0 0.1 5.0 0.0 0.1 11.6 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: " "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favourable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favourable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.9 0.0 0.0 6.7 0.0 0.0 0.2 0.2 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Cell line enhanced" "Detected in many" "A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: " "prognostic favourable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.6 24.6 3.8 0.0 2.7 0.2 38.4 13.9 32.8 5.6 9.2 0.9 17.4 2.4 5.6 15.1 11.0 0.0 0.7 3.4 1.3 1.9 0.0 1.4 0.0 2.7 0.0 3.3 1.2 0.5 0.8 0.0 0.3 0.0 2.0 2.7 4.3 0.1 0.1 2.8 3.0 1.9 0.0 0.0 8.6 1.5 34.1 1.9 0.6 1.2 0.0 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.5 0.0 0.0 3.1 0.0 3.7 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 HSPA4 "HS24/P52, HSPH2" ENSG00000170606 "Heat shock protein family A (Hsp70) member 4" P34932 5 133051962-133106449 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010023, CAB025529" Uncertain Supported Nucleoplasm,Cytosol 10000000 "Nucleoplasm, Cytosol" "CAB025529: , HPA010023: AB_1851206" "unprognostic (2.54e-2)" "unprognostic (3.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.62e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-3)" "prognostic unfavourable (4.13e-4)" "unprognostic (2.31e-3)" "unprognostic (2.90e-1)" "unprognostic (2.40e-1)" "unprognostic (1.53e-1)" "unprognostic (2.85e-1)" "unprognostic (4.44e-3)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-1)" 20.6 35.0 26.6 25.6 27.6 20.5 39.0 25.9 35.6 19.4 20.5 18.7 19.9 17.4 23.3 20.2 42.0 19.2 18.9 32.9 26.4 31.9 30.3 31.1 17.2 28.9 30.9 24.5 23.2 19.5 37.1 32.8 24.5 34.3 18.9 23.9 16.0 20.3 19.2 48.3 19.6 18.5 23.6 25.9 20.0 20.9 39.8 29.5 27.3 26.8 24.8 38.6 24.5 77.1 27.7 17.9 15.5 23.0 14.1 14.9 11.5 34.2 47.2 33.0 53.7 31.4 26.5 59.9 37.6 28.3 36.5 45.3 88.6 36.0 57.0 39.6 36.1 30.6 57.2 62.2 52.9 26.3 32.8 42.0 31.7 48.5 25.1 26.0 36.9 26.3 26.3 47.0 30.9 34.8 43.9 17.7 39.8 30.2 36.6 19.4 45.2 21.9 33.6 40.4 30.3 33.0 45.2 26.3 21.6 35.8 18.8 50.0 27.6 25.6 30.4 33.3 47.9 28.4 44.5 20.3 45.0 43.8 28.5 43.3 33.0 14.8 14.4 15.5 12.6 23.0 14.9 22.6 11.6 13.0 17.9 27.7 12.1 11.2 9.6 14.1 16.4 6.8 11.3 11.5 26.6 27.6 25.9 35.6 26.4 31.9 30.9 24.5 34.3 29.5 HSPA4L "APG-1, HSPH3, Osp94" ENSG00000164070 "Heat shock protein family A (Hsp70) member 4 like" O95757 4 127781821-127840733 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.0;vagina: 32.0" "Cell line enhanced" "Detected in many" "HAP1: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034450, HPA039149, HPA061446" Enhanced Approved Centrosome,Cytosol "Centrosome, Cytosol" "CAB034450: AB_2119823, HPA039149: , HPA061446: " "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (5.33e-2)" "unprognostic (9.40e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (1.23e-3)" "unprognostic (2.41e-1)" "unprognostic (3.90e-1)" "unprognostic (2.38e-4)" "unprognostic (1.40e-2)" "unprognostic (3.28e-1)" "prognostic favourable (3.80e-9)" "unprognostic (8.53e-2)" "unprognostic (1.56e-1)" "unprognostic (8.99e-2)" "prognostic unfavourable (6.78e-4)" 1.6 9.3 7.4 1.4 9.0 2.8 5.5 16.6 11.4 2.9 2.5 1.7 1.6 2.5 1.5 1.7 10.9 5.9 3.5 5.3 6.1 10.1 10.6 5.9 1.9 1.0 6.6 6.6 3.5 3.6 12.2 23.2 2.8 20.1 3.9 3.5 3.5 4.6 4.7 1.5 6.5 1.6 3.8 5.0 1.4 2.1 73.0 5.2 1.0 3.7 4.1 4.0 2.8 32.0 0.7 0.5 3.9 0.4 0.5 0.4 0.1 8.9 11.8 6.4 10.1 4.4 4.5 7.4 4.1 1.7 4.0 4.4 8.6 4.1 0.0 7.5 1.1 2.1 37.3 14.7 5.5 16.7 11.1 4.8 16.2 10.4 1.6 18.5 8.2 4.1 13.7 2.6 9.4 5.1 8.5 5.5 4.9 6.5 5.8 1.6 1.5 9.8 0.0 0.7 0.9 13.5 4.1 11.8 4.3 7.4 12.9 0.6 9.8 3.1 1.4 1.4 0.0 1.7 9.8 10.8 12.4 2.8 5.4 12.6 4.2 1.6 0.4 3.9 0.4 0.2 0.2 0.4 0.3 0.3 0.5 0.7 0.4 0.4 1.3 0.5 0.3 0.4 0.3 0.1 7.4 9.0 16.6 11.4 6.1 10.1 6.6 6.6 20.1 5.2 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell line enriched" "Detected in some" 7 "Karpas-707: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: " "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 0.9 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.4 33.3 0.0 0.0 0.1 0.8 0.0 3.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 1.9 0.2 0.4 0.1 0.1 0.3 0.2 2.2 4.5 0.2 0.0 0.8 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: " "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favourable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favourable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 82.8 125.6 83.4 72.0 77.2 82.8 110.5 164.7 91.3 201.5 121.3 188.4 109.0 134.9 104.0 91.6 112.9 238.2 59.7 201.2 116.6 36.2 146.4 59.0 91.8 21.1 142.2 112.5 44.1 96.6 61.9 19.3 107.8 158.4 70.2 161.4 73.8 147.8 105.6 131.9 111.9 133.4 59.5 76.3 104.4 60.6 85.6 64.9 120.0 130.3 45.4 113.6 55.7 105.9 101.2 81.3 87.0 145.9 47.4 116.9 115.8 112.8 203.3 122.1 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302544-76304295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 565.5" "Cell line enhanced" "Detected in many" "hTCEpi: 162.0;MCF7: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" 57000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavourable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 67.6 41.7 23.0 42.9 22.8 7.3 186.2 10.1 21.3 127.6 84.9 10.8 89.2 27.1 126.5 65.9 410.5 57.7 52.2 164.8 21.4 22.5 85.4 26.3 43.3 25.1 25.7 14.3 63.4 34.7 16.6 15.5 106.9 32.8 99.6 12.0 31.1 50.5 101.3 439.2 164.4 24.6 139.7 27.3 17.8 37.6 22.0 23.4 31.9 72.9 207.3 126.8 146.2 565.5 27.8 17.8 4.1 27.9 23.2 36.8 14.4 72.6 54.0 5.8 43.1 35.1 31.1 0.3 30.9 16.3 16.8 21.1 4.8 42.6 0.6 23.9 40.0 66.7 25.3 18.1 5.4 40.5 8.5 3.3 41.7 22.8 18.8 4.9 30.5 38.6 162.0 25.3 3.7 55.4 26.4 74.3 19.2 227.6 8.3 33.6 29.6 47.3 25.7 11.9 59.0 24.9 27.7 0.4 33.1 21.7 88.6 27.6 104.4 34.8 29.9 50.5 75.3 15.7 77.9 5.2 8.6 0.7 36.9 15.2 36.7 4.1 4.5 2.8 18.6 21.1 9.6 27.5 30.6 20.2 11.1 27.8 36.8 31.5 1.7 23.2 27.9 17.8 19.7 14.4 23.0 22.8 10.1 21.3 21.4 22.5 25.7 14.3 32.8 23.4 HSPB11 "C1orf41, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945929 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol 18000 Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 12.2 19.7 21.5 20.1 19.5 22.6 19.5 13.1 18.6 17.4 15.6 9.5 19.4 11.0 19.1 30.6 19.0 31.9 11.0 12.9 15.4 16.0 16.0 20.0 19.9 24.0 15.0 18.7 20.8 13.4 9.5 31.3 18.2 16.8 15.1 14.6 22.4 13.3 25.1 5.6 16.0 13.1 17.8 17.3 16.0 15.6 19.6 10.0 27.1 40.4 15.0 24.2 23.5 14.3 28.6 35.9 37.5 20.0 31.1 35.0 16.8 20.8 8.9 27.7 6.5 9.6 12.7 11.2 18.7 16.0 26.0 30.7 20.6 11.7 25.3 14.6 12.6 17.0 11.4 17.8 31.1 20.5 16.4 31.0 19.4 27.6 10.4 15.5 21.7 13.2 13.6 24.6 6.9 13.6 18.1 6.0 32.3 4.3 34.5 23.9 11.1 19.4 23.5 35.1 13.0 21.0 23.2 14.1 11.6 26.5 12.2 16.8 76.0 22.6 10.1 18.2 22.3 20.3 19.7 10.9 16.3 25.0 28.8 14.6 15.6 35.4 14.8 37.5 28.0 19.0 25.1 28.6 27.8 33.0 16.8 22.9 21.9 28.0 10.3 31.1 20.0 35.9 35.0 16.8 21.5 19.5 13.1 18.6 15.4 16.0 15.0 18.7 16.8 10.0 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Cell line enhanced" "Detected in some" "ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: , HPA054811: " "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavourable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavourable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 184.7 77.9 0.1 8.2 0.1 0.5 0.9 0.1 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 62.6 0.0 0.0 72.9 0.0 1.9 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 1.7 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Cell line enhanced" "Detected in many" "EFO-21: 29.1;HeLa: 21.7;MCF7: 38.2;U-87 MG: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavourable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.4 4.9 0.2 0.0 5.7 4.5 19.1 10.7 9.5 2.2 0.1 12.0 0.2 0.0 29.1 14.8 0.8 0.1 0.0 0.3 0.0 0.4 0.0 21.7 1.0 3.9 0.0 0.0 5.0 1.7 7.2 0.7 4.4 0.0 0.0 5.3 38.2 0.0 0.1 2.2 7.0 0.0 7.9 1.0 15.7 2.0 0.1 0.3 4.1 0.5 2.2 9.9 0.0 6.1 5.3 13.4 6.9 0.5 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 HSPBP1 "FES1, HspBP1" ENSG00000133265 "HSPA (Hsp70) binding protein 1" Q9NZL4 19 55262231-55280381 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005865, HPA070398, HPA071444" Supported Approved Vesicles,Centrosome,Cytosol Cytosol "Vesicles, Centrosome" "CAB005865: AB_304116, HPA070398: , HPA071444: " "unprognostic (3.07e-2)" "unprognostic (6.36e-2)" "unprognostic (5.41e-2)" "unprognostic (8.05e-2)" "unprognostic (9.24e-2)" "unprognostic (1.43e-1)" "unprognostic (3.71e-3)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (1.52e-1)" "unprognostic (6.20e-3)" "unprognostic (7.23e-2)" "unprognostic (4.28e-3)" "unprognostic (2.44e-2)" "unprognostic (2.62e-1)" "unprognostic (9.45e-2)" "unprognostic (2.14e-2)" 14.1 13.9 24.5 15.8 42.9 16.4 13.8 13.3 32.5 11.3 17.3 9.1 13.0 18.8 14.8 12.4 14.5 30.3 13.3 19.1 25.3 20.1 15.4 18.0 18.2 17.6 16.2 20.0 17.4 21.1 13.0 10.2 9.8 15.2 12.0 8.3 7.6 19.3 13.6 35.4 15.4 17.2 16.8 15.0 11.6 15.3 21.1 9.3 11.7 12.0 24.4 8.9 10.5 10.5 24.0 23.0 3.0 19.0 18.4 20.5 11.5 22.0 39.7 7.0 10.3 4.2 3.5 21.6 11.6 4.7 11.6 9.9 22.4 15.4 14.6 11.3 6.2 15.4 8.3 11.2 3.1 12.4 68.3 19.5 12.6 20.6 9.1 18.2 10.3 4.9 10.1 11.6 5.5 5.8 15.5 8.3 4.0 20.9 16.4 16.9 25.2 33.4 16.0 11.1 31.5 7.8 14.5 19.4 29.0 14.3 14.8 11.1 11.3 14.2 8.0 14.0 15.2 7.9 21.1 13.3 30.6 15.2 15.6 15.8 14.8 0.8 11.5 3.0 18.0 19.0 18.7 21.0 19.8 20.5 23.0 24.0 19.9 19.3 0.8 18.4 16.0 13.1 17.8 11.5 24.5 42.9 13.3 32.5 25.3 20.1 16.2 20.0 15.2 9.3 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell line enhanced" "Detected in many" "EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597" "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavourable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 6.8 6.4 2.1 7.5 22.1 16.8 8.5 10.4 2.7 3.0 2.8 7.7 14.1 0.5 45.8 16.1 4.3 0.5 5.1 0.7 0.1 0.7 2.3 6.8 5.6 4.6 0.0 0.6 10.1 1.5 3.1 0.9 101.1 3.1 0.9 4.1 1.9 0.0 3.1 1.9 2.9 1.0 9.0 0.9 5.8 0.9 0.2 0.6 7.9 3.3 4.6 1.3 1.1 80.7 6.0 7.8 4.6 0.3 0.0 1.0 0.3 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.90e-4)" "prognostic unfavourable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 14.5 27.8 23.0 2.2 22.1 12.6 15.3 25.2 22.4 39.2 18.3 32.7 22.6 37.7 15.8 17.5 28.2 88.5 22.4 50.6 29.5 11.1 32.7 15.4 28.8 7.3 22.6 26.1 7.9 51.8 26.1 15.0 22.6 27.3 6.0 27.4 19.8 32.4 25.9 32.7 20.8 25.6 18.8 12.5 29.5 17.7 23.8 19.8 22.9 22.6 11.6 7.5 22.0 13.7 13.5 17.2 19.4 27.8 4.7 15.4 32.3 11.2 27.5 22.5 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58318574 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066812 Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA066812: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.9 8.9 9.0 6.6 13.9 6.9 9.4 17.0 11.5 7.4 9.2 6.4 7.1 11.3 8.6 8.5 9.4 7.8 7.1 15.9 7.9 9.3 12.1 16.2 6.9 8.2 8.5 10.7 11.0 12.9 8.8 14.2 6.7 7.8 9.6 10.1 9.7 9.2 9.4 35.2 7.2 9.7 12.6 6.0 9.7 8.6 9.8 6.4 6.8 10.7 19.8 9.2 7.8 8.1 23.9 21.6 23.7 20.4 21.3 26.5 13.5 8.0 6.1 9.4 6.7 8.0 9.0 12.1 11.5 8.7 14.3 12.6 13.4 6.1 16.0 3.4 8.3 7.1 15.8 10.4 14.8 8.9 11.0 9.6 13.6 11.3 8.7 12.6 9.1 11.1 10.7 15.2 9.2 12.5 9.4 15.2 9.0 4.7 8.1 6.4 12.2 14.0 5.7 6.0 11.4 9.6 11.9 5.9 8.8 7.1 6.6 13.1 8.9 11.1 7.3 12.2 8.6 11.0 14.0 11.6 20.9 12.5 9.8 9.4 7.4 13.5 17.3 23.7 18.7 20.4 20.1 23.9 18.7 23.5 17.5 23.8 26.5 20.2 18.4 21.3 16.7 21.6 13.4 13.5 9.0 13.9 17.0 11.5 7.9 9.3 8.5 10.7 7.8 6.4 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90857698 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.8;testis: 14.3" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "myeloid DC: 4.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: " "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 1.0 0.5 2.4 1.1 2.5 0.5 0.7 0.3 4.3 0.6 0.8 1.7 1.2 0.8 0.4 0.3 1.0 0.4 1.3 0.6 9.9 5.1 0.3 0.6 0.5 0.7 1.7 1.8 0.4 1.4 30.8 0.2 0.5 3.1 1.0 1.2 0.4 0.6 0.3 1.7 0.9 2.2 3.6 1.5 1.3 1.5 14.3 1.0 0.0 0.3 0.1 0.6 3.5 2.1 0.0 4.6 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.2 0.5 0.7 0.0 0.9 0.0 0.0 0.1 3.3 0.9 8.1 2.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.4 5.8 7.3 2.4 24.5 0.0 0.0 0.0 9.8 0.0 0.0 0.1 0.9 1.2 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 3.8 0.0 0.2 0.2 4.5 0.0 0.0 6.8 0.0 0.0 0.0 7.5 0.0 9.3 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 2.4 2.5 0.3 4.3 9.9 5.1 1.7 1.8 3.1 1.0 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3074681-3243960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favourable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 12.9 13.8 19.4 16.6 18.3 14.1 12.3 24.7 32.3 10.0 13.6 11.6 11.0 10.5 11.5 15.9 16.3 11.6 9.4 8.9 19.7 12.1 11.3 13.1 21.5 18.1 11.8 19.5 13.0 27.0 29.5 13.0 12.0 12.8 10.5 11.4 13.3 10.2 11.4 19.1 25.4 12.8 12.0 10.4 17.4 12.0 14.9 10.4 17.4 13.3 7.3 15.6 11.7 9.6 2.9 3.5 2.8 4.5 2.9 4.3 1.9 12.3 8.6 12.1 7.1 22.3 12.7 12.3 5.8 7.1 8.7 8.3 11.4 8.1 19.0 6.2 13.9 7.1 14.3 10.5 8.8 5.0 10.5 18.1 12.3 12.2 5.2 12.1 26.5 8.8 6.5 17.1 8.0 10.1 11.8 6.8 7.7 11.9 12.9 11.5 14.8 14.0 11.6 11.6 3.7 9.3 12.8 13.3 9.4 10.3 3.9 10.1 10.7 7.6 14.0 12.2 7.7 8.4 12.9 5.3 6.2 15.1 9.1 11.2 8.7 0.0 2.6 2.8 3.5 3.4 2.4 2.9 2.7 4.3 3.5 2.4 2.0 2.4 0.4 2.9 4.5 2.6 3.5 1.9 19.4 18.3 24.7 32.3 19.7 12.1 11.8 19.5 12.8 10.4 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873315-32044633 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.4;BEWO: 12.9;RH-30: 14.2;SCLC-21H: 11.6;SiHa: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA027295: , HPA027372: " "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favourable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 1.7 1.9 2.7 2.9 3.5 0.5 2.1 3.2 6.4 1.1 5.9 0.2 12.6 2.4 9.0 3.4 1.1 3.3 1.0 1.7 3.7 3.2 6.0 1.3 1.7 0.7 1.2 2.1 1.8 15.7 0.2 4.7 7.6 1.4 4.0 6.5 9.1 1.5 11.1 0.6 5.0 4.4 4.1 0.9 0.4 2.1 1.8 0.2 0.4 1.1 2.2 1.0 3.8 7.7 1.0 0.7 1.7 0.5 0.5 0.5 0.1 0.0 3.0 10.4 0.1 0.0 0.0 12.9 1.0 0.0 0.2 0.0 4.1 0.1 0.0 0.4 4.8 0.0 6.2 0.0 0.0 0.0 3.1 0.0 2.7 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.9 7.9 0.1 0.1 14.2 0.0 1.1 0.0 11.6 7.7 10.2 0.8 0.4 4.2 1.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 4.9 0.8 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.2 1.0 0.5 0.5 1.7 0.5 0.3 0.7 0.4 0.1 2.7 3.5 3.2 6.4 3.7 3.2 1.2 2.1 1.4 0.2 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;U-266/84: 5.0;WM-115: 5.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034511: , HPA063449: " "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.5 0.1 0.1 0.5 0.1 3.3 0.6 0.0 0.0 1.4 0.4 1.3 0.9 0.7 0.9 0.2 0.6 0.5 0.2 0.1 0.6 0.8 1.0 0.2 0.3 0.8 0.0 0.0 0.8 1.1 1.4 0.2 0.5 0.1 0.0 0.9 0.3 1.0 0.6 1.0 0.1 4.3 0.7 0.2 0.3 1.2 1.6 1.6 0.0 0.7 0.0 1.9 0.6 0.6 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.8 0.1 0.3 0.5 0.1 0.0 0.5 0.0 0.4 1.3 4.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.3 0.4 0.4 0.1 1.7 1.0 0.5 0.0 0.4 2.4 2.8 1.4 0.9 0.8 2.5 0.2 0.6 1.0 0.1 0.3 0.0 0.7 0.1 0.1 0.4 0.7 0.8 1.5 0.4 2.2 5.0 1.0 0.1 0.5 5.4 0.0 0.7 0.0 0.7 0.3 0.5 1.6 1.1 0.9 0.0 0.8 1.0 1.9 0.0 0.0 0.0 1.6 0.7 0.6 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase" Q7Z6Z7 X 53532096-53686729 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol 3400 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 24.6 28.2 27.7 23.8 43.3 22.4 28.0 37.0 41.1 31.8 25.9 34.3 26.6 17.1 31.9 52.4 27.4 26.5 23.1 27.1 28.0 31.8 30.3 26.2 20.3 23.1 30.0 30.2 43.3 27.8 59.8 34.2 27.2 34.6 27.3 22.7 25.6 26.4 29.6 59.1 50.1 22.1 33.9 23.9 26.6 25.7 28.4 27.7 32.4 27.6 20.7 28.6 27.0 22.9 5.1 7.2 8.2 7.0 6.9 8.9 3.5 50.1 30.9 20.1 14.2 35.3 21.1 24.8 15.1 19.5 15.9 16.7 23.5 16.2 26.3 10.3 27.4 24.1 45.4 25.3 21.8 37.9 20.1 20.9 27.7 18.3 32.5 31.3 12.9 20.1 19.0 38.2 43.9 27.5 20.8 17.1 20.6 30.9 16.9 17.5 27.5 22.3 15.7 27.8 15.9 26.4 34.8 16.8 12.1 42.6 19.0 13.6 27.2 15.2 35.0 14.7 21.1 20.9 19.2 15.0 14.7 23.0 15.7 30.7 21.1 4.0 4.7 8.2 7.2 3.8 8.9 5.1 6.9 7.6 6.7 5.1 4.9 4.9 4.2 6.9 7.0 7.2 5.7 3.5 27.7 43.3 37.0 41.1 28.0 31.8 30.0 30.2 34.6 27.7 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 5.2;SiHa: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA067155: , HPA074129: " "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.3 0.3 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.7 0.2 0.2 0.8 5.2 0.7 2.4 0.5 10.9 0.3 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43451003-43453989 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 130.4;seminal vesicle: 80.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 38.7;WM-115: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040092 Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favourable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavourable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavourable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favourable (2.72e-5)" 16.5 12.5 11.6 12.1 10.1 5.3 12.8 11.3 9.7 14.6 16.5 13.0 130.4 23.4 15.8 14.8 8.4 15.3 16.7 10.9 9.2 10.0 15.9 25.8 17.8 6.7 10.9 9.3 25.1 34.0 13.8 11.2 10.8 9.0 15.6 7.5 15.0 20.8 80.0 8.8 8.4 22.1 13.4 14.3 7.6 14.1 4.5 11.1 4.9 12.8 9.6 6.4 10.7 11.3 3.2 21.6 6.2 1.2 4.8 5.4 3.0 17.2 2.2 0.7 1.2 3.4 6.3 0.0 15.1 13.5 19.0 12.7 8.8 30.1 0.0 1.1 9.7 3.2 0.0 15.9 7.8 4.2 6.2 2.8 7.9 0.0 22.4 0.0 0.0 3.7 4.6 21.5 0.0 38.7 0.2 0.0 12.7 0.3 2.5 2.9 3.2 4.4 13.3 0.0 0.1 13.2 0.6 8.2 6.1 16.8 9.5 3.7 2.4 21.6 17.8 1.2 0.0 3.4 29.3 0.0 0.0 0.0 1.0 4.0 32.8 6.2 1.1 2.4 3.3 0.9 4.1 3.2 5.4 2.6 4.1 2.7 5.1 1.5 0.1 4.8 1.2 21.6 0.5 3.0 11.6 10.1 11.3 9.7 9.2 10.0 10.9 9.3 9.0 11.1 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 17.5;U-266/84: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 7.1" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 6.3 7.5 6.4 4.8 8.0 1.7 7.7 2.3 6.1 8.2 14.3 2.5 6.8 11.1 6.4 11.0 7.0 6.5 7.5 8.5 4.3 3.5 19.4 10.5 3.6 4.3 3.5 3.6 9.7 15.5 4.0 8.8 1.5 4.3 8.0 6.2 10.1 7.9 10.1 8.9 3.9 21.2 9.4 3.4 1.6 6.8 7.8 2.2 5.7 7.3 3.7 4.1 7.1 5.1 0.4 0.6 0.8 0.2 0.5 7.1 1.2 3.1 5.1 0.5 9.0 2.0 4.4 1.9 1.0 2.1 3.0 3.5 1.7 3.7 2.5 1.1 2.0 3.6 8.2 2.7 2.8 1.1 17.5 1.1 2.2 4.2 5.1 0.3 1.4 4.0 5.1 1.1 2.3 2.1 3.0 6.5 1.7 3.8 2.9 0.5 0.5 6.5 1.7 9.9 2.0 5.6 3.5 0.9 1.2 2.2 6.7 7.9 7.6 0.2 0.9 1.9 1.4 3.6 3.3 10.2 17.8 0.1 2.2 0.1 2.7 0.8 0.2 0.5 0.3 0.1 0.4 0.4 2.4 0.4 0.1 0.4 7.1 1.3 0.8 0.5 0.1 0.6 1.0 1.2 6.4 8.0 2.3 6.1 4.3 3.5 3.5 3.6 4.3 2.2 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavourable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.4 3.8 2.8 7.5 5.1 6.6 12.0 4.8 11.2 7.6 0.1 7.8 2.0 5.0 10.5 7.1 5.4 4.2 13.1 11.5 3.8 1.5 1.1 2.1 5.6 5.3 8.0 3.3 4.9 11.1 12.7 8.1 2.6 12.8 14.6 7.9 3.8 15.9 8.4 17.5 8.1 0.0 6.9 12.0 7.9 5.4 3.3 12.7 9.8 4.7 24.2 11.7 7.3 0.8 9.8 8.9 2.0 4.7 4.7 4.9 2.4 11.6 9.8 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 HYPK "C15orf63, FLJ20431, HSPC136" ENSG00000242028 "Huntingtin interacting protein K" Q9NX55 15 43796142-43803043 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055252 Uncertain Supported Nucleoplasm,Microtubules Nucleoplasm Microtubules "HPA055252: " "unprognostic (2.89e-2)" "unprognostic (5.82e-2)" "unprognostic (2.14e-2)" "unprognostic (7.58e-3)" "unprognostic (1.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.55e-1)" "unprognostic (1.48e-1)" "unprognostic (4.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.36e-3)" "unprognostic (2.39e-3)" "unprognostic (6.52e-7)" "unprognostic (2.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.61e-1)" "unprognostic (2.78e-4)" 7.5 11.3 10.8 10.1 13.7 22.1 7.3 29.4 11.1 7.0 8.3 8.4 7.0 8.4 8.5 8.8 8.2 7.9 7.3 17.3 9.3 6.5 13.2 30.5 13.7 11.3 13.3 9.7 10.4 18.0 6.7 11.9 8.1 14.1 13.3 13.5 5.7 11.0 7.1 36.8 13.4 10.2 7.4 8.6 11.1 14.4 14.0 12.0 6.0 11.1 13.1 11.0 8.3 10.8 7.8 3.9 8.3 8.9 4.4 9.6 1.5 1.5 1.9 5.6 3.4 4.7 5.4 3.5 3.0 1.3 2.2 1.6 4.9 1.8 2.5 1.7 1.5 5.2 4.7 3.6 2.1 2.5 3.3 3.5 9.0 2.7 2.4 2.0 2.7 4.2 6.7 1.6 3.0 2.3 3.9 4.9 2.3 4.1 2.5 5.1 1.8 4.1 3.2 1.8 2.9 3.7 5.4 3.5 2.5 2.4 5.0 0.7 5.0 2.4 4.4 6.1 3.6 4.1 2.8 5.8 6.0 5.8 4.8 5.8 2.4 6.2 4.4 4.2 5.4 3.2 8.0 3.2 7.5 6.3 3.0 7.8 9.6 7.8 8.3 4.4 8.9 3.9 5.2 1.5 10.8 13.7 29.4 11.1 9.3 6.5 13.3 9.7 14.1 12.0 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: " "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favourable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.2 0.1 1.6 0.0 0.0 0.3 0.7 0.0 0.0 2.4 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 11.8 9.5 0.0 0.0 15.2 0.1 0.0 3.7 0.1 0.0 0.0 7.0 6.9 17.8 24.9 41.0 0.0 19.5 0.2 15.8 5.1 6.9 0.0 0.3 0.0 0.3 5.1 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell line enhanced" "Detected in many" "HHSteC: 31.1;Karpas-707: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Uncertain "Plasma membrane,Cytosol" 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favourable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.2 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.5 4.1 12.5 2.7 9.3 7.6 25.8 0.7 1.7 0.3 0.0 8.7 22.7 0.0 0.7 0.2 11.3 31.1 0.2 4.5 10.9 0.7 2.6 4.0 2.1 2.8 88.5 0.3 0.6 0.1 6.4 0.5 4.7 0.2 0.0 28.1 7.0 0.0 0.0 0.2 11.4 0.6 18.1 1.4 0.5 6.4 4.2 0.4 2.3 0.1 27.0 27.8 4.7 6.8 4.9 6.2 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 163.3;TIME: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.3 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.8 11.5 2.1 0.0 0.0 0.1 0.0 0.2 2.5 0.0 10.3 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 163.3 8.4 6.7 0.0 0.0 12.8 1.5 0.0 0.0 7.8 0.0 15.9 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 41.2 0.0 0.1 0.8 0.0 6.4 2.2 10.2 0.0 2.1 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell line enhanced" "Detected in many" "Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: " "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.6 1.3 0.9 2.9 1.6 1.3 1.6 1.6 1.1 1.4 1.2 1.1 1.8 0.0 5.7 1.4 1.1 0.0 1.2 0.4 19.8 0.8 5.0 1.2 5.0 0.8 18.3 20.7 1.1 1.0 1.6 0.5 0.6 2.7 64.3 1.5 5.4 2.4 41.4 0.7 9.0 1.5 0.6 48.2 1.4 2.3 0.3 1.2 1.4 4.5 3.6 3.9 5.2 1.1 6.3 0.5 7.0 1.6 3.1 34.1 7.6 4.5 33.8 4.9 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490234 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA054452: , HPA061934: " "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 14.3 13.2 16.3 13.2 17.3 17.4 18.1 26.7 20.6 17.7 15.1 10.3 13.4 10.6 18.3 14.2 11.6 15.0 10.8 12.3 14.4 13.3 15.5 11.3 12.0 15.5 15.5 16.8 21.7 14.2 27.3 22.5 18.5 17.1 13.5 12.0 8.8 12.9 14.0 28.2 12.8 13.4 20.0 16.3 14.0 13.6 10.7 14.2 21.6 15.5 13.8 16.2 15.5 17.8 3.4 3.8 3.6 2.3 3.4 3.9 1.2 9.2 11.8 13.5 12.9 13.2 13.0 17.5 8.1 9.7 9.8 10.8 9.0 6.9 12.6 11.3 11.6 8.9 18.5 9.5 16.5 17.4 9.4 10.2 35.6 6.5 8.0 23.0 8.4 10.3 10.2 11.6 18.1 12.0 14.5 10.6 10.1 8.1 16.7 8.3 11.4 10.0 19.7 12.3 8.5 8.2 10.6 8.8 9.1 28.1 9.2 10.8 7.9 7.3 13.5 12.7 16.3 16.3 12.5 11.6 13.6 21.4 10.7 17.5 10.7 1.5 1.8 3.6 3.3 2.3 3.9 3.4 3.0 3.1 1.7 3.0 2.7 3.2 0.5 3.4 1.2 3.8 3.5 1.2 16.3 17.3 26.7 20.6 14.4 13.3 15.5 16.8 17.1 14.2 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 12.1 11.5 7.7 9.2 11.5 6.7 11.0 9.8 9.2 11.4 9.1 10.2 14.1 6.1 11.9 8.0 9.6 10.3 8.8 8.2 8.2 6.0 10.6 9.2 8.6 10.9 13.3 6.3 15.4 9.1 44.0 25.6 10.2 9.7 11.7 9.6 7.7 9.4 9.9 10.7 9.1 8.6 10.8 10.1 10.0 9.0 8.6 13.4 19.5 14.0 8.1 12.3 10.7 11.3 10.9 6.6 5.9 7.4 4.4 11.7 6.9 8.7 15.6 13.1 12.6 10.0 11.0 6.9 5.2 8.1 8.4 9.1 12.1 6.5 15.4 11.5 5.6 16.8 17.4 7.0 11.6 18.5 7.8 15.5 11.0 7.1 5.4 17.0 11.0 5.4 8.5 6.9 12.4 13.7 23.6 14.5 10.3 3.8 13.4 4.5 16.3 10.5 16.2 10.4 13.5 6.7 10.9 14.9 14.3 7.3 7.5 9.2 12.2 8.8 6.4 11.7 10.3 9.8 16.0 6.8 18.3 22.5 7.6 19.6 10.7 4.5 5.1 5.9 7.1 7.4 11.7 9.1 8.7 9.2 6.6 10.9 11.6 11.2 0.8 4.4 6.0 5.6 8.9 6.9 7.7 11.5 9.8 9.2 8.2 6.0 13.3 6.3 9.7 13.4 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Group enriched" "Detected in some" 100 "HEL: 5.9;MOLT-4: 15.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favourable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: " "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.6 0.4 0.2 5.6 0.4 14.0 2.1 0.3 4.2 1.9 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.0 10.3 1.1 1.9 0.9 0.9 0.8 2.3 1.3 0.2 3.6 0.3 7.9 2.0 3.5 11.9 0.9 8.2 0.6 7.4 1.4 0.0 9.3 13.2 0.3 3.8 8.6 0.8 0.4 3.3 0.3 0.2 12.1 8.2 11.7 4.3 5.6 1.8 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell line enhanced" "Detected in many" "HDLM-2: 107.5;HEK 293: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favourable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 19.9 8.2 10.1 13.2 2.1 31.4 22.7 2.7 10.2 4.3 39.8 1.0 0.5 27.0 38.8 17.1 5.3 0.1 3.0 107.5 69.6 14.3 12.2 48.6 3.9 10.6 40.3 3.6 0.4 4.6 0.2 0.2 0.8 17.0 15.7 6.7 1.1 1.2 14.9 15.7 1.4 5.7 10.7 10.2 8.9 15.5 22.0 1.2 17.3 1.7 2.8 6.3 4.1 12.6 2.2 18.6 1.3 1.3 1.0 12.4 15.9 32.8 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1, cytosolic" O75874 2 208236227-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 108.5;RT4: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" 16000000 "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: , HPA035248: AB_10600714, HPA057936: " "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavourable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavourable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 41.3 82.3 6.2 8.8 7.0 1.3 20.9 6.5 8.3 12.6 35.2 8.7 38.0 30.6 8.0 29.9 30.3 8.8 18.7 10.8 6.3 6.2 20.5 91.0 19.8 14.3 8.1 4.7 19.4 21.5 4.8 6.2 24.1 8.7 38.5 23.1 15.4 18.7 39.0 4.7 7.4 54.1 10.1 9.3 21.3 20.4 15.6 8.4 3.5 7.9 11.0 11.9 43.4 12.1 4.9 22.8 6.4 31.6 7.4 6.6 12.0 9.6 16.2 23.2 9.4 42.2 30.1 13.2 4.0 18.4 6.8 16.6 25.6 23.6 1.9 25.6 12.5 14.9 16.7 19.4 6.6 1.3 6.3 8.3 13.4 108.5 56.2 5.4 8.3 25.9 41.3 15.5 11.3 18.7 8.3 6.7 10.4 6.1 3.8 9.3 42.4 6.7 3.7 8.4 5.4 30.6 75.8 4.0 6.9 15.3 14.8 50.1 5.7 15.8 12.3 6.9 7.0 9.8 4.3 3.2 5.0 2.5 22.4 32.8 5.5 5.7 31.6 4.8 4.5 14.5 5.1 4.9 4.0 5.3 22.8 4.9 3.3 3.9 6.4 7.4 6.5 8.4 6.6 12.0 6.2 7.0 6.5 8.3 6.3 6.2 8.1 4.7 8.7 8.4 IDH3G ENSG00000067829 "Isocitrate dehydrogenase 3 (NAD(+)) gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favourable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 24.5 34.0 27.7 26.8 47.2 37.1 24.1 37.2 61.5 25.0 28.8 25.7 24.6 34.7 26.6 21.3 31.8 29.4 25.6 50.8 35.0 25.2 40.6 29.5 20.9 25.6 27.3 35.6 31.8 40.5 29.1 24.9 22.5 40.5 21.4 25.2 26.0 34.5 29.8 54.9 36.3 34.9 24.8 20.1 26.9 24.8 16.0 23.3 31.2 24.3 37.1 28.2 24.4 21.1 20.6 45.5 43.7 44.4 23.7 28.8 33.6 28.9 26.7 15.8 22.2 24.8 20.5 19.4 15.1 21.3 26.8 28.5 22.1 22.1 36.9 26.2 24.2 21.7 23.9 20.6 9.9 12.1 30.5 13.8 36.3 17.7 28.1 19.2 29.2 23.1 14.9 20.7 22.6 20.5 7.6 20.3 21.6 40.5 21.8 22.6 7.1 35.4 19.3 13.5 32.2 29.9 18.0 20.2 13.8 9.4 32.0 15.0 13.3 16.6 18.1 17.0 10.7 25.0 35.7 27.9 6.9 47.0 27.8 23.9 18.8 42.5 43.9 43.7 21.5 44.4 19.9 19.1 22.0 20.9 45.5 20.6 17.6 19.2 16.3 23.7 43.1 27.9 28.8 33.6 27.7 47.2 37.2 61.5 35.0 25.2 27.3 35.6 40.5 23.3 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK, gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9;liver: 39.1" "Cell line enhanced" "Detected in many" "MCF7: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: " "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favourable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 4.3 6.1 9.4 2.9 20.3 2.2 4.5 12.3 8.3 2.3 11.3 7.0 3.1 14.2 2.5 7.4 4.1 6.8 4.5 2.8 7.6 8.6 27.2 39.1 3.7 4.7 7.3 6.3 3.2 6.6 3.6 5.2 1.8 6.2 4.2 4.7 5.2 4.6 5.0 1.2 3.3 20.2 3.5 7.0 4.2 4.3 2.0 6.8 14.5 7.0 1.2 4.3 2.8 2.1 17.5 9.6 35.9 20.5 15.0 23.0 11.4 3.4 8.4 1.1 1.3 3.8 5.5 6.1 2.4 7.0 2.6 2.1 2.2 3.1 4.4 4.1 3.7 5.9 0.9 1.6 2.8 9.6 1.0 1.6 3.3 9.6 16.7 1.0 2.0 3.7 2.2 5.8 5.5 6.0 1.3 4.6 3.9 19.3 2.7 1.1 1.0 3.8 3.3 3.2 2.5 7.0 4.0 5.4 6.9 5.6 4.4 5.9 4.4 5.9 6.1 1.2 0.8 10.9 4.5 6.8 7.8 0.6 6.0 1.8 2.1 35.9 6.1 8.6 14.7 10.6 12.3 17.5 12.7 12.1 8.5 11.4 10.2 13.8 1.1 15.0 20.5 9.6 23.0 11.4 9.4 20.3 12.3 8.3 7.6 8.6 7.3 6.3 6.2 6.8 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell line enriched" "Detected in some" 7 "EFO-21: 35.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favourable (5.27e-4)" "prognostic favourable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.4 2.5 0.1 0.3 0.0 35.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088712-181092899 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favourable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavourable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 9.4 7.2 4.7 16.2 5.4 45.7 13.8 6.2 12.6 7.8 7.8 5.1 5.9 6.6 12.8 5.3 20.9 14.3 10.3 22.9 6.0 4.9 3.7 6.7 22.6 9.6 10.1 5.7 4.4 4.3 1.8 4.6 34.5 6.9 6.7 6.9 3.7 5.7 4.9 42.3 16.6 10.8 9.6 7.2 27.3 6.8 5.1 5.0 11.2 4.3 22.9 19.8 8.4 16.3 5.4 1.6 5.4 7.8 1.5 2.1 0.9 12.0 10.5 5.8 5.1 8.1 11.2 15.6 21.3 22.6 12.1 10.8 2.9 6.8 3.9 9.5 8.2 22.2 1.8 14.5 7.8 22.6 9.2 3.5 5.4 1.9 12.7 4.1 11.5 8.0 14.7 14.0 9.4 8.1 14.6 18.0 21.3 5.4 4.0 6.5 6.1 5.3 4.7 10.2 14.9 4.3 6.6 8.4 9.1 10.8 10.6 23.5 8.4 3.5 12.3 8.7 15.3 9.9 12.8 12.0 4.2 3.1 6.8 4.3 2.4 5.4 2.1 3.8 1.6 7.8 1.9 5.4 1.4 2.1 1.6 3.6 0.3 0.9 1.8 1.5 7.3 0.2 1.8 0.9 4.7 5.4 6.2 12.6 6.0 4.9 10.1 5.7 6.9 5.0 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell line enhanced" "Detected in many" "HDLM-2: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: " "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.2 13.5 3.6 10.0 2.3 1.9 5.9 6.2 4.1 3.4 2.4 18.5 9.7 0.1 8.1 4.7 20.8 2.7 13.3 2.8 49.4 2.4 0.1 2.5 7.2 1.7 1.4 15.9 1.2 13.5 4.6 5.9 7.3 0.6 1.6 2.2 1.7 1.3 1.3 1.5 3.2 4.6 2.2 3.5 2.0 5.3 11.7 0.6 4.7 6.7 4.6 1.8 0.7 19.8 4.6 6.4 2.7 18.0 3.6 3.9 0.2 3.1 2.0 5.4 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 6.9 0.5 2.4 0.1 16.8 55.6 0.0 14.8 39.7 41.7 55.5 0.0 8.9 40.9 12.8 9.0 20.3 0.3 15.0 16.7 12.6 0.1 10.5 3.1 0.0 31.4 3.6 0.7 52.3 26.9 21.3 30.4 43.8 0.2 30.0 23.1 0.0 48.0 3.3 6.4 5.4 22.7 15.4 47.2 5.8 2.6 1.1 0.0 19.4 0.1 42.1 0.0 4.2 24.7 10.7 5.1 30.2 6.2 28.0 13.1 38.4 30.8 11.8 25.8 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 11.4 39.9 38.6 18.3 23.8 17.0 18.8 15.2 24.7 19.9 16.0 23.5 8.7 11.6 15.8 9.6 24.5 21.9 20.8 38.9 29.7 32.4 13.2 3.7 16.5 21.5 37.1 22.8 25.9 13.2 11.7 20.6 5.4 27.4 10.6 9.7 20.4 7.2 12.5 4.0 16.0 13.5 15.5 35.7 17.0 15.7 9.1 22.9 13.8 8.5 16.0 22.5 12.0 17.2 31.5 29.6 19.8 38.7 6.0 30.5 31.9 8.3 5.9 1.7 11.9 8.6 22.1 1.0 15.6 16.1 11.8 13.9 1.6 3.8 3.7 17.1 16.8 10.3 1.2 20.8 4.8 24.9 0.9 5.7 5.8 0.5 14.5 6.7 15.7 20.0 7.7 7.0 4.3 7.8 0.5 56.9 12.2 15.7 3.9 4.1 2.1 6.7 0.1 5.5 4.9 18.0 3.2 3.1 4.7 0.4 0.1 10.0 19.3 11.2 7.6 7.9 4.8 10.6 4.3 23.2 19.2 1.2 25.2 14.9 5.1 19.8 38.7 7.1 25.6 25.9 16.4 31.5 24.4 28.1 29.6 27.4 17.6 23.0 5.7 6.0 18.8 24.6 30.5 31.9 38.6 23.8 15.2 22.8 29.7 32.4 37.1 22.8 27.4 22.9 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 75.3;RPMI-8226: 81.6;SK-BR-3: 55.1;U-266/84: 90.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.7 6.7 0.0 4.4 1.3 1.8 12.1 1.4 1.8 3.9 10.1 15.2 22.8 75.3 11.6 4.3 10.0 8.0 2.9 0.4 20.0 5.7 0.8 12.5 21.5 12.8 2.2 5.8 7.8 6.8 6.4 2.2 0.2 10.6 47.3 1.9 24.9 1.0 0.2 2.5 6.7 7.3 0.5 81.6 11.6 0.4 0.6 0.8 23.4 55.1 1.3 3.7 0.9 0.3 6.7 4.0 13.8 1.4 1.6 90.3 42.9 18.7 14.9 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.4;BJ hTERT+ SV40 Large T+ RasG12V: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Approved Nucleoplasm,Cytosol 93000 "Nucleoplasm, Cytosol" "HPA045946: , HPA075580: " "prognostic favourable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavourable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 6.9 0.0 0.3 6.0 7.3 1.4 1.9 20.5 50.4 74.4 2.5 11.1 0.9 3.9 5.9 1.6 0.3 3.1 4.0 7.8 1.4 2.1 2.5 9.2 15.0 2.4 4.7 10.1 1.2 7.1 0.8 4.5 1.2 14.8 2.0 2.9 5.1 1.9 0.0 3.1 4.2 0.0 5.4 6.2 2.5 1.3 0.0 3.9 1.4 20.2 6.4 4.7 2.2 3.7 0.0 1.1 3.1 13.2 4.9 0.2 6.6 1.9 3.5 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Group enriched" "Detected in many" 4 "BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA059914: " "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.2 0.4 0.1 1.7 7.3 7.9 0.0 4.0 34.4 80.5 93.5 0.3 9.1 0.5 1.7 6.4 5.6 0.1 0.8 5.9 0.9 0.0 2.4 1.8 0.2 4.2 0.7 2.0 4.9 0.1 7.0 0.5 0.4 0.1 1.4 2.0 0.0 1.5 1.9 0.1 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 15.8 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.2 1.8 0.1 1.8 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33402896-33479348 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 55.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 27.2 13.4 11.9 20.8 12.6 45.1 64.4 4.6 18.0 12.5 21.6 5.7 13.0 18.5 10.6 14.1 21.9 11.5 15.2 17.7 11.1 10.1 14.6 20.2 26.3 46.3 8.7 9.4 13.0 21.7 7.1 12.6 20.5 12.2 14.9 11.7 12.1 21.9 11.7 13.1 16.7 20.0 15.3 18.1 27.4 30.3 14.1 7.2 7.9 18.1 19.4 18.9 14.8 26.8 13.2 7.7 55.1 22.8 0.3 3.3 13.8 3.0 2.6 1.3 2.7 3.7 6.4 4.3 8.6 6.3 2.0 3.3 3.0 1.7 5.2 4.8 5.2 2.3 2.7 6.0 1.1 20.0 16.9 1.5 1.1 2.7 2.5 7.5 4.7 4.8 4.0 3.4 3.5 5.1 7.9 2.5 2.7 0.9 1.8 5.1 4.9 16.4 4.4 4.1 4.3 2.2 4.1 1.8 4.6 4.3 0.5 8.2 1.6 4.8 8.6 2.5 5.4 2.1 2.1 5.5 7.5 6.7 2.2 6.7 11.8 12.9 22.2 14.8 0.1 22.0 0.1 11.5 1.3 0.1 7.7 13.2 3.3 1.4 55.1 0.3 22.8 2.4 1.4 13.8 11.9 12.6 4.6 18.0 11.1 10.1 8.7 9.4 12.2 7.2 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024122 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA024122: AB_1851452" "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favourable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.2 15.8 14.8 27.0 17.5 14.6 14.9 14.3 19.4 17.4 16.8 12.8 7.3 28.6 7.8 9.0 10.9 12.6 26.5 12.4 15.6 8.2 18.8 16.0 30.9 11.1 6.5 13.4 27.1 20.4 23.4 8.0 25.1 16.5 7.8 13.6 14.1 18.8 35.9 17.8 12.3 6.3 13.6 5.9 4.2 25.4 13.1 17.0 14.5 48.3 5.6 12.0 6.9 32.9 7.0 25.7 45.0 14.8 17.5 20.0 9.0 31.0 37.7 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 IFT122 "SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 84.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 7.4 5.7 11.1 4.9 14.0 6.4 9.1 13.3 13.1 10.2 5.6 7.6 6.4 3.5 10.2 9.6 5.4 18.5 5.0 10.0 7.8 6.4 8.8 6.7 6.7 4.5 4.4 9.2 19.0 9.6 13.1 18.9 7.7 7.2 5.7 5.2 10.5 6.3 6.7 3.7 9.9 4.1 7.6 4.2 3.7 6.7 84.7 5.7 7.6 9.6 2.0 4.2 5.3 6.9 4.7 6.0 8.3 5.7 2.8 5.5 3.8 10.8 16.5 14.3 9.4 20.8 14.8 7.6 5.8 8.8 10.2 9.9 7.9 7.2 7.0 6.9 7.5 7.0 5.5 5.1 9.3 3.8 5.9 5.3 13.5 6.7 5.7 14.7 5.0 17.3 3.9 7.8 6.1 13.7 5.4 15.1 8.2 12.0 12.0 7.6 9.5 4.7 10.7 5.5 5.0 10.9 2.0 18.2 7.4 16.7 5.6 5.0 15.3 11.8 6.0 7.2 6.2 9.3 6.9 10.3 7.2 6.1 6.5 7.5 5.5 8.3 5.7 6.6 1.9 3.9 3.3 3.8 3.3 4.5 6.0 4.7 3.7 4.5 2.7 2.8 1.7 1.4 5.5 3.8 11.1 14.0 13.3 13.1 7.8 6.4 4.4 9.2 7.2 5.7 IFT22 "DKFZp761N0823, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101313367-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.5" "Cell line enhanced" "Detected in many" "MCF7: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 6.6 12.3 18.1 4.4 19.9 2.9 9.3 4.8 17.1 11.2 9.9 10.1 9.5 3.1 13.0 28.8 7.6 39.9 12.0 15.9 14.6 15.8 25.5 6.1 7.9 5.7 12.9 13.9 15.3 13.2 15.6 16.2 3.9 13.5 11.2 4.6 15.5 10.6 12.7 14.7 6.5 3.5 13.8 8.6 2.9 7.7 59.5 6.4 9.2 26.2 6.7 4.6 9.3 5.8 9.9 6.7 1.5 5.1 8.3 7.9 3.0 15.0 18.9 15.3 29.4 9.7 12.4 3.8 8.0 7.0 10.7 8.3 7.2 13.6 2.2 14.7 12.4 8.0 7.7 9.2 7.4 3.5 7.6 0.7 9.6 6.3 9.1 5.3 3.1 9.9 8.2 16.1 4.3 8.6 6.2 1.4 8.8 46.9 11.5 6.2 11.3 9.9 9.4 8.9 2.3 17.7 8.1 12.8 22.7 18.1 11.3 7.4 12.0 2.9 7.5 18.4 15.7 42.0 11.0 1.3 7.1 4.7 14.6 1.2 10.6 1.0 1.2 1.5 6.5 2.0 6.7 9.9 7.9 5.9 2.3 9.3 7.0 6.8 1.1 8.3 5.1 6.7 3.1 3.0 18.1 19.9 4.8 17.1 14.6 15.8 12.9 13.9 13.5 6.4 IFT27 "BBS19, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018418 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA018418: AB_1856029" "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favourable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favourable (5.55e-4)" 10.9 17.0 21.1 12.7 27.4 8.5 9.2 13.4 20.6 14.9 12.8 15.8 21.9 13.4 12.5 22.1 10.9 40.5 13.0 18.5 19.3 20.6 16.4 17.4 10.2 9.5 19.4 16.4 14.9 17.6 20.9 30.2 8.9 20.0 16.4 11.0 16.1 15.4 19.6 14.7 9.6 12.9 9.9 17.4 9.3 13.7 20.1 14.5 18.6 23.2 6.0 9.8 11.0 11.8 17.7 27.0 23.3 22.6 14.5 19.9 13.9 6.1 7.7 9.1 10.3 7.3 7.0 5.4 5.0 6.5 6.6 5.9 0.3 5.6 6.7 8.8 4.6 5.7 4.9 5.6 5.1 12.9 13.3 1.8 1.6 0.0 13.5 2.1 8.4 5.7 9.2 7.0 3.2 6.9 3.1 5.6 4.4 11.3 2.6 1.8 4.9 10.1 12.7 0.0 3.7 6.5 4.0 8.8 9.6 5.3 4.1 12.6 9.2 3.8 4.1 59.5 3.4 7.6 0.9 13.2 8.0 2.4 9.2 5.4 12.6 8.5 22.6 23.3 18.3 16.4 18.2 16.7 15.2 16.8 27.0 17.7 15.1 14.3 8.1 14.5 19.3 20.9 19.9 13.9 21.1 27.4 13.4 20.6 19.3 20.6 19.4 16.4 20.0 14.5 IFT43 "C14orf179, FLJ32173, MGC16028" ENSG00000119650 "Intraflagellar transport 43" Q96FT9 14 75902136-76084585 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003438 Approved Supported "Microtubules,Centriolar satellite" Microtubules "Centriolar satellite" "HPA003438: AB_1078327" "unprognostic (1.64e-2)" "unprognostic (5.75e-3)" "unprognostic (2.10e-1)" "unprognostic (1.81e-3)" "unprognostic (1.48e-1)" "unprognostic (8.73e-2)" "unprognostic (1.53e-2)" "unprognostic (5.27e-2)" "unprognostic (8.87e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-2)" "unprognostic (9.78e-2)" "unprognostic (4.43e-2)" "unprognostic (2.51e-1)" "unprognostic (2.70e-2)" "unprognostic (1.75e-1)" "unprognostic (1.07e-2)" 13.9 16.0 17.1 10.2 21.2 3.4 18.5 11.6 17.8 19.2 18.1 17.9 18.1 16.2 20.0 36.8 12.7 46.0 17.2 28.9 14.9 14.4 22.3 30.7 12.9 7.3 12.8 13.8 15.3 24.2 15.4 27.9 15.0 16.8 17.5 14.2 19.8 12.7 23.0 8.2 9.2 21.6 20.1 11.5 12.2 13.7 23.5 13.5 9.8 25.6 7.5 11.7 15.5 11.9 21.9 15.2 19.5 11.6 10.9 19.5 10.4 12.1 13.7 10.0 15.4 12.6 20.5 7.1 8.0 15.3 12.2 12.4 5.1 12.5 1.3 8.8 14.0 12.9 9.4 14.7 13.9 6.3 9.3 0.6 7.9 0.0 35.6 1.3 2.9 18.1 16.1 13.5 17.8 18.8 3.3 5.5 14.7 24.4 4.9 2.1 5.2 17.6 3.2 8.1 3.8 28.0 10.7 9.7 11.7 15.7 10.9 10.8 28.0 3.6 8.6 7.2 9.1 10.5 6.9 7.3 6.3 1.5 28.4 0.5 7.4 19.5 8.9 14.2 11.0 11.6 13.6 21.9 12.0 11.1 11.8 16.1 19.5 18.6 4.3 10.9 11.4 15.2 13.9 10.4 17.1 21.2 11.6 17.8 14.9 14.4 12.8 13.8 16.8 13.5 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222570 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 22.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favourable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favourable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.5 13.1 9.4 12.1 11.0 8.8 10.4 5.5 16.4 13.3 10.9 6.3 15.7 5.0 11.8 36.3 11.6 24.8 11.6 12.1 9.2 11.2 19.7 3.7 34.3 12.2 9.1 9.9 21.6 13.4 16.4 30.6 6.2 13.5 21.9 11.6 9.4 8.2 16.0 5.7 7.1 9.4 13.1 6.2 14.3 10.0 38.6 5.6 8.3 31.3 7.4 12.2 14.1 9.1 22.4 5.8 1.8 6.7 3.6 4.7 2.9 18.6 9.7 7.0 12.5 14.7 15.2 3.9 5.7 14.0 8.5 7.6 6.6 3.3 21.1 7.4 9.5 7.5 6.2 9.5 14.5 3.3 6.7 7.2 4.3 1.7 11.0 14.9 16.7 9.2 8.9 10.9 19.0 9.5 3.3 3.8 9.6 10.4 4.9 13.7 7.5 11.5 3.2 6.3 3.6 17.4 6.8 11.6 8.1 8.6 2.8 5.2 6.1 4.6 4.0 10.9 5.6 5.7 6.7 4.5 3.2 11.1 15.8 1.5 4.0 0.1 2.1 1.8 2.2 3.6 3.6 22.4 4.7 2.8 5.8 18.6 4.1 2.3 1.1 3.6 6.7 1.2 2.9 2.9 9.4 11.0 5.5 16.4 9.2 11.2 9.1 9.9 13.5 5.6 IFT81 "CDV-1R, CDV1, MGC4027" ENSG00000122970 "Intraflagellar transport 81" Q8WYA0 12 110124335-110218797 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019087, HPA020051" Enhanced Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA019087: AB_1851462, HPA020051: AB_1851465" "unprognostic (2.54e-1)" "unprognostic (1.47e-1)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "unprognostic (9.79e-2)" "unprognostic (1.10e-1)" "unprognostic (7.95e-2)" "unprognostic (3.91e-1)" "unprognostic (3.21e-1)" "unprognostic (1.40e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (1.88e-1)" "unprognostic (2.45e-1)" 5.3 9.6 8.9 4.6 13.2 1.7 9.2 14.4 11.9 12.6 11.5 6.6 18.8 3.0 14.9 19.6 6.4 18.8 8.9 7.3 8.9 8.5 10.0 4.4 8.5 3.0 5.9 8.4 14.7 5.1 21.8 30.4 5.2 10.7 13.7 6.2 11.8 8.9 15.5 6.4 5.9 4.6 17.7 8.5 4.0 7.4 29.8 8.4 6.2 14.3 5.4 3.1 13.5 10.4 1.8 3.5 3.0 1.3 2.1 1.9 1.3 7.3 13.9 28.7 12.1 5.3 10.9 2.1 4.7 7.2 10.1 8.7 2.6 4.1 2.4 2.6 8.9 6.5 10.5 5.5 13.2 3.0 5.7 5.0 8.2 4.3 4.5 3.1 2.4 7.8 6.2 9.5 2.4 6.3 6.1 1.3 9.3 1.5 6.3 5.2 14.1 4.6 7.4 7.5 3.2 12.6 4.9 17.8 19.8 12.7 2.7 19.0 14.4 4.7 4.2 5.7 3.0 4.7 4.3 4.2 4.1 3.3 13.8 3.9 6.4 0.3 1.3 0.6 0.7 0.8 1.9 1.6 1.7 0.8 3.5 1.8 1.5 0.7 3.0 2.1 1.0 3.5 0.7 1.3 8.9 13.2 14.4 11.9 8.9 8.5 5.9 8.4 10.7 8.4 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Group enriched" "Detected in some" 5 "AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell line enhanced" "Detected in some" "A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.6 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Cell line enhanced" "Detected in some" "CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: , HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favourable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 14.9 0.1 0.4 0.0 112.8 0.0 0.0 1.1 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 77.4 19.8 0.0 0.0 24.1 0.0 0.1 0.0 0.1 0.0 0.0 44.5 0.2 0.0 0.1 0.1 0.2 0.0 55.3 0.1 0.0 0.1 4.4 67.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969099-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 59.6;hTERT-HME1: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" 150000000 "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavourable (3.01e-4)" "prognostic unfavourable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (6.08e-4)" 28.0 22.2 6.8 13.5 8.1 16.7 39.4 6.4 8.2 14.9 17.3 9.5 13.0 9.4 19.6 16.0 16.7 13.1 17.9 27.9 6.7 6.2 20.6 26.6 32.6 44.7 12.3 3.6 18.0 19.6 23.5 13.6 15.5 10.0 14.1 13.3 13.9 18.2 13.5 62.0 15.9 15.4 16.5 7.6 30.2 14.4 13.8 9.0 37.9 18.5 17.3 14.1 16.3 26.9 0.4 2.9 13.3 2.0 1.0 3.6 0.9 7.7 7.0 12.4 17.4 45.3 25.0 16.8 12.2 26.4 10.1 17.4 10.6 12.2 3.2 13.7 13.4 10.4 9.3 59.6 17.0 16.8 6.6 1.4 12.2 19.1 26.8 7.4 12.1 19.9 19.1 21.0 60.7 6.5 13.9 17.4 15.9 5.7 3.4 7.4 5.5 7.5 8.0 8.5 16.3 14.3 7.8 4.1 9.1 16.5 14.8 16.5 6.2 21.0 9.8 9.8 10.3 21.1 22.3 10.3 14.4 3.3 18.9 10.2 15.1 0.1 2.0 1.1 3.6 0.8 1.4 0.3 1.2 1.7 0.3 0.4 1.0 2.4 13.3 1.0 1.4 2.9 0.7 0.9 6.8 8.1 6.4 8.2 6.7 6.2 12.3 3.6 10.0 9.0 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 3247666667 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavourable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavourable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.3 2.8 5.5 0.0 4.2 1.7 0.0 41.2 7.5 3.5 1.9 0.0 7.6 0.0 13.1 412.2 22.6 0.0 0.1 1.4 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.4 0.6 0.7 2.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.5 0.0 0.0 3.8 2.6 20.4 0.6 1.6 14.2 0.5 0.7 0.0 0.0 0.0 40.7 0.0 171.0 2.3 0.5 0.0 0.0 88.5 0.0 13.7 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695525 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 245.3" "Cell line enhanced" "Detected in many" "BJ: 77.9;BJ hTERT+: 207.2;T-47d: 50.4;U-138 MG: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" 109650000 330000000 "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: , HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 47.3 23.4 6.2 19.2 6.3 0.1 41.3 3.6 6.5 191.7 23.1 19.7 15.8 3.9 94.6 91.0 30.0 96.9 21.4 16.9 8.2 2.4 34.8 7.8 9.3 14.5 12.1 7.4 245.3 3.5 6.5 37.7 32.7 7.0 31.4 7.9 188.5 12.0 15.1 47.0 13.5 14.2 71.8 7.4 7.6 36.9 51.7 12.0 1.5 130.1 34.5 17.6 28.8 45.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.1 0.0 23.2 0.7 0.0 77.9 207.2 10.4 1.0 0.0 0.0 0.0 0.3 0.2 0.0 2.4 0.0 0.5 0.0 0.7 20.0 0.4 0.0 10.1 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.2 0.3 0.0 0.0 0.1 6.7 23.1 1.3 0.8 1.3 9.6 0.0 50.4 0.0 7.5 68.7 4.2 10.4 3.7 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.2 6.3 3.6 6.5 8.2 2.4 12.1 7.4 7.0 12.0 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 68.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 18.7 0.1 0.0 19.5 0.1 0.0 0.0 70.0 67.9 1.1 0.0 0.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell line enriched" "Detected in single" 42 "CACO-2: 42.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" Nucleoplasm "Plasma membrane" "HPA059137: " "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Group enriched" "Detected in some" 5 "HeLa: 25.0;HL-60: 12.1;REH: 9.0;RPMI-8226: 29.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA012921 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Secreted - unknown location" 280000 "Intermediate filaments" Nucleoplasm "HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.2 3.9 25.0 0.0 0.9 12.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 29.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Cell line enhanced" "Detected in some" "A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 5.9 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 25.6 0.5 0.1 0.0 0.0 1.0 0.0 0.0 8.9 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA051811: , HPA054591: " "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.6 0.0 0.6 13.7 0.4 0.0 1.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.3 2.2 0.0 0.3 0.0 2.5 0.4 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Cell line enhanced" "Detected in many" "HDLM-2: 61.2;WM-115: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036305: , HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favourable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.3 9.1 7.0 1.7 1.6 3.4 18.9 0.0 0.2 0.7 0.2 5.2 3.0 0.0 2.8 0.0 14.9 3.1 7.3 0.3 61.2 2.3 2.9 3.5 0.1 0.0 0.2 5.5 0.4 5.8 0.0 1.3 0.0 0.8 0.0 0.1 18.7 0.2 0.1 4.4 0.2 2.1 8.6 0.0 5.4 6.7 4.1 12.5 2.2 21.0 13.5 7.0 0.3 0.0 1.2 4.2 0.0 5.5 0.0 0.3 0.0 0.5 0.1 59.0 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell line enhanced" "Detected in many" "MOLT-4: 19.2;RT4: 18.3;U-698: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.8 0.6 3.5 0.2 11.5 11.6 2.2 2.2 2.5 0.5 1.1 0.9 3.0 2.3 2.9 1.3 4.2 0.0 1.1 1.8 0.0 0.6 1.2 2.3 0.3 0.1 5.5 0.4 11.3 1.0 0.0 0.3 0.0 0.7 2.0 1.0 3.3 19.2 5.6 0.7 0.5 11.4 2.3 0.0 1.0 18.3 1.1 0.6 0.0 2.3 0.0 3.1 0.6 5.9 3.3 2.5 1.5 0.4 3.9 1.2 13.2 1.6 0.0 0.7 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757715-39864188 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;lymphoid tissue: 55.1" "Group enriched" "Detected in some" 4 "Daudi: 26.5;Karpas-707: 14.0;U-266/70: 16.9;U-266/84: 18.8;U-698: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.3;T-cells: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024377, HPA073266" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favourable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favourable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favourable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavourable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.7 0.7 0.5 41.7 0.5 3.1 1.0 0.5 0.5 1.1 4.5 0.0 0.6 1.8 1.2 0.6 3.6 1.2 2.4 0.9 0.6 0.6 1.5 1.4 5.3 30.5 0.6 0.0 0.9 0.9 0.0 0.7 0.4 0.1 1.5 1.7 1.2 5.5 1.3 0.6 0.8 11.3 1.2 0.9 41.0 3.3 2.6 0.1 55.1 1.6 1.8 54.1 4.0 1.3 8.3 0.3 0.7 0.1 2.6 17.7 4.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 26.5 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 14.0 0.0 0.1 2.3 0.9 0.1 0.0 0.1 0.1 4.8 0.0 1.6 0.1 0.1 0.5 0.2 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 16.9 18.8 43.1 0.0 0.1 0.0 0.5 0.1 0.4 16.3 0.1 17.7 8.3 6.7 12.1 0.0 7.7 2.8 7.5 0.7 2.6 0.1 0.3 10.6 4.1 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.0 0.1 0.1 IKZF4 "Eos, ZNFN1A4" ENSG00000123411 "IKAROS family zinc finger 4" Q9H2S9 12 56007659-56038435 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.3;T-reg: 5.3" "Lineage enriched" "Detected in single" 13 "T-cells: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046270, HPA049016" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046270: , HPA049016: " "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (1.34e-1)" "unprognostic (8.95e-3)" "unprognostic (5.67e-2)" "unprognostic (2.08e-2)" "unprognostic (3.63e-3)" "prognostic favourable (3.46e-4)" "unprognostic (2.42e-1)" "unprognostic (5.43e-2)" "prognostic favourable (4.37e-4)" "unprognostic (6.52e-2)" "unprognostic (7.97e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (9.98e-3)" "unprognostic (7.74e-3)" 5.6 14.5 7.7 7.4 8.5 6.7 8.1 13.9 7.6 7.2 6.9 6.5 7.1 3.4 7.7 8.5 4.1 10.0 5.9 5.6 6.3 6.3 5.6 4.1 7.3 4.2 5.9 9.8 16.2 5.7 20.8 22.1 5.9 9.2 8.1 4.3 9.2 3.7 8.6 16.8 4.1 4.5 10.8 8.4 4.1 5.7 9.1 5.9 5.2 8.8 4.5 4.5 6.4 14.0 0.3 0.3 0.0 0.4 0.1 5.3 0.3 1.2 1.5 9.0 3.0 1.9 2.0 2.1 1.4 2.4 1.7 2.4 4.6 1.9 0.8 1.6 2.2 0.8 1.1 1.2 3.7 27.6 1.4 5.1 1.5 2.2 2.1 2.4 2.1 3.3 1.7 1.7 1.4 1.7 8.0 4.4 2.7 1.5 3.0 1.2 3.9 1.1 2.6 2.5 1.0 2.4 1.4 3.5 2.9 1.9 0.6 3.2 2.3 2.5 0.9 1.4 2.5 1.4 1.1 2.7 1.6 1.3 2.9 2.4 1.9 0.0 0.3 0.0 0.3 0.3 0.5 0.3 1.3 0.0 0.2 0.2 0.3 0.4 0.0 0.1 0.4 0.3 5.3 0.3 7.7 8.5 13.9 7.6 6.3 6.3 5.9 9.8 9.2 5.9 IKZF5 "FLJ22973, Pegasus, ZNFN1A5" ENSG00000095574 "IKAROS family zinc finger 5" Q9H5V7 10 122990806-123008817 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015297, HPA051574" Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA015297: AB_1855183, HPA051574: " "unprognostic (2.42e-1)" "unprognostic (1.08e-1)" "unprognostic (4.64e-2)" "unprognostic (2.76e-2)" "unprognostic (1.44e-2)" "unprognostic (1.66e-3)" "unprognostic (2.68e-1)" "unprognostic (9.14e-3)" "unprognostic (5.43e-2)" "unprognostic (2.99e-1)" "unprognostic (6.88e-2)" "unprognostic (1.63e-2)" "unprognostic (3.98e-3)" "unprognostic (4.17e-2)" "unprognostic (6.03e-2)" "unprognostic (6.96e-2)" "unprognostic (3.15e-2)" 11.7 11.7 20.3 9.2 23.5 38.0 16.6 24.9 20.5 12.0 9.2 22.1 7.5 8.8 12.5 13.6 9.4 9.9 8.4 9.4 18.0 14.5 11.8 14.7 10.6 13.4 28.9 13.5 19.3 14.8 14.2 22.9 10.7 21.2 11.6 9.8 11.2 10.6 8.8 12.3 13.7 10.8 9.8 21.8 11.6 9.9 13.4 26.8 14.7 13.6 7.0 12.4 9.4 11.1 7.6 6.7 8.2 8.0 9.7 13.4 6.7 5.9 3.0 6.0 10.2 9.7 8.9 6.6 5.0 10.8 6.7 8.2 4.8 7.0 15.0 3.7 6.1 8.2 10.6 7.5 9.9 8.4 9.4 9.6 4.9 7.1 6.5 11.6 8.8 7.0 10.4 8.0 17.4 7.3 13.1 10.1 7.2 4.3 10.5 12.7 5.5 4.2 8.6 7.5 8.6 5.5 4.1 6.6 5.9 4.2 5.1 9.7 4.2 7.5 7.5 4.9 4.1 7.1 8.0 9.4 5.1 14.2 6.2 20.4 2.9 7.5 6.3 8.2 9.4 8.0 10.9 6.2 8.6 9.0 6.7 7.6 11.9 13.4 6.1 9.7 7.7 4.7 10.9 6.7 20.3 23.5 24.9 20.5 18.0 14.5 28.9 13.5 21.2 26.8 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Cell line enriched" "Detected in single" 177 "HDLM-2: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" 33773 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.2 4.9 13.4 11.1 33.1 8.8 17.3 24.1 8.3 10.8 5.9 15.3 0.0 30.5 23.8 7.9 5.3 7.3 9.2 45.1 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 13.9 17.2 4.4 0.9 11.7 12.1 0.0 2.2 4.4 9.9 0.0 12.0 0.0 12.4 9.0 1.8 1.7 27.2 10.0 6.8 6.4 7.8 21.9 16.2 7.7 27.2 13.5 0.2 4.1 0.0 35.7 4.2 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Group enriched" "Detected in some" 9 "PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 0.0 3.0 0.0 84.9 57.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 IL15 "IL-15, MGC9721" ENSG00000164136 "Interleukin 15" P40933 4 141636599-141733987 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.5;Karpas-707: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB004457, HPA037738" Approved Supported "Nucleoplasm,Nuclear speckles" "Secreted to blood" 20753 "Nucleoplasm, Nuclear speckles" "CAB004457: AB_2124575, HPA037738: " "unprognostic (1.10e-2)" "unprognostic (1.53e-1)" "unprognostic (1.04e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-3)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (2.90e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (5.20e-2)" "unprognostic (1.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.09e-1)" "unprognostic (4.03e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" 7.7 3.7 1.1 21.3 1.5 2.9 9.2 1.8 2.2 6.0 8.8 0.8 2.2 6.3 11.3 7.4 5.6 4.6 9.9 9.3 1.1 1.5 6.9 3.7 14.4 18.8 2.3 1.6 3.2 3.1 0.5 4.5 9.9 2.1 7.7 5.7 5.9 6.9 3.6 9.1 3.2 14.2 7.1 2.6 17.0 5.3 2.6 2.0 9.8 18.1 5.9 11.0 9.8 16.9 3.7 4.6 8.1 14.0 2.6 4.5 4.4 2.4 5.2 0.2 0.5 0.8 4.7 1.3 5.6 5.3 5.8 4.7 2.8 6.8 2.3 7.3 4.8 3.6 0.1 3.0 3.2 15.5 1.4 0.4 13.7 0.4 3.9 1.6 1.1 1.7 1.2 3.8 0.4 3.7 3.8 15.2 3.7 0.8 3.4 0.3 2.6 1.6 0.9 13.4 0.3 7.6 0.6 0.5 1.3 2.4 3.7 2.7 0.9 0.2 5.5 5.9 3.8 1.7 3.4 10.7 1.3 0.7 6.3 0.6 2.1 8.1 14.0 0.8 2.5 12.4 4.5 3.7 2.9 2.2 4.6 3.4 1.2 1.3 1.0 2.6 12.5 0.1 1.5 4.4 1.1 1.5 1.8 2.2 1.1 1.5 2.3 1.6 2.1 2.0 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell line enhanced" "Detected in some" "Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 38 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Midbody ring,Cytosol" "Secreted to blood" 125370 14000 "Nuclear speckles" "Plasma membrane, Midbody ring, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.9 0.0 0.0 0.4 9.1 23.3 0.4 0.0 0.0 0.2 0.1 1.3 4.9 0.0 0.0 0.7 9.7 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 2.0 0.1 0.1 0.1 0.4 0.0 27.7 2.3 11.4 0.8 15.5 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell line enhanced" "Detected in many" "HL-60: 27.0;NB-4: 23.7;THP-1: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favourable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.4 3.8 2.2 2.4 5.3 3.5 2.5 3.2 2.0 2.4 3.3 2.2 5.3 5.8 2.6 2.5 1.8 5.3 3.1 0.0 1.2 1.2 4.4 27.0 8.4 3.3 3.7 2.2 1.7 2.7 1.4 3.4 2.5 3.0 3.2 23.7 1.0 2.0 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.7 3.2 2.6 2.5 34.1 7.4 2.0 2.8 2.9 1.9 2.8 1.5 1.6 2.8 13.1 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.4;AN3-CA: 28.1;NTERA-2: 16.2;SH-SY5Y: 42.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039577: , HPA043550: " "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favourable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 2.7 1.3 5.2 1.8 6.5 0.4 8.9 2.8 6.1 14.7 7.7 7.6 7.4 0.9 18.5 13.7 3.4 8.4 6.1 3.0 4.8 3.6 7.1 0.5 1.1 0.7 4.0 2.4 12.6 1.4 20.8 14.0 0.7 5.7 8.1 2.5 10.2 7.2 10.8 1.0 2.6 1.8 14.7 7.2 3.1 2.2 11.2 3.1 0.0 1.0 2.2 1.4 8.9 5.2 0.6 0.6 1.5 0.5 0.6 0.4 0.0 1.5 0.3 10.4 28.1 0.0 0.2 1.7 0.1 0.1 0.1 0.3 0.2 0.7 0.0 0.0 0.5 0.1 2.0 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.2 0.4 0.0 0.0 0.5 0.2 0.0 0.0 16.2 0.8 0.0 3.7 0.0 2.1 0.4 0.2 42.7 0.4 0.6 1.2 0.3 0.0 0.3 0.5 0.7 0.5 1.6 0.0 0.0 0.0 0.2 0.0 0.7 1.4 0.5 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.6 0.4 0.4 1.5 0.6 0.3 0.6 0.3 0.0 5.2 6.5 2.8 4.0 4.8 3.6 4.0 2.4 5.7 3.1 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell line enhanced" "Detected in many" "A-431: 26.0;CAPAN-2: 41.2;HaCaT: 37.8;HBEC3-KT: 28.4;hTCEpi: 43.5;PC-3: 25.2;U-2 OS: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" 136427 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favourable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.0 9.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.0 41.2 0.0 6.0 0.0 37.8 0.0 28.4 0.0 0.0 0.2 3.9 9.3 2.1 0.9 2.0 7.6 0.0 43.5 0.0 10.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 25.2 0.0 0.0 0.0 18.6 5.6 0.0 0.0 17.9 11.9 0.1 7.1 5.7 0.0 0.1 49.0 0.3 8.0 0.1 0.0 0.1 0.0 15.1 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: " "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 93.4 41.7 0.6 3.9 17.7 2.8 4.2 0.8 0.4 0.0 2.9 7.8 0.7 0.0 0.3 2.3 7.7 0.0 0.1 0.4 4.3 29.3 0.0 0.0 115.0 0.3 3.1 0.7 1.2 0.4 0.1 4.0 0.7 0.0 0.1 0.1 0.1 0.0 0.2 0.0 2.6 1.9 0.0 0.0 1.7 1.1 0.0 1.6 0.1 0.0 8.0 0.5 13.4 0.3 0.0 0.0 0.0 3.1 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.8 1.0 1.6 0.2 2.8 2.3 3.0 1.7 3.5 4.0 3.9 1.6 8.6 0.6 17.9 4.7 10.0 0.8 16.7 5.6 0.7 1.0 0.8 1.7 4.1 6.0 5.7 2.8 3.1 6.9 5.8 18.5 1.7 0.1 0.0 1.8 1.8 0.4 2.6 2.5 1.8 2.7 2.5 1.3 1.5 4.1 0.3 0.0 7.8 4.4 71.2 2.8 4.1 2.3 3.1 3.2 9.5 7.8 1.4 0.0 0.1 5.2 5.1 18.2 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Group enriched" "Detected in some" 6 "HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" 19074133 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 3.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.5 0.1 0.1 54.1 0.4 80.5 1.1 0.3 1.3 8.7 39.3 0.1 0.1 0.1 0.0 0.1 1.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell line enhanced" "Detected in some" "A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" 421933 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavourable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavourable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.2 0.1 0.1 0.0 40.8 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.1 7.7 0.0 5.3 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 0.3 0.0 0.0 11.5 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.0 3.9 4.6 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Cell line enriched" "Detected in some" 4 "hTCEpi: 104.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol Vesicles Cytosol "HPA063914: " "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.8 0.0 0.0 0.0 2.9 12.6 0.4 0.1 0.3 0.0 0.1 0.4 0.5 0.0 2.7 1.7 15.7 0.0 25.8 0.1 0.0 0.0 0.0 3.2 0.0 17.4 0.0 0.0 2.1 104.1 0.8 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 10.1;HDLM-2: 42.9;Karpas-707: 19.9;RH-30: 15.1;RPMI-8226: 24.0;U-266/70: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favourable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.1 0.1 0.8 0.0 0.0 0.0 0.0 42.9 0.0 2.1 0.0 0.2 1.4 0.0 0.6 1.5 0.0 2.7 0.0 0.0 0.1 19.9 1.5 0.0 0.0 0.2 0.3 0.0 0.1 15.1 24.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 1.1 0.8 0.2 0.2 0.0 10.0 3.5 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051532: , HPA068114: " "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.1 1.1 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 8.9 1.8 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 6.0 3.0 4.3 10.8 3.3 0.0 0.4 1.4 0.0 0.0 1.4 0.0 6.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.5 0.5 16.0 0.0 1.0 0.0 0.0 0.0 18.5 0.0 2.5 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 55.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.8;PC-3: 10.4;RT4: 5.5" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Cell type enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" 76703 "Nucleoplasm, Vesicles" "HPA054371: , HPA057950: " "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.8 0.1 0.0 0.0 0.2 0.4 4.8 0.3 0.5 0.4 0.5 0.0 0.5 0.3 0.1 0.2 0.8 1.5 0.3 0.0 1.8 0.2 0.8 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.1 1.1 0.0 0.0 1.4 0.5 10.4 0.1 0.0 0.0 0.0 5.5 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell line enhanced" "Detected in some" "EFO-21: 17.6;HDLM-2: 30.5;Karpas-707: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.7 1.0 0.3 1.0 1.7 17.6 0.2 0.3 0.2 0.0 0.1 30.5 0.1 0.8 0.0 0.2 0.1 0.6 6.3 0.5 0.2 0.3 0.0 1.3 0.1 24.7 0.0 0.2 0.3 1.0 0.2 0.1 0.5 0.5 1.7 1.2 1.5 0.3 0.4 0.2 0.4 0.3 0.2 1.4 1.5 3.7 0.5 0.0 0.5 2.1 4.6 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 35.8;HBEC3-KT: 34.4;U-698: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" 49000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "CAB004451: AB_626889, HPA050124: , HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favourable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.3 3.0 1.9 3.9 0.9 4.5 4.1 7.2 8.3 2.9 2.3 6.1 31.4 35.8 9.0 11.3 12.1 2.1 34.4 2.5 31.0 1.0 6.7 1.8 9.3 13.0 1.8 19.1 6.9 13.9 13.2 7.9 15.4 2.9 3.0 4.6 5.0 0.1 5.4 2.4 2.6 0.1 14.9 2.9 13.3 13.0 0.6 0.3 1.0 6.9 1.5 2.6 6.9 23.0 6.5 2.9 5.8 5.0 1.8 0.5 33.3 0.7 6.0 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 IL6ST "CD130, GP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55994993 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.0;BJ hTERT+: 58.0;HHSteC: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 21.0" "Lineage enriched" "Detected in many" 5 "T-cells: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" 100000000 "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 44.8 34.2 24.7 25.5 23.4 8.8 76.9 15.9 22.9 38.1 23.9 15.0 29.0 8.7 26.1 24.9 22.7 23.1 31.1 31.9 21.9 19.7 37.2 71.2 36.3 70.0 25.8 14.7 42.1 16.4 35.8 36.2 97.0 22.5 31.9 17.1 20.0 26.3 33.0 27.1 12.5 20.6 36.6 33.8 35.5 19.7 13.7 20.3 19.4 37.6 12.5 18.7 33.7 51.1 0.7 2.1 0.9 3.8 0.8 21.0 4.0 9.4 11.8 3.8 9.1 27.3 57.0 15.8 28.2 58.0 15.2 22.7 16.5 9.0 0.3 21.1 17.4 4.1 3.0 8.4 31.2 0.8 3.0 2.2 9.7 13.6 64.9 0.2 4.5 49.9 4.6 33.0 16.1 34.7 1.6 39.8 17.5 1.6 0.4 0.4 0.6 3.9 0.5 10.7 5.4 8.3 5.6 2.0 3.4 11.4 3.8 11.6 19.0 1.5 55.7 5.9 6.7 23.8 14.8 9.8 4.2 0.3 15.8 0.4 15.3 0.2 3.8 0.1 0.8 3.5 0.4 0.7 4.9 0.8 2.1 0.6 21.0 5.9 0.9 0.8 0.6 1.8 3.4 4.0 24.7 23.4 15.9 22.9 21.9 19.7 25.8 14.7 22.5 20.3 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Cell line enhanced" "Detected in many" "BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" CAB010215 Supported "Plasma membrane,Centriolar satellite" "Intracellular and membrane" 180000 "Plasma membrane, Centriolar satellite" "CAB010215: AB_673727" "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 21.7 11.0 19.6 11.6 0.1 0.1 2.1 0.0 40.7 3.5 0.0 1.3 37.4 1.8 0.2 0.6 2.3 0.0 0.3 0.1 1.5 0.3 0.0 4.2 0.9 0.5 0.1 0.3 15.4 0.0 0.5 0.2 0.1 1.0 84.6 1.1 0.1 0.0 1.2 0.0 0.0 3.6 0.3 0.0 0.1 0.0 1.5 7.7 13.1 3.3 2.8 0.1 0.0 2.4 3.9 2.0 5.9 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Supported Nucleoplasm,Nucleoli,Mitochondria 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavourable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavourable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.4 37.0 60.0 54.9 13.0 17.9 34.9 29.1 24.7 48.9 38.3 42.4 26.4 56.8 29.0 26.1 40.8 64.8 39.3 44.1 36.3 57.7 73.7 32.7 39.5 18.7 53.0 36.8 16.9 17.6 38.8 43.5 41.7 62.9 44.7 28.4 37.4 87.9 85.3 72.0 40.7 64.8 57.2 39.3 19.4 48.3 66.3 48.2 37.5 29.8 21.6 25.2 34.1 33.4 40.1 38.2 41.5 57.4 38.4 52.4 69.0 22.4 56.7 43.2 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Cell Junctions,Focal adhesion sites" 130000000 "Cell Junctions, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: " "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favourable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 20.9 17.6 11.0 22.3 11.9 7.5 37.0 9.4 14.6 40.2 75.1 14.7 41.9 13.5 75.4 25.2 35.7 33.2 41.1 35.1 11.1 9.2 21.6 15.1 21.9 18.9 11.5 14.0 24.2 22.3 20.4 10.9 22.2 11.5 39.9 24.6 19.3 19.4 89.9 18.5 12.4 22.2 103.5 10.6 20.2 33.2 14.2 11.0 8.2 17.5 14.1 13.6 60.8 25.9 19.5 45.9 76.5 49.4 45.3 25.8 63.7 23.8 18.4 29.1 10.0 44.9 31.9 13.2 35.1 69.4 41.6 50.8 19.2 28.1 9.0 9.3 57.4 19.2 16.2 29.7 41.8 15.7 14.8 12.9 17.6 14.9 30.1 10.3 14.8 30.6 14.0 28.1 21.5 39.6 11.8 10.7 54.2 17.9 9.1 17.7 18.3 21.6 9.6 15.2 9.5 30.5 19.1 5.0 11.4 16.6 23.0 19.3 16.0 11.8 45.8 52.2 23.6 21.6 17.0 7.8 4.8 12.6 38.7 15.6 24.3 48.3 49.4 76.5 25.8 47.9 25.1 19.5 23.3 24.4 45.9 17.1 14.7 18.5 31.7 45.3 44.4 18.5 25.7 63.7 11.0 11.9 9.4 14.6 11.1 9.2 11.5 14.0 11.5 11.0 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125785 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA067682: " "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 13.7 22.1 10.4 8.3 13.6 7.7 12.1 12.4 18.9 11.5 34.9 21.3 16.7 29.1 13.4 11.1 18.9 13.8 24.8 32.9 10.5 9.7 24.9 34.8 10.0 13.2 18.5 9.2 15.9 24.7 21.1 16.5 35.9 14.0 11.1 11.0 29.4 16.1 14.9 10.0 19.4 26.8 10.9 14.3 8.3 18.2 14.7 17.7 10.0 28.6 16.7 12.2 14.8 14.5 9.8 17.5 10.8 20.7 15.3 16.9 15.1 21.8 13.3 11.4 13.4 14.9 10.2 13.2 10.3 13.9 12.4 16.0 21.1 53.1 9.5 20.4 11.1 16.6 6.9 12.5 3.6 8.7 13.5 13.9 13.6 23.0 23.9 11.7 12.3 15.2 14.6 7.2 9.5 11.5 5.6 12.4 9.6 50.7 7.8 9.4 10.5 19.4 11.4 10.3 14.8 10.8 10.9 9.5 12.8 6.1 26.8 20.2 12.3 10.1 12.2 18.8 10.4 23.6 14.4 8.7 8.9 4.7 12.0 11.5 14.1 10.8 14.8 3.5 15.1 20.7 16.9 8.6 12.6 15.4 17.5 9.8 16.7 16.9 1.6 15.3 18.7 12.7 12.9 15.1 10.4 13.6 12.4 18.9 10.5 9.7 18.5 9.2 14.0 17.7 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP3, U3 small nucleolar ribonucleoprotein" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA060955: , HPA061177: " "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 21.2 28.4 21.9 23.0 24.0 18.9 34.3 20.1 28.8 19.4 31.0 15.4 17.5 27.5 14.7 24.5 35.6 20.1 25.2 21.7 21.1 19.7 28.2 49.7 21.1 28.5 17.6 19.6 23.0 29.1 12.6 17.3 16.9 16.7 23.3 19.2 17.5 28.3 25.4 37.6 29.3 31.5 11.0 15.5 28.5 25.9 12.4 13.3 33.7 30.0 37.5 27.9 19.6 21.8 40.7 34.0 23.0 31.1 33.3 47.2 48.1 20.1 22.8 11.1 19.2 19.8 11.3 16.5 17.0 13.6 13.9 16.1 17.5 17.8 24.1 18.6 8.8 33.5 36.4 27.6 12.4 18.1 43.7 25.3 18.8 30.3 14.6 25.6 17.6 10.4 22.8 11.2 13.9 9.1 32.6 19.7 12.6 24.2 20.2 62.6 29.8 24.1 22.1 13.6 26.4 18.9 27.4 18.9 19.6 14.4 25.1 30.9 21.9 23.8 10.3 18.2 14.6 13.0 22.9 26.9 49.5 27.0 20.1 41.6 11.9 18.5 31.1 23.0 42.0 23.9 45.1 40.7 40.5 40.4 33.4 38.7 47.2 44.5 4.0 33.3 23.0 34.0 38.7 48.1 21.9 24.0 20.1 28.8 21.1 19.7 17.6 19.6 16.7 13.3 IMPA1 IMPA ENSG00000133731 "Inositol monophosphatase 1" P29218 8 81657961-81686693 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037489 Approved Approved Nucleoplasm,Mitochondria 390000 Mitochondria Nucleoplasm "HPA037489: AB_10671757" "unprognostic (1.78e-1)" "unprognostic (3.59e-2)" "unprognostic (6.95e-3)" "unprognostic (2.15e-3)" "unprognostic (1.31e-1)" "unprognostic (6.27e-2)" "unprognostic (3.80e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-1)" "unprognostic (4.68e-2)" "unprognostic (7.78e-2)" "unprognostic (6.26e-2)" "unprognostic (2.52e-2)" "unprognostic (5.87e-2)" "unprognostic (1.84e-1)" "unprognostic (2.42e-1)" "unprognostic (5.41e-3)" 10.8 10.9 16.2 10.5 20.9 20.8 9.2 11.2 29.7 9.4 22.4 15.3 4.7 20.1 10.8 12.0 17.2 10.3 11.0 22.3 17.6 19.7 25.5 29.4 9.8 14.3 18.9 20.7 12.1 8.5 8.6 20.1 7.2 27.3 10.6 25.4 14.8 8.9 7.3 11.2 5.0 23.5 15.0 19.1 12.9 12.2 30.5 13.8 16.2 20.3 12.0 13.7 10.5 10.7 13.2 8.2 24.1 7.5 13.6 12.9 7.2 5.7 15.8 11.0 8.3 6.4 10.2 4.5 16.6 12.0 14.9 18.0 7.4 9.1 21.8 13.3 11.8 4.4 12.7 5.7 20.1 22.8 13.0 16.4 8.7 9.2 11.6 16.4 16.8 9.7 8.3 11.4 22.6 16.2 14.8 18.5 14.9 3.6 20.8 9.5 4.7 16.9 9.8 8.3 8.9 17.2 18.6 4.5 19.0 10.9 2.9 19.9 9.5 13.2 12.5 12.3 15.7 9.5 20.5 21.7 25.8 30.5 14.3 9.9 16.8 24.1 4.7 19.5 9.9 6.6 12.1 13.2 10.1 10.7 5.0 9.5 10.7 12.6 7.5 13.6 7.5 8.2 12.9 7.2 16.2 20.9 11.2 29.7 17.6 19.7 18.9 20.7 27.3 13.8 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell line enhanced" "Detected in many" "BEWO: 67.4;RPTEC TERT1: 32.6;SiHa: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favourable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.9 10.8 2.9 5.2 3.8 2.8 67.4 1.8 4.8 0.8 1.1 8.6 5.6 1.5 4.3 2.6 4.8 3.4 1.8 0.2 8.2 4.2 0.0 14.2 7.4 2.2 11.9 0.6 6.4 9.7 2.6 1.3 1.0 1.7 0.0 2.8 7.0 4.8 6.3 10.2 8.2 8.2 8.1 7.1 32.6 3.9 3.9 0.0 40.7 9.2 3.9 8.7 14.9 0.0 1.5 2.8 19.9 1.8 5.6 14.8 4.1 6.4 8.0 2.5 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.1 14.3 11.0 11.3 33.9 23.3 15.2 26.1 25.4 18.7 16.4 7.1 12.2 10.7 20.0 27.7 14.1 13.3 17.6 27.9 14.7 9.5 20.9 10.1 12.7 21.1 13.2 14.9 18.7 17.7 16.8 27.4 24.8 9.0 19.5 20.5 9.1 16.1 8.0 8.2 5.3 11.3 9.9 12.1 19.5 10.2 4.3 12.0 14.6 18.1 14.8 16.1 9.7 20.7 25.4 14.7 25.0 18.7 20.2 16.8 11.5 34.8 11.1 15.6 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 IMPDH1 "LCA11, RP10, sWSS2608" ENSG00000106348 "Inosine monophosphate dehydrogenase 1" P20839 7 128392277-128410252 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 21.6;eosinophil: 20.2;intermediate monocyte: 26.2;myeloid DC: 15.1;neutrophil: 49.9;non-classical monocyte: 31.0" "Group enriched" "Detected in all" 5 "dendritic cells: 15.1;granulocytes: 49.9;monocytes: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001400 Approved Supported "Cytosol,Rods & Rings" Cytosol "Rods & Rings" "HPA001400: AB_1079139" "unprognostic (2.84e-1)" "prognostic unfavourable (3.87e-4)" "unprognostic (2.23e-2)" "unprognostic (6.45e-2)" "prognostic unfavourable (7.31e-5)" "unprognostic (6.03e-2)" "prognostic unfavourable (1.12e-7)" "unprognostic (1.24e-1)" "unprognostic (7.45e-3)" "unprognostic (1.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "prognostic unfavourable (1.78e-12)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "prognostic unfavourable (3.72e-5)" 26.0 7.4 7.5 20.7 8.5 24.5 37.1 7.7 10.2 11.3 10.9 3.6 12.4 5.2 8.5 6.5 14.6 9.1 7.6 12.6 7.6 5.0 7.5 3.5 14.8 31.2 5.1 5.8 10.7 20.3 5.2 12.0 7.2 9.9 12.1 6.3 19.5 20.6 11.4 3.5 11.9 8.8 12.3 6.4 25.1 20.6 7.1 5.6 3.9 5.5 11.2 9.7 14.2 9.9 4.1 15.1 49.9 31.0 2.8 6.4 11.7 25.1 21.6 3.2 24.2 13.7 10.0 9.2 17.2 10.9 14.8 9.6 15.7 8.1 16.0 5.9 25.6 19.3 18.3 24.3 7.4 5.8 20.4 10.6 16.0 11.1 12.5 13.9 5.0 11.8 11.6 15.0 14.9 17.4 10.5 12.1 4.9 17.3 9.7 37.4 18.3 25.4 11.7 6.0 33.2 6.5 8.1 13.0 13.1 11.1 88.5 15.6 10.0 27.0 15.9 24.9 9.1 13.0 12.2 9.1 8.4 20.6 12.7 30.9 15.1 2.3 21.6 20.2 5.9 26.2 6.4 4.1 4.7 5.1 15.1 2.4 2.8 3.4 49.9 2.8 31.0 1.5 5.2 11.7 7.5 8.5 7.7 10.2 7.6 5.0 5.1 5.8 9.9 5.6 IMPDH2 ENSG00000178035 "Inosine monophosphate dehydrogenase 2" P12268 3 49024325-49029408 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001400, CAB020717" Approved Enhanced "Cytosol,Rods & Rings" 19000 Cytosol "Rods & Rings" "CAB020717: , HPA001400: AB_1079139" "unprognostic (2.09e-2)" "unprognostic (2.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (7.31e-3)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.30e-1)" "unprognostic (2.65e-1)" "unprognostic (2.17e-1)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.30e-1)" "unprognostic (3.85e-1)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (4.47e-2)" 25.0 21.5 16.1 25.7 15.4 23.9 47.0 9.7 21.1 34.7 24.9 15.1 19.1 18.9 29.5 19.8 40.1 51.9 33.3 29.3 13.0 11.2 21.4 29.4 19.9 52.5 18.1 13.0 89.0 88.8 19.1 16.6 23.2 15.6 33.2 31.7 10.8 22.1 22.2 61.4 40.7 17.8 34.1 15.2 23.7 22.2 15.3 15.4 31.2 29.8 51.3 33.4 30.3 32.1 31.6 18.8 6.2 16.8 21.6 34.8 16.0 39.6 22.9 31.8 32.8 47.6 86.9 30.9 27.5 44.6 66.4 56.6 39.8 35.8 72.4 19.7 33.1 27.7 65.6 55.9 58.2 19.0 21.9 53.6 33.8 36.4 40.8 56.8 22.1 77.2 61.6 63.4 115.3 46.6 32.0 41.0 53.4 32.2 48.0 39.5 41.2 46.3 21.0 33.5 71.0 37.8 25.7 20.6 20.3 29.9 33.8 49.7 41.9 25.3 23.4 29.1 54.0 70.7 70.5 39.8 28.7 34.7 33.6 63.4 28.4 6.2 10.1 4.0 17.0 16.8 31.7 31.6 23.3 19.6 18.8 31.1 34.8 28.6 4.4 21.6 13.9 14.5 15.5 16.0 16.1 15.4 9.7 21.1 13.0 11.2 18.1 13.0 15.6 15.4 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell line enhanced" "Detected in many" "Daudi: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: " "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favourable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 3.9 4.5 3.2 3.0 2.2 0.9 3.8 4.3 0.4 1.1 1.2 3.2 4.7 18.8 2.9 1.1 11.2 0.5 0.2 0.7 7.8 4.8 4.0 5.4 2.1 1.5 0.6 10.0 1.2 0.0 0.6 0.3 0.4 5.1 8.9 0.8 2.0 5.7 1.3 1.4 1.2 7.0 1.6 1.7 0.8 1.2 9.6 2.9 2.1 2.7 2.5 5.6 0.9 8.6 4.0 1.5 3.9 3.2 1.5 0.7 0.9 4.0 10.0 2.0 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Midbody" "Nucleoplasm, Nuclear bodies, Midbody" "CAB013292: AB_2533405, HPA051339: , HPA070550: " "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (1.25e-4)" "prognostic unfavourable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavourable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 26.9 25.8 19.6 16.7 2.6 3.1 10.5 16.9 7.4 15.8 10.1 13.6 18.3 25.0 14.0 5.8 26.4 19.4 10.2 12.4 22.1 13.5 16.3 25.4 11.0 1.0 18.7 23.3 1.6 2.2 15.2 8.8 9.5 17.2 20.8 8.7 21.9 30.1 15.3 21.1 12.6 28.3 24.7 18.8 4.5 13.6 15.0 16.2 17.0 11.1 10.5 17.3 6.8 10.6 15.6 19.9 22.3 18.0 11.2 17.1 28.0 8.7 12.4 18.7 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 INF2 "C14orf151, C14orf173, MGC13251" ENSG00000203485 "Inverted formin, FH2 and WH2 domain containing" Q27J81 14 104689606-104722535 "Disease related genes, Predicted intracellular proteins" Actin-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 200.6" HPA000724 Approved Approved "Nuclear bodies,Endoplasmic reticulum" 15000000 "Endoplasmic reticulum" "Nuclear bodies" "HPA000724: AB_1078325" "unprognostic (1.42e-1)" "unprognostic (9.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.00e-2)" "unprognostic (1.49e-2)" "unprognostic (5.90e-3)" "prognostic unfavourable (8.18e-4)" "unprognostic (1.13e-2)" "unprognostic (9.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (1.36e-3)" "unprognostic (7.24e-2)" "unprognostic (4.01e-1)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.70e-2)" 34.7 13.1 14.4 17.8 49.9 12.7 20.2 4.4 37.9 13.3 27.0 70.2 6.1 43.1 12.8 6.3 12.5 9.3 26.5 14.1 19.7 12.6 17.9 21.3 22.2 15.0 66.2 22.5 7.7 14.8 4.1 4.7 28.0 28.5 13.2 13.2 18.8 15.4 16.3 10.0 23.9 36.5 10.7 36.8 24.4 48.2 18.1 54.6 3.2 11.7 9.8 9.1 16.8 15.5 3.1 11.0 2.3 3.3 2.0 5.3 4.8 17.2 35.2 3.2 7.8 6.5 8.4 46.5 19.0 9.9 10.5 7.8 12.8 38.7 2.5 21.1 13.5 26.2 3.9 18.6 4.0 7.3 9.5 8.9 24.2 12.7 13.5 2.8 8.6 7.9 10.5 10.0 6.9 12.4 4.3 8.8 9.8 39.0 3.3 7.0 7.9 37.6 14.6 10.5 6.8 13.1 23.5 9.0 4.2 15.4 29.3 9.9 10.0 6.4 21.9 13.2 9.2 25.3 10.6 3.1 1.4 1.3 22.7 7.8 14.2 1.3 3.3 0.2 1.6 1.1 0.8 3.1 5.3 1.1 4.1 3.1 4.4 2.9 2.3 2.0 0.7 11.0 5.3 4.8 14.4 49.9 4.4 37.9 19.7 12.6 66.2 22.5 28.5 54.6 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: " "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favourable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 11.8 11.1 8.9 11.7 10.2 24.9 19.8 12.8 12.1 15.7 14.9 6.9 9.5 13.9 16.3 8.3 10.7 13.7 20.0 9.5 9.4 9.0 9.3 16.7 14.1 20.5 11.6 8.0 25.8 11.8 3.8 9.5 13.3 11.7 13.3 6.6 9.5 13.6 10.9 12.2 8.5 13.6 11.1 10.2 17.6 10.0 26.0 12.0 22.0 11.5 8.3 10.6 18.3 14.8 15.5 3.0 21.4 3.7 12.3 11.6 6.1 17.4 6.9 12.5 12.0 5.9 4.1 12.5 9.0 7.6 5.9 7.1 13.2 12.4 11.2 14.7 3.5 11.0 5.0 4.4 4.9 21.1 9.6 9.9 9.5 9.8 3.3 13.0 9.6 3.7 4.7 5.1 3.1 4.1 9.1 9.5 3.8 10.0 22.5 15.1 12.3 5.8 16.4 6.4 6.3 5.1 9.0 12.3 13.3 8.9 17.9 12.3 6.0 15.5 6.1 7.2 8.9 7.5 10.0 11.5 11.5 14.3 12.1 10.8 11.8 21.4 2.9 11.1 10.8 3.6 11.1 14.8 9.1 9.7 2.8 15.5 9.4 7.8 4.0 12.3 3.7 3.0 11.6 6.1 8.9 10.2 12.8 12.1 9.4 9.0 11.6 8.0 11.7 12.0 ING2 "ING1L, p33ING2" ENSG00000168556 "Inhibitor of growth family member 2" Q9H160 4 183504994-183511096 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019486, HPA021517" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA019486: AB_1851780, HPA021517: AB_10601914" "prognostic favourable (5.43e-4)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (3.74e-2)" "unprognostic (3.89e-3)" "unprognostic (4.56e-2)" "prognostic unfavourable (8.87e-4)" "unprognostic (7.47e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-3)" "unprognostic (1.65e-2)" "unprognostic (1.97e-1)" "unprognostic (2.30e-3)" "unprognostic (6.19e-2)" "unprognostic (4.43e-1)" "unprognostic (5.52e-2)" "unprognostic (7.82e-2)" 6.1 28.5 7.8 4.4 12.2 20.0 7.6 8.3 10.3 6.2 13.0 6.0 5.9 10.1 4.2 11.6 15.7 8.0 8.1 5.0 8.0 8.9 10.4 9.4 6.1 6.0 9.9 6.0 34.4 17.3 6.3 18.8 11.5 9.5 6.0 6.3 6.5 6.8 6.7 16.2 7.4 23.1 6.8 11.0 7.2 7.5 16.9 7.2 11.5 9.1 10.9 6.8 10.3 9.4 11.4 7.4 21.8 7.9 3.5 10.7 3.9 14.5 7.7 12.6 10.2 20.0 13.1 10.9 16.3 13.8 12.8 11.7 7.5 14.7 11.3 3.6 11.9 6.2 7.5 13.9 18.4 7.9 6.8 16.7 8.9 8.9 5.8 12.9 19.0 9.9 11.1 13.4 5.2 6.5 10.2 40.2 10.3 14.2 18.1 15.5 9.1 10.3 8.5 6.3 17.5 14.7 7.2 11.9 8.1 9.5 13.3 3.9 6.3 9.7 4.5 8.6 14.6 6.7 9.5 8.5 5.6 7.1 16.6 11.8 6.0 13.1 6.2 21.8 3.6 6.3 5.5 11.4 7.6 6.5 7.4 8.1 10.7 9.0 7.4 3.5 7.9 7.0 5.6 3.9 7.8 12.2 8.3 10.3 8.0 8.9 9.9 6.0 9.5 7.2 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 73.5" "Group enriched" "Detected in some" 5 "CACO-2: 18.2;HHSteC: 7.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA061343 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA061343: " "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favourable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 19.7 18.0 0.3 3.0 0.7 0.0 5.9 0.3 0.6 4.9 3.7 1.3 14.0 0.8 9.8 18.9 12.4 16.3 14.7 24.6 0.6 0.4 11.8 24.3 73.5 12.1 1.1 0.8 20.2 4.0 0.7 3.2 12.9 2.5 10.1 1.6 13.0 6.1 19.9 4.7 1.5 3.9 11.3 1.3 6.5 5.0 28.2 0.2 0.5 9.4 3.8 2.8 9.6 6.4 1.7 1.1 4.2 1.0 2.2 1.0 0.6 0.0 0.1 0.1 0.1 1.8 2.5 0.4 0.2 2.3 0.0 0.0 18.2 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 7.8 0.1 0.3 0.9 0.0 0.0 0.1 0.4 0.1 0.3 0.3 0.1 0.0 0.4 0.8 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.6 0.1 0.7 0.0 0.2 0.1 1.1 0.1 0.8 0.3 0.1 0.8 0.3 0.1 0.2 0.1 0.3 4.2 1.0 0.8 0.7 0.4 0.7 1.2 0.7 0.6 0.4 1.7 1.0 0.8 3.0 2.2 0.4 1.1 0.6 0.6 0.3 0.7 0.3 0.6 0.6 0.4 1.1 0.8 2.5 0.2 INO80 "hINO80, Ino80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex subunit" Q9ULG1 15 40978880-41116354 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041417, HPA041484" Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA041417: , HPA041484: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favourable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 14.0 10.6 11.8 13.9 13.4 20.7 13.9 29.5 13.0 12.3 13.2 17.4 11.5 11.3 14.9 13.4 15.1 12.6 12.4 10.6 12.8 7.8 12.1 12.9 14.8 13.4 10.2 10.3 15.4 17.8 18.8 13.3 16.4 12.1 12.5 13.9 13.8 11.9 15.7 23.0 16.4 13.2 13.3 9.5 14.5 12.3 13.9 11.6 18.1 13.3 12.6 15.8 13.9 13.3 5.2 2.3 0.9 2.7 5.7 3.4 1.5 9.1 9.1 7.9 7.7 12.5 10.5 9.2 8.5 14.0 13.0 11.3 11.1 7.7 9.8 6.9 13.0 18.0 14.5 14.9 13.8 11.3 7.5 12.2 12.7 8.4 12.0 12.0 12.0 10.4 13.8 10.4 27.7 12.4 13.6 8.5 8.7 7.6 8.7 8.0 8.3 10.0 13.5 8.4 7.9 9.8 19.3 10.6 7.2 6.2 13.8 5.8 7.8 14.6 14.2 10.3 9.4 13.1 13.7 9.4 6.4 16.0 12.2 17.8 8.5 0.9 2.7 0.6 2.7 1.7 3.3 3.2 3.4 3.0 2.3 5.2 3.4 3.2 0.9 5.7 1.2 1.8 2.6 1.5 11.8 13.4 29.5 13.0 12.8 7.8 10.2 10.3 12.1 11.6 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455023-74457960 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA070644 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA070644: " "prognostic favourable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavourable (1.56e-5)" "prognostic favourable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 18.7 22.4 31.0 20.5 33.4 21.4 22.6 31.3 48.6 23.3 16.2 15.6 24.8 24.0 28.5 23.4 22.6 26.8 21.5 19.7 39.3 20.0 20.3 22.5 18.7 22.5 19.6 32.6 39.8 31.8 36.6 32.3 14.0 38.2 25.6 16.7 15.5 32.1 37.6 28.1 39.7 18.0 20.0 49.6 19.3 22.1 28.3 25.0 21.3 30.0 15.9 24.7 20.6 23.8 4.9 6.5 6.8 5.4 4.4 3.8 1.3 12.8 14.3 3.9 5.7 8.2 13.3 11.9 12.2 9.9 8.4 7.4 9.2 14.2 22.1 15.0 8.0 13.7 3.7 8.3 8.0 20.9 14.2 16.6 6.7 9.0 8.4 16.1 7.4 12.1 14.7 12.0 14.7 10.9 9.3 7.2 7.2 15.5 18.4 21.3 2.8 19.8 10.7 15.8 20.1 10.3 9.0 7.3 15.3 6.3 16.2 5.4 5.5 5.1 9.7 6.9 12.5 14.1 8.7 28.6 22.1 8.0 15.3 9.6 7.0 3.9 5.4 2.0 2.7 3.7 3.2 4.8 2.9 1.5 3.1 4.9 2.7 2.3 6.8 4.4 2.8 6.5 3.8 1.3 31.0 33.4 31.3 48.6 39.3 20.0 19.6 32.6 38.2 25.0 INO80E "CCDC95, FLJ90652" ENSG00000169592 "INO80 complex subunit E" Q8NBZ0 16 29995294-30005793 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043146 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA043146: AB_10794923" "unprognostic (5.61e-2)" "unprognostic (3.50e-2)" "unprognostic (3.46e-2)" "unprognostic (2.75e-2)" "unprognostic (3.38e-1)" "unprognostic (5.73e-2)" "unprognostic (7.14e-2)" "unprognostic (1.90e-2)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "unprognostic (1.13e-2)" "unprognostic (3.41e-2)" "unprognostic (2.02e-2)" "unprognostic (4.74e-3)" "unprognostic (5.21e-2)" "unprognostic (2.55e-1)" "unprognostic (3.98e-3)" 26.7 30.0 31.2 37.1 31.6 27.5 29.1 28.8 37.9 32.9 35.4 35.1 37.7 18.0 33.8 34.0 31.7 43.8 29.2 25.0 30.1 26.1 30.1 31.0 28.5 30.2 30.7 30.0 39.7 29.2 44.7 29.8 24.8 27.8 32.2 39.5 26.3 33.9 39.3 28.1 28.3 38.9 43.0 33.8 30.6 28.6 28.3 28.0 39.1 35.9 24.6 46.9 34.1 28.3 4.5 4.8 4.2 5.4 2.6 4.8 15.3 23.1 27.7 18.3 27.6 17.4 15.3 17.3 20.7 24.0 31.4 30.7 16.2 26.4 31.3 32.1 23.5 15.2 23.4 35.0 27.0 32.1 21.7 15.2 17.7 22.4 20.5 20.0 17.3 17.3 29.2 35.6 29.2 37.7 19.3 16.5 29.2 33.9 42.1 24.0 37.7 13.6 55.7 22.6 30.0 22.7 12.0 28.9 35.5 11.4 19.4 25.4 25.0 16.7 20.0 20.9 15.2 18.6 25.7 15.9 35.4 28.8 23.4 29.1 29.7 0.7 4.7 4.2 3.9 3.2 3.4 4.5 2.9 4.8 4.8 2.9 2.5 3.0 2.7 2.6 5.4 4.0 4.3 15.3 31.2 31.6 28.8 37.9 30.1 26.1 30.7 30.0 27.8 28.0 INPP1 ENSG00000151689 "Inositol polyphosphate-1-phosphatase" P49441 2 190343470-190371665 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 36.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036698, HPA036699" Supported Approved "Centriolar satellite,Cytosol" 15000 "Centriolar satellite" Cytosol "HPA036698: AB_10672226, HPA036699: " "unprognostic (1.08e-3)" "unprognostic (4.50e-3)" "unprognostic (3.87e-2)" "unprognostic (2.70e-1)" "unprognostic (7.85e-2)" "unprognostic (3.67e-3)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (1.75e-1)" "unprognostic (2.96e-2)" "unprognostic (7.28e-2)" "unprognostic (2.41e-1)" "unprognostic (2.54e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "prognostic favourable (1.12e-5)" "prognostic favourable (5.70e-4)" 14.9 25.8 18.3 9.1 26.5 10.3 32.5 17.4 25.1 15.0 19.8 20.4 11.5 27.4 12.0 10.8 42.7 9.8 20.6 17.7 21.2 17.9 11.0 24.8 19.9 8.8 21.0 16.5 10.0 25.6 32.3 17.0 10.4 18.6 10.0 16.8 12.0 9.9 16.0 13.1 28.3 28.0 15.5 23.6 15.7 13.9 31.4 17.1 4.6 12.9 14.0 15.4 19.2 18.8 1.8 3.5 36.6 3.4 6.2 8.0 1.9 10.8 3.0 5.9 0.0 6.5 14.0 0.1 13.1 17.5 12.3 16.2 11.8 6.9 0.0 15.6 12.5 15.0 2.4 8.4 15.1 13.3 4.6 8.2 9.6 7.0 13.7 6.0 2.6 9.5 13.0 14.0 8.1 22.9 19.4 6.9 21.6 0.0 0.4 5.8 1.7 16.8 0.2 4.8 0.1 9.5 25.9 8.8 3.3 9.0 0.5 12.7 0.0 8.8 21.2 7.9 5.6 14.1 7.6 1.3 1.4 0.1 2.5 2.4 6.2 8.1 3.4 36.6 3.0 3.1 2.7 1.4 1.9 2.0 3.5 1.8 1.0 1.5 1.6 6.2 1.8 0.1 8.0 1.9 18.3 26.5 17.4 25.1 21.2 17.9 21.0 16.5 18.6 17.1 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594390 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 9.0 15.0 11.4 13.5 23.1 12.3 7.0 24.0 28.4 7.5 8.5 8.3 3.8 7.7 8.2 5.7 8.4 6.7 11.0 10.8 12.9 7.8 8.1 7.2 13.5 17.0 6.1 19.8 8.3 8.2 12.7 7.0 8.6 17.9 6.8 8.6 16.1 9.3 7.2 13.6 7.3 12.1 10.5 10.4 24.0 8.4 6.4 6.8 17.6 8.4 2.7 13.4 16.8 6.9 0.8 5.9 3.8 5.1 5.8 6.4 1.8 6.4 5.4 10.0 8.1 5.8 6.6 10.1 5.7 5.0 6.1 6.2 7.0 5.7 4.2 6.4 8.2 6.0 7.2 5.6 4.9 13.8 6.1 4.8 4.9 3.2 5.2 9.1 17.9 5.9 5.2 5.8 5.1 8.5 4.4 34.5 4.5 7.8 13.9 8.2 9.5 5.4 6.0 7.1 26.9 2.9 20.0 6.6 8.7 6.4 5.3 5.1 2.4 7.3 8.0 7.0 9.0 5.5 3.9 24.5 14.2 2.9 5.8 8.8 6.0 2.0 1.8 3.8 5.5 3.9 6.4 0.8 3.1 3.7 1.9 0.2 4.3 4.9 2.0 5.8 5.1 5.9 1.6 1.8 11.4 23.1 24.0 28.4 12.9 7.8 6.1 19.8 17.9 6.8 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.2;thyroid gland: 71.2" "Cell line enhanced" "Detected in many" "HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034539 Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favourable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favourable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 0.9 4.6 0.8 6.3 0.5 3.7 27.4 13.4 1.5 6.4 0.8 16.7 7.9 1.3 0.8 1.0 1.0 1.0 9.5 7.4 2.0 9.5 0.5 1.5 0.7 2.3 4.6 0.8 5.3 65.2 3.7 0.5 5.5 3.5 2.2 5.6 15.5 19.2 1.6 1.7 21.7 1.2 0.9 0.6 3.8 1.6 1.1 0.0 71.2 0.0 0.7 1.1 0.9 0.3 2.4 0.0 0.4 0.0 0.0 0.2 1.3 1.3 0.8 1.4 0.2 0.1 0.7 0.5 0.5 2.6 2.6 0.7 0.8 0.0 0.6 0.2 1.5 1.6 0.7 1.1 0.0 4.2 0.0 5.5 0.2 0.5 12.1 0.1 0.1 0.8 2.2 0.2 0.1 1.1 1.8 0.0 4.0 0.1 0.0 1.4 0.2 0.0 0.3 2.8 1.1 1.6 6.4 4.8 1.0 26.2 0.3 16.5 1.0 0.0 0.1 4.8 0.5 0.3 0.0 2.0 11.4 0.4 0.0 2.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 4.6 6.3 27.4 13.4 7.4 2.0 2.3 4.6 5.5 1.1 INPPL1 SHIP2 ENSG00000165458 "Inositol polyphosphate phosphatase like 1" O15357 11 72223701-72239105 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Immunity" "Actin-binding, Hydrolase" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037601 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA037601: AB_10672281" "unprognostic (2.68e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.68e-3)" "unprognostic (1.58e-1)" "prognostic unfavourable (7.37e-4)" "unprognostic (2.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.51e-2)" "unprognostic (1.64e-1)" "unprognostic (4.34e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (1.99e-3)" "unprognostic (2.07e-1)" 20.9 23.7 22.2 20.4 19.5 25.1 18.6 11.1 18.9 25.2 32.0 22.7 28.8 19.8 24.7 18.4 17.4 24.3 29.6 29.5 24.1 10.3 23.9 17.1 24.9 19.0 27.6 10.4 30.1 22.7 21.6 26.9 31.9 20.4 28.7 13.5 30.7 27.5 24.2 60.0 17.7 23.0 34.7 27.5 28.3 24.5 11.8 24.3 16.0 29.1 19.3 18.3 25.0 18.1 2.6 5.2 7.0 7.6 4.2 4.5 3.3 6.4 13.8 16.6 11.3 8.2 9.8 29.6 29.8 13.9 18.7 11.9 18.9 16.3 18.4 30.5 22.8 24.6 13.6 8.4 6.4 23.8 14.2 19.1 70.0 6.9 16.1 12.6 42.8 13.9 8.9 18.1 7.2 10.0 13.4 7.9 10.2 17.4 9.3 51.0 16.9 21.6 43.9 37.7 4.1 21.7 10.8 8.1 11.8 32.0 19.3 41.6 20.4 23.9 16.9 20.1 23.5 30.7 9.7 22.9 3.8 17.9 5.7 12.0 10.8 5.2 7.6 7.0 4.5 4.4 3.7 2.2 3.7 3.0 5.2 2.6 2.7 3.7 5.2 4.2 7.0 3.9 3.3 3.3 22.2 19.5 11.1 18.9 24.1 10.3 27.6 10.4 20.4 24.3 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell line enhanced" "Detected in many" "Karpas-707: 30.6;U-266/70: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" 72000 Vesicles "Plasma membrane" "HPA036302: , HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.7 2.1 1.9 2.9 10.6 3.7 6.4 2.1 1.9 1.2 1.2 5.3 4.3 4.7 5.3 3.8 1.0 4.6 0.9 0.7 0.0 3.7 0.0 1.5 11.5 4.6 2.2 3.8 5.7 2.4 0.1 2.8 2.1 5.7 30.6 0.9 1.7 1.6 3.8 1.8 3.3 16.3 1.1 4.1 0.1 15.5 3.7 2.8 3.8 2.0 2.1 0.9 10.8 2.0 2.2 1.4 4.7 2.8 22.6 12.3 10.9 2.6 3.8 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817140-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: " "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favourable (4.00e-4)" "prognostic favourable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 21.9 20.9 31.4 18.9 30.2 22.8 23.5 38.5 28.4 23.7 23.2 23.2 19.9 21.3 18.8 17.4 21.8 31.4 17.0 20.9 31.1 27.1 25.0 42.7 19.2 21.9 28.3 18.4 21.6 39.1 18.1 25.5 18.0 21.2 24.5 22.2 17.3 23.2 26.0 20.7 25.7 19.5 22.0 28.7 21.4 19.4 12.0 24.3 26.9 34.9 21.1 25.0 20.8 23.7 17.8 20.0 8.8 15.0 16.9 21.2 12.6 15.2 22.3 12.3 16.0 18.4 20.6 16.8 11.1 18.9 15.6 14.8 12.4 7.7 42.9 19.6 12.1 16.4 14.5 14.3 17.6 8.5 16.3 19.9 24.9 24.0 13.7 17.1 13.7 16.4 22.5 11.6 18.1 14.9 23.9 34.5 10.6 13.3 30.9 20.4 17.4 12.2 16.7 14.8 27.8 19.3 23.7 12.5 9.9 15.7 19.7 13.8 10.2 17.6 12.1 9.9 14.2 23.3 15.5 9.7 12.4 32.5 20.2 24.2 16.3 6.6 15.0 8.8 13.9 13.8 21.2 17.8 17.8 17.5 20.0 15.1 19.9 17.6 5.4 16.9 11.5 17.0 19.9 12.6 31.4 30.2 38.5 28.4 31.1 27.1 28.3 18.4 21.2 24.3 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324691 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 21.4 22.5 22.8 25.4 24.9 23.2 26.9 50.8 30.4 26.5 31.2 32.1 24.1 29.1 33.1 39.8 25.3 39.1 24.8 29.8 23.7 19.8 23.5 26.7 19.7 25.7 25.9 25.8 34.1 33.5 24.1 26.9 25.8 21.0 29.5 19.9 20.4 33.8 28.0 52.8 28.6 25.4 34.0 20.0 27.3 27.9 57.8 25.9 28.5 23.3 23.5 22.5 27.5 25.7 24.6 37.7 22.0 42.2 28.4 35.2 32.4 21.1 21.9 12.4 23.7 21.3 17.3 13.4 11.7 19.7 27.2 20.2 19.7 26.9 23.7 17.0 23.8 15.6 18.4 26.2 12.1 22.2 24.0 18.2 29.8 26.5 32.8 14.4 20.1 29.2 14.3 24.7 37.2 28.4 21.6 21.6 13.4 19.1 28.4 19.6 15.0 23.6 22.4 11.7 34.1 19.1 10.8 17.5 16.2 11.8 31.9 33.2 17.2 21.1 20.4 16.9 15.4 19.2 14.9 33.9 36.3 30.8 23.7 25.6 8.3 22.0 32.3 20.8 31.7 37.2 33.8 24.6 28.1 29.3 37.7 20.3 26.5 24.9 15.3 28.4 42.2 24.5 35.2 32.4 22.8 24.9 50.8 30.4 23.7 19.8 25.9 25.8 21.0 25.9 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: " "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavourable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 16.7 13.5 18.7 12.5 20.7 25.3 20.0 17.3 18.1 14.5 17.0 13.4 11.6 17.0 16.1 17.9 13.6 14.4 12.3 19.3 18.3 15.3 18.2 21.4 15.4 12.1 16.5 11.5 15.0 16.0 17.3 20.7 11.2 17.4 18.1 15.4 10.4 14.8 13.7 28.2 14.1 21.0 16.6 19.3 15.9 14.9 12.6 13.8 22.1 31.1 15.9 15.4 13.8 12.6 20.6 27.6 33.3 17.0 27.1 21.9 14.0 12.5 6.7 15.4 15.9 15.2 18.2 11.2 14.9 15.5 18.8 19.6 9.4 14.3 18.1 8.3 16.7 7.3 16.8 21.5 23.4 18.9 10.2 13.6 10.9 13.2 24.5 23.9 12.4 17.1 28.0 18.6 28.1 17.2 20.2 14.3 20.2 13.2 28.0 14.9 6.6 10.3 14.4 16.7 13.8 17.5 8.5 16.6 13.3 10.5 17.4 16.3 14.1 14.1 11.2 12.4 12.7 13.3 15.9 22.1 20.4 27.0 13.7 16.4 24.4 33.3 15.9 24.1 17.9 16.8 20.0 20.6 20.6 20.2 18.0 19.3 21.6 20.2 12.1 27.1 17.0 27.6 21.9 14.0 18.7 20.7 17.3 18.1 18.3 15.3 16.5 11.5 17.4 13.8 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavourable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavourable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 10.0 20.9 10.5 11.5 14.7 15.3 11.5 11.4 11.4 10.5 10.0 22.3 4.6 9.0 10.6 10.4 14.1 8.1 7.5 10.2 12.3 9.8 12.6 14.3 8.0 14.1 18.8 7.4 9.2 11.9 9.3 17.6 9.2 22.4 10.1 10.4 8.9 9.4 6.6 16.9 11.4 8.5 11.6 30.2 17.9 14.1 10.9 14.1 26.6 10.7 11.6 15.1 16.9 9.6 7.4 6.8 5.1 5.4 16.4 18.7 7.1 9.3 10.3 6.3 13.3 9.0 14.5 8.9 13.0 7.8 12.3 13.9 15.4 12.3 23.5 13.6 7.2 13.3 15.3 12.2 20.9 10.8 9.4 18.4 12.8 12.7 16.2 31.1 11.3 7.9 9.4 20.0 42.6 15.9 19.4 9.3 13.4 10.7 16.2 57.1 27.3 18.5 11.5 18.3 31.4 10.5 8.5 5.0 4.8 11.4 9.0 13.0 12.2 6.8 10.4 14.6 10.8 24.4 15.7 4.9 5.5 34.4 9.7 21.6 10.2 4.2 5.4 5.1 10.5 3.7 15.5 6.8 13.1 12.9 6.8 7.4 9.4 11.5 1.8 16.4 3.2 4.6 18.7 7.1 10.5 14.7 11.4 11.4 12.3 9.8 18.8 7.4 22.4 14.1 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.1 22.0 22.2 17.7 12.4 15.6 14.3 13.4 17.4 22.4 20.8 19.6 28.8 19.9 18.9 16.7 24.7 47.3 22.6 19.8 17.4 28.7 17.3 16.4 21.2 24.7 17.7 22.3 15.1 22.5 17.0 26.2 24.2 23.7 11.6 15.7 19.3 20.1 17.1 16.2 12.2 17.3 18.7 22.8 17.4 22.7 16.0 12.7 16.2 16.5 22.4 15.4 20.7 11.8 15.5 16.3 13.8 21.2 11.5 21.4 26.9 15.6 32.4 18.0 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728067-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoli Nucleoplasm "HPA074391: " "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favourable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavourable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 16.2 21.9 18.8 14.4 20.0 12.0 16.3 20.7 23.1 20.4 19.9 19.5 25.1 10.0 24.4 23.7 14.3 26.7 20.5 15.3 16.0 10.6 17.9 11.1 16.6 12.6 15.9 16.4 30.8 17.5 23.6 23.6 16.5 15.6 15.9 11.4 16.1 14.0 31.0 16.2 16.9 14.7 21.2 13.4 15.4 17.6 16.5 16.0 16.2 18.6 9.2 14.1 19.9 18.8 1.8 3.8 2.7 6.2 2.7 2.5 1.5 13.1 13.8 10.0 14.4 11.4 12.8 10.2 10.0 7.2 12.0 9.7 9.6 12.4 11.4 20.1 13.2 13.4 19.1 12.8 9.8 11.9 11.2 7.1 21.0 4.5 7.8 10.6 12.9 11.6 6.5 10.3 9.4 11.5 10.0 9.3 9.2 10.7 9.9 5.6 12.3 12.7 13.4 5.6 7.3 6.2 17.2 7.9 11.6 9.5 23.0 6.4 13.3 14.4 8.4 11.9 5.1 11.7 9.0 8.3 7.6 12.6 13.0 6.5 8.2 1.3 1.8 2.0 2.1 1.4 2.5 1.3 1.3 2.0 3.8 1.8 1.4 1.5 2.7 2.7 6.2 0.8 1.3 1.5 18.8 20.0 20.7 23.1 16.0 10.6 15.9 16.4 15.6 16.0 INTS5 "INT5, KIAA1698" ENSG00000185085 "Integrator complex subunit 5" Q6P9B9 11 62646848-62653302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046181, HPA056915" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046181: , HPA056915: " "unprognostic (2.87e-1)" "unprognostic (9.51e-2)" "unprognostic (9.11e-2)" "unprognostic (9.70e-2)" "unprognostic (2.71e-1)" "unprognostic (6.41e-2)" "unprognostic (1.97e-2)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.33e-1)" "unprognostic (5.09e-2)" "prognostic favourable (8.44e-5)" "unprognostic (7.08e-3)" "unprognostic (2.97e-2)" "unprognostic (3.36e-1)" "unprognostic (1.35e-2)" 13.8 13.2 9.1 14.0 8.9 6.5 17.2 9.7 16.5 12.8 11.0 7.0 14.3 10.9 16.0 10.6 16.0 19.1 14.0 14.3 7.4 6.7 12.0 19.9 11.6 22.3 7.8 7.6 15.4 21.3 17.4 9.5 12.1 6.9 12.4 8.5 11.0 16.0 17.4 17.3 15.7 11.2 11.9 5.5 14.8 12.4 9.4 6.6 26.0 16.4 10.8 12.8 12.6 15.7 7.6 7.2 5.1 6.2 10.1 14.3 7.0 11.2 13.9 8.2 7.6 16.2 11.9 7.7 9.3 9.6 12.7 9.1 9.8 12.6 21.5 17.0 11.8 17.7 16.4 21.7 6.1 13.4 11.4 11.1 11.1 6.6 14.7 12.2 10.7 13.7 17.1 13.5 11.7 12.5 16.9 12.7 10.8 23.1 13.9 14.3 12.5 17.7 14.4 11.1 25.8 9.7 7.4 11.1 9.4 10.5 14.7 14.5 21.0 8.4 10.3 12.2 9.4 18.6 8.4 17.9 13.7 15.4 14.0 9.3 11.4 5.1 6.2 4.8 8.7 4.6 14.3 5.8 8.2 7.7 7.1 7.6 9.6 8.7 2.6 10.1 5.1 7.2 6.1 7.0 9.1 8.9 9.7 16.5 7.4 6.7 7.8 7.6 6.9 6.6 INTS6 "DBI-1, DDX26, DDX26A, DICE1, HDB, INT6, Notchl2" ENSG00000102786 "Integrator complex subunit 6" Q9UL03 13 51354077-51454264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA001846" Supported Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA001552: AB_1078659, HPA001846: AB_1847669" "unprognostic (1.99e-1)" "unprognostic (4.81e-2)" "unprognostic (3.58e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.19e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (3.32e-2)" "unprognostic (3.18e-2)" "unprognostic (2.80e-1)" "unprognostic (5.83e-2)" "unprognostic (2.36e-1)" "unprognostic (6.26e-2)" 13.3 13.7 12.9 14.4 14.6 11.3 23.9 23.8 15.8 12.5 11.9 10.6 17.4 9.5 12.1 10.9 16.4 10.3 12.3 13.0 14.1 8.9 11.1 24.5 13.6 15.7 16.9 9.1 14.6 44.2 14.4 24.1 11.5 13.2 12.2 9.5 8.5 12.3 19.2 10.6 13.3 13.9 12.2 12.3 11.4 12.9 46.4 17.8 21.7 13.0 9.5 13.4 12.3 15.9 6.1 6.5 7.8 2.8 6.7 9.2 3.2 7.7 6.2 15.0 7.2 8.5 18.5 9.9 15.1 15.1 16.0 12.0 7.9 19.4 9.6 3.4 12.7 13.9 19.5 9.3 23.8 17.5 5.6 16.7 9.9 9.6 20.9 19.8 16.1 13.6 18.2 16.6 26.4 14.8 11.2 14.2 17.4 6.1 13.7 15.0 11.3 7.5 9.4 10.0 7.6 12.7 5.1 8.9 9.6 15.7 12.3 12.1 7.1 22.6 10.2 8.6 7.1 10.2 9.9 14.0 8.8 14.9 7.8 11.9 14.6 7.3 2.8 4.2 7.9 1.8 8.9 4.9 5.9 7.1 2.8 6.1 8.4 9.2 7.8 6.7 2.0 6.5 6.3 3.2 12.9 14.6 23.8 15.8 14.1 8.9 16.9 9.1 13.2 17.8 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520643-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 16.1;U-937: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: , HPA013335: AB_1847553, HPA030747: " "unprognostic (2.03e-1)" "prognostic favourable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favourable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavourable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favourable (2.94e-4)" 4.2 9.8 5.5 10.6 6.7 15.4 5.4 22.6 6.1 8.4 7.8 7.4 3.8 3.6 7.8 4.6 6.4 8.6 6.6 5.9 4.8 3.2 4.4 1.7 5.6 15.6 6.8 6.2 11.5 2.9 3.7 11.5 4.5 6.5 6.5 10.0 5.3 18.2 7.9 1.5 8.3 9.3 5.4 4.9 13.3 4.5 9.7 10.4 17.8 4.6 2.8 15.0 8.6 7.5 5.5 3.6 2.2 2.7 2.7 9.0 4.0 0.1 0.0 6.1 7.1 1.8 2.1 0.0 1.5 3.2 1.8 5.5 0.5 2.6 6.1 5.2 1.3 4.5 6.8 2.0 1.3 4.5 2.5 5.0 0.5 0.0 1.6 5.2 0.4 2.7 2.0 2.1 2.0 2.3 3.2 9.6 1.3 4.4 5.1 16.1 2.8 2.5 4.2 2.1 4.9 1.4 2.5 1.0 2.2 2.0 2.1 0.2 2.2 9.8 1.2 4.7 2.7 0.0 1.7 11.1 8.7 9.0 1.5 15.0 0.9 0.0 2.5 2.2 5.1 2.2 6.1 5.5 5.8 5.9 3.6 4.9 9.0 5.8 1.6 2.7 2.7 3.5 3.1 4.0 5.5 6.7 22.6 6.1 4.8 3.2 6.8 6.2 6.5 10.4 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favourable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favourable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favourable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 14.2 17.5 23.5 12.9 26.9 12.1 15.8 38.6 40.4 17.7 16.1 20.7 16.1 13.6 21.4 14.5 19.6 20.0 14.7 13.7 23.8 23.5 16.3 15.9 16.9 16.3 17.9 18.3 30.2 21.9 30.3 16.7 18.3 21.2 14.3 13.2 18.6 18.3 21.1 9.0 18.2 12.7 19.5 16.9 16.9 13.7 27.3 14.8 22.3 17.1 8.4 14.4 16.3 15.6 6.8 4.1 24.0 4.8 6.9 9.7 6.0 12.3 15.0 17.6 20.6 18.4 14.2 14.2 16.5 17.4 27.1 23.8 19.4 12.9 10.8 10.7 18.2 9.2 24.8 14.9 15.4 21.6 19.7 24.4 23.0 13.1 20.3 14.9 17.1 16.5 18.6 29.2 17.7 22.6 15.9 12.7 13.3 11.0 18.1 15.6 18.9 25.0 11.5 12.5 21.6 17.5 18.9 9.5 19.0 21.0 13.7 18.9 11.0 22.0 20.2 15.2 15.3 20.8 19.1 15.5 20.8 11.5 13.9 17.3 15.5 2.5 4.8 8.2 8.7 3.9 8.8 4.6 8.0 9.6 4.1 6.8 9.7 9.5 24.0 6.9 4.8 2.9 8.2 6.0 23.5 26.9 38.6 40.4 23.8 23.5 17.9 18.3 21.2 14.8 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: " "prognostic favourable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favourable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favourable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.7 17.2 35.7 25.1 20.1 25.2 25.8 16.8 18.9 19.3 22.4 14.2 23.6 15.6 13.8 15.6 23.0 17.8 25.1 18.0 18.3 15.7 17.8 53.2 30.4 16.3 16.8 17.4 23.9 36.6 26.1 21.6 26.6 13.3 19.6 22.3 19.5 36.0 23.1 27.4 31.9 15.1 11.8 17.0 26.2 42.2 22.3 33.7 36.3 24.7 17.8 23.9 28.5 18.9 21.0 20.9 13.1 16.5 18.1 21.4 21.9 19.1 19.7 18.3 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell line enhanced" "Detected in some" "HHSteC: 15.8;HSkMC: 5.7;LHCN-M2: 25.1;RH-30: 11.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA053644 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053644: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavourable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.1 0.2 0.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 5.7 0.8 0.1 0.4 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Group enriched" "Detected in some" 5 "HMC-1: 19.3;THP-1: 9.8;U-937: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: " "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 1.0 0.4 0.2 0.2 0.5 0.9 2.1 0.3 0.3 0.0 0.1 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 IPO11 RanBP11 ENSG00000086200 "Importin 11" Q9UI26 5 62403972-62628582 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065346, HPA067097" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA065346: , HPA067097: AB_2685776" "unprognostic (9.29e-2)" "unprognostic (2.88e-2)" "prognostic favourable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.35e-2)" "unprognostic (9.21e-2)" "prognostic unfavourable (4.28e-5)" "unprognostic (4.26e-2)" "unprognostic (6.45e-2)" "unprognostic (1.26e-3)" "unprognostic (9.63e-2)" "unprognostic (5.09e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.24e-2)" 25.5 15.3 13.6 14.2 17.1 8.8 22.2 18.4 18.3 19.5 13.7 14.2 17.4 10.4 19.9 13.9 18.6 16.1 16.4 20.0 15.2 13.4 18.5 16.9 12.8 14.2 14.9 13.7 18.6 14.4 23.9 20.9 24.4 17.1 15.9 13.7 13.2 14.8 16.6 19.0 14.0 12.3 17.0 14.4 26.3 13.7 30.9 13.3 18.8 21.7 15.7 15.0 19.8 24.4 4.2 3.6 12.2 5.6 18.0 5.3 3.2 11.7 11.1 10.3 15.9 8.4 11.4 14.0 12.7 9.7 13.3 15.0 12.4 9.3 20.2 10.2 12.9 9.7 21.3 14.8 21.1 7.6 11.2 9.4 11.4 11.1 6.1 10.6 5.4 8.1 8.6 16.0 17.2 50.4 17.7 6.6 13.3 11.1 11.2 13.8 13.2 6.8 13.7 15.2 18.3 8.3 11.6 11.0 6.4 11.1 8.8 9.0 11.3 7.4 22.7 8.0 8.9 8.9 11.6 5.2 8.5 14.0 10.0 14.8 9.6 12.2 2.1 1.8 3.5 3.4 4.2 3.1 3.7 3.6 3.6 4.2 5.3 3.8 2.1 18.0 5.6 2.3 2.3 3.2 13.6 17.1 18.4 18.3 15.2 13.4 14.9 13.7 17.1 13.3 IPO5 "IMB3, KPNB3, MGC2068, Pse1, RANBP5" ENSG00000065150 "Importin 5" O00410 13 97953658-98024297 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009110, HPA040983, HPA056548" Approved Supported Nucleoplasm,Cytosol 92000 "Nucleoplasm, Cytosol" "CAB009110: AB_2264985, HPA040983: , HPA056548: " "unprognostic (5.20e-2)" "unprognostic (6.94e-2)" "unprognostic (9.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.96e-3)" "unprognostic (2.16e-3)" "unprognostic (2.19e-2)" "unprognostic (5.27e-3)" "unprognostic (6.19e-2)" "unprognostic (2.51e-1)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (9.64e-2)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (2.73e-1)" 26.3 13.8 16.5 14.5 18.3 13.0 23.5 16.3 20.2 20.2 19.7 15.9 13.5 9.6 21.1 13.4 19.4 18.9 12.4 23.9 15.7 12.7 18.9 23.2 14.1 16.0 20.8 15.9 33.5 60.7 12.5 13.0 14.3 15.3 19.1 16.6 11.0 13.9 20.2 65.0 13.5 11.3 25.5 24.3 14.9 18.9 79.5 19.4 23.3 23.0 24.1 21.1 21.8 23.9 8.0 11.0 1.1 7.3 10.3 12.3 6.1 28.2 19.1 35.8 32.8 24.4 62.1 22.0 41.6 32.8 58.7 41.8 39.1 21.8 81.8 14.6 50.0 24.6 74.4 28.5 81.2 20.6 23.4 44.5 36.2 30.6 17.4 48.0 15.9 34.8 18.8 47.6 40.1 33.4 30.7 11.0 50.1 7.7 36.2 13.0 36.0 22.9 46.6 40.7 24.2 14.1 18.6 26.6 21.7 21.4 25.0 15.6 18.9 26.5 23.4 39.7 20.0 19.8 37.8 14.8 18.2 25.5 41.0 30.5 27.1 0.5 4.4 1.1 7.1 7.3 12.3 8.0 8.3 8.8 11.0 7.6 11.6 9.6 0.6 10.3 5.1 5.4 8.5 6.1 16.5 18.3 16.3 20.2 15.7 12.7 20.8 15.9 15.3 19.4 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384622-9448126 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol 26000 "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: " "unprognostic (1.92e-1)" "prognostic unfavourable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavourable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 23.9 20.6 21.8 18.6 24.4 12.3 36.0 24.1 30.6 24.3 27.4 14.4 19.3 17.0 25.7 19.3 29.0 20.3 20.3 37.7 22.8 23.4 26.5 24.7 22.0 23.2 23.3 17.4 23.4 25.9 33.1 19.1 26.5 24.8 24.4 22.1 12.0 21.4 22.4 88.2 17.1 16.1 53.4 25.7 16.6 21.5 9.7 16.8 20.8 34.3 28.5 20.9 43.7 33.9 3.8 5.8 1.3 6.3 6.9 5.4 1.6 37.3 29.2 34.4 27.3 34.9 45.1 27.6 45.5 29.3 33.7 36.5 25.3 34.4 35.1 16.6 35.0 29.4 48.8 35.3 56.3 16.7 40.3 29.0 33.2 25.3 21.8 44.3 22.1 28.8 38.3 22.1 52.2 39.7 43.4 21.1 43.8 15.2 26.7 21.7 33.9 34.0 28.1 54.2 15.8 27.8 35.3 13.7 26.9 20.3 40.3 32.8 18.5 22.3 31.1 41.5 28.6 42.7 48.6 6.1 23.4 24.2 27.2 23.9 22.5 0.1 2.5 0.6 2.7 4.8 5.4 3.8 3.1 3.9 5.8 3.1 3.9 3.2 1.3 6.9 6.3 2.7 2.8 1.6 21.8 24.4 24.1 30.6 22.8 23.4 23.3 17.4 24.8 16.8 IPO9 "FLJ10402, Imp9" ENSG00000198700 "Importin 9" Q96P70 1 201829141-201884294 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059540 Approved Vesicles,Cytosol "Intracellular and membrane" 30000 Cytosol Vesicles "HPA059540: " "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.44e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (4.99e-2)" "prognostic unfavourable (4.11e-5)" "unprognostic (8.92e-3)" "unprognostic (2.23e-3)" "unprognostic (2.52e-1)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.86e-4)" "unprognostic (5.05e-2)" "unprognostic (2.57e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (5.78e-4)" 16.8 18.0 27.1 14.2 26.5 11.0 15.2 29.1 27.8 14.2 14.3 18.7 11.0 11.5 19.7 24.2 15.2 17.4 12.2 12.0 22.3 17.9 14.9 23.1 16.5 15.7 17.7 22.8 20.9 16.5 24.9 26.0 18.1 21.2 16.3 18.1 24.7 11.2 14.7 15.4 21.9 13.3 21.5 15.0 18.3 13.4 12.8 17.2 21.1 18.4 8.4 20.3 14.4 13.7 10.9 14.6 10.7 15.3 11.0 13.3 8.3 18.4 19.6 26.9 21.8 15.6 10.6 20.2 14.3 14.5 23.9 23.3 31.4 16.2 11.0 8.1 13.7 17.2 18.2 19.8 20.7 10.0 16.1 8.2 31.9 23.4 11.9 10.7 13.5 11.7 9.1 25.7 21.0 23.9 16.3 10.5 17.0 18.5 12.3 14.0 27.0 6.4 13.2 28.0 10.9 13.0 29.6 22.9 26.0 15.7 25.0 12.6 18.3 13.5 13.0 22.5 20.1 12.6 26.1 7.7 4.7 12.7 11.2 12.6 16.8 10.7 11.7 9.7 12.2 15.3 10.6 10.9 11.9 13.3 14.6 10.3 9.7 10.4 2.9 11.0 14.9 7.7 10.7 8.3 27.1 26.5 29.1 27.8 22.3 17.9 17.7 22.8 21.2 17.2 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769763-121835079 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: " "unprognostic (3.82e-2)" "prognostic favourable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavourable (3.08e-5)" "prognostic favourable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.5 10.8 9.9 25.1 12.6 16.6 21.9 14.7 16.8 14.4 11.8 8.8 16.9 11.0 14.7 19.4 13.1 15.9 11.5 10.4 10.1 10.1 10.6 9.0 15.0 20.6 12.5 14.5 19.8 22.7 13.9 20.7 12.1 12.4 16.2 15.6 10.9 14.4 30.2 11.4 14.2 14.0 14.6 11.4 19.3 11.2 40.1 12.5 16.2 11.4 9.5 23.0 16.7 14.1 18.9 7.6 8.9 10.4 8.6 10.0 4.9 13.7 3.7 18.4 20.7 3.0 4.5 21.6 6.6 4.0 7.4 9.0 12.7 6.7 27.9 9.2 3.7 10.6 11.3 5.3 11.1 5.4 9.1 18.5 7.3 10.4 7.7 22.9 5.6 2.8 10.2 5.1 11.5 5.6 11.0 10.4 8.3 6.9 14.9 16.2 15.5 6.8 14.8 8.8 8.9 4.3 6.1 9.9 8.0 6.3 4.5 11.4 4.0 17.9 4.7 7.1 8.5 3.4 8.5 25.2 16.0 47.4 6.8 10.5 6.4 2.5 5.2 8.9 6.3 9.9 9.0 18.9 8.3 7.6 7.6 17.5 10.0 6.3 2.1 8.6 10.4 7.2 8.7 4.9 9.9 12.6 14.7 16.8 10.1 10.1 12.5 14.5 12.4 12.5 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favourable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 5.5 7.6 15.1 6.8 17.0 7.0 7.4 11.1 18.7 6.9 10.2 12.8 6.7 13.1 9.6 12.3 6.6 17.1 11.2 7.1 14.3 15.6 7.1 3.6 9.1 4.7 12.0 12.1 9.7 8.4 12.9 15.4 4.1 11.3 8.1 9.9 7.3 9.8 11.2 4.5 8.1 10.9 7.9 11.1 5.1 10.6 35.3 9.6 2.8 11.9 3.0 3.9 6.0 7.4 0.7 4.3 8.3 2.1 0.3 1.3 0.3 19.7 10.3 4.5 13.6 5.5 8.4 7.7 4.2 7.0 5.5 6.0 5.3 11.4 1.4 4.8 9.7 10.3 3.0 4.8 5.8 3.4 6.4 2.7 12.5 1.7 4.1 7.0 4.0 3.5 8.0 5.3 5.6 5.9 8.5 2.6 7.3 20.1 3.1 5.4 3.8 7.6 3.0 5.1 5.1 5.9 9.2 9.4 11.0 4.7 19.7 4.3 24.1 9.6 5.8 4.6 9.3 17.5 7.0 2.9 4.8 0.3 9.1 5.1 12.9 1.1 1.4 3.6 1.3 2.1 0.5 0.5 0.7 0.6 0.6 0.7 0.5 1.1 8.3 0.3 0.7 4.3 0.3 0.3 15.1 17.0 11.1 18.7 14.3 15.6 12.0 12.1 11.3 9.6 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889075-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 44.9;testis: 34.2" "Cell line enhanced" "Detected in many" "T-47d: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: " "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.2 5.0 10.9 3.0 14.6 3.0 5.4 3.6 7.6 5.7 3.0 12.3 4.1 2.5 4.5 11.6 3.9 44.9 4.4 4.2 12.6 12.9 5.9 3.6 8.0 3.9 9.0 5.7 5.0 2.1 4.5 12.0 3.4 20.8 3.9 3.7 5.3 2.5 4.6 2.0 2.8 2.6 4.1 9.2 3.1 3.4 34.2 11.2 1.4 7.4 1.0 3.9 4.5 2.2 8.9 7.3 8.9 8.4 6.6 9.1 5.0 3.8 4.2 5.5 5.3 11.9 12.2 2.2 4.7 5.2 5.5 5.8 0.8 3.7 1.3 5.3 3.8 3.6 3.9 3.6 9.1 2.9 2.7 2.3 2.2 2.0 2.7 3.1 3.7 6.2 4.6 6.0 2.0 2.6 2.4 5.2 4.2 8.8 1.7 1.5 3.3 5.6 4.9 3.6 1.9 5.4 1.6 4.8 5.8 7.9 3.2 3.2 23.9 2.1 2.7 3.6 2.4 10.8 4.3 4.6 12.9 2.3 13.3 4.4 5.8 4.6 8.4 8.9 8.2 6.4 5.3 8.9 6.9 5.4 7.3 4.2 6.2 9.1 5.8 6.6 5.7 6.5 6.8 5.0 10.9 14.6 3.6 7.6 12.6 12.9 9.0 5.7 20.8 11.2 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: " "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 5.5 4.8 9.3 2.8 11.4 1.1 7.8 3.7 7.1 10.1 3.7 13.9 19.4 5.1 6.3 19.9 2.5 25.2 7.5 4.8 10.4 11.2 11.2 3.0 5.3 2.3 8.3 8.9 8.9 5.7 20.7 14.6 4.4 12.1 5.4 4.2 9.3 8.2 22.4 4.0 3.3 2.7 5.3 8.5 2.6 5.1 27.2 7.9 1.1 21.0 3.2 1.9 5.7 3.5 1.5 1.0 0.0 3.8 0.1 3.0 1.0 2.5 7.1 9.0 6.0 2.7 8.9 0.5 0.0 4.5 4.3 3.3 0.4 4.9 0.3 5.0 2.5 3.0 2.0 3.4 2.9 1.1 1.9 0.1 1.8 3.4 8.9 1.6 0.1 5.0 3.0 5.4 1.3 4.5 2.7 0.8 2.6 8.6 1.6 1.0 2.7 6.6 5.3 0.7 0.4 10.6 1.8 8.3 3.6 3.6 1.2 5.5 3.6 0.9 3.1 0.9 0.9 4.8 0.9 0.2 0.5 0.0 5.5 0.2 1.8 0.0 0.7 0.0 1.4 3.8 2.5 1.5 1.6 2.3 0.4 0.6 3.0 1.5 0.0 0.1 3.5 1.0 1.2 1.0 9.3 11.4 3.7 7.1 10.4 11.2 8.3 8.9 12.1 7.9 IQGAP1 "HUMORFA01, KIAA0051, p195, SAR1" ENSG00000140575 "IQ motif containing GTPase activating protein 1" P46940 15 90388218-90502243 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013302, HPA014055" Enhanced Supported "Plasma membrane,Cell Junctions" 890000 "Plasma membrane, Cell Junctions" "CAB013302: AB_2533146, HPA014055: AB_1851856" "unprognostic (2.83e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (5.95e-2)" "unprognostic (4.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.67e-5)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.87e-1)" "unprognostic (1.25e-3)" 46.2 23.2 9.9 27.8 17.1 23.7 31.7 5.9 11.2 41.8 26.7 18.1 19.7 12.3 50.8 28.8 41.3 27.4 22.0 17.6 12.0 9.1 25.9 9.8 38.3 45.3 17.5 6.6 31.3 16.4 27.6 19.1 53.7 15.5 28.9 27.1 12.0 37.8 22.0 23.1 32.7 25.8 37.6 17.4 48.0 20.3 11.4 15.4 39.5 32.7 29.6 34.9 43.0 40.8 5.9 9.9 39.3 12.4 11.5 9.9 6.3 31.6 17.5 8.8 10.3 22.8 29.7 51.4 30.3 28.2 27.9 30.1 20.1 33.1 17.7 14.8 50.6 57.2 17.6 33.9 33.9 22.5 12.5 11.8 33.9 7.4 27.6 21.6 25.4 17.5 31.4 32.9 47.0 38.3 10.2 25.0 42.6 16.4 11.7 6.5 11.5 10.0 14.3 23.7 15.5 28.8 50.4 11.1 8.4 42.2 21.6 22.5 18.9 18.7 48.5 31.9 16.6 26.7 31.2 9.7 13.8 17.9 29.0 21.3 17.1 10.5 11.6 8.1 9.9 10.9 8.9 5.6 6.2 8.5 9.9 5.9 3.8 6.6 39.3 11.5 12.4 6.0 6.7 6.3 9.9 17.1 5.9 11.2 12.0 9.1 17.5 6.6 15.5 15.4 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403249-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.1" "Cell line enhanced" "Detected in many" "CACO-2: 21.5;Hep G2: 17.8;HMC-1: 63.8;RPMI-8226: 23.3;U-937: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 34.4" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" 8400000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: , HPA037404: " "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favourable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favourable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 11.1 11.3 1.4 14.7 1.7 6.3 8.0 1.1 1.2 6.1 21.6 0.6 36.2 16.8 2.6 14.7 3.3 2.7 21.7 4.2 1.6 1.6 13.2 66.1 7.8 13.0 1.3 0.7 4.2 14.8 25.5 2.3 42.5 2.1 9.1 6.8 15.2 18.9 34.3 1.4 3.7 35.7 3.4 2.0 16.5 12.4 30.7 0.4 7.7 12.8 2.8 7.7 4.3 4.2 0.6 7.8 14.9 3.2 4.1 5.9 1.3 0.0 2.8 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.2 0.8 0.0 0.0 3.6 0.0 0.0 2.4 3.5 7.9 2.1 17.8 0.0 4.4 63.8 0.0 0.0 0.0 0.0 0.3 6.9 6.4 0.0 0.0 3.8 12.1 4.4 0.1 1.4 0.0 23.3 0.0 0.0 0.1 0.9 5.0 0.2 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 5.9 0.0 5.5 0.0 16.7 0.9 14.9 3.2 1.8 4.8 2.4 4.0 0.6 5.0 4.1 2.9 0.2 2.0 3.6 6.3 4.1 3.1 7.8 5.9 1.3 1.4 1.7 1.1 1.2 1.6 1.6 1.3 0.7 2.1 0.4 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavourable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.3 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.4 13.0 21.7 2.1 6.5 10.2 22.4 7.2 9.0 15.4 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.2 9.9 6.3 3.4 12.5 12.3 2.2 5.5 7.7 11.4 7.5 12.0 2.4 4.3 8.0 6.7 10.5 15.9 18.7 6.4 14.9 10.3 6.5 15.6 18.6 12.7 20.5 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain 1" Q6DN90 3 12897220-13073117 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 34.2;U-266/84: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA038143: AB_10697241, HPA038144: " "prognostic unfavourable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favourable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favourable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 17.8 14.1 27.8 12.3 27.0 32.5 7.1 31.9 41.5 9.5 6.7 18.5 3.5 4.8 8.0 4.7 6.1 8.5 7.4 16.0 25.0 17.8 7.0 11.5 12.4 14.8 16.4 24.8 12.3 13.0 25.7 7.8 13.4 36.7 11.6 4.8 17.0 9.3 10.0 21.0 6.2 7.7 8.4 10.6 20.6 6.9 5.6 15.5 2.6 6.3 4.3 14.0 7.8 5.9 6.2 6.8 12.9 4.0 1.8 3.6 2.3 4.9 6.7 6.0 6.8 5.1 7.1 34.2 5.6 4.6 3.7 2.9 4.6 4.4 10.5 6.4 10.5 2.8 4.6 2.9 2.8 7.1 9.7 6.2 4.0 19.6 5.6 0.1 2.6 7.0 5.4 7.6 4.3 3.4 17.5 11.2 2.5 15.8 3.9 6.6 6.3 13.8 5.3 2.0 15.1 2.2 6.4 5.3 9.7 4.0 14.1 3.3 6.0 4.3 9.2 4.1 10.4 3.5 0.7 22.3 30.6 4.1 7.7 3.1 3.3 5.0 3.8 4.8 3.6 4.0 2.7 6.2 2.4 2.7 1.9 6.1 2.4 3.0 12.9 1.8 3.9 6.8 1.7 2.3 27.8 27.0 31.9 41.5 25.0 17.8 16.4 24.8 36.7 15.5 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Cell line enhanced" "Detected in some" "HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.7 3.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452400-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.8;testis: 35.5" "Cell line enhanced" "Detected in some" "K-562: 1.8;RPTEC TERT1: 7.1;T-47d: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments" Cytosol "HPA049626: " "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.6 1.0 1.3 0.3 2.9 0.3 0.9 3.0 3.5 1.2 0.5 1.8 3.2 0.4 1.4 6.9 1.8 5.7 1.6 0.6 2.6 1.2 8.5 0.4 3.2 0.3 0.7 1.2 2.7 0.7 2.7 20.8 0.5 6.4 0.9 0.4 0.3 0.7 4.3 0.6 0.5 0.5 0.6 1.0 0.4 0.6 35.5 2.8 0.0 5.6 0.0 0.3 0.7 0.6 0.8 0.0 0.0 0.3 0.5 0.7 0.0 0.3 0.0 1.3 0.6 0.6 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.8 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.7 0.3 0.2 0.3 0.0 1.8 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.1 1.6 1.1 0.4 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.3 0.4 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.3 0.4 0.2 0.2 0.2 0.0 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.3 0.0 1.3 2.9 3.0 3.5 2.6 1.2 0.7 1.2 6.4 2.8 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010500-154019980 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: " "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavourable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavourable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 22.3 23.7 12.1 25.0 11.4 48.3 38.5 7.7 14.8 11.1 24.8 10.8 13.4 29.9 13.2 12.4 25.5 12.2 23.1 14.1 9.9 12.3 23.7 46.9 18.5 37.5 12.6 7.9 15.1 34.6 8.1 15.2 14.3 11.9 18.0 11.0 10.1 31.9 15.9 32.6 15.9 34.6 11.5 12.7 34.0 19.3 14.3 9.8 17.0 12.6 20.4 26.7 17.2 15.3 10.0 13.0 6.7 10.6 6.3 6.7 3.4 76.3 29.7 4.2 34.3 8.4 6.7 18.3 11.4 10.8 17.6 16.4 23.5 34.0 32.6 64.3 12.2 20.9 9.7 18.6 6.9 25.6 29.0 11.9 26.7 14.0 19.4 28.1 20.5 9.3 16.4 16.8 18.6 10.5 20.9 37.8 12.3 28.1 11.5 25.1 10.4 59.3 30.0 21.3 54.8 11.7 14.5 23.6 17.0 13.6 15.2 22.5 5.9 29.9 14.3 21.4 33.9 48.9 70.7 47.6 30.4 59.8 31.3 33.8 22.2 1.3 8.7 6.7 6.7 10.6 5.9 7.5 5.3 5.3 5.4 10.0 3.1 6.1 5.9 6.3 8.1 13.0 2.5 3.4 12.1 11.4 7.7 14.8 9.9 12.3 12.6 7.9 11.9 9.8 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favourable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favourable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 3.9 2.8 3.7 10.1 17.0 4.0 7.5 5.3 6.0 5.5 3.3 5.1 9.1 7.4 6.2 4.4 3.1 4.8 8.6 13.0 2.9 8.7 3.0 2.1 5.8 12.0 10.7 9.0 7.8 7.6 4.4 8.8 8.0 6.8 16.4 2.9 10.4 6.8 1.0 4.6 6.9 3.4 4.8 4.6 5.1 2.0 1.9 3.6 4.7 3.6 5.9 10.7 7.8 7.4 1.4 9.0 5.1 8.4 10.8 7.9 7.6 32.4 4.0 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501456 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: , HPA068982: " "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 18.9 42.4 12.0 16.2 22.0 22.6 18.3 22.3 24.9 19.0 16.2 14.8 14.3 16.6 20.4 17.9 19.7 17.6 14.4 13.6 10.7 11.8 18.2 21.1 22.4 31.1 10.3 16.7 23.1 17.0 20.3 23.6 23.2 21.7 16.5 19.7 19.2 17.1 15.8 27.3 18.6 25.3 15.5 13.7 25.5 15.7 18.0 12.3 39.6 27.8 14.0 20.3 17.8 18.4 7.1 9.5 7.1 7.8 7.2 8.8 3.4 7.4 13.2 20.6 12.9 18.2 12.0 13.9 12.7 9.9 11.6 10.6 13.0 13.0 27.6 8.7 10.6 14.5 47.9 12.9 10.3 8.7 16.6 23.9 13.9 9.1 9.5 25.7 25.8 12.6 8.8 8.9 10.9 13.6 25.0 9.9 9.9 11.2 15.7 13.1 26.9 4.8 18.5 20.6 7.8 12.7 20.6 12.4 18.6 17.3 12.2 13.3 11.4 22.6 11.0 12.0 8.2 6.5 11.0 12.3 27.0 15.8 8.6 23.9 8.5 7.1 5.8 4.4 6.0 7.8 7.7 6.5 6.6 5.9 8.0 7.1 6.5 8.8 6.8 7.2 6.0 9.5 5.3 3.4 12.0 22.0 22.3 24.9 10.7 11.8 10.3 16.7 21.7 12.3 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132481609-132490798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 103.0" "Cell line enhanced" "Detected in many" "HHSteC: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: " "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 19.7 8.5 4.1 64.2 9.9 43.8 21.0 3.9 4.6 10.6 27.3 4.0 4.4 31.1 11.4 9.9 12.4 11.8 18.1 11.8 4.2 3.5 14.2 20.9 49.3 41.0 6.8 1.4 11.5 14.5 2.8 8.8 24.7 10.3 18.9 13.6 10.3 13.2 10.3 14.0 8.4 52.1 11.3 8.0 51.7 17.5 5.7 4.9 36.6 26.5 14.7 33.0 14.7 26.7 12.1 16.2 103.0 42.1 21.3 28.5 21.3 8.9 7.2 0.6 2.5 7.1 6.2 14.7 4.3 18.3 13.7 17.2 3.7 26.7 8.9 5.8 6.4 12.5 2.2 10.4 4.6 18.8 2.4 11.9 3.4 2.7 46.9 5.8 10.2 11.6 2.6 10.1 9.7 6.4 2.1 34.3 3.8 4.9 31.6 9.7 0.8 5.1 36.7 7.7 10.8 7.0 10.1 1.3 1.1 4.5 10.2 4.4 1.7 8.0 4.0 7.8 2.8 4.5 6.3 27.2 6.8 6.3 9.0 9.3 5.6 23.1 26.2 40.2 28.5 40.0 19.4 12.1 18.7 22.9 16.2 11.5 11.5 16.0 103.0 21.3 42.1 8.2 20.2 21.3 4.1 9.9 3.9 4.6 4.2 3.5 6.8 1.4 10.3 4.9 IRF2 ENSG00000168310 "Interferon regulatory factor 2" P14316 4 184387713-184474580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 49.8;Karpas-707: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030813, CAB032306, HPA057327" Supported Enhanced "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: " "prognostic favourable (6.95e-5)" "unprognostic (1.69e-3)" "unprognostic (5.43e-2)" "unprognostic (1.59e-3)" "unprognostic (2.70e-2)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-3)" "unprognostic (2.90e-2)" "unprognostic (4.00e-2)" "unprognostic (2.35e-1)" "unprognostic (6.87e-3)" "unprognostic (8.55e-3)" "unprognostic (5.25e-2)" "prognostic favourable (8.34e-5)" "unprognostic (1.31e-3)" 27.5 30.6 15.2 31.0 19.3 11.3 21.0 21.5 16.4 21.5 23.7 28.8 16.6 21.2 19.8 16.5 20.5 18.1 17.3 16.1 15.3 12.1 15.3 26.1 24.0 38.7 22.8 9.7 28.0 14.9 12.4 24.5 19.7 17.8 20.5 20.4 16.8 22.1 16.1 21.9 18.1 27.7 21.2 22.4 39.4 21.3 8.4 22.0 36.1 24.0 12.6 34.5 28.8 26.4 22.2 16.2 83.9 27.5 18.1 21.9 17.2 6.0 4.4 5.5 3.6 12.1 12.4 3.3 4.4 13.9 10.9 11.5 1.3 11.6 3.7 2.3 6.6 5.6 3.7 8.4 7.1 49.8 2.0 10.3 2.5 8.0 12.0 6.2 8.7 13.3 7.8 6.2 16.1 8.3 2.0 52.0 4.5 4.2 12.0 7.7 1.2 3.3 15.9 2.1 16.5 8.3 9.3 2.3 3.6 6.2 5.2 9.1 4.0 5.7 6.8 3.1 3.4 3.5 3.9 14.9 11.9 3.2 6.6 6.1 5.5 17.7 19.4 34.5 16.4 25.3 16.9 21.2 16.3 17.6 16.2 22.2 17.5 17.3 83.9 18.1 27.5 4.1 21.9 17.2 15.2 19.3 21.5 16.4 15.3 12.1 22.8 9.7 17.8 22.0 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391739-411447 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.7" "Cell line enhanced" "Detected in some" "HDLM-2: 49.1;Karpas-707: 45.6;RPMI-8226: 44.1;U-266/70: 41.3;U-266/84: 30.7;WM-115: 25.0" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8" "Group enriched" "Detected in many" 5 "B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favourable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favourable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 7.1 0.5 0.4 36.6 0.4 18.4 4.0 0.4 0.4 17.4 13.9 0.1 0.4 5.0 2.2 0.7 6.4 1.2 4.1 1.6 0.4 0.5 1.4 5.6 4.2 31.5 0.5 0.0 1.9 0.7 0.0 0.7 0.5 0.1 1.5 4.8 15.8 21.3 1.9 0.7 4.5 11.1 0.3 0.6 33.8 4.6 1.7 0.1 15.2 1.3 2.4 48.7 8.4 4.2 9.7 10.4 0.0 1.6 0.2 4.8 1.3 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 45.6 0.0 0.0 0.0 0.0 0.2 0.0 5.8 0.0 44.1 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 30.7 13.4 0.0 0.0 25.0 0.0 1.6 0.0 0.6 1.2 0.0 9.5 0.9 0.9 9.0 9.7 1.6 0.7 0.0 0.2 1.2 10.4 4.8 1.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.0 0.1 0.1 IRF6 "LPS, OFC6, VWS, VWS1" ENSG00000117595 "Interferon regulatory factor 6" O14896 1 209785623-209806175 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 16.0;HaCaT: 58.3;HBEC3-KT: 21.3;hTCEpi: 47.0;hTERT-HME1: 23.5;RT4: 20.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 8.6;pons and medulla: 4.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA063121, HPA076162" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA063121: AB_2684942, HPA076162: AB_2686780" "unprognostic (2.59e-1)" "unprognostic (1.79e-3)" "unprognostic (1.74e-1)" "unprognostic (7.80e-2)" "unprognostic (1.33e-2)" "unprognostic (4.94e-3)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (7.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (2.03e-1)" "prognostic favourable (0.00e+0)" "unprognostic (2.70e-1)" "unprognostic (2.66e-2)" "unprognostic (2.14e-1)" "unprognostic (4.42e-2)" 1.0 6.3 1.1 4.1 1.0 0.3 13.3 8.6 0.9 11.7 12.9 1.0 38.6 9.2 3.9 31.4 63.7 7.6 17.5 10.3 1.1 0.8 12.9 18.4 8.8 0.3 0.9 0.7 3.9 13.9 10.3 6.8 26.7 4.4 21.8 11.3 1.5 24.8 34.6 0.6 45.6 20.3 3.1 1.1 1.2 9.5 4.3 0.3 13.0 22.1 32.3 33.8 15.0 19.1 0.9 0.5 2.0 1.0 0.6 2.8 0.7 16.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.1 0.0 0.0 3.4 5.7 0.0 0.0 0.0 58.3 0.0 21.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 23.5 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 20.8 5.2 1.7 0.4 9.3 0.5 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.2 0.1 2.0 2.8 1.0 1.9 0.6 0.6 0.9 0.5 0.9 2.1 1.1 0.1 0.6 0.1 0.2 0.0 0.7 1.1 1.0 8.6 0.9 1.1 0.8 0.9 0.7 4.4 0.3 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615999 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.0;Karpas-707: 10.6;SCLC-21H: 5.2;SK-BR-3: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 12 "plasmacytoid DC: 81.1" "Lineage enriched" "Detected in all" 12 "dendritic cells: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017694, HPA052757" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: " "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavourable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 9.6 4.7 4.5 9.9 6.1 17.2 12.1 2.9 4.9 4.8 4.6 2.5 2.2 2.2 4.2 5.1 6.9 4.9 9.0 5.2 3.7 2.0 8.2 23.3 11.6 12.8 4.6 1.4 4.8 3.6 2.2 3.8 4.8 5.5 5.3 2.9 5.2 5.4 7.4 6.1 4.1 8.4 5.7 4.5 19.0 4.5 4.0 5.2 8.5 9.0 2.4 12.8 7.5 3.9 2.5 81.1 3.7 6.6 2.1 1.5 1.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.1 0.0 10.6 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 5.2 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 3.7 1.1 6.6 1.1 2.5 1.0 1.2 3.3 2.4 1.1 1.2 1.7 2.1 6.1 81.1 1.5 1.8 4.5 6.1 2.9 4.9 3.7 2.0 4.6 1.4 5.5 5.2 IRS1 HIRS-1 ENSG00000169047 "Insulin receptor substrate 1" P35568 2 226731317-226799759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005261, HPA046433" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005261: AB_649615, HPA046433: " "unprognostic (2.20e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.59e-2)" "unprognostic (3.86e-3)" "unprognostic (1.61e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-3)" "unprognostic (5.47e-2)" "unprognostic (2.24e-2)" "unprognostic (5.48e-3)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.46e-2)" "unprognostic (6.92e-2)" "unprognostic (3.23e-2)" "unprognostic (7.55e-3)" 7.0 9.9 3.1 5.0 2.7 0.6 11.7 9.6 5.4 13.3 14.2 1.4 3.9 4.0 17.2 5.0 3.8 13.9 11.5 6.3 3.9 2.2 5.2 12.0 5.0 2.5 2.3 2.6 21.9 7.1 3.4 2.5 9.1 4.2 9.8 2.9 5.5 3.3 7.5 23.3 5.1 6.5 11.7 2.6 3.3 5.8 2.4 1.7 17.1 23.4 5.6 2.5 14.6 15.8 1.2 0.4 0.0 0.2 0.0 0.3 0.2 3.2 14.7 10.8 0.4 14.9 8.9 0.0 8.8 7.0 11.9 7.7 8.4 8.2 1.3 1.5 6.0 5.6 0.7 8.5 6.8 3.2 0.6 0.0 0.9 3.9 7.4 0.3 0.0 12.3 4.7 9.3 8.5 0.0 1.6 13.1 8.0 12.6 2.7 3.7 4.3 8.2 0.6 14.0 0.1 5.4 10.7 1.9 0.3 2.8 2.0 4.7 7.9 0.1 0.7 15.7 14.4 12.1 8.5 6.1 2.5 1.9 15.5 0.3 4.6 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.1 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.2 3.1 2.7 9.6 5.4 3.9 2.2 2.3 2.6 4.2 1.7 IRS2 ENSG00000185950 "Insulin receptor substrate 2" Q9Y4H2 13 109752698-109786568 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 18.0;SH-SY5Y: 18.9;THP-1: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016944, HPA054664" Approved Supported Aggresome,Cytosol Cytosol Aggresome "CAB016944: , HPA054664: " "unprognostic (2.87e-3)" "unprognostic (5.73e-3)" "unprognostic (4.39e-2)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (5.49e-3)" "unprognostic (2.10e-1)" "unprognostic (9.28e-2)" "unprognostic (9.70e-2)" "unprognostic (2.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.09e-2)" "unprognostic (6.21e-3)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (3.17e-2)" "unprognostic (1.24e-1)" 38.9 24.3 27.6 10.9 25.2 70.1 33.5 19.6 30.6 13.5 10.9 13.0 6.7 8.7 14.4 12.2 7.1 7.7 8.4 13.5 23.6 14.6 7.7 24.6 11.6 5.3 24.2 22.1 27.1 7.9 6.1 23.0 13.6 19.5 20.0 7.5 9.3 11.5 12.2 20.9 15.3 9.7 9.7 25.1 9.0 8.3 6.3 21.3 2.0 10.7 4.7 5.3 8.4 17.8 0.5 0.1 6.9 1.4 0.2 0.5 0.2 2.6 3.0 1.9 0.0 16.5 3.3 1.0 2.9 3.4 1.7 1.5 0.2 3.2 0.0 1.8 2.0 1.2 1.0 2.6 2.2 1.0 13.6 1.2 4.3 0.0 16.7 4.7 1.5 6.9 13.9 0.5 18.0 0.6 0.8 0.0 17.0 1.3 0.0 13.9 2.1 0.6 5.9 1.8 1.2 4.9 0.7 2.9 18.9 1.5 0.0 11.6 0.3 28.3 0.0 3.7 0.0 0.2 3.8 0.0 1.3 0.9 2.7 4.6 6.3 2.7 1.4 1.9 0.2 0.3 0.3 0.1 0.4 0.1 0.1 0.5 0.5 0.4 6.9 0.2 0.4 0.1 0.5 0.2 27.6 25.2 19.6 30.6 23.6 14.6 24.2 22.1 19.5 21.3 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Group enriched" "Detected in some" 4 "AF22: 7.0;REH: 28.3;U-251 MG: 11.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 28.3 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell line enhanced" "Detected in many" "AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: " "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favourable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 39.8 0.0 2.2 1.5 23.9 2.3 1.3 2.0 1.5 4.7 0.0 0.0 0.0 4.4 13.5 0.0 9.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.2 0.9 8.1 0.0 0.0 0.0 1.4 7.7 0.0 0.0 4.4 0.0 0.0 2.5 0.0 8.9 0.0 1.5 0.0 7.8 16.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell line enhanced" "Detected in some" "BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.3 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930862-54934485 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 19.0;heart muscle: 26.5" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.8;T-47d: 24.3;THP-1: 13.0" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favourable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 3.3 0.7 0.2 0.2 1.4 0.2 19.0 5.8 0.3 3.6 0.5 1.7 0.2 0.2 0.4 1.9 7.6 0.3 0.4 26.5 0.9 1.3 4.7 0.2 10.3 0.3 2.6 0.0 0.5 0.3 0.5 0.3 0.2 5.3 4.2 0.2 6.5 13.6 0.5 6.7 13.9 0.2 0.3 4.5 0.2 3.3 0.9 2.2 0.4 0.2 1.0 2.4 0.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 5.7 2.1 2.1 0.4 0.2 2.2 5.4 0.7 0.5 1.2 0.5 0.0 0.5 2.9 5.5 2.0 2.3 0.4 3.8 2.7 0.6 2.3 0.0 0.0 1.3 2.2 0.6 10.1 3.6 1.5 0.0 0.3 0.0 4.1 2.0 6.0 7.8 0.1 1.6 3.2 2.9 0.3 17.8 0.1 2.0 2.0 0.9 4.9 2.4 24.3 13.0 0.3 4.0 0.1 2.8 0.8 2.4 1.4 1.8 6.4 2.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 5.8 0.2 0.9 1.3 2.6 0.0 5.3 2.2 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favourable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 10.4 0.0 0.2 0.1 0.1 1.7 6.6 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173671-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 33.1;ASC TERT1: 17.8;fHDF/TERT166: 74.3;HSkMC: 13.5;RPMI-8226: 22.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "olfactory region: 145.0" "Low region specificity" "Detected in many" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" 110000000 "Plasma membrane" "Golgi apparatus" "HPA040326: , HPA050811: " "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavourable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 24.6 6.8 3.3 10.4 4.6 0.1 21.4 2.0 12.1 72.8 19.7 2.9 13.2 4.1 67.3 36.3 23.0 22.1 29.6 17.7 1.7 1.7 8.0 2.5 10.2 5.8 3.3 7.2 80.2 3.4 1.2 13.8 31.5 3.9 32.2 4.0 36.4 10.0 17.9 12.5 13.6 8.8 27.5 9.0 9.8 10.3 16.3 0.6 1.3 18.9 17.0 9.9 27.9 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 33.1 17.8 0.1 5.1 0.0 0.0 0.0 0.0 2.0 0.0 0.3 74.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 22.8 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.9 0.0 0.1 0.5 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.6 2.0 12.1 1.7 1.7 3.3 7.2 3.9 0.6 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094751-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" 1500000 "Endoplasmic reticulum, Vesicles" "HPA070307: " "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 10.5 13.1 9.2 8.9 9.7 4.1 20.7 2.2 8.4 26.3 14.6 7.5 2.1 12.8 44.3 9.0 17.1 13.6 6.4 48.6 7.3 14.2 13.7 40.3 7.1 10.3 11.3 9.5 14.7 22.0 6.8 18.0 7.5 11.2 9.2 9.1 5.4 19.0 3.8 6.6 11.4 19.6 27.1 11.5 5.8 7.9 5.5 9.2 10.4 9.3 11.2 10.2 8.2 10.9 23.2 15.6 24.2 12.8 26.9 32.8 22.0 8.5 6.8 7.0 10.8 11.6 6.2 31.2 3.7 3.2 4.3 7.6 23.7 12.2 6.1 9.3 2.1 4.7 14.9 11.2 7.9 33.5 17.0 12.2 6.9 17.3 8.2 4.8 4.4 4.0 3.4 6.6 5.8 10.1 13.2 10.7 3.7 34.3 8.9 7.8 10.8 18.6 12.9 20.6 6.0 10.6 17.5 12.0 51.3 10.7 13.6 6.7 11.2 4.0 4.2 4.8 9.2 3.8 12.0 9.0 7.0 10.2 5.4 15.2 5.4 24.2 12.8 18.1 28.5 12.2 31.9 23.2 26.8 30.0 15.6 21.1 23.7 27.9 15.9 26.9 11.5 14.2 32.8 22.0 9.2 9.7 2.2 8.4 7.3 14.2 11.3 9.5 11.2 9.2 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.9" "Cell line enhanced" "Detected in many" "HEK 293: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol 230000 Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 12.7 16.4 13.4 12.8 15.0 10.5 28.1 9.0 15.6 10.9 15.9 9.9 17.1 20.6 8.9 13.5 14.7 10.7 19.2 20.9 13.4 12.9 33.2 93.9 11.2 10.2 15.4 11.2 9.1 23.8 12.8 14.2 5.5 14.6 12.0 10.0 7.2 23.3 21.2 47.2 10.0 20.5 12.0 13.9 15.8 12.9 23.3 13.4 5.9 14.9 22.9 11.8 12.8 8.8 11.5 18.1 0.5 20.0 14.1 10.4 9.1 12.6 19.3 5.3 14.3 3.7 7.7 17.0 9.0 9.6 11.9 12.2 9.5 22.6 24.2 16.8 10.9 12.7 10.3 11.9 4.0 9.2 68.2 13.7 4.6 31.2 14.7 15.3 42.0 11.4 11.4 7.6 5.9 10.8 22.3 16.2 7.6 25.0 0.0 18.0 8.2 54.9 17.4 11.0 31.6 19.8 12.0 6.3 18.0 8.8 19.8 10.2 16.5 27.3 7.7 8.7 12.5 9.8 10.8 19.6 16.9 18.8 13.7 19.5 15.0 0.4 9.9 0.5 8.3 20.0 8.2 11.5 7.7 10.4 18.1 8.8 7.8 7.8 0.4 14.1 16.1 14.8 9.1 9.1 13.4 15.0 9.0 15.6 13.4 12.9 15.4 11.2 14.6 13.4 ISPD "hCG_1745121, IspD, Nip" ENSG00000214960 "Isoprenoid synthase domain containing" A4D126 7 16087527-16421322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 8.3;HEL: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "basophil: 10.7" "Lineage enriched" "Detected in single" 22 "granulocytes: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043810, HPA053554" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA043810: AB_10964489, HPA053554: " "unprognostic (4.65e-3)" "unprognostic (5.92e-2)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-2)" "unprognostic (2.07e-1)" "prognostic favourable (1.38e-11)" "unprognostic (4.01e-2)" "unprognostic (1.78e-4)" "unprognostic (6.26e-2)" "unprognostic (2.79e-1)" 3.0 3.8 4.2 1.9 4.5 2.6 3.0 7.7 7.7 3.7 2.9 3.9 3.4 1.8 4.7 2.4 2.0 2.8 3.2 7.1 4.4 4.5 7.0 10.0 2.9 1.5 4.7 3.9 2.7 3.9 3.6 5.7 8.0 4.6 3.5 3.0 5.7 5.5 10.1 4.5 2.6 1.8 3.7 4.9 1.4 10.2 3.9 2.4 1.1 2.6 2.4 1.4 3.2 3.7 0.3 0.4 10.7 0.1 0.4 0.3 0.0 0.3 2.3 1.2 1.8 1.0 1.5 8.3 1.8 1.2 1.6 1.3 2.6 2.2 0.0 4.0 2.6 3.0 1.4 0.0 2.9 1.0 1.4 11.5 1.4 0.6 1.3 0.9 1.4 2.7 1.2 1.3 0.2 1.2 2.7 0.2 4.1 0.5 1.1 1.0 2.2 0.3 0.0 1.8 0.1 2.7 0.8 2.0 1.3 1.3 2.4 2.5 1.7 2.6 1.3 2.3 2.1 0.3 2.2 0.2 0.0 0.0 1.9 2.7 2.8 10.7 0.1 0.4 0.3 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.0 0.4 0.0 0.0 4.2 4.5 7.7 7.7 4.4 4.5 4.7 3.9 4.6 2.4 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 22.2" "Group enriched" "Detected in some" 15 "CACO-2: 3.4;Hep G2: 9.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060328 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA060328: " "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.1 0.0 0.1 2.0 0.1 0.0 0.1 0.1 0.1 0.1 16.3 0.1 0.1 22.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 15.8 0.1 0.1 0.1 0.1 0.0 19.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438301 "Enzymes, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.6" "Cell line enriched" "Detected in many" 4 "BEWO: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavourable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 7.9 8.4 7.1 3.0 5.7 4.5 7.1 2.7 6.7 9.9 3.5 10.0 44.2 3.4 13.9 12.3 4.5 20.0 6.5 8.0 5.7 7.4 12.7 4.1 4.7 3.8 4.1 4.1 31.6 25.5 7.7 12.6 44.2 16.2 9.5 1.3 19.3 8.8 34.4 8.2 3.4 3.9 3.0 2.3 10.5 3.7 83.6 3.5 3.0 5.6 3.8 3.3 5.9 7.8 4.0 1.9 0.9 0.2 11.9 8.5 4.9 2.7 8.4 20.1 5.9 0.1 0.0 101.5 1.3 0.2 0.1 0.0 4.8 5.1 0.0 6.9 0.6 7.2 0.6 0.0 0.0 7.5 23.1 10.1 0.5 15.5 2.1 0.1 0.2 1.6 0.1 0.5 0.1 1.2 20.6 0.4 0.0 16.2 0.7 0.7 10.5 6.8 13.9 0.0 4.7 1.7 0.0 6.2 15.5 0.3 1.9 10.2 13.7 1.1 3.9 0.1 0.2 0.1 0.3 3.2 1.4 0.6 0.6 0.4 3.5 0.9 0.1 0.0 7.6 0.2 5.9 4.0 7.4 6.7 0.7 2.3 6.1 8.5 0.8 11.9 0.1 1.9 5.2 4.9 7.1 5.7 2.7 6.7 5.7 7.4 4.1 4.1 16.2 3.5 ITCH AIP4 ENSG00000078747 "Itchy E3 ubiquitin protein ligase" Q96J02 20 34363235-34511393 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021126, HPA049032, CAB072824, CAB072825" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: " "unprognostic (2.51e-1)" "unprognostic (6.95e-2)" "unprognostic (1.25e-3)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (9.29e-3)" "unprognostic (1.94e-1)" "unprognostic (3.89e-3)" "unprognostic (1.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.24e-1)" "unprognostic (3.23e-2)" "unprognostic (2.21e-1)" 20.7 16.7 18.9 15.4 26.9 20.5 17.5 19.8 26.7 23.9 18.2 37.9 15.2 16.9 18.4 15.1 35.9 14.5 14.5 17.9 20.4 15.9 21.1 46.5 18.5 16.8 29.2 16.5 19.3 17.1 21.6 26.3 26.9 29.0 17.5 20.4 16.7 20.1 18.4 24.0 19.2 20.3 19.8 30.4 17.3 17.3 34.8 32.3 22.3 22.7 13.0 23.6 19.6 21.0 7.3 11.4 19.6 6.2 6.2 11.4 2.7 20.0 13.2 13.5 9.7 14.9 21.3 16.2 16.3 18.7 20.4 20.0 37.2 30.9 9.8 15.8 20.8 25.4 20.5 32.9 24.9 7.4 6.6 28.4 11.2 22.2 15.6 11.6 12.9 10.8 16.8 17.2 27.0 15.3 16.1 17.0 15.9 10.0 17.0 6.2 6.5 15.7 14.3 28.5 22.6 12.1 34.8 8.3 6.1 30.5 11.9 18.3 14.3 10.5 14.8 24.4 14.7 15.9 12.0 13.5 14.1 14.3 15.1 7.5 14.3 3.6 5.8 6.1 10.8 6.2 11.4 7.3 3.8 5.7 4.5 6.9 3.3 4.9 19.6 6.2 3.8 11.4 4.8 2.7 18.9 26.9 19.8 26.7 20.4 15.9 29.2 16.5 29.0 32.3 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" 21000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favourable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 14.0 26.6 19.9 8.8 52.4 6.4 15.0 31.2 34.6 18.3 20.0 14.8 9.8 17.3 17.5 19.0 11.5 15.8 17.1 26.0 20.7 26.6 28.7 26.5 15.8 11.0 17.0 19.0 17.4 20.2 43.0 22.9 30.7 28.7 17.9 19.9 13.8 15.1 18.1 14.6 10.8 19.4 17.4 17.6 12.4 16.0 20.7 15.7 13.4 25.8 7.6 11.5 15.3 11.6 12.8 18.7 23.4 24.4 16.6 18.3 17.7 8.1 9.6 17.5 12.1 34.3 26.5 20.9 20.0 28.5 18.2 9.7 5.5 20.1 10.0 27.2 24.6 12.3 8.5 12.7 18.1 4.3 5.9 5.3 9.2 12.7 16.0 12.4 23.3 19.4 22.2 9.2 12.1 17.4 14.9 13.2 22.7 8.0 7.7 5.8 5.6 9.4 11.7 17.3 24.8 24.1 6.1 8.6 12.1 18.1 21.0 8.8 9.2 11.4 16.8 19.4 9.5 10.3 7.6 18.6 24.4 18.6 19.3 7.9 15.1 13.5 24.4 23.4 12.4 23.8 12.0 12.8 15.4 13.7 18.7 11.4 16.9 14.1 15.4 16.6 21.9 13.0 18.3 17.7 19.9 52.4 31.2 34.6 20.7 26.6 17.0 19.0 28.7 15.7 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoplasm, Endoplasmic reticulum" "Cytokinetic bridge" "HPA038664: AB_10672722, HPA038665: " "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.2 16.1 11.1 15.4 14.0 12.0 14.3 17.8 17.2 16.2 13.2 23.2 21.3 11.8 19.6 16.6 13.2 17.2 14.7 12.0 8.7 9.8 15.0 11.4 14.4 14.0 13.3 9.9 29.0 28.4 22.7 23.0 13.8 13.3 13.8 14.7 22.1 23.0 19.5 7.8 10.9 13.9 13.5 10.6 20.3 14.8 10.6 15.2 25.4 26.2 9.3 23.0 14.4 15.3 17.7 12.9 5.4 21.2 13.8 14.4 10.0 4.7 7.0 8.2 6.5 7.0 8.1 7.5 10.6 6.0 12.8 9.5 15.0 11.8 10.9 3.0 9.9 6.1 12.4 10.5 9.6 9.6 7.4 15.4 7.9 6.0 13.0 13.9 8.3 10.9 12.5 11.7 18.0 8.8 8.2 11.8 7.3 14.3 20.1 8.1 16.6 5.4 10.2 9.0 6.3 7.7 8.1 3.9 12.4 13.1 11.6 4.7 7.1 6.4 8.9 8.6 5.2 8.2 20.1 1.5 0.9 16.6 5.6 8.1 8.5 2.8 10.9 5.4 13.7 14.3 12.8 17.7 10.5 13.4 12.9 17.1 14.4 13.5 1.3 13.8 21.2 9.8 8.5 10.0 11.1 14.0 17.8 17.2 8.7 9.8 13.3 9.9 13.3 15.2 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.1;HaCaT: 30.4;HUVEC TERT2: 28.0;TIME: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.5 5.0 0.4 0.2 1.3 2.4 1.5 19.8 30.1 0.7 1.2 9.4 13.8 0.0 3.4 8.4 30.4 1.6 22.2 2.9 0.0 1.5 1.4 1.3 5.6 4.6 0.2 0.4 1.0 3.9 19.9 3.5 28.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 10.1 0.0 0.1 0.0 6.3 10.4 0.2 1.1 1.0 1.3 2.0 3.2 0.0 23.9 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.8 0.0 15.9 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favourable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.1 1.7 3.2 5.2 29.5 5.9 0.3 2.2 3.7 5.0 5.2 3.5 2.8 0.9 3.2 1.4 0.4 2.2 0.1 4.5 0.1 1.6 0.3 1.1 1.3 0.2 0.1 1.1 8.3 0.0 27.9 0.1 0.0 0.4 0.6 16.9 2.1 0.1 1.2 9.0 0.2 0.0 12.2 0.2 0.1 0.0 0.4 1.2 0.2 0.0 20.4 0.3 5.7 0.0 0.5 5.5 0.3 3.5 1.3 0.9 0.3 25.2 3.4 0.3 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.6 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 10.6 0.0 3.4 1.5 0.0 0.2 4.1 0.0 0.0 0.1 0.6 8.5 0.2 0.2 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.2 0.6 12.7 0.1 0.6 0.7 0.0 3.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.6 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavourable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.7 11.7 7.8 24.9 28.7 19.4 29.7 19.2 15.5 6.8 6.8 10.2 33.8 0.0 37.9 21.6 12.3 3.9 18.1 9.8 1.9 3.5 2.3 15.4 14.0 11.3 1.6 1.4 14.1 8.6 15.2 12.9 16.2 2.2 4.9 18.1 3.8 0.9 1.3 5.9 5.9 0.0 15.9 1.3 17.6 75.3 1.6 4.8 22.2 6.9 8.1 5.4 4.5 49.1 42.2 13.2 8.6 16.2 1.2 2.0 1.1 17.0 0.6 20.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 ITGB1 "CD29, FNRB, GPIIA, MDF2, MSK12" ENSG00000150093 "Integrin subunit beta 1" P05556 10 32900319-33005792 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003434, HPA059297, HPA069003" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Focal adhesion sites" 540000000 "Plasma membrane, Focal adhesion sites" "Endoplasmic reticulum" "CAB003434: AB_303570, HPA059297: , HPA069003: " "unprognostic (3.07e-2)" "prognostic unfavourable (5.01e-4)" "unprognostic (8.67e-2)" "unprognostic (4.36e-1)" "unprognostic (1.20e-2)" "unprognostic (3.87e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (3.36e-6)" "unprognostic (3.22e-1)" "unprognostic (2.36e-3)" "unprognostic (3.68e-3)" "unprognostic (2.42e-1)" "unprognostic (1.02e-3)" "unprognostic (1.25e-2)" "unprognostic (2.23e-1)" "unprognostic (2.48e-1)" "unprognostic (3.08e-2)" 95.2 30.6 13.7 32.1 19.7 9.7 107.7 6.5 14.8 55.1 61.3 17.0 80.2 20.2 84.2 56.2 59.9 45.0 49.8 68.7 15.0 14.4 47.3 85.8 55.4 34.5 23.0 11.1 47.4 37.4 17.6 35.2 83.3 19.5 53.1 32.2 18.6 30.3 76.2 58.0 19.5 42.3 109.3 30.1 59.8 45.4 26.9 18.8 12.7 36.8 27.6 19.4 92.7 47.4 31.3 9.1 4.3 27.1 21.9 68.4 26.2 47.4 69.7 37.6 41.7 90.9 78.3 32.8 159.7 92.6 76.1 69.6 15.6 111.2 12.8 28.9 133.9 33.2 11.3 90.9 84.9 12.6 9.2 15.4 33.2 18.2 64.0 3.4 15.3 79.3 49.7 80.0 32.6 93.4 10.6 5.7 125.4 7.8 5.9 3.5 8.4 35.4 3.9 27.9 2.3 108.5 13.8 8.9 22.3 49.8 8.5 35.8 11.4 12.4 104.5 98.0 56.9 69.6 53.2 5.2 1.1 7.2 72.2 14.6 38.4 1.6 9.8 4.3 25.5 17.8 6.0 31.3 54.6 37.5 9.1 8.6 7.1 19.1 2.3 21.9 27.1 3.7 68.4 26.2 13.7 19.7 6.5 14.8 15.0 14.4 23.0 11.1 19.5 18.8 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423547 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Centriolar satellite,Cytosol" Nucleoplasm "Nuclear bodies, Centriolar satellite, Cytosol" "HPA067348: , HPA071538: " "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavourable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavourable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavourable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 61.1 15.0 19.0 11.6 29.2 16.1 73.0 17.6 24.0 24.5 16.3 9.9 10.2 7.7 18.0 16.6 13.3 15.0 14.4 23.9 17.1 15.6 23.6 7.7 13.4 12.1 19.7 18.7 14.3 7.6 14.8 9.7 14.1 19.4 11.1 14.8 11.4 7.7 15.1 16.0 16.6 8.6 22.1 19.2 8.6 11.2 5.6 17.0 10.2 11.2 12.1 14.8 12.8 33.6 20.7 29.5 35.2 27.3 24.1 31.3 24.9 16.0 11.5 13.6 15.5 48.5 41.2 7.4 29.4 20.2 26.6 20.7 15.3 10.0 17.7 13.3 40.3 15.2 20.7 19.2 29.4 47.7 10.5 16.1 13.6 19.0 16.9 12.4 17.6 23.2 15.9 24.3 17.4 23.2 9.0 14.7 32.9 14.3 21.9 8.1 11.0 19.3 12.6 18.6 16.4 26.9 13.2 14.8 14.3 16.4 12.6 19.8 9.3 9.4 14.7 23.9 17.6 31.8 32.6 14.7 31.6 25.9 32.7 17.1 16.5 35.2 23.0 27.9 30.4 27.3 28.9 20.7 26.5 29.4 29.5 17.5 20.6 26.5 5.0 24.1 20.0 26.6 31.3 24.9 19.0 29.2 17.6 24.0 17.1 15.6 19.7 18.7 19.4 17.0 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6" "Group enriched" "Detected in some" 5 "THP-1: 114.8;U-937: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" 2500000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 59.1 9.8 9.0 47.5 16.8 91.4 8.4 1.7 8.0 5.6 7.4 12.2 1.2 6.3 4.9 9.0 4.8 10.7 10.3 9.7 7.2 6.4 8.1 7.0 32.9 73.8 14.3 2.9 6.6 5.1 1.1 3.3 12.7 12.1 6.9 4.2 5.2 8.8 2.7 3.0 4.1 13.2 12.3 18.3 75.6 7.6 4.2 12.2 53.5 4.5 2.2 29.0 15.7 4.2 9.5 76.0 104.6 122.9 41.0 57.4 159.7 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.4 19.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.4 0.0 15.0 3.9 0.2 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.5 17.0 18.0 0.0 0.3 0.2 3.5 9.3 0.7 0.0 0.0 0.2 0.5 0.3 0.3 0.0 114.8 0.3 0.0 1.0 0.0 0.5 0.1 0.8 0.4 0.0 85.3 0.1 10.5 122.9 85.7 57.4 84.1 25.8 6.7 28.4 39.5 76.0 9.5 19.1 32.0 104.6 41.0 81.0 11.6 20.7 159.7 9.0 16.8 1.7 8.0 7.2 6.4 14.3 2.9 12.1 12.2 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell line enhanced" "Detected in some" "EFO-21: 45.5;HEL: 40.3;RPTEC TERT1: 26.2;U-87 MG: 20.6;WM-115: 65.7" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.3 1.0 0.0 1.2 6.0 2.6 2.4 0.0 0.0 0.1 45.5 0.3 0.0 0.0 0.0 3.4 0.8 0.0 40.3 0.1 0.0 1.9 0.0 0.0 0.9 0.0 15.2 0.3 11.3 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 26.2 0.0 0.0 0.1 1.5 0.0 8.2 0.0 0.0 12.3 0.5 0.6 0.3 2.8 0.0 0.0 0.2 20.6 0.0 65.7 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 ITGB4 CD104 ENSG00000132470 "Integrin subunit beta 4" P16144 17 75721328-75757818 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 117.5;HaCaT: 45.0;HBEC3-KT: 100.3;hTCEpi: 34.3;RT4: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002422, CAB005258, HPA036348, HPA036349" Enhanced Supported "Plasma membrane,Cell Junctions" 79000 "Plasma membrane, Cell Junctions" "CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078" "unprognostic (3.17e-3)" "unprognostic (3.52e-1)" "unprognostic (4.19e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" "prognostic unfavourable (6.39e-4)" "unprognostic (1.02e-1)" "unprognostic (2.23e-2)" "unprognostic (1.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" 6.3 3.4 9.7 10.9 9.7 1.4 13.7 4.7 7.7 14.3 32.1 15.6 10.0 35.3 9.7 8.8 24.0 13.7 47.8 4.3 9.4 7.9 4.8 1.5 7.4 3.7 10.1 9.1 4.7 6.7 3.1 5.7 50.0 17.2 19.7 10.4 9.8 52.3 13.2 2.4 47.0 58.5 7.4 10.7 17.0 41.0 3.9 9.8 1.8 3.2 22.1 15.9 17.2 20.5 2.4 8.2 1.3 0.7 0.0 2.2 0.8 21.8 19.3 0.0 0.2 0.0 0.1 26.6 0.1 0.0 0.0 0.1 2.0 117.5 0.0 4.2 0.0 45.0 0.1 100.3 0.0 0.1 0.0 0.1 4.9 2.1 0.1 0.0 0.2 0.1 34.3 0.0 21.4 0.7 0.0 2.0 0.0 12.2 0.2 0.2 0.1 16.8 0.3 0.5 0.2 26.8 33.0 0.0 0.2 0.6 2.0 0.3 8.4 0.2 2.2 0.6 1.0 0.0 0.2 0.7 0.2 0.0 0.2 0.1 0.3 0.0 0.4 0.0 0.7 0.7 2.2 1.4 0.3 1.0 0.1 2.4 0.9 0.6 1.3 0.0 0.0 8.2 1.4 0.8 9.7 9.7 4.7 7.7 9.4 7.9 10.1 9.1 17.2 9.8 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 74.0;WM-115: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 29.6 74.0 5.3 13.4 50.2 14.6 27.5 31.8 19.7 5.9 9.6 14.7 38.8 0.1 15.5 54.0 23.8 4.8 16.5 5.2 0.3 3.2 10.5 11.4 15.5 8.8 0.0 19.3 8.7 3.8 14.9 7.8 19.8 9.3 15.9 20.3 30.2 0.1 0.1 23.8 8.2 0.0 8.5 11.2 16.8 6.5 0.1 11.1 23.6 35.1 26.8 19.8 0.6 51.0 22.4 33.8 19.4 16.4 2.7 2.8 0.2 23.4 0.1 77.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Group enriched" "Detected in some" 5 "CAPAN-2: 36.6;RPTEC TERT1: 73.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: " "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavourable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.2 0.0 7.5 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 73.2 12.1 0.0 0.0 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Group enriched" "Detected in some" 99 "Karpas-707: 288.3;RPMI-8226: 225.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA042277 Uncertain "Plasma membrane,Cytosol" 42000 "Plasma membrane, Cytosol" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 288.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 225.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.2 0.1 0.0 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 21.0;RPTEC TERT1: 32.6;WM-115: 46.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favourable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.0 0.4 16.3 2.0 1.4 5.7 0.0 0.0 0.1 0.1 0.5 0.1 2.5 0.0 21.0 0.7 11.2 0.7 1.6 0.2 0.0 0.2 0.0 7.8 0.0 0.7 0.0 0.0 0.6 4.6 0.2 0.8 0.8 0.0 3.0 0.3 0.0 0.0 0.0 1.2 1.8 0.0 1.4 0.0 32.6 0.8 0.2 0.7 3.1 0.0 8.1 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.8 0.0 0.0 1.0 0.0 46.6 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain family member 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 58.6" "Cell line enriched" "Detected in some" 6 "WM-115: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 42.6 2.4 3.7 15.2 5.0 0.0 33.7 2.9 5.1 8.1 9.4 3.6 4.4 4.1 12.0 8.6 6.9 3.4 18.8 4.8 4.4 4.0 5.3 2.3 6.9 3.2 4.4 4.3 7.2 4.4 1.4 3.1 58.6 4.6 11.0 5.3 12.7 3.4 16.2 4.7 4.1 5.7 37.5 3.9 2.2 5.6 4.0 2.2 0.0 6.4 5.2 5.5 24.0 11.7 0.8 0.4 1.4 0.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.1 1.4 0.3 0.3 0.4 0.4 0.5 0.4 0.6 0.4 0.2 0.8 0.6 0.5 1.0 0.5 0.5 0.4 0.5 0.1 3.7 5.0 2.9 5.1 4.4 4.0 4.4 4.3 4.6 2.2 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell line enriched" "Detected in some" 8 "MOLT-4: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favourable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.3 0.0 0.4 0.0 7.6 0.0 0.0 0.0 12.2 14.2 2.3 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 187.9 8.5 2.8 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.1 0.0 0.1 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.1 23.7 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48233158-48270357 "Disease related genes, Predicted membrane proteins" "Amyloidosis, Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 346.2" "Cell line enhanced" "Detected in many" "HMC-1: 108.7;RPTEC TERT1: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 236.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 236.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Approved Enhanced "Golgi apparatus,Vesicles" "Intracellular and membrane" 2600000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: " "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favourable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 89.3 79.6 60.6 41.3 61.6 25.0 79.6 87.2 65.8 72.6 58.3 64.9 93.4 83.4 61.2 346.2 71.5 53.2 59.4 86.9 75.9 61.4 198.7 65.1 80.2 75.9 71.7 49.8 100.7 48.5 27.0 63.1 132.0 50.2 66.5 36.0 80.8 75.1 99.8 30.9 73.5 81.0 53.1 90.0 78.5 64.5 44.7 48.3 35.0 73.1 63.0 47.7 63.3 74.5 13.3 23.3 236.4 46.6 17.2 31.7 73.7 8.6 7.5 12.7 23.8 48.5 29.4 18.9 22.9 29.0 11.5 14.6 5.3 41.5 2.3 19.5 16.7 35.3 6.8 16.5 9.7 6.7 16.1 16.4 6.1 14.6 20.9 16.1 108.7 17.6 14.8 6.7 7.5 14.8 4.2 19.9 14.0 5.8 25.9 35.6 34.8 10.2 11.7 12.6 11.7 154.6 40.9 4.3 17.1 20.3 16.7 11.8 10.9 17.1 23.8 9.6 9.6 12.5 11.1 7.8 7.2 0.3 14.0 9.4 21.4 136.9 46.6 141.3 21.3 35.7 28.1 12.0 29.8 26.5 23.3 13.3 31.7 26.5 236.4 17.2 35.5 10.3 28.7 73.7 60.6 61.6 87.2 58.0 75.9 61.4 71.7 49.8 50.2 48.3 ITPA "C20orf37, dJ794I6.3, HLC14-06-P" ENSG00000125877 "Inosine triphosphatase" Q9BY32 20 3208868-3223870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022824, HPA073963" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" 69000 Cytosol "Nucleoplasm, Nuclear bodies" "HPA022824: AB_1851960, HPA073963: " "unprognostic (1.58e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-1)" "unprognostic (3.57e-1)" "unprognostic (4.63e-2)" "unprognostic (1.53e-2)" "prognostic unfavourable (2.54e-5)" "unprognostic (1.11e-2)" "unprognostic (1.68e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-1)" "unprognostic (1.94e-2)" "unprognostic (8.34e-2)" "unprognostic (3.63e-1)" "unprognostic (1.24e-1)" "unprognostic (1.84e-1)" 17.7 27.5 18.6 24.7 21.2 20.4 17.7 10.2 22.7 21.3 21.4 18.3 20.6 22.9 18.1 17.3 31.0 26.6 19.6 25.9 18.1 13.5 22.9 20.3 22.7 30.6 20.5 24.1 16.5 43.8 17.6 10.2 17.0 16.2 14.6 16.8 13.2 19.9 21.5 19.5 23.4 19.0 16.3 16.3 20.6 19.3 16.7 19.5 15.2 24.9 29.0 24.1 14.6 17.7 19.3 30.7 11.3 31.0 24.7 24.1 18.2 33.1 26.2 13.0 13.4 8.6 12.7 8.6 15.0 21.0 19.8 17.4 21.0 30.9 14.3 13.8 13.8 28.9 17.8 22.6 13.9 9.3 26.6 35.8 10.9 31.8 16.3 15.3 12.2 12.1 17.3 18.7 11.6 15.1 24.5 9.9 17.8 15.2 18.0 44.4 21.7 26.5 17.3 18.1 37.5 27.1 10.5 19.7 23.2 11.9 41.7 27.6 17.3 25.6 10.6 22.3 12.4 14.6 31.8 14.7 18.4 27.0 10.4 28.4 24.2 11.3 25.7 8.8 20.7 31.0 18.0 19.3 18.9 21.8 30.7 17.8 14.2 17.2 1.4 24.7 21.9 28.3 24.1 18.2 18.6 21.2 10.2 22.7 18.1 13.5 20.5 24.1 16.2 19.5 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell line enhanced" "Detected in many" "TIME: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA059144: , HPA062260: " "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.6 1.1 1.6 2.6 4.9 5.0 1.7 2.5 3.4 1.7 1.8 0.1 1.4 9.2 1.6 3.3 2.9 8.6 5.2 2.3 2.2 2.8 7.4 2.4 14.8 4.5 6.6 3.3 4.7 0.7 3.7 6.8 16.3 3.2 2.9 2.2 2.2 4.6 8.8 7.1 0.8 1.5 3.8 5.8 4.0 4.2 0.5 2.6 11.2 2.0 6.2 4.2 3.3 35.6 3.5 1.3 3.4 3.1 2.7 2.1 17.2 3.2 3.0 2.2 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360714 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favourable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 16.8 18.8 13.4 30.7 14.8 41.4 16.6 15.2 18.3 17.4 16.8 11.5 17.9 11.3 15.1 11.8 31.4 13.3 12.6 17.3 12.0 10.3 15.3 17.7 23.6 31.7 15.0 11.7 16.4 42.6 16.1 27.2 15.9 14.3 19.1 13.5 9.9 17.2 17.2 23.5 20.5 20.2 18.0 13.3 27.8 16.2 9.6 17.0 27.0 35.1 15.6 31.8 19.8 22.9 27.2 10.6 43.0 20.4 8.9 13.0 6.8 15.9 7.8 1.9 5.7 5.7 7.6 17.6 9.7 9.2 4.5 5.4 7.5 8.6 24.8 8.6 8.1 7.3 8.8 6.1 7.6 19.7 8.2 33.7 4.8 8.4 9.6 17.2 19.5 5.9 7.2 7.9 13.9 14.2 9.5 18.9 7.1 6.5 7.1 8.5 3.6 7.7 8.9 22.7 7.4 8.0 30.2 1.3 4.0 7.7 8.3 11.7 5.7 9.3 19.5 9.7 8.5 8.0 9.0 20.8 22.9 26.0 7.7 16.0 8.5 20.6 11.4 19.9 12.4 13.9 13.0 24.1 10.8 10.8 10.6 27.2 11.0 9.9 43.0 8.9 20.4 7.0 11.2 6.8 13.4 14.8 15.2 18.3 12.0 10.3 15.0 11.7 14.3 17.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria 66000 Mitochondria Nucleoplasm "HPA041391: , HPA044250: " "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favourable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favourable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.6 17.3 15.4 13.5 0.4 13.5 13.1 17.3 10.7 19.7 7.6 0.3 25.7 16.9 10.3 18.4 19.8 10.6 12.5 14.8 22.6 15.4 18.9 27.0 9.2 22.5 20.5 6.9 9.6 20.1 17.0 1.0 1.1 15.4 13.7 11.4 14.2 8.1 16.8 16.7 13.3 10.4 20.4 23.6 16.5 9.2 18.5 40.4 8.1 34.7 40.6 14.5 14.3 9.4 10.1 10.7 21.8 14.9 0.3 13.5 9.1 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 IVL ENSG00000163207 Involucrin P07476 1 152908545-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 97.1;tongue: 152.1" "Group enriched" "Detected in some" 25 "HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" 8000000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: " "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 39.0 0.1 0.0 0.4 0.1 4.2 11.5 97.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 1.8 0.1 0.0 18.7 0.1 0.2 34.2 0.1 1.0 0.0 0.1 0.1 0.1 0.0 1.9 0.1 152.1 49.1 4.9 43.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 77.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 23.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 9 "B-cells: 4.8;dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: " "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 4.9 12.6 3.5 2.7 5.1 1.5 6.2 3.3 4.9 5.7 4.5 7.1 14.0 1.9 9.5 16.3 4.7 4.3 3.2 5.2 3.9 3.3 3.7 7.7 4.3 4.1 9.2 1.4 7.2 8.7 3.0 2.1 15.9 4.7 5.4 3.2 2.1 4.3 12.2 3.3 3.8 3.5 6.0 8.5 9.8 4.7 14.5 8.4 8.4 4.2 1.4 7.5 7.6 13.1 4.8 1.7 0.0 0.3 0.2 0.2 0.4 6.3 5.7 9.4 6.5 3.5 2.6 36.2 3.8 3.2 4.3 4.8 6.5 5.6 0.0 2.7 2.8 2.5 11.4 3.1 6.2 17.1 7.5 5.0 6.5 6.3 5.7 3.8 2.7 2.0 4.3 3.0 9.8 8.0 3.4 3.0 3.3 6.6 13.7 4.6 7.4 4.9 14.2 10.6 8.9 3.6 5.9 8.2 7.3 11.0 10.2 6.0 6.7 4.0 5.0 4.5 8.0 6.4 2.5 2.3 2.0 12.2 1.2 3.2 4.4 0.0 0.1 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.2 0.3 1.7 0.0 0.4 3.5 5.1 3.3 4.9 3.9 3.3 9.2 1.4 4.7 8.4 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 55.8;hTERT-HME1: 34.5;U-251 MG: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" 14000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 27.7 5.6 6.8 14.5 5.4 9.7 56.5 2.9 6.7 34.2 20.1 4.3 17.4 7.2 26.1 22.8 33.9 16.7 23.1 18.8 5.4 5.1 12.9 3.8 22.0 12.4 5.4 4.0 14.7 22.2 21.7 6.0 36.3 6.0 19.2 12.7 21.4 11.2 23.4 16.8 34.8 11.7 21.4 13.0 14.2 13.4 9.1 3.8 1.5 14.5 24.6 16.1 18.7 31.4 0.0 0.9 2.4 2.0 0.4 0.1 0.4 1.0 5.2 16.4 20.1 3.1 3.0 0.6 0.6 3.0 0.8 0.4 4.6 2.8 0.1 15.4 0.6 21.9 2.4 55.8 0.7 0.0 1.1 1.7 0.5 21.9 1.5 7.0 0.1 1.2 16.6 2.7 34.5 5.4 0.0 2.2 1.5 0.0 0.0 5.0 4.7 5.2 1.3 1.0 3.2 7.8 6.4 0.7 0.5 1.6 1.1 6.6 0.1 0.8 20.4 3.7 2.6 3.0 46.9 0.9 0.1 0.2 2.4 2.5 2.9 0.0 2.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.4 0.3 0.9 0.0 0.4 6.8 5.4 2.9 6.7 5.4 5.1 5.4 4.0 6.0 3.8 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell line enhanced" "Detected in many" "HaCaT: 32.3;SCLC-21H: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: " "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.4 3.4 0.2 0.8 0.0 0.0 10.5 0.1 0.1 0.0 0.0 2.8 10.5 0.0 7.3 0.0 32.3 2.1 10.8 0.0 1.1 5.0 0.0 9.3 0.0 0.1 0.0 2.0 0.1 5.3 0.0 1.2 2.6 2.0 0.0 0.0 3.8 0.0 0.0 1.0 1.2 2.6 2.0 3.6 0.1 2.2 16.6 0.5 2.9 0.7 0.1 8.2 1.2 8.9 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 JAK2 JTK10 ENSG00000096968 "Janus kinase 2" O60674 9 4984390-5128183 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 40.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013089, HPA040820, HPA043870" Approved Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "CAB013089: AB_2533647, HPA040820: , HPA043870: " "unprognostic (2.24e-3)" "unprognostic (2.76e-2)" "unprognostic (1.50e-2)" "unprognostic (7.67e-2)" "unprognostic (5.50e-2)" "unprognostic (3.09e-2)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" "unprognostic (3.85e-1)" "unprognostic (4.53e-2)" "unprognostic (3.43e-2)" "unprognostic (1.96e-1)" "unprognostic (7.37e-3)" 19.8 8.8 11.5 19.0 10.5 19.0 17.7 14.7 14.4 17.8 10.6 7.0 10.3 7.2 14.8 13.6 12.4 13.4 14.6 27.6 10.3 6.7 7.7 5.6 16.1 19.4 7.0 10.5 15.9 6.7 10.1 7.5 12.0 10.0 12.0 7.4 9.4 7.2 7.4 14.4 19.0 12.3 10.4 11.7 21.5 14.1 10.1 9.0 13.6 8.6 6.5 13.5 13.9 15.6 2.1 9.6 40.8 7.5 3.4 2.1 2.5 2.5 1.4 1.4 2.5 18.9 4.9 0.4 3.4 2.9 2.6 1.7 0.1 0.8 0.1 0.8 2.0 0.8 1.5 2.1 1.9 26.7 0.5 54.8 2.9 0.7 3.9 3.7 2.8 4.0 0.9 1.1 1.8 2.4 3.9 6.4 4.7 0.9 0.9 5.2 1.3 1.7 1.9 2.7 0.7 2.0 1.3 1.6 0.9 1.0 1.5 1.0 0.7 6.5 5.0 4.0 1.3 4.1 2.4 1.2 2.2 0.5 5.2 1.8 2.0 40.8 7.5 13.4 2.1 7.3 1.7 2.1 1.6 1.2 9.6 1.9 0.9 1.1 7.1 3.4 5.8 3.6 1.6 2.5 11.5 10.5 14.7 14.4 10.3 6.7 7.0 10.5 10.0 9.0 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell line enhanced" "Detected in some" "HDLM-2: 20.1;HEL: 9.0;HMC-1: 9.2;Karpas-707: 23.5;U-266/70: 9.1;U-266/84: 13.5;U-937: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA070314: " "unprognostic (5.59e-3)" "prognostic favourable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.0 0.4 1.4 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 1.9 0.4 0.1 0.0 0.2 0.0 20.1 0.0 9.0 0.0 0.8 0.7 0.0 9.2 5.0 0.2 0.0 0.0 0.2 0.0 23.5 0.0 0.4 3.6 0.0 0.1 0.7 4.6 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 2.0 1.3 0.4 0.0 0.4 0.0 0.0 9.1 13.5 2.5 0.1 13.7 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell line enhanced" "Detected in some" "AF22: 18.9;BJ hTERT+: 12.0;HDLM-2: 11.8;U-138 MG: 13.6;U-87 MG: 10.0" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" 17000 "Plasma membrane" Nucleoplasm "HPA028789: , HPA077346: " "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.9 0.1 0.7 0.2 0.4 0.5 12.0 1.5 5.7 0.0 0.0 0.1 0.0 0.2 0.1 1.6 0.0 3.5 11.8 0.5 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.3 0.0 0.0 0.0 0.2 5.8 0.1 0.3 0.1 6.0 0.0 2.2 3.9 0.1 0.0 0.0 0.3 2.8 0.1 0.2 0.0 0.7 0.1 0.0 13.6 1.3 0.1 1.9 1.5 0.0 0.0 10.0 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246296-15522040 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: " "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 10.2 5.3 6.9 11.5 8.8 53.3 7.2 40.6 9.3 6.3 8.3 11.4 9.4 6.9 8.8 8.4 15.4 5.0 7.9 5.9 6.8 7.1 4.6 4.4 8.2 12.8 6.8 3.8 7.2 4.4 6.1 8.2 8.4 8.4 5.5 5.9 15.1 10.7 11.9 12.5 14.9 12.5 5.3 6.6 14.2 8.2 17.5 6.5 41.3 5.0 8.9 19.2 6.5 7.7 4.2 4.6 14.4 4.0 4.9 3.9 2.0 6.2 4.3 17.9 10.3 2.2 2.2 17.7 1.8 4.3 2.3 3.0 4.5 4.9 3.3 6.5 3.6 3.2 4.1 10.4 2.2 6.4 6.4 11.7 5.1 5.8 2.4 11.8 13.8 3.1 6.6 3.5 14.0 2.5 15.2 5.6 1.4 6.2 23.5 22.3 19.1 2.0 10.5 5.4 9.3 2.2 6.6 13.8 7.9 3.7 13.0 16.3 4.5 12.8 4.3 11.0 6.1 6.0 6.2 3.6 8.6 5.9 3.7 11.1 13.8 9.6 4.0 3.2 3.9 2.6 3.3 2.6 1.9 2.3 3.3 4.2 2.4 3.3 14.4 4.9 2.7 4.6 1.5 2.0 6.9 8.8 40.6 7.9 6.8 7.1 6.8 3.8 8.4 6.5 JAZF1 "DKFZp761K2222, TIP27, ZNF802" ENSG00000153814 "JAZF zinc finger 1" Q86VZ6 7 27830573-28180743 "Disease related genes, Predicted intracellular proteins" "Lipid metabolism, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019271, HPA066967" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB019271: , HPA066967: " "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.18e-2)" "unprognostic (7.48e-2)" "unprognostic (9.08e-2)" "unprognostic (1.14e-1)" "unprognostic (2.74e-1)" "unprognostic (8.88e-2)" "unprognostic (2.50e-1)" "unprognostic (1.44e-1)" "unprognostic (8.27e-3)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.18e-3)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-2)" 11.9 65.2 18.7 13.4 13.1 16.7 17.7 26.9 19.2 50.1 23.0 8.5 12.8 3.4 34.1 18.4 8.4 11.9 9.9 17.0 14.0 14.8 4.8 12.2 9.9 10.8 8.9 16.9 11.6 5.7 5.6 19.0 12.3 11.1 23.6 7.3 4.8 4.2 28.1 5.6 5.9 6.7 29.7 12.2 11.0 7.4 14.3 10.0 6.3 12.1 5.5 11.9 18.7 24.3 4.6 12.5 17.6 3.7 4.3 4.6 2.4 0.7 0.6 2.4 0.6 18.3 22.3 0.0 5.7 14.4 9.5 11.6 0.0 3.8 16.5 11.6 11.5 0.3 3.1 4.2 7.6 2.4 5.1 5.9 4.1 0.0 12.5 2.4 1.6 10.0 5.2 7.1 4.7 5.8 0.1 27.1 5.1 0.7 0.7 8.6 5.2 3.8 1.8 1.1 5.0 3.3 0.1 1.5 2.6 4.5 0.1 5.9 1.7 2.9 5.7 15.1 5.9 4.1 6.3 4.9 1.4 6.4 4.8 6.1 8.2 17.6 3.7 5.5 4.6 3.0 1.3 2.9 1.4 3.1 3.3 4.6 0.6 3.1 3.2 4.3 3.2 12.5 2.9 2.4 18.7 13.1 26.9 18.7 14.0 14.8 8.9 16.9 11.1 10.0 JCAD KIAA1462 ENSG00000165757 "Junctional cadherin 5 associated" Q9P266 10 30012800-30115494 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 14.8;HUVEC TERT2: 15.3;LHCN-M2: 12.8;TIME: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017956 Enhanced Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA017956: AB_1852408" "unprognostic (1.78e-1)" "unprognostic (8.33e-2)" "unprognostic (5.37e-2)" "unprognostic (8.07e-2)" "unprognostic (6.32e-2)" "unprognostic (7.09e-2)" "unprognostic (9.36e-2)" "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (3.08e-2)" "prognostic unfavourable (2.54e-4)" "prognostic unfavourable (2.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.34e-2)" 27.0 7.5 6.2 9.1 12.4 0.5 18.0 2.2 8.8 10.1 29.4 3.2 5.4 1.7 16.5 8.1 5.9 10.8 9.9 16.3 6.2 4.7 6.0 2.0 22.3 3.2 6.7 8.9 11.3 15.7 4.7 4.8 30.5 8.9 14.1 4.1 24.4 2.5 9.7 9.2 3.7 3.7 27.8 6.8 1.2 5.0 13.0 4.4 1.4 13.0 3.9 2.0 18.3 22.8 0.2 0.1 0.8 0.0 0.3 0.2 0.0 7.5 3.4 3.1 0.0 1.9 0.4 4.5 4.1 4.3 0.6 1.0 1.3 0.0 0.0 0.3 14.8 0.1 0.8 0.2 1.7 0.8 1.8 0.0 0.0 0.0 8.5 0.0 0.5 4.8 0.1 10.3 0.7 15.3 0.0 0.0 12.8 0.2 0.0 0.3 0.6 5.2 0.0 1.7 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.7 34.4 7.8 1.9 2.4 0.3 3.2 0.4 0.0 1.8 5.2 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 6.2 12.4 2.2 8.7 6.2 4.7 6.7 8.9 8.9 4.4 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA059511: " "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavourable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 27.0 14.4 11.2 19.3 12.5 46.0 59.6 10.6 15.1 16.3 15.3 13.7 6.5 15.3 12.7 10.5 17.1 14.8 21.3 20.7 13.5 9.0 9.7 14.3 24.8 13.2 14.0 8.7 21.8 15.8 7.4 10.1 12.0 11.2 13.9 8.1 16.6 19.5 11.4 13.3 15.2 22.4 17.8 15.7 39.7 15.8 4.7 11.8 1.4 20.7 18.7 9.7 14.2 60.4 11.0 2.1 6.9 10.5 0.1 0.2 1.1 4.3 3.8 0.7 7.7 24.2 18.0 26.3 13.5 14.7 8.9 11.2 9.3 3.8 3.4 6.9 25.7 17.1 4.8 4.6 3.8 4.6 0.5 4.7 7.1 3.3 49.8 6.6 0.3 31.8 27.7 3.6 8.9 0.4 0.6 6.7 7.9 21.3 0.3 11.0 2.6 2.5 2.4 0.1 9.3 4.2 2.4 0.6 3.0 13.9 20.0 15.5 19.1 14.7 1.7 11.2 17.3 0.7 2.0 5.6 1.6 8.2 3.4 25.3 5.5 0.1 4.1 3.8 0.0 7.0 0.0 11.0 0.2 0.0 2.1 5.1 0.0 0.0 6.9 0.1 10.5 1.8 0.2 1.1 11.2 12.5 10.6 15.1 13.5 9.0 14.0 8.7 11.2 11.8 JHY "C11orf63, FLJ23554, Jhy" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882528-122959798 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 51.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: , HPA077658: , HPA077748: " "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favourable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favourable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavourable (2.58e-4)" "unprognostic (7.79e-2)" 3.6 0.9 1.9 1.6 2.1 0.2 2.3 1.6 2.2 2.1 2.4 1.2 1.0 0.7 1.5 2.5 1.0 5.1 1.5 1.6 1.5 2.6 5.3 1.0 2.8 1.0 1.7 1.4 2.1 1.5 6.3 4.2 2.3 1.7 2.3 0.8 1.9 1.0 1.5 2.4 1.0 1.2 1.0 2.2 1.3 1.0 51.0 1.3 1.4 3.4 1.5 1.2 1.7 1.2 2.4 4.9 0.3 0.6 4.3 4.1 1.1 2.8 3.9 2.3 0.1 0.6 0.4 0.7 6.0 7.0 2.5 1.1 0.2 10.5 0.0 1.5 9.2 2.4 2.7 1.4 1.2 9.3 2.8 0.1 1.9 0.1 0.9 1.6 4.9 2.9 7.7 0.4 0.6 3.8 0.0 0.0 1.9 1.7 0.0 0.6 0.3 3.6 0.9 0.0 1.2 7.2 3.2 6.0 4.3 7.2 3.9 2.6 4.8 0.6 1.2 8.3 1.0 0.2 4.8 0.1 0.0 0.0 2.2 2.1 5.5 0.3 0.6 0.1 2.9 0.1 4.1 2.4 3.0 3.9 4.9 1.4 2.1 2.1 0.3 4.3 0.0 1.1 0.6 1.1 1.9 2.1 1.6 2.2 1.5 2.6 1.7 1.4 1.7 1.3 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: " "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favourable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.7 23.3 20.1 16.4 15.0 19.9 15.3 31.0 26.5 18.3 21.8 7.3 36.2 9.8 27.8 28.6 14.4 14.7 19.1 24.7 29.3 8.4 9.8 15.0 14.5 20.0 16.5 19.4 21.7 21.7 17.1 11.8 18.6 8.9 19.7 34.4 17.8 9.0 12.7 11.0 20.6 10.6 24.4 9.0 31.5 19.6 8.6 15.0 28.1 22.5 16.4 22.7 12.7 24.4 19.3 25.3 17.6 20.3 9.2 16.3 11.4 27.3 11.2 24.2 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056175: , HPA066195: " "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 31.7 10.9 8.7 26.0 10.9 25.9 16.2 43.0 11.1 21.8 16.6 5.4 11.8 12.2 18.1 17.4 16.4 13.1 18.5 11.7 10.8 8.1 14.1 16.7 29.9 20.9 9.6 6.5 19.2 12.6 27.1 18.6 10.3 14.1 14.1 9.2 13.8 15.3 15.6 13.4 11.0 22.2 11.7 17.6 29.1 12.9 10.9 13.3 27.2 15.6 20.1 15.3 21.9 11.8 4.8 4.2 15.2 2.8 1.7 3.1 1.1 10.9 5.5 13.1 10.0 7.0 12.8 4.6 7.6 15.8 6.9 9.5 9.4 11.7 14.9 4.7 7.1 9.0 3.7 7.3 12.3 4.0 4.7 5.6 5.7 6.8 8.5 12.0 2.1 12.7 7.6 12.2 35.7 12.3 9.9 11.2 16.2 2.9 9.2 6.5 13.9 19.5 16.0 28.4 7.0 7.0 7.9 7.1 11.6 11.5 7.2 11.0 7.1 22.0 14.8 6.4 9.1 5.6 9.5 10.1 8.0 14.1 7.8 7.2 5.7 0.6 2.8 3.1 2.0 1.9 3.1 4.7 2.2 2.1 2.4 4.8 3.1 2.6 15.2 1.7 1.6 4.2 1.9 1.1 8.7 10.9 43.0 11.1 10.8 8.1 9.6 6.5 14.1 13.3 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: " "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavourable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 10.1 17.5 9.6 8.3 8.3 5.9 13.1 10.1 17.1 10.1 12.0 9.7 13.1 7.9 11.7 12.8 10.0 13.5 11.7 11.7 10.0 9.6 8.7 19.8 7.9 25.0 9.7 10.0 14.9 17.5 9.5 14.4 12.0 6.3 12.2 4.6 11.8 18.2 11.6 14.9 9.8 8.7 8.3 7.2 13.7 8.6 20.1 3.2 21.5 9.7 11.1 14.4 8.5 6.8 8.5 11.6 2.9 6.4 13.2 12.7 7.0 10.6 15.8 5.2 5.7 5.6 3.2 19.0 6.7 7.1 10.5 6.5 13.5 9.2 14.4 10.3 6.4 10.9 3.5 10.8 1.2 7.7 17.0 8.8 7.9 10.4 10.0 9.2 4.4 5.7 6.9 10.0 7.4 5.4 11.4 4.8 5.1 9.0 11.2 4.8 8.9 24.9 10.4 6.3 12.9 6.2 10.0 10.1 6.8 6.4 23.0 8.6 18.4 10.0 4.6 5.4 5.4 6.4 12.4 8.9 2.7 5.5 5.3 4.5 14.6 2.9 6.4 2.3 10.2 6.4 11.7 8.3 7.9 7.2 5.8 8.5 12.7 11.0 0.6 13.2 3.4 11.6 8.8 7.0 9.6 8.3 10.1 17.1 10.0 9.6 9.7 10.0 6.3 3.2 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell line enhanced" "Detected in some" "MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA076304: " "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 9.9 24.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavourable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favourable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavourable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 91.6 91.4 48.1 47.7 10.2 10.5 38.4 48.3 14.4 47.5 36.6 74.8 55.0 25.8 31.0 38.6 54.8 44.9 60.1 35.8 25.8 56.4 41.5 36.3 74.0 24.0 31.1 40.1 16.0 28.8 38.6 39.8 86.2 23.4 53.2 43.4 66.4 99.7 30.4 28.0 120.5 63.7 57.5 40.0 50.7 57.6 59.8 48.6 69.1 36.6 25.7 98.1 19.1 49.6 27.2 76.9 38.1 56.0 20.8 33.5 38.6 23.7 29.2 31.0 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 JPT2 "C16orf34, FLJ13092, HN1L, KIAA1426, L11" ENSG00000206053 "Jupiter microtubule associated homolog 2" Q9H910 16 1678256-1702280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041888, HPA041908" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041888: AB_10793937, HPA041908: AB_10794160" "unprognostic (1.49e-2)" "unprognostic (1.76e-1)" "unprognostic (1.30e-3)" "prognostic favourable (7.85e-4)" "unprognostic (3.60e-1)" "unprognostic (2.37e-2)" "prognostic unfavourable (9.14e-4)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (1.50e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (1.01e-2)" "unprognostic (9.22e-3)" "unprognostic (1.65e-1)" "unprognostic (4.14e-2)" "unprognostic (2.78e-2)" 10.6 11.3 6.7 10.4 24.3 4.9 19.9 11.1 12.3 22.5 16.7 24.1 12.6 11.3 11.5 11.1 28.6 34.4 12.4 10.1 10.5 8.7 18.5 37.3 12.0 11.7 33.8 6.2 12.3 31.0 13.2 10.1 33.6 37.7 26.3 16.5 6.8 15.7 12.7 12.8 16.2 12.8 12.4 72.4 8.7 14.8 14.1 17.3 20.3 16.1 15.7 16.8 16.9 16.8 9.7 8.2 4.7 4.6 7.5 10.0 5.4 31.2 32.1 37.3 20.7 5.4 9.0 33.8 31.1 9.9 26.3 22.5 41.8 41.1 20.3 24.0 15.4 30.8 49.0 42.3 30.3 16.3 29.5 16.7 18.4 23.7 8.3 19.6 10.0 6.3 26.8 25.8 33.6 16.6 39.2 8.2 15.1 36.2 24.4 9.7 40.9 24.4 45.1 35.3 29.2 41.0 17.7 34.8 19.2 46.8 45.4 14.2 55.0 12.7 19.1 25.6 45.1 12.1 30.3 7.0 27.9 42.3 8.0 15.2 37.3 2.6 4.6 4.7 7.1 4.1 10.0 6.3 7.8 5.6 3.6 9.7 8.5 7.1 0.4 7.5 2.0 8.2 7.0 5.4 6.7 24.3 11.1 12.3 10.5 8.7 33.8 6.2 37.7 17.3 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: " "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.4 5.9 6.9 5.6 6.7 9.9 4.3 8.5 3.6 10.5 6.0 5.3 11.4 9.4 3.7 7.0 7.4 6.1 5.3 5.3 7.2 10.4 9.4 18.8 6.1 2.8 7.2 6.6 6.3 4.7 6.7 3.8 5.9 10.0 4.2 8.8 9.4 8.3 4.0 5.9 8.4 11.0 4.4 5.2 3.6 9.4 12.8 8.5 15.7 6.4 3.7 6.3 4.5 6.9 8.2 17.6 8.0 4.7 5.5 6.1 5.6 6.2 9.1 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: " "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 11.5 7.8 10.4 10.2 12.3 1.4 10.3 11.1 9.8 12.5 10.1 6.2 7.9 8.2 13.0 9.1 9.7 12.3 8.7 8.4 9.2 6.8 9.1 5.9 8.0 9.7 10.0 7.8 16.4 7.0 13.4 15.6 12.0 10.0 13.5 10.7 6.0 9.7 11.7 9.9 8.9 12.4 12.8 17.9 10.4 9.9 17.9 13.1 11.6 14.0 6.3 10.3 12.4 14.8 5.3 9.0 6.0 5.7 3.9 7.6 3.4 6.7 4.3 9.0 6.6 18.0 20.1 6.5 11.5 7.9 8.4 10.9 7.2 16.5 9.3 16.9 10.6 10.7 4.4 7.8 9.7 10.0 4.1 8.6 11.1 5.4 14.5 4.8 5.5 9.5 12.5 12.0 15.1 7.5 4.5 4.1 13.4 1.4 6.2 14.0 1.3 5.9 6.4 8.6 7.5 10.2 7.1 3.6 6.5 6.7 4.7 5.0 5.6 6.6 9.1 16.0 7.1 13.9 4.6 3.5 7.7 5.5 7.4 7.9 6.9 6.0 5.7 5.5 3.8 4.5 5.3 5.3 6.0 4.7 5.7 4.1 7.6 6.8 2.1 3.9 5.2 9.0 2.8 3.4 10.4 12.3 11.1 9.8 9.2 6.8 10.0 7.8 10.0 13.1 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977688 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Approved "Vesicles,Actin filaments" Vesicles "Actin filaments" "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favourable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 23.9 30.2 28.5 23.0 32.7 43.2 32.6 30.7 32.3 31.8 36.0 23.6 51.3 35.9 25.1 41.0 30.4 26.1 37.1 36.2 25.4 23.9 34.2 81.1 27.7 34.7 27.7 19.8 26.9 106.8 24.8 49.8 30.0 24.4 33.4 36.0 24.9 100.6 45.9 42.1 23.4 45.6 21.6 20.5 35.9 42.4 15.3 25.2 30.5 58.5 32.0 34.0 25.2 33.0 47.4 54.1 60.7 43.0 30.4 46.4 30.2 39.5 27.4 11.8 21.6 38.8 24.1 33.3 28.9 28.2 19.3 19.5 26.3 32.9 37.8 41.0 33.4 36.2 29.8 22.2 15.8 35.6 59.6 21.9 32.6 26.6 40.7 42.2 33.8 22.9 42.0 20.3 24.1 22.8 32.5 27.8 13.5 68.8 30.4 54.2 25.3 48.3 32.2 16.1 75.9 24.4 21.7 32.4 32.8 22.9 66.5 38.7 41.8 61.4 17.8 9.6 16.5 28.9 36.8 41.5 46.3 41.0 23.6 40.6 20.6 32.6 43.0 60.7 29.4 30.3 35.5 47.4 41.1 46.4 33.4 45.2 42.4 33.7 39.9 30.4 33.4 54.1 33.6 30.2 28.5 32.7 30.7 32.3 25.4 23.9 27.7 19.8 24.4 25.2 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 146.3;skin 1: 126.1;tongue: 122.8" "Cell line enhanced" "Detected in many" "HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" 61000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: " "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favourable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 12.5 2.6 2.8 9.5 4.5 3.3 13.0 6.5 3.7 34.5 17.9 8.7 12.3 15.6 12.2 9.6 146.3 13.0 19.0 34.5 3.3 1.6 31.6 11.7 13.2 4.0 5.3 2.2 12.5 12.8 3.6 5.8 42.4 4.0 14.0 8.8 8.3 34.3 14.3 17.6 126.1 36.1 4.3 3.2 4.5 15.4 3.6 4.6 10.8 27.9 122.8 84.8 12.5 55.4 7.9 7.8 14.8 20.6 0.3 0.1 2.9 30.2 25.1 2.5 2.1 0.0 0.0 39.3 1.7 10.4 0.7 0.6 37.9 33.5 0.6 18.7 1.1 126.0 3.6 28.0 0.1 0.0 8.9 1.3 20.0 8.3 4.2 0.8 13.4 0.0 63.6 0.1 5.2 11.2 11.1 11.0 0.0 38.8 0.2 10.9 4.9 4.2 35.4 0.0 22.7 19.4 77.4 6.2 4.6 3.9 76.5 0.2 63.8 0.9 17.6 0.0 1.8 0.8 0.5 0.9 3.4 0.6 0.1 1.4 0.3 1.7 7.6 14.8 0.0 12.8 0.0 7.9 0.0 0.1 7.8 7.4 0.1 0.1 0.3 0.3 20.6 2.5 0.0 2.9 2.8 4.5 6.5 3.7 3.3 1.6 5.3 2.2 4.0 4.6 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell line enhanced" "Detected in many" "CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.6 1.4 0.8 1.4 0.6 32.1 2.5 0.1 0.4 3.6 0.2 0.8 0.0 1.1 0.0 0.3 19.6 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.6 4.5 0.1 0.4 2.3 0.0 0.0 2.0 3.1 1.0 1.6 0.0 0.1 0.3 1.2 9.2 0.4 0.3 0.3 0.7 0.1 8.1 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell line enhanced" "Detected in some" "BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.0 0.1 0.0 0.1 0.0 3.7 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 10.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 KANSL2 "C12orf41, FLJ20436, NSL2" ENSG00000139620 "KAT8 regulatory NSL complex subunit 2" Q9H9L4 12 48653401-48682238 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038497, HPA038498" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038497: AB_10674685, HPA038498: " "unprognostic (3.87e-3)" "unprognostic (6.18e-2)" "unprognostic (3.67e-1)" "unprognostic (8.89e-2)" "unprognostic (5.37e-2)" "unprognostic (4.73e-2)" "prognostic unfavourable (4.98e-4)" "unprognostic (5.46e-2)" "unprognostic (1.35e-3)" "unprognostic (6.16e-2)" "unprognostic (6.75e-3)" "unprognostic (4.19e-3)" "unprognostic (8.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "prognostic favourable (4.32e-4)" 11.4 12.3 9.8 9.0 14.0 41.3 14.5 19.7 14.7 12.0 10.7 15.6 8.9 8.9 14.9 14.3 13.7 12.0 9.0 12.8 8.6 8.6 13.8 10.2 11.0 16.8 13.0 11.2 17.4 14.3 10.6 21.0 18.2 11.3 12.5 11.3 14.1 13.2 10.4 36.3 13.1 11.6 13.5 11.2 14.0 10.8 16.5 12.7 20.1 16.4 12.6 16.5 11.8 12.8 23.6 21.3 28.2 18.4 19.8 26.8 18.7 9.4 12.7 11.5 5.5 12.8 11.4 24.1 10.7 8.6 17.5 10.0 22.4 12.2 15.3 19.1 12.7 9.5 18.6 12.5 14.6 13.7 11.1 17.9 11.4 6.2 14.4 19.8 7.0 11.8 15.9 13.3 23.3 8.5 20.7 10.3 12.7 8.8 19.4 15.1 14.8 12.8 16.7 11.3 17.5 9.5 13.1 13.1 9.1 20.8 15.4 12.7 20.3 19.4 7.2 13.3 9.8 5.7 9.7 15.5 22.9 22.4 6.6 45.1 6.8 28.2 16.8 19.3 23.0 17.4 22.0 23.6 22.9 23.8 21.3 21.1 26.8 25.5 7.7 19.8 18.4 17.3 25.1 18.7 9.8 14.0 19.7 14.7 8.6 8.6 13.0 11.2 11.3 12.7 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040023-20154404 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526" Supported Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "CAB004526: AB_2128417, HPA002470: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 10.6 6.6 30.1 9.4 27.5 24.9 6.8 22.0 20.1 10.2 9.4 27.6 7.9 10.9 7.8 5.4 17.3 7.7 8.0 21.9 24.7 18.0 10.8 24.0 10.1 12.7 26.8 15.9 18.2 11.6 38.1 8.7 8.5 24.2 9.5 8.1 10.7 20.9 9.2 33.4 8.9 13.0 8.7 21.4 11.7 9.0 1.8 31.1 8.7 10.0 7.4 12.0 8.7 11.0 2.1 2.7 5.5 1.5 1.1 4.8 0.8 1.5 3.9 2.2 3.6 9.0 8.4 5.1 5.0 7.4 5.3 7.8 1.1 2.6 13.4 2.1 9.4 1.1 5.4 1.6 4.5 12.2 5.1 11.8 6.2 0.4 4.2 1.8 15.3 3.6 2.9 4.6 3.0 5.0 7.5 19.0 7.5 1.8 3.8 3.5 0.9 3.9 5.1 4.1 2.8 7.2 8.0 1.1 2.4 2.8 4.5 17.0 4.7 8.0 4.8 9.0 3.6 3.3 5.7 7.3 15.1 3.2 8.2 7.8 18.9 1.3 1.1 2.8 3.6 1.5 3.4 1.0 3.1 2.5 0.9 2.1 1.1 2.1 5.5 1.1 1.1 2.7 4.8 0.8 30.1 27.5 22.0 20.1 24.7 18.0 26.8 15.9 24.2 31.1 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: , HPA065052: " "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 12.9 10.6 17.5 11.1 9.8 11.2 5.9 8.7 11.3 10.8 8.4 6.7 6.2 19.2 8.7 8.5 8.3 13.6 8.2 12.7 9.9 7.9 27.6 6.6 5.0 7.4 14.5 12.7 9.3 9.4 10.0 12.4 10.3 23.1 12.2 9.8 5.7 29.5 4.6 6.7 4.2 23.6 19.6 6.1 5.3 14.9 10.9 9.4 10.1 6.8 7.0 15.6 6.4 12.0 13.3 9.4 11.8 9.3 10.0 16.1 20.8 7.1 6.6 11.5 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74825582-75032622 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favourable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 11.6 9.5 11.1 13.2 11.9 15.1 12.4 19.0 11.6 16.7 12.2 13.3 15.3 7.2 25.1 13.0 12.0 13.2 12.0 10.0 10.6 9.5 9.0 7.3 9.2 9.0 9.0 9.9 24.6 13.3 24.8 31.1 9.4 8.9 13.5 9.6 10.1 17.9 12.0 15.3 10.6 11.3 16.2 9.3 10.4 13.0 12.8 12.1 26.6 13.0 8.9 12.5 14.3 12.7 3.2 1.9 1.6 1.1 5.3 3.7 1.5 3.9 4.1 7.4 6.2 5.8 8.6 3.6 3.5 6.9 3.0 3.3 2.7 4.6 8.4 1.9 6.4 3.1 3.9 3.0 4.9 3.5 5.7 3.1 3.3 3.8 4.4 7.3 2.1 5.6 5.0 4.1 6.6 3.4 3.3 7.3 3.8 4.2 7.0 3.4 4.1 22.7 11.0 3.8 1.8 2.2 2.0 3.7 6.1 3.6 6.5 3.2 3.7 2.9 4.2 4.2 5.0 2.8 3.3 5.4 6.2 5.6 4.6 7.8 0.9 0.7 1.1 1.6 3.2 0.9 3.4 2.4 2.4 2.7 1.2 3.2 3.7 3.4 0.9 5.3 0.8 1.9 2.4 1.5 11.1 11.9 19.0 11.6 10.6 9.5 9.0 9.9 8.9 12.1 KAT7 "HBO1, HBOA, MYST2, ZC2HC7" ENSG00000136504 "Lysine acetyltransferase 7" O95251 17 49788555-49835030 "Enzymes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044470, HPA071116" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044470: AB_10965785, HPA071116: " "unprognostic (1.30e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-3)" "unprognostic (2.20e-2)" "unprognostic (7.99e-2)" "unprognostic (1.53e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (1.36e-1)" "unprognostic (6.26e-2)" "unprognostic (1.44e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-3)" "unprognostic (2.75e-1)" "unprognostic (5.03e-2)" "unprognostic (6.23e-2)" "unprognostic (7.68e-2)" 15.8 14.3 16.9 16.2 25.9 44.4 17.5 37.0 35.0 19.5 17.3 23.8 17.9 13.1 27.3 18.6 18.8 19.5 14.6 25.3 16.8 21.8 18.7 11.3 13.9 15.3 17.0 23.6 21.9 13.6 44.4 19.8 19.8 21.9 20.4 14.9 20.8 18.9 23.3 31.7 22.7 14.7 21.8 17.9 15.8 15.5 63.7 19.1 25.9 28.6 14.5 20.6 22.7 17.4 13.0 12.7 15.2 11.4 20.6 20.7 14.2 13.0 18.4 17.8 12.5 8.4 11.2 21.6 11.4 13.3 20.5 14.7 28.4 9.3 15.0 18.5 12.1 11.5 17.0 11.9 24.2 16.3 16.8 17.8 13.4 11.8 12.6 18.2 14.8 10.6 11.9 18.4 23.0 15.1 19.7 14.9 19.1 19.9 25.8 13.1 44.3 16.1 16.3 28.5 12.9 9.6 14.8 19.4 16.5 11.6 7.0 10.7 25.6 16.1 9.0 26.0 14.1 11.3 14.7 21.9 23.9 17.6 11.8 10.9 16.2 15.2 11.0 15.1 16.9 8.9 20.7 13.0 16.3 17.1 12.7 12.2 20.6 16.2 13.1 20.6 11.4 6.6 14.3 14.2 16.9 25.9 37.0 35.0 16.8 21.8 17.0 23.6 21.9 19.1 KATNA1 ENSG00000186625 "Katanin catalytic subunit A1" O75449 6 149594873-149648972 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036207 Approved Supported "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA036207: AB_10672238" "unprognostic (1.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.95e-2)" "unprognostic (3.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (3.57e-7)" "unprognostic (9.78e-2)" "unprognostic (8.89e-2)" "unprognostic (7.40e-2)" "unprognostic (2.70e-2)" "unprognostic (4.50e-2)" "unprognostic (3.92e-2)" "unprognostic (2.10e-1)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (8.85e-2)" 12.5 7.8 9.3 11.9 9.8 14.2 11.7 13.0 9.5 13.8 12.1 15.0 6.0 7.6 15.3 10.3 12.5 10.9 10.1 11.3 9.1 6.7 13.7 8.4 10.8 11.8 10.4 7.9 18.7 9.6 5.7 12.1 11.0 15.0 12.7 9.5 17.5 10.1 10.5 21.2 12.0 10.8 12.4 8.9 12.2 10.4 36.7 12.0 22.5 13.9 10.3 14.0 15.1 12.7 19.6 19.4 23.5 20.8 12.7 24.2 14.9 11.3 4.1 9.3 20.4 11.3 18.1 14.5 14.2 12.1 15.1 20.0 9.8 6.0 15.8 8.3 14.2 9.0 18.3 9.4 19.7 14.5 15.5 21.0 8.7 13.5 15.6 29.4 7.9 11.4 11.2 17.3 13.7 13.8 21.8 11.6 13.3 15.7 20.1 19.2 9.2 6.9 13.9 17.1 7.7 10.7 6.4 7.6 10.7 26.0 7.5 10.0 7.6 28.7 11.8 7.9 12.0 20.7 16.4 10.8 9.9 21.8 10.4 21.0 12.8 23.5 15.2 21.0 19.9 20.8 17.5 19.6 20.2 20.0 19.4 14.2 17.2 17.3 7.0 12.7 18.0 16.7 24.2 14.9 9.3 9.8 13.0 9.5 9.1 6.7 10.4 7.9 15.0 12.0 KATNAL1 MGC2599 ENSG00000102781 "Katanin catalytic subunit A1 like 1" Q9BW62 13 30202630-30307484 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046205 Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA046205: AB_10965325" "unprognostic (3.34e-1)" "unprognostic (6.44e-3)" "unprognostic (2.08e-2)" "unprognostic (6.91e-2)" "unprognostic (2.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.57e-2)" "unprognostic (2.84e-2)" "unprognostic (3.43e-1)" "unprognostic (4.68e-3)" "unprognostic (4.54e-2)" "unprognostic (2.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.41e-2)" "unprognostic (6.42e-2)" "unprognostic (5.12e-2)" "unprognostic (1.83e-3)" 11.0 5.7 12.2 6.4 12.5 7.6 12.0 11.0 14.4 14.1 11.4 10.4 4.6 2.2 12.7 4.2 8.1 6.6 5.4 22.6 8.5 9.8 5.9 5.4 6.7 8.2 10.3 14.9 6.3 2.9 3.2 11.9 4.2 11.9 6.7 5.9 4.1 3.5 8.5 7.1 3.8 4.2 19.7 10.8 4.5 4.7 25.1 7.8 12.0 4.4 3.3 9.1 7.7 7.9 5.2 6.9 3.4 1.0 9.5 7.1 1.4 5.4 4.6 8.1 4.3 6.1 13.1 0.2 22.8 7.3 12.2 9.6 0.9 5.6 8.9 2.7 30.4 1.5 5.7 5.9 18.6 7.6 2.1 6.3 5.7 2.0 3.2 3.1 4.3 5.0 2.9 13.7 3.4 12.8 3.3 3.9 14.9 1.1 7.0 2.9 3.5 2.9 7.9 9.5 0.9 4.4 0.4 3.3 7.0 6.0 1.2 4.3 2.0 1.9 11.6 10.8 16.4 5.9 9.1 2.1 3.7 12.2 4.3 3.1 15.5 1.9 0.9 3.4 5.8 0.5 2.9 2.6 4.6 5.8 2.3 5.2 1.1 2.6 0.3 9.5 1.0 6.9 7.1 1.4 12.2 12.5 11.0 14.4 8.5 9.8 10.3 14.9 11.9 7.8 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 30.3;testis: 33.2" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;Daudi: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA040712: , HPA042029: " "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favourable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.5 2.9 8.2 4.1 9.7 2.8 7.1 4.0 7.5 2.5 2.4 11.3 2.5 1.8 2.8 7.1 2.7 8.6 5.1 4.3 8.1 7.6 9.5 5.2 4.6 3.4 9.6 6.2 3.1 3.3 30.3 7.0 2.2 9.0 3.4 3.1 6.4 3.4 3.7 6.0 8.0 1.5 2.3 8.7 3.3 2.0 33.2 6.3 2.4 15.5 1.1 3.0 2.3 2.5 3.1 0.6 2.7 1.3 0.8 1.5 0.3 1.9 4.3 2.3 14.8 4.8 5.9 1.1 1.8 1.6 1.5 1.9 0.2 5.0 19.6 1.5 2.8 0.6 4.7 0.5 1.1 2.0 2.5 0.8 1.3 0.3 2.0 1.2 1.9 12.1 1.8 2.5 0.6 0.5 0.7 1.5 8.4 1.9 1.1 2.6 5.3 2.6 5.4 1.1 0.0 4.7 0.4 5.4 5.9 1.9 0.4 0.6 11.2 10.9 1.0 5.0 0.5 1.9 1.2 1.3 1.0 13.2 2.7 12.4 9.5 1.7 0.7 0.5 1.1 1.3 0.9 2.2 0.9 0.5 0.3 3.1 1.5 1.4 2.7 0.8 0.9 0.6 0.2 0.3 8.2 9.7 4.0 7.5 8.1 7.6 9.6 6.2 9.0 6.3 KATNB1 ENSG00000140854 "Katanin regulatory subunit B1" Q9BVA0 16 57735730-57757250 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041165, HPA041839" Enhanced Supported "Plasma membrane,Microtubules,Cytosol" "Plasma membrane, Cytosol" Microtubules "HPA041165: AB_10795584, HPA041839: AB_10795598" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "prognostic favourable (9.24e-4)" "unprognostic (2.54e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (3.93e-4)" "unprognostic (1.42e-1)" "unprognostic (2.92e-1)" "unprognostic (1.75e-1)" "prognostic favourable (8.44e-4)" "unprognostic (2.89e-2)" "unprognostic (1.03e-3)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (6.88e-2)" "unprognostic (1.54e-1)" 6.9 9.1 15.3 9.3 21.4 18.7 6.3 13.2 29.0 7.0 7.4 8.8 6.7 9.4 6.6 5.8 11.0 18.7 5.9 8.5 16.0 14.5 5.8 10.3 8.0 8.8 9.3 14.1 7.0 9.4 9.5 8.0 7.9 10.6 6.3 5.2 6.2 11.9 8.0 7.1 21.4 8.5 6.0 6.9 8.0 9.1 32.7 8.1 10.8 7.2 10.3 8.6 7.4 6.4 5.8 9.8 24.6 11.6 8.4 12.4 10.5 7.4 13.6 7.5 9.6 4.1 3.7 13.3 5.3 7.0 13.9 7.7 11.3 6.7 6.1 10.6 3.3 10.1 10.0 10.5 6.3 4.1 28.6 7.9 7.6 15.5 4.4 17.2 29.8 3.8 6.5 10.9 6.4 8.2 15.5 3.0 5.4 8.0 24.9 22.4 13.2 23.7 20.0 9.3 22.0 4.1 3.6 38.0 11.4 8.5 10.4 6.2 3.9 8.9 5.8 9.7 8.5 8.5 11.4 6.9 5.5 7.4 13.5 13.4 5.9 24.1 10.1 24.6 12.4 11.2 12.4 5.6 10.5 9.9 9.8 5.8 10.1 10.0 15.5 8.4 11.6 7.4 10.9 10.5 15.3 21.4 13.2 29.0 16.0 14.5 9.3 14.1 10.6 8.1 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: " "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavourable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.9 15.7 25.1 16.8 20.3 20.4 18.7 24.4 14.9 19.6 19.6 8.9 10.0 8.8 16.1 15.8 23.7 12.2 14.0 23.2 18.0 6.6 15.5 16.6 10.5 14.2 16.2 16.8 12.1 20.7 13.3 26.2 35.0 16.5 18.4 26.6 8.7 10.1 13.3 18.4 12.5 15.7 15.3 8.2 18.1 24.2 14.2 12.7 15.0 11.0 7.2 13.6 19.4 20.0 26.7 13.7 23.6 19.3 11.5 15.4 18.0 23.9 17.7 19.8 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 KAZN "FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.9" "Cell line enhanced" "Detected in many" "AN3-CA: 39.7;SK-BR-3: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 6.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 6.9" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: , HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favourable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 8.0 11.0 13.4 3.0 17.4 1.2 7.6 41.1 21.9 8.0 3.8 27.5 5.7 4.6 3.1 11.1 18.8 11.0 7.0 4.1 12.4 12.4 13.2 5.2 8.5 1.5 25.1 12.1 10.4 8.0 22.9 2.7 11.0 15.0 4.1 4.0 10.5 16.8 7.2 1.7 14.2 4.9 3.7 25.0 64.9 4.9 4.1 18.9 0.0 6.6 7.0 6.3 7.9 9.4 0.3 0.0 6.9 0.0 0.0 0.0 0.0 7.8 1.4 8.6 39.7 3.8 3.9 2.9 3.8 3.2 7.1 5.1 1.8 4.2 0.0 9.9 8.1 2.8 1.9 6.2 3.5 0.2 3.9 4.5 4.7 11.8 2.8 0.0 2.3 5.5 8.3 1.6 1.1 0.0 1.8 9.2 5.6 5.7 0.0 0.4 2.4 1.2 2.7 0.2 4.8 11.9 2.4 4.6 3.3 0.6 21.6 14.8 1.2 3.0 0.0 5.8 5.5 9.2 4.5 1.5 1.3 0.0 5.4 7.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 13.4 17.4 41.1 21.4 12.4 12.4 25.1 12.1 15.0 18.9 KBTBD2 "BKLHD1, DKFZP566C134" ENSG00000170852 "Kelch repeat and BTB domain containing 2" Q8IY47 7 32868172-32894131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021133 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA021133: AB_1852093" "unprognostic (1.01e-1)" "prognostic unfavourable (1.89e-4)" "unprognostic (3.17e-2)" "unprognostic (9.19e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "prognostic unfavourable (5.69e-4)" "unprognostic (3.96e-3)" "unprognostic (1.05e-1)" "unprognostic (2.61e-1)" "unprognostic (2.80e-3)" "unprognostic (5.05e-1)" "unprognostic (6.79e-3)" "unprognostic (3.81e-3)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.96e-1)" 20.9 12.3 13.9 15.0 15.7 34.4 16.4 18.3 18.0 13.6 12.2 12.9 10.2 11.3 17.3 8.1 12.8 12.0 18.5 17.0 13.8 14.3 11.2 15.3 17.5 24.9 18.2 13.4 13.9 9.6 16.2 13.8 18.4 17.5 12.5 14.6 12.1 11.7 11.6 36.5 12.2 13.4 18.3 21.1 21.1 10.9 12.5 13.8 26.3 15.2 18.2 16.8 13.6 20.4 6.9 3.5 25.1 8.6 6.8 7.4 2.3 18.2 9.1 23.8 11.7 14.4 14.5 8.6 16.4 16.7 15.6 19.0 9.0 14.2 15.4 11.4 16.9 13.5 12.1 12.8 19.8 6.1 8.7 13.0 15.2 11.7 14.8 13.9 17.2 15.4 13.5 17.0 16.6 17.2 23.6 23.0 23.0 15.0 11.7 22.9 19.2 8.7 11.2 20.8 12.9 13.8 11.1 12.5 23.4 10.5 14.5 18.2 10.2 23.9 14.9 15.3 19.7 14.1 22.4 19.2 18.8 28.3 14.9 16.9 37.9 9.2 4.2 13.0 7.4 7.7 6.2 4.5 3.6 6.5 3.5 6.9 2.8 4.7 25.1 6.8 8.6 1.8 4.7 2.3 13.9 15.7 18.3 18.0 13.8 14.3 18.2 13.4 17.5 13.8 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: " "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favourable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.0 10.5 11.3 9.5 6.9 9.4 4.0 8.5 10.1 11.1 9.6 4.4 9.4 9.3 4.9 9.7 8.4 6.3 11.2 9.5 11.9 10.1 6.7 14.6 4.9 5.1 13.9 13.6 8.5 7.8 4.4 6.0 11.2 5.3 7.2 8.6 12.6 10.2 4.4 6.2 7.5 10.2 15.3 5.9 11.8 10.6 15.7 10.4 7.3 9.8 6.4 16.5 4.5 10.2 8.0 8.9 11.0 8.4 11.2 17.2 12.8 11.1 4.0 8.2 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 KCMF1 "DEBT91, DKFZP434L1021, PCMF, ZZZ1" ENSG00000176407 "Potassium channel modulatory factor 1" Q9P0J7 2 84971093-85059472 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030383, HPA030384" Enhanced Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030383: AB_10599977, HPA030384: AB_10601230" "unprognostic (8.01e-2)" "unprognostic (1.98e-2)" "unprognostic (9.95e-2)" "unprognostic (7.42e-3)" "unprognostic (1.24e-2)" "unprognostic (8.54e-2)" "prognostic unfavourable (2.33e-7)" "unprognostic (5.68e-3)" "unprognostic (1.43e-1)" "unprognostic (9.81e-2)" "prognostic unfavourable (6.10e-5)" "unprognostic (4.98e-2)" "prognostic unfavourable (4.18e-6)" "unprognostic (6.11e-2)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (1.01e-1)" 19.2 13.3 17.9 20.2 16.0 23.6 26.1 13.4 18.6 15.0 20.2 10.7 20.3 15.4 16.3 18.8 28.5 12.8 17.9 30.4 16.5 12.0 14.8 20.7 16.4 18.8 13.7 11.1 17.2 48.6 14.7 18.7 20.5 14.4 17.5 21.4 14.0 19.4 15.7 67.2 17.6 20.6 25.7 10.3 16.7 16.8 29.0 11.5 19.7 18.7 21.8 22.5 23.9 34.0 4.0 4.2 8.1 3.4 2.8 8.8 1.5 27.1 21.4 19.1 14.7 20.2 19.5 32.5 29.1 27.1 28.0 18.7 26.1 29.4 29.6 29.3 39.4 18.1 14.8 28.2 36.9 22.1 10.4 18.9 16.1 26.6 39.5 20.7 18.1 20.1 44.6 27.4 76.0 21.0 18.7 23.6 27.9 25.1 20.0 11.5 20.8 18.0 14.4 26.8 18.5 25.3 23.9 18.4 13.8 16.9 21.6 28.2 10.0 13.2 17.9 28.6 27.9 26.6 30.2 26.9 33.2 30.0 21.5 15.3 21.4 5.0 2.6 8.1 4.5 2.2 3.6 3.5 3.2 3.4 2.2 4.0 2.8 3.1 7.5 2.8 3.4 4.2 8.8 1.5 17.9 16.0 13.4 18.6 16.5 12.0 13.7 11.1 14.4 11.5 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Cell line enhanced" "Detected in many" "HEL: 5.8;hTEC/SVTERT24-B: 9.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.8 0.8 1.2 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.6 1.7 5.8 1.0 2.6 0.0 1.6 0.5 0.0 0.0 9.1 0.0 3.6 0.2 0.5 0.4 0.2 0.5 1.0 1.8 0.4 0.9 1.2 4.6 0.0 0.4 1.3 1.4 0.5 1.1 1.1 1.4 0.9 3.7 1.5 0.9 2.4 1.9 3.2 0.7 0.7 4.5 1.9 1.6 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" "Plasma membrane" "Nucleoli, Midbody" "HPA065970: " "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110211343-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 16.1;U-87 MG: 14.4;WM-115: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 2.3 4.7 12.1 1.6 3.2 0.7 3.3 9.2 12.7 1.9 1.4 1.9 1.1 0.8 4.5 3.1 2.1 3.7 4.8 4.5 9.1 14.2 5.1 1.1 3.0 1.9 6.8 2.0 3.4 4.3 11.2 3.8 2.8 14.3 2.4 1.3 4.7 7.1 3.7 4.5 4.0 2.0 2.6 3.6 3.3 2.8 2.2 1.1 7.2 2.3 7.8 2.3 1.2 1.5 0.8 0.7 0.9 0.4 0.3 1.5 0.1 1.9 1.5 0.4 2.8 1.1 0.3 3.4 8.4 1.4 0.6 0.8 4.7 0.9 3.2 3.3 3.1 3.1 1.4 0.7 0.4 16.1 1.6 0.1 3.2 0.7 0.5 2.7 0.8 0.3 0.3 1.9 0.2 4.3 0.6 1.4 0.0 0.4 1.8 0.6 1.6 3.8 2.6 0.1 0.5 4.0 0.1 0.6 0.8 0.4 8.1 0.8 1.1 1.4 1.6 1.0 3.9 0.6 0.3 2.1 1.9 0.6 14.4 2.3 9.3 0.8 0.4 0.2 0.5 0.2 1.5 0.6 0.9 0.4 0.0 0.8 1.3 0.5 0.9 0.3 0.3 0.7 0.4 0.1 12.1 3.2 9.2 12.7 9.1 14.2 6.8 2.0 14.3 1.1 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 27.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 59.6" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011420 Approved Approved "Nuclear bodies,Microtubules" Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavourable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 9.0 2.4 5.5 7.5 5.7 0.2 6.6 2.6 11.9 4.5 3.3 1.2 1.4 0.8 21.9 4.4 3.7 3.4 14.8 3.5 6.5 2.5 2.4 3.6 2.1 3.3 9.4 0.7 9.2 6.4 0.7 5.3 4.6 8.7 3.7 1.4 11.6 2.3 4.2 2.1 2.1 2.3 27.0 21.5 4.7 4.9 2.2 8.4 0.0 5.2 1.7 0.6 7.7 12.5 0.7 0.3 2.3 0.3 0.4 0.3 0.0 0.0 0.3 0.0 59.6 13.7 1.4 0.0 1.4 1.3 0.3 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 0.0 4.4 0.2 0.0 0.0 0.0 1.4 0.0 1.1 2.3 0.3 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.0 0.7 0.3 0.3 0.9 0.4 0.2 0.3 0.1 0.0 5.5 5.7 2.6 11.9 6.5 2.5 9.4 0.7 8.7 8.4 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell line enhanced" "Detected in some" "A549: 9.4;AN3-CA: 4.4;HMC-1: 4.5;RPTEC TERT1: 11.6;U-2 OS: 12.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051088: " "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 2.2 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.1 0.0 0.0 0.6 11.6 0.0 1.8 0.3 0.3 0.0 0.3 1.0 0.2 0.1 0.0 12.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Group enriched" "Detected in some" 5 "HeLa: 9.9;RT4: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.7;HeLa: 6.2;PC-3: 6.5;SCLC-21H: 7.6;SiHa: 3.8;U-2197: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavourable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 3.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.5 0.1 0.1 0.0 1.5 6.5 0.0 1.0 1.7 0.0 0.0 7.6 0.4 3.8 0.0 1.6 0.0 0.0 2.9 0.0 0.5 6.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favourable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favourable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.5 28.0 0.2 0.4 1.9 0.0 0.0 0.0 0.2 0.1 0.0 2.9 9.4 0.0 26.9 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 2.7 7.0 1.5 1.3 0.1 0.2 12.3 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 26.8 31.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.1 1.4 0.0 0.7 0.1 0.0 2.2 1.6 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.2" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell line enhanced" "Detected in some" "MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" "Nuclear speckles, Cell Junctions" "HPA003514: " "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.9 1.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.5 5.1 2.2 0.7 0.0 2.2 1.4 0.0 1.9 0.0 0.0 2.5 0.0 0.8 0.7 2.2 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 41.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 KCNK6 "K2p6.1, TWIK-2" ENSG00000099337 "Potassium two pore domain channel subfamily K member 6" Q9Y257 19 38319844-38332076 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 21.7;HMC-1: 24.3;T-47d: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.2" "Group enriched" "Detected in many" 5 "dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022637, HPA040184" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "CAB022637: , HPA040184: " "unprognostic (7.98e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.45e-6)" "unprognostic (3.76e-1)" "unprognostic (6.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.08e-2)" "unprognostic (4.31e-1)" "unprognostic (4.91e-1)" "unprognostic (4.10e-3)" "unprognostic (3.15e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.07e-2)" "unprognostic (3.46e-1)" "unprognostic (5.88e-2)" "unprognostic (4.59e-3)" 3.0 2.0 2.1 7.4 2.5 2.8 4.9 0.8 2.0 25.3 9.2 1.7 10.6 3.8 20.1 5.2 21.7 8.6 13.1 4.3 2.1 1.0 2.8 2.7 7.1 8.9 2.0 1.3 8.0 21.3 0.2 1.7 11.6 2.3 7.3 8.3 2.3 29.0 13.5 0.9 15.1 10.1 13.4 3.7 12.7 7.0 2.0 2.2 4.2 1.7 17.5 18.8 14.3 12.5 1.2 8.9 16.2 5.4 0.6 1.9 1.5 5.3 1.9 0.3 0.3 3.1 2.0 0.4 4.6 2.2 1.2 1.6 1.5 5.8 0.4 2.2 6.5 6.9 2.5 10.4 0.8 0.2 0.2 21.7 1.0 0.2 2.8 1.6 24.3 0.5 9.4 1.5 2.9 3.1 0.3 1.7 3.4 11.6 1.5 1.4 0.3 1.3 2.3 0.4 1.6 4.2 0.5 0.3 0.5 0.5 0.5 0.2 13.7 6.1 3.5 0.4 2.7 2.5 0.2 0.6 0.1 0.6 0.4 7.8 0.2 16.2 5.4 11.7 1.3 4.8 1.1 1.2 1.7 1.6 8.9 1.1 1.5 1.1 4.2 0.6 5.1 2.5 1.9 1.5 2.1 2.5 0.8 2.0 2.1 1.0 2.0 1.3 2.3 2.2 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.9;NB-4: 7.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.4 2.6 0.1 3.0 0.6 1.1 0.0 0.2 1.5 3.7 0.4 10.9 2.9 2.5 1.2 0.2 3.6 1.9 0.6 0.9 0.0 1.1 0.4 0.1 1.5 1.8 0.1 7.4 0.0 2.3 3.2 0.0 0.1 1.0 2.0 1.5 0.4 0.9 1.2 0.7 3.0 6.0 0.7 0.6 1.0 0.3 0.9 1.0 0.4 3.5 0.6 4.2 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell line enriched" "Detected in some" 12 "REH: 57.4" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA065938: " "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.1 0.9 1.8 0.1 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 57.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Group enriched" "Detected in some" 5 "BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 14.7 2.2 0.3 0.1 0.0 0.2 0.0 0.5 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 5.6 0.0 0.1 0.0 0.7 0.2 0.1 1.8 0.0 0.0 0.1 10.4 0.2 18.3 0.2 0.0 0.4 1.6 0.0 0.1 0.0 0.1 1.8 6.5 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.4" "Cell line enhanced" "Detected in many" "RH-30: 33.1;RPMI-8226: 13.3;RT4: 22.5;U-266/84: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.2 1.1 2.7 5.6 3.2 0.4 14.8 0.5 5.1 6.8 7.9 4.8 1.3 3.1 4.5 2.4 7.2 3.3 5.3 4.6 3.9 3.4 4.2 2.6 17.6 1.2 6.8 1.4 1.1 7.7 1.9 0.8 8.3 15.2 4.4 4.1 9.9 7.6 2.8 54.4 3.7 4.3 9.7 4.7 1.1 7.0 3.9 1.4 0.2 2.4 19.0 3.6 5.0 4.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.3 0.0 0.8 0.4 1.8 1.3 4.0 0.8 1.0 0.0 8.1 0.0 0.4 1.4 1.2 9.8 0.0 0.9 0.0 2.5 0.0 0.1 0.0 4.0 0.1 0.3 0.3 6.2 0.0 0.6 0.2 0.2 0.0 0.5 1.0 0.0 0.0 4.8 0.1 1.1 33.1 13.3 0.8 22.5 9.8 0.3 0.0 2.5 2.7 1.3 0.0 0.0 1.3 0.0 0.1 9.9 0.0 15.4 0.0 7.4 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 0.5 5.1 3.9 3.4 6.8 1.4 15.2 1.4 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 35.6;HaCaT: 37.0;hTCEpi: 33.5;RPTEC TERT1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavourable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favourable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 3.9 11.8 15.9 2.1 37.3 0.7 22.2 13.7 29.0 12.6 5.0 6.9 6.2 3.2 10.0 15.8 32.8 33.8 5.8 12.9 16.7 6.7 20.1 2.6 4.0 2.0 6.6 18.4 11.1 5.2 7.4 6.1 17.2 6.8 15.3 7.3 8.4 12.5 16.4 2.8 39.3 2.2 8.7 6.0 2.9 7.0 4.1 10.7 5.7 13.6 20.1 11.7 8.5 18.3 0.3 0.7 0.7 0.3 0.0 1.8 0.2 5.4 19.0 35.6 3.8 20.9 3.4 4.5 4.6 7.0 7.4 7.3 1.8 6.3 1.1 17.7 9.8 37.0 6.8 10.0 6.9 1.0 3.2 1.1 4.2 3.0 3.9 0.6 1.8 5.7 33.5 2.1 13.9 6.9 0.4 0.5 5.2 7.8 5.4 1.7 3.6 8.7 2.9 2.1 0.8 32.6 8.2 3.7 14.1 6.7 9.2 3.1 8.3 1.5 3.7 8.2 2.6 1.6 5.1 1.7 1.4 0.1 3.1 3.7 12.2 0.0 0.1 0.7 0.8 0.1 1.6 0.0 1.8 0.6 0.7 0.3 0.7 0.5 0.0 0.0 0.3 0.3 0.0 0.2 15.9 37.3 13.7 29.0 16.7 6.7 6.6 18.4 6.8 10.7 KCTD10 "BTBD28, MSTP028" ENSG00000110906 "Potassium channel tetramerization domain containing 10" Q9H3F6 12 109448656-109477544 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014273 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA014273: AB_1852159" "unprognostic (7.21e-3)" "unprognostic (3.04e-1)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.93e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (5.32e-4)" "unprognostic (1.84e-2)" "unprognostic (1.85e-1)" "unprognostic (7.01e-2)" "unprognostic (9.33e-2)" "unprognostic (3.45e-1)" "unprognostic (7.72e-2)" "unprognostic (5.76e-2)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" 29.1 16.2 10.4 16.3 17.1 8.4 21.3 10.6 20.0 25.3 26.9 14.1 15.1 8.5 30.5 15.6 24.4 18.1 23.2 16.1 11.0 16.4 23.2 9.3 20.5 13.9 11.7 8.4 16.7 7.9 14.6 12.7 19.2 16.9 19.8 22.2 29.4 14.4 29.8 9.9 19.3 14.1 36.4 9.6 17.5 19.4 13.5 12.6 12.8 30.8 15.4 17.5 27.8 19.0 6.2 10.4 7.9 14.0 20.8 12.7 11.8 9.1 9.7 28.4 9.4 23.0 32.9 6.3 20.0 26.3 13.3 13.2 9.1 7.5 8.9 11.7 45.6 7.3 10.0 16.5 12.8 8.6 6.8 10.3 6.2 5.7 14.7 7.5 9.0 31.3 10.2 17.5 9.6 31.0 6.9 3.9 23.1 4.8 9.7 10.2 16.8 12.0 9.6 12.4 6.9 13.3 15.8 10.1 15.1 12.0 12.5 12.5 15.4 6.2 22.9 14.1 5.4 8.0 11.0 8.7 16.4 12.4 16.0 6.6 20.7 7.9 8.1 5.4 12.7 12.4 9.3 6.2 7.6 9.2 10.4 6.2 8.4 10.5 5.9 20.8 14.0 7.9 8.4 11.8 10.4 17.1 10.6 20.0 11.0 16.4 11.7 8.4 16.9 12.6 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29927035 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA043524: " "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavourable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favourable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 5.7 5.4 20.4 12.3 28.4 9.5 5.6 11.4 26.0 6.0 6.6 16.0 6.2 11.5 7.2 13.2 5.8 6.3 13.1 3.8 24.4 11.4 6.1 4.2 4.3 13.5 15.7 14.7 8.0 5.7 9.2 11.9 5.3 10.5 7.4 10.6 6.1 6.9 9.6 3.1 15.1 9.9 4.3 9.7 9.7 9.2 33.9 15.7 6.4 10.5 3.6 11.0 5.6 5.7 3.9 2.5 8.8 2.8 2.9 5.7 1.6 5.9 10.8 3.4 7.3 1.8 2.7 7.8 3.1 0.6 0.9 3.1 4.7 11.3 11.9 3.9 2.7 10.0 3.2 3.4 2.2 5.0 7.3 2.7 7.6 2.5 0.8 4.2 6.7 4.2 5.5 6.1 1.4 2.2 5.7 6.4 4.0 6.8 5.2 4.9 4.1 2.4 9.4 3.6 3.2 2.4 6.6 9.3 3.1 3.4 4.9 8.5 5.1 2.6 5.3 4.4 3.3 8.6 4.9 6.1 2.3 4.6 3.5 8.0 6.2 4.9 2.8 7.4 3.0 2.3 3.5 2.2 5.7 4.6 2.5 3.9 5.0 4.0 8.8 2.9 2.7 2.1 4.0 1.6 20.4 28.4 11.4 26.0 24.4 11.4 15.7 14.7 10.5 15.7 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (3.96e-5)" "prognostic favourable (8.01e-4)" "prognostic unfavourable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favourable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favourable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.0 0.3 0.3 0.8 0.4 2.1 1.1 0.9 2.0 5.0 7.8 5.1 0.0 5.6 0.6 0.6 0.3 15.1 5.3 0.2 7.7 0.0 1.8 16.5 3.0 0.1 0.0 2.4 0.4 8.2 6.5 0.5 0.1 0.0 0.8 0.1 0.2 0.4 3.8 0.3 0.2 0.0 0.0 26.8 2.0 1.3 0.1 0.0 0.1 2.5 0.8 0.6 0.4 0.1 12.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 47.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA050822: " "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 8.7 4.0 10.5 7.1 7.9 3.4 7.7 7.7 11.0 15.5 13.6 8.6 4.6 4.7 20.3 6.2 14.6 12.7 9.4 6.8 13.0 5.1 6.2 7.1 13.3 4.1 5.8 8.4 14.3 15.6 1.6 3.4 7.3 9.4 9.0 4.2 12.4 3.7 13.7 4.8 47.3 5.8 13.8 9.3 8.3 8.1 10.6 8.9 1.0 8.9 5.1 4.6 9.4 13.0 0.0 3.4 7.7 6.3 0.0 1.2 0.9 5.7 13.3 12.0 18.2 4.0 2.1 9.5 7.6 1.4 4.3 2.2 7.4 3.9 0.0 17.3 10.6 6.8 8.7 6.0 1.6 6.2 15.3 23.8 8.2 7.1 11.1 4.6 4.3 4.1 25.2 1.6 9.7 8.3 5.8 0.1 0.7 14.6 0.1 13.1 10.9 22.5 11.1 6.5 2.2 4.8 2.6 9.3 32.0 14.9 21.3 27.7 15.7 12.2 13.5 20.0 18.0 0.4 1.3 14.8 0.7 9.4 0.0 8.0 24.4 0.6 2.5 7.7 0.0 4.6 0.1 0.0 1.2 0.2 3.4 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.7 0.9 10.5 7.9 7.7 9.2 13.0 5.1 5.8 8.4 9.4 8.9 KCTD20 "C6orf69, dJ108K11.3, MGC14254" ENSG00000112078 "Potassium channel tetramerization domain containing 20" Q7Z5Y7 6 36442767-36491143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030092 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA030092: AB_10601437" "unprognostic (2.17e-1)" "unprognostic (2.02e-1)" "unprognostic (5.20e-3)" "unprognostic (2.43e-2)" "unprognostic (1.00e-3)" "unprognostic (5.03e-3)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.63e-1)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (9.31e-4)" "unprognostic (2.94e-2)" 34.3 23.1 18.4 22.8 17.6 20.1 39.0 15.7 21.4 22.2 20.7 18.7 22.4 12.0 25.5 23.1 24.6 22.0 25.1 21.0 16.3 17.1 16.2 29.7 20.5 26.2 18.0 14.4 25.6 12.7 15.7 16.1 21.7 16.5 17.5 16.0 17.9 16.2 19.2 20.4 24.6 17.6 30.8 17.3 24.2 16.6 10.2 13.3 31.6 13.6 18.1 24.9 21.5 18.3 6.2 14.0 19.4 14.4 6.4 8.5 10.9 10.9 5.0 14.5 27.7 19.9 12.8 7.0 13.3 18.4 14.5 16.2 12.8 6.2 36.8 12.0 21.6 10.1 18.9 9.6 24.1 26.2 10.4 20.9 7.9 13.5 9.3 20.2 14.6 12.9 10.0 11.1 7.1 14.8 32.3 21.1 13.6 9.6 23.0 7.7 5.4 4.5 22.9 16.5 20.7 7.8 12.3 3.5 20.5 11.6 11.8 35.4 16.3 20.2 16.8 39.3 13.5 11.6 16.5 16.7 38.7 26.7 6.8 28.0 40.1 19.4 14.4 9.2 7.5 13.1 8.5 6.2 5.9 6.2 14.0 5.1 6.2 6.1 10.6 6.4 7.2 7.6 6.9 10.9 18.4 17.6 15.7 21.4 16.3 17.1 18.0 14.4 16.5 13.3 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492114-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavourable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favourable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 7.8 8.4 15.3 4.4 13.2 13.5 11.4 35.9 21.8 11.1 7.9 10.0 6.4 5.6 12.3 28.8 10.9 12.4 8.8 7.7 16.9 11.7 15.4 12.2 6.6 9.1 15.3 10.5 13.1 7.1 10.4 14.4 10.9 11.9 9.2 8.1 14.7 7.3 9.4 6.8 7.5 5.3 11.2 12.5 8.8 5.7 5.7 12.4 6.3 14.1 6.3 7.3 6.4 11.9 13.0 20.2 17.1 14.6 8.2 15.6 6.6 5.7 5.4 16.3 7.0 14.3 10.3 6.1 6.9 6.2 10.2 12.1 5.2 3.2 11.3 2.3 4.9 3.1 13.2 4.0 9.2 11.6 6.0 5.2 12.5 6.5 6.8 4.1 4.2 6.2 6.3 8.1 5.1 6.7 2.8 5.4 8.8 5.3 6.0 6.3 12.0 10.4 6.1 4.5 7.9 9.6 2.6 9.2 8.0 3.9 9.1 4.9 36.4 3.0 3.6 9.4 8.5 11.9 10.3 5.9 9.2 13.3 8.0 8.4 7.1 17.1 14.6 9.8 13.7 14.6 15.6 13.0 10.1 12.8 20.2 10.3 11.5 9.8 5.0 8.2 10.5 7.8 9.5 6.6 15.3 13.2 35.9 16.2 16.9 11.7 15.3 10.5 11.9 12.4 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: " "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favourable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 14.4 5.8 7.4 17.3 7.7 11.5 14.6 17.7 10.1 15.7 14.1 5.4 16.8 12.4 15.6 12.2 18.2 11.3 12.8 48.4 5.9 5.2 9.6 6.6 10.3 6.9 7.4 5.3 12.4 8.3 7.3 11.2 7.4 14.6 11.8 14.8 9.4 14.6 18.4 19.0 15.0 10.9 16.7 10.8 8.6 10.6 11.2 6.6 11.8 8.7 11.7 8.7 19.1 14.8 2.2 3.2 3.7 2.9 0.9 3.8 1.5 17.9 12.8 14.0 4.8 18.2 24.2 11.5 27.3 24.6 18.0 18.3 9.1 13.2 11.8 11.7 27.2 12.1 12.2 12.8 21.7 6.0 7.3 13.7 12.5 8.4 22.1 4.8 10.2 18.6 15.6 16.3 13.6 15.1 14.4 9.3 20.3 4.8 18.4 8.3 6.8 6.8 7.2 16.2 4.3 18.3 10.3 3.5 4.6 20.9 9.3 14.1 7.1 5.5 16.7 19.9 11.6 38.1 14.7 2.7 4.9 15.6 13.9 8.5 14.3 2.6 1.7 3.7 3.4 2.5 3.8 2.2 3.6 3.6 1.1 1.2 2.2 3.6 1.8 0.9 2.9 3.2 3.5 1.5 7.4 7.7 17.7 10.1 5.9 5.2 7.4 5.3 14.6 6.6 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: " "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavourable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.1 14.4 23.8 27.7 13.5 14.0 13.1 20.1 21.9 17.2 23.4 0.0 8.8 18.2 2.3 10.6 0.3 21.3 5.6 8.2 5.3 4.0 7.9 9.6 13.7 0.0 15.9 4.4 10.6 0.3 16.9 11.8 0.1 30.4 2.3 8.8 7.9 6.1 10.4 0.4 22.0 0.0 3.7 8.8 2.9 9.0 26.5 1.8 3.8 12.7 5.3 16.8 39.0 7.7 3.3 14.5 0.1 0.0 0.0 10.0 14.5 30.9 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 KDELR1 "ERD2, ERD2.1, HDEL" ENSG00000105438 "KDEL endoplasmic reticulum protein retention receptor 1" P24390 19 48382570-48391553 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017455 Approved Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus" "Vesicles, Cytosol" "CAB017455: AB_10615208" "unprognostic (3.10e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.49e-4)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.35e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (7.55e-2)" "unprognostic (4.97e-2)" "unprognostic (3.81e-1)" "unprognostic (2.74e-1)" "unprognostic (3.06e-1)" "unprognostic (1.68e-2)" 46.9 49.3 22.6 23.4 21.5 14.5 60.6 16.1 28.8 51.8 43.3 24.4 64.8 47.7 44.0 45.2 41.3 40.3 56.5 42.8 20.9 20.4 57.3 81.3 38.0 44.6 18.6 20.4 68.9 61.0 63.5 45.7 81.4 20.9 44.8 47.7 39.7 65.8 69.9 31.8 37.4 59.9 39.6 26.0 33.7 42.5 33.2 18.6 26.2 75.5 32.9 42.3 53.2 54.4 10.6 26.5 6.8 23.3 11.6 12.8 9.3 30.1 43.7 25.4 26.9 57.1 66.8 18.6 29.8 52.8 36.4 41.8 28.8 34.5 12.6 19.6 65.2 27.1 30.5 31.9 34.8 10.1 32.6 10.5 15.5 53.6 49.7 11.7 19.7 63.1 39.4 24.7 26.5 33.8 18.2 23.5 48.3 24.3 11.0 120.2 18.4 17.8 15.7 15.1 19.7 46.2 25.2 25.5 19.8 26.1 23.5 15.6 18.4 14.4 26.1 25.8 21.3 21.3 25.3 66.5 52.0 8.5 16.3 15.8 26.2 5.9 23.3 6.8 11.2 19.8 12.8 10.6 11.0 12.1 17.7 9.6 9.2 9.9 5.9 11.6 16.5 26.5 11.7 9.3 22.6 21.5 16.1 28.8 20.9 20.4 18.6 20.4 20.9 18.6 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 13.6;BEWO: 12.0;CAPAN-2: 12.9;HaCaT: 12.1;HBEC3-KT: 16.7;hTCEpi: 21.9;SK-BR-3: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: " "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favourable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favourable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 6.8 12.9 0.0 0.5 0.0 12.1 0.0 16.7 0.0 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 21.9 0.0 1.8 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.9 0.1 0.0 0.0 2.0 3.0 6.5 8.5 0.0 0.1 14.3 0.0 9.2 0.2 0.1 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 KDM1A "AOF2, BHC110, KDM1, KIAA0601, LSD1" ENSG00000004487 "Lysine demethylase 1A" O60341 1 23019443-23083689 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005884, HPA053660" Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "CAB005884: AB_443964, HPA053660: " "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic favourable (6.31e-4)" "unprognostic (1.50e-1)" "unprognostic (6.83e-2)" "unprognostic (3.95e-2)" "prognostic unfavourable (4.47e-12)" "unprognostic (1.80e-2)" "unprognostic (1.99e-2)" "unprognostic (9.41e-2)" "unprognostic (3.34e-3)" "unprognostic (2.13e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (7.74e-2)" "unprognostic (1.39e-1)" 15.1 19.0 19.7 16.8 23.2 24.9 19.3 28.0 26.6 20.0 20.6 15.1 21.0 16.2 28.9 30.6 20.9 22.0 15.7 18.6 16.4 18.9 15.9 14.8 15.1 19.5 13.8 25.4 27.4 21.4 24.6 28.7 19.3 20.3 20.9 21.6 16.4 21.3 19.9 24.8 23.3 16.9 19.1 10.7 16.2 17.1 78.4 12.1 48.1 20.9 19.1 22.1 18.7 21.9 9.1 9.7 5.7 6.9 3.8 7.4 1.9 30.0 15.6 44.5 39.3 11.8 15.1 31.7 12.8 16.2 26.2 23.4 14.6 29.3 22.4 18.4 21.0 33.8 41.2 24.4 33.3 20.3 25.0 31.5 26.0 35.5 15.1 24.2 13.9 14.0 17.6 27.8 19.7 32.6 34.4 10.6 18.6 17.9 52.8 18.6 29.0 22.7 50.7 29.4 15.1 22.0 19.4 55.7 42.1 57.8 15.3 19.0 15.3 18.1 26.4 11.7 19.8 21.6 17.4 13.8 10.8 26.1 12.2 28.8 16.6 2.8 3.7 5.7 5.9 5.9 5.2 9.1 5.4 5.7 4.4 3.3 7.1 7.4 0.3 3.8 6.9 9.7 5.8 1.9 19.7 23.2 28.0 26.6 16.4 18.9 13.8 25.4 20.3 12.1 KDM4B "JMJD2B, KIAA0876, TDRD14B" ENSG00000127663 "Lysine demethylase 4B" O94953 19 4969113-5153595 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062872 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA062872: " "prognostic favourable (7.39e-4)" "unprognostic (1.99e-1)" "prognostic unfavourable (2.74e-4)" "prognostic favourable (4.25e-7)" "unprognostic (5.95e-2)" "unprognostic (7.96e-3)" "unprognostic (2.72e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.13e-4)" "unprognostic (3.89e-2)" "unprognostic (8.24e-3)" "unprognostic (5.14e-3)" "unprognostic (8.66e-2)" "unprognostic (1.98e-1)" "unprognostic (3.82e-1)" "unprognostic (4.14e-2)" "unprognostic (5.44e-2)" 13.3 16.0 14.8 15.1 13.4 22.0 20.0 26.1 18.7 19.4 12.6 18.3 24.3 12.1 24.2 18.1 15.9 18.4 12.0 12.6 13.3 9.2 10.4 18.2 11.8 19.2 13.8 12.9 18.5 19.0 12.1 17.9 29.4 11.2 24.8 6.0 18.8 16.5 22.6 38.0 21.1 12.9 16.2 13.3 21.2 12.0 19.9 13.8 14.6 28.9 8.8 13.7 13.3 21.9 7.1 2.5 6.9 0.9 1.3 0.8 0.5 8.8 3.1 7.3 8.7 4.2 4.2 14.7 4.4 3.3 3.9 4.9 5.2 2.5 12.3 4.7 5.0 5.0 4.4 5.2 2.4 5.5 11.2 4.1 5.3 4.3 7.9 4.1 9.6 6.5 5.6 3.2 2.7 5.2 10.1 7.6 3.5 4.5 4.7 6.3 6.4 7.7 8.0 5.5 10.2 3.9 5.8 13.6 10.4 5.7 6.4 7.0 34.9 10.9 7.5 5.8 3.3 7.1 4.4 20.9 8.6 9.5 11.5 8.3 3.3 1.6 0.9 2.6 0.5 0.3 0.3 6.1 0.4 0.4 0.4 7.1 0.6 0.8 6.9 1.3 0.4 2.5 0.5 0.5 14.8 13.4 26.1 18.7 13.3 9.2 13.8 12.9 11.2 13.8 KDM5A "JARID1A, RBBP2" ENSG00000073614 "Lysine demethylase 5A" P29375 12 280129-389454 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006201 Supported "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA006201: AB_1079160" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (4.46e-2)" "unprognostic (1.60e-1)" "unprognostic (3.53e-3)" "unprognostic (1.81e-2)" "unprognostic (5.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.77e-3)" "unprognostic (6.11e-2)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (2.60e-2)" "unprognostic (7.69e-2)" 13.6 14.4 10.6 13.7 13.0 41.6 13.1 21.8 13.2 11.8 10.3 14.8 11.3 7.8 14.2 8.1 13.6 11.2 10.0 10.1 11.5 5.7 9.0 10.7 13.1 14.9 15.1 9.1 15.2 11.5 16.8 13.8 12.4 11.3 10.6 10.9 10.6 12.9 8.6 9.7 20.3 13.0 10.4 10.1 15.5 10.6 21.2 14.8 28.8 11.4 7.1 16.1 13.1 18.8 17.2 16.8 33.7 14.1 18.6 18.1 10.1 7.6 13.7 10.1 7.8 9.1 8.7 11.2 6.8 9.0 10.2 11.1 8.1 9.3 12.8 2.1 11.3 7.2 10.5 7.7 12.3 20.1 8.7 15.6 14.4 4.8 7.4 20.3 12.3 9.4 7.3 12.5 16.8 10.3 9.3 18.0 8.6 5.1 14.5 5.8 15.7 4.3 13.6 26.4 6.0 4.9 17.6 3.9 11.4 13.3 6.0 7.2 6.5 12.8 14.1 6.7 9.7 7.5 11.3 6.4 7.0 29.4 8.7 8.9 9.9 30.2 11.3 22.2 17.7 13.1 18.1 14.1 13.8 14.2 11.8 17.2 15.1 12.9 33.7 18.6 14.1 16.8 10.5 10.1 10.6 13.0 21.8 13.2 11.5 5.7 15.1 9.1 11.3 14.8 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB068193: , HPA027179: AB_1851987, HPA053723: " "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 11.1 4.6 30.4 14.6 14.4 13.1 25.7 7.7 11.9 8.1 8.6 3.8 11.9 0.0 5.3 12.1 17.3 14.4 12.6 10.5 0.1 5.5 6.1 4.3 6.1 12.4 19.0 8.1 13.5 21.0 11.6 15.3 18.0 19.0 0.0 8.2 11.4 5.3 22.7 20.6 8.0 22.4 0.0 0.0 11.7 19.4 9.3 20.5 16.3 10.1 13.6 20.6 13.6 13.3 7.2 5.4 0.9 4.5 1.2 0.8 4.7 6.3 7.0 2.9 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 KDM5C "DXS1272E, JARID1C, MRX13, SMCX, XE169" ENSG00000126012 "Lysine demethylase 5C" P41229 X 53191321-53225422 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038244, HPA046147" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038244: , HPA046147: " "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (1.56e-2)" "unprognostic (7.10e-2)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (2.08e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.45e-2)" "unprognostic (1.58e-2)" "unprognostic (5.05e-3)" "unprognostic (1.96e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.00e-1)" 19.5 22.9 22.4 22.6 24.7 26.3 17.9 43.0 31.7 25.9 19.5 23.4 16.7 22.2 29.2 13.3 26.9 24.8 15.2 17.6 21.6 15.3 17.0 18.8 20.6 25.8 24.6 21.8 33.1 22.5 37.7 31.8 34.0 22.8 18.7 13.5 17.0 25.6 17.1 36.6 28.4 22.2 23.6 16.0 25.0 19.4 10.6 26.2 29.0 22.2 11.3 24.5 21.5 26.4 4.5 4.3 4.8 4.0 2.8 6.1 3.8 17.3 23.8 25.5 19.5 17.7 16.2 18.1 10.9 12.8 14.8 13.8 16.0 11.4 16.2 14.2 14.3 15.6 28.8 23.3 11.3 12.1 42.6 15.7 25.3 11.3 21.8 18.6 31.4 12.7 17.2 28.9 35.6 21.8 30.6 10.8 10.8 22.3 13.6 20.9 21.6 22.3 15.4 15.2 17.6 9.4 16.7 19.2 24.8 33.1 30.7 12.4 21.5 16.4 14.9 16.5 14.3 14.8 10.5 15.7 12.8 12.4 21.4 22.1 12.2 3.0 3.8 2.7 6.1 3.6 5.1 4.5 3.7 5.7 3.1 3.2 4.5 2.9 4.8 2.8 4.0 4.3 4.3 3.8 22.4 24.7 43.0 31.7 21.6 15.3 24.6 21.8 22.8 26.2 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoplasm Nucleoli "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.9 7.8 11.6 11.7 8.3 8.6 24.9 7.0 5.0 8.4 8.8 18.4 7.7 5.9 3.8 6.5 19.3 14.8 12.3 7.8 8.5 15.9 7.3 9.9 6.8 5.9 3.9 20.7 4.6 10.2 13.8 14.5 6.5 10.1 14.6 5.2 5.8 8.1 11.5 9.7 9.0 9.0 11.1 1.0 4.8 16.8 10.0 5.4 22.3 11.2 9.5 10.8 0.1 5.5 8.0 6.2 8.0 3.6 9.2 11.1 8.9 5.6 4.1 4.6 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140177035 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 20.1 3.2 6.6 15.2 4.7 18.7 10.4 8.7 6.1 13.2 12.0 4.7 4.6 10.3 8.9 5.8 13.0 5.8 6.0 8.0 5.7 3.5 4.9 8.5 9.7 10.1 4.8 2.8 5.0 6.4 7.0 6.7 15.5 6.7 6.9 12.2 3.7 11.4 4.5 24.6 15.0 16.3 9.3 6.0 6.7 11.9 9.4 5.9 10.8 6.4 10.3 15.2 13.1 9.1 2.8 3.0 6.1 2.3 1.8 1.6 0.8 0.9 0.4 2.9 3.1 2.6 2.3 5.9 1.3 1.9 0.5 0.6 0.3 0.4 2.0 2.0 1.3 1.1 4.0 2.4 0.9 11.2 2.5 0.1 0.4 5.2 2.7 1.8 2.1 2.7 5.5 1.6 8.7 2.8 6.3 8.9 0.5 0.8 3.5 3.1 4.6 1.6 3.9 0.2 4.0 1.0 1.2 5.1 6.3 3.0 7.0 3.0 9.5 0.7 4.9 0.6 1.1 1.9 0.8 3.1 0.4 6.6 1.6 5.2 1.1 1.6 2.3 0.9 1.1 1.3 0.9 1.5 1.6 1.5 3.0 2.8 1.5 1.0 6.1 1.8 0.5 1.2 1.3 0.8 6.6 4.7 8.7 6.1 5.7 3.5 4.8 2.8 6.7 5.9 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203495-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favourable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 1.9 3.2 2.7 3.6 3.5 1.4 2.1 5.9 5.9 2.2 4.2 3.7 3.2 12.0 3.1 2.2 2.1 2.5 2.5 2.0 2.7 3.2 2.3 44.9 2.0 3.3 2.3 5.1 3.0 4.5 2.8 3.3 1.7 3.7 2.9 1.9 2.1 2.6 2.5 4.0 1.9 16.8 1.9 2.2 3.7 2.3 2.2 2.2 5.9 2.9 2.0 3.7 2.8 2.2 5.6 6.5 1.3 3.4 2.2 8.2 3.5 1.6 3.7 6.3 3.2 1.6 1.8 3.4 2.1 2.3 4.7 4.2 3.1 2.9 9.5 3.6 3.5 1.9 3.6 3.2 2.8 10.9 5.4 6.0 4.1 7.2 3.4 4.2 7.2 2.5 2.5 3.1 2.0 3.6 7.6 5.8 2.9 2.8 4.2 7.6 11.0 2.2 6.2 3.9 8.4 1.8 1.9 5.9 3.8 0.9 3.0 2.2 3.2 5.6 4.1 5.7 2.9 2.0 2.2 3.6 3.8 7.6 2.3 3.9 0.5 0.4 3.2 1.3 4.2 3.4 3.6 3.2 6.2 6.0 3.0 5.6 6.0 8.2 0.1 2.2 2.9 6.5 3.6 3.5 2.7 3.5 5.9 5.9 2.7 3.2 2.3 5.1 3.7 2.2 KEAP1 "INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454" ENSG00000079999 "Kelch like ECH associated protein 1" Q14145 19 10486120-10503741 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005558, CAB025337" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite" Cytosol "CAB025337: , HPA005558: AB_1079175" "unprognostic (1.98e-1)" "prognostic favourable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-2)" "unprognostic (2.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (5.22e-3)" "unprognostic (2.04e-1)" "unprognostic (9.99e-2)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.06e-1)" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" 16.0 13.7 13.5 10.4 14.3 9.1 12.4 13.2 15.1 13.1 15.7 15.4 13.8 13.6 11.0 12.7 26.3 15.1 12.7 19.7 13.9 13.7 13.2 22.0 10.8 15.5 16.7 7.4 11.8 14.3 11.1 10.2 11.5 14.3 13.9 8.8 11.8 11.3 13.9 63.9 16.8 13.8 11.6 16.5 11.3 10.6 12.2 13.8 13.1 14.5 29.1 16.1 14.5 11.2 14.6 23.7 21.3 19.8 21.0 30.8 19.6 17.2 31.7 8.8 11.7 18.1 15.5 9.4 14.7 11.0 15.1 13.6 22.5 17.4 24.6 38.8 16.3 15.5 17.4 11.5 7.5 23.8 19.1 37.2 9.4 26.6 17.5 19.4 20.2 16.0 15.6 17.0 7.9 14.3 22.7 45.6 13.1 23.9 14.1 53.4 25.6 26.7 25.6 11.0 28.7 9.8 20.7 24.2 12.6 20.5 13.8 12.7 11.9 26.0 17.6 24.4 13.1 27.3 17.8 26.6 33.3 24.1 18.8 23.2 17.9 16.1 19.8 21.3 30.8 17.0 29.3 14.6 21.5 28.3 23.7 5.7 13.5 19.1 10.9 21.0 16.6 16.3 25.4 19.6 13.5 14.3 13.2 12.8 13.9 13.7 16.7 7.4 14.3 13.8 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Group enriched" "Detected in some" 12 "HEL: 14.9;K-562: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA064442 Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.1 0.1 0.0 0.0 0.5 0.2 0.3 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.8 4.2 0.8 2.2 4.0 4.5 2.0 5.6 5.4 8.7 12.8 4.0 2.2 6.1 2.2 2.4 2.8 5.8 1.1 6.6 5.8 4.2 4.1 3.4 0.0 5.1 1.9 0.1 5.8 2.4 8.6 2.4 1.9 3.0 7.3 3.4 6.8 0.4 1.8 3.8 8.3 0.9 0.0 4.9 1.3 0.1 10.3 2.1 3.2 0.1 0.2 0.1 6.1 0.1 1.8 4.0 1.1 5.9 12.5 7.5 4.4 0.1 1.7 0.6 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavourable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 18.3 16.7 8.3 24.2 12.8 21.1 18.1 18.9 9.4 21.6 22.4 14.3 25.2 16.9 18.7 19.5 24.3 18.3 28.8 11.2 8.6 5.9 11.8 12.5 16.8 19.2 12.9 7.2 30.7 23.2 17.6 12.8 31.5 11.3 21.5 16.1 10.8 17.0 20.0 15.1 16.9 21.2 24.5 13.6 22.7 24.6 9.3 12.5 20.1 16.1 16.6 26.0 19.7 30.7 6.6 4.5 7.0 5.8 4.5 5.8 3.7 12.4 15.1 12.6 10.0 13.9 13.7 13.4 12.3 14.2 14.2 11.1 9.4 21.5 17.6 7.1 10.9 11.8 11.0 19.3 10.1 26.8 5.5 7.9 13.5 17.0 14.9 11.5 16.8 13.9 43.6 15.2 19.0 15.9 10.1 15.7 8.2 16.7 4.0 6.9 3.3 13.1 6.3 0.1 8.7 8.6 17.9 9.2 9.8 10.4 6.5 16.0 7.6 12.9 16.0 12.4 11.2 14.7 7.0 30.3 16.3 11.7 6.8 6.2 11.6 4.7 4.1 7.0 5.8 5.8 3.4 4.6 4.5 4.9 3.1 6.6 3.5 3.3 5.7 4.5 4.8 4.5 4.4 3.7 8.3 12.8 18.9 9.4 8.6 5.9 12.9 7.2 11.3 12.5 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614440-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavourable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 27.7 31.2 22.3 21.3 34.7 21.9 26.3 28.1 40.1 20.0 24.0 28.2 20.9 15.5 24.7 21.6 25.4 24.0 20.1 21.4 22.0 22.4 38.1 30.7 24.1 26.3 23.1 19.6 25.6 24.6 48.0 27.0 32.7 35.6 22.7 28.5 22.1 27.0 23.3 40.7 25.0 27.9 28.4 21.4 26.4 22.8 24.8 18.6 26.3 28.6 20.2 26.6 22.7 18.8 2.9 7.2 3.5 3.0 2.0 3.3 1.3 19.3 37.0 18.8 17.8 34.3 20.5 13.7 18.2 24.2 22.2 21.0 25.4 8.8 27.0 21.8 33.1 25.9 27.6 26.9 27.0 29.9 25.8 21.5 29.4 13.9 14.8 37.5 37.3 20.8 20.9 30.0 23.0 31.7 20.2 8.8 20.2 27.7 27.3 17.9 8.2 13.7 21.0 21.0 17.6 13.4 34.9 18.5 14.2 22.9 62.6 15.2 37.4 26.2 29.3 17.0 18.8 22.7 34.2 8.3 9.6 17.4 19.4 24.3 19.8 0.8 3.0 3.5 3.0 2.5 3.3 2.9 1.5 2.7 3.3 1.7 1.8 1.8 1.8 2.0 2.7 7.2 1.7 1.3 22.3 34.7 28.1 40.1 22.0 22.4 23.1 19.6 35.6 18.6 KIAA0141 DELE ENSG00000081791 KIAA0141 Q14154 5 141923808-141942047 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036548, HPA061490" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA036548: AB_10673356, HPA061490: " "unprognostic (1.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.78e-3)" "unprognostic (1.00e-1)" "unprognostic (1.80e-1)" "unprognostic (7.77e-2)" "unprognostic (2.72e-2)" "unprognostic (7.99e-2)" "unprognostic (2.63e-1)" "prognostic unfavourable (6.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.80e-1)" "unprognostic (2.15e-3)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (2.28e-3)" 26.2 35.7 17.9 28.5 21.0 31.0 27.4 39.6 26.8 24.8 27.2 28.1 33.5 27.3 32.9 29.0 23.5 26.1 29.4 66.5 17.9 16.2 27.0 35.2 28.9 35.6 21.7 25.8 26.2 28.4 25.2 25.2 28.2 22.0 26.2 28.6 23.1 22.1 38.8 40.9 20.1 24.6 27.5 23.2 43.0 26.0 19.0 21.2 19.9 26.9 26.5 24.8 27.6 24.9 10.2 26.2 8.8 28.8 10.9 12.3 10.7 10.0 13.6 19.9 29.2 15.8 20.9 13.3 13.2 21.4 23.0 25.6 19.4 23.6 23.7 15.1 14.2 15.6 11.9 27.5 12.8 13.5 10.5 14.3 15.7 15.0 20.0 20.3 28.4 25.4 13.8 20.2 16.6 24.0 9.0 32.3 11.8 13.1 5.4 11.2 7.6 21.1 18.5 13.2 26.3 16.6 14.9 11.2 14.2 15.2 24.0 31.0 31.0 18.3 19.2 17.6 10.8 9.2 11.6 9.1 9.6 14.4 14.4 16.4 19.3 7.7 20.3 6.5 10.4 26.4 9.8 10.2 8.4 10.2 26.2 9.4 7.2 9.2 8.8 10.9 28.8 10.6 12.3 10.7 17.9 21.0 39.6 26.8 17.9 16.2 21.7 25.8 22.0 21.2 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433490-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" 870000 "Golgi apparatus" Nucleoli "HPA072692: " "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favourable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 10.6 23.5 20.3 10.6 29.0 9.9 20.1 21.9 37.2 19.2 17.7 24.1 17.0 18.1 19.7 19.2 14.4 25.1 15.7 30.7 19.4 20.0 27.5 32.1 21.3 11.0 19.4 20.1 13.0 32.8 38.5 28.1 21.1 23.0 25.3 21.3 24.5 33.9 20.5 27.4 13.8 19.8 12.7 16.6 17.1 23.3 14.0 17.5 11.9 29.3 11.9 17.4 12.9 12.0 2.3 3.2 27.1 11.0 5.5 3.5 4.5 6.1 9.2 19.2 15.1 26.0 18.4 18.2 8.4 18.0 12.3 18.3 9.9 25.1 6.9 23.3 9.2 12.4 14.1 13.6 14.1 11.0 10.3 9.4 11.3 10.9 20.4 7.7 13.0 25.8 17.5 14.2 18.5 20.1 12.3 10.1 16.7 6.2 4.6 6.5 21.7 5.5 5.2 16.3 8.6 20.4 15.2 4.2 11.9 12.2 14.7 25.1 15.4 11.0 20.5 8.5 9.2 7.1 13.0 15.0 12.0 4.6 21.6 10.2 8.4 4.5 11.0 5.0 3.0 3.6 2.9 2.0 2.5 2.8 3.2 2.3 3.5 2.5 27.1 5.5 2.2 2.1 2.3 4.5 20.3 29.0 21.9 37.2 19.4 20.0 19.4 20.1 23.0 17.5 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA020459: " "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.7 18.1 12.6 16.7 13.9 16.4 11.1 15.3 13.8 19.6 17.0 17.2 14.1 25.0 19.9 14.5 17.6 23.2 26.5 22.1 19.6 7.2 11.2 14.0 36.7 14.3 13.8 12.3 17.5 20.4 18.5 17.1 28.4 18.1 7.3 23.9 25.7 20.9 15.2 13.5 18.0 20.0 21.0 14.5 27.5 23.3 11.8 13.3 19.8 22.0 12.7 32.0 11.4 21.5 15.1 13.6 11.7 13.1 7.9 18.5 26.2 7.7 15.0 15.8 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127440343-127459391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6;smooth muscle: 37.2" "Cell line enhanced" "Detected in many" "AF22: 12.4;SCLC-21H: 31.2;SH-SY5Y: 15.4;U-138 MG: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: " "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 22.9 3.1 9.1 3.4 6.9 0.0 2.8 12.4 21.0 7.4 12.0 0.6 1.9 1.1 2.6 4.7 16.7 1.1 2.9 2.6 10.2 9.7 0.6 0.7 15.3 0.5 11.5 0.7 3.3 0.5 0.0 6.8 1.1 0.9 20.4 5.0 0.7 1.9 1.7 38.6 0.4 6.7 37.2 13.1 2.0 3.7 3.4 1.2 0.7 1.5 15.4 0.8 25.2 11.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 2.8 12.4 0.0 1.1 2.9 0.0 0.3 2.2 1.9 4.4 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 8.1 0.0 0.0 0.0 0.3 2.3 0.0 4.3 0.0 4.2 0.0 0.0 2.1 0.0 0.7 0.0 31.2 15.4 0.0 0.0 0.3 0.0 0.8 0.0 8.5 1.4 0.0 2.0 0.0 0.0 0.0 4.9 0.2 6.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 6.9 12.4 11.8 10.2 9.7 11.5 0.7 0.9 1.2 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favourable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.6 6.1 4.1 5.9 7.8 5.8 1.0 5.7 9.1 8.2 4.8 2.7 2.7 2.0 2.5 6.8 5.0 3.8 9.0 5.1 4.2 3.1 3.6 1.9 1.5 3.7 0.4 5.2 10.7 4.8 9.4 1.2 4.3 15.8 4.7 7.2 8.8 0.7 1.5 4.0 4.9 0.6 5.3 1.2 7.6 4.1 12.2 1.9 6.7 11.1 2.7 9.0 1.1 8.7 5.1 3.8 7.7 2.0 7.4 1.3 4.0 6.7 2.8 5.4 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 KIAA0556 "JBTS26, KATNIP" ENSG00000047578 KIAA0556 O60303 16 27550133-27780369 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.0" "Group enriched" "Detected in all" 4 "granulocytes: 11.0;NK-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favourable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 6.1 6.2 7.1 8.7 10.9 7.9 6.8 6.3 10.8 8.4 8.2 12.0 13.2 6.5 15.1 13.1 11.2 38.6 7.5 7.0 7.1 6.7 9.7 5.0 8.2 5.6 6.5 7.3 8.2 11.7 14.9 19.0 6.8 8.6 11.9 9.8 11.8 9.8 9.7 4.1 11.0 7.9 8.4 9.3 7.9 12.1 22.8 8.4 8.7 20.9 5.0 11.1 7.6 9.0 1.4 1.5 11.0 2.0 5.5 1.8 0.4 5.3 11.0 6.2 5.8 9.4 8.7 10.4 7.3 7.9 6.5 8.8 9.7 9.0 4.6 10.5 10.4 9.0 7.9 9.4 13.0 21.1 5.5 3.6 11.1 5.6 5.7 4.8 9.2 9.2 8.3 14.3 15.4 12.7 5.8 3.9 9.1 12.3 5.3 6.0 3.8 4.5 7.6 7.6 5.0 11.9 7.5 8.0 5.1 7.3 6.6 4.0 14.7 4.3 11.0 8.3 5.3 6.4 6.3 5.2 4.4 4.9 9.5 4.8 7.4 9.5 2.0 3.8 0.8 1.3 0.8 0.9 0.4 1.4 1.3 1.4 1.8 0.3 11.0 5.5 0.5 1.5 1.5 0.4 7.1 10.9 6.3 10.8 7.1 6.7 6.5 7.3 8.6 8.4 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551289 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favourable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 9.5 9.9 10.2 9.2 14.7 9.8 9.9 23.9 13.0 9.9 8.3 7.5 8.0 6.1 9.4 10.7 9.4 7.5 8.3 8.0 12.4 9.6 7.4 11.1 7.9 11.2 15.3 10.7 13.5 8.2 14.6 33.2 6.7 14.5 9.7 11.0 7.0 8.1 8.6 10.4 9.1 8.3 15.8 19.8 9.5 7.6 25.0 14.8 24.5 9.0 7.4 12.7 10.0 8.6 9.1 5.0 13.5 3.6 13.1 10.9 3.1 14.3 10.7 17.8 7.3 12.2 10.9 6.6 13.4 9.5 11.4 10.4 4.3 8.0 17.9 8.5 8.8 9.2 16.5 8.0 19.5 15.7 6.0 14.6 9.1 12.4 7.2 19.8 10.8 7.0 3.4 9.4 12.4 13.4 14.8 9.5 18.3 9.0 10.7 8.4 7.1 17.4 15.3 20.1 10.8 8.2 6.7 11.1 6.9 13.8 8.3 6.5 10.6 10.5 12.7 16.8 14.6 9.5 10.6 4.8 8.6 14.3 11.2 14.6 10.5 13.5 2.8 6.1 9.3 2.4 8.6 7.3 9.0 7.1 3.2 9.1 10.9 8.7 3.2 13.1 3.6 5.0 8.5 3.1 10.2 14.7 23.9 13.0 12.4 9.6 15.3 10.7 14.5 14.8 KIAA0753 "MNR, OFIP" ENSG00000198920 KIAA0753 Q2KHM9 17 6578148-6640927 "Disease related genes, Predicted intracellular proteins" Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023057, HPA023494" Enhanced Enhanced Centrosome,Cytosol "Centrosome, Cytosol" "HPA023057: AB_1852338, HPA023494: AB_1852339" "unprognostic (3.72e-2)" "unprognostic (5.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.93e-2)" "unprognostic (5.17e-2)" "unprognostic (1.47e-1)" "unprognostic (4.19e-3)" "unprognostic (1.47e-1)" "unprognostic (3.01e-3)" "unprognostic (1.82e-1)" "unprognostic (6.10e-3)" "unprognostic (1.47e-2)" "unprognostic (9.57e-2)" "unprognostic (1.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" 6.5 7.0 7.5 11.7 12.8 4.5 9.9 7.4 9.4 10.1 7.7 7.3 20.1 4.4 17.8 15.6 8.5 13.4 10.7 5.0 8.3 7.7 8.7 4.3 8.3 6.6 4.9 7.9 15.4 10.5 26.4 26.0 7.4 8.0 9.6 9.2 9.6 7.0 13.6 5.4 7.4 6.4 11.5 7.2 9.0 7.9 20.1 5.1 13.7 12.1 4.1 6.8 8.4 7.7 2.3 1.8 5.5 2.2 1.1 2.0 0.7 15.6 12.1 15.8 11.0 6.0 10.4 6.0 8.5 8.0 12.1 10.6 8.9 3.6 5.6 5.7 7.8 14.6 14.9 7.7 19.4 5.6 11.9 3.2 10.5 6.3 8.9 5.5 7.2 6.8 10.9 12.1 10.0 8.8 7.9 0.8 9.4 5.5 6.0 4.8 9.6 6.4 8.8 5.3 1.8 10.8 10.2 5.9 10.6 11.2 2.9 6.5 5.0 3.6 8.1 11.4 5.2 5.9 12.5 1.3 1.9 2.4 8.0 3.2 7.6 0.0 2.0 1.7 1.8 2.2 2.0 2.3 1.5 1.6 1.3 1.4 1.2 1.1 5.5 1.1 1.1 1.8 1.1 0.7 7.5 12.8 7.4 9.4 8.3 7.7 4.9 7.9 8.0 5.1 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: , HPA061066: " "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.2 4.4 9.1 8.9 0.2 0.2 2.0 1.9 2.2 4.3 5.3 1.9 3.7 0.0 2.0 0.4 4.2 11.8 3.8 3.8 0.6 7.5 0.1 6.9 1.7 1.6 1.1 0.2 1.0 7.0 3.9 4.9 0.1 2.9 0.1 0.4 2.3 3.6 2.5 0.4 1.0 1.4 0.3 0.0 9.9 0.8 27.9 9.7 3.6 8.5 2.5 8.5 1.2 0.0 0.6 2.2 1.3 2.8 4.1 9.2 0.0 1.7 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175602-67184040 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.3;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065996: " "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favourable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 9.5 20.7 18.1 8.1 19.8 5.2 5.9 46.3 25.0 8.8 6.8 11.5 11.5 10.7 15.4 13.4 6.6 15.0 10.0 7.7 15.1 10.6 9.8 4.6 8.7 3.6 13.0 27.7 21.8 7.6 18.0 24.1 9.5 18.5 10.5 8.8 13.2 8.4 10.3 5.9 9.8 9.5 11.7 16.2 11.0 13.7 13.5 12.4 4.4 13.2 4.3 3.2 7.2 6.8 0.0 2.8 0.0 0.8 0.2 1.1 0.3 2.3 4.0 14.6 9.1 2.7 6.4 9.7 6.3 1.6 2.8 2.6 4.0 2.4 4.4 4.2 2.4 9.1 4.1 3.5 1.7 4.2 5.7 6.4 10.4 3.7 2.1 2.7 13.2 3.6 1.5 3.5 1.3 4.6 6.5 4.3 3.5 3.7 6.6 4.9 3.3 6.6 18.4 7.1 8.2 4.8 5.6 17.3 14.6 7.1 3.6 1.8 8.0 4.7 5.3 9.9 7.0 4.6 2.6 5.6 4.6 4.5 12.5 4.2 5.1 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.9 1.1 2.3 0.0 0.1 0.2 0.0 0.2 0.4 2.8 0.0 0.3 18.1 19.8 46.3 24.1 15.1 10.6 13.0 27.7 18.5 12.4 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45190338-45240769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.8" "Cell line enhanced" "Detected in many" "THP-1: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nuclear membrane,Mitochondria" "Nuclear membrane, Mitochondria" "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favourable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavourable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavourable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 13.4 18.0 51.3 17.1 50.0 14.4 12.9 9.9 41.3 15.3 11.6 52.8 10.3 9.6 8.3 28.4 14.2 10.0 10.7 6.6 50.2 39.9 5.9 12.7 12.5 16.6 48.2 36.8 6.7 8.2 10.2 5.6 7.9 28.9 9.5 7.6 4.9 8.6 18.1 15.6 34.2 12.9 10.3 29.3 15.4 8.5 10.1 50.0 6.5 5.2 6.7 14.3 14.1 9.6 1.8 9.8 6.5 12.9 1.5 2.2 2.6 12.1 7.9 4.9 9.7 16.8 8.0 4.9 6.7 6.8 7.2 6.2 7.3 6.7 8.2 10.1 10.6 13.7 7.4 29.9 2.8 8.7 11.7 0.0 9.8 8.4 6.7 21.7 5.0 4.5 15.2 7.0 11.8 6.8 2.8 13.5 4.4 14.0 9.6 20.2 4.8 6.7 11.8 3.3 26.8 10.9 7.5 4.1 7.3 10.7 14.7 18.5 7.1 81.3 9.1 7.5 13.2 10.1 3.8 11.5 7.7 7.8 8.7 33.1 7.6 0.9 9.1 6.5 2.0 11.1 1.3 1.8 0.8 2.2 9.8 1.6 0.8 1.4 2.2 1.5 12.9 8.2 1.5 2.6 51.3 50.0 9.9 41.3 50.2 39.9 48.2 36.8 28.9 50.0 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favourable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.7 5.5 12.8 8.4 21.4 27.9 6.7 7.6 14.3 7.9 8.7 4.0 8.9 8.8 4.4 18.0 6.3 7.9 9.4 12.8 6.6 5.0 9.7 10.0 7.6 11.1 9.1 5.4 16.0 11.3 9.4 13.0 16.7 6.3 10.7 16.1 5.6 7.8 7.1 4.2 6.1 4.5 17.8 2.2 13.8 12.7 7.5 6.7 4.8 5.5 10.7 6.0 7.5 22.3 9.8 9.7 8.0 7.7 10.4 6.7 6.4 10.4 8.0 7.1 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favourable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favourable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.5 4.3 12.2 8.4 8.3 13.0 6.1 7.6 10.7 9.7 10.0 4.3 5.9 16.1 5.8 7.9 4.6 14.3 8.0 12.9 8.9 4.9 11.7 8.0 5.2 5.7 14.7 8.3 9.3 9.7 9.9 9.5 8.1 16.6 8.9 9.5 3.7 16.3 10.4 11.4 5.5 6.7 11.6 9.1 6.2 5.6 6.1 10.4 8.8 6.9 6.0 11.4 12.6 9.3 5.5 4.9 14.2 8.6 5.7 16.3 9.9 10.0 14.3 7.9 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 KIAA1211 ENSG00000109265 KIAA1211 Q6ZU35 4 56049073-56328625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 39.9;testis: 27.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 15.7;SH-SY5Y: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enhanced" "Detected in single" "B-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA043249: , HPA048148: " "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 1.0 2.1 4.5 4.2 3.7 3.0 0.8 4.2 6.8 2.3 12.6 3.3 3.2 11.8 3.7 3.9 1.0 2.7 14.4 1.6 5.7 7.0 1.6 1.0 1.4 1.8 5.3 3.0 2.2 1.6 7.6 1.9 2.3 13.4 1.6 7.2 4.7 0.9 5.5 0.7 0.9 39.9 4.0 4.8 2.1 2.4 27.0 1.5 0.2 0.8 0.0 1.6 1.5 2.2 1.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 1.7 6.6 0.5 0.2 0.0 2.4 0.0 0.2 0.3 0.7 1.9 0.2 5.7 0.1 0.0 0.0 5.5 0.1 0.2 0.5 3.2 3.2 2.9 0.3 0.9 2.7 0.4 0.2 0.1 0.0 0.1 3.1 0.0 5.7 0.0 0.8 3.9 0.2 3.5 4.2 3.8 3.6 0.1 0.0 1.4 15.7 33.5 0.6 0.2 4.0 1.4 0.3 1.2 0.1 1.7 0.4 1.5 5.7 3.8 0.0 1.7 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 3.7 4.2 6.8 5.7 7.0 5.3 3.0 13.4 1.5 KIAA1211L "C2orf55, MGC42367" ENSG00000196872 "KIAA1211 like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;epididymis: 27.7" "Cell line enhanced" "Detected in some" "BEWO: 21.9;HDLM-2: 31.3;Karpas-707: 9.2;SiHa: 8.9;SK-BR-3: 11.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 15 "amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: , HPA061678: " "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favourable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favourable (1.33e-5)" "unprognostic (2.22e-2)" 2.7 0.8 19.0 1.3 23.7 0.5 3.5 2.4 27.4 4.6 5.0 0.8 3.5 6.7 1.5 27.7 9.1 19.3 2.5 1.4 12.9 1.9 2.5 0.4 3.9 0.6 2.7 18.3 1.4 3.7 9.6 4.3 4.0 0.1 1.6 4.0 0.0 9.0 4.3 1.3 4.3 6.1 2.1 1.2 1.0 6.8 3.6 3.6 0.0 4.3 3.3 2.5 2.4 3.2 0.0 0.7 1.4 0.3 0.2 0.9 0.0 4.2 0.2 0.1 1.7 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 2.5 0.0 5.5 0.0 3.8 0.1 0.2 0.0 31.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.6 1.3 0.0 9.2 0.0 8.4 0.1 0.6 0.0 0.4 0.0 0.0 0.4 1.7 3.4 3.1 0.5 8.9 11.9 0.0 4.6 0.7 5.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.7 0.0 0.0 19.0 23.7 2.4 27.4 12.9 1.9 2.7 18.3 0.1 3.6 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 91.1" "Cell line enhanced" "Detected in many" "BEWO: 33.6;Karpas-707: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavourable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 24.9 12.7 3.3 6.6 8.7 0.0 21.6 5.5 16.2 10.2 15.1 2.7 18.0 7.5 7.2 16.5 22.6 10.4 11.9 8.6 5.1 3.7 13.5 10.4 8.6 1.4 4.3 8.1 8.4 10.1 34.1 5.5 12.2 8.8 15.1 8.9 16.9 28.8 26.6 91.1 12.0 13.7 4.1 3.8 5.7 10.1 16.8 1.8 3.3 20.5 20.4 8.8 10.1 13.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 7.5 3.8 1.5 0.0 1.0 2.8 33.6 1.5 2.4 3.5 7.5 6.5 12.1 0.4 7.6 3.0 12.6 1.9 14.4 3.9 2.8 1.4 0.1 8.8 7.6 1.7 0.0 0.1 10.5 9.3 7.7 2.1 0.0 0.0 30.6 1.7 2.6 4.1 0.2 3.4 3.5 0.3 9.0 6.2 8.2 10.0 1.0 0.5 3.7 12.7 0.0 6.1 0.0 8.0 5.4 5.8 21.5 1.9 13.6 11.5 0.0 17.9 0.2 0.2 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.3 8.7 5.5 16.2 5.1 3.7 4.3 8.1 8.8 1.8 KIAA1328 ENSG00000150477 KIAA1328 Q86T90 18 36829106-37232172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040946 Approved Approved "Nuclear speckles,Vesicles,Lipid droplets" "Nuclear speckles" "Vesicles, Lipid droplets" "HPA040946: AB_10794998" "unprognostic (3.66e-2)" "unprognostic (5.37e-4)" "unprognostic (2.76e-2)" "unprognostic (1.55e-3)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (2.46e-2)" "unprognostic (1.51e-3)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (3.18e-3)" "unprognostic (4.85e-2)" "unprognostic (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (2.25e-2)" "unprognostic (3.36e-2)" "unprognostic (2.64e-3)" 11.1 8.1 14.0 10.7 14.3 23.1 11.1 27.4 13.0 13.7 7.5 13.0 6.1 9.2 12.6 11.1 7.9 9.4 8.3 9.8 10.7 8.5 9.2 7.7 10.4 8.5 12.3 9.0 18.3 6.9 9.0 18.6 9.7 10.3 11.1 7.4 10.9 10.9 9.5 11.4 15.7 9.7 15.8 13.2 8.9 10.7 19.6 14.4 5.4 11.1 9.7 11.5 10.1 11.0 12.7 5.7 17.1 7.4 7.5 10.4 3.6 14.5 4.4 6.5 7.9 2.3 3.1 6.3 5.6 2.1 2.6 1.9 7.7 9.7 9.5 21.1 2.1 6.5 2.6 2.7 3.4 7.4 2.7 12.4 12.0 4.8 1.8 7.9 6.0 3.2 3.0 3.1 2.7 2.3 9.8 23.7 2.6 14.3 5.5 6.0 14.9 7.7 7.9 6.8 7.0 2.5 14.8 7.1 8.2 7.6 9.2 3.7 14.8 4.5 8.0 13.0 19.0 7.5 6.7 18.8 24.0 7.5 6.6 5.7 8.5 17.1 6.8 9.2 9.0 4.8 10.4 7.5 8.0 7.4 3.1 12.7 10.1 8.4 15.1 7.5 7.4 5.7 8.9 3.6 14.0 14.3 27.4 13.0 10.7 8.5 12.3 9.0 10.3 14.4 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.0 8.6 8.2 9.2 10.8 9.2 13.9 11.6 12.4 13.8 3.6 7.2 5.3 7.2 12.2 16.1 12.2 8.3 15.4 4.8 7.6 4.4 7.9 8.2 8.2 8.5 6.3 8.0 10.2 10.6 6.5 8.5 3.3 5.4 13.1 4.5 5.2 7.3 5.0 6.0 6.5 10.8 6.2 14.2 15.5 12.3 6.5 8.3 12.3 7.1 6.3 9.3 10.8 13.4 4.2 5.8 6.9 16.0 2.9 5.2 9.4 9.2 10.6 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741885-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;hTCEpi: 31.4;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: , HPA064839: " "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavourable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavourable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favourable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 3.7 39.4 12.1 8.6 8.7 0.7 14.1 1.6 15.8 8.7 25.9 2.7 27.8 28.1 5.4 8.7 33.8 13.5 28.8 2.3 6.4 4.5 23.1 5.9 13.4 0.8 2.4 6.6 18.0 32.8 21.7 4.8 19.3 7.3 18.5 17.4 10.0 36.9 44.6 1.8 33.4 36.0 6.8 1.6 1.1 25.5 2.9 3.0 3.1 19.2 17.9 20.3 15.0 22.3 0.0 2.1 0.0 1.0 0.0 0.4 0.2 19.0 10.0 1.6 2.8 0.7 1.4 7.5 2.3 4.6 2.7 2.7 10.9 37.7 0.0 9.9 3.4 28.5 3.1 20.2 1.4 0.0 4.0 4.0 14.3 8.8 1.2 0.0 10.2 0.5 31.4 7.2 8.7 5.6 5.7 0.1 1.3 15.8 0.1 0.1 3.3 6.3 2.5 2.0 4.9 26.1 34.9 1.4 1.4 14.7 21.3 2.9 22.6 1.2 5.3 4.6 12.4 4.2 5.0 0.2 0.1 0.1 4.7 0.7 5.2 0.0 0.6 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 12.1 8.7 1.6 15.8 6.4 4.5 2.4 6.6 7.3 3.0 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 27.5;seminal vesicle: 39.0" "Cell line enhanced" "Detected in many" "PC-3: 20.0;SH-SY5Y: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.2;neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favourable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 2.1 3.2 3.3 0.6 4.4 0.6 2.9 1.2 8.3 2.7 1.8 1.6 27.5 1.5 3.7 4.1 1.4 4.9 2.5 1.9 3.1 2.0 8.0 1.5 4.7 0.3 1.6 3.8 2.6 12.9 6.5 3.6 4.6 3.7 3.1 1.5 2.0 4.4 39.0 1.4 2.6 1.8 2.9 3.3 1.2 3.0 2.9 1.2 3.1 2.2 0.1 0.4 3.8 4.4 0.3 0.1 1.5 0.1 0.3 0.2 0.0 5.0 9.5 8.4 14.8 0.1 0.0 4.9 5.1 4.6 3.0 3.8 8.9 3.1 0.0 3.2 7.8 1.0 5.3 1.5 3.6 2.4 3.2 2.4 10.3 2.2 1.3 3.6 3.4 1.2 2.3 1.1 1.6 4.9 1.9 0.1 3.3 4.7 2.6 3.5 8.0 20.0 7.1 4.3 0.0 1.5 3.1 11.2 19.2 2.7 5.1 2.2 4.2 2.2 3.1 3.0 3.1 0.0 4.8 0.7 0.0 0.2 4.0 1.4 7.1 1.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.5 0.3 0.1 0.1 0.0 0.0 3.3 4.4 1.2 8.3 3.1 2.0 1.6 3.8 3.7 1.2 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell line enhanced" "Detected in many" "TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.1 7.7 2.1 1.2 0.0 0.3 10.1 0.1 11.6 0.7 0.4 3.8 3.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.2 5.7 9.3 0.0 9.6 8.2 0.0 0.1 0.0 0.7 4.8 0.0 0.8 0.0 0.0 5.0 1.1 1.2 0.1 0.0 3.1 0.0 0.0 22.7 30.0 6.3 0.7 10.5 0.0 0.0 0.0 7.9 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Intermediate filaments,Cytosol" Nucleoli "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavourable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.9 5.3 9.2 3.5 4.2 5.0 13.7 3.6 3.6 2.6 2.8 20.0 19.6 14.3 9.0 3.0 4.0 12.6 2.4 3.7 10.5 1.7 20.0 2.6 2.6 8.2 14.4 32.4 2.7 3.7 2.9 4.8 20.2 11.4 22.8 2.7 1.4 20.2 6.0 19.6 2.2 9.4 8.8 6.2 2.6 5.5 3.7 3.3 4.7 2.4 2.5 8.4 16.0 12.7 2.7 4.4 4.7 3.8 13.9 14.7 17.6 1.5 8.1 3.0 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 7.2 8.7 11.9 5.7 19.7 11.7 9.0 33.8 15.7 9.1 6.8 2.9 6.5 3.6 10.4 6.5 5.7 6.1 7.8 6.0 10.4 8.7 6.1 8.0 5.9 6.9 10.9 9.3 13.3 5.4 9.8 19.7 15.3 12.4 9.1 4.5 2.6 5.0 6.5 4.1 4.3 5.3 7.5 8.4 7.4 4.7 12.5 10.4 6.2 9.6 3.6 6.4 9.0 6.6 5.5 6.3 3.1 4.2 8.2 7.1 3.2 4.8 2.1 12.9 14.7 5.2 8.5 7.2 8.2 6.8 7.2 8.6 3.4 1.6 1.9 6.8 6.0 2.4 9.9 4.8 9.8 6.1 7.5 20.3 4.7 7.7 6.8 16.2 7.6 6.1 3.5 6.3 7.0 6.7 27.9 1.6 8.3 3.9 7.8 9.9 8.3 3.0 7.2 9.5 4.7 4.8 10.2 11.0 10.1 5.3 1.8 6.1 4.2 14.8 5.4 11.1 4.6 10.6 5.8 6.5 8.5 9.5 6.8 12.0 4.5 0.3 4.2 3.1 3.9 3.0 4.3 5.5 5.7 4.9 5.9 4.4 7.1 6.0 0.3 8.2 2.8 6.3 6.5 3.2 11.9 19.7 33.8 15.7 10.4 8.7 10.9 9.3 12.4 10.4 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Cell line enhanced" "Detected in many" "RH-30: 12.0;SH-SY5Y: 30.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: " "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.0 3.0 7.3 3.2 2.2 2.6 1.1 0.6 1.0 1.1 0.5 2.1 2.7 2.1 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.1 3.5 0.1 0.1 0.0 1.5 1.3 0.7 0.9 0.9 1.3 0.4 2.2 0.3 0.7 12.0 1.6 1.7 1.0 8.3 30.4 0.6 0.8 4.8 0.8 1.4 3.4 2.3 1.7 2.7 0.8 1.5 2.0 1.0 0.3 0.8 1.5 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell line enhanced" "Detected in some" "AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA051064: " "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.1 39.9 0.0 6.1 9.2 0.0 3.9 2.2 0.0 0.0 0.2 1.1 0.0 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.1 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051240: " "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 5.1 3.6 9.8 3.9 8.9 2.3 4.3 13.3 12.4 10.0 7.1 7.0 1.0 5.5 4.4 6.8 3.8 7.5 3.6 5.2 9.6 11.6 2.6 2.3 8.0 3.2 8.8 12.1 2.4 3.6 3.9 8.2 3.5 20.6 9.6 8.3 3.6 3.6 3.1 3.7 8.5 5.9 5.4 10.1 3.3 5.6 7.5 6.2 3.3 4.0 2.7 3.5 4.3 3.7 1.5 1.2 4.8 2.5 1.4 3.7 0.6 4.6 9.0 11.8 5.1 6.8 7.6 3.7 8.9 2.2 4.6 4.3 2.7 3.0 1.9 2.3 6.8 5.8 7.4 3.0 6.4 8.0 1.8 1.7 6.2 7.5 3.6 2.1 1.7 3.6 4.8 8.3 2.9 6.3 1.7 1.5 12.7 0.4 1.8 1.4 3.7 1.8 6.0 9.7 0.4 5.8 9.5 7.0 4.3 10.7 2.4 3.2 1.8 2.5 8.4 7.5 2.8 6.0 6.0 0.8 2.4 2.8 5.4 1.5 5.1 0.8 1.4 4.8 1.3 1.5 1.2 1.5 1.2 0.6 1.2 0.6 0.2 1.0 3.0 1.4 2.5 0.8 3.7 0.6 9.8 8.9 13.3 12.4 9.6 11.6 8.8 12.1 20.6 6.2 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486847-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 2.6 14.7 8.6 2.8 14.4 8.7 6.3 21.2 11.7 10.4 3.0 10.8 5.6 3.7 7.0 3.1 3.6 6.3 3.1 2.8 7.8 5.2 11.7 6.9 7.8 2.9 14.0 6.2 19.9 10.8 4.1 8.0 1.9 11.3 3.5 3.4 5.5 5.5 8.0 2.7 4.0 3.9 6.5 10.6 3.2 8.8 11.0 16.5 4.7 5.0 0.4 2.9 3.8 4.8 2.1 2.4 2.6 2.8 2.4 2.7 1.5 2.9 4.2 17.3 5.0 1.2 0.3 8.3 2.2 0.7 2.7 3.0 7.7 2.0 9.5 2.6 7.2 2.6 12.6 1.2 3.8 2.9 5.1 3.7 5.7 5.4 0.7 5.6 4.7 0.5 1.0 3.5 1.7 2.1 8.6 2.4 0.8 3.4 8.7 3.2 9.5 2.0 7.1 9.9 2.7 3.6 4.1 8.9 9.4 3.7 3.9 2.2 3.5 5.7 0.4 0.9 5.2 0.6 2.7 4.5 8.1 5.7 1.2 3.9 0.7 1.4 2.8 0.2 2.1 0.9 0.9 0.3 0.8 1.6 0.9 2.1 2.0 2.7 2.6 2.4 0.8 2.4 0.4 1.5 8.6 14.4 21.2 11.7 7.8 5.2 14.0 6.2 11.3 16.5 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA052677: , HPA060536: " "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 13.8 13.9 12.0 10.6 16.7 10.9 12.9 11.9 18.7 13.7 32.0 25.2 16.7 42.6 19.1 24.9 15.4 14.7 19.7 18.9 12.5 10.8 17.1 34.4 12.4 12.6 22.8 10.6 12.2 34.0 9.6 17.7 24.6 16.1 15.1 13.5 14.8 26.2 18.6 24.4 18.6 55.1 14.4 16.0 19.2 16.0 21.7 19.0 15.0 19.8 11.2 14.1 17.4 13.1 7.0 10.8 13.8 6.3 4.6 6.3 3.0 23.5 17.6 8.3 16.3 14.1 9.7 13.7 15.1 16.0 18.3 19.0 21.6 24.6 15.5 23.2 14.2 27.6 11.2 14.9 9.8 17.9 28.6 10.6 16.3 36.9 16.0 22.0 22.1 12.3 16.7 17.9 7.9 17.5 16.3 20.8 10.9 17.9 14.0 31.0 10.9 24.3 18.0 15.2 37.5 11.6 6.5 31.0 17.5 12.2 13.7 28.8 11.5 20.6 16.6 15.5 20.3 22.7 20.5 25.1 17.7 17.7 18.4 35.9 16.4 4.2 6.3 6.1 6.2 5.3 4.9 6.1 3.4 4.7 4.3 7.0 3.4 4.5 13.8 4.6 4.2 10.8 6.3 3.0 12.0 16.7 11.9 18.7 12.5 10.8 22.8 10.6 16.1 19.0 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favourable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.8 2.9 5.9 3.8 4.5 7.2 2.9 4.0 5.6 3.6 3.4 1.8 3.2 7.3 1.5 4.8 3.0 3.4 3.0 5.5 16.8 2.8 21.9 6.4 2.9 3.5 7.7 10.1 4.4 4.1 3.1 5.3 5.6 2.3 13.1 4.6 1.6 4.1 13.3 3.4 2.5 4.6 3.8 3.7 3.9 3.8 8.1 4.8 3.7 3.3 3.0 3.3 9.9 6.7 6.9 4.2 3.5 4.3 10.2 8.0 7.3 3.5 3.6 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: , HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavourable (8.19e-7)" "prognostic unfavourable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 30.6 13.7 31.0 28.8 2.2 3.4 7.7 22.1 19.3 24.6 24.4 12.0 20.4 33.9 11.4 10.3 22.2 22.1 11.3 28.9 20.2 12.7 21.2 13.1 12.5 0.4 34.1 19.8 1.1 1.0 19.0 17.7 15.2 15.0 39.7 18.5 12.3 29.0 19.2 12.3 9.5 31.3 30.7 12.0 6.4 9.0 9.5 13.6 17.3 7.8 9.0 21.2 10.9 8.6 11.2 16.2 11.4 29.0 11.1 17.0 34.9 9.1 24.7 15.2 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620734 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 9.0;lymphoid tissue: 34.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: " "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavourable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.4 0.6 0.2 2.7 0.4 9.0 2.6 0.3 0.3 0.7 2.0 0.4 0.2 1.8 0.4 0.5 3.8 0.2 0.2 0.5 0.3 0.3 0.4 0.8 1.2 4.7 0.2 0.2 0.3 0.3 0.0 0.2 2.8 0.6 0.6 1.8 0.4 0.9 0.2 0.2 1.4 2.4 0.8 0.6 2.0 1.1 4.5 0.2 34.4 0.3 0.6 4.9 0.8 1.3 0.5 0.1 2.4 0.2 0.7 1.9 0.2 15.5 9.2 14.6 8.1 0.4 1.7 8.1 10.7 6.3 10.3 9.3 5.5 8.1 9.4 3.8 5.1 12.4 11.6 7.1 14.8 11.5 6.1 15.1 13.1 5.4 0.0 23.6 8.6 0.3 0.3 11.4 9.8 7.2 22.6 12.3 12.7 6.3 13.8 7.4 12.3 8.1 12.7 19.3 12.0 3.4 4.4 6.9 7.7 15.1 5.2 6.2 7.0 6.1 5.9 8.1 9.7 8.8 18.6 4.5 4.5 13.8 4.7 12.7 16.5 2.4 0.1 0.1 0.1 0.2 0.1 0.5 0.5 0.4 0.0 0.4 0.2 0.1 0.5 0.7 0.1 0.1 1.9 0.2 0.2 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.7 1.5 0.9 0.4 1.0 0.0 1.2 1.9 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.2 0.0 0.6 0.0 1.8 0.1 0.0 0.0 2.5 1.7 0.0 0.1 0.0 0.6 0.0 0.6 1.5 0.4 0.0 0.3 0.0 0.0 0.0 0.6 4.9 0.5 0.3 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020620-28108308 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3;testis: 16.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.9 0.5 0.6 3.9 0.8 7.9 0.6 0.9 0.9 0.8 2.1 0.3 0.0 1.5 0.5 0.8 3.1 0.5 0.4 0.5 0.7 0.5 1.8 0.5 1.5 4.8 0.5 0.0 0.6 0.5 0.0 0.6 3.4 0.8 0.5 2.2 1.3 0.9 1.6 0.8 1.3 1.9 0.6 0.9 2.7 1.0 16.9 0.2 31.3 2.8 2.0 4.9 1.0 1.2 2.3 0.7 6.4 0.4 2.8 2.2 0.4 12.3 12.3 12.5 8.7 0.4 1.8 4.2 12.8 6.0 20.5 21.5 4.1 5.0 10.4 4.6 6.6 12.4 10.7 5.0 28.8 10.3 6.5 6.7 8.4 5.2 1.0 9.9 6.2 3.2 0.6 7.1 8.5 7.8 10.7 9.2 11.5 6.5 10.0 7.4 6.1 5.1 7.8 30.0 5.1 5.7 3.6 7.6 5.8 10.7 5.1 3.5 10.9 3.0 4.5 16.4 12.8 15.3 16.7 3.7 8.5 10.5 9.8 7.4 11.5 6.4 0.0 0.8 0.2 0.4 0.8 2.3 0.9 0.5 0.7 1.0 0.8 0.3 0.0 2.8 0.1 0.6 2.2 0.4 0.6 0.8 0.9 0.9 0.7 0.5 0.5 0.0 0.8 0.2 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavourable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavourable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.2 18.6 15.9 14.9 0.3 1.3 13.4 12.2 4.6 15.4 12.1 15.4 12.3 12.6 5.3 4.6 15.7 11.0 4.9 7.8 26.0 16.4 16.3 20.9 9.5 0.0 13.4 14.3 0.3 0.2 13.3 5.3 7.8 12.2 21.5 7.9 11.1 24.9 13.3 11.7 12.8 19.1 24.3 8.4 2.5 7.7 12.0 11.7 8.2 7.4 4.5 13.9 9.6 5.1 23.0 22.8 13.6 25.6 6.9 6.8 15.5 7.4 10.2 14.8 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: " "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 9.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713764-240820308 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.1" "Cell line enhanced" "Detected in some" "AN3-CA: 18.8;HAP1: 33.3;K-562: 29.1;SCLC-21H: 89.7;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 2.1 15.2 47.0 2.9 37.0 2.0 2.0 28.4 144.1 1.9 2.7 35.8 0.0 2.9 2.3 3.1 2.0 2.3 2.1 8.2 40.9 28.4 2.1 2.3 2.1 2.0 35.1 46.8 3.5 31.3 2.0 15.7 2.0 38.7 6.4 2.6 8.6 2.0 2.2 1.9 2.8 2.9 2.3 35.0 2.2 5.0 10.0 30.9 0.0 2.9 0.0 1.9 2.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.5 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 1.0 0.0 0.0 33.3 0.0 0.0 2.6 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.1 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 89.7 14.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 47.0 37.0 28.4 62.2 40.9 28.4 35.1 46.8 38.7 30.9 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavourable (2.14e-12)" "prognostic unfavourable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.3 15.1 33.5 22.2 1.7 3.3 14.4 19.4 17.8 42.5 32.1 28.4 20.9 9.7 10.5 24.4 22.2 31.3 36.4 42.5 14.1 14.8 14.3 27.0 18.1 0.1 7.0 6.6 1.2 0.6 22.6 13.0 27.4 6.0 18.5 29.3 20.6 11.7 6.9 21.1 16.5 12.8 33.6 10.0 11.6 11.1 10.0 9.9 36.8 12.5 8.5 16.0 7.3 13.0 11.1 16.5 10.0 32.4 9.6 9.2 10.8 7.1 20.7 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031263, HPA050214" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA031263: AB_10602610, HPA050214: " "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavourable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 35.5 7.3 10.7 9.4 2.1 3.6 8.9 14.6 13.4 15.3 16.2 9.6 16.5 13.8 4.6 7.4 18.1 11.8 8.2 20.7 16.6 8.1 14.0 12.7 8.2 0.6 23.8 11.6 1.5 1.2 14.8 15.2 9.8 13.3 15.9 13.6 6.1 13.9 4.6 10.9 7.0 9.7 21.0 6.0 4.8 4.8 3.4 6.1 10.5 4.8 5.5 12.4 6.9 7.7 9.9 9.9 12.8 23.4 4.4 12.0 18.6 9.3 21.2 7.3 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB022079: , HPA058432: " "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favourable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.8 7.5 10.5 4.5 2.0 1.0 8.4 1.4 0.7 1.9 1.3 13.5 7.3 0.0 4.7 0.6 5.1 6.0 3.6 1.8 11.4 4.8 0.0 13.1 12.3 1.5 9.7 0.0 0.6 8.1 2.4 11.8 2.5 11.0 12.1 1.5 3.5 1.2 0.0 14.1 6.5 0.0 0.0 6.7 7.4 9.7 14.4 62.6 5.7 9.1 3.4 10.5 1.2 1.7 1.1 4.6 0.3 4.1 5.5 1.8 0.0 2.7 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell line enhanced" "Detected in many" "Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.6 4.9 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 16.4 0.2 0.0 0.1 0.5 0.1 0.1 0.8 0.1 3.9 0.1 0.1 0.4 12.0 17.5 0.4 1.7 0.1 0.3 0.6 1.8 20.7 0.0 0.0 9.5 4.3 2.1 0.0 3.3 0.0 17.6 0.1 0.0 3.4 0.4 0.2 0.2 0.2 0.0 3.6 1.1 0.0 1.5 0.0 0.1 37.8 17.5 8.2 1.7 5.2 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: , HPA068831: " "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavourable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavourable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 24.8 21.6 16.0 15.3 1.0 1.9 9.8 27.3 14.8 39.6 30.9 13.1 19.5 14.6 8.3 14.1 28.8 33.1 10.2 40.3 13.5 15.5 13.7 20.3 8.1 0.6 14.1 12.7 0.9 1.0 18.9 16.0 13.4 9.1 18.3 24.9 11.0 7.9 7.6 19.9 8.7 9.0 35.8 8.1 10.4 12.9 8.2 6.8 31.7 13.9 12.0 13.3 6.4 8.7 24.0 31.9 16.6 40.1 7.1 19.2 13.1 8.4 19.1 21.1 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 16.8;MCF7: 14.3;NTERA-2: 12.6;REH: 10.9;SCLC-21H: 11.7;SH-SY5Y: 23.8" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: , HPA060346: " "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.3 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 3.2 0.0 1.5 1.8 0.0 0.0 0.0 2.9 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 14.3 0.0 0.0 12.6 1.2 10.9 4.8 1.1 0.0 0.0 11.7 23.8 2.6 0.4 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709431 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.4;REH: 18.5;SH-SY5Y: 10.1;U-937: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 58 "dendritic cells: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.7 3.9 7.1 3.0 6.3 0.7 2.1 10.2 9.7 5.2 1.7 8.7 6.0 1.2 3.7 2.9 1.3 2.1 4.2 1.3 5.6 7.2 3.2 1.1 2.7 1.7 7.8 4.6 1.2 1.8 1.4 1.4 7.6 9.6 3.7 0.8 1.1 1.2 7.7 0.9 2.7 1.1 2.3 4.9 1.1 2.9 2.9 3.7 1.3 3.4 1.2 1.4 4.0 0.8 0.0 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.5 0.5 0.8 1.9 2.0 1.5 0.1 0.1 3.1 0.0 0.0 3.4 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.3 10.4 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 18.5 0.1 0.0 1.8 0.0 2.6 10.1 0.0 0.0 0.0 0.0 1.0 0.3 1.9 0.1 0.0 0.8 0.0 0.0 0.0 0.3 9.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 7.1 6.3 10.2 9.7 5.6 7.2 7.8 4.6 9.6 3.7 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: , HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favourable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favourable (5.45e-4)" "prognostic unfavourable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.2 17.3 28.9 25.6 10.9 15.4 23.6 18.5 15.3 20.2 25.6 18.6 18.9 42.8 20.4 16.3 11.0 21.9 14.9 27.0 42.9 15.3 43.0 16.2 10.1 12.9 23.4 16.4 12.7 9.8 19.6 17.8 18.4 30.4 26.1 16.8 13.0 39.1 11.6 16.8 10.9 28.9 22.9 23.6 9.0 21.0 25.9 21.5 25.1 10.6 13.0 13.8 13.2 15.9 12.0 19.9 13.9 18.4 24.7 35.6 45.2 13.9 28.2 14.7 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006219 Supported Nucleoplasm,Midbody,Centrosome "Nucleoplasm, Centrosome" Midbody "HPA006219: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavourable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavourable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 28.7 11.2 25.0 20.0 1.3 2.9 16.8 21.6 15.4 44.2 38.6 18.9 20.8 33.1 10.4 10.6 13.7 25.4 14.5 40.5 21.4 10.9 39.2 19.8 15.7 0.1 28.9 18.2 0.7 1.4 31.5 15.4 14.2 30.9 28.4 27.9 11.2 30.4 17.5 24.4 14.1 24.4 37.8 20.8 7.4 10.4 17.2 12.3 28.7 20.5 18.1 11.8 22.0 8.4 16.1 31.9 17.4 37.8 15.1 15.3 47.8 10.3 28.2 30.9 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.1 8.8 7.9 14.2 5.3 5.3 6.3 6.0 4.7 5.7 8.0 8.6 5.8 19.5 8.3 6.9 4.6 6.1 11.8 11.8 5.8 7.2 2.8 4.4 3.2 5.2 3.6 7.7 4.0 6.1 8.2 9.1 7.0 2.9 11.3 6.9 5.1 22.9 2.7 3.9 3.3 6.4 6.3 2.3 5.6 6.1 24.5 7.7 8.9 2.9 9.0 9.0 1.1 7.4 7.1 12.4 5.2 7.2 8.2 11.9 11.2 8.7 2.9 7.8 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favourable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.6 15.5 10.7 13.8 14.3 22.8 11.0 11.3 15.9 13.7 10.8 26.3 12.5 12.2 13.6 21.2 14.7 13.8 16.7 17.5 5.8 6.3 10.6 12.3 12.9 9.1 8.9 8.1 14.0 12.0 23.6 9.4 11.1 6.5 4.9 11.0 10.4 4.1 4.1 5.8 13.6 3.8 17.7 4.4 14.1 16.8 17.7 14.9 29.5 7.9 11.3 17.4 6.9 13.5 25.8 17.6 15.0 13.9 8.3 11.8 6.4 25.7 15.6 10.4 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favourable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.6 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.7 6.2 1.4 8.0 4.1 2.8 2.2 3.8 4.7 1.5 7.1 3.7 1.2 4.1 5.2 1.2 12.9 2.6 13.6 1.7 1.7 4.3 0.9 3.3 1.6 10.8 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.1 2.7 1.2 14.3 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: " "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.4 15.7 23.8 11.7 1.1 2.0 9.4 17.1 9.2 23.4 20.4 17.6 13.2 13.8 10.8 8.4 13.5 25.7 9.3 26.4 15.8 12.9 15.6 19.2 12.5 0.2 17.3 10.9 0.6 0.5 19.4 11.1 14.3 19.8 30.8 22.0 14.4 15.8 8.6 24.0 16.7 17.6 32.1 13.0 5.6 8.9 15.7 13.1 27.9 11.8 7.3 9.5 6.8 9.9 15.5 20.2 16.6 20.3 8.9 15.2 20.0 8.2 19.1 23.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: " "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.2 0.0 0.9 0.0 0.5 0.0 0.5 0.1 0.0 0.1 0.7 0.0 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 1.1 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.5 0.7 1.1 1.0 0.0 0.7 0.5 0.5 1.3 0.2 0.3 0.5 0.5 0.2 0.7 1.2 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell line enhanced" "Detected in some" "HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: " "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favourable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.6 0.1 2.0 0.0 1.0 20.0 1.4 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.2 8.4 4.4 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 21.3 4.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.8 3.4 0.3 7.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009010-32056431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" 260000 "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 26.3 19.9 55.7 20.2 55.5 34.1 23.0 22.2 42.4 23.8 34.2 21.7 20.9 23.5 25.7 17.8 28.0 20.3 28.0 48.4 51.5 39.3 21.1 15.3 23.8 16.5 62.9 26.1 18.2 18.9 56.8 22.4 27.7 38.3 31.8 30.0 8.9 20.1 25.6 34.3 17.6 28.6 37.2 80.4 21.1 23.1 27.7 43.7 25.0 23.5 21.5 16.1 33.8 28.1 13.8 27.6 30.0 18.9 13.4 16.5 9.2 29.4 25.1 34.0 23.8 24.4 26.9 14.5 40.7 19.3 31.5 26.9 27.5 32.6 20.2 17.7 48.3 24.5 31.0 26.0 42.3 17.4 16.9 25.7 23.5 26.8 28.1 17.8 28.3 21.8 37.0 36.3 25.4 40.2 30.9 21.3 43.5 17.7 18.6 10.1 5.5 11.5 24.4 63.4 8.3 24.3 20.7 33.1 24.2 31.5 12.6 30.3 15.2 25.6 33.5 32.1 30.1 37.1 30.1 6.4 7.4 23.9 30.6 36.9 30.1 20.8 15.2 24.2 11.8 18.9 11.4 13.6 14.9 12.5 14.2 13.8 13.3 13.0 30.0 13.4 18.9 27.6 16.5 9.2 55.7 55.5 22.2 42.4 51.5 39.3 62.9 26.1 38.3 43.7 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell line enhanced" "Detected in many" "T-47d: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 7.9 6.8 3.3 7.2 4.8 2.9 7.8 4.8 3.4 2.6 2.6 2.7 9.9 8.3 2.7 2.7 16.3 3.3 4.3 1.1 8.4 2.9 5.0 16.7 3.5 6.2 1.3 14.8 3.7 15.5 2.6 3.4 1.7 5.4 8.7 1.9 13.6 6.0 4.2 0.5 10.1 15.1 0.2 4.9 10.8 12.5 10.4 9.5 3.4 10.6 3.8 27.9 2.7 4.6 5.1 15.4 5.4 4.8 4.3 2.0 2.3 9.9 7.0 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell line enhanced" "Detected in some" "K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA007156: , HPA071913: " "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavourable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.7 0.0 25.7 0.0 0.0 5.4 14.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: , HPA052450: " "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favourable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavourable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.3 22.0 42.5 23.1 28.7 31.4 19.5 38.5 31.6 36.2 24.8 18.8 17.9 21.7 20.1 41.5 27.3 25.9 20.3 34.4 26.1 13.0 12.1 26.0 19.0 32.7 23.7 24.1 22.8 33.1 27.3 33.3 31.1 18.0 24.9 31.5 27.5 15.9 20.9 13.6 40.6 15.3 17.8 10.7 22.5 36.3 50.1 28.0 31.3 15.9 25.4 14.0 11.7 45.2 26.9 13.3 36.8 21.3 20.0 13.9 24.1 30.8 13.7 28.8 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.2 24.8 12.1 7.2 7.3 5.9 9.4 14.3 10.3 14.7 11.4 13.5 6.1 9.1 13.8 10.6 17.1 12.4 13.9 4.9 14.6 15.6 1.8 19.6 9.1 14.2 4.0 9.7 5.9 18.4 17.2 14.1 6.8 9.8 12.4 11.7 28.5 22.9 6.1 11.9 20.6 8.8 6.3 12.4 11.5 11.4 33.0 16.0 10.4 9.4 17.1 15.5 2.8 11.2 24.2 21.7 29.2 18.8 12.9 10.8 4.9 17.1 2.8 9.7 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell line enhanced" "Detected in some" "A-431: 25.2;HaCaT: 11.7;HBEC3-KT: 7.6;hTCEpi: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: , HPA056508: " "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavourable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.2 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.5 4.7 0.2 2.1 0.0 11.7 1.6 7.6 0.1 0.6 3.8 0.1 0.7 0.5 0.0 0.2 1.6 0.0 9.5 0.1 1.8 0.0 0.4 0.3 0.1 3.3 0.1 0.3 0.6 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.5 0.2 5.4 0.7 4.7 0.1 0.0 0.3 2.7 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 KLC4 "bA387M24.3, KNSL8" ENSG00000137171 "Kinesin light chain 4" Q9NSK0 6 43040777-43075099 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030168, HPA030169" Enhanced Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA030168: AB_10599285, HPA030169: AB_10601105" "unprognostic (2.96e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" "unprognostic (3.67e-2)" "unprognostic (5.63e-3)" "unprognostic (6.36e-3)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.30e-1)" "unprognostic (1.47e-2)" "unprognostic (9.22e-2)" "prognostic favourable (6.99e-6)" "unprognostic (2.08e-1)" "unprognostic (3.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" 6.1 9.7 13.1 8.5 11.5 5.3 6.9 25.0 15.2 7.6 35.0 10.2 8.1 35.1 8.5 12.3 5.6 9.3 15.2 12.2 13.8 10.8 13.6 47.2 8.2 5.8 12.2 13.7 11.2 9.1 17.6 13.3 5.9 12.1 8.6 17.4 9.0 11.4 8.4 9.9 8.7 55.7 7.4 9.2 6.6 16.0 22.6 13.2 6.7 10.9 4.5 5.4 10.2 9.9 5.6 12.2 9.0 3.7 6.1 7.0 3.3 4.2 3.9 10.3 12.4 10.2 10.1 9.2 3.4 5.7 6.3 9.7 6.3 7.5 6.3 12.7 8.3 7.5 10.3 9.7 5.1 6.3 12.6 7.4 10.9 27.8 9.8 3.5 5.8 13.1 12.2 7.6 7.5 8.0 4.9 8.4 5.2 8.6 9.4 7.7 4.1 5.2 7.5 5.8 12.1 9.6 4.3 16.9 8.3 6.7 5.9 13.2 10.9 9.0 5.7 7.2 8.5 3.6 3.5 16.7 5.9 15.4 3.9 5.3 2.5 2.6 3.7 4.4 4.0 3.6 5.1 5.6 5.5 3.9 4.2 4.3 7.0 4.8 9.0 6.1 3.6 12.2 6.4 3.3 13.1 11.5 25.0 15.2 13.8 10.8 12.2 13.7 12.1 13.2 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: " "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 28.7 9.1 2.5 7.0 3.5 11.8 33.1 8.2 4.4 12.9 13.0 5.1 10.8 3.5 12.8 11.7 8.3 11.2 11.6 19.4 2.9 2.3 12.7 27.9 14.6 15.9 5.5 2.4 13.7 38.3 7.3 2.4 9.9 3.4 13.9 4.7 9.2 11.3 10.9 14.0 19.1 7.7 30.4 3.5 16.1 10.2 16.7 2.7 1.5 9.1 8.5 5.6 11.1 42.7 2.9 6.6 1.7 12.7 5.4 2.7 3.8 3.7 1.8 4.4 0.3 3.0 5.4 10.6 4.3 4.4 2.5 2.6 4.2 8.7 0.0 7.8 5.2 0.8 3.7 3.3 1.6 25.5 2.9 1.9 5.3 0.8 3.0 7.7 12.4 8.4 12.5 4.7 1.3 2.1 5.1 17.2 2.5 4.4 0.0 1.4 7.0 3.7 4.1 0.1 7.2 6.0 4.6 5.6 3.5 6.6 13.7 12.7 3.2 10.6 6.1 10.9 9.2 8.2 1.4 15.7 18.6 10.1 2.8 2.1 5.8 0.0 6.9 1.7 2.6 11.0 0.8 2.8 1.7 1.8 6.6 2.9 0.5 1.0 0.2 5.4 12.7 0.3 2.7 3.8 2.5 3.5 8.2 4.4 2.9 2.3 5.5 2.4 3.4 2.7 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064146: , HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavourable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.1 0.9 0.4 2.9 0.4 0.9 1.9 0.6 3.4 2.1 1.5 0.1 1.7 7.1 0.7 1.1 1.1 3.2 0.4 0.5 2.9 5.8 2.0 6.1 0.5 2.8 0.6 0.0 3.5 0.0 1.2 1.1 0.9 1.4 1.9 1.4 1.2 1.4 1.3 3.9 1.4 1.5 2.1 5.5 1.7 2.1 1.7 0.9 0.9 0.6 2.6 5.1 1.4 0.0 1.0 10.1 0.0 5.7 12.5 0.1 3.9 1.9 4.4 4.7 0.8 2.5 7.5 1.9 5.9 2.7 2.6 3.1 11.9 4.9 3.6 0.2 4.5 0.0 1.9 4.9 1.8 10.8 0.8 6.2 5.1 8.7 0.0 1.9 13.2 0.8 9.5 0.0 1.4 2.0 5.3 3.7 0.0 2.5 0.2 2.4 10.3 2.7 1.3 4.5 0.3 0.8 0.0 8.6 2.6 3.8 1.8 5.2 6.6 2.4 15.2 0.0 4.3 0.9 0.1 0.1 4.2 0.4 5.1 1.7 3.7 4.7 0.5 1.4 2.6 4.0 0.0 2.6 0.6 0.9 1.9 1.4 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in many" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavourable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.7 8.1 0.0 0.1 0.3 0.4 9.2 3.4 7.9 1.5 1.9 7.4 29.8 0.1 18.1 3.0 34.2 10.4 29.8 2.4 0.2 2.7 0.1 17.0 0.7 2.1 2.7 0.5 2.2 42.6 0.4 16.7 0.0 0.4 0.6 6.8 2.0 0.5 0.2 0.3 11.5 0.5 7.6 0.6 23.6 36.0 0.7 0.3 30.4 4.9 2.1 0.6 0.6 0.0 2.1 6.2 0.0 1.4 0.9 0.4 1.0 2.9 0.5 2.5 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: " "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favourable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.0 3.5 6.8 2.2 39.6 39.8 4.3 22.5 11.5 24.1 16.4 9.1 17.6 3.7 5.2 24.3 7.9 4.2 20.7 20.1 18.3 2.5 0.5 4.1 8.6 17.0 2.4 12.9 13.1 39.6 17.1 32.7 24.5 4.1 29.2 30.5 0.9 4.5 3.8 2.5 6.4 3.0 7.0 13.1 23.6 13.0 3.0 2.9 5.5 16.0 33.7 7.9 2.0 31.9 32.5 4.5 19.2 10.3 5.6 18.2 6.9 8.7 3.3 10.0 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 KLF9 BTEB1 ENSG00000119138 "Kruppel like factor 9" Q13886 9 70384597-70414624 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 22.4;ASC TERT1: 31.1;HHSteC: 40.0;HSkMC: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029308 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA029308: AB_10601923" "unprognostic (2.12e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.69e-2)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (3.64e-3)" "unprognostic (4.34e-1)" "unprognostic (5.55e-1)" "unprognostic (9.47e-2)" "unprognostic (7.86e-2)" "unprognostic (3.44e-1)" "prognostic favourable (6.59e-6)" "unprognostic (1.43e-3)" "unprognostic (1.75e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" 35.9 15.3 6.8 8.8 25.8 6.1 25.7 42.6 21.4 10.2 20.0 9.7 16.1 6.0 19.6 13.2 17.0 22.2 17.8 18.2 8.4 4.0 26.2 36.7 22.6 5.1 26.3 8.0 22.1 21.3 13.0 8.6 3.9 14.7 12.4 11.0 20.4 31.4 10.7 38.9 12.6 17.6 25.0 12.0 8.6 16.7 5.5 25.2 1.9 24.0 20.3 5.4 15.4 11.9 2.8 1.7 2.8 0.7 0.7 2.8 0.6 0.1 0.2 0.0 2.8 22.4 31.1 0.3 1.4 9.7 0.5 1.1 0.0 1.3 0.0 1.1 2.6 0.0 4.2 6.5 1.0 0.0 3.3 1.4 4.8 0.8 40.0 0.7 4.0 26.6 6.7 0.4 9.5 8.5 2.8 5.9 3.6 0.4 0.1 2.1 0.2 1.4 0.0 1.3 3.7 1.8 0.0 0.3 1.9 13.2 7.7 15.1 2.5 2.3 11.6 2.6 1.9 2.9 0.7 4.3 4.5 0.2 2.3 2.3 12.8 2.8 0.5 0.3 1.6 0.3 2.3 2.8 2.1 1.6 1.2 2.5 2.8 1.6 0.0 0.7 0.7 1.7 2.2 0.6 6.8 25.8 42.6 21.4 8.4 4.0 26.3 8.0 14.7 25.2 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49767608-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: " "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favourable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 17.0 20.2 18.2 9.6 18.0 7.6 20.7 21.0 22.3 15.4 22.0 10.8 16.2 15.9 18.4 14.3 13.6 13.4 15.2 47.1 16.0 14.3 29.7 41.7 12.6 13.1 17.6 16.8 22.9 43.2 16.2 15.5 11.1 17.6 16.9 16.1 18.5 16.2 18.8 40.7 14.9 22.5 20.7 13.5 10.2 20.3 21.7 18.3 15.0 24.8 13.1 9.5 23.9 13.0 13.1 7.0 15.0 7.0 12.5 19.9 8.7 8.4 7.1 13.4 6.5 19.3 16.9 14.1 8.9 16.9 11.2 11.4 4.1 11.5 16.9 12.5 15.8 7.6 8.1 8.1 9.6 11.6 9.2 5.2 5.3 9.7 14.1 11.1 4.6 17.4 14.0 5.1 10.2 10.2 6.7 12.6 8.9 9.9 11.4 4.8 9.8 20.9 9.1 14.3 10.2 5.1 18.0 16.6 13.2 14.9 27.6 9.6 10.5 4.3 8.7 10.4 8.2 8.2 4.6 17.4 11.2 9.9 5.8 5.8 5.4 8.8 7.0 15.0 9.2 4.5 11.5 13.0 14.0 14.5 7.0 13.1 19.9 13.3 6.8 12.5 4.4 5.4 13.3 8.7 18.2 18.0 21.0 22.3 16.0 14.3 17.6 16.8 17.6 18.3 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Cell line enhanced" "Detected in some" "EFO-21: 4.9;HDLM-2: 3.5;HEK 293: 3.6;MCF7: 3.3;T-47d: 3.2;U-266/70: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favourable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 4.9 0.0 1.6 0.0 0.0 0.0 3.5 3.6 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.5 0.0 1.4 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.0 0.0 0.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 KLHL12 C3IP1 ENSG00000117153 "Kelch like family member 12" Q53G59 1 202891100-202928636 "Predicted intracellular proteins" "ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071324 Supported "Vesicles,Centriolar satellite" 9600000 "Vesicles, Centriolar satellite" "HPA071324: " "unprognostic (1.69e-2)" "unprognostic (2.84e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-3)" "unprognostic (3.35e-2)" "unprognostic (1.15e-2)" "unprognostic (9.11e-2)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (2.20e-3)" "unprognostic (6.22e-2)" "unprognostic (6.01e-2)" "unprognostic (3.32e-1)" "unprognostic (4.87e-2)" 14.1 18.3 19.3 17.1 20.2 16.1 20.1 18.6 35.5 14.1 18.4 14.2 13.5 13.9 14.7 23.2 17.2 18.5 12.6 25.2 19.2 25.6 21.5 17.1 20.4 29.6 19.6 20.1 18.1 25.6 17.9 19.0 15.0 24.7 19.6 23.2 12.7 13.8 16.6 14.6 13.5 14.3 19.7 25.2 19.4 15.4 41.3 14.6 15.9 19.6 10.1 20.6 16.1 16.2 9.5 12.7 18.4 14.9 10.2 13.3 9.9 10.3 12.5 15.9 17.9 24.7 18.7 18.6 12.6 14.6 15.8 14.5 11.7 17.1 29.0 9.8 14.2 13.3 21.3 17.5 17.4 15.1 9.0 10.2 9.8 11.8 17.9 21.1 17.0 17.8 22.5 13.7 30.1 14.1 25.3 19.3 21.5 14.0 17.6 10.3 22.6 9.5 18.7 27.9 18.5 13.6 12.9 11.8 13.5 15.6 14.3 16.9 26.0 14.9 11.4 15.5 10.9 3.7 11.1 13.9 11.1 24.5 15.2 15.2 14.7 9.2 12.0 18.4 9.1 14.9 13.2 9.5 9.1 10.8 12.7 9.3 9.6 10.3 12.4 10.2 14.7 7.6 13.3 9.9 19.3 20.2 18.6 35.5 19.2 25.6 19.6 20.1 24.7 14.6 KLHL14 KIAA1384 ENSG00000197705 "Kelch like family member 14" Q9P2G3 18 32672671-32773062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 14.6;seminal vesicle: 19.3" "Cell line enhanced" "Detected in some" "EFO-21: 3.4;Hep G2: 16.4;REH: 4.4;RPTEC TERT1: 9.1;SCLC-21H: 3.5;U-698: 4.8" "Group enriched" "Detected in many" 10 "endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 97 "memory B-cell: 10.7;naive B-cell: 8.5" "Lineage enriched" "Detected in single" 108 "B-cells: 10.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "hippocampal formation: 22.7;olfactory region: 20.4" HPA024777 Uncertain Supported "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA024777: AB_1852576" "unprognostic (3.93e-2)" "unprognostic (7.87e-2)" "unprognostic (7.09e-2)" "unprognostic (5.61e-3)" "unprognostic (1.87e-1)" "unprognostic (2.16e-6)" "unprognostic (2.14e-1)" "unprognostic (4.30e-2)" "unprognostic (4.81e-2)" "unprognostic (2.32e-3)" "unprognostic (2.32e-1)" "unprognostic (7.64e-2)" "unprognostic (8.91e-2)" "unprognostic (8.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.65e-2)" "unprognostic (1.43e-2)" 0.6 0.1 0.4 1.0 0.4 1.5 0.6 0.4 1.0 2.4 0.4 0.4 14.6 0.0 1.5 1.4 0.4 6.3 0.4 0.4 0.4 0.3 4.3 0.4 0.4 5.1 0.4 0.4 1.1 0.4 10.3 1.1 0.4 1.5 1.6 0.0 1.0 0.4 19.3 0.4 0.1 2.3 0.4 0.4 9.5 0.1 2.8 0.4 0.4 11.7 0.4 3.8 0.4 0.7 10.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 16.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 4.4 1.4 0.0 9.1 0.0 3.5 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.4 1.0 0.4 0.3 0.4 0.4 1.5 0.4 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 25.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol Cytosol Aggresome "HPA065730: " "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 2.9 6.1 1.7 1.3 2.3 25.1 1.3 2.8 1.8 1.9 2.0 1.0 2.3 4.0 4.3 3.8 1.9 2.1 1.6 1.9 2.2 6.4 1.6 1.4 1.3 4.6 2.9 4.3 2.6 1.2 2.8 1.2 1.3 1.8 2.6 1.0 1.5 2.2 1.6 1.5 3.4 9.0 2.3 1.2 1.3 1.1 1.4 2.1 2.8 2.6 1.6 2.8 1.3 4.2 4.1 4.6 6.8 6.9 4.9 4.8 6.9 6.0 3.2 3.9 3.7 3.8 11.2 2.5 4.4 3.2 7.3 3.7 7.8 4.3 15.0 7.1 11.1 2.0 4.3 9.2 5.0 5.1 1.9 5.4 5.4 2.3 4.5 15.8 5.9 1.5 8.3 9.0 8.7 5.1 6.6 8.4 6.9 2.9 3.8 12.2 5.7 9.6 2.3 7.9 3.2 8.3 2.9 4.9 3.0 9.7 4.4 8.8 8.8 12.9 3.9 6.0 3.8 1.5 1.1 2.8 2.0 2.6 2.8 1.0 1.8 2.3 2.1 1.4 2.4 2.4 1.5 1.6 2.6 1.7 1.8 1.3 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960587-965715 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavourable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 4.7 7.0 9.9 8.7 8.9 8.2 8.8 14.0 10.0 6.2 5.1 4.9 4.1 8.4 6.5 4.8 9.9 4.6 5.8 4.2 8.4 4.2 7.2 6.1 5.6 8.1 6.7 3.4 1.5 9.5 5.4 12.4 5.7 6.3 6.8 2.3 6.0 11.6 5.6 5.2 19.1 6.1 6.6 4.2 9.8 7.7 9.8 8.2 5.6 5.4 4.0 7.6 6.5 6.7 0.4 1.0 0.0 1.2 0.0 1.7 0.4 4.5 5.1 6.4 15.3 2.2 2.4 7.0 9.0 2.4 5.1 4.9 6.7 6.9 1.6 6.3 3.9 9.8 5.9 3.7 0.8 9.2 14.3 3.0 18.6 9.4 1.5 3.4 9.4 2.0 1.8 4.9 1.4 3.1 9.8 3.0 2.2 5.3 5.5 11.9 7.0 7.6 9.0 2.6 3.2 2.7 1.8 15.6 14.7 2.6 8.1 8.2 4.4 6.0 5.3 9.7 13.0 8.4 7.4 5.9 2.1 3.9 5.6 7.7 4.4 0.0 1.2 0.0 1.7 0.1 0.4 0.4 0.3 0.4 0.0 0.4 0.7 0.4 0.0 0.0 0.6 1.0 0.0 0.4 9.9 8.9 14.0 10.0 8.4 4.2 6.7 3.4 6.3 8.2 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 9.1 9.0 11.5 9.7 12.2 21.1 7.1 16.7 15.7 7.8 8.2 10.4 11.7 6.8 9.1 8.4 13.8 7.7 8.5 9.3 8.8 9.4 7.2 5.8 9.6 9.7 7.7 13.5 6.6 8.5 13.9 9.8 8.6 10.6 8.2 7.4 16.0 7.2 10.7 23.7 20.0 8.4 10.3 6.3 13.9 7.6 9.6 9.9 7.0 11.3 9.3 11.2 9.5 10.1 3.5 6.7 4.6 14.0 1.1 3.7 4.5 7.3 9.4 7.3 10.7 8.0 5.8 5.2 10.0 5.2 10.2 8.4 10.0 4.5 14.3 5.7 8.4 4.5 21.9 10.6 10.6 11.2 7.3 21.0 13.6 9.1 8.3 11.1 9.7 6.7 8.2 14.7 13.8 11.3 25.3 6.0 8.2 6.0 8.4 6.5 13.3 19.0 5.9 4.8 8.3 9.6 13.8 5.0 6.7 7.0 8.6 5.0 5.0 6.2 11.8 9.5 9.8 10.9 12.6 6.8 13.0 12.4 6.1 13.0 9.9 4.6 10.2 3.2 1.9 9.2 2.9 3.5 1.5 3.7 6.7 2.1 1.3 1.8 4.5 1.1 14.0 1.8 1.5 4.5 11.5 12.2 16.7 15.7 8.8 9.4 7.7 13.5 10.6 9.9 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favourable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.6 7.9 5.5 5.7 8.5 7.7 5.9 11.7 9.2 6.1 6.6 4.8 6.5 9.0 2.9 5.9 6.0 8.9 6.2 7.9 14.6 3.4 7.5 7.1 7.4 7.5 7.7 10.9 6.4 17.7 5.5 20.8 14.6 3.3 18.9 9.4 3.3 0.2 2.4 3.4 3.6 3.0 4.1 2.7 11.1 8.3 28.4 4.7 7.4 2.7 7.1 1.8 8.7 20.1 4.8 10.0 5.5 7.9 12.3 8.5 7.1 5.9 5.5 9.4 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 KLHL20 "KHLHX, KLEIP" ENSG00000076321 "Kelch like family member 20" Q9Y2M5 1 173714941-173786702 "Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025034, HPA053704" Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA025034: AB_1852578, HPA053704: " "unprognostic (2.97e-3)" "unprognostic (3.11e-2)" "unprognostic (8.27e-2)" "unprognostic (6.48e-3)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (8.66e-2)" "unprognostic (3.02e-1)" "unprognostic (1.90e-1)" "unprognostic (2.62e-2)" 18.2 14.5 10.4 12.5 15.1 6.9 15.4 18.8 18.0 17.9 16.1 14.3 17.3 9.1 21.9 13.0 14.4 14.2 13.9 15.2 11.6 10.3 15.1 21.7 13.6 12.0 13.3 10.5 18.0 9.7 12.3 20.6 15.4 16.2 18.8 12.7 11.5 11.3 15.4 17.1 12.9 16.0 18.8 14.8 16.4 11.0 20.7 15.2 20.7 13.3 14.7 13.6 14.3 14.8 6.2 7.1 9.7 5.0 4.7 9.5 3.3 8.2 5.2 8.4 8.7 19.7 18.3 6.9 13.0 12.7 10.0 10.6 3.8 5.8 5.8 11.1 13.9 8.2 7.4 9.3 11.9 7.1 4.0 5.3 7.2 4.5 12.7 9.9 6.3 15.5 10.9 9.3 12.5 14.7 11.7 6.7 18.3 3.0 5.7 5.1 8.9 24.0 6.2 10.3 6.2 7.7 5.3 3.6 10.0 11.8 8.1 7.7 7.2 11.7 14.5 9.7 5.8 11.8 10.1 9.0 4.6 8.9 6.4 7.2 10.8 9.7 4.5 6.3 7.3 5.0 6.5 5.9 7.2 8.7 4.3 6.2 9.5 9.1 2.5 4.7 3.5 7.1 8.1 3.3 10.4 15.1 18.8 18.0 11.6 10.3 13.3 10.5 16.2 15.2 KLHL22 "FLJ14360, KELCHL" ENSG00000099910 "Kelch like family member 22" Q53GT1 22 20441519-20495883 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040766 Supported "Golgi apparatus,Microtubules,Cytokinetic bridge,Mitotic spindle" "Golgi apparatus, Mitotic spindle" "Microtubules, Cytokinetic bridge" "HPA040766: " "unprognostic (4.15e-1)" "unprognostic (9.34e-3)" "unprognostic (5.37e-2)" "prognostic favourable (4.88e-6)" "unprognostic (1.17e-1)" "unprognostic (2.30e-3)" "unprognostic (1.00e-2)" "unprognostic (1.19e-3)" "unprognostic (2.20e-1)" "unprognostic (8.99e-2)" "prognostic favourable (3.85e-6)" "unprognostic (3.94e-2)" "prognostic favourable (1.34e-8)" "unprognostic (3.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.64e-2)" "unprognostic (1.08e-2)" 10.8 12.4 15.2 11.2 17.8 8.6 9.6 26.9 24.0 15.4 10.7 11.8 13.1 6.5 17.8 15.7 8.5 15.1 15.9 11.2 14.2 14.9 13.7 9.0 11.1 13.1 11.5 16.3 19.8 16.3 20.7 14.7 13.2 10.9 16.6 9.2 17.0 11.3 16.2 16.3 9.9 8.0 19.0 7.8 12.5 9.9 8.3 9.6 5.0 18.5 6.8 17.1 11.1 12.3 7.1 12.9 15.1 6.6 13.7 16.0 5.1 8.9 8.8 19.8 16.5 16.9 19.5 4.9 11.4 18.9 11.7 12.9 4.5 3.4 5.9 3.8 20.1 11.5 13.7 5.1 10.5 12.1 7.4 5.6 8.6 4.5 15.6 1.4 6.6 15.1 7.7 10.1 7.1 16.3 16.4 6.3 11.3 14.0 1.2 8.3 3.5 6.3 12.3 7.3 0.3 6.8 10.9 10.7 11.1 11.8 9.2 8.3 8.1 5.0 7.2 14.2 6.8 9.5 4.8 3.6 3.6 4.4 7.5 5.5 9.2 5.4 3.6 15.1 7.3 5.1 5.7 7.1 9.3 6.6 12.9 6.1 7.3 7.3 8.7 13.7 6.6 4.9 16.0 5.1 15.2 17.8 26.9 24.0 14.2 14.9 11.5 16.3 10.9 9.6 KLHL23 "FLJ37812, MGC22679, MGC2610" ENSG00000213160 "Kelch like family member 23" Q8NBE8 2 169694488-169776989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Group enriched" "Detected in many" 4 "dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047593 Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA047593: " "unprognostic (4.77e-2)" "unprognostic (2.65e-2)" "unprognostic (7.48e-2)" "unprognostic (4.12e-3)" "unprognostic (1.66e-2)" "unprognostic (2.13e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (4.19e-2)" "unprognostic (3.64e-3)" "unprognostic (1.05e-2)" "unprognostic (4.09e-1)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.43e-5)" "unprognostic (2.61e-1)" "unprognostic (1.45e-1)" "unprognostic (2.70e-1)" "unprognostic (4.87e-3)" 6.8 2.5 14.1 6.1 13.6 1.8 8.3 16.4 16.4 11.9 26.0 6.9 7.5 11.3 26.7 5.8 12.7 11.4 8.7 10.8 12.7 10.7 7.1 6.3 7.8 3.2 8.9 14.3 19.3 7.9 8.8 17.2 13.0 8.1 14.6 14.7 8.6 8.1 13.8 11.0 2.5 11.8 25.4 8.7 2.9 8.6 20.1 7.9 9.1 10.3 4.5 3.3 11.0 6.2 0.8 2.0 0.1 0.1 6.6 2.3 0.7 6.0 3.1 24.1 6.8 1.3 0.5 16.4 2.9 2.2 5.4 6.0 6.6 5.3 3.8 2.5 0.2 0.9 25.0 2.1 8.3 13.5 12.3 11.2 6.4 10.8 2.1 15.7 1.7 0.9 1.7 2.2 3.9 4.1 15.3 0.5 1.8 2.9 23.0 6.4 19.7 2.5 7.4 20.6 0.4 4.9 18.2 31.4 21.6 4.6 0.4 2.8 3.9 5.1 1.5 2.2 7.1 2.1 4.9 1.8 1.7 17.2 1.7 4.7 3.3 0.0 0.1 0.0 1.6 0.0 2.2 0.6 1.4 1.2 0.2 0.8 2.3 2.2 0.1 6.6 0.0 2.0 1.6 0.7 14.1 13.6 16.4 13.1 12.7 10.7 8.9 14.3 8.1 7.9 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759323-85795030 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 31.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 36.7;hippocampal formation: 25.8" HPA023450 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 10.6 4.2 5.2 6.8 12.1 1.5 12.7 3.9 21.5 4.7 4.8 7.5 7.7 9.9 7.9 7.2 8.2 6.2 5.2 4.2 5.7 5.9 4.3 18.3 4.8 4.0 5.3 5.8 4.4 3.6 4.4 4.6 2.8 5.4 5.7 2.9 3.8 6.2 7.6 7.8 9.7 7.0 6.2 3.0 2.6 7.5 16.3 4.3 3.7 4.7 2.5 3.9 4.1 31.5 0.6 1.2 0.5 6.1 5.1 3.5 1.0 2.3 7.0 10.3 5.0 2.1 1.1 5.3 2.9 1.4 4.2 3.2 9.4 3.9 1.4 1.5 2.4 5.8 11.1 5.6 0.9 1.4 5.1 0.4 3.0 7.1 2.4 0.4 1.8 2.1 1.9 4.0 1.4 2.2 0.6 1.3 1.7 4.3 3.6 2.2 9.3 3.7 7.4 6.2 2.4 1.5 4.9 14.4 10.0 4.3 5.0 1.8 9.1 0.6 1.9 4.4 8.1 2.8 5.3 1.5 3.0 1.5 1.9 2.6 2.4 0.0 0.2 0.5 2.0 2.3 1.1 0.1 2.1 1.5 0.5 0.6 3.5 2.2 0.0 5.1 6.1 1.2 1.8 1.0 5.2 12.1 3.9 11.1 5.7 5.9 5.3 5.8 5.4 4.3 KLHL29 "KBTBD9, KIAA1921" ENSG00000119771 "Kelch like family member 29" Q96CT2 2 23385217-23708611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049057, HPA057379" Approved Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA049057: , HPA057379: " "unprognostic (8.08e-3)" "unprognostic (2.91e-1)" "unprognostic (7.43e-3)" "unprognostic (2.65e-2)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (3.54e-3)" "unprognostic (1.16e-1)" "unprognostic (4.71e-2)" "unprognostic (2.18e-1)" "prognostic favourable (2.19e-4)" "unprognostic (2.53e-1)" "prognostic unfavourable (6.29e-4)" "unprognostic (1.12e-2)" "unprognostic (9.06e-2)" "unprognostic (7.44e-2)" "unprognostic (5.25e-4)" 9.5 20.8 8.9 6.4 14.5 0.8 7.4 9.0 11.7 6.7 9.4 2.6 5.2 2.6 10.9 3.5 5.4 4.8 10.7 3.3 6.7 7.5 4.7 5.4 6.2 5.7 3.6 9.0 4.0 4.7 5.8 17.7 7.6 6.3 10.8 3.4 11.7 4.2 11.7 12.0 6.9 4.2 7.2 2.7 10.6 5.5 2.5 3.7 0.5 1.9 1.8 4.0 7.5 6.4 0.1 0.4 0.0 0.0 0.9 0.7 0.0 1.0 0.9 6.1 3.1 5.8 3.9 10.5 6.2 4.8 2.5 1.8 0.0 0.3 4.0 2.1 2.4 0.2 1.4 5.3 1.7 0.0 6.4 0.0 5.2 0.0 2.0 0.0 8.0 2.8 7.2 3.3 9.5 4.3 0.0 0.0 1.4 0.5 1.3 0.0 3.0 1.8 0.3 15.6 0.0 4.7 1.8 9.2 1.9 0.8 0.7 3.5 0.0 0.0 4.2 2.5 11.9 5.4 2.1 0.1 0.0 0.0 9.7 0.4 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.7 0.0 0.9 0.0 0.4 0.0 0.0 8.9 14.5 9.0 11.7 6.7 7.5 3.6 9.0 6.3 3.7 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell line enhanced" "Detected in some" "CACO-2: 13.9;HMC-1: 9.3;PC-3: 8.0;SiHa: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favourable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.2 0.0 0.8 0.0 0.8 0.1 13.9 1.2 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.7 3.5 9.3 0.2 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.6 0.3 0.1 0.1 8.0 0.0 0.0 0.8 0.6 0.1 1.0 0.9 16.4 3.1 0.0 3.1 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.7 1.0 0.0 0.0 0.0 0.2 9.5 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KLHL4 "DKELCHL, KHL4, KIAA1687" ENSG00000102271 "Kelch like family member 4" Q9C0H6 X 87517749-87670050 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.4;brain: 16.3" "Cell line enhanced" "Detected in some" "AF22: 9.7;HHSteC: 8.2;HUVEC TERT2: 20.6;NTERA-2: 15.6;RH-30: 8.4;TIME: 22.6" "Cancer enriched" "Detected in some" 8 "glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 10 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029192 Approved Supported "Microtubules,Centriolar satellite" Microtubules "Centriolar satellite" "HPA029192: AB_10602341" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (8.74e-2)" "unprognostic (2.84e-3)" "unprognostic (1.48e-2)" "unprognostic (5.90e-2)" "unprognostic (1.71e-2)" "unprognostic (1.89e-2)" "unprognostic (5.21e-2)" "unprognostic (2.63e-1)" "unprognostic (5.98e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (8.08e-5)" "unprognostic (2.40e-4)" "unprognostic (1.05e-1)" "unprognostic (5.87e-2)" "unprognostic (7.25e-4)" 2.3 34.4 6.8 1.0 12.1 0.5 1.9 1.1 11.2 2.4 1.0 16.3 0.9 0.7 4.8 1.4 1.3 3.7 2.5 1.5 7.0 4.0 2.1 1.4 1.8 1.0 15.9 7.4 11.7 0.9 0.6 0.6 0.6 11.9 1.1 1.1 0.0 0.5 2.8 0.8 0.6 0.9 8.0 12.7 2.4 0.9 9.7 16.2 0.0 1.4 0.2 0.7 1.9 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.2 0.0 2.9 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.2 0.0 2.0 0.0 8.2 0.1 0.0 1.3 3.9 4.2 1.0 20.6 0.1 1.7 5.6 0.0 0.0 0.0 15.6 4.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 22.6 0.0 4.8 0.0 0.3 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.2 6.8 12.1 1.1 11.2 7.0 4.0 15.9 7.4 11.9 16.2 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Group enriched" "Detected in some" 9 "HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.1 0.0 12.5 0.2 0.1 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.1 0.0 31.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487531-183555689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.2" "Cell line enhanced" "Detected in some" "Daudi: 15.0;U-266/70: 30.9;U-266/84: 16.0;U-698: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavourable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 4.4 1.2 1.4 43.2 3.3 2.9 2.2 0.5 1.8 1.7 4.1 2.4 0.5 2.3 1.1 0.3 1.7 4.2 2.3 1.9 1.8 1.3 1.4 1.4 8.0 23.8 4.4 0.0 0.7 0.8 0.2 1.0 1.8 2.8 1.4 2.2 0.8 4.6 0.6 0.7 0.8 9.9 0.7 8.8 15.1 3.5 0.7 2.3 21.4 1.6 0.5 34.5 2.8 2.7 4.4 5.2 13.3 3.3 2.8 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 9.6 0.0 0.0 0.0 2.6 10.1 0.0 0.0 0.0 0.0 1.7 0.1 6.9 0.0 0.0 3.1 1.4 0.0 0.0 5.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 30.9 16.0 45.3 0.0 2.9 0.0 7.1 3.3 13.3 0.8 2.7 0.9 4.4 3.0 1.3 2.3 3.3 3.6 2.2 3.1 2.8 3.0 5.2 4.8 2.7 1.4 3.3 0.5 1.8 1.8 1.3 4.4 0.0 2.8 2.3 KLHL7 "KLHL6, RP42, SBBI26" ENSG00000122550 "Kelch like family member 7" Q8IXQ5 7 23105758-23177914 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029491, HPA029492" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029491: AB_10599605, HPA029492: AB_10600881" "unprognostic (1.24e-2)" "unprognostic (4.45e-1)" "unprognostic (1.77e-1)" "unprognostic (4.55e-2)" "unprognostic (1.29e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (3.78e-1)" "unprognostic (6.10e-2)" "unprognostic (6.41e-3)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "prognostic favourable (8.98e-5)" "unprognostic (2.46e-2)" "unprognostic (3.55e-3)" "unprognostic (3.23e-2)" "unprognostic (2.27e-2)" 7.5 14.6 9.2 5.6 13.0 8.2 10.3 12.6 15.1 8.8 5.7 7.9 4.7 5.9 9.1 9.9 7.7 7.4 7.6 37.1 8.1 8.7 9.2 7.7 6.4 5.8 8.3 9.7 9.6 5.9 7.1 6.1 6.5 15.9 8.1 6.3 8.6 7.2 6.8 7.4 8.6 5.8 8.1 10.6 5.8 5.2 40.7 6.2 9.6 7.2 5.1 6.7 6.9 7.1 5.5 5.5 32.0 8.7 4.2 8.0 6.0 10.8 9.3 25.7 30.3 12.6 11.0 9.4 9.6 14.3 14.2 16.6 11.3 7.9 10.7 7.8 11.7 11.8 9.8 6.8 12.0 2.8 7.1 7.0 8.1 14.5 9.4 14.2 5.5 9.7 8.8 16.2 13.4 18.0 12.3 11.7 23.1 12.5 11.8 22.6 35.4 11.2 10.5 14.4 9.8 13.3 9.4 15.5 15.1 20.9 10.4 9.8 8.6 7.5 7.7 12.0 12.5 26.3 11.4 18.5 15.0 25.5 7.9 15.1 14.3 18.7 7.8 32.0 6.8 8.7 7.1 4.5 7.3 6.4 5.5 5.5 5.5 5.4 7.4 4.2 7.5 4.0 8.0 6.0 9.2 13.0 12.6 15.1 8.1 8.7 8.3 9.7 15.9 6.2 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Group enriched" "Detected in some" 14 "A-431: 68.4;CAPAN-2: 163.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavourable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 163.7 0.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976482-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 29.1;skin 1: 77.5;tongue: 90.2" "Group enriched" "Detected in some" 6 "CAPAN-2: 6.6;HaCaT: 25.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" 960000 "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavourable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 2.1 0.3 5.4 0.3 4.3 0.4 5.6 0.5 11.3 5.4 0.3 0.0 0.0 0.5 0.7 0.3 29.1 7.8 3.3 0.2 4.8 0.5 2.6 0.2 1.6 0.3 0.3 3.5 1.0 0.2 0.2 0.1 0.5 4.2 0.3 0.2 0.0 7.4 0.3 0.6 77.5 0.3 0.4 0.3 0.5 0.4 0.3 0.0 0.0 0.4 90.2 15.3 0.2 9.0 1.1 0.4 1.3 0.8 2.1 1.0 0.6 2.6 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 6.6 0.0 1.0 0.0 25.9 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 1.3 0.8 0.4 0.4 0.4 0.7 0.6 0.6 0.4 0.4 1.1 1.0 0.9 0.9 2.1 0.4 0.4 0.7 0.6 5.4 4.3 0.5 11.3 4.8 0.5 0.3 3.5 4.2 0.0 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859161-87863437 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 6.3;skeletal muscle: 7.4" "Cell line enhanced" "Detected in many" "Karpas-707: 8.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA074502 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA074502: " "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.7 1.5 1.2 0.8 1.9 0.6 1.4 2.0 1.4 1.3 1.6 0.7 1.2 2.0 0.6 2.9 0.6 0.7 1.0 1.8 1.7 1.7 0.5 1.3 1.1 0.7 0.6 1.3 1.9 0.9 0.6 1.6 0.4 0.8 7.4 0.4 0.7 0.8 0.9 1.7 0.9 2.4 1.3 1.4 0.9 0.9 1.7 1.4 6.3 1.6 1.7 1.2 0.5 1.4 1.6 2.0 1.4 1.0 0.6 1.5 1.2 1.6 0.9 1.2 1.0 4.4 3.4 0.6 0.5 1.7 1.2 1.3 0.7 0.9 0.5 1.1 2.6 1.1 1.1 2.4 0.9 1.1 1.5 1.2 1.5 0.5 0.8 8.7 0.9 2.9 6.6 2.7 0.8 0.8 4.3 0.3 4.2 0.8 1.4 0.8 1.7 1.5 1.1 0.2 2.8 2.0 0.5 1.0 0.5 1.7 0.6 5.1 5.2 4.9 1.7 4.8 1.0 3.1 1.0 1.5 0.7 1.4 1.1 1.2 0.9 0.9 0.8 1.7 1.2 1.1 6.3 1.7 1.6 1.4 0.7 0.5 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favourable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favourable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favourable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favourable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.0 1.1 0.2 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 0.9 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 KMT2A "ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1" ENSG00000118058 "Lysine methyltransferase 2A" Q03164 11 118436490-118526832 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017794, CAB024270, HPA044910" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017794: , CAB024270: , HPA044910: " "unprognostic (6.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.83e-1)" "unprognostic (4.56e-1)" "unprognostic (4.96e-2)" "unprognostic (1.72e-3)" "unprognostic (4.52e-3)" "unprognostic (6.07e-2)" "unprognostic (1.61e-1)" "unprognostic (8.46e-2)" "unprognostic (3.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.91e-3)" "unprognostic (7.90e-2)" "unprognostic (3.73e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" 14.4 11.3 17.7 17.0 19.2 28.6 16.8 43.8 21.2 17.3 14.6 19.8 18.1 8.5 21.8 17.1 10.6 15.7 14.1 10.2 17.3 13.4 13.1 9.3 15.3 19.6 16.6 18.7 35.6 16.8 28.9 21.8 10.2 15.4 15.6 12.4 14.4 14.2 19.2 11.1 16.8 14.2 15.2 12.1 15.7 12.3 7.9 23.4 16.6 16.6 7.8 19.4 18.8 24.6 6.7 3.5 8.3 2.0 6.5 5.3 0.8 11.9 5.5 14.9 11.2 9.1 10.9 4.4 5.4 7.8 5.7 6.6 11.1 8.7 14.7 11.1 7.9 10.4 15.8 5.9 11.3 16.2 6.1 28.8 5.1 6.0 5.1 17.2 5.6 5.2 6.1 12.4 16.7 8.8 18.7 12.6 7.1 9.3 11.4 10.1 9.0 8.2 8.7 14.3 4.9 8.4 9.0 12.3 8.0 13.5 4.4 2.8 7.6 5.8 13.0 9.8 8.8 7.1 9.6 3.7 2.8 9.9 3.7 12.7 5.8 8.3 2.0 4.6 5.3 1.3 4.3 6.2 4.8 4.6 0.8 6.7 4.9 4.8 1.3 6.5 1.4 3.5 3.9 0.8 17.7 19.2 43.8 21.2 17.3 13.4 16.6 18.7 15.4 23.4 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35718019-35738878 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 10.2 9.3 11.4 14.2 13.1 18.4 10.4 23.9 11.4 10.0 12.0 14.2 12.9 13.8 13.0 7.1 11.4 11.6 12.6 7.5 11.0 5.3 9.9 8.9 10.6 14.7 14.7 6.8 15.3 19.6 10.8 13.3 9.3 11.2 12.1 5.6 13.8 14.7 10.0 13.3 19.9 12.3 12.2 12.4 15.8 12.1 21.5 14.9 14.1 14.9 7.0 14.2 12.4 14.2 0.4 0.7 3.2 0.7 2.1 0.7 0.2 11.3 19.2 8.9 9.7 4.6 4.5 9.3 5.5 4.0 5.6 4.3 12.8 5.8 10.1 8.7 4.6 7.5 8.0 4.7 2.5 15.0 8.9 18.2 9.0 6.4 4.5 11.1 20.9 6.1 6.4 5.7 6.3 5.5 15.2 12.7 3.6 11.6 9.4 9.6 8.2 6.8 14.8 5.8 5.5 3.1 10.1 10.1 8.1 8.4 13.6 5.8 8.3 11.8 7.6 11.3 12.2 7.5 11.7 17.5 10.7 8.1 6.1 10.3 7.8 1.0 0.7 0.6 0.7 0.4 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.4 3.2 2.1 0.3 0.7 0.2 0.2 11.4 13.1 23.9 11.4 11.0 5.3 14.7 6.8 11.2 14.9 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.0 16.2 16.4 13.2 17.0 11.4 17.6 9.0 9.4 11.7 6.3 28.4 7.2 17.7 11.7 12.6 11.6 21.6 10.0 9.8 10.3 17.3 22.5 16.9 15.2 11.7 26.7 22.6 9.7 14.3 16.4 17.0 17.4 28.2 9.8 13.2 18.7 13.2 24.9 15.5 14.0 19.9 10.1 6.4 9.8 18.9 13.7 11.6 13.9 13.7 9.5 13.6 23.4 23.1 9.2 16.5 8.1 15.1 14.0 9.0 17.2 10.6 13.8 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E" Q8IZD2 7 105014179-105114361 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042866: , HPA056125: " "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavourable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 22.7 11.8 18.6 24.5 23.5 44.8 20.9 41.6 22.4 26.4 20.9 18.6 21.7 14.7 25.3 15.8 16.5 18.6 18.2 16.8 20.6 15.1 14.2 11.6 22.8 20.1 22.7 17.4 33.5 15.6 20.5 20.1 18.7 18.6 21.2 20.5 17.6 19.6 19.2 21.3 25.7 18.5 26.2 23.1 21.6 17.9 12.9 27.2 24.6 21.7 15.1 22.7 26.6 21.4 38.2 24.7 72.9 20.8 20.3 30.6 14.7 14.8 10.5 22.3 19.1 13.8 16.6 5.7 11.4 17.1 9.6 11.9 8.5 13.7 12.4 11.4 13.4 11.6 12.3 11.3 16.0 19.9 7.1 12.5 13.8 7.3 13.0 16.7 15.7 11.6 10.6 13.3 14.4 17.4 17.0 35.5 13.6 11.7 26.7 14.3 7.8 8.5 23.0 13.7 14.3 9.5 15.1 12.8 15.4 15.8 13.6 8.6 5.9 10.0 21.4 22.8 15.9 26.0 11.3 27.1 21.4 28.6 15.0 12.8 15.6 48.5 18.0 39.4 30.6 13.6 30.3 35.6 28.4 26.1 12.8 38.2 28.0 26.0 72.9 20.3 20.8 24.7 23.6 14.7 18.6 23.5 41.6 22.4 20.6 15.1 22.7 17.4 18.6 27.2 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064495: " "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.2 7.8 9.3 14.3 6.0 10.7 12.8 18.2 8.8 10.6 9.4 8.9 7.2 28.3 10.6 12.1 11.4 13.3 6.7 11.4 11.9 13.8 23.7 8.2 4.4 9.0 18.4 6.0 4.6 8.4 11.5 10.7 8.7 42.9 13.1 8.7 8.9 18.6 27.5 4.3 8.9 22.2 8.0 7.6 7.4 14.9 12.8 10.1 18.2 9.3 8.4 12.9 23.5 11.0 12.0 8.7 14.2 13.1 7.3 7.6 25.9 8.2 9.7 10.0 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: " "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.8 5.6 11.4 8.2 0.3 1.7 5.1 12.7 5.1 10.0 8.4 6.8 4.4 7.2 4.0 5.5 13.6 10.8 5.9 10.6 12.5 2.9 21.2 9.6 2.0 0.0 16.2 10.7 0.3 0.2 6.7 4.2 8.5 13.5 12.1 11.6 3.7 13.8 3.2 5.6 5.9 12.6 16.3 3.6 1.5 9.6 9.9 4.6 11.0 6.2 1.3 6.7 4.9 7.8 11.6 10.3 13.3 7.0 4.6 15.8 14.1 4.7 11.0 11.0 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701934-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced Nucleoli,Cytosol Nucleoli Cytosol "HPA041079: AB_10962350, HPA066169: " "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavourable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 6.9 7.1 13.9 7.6 34.7 3.9 13.8 11.1 23.7 7.1 9.5 20.9 8.5 8.2 8.5 10.9 10.1 8.1 7.3 6.9 17.0 10.5 6.2 7.6 5.5 9.4 33.1 9.1 12.8 19.6 17.2 6.4 10.3 18.1 8.1 11.1 4.9 13.9 9.8 15.2 15.0 8.2 5.8 21.2 6.4 9.3 10.0 33.2 4.9 7.3 5.8 7.5 8.4 7.7 7.0 5.2 1.6 8.0 4.5 12.8 4.4 12.2 18.9 21.1 15.9 5.2 4.9 10.8 7.6 4.2 7.3 7.4 13.3 10.7 14.6 31.1 4.6 11.4 16.3 10.4 7.1 9.8 11.4 8.6 10.7 17.4 9.5 13.4 6.8 3.1 14.9 9.5 7.9 7.7 26.4 6.6 6.8 16.0 11.9 11.2 40.9 7.5 25.6 11.3 17.0 7.7 11.7 18.9 16.0 9.5 12.2 12.4 14.2 9.2 8.8 11.4 11.8 7.0 10.0 9.8 20.1 18.4 6.2 10.4 11.1 0.4 3.5 1.6 4.8 8.0 7.2 6.6 6.9 4.8 4.2 7.0 12.8 7.2 1.0 4.5 7.0 5.2 4.4 4.4 13.9 34.7 11.1 23.7 17.0 10.5 33.1 9.1 18.1 33.2 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavourable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavourable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.1 14.7 29.3 19.2 6.5 10.1 15.3 21.7 16.9 44.8 39.6 31.4 13.8 12.1 11.1 14.5 36.1 31.2 20.1 40.6 21.4 15.2 35.8 33.0 19.8 6.1 19.2 18.7 5.2 11.6 22.6 22.6 25.1 25.8 21.0 37.6 15.8 16.6 15.5 18.4 22.3 17.1 22.1 14.0 15.6 13.0 28.6 19.9 18.1 19.9 4.8 20.9 13.8 12.8 21.6 22.2 22.0 29.9 18.0 29.1 21.7 13.4 25.7 17.6 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favourable (8.69e-4)" "prognostic unfavourable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavourable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 5.6 5.6 4.5 15.3 5.4 28.9 5.8 7.5 5.6 5.2 6.4 2.7 3.9 7.0 5.4 5.5 9.6 4.9 2.9 2.9 4.6 1.8 4.9 4.5 5.8 11.8 4.0 3.8 6.7 4.9 3.5 5.9 8.1 3.6 5.3 9.7 3.9 6.1 2.8 1.6 11.7 10.9 7.7 3.1 14.1 5.5 23.2 2.8 39.6 4.0 7.0 15.6 4.4 6.6 4.8 2.1 5.0 2.6 2.2 3.6 0.8 13.0 10.9 31.5 7.2 2.5 4.5 14.2 12.1 7.9 12.0 11.4 10.3 11.0 15.6 6.3 5.8 18.0 13.6 7.6 16.0 11.1 9.4 19.2 20.4 10.5 0.8 18.9 13.3 2.4 1.7 12.4 8.3 8.1 19.2 11.8 9.0 9.7 15.6 43.8 15.9 13.8 21.4 15.3 17.3 7.2 14.0 9.8 12.6 22.0 4.7 6.5 17.8 10.9 5.9 13.8 13.2 13.4 14.1 15.9 16.0 24.1 8.2 12.3 15.7 5.0 1.4 4.6 2.0 1.9 1.8 4.8 3.3 3.6 1.3 3.0 2.5 2.9 4.4 2.2 2.6 2.1 1.4 0.8 4.5 5.4 7.5 5.6 4.6 1.8 4.0 3.8 3.6 2.8 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421949-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053627: , HPA063426: " "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 15.4 16.9 15.1 14.4 15.5 7.6 17.8 14.6 19.3 11.8 13.6 12.0 9.0 9.9 14.4 12.3 17.2 10.8 9.6 18.7 13.9 11.6 13.1 24.6 12.5 11.2 14.4 16.8 10.8 14.5 19.6 13.8 13.6 16.5 12.3 12.3 8.6 13.2 15.1 89.4 13.1 11.3 17.7 15.8 10.9 12.3 15.2 13.5 12.4 14.1 10.9 15.3 14.5 13.6 11.4 17.3 29.3 18.2 13.5 13.9 10.9 29.5 17.6 30.3 15.3 19.7 21.9 9.6 22.9 19.4 25.1 22.8 21.2 14.5 21.6 21.2 25.1 15.6 23.7 19.5 37.2 5.8 9.0 26.5 15.8 11.7 11.6 23.4 12.3 15.1 25.5 18.1 25.5 27.5 18.5 12.5 22.8 13.9 17.0 5.6 13.1 18.9 17.5 25.2 13.8 11.0 20.9 20.9 12.6 24.6 13.4 20.0 17.8 13.9 23.4 15.8 17.4 7.7 17.6 12.1 12.1 40.2 22.1 16.5 16.0 15.7 13.1 12.5 12.6 13.4 13.5 11.4 11.2 13.9 17.3 8.8 11.6 11.8 29.3 13.5 18.2 5.5 11.8 10.9 15.1 15.5 14.6 16.7 13.9 11.6 14.4 16.8 16.5 13.5 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: " "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favourable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavourable (2.12e-10)" "prognostic unfavourable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavourable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavourable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 61.9 81.5 77.8 31.2 11.5 11.2 49.4 54.7 42.5 88.4 69.0 56.0 29.0 58.2 17.3 31.5 34.4 86.0 42.7 101.8 23.4 50.7 51.5 39.3 53.4 12.2 44.3 35.5 6.9 8.1 50.8 31.4 85.0 40.9 42.1 78.4 57.8 55.2 28.5 52.5 42.3 30.5 71.0 31.9 34.9 29.1 30.9 34.4 30.7 99.2 32.1 57.8 22.3 33.1 49.1 60.6 34.5 73.5 35.0 49.9 58.1 23.9 38.1 52.6 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046852 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA046852: " "unprognostic (4.20e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favourable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 13.8 9.6 18.5 15.4 18.9 20.9 9.3 25.3 20.9 22.2 16.2 29.1 13.0 29.9 5.2 29.3 16.4 22.0 20.3 37.1 17.9 15.4 21.9 9.5 33.9 18.5 32.7 14.2 15.3 14.7 18.6 24.6 27.4 12.1 8.1 30.6 6.3 17.5 17.8 21.3 6.8 23.0 18.2 9.1 13.6 11.5 7.8 12.4 9.2 11.6 10.0 6.8 13.2 24.8 16.5 13.4 15.0 16.8 6.6 9.2 26.4 10.0 15.1 16.3 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108038-32176568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol 11000 Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavourable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 16.1 18.7 24.6 14.6 19.0 22.9 18.1 23.9 25.2 16.3 18.8 15.7 23.0 11.5 21.3 17.5 21.4 15.9 12.1 23.4 22.7 18.2 18.3 18.0 17.3 13.2 15.4 19.8 16.9 17.1 40.9 18.0 23.5 29.7 17.6 17.3 14.1 16.2 19.8 54.0 20.5 14.2 23.1 29.2 14.8 17.4 22.2 17.6 12.6 17.8 14.5 18.3 17.9 17.8 9.1 9.3 9.5 12.5 5.0 11.2 6.4 17.4 13.8 12.3 15.9 19.0 16.8 14.5 14.1 16.7 20.6 20.0 15.3 19.1 14.6 16.8 25.3 15.1 18.9 21.6 26.4 14.7 10.4 15.1 21.3 12.4 16.9 16.4 12.4 16.9 20.6 25.6 24.5 21.5 14.5 13.5 19.5 9.6 13.2 9.4 28.7 10.4 13.4 17.8 12.0 18.0 16.1 11.9 10.0 25.6 15.4 13.7 10.9 8.8 24.9 19.2 13.3 24.9 20.2 9.7 11.0 11.6 21.0 15.4 18.3 4.0 10.2 9.5 11.2 12.5 11.0 7.8 9.7 8.7 8.3 9.1 11.2 10.8 6.0 5.0 12.5 9.3 9.6 6.4 24.6 19.0 23.9 25.2 22.7 18.2 15.4 19.8 29.7 17.6 KPNB1 "IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97" ENSG00000108424 "Karyopherin subunit beta 1" Q14974 17 47649476-47685505 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029878, CAB034449, HPA050302" Supported Enhanced "Nucleoplasm,Nuclear membrane,Cytosol" 5500000 "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: " "unprognostic (2.57e-1)" "unprognostic (1.15e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (8.15e-2)" "prognostic unfavourable (2.55e-7)" "unprognostic (7.18e-3)" "unprognostic (9.52e-2)" "unprognostic (5.47e-3)" "unprognostic (4.37e-2)" "unprognostic (8.41e-3)" "prognostic unfavourable (8.43e-6)" "unprognostic (1.34e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (3.44e-2)" 38.0 42.1 31.9 46.1 30.7 22.1 33.3 32.9 33.5 37.6 37.9 29.7 39.9 24.5 39.3 35.4 51.2 33.1 35.0 43.5 28.1 30.5 33.8 48.8 35.8 50.5 31.6 35.3 47.2 32.3 42.3 29.4 34.6 34.9 36.1 39.3 23.7 35.2 45.9 74.6 31.7 32.1 40.7 36.6 50.3 35.7 62.4 34.8 47.6 37.0 34.3 62.8 50.8 47.5 5.4 4.0 28.2 3.9 3.7 6.3 2.8 43.2 73.6 46.9 42.6 22.7 39.5 47.1 51.5 46.2 67.6 53.1 128.4 25.7 55.7 35.2 48.0 30.6 84.6 47.5 102.7 34.2 51.6 61.6 59.4 40.2 23.4 69.6 40.6 32.0 21.0 77.6 76.0 44.5 69.6 38.2 52.2 47.0 64.6 20.9 44.6 46.6 40.0 82.9 32.4 27.7 61.9 41.2 38.3 35.2 18.9 29.8 41.0 26.9 37.0 73.9 45.9 38.4 62.4 46.7 54.0 79.9 31.5 33.7 54.1 4.3 3.5 7.1 4.9 3.6 6.3 5.4 5.5 5.5 2.1 5.1 5.2 4.9 28.2 3.7 3.9 4.0 4.0 2.8 31.9 30.7 32.9 33.3 28.1 30.5 31.6 35.3 34.9 34.8 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavourable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavourable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.2 10.9 8.6 5.3 8.8 6.9 6.0 3.5 6.6 19.1 11.9 7.8 7.4 7.5 2.7 6.2 7.2 7.3 12.5 5.3 7.0 11.3 3.2 7.4 7.0 7.9 6.3 9.1 7.9 8.2 6.3 5.9 7.2 6.3 7.3 5.5 4.8 11.2 27.0 7.7 6.6 8.1 4.3 3.2 5.9 9.3 18.4 14.1 5.8 6.6 4.3 5.5 9.2 4.1 4.5 5.2 2.4 7.8 1.8 2.9 3.3 4.1 4.1 6.8 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 30.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: " "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favourable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 3.8 4.6 5.6 6.2 8.1 4.7 5.6 8.7 12.8 5.2 5.2 7.6 11.0 2.2 7.8 4.9 5.5 5.2 5.8 30.6 6.7 5.2 5.3 2.2 4.5 5.7 6.3 9.0 7.9 7.0 9.7 16.9 3.1 7.1 6.0 1.9 9.4 17.2 9.5 7.4 6.4 3.6 8.5 5.1 6.4 5.0 5.7 6.5 2.5 4.3 5.5 4.8 5.0 5.3 4.1 3.7 1.3 3.7 0.3 4.2 1.7 6.2 3.9 7.7 16.1 3.5 3.5 6.7 3.3 4.1 5.4 6.2 0.4 1.7 1.9 7.0 4.2 6.2 5.8 11.2 2.7 8.7 11.0 3.5 5.0 3.6 4.4 0.0 9.8 7.7 5.2 3.7 2.0 4.9 14.1 2.0 2.7 2.4 8.9 5.3 9.3 3.8 9.5 3.1 1.0 4.1 5.0 6.1 10.4 5.1 14.8 3.5 2.6 5.4 5.0 6.6 2.8 0.0 4.6 9.6 3.1 8.3 3.9 6.0 6.8 0.0 1.8 0.4 3.8 1.7 2.6 1.8 1.9 2.2 2.6 4.1 3.4 2.9 1.3 0.3 3.7 3.7 4.2 1.7 5.6 8.1 8.7 12.8 6.7 5.2 6.3 9.0 7.1 6.5 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.7;CAPAN-2: 23.0;EFO-21: 11.3;hTEC/SVTERT24-B: 16.2;hTERT-HME1: 10.9;U-2197: 32.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" HPA046901 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA046901: " "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.7 0.0 0.0 0.0 23.0 0.0 11.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 16.2 10.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 8.3 0.0 32.0 0.0 3.4 1.1 0.0 1.8 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88055729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: " "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 22.5 15.0 23.1 30.6 27.3 5.7 25.9 23.5 20.4 23.3 29.9 15.8 19.9 20.7 17.8 29.1 26.4 18.4 16.5 21.4 27.0 15.7 21.5 28.1 23.4 22.3 30.3 15.2 20.3 19.4 24.8 23.8 17.3 23.8 24.0 29.7 12.1 20.8 37.9 23.0 16.7 28.9 24.7 28.2 22.0 17.5 10.0 29.9 20.2 26.9 14.5 20.5 22.1 20.2 18.3 12.7 37.2 11.6 14.8 16.5 8.0 11.5 7.1 11.2 8.1 27.0 32.0 8.3 18.3 20.4 9.8 9.6 0.6 15.5 16.4 6.6 11.5 6.0 2.5 3.8 11.1 17.1 3.5 3.1 1.8 1.1 19.7 4.7 2.2 16.0 19.1 6.5 14.0 11.0 4.4 8.2 21.1 9.8 5.4 6.6 8.5 4.7 11.1 2.0 1.7 14.7 6.3 8.7 8.8 6.9 9.7 21.3 6.8 19.5 15.3 11.6 0.8 19.0 5.7 18.6 12.9 13.1 12.5 12.7 27.3 24.7 11.0 37.2 10.1 11.6 11.7 18.3 12.4 12.3 12.7 16.9 14.2 11.2 17.9 14.8 10.0 11.2 16.5 8.0 23.1 27.3 23.5 20.4 27.0 15.7 30.3 15.2 23.8 29.9 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: " 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.3 3.2 2.1 6.5 5.3 0.7 6.3 2.0 3.0 8.4 1.2 0.1 2.4 2.9 12.9 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.3 2.7 0.2 2.5 2.2 0.0 0.8 0.3 1.4 0.4 18.3 0.2 2.2 5.0 12.5 7.0 7.3 2.6 9.6 9.7 0.4 0.2 8.4 2.6 31.3 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 KRR1 "HRB2, RIP-1" ENSG00000111615 "KRR1, small subunit processome component homolog" Q13601 12 75490861-75511636 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043433, HPA051690" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043433: AB_10960988, HPA051690: " "unprognostic (2.77e-1)" "unprognostic (1.02e-1)" "unprognostic (8.21e-2)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" "unprognostic (4.71e-2)" "unprognostic (6.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.38e-1)" "unprognostic (5.85e-2)" "unprognostic (1.88e-1)" "unprognostic (2.32e-2)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-2)" 22.5 18.4 14.2 15.1 22.0 38.0 17.8 29.1 23.3 21.2 14.3 6.7 14.6 12.6 18.3 15.2 24.2 14.7 10.5 12.5 12.6 10.8 23.7 25.0 13.5 18.2 12.8 16.4 21.7 15.0 17.8 33.5 21.4 19.8 20.9 11.8 6.3 20.7 14.2 28.8 16.6 15.2 15.7 16.1 19.8 15.1 12.3 17.3 24.3 20.5 22.4 18.1 19.6 16.4 15.8 10.8 8.9 4.6 8.6 14.7 5.6 25.0 20.8 13.1 11.7 10.3 9.4 24.0 22.0 14.0 17.3 11.2 15.2 13.2 26.7 17.9 10.9 13.2 17.5 19.3 19.6 22.0 17.8 25.8 11.5 17.6 12.5 45.4 16.4 9.8 16.5 19.9 19.1 11.8 28.5 8.6 17.0 16.5 26.4 12.9 19.3 19.0 21.0 25.2 16.0 19.3 31.7 15.7 13.1 20.8 14.7 25.9 24.6 18.5 14.7 16.0 10.7 16.6 22.7 17.1 21.5 16.8 8.7 16.1 28.9 7.7 2.4 8.9 10.1 4.6 12.4 15.8 14.1 11.4 3.9 14.4 14.7 13.8 1.1 8.6 3.7 10.8 12.5 5.6 14.2 22.0 29.1 23.3 12.6 10.8 12.8 16.4 19.8 17.3 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513743-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6" "Group enriched" "Detected in some" 10 "HaCaT: 120.2;hTCEpi: 92.9" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" 580000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favourable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 0.6 0.0 1.4 0.6 1.5 0.0 37.4 0.6 1.1 14.6 1.1 0.6 0.6 0.0 0.6 0.6 115.3 2.7 10.6 0.6 1.3 0.0 1.1 0.6 2.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 3.0 1.1 16.4 0.0 1.4 15.1 0.6 0.6 119.3 3.5 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 1.9 6.2 0.8 38.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.6 2.1 0.0 0.2 0.0 120.2 0.0 4.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 92.9 0.2 0.7 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 10.2 0.3 0.7 0.2 0.0 0.1 1.7 0.1 2.3 0.0 2.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.5 0.6 1.1 1.3 0.0 0.6 0.6 1.1 0.6 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652164 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 289.9" "Group enriched" "Detected in some" 6 "HEL: 6.5;HMC-1: 2.8" "Group enriched" "Detected in some" 35 "head and neck cancer: 4.7;melanoma: 23.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Group enriched" "Detected in some" 6 "amygdala: 1.8;hippocampal formation: 2.9" "Low region specificity" "Detected in single" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" 14000000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 9.5 0.1 0.1 18.3 0.1 0.1 0.1 0.0 2.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.4 289.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 6.8 0.1 19.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 15.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: " "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 3.8 5.0 9.6 0.7 18.3 0.6 1.3 15.6 21.7 2.3 1.8 0.2 0.9 1.2 1.9 11.8 1.2 1.2 8.3 1.0 10.0 10.0 1.3 9.4 1.4 1.1 8.6 13.4 0.9 1.7 1.6 5.2 0.6 14.3 3.2 2.3 0.8 0.7 4.6 0.6 0.8 2.3 3.1 3.3 3.4 1.0 1.4 3.3 0.0 1.2 0.3 1.1 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 18.3 15.6 21.7 10.0 10.0 8.6 13.4 14.3 3.3 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922696-40937634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.3;salivary gland: 99.8;skin 1: 48.2" "Group enriched" "Detected in some" 9 "HBEC3-KT: 20.7;Hep G2: 12.8;T-47d: 35.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 12 "neutrophil: 30.1" "Lineage enriched" "Detected in single" 70 "granulocytes: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" 170000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavourable (8.26e-4)" 0.3 0.0 0.2 0.5 0.2 0.5 10.0 0.3 0.3 9.8 0.2 0.2 2.1 0.0 1.1 1.2 2.5 1.5 4.5 0.2 0.2 0.0 0.3 0.6 1.1 0.6 0.2 0.2 0.6 1.2 0.0 0.9 128.3 0.2 6.9 0.0 0.3 99.8 2.8 0.3 48.2 0.2 0.3 0.2 1.0 0.0 9.1 0.2 2.0 0.3 11.7 9.5 2.3 3.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.3 0.0 0.6 0.0 20.7 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.2 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703750 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 12.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "T-reg: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Region enriched" "Detected in single" 18 "cerebellum: 1.1" "Low region specificity" "Detected in all" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 9.2 4.1 0.0 0.0 0.0 0.7 9.3 62.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 48.6 0.0 0.1 3.1 0.0 1.2 0.8 0.1 0.1 0.2 3.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 1.4 68.9 0.6 3.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2" "Cell line enriched" "Detected in some" 4 "BJ: 64.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles 170000000 "Nucleoplasm, Vesicles" "HPA055194: , HPA072208: " "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 64.5 2.8 7.7 15.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434525 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 22.9;tongue: 18.8" "Group enriched" "Detected in some" 6 "PC-3: 21.7;U-2 OS: 29.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hippocampal formation: 0.1" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" 2200000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: " "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.5 0.0 18.8 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell line enriched" "Detected in single" 90 "HaCaT: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 97.6" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: " "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 97.6 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRTAP25-1 KAP25.1 ENSG00000232263 "Keratin associated protein 25-1" Q3LHN0 21 30289145-30289514 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031438 Uncertain Approved "Nuclear membrane,Plasma membrane,Cytosol" "Nuclear membrane" "Plasma membrane, Cytosol" "HPA031438: AB_10610000" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell line enhanced" "Detected in some" "A-431: 27.9;CAPAN-2: 32.0;HaCaT: 10.2;SCLC-21H: 15.0;SK-BR-3: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: " "prognostic favourable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 27.9 0.2 0.7 0.5 0.0 0.0 5.8 0.0 0.0 0.0 0.1 9.0 32.0 0.2 0.2 0.0 10.2 0.2 7.2 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.3 0.1 0.0 7.5 0.3 1.9 6.0 0.1 0.1 0.2 0.7 0.0 0.0 15.0 0.5 0.4 9.3 0.6 0.2 0.2 0.0 0.3 0.7 0.2 0.2 1.6 1.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 KTI12 "MGC20419, SBBI81, TOT4" ENSG00000198841 "KTI12 chromatin associated homolog" Q96EK9 1 52032103-52033816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031203, HPA031204, HPA031205" Approved Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles, Cytoplasmic bodies" "HPA031203: , HPA031204: AB_10600110, HPA031205: AB_10611380" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-3)" "unprognostic (3.36e-3)" "unprognostic (4.18e-1)" "unprognostic (1.83e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.74e-1)" "unprognostic (2.94e-1)" "unprognostic (3.72e-2)" "unprognostic (4.06e-2)" "unprognostic (8.08e-3)" "unprognostic (6.59e-2)" "unprognostic (3.36e-3)" "unprognostic (2.39e-1)" "unprognostic (3.59e-2)" "unprognostic (1.64e-2)" 14.9 14.6 5.9 9.9 7.4 22.1 9.7 8.1 9.3 7.8 8.4 6.7 7.2 7.4 10.5 7.6 8.1 10.6 10.9 8.1 5.6 7.6 14.1 14.1 6.4 11.9 5.4 5.9 16.1 10.7 4.3 11.0 15.5 5.5 9.6 6.3 9.1 6.4 7.7 9.4 7.3 10.0 8.9 3.9 12.2 9.5 10.6 4.8 15.4 14.5 9.2 11.3 9.7 10.5 19.4 27.7 9.7 15.2 13.4 19.9 11.7 9.3 9.3 3.6 8.7 12.7 10.7 11.6 9.5 11.8 14.0 12.0 10.3 4.6 10.8 10.7 9.9 10.7 12.9 11.3 9.8 10.9 14.4 11.1 10.5 10.0 8.8 15.9 11.1 10.0 8.7 11.2 6.0 9.5 16.6 5.8 11.7 7.4 11.6 17.8 7.2 10.5 11.2 10.2 14.4 13.3 6.8 6.7 9.5 9.2 16.3 17.0 3.1 25.1 7.1 11.4 7.1 13.7 17.8 20.1 16.6 16.8 12.6 17.0 8.3 7.8 13.9 9.7 14.8 15.2 16.3 19.4 16.7 17.9 18.4 15.2 19.9 14.0 2.9 13.4 11.4 27.7 16.2 11.7 5.9 7.4 8.1 9.3 5.6 7.6 5.4 5.9 5.5 4.8 KXD1 "BORCS4, C19orf50, FLJ25480, KXDL, MGC2749" ENSG00000105700 "KxDL motif containing 1" Q9BQD3 19 18557762-18569387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041507, HPA041599" Approved Approved "Nucleoli fibrillar center,Centrosome,Cytosol" "Nucleoli fibrillar center, Centrosome, Cytosol" "HPA041507: AB_10795698, HPA041599: AB_10795502" "unprognostic (8.48e-2)" "unprognostic (5.30e-2)" "unprognostic (3.16e-3)" "unprognostic (1.35e-1)" "unprognostic (8.60e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (8.46e-4)" "unprognostic (7.36e-2)" "unprognostic (1.81e-2)" "unprognostic (5.25e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic unfavourable (7.71e-10)" "unprognostic (7.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.45e-2)" "unprognostic (1.63e-1)" 52.9 42.2 47.2 48.7 44.9 49.1 42.8 28.4 60.9 37.2 44.5 56.7 34.3 43.7 48.9 43.2 45.9 45.6 44.1 43.2 43.3 41.8 39.6 73.3 42.2 56.1 46.7 34.2 52.3 58.9 33.6 48.2 53.7 43.7 46.6 43.2 40.0 60.4 45.4 58.3 46.8 39.9 49.3 56.2 48.3 44.5 75.4 38.9 42.1 47.0 45.5 53.2 57.2 54.0 26.9 37.1 41.3 46.4 29.7 37.6 30.6 32.8 33.2 27.3 31.0 28.3 32.8 44.7 36.5 29.3 27.3 31.7 27.2 39.4 22.7 42.9 32.4 25.1 41.9 44.6 24.6 27.5 59.2 24.9 26.0 24.5 32.7 38.8 27.4 34.8 31.8 40.9 49.0 38.6 38.6 35.9 28.4 38.2 34.9 28.6 34.4 50.9 33.6 21.4 33.0 27.8 30.1 25.4 32.7 23.8 21.4 30.6 18.2 26.8 31.3 24.6 21.7 78.6 47.2 42.8 31.9 33.9 42.5 45.6 35.5 15.0 41.0 35.0 29.8 46.4 27.7 26.9 27.6 29.5 37.1 26.4 22.2 24.2 41.3 29.7 43.4 22.1 37.6 30.6 47.2 44.9 28.4 60.9 43.3 41.8 46.7 34.2 43.7 38.9 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favourable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favourable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favourable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favourable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 22.2 26.8 16.6 13.2 19.3 10.6 27.5 14.9 23.5 23.7 17.5 20.0 13.0 19.4 24.1 21.2 27.2 18.9 17.8 13.2 18.6 14.2 27.3 23.8 17.1 17.6 16.9 22.2 27.4 28.6 27.0 19.5 21.9 23.4 19.0 19.6 19.5 21.0 20.7 10.4 22.0 17.2 22.1 14.8 20.7 23.5 15.6 17.2 15.5 24.5 13.4 20.2 25.2 17.7 9.6 17.0 9.2 12.7 11.5 16.7 8.2 20.4 4.3 20.9 7.0 7.5 21.0 18.2 12.6 23.7 16.1 21.0 6.2 7.2 13.5 9.6 9.3 5.8 5.9 9.7 24.7 7.9 8.4 12.1 4.1 10.3 24.6 16.9 3.3 17.7 9.8 11.0 20.0 15.6 15.5 7.1 15.1 6.7 18.0 8.2 12.5 3.8 18.4 14.7 7.2 33.9 20.9 15.3 18.6 16.7 22.3 10.9 12.3 4.1 10.4 6.8 4.5 21.6 9.1 9.6 4.8 9.0 3.3 7.5 5.7 5.6 12.7 7.1 9.1 7.9 12.6 9.6 11.8 10.5 17.0 9.3 12.4 10.4 9.2 11.5 10.2 6.3 16.7 8.2 16.6 19.3 14.9 23.5 18.6 14.2 16.9 22.2 23.4 17.2 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell line enhanced" "Detected in some" "A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol 360000 Cytosol Nucleoplasm "HPA031686: " "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 40.1 0.1 0.1 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.7 0.5 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 44.8 27.2 0.5 0.1 0.2 3.9 3.2 23.5 0.1 0.0 0.1 0.2 0.3 20.5 0.0 2.4 0.1 0.1 0.0 0.2 0.1 0.6 20.7 0.1 0.0 22.2 3.3 0.2 11.1 5.7 0.3 1.3 0.1 19.6 0.0 0.1 0.0 0.0 70.2 4.6 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" 59000000 Nucleoplasm "Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavourable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavourable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.6 1.3 5.4 0.0 0.0 0.0 2.3 25.0 72.2 24.2 39.7 7.1 0.1 0.0 23.9 0.1 0.7 0.6 0.4 12.7 0.0 0.1 0.0 52.1 1.1 0.0 0.0 4.0 0.1 0.3 3.6 2.5 0.0 0.0 0.0 0.1 23.9 0.0 0.5 1.2 0.9 0.0 31.7 0.1 42.4 0.3 15.9 10.4 14.0 12.5 10.2 1.3 0.3 0.0 0.0 10.6 1.1 11.9 0.2 0.3 0.1 0.1 0.2 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 L3MBTL3 KIAA1798 ENSG00000198945 "L3MBTL3, histone methyl-lysine binding protein" Q96JM7 6 130013699-130141451 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 30.9;HUVEC TERT2: 30.1;TIME: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044382, HPA053035" Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044382: , HPA053035: " "unprognostic (2.33e-1)" "unprognostic (9.92e-2)" "unprognostic (1.40e-1)" "unprognostic (7.82e-2)" "unprognostic (4.22e-3)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (7.56e-3)" "unprognostic (1.07e-1)" "unprognostic (8.44e-2)" "unprognostic (3.94e-3)" "unprognostic (2.88e-1)" "unprognostic (2.45e-2)" "unprognostic (1.60e-2)" 8.8 16.7 5.2 16.4 8.2 7.5 7.5 2.4 7.7 17.1 5.6 3.6 9.3 3.1 17.5 14.1 5.7 7.4 6.0 4.1 5.4 5.8 6.1 6.4 7.4 11.4 5.2 5.9 12.1 3.8 8.1 17.0 6.5 5.7 10.3 5.7 4.8 5.8 7.5 5.3 4.3 7.6 9.9 5.4 18.5 4.6 7.5 3.9 25.5 10.2 4.3 12.8 10.4 11.6 10.7 10.8 3.9 14.1 1.7 4.2 0.6 0.8 3.1 7.3 1.1 5.0 6.8 1.5 3.6 7.5 1.5 2.7 3.7 3.9 1.3 5.3 4.7 3.1 4.2 6.5 2.3 2.8 4.2 8.5 1.5 0.9 2.6 5.0 30.9 4.2 4.7 1.7 5.0 30.1 6.1 3.4 3.7 0.3 10.6 0.8 3.4 1.6 4.0 2.0 0.0 4.8 1.2 0.2 1.0 1.4 0.3 2.9 7.6 4.4 20.5 2.4 3.4 0.4 2.3 0.6 0.0 2.2 1.2 2.1 2.5 3.9 3.5 3.5 2.7 4.0 2.7 7.6 2.7 3.8 1.3 10.7 2.4 3.0 3.7 1.7 14.1 10.8 4.2 0.6 5.2 8.2 2.4 7.7 5.4 5.8 5.2 5.9 5.7 3.9 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL4, histone methyl-lysine binding protein" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;RPMI-8226: 13.6;SCLC-21H: 6.6;SH-SY5Y: 7.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 5.3;NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA064194: , HPA069042: " "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 6.3 6.9 8.4 3.7 12.8 2.1 6.8 0.8 8.1 6.2 3.4 12.3 4.8 4.2 4.9 5.4 5.9 6.2 4.3 8.6 9.6 3.5 9.9 12.0 5.9 2.7 13.7 5.5 12.3 14.2 18.8 8.2 1.1 4.6 3.4 3.0 6.0 5.9 9.6 1.4 9.9 4.8 2.0 3.6 4.0 4.4 17.0 13.4 0.6 8.2 2.5 2.3 3.1 7.1 5.3 1.3 0.4 2.2 6.4 1.4 0.8 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.1 0.2 2.9 2.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 1.8 3.7 0.0 13.6 0.0 2.4 6.6 7.2 0.0 0.1 0.3 0.0 0.0 0.1 0.1 4.4 0.1 1.7 0.2 0.0 0.1 1.7 0.1 2.1 0.4 2.2 0.1 1.4 0.6 0.1 1.1 0.2 0.2 1.3 5.3 0.3 0.4 0.3 6.4 1.4 0.3 0.1 0.8 8.4 12.8 0.8 8.1 9.6 3.5 13.7 5.5 4.6 13.4 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell line enhanced" "Detected in many" "SK-BR-3: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: " "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favourable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.0 14.7 4.6 1.9 8.1 12.5 2.8 7.9 4.6 8.6 6.4 7.0 15.9 0.0 3.2 3.8 10.1 5.6 8.3 6.8 8.5 6.2 6.6 1.9 3.8 17.1 6.4 5.7 15.0 10.2 4.2 6.4 2.2 11.3 13.4 11.2 4.2 3.6 1.2 5.0 13.9 3.2 2.7 2.9 32.6 7.5 6.7 2.3 17.6 97.4 8.8 16.3 8.6 3.5 0.6 4.7 15.1 6.4 10.9 8.2 0.0 4.8 11.0 6.3 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 LAGE3 "CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1" ENSG00000196976 "L antigen family member 3" Q14657 X 154477769-154479257 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA036122, HPA036123" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA036122: , HPA036123: AB_10601926" "unprognostic (1.70e-1)" "prognostic favourable (5.29e-6)" "unprognostic (1.09e-2)" "prognostic unfavourable (7.60e-4)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "prognostic unfavourable (8.63e-5)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" "unprognostic (3.04e-2)" "unprognostic (4.88e-3)" "unprognostic (6.73e-2)" "prognostic unfavourable (5.42e-5)" "unprognostic (7.37e-2)" "unprognostic (3.57e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" 10.9 18.3 24.6 9.1 23.0 20.1 7.9 12.4 27.4 10.0 9.7 9.4 5.3 8.5 6.1 11.1 6.8 7.3 7.9 11.0 22.3 15.6 6.7 12.3 7.3 11.3 16.3 20.7 11.3 20.2 5.1 16.6 6.9 12.1 9.7 6.2 8.6 17.5 9.0 22.0 12.2 7.5 7.4 12.3 10.9 11.2 5.0 10.4 16.7 6.2 8.1 10.8 8.4 6.3 14.5 27.5 10.8 10.8 18.4 36.5 15.6 12.4 11.9 4.4 9.3 4.8 4.0 13.1 3.8 2.7 5.8 6.5 7.6 6.8 26.7 35.0 5.0 5.4 10.9 3.8 2.0 15.1 17.4 9.7 11.1 4.3 8.2 12.8 14.4 6.1 2.5 8.7 2.3 4.1 9.4 13.0 7.9 29.4 17.1 37.6 8.3 29.0 15.1 7.6 29.7 3.3 3.4 12.3 11.4 8.9 21.5 15.5 9.3 9.5 4.5 4.2 12.4 17.4 14.4 30.7 31.9 40.1 7.3 23.1 9.6 10.8 10.8 4.2 11.7 9.8 14.8 14.5 16.2 17.1 14.8 12.2 36.5 18.7 1.2 18.4 8.0 27.5 12.3 15.6 24.6 23.0 12.4 27.4 22.3 15.6 16.3 20.7 12.1 10.4 LAMA4 LAMA3 ENSG00000112769 "Laminin subunit alpha 4" Q16363 6 112108760-112254939 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 51.3;ASC TERT1: 78.1;HSkMC: 60.8;HUVEC TERT2: 64.1;TIME: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015693, CAB078156" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 350000 "Plasma membrane, Cytosol" "CAB078156: , HPA015693: AB_1852687" "unprognostic (1.87e-2)" "unprognostic (6.48e-2)" "unprognostic (8.37e-2)" "unprognostic (2.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.52e-2)" "unprognostic (5.07e-2)" "unprognostic (4.59e-2)" "unprognostic (2.93e-2)" "unprognostic (9.06e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (4.40e-3)" "unprognostic (1.85e-1)" "unprognostic (2.80e-2)" "unprognostic (1.15e-2)" 42.3 3.6 5.8 20.7 5.4 0.0 21.7 3.7 4.6 28.7 28.6 4.7 12.9 6.3 41.0 24.8 29.7 29.6 23.3 13.8 5.1 4.1 4.6 1.8 27.9 8.8 5.5 2.1 19.9 1.6 3.6 5.6 25.4 5.0 21.3 13.2 18.4 22.9 15.7 5.7 6.8 13.1 53.6 3.6 0.4 15.6 9.4 2.5 1.1 9.1 15.2 6.6 35.6 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 51.3 78.1 0.0 12.8 7.7 1.3 0.2 0.0 4.8 0.0 8.5 22.2 0.0 0.5 0.0 0.2 0.0 6.6 0.0 6.4 0.0 10.5 0.0 0.0 60.8 0.0 9.3 0.0 64.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 21.0 0.3 0.0 0.3 1.9 0.0 9.9 0.0 0.0 58.6 21.1 1.1 23.6 4.3 0.0 0.0 0.0 5.3 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.4 3.7 4.6 5.1 4.1 5.5 2.1 5.0 2.5 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 30.3;CACO-2: 41.8;EFO-21: 31.2;TIME: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054609, CAB078157" Enhanced Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" 1200000 Vesicles Nucleoplasm "CAB078157: , HPA054609: " "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 22.6 5.9 5.6 8.1 5.9 2.5 16.8 24.0 6.6 16.7 28.0 3.1 18.6 7.6 23.2 13.8 18.0 14.2 27.4 13.7 4.7 2.9 17.0 7.3 19.7 4.4 3.7 2.3 6.9 13.9 8.3 6.0 33.3 5.5 17.4 2.6 18.6 12.7 25.0 9.4 45.2 9.0 25.0 4.5 8.8 13.3 4.4 3.4 2.0 18.4 11.8 10.4 19.4 24.9 0.9 1.2 0.2 0.0 0.0 0.0 0.0 3.9 30.3 0.6 4.0 0.7 8.6 23.3 1.1 0.6 0.9 0.1 41.8 15.7 0.3 31.2 0.0 28.4 0.8 12.1 0.0 0.1 1.7 0.9 27.3 11.9 2.7 0.0 4.5 0.4 8.1 2.1 2.1 4.0 1.8 0.4 0.0 5.8 0.0 0.1 1.9 17.7 0.0 0.3 3.3 7.8 18.5 0.3 12.1 16.7 16.8 0.3 16.6 0.2 36.6 0.4 11.6 0.2 4.9 0.2 0.0 0.1 8.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 5.6 5.9 24.0 6.6 4.7 2.9 3.7 2.3 5.5 3.4 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 45.0;fHDF/TERT166: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;myeloid DC: 2.0" "Group enriched" "Detected in many" 9 "dendritic cells: 2.0;monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" 18000000 Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: , HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 46.1 35.3 7.4 13.0 7.7 0.9 29.0 5.1 8.3 55.0 25.9 10.5 41.3 9.3 43.4 38.6 34.3 27.1 37.7 62.5 9.7 4.1 30.6 29.6 28.2 5.7 8.2 6.1 56.0 12.9 51.7 8.0 41.3 9.9 37.7 7.3 45.1 17.4 39.2 22.7 17.0 23.0 31.5 6.9 16.7 22.7 24.1 8.1 2.1 36.5 21.8 11.4 45.3 38.4 0.0 2.0 0.2 2.4 0.0 0.0 0.4 3.2 8.0 7.4 26.4 43.4 45.0 6.7 28.0 34.7 16.7 16.8 3.8 11.1 0.0 9.7 63.2 10.5 6.4 10.0 11.5 0.0 2.0 1.4 12.6 6.6 29.3 0.0 0.0 39.1 15.0 13.3 13.6 16.3 0.8 0.0 13.5 6.2 0.0 0.0 3.2 6.7 0.0 3.6 0.1 11.7 4.1 0.0 4.4 16.0 9.3 14.6 20.2 0.2 27.0 18.1 7.9 6.4 7.3 0.0 0.0 0.0 8.6 0.0 12.2 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 7.4 7.7 5.1 8.3 9.7 4.1 8.2 6.1 9.9 8.1 LAMC1 LAMB2 ENSG00000135862 "Laminin subunit gamma 1" P11047 1 183023460-183145592 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 167.8;ASC TERT1: 92.4;HSkMC: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 15 "B-cells: 3.2;dendritic cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001908, HPA001909, CAB004486, CAB078163" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to extracellular matrix" 90000000 "Endoplasmic reticulum, Plasma membrane" "CAB004486: AB_627870, CAB078163: , HPA001908: AB_1079229, HPA001909: AB_1079230" "unprognostic (1.46e-1)" "unprognostic (1.05e-2)" "unprognostic (8.30e-2)" "unprognostic (8.84e-3)" "unprognostic (3.75e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-2)" "unprognostic (2.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-3)" "unprognostic (1.10e-3)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (8.85e-5)" 49.0 6.8 2.9 11.3 4.0 0.2 51.5 5.9 3.4 30.4 27.7 2.8 12.8 4.9 30.5 28.7 31.5 21.5 25.9 39.5 3.4 2.0 10.0 6.8 22.5 10.6 3.9 2.7 22.7 9.8 7.4 4.1 73.1 3.5 23.9 11.4 11.7 11.6 17.3 32.2 15.6 17.6 41.3 3.0 4.7 22.3 16.1 2.7 3.5 21.7 16.4 7.3 40.2 37.6 3.2 1.3 0.0 0.1 0.0 0.0 0.2 5.1 8.4 27.7 7.8 167.8 92.4 42.0 38.0 38.2 15.3 9.1 24.9 5.9 1.8 17.6 18.2 12.9 5.2 10.0 11.8 0.0 5.3 0.0 7.6 9.0 26.4 1.6 0.9 104.0 5.4 18.3 14.5 26.7 0.0 5.7 18.6 2.2 0.0 1.7 11.2 1.6 1.3 23.4 0.9 24.8 13.7 1.8 5.2 10.0 0.0 9.7 2.1 4.3 49.2 18.8 7.4 17.3 9.5 2.2 0.0 1.2 15.5 1.2 18.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 2.9 4.0 5.9 3.4 3.4 2.0 3.9 2.7 3.5 2.7 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120427827-120469365 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 112.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100, HPA029101" Supported Approved "Vesicles,Plasma membrane" 820000000 "Vesicles, Plasma membrane" "CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: " "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 21.8 33.6 39.9 16.1 87.9 22.6 27.1 16.2 55.5 33.0 18.3 88.7 27.9 25.1 20.8 37.5 34.6 22.4 43.3 20.9 52.5 30.3 55.0 83.7 25.3 14.3 131.0 36.9 22.7 27.4 28.8 20.2 35.4 58.6 37.3 19.7 17.2 47.8 32.9 32.4 26.9 20.5 21.1 84.3 17.9 23.6 11.9 116.9 21.2 33.7 14.3 15.4 21.1 27.0 3.7 11.6 112.9 21.7 5.4 5.8 10.5 11.8 11.7 8.6 11.1 113.5 38.8 23.9 20.5 35.8 20.0 37.4 9.7 21.2 8.4 18.1 35.6 20.0 12.5 15.5 32.6 9.4 8.9 6.6 13.0 13.0 37.8 29.0 18.4 42.0 31.2 26.6 17.6 27.2 7.6 30.0 32.3 21.9 8.0 14.8 6.7 10.4 6.2 14.6 15.0 29.2 8.8 2.9 4.6 22.0 22.4 43.8 13.3 32.4 28.1 28.7 13.9 36.9 55.3 15.1 14.4 5.5 27.4 35.1 68.7 4.9 21.7 41.3 5.0 18.7 4.0 3.1 4.8 4.7 11.6 3.7 4.3 4.1 112.9 5.4 17.3 6.3 5.8 10.5 39.9 87.9 16.2 55.5 52.5 30.3 131.0 36.9 58.6 116.9 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell line enhanced" "Detected in some" "Karpas-707: 92.7;SH-SY5Y: 17.0;THP-1: 32.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: " "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 92.7 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 LAMTOR1 "C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1" ENSG00000149357 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1" Q6IAA8 11 72085895-72103387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002997 Approved Supported "Golgi apparatus,Vesicles,Plasma membrane" 270000 "Golgi apparatus" "Vesicles, Plasma membrane" "HPA002997: AB_1845531" "unprognostic (7.32e-2)" "unprognostic (1.79e-1)" "unprognostic (3.94e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-1)" "unprognostic (2.71e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-3)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.04e-1)" 47.3 55.3 51.3 33.3 55.6 49.7 69.1 23.1 51.1 43.3 40.4 44.1 39.4 35.1 36.0 48.1 42.2 40.7 44.0 59.9 45.4 41.4 58.0 60.5 44.3 71.5 52.5 29.9 38.0 45.0 33.3 37.6 41.6 38.1 39.8 40.2 40.4 45.0 45.5 57.6 33.2 41.8 38.8 49.0 52.9 35.6 22.6 31.9 28.2 61.3 39.4 40.0 32.7 35.0 25.7 57.7 44.9 68.7 19.7 16.4 55.4 17.6 35.0 18.9 23.1 41.7 28.9 19.0 24.6 35.1 38.0 29.0 44.3 24.3 17.8 31.9 38.7 25.7 29.7 49.4 27.4 22.4 19.6 46.7 22.5 29.7 59.4 18.0 27.8 50.0 36.2 40.2 38.3 30.4 19.5 16.5 37.3 55.9 13.9 28.1 17.8 38.4 12.3 32.8 14.3 47.5 37.5 11.5 19.8 24.9 23.4 62.7 34.5 16.1 24.4 26.1 19.2 61.6 17.1 22.2 25.3 13.6 15.2 14.5 19.7 17.7 68.7 44.9 15.0 38.6 14.4 23.8 14.2 14.9 57.7 25.7 12.0 14.6 40.5 19.7 29.3 34.3 16.4 55.4 51.3 55.6 23.1 51.1 45.4 41.4 52.5 29.9 38.1 31.9 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054752-156058510 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles 17000 "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavourable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 24.3 33.5 30.3 18.8 27.2 23.4 35.3 14.2 30.6 22.5 27.5 13.8 34.3 24.5 17.0 38.1 27.6 25.4 25.7 37.2 25.8 24.9 31.7 63.5 27.7 37.9 26.4 22.8 11.4 75.2 16.6 18.0 21.1 23.4 18.8 27.5 16.4 35.9 34.3 35.5 20.4 26.2 26.2 19.3 26.0 27.3 12.1 20.3 20.2 20.9 30.2 23.6 21.9 17.0 47.2 89.8 60.4 80.6 32.6 47.6 56.7 15.7 35.7 16.9 23.2 34.4 28.0 18.6 14.1 23.8 17.6 20.2 16.3 26.9 23.3 24.5 27.0 23.2 17.2 37.9 9.9 19.3 26.1 13.5 24.2 21.5 27.3 19.1 22.2 33.0 23.8 18.7 24.0 35.7 12.2 17.5 25.3 31.7 19.7 27.3 17.8 53.6 16.7 12.6 34.0 38.6 23.1 6.5 37.8 17.8 49.8 28.4 35.0 56.3 24.2 14.9 13.7 21.6 13.1 26.4 38.8 13.5 26.6 21.3 15.9 41.8 80.6 60.4 30.9 71.6 30.2 47.2 34.2 33.5 89.8 38.3 26.2 28.2 39.6 32.6 56.5 47.5 47.6 56.7 30.3 27.2 14.2 30.6 25.8 24.9 26.4 22.8 23.4 20.3 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365448-55433742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell line enriched" "Detected in all" 7 "A-431: 57.1" "Cancer enhanced" "Detected in all" "glioma: 52.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favourable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favourable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.1 4.9 20.4 2.3 17.0 3.1 5.9 9.9 28.5 6.1 4.6 19.8 1.8 5.0 9.6 5.3 3.5 5.6 3.8 3.9 17.2 11.3 6.0 4.8 3.0 4.0 12.9 21.1 9.6 3.4 10.4 4.2 3.9 10.1 5.9 4.7 2.4 3.3 6.9 5.7 5.3 4.2 7.0 10.8 2.8 3.5 5.7 13.1 3.3 6.6 0.3 2.7 2.8 2.7 2.7 4.7 0.7 4.5 3.6 6.0 2.6 57.1 2.0 4.0 2.7 1.2 2.1 2.2 2.6 3.1 4.0 3.4 2.0 1.6 4.0 2.4 3.7 2.6 2.1 1.4 2.5 1.7 4.2 1.4 1.6 2.0 2.2 4.4 2.7 3.8 1.5 3.0 1.0 2.0 2.5 2.6 3.7 1.7 1.1 2.0 7.7 2.5 1.7 1.8 2.0 2.6 4.5 7.0 6.7 3.7 5.6 1.5 2.3 4.7 3.3 2.5 3.5 4.8 5.0 2.5 3.0 4.3 2.0 1.0 4.8 0.4 3.6 0.7 2.6 4.5 4.5 2.7 3.4 3.9 4.7 2.6 3.1 2.7 0.5 3.6 3.0 3.7 6.0 2.6 20.4 17.0 9.9 28.5 17.2 11.3 12.9 21.1 10.1 13.1 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.8 9.5 9.1 8.6 18.1 22.1 0.1 17.1 19.3 62.3 75.7 17.3 20.7 42.7 11.4 13.1 6.7 34.2 12.1 23.7 16.3 9.8 23.7 10.5 22.6 21.1 21.3 15.2 22.4 7.7 20.4 10.7 21.6 22.9 30.5 14.6 11.7 18.9 29.2 19.0 18.2 29.4 8.7 21.6 16.2 12.7 13.5 11.1 15.7 9.7 33.5 8.2 8.2 14.0 15.8 10.7 16.6 29.7 28.1 42.9 36.9 21.4 35.5 15.3 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 LAPTM4A "HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp" ENSG00000068697 "Lysosomal protein transmembrane 4 alpha" Q15012 2 20032650-20052028 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031402, HPA031404, HPA068554" Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles" "Plasma membrane" "HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: " "unprognostic (2.01e-1)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (5.73e-1)" "unprognostic (6.04e-2)" "unprognostic (3.00e-2)" "unprognostic (1.53e-3)" "unprognostic (5.37e-2)" "unprognostic (1.27e-1)" "unprognostic (3.65e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (8.70e-2)" "unprognostic (1.05e-2)" "unprognostic (7.78e-3)" "unprognostic (2.18e-2)" "unprognostic (7.98e-3)" "unprognostic (2.36e-1)" 59.2 63.8 23.4 20.1 22.8 19.8 53.6 15.9 23.4 85.7 44.0 25.9 181.0 26.0 80.3 57.4 50.4 53.0 49.9 50.1 22.3 19.0 95.9 83.0 48.7 24.3 22.0 17.3 72.7 63.6 28.9 46.5 137.6 24.9 64.9 28.4 56.8 49.9 175.6 33.6 41.2 44.9 56.4 21.6 34.8 40.7 83.3 18.6 13.7 75.3 37.9 37.7 65.3 57.8 27.2 37.4 82.4 53.4 16.5 19.4 48.0 36.9 20.5 12.6 26.1 131.1 97.5 47.2 47.0 59.0 32.2 36.6 16.0 36.4 6.5 10.9 57.0 36.8 10.4 22.5 29.5 16.0 16.7 10.0 24.2 45.6 50.6 7.6 27.6 65.0 45.9 31.2 35.9 33.2 7.5 12.5 47.6 21.3 4.5 10.1 27.8 18.8 8.0 36.9 12.3 78.7 31.0 20.0 19.3 43.7 36.1 29.5 15.6 6.3 42.3 54.2 19.4 46.5 30.1 20.9 29.9 10.5 42.8 15.3 21.4 82.4 53.4 38.5 14.2 44.2 17.1 27.2 17.0 15.7 37.4 26.2 19.4 17.3 28.1 16.5 50.3 31.3 15.9 48.0 23.4 22.8 15.9 23.4 22.3 19.0 22.0 17.3 24.9 18.6 LARP1 "KIAA0731, LARP, MGC19556" ENSG00000155506 "La ribonucleoprotein domain family member 1" Q6PKG0 5 154712902-154817607 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: , HPA054819: " "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 24.9 30.1 30.5 21.9 31.9 18.9 20.3 25.7 46.5 21.3 20.4 27.3 23.2 21.0 26.5 23.0 29.2 25.4 18.5 28.5 27.8 29.1 25.6 22.6 19.9 23.1 26.8 29.7 28.4 81.2 55.9 23.6 25.1 29.2 18.2 21.3 18.9 38.8 21.4 41.7 24.7 22.3 23.8 22.2 21.5 24.4 27.8 27.4 26.1 33.5 16.4 25.8 22.1 28.7 5.2 6.4 2.8 7.9 10.1 5.8 2.5 26.0 36.5 28.5 32.7 24.8 20.2 31.6 26.5 27.1 31.1 30.4 57.3 31.4 68.9 37.7 33.1 26.3 51.9 48.8 36.0 22.8 29.3 49.8 38.0 26.4 31.6 66.5 23.1 24.9 28.3 38.6 49.4 27.3 40.9 47.8 28.8 25.7 39.4 26.0 30.3 18.4 44.1 27.1 32.8 19.1 32.5 51.7 27.8 36.0 57.8 31.9 34.4 31.4 36.1 39.1 24.5 29.5 47.5 42.8 30.7 58.7 26.0 36.9 27.3 2.8 4.0 1.1 4.5 4.9 5.8 4.3 5.4 5.3 4.0 5.2 4.3 4.7 2.4 10.1 7.9 6.4 3.4 2.5 30.5 31.9 25.7 46.5 27.8 29.1 26.8 29.7 29.2 27.4 LARP4 PP13296 ENSG00000161813 "La ribonucleoprotein domain family member 4" Q71RC2 12 50392383-50480004 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039306, HPA039673" Approved Enhanced "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA039306: AB_10805362, HPA039673: AB_10795110" "unprognostic (4.41e-3)" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (8.50e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (9.93e-3)" "unprognostic (9.08e-2)" "unprognostic (8.94e-2)" "unprognostic (8.51e-3)" "unprognostic (1.91e-2)" "unprognostic (3.14e-1)" "unprognostic (9.06e-2)" "unprognostic (3.99e-3)" 15.1 22.5 12.3 13.5 14.4 9.4 15.0 12.2 13.1 12.1 13.8 8.1 17.7 13.0 12.4 11.6 15.1 10.7 10.4 14.7 11.3 10.4 28.5 47.8 13.6 11.3 15.6 9.0 11.5 17.1 18.3 23.1 17.7 14.8 13.1 11.7 13.4 17.3 14.7 31.3 10.2 14.8 15.7 17.9 10.9 13.2 11.2 13.5 14.0 15.9 11.2 11.8 14.0 21.4 11.8 15.6 8.9 14.6 10.9 12.1 8.9 14.8 21.1 14.0 10.2 13.1 11.0 23.9 18.3 10.9 18.1 14.5 41.2 17.3 34.9 22.6 11.4 14.2 30.5 12.4 23.9 21.6 12.5 28.3 19.9 14.7 12.3 31.4 16.8 9.9 11.9 21.4 23.1 15.9 40.7 16.7 16.8 13.2 25.7 10.6 20.3 18.5 19.0 22.4 20.7 9.8 22.3 16.7 9.8 32.4 16.9 18.8 14.7 12.7 22.9 12.0 17.9 13.9 17.2 16.4 43.7 31.0 16.7 12.9 10.0 8.9 11.6 7.7 11.4 13.0 10.8 11.7 10.1 6.4 15.6 11.8 12.1 9.6 6.5 10.9 14.6 13.5 9.8 8.9 12.3 14.4 12.2 13.1 11.3 10.4 15.6 9.0 14.8 13.5 LARP6 "acheron, FLJ11196" ENSG00000166173 "La ribonucleoprotein domain family member 6" Q9BRS8 15 70829130-70854159 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020338, HPA049029" Approved Approved "Microtubules,Cytokinetic bridge" Microtubules "Cytokinetic bridge" "HPA020338: AB_1844500, HPA049029: " "unprognostic (1.35e-3)" "unprognostic (1.95e-1)" "unprognostic (7.43e-2)" "unprognostic (2.63e-3)" "unprognostic (2.96e-2)" "unprognostic (4.70e-2)" "unprognostic (2.44e-2)" "unprognostic (2.80e-3)" "unprognostic (4.27e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "prognostic unfavourable (9.90e-5)" "unprognostic (4.51e-3)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" "unprognostic (3.43e-1)" 28.3 10.1 25.5 7.7 36.9 1.3 27.4 10.8 57.2 24.1 6.2 44.7 3.4 3.4 17.6 32.6 9.4 13.4 12.6 27.9 33.1 20.9 17.1 4.6 6.3 3.4 36.0 19.3 24.7 8.6 11.4 8.8 9.1 25.1 16.6 5.6 4.3 12.3 17.1 10.8 4.9 4.1 14.1 43.1 2.5 9.3 9.7 31.7 0.7 27.0 4.0 2.7 10.3 16.9 0.3 0.3 2.6 0.3 0.5 0.4 0.1 9.9 10.7 3.5 6.9 17.7 19.8 0.0 30.9 24.1 16.7 17.8 3.1 2.9 0.0 12.7 16.8 5.4 7.8 2.7 16.6 0.1 19.1 0.0 8.8 2.8 32.2 0.0 0.0 12.4 11.3 16.7 26.8 5.4 0.0 0.1 7.4 1.7 0.0 0.0 3.6 27.8 0.0 12.5 0.0 5.4 8.6 2.1 4.6 10.2 0.1 21.1 0.5 0.5 7.1 6.8 27.3 57.3 25.4 0.0 0.0 0.0 29.2 0.0 3.4 1.1 0.3 0.3 0.4 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.3 2.6 0.5 0.2 0.3 0.2 0.1 25.5 36.9 10.8 34.8 33.1 20.9 36.0 19.3 25.1 31.7 LARP7 "DKFZP564K112, HDCMA18P, PIP7S" ENSG00000174720 "La ribonucleoprotein domain family member 7" Q4G0J3 4 112636964-112657592 "Disease related genes, Predicted intracellular proteins" RNA-binding "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026842, HPA027930" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026842: AB_10611116, HPA027930: AB_10601233" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (5.72e-2)" "unprognostic (2.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.82e-2)" "unprognostic (1.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-2)" "prognostic favourable (4.33e-4)" 22.9 20.2 26.5 24.2 37.0 23.9 23.9 32.5 33.2 26.8 24.7 15.0 24.5 20.7 26.8 23.3 26.4 21.9 20.0 38.3 34.3 21.3 38.8 26.9 18.1 25.6 33.3 26.5 26.3 14.4 21.4 42.6 23.1 34.7 27.3 23.9 11.5 19.2 19.9 35.5 19.1 35.2 31.1 46.9 32.4 20.0 16.0 41.2 27.5 26.4 21.2 25.2 30.1 20.9 23.8 34.6 30.7 27.8 17.8 19.2 10.4 11.4 11.3 23.9 12.0 16.4 19.1 12.1 14.5 12.1 13.5 12.9 7.8 18.1 27.9 12.9 13.9 7.7 22.5 13.1 18.2 23.4 15.9 16.0 9.5 12.3 12.2 37.9 23.9 15.3 15.5 12.1 7.1 12.6 19.5 14.3 17.5 9.8 30.4 14.1 61.7 8.5 17.1 19.2 12.2 20.9 12.5 13.2 18.2 9.3 23.1 14.3 10.1 14.9 12.1 12.7 12.9 12.9 15.4 9.7 16.1 28.4 16.4 14.2 13.5 30.7 15.0 25.3 18.5 20.7 16.5 23.8 18.8 19.2 12.3 22.8 18.4 17.8 18.3 17.8 27.8 34.6 18.1 10.4 26.5 37.0 32.5 33.2 34.3 21.3 33.3 26.5 34.7 41.2 LARS "FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS" ENSG00000133706 "Leucyl-tRNA synthetase" Q9P2J5 5 146113038-146182660 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036424, HPA040881" Supported Enhanced "Nuclear bodies,Cytosol" 14000 "Nuclear bodies, Cytosol" "HPA036424: AB_10670102, HPA040881: " "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-3)" "unprognostic (1.92e-1)" "unprognostic (2.69e-1)" "unprognostic (3.39e-1)" "prognostic unfavourable (3.78e-5)" "unprognostic (8.17e-2)" "unprognostic (2.72e-1)" "unprognostic (6.80e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (2.98e-4)" "unprognostic (2.96e-2)" 32.2 30.1 27.0 25.8 31.2 17.8 38.6 31.8 33.7 25.5 25.3 30.1 23.9 16.8 35.8 31.3 28.5 26.8 16.4 29.0 24.2 22.2 26.5 18.4 20.0 24.8 27.3 26.1 32.0 40.8 35.0 43.0 20.6 31.6 26.3 29.9 19.5 39.9 24.8 55.5 24.1 21.5 32.5 30.9 25.2 24.9 20.5 30.5 25.6 30.8 22.8 28.9 30.9 29.2 21.3 28.0 5.8 18.3 19.0 21.8 11.2 20.4 24.2 28.0 45.9 23.2 30.3 43.6 23.9 17.7 24.2 35.1 25.2 22.4 31.1 14.8 31.4 17.5 47.3 39.3 42.4 26.7 27.8 35.5 30.6 14.6 32.2 50.4 23.5 23.8 39.6 39.6 68.8 33.0 39.4 58.3 26.0 16.9 38.9 30.9 43.4 26.8 30.1 35.3 31.0 18.5 18.5 27.6 34.8 26.0 28.7 60.4 32.6 43.5 32.2 28.3 18.8 25.6 35.7 30.3 44.7 50.9 30.8 53.2 33.0 2.5 13.5 5.8 14.8 18.3 19.8 21.1 16.4 13.6 18.6 21.3 21.8 18.0 1.2 19.0 13.6 28.0 14.8 11.2 27.0 31.2 31.8 33.7 24.2 22.2 27.3 26.1 31.6 30.5 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: , HPA066085: " "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favourable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favourable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.2 7.9 9.2 8.7 8.4 9.5 9.9 9.8 10.1 18.3 13.7 14.0 8.8 13.0 8.4 11.4 6.8 34.2 20.5 13.9 11.4 8.6 14.1 12.8 13.5 8.8 20.4 5.2 12.3 12.7 17.5 9.2 11.4 21.9 7.4 11.4 6.9 14.6 7.5 23.0 14.6 8.3 9.2 14.5 16.3 15.2 7.3 9.1 15.6 8.8 8.1 14.0 12.0 10.0 11.2 8.3 9.3 11.7 5.8 10.6 13.9 13.2 13.9 9.9 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 LAS1L FLJ12525 ENSG00000001497 "LAS1 like, ribosome biogenesis factor" Q9Y4W2 X 65512582-65534775 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Disease mutation, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044431, HPA061463" Supported Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA044431: AB_10965695, HPA061463: " "unprognostic (9.71e-2)" "unprognostic (1.62e-3)" "unprognostic (1.57e-1)" "unprognostic (1.47e-1)" "unprognostic (3.39e-2)" "unprognostic (2.38e-1)" "unprognostic (7.15e-3)" "unprognostic (2.83e-2)" "unprognostic (3.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.14e-1)" "unprognostic (5.06e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-1)" "unprognostic (1.17e-3)" "unprognostic (2.00e-3)" "unprognostic (1.53e-1)" 16.4 14.7 22.6 17.8 26.4 27.9 21.4 38.3 26.1 18.0 17.9 30.1 14.1 11.1 21.9 17.4 17.1 23.8 14.2 14.0 24.2 22.0 15.7 24.4 15.5 23.2 26.4 23.4 26.2 19.8 29.0 13.8 16.3 26.0 17.8 17.2 19.7 19.5 22.5 20.4 23.9 13.4 20.4 29.7 17.8 14.6 23.7 25.7 26.7 16.4 15.4 26.7 15.3 16.2 20.7 22.0 12.4 20.8 17.8 22.5 17.3 20.0 33.3 15.9 13.2 6.9 8.8 15.5 12.1 7.8 18.9 16.7 16.3 15.0 31.3 17.4 9.1 14.2 31.9 21.3 21.4 11.9 26.1 14.1 29.1 16.0 8.4 36.1 12.8 9.1 12.6 18.9 13.5 12.5 33.0 32.7 11.2 23.8 27.4 27.6 23.5 30.8 23.6 22.1 34.7 13.0 9.1 12.6 14.5 19.3 14.2 8.8 10.6 19.2 9.0 11.7 23.2 35.7 18.2 11.9 14.0 34.4 11.4 38.2 6.2 12.4 15.7 7.8 18.8 20.8 20.8 20.2 17.6 22.3 22.0 20.7 22.5 18.5 1.7 17.8 15.0 16.4 17.6 17.3 22.6 26.4 38.3 26.1 24.2 22.0 26.4 23.4 26.0 25.7 LASP1 "Lasp-1, MLN50" ENSG00000002834 "LIM and SH3 protein 1" Q14847 17 38869859-38921770 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 124.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012072, CAB022049" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" 26000000 "Plasma membrane, Cytosol" "Focal adhesion sites" "CAB022049: , HPA012072: AB_1852714" "unprognostic (1.23e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "prognostic unfavourable (4.57e-4)" "unprognostic (1.47e-1)" "unprognostic (3.03e-2)" "prognostic unfavourable (2.41e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-1)" "unprognostic (9.60e-2)" "unprognostic (9.87e-3)" "unprognostic (1.01e-1)" "unprognostic (9.65e-3)" "unprognostic (1.29e-3)" "unprognostic (3.95e-2)" "unprognostic (1.60e-3)" "unprognostic (4.53e-2)" 51.2 20.0 23.8 40.3 22.4 45.4 35.5 15.5 25.7 23.6 57.4 16.3 18.7 54.4 23.4 24.1 22.4 20.8 48.3 15.2 18.4 23.3 33.1 47.5 33.3 44.2 20.0 14.3 28.4 30.1 10.1 17.6 40.0 16.1 18.9 38.6 24.2 22.4 24.1 10.7 18.3 124.5 21.3 12.2 43.1 39.5 13.9 12.9 40.5 18.3 18.7 33.7 22.0 28.3 6.4 13.9 34.0 19.9 17.3 16.5 13.1 34.8 72.7 21.3 18.8 31.3 34.0 36.7 43.9 42.9 46.3 34.0 21.7 38.0 15.9 36.7 67.8 55.6 9.6 33.4 40.5 11.6 5.2 7.6 21.0 37.7 29.7 17.5 23.1 30.1 11.7 39.2 11.1 31.0 12.9 5.3 64.3 11.5 20.8 27.0 10.6 18.2 11.8 11.3 20.1 56.8 30.7 3.2 7.8 26.1 27.4 22.7 43.3 21.4 54.1 27.8 40.5 32.4 26.6 13.7 18.1 12.3 29.3 15.8 33.4 9.9 14.8 16.8 16.5 17.1 11.3 6.4 8.4 11.0 13.9 6.3 7.2 10.9 34.0 17.3 19.9 10.7 10.7 13.1 23.8 22.4 15.5 25.7 18.4 23.3 20.0 14.3 16.1 12.9 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Cell line enhanced" "Detected in some" "HEL: 30.3;HMC-1: 128.1;MOLT-4: 43.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.3 0.6 0.3 0.7 0.8 0.2 0.2 0.3 0.3 0.4 0.1 1.1 0.3 0.4 0.4 0.2 0.1 0.2 0.5 30.3 0.7 0.5 0.1 0.9 128.1 0.3 0.6 0.2 0.1 0.1 0.3 3.6 0.1 0.8 43.6 6.0 0.5 0.4 0.4 0.1 3.8 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.4 5.0 0.5 0.6 2.9 0.6 0.2 1.2 1.0 0.4 7.7 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718256 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 15.4 12.9 17.6 12.5 17.6 19.4 14.7 38.4 16.9 15.9 13.6 17.4 9.5 10.1 17.7 11.8 12.2 14.6 11.1 11.7 15.1 8.8 11.5 11.1 12.7 12.6 18.2 8.8 23.6 12.2 22.3 21.8 17.2 15.5 16.3 12.5 14.1 13.8 11.9 12.4 12.8 14.7 15.8 13.0 13.5 11.6 10.6 19.6 20.5 12.9 6.5 12.8 14.7 14.7 7.4 4.6 9.5 11.4 4.2 8.9 2.9 6.1 4.8 10.2 14.4 9.6 12.6 7.8 8.1 8.2 8.8 8.8 7.8 5.3 9.9 8.3 11.3 8.6 13.3 8.7 13.9 9.1 10.6 20.0 6.1 7.0 8.9 18.7 14.6 8.4 14.0 9.9 17.0 10.9 24.6 10.2 8.6 7.3 9.7 7.7 6.0 4.7 9.5 12.2 4.6 8.1 8.7 6.8 10.9 11.4 8.3 6.0 8.6 16.2 13.4 7.0 11.0 8.3 13.0 8.5 9.3 11.4 6.4 10.6 10.3 9.5 4.2 6.6 8.9 7.7 8.0 5.8 7.0 7.4 4.6 7.4 6.0 7.8 2.9 4.2 11.4 4.1 6.7 2.9 17.6 17.6 38.4 16.9 15.1 8.8 18.2 8.8 15.5 19.6 LATS2 ENSG00000150457 "Large tumor suppressor kinase 2" Q9NRM7 13 20973032-21061547 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039191, HPA049037" Approved Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA039191: , HPA049037: " "unprognostic (2.77e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (6.22e-3)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (1.84e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-3)" "unprognostic (4.48e-1)" "unprognostic (6.57e-3)" "unprognostic (8.03e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (1.66e-2)" "unprognostic (1.25e-1)" "unprognostic (7.97e-2)" "unprognostic (1.11e-2)" 22.9 13.0 3.0 8.6 5.7 12.8 33.0 7.9 3.7 16.6 14.0 6.8 9.3 2.9 21.2 12.7 15.1 11.0 20.6 14.1 5.4 2.6 12.4 11.0 19.8 10.9 5.2 2.4 17.4 10.2 5.0 3.5 18.3 6.3 13.7 4.5 16.7 8.0 11.1 23.0 9.3 7.4 34.6 7.5 15.2 10.4 27.8 5.2 1.4 17.2 13.8 7.0 20.3 28.0 0.1 1.5 3.3 1.9 1.3 3.1 0.5 3.3 3.7 8.3 5.0 9.8 12.9 7.6 11.2 11.7 11.8 10.1 10.6 5.1 0.0 5.5 17.1 4.9 4.9 5.1 17.5 1.9 1.2 6.2 4.7 7.9 15.3 1.6 2.2 19.1 9.4 7.7 5.2 16.4 1.1 0.2 14.8 5.8 0.1 5.8 2.0 1.8 1.4 14.8 0.0 8.4 1.6 0.1 0.0 8.8 5.8 11.6 5.0 3.2 20.6 12.5 8.4 9.1 7.1 1.5 0.8 0.0 3.0 1.9 9.5 0.4 1.9 1.8 1.6 1.5 3.1 0.1 0.2 0.5 1.5 0.0 0.1 0.3 3.3 1.3 0.6 0.1 0.0 0.5 3.0 5.7 7.9 3.7 5.4 2.6 5.2 2.4 6.3 5.2 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 3.7 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 31.7 12.1 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Group enriched" "Detected in some" 5 "HEK 293: 4.9;RH-30: 6.2;SCLC-21H: 13.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 20 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002016: , HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 13.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell line enhanced" "Detected in many" "CACO-2: 9.1;Hep G2: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA044257: " "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.7 1.3 0.0 0.1 1.7 1.4 6.4 0.3 0.2 0.4 0.4 9.1 5.6 0.2 1.5 0.7 1.5 0.0 0.2 0.0 7.8 1.7 4.0 0.5 18.9 1.3 0.2 2.6 1.8 1.4 1.4 0.3 1.6 2.6 2.0 0.3 1.9 0.1 0.8 0.4 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.0 2.3 0.3 8.3 0.2 0.3 3.6 1.4 6.0 7.3 0.1 2.5 1.9 0.2 1.4 0.7 4.2 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell line enhanced" "Detected in many" "MCF7: 6.7;T-47d: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: " "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.1 1.5 1.3 0.2 0.4 0.8 0.9 0.1 1.0 1.9 1.2 1.5 1.6 0.4 0.1 1.0 0.6 0.6 1.5 0.9 1.8 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.3 0.6 3.1 1.2 1.1 6.7 0.6 0.7 6.0 1.8 0.4 0.3 1.2 3.2 0.6 2.1 0.9 3.8 1.6 2.4 7.2 0.3 0.1 0.5 0.4 1.8 0.5 3.6 1.9 0.4 2.7 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 LCLAT1 "AGPAT8, ALCAT1, FLJ37965, LYCAT" ENSG00000172954 "Lysocardiolipin acyltransferase 1" Q6UWP7 2 30447226-30644225 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031880, HPA049217" Uncertain Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA031880: AB_10610002, HPA049217: " "unprognostic (6.60e-2)" "unprognostic (2.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.52e-3)" "unprognostic (4.10e-1)" "prognostic unfavourable (9.67e-4)" "prognostic unfavourable (8.72e-4)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-2)" "unprognostic (7.11e-3)" "unprognostic (2.85e-2)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (3.93e-3)" "unprognostic (1.10e-1)" 7.7 9.7 7.0 13.7 8.7 12.3 7.1 10.2 10.1 11.6 10.7 5.2 12.6 15.7 18.7 15.0 13.0 9.9 12.6 21.7 7.5 9.2 15.2 13.8 10.0 12.5 6.1 6.0 15.4 16.7 10.8 21.8 5.7 7.0 10.7 10.6 9.7 9.5 16.3 10.9 9.4 25.0 11.3 5.5 8.0 8.4 12.1 4.2 20.7 17.9 11.9 11.7 9.1 10.4 9.6 2.8 10.5 3.9 4.1 12.6 2.8 10.9 14.6 7.9 13.3 1.8 4.2 11.2 8.0 7.9 8.5 7.2 14.6 13.0 7.1 7.4 12.3 12.5 26.0 10.7 8.4 8.9 8.9 13.0 9.1 14.1 8.4 18.4 10.0 3.2 8.5 9.0 12.5 5.9 11.9 6.8 6.5 8.5 10.5 10.9 8.6 8.4 10.3 15.8 14.5 6.7 16.2 9.2 14.2 17.8 11.9 10.3 8.6 6.3 6.7 15.5 12.8 8.2 12.5 4.9 10.2 16.0 15.8 13.5 11.8 10.5 2.5 4.8 5.6 3.9 6.6 7.5 8.7 7.1 2.8 9.6 12.6 12.1 7.4 4.1 3.5 2.2 4.0 2.8 7.0 8.7 10.2 10.1 7.5 9.2 6.1 6.0 7.0 4.2 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111729-25178231 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041559: , HPA043530: " "unprognostic (9.08e-2)" "prognostic favourable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favourable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 9.8 18.0 27.9 11.6 30.6 13.9 18.1 27.5 36.4 15.4 17.1 15.5 17.5 13.1 16.2 26.7 13.4 16.8 14.1 25.3 22.8 27.5 17.8 7.5 10.8 11.9 21.7 26.7 23.8 31.4 25.3 20.5 18.9 24.8 15.7 17.2 15.0 14.4 18.3 31.6 16.5 12.7 15.1 18.9 10.1 12.6 29.8 14.4 16.9 15.5 14.3 15.3 11.7 12.1 19.7 17.6 21.6 18.9 15.8 38.9 19.5 16.8 15.9 14.9 20.5 13.4 19.6 15.3 10.6 17.5 15.5 20.4 20.1 15.5 10.3 15.2 16.0 8.7 15.4 14.5 21.0 10.5 23.4 5.5 16.2 32.5 30.5 13.3 9.2 22.1 16.1 17.6 18.4 14.1 8.8 13.6 17.0 43.1 15.8 25.5 22.7 16.5 18.8 13.6 20.0 17.5 11.9 24.3 15.1 12.6 19.6 24.1 19.9 6.1 8.3 15.4 10.8 10.0 10.4 17.7 17.9 10.9 18.9 11.6 11.3 12.7 18.9 21.6 20.6 16.7 22.6 19.7 25.6 22.3 17.6 14.3 23.1 21.1 7.4 15.8 17.5 9.1 38.9 19.5 27.9 30.6 27.5 36.4 22.8 27.5 21.7 26.7 24.8 14.4 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330605 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039401, HPA048176" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA039401: AB_10805478, HPA048176: " "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favourable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 7.9 10.9 6.5 8.3 8.1 2.5 25.9 11.4 10.1 10.8 7.4 7.2 10.6 5.2 10.3 12.7 11.0 10.2 6.7 8.4 6.7 8.4 11.9 9.2 6.2 9.9 6.1 7.6 13.0 8.2 13.7 10.1 6.4 9.6 10.2 7.5 8.9 10.3 13.8 7.9 6.2 8.4 8.6 4.8 9.6 8.7 7.1 9.6 12.2 9.8 11.2 13.9 7.4 9.6 6.3 6.9 5.5 4.0 3.3 10.5 5.0 6.0 4.8 11.3 9.8 12.1 3.7 5.5 7.4 8.9 9.7 10.7 7.1 2.8 5.1 15.2 8.4 14.3 0.0 9.8 7.4 7.9 5.2 9.2 12.9 4.1 7.4 0.0 6.9 5.8 9.5 7.2 6.6 3.1 11.6 6.9 11.6 9.4 10.3 4.3 4.9 4.0 12.2 10.0 5.0 16.9 6.9 15.2 12.9 9.8 8.3 4.2 10.1 14.1 2.6 11.4 5.2 13.0 12.0 4.7 11.0 2.1 7.1 7.6 11.8 2.4 4.0 5.5 4.0 3.8 5.5 5.0 6.7 4.8 6.9 6.3 10.5 6.8 1.3 3.3 3.5 3.9 5.3 5.0 6.5 8.1 11.4 10.1 6.7 8.4 6.1 7.6 9.6 9.6 LCORL "FLJ30696, MLR1" ENSG00000178177 "Ligand dependent nuclear receptor corepressor like" Q8N3X6 4 17841199-18021876 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028794, HPA028795, HPA060033" Uncertain Supported "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" Nucleoplasm "Nuclear membrane" "HPA028794: AB_10600664, HPA028795: AB_10600882, HPA060033: " "unprognostic (1.06e-1)" "unprognostic (4.95e-2)" "prognostic favourable (9.65e-4)" "unprognostic (3.22e-3)" "unprognostic (3.62e-2)" "unprognostic (2.54e-4)" "unprognostic (8.90e-4)" "unprognostic (3.46e-1)" "unprognostic (3.52e-2)" "unprognostic (7.59e-2)" "unprognostic (2.10e-1)" "unprognostic (1.22e-1)" "unprognostic (7.39e-2)" "unprognostic (1.70e-2)" "unprognostic (6.06e-2)" "unprognostic (1.32e-1)" "unprognostic (7.27e-4)" 8.3 7.8 11.3 5.7 11.9 5.1 6.6 21.9 10.4 7.0 9.2 6.9 4.7 14.2 6.3 5.1 7.3 4.6 7.1 3.9 10.3 9.8 9.6 7.2 7.5 8.0 14.8 6.5 7.6 6.4 8.4 11.3 8.7 8.9 5.9 8.8 5.0 7.0 5.3 7.9 8.6 22.3 5.8 16.2 12.6 9.1 12.2 15.3 17.1 8.1 2.7 5.7 6.5 5.4 4.4 3.8 8.2 4.6 2.4 3.2 1.5 4.7 3.2 12.7 4.0 6.8 10.6 3.2 5.9 5.8 5.1 6.7 1.6 6.4 9.2 3.1 3.9 2.1 6.1 2.5 7.2 2.6 3.9 7.4 5.6 3.8 4.4 5.9 6.0 5.8 2.9 3.5 7.2 6.8 4.4 14.7 6.9 1.3 5.7 12.1 4.4 4.6 5.7 7.9 5.1 8.3 2.6 9.5 9.1 4.2 2.1 4.1 3.8 5.7 4.6 8.1 4.0 5.0 9.3 12.0 4.6 7.8 6.6 7.9 6.4 8.2 4.5 4.9 2.9 4.6 2.4 4.4 2.0 1.8 3.8 3.0 2.3 2.7 2.2 2.4 3.6 2.6 3.2 1.5 11.3 11.9 21.9 10.4 10.3 9.8 14.8 6.5 8.9 15.3 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 188.6;lymphoid tissue: 118.2" "Cell line enhanced" "Detected in many" "Daudi: 82.6;HDLM-2: 75.5;HL-60: 80.2;HMC-1: 85.1;THP-1: 74.8;U-698: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" 2200000000 "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 57.1 10.0 5.6 44.3 9.4 71.2 8.7 3.9 4.6 3.6 6.2 4.5 5.0 4.5 5.3 43.1 6.2 8.3 8.9 5.5 4.3 3.8 7.2 12.2 33.7 59.1 12.0 1.0 5.7 3.9 0.1 2.8 24.7 7.7 21.5 8.1 5.5 9.5 2.5 3.5 6.8 21.7 6.5 11.9 112.9 6.1 8.2 9.2 118.2 4.5 4.1 68.7 14.0 7.1 25.4 79.3 133.5 127.6 43.2 67.2 188.6 3.3 0.0 0.1 0.0 0.0 0.0 40.1 0.0 0.1 0.3 0.2 22.1 0.1 82.6 17.6 0.0 0.1 0.0 0.0 0.3 75.5 19.6 17.8 0.0 0.0 0.0 80.2 85.1 0.2 0.0 0.1 0.1 0.0 9.3 55.0 0.0 0.1 56.8 55.5 0.0 0.8 42.3 0.1 59.0 0.0 22.8 0.1 0.7 0.1 8.8 0.6 0.4 74.8 0.2 2.1 1.3 0.1 2.4 13.1 27.3 106.3 1.6 48.9 0.3 57.1 96.6 54.3 67.2 127.6 60.8 25.4 40.4 55.5 79.3 18.3 25.2 42.3 133.5 43.2 118.1 20.8 40.5 188.6 5.6 9.4 3.9 4.6 4.3 3.8 12.0 1.0 7.7 9.2 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;NTERA-2: 5.9;U-2 OS: 16.6;U-251 MG: 7.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" "Plasma membrane" "Endoplasmic reticulum" "HPA071640: " "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.1 0.4 0.4 0.4 0.5 6.4 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.6 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.1 0.3 0.4 5.9 0.1 0.2 3.5 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 0.4 0.5 0.4 1.7 16.6 0.6 7.0 0.2 0.2 0.2 2.2 0.7 3.0 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 LDAH "C2orf43, FLJ21820" ENSG00000118961 "Lipid droplet associated hydrolase" Q9H6V9 2 20684014-20823130 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034729, HPA034730" Approved Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA034729: AB_10603684, HPA034730: " "unprognostic (1.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" "unprognostic (2.21e-2)" "unprognostic (6.34e-2)" "prognostic unfavourable (6.09e-6)" "unprognostic (3.57e-2)" "unprognostic (1.36e-1)" "unprognostic (1.27e-2)" "unprognostic (6.45e-2)" "unprognostic (2.44e-1)" "prognostic favourable (1.18e-4)" "unprognostic (1.05e-1)" "unprognostic (2.31e-1)" "unprognostic (2.22e-1)" "unprognostic (3.97e-2)" 10.4 23.6 8.7 13.3 18.7 4.9 10.6 3.1 11.7 10.5 12.5 8.2 8.8 9.9 12.7 13.2 10.4 7.6 8.4 6.9 7.7 8.6 20.3 14.8 8.1 12.3 7.9 8.3 10.8 10.0 15.1 22.4 15.4 9.6 9.6 14.5 10.4 10.8 9.9 2.0 8.8 9.9 11.4 9.7 17.2 10.3 10.0 8.5 22.9 9.4 4.6 15.4 13.6 10.0 9.8 6.5 1.1 5.8 6.0 8.5 4.2 10.0 10.6 23.8 0.0 10.2 14.2 14.9 8.7 6.2 8.1 6.0 10.0 6.4 13.1 0.0 6.7 8.5 18.5 7.4 8.6 15.1 8.7 18.5 8.5 16.8 9.9 14.1 4.8 11.7 11.3 7.2 1.9 15.5 25.2 9.6 14.2 6.5 20.6 10.8 14.9 0.0 16.3 19.1 14.8 16.6 14.4 13.2 20.7 5.9 10.8 10.0 8.4 10.5 13.3 7.1 3.6 8.6 5.6 11.8 20.9 5.8 13.1 14.6 12.5 1.1 3.5 0.3 8.5 5.8 5.2 9.8 8.3 6.9 6.5 6.6 7.5 7.3 0.3 6.0 4.5 6.3 6.4 4.2 8.7 18.7 3.1 11.7 7.7 8.6 7.9 8.3 9.6 8.5 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.5;fHDF/TERT166: 9.6;HAP1: 17.6;HUVEC TERT2: 33.3;U-138 MG: 13.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: " "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.5 0.0 5.5 9.1 0.0 5.2 4.0 0.6 1.4 0.0 0.0 0.0 0.0 9.6 0.0 17.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.1 0.0 6.5 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 13.4 0.0 0.6 0.0 4.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell line enhanced" "Detected in some" "HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: " "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.3 0.4 3.2 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.3 0.6 0.0 0.4 0.2 0.0 0.1 0.9 0.8 0.7 0.9 0.1 0.1 0.1 1.7 6.0 0.5 0.1 0.0 0.0 0.3 1.9 0.3 1.6 0.4 0.2 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.7 1.8 0.3 0.2 4.7 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.8 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394388-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 249.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol 300000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavourable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavourable (3.26e-8)" "prognostic unfavourable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavourable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavourable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 84.2 56.4 24.5 52.6 32.5 64.0 56.0 22.3 40.2 38.1 53.5 13.5 9.1 60.5 24.9 36.2 77.7 29.0 31.6 59.4 24.4 33.0 100.1 249.1 37.1 59.4 29.7 25.7 49.7 34.1 10.5 16.4 49.7 44.3 33.3 51.2 45.9 46.3 37.0 199.6 70.2 128.3 50.7 35.5 45.0 31.2 25.9 23.9 45.0 56.4 90.6 60.1 81.9 44.8 27.6 76.5 29.1 61.2 32.8 52.2 72.1 131.7 82.0 3.1 46.2 72.2 49.3 44.0 127.5 135.5 112.0 166.7 36.6 21.7 99.7 41.9 128.8 106.6 82.0 195.4 242.9 34.0 48.5 34.5 74.9 62.8 17.8 85.1 25.9 49.2 90.1 44.0 44.1 66.1 48.6 48.0 131.1 34.9 70.0 53.9 19.8 102.6 45.4 32.7 83.5 178.0 30.6 24.6 30.4 69.1 57.0 23.6 26.8 20.3 59.5 140.3 50.9 122.1 1.5 38.2 55.9 95.9 200.8 44.1 47.2 28.9 53.1 29.1 38.1 61.2 42.6 27.6 50.2 40.1 76.5 19.2 32.8 33.3 18.1 32.8 59.5 25.8 52.2 72.1 24.5 32.5 22.3 40.2 24.4 33.0 29.7 25.7 44.3 23.9 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.6;Hep G2: 14.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA052489: " "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favourable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.6 0.0 1.8 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.8 14.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.3 0.0 0.1 1.0 0.0 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1, regulator of NFKB signaling" O95751 X 141175745-141177125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 29.2;MCF7: 39.3;PC-3: 49.3;U-251 MG: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.2" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 21.5" "Low region specificity" "Detected in all" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051768: , HPA061842: " "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 21.1 24.2 24.4 5.9 31.8 2.0 9.9 18.3 51.2 24.2 5.5 21.0 11.0 5.1 17.3 12.1 10.0 30.3 10.4 6.7 27.3 25.6 15.6 3.1 9.7 5.5 23.2 23.3 31.8 18.3 13.0 54.9 1.8 30.2 23.1 3.5 13.5 47.9 36.4 3.8 17.9 5.2 12.5 19.5 9.3 7.8 6.6 16.6 1.8 22.6 3.7 5.7 11.2 9.9 8.2 4.8 8.2 0.0 19.2 8.9 3.0 0.0 29.2 4.5 12.5 7.9 9.6 0.0 7.0 8.7 9.5 13.4 0.0 11.5 0.0 5.5 11.4 13.7 4.9 10.2 6.8 0.0 9.1 0.0 15.8 0.0 3.0 0.0 2.7 16.9 5.3 8.2 4.4 8.1 0.2 0.0 8.5 39.3 0.0 0.0 4.7 49.3 0.0 4.1 0.0 11.7 6.9 0.0 3.9 0.0 6.1 0.0 7.8 0.0 14.5 0.0 9.5 0.0 29.3 0.0 0.0 0.0 4.9 0.0 0.0 8.2 0.0 0.1 4.3 0.0 3.1 3.3 8.9 3.3 0.8 8.2 7.9 5.1 0.2 19.2 0.0 4.8 8.1 3.0 24.4 31.8 18.3 47.4 27.3 25.6 23.2 23.3 30.2 16.6 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Cell line enhanced" "Detected in many" "A-431: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.5 2.7 0.1 1.6 1.1 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 1.9 1.1 2.5 0.0 0.5 2.6 1.2 0.6 2.5 0.4 0.0 0.0 2.1 0.5 3.1 1.6 0.5 1.9 0.6 1.5 1.6 2.4 2.4 0.0 1.9 2.1 1.5 0.0 1.7 1.5 2.1 0.6 4.1 1.7 2.1 1.5 0.1 4.5 3.6 0.0 0.4 0.7 0.5 1.0 6.1 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.26e-4)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 5.6;HaCaT: 8.1;HDLM-2: 5.0;HSkMC: 3.8;LHCN-M2: 4.7;U-87 MG: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favourable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favourable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 9.6 8.0 8.2 8.0 11.1 6.1 7.3 10.1 9.5 7.5 10.8 11.5 10.8 7.6 13.4 8.7 6.1 11.9 9.6 12.7 8.2 7.9 7.6 7.2 8.9 6.3 11.2 7.6 10.3 9.7 7.3 8.5 7.3 10.3 9.3 10.7 6.6 21.6 10.4 13.1 9.9 14.8 7.5 10.8 21.8 8.8 12.3 13.1 10.1 10.8 7.6 6.8 8.2 15.8 3.8 3.2 4.1 3.3 2.8 3.8 0.8 0.1 0.4 5.6 0.2 0.5 0.2 0.4 0.8 0.1 0.5 0.3 0.2 0.0 0.0 0.2 0.0 8.1 0.3 0.2 0.2 5.0 1.2 0.0 0.5 0.1 0.0 0.0 0.5 3.8 0.6 0.2 0.4 0.1 0.1 0.0 4.7 0.6 0.4 0.5 0.0 0.5 0.0 0.1 0.7 0.5 0.5 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.7 0.4 0.4 0.2 0.4 0.1 0.2 0.0 5.5 0.1 2.6 1.0 2.7 4.1 2.5 3.3 2.8 1.6 3.7 3.8 2.2 3.8 3.7 2.9 3.7 2.8 1.6 3.2 2.7 0.8 8.2 11.1 10.1 9.5 8.2 7.9 11.2 7.6 10.3 13.1 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971806 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.7 15.2 15.0 15.3 27.9 8.3 17.0 42.6 24.4 13.4 17.8 14.1 9.7 13.9 12.6 11.2 24.4 9.7 14.2 10.6 14.0 14.0 21.4 27.8 10.2 17.2 14.8 14.9 10.6 10.3 25.2 22.4 12.7 22.7 13.8 21.0 9.1 21.2 12.5 13.5 21.8 19.8 12.6 15.3 14.3 13.9 9.8 18.5 23.4 12.0 9.4 18.2 16.9 15.7 12.3 15.3 9.6 15.3 18.9 19.7 10.0 9.5 22.3 14.4 11.6 14.9 12.9 10.3 15.6 12.9 13.4 12.3 15.4 6.3 19.4 9.1 15.9 18.7 19.1 13.9 13.0 12.8 8.6 30.5 18.2 27.0 11.8 27.4 42.6 13.9 10.9 10.4 13.6 13.0 18.4 10.7 15.9 40.6 14.5 20.9 6.2 9.6 16.3 25.0 20.3 11.8 26.8 10.2 15.6 11.9 18.3 12.1 15.2 25.0 15.5 13.3 9.2 12.2 18.5 8.4 26.1 17.8 11.7 39.3 14.1 5.4 9.4 9.6 18.7 14.6 17.5 12.3 18.7 15.2 15.3 10.1 19.5 17.5 2.3 18.9 15.3 11.5 19.7 10.0 15.0 27.9 42.6 24.4 14.0 14.0 14.8 14.9 22.7 18.5 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.6 2.5 1.9 1.7 1.5 4.2 1.4 4.6 5.5 6.6 4.0 1.0 5.4 1.7 10.8 1.0 1.5 3.8 16.5 6.9 0.8 1.5 2.0 1.9 2.4 1.8 0.3 1.9 1.2 4.6 7.0 15.0 6.9 1.7 2.7 5.8 2.8 4.9 1.2 0.4 11.6 1.7 3.1 1.0 10.8 0.6 1.6 1.5 1.5 0.3 0.5 1.6 0.8 11.8 2.0 14.6 3.7 1.1 1.7 1.0 1.3 3.2 2.1 1.5 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: " "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favourable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favourable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.5 5.1 7.7 12.8 8.2 9.2 16.2 15.4 19.7 9.6 8.3 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 8.2 14.7 14.3 11.1 11.6 8.9 12.3 3.4 18.3 7.6 6.1 10.7 10.2 11.4 15.1 6.9 5.8 13.1 17.6 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786167 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 1.0;HDLM-2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675608-37679806 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" 19000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favourable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavourable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavourable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavourable (5.10e-4)" 167.5 49.3 23.0 56.0 22.9 29.8 213.7 7.6 30.9 158.6 94.5 20.1 44.2 22.0 150.9 80.3 74.0 66.8 78.8 108.6 18.9 29.3 24.0 20.8 55.8 45.4 41.4 28.9 105.1 18.2 5.1 17.5 80.1 53.6 85.9 23.4 35.7 34.9 89.6 117.1 29.2 29.2 145.8 88.3 40.3 40.0 42.4 20.5 16.7 19.6 59.1 20.4 99.8 81.7 29.0 185.2 44.0 149.1 19.6 73.1 180.2 93.4 55.1 1.2 49.0 114.7 225.4 1.1 217.4 255.3 161.1 160.6 6.1 12.4 0.1 22.4 219.6 10.0 1.9 143.0 56.3 96.0 1.0 8.2 57.9 25.3 74.9 4.7 109.7 139.5 9.7 128.5 55.0 176.9 5.9 39.6 124.6 41.7 0.1 66.6 0.4 131.0 0.1 82.1 25.7 66.3 0.2 0.1 29.0 43.4 7.6 54.3 40.4 56.3 239.1 215.3 107.7 95.5 111.0 24.3 16.2 0.3 252.9 24.9 85.7 44.0 149.1 5.3 40.8 114.2 6.1 29.0 38.0 39.8 185.2 10.8 6.6 26.8 6.3 19.6 120.0 45.7 73.1 180.2 23.0 22.9 7.6 30.9 18.9 29.3 41.4 28.9 53.6 20.5 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Group enriched" "Detected in some" 13 "CACO-2: 45.9;Hep G2: 25.8" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 45.9 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 25.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.7 0.7 2.7 0.9 0.4 1.8 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 LGALS3 "GALIG, LGALS2, MAC-2" ENSG00000131981 "Galectin 3" P17931 14 55124110-55145413 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing" "IgE-binding protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 93.8;CAPAN-2: 74.5;SK-MEL-30: 175.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9" "Group enriched" "Detected in all" 12 "dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003162, CAB005191" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 2300000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005191: AB_2136784, HPA003162: AB_1078937" "unprognostic (1.42e-1)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" "unprognostic (3.15e-1)" "unprognostic (2.46e-2)" "unprognostic (3.34e-2)" "unprognostic (1.73e-3)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.08e-3)" "unprognostic (5.97e-2)" "unprognostic (8.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.96e-2)" "unprognostic (2.65e-3)" "unprognostic (7.60e-3)" 95.7 11.0 10.4 50.9 13.6 29.8 53.2 6.5 11.7 54.1 127.1 6.1 42.4 75.7 50.3 30.7 76.1 26.1 83.9 42.3 8.4 5.7 19.9 3.9 65.5 16.6 8.5 9.4 58.9 24.2 0.5 11.0 78.7 5.5 51.7 93.7 25.7 78.3 51.7 31.3 76.1 182.4 48.2 8.7 11.1 36.9 20.4 5.7 5.5 18.0 65.7 41.7 41.1 44.4 1.3 41.7 3.6 67.4 2.5 25.9 37.2 22.4 7.2 0.2 0.1 46.8 93.8 27.4 18.0 37.9 5.0 8.9 15.5 74.5 0.0 9.5 20.9 22.5 0.4 18.8 2.8 26.6 0.3 0.0 8.0 7.1 35.5 0.0 0.0 29.3 28.7 5.7 12.1 7.8 0.1 21.7 11.3 15.1 0.0 5.4 0.4 20.2 0.0 0.9 1.6 46.8 30.0 0.6 1.7 42.1 0.0 175.1 18.5 2.4 14.2 23.7 3.3 8.8 0.3 12.1 38.3 0.1 34.1 1.4 2.5 1.7 67.4 3.4 1.8 55.4 11.4 1.3 6.8 5.1 41.7 0.4 0.3 1.0 3.6 2.5 44.2 1.1 25.9 37.2 10.4 13.6 6.5 11.7 8.4 5.7 8.5 9.4 5.5 5.7 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748702 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "RPMI-8226: 127.6;U-266/70: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 11 "dendritic cells: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" 1200000 Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favourable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 42.9 16.3 8.6 17.4 10.7 3.5 19.9 5.8 17.9 13.3 22.3 11.7 13.9 24.2 12.1 48.1 17.4 14.1 32.7 38.8 10.3 10.1 87.6 44.6 31.5 42.4 8.3 10.1 20.5 14.6 54.4 9.7 113.6 9.9 22.0 24.5 23.2 22.6 8.4 17.3 11.9 37.1 23.3 11.5 58.3 23.7 14.0 7.9 17.2 36.8 19.2 17.3 31.4 18.2 4.7 54.2 0.7 0.8 1.0 4.3 1.7 4.8 7.0 4.7 8.6 14.6 11.8 16.4 10.5 10.0 10.9 12.9 5.4 8.7 2.7 15.5 17.1 12.1 0.0 9.0 5.2 0.2 5.4 0.1 3.9 6.2 4.3 0.1 0.4 8.3 4.4 10.5 6.0 12.9 1.0 22.6 0.7 6.5 1.2 0.2 2.3 4.8 1.2 4.1 127.6 11.8 19.0 5.1 3.5 14.5 8.9 7.5 6.6 0.0 7.0 5.4 6.9 9.7 3.1 70.2 8.2 3.6 3.0 0.1 10.3 0.7 0.4 0.1 0.2 0.8 0.4 4.7 1.4 0.4 5.0 3.4 4.3 2.5 0.5 1.0 0.2 54.2 2.6 1.7 8.6 10.7 5.8 17.9 10.3 10.1 8.3 10.1 9.9 7.9 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell line enhanced" "Detected in some" "A549: 16.3;CAPAN-2: 14.5;HaCaT: 7.8;HeLa: 3.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 1.6 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell line enhanced" "Detected in some" "A549: 10.4;BEWO: 5.5;CACO-2: 3.3;HeLa: 3.8;Karpas-707: 2.6" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.4 0.1 0.1 0.0 0.0 5.5 0.1 0.1 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0;plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 7 "dendritic cells: 7.9;granulocytes: 8.0;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042402 Uncertain Approved "Vesicles,Actin filaments" 110000 "Actin filaments" Vesicles "HPA042402: AB_10794276" "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 17.1 18.2 10.3 16.1 11.7 11.5 34.7 3.5 9.1 15.8 15.4 12.0 14.1 17.6 14.6 15.0 7.6 10.7 17.6 14.1 11.7 7.6 3.8 4.7 17.2 10.3 15.2 7.2 18.7 18.0 9.2 7.3 11.3 12.9 13.3 13.5 18.2 21.4 20.5 4.6 6.7 27.1 16.6 18.0 4.7 10.8 10.9 13.1 5.7 10.3 4.9 10.4 15.4 18.2 0.9 7.9 8.0 4.7 0.0 0.1 1.5 3.5 13.1 4.0 5.2 24.3 7.0 12.3 4.0 10.4 7.1 12.4 4.6 10.5 8.8 1.8 7.9 6.1 3.8 4.3 11.7 0.1 3.4 8.8 2.7 7.8 18.0 0.0 0.0 7.9 17.6 21.6 33.7 16.6 0.0 6.6 16.0 1.8 0.0 0.5 4.4 3.8 1.7 5.6 2.4 2.6 15.6 0.7 5.4 6.6 2.4 22.5 1.4 1.1 10.9 8.2 4.5 22.6 12.0 0.2 0.0 12.7 21.9 0.0 14.7 8.0 4.7 4.8 0.0 1.8 0.1 0.9 0.0 0.0 1.1 0.9 0.0 0.0 1.0 0.0 0.6 7.9 0.1 1.5 10.3 11.7 3.5 9.1 11.7 7.6 15.2 7.2 12.9 13.1 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Cell line enhanced" "Detected in some" "NTERA-2: 4.6;SCLC-21H: 10.7;SH-SY5Y: 13.4;U-266/84: 11.2;WM-115: 4.1" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.0 11.2 0.0 0.5 0.0 4.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.7 7.3 3.0 7.5 11.6 9.5 7.9 5.4 11.1 3.4 6.3 1.3 13.7 14.6 12.6 8.1 16.0 0.9 2.8 3.6 3.2 10.5 10.6 2.3 6.7 11.8 2.1 17.3 7.0 12.5 3.4 8.2 5.4 5.2 5.8 4.2 14.6 7.0 6.8 5.3 4.1 7.5 3.3 18.6 7.4 1.9 1.6 9.0 3.8 13.9 4.9 10.5 0.3 2.5 5.3 7.9 4.4 1.4 4.9 1.5 4.7 4.9 4.1 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell line enhanced" "Detected in some" "HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: , HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.5;K-562: 8.3;NB-4: 15.7;PC-3: 10.9;U-87 MG: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7" "Group enriched" "Detected in many" 7 "amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: , HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 14.4 1.2 7.3 4.2 11.5 0.5 10.6 0.4 17.4 3.6 3.0 0.9 0.9 2.6 3.8 2.5 4.1 2.6 6.1 6.4 12.3 3.5 1.9 0.9 5.2 2.2 2.0 12.4 2.1 1.1 2.3 0.3 6.0 1.1 2.4 3.2 1.4 2.3 2.3 4.3 2.5 3.1 7.4 1.5 0.6 2.3 7.8 2.2 0.0 3.2 4.6 2.5 5.3 7.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 2.3 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 11.5 2.9 0.0 2.6 0.0 0.0 1.2 3.2 0.0 0.0 1.9 0.1 0.8 0.5 0.0 2.1 0.6 0.0 0.8 0.0 0.2 4.2 8.3 0.0 0.0 2.4 0.0 15.7 2.5 10.9 0.0 5.5 0.0 1.9 0.0 1.7 0.4 2.9 0.9 3.0 2.4 0.0 0.7 0.8 1.2 0.0 0.2 0.3 0.1 0.2 8.7 3.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 11.5 0.4 17.4 12.3 3.5 2.0 12.4 1.1 2.2 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.3;U-266/70: 7.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA071806: " "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 7.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39458587-39485109 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favourable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 9.8 12.9 9.9 7.0 12.7 10.2 11.3 10.2 13.3 7.0 10.7 12.9 8.1 10.4 9.1 10.7 11.6 11.9 7.4 14.0 10.6 10.6 15.7 15.5 5.7 9.0 12.3 10.5 19.2 12.4 10.0 11.5 6.8 15.7 8.2 12.4 9.0 7.8 7.0 42.7 8.8 9.9 13.6 12.4 8.9 9.9 20.1 13.2 8.7 8.8 13.5 8.3 10.0 7.9 9.6 5.8 3.7 7.1 6.9 16.7 4.3 3.9 3.0 4.0 3.7 8.3 8.1 3.4 4.6 2.5 4.3 2.9 5.0 5.5 14.4 5.3 1.7 3.5 11.1 6.3 5.7 1.6 2.8 6.0 1.6 5.0 7.6 13.1 3.9 7.8 10.4 5.0 16.0 4.9 14.3 3.6 5.2 2.5 7.3 16.8 5.2 10.0 6.4 10.7 8.7 5.1 2.1 4.3 3.7 2.6 3.5 14.8 3.9 6.0 1.8 3.4 7.6 4.5 10.6 7.0 10.6 10.1 5.3 15.3 2.9 2.0 6.2 3.7 6.1 7.1 12.6 9.6 8.3 8.0 5.8 8.5 16.7 11.5 3.3 6.9 5.1 5.4 5.2 4.3 9.9 12.7 10.2 13.3 10.6 10.6 12.3 10.5 15.7 13.2 LIFR CD118 ENSG00000113594 "LIF receptor alpha" P42702 5 38474963-38608354 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 39.8;HHSteC: 17.0;SCLC-21H: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004478, CAB010252" Approved "Nuclear speckles,Golgi apparatus" "Intracellular and membrane" 74000 "Nuclear speckles" "Golgi apparatus" "CAB010252: AB_2128043, HPA004478: " "unprognostic (6.00e-3)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-3)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (1.11e-1)" "prognostic favourable (1.92e-4)" "unprognostic (1.78e-1)" "unprognostic (9.80e-2)" "unprognostic (2.73e-3)" "unprognostic (1.06e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" "unprognostic (1.65e-1)" 35.3 14.7 15.8 8.2 19.2 0.5 33.9 10.1 21.3 27.7 10.4 25.3 22.8 4.9 34.8 14.8 10.4 26.0 10.2 16.3 19.1 11.0 20.3 23.9 21.7 20.2 24.3 11.8 17.9 17.8 13.5 12.5 41.5 23.4 23.6 7.5 17.1 24.9 24.7 24.0 10.5 11.7 26.9 21.4 22.5 18.8 9.3 25.3 4.7 31.4 7.3 8.1 13.6 15.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.2 39.8 3.0 11.2 12.4 0.3 3.3 1.9 2.7 1.6 0.4 2.1 0.0 0.5 4.7 0.3 2.6 0.9 4.6 0.0 3.6 0.0 4.2 1.5 17.0 0.0 0.2 10.4 0.7 6.5 0.7 3.7 1.0 6.4 3.3 0.5 0.0 0.1 1.0 7.1 0.0 8.4 0.0 2.6 1.0 26.1 3.2 13.7 0.6 0.0 0.9 0.0 0.7 4.3 8.5 10.1 2.0 0.0 0.0 0.0 7.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 19.2 10.1 21.3 19.1 11.0 24.3 11.8 23.4 25.3 LIG1 ENSG00000105486 "DNA ligase 1" P18858 19 48115445-48170603 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037015, HPA041431, HPA048071" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB037015: , HPA041431: , HPA048071: " "unprognostic (1.83e-1)" "unprognostic (1.48e-3)" "unprognostic (6.45e-2)" "unprognostic (9.76e-2)" "unprognostic (9.47e-2)" "unprognostic (9.24e-3)" "unprognostic (1.17e-3)" "unprognostic (2.28e-1)" "unprognostic (6.03e-3)" "unprognostic (4.26e-1)" "unprognostic (1.78e-2)" "unprognostic (1.10e-3)" "prognostic unfavourable (5.75e-5)" "unprognostic (3.59e-2)" "unprognostic (4.09e-2)" "unprognostic (1.59e-2)" "unprognostic (1.55e-2)" 4.1 5.6 8.1 25.2 10.4 37.8 6.4 17.2 10.6 6.5 9.2 6.5 8.7 12.0 6.8 6.1 11.0 7.8 6.9 2.6 6.3 5.3 6.0 6.2 5.9 18.6 7.7 7.4 10.8 10.3 9.1 9.7 11.7 8.1 7.5 6.0 4.6 7.2 7.9 6.1 12.5 12.8 3.6 7.1 11.2 6.7 15.1 11.5 34.7 10.7 12.1 16.9 6.6 8.6 10.4 1.3 2.0 5.6 10.9 11.5 4.8 15.7 20.3 21.7 14.0 0.9 1.1 15.7 9.1 6.8 14.8 16.3 11.5 15.5 28.5 5.6 3.8 10.6 8.9 9.0 6.4 15.4 15.4 17.6 14.3 14.8 0.3 21.8 14.6 2.0 0.7 7.9 1.2 7.9 14.9 10.7 7.4 12.6 34.9 32.5 12.3 4.7 30.1 17.0 14.1 4.5 24.1 13.8 13.7 11.0 12.9 3.1 8.3 16.8 7.7 11.8 19.9 9.9 14.2 10.6 16.7 29.0 4.8 12.3 13.0 0.0 1.4 2.0 7.6 5.6 6.8 10.3 8.4 7.6 1.3 10.4 11.5 8.0 1.1 10.9 2.7 1.2 8.9 4.8 8.1 10.4 17.2 10.6 6.3 5.3 7.7 7.4 8.1 11.5 LIG4 ENSG00000174405 "DNA ligase 4" P49917 13 108207439-108218368 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001334, HPA057325" Supported Supported "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "HPA001334: AB_1078689, HPA057325: " "unprognostic (9.93e-2)" "unprognostic (1.56e-1)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (1.40e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.21e-3)" "unprognostic (1.94e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (1.50e-2)" "unprognostic (9.03e-3)" 8.8 12.4 11.6 10.4 15.9 4.3 9.1 14.2 20.6 5.4 7.1 10.2 7.8 8.9 5.8 11.4 8.1 5.9 8.7 8.8 15.6 14.4 11.2 16.7 8.7 12.7 15.5 10.6 7.9 8.3 17.0 20.3 8.3 19.6 7.5 8.7 3.8 6.7 7.1 9.5 6.6 8.6 8.4 14.4 12.6 9.7 11.7 13.6 18.6 10.0 5.4 10.2 8.1 5.3 3.3 2.1 6.8 10.7 2.7 2.7 1.5 9.4 3.6 9.8 6.5 8.2 8.8 3.5 9.4 7.1 7.2 8.7 4.3 4.3 16.2 7.7 6.1 3.9 6.5 6.3 12.5 9.4 6.2 7.6 8.3 2.2 9.8 10.2 8.1 8.0 10.5 7.0 6.3 8.6 2.7 3.0 11.1 5.1 16.8 7.4 2.5 2.3 15.5 3.9 2.6 9.4 6.1 6.2 6.4 2.1 5.8 7.1 4.9 15.7 12.7 4.3 4.7 4.8 8.4 8.0 5.2 26.3 16.6 5.9 9.7 0.8 2.3 6.8 1.8 3.8 2.5 2.6 2.0 1.9 2.1 3.3 2.0 2.7 3.2 2.7 10.7 1.4 2.7 1.5 11.6 15.9 14.2 20.6 15.6 14.4 15.5 10.6 19.6 13.6 LIMA1 EPLIN ENSG00000050405 "LIM domain and actin binding 1" Q9UHB6 12 50175788-50283546 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 83.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 73.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023871, HPA052645" Enhanced Enhanced "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" 160000 "Plasma membrane, Actin filaments" "Focal adhesion sites, Cytosol" "HPA023871: AB_1852875, HPA052645: AB_2681898" "unprognostic (6.22e-2)" "unprognostic (9.39e-3)" "unprognostic (8.13e-2)" "unprognostic (1.42e-1)" "unprognostic (8.08e-2)" "prognostic unfavourable (1.76e-6)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (1.28e-3)" "unprognostic (6.27e-2)" "prognostic favourable (2.79e-4)" "unprognostic (7.12e-2)" "unprognostic (9.26e-3)" "unprognostic (1.46e-1)" "unprognostic (1.43e-1)" 50.3 19.8 6.6 22.3 6.8 0.9 34.1 73.6 6.6 30.9 49.2 10.4 21.3 35.2 31.1 22.1 25.0 18.0 31.1 12.6 6.6 5.1 29.3 11.1 23.3 11.8 7.2 4.1 21.1 12.4 12.4 18.6 42.0 15.4 28.2 42.8 20.7 27.0 22.1 10.5 16.3 90.5 33.8 10.4 23.6 30.3 11.8 6.0 12.1 17.0 20.7 18.0 41.8 21.4 0.6 4.4 1.3 2.1 5.8 13.6 2.7 24.0 0.7 7.7 11.3 35.4 35.6 29.1 60.5 42.6 48.7 39.0 9.1 35.4 1.0 5.6 83.2 27.4 6.9 55.8 42.7 15.3 7.3 10.0 2.7 3.2 22.7 3.6 14.3 23.8 16.5 17.1 49.3 17.1 7.0 4.9 15.6 4.1 4.4 1.1 3.9 3.3 4.4 18.8 0.3 11.3 28.7 5.7 12.4 8.2 16.7 25.9 7.9 2.2 26.6 20.9 16.1 19.3 9.8 2.7 0.3 4.4 22.7 4.0 8.9 0.1 0.2 1.3 6.4 1.0 2.5 0.1 8.1 7.8 4.4 0.6 3.3 5.9 0.1 5.8 2.1 1.1 13.6 2.7 6.6 6.8 73.6 5.6 6.6 5.1 7.2 4.1 15.4 6.0 LIMD1 ENSG00000144791 "LIM domains containing 1" Q9UGP4 3 45555394-45686338 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064220 Supported "Nucleoplasm,Focal adhesion sites" "Nucleoplasm, Focal adhesion sites" "HPA064220: " "unprognostic (2.77e-1)" "unprognostic (3.22e-2)" "unprognostic (5.43e-2)" "unprognostic (7.78e-2)" "unprognostic (6.53e-2)" "unprognostic (2.07e-2)" "unprognostic (9.44e-2)" "unprognostic (1.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (2.11e-3)" "prognostic favourable (6.73e-5)" "unprognostic (8.02e-2)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (6.61e-3)" 12.6 7.0 4.8 14.9 5.5 6.2 13.9 2.5 6.0 10.2 9.7 8.1 13.0 8.4 14.4 12.0 10.4 9.6 10.9 11.5 5.1 4.1 8.3 16.6 24.8 17.1 9.2 2.2 7.6 24.5 11.3 5.5 11.7 9.4 12.1 9.2 20.2 19.1 8.2 25.2 8.3 12.2 12.5 6.8 16.4 11.4 6.2 6.4 20.3 17.9 10.7 24.9 12.9 18.9 6.7 8.8 4.1 5.5 1.1 1.6 1.0 7.3 14.0 5.1 6.9 4.5 8.9 10.3 7.1 10.0 7.6 6.7 6.6 3.9 0.9 4.7 6.5 5.0 10.9 5.8 6.3 15.5 6.7 8.2 11.1 5.4 4.6 7.3 10.6 3.7 4.8 11.3 6.0 6.6 6.8 23.2 7.5 4.9 8.9 4.6 8.3 13.5 4.4 6.0 11.2 4.0 13.2 2.4 4.6 6.0 10.9 7.2 6.6 6.6 11.8 8.4 7.7 8.4 7.5 22.2 28.5 3.7 18.2 6.7 9.1 4.1 1.4 1.4 1.6 3.1 1.0 3.9 1.3 1.4 1.4 6.7 1.4 1.4 1.6 1.1 5.5 8.8 1.3 1.0 4.8 5.5 2.5 6.0 5.1 4.1 9.2 2.2 9.4 6.4 LIMD2 MGC10986 ENSG00000136490 "LIM domain containing 2" Q9BT23 17 63695902-63701172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 175.1;lymphoid tissue: 98.4" "Cell line enhanced" "Detected in many" "Daudi: 53.5;NB-4: 37.3;SH-SY5Y: 37.3;U-698: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062432, HPA075172" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA062432: , HPA075172: " "unprognostic (2.90e-3)" "unprognostic (2.89e-3)" "unprognostic (6.34e-2)" "unprognostic (6.53e-2)" "unprognostic (8.72e-2)" "unprognostic (2.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.67e-2)" "unprognostic (6.68e-2)" "unprognostic (2.01e-2)" "unprognostic (1.20e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (5.36e-11)" "unprognostic (1.21e-1)" "unprognostic (2.21e-1)" "unprognostic (2.26e-2)" "unprognostic (6.08e-2)" 3.6 2.0 6.5 54.8 14.8 28.7 2.3 1.2 8.5 2.7 2.9 3.0 1.3 3.9 2.6 3.2 3.0 2.6 5.1 2.7 9.6 3.3 3.7 5.1 8.1 63.5 3.6 3.7 2.8 1.7 0.8 3.5 6.4 2.8 4.1 2.8 5.0 11.3 1.7 1.1 1.8 12.9 2.6 3.0 51.1 5.5 6.1 1.7 98.4 2.5 2.2 79.7 7.4 2.6 81.9 55.1 175.1 65.1 46.6 67.5 73.0 0.1 1.7 21.1 5.1 0.2 0.5 0.5 0.5 0.3 2.1 1.4 0.9 0.4 53.5 4.7 2.5 0.8 4.6 0.2 0.6 18.4 1.9 15.9 0.3 4.5 4.1 20.6 1.7 5.3 0.2 2.1 0.0 5.7 1.4 3.1 2.4 0.2 18.2 37.3 11.4 1.0 7.5 8.5 9.4 2.9 0.2 25.5 37.3 2.6 0.0 4.9 0.1 28.0 7.1 2.9 6.5 0.1 0.7 0.6 0.2 55.8 0.3 2.9 5.1 175.1 54.6 122.9 35.7 63.3 35.1 64.6 49.4 41.5 55.1 81.9 67.5 48.1 112.7 46.6 65.1 20.8 58.1 73.0 6.5 14.8 1.2 8.5 9.6 3.3 3.6 3.7 2.8 1.7 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.2" "Cell line enhanced" "Detected in all" "U-87 MG: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028064, HPA028516" Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA028064: AB_10600111, HPA028516: AB_10601751" "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavourable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavourable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 8.8 8.6 31.6 18.2 18.6 6.3 7.4 14.3 44.1 11.5 6.6 7.1 6.6 6.9 7.3 5.3 6.4 6.0 10.8 6.3 26.8 32.9 5.2 2.6 12.5 22.0 33.4 22.2 12.1 8.1 4.0 7.2 8.0 45.2 6.1 4.7 4.8 18.1 9.6 10.9 6.8 7.2 7.6 10.8 18.4 7.8 10.4 6.5 4.3 7.5 3.7 18.1 14.1 7.2 4.6 8.6 3.8 7.7 6.9 2.4 3.1 17.2 13.5 10.3 17.1 13.6 18.5 7.5 10.7 10.3 8.7 9.7 7.8 17.0 10.7 4.8 13.1 10.4 3.8 6.6 3.3 18.5 6.7 7.9 4.6 8.9 15.6 6.0 29.0 18.2 5.9 7.0 3.7 12.9 5.3 3.4 10.8 15.1 5.1 10.8 19.5 8.4 7.5 16.0 6.7 9.6 3.7 4.1 9.4 6.9 16.5 8.6 5.2 5.4 15.3 13.9 12.9 35.7 17.1 3.9 4.3 19.5 51.4 4.4 9.4 0.1 6.5 3.8 2.4 7.7 1.8 4.6 0.6 1.5 8.6 2.4 0.2 0.7 0.7 6.9 4.7 0.8 0.4 3.1 31.6 18.6 14.3 44.1 26.8 32.9 33.4 22.2 45.2 6.5 LIMK2 ENSG00000182541 "LIM domain kinase 2" P53671 22 31212239-31280080 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 37.8;hTCEpi: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 14.7;neutrophil: 37.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008183, CAB019313, HPA053882" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB019313: , HPA008183: AB_1079252, HPA053882: " "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.04e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (4.02e-2)" "unprognostic (5.99e-2)" "unprognostic (1.21e-1)" "unprognostic (2.95e-1)" "unprognostic (3.96e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (4.57e-6)" "unprognostic (4.48e-2)" "unprognostic (1.48e-2)" "unprognostic (5.72e-2)" "unprognostic (1.37e-1)" 9.4 6.6 23.5 23.6 26.2 29.4 17.0 9.9 16.8 11.0 20.9 15.6 10.7 13.1 12.9 8.7 33.7 22.1 28.7 6.0 15.4 10.7 15.4 19.9 21.6 18.1 20.8 7.2 11.4 19.9 20.0 12.8 64.3 23.3 17.1 22.1 10.1 25.7 16.2 9.7 36.7 13.3 10.1 28.3 17.4 18.5 16.8 17.9 12.4 25.8 15.6 15.3 13.1 20.0 1.0 1.6 37.2 1.9 2.4 5.6 1.6 7.0 1.1 4.9 2.7 2.1 2.5 37.8 4.7 2.2 4.7 4.0 6.1 3.3 6.9 8.4 7.0 14.4 5.7 24.6 3.0 5.0 6.2 5.0 5.6 6.5 3.2 9.2 9.2 4.0 70.1 3.8 11.5 12.0 2.8 5.0 6.4 5.5 5.6 3.2 4.6 1.8 7.5 8.3 3.8 5.5 16.8 6.3 5.7 3.5 22.7 9.4 18.9 3.7 7.2 4.2 6.6 2.3 4.3 2.8 4.1 6.0 2.7 4.4 1.8 2.1 1.9 14.7 1.3 1.3 2.4 0.8 2.3 1.7 0.7 1.0 2.3 1.8 37.2 2.4 0.5 1.6 5.6 1.6 23.5 26.2 9.9 16.8 15.4 10.7 20.8 7.2 23.3 17.9 LIMS1 "PINCH, PINCH1" ENSG00000169756 "LIM zinc finger domain containing 1" P48059 2 108534355-108687246 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA058455, HPA061230" Approved Supported "Focal adhesion sites,Cytosol" 130000000 Cytosol "Focal adhesion sites" "HPA058455: , HPA061230: " "unprognostic (1.79e-1)" "unprognostic (8.82e-3)" "unprognostic (5.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.52e-1)" "unprognostic (4.23e-2)" "unprognostic (1.08e-3)" "unprognostic (1.09e-1)" "unprognostic (8.96e-2)" "unprognostic (1.18e-1)" "unprognostic (5.95e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (7.88e-4)" "unprognostic (7.51e-2)" "unprognostic (8.60e-3)" "unprognostic (1.43e-2)" "unprognostic (2.11e-1)" 39.3 26.3 7.8 18.3 13.3 14.9 21.5 3.9 9.6 18.1 16.9 14.4 38.2 8.3 21.9 21.7 18.4 16.9 16.5 20.2 8.0 7.5 20.8 18.0 26.3 21.2 13.3 4.6 18.3 10.6 6.6 13.6 19.0 10.8 15.8 9.5 11.0 13.8 43.6 54.0 11.2 17.9 18.8 16.7 24.3 13.0 9.3 10.7 20.2 13.1 15.0 25.5 21.1 16.1 4.4 14.2 45.6 34.0 8.8 20.9 29.6 9.2 10.4 4.1 4.9 6.8 10.0 19.9 10.4 12.0 8.1 8.3 18.0 20.1 9.0 31.9 13.3 6.0 6.2 10.7 10.8 22.2 11.1 47.2 7.4 9.5 15.7 8.8 88.1 9.7 9.9 21.4 17.7 29.2 16.6 12.6 24.9 7.6 8.4 6.5 8.1 10.7 10.8 14.3 7.3 15.4 16.8 7.5 10.1 16.4 7.0 7.3 3.6 8.3 39.2 36.8 16.8 8.1 21.3 12.3 16.3 12.8 30.7 10.0 9.3 38.3 16.9 45.6 4.3 28.7 7.8 4.4 18.5 5.7 14.2 3.5 5.0 1.8 8.0 8.8 34.0 1.8 20.9 29.6 7.8 13.3 3.9 9.6 8.0 7.5 13.3 4.6 10.8 10.7 LIMS3 ENSG00000256977 "LIM zinc finger domain containing 3" P0CW19 2 109898428-109924868 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 11.9;endometrium 1: 9.7" "Cell line enhanced" "Detected in many" "HEL: 9.6;HMC-1: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 11.9" "Low lineage specificity" "Detected in many" HPA058455 Uncertain Approved "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "HPA058455: " "unprognostic (2.23e-2)" 1.2 2.8 0.5 2.2 0.5 0.0 1.0 0.8 0.5 1.0 0.7 0.3 4.2 0.2 9.7 2.8 1.2 7.1 0.9 2.6 0.5 0.5 2.6 0.6 0.8 2.8 0.6 0.3 2.2 0.7 0.3 2.4 5.6 0.3 1.0 0.8 0.6 2.2 0.6 3.0 0.8 0.5 1.2 0.6 0.6 0.7 3.7 0.3 0.3 1.0 0.3 0.3 2.6 0.7 0.7 2.5 11.9 5.5 1.1 6.2 8.0 0.0 0.1 1.2 1.5 0.5 0.4 0.0 1.5 0.0 0.2 0.6 1.5 0.0 0.0 4.6 0.3 0.8 0.0 1.8 1.3 2.3 0.0 9.6 0.4 0.9 1.4 1.7 29.2 2.1 1.1 1.1 1.3 2.4 2.0 1.6 3.2 0.1 0.0 0.2 1.5 0.5 1.7 3.1 1.0 0.8 1.5 0.4 3.5 3.9 0.0 0.7 0.0 0.5 7.1 6.3 5.8 3.2 0.3 0.0 0.0 1.8 0.8 0.0 1.9 4.7 3.3 11.9 0.9 5.5 1.5 0.7 5.0 1.7 2.5 0.2 0.9 0.3 0.7 1.1 5.2 0.2 6.2 8.0 0.5 0.5 0.8 0.5 0.5 0.5 0.6 0.3 0.3 0.3 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.6;HHSteC: 2.5;hTEC/SVTERT24-B: 4.8;HUVEC TERT2: 2.8;U-138 MG: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "HPA058455: " "unprognostic (2.12e-1)" 4.0 4.1 0.0 0.3 0.0 0.6 1.5 0.0 0.3 0.3 0.6 0.3 4.1 0.3 0.3 3.7 0.3 3.5 0.0 0.0 5.5 2.7 0.8 0.3 0.0 1.9 2.2 0.3 0.8 0.6 0.3 0.3 0.3 0.3 5.6 0.4 0.3 0.3 0.0 0.3 0.3 1.3 1.1 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.6 0.2 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.8 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Cell line enriched" "Detected in some" 10 "NTERA-2: 137.5" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell line enhanced" "Detected in some" "AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 13.9 2.8 0.0 0.0 71.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 6.7 9.9 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.3 0.0 0.0 1.4 1.6 12.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.2 5.9 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 LIPT2 ENSG00000175536 "Lipoyl(octanoyl) transferase 2" A6NK58 11 74491712-74493733 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040249 Approved Approved Vesicles,Centrosome Vesicles Centrosome "HPA040249: AB_10795275" "unprognostic (8.80e-2)" "unprognostic (9.67e-2)" "unprognostic (5.12e-3)" "unprognostic (1.09e-1)" "unprognostic (6.74e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-2)" "unprognostic (8.96e-2)" "unprognostic (1.11e-2)" "prognostic favourable (1.63e-4)" "unprognostic (6.11e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (9.45e-2)" "unprognostic (1.01e-1)" "unprognostic (1.51e-2)" "unprognostic (1.35e-1)" 2.0 4.1 2.6 2.6 3.0 2.1 5.8 2.3 4.3 3.1 4.0 3.4 6.5 5.8 3.4 6.5 3.6 5.8 8.8 2.9 3.3 2.6 8.1 5.3 4.0 8.4 3.5 1.0 6.2 10.8 6.2 4.3 8.3 2.9 4.6 3.6 3.8 5.9 6.9 11.3 2.4 6.3 3.1 2.9 4.2 5.6 19.0 0.8 8.7 6.4 5.5 4.3 4.6 3.8 11.2 7.2 6.6 4.9 8.1 14.8 5.4 2.5 3.2 7.0 3.3 2.9 0.6 9.9 0.9 1.6 4.4 2.8 10.5 3.5 15.5 6.0 0.6 3.7 3.2 2.4 1.7 3.6 3.2 4.5 2.8 2.8 3.3 5.2 6.2 1.6 2.6 2.2 2.9 0.3 3.5 4.4 1.3 4.0 6.9 7.9 6.2 4.2 5.6 7.7 4.3 2.9 8.7 7.1 4.5 6.5 2.0 9.4 6.3 3.9 1.2 1.0 2.6 1.5 2.3 7.3 6.5 10.5 0.8 3.0 3.4 0.0 4.9 6.6 5.9 3.0 8.8 11.2 7.9 7.2 5.3 11.0 14.8 11.2 1.1 8.1 3.7 7.2 3.7 5.4 2.6 3.0 2.3 4.3 3.3 2.6 3.5 1.0 2.9 0.8 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.7 25.6 16.2 7.8 2.5 1.9 16.4 17.9 55.1 17.0 25.4 10.6 37.1 6.9 22.9 15.1 17.0 6.8 30.0 16.3 52.7 7.1 0.5 22.3 53.7 38.0 2.1 2.3 5.7 58.3 13.9 38.2 0.0 4.2 26.8 0.2 13.1 0.3 31.8 26.4 0.1 2.1 3.5 39.6 14.3 19.4 4.0 12.2 30.9 39.5 31.8 22.1 11.7 0.1 7.1 12.0 4.1 4.1 10.5 23.1 17.7 8.1 16.8 40.5 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell line enriched" "Detected in some" 12 "RPTEC TERT1: 26.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: " "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL2, scribble cell polarity complex component" Q6P1M3 17 75525080-75575208 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 25.9;CAPAN-2: 38.2;MCF7: 36.7;RT4: 26.1;SK-BR-3: 36.6;T-47d: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 6.2" "Group enriched" "Detected in many" 6 "dendritic cells: 2.2;NK-cells: 4.1;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favourable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favourable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favourable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 1.7 3.9 1.5 17.3 4.2 1.4 4.2 5.1 3.7 7.1 27.5 5.2 23.0 22.9 2.8 17.1 24.3 6.4 45.7 1.7 1.7 1.0 35.6 17.1 16.0 2.1 11.2 1.8 4.6 37.5 5.0 8.3 5.1 3.6 6.6 11.9 6.3 21.4 20.0 0.7 13.9 36.0 1.2 2.5 9.6 27.7 4.3 4.9 1.5 13.4 13.0 13.6 7.0 10.6 0.6 2.2 0.3 0.6 4.1 6.2 0.9 16.5 15.4 0.0 2.9 0.0 0.0 6.5 0.1 0.1 0.3 0.2 25.9 38.2 1.1 3.9 0.0 20.9 2.9 2.8 0.0 1.4 5.2 1.1 4.3 9.8 0.1 0.1 2.5 0.0 3.9 0.0 0.6 0.6 2.1 1.5 0.0 36.7 0.9 1.9 2.1 6.1 1.9 0.0 4.1 8.2 26.1 6.4 1.2 3.3 36.6 1.1 27.7 2.6 0.1 0.0 0.1 0.0 0.2 1.8 2.4 0.4 0.1 0.1 0.7 0.0 0.3 0.1 6.2 0.6 1.4 0.6 1.5 4.2 0.3 0.6 0.2 2.5 0.3 4.1 0.2 2.2 1.0 0.9 1.5 4.2 5.1 3.7 1.7 1.0 11.2 1.8 3.6 4.9 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098412-36151961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 11.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 6.2 9.7 12.1 6.6 21.4 2.2 8.8 12.8 25.5 7.3 8.7 9.5 7.6 9.6 5.3 7.2 6.8 4.8 5.8 8.2 14.2 11.4 10.5 14.2 5.7 7.6 9.9 15.6 5.0 7.7 16.9 16.9 8.4 14.1 9.7 9.1 4.8 7.6 6.8 11.1 7.7 9.6 5.5 10.5 6.7 10.1 5.2 8.6 8.4 12.8 2.9 7.4 7.6 6.1 1.5 1.2 11.0 1.2 1.0 2.3 0.8 4.8 3.6 4.4 7.3 9.2 8.1 15.6 10.1 5.3 7.4 7.5 4.5 10.6 8.7 5.1 5.3 6.7 5.8 3.5 12.3 12.4 3.5 6.8 12.4 0.8 5.9 8.2 9.0 4.8 6.3 6.4 6.4 4.0 7.9 9.2 9.0 3.2 7.0 5.4 2.4 4.6 5.3 10.3 5.3 6.4 4.3 8.3 6.4 14.5 8.6 3.5 9.8 9.9 5.3 8.9 2.3 11.3 5.3 7.6 11.1 7.7 8.4 9.3 6.1 11.0 1.2 2.0 1.6 1.2 1.1 1.5 1.4 1.4 1.0 1.3 1.9 1.9 0.8 1.0 1.2 1.2 2.3 0.8 12.1 21.4 12.8 25.5 14.2 11.4 9.9 15.6 14.1 8.6 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell line enhanced" "Detected in many" "HHSteC: 29.8;HSkMC: 41.7;hTEC/SVTERT24-B: 30.6;U-2197: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavourable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.6 2.8 2.1 20.7 11.7 2.9 12.1 6.2 6.7 16.5 12.2 3.7 0.0 1.4 14.0 0.2 1.6 3.1 2.7 5.0 1.1 3.6 1.1 2.4 29.8 0.0 0.3 41.7 0.0 30.6 0.2 3.2 0.0 0.0 8.6 2.1 0.0 0.0 5.4 0.7 0.0 9.2 0.0 6.1 1.1 0.1 6.9 2.0 10.1 6.3 13.2 0.0 1.5 6.7 13.5 27.0 8.1 1.6 1.9 0.8 1.3 0.9 8.7 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favourable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 3.9 4.9 5.2 2.5 11.0 2.3 4.5 6.1 9.1 6.2 3.5 5.8 14.3 2.2 4.8 20.3 3.5 9.3 5.1 5.9 5.7 7.4 6.6 3.7 8.1 3.5 5.6 8.9 6.5 6.1 8.8 15.0 3.9 11.6 4.6 4.1 5.4 4.2 11.7 3.7 6.5 2.3 4.0 5.5 3.0 3.9 27.0 4.4 1.2 7.6 3.0 2.6 3.5 3.7 1.9 1.9 0.8 2.4 1.8 2.4 1.2 6.5 2.5 3.0 3.5 5.9 8.3 2.5 3.4 3.1 6.2 5.1 2.4 2.4 2.1 16.0 2.4 2.5 2.8 2.7 9.0 0.3 2.0 1.2 2.1 1.8 3.7 3.7 1.8 3.9 6.1 7.7 5.0 2.7 6.3 4.0 5.9 4.9 2.2 3.2 3.3 6.0 2.5 0.7 2.2 6.4 1.7 4.8 1.4 4.8 4.3 3.4 11.1 2.8 5.7 7.6 1.1 9.2 5.7 7.1 13.8 0.6 10.9 6.4 6.9 0.2 0.6 0.5 1.2 2.4 1.7 1.9 0.8 1.6 1.9 1.1 2.2 2.4 0.8 1.8 0.9 0.5 0.0 1.2 5.2 11.0 6.1 9.1 5.7 7.4 5.6 8.9 11.6 4.4 LMNA "CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1" ENSG00000160789 "Lamin A/C" P02545 1 156082573-156140089 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4" "Group enriched" "Detected in all" 8 "dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004022, HPA006660, HPA012078" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" 3200000 Nucleoplasm "Nuclear bodies, Cytosol" "CAB004022: AB_2136278, HPA006660: AB_1079231, HPA012078: " "unprognostic (2.22e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-2)" "unprognostic (5.75e-2)" "unprognostic (7.43e-3)" "unprognostic (1.47e-1)" "unprognostic (5.23e-3)" "unprognostic (3.27e-2)" "unprognostic (8.33e-2)" "unprognostic (5.90e-2)" "unprognostic (5.10e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "unprognostic (2.89e-1)" "unprognostic (3.08e-2)" "unprognostic (1.44e-2)" 64.0 37.3 7.4 51.4 11.8 21.3 88.6 9.0 10.8 62.8 32.6 21.9 27.2 28.6 69.1 52.3 62.2 40.1 77.7 62.5 8.8 7.5 25.9 26.6 51.8 39.6 15.7 11.2 60.3 30.9 15.2 17.4 73.3 18.1 34.0 15.2 32.7 37.5 26.4 36.3 68.7 29.9 63.0 10.3 22.4 36.7 30.2 12.9 9.4 31.5 140.0 35.6 46.4 51.2 1.1 34.8 10.4 3.5 1.7 35.4 6.4 58.6 58.2 6.4 17.3 32.6 56.6 19.9 63.4 80.9 47.9 33.2 14.7 58.1 0.5 37.7 97.5 68.7 9.4 49.2 12.4 19.9 5.5 18.5 46.9 34.0 29.5 3.2 54.7 33.9 21.4 38.9 26.8 42.7 9.9 4.5 52.4 46.3 0.1 10.2 4.8 74.2 0.2 22.6 17.2 47.4 28.2 6.6 13.2 42.8 46.5 58.9 39.3 15.3 76.1 45.7 29.1 56.4 51.2 4.4 1.1 1.2 74.7 3.0 136.2 10.4 3.5 0.1 1.2 0.8 1.0 1.1 8.9 3.4 34.8 0.0 0.1 0.3 0.8 1.7 0.1 0.3 35.4 6.4 7.4 11.8 9.0 10.8 8.8 7.5 15.7 11.2 18.1 12.9 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038640: " "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.5 2.3 3.1 5.4 1.2 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.9 0.1 0.9 0.8 1.9 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.6 0.5 0.4 0.2 0.2 0.2 6.6 0.1 6.7 0.2 0.4 3.8 0.3 1.5 0.3 0.2 0.9 23.5 0.2 0.8 1.3 1.6 0.3 1.5 2.5 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328468-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.4" "Cell line enhanced" "Detected in many" "AN3-CA: 102.8;T-47d: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: , HPA061638: " "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favourable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favourable (1.42e-4)" "unprognostic (1.70e-1)" 19.3 7.5 39.8 11.7 36.4 8.0 13.9 10.3 102.4 22.7 16.2 9.8 10.9 11.5 19.4 18.1 22.2 13.7 21.0 17.2 62.3 18.0 12.8 14.5 16.6 11.5 21.0 50.9 18.4 10.4 11.6 13.3 27.5 13.0 26.0 14.3 11.2 36.2 37.9 18.4 17.1 21.1 15.3 16.5 15.8 38.6 12.0 11.0 4.4 14.2 12.5 36.3 15.4 21.4 7.8 7.2 18.9 8.2 15.3 6.9 3.6 9.2 7.3 5.7 102.8 17.5 20.8 14.4 8.4 6.7 7.9 8.9 17.8 5.9 21.7 10.7 9.8 7.7 2.2 5.8 7.9 11.5 5.6 19.8 15.8 5.4 16.8 10.6 26.8 10.8 13.5 12.3 7.1 5.3 4.4 19.3 4.2 3.7 0.3 6.9 20.8 6.8 12.3 7.9 4.7 9.8 35.5 4.7 0.3 33.8 5.0 24.9 65.4 29.3 3.4 37.3 7.0 8.9 27.4 17.6 11.6 4.9 4.6 2.3 5.3 18.9 6.8 13.0 6.0 8.2 6.9 7.8 5.4 6.1 5.0 4.4 1.4 3.5 10.9 15.3 7.7 7.2 1.4 3.6 39.8 36.4 10.3 102.4 62.3 18.0 21.0 50.9 13.0 11.0 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6" "Cell line enhanced" "Detected in many" "BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.1" "Lineage enriched" "Detected in many" 5 "T-cells: 14.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2" "HPA020923, HPA050184" Approved Supported "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: " "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavourable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favourable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 2.2 2.2 10.1 6.3 32.6 0.9 2.5 2.7 13.2 6.7 24.3 0.5 2.4 17.5 2.3 7.8 42.5 4.0 16.3 65.6 9.8 2.5 21.7 19.9 57.0 2.6 2.3 8.8 5.5 6.8 6.2 3.1 10.9 1.1 7.6 8.9 2.7 14.3 7.0 44.4 8.6 55.0 2.1 2.0 1.5 16.7 4.7 4.1 16.2 25.7 36.3 23.7 4.6 15.4 2.4 1.1 3.0 0.5 0.5 14.1 2.6 12.1 6.9 0.2 0.2 14.4 10.2 2.4 54.7 27.0 13.9 15.1 16.9 15.7 1.0 4.2 90.2 11.8 3.0 2.6 16.1 16.3 0.7 7.4 36.7 15.8 4.1 2.3 3.9 7.0 5.1 6.0 6.9 5.8 0.2 0.0 84.9 4.7 1.8 1.0 0.3 10.4 1.1 25.5 0.2 5.9 2.8 0.8 1.9 9.9 1.7 2.2 2.2 1.7 8.8 34.4 6.4 4.1 13.3 3.7 2.7 4.3 10.1 2.6 15.6 3.0 0.2 2.4 0.7 0.5 0.9 1.1 3.2 1.0 0.4 2.4 14.1 8.5 0.1 0.5 0.3 1.1 1.2 2.6 10.1 32.6 2.7 13.2 9.8 2.5 2.3 8.8 1.1 4.1 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: " "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavourable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.9 11.7 9.1 9.3 4.9 3.9 8.5 4.1 4.5 4.1 4.9 9.2 9.1 5.2 11.9 5.3 10.9 10.5 6.3 6.4 7.4 7.4 3.5 10.5 9.2 6.0 6.3 6.4 2.7 8.8 8.4 11.4 6.1 9.2 11.1 3.7 13.5 6.6 3.8 11.1 5.7 7.3 6.2 10.3 6.8 17.5 6.5 13.1 8.3 15.2 6.0 4.2 2.6 7.4 8.5 14.0 16.9 9.4 4.9 8.6 10.5 5.7 5.0 10.1 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 4.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.8 1.6 8.3 1.2 5.4 2.3 0.7 2.2 5.5 1.8 2.2 0.6 0.7 2.5 1.0 1.6 1.8 2.2 1.9 2.2 2.6 2.3 6.1 0.8 2.8 1.6 3.5 0.7 2.5 0.7 1.0 4.7 0.4 2.3 9.5 1.6 2.1 4.9 3.5 5.7 12.5 3.8 4.6 5.0 1.7 0.3 8.6 4.3 1.6 2.4 3.4 0.6 0.4 0.6 0.9 8.9 0.8 2.0 11.2 11.9 7.3 2.5 3.0 1.5 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.5 4.3 10.3 14.6 21.8 13.6 5.1 25.3 12.2 11.8 16.7 6.0 10.1 8.6 14.5 11.2 9.5 9.7 6.7 16.5 13.0 9.9 9.7 5.6 5.3 5.1 16.4 12.0 11.2 6.4 11.5 5.7 2.1 9.9 11.5 16.2 5.6 10.8 6.5 3.3 8.4 10.9 10.4 6.3 5.0 7.9 11.9 12.1 11.1 6.4 8.5 9.5 5.4 3.2 58.8 8.7 19.6 11.8 6.8 12.4 7.1 18.2 5.4 10.9 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 LNX1 "LNX, MPDZ, PDZRN2" ENSG00000072201 "Ligand of numb-protein X 1" Q8TBB1 4 53459301-53701405 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002235, HPA071091" Approved Supported "Cell Junctions,Cytosol" "Intracellular and membrane" "Cell Junctions" Cytosol "HPA002235: AB_1079261, HPA071091: " "unprognostic (4.95e-2)" "unprognostic (1.74e-2)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (2.79e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (5.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "prognostic favourable (3.08e-7)" "unprognostic (2.67e-1)" "unprognostic (5.49e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" 16.9 2.5 11.8 1.7 24.6 0.8 13.2 4.4 33.3 5.9 7.2 1.5 11.2 8.3 4.5 3.2 21.7 5.6 4.8 6.9 6.1 5.5 10.0 3.7 2.5 1.8 3.8 11.6 2.1 12.9 10.8 5.0 21.6 4.8 5.1 5.6 2.0 22.1 10.0 5.1 10.0 8.2 2.8 1.3 0.9 8.0 4.1 2.0 0.7 15.0 5.7 7.8 5.8 7.7 1.4 1.1 1.5 1.9 3.8 1.6 0.6 1.6 0.6 1.9 1.0 3.5 7.3 9.2 1.5 0.7 0.0 0.0 2.7 8.4 2.1 1.2 4.2 1.6 0.0 0.3 0.0 0.5 4.6 2.9 1.7 1.6 1.4 2.7 0.8 5.4 0.3 0.5 0.0 2.8 1.7 1.0 6.6 4.7 2.4 1.8 4.8 1.0 1.5 0.7 0.9 6.3 8.8 2.3 2.6 0.7 9.7 1.0 5.2 1.4 8.0 10.5 3.1 3.4 1.8 3.9 0.6 1.4 9.6 2.4 1.9 1.5 0.5 0.3 1.0 0.5 1.5 1.4 1.5 1.5 0.8 0.9 1.6 1.2 0.4 3.8 1.9 1.1 1.3 0.6 11.8 24.6 4.4 33.3 6.1 5.5 3.8 11.6 4.8 2.0 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545911-27620404 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favourable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 4.6 10.3 2.5 6.7 4.2 2.7 9.8 7.6 4.1 6.0 13.2 2.3 8.3 12.2 4.4 4.3 12.4 4.1 9.7 8.8 2.8 2.9 9.2 24.5 22.1 4.9 3.4 3.1 6.3 24.7 7.6 9.6 10.8 3.7 7.0 9.3 10.2 12.1 9.9 8.0 7.6 19.6 6.5 3.3 4.6 9.0 10.3 2.6 13.4 9.9 4.2 10.0 6.2 8.5 1.6 0.8 5.3 0.9 3.3 2.8 0.6 5.1 2.8 5.4 5.9 5.7 2.6 5.7 4.6 4.0 4.5 4.1 10.2 10.3 7.8 4.0 4.0 9.8 9.6 12.2 5.9 4.7 4.0 9.9 6.0 7.4 9.0 5.3 6.3 2.2 19.0 3.1 12.5 8.1 3.0 3.0 6.5 6.3 7.8 3.5 6.0 3.2 7.2 10.6 4.0 9.9 9.0 13.9 2.9 6.3 12.7 8.0 8.9 4.1 10.3 2.6 3.6 2.6 3.7 2.9 4.9 8.1 1.7 5.1 3.6 5.3 0.9 2.4 1.7 0.3 2.3 1.6 1.8 2.1 0.8 1.3 1.9 1.8 1.1 3.3 0.7 0.4 2.8 0.6 2.5 4.2 7.6 4.1 2.8 2.9 3.4 3.1 3.7 2.6 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 29.0 20.6 15.4 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 12.7 42.3 57.8 7.3 15.3 18.0 21.7 28.3 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 11.1 45.7 9.0 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 LONRF1 "FLJ23749, RNF191" ENSG00000154359 "LON peptidase N-terminal domain and ring finger 1" Q17RB8 8 12721894-12756073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023584, HPA024814" Uncertain Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" Centrosome "HPA023584: AB_1853233, HPA024814: AB_1853235" "unprognostic (2.59e-1)" "unprognostic (2.17e-3)" "unprognostic (1.35e-2)" "unprognostic (3.56e-1)" "unprognostic (9.09e-2)" "unprognostic (3.96e-3)" "unprognostic (3.13e-1)" "unprognostic (5.78e-2)" "unprognostic (2.74e-3)" "unprognostic (1.18e-1)" "unprognostic (5.83e-2)" "unprognostic (3.39e-1)" "unprognostic (5.46e-3)" "unprognostic (8.97e-2)" "unprognostic (8.90e-2)" "unprognostic (3.08e-3)" "unprognostic (1.15e-1)" 16.5 7.6 7.6 4.9 9.9 4.9 10.4 9.9 8.4 14.0 8.1 6.3 8.8 2.2 11.1 13.0 12.9 11.2 9.4 6.5 8.9 5.3 6.3 9.3 8.1 8.7 6.9 6.9 20.4 10.3 12.6 4.9 9.6 5.5 12.8 4.2 13.9 7.9 10.9 18.4 29.7 5.3 10.0 6.1 9.2 6.9 16.1 4.5 6.2 8.6 7.3 7.3 10.6 19.0 1.1 0.9 2.4 2.1 0.1 1.6 0.2 0.6 1.6 8.4 2.6 8.9 4.3 5.6 2.1 3.5 2.3 3.2 0.5 2.1 12.9 0.5 3.6 1.0 6.6 2.5 2.6 2.0 3.7 4.2 0.3 3.4 8.3 1.1 1.6 4.0 4.6 1.4 5.1 3.6 0.6 31.8 1.5 2.3 5.5 3.7 8.6 0.5 3.1 5.7 2.3 2.0 5.6 17.7 2.1 1.2 2.8 16.4 0.6 5.7 1.6 1.2 2.1 5.0 1.6 2.4 10.7 6.8 6.8 3.9 3.8 0.0 0.5 2.4 0.5 1.8 1.6 1.0 1.0 0.6 0.4 1.1 0.0 0.0 1.9 0.1 2.1 0.9 0.0 0.2 7.6 9.9 9.9 8.4 8.9 5.3 6.9 6.9 5.5 4.5 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 9.3;K-562: 11.0;PC-3: 12.6;SiHa: 11.4;SK-MEL-30: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.4" "Lineage enriched" "Detected in single" 8 "T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA050422: , HPA061162: " "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavourable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.8 3.9 4.2 2.1 3.4 4.6 10.8 15.8 6.1 1.9 4.1 2.0 1.6 2.9 2.4 3.1 1.7 2.5 3.9 3.9 5.0 1.9 3.6 15.4 11.8 0.8 1.7 3.7 2.0 8.1 0.4 3.5 0.9 4.4 3.0 5.5 4.1 8.1 3.0 13.8 1.4 2.3 10.8 2.7 1.1 4.5 2.7 2.5 0.0 9.9 1.9 1.1 4.7 6.6 0.0 0.1 0.8 0.8 0.0 7.4 0.7 3.8 5.7 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.8 0.0 2.8 0.0 0.0 1.2 0.0 0.1 0.1 3.2 4.9 9.3 5.5 3.2 4.2 0.6 0.0 0.0 0.0 0.0 1.5 11.0 0.0 0.8 4.7 0.0 1.8 0.0 12.6 0.0 2.6 0.0 3.5 1.6 0.2 0.0 11.4 0.3 10.0 0.0 3.7 0.2 0.1 0.2 0.0 6.1 1.2 4.9 0.0 2.7 4.3 2.5 0.0 0.8 0.0 4.5 0.0 7.4 0.0 2.0 1.5 0.1 0.0 1.1 1.6 0.8 0.0 0.0 0.0 0.7 0.7 4.2 3.4 15.8 6.1 5.0 1.9 1.7 3.7 4.4 2.5 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell line enhanced" "Detected in many" "ASC diff: 96.2;ASC TERT1: 56.2;BJ hTERT+: 68.0;HSkMC: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 4.9 0.0 96.2 56.2 0.0 24.0 68.0 16.8 7.6 0.4 0.2 0.0 0.0 24.8 7.2 0.0 18.7 13.9 0.0 0.6 0.0 0.2 0.0 26.0 0.0 0.0 40.8 1.1 8.3 15.8 0.3 0.0 0.0 12.9 0.0 0.0 0.0 0.9 19.4 0.0 3.6 0.0 3.8 3.2 0.1 1.1 0.4 0.0 0.0 1.6 0.0 0.0 8.0 0.2 5.7 0.0 0.2 0.0 0.0 1.2 0.0 8.7 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell line enhanced" "Detected in some" "AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: , HPA054951: , HPA055571: " "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.3 0.0 0.4 1.8 16.4 0.2 0.8 6.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.2 0.0 0.6 1.4 0.0 0.7 0.7 3.9 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell line enhanced" "Detected in many" "BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavourable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavourable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favourable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavourable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.2 0.3 0.5 34.2 7.7 0.4 0.4 0.3 1.1 0.9 6.7 32.9 0.2 5.7 0.6 0.2 0.2 16.2 13.9 1.6 4.8 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.4 3.6 1.2 0.0 4.2 6.3 2.6 12.0 22.9 12.0 0.5 4.9 1.3 2.7 4.3 4.2 6.1 5.5 1.8 2.6 2.6 3.8 0.6 7.5 2.3 2.7 4.3 4.1 1.5 1.4 2.8 2.0 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 LPCAT2 "AGPAT11, AYTL1, FLJ20481, LysoPAFAT" ENSG00000087253 "Lysophosphatidylcholine acyltransferase 2" Q7L5N7 16 55508998-55586670 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.5;HaCaT: 25.7;HL-60: 28.7;HMC-1: 47.8;WM-115: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.8;eosinophil: 49.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007891, HPA008433" Enhanced Supported Supported "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA007891: AB_1845223, HPA008433: " "unprognostic (1.43e-1)" "unprognostic (2.44e-2)" "prognostic favourable (3.43e-4)" "prognostic favourable (8.03e-6)" "unprognostic (2.91e-1)" "unprognostic (9.65e-3)" "unprognostic (8.12e-3)" "unprognostic (3.26e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (3.18e-3)" "unprognostic (9.16e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" 10.5 7.5 10.5 8.0 16.2 43.5 9.9 1.7 7.5 11.0 5.2 18.2 36.5 4.3 17.0 21.5 7.2 8.5 6.2 5.7 9.6 6.3 6.7 2.4 7.4 10.3 18.6 3.1 11.0 3.8 12.7 1.9 9.0 16.1 8.2 5.5 5.1 7.7 33.2 3.0 10.2 5.4 8.9 30.7 8.9 5.3 4.6 14.9 0.9 49.0 5.2 2.6 8.5 8.5 0.0 5.4 49.4 9.3 0.0 0.0 1.4 9.4 1.2 1.0 0.1 3.3 1.2 1.7 4.0 3.9 2.0 2.0 2.1 33.5 0.0 13.8 5.7 25.7 0.6 5.5 3.2 2.5 2.8 9.6 3.1 4.9 1.2 28.7 47.8 0.6 5.6 2.2 1.8 15.4 0.4 0.1 3.3 0.6 0.0 11.6 1.5 0.1 2.9 1.1 1.4 1.9 3.7 0.6 7.4 7.7 3.1 5.6 1.3 7.3 17.3 0.3 0.0 2.0 2.7 0.1 0.0 0.0 0.8 14.0 34.0 28.8 4.5 49.4 0.0 6.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 12.1 0.0 9.3 0.1 0.0 1.4 10.5 16.2 1.7 7.5 9.6 6.3 18.6 3.1 16.1 14.9 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.4 6.5 5.4 12.1 25.1 27.9 2.8 7.6 13.2 5.0 8.6 2.3 5.4 2.7 1.0 6.5 5.9 6.1 16.8 4.6 11.2 3.4 6.7 3.6 3.5 8.8 4.6 31.6 25.1 7.5 20.5 7.8 9.5 9.2 24.3 3.6 2.1 4.3 4.0 5.6 6.6 6.0 10.0 17.0 12.5 3.5 15.1 11.9 2.7 6.6 17.3 1.6 2.6 6.7 7.9 7.1 5.0 6.6 38.2 29.5 5.1 11.1 8.3 5.8 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: " "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favourable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 11.9 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.1 17.2 2.5 11.8 10.3 14.8 8.3 1.9 16.6 3.7 9.1 6.3 3.4 9.6 16.0 9.2 13.4 9.5 11.1 8.9 6.2 11.2 5.3 3.8 0.0 10.0 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 127.8;urinary bladder: 105.1" "Cell line enhanced" "Detected in many" "Daudi: 28.8;EFO-21: 35.8;U-698: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 18.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Enhanced "Focal adhesion sites,Cytosol" 520000 "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 19.6 4.2 2.7 29.5 2.8 3.1 12.5 3.0 2.7 42.2 29.9 2.1 19.6 5.0 68.6 14.9 59.7 10.0 37.9 9.3 2.6 2.8 10.9 5.3 11.4 6.0 2.8 1.6 26.1 4.4 4.7 3.2 5.2 3.0 37.7 12.8 8.5 7.0 28.4 11.6 5.9 17.2 127.8 3.2 9.5 12.1 30.7 1.5 5.1 5.4 4.2 7.8 105.1 38.3 5.9 4.9 18.0 4.5 4.3 5.0 1.4 7.5 7.0 5.1 3.4 11.1 11.4 5.5 4.9 6.3 3.6 2.4 12.6 3.6 28.8 35.8 11.2 3.2 1.5 3.3 9.1 3.1 1.7 1.4 5.4 3.3 4.7 0.6 1.7 8.1 4.7 8.1 7.0 6.1 0.0 0.6 6.3 2.4 1.4 0.6 2.0 2.3 1.8 3.8 0.1 4.0 8.0 0.3 0.0 10.6 3.5 6.0 2.7 2.4 13.1 8.4 6.5 6.0 12.2 0.0 1.1 59.7 4.2 1.3 7.6 0.8 4.5 1.9 5.0 4.2 3.2 2.9 4.3 3.6 2.4 5.9 2.3 2.9 18.0 4.3 4.0 4.9 1.6 1.4 2.7 2.8 3.0 2.7 2.6 2.8 2.8 1.6 3.0 1.5 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.0;lymphoid tissue: 75.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.3;HMC-1: 65.8;Karpas-707: 56.4;U-2197: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favourable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 16.3 5.6 5.1 34.2 4.7 4.2 5.1 3.5 4.9 4.4 6.7 9.0 4.1 5.1 6.5 5.9 3.8 4.7 7.2 3.9 5.2 5.1 6.3 7.1 19.7 37.2 6.3 2.5 6.6 5.6 3.9 4.8 2.6 5.0 5.7 9.6 6.2 7.6 5.1 2.1 3.7 16.0 4.7 11.4 32.2 5.7 5.9 4.9 75.1 6.8 4.4 52.9 11.2 3.9 19.9 36.5 3.8 19.1 20.1 42.0 20.9 0.3 0.4 0.4 0.7 1.5 1.9 0.2 9.8 39.3 2.4 4.4 0.0 1.0 28.7 0.4 11.9 0.3 0.3 26.7 10.3 12.4 0.1 1.3 0.2 0.1 2.6 7.7 65.8 1.4 0.6 33.9 4.4 15.8 0.3 56.4 19.9 0.2 27.1 9.7 0.3 8.9 0.4 0.5 24.7 1.6 13.7 0.2 0.3 0.4 0.6 3.9 0.5 2.2 15.4 6.2 1.8 39.6 8.8 3.6 3.5 28.2 14.3 7.0 14.0 1.7 19.1 3.1 28.2 11.0 42.0 19.9 29.0 32.4 36.5 11.5 22.6 26.8 3.8 20.1 5.6 33.1 38.7 20.9 5.1 4.7 3.5 4.9 5.2 5.1 6.3 2.5 5.0 4.9 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.6 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.3 16.1 0.0 0.1 0.0 0.1 1.9 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 LRBA "BGL, CDC4L, LAB300, LBA" ENSG00000198589 "LPS responsive beige-like anchor protein" P50851 4 150264531-151015727 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019366, HPA023597" Approved Approved "Golgi apparatus,Cytosol" 190000 "Golgi apparatus" Cytosol "HPA019366: AB_2138441, HPA023597: AB_1853256" "unprognostic (2.60e-1)" "unprognostic (4.70e-2)" "unprognostic (1.64e-3)" "unprognostic (4.49e-3)" "unprognostic (4.38e-1)" "unprognostic (8.65e-2)" "unprognostic (5.88e-2)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (6.92e-2)" "unprognostic (2.29e-2)" "unprognostic (5.88e-2)" "prognostic favourable (2.22e-16)" "unprognostic (7.15e-2)" "unprognostic (2.36e-1)" "unprognostic (4.79e-1)" "unprognostic (3.00e-1)" 7.6 15.8 7.1 14.7 10.9 7.2 16.5 14.4 8.3 11.3 12.2 7.3 17.9 9.8 12.9 11.8 21.4 11.9 12.7 10.5 6.4 4.3 18.4 10.2 10.1 14.2 7.4 5.6 10.1 13.8 33.0 32.1 8.8 7.7 14.3 13.0 8.3 18.2 15.1 10.5 20.5 14.7 7.9 8.3 11.3 12.8 10.1 7.8 26.5 15.2 11.0 17.9 14.0 12.4 5.7 2.6 5.9 0.8 3.8 7.9 2.3 15.3 7.9 7.2 6.2 7.7 10.6 9.0 3.3 8.8 6.2 6.1 17.0 19.5 17.8 4.1 4.9 7.9 12.0 19.2 9.4 13.3 8.6 12.5 12.2 9.1 4.5 16.8 10.0 8.3 11.5 9.2 14.2 18.7 13.0 12.7 7.3 10.2 12.3 2.1 6.1 5.9 10.0 7.5 6.5 20.1 20.3 18.6 7.5 8.7 17.8 4.3 17.6 3.2 9.9 9.0 6.6 4.9 6.3 11.8 11.5 12.1 14.0 6.9 4.6 5.9 0.7 1.6 7.9 0.3 4.7 5.7 5.3 6.9 1.5 3.5 3.7 5.6 0.2 3.8 0.8 2.6 5.9 2.3 7.1 10.9 14.4 8.3 6.4 4.3 7.4 5.6 7.7 7.8 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavourable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavourable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavourable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.6 6.7 6.1 6.3 4.5 8.6 15.7 8.0 10.5 10.0 9.5 15.1 8.0 15.0 2.2 7.5 6.8 4.6 8.1 14.5 15.4 4.3 13.4 2.7 7.0 5.6 8.7 23.0 5.4 6.4 9.2 11.3 8.6 2.6 4.5 7.3 9.0 9.3 10.9 3.4 3.6 5.1 6.6 4.0 18.6 4.9 9.7 9.7 4.5 4.5 12.0 3.4 11.7 8.1 5.9 4.0 7.3 7.6 0.8 2.3 6.7 6.9 7.6 7.1 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234072 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.8;U-266/70: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003233 Approved Approved "Nucleoli,Plasma membrane" Nucleoli "Plasma membrane" "HPA003233: AB_2265929" "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 5.1 8.7 11.6 3.4 10.2 0.7 3.3 11.2 10.6 11.2 11.6 5.5 4.0 1.6 9.9 4.5 3.6 4.6 5.3 4.7 7.9 8.9 2.6 1.0 5.7 1.8 5.7 4.6 13.8 1.6 1.3 20.9 13.7 7.6 16.4 4.2 2.5 1.3 14.5 1.2 1.1 3.2 13.7 6.4 3.7 3.6 4.3 7.9 0.0 4.8 0.4 1.1 11.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 5.5 4.6 0.0 3.5 7.6 3.4 7.9 0.0 0.0 0.1 0.0 4.6 0.3 17.8 0.0 5.2 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.1 2.7 0.0 1.4 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.2 0.0 3.8 0.0 4.3 0.5 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.9 11.8 2.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 10.2 11.2 8.4 7.9 8.9 5.7 4.6 7.6 7.9 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8;NB-4: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.8 4.4 4.4 4.0 2.6 2.0 8.4 7.6 3.4 4.5 3.6 7.3 11.4 5.6 8.5 2.2 6.7 2.1 3.2 1.2 5.6 5.9 6.5 5.2 3.5 8.4 11.2 44.8 3.4 3.4 3.7 2.1 4.5 8.0 11.7 3.1 14.7 12.8 69.2 4.6 5.2 14.3 3.6 6.9 3.4 2.7 5.7 8.6 3.6 11.6 8.8 7.8 24.4 7.0 6.1 11.0 8.4 4.5 11.9 5.6 5.1 4.7 27.7 10.4 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 LRIF1 "C1orf103, FLJ11269, RIF1" ENSG00000121931 "Ligand dependent nuclear receptor interacting factor 1" Q5T3J3 1 110947185-110964079 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044515 Uncertain Supported "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA044515: AB_10796800" "unprognostic (5.06e-2)" "unprognostic (4.82e-2)" "unprognostic (4.74e-1)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "prognostic favourable (1.73e-4)" "unprognostic (5.14e-2)" "unprognostic (9.23e-3)" "unprognostic (3.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-1)" "unprognostic (3.88e-2)" "unprognostic (2.70e-1)" 9.0 11.2 13.7 15.4 15.5 5.9 20.7 15.6 14.7 7.9 7.5 6.6 7.8 7.0 8.1 23.9 8.1 9.6 6.7 16.1 12.7 13.3 9.6 16.7 11.9 17.6 10.5 7.5 18.4 6.9 5.8 17.5 25.1 10.3 9.9 7.6 7.3 8.6 9.2 20.5 10.6 8.4 6.0 12.4 14.0 8.1 27.7 10.1 16.8 12.6 10.2 19.0 10.0 28.5 21.0 11.4 21.4 8.2 18.0 19.4 8.4 11.8 5.2 10.0 6.8 4.6 7.6 11.3 7.3 8.4 12.8 10.4 13.1 15.0 9.1 10.5 5.5 7.7 4.7 4.3 15.6 16.4 5.6 10.0 5.3 13.5 13.7 18.8 12.3 4.7 12.2 8.8 15.6 6.8 31.3 41.9 8.6 3.9 1.9 15.0 15.0 12.1 12.6 16.4 11.0 3.3 6.2 8.4 9.2 0.0 12.6 21.2 10.5 30.7 4.8 11.4 0.4 13.3 5.9 19.4 6.7 17.0 6.5 21.6 19.6 13.0 5.7 12.3 15.3 6.3 19.4 21.0 12.1 15.8 11.4 15.5 13.5 18.5 21.4 18.0 8.2 10.3 11.1 8.4 13.7 15.5 15.6 14.7 12.7 13.3 10.5 7.5 10.3 10.1 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavourable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.4 2.4 6.7 5.1 6.5 6.7 3.9 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.6 5.0 4.6 3.0 5.8 3.1 2.7 4.8 4.6 1.7 6.6 5.7 2.3 6.5 5.5 5.4 7.1 4.4 5.7 4.3 4.2 3.2 5.8 6.1 6.3 4.0 5.3 8.4 2.2 3.3 3.0 4.8 3.9 5.0 3.3 6.4 2.5 6.5 6.6 6.4 3.5 8.7 4.5 4.8 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.1 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431453-76560167 "Disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Hep G2: 18.0;HMC-1: 14.0;NB-4: 25.9;SK-MEL-30: 36.5;THP-1: 19.4;U-937: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 23.6;myeloid DC: 27.3" "Group enriched" "Detected in many" 8 "dendritic cells: 27.3;granulocytes: 8.7;monocytes: 23.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 12.7 35.3 4.6 4.7 6.4 13.2 6.1 2.6 3.6 7.1 4.6 8.2 12.5 3.1 12.5 34.9 5.3 5.7 8.9 13.2 3.7 5.1 11.5 19.1 13.1 5.6 7.4 3.1 8.6 21.0 6.8 9.7 6.9 6.7 8.3 4.0 19.8 10.7 8.8 2.2 2.3 4.5 5.3 8.1 7.8 8.6 5.8 5.0 0.1 13.2 6.9 3.9 5.5 5.3 0.0 27.3 8.7 23.6 2.6 0.1 6.7 0.1 2.5 0.1 0.0 1.2 1.5 0.0 0.2 0.0 0.1 0.2 3.0 5.4 0.0 10.6 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.6 1.3 18.0 0.5 3.6 14.0 0.7 0.5 0.2 0.0 0.5 0.0 0.6 0.0 0.3 0.0 25.9 0.1 1.1 0.0 0.1 0.0 0.2 3.3 0.1 0.2 3.2 0.0 36.5 0.2 19.4 0.3 0.1 1.3 0.9 2.0 0.2 0.0 0.0 9.4 17.4 4.6 2.6 23.6 8.7 0.0 11.2 0.1 0.0 0.0 0.0 27.3 0.0 0.0 0.0 1.3 2.6 6.4 0.2 0.0 6.7 4.6 6.4 2.6 3.6 3.7 5.1 7.4 3.1 6.7 5.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Group enriched" "Detected in some" 6 "Daudi: 94.1;REH: 32.7;U-698: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.1 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 5.6 0.0 0.0 0.0 7.2 8.3 0.0 0.0 0.1 0.0 0.0 1.1 6.3 0.0 0.0 7.9 13.4 0.0 0.0 32.7 0.0 9.3 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 0.0 6.2 1.1 107.6 0.0 3.2 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128493-57213351 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 82.6;ASC TERT1: 83.9;fHDF/TERT166: 36.0;HSkMC: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 20 "dendritic cells: 2.8;monocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" 88000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: , HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavourable (1.29e-5)" 77.8 12.0 19.8 21.5 21.3 6.1 27.7 28.1 25.3 31.4 19.7 11.9 9.0 17.8 26.9 18.2 19.2 21.0 24.1 26.0 18.6 10.4 6.3 31.4 24.7 5.5 13.9 15.6 56.9 8.8 8.5 8.0 29.4 17.1 21.4 9.5 20.0 14.8 17.0 11.3 15.7 14.2 22.4 14.3 11.3 11.8 11.1 15.4 0.3 13.2 9.3 3.1 22.9 39.4 0.0 2.8 0.1 7.6 0.0 0.2 1.9 1.2 2.3 5.0 4.0 82.6 83.9 15.2 13.9 18.0 4.6 4.5 4.3 2.0 0.0 1.7 36.0 5.5 0.8 1.4 1.6 0.1 0.2 0.0 2.7 9.0 11.3 0.0 2.4 54.3 0.5 10.3 1.2 0.2 0.0 0.2 14.3 0.2 0.0 0.0 5.8 1.4 0.5 28.6 0.2 0.3 0.3 0.2 2.7 3.1 0.1 2.2 0.4 0.2 0.2 16.1 6.0 8.9 0.8 0.1 0.0 0.0 28.2 0.0 3.0 0.0 7.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 1.9 19.8 21.3 28.1 19.7 18.6 10.4 13.9 15.6 17.1 15.4 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavourable (3.54e-7)" "prognostic unfavourable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favourable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.8 4.1 10.8 56.5 32.8 14.1 24.4 46.5 15.4 21.4 5.7 54.9 8.1 12.2 55.0 22.1 2.7 27.9 6.1 13.2 2.9 2.8 10.3 4.0 25.2 6.4 25.8 35.8 32.7 23.1 12.0 28.1 3.4 31.3 20.7 17.8 1.8 1.9 0.9 25.4 4.0 4.2 8.0 16.5 27.5 0.3 4.5 13.5 26.0 10.6 13.6 4.6 29.3 23.8 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.1 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589024 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 22.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 6.1 5.3 10.7 4.0 23.4 2.1 4.7 11.3 16.3 7.4 5.1 4.3 5.1 3.3 18.2 4.5 4.6 6.9 8.1 14.2 8.7 6.5 7.2 1.6 4.8 1.6 4.6 9.5 6.9 5.4 13.0 11.0 5.6 7.1 7.4 5.3 3.3 5.0 6.8 11.8 5.1 3.1 20.2 4.1 3.8 3.8 5.0 5.2 18.0 7.4 3.4 2.4 6.2 5.4 0.0 0.3 22.6 0.4 0.4 1.0 0.2 7.4 4.3 8.9 15.6 10.1 8.1 2.0 21.4 21.4 7.5 10.5 0.9 7.4 0.0 8.6 20.2 3.3 3.6 9.1 16.1 13.8 3.4 11.6 2.0 0.3 6.3 0.1 9.4 10.7 6.5 12.5 10.2 3.8 2.4 0.0 26.7 1.2 10.6 0.2 2.2 7.6 0.8 8.7 1.6 6.0 0.3 11.4 7.0 6.8 0.3 18.2 2.1 2.3 10.6 20.6 13.4 6.6 13.7 10.1 7.9 0.0 11.1 0.0 22.5 22.6 0.2 3.5 0.1 0.4 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 10.7 23.4 11.3 16.3 8.7 6.5 4.6 9.5 7.1 5.2 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Group enriched" "Detected in some" 12 "AF22: 21.4;CACO-2: 35.6" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: " "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favourable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 17.3 5.2 10.8 2.9 4.0 0.7 1.5 2.3 2.6 2.2 0.0 0.0 1.1 8.9 3.1 9.6 5.9 1.8 0.0 8.1 0.8 3.0 5.3 2.3 0.1 1.5 3.7 3.4 3.6 0.9 2.0 0.7 0.0 1.3 0.6 0.1 0.2 9.4 0.7 1.2 5.9 0.0 0.2 2.2 0.0 11.4 0.9 0.0 2.8 0.2 0.4 0.1 4.7 2.9 5.3 1.6 0.0 0.0 0.3 3.5 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: , HPA069364: " "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavourable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.9 12.1 11.1 27.6 25.0 14.4 18.9 20.4 8.4 7.3 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.2 2.3 23.2 12.9 2.2 3.8 12.4 5.6 13.1 9.9 13.7 13.6 20.1 27.1 19.4 7.7 21.0 19.1 21.7 14.6 9.3 9.3 12.8 7.2 11.6 13.9 8.4 17.9 15.2 5.0 19.2 31.8 8.4 14.9 7.5 10.8 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Group enriched" "Detected in some" 5 "AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA047619: " "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 12.8 0.0 0.0 0.0 6.7 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favourable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 9.4 10.3 11.9 15.0 11.9 9.5 26.5 14.3 22.3 10.4 10.5 15.1 5.0 11.0 13.7 8.9 11.5 10.6 11.3 9.7 12.4 8.2 9.4 8.9 10.0 12.2 15.3 16.0 11.2 17.5 16.9 13.5 8.4 12.7 15.6 7.9 9.4 16.8 12.9 9.8 17.6 10.6 12.7 9.2 11.9 11.0 9.6 12.1 9.7 13.8 6.2 9.8 11.9 9.4 10.6 9.8 4.7 8.6 13.1 10.3 8.7 9.5 19.6 5.3 8.6 5.7 4.7 7.6 8.5 3.7 6.9 6.0 8.7 11.7 7.8 9.1 6.3 10.5 8.3 8.5 3.2 10.4 19.2 11.6 20.9 3.6 5.4 4.9 9.6 5.7 7.3 6.9 3.4 5.9 15.2 9.3 6.7 11.7 18.1 6.4 4.3 28.5 15.5 4.4 10.9 4.2 8.4 14.5 8.1 13.1 10.5 6.1 16.2 5.5 6.3 11.9 21.1 10.4 12.5 5.3 3.1 9.6 11.1 11.4 7.3 1.9 8.6 1.8 10.3 8.1 10.2 9.0 7.7 9.6 8.4 10.6 8.6 7.0 4.7 13.1 6.7 9.8 7.2 8.7 11.9 11.9 14.3 22.3 12.4 8.2 15.3 16.0 12.7 12.1 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191511-195353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3" "Cell line enriched" "Detected in some" 4 "U-266/84: 28.5" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: " "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 30.6 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 0.4 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 14.3 0.7 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 3.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 7.0 28.5 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.2 0.0 0.5 0.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 1.5 1.2 0.0 0.0 0.0 0.0 25.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102912991-102944949 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.0" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 168.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 75 "granulocytes: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (6.30e-4)" 5.1 1.3 1.1 0.5 1.2 0.0 6.2 1.4 2.0 15.0 1.4 1.5 5.6 0.5 8.3 17.1 5.2 8.9 13.5 6.4 1.2 1.3 1.5 1.4 1.6 1.6 1.1 2.1 39.0 2.6 1.2 1.7 1.8 2.5 7.8 1.4 2.7 2.8 2.5 5.3 2.0 2.6 5.1 1.2 1.2 3.5 5.1 0.2 2.2 2.6 6.7 1.3 6.7 4.2 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.8 4.2 0.0 0.2 2.4 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 3.9 0.1 2.9 0.0 19.1 0.0 0.0 168.8 0.0 0.0 0.0 0.4 0.0 0.0 33.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 2.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.4 2.0 1.2 1.3 1.1 2.1 2.5 0.2 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 9.7 2.1 4.7 4.6 2.3 16.0 3.5 2.4 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 51.5" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: " "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favourable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favourable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 8.5 0.0 51.5 0.0 0.0 0.4 0.1 0.2 2.5 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: " "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.7 5.0 11.2 15.7 9.8 10.1 1.1 2.7 8.8 4.5 4.1 0.8 5.7 1.5 1.6 6.3 1.9 2.5 1.3 2.9 3.2 2.2 0.3 3.5 2.6 7.0 1.2 1.8 4.4 8.7 4.6 6.1 3.2 0.9 1.1 3.5 4.6 2.3 3.4 3.1 1.7 2.1 1.8 0.8 8.1 0.7 2.0 5.7 1.3 0.9 3.5 2.5 2.8 4.2 1.8 2.3 4.1 1.6 0.8 0.3 0.8 8.3 2.3 1.1 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: " "unprognostic (4.84e-2)" "prognostic favourable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favourable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 3.1 7.5 7.5 9.7 10.8 15.3 3.2 3.3 9.2 5.7 6.7 5.8 6.7 6.3 6.1 7.8 6.9 5.4 10.5 8.3 3.9 8.0 4.2 3.5 5.9 9.6 4.1 6.9 9.0 14.5 5.3 10.7 17.8 3.7 6.3 11.7 6.0 11.3 7.0 3.1 2.7 6.9 6.4 5.7 12.0 9.9 3.4 4.4 7.8 4.2 12.1 6.6 7.8 6.4 5.6 3.9 4.2 6.4 12.9 17.7 3.9 7.1 4.1 10.4 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793428-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 13.7;testis: 23.8" "Cell line enhanced" "Detected in many" "HEK 293: 7.5;HEL: 9.4;HL-60: 9.9;NTERA-2: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 7 "B-cells: 2.2;dendritic cells: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules" "Cell Junctions, Microtubules" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 2.8 1.1 4.8 1.2 9.6 2.7 2.3 1.1 4.0 2.3 0.9 4.2 1.4 1.0 1.9 3.9 1.0 13.7 1.1 2.0 4.1 3.8 2.1 0.9 3.4 1.9 3.5 5.6 2.2 0.5 1.0 7.9 0.9 11.8 2.0 0.7 2.6 1.3 2.4 0.9 1.0 1.1 2.0 3.6 1.8 1.1 23.8 4.8 1.7 2.7 0.5 1.2 1.0 0.9 2.2 4.6 0.1 0.3 0.0 0.5 0.4 2.7 0.4 0.8 0.0 1.1 4.1 0.0 1.2 2.4 2.8 2.7 0.1 0.0 1.6 0.0 0.7 0.0 2.5 0.0 1.0 0.4 7.5 9.4 0.1 0.0 0.7 9.9 2.5 1.4 0.5 1.1 0.0 1.8 0.2 0.0 1.1 0.0 0.9 2.0 10.0 3.1 4.9 0.0 0.5 2.3 0.2 4.9 3.8 0.8 0.1 0.0 0.0 4.8 0.4 0.6 0.0 0.3 0.0 0.0 0.0 2.3 4.5 0.1 2.7 0.0 0.2 0.0 0.0 0.3 0.2 2.2 0.0 0.0 1.4 1.5 0.0 0.0 0.1 0.0 0.0 4.6 0.5 0.4 4.8 9.6 1.1 4.0 4.1 3.8 3.5 5.6 11.8 4.8 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303608 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA051941: " "unprognostic (1.57e-2)" "prognostic unfavourable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 24.2 27.6 19.7 14.6 20.3 14.1 23.3 26.0 31.9 29.9 23.6 25.7 32.6 18.4 35.0 25.1 29.1 36.2 25.2 25.7 19.5 17.3 21.8 27.6 21.5 16.4 17.5 20.2 38.3 30.6 37.4 29.4 45.2 17.7 28.8 16.6 25.4 27.0 36.7 32.2 26.3 25.1 29.4 15.3 19.1 22.6 26.1 17.9 30.4 31.7 21.8 24.1 29.5 25.1 14.8 29.1 16.4 20.1 19.4 16.9 17.0 14.4 10.6 18.4 19.9 24.9 31.2 17.3 15.1 28.0 22.0 14.8 8.9 4.8 9.2 20.1 35.7 11.3 17.9 21.3 11.2 11.1 19.4 15.0 12.3 13.0 35.0 9.2 8.0 38.2 28.8 20.5 24.8 28.0 14.8 9.5 24.0 9.2 12.2 12.3 27.5 10.4 10.2 9.5 14.9 24.6 17.8 17.1 19.5 20.3 20.3 24.2 11.9 28.1 18.4 19.3 8.8 16.0 14.3 15.7 7.3 4.0 18.1 7.1 13.3 16.4 20.1 9.2 14.3 19.0 15.1 12.7 15.4 15.9 29.1 14.8 16.9 13.0 2.0 19.4 12.7 16.6 14.9 17.0 19.7 20.3 26.0 31.9 19.5 17.3 17.5 20.2 17.7 17.9 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6" "Cell line enhanced" "Detected in some" "HHSteC: 2.8;HSkMC: 3.2;HUVEC TERT2: 6.4;SCLC-21H: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA039425: " "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.9 0.9 3.0 0.3 5.0 0.8 0.7 1.2 4.6 1.5 0.7 4.1 1.3 1.0 1.4 6.6 0.4 26.6 1.6 1.5 4.5 3.0 3.1 0.5 2.5 0.4 3.1 1.5 3.3 1.2 3.5 3.4 0.5 6.4 1.3 0.5 2.9 1.8 2.2 0.4 0.8 0.5 0.6 1.0 0.8 0.7 10.8 1.8 0.0 2.5 0.0 0.4 0.7 0.3 0.0 0.9 0.0 0.6 2.9 1.9 0.8 0.0 0.0 0.3 0.0 0.3 0.7 0.4 0.0 1.8 0.5 0.5 0.6 0.1 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 2.8 0.1 0.6 3.2 0.0 1.0 0.0 6.4 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.3 0.1 0.0 0.1 0.0 0.3 5.2 1.1 0.0 0.2 0.3 0.8 1.6 0.5 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.9 0.0 2.9 0.6 0.9 0.0 0.8 3.0 5.0 1.2 4.6 4.5 3.0 3.1 1.5 6.4 1.8 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavourable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.7 11.1 3.4 6.9 1.4 1.9 13.2 6.8 2.8 4.1 3.5 9.9 6.7 7.3 6.2 1.3 11.4 3.2 4.1 0.9 4.4 20.9 4.6 20.2 13.3 1.1 5.4 11.6 1.8 1.7 2.4 0.6 6.0 3.2 3.2 1.0 16.5 12.1 18.1 3.5 14.9 10.0 6.6 4.0 2.6 9.0 10.5 10.2 3.1 16.3 5.7 13.3 6.3 3.5 7.2 9.1 11.4 11.5 6.3 1.6 1.1 3.9 4.7 7.5 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol 230000 "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favourable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 13.9 14.7 15.8 11.6 13.6 32.7 19.2 12.4 19.1 11.8 16.0 10.6 9.7 12.3 15.7 12.2 18.0 15.3 10.2 15.6 18.0 8.4 14.2 11.1 15.9 11.2 11.8 16.5 17.6 14.5 13.2 12.2 14.4 9.9 12.3 18.9 16.4 15.7 11.6 11.0 16.5 14.5 12.8 10.3 13.0 14.1 12.4 11.3 14.9 15.1 10.0 12.8 13.1 15.6 4.8 6.9 22.1 12.0 11.1 6.7 4.3 10.3 7.8 14.3 10.7 11.8 9.4 7.7 14.8 7.9 10.5 11.1 16.1 8.3 4.9 10.4 11.5 17.0 9.5 11.6 10.6 10.2 8.9 19.3 17.3 7.2 11.5 11.9 12.4 10.3 15.5 9.5 11.8 16.7 14.8 11.7 9.5 4.8 6.9 5.3 3.8 7.1 10.9 13.7 7.6 7.2 16.9 7.4 8.8 17.1 12.4 8.6 11.5 14.2 17.0 12.6 8.9 13.0 11.0 9.9 24.6 20.1 7.2 12.0 15.5 22.1 6.5 20.5 5.4 9.4 6.7 4.2 5.2 4.9 6.9 4.8 4.3 5.3 8.5 11.1 12.0 4.0 5.2 4.3 15.8 13.6 12.4 19.1 18.0 8.4 11.8 16.5 9.9 11.3 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057574: " "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (6.18e-4)" "unprognostic (1.06e-1)" 15.8 30.1 12.7 10.7 14.3 10.0 15.4 13.9 14.8 15.4 13.3 16.3 11.3 9.6 14.5 11.3 14.6 11.0 9.7 9.6 12.9 9.6 19.2 14.1 10.9 12.7 15.9 10.5 19.7 13.1 21.0 9.8 12.1 14.4 15.1 9.9 13.2 11.6 12.1 9.2 13.8 12.2 15.5 22.9 14.6 10.0 7.9 15.5 27.9 18.3 9.0 11.0 17.2 16.1 5.7 6.4 3.5 5.8 3.7 8.4 3.4 24.5 8.7 6.0 7.6 13.8 13.2 9.5 8.8 7.7 9.4 11.9 8.1 7.6 16.1 11.1 9.4 10.8 10.9 8.7 18.1 6.2 6.8 17.2 11.9 9.4 9.3 27.8 8.9 9.7 11.2 11.5 14.8 5.5 9.7 20.8 10.2 11.2 21.8 8.9 6.0 15.9 4.8 16.0 10.4 7.2 9.1 7.7 10.2 15.6 10.7 22.0 11.7 12.6 8.2 15.9 17.7 10.6 11.1 17.9 20.5 34.2 16.0 21.1 13.2 2.4 5.8 2.3 4.4 5.1 6.4 5.4 5.5 5.6 5.5 5.7 8.4 6.2 3.5 3.7 3.9 6.4 5.4 3.4 12.7 14.3 13.9 13.5 12.9 9.6 15.9 10.5 14.4 15.5 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Group enriched" "Detected in some" 6 "HaCaT: 10.3;HEL: 30.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 10.3 0.2 0.0 0.0 0.0 0.5 30.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Cell line enhanced" "Detected in some" "HEL: 11.8;HUVEC TERT2: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favourable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.1 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.7 2.2 1.1 0.3 0.0 0.8 0.1 0.4 0.3 0.2 0.1 0.4 0.9 11.8 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 3.8 0.5 0.2 0.0 1.9 1.9 0.8 0.2 0.1 0.6 0.7 0.1 0.5 0.2 2.3 0.6 0.0 0.2 2.8 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.7;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;NK-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 4.2 1.9 7.5 1.4 6.0 3.0 2.6 3.8 6.6 3.5 3.8 2.6 11.5 1.4 2.4 5.8 3.4 3.3 9.8 4.3 5.5 9.1 6.0 3.4 1.7 1.7 7.8 4.0 7.3 7.2 1.4 1.5 2.3 4.1 6.9 2.0 4.9 7.5 15.0 10.7 4.3 8.2 6.7 7.0 2.7 2.6 8.3 0.5 0.0 8.6 3.0 2.1 5.5 2.7 0.0 0.3 2.7 0.4 2.0 0.2 0.0 0.1 4.2 0.0 2.3 0.6 1.7 0.4 0.6 0.7 1.5 1.6 3.0 0.0 0.0 1.0 1.2 4.7 0.4 2.3 0.0 1.3 2.8 0.3 0.6 8.3 4.2 0.0 0.0 0.0 1.7 1.5 0.2 1.1 0.4 0.0 0.1 7.4 0.0 1.5 2.1 1.7 0.0 0.2 0.0 1.9 0.4 2.2 6.6 2.2 0.7 0.6 0.0 0.7 2.3 2.5 1.6 0.9 0.8 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 7.5 6.0 3.8 5.6 5.5 9.1 7.8 4.0 4.1 0.5 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014745 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA014745: AB_1853348" "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavourable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.3 15.9 6.5 15.4 11.7 9.9 22.1 16.7 25.3 9.5 12.0 6.8 6.2 19.3 19.1 27.7 32.1 14.9 20.0 12.1 15.0 8.3 22.6 14.4 14.4 22.9 25.7 7.1 6.2 16.7 8.1 17.7 16.1 12.3 6.1 10.3 7.3 10.6 16.7 11.3 14.6 14.5 9.5 13.8 24.0 8.7 12.2 8.5 20.8 21.6 46.2 5.1 25.6 7.1 10.2 3.5 20.8 12.6 7.5 12.7 11.6 3.9 32.6 9.0 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052656-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" 1000000 "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: " "unprognostic (2.03e-3)" "prognostic favourable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 15.4 17.3 23.0 17.5 22.0 27.5 21.9 30.0 22.8 35.7 35.8 26.5 17.7 24.7 28.2 20.0 33.0 15.7 22.8 47.4 23.8 25.3 19.8 33.9 18.7 19.3 24.2 19.4 20.6 16.9 33.9 18.3 16.9 24.4 30.3 24.8 19.6 19.3 19.5 58.5 23.2 37.1 27.3 31.2 29.7 17.0 47.2 24.8 11.6 20.6 33.6 21.6 23.7 25.1 7.1 9.8 22.7 17.2 11.9 8.8 7.5 15.3 8.6 9.9 7.8 13.3 20.4 8.7 41.9 41.8 23.7 27.2 8.0 7.1 6.1 6.9 40.4 8.0 7.2 20.7 38.8 13.5 5.7 10.9 12.2 7.8 19.0 8.6 6.6 9.0 14.9 30.8 31.9 16.3 8.6 10.7 19.6 3.9 7.3 4.6 6.5 11.0 3.5 28.3 6.1 16.6 6.0 3.6 5.7 16.2 15.0 13.5 8.6 8.9 15.7 18.2 12.2 26.6 19.7 8.3 14.9 9.3 10.7 7.7 25.7 12.2 15.0 22.7 6.6 10.4 8.5 7.1 7.0 7.0 9.8 5.4 5.2 6.2 14.0 11.9 17.2 5.5 8.8 7.5 23.0 22.0 30.0 22.8 23.8 25.3 24.2 19.4 24.4 24.8 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.4 1.9 0.3 0.8 2.1 0.8 1.3 1.2 0.9 1.7 1.8 0.2 2.8 2.8 2.5 0.2 0.3 4.3 4.0 2.1 6.8 0.1 2.5 0.6 1.3 0.3 4.4 1.4 1.4 2.2 2.9 1.1 0.8 2.1 3.9 2.7 0.0 1.7 0.7 2.2 1.3 2.1 1.6 2.8 2.5 0.3 2.1 1.4 0.3 0.3 6.0 1.7 2.5 0.3 0.3 1.4 1.0 2.3 4.0 1.4 2.2 3.0 0.5 2.2 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919215-101078254 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell line enhanced" "Detected in many" "Daudi: 23.1;Karpas-707: 17.0;U-266/84: 15.4;U-698: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.2;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010537 Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 6.1 1.9 4.5 26.3 3.9 6.5 5.0 2.1 8.1 6.4 8.0 5.9 2.2 2.9 7.9 6.0 5.4 7.1 4.2 3.4 4.0 1.5 2.7 1.0 4.7 15.0 4.5 4.0 6.3 5.3 2.8 2.3 4.4 2.5 7.1 6.5 2.8 7.7 6.8 1.6 7.3 8.5 5.7 3.7 11.1 3.9 5.1 3.4 1.2 3.5 2.1 17.4 7.5 6.7 2.3 3.3 3.2 1.1 0.0 0.0 0.1 0.8 4.7 0.0 0.0 7.3 7.5 0.0 2.8 2.1 2.6 1.8 0.8 2.1 23.1 1.0 7.7 4.7 0.6 0.5 1.3 0.4 1.1 7.0 1.0 0.0 0.5 3.7 5.4 5.9 1.0 1.7 1.5 4.7 1.1 17.0 0.5 0.0 0.0 2.3 0.2 2.0 1.6 0.4 6.3 0.0 0.0 0.0 1.6 1.8 2.7 5.3 0.3 4.5 5.4 0.0 0.8 1.0 0.0 8.7 15.4 15.0 0.3 0.5 4.3 0.0 0.7 3.2 0.0 0.3 0.0 2.3 0.0 0.0 0.9 1.5 0.0 0.0 0.8 0.0 1.1 3.3 0.0 0.1 4.5 3.9 2.1 8.1 4.0 1.5 4.5 4.0 2.5 3.4 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell line enhanced" "Detected in some" "A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favourable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.7 0.1 0.0 3.9 10.0 0.1 2.1 5.6 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.4 0.0 0.7 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 0.6 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.0 10.7 0.0 0.1 0.6 0.0 0.2 2.7 2.8 2.2 1.4 1.1 1.1 1.2 0.7 0.0 0.0 0.0 2.3 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell line enhanced" "Detected in some" "AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043820: , HPA046792: " "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.6 1.7 6.8 2.9 0.0 8.2 18.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 7.1 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.2 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.6;ASC TERT1: 18.7;HHSteC: 14.6;HSkMC: 7.9;LHCN-M2: 9.5" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.0 0.2 0.2 5.6 18.7 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.6 0.2 0.1 7.9 0.1 0.4 0.0 0.0 0.2 0.1 9.5 0.0 0.2 0.4 0.4 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.2 0.2 0.6 0.1 0.2 0.2 1.7 0.1 2.0 0.1 0.2 0.1 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Cell line enhanced" "Detected in some" "AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.4 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.3 10.2 5.5 15.5 4.2 3.2 8.6 7.8 5.1 13.3 9.2 9.7 4.3 18.1 11.2 5.9 7.8 8.1 7.0 4.0 6.3 15.7 3.7 4.6 6.0 5.6 6.9 7.3 3.0 4.3 15.4 3.3 7.0 17.5 5.6 7.2 22.1 21.0 16.7 11.7 14.7 11.1 5.1 19.5 4.0 4.6 7.3 20.7 8.6 8.2 7.6 4.7 5.8 4.1 7.4 15.8 22.8 12.4 20.6 35.5 17.3 8.2 6.5 12.8 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640788-194672477 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavourable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 20.4 17.8 14.2 17.9 20.7 28.8 21.8 14.5 18.9 17.7 18.5 19.2 16.6 20.4 21.6 24.8 22.5 18.3 15.3 17.8 13.3 15.1 20.4 30.6 18.2 20.2 19.9 13.3 21.9 25.6 20.6 24.4 24.2 23.8 21.0 22.3 15.9 19.8 22.2 30.1 26.0 20.0 18.0 16.3 22.2 18.5 18.6 15.9 25.0 23.5 15.8 28.1 18.7 20.3 13.2 14.0 10.7 10.6 17.0 14.9 8.2 20.5 13.7 8.3 13.9 13.0 7.1 16.9 12.4 12.0 17.0 15.1 18.0 9.5 16.3 37.3 11.3 15.0 26.2 14.1 20.7 21.0 12.6 17.4 14.2 10.2 9.3 19.1 16.9 6.9 12.2 17.6 16.4 18.4 14.5 18.1 14.0 28.7 17.2 11.4 22.6 25.2 20.9 13.7 18.4 9.1 17.9 15.8 10.9 16.1 14.7 15.0 34.7 12.5 14.0 13.0 14.8 18.2 25.3 20.0 26.2 38.7 10.4 24.7 20.0 2.8 8.1 10.7 13.5 10.6 14.9 13.2 11.0 11.9 14.0 11.0 12.9 11.5 1.1 17.0 7.1 7.4 12.2 8.2 14.2 20.7 14.5 18.9 13.3 15.1 19.9 13.3 23.8 15.9 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163321-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 21.8 27.6 25.5 20.0 23.5 21.6 34.1 20.8 23.2 19.5 23.4 15.3 21.2 20.6 24.9 27.2 24.9 17.8 21.6 44.2 21.2 23.2 35.3 30.7 16.2 22.5 25.1 18.4 18.0 24.7 14.5 23.2 29.8 22.5 21.3 21.5 18.7 27.7 29.0 26.6 17.7 26.3 31.3 17.1 20.5 22.6 17.6 19.9 18.8 25.7 25.6 22.2 23.5 22.7 21.1 38.2 42.8 26.0 19.9 27.3 26.5 21.5 25.3 14.9 18.2 27.4 23.0 13.8 26.4 26.9 24.5 26.2 17.3 14.9 10.7 23.7 31.3 11.5 20.1 21.8 25.8 16.2 25.3 33.7 18.1 21.3 24.3 11.4 21.5 24.0 20.1 21.2 16.8 20.8 26.7 25.5 30.2 22.9 35.5 22.3 23.4 25.8 17.3 16.3 12.6 33.8 24.0 28.0 23.3 11.7 17.5 31.1 13.9 24.5 21.9 21.9 26.9 32.2 20.8 28.2 36.6 21.1 25.3 23.8 22.3 42.8 24.0 32.7 21.8 24.7 23.2 21.1 24.5 23.8 23.2 16.4 22.2 25.5 18.3 19.9 26.0 38.2 27.3 26.5 25.5 23.5 20.8 23.2 21.2 23.2 25.1 18.4 22.5 19.9 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397892 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favourable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 15.0 11.9 19.8 17.7 20.2 12.6 21.1 11.1 20.9 12.3 20.8 9.5 16.7 11.9 14.2 19.1 15.0 11.4 15.7 28.2 18.6 19.7 17.3 21.3 11.8 27.3 17.7 14.4 14.6 18.6 12.1 16.4 13.2 17.0 16.2 11.0 13.8 16.9 19.5 82.0 10.1 13.0 17.8 12.5 21.1 14.5 12.1 10.3 10.3 18.9 22.0 26.8 19.1 25.0 73.8 45.9 66.7 50.5 19.1 31.0 49.9 18.5 28.4 10.7 28.6 25.3 24.9 11.1 16.8 24.7 27.0 20.7 12.7 17.8 44.1 23.3 22.7 10.3 18.1 21.8 18.0 29.8 21.7 22.1 16.8 29.8 30.8 16.6 32.5 20.8 19.4 24.2 17.2 27.6 20.3 21.6 19.0 33.1 18.5 18.9 27.6 29.6 14.0 10.3 29.7 26.1 11.4 13.7 10.3 13.6 17.5 40.7 9.1 14.3 18.3 12.3 17.1 32.1 26.1 28.6 38.4 34.4 24.8 25.5 27.8 35.7 50.5 61.4 25.6 48.7 27.8 70.6 25.5 26.5 36.0 73.8 23.1 25.0 66.7 19.1 44.9 45.9 31.0 49.9 19.8 20.2 11.1 20.9 18.6 19.7 17.7 14.4 17.0 10.3 LSM11 FLJ38273 ENSG00000155858 "LSM11, U7 small nuclear RNA associated" P83369 5 157743695-157760709 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039587 Uncertain Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA039587: AB_10796330" "unprognostic (3.99e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (6.90e-2)" "unprognostic (2.32e-2)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (9.68e-3)" "unprognostic (1.70e-1)" "unprognostic (2.89e-2)" "unprognostic (3.77e-2)" "unprognostic (3.57e-1)" "unprognostic (1.62e-3)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (3.01e-2)" 3.4 3.7 10.8 3.6 4.7 2.9 6.4 13.6 11.8 5.3 8.9 1.9 4.9 4.6 9.1 3.2 4.7 4.6 4.7 2.4 5.1 6.1 2.8 2.7 3.1 3.9 4.7 9.2 7.3 3.7 5.0 4.2 4.2 5.8 9.2 5.4 2.7 3.4 10.2 2.5 4.4 3.8 21.0 3.3 3.1 4.1 9.0 1.4 1.9 2.6 2.6 4.2 15.0 8.0 1.0 0.6 1.6 0.9 2.7 1.8 0.5 3.7 2.7 7.5 7.9 3.4 4.4 6.5 5.1 2.3 4.3 5.7 8.1 3.8 8.2 6.0 3.0 4.4 9.6 5.6 4.7 5.8 9.1 3.4 9.6 5.1 1.2 9.9 4.3 1.9 3.7 5.3 5.4 7.0 6.3 4.4 4.6 3.5 5.6 5.8 2.2 8.3 9.0 9.3 3.4 2.2 3.5 4.4 7.0 3.4 4.6 4.5 3.8 6.2 5.1 8.5 3.3 4.9 8.0 3.6 2.3 8.2 3.4 10.5 3.7 1.6 0.9 0.5 1.4 0.7 1.8 0.7 1.8 1.4 0.6 1.0 1.6 1.5 0.7 2.7 0.4 0.4 1.2 0.5 10.8 4.7 13.6 11.8 5.1 6.1 4.7 9.2 5.8 1.4 LSM14A "C19orf13, DKFZP434D1335, FAM61A, RAP55, RAP55A" ENSG00000257103 "LSM14A, mRNA processing body assembly factor" Q8ND56 19 34172504-34229515 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Repressor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017961 Approved Supported "Cytosol,Cytoplasmic bodies" "Cytoplasmic bodies" Cytosol "HPA017961: AB_1845610" "unprognostic (2.38e-1)" "unprognostic (3.30e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-2)" "unprognostic (2.45e-3)" "unprognostic (1.88e-1)" "unprognostic (9.62e-3)" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (4.98e-2)" "unprognostic (4.17e-2)" "unprognostic (2.52e-2)" "unprognostic (5.55e-2)" "unprognostic (1.56e-1)" 22.7 22.9 20.8 28.4 23.7 78.7 36.1 33.4 24.9 26.4 26.2 20.3 21.2 13.4 31.5 51.6 22.2 21.0 20.8 22.5 21.3 18.9 33.9 30.7 25.6 32.7 24.6 19.3 30.3 18.2 32.1 18.5 38.1 23.1 27.8 21.8 21.0 20.2 30.2 38.8 38.3 25.9 29.0 25.6 23.2 17.9 20.1 25.7 42.1 37.9 21.5 23.2 26.6 25.3 8.2 10.7 16.4 10.1 10.9 12.0 7.6 1.0 0.4 1.6 1.9 0.7 2.1 0.8 0.7 4.6 0.6 0.9 1.6 1.1 2.0 0.6 1.3 0.2 7.0 10.1 12.9 0.9 1.2 0.4 2.9 1.8 11.5 1.2 0.8 8.3 6.4 1.2 2.0 1.5 0.8 0.0 9.8 3.1 5.8 8.3 9.9 0.1 1.6 0.4 4.8 8.0 0.1 1.0 2.9 0.6 13.0 7.9 1.4 27.6 0.5 1.7 1.4 0.0 0.6 0.4 4.1 4.4 10.0 4.4 0.6 11.2 8.2 16.4 10.5 10.0 12.0 7.8 9.1 8.5 10.7 8.2 10.4 9.6 6.1 10.9 10.1 2.8 8.9 7.6 20.8 23.7 33.4 24.9 21.3 18.9 24.6 19.3 23.1 25.7 LSM14B "bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B" ENSG00000149657 "LSM family member 14B" Q9BX40 20 62122461-62135378 "Predicted intracellular proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041274, HPA061189" Approved Supported "Nucleoli fibrillar center,Vesicles" Vesicles "Nucleoli fibrillar center" "HPA041274: , HPA061189: AB_2684448" "unprognostic (2.24e-1)" "unprognostic (2.35e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-2)" "unprognostic (1.20e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.61e-5)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (5.43e-2)" "unprognostic (4.93e-3)" "unprognostic (4.69e-2)" "unprognostic (3.34e-3)" "unprognostic (6.61e-2)" "unprognostic (2.00e-1)" "unprognostic (4.53e-3)" "unprognostic (1.98e-1)" 13.6 19.6 21.4 17.3 24.4 20.2 24.0 50.0 38.6 19.5 16.1 15.9 11.9 20.4 21.9 15.6 20.1 16.8 16.1 28.7 20.8 18.9 14.9 15.1 15.3 18.9 17.3 28.2 30.6 26.5 19.4 16.9 13.2 20.4 18.2 13.2 16.8 20.2 16.9 55.5 23.4 19.5 17.9 18.6 18.1 18.3 35.2 12.2 28.8 16.6 20.1 16.7 19.1 17.7 1.4 1.3 5.8 1.1 0.1 1.2 0.2 13.9 13.3 21.2 20.3 9.7 10.2 18.2 14.7 11.0 30.8 13.5 39.0 9.7 14.7 17.1 10.1 20.2 10.2 12.8 15.4 6.0 7.4 35.4 17.0 23.2 13.4 15.1 21.5 8.7 23.2 12.8 11.9 7.8 18.9 10.6 10.7 18.4 25.1 22.8 13.1 19.7 32.8 42.0 11.6 8.3 16.5 29.2 25.3 26.9 23.9 18.9 29.7 19.2 10.1 43.9 30.1 22.6 14.9 13.5 15.9 18.2 19.3 10.1 14.0 0.2 1.1 5.8 1.0 1.0 0.4 1.2 0.7 1.2 0.9 1.4 0.8 0.8 1.8 0.1 0.5 1.3 0.5 0.2 21.4 24.4 50.0 38.6 20.8 18.9 17.3 28.2 20.4 12.2 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178358-14201119 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044966: " "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 14.1 13.6 18.2 12.5 17.1 18.9 15.5 13.2 17.3 11.5 15.6 11.8 7.6 15.0 11.6 13.4 19.1 10.3 11.3 20.1 15.1 12.5 27.6 26.7 10.1 14.2 14.2 13.5 12.4 15.6 7.3 12.4 16.5 14.4 14.2 13.9 12.3 13.3 11.0 31.9 12.1 17.6 15.8 15.0 16.3 12.5 21.5 13.9 24.4 19.7 21.4 13.9 12.9 11.1 21.3 23.1 27.2 18.3 17.1 17.7 18.7 14.4 11.7 12.6 13.0 5.9 6.9 32.2 12.0 8.0 15.3 14.7 13.2 11.4 15.9 10.0 8.2 6.8 14.2 11.6 15.2 15.0 17.6 16.9 16.9 12.6 3.0 18.8 12.3 5.1 8.4 15.3 6.6 7.8 18.1 12.8 11.3 16.6 19.9 25.7 21.8 15.9 11.0 15.6 17.5 14.3 14.9 7.1 11.5 13.7 19.2 11.1 22.1 24.0 7.1 9.8 15.7 11.9 20.4 9.1 26.4 30.0 12.5 18.5 14.0 27.2 15.9 23.3 12.8 18.3 15.0 21.3 15.0 14.9 14.6 17.1 16.5 17.3 15.2 17.1 15.3 23.1 17.7 18.7 18.2 17.1 13.2 17.3 15.1 12.5 14.2 13.5 14.4 13.9 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184032-118192824 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 27.5 20.8 16.8 30.8 19.7 39.7 27.1 33.1 25.9 18.5 20.1 12.8 18.8 20.6 23.0 25.4 26.2 19.3 16.2 25.1 19.1 10.1 20.2 19.9 23.1 34.1 19.8 17.2 22.9 27.0 13.2 28.3 16.8 20.1 22.3 22.8 13.6 24.5 21.2 21.4 21.9 26.2 23.6 28.3 33.8 22.3 21.0 20.2 30.0 24.6 23.2 38.2 22.1 21.6 29.8 40.6 22.0 28.2 18.2 35.3 16.2 14.4 9.7 22.1 16.8 8.1 13.1 9.0 15.7 13.7 10.9 14.2 7.8 15.2 30.0 32.9 8.2 10.3 13.2 10.2 11.5 15.5 14.2 20.0 20.2 15.6 17.9 26.0 23.2 11.7 12.4 13.4 12.4 11.1 20.8 29.9 13.5 6.6 45.8 65.5 20.0 14.7 14.5 13.1 20.8 11.4 9.7 13.1 16.8 14.0 35.7 30.2 7.4 29.2 9.1 17.5 9.9 20.5 19.6 25.6 18.2 34.7 12.8 31.9 22.2 22.0 21.0 19.1 29.0 28.2 28.1 29.8 32.2 35.3 22.4 26.5 31.2 31.7 7.0 18.2 26.6 40.6 31.4 16.2 16.8 19.7 33.1 25.9 19.1 10.1 19.8 17.2 20.1 20.2 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell line enhanced" "Detected in many" "A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007270 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 2100000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA007270: AB_1079253" "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favourable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 89.3 1.5 0.1 0.2 0.2 0.1 16.2 0.2 0.3 0.4 0.3 39.1 41.6 3.5 13.8 0.2 37.5 8.3 13.7 0.0 5.4 15.1 0.0 1.2 17.3 0.3 0.0 0.1 0.2 15.3 0.3 4.5 0.1 14.1 3.2 0.2 31.7 0.1 0.1 12.8 0.5 0.7 0.1 9.7 8.6 36.2 7.1 0.2 7.5 24.4 6.7 20.9 0.5 0.0 0.7 8.6 0.5 0.4 5.1 9.0 8.1 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 LTA4H ENSG00000111144 "Leukotriene A4 hydrolase" P09960 12 96000828-96043520 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Leukotriene biosynthesis" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008399, CAB015221, HPA017017" Supported Approved Nucleoplasm,Cytosol 85000000 "Nucleoplasm, Cytosol" "CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818" "prognostic favourable (9.79e-4)" "unprognostic (6.62e-2)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (4.25e-3)" "prognostic favourable (8.96e-4)" "unprognostic (1.72e-1)" "unprognostic (1.75e-2)" "unprognostic (3.38e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.74e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-1)" 27.9 33.2 11.2 21.5 16.7 55.7 19.0 24.1 15.6 27.2 29.1 13.1 16.7 27.6 27.6 14.1 53.4 22.7 14.5 19.2 10.6 12.2 27.2 19.4 68.0 33.4 12.3 11.3 49.9 28.2 21.2 31.8 11.3 13.3 29.6 17.8 20.7 21.1 16.1 20.6 23.6 41.2 21.5 13.3 44.3 22.1 13.7 11.5 29.2 38.8 22.3 43.1 30.1 25.2 20.6 35.3 6.1 84.2 14.2 9.0 54.6 23.5 25.4 35.7 21.3 31.0 34.7 15.6 9.9 29.3 19.6 22.8 18.6 20.5 52.9 12.4 14.7 31.1 29.2 40.3 26.8 18.1 28.3 19.4 16.3 22.5 18.3 10.2 11.8 33.0 34.0 27.0 33.1 38.7 11.8 9.3 28.2 16.2 26.8 31.5 41.6 34.5 25.2 26.6 30.5 35.9 30.1 18.5 21.9 20.0 23.4 21.4 29.0 12.5 13.8 8.3 14.0 11.8 10.7 12.6 21.8 24.5 5.9 18.6 6.5 0.4 76.0 2.2 4.5 84.2 8.4 15.1 6.3 5.8 35.3 20.6 9.0 6.7 6.1 14.2 73.2 8.7 6.3 54.6 11.2 16.7 24.1 15.6 10.6 12.2 12.3 11.3 13.3 11.5 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell line enhanced" "Detected in many" "HaCaT: 15.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: " "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.4 4.3 1.8 1.8 0.4 0.6 7.6 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 15.7 1.3 2.7 0.9 3.9 4.8 2.2 3.5 1.6 0.5 3.6 4.1 0.5 3.6 1.9 2.3 0.6 2.7 3.5 0.6 4.8 1.9 3.8 1.0 5.4 7.8 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.2 5.2 0.5 6.0 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 50.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.1 0.0 0.2 0.2 0.3 50.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843344-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavourable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavourable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 20.0 20.6 15.6 19.5 26.2 39.3 26.7 19.4 26.0 14.6 16.5 11.1 17.9 13.8 21.2 14.7 21.2 18.0 11.3 15.7 25.1 10.9 14.4 29.0 18.9 21.2 21.0 17.1 20.6 20.9 13.3 19.7 17.3 17.4 16.3 18.9 8.0 16.6 18.5 52.0 23.5 17.2 20.7 18.5 20.8 18.3 17.5 18.1 15.0 16.1 26.4 21.8 16.6 25.5 17.3 18.4 4.1 12.9 21.2 16.1 8.3 11.5 10.8 12.9 28.7 9.6 11.7 15.0 18.0 13.3 20.0 16.0 17.6 6.0 24.4 14.6 16.3 13.1 21.5 17.7 28.0 14.0 21.0 48.3 12.5 26.9 17.0 59.3 28.1 13.2 13.0 22.2 24.4 13.8 45.9 16.2 15.4 19.5 20.2 25.3 15.2 12.0 17.5 24.5 10.9 14.8 16.2 11.5 13.8 18.4 15.3 16.8 8.5 38.0 12.5 12.8 14.8 28.5 33.0 20.3 25.0 33.3 12.9 31.1 18.0 1.2 10.1 4.1 12.1 12.9 13.1 17.3 12.7 13.0 15.2 14.3 14.1 16.1 0.3 21.2 11.0 18.4 10.9 8.3 15.6 26.2 19.4 26.0 25.1 10.9 21.0 17.1 17.4 18.1 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA056424: , HPA069321: " "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favourable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 23.8 24.5 30.4 26.5 30.9 25.3 24.0 42.6 30.0 21.9 20.1 29.9 25.8 21.3 29.4 37.7 15.5 19.2 24.5 12.7 34.1 26.5 26.9 19.9 18.8 31.0 33.1 24.3 29.3 24.2 31.2 40.3 23.1 25.4 35.2 18.2 24.3 25.1 25.2 20.3 28.8 23.9 24.4 29.2 32.1 22.6 29.8 33.1 23.2 40.2 15.9 21.0 16.6 26.3 6.5 11.1 3.5 11.7 3.9 6.9 5.6 5.3 23.9 25.4 9.5 9.8 7.6 11.2 9.9 7.6 16.2 11.7 24.9 6.3 9.7 13.0 5.6 6.8 30.2 9.0 16.3 17.4 20.7 11.9 16.3 29.1 11.0 13.7 13.3 6.7 10.5 13.1 5.2 12.4 14.0 6.3 13.0 25.7 22.5 23.9 37.8 11.6 19.4 11.1 10.2 23.1 5.7 15.1 17.0 10.7 7.4 9.3 9.7 7.4 10.1 11.8 17.7 4.9 11.9 6.9 9.1 10.3 3.6 9.8 10.5 0.3 9.1 3.5 6.7 10.4 5.2 6.5 6.3 6.5 9.8 3.0 3.7 2.8 1.2 3.9 11.7 11.1 6.9 5.6 30.4 30.9 42.6 30.0 34.1 26.5 33.1 24.3 25.4 33.1 LURAP1 "C1orf190, FLJ25163, LRAP35a" ENSG00000171357 "Leucine rich adaptor protein 1" Q96LR2 1 46203334-46221261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 110.5" "HPA030060, HPA030061" Uncertain Supported Vesicles,Cytosol Cytosol Vesicles "HPA030060: AB_10599997, HPA030061: AB_10601990" "unprognostic (3.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.22e-3)" "unprognostic (8.82e-2)" "unprognostic (1.91e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.47e-2)" "unprognostic (2.44e-2)" "unprognostic (2.95e-2)" "unprognostic (4.14e-2)" "unprognostic (1.33e-1)" "prognostic favourable (8.81e-8)" "unprognostic (1.32e-2)" "unprognostic (2.80e-1)" "unprognostic (3.11e-2)" "unprognostic (2.39e-2)" 3.0 7.3 7.1 2.2 13.2 3.4 3.9 12.7 12.7 5.8 3.8 15.2 2.2 2.0 5.5 4.9 4.0 4.0 3.7 8.7 6.7 5.8 7.4 1.1 3.2 1.6 18.8 6.0 7.2 1.1 21.5 3.2 2.3 11.2 7.5 2.5 4.7 5.2 9.8 2.5 4.2 1.9 5.6 17.5 3.5 3.7 10.8 13.6 0.0 19.6 0.0 2.1 5.6 5.3 1.0 0.7 6.2 1.1 1.9 0.8 0.3 0.2 0.2 3.0 0.2 4.1 5.6 3.1 2.1 5.4 2.9 3.5 0.1 0.2 0.2 0.1 5.1 0.3 3.2 6.8 2.4 0.6 1.5 0.2 0.7 0.3 1.2 0.2 0.1 2.9 4.6 5.7 2.7 4.2 2.6 0.6 1.7 0.3 0.3 0.3 1.1 0.5 1.1 1.5 0.0 7.6 0.1 0.4 1.2 0.1 0.2 4.9 1.5 0.3 0.2 1.8 2.3 1.5 0.4 0.3 0.1 0.3 1.7 0.3 0.4 1.3 1.1 0.4 0.3 0.5 0.8 0.5 0.4 0.3 0.4 1.0 0.8 0.6 6.2 1.9 0.5 0.7 0.1 0.3 7.1 13.2 12.7 12.7 6.7 5.8 18.8 6.0 11.2 13.6 LURAP1L "bA3L8.2, C9orf150, FLJ38505, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775021-12822131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 48.7" "Cell line enhanced" "Detected in many" "HHSteC: 44.4;hTERT-HME1: 35.5;T-47d: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 10.6 7.2 2.9 7.9 9.2 0.1 13.0 23.4 5.5 11.5 13.7 7.1 2.9 4.0 5.0 7.9 8.5 4.1 14.7 3.5 3.5 3.3 4.1 48.7 17.8 5.3 7.7 4.0 4.5 19.9 0.2 7.3 21.0 5.9 8.0 9.6 4.7 21.6 7.3 2.4 8.8 6.6 13.2 8.1 11.0 9.9 3.7 7.9 0.9 8.6 2.8 5.3 10.3 9.4 0.0 0.1 1.2 0.0 0.0 0.0 1.6 0.9 3.1 0.0 1.0 4.8 6.7 0.0 1.6 8.9 2.2 2.4 0.0 1.1 0.0 0.6 8.5 1.3 0.0 0.1 1.6 0.0 0.3 0.4 2.9 1.6 44.4 0.0 0.0 2.6 4.2 7.9 35.5 1.4 0.0 11.6 1.2 0.7 0.0 0.0 0.0 3.4 0.0 0.6 0.0 8.7 0.5 6.8 0.6 1.9 1.2 1.5 51.0 0.1 0.5 1.9 0.3 4.9 1.2 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 9.2 23.4 5.5 3.5 3.3 7.7 4.0 5.9 7.9 LUZP1 LUZP ENSG00000169641 "Leucine zipper protein 1" Q86V48 1 23084023-23177808 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028506, HPA028542" Enhanced Uncertain "Vesicles,Actin filaments,Cytosol" "Actin filaments" "Vesicles, Cytosol" "HPA028506: AB_10600083, HPA028542: AB_10601986" "unprognostic (3.04e-2)" "prognostic unfavourable (5.57e-4)" "unprognostic (7.35e-3)" "unprognostic (7.20e-2)" "unprognostic (3.96e-2)" "unprognostic (8.27e-2)" "unprognostic (8.46e-3)" "unprognostic (9.77e-3)" "unprognostic (7.34e-2)" "unprognostic (2.56e-3)" "unprognostic (1.19e-1)" "unprognostic (3.50e-1)" "prognostic favourable (1.46e-7)" "unprognostic (4.49e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-1)" "unprognostic (1.33e-1)" 9.7 10.3 5.2 6.5 10.7 8.3 7.3 7.8 18.2 7.5 11.7 2.5 4.4 15.7 9.6 4.5 7.5 6.6 9.1 9.2 6.3 6.1 8.1 4.0 9.1 4.0 5.4 9.5 6.6 4.4 21.8 4.9 8.6 21.8 7.0 9.4 4.6 7.1 7.1 4.2 6.8 27.1 8.9 5.0 9.4 5.9 20.4 3.4 5.2 7.9 4.7 5.5 7.9 9.9 4.5 11.9 21.5 7.4 4.8 10.5 2.1 9.5 6.6 9.3 10.8 9.6 12.3 6.8 9.4 15.1 11.8 12.5 3.7 4.5 0.2 8.7 15.9 13.0 9.2 25.6 14.5 3.5 6.1 13.5 8.2 3.5 6.3 6.6 8.7 10.8 10.1 17.3 13.7 26.5 4.9 0.8 9.5 2.5 4.5 2.8 7.9 7.2 6.9 14.0 1.1 5.4 6.3 1.7 4.4 22.5 6.4 7.7 3.6 3.5 47.3 13.9 10.6 10.4 9.3 1.2 2.8 3.7 6.2 11.0 11.9 21.5 5.8 6.1 9.3 4.0 10.5 2.4 7.0 5.8 5.6 4.5 5.6 5.5 3.2 4.8 7.4 11.9 3.7 2.1 5.2 10.7 7.8 18.2 6.3 6.1 5.4 9.5 21.8 3.4 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "HaCaT: 14.3;HAP1: 7.1" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: , HPA046161: " "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 14.3 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672693 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 31.8;HUVEC TERT2: 69.1;MCF7: 37.6;RT4: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Approved Approved Nucleoplasm,Cytosol 4200000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 32.3 31.5 2.8 13.6 3.3 9.4 35.8 11.7 3.5 11.8 20.9 1.2 12.7 12.4 9.8 17.7 14.0 15.2 17.2 24.4 5.7 3.6 13.6 4.0 16.9 17.8 3.0 2.1 37.1 15.0 7.9 20.6 15.5 4.4 34.0 18.6 11.1 29.3 11.3 7.8 4.8 24.1 22.8 2.6 10.0 7.0 8.5 1.3 12.4 15.8 6.6 7.3 29.3 31.5 5.9 4.5 22.2 3.6 5.2 17.0 4.2 0.0 9.4 0.7 0.1 4.1 14.2 0.8 7.2 18.7 1.8 3.6 0.0 21.3 0.0 6.7 2.0 3.3 1.9 2.9 2.7 0.0 9.3 4.4 8.2 0.1 4.7 1.1 0.1 31.8 0.5 3.4 0.5 69.1 0.0 0.2 0.0 37.6 0.4 0.0 0.8 2.4 1.2 0.0 9.0 6.4 26.1 1.2 0.0 0.0 10.0 2.4 0.0 0.0 9.9 0.1 0.0 10.0 0.0 0.1 0.0 0.0 3.5 0.3 0.1 13.8 3.6 5.0 3.7 3.4 3.6 5.9 7.6 5.9 4.3 4.1 8.5 4.7 22.2 5.2 2.1 4.5 17.0 4.2 2.8 3.3 11.7 3.5 5.7 3.6 3.0 2.1 4.4 1.3 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favourable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.0 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.1 1.8 0.0 0.2 1.0 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell line enhanced" "Detected in many" "A-431: 28.2;BJ: 30.6;HeLa: 33.3;SiHa: 47.9;U-2197: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "HPA017770, CAB075742, CAB075743" Enhanced Supported "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" "Plasma membrane" Nucleoplasm "CAB075742: , CAB075743: , HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.2 0.5 0.0 1.5 0.6 1.9 0.3 30.6 3.6 9.5 5.7 0.0 0.2 0.0 2.6 3.4 2.5 0.0 1.7 8.0 0.3 0.0 0.0 33.3 0.0 0.4 0.0 0.0 2.8 5.0 7.0 9.1 0.8 0.0 0.1 17.8 0.2 0.0 0.0 1.0 0.4 0.0 0.1 0.0 1.5 0.3 0.8 0.1 47.9 0.6 9.3 0.1 0.0 1.2 0.4 2.8 64.7 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favourable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavourable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.1 6.9 6.2 9.0 5.4 6.2 10.6 12.0 4.1 12.5 8.6 21.6 17.3 35.3 8.7 5.1 8.4 23.1 12.5 16.4 6.3 17.0 35.4 6.6 24.2 9.2 40.8 9.6 4.8 8.0 14.3 24.5 10.8 47.3 11.8 8.7 13.3 13.8 52.6 30.8 22.6 21.3 11.3 17.0 5.6 9.2 14.7 6.3 6.5 7.1 12.2 7.4 12.2 10.0 12.5 9.9 16.2 37.7 8.4 12.6 56.4 8.5 34.5 10.1 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 LYN JTK8 ENSG00000254087 "LYN proto-oncogene, Src family tyrosine kinase" P07948 8 55879813-56014168 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.9" "Cell line enhanced" "Detected in many" "HEL: 56.8;HMC-1: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001231, CAB004492" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" 11000000 "Golgi apparatus, Plasma membrane" Vesicles "CAB004492: AB_627897, HPA001231: AB_1079286" "unprognostic (7.87e-2)" "unprognostic (4.89e-2)" "unprognostic (9.04e-2)" "unprognostic (3.74e-1)" "unprognostic (8.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.70e-2)" "unprognostic (1.11e-1)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (7.15e-2)" "prognostic unfavourable (3.43e-4)" "unprognostic (2.13e-1)" "unprognostic (2.72e-3)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" 8.8 6.8 4.5 34.0 6.3 33.6 11.1 9.5 4.1 5.3 10.5 5.8 7.2 15.6 3.4 7.8 7.2 6.7 13.7 8.9 4.8 3.6 6.1 13.8 34.6 70.9 7.7 2.1 5.3 9.8 3.1 4.9 19.1 5.6 5.7 6.6 6.3 14.9 8.5 2.7 3.4 16.2 6.6 8.5 69.4 7.4 3.6 5.1 3.8 9.4 5.3 25.8 10.7 7.5 8.4 9.2 36.8 26.5 1.9 0.9 2.7 12.6 7.5 1.7 0.3 0.1 0.0 13.7 9.7 14.2 6.1 4.3 5.2 4.4 12.2 4.3 3.8 5.9 7.1 7.2 5.2 19.8 7.1 56.8 2.3 1.8 1.9 5.7 57.7 0.3 2.5 0.1 4.4 8.2 30.0 26.5 0.9 0.7 0.0 6.0 10.9 0.8 0.9 2.8 1.5 3.9 6.0 1.1 22.0 4.8 0.0 2.0 1.1 13.4 9.6 0.0 2.8 0.0 4.4 8.9 3.2 27.6 0.6 11.3 0.4 2.1 7.2 12.3 0.9 16.8 0.7 8.2 0.2 0.3 6.4 8.4 0.1 0.4 36.8 1.9 26.5 9.2 0.0 2.7 4.5 6.3 9.5 4.1 4.8 3.6 7.7 2.1 5.6 5.1 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.0 0.1 0.0 0.2 0.1 0.0 4.6 0.4 1.1 0.4 0.5 0.1 12.5 0.0 0.5 0.3 29.4 0.0 1.3 0.2 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.1 0.0 0.1 0.0 0.0 0.0 0.0 32.8 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.3 31.5 0.0 0.0 0.1 47.3 0.5 5.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell line enhanced" "Detected in some" "A-431: 5.8;BEWO: 9.0;HaCaT: 9.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: " "unprognostic (4.27e-3)" "prognostic favourable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.8 0.0 0.3 0.0 0.1 0.0 9.0 0.4 0.0 0.8 1.0 0.6 2.0 0.3 1.1 0.7 9.3 0.0 1.0 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.8 2.6 0.4 1.1 0.3 0.1 0.3 0.0 0.3 0.2 0.1 0.6 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol 1700000 "Nucleoplasm, Cytosol" "HPA050941: , HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.3 17.2 22.4 20.1 8.1 13.3 28.3 18.2 10.5 16.8 15.9 12.4 29.5 53.3 21.3 11.8 20.4 31.5 30.3 23.6 19.3 17.2 37.1 11.0 19.9 13.4 22.7 50.3 11.6 26.7 13.1 29.5 43.6 37.6 16.2 23.4 8.0 34.5 17.3 33.3 7.9 20.9 11.8 24.4 26.0 41.2 11.8 20.1 12.8 23.9 27.9 34.9 20.3 20.9 10.2 14.9 17.6 16.8 22.6 34.0 48.1 13.8 24.1 19.9 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 LYPLA2 APT-2 ENSG00000011009 "Lysophospholipase II" O95372 1 23790970-23795539 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063151 Uncertain Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA063151: " "unprognostic (8.84e-2)" "unprognostic (6.87e-2)" "unprognostic (2.65e-1)" "unprognostic (7.81e-3)" "unprognostic (2.12e-2)" "unprognostic (2.22e-2)" "prognostic unfavourable (5.84e-5)" "unprognostic (3.06e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-2)" "unprognostic (2.52e-1)" "unprognostic (2.40e-1)" "prognostic favourable (4.99e-4)" "unprognostic (6.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (1.24e-1)" 12.4 13.6 14.8 13.3 34.8 20.6 13.5 10.7 17.7 9.9 21.2 12.3 5.6 21.3 10.9 17.2 25.4 19.2 21.6 14.4 9.9 9.5 33.2 34.5 14.3 19.0 7.6 12.8 10.3 18.3 32.0 12.0 31.6 35.4 14.8 12.7 11.3 21.1 11.2 14.2 17.7 24.0 9.5 5.4 22.1 19.1 9.9 6.9 27.7 16.5 9.5 16.5 15.3 13.5 29.5 32.3 50.0 40.6 32.0 48.0 42.4 25.1 15.6 19.0 22.1 9.6 11.7 26.2 15.6 14.9 14.8 12.7 21.6 41.1 13.8 22.0 14.7 24.0 13.7 40.5 6.3 25.7 19.4 17.2 25.7 35.4 15.0 16.2 22.8 14.6 25.0 22.3 8.5 34.9 24.1 13.8 16.2 25.0 21.7 26.4 38.8 22.0 24.1 11.0 25.3 34.9 19.4 27.7 48.0 17.7 28.4 26.5 23.0 17.1 29.9 14.9 19.8 18.0 13.0 37.5 31.7 19.2 24.6 37.5 18.8 28.9 40.6 50.0 48.0 39.6 38.7 27.6 40.1 41.6 32.3 29.5 35.2 36.0 48.4 32.0 31.2 24.6 35.6 42.4 14.8 34.8 10.7 17.7 9.9 9.5 7.6 12.8 35.4 6.9 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Nucleoplasm Midbody "HPA059840: " "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favourable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavourable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favourable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 11.8 12.8 11.9 9.4 32.3 25.7 3.9 9.9 16.6 5.7 8.7 14.3 14.9 8.4 38.7 11.9 8.4 5.2 10.4 9.4 15.6 8.1 3.8 3.5 36.9 24.0 12.4 7.5 18.6 9.2 16.0 46.0 23.6 8.4 14.8 24.7 15.8 12.3 8.4 12.4 6.7 16.9 6.6 10.0 20.6 7.0 11.6 11.2 6.1 10.3 16.5 10.6 7.3 6.2 8.2 6.0 12.9 6.8 14.7 20.5 13.1 21.5 13.4 7.1 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7" "Cell line enhanced" "Detected in many" "U-937: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 5.3 13.4 17.7 13.8 26.2 7.9 5.1 19.9 35.8 6.5 6.1 7.9 7.2 10.0 6.1 7.5 4.6 6.9 7.6 3.6 17.9 19.1 6.7 13.9 9.3 17.2 14.6 17.6 5.8 8.6 7.1 15.2 6.1 25.2 6.2 6.5 4.1 4.3 9.8 10.9 2.7 8.1 7.8 8.2 12.9 7.7 15.6 5.9 6.1 4.9 2.3 16.7 7.4 4.6 17.0 18.2 38.7 20.4 11.9 16.3 12.2 6.0 4.4 0.7 5.9 2.0 3.4 0.0 7.1 4.1 9.0 11.8 0.5 5.5 23.3 1.0 3.9 8.5 4.8 4.7 6.4 19.7 2.3 6.9 4.1 0.1 4.3 16.0 3.0 3.9 9.6 3.6 3.9 5.3 0.3 0.0 2.8 9.0 6.0 20.2 1.9 5.0 9.2 0.1 8.7 8.8 4.9 17.9 4.4 6.6 0.1 11.9 5.0 12.3 3.1 8.9 4.5 9.3 9.9 0.0 0.0 0.1 4.5 32.8 6.6 0.0 13.2 24.4 10.9 15.9 16.3 17.0 11.0 13.1 11.1 16.2 13.3 11.0 38.7 11.9 20.4 18.2 6.4 12.2 17.7 26.2 19.9 35.8 17.9 19.1 14.6 17.6 25.2 5.9 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA029152: AB_10602033, HPA059824: " "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 8.8 4.7 5.8 11.6 8.7 4.7 11.1 8.6 14.1 9.5 6.4 7.8 3.6 8.1 9.3 11.4 11.4 5.5 8.3 9.2 7.1 5.6 4.7 6.6 7.0 3.9 4.7 5.7 7.8 6.5 14.9 5.4 5.0 6.7 6.3 5.9 8.3 15.9 7.7 12.3 25.2 6.5 6.9 7.9 4.5 5.6 6.8 6.3 5.4 4.1 11.1 6.3 4.6 8.4 3.1 4.8 8.0 4.0 1.0 6.2 3.4 3.8 3.7 7.6 4.4 8.5 7.7 4.5 4.5 3.1 3.9 5.7 9.2 3.5 4.3 2.7 4.1 11.5 5.9 7.2 4.5 0.9 10.6 2.8 7.5 6.3 4.9 2.0 5.4 4.4 10.7 3.5 4.2 5.2 6.8 5.5 2.5 4.6 5.3 5.6 5.0 4.2 3.7 5.4 2.1 6.9 10.2 4.4 3.9 8.2 2.5 4.3 1.7 3.9 6.6 3.2 8.7 4.3 1.8 7.4 9.8 3.5 4.1 5.0 3.4 0.0 2.0 8.0 3.8 3.3 2.9 1.8 5.2 4.5 1.1 3.1 6.2 2.8 0.7 1.0 4.0 4.8 5.0 3.4 5.8 8.7 8.6 14.1 7.1 5.6 4.7 5.7 6.7 6.3 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell line enhanced" "Detected in many" "HDLM-2: 13.4;SK-MEL-30: 12.4;THP-1: 43.9;U-937: 16.8" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: , HPA055725: " "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.7 0.8 0.4 0.9 5.9 6.8 0.6 1.4 5.6 1.5 1.4 0.0 1.0 0.5 0.5 3.0 1.8 0.5 0.7 1.3 13.4 1.2 1.2 0.8 0.3 1.0 1.8 1.6 2.2 3.6 1.8 4.6 1.2 0.1 0.8 1.1 0.1 2.3 3.8 0.1 0.4 0.1 0.5 0.0 4.3 4.1 2.4 0.5 1.5 0.0 12.4 0.5 43.9 2.6 1.1 0.5 1.2 1.2 0.9 0.0 0.0 1.9 16.8 3.1 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 LYZ ENSG00000090382 Lysozyme P61626 12 69348341-69354234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 490.0;salivary gland: 1017.8" "Group enriched" "Detected in some" 6 "Hep G2: 126.5;THP-1: 65.3;U-937: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 490.0;myeloid DC: 308.1" "Group enriched" "Detected in all" 18 "dendritic cells: 308.1;monocytes: 490.0" "Not detected" "Not detected" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" 1500000000 2600000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: , HPA066182: " "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favourable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 19.1 2.4 1.7 42.1 1.8 187.0 2.9 1.6 1.6 2.9 52.5 2.0 0.1 72.4 2.3 6.9 3.9 3.4 105.0 15.4 1.8 1.8 4.8 4.8 81.0 57.2 2.1 0.0 4.5 5.0 0.0 1.8 8.3 0.9 2.4 5.0 2.7 1017.8 2.8 1.8 2.1 95.0 1.8 2.5 34.2 212.1 1.6 0.5 24.5 2.4 207.7 75.7 6.6 2.4 1.6 308.1 21.9 490.0 2.3 1.1 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.8 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 7.7 0.1 126.5 0.0 14.8 7.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 14.4 0.3 0.0 0.2 0.2 2.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.3 0.3 0.1 0.3 0.1 0.1 0.0 70.7 0.0 7.5 490.0 5.9 0.7 102.3 1.1 1.6 0.4 0.5 308.1 0.4 0.4 0.4 21.9 2.3 17.6 6.5 0.6 407.9 1.7 1.8 1.6 1.6 1.8 1.8 2.1 0.0 0.9 0.5 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol 110000 Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: " "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavourable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favourable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 13.6 14.2 21.4 12.8 18.0 11.4 17.7 13.6 21.6 18.2 19.2 24.5 15.1 19.5 18.3 13.5 17.6 16.9 14.1 21.0 19.8 16.5 20.0 20.4 11.5 13.6 24.3 10.3 25.5 15.3 26.1 15.9 14.9 20.5 15.8 19.4 13.0 16.6 14.6 21.7 13.9 23.7 21.3 28.2 11.0 12.2 44.3 20.1 20.2 17.2 13.2 15.6 14.9 23.1 13.9 28.1 28.3 22.7 16.8 21.0 12.9 15.8 10.5 20.3 14.3 12.6 21.0 9.0 14.4 12.3 20.4 19.8 13.1 27.9 19.3 16.5 18.2 12.1 19.1 21.0 30.8 17.8 13.0 28.1 13.7 21.5 12.2 25.6 14.5 13.7 30.1 28.6 27.1 16.0 34.7 11.0 18.8 11.2 21.0 12.5 10.2 17.2 22.5 26.9 15.4 11.0 7.2 10.1 16.0 17.7 7.8 34.0 12.9 13.2 14.6 14.2 19.5 20.2 15.1 9.0 20.6 33.1 14.6 38.3 18.9 22.0 18.8 28.3 16.0 20.7 14.0 13.9 16.3 15.5 18.1 13.8 16.3 16.9 18.9 16.8 22.7 28.1 21.0 12.9 21.4 18.0 13.6 21.6 19.8 16.5 24.3 10.3 20.5 20.1 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: , HPA071248: " "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavourable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.2 5.1 7.6 9.2 17.6 12.2 6.2 12.8 9.0 7.3 10.0 3.0 2.6 6.6 4.8 14.2 8.4 5.7 10.5 2.9 12.3 13.3 7.1 6.7 4.4 9.4 3.8 9.4 11.2 5.3 9.2 6.7 14.1 29.4 11.5 8.2 3.8 6.8 3.6 2.4 5.6 8.0 11.1 2.6 5.7 8.4 7.5 11.2 6.9 12.1 7.5 5.6 7.1 12.6 17.0 8.7 7.7 6.9 5.0 4.4 2.0 7.7 3.7 8.2 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell line enhanced" "Detected in some" "SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 10 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavourable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavourable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.7 4.0 0.0 0.0 0.5 2.3 0.0 2.0 1.8 0.1 0.0 5.2 1.7 1.4 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.0 0.0 0.0 6.9 0.0 9.0 0.0 5.9 0.0 0.0 7.5 0.0 1.3 0.2 7.2 6.2 0.0 0.0 35.9 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.0 0.0 0.5 24.3 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 34.2 25.8 14.6 12.4 21.4 10.9 24.7 15.4 25.0 29.3 30.2 41.0 16.4 15.2 33.7 18.6 28.0 22.6 21.0 20.0 19.0 13.6 18.2 7.4 18.6 9.5 32.8 14.4 30.1 13.9 22.7 16.1 24.5 20.6 32.9 8.2 22.3 34.6 38.4 28.5 24.7 14.9 32.0 29.9 20.1 19.6 18.7 25.6 9.5 29.7 11.8 13.7 38.8 22.7 5.0 2.8 0.5 1.2 4.4 6.1 2.3 11.1 14.9 12.2 20.9 16.3 13.3 25.1 13.4 25.7 11.3 12.9 17.3 9.3 4.5 12.5 18.1 18.9 7.6 9.8 2.8 4.3 11.2 4.1 14.7 22.4 23.2 2.1 5.4 24.0 7.1 8.9 10.7 11.5 12.9 2.6 10.0 10.7 1.9 5.3 13.6 12.3 25.4 35.9 4.5 8.6 13.6 3.0 22.3 9.1 4.2 34.4 21.5 17.7 14.6 13.6 15.5 14.3 7.0 4.9 3.3 1.1 23.0 6.1 6.8 0.0 1.2 0.5 4.5 0.5 6.1 3.7 5.4 4.9 1.8 5.0 5.8 4.9 0.5 4.4 0.1 2.8 4.5 2.3 14.6 21.4 15.4 25.0 19.0 13.6 32.8 14.4 20.6 25.6 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.8;testis: 13.2" "Group enriched" "Detected in some" 9 "NTERA-2: 5.9;RT4: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: " "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.7 0.6 5.2 0.2 1.5 3.7 3.7 1.2 3.4 4.6 0.2 0.3 1.0 0.2 2.1 0.5 0.3 4.6 0.5 0.1 0.9 1.8 1.5 0.1 0.6 0.1 0.5 1.6 0.3 0.4 1.7 8.8 1.2 0.9 0.2 0.0 2.0 1.5 1.0 0.1 0.2 0.2 0.2 0.7 0.4 0.7 13.2 0.2 1.0 3.6 0.0 0.5 0.9 0.5 0.0 0.9 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.2 0.5 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 5.2 1.5 1.2 3.4 0.9 1.8 0.5 1.6 0.9 0.2 MACF1 "ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF" ENSG00000127603 "Microtubule-actin crosslinking factor 1" Q9UPN3 1 39081316-39487177 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" Actin-binding "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013713, HPA068064, HPA068103" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" "Plasma membrane, Cell Junctions, Actin filaments" "HPA013713: AB_10600821, HPA068064: , HPA068103: " "unprognostic (2.71e-1)" "unprognostic (3.14e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (9.00e-2)" "unprognostic (6.19e-3)" "unprognostic (1.32e-1)" "unprognostic (7.40e-3)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.34e-1)" "unprognostic (3.98e-1)" "prognostic favourable (2.77e-5)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (8.57e-2)" "unprognostic (4.22e-2)" 24.1 22.6 41.4 21.4 44.0 21.2 25.2 62.6 54.0 37.1 42.2 35.3 22.7 11.9 66.5 33.6 20.3 28.0 31.5 39.0 35.9 32.7 27.2 24.4 53.5 21.2 41.1 28.6 41.5 25.0 46.2 37.1 22.8 40.5 26.3 18.2 23.3 26.0 32.0 40.8 59.2 18.4 56.7 37.0 29.7 22.9 17.7 39.0 13.3 34.5 17.9 16.0 28.0 34.8 4.8 2.6 4.9 2.8 6.4 13.7 2.0 12.4 15.2 18.8 8.4 16.6 17.2 8.1 17.2 23.3 10.7 10.6 9.1 15.1 6.5 18.1 24.4 8.3 3.3 12.3 14.9 12.5 9.2 11.6 11.3 14.7 19.0 10.7 5.0 11.7 12.7 29.6 15.9 37.7 17.0 8.9 41.8 4.1 6.0 13.9 25.9 9.0 11.4 28.7 1.2 55.7 13.5 10.4 10.6 6.8 4.6 16.4 2.0 10.6 42.4 17.5 14.1 8.3 30.1 5.3 5.1 7.8 28.6 10.1 16.0 4.9 1.5 3.8 13.7 2.7 6.7 2.3 6.8 8.6 1.9 4.8 5.4 6.8 1.3 6.4 2.8 2.6 2.9 2.0 41.4 44.0 62.6 54.0 35.9 32.7 41.1 28.6 40.5 39.0 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "MACRO domain containing 2" A1Z1Q3 20 13995369-16053197 "Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5" "Cell line enhanced" "Detected in many" "EFO-21: 14.5;Karpas-707: 17.9;RT4: 7.9;SCLC-21H: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 14.1;granulocytes: 3.8" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 2.8 5.1 15.2 3.0 47.5 2.0 4.2 20.8 13.6 6.4 2.7 3.7 2.0 1.4 12.1 3.9 2.3 10.3 4.1 1.9 10.5 8.2 5.6 2.7 15.7 5.5 7.6 8.9 4.5 4.2 5.4 12.0 1.8 10.5 7.1 2.1 4.0 2.4 14.9 3.1 3.9 1.8 5.8 6.9 6.9 3.4 7.9 9.9 0.0 4.1 0.1 7.2 10.6 3.1 14.1 0.5 3.8 1.8 0.3 0.6 0.5 1.0 0.6 2.7 0.9 0.9 0.8 0.5 0.5 2.0 1.1 0.6 1.0 0.7 1.9 14.5 1.4 1.4 0.4 0.6 1.8 0.9 0.8 1.1 1.1 1.8 3.5 0.3 0.3 1.6 1.1 0.0 0.8 1.1 1.3 17.9 3.0 0.4 0.5 0.7 0.9 0.4 1.1 0.5 3.4 2.1 7.9 9.9 4.3 1.5 0.1 0.7 1.0 1.6 0.8 1.5 3.0 0.2 0.1 1.5 0.4 1.8 0.9 1.0 1.8 0.3 0.6 0.6 0.4 1.3 0.4 7.4 0.3 0.4 0.5 14.1 0.4 0.6 3.8 0.3 1.8 0.2 0.2 0.5 15.2 47.5 20.8 12.8 10.5 8.2 7.6 8.9 10.5 9.9 MAD1L1 "HsMAD1, MAD1, PIG9, TP53I9, TXBP181" ENSG00000002822 "Mitotic arrest deficient 1 like 1" Q9Y6D9 7 1815793-2233243 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003635, CAB015338" Supported Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB015338: AB_627901, HPA003635: AB_1853472" "unprognostic (1.85e-1)" "unprognostic (3.76e-2)" "unprognostic (4.26e-3)" "unprognostic (8.32e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" "unprognostic (2.70e-2)" "unprognostic (1.18e-2)" "unprognostic (4.78e-2)" "unprognostic (5.76e-2)" "unprognostic (1.89e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (5.18e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (4.57e-1)" 11.8 7.6 11.4 17.3 29.7 19.1 9.0 15.7 15.0 10.0 9.3 12.1 6.1 8.8 10.4 8.5 12.3 9.2 10.9 11.4 12.3 10.0 7.9 17.6 13.3 23.2 14.8 13.3 10.3 10.7 7.8 10.7 9.3 10.5 9.4 6.8 12.0 10.3 8.3 16.8 17.4 9.8 10.3 11.9 21.2 9.8 15.4 11.0 25.9 10.5 7.2 19.1 11.3 11.3 25.4 21.9 25.8 21.6 6.7 46.8 18.2 16.9 6.8 8.4 12.9 6.0 5.2 11.2 12.6 7.9 13.6 11.0 13.4 10.3 10.6 4.8 7.5 13.6 7.9 9.2 7.8 5.4 8.0 11.8 10.3 20.8 7.8 8.1 23.3 6.6 7.6 14.8 7.6 6.7 13.4 8.2 7.1 17.1 3.4 32.0 13.9 8.1 18.3 9.1 7.9 7.5 9.8 5.9 16.2 10.0 10.2 28.9 7.8 28.0 8.3 9.8 27.5 27.8 12.6 12.9 12.0 13.0 8.6 25.7 33.4 25.8 12.1 8.6 27.9 21.6 26.0 19.7 27.2 27.1 21.9 25.4 37.7 26.2 3.4 6.7 19.6 8.1 46.8 18.2 11.4 29.7 15.7 15.0 12.3 10.0 14.8 13.3 10.5 11.0 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: " "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 19.1 8.9 14.0 15.5 12.2 13.3 8.5 11.5 18.7 25.6 24.0 18.1 7.8 14.9 6.6 13.5 12.6 21.7 16.0 19.8 13.7 16.9 18.4 9.8 15.5 13.2 10.8 11.2 13.4 19.7 19.0 11.7 19.1 23.6 8.1 17.7 18.0 9.6 20.1 8.6 11.5 11.2 10.9 14.1 18.2 15.4 16.7 16.9 8.3 12.8 54.2 15.0 28.9 10.4 13.7 11.5 9.0 18.3 10.4 8.8 35.0 12.5 18.3 15.0 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Approved Nucleoli,Cytosol Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: , HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 12.4 10.1 15.4 15.7 15.6 37.9 13.7 15.5 13.5 10.0 10.5 14.5 11.9 8.6 10.4 11.8 9.8 9.9 10.3 17.3 13.2 11.2 13.2 34.4 12.9 18.3 19.6 9.7 14.6 23.0 5.8 11.1 8.2 12.4 11.8 6.1 8.4 21.0 9.2 23.0 12.0 7.4 11.5 15.0 11.9 12.4 37.0 15.8 42.1 12.0 10.4 19.0 11.9 13.4 19.5 46.9 13.8 31.7 13.2 29.8 27.7 11.5 10.6 17.9 20.1 5.5 10.8 7.2 10.8 12.1 21.2 18.9 13.7 11.2 16.3 13.2 11.3 5.1 22.2 11.1 12.3 24.6 24.6 7.3 16.4 16.9 9.7 14.7 12.1 7.0 11.4 15.5 13.4 9.6 30.0 26.2 10.4 17.1 67.9 69.8 46.0 17.3 46.2 19.7 20.0 7.6 2.5 33.2 23.3 17.9 6.9 31.1 10.1 32.0 5.0 17.6 22.3 16.3 15.2 21.0 14.7 42.4 13.0 51.9 13.4 11.9 29.4 13.8 29.8 31.7 23.9 19.5 20.1 23.1 34.0 15.9 13.7 20.3 12.5 13.2 27.2 46.9 22.9 27.7 15.4 15.6 15.5 13.4 13.2 11.2 19.6 9.7 12.4 15.8 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favourable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favourable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favourable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.3 13.3 14.6 13.0 10.0 7.0 3.3 9.0 12.1 11.5 12.5 9.7 6.0 13.6 2.9 9.9 12.7 11.8 6.3 10.0 15.0 12.0 24.1 24.7 8.3 7.2 16.3 33.2 6.7 6.8 6.0 7.6 10.5 15.4 10.0 10.1 9.0 7.7 17.6 8.7 9.2 10.6 23.5 8.9 5.9 30.6 23.1 15.1 11.6 13.7 7.9 10.8 12.4 8.9 10.8 6.8 15.3 6.0 11.9 12.3 7.7 10.0 11.6 10.1 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA024821: , HPA058548: " "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavourable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 23.9 38.6 17.9 17.9 49.1 24.5 14.6 18.9 31.3 29.6 30.2 14.1 26.7 26.7 32.2 31.6 14.8 24.3 26.7 21.8 23.5 29.4 29.1 26.6 22.1 33.1 12.3 20.0 21.6 31.4 23.7 44.7 31.8 22.5 18.2 17.6 57.2 46.0 22.8 13.4 103.8 18.4 25.1 28.4 18.5 18.1 26.2 21.8 25.1 32.7 30.5 22.2 19.0 19.1 13.8 31.6 24.3 23.7 22.0 16.7 12.5 22.9 23.1 9.1 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell line enhanced" "Detected in some" "HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavourable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.0 0.2 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 15.8 33.3 0.1 1.1 0.2 0.0 0.0 0.0 0.5 0.1 3.8 1.4 0.0 0.0 0.0 0.0 0.3 0.2 9.1 0.7 8.2 0.8 2.0 0.8 0.1 0.2 9.0 0.1 13.1 0.0 0.0 0.0 0.0 8.7 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 30.7;SK-MEL-30: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "CAB025341: , HPA055371: " "prognostic favourable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.3 1.2 1.7 2.6 2.7 8.5 7.7 15.0 20.8 7.7 8.3 2.2 6.1 0.2 1.4 6.4 5.0 0.4 6.0 13.0 1.4 0.2 0.8 0.7 1.9 7.1 0.5 2.7 3.7 10.0 30.7 17.1 16.1 1.4 7.2 5.9 1.7 0.3 1.9 1.2 6.1 0.5 1.4 1.5 7.7 11.4 0.9 1.3 2.2 6.0 36.5 1.3 0.5 20.9 9.7 7.2 7.1 5.0 2.7 2.8 0.3 14.7 0.6 6.1 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 7 "PC-3: 9.3;SH-SY5Y: 5.9;U-266/84: 6.3;WM-115: 14.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: " "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.1 0.0 9.3 0.0 0.1 0.0 0.0 0.0 0.2 5.9 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.2 0.0 0.0 1.2 6.3 0.0 0.5 0.0 14.9 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717266 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 36.5;testis: 9.3" "Cell line enriched" "Detected in some" 4 "U-2 OS: 22.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: " "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 36.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 22.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell line enhanced" "Detected in some" "A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 19.6 0.0 0.3 15.6 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 9.3" "Group enriched" "Detected in some" 7 "U-266/70: 28.9;U-266/84: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 14.2" "Group enriched" "Detected in some" 14 "RT4: 48.6;U-266/70: 21.1;U-266/84: 26.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 21.1 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Cell line enriched" "Detected in some" 5 "U-266/70: 36.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA055743: , HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Cell line enhanced" "Detected in some" "K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 15.1 28.5 0.0 20.4 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 8 "K-562: 34.9;U-266/84: 39.4" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA062230: " "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 1.5 0.0 0.0 0.1 2.4 0.4 4.8 0.0 0.0 39.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Supported Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favourable (2.88e-4)" "prognostic favourable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavourable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.5 10.3 61.7 18.8 29.4 40.0 11.4 23.1 41.2 18.3 32.6 10.2 14.2 7.7 60.6 46.4 7.6 17.5 17.4 13.2 13.8 14.5 16.1 12.2 20.0 25.2 4.1 12.4 52.4 7.3 18.6 9.4 34.8 3.9 9.5 35.0 15.4 9.1 6.9 22.8 12.3 6.1 22.1 11.0 25.1 4.2 9.7 25.1 9.2 10.7 53.4 44.0 7.0 29.9 15.6 24.4 23.3 6.5 6.1 5.1 5.6 22.8 10.8 79.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427724-76431353 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell line enhanced" "Detected in many" "AN3-CA: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favourable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favourable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 2.6 5.8 13.8 3.0 23.5 1.1 3.3 18.7 33.9 4.7 1.9 3.2 0.5 1.5 5.4 3.5 2.3 4.8 2.3 3.9 18.9 20.3 4.1 1.1 2.6 4.1 10.2 22.0 8.4 4.1 15.1 5.1 0.8 19.8 5.9 2.1 2.3 3.4 7.4 2.2 3.3 2.0 4.8 5.4 4.5 2.6 1.3 4.9 1.1 4.0 0.1 3.6 2.4 1.8 1.0 0.0 0.0 0.0 1.5 2.4 0.4 0.2 4.7 4.8 9.2 3.4 2.0 4.3 3.5 3.5 3.0 1.7 1.0 0.7 1.0 1.8 3.1 3.6 7.1 6.6 2.5 2.3 0.1 0.0 0.0 3.0 0.7 1.8 0.6 1.5 3.0 0.8 0.8 1.1 0.3 0.0 4.5 0.6 5.1 0.2 5.8 7.1 4.0 3.6 0.0 3.9 0.0 0.0 2.5 0.0 0.5 0.7 2.2 0.1 0.6 4.5 5.8 4.8 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.8 1.1 2.3 0.0 1.0 1.4 1.3 0.0 1.5 0.0 0.0 0.0 0.4 13.8 23.5 18.7 33.9 18.9 20.3 10.2 22.0 19.8 4.9 MAGI1 "AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3" ENSG00000151276 "Membrane associated guanylate kinase, WW and PDZ domain containing 1" Q96QZ7 3 65353525-66038834 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031851, HPA031852, HPA031853, HPA077002" Supported Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA031851: AB_10599289, HPA031852: , HPA031853: AB_10602095, HPA077002: " "unprognostic (5.00e-2)" "unprognostic (9.84e-2)" "unprognostic (6.00e-3)" "unprognostic (1.73e-3)" "unprognostic (1.64e-1)" "unprognostic (2.17e-2)" "unprognostic (1.46e-3)" "unprognostic (9.46e-3)" "unprognostic (8.59e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (2.05e-3)" "prognostic favourable (4.55e-8)" "unprognostic (3.51e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-2)" "unprognostic (8.03e-2)" 18.0 6.0 10.1 6.4 9.8 1.0 16.5 38.6 16.8 6.9 11.2 10.1 25.7 10.7 11.6 7.6 9.4 12.6 19.7 11.1 9.4 11.8 14.3 17.6 13.3 2.9 8.8 10.4 4.3 16.7 18.7 13.1 11.1 9.6 9.2 9.5 7.7 17.4 37.9 7.7 13.0 11.6 7.9 8.3 13.9 19.8 10.7 7.7 0.6 23.2 5.8 4.4 6.9 13.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.8 1.5 8.7 0.9 1.7 1.3 3.9 4.8 4.1 1.8 2.8 10.3 2.4 0.0 0.7 5.7 0.8 2.4 1.6 2.9 0.0 1.3 24.5 3.0 6.9 1.1 0.0 0.8 1.9 1.4 6.3 1.3 4.2 10.3 0.0 1.9 2.1 0.0 0.0 11.6 1.5 0.0 2.4 0.6 2.2 9.3 2.8 7.6 1.9 2.3 0.0 4.5 0.0 1.1 5.9 4.3 1.5 1.9 0.0 0.0 0.0 3.4 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 9.8 38.6 15.5 9.4 11.8 8.8 10.4 9.6 7.7 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33484750-33501260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA044417: , HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 22.3 11.0 10.6 14.9 15.3 13.5 15.2 11.5 17.6 13.2 11.5 12.5 8.3 9.1 20.8 9.1 15.2 13.6 11.3 13.1 10.5 13.4 17.9 20.0 10.5 17.3 11.4 10.3 24.8 15.7 10.4 19.2 13.1 19.2 14.2 11.3 8.9 10.6 10.3 25.2 12.4 10.8 19.7 13.1 17.3 11.9 9.5 7.1 20.3 14.8 14.3 17.4 16.8 11.3 3.8 4.0 0.9 9.4 5.7 6.2 3.3 5.9 8.4 5.9 13.5 7.0 8.4 8.8 10.8 7.1 11.8 11.1 12.5 5.3 21.1 10.7 9.5 7.9 19.7 12.0 15.9 4.5 5.5 19.9 6.0 11.0 10.4 8.0 12.2 8.7 11.1 15.3 18.0 8.6 24.7 12.3 9.8 7.0 28.5 9.7 31.2 5.9 10.2 8.9 9.5 10.0 10.2 15.1 12.0 6.6 9.4 13.0 6.5 8.5 7.6 11.1 8.7 14.3 12.3 6.1 6.7 21.8 6.9 17.2 11.8 0.0 3.2 0.9 4.8 6.8 5.4 3.2 4.7 4.1 3.9 3.8 6.0 6.2 0.7 5.7 9.4 4.0 3.6 3.3 10.6 15.3 11.5 17.6 10.5 13.4 11.4 10.3 19.2 7.1 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell line enhanced" "Detected in some" "HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" "Golgi apparatus" Centrosome "HPA065691: " "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favourable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 22.2 227.3 5.7 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 MALT1 "MLT, PCASP1" ENSG00000172175 "MALT1 paracaspase" Q9UDY8 18 58671386-58754477 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004494, HPA048432" Enhanced Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "CAB004494: AB_627909, HPA048432: " "unprognostic (3.25e-1)" "unprognostic (2.31e-1)" "unprognostic (3.64e-2)" "unprognostic (3.25e-2)" "unprognostic (1.65e-3)" "unprognostic (4.67e-2)" "unprognostic (6.46e-2)" "unprognostic (4.50e-2)" "unprognostic (3.33e-2)" "unprognostic (4.16e-3)" "unprognostic (3.74e-1)" "unprognostic (2.07e-1)" "unprognostic (2.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.97e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" 11.2 3.9 4.1 21.7 5.6 10.2 10.6 9.1 6.8 11.0 10.7 3.9 10.9 5.5 8.1 10.5 16.4 6.6 8.1 8.7 4.0 4.3 14.9 10.5 14.3 29.0 4.1 1.8 8.1 6.2 10.0 9.3 8.8 4.9 18.1 7.9 7.5 10.7 8.4 10.7 12.6 12.2 6.6 6.2 19.9 6.2 11.8 4.8 22.4 7.9 12.4 24.0 9.6 12.3 6.3 3.6 1.2 1.7 1.6 4.8 1.1 7.4 10.6 13.0 3.2 2.6 5.8 5.8 13.3 9.4 11.6 9.9 8.6 9.6 11.8 6.0 16.5 7.3 5.6 5.5 14.3 7.9 3.1 4.2 7.6 13.8 4.2 8.5 5.7 3.6 11.7 9.1 9.2 2.5 6.8 20.6 6.3 2.4 1.8 3.6 3.2 3.6 6.4 7.7 8.3 50.8 3.1 1.4 3.0 7.3 3.8 5.0 3.7 4.9 3.4 15.0 6.6 4.4 12.2 18.4 21.8 10.3 6.0 6.4 5.9 0.8 1.5 1.0 2.7 1.7 2.1 3.6 4.8 2.9 2.2 6.3 4.3 2.8 1.2 1.6 1.6 3.6 2.9 1.1 4.1 5.6 9.1 6.8 4.0 4.3 4.1 1.8 4.9 4.8 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 22.6;HHSteC: 23.6;LHCN-M2: 29.4;TIME: 28.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavourable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 22.6 7.7 0.7 4.4 1.9 1.0 1.8 0.0 0.5 0.0 0.3 0.8 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.3 0.0 23.6 0.0 0.0 1.4 0.2 0.6 0.4 1.9 0.0 0.2 29.4 0.0 0.0 0.0 3.1 0.0 0.0 3.5 2.7 9.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell line enhanced" "Detected in many" "BEWO: 18.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026377: , HPA059977: " "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favourable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.5 2.5 1.4 2.8 0.6 0.1 18.5 2.7 0.3 0.3 0.6 2.0 1.6 1.3 0.6 0.7 2.2 0.3 1.3 0.0 2.0 0.9 0.8 5.2 2.2 1.2 0.1 4.8 0.8 1.7 1.4 0.6 0.6 2.6 1.2 0.2 4.1 0.9 3.6 1.4 0.7 1.6 0.4 2.4 0.9 1.3 1.6 2.0 0.5 1.2 1.1 4.3 0.8 0.8 7.5 4.7 1.5 0.4 3.1 1.6 0.4 1.7 1.9 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343180 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavourable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favourable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 26.3 5.5 10.2 16.1 8.1 4.2 19.7 27.8 13.4 15.8 9.2 10.4 8.4 4.3 11.2 8.5 9.3 11.7 10.8 8.9 10.5 6.9 13.8 3.5 15.0 10.9 6.9 3.4 11.7 8.2 13.3 15.2 18.8 9.3 12.3 8.9 10.8 16.6 12.3 4.4 14.2 8.9 10.2 14.4 16.8 6.5 4.3 10.6 21.2 11.8 4.8 13.6 16.0 15.3 2.1 1.2 4.7 1.1 4.2 6.4 2.0 5.5 1.1 9.6 2.5 10.0 11.6 2.1 6.4 9.6 4.2 4.4 0.6 11.8 1.2 15.2 14.8 5.1 1.9 6.2 5.9 27.4 0.7 0.7 2.0 2.1 5.8 0.0 0.0 16.9 0.6 7.5 4.5 2.4 3.1 1.7 7.5 0.4 0.1 1.5 1.0 1.8 1.9 1.8 6.4 6.3 7.8 0.1 0.8 2.4 1.0 2.7 0.9 0.2 10.4 7.5 1.8 2.5 4.0 1.2 0.2 1.8 3.6 1.1 13.7 0.1 1.1 0.0 1.5 0.6 2.6 1.9 3.2 4.1 1.2 2.1 6.4 4.3 4.7 4.2 0.7 0.9 1.2 2.0 10.2 8.1 27.8 7.0 10.5 6.9 6.9 3.4 9.3 10.6 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.5;HSkMC: 46.0;U-266/70: 13.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles 1200000 "Nucleoplasm, Vesicles" "HPA048352: " "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favourable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favourable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.5 2.6 9.3 7.3 3.6 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 0.1 1.1 0.1 0.2 3.9 0.5 0.2 0.1 0.0 1.1 2.1 5.2 46.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 2.3 3.2 0.0 0.2 7.7 0.2 0.1 0.2 7.3 0.2 0.3 1.9 0.6 1.0 1.5 0.0 0.0 0.7 8.4 0.3 13.7 0.0 0.0 1.9 4.4 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 MAN2B1 "LAMAN, MANB" ENSG00000104774 "Mannosidase alpha class 2B member 1" O00754 19 12646511-12666742 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9" "Group enriched" "Detected in all" 5 "dendritic cells: 41.9;monocytes: 42.1" "HPA041530, HPA053404" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" 3400000 "Nucleoplasm, Vesicles" "HPA041530: AB_10795639, HPA053404: " "unprognostic (6.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.20e-2)" "unprognostic (5.48e-2)" "unprognostic (3.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.84e-2)" "unprognostic (9.55e-2)" "unprognostic (1.95e-1)" "unprognostic (2.79e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (1.94e-5)" "unprognostic (4.00e-1)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.51e-1)" 25.2 15.6 7.9 26.7 11.0 33.4 24.4 4.4 7.0 10.5 15.0 14.0 8.6 14.2 15.3 16.5 12.2 13.4 16.4 19.4 6.4 4.4 13.6 16.3 30.2 68.6 10.0 4.7 12.2 21.7 9.1 7.2 15.8 8.6 13.7 10.6 12.0 22.0 8.1 7.7 18.0 20.0 10.2 11.7 51.3 19.5 6.3 8.2 22.1 11.3 7.8 30.0 18.7 11.2 7.7 41.9 6.5 42.1 2.7 8.4 26.0 16.3 8.4 8.6 10.1 28.8 19.3 24.3 12.2 25.8 10.9 10.7 6.7 6.9 18.0 14.8 9.6 12.9 4.4 8.1 5.2 8.9 13.4 6.2 4.2 10.9 14.6 41.0 42.9 23.0 16.1 6.1 7.7 10.3 7.9 13.6 5.7 12.8 5.5 23.1 7.1 10.7 12.8 11.8 8.9 12.8 19.0 2.7 8.4 12.1 10.4 19.8 16.0 25.4 13.5 14.8 6.1 14.4 11.4 18.2 20.0 8.9 10.0 40.5 16.5 2.2 42.1 6.2 7.5 39.4 8.4 7.7 6.9 6.7 35.2 6.5 3.8 3.8 6.5 2.7 28.4 41.9 6.8 26.0 7.9 11.0 4.4 7.0 6.4 4.4 10.0 4.7 8.6 8.2 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA052348: " "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavourable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favourable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 16.9 33.5 17.0 17.1 28.0 20.4 14.8 23.8 24.9 23.1 18.2 39.4 23.3 4.4 28.6 28.9 23.5 16.1 37.2 15.9 3.3 16.7 4.6 14.1 34.9 30.3 4.9 2.9 22.2 26.5 21.5 35.6 16.1 7.4 4.9 23.0 20.0 6.1 6.5 13.5 31.4 3.7 22.4 5.1 21.9 23.8 16.4 18.7 24.2 36.4 19.6 24.5 7.9 17.6 42.6 16.0 23.9 18.3 6.5 8.8 3.6 30.6 2.7 22.0 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350541 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.9;RPTEC TERT1: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 24 "neutrophil: 37.5" "Lineage enriched" "Detected in many" 36 "granulocytes: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" 28000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favourable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 13.1 8.8 9.7 5.1 13.7 4.2 14.7 10.1 18.4 13.5 17.8 7.5 12.9 13.4 15.1 14.1 27.3 11.2 19.3 7.9 9.2 7.6 9.5 7.6 8.4 6.6 6.9 9.0 11.3 26.4 18.5 19.5 11.0 9.0 15.0 18.5 12.8 42.6 15.2 3.6 13.3 13.3 14.4 5.8 8.4 21.3 9.1 6.2 0.0 9.5 16.7 18.2 12.6 12.9 0.2 0.2 37.5 0.5 0.2 1.0 0.1 0.2 3.3 1.0 0.0 3.4 3.3 3.6 2.3 2.7 1.2 1.5 2.7 10.7 0.0 2.5 2.2 0.4 4.2 1.9 0.9 0.0 3.8 4.7 4.1 2.2 0.6 0.7 1.4 2.1 3.1 0.7 0.5 29.9 3.0 0.0 0.4 6.2 0.0 0.3 3.7 1.8 0.1 0.0 0.1 15.5 10.9 1.4 5.9 1.2 10.0 3.4 9.0 3.0 11.7 1.7 1.4 0.4 3.1 0.2 0.1 1.6 1.2 0.0 1.2 1.5 0.5 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 1.0 0.1 37.5 0.2 0.1 0.0 0.0 0.1 9.7 13.7 10.1 18.4 9.2 7.6 6.9 9.0 9.0 6.2 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: , HPA059299: " "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.3 39.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.4 5.3 0.0 0.0 0.5 1.6 0.1 4.2 74.2 0.0 4.0 18.6 20.9 0.0 10.9 4.7 0.0 0.1 1.3 0.6 0.0 0.1 0.3 1.2 0.0 0.0 0.1 5.3 30.6 0.7 1.8 0.0 0.0 0.0 0.1 0.0 2.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 MAP1LC3B ATG8F ENSG00000140941 "Microtubule associated protein 1 light chain 3 beta" Q9GZQ8 16 87383995-87404779 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037216, HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB037216: AB_796155, HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (4.70e-3)" "unprognostic (2.89e-1)" "unprognostic (3.21e-1)" "unprognostic (9.70e-3)" "unprognostic (4.28e-1)" "unprognostic (1.79e-2)" "unprognostic (4.98e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "prognostic favourable (2.77e-7)" "prognostic unfavourable (8.97e-4)" "unprognostic (9.66e-2)" "unprognostic (1.14e-1)" "unprognostic (1.60e-1)" 35.8 36.4 37.4 15.3 34.6 89.0 35.9 58.5 46.6 21.2 18.7 25.8 22.9 11.1 22.7 20.0 19.5 17.5 24.5 41.0 35.6 40.5 24.7 22.2 20.6 22.3 49.0 40.2 19.6 15.9 27.9 20.5 31.2 46.7 19.6 20.4 18.6 19.6 22.4 67.4 22.9 13.6 28.3 43.1 18.0 15.8 27.5 28.8 13.6 27.2 23.1 20.9 22.0 31.9 15.5 15.8 50.0 18.6 20.8 21.8 19.9 10.3 6.0 11.8 10.7 35.6 27.6 7.9 20.5 23.6 16.2 11.2 9.7 7.5 6.7 15.8 27.8 9.5 17.2 13.0 23.1 8.8 15.1 7.0 7.7 16.4 59.0 5.0 7.8 36.6 43.2 25.1 60.3 19.2 18.7 14.4 27.4 10.7 8.9 11.2 12.4 14.6 14.1 7.8 6.6 21.7 4.9 9.7 11.1 31.7 5.3 39.6 8.7 6.1 24.2 17.6 11.4 15.9 11.5 19.0 23.3 24.4 25.0 12.1 12.6 48.1 18.6 42.0 17.5 16.5 17.8 15.5 16.9 17.7 14.4 12.8 13.1 13.8 50.0 20.8 17.2 15.8 21.8 19.9 37.4 34.6 58.5 46.6 35.6 40.5 49.0 40.2 46.7 28.8 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.6 0.0 0.7 2.9 0.4 1.4 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.1 3.7 0.7 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.1 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.5 1.6 4.7 0.7 0.9 1.4 2.9 1.6 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.3 1.2 1.1 11.1 1.5 0.2 0.9 4.0 1.1 3.5 2.6 3.8 2.9 4.6 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386817-66492312 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" 62000 "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavourable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 28.6 16.9 33.9 19.1 54.1 29.0 23.6 32.5 48.4 12.5 12.1 8.4 10.2 10.0 11.8 16.5 22.0 10.6 14.4 19.1 49.2 26.4 15.3 53.1 16.4 23.3 17.6 31.2 13.5 11.7 23.4 12.0 15.4 17.2 14.4 12.9 9.1 13.2 12.4 39.5 12.3 10.9 16.9 17.4 14.5 10.8 7.8 12.6 12.6 12.3 9.7 27.9 13.6 18.7 4.6 16.2 5.5 8.2 8.4 7.9 2.7 33.1 15.6 31.5 13.1 19.0 14.3 18.2 24.1 20.6 26.2 23.4 23.5 27.3 30.5 29.9 19.8 29.6 29.4 35.2 30.8 24.5 17.5 9.8 16.4 12.7 15.4 12.9 14.6 11.0 21.8 18.9 28.1 20.4 17.3 39.0 38.1 12.8 10.3 16.8 16.1 13.7 11.7 19.5 27.1 25.4 14.3 19.4 10.8 19.5 15.3 20.2 13.8 11.0 28.1 34.1 20.9 24.0 35.7 24.2 43.0 19.4 36.0 22.8 15.9 3.2 8.2 5.5 7.4 8.2 6.7 3.0 6.6 6.9 8.3 4.6 7.9 4.9 3.9 8.4 7.3 16.2 4.9 2.7 33.9 54.1 32.5 46.9 49.2 26.4 17.6 31.2 17.2 12.6 MAP2K3 "MAPKK3, MEK3, MKK3, PRKMK3" ENSG00000034152 "Mitogen-activated protein kinase kinase 3" P46734 17 21284672-21315240 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018548 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB018548: AB_631927" "unprognostic (2.31e-1)" "unprognostic (6.39e-2)" "unprognostic (4.63e-2)" "unprognostic (3.68e-1)" "unprognostic (3.54e-3)" "unprognostic (1.60e-1)" "unprognostic (2.97e-2)" "unprognostic (1.35e-2)" "unprognostic (5.25e-3)" "unprognostic (1.88e-2)" "unprognostic (3.16e-2)" "unprognostic (2.18e-2)" "unprognostic (1.33e-1)" "unprognostic (6.48e-2)" "unprognostic (1.22e-2)" "unprognostic (2.92e-1)" "unprognostic (1.77e-1)" 16.1 12.1 5.5 14.8 7.3 66.9 29.0 12.4 8.9 10.2 12.4 6.3 10.3 18.1 7.6 11.1 24.2 11.6 25.1 26.8 5.6 5.3 15.8 37.1 25.5 34.0 7.4 3.9 10.1 26.3 9.6 15.8 26.7 9.5 12.2 9.3 12.7 18.5 9.2 46.4 20.9 23.8 18.1 7.6 26.7 16.3 5.3 4.1 16.4 11.5 45.0 21.4 16.0 17.3 13.2 17.3 49.2 33.3 5.4 16.2 10.0 21.6 22.0 2.9 13.3 17.8 11.4 11.1 33.6 36.5 26.8 24.7 24.3 14.0 19.6 13.7 52.5 21.5 9.3 29.8 19.1 20.3 17.0 11.4 12.6 22.0 5.5 14.9 23.4 8.8 8.5 36.5 11.0 12.0 2.2 9.8 22.3 21.5 7.4 14.2 8.4 12.6 15.5 18.9 14.5 15.1 22.9 8.0 2.8 12.4 13.4 23.3 6.7 5.1 10.9 25.5 20.8 27.2 21.6 12.3 6.2 25.2 24.6 12.9 13.1 14.5 16.0 25.2 14.6 24.0 12.6 13.2 12.1 13.6 17.3 10.6 7.8 10.1 49.2 5.4 33.3 12.7 16.2 10.0 5.5 7.3 12.4 8.9 5.6 5.3 7.4 3.9 9.5 4.1 MAP2K4 "JNKK1, MEK4, MKK4, PRKMK4, SERK1" ENSG00000065559 "Mitogen-activated protein kinase kinase 4" P45985 17 12020824-12143830 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007751, HPA060074" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB007751: , HPA060074: " "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (4.47e-2)" "unprognostic (1.02e-2)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (2.89e-1)" "unprognostic (2.16e-1)" "unprognostic (1.93e-3)" "unprognostic (2.53e-1)" "unprognostic (2.76e-3)" "unprognostic (4.82e-2)" "unprognostic (5.32e-3)" "unprognostic (3.13e-1)" "unprognostic (2.30e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" 10.7 13.2 23.7 9.4 21.0 3.1 14.4 25.0 42.7 12.5 11.5 7.9 8.5 9.6 12.1 17.8 18.5 11.5 10.7 14.9 31.7 29.3 15.8 20.6 11.4 14.6 24.5 27.1 13.0 11.1 19.6 16.7 15.1 23.4 14.5 13.1 6.5 9.8 13.2 20.6 14.4 9.9 13.5 16.3 10.7 10.7 10.3 9.8 10.3 16.5 11.6 13.4 11.1 11.2 2.8 1.8 13.2 4.3 3.5 3.3 2.3 17.9 15.5 20.4 10.5 11.3 14.7 13.0 12.3 16.2 14.0 13.4 9.2 6.2 7.5 10.0 19.1 12.1 17.7 17.1 21.1 13.2 20.8 8.3 9.1 17.3 13.3 7.9 12.6 12.1 17.0 16.4 17.2 12.7 8.8 4.4 17.6 6.7 9.6 7.4 11.9 7.6 11.8 22.9 5.1 19.2 11.6 4.1 12.1 14.2 7.6 11.8 9.6 5.8 11.6 6.9 10.7 9.5 14.5 8.7 9.7 5.9 13.0 6.3 10.0 0.6 2.7 2.0 3.0 1.5 2.7 2.8 2.4 2.4 1.8 2.7 2.0 3.3 13.2 3.5 4.3 1.8 2.6 2.3 23.7 21.0 25.0 42.7 31.7 29.3 24.5 27.1 23.4 9.8 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542709-67807123 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favourable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 18.6 22.2 20.3 13.8 30.9 14.6 23.7 25.0 25.4 17.0 19.3 17.2 19.9 14.7 17.4 11.3 13.5 16.2 14.4 18.8 17.1 16.4 14.2 15.5 13.5 27.9 12.6 11.5 29.0 21.0 34.1 14.4 17.7 22.2 15.9 14.8 15.6 15.7 18.5 28.5 18.7 15.0 19.4 17.2 13.0 15.4 20.3 16.2 40.2 16.9 9.2 11.9 17.0 17.9 6.6 10.2 10.3 7.3 11.7 11.2 5.5 5.5 14.6 8.8 10.3 13.0 22.8 6.9 5.5 11.2 10.4 11.4 5.8 9.9 9.1 11.7 9.2 8.3 14.9 8.8 8.6 13.1 14.9 12.3 10.9 6.3 16.4 7.4 7.7 15.6 11.7 7.5 17.1 13.7 10.8 15.2 8.6 7.1 12.1 8.8 12.3 7.1 12.0 10.2 15.1 6.3 10.1 5.5 8.6 6.2 9.2 22.0 11.5 14.6 11.4 10.7 7.1 7.4 7.4 21.5 25.3 10.6 14.4 17.0 7.7 10.3 7.3 6.6 7.7 5.6 11.2 6.6 7.3 9.0 10.2 6.2 10.4 9.5 1.7 11.7 6.2 3.9 7.4 5.5 20.3 30.9 25.0 25.4 17.1 16.4 12.6 11.5 22.2 16.2 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414698-69553861 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.9;skeletal muscle: 55.6" "Cell line enhanced" "Detected in many" "A549: 23.9;HUVEC TERT2: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9" "Group enriched" "Detected in all" 9 "dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favourable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favourable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 4.5 2.0 3.2 8.6 5.9 10.1 14.0 13.7 7.5 19.8 21.5 6.2 4.7 7.2 4.7 3.1 3.4 3.3 5.1 2.5 3.9 3.5 4.1 8.6 2.6 10.3 5.4 4.1 2.7 8.5 0.0 3.2 1.1 5.3 2.8 22.8 5.3 4.0 4.6 55.6 2.3 7.3 2.3 6.2 5.9 5.4 2.1 5.4 13.7 2.8 4.8 5.1 3.0 2.5 2.3 31.9 19.3 9.3 1.8 2.1 2.6 0.1 23.9 10.8 13.0 4.7 2.5 1.6 0.1 3.5 1.0 1.5 0.7 1.1 0.6 8.8 0.5 1.2 3.7 0.5 0.3 0.8 1.9 0.1 6.7 6.7 4.6 1.0 0.9 11.9 0.3 0.3 0.0 17.2 0.0 1.7 0.0 0.1 12.5 0.4 7.6 4.4 4.5 1.1 0.3 4.8 3.3 4.8 7.3 1.0 0.9 2.2 3.3 1.3 3.0 1.3 1.5 1.1 0.4 1.2 1.3 0.3 1.0 1.5 1.0 0.8 9.3 1.6 1.2 1.1 2.1 1.6 1.4 1.5 2.9 2.3 1.6 1.5 19.3 1.8 0.4 31.9 1.9 2.6 3.2 5.9 13.7 7.5 3.9 3.5 5.4 4.1 5.3 5.4 MAP2K7 "Jnkk2, MKK7, PRKMK7" ENSG00000076984 "Mitogen-activated protein kinase kinase 7" O14733 19 7903843-7914478 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001633, CAB004262, HPA064711" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: " "unprognostic (1.77e-1)" "unprognostic (5.04e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-1)" "unprognostic (4.24e-2)" "prognostic favourable (8.54e-5)" "unprognostic (1.80e-3)" "unprognostic (2.55e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-2)" "unprognostic (1.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.54e-2)" "unprognostic (3.71e-2)" "unprognostic (6.05e-2)" "unprognostic (1.73e-2)" "prognostic favourable (1.56e-4)" 16.3 14.9 13.5 16.4 16.4 23.8 13.6 28.7 21.5 14.3 15.6 23.2 15.1 19.3 19.1 9.9 13.6 13.1 14.3 15.8 14.6 11.9 12.8 15.9 12.5 15.9 17.2 13.9 18.4 22.3 13.9 17.0 16.4 16.2 14.4 7.9 14.2 23.0 13.4 61.6 21.3 18.7 14.1 12.5 19.4 14.8 21.5 16.5 9.8 13.7 17.3 12.8 15.4 15.2 3.0 2.6 4.8 2.7 3.3 2.5 1.0 12.7 7.3 6.4 10.4 5.1 5.0 11.9 8.4 4.1 5.7 6.0 10.5 7.8 15.2 13.6 4.4 11.7 5.5 6.4 2.2 12.1 27.4 10.7 9.7 7.8 6.6 9.9 13.6 5.7 8.4 4.5 5.2 5.2 15.6 20.0 3.3 6.7 14.2 24.2 11.2 16.5 14.1 6.9 15.4 5.1 10.7 11.7 11.8 5.7 10.1 11.7 10.8 11.4 7.7 17.5 10.0 12.3 11.3 29.0 13.4 14.3 8.7 14.7 7.0 0.0 2.7 1.9 2.3 2.5 1.5 2.1 1.9 2.0 1.3 3.0 1.7 2.5 4.8 3.3 1.5 2.6 0.7 1.0 13.5 16.4 28.7 21.5 14.6 11.9 17.2 13.9 16.2 16.5 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favourable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favourable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.2 7.5 2.3 5.5 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.7 4.6 1.5 2.0 0.9 2.2 0.3 10.9 7.1 1.5 3.2 1.7 4.2 1.2 3.7 1.2 5.4 2.2 1.5 1.9 5.4 9.8 0.6 3.7 4.7 2.3 2.8 4.9 5.9 2.5 3.4 1.8 4.0 7.8 11.3 5.1 1.8 10.3 2.5 2.3 3.1 5.3 5.1 7.8 8.4 13.0 7.5 2.5 6.2 2.4 7.7 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 MAP3K11 "MEKK11, MLK3, PTK1, SPRK" ENSG00000173327 "Mitogen-activated protein kinase kinase kinase 11" Q16584 11 65597755-65615382 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 75.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010165 Approved Supported "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "CAB010165: AB_631936" "unprognostic (8.36e-2)" "unprognostic (1.17e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-1)" "unprognostic (7.56e-3)" "unprognostic (3.10e-2)" "unprognostic (4.50e-2)" "unprognostic (4.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.77e-2)" "unprognostic (3.13e-2)" "unprognostic (2.01e-2)" "unprognostic (7.62e-2)" "unprognostic (1.95e-1)" "unprognostic (8.27e-3)" 23.2 10.8 11.4 23.7 21.2 14.2 27.4 7.9 13.8 8.6 15.8 29.8 6.1 31.9 11.0 8.1 14.7 11.6 12.0 11.6 13.3 8.1 16.1 31.2 21.1 14.4 30.9 8.2 8.4 12.5 8.3 10.3 14.7 16.7 13.4 8.2 15.4 13.5 9.5 11.9 13.7 31.9 8.6 17.7 28.8 16.9 8.6 19.0 8.9 13.6 7.6 12.7 8.9 75.8 2.3 7.6 13.8 12.0 1.8 3.5 5.6 16.5 14.6 7.9 8.4 2.5 3.2 8.1 6.4 4.5 7.7 5.3 14.6 16.0 6.2 23.7 5.0 14.4 4.7 6.9 2.8 13.6 6.0 17.5 10.0 17.4 7.0 10.0 26.5 5.0 6.7 5.7 5.2 21.5 7.5 12.5 4.0 20.4 11.7 18.9 8.6 18.7 19.5 5.1 12.6 7.2 14.3 7.1 8.0 7.5 21.8 37.5 17.4 16.3 23.9 11.8 12.8 17.2 11.3 8.0 9.0 5.5 13.8 11.6 27.3 4.3 7.7 9.2 2.4 12.0 2.4 2.0 2.6 3.5 7.6 2.3 2.0 1.5 13.8 1.8 11.7 2.3 1.4 5.6 11.4 21.2 7.9 13.8 13.3 8.1 30.9 8.2 16.7 19.0 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell line enhanced" "Detected in many" "ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA039936: AB_10795239, HPA071996: " "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favourable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavourable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.5 4.7 7.3 28.4 15.2 0.6 5.1 9.6 5.6 5.6 0.1 0.9 1.7 2.9 5.4 0.0 2.1 3.4 2.2 2.5 2.6 1.8 3.8 0.0 27.1 0.0 1.9 27.0 2.4 7.6 4.0 8.7 0.0 8.1 5.3 3.3 1.8 0.4 1.6 2.8 2.6 3.2 0.4 2.8 0.0 4.7 6.4 2.7 3.5 7.2 2.4 4.7 6.4 5.4 5.8 2.4 1.3 3.3 3.7 0.0 8.7 3.3 5.2 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489097 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favourable (1.11e-4)" "prognostic unfavourable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 9.8 24.8 21.7 8.7 22.2 9.5 15.1 16.4 26.1 12.9 16.9 18.4 10.5 16.8 12.9 42.1 15.2 14.6 13.1 8.1 19.2 18.6 21.9 20.7 15.2 7.4 23.2 17.1 16.5 24.9 20.9 24.5 9.1 21.8 14.5 18.9 18.6 26.2 11.4 3.3 9.8 23.4 12.1 26.4 8.7 16.4 12.9 15.8 4.4 18.6 8.3 10.3 12.5 11.5 23.7 21.5 21.1 13.2 11.5 17.4 7.8 29.1 5.8 11.3 0.3 10.3 12.7 6.6 6.7 4.6 10.9 13.2 11.2 11.0 0.2 23.0 12.2 16.7 0.3 15.5 19.4 32.4 15.0 0.1 7.9 9.2 11.2 15.3 8.4 11.5 13.6 9.3 11.7 12.1 0.3 23.7 9.7 9.1 1.8 7.2 13.0 13.7 0.2 13.5 16.0 19.2 7.6 18.6 12.4 11.3 17.1 23.2 25.8 8.6 8.0 9.0 11.7 16.2 14.5 12.1 15.6 9.6 13.2 7.8 14.7 6.4 13.2 5.1 10.3 12.2 15.8 23.7 12.4 12.8 21.5 19.0 17.4 16.8 21.1 11.5 8.6 9.4 4.8 7.8 21.7 22.2 16.4 26.1 19.2 18.6 23.2 17.1 21.8 15.8 MAP3K14 "FTDCR1B, HS, HSNIK, NIK" ENSG00000006062 "Mitogen-activated protein kinase kinase kinase 14" Q99558 17 45263121-45317040 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.0;HDLM-2: 22.6;U-251 MG: 22.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027269, HPA027270" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "HPA027269: AB_10600302, HPA027270: AB_10600884" "unprognostic (1.05e-2)" "prognostic favourable (5.27e-5)" "unprognostic (2.71e-2)" "unprognostic (9.42e-2)" "unprognostic (5.31e-2)" "unprognostic (2.61e-3)" "unprognostic (2.70e-2)" "unprognostic (1.72e-1)" "unprognostic (3.40e-1)" "unprognostic (3.45e-1)" "unprognostic (1.07e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (8.82e-2)" "unprognostic (3.49e-2)" "unprognostic (1.03e-2)" "unprognostic (2.28e-1)" 3.7 3.4 3.0 14.7 4.0 3.4 2.7 4.9 3.6 5.0 7.3 4.5 3.5 6.0 5.5 3.3 6.8 4.2 6.2 4.5 3.0 4.4 5.1 4.9 12.0 3.0 0.6 3.5 5.7 3.5 7.7 1.5 4.6 5.2 3.5 4.3 7.5 4.8 14.5 6.1 9.6 5.2 4.1 8.4 4.0 4.5 4.5 7.1 2.2 6.9 18.0 4.9 2.8 9.5 4.8 7.7 3.6 5.6 5.2 2.3 9.4 22.0 2.2 3.9 1.5 3.7 5.6 2.6 1.8 8.3 5.1 3.4 11.6 4.2 13.3 2.7 6.6 1.0 3.5 4.3 22.6 1.7 0.9 6.0 1.5 4.0 0.7 4.4 5.8 2.2 4.1 2.2 1.6 1.8 18.0 4.2 3.4 3.9 1.5 1.2 3.1 5.2 6.7 9.5 6.0 1.9 2.3 1.9 4.0 2.7 2.8 1.7 0.4 3.5 3.8 5.9 3.2 22.1 17.2 6.4 2.2 2.1 2.4 5.1 1.5 3.4 1.6 3.5 3.6 2.0 7.6 2.4 2.5 2.3 9.5 2.6 2.5 7.7 5.6 2.2 4.8 5.2 2.3 MAP3K2 "MEKK2, MEKK2B" ENSG00000169967 "Mitogen-activated protein kinase kinase kinase 2" Q9Y2U5 2 127298730-127388465 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 13.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021540 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021540: " "unprognostic (5.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.58e-1)" "unprognostic (9.46e-2)" "unprognostic (1.02e-1)" "unprognostic (5.76e-2)" "unprognostic (7.19e-2)" "unprognostic (4.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.97e-3)" "unprognostic (7.56e-2)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (2.11e-1)" 18.5 14.5 13.7 20.1 14.5 41.0 22.6 20.1 16.3 16.6 19.6 12.7 18.9 18.8 19.8 18.0 13.4 15.9 18.6 13.3 12.5 10.2 15.5 27.6 20.0 28.5 17.9 13.0 20.3 15.4 23.8 21.2 13.9 12.3 13.6 13.1 12.2 18.1 25.5 24.5 19.4 22.5 18.1 14.9 17.0 18.0 14.9 14.3 25.8 22.5 13.7 16.8 17.1 20.3 3.1 5.1 13.6 2.9 2.3 2.1 1.1 16.3 7.0 5.6 5.6 7.8 10.4 9.3 10.2 11.1 10.1 8.2 8.3 7.3 10.8 17.6 14.5 13.9 8.9 6.8 11.3 27.0 6.9 10.0 12.6 7.3 9.1 10.0 21.7 9.3 7.6 12.2 15.0 4.6 4.7 21.6 9.9 5.9 11.7 7.1 5.7 9.1 7.7 10.5 8.0 4.1 15.3 11.1 5.9 14.8 9.1 9.2 5.9 7.7 10.6 19.8 18.6 9.1 13.8 22.4 16.1 11.1 9.5 6.6 8.5 4.0 2.9 2.0 1.7 1.8 2.1 3.1 1.6 1.7 2.4 2.6 1.9 2.0 13.6 2.3 2.2 5.1 1.4 1.1 13.7 14.5 20.1 16.3 12.5 10.2 17.9 13.0 12.3 14.3 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327768-233385148 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell line enhanced" "Detected in many" "HEK 293: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.6 3.2 2.0 3.4 2.2 1.3 2.2 10.0 3.3 1.5 11.4 0.6 9.1 9.9 0.8 5.2 2.4 3.9 3.9 0.7 1.3 2.1 12.5 13.3 5.6 0.5 0.9 1.7 0.8 28.9 4.4 2.6 1.0 1.2 1.3 6.0 1.0 3.7 2.5 0.4 2.7 17.2 0.3 0.9 0.7 10.1 12.4 0.6 0.5 2.4 0.8 1.3 1.1 1.6 0.5 0.8 0.1 0.3 5.0 0.2 0.1 7.3 12.5 0.2 0.0 0.0 0.0 6.3 0.2 0.0 0.3 0.5 6.9 6.4 0.7 5.2 0.1 3.9 9.4 3.8 0.8 13.6 18.0 0.1 7.0 0.0 0.4 11.9 2.9 0.1 5.1 0.2 7.3 0.4 0.1 2.4 0.0 1.6 3.8 4.3 8.9 5.5 0.0 0.0 13.1 8.6 3.1 9.2 2.5 4.3 0.2 0.0 3.7 3.8 0.0 0.0 1.2 0.0 7.3 2.2 2.8 0.0 1.2 3.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.8 0.5 0.0 0.0 0.1 5.0 0.0 0.2 0.2 0.1 2.0 2.2 10.0 3.3 1.3 2.1 0.9 1.7 1.2 0.6 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: " "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.13e-4)" "prognostic favourable (7.26e-4)" "prognostic unfavourable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.4 6.9 6.2 6.9 8.7 15.3 1.6 9.3 5.4 7.0 5.3 2.0 10.0 0.1 8.3 14.1 11.8 2.1 6.5 3.5 6.2 5.1 0.5 16.0 3.1 2.7 0.5 0.6 12.2 15.9 7.3 2.6 4.7 2.3 4.1 11.1 18.4 0.3 8.4 1.9 5.7 2.7 4.1 1.7 10.5 7.8 2.3 3.4 9.8 8.6 7.3 4.6 6.4 9.8 17.6 7.4 19.7 4.8 3.3 4.1 0.1 15.6 6.1 5.1 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 MAP3K7 "MEKK7, TAK1" ENSG00000135341 "Mitogen-activated protein kinase kinase kinase 7" O43318 6 90513573-90587045 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007633, HPA075335" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" Cytosol "Nuclear speckles, Plasma membrane" "HPA007633: AB_1079359, HPA075335: " "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (3.51e-4)" "unprognostic (9.77e-2)" "unprognostic (6.51e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (2.56e-3)" "unprognostic (4.76e-2)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (1.17e-1)" 15.5 17.6 19.6 17.3 26.3 10.3 21.6 27.5 27.3 21.1 16.4 15.7 15.8 12.5 23.1 23.6 15.2 15.5 17.6 22.2 20.5 17.5 15.9 15.5 20.0 22.2 22.9 16.4 25.0 13.5 25.8 25.6 23.6 20.7 21.2 15.3 12.4 17.0 23.3 24.3 18.7 14.7 19.4 23.0 23.3 14.7 13.8 21.7 28.2 20.3 10.8 21.9 17.2 18.9 14.2 15.9 19.4 17.7 18.2 22.1 13.6 7.7 6.9 20.1 17.2 14.7 19.7 14.2 15.6 18.1 14.1 17.8 8.8 7.5 17.3 10.0 16.9 8.3 12.6 12.2 24.0 8.8 13.4 15.4 9.5 11.7 15.4 17.1 11.9 16.2 14.9 13.7 16.9 13.2 30.8 14.2 20.1 9.5 7.9 14.5 16.5 8.7 13.7 36.1 8.4 11.8 8.7 10.2 14.5 10.9 7.6 11.8 7.5 30.5 12.6 11.5 7.3 10.5 14.5 12.7 11.3 7.5 17.6 18.8 16.8 15.5 12.7 19.4 15.1 17.4 16.8 14.2 14.5 14.4 15.9 10.5 16.5 16.0 12.5 18.2 17.7 9.8 22.1 13.6 19.6 26.3 27.5 27.3 20.5 17.5 22.9 16.4 20.7 21.7 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell line enhanced" "Detected in many" "A-431: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 17.7 8.2 1.6 2.0 0.0 0.0 5.5 0.3 0.2 1.7 1.5 5.9 6.8 3.6 2.4 0.1 8.4 5.2 10.0 1.8 2.4 1.5 0.2 2.9 3.9 0.2 0.4 0.8 0.1 5.5 1.2 10.4 0.0 1.3 0.8 0.4 7.1 2.8 0.4 3.5 3.8 1.0 3.1 0.7 3.9 8.2 11.3 2.4 5.1 6.1 1.0 5.5 0.6 0.0 0.0 7.2 0.0 2.8 1.9 4.3 1.9 2.7 0.3 1.0 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 131.5;skeletal muscle: 197.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Enhanced "Plasma membrane,Microtubules,Cytosol" 120000 "Plasma membrane, Microtubules, Cytosol" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 39.3 14.8 60.5 18.2 50.9 6.3 16.4 29.3 56.0 26.9 26.4 80.8 15.8 13.6 25.8 27.4 27.0 24.6 20.1 110.2 63.7 57.5 20.8 13.8 22.7 12.4 86.8 26.1 26.8 18.9 14.6 9.3 24.0 59.5 21.8 18.8 25.2 14.0 34.9 197.9 25.1 15.2 35.0 131.5 18.3 16.2 21.2 41.8 7.3 15.4 31.3 14.2 24.3 18.1 9.9 8.9 6.3 19.7 10.7 13.4 6.7 21.9 17.6 22.1 16.7 32.6 58.2 9.3 41.2 45.0 34.9 39.2 14.8 13.8 18.6 9.6 62.1 14.7 28.2 37.3 39.2 26.8 11.9 12.6 19.7 19.1 44.3 8.7 10.2 48.6 46.7 42.3 51.9 45.7 16.2 21.6 27.4 12.4 12.3 10.6 13.3 36.5 6.6 20.8 23.1 22.3 18.4 8.8 13.7 31.6 12.8 21.8 9.4 8.1 61.7 33.0 25.5 34.4 26.3 15.2 11.8 8.8 42.4 10.7 31.2 6.3 5.3 2.8 13.4 9.0 6.5 9.9 9.0 10.9 5.7 9.4 4.3 6.7 2.2 10.7 19.7 8.9 10.2 6.7 60.5 50.9 29.3 51.8 63.7 57.5 86.8 26.1 59.5 41.8 MAP4K1 HPK1 ENSG00000104814 "Mitogen-activated protein kinase kinase kinase kinase 1" Q92918 19 38587641-38618882 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2" "Cell line enhanced" "Detected in some" "Daudi: 20.5;HDLM-2: 20.3;Karpas-707: 21.1;REH: 11.2;RPMI-8226: 12.7;U-266/70: 16.6;U-266/84: 16.3;U-698: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007419, CAB007754" Enhanced Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "CAB007754: AB_562299, HPA007419: AB_1853778" "unprognostic (1.99e-3)" "prognostic favourable (6.17e-5)" "unprognostic (9.50e-3)" "unprognostic (3.27e-1)" "unprognostic (6.03e-2)" "prognostic favourable (3.26e-4)" "unprognostic (4.88e-3)" "unprognostic (5.32e-3)" "unprognostic (2.79e-1)" "unprognostic (2.51e-1)" "unprognostic (3.92e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (7.99e-10)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-2)" "unprognostic (1.50e-2)" 1.6 0.9 1.2 31.4 2.3 6.3 1.1 1.0 1.2 1.0 3.1 1.7 0.1 2.1 0.9 1.4 2.6 1.2 2.9 0.9 1.1 1.4 2.2 1.6 3.9 23.0 2.3 0.7 0.8 1.2 0.2 1.2 1.4 2.1 1.6 1.9 2.0 4.4 0.8 0.5 1.2 16.9 0.7 3.4 34.4 2.3 0.9 1.3 19.1 1.9 1.4 39.2 3.1 1.3 16.2 15.9 1.3 6.2 3.7 14.6 7.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.3 0.0 0.0 0.0 0.0 0.0 20.3 0.1 4.3 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 21.1 0.0 0.1 4.9 5.1 0.6 0.0 11.2 0.0 12.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.0 0.1 0.0 0.0 16.6 16.3 25.8 0.0 5.8 0.0 1.3 3.2 1.2 13.4 6.2 12.4 16.2 11.2 14.0 15.9 10.7 6.2 8.7 0.3 3.7 3.4 14.0 14.6 7.3 1.2 2.3 1.0 1.2 1.1 1.4 2.3 0.7 2.1 1.3 MAP4K3 "GLK, MAPKKKK3, RAB8IPL1" ENSG00000011566 "Mitogen-activated protein kinase kinase kinase kinase 3" Q8IVH8 2 39249266-39437312 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 40.8;RT4: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030380 Approved Approved "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA030380: AB_10601132" "unprognostic (4.82e-2)" "unprognostic (7.22e-2)" "unprognostic (5.87e-3)" "unprognostic (7.34e-3)" "unprognostic (6.77e-2)" "unprognostic (2.57e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.66e-1)" "unprognostic (6.73e-2)" "unprognostic (4.33e-3)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (2.43e-1)" "unprognostic (5.08e-2)" 19.7 18.9 17.6 15.4 17.6 9.6 17.8 37.1 19.6 19.2 16.9 14.6 9.8 13.7 23.5 14.8 11.1 15.3 18.7 19.5 15.4 12.5 26.2 15.4 15.6 5.8 15.4 13.4 24.6 14.0 25.7 24.6 30.8 14.4 18.6 14.1 17.9 13.3 15.7 33.0 17.8 17.2 18.6 15.3 11.5 26.1 21.0 16.5 9.4 25.9 11.3 7.5 18.8 32.6 0.7 0.5 2.5 1.9 1.0 1.3 0.4 9.7 6.1 40.8 6.4 6.6 13.4 11.2 8.7 11.1 8.6 7.4 5.1 4.9 2.1 9.8 5.9 5.3 15.3 7.7 13.2 2.4 6.3 3.5 4.3 11.9 17.3 1.5 5.8 11.9 7.7 11.2 12.1 7.4 4.5 4.0 11.5 5.3 3.4 2.3 12.3 9.3 3.7 13.3 1.6 11.4 37.8 7.3 8.3 5.1 8.2 22.6 5.5 2.2 6.0 6.7 8.0 6.0 4.7 6.1 3.4 0.7 8.3 2.5 7.8 2.5 0.7 0.0 1.2 1.1 0.1 0.1 1.2 0.9 0.1 0.7 1.1 1.3 0.0 1.0 1.9 0.5 0.6 0.4 17.6 17.6 37.1 19.6 15.4 12.5 15.4 13.4 14.4 16.5 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" 14 50418501-50561126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036696 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA036696: AB_10672362" "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 17.4 11.8 23.4 12.1 44.4 16.5 19.7 24.6 32.3 25.8 17.1 43.5 13.4 11.3 29.9 12.1 18.7 17.4 19.3 10.3 24.4 14.0 10.9 8.7 15.2 9.9 48.8 17.1 29.9 13.3 16.7 17.5 17.3 26.0 16.6 15.1 9.1 16.9 19.9 10.7 24.8 12.7 22.3 30.7 13.0 14.4 6.8 51.1 8.4 15.3 8.7 11.2 19.3 21.2 5.0 2.7 26.1 1.8 5.4 3.9 1.0 23.1 7.0 17.1 14.7 15.9 16.7 16.8 27.3 24.7 18.6 16.6 8.8 16.3 16.0 16.3 25.0 16.6 15.9 14.7 28.5 13.2 11.6 9.8 12.3 7.9 13.5 8.7 15.5 12.1 12.1 16.4 17.2 24.4 9.2 10.5 27.3 8.7 11.8 8.4 8.3 13.8 14.3 26.1 6.0 18.4 18.1 5.5 12.6 15.4 10.8 10.6 12.0 6.7 24.8 24.3 17.0 16.5 12.8 7.7 7.8 10.7 9.1 6.1 17.3 26.1 1.5 13.5 3.9 1.8 2.2 3.2 2.4 3.3 1.6 5.0 2.6 2.7 0.6 5.4 1.1 2.7 0.5 1.0 23.4 44.4 24.6 32.3 24.4 14.0 48.8 17.1 26.0 51.1 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.4" "Cell line enhanced" "Detected in many" "CACO-2: 21.7;HeLa: 25.9;MCF7: 31.8;RT4: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol "Microtubules, Cytosol" "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavourable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favourable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favourable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.2 6.8 24.1 3.6 41.3 3.4 10.4 36.9 29.3 5.2 18.5 49.8 6.0 21.8 2.1 15.7 11.9 7.9 6.5 1.5 30.7 18.3 25.3 13.3 5.5 1.3 47.6 16.5 1.5 19.0 18.9 13.8 5.3 26.2 15.8 18.0 6.6 14.0 8.2 1.1 13.0 19.7 2.1 55.4 1.5 14.4 17.1 52.7 0.4 12.6 4.3 3.9 6.3 6.0 1.6 5.9 13.0 2.8 0.7 0.6 0.7 9.1 14.3 0.1 0.0 0.1 0.0 15.2 0.2 0.4 0.1 0.2 21.7 9.7 0.0 2.0 0.3 14.1 4.1 12.7 0.2 0.0 9.1 9.6 25.9 0.1 0.1 9.3 1.1 0.0 11.9 0.0 0.9 0.1 6.5 0.2 0.0 31.8 0.1 0.9 1.9 2.1 0.0 0.3 1.7 8.9 25.0 9.2 1.9 10.1 19.3 0.2 7.6 0.9 0.2 0.0 0.7 0.1 0.6 1.7 2.2 0.0 0.2 3.7 0.2 3.0 2.6 0.0 0.0 1.7 0.3 1.6 0.6 0.0 5.9 1.2 0.1 0.0 13.0 0.7 2.8 0.0 0.2 0.7 24.1 41.3 36.9 29.3 30.7 18.3 47.6 16.5 26.2 52.7 MAP7D1 "FLJ10350, FLJ39022, PARCC1, RPRC1" ENSG00000116871 "MAP7 domain containing 1" Q3KQU3 1 36155579-36180849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028075 Approved Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA028075: AB_10603778" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (5.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (1.49e-6)" "unprognostic (6.00e-3)" "unprognostic (2.05e-1)" "unprognostic (3.57e-2)" "unprognostic (1.88e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (8.56e-6)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (9.32e-3)" 39.4 12.8 25.4 24.4 27.8 19.4 17.4 26.4 44.7 11.2 24.0 32.4 4.6 12.4 16.6 5.5 25.9 10.6 18.4 51.7 25.1 22.5 7.4 4.9 21.3 14.7 31.2 24.1 10.2 10.0 8.3 12.2 15.4 30.8 18.4 7.1 10.2 11.0 19.5 144.7 20.9 10.9 21.1 40.7 17.8 14.2 6.7 22.8 14.9 10.5 18.6 11.5 22.8 12.4 0.4 0.8 4.7 1.4 0.4 1.9 0.2 28.8 17.0 26.8 16.9 16.4 12.5 19.8 29.0 29.6 30.6 27.1 9.4 29.8 12.1 24.9 26.3 31.8 11.0 39.4 10.1 20.7 9.8 8.2 12.7 3.6 25.9 12.1 21.3 21.7 11.2 41.3 25.7 20.9 7.9 18.8 16.9 5.8 22.3 10.2 24.4 9.6 23.2 19.8 11.5 15.5 10.0 10.4 20.0 16.6 9.3 22.5 6.2 8.6 39.1 36.2 27.6 30.6 39.2 18.7 5.5 14.2 31.0 8.3 21.7 0.5 1.4 1.4 1.1 0.7 1.5 0.1 1.0 0.8 0.6 0.4 1.9 0.6 4.7 0.4 0.5 0.8 0.3 0.2 25.4 27.8 26.4 43.8 25.1 22.5 31.2 24.1 30.8 22.8 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell line enhanced" "Detected in some" "A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051508: , HPA059537: " "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavourable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.6 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.4 0.3 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.6 17.0 0.0 14.7 7.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.0 1.0 0.0 19.6 3.3 8.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.9 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB025483: , HPA054562: " "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.3 6.4 2.4 7.4 5.6 6.2 3.5 7.9 6.9 13.3 8.5 9.2 3.2 19.4 10.8 8.7 6.9 11.0 1.6 2.5 5.6 15.4 12.7 19.3 11.4 17.9 11.9 25.2 13.4 2.9 3.0 0.0 15.0 11.2 18.1 6.1 5.7 0.0 15.9 7.5 10.4 18.1 6.7 19.7 7.9 1.4 8.5 2.9 6.1 0.2 9.8 3.3 13.8 7.8 13.7 12.4 2.9 4.9 4.2 3.2 10.4 3.5 11.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favourable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.3 0.1 0.3 0.2 1.1 5.6 2.7 1.5 0.2 0.2 0.5 16.2 19.1 4.6 1.2 1.5 15.1 0.0 45.7 0.4 11.8 5.1 0.1 0.5 16.0 1.9 0.1 1.2 4.8 16.2 2.9 0.6 3.0 0.3 5.2 0.5 10.2 0.1 1.2 0.1 0.3 11.4 0.2 27.6 8.8 28.6 19.3 0.3 1.7 0.3 0.1 21.7 2.5 4.0 1.4 0.2 0.5 0.3 0.3 6.9 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 MAPK14 "CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15" ENSG00000112062 "Mitogen-activated protein kinase 14" Q16539 6 36027677-36111236 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 32.1;neutrophil: 12.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010285, CAB040578, HPA051825" Approved Supported "Nuclear speckles,Cytosol" 7100000 "Nuclear speckles" Cytosol "CAB010285: AB_632140, CAB040578: , HPA051825: " "unprognostic (6.76e-3)" "unprognostic (6.28e-2)" "unprognostic (6.30e-3)" "unprognostic (3.30e-3)" "unprognostic (6.98e-2)" "unprognostic (4.04e-2)" "unprognostic (8.10e-2)" "unprognostic (1.93e-1)" "unprognostic (2.20e-3)" "unprognostic (8.39e-2)" "unprognostic (6.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.47e-2)" "unprognostic (3.66e-3)" "unprognostic (6.66e-2)" "unprognostic (3.25e-1)" "unprognostic (1.58e-1)" 21.5 20.6 11.7 18.4 15.5 49.9 20.7 26.5 18.1 22.0 20.5 12.5 11.9 16.9 38.8 12.1 24.0 18.9 16.0 16.4 9.3 9.5 16.0 29.8 21.5 29.0 12.0 11.3 17.7 18.5 15.0 27.2 27.3 10.2 23.4 18.3 17.0 16.7 16.5 21.2 25.6 22.5 26.0 10.6 35.5 18.2 11.1 10.3 34.1 20.9 17.6 20.8 25.0 30.0 2.3 4.0 32.1 4.9 3.0 2.8 2.1 18.3 10.1 10.9 17.5 24.8 24.8 24.0 19.2 25.0 22.8 23.8 24.7 9.5 14.9 19.1 21.1 13.2 18.0 16.6 23.9 16.8 14.3 34.4 14.4 20.6 13.7 21.6 20.8 17.4 16.2 16.4 16.3 25.8 19.0 18.7 15.5 8.7 22.2 26.0 6.7 10.1 26.4 17.7 13.8 16.1 25.3 8.2 7.0 17.3 13.0 20.1 15.3 40.4 18.1 20.5 11.9 12.9 17.6 9.2 21.0 14.9 9.3 42.8 16.8 32.1 4.9 3.0 2.4 3.5 2.8 1.5 2.2 2.6 4.0 2.3 2.5 2.4 12.3 3.0 4.7 1.9 2.6 2.1 11.7 15.5 26.5 18.1 9.3 9.5 12.0 11.3 10.2 10.3 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.1 0.0 1.3 0.0 5.3 0.0 0.2 0.0 1.1 1.6 0.0 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 13.6 0.0 0.0 2.0 1.1 0.0 2.9 0.3 0.9 1.3 3.9 3.9 0.0 2.8 0.0 12.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051631-55070192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favourable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 37.7 27.1 22.9 23.9 23.7 65.9 27.9 25.7 29.3 26.3 24.7 24.2 20.0 17.3 32.1 28.6 28.6 31.5 24.9 32.6 20.1 25.8 41.9 32.6 27.6 33.6 21.3 18.0 41.1 21.2 25.7 32.8 36.4 22.8 23.9 23.6 28.5 33.8 30.6 38.5 26.7 29.5 32.8 19.9 33.3 26.7 30.8 17.4 37.7 25.9 26.6 39.1 32.9 24.2 27.5 30.8 28.8 30.4 21.4 30.7 19.6 19.5 17.3 30.5 19.4 24.7 24.4 23.7 22.0 23.5 27.4 31.9 13.8 17.4 22.7 18.7 29.3 21.6 32.7 33.3 38.5 20.5 20.9 21.8 16.9 20.7 27.1 26.7 24.1 31.5 25.2 22.8 36.4 36.3 20.2 20.2 39.5 23.6 22.4 20.7 22.1 29.2 19.3 33.6 13.6 37.6 22.1 19.9 23.1 21.3 15.3 19.8 27.2 15.5 27.3 28.2 37.0 17.4 19.6 12.5 18.0 30.0 22.5 14.0 20.2 28.8 22.2 25.7 21.4 30.4 28.2 27.5 25.5 23.1 23.9 23.6 23.8 23.4 16.5 21.4 28.1 30.8 30.7 19.6 22.9 23.7 25.7 29.3 20.1 25.8 21.3 18.0 22.8 17.4 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 15.4 3.7 0.0 1.1 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 MAPK7 "BMK1, ERK5, PRKM7" ENSG00000166484 "Mitogen-activated protein kinase 7" Q13164 17 19377721-19383544 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018561, HPA031031" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB018561: AB_2140544, HPA031031: " "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.72e-1)" "unprognostic (2.90e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.86e-4)" "unprognostic (5.67e-3)" "unprognostic (1.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-2)" "unprognostic (4.75e-2)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (5.71e-1)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 11.5 15.0 6.4 7.3 7.6 9.2 11.8 12.5 7.9 13.4 15.3 7.2 6.0 9.2 13.1 14.1 17.3 9.4 11.8 8.2 5.9 4.7 10.8 4.8 9.9 9.2 8.2 5.2 25.4 5.7 7.3 7.5 12.5 6.7 14.0 6.9 10.5 7.8 12.3 7.5 13.1 11.2 13.8 7.1 13.2 8.0 13.3 7.5 4.5 8.6 11.3 10.6 12.7 15.9 2.2 2.6 11.5 7.4 5.5 4.7 3.0 4.1 6.5 5.4 4.2 27.1 11.3 6.3 5.6 5.2 7.8 7.2 7.5 0.7 2.5 4.6 9.7 4.6 6.3 5.1 4.9 4.3 4.8 1.2 4.7 3.3 11.7 1.1 4.2 11.9 3.6 11.8 4.2 5.7 2.2 0.9 7.7 2.7 8.3 4.4 6.2 4.3 4.5 7.9 1.7 2.6 2.3 2.4 7.2 5.7 0.5 2.9 3.5 1.4 3.2 8.4 6.2 9.2 3.8 1.6 2.4 0.6 9.7 1.0 5.0 1.0 3.6 11.5 4.7 7.4 2.5 2.2 2.2 4.1 2.6 1.4 2.1 2.6 1.3 5.5 6.5 1.7 1.0 3.0 6.4 7.6 12.5 7.9 5.9 4.7 8.2 5.2 6.7 7.5 MAPKAP1 "MGC2745, MIP1, SIN1" ENSG00000119487 "Mitogen-activated protein kinase associated protein 1" Q9BPZ7 9 125437393-125707234 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029091, HPA029092" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029091: AB_10599732, HPA029092: AB_10601568" "unprognostic (6.65e-2)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (5.11e-2)" "unprognostic (2.57e-2)" "unprognostic (1.68e-1)" "unprognostic (8.94e-2)" "unprognostic (2.59e-1)" "unprognostic (8.08e-2)" "prognostic favourable (7.23e-6)" "unprognostic (1.66e-1)" "unprognostic (2.04e-1)" "unprognostic (2.98e-1)" "unprognostic (4.27e-2)" 27.2 33.9 35.0 24.4 41.4 20.4 22.6 20.3 30.4 27.0 30.1 21.0 20.6 20.1 26.4 25.6 30.3 20.5 21.3 44.9 29.5 24.9 37.5 37.5 20.1 21.3 28.3 20.4 29.1 24.8 29.8 24.1 31.3 27.1 21.7 26.7 22.8 29.7 26.2 60.7 18.2 23.3 33.2 28.5 27.0 25.1 24.9 22.1 24.1 32.7 23.2 24.7 27.2 25.7 7.6 7.1 18.8 6.1 5.4 7.5 2.5 23.9 27.2 18.4 19.5 25.4 24.3 30.7 30.4 31.2 23.6 16.6 27.5 27.1 24.6 18.7 42.4 33.5 28.4 35.7 32.2 27.8 11.6 17.7 32.9 26.0 28.6 31.6 20.7 23.8 33.0 33.7 35.3 34.8 28.1 19.4 50.0 50.0 23.3 12.8 29.2 34.2 19.7 43.6 32.7 25.9 17.5 22.3 21.9 30.5 28.8 19.1 33.3 18.5 22.3 33.6 22.2 40.2 50.4 24.4 59.9 25.1 47.9 14.6 36.2 3.6 6.1 5.3 4.6 5.8 6.2 7.5 5.0 5.0 4.8 7.6 4.4 7.5 18.8 5.4 5.2 7.1 5.4 2.5 35.0 41.4 20.3 30.4 29.5 24.9 28.3 20.4 27.1 22.1 MAPKAPK2 ENSG00000162889 "Mitogen-activated protein kinase-activated protein kinase 2" P49137 1 206684944-206734283 "Cancer-related genes, Enzymes, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in all" 6 "dendritic cells: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: " "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 23.0 25.3 11.6 21.2 15.7 58.6 23.9 11.1 14.5 19.3 25.6 17.2 14.5 25.7 20.0 18.5 23.5 17.3 26.0 89.2 12.3 8.7 33.7 26.7 26.7 21.5 16.7 6.5 23.3 19.1 16.9 22.8 13.6 15.7 20.2 14.4 17.8 19.8 14.4 62.9 18.3 32.9 18.3 14.6 37.7 23.1 21.3 14.6 26.9 24.3 25.2 28.2 22.9 46.1 1.1 18.7 3.2 1.1 2.3 1.6 0.5 20.9 8.3 11.5 12.9 34.0 20.0 14.3 14.6 33.1 22.3 21.1 15.8 10.2 10.1 10.2 29.4 15.9 8.6 15.5 16.1 11.7 6.5 16.9 10.3 10.2 26.3 24.9 56.6 27.5 19.9 21.4 23.7 18.2 19.4 45.9 18.0 26.0 10.0 18.0 13.3 11.6 25.8 24.1 3.2 16.8 12.8 9.2 11.9 17.2 29.1 20.2 14.1 24.2 17.3 20.1 17.0 23.3 19.8 59.8 53.1 8.2 22.8 15.2 6.6 1.1 0.7 1.4 1.6 1.1 1.5 1.0 1.2 1.5 0.6 1.1 0.6 1.1 3.2 2.3 1.0 18.7 1.4 0.5 11.6 15.7 11.1 14.5 12.3 8.7 16.7 6.5 15.7 14.6 MAPKAPK5 PRAK ENSG00000089022 "Mitogen-activated protein kinase-activated protein kinase 5" Q8IW41 12 111841978-111902238 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 20.7 26.2 21.4 17.5 26.4 24.1 21.7 23.7 28.3 17.3 28.8 26.1 21.9 26.3 25.8 22.8 20.8 17.5 22.7 20.7 17.7 15.2 21.7 21.5 18.9 19.4 22.3 20.4 21.3 24.5 19.8 20.4 21.0 17.3 18.7 32.9 23.6 23.3 20.5 33.2 23.0 28.4 21.1 18.0 18.4 19.8 16.7 22.0 19.3 20.5 15.1 19.3 19.9 16.5 4.9 4.1 3.2 11.4 3.9 6.8 2.5 15.1 20.2 19.5 16.4 14.1 14.3 29.7 15.2 18.4 23.4 16.2 26.0 12.5 22.9 11.3 17.9 15.2 25.6 15.9 22.0 15.2 14.0 20.4 14.0 20.8 17.1 25.6 14.5 15.1 22.9 22.3 26.6 17.1 28.1 9.1 17.0 17.0 25.4 40.5 27.7 14.2 25.2 14.2 22.0 18.6 22.0 24.1 20.4 17.3 29.5 21.1 23.8 29.3 14.9 13.3 13.4 13.6 19.0 18.6 22.7 27.1 16.2 18.7 18.8 1.3 4.8 3.2 6.5 3.5 3.5 4.9 4.3 4.7 3.3 4.0 6.8 5.1 2.5 3.9 11.4 4.1 6.6 2.5 21.4 26.4 23.7 28.3 17.7 15.2 22.3 20.4 17.3 22.0 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030832: AB_10601869, HPA030833: " "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favourable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.0 6.6 7.8 7.7 4.7 7.0 17.5 6.3 4.7 5.1 1.8 1.2 5.8 5.6 11.8 6.8 19.4 4.6 4.4 2.0 4.9 8.0 1.7 3.3 3.1 10.2 3.9 15.6 10.0 18.3 9.2 3.0 2.3 8.9 1.0 2.6 2.8 0.8 5.3 2.8 5.0 0.5 3.7 5.5 7.9 4.5 4.1 4.1 3.0 4.9 2.5 7.3 9.1 4.4 8.8 6.8 5.1 8.4 2.9 6.1 4.3 7.6 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 MAPRE1 EB1 ENSG00000101367 "Microtubule associated protein RP/EB family member 1" Q15691 20 32819893-32850405 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003600, CAB009337, CAB019391" Supported Enhanced "Centriolar satellite,Cytosol" 17000000 "Centriolar satellite, Cytosol" "CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309" "unprognostic (3.74e-1)" "unprognostic (1.89e-1)" "unprognostic (2.68e-1)" "unprognostic (4.48e-3)" "unprognostic (2.98e-3)" "unprognostic (1.10e-2)" "prognostic unfavourable (6.33e-4)" "unprognostic (1.25e-2)" "unprognostic (1.17e-1)" "unprognostic (7.24e-2)" "unprognostic (5.99e-2)" "unprognostic (6.05e-2)" "unprognostic (3.76e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (5.42e-2)" "unprognostic (4.59e-3)" 35.4 23.4 30.9 30.9 28.7 77.5 27.2 12.3 25.3 26.1 39.3 34.0 25.9 18.3 40.0 29.8 30.0 28.4 27.4 31.7 26.9 25.0 33.6 14.2 30.3 31.9 36.6 17.5 29.5 22.1 19.7 20.0 35.2 27.9 29.1 28.1 24.7 22.0 35.3 20.4 19.3 25.8 42.5 37.1 38.5 29.1 31.7 24.1 48.4 35.2 26.1 31.0 39.1 30.0 19.7 25.7 66.8 41.4 27.3 30.3 42.1 30.5 28.1 31.5 18.0 17.1 15.5 44.9 30.0 18.7 46.8 34.6 81.2 28.5 46.7 30.2 26.9 28.1 37.6 33.5 51.4 15.7 14.6 89.9 19.6 43.4 18.1 32.3 40.0 16.7 16.8 38.2 25.6 29.1 40.4 26.7 41.0 19.0 44.2 28.3 22.7 26.1 29.8 55.9 25.0 25.5 21.2 19.7 20.7 53.8 23.9 30.8 34.5 24.1 25.7 52.8 28.5 26.3 38.6 23.6 32.4 50.3 28.0 74.1 29.3 55.1 33.6 66.8 28.1 39.3 29.1 19.7 26.9 25.9 25.7 18.9 27.3 30.3 36.8 27.3 41.4 23.6 27.0 42.1 30.9 28.7 12.3 25.3 26.9 25.0 36.6 17.5 27.9 24.1 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell line enhanced" "Detected in some" "HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: , HPA069524: , HPA069570: " "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.1 0.0 27.3 1.4 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.2 1.3 0.0 4.1 0.5 0.1 0.0 1.1 0.0 2.2 2.7 0.0 3.5 9.8 4.6 1.0 0.0 0.9 12.4 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.1 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Cell line enhanced" "Detected in some" "BEWO: 3.8;EFO-21: 7.2;HSkMC: 3.2;SCLC-21H: 12.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.8 1.6 0.2 1.2 0.3 0.0 0.1 0.0 7.2 0.5 0.0 0.0 0.4 1.3 0.0 0.0 1.2 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.8 1.4 0.1 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.0 12.4 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 MARCH2 "HSPC240, MARCH-II, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.48e-4)" "prognostic favourable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favourable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favourable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 37.7 12.4 30.7 13.5 28.3 17.5 23.9 8.6 39.1 9.8 29.8 20.7 9.7 11.2 12.5 39.0 19.3 10.0 11.4 38.9 23.5 21.9 11.0 17.9 18.2 15.0 30.8 19.8 8.2 10.0 10.5 11.3 13.9 20.2 16.0 10.3 12.7 13.4 21.8 46.9 12.7 11.7 28.5 27.8 18.9 13.3 8.6 13.3 8.4 21.3 14.1 10.0 20.4 9.7 3.6 26.5 20.4 14.6 3.7 7.3 10.1 5.4 7.0 3.2 14.7 19.5 6.4 5.4 6.0 7.3 4.8 5.0 3.4 2.6 2.2 17.6 12.8 3.9 4.1 8.4 3.7 10.9 9.7 16.7 3.3 7.6 10.5 2.4 25.1 7.6 9.7 4.6 4.1 18.7 2.3 12.3 3.7 10.5 3.3 7.9 6.6 17.0 5.3 1.0 5.5 11.0 6.5 1.6 8.9 0.4 6.4 11.3 4.9 5.2 18.8 6.7 4.1 22.3 5.0 11.0 13.0 2.5 10.9 5.0 5.1 20.4 10.0 15.4 5.7 14.6 5.9 3.6 5.9 4.6 6.7 3.5 4.0 5.4 12.5 3.7 12.8 26.5 7.3 10.1 30.7 28.3 8.6 39.1 23.5 21.9 30.8 19.8 20.2 13.3 MARCH7 "AXOT, MARCH-VII, RNF177" ENSG00000136536 "Membrane associated ring-CH-type finger 7" Q9H992 2 159712457-159771027 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014275, HPA022152" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA014275: AB_10599820, HPA022152: AB_10601107" "unprognostic (2.42e-1)" "unprognostic (2.24e-1)" "unprognostic (1.02e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (3.17e-2)" "unprognostic (3.53e-2)" "prognostic unfavourable (1.84e-4)" "unprognostic (1.41e-3)" "unprognostic (1.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 31.6 21.1 18.3 27.4 29.0 22.6 28.9 33.1 23.0 33.4 25.3 17.0 22.0 17.1 32.3 24.1 47.6 22.7 22.4 28.1 16.9 14.4 21.8 30.9 29.5 32.9 21.6 17.8 31.6 15.4 25.3 31.5 41.3 21.5 28.8 22.3 24.8 25.7 22.6 48.0 24.2 25.2 33.8 20.4 28.9 20.0 34.1 21.8 60.4 28.5 25.5 32.9 30.0 35.1 10.0 10.1 46.1 14.5 14.0 14.6 10.5 18.5 12.8 34.5 15.5 25.0 33.1 33.4 31.2 31.6 32.1 29.5 26.4 22.3 26.4 14.2 32.5 23.5 21.2 28.8 41.2 27.0 15.6 35.8 18.6 19.9 24.3 29.3 28.0 29.4 32.9 39.2 34.0 38.5 27.2 25.5 32.4 15.2 18.7 28.1 32.5 18.4 27.9 25.5 21.9 29.5 38.7 20.5 19.3 25.5 18.8 25.0 21.8 35.6 34.7 34.4 20.8 21.1 17.6 20.4 21.4 36.0 21.3 17.8 32.0 24.8 10.3 20.6 11.1 10.6 13.3 10.0 12.1 12.6 10.1 9.7 14.6 14.1 46.1 14.0 14.5 7.9 12.5 10.5 18.3 29.0 33.1 23.0 16.9 14.4 21.6 17.8 21.5 21.8 MARCKS "80K-L, MACS, PKCSL" ENSG00000277443 "Myristoylated alanine rich protein kinase C substrate" P29966 6 113857362-113863471 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 74.3;TIME: 58.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.1;neutrophil: 15.0" "Group enriched" "Detected in many" 10 "B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022062, HPA054820, HPA067595, HPA069443" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" 17000000 "Plasma membrane" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB022062: AB_309681, HPA054820: , HPA067595: , HPA069443: " "unprognostic (4.71e-1)" "unprognostic (1.91e-2)" "unprognostic (2.46e-1)" "unprognostic (5.51e-3)" "unprognostic (8.22e-3)" "unprognostic (2.38e-2)" "prognostic unfavourable (2.78e-8)" "unprognostic (7.82e-2)" "unprognostic (2.57e-1)" "unprognostic (6.92e-2)" "unprognostic (2.27e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (4.85e-4)" "unprognostic (1.36e-3)" "unprognostic (2.77e-2)" "unprognostic (8.07e-2)" "unprognostic (2.70e-2)" 13.0 5.0 11.2 17.0 12.9 26.9 16.0 18.5 43.3 12.1 23.2 17.9 0.9 11.6 9.7 4.0 17.0 8.4 10.9 9.7 10.5 5.3 8.7 12.9 13.3 8.8 15.9 12.6 11.2 1.2 6.5 39.5 13.8 14.1 21.6 11.4 8.2 5.6 5.0 9.5 12.9 9.1 42.3 20.9 18.8 5.2 8.5 30.0 4.9 7.9 13.6 23.5 7.8 3.9 0.9 15.0 10.1 0.0 0.0 0.4 6.8 4.0 74.3 4.0 25.1 16.4 0.4 22.0 31.0 15.6 26.1 7.2 9.7 0.0 4.6 40.6 21.2 12.2 6.4 20.3 0.0 7.3 0.0 4.3 9.3 16.7 1.7 0.1 16.9 12.6 15.0 14.3 43.9 0.8 19.6 22.1 0.0 0.2 0.0 9.6 5.3 0.0 7.4 0.7 4.9 13.1 10.3 30.1 14.1 7.2 15.1 0.3 2.0 58.3 14.5 0.0 23.7 37.5 53.0 3.8 2.0 11.1 9.8 27.7 0.0 3.4 0.0 0.0 10.1 0.0 3.9 0.0 0.0 0.9 1.6 0.0 0.0 15.0 0.0 5.5 0.0 0.0 0.4 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell line enhanced" "Detected in many" "AF22: 106.6;NTERA-2: 102.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: " "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavourable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.2 7.5 106.6 43.5 2.4 0.8 19.0 3.5 2.1 10.4 6.9 17.7 6.1 18.7 13.1 2.3 4.4 34.4 0.3 7.7 0.4 25.4 1.0 2.9 39.1 7.3 4.8 0.1 12.2 1.4 7.8 0.2 30.4 28.7 0.2 13.9 19.7 60.7 20.6 102.8 17.4 76.0 11.4 8.9 15.6 16.5 66.1 62.9 18.3 20.3 57.6 14.1 8.6 8.9 4.4 25.9 0.4 6.6 2.9 0.2 49.1 0.5 7.4 23.3 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" 24000000 "Golgi apparatus" Vesicles "HPA063793: " "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.6 0.0 0.0 6.0 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 MARF1 "KIAA0430, LKAP, LMKB, Marf1, PPP1R34" ENSG00000166783 "Meiosis regulator and mRNA stability factor 1" Q9Y4F3 16 15594386-15643166 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.0" "Group enriched" "Detected in many" 4 "B-cells: 6.4;granulocytes: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017992 Uncertain Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA017992: AB_1852921" "unprognostic (2.33e-1)" "unprognostic (6.44e-3)" "unprognostic (8.84e-2)" "unprognostic (3.78e-2)" "unprognostic (1.28e-1)" "unprognostic (6.13e-3)" "unprognostic (2.35e-1)" "unprognostic (2.10e-2)" "unprognostic (2.47e-2)" "unprognostic (6.93e-2)" "unprognostic (8.44e-3)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (8.74e-2)" "unprognostic (7.94e-2)" 12.2 9.1 22.4 12.3 17.7 16.7 11.2 25.9 40.0 16.9 17.2 12.0 7.6 8.9 15.2 7.1 10.7 15.1 11.0 8.8 20.7 15.4 13.0 9.0 10.8 17.2 15.1 18.4 20.8 12.0 18.8 12.0 9.3 16.5 12.8 12.8 9.1 12.4 12.8 20.4 11.9 13.0 15.5 13.6 14.6 12.0 6.8 14.0 11.8 15.5 4.2 26.1 18.8 13.9 6.4 0.8 12.0 1.9 0.8 2.1 0.8 4.2 8.0 10.3 7.4 9.5 13.6 4.2 4.8 6.6 4.4 7.7 1.3 5.9 19.4 9.6 9.5 3.0 6.1 6.7 8.1 6.6 4.2 8.2 7.3 6.1 7.9 9.2 10.8 8.1 7.4 9.7 11.7 11.3 7.1 7.3 8.8 4.0 7.5 4.2 2.8 4.0 10.4 13.5 4.8 3.9 8.2 5.9 7.5 7.1 4.6 8.7 4.9 8.1 11.7 6.6 4.3 11.4 3.9 8.5 7.9 11.8 9.0 6.0 8.6 2.4 1.6 4.3 1.4 1.4 0.8 4.2 2.1 1.4 0.7 6.4 1.9 2.0 12.0 0.8 1.9 0.8 1.9 0.8 22.4 17.7 25.9 40.0 20.7 15.4 15.1 18.4 16.5 14.0 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911019 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: " "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavourable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 9.7 11.6 16.5 16.3 21.4 18.5 13.8 24.7 26.1 15.2 20.5 20.0 11.1 21.3 13.6 7.5 48.4 13.6 14.4 14.7 17.0 10.1 11.9 12.4 15.4 16.3 18.1 13.7 11.0 17.3 21.8 22.4 21.1 15.0 14.9 19.8 10.6 20.7 14.3 15.7 35.8 26.9 13.3 13.3 21.6 16.8 9.8 18.7 22.9 15.9 13.6 23.5 14.8 21.3 2.9 1.9 9.8 1.9 3.3 4.5 1.2 22.4 15.0 12.3 12.9 6.7 8.9 17.1 9.1 8.8 13.2 10.2 16.1 23.7 16.6 16.2 9.5 29.0 11.8 14.3 11.5 11.4 9.3 18.2 11.8 10.4 7.6 19.8 24.1 4.9 19.5 12.1 10.5 10.8 15.5 19.1 8.7 27.6 20.7 14.1 14.0 10.9 17.1 9.1 18.3 9.8 18.6 17.0 11.4 15.8 40.4 10.6 29.4 11.8 10.3 14.0 8.8 18.0 10.1 11.6 12.0 16.2 9.5 10.4 11.1 2.7 1.7 4.4 2.9 1.5 4.5 2.3 3.2 3.1 1.9 2.9 2.6 2.4 9.8 3.3 1.9 1.7 1.5 1.2 16.5 21.4 24.7 26.1 17.0 10.1 18.1 13.7 15.0 18.7 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell line enhanced" "Detected in some" "A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favourable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.5 0.4 0.2 0.5 0.0 0.1 17.3 0.0 0.0 0.0 0.0 12.8 12.4 0.1 1.3 0.0 11.7 1.0 5.6 0.0 0.0 6.7 0.0 0.1 3.3 0.0 0.1 0.1 0.5 7.0 0.0 0.1 0.0 0.2 0.1 0.0 21.8 0.1 0.2 1.9 0.1 0.0 0.0 4.6 0.2 10.2 2.1 0.1 0.2 10.3 0.0 14.6 0.2 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell line enriched" "Detected in single" 39 "HEL: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217285-187292022 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 43.4;liver: 80.1" "Group enriched" "Detected in some" 8 "BJ: 26.5;BJ hTERT+: 101.0" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" 8673000000 1800000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favourable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 2.1 1.4 3.6 1.2 3.8 0.1 1.2 1.9 10.2 43.4 19.1 14.8 2.4 0.8 34.9 7.1 4.1 6.7 3.3 39.6 6.1 2.5 1.6 80.1 2.2 0.4 6.4 3.0 1.7 0.2 0.2 0.5 3.2 13.0 17.4 2.1 0.1 0.9 19.4 12.2 2.5 2.6 17.1 21.8 0.4 0.6 1.5 6.7 0.0 1.3 6.3 3.5 4.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.7 0.0 26.5 101.0 0.3 0.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 1.9 3.5 6.1 2.5 6.4 3.0 13.0 6.7 MAST4 KIAA0303 ENSG00000069020 "Microtubule associated serine/threonine kinase family member 4" O15021 5 66596361-67169595 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.5;HDLM-2: 22.2;HEL: 18.4;RT4: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000544 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000544: AB_1079315" "unprognostic (1.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.80e-1)" "unprognostic (4.99e-3)" "unprognostic (2.83e-2)" "prognostic favourable (5.18e-5)" "unprognostic (9.01e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-2)" "unprognostic (9.47e-2)" "unprognostic (5.03e-2)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (1.37e-2)" "unprognostic (2.63e-1)" "unprognostic (2.63e-1)" "unprognostic (3.08e-2)" 16.2 12.9 10.2 6.9 11.8 2.5 12.6 6.2 19.4 13.9 6.9 6.3 6.3 6.3 14.4 8.9 31.2 11.6 9.7 24.5 9.9 8.1 14.2 9.5 13.1 5.0 6.5 9.2 20.2 5.9 35.6 16.7 18.4 11.1 10.1 5.3 5.7 13.7 8.7 12.7 16.9 6.8 11.4 5.6 6.0 8.2 10.7 5.0 37.5 8.1 21.8 20.6 13.6 22.3 3.4 1.1 12.1 0.9 2.4 7.5 1.4 7.4 4.1 2.0 0.1 6.8 6.1 4.9 1.7 2.6 0.6 0.5 3.8 2.0 0.5 3.5 1.4 6.7 6.3 17.5 0.7 22.2 2.0 18.4 2.3 1.6 0.5 0.0 6.5 10.1 9.7 3.8 7.7 13.9 1.7 2.1 4.7 6.5 2.6 0.1 1.3 3.3 0.6 1.8 0.4 1.6 22.5 3.0 2.4 2.2 0.9 0.1 1.5 0.1 13.2 1.6 2.2 2.4 2.8 5.4 2.4 0.1 4.2 0.0 1.3 12.1 0.4 0.8 1.2 0.5 2.9 3.4 4.7 1.2 0.4 2.1 5.0 2.1 4.1 2.4 0.9 1.1 7.5 1.4 10.2 11.8 6.2 19.4 9.9 8.1 6.5 9.2 11.1 5.0 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539165-85545280 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 205.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol 950000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavourable (4.87e-4)" "prognostic favourable (8.94e-4)" "prognostic unfavourable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 55.9 68.9 37.4 35.3 54.1 20.4 30.3 37.5 50.0 28.6 35.3 74.5 39.7 33.6 35.8 59.8 33.5 44.9 51.6 35.0 41.7 28.5 52.3 26.4 32.9 27.0 74.8 37.6 44.2 205.8 38.8 60.5 29.3 48.9 40.6 36.8 35.0 28.2 31.3 51.4 33.7 35.8 47.6 57.7 24.7 44.6 34.9 69.4 22.7 94.0 34.1 30.8 46.9 33.4 13.8 15.3 4.9 17.2 16.9 22.8 14.9 29.7 44.2 51.9 32.2 35.7 43.7 30.7 37.4 34.5 39.4 42.1 36.1 100.4 69.8 24.7 45.4 46.4 65.2 55.8 50.7 35.3 47.9 41.7 64.0 31.1 65.3 61.8 46.6 39.5 56.7 42.5 29.7 37.3 46.8 55.0 89.4 25.5 56.3 68.1 34.4 56.9 60.0 49.2 45.2 59.5 47.2 40.9 37.7 33.8 32.7 60.3 27.7 33.2 36.3 48.4 29.2 26.6 44.7 33.9 26.9 50.5 31.6 77.6 25.4 4.8 15.2 4.9 15.4 17.2 22.8 13.8 17.5 16.2 15.3 12.2 16.4 14.3 1.6 16.9 13.7 10.9 15.3 14.9 37.4 54.1 37.5 50.0 41.7 28.5 74.8 37.6 48.9 69.4 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.3;bone marrow: 19.1;brain: 27.4" "Cell line enhanced" "Detected in some" "HL-60: 40.7;HMC-1: 12.5;K-562: 18.1;MCF7: 13.2;NB-4: 28.4;SCLC-21H: 12.4;THP-1: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 19.4;NK-cell: 29.3" "Group enriched" "Detected in many" 54 "NK-cells: 29.3;T-cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favourable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 11.2 1.6 22.1 6.8 18.1 19.1 2.2 1.5 27.4 1.5 2.3 1.7 0.0 7.0 1.2 0.4 1.1 4.7 5.1 1.7 25.1 10.0 1.1 2.8 7.3 9.6 7.0 11.0 1.0 1.6 0.1 1.4 1.4 6.1 1.2 1.4 0.6 3.8 1.0 0.8 1.6 6.7 1.1 2.8 14.8 4.1 2.1 1.3 3.5 0.9 0.0 4.5 2.4 0.7 0.4 0.3 0.4 0.0 29.3 19.4 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 4.1 5.4 0.1 0.0 0.0 7.0 4.5 0.5 1.1 0.0 40.7 12.5 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 13.2 0.1 28.4 3.3 0.1 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 10.7 1.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 13.2 0.0 2.5 12.2 0.3 0.4 1.2 7.1 0.4 29.3 0.0 0.1 0.1 2.7 22.1 18.1 1.5 27.4 25.1 10.0 7.0 11.0 6.1 1.3 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Cell line enriched" "Detected in many" 6 "Hep G2: 55.1" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.9;hypothalamus: 3.2" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" "Endoplasmic reticulum, Golgi apparatus" "HPA051250: " "unprognostic (3.47e-1)" "prognostic unfavourable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavourable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavourable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 1.9 6.4 0.0 1.8 4.0 0.4 0.7 0.4 2.6 3.3 1.8 1.0 0.0 0.3 0.6 0.4 0.1 4.9 3.7 0.0 0.1 0.0 0.4 55.1 0.4 0.0 0.0 8.7 0.3 2.8 0.6 3.4 0.0 0.0 5.4 0.9 0.0 0.0 1.9 0.9 0.0 0.0 0.0 7.8 1.7 0.0 0.8 4.1 0.7 2.4 7.6 0.0 1.9 3.8 4.7 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 MAU2 "KIAA0892, mau-2, MAU2L, MGC75361, SCC4" ENSG00000129933 "MAU2 sister chromatid cohesion factor" Q9Y6X3 19 19320681-19358755 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059897 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" Nucleoplasm "Nuclear bodies" "HPA059897: " "unprognostic (3.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.18e-1)" "unprognostic (9.57e-3)" "unprognostic (1.87e-1)" "prognostic favourable (3.90e-5)" "unprognostic (1.68e-2)" "unprognostic (3.49e-3)" "unprognostic (5.56e-3)" "unprognostic (3.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.28e-1)" "unprognostic (4.27e-3)" "unprognostic (2.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 15.3 15.2 17.5 17.4 23.6 24.5 15.8 30.5 21.1 15.7 15.0 28.2 18.9 16.9 18.9 21.6 20.8 20.1 16.9 19.9 15.7 14.4 14.8 12.7 19.5 26.5 28.3 13.1 25.2 19.3 17.8 20.9 15.9 18.3 16.6 10.5 17.2 16.8 20.4 43.6 25.0 15.9 17.8 19.7 22.0 14.1 18.0 25.9 20.6 16.6 12.2 18.6 15.3 16.0 7.0 6.8 14.1 13.4 8.2 9.8 7.4 8.5 6.5 11.7 10.4 9.7 10.2 16.2 8.0 8.3 10.9 9.9 9.4 12.0 10.5 17.5 8.6 10.0 9.9 8.2 5.1 5.5 25.5 8.2 10.2 8.1 11.3 14.6 12.9 11.2 9.3 7.8 9.0 10.4 11.0 13.1 7.2 9.7 15.0 20.3 10.1 18.8 16.8 7.5 11.3 7.7 11.0 17.0 15.5 9.9 10.4 10.4 9.0 20.6 9.2 17.1 3.9 16.7 12.1 17.1 14.3 10.6 8.3 15.5 12.8 4.1 7.7 5.5 8.7 6.5 9.8 6.9 7.5 8.0 6.8 7.0 8.3 7.6 14.1 8.2 13.4 6.8 7.1 7.4 17.5 23.6 30.5 21.1 15.7 14.4 28.3 13.1 18.3 25.9 MAX "bHLHd4, bHLHd5, bHLHd6, bHLHd7, bHLHd8" ENSG00000125952 "MYC associated factor X" P61244 14 65006174-65102695 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000328, HPA003474" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB000328: AB_2281783, HPA003474: AB_1079317" "unprognostic (4.50e-3)" "unprognostic (1.51e-3)" "unprognostic (4.08e-2)" "unprognostic (2.87e-1)" "unprognostic (8.37e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (1.30e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-3)" "unprognostic (7.19e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (5.57e-4)" "unprognostic (2.99e-1)" "unprognostic (4.68e-2)" "prognostic favourable (2.12e-4)" "unprognostic (6.03e-2)" 33.4 25.5 31.3 31.5 38.6 68.7 25.8 59.0 38.2 34.6 29.4 37.2 26.3 31.5 34.3 24.0 47.6 38.2 27.9 30.1 29.9 28.4 26.3 21.8 31.4 43.4 37.1 21.6 39.7 20.0 17.4 23.7 30.2 32.7 31.9 25.0 26.8 33.6 37.7 27.8 32.1 40.2 30.7 34.8 42.9 24.8 15.7 40.9 41.3 30.2 22.5 40.7 35.1 40.7 18.7 19.1 87.5 23.6 19.2 30.0 44.8 28.3 11.1 6.8 11.0 18.0 14.1 8.9 10.0 15.3 12.5 15.4 7.1 19.9 23.6 8.4 12.0 14.1 17.1 13.9 9.4 23.8 10.4 36.7 7.3 7.8 21.1 13.8 92.4 16.8 9.9 11.5 12.7 13.8 17.2 9.6 12.6 15.7 31.9 47.6 9.1 18.2 18.1 10.8 10.6 11.5 9.5 14.7 9.6 13.1 14.0 12.8 13.7 17.7 17.2 11.5 13.9 10.6 8.0 11.8 10.0 14.9 14.3 13.3 11.4 87.5 23.6 80.6 21.7 20.1 23.7 18.7 25.4 22.1 19.1 17.6 26.6 22.3 49.5 19.2 17.4 18.3 30.0 44.8 31.3 38.6 59.0 38.2 29.9 28.4 37.1 21.6 32.7 40.9 MBD1 "CXXC3, PCM1" ENSG00000141644 "Methyl-CpG binding domain protein 1" Q9UIS9 18 50266882-50281774 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009017, CAB036003, HPA068850" Approved Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009017: AB_2095559, CAB036003: , HPA068850: " "unprognostic (2.12e-2)" "unprognostic (5.05e-2)" "unprognostic (6.88e-2)" "unprognostic (5.01e-3)" "unprognostic (9.20e-2)" "unprognostic (6.85e-2)" "prognostic unfavourable (5.08e-6)" "unprognostic (5.91e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.96e-3)" "prognostic unfavourable (1.70e-6)" "unprognostic (7.06e-3)" "unprognostic (7.70e-2)" "unprognostic (7.05e-2)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 14.7 21.7 18.0 18.8 20.8 29.4 15.7 27.1 29.4 15.3 17.2 18.8 16.2 18.7 18.4 16.6 21.1 16.4 16.8 19.7 19.2 14.0 17.4 18.9 16.0 20.9 21.8 23.1 20.7 19.7 28.2 24.2 19.4 18.2 18.0 13.9 15.0 19.6 19.5 25.9 24.2 18.3 18.3 15.2 22.6 18.0 72.3 21.5 19.1 19.9 20.0 18.2 19.1 20.0 13.1 11.7 22.2 11.6 14.3 17.4 12.1 10.2 9.7 11.0 12.4 11.8 9.7 11.8 12.4 14.3 17.2 13.3 7.3 8.2 16.3 9.0 12.0 18.6 12.5 21.7 10.0 18.2 8.0 10.3 13.8 7.7 22.9 24.8 21.8 11.3 35.1 19.6 45.0 14.1 12.9 25.6 13.2 9.5 20.8 13.0 10.3 7.8 19.3 8.1 17.7 8.5 4.7 14.5 13.8 9.2 8.8 11.3 11.2 22.8 15.2 18.7 8.6 6.0 12.5 47.6 20.1 17.2 12.1 19.1 16.9 15.2 11.6 22.2 17.4 10.1 16.4 13.0 15.2 14.4 11.7 13.1 15.9 12.8 15.6 14.3 7.9 10.7 13.9 12.1 18.0 20.8 27.1 29.4 19.2 14.0 21.8 23.1 18.2 21.5 MBD5 "FLJ11113, KIAA1461" ENSG00000204406 "Methyl-CpG binding domain protein 5" Q9P267 2 148021011-148516971 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035964 Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA035964: " "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (3.72e-4)" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.65e-1)" "unprognostic (9.86e-2)" "unprognostic (7.72e-2)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" "unprognostic (2.39e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (6.59e-2)" "unprognostic (1.82e-1)" 8.5 11.3 13.9 14.1 13.7 6.8 9.0 26.1 14.7 13.7 16.3 10.1 8.9 7.2 12.6 8.7 9.9 9.6 13.4 10.3 11.7 10.6 13.7 6.9 8.2 8.7 9.3 9.9 14.2 5.7 25.5 24.7 10.4 11.3 11.5 8.1 10.8 7.5 11.6 9.9 6.6 8.2 15.7 11.8 9.8 9.1 11.0 12.5 17.3 12.8 6.0 8.6 15.1 10.1 1.3 1.1 3.6 1.2 1.0 2.2 0.7 1.4 1.5 9.0 6.5 6.5 7.4 4.0 6.7 7.3 4.5 3.8 3.4 4.5 2.5 1.7 5.7 1.0 4.7 7.4 6.4 2.2 2.2 5.4 4.9 1.7 2.7 0.7 0.8 5.6 6.5 6.0 4.0 7.5 2.0 6.1 7.6 3.4 2.9 3.9 3.0 2.4 2.9 1.5 0.9 6.0 7.2 5.2 7.3 4.3 2.3 4.5 2.9 4.5 5.5 5.3 2.2 0.7 2.8 4.4 1.7 2.2 9.0 2.5 6.1 3.6 0.4 1.9 1.6 0.3 1.1 0.7 1.8 1.5 0.9 1.3 1.4 2.2 0.6 1.0 1.2 1.1 0.6 0.7 13.9 13.7 26.1 14.7 11.7 10.6 9.3 9.9 11.3 12.5 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favourable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favourable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favourable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.5 8.7 18.5 18.6 18.6 18.0 14.0 14.2 17.7 18.8 19.8 17.7 16.6 15.7 21.7 18.2 12.6 19.4 13.1 23.2 22.6 14.6 9.2 8.6 30.0 20.3 18.7 10.2 18.4 20.2 12.2 15.9 11.7 15.6 19.6 13.8 15.9 17.9 15.2 15.6 25.8 8.6 16.2 10.9 21.2 12.8 27.7 11.0 11.6 11.3 18.7 18.4 12.2 9.1 21.0 13.7 15.3 14.6 16.3 18.7 24.5 8.0 9.6 14.5 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458203-90474768 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 5.2 7.4 11.2 5.7 16.8 2.7 9.5 16.7 14.7 8.7 5.7 7.4 7.4 6.1 9.6 6.6 7.2 7.5 5.0 5.2 12.7 14.2 9.3 11.1 5.5 11.1 10.6 9.8 16.3 7.4 21.8 10.0 5.4 9.7 8.6 6.2 4.8 7.8 7.8 4.3 9.5 5.4 7.1 10.7 6.6 4.8 6.1 7.0 8.1 9.7 3.1 7.0 6.5 6.9 5.3 2.9 1.1 3.8 3.3 4.8 2.3 5.8 2.5 4.4 5.5 5.8 7.9 5.4 4.6 4.2 4.0 4.2 1.9 4.4 13.6 2.8 4.1 6.0 5.6 7.0 6.3 7.7 3.9 6.1 4.1 4.4 6.1 6.0 2.7 6.8 9.4 2.9 11.1 5.1 9.1 7.6 6.7 3.5 5.8 8.2 2.8 12.3 6.2 7.3 18.5 6.0 2.2 7.5 8.8 4.2 6.1 11.1 5.0 4.5 6.2 5.0 3.4 6.1 5.9 5.3 6.0 6.0 4.3 12.7 6.8 0.0 1.5 1.1 3.2 3.8 3.9 3.1 3.6 3.5 2.9 5.3 4.8 3.7 0.1 3.3 1.9 1.0 1.3 2.3 11.2 16.8 16.7 14.7 12.7 14.2 10.6 9.8 9.7 7.0 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: " "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 55.9 17.5 14.5 50.8 17.0 28.5 43.8 11.8 14.5 46.4 44.0 10.8 18.0 15.2 41.1 23.6 33.3 22.3 27.5 29.9 14.3 12.9 18.6 16.5 39.6 45.6 18.0 9.1 30.5 12.5 12.5 16.0 10.4 12.6 30.5 26.0 12.7 18.3 25.1 87.6 22.8 29.5 59.8 22.1 39.6 23.1 14.6 17.4 71.9 18.5 34.5 46.0 64.4 29.3 25.0 30.7 38.2 27.4 33.6 39.9 40.2 27.7 22.9 3.7 8.4 29.5 30.5 2.7 34.8 28.3 23.0 19.4 10.1 16.3 28.6 17.8 48.9 12.8 6.9 20.1 34.1 22.2 9.4 31.2 11.6 4.7 16.5 37.3 22.8 14.2 10.9 26.5 20.7 47.2 15.8 39.0 22.3 9.6 34.7 13.7 1.5 18.4 35.5 11.5 35.8 11.6 14.0 3.0 3.4 15.1 8.2 14.7 11.4 56.9 39.6 31.6 12.1 20.9 30.0 40.8 23.3 32.9 18.4 46.6 17.0 32.6 22.7 38.2 37.2 27.4 39.9 25.0 30.5 30.9 30.7 24.1 38.9 33.3 35.4 33.6 22.8 11.1 27.0 40.2 14.5 17.0 11.8 14.5 14.3 12.9 18.0 9.1 12.6 17.4 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.0" "Cell line enhanced" "Detected in many" "CACO-2: 38.9;Hep G2: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.6 10.4 1.8 14.7 1.9 5.1 7.5 0.9 1.6 3.8 5.9 2.8 10.8 4.0 4.8 25.8 9.6 4.6 4.6 14.2 1.6 1.9 5.6 23.5 12.0 16.2 3.0 1.1 5.5 10.4 2.4 6.3 67.0 1.8 5.4 4.7 2.8 5.5 6.1 1.6 5.5 9.7 6.7 3.5 15.2 5.2 23.8 1.9 18.6 3.5 7.9 10.8 8.3 8.3 18.1 12.3 7.2 14.0 13.4 12.5 6.2 2.2 0.0 2.8 0.4 0.5 1.2 5.1 0.1 1.0 0.3 0.0 38.9 7.2 10.2 0.2 0.4 2.5 6.3 2.6 0.2 1.0 2.4 9.1 8.4 53.4 0.5 10.1 3.3 0.5 2.3 0.0 1.1 0.3 0.8 2.9 0.5 6.0 17.2 3.8 0.4 0.5 16.5 3.4 5.8 1.8 5.9 1.0 3.4 4.7 2.7 1.4 1.0 2.6 1.2 2.0 0.4 2.6 2.1 5.9 3.9 15.0 0.4 6.8 6.4 7.2 5.9 3.7 12.5 6.9 11.1 15.0 7.7 8.6 6.2 18.1 7.8 8.7 0.9 13.4 14.0 12.3 1.5 6.2 1.8 1.9 0.9 1.6 1.6 1.9 3.0 1.1 1.8 1.9 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 9.0 6.8 8.8 10.6 14.2 11.0 13.5 21.2 12.0 10.7 8.8 13.2 8.6 9.2 14.3 9.6 9.3 8.3 7.1 5.8 9.9 5.8 7.4 11.2 7.2 9.3 12.6 8.1 15.4 11.0 8.8 9.6 10.0 8.8 8.9 9.3 8.3 9.0 8.8 7.9 16.7 9.8 11.9 7.7 11.7 9.5 27.9 11.7 32.4 10.1 4.8 9.0 9.5 10.5 0.9 1.1 5.1 0.4 0.4 0.9 0.1 3.8 3.5 19.0 7.7 4.6 5.4 10.1 2.9 3.6 3.1 3.9 4.2 4.9 14.8 6.9 2.1 3.7 8.7 2.1 5.9 4.1 7.9 15.3 4.1 6.4 3.1 10.3 4.6 4.6 4.2 2.3 4.3 5.5 11.8 3.7 2.4 3.8 13.9 10.8 10.8 3.3 16.2 11.5 7.4 4.8 7.2 12.2 18.5 2.6 5.1 6.1 7.3 20.3 3.3 3.4 3.5 2.5 3.1 9.3 5.8 13.3 2.0 6.8 1.9 5.1 0.4 1.9 0.7 0.3 0.2 0.9 0.7 0.5 0.7 0.6 0.4 0.9 0.9 0.4 0.4 1.1 0.8 0.1 8.8 14.2 21.2 12.0 9.9 5.8 12.6 8.1 8.8 11.7 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 9.1 19.0 9.1 9.2 11.5 14.3 4.4 13.5 13.8 12.9 11.3 7.5 12.6 7.9 7.1 14.4 8.6 12.5 7.8 16.0 5.9 10.0 3.9 12.1 6.2 15.8 8.4 3.9 13.5 8.4 19.5 14.4 9.9 10.9 8.9 14.7 5.7 3.4 4.4 8.5 14.1 4.3 16.9 8.8 9.0 4.6 2.2 18.7 19.1 12.1 16.7 16.3 7.2 11.7 16.3 3.8 23.7 10.1 10.9 13.8 3.8 18.1 3.5 15.6 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 27.7;hTCEpi: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favourable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.0 0.6 6.1 5.7 7.8 1.1 3.1 1.3 1.6 0.2 6.4 0.0 7.5 0.5 8.6 4.3 27.7 0.6 2.2 2.6 0.0 2.4 1.8 1.8 0.3 0.1 7.6 18.6 3.5 13.2 8.2 0.0 10.5 2.9 0.6 0.1 0.1 3.8 0.5 0.1 6.1 1.9 0.1 17.3 3.1 6.7 5.7 0.0 15.2 2.3 0.0 9.8 4.8 4.5 7.5 2.1 3.0 0.0 0.0 12.9 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Cell line enhanced" "Detected in many" "HDLM-2: 9.2;Karpas-707: 8.1;REH: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.7 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 0.0 0.3 0.2 0.1 9.2 1.4 3.9 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.6 0.7 1.2 8.1 0.4 1.2 1.2 0.8 1.3 1.6 5.3 0.0 1.5 0.4 0.1 2.5 0.9 1.0 0.0 2.0 0.5 0.8 0.6 0.0 0.9 0.1 0.1 3.2 3.4 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: " "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.5 15.3 18.2 13.7 0.6 1.1 7.9 14.2 2.2 16.0 16.7 14.9 9.7 20.4 6.5 3.6 15.9 25.5 8.3 14.8 10.6 12.1 25.5 6.8 9.9 0.0 13.0 11.6 0.2 0.3 16.2 1.5 5.2 30.0 14.0 8.6 12.2 30.9 5.6 10.7 3.8 24.5 16.1 12.6 3.6 5.0 3.6 13.8 11.5 8.2 2.1 10.3 9.0 3.1 10.2 19.2 15.3 15.3 4.4 16.9 26.9 6.5 14.4 7.9 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 MCM3AP "GANP, KIAA0572, Map80, SAC3" ENSG00000160294 "Minichromosome maintenance complex component 3 associated protein" O60318 21 46235126-46286297 "Predicted intracellular proteins, Transporters" "Immunity, mRNA transport, Protein transport, Translocation, Transport" "Acyltransferase, Transferase" "Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021527, HPA032103" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" Nucleoplasm "HPA021527: AB_1853626, HPA032103: " "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (6.31e-3)" "unprognostic (1.48e-2)" "unprognostic (2.06e-1)" "unprognostic (4.17e-2)" "unprognostic (4.76e-3)" "prognostic favourable (2.05e-4)" "unprognostic (1.96e-1)" "unprognostic (2.81e-3)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (2.28e-1)" 19.4 16.7 14.2 21.5 25.3 19.5 19.0 26.6 29.2 18.3 17.2 27.7 19.3 15.4 24.8 18.0 18.1 21.1 16.3 17.9 14.4 13.2 15.5 13.3 18.2 21.9 16.5 14.6 23.7 17.5 25.7 20.6 18.2 18.2 17.7 17.6 21.3 22.1 21.4 52.9 18.2 19.9 19.5 15.1 20.7 18.7 15.7 15.7 31.8 19.6 15.7 26.0 21.1 16.4 4.8 4.8 3.8 4.9 3.0 6.9 4.1 15.7 15.6 18.2 19.7 15.0 18.7 16.6 17.4 21.4 16.6 13.4 14.1 9.4 22.5 14.4 18.4 9.4 24.0 14.6 14.5 23.0 21.8 36.9 14.9 11.1 13.5 16.7 20.9 14.5 12.7 22.5 15.6 17.5 43.9 17.2 19.0 9.0 17.9 11.3 31.3 13.0 23.3 11.5 20.3 8.1 14.6 15.4 16.4 22.2 14.7 17.0 20.1 17.4 22.1 17.3 13.2 14.3 13.0 31.4 34.7 14.0 15.6 16.2 22.4 1.5 4.7 3.8 6.1 4.9 6.5 2.9 3.7 6.9 4.8 4.8 3.3 3.4 2.9 3.0 2.7 4.2 4.4 4.1 14.2 25.3 26.6 29.2 14.4 13.2 16.5 14.6 18.2 15.7 MCMBP "C10orf119, FLJ13081, MCM-BP" ENSG00000197771 "Minichromosome maintenance complex binding protein" Q9BTE3 10 119829404-119892556 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013792, HPA038481" Uncertain Enhanced "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "CAB013792: , HPA038481: AB_10794620" "unprognostic (1.26e-1)" "unprognostic (7.92e-2)" "unprognostic (4.62e-2)" "unprognostic (2.31e-2)" "unprognostic (1.72e-2)" "unprognostic (4.64e-2)" "unprognostic (1.31e-3)" "unprognostic (5.61e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (7.32e-2)" "prognostic unfavourable (6.18e-4)" "unprognostic (2.23e-2)" "unprognostic (8.24e-2)" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" 33.6 15.3 11.7 23.2 13.8 14.6 35.5 17.2 13.8 27.0 26.3 16.9 11.4 15.5 28.0 14.9 26.4 23.0 18.7 26.3 12.0 10.2 18.7 23.7 28.5 38.6 17.4 8.5 29.2 18.2 23.2 17.6 35.4 14.2 22.5 21.4 15.7 21.0 17.4 30.1 23.8 20.7 26.0 16.8 26.0 20.7 15.4 15.5 38.0 24.5 28.2 24.7 32.5 28.6 4.5 6.9 12.1 9.7 4.1 5.1 2.4 30.4 21.6 30.4 21.0 15.4 18.9 17.8 28.2 31.0 36.0 37.3 28.2 24.9 35.5 13.0 22.5 28.4 36.2 28.4 42.2 26.0 26.8 18.2 17.2 21.6 23.9 33.6 44.1 15.5 16.1 32.6 42.9 24.6 16.8 26.8 23.5 22.6 42.2 20.3 15.3 15.7 26.6 58.8 18.1 15.4 20.9 13.1 16.9 20.6 17.2 23.6 11.6 24.0 19.0 17.7 17.4 18.0 33.6 19.3 21.5 39.3 21.1 22.6 10.8 12.1 5.3 3.6 4.2 9.7 5.1 4.5 3.9 4.4 6.9 1.8 4.2 3.8 6.4 4.1 6.1 3.5 3.9 2.4 11.7 13.8 17.2 13.8 12.0 10.2 17.4 8.5 14.2 15.5 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favourable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.3 6.5 3.2 10.8 18.7 6.0 9.2 11.9 9.6 14.4 12.5 5.0 5.6 3.5 14.7 8.0 2.9 5.4 4.1 4.3 6.9 11.9 3.1 6.4 4.0 16.4 3.6 14.0 8.5 9.6 13.8 2.4 6.1 5.9 15.9 8.3 2.1 4.9 3.6 7.1 14.1 6.8 5.4 7.6 5.4 5.5 8.3 10.2 5.1 9.0 15.0 5.4 6.3 7.5 6.9 3.9 27.8 8.8 12.3 18.8 2.5 11.1 5.0 10.3 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.8;HAP1: 9.8;RH-30: 11.9;SK-MEL-30: 21.2" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: " "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.4 1.5 0.0 0.0 5.2 4.7 1.6 0.1 9.8 2.5 6.9 0.5 1.2 0.0 0.7 0.1 0.0 9.8 3.2 1.6 2.6 5.8 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.1 0.0 0.0 0.0 4.8 0.6 0.0 0.0 0.7 0.6 0.0 11.9 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.2 4.0 4.9 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 MCPH1 "BRIT1, FLJ12847" ENSG00000147316 "Microcephalin 1" Q8NEM0 8 6406592-6648504 "Disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008238, HPA012064, CAB012177" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: " "unprognostic (1.00e-1)" "unprognostic (2.17e-2)" "prognostic favourable (8.52e-4)" "unprognostic (6.45e-2)" "unprognostic (1.16e-2)" "unprognostic (1.19e-2)" "unprognostic (1.14e-2)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "unprognostic (4.79e-2)" "unprognostic (5.55e-3)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (4.79e-2)" "unprognostic (2.94e-1)" 13.5 10.0 11.6 10.7 14.6 35.0 14.0 19.9 16.8 13.6 11.7 12.4 15.1 9.1 17.2 10.0 12.2 12.5 9.4 11.9 12.2 10.0 11.4 11.0 10.8 15.0 11.0 11.3 14.3 13.4 13.2 19.4 14.4 13.9 13.6 10.6 10.2 14.4 15.4 24.9 11.9 11.2 12.3 14.2 15.3 11.7 17.1 12.5 21.6 14.0 10.7 17.0 14.3 17.6 6.9 4.1 11.7 4.1 6.0 6.2 3.0 4.5 4.0 7.3 5.1 3.7 6.6 6.3 6.9 6.1 8.8 6.6 5.1 3.4 8.8 1.9 5.6 5.3 9.3 6.6 10.5 3.6 5.1 11.2 4.2 6.8 6.1 5.6 8.9 6.3 6.9 6.0 8.7 6.4 13.6 8.9 6.7 2.9 15.1 6.1 12.7 4.1 9.0 7.0 5.3 5.1 8.4 5.1 6.8 5.1 5.4 7.5 4.7 8.0 5.3 6.9 3.8 2.2 6.5 4.1 5.6 13.1 6.4 6.5 9.3 2.2 3.0 11.7 4.8 3.4 6.2 6.0 4.2 5.5 3.0 6.9 5.4 5.6 0.5 6.0 4.1 4.1 4.2 3.0 11.6 14.6 19.9 16.8 12.2 10.0 11.0 11.3 13.9 12.5 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 19.9 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.8 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 20.7 0.1 28.3 7.4 0.2 0.5 6.8 1.6 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.5 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell line enhanced" "Detected in many" "HEL: 14.2;HMC-1: 11.7;U-698: 15.5;U-87 MG: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051176: , HPA070541: " "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.4 0.0 0.0 0.0 0.0 0.0 1.7 1.3 0.8 0.2 0.1 1.6 3.1 7.1 0.3 0.0 5.6 0.1 4.6 0.0 1.3 0.5 14.2 1.9 0.8 1.0 2.9 11.7 0.8 5.7 0.1 5.8 0.0 0.5 4.0 0.0 0.0 1.3 7.9 0.5 2.6 3.2 0.1 2.7 0.3 7.4 1.4 0.3 0.1 2.4 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.6 0.1 15.5 17.7 7.7 0.8 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 MCTS1 MCT-1 ENSG00000232119 "MCTS1, re-initiation and release factor" Q9ULC4 X 120594010-120621074 "Predicted intracellular proteins" "Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation" "Initiation factor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001045 Supported "Plasma membrane,Cytosol" 52000 Cytosol "Plasma membrane" "HPA001045: " "prognostic unfavourable (1.38e-4)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (9.37e-3)" "unprognostic (7.29e-2)" "prognostic unfavourable (3.27e-5)" "unprognostic (2.94e-3)" "unprognostic (9.59e-2)" "unprognostic (8.28e-2)" "unprognostic (4.89e-2)" "unprognostic (7.42e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (4.35e-5)" "unprognostic (1.95e-1)" "unprognostic (7.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 20.2 26.8 23.7 22.5 29.3 16.9 27.4 16.8 33.8 20.7 24.0 14.3 26.6 23.2 17.4 30.7 31.7 16.6 16.8 24.6 25.2 22.4 22.7 37.9 17.2 31.1 22.6 25.0 14.7 42.0 21.1 38.2 20.7 22.3 16.6 29.7 13.4 31.0 27.3 20.9 18.1 21.2 19.2 20.8 24.1 22.9 13.1 19.0 28.5 23.1 32.1 36.1 20.5 19.1 28.2 32.0 13.7 24.4 17.7 24.5 15.5 33.6 23.7 19.3 19.3 24.7 35.9 26.2 25.3 23.3 31.9 30.6 20.6 33.4 36.2 36.4 31.2 22.4 33.8 32.2 46.3 22.8 22.5 11.7 26.2 16.2 28.1 29.3 22.5 24.6 28.6 27.8 30.3 38.5 31.9 24.2 39.2 38.6 28.1 39.3 21.5 46.9 21.7 17.8 43.8 34.0 16.8 24.4 22.8 17.7 28.8 22.8 21.2 27.2 26.3 25.9 15.8 28.0 46.4 18.3 24.7 49.3 30.1 43.4 28.1 11.9 20.1 13.7 15.1 24.4 24.5 28.2 19.8 19.3 24.8 20.7 18.3 18.5 9.9 17.7 22.4 32.0 22.9 15.5 23.7 29.3 16.8 33.8 25.2 22.4 22.6 25.0 22.3 19.0 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell line enhanced" "Detected in many" "Daudi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: " "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.3 4.4 2.4 12.6 2.7 7.3 9.5 8.9 5.4 9.8 8.7 0.2 8.3 36.1 1.8 7.6 2.9 9.3 5.4 8.6 23.0 7.3 4.4 4.9 0.6 4.8 8.8 0.1 4.6 1.5 5.9 5.1 13.0 1.2 23.0 7.4 12.6 20.1 0.1 11.4 6.4 7.7 19.1 4.0 11.4 4.6 10.2 4.4 9.5 28.5 2.9 3.5 0.4 9.2 3.9 5.0 20.3 15.4 8.9 6.2 8.7 11.8 1.9 2.6 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717889 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 15.4;AN3-CA: 12.1;HEK 293: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 10.8 3.6 5.7 9.5 5.9 4.9 5.5 10.2 8.0 6.9 6.3 8.5 3.8 3.8 9.9 5.1 3.7 8.3 5.0 5.0 5.2 2.4 5.1 6.2 5.1 5.4 4.9 3.7 11.3 5.7 3.1 12.5 3.1 6.0 6.4 2.9 9.4 5.5 3.5 11.1 11.7 6.4 6.1 5.5 7.1 7.7 26.7 5.3 11.4 11.9 2.4 13.0 5.2 5.4 2.0 1.8 0.4 0.2 3.8 1.2 0.3 15.4 1.0 1.2 12.1 3.9 3.8 1.0 1.3 0.7 2.7 1.0 1.0 1.7 2.6 6.6 7.7 1.6 2.4 4.4 2.5 2.1 29.3 1.9 2.9 0.6 0.4 1.1 1.4 0.9 0.9 4.1 1.9 0.4 3.8 2.9 0.4 1.4 0.7 0.2 0.8 0.8 2.2 1.3 2.9 4.5 3.3 2.6 1.3 0.6 3.1 0.5 2.8 2.2 0.9 1.0 1.5 2.0 1.4 1.9 7.2 6.7 0.3 4.3 2.1 0.4 0.1 0.3 1.1 0.2 0.9 0.8 0.9 1.2 0.2 2.0 1.0 0.8 0.1 3.8 0.1 1.8 0.0 0.3 5.7 5.9 10.2 8.0 5.2 2.4 4.9 3.7 6.0 5.3 MDFIC "HIC, MDFIC1" ENSG00000135272 "MyoD family inhibitor domain containing" Q9P1T7 7 114922154-115019202 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030716 Approved Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus" "HPA030716: AB_10671364" "unprognostic (1.24e-3)" "unprognostic (4.15e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.73e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (6.38e-3)" "unprognostic (3.68e-2)" "prognostic unfavourable (3.65e-4)" "unprognostic (6.13e-3)" "unprognostic (7.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.55e-1)" 39.4 21.1 4.6 29.3 4.6 5.1 62.4 2.5 4.0 18.4 15.5 5.1 13.9 3.7 22.8 8.8 18.2 7.7 9.7 15.9 4.4 4.7 8.3 8.6 17.5 48.0 4.7 4.1 11.2 5.9 15.2 6.6 11.2 13.6 11.9 5.8 11.2 14.4 19.4 13.7 8.1 9.4 16.7 13.7 28.3 6.6 4.0 3.4 17.8 16.1 11.2 24.1 18.0 25.4 3.6 8.1 1.1 2.5 2.7 6.9 1.2 0.0 4.8 6.3 0.0 13.5 18.7 2.7 24.0 28.9 5.5 7.0 0.1 14.3 3.4 0.3 15.7 2.8 1.9 4.1 9.5 11.8 5.6 0.0 5.9 0.0 6.9 7.3 4.9 15.6 4.0 12.5 3.9 3.6 0.0 23.2 18.7 0.0 0.0 0.6 5.1 5.4 0.0 18.6 7.2 5.6 5.8 0.2 0.0 10.4 9.8 10.8 3.1 6.6 10.3 20.5 5.8 38.0 11.5 9.5 0.0 0.0 14.4 0.0 17.5 0.2 1.5 1.1 3.0 1.9 4.6 3.6 6.9 6.4 2.4 3.2 4.0 3.4 0.1 2.7 2.5 8.1 5.6 1.2 4.6 4.6 2.5 4.0 4.4 4.7 4.7 4.1 13.6 3.4 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: " "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.5 3.9 0.7 0.0 0.9 0.6 1.7 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.4 7.4 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.9 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 MDH1 ENSG00000014641 "Malate dehydrogenase 1" P40925 2 63588609-63607197 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 155.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027296, CAB047333, HPA054276" Uncertain Supported Centrosome,Cytosol 63000000 "Centrosome, Cytosol" "CAB047333: , HPA027296: AB_10611118, HPA054276: " "unprognostic (1.01e-1)" "unprognostic (6.52e-3)" "unprognostic (1.61e-2)" "prognostic unfavourable (7.13e-4)" "unprognostic (1.83e-1)" "unprognostic (8.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.79e-2)" "unprognostic (9.52e-2)" "unprognostic (2.05e-1)" "unprognostic (3.26e-1)" "unprognostic (8.80e-2)" "prognostic favourable (9.95e-4)" "unprognostic (6.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.97e-2)" "unprognostic (3.05e-1)" 32.0 28.6 28.0 10.5 58.1 9.2 18.4 38.0 69.5 12.4 21.4 12.5 9.0 19.3 13.4 22.6 16.7 14.7 11.5 155.8 33.6 37.5 47.6 33.2 11.2 14.7 33.4 40.1 10.9 8.9 26.0 18.3 11.4 65.9 16.1 24.9 13.8 15.4 19.9 91.1 11.1 17.1 21.5 18.6 9.4 22.4 8.6 12.2 14.1 15.6 47.1 20.2 15.6 10.2 61.7 57.1 50.7 61.5 46.7 74.5 67.8 44.0 36.1 48.8 31.9 69.4 51.4 50.6 34.7 51.3 52.9 53.7 42.7 39.1 55.5 20.6 45.4 38.8 54.9 64.3 75.9 33.6 42.4 52.1 33.8 67.8 38.1 59.9 41.3 50.9 43.9 49.5 29.3 40.3 28.8 40.4 69.5 26.5 52.4 60.5 28.6 45.0 41.9 57.5 54.4 87.5 41.8 45.3 27.0 29.1 46.9 66.5 34.2 62.5 23.4 40.6 39.8 33.7 43.6 50.4 44.2 67.9 50.1 54.2 33.5 50.7 45.8 45.8 52.7 61.5 55.0 61.7 61.3 57.6 57.1 56.4 60.5 57.5 7.0 46.7 55.7 43.3 74.5 67.8 28.0 58.1 38.0 69.5 33.6 37.5 33.4 40.1 65.9 12.2 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favourable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 4.9 4.1 8.0 7.7 4.0 5.4 6.1 6.6 3.7 10.6 9.8 4.9 2.3 11.4 4.4 3.0 5.1 5.4 3.5 12.1 14.9 5.2 25.0 5.3 3.4 6.1 13.8 9.9 2.4 4.6 7.1 6.9 5.9 4.7 12.8 6.1 3.6 19.5 9.8 4.2 5.1 19.2 7.1 3.3 5.0 4.3 7.3 3.9 6.4 3.8 6.5 9.2 10.0 3.1 8.5 3.7 5.3 6.0 6.7 19.5 7.7 4.5 9.0 5.4 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642499-89819723 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 26.6;NTERA-2: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 10.0 8.8 8.6 10.1 18.2 16.1 14.9 19.2 18.7 9.1 7.5 14.8 8.6 5.9 14.1 10.0 9.2 10.2 6.4 8.6 9.4 9.6 9.4 15.1 7.3 10.9 13.1 12.4 22.3 10.7 19.0 10.9 5.9 15.9 8.1 8.6 9.4 9.3 8.3 16.2 19.6 8.8 9.2 12.7 9.0 8.2 14.0 13.7 8.4 12.8 8.2 12.7 7.5 7.8 3.8 8.9 6.7 1.0 3.3 4.2 0.3 4.5 4.5 4.7 4.4 7.7 7.4 4.7 3.1 2.3 3.6 4.4 10.3 1.7 13.7 3.6 3.2 4.0 12.1 4.2 6.4 5.3 8.1 14.9 5.8 6.7 3.0 19.2 3.7 4.5 3.6 9.5 8.8 6.3 26.6 3.3 3.5 5.5 3.0 7.3 25.9 4.0 6.0 8.9 3.4 3.1 6.5 8.6 3.8 4.4 2.7 2.8 1.9 8.5 8.0 2.4 4.4 3.2 7.2 3.8 4.2 6.7 3.3 11.0 4.1 6.7 1.0 1.9 2.4 0.8 2.1 3.0 3.3 2.6 0.6 3.8 4.2 3.3 0.2 3.3 1.0 8.9 1.3 0.3 8.6 18.2 19.2 18.7 9.4 9.6 13.1 12.4 15.9 13.7 ME1 ENSG00000065833 "Malic enzyme 1" P48163 6 83210389-83431071 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 15.6" "Lineage enriched" "Detected in many" 11 "T-cells: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006493 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" 3800000 "Nucleoplasm, Plasma membrane" Cytosol "HPA006493: AB_1078272" "unprognostic (7.21e-2)" "unprognostic (3.99e-2)" "unprognostic (2.24e-1)" "unprognostic (3.12e-3)" "prognostic unfavourable (7.73e-4)" "unprognostic (7.98e-3)" "prognostic unfavourable (4.57e-5)" "unprognostic (3.24e-1)" "unprognostic (4.44e-3)" "unprognostic (1.41e-3)" "unprognostic (7.10e-3)" "unprognostic (2.43e-1)" "prognostic unfavourable (1.81e-7)" "unprognostic (4.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.85e-2)" "unprognostic (4.51e-2)" 30.7 35.3 16.3 4.6 17.7 0.8 27.1 5.5 13.1 5.9 6.7 5.4 39.2 18.1 3.8 7.4 24.5 4.2 13.5 21.3 10.5 14.0 3.6 12.4 7.7 6.0 16.8 11.8 10.0 3.3 30.0 11.1 2.9 16.3 7.9 10.1 9.3 7.8 30.2 25.7 10.1 8.7 18.7 17.2 6.3 20.0 13.4 7.2 1.4 6.3 20.9 4.5 13.7 14.9 0.0 0.0 0.0 1.4 0.0 15.6 0.5 9.5 19.8 0.4 0.0 16.9 15.8 0.0 6.2 15.9 6.6 12.9 46.4 8.4 0.0 16.2 14.5 10.1 14.7 5.5 7.3 0.0 8.3 0.0 12.7 0.0 21.7 4.6 17.4 17.2 11.1 13.3 9.1 10.3 6.6 0.0 8.9 10.7 0.0 5.3 0.0 7.8 0.0 16.7 9.2 19.6 4.6 2.0 5.1 10.5 15.6 0.3 0.0 11.4 10.9 4.1 4.9 1.3 0.0 3.7 4.2 0.0 0.0 0.0 12.1 0.0 1.4 0.0 0.8 0.3 15.6 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 16.3 17.7 5.5 13.1 10.5 14.0 16.8 11.8 16.3 7.2 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017921 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017921: AB_1853708" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favourable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavourable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 16.8 17.4 26.6 13.9 23.4 11.8 17.4 13.1 29.9 16.2 14.3 17.2 14.0 12.7 20.1 25.2 16.8 20.5 17.2 12.5 20.9 25.4 16.5 18.7 15.2 14.2 21.9 20.8 22.7 26.7 13.2 17.7 17.3 17.5 20.9 17.0 19.6 16.6 20.3 14.6 15.2 13.1 19.5 15.7 12.8 13.0 109.4 8.7 19.1 15.8 13.4 21.2 21.5 14.1 61.2 40.9 70.6 51.0 46.6 51.7 59.9 46.1 26.7 40.0 31.6 36.6 24.5 16.0 30.9 32.9 38.7 42.5 39.7 12.1 24.2 32.5 37.7 23.5 30.8 42.1 36.4 27.6 41.8 44.8 29.2 42.7 18.9 32.6 23.6 19.5 21.0 51.3 33.5 23.2 30.2 27.1 42.3 88.4 43.6 37.8 18.8 23.6 21.5 23.8 24.0 26.7 43.8 38.7 27.1 23.8 20.5 35.2 31.2 35.8 17.2 42.7 34.4 27.6 53.3 30.9 25.6 40.4 21.4 24.5 34.6 64.5 39.2 70.6 46.7 44.5 42.9 61.2 42.9 45.6 40.9 56.8 43.2 45.8 35.9 46.6 51.0 40.0 51.7 59.9 26.6 23.4 13.1 29.9 20.9 25.4 21.9 20.8 17.5 8.7 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733610 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA056669: " "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favourable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 12.8 30.8 15.5 16.5 26.4 7.0 16.2 14.5 19.3 16.6 20.9 16.4 22.3 20.7 14.7 22.8 20.5 19.7 21.5 22.0 16.9 13.2 29.5 35.4 16.4 19.6 25.0 19.7 13.8 30.6 24.3 14.4 19.0 22.8 17.5 18.4 13.7 27.7 16.4 24.7 20.8 26.8 18.8 21.9 25.4 20.3 11.7 23.3 13.9 22.8 25.9 19.9 16.4 14.7 23.8 18.6 51.3 23.3 14.2 21.5 13.0 12.0 35.4 13.1 13.5 14.2 17.4 10.2 8.7 14.9 13.0 16.1 12.2 9.5 16.9 9.4 10.7 18.6 13.2 24.8 9.6 20.0 30.2 8.2 19.8 18.7 8.8 6.0 10.1 15.1 17.5 13.8 8.6 14.6 8.4 12.9 11.3 17.6 11.5 7.5 7.8 11.3 11.4 9.5 10.9 26.3 12.6 5.4 8.9 11.3 15.4 8.5 13.7 7.1 8.6 7.0 7.0 13.3 13.9 6.1 5.3 6.4 12.0 10.3 9.1 14.7 11.8 28.0 16.8 16.6 17.9 22.8 16.5 16.8 11.6 23.8 19.6 21.5 51.3 14.2 23.3 18.6 12.4 13.0 15.5 26.4 14.5 19.3 16.9 13.2 25.0 19.7 22.8 23.3 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13 like" Q71F56 12 115953872-116277338 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 21.3 7.9 9.8 14.7 10.6 39.1 22.0 29.7 11.1 17.3 13.6 12.1 12.3 7.8 21.6 11.1 13.2 13.9 12.2 9.4 11.0 7.0 9.0 7.3 15.2 16.7 11.5 9.1 20.5 15.6 14.3 13.6 13.4 9.6 14.6 10.9 11.7 14.2 14.2 18.1 21.9 13.1 15.3 11.9 14.3 12.8 14.9 11.2 55.9 14.0 10.8 15.4 13.8 22.7 2.5 1.9 13.1 1.1 1.4 1.1 0.7 6.3 15.2 7.1 8.0 9.6 15.8 7.6 6.7 8.9 9.3 6.6 15.1 2.3 4.4 5.6 12.1 4.7 8.1 5.3 12.3 9.9 5.2 8.9 4.5 5.6 10.6 8.0 12.0 12.7 9.2 10.2 15.6 6.7 9.8 4.3 8.0 14.3 15.7 16.8 4.0 3.6 11.1 7.7 10.5 6.0 5.8 7.3 6.3 6.0 3.2 5.9 50.1 17.7 8.3 10.6 7.0 7.7 8.0 8.3 3.8 8.0 4.9 8.8 5.6 13.1 1.1 3.6 1.0 0.9 1.1 2.5 1.0 1.1 1.5 1.3 0.8 0.9 4.1 1.4 1.1 1.9 0.7 0.7 9.8 10.6 29.7 11.1 11.0 7.0 11.5 9.1 9.6 11.2 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavourable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 9.0 7.4 5.8 9.9 8.0 9.5 9.2 13.9 10.7 10.7 10.2 9.0 9.4 4.3 12.1 7.5 7.9 10.4 7.3 11.5 6.3 5.4 6.4 4.6 8.2 8.1 9.5 7.3 13.8 9.9 5.4 13.1 9.5 6.1 8.2 4.9 8.0 9.4 6.6 9.3 10.2 14.0 7.7 7.7 13.9 12.1 7.9 8.8 20.7 7.8 5.5 9.8 11.2 11.6 10.5 6.8 10.8 5.7 10.2 8.5 5.1 3.0 1.0 2.6 5.6 3.2 0.4 5.1 6.7 2.3 4.5 2.8 5.3 6.3 5.0 11.3 0.6 9.4 2.4 1.4 1.2 6.0 2.7 5.6 3.4 1.5 1.7 9.4 9.5 1.3 3.3 3.3 2.2 1.8 5.0 3.0 2.7 0.9 11.2 2.7 4.9 0.8 8.6 7.6 4.1 2.7 2.1 9.2 11.7 5.6 4.7 2.8 7.0 2.3 6.1 7.0 5.6 9.3 5.8 4.7 9.1 3.6 1.8 6.7 8.0 4.9 4.6 10.8 6.4 5.7 7.6 10.5 8.2 8.0 6.0 9.0 8.5 4.8 4.7 10.2 3.3 6.8 8.1 5.1 5.8 8.0 13.9 7.9 6.3 5.4 9.5 7.3 6.1 8.8 MED20 "DKFZp586D2223, PRO0213, SRB2, TRFP" ENSG00000124641 "Mediator complex subunit 20" Q9H944 6 41905354-41921139 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040717 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA040717: AB_10794146" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (2.58e-3)" "unprognostic (8.32e-2)" "unprognostic (9.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.16e-3)" "unprognostic (1.22e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (1.58e-3)" "unprognostic (4.23e-2)" "unprognostic (5.10e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.71e-2)" "unprognostic (4.63e-1)" "unprognostic (4.13e-3)" "unprognostic (2.31e-1)" 11.8 22.1 12.4 12.1 14.2 7.0 14.2 17.0 15.4 15.3 14.0 16.4 17.4 13.1 16.1 17.8 17.0 13.2 9.9 15.3 12.7 9.5 17.5 14.7 10.4 11.4 14.8 9.3 12.8 17.6 14.5 23.5 17.4 13.8 16.3 15.4 13.2 15.3 14.0 23.0 12.1 15.4 15.3 9.6 13.3 12.9 14.6 11.5 20.9 15.5 13.1 16.4 16.0 12.9 15.0 20.0 13.6 22.1 11.6 10.8 11.5 14.8 12.6 13.6 16.2 12.9 14.2 16.8 9.5 9.1 13.5 10.8 16.0 10.2 20.2 18.8 11.1 11.3 23.2 12.7 17.1 11.6 7.4 18.1 9.7 14.1 12.3 15.4 11.5 11.1 20.0 12.9 19.3 16.7 24.5 9.7 16.1 13.3 17.1 11.0 17.7 10.2 23.8 16.4 7.3 19.3 9.6 12.6 10.0 13.5 6.4 12.7 12.9 16.1 16.3 9.6 20.8 5.8 11.7 10.1 13.5 42.7 5.3 17.1 13.5 13.0 19.6 13.6 8.7 22.1 10.8 14.2 5.8 9.8 20.0 15.0 7.9 9.3 7.3 11.6 14.8 17.8 10.2 11.5 12.4 14.2 17.0 15.4 12.7 9.5 14.8 9.3 13.8 11.5 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favourable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.8 17.7 9.4 14.9 20.9 21.2 15.6 19.2 14.4 16.2 21.2 18.6 19.1 11.1 12.2 14.7 13.9 20.0 17.8 28.0 9.7 17.8 16.0 18.4 11.4 11.7 19.5 11.5 14.9 26.0 20.1 24.1 23.5 12.9 14.9 18.3 12.6 17.0 35.9 28.8 23.4 14.7 60.2 12.5 16.9 19.3 7.1 10.5 23.4 10.1 15.1 17.8 13.0 17.0 18.1 14.1 22.5 19.3 4.6 9.4 18.2 17.3 21.7 12.2 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 MED23 "CRSP130, CRSP3, DRIP130, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628229 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070341: " "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 14.0 17.1 12.1 19.7 12.7 21.8 16.3 23.0 17.6 14.7 12.3 12.1 17.8 12.7 21.6 13.3 14.9 14.6 10.2 10.2 11.7 8.3 12.2 9.6 13.1 15.4 15.9 12.3 20.5 18.7 23.9 16.1 12.3 11.3 13.9 14.4 12.3 19.8 16.8 14.8 15.0 15.4 14.3 11.0 13.7 14.9 13.1 13.3 22.7 18.0 7.4 16.7 16.2 20.7 6.0 6.8 8.8 5.7 15.0 10.9 4.6 5.1 5.8 13.8 17.4 17.2 13.2 12.7 13.1 14.9 12.1 17.7 6.0 7.3 11.6 9.6 13.4 9.4 7.4 8.5 18.9 13.1 10.3 12.1 10.6 10.2 12.5 20.0 20.7 11.5 10.2 13.4 13.7 15.0 15.5 12.2 12.8 8.0 15.1 12.6 6.6 5.8 13.7 8.6 6.9 9.4 7.7 10.4 9.4 9.3 13.1 8.5 3.6 14.1 15.1 9.0 10.3 14.4 11.9 13.0 8.7 16.7 11.1 9.2 12.1 4.5 5.3 8.8 7.3 5.7 10.9 6.0 7.2 8.0 6.8 5.2 7.4 6.7 4.5 15.0 3.9 3.6 7.8 4.6 12.1 12.7 23.0 17.6 11.7 8.3 15.9 12.3 11.3 13.3 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA057997: , HPA071835: " "unprognostic (2.02e-2)" "prognostic favourable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavourable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.5 3.3 7.1 4.3 3.4 9.6 5.3 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 6.9 5.1 5.4 4.0 10.7 10.4 5.7 3.3 4.2 4.2 6.5 5.5 4.0 5.3 4.9 5.2 3.1 9.4 17.7 3.6 9.1 6.8 6.1 7.8 11.5 7.2 5.0 15.9 3.4 3.6 8.7 4.6 4.6 4.6 5.3 3.3 8.6 3.7 7.4 5.9 8.9 7.1 12.4 10.0 11.8 5.2 8.6 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favourable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.0 15.8 18.2 14.4 13.1 12.1 15.4 16.7 22.2 33.4 26.2 23.5 13.0 15.9 11.3 17.3 29.1 25.2 23.7 21.9 17.0 14.9 11.9 16.6 14.0 19.6 21.3 15.0 13.3 16.3 26.4 27.0 17.4 17.3 13.2 24.3 25.5 22.8 12.4 18.6 26.8 20.2 25.7 19.4 13.4 8.9 34.1 13.8 21.5 11.1 11.1 17.6 10.0 14.6 34.1 15.0 25.2 25.0 5.4 16.5 28.1 18.9 14.9 23.1 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 MED8 "ARC32, MGC17544, MGC19641" ENSG00000159479 "Mediator complex subunit 8" Q96G25 1 43383917-43389808 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028377, HPA028438" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA028377: AB_10600112, HPA028438: AB_10600057" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (1.49e-2)" "unprognostic (2.37e-2)" "unprognostic (8.58e-3)" "prognostic unfavourable (2.04e-7)" "unprognostic (2.60e-2)" "unprognostic (1.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.17e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.11e-7)" "unprognostic (7.08e-2)" "unprognostic (3.28e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-1)" 22.7 21.9 19.0 18.3 22.0 22.0 22.9 30.0 25.8 20.4 21.1 21.9 19.0 21.7 18.4 24.8 33.4 15.0 16.1 15.9 18.5 19.0 22.1 34.6 19.4 18.3 21.0 17.2 19.2 25.6 17.7 34.5 26.8 20.3 19.3 24.5 19.2 25.0 21.1 16.5 27.3 21.2 23.5 21.3 20.9 22.5 18.5 20.6 14.2 27.0 19.3 25.9 24.9 20.6 27.0 34.6 32.5 35.0 18.4 25.5 22.1 21.8 13.8 13.0 15.5 20.1 20.2 17.1 22.0 20.3 26.6 28.1 26.2 16.1 13.3 15.8 27.6 14.0 20.4 18.7 25.8 18.4 20.0 21.8 24.0 32.8 34.2 19.2 23.2 19.7 24.8 28.1 34.5 21.2 19.3 22.7 17.1 14.1 10.0 15.8 12.4 16.0 11.8 15.0 20.4 17.7 14.3 13.6 10.3 13.1 21.5 43.3 14.5 38.7 15.7 11.6 21.1 22.8 31.2 27.1 31.2 15.5 24.7 24.0 15.4 25.3 35.0 32.5 22.0 31.3 20.9 27.0 20.2 24.8 34.6 21.1 20.7 21.5 28.0 18.4 27.3 16.0 25.5 22.1 19.0 22.0 30.0 25.8 18.5 19.0 21.0 17.2 20.3 20.6 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476986-17493226 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA056415: " "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favourable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favourable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 10.2 12.7 16.0 6.5 23.5 12.3 14.1 16.3 29.1 13.0 11.2 9.2 10.9 11.2 11.7 17.3 8.2 11.7 6.6 30.0 14.3 13.6 13.9 19.1 8.2 11.5 13.6 14.5 12.4 10.2 20.3 11.3 7.9 12.6 11.4 10.5 8.9 15.8 14.9 34.4 11.3 10.5 8.6 10.3 9.5 10.1 12.9 8.6 14.9 13.4 15.2 9.1 7.5 7.8 11.4 12.8 11.8 11.4 10.3 13.4 7.4 8.5 11.0 9.5 10.2 7.6 6.9 8.1 7.0 8.7 10.8 9.8 15.9 4.3 10.6 8.1 7.2 11.2 12.0 9.7 10.3 6.7 19.1 6.4 7.3 11.4 8.2 5.1 5.6 11.2 9.2 9.1 9.4 7.4 7.6 4.9 7.2 7.2 22.9 10.6 8.7 11.3 17.8 21.4 6.8 9.5 6.1 6.2 9.8 9.2 7.3 15.5 8.6 6.7 5.0 8.0 9.3 13.7 11.0 9.3 6.6 5.9 10.1 9.1 8.4 2.7 7.0 11.8 10.3 9.6 13.4 11.4 10.7 10.6 7.8 10.4 11.6 12.8 2.4 10.3 11.4 12.8 10.3 7.4 16.0 23.5 16.3 29.1 14.3 13.6 13.6 14.5 12.6 8.6 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Group enriched" "Detected in some" 12 "Daudi: 49.8;U-266/70: 50.0;U-698: 65.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 49.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.4 0.5 0.1 50.0 4.6 65.8 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 5 "B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5" "Group enriched" "Detected in many" 7 "amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3" "Group enriched" "Detected in all" 4 "amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB068196: , CAB068197: , HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 13.9 10.8 17.0 15.0 26.7 3.8 10.7 4.3 52.8 8.2 6.8 6.1 1.5 2.8 10.9 5.4 5.0 6.4 9.8 11.2 11.1 6.8 4.5 4.0 8.3 19.3 6.6 28.0 12.3 2.9 5.2 6.5 14.8 4.8 7.1 5.7 4.6 6.6 6.6 154.8 3.9 7.4 10.8 8.3 16.0 4.5 3.6 4.4 1.6 9.6 3.5 24.0 8.9 5.8 48.2 23.8 5.8 19.5 4.0 0.1 7.2 0.3 0.0 1.7 0.0 1.8 1.1 0.0 0.5 1.0 0.0 0.2 0.0 0.2 23.7 0.1 2.7 0.7 2.2 2.1 0.0 7.2 2.9 52.3 3.1 0.0 0.6 2.3 0.1 5.2 0.0 0.0 0.0 8.2 2.7 28.8 2.1 0.0 0.0 0.0 0.5 1.9 59.6 15.0 11.4 0.0 0.2 0.0 2.0 0.0 0.1 6.9 0.0 13.3 9.4 1.3 0.2 0.1 1.2 21.9 2.5 14.3 0.3 16.2 34.1 0.1 17.2 0.0 0.0 19.5 0.0 32.6 0.0 0.0 22.3 48.2 0.0 0.0 5.8 4.0 15.9 23.8 0.1 7.2 17.0 26.7 4.3 52.8 11.1 6.8 6.6 28.0 4.8 4.4 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500828 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell line enhanced" "Detected in all" "THP-1: 53.9;U-266/70: 47.4;U-266/84: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavourable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 18.1 19.6 14.9 15.7 27.5 47.6 15.5 27.0 40.3 23.8 21.1 12.1 10.5 11.0 28.6 12.9 13.8 19.5 16.6 26.3 11.8 9.6 10.4 10.6 20.0 13.9 8.6 21.1 26.7 22.4 21.4 15.0 16.2 11.6 17.2 10.6 22.3 11.3 18.8 97.8 17.5 14.8 22.0 8.4 17.2 16.1 9.9 9.9 17.2 14.7 19.4 15.6 21.9 19.3 1.7 8.5 8.1 2.0 1.5 2.3 0.8 4.5 8.5 1.8 2.7 4.3 6.0 2.7 6.0 7.8 3.2 3.4 2.7 6.2 10.6 6.9 8.0 4.5 2.1 3.4 1.9 14.4 2.8 2.5 10.4 1.5 5.3 6.2 8.4 6.7 5.8 5.5 7.5 6.0 1.8 18.7 5.0 4.3 4.1 14.3 2.6 4.3 20.4 3.9 12.2 2.7 2.2 2.9 4.6 5.8 12.6 10.0 3.4 53.9 10.0 7.5 7.1 5.5 4.4 47.4 48.8 20.3 6.4 4.9 4.0 1.3 2.0 2.3 1.9 1.1 2.3 1.7 1.4 1.7 1.4 1.7 0.7 1.3 8.1 1.5 1.9 8.5 1.6 0.8 14.9 27.5 27.0 40.3 11.8 9.6 8.6 21.1 11.6 9.9 MEFV "FMF, MEF, TRIM20" ENSG00000103313 "MEFV, pyrin innate immunity regulator" O15553 16 3242028-3256627 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" Actin-binding "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.3" "Cell line enriched" "Detected in some" 6 "THP-1: 11.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" HPA077497 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA077497: " "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (2.01e-1)" "unprognostic (2.49e-2)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "unprognostic (3.35e-2)" "unprognostic (2.97e-2)" "unprognostic (1.09e-1)" "unprognostic (8.89e-2)" "unprognostic (3.27e-1)" "unprognostic (7.58e-7)" "unprognostic (1.08e-1)" "unprognostic (7.16e-4)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" 4.2 1.2 0.5 9.8 1.0 9.7 0.9 0.4 0.9 1.1 1.4 0.3 0.0 1.0 0.6 2.7 1.2 1.6 1.8 4.2 0.5 0.5 1.3 1.5 11.4 14.8 2.8 0.1 1.2 1.8 0.2 0.7 1.8 0.8 0.9 0.6 1.7 0.8 0.7 1.7 0.6 1.3 1.6 2.2 23.3 1.0 2.2 1.3 1.2 1.7 0.2 1.4 2.7 4.1 0.4 2.1 10.0 6.5 0.5 0.3 1.3 0.1 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.1 11.8 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.2 0.4 2.0 0.0 2.5 3.8 0.2 0.1 4.2 0.1 0.2 0.2 0.1 2.1 0.4 0.1 0.3 10.0 0.5 6.5 0.3 0.1 1.3 0.5 1.0 0.4 0.9 0.5 0.5 2.8 0.1 0.8 1.3 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3489920-3611495 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.8" "Cell line enhanced" "Detected in many" "BJ: 23.9;HeLa: 21.6;U-2197: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;T-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted - unknown location" 580000 Microtubules "Cytokinetic bridge" "HPA052129: " "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favourable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 15.0 2.3 0.5 8.5 1.0 9.2 13.4 0.8 2.0 8.1 5.9 1.8 7.5 2.3 5.1 13.1 6.6 14.6 21.0 6.1 1.4 0.5 2.7 1.9 12.6 12.6 0.7 1.9 8.8 4.8 0.8 1.5 2.8 2.3 12.0 0.9 11.0 8.7 5.5 6.1 37.8 4.2 3.0 0.8 5.7 4.2 4.6 1.4 5.0 5.2 12.0 12.0 6.7 10.1 0.8 0.3 4.8 0.1 0.0 1.9 0.2 4.8 7.6 1.7 3.3 0.1 0.1 0.6 23.9 6.7 2.1 0.6 1.6 5.6 0.0 7.6 8.2 3.0 0.0 0.2 0.2 0.0 0.1 0.0 21.6 1.4 0.0 0.1 0.5 0.0 0.2 0.1 0.2 2.6 0.0 0.0 0.0 2.7 0.0 4.4 1.0 0.4 1.0 1.0 2.9 0.4 1.5 1.7 1.6 8.7 0.5 3.0 2.3 0.5 1.1 8.7 0.8 21.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 4.8 0.1 0.0 0.4 0.0 0.4 0.4 0.3 0.8 0.8 0.1 2.2 0.0 0.0 0.0 1.9 0.2 0.5 1.0 0.8 2.0 1.4 0.5 0.7 1.9 2.3 1.4 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: " "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favourable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.8 11.3 9.9 3.0 13.8 8.5 3.2 2.9 2.5 0.8 1.1 0.6 1.7 10.6 4.5 2.8 12.4 14.2 5.1 2.1 8.6 4.1 1.4 21.1 4.6 5.9 4.2 9.1 4.0 15.5 4.9 3.9 6.9 3.3 5.1 8.2 8.2 8.3 1.5 0.4 3.0 6.4 11.0 4.5 20.3 9.3 9.8 8.3 3.5 2.8 8.3 8.6 4.3 8.1 3.0 1.7 10.9 4.4 9.3 10.9 3.5 4.2 5.0 16.9 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 41.0;SH-SY5Y: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 49 "basophil: 4.8;eosinophil: 4.9" "Lineage enriched" "Detected in single" 49 "granulocytes: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 83.2;olfactory region: 364.7" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 6.3 16.5 9.6 6.5 36.8 0.4 7.7 7.4 12.4 26.4 17.0 4.3 12.0 15.1 35.6 6.3 10.6 17.8 16.9 11.3 6.7 3.9 7.3 5.9 7.5 5.2 3.9 6.9 16.4 10.0 2.8 19.8 6.4 10.7 28.8 5.2 6.4 39.0 16.7 1.0 2.9 5.2 34.6 6.2 5.6 11.3 2.6 8.6 2.2 3.5 4.6 3.2 19.5 16.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 4.6 4.3 5.6 16.0 6.4 7.9 1.3 10.2 5.7 12.1 6.8 6.1 3.9 2.7 0.2 41.0 8.1 9.9 2.6 6.8 3.8 6.3 20.7 5.8 5.0 10.8 6.1 21.2 10.4 2.3 8.1 2.4 6.9 6.9 0.0 2.4 5.0 0.0 2.4 0.0 1.4 0.0 4.1 1.4 0.0 9.2 4.3 38.8 3.8 2.6 2.9 1.2 4.9 9.7 14.0 1.7 3.7 4.3 2.8 2.7 5.2 16.5 3.4 3.5 4.8 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 36.8 7.4 8.0 6.7 3.9 3.9 6.9 10.7 8.6 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favourable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 12.1 20.6 13.2 15.6 17.7 11.8 12.5 25.8 26.9 15.5 14.9 16.4 22.2 16.9 14.8 18.4 18.9 17.6 14.7 9.0 12.4 11.5 15.9 23.0 12.8 22.1 12.5 15.6 19.7 25.9 16.8 18.0 16.1 16.0 15.9 11.6 16.6 23.3 19.9 8.4 21.6 15.8 11.0 9.8 20.6 15.3 21.2 12.3 33.2 23.9 6.2 20.3 13.7 15.5 5.2 2.9 3.4 1.5 1.8 4.8 1.0 16.4 22.1 14.1 22.2 15.8 10.3 16.6 11.8 11.8 18.5 12.4 12.7 16.2 23.4 19.4 9.1 23.5 19.1 16.4 11.1 19.9 28.3 19.4 17.7 17.0 14.0 12.4 13.2 11.8 12.3 15.5 12.9 17.1 28.1 8.9 10.2 30.7 31.4 25.2 18.5 33.2 24.4 16.1 22.4 11.9 15.2 20.0 17.6 14.0 19.8 14.4 29.5 13.9 10.8 17.5 16.8 20.9 10.0 14.1 16.3 11.8 13.8 9.7 11.1 0.9 1.3 3.4 3.7 1.5 4.8 3.7 2.6 4.6 1.3 5.2 4.5 2.6 0.2 1.8 0.5 2.9 1.9 1.0 13.2 17.7 25.8 26.9 12.4 11.5 12.5 15.6 16.0 12.3 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640388-43661954 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "HeLa: 23.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 17.9" "Lineage enriched" "Detected in single" 66 "T-cells: 17.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 24.3 0.3 0.1 7.4 0.1 0.0 17.3 0.1 0.1 12.4 3.2 0.1 2.3 1.2 11.6 5.7 10.9 6.7 6.5 17.8 0.1 0.1 0.2 0.3 1.2 5.4 0.1 0.1 4.8 1.2 1.5 0.5 0.3 0.1 8.2 1.9 0.8 5.8 2.0 19.8 4.6 3.5 8.6 0.1 8.9 2.4 3.5 0.1 3.2 1.7 15.4 7.1 6.1 16.7 0.0 0.0 0.0 0.0 0.2 17.9 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 3.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.0 17.9 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 MEPCE "BCDIN3, FLJ20257, MePCE" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434126 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: " "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favourable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 17.5 24.1 17.7 13.9 22.8 18.5 15.0 24.1 24.1 15.7 14.0 16.7 26.9 14.1 18.8 22.5 16.1 18.6 22.9 12.4 20.1 13.7 18.7 20.8 13.5 19.7 19.7 16.4 29.2 18.3 32.5 15.0 19.0 19.3 15.8 10.2 17.2 18.5 24.2 21.4 26.1 15.8 15.7 17.7 34.9 14.4 63.1 20.4 21.7 25.7 17.1 17.9 16.3 20.4 8.4 8.7 9.3 3.6 7.3 9.1 10.6 13.5 17.5 13.0 13.9 12.6 12.7 9.6 15.1 22.2 16.4 12.7 14.3 19.9 27.9 25.3 9.5 12.5 14.2 11.5 10.9 12.5 16.1 14.4 13.5 10.7 10.7 18.3 17.8 13.1 13.8 18.7 23.8 13.6 28.3 20.7 15.7 50.3 20.9 41.8 24.0 19.6 16.9 10.5 25.3 11.0 8.4 19.6 16.9 23.7 46.5 15.8 11.8 16.8 11.7 27.7 21.5 18.6 19.9 13.8 13.0 31.1 15.5 23.0 24.2 2.5 3.6 4.8 5.6 3.2 6.5 8.0 6.4 6.0 4.4 8.4 9.1 8.0 9.3 7.3 2.6 8.7 5.7 10.6 17.7 22.8 24.1 24.1 20.1 13.7 19.7 16.4 19.3 20.4 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Approved Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: " "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favourable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favourable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.3 9.7 0.2 0.1 6.9 0.0 0.1 0.5 1.0 20.8 1.3 0.1 4.6 0.0 0.1 5.7 0.0 0.8 0.8 3.0 3.7 0.0 21.6 0.1 0.1 0.8 0.2 0.0 5.0 0.3 21.5 1.1 2.0 1.6 0.9 0.0 4.9 2.7 3.4 1.4 1.2 1.6 10.9 12.9 0.1 4.1 0.1 0.3 1.7 0.0 0.2 3.2 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989878 "Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 690000 "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favourable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favourable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 15.5 19.5 15.5 19.7 17.6 5.7 23.5 15.6 14.4 21.1 15.8 15.3 31.3 14.0 14.5 48.3 17.1 14.3 16.2 15.5 14.0 17.6 16.4 28.2 17.6 23.8 20.9 13.4 22.2 34.7 12.8 23.4 32.1 17.0 20.8 16.4 15.0 20.4 37.6 14.2 12.3 13.7 13.9 22.4 16.2 16.5 13.6 17.8 13.0 37.1 12.7 14.3 13.7 17.1 19.0 25.6 17.7 15.0 24.7 25.1 16.0 12.3 18.7 16.7 10.7 28.3 16.2 25.9 19.0 22.6 20.7 25.3 16.7 34.8 10.4 22.0 15.2 20.9 25.8 19.4 19.7 22.9 16.5 13.1 16.2 28.4 21.7 15.5 14.5 16.7 22.5 17.4 20.8 19.6 15.7 26.8 17.6 15.5 9.5 13.0 20.2 7.7 14.7 10.3 27.7 17.1 17.0 14.5 8.5 20.8 14.1 31.0 16.3 12.5 15.2 20.1 19.1 10.7 24.2 16.9 21.5 14.3 18.8 27.9 20.9 17.7 15.0 10.3 21.6 13.8 25.1 19.0 22.8 21.1 15.3 18.1 21.5 21.6 4.5 24.7 11.6 25.6 22.8 16.0 15.5 17.6 15.6 14.4 14.0 17.6 20.9 13.4 17.0 17.8 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 14.1;prostate: 10.9" "Cell line enhanced" "Detected in some" "A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3" "Group enriched" "Detected in many" 5 "endometrial cancer: 6.3;prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA069981: " "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 14.1 1.6 6.8 1.4 4.3 1.1 3.8 7.3 8.8 2.5 1.9 1.1 0.1 1.3 1.0 1.0 0.9 1.0 2.9 3.9 4.9 5.0 1.3 1.2 1.1 1.1 3.3 4.3 1.0 1.2 1.1 1.1 0.8 2.4 10.9 1.0 1.3 3.0 1.2 7.0 0.9 1.1 0.9 1.4 0.9 1.0 1.4 1.9 0.0 1.0 2.2 0.9 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 5.6 2.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.3 0.0 2.2 0.0 0.0 0.4 0.0 0.0 4.9 4.9 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.8 1.4 0.0 9.3 0.2 0.0 1.3 0.1 0.0 4.3 0.1 1.1 1.8 1.1 0.1 0.7 0.0 0.0 0.3 3.4 1.1 2.2 0.7 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.8 4.3 7.3 8.8 4.9 5.0 3.3 4.3 2.4 1.9 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Cell line enriched" "Detected in many" 6 "AN3-CA: 513.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.1 1.7 8.3 513.1 0.1 0.0 0.0 3.5 1.6 3.6 1.7 9.8 4.8 1.5 1.1 0.1 0.4 0.1 0.0 1.4 0.0 0.0 2.7 2.6 1.6 14.1 0.1 0.0 0.2 0.1 2.7 0.0 1.3 3.0 0.0 6.9 4.4 0.3 3.4 5.2 0.8 0.0 92.3 1.0 3.9 2.9 29.2 0.0 3.0 10.0 0.0 0.3 2.3 1.3 1.2 0.0 11.5 0.2 0.1 0.3 0.0 4.4 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" 178550000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: " "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.4 26.1 0.0 0.1 2.0 2.0 1.8 26.0 10.6 14.0 11.8 5.4 49.6 2.0 43.3 16.3 12.0 4.5 24.7 28.7 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.1 9.6 0.9 0.2 25.9 1.0 0.0 0.0 3.9 26.7 0.0 22.0 0.0 24.6 5.2 3.8 0.0 10.7 3.4 10.1 0.0 0.2 17.7 20.9 7.4 11.0 20.1 0.5 4.0 0.2 23.0 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: , HPA037998: " "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favourable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favourable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favourable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.2 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.2 12.5 25.2 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.8 16.3 38.9 24.1 17.3 22.7 22.6 24.1 21.9 22.5 19.5 28.5 16.5 34.0 18.6 23.2 17.5 22.4 29.5 17.2 42.8 28.2 25.9 15.3 10.4 32.3 12.3 12.4 14.9 17.8 21.6 27.5 19.7 27.1 14.1 19.9 25.5 18.6 19.9 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 METAP2 "MAP2, MNPEP, p67" ENSG00000111142 "Methionyl aminopeptidase 2" P50579 12 95473520-95515839 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013025, HPA019095" Enhanced Supported "Plasma membrane,Cytosol" 22000 "Plasma membrane, Cytosol" "CAB013025: AB_2533993, HPA019095: AB_1853823" "unprognostic (1.91e-1)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.44e-1)" "unprognostic (3.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (4.51e-6)" "unprognostic (1.25e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-2)" "unprognostic (8.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" 24.2 36.4 25.8 49.9 33.7 39.1 25.1 25.9 32.3 23.9 26.2 16.3 102.5 16.6 28.7 25.4 30.1 22.5 21.7 30.7 29.6 24.0 26.0 46.8 22.1 32.6 29.1 23.4 29.4 31.9 21.0 36.1 25.1 42.9 24.2 24.0 10.1 22.1 140.7 94.4 28.7 19.7 26.1 48.2 25.2 22.2 26.3 27.7 32.1 24.1 29.0 55.2 33.4 37.3 39.4 31.8 21.3 27.1 25.7 32.0 16.2 33.2 28.1 30.1 23.3 18.3 29.4 23.1 32.8 23.0 32.4 23.0 40.8 16.0 97.0 20.7 23.4 21.5 33.8 25.1 37.3 23.0 29.1 43.4 21.4 28.7 19.6 53.7 21.3 25.4 26.9 30.6 30.1 34.4 56.1 11.0 24.0 21.9 39.7 36.7 36.8 42.0 31.3 26.0 31.8 22.2 35.4 23.4 30.7 29.2 23.9 28.7 28.8 25.6 29.5 18.6 18.1 20.8 34.6 15.9 41.4 104.0 10.6 30.3 23.4 21.3 27.1 11.1 23.8 19.1 29.2 39.4 26.7 26.6 24.4 37.6 32.0 29.7 1.2 25.7 22.3 31.8 25.3 16.2 25.8 33.7 25.9 32.3 29.6 24.0 29.1 23.4 42.9 27.7 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell line enhanced" "Detected in many" "MCF7: 52.2;PC-3: 40.4" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in many" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: " "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.1 4.3 22.0 7.7 4.3 7.0 5.2 2.6 2.1 1.3 3.2 6.5 0.4 12.3 3.7 9.7 0.6 5.1 0.3 1.4 9.7 0.8 4.0 16.6 4.7 1.8 2.8 10.4 5.6 0.6 1.3 0.7 1.5 0.5 1.5 52.2 0.7 6.4 1.6 40.4 7.1 5.0 7.1 5.4 0.7 6.9 8.7 2.1 5.8 26.8 8.7 3.7 2.4 6.0 11.4 6.9 4.5 3.3 0.9 0.4 9.4 1.4 14.1 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 METTL15 "FLJ33979, METT5D1" ENSG00000169519 "Methyltransferase like 15" A6NJ78 11 28108248-28527041 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039885 Approved "Golgi apparatus,Plasma membrane,Actin filaments" "Golgi apparatus, Plasma membrane" "Actin filaments" "HPA039885: " "unprognostic (2.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-2)" "unprognostic (2.66e-2)" "unprognostic (1.83e-1)" "unprognostic (4.17e-2)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-3)" "unprognostic (2.28e-1)" "prognostic favourable (7.95e-5)" "unprognostic (7.77e-2)" "unprognostic (1.38e-1)" "unprognostic (6.58e-2)" "unprognostic (6.84e-3)" 10.3 17.5 11.2 13.4 11.2 4.3 12.4 16.0 13.4 13.6 13.4 12.2 15.0 9.9 21.0 14.8 10.8 11.8 12.3 14.7 11.3 12.0 15.4 17.9 9.6 9.5 10.5 10.1 12.3 11.4 18.8 32.6 11.1 13.6 12.9 13.8 15.5 12.4 13.7 16.9 10.0 9.8 13.3 12.7 9.8 10.3 11.8 11.2 16.5 15.3 11.0 14.3 10.6 9.8 6.4 3.3 6.0 2.7 7.6 6.8 2.9 7.2 7.8 7.9 6.0 9.8 15.9 5.5 8.9 6.8 9.0 9.3 5.2 4.9 16.6 5.3 7.3 6.1 10.3 9.1 17.5 10.2 9.1 5.2 5.8 6.0 11.0 9.7 4.7 8.9 13.6 5.0 13.1 8.7 11.0 7.6 10.6 4.9 6.7 6.1 6.1 5.8 3.7 17.2 6.0 13.5 4.1 7.0 5.8 7.3 6.6 10.4 13.0 6.0 6.5 8.3 6.4 10.5 7.8 5.1 6.0 9.7 11.7 9.9 8.9 3.1 2.7 6.0 4.2 1.7 5.3 6.4 5.2 5.5 3.0 3.3 5.6 6.8 1.3 7.6 2.2 3.3 5.5 2.9 11.2 11.2 16.0 13.4 11.3 12.0 10.5 10.1 13.6 11.2 METTL16 "METT10D, MGC3329" ENSG00000127804 "Methyltransferase like 16" Q86W50 17 2405562-2511891 "Enzymes, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020352, HPA059798" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA020352: AB_1853828, HPA059798: AB_2684128" "unprognostic (4.94e-3)" "unprognostic (2.86e-2)" "unprognostic (2.29e-2)" "unprognostic (5.66e-3)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (3.35e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-1)" "prognostic favourable (3.06e-4)" "unprognostic (5.35e-2)" "unprognostic (4.85e-3)" "unprognostic (2.91e-2)" "unprognostic (2.32e-1)" "unprognostic (1.61e-1)" "unprognostic (2.68e-2)" 12.7 14.0 13.1 11.0 15.2 13.1 14.1 22.5 14.4 14.9 13.1 19.8 11.2 8.6 21.6 10.6 11.0 16.5 9.6 12.4 12.6 9.7 11.5 6.9 12.2 13.1 18.3 9.7 22.5 13.5 19.7 22.8 7.5 13.6 13.5 10.4 18.3 12.1 13.1 14.2 14.7 10.4 16.5 14.6 11.1 11.2 11.0 17.5 15.7 16.5 8.8 17.5 15.3 12.7 5.7 3.1 2.3 3.2 2.0 8.1 2.0 6.0 16.1 9.1 8.8 6.9 8.7 8.5 7.7 6.6 8.8 7.3 21.3 3.9 18.9 8.3 6.9 8.7 21.0 10.5 12.0 7.2 13.3 9.7 13.2 9.7 7.5 8.9 7.9 7.3 10.0 12.1 17.8 9.0 12.6 10.2 5.8 6.5 12.7 5.3 10.4 6.8 21.3 9.6 8.5 6.3 5.4 4.8 7.6 11.4 6.3 6.7 7.9 5.7 6.5 8.0 5.2 11.3 11.1 6.0 7.3 13.5 10.9 7.5 10.9 2.3 3.2 1.2 5.7 2.1 7.2 5.7 5.6 5.5 2.2 5.0 8.1 5.9 0.1 2.0 1.5 3.1 3.5 2.0 13.1 15.2 22.5 14.4 12.6 9.7 18.3 9.7 13.6 17.5 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794966 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favourable (3.28e-4)" 8.7 7.3 12.1 9.9 9.0 3.8 11.5 13.5 11.8 6.5 6.8 3.5 8.4 5.6 7.7 9.8 7.8 8.2 5.2 10.2 8.5 6.8 8.6 8.5 5.9 16.5 11.1 10.1 10.4 9.4 31.9 9.4 6.3 9.2 11.2 6.8 3.4 8.4 7.5 5.0 6.5 9.2 6.3 12.7 14.3 8.2 6.7 11.2 9.8 10.0 8.0 11.8 7.8 8.9 13.4 5.4 12.2 5.8 12.4 19.3 9.8 9.1 5.3 8.7 6.0 5.1 9.5 6.0 4.3 5.0 5.5 4.8 6.8 15.0 15.7 12.0 5.7 10.6 8.7 9.8 7.5 9.4 7.0 11.2 4.8 5.5 10.5 11.8 5.2 4.3 10.4 5.6 6.2 10.5 11.8 7.5 7.4 4.5 12.5 8.1 10.9 13.4 9.3 8.6 11.8 8.9 9.2 6.5 9.9 9.2 10.4 12.7 13.8 13.0 4.7 7.0 6.7 6.9 10.0 14.6 19.0 21.3 5.1 9.5 7.0 9.3 5.2 12.2 14.6 5.8 18.5 12.1 16.3 17.0 5.4 13.4 19.3 18.3 3.0 12.4 3.4 4.2 18.4 9.8 12.1 9.0 13.5 11.8 8.5 6.8 11.1 10.1 9.2 11.2 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 7.9 7.5 12.5 9.4 5.5 5.8 24.2 4.5 5.5 7.3 7.4 14.3 12.8 11.5 9.9 3.4 4.6 17.8 5.9 6.0 6.7 12.2 13.5 12.0 23.4 9.8 17.6 13.7 5.2 7.9 3.6 6.1 8.1 19.3 6.8 4.8 12.9 17.7 30.2 20.6 5.3 13.1 5.2 16.8 10.4 6.8 14.8 12.1 9.6 3.4 9.3 4.6 26.2 4.2 6.3 13.9 5.8 7.8 10.1 12.7 23.8 10.4 13.9 9.4 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 METTL22 "C16orf68, FLJ12433, MGC2654" ENSG00000067365 "Methyltransferase like 22" Q9BUU2 16 8621683-8649654 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040803, HPA059882, HPA074173" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA040803: AB_10795479, HPA059882: , HPA074173: " "unprognostic (1.74e-1)" "unprognostic (6.50e-2)" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (7.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-3)" "unprognostic (3.82e-2)" "prognostic unfavourable (2.79e-8)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" "unprognostic (1.15e-2)" "unprognostic (8.90e-2)" 8.4 10.6 5.4 10.5 8.8 12.5 8.0 17.1 10.2 9.6 10.9 10.9 13.6 9.2 13.0 12.2 7.6 8.6 9.8 15.0 7.0 7.3 7.1 9.5 6.5 10.8 7.9 6.8 10.8 10.6 7.3 7.6 9.4 9.3 10.5 7.9 10.2 9.5 15.6 45.2 15.7 6.4 11.4 6.3 8.1 9.8 27.8 9.3 10.4 10.1 10.0 9.1 9.7 9.9 1.1 2.8 12.6 3.0 1.8 1.6 1.4 3.7 7.7 8.8 8.4 3.3 8.5 7.6 6.4 3.4 7.7 8.7 7.5 8.7 5.8 5.8 5.6 7.1 5.5 10.2 5.1 8.5 7.5 6.0 13.5 21.2 10.0 6.1 4.6 8.5 7.4 8.4 9.3 6.1 8.1 6.0 5.8 13.3 6.3 14.8 4.7 7.6 9.6 6.6 12.1 3.8 4.0 10.8 7.2 5.6 6.6 4.2 7.2 5.1 4.7 9.1 8.0 7.4 2.9 8.1 4.3 9.1 3.3 8.2 4.2 1.4 3.0 2.4 1.3 2.3 1.2 1.1 1.1 1.3 2.8 1.1 1.5 0.7 12.6 1.8 2.5 1.6 1.6 1.4 5.4 8.8 17.1 10.2 7.0 7.3 7.9 6.8 9.3 9.3 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358497-82479236 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Uncertain Uncertain "Plasma membrane,Mitochondria,Cytosol" "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 8.3 9.2 8.7 8.5 8.1 5.0 11.1 23.6 8.3 8.2 7.7 8.1 9.0 7.5 8.2 9.1 10.0 8.0 5.8 8.7 9.1 3.1 8.8 6.3 6.5 8.1 7.6 5.7 10.8 6.5 7.8 25.9 6.8 7.6 8.0 9.2 5.8 10.5 6.0 10.7 9.7 8.2 7.5 5.8 8.6 6.7 11.0 13.0 9.9 10.2 8.7 7.4 8.8 8.5 7.9 13.2 14.4 7.6 9.8 7.6 3.8 1.4 3.3 4.5 0.9 5.1 6.0 4.5 7.0 4.0 3.7 2.7 4.3 3.8 8.5 1.5 5.1 1.5 8.8 1.1 2.4 8.1 7.5 4.1 1.8 4.0 3.1 7.1 4.9 4.4 4.1 1.2 0.0 7.6 3.0 3.8 3.7 4.9 3.0 6.3 6.8 1.0 1.7 2.7 4.4 11.4 5.1 3.3 2.6 2.5 4.2 4.4 3.7 6.8 2.8 1.7 1.6 2.8 3.9 4.9 2.9 3.2 2.8 4.4 3.9 14.4 7.6 4.4 4.9 6.4 7.3 6.4 5.3 4.0 6.0 7.9 7.6 5.4 13.6 9.8 5.7 13.2 4.5 3.8 8.7 8.1 23.6 8.3 9.1 3.1 7.6 5.7 7.6 13.0 METTL5 HSPC133 ENSG00000138382 "Methyltransferase like 5" Q9NRN9 2 169810081-169824931 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038223 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA038223: AB_10672509" "unprognostic (2.55e-2)" "unprognostic (8.41e-2)" "unprognostic (4.73e-1)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-3)" "prognostic unfavourable (6.64e-5)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-2)" "prognostic unfavourable (3.06e-8)" "unprognostic (8.53e-2)" "unprognostic (1.70e-1)" "unprognostic (1.95e-2)" "unprognostic (6.87e-3)" 28.9 25.2 30.1 15.8 29.3 17.6 31.2 18.1 30.2 19.8 28.6 14.2 14.9 17.7 18.8 40.4 29.0 17.9 17.3 38.2 25.6 28.5 27.8 29.2 15.8 19.4 25.6 20.8 16.6 32.5 18.0 24.2 22.3 30.2 25.3 26.5 11.9 27.9 20.9 50.1 19.6 24.9 38.4 26.5 17.8 25.1 14.1 23.9 18.1 26.1 33.9 22.3 31.6 26.5 28.6 21.9 15.0 14.1 18.8 29.1 15.1 23.9 13.3 19.3 21.4 17.7 26.6 31.8 20.3 19.2 24.8 20.0 41.3 28.4 30.7 24.9 16.6 25.1 26.3 42.6 35.0 23.6 18.9 46.3 10.9 45.0 24.2 58.0 22.9 19.5 57.2 31.4 38.7 23.0 43.0 25.8 31.5 23.2 27.8 47.1 26.1 25.3 28.2 18.1 47.5 42.6 22.1 23.5 17.6 13.1 20.7 35.3 19.5 26.2 15.7 27.1 22.1 16.9 26.0 25.2 38.0 51.0 22.6 28.4 24.4 15.0 11.7 9.0 19.0 14.1 29.1 28.6 26.3 25.2 14.2 24.1 27.5 24.9 3.5 18.8 12.9 21.9 24.9 15.1 30.1 29.3 18.1 30.2 25.6 28.5 25.6 20.8 30.2 23.9 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681546-55684611 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0" "Group enriched" "Detected in many" 56 "B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038644 Enhanced Supported Vesicles,Microtubules Microtubules Vesicles "HPA038644: " "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favourable (2.37e-4)" "unprognostic (2.43e-1)" 1.3 0.9 1.2 2.1 0.9 0.1 0.5 0.5 2.2 0.4 15.2 3.0 0.0 15.2 0.4 35.7 0.3 0.7 8.1 46.1 4.6 0.6 12.6 82.4 0.8 0.8 1.8 1.5 0.3 1.2 0.0 1.3 4.3 3.2 0.3 6.0 1.4 0.4 0.1 2.7 0.5 44.7 0.4 1.0 3.1 1.0 0.4 0.6 0.0 1.0 0.1 0.0 0.3 0.3 2.5 8.6 0.0 5.4 0.0 0.0 0.4 0.2 9.1 0.0 0.2 1.9 6.7 0.1 0.3 1.3 0.1 0.6 11.8 23.9 4.8 17.9 0.5 0.0 1.7 0.1 0.3 0.0 2.3 0.4 1.5 11.6 0.0 0.2 0.0 1.7 0.0 0.4 0.0 0.0 0.1 0.0 19.8 8.2 0.0 0.1 2.4 1.1 0.0 0.6 1.1 0.2 0.0 0.0 0.1 0.9 0.0 1.6 1.6 17.5 0.0 1.3 1.6 0.2 1.2 0.0 0.2 1.4 18.2 4.1 0.1 0.0 1.0 0.0 0.0 5.4 0.0 0.7 0.0 0.0 8.6 2.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.4 1.2 0.9 0.5 2.2 4.6 0.6 1.8 1.5 3.2 0.6 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: , HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.4 10.3 26.0 22.5 26.9 48.8 9.3 21.6 31.0 17.1 20.7 7.4 24.6 23.7 18.5 37.8 8.4 17.2 19.3 23.4 18.0 14.1 10.2 10.4 27.5 19.3 8.0 21.3 28.7 20.6 17.6 23.1 32.6 15.1 19.5 33.8 14.9 20.8 13.4 23.3 10.7 30.4 20.3 21.5 28.2 13.2 15.1 27.3 18.3 12.7 46.0 12.9 4.2 18.4 28.5 12.4 17.3 13.3 16.6 26.6 19.0 27.9 19.9 20.0 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Cell line enhanced" "Detected in many" "AN3-CA: 32.7;HEL: 24.0;SH-SY5Y: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.6 32.7 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.1 1.5 0.6 1.9 0.2 4.1 0.1 1.3 0.3 2.7 24.0 1.4 1.0 1.4 0.2 7.6 0.5 0.6 1.0 2.0 3.7 1.1 0.0 3.1 0.8 3.9 2.0 11.2 0.3 5.5 5.2 0.8 0.0 0.0 6.9 13.4 1.7 0.3 1.1 0.1 0.4 3.4 4.5 5.3 2.5 1.5 3.1 1.6 1.8 1.4 2.4 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824802 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavourable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favourable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 23.7 32.9 23.8 25.4 25.0 12.5 24.3 35.5 29.2 22.5 19.5 17.7 20.0 15.9 25.2 27.2 28.0 21.2 16.8 21.9 24.6 21.2 28.1 20.0 16.8 26.7 21.5 30.9 29.2 20.0 38.5 33.0 25.2 24.0 26.3 20.7 15.5 21.9 21.8 33.3 24.4 19.3 21.5 26.7 23.9 21.0 21.7 27.3 33.9 28.2 19.2 34.1 24.1 28.2 21.2 20.3 34.3 21.5 29.6 26.0 15.1 15.2 15.9 27.7 18.2 23.6 14.9 17.1 24.7 17.2 20.1 23.5 24.7 10.0 16.4 23.6 15.2 27.8 24.6 20.1 23.8 27.7 14.8 39.8 28.7 18.5 18.5 23.6 21.3 13.8 22.1 19.1 17.4 19.6 35.9 14.1 23.9 11.4 19.2 17.9 19.5 13.9 28.2 27.8 10.5 20.8 22.9 17.6 17.3 21.7 18.6 10.0 28.0 15.2 18.5 20.4 14.5 22.4 19.9 17.4 41.9 35.9 17.2 22.6 14.9 21.4 15.8 34.3 23.4 21.5 22.9 21.2 23.4 22.0 20.3 18.6 24.1 23.5 14.4 29.6 17.1 16.7 26.0 15.1 23.8 25.0 35.5 29.2 24.6 21.2 21.5 30.9 24.0 27.3 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: " "unprognostic (6.02e-2)" "prognostic unfavourable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.5 12.5 21.3 22.3 19.2 18.0 20.9 17.4 18.6 18.1 23.5 18.8 21.8 13.8 20.1 16.3 21.6 20.0 21.7 29.0 6.2 13.1 9.0 19.2 6.8 18.3 16.1 10.6 19.4 21.5 21.7 18.5 25.3 10.3 15.0 15.7 6.3 8.9 3.7 11.0 7.4 8.6 25.2 12.6 11.7 13.6 22.0 24.5 19.0 21.5 17.1 22.6 8.0 23.0 23.6 16.5 13.0 17.6 15.0 19.3 13.0 12.0 11.2 18.5 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.9" "Cell line enhanced" "Detected in many" "HMC-1: 14.3;RT4: 23.4;SK-BR-3: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306" Approved Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: " "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favourable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 15.0 1.3 19.6 2.7 10.2 4.9 19.4 11.4 2.1 21.1 4.2 1.0 4.9 32.9 1.2 4.0 2.6 1.9 15.4 11.1 25.6 29.5 2.7 1.2 21.8 10.0 1.1 1.6 5.7 3.3 5.5 21.1 2.9 2.2 17.5 2.0 11.7 4.2 19.7 1.1 3.9 16.4 1.7 1.3 30.6 20.8 0.0 2.8 0.2 1.0 11.9 1.5 0.0 0.7 7.9 0.8 0.0 0.8 6.9 0.2 3.5 1.9 1.9 1.6 0.8 0.7 3.8 0.5 1.8 1.6 1.2 0.2 0.0 0.1 5.9 1.8 6.8 0.8 0.8 0.0 2.6 0.0 3.7 1.4 0.9 0.0 14.3 1.1 2.1 0.2 0.6 0.2 0.5 0.7 3.6 2.0 0.6 0.5 2.0 3.0 0.0 1.1 0.0 5.1 23.4 1.6 3.5 3.2 21.6 6.9 1.2 0.0 0.1 1.8 7.1 3.5 7.3 0.3 0.0 0.0 4.8 0.7 7.1 7.9 0.2 2.1 0.8 0.8 0.4 0.0 0.7 0.2 0.3 0.0 0.3 0.1 4.9 0.0 0.0 0.7 0.1 6.9 15.0 19.6 4.9 15.4 15.4 11.1 21.8 10.0 21.1 20.8 MFHAS1 "LRRC65, MASL1, ROCO4" ENSG00000147324 "Malignant fibrous histiocytoma amplified sequence 1" Q9Y4C4 8 8783354-8893645 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051213, HPA054471" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051213: , HPA054471: " "unprognostic (1.33e-1)" "unprognostic (4.46e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.95e-1)" "unprognostic (8.91e-3)" "unprognostic (2.70e-2)" "unprognostic (2.68e-3)" "unprognostic (9.23e-3)" "unprognostic (7.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.81e-1)" "unprognostic (2.01e-3)" "unprognostic (5.93e-2)" "unprognostic (4.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.81e-1)" 8.0 2.7 10.1 14.9 10.2 12.5 5.8 10.3 10.0 8.7 16.6 5.0 5.0 7.6 7.7 4.8 7.6 9.9 10.7 7.6 10.0 6.5 15.8 10.5 12.5 12.1 6.2 4.7 6.8 6.3 6.2 3.3 11.1 7.4 8.9 14.9 5.4 7.6 6.1 4.4 8.5 9.5 10.4 3.6 13.5 9.0 7.6 5.2 24.9 10.8 3.6 10.6 9.3 15.0 1.1 0.5 0.0 0.3 0.4 3.9 0.9 7.7 5.9 3.6 2.7 3.4 4.4 11.9 3.2 7.0 2.3 3.2 9.4 1.5 11.5 4.0 3.1 2.6 3.7 2.9 2.1 14.8 3.3 0.8 2.2 6.1 4.0 3.2 1.2 2.3 6.3 3.2 3.2 5.2 5.3 0.0 1.9 2.8 50.5 2.9 7.0 2.5 6.9 5.5 1.8 16.5 8.1 5.7 4.6 1.9 3.0 5.1 2.0 4.5 2.2 2.8 4.3 11.4 6.2 0.6 2.7 9.0 5.3 4.4 1.7 0.0 0.3 0.0 2.5 0.1 2.1 1.1 3.9 2.2 0.5 1.0 1.9 1.7 0.0 0.4 0.0 0.1 3.1 0.9 10.1 10.2 10.3 10.0 10.0 6.5 6.2 4.7 7.4 5.2 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057924, HPA065858" Approved Approved Nucleoplasm,Nucleoli 14000 Nucleoplasm Nucleoli "HPA057924: , HPA065858: " "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.7 6.3 1.6 4.9 8.6 8.1 10.2 23.1 10.4 8.2 8.1 2.6 14.6 4.1 17.0 14.8 7.7 4.0 5.1 7.7 16.4 10.7 11.1 4.8 1.1 9.3 40.9 27.8 12.1 6.7 7.4 2.0 6.4 8.6 8.5 14.6 3.4 2.5 12.0 1.6 16.2 5.5 2.4 36.3 3.0 3.9 4.8 7.2 17.1 13.2 4.1 10.4 16.0 21.1 11.8 4.5 17.4 11.3 27.1 19.0 2.3 14.8 29.6 8.2 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA043209: " "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavourable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.7 12.0 3.4 8.8 5.9 4.2 9.6 11.7 5.8 5.7 6.6 6.3 30.7 2.2 6.2 7.3 11.9 3.1 17.0 1.6 14.3 10.8 4.8 10.3 6.6 9.9 15.2 7.0 6.4 10.0 6.5 4.1 6.5 6.6 4.7 4.3 13.7 4.3 70.3 11.4 14.5 5.3 1.7 10.5 8.6 7.8 9.1 10.9 2.8 8.2 12.3 21.6 28.9 9.6 4.6 8.1 5.8 9.3 3.1 1.4 3.4 13.4 38.9 7.3 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.3;WM-115: 111.4" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA042149: , HPA043088: " "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favourable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavourable (6.61e-4)" "prognostic unfavourable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favourable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 16.6 13.5 3.3 8.8 6.9 5.4 12.0 10.2 5.5 12.0 13.2 5.7 5.7 4.7 7.8 5.4 10.5 4.3 5.3 4.3 10.3 12.2 2.7 43.2 5.9 8.7 5.9 9.3 4.8 8.0 12.3 2.9 3.2 13.1 6.8 3.0 10.0 5.8 10.6 6.2 11.0 4.2 4.8 19.9 5.0 7.2 12.7 6.4 20.3 9.5 58.3 3.2 12.4 13.3 5.4 8.1 22.2 11.6 7.9 4.4 4.3 24.1 15.2 111.4 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favourable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavourable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 3.8 3.3 8.8 5.9 15.7 9.0 2.6 18.0 18.7 2.4 7.0 8.5 0.4 10.2 4.3 1.8 3.0 2.4 4.7 5.2 9.0 6.5 3.3 5.7 14.1 5.6 7.9 8.7 2.3 5.1 2.8 4.4 7.2 8.2 3.1 6.4 3.9 3.0 2.3 3.9 17.4 7.5 4.9 5.2 6.9 7.1 5.8 8.6 2.3 5.7 1.8 6.7 3.1 2.5 5.0 7.5 5.5 7.2 2.2 5.8 3.4 9.3 4.3 3.3 7.9 0.3 0.3 5.1 1.9 4.9 3.7 8.7 8.5 12.9 8.4 9.8 0.7 11.7 6.1 5.0 1.4 10.5 5.5 10.3 6.1 4.4 8.5 5.2 10.1 4.3 2.1 2.1 3.8 4.3 2.3 4.6 0.3 1.9 8.7 3.4 5.6 4.2 10.6 0.5 1.4 1.7 2.5 8.2 7.8 1.8 1.0 4.2 4.8 3.5 1.3 1.7 2.1 2.1 2.6 1.6 4.1 10.9 9.6 8.6 2.4 0.7 7.2 5.5 5.2 5.3 5.2 5.0 5.0 4.1 7.5 2.8 5.2 5.8 4.4 2.2 3.0 0.8 1.4 3.4 8.8 15.7 18.0 18.7 9.0 6.5 7.9 8.7 8.2 8.6 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.8 13.1 10.3 28.9 20.7 20.9 25.3 22.0 22.6 22.2 8.4 31.2 31.3 15.1 21.8 57.6 15.6 16.2 22.0 22.3 8.4 10.8 16.1 12.6 20.5 33.9 20.0 19.0 24.4 23.9 18.4 19.3 20.3 18.7 30.0 19.7 24.8 19.5 19.2 13.5 12.5 30.2 10.1 24.0 20.1 12.6 16.7 21.6 25.5 26.8 11.6 20.1 20.6 23.7 16.7 36.3 23.4 20.7 25.6 8.6 21.1 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.5;THP-1: 58.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 11 "dendritic cells: 16.7;monocytes: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favourable (2.33e-4)" 2.0 0.9 6.0 1.6 7.2 3.3 6.2 2.4 6.5 1.6 5.6 4.3 96.9 6.4 4.3 45.0 5.0 1.5 1.2 0.7 7.6 6.1 7.2 87.9 15.8 1.1 7.5 2.6 0.8 0.5 0.3 3.0 111.3 7.8 1.0 2.5 2.0 1.7 121.2 0.3 27.0 20.4 1.8 7.3 0.8 1.0 17.7 2.3 0.2 2.9 4.7 1.7 2.6 4.6 1.1 16.7 0.9 9.3 0.1 0.1 2.3 2.1 0.9 4.4 6.6 3.1 0.6 0.0 2.0 3.9 4.5 5.4 0.2 1.1 13.0 1.2 1.0 5.2 4.3 7.5 3.5 1.6 2.1 1.5 0.0 0.0 10.5 2.3 7.7 3.5 4.7 18.5 7.6 1.1 0.0 3.3 2.0 0.2 3.5 3.5 3.5 1.6 2.5 6.5 3.0 0.7 6.1 1.6 2.4 1.5 11.1 1.1 0.5 58.2 0.7 1.0 1.9 3.3 8.5 0.6 1.1 2.9 10.4 8.8 3.2 0.0 9.3 0.9 0.1 4.6 0.1 1.1 0.0 0.1 10.3 0.2 0.0 0.0 0.5 0.1 0.8 16.7 0.0 2.3 6.0 7.2 2.4 6.5 7.6 6.1 7.5 2.6 7.8 2.3 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" Cytosol "Nucleoplasm, Actin filaments" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favourable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.5 6.5 0.2 2.3 4.8 6.2 9.0 5.4 11.0 3.7 4.7 2.4 13.4 16.5 2.6 11.3 17.9 3.2 9.5 4.2 33.4 4.9 8.8 6.4 1.2 1.9 3.4 2.8 0.9 17.3 5.4 3.6 1.3 2.2 18.4 0.9 4.0 16.0 0.7 1.5 7.0 3.6 0.5 14.1 7.0 19.3 21.0 5.4 7.7 18.2 10.5 5.9 4.0 5.4 0.6 1.3 7.2 8.3 8.4 3.5 5.9 6.0 7.2 2.9 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favourable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.0 8.1 8.2 4.3 11.9 3.9 12.2 11.2 6.9 8.4 6.3 11.8 9.0 6.7 4.7 7.8 6.6 7.1 5.0 5.9 6.2 2.1 7.6 5.8 8.6 8.1 5.2 11.5 7.6 4.3 1.7 1.4 4.6 4.6 0.5 4.5 5.8 11.8 7.3 2.6 7.8 7.9 3.3 4.6 3.4 4.5 2.7 2.8 10.1 5.8 11.4 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MGA, MAX dimerization protein" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: " "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 9.3 11.3 13.8 13.6 15.3 14.3 13.0 28.2 16.9 14.5 10.1 13.3 12.2 6.8 14.2 11.5 9.8 11.3 7.8 10.1 11.2 7.7 10.1 8.5 8.5 12.7 18.7 10.5 22.7 12.0 18.0 27.6 12.4 13.7 11.0 9.7 7.2 10.3 10.8 11.8 11.2 10.6 11.8 16.1 12.5 9.8 16.4 14.7 22.4 13.9 5.3 13.4 11.6 11.5 5.0 4.1 4.9 4.9 9.8 5.0 1.5 1.4 8.4 10.6 6.9 8.3 6.6 8.5 4.2 4.2 5.0 5.0 8.9 4.9 9.9 7.6 4.8 5.8 16.3 3.6 6.9 4.7 5.3 21.0 13.8 7.8 7.4 19.2 10.5 5.0 4.6 6.9 6.9 6.4 24.4 4.5 4.4 4.1 11.6 7.5 6.5 4.3 13.2 10.8 5.1 2.6 6.0 10.0 9.8 14.9 5.2 2.7 4.2 12.3 6.8 6.1 8.6 6.2 4.9 6.2 9.2 9.7 3.8 7.4 3.0 4.9 2.3 2.5 4.7 1.8 4.6 4.8 3.7 5.0 2.4 5.0 3.9 4.3 1.2 9.8 4.9 4.1 1.8 1.5 13.8 15.3 28.2 16.9 11.2 7.7 18.7 10.5 13.7 14.7 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Cell line enriched" "Detected in single" 7 "RH-30: 5.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Low region specificity" "Detected in all" HPA055697 Enhanced Approved Vesicles,Cytosol Vesicles Cytosol "HPA055697: " "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell line enhanced" "Detected in many" "ASC diff: 335.0;ASC TERT1: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favourable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.0 7.1 8.3 335.0 129.3 0.0 24.6 25.2 13.4 20.9 11.3 50.2 0.0 3.0 31.4 0.1 18.6 39.3 12.2 0.0 2.5 10.2 16.6 39.9 78.3 19.8 0.0 83.9 43.9 40.9 43.2 23.5 7.2 0.0 28.8 6.1 0.0 8.0 59.7 23.8 0.0 4.2 13.5 30.2 59.3 1.3 1.0 38.4 24.6 1.0 26.6 11.2 14.8 13.8 1.8 27.1 31.7 0.0 0.0 0.0 45.5 31.6 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 12.1 9.1 15.3 7.9 20.6 5.9 15.7 16.1 17.4 16.6 10.9 16.3 9.7 6.9 19.1 13.7 11.4 11.5 12.0 9.4 16.3 12.9 15.7 14.1 10.1 9.6 17.4 16.5 17.2 11.7 18.4 11.5 14.9 15.5 14.7 10.1 14.6 12.0 12.6 9.6 12.5 8.4 17.9 13.8 9.4 10.7 11.5 18.1 13.9 19.1 9.8 10.6 13.0 13.8 1.2 1.2 3.5 1.7 2.5 2.0 0.6 8.4 3.3 16.5 11.4 8.8 10.6 3.9 6.8 7.6 4.9 7.1 4.9 3.1 7.2 6.3 9.4 5.7 9.6 9.2 11.1 9.4 4.5 8.0 4.3 6.8 7.2 16.3 3.4 6.8 10.2 5.7 14.7 12.2 11.0 21.3 7.5 4.1 7.8 6.2 4.2 4.4 51.5 13.6 17.8 8.3 7.5 5.4 13.3 11.7 5.4 6.0 3.9 10.7 10.4 12.5 6.3 5.2 9.0 11.2 3.9 11.1 5.3 10.4 7.4 3.5 1.7 0.6 1.0 0.9 1.2 1.2 1.5 1.0 0.6 0.6 1.2 0.9 1.5 2.5 0.5 1.2 2.0 0.6 15.3 20.6 16.1 17.4 16.3 12.9 17.4 16.5 15.5 18.1 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell line enhanced" "Detected in many" "U-138 MG: 39.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.6 6.2 0.2 1.4 1.6 2.9 7.4 18.6 21.1 7.3 11.4 13.0 8.4 0.3 4.0 13.0 8.2 2.2 30.0 18.2 13.5 1.5 11.0 1.2 0.9 14.1 2.0 1.4 5.2 5.3 32.2 31.5 16.6 19.3 0.5 11.7 0.7 0.1 1.0 0.4 5.8 0.1 7.4 7.8 1.5 14.7 6.1 0.5 6.1 17.1 1.2 1.7 0.6 29.7 39.8 15.0 6.5 16.2 0.4 0.9 0.4 24.2 2.9 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: " "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.7 15.1 8.0 13.0 6.0 7.8 9.7 12.1 13.2 17.2 13.6 14.4 1.9 15.4 6.2 16.5 15.9 11.8 14.0 16.7 14.9 11.2 16.0 16.1 6.0 4.0 7.1 8.6 6.3 11.2 18.1 19.2 10.0 17.5 9.9 6.3 12.3 6.7 4.4 5.5 9.9 9.4 12.0 0.7 13.8 9.7 21.2 8.3 17.1 10.9 25.8 4.3 3.0 17.6 17.7 11.4 12.1 25.2 6.5 11.5 20.6 15.4 3.2 50.7 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 MICALL1 "KIAA1668, MICAL-L1, MIRAB13" ENSG00000100139 "MICAL like 1" Q8N3F8 22 37905657-37942822 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043480, HPA051956" Uncertain Supported "Cell Junctions,Centriolar satellite,Cytosol" "Cell Junctions, Centriolar satellite, Cytosol" "HPA043480: AB_10793950, HPA051956: " "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (4.94e-2)" "unprognostic (4.90e-1)" "unprognostic (1.57e-1)" "unprognostic (2.37e-1)" "prognostic unfavourable (3.08e-6)" "unprognostic (3.46e-2)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-3)" "unprognostic (6.61e-2)" "unprognostic (8.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" 8.0 4.8 5.3 10.1 10.3 6.3 12.6 5.9 7.3 19.1 25.2 21.4 17.6 6.1 21.3 11.0 32.3 11.1 14.4 6.0 7.5 5.5 6.4 5.7 11.8 9.2 17.4 5.1 6.8 14.2 19.2 4.3 29.6 12.5 15.3 7.5 8.7 13.4 25.2 8.5 24.4 9.2 43.5 18.7 5.9 28.5 7.4 11.1 5.3 9.4 15.5 13.5 21.4 17.5 2.8 3.3 2.3 1.6 4.1 2.6 1.6 10.7 6.0 6.5 7.0 6.5 5.6 26.0 15.3 8.7 15.0 11.3 8.2 5.8 4.7 4.7 10.1 28.0 5.0 29.9 10.9 8.0 13.2 1.9 6.3 8.0 10.7 5.3 5.4 4.7 46.8 17.9 37.2 10.3 3.3 4.5 13.1 5.1 1.3 2.4 2.3 4.5 7.1 12.4 2.5 3.9 29.9 4.5 8.0 9.5 8.4 8.1 5.0 5.1 14.2 25.2 20.8 16.7 12.4 4.6 1.5 3.0 22.8 2.4 12.2 0.4 1.1 0.6 1.8 1.6 2.3 2.5 1.4 2.2 1.7 2.8 2.6 1.3 2.3 4.1 0.6 3.3 0.9 1.6 5.3 10.3 5.9 7.3 7.5 5.5 17.4 5.1 12.5 11.1 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell line enhanced" "Detected in many" "U-266/70: 11.4;U-266/84: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA064618 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA064618: " "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavourable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.4 0.0 1.7 1.6 2.2 2.8 0.0 0.3 2.7 6.1 3.1 0.6 0.7 2.8 0.8 2.4 2.6 3.2 0.4 1.1 0.5 1.0 2.6 3.1 0.6 3.7 2.2 1.4 3.3 5.8 2.6 0.0 0.9 4.2 0.3 0.4 3.3 0.0 5.8 2.5 0.1 0.0 0.0 1.1 0.0 0.5 1.5 1.1 1.4 1.7 0.0 1.4 0.0 11.4 26.1 6.1 0.4 8.6 3.6 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: " "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 12.0 6.9 16.6 10.5 14.8 19.9 14.3 20.6 16.8 22.0 15.3 10.1 19.6 18.9 13.3 19.6 16.2 16.3 17.2 30.3 19.1 16.9 32.6 7.6 11.6 17.9 24.4 19.0 17.2 17.1 12.3 8.7 14.6 11.5 8.5 35.8 10.5 16.2 23.3 11.3 11.0 17.9 42.3 12.6 43.2 9.9 13.4 10.3 14.0 16.5 13.3 16.1 23.1 18.0 9.6 8.6 19.5 16.9 6.4 8.3 13.8 9.4 20.5 23.7 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favourable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 7.9 8.0 8.8 14.0 8.4 9.2 10.2 7.6 9.1 8.8 8.1 13.1 4.2 22.1 6.4 8.2 10.1 19.9 10.6 11.0 9.4 18.4 9.1 11.3 13.3 16.3 32.1 12.1 12.0 12.9 7.8 16.7 9.3 16.0 12.2 8.7 5.4 10.1 8.9 8.2 8.8 13.9 12.5 22.6 10.1 9.7 8.1 6.7 8.5 14.7 21.8 6.5 11.7 9.0 8.3 11.8 7.4 9.3 22.4 23.3 22.6 9.6 14.1 12.7 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavourable (2.89e-4)" "prognostic favourable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavourable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 15.5 6.8 9.1 9.3 11.8 4.3 9.7 14.4 12.5 8.6 7.5 10.0 6.6 9.8 12.0 7.8 9.4 7.9 8.5 9.1 9.8 6.7 6.4 3.4 12.5 8.5 9.1 7.8 8.5 11.6 3.7 9.8 13.5 9.1 10.9 3.3 8.3 12.9 10.9 17.0 18.4 9.3 6.4 6.4 17.2 10.3 31.5 12.1 4.6 8.3 7.1 6.6 9.1 16.5 2.2 6.6 6.4 5.8 1.6 3.3 3.0 8.8 5.6 5.0 5.8 1.8 2.8 10.9 7.3 3.5 5.5 5.8 8.6 2.8 4.6 3.9 3.8 7.5 3.2 4.3 1.7 11.0 15.6 2.7 4.5 6.5 5.5 0.0 21.9 3.6 3.3 4.5 1.6 6.2 7.7 0.0 3.0 9.3 7.2 9.9 13.0 0.0 6.3 1.6 1.2 2.6 5.0 8.1 7.3 4.2 3.2 7.2 3.6 4.9 6.5 7.5 5.3 11.4 8.0 13.4 6.6 3.7 7.1 3.9 7.4 6.4 5.8 4.2 2.0 5.2 1.8 0.9 2.7 3.0 6.6 2.2 3.3 2.2 0.5 1.6 5.8 3.7 1.1 3.0 9.1 11.8 14.4 12.5 9.8 6.7 9.1 7.8 9.1 12.1 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894004-23895227 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 127.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" 13800000 14000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 30.6 49.8 43.9 42.0 39.9 46.0 71.6 19.0 66.1 23.0 42.7 10.4 55.6 39.9 22.5 113.3 51.9 23.3 42.5 60.7 42.8 40.3 71.8 58.8 46.2 113.9 33.5 43.7 24.5 80.2 16.2 41.1 30.5 45.2 54.8 11.6 15.0 57.3 101.2 36.0 63.3 50.6 26.7 78.3 42.5 56.2 24.9 19.2 19.0 28.9 43.7 16.7 21.4 44.6 56.8 42.5 17.6 23.8 38.3 52.7 66.0 48.9 10.9 2.4 11.0 0.9 2.2 18.4 18.5 3.1 5.9 7.7 8.1 8.1 23.3 14.7 1.3 21.8 2.5 11.2 0.7 19.6 127.1 8.8 9.9 16.9 4.8 34.0 20.7 4.7 6.7 3.5 1.7 4.7 13.6 11.8 2.0 24.6 23.1 63.0 14.0 59.3 29.7 4.1 65.3 4.6 3.4 31.9 37.2 11.8 12.5 30.5 16.1 10.2 13.5 5.2 35.0 3.1 0.4 51.4 18.1 24.0 21.1 12.7 10.6 16.3 23.8 17.6 37.4 22.3 52.7 56.8 51.8 40.4 31.6 49.1 46.1 38.0 7.1 38.3 14.6 42.5 48.3 66.0 43.9 39.9 19.0 66.1 42.8 40.3 33.5 43.7 45.2 19.2 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA051222: " "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favourable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 11.8 21.0 4.7 10.9 7.6 2.2 6.7 3.0 8.6 6.1 4.2 7.4 13.4 18.5 5.5 4.8 9.5 5.7 10.6 4.6 9.1 14.4 9.1 9.1 6.5 8.4 8.0 10.7 2.1 16.7 4.2 17.4 12.6 12.0 22.6 1.6 23.1 25.5 19.1 2.1 10.3 16.6 6.0 25.2 12.3 6.5 7.0 10.3 6.2 16.4 15.2 30.3 18.7 4.8 3.1 7.6 3.9 6.1 33.1 8.5 15.6 5.8 14.2 4.1 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favourable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 10.1 14.3 7.7 11.5 10.2 17.3 6.8 17.6 16.0 5.6 17.2 8.9 14.6 23.7 7.6 8.7 11.5 7.1 13.3 24.4 7.9 11.6 7.6 7.4 5.2 7.5 9.0 10.9 8.4 6.8 7.5 8.5 3.1 9.4 9.3 5.5 8.7 11.1 12.3 13.0 9.8 21.6 9.0 7.6 7.1 9.9 7.0 7.2 8.0 9.6 5.3 10.8 10.0 9.8 2.8 3.9 8.5 3.1 1.2 6.5 2.2 4.0 8.3 2.6 13.0 7.1 3.7 5.7 7.2 5.5 8.4 5.3 7.1 8.4 6.1 3.3 5.6 19.2 3.5 5.4 1.3 5.6 5.1 4.4 16.1 5.2 7.9 4.9 10.1 5.2 4.3 7.5 3.9 5.7 6.4 2.6 4.5 10.6 4.9 10.3 5.9 12.0 10.2 7.6 10.0 4.4 7.8 8.2 5.8 8.0 12.9 4.5 9.2 5.4 5.7 5.4 6.2 9.1 5.5 3.5 5.0 5.6 7.7 4.0 6.4 8.5 2.6 2.4 3.0 3.1 6.5 2.3 2.2 3.9 2.9 2.8 2.2 1.3 4.8 1.2 1.7 3.9 1.9 2.2 7.7 10.2 17.6 16.0 7.9 11.6 9.0 10.9 9.4 7.2 MIIP "FLJ12438, IIp45" ENSG00000116691 "Migration and invasion inhibitory protein" Q5JXC2 1 12019466-12032045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "HDLM-2: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044948 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044948: AB_10795887" "unprognostic (1.36e-2)" "unprognostic (1.95e-2)" "unprognostic (5.02e-3)" "unprognostic (3.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.65e-3)" "unprognostic (7.16e-2)" "unprognostic (2.97e-1)" "unprognostic (4.03e-2)" "unprognostic (3.73e-3)" "unprognostic (6.56e-2)" "prognostic unfavourable (8.26e-7)" "unprognostic (8.02e-3)" "unprognostic (5.09e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 13.2 9.4 12.2 17.0 17.3 53.4 10.8 13.7 15.3 11.1 11.4 11.9 11.6 11.0 16.5 8.8 11.1 13.0 8.9 13.3 12.9 10.1 9.2 11.7 13.3 18.3 15.9 10.6 20.4 13.5 5.8 7.1 14.6 17.0 11.3 4.5 8.5 18.1 14.2 26.3 14.8 12.7 12.3 11.0 20.4 10.0 18.2 15.2 10.5 22.5 9.7 12.5 12.3 11.9 14.8 45.0 18.3 27.1 10.6 19.0 12.5 4.9 3.3 2.6 5.1 1.4 1.6 9.2 2.7 1.4 5.3 4.0 6.5 7.9 6.3 6.4 1.4 5.1 1.9 3.0 0.6 88.7 7.4 3.9 5.3 6.8 3.0 5.9 12.1 2.1 3.9 4.6 2.0 2.9 11.7 5.8 1.6 5.0 5.9 8.9 4.7 5.0 8.4 3.3 9.6 2.2 1.5 4.9 5.2 3.9 5.0 9.6 3.3 10.4 3.1 4.8 5.2 9.7 4.1 4.9 6.2 8.4 3.1 10.4 4.9 4.9 23.2 7.1 9.0 25.9 8.4 14.8 9.3 7.8 14.2 13.0 5.8 4.5 18.3 10.6 27.1 45.0 19.0 12.5 12.2 17.3 13.7 15.3 12.9 10.1 15.9 10.6 17.0 15.2 MINDY3 "C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042" ENSG00000148481 "MINDY lysine 48 deubiquitinase 3" Q9H8M7 10 15778170-15860520 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038400, HPA038406" Uncertain Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA038400: AB_10669724, HPA038406: " "unprognostic (9.20e-2)" "unprognostic (5.84e-2)" "unprognostic (3.09e-1)" "unprognostic (3.26e-1)" "unprognostic (1.99e-2)" "unprognostic (3.67e-1)" "unprognostic (8.29e-2)" "unprognostic (2.81e-2)" "unprognostic (3.85e-2)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (6.50e-2)" "unprognostic (1.32e-1)" "unprognostic (2.97e-1)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.19e-1)" 14.6 22.0 17.9 10.0 22.2 15.2 18.4 22.0 32.0 19.1 13.7 19.7 11.4 8.2 18.6 20.0 13.4 15.3 13.3 8.9 20.1 18.8 16.0 15.8 15.5 11.9 22.9 14.0 18.1 12.8 16.3 14.4 20.1 25.8 18.9 18.0 13.5 11.8 16.5 4.1 15.3 11.4 16.7 32.0 11.8 14.6 18.8 16.1 10.5 17.2 7.7 12.6 17.8 14.1 3.4 4.2 5.7 8.0 3.4 6.2 2.9 6.5 6.1 11.9 12.6 17.6 16.8 9.8 20.9 10.6 16.0 18.7 5.3 10.3 4.9 4.0 22.5 6.1 10.1 12.4 14.3 14.9 14.1 15.9 8.7 5.7 22.2 3.2 13.4 12.6 10.9 14.2 10.1 12.5 9.7 4.1 15.8 7.1 6.9 3.9 4.3 11.7 3.4 7.0 3.4 17.8 4.9 9.8 10.9 10.2 9.9 8.3 11.1 7.9 13.2 10.4 8.0 17.5 6.0 22.6 9.6 8.4 11.9 7.3 8.3 5.7 3.6 3.1 4.9 7.1 4.1 3.1 3.4 5.2 4.0 3.4 2.3 4.4 3.1 3.4 8.0 4.2 6.2 2.9 17.9 22.2 22.0 32.0 20.1 18.8 22.9 14.0 25.8 16.1 MINDY4 "C7orf67, FAM188B, FLJ22374" ENSG00000106125 "MINDY lysine 48 deubiquitinase 4" Q4G0A6 7 30771417-30892387 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 16.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019475, HPA030129, HPA030130" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565" "unprognostic (2.96e-1)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.07e-1)" "unprognostic (6.01e-3)" "unprognostic (3.81e-2)" "unprognostic (5.25e-3)" "unprognostic (1.97e-1)" "unprognostic (5.59e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-1)" "unprognostic (9.55e-2)" "unprognostic (1.12e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" 9.3 6.7 9.3 2.6 15.2 4.1 7.0 3.4 15.1 10.8 6.6 5.4 16.6 2.9 15.6 16.2 5.7 20.7 10.0 7.5 8.4 5.1 9.4 3.8 14.2 2.4 4.3 9.5 14.8 5.6 9.6 16.1 6.2 9.0 9.4 4.3 7.8 5.3 15.9 3.7 5.1 3.7 10.8 3.6 2.3 5.8 20.1 5.0 1.5 12.5 3.6 2.2 6.4 6.3 0.0 1.1 0.0 0.3 0.0 2.7 0.7 2.1 5.3 2.7 8.4 2.4 9.5 4.1 3.1 5.3 2.3 2.0 0.0 3.9 0.0 3.6 2.0 2.2 1.8 1.7 2.2 0.0 3.1 1.6 2.8 0.0 3.1 2.3 1.2 4.8 2.8 7.0 1.4 3.4 16.2 1.0 2.0 0.0 1.2 0.7 7.9 1.2 0.4 0.0 0.5 6.3 1.0 5.1 7.0 2.1 11.2 1.2 5.7 1.7 2.0 0.1 1.3 2.4 1.3 2.3 2.9 0.0 4.4 0.1 9.8 0.0 0.1 0.0 0.6 0.0 2.7 0.0 0.8 0.2 1.1 0.0 0.3 0.5 0.0 0.0 0.3 0.0 0.5 0.7 9.3 15.2 3.4 15.1 8.4 5.1 4.3 9.5 9.0 5.0 MIOS "FLJ20323, MIO, Sea4" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566872-7608929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: " "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favourable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favourable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 9.9 7.8 6.7 14.4 9.5 10.3 9.6 11.7 10.3 9.9 7.0 7.3 10.3 5.5 8.8 8.7 17.1 8.1 6.4 8.0 7.3 5.6 12.0 11.2 7.4 13.9 5.7 7.2 9.0 16.2 24.6 14.9 11.0 16.8 14.7 8.7 10.9 12.3 14.3 67.7 15.3 8.9 8.0 8.8 15.2 10.6 11.9 7.8 14.0 6.8 14.6 19.0 9.3 12.2 10.5 8.3 8.9 11.0 6.4 7.5 4.2 19.1 8.6 10.4 12.4 8.2 17.6 8.7 15.1 12.0 9.6 9.7 10.6 7.5 16.9 4.7 8.9 17.4 10.5 11.0 12.8 6.8 9.2 4.2 10.3 7.0 11.5 18.1 4.8 14.6 13.9 8.5 21.6 8.6 21.1 13.9 40.6 13.3 4.0 8.3 21.0 9.2 12.6 15.9 16.2 8.7 9.8 10.9 17.7 7.9 22.9 8.9 12.5 16.4 7.4 15.0 16.1 8.3 12.7 12.5 13.7 15.2 13.1 10.6 17.4 0.0 5.9 8.9 5.1 11.0 4.3 10.5 5.5 4.7 8.3 9.5 7.5 5.8 0.6 6.4 5.3 5.0 5.4 4.2 6.7 9.5 11.7 10.3 7.3 5.6 5.7 7.2 16.8 7.8 MIS18A "B28, C21orf45, C21orf46, FASP1, hMis18alpha" ENSG00000159055 "MIS18 kinetochore protein A" Q9NYP9 21 32268219-32279069 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018286, HPA020585" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA018286: AB_1845693, HPA020585: AB_1845694" "unprognostic (1.19e-1)" "unprognostic (1.55e-2)" "unprognostic (4.44e-2)" "unprognostic (1.98e-3)" "unprognostic (3.45e-2)" "unprognostic (2.29e-2)" "unprognostic (1.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.19e-2)" "unprognostic (4.39e-3)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" "unprognostic (3.34e-2)" "unprognostic (1.85e-2)" "unprognostic (1.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.28e-1)" 5.5 7.5 7.8 6.6 10.7 13.8 7.4 16.4 8.3 6.1 8.9 5.4 1.9 7.9 6.6 6.3 11.4 5.6 5.3 3.9 6.8 4.7 6.7 5.7 3.7 9.7 6.8 9.3 9.8 5.8 3.3 4.3 7.1 6.6 5.5 10.6 4.4 6.0 4.1 4.0 7.8 8.5 7.7 6.2 7.3 6.1 26.6 5.4 19.3 3.9 6.8 11.3 5.3 6.5 18.5 13.2 8.2 11.7 10.4 15.5 6.4 20.9 5.2 15.1 14.5 2.3 4.0 23.2 11.1 5.7 10.9 9.5 10.4 11.7 23.0 8.2 4.2 7.1 14.8 8.4 13.1 13.1 16.5 26.3 5.5 13.3 1.5 22.5 8.9 1.7 3.7 9.1 6.6 7.6 30.6 19.4 10.6 14.3 25.7 20.5 31.2 15.4 22.5 22.6 21.4 7.5 7.2 18.2 8.9 16.9 14.4 10.3 17.4 13.8 4.4 13.7 25.4 10.6 11.3 10.5 16.6 28.9 8.7 36.2 12.4 2.4 5.3 8.2 10.2 6.8 10.2 18.2 11.2 11.7 4.9 18.5 15.5 11.5 1.7 10.4 11.7 13.2 14.6 6.4 7.8 10.7 16.4 8.3 6.8 4.7 6.8 9.3 6.6 5.4 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavourable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 10.3 5.2 5.1 22.5 5.7 26.3 14.1 1.8 5.7 9.0 11.8 2.3 7.6 6.0 9.8 9.5 10.2 8.6 5.7 5.3 5.1 2.8 5.0 4.3 14.3 23.9 4.5 4.1 12.5 7.1 1.8 5.2 9.5 6.7 7.9 7.6 1.9 12.5 10.2 3.0 8.4 10.7 7.3 10.2 22.5 6.9 9.5 3.1 38.4 7.1 8.2 15.5 8.2 7.7 13.1 14.7 23.6 22.6 4.5 4.8 4.0 20.6 7.8 16.2 7.1 5.0 7.2 12.0 14.4 7.6 12.0 14.9 4.1 20.1 28.6 6.3 7.1 14.5 9.5 7.2 22.6 15.1 6.0 17.1 9.6 5.3 3.3 39.4 16.0 5.1 3.0 7.1 6.7 14.6 7.5 6.8 11.6 7.6 16.4 17.4 12.3 9.8 19.7 6.6 11.0 6.1 8.6 11.4 5.0 5.8 9.8 5.2 11.7 22.6 7.9 6.4 19.5 7.8 6.3 6.1 8.1 13.3 3.6 16.5 8.9 23.6 14.2 16.2 3.9 13.2 4.1 13.1 3.6 3.2 9.6 12.9 2.4 2.5 8.5 4.5 22.6 14.7 4.8 4.0 5.1 5.7 1.8 5.7 5.1 2.8 4.5 4.1 6.7 3.1 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751126-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "gallbladder: 24.6;intestine: 63.8" "Cell line enhanced" "Detected in some" "A549: 37.1;HaCaT: 27.5;hTCEpi: 25.8;MCF7: 18.9;SK-BR-3: 41.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 0.5 0.1 0.3 7.9 0.3 0.0 0.7 0.2 0.2 1.5 42.8 0.2 0.2 45.9 0.7 0.8 0.4 2.4 24.6 0.2 0.5 0.2 6.9 0.4 6.8 0.2 0.3 0.3 2.2 2.0 0.0 4.2 2.1 0.2 2.2 13.0 0.2 0.5 0.5 0.2 0.3 63.8 0.7 0.2 0.2 5.8 0.2 0.2 0.3 0.2 0.8 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 37.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.7 13.6 3.2 3.6 0.0 27.5 0.0 11.5 0.0 0.0 0.0 0.0 14.6 3.9 0.0 0.0 0.5 0.0 25.8 0.1 1.4 0.0 0.0 0.1 0.0 18.9 0.0 0.2 0.0 7.6 0.0 0.1 0.3 9.3 10.3 0.4 0.1 13.1 41.8 0.0 9.1 0.0 0.0 0.0 4.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB000058: AB_2142367, CAB068198: , HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavourable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavourable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 47.3 24.1 25.1 17.8 1.0 2.1 7.8 18.0 13.3 17.1 15.3 19.7 19.7 35.7 5.2 12.3 28.9 26.3 13.5 25.8 37.6 12.7 30.6 17.8 12.3 0.0 43.0 16.6 0.5 0.6 17.6 18.0 16.7 14.0 34.4 16.9 18.8 25.6 13.1 10.0 11.0 19.1 32.9 4.7 6.2 13.3 8.7 9.5 25.5 9.2 4.4 7.5 9.2 15.4 9.1 18.2 12.8 48.6 15.7 12.4 43.3 7.5 19.7 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 MKL1 "BSAC, KIAA1438, MAL, MKL, MRTF-A" ENSG00000196588 "Megakaryoblastic leukemia (translocation) 1" Q969V6 22 40410281-40636702 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Actin-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 50.9" "Group enriched" "Detected in all" 5 "dendritic cells: 26.4;granulocytes: 50.9;monocytes: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030782 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030782: AB_10600930" "unprognostic (7.90e-3)" "unprognostic (4.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (9.37e-2)" "unprognostic (4.38e-3)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-2)" "prognostic unfavourable (1.58e-7)" "unprognostic (9.05e-2)" "unprognostic (8.15e-2)" "unprognostic (1.30e-2)" "unprognostic (3.98e-1)" 18.1 11.1 15.4 25.4 19.1 69.2 15.8 16.2 26.1 17.6 14.2 13.5 10.1 11.3 27.6 12.9 12.3 17.5 13.2 16.3 14.2 11.1 11.3 8.9 17.4 25.6 11.8 16.6 16.9 14.5 10.2 10.5 18.9 12.6 14.2 9.4 13.3 16.9 15.7 14.3 18.0 13.6 15.7 11.0 23.9 14.3 25.4 10.8 28.2 17.3 9.0 25.5 15.5 14.6 4.9 26.4 50.9 15.0 3.8 5.6 7.5 10.7 14.6 6.3 7.5 8.0 6.1 12.4 10.5 6.8 9.7 9.4 6.8 3.3 11.5 4.3 11.0 14.2 5.3 12.9 6.3 12.7 9.3 19.0 16.3 10.1 7.9 22.0 37.5 6.6 15.6 9.4 6.5 7.1 5.3 5.2 4.6 10.5 8.6 24.7 5.0 5.1 14.0 7.1 5.8 7.7 8.1 3.5 3.8 17.2 8.7 6.3 5.8 24.9 11.6 6.6 17.7 8.7 9.0 7.0 6.2 16.5 5.4 11.1 12.7 12.0 15.0 50.9 4.4 11.6 4.1 3.2 4.0 3.4 17.8 4.9 5.6 4.7 14.5 3.8 15.0 26.4 5.2 7.5 15.4 19.1 16.2 26.1 14.2 11.1 11.8 16.6 12.6 10.8 MKLN1 TWA2 ENSG00000128585 "Muskelin 1" Q9UL63 7 131110096-131496636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022817, HPA041810" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA022817: AB_1853974, HPA041810: " "unprognostic (1.97e-1)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.03e-1)" "unprognostic (4.20e-2)" "unprognostic (1.44e-3)" "unprognostic (4.58e-2)" "unprognostic (1.94e-2)" "unprognostic (1.97e-1)" "unprognostic (2.43e-3)" "unprognostic (1.55e-1)" "unprognostic (9.18e-3)" "unprognostic (1.70e-1)" "unprognostic (4.13e-1)" "unprognostic (1.13e-2)" "unprognostic (2.32e-1)" 22.7 21.1 22.1 15.7 27.6 12.8 34.4 27.5 25.8 18.8 15.0 11.7 26.6 14.2 19.3 19.8 11.8 19.6 11.6 16.7 21.9 14.4 23.0 22.8 19.3 18.7 26.6 17.5 23.2 12.6 20.9 28.8 18.2 25.0 26.4 12.2 10.0 18.1 28.9 28.6 15.4 13.5 20.8 30.3 13.1 14.4 16.9 24.0 14.7 18.0 9.9 12.0 17.8 21.5 2.3 1.6 12.4 1.6 0.9 2.3 0.5 8.3 9.6 8.4 8.5 20.8 18.8 5.1 8.1 18.8 9.2 11.9 4.4 7.2 8.7 5.5 10.0 5.8 8.8 7.7 15.1 8.4 4.3 3.7 7.5 5.1 10.0 6.1 5.4 11.2 5.4 12.5 6.2 8.4 13.5 6.3 11.4 3.1 7.1 6.6 9.6 5.1 4.5 9.9 6.0 10.3 4.9 4.4 9.4 15.8 15.8 7.3 3.1 7.7 8.5 7.2 4.1 13.1 6.5 15.4 5.7 14.9 24.8 7.4 10.5 1.2 1.0 1.7 1.6 1.1 1.2 1.2 1.5 1.3 1.0 2.3 2.3 1.9 12.4 0.9 1.6 1.6 0.9 0.5 22.1 27.6 27.5 25.8 21.9 14.4 26.6 17.5 25.0 24.0 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453040-140479569 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 16.8 17.6 26.8 20.8 28.8 69.9 20.1 37.2 32.6 20.4 39.6 16.1 19.7 28.4 20.1 18.6 23.3 22.2 22.4 38.5 24.9 29.8 20.6 17.5 23.6 18.3 25.7 23.3 24.9 27.3 28.2 21.5 31.7 29.4 21.0 33.7 19.4 24.8 23.1 38.5 24.4 26.6 26.3 20.5 22.5 21.7 95.4 20.2 21.0 23.6 18.8 22.3 25.3 36.4 13.1 7.5 39.3 10.5 12.8 17.8 6.4 27.9 21.6 16.9 25.0 26.8 23.5 23.9 19.3 25.1 15.2 17.6 8.8 29.5 20.3 30.3 18.8 13.6 19.0 21.2 19.3 40.2 16.5 21.1 13.0 16.3 21.6 18.0 32.7 23.4 32.0 17.1 16.2 15.1 16.6 25.7 14.6 24.1 21.1 32.4 43.4 16.0 15.3 14.5 31.1 24.4 32.4 23.4 24.2 24.2 32.8 34.5 16.1 15.7 21.4 10.7 8.5 26.1 17.6 61.3 44.9 17.8 30.6 28.4 22.0 19.4 9.2 39.3 6.7 8.7 8.0 13.1 13.0 10.1 7.5 10.9 17.8 11.3 18.1 12.8 10.5 2.5 14.0 6.4 26.8 28.8 37.2 32.6 24.9 29.8 25.7 23.3 29.4 20.2 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557014-12583713 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favourable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 13.7 10.4 15.1 11.1 18.3 16.4 11.6 29.3 19.5 13.7 12.7 12.4 16.1 12.5 15.2 12.3 16.2 13.1 10.9 26.3 14.0 15.1 13.7 12.5 12.1 12.6 15.2 14.8 20.8 26.6 17.3 11.9 14.4 16.0 11.3 11.5 13.2 12.8 13.1 24.5 12.8 10.9 15.9 16.2 10.1 11.7 46.1 14.7 15.4 18.2 17.0 13.7 13.0 12.6 21.3 19.0 30.0 20.3 25.3 26.2 18.7 10.7 12.4 14.8 11.1 23.2 22.6 28.7 16.6 17.8 21.2 17.8 12.0 10.7 15.2 9.5 18.3 6.6 19.3 16.3 18.9 17.2 16.2 21.7 14.2 16.0 26.7 21.3 9.9 25.1 15.2 24.6 15.6 17.4 20.2 21.6 18.2 15.1 26.1 11.1 9.9 21.8 25.2 14.3 17.1 14.9 14.2 8.7 14.7 14.4 7.4 14.8 16.7 18.9 17.5 14.5 14.3 17.2 22.5 16.4 33.6 32.7 15.7 25.5 21.8 18.9 17.2 30.0 21.5 15.6 26.2 21.3 22.1 22.0 19.0 16.4 23.9 22.3 15.0 25.3 20.3 15.1 23.4 18.7 15.1 18.3 29.3 19.2 14.0 15.1 15.2 14.8 16.0 14.7 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.7 3.4 3.0 3.1 0.0 0.0 7.1 0.3 0.0 2.9 2.0 8.5 0.0 0.2 0.1 0.0 8.2 1.3 0.0 0.7 0.0 0.3 6.8 9.1 0.3 0.2 8.0 6.1 0.1 0.0 6.0 0.0 0.0 17.5 7.5 0.8 0.0 8.4 3.5 0.0 10.4 6.0 1.1 4.2 0.0 0.1 0.7 2.4 0.0 3.4 0.0 2.7 2.4 0.1 8.0 6.7 0.4 5.6 9.4 11.5 5.6 4.7 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell line enhanced" "Detected in some" "BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 10.8 12.4 8.5 0.0 0.0 0.0 0.0 53.9 0.0 0.1 0.0 3.3 0.0 1.2 0.0 3.4 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.2 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1" "Cell line enhanced" "Detected in many" "A-431: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in single" 12 "T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069479 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA069479: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavourable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 3.5 2.6 6.0 1.8 11.9 0.9 5.3 3.4 7.1 3.1 2.7 6.5 0.5 0.8 4.9 5.6 3.5 18.3 4.9 41.4 6.3 6.3 5.7 1.2 5.2 1.0 4.9 6.3 6.2 3.1 5.2 10.4 1.0 20.1 2.0 1.7 2.8 2.2 1.6 53.6 1.8 1.3 4.5 4.7 1.2 1.9 101.1 5.7 0.0 5.3 18.9 1.4 4.2 1.5 0.6 0.3 0.4 0.3 0.8 10.4 2.3 34.1 4.5 11.5 0.0 6.1 7.2 3.4 3.5 3.4 13.0 11.8 0.0 19.5 0.0 13.5 6.1 6.6 0.1 6.0 17.3 0.0 7.5 2.0 3.3 0.3 4.2 0.0 2.6 4.4 8.8 6.2 3.4 3.0 2.5 0.0 8.5 5.0 0.0 0.1 2.7 10.0 0.0 6.4 0.4 9.9 2.4 14.9 8.8 16.1 5.7 16.9 16.4 3.4 1.1 12.1 12.4 14.3 13.7 6.1 3.8 0.0 8.7 0.0 8.7 0.0 0.0 0.0 3.6 0.0 1.6 0.6 8.3 8.7 0.3 0.3 2.1 4.4 0.4 0.8 0.3 0.2 10.4 2.3 6.0 11.9 3.4 7.1 6.3 6.3 4.9 6.3 20.1 5.7 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.0 64.6 33.2 58.5 31.1 31.7 51.1 38.4 46.2 66.2 58.1 62.4 38.8 28.2 10.2 50.0 32.8 40.9 55.6 41.2 44.4 37.9 19.9 34.2 35.7 34.4 21.1 27.5 29.7 45.4 51.1 39.2 26.9 25.0 11.8 46.0 55.4 29.0 32.7 107.4 22.3 18.6 30.6 25.0 55.2 49.3 21.2 42.0 34.7 61.4 37.1 17.8 35.0 26.5 39.5 52.6 41.6 56.1 14.3 16.2 37.4 52.7 18.4 46.4 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell line enhanced" "Detected in many" "AF22: 38.4;EFO-21: 29.2;SH-SY5Y: 42.1;U-698: 35.8" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000540: " "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.2 38.4 6.0 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.2 1.8 1.5 9.2 2.2 1.3 11.2 2.5 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 16.9 5.3 0.9 7.4 0.4 17.6 3.3 16.7 0.8 16.8 5.1 0.1 4.3 1.1 23.1 42.1 0.2 0.4 1.2 1.4 0.6 11.8 5.0 5.5 1.8 4.3 0.9 0.8 35.8 12.4 0.3 9.3 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 MLLT3 "AF-9, AF9, YEATS3" ENSG00000171843 "MLLT3, super elongation complex subunit" P42568 9 20341665-20622543 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.4" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001824 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001824: AB_1079394" "unprognostic (3.31e-1)" "unprognostic (2.22e-1)" "unprognostic (1.23e-3)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (3.83e-2)" "unprognostic (1.01e-3)" "unprognostic (2.12e-1)" "unprognostic (3.92e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-2)" "prognostic favourable (1.84e-4)" "unprognostic (1.85e-1)" "unprognostic (4.81e-2)" "unprognostic (1.40e-2)" "unprognostic (1.68e-1)" 8.6 17.3 18.0 10.4 25.8 19.7 11.4 34.6 20.3 12.3 20.9 7.2 10.6 7.2 13.6 7.9 10.2 11.5 12.7 8.6 18.0 12.8 10.1 2.1 10.7 9.1 14.8 13.8 10.5 4.6 18.3 24.7 10.3 13.2 11.7 22.8 7.4 21.3 12.1 9.1 7.9 12.3 13.5 12.0 5.9 15.3 3.6 21.4 22.1 22.5 6.1 6.5 12.9 10.4 1.4 0.7 1.6 0.3 3.8 14.4 2.8 2.5 7.1 2.5 2.9 5.9 3.7 1.6 6.7 11.3 3.0 3.4 6.9 2.4 9.8 3.6 3.1 1.3 2.4 11.6 2.7 20.2 6.2 72.2 21.9 3.2 4.3 1.3 6.1 2.7 4.5 1.0 7.3 3.0 0.0 12.7 6.3 1.9 7.0 4.2 1.6 2.1 0.0 4.6 2.6 13.9 3.8 8.2 2.9 5.4 2.7 2.9 2.8 1.9 1.9 0.0 1.7 1.7 2.3 5.7 5.2 4.0 0.0 3.1 1.4 1.6 0.3 0.5 3.9 0.2 3.6 0.5 7.0 5.3 0.7 1.4 14.4 8.3 0.1 3.8 0.3 0.4 7.3 2.8 18.0 25.8 34.6 20.3 18.0 12.8 14.8 13.8 13.2 21.4 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: " "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.9 8.7 22.1 11.4 8.0 14.3 6.0 8.2 10.5 9.7 28.3 10.2 18.7 15.1 7.1 8.9 8.8 18.1 1.2 14.2 40.0 12.7 20.7 18.1 16.6 19.5 18.0 11.5 13.1 12.2 15.8 11.2 18.3 13.0 5.5 30.6 18.4 26.1 16.7 19.5 19.4 8.7 32.9 7.9 4.3 27.4 14.0 9.9 22.4 15.9 13.2 19.1 7.9 12.3 13.9 9.8 8.1 14.9 9.0 20.5 6.1 17.2 10.3 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 MLX "bHLHd13, MAD7, MXD7, TCFL4" ENSG00000108788 "MLX, MAX dimerization protein" Q9UH92 17 42567068-42573239 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025329, HPA052766, HPA064438" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "CAB025329: , HPA052766: , HPA064438: " "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.21e-3)" "unprognostic (3.88e-1)" "unprognostic (2.46e-2)" "unprognostic (8.55e-3)" "unprognostic (2.49e-1)" "unprognostic (4.87e-2)" "unprognostic (8.66e-2)" "unprognostic (9.66e-2)" "unprognostic (2.89e-1)" "unprognostic (1.61e-2)" "unprognostic (7.43e-2)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (3.25e-1)" 21.3 19.2 10.4 12.6 11.9 8.3 22.5 10.3 14.3 12.3 32.2 10.8 15.4 27.5 11.0 15.1 18.8 10.5 19.2 38.1 9.8 9.8 23.5 34.7 19.0 18.6 11.3 6.6 10.4 36.8 8.5 13.0 13.7 9.4 13.4 23.1 11.6 18.5 14.8 43.3 15.6 42.5 12.1 10.2 18.7 20.6 7.4 8.9 20.3 23.5 24.9 19.7 16.5 13.1 14.6 26.3 34.7 33.5 12.8 18.2 23.0 16.0 18.6 14.6 14.8 22.3 25.8 10.1 24.2 21.5 26.1 23.7 16.8 16.7 19.4 17.0 20.5 24.3 26.6 15.6 23.0 15.3 25.0 20.0 13.4 18.6 26.3 26.8 28.9 22.3 17.5 20.9 19.2 19.2 21.8 17.4 29.7 21.4 37.6 13.2 10.3 16.9 17.0 30.4 20.7 21.1 19.9 22.8 11.3 10.7 13.9 27.1 28.6 31.8 13.6 23.3 15.1 25.4 35.6 17.7 20.0 18.2 26.0 17.2 27.3 14.2 25.0 34.7 14.3 30.8 15.8 14.6 14.8 14.3 26.3 11.8 13.1 13.1 32.3 12.8 33.5 14.1 18.2 23.0 10.4 11.9 10.3 14.3 9.8 9.8 11.3 6.6 9.4 8.9 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.6 6.1 9.3 5.8 3.5 7.6 5.3 3.6 9.7 8.8 7.3 4.3 10.7 7.0 4.4 5.7 11.2 12.7 8.9 2.9 10.3 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 4.6 9.4 6.1 7.4 7.3 7.9 3.8 10.0 8.3 9.8 2.5 11.9 5.7 5.4 9.8 5.0 8.0 13.3 17.4 7.7 4.3 2.1 6.9 9.4 7.7 2.9 9.2 7.4 6.3 5.0 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell line enhanced" "Detected in some" "BJ: 12.3;HUVEC TERT2: 15.8;SCLC-21H: 5.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favourable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.3 0.7 0.1 0.1 0.3 0.0 0.0 3.6 1.9 2.8 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 15.8 0.7 0.0 0.0 0.0 0.0 0.3 2.9 1.7 0.0 0.0 0.0 0.0 0.7 5.0 0.0 2.5 0.0 0.0 0.0 0.0 2.0 3.8 1.2 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: " "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.9 0.1 2.4 0.1 98.0 62.3 45.0 25.1 50.6 7.6 13.6 2.3 29.9 0.1 14.0 26.4 20.3 0.0 26.1 9.8 0.1 0.1 3.7 0.1 0.5 92.7 0.0 0.1 94.2 15.8 31.7 27.2 46.0 0.1 0.2 17.9 0.1 0.0 9.0 1.5 4.3 0.3 8.6 0.0 6.9 13.7 0.0 0.0 16.4 0.0 54.4 0.1 8.1 40.7 61.9 5.3 18.0 28.6 0.1 0.1 0.1 37.7 0.0 35.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell line enhanced" "Detected in many" "BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: " "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favourable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.3 2.3 11.8 2.4 0.1 36.8 0.5 0.3 2.1 0.4 3.4 14.8 0.0 7.0 0.6 8.1 1.9 1.7 0.6 0.0 3.9 0.0 1.9 19.1 3.1 0.1 7.7 1.2 3.0 0.3 0.9 1.4 4.7 0.0 0.7 2.8 0.2 0.9 6.7 1.2 2.8 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.5 3.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell line enhanced" "Detected in many" "AN3-CA: 20.0;HUVEC TERT2: 8.7;SH-SY5Y: 11.1;U-138 MG: 9.5;WM-115: 19.5" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 20.0 0.7 1.4 0.0 7.3 1.0 2.1 1.2 0.0 0.0 0.0 0.0 3.3 0.0 3.9 0.0 2.5 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.0 0.9 8.7 0.0 0.7 1.1 0.0 0.0 0.0 1.1 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.1 0.0 0.0 0.1 0.8 0.0 4.8 9.5 5.4 0.1 2.7 0.0 0.0 0.0 3.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.7" "Cell line enriched" "Detected in many" 6 "BEWO: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 16 "classical monocyte: 3.2;myeloid DC: 1.0" "Group enriched" "Detected in many" 16 "dendritic cells: 1.0;monocytes: 3.2" "Region enriched" "Detected in single" 6 "olfactory region: 8.8" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" 800000 "Endoplasmic reticulum, Vesicles" "HPA070804: " "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavourable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 60.7 1.9 0.2 10.9 0.7 0.0 9.9 0.2 0.5 7.6 3.9 0.4 1.4 0.8 12.7 6.0 3.6 11.8 30.3 4.7 0.6 0.1 4.1 3.0 14.0 15.5 0.5 0.2 7.4 8.1 0.0 0.5 24.5 1.0 2.9 2.8 3.1 2.0 3.5 2.1 2.7 4.1 7.7 0.8 27.4 5.0 2.9 0.2 2.7 3.3 1.8 7.1 5.9 3.5 0.0 1.0 0.1 3.2 0.0 0.0 0.6 0.8 0.0 0.0 0.0 6.2 7.9 55.9 5.9 6.9 2.4 2.8 0.3 0.2 0.0 0.0 8.2 0.0 0.0 1.8 3.3 0.3 0.0 0.0 0.0 0.1 5.1 0.0 0.2 8.2 0.2 1.5 1.5 0.4 0.1 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 1.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 1.5 3.3 0.0 0.2 0.0 0.0 0.0 4.3 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.7 0.2 0.5 0.6 0.1 0.5 0.2 1.0 0.2 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell line enhanced" "Detected in some" "A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favourable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 19.6 0.0 0.1 0.1 0.0 0.6 1.1 1.2 2.1 1.1 29.9 5.3 0.0 8.8 1.3 0.3 4.6 0.0 0.9 0.1 0.2 1.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 7.5 1.3 0.0 0.1 0.0 13.5 0.1 7.8 5.4 1.4 0.5 0.2 0.3 0.1 0.3 4.2 10.1 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "HaCaT: 28.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9" "Lineage enriched" "Detected in many" 5 "T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 8.0 1.6 1.8 2.7 3.7 0.5 4.3 0.0 5.1 1.7 7.3 1.6 1.4 3.0 3.2 4.8 4.3 1.5 12.3 0.5 2.8 0.8 0.2 10.3 0.4 0.0 2.9 0.1 1.3 0.5 0.0 0.7 1.3 2.9 4.1 2.7 0.1 2.1 0.6 4.5 9.3 4.3 0.2 0.6 7.2 13.4 0.2 0.0 4.2 4.4 2.5 5.5 2.2 1.1 1.5 0.1 0.2 1.3 7.2 0.9 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.7 0.0 28.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.5 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.0 1.1 0.4 1.7 0.1 0.9 7.2 5.9 0.1 1.3 0.2 1.5 0.0 0.9 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell line enhanced" "Detected in some" "A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: " "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavourable (2.53e-4)" "prognostic unfavourable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 126.5 0.0 30.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in some" 15 "NB-4: 35.9;THP-1: 67.7;U-937: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported Nucleoplasm,Nucleoli 110000 "Nucleoplasm, Nucleoli" "HPA034532: AB_10669677, HPA073215: " "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.0 4.5 2.4 7.0 2.0 4.3 0.4 4.6 2.7 5.5 11.8 6.3 9.2 10.7 5.9 1.9 7.5 2.9 2.6 11.3 0.0 1.2 13.7 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.1 1.6 1.0 3.0 0.0 4.6 2.5 0.1 5.8 0.7 2.6 8.9 14.0 0.1 5.4 3.7 18.4 5.6 7.7 2.3 8.1 5.6 7.2 0.4 7.5 8.6 7.2 11.3 2.2 7.0 0.2 8.4 11.0 8.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA071717: " "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 3.8 0.0 11.5 0.0 0.0 8.6 0.0 0.0 0.1 0.0 5.0 1.6 0.9 11.1 0.0 0.2 2.0 1.5 0.9 1.4 8.8 0.0 0.7 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 3.6 1.9 0.0 6.4 0.6 0.1 0.0 0.7 0.0 1.7 24.2 4.3 0.4 13.0 0.0 1.6 1.4 0.2 3.6 2.9 0.0 0.0 0.0 0.0 0.0 3.6 1.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000939 Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA000939: AB_1079402" "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favourable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favourable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 5.7 2.3 7.1 5.3 15.9 9.1 5.5 3.3 3.9 5.6 9.9 7.0 11.9 10.9 16.8 14.6 4.6 6.5 18.4 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavourable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 20.7 11.9 15.0 16.1 24.7 27.0 17.7 16.7 22.5 21.8 21.6 16.2 15.1 42.6 14.3 20.9 17.4 19.1 19.1 33.2 29.9 11.4 38.4 8.2 17.1 19.7 33.2 62.1 22.8 18.7 17.4 14.8 22.8 16.4 15.8 21.1 11.2 41.6 28.3 13.9 9.8 28.7 51.5 22.6 18.7 26.0 7.6 9.9 23.7 17.6 15.2 14.0 15.8 21.6 28.4 15.0 19.8 26.4 11.8 10.4 32.7 19.1 28.4 15.1 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.8 3.1 11.9 9.7 6.5 8.3 9.8 11.7 6.4 6.6 5.8 4.1 7.4 21.6 5.6 10.4 2.7 7.4 9.8 16.0 11.4 2.6 33.8 3.6 3.2 6.5 7.3 6.8 6.8 5.4 7.3 6.0 7.7 20.7 7.1 10.4 4.1 22.8 4.6 3.9 4.2 7.3 11.6 2.9 10.9 6.8 4.2 8.0 5.0 2.2 15.7 5.3 4.8 9.2 18.3 9.4 8.2 4.7 4.6 1.5 9.2 6.4 5.4 8.4 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavourable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favourable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.6 16.6 8.7 11.0 16.1 21.3 16.8 9.7 19.2 10.3 8.5 25.9 17.1 14.6 24.8 13.0 13.8 21.8 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.4 22.5 12.6 10.7 10.8 9.9 13.2 17.4 11.6 14.2 9.6 9.7 10.7 17.7 13.4 17.6 18.8 13.7 17.2 13.3 7.9 10.3 18.5 13.0 6.6 4.2 7.0 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071038-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favourable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 19.6 9.5 9.8 31.9 10.0 27.4 11.9 11.1 9.2 15.5 19.2 12.7 7.7 7.7 19.9 9.2 14.3 16.7 14.1 10.6 10.0 6.9 10.7 5.7 14.9 39.6 9.4 6.4 15.6 8.2 6.7 7.0 15.9 8.8 15.3 9.2 13.4 11.6 13.1 7.9 12.0 18.2 17.0 7.6 37.3 12.5 8.3 10.0 39.3 11.7 6.7 42.2 17.1 13.1 11.6 14.5 69.3 22.0 13.0 16.5 17.1 13.8 5.7 6.8 6.5 16.2 17.9 5.3 8.7 5.6 6.0 4.8 2.2 5.0 35.7 3.2 15.1 5.9 3.7 19.4 4.8 12.5 1.9 7.7 4.0 3.0 16.0 12.1 40.2 10.5 12.8 16.4 6.9 11.2 4.0 35.9 8.6 5.5 6.2 12.3 2.1 4.1 3.8 2.0 27.7 7.4 3.5 4.3 5.8 4.4 4.7 4.8 5.0 19.7 18.9 7.3 4.0 13.5 5.1 7.1 25.2 28.2 19.6 8.2 8.7 18.0 20.6 23.9 16.5 20.8 14.2 11.6 12.3 13.6 14.5 10.7 9.4 11.8 69.3 13.0 22.0 8.3 14.7 17.1 9.8 10.0 11.1 9.2 10.0 6.9 9.4 6.4 8.8 10.0 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell line enhanced" "Detected in many" "BEWO: 10.0;HAP1: 10.2;K-562: 29.2;SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favourable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.7 0.0 1.2 0.1 10.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 2.0 0.0 6.6 10.2 8.0 0.0 4.6 1.6 2.9 6.2 0.0 0.0 0.0 0.6 2.1 8.5 0.0 1.5 0.0 29.2 0.1 0.0 0.0 0.0 0.0 6.0 0.5 1.9 0.4 0.0 2.8 3.9 0.0 1.5 1.6 12.3 2.8 0.8 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favourable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 16.9 9.0 8.8 8.0 14.7 4.1 12.1 19.7 7.5 10.7 11.2 9.3 11.8 8.8 8.4 12.9 12.6 9.6 10.8 12.3 10.1 5.6 9.1 8.8 13.3 7.8 13.2 6.8 12.6 29.8 10.4 10.9 12.8 12.5 12.2 9.3 9.5 16.8 12.5 20.2 6.0 12.5 9.8 5.5 14.7 10.9 4.2 9.4 3.1 11.1 19.1 11.4 10.8 16.0 9.3 7.1 15.1 9.0 16.1 21.5 11.4 7.4 3.0 1.5 4.5 14.9 11.6 0.6 4.2 10.7 7.7 7.5 0.9 5.3 0.6 4.6 7.1 10.7 1.6 5.4 4.0 11.1 0.2 17.5 4.0 1.1 7.8 1.5 6.6 9.5 8.4 7.3 2.0 5.0 2.6 4.4 3.2 3.1 0.7 2.3 0.5 9.0 1.9 4.9 3.2 4.3 13.5 0.6 1.8 6.5 4.6 5.2 2.8 5.9 3.7 3.9 2.7 6.4 3.7 4.1 0.9 0.5 5.8 2.6 3.2 2.1 8.4 15.1 12.2 9.0 21.5 6.9 12.0 12.3 5.8 9.3 10.7 10.8 6.0 16.1 5.7 7.1 8.1 11.4 8.8 14.7 19.7 7.5 10.1 5.6 13.2 6.8 12.5 9.4 MOCOS "FLJ20733, HMCS, MOS" ENSG00000075643 "Molybdenum cofactor sulfurase" Q96EN8 18 36187519-36272157 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.0;liver: 36.6" "Cell line enhanced" "Detected in many" "hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039412, HPA047958" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA039412: , HPA047958: " "unprognostic (3.07e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (3.18e-3)" "unprognostic (2.55e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.84e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.91e-2)" "prognostic unfavourable (3.03e-12)" "unprognostic (8.98e-2)" "unprognostic (2.37e-1)" "unprognostic (4.09e-1)" "unprognostic (6.35e-2)" 3.7 12.7 0.6 1.6 0.5 0.2 6.4 0.4 0.4 1.4 10.4 0.7 8.0 6.7 1.3 4.6 4.8 1.9 5.8 1.3 0.4 0.5 1.7 36.6 1.8 0.2 0.4 0.1 17.2 3.2 1.1 9.4 11.2 2.2 2.8 1.8 2.1 2.5 7.2 1.3 2.6 33.0 1.0 0.4 0.7 1.7 1.3 0.2 0.0 1.2 2.9 3.5 2.6 1.7 0.4 0.3 1.9 0.3 1.1 0.3 0.1 6.8 2.3 0.1 0.0 2.2 2.8 1.4 4.0 2.2 1.9 5.0 1.5 2.1 0.0 1.2 6.5 4.2 1.4 6.3 2.7 1.1 1.1 0.1 6.8 5.6 7.5 0.0 1.9 4.4 20.4 7.6 25.1 0.3 2.3 0.0 3.1 1.7 0.0 0.0 0.4 2.0 0.0 0.0 0.0 2.7 9.0 0.0 0.6 26.9 1.7 18.7 1.2 0.1 1.3 1.5 1.9 3.3 0.6 0.0 0.0 0.0 3.9 0.0 0.6 1.7 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.2 0.3 1.9 1.1 0.2 0.3 0.1 0.1 0.6 0.5 0.4 0.4 0.4 0.5 0.4 0.1 2.2 0.2 MOCS1 MOCOD ENSG00000124615 "Molybdenum cofactor synthesis 1" Q9NZB8 6 39899578-39934551 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5" "Group enriched" "Detected in many" 9 "NK-cells: 1.5;T-cells: 2.9" "Low region specificity" "Detected in all" "HPA045783, HPA058177, HPA075505" Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA045783: AB_10960058, HPA058177: , HPA075505: " "unprognostic (1.22e-1)" "prognostic unfavourable (1.07e-5)" "unprognostic (3.26e-2)" "unprognostic (1.44e-1)" "unprognostic (9.03e-2)" "unprognostic (1.99e-1)" "unprognostic (2.61e-2)" "unprognostic (4.85e-2)" "unprognostic (3.14e-2)" "unprognostic (1.08e-1)" "prognostic favourable (6.07e-5)" "unprognostic (5.34e-3)" "unprognostic (1.21e-1)" "unprognostic (3.97e-3)" "unprognostic (2.78e-1)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" 26.6 9.6 4.6 5.3 7.9 0.2 27.1 5.9 8.7 6.4 17.5 10.5 5.0 15.4 10.1 8.7 6.9 7.9 8.0 18.0 6.2 2.3 17.5 34.9 19.6 9.2 9.5 6.2 9.0 10.9 4.5 6.3 30.2 7.0 6.7 5.2 11.2 5.9 7.6 19.9 7.1 13.1 8.9 7.1 3.5 6.5 4.0 7.6 0.2 15.4 5.9 3.1 9.7 7.7 0.0 0.1 0.0 0.2 1.5 2.9 0.8 0.0 1.4 5.0 8.0 13.5 5.2 10.1 5.4 9.9 7.8 7.1 26.4 0.1 0.0 5.7 5.4 0.4 6.0 6.6 6.1 0.0 5.4 0.0 0.0 8.3 8.6 0.0 2.2 9.1 2.4 5.4 3.0 6.7 5.4 0.5 7.9 3.4 10.2 0.0 4.5 2.9 0.0 3.8 0.8 4.8 5.1 4.1 5.2 0.0 3.2 4.6 3.4 1.0 10.4 7.9 6.8 5.1 2.8 0.0 1.0 0.0 0.9 0.0 2.8 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.6 0.5 0.1 0.0 2.9 2.5 0.0 1.5 0.2 0.0 0.0 0.8 4.6 7.9 5.9 8.7 6.2 2.3 9.5 6.2 7.0 7.6 MOCS2 MOCO1 ENSG00000164172 "Molybdenum cofactor synthesis 2" "O96007, O96033" 5 53095679-53110063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037679, HPA037680" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037679: AB_2675604, HPA037680: AB_10673635" "unprognostic (3.27e-1)" "unprognostic (3.11e-2)" "unprognostic (2.82e-1)" "unprognostic (8.37e-3)" "unprognostic (2.12e-1)" "unprognostic (3.48e-2)" "unprognostic (1.60e-2)" "unprognostic (1.33e-1)" "unprognostic (6.66e-2)" "unprognostic (7.59e-2)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" "prognostic favourable (3.68e-6)" "unprognostic (1.04e-1)" "unprognostic (1.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.86e-2)" 18.1 34.6 41.5 9.8 38.0 4.0 19.6 21.7 41.8 16.0 17.1 20.7 10.4 17.6 14.8 28.2 17.0 12.9 15.9 39.9 36.7 32.1 49.7 52.0 13.1 11.4 30.0 22.4 21.2 18.4 30.4 23.3 16.2 28.7 18.6 14.9 17.2 21.2 20.8 38.3 8.9 17.6 16.1 27.1 10.7 16.6 11.0 20.0 8.2 31.5 19.4 11.2 16.9 15.4 16.9 12.5 6.3 10.9 17.3 25.8 12.9 20.1 16.6 12.0 28.6 24.6 22.7 15.2 24.8 26.1 22.2 26.3 22.6 15.2 20.7 37.5 19.6 12.3 24.0 25.5 35.0 5.2 23.4 15.9 16.3 20.4 25.3 17.1 11.9 18.0 12.8 25.2 22.4 23.8 15.3 11.3 36.9 30.0 18.5 9.8 10.6 34.5 9.3 25.8 18.8 38.4 15.4 8.9 10.3 18.1 14.8 18.6 28.6 4.4 15.2 21.3 22.0 18.9 31.9 13.2 19.6 23.4 30.5 4.9 32.8 5.2 9.2 6.3 16.9 10.9 20.2 16.5 19.0 19.2 12.5 16.9 25.8 22.2 1.7 17.3 9.8 11.4 18.3 12.9 41.5 38.0 21.7 41.8 36.7 32.1 30.0 22.4 28.7 20.0 MON2 KIAA1040 ENSG00000061987 "MON2 homolog, regulator of endosome-to-Golgi trafficking" Q7Z3U7 12 62466817-62600479 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038697, HPA057607" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA038697: AB_10697396, HPA057607: " "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (9.91e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "prognostic favourable (2.03e-4)" "unprognostic (7.69e-2)" "unprognostic (5.99e-2)" "unprognostic (2.24e-2)" "unprognostic (6.20e-2)" "unprognostic (5.57e-2)" "unprognostic (1.58e-2)" "unprognostic (1.93e-1)" "unprognostic (1.77e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-3)" "unprognostic (4.36e-2)" 16.4 14.8 12.1 16.9 20.7 13.3 16.8 28.6 20.6 20.8 14.4 25.8 21.3 13.3 22.3 16.8 16.2 16.8 15.6 14.5 14.2 13.0 17.5 22.6 14.3 14.3 20.4 18.7 22.8 24.0 36.7 31.9 17.8 22.6 16.9 17.3 16.7 22.4 24.3 15.7 16.4 15.0 15.2 17.4 15.7 17.0 11.2 18.1 21.8 21.3 10.9 17.6 15.8 17.2 6.2 5.5 8.9 6.2 3.7 7.2 3.6 10.3 16.1 12.1 6.4 15.8 14.7 11.1 11.3 9.6 10.5 10.4 7.2 4.2 7.3 8.8 10.9 10.0 11.9 8.3 14.4 9.4 9.4 11.6 11.9 7.2 6.8 10.1 8.3 10.0 6.3 11.3 14.0 10.1 10.9 17.9 9.1 12.0 8.8 4.8 7.2 8.9 8.2 10.9 10.1 5.8 14.1 5.2 5.7 19.0 10.4 7.8 22.5 7.4 14.0 10.1 7.4 12.7 7.2 9.9 9.1 8.4 10.8 6.3 11.3 2.0 6.1 6.3 5.5 6.2 7.0 5.0 4.4 7.2 5.5 6.2 6.2 6.9 8.9 3.7 4.6 3.2 5.0 3.6 12.1 20.7 28.6 20.6 14.2 13.0 20.4 18.7 22.6 18.1 MORC2 "AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1" ENSG00000133422 "MORC family CW-type zinc finger 2" Q9Y6X9 22 30925130-30968298 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7" "Lineage enriched" "Detected in many" 8 "T-cells: 17.7" "Low region specificity" "Detected in all" HPA000436 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000436: AB_1079404" "unprognostic (3.43e-2)" "unprognostic (1.71e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-2)" "unprognostic (6.15e-2)" "unprognostic (3.56e-3)" "unprognostic (2.89e-3)" "unprognostic (4.63e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-1)" "unprognostic (5.46e-3)" "unprognostic (1.32e-1)" "prognostic unfavourable (6.54e-8)" "unprognostic (5.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.02e-2)" "unprognostic (6.66e-3)" 6.7 5.3 4.6 6.0 7.0 5.2 16.9 6.4 7.5 6.8 7.1 6.5 14.8 4.7 7.4 5.9 6.1 6.3 4.7 7.7 4.7 5.0 5.3 9.6 6.3 8.8 4.8 4.1 8.1 7.5 9.4 8.1 7.7 7.7 8.0 4.5 7.7 11.0 7.9 9.8 10.4 5.6 6.7 5.3 7.3 5.9 50.5 5.0 5.5 6.6 6.1 6.6 6.8 9.7 1.7 2.2 0.8 2.0 1.2 17.7 3.9 18.5 17.0 20.1 22.2 21.1 15.6 15.2 13.8 10.8 14.2 14.6 22.1 9.0 16.7 12.4 12.0 16.0 18.0 8.5 11.8 13.1 21.9 17.4 13.5 25.9 18.2 14.2 18.0 14.9 12.6 14.8 19.3 14.2 22.8 17.3 14.8 30.3 15.1 29.0 18.6 12.6 28.9 11.8 21.4 13.7 17.0 18.0 14.1 14.6 23.9 10.5 12.8 24.1 14.2 17.2 17.0 12.1 12.1 15.5 19.0 18.8 12.6 10.1 12.2 0.5 1.1 0.8 10.3 1.9 9.1 1.5 14.3 8.3 1.2 1.7 14.7 8.9 0.3 1.2 2.0 2.2 17.7 3.9 4.6 7.0 6.4 7.5 4.7 5.0 4.8 4.1 7.7 5.0 MORC3 "KIAA0136, NXP2, ZCW5, ZCWCC3" ENSG00000159256 "MORC family CW-type zinc finger 3" Q14149 21 36320189-36386148 "Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018406, HPA034848" Approved Enhanced Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA018406: AB_1858988, HPA034848: " "unprognostic (4.01e-3)" "unprognostic (4.86e-2)" "unprognostic (4.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (6.29e-2)" "unprognostic (6.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.53e-1)" "unprognostic (6.40e-2)" "unprognostic (8.61e-2)" "unprognostic (1.18e-3)" "unprognostic (1.38e-2)" "unprognostic (3.91e-1)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" 18.0 11.2 15.6 15.4 16.4 28.0 17.5 30.9 16.3 20.3 15.3 10.1 14.1 10.6 22.5 10.6 23.0 17.9 13.5 12.5 14.6 7.9 11.6 13.0 17.0 20.6 17.5 12.1 29.3 11.3 14.8 25.1 20.6 16.6 16.1 12.1 7.3 20.6 14.2 28.1 20.1 14.8 21.4 21.0 19.1 14.0 10.8 18.2 25.5 15.0 17.6 20.0 22.9 23.5 11.2 7.6 21.9 10.7 8.2 11.9 6.6 12.0 4.6 11.2 7.4 11.6 12.6 15.8 11.4 20.0 13.2 10.9 7.5 7.8 5.8 4.4 13.0 6.1 8.7 11.4 13.9 10.9 6.8 24.0 5.0 5.5 7.6 12.3 21.4 7.8 14.3 12.6 17.4 10.5 19.2 14.8 10.6 4.0 7.9 6.7 9.3 5.6 9.8 5.6 10.4 5.8 12.6 4.7 12.1 13.3 8.7 13.6 9.7 10.4 14.0 12.8 3.1 8.6 9.8 6.6 5.8 5.6 8.3 19.6 9.2 21.9 7.5 16.1 8.4 9.4 8.3 10.0 9.2 7.9 7.6 11.2 11.9 8.5 11.7 8.2 10.7 4.9 11.3 6.6 15.6 16.4 30.9 16.3 14.6 7.9 17.5 12.1 16.6 18.2 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: " "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 4.2 4.0 6.9 5.6 15.1 2.5 4.9 25.8 6.6 7.3 4.4 6.1 14.4 4.5 9.3 13.9 3.7 23.5 7.4 3.0 5.5 5.7 7.8 4.1 5.8 3.5 3.9 8.0 15.2 8.6 4.9 11.6 2.5 11.7 6.7 3.1 8.8 9.1 11.7 4.7 6.4 4.3 6.0 4.9 4.6 5.4 17.3 4.8 5.8 15.0 3.3 3.8 3.5 4.6 2.1 3.7 4.2 4.3 0.8 2.6 1.0 6.3 7.6 5.3 4.8 1.8 0.9 5.5 1.9 1.3 3.1 2.7 3.6 7.1 1.7 4.1 1.2 7.8 1.1 3.1 3.1 3.8 8.2 1.7 14.0 4.1 1.6 2.1 0.9 1.1 0.7 3.0 2.6 2.2 2.6 2.0 1.1 8.7 2.1 0.7 3.1 6.7 2.2 4.8 2.7 2.5 2.8 8.7 4.3 5.0 9.3 4.0 4.9 0.6 0.7 3.6 5.2 2.5 2.3 4.7 1.7 1.1 7.2 1.2 2.4 0.0 0.8 0.2 1.4 0.3 0.8 1.0 1.5 1.1 1.0 2.1 2.6 1.2 4.2 0.8 4.3 3.7 0.1 1.0 6.9 15.1 25.8 6.6 5.5 5.7 3.9 8.0 11.7 4.8 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.9 6.3 5.3 3.6 8.4 4.9 11.6 13.4 24.4 12.9 12.6 15.3 3.2 2.7 18.7 8.5 2.9 8.2 6.9 17.1 8.9 4.8 2.2 16.6 6.2 35.8 6.3 3.9 8.9 8.5 14.5 6.3 9.4 2.8 10.9 15.6 11.1 4.4 2.8 5.4 14.3 3.3 9.4 5.0 5.5 22.8 3.1 3.9 6.8 6.8 23.1 2.7 3.9 4.7 6.4 3.9 23.7 11.9 8.5 11.4 4.3 8.7 10.8 8.3 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: " "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 5.9 8.1 6.5 11.2 3.4 2.5 4.6 4.5 5.4 4.7 4.8 7.4 8.0 3.7 10.0 4.1 4.6 3.8 6.5 0.8 9.7 5.0 3.8 6.0 11.1 4.4 2.9 14.9 7.2 5.6 4.0 2.4 8.0 9.0 7.7 4.8 17.6 8.3 22.6 5.9 12.2 7.7 6.7 8.9 7.4 8.9 3.6 21.3 8.5 13.1 4.5 8.0 8.8 9.1 9.2 14.4 18.9 4.3 6.0 5.7 2.5 9.1 33.1 11.2 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.3 25.8 18.8 12.4 23.9 21.9 11.4 20.4 30.0 38.7 28.5 13.4 20.8 7.3 14.8 35.3 23.9 28.5 35.0 33.0 15.3 26.1 13.4 17.1 22.9 29.8 11.1 20.8 22.3 28.9 36.1 21.4 29.3 21.8 9.5 41.9 17.6 7.3 6.9 20.3 12.2 16.9 14.6 12.5 38.8 12.1 11.8 21.5 26.6 18.5 7.0 21.6 9.0 19.7 16.0 8.2 9.3 25.4 4.8 8.8 6.1 22.9 14.4 22.7 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85853 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favourable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 20.8 32.1 18.4 21.1 18.4 25.3 33.2 18.3 32.1 19.5 20.4 12.6 24.6 21.0 22.6 30.5 21.5 18.5 28.5 37.4 16.7 15.1 16.1 32.0 20.1 39.7 15.8 18.2 23.8 36.5 8.0 21.7 19.0 16.5 23.2 7.2 15.2 47.1 24.2 33.6 19.0 19.4 19.2 13.6 25.6 27.3 10.9 11.2 18.3 29.2 22.4 22.8 27.2 25.2 33.5 38.8 27.2 27.4 41.2 31.1 22.4 13.8 20.3 5.5 17.0 10.2 23.3 13.9 20.0 27.6 13.0 14.3 12.8 18.8 9.9 17.5 11.3 17.9 3.8 8.7 2.0 17.0 14.7 6.4 10.4 19.0 29.5 6.7 39.8 22.4 12.2 14.6 6.0 22.6 14.1 17.9 16.9 48.0 11.6 30.9 10.0 22.2 22.2 6.7 37.7 10.8 5.0 4.5 11.6 10.5 11.4 25.1 16.3 34.7 19.8 10.6 13.5 14.4 9.8 17.4 5.9 12.6 19.6 19.4 37.8 14.2 27.4 27.2 22.7 19.2 20.6 33.5 21.8 22.6 28.5 30.6 16.8 17.2 14.0 41.2 15.7 38.8 31.1 22.4 18.4 18.4 18.3 32.1 16.7 15.1 15.8 18.2 16.5 11.2 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170226 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavourable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favourable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 13.7 15.5 32.0 17.5 25.1 12.3 54.1 37.1 32.6 18.5 16.0 9.3 7.0 9.9 18.9 17.1 26.5 11.9 12.3 9.4 25.4 22.2 12.0 11.5 13.6 16.1 17.5 21.9 10.4 7.2 13.6 43.5 17.4 24.0 11.3 18.7 10.8 18.1 10.3 15.4 28.4 11.0 16.8 31.7 12.7 11.2 9.9 17.9 10.8 8.7 12.9 18.2 19.6 18.5 18.6 24.6 19.4 25.2 17.1 28.3 15.6 19.3 10.6 23.7 11.6 11.6 16.3 13.1 20.9 25.1 18.3 8.9 17.0 11.4 16.0 12.7 11.4 20.4 22.6 21.7 24.6 11.8 14.8 12.8 8.8 30.6 11.5 31.9 19.9 10.3 19.5 10.8 31.3 20.9 30.1 4.5 27.8 15.7 24.5 37.7 21.7 14.7 30.4 11.0 10.5 16.5 20.4 16.3 7.0 35.2 15.7 15.0 27.5 19.9 16.4 17.2 17.1 15.1 14.8 6.7 16.2 63.5 15.5 26.2 21.7 13.0 22.0 19.4 22.3 25.2 28.3 18.6 23.1 23.2 24.6 14.6 24.8 23.6 2.7 17.1 17.4 14.7 23.0 15.6 32.0 25.1 37.1 32.6 25.4 22.2 17.5 21.9 24.0 17.9 MPHOSPH8 "HSMPP8, mpp8" ENSG00000196199 "M-phase phosphoprotein 8" Q99549 13 19633681-19673459 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039701, HPA040035" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039701: AB_10805484, HPA040035: AB_10794207" "unprognostic (4.22e-1)" "unprognostic (5.58e-2)" "unprognostic (2.66e-1)" "unprognostic (4.01e-3)" "unprognostic (3.05e-2)" "unprognostic (1.86e-1)" "unprognostic (2.81e-3)" "unprognostic (4.90e-2)" "unprognostic (4.55e-2)" "unprognostic (1.59e-1)" "unprognostic (3.52e-3)" "unprognostic (3.40e-2)" "unprognostic (6.49e-2)" "unprognostic (3.86e-2)" "unprognostic (4.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.02e-1)" 20.6 27.1 37.7 33.4 37.1 19.2 21.4 48.9 45.0 32.0 26.6 13.2 31.7 17.8 29.4 26.7 19.1 22.3 18.8 27.9 31.0 27.2 18.9 16.5 22.9 28.4 28.8 32.8 43.6 22.0 20.9 44.3 20.0 28.4 26.1 20.1 11.9 24.5 38.8 25.7 26.6 23.9 31.3 37.1 30.0 22.5 16.6 33.5 16.5 26.8 11.7 20.4 31.3 37.9 21.7 13.8 39.4 9.9 11.5 17.6 3.6 12.8 8.3 12.3 20.0 16.0 20.4 21.8 19.3 14.0 12.2 10.5 12.6 22.7 20.3 15.5 11.7 21.5 22.6 13.5 15.8 25.2 11.6 32.7 13.6 15.3 14.3 23.5 26.7 12.0 17.5 9.6 13.6 16.1 15.8 13.1 11.3 12.5 17.9 19.7 12.0 9.2 14.5 28.5 16.0 21.2 10.0 17.0 10.4 18.1 16.7 17.5 10.1 19.5 18.8 9.5 8.6 17.9 9.7 8.9 9.2 20.2 7.2 21.8 14.6 39.4 9.5 15.4 13.0 6.9 11.5 21.5 14.6 12.5 4.3 21.7 17.6 14.4 27.5 11.5 9.9 13.8 11.3 3.6 37.7 37.1 48.9 45.0 31.0 27.2 28.8 32.8 28.4 33.5 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.7 9.3 14.9 16.8 6.7 6.3 5.6 9.0 4.6 11.3 9.1 8.8 4.2 17.2 6.7 5.9 6.3 19.3 7.3 15.9 11.0 12.5 17.5 10.3 8.6 5.1 16.3 15.2 6.8 2.8 10.8 10.8 11.6 12.1 7.6 10.3 7.3 18.5 25.7 10.2 10.2 16.6 15.0 11.1 8.8 8.6 19.2 9.0 14.0 5.6 8.8 10.5 12.3 6.5 9.3 13.4 10.8 12.8 11.9 19.1 14.3 7.4 15.7 19.2 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" 170000 Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 13.6 33.3 24.2 11.2 26.2 7.4 14.7 19.2 33.7 16.7 22.6 26.1 15.3 32.6 15.7 26.8 17.1 20.7 13.4 28.8 22.7 22.2 22.5 30.2 10.6 16.2 28.1 28.3 23.2 34.2 24.7 15.0 11.4 37.4 20.6 23.1 18.3 18.6 17.9 33.3 11.7 27.4 16.4 21.7 14.7 14.3 23.5 17.7 16.4 17.1 15.0 16.6 15.6 11.7 12.8 10.2 2.4 7.4 17.7 27.1 12.9 10.4 14.5 12.0 13.6 27.5 13.4 10.5 9.0 14.8 15.5 21.8 14.3 13.9 14.9 19.7 13.1 26.1 23.8 26.3 14.8 11.3 29.8 26.6 13.8 15.3 19.6 12.2 7.9 17.8 6.8 14.6 26.3 21.0 8.9 12.2 20.0 8.9 13.1 5.4 6.6 12.4 13.5 11.3 36.4 18.2 11.9 22.5 9.8 10.5 19.0 11.3 26.1 8.5 9.5 9.3 8.0 6.9 8.7 30.3 17.9 9.7 19.5 17.8 6.7 0.7 7.2 2.4 13.5 7.4 17.5 12.8 18.3 15.4 10.2 12.5 27.1 19.7 1.1 17.7 6.3 8.5 22.7 12.9 24.2 26.2 19.2 33.7 22.7 22.2 28.1 28.3 37.4 17.7 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell line enriched" "Detected in single" 17 "HEL: 11.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" 7400000 "Endoplasmic reticulum, Golgi apparatus" "Plasma membrane, Cytosol" "HPA054404: , HPA073017: " "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Cell line enriched" "Detected in single" 78 "HEL: 40.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 40.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126023-40134652 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: , HPA065463: " "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 13.7 15.2 11.6 9.3 12.7 8.7 14.8 13.9 12.1 12.7 14.5 12.6 9.5 11.9 11.0 13.6 12.9 10.0 9.3 9.3 11.8 11.4 20.5 52.1 8.7 13.3 15.0 8.8 12.0 17.3 10.1 16.1 13.8 10.4 11.5 11.6 11.1 14.4 10.5 10.1 11.3 13.4 9.2 11.9 12.7 10.8 11.0 12.0 25.5 19.2 7.9 12.8 11.3 12.6 53.8 41.9 52.9 38.0 30.7 45.0 40.9 23.7 7.0 13.0 16.4 13.1 15.5 14.4 8.5 10.1 13.6 13.8 9.5 11.5 19.3 12.6 8.8 29.2 7.8 16.0 17.1 14.8 28.4 14.8 10.3 20.0 15.8 17.4 14.1 14.5 22.2 9.7 12.7 16.4 38.6 14.8 13.8 12.2 17.7 59.2 18.0 23.7 25.9 9.1 25.4 15.1 5.6 19.0 23.6 14.1 13.3 20.5 17.2 26.3 14.8 7.4 22.3 8.9 13.2 24.2 28.5 32.8 12.6 30.0 21.7 43.4 38.0 52.9 28.0 34.3 31.3 53.8 35.9 32.8 39.4 47.0 40.0 35.1 20.4 30.7 31.5 41.9 45.0 40.9 11.6 12.7 13.9 12.1 11.8 11.4 15.0 8.8 10.4 12.0 MPND FLJ14981 ENSG00000008382 "MPN domain containing" Q8N594 19 4343527-4360086 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043274, HPA045475" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043274: AB_2678403, HPA045475: " "unprognostic (3.16e-2)" "prognostic favourable (2.99e-4)" "unprognostic (4.85e-2)" "prognostic favourable (6.12e-4)" "unprognostic (8.60e-2)" "unprognostic (5.37e-3)" "unprognostic (3.16e-2)" "prognostic favourable (1.55e-4)" "unprognostic (1.23e-1)" "unprognostic (2.87e-2)" "unprognostic (3.94e-3)" "unprognostic (5.18e-2)" "prognostic favourable (7.04e-4)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (5.44e-2)" "unprognostic (9.04e-2)" 7.7 13.7 18.9 14.1 12.3 11.5 8.0 12.1 21.6 6.5 19.9 6.6 15.7 25.9 8.5 7.8 13.8 8.2 11.8 12.1 14.2 11.3 12.8 25.1 14.3 8.5 12.7 20.0 8.7 20.7 14.5 7.2 7.0 11.9 12.1 13.9 11.5 14.3 9.0 17.4 12.5 20.7 9.3 8.9 10.1 12.5 4.2 6.7 13.5 8.6 8.3 10.1 9.3 11.0 3.1 4.5 10.3 6.0 2.4 5.6 1.9 7.9 6.7 11.1 12.6 6.9 3.3 11.3 3.8 3.7 3.2 4.0 12.9 4.1 7.2 12.2 5.0 8.2 5.0 6.7 1.8 8.1 11.3 5.5 9.4 20.8 5.5 7.3 9.9 5.0 4.8 3.5 3.7 9.8 2.9 18.8 4.0 22.9 17.3 6.3 5.0 9.7 14.3 3.4 10.4 8.2 14.0 12.4 12.7 7.0 10.0 5.3 6.7 9.0 3.7 5.1 5.5 31.3 7.7 15.6 9.6 4.7 5.7 4.1 5.9 10.3 5.1 2.4 2.2 6.0 3.4 1.8 2.6 3.1 4.5 3.1 1.7 1.9 1.2 2.4 2.7 4.5 5.6 1.9 18.9 12.3 12.1 21.6 14.2 11.3 12.7 20.0 11.9 6.7 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Group enriched" "Detected in some" 93 "HL-60: 212.9;NB-4: 279.1" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 279.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 MPP1 "DXS552E, PEMP" ENSG00000130830 "Membrane palmitoylated protein 1" Q00013 X 154778684-154821007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 58.4;REH: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 46.4;neutrophil: 45.3" "Group enriched" "Detected in all" 7 "dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076675 Enhanced Supported "Plasma membrane,Centriolar satellite" 4300000 "Plasma membrane" "Centriolar satellite" "HPA076675: " "unprognostic (2.15e-1)" "unprognostic (4.06e-2)" "unprognostic (4.52e-2)" "unprognostic (1.83e-3)" "unprognostic (7.14e-2)" "unprognostic (2.60e-2)" "unprognostic (7.47e-2)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (7.79e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-3)" "prognostic favourable (4.60e-6)" "unprognostic (6.69e-2)" "unprognostic (2.53e-2)" "unprognostic (4.68e-2)" "unprognostic (6.67e-3)" 18.7 18.2 12.7 14.4 19.2 52.9 9.9 25.8 30.9 7.1 18.3 10.0 15.1 32.0 8.9 9.5 6.1 10.0 13.5 14.1 14.3 13.0 23.3 20.4 18.2 11.9 15.9 13.5 7.2 18.9 19.5 6.5 45.6 28.8 9.1 10.1 6.4 17.1 10.9 14.6 6.3 42.7 11.0 15.8 27.4 7.9 4.1 7.4 27.1 8.3 6.4 6.9 10.0 7.1 1.6 12.7 46.4 20.9 2.0 3.8 15.8 11.1 2.3 5.2 5.2 5.4 5.7 16.9 4.2 6.4 7.1 8.7 6.3 1.0 8.7 8.2 4.6 1.3 5.9 1.8 5.6 9.2 10.4 58.4 1.6 6.7 8.1 11.9 33.9 5.5 2.5 7.8 1.9 16.0 25.2 1.4 7.9 0.0 27.0 15.8 0.5 7.7 36.9 1.3 4.2 4.1 0.9 1.3 2.1 3.4 0.3 3.6 0.9 7.0 7.4 6.5 3.5 14.3 11.3 10.2 13.9 3.4 9.1 16.8 3.1 9.0 20.9 46.4 1.2 16.7 1.4 1.6 1.4 1.3 12.7 0.7 3.8 1.9 45.3 2.0 20.3 3.5 0.7 15.8 12.7 19.2 25.8 30.9 14.3 13.0 15.9 13.5 28.8 7.4 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1" "Cell line enhanced" "Detected in many" "T-47d: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 14 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026486 Approved Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA026486: AB_1854085" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavourable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.1 5.0 12.1 2.1 11.8 1.1 3.1 19.5 26.3 3.5 5.1 19.8 2.7 1.9 4.6 31.0 4.1 3.3 3.0 9.0 13.8 14.2 2.0 0.9 2.0 1.2 15.3 14.4 2.8 4.4 31.1 8.4 3.4 11.5 7.1 2.0 6.5 2.3 10.7 1.7 2.0 2.0 6.5 20.3 1.3 2.5 13.8 12.3 0.0 4.5 0.0 1.4 3.6 2.8 0.1 0.0 0.0 0.1 0.0 1.9 0.7 4.9 7.3 7.8 11.3 1.1 0.7 4.3 1.7 0.2 6.8 6.5 2.5 3.3 7.1 4.0 1.7 2.0 10.5 4.1 5.3 0.0 8.1 0.6 6.7 0.1 0.2 0.0 2.1 1.1 0.3 4.9 0.0 0.4 2.7 0.0 2.0 1.9 1.0 0.5 14.0 4.5 5.0 11.2 0.5 0.1 0.1 8.4 7.8 2.1 0.7 2.9 17.2 3.4 0.1 7.6 9.6 2.9 3.1 2.4 4.9 0.0 11.4 4.8 1.4 0.0 0.1 0.0 1.4 0.0 0.2 0.0 0.5 1.2 0.0 0.1 1.6 1.9 0.0 0.0 0.0 0.0 0.1 0.7 12.1 11.8 19.5 22.5 13.8 14.2 15.3 14.4 11.5 12.3 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.4;SCLC-21H: 13.0;T-47d: 6.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.8 0.7 1.8 1.4 0.0 1.5 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 1.5 1.2 2.3 1.7 0.0 1.5 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.4 1.5 0.9 0.0 0.6 0.9 0.0 0.0 0.8 1.2 0.0 1.0 0.4 4.3 0.6 13.0 3.4 0.7 2.8 0.5 6.9 1.5 1.4 3.4 3.2 0.9 3.0 0.9 0.4 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 MPP4 DLG6 ENSG00000082126 "Membrane palmitoylated protein 4" Q96JB8 2 201644870-201698694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 78.2" "Cell line enhanced" "Detected in some" "HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;LHCN-M2: 41.4;TIME: 8.2;U-87 MG: 10.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057393 Supported "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA057393: " "unprognostic (1.42e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-1)" "unprognostic (2.50e-2)" "unprognostic (2.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.09e-2)" "unprognostic (9.42e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (9.20e-2)" "unprognostic (3.33e-16)" "unprognostic (1.82e-2)" "unprognostic (8.23e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" 0.4 1.7 0.3 0.5 0.6 0.0 0.3 4.9 1.1 1.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.1 0.4 0.2 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.0 0.7 0.7 0.3 0.3 0.3 78.2 0.2 0.5 0.6 4.1 0.2 0.3 0.2 3.8 0.1 2.2 0.2 0.2 0.6 0.6 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 5.3 1.3 3.3 3.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 10.2 0.0 6.0 0.0 0.0 41.4 0.0 0.0 0.0 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 4.2 1.2 0.9 3.7 0.0 0.0 0.0 10.8 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 4.9 0.6 0.5 0.4 0.2 0.2 0.3 0.2 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favourable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 53.7 8.6 8.7 7.0 5.1 4.6 7.7 16.4 8.6 12.1 8.1 8.5 16.5 4.6 7.8 13.3 11.3 5.0 9.4 18.5 2.2 3.4 4.2 9.1 5.8 5.9 1.6 3.2 4.8 3.6 7.0 8.9 6.7 4.4 2.0 19.2 7.2 5.1 1.9 2.9 5.9 4.6 13.9 5.5 10.9 13.4 4.9 3.5 10.2 10.0 5.6 10.3 3.3 10.3 15.4 32.7 5.4 7.2 3.2 2.8 7.0 10.2 3.7 5.3 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.2" "Cell line enhanced" "Detected in many" "BEWO: 10.7;CACO-2: 20.2;CAPAN-2: 12.6;T-47d: 40.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Enhanced Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA037597: , HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favourable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favourable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 1.9 1.2 1.9 3.2 1.9 2.6 3.7 3.2 3.0 2.3 6.3 1.9 1.9 1.8 1.9 3.7 16.3 4.6 2.0 2.0 1.9 0.6 4.9 1.9 3.7 4.6 1.9 1.9 1.9 11.3 1.8 7.8 4.2 2.2 2.8 3.5 2.6 5.0 1.9 4.7 11.2 3.3 3.0 1.9 2.4 5.9 33.2 1.9 1.9 5.7 1.9 3.0 3.4 5.4 0.7 8.1 9.0 8.2 4.9 9.2 5.3 2.6 0.0 0.2 0.0 0.0 0.0 10.7 0.5 0.4 2.2 3.5 20.2 12.6 0.0 0.1 1.5 4.7 1.8 3.4 5.1 0.0 3.4 0.0 0.6 1.2 0.0 0.0 0.0 0.1 5.3 0.3 0.2 0.0 0.4 0.0 2.8 4.8 1.0 0.0 0.6 0.9 0.5 6.1 0.0 0.2 8.5 0.5 0.0 1.0 5.2 0.0 40.8 0.5 0.0 0.8 5.9 0.0 0.4 0.1 0.0 0.0 0.0 4.8 0.0 0.0 8.2 9.0 4.3 2.7 6.3 0.7 4.7 2.9 8.1 0.6 9.2 6.4 3.3 4.9 1.4 0.1 1.1 5.3 1.9 1.9 3.2 3.0 1.9 0.6 1.9 1.9 2.2 1.9 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favourable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 4.3 6.2 4.7 11.5 13.7 16.2 4.5 10.3 14.9 6.1 9.7 11.6 12.3 8.6 22.8 9.9 4.7 3.3 5.8 5.8 9.4 5.6 2.4 12.5 2.6 19.2 11.0 17.8 23.9 7.7 5.4 3.9 3.6 3.1 8.3 10.2 10.1 8.1 7.4 3.3 1.7 3.3 3.0 10.4 10.0 6.6 6.7 3.8 9.6 7.6 9.0 5.6 14.4 7.4 12.4 4.8 11.9 5.7 13.0 11.4 10.8 9.3 5.8 12.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell line enhanced" "Detected in some" "HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria Nucleoli "Vesicles, Mitochondria" "HPA062575: " "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 11.5 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.0 0.0 3.1 0.2 0.0 8.1 0.1 6.1 0.0 0.0 3.1 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 MPRIP "M-RIP, p116Rip, RHOIP3" ENSG00000133030 "Myosin phosphatase Rho interacting protein" Q6WCQ1 17 17042545-17217679 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 27.5" "Lineage enriched" "Detected in all" 6 "T-cells: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022034, HPA022901" Enhanced Supported "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA022034: AB_1854093, HPA022901: AB_2297761" "unprognostic (1.92e-2)" "unprognostic (1.53e-3)" "unprognostic (5.81e-3)" "unprognostic (9.92e-3)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (5.18e-2)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (1.60e-1)" "unprognostic (6.56e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" 46.5 38.7 46.7 33.7 58.8 27.7 47.4 47.7 62.0 48.4 35.3 45.8 31.9 36.1 54.9 40.9 51.6 32.9 38.2 63.7 46.9 39.7 30.2 31.3 40.2 34.5 46.8 44.9 33.5 46.6 55.0 35.8 37.4 36.5 33.4 29.0 41.0 34.0 46.8 66.7 35.1 32.9 63.0 38.2 35.3 45.9 31.4 47.7 19.9 38.4 30.1 35.4 39.8 55.3 4.4 4.8 1.5 1.2 1.9 27.5 5.0 62.6 45.9 19.8 16.1 20.9 15.7 29.7 32.5 22.3 25.6 19.2 35.6 46.1 24.7 33.3 47.4 60.3 25.0 43.0 27.0 25.4 13.3 13.4 39.4 12.4 14.2 7.1 10.7 15.0 26.0 28.7 22.1 26.4 8.3 13.9 40.9 20.7 28.8 24.2 9.5 53.0 25.6 32.1 9.1 19.5 28.9 11.4 18.5 34.4 28.2 15.5 13.2 11.1 25.5 23.9 27.0 63.3 55.3 10.9 8.6 11.4 43.2 12.8 56.9 1.1 1.2 1.5 4.5 0.8 9.2 4.4 17.5 7.3 1.1 3.8 12.6 6.0 0.5 1.9 0.8 4.8 27.5 5.0 46.7 58.8 47.7 62.0 46.9 39.7 46.8 44.9 36.5 47.7 MPST "MST, TST2, TUM1" ENSG00000128309 "Mercaptopyruvate sulfurtransferase" P25325 22 37019635-37029822 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001240 Enhanced Approved Mitochondria,Cytosol 2800000 Mitochondria Cytosol "HPA001240: AB_1079408" "unprognostic (7.18e-3)" "unprognostic (4.45e-1)" "unprognostic (1.80e-1)" "unprognostic (1.30e-3)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (7.07e-2)" "unprognostic (2.15e-1)" "unprognostic (2.22e-1)" "unprognostic (1.35e-1)" "unprognostic (2.25e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-3)" "unprognostic (3.98e-2)" "unprognostic (3.51e-1)" "unprognostic (2.52e-1)" "prognostic favourable (5.89e-4)" 8.7 7.2 4.5 6.8 6.4 10.5 22.7 2.6 5.4 8.8 39.1 8.0 2.8 36.8 6.1 3.0 19.8 4.3 15.3 14.1 4.6 2.3 14.1 106.2 10.3 5.4 8.8 3.8 12.6 20.7 0.7 2.7 4.2 5.6 6.6 5.7 3.8 13.4 3.9 11.5 15.9 33.7 4.8 4.8 4.1 12.8 24.9 7.1 2.1 6.3 6.2 5.1 8.7 11.6 9.6 37.1 18.5 26.5 28.8 16.1 12.5 14.1 16.7 8.2 16.9 9.6 6.0 13.0 7.7 6.9 8.4 11.4 15.9 6.3 22.3 11.2 5.5 9.9 7.1 11.2 1.2 13.4 39.7 8.6 7.3 37.4 30.6 9.2 12.1 10.5 21.9 5.5 5.1 17.0 15.3 6.5 2.3 11.0 0.8 31.5 15.4 17.4 23.9 9.7 16.6 8.5 4.6 4.2 31.6 5.1 8.1 14.7 8.7 15.0 13.1 7.3 20.7 8.0 5.2 11.4 5.3 6.7 2.6 11.3 3.7 15.3 26.5 18.5 11.8 9.4 16.1 9.6 7.7 9.9 37.1 9.6 1.1 4.1 7.9 28.8 4.3 6.0 15.2 12.5 4.5 6.4 2.6 5.4 4.6 2.3 8.8 3.8 5.6 7.1 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: " "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (4.27e-6)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (8.08e-4)" "unprognostic (4.21e-2)" 34.4 19.1 13.6 21.4 13.9 3.2 42.0 14.3 13.7 32.2 27.3 15.4 15.9 18.5 34.8 25.2 32.1 30.1 34.3 29.2 12.0 14.0 22.2 20.9 22.2 20.7 14.4 10.0 38.3 25.4 13.7 24.3 34.0 14.3 28.3 28.2 28.0 51.7 19.4 11.0 17.7 26.6 30.5 13.0 19.6 21.3 27.7 10.9 9.7 29.0 25.8 28.0 33.6 35.0 4.2 12.5 51.4 8.9 2.9 2.4 3.0 18.1 26.5 20.8 16.1 67.2 30.5 65.8 28.4 36.7 18.6 23.2 48.9 25.3 6.4 33.3 35.9 30.6 20.7 31.4 15.8 14.5 11.2 5.3 14.1 11.7 41.8 6.2 3.4 27.9 39.7 29.6 33.4 24.7 19.7 13.5 22.0 6.0 20.9 7.4 13.2 11.4 12.8 17.9 28.3 28.5 17.6 12.0 19.9 25.2 26.3 14.6 14.2 3.3 28.0 21.4 9.6 27.3 15.3 20.2 31.3 29.8 30.6 7.3 3.3 1.9 8.1 5.4 0.8 6.8 0.4 4.2 0.8 1.2 10.9 2.5 2.4 0.8 51.4 2.9 8.9 12.5 0.1 3.0 13.6 13.9 14.3 13.7 12.0 14.0 14.4 10.0 14.3 10.9 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013409 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 26.2;ASC TERT1: 11.7;BJ: 14.7;BJ hTERT+: 37.3;BJ hTERT+ SV40 Large T+: 14.0;U-2197: 17.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 16.6" "Low region specificity" "Detected in all" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 10.8 1.7 0.8 7.6 1.2 0.0 26.6 7.8 1.5 61.9 39.5 1.2 13.9 4.8 49.2 22.3 28.2 28.0 30.6 6.2 0.7 0.4 4.2 2.1 4.8 5.6 1.1 1.3 25.6 0.9 0.4 1.1 5.9 1.8 29.6 4.8 5.8 2.9 25.5 3.1 4.0 10.1 41.1 1.0 8.2 14.2 13.1 0.6 0.1 3.8 6.4 2.7 42.2 19.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.2 11.7 0.5 14.7 37.3 14.0 9.3 0.0 0.6 0.0 0.3 11.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 3.3 0.0 0.0 8.6 0.0 8.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 17.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 7.8 1.5 0.7 0.4 1.1 1.3 1.8 0.6 MRI1 "MGC3207, MRDI, mtnA, Ypr118w" ENSG00000037757 "Methylthioribose-1-phosphate isomerase 1" Q9BV20 19 13764532-13774282 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042744, CAB045988" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" 2600000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "CAB045988: AB_2145566, HPA042744: " "unprognostic (1.16e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-3)" "unprognostic (1.61e-1)" "unprognostic (8.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.28e-1)" 14.5 18.5 12.5 21.8 18.3 16.6 16.8 24.5 21.8 21.5 17.2 23.6 23.5 19.0 24.2 21.3 20.7 19.9 17.6 13.5 14.6 12.1 24.4 20.1 15.4 19.5 16.5 14.3 24.0 20.5 21.3 17.3 24.2 17.2 17.8 13.4 18.5 23.4 21.6 13.0 28.6 18.5 13.3 16.6 22.0 19.8 5.0 16.7 20.0 21.8 10.5 18.2 18.1 20.6 5.7 8.9 6.9 5.8 5.0 6.6 3.6 10.5 7.9 3.9 9.4 4.3 8.1 9.7 12.6 7.3 11.4 10.4 8.3 8.5 5.7 5.0 4.7 17.9 18.3 13.0 7.0 10.0 31.7 4.5 12.5 8.9 3.8 13.7 10.6 8.1 7.2 5.8 4.6 10.6 8.7 0.3 4.9 15.5 15.1 8.7 6.5 22.5 14.3 5.3 12.9 5.9 8.3 7.9 7.1 4.6 10.3 9.8 8.0 5.0 6.4 5.9 5.5 20.8 6.1 7.8 8.2 1.7 5.0 15.9 7.0 6.9 5.5 1.9 6.2 5.8 6.0 5.0 5.3 6.6 4.7 5.7 4.3 3.3 4.1 5.0 3.2 8.9 4.8 3.6 12.5 18.3 24.5 21.8 14.6 12.1 16.5 14.3 17.2 16.7 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043975: " "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavourable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 6.6 6.3 11.8 10.7 12.2 4.6 10.8 30.0 16.1 14.8 8.5 14.2 14.3 7.8 13.7 16.1 4.8 23.5 7.7 7.8 12.6 11.8 8.8 6.0 8.8 14.1 16.0 13.4 21.1 9.7 11.2 22.7 5.0 12.1 11.1 8.4 12.9 9.1 19.8 5.8 12.0 11.0 11.7 10.1 13.3 7.1 8.0 14.7 2.7 11.6 3.5 14.0 8.6 10.5 10.7 5.5 2.9 1.0 4.0 8.1 2.8 1.2 2.8 4.4 10.7 9.0 8.1 5.4 3.1 2.8 3.9 5.8 4.5 4.2 5.1 3.7 1.4 3.4 5.0 10.1 3.0 4.8 4.9 1.7 4.8 3.1 5.5 2.1 2.1 6.1 8.2 4.5 3.5 4.3 2.5 2.4 4.0 5.2 3.3 2.2 2.2 2.5 4.0 1.7 3.7 7.0 1.0 8.4 2.6 1.5 4.4 3.6 5.5 1.8 1.0 2.4 2.0 1.9 2.1 2.9 1.8 3.6 2.3 3.6 1.7 1.3 0.7 2.9 3.4 0.7 4.5 10.7 5.1 4.2 0.9 10.3 8.1 5.9 1.1 4.0 1.0 5.5 2.9 2.8 11.8 12.2 30.0 16.1 12.6 11.8 16.0 13.4 12.1 14.7 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: " "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favourable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 11.4 13.3 6.7 11.6 8.2 6.5 10.4 5.2 7.3 13.5 12.1 25.4 4.0 16.3 12.9 7.2 12.2 14.3 13.8 8.5 9.5 29.7 13.2 10.7 30.7 16.0 10.9 6.4 8.5 14.7 15.6 21.2 9.4 22.0 11.0 7.2 22.4 14.1 39.0 6.0 15.7 16.5 6.6 20.9 10.1 7.3 16.0 8.3 5.1 9.0 15.9 10.1 19.7 8.6 7.9 10.6 10.4 14.4 12.8 11.6 33.7 5.8 17.7 7.7 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" "Nucleoplasm, Mitochondria" "HPA051657: " "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavourable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 16.5 18.0 30.5 21.4 29.7 25.5 26.5 27.7 28.0 19.6 24.0 13.3 26.8 18.9 20.4 25.2 24.2 23.0 28.3 47.3 24.6 26.1 33.1 33.7 12.4 30.0 27.6 21.0 21.4 23.8 13.2 17.7 16.1 25.6 18.0 21.8 14.4 56.9 39.4 56.6 17.9 25.0 17.6 16.4 14.9 19.3 18.7 21.9 21.3 22.2 40.3 20.4 17.2 16.5 49.1 42.2 20.3 39.3 29.1 36.4 34.6 23.7 33.0 20.1 19.2 14.2 15.5 23.9 16.6 17.9 31.4 21.7 67.6 30.6 36.8 37.1 18.0 29.6 33.5 31.6 24.7 24.1 25.3 26.0 25.4 40.5 28.3 44.6 19.7 22.8 16.3 31.3 37.2 21.5 50.3 28.0 18.7 43.8 21.1 47.2 18.3 48.7 29.9 24.3 57.2 30.9 27.5 32.7 26.1 21.1 42.5 65.8 43.9 25.9 18.0 21.5 21.5 47.1 30.2 20.9 32.2 51.8 28.7 27.5 29.1 20.3 39.3 19.4 25.9 39.3 27.2 49.1 34.1 28.7 42.2 33.4 32.7 27.0 10.8 29.1 36.1 31.0 36.4 34.6 30.5 29.7 27.7 28.0 24.6 26.1 27.6 21.0 25.6 21.9 MRPL23 "L23MRP, RPL23L" ENSG00000214026 "Mitochondrial ribosomal protein L23" Q16540 11 1947278-1984522 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA050406 Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA050406: " "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "prognostic favourable (3.97e-4)" "unprognostic (3.45e-2)" "unprognostic (2.08e-1)" "unprognostic (2.40e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-2)" "unprognostic (8.32e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (8.43e-2)" "unprognostic (1.82e-1)" "unprognostic (6.33e-2)" "unprognostic (7.23e-3)" "unprognostic (4.08e-2)" 19.4 32.7 19.3 21.8 19.3 37.3 22.1 14.0 25.1 18.1 21.0 17.2 22.5 28.7 19.9 31.4 31.5 30.7 29.9 39.8 16.6 16.8 25.1 43.8 17.4 42.9 18.4 16.9 29.4 69.1 22.6 25.8 14.5 17.4 17.9 21.0 21.2 48.7 25.9 61.0 35.5 23.8 15.9 14.3 22.4 25.6 11.1 11.4 32.5 21.1 44.3 30.1 12.7 17.9 24.1 20.2 12.6 14.5 6.8 22.1 3.3 23.1 27.3 14.7 17.5 6.0 16.9 21.4 6.9 10.3 11.8 8.8 1.7 28.1 23.5 13.8 16.1 23.2 23.7 32.4 5.6 26.2 115.1 8.4 8.6 33.4 15.9 22.2 13.3 13.3 12.6 8.2 2.4 8.4 6.3 12.7 17.1 25.4 17.7 4.6 20.1 20.7 24.4 7.7 24.5 10.5 9.1 29.6 25.0 8.7 20.6 12.8 0.5 28.1 10.6 16.2 10.0 4.0 15.3 17.8 15.8 22.1 25.2 19.3 0.0 1.9 14.5 12.6 7.0 10.7 5.6 24.1 10.3 7.8 20.2 20.3 22.1 6.7 0.8 6.8 7.8 8.6 14.6 3.3 19.3 19.3 14.0 25.1 16.6 16.8 18.4 16.9 17.4 11.4 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798386-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 90.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 16.8 20.7 14.3 12.9 14.8 8.2 17.9 9.3 15.4 12.3 15.9 9.0 13.7 14.1 13.5 15.1 20.8 12.7 19.0 32.4 13.5 13.0 22.4 44.6 11.6 13.6 14.2 8.6 16.5 28.9 9.0 10.1 13.9 12.3 17.0 10.5 9.6 27.3 12.3 52.5 11.7 16.2 16.1 11.9 11.5 14.4 46.0 11.1 14.1 18.1 35.8 15.3 16.3 14.4 24.5 90.2 12.9 20.3 18.4 25.8 24.1 22.9 34.1 15.9 30.0 29.4 24.3 20.9 20.1 17.8 24.0 23.0 24.7 18.7 30.9 36.6 21.5 25.1 35.7 33.1 17.4 33.7 39.8 15.0 75.8 39.0 37.6 19.4 11.8 21.4 25.6 26.8 34.9 23.3 22.7 20.0 34.1 42.1 22.7 43.9 15.4 42.0 18.3 11.9 37.3 21.7 18.8 17.7 12.2 43.8 34.2 20.9 20.1 21.1 14.0 20.9 22.7 14.1 22.2 19.2 23.9 40.8 26.2 36.0 28.4 12.9 20.3 12.5 18.6 19.4 22.1 24.5 21.0 22.4 24.3 17.9 18.6 22.1 5.8 18.4 16.5 90.2 25.8 24.1 14.3 14.8 9.3 15.4 13.5 13.0 14.2 8.6 12.3 11.1 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favourable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 13.1 13.9 15.9 11.8 11.7 21.2 10.5 6.5 13.3 20.2 14.9 7.0 13.1 15.4 10.3 18.5 9.4 42.4 11.0 13.6 10.1 7.8 8.9 3.6 12.5 7.3 14.5 5.3 16.7 5.5 7.6 7.0 15.3 12.9 19.1 11.4 8.7 11.7 18.8 17.3 7.4 9.6 10.6 14.2 16.9 12.2 10.2 13.5 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favourable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.0 18.3 29.5 23.9 17.6 26.6 25.0 21.1 21.4 32.2 26.2 24.6 13.7 24.0 9.2 19.3 15.4 38.0 28.5 49.5 28.1 29.3 27.7 12.6 30.6 24.2 32.0 13.9 19.6 31.2 28.0 41.5 31.2 36.5 13.1 36.7 18.1 35.9 25.1 44.1 33.8 29.7 14.9 29.3 35.6 35.0 36.2 19.7 18.1 30.2 22.7 29.9 17.7 15.4 23.7 13.5 15.0 28.3 15.7 22.8 26.5 9.3 25.3 35.5 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 MRPL43 bMRP36a ENSG00000055950 "Mitochondrial ribosomal protein L43" Q8N983 10 100969458-100987515 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073022 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073022: " "unprognostic (2.65e-1)" "unprognostic (1.10e-2)" "unprognostic (2.01e-2)" "unprognostic (4.11e-3)" "unprognostic (6.07e-2)" "unprognostic (3.74e-1)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.03e-1)" "unprognostic (6.04e-3)" "unprognostic (3.02e-1)" "unprognostic (3.53e-2)" "unprognostic (7.29e-2)" "unprognostic (2.53e-2)" 34.6 34.5 25.9 20.1 24.2 22.5 25.0 24.0 32.9 26.0 26.1 32.5 25.5 28.5 24.7 29.9 31.8 25.9 30.2 25.0 24.4 20.9 37.2 39.6 20.5 20.3 26.5 19.3 32.7 62.2 16.7 21.4 26.6 22.9 31.9 8.3 30.1 61.4 34.4 100.4 26.8 30.1 25.5 32.1 24.8 32.0 28.6 20.3 23.5 45.2 35.2 25.6 27.6 22.6 36.2 36.6 41.3 32.3 36.4 39.4 33.4 30.1 34.4 7.2 12.7 7.6 9.7 22.4 21.1 19.2 16.4 16.7 19.5 23.7 26.0 28.8 8.8 18.9 2.6 17.6 2.2 19.6 44.6 20.5 25.0 30.2 16.2 16.1 16.5 15.1 13.8 13.9 6.2 15.4 10.1 13.3 4.9 31.9 15.0 36.7 11.7 32.4 16.2 24.1 17.4 9.1 15.6 8.1 21.0 15.4 7.5 23.7 40.2 7.8 18.8 15.4 20.6 16.5 22.1 27.9 21.3 13.1 19.7 30.2 11.1 41.3 32.3 35.1 32.3 30.0 33.2 36.2 35.7 32.1 36.6 33.3 34.7 30.9 11.0 36.4 28.8 28.6 39.4 33.4 25.9 24.2 24.0 32.9 24.4 20.9 26.5 19.3 22.9 20.3 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA038147: AB_10671521, HPA038148: " "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favourable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 11.9 10.1 15.1 17.4 14.3 17.0 24.0 13.5 15.1 22.0 23.3 35.9 15.0 18.1 14.7 11.5 16.0 24.5 18.6 20.4 17.0 17.4 19.7 11.7 28.1 21.1 21.8 15.2 19.9 23.3 13.3 17.9 21.5 18.8 14.4 17.6 13.8 16.2 27.6 22.6 10.6 19.2 18.6 11.1 29.3 10.1 20.6 11.9 9.9 22.3 32.5 18.8 31.5 14.1 14.7 11.4 12.5 10.8 15.9 11.0 25.9 14.9 20.8 16.1 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: " "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favourable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 9.8 31.6 10.4 11.1 14.9 10.9 19.3 14.1 13.2 21.4 19.2 38.9 21.8 23.5 14.5 12.8 24.2 40.0 17.4 17.3 9.5 31.8 19.6 22.8 40.6 9.4 19.1 15.3 12.6 21.2 16.1 11.1 18.4 21.4 10.0 15.5 21.1 16.0 24.1 16.1 19.2 18.4 14.4 17.7 16.6 31.7 15.8 10.3 13.4 21.2 29.0 23.8 23.7 11.3 16.7 15.8 8.8 20.4 9.3 19.2 19.1 18.3 21.0 12.5 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.7 34.4 18.8 23.3 11.7 13.8 45.9 30.6 22.1 27.4 26.1 42.2 61.4 33.4 33.7 21.0 40.0 15.4 42.3 20.7 35.3 25.3 24.8 13.7 95.7 35.8 39.0 35.7 20.7 29.3 35.4 30.2 43.4 25.4 33.3 20.0 61.5 31.5 59.3 34.7 76.2 39.0 23.5 39.3 28.5 26.2 18.8 24.3 23.7 23.2 32.5 22.3 37.3 33.4 28.7 33.6 35.8 46.3 32.9 38.9 40.6 26.1 26.8 45.7 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 MRPL58 "DS-1, ICT1" ENSG00000167862 "Mitochondrial ribosomal protein L58" Q14197 17 75012670-75021261 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "Protein biosynthesis" "Hydrolase, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003634 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003634: AB_1851388" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" "unprognostic (1.94e-3)" "unprognostic (7.12e-2)" "unprognostic (3.16e-2)" "unprognostic (4.35e-2)" "unprognostic (1.38e-3)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (3.79e-3)" "unprognostic (4.98e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.66e-2)" "unprognostic (1.71e-1)" 12.4 23.4 13.9 18.4 14.8 13.7 17.6 18.1 15.7 10.6 15.2 9.8 17.5 13.1 12.5 15.1 19.4 12.5 16.3 31.2 12.2 12.0 25.7 41.7 10.2 15.2 14.3 14.0 10.5 24.2 13.5 9.1 13.9 14.0 13.6 16.3 10.1 17.7 22.5 57.3 16.5 13.4 14.8 12.9 14.6 15.1 7.6 14.0 13.2 14.8 31.2 15.7 14.3 11.6 18.3 28.9 11.2 22.0 20.0 33.5 20.9 26.2 37.1 12.4 14.2 13.3 13.2 17.3 15.6 17.0 32.5 27.7 28.4 16.5 18.3 12.8 15.4 18.8 25.3 26.8 34.4 9.3 30.0 14.3 17.5 23.6 25.2 29.9 9.9 14.3 12.8 21.6 34.6 24.7 23.1 13.4 18.3 32.8 25.8 20.6 9.3 50.3 13.4 22.0 26.6 23.9 19.5 11.5 22.1 13.5 24.7 30.2 32.9 24.8 10.4 17.6 19.3 18.4 29.3 14.0 11.1 20.2 20.1 33.6 14.5 11.2 22.0 10.5 17.3 20.7 14.9 18.3 21.1 17.2 28.9 14.8 15.7 17.6 2.0 20.0 17.4 19.4 33.5 20.9 13.9 14.8 18.1 15.7 12.2 12.0 14.3 14.0 14.0 14.0 MRPS10 FLJ10567 ENSG00000048544 "Mitochondrial ribosomal protein S10" P82664 6 42206801-42217865 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029133, HPA029134" Supported Approved "Actin filaments,Mitochondria" Mitochondria "Actin filaments" "HPA029133: AB_10600084, HPA029134: AB_10600058" "unprognostic (1.06e-1)" "unprognostic (3.90e-2)" "unprognostic (5.55e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-1)" "unprognostic (1.78e-3)" "unprognostic (2.37e-2)" "unprognostic (8.65e-2)" "unprognostic (1.50e-3)" "unprognostic (5.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.29e-2)" "unprognostic (3.17e-2)" "unprognostic (8.54e-2)" "unprognostic (3.45e-1)" "unprognostic (3.36e-2)" "unprognostic (5.04e-2)" 17.3 21.0 16.6 14.2 23.3 15.3 16.3 16.4 22.9 15.5 15.0 17.2 8.6 13.9 16.2 14.0 34.3 12.0 11.9 33.4 15.2 16.8 21.7 30.5 11.7 16.2 16.8 14.7 13.7 14.1 13.0 20.3 18.8 22.1 14.1 17.9 17.1 16.9 13.5 47.7 14.7 14.9 18.1 16.2 14.7 14.2 13.3 16.5 19.3 18.7 25.6 21.4 15.6 18.4 22.5 28.4 14.4 22.7 21.2 25.7 20.1 31.8 11.5 12.1 20.6 17.0 16.5 10.9 21.2 21.0 20.6 18.2 13.1 12.7 22.8 14.2 19.7 11.7 20.0 28.8 27.8 20.7 16.4 20.2 11.2 21.7 17.7 29.8 13.1 14.2 22.2 19.2 41.2 20.8 35.0 17.8 24.8 20.5 19.3 21.6 10.3 19.0 16.7 18.2 21.6 35.3 14.5 18.6 13.7 12.1 16.7 38.9 27.7 40.6 13.4 17.6 17.4 16.9 31.4 13.4 20.2 48.4 12.0 29.8 17.5 13.4 19.6 14.4 19.3 22.7 22.4 22.5 23.7 22.8 22.0 20.5 24.4 23.7 10.1 21.2 20.4 28.4 25.7 20.1 16.6 23.3 16.4 22.9 15.2 16.8 16.8 14.7 22.1 16.5 MRPS14 HSMRPS14 ENSG00000120333 "Mitochondrial ribosomal protein S14" O60783 1 175010789-175023425 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051087 Uncertain Supported "Nuclear membrane,Mitochondria" "Intracellular and membrane" "Nuclear membrane, Mitochondria" "HPA051087: " "unprognostic (9.24e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.46e-1)" "unprognostic (3.44e-2)" "unprognostic (5.39e-2)" "unprognostic (1.61e-2)" "unprognostic (3.01e-2)" "unprognostic (7.32e-2)" "unprognostic (4.85e-2)" "unprognostic (7.67e-2)" "unprognostic (3.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.67e-1)" "unprognostic (8.04e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-2)" 17.7 23.6 31.8 11.8 27.6 4.5 23.7 19.6 26.3 19.5 14.9 22.9 18.3 13.8 20.1 25.6 15.4 18.0 15.8 16.6 26.9 26.5 23.4 29.7 14.7 16.0 32.7 14.5 21.8 19.1 28.3 26.1 17.1 22.5 23.6 18.1 15.4 18.4 20.4 13.7 12.7 14.7 17.2 33.5 17.4 15.3 15.8 24.5 22.6 26.5 14.5 16.2 14.3 11.7 14.5 13.6 6.5 12.9 14.3 19.2 11.6 11.1 9.0 21.4 7.6 24.2 17.4 6.8 9.8 12.0 16.7 17.4 11.7 9.9 14.2 12.0 13.1 9.9 13.2 11.4 17.8 15.6 18.2 11.7 17.6 13.3 10.2 12.9 10.5 19.0 14.1 9.8 6.9 13.8 14.1 12.6 11.6 6.1 14.1 9.4 11.6 4.8 12.3 11.3 16.9 11.5 9.0 18.0 12.7 14.2 13.2 9.4 15.6 13.8 11.2 5.7 6.3 11.9 8.8 13.9 11.8 17.8 8.1 12.3 11.9 6.5 12.9 6.2 13.4 12.7 18.8 14.5 14.2 14.1 13.6 13.5 19.2 16.2 4.5 14.3 9.7 11.8 15.1 11.6 31.8 27.6 19.6 22.6 26.9 26.5 32.7 14.5 22.5 24.5 MRPS16 CGI-132 ENSG00000182180 "Mitochondrial ribosomal protein S16" Q9Y3D3 10 73248843-73252693 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050081, HPA054538" Supported Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA050081: AB_2681007, HPA054538: AB_2682519" "unprognostic (9.19e-2)" "unprognostic (5.19e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.23e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (1.68e-2)" "unprognostic (6.44e-2)" "unprognostic (2.98e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.20e-1)" "unprognostic (5.84e-2)" 16.6 28.4 16.4 16.9 15.8 15.8 28.6 12.6 26.6 13.3 22.1 12.4 18.0 20.8 16.3 16.8 22.7 16.5 20.8 42.2 17.6 15.7 23.4 35.1 17.7 30.0 16.2 16.0 16.5 37.0 15.7 15.5 17.0 15.9 15.4 21.1 14.4 18.4 19.0 53.2 16.8 18.4 18.0 14.7 18.4 18.3 13.7 9.8 32.7 16.9 26.1 20.1 15.5 13.9 30.0 28.3 17.0 24.2 17.7 22.3 24.3 22.5 32.7 12.7 16.7 10.1 8.3 18.6 10.4 18.2 14.6 15.2 38.6 22.2 27.4 11.6 11.0 21.2 14.5 20.8 9.2 15.4 14.2 17.2 17.6 29.2 17.2 22.2 15.4 12.6 15.9 14.9 35.8 15.9 25.1 15.4 15.1 25.1 23.9 20.5 15.3 61.4 21.7 17.0 19.7 15.3 13.5 8.5 15.7 11.9 49.4 22.9 34.7 11.8 12.6 13.9 24.3 15.0 20.2 23.1 24.5 21.3 15.2 25.8 9.4 16.7 22.7 17.0 19.0 24.2 20.5 28.7 20.8 17.8 18.5 30.0 22.3 19.6 10.4 17.7 19.1 28.3 20.6 24.3 16.4 15.8 12.6 26.6 17.6 15.7 16.2 16.0 15.9 9.8 MRPS18B "C6orf14, HSPC183, MRPS18-2, PTD017" ENSG00000204568 "Mitochondrial ribosomal protein S18B" Q9Y676 6 30617709-30626395 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043485, HPA050334" Supported Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA043485: , HPA050334: " "unprognostic (8.18e-3)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (2.51e-2)" "unprognostic (4.20e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (2.98e-2)" "unprognostic (1.76e-1)" "unprognostic (1.40e-2)" "prognostic favourable (3.99e-5)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.39e-2)" 17.1 18.9 9.9 10.3 10.7 5.4 16.0 8.5 13.1 11.6 13.4 12.8 11.9 12.8 9.3 15.5 15.5 16.5 12.3 26.6 9.0 8.0 22.4 49.1 10.5 17.3 13.1 9.3 16.4 21.8 17.4 10.2 11.8 9.1 10.9 16.4 10.1 17.1 18.0 55.4 13.7 14.0 10.4 12.4 14.4 13.5 10.2 11.2 13.5 21.5 31.1 15.6 11.2 9.3 15.7 8.9 6.3 10.2 12.4 15.2 11.2 9.5 5.8 4.6 6.6 7.0 9.5 8.5 3.6 8.2 11.2 7.0 9.0 4.6 9.8 8.3 5.5 7.7 10.7 10.0 11.0 5.9 11.4 9.5 4.5 10.5 6.2 8.9 4.2 8.2 12.6 9.3 25.5 6.3 14.4 9.5 10.2 7.3 5.9 5.5 3.3 7.4 7.8 6.3 18.8 10.4 4.0 10.1 3.3 3.2 13.4 13.5 17.2 4.7 3.6 7.4 7.1 4.2 6.1 8.0 9.6 8.3 3.5 13.6 10.8 6.3 8.0 4.0 9.1 10.1 12.3 15.7 12.1 9.8 8.9 14.7 15.2 12.2 0.6 12.4 10.2 8.1 11.4 11.2 9.9 10.7 8.5 13.1 9.0 8.0 13.1 9.3 9.1 11.2 MRPS23 "CGI-138, HSPC329, MRP-S23" ENSG00000181610 "Mitochondrial ribosomal protein S23" Q9Y3D9 17 57834781-57850056 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023453 Supported Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA023453: AB_1854125" "unprognostic (3.84e-3)" "unprognostic (3.36e-1)" "unprognostic (1.75e-2)" "unprognostic (2.00e-2)" "unprognostic (7.96e-2)" "unprognostic (3.06e-3)" "prognostic unfavourable (9.52e-4)" "unprognostic (3.71e-1)" "unprognostic (7.92e-2)" "unprognostic (2.63e-3)" "unprognostic (1.39e-2)" "unprognostic (8.74e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (2.83e-1)" 15.1 28.5 23.0 19.0 27.5 16.0 19.9 16.4 32.0 13.4 16.4 17.6 28.3 18.1 18.0 23.1 18.1 19.3 17.2 53.5 22.5 22.1 36.6 19.9 16.5 21.3 23.6 26.2 16.3 29.9 17.3 16.7 15.5 23.7 28.3 16.0 15.3 16.9 24.7 39.2 14.1 15.5 17.0 19.4 17.4 25.7 21.9 17.2 14.8 28.4 19.8 19.7 15.3 16.5 25.1 30.8 33.4 26.7 23.5 24.3 22.8 32.1 32.5 17.6 18.5 10.7 12.5 20.3 20.9 15.8 29.2 22.6 24.4 19.4 40.8 62.3 16.0 16.0 27.7 24.6 24.5 32.4 32.1 29.5 13.6 42.2 20.5 38.7 28.6 11.4 22.2 21.6 22.6 18.4 43.7 14.8 22.8 27.5 35.7 22.3 21.3 34.0 26.1 29.5 34.1 22.6 15.5 23.6 36.8 15.8 13.3 41.6 41.4 28.8 15.6 24.8 31.7 24.8 44.2 32.4 68.4 45.5 23.7 24.3 22.8 24.9 21.8 33.4 22.4 26.7 23.4 23.6 22.4 22.6 30.8 25.1 24.3 24.0 3.5 23.5 18.8 29.0 21.4 22.8 23.0 27.5 16.4 32.0 22.5 22.1 23.6 26.2 23.7 17.2 MRPS26 "C20orf193, dJ534B8.3, MRP-S13, MRP-S26, RPMS13" ENSG00000125901 "Mitochondrial ribosomal protein S26" Q9BYN8 20 3045945-3048254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045472, HPA054610" Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045472: AB_10962052, HPA054610: " "unprognostic (1.53e-1)" "unprognostic (2.18e-1)" "unprognostic (3.71e-1)" "unprognostic (4.41e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (8.13e-3)" "unprognostic (3.14e-1)" "unprognostic (6.83e-2)" "unprognostic (8.21e-2)" "unprognostic (9.65e-3)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (3.77e-1)" "unprognostic (4.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.93e-3)" 20.2 30.4 27.1 14.4 29.2 13.4 20.9 25.9 31.7 19.2 19.8 15.3 32.3 22.5 18.1 30.6 19.6 24.4 21.2 25.8 24.4 28.2 28.8 39.6 14.7 15.4 24.6 27.0 28.9 43.4 21.0 28.1 16.4 20.0 31.0 16.4 15.2 32.3 27.9 37.1 22.3 20.1 27.8 19.0 16.2 22.1 13.3 20.7 12.3 28.9 23.0 16.9 18.4 19.2 36.5 28.4 10.3 24.4 29.2 30.8 23.0 26.3 35.5 8.1 14.7 8.8 6.7 21.2 10.4 6.9 11.9 9.1 31.0 12.1 26.3 13.2 5.3 25.0 15.9 21.3 6.9 6.7 34.0 12.0 12.9 51.5 12.3 18.8 5.9 7.5 16.6 9.9 15.0 8.8 19.2 6.2 7.0 22.8 19.5 33.2 39.8 35.2 21.6 13.9 28.0 11.6 17.7 25.4 32.9 11.8 39.8 23.9 17.9 10.7 8.2 7.8 12.4 14.0 19.0 28.2 36.3 15.9 5.1 15.8 8.6 7.6 21.4 10.3 24.0 24.4 30.0 36.5 26.6 25.6 28.4 34.9 30.8 26.4 1.7 29.2 19.0 17.2 20.6 23.0 27.1 29.2 25.9 31.7 24.4 28.2 24.6 27.0 20.0 20.7 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219409-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Nucleoli, Plasma membrane" "HPA071751: " "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 26.9 32.3 19.0 20.9 26.8 13.6 26.1 24.6 31.8 25.1 21.0 20.1 21.8 16.5 28.6 23.7 33.6 26.3 18.0 43.6 18.9 17.5 25.1 30.9 14.9 27.4 18.1 21.7 33.9 25.1 24.5 23.7 17.5 23.5 26.2 26.4 25.5 31.0 26.5 43.7 23.9 17.5 25.0 17.5 22.2 20.9 12.1 12.6 34.2 32.1 26.7 32.4 25.9 21.0 19.6 23.3 6.1 14.1 21.5 21.5 16.1 16.3 22.0 19.6 32.3 25.8 33.3 25.2 15.8 22.7 30.1 24.3 27.3 23.3 42.5 22.2 18.4 18.3 38.0 56.1 32.7 16.0 23.5 21.8 26.5 30.1 25.7 19.1 17.0 31.1 23.7 31.5 35.4 32.0 21.8 12.9 24.9 19.7 28.5 23.2 22.6 13.8 30.4 32.6 43.5 27.8 17.6 30.3 16.2 26.5 21.9 19.6 33.6 23.3 18.1 12.3 18.2 17.3 28.3 13.1 19.6 30.0 21.2 31.5 19.4 6.1 12.1 4.1 14.0 14.1 20.6 19.6 17.4 17.0 23.3 16.5 20.3 21.5 1.8 21.5 11.3 8.9 17.8 16.1 19.0 26.8 24.6 31.8 18.9 17.5 18.1 21.7 23.5 12.6 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729135-40771173 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA039083: , HPA046344: " "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 14.2 20.1 19.3 17.9 21.2 13.2 18.2 27.7 22.9 14.4 16.4 16.9 10.7 15.4 18.0 15.4 18.9 16.6 10.9 24.3 18.4 16.9 26.7 29.9 12.1 22.5 17.9 17.1 21.5 15.0 10.7 35.3 13.1 22.1 12.6 17.0 12.4 14.7 12.5 32.5 14.2 16.3 16.3 16.0 16.0 15.3 17.9 23.3 22.9 21.1 17.2 25.1 18.0 15.9 22.2 11.8 17.2 10.4 15.9 25.7 10.9 8.0 7.8 13.2 8.6 9.0 10.7 13.2 10.4 7.3 13.7 9.3 19.9 12.0 47.5 10.2 5.9 21.4 16.5 12.9 16.4 12.5 12.4 19.7 5.8 12.7 7.5 20.1 9.5 8.5 9.6 11.3 9.6 10.4 13.1 5.0 8.7 9.2 15.6 19.7 12.8 9.2 14.9 10.8 8.9 17.9 9.4 5.7 8.4 7.2 12.0 16.3 10.5 17.8 6.3 4.3 7.2 9.9 10.7 3.9 7.2 23.9 8.8 14.4 8.2 17.2 9.6 14.4 19.1 9.7 18.6 22.2 21.4 19.2 11.8 18.9 25.7 22.6 7.0 15.9 10.4 11.6 21.4 10.9 19.3 21.2 27.7 22.9 18.4 16.9 17.9 17.1 22.1 23.3 MRPS35 "MDS023, MRPS28" ENSG00000061794 "Mitochondrial ribosomal protein S35" P82673 12 27710773-27756295 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038513 Supported Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA038513: AB_10794084" "prognostic unfavourable (9.41e-4)" "unprognostic (8.35e-2)" "prognostic favourable (5.01e-4)" "unprognostic (2.59e-2)" "unprognostic (5.31e-2)" "unprognostic (2.78e-2)" "prognostic unfavourable (1.64e-4)" "unprognostic (7.32e-2)" "unprognostic (2.12e-3)" "unprognostic (2.05e-1)" "unprognostic (3.24e-2)" "unprognostic (7.19e-2)" "prognostic favourable (1.51e-5)" "unprognostic (4.63e-2)" "unprognostic (2.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" 18.3 32.3 21.0 19.4 22.4 14.2 23.2 21.2 25.7 14.0 31.0 16.3 18.5 27.7 17.1 17.6 25.0 16.1 20.5 31.9 19.5 20.6 42.2 52.1 15.9 20.2 20.1 19.4 17.3 18.4 18.2 11.9 18.8 24.4 17.5 33.2 11.9 17.6 14.8 46.3 15.1 24.5 19.9 18.1 17.3 23.1 13.5 13.5 19.3 28.9 27.6 18.5 17.8 14.3 12.4 17.4 4.2 24.8 14.2 14.7 12.6 24.2 26.6 11.2 17.1 16.1 19.6 41.7 16.1 13.8 22.6 20.7 32.6 34.7 22.6 23.8 16.4 18.4 23.1 20.3 26.6 19.2 22.8 25.6 11.3 26.4 16.0 34.8 13.8 16.7 25.4 19.0 38.5 18.2 27.9 15.6 20.4 14.7 24.5 57.8 42.3 40.0 26.0 29.2 37.2 34.7 19.9 6.4 13.0 22.2 34.7 26.9 35.4 27.7 14.2 13.8 14.9 31.3 28.7 6.2 9.3 48.8 18.5 26.9 18.0 4.2 12.2 4.1 9.3 21.4 14.5 12.4 11.7 11.3 17.4 11.9 13.9 12.4 0.7 14.2 24.8 8.1 14.7 12.6 21.0 22.4 21.2 25.7 19.5 20.6 20.1 19.4 24.4 13.5 MRRF RRF ENSG00000148187 "Mitochondrial ribosome recycling factor" Q96E11 9 122264603-122331343 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047177, HPA049987" Supported Approved "Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" "HPA047177: , HPA049987: " "unprognostic (8.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.40e-2)" "unprognostic (6.06e-3)" "unprognostic (3.64e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.71e-2)" "unprognostic (1.89e-2)" "unprognostic (4.44e-2)" "unprognostic (2.98e-1)" "unprognostic (9.01e-2)" "prognostic favourable (2.14e-8)" "unprognostic (3.89e-2)" "unprognostic (4.05e-1)" "unprognostic (8.02e-2)" "unprognostic (8.88e-3)" 20.1 17.0 10.1 12.6 14.8 13.4 21.0 15.0 14.5 13.0 26.3 14.0 20.3 25.3 23.3 17.8 21.6 10.4 9.9 18.8 10.5 11.2 23.3 21.7 12.5 14.8 17.1 11.7 12.1 17.6 24.3 20.1 12.7 15.9 14.3 31.6 14.8 15.8 14.7 31.1 19.1 19.4 15.7 15.4 15.7 13.5 17.1 15.1 10.6 16.1 23.3 20.9 15.2 14.3 10.3 19.6 3.8 18.7 13.7 11.6 7.1 13.1 17.8 10.2 17.0 14.6 13.4 19.4 13.1 17.0 17.8 10.5 21.2 16.0 28.8 6.7 10.5 38.9 29.1 30.8 14.6 9.6 11.9 9.8 21.8 11.6 9.6 27.3 13.1 12.4 21.0 15.9 28.6 19.8 16.6 11.0 17.8 21.0 13.6 9.0 11.9 18.0 10.2 19.5 30.5 30.3 13.5 12.1 8.0 14.1 23.1 10.5 24.9 7.0 10.5 7.9 12.0 20.3 16.1 7.6 18.5 13.0 14.9 16.4 9.0 2.7 11.5 3.8 9.3 18.7 10.0 10.3 9.4 8.7 19.6 9.2 9.8 11.6 1.4 13.7 18.7 8.4 10.4 7.1 10.1 14.8 15.0 14.5 10.5 11.2 17.1 11.7 15.9 15.1 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavourable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.1 17.2 14.2 18.6 6.9 11.1 12.6 18.9 10.7 32.5 21.4 24.8 25.1 35.7 15.9 15.6 19.2 39.4 28.5 32.8 12.7 30.1 26.4 15.4 21.2 8.8 34.8 11.1 9.7 18.9 36.6 19.0 18.2 39.9 11.6 19.2 17.7 28.3 25.2 18.2 26.2 26.6 17.4 27.6 17.6 8.3 23.0 16.8 14.5 20.0 20.0 14.2 20.5 11.9 17.8 22.0 27.2 32.2 9.4 16.4 47.1 17.3 44.8 28.3 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 MRVI1 "IRAG, JAW1L" ENSG00000072952 "Murine retrovirus integration site 1 homolog" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 17.6;BJ: 12.4;BJ hTERT+: 14.4;fHDF/TERT166: 5.6;REH: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 18.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 18.5" "Region enriched" "Detected in many" 5 "thalamus: 8.3" "Low region specificity" "Detected in many" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" 280000 Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favourable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 15.7 6.3 19.4 12.4 22.0 1.5 6.6 4.4 13.7 31.6 26.7 15.5 10.7 6.3 42.1 17.1 27.1 19.6 23.2 6.3 13.8 12.0 5.3 1.7 5.5 2.9 21.3 10.6 16.4 1.9 2.8 1.8 8.7 18.2 24.8 12.9 37.6 3.3 29.0 4.1 4.0 9.4 47.3 12.1 3.5 16.4 8.3 10.3 0.0 4.5 2.3 1.8 27.3 10.4 0.7 0.4 18.5 4.1 0.0 0.0 0.5 0.1 0.0 3.5 0.0 17.6 3.5 0.1 12.4 14.4 0.0 0.0 0.3 1.4 0.0 0.1 5.6 0.1 0.0 0.2 0.1 0.1 0.1 0.6 0.0 0.1 0.2 0.0 0.2 4.0 0.3 0.0 0.1 1.0 0.5 0.1 0.2 0.0 0.1 0.2 0.4 0.0 5.4 0.0 0.2 0.0 0.0 0.0 2.6 0.0 2.1 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.8 0.0 0.6 1.7 1.2 0.0 2.9 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 18.5 0.0 4.1 0.1 0.0 0.5 19.4 22.0 4.4 13.2 13.8 12.0 21.3 10.6 18.2 10.3 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Cell line enhanced" "Detected in some" "HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: " "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Cell line enriched" "Detected in single" 24 "THP-1: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" HPA058973 Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Group enriched" "Detected in some" 4 "HEL: 9.0;Karpas-707: 3.7;MOLT-4: 4.0;U-266/70: 13.2;U-266/84: 5.6" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 29 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.2 0.1 9.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.6 3.7 0.0 0.0 4.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.2 5.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071128 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 196.2;bone marrow: 105.4" "Group enriched" "Detected in some" 4 "HEL: 36.3;K-562: 30.9;NB-4: 25.1;THP-1: 73.3;U-937: 28.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 1061 "basophil: 196.2" "Lineage enriched" "Detected in single" 1963 "granulocytes: 196.2" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.2 0.0 0.1 0.1 0.3 105.4 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 14.7 0.1 0.1 0.1 0.5 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 8.6 0.0 1.0 0.0 7.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 196.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.0 MSANTD2 "C11orf61, FLJ23342" ENSG00000120458 "Myb/SANT DNA binding domain containing 2" Q6P1R3 11 124766498-124800673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038694, HPA038695" Approved Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038694: , HPA038695: AB_10674693" "unprognostic (2.20e-1)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (6.19e-2)" "unprognostic (7.77e-4)" "unprognostic (4.77e-3)" "unprognostic (3.32e-2)" "unprognostic (3.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.60e-3)" "prognostic unfavourable (2.50e-4)" "unprognostic (5.67e-2)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "prognostic favourable (2.65e-4)" 12.4 7.3 12.4 11.8 20.3 2.7 13.0 20.8 12.8 13.8 9.4 14.8 14.1 7.7 15.7 17.8 7.7 11.7 10.0 6.4 9.2 7.3 12.8 7.8 9.2 10.4 16.4 7.6 15.8 13.9 12.1 19.9 12.9 12.3 13.3 9.7 8.6 11.0 12.1 7.7 17.5 9.7 9.4 9.2 13.6 10.7 6.2 19.6 8.6 26.2 5.2 10.1 7.7 17.0 2.4 1.3 1.6 1.9 0.5 4.4 1.0 2.8 1.9 15.7 11.4 7.4 9.7 6.4 6.4 7.0 4.6 5.9 6.4 6.7 3.9 6.1 4.7 5.9 7.2 3.9 7.6 5.5 4.2 3.5 3.7 5.5 4.6 2.8 2.9 4.3 4.3 5.8 5.4 8.4 4.0 6.0 7.0 3.3 1.7 9.4 9.9 14.8 4.4 4.3 3.1 6.2 3.1 4.4 12.8 3.5 5.4 2.7 8.9 2.9 7.1 17.2 4.3 4.8 6.7 2.8 2.0 2.9 3.5 3.8 9.5 0.0 1.2 1.6 2.2 1.9 1.1 1.5 2.3 3.3 1.3 2.4 2.4 2.0 0.0 0.5 1.9 1.2 4.4 1.0 12.4 20.3 20.8 12.8 9.2 7.3 16.4 7.6 12.3 19.6 MSH2 "COCA1, HNPCC, HNPCC1" ENSG00000095002 "MutS homolog 2" P43246 2 47402969-47663146 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009572, HPA066845, CAB070867" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB009572: AB_2144828, CAB070867: , HPA066845: " "unprognostic (2.35e-1)" "unprognostic (1.54e-2)" "unprognostic (2.89e-3)" "prognostic unfavourable (4.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.31e-3)" "prognostic unfavourable (1.72e-9)" "unprognostic (1.77e-1)" "unprognostic (7.09e-3)" "unprognostic (8.57e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (5.38e-2)" "unprognostic (3.29e-3)" "unprognostic (1.20e-3)" "unprognostic (5.74e-1)" "unprognostic (8.46e-2)" "unprognostic (1.48e-1)" 7.3 9.8 14.2 12.2 25.5 11.4 14.1 22.6 18.1 9.4 11.6 7.6 5.6 6.5 10.5 13.3 10.8 11.1 4.9 8.4 13.0 14.0 7.3 5.5 7.1 19.7 12.5 17.0 7.9 8.4 15.3 9.1 9.9 18.5 7.9 13.8 12.3 9.4 7.3 6.7 10.3 8.0 7.8 13.8 9.4 6.7 13.4 13.5 37.0 13.9 6.6 21.4 8.5 7.6 7.4 2.9 3.9 4.2 12.2 12.6 6.2 28.0 9.6 26.3 14.1 1.9 5.5 15.9 16.7 8.3 20.8 20.1 18.0 12.1 34.5 22.6 5.9 11.9 19.6 9.5 31.4 17.8 14.6 24.9 11.1 16.3 2.0 24.3 8.8 3.1 2.8 17.7 4.8 11.4 41.4 8.0 15.8 11.2 28.1 18.3 49.4 11.4 37.7 46.9 20.2 9.0 14.9 21.8 23.6 14.8 11.5 11.8 11.5 9.5 4.6 13.8 18.1 14.2 18.6 5.1 18.3 48.4 8.4 18.0 8.5 2.8 1.0 3.9 7.9 4.2 8.6 6.3 7.4 9.5 2.3 7.4 12.6 11.9 0.7 12.2 3.2 2.9 10.1 6.2 14.2 25.5 22.6 18.1 13.0 14.0 12.5 17.0 18.5 13.5 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739948-31762834 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 9.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.3" HPA062688 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA062688: " "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 3.6 2.7 3.2 8.0 4.4 6.8 4.1 1.6 4.4 3.9 5.8 6.9 9.3 3.0 9.8 8.5 4.7 5.8 15.2 2.0 3.2 2.1 10.5 4.7 4.3 5.7 4.0 3.6 6.9 4.0 1.6 6.5 3.0 4.1 7.9 5.3 12.4 4.7 9.2 2.3 12.3 5.2 6.0 5.7 7.6 6.8 15.9 3.8 12.0 4.3 2.7 10.6 3.6 4.0 1.0 0.5 9.3 0.9 0.1 0.8 0.0 2.0 1.9 2.3 4.7 0.8 0.7 0.7 0.6 0.2 0.8 0.3 1.2 2.6 2.5 0.7 0.5 2.9 0.0 1.2 0.3 0.4 1.1 2.4 0.6 1.4 0.3 1.9 1.9 0.8 0.5 1.9 2.4 0.9 4.8 6.0 0.7 2.6 3.6 4.1 0.9 0.4 1.3 1.0 3.9 1.4 0.4 0.6 2.4 0.8 0.0 0.0 1.3 2.7 0.7 1.7 3.5 0.0 1.5 2.7 1.0 2.8 0.7 3.9 3.6 9.3 0.4 0.0 0.7 0.3 0.2 1.0 0.4 0.2 0.2 0.5 0.1 0.0 0.0 0.1 0.9 0.5 0.8 0.0 3.2 4.4 1.6 4.4 3.2 2.1 4.0 3.6 4.1 3.8 MSH6 GTBP ENSG00000116062 "MutS homolog 6" P52701 2 47695530-47810101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" DNA-binding "Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009091, HPA028376, HPA028446, CAB070870" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182" "unprognostic (5.10e-2)" "unprognostic (5.87e-3)" "unprognostic (3.29e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (1.98e-1)" "unprognostic (3.09e-2)" "prognostic unfavourable (7.86e-4)" "unprognostic (1.79e-1)" "unprognostic (2.35e-3)" "unprognostic (1.01e-1)" "unprognostic (1.74e-3)" "unprognostic (8.99e-2)" "prognostic unfavourable (1.06e-7)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (9.68e-2)" "unprognostic (3.48e-2)" 13.0 20.5 9.7 13.1 18.8 13.6 13.0 20.5 13.1 17.9 13.3 17.6 10.7 6.1 28.2 11.0 12.4 18.3 8.4 8.6 11.4 8.8 9.5 14.6 11.0 21.7 23.9 9.6 43.2 27.6 16.2 17.3 14.9 15.0 14.6 10.3 8.7 12.0 13.2 10.4 10.3 10.5 22.1 14.9 11.6 11.1 25.1 22.0 40.4 13.4 10.4 25.8 14.2 16.4 8.4 8.4 7.6 9.8 9.7 15.1 5.7 27.2 20.3 37.9 9.0 11.4 12.1 17.1 15.2 13.4 15.7 16.6 14.9 9.5 45.0 22.7 16.4 11.5 34.1 19.3 20.5 19.6 17.0 28.8 16.2 15.1 7.0 28.9 10.6 9.8 6.2 16.0 10.7 9.8 25.0 16.6 15.3 19.6 30.7 13.7 33.3 9.4 73.0 49.7 20.3 9.6 17.8 21.2 23.0 21.1 10.1 9.2 12.0 10.2 6.0 18.3 22.4 13.8 19.6 15.6 21.0 75.4 15.5 18.5 11.2 7.6 5.8 4.9 8.4 9.8 10.4 8.4 9.5 8.3 8.4 8.1 15.1 7.6 3.9 9.7 9.3 4.2 9.5 5.7 9.7 18.8 20.5 13.1 11.4 8.8 23.9 9.6 15.0 22.0 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell line enhanced" "Detected in some" "AF22: 42.9;HAP1: 19.6;NTERA-2: 22.3;SCLC-21H: 31.8;SH-SY5Y: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favourable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 42.9 10.8 0.0 0.0 5.4 0.0 0.0 0.2 0.5 7.5 0.2 0.0 0.6 0.0 0.1 19.6 0.0 0.1 0.2 4.4 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.1 22.3 0.2 0.1 0.0 0.1 0.0 0.0 31.8 15.5 0.0 0.3 0.3 6.6 0.0 0.0 0.1 5.9 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148922-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003339, HPA003413" Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA003339: , HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favourable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 13.1 10.1 13.3 16.2 15.6 40.2 13.5 31.0 15.8 13.7 11.3 14.8 9.9 11.1 15.5 8.2 12.2 14.1 10.0 9.8 12.4 9.0 10.0 14.1 13.4 23.7 12.6 11.2 18.3 12.7 19.9 19.8 15.9 12.0 13.0 10.1 10.6 13.2 9.8 14.9 14.1 18.2 9.6 14.2 24.2 12.3 13.6 15.6 59.3 13.8 7.4 23.9 13.4 12.9 7.6 3.8 8.7 3.9 6.6 13.3 5.4 12.5 4.2 8.6 9.8 6.0 6.7 15.7 7.6 6.4 6.1 6.1 8.3 6.6 23.5 10.5 5.6 9.0 9.9 6.6 9.6 12.4 7.6 25.6 8.3 4.7 6.2 21.0 13.4 5.2 7.2 5.0 14.1 6.1 9.1 20.4 5.1 7.7 37.9 12.3 11.5 7.3 17.7 14.7 14.9 3.0 8.9 11.2 8.0 17.3 7.1 11.5 6.3 13.8 9.5 8.3 7.2 7.6 7.0 24.2 12.6 35.1 7.0 9.0 5.5 5.2 3.7 5.0 7.0 3.9 8.8 4.5 6.6 8.2 3.8 7.6 13.3 8.9 8.7 6.6 2.8 2.5 5.0 5.4 13.3 15.6 31.0 15.8 12.4 9.0 12.6 11.2 12.0 15.6 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favourable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.4 102.3 0.0 15.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.2 1.1 0.9 0.0 0.0 0.0 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 34.3;PC-3: 43.7" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" Vesicles Cytosol "HPA055174: " 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA053069" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" 25000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA023804: AB_1853826, HPA053069: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 0.9 0.5 0.3 5.9 0.2 0.0 0.3 0.8 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "parathyroid gland: 34.4;skeletal muscle: 66.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 2.8 0.3 0.4 0.4 0.4 0.3 0.4 2.7 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.4 0.9 0.6 0.4 3.9 0.4 0.1 0.4 0.4 0.6 0.4 0.4 0.4 1.1 0.5 34.4 0.7 0.4 0.4 0.8 0.3 0.4 2.3 0.4 66.9 0.8 0.8 0.4 0.4 1.4 0.4 0.4 0.4 0.6 0.4 1.2 0.4 0.5 0.6 0.1 0.0 0.0 0.5 0.0 1.7 0.4 1.2 1.3 3.0 4.7 4.2 6.0 2.6 1.4 1.1 0.6 1.3 0.7 1.5 3.8 0.5 1.5 2.3 1.9 0.4 1.7 1.8 1.5 3.3 2.0 1.1 1.5 2.2 3.1 4.7 1.5 1.3 3.5 0.6 1.1 2.0 2.5 0.5 1.8 3.0 0.9 1.6 1.1 7.7 0.2 1.8 1.9 0.6 1.2 1.0 2.2 1.7 1.9 1.8 2.6 2.3 1.4 0.9 3.0 1.2 3.4 2.0 1.0 3.8 0.6 0.0 0.4 0.0 1.7 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.4 0.4 0.4 2.7 0.4 0.4 0.1 0.4 0.4 0.4 0.4 MTA1 ENSG00000182979 "Metastasis associated 1" Q13330 14 105419820-105470729 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004508, HPA005544" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004508: AB_627969, HPA005544: AB_1079420" "unprognostic (6.79e-3)" "unprognostic (4.22e-2)" "unprognostic (1.06e-1)" "unprognostic (6.36e-2)" "unprognostic (2.91e-2)" "unprognostic (7.74e-2)" "prognostic unfavourable (4.62e-4)" "unprognostic (6.59e-2)" "unprognostic (1.47e-1)" "unprognostic (6.72e-3)" "prognostic favourable (9.48e-5)" "unprognostic (4.57e-3)" "unprognostic (1.39e-2)" "unprognostic (2.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-1)" 23.4 20.1 22.4 24.7 24.3 22.0 22.9 33.8 23.4 17.9 18.9 21.9 22.5 22.3 22.1 21.3 14.9 22.5 20.0 27.7 22.1 17.3 14.8 15.1 20.1 22.3 22.8 18.4 31.4 31.1 15.7 26.5 16.1 19.4 21.9 10.6 22.2 28.7 24.8 29.1 20.0 19.8 27.1 15.0 23.6 18.9 31.4 24.1 27.3 21.1 16.1 16.3 19.3 20.5 1.8 3.7 2.8 0.9 1.8 1.8 0.6 13.1 10.5 19.6 19.5 7.5 12.9 17.4 10.5 8.0 10.4 10.1 13.6 17.8 25.8 11.0 7.6 18.2 14.2 10.0 7.1 16.9 23.9 13.4 9.5 13.9 16.6 16.8 10.4 14.4 12.7 7.4 17.0 14.8 15.2 11.3 5.4 23.6 30.3 33.4 28.3 22.3 28.7 11.9 8.4 8.3 10.3 31.7 33.0 14.1 16.5 15.0 14.8 16.1 10.6 8.5 9.0 13.9 10.9 23.0 11.1 16.4 10.5 11.4 14.7 0.5 0.9 2.8 1.4 0.9 1.2 1.5 1.2 1.1 1.1 1.8 1.5 1.8 0.2 1.8 0.5 3.7 0.9 0.6 22.4 24.3 33.8 23.4 22.1 17.3 22.8 18.4 19.4 24.1 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavourable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 8.8 35.0 19.2 16.7 21.0 1.6 14.6 11.4 23.7 14.5 12.5 10.2 16.8 9.0 17.2 25.0 16.7 14.1 11.3 11.1 18.3 14.0 14.5 7.6 8.3 11.5 12.3 14.6 33.3 15.0 18.3 15.8 16.1 12.5 15.0 14.1 12.6 10.6 20.8 9.8 15.4 8.7 14.3 10.4 6.4 12.5 21.0 9.3 74.3 13.0 7.7 15.0 13.5 13.4 2.9 3.2 7.7 1.9 3.3 8.8 3.3 7.7 8.1 12.1 7.3 9.7 13.6 24.0 4.8 8.7 10.9 9.3 10.2 13.4 25.3 8.4 10.5 4.8 25.6 11.5 16.0 9.3 8.7 4.5 4.7 16.0 10.5 2.7 15.5 14.3 12.9 7.4 7.9 14.6 8.2 2.9 11.9 11.4 17.6 8.5 43.2 4.9 10.2 10.6 0.0 10.9 6.3 6.4 20.9 7.5 23.5 9.9 12.7 3.5 9.1 5.2 8.6 3.9 4.7 6.1 2.8 37.1 6.9 2.8 6.7 7.7 1.9 0.0 4.1 0.7 5.7 2.5 4.4 6.2 3.2 2.9 8.8 5.9 0.3 3.3 1.2 1.0 2.2 3.3 19.2 21.0 11.4 23.7 18.3 14.0 12.3 14.6 12.5 9.3 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: " "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 3.7 2.4 4.9 8.3 6.9 7.1 5.4 16.8 7.3 3.8 3.4 4.1 3.2 3.0 5.8 5.2 4.2 3.6 2.5 2.2 3.6 3.2 2.3 1.8 2.6 8.2 4.8 3.3 5.3 2.7 2.6 3.9 4.2 5.1 3.2 5.5 3.2 3.6 2.3 2.0 6.0 3.2 4.2 4.6 4.6 2.7 11.0 4.8 12.6 2.3 3.4 8.0 2.9 3.5 2.7 0.6 0.6 2.0 1.7 3.2 1.1 9.7 2.9 9.7 3.9 1.4 2.4 4.8 7.4 4.3 10.9 14.2 3.1 5.4 8.9 7.5 2.4 8.4 9.1 4.5 13.5 7.3 6.9 7.4 4.2 3.6 0.7 7.8 5.7 0.9 1.9 8.3 5.4 4.8 4.7 6.7 6.3 4.3 12.4 4.8 4.3 5.8 7.2 10.0 6.3 2.6 3.4 5.0 5.8 5.0 29.7 4.5 5.6 5.7 2.9 4.7 8.6 6.0 11.9 2.6 5.5 5.1 4.5 9.7 5.3 0.0 0.4 0.6 1.3 2.0 2.0 2.7 1.9 2.3 0.6 1.9 3.2 2.7 0.2 1.7 1.0 0.0 2.2 1.1 4.9 6.9 16.8 7.3 3.6 3.2 4.8 3.3 5.1 4.8 MTCP1 "P13MTCP1, p8MTCP1" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155061622-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA032040: " "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 6.4 7.1 4.1 5.3 5.3 7.2 15.8 4.4 4.8 6.0 6.2 3.4 7.7 5.7 6.0 8.2 7.0 6.1 4.4 30.1 4.7 2.9 6.7 12.8 8.5 15.5 4.5 2.7 9.1 20.7 3.9 6.5 3.5 6.4 5.8 6.1 3.9 7.3 7.0 11.4 12.0 6.7 8.7 7.2 6.7 6.2 16.1 3.8 2.5 8.2 5.4 7.2 6.9 4.0 0.2 0.0 0.8 0.7 0.5 2.0 0.1 1.4 4.9 2.4 3.8 1.6 1.3 2.6 3.0 1.5 1.9 4.7 4.2 7.4 2.6 3.0 0.6 4.7 3.1 3.5 2.3 1.8 3.1 1.2 14.0 2.3 1.3 2.8 3.2 2.4 1.6 3.1 3.0 1.7 1.1 4.8 1.3 2.0 3.7 6.0 1.1 0.8 3.9 2.5 6.0 2.4 2.0 1.2 1.8 2.1 1.2 2.1 2.1 1.3 1.8 2.2 3.8 2.1 2.2 10.5 4.5 5.1 4.2 3.4 3.1 0.0 0.6 0.8 1.1 0.0 2.0 0.2 1.2 0.4 0.0 0.1 0.2 1.4 0.0 0.5 0.7 0.0 0.0 0.1 4.1 5.3 4.4 4.8 4.7 2.9 4.5 2.7 6.4 3.8 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002966 Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA002966: AB_2147359" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavourable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 19.3 12.5 18.7 14.8 13.4 13.9 8.5 14.9 12.3 21.9 22.1 8.9 14.4 17.4 31.5 8.7 10.9 19.3 11.6 26.7 16.7 14.2 24.9 9.6 10.7 18.8 8.4 10.2 13.9 17.4 17.7 16.7 17.8 20.9 9.2 21.9 12.5 35.6 24.8 9.8 19.4 21.6 15.3 13.6 16.0 10.3 12.8 10.1 11.1 3.2 15.8 16.8 11.9 7.9 15.4 10.4 17.7 13.1 10.5 13.1 20.2 16.7 22.5 20.1 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 MTERF4 "MGC61716, MTERFD2" ENSG00000122085 "Mitochondrial transcription termination factor 4" Q7Z6M4 2 241072169-241102332 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027097 Uncertain Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA027097: AB_10603879" "unprognostic (4.58e-2)" "unprognostic (3.66e-1)" "unprognostic (2.82e-1)" "unprognostic (5.95e-2)" "unprognostic (1.50e-1)" "unprognostic (6.70e-2)" "unprognostic (1.17e-3)" "unprognostic (2.99e-2)" "unprognostic (2.68e-2)" "unprognostic (1.20e-2)" "prognostic favourable (3.48e-4)" "unprognostic (2.28e-2)" "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-1)" 14.2 15.5 14.4 17.6 22.1 17.2 18.6 42.2 21.7 16.2 14.6 25.3 12.5 13.4 23.2 14.1 17.6 17.7 12.1 13.4 14.4 12.1 13.4 16.5 14.2 29.8 19.2 19.4 25.7 20.9 11.7 25.7 11.6 20.4 28.9 17.2 16.3 19.5 18.1 38.8 15.5 19.6 17.3 17.8 20.3 14.7 12.7 22.3 23.7 29.4 20.5 29.7 14.3 15.2 16.6 6.2 11.4 5.4 8.0 24.9 10.2 8.6 8.2 16.3 9.4 22.2 9.9 12.1 14.7 16.4 14.3 20.3 5.6 13.0 13.4 5.3 17.0 9.7 22.2 21.0 19.3 18.1 16.0 17.1 15.7 24.7 14.5 20.4 13.1 16.9 20.6 16.7 19.3 16.3 15.2 5.9 17.1 12.2 14.9 14.1 18.6 14.1 14.6 18.5 7.5 13.6 17.3 14.9 12.9 12.0 14.9 11.1 11.0 10.6 22.4 13.2 12.8 15.4 13.1 15.8 4.0 32.7 11.1 12.9 12.1 4.2 5.4 11.4 10.0 5.2 12.5 16.6 15.5 13.7 6.2 15.4 24.9 19.5 1.9 8.0 4.4 4.7 15.8 10.2 14.4 22.1 42.2 21.7 14.4 12.1 19.2 19.4 20.4 22.3 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favourable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 8.7 10.2 7.9 10.0 11.5 11.6 7.5 13.5 12.7 9.5 12.7 6.8 8.0 9.7 11.8 10.6 9.5 10.9 9.7 13.8 8.0 7.8 12.8 13.4 8.4 8.6 6.8 9.4 14.0 5.9 7.3 9.3 7.5 10.3 10.8 10.8 12.2 8.7 9.8 13.3 11.6 13.9 12.0 5.7 9.2 8.7 7.2 5.2 9.2 11.7 4.6 8.8 12.0 9.1 5.0 9.6 16.9 3.6 4.6 5.9 1.9 2.6 3.6 3.5 6.1 5.0 3.5 3.1 2.4 4.3 3.2 3.0 2.2 3.0 9.1 3.3 4.4 7.7 6.5 4.3 3.1 3.5 4.8 3.9 3.4 2.5 5.9 5.3 1.2 5.1 5.4 1.7 3.8 2.9 4.1 4.4 4.8 3.6 4.2 5.6 4.8 6.2 3.9 5.1 4.2 5.2 3.1 3.6 3.6 5.8 5.4 4.4 3.3 3.8 5.3 3.8 3.9 4.4 4.8 3.7 5.4 3.6 3.3 8.6 3.9 3.1 3.6 2.4 4.9 2.9 4.9 4.7 4.9 5.2 5.6 5.0 5.5 5.9 16.9 4.6 2.0 9.6 4.9 1.9 7.9 11.5 13.5 12.7 8.0 7.8 6.8 9.4 10.3 5.2 MTFR1 "CHPPR, FAM54A2, KIAA0009" ENSG00000066855 "Mitochondrial fission regulator 1" Q15390 8 65644734-65771261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023152, HPA056120" Uncertain Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA023152: AB_1854176, HPA056120: " "prognostic unfavourable (4.06e-4)" "unprognostic (4.58e-2)" "unprognostic (4.01e-2)" "unprognostic (4.57e-2)" "unprognostic (6.56e-3)" "unprognostic (3.93e-2)" "unprognostic (1.66e-1)" "unprognostic (3.28e-2)" "unprognostic (1.50e-1)" "unprognostic (3.53e-1)" "unprognostic (5.69e-3)" "unprognostic (5.44e-2)" "unprognostic (6.63e-3)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (5.21e-4)" "unprognostic (8.25e-2)" 10.7 17.7 6.6 5.5 11.7 3.9 9.5 10.1 8.8 9.7 10.7 10.8 14.2 11.1 9.9 11.9 12.3 7.2 6.2 8.7 6.8 5.5 28.4 37.7 7.1 3.9 10.3 5.4 7.9 19.1 8.0 15.0 16.2 9.7 8.1 11.2 14.8 11.0 11.5 11.7 8.3 16.2 8.8 11.3 6.5 13.2 16.8 11.7 5.4 13.0 11.2 9.3 10.5 9.7 1.7 3.1 4.3 2.8 0.8 2.9 1.7 14.4 10.8 8.5 10.0 12.0 11.7 6.9 9.5 8.8 11.9 12.5 9.2 15.1 8.1 3.1 9.2 9.5 19.5 13.0 16.1 2.9 10.5 10.0 8.0 18.4 14.9 2.6 4.9 8.0 14.0 15.2 48.7 14.4 13.6 8.4 13.7 13.0 8.8 6.1 9.1 9.7 4.5 11.8 6.7 14.6 13.1 3.8 5.7 9.6 16.3 12.6 17.9 5.7 10.8 7.2 10.0 17.1 8.2 8.2 5.3 5.9 8.8 10.6 9.5 4.3 2.8 1.2 2.0 2.5 2.9 1.7 2.6 2.2 3.1 1.4 2.6 2.9 0.7 0.8 1.2 1.9 2.5 1.7 6.6 11.7 10.1 8.8 6.8 5.5 10.3 5.4 9.7 11.7 MTFR1L FAM54B ENSG00000117640 "Mitochondrial fission regulator 1 like" Q9H019 1 25818640-25832942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027124, HPA027130" Approved Approved "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA027124: AB_10600211, HPA027130: AB_10611251" "unprognostic (9.90e-2)" "unprognostic (6.86e-3)" "unprognostic (9.29e-2)" "prognostic favourable (6.81e-4)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.52e-3)" "unprognostic (2.12e-1)" "unprognostic (2.24e-1)" "unprognostic (9.89e-3)" "unprognostic (5.33e-2)" "prognostic favourable (5.89e-12)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.69e-1)" "unprognostic (1.33e-1)" 13.2 43.5 17.8 8.1 23.9 6.2 14.0 19.4 26.5 13.8 20.2 17.1 21.6 18.2 16.7 23.3 19.2 17.1 13.4 58.7 16.8 17.6 27.7 25.1 10.7 9.0 17.7 20.7 26.8 14.5 38.7 16.4 15.6 19.2 19.9 14.8 24.2 16.3 28.8 76.9 11.4 15.3 28.0 13.0 13.4 16.4 46.4 15.0 5.8 16.5 23.1 9.9 21.1 16.6 10.1 21.1 41.1 20.3 10.3 10.6 18.1 7.6 10.5 21.3 21.6 27.7 26.2 9.0 17.8 25.3 18.2 20.1 3.4 15.9 2.6 15.8 31.4 7.0 17.4 15.2 18.0 17.2 15.7 21.8 17.6 13.8 26.6 17.8 21.9 26.9 14.4 19.4 14.6 14.9 13.2 11.7 26.0 8.0 10.1 12.7 11.7 15.5 10.2 19.2 7.6 18.8 7.0 21.8 19.9 13.3 12.9 26.5 10.8 16.6 15.4 15.1 12.0 35.2 11.1 12.3 7.4 9.2 26.4 24.3 16.7 20.4 19.4 41.1 10.4 18.8 6.2 10.1 9.9 9.3 21.1 10.0 10.6 9.7 5.2 10.3 20.3 8.5 10.3 18.1 17.8 23.9 19.4 26.5 16.8 17.6 17.7 20.7 19.2 15.0 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530176-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 12.6 12.6 10.9 10.0 11.4 7.1 13.1 17.1 16.5 12.1 10.8 19.3 18.2 9.1 17.5 15.6 14.4 16.8 11.9 10.0 11.1 7.9 12.2 11.9 10.4 13.3 13.4 13.6 14.8 14.2 24.0 15.8 10.1 14.4 15.9 13.4 16.2 17.2 15.7 14.7 15.6 12.5 14.1 9.5 15.9 12.1 21.5 12.8 14.7 14.7 13.3 14.9 13.3 18.7 8.3 9.9 10.1 7.6 9.3 9.3 7.2 9.3 9.0 8.8 7.7 7.6 11.6 10.8 9.4 7.0 11.9 6.0 7.8 15.9 8.4 10.2 8.2 13.0 9.7 9.2 11.2 5.6 7.9 7.4 11.8 7.3 10.2 5.9 4.3 7.3 14.9 15.3 13.2 7.1 15.9 0.0 8.6 12.0 7.5 9.0 5.8 11.3 22.8 5.2 6.6 6.9 5.8 8.6 5.9 21.4 4.2 7.9 21.4 6.3 7.3 11.6 10.0 7.7 9.0 7.0 8.5 24.8 10.6 9.7 11.3 10.1 7.6 3.8 8.5 5.8 8.8 8.3 9.3 8.5 9.9 6.8 7.8 8.8 3.1 9.3 7.1 4.5 7.6 7.2 10.9 11.4 17.1 16.5 11.1 7.9 13.4 13.6 14.4 12.8 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favourable (8.41e-4)" 36.9 30.4 29.8 21.9 26.3 8.5 28.4 22.8 26.7 21.5 24.8 16.9 25.9 23.7 15.1 38.5 25.5 16.5 20.5 55.7 27.5 22.8 41.5 38.7 15.1 22.2 28.9 19.7 23.1 28.3 14.5 40.3 20.2 28.3 22.7 24.8 17.4 43.3 28.1 46.1 21.6 29.7 18.2 28.7 24.9 22.7 28.3 26.2 29.7 22.9 38.5 24.0 27.8 16.4 25.3 44.3 35.9 26.5 18.5 24.1 19.4 13.4 9.4 21.1 10.6 23.7 35.6 10.8 19.9 21.8 14.6 14.9 12.4 16.6 14.7 13.5 21.6 11.6 11.4 15.6 20.2 15.4 14.1 18.6 8.6 15.5 23.1 19.2 17.8 19.9 28.8 12.0 15.3 25.4 10.6 5.9 22.2 23.7 16.8 23.5 11.0 10.7 9.9 11.5 16.8 30.2 13.8 15.6 9.5 12.1 17.7 22.5 13.8 29.0 17.3 9.9 5.9 25.5 13.5 4.6 6.4 8.5 10.3 19.4 14.1 34.2 26.5 35.9 17.1 25.5 18.4 25.3 21.8 17.2 27.9 21.7 19.3 19.6 17.7 18.5 22.1 44.3 24.1 19.4 29.8 26.3 22.8 26.7 27.5 22.8 28.9 19.7 28.3 26.2 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: " "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favourable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.3 6.1 5.6 3.1 12.6 6.9 4.1 7.8 16.5 6.6 6.5 3.9 1.9 2.2 10.7 10.4 8.0 4.4 4.7 6.3 8.1 1.2 2.8 4.0 5.8 7.4 5.4 5.7 9.2 3.8 4.2 4.7 16.3 3.1 6.4 6.0 1.6 5.7 1.5 2.8 2.5 4.3 4.9 12.8 24.7 8.6 2.1 5.3 3.8 4.5 1.6 2.9 10.2 7.8 7.7 4.8 4.0 4.8 5.8 4.9 5.9 4.5 2.0 8.6 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 MTMR3 "FYVE-DSP1, KIAA0371, ZFYVE10" ENSG00000100330 "Myotubularin related protein 3" Q13615 22 29883155-30030866 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034515, HPA034516, HPA061399" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: " "unprognostic (4.39e-3)" "unprognostic (7.84e-2)" "unprognostic (2.46e-2)" "unprognostic (1.76e-2)" "unprognostic (5.61e-2)" "unprognostic (4.51e-3)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (3.42e-1)" "unprognostic (4.39e-1)" "unprognostic (8.33e-4)" "unprognostic (1.28e-1)" "unprognostic (5.35e-4)" "unprognostic (7.96e-2)" "unprognostic (7.64e-2)" "unprognostic (2.49e-1)" "unprognostic (8.38e-2)" 15.8 17.2 15.7 12.6 20.6 66.7 16.0 24.2 18.0 13.7 12.6 18.9 14.8 10.6 18.8 13.5 20.1 16.7 13.0 14.4 13.0 11.7 12.4 9.9 18.3 12.6 14.7 11.4 20.3 15.8 22.1 20.6 20.6 15.8 15.1 12.9 18.1 15.9 14.7 30.7 22.5 13.1 16.0 17.0 20.7 14.1 23.7 14.6 14.0 16.6 11.9 14.9 14.0 19.3 2.6 3.9 16.5 6.6 3.9 4.1 3.5 8.4 6.6 11.4 12.1 11.5 8.4 8.4 7.5 11.4 10.3 11.9 6.1 5.1 6.4 5.0 14.4 10.4 12.0 9.5 10.4 12.7 10.0 11.6 6.6 6.6 10.6 9.8 29.5 8.9 15.8 10.0 18.2 10.2 7.1 11.5 6.3 10.5 6.6 7.2 4.2 4.9 7.8 15.5 6.5 9.7 15.7 12.7 8.7 14.3 13.0 7.7 7.3 9.9 10.9 16.9 11.4 3.4 5.3 10.0 6.7 6.0 7.3 4.9 7.7 6.4 6.6 10.0 3.1 4.6 4.1 2.2 2.5 3.4 3.9 2.6 3.1 2.7 16.5 3.9 4.7 1.5 2.7 3.5 15.7 20.6 24.2 18.0 13.0 11.7 14.7 11.4 15.8 14.6 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell line enhanced" "Detected in some" "NTERA-2: 5.3;SCLC-21H: 14.0;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.7 0.6 1.1 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.8 0.5 0.0 0.4 4.1 0.0 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.0 0.0 0.2 0.6 0.7 0.0 0.6 1.3 1.7 5.3 0.5 0.4 1.8 0.5 0.0 3.3 14.0 8.1 0.6 0.8 0.9 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.6 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 MTMR9 "C8orf9, DKFZp434K171, LIP-STYX, MTMR8" ENSG00000104643 "Myotubularin related protein 9" Q96QG7 8 11284416-11328146 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070944 Approved "Actin filaments,Centrosome" Centrosome "Actin filaments" "HPA070944: " "unprognostic (1.97e-2)" "unprognostic (1.95e-1)" "unprognostic (2.30e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-1)" "unprognostic (2.64e-2)" "unprognostic (8.09e-3)" "unprognostic (3.25e-1)" "unprognostic (2.05e-1)" "unprognostic (1.46e-1)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.08e-1)" "unprognostic (1.43e-2)" 8.2 7.0 11.5 7.5 14.0 8.0 9.2 18.2 26.2 6.6 9.9 10.3 2.7 4.4 8.3 5.7 6.4 5.6 5.9 12.9 11.6 14.4 8.2 5.7 6.6 6.9 11.7 12.2 6.9 7.2 9.4 8.4 7.8 13.1 9.3 6.3 6.4 4.8 7.6 9.1 6.9 5.2 11.1 10.8 6.6 5.3 16.8 7.4 8.2 7.1 3.7 7.4 6.4 5.6 4.5 4.1 3.6 3.9 2.3 3.7 1.2 2.6 7.3 6.6 5.2 8.1 6.9 5.1 8.2 5.4 6.6 6.1 6.5 2.0 6.7 2.2 9.8 3.7 7.2 7.2 7.6 1.4 4.4 8.9 5.8 3.3 8.8 2.3 5.2 6.8 5.8 9.5 12.0 10.3 6.0 5.4 10.7 2.0 4.0 2.4 11.7 4.4 2.9 10.7 2.1 7.2 6.7 2.5 10.0 5.5 2.4 5.8 3.0 4.7 12.8 7.9 5.8 4.4 4.3 1.5 3.0 3.8 6.5 5.1 7.6 1.5 3.2 3.6 3.2 3.9 2.8 3.5 2.7 2.7 2.8 4.5 3.2 3.7 3.1 2.3 3.2 4.1 2.0 1.2 11.5 14.0 18.2 23.2 11.6 14.4 11.7 12.2 13.1 7.4 MTO1 ENSG00000135297 "Mitochondrial tRNA translation optimization 1" Q9Y2Z2 6 73461578-73509236 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030230, HPA030232" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030230: AB_10598910, HPA030232: AB_10600891" "unprognostic (2.17e-2)" "unprognostic (5.29e-2)" "unprognostic (1.05e-2)" "unprognostic (3.22e-2)" "unprognostic (6.47e-2)" "unprognostic (8.58e-2)" "unprognostic (6.28e-2)" "unprognostic (5.48e-2)" "unprognostic (2.97e-1)" "unprognostic (2.12e-3)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" "unprognostic (1.64e-1)" 10.4 11.0 11.1 13.5 13.7 14.7 11.5 21.8 13.6 14.0 14.0 11.3 12.4 12.7 12.6 11.2 12.1 10.0 8.1 13.3 10.0 10.9 19.7 28.4 9.8 15.8 19.3 10.0 14.5 12.1 24.6 15.6 8.7 13.9 12.2 12.7 10.1 10.7 12.3 15.8 9.8 13.6 11.9 12.1 18.6 11.9 20.5 15.0 13.0 14.0 11.0 16.6 12.1 15.0 10.4 7.4 5.3 7.8 10.5 14.0 8.7 5.0 4.6 6.4 5.2 9.3 10.8 5.8 10.5 9.6 10.3 12.6 9.5 3.9 13.2 8.2 9.8 8.7 11.7 8.4 15.8 7.7 7.7 10.1 11.2 10.3 12.2 18.2 6.9 9.3 13.3 11.1 12.5 7.7 17.3 12.8 10.7 8.8 5.0 15.7 4.7 4.7 8.4 18.3 21.9 8.2 7.9 5.4 3.3 5.4 9.1 9.4 6.0 19.2 4.9 6.1 6.0 3.5 10.0 8.3 12.8 5.3 3.1 13.6 8.0 1.7 6.4 5.3 9.7 7.2 11.9 10.4 11.7 9.8 7.4 7.9 12.9 10.5 1.8 10.5 7.8 5.5 14.0 8.7 11.1 13.7 21.8 13.6 10.0 10.9 19.3 10.0 13.9 15.0 MTOR "FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1" ENSG00000198793 "Mechanistic target of rapamycin kinase" P42345 1 11106535-11262507 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB069425, HPA071227" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB069425: , HPA071227: " "unprognostic (3.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (2.45e-3)" "unprognostic (5.50e-2)" "unprognostic (2.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (8.24e-3)" "unprognostic (3.48e-2)" "unprognostic (1.88e-1)" "prognostic favourable (1.49e-5)" "unprognostic (1.27e-1)" "unprognostic (2.45e-1)" "unprognostic (6.60e-2)" "unprognostic (7.55e-2)" 11.3 13.9 18.7 13.0 22.5 12.3 14.9 25.2 25.2 11.3 14.5 18.2 10.4 11.2 13.8 23.6 13.1 10.5 15.7 14.2 14.5 13.6 15.8 19.4 10.8 14.3 14.0 14.4 10.7 16.6 26.5 16.0 12.5 15.5 15.2 17.1 14.4 14.2 15.2 24.6 16.5 13.6 15.2 10.4 15.4 13.1 38.6 13.1 16.6 13.2 9.9 15.7 11.7 10.2 3.9 4.0 3.0 6.4 2.6 5.6 2.3 15.2 13.8 18.7 14.1 22.6 10.8 9.3 12.9 12.4 17.2 17.0 14.2 14.1 16.9 11.1 15.2 18.2 25.2 19.7 22.3 13.5 18.4 22.5 28.6 17.9 14.2 21.9 16.8 13.8 15.0 24.6 25.0 21.8 25.1 14.6 12.0 17.4 15.1 16.7 14.1 13.1 15.2 22.0 11.3 15.2 13.8 18.9 13.8 27.6 14.9 16.9 12.1 13.0 23.2 15.1 13.7 11.5 17.2 14.4 13.4 33.3 10.9 23.7 15.8 0.7 2.9 3.0 5.2 6.4 4.3 3.9 3.0 2.7 4.0 3.4 3.6 3.1 2.0 2.6 3.3 3.1 5.6 2.3 18.7 22.5 25.2 25.2 14.5 13.6 14.0 14.4 15.5 13.1 MTPN "GCDP, MYOTROPHIN, V-1" ENSG00000105887 Myotrophin P58546 7 135926761-135977353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019735 Approved Approved "Plasma membrane,Cytosol" 48000000 "Plasma membrane, Cytosol" "HPA019735: AB_1858710" "unprognostic (5.97e-2)" "unprognostic (2.53e-2)" "unprognostic (8.52e-2)" "unprognostic (3.62e-3)" "unprognostic (2.20e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.19e-4)" "unprognostic (2.06e-3)" "unprognostic (3.30e-2)" "unprognostic (8.11e-2)" "prognostic unfavourable (3.05e-4)" "unprognostic (4.50e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" "unprognostic (2.43e-1)" "unprognostic (9.00e-3)" "unprognostic (4.86e-3)" 31.0 22.1 40.2 28.5 53.2 55.1 39.6 34.4 50.0 30.9 21.4 20.4 16.0 17.2 29.5 21.9 62.1 27.0 23.7 31.6 38.0 31.6 25.1 20.5 31.6 49.3 24.2 32.4 22.0 10.7 29.2 22.5 26.3 22.9 23.4 23.6 21.5 22.2 24.0 27.4 19.1 23.1 27.9 23.3 42.4 17.6 23.4 19.9 36.4 36.9 24.9 42.8 26.1 30.5 37.9 24.6 50.6 43.5 12.8 16.7 17.0 27.2 21.6 23.9 35.7 34.3 40.8 12.5 43.2 43.9 27.7 30.4 24.6 29.4 48.1 32.0 53.1 17.4 22.3 33.9 51.4 35.6 22.0 32.9 23.4 16.0 28.2 44.0 47.4 29.8 33.6 33.0 31.0 43.1 39.0 29.1 52.2 20.8 44.4 32.6 33.8 30.7 25.8 18.3 39.2 30.1 22.6 30.8 56.2 35.2 21.9 33.2 16.1 26.9 46.2 42.0 19.2 41.7 40.7 24.3 35.7 71.1 67.1 38.7 89.2 25.4 21.4 22.6 16.7 28.9 14.3 30.9 10.4 12.5 24.6 37.9 6.9 9.9 50.6 12.8 43.5 24.2 9.0 17.0 40.2 53.2 34.4 50.0 38.0 31.6 24.2 32.4 22.9 19.9 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.3 8.8 4.7 10.4 17.9 5.8 13.3 14.5 8.6 7.2 8.2 13.2 7.5 15.7 13.9 11.6 6.0 7.2 7.1 13.6 9.9 8.1 7.5 30.5 7.0 10.9 11.4 3.2 9.4 6.5 12.2 9.0 4.7 9.7 11.9 4.2 1.8 7.3 5.8 3.5 9.8 6.0 5.0 6.6 7.8 7.3 7.3 0.9 25.4 18.5 15.9 5.7 8.9 7.2 16.8 10.6 12.9 11.3 17.7 5.8 12.9 12.2 25.2 8.9 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 MTSS1 "KIAA0429, MIM, MIMA, MIMB" ENSG00000170873 "MTSS1, I-BAR domain containing" O43312 8 124550790-124728429 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 20.7;HDLM-2: 23.8;HEL: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 44.8" "Group enriched" "Detected in many" 4 "B-cells: 16.1;monocytes: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019613, HPA064003, HPA075540" Approved Supported Uncertain "Plasma membrane,Cytosol" 10000 "Plasma membrane, Cytosol" "HPA019613: , HPA064003: , HPA075540: " "unprognostic (1.70e-1)" "unprognostic (4.13e-2)" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (3.87e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-1)" "unprognostic (2.50e-1)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favourable (2.11e-7)" "unprognostic (6.74e-2)" "unprognostic (1.04e-1)" "unprognostic (2.41e-1)" "unprognostic (8.92e-3)" 18.7 27.3 14.0 9.2 16.3 8.5 12.4 36.0 19.1 8.1 8.2 32.1 1.7 5.0 5.6 15.8 32.4 8.9 7.0 13.4 13.5 13.6 18.2 51.5 12.0 12.1 18.1 10.3 8.2 21.0 2.6 10.5 25.3 16.9 7.9 7.0 19.8 10.2 5.3 16.5 21.3 5.0 7.2 20.9 23.9 9.0 15.8 20.0 8.2 4.1 12.1 12.2 9.7 13.7 16.1 3.3 0.6 44.8 0.6 6.9 6.8 0.9 0.2 12.9 0.3 20.7 10.7 0.0 0.5 3.5 0.2 0.1 1.2 0.1 0.4 1.3 0.0 0.2 0.1 7.1 0.2 23.8 0.4 81.4 0.2 6.4 4.7 0.0 8.7 17.0 16.5 3.9 10.3 7.8 0.1 0.1 1.4 0.6 0.2 1.0 0.5 0.1 0.1 0.0 0.1 2.9 2.8 9.3 0.8 2.0 1.9 6.6 0.3 0.2 4.0 0.7 0.4 0.0 0.2 0.2 0.2 1.4 7.5 0.2 2.7 0.6 3.9 0.0 6.9 25.6 0.8 13.2 1.5 2.6 3.3 16.1 0.7 2.1 0.6 0.6 44.8 0.0 0.1 6.8 14.0 16.3 36.0 16.7 13.5 13.6 18.1 10.3 16.9 20.0 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.1;AN3-CA: 25.6;HUVEC TERT2: 75.5;SK-MEL-30: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 21 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules "Nucleoli, Microtubules" "HPA067903: , HPA069795: " "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favourable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favourable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 45.0 20.8 20.9 6.8 38.2 0.4 21.8 51.0 27.7 19.8 19.0 56.5 9.9 16.9 16.9 12.6 20.3 12.8 20.0 44.3 27.4 17.3 14.4 29.3 20.9 4.4 34.7 18.0 28.2 47.1 43.8 15.0 36.1 33.7 17.5 21.1 10.3 24.3 14.0 49.7 12.2 17.4 20.5 48.3 8.2 21.4 6.5 49.3 0.7 15.7 10.9 7.5 21.4 26.7 0.2 0.0 0.0 0.0 0.0 4.8 1.0 5.3 29.1 4.7 25.6 0.0 0.1 8.6 0.2 1.9 0.1 0.6 2.1 1.9 0.7 2.2 0.0 5.6 7.8 2.7 0.2 3.9 3.3 0.0 5.0 13.8 1.7 0.0 0.1 2.4 4.2 0.6 8.6 75.5 0.0 11.1 0.0 1.4 1.0 1.4 6.8 0.7 0.0 4.3 2.8 1.5 11.1 2.4 0.5 3.7 6.8 21.4 4.9 0.0 15.4 0.0 6.4 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.0 0.2 4.8 3.6 0.0 0.0 0.0 0.0 0.0 1.0 20.9 38.2 51.0 27.7 27.4 17.3 34.7 18.0 33.7 49.3 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820348-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 46.8;pituitary gland: 19.3" "Group enriched" "Detected in some" 4 "HaCaT: 16.3;HeLa: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.9;intermediate monocyte: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" "HPA031473: , HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.6 0.8 2.3 0.7 6.1 0.7 0.6 12.2 8.8 1.1 0.8 0.1 0.0 0.7 2.1 0.6 0.8 1.4 0.7 46.8 3.4 1.9 0.6 1.1 0.7 1.0 1.2 4.6 8.2 4.7 0.5 19.3 0.5 2.3 0.8 0.8 2.0 1.0 0.7 0.6 0.7 0.9 1.7 0.7 1.0 1.5 1.6 0.9 0.0 1.1 0.0 0.6 2.6 0.7 0.0 1.3 1.9 1.7 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 16.3 0.5 0.0 0.0 0.1 0.7 0.0 6.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 1.2 0.0 2.8 2.1 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.3 0.1 0.4 0.0 0.0 0.0 0.2 1.9 0.0 1.7 0.1 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 2.3 6.1 12.2 8.8 3.4 1.9 1.2 4.6 2.3 0.9 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavourable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 13.2 26.4 21.3 12.0 22.3 5.5 18.8 15.0 44.9 13.0 20.7 18.5 16.6 15.4 15.5 27.9 22.2 20.0 12.0 33.6 23.6 26.3 31.5 20.2 10.6 8.9 21.5 16.5 13.2 16.4 23.7 25.7 17.3 21.8 18.9 24.6 16.3 24.7 16.5 45.0 12.5 14.8 17.6 25.7 9.4 14.6 40.6 14.0 10.2 14.7 19.8 13.6 14.4 13.6 16.2 12.1 4.7 12.6 15.1 13.4 7.9 17.8 10.6 21.6 13.2 14.5 16.8 20.8 19.3 18.1 17.7 20.7 18.2 19.5 22.9 32.7 17.0 12.1 23.5 23.7 24.4 22.7 17.0 21.8 13.4 32.1 23.0 33.7 7.4 18.7 29.6 18.5 32.0 25.2 28.9 17.8 20.8 16.3 11.8 34.3 20.6 16.8 0.0 15.7 20.4 50.2 32.5 30.9 26.5 16.1 21.5 39.7 12.0 22.0 22.1 17.7 15.7 18.5 20.1 20.0 20.8 27.4 22.0 17.0 21.4 4.7 7.7 3.2 8.5 12.6 11.5 16.2 10.9 9.6 12.1 11.4 13.2 13.4 0.0 15.1 10.9 9.8 13.4 7.9 21.3 22.3 15.0 44.9 23.6 26.3 21.5 16.5 21.8 14.0 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.5 0.0 1.3 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 24.8 0.1 0.1 0.0 0.0 0.2 0.7 0.8 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favourable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 16.9 16.4 9.5 19.6 20.6 11.6 10.3 16.9 20.2 21.0 20.3 10.1 28.2 12.8 18.9 23.8 25.9 17.0 24.4 15.3 12.7 13.5 9.8 11.1 14.6 24.3 13.4 16.8 18.9 32.2 21.5 22.4 13.7 12.7 15.6 22.8 8.6 8.0 9.0 9.7 15.7 7.9 11.9 16.5 24.7 9.5 9.7 14.3 15.1 16.2 20.7 11.4 12.9 15.4 20.5 11.8 17.8 15.1 18.3 15.9 13.8 16.1 18.2 19.0 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 MUM1 "EXPAND1, MUM-1" ENSG00000160953 "Melanoma associated antigen (mutated) 1" Q2TAK8 19 1354711-1378431 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048063 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA048063: " "unprognostic (2.50e-2)" "unprognostic (4.67e-1)" "unprognostic (1.72e-1)" "prognostic favourable (4.82e-4)" "unprognostic (1.14e-1)" "unprognostic (4.21e-3)" "unprognostic (4.84e-2)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.24e-2)" "prognostic favourable (2.25e-6)" "unprognostic (1.60e-1)" "unprognostic (6.05e-3)" "unprognostic (5.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (7.29e-3)" 6.7 5.3 14.4 3.6 20.9 2.1 5.6 21.9 19.2 7.0 5.8 13.6 4.5 3.7 10.4 5.6 4.3 13.0 5.4 5.3 13.6 9.1 4.9 8.3 6.8 3.6 14.2 11.5 18.4 4.0 7.7 7.5 6.0 11.5 6.7 4.8 5.8 6.7 8.7 5.5 8.1 4.8 11.5 10.5 6.0 4.8 19.9 13.1 1.9 6.0 0.9 4.5 5.6 11.5 4.3 3.9 11.8 2.6 3.8 4.5 1.3 7.1 9.2 13.0 13.8 10.5 14.1 15.9 12.5 7.8 11.5 8.6 6.3 4.8 14.6 5.9 16.1 8.2 13.0 8.1 8.8 15.7 8.2 7.9 9.5 9.6 10.1 6.0 17.7 9.2 5.1 6.5 4.7 11.8 12.1 7.4 11.0 8.0 10.4 6.4 14.6 5.3 16.7 10.8 6.1 7.7 10.5 9.4 21.4 11.0 13.1 8.4 6.4 14.0 11.3 10.5 14.5 8.5 11.6 14.9 12.6 6.7 13.9 9.9 14.1 11.8 1.1 6.8 4.5 2.6 3.8 3.9 2.5 3.3 2.1 4.3 3.7 4.0 2.2 3.8 2.2 3.9 1.6 1.3 14.4 20.9 21.9 19.2 13.6 9.1 14.2 11.5 11.5 13.1 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA059530: " "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 15.6 14.3 17.2 21.4 19.5 13.6 24.7 21.6 19.5 19.3 22.2 19.1 18.3 22.1 28.2 12.4 14.4 20.4 19.5 18.4 16.6 12.3 17.7 13.8 17.9 22.2 24.0 14.1 23.5 17.0 19.5 17.2 16.6 17.2 19.4 9.8 13.4 14.9 23.2 28.1 18.2 26.5 19.4 17.5 21.6 17.7 11.3 22.4 32.2 17.8 15.6 17.7 18.2 21.7 12.5 13.2 23.2 15.2 10.8 20.0 11.2 10.7 6.8 11.7 11.5 5.2 6.4 14.9 11.7 9.5 15.1 10.2 9.1 17.8 10.4 15.9 9.3 10.6 10.5 10.4 3.4 22.5 7.7 18.9 18.5 5.4 15.9 13.3 20.2 10.1 19.4 19.1 15.2 12.7 11.3 29.4 9.9 7.2 19.0 20.7 8.4 15.4 18.8 5.6 19.9 11.5 6.9 11.7 13.4 8.0 14.5 25.2 16.9 14.0 11.1 11.4 9.6 14.4 12.6 19.8 13.1 15.0 12.8 9.0 18.8 16.2 12.4 23.2 20.0 14.3 19.6 12.5 15.1 17.2 13.0 10.6 12.0 14.7 8.5 10.8 15.2 13.2 12.8 11.2 17.2 19.5 21.6 19.5 16.6 12.3 24.0 14.1 17.2 22.4 MUT ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463191 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol 110000 Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favourable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 10.7 14.3 10.9 5.7 13.4 4.1 9.7 10.0 12.1 8.9 12.7 8.6 9.0 13.6 8.7 8.6 13.2 8.4 7.5 16.6 10.1 10.0 25.5 96.5 7.8 5.7 11.8 9.5 13.1 15.7 15.8 13.5 7.5 12.0 11.2 11.2 8.0 9.3 9.2 13.7 9.0 14.7 11.8 9.7 6.4 10.9 9.1 9.9 8.2 11.2 9.1 5.8 12.8 8.1 9.4 8.9 14.0 15.2 14.2 12.0 6.7 13.2 4.7 14.3 16.6 28.5 27.1 7.9 11.9 15.7 12.6 18.7 5.4 6.9 12.3 9.5 12.7 7.6 15.9 8.4 17.8 10.5 11.5 6.5 10.8 14.2 20.8 8.3 6.3 16.4 12.6 12.8 15.0 12.1 11.9 14.8 14.8 8.3 9.7 8.3 6.1 3.5 8.8 17.9 17.0 14.6 12.8 13.3 9.2 13.1 9.4 19.7 8.2 13.4 8.7 11.8 8.7 15.9 16.0 5.9 6.6 10.6 16.6 9.9 10.2 14.0 7.5 12.5 7.9 9.9 9.9 9.4 9.5 9.9 8.9 8.3 12.0 9.0 4.3 14.2 15.2 6.3 11.9 6.7 10.9 13.4 10.0 12.1 10.1 10.0 11.8 9.5 12.0 9.9 MVB12A "FAM125A, FLJ32495" ENSG00000141971 "Multivesicular body subunit 12A" Q96EY5 19 17405722-17433724 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041885, HPA042231" Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA041885: AB_10964218, HPA042231: AB_10961043" "unprognostic (1.34e-2)" "prognostic favourable (3.26e-4)" "unprognostic (1.48e-1)" "unprognostic (2.35e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (5.96e-3)" "unprognostic (8.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.77e-1)" "unprognostic (9.93e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" 18.4 24.6 9.4 16.2 9.8 14.1 21.1 10.1 12.3 13.4 16.3 13.3 22.2 19.0 16.4 15.2 24.0 16.8 17.1 10.4 8.2 6.1 17.4 16.6 12.4 21.1 11.8 7.1 33.8 16.8 9.6 7.2 15.1 8.8 12.5 9.5 15.6 17.0 17.3 11.4 20.0 20.4 9.0 9.2 17.7 14.2 10.7 11.3 19.6 29.5 12.4 22.8 15.6 15.3 13.8 28.2 24.6 30.6 17.7 26.3 17.4 16.3 9.2 4.3 12.9 6.0 9.6 23.7 5.1 10.2 13.8 17.1 8.5 24.4 13.1 17.0 11.2 7.9 8.4 12.6 3.7 13.9 23.4 2.9 19.1 19.8 18.6 5.2 12.6 10.6 9.7 10.7 6.7 15.2 9.2 25.6 5.5 12.3 9.3 8.1 6.2 26.0 11.8 4.7 19.2 11.4 9.1 8.2 12.2 7.4 11.1 26.5 14.6 10.9 7.4 10.5 5.5 11.2 6.1 18.2 22.6 14.3 10.9 18.4 12.8 24.6 30.1 19.2 17.3 30.6 16.2 11.9 17.5 16.3 28.2 13.8 14.7 14.4 17.6 17.7 23.8 25.5 26.3 17.4 9.4 9.8 10.1 12.3 8.2 6.1 11.8 7.1 8.8 11.3 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326849-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "AF22: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA043683: , HPA049383: " "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favourable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.6 5.5 15.2 4.3 21.2 10.7 5.0 7.3 22.9 6.3 6.1 52.0 2.4 3.7 5.9 3.3 4.3 10.2 3.9 4.6 22.8 15.3 3.4 4.0 17.7 5.9 31.1 9.8 6.6 3.3 8.8 5.3 14.8 28.2 5.9 6.4 5.8 3.1 9.0 21.4 3.3 4.2 6.6 62.2 10.3 4.0 5.4 28.8 4.8 5.7 1.5 2.6 6.9 3.2 0.4 2.0 0.2 1.5 0.1 5.7 1.4 2.9 4.1 22.2 12.2 0.8 0.2 13.2 2.5 2.0 4.5 0.9 3.4 0.1 0.0 1.5 2.3 1.3 6.8 1.2 2.8 4.9 4.3 1.1 0.7 15.1 1.8 1.9 0.9 1.7 2.3 0.9 0.0 3.4 0.0 0.0 3.3 2.4 3.2 6.2 4.8 5.5 4.7 12.1 0.0 0.2 12.2 5.6 10.3 4.1 3.0 2.5 2.9 11.9 5.0 5.1 3.8 2.8 5.1 0.0 0.0 1.2 1.4 8.8 2.7 0.0 1.5 0.2 3.1 0.4 5.7 0.2 1.4 5.0 2.0 0.4 0.3 2.2 0.1 0.1 0.4 0.1 0.0 1.4 15.2 21.2 7.3 15.9 22.8 15.3 31.1 9.8 28.2 28.8 MVD MPD ENSG00000167508 "Mevalonate diphosphate decarboxylase" P53602 16 88651935-88663161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041404, HPA048250" Uncertain Approved "Cell Junctions,Cytosol" 30000 Cytosol "Cell Junctions" "HPA041404: , HPA048250: " "unprognostic (1.67e-1)" "unprognostic (3.05e-1)" "unprognostic (2.42e-1)" "prognostic favourable (2.17e-4)" "unprognostic (1.89e-1)" "unprognostic (9.56e-2)" "unprognostic (9.26e-3)" "unprognostic (8.33e-2)" "unprognostic (6.68e-2)" "unprognostic (5.47e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-2)" "unprognostic (1.19e-3)" "unprognostic (4.12e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (5.00e-2)" 11.9 18.5 15.8 16.9 19.7 7.6 12.5 21.7 27.9 10.8 19.4 17.1 10.8 39.6 8.4 7.3 30.0 7.4 8.7 11.9 17.2 18.2 9.2 25.9 14.6 12.6 14.6 17.3 11.1 19.0 11.0 7.8 7.6 24.5 13.7 5.1 10.8 16.1 8.7 27.8 18.3 20.7 6.6 23.8 11.1 21.2 23.0 14.6 4.3 9.2 18.6 12.2 7.3 13.8 15.0 17.6 2.5 8.9 18.1 18.1 9.4 14.6 9.4 15.7 10.2 5.3 11.8 8.9 7.3 7.6 5.0 4.2 24.8 37.1 7.1 11.7 4.3 21.8 7.0 38.6 1.4 4.4 11.9 5.2 5.2 37.7 10.8 3.3 3.7 9.3 7.4 13.2 4.2 5.3 14.4 3.9 2.7 34.2 11.1 16.8 18.9 9.2 11.7 4.5 18.3 14.6 9.2 15.9 5.3 18.1 4.1 5.3 20.6 14.8 11.3 4.6 9.4 8.2 4.1 10.8 4.8 24.2 5.6 16.2 7.6 2.5 8.2 1.5 18.1 8.6 13.5 10.3 12.1 11.9 9.5 15.0 9.4 11.5 1.1 18.1 8.9 17.6 12.6 9.4 15.8 19.7 21.7 27.9 17.2 18.2 14.6 17.3 24.5 14.6 MVK "LRBP, MK" ENSG00000110921 "Mevalonate kinase" Q03426 12 109573255-109598117 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016961, HPA044110" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA016961: AB_1854220, HPA044110: " "unprognostic (3.10e-1)" "unprognostic (2.27e-2)" "unprognostic (1.85e-1)" "unprognostic (4.43e-2)" "unprognostic (3.66e-2)" "unprognostic (2.08e-2)" "unprognostic (4.30e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (2.73e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-1)" "unprognostic (6.43e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (3.88e-1)" "unprognostic (3.28e-1)" 4.7 14.3 6.8 5.9 11.7 6.8 11.2 6.3 13.1 7.1 7.8 16.7 5.1 11.5 4.2 9.5 23.0 5.1 5.3 6.7 7.8 9.0 16.5 33.1 8.7 4.9 12.5 8.3 8.5 9.3 7.0 6.5 5.5 22.5 9.0 6.3 6.4 8.1 5.8 6.3 19.5 6.9 3.7 18.0 3.8 6.1 17.5 10.5 2.8 11.9 8.5 8.8 5.5 9.9 11.5 7.4 3.4 5.9 8.3 12.2 5.4 12.3 10.4 12.7 6.3 4.1 10.1 6.8 4.5 8.4 11.8 12.9 15.0 15.1 8.7 3.5 4.5 15.1 13.5 21.2 5.7 8.5 9.6 4.6 7.1 22.4 12.7 4.9 5.9 11.0 17.9 21.4 5.8 8.0 8.0 8.3 5.3 15.6 5.0 15.7 10.7 16.1 4.6 9.7 17.0 27.2 18.4 11.8 10.2 8.8 25.1 6.2 23.1 8.6 7.0 5.4 7.1 5.2 5.7 7.0 9.2 12.8 6.5 12.7 7.4 0.7 5.9 3.4 12.2 5.8 9.9 8.4 7.4 11.6 7.4 11.5 11.7 8.3 1.7 8.3 3.7 6.2 6.2 5.4 6.8 11.7 6.3 13.1 7.8 9.0 12.5 8.3 22.5 10.5 MX1 "IFI-78K, MxA" ENSG00000157601 "MX dynamin like GTPase 1" P20591 21 41420304-41459214 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 117.5;BJ hTERT+ SV40 Large T+ RasG12V: 105.8;Karpas-707: 27.1;SK-MEL-30: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030917, HPA030918, HPA049724" Approved Approved Supported "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862" "unprognostic (3.62e-1)" "unprognostic (6.84e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (2.27e-1)" "unprognostic (1.35e-3)" "unprognostic (5.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (6.88e-2)" "prognostic unfavourable (1.57e-4)" "unprognostic (9.95e-2)" "unprognostic (8.10e-2)" "unprognostic (3.24e-1)" "unprognostic (1.81e-1)" 19.3 7.5 8.6 19.8 22.5 25.7 11.6 3.1 15.5 14.4 12.8 9.4 4.7 14.7 13.2 19.3 19.2 12.4 19.0 8.1 12.4 16.2 20.8 11.9 28.4 17.3 14.3 11.4 16.3 7.2 7.5 16.2 9.7 20.5 7.2 5.4 15.9 54.0 8.4 3.7 5.7 15.4 11.3 13.1 34.5 16.2 5.2 4.8 33.7 16.9 14.5 20.7 15.6 11.5 22.8 25.0 36.5 27.0 9.2 29.5 17.0 2.3 0.0 0.1 0.2 0.1 1.0 0.0 0.1 3.7 117.5 105.8 0.7 4.9 0.0 1.0 0.4 0.3 0.1 0.1 2.3 0.7 0.1 0.2 0.4 0.3 1.1 0.1 0.1 1.0 0.3 7.0 0.2 0.4 0.0 27.1 0.0 0.2 2.0 0.4 0.4 1.1 2.0 0.0 3.7 0.5 1.5 0.2 0.1 0.1 0.2 35.4 1.6 0.9 0.2 0.1 0.1 0.0 0.1 6.0 5.6 0.2 0.1 0.4 0.3 13.7 24.0 14.0 10.9 27.0 14.6 22.8 16.0 12.7 16.9 20.1 14.5 10.7 36.5 9.2 22.0 25.0 29.5 17.0 8.6 22.5 3.1 15.5 12.4 16.2 14.3 11.4 20.5 4.8 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavourable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.4 1.5 2.2 1.6 4.9 2.4 8.2 3.8 2.2 1.9 1.3 4.9 2.7 2.0 2.0 1.5 12.3 4.2 7.7 2.0 1.1 5.0 4.1 4.4 4.8 16.4 4.9 4.1 2.8 13.0 4.3 20.0 2.4 7.1 7.9 1.2 2.8 2.4 9.9 0.6 2.5 1.1 2.2 4.9 2.5 4.1 7.1 3.0 5.1 6.8 2.7 1.0 2.9 9.4 2.7 0.7 2.9 3.6 5.4 9.1 0.7 2.8 8.7 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell line enhanced" "Detected in many" "HDLM-2: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA070111: " "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavourable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.0 5.6 3.4 9.4 0.2 0.4 5.7 10.6 3.5 4.8 4.6 3.6 8.4 4.3 4.4 1.4 4.0 0.4 1.2 0.2 58.7 7.1 2.4 8.0 5.3 0.5 2.3 7.4 0.3 0.6 0.3 0.2 4.4 1.4 13.5 0.9 10.3 21.4 6.4 1.2 9.7 10.5 10.7 6.1 1.0 1.1 8.5 7.0 6.8 6.9 3.6 10.8 6.1 3.2 5.8 14.9 4.5 5.6 17.9 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 29.5;SK-MEL-30: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: " "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavourable (9.17e-4)" "prognostic unfavourable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.5 2.2 5.7 11.4 9.0 6.8 2.5 3.2 11.0 2.1 6.8 1.0 10.0 7.3 5.2 5.6 7.2 6.8 7.7 5.7 3.7 9.2 1.9 4.5 4.1 5.9 3.9 4.4 7.2 29.5 3.7 15.0 2.1 7.3 15.9 3.5 3.6 2.6 7.9 2.4 6.8 1.6 7.5 11.6 7.5 0.5 9.7 15.9 3.2 2.4 53.2 2.7 12.7 2.1 3.8 6.5 4.0 1.7 13.2 6.9 2.6 10.1 14.5 4.0 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181315-135219173 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 104.9" "Cell line enhanced" "Detected in many" "HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7" "Cancer enhanced" "Detected in many" "breast cancer: 17.7" "Region enhanced" "Detected in some" "basal ganglia: 4.7" "Group enriched" "Detected in some" 4 "basophil: 5.6;eosinophil: 10.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favourable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favourable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.5 0.7 1.3 9.1 4.7 18.9 13.2 0.3 0.6 1.4 15.4 0.5 0.3 6.5 0.9 1.0 3.7 5.0 1.7 0.6 0.7 0.7 0.4 0.5 1.8 3.3 0.3 0.5 1.0 0.3 0.4 0.3 0.6 0.5 1.6 16.7 0.5 0.8 1.5 1.0 3.5 5.9 0.7 0.4 1.4 0.9 2.0 0.6 104.9 0.4 2.0 4.7 0.7 1.5 0.1 1.7 10.0 0.8 0.0 0.5 0.1 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 1.8 0.0 0.0 0.1 1.0 0.0 0.1 3.1 0.4 24.8 0.1 0.0 0.0 38.9 19.6 0.0 0.0 0.1 0.0 0.0 20.1 3.7 0.2 2.0 70.8 36.9 0.2 0.3 43.7 1.0 6.0 0.0 0.2 1.9 1.2 0.0 1.9 0.0 1.4 61.8 0.0 0.0 0.3 1.4 0.4 4.7 1.2 12.0 0.0 33.7 0.4 5.6 0.8 10.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.5 0.1 1.3 4.7 0.3 0.6 0.7 0.7 0.3 0.5 0.5 0.6 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555631 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favourable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavourable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (8.12e-4)" "unprognostic (9.70e-2)" 14.1 11.6 13.8 16.5 14.6 13.2 16.2 15.0 21.5 11.3 10.2 14.9 11.1 12.9 15.4 11.7 17.1 15.8 12.4 11.5 11.7 9.2 8.7 21.5 11.6 16.0 15.2 11.1 15.3 23.7 10.5 13.1 7.2 13.0 17.0 7.2 12.7 24.5 15.3 30.8 25.0 12.8 10.9 7.3 15.0 12.9 9.3 12.6 14.6 11.7 18.2 17.6 15.4 13.2 5.3 4.9 0.4 4.9 4.3 5.9 3.8 19.4 31.2 4.1 18.8 5.3 6.2 14.0 13.5 6.0 13.7 10.6 23.0 8.0 26.6 15.8 8.0 24.7 17.0 20.4 6.4 13.3 45.8 12.8 19.3 20.3 8.5 15.0 11.7 9.0 11.7 20.1 10.0 9.1 20.9 12.3 5.8 16.9 17.5 5.9 18.8 16.3 22.7 6.9 17.6 3.2 15.7 8.7 16.7 13.8 9.7 9.1 9.3 6.1 11.7 11.9 10.7 11.1 38.7 11.1 7.5 10.8 11.3 17.6 15.2 0.0 2.8 0.4 5.1 2.7 5.9 5.3 4.2 5.5 4.9 3.3 4.5 4.6 0.1 4.3 4.9 3.5 1.8 3.8 13.8 14.6 15.0 21.5 11.7 9.2 15.2 11.1 13.0 12.6 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell line enhanced" "Detected in many" "MCF7: 101.9" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017114: , HPA030530: , HPA055416: " "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavourable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 25.8 16.5 14.6 15.1 0.1 0.5 19.0 11.7 4.0 37.1 27.4 80.9 16.3 52.3 6.8 5.1 15.8 26.4 8.1 13.9 9.8 16.9 24.5 16.5 21.8 0.0 22.3 17.0 0.3 0.7 14.1 3.2 9.9 24.4 65.1 3.2 101.9 45.3 31.4 16.8 14.5 31.6 30.1 30.0 6.8 5.3 13.5 19.6 34.8 35.0 3.5 23.1 24.5 4.6 2.3 37.4 16.4 20.1 22.6 46.5 82.3 4.8 19.1 14.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Group enriched" "Detected in some" 5 "CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: " "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862964-38874105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: " "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 8.6 10.5 4.8 13.6 7.4 9.0 14.5 4.6 4.9 11.6 14.9 3.6 21.3 10.5 9.6 18.2 23.4 17.7 15.6 16.8 5.2 4.9 26.5 21.1 16.1 20.7 4.6 3.1 9.3 20.0 13.9 12.5 24.8 11.2 13.6 15.6 6.6 22.9 17.3 11.8 12.0 24.4 14.6 4.9 16.8 13.1 28.9 5.2 16.8 24.3 18.1 19.6 13.0 11.9 9.0 21.7 32.1 15.1 11.0 12.9 8.1 18.8 8.2 7.3 5.3 4.2 7.5 29.1 15.1 4.9 15.3 12.0 9.6 22.6 15.5 16.8 6.9 14.0 11.3 19.7 18.5 19.4 18.9 16.5 11.8 10.2 1.1 41.0 15.0 6.7 15.7 12.7 8.0 11.1 24.0 14.4 16.0 11.1 13.1 19.7 18.5 20.7 12.6 21.5 21.7 20.0 16.0 13.8 9.4 14.5 19.3 9.7 13.2 19.8 8.8 8.0 13.5 12.3 17.3 9.6 17.3 17.1 8.0 24.2 10.4 14.8 12.6 32.1 7.8 15.1 8.9 9.0 9.7 9.3 16.0 6.4 8.4 9.3 25.1 11.0 13.5 21.7 12.9 8.1 4.8 7.4 4.6 4.9 5.2 4.9 4.6 3.1 11.2 5.2 MYCBP2 "FLJ10106, KIAA0916, PAM" ENSG00000005810 "MYC binding protein 2, E3 ubiquitin protein ligase" O75592 13 77044655-77327050 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058807 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA058807: " "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (8.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "prognostic favourable (5.01e-5)" "unprognostic (2.63e-1)" "unprognostic (9.84e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" 28.0 13.4 31.0 26.1 28.8 24.1 22.4 31.3 32.7 15.5 10.9 8.1 11.5 8.0 16.2 26.7 18.9 11.7 11.1 13.5 24.1 18.6 12.3 13.2 12.4 29.8 15.3 31.1 22.8 12.6 14.5 17.2 9.6 20.0 17.9 11.5 9.6 12.9 12.4 13.7 57.6 13.6 13.2 14.0 24.1 10.3 14.1 16.2 18.6 11.6 12.6 30.7 13.3 34.0 8.3 4.6 3.3 3.7 4.2 7.3 2.5 7.7 3.9 4.8 5.2 24.0 10.7 2.8 4.9 7.3 4.3 5.5 3.5 4.0 22.1 3.1 9.6 7.1 8.2 9.0 5.8 8.7 8.2 18.7 8.0 7.2 8.2 39.2 6.6 12.0 7.5 3.9 7.9 9.7 3.9 7.0 7.6 4.6 10.7 26.5 2.5 5.0 12.2 4.9 5.3 7.2 7.7 7.5 3.5 5.9 8.6 4.4 3.2 30.1 12.8 4.1 3.4 2.7 4.7 7.6 5.2 15.7 8.3 32.3 4.1 2.0 3.5 3.2 5.8 3.7 5.1 7.9 6.5 5.0 3.2 8.3 7.3 5.8 3.3 4.2 2.5 4.6 7.3 2.5 31.0 28.8 31.3 32.7 24.1 18.6 15.3 31.1 20.0 16.2 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell line enhanced" "Detected in some" "AF22: 12.7;BEWO: 68.9;HMC-1: 16.6;NTERA-2: 26.1;RH-30: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA057420: " "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 68.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 26.1 0.0 0.0 18.2 3.5 0.0 0.8 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 45.9;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Supported Nucleoplasm,Vesicles 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 45.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.2 0.2 0.5 0.0 0.4 0.0 5.7 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 MYD88 ENSG00000172936 "Myeloid differentiation primary response 88" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favourable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 25.0 11.3 5.9 19.5 6.9 18.1 14.7 5.2 4.6 10.0 13.4 5.8 5.0 15.1 9.5 12.3 25.5 9.8 12.4 10.4 5.3 3.2 15.1 47.9 25.6 40.1 6.2 3.5 13.3 10.3 5.4 10.4 17.8 6.7 11.3 14.3 8.8 13.9 5.4 3.9 12.5 30.4 10.7 7.0 39.0 12.5 5.8 5.1 28.5 10.4 17.5 30.8 13.9 13.7 7.8 34.7 49.0 68.0 8.3 14.3 34.6 8.1 12.0 1.8 10.7 8.5 11.1 3.7 8.0 13.1 22.6 24.0 7.5 9.9 17.4 4.8 14.3 10.2 14.2 8.0 7.6 13.5 2.9 9.4 6.1 11.4 7.0 11.9 24.6 12.7 8.5 12.8 4.8 12.8 4.1 7.1 11.8 8.2 19.6 3.8 7.6 12.0 8.5 2.3 7.5 11.6 19.0 0.8 3.9 11.3 54.5 7.1 8.5 13.5 11.9 4.4 2.7 20.4 7.6 10.5 11.7 12.9 8.6 20.9 9.6 38.3 37.6 48.1 12.2 56.5 10.4 7.8 11.0 12.2 34.7 6.7 7.7 10.9 49.0 8.3 68.0 16.6 14.3 34.6 5.9 6.9 5.2 4.6 5.3 3.2 6.2 3.5 6.7 5.1 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell line enhanced" "Detected in some" "A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" HPA012949 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavourable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 57.8 27.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.5 0.2 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.0 0.1 0.8 0.0 12.8 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 MYH10 NMMHCB ENSG00000133026 "Myosin heavy chain 10" P35580 17 8474205-8630761 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB017180, HPA047541, HPA057198" Enhanced Supported "Actin filaments,Mitochondria,Cytosol" 130000000 "Actin filaments" "Mitochondria, Cytosol" "CAB017180: , HPA047541: , HPA057198: " "unprognostic (4.67e-2)" "unprognostic (9.64e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (2.40e-1)" "unprognostic (2.33e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (4.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-3)" "unprognostic (1.69e-2)" "prognostic favourable (1.38e-4)" "unprognostic (2.02e-2)" "unprognostic (2.73e-1)" "unprognostic (5.58e-2)" "prognostic unfavourable (6.42e-4)" 18.3 12.3 12.6 5.4 24.7 7.9 9.6 15.6 30.8 16.9 7.3 5.4 5.3 1.9 19.9 12.4 5.0 18.0 18.2 25.7 15.1 12.9 23.7 13.0 40.0 4.2 9.5 16.7 21.8 6.9 14.7 18.4 35.9 19.2 12.9 3.1 8.6 4.7 19.6 3.3 5.1 3.9 15.7 4.9 3.3 7.1 5.3 5.9 2.7 9.7 2.6 3.0 9.8 7.4 0.5 0.2 2.8 0.1 0.0 1.1 0.2 13.6 9.0 57.2 19.1 7.5 9.0 25.7 11.4 10.4 13.8 14.9 24.2 2.1 0.1 7.6 11.3 1.3 28.4 13.7 15.6 0.3 23.1 15.8 5.8 21.0 17.5 1.3 1.1 12.8 5.0 17.9 6.9 22.3 21.9 0.0 8.6 5.4 16.7 0.4 26.9 2.0 26.8 17.0 0.0 15.7 5.7 4.7 25.7 17.9 0.9 18.3 4.8 0.9 0.7 13.0 9.6 0.1 9.8 2.2 2.6 3.4 0.0 1.3 29.2 0.0 0.1 0.1 0.3 0.0 0.3 0.5 0.3 0.6 0.0 0.2 1.1 0.5 2.8 0.0 0.0 0.2 0.3 0.2 12.6 24.7 15.6 30.8 15.1 12.9 9.5 16.7 19.2 5.9 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703172-15857033 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 507.4;urinary bladder: 394.5" "Cell line enhanced" "Detected in some" "BEWO: 3.5;NB-4: 3.8;U-698: 9.7" "Cancer enhanced" "Detected in many" "prostate cancer: 173.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 54.5" "CAB002302, HPA014539, HPA015310" Enhanced Supported "Plasma membrane,Cytosol" 130000000 "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1854260, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favourable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 13.2 3.0 0.6 31.5 1.2 0.0 5.9 0.5 1.7 90.3 227.5 1.3 100.0 11.6 102.0 38.4 233.0 43.8 94.3 6.2 0.6 0.7 4.7 0.7 8.5 1.5 1.4 2.6 45.5 1.3 0.0 1.0 5.3 3.6 164.7 22.2 37.0 8.8 127.2 6.4 5.0 50.6 507.4 1.4 3.7 77.7 22.3 0.2 0.1 3.7 6.2 3.0 394.5 57.5 1.5 0.9 6.0 0.9 1.1 1.5 0.4 0.1 0.4 0.2 0.1 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.2 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.3 3.8 0.4 0.1 0.4 0.1 1.9 0.0 0.2 0.7 1.4 0.2 0.5 1.2 0.4 0.0 0.3 0.1 0.3 2.0 0.1 0.4 0.4 9.7 0.4 0.4 0.4 3.1 0.9 2.7 1.2 0.6 1.2 1.5 1.5 1.4 0.5 1.2 1.4 1.4 6.0 1.1 0.6 0.9 1.4 0.4 0.6 1.2 0.5 1.7 0.6 0.7 1.4 2.6 3.6 0.2 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281277-36388067 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" 3100000000 "Plasma membrane, Actin filaments" Cytosol "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 115.5 26.1 11.9 43.7 12.9 55.6 59.0 9.3 16.8 67.1 44.6 18.0 26.4 26.9 120.8 39.7 48.3 45.6 66.9 39.2 11.0 8.1 45.0 42.8 74.4 57.7 15.1 9.2 56.4 43.9 19.0 15.4 65.7 17.9 47.6 23.6 32.4 66.2 27.2 36.9 40.3 49.8 46.7 13.5 91.5 37.1 25.8 11.9 76.0 42.5 38.4 65.0 56.0 53.7 6.9 8.2 28.5 11.5 4.2 16.6 19.3 60.6 28.2 9.0 7.6 16.8 21.1 45.7 40.7 52.7 58.2 43.7 30.4 17.5 15.7 24.2 68.1 42.1 13.1 79.7 60.0 35.4 12.4 30.3 30.3 25.9 51.5 34.4 48.6 24.9 24.6 78.6 66.8 47.9 6.6 21.3 46.5 16.1 12.2 20.3 5.3 17.4 23.3 27.9 14.6 32.9 59.1 13.5 5.5 57.2 22.5 26.2 16.8 17.8 137.0 129.1 39.2 24.7 73.5 14.1 11.1 13.3 48.9 17.4 37.4 26.8 10.4 28.5 16.6 9.6 14.7 6.9 12.0 13.2 8.2 6.4 9.6 10.1 19.7 4.2 11.5 3.8 12.6 19.3 11.9 12.9 9.3 16.8 11.0 8.1 15.1 9.2 17.9 11.9 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" 70000000 "Nucleoplasm, Nucleoli fibrillar center" "CAB004503: AB_2282358, HPA039262: , HPA045244: , HPA059197: " "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 60.9 19.9 7.1 31.1 13.1 21.7 63.9 5.1 7.6 25.1 31.2 7.4 22.5 15.6 24.1 29.0 43.6 22.8 32.4 248.0 8.2 6.8 52.7 43.1 58.3 58.4 14.6 5.7 28.6 24.8 24.9 11.1 49.5 18.9 24.3 27.2 14.7 26.5 18.6 423.8 24.2 41.5 27.9 22.1 68.6 22.5 20.4 10.3 40.3 38.6 80.1 42.0 30.6 31.2 103.4 166.8 173.4 91.9 104.2 168.7 245.4 30.7 19.6 44.7 18.7 52.8 55.6 27.4 70.1 92.6 66.7 72.8 29.6 39.0 14.9 18.5 101.7 13.4 25.8 44.0 59.9 21.0 9.2 15.2 23.3 26.0 88.5 43.2 29.7 87.0 62.4 51.8 31.3 104.6 19.0 52.1 136.8 52.6 20.1 43.5 18.3 14.5 11.6 23.4 26.2 146.3 49.8 6.3 15.3 55.4 23.9 48.5 16.8 63.9 111.9 16.5 37.7 45.2 55.4 11.9 17.2 24.1 49.7 17.4 59.1 173.4 74.5 154.6 166.4 77.4 166.7 103.4 156.8 168.7 109.0 80.4 142.5 167.0 122.8 104.2 91.9 166.8 133.2 245.4 7.1 13.1 5.1 7.6 8.2 6.8 14.6 5.7 18.9 10.3 MYL12B MRLC2 ENSG00000118680 "Myosin light chain 12B" O14950 18 3261909-3278284 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: , HPA045244: , HPA059197: " "unprognostic (2.55e-2)" "unprognostic (7.31e-2)" "unprognostic (5.69e-2)" "unprognostic (4.05e-2)" "unprognostic (3.66e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-2)" "unprognostic (7.65e-2)" "unprognostic (2.89e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (9.69e-4)" "unprognostic (1.18e-1)" "prognostic favourable (8.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.77e-1)" "prognostic favourable (6.62e-6)" "unprognostic (1.27e-2)" 64.1 82.2 38.7 46.1 38.2 41.9 66.1 27.0 48.9 63.9 84.8 21.4 58.7 67.6 52.9 86.8 106.9 49.6 65.2 53.0 37.8 34.0 150.0 105.3 85.9 68.7 36.0 31.9 53.4 48.9 48.4 37.5 139.8 46.8 56.8 75.0 37.1 69.8 52.8 71.8 59.6 129.4 54.7 30.9 62.2 52.8 42.8 26.0 65.1 107.2 89.8 61.1 58.6 61.5 46.7 83.6 151.5 78.1 47.6 77.7 109.0 48.0 25.5 22.6 21.8 65.9 56.3 39.0 73.4 64.6 68.6 70.8 53.4 38.6 24.1 32.4 99.7 24.4 37.4 84.4 70.5 14.1 15.8 24.3 28.9 42.8 68.0 54.4 38.3 48.4 81.0 45.6 29.2 102.7 20.8 23.7 89.0 97.5 31.1 39.3 15.1 21.9 15.5 28.5 19.3 144.6 89.2 18.6 19.4 72.9 44.4 44.2 38.0 32.6 123.6 66.8 99.7 58.2 88.8 13.2 12.6 29.4 40.5 22.1 51.9 123.3 51.4 151.5 72.2 68.0 61.4 46.7 70.7 77.7 60.9 37.8 58.0 66.8 120.5 47.6 78.1 83.6 75.2 109.0 38.7 38.2 27.0 48.9 37.8 34.0 36.0 31.9 46.8 26.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46857872-46882169 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 398.1;skeletal muscle: 319.8" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 27.9" "Cancer enhanced" "Detected in many" "renal cancer: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria 15000000 "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: , HPA063034: " "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favourable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 0.9 0.2 0.5 0.2 0.4 0.0 0.6 0.2 0.4 0.5 0.1 0.3 0.0 0.0 0.2 10.1 10.5 0.1 0.2 398.1 0.7 0.4 2.3 0.1 0.2 0.1 0.7 0.3 0.3 0.1 0.0 0.0 0.3 0.3 1.6 0.0 0.3 5.5 0.0 319.8 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.4 0.0 1.1 30.1 3.1 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 1.6 0.3 0.1 0.0 0.1 5.8 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.7 0.4 0.7 0.3 0.3 0.4 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell line enhanced" "Detected in many" "ASC diff: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: " "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.6 13.3 7.0 33.2 22.9 6.4 5.3 7.2 5.5 5.0 4.4 9.3 2.5 2.6 8.7 3.2 2.1 3.7 1.6 4.7 2.6 3.8 5.0 4.1 11.6 5.8 3.5 17.2 3.5 4.3 4.6 3.3 3.9 3.5 6.7 4.1 3.1 4.0 2.8 5.5 2.8 2.8 1.5 9.0 10.4 6.1 3.4 1.8 4.5 3.6 7.3 5.3 5.4 4.7 0.9 4.0 3.1 13.3 2.6 1.5 5.2 5.2 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541484-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 717.2;urinary bladder: 496.7" "Cell line enhanced" "Detected in many" "ASC diff: 85.0;BJ: 110.2;fHDF/TERT166: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.6;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" 92000000 "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: , HPA045244: , HPA059197: " "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavourable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 61.9 46.0 2.0 58.1 5.8 0.2 64.8 1.4 6.4 123.3 361.6 6.0 162.9 22.7 278.8 102.0 242.7 80.3 199.0 169.8 1.9 2.1 27.7 6.8 36.0 14.9 4.7 8.7 107.8 5.4 2.8 4.8 31.7 10.5 218.9 30.4 71.8 22.6 203.9 22.2 14.7 70.3 717.2 5.2 22.8 120.7 55.1 1.4 1.4 48.8 21.9 8.7 496.7 107.7 1.2 0.5 2.7 0.2 0.3 0.1 10.8 8.0 0.1 6.4 0.1 85.0 32.7 28.3 110.2 47.7 57.7 37.5 63.5 0.9 0.0 57.8 87.5 3.0 0.0 0.2 13.6 0.0 0.0 1.6 12.4 5.9 54.9 0.0 1.9 45.7 5.8 38.1 0.1 2.0 0.2 2.9 48.4 0.0 0.0 0.8 2.5 0.5 0.0 0.0 0.5 0.4 0.6 0.0 0.4 1.1 2.8 0.0 24.6 1.6 14.1 55.2 23.3 8.0 0.1 0.0 0.4 0.2 20.9 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.1 1.2 0.0 0.1 0.3 0.2 0.0 0.0 2.7 0.3 0.0 0.5 0.0 10.8 2.0 5.8 1.4 6.4 1.9 2.1 4.7 8.7 10.5 1.4 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884331 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 191.1" "Cell line enhanced" "Detected in many" "BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" 3000000 "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: " "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavourable (4.46e-4)" 14.9 4.9 4.5 19.8 10.9 0.0 14.4 0.8 5.8 77.1 107.3 22.0 93.2 9.4 111.2 48.3 96.0 56.3 40.6 6.6 4.7 3.2 8.3 5.4 13.2 6.5 25.8 2.8 50.2 1.6 0.5 1.1 8.0 16.0 85.1 27.6 6.0 17.6 158.6 1.6 4.8 33.3 191.1 28.8 7.4 38.7 17.4 13.0 0.2 4.1 2.5 3.4 137.1 21.3 0.2 2.8 4.5 1.3 0.0 0.2 17.3 2.5 7.7 2.1 1.3 2.1 0.4 0.9 36.5 55.2 23.6 17.0 1.6 1.4 0.1 8.2 45.0 0.9 0.9 0.3 29.0 0.0 0.1 20.3 0.2 5.0 11.0 0.1 1.9 6.8 0.7 4.6 6.9 1.8 0.2 0.1 17.5 0.3 0.0 0.5 2.2 1.0 2.3 1.2 6.6 59.6 1.4 0.3 1.1 3.7 0.4 0.6 0.2 0.0 6.7 7.2 2.6 1.7 5.9 0.6 0.7 0.0 18.5 0.2 1.8 3.6 1.3 0.3 0.1 0.2 0.0 0.2 0.0 0.0 2.8 0.1 0.2 0.1 4.5 0.0 0.0 2.7 0.1 17.3 4.5 10.9 0.8 5.8 4.7 3.2 25.8 2.8 16.0 13.0 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in some" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073447: " "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 1.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell line enriched" "Detected in some" 6 "HEL: 12.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.1 0.6 1.1 1.0 1.2 0.6 0.7 1.5 0.5 0.4 0.5 1.0 1.0 1.6 0.8 1.9 0.2 0.4 0.7 0.2 0.6 12.4 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.5 0.1 0.1 0.3 0.5 0.1 1.3 0.2 0.0 0.9 0.0 0.0 0.8 0.3 1.0 0.6 0.3 0.2 0.5 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.2 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216939-44218236 "Predicted intracellular proteins" Myogenesis "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "adipose tissue: 27.4;blood: 12.2;pancreas: 9.0" "Cell line enriched" "Detected in some" 31 "RH-30: 55.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 121 "dendritic cells: 12.2" "Not detected" "Not detected" HPA051451 Approved Approved Vesicles,Mitochondria,Cytosol Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 27.4 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.8 0.0 1.1 0.0 0.5 1.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.7 0.0 2.2 0.0 0.1 0.0 0.0 1.8 3.2 0.6 0.0 2.8 0.4 0.0 0.4 0.5 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 55.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.1 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661914-16936276 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 38.8;SK-MEL-30: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.0" "Lineage enriched" "Detected in many" 5 "monocytes: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favourable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 10.5 3.4 28.1 5.1 30.1 3.0 8.0 8.9 39.7 6.3 15.3 17.3 6.6 19.5 5.7 4.3 7.7 3.8 7.7 3.7 26.2 10.9 13.3 7.1 14.5 1.6 14.6 15.3 12.1 22.0 10.4 16.2 22.0 10.6 5.4 15.8 19.7 9.8 7.4 6.6 13.4 14.6 4.3 11.1 10.9 24.2 12.4 18.5 0.5 28.6 3.3 2.3 6.6 7.1 0.9 0.5 1.1 6.0 0.5 0.6 0.3 13.1 20.9 8.7 4.1 6.4 3.5 8.0 23.6 16.7 6.6 5.4 13.2 2.2 0.4 16.2 10.7 7.0 38.8 15.5 12.3 0.0 3.9 0.0 34.9 3.7 23.6 0.1 0.4 7.1 6.8 15.9 19.0 22.0 0.0 1.3 6.4 2.6 0.0 0.1 22.5 7.6 5.3 2.2 13.9 6.6 10.2 1.1 0.6 5.1 2.6 45.3 1.7 2.1 26.6 16.0 5.9 0.2 12.9 0.2 0.1 0.1 7.9 2.5 15.9 1.0 0.6 0.5 0.3 1.5 0.4 0.3 0.4 0.3 0.5 0.9 0.6 0.6 1.1 0.5 6.0 0.4 0.3 0.3 28.1 30.1 8.9 20.7 26.2 10.9 14.6 15.3 10.6 18.5 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" 22 25742144-26031041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 141.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.0 0.0 141.2 0.1 0.0 1.5 0.0 0.0 0.3 2.4 0.0 0.3 1.1 16.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 3.9 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.9 0.7 2.9 0.0 0.3 1.1 0.0 0.0 10.9 23.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYO19 "FLJ22865, MYOHD1" ENSG00000278259 "Myosin XIX" Q96H55 17 36495633-36543435 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059715 Approved Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA059715: " "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (8.44e-3)" "unprognostic (1.46e-1)" "unprognostic (2.02e-1)" "unprognostic (4.89e-3)" "prognostic unfavourable (8.33e-6)" "unprognostic (1.07e-3)" "unprognostic (1.39e-2)" "unprognostic (2.41e-1)" "unprognostic (1.67e-1)" "unprognostic (3.70e-3)" "unprognostic (1.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.57e-1)" "unprognostic (1.89e-1)" "unprognostic (4.17e-2)" 5.2 1.9 3.1 5.4 6.2 7.8 4.7 2.7 6.5 4.7 7.7 7.0 6.8 7.5 4.3 4.1 9.8 3.4 4.1 1.4 4.7 5.7 7.0 3.8 5.2 6.1 3.1 2.9 5.8 9.8 7.2 8.1 5.0 2.8 11.2 4.8 9.5 9.3 6.3 13.1 7.9 5.2 5.4 3.0 8.3 8.0 5.7 5.8 4.2 5.6 7.2 3.3 2.8 2.2 3.4 1.7 1.7 3.7 3.9 1.4 13.8 17.0 8.1 9.3 4.5 4.5 9.9 13.8 11.0 22.0 22.5 16.8 14.5 8.7 5.5 9.4 21.0 19.2 14.5 15.8 6.2 13.0 13.9 18.6 10.5 3.0 13.5 15.2 4.2 7.2 15.7 17.2 9.8 16.3 9.2 11.1 10.5 9.4 11.0 9.0 10.0 10.9 13.1 10.3 10.3 11.3 14.0 8.7 18.4 11.3 5.8 18.5 5.5 6.3 12.4 14.0 16.8 24.3 7.1 14.0 8.0 7.7 8.3 14.4 1.7 1.7 1.7 3.8 1.2 2.8 2.2 2.4 2.6 3.4 1.7 1.7 3.9 0.1 3.7 0.5 1.9 2.0 1.4 MYO1C myr2 ENSG00000197879 "Myosin IC" O00159 17 1464186-1492812 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001768, HPA005924, CAB037023" Enhanced Enhanced "Nuclear bodies,Plasma membrane" 30000 "Nuclear bodies, Plasma membrane" "CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: " "unprognostic (3.60e-1)" "unprognostic (4.71e-3)" "unprognostic (2.89e-1)" "unprognostic (2.96e-3)" "unprognostic (1.38e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-2)" "unprognostic (1.99e-2)" "unprognostic (5.02e-2)" "unprognostic (4.66e-2)" "unprognostic (4.93e-2)" "unprognostic (3.47e-2)" 61.5 8.6 3.3 20.1 4.1 0.9 45.7 4.4 4.3 33.8 35.5 5.3 17.2 14.0 36.0 20.5 34.3 20.3 38.2 29.3 3.3 2.5 24.8 24.8 30.3 13.4 3.3 3.8 23.7 44.8 8.6 7.6 32.2 6.1 27.4 12.7 20.0 44.5 19.0 20.0 17.1 29.9 40.8 3.6 12.3 24.2 12.6 2.9 9.4 23.0 21.3 18.6 32.0 32.4 7.9 1.7 0.8 3.1 0.0 3.5 2.2 35.5 39.1 4.2 17.3 19.9 19.8 16.3 36.3 30.2 24.0 20.2 26.0 19.6 3.5 26.3 55.9 30.2 6.3 25.2 12.5 15.8 16.0 3.4 21.3 9.5 29.6 0.3 18.0 15.4 12.6 22.0 12.7 30.8 2.7 3.0 20.3 27.1 0.4 0.2 2.7 7.2 1.4 5.8 6.4 22.0 18.6 1.7 9.5 22.8 33.4 14.6 27.3 1.8 40.4 34.8 26.8 17.0 31.3 2.3 1.8 1.5 27.7 0.8 30.1 0.2 1.3 0.0 1.5 3.1 0.8 7.9 3.5 1.6 1.7 6.7 1.3 0.7 0.8 0.0 2.6 1.6 3.0 2.2 3.3 4.1 4.4 4.3 3.3 2.5 3.3 3.8 6.1 2.9 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934071-26212536 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.1;testis: 12.5" "Cell line enhanced" "Detected in some" "AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA048951, HPA051893" Approved Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA048951: , HPA051893: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.8 0.7 0.4 0.3 5.0 0.5 1.5 0.3 1.9 2.1 0.6 0.1 0.7 0.4 0.3 3.2 0.9 1.1 0.3 0.3 0.5 1.3 0.9 0.2 1.0 0.3 0.2 0.0 0.5 2.1 0.2 8.1 0.2 5.4 0.5 1.1 3.8 0.2 0.6 0.3 2.2 0.6 1.0 0.4 0.3 0.9 12.5 0.8 0.0 1.3 1.4 0.9 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 1.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.0 0.3 1.9 0.5 1.3 0.2 0.0 5.4 0.8 MYO5A "GS1, MYH12, MYO5, MYR12" ENSG00000197535 "Myosin VA" Q9Y4I1 15 52307283-52529050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;parathyroid gland: 47.6" "Cell line enhanced" "Detected in many" "Karpas-707: 58.9;RPMI-8226: 39.9" "Cancer enhanced" "Detected in all" "melanoma: 25.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001356 Enhanced Approved "Focal adhesion sites,Centriolar satellite" "Focal adhesion sites, Centriolar satellite" "HPA001356: AB_1079441" "unprognostic (1.54e-1)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (2.29e-2)" "unprognostic (1.97e-2)" "unprognostic (3.91e-2)" "unprognostic (2.30e-2)" "unprognostic (6.65e-2)" "unprognostic (7.89e-2)" "unprognostic (4.74e-2)" "unprognostic (9.36e-3)" "unprognostic (1.71e-1)" "unprognostic (5.63e-3)" "unprognostic (3.79e-3)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "prognostic unfavourable (4.22e-4)" 8.4 7.1 16.6 9.5 27.5 15.7 5.5 27.4 34.5 6.2 4.4 7.8 0.4 3.3 4.2 3.2 5.0 3.6 7.3 4.6 15.9 15.4 4.6 2.7 7.3 11.2 15.6 17.6 5.4 4.3 47.6 10.5 5.2 29.3 4.5 5.2 9.9 4.0 3.4 4.1 10.4 3.9 7.7 10.1 7.3 4.1 4.6 7.1 3.1 6.8 2.7 10.3 7.3 4.2 2.3 5.2 6.3 4.4 0.7 4.5 1.9 5.4 9.6 5.1 6.1 5.2 6.4 5.5 9.9 9.0 5.3 4.2 0.9 2.2 5.2 2.6 11.8 4.5 11.7 10.2 6.6 29.4 2.7 4.8 2.5 1.1 2.7 2.5 4.7 4.2 6.4 7.8 15.5 30.8 0.1 58.9 10.2 9.6 2.2 0.3 2.3 7.7 4.1 8.2 39.9 4.4 3.9 3.8 2.2 9.2 7.6 18.0 4.0 2.8 14.7 10.7 4.6 5.0 9.6 6.1 13.5 6.3 11.7 7.3 15.4 0.9 4.4 5.4 2.9 3.6 4.5 2.3 2.9 1.9 5.2 1.6 0.5 1.0 6.3 0.7 2.6 3.1 4.1 1.9 16.6 27.5 27.4 34.5 15.9 15.4 15.6 17.6 29.3 7.1 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295798 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.1;MCF7: 23.4;RT4: 13.6;SK-BR-3: 17.9;T-47d: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB020790: , HPA032115: , HPA032116: " "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favourable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favourable (2.47e-5)" "prognostic favourable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 11.2 1.5 2.7 4.0 4.0 0.4 10.7 14.7 3.4 11.1 10.0 3.4 9.5 3.7 3.7 9.8 6.6 8.6 12.2 1.7 2.5 1.7 6.4 2.7 11.4 1.2 2.6 3.0 2.6 33.9 18.5 7.8 2.1 7.5 7.8 13.2 6.5 22.6 12.8 2.1 4.3 4.1 4.2 4.3 2.7 14.2 4.7 3.4 0.5 15.1 3.7 3.8 4.5 18.4 1.2 1.6 1.5 0.0 0.0 2.9 0.1 10.8 13.1 1.8 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 2.0 4.6 0.6 2.8 0.0 1.8 2.7 3.8 0.0 0.5 4.4 0.0 9.3 8.0 0.0 0.0 0.1 0.0 3.8 0.0 3.6 2.9 0.0 0.2 0.0 23.4 0.6 0.1 0.7 6.2 8.9 1.1 5.4 10.4 13.6 1.9 2.0 0.8 17.9 0.0 21.5 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.3 1.1 0.1 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.2 1.0 0.4 0.4 0.3 1.5 0.0 0.0 1.6 2.9 0.1 2.7 4.0 14.7 3.4 2.5 1.7 2.6 3.0 7.5 3.4 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482317 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 15.9;non-classical monocyte: 18.0" "Group enriched" "Detected in many" 65 "dendritic cells: 6.2;monocytes: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" 14000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.5 7.3 2.1 8.9 4.1 0.2 21.7 1.3 2.7 27.0 12.3 5.1 16.0 2.0 27.2 17.7 27.2 16.2 11.4 7.2 3.5 2.1 12.2 1.7 18.7 7.5 5.8 2.5 12.7 3.3 16.1 4.2 31.9 15.0 20.7 12.8 10.1 14.9 17.4 5.7 22.4 6.8 49.0 9.4 10.0 8.8 5.7 4.4 1.5 15.7 14.2 9.4 35.0 20.0 0.0 6.2 0.1 18.0 0.0 0.1 1.1 35.7 33.8 3.6 2.3 25.3 56.3 10.2 31.5 75.3 19.2 19.0 8.2 28.1 0.0 12.6 57.5 54.7 0.2 32.2 14.2 0.2 0.1 0.0 13.2 0.3 8.8 0.0 0.0 29.6 11.2 12.9 53.0 49.7 0.0 0.0 45.1 5.7 0.0 0.1 0.2 30.2 0.0 2.6 0.0 49.8 44.7 0.0 0.0 21.5 4.5 7.9 22.4 0.7 62.1 28.3 1.9 18.6 18.3 0.0 0.0 0.0 20.9 0.4 33.3 0.0 4.3 0.0 0.0 15.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 18.0 2.1 0.1 1.1 2.1 4.1 1.3 2.7 3.5 2.1 5.8 2.5 15.0 4.4 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7" "Group enriched" "Detected in some" 6 "A549: 5.0;Hep G2: 19.3" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" 680000 Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favourable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 6.3 2.7 0.2 0.0 59.5 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.7 0.0 104.6 0.4 1.5 0.0 0.0 0.0 0.0 1.9 0.1 0.0 2.7 39.7 2.8 0.2 0.1 0.8 0.4 2.3 0.4 0.2 0.4 0.0 0.1 5.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 1.5 0.0 2.1 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 19.3 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.1 1.1 0.2 0.6 0.7 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.3 0.4 0.1 0.4 0.2 0.2 0.0 0.8 0.3 0.4 2.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 MYOZ2 "C4orf5, CS-1" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135784-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 219.1;skeletal muscle: 188.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.2;HSkMC: 3.7;SK-MEL-30: 9.3;U-87 MG: 9.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 3.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 2.4 2.6 0.2 0.1 219.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.9 0.1 188.6 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.0 13.9 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.6 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.3 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell line enhanced" "Detected in some" "BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: " "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.1 0.5 0.0 0.0 0.3 1.7 0.0 16.3 8.2 6.1 2.3 0.0 0.0 0.0 0.0 45.8 0.3 0.0 0.1 10.8 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.3 0.1 0.0 0.1 19.7 3.4 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 1.9 0.0 1.7 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell line enhanced" "Detected in some" "A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 18.3 3.3 1.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 30.5 17.6 0.6 23.9 0.0 0.8 1.0 0.1 1.3 0.1 0.3 0.1 0.4 12.9 13.7 0.0 0.3 0.3 0.2 0.4 0.0 0.1 5.6 0.2 0.1 0.3 0.0 0.6 0.9 2.4 0.0 0.1 1.2 8.1 0.1 0.1 0.6 0.1 1.3 0.3 0.4 0.1 0.6 0.2 10.6 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell line enhanced" "Detected in some" "HAP1: 4.4;HUVEC TERT2: 16.6;REH: 3.9;SCLC-21H: 3.5;SH-SY5Y: 10.3;T-47d: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favourable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.1 3.9 0.0 0.0 0.4 2.1 3.5 10.3 0.0 0.0 0.0 4.1 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58654739-58700092 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA067133" Approved Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA054291: , HPA067133: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favourable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 13.2 12.3 14.1 14.4 15.7 24.4 17.3 16.9 24.3 14.3 13.7 11.4 11.9 12.5 17.5 14.3 13.5 13.0 9.9 14.1 11.7 8.1 11.0 11.0 12.9 14.3 14.0 13.3 18.1 14.0 16.5 19.2 11.3 18.0 14.4 11.6 9.3 15.5 15.2 23.2 20.4 14.6 13.7 15.2 14.2 11.5 8.3 14.7 11.9 15.5 10.6 12.9 13.3 14.7 1.1 0.7 2.2 2.1 0.2 2.3 0.5 8.2 2.4 6.1 6.5 5.6 7.2 8.8 4.9 5.5 4.9 4.3 4.1 3.6 8.6 1.5 3.7 6.3 6.7 2.9 9.5 5.8 4.6 10.3 1.1 4.5 6.8 15.6 7.9 5.2 4.9 6.4 3.3 1.2 11.0 5.5 5.6 2.8 7.7 13.1 9.7 4.5 6.5 14.8 5.3 4.0 3.2 5.1 4.9 4.2 8.2 11.6 2.5 8.9 4.0 8.8 4.0 6.8 9.4 10.1 4.7 11.4 5.1 11.4 9.6 0.8 0.7 0.5 2.0 1.0 1.4 0.9 1.4 1.6 0.6 1.1 2.3 1.1 2.2 0.2 2.1 0.7 1.4 0.5 14.1 15.7 16.9 24.3 11.7 8.1 14.0 13.3 18.0 14.7 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell line enhanced" "Detected in some" "HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.0 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.2 13.0 0.0 0.0 0.0 0.0 16.2 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 MZT2A "FAM128A, MOZART2A" ENSG00000173272 "Mitotic spindle organizing protein 2A" Q6P582 2 131464900-131492743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.9" "Low lineage specificity" "Detected in all" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol Centrosome Cytosol "HPA051758: , HPA052623: " "prognostic favourable (3.04e-4)" "unprognostic (3.82e-2)" "unprognostic (7.14e-2)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-2)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (3.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.72e-2)" "prognostic unfavourable (3.04e-11)" "unprognostic (1.51e-2)" "unprognostic (5.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.66e-1)" 17.7 17.1 34.7 22.1 22.6 31.3 17.1 9.6 25.1 17.5 20.3 7.6 23.0 30.0 11.9 22.3 23.5 14.0 17.5 57.5 28.0 20.7 14.4 15.9 7.5 15.6 18.9 16.4 20.8 55.4 5.6 7.2 5.3 8.8 16.4 3.4 9.3 48.5 19.7 40.7 12.6 22.8 17.3 12.0 15.5 24.0 11.1 5.5 28.3 17.8 23.8 17.0 16.2 12.8 11.9 5.4 31.9 1.0 2.6 9.3 2.2 35.6 19.2 0.4 7.4 0.5 1.3 7.7 12.1 2.8 4.7 4.6 47.2 12.3 23.1 15.7 0.5 16.1 1.2 8.1 0.1 9.1 58.8 9.5 21.6 55.8 2.9 16.6 3.6 3.7 4.4 3.0 1.4 3.8 18.7 24.4 1.1 32.2 23.0 70.0 12.5 44.1 19.6 6.7 51.7 2.9 16.5 28.0 3.5 12.3 8.4 22.0 13.1 30.0 10.6 12.3 29.8 5.2 11.8 22.8 16.9 18.6 17.2 10.8 7.3 6.9 1.0 31.9 3.8 0.6 4.2 11.9 8.5 4.9 3.4 6.2 9.3 4.5 0.4 2.6 0.3 5.4 8.4 2.2 34.7 22.6 9.6 23.1 28.0 20.7 18.9 16.4 8.8 5.5 MZT2B "FAM128B, FLJ14346, MOZART2B" ENSG00000152082 "Mitotic spindle organizing protein 2B" Q6NZ67 2 130181737-130190729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA051758, HPA052623" Approved Supported Centrosome,Cytosol Centrosome Cytosol "HPA051758: , HPA052623: " "unprognostic (8.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.40e-2)" "unprognostic (1.31e-2)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (9.65e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (9.37e-8)" "unprognostic (1.67e-1)" "unprognostic (2.04e-1)" "unprognostic (3.04e-1)" "unprognostic (2.09e-1)" 28.9 39.1 50.8 23.9 33.5 63.4 23.8 19.5 35.1 24.3 31.3 14.4 27.7 34.2 24.7 24.0 30.6 19.4 26.7 56.6 33.7 29.3 22.5 31.1 14.4 27.8 32.8 33.3 31.0 104.2 10.9 17.1 16.2 19.7 28.4 11.6 18.6 63.6 24.9 87.5 20.9 32.1 31.8 21.7 26.8 33.8 26.1 15.4 35.3 36.0 27.1 22.2 24.4 34.9 15.3 21.7 31.7 9.3 12.1 13.3 4.9 40.8 17.3 4.4 21.0 1.7 6.4 20.4 19.6 7.3 7.6 5.5 35.3 21.3 22.5 30.6 4.4 23.2 2.3 6.4 1.2 33.3 53.5 12.1 25.3 38.5 7.5 16.0 12.1 6.9 9.1 5.1 2.5 8.3 16.0 33.7 5.4 47.4 35.8 93.1 14.0 31.7 41.8 11.0 70.6 4.5 13.5 30.5 37.2 11.8 21.4 31.8 25.3 47.3 14.8 21.9 35.5 17.5 18.5 41.1 25.6 27.7 33.0 23.7 15.8 0.1 9.3 31.7 7.7 9.1 6.2 15.3 11.3 10.7 11.2 14.8 13.3 10.7 4.6 12.1 8.4 21.7 8.7 4.9 50.8 33.5 19.5 35.1 33.7 29.3 32.8 33.3 19.7 15.4 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell line enhanced" "Detected in many" "MOLT-4: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: , HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.3 1.5 0.6 3.1 7.6 1.7 1.9 1.0 2.2 2.9 3.1 8.2 3.4 1.6 1.1 5.9 1.9 2.4 2.6 1.9 3.7 1.4 1.4 1.6 9.9 8.8 3.4 2.7 1.7 3.7 2.7 8.1 3.6 2.0 1.5 20.0 4.3 4.6 1.3 11.7 11.0 1.9 0.8 3.6 3.8 6.6 1.6 1.3 1.5 1.1 2.7 3.6 1.1 5.9 0.7 1.3 5.9 5.9 5.6 1.1 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 13.0;NB-4: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038971 Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038971: AB_10673408" "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favourable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 12.1 9.4 19.6 10.5 22.2 29.5 22.1 24.5 21.8 12.3 11.0 9.4 4.2 11.6 14.6 12.8 8.3 14.0 9.6 6.3 15.0 16.6 7.4 57.8 17.3 17.6 12.1 18.8 30.1 11.0 7.3 21.2 10.0 11.0 11.3 11.3 7.3 7.6 9.5 11.0 17.5 13.4 11.3 10.6 19.2 7.2 3.6 15.5 14.2 10.4 5.1 12.9 13.5 16.5 15.9 28.0 24.2 25.5 15.2 13.5 17.4 0.5 0.1 0.7 0.2 2.9 2.3 0.2 0.3 1.2 0.7 1.1 2.1 2.9 5.6 0.8 0.6 0.0 2.1 0.2 0.9 8.4 1.3 13.0 0.6 6.2 4.5 4.8 0.8 1.6 0.5 0.5 0.6 0.4 0.0 10.4 0.5 0.4 9.9 32.8 1.0 0.3 9.5 0.3 4.7 2.8 1.0 1.9 2.4 2.1 0.0 0.9 0.3 9.3 0.2 0.2 0.1 0.1 0.1 5.9 3.5 0.3 0.3 1.8 0.4 24.2 25.5 6.6 9.8 23.1 8.5 14.0 9.5 11.9 21.9 15.9 13.1 11.3 6.2 15.2 15.8 28.0 13.5 17.4 19.6 22.2 24.5 21.8 15.0 16.6 12.1 18.8 11.0 15.5 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell line enhanced" "Detected in many" "BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favourable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 7.9 0.0 0.0 0.0 0.0 1.6 0.5 0.7 1.0 0.0 2.4 0.2 0.0 0.0 1.2 0.4 2.0 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 6.3 1.3 0.5 0.0 10.6 0.1 0.1 5.9 0.0 5.9 10.7 2.7 0.6 1.2 0.9 0.4 0.3 37.9 2.5 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.1 6.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 N6AMT1 "C21orf127, HEMK2, MTQ2, N6AMT, PRED28" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: " "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 5.4 10.9 10.1 6.0 18.6 2.0 10.5 7.4 14.8 9.9 7.0 17.0 6.0 6.7 13.8 13.7 5.6 9.3 6.2 10.8 10.8 9.2 9.0 6.3 5.5 6.7 21.3 8.4 18.3 6.6 14.6 15.6 13.1 14.1 10.1 7.4 8.4 6.5 9.0 11.3 8.0 6.2 7.8 14.5 7.9 6.7 7.6 19.3 3.9 12.1 4.0 6.9 8.7 9.2 2.2 2.0 1.6 2.1 4.1 4.8 1.8 3.4 3.0 7.7 10.7 6.4 7.1 5.9 7.4 3.0 4.3 2.6 3.8 6.1 3.8 3.7 4.0 4.0 6.6 3.7 5.4 4.8 5.0 8.0 4.7 4.7 5.8 4.8 3.1 3.6 8.0 4.4 3.0 3.2 9.8 6.7 8.9 3.4 2.2 3.8 9.7 4.3 3.4 7.3 2.8 8.0 5.0 5.9 8.3 6.7 2.4 2.7 3.3 4.2 7.4 3.7 6.5 6.6 4.4 4.1 4.6 2.1 5.7 12.5 6.8 1.1 1.5 1.6 1.8 2.1 2.0 2.2 3.4 2.3 2.0 2.2 4.8 3.4 0.5 4.1 1.6 1.7 1.4 1.8 10.1 18.6 7.4 14.8 10.8 9.2 21.3 8.4 14.1 19.3 NAA10 "ARD1, ARD1A, DXS707, TE2" ENSG00000102030 "N(alpha)-acetyltransferase 10, NatA catalytic subunit" P41227 X 153929242-153935223 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006269, HPA030711" Supported Supported Nucleoli,Cytosol Cytosol Nucleoli "CAB006269: AB_425759, HPA030711: " "unprognostic (7.57e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (1.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.04e-1)" "unprognostic (9.01e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (3.29e-8)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (7.48e-3)" 18.9 21.2 17.7 20.3 14.0 12.5 31.8 15.5 20.8 12.4 15.3 8.1 19.2 16.7 17.2 17.6 19.7 16.5 17.6 26.4 15.0 14.2 16.3 18.6 20.7 30.0 15.0 18.0 14.1 33.3 12.3 12.0 13.7 17.5 13.6 11.7 9.3 19.0 17.9 57.8 14.1 14.7 21.7 14.7 14.9 17.7 7.1 11.8 11.4 12.2 25.3 16.3 17.1 22.1 33.7 34.8 35.0 31.9 27.6 44.8 29.0 31.8 33.6 6.3 20.6 9.1 9.5 18.0 11.2 6.6 15.3 13.5 21.8 10.1 24.2 37.4 9.3 15.3 13.3 13.5 6.0 10.1 61.9 8.7 23.5 21.9 12.4 16.9 19.3 7.2 15.2 14.3 14.8 17.3 17.4 10.3 10.1 41.9 27.0 25.3 10.6 46.6 21.5 16.4 26.6 11.2 14.7 13.6 16.4 4.4 17.7 26.5 9.5 14.1 10.0 6.4 22.1 22.3 34.0 21.8 24.3 45.5 8.7 21.9 18.7 12.0 24.2 35.0 29.0 28.0 38.0 33.7 31.2 31.7 31.6 32.6 18.7 28.0 22.6 27.6 31.9 34.8 44.8 29.0 17.7 14.0 15.5 20.8 15.0 14.2 15.0 18.0 17.5 11.8 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 6 "K-562: 9.1;U-266/70: 26.0;U-266/84: 8.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 26.0 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N(alpha)-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112109022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavourable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavourable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 12.8 11.4 12.7 12.3 19.3 18.4 14.9 21.0 17.0 10.4 11.7 17.9 11.2 8.3 18.1 10.3 14.7 11.3 8.5 10.7 11.6 10.7 8.0 10.2 9.0 12.9 21.7 12.4 15.8 15.1 14.3 13.5 11.4 16.3 11.7 9.4 15.6 9.5 10.5 25.9 15.7 8.8 11.9 16.7 10.3 9.2 10.8 17.9 8.7 12.5 10.8 14.2 10.2 12.1 4.7 5.5 0.5 3.6 2.3 7.0 2.5 10.4 10.4 9.8 7.5 5.4 9.5 11.8 9.9 8.0 12.5 8.3 10.9 5.4 18.3 9.9 7.9 12.6 21.9 8.2 16.7 10.4 15.0 14.9 10.6 9.6 9.1 21.0 9.3 8.3 10.4 14.2 14.4 10.6 21.7 2.3 11.1 8.6 12.3 15.8 15.1 12.5 13.5 10.0 12.6 9.4 17.5 12.5 6.9 11.4 12.9 9.4 12.8 8.6 8.5 10.1 9.2 11.2 13.6 9.7 18.6 21.5 13.3 9.4 9.9 0.0 2.7 0.5 4.0 3.1 6.1 4.1 4.7 3.6 5.4 4.7 7.0 6.5 0.1 2.3 3.6 5.5 3.6 2.5 12.7 19.3 21.0 17.0 11.6 10.7 21.7 12.4 16.3 17.9 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N(alpha)-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443611-3486963 "Enzymes, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favourable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favourable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 18.5 28.7 24.2 17.9 30.8 26.6 16.2 38.1 40.2 17.1 29.4 29.1 34.0 36.8 24.3 18.6 21.3 21.7 23.7 26.2 25.6 21.3 35.8 40.3 23.6 19.4 21.6 17.7 21.2 41.8 46.4 29.0 27.0 24.4 23.7 21.4 29.1 20.7 31.6 38.9 16.9 42.2 19.9 25.7 28.1 34.8 25.3 19.0 22.8 21.8 21.8 24.1 21.7 22.1 8.5 11.2 34.8 13.2 11.6 13.4 10.0 8.1 32.0 22.7 23.8 18.1 12.4 20.3 15.6 16.6 16.1 14.6 21.9 17.6 16.9 15.9 17.7 19.1 22.4 18.2 15.8 25.5 15.1 20.6 20.2 25.6 19.7 26.4 27.3 15.2 14.1 11.1 21.4 25.9 21.7 24.2 11.4 37.3 16.6 19.4 27.7 9.4 20.8 17.2 25.6 16.7 17.2 12.0 26.0 23.2 25.9 12.3 23.0 18.6 19.1 20.8 17.8 6.7 14.4 20.2 18.7 16.5 6.6 16.3 15.8 19.8 10.5 34.8 11.8 12.3 12.5 8.0 10.8 11.5 11.2 8.5 9.3 10.8 13.2 11.6 13.2 7.8 13.4 10.0 24.2 30.8 38.1 40.2 25.6 21.3 21.6 17.7 24.4 19.0 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 19.1 10.3 12.1 12.5 13.7 7.6 28.3 28.2 15.7 18.5 19.9 10.4 7.2 7.4 16.2 26.4 32.3 14.1 13.9 21.2 12.1 9.7 10.6 18.6 12.5 13.8 14.5 12.0 15.7 9.3 16.4 20.2 12.8 12.4 16.3 12.9 19.8 15.9 17.5 6.9 33.2 10.9 13.3 14.3 9.3 18.4 12.3 12.4 13.6 19.0 15.7 13.0 13.0 25.8 1.4 1.7 5.4 6.1 4.6 6.0 1.4 12.1 9.1 23.1 8.0 9.0 15.8 40.0 12.4 19.7 9.4 10.7 22.0 13.6 13.6 14.7 9.8 31.3 13.2 16.0 18.7 43.6 11.2 16.0 32.4 10.5 5.8 6.7 8.1 9.1 25.7 20.0 6.1 14.6 15.7 11.8 14.5 6.0 9.7 7.0 8.1 12.5 12.0 16.7 5.4 7.1 11.9 20.9 17.0 14.7 5.0 13.1 4.0 10.6 10.1 19.8 15.8 11.2 7.4 9.4 10.0 10.2 20.9 6.2 15.4 0.0 2.6 1.1 2.7 2.0 4.0 1.4 2.8 3.5 1.7 0.9 2.9 3.1 5.4 4.6 6.1 1.6 6.0 1.4 12.1 13.7 28.2 15.7 12.1 9.7 14.5 12.0 12.4 12.4 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57088894-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favourable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 9.5 12.6 11.7 9.9 14.2 4.8 7.9 33.3 20.4 18.7 13.7 5.3 9.6 8.2 22.8 18.9 10.5 15.6 14.5 9.6 8.6 6.8 8.4 18.7 12.8 9.1 4.4 14.6 29.2 8.5 14.5 17.0 13.4 6.8 15.0 4.4 8.5 5.6 14.5 7.1 18.6 7.1 14.5 4.1 8.0 8.2 11.8 7.0 12.4 9.8 7.7 8.6 14.5 26.5 4.2 1.2 0.9 5.4 0.9 2.5 1.2 5.5 3.5 18.7 17.1 16.8 22.0 2.0 16.6 15.0 10.5 8.8 5.7 3.2 3.5 6.8 16.3 10.0 6.4 12.2 5.6 1.4 1.7 4.1 2.7 5.8 12.8 3.3 10.0 24.5 13.5 12.5 4.3 2.8 9.4 3.6 12.2 25.7 5.0 16.1 3.8 6.2 3.7 24.6 1.8 4.5 2.1 2.1 4.9 8.0 4.7 34.9 10.5 7.3 3.1 15.5 13.0 11.0 4.8 8.6 2.1 1.8 15.1 2.2 9.3 0.0 2.3 0.3 1.2 5.3 1.4 2.1 2.0 1.5 1.2 4.2 2.5 2.5 0.9 0.9 5.4 0.0 1.9 1.2 11.7 14.2 33.3 20.4 8.6 6.8 4.4 14.6 6.8 7.0 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191696659 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054978: , HPA067802: " "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavourable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 20.8 4.9 2.4 26.0 2.3 4.2 22.2 1.1 2.1 4.4 14.1 1.9 1.6 13.3 6.7 9.2 12.1 4.9 8.1 6.9 4.7 2.0 8.8 8.7 18.6 39.6 3.9 1.3 4.9 6.3 0.8 4.4 28.0 6.1 4.7 5.2 2.6 6.2 3.9 3.1 4.3 30.6 4.7 5.3 40.0 4.6 18.4 1.5 7.4 3.6 12.1 23.0 8.7 8.8 3.8 2.2 18.6 7.7 1.6 14.2 1.9 14.7 2.3 0.3 0.4 11.2 13.6 3.9 23.0 18.9 14.3 8.6 12.2 8.3 0.8 18.3 13.8 4.2 2.1 9.8 15.8 7.7 1.9 7.3 4.7 3.1 8.2 3.4 8.4 17.8 12.3 20.5 14.7 5.4 10.3 32.6 22.3 1.2 1.1 3.9 1.3 11.6 2.5 2.5 6.9 21.4 10.9 0.5 0.1 7.9 2.7 6.4 0.7 2.2 13.6 12.0 10.1 6.3 14.4 10.7 4.4 3.0 9.9 4.1 2.1 2.5 4.0 1.9 6.4 6.7 8.7 3.8 8.6 6.6 2.2 0.6 2.2 3.8 18.6 1.6 7.7 1.4 14.2 1.9 2.4 2.3 1.1 1.9 4.7 2.0 3.9 1.3 6.1 1.5 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 6.5;SCLC-21H: 21.5;SH-SY5Y: 14.9" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020981 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020981: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavourable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 2.1 0.0 1.3 0.6 0.0 2.3 2.9 6.5 4.1 0.2 0.1 0.0 1.9 4.2 0.2 1.8 1.6 2.3 0.0 0.6 0.0 1.4 0.0 1.6 0.0 0.0 1.4 0.0 2.8 0.3 2.0 0.0 2.9 1.6 0.0 0.0 0.0 1.9 1.8 0.0 0.8 0.0 0.2 0.0 21.5 14.9 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.4 1.5 0.8 0.0 1.2 0.0 4.4 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13118103-13141141 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: " "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.5 13.7 27.2 18.2 22.3 10.0 6.7 19.8 38.7 10.8 16.6 20.1 11.7 16.6 12.8 10.0 17.9 10.5 9.4 13.2 23.6 14.2 10.8 15.6 11.3 14.9 17.1 14.2 7.8 16.8 10.5 10.6 15.4 16.0 11.9 8.4 7.8 15.3 15.6 17.6 10.9 18.3 9.2 17.2 15.2 16.1 18.8 15.4 10.7 9.8 9.6 9.9 13.2 7.9 0.7 0.9 1.8 0.8 0.6 1.3 0.5 27.9 34.0 7.9 17.6 4.5 5.6 21.6 13.7 10.3 13.3 10.4 34.3 12.0 14.0 30.8 11.4 14.0 10.2 25.0 4.9 24.8 16.2 8.9 27.8 24.0 10.7 14.0 25.2 8.5 8.3 13.0 7.1 15.1 19.5 5.6 6.5 57.8 22.5 11.1 35.3 31.5 13.9 9.1 14.0 8.1 30.7 17.2 10.8 13.3 19.6 12.1 17.4 12.9 21.5 28.3 17.7 20.8 24.1 15.5 24.2 11.6 30.3 14.1 17.6 0.1 0.5 0.0 0.8 0.8 0.6 0.7 1.3 0.8 0.9 0.4 0.4 0.7 1.8 0.6 0.6 0.8 0.2 0.5 27.2 22.3 19.8 38.7 23.6 14.2 17.1 14.2 16.0 15.4 NACC2 "BEND9, BTBD14A, BTBD31, MGC23427" ENSG00000148411 "NACC family member 2" Q96BF6 9 136006537-136095285 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047924, HPA052962" Approved Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA047924: , HPA052962: " "unprognostic (1.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-2)" "unprognostic (8.73e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (9.25e-3)" "unprognostic (2.25e-2)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-1)" "prognostic favourable (8.28e-5)" "prognostic favourable (8.63e-4)" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (4.12e-2)" 15.3 9.0 27.4 10.9 26.3 2.7 12.8 16.3 37.3 10.0 15.5 14.5 11.7 8.3 11.4 6.9 11.6 10.1 16.6 16.8 20.7 16.7 8.0 15.2 8.3 7.6 30.3 6.4 10.3 10.0 6.2 3.8 3.9 15.2 12.7 5.5 10.2 9.9 23.8 12.6 5.8 9.5 31.7 33.4 7.8 8.2 7.8 11.0 0.0 5.8 4.7 3.1 21.8 4.6 0.0 2.4 5.7 4.5 0.5 1.7 1.4 3.0 17.0 1.9 25.9 8.4 4.7 2.4 7.6 5.1 2.5 0.8 7.2 5.6 0.0 9.2 12.0 12.2 4.1 4.1 0.8 9.4 3.7 2.1 16.4 9.0 8.6 0.0 3.9 7.9 3.8 2.3 2.3 6.8 6.4 0.0 4.7 10.5 0.0 5.9 5.8 10.6 0.0 2.0 5.1 10.2 3.6 0.6 0.8 10.7 9.0 9.3 9.2 19.5 11.2 6.6 7.5 5.6 5.2 0.0 0.0 0.1 8.7 0.7 13.2 2.8 4.5 1.5 1.7 3.6 0.7 0.0 0.6 1.5 2.4 0.0 0.5 0.6 5.7 0.5 3.4 0.3 0.4 1.4 27.4 26.3 16.3 17.7 20.7 16.7 30.3 6.4 15.2 11.0 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.4" "Group enriched" "Detected in many" 7 "granulocytes: 80.4;monocytes: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048909: , HPA053368: " "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 24.7 34.3 11.1 19.0 11.9 49.0 25.5 9.9 12.6 12.4 18.2 10.8 14.1 20.3 13.9 14.5 12.5 14.3 17.1 11.9 9.9 7.9 12.7 52.3 17.5 27.0 15.8 8.6 16.9 32.2 8.3 11.9 22.5 10.3 13.7 14.1 13.9 21.4 14.5 10.6 11.7 19.4 14.4 8.3 39.4 22.1 17.3 9.6 10.8 14.0 12.0 19.2 13.7 28.3 1.8 7.2 80.4 24.7 0.5 1.4 10.4 15.1 14.6 13.1 19.2 18.7 13.6 16.9 15.3 13.4 17.5 15.6 15.6 27.9 20.1 11.7 11.3 12.9 14.0 12.1 7.8 19.5 22.3 16.4 22.9 26.9 18.1 23.0 27.7 15.9 11.0 10.8 15.5 16.9 20.1 28.8 13.0 17.4 17.3 20.0 8.9 16.6 22.1 11.2 41.1 15.1 12.6 17.7 13.5 17.1 37.7 15.7 13.0 16.1 16.3 12.8 9.2 13.1 13.7 25.7 11.6 45.0 12.6 25.6 6.6 11.8 21.1 49.5 1.2 24.7 1.4 1.8 0.7 0.9 7.2 1.7 0.5 0.7 80.4 0.5 23.8 5.9 1.0 10.4 11.1 11.9 9.9 12.6 9.9 7.9 15.8 8.6 10.3 9.6 NADSYN1 FLJ10631 ENSG00000172890 "NAD synthetase 1" Q6IA69 11 71453109-71524107 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017798, HPA038523, HPA038524" Approved Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "CAB017798: , HPA038523: , HPA038524: " "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" "unprognostic (7.30e-2)" "unprognostic (2.63e-3)" "unprognostic (1.75e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (5.17e-6)" "unprognostic (1.19e-2)" "unprognostic (4.38e-2)" "unprognostic (1.41e-1)" "unprognostic (9.41e-2)" "unprognostic (1.99e-2)" "prognostic unfavourable (8.72e-5)" "unprognostic (4.12e-3)" "unprognostic (1.38e-1)" "unprognostic (1.54e-2)" "prognostic favourable (5.10e-4)" 14.5 16.9 10.8 23.2 21.2 39.6 14.0 12.2 18.5 12.4 30.6 21.9 24.1 26.3 15.0 17.5 29.1 16.4 33.1 10.6 10.4 9.5 16.5 24.8 18.1 20.5 22.7 9.2 15.6 20.6 13.5 20.2 17.1 15.6 23.9 25.3 12.9 18.0 17.2 9.8 15.0 36.8 13.6 14.6 30.7 19.2 17.4 20.0 26.4 17.3 21.7 29.8 26.1 17.1 9.5 22.3 12.8 19.7 11.9 12.6 13.1 6.1 14.9 4.8 8.8 14.6 21.4 13.3 12.1 10.9 6.3 6.9 12.7 10.5 5.4 13.7 14.1 22.1 6.3 17.2 3.3 10.9 5.1 8.8 10.0 14.2 18.3 17.6 17.0 30.3 27.1 8.1 7.4 22.1 4.5 7.6 8.9 19.3 8.6 11.5 2.9 8.7 10.8 15.3 5.3 15.5 28.6 3.6 5.2 8.6 11.3 22.0 10.0 9.6 26.6 7.0 6.0 12.7 4.6 9.8 4.2 4.6 12.3 10.1 4.8 4.5 19.7 11.8 11.7 17.4 9.9 9.5 10.5 10.6 22.3 7.4 7.0 8.8 12.8 11.9 15.1 16.7 12.6 13.1 10.8 21.2 12.2 18.5 10.4 9.5 22.7 9.2 15.6 20.0 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome 53000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavourable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favourable (9.44e-5)" "unprognostic (1.97e-1)" 23.6 27.4 25.3 20.2 31.8 27.2 27.3 36.7 41.7 26.0 25.8 24.4 23.7 26.2 27.9 31.0 27.5 23.9 20.2 23.6 25.4 29.0 24.3 25.9 18.3 27.0 27.7 31.9 31.0 26.6 38.8 42.2 26.4 34.9 24.9 30.0 22.1 24.3 23.5 33.2 26.9 27.6 25.4 25.3 18.4 22.2 36.9 25.9 28.9 27.9 28.0 24.9 24.7 22.4 9.4 6.4 6.7 3.2 8.6 19.4 9.4 22.6 17.5 31.2 30.7 12.5 17.8 25.9 17.3 17.6 25.7 31.2 21.2 17.6 25.1 19.9 13.0 23.0 23.4 20.8 36.5 9.2 26.7 17.8 12.1 32.9 14.4 33.1 22.4 14.4 15.5 20.4 18.0 17.9 42.1 8.9 19.7 7.9 34.6 37.9 43.2 31.6 37.2 37.2 33.5 19.8 20.0 33.6 24.7 51.8 11.1 19.9 11.9 22.4 13.9 18.0 18.0 18.7 20.0 16.8 25.9 90.5 16.2 22.0 21.7 1.3 3.1 6.7 15.4 3.0 19.4 9.4 16.4 16.6 4.2 7.9 17.8 17.7 1.4 8.6 3.2 6.4 14.0 9.4 25.3 31.8 36.7 41.7 25.4 29.0 27.7 31.9 34.9 25.9 NAF1 ENSG00000145414 "Nuclear assembly factor 1 ribonucleoprotein" Q96HR8 4 163110073-163166921 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036241, HPA036242, HPA066090" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036241: , HPA036242: AB_10673616, HPA066090: " "unprognostic (6.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-2)" "unprognostic (2.58e-1)" "unprognostic (8.99e-2)" "unprognostic (2.00e-2)" "unprognostic (1.18e-2)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.64e-3)" "unprognostic (1.45e-1)" "unprognostic (8.73e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.17e-2)" "unprognostic (3.05e-1)" 13.3 12.3 8.6 9.6 19.8 8.7 11.9 10.7 18.9 12.9 10.6 14.7 6.4 6.2 18.8 8.6 11.0 17.3 10.9 11.7 10.5 7.8 9.5 10.5 10.9 10.7 7.2 9.1 20.1 11.1 15.7 18.7 8.8 10.1 12.0 11.4 13.4 10.4 12.5 36.4 14.3 8.3 12.7 7.4 10.0 11.3 17.2 7.5 12.3 14.0 12.2 12.2 12.5 10.4 2.5 2.4 0.1 1.6 1.2 3.5 1.4 8.9 7.6 9.8 10.0 5.8 9.2 11.5 10.6 7.1 9.3 9.3 8.6 10.7 23.3 3.1 6.5 7.5 19.9 11.4 12.3 10.2 12.3 24.6 6.8 7.2 10.1 15.9 8.8 8.7 10.2 11.3 9.2 8.2 27.6 12.4 12.4 8.8 18.4 9.1 12.8 7.6 15.3 7.3 12.2 9.3 4.1 10.7 8.0 7.0 12.8 7.6 6.9 6.9 8.6 11.2 9.6 8.7 11.9 7.8 10.8 17.9 10.6 9.3 11.0 0.0 1.5 0.1 2.2 1.6 0.9 1.9 2.5 3.3 2.4 2.5 3.5 2.3 0.0 1.2 1.5 2.4 0.7 1.4 8.6 19.8 10.7 18.9 10.5 7.8 7.2 9.1 10.1 7.5 NAGK GNK ENSG00000124357 "N-acetylglucosamine kinase" Q9UJ70 2 71064344-71079805 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035206, HPA035207" Enhanced Approved Nucleoplasm,Cytosol 690000 Cytosol Nucleoplasm "HPA035206: AB_2674517, HPA035207: AB_10602031" "unprognostic (6.15e-2)" "unprognostic (4.23e-3)" "unprognostic (2.97e-2)" "prognostic unfavourable (6.88e-4)" "unprognostic (2.44e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.65e-3)" "unprognostic (2.18e-2)" "unprognostic (2.31e-1)" "unprognostic (9.99e-2)" "unprognostic (4.32e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (4.35e-4)" "unprognostic (8.60e-2)" "unprognostic (1.45e-2)" "unprognostic (5.50e-3)" "unprognostic (2.13e-2)" 20.0 17.6 21.8 30.9 24.5 9.8 15.7 13.9 18.8 23.6 15.5 23.7 17.4 11.4 16.4 19.7 67.0 13.7 20.0 14.0 17.6 20.4 16.9 20.2 18.3 30.6 31.1 20.3 15.0 25.8 27.5 21.8 43.9 26.2 15.8 15.8 14.7 49.0 17.8 11.3 29.5 14.6 22.8 21.6 43.4 15.5 24.8 26.7 20.2 13.0 27.2 39.9 24.5 26.1 14.3 53.0 37.4 79.3 8.5 7.1 52.2 18.8 15.3 8.6 8.8 34.5 21.1 33.9 42.1 18.2 28.2 25.7 17.9 9.9 10.5 10.1 29.2 9.1 6.6 12.5 17.5 15.0 5.2 5.9 5.0 11.1 25.9 3.7 15.1 18.9 13.1 30.3 4.7 29.6 2.7 11.9 39.1 17.3 9.3 13.2 9.2 11.9 7.3 24.1 5.4 17.1 33.8 9.0 4.9 12.7 20.1 13.2 10.4 4.7 26.0 33.7 13.1 13.0 14.7 8.3 7.2 6.2 23.0 10.1 18.4 10.3 79.3 31.5 5.4 69.8 5.5 14.3 6.4 5.2 53.0 13.3 5.5 4.5 37.4 8.5 46.6 42.4 7.1 52.2 21.8 24.5 13.9 18.8 17.6 20.4 31.1 20.3 26.2 26.7 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: , HPA064931: " "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favourable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favourable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.1 2.6 6.8 2.5 2.2 6.0 3.7 2.2 3.1 2.5 3.3 3.8 5.8 3.2 2.3 3.6 2.7 2.8 2.6 17.8 3.7 4.3 5.0 1.9 4.1 5.9 12.2 2.0 3.3 2.4 3.9 2.8 10.1 3.7 2.9 5.5 5.7 7.2 2.9 7.1 5.5 4.2 5.3 2.4 3.0 3.8 4.4 3.5 5.0 3.8 3.9 5.9 1.9 3.7 11.7 3.1 4.2 6.1 12.7 3.9 3.5 3.9 4.9 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 NAMPT "PBEF, PBEF1" ENSG00000105835 "Nicotinamide phosphoribosyltransferase" P43490 7 106248285-106286326 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Biological rhythms, Pyridine nucleotide biosynthesis" "Cytokine, Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 143.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 143.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034349, HPA047776, HPA057722" Approved Approved "Nuclear speckles,Cell Junctions" "Secreted to blood" 2140000 410000 "Nuclear speckles" "Cell Junctions" "CAB034349: AB_2251220, HPA047776: , HPA057722: " "unprognostic (2.87e-1)" "prognostic unfavourable (4.78e-4)" "unprognostic (5.90e-3)" "unprognostic (1.63e-2)" "unprognostic (1.50e-2)" "prognostic unfavourable (8.81e-4)" "unprognostic (2.15e-1)" "unprognostic (2.74e-2)" "unprognostic (2.74e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (1.51e-4)" "unprognostic (3.02e-1)" "prognostic unfavourable (2.49e-6)" "unprognostic (6.83e-2)" "unprognostic (6.96e-2)" "unprognostic (7.76e-2)" "unprognostic (6.44e-3)" 67.3 22.2 8.1 113.6 18.1 110.4 52.6 7.8 12.9 11.6 18.2 2.9 9.5 9.3 9.9 13.5 53.4 27.8 28.1 84.4 13.4 6.3 13.5 92.9 48.9 117.5 10.3 5.2 27.3 18.3 5.5 10.0 23.9 29.2 17.4 10.5 8.2 32.9 14.3 41.0 12.9 14.1 44.9 59.1 41.1 26.4 11.9 7.1 6.2 13.5 40.7 13.2 48.8 26.4 0.8 2.0 143.5 7.3 1.0 1.5 1.3 18.9 12.6 4.6 7.6 19.4 22.6 7.5 6.0 34.0 12.2 21.6 7.4 11.5 15.9 14.4 6.7 15.0 8.4 18.1 26.8 9.4 9.1 6.4 5.4 5.8 72.5 12.4 11.9 21.6 20.7 21.8 25.5 38.8 13.4 60.9 14.5 9.9 12.3 5.2 8.8 10.2 5.9 6.5 34.9 11.6 17.8 9.3 5.1 8.4 18.5 21.4 5.9 3.6 33.0 18.2 14.1 26.1 11.0 42.0 23.8 22.8 108.1 14.1 26.9 8.1 2.3 3.5 0.4 5.6 0.7 0.8 0.5 0.6 2.0 0.7 0.8 0.4 143.5 1.0 7.3 0.8 1.5 1.3 8.1 18.1 7.8 12.9 13.4 6.3 10.3 5.2 29.2 7.1 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029716-119033732 "Disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.7" "Cell line enhanced" "Detected in many" "SH-SY5Y: 38.7;SK-BR-3: 22.2;SK-MEL-30: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012219 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavourable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 8.5 10.5 8.1 1.0 7.1 1.0 6.4 6.5 4.8 4.9 2.1 4.5 1.3 1.2 2.1 4.4 2.1 1.5 1.0 16.7 5.0 6.7 3.5 1.0 1.3 1.1 3.4 2.4 0.9 3.3 0.9 2.2 8.2 6.0 3.5 1.2 8.8 1.5 2.5 40.7 1.7 1.4 3.4 6.7 0.9 3.1 2.9 3.0 0.1 9.3 0.3 1.0 3.3 9.8 0.6 0.5 3.2 0.3 0.6 0.3 0.1 7.5 0.6 1.0 0.2 3.6 0.5 4.6 0.1 0.2 0.2 0.1 0.9 2.6 4.0 1.0 0.0 2.7 1.3 1.3 0.3 1.2 3.1 0.1 1.9 0.8 1.7 0.4 0.0 0.7 5.6 0.0 0.7 0.1 0.7 0.5 0.2 1.0 1.0 1.3 3.4 0.6 0.0 1.3 2.7 1.5 0.6 3.0 38.7 2.2 22.2 16.8 3.5 2.1 0.2 0.0 1.7 0.0 0.3 1.1 3.8 1.4 0.3 1.0 0.0 3.2 0.3 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.6 0.3 0.2 1.3 0.6 0.2 0.5 0.1 0.1 8.1 7.1 6.5 4.8 5.0 6.7 3.4 2.4 6.0 3.0 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell line enhanced" "Detected in some" "EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054050: , HPA057065: " "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favourable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.3 0.1 6.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.0 0.0 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.7 0.2 0.2 10.0 0.0 1.2 3.9 0.0 12.8 5.9 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.1 0.0 7.5 10.4 0.8 4.7 20.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058227: " "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.0 7.1 4.3 10.5 6.7 0.0 7.7 4.7 3.9 6.2 0.0 0.9 0.0 3.1 4.4 1.4 12.7 3.0 7.1 2.4 0.0 13.3 4.6 1.1 9.1 6.8 8.8 10.6 1.0 4.6 0.7 6.9 3.7 0.0 11.5 0.1 8.3 0.5 2.9 0.0 4.5 2.0 0.8 2.6 3.2 9.6 29.0 0.0 1.3 5.6 0.0 1.9 5.0 4.5 1.1 2.8 3.8 2.0 0.0 0.0 9.6 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favourable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.7 3.4 6.1 5.2 17.5 12.0 8.9 12.3 17.7 12.0 15.4 7.6 8.8 7.7 9.9 16.8 5.7 8.0 11.1 17.3 6.6 4.9 5.6 6.0 7.8 16.8 15.5 10.6 12.6 12.9 13.8 10.3 11.3 9.1 18.3 17.5 8.0 11.9 6.6 4.7 5.2 5.3 10.1 12.8 14.1 13.6 24.3 6.4 10.0 10.6 14.1 4.9 10.3 12.6 19.1 9.2 17.4 12.9 11.8 12.1 8.5 12.8 10.9 8.7 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.9;SK-BR-3: 23.5;U-937: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" 2000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: , CAB068207: , HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favourable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 9.7 6.4 4.9 9.7 6.2 21.1 13.2 10.7 5.4 6.7 25.2 2.3 9.9 33.0 4.7 4.7 16.4 4.8 15.5 4.9 3.9 2.1 10.7 28.3 8.3 12.1 3.7 0.1 5.9 6.5 2.4 2.8 8.6 4.1 6.9 3.8 5.2 12.8 3.8 7.1 12.4 34.4 5.2 2.2 9.8 11.8 5.5 4.0 3.0 6.8 8.9 9.5 7.6 8.1 0.8 4.7 4.6 8.4 0.5 1.6 2.4 3.4 3.9 0.4 0.8 0.3 1.2 2.5 0.8 0.4 1.3 0.8 3.2 21.9 0.9 6.1 0.2 7.5 0.2 6.2 0.0 4.0 6.3 5.2 10.3 0.9 2.8 1.2 2.8 0.1 2.2 0.1 0.0 1.4 4.8 4.1 0.1 4.2 2.5 2.7 1.0 2.5 4.5 0.1 10.8 0.9 1.3 1.7 0.4 9.9 23.5 2.9 0.9 3.0 4.1 0.7 6.2 4.6 1.7 0.5 0.2 1.1 1.1 18.2 3.2 0.0 4.4 4.6 1.6 8.4 0.5 0.8 0.7 1.5 4.7 0.2 0.8 0.7 2.7 0.5 8.4 1.5 0.2 2.4 4.9 6.2 10.7 5.4 3.9 2.1 3.7 0.1 4.1 4.0 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA053006: " "unprognostic (1.84e-1)" "prognostic favourable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavourable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 13.7 10.6 21.2 15.7 20.2 35.0 17.4 24.2 23.5 8.2 13.1 10.1 11.1 13.8 9.5 11.0 13.1 11.2 10.6 28.5 15.7 12.3 10.1 21.3 11.8 15.1 16.4 15.0 11.2 13.8 9.0 11.9 10.2 16.3 10.9 9.0 14.7 13.6 12.0 44.4 15.4 11.0 9.8 10.6 17.7 13.6 35.4 18.1 12.4 11.7 11.2 11.5 11.7 12.4 11.6 10.1 50.6 10.6 15.9 13.6 11.5 8.5 8.1 13.8 21.7 6.5 6.4 7.8 5.1 5.4 8.9 9.1 9.3 3.1 5.5 5.8 4.1 7.7 10.1 6.5 6.1 5.8 22.4 11.6 11.6 11.5 5.8 11.8 20.6 9.6 10.8 7.0 2.4 16.7 26.3 4.1 3.9 7.4 20.6 19.1 5.8 17.6 17.2 14.0 8.8 4.2 8.9 16.8 23.9 13.5 9.1 15.7 7.8 9.7 8.3 11.5 9.8 9.4 8.7 38.0 14.4 12.2 10.5 8.3 6.8 24.4 10.6 29.5 11.6 9.4 12.7 11.6 11.4 11.2 10.1 11.0 13.1 10.9 50.6 15.9 7.0 8.3 13.6 11.5 21.2 20.2 24.2 23.5 15.7 12.3 16.4 15.0 16.3 18.1 NARFL "FLJ21988, HPRN, IOP1, NAR1, PRN" ENSG00000103245 "Nuclear prelamin A recognition factor like" Q9H6Q4 16 729753-741329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040851 Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA040851: AB_10794427" "unprognostic (6.31e-2)" "prognostic favourable (1.32e-5)" "unprognostic (7.61e-2)" "unprognostic (8.25e-2)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (8.85e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (8.39e-2)" "unprognostic (4.45e-3)" "unprognostic (3.02e-1)" "prognostic favourable (9.83e-5)" "unprognostic (2.49e-2)" "unprognostic (8.15e-2)" "unprognostic (2.62e-1)" "unprognostic (8.33e-3)" 10.2 11.9 16.4 15.3 19.7 15.0 10.3 21.8 28.8 10.0 12.6 21.6 21.1 20.9 11.1 19.2 15.2 13.7 10.6 20.9 18.1 14.2 16.1 17.6 9.1 16.2 15.1 9.8 11.3 18.4 18.5 13.1 11.1 16.7 15.7 8.1 14.3 25.4 17.5 24.1 14.9 15.5 8.7 14.1 15.0 14.5 8.7 13.1 18.4 12.6 13.7 18.9 11.7 11.3 16.0 11.8 8.3 10.9 13.9 12.9 9.4 3.5 10.4 4.1 6.0 4.3 3.0 10.0 5.1 3.8 7.1 6.2 7.4 8.8 5.0 7.8 3.2 8.0 4.0 6.2 2.5 9.3 9.2 4.2 6.0 6.0 5.5 7.5 6.1 3.8 7.8 4.2 3.5 5.2 7.8 4.8 3.4 13.2 6.7 3.4 3.4 6.7 55.6 6.3 9.1 4.3 3.6 4.7 6.6 6.0 14.6 5.1 13.3 7.6 5.5 5.9 5.6 6.5 4.5 6.4 4.5 14.0 4.1 4.3 7.7 2.7 10.9 8.3 11.5 9.9 8.9 16.0 11.7 9.5 11.8 10.5 9.5 12.9 2.3 13.9 10.6 9.5 11.1 9.4 16.4 19.7 21.8 28.8 18.1 14.2 15.1 9.8 16.7 13.1 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favourable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.4 10.5 11.0 7.2 7.7 6.5 9.2 6.2 6.1 9.7 8.0 17.9 8.1 18.5 16.2 3.9 9.9 18.5 12.1 13.5 12.1 9.9 13.0 8.1 15.2 6.4 13.9 4.8 4.5 7.8 8.5 15.2 8.3 19.6 5.1 10.8 8.7 14.4 22.6 12.0 12.7 15.1 18.0 25.0 12.9 10.6 13.1 8.3 9.2 11.9 15.9 11.2 5.5 5.0 13.2 15.6 15.0 10.4 8.5 14.3 40.8 2.5 12.6 8.9 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105602-34147670 "Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Nucleoli Midbody "CAB035546: , HPA057576: , HPA071628: " "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavourable (1.07e-4)" "prognostic unfavourable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 18.5 22.8 20.5 21.9 27.5 23.6 20.8 21.9 29.9 18.1 17.6 24.3 16.4 13.7 30.6 19.8 25.2 21.7 14.7 16.4 17.2 18.6 15.9 21.8 15.1 28.7 16.9 19.8 26.4 24.9 31.5 23.1 20.1 23.4 19.5 21.7 23.0 22.5 17.8 23.4 31.0 16.6 21.5 15.1 23.6 18.0 30.9 16.9 31.2 18.3 19.4 35.3 17.8 19.7 10.4 12.8 2.2 11.1 11.8 13.7 6.9 12.2 17.3 9.3 19.7 11.2 10.0 10.8 12.2 9.0 15.5 12.4 19.4 7.1 39.4 9.1 10.3 18.7 34.9 18.6 19.9 10.9 22.4 17.9 14.2 18.1 10.2 44.7 13.0 10.1 12.8 10.1 28.6 11.8 38.9 13.8 12.9 23.3 36.4 20.3 13.3 20.9 27.4 31.5 16.4 8.9 21.5 13.8 10.5 16.4 17.5 7.3 17.5 12.3 9.5 13.9 11.0 20.3 22.6 15.1 18.1 37.6 14.0 18.6 13.7 0.5 6.6 2.2 10.3 11.1 13.7 10.4 11.1 11.7 12.8 9.6 11.5 11.2 0.8 11.8 9.7 9.7 9.6 6.9 20.5 27.5 21.9 29.9 17.2 18.6 16.9 19.8 23.4 16.9 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213008 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;ovary: 29.6" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.4;THP-1: 20.5;U-138 MG: 15.7;WM-115: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 6.2 8.5 17.8 2.4 14.2 1.5 7.1 14.7 25.2 2.8 2.1 9.7 2.6 1.2 4.1 5.8 3.8 3.6 8.6 3.7 14.2 7.5 1.4 2.3 3.8 1.6 7.8 13.0 29.6 1.4 2.2 9.3 4.3 7.1 4.5 2.0 12.3 2.2 5.1 2.6 4.1 1.3 4.6 10.6 12.7 1.6 5.0 8.3 0.0 1.7 0.0 1.4 3.9 2.3 0.3 0.1 3.8 0.2 0.1 0.0 0.0 1.8 4.3 0.3 0.1 4.5 9.3 0.1 13.1 10.3 5.4 2.8 1.2 0.3 0.1 1.0 10.5 1.4 3.8 2.0 9.6 0.0 0.0 0.0 1.8 0.1 3.5 0.0 0.1 3.4 0.0 23.4 5.9 8.0 0.0 0.0 13.2 0.1 0.0 5.9 1.5 1.2 0.6 1.1 0.0 0.9 0.0 0.3 0.0 0.9 0.1 1.8 0.0 20.5 6.9 15.7 4.4 6.7 9.0 0.7 0.0 0.4 4.7 0.2 19.4 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.1 0.2 0.1 0.0 0.0 17.8 14.2 14.7 20.5 14.2 7.5 7.8 13.0 7.1 8.3 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591762-156594299 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Isomerase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Enhanced Nucleoplasm,Cytosol "Secreted to blood" 3300000 Nucleoplasm Cytosol "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 19.1 29.9 31.6 14.4 28.5 12.1 22.6 17.6 42.5 23.0 30.0 31.0 17.4 28.4 28.5 57.9 23.4 29.4 25.8 46.3 28.5 25.0 41.6 41.0 17.2 16.9 33.2 29.3 29.3 37.3 36.3 29.0 21.8 28.8 27.9 26.6 23.0 29.5 36.3 30.9 20.2 25.9 25.0 29.1 17.4 25.0 29.5 22.2 17.7 32.4 19.5 20.4 20.8 18.3 52.4 53.8 12.4 26.5 31.6 32.5 40.6 31.4 41.8 13.4 23.9 17.8 12.2 16.0 10.9 16.6 18.6 19.7 34.8 21.2 21.4 33.0 13.8 30.7 13.3 26.0 13.2 22.5 29.1 17.7 23.8 22.9 20.4 22.2 18.2 12.3 33.6 23.7 22.1 25.3 18.0 19.5 19.0 56.0 24.4 27.0 16.6 32.7 24.6 12.5 56.5 25.2 26.2 32.3 30.8 26.1 49.8 38.3 48.3 32.7 14.7 13.4 20.9 19.0 23.6 50.6 30.5 20.4 18.5 13.2 20.6 4.9 24.1 12.4 31.6 26.5 31.3 52.4 29.2 32.2 21.7 41.7 32.5 30.9 2.9 31.6 20.6 53.8 25.5 40.6 31.6 28.5 17.6 42.5 28.5 25.0 33.2 29.3 28.8 22.2 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavourable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.4 7.2 8.0 5.5 20.9 23.0 8.2 10.1 11.1 7.9 8.0 7.2 7.9 7.0 2.3 15.3 6.6 8.6 12.7 9.4 6.9 5.5 26.6 6.4 20.1 21.5 6.9 13.6 15.1 10.1 10.4 17.5 16.2 20.6 8.0 12.0 6.7 5.7 15.5 6.9 6.9 6.0 14.0 8.3 16.3 7.4 4.7 7.7 8.6 7.1 12.7 5.0 6.3 14.0 10.0 6.2 7.1 7.3 12.0 10.2 9.9 17.8 8.1 8.9 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favourable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.4 3.0 0.4 0.0 0.1 3.4 5.3 4.0 3.3 0.0 0.5 1.4 0.0 5.8 0.1 1.8 0.7 8.5 0.7 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 0.7 0.0 9.7 0.5 1.0 0.5 0.0 2.3 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.2 2.5 0.0 1.7 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.6 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049189: , HPA049447: " "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 11.2 7.8 5.2 7.3 7.9 2.7 13.4 7.5 6.0 9.2 14.5 6.5 8.4 9.9 19.1 7.0 8.7 7.9 8.9 8.2 4.8 2.9 14.4 12.3 14.7 3.3 5.1 2.7 8.8 8.5 9.2 13.6 10.2 7.0 6.7 14.4 9.7 8.1 10.6 6.9 6.6 11.7 11.9 7.3 5.0 14.7 9.9 6.2 2.8 10.1 6.4 5.3 9.8 9.5 0.9 0.7 0.9 0.6 0.6 3.0 0.2 4.9 4.6 1.9 1.7 12.0 9.4 2.7 4.7 3.5 2.5 3.9 5.2 2.6 1.1 3.9 7.9 4.0 3.8 5.5 5.9 2.2 1.6 1.9 6.9 2.9 2.9 1.7 2.3 3.6 3.7 4.2 5.2 4.0 3.3 1.7 5.7 3.4 0.7 0.9 0.9 4.3 0.8 3.2 1.1 7.1 9.2 1.2 0.9 4.1 3.0 3.1 3.5 1.7 6.7 6.7 5.7 3.2 2.1 2.9 2.2 1.5 4.0 0.8 2.3 0.0 0.5 0.9 0.8 0.4 1.0 0.4 0.9 0.5 0.4 0.9 0.7 0.5 0.3 0.6 0.6 0.7 3.0 0.2 5.2 7.9 7.5 6.0 4.8 2.9 5.1 2.7 7.0 6.2 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933336-90003228 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 19.2 16.1 17.9 23.6 29.5 41.3 23.0 17.4 21.0 19.3 22.6 12.2 16.9 13.3 33.2 16.6 19.7 17.5 20.2 14.2 19.4 16.7 25.9 19.3 17.9 26.7 16.9 18.1 19.3 17.1 21.0 29.4 13.2 18.4 17.6 20.9 7.1 18.4 17.6 15.7 11.2 18.0 22.2 18.1 26.5 14.7 13.9 18.9 23.4 20.8 14.7 22.8 17.5 16.0 10.1 12.0 21.8 18.5 9.7 8.6 7.6 15.1 8.5 8.6 4.5 4.7 11.8 5.5 10.8 14.4 13.8 15.0 4.9 11.5 22.9 12.6 9.8 5.1 10.4 10.1 17.7 10.7 6.0 19.4 5.3 6.9 9.2 11.6 10.3 8.8 5.4 7.7 17.1 11.1 14.2 13.4 15.6 13.5 17.7 7.3 2.5 9.3 11.9 7.5 13.6 17.8 20.9 2.5 7.9 6.8 76.8 6.4 14.4 8.6 8.3 12.0 8.5 7.2 10.6 6.2 7.1 12.8 12.1 10.9 11.0 14.1 11.1 20.3 8.1 12.5 8.6 10.1 5.9 5.9 12.0 6.1 5.7 6.2 21.8 9.7 18.5 6.6 3.7 7.6 17.9 29.5 17.4 21.0 19.4 16.7 16.9 18.1 18.4 18.9 NBPF1 "FLJ20719, KIAA1693" ENSG00000219481 "NBPF member 1" 1 16562319-16613562 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (8.16e-3)" "unprognostic (6.96e-2)" "unprognostic (1.33e-2)" "unprognostic (6.09e-2)" "unprognostic (3.49e-1)" "unprognostic (4.76e-2)" "unprognostic (1.15e-5)" "unprognostic (2.16e-2)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.90e-2)" "unprognostic (2.14e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.68e-1)" 6.8 23.3 14.2 6.4 18.3 4.5 7.4 32.7 13.1 11.7 11.6 21.5 6.0 7.5 9.5 6.2 6.6 13.9 7.9 5.2 13.4 9.3 8.1 7.7 7.3 3.2 32.8 4.2 18.6 5.5 22.3 12.3 9.7 18.4 9.0 11.3 9.3 6.5 9.6 4.5 5.9 16.6 12.2 21.3 6.7 7.3 22.3 21.5 3.7 9.5 3.3 4.3 10.4 8.5 2.0 0.9 4.3 1.0 0.4 1.7 0.5 5.4 7.8 7.9 4.8 2.2 2.6 1.5 3.8 4.9 7.2 6.5 2.8 2.3 4.3 1.1 10.6 5.1 3.8 2.3 8.5 2.7 4.2 1.4 2.6 2.7 3.5 2.1 3.4 2.8 2.9 10.4 3.0 3.2 4.6 2.4 2.8 4.3 9.2 1.6 1.5 15.4 7.9 4.3 0.4 2.0 1.1 9.8 9.6 9.7 4.0 5.4 6.1 1.5 3.8 6.4 3.5 8.6 3.3 1.3 5.9 2.4 1.5 3.2 2.6 0.4 0.7 4.3 1.2 0.8 1.4 1.1 1.1 1.5 0.5 2.0 1.3 1.7 0.2 0.4 1.0 0.9 0.0 0.5 14.2 18.3 32.7 13.1 13.4 9.3 32.8 4.2 18.4 21.5 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064699-146144804 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 1.5 0.0 0.9 3.3 2.3 0.0 3.0 0.9 0.0 1.6 1.9 1.0 1.3 0.5 0.0 0.4 1.2 1.3 0.6 3.2 1.1 1.5 0.7 1.1 1.1 0.3 1.3 0.0 4.2 0.0 1.5 2.0 0.1 1.2 0.7 0.6 0.2 1.3 2.4 3.7 1.5 0.4 0.4 0.2 5.4 1.4 3.2 2.3 11.3 13.5 2.8 3.1 4.2 3.1 3.2 1.4 2.5 2.5 0.6 6.1 2.7 3.8 4.2 6.4 2.8 2.4 5.4 3.8 0.7 4.5 2.5 1.7 12.3 4.0 8.3 8.5 3.8 1.7 7.7 6.7 6.7 1.0 2.2 1.5 4.4 1.3 2.0 3.3 2.4 3.7 0.3 0.4 4.7 4.7 1.6 3.8 3.1 11.4 3.1 2.7 2.9 3.8 4.7 1.9 3.0 2.8 2.7 2.4 0.8 1.5 1.8 0.4 1.1 0.2 1.1 0.2 0.3 0.7 1.3 0.4 0.3 3.7 0.4 1.2 2.4 0.3 0.2 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favourable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favourable (3.20e-5)" 1.5 2.1 3.4 2.1 3.9 3.0 3.8 5.7 5.3 4.6 1.5 3.1 9.6 1.4 5.7 9.6 1.2 3.0 1.5 0.7 3.0 1.4 3.7 3.3 3.0 6.0 1.1 5.3 3.2 5.4 1.6 3.3 4.4 2.9 2.4 3.4 3.2 5.6 0.6 5.7 2.0 3.0 5.7 3.1 2.1 1.5 3.1 1.5 3.0 0.0 3.5 1.3 0.0 5.2 3.9 6.1 3.5 1.0 4.1 1.0 5.6 4.5 8.9 8.6 6.2 5.2 6.0 5.1 4.7 4.3 4.6 3.5 5.7 9.4 4.0 6.0 7.3 5.6 1.9 5.3 5.1 6.1 4.1 14.0 3.7 4.4 5.9 15.2 4.5 5.2 5.5 10.4 3.1 6.7 0.6 4.3 11.0 6.7 10.7 7.8 5.8 9.1 5.2 3.6 4.2 10.9 3.6 9.4 8.0 5.5 7.6 8.0 10.1 7.7 5.7 4.7 8.8 6.4 5.6 4.6 6.5 5.4 3.8 3.2 6.1 1.9 5.7 4.1 1.3 2.9 3.3 3.4 2.4 1.9 5.2 3.8 2.9 0.3 1.0 3.5 3.9 1.3 1.0 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 29.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favourable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favourable (2.47e-5)" 2.7 1.7 2.2 4.0 3.9 5.1 3.2 4.4 4.7 2.6 1.9 5.8 2.2 2.4 6.0 3.6 1.5 2.4 3.1 0.9 2.3 1.7 6.1 2.8 3.4 4.2 4.2 4.3 29.8 4.2 5.0 1.8 3.8 2.5 1.8 4.2 3.5 4.0 0.9 2.5 1.9 3.0 3.2 3.1 5.3 7.0 1.1 3.3 2.9 0.9 2.9 1.2 3.9 3.8 2.6 6.1 2.3 0.9 3.5 0.8 6.9 5.6 11.8 10.1 5.5 5.2 7.6 7.2 5.4 5.1 5.2 5.1 6.6 15.5 4.5 6.2 5.2 8.4 4.1 5.0 5.8 5.9 6.8 12.1 4.3 4.6 5.1 10.1 5.4 7.5 5.1 11.8 4.6 10.8 2.7 4.1 10.6 10.9 6.4 6.8 7.3 10.6 4.3 3.7 3.9 15.4 5.9 12.4 9.5 8.4 4.7 7.1 15.4 5.5 4.6 7.5 10.3 10.0 9.5 7.0 6.5 4.9 3.6 5.1 6.1 2.3 1.8 3.5 1.1 2.0 3.4 2.3 1.9 1.0 3.8 2.6 2.0 0.7 0.9 1.4 2.6 2.2 0.8 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679751 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 4.4 0.7 2.5 3.2 4.6 6.7 4.3 2.1 4.3 5.4 2.4 2.1 0.9 0.4 4.3 11.2 3.9 3.4 2.9 6.7 4.2 3.4 3.4 3.4 4.0 2.6 2.8 7.7 6.3 3.1 0.9 1.8 4.6 3.6 2.7 6.9 3.2 1.9 1.2 8.5 1.9 4.1 3.8 4.5 0.8 5.2 5.1 2.8 2.6 9.1 4.7 1.8 4.7 21.8 16.5 25.2 17.2 3.4 3.1 3.5 26.7 5.1 10.1 7.4 21.1 29.5 5.0 10.0 10.2 7.0 8.0 4.1 8.9 5.0 2.6 10.3 8.1 6.7 10.5 10.1 9.8 7.6 13.3 16.4 1.0 8.3 10.4 5.4 29.6 8.7 18.5 24.7 10.7 4.5 27.2 16.4 16.0 2.7 7.5 4.3 12.4 4.3 9.1 15.8 8.6 11.1 0.1 0.1 20.4 11.3 4.8 14.1 9.0 42.8 7.9 8.8 9.5 16.6 47.9 15.3 12.3 14.3 9.1 11.9 9.8 17.2 25.2 2.3 11.5 1.7 21.8 2.4 2.1 14.9 15.1 3.1 2.6 22.9 3.4 13.1 16.5 3.1 3.5 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 2.2 1.1 1.3 2.7 3.3 0.0 4.9 6.1 3.6 3.2 1.1 1.8 2.9 0.4 4.0 7.7 1.7 2.4 1.9 0.5 7.1 1.5 4.9 2.8 5.0 1.4 1.5 3.4 1.7 3.6 3.2 2.7 4.2 2.8 2.1 3.0 5.2 3.1 0.7 2.2 0.7 3.8 6.3 3.6 0.9 0.9 4.8 1.0 3.0 1.9 3.7 1.4 0.5 3.1 0.2 0.6 0.4 2.7 5.5 1.8 7.4 4.8 8.9 16.6 10.5 16.6 10.9 13.5 13.2 8.3 8.5 4.2 8.1 3.7 3.7 9.8 5.8 9.7 4.3 13.2 12.4 5.2 0.3 11.0 5.2 8.0 0.3 3.7 13.5 7.6 9.8 20.6 11.5 1.6 11.4 19.9 15.9 0.2 3.3 3.6 11.0 3.3 5.2 5.9 9.1 6.8 0.8 20.0 5.7 8.8 9.3 8.8 3.3 12.3 13.4 8.8 11.8 12.5 10.1 10.9 6.4 0.2 0.4 6.2 0.2 0.3 0.1 1.3 0.0 1.9 3.1 3.5 2.4 0.2 1.8 4.2 1.6 0.6 2.7 0.4 0.2 5.5 1.8 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149390623-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 6.8 0.9 3.2 10.4 2.7 9.5 8.4 1.7 4.5 6.6 3.7 4.0 10.1 1.1 8.8 8.0 5.3 6.0 7.3 4.8 3.4 2.3 3.1 12.1 6.0 3.2 4.7 10.6 6.2 4.0 0.9 7.0 5.5 5.0 3.9 7.5 7.7 8.6 6.2 13.0 1.7 6.0 2.6 6.7 1.7 9.5 2.9 2.5 6.3 5.2 5.2 3.9 7.4 6.2 11.7 18.0 16.7 6.9 7.0 1.5 23.4 6.3 13.6 6.9 26.7 23.1 6.4 11.6 8.9 8.2 8.0 5.5 8.5 6.9 2.9 17.9 10.8 18.7 10.8 12.7 12.4 10.4 19.6 17.5 1.9 5.5 19.6 7.1 16.1 4.8 23.4 30.6 5.2 4.7 11.2 17.1 17.2 10.7 11.7 11.8 9.7 9.7 14.9 11.3 5.1 11.9 1.2 2.8 27.5 9.6 5.2 17.8 26.9 31.1 16.4 12.1 10.1 17.9 9.4 5.4 21.7 18.7 13.7 4.8 9.8 16.7 5.3 7.0 6.4 4.7 2.3 3.8 2.5 3.2 6.2 5.2 6.5 18.0 6.9 5.2 11.7 1.4 1.5 NBPF20 ENSG00000162825 "NBPF member 20" 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 1.1 1.2 1.1 1.2 1.2 1.0 1.5 2.5 1.2 1.4 1.1 0.0 1.3 1.8 1.1 1.2 0.7 1.1 1.1 1.1 1.1 2.6 1.1 1.2 1.0 2.2 1.3 5.9 1.1 0.0 1.5 1.1 1.6 2.1 1.1 2.4 1.1 1.7 1.0 1.1 1.1 3.6 1.1 1.5 1.4 1.1 4.0 13.3 1.0 1.8 2.9 1.0 0.3 14.4 7.4 2.1 5.9 13.0 22.9 5.3 7.1 1.7 2.5 2.6 8.0 1.8 3.4 2.8 7.3 4.5 7.2 8.4 7.2 6.9 8.8 2.2 9.3 5.8 2.7 4.0 3.9 6.8 6.5 14.0 11.9 6.7 9.1 5.2 10.3 9.5 0.6 1.8 2.0 11.8 3.4 6.0 2.2 3.7 2.7 3.7 6.5 14.5 7.5 4.0 5.7 5.6 12.2 12.5 15.6 6.6 16.4 3.0 2.5 7.9 6.8 1.7 1.8 0.5 1.5 0.5 1.0 0.9 0.8 1.5 0.7 1.0 0.4 4.0 1.0 0.9 1.0 2.9 1.8 13.3 0.9 0.3 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723923-120841481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in all" "neutrophil: 17.7" "Group enriched" "Detected in all" 4 "granulocytes: 17.7;monocytes: 10.0" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 2.7 0.8 2.3 4.3 2.2 2.1 1.8 1.1 2.5 3.2 1.9 1.1 1.1 0.0 3.0 5.6 4.8 2.4 3.1 1.1 1.1 3.5 1.7 2.3 2.0 1.1 1.1 3.6 1.1 1.1 1.1 1.1 2.0 2.5 1.4 1.7 1.6 1.3 1.1 9.9 1.1 6.0 2.4 10.6 0.5 3.4 1.1 1.1 1.8 3.3 1.8 2.0 1.1 3.4 2.8 17.7 10.0 2.4 2.1 1.0 26.9 0.1 8.1 8.9 11.4 9.4 0.6 9.6 4.9 6.0 6.5 5.8 1.0 1.9 9.1 11.1 8.0 13.1 13.7 8.4 12.8 0.5 18.5 2.9 2.3 5.2 7.6 5.6 5.7 5.9 15.7 17.3 0.3 1.5 16.7 15.7 15.1 2.1 12.3 2.9 10.9 3.0 9.1 4.9 4.7 11.0 0.7 0.5 11.2 16.3 8.4 0.6 3.3 8.2 7.2 19.2 23.7 7.6 7.4 2.0 7.9 6.7 11.4 1.0 7.7 6.4 7.2 1.9 5.2 1.7 1.2 2.0 1.9 2.8 3.4 1.7 2.1 17.7 2.4 10.0 2.1 1.1 1.0 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.1;HHSteC: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Supported Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 3.2 5.1 4.5 2.6 4.6 2.3 6.5 12.7 5.3 4.1 3.5 3.7 4.2 1.5 3.7 4.6 3.7 3.6 2.9 2.8 4.7 3.5 4.0 4.6 3.0 3.0 5.0 3.8 4.7 4.3 2.6 9.4 11.7 4.5 4.5 3.6 3.3 4.9 4.0 2.2 6.2 4.0 5.3 4.6 3.2 4.7 29.5 4.9 2.4 4.8 1.3 4.5 5.1 5.6 1.1 0.3 2.3 0.7 1.1 5.3 1.6 1.7 2.4 0.2 5.6 3.7 1.3 4.7 3.2 15.1 4.4 3.7 3.3 5.7 2.8 1.3 8.3 0.2 2.6 3.8 0.5 1.5 2.9 1.9 0.1 1.2 14.6 1.1 1.9 1.0 1.1 4.0 0.7 0.4 0.8 1.0 1.0 6.3 0.0 2.8 0.8 3.5 0.0 0.0 2.6 0.7 2.4 3.9 4.0 4.9 1.3 3.9 1.8 2.4 3.6 1.8 2.2 5.5 1.3 0.0 1.6 4.5 0.4 2.4 2.5 0.0 0.5 2.3 3.8 0.7 5.3 1.1 1.6 3.0 0.3 0.5 2.8 3.5 0.2 1.1 0.0 0.0 1.5 1.6 4.5 4.6 12.7 5.3 4.7 3.5 5.0 3.8 4.5 4.9 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Group enriched" "Detected in some" 4 "BEWO: 8.0;K-562: 11.5;Karpas-707: 3.4;MCF7: 13.6;THP-1: 4.1" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045044: , HPA046411: , HPA047447: , HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 3.4 0.0 13.6 0.0 0.0 0.6 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.6 0.2 4.1 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Cell line enhanced" "Detected in some" "BEWO: 8.7;K-562: 13.6;SK-BR-3: 3.3;SK-MEL-30: 2.4" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045044: , HPA046411: , HPA047447: , HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.4 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.9" "Low lineage specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 3.3 2.0 5.6 6.5 5.3 2.4 2.6 12.3 5.0 4.2 3.3 2.1 4.5 1.7 4.9 7.2 2.8 2.9 4.7 3.8 5.3 3.6 5.4 8.3 4.6 2.8 1.8 4.9 6.3 4.4 1.9 2.2 4.3 3.0 3.1 6.8 2.2 2.4 1.7 4.5 3.2 4.4 2.0 2.7 1.8 2.9 2.0 1.8 5.2 2.5 4.0 2.3 0.0 4.2 5.2 21.9 7.6 5.6 1.8 0.8 22.2 9.8 12.2 16.4 11.1 13.5 9.7 20.5 15.0 10.8 11.8 7.3 9.7 5.3 5.7 10.5 6.6 8.4 9.6 18.7 13.4 8.8 1.7 16.5 4.4 12.9 2.2 6.5 13.3 7.2 11.8 20.8 9.4 6.1 13.9 13.2 17.5 0.7 3.6 4.6 13.3 6.0 7.5 8.0 8.9 10.3 7.9 16.4 6.7 16.6 9.1 12.3 4.2 22.1 24.5 7.2 17.9 31.5 17.2 9.1 10.5 8.9 1.6 8.6 21.9 7.6 0.3 0.4 3.6 0.7 1.9 1.3 0.4 1.3 4.2 1.8 1.0 5.8 5.6 1.2 5.2 1.6 0.8 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1, autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: , HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favourable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 26.3 29.5 27.1 17.2 27.3 7.7 28.0 27.3 29.4 25.6 32.9 33.3 29.0 31.0 28.4 25.5 23.1 25.6 20.7 29.8 26.0 22.0 38.3 39.6 21.1 25.4 27.2 21.8 34.1 26.5 55.8 25.0 31.2 22.8 30.1 32.1 20.7 25.5 29.5 62.9 23.9 37.7 24.2 34.2 23.3 23.2 57.0 31.7 29.8 32.1 24.5 19.8 32.5 23.7 9.6 12.6 25.2 21.5 15.5 17.1 14.4 12.5 15.4 13.2 13.9 30.0 31.2 12.7 23.8 47.2 19.8 16.4 8.0 20.0 6.7 24.7 33.0 13.9 15.0 30.7 28.8 20.9 15.9 8.0 19.5 17.1 28.7 6.7 12.4 35.5 34.8 21.6 42.7 30.7 17.1 18.1 26.1 7.1 14.3 4.9 4.2 10.0 4.8 20.7 21.9 25.0 14.3 7.9 14.2 16.4 8.1 23.8 22.1 11.1 25.5 29.1 10.8 13.3 9.4 21.7 17.6 8.8 19.7 9.3 19.9 23.5 16.1 25.2 14.2 15.3 14.6 9.6 12.9 13.7 12.6 6.7 12.4 11.9 23.1 15.5 21.5 8.0 17.1 14.4 27.1 27.3 27.3 29.4 26.0 22.0 27.2 21.8 22.8 31.7 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Cell line enhanced" "Detected in some" "HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: " "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favourable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.7 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 0.9 6.0 6.3 0.1 0.0 0.0 0.0 0.1 3.8 19.1 0.0 0.0 0.7 0.0 3.1 4.1 0.0 0.0 6.1 0.0 0.0 0.3 6.7 0.0 0.0 1.6 0.5 0.1 0.0 43.1 3.1 0.0 0.0 35.1 17.2 0.0 0.1 0.0 0.0 0.2 0.0 24.0 11.2 0.1 10.0 0.0 0.1 0.0 2.7 9.0 25.4 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998315-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.9;brain: 52.7" "Cell line enriched" "Detected in some" 4 "T-47d: 44.1" "Cancer enhanced" "Detected in some" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" 100000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: " "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 2.0 15.9 25.8 2.0 22.3 1.1 3.1 7.0 52.7 3.3 2.1 14.7 0.0 1.3 2.3 1.8 1.7 1.8 2.6 3.1 18.7 13.9 1.3 9.1 4.4 1.2 21.6 19.4 1.4 1.3 1.1 1.0 1.7 17.9 2.2 2.4 0.5 1.8 2.3 1.5 2.0 1.9 2.7 17.3 2.0 1.3 8.3 26.6 0.0 1.5 0.0 1.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.6 0.0 1.1 0.0 0.0 5.6 0.0 1.7 0.0 0.0 5.1 1.1 0.1 7.1 0.1 0.0 0.2 0.0 0.5 0.0 2.1 0.0 0.0 0.0 2.6 0.0 0.3 0.3 44.1 3.3 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 1.2 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 22.3 7.0 22.4 18.7 13.9 21.6 19.4 17.9 26.6 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavourable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavourable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 21.9 20.4 21.9 15.8 5.7 6.0 25.6 15.1 12.2 24.6 19.9 18.3 23.3 23.1 4.5 9.9 19.4 36.0 17.7 47.0 41.8 20.2 21.1 23.3 10.4 2.4 26.2 15.3 3.8 6.6 19.2 19.6 16.2 13.4 9.4 21.7 10.9 29.6 17.2 34.2 15.9 25.3 49.8 12.2 8.2 12.3 9.0 9.5 22.6 10.7 8.1 4.7 16.5 10.1 16.2 26.6 10.9 29.4 7.4 9.9 32.9 9.5 15.2 20.0 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631311-158704829 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavourable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favourable (1.91e-4)" "prognostic unfavourable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavourable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavourable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavourable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 5.9 4.0 4.4 8.6 4.2 20.1 5.4 9.0 5.1 4.4 6.6 5.8 3.5 4.2 5.1 5.1 9.9 3.7 3.1 4.0 4.3 3.5 3.3 3.9 4.4 11.4 6.2 4.2 4.4 4.4 6.0 5.8 6.9 4.9 4.5 7.7 3.9 5.3 4.2 4.5 6.5 5.5 4.6 6.2 6.1 5.3 14.6 5.1 39.1 3.6 7.6 13.0 4.8 5.5 1.8 2.8 6.9 5.4 6.1 9.3 2.5 29.7 15.8 19.3 12.4 2.9 4.7 7.7 21.8 14.1 27.0 30.3 14.0 15.6 18.4 13.6 8.9 15.3 16.0 10.0 36.1 19.6 11.9 16.6 19.7 11.0 1.3 20.5 18.8 2.0 1.1 22.0 6.3 15.0 20.3 27.7 24.8 31.6 34.0 13.9 19.0 12.8 20.0 20.3 17.5 6.7 13.4 21.1 16.3 26.9 10.5 5.9 9.5 13.4 7.8 18.5 14.1 49.9 34.9 18.3 13.5 22.4 19.6 26.2 35.1 6.9 1.0 1.2 6.5 1.4 9.3 1.8 6.6 4.5 2.8 1.2 2.2 2.4 0.6 6.1 5.4 1.4 8.3 2.5 4.4 4.2 9.0 5.1 4.3 3.5 6.2 4.2 4.9 5.1 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavourable (9.53e-6)" "prognostic unfavourable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 30.9 11.8 29.9 15.5 1.1 1.6 19.8 14.7 10.3 28.4 30.0 21.8 17.4 28.9 10.4 6.4 14.0 25.6 10.0 30.5 25.4 17.0 29.8 12.3 19.6 0.2 27.5 25.5 0.5 1.1 22.0 9.3 11.2 20.6 21.5 13.4 14.6 40.4 28.7 21.4 14.9 31.4 27.2 23.5 5.6 12.0 17.8 13.6 8.5 12.0 5.2 8.8 20.4 6.5 21.0 32.1 19.6 23.7 11.5 16.3 30.8 9.1 27.6 23.7 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 NCAPH2 "384D8-2, CAP-H2, hCAP-H2" ENSG00000025770 "Non-SMC condensin II complex subunit H2" Q6IBW4 22 50508216-50523472 "Predicted intracellular proteins" "DNA condensation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067932, HPA069056" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA067932: , HPA069056: " "unprognostic (2.01e-1)" "prognostic favourable (2.24e-8)" "unprognostic (3.65e-2)" "unprognostic (2.81e-1)" "unprognostic (5.04e-2)" "unprognostic (1.57e-2)" "prognostic unfavourable (8.25e-4)" "unprognostic (2.92e-2)" "unprognostic (8.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-2)" "unprognostic (6.31e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.00e-1)" 15.7 12.4 24.5 17.8 18.8 57.4 14.7 33.5 29.4 14.5 14.2 17.4 14.6 15.6 17.5 15.7 18.0 17.2 11.4 18.2 20.0 19.6 14.5 13.8 17.0 22.2 17.8 19.2 22.8 22.6 16.3 22.0 20.0 19.0 15.2 10.8 16.8 22.4 16.6 20.2 23.2 15.7 20.5 15.7 18.4 15.7 26.1 20.4 25.2 16.3 16.8 21.0 12.0 14.5 13.7 10.1 14.5 11.6 11.3 20.9 12.8 19.8 10.8 18.8 19.2 5.6 6.5 24.4 15.8 10.9 28.5 31.1 21.9 13.7 23.0 8.7 11.3 15.8 17.1 15.1 8.2 13.1 28.4 13.2 27.3 19.6 6.8 29.3 23.9 5.9 9.5 22.5 7.6 9.1 16.6 44.8 11.5 27.4 20.0 33.4 13.3 12.9 33.6 24.4 25.3 8.3 13.1 12.3 16.1 12.4 18.5 14.7 12.6 28.8 5.9 22.3 26.8 18.2 23.3 23.4 13.0 34.1 16.7 15.0 20.9 10.6 8.4 14.5 17.1 10.4 20.9 13.7 17.7 17.4 7.0 13.2 18.7 15.5 10.2 11.3 11.6 10.1 16.8 12.8 24.5 18.8 33.5 29.4 20.0 19.6 17.8 19.2 19.0 20.4 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633626-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favourable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 18.5 17.2 19.8 27.4 26.2 37.2 23.6 25.5 27.1 17.0 21.9 18.7 19.8 18.0 19.2 15.3 21.7 15.9 16.3 20.4 23.7 17.8 17.9 22.7 17.3 25.9 16.6 23.8 22.8 22.0 17.1 26.9 20.3 22.6 18.4 25.7 18.1 18.3 17.7 25.5 22.4 19.3 16.3 18.7 20.5 19.4 26.8 17.8 36.1 22.5 15.1 25.0 18.5 19.4 7.6 13.7 12.9 14.6 14.9 10.0 7.7 24.5 16.9 19.0 17.7 13.4 13.5 18.6 18.8 10.9 17.2 16.2 22.6 12.8 21.2 8.1 16.9 27.8 30.2 21.4 24.7 14.1 9.7 19.5 25.5 14.1 13.1 26.0 20.3 10.1 10.7 20.0 15.5 17.8 28.7 11.9 28.8 17.7 18.8 13.8 20.6 18.3 18.1 44.1 8.5 14.0 18.3 24.2 16.3 18.8 16.5 9.8 10.2 15.9 14.9 13.5 12.6 26.8 19.3 11.5 14.1 11.0 12.4 20.2 17.7 12.9 11.4 11.0 8.7 14.6 9.9 6.5 9.9 9.1 13.7 7.6 8.7 10.0 3.5 14.9 14.3 5.9 8.6 7.7 19.8 26.2 25.5 27.1 23.7 17.8 16.6 23.8 22.6 17.8 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555563-183590876 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4" "Cell line enhanced" "Detected in many" "A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 125.2;neutrophil: 80.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002327, HPA006040, CAB022160" Enhanced Supported Nucleoli,Cytosol Cytosol Nucleoli "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavourable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 15.3 3.1 2.0 23.0 4.5 53.0 3.9 0.7 2.8 2.9 2.8 3.7 0.2 2.3 1.8 6.1 4.1 5.2 7.2 6.4 2.0 1.8 2.9 5.4 39.5 42.7 6.8 0.4 3.5 4.2 0.6 1.9 11.5 3.8 3.4 3.7 4.2 4.4 0.8 3.5 7.1 3.8 5.8 5.5 45.4 2.6 3.9 3.2 4.2 2.0 5.6 5.5 7.3 3.5 1.4 24.3 125.2 45.7 0.2 1.0 22.7 13.1 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.8 0.8 0.1 0.4 1.6 2.3 0.4 7.4 0.0 9.7 1.6 8.2 0.0 0.0 3.3 3.0 0.0 1.0 11.4 0.0 2.1 1.7 27.4 0.0 0.0 2.9 3.0 0.1 0.1 0.5 0.2 0.7 3.5 1.1 9.9 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.4 4.6 0.6 0.0 26.6 0.0 2.4 0.5 0.7 0.2 0.2 5.2 0.0 15.5 45.7 125.2 0.1 34.4 0.1 1.4 0.4 0.1 24.3 0.8 0.2 0.1 80.6 0.2 29.7 1.3 1.0 22.7 2.0 4.5 0.7 2.8 2.0 1.8 6.8 0.4 3.8 3.2 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136949823 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: " "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 44.5 15.7 11.5 24.5 13.4 19.3 38.9 22.6 11.6 23.7 18.3 8.4 16.5 10.2 20.8 19.2 35.9 14.6 13.9 16.8 11.8 11.1 14.0 20.9 22.4 33.0 13.9 12.1 19.6 14.3 17.9 17.7 22.7 13.5 26.3 19.5 10.8 24.0 15.8 29.0 27.3 14.3 24.0 13.5 18.7 12.8 14.7 12.7 41.1 23.8 23.5 29.0 27.3 43.3 8.5 13.3 26.8 27.1 11.2 20.2 11.9 19.6 8.7 11.5 9.5 26.8 26.1 12.9 14.5 26.2 16.9 17.7 12.7 19.6 19.3 30.2 17.0 15.2 16.2 14.8 22.6 13.9 6.6 16.7 12.4 9.9 43.7 12.1 11.6 23.6 19.5 16.4 32.8 25.9 10.0 17.3 17.7 10.7 27.3 9.7 11.0 11.1 14.9 10.8 18.5 15.8 13.5 8.2 8.0 26.2 11.8 23.4 16.9 13.3 12.8 11.0 7.2 15.6 8.3 17.3 13.6 23.9 11.7 10.9 11.7 26.8 12.4 13.2 19.7 27.1 20.2 8.1 15.6 19.8 13.3 8.5 12.6 15.0 7.2 11.2 13.4 5.2 15.0 11.9 11.5 13.4 22.6 11.6 11.8 11.1 13.9 12.1 13.5 12.7 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497711-54548238 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.1;lymphoid tissue: 56.7" "Cell line enhanced" "Detected in some" "HL-60: 32.9;HMC-1: 34.8;NB-4: 24.2;REH: 17.4;THP-1: 36.1;U-937: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" 52000 Cytosol "Plasma membrane" "HPA039490: , HPA040772: " "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 18.1 5.0 5.9 22.0 10.5 16.9 7.2 1.2 5.8 3.1 15.0 8.1 0.6 4.0 3.1 4.3 4.8 4.0 5.1 6.5 4.1 3.5 3.9 6.5 19.7 56.7 9.3 2.5 2.2 2.4 4.4 2.3 7.3 6.6 4.8 6.9 3.0 4.3 4.0 1.5 2.8 15.4 7.0 13.9 44.7 4.7 1.7 7.9 47.2 2.8 1.8 30.0 22.2 3.3 11.2 25.4 18.4 39.1 12.3 15.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 11.9 0.1 14.2 0.0 0.0 0.0 32.9 34.8 0.0 0.0 0.0 0.0 0.2 2.2 13.3 0.0 0.0 13.8 24.2 0.0 0.0 17.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.7 0.8 11.6 0.0 21.1 0.0 8.6 23.3 18.4 11.9 36.4 9.8 11.2 10.7 12.1 25.4 11.0 6.9 10.0 5.9 12.3 39.1 14.4 15.2 19.2 5.9 10.5 1.2 5.8 4.1 3.5 9.3 2.5 6.6 7.9 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell line enriched" "Detected in some" 6 "AF22: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: " "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 31.7 0.0 0.0 0.3 0.1 0.5 5.6 0.5 0.5 0.0 0.0 2.4 0.0 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.7 0.0 0.0 0.0 0.0 0.3 2.6 3.0 0.4 0.5 0.0 0.0 0.9 0.3 0.0 0.0 0.7 1.0 0.3 0.0 1.2 0.7 0.7 0.1 1.0 0.0 1.1 1.6 0.5 0.0 1.6 0.2 0.2 4.6 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced Nucleoplasm,Nucleoli 600000 "Nucleoplasm, Nucleoli" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavourable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 71.2 68.2 59.6 67.7 77.0 96.6 71.0 72.8 69.2 72.1 63.0 79.2 46.0 48.1 80.3 63.7 85.2 65.7 45.9 55.9 57.7 53.3 66.7 94.7 55.6 78.4 67.4 51.8 93.9 77.5 94.8 83.4 69.5 79.8 64.6 75.4 47.1 58.1 51.8 120.6 70.3 56.9 70.9 88.4 80.2 59.4 41.7 76.4 118.9 67.8 82.6 105.5 79.9 60.6 40.8 41.3 20.4 36.4 52.6 53.9 40.8 62.2 58.2 70.7 51.7 41.7 45.4 72.7 70.5 47.8 66.5 58.9 96.1 44.8 82.8 60.7 54.3 61.1 141.3 94.6 114.1 48.3 59.3 138.0 55.3 129.6 45.8 157.2 52.3 43.0 54.9 83.0 87.5 69.7 122.9 28.4 58.5 84.6 137.7 97.6 105.2 41.8 102.8 127.4 72.6 48.8 82.7 61.2 43.7 47.1 54.1 62.2 40.7 79.7 59.2 53.3 55.2 62.3 92.5 53.8 52.8 178.1 38.8 102.7 55.2 9.5 27.9 20.4 47.4 33.2 53.9 40.8 41.7 42.6 41.3 38.9 46.6 42.1 6.0 52.6 36.4 35.5 34.4 40.8 59.6 77.0 72.8 69.2 57.7 53.3 67.4 51.8 79.8 76.4 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" 12000 "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favourable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavourable (8.37e-5)" "prognostic favourable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 15.8 27.4 10.2 18.2 15.3 31.1 10.2 21.2 23.6 9.3 20.4 14.7 14.9 32.9 12.7 7.2 14.1 11.0 15.5 10.5 12.2 8.5 13.3 48.3 15.5 19.8 9.7 9.0 12.1 41.3 9.5 11.5 11.3 10.8 13.3 9.7 13.0 18.7 9.9 16.3 14.9 27.8 9.5 8.0 20.6 18.9 17.2 12.1 11.8 11.8 11.8 13.2 9.4 11.8 5.3 17.8 8.8 12.2 4.3 7.7 7.1 27.1 31.8 7.9 24.6 7.8 6.5 20.6 30.0 12.6 22.6 18.4 43.1 15.8 16.5 26.1 19.7 32.3 9.4 22.8 5.0 21.5 21.5 11.5 19.6 29.3 15.6 20.5 21.5 11.3 14.5 18.2 9.9 12.5 29.4 18.5 10.3 24.1 17.8 21.9 22.4 22.5 28.7 8.4 26.2 13.3 18.7 17.1 16.9 12.1 22.6 19.0 16.4 23.6 16.9 19.7 17.1 32.0 36.2 23.2 21.0 12.7 20.7 26.3 30.1 1.1 11.9 8.8 6.9 12.2 6.1 5.3 4.2 7.7 8.7 4.4 4.6 6.1 7.3 4.3 4.9 17.8 3.8 7.1 10.2 15.3 21.2 23.6 12.2 8.5 9.7 9.0 10.8 12.1 NCOA1 "bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1" ENSG00000084676 "Nuclear receptor coactivator 1" Q15788 2 24491914-24770702 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019402, HPA070213, HPA070520" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB019402: AB_2196189, HPA070213: , HPA070520: " "unprognostic (2.73e-1)" "unprognostic (5.82e-2)" "unprognostic (2.46e-2)" "unprognostic (9.89e-3)" "unprognostic (7.60e-2)" "unprognostic (2.36e-2)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (1.72e-1)" "unprognostic (2.93e-3)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.15e-2)" "unprognostic (3.08e-1)" "unprognostic (1.29e-1)" "unprognostic (2.92e-2)" 9.8 10.0 15.3 7.3 18.0 8.9 10.5 15.9 17.1 13.7 8.9 13.5 4.9 12.5 13.0 11.5 10.8 10.0 8.3 8.8 20.8 12.2 11.9 8.8 9.4 8.2 10.8 9.9 17.2 10.3 23.9 16.0 10.1 14.2 9.6 10.1 19.9 10.6 13.0 42.5 9.3 10.9 11.6 9.7 9.6 7.6 11.4 10.7 8.5 7.0 12.2 9.3 9.7 10.8 2.5 5.5 14.2 3.5 3.4 4.1 1.8 6.6 4.9 8.7 4.5 9.6 8.8 13.3 3.5 7.1 4.5 4.0 4.6 2.8 4.8 1.5 6.4 1.6 5.2 3.0 4.9 22.8 7.5 17.2 2.0 1.9 6.0 7.9 14.4 14.0 4.6 4.3 3.5 4.5 10.4 8.0 6.8 4.4 7.0 2.8 4.1 3.3 5.5 40.1 2.4 4.9 9.0 8.0 6.3 8.2 5.0 3.6 6.0 4.0 4.9 7.5 5.9 5.1 3.5 9.3 8.0 8.4 4.3 5.0 3.7 11.0 3.5 6.9 3.8 2.7 4.1 1.8 3.4 4.1 2.6 2.5 3.3 4.0 14.2 3.4 2.8 5.5 3.7 1.8 15.3 18.0 15.9 17.1 20.8 12.2 10.8 9.9 14.2 10.7 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109762-70403805 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA060243: " "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favourable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 13.6 13.2 16.9 13.1 14.0 22.5 14.9 19.2 14.0 13.9 17.3 10.1 49.7 12.4 16.6 33.6 20.0 12.5 12.6 15.8 13.9 13.0 16.4 25.5 15.5 16.9 10.8 11.4 18.5 9.7 23.4 17.1 16.2 10.0 14.8 11.8 15.3 14.8 21.7 13.2 14.9 28.8 19.2 9.6 14.5 11.7 15.5 12.9 15.3 13.4 10.3 13.8 18.9 17.2 3.8 2.5 9.4 7.8 2.1 3.8 1.6 8.6 10.8 11.9 6.7 10.8 11.2 12.2 5.0 5.0 3.8 3.7 5.5 10.0 10.2 2.0 9.1 5.1 14.6 6.9 4.3 24.2 11.6 17.9 5.5 8.7 5.7 3.6 4.8 9.7 7.7 5.2 7.5 2.6 5.6 15.7 4.4 8.6 8.9 3.6 6.2 5.1 8.8 5.0 6.4 6.1 14.4 9.1 6.7 8.6 4.6 7.1 10.9 6.6 3.4 5.6 7.1 7.0 2.6 20.7 10.5 10.0 5.7 4.8 8.1 4.5 2.5 3.5 3.8 3.9 2.8 2.2 2.3 3.3 2.5 3.8 2.8 2.7 9.4 2.1 7.8 1.1 3.2 1.6 16.9 14.0 19.2 13.5 13.9 13.0 10.8 11.4 10.0 12.9 NCOA3 "ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1" ENSG00000124151 "Nuclear receptor coactivator 3" Q9Y6Q9 20 47501902-47656877 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009800, HPA024210" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009800: AB_2251314, HPA024210: AB_10602011" "unprognostic (7.26e-3)" "unprognostic (1.00e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-2)" "unprognostic (5.78e-2)" "unprognostic (4.33e-2)" "prognostic unfavourable (8.09e-4)" "unprognostic (2.83e-2)" "unprognostic (1.47e-1)" "unprognostic (5.22e-3)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.95e-1)" "unprognostic (2.04e-2)" "unprognostic (4.18e-1)" "unprognostic (1.63e-1)" 20.1 8.9 6.6 34.0 7.4 11.1 15.7 11.9 9.9 12.3 10.1 8.1 9.0 6.7 15.5 8.8 16.7 12.0 8.6 11.5 6.7 4.8 9.1 9.3 17.4 25.8 7.9 4.7 13.3 10.7 13.5 13.5 54.7 7.9 9.7 9.0 10.8 13.5 10.0 32.5 15.0 17.1 11.3 9.5 30.8 11.4 9.2 7.2 17.6 13.5 10.5 33.3 15.1 17.7 13.0 6.7 6.0 7.3 2.7 4.0 3.5 5.7 18.8 5.3 7.2 12.5 14.7 37.3 5.6 8.4 9.6 5.1 9.0 6.4 20.1 3.7 9.6 14.2 4.1 6.9 7.3 10.6 2.2 2.7 5.3 12.5 7.4 2.1 15.0 6.7 19.8 9.1 10.6 6.8 6.2 4.7 5.3 62.6 3.2 3.7 1.8 7.2 6.0 3.7 8.6 5.3 13.6 1.0 1.9 14.1 17.6 6.0 8.1 5.5 11.8 5.7 5.0 6.9 2.4 12.9 11.8 20.7 6.6 2.2 3.8 3.4 5.2 4.0 3.5 7.3 3.2 13.0 3.2 3.1 6.7 10.0 3.7 4.0 6.0 2.7 7.0 5.5 4.0 3.5 6.6 7.4 11.9 9.9 6.7 4.8 7.9 4.7 7.9 7.2 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA051260: , HPA065208: " "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favourable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.3 13.3 15.6 16.0 41.4 37.6 39.1 28.8 46.7 28.5 27.9 20.4 23.2 35.4 34.7 47.1 32.0 16.3 31.7 31.7 25.0 16.8 23.9 18.3 58.5 29.1 60.8 53.4 36.5 31.8 24.2 40.7 41.8 26.0 21.4 38.7 14.0 29.5 22.8 9.4 7.8 17.5 22.7 21.2 34.1 26.7 15.7 10.6 29.1 33.3 28.8 24.0 29.9 38.5 17.6 21.2 18.6 19.4 15.9 17.0 35.2 22.0 51.2 9.3 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 NCOA5 "bA465L10.6, CIA" ENSG00000124160 "Nuclear receptor coactivator 5" Q9HCD5 20 46060985-46089952 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050231 Uncertain Supported "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA050231: " "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (7.93e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (1.41e-5)" "prognostic favourable (8.07e-4)" "unprognostic (2.32e-1)" "unprognostic (7.75e-2)" "prognostic favourable (1.09e-4)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.07e-1)" "unprognostic (8.78e-2)" "unprognostic (1.91e-2)" 16.0 15.0 20.9 25.8 18.5 8.1 55.1 31.2 25.6 19.3 17.7 12.0 18.5 14.0 23.4 20.3 16.5 21.1 15.8 13.8 19.3 13.1 14.1 12.9 21.7 23.0 14.6 16.2 29.8 27.0 23.4 26.2 18.4 15.7 19.2 16.5 14.7 18.5 23.6 22.8 19.4 18.1 19.8 13.6 23.3 16.5 44.4 16.7 23.8 19.2 14.2 23.8 18.2 42.5 17.4 18.5 10.7 8.6 7.4 14.0 5.4 19.2 17.1 24.2 24.8 11.6 12.3 19.4 13.4 12.1 21.8 17.9 23.6 15.4 31.6 22.7 12.9 25.8 19.9 16.7 18.8 19.1 10.0 18.9 17.0 19.9 12.3 26.0 18.5 8.8 22.4 11.5 10.5 15.4 17.6 25.8 17.1 24.9 35.7 20.1 22.0 21.1 27.2 16.0 13.8 12.8 21.9 21.8 19.7 21.4 26.2 18.7 20.8 30.7 14.3 23.1 17.5 13.8 20.7 16.9 23.8 21.3 16.0 15.3 14.6 3.3 8.3 10.7 12.2 8.5 14.0 11.6 12.8 12.3 8.3 17.4 12.3 11.1 6.0 7.4 8.6 18.5 8.2 5.4 20.9 18.5 31.2 25.6 19.3 13.1 14.6 16.2 15.7 16.7 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932030 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nuclear bodies,Golgi apparatus" "Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favourable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 32.0 37.6 24.8 26.6 33.7 23.1 20.4 39.7 32.6 19.2 18.0 17.9 3.9 19.8 13.9 6.4 22.7 11.3 28.9 12.3 23.2 24.1 33.7 21.5 30.8 19.0 35.7 25.6 12.5 11.8 7.4 49.3 8.0 39.5 12.2 18.4 7.6 31.6 8.5 6.3 8.7 23.1 17.1 30.9 16.2 18.7 4.9 35.4 4.7 15.6 12.0 16.6 44.1 20.8 12.8 22.6 10.5 8.8 9.1 17.5 3.5 4.4 12.1 0.8 5.4 27.1 16.1 7.9 6.0 24.0 7.5 10.3 11.3 4.1 17.7 32.5 3.3 26.3 4.1 4.1 4.5 37.7 4.7 9.1 15.5 4.1 15.4 5.1 8.6 11.5 10.0 7.1 5.5 15.5 12.8 10.6 4.6 5.0 5.0 5.4 0.9 2.4 3.8 1.9 3.3 13.3 30.5 12.4 10.8 30.7 8.4 13.4 2.1 6.7 8.8 1.8 3.7 8.8 4.5 13.0 10.6 9.3 3.8 7.3 5.9 10.5 8.1 2.8 14.1 6.3 17.5 12.8 13.4 11.2 6.5 7.5 7.4 7.2 5.0 9.1 8.8 22.6 5.2 3.5 24.8 33.7 39.7 32.0 23.2 24.1 35.7 25.6 39.5 35.4 NCOR1 "hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1" ENSG00000141027 "Nuclear receptor corepressor 1" O75376 17 16029157-16218185 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043246, HPA050288, HPA051168, CAB072830" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB072830: , HPA043246: , HPA050288: , HPA051168: " "unprognostic (1.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.10e-1)" "unprognostic (7.38e-2)" "unprognostic (3.59e-2)" "unprognostic (2.55e-2)" "unprognostic (4.27e-2)" "unprognostic (4.87e-2)" "unprognostic (4.06e-2)" "unprognostic (7.07e-2)" "unprognostic (1.52e-2)" "prognostic favourable (7.92e-5)" "unprognostic (4.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" 19.6 21.2 25.4 24.0 30.8 27.0 25.0 41.8 31.5 24.0 30.6 19.6 18.6 33.2 29.0 19.5 25.0 20.5 21.9 17.8 22.4 17.8 25.6 33.8 20.1 19.5 25.1 19.1 25.9 24.3 39.9 39.8 19.8 21.6 20.8 29.7 17.1 20.9 29.1 43.0 23.8 36.9 29.7 26.4 23.7 29.8 22.1 26.4 38.8 25.3 15.7 23.8 29.6 27.0 43.4 29.9 78.2 24.8 30.4 35.5 19.7 23.8 39.9 28.5 23.7 23.5 17.9 14.2 17.6 19.9 19.4 17.6 21.3 10.9 25.1 12.4 30.7 18.3 35.0 21.3 28.8 33.4 25.9 25.0 34.5 25.0 23.0 15.6 29.8 18.3 22.4 30.0 35.2 26.9 21.8 10.4 19.0 15.5 27.5 10.1 14.1 10.9 27.5 28.9 11.7 20.1 27.1 9.7 16.2 29.1 12.7 13.8 12.2 17.9 23.4 20.0 11.8 14.6 24.2 7.2 8.3 14.7 19.0 18.6 17.1 78.2 24.8 52.2 31.3 19.5 25.9 40.7 35.5 34.1 17.5 43.4 34.7 34.8 48.5 30.4 24.0 29.9 31.7 19.7 25.4 30.8 41.8 31.5 22.4 17.8 25.1 19.1 21.6 26.4 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: , HPA070882: " "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favourable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavourable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 19.6 10.4 14.2 14.5 5.2 5.3 16.7 13.5 10.1 21.2 17.2 15.3 13.2 38.9 8.9 6.0 23.8 23.9 14.1 30.1 9.7 17.2 18.9 15.3 13.0 4.9 30.4 10.8 3.2 5.6 20.9 12.5 12.8 21.6 5.6 11.6 7.1 14.8 12.1 33.6 16.6 16.8 22.9 21.3 9.9 13.6 8.6 10.9 12.1 23.6 11.6 18.3 16.1 7.4 11.1 11.1 15.2 24.2 6.2 15.3 27.7 9.2 23.1 13.8 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80, kinetochore complex component" O14777 18 2571511-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 51.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066330 Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA066330: " "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavourable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 2.9 1.3 0.8 15.3 0.8 14.6 0.9 0.7 0.9 2.9 3.8 0.8 0.6 2.7 4.2 3.8 8.3 1.3 1.8 2.7 0.6 0.4 1.6 1.4 2.9 10.1 0.6 0.8 1.2 0.8 0.0 0.6 6.0 1.1 4.3 5.1 0.8 1.9 7.6 0.6 4.0 4.8 2.2 0.6 7.9 3.0 15.9 0.6 51.3 0.9 8.1 9.9 2.2 6.7 7.9 1.6 9.3 0.7 2.2 11.5 1.4 21.5 4.9 24.5 10.8 1.3 2.9 12.6 25.4 13.6 33.3 28.4 13.4 12.3 23.6 11.5 9.8 13.4 27.3 11.0 35.3 8.8 6.9 18.6 14.0 10.3 0.4 35.6 15.7 1.5 1.0 19.1 13.6 15.1 15.1 30.1 29.0 9.7 17.3 15.5 12.6 7.2 19.2 25.0 18.9 8.7 10.5 19.8 8.9 23.2 6.1 9.2 10.3 14.2 9.2 21.7 48.4 17.1 33.4 13.2 20.8 31.7 9.6 16.5 18.3 3.7 0.7 2.8 2.2 0.6 2.0 7.9 3.7 4.3 0.3 5.7 2.4 2.4 9.3 2.2 0.5 1.6 11.5 1.4 0.8 0.8 0.7 0.9 0.6 0.4 0.6 0.8 1.1 0.6 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA074457: " "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.7 0.0 20.4 7.8 0.0 13.1 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.5 0.0 3.8 0.0 0.0 0.4 0.0 6.7 0.0 9.8 0.0 16.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 1.0 30.8 0.0 0.0 19.5 18.1 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.1 10.8 7.4 11.3 3.1 3.2 22.4 10.5 4.9 10.3 7.1 10.8 8.5 10.0 8.3 4.1 26.8 5.3 7.4 2.1 12.9 8.3 8.9 26.0 5.8 5.3 10.0 19.1 4.3 5.3 11.5 4.3 4.7 14.4 10.7 3.7 12.9 10.3 17.7 11.8 13.5 19.1 8.7 14.3 3.2 6.3 9.3 9.2 8.7 8.9 5.4 14.2 11.6 6.2 19.0 12.4 21.8 11.7 6.6 13.1 10.5 8.2 9.1 10.7 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell line enriched" "Detected in some" 17 "U-87 MG: 40.3" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.9 0.0 0.1 1.0 0.7 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 40.3 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 NDRG1 "CAP43, DRG1, NDR1, RTP, TDD5" ENSG00000104419 "N-myc downstream regulated 1" Q92597 8 133237171-133302022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 69.0;hTERT-HME1: 139.1;U-87 MG: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006881 Approved Supported Microtubules,Cytosol Cytosol Microtubules "HPA006881: AB_1078392" "unprognostic (6.96e-3)" "unprognostic (3.31e-3)" "unprognostic (8.53e-2)" "unprognostic (1.41e-3)" "unprognostic (1.54e-3)" "unprognostic (2.60e-2)" "prognostic unfavourable (1.47e-4)" "unprognostic (3.04e-3)" "unprognostic (5.33e-2)" "unprognostic (4.29e-2)" "unprognostic (9.09e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (4.13e-4)" "unprognostic (7.27e-2)" "unprognostic (1.91e-1)" "unprognostic (2.47e-3)" "unprognostic (4.28e-2)" 43.9 23.6 42.0 17.0 80.9 18.0 29.8 6.4 36.2 33.1 47.7 73.2 24.2 74.2 20.9 20.6 83.0 24.7 26.8 22.2 48.7 32.9 62.6 12.1 31.0 11.4 96.3 19.8 37.5 16.7 17.8 18.6 32.5 50.0 115.0 22.4 16.2 29.0 26.4 13.2 56.9 78.2 19.2 102.0 11.5 45.7 15.0 74.3 10.3 21.4 40.0 34.9 58.7 64.9 1.9 12.2 8.9 4.1 1.3 9.3 2.9 21.5 2.7 0.1 0.1 13.7 9.6 2.9 1.5 11.8 1.1 6.1 1.3 3.0 0.1 15.5 6.4 7.0 0.2 34.0 2.4 1.3 25.5 0.2 5.5 1.6 5.2 0.7 0.5 8.9 69.0 5.8 139.1 5.1 0.2 15.1 1.9 1.2 2.0 2.1 0.3 17.9 0.2 2.4 10.0 3.5 3.2 1.6 1.6 3.3 35.7 8.6 0.1 2.3 6.6 9.7 5.0 4.2 1.2 11.3 29.6 0.1 93.6 8.1 19.0 8.9 4.1 0.0 6.3 3.7 9.3 1.7 5.9 7.5 6.1 1.9 4.6 3.1 4.2 1.3 4.0 12.2 8.0 2.9 42.0 80.9 6.4 36.2 48.7 32.9 96.3 19.8 50.0 74.3 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favourable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favourable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 8.8 15.4 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 0.0 13.9 0.6 0.3 4.6 2.4 1.9 9.1 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Cell line enhanced" "Detected in many" "EFO-21: 19.0;HUVEC TERT2: 12.1;SCLC-21H: 28.7" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.6 9.2 1.8 0.2 1.7 0.7 3.0 4.7 1.4 0.9 3.6 2.5 0.2 19.0 2.3 0.8 0.7 0.5 1.3 0.0 1.9 0.4 1.6 2.6 2.6 0.1 0.1 2.1 0.2 0.9 0.0 12.1 0.1 0.1 1.3 2.4 0.9 0.1 0.8 7.1 0.2 2.5 0.2 0.4 6.0 28.7 10.8 0.3 0.8 0.1 0.3 0.1 4.3 1.2 3.6 0.3 0.4 0.5 0.2 3.1 6.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA029768: , HPA054359: " "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favourable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 34.5 37.3 26.7 28.4 32.2 20.4 33.4 27.3 24.9 19.2 23.9 20.8 28.9 28.1 42.1 28.5 33.4 37.4 26.2 22.0 38.9 51.7 29.2 68.1 46.7 25.0 44.6 32.5 33.2 35.7 20.4 15.9 23.8 15.8 43.8 26.3 61.1 31.7 42.3 39.4 66.7 32.1 25.4 84.6 57.8 49.2 19.5 25.7 56.1 69.6 37.4 17.6 52.6 30.6 16.4 16.6 34.0 53.2 40.4 50.0 36.8 29.7 53.0 20.2 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA042268: AB_2677922, HPA073212: " "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favourable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.7 19.5 9.6 12.7 7.1 7.1 27.9 8.3 8.4 16.0 12.2 42.2 21.7 12.2 4.4 8.9 18.2 13.9 12.2 10.5 23.6 24.4 11.9 20.7 31.9 15.6 17.4 12.9 9.0 11.9 10.9 14.9 12.0 8.3 23.1 11.8 20.9 17.3 20.0 24.8 16.2 24.5 14.2 12.7 22.0 24.7 7.0 7.8 10.4 28.1 14.5 5.8 16.6 8.4 12.2 24.8 11.1 19.1 4.5 5.3 20.1 12.7 10.8 13.3 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054364 Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA054364: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favourable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 27.7 20.5 25.7 22.9 18.3 19.9 35.8 21.4 15.9 21.6 17.8 17.8 22.6 46.0 35.2 15.4 23.0 44.7 25.4 17.1 26.0 51.6 24.7 36.8 87.3 19.2 45.7 20.5 18.4 35.4 15.9 17.2 27.4 51.6 23.4 23.3 42.0 35.4 69.6 66.8 47.7 48.7 28.9 62.5 19.8 25.0 35.4 27.6 23.9 43.9 40.0 35.4 38.3 21.5 19.8 20.9 19.2 29.3 29.9 43.4 51.5 22.2 37.1 22.4 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA063737: " "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favourable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.9 56.7 46.1 29.7 30.2 22.6 21.1 34.5 19.4 20.5 19.0 34.1 47.6 25.3 32.1 19.3 35.0 26.3 28.0 18.5 39.7 60.3 48.9 89.0 40.7 24.0 38.6 28.0 27.8 17.0 21.4 19.0 18.2 26.5 52.0 28.0 105.8 38.1 34.6 23.3 69.5 34.1 43.8 37.5 51.0 69.3 30.8 22.4 67.6 41.1 43.8 61.6 60.4 40.7 13.0 24.8 26.1 23.0 41.1 64.2 56.1 39.3 28.6 26.9 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051377: " "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favourable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.1 24.0 52.4 38.7 39.3 34.9 30.0 26.2 31.1 29.6 51.8 41.2 31.4 44.9 36.2 20.4 21.4 42.1 24.7 52.3 73.7 23.0 57.3 58.2 30.6 35.3 30.9 43.6 36.5 29.5 18.1 46.1 38.7 37.9 42.9 122.1 55.4 91.2 55.7 76.7 31.9 23.4 72.2 62.2 81.9 48.9 48.3 41.0 67.2 35.9 29.2 40.5 38.5 41.0 24.2 48.4 51.5 36.2 67.3 54.9 62.5 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051739 Enhanced Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA051739: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favourable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.9 37.9 45.3 45.4 28.7 34.2 36.9 29.2 38.8 38.0 42.0 36.8 39.9 26.4 59.3 32.7 50.3 34.9 37.2 28.7 40.4 40.3 40.8 39.8 37.0 17.4 35.8 48.3 30.8 49.7 18.5 24.4 47.4 24.1 40.6 40.8 40.7 70.8 51.9 36.1 103.9 41.0 25.9 58.0 61.6 32.5 51.1 52.4 34.2 38.4 62.2 64.7 57.2 36.3 33.7 44.3 14.2 40.7 50.2 45.2 79.8 53.1 50.4 45.5 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favourable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.2 6.5 16.3 19.7 21.5 29.0 22.1 14.8 18.7 21.2 21.4 19.6 17.0 20.4 44.9 12.5 25.8 17.6 19.6 21.4 42.1 14.7 21.9 11.9 16.3 19.8 26.1 17.4 26.7 25.4 11.9 19.9 24.3 18.4 29.7 22.7 16.6 15.0 20.3 23.5 26.5 16.7 18.9 63.1 38.3 18.0 11.6 19.5 9.0 50.6 34.9 77.1 42.6 15.6 14.0 13.3 19.1 35.2 39.5 40.9 30.1 22.6 28.0 19.9 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004484 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favourable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 21.9 18.6 19.3 16.1 16.6 15.9 11.0 18.8 27.1 25.8 32.2 20.3 25.6 10.9 15.6 21.3 26.2 19.7 22.1 13.7 42.3 15.5 30.8 31.1 16.5 37.9 20.2 16.2 14.3 10.2 17.0 17.0 22.6 17.8 17.5 35.2 25.9 49.2 26.3 31.0 31.7 26.7 21.1 23.2 18.0 20.8 15.0 14.0 24.1 24.8 26.9 36.3 11.9 16.2 18.2 18.8 24.7 20.4 27.0 28.4 16.5 29.2 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Approved Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: " "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favourable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 26.2 28.2 14.4 28.8 18.0 18.1 26.9 16.4 15.8 25.7 17.2 53.3 31.8 48.5 34.6 14.1 35.4 30.3 25.6 8.1 24.6 23.9 19.9 38.3 26.3 25.5 27.0 22.2 26.8 24.8 20.9 18.7 22.7 36.1 39.7 15.6 39.4 31.5 53.5 14.1 35.5 36.6 27.9 78.7 20.8 19.7 22.9 21.6 20.7 72.5 54.7 36.8 27.5 18.0 24.9 18.6 35.4 17.2 38.8 22.1 24.2 29.0 28.6 23.9 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell line enhanced" "Detected in many" "HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.2 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 1.0 0.0 0.1 0.0 4.7 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 4.1 4.4 0.0 4.9 6.4 3.1 0.9 0.1 0.0 4.0 0.0 0.0 0.0 4.1 4.4 0.1 0.0 2.1 0.0 0.2 1.5 3.9 3.8 0.0 1.6 6.1 3.7 3.2 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097859 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol Vesicles Cytosol "HPA053980: , HPA063300: " "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 7.5 19.1 25.5 9.2 34.1 6.5 10.5 45.9 53.2 11.9 13.1 9.6 5.1 12.1 8.4 8.1 9.3 12.0 7.8 9.4 27.6 36.8 12.5 11.1 8.5 6.0 19.2 22.1 13.1 17.4 16.3 17.9 11.6 32.5 12.7 13.3 11.1 10.9 10.1 5.0 5.9 11.8 9.0 9.6 7.0 12.0 10.0 7.5 5.3 9.6 4.4 8.0 8.9 5.8 7.0 8.9 25.4 14.3 6.8 12.0 8.5 10.7 9.7 7.1 9.7 16.3 12.4 15.8 23.1 14.0 19.4 19.5 21.0 12.3 5.5 4.0 11.0 7.5 18.8 12.1 16.6 14.7 14.8 6.0 12.5 10.5 14.8 5.6 17.6 15.8 14.7 21.3 26.6 14.0 13.8 8.1 20.5 13.1 9.4 1.8 19.1 9.0 3.7 17.0 5.1 13.4 16.2 11.3 8.8 11.4 16.3 9.0 5.5 4.9 13.6 9.4 18.9 11.0 15.9 5.4 9.4 11.1 16.4 6.2 13.7 18.5 11.5 25.4 8.4 11.5 9.4 6.6 7.9 8.6 8.9 7.0 9.5 8.8 18.8 6.8 14.3 4.8 12.0 8.5 25.5 34.1 45.9 47.0 27.6 36.8 19.2 22.1 32.5 7.5 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889228 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 11.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" 3400000 "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 29.5 28.2 7.9 15.6 7.7 5.6 38.0 4.5 9.0 24.2 34.0 9.3 22.3 24.2 23.2 27.4 33.6 16.7 54.1 21.9 10.5 8.1 29.0 53.7 39.6 23.0 8.2 6.8 25.5 20.6 22.5 15.9 45.8 11.2 25.8 14.8 22.9 24.4 28.9 14.6 18.3 42.9 13.8 8.4 31.4 26.2 38.7 5.8 3.8 32.2 19.2 24.1 21.6 31.4 0.0 3.3 11.5 2.6 0.0 0.3 0.7 17.8 21.4 27.7 32.7 14.0 8.5 32.2 15.3 18.9 27.1 31.3 44.1 39.3 0.1 20.7 17.7 24.5 24.5 12.6 21.6 0.7 12.8 10.8 7.4 28.5 33.7 0.1 29.0 14.9 5.1 12.9 10.5 35.0 17.6 0.1 13.5 32.5 0.1 1.2 23.0 6.4 1.0 9.4 0.7 32.1 22.1 1.3 3.7 19.0 28.9 6.5 22.5 10.6 34.9 7.4 26.3 5.5 11.2 2.2 6.4 0.1 13.6 2.3 19.3 1.5 2.6 11.5 0.0 0.9 0.3 0.0 0.1 0.0 3.3 0.0 0.0 0.0 2.4 0.0 0.5 0.3 0.0 0.7 7.9 7.7 4.5 9.0 10.5 8.1 8.2 6.8 11.2 5.8 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavourable (1.94e-4)" "prognostic unfavourable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.4 8.9 15.4 9.4 7.7 6.9 10.9 46.8 16.6 21.6 18.7 5.8 5.0 8.3 4.5 37.4 12.1 10.4 10.8 29.2 15.9 8.9 10.4 5.9 5.1 6.4 14.1 9.4 5.1 8.9 13.1 10.2 10.5 6.0 6.1 15.4 5.5 25.7 6.4 8.5 28.5 13.6 15.7 8.2 8.8 8.8 4.8 8.5 13.1 7.4 8.1 10.0 5.0 7.5 13.6 10.5 9.7 11.0 6.0 7.3 11.1 4.2 7.2 16.4 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 NEDD8 Nedd-8 ENSG00000129559 "Neural precursor cell expressed, developmentally down-regulated 8" Q15843 14 24216852-24232454 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol 5700000 Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: , HPA060254: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 38.2 48.1 55.5 30.7 58.1 34.6 42.2 34.1 62.4 41.0 36.3 26.8 32.6 25.0 32.2 59.9 40.3 34.3 31.3 50.7 47.1 49.5 46.5 48.4 30.5 31.5 49.4 54.6 34.3 33.4 101.1 31.3 39.7 45.5 31.6 40.0 27.4 37.2 40.7 70.7 36.5 28.4 43.0 36.0 34.9 29.9 25.7 34.3 26.9 37.5 44.7 46.8 30.7 32.0 60.2 76.1 90.2 60.1 43.2 64.1 89.9 25.5 44.8 36.5 25.7 41.4 36.2 26.5 35.0 37.1 41.2 38.1 30.9 31.3 22.1 20.5 49.2 27.0 36.3 54.6 58.0 31.2 22.0 23.6 41.3 105.3 36.0 39.0 24.7 38.4 36.3 34.7 27.3 49.2 21.0 25.9 63.5 56.9 31.0 37.0 26.9 52.5 22.1 28.9 22.5 47.5 48.7 15.4 35.9 30.2 30.8 25.1 18.6 31.0 36.8 23.5 23.6 30.0 30.9 30.8 46.4 32.0 16.8 22.5 22.2 73.5 57.9 90.2 46.8 60.1 50.7 60.2 54.4 51.9 56.9 51.1 51.2 52.0 62.2 43.2 59.0 76.1 64.1 89.9 55.5 58.1 34.1 62.4 47.1 49.5 49.4 54.6 45.5 34.3 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell line enhanced" "Detected in many" "EFO-21: 49.0;HSkMC: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009720, HPA038768, HPA039270" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "CAB009720: , HPA038768: , HPA039270: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.0 9.3 0.1 6.4 0.8 9.8 2.3 2.8 4.3 8.0 3.2 0.6 3.1 49.0 5.0 4.3 12.5 4.7 5.6 1.4 0.3 0.3 1.5 21.1 3.0 3.3 0.1 24.5 1.4 2.8 0.4 7.3 0.0 2.6 9.7 0.4 1.9 1.3 1.4 1.0 0.5 0.2 1.8 2.1 13.7 0.2 1.7 0.4 11.0 19.0 0.8 2.6 18.6 2.9 5.2 0.3 5.6 2.8 11.3 3.9 0.0 2.7 12.7 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Group enriched" "Detected in some" 5 "HEK 293: 112.2;PC-3: 30.1" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nuclear speckles,Intermediate filaments" "Nuclear speckles" "Intermediate filaments" "HPA014850: AB_1854397, HPA015021: " "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 112.2 0.0 0.0 0.0 4.9 0.0 0.1 1.8 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.8 30.1 0.0 0.0 0.0 6.9 1.0 6.2 6.4 2.6 0.0 0.4 0.0 0.0 0.0 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;TIME: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.4 0.2 15.8 12.5 0.1 11.0 4.1 6.1 7.4 0.1 0.1 0.2 0.1 12.1 0.3 0.0 0.0 13.2 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.0 0.0 5.1 0.9 7.1 0.1 0.5 11.2 0.1 0.1 0.2 1.8 6.3 7.6 11.8 0.2 1.0 0.2 0.8 1.0 3.8 0.1 0.1 0.1 0.2 16.1 1.3 13.4 0.6 13.6 0.3 0.2 0.1 3.0 7.3 4.7 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 NEIL2 "FLJ31644, MGC2832, MGC4505, NEH2" ENSG00000154328 "Nei like DNA glycosylase 2" Q969S2 8 11769639-11787346 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA073029, HPA073916" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073029: , HPA073916: " "unprognostic (1.52e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (9.88e-2)" "unprognostic (2.18e-2)" "unprognostic (5.72e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (5.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.29e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (4.05e-1)" 10.2 21.8 18.7 6.8 17.7 2.7 10.3 11.8 20.9 11.3 5.6 9.0 7.0 3.6 9.9 15.4 6.5 17.9 6.9 14.2 15.4 20.0 9.3 11.0 7.7 8.4 18.4 16.1 12.6 10.9 7.8 13.2 7.6 20.3 10.5 6.1 9.7 11.5 10.3 24.7 18.1 4.6 10.2 12.3 9.5 5.1 26.8 13.3 1.8 15.5 7.1 7.9 7.4 15.8 14.7 5.5 0.8 2.5 9.1 13.6 4.7 5.1 14.5 9.1 17.7 4.4 8.1 4.1 8.2 6.8 8.0 5.5 4.4 5.6 2.0 3.2 9.8 4.5 8.6 9.0 11.0 6.0 4.3 7.1 3.4 8.6 3.5 3.0 5.3 7.2 13.3 6.9 6.4 7.4 9.9 6.9 9.4 5.4 0.5 3.2 8.1 7.8 8.9 11.7 5.5 9.2 7.7 14.0 11.1 6.4 3.4 11.6 5.4 0.5 9.1 9.1 13.1 2.4 11.4 6.5 13.5 3.6 23.9 10.5 18.4 0.4 1.5 0.1 9.1 2.5 12.1 14.7 9.3 10.8 3.0 11.4 13.6 12.0 0.8 9.1 1.1 5.5 5.8 4.7 18.7 17.7 11.8 19.8 15.4 20.0 18.4 16.1 20.3 13.3 NEK1 "KIAA1901, NY-REN-55" ENSG00000137601 "NIMA related kinase 1" Q96PY6 4 169392857-169612629 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020873, HPA040413" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" Cytosol "Nucleoplasm, Centriolar satellite" "HPA020873: AB_10671583, HPA040413: AB_10671169" "unprognostic (4.10e-2)" "unprognostic (2.97e-1)" "unprognostic (1.59e-2)" "unprognostic (1.97e-1)" "unprognostic (6.98e-2)" "unprognostic (3.10e-1)" "unprognostic (3.95e-1)" "unprognostic (3.29e-1)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "unprognostic (4.06e-3)" "unprognostic (2.21e-1)" "prognostic favourable (1.42e-4)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.10e-2)" "unprognostic (3.46e-1)" 9.6 10.5 13.5 9.2 15.8 6.0 8.7 20.7 14.5 13.6 8.4 12.5 7.1 5.4 12.4 9.1 7.9 15.7 10.2 11.4 13.7 13.2 10.2 6.9 7.7 8.0 15.9 11.3 16.3 6.6 15.3 16.5 7.2 16.0 11.6 7.7 8.9 6.4 10.6 7.1 4.7 5.7 11.1 18.2 8.0 8.1 18.3 14.8 14.7 13.3 6.4 7.4 10.0 8.2 4.5 3.3 6.7 3.3 2.2 5.3 1.3 4.2 1.9 7.8 8.4 12.1 13.6 2.5 9.0 8.1 7.2 6.9 2.4 5.1 11.3 1.7 7.8 1.4 7.3 7.6 8.2 12.4 5.0 7.6 7.8 2.9 7.2 7.7 6.1 10.8 4.4 7.3 12.9 7.0 13.5 21.6 9.2 2.7 9.9 3.4 2.5 4.5 6.1 5.1 3.6 7.6 5.0 8.5 9.7 6.5 3.2 6.0 4.0 3.4 8.4 4.6 4.2 4.8 6.0 8.7 13.4 8.7 7.6 3.8 8.0 6.7 2.1 1.8 4.4 3.3 4.8 4.4 3.4 2.7 1.5 4.5 5.1 5.3 1.1 2.2 1.6 3.3 3.2 1.3 13.5 15.8 20.7 12.9 13.7 13.2 15.9 11.3 16.0 14.8 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell line enhanced" "Detected in many" "BJ: 7.6;LHCN-M2: 10.5;U-2 OS: 8.9" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favourable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.0 1.0 1.2 0.9 2.0 0.4 7.6 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.4 0.5 3.2 0.1 1.4 0.1 0.7 10.5 0.1 0.8 0.5 0.7 0.3 1.0 0.4 0.3 4.0 0.6 0.2 0.2 1.2 0.4 0.6 6.1 0.4 0.9 5.6 8.9 0.3 0.7 0.3 0.2 0.5 4.8 0.8 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0;testis: 41.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Low region specificity" "Detected in all" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: " "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavourable (9.47e-6)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 1.1 0.7 0.6 6.7 0.5 7.4 1.3 0.3 0.9 0.9 2.5 0.3 0.3 3.4 0.3 1.2 4.2 0.7 1.4 0.9 1.0 0.3 0.6 0.6 1.0 3.9 0.3 0.3 0.6 0.3 0.0 0.3 1.2 0.4 0.9 3.6 0.4 1.0 0.3 0.3 1.8 3.0 0.6 0.6 1.6 1.1 41.0 0.4 14.0 0.3 1.5 4.8 0.6 1.6 1.8 0.9 2.7 0.5 3.9 4.3 0.9 30.3 21.9 16.8 12.0 1.0 1.7 18.5 11.7 11.0 20.7 17.8 11.7 29.8 16.1 5.7 9.0 16.3 14.5 8.8 26.1 24.6 12.1 7.7 19.1 15.7 0.1 15.2 10.5 0.5 1.0 15.9 17.2 13.2 21.1 28.4 20.7 8.4 16.5 10.3 15.9 11.2 16.4 25.7 24.5 7.2 8.7 15.2 16.9 16.9 19.0 14.7 29.2 9.1 6.9 10.3 20.5 20.3 31.4 11.8 21.7 21.3 9.0 11.7 17.1 2.7 0.5 0.4 0.5 0.3 0.2 1.5 0.6 0.3 0.1 1.8 1.1 0.7 2.4 3.9 0.4 0.9 4.3 0.9 0.6 0.5 0.3 0.9 1.0 0.3 0.3 0.3 0.4 0.4 NEK6 SID6-1512 ENSG00000119408 "NIMA related kinase 6" Q9HC98 9 124257606-124353307 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045993, HPA056828" Approved Supported "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite, Cytosol" "CAB045993: AB_2150651, HPA056828: " "unprognostic (6.27e-2)" "unprognostic (1.02e-2)" "unprognostic (4.15e-2)" "unprognostic (1.65e-2)" "unprognostic (5.22e-2)" "unprognostic (2.47e-2)" "unprognostic (3.13e-3)" "unprognostic (2.13e-2)" "unprognostic (2.38e-1)" "unprognostic (3.30e-2)" "unprognostic (1.38e-3)" "unprognostic (6.53e-2)" "unprognostic (5.03e-3)" "unprognostic (1.97e-1)" "prognostic unfavourable (7.66e-4)" "unprognostic (5.27e-2)" "unprognostic (4.77e-3)" 14.8 5.3 26.1 22.2 29.1 12.8 18.8 7.2 21.2 20.5 15.6 13.4 4.3 12.5 9.2 7.5 6.8 8.5 18.4 7.0 17.1 16.6 12.9 51.9 17.0 18.1 19.4 13.3 11.2 20.5 1.6 6.4 21.4 14.7 14.8 16.6 18.5 16.9 13.2 5.5 5.1 18.2 23.4 13.0 11.3 19.0 5.8 12.9 4.0 6.3 1.9 22.0 17.7 10.1 21.9 11.5 29.0 18.8 8.3 3.8 7.6 7.7 12.7 12.3 4.8 23.4 30.4 15.3 9.7 15.6 15.1 12.6 12.1 14.5 9.4 15.6 18.8 1.5 6.3 28.3 10.3 10.3 5.6 25.9 10.7 21.1 27.9 4.6 65.0 40.6 4.6 14.3 14.9 16.4 4.6 0.4 27.0 8.1 0.2 5.1 3.1 11.6 10.0 9.2 4.8 16.2 2.8 5.5 1.9 3.2 6.1 13.8 13.1 19.1 32.1 11.1 11.2 7.6 6.6 2.1 2.6 5.4 13.9 10.6 14.7 10.2 18.8 29.0 3.8 12.3 2.4 21.9 2.3 3.2 11.5 9.0 0.4 1.6 23.4 8.3 14.7 10.6 2.8 7.6 26.1 29.1 7.2 21.2 17.1 16.6 19.4 13.3 14.7 12.9 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982714-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: , HPA043931: " "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 14.8 13.7 18.3 17.2 19.0 20.0 16.5 36.4 23.2 17.0 15.1 22.5 15.7 21.6 19.5 15.1 26.1 21.0 11.4 10.8 16.8 12.2 14.7 10.9 11.4 15.8 14.1 12.0 26.9 27.0 12.5 19.1 16.8 13.6 15.7 8.3 16.2 28.6 28.4 17.4 23.4 21.2 13.3 11.9 18.4 20.6 26.5 18.3 18.0 16.8 10.9 21.6 18.1 19.5 20.5 14.9 12.0 14.0 13.1 18.5 10.3 10.6 9.9 8.6 15.7 3.6 3.7 17.1 5.7 4.1 6.9 5.5 16.3 18.4 18.8 8.3 3.7 10.1 8.7 7.2 3.4 9.6 13.4 12.4 7.3 15.4 5.2 12.8 12.7 3.2 6.4 4.6 4.9 5.2 23.4 9.1 3.0 12.4 24.7 36.8 24.9 14.9 22.6 7.5 11.8 5.0 9.0 23.5 14.6 6.6 7.9 9.7 15.1 9.8 5.9 7.0 8.0 8.1 12.6 19.4 19.9 20.9 8.0 13.5 8.7 6.0 12.3 12.0 14.2 14.0 17.1 14.6 16.3 12.6 11.9 20.5 14.2 11.0 4.7 13.1 11.2 14.9 18.5 10.3 18.3 19.0 36.4 23.2 16.8 12.2 14.1 12.0 13.6 18.3 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" 20 58981208-58995133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262" Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: , HPA066262: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavourable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 9.1 11.1 10.2 9.4 13.0 8.8 12.7 18.1 13.7 10.2 10.8 15.2 9.2 8.4 11.2 8.2 14.6 12.5 8.6 9.2 10.9 8.2 16.4 15.9 7.9 11.2 16.7 13.4 15.4 10.3 19.1 18.1 12.1 12.5 10.2 8.9 9.4 14.7 9.1 12.0 11.9 8.8 8.1 11.8 9.2 8.9 26.1 12.4 17.4 14.4 10.0 13.6 9.8 11.3 22.7 29.6 9.4 27.7 19.4 24.6 20.5 12.5 14.5 17.5 18.6 6.0 10.7 11.2 10.2 10.0 31.0 18.0 48.0 18.1 16.6 16.1 10.2 22.0 23.4 25.8 25.1 5.1 16.6 21.9 18.2 37.5 7.2 15.6 15.0 11.3 8.3 11.3 7.9 17.8 29.0 12.7 14.1 49.9 33.7 23.6 10.1 32.2 18.9 14.5 30.7 13.0 19.5 19.3 28.7 31.9 38.5 21.2 41.5 18.3 7.1 23.9 22.7 9.3 16.9 10.1 18.6 16.9 14.2 13.9 20.6 7.2 20.4 9.4 20.3 22.8 23.9 22.7 19.3 24.6 29.6 20.0 18.9 19.9 2.2 19.4 27.7 15.0 17.6 20.5 10.2 13.0 18.1 13.7 10.9 8.2 16.7 13.4 12.5 12.4 NELFE "D6S45, NELF-E, RD, RDBP, RDP" ENSG00000204356 "Negative elongation factor complex member E" P18615 6 31952087-31959110 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007187, HPA007594, HPA046502" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA007187: AB_1856161, HPA007594: , HPA046502: AB_2679677" "unprognostic (1.09e-1)" "unprognostic (3.28e-1)" "unprognostic (1.45e-1)" "unprognostic (6.33e-3)" "unprognostic (4.43e-2)" "unprognostic (4.25e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.97e-1)" "unprognostic (7.78e-2)" "prognostic unfavourable (2.70e-4)" "unprognostic (5.21e-2)" "unprognostic (1.07e-1)" "unprognostic (2.21e-1)" "unprognostic (3.68e-2)" 19.4 21.1 18.5 17.6 20.4 18.4 26.8 10.2 18.2 22.8 20.4 19.0 23.5 15.8 20.7 30.2 21.7 30.4 20.4 22.6 18.5 17.0 19.2 13.5 17.0 20.9 18.5 18.7 21.2 46.1 12.4 18.0 23.7 27.5 14.4 17.9 12.7 24.9 22.4 40.4 19.6 18.1 19.5 28.0 16.3 18.1 58.1 18.2 28.3 20.8 16.9 14.7 15.3 18.8 23.6 25.2 28.8 33.4 20.7 22.5 23.4 17.5 12.5 17.6 13.6 6.3 10.3 14.1 13.0 14.1 11.9 6.6 18.9 10.0 13.5 14.6 13.6 12.9 6.2 6.4 7.0 11.5 13.7 8.1 13.5 23.8 10.3 15.7 9.1 9.2 17.4 10.5 19.7 11.0 13.0 16.1 13.5 29.0 23.1 10.3 6.7 4.4 20.6 14.0 21.2 15.0 16.4 11.2 18.5 10.2 11.3 24.5 17.0 30.1 10.1 10.9 22.2 11.6 24.3 26.5 27.4 15.0 7.0 9.9 21.2 20.0 25.4 28.8 21.6 30.5 21.8 23.6 22.2 22.5 25.2 23.6 20.1 20.4 14.5 20.7 33.4 18.5 20.5 23.4 18.5 20.4 10.2 18.2 18.5 17.0 18.5 18.7 27.5 18.2 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49853203 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favourable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 13.6 12.2 15.0 14.8 20.9 30.9 12.5 28.0 22.1 15.0 14.4 14.6 14.4 8.1 14.3 12.2 18.2 11.6 11.2 15.0 16.9 15.0 14.6 11.2 11.6 13.4 21.1 17.2 15.2 13.1 26.4 30.9 15.5 27.9 13.9 12.4 10.7 14.8 14.8 17.4 11.5 15.1 13.9 24.8 14.7 13.7 8.4 23.2 17.0 15.7 9.8 14.5 13.5 13.4 36.1 33.0 28.4 21.9 20.3 26.8 7.8 18.7 21.0 20.1 13.3 22.7 18.4 18.0 23.7 15.7 15.6 15.4 10.7 20.1 5.2 18.2 19.5 26.9 18.9 14.8 25.3 20.9 10.8 20.8 20.0 16.2 13.3 27.1 19.1 16.3 10.9 16.5 15.5 22.2 25.7 19.7 21.3 17.2 16.1 8.9 12.0 21.2 16.7 19.9 11.9 18.4 24.8 13.3 12.4 21.9 23.7 21.9 20.4 17.7 26.2 23.0 20.2 14.9 16.2 14.0 24.9 22.3 8.5 12.9 20.5 27.6 18.2 20.1 20.5 16.3 19.5 32.8 21.0 19.2 15.2 36.1 24.8 26.8 28.4 20.3 21.9 33.0 17.9 7.8 15.0 20.9 28.0 22.1 16.9 15.0 21.1 17.2 27.9 23.2 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.2 21.8 14.4 13.2 3.9 5.4 1.4 1.7 3.6 0.7 2.7 18.4 1.0 2.1 4.0 0.8 15.2 8.3 1.5 6.6 11.2 12.2 0.2 2.5 3.8 0.3 0.4 9.5 15.5 0.7 7.1 0.0 0.0 23.4 0.8 11.2 4.3 0.2 20.8 1.5 10.0 11.7 2.4 6.9 10.0 9.9 14.0 17.1 7.6 9.0 8.0 2.2 0.0 16.8 9.0 5.4 3.9 10.0 18.5 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002440-113019861 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA069654: " "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 15.1 12.3 12.6 12.9 19.8 15.9 15.5 22.8 21.3 14.4 12.8 15.3 11.6 12.3 15.4 19.0 12.7 12.8 13.0 14.0 13.2 12.5 12.4 10.3 11.3 19.3 14.2 13.7 14.8 16.5 13.4 18.2 12.4 15.6 12.4 9.8 11.5 13.5 15.1 28.1 18.2 13.6 16.0 17.5 17.5 14.2 19.1 12.8 21.9 20.0 16.4 15.5 17.5 10.9 3.8 3.4 2.9 3.0 7.9 6.4 2.7 9.9 8.3 13.3 10.0 4.4 8.0 7.1 9.6 6.1 5.3 3.6 7.6 6.6 13.3 5.3 3.1 10.6 9.7 4.3 7.5 2.6 6.1 20.3 7.4 5.6 8.0 12.9 7.5 12.5 7.8 4.4 11.2 4.6 6.9 10.7 3.9 6.4 11.0 7.6 13.9 10.7 9.1 10.6 6.9 6.1 8.9 9.2 13.6 5.5 6.9 15.9 8.0 11.1 9.4 7.5 7.4 2.7 6.8 10.6 8.1 15.6 12.0 10.2 5.3 2.9 2.3 2.7 4.4 3.0 4.5 3.8 5.1 3.7 3.4 3.1 6.4 6.3 1.5 7.9 1.2 2.4 2.2 2.7 12.6 19.8 22.8 21.3 13.2 12.5 14.2 13.7 15.6 12.8 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA020068: " "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.6 11.6 12.9 6.8 3.1 63.7 16.9 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 7.9 32.8 16.3 7.5 13.3 17.9 7.4 15.6 12.7 11.3 21.4 8.0 8.4 14.0 9.9 5.5 14.9 27.7 5.0 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 NEU1 NEU ENSG00000204386 "Neuraminidase 1" Q99519 6 31857659-31862906 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015634, HPA021506" Approved Supported "Vesicles,Cell Junctions" 86000 Vesicles "Cell Junctions" "HPA015634: AB_1854386, HPA021506: AB_1854385" "unprognostic (3.84e-2)" "unprognostic (7.47e-2)" "unprognostic (9.64e-2)" "unprognostic (4.65e-2)" "unprognostic (3.00e-1)" "unprognostic (4.42e-3)" "unprognostic (1.38e-3)" "unprognostic (8.58e-3)" "unprognostic (7.49e-2)" "unprognostic (5.21e-2)" "unprognostic (4.44e-3)" "unprognostic (1.27e-1)" "unprognostic (2.70e-2)" "unprognostic (6.22e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (2.13e-3)" 10.5 30.2 8.6 9.4 11.1 5.2 10.5 15.5 14.6 13.4 14.1 7.4 16.1 14.1 9.8 13.9 9.0 8.3 16.1 9.8 8.0 9.5 29.7 24.2 16.1 7.2 9.4 6.6 12.7 20.6 13.6 16.5 19.8 10.3 15.1 9.1 14.7 18.1 13.8 10.0 9.1 23.5 9.8 4.7 13.4 12.7 6.5 10.0 5.8 22.7 7.0 9.6 13.6 9.5 4.2 7.7 15.2 13.4 3.0 5.1 7.4 2.9 3.0 3.0 6.9 10.1 3.8 5.9 2.7 9.3 8.1 11.8 17.4 3.3 1.0 7.0 3.6 1.7 6.3 2.5 3.1 2.5 4.2 1.5 1.8 20.3 18.1 1.9 8.5 6.3 4.7 9.7 5.0 7.2 3.2 7.2 4.1 5.3 1.6 2.9 2.3 2.4 2.1 1.6 10.4 13.3 6.5 2.3 1.3 3.0 4.0 7.1 7.7 8.7 3.0 5.3 3.1 7.4 4.8 8.9 14.2 2.1 3.9 4.8 3.7 6.4 13.4 8.7 5.1 10.3 4.2 3.9 3.9 4.1 7.7 4.2 4.0 3.9 15.2 3.0 9.2 4.3 4.8 7.4 8.6 11.1 15.5 14.6 8.0 9.5 9.4 6.6 10.3 10.0 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988134-75018893 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038729: , HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favourable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 5.4 13.4 3.7 10.5 6.9 17.0 5.4 7.9 9.1 4.0 3.9 3.0 4.1 3.6 5.4 4.8 3.9 4.4 3.6 5.9 4.0 4.5 4.3 6.7 8.7 9.0 3.8 6.6 7.2 7.3 15.1 11.2 3.1 4.2 9.7 5.4 5.6 4.8 4.6 19.1 6.7 4.7 4.0 3.5 5.5 5.1 44.6 3.0 19.0 6.8 3.5 7.5 4.5 3.1 3.2 3.8 5.8 6.4 1.2 4.2 2.2 4.6 4.0 3.4 6.6 2.6 2.5 3.8 4.5 2.9 5.2 4.0 13.7 3.9 13.3 4.6 3.6 4.3 8.3 5.8 7.9 7.0 4.4 11.0 7.5 5.6 2.9 17.2 10.6 3.0 4.9 5.2 8.1 3.7 17.7 10.0 5.9 5.0 16.9 8.9 4.2 5.4 14.9 9.0 11.7 6.4 4.9 6.3 4.0 6.9 4.6 20.3 9.9 4.5 5.6 6.5 6.5 4.3 4.5 8.3 8.0 26.7 1.9 8.9 5.5 2.1 6.4 5.8 4.1 3.7 3.0 2.8 3.2 3.9 3.8 3.2 3.5 4.2 3.3 1.2 4.6 2.7 2.3 2.2 3.7 6.9 7.9 9.1 4.0 4.5 3.8 6.6 4.2 3.0 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Cell line enriched" "Detected in some" 5 "THP-1: 15.0" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 9 "HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: " "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 9.3 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favourable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 11.8 12.4 23.6 11.1 20.1 10.0 15.4 20.8 28.1 10.8 9.7 9.0 11.8 7.8 10.5 11.3 14.2 11.3 8.0 19.7 26.6 16.4 13.5 11.1 11.9 24.1 18.0 13.5 11.0 12.9 46.8 8.6 6.9 11.4 10.2 8.7 9.5 9.3 15.4 25.7 12.1 8.5 11.9 10.7 10.4 8.8 21.6 10.1 14.9 15.6 11.5 9.9 10.6 10.2 8.5 13.6 6.6 17.3 11.6 15.0 9.8 26.3 10.6 3.7 24.3 7.3 7.3 3.6 21.4 12.1 23.5 20.3 10.5 6.5 7.0 17.8 22.0 9.3 7.7 12.4 21.1 10.2 6.1 8.3 7.9 7.5 7.8 11.9 9.9 6.7 5.7 16.6 20.3 16.5 4.0 6.5 22.8 11.0 7.2 4.7 2.8 10.1 7.5 20.0 6.7 23.8 12.3 5.8 4.0 12.3 8.3 4.8 5.3 4.8 30.6 35.0 39.9 15.2 36.1 10.2 8.1 8.4 9.3 4.7 22.3 6.6 9.5 3.6 15.0 13.5 12.8 8.2 11.3 10.1 13.6 8.5 9.8 9.2 2.3 11.6 17.3 9.3 9.4 9.8 23.6 20.1 20.8 28.1 26.6 16.4 18.0 13.5 11.4 10.1 NFAT5 "KIAA0827, NF-AT5, NFATL1, NFATZ, OREBP, TONEBP" ENSG00000102908 "Nuclear factor of activated T cells 5" O94916 16 69565094-69704666 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057304, HPA069711" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057304: , HPA069711: " "unprognostic (2.71e-1)" "unprognostic (1.50e-2)" "unprognostic (1.77e-1)" "unprognostic (3.57e-2)" "unprognostic (5.65e-3)" "unprognostic (2.08e-1)" "unprognostic (2.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (3.56e-2)" "unprognostic (4.05e-3)" "unprognostic (1.87e-1)" "prognostic favourable (1.08e-4)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (6.32e-2)" "unprognostic (9.42e-2)" 15.4 19.1 19.0 17.0 17.1 25.1 15.8 22.4 18.0 19.3 11.9 11.9 12.5 7.7 18.7 19.5 15.7 15.0 11.7 11.6 15.6 8.2 15.7 10.2 15.6 10.5 13.0 12.7 15.6 13.8 35.6 24.2 30.8 13.1 14.7 12.8 13.9 20.1 15.6 12.1 26.5 14.0 12.5 10.5 11.6 12.0 10.1 14.4 10.3 21.9 7.7 10.8 19.6 30.4 2.1 2.9 5.5 4.6 1.1 2.6 0.5 11.0 14.5 7.1 8.8 10.7 12.9 7.8 11.5 13.8 12.2 8.9 10.9 9.1 5.0 6.8 13.9 9.6 6.3 6.5 12.8 2.9 2.5 4.0 5.3 13.4 8.7 3.9 7.5 9.0 4.4 9.2 11.3 11.9 7.7 2.7 11.2 4.9 2.9 5.6 4.2 1.7 5.2 3.1 2.8 11.7 19.0 3.9 2.4 24.7 2.7 6.8 5.4 3.1 14.8 10.7 6.6 5.7 3.9 5.8 4.5 8.9 7.1 3.3 6.3 3.5 1.3 1.4 2.2 0.8 1.6 2.1 1.1 2.6 0.6 1.9 0.9 0.8 5.5 1.1 4.6 2.9 1.6 0.5 19.0 17.1 22.4 18.0 15.6 8.2 13.0 12.7 13.1 14.4 NFATC1 "NF-ATC, NFAT2, NFATc" ENSG00000131196 "Nuclear factor of activated T cells 1" O95644 18 79395856-79529325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004513, HPA071732" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "CAB004513: AB_628011, HPA071732: " "unprognostic (3.53e-2)" "unprognostic (2.16e-3)" "unprognostic (3.08e-3)" "unprognostic (3.40e-2)" "unprognostic (4.54e-2)" "unprognostic (2.79e-2)" "unprognostic (1.92e-1)" "unprognostic (4.85e-3)" "unprognostic (7.02e-2)" "unprognostic (8.37e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (5.87e-2)" "unprognostic (1.38e-1)" "unprognostic (4.54e-2)" "unprognostic (5.04e-2)" "unprognostic (3.11e-3)" 12.2 4.2 4.0 35.4 4.0 4.1 9.2 2.7 3.9 9.3 7.6 5.4 7.0 3.7 10.7 6.5 5.9 7.0 11.8 13.4 3.2 2.9 4.7 2.9 13.9 21.9 4.3 2.2 7.0 8.3 6.4 3.3 4.8 11.4 6.4 2.1 9.9 5.5 9.0 27.9 8.6 10.8 12.0 5.9 16.9 6.0 7.1 4.6 21.1 6.8 15.2 27.0 13.2 14.2 11.3 3.2 7.1 13.4 2.1 6.9 4.9 0.0 2.2 1.1 2.0 1.9 2.1 3.9 1.3 0.1 0.3 0.2 0.2 2.0 12.0 0.8 1.7 0.2 5.5 0.0 0.4 8.3 4.6 8.4 0.5 0.0 4.2 2.6 4.6 2.5 0.0 0.7 0.1 6.8 6.7 2.5 1.3 4.6 6.9 0.9 1.9 1.5 2.3 1.4 2.7 1.0 0.9 0.0 0.0 1.9 1.4 3.1 1.8 10.8 6.3 2.8 12.1 0.0 0.1 0.0 0.0 33.7 0.0 3.6 5.2 1.9 3.4 7.1 4.4 9.2 4.7 8.6 6.9 6.2 3.2 11.3 6.0 4.1 3.0 2.1 13.4 3.1 5.0 4.9 4.0 4.0 2.7 3.9 3.2 2.9 4.3 2.2 11.4 4.6 NFATC2 "NF-ATP, NFAT1, NFATp" ENSG00000101096 "Nuclear factor of activated T cells 2" Q13469 20 51386957-51562831 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.6" "Cell line enhanced" "Detected in many" "HDLM-2: 14.2;HMC-1: 16.3;WM-115: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008789, CAB018567, HPA024369" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413" "unprognostic (2.69e-3)" "unprognostic (2.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (4.05e-2)" "unprognostic (9.26e-2)" "unprognostic (3.74e-3)" "unprognostic (2.17e-2)" "unprognostic (4.86e-2)" "prognostic unfavourable (1.57e-4)" "unprognostic (9.25e-2)" "unprognostic (1.02e-1)" "unprognostic (1.05e-2)" "unprognostic (6.59e-2)" 8.6 2.4 4.1 44.6 8.2 4.4 9.8 1.1 5.1 8.4 7.8 6.8 3.9 8.4 7.0 7.6 4.0 5.6 19.4 8.5 4.1 3.3 3.4 6.7 6.1 25.2 8.4 0.7 5.0 8.7 3.9 3.7 8.1 10.4 5.4 4.1 6.2 7.9 7.2 5.4 7.0 11.7 5.9 6.5 16.0 11.0 4.5 6.5 8.6 7.0 13.2 18.7 4.5 4.9 1.6 1.7 3.8 0.7 7.6 7.7 1.6 1.5 1.7 0.0 2.1 0.0 0.0 4.5 0.2 1.1 0.7 0.3 8.2 1.5 10.9 1.3 0.5 0.0 0.5 0.0 0.6 14.2 0.2 4.6 1.2 2.1 0.0 1.3 16.3 0.0 0.0 0.6 0.0 5.0 4.5 7.3 0.0 1.8 1.9 7.7 0.1 3.9 0.8 0.0 4.8 0.2 0.0 0.1 0.0 5.1 1.2 11.9 2.0 3.1 0.5 1.0 1.9 2.5 0.1 6.2 4.0 11.2 1.0 5.1 24.5 0.3 0.0 3.8 7.7 0.7 3.2 1.6 4.3 6.1 1.7 1.6 2.4 4.4 0.2 7.6 0.2 0.6 2.3 1.6 4.1 8.2 1.1 5.1 4.1 3.3 8.4 0.7 10.4 6.5 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 129.5" "Cell line enhanced" "Detected in all" "HMC-1: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050665: " "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 9.6 6.8 4.3 16.0 6.6 12.0 7.8 7.5 5.8 9.8 11.0 9.7 7.6 7.1 12.2 6.5 7.7 8.3 7.6 7.0 4.7 4.0 8.2 12.1 11.3 14.2 8.7 3.5 10.0 7.0 18.7 6.8 6.6 5.1 10.5 6.1 11.1 7.9 7.6 27.1 14.0 12.0 9.0 6.7 12.3 6.2 25.9 5.8 129.5 11.0 8.1 16.0 10.2 14.1 6.7 3.1 12.0 7.1 13.4 15.6 9.0 4.9 5.8 9.4 10.3 8.4 5.4 8.6 3.2 4.0 9.1 7.9 8.4 4.4 16.5 4.9 5.3 7.4 11.7 5.5 8.9 3.4 7.6 16.2 6.1 18.9 5.6 14.5 42.7 4.1 7.1 9.2 5.0 7.6 20.9 4.7 6.7 9.9 22.3 19.7 6.1 3.1 12.7 9.0 17.0 3.9 5.7 7.1 7.6 24.0 6.1 3.1 8.4 11.0 4.8 4.7 5.1 5.4 4.8 6.5 11.2 30.0 3.6 13.5 6.5 12.0 2.4 5.3 15.6 3.7 14.8 5.2 8.9 15.2 2.9 6.7 9.1 14.0 3.3 13.4 7.1 3.1 6.0 9.0 4.3 6.6 7.5 5.8 4.7 4.0 8.7 3.5 5.1 5.8 NFATC4 NFAT3 ENSG00000100968 "Nuclear factor of activated T cells 4" Q14934 14 24365673-24379604 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.7;BJ hTERT+: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA031641, CAB032859, HPA076526" Uncertain Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: " "unprognostic (3.51e-1)" "unprognostic (5.61e-2)" "prognostic unfavourable (5.84e-4)" "unprognostic (8.08e-2)" "unprognostic (1.67e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-1)" "unprognostic (9.11e-2)" "prognostic unfavourable (1.81e-6)" "unprognostic (1.47e-2)" "unprognostic (1.07e-1)" "unprognostic (1.35e-1)" "unprognostic (4.19e-2)" 9.0 11.3 4.3 5.5 6.7 0.4 10.9 4.2 5.1 28.2 14.0 3.3 8.9 3.4 19.0 11.4 9.1 13.8 21.6 7.8 4.9 1.3 6.4 0.9 5.6 3.3 8.0 4.1 33.1 2.7 8.4 8.6 14.0 6.3 14.8 3.9 9.3 4.0 13.5 4.6 6.9 5.9 20.9 2.8 4.2 7.7 9.6 3.1 1.5 11.0 5.9 5.8 22.3 14.7 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 13.4 19.7 0.0 8.8 25.4 12.0 10.5 0.0 7.4 7.4 0.2 12.6 0.0 3.6 0.1 7.3 0.0 0.3 5.7 9.2 0.0 6.5 0.0 0.0 14.2 0.1 7.2 0.0 9.3 1.8 0.0 2.3 0.4 0.0 0.8 1.1 0.0 0.5 0.8 1.0 0.0 0.1 1.5 6.3 0.0 1.7 2.9 5.3 2.3 5.3 11.2 2.3 10.5 0.0 5.4 0.7 5.2 2.3 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 6.7 4.2 5.1 4.9 1.3 8.0 4.1 6.3 3.1 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2" "Group enriched" "Detected in some" 4 "HEL: 83.6;K-562: 36.2;NB-4: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 119.7;neutrophil: 80.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 119.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 2.3 0.3 0.9 3.5 1.5 54.3 0.5 0.4 1.7 0.9 0.4 0.2 0.0 0.5 0.4 0.4 0.7 2.0 0.9 7.8 1.5 0.4 0.9 2.6 9.6 20.9 5.2 0.2 1.2 0.6 1.2 0.8 15.9 1.2 1.0 0.3 1.2 0.5 0.2 1.0 2.9 0.5 1.1 1.0 32.2 0.7 0.9 0.7 1.8 1.7 0.2 0.5 1.2 8.1 0.0 15.2 119.7 23.1 0.0 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.1 0.2 1.1 2.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.2 1.9 0.0 1.2 11.0 0.1 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 3.3 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 119.7 23.1 21.7 0.0 6.4 0.1 0.0 0.0 0.0 15.2 0.0 0.1 0.0 80.0 0.0 3.8 0.2 0.0 12.9 0.9 1.5 0.4 1.7 1.5 0.4 5.2 0.2 1.2 0.7 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061487 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 194.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA063384: , HPA065424: " "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favourable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favourable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 24.2 25.7 15.5 13.1 15.5 4.6 50.3 9.1 19.8 18.8 17.5 17.4 32.3 17.4 31.4 30.5 21.4 22.7 16.3 85.5 18.2 19.2 27.9 18.4 13.9 12.6 21.7 21.2 26.2 11.1 16.6 16.3 16.6 25.0 16.5 13.6 22.6 17.7 26.1 194.7 19.9 18.3 24.3 27.5 17.7 13.9 18.8 16.5 5.8 22.4 58.9 10.7 17.3 24.2 4.1 9.4 19.7 9.4 2.1 2.6 0.9 18.9 42.3 27.7 23.4 58.2 28.4 20.8 31.0 43.1 22.0 24.6 51.5 21.9 21.8 62.9 39.0 39.4 19.6 24.7 23.7 37.4 16.3 12.3 28.6 17.2 69.1 27.3 19.9 38.7 61.7 40.1 45.0 34.4 21.7 60.6 27.0 16.2 17.3 8.5 17.9 16.1 12.3 39.2 20.8 24.3 28.4 17.1 25.9 21.2 14.2 43.6 28.1 18.8 45.9 54.0 23.4 18.2 31.0 101.3 67.8 20.4 51.3 11.6 30.6 7.9 9.4 2.7 2.6 4.8 1.5 3.8 2.5 2.6 1.9 4.1 1.9 2.1 19.7 2.1 5.6 9.4 0.9 0.9 15.5 15.5 9.1 19.8 18.2 19.2 21.7 21.2 25.0 16.5 NFE2L2 NRF2 ENSG00000116044 "Nuclear factor, erythroid 2 like 2" Q16236 2 177227595-177392697 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002990, CAB020317, HPA043438" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "CAB020317: , HPA002990: AB_1079476, HPA043438: " "unprognostic (2.11e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.41e-1)" "unprognostic (5.95e-2)" "unprognostic (3.90e-1)" "unprognostic (5.27e-2)" "unprognostic (9.58e-2)" "unprognostic (3.48e-2)" "unprognostic (9.86e-2)" "unprognostic (4.86e-2)" "unprognostic (1.83e-1)" "prognostic favourable (2.26e-4)" "unprognostic (1.97e-2)" "unprognostic (1.61e-1)" "unprognostic (1.26e-1)" "unprognostic (9.77e-3)" 30.9 24.4 25.4 19.3 34.7 15.0 24.6 36.4 29.7 31.7 28.3 25.8 22.2 28.1 27.7 30.9 82.5 27.0 28.9 32.3 28.0 16.9 44.8 49.3 29.0 19.7 49.0 18.7 53.1 16.3 21.7 52.5 29.4 33.5 39.0 25.4 21.7 34.7 28.1 25.9 48.1 29.2 42.1 42.7 26.8 45.9 21.9 41.6 21.1 49.5 35.8 25.5 43.7 47.1 23.5 41.1 42.4 35.6 25.8 43.2 22.6 10.9 12.7 11.5 12.4 39.0 42.1 13.2 18.7 26.1 17.1 19.4 16.8 21.0 10.8 20.4 21.2 20.4 13.5 28.6 24.0 8.4 8.2 13.9 22.3 32.6 49.9 8.2 13.2 28.9 67.3 24.3 36.2 16.9 14.5 21.3 23.5 10.9 8.4 21.8 12.6 11.9 6.9 10.1 10.9 26.1 41.4 15.1 9.8 42.5 13.7 44.4 10.6 22.3 25.5 17.8 11.8 19.7 11.5 15.0 9.0 9.1 17.8 9.2 34.0 42.4 35.6 21.4 23.0 34.1 26.6 23.5 26.9 23.6 41.1 19.9 43.2 28.2 39.9 25.8 31.9 15.5 25.0 22.6 25.4 34.7 36.4 29.7 28.0 16.9 49.0 18.7 33.5 41.6 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Cell line enhanced" "Detected in many" "BEWO: 43.4;NTERA-2: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA055889: " "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavourable (7.58e-12)" "prognostic favourable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.5 1.1 0.5 1.3 0.0 0.0 43.4 2.5 4.9 4.9 9.0 8.3 22.0 0.9 16.6 0.2 2.6 1.9 4.2 11.2 8.6 2.7 1.7 1.8 6.1 3.4 1.5 16.8 0.4 0.5 2.0 0.7 11.3 2.6 22.3 0.9 1.7 1.0 2.7 36.4 4.4 1.5 0.1 6.2 6.6 12.4 3.9 4.7 0.0 1.0 0.3 0.6 0.9 23.5 0.4 0.7 0.2 10.1 13.6 21.6 1.0 0.0 5.4 16.8 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 NFIB "NFI-RED, NFIB2, NFIB3" ENSG00000147862 "Nuclear factor I B" O00712 9 14081843-14398983 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 53.9;HBEC3-KT: 21.8;HUVEC TERT2: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003956 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA003956: AB_1854424" "unprognostic (1.93e-1)" "unprognostic (3.18e-2)" "unprognostic (4.00e-1)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (2.55e-2)" "unprognostic (1.32e-1)" "unprognostic (4.72e-3)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (3.68e-1)" "unprognostic (1.12e-1)" "prognostic favourable (3.53e-4)" "unprognostic (4.69e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-2)" "unprognostic (1.62e-1)" 29.3 9.5 22.6 9.2 12.9 1.0 39.7 30.0 22.9 14.8 17.0 13.6 34.1 11.3 16.8 22.3 11.5 17.0 18.0 24.1 22.0 9.3 18.8 22.3 16.3 9.8 10.8 15.5 18.7 17.5 8.2 6.0 14.7 13.7 21.3 10.4 9.2 40.0 41.3 20.8 23.6 16.8 24.2 14.9 10.4 14.2 7.6 15.6 2.7 18.8 13.9 7.7 27.4 23.4 0.3 0.3 2.4 0.4 0.5 1.0 1.3 6.3 4.5 2.8 53.9 13.6 7.9 0.1 0.1 0.0 1.3 4.7 0.0 2.6 0.1 4.2 0.4 1.4 2.6 21.8 2.3 0.9 2.6 19.4 10.1 0.6 4.5 0.5 0.1 6.8 3.0 4.9 18.1 21.8 0.6 0.1 1.8 2.9 0.0 0.1 1.0 5.3 0.0 2.5 0.0 4.0 2.3 4.5 16.8 4.6 5.7 1.8 11.5 0.0 21.2 4.2 6.3 3.2 4.0 0.5 0.4 1.5 3.7 0.0 5.3 1.3 0.1 0.2 0.3 0.2 1.0 0.2 0.2 0.2 0.1 0.3 0.2 0.1 2.4 0.5 0.4 0.3 0.5 1.3 22.6 12.9 30.0 18.8 22.0 9.3 10.8 15.5 13.7 15.6 NFIC "CTF, CTF5, NF-I, NFI" ENSG00000141905 "Nuclear factor I C" P08651 19 3314403-3469217 "Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.7" "Cell line enhanced" "Detected in many" "SiHa: 50.2;U-2197: 49.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004300, CAB004674, HPA052625" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB004300: , CAB004674: AB_425564, HPA052625: " "unprognostic (2.59e-1)" "unprognostic (5.07e-3)" "unprognostic (2.11e-1)" "prognostic favourable (1.52e-6)" "unprognostic (8.38e-2)" "unprognostic (1.71e-3)" "unprognostic (1.14e-1)" "unprognostic (3.04e-1)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.81e-2)" "unprognostic (3.16e-2)" "unprognostic (2.03e-2)" "unprognostic (2.54e-1)" "unprognostic (9.65e-2)" "unprognostic (2.85e-2)" "unprognostic (1.80e-3)" 25.1 19.8 8.5 11.1 11.1 5.7 14.9 15.3 19.9 23.3 19.7 16.8 27.1 6.4 20.8 14.2 19.6 18.5 21.5 25.7 9.5 6.3 14.4 29.0 12.9 9.1 11.8 8.1 31.8 46.9 22.7 14.6 5.1 11.7 18.8 5.3 20.4 33.9 22.2 101.7 16.8 8.5 26.5 10.9 11.6 16.4 8.6 11.3 2.7 15.6 23.2 10.2 22.4 17.4 2.3 4.0 11.3 5.3 8.4 3.3 3.2 17.8 26.2 0.3 15.9 14.5 12.6 1.7 16.3 9.2 11.1 7.9 0.6 6.3 0.1 5.9 14.9 8.7 4.4 11.0 4.5 12.6 3.8 3.4 21.2 5.2 11.4 5.2 6.7 11.0 7.8 15.2 6.0 10.2 9.0 16.8 8.0 12.8 3.0 1.1 0.8 10.9 7.8 10.1 7.0 4.2 3.6 3.6 9.7 50.2 5.0 4.9 14.7 4.1 15.3 19.0 17.1 49.6 22.2 0.5 0.7 0.1 26.2 11.5 27.5 1.8 5.2 2.4 3.3 5.3 2.8 2.1 3.0 3.0 4.0 2.3 2.1 2.1 11.3 8.4 1.1 1.6 1.1 3.2 8.5 11.1 15.3 19.9 9.5 6.3 11.8 8.1 11.7 11.3 NFKB1 "KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50" ENSG00000109320 "Nuclear factor kappa B subunit 1" P19838 4 102501329-102617302 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004031, HPA027305" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004031: AB_330564, HPA027305: AB_1854429" "unprognostic (1.06e-1)" "unprognostic (1.61e-2)" "unprognostic (4.37e-2)" "unprognostic (2.38e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (8.98e-2)" "unprognostic (1.96e-1)" "unprognostic (9.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.71e-1)" "prognostic favourable (1.76e-4)" "unprognostic (1.84e-2)" "unprognostic (6.75e-3)" "unprognostic (1.74e-1)" "unprognostic (6.92e-3)" 19.8 14.7 8.2 37.7 12.0 44.5 26.6 12.4 10.3 18.2 17.1 10.4 10.4 10.7 17.5 11.2 20.5 16.4 20.3 14.5 7.5 5.1 13.2 15.8 26.9 46.0 11.4 4.8 17.5 14.3 10.2 8.7 13.7 10.0 18.8 14.6 10.8 17.7 13.5 17.1 19.6 16.7 16.0 10.1 30.0 14.6 9.3 12.5 37.5 14.7 16.3 26.7 18.4 22.7 5.8 10.4 5.5 7.1 14.3 10.6 3.5 16.9 9.5 5.1 7.8 16.0 14.4 6.3 9.7 28.8 12.1 12.4 10.5 24.3 27.7 8.8 15.3 13.5 10.2 17.0 16.7 25.0 6.0 11.8 7.7 11.3 15.0 21.0 25.1 11.9 12.0 11.8 16.4 15.2 11.4 20.4 8.7 11.9 1.8 11.5 3.1 8.8 14.8 12.2 12.5 11.3 23.9 3.5 5.8 17.9 25.0 9.8 5.1 15.7 19.4 16.5 8.6 8.9 13.6 9.0 6.2 26.9 10.5 10.8 23.3 5.2 5.4 4.9 3.4 7.1 6.0 5.6 8.4 5.6 10.4 5.8 10.6 8.9 5.5 14.3 5.9 7.4 4.5 3.5 8.2 12.0 12.4 10.3 7.5 5.1 11.4 4.8 10.0 12.5 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 49.5;Karpas-707: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favourable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavourable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 14.9 10.8 5.6 43.6 7.1 40.6 18.7 2.0 4.9 12.5 20.1 4.2 9.4 11.3 18.8 11.0 12.9 10.8 20.4 10.9 4.6 2.5 15.5 14.5 20.6 34.2 6.6 2.5 15.1 17.4 5.2 6.3 12.8 7.9 19.6 5.2 7.3 16.7 15.1 13.6 10.4 14.1 24.0 7.7 28.0 13.1 6.6 5.8 19.5 11.5 14.8 39.2 21.9 24.4 5.2 1.4 7.5 3.4 1.3 2.0 0.9 21.0 13.1 2.6 10.5 3.3 5.0 6.2 6.0 19.2 6.1 8.9 7.8 17.3 9.7 15.0 3.6 12.8 6.0 8.2 2.4 49.5 3.5 2.4 3.2 4.5 9.2 1.6 14.1 6.9 4.0 10.2 10.1 2.1 2.3 54.1 2.3 7.2 2.4 6.6 3.3 4.7 5.3 7.3 7.7 10.3 6.2 0.5 2.9 4.9 11.9 8.4 9.2 4.7 6.3 6.3 9.3 8.9 15.9 35.8 33.1 10.2 10.3 4.2 3.3 0.3 2.4 0.1 1.4 1.5 1.4 5.2 1.7 1.5 1.4 4.5 1.8 1.5 7.5 1.3 3.4 0.9 2.0 0.9 5.6 7.1 2.0 4.9 4.6 2.5 6.6 2.5 7.9 5.8 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA063734: " "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.0 10.0 1.4 3.6 1.5 0.9 4.8 5.4 2.2 2.9 3.3 7.1 4.4 8.9 6.1 1.2 4.4 3.8 2.6 0.9 27.2 4.8 5.9 1.9 4.0 5.2 6.8 12.6 1.2 3.0 3.2 4.1 1.6 6.9 8.2 1.1 5.2 8.4 6.7 5.1 4.1 11.8 6.2 8.1 1.4 3.2 8.7 5.2 3.4 5.0 3.8 3.0 5.8 3.8 5.0 6.4 8.6 8.3 17.0 15.1 19.0 3.2 7.1 6.1 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 NFKBIE IKBE ENSG00000146232 "NFKB inhibitor epsilon" O00221 6 44258166-44265788 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002692, HPA005941, CAB010272" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478" "prognostic favourable (1.72e-5)" "unprognostic (1.43e-1)" "unprognostic (1.39e-2)" "unprognostic (2.37e-2)" "unprognostic (6.32e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (4.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-2)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "prognostic unfavourable (1.37e-6)" "unprognostic (2.61e-2)" "unprognostic (8.83e-2)" "unprognostic (1.37e-2)" "prognostic favourable (8.07e-4)" 5.8 5.2 7.6 24.6 5.4 24.0 5.2 9.4 7.8 3.7 8.0 4.2 3.2 6.7 4.7 5.5 6.9 3.0 9.8 4.6 7.9 5.5 11.5 8.7 15.9 17.1 6.0 4.1 6.1 7.1 3.5 4.1 6.0 4.8 7.1 5.9 3.6 7.7 4.1 3.7 7.4 9.5 3.6 5.0 29.6 6.3 7.9 3.7 14.5 5.5 4.6 22.7 6.7 6.7 8.1 8.2 7.1 10.2 0.8 3.5 1.6 14.4 3.7 5.1 8.0 2.0 1.5 2.7 2.5 12.6 8.0 8.4 7.8 6.8 7.8 9.2 2.6 3.1 5.4 8.1 9.0 13.4 3.0 4.0 1.5 8.7 6.2 13.2 12.2 3.9 3.6 7.4 4.6 5.4 3.7 20.9 2.0 7.4 2.5 27.0 2.7 2.0 4.9 4.5 7.2 18.4 15.8 3.3 4.1 1.8 6.7 10.5 4.6 15.5 9.5 4.5 5.3 2.8 8.0 13.3 5.6 14.4 4.0 14.7 8.5 7.1 8.1 3.8 1.8 9.4 3.5 8.1 2.4 1.6 6.8 7.3 1.1 1.7 3.2 0.8 10.2 8.2 3.0 1.6 7.6 5.4 9.4 7.8 7.9 5.5 6.0 4.1 4.8 3.7 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 116.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 31.3;RPTEC TERT1: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 20.0" "Group enriched" "Detected in many" 4 "granulocytes: 15.8;monocytes: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: " "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavourable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 26.4 4.4 2.2 35.5 3.4 116.9 46.9 2.4 2.0 17.4 23.7 3.6 5.5 16.8 21.3 13.0 22.1 39.5 31.5 17.3 2.8 1.9 13.8 26.8 29.6 21.3 4.4 0.3 18.2 15.7 2.4 7.2 18.8 5.0 16.3 10.4 10.9 37.4 8.1 9.8 21.0 18.5 17.9 5.2 21.5 16.8 7.1 3.3 3.3 26.5 30.8 23.8 18.7 20.0 3.2 3.8 15.8 20.0 0.5 4.1 1.1 2.7 2.2 1.5 1.9 4.4 7.6 2.4 11.3 31.3 5.0 4.8 2.6 3.4 5.2 14.5 3.0 8.9 1.1 4.9 13.1 15.2 1.0 4.9 3.9 1.4 6.8 0.3 0.3 5.2 7.7 13.4 6.2 3.7 0.8 10.8 7.1 3.5 0.1 2.9 2.6 6.7 0.6 6.9 0.7 31.4 18.3 0.7 0.9 1.9 2.3 12.2 2.7 2.1 4.6 8.1 8.2 3.0 3.6 9.1 3.1 3.6 14.8 1.0 1.1 4.9 3.6 1.0 1.0 8.3 1.1 1.9 1.4 1.0 2.4 3.2 4.1 2.7 15.8 0.5 20.0 3.8 0.7 1.1 2.2 3.4 2.4 2.0 2.8 1.9 4.4 0.3 5.0 3.3 NFS1 "IscS, NifS" ENSG00000244005 "NFS1, cysteine desulfurase" Q9Y697 20 35668055-35699359 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB034314, HPA051801, HPA054755" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB034314: AB_2235980, HPA051801: AB_2681616, HPA054755: AB_2682594" "unprognostic (1.72e-1)" "unprognostic (2.96e-1)" "unprognostic (1.27e-2)" "unprognostic (5.88e-3)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (2.02e-1)" "unprognostic (9.00e-2)" "unprognostic (1.73e-1)" "unprognostic (6.52e-3)" "unprognostic (3.93e-2)" "prognostic favourable (4.72e-6)" "unprognostic (2.33e-2)" "unprognostic (1.97e-1)" "unprognostic (1.64e-2)" "unprognostic (5.54e-2)" 10.2 28.0 16.9 6.7 19.3 3.7 9.7 15.3 20.8 11.2 11.7 12.0 10.0 11.0 8.4 9.9 10.1 11.7 9.9 19.2 14.6 14.0 36.9 33.0 7.8 7.0 16.5 15.5 12.5 14.0 20.7 14.8 7.8 14.3 9.5 13.0 12.2 12.6 12.2 19.7 9.5 9.6 10.1 12.4 6.6 10.3 25.3 15.8 4.9 10.2 8.4 10.4 8.1 7.7 10.4 11.2 7.4 8.1 12.8 11.4 6.1 13.3 16.7 5.8 6.1 15.9 14.6 11.8 10.2 10.8 15.5 10.1 30.0 7.6 11.4 20.1 9.5 16.9 19.9 20.6 14.0 5.1 9.3 24.4 17.8 23.3 13.3 10.2 4.7 11.7 19.8 12.1 13.4 11.5 17.4 7.7 10.8 20.5 11.5 10.8 6.7 25.1 4.6 18.9 19.2 15.7 9.1 7.3 6.7 25.5 24.7 16.6 22.1 9.2 8.4 17.5 8.3 10.2 10.0 11.1 15.2 10.4 14.8 11.1 8.6 2.5 8.1 7.4 7.6 7.7 9.7 10.4 8.8 11.2 11.2 7.6 10.3 9.3 3.4 12.8 6.0 5.6 11.4 6.1 16.9 19.3 15.3 20.8 14.6 14.0 16.5 15.5 14.3 15.8 NFU1 "CGI-33, HIRIP5, NifU, NIFUC" ENSG00000169599 "NFU1 iron-sulfur cluster scaffold" Q9UMS0 2 69395750-69437628 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035826 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA035826: " "unprognostic (4.49e-3)" "unprognostic (5.62e-2)" "unprognostic (5.40e-2)" "unprognostic (1.84e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-3)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-1)" "unprognostic (2.21e-3)" "unprognostic (2.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.87e-1)" 32.3 26.0 24.9 14.7 23.5 14.9 59.9 19.7 40.4 14.7 20.0 12.1 16.0 15.9 17.1 31.8 13.9 17.6 15.9 83.2 21.4 23.6 32.8 20.0 23.0 20.8 24.1 29.7 18.5 21.7 22.9 23.0 19.1 23.7 17.5 20.8 12.2 19.1 19.8 69.3 9.7 16.3 28.9 24.8 13.9 18.7 16.5 16.8 7.8 21.4 28.3 14.4 19.0 19.4 18.2 17.7 16.0 17.5 12.9 18.2 8.0 20.0 18.6 19.4 19.4 24.8 23.5 21.2 21.6 19.1 19.0 14.3 40.3 17.6 12.2 11.3 17.8 9.1 19.9 20.3 26.6 25.6 19.5 13.6 15.9 36.7 25.4 24.8 20.7 19.6 11.9 20.5 14.1 24.3 23.4 14.9 34.2 4.2 13.0 42.5 17.7 20.9 14.4 30.4 4.9 29.1 21.2 15.7 12.4 11.8 10.9 33.7 13.1 17.3 23.9 24.2 17.3 18.8 29.0 19.6 16.5 8.0 18.3 25.1 18.6 13.5 8.5 16.0 12.1 12.4 11.8 15.9 12.3 14.4 8.6 18.2 12.8 14.4 2.8 12.9 17.5 17.7 18.2 8.0 24.9 23.5 19.7 40.4 21.4 23.6 24.1 29.7 23.7 16.8 NFX1 "MGC20369, NFX2, TEG-42, Tex42" ENSG00000086102 "Nuclear transcription factor, X-box binding 1" Q12986 9 33290511-33371157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056310, HPA061382, HPA073519" Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA056310: , HPA061382: , HPA073519: " "unprognostic (3.90e-2)" "unprognostic (6.01e-2)" "unprognostic (1.19e-2)" "unprognostic (1.40e-1)" "unprognostic (3.07e-2)" "unprognostic (2.02e-2)" "unprognostic (9.11e-2)" "unprognostic (1.81e-2)" "unprognostic (8.71e-2)" "prognostic favourable (3.75e-4)" "unprognostic (3.40e-2)" "unprognostic (1.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.36e-2)" "unprognostic (1.14e-2)" "unprognostic (9.62e-2)" "unprognostic (3.20e-2)" 23.7 19.8 17.6 17.8 26.3 22.5 24.1 33.0 26.7 19.2 24.4 24.7 18.0 19.2 26.3 19.2 22.3 18.6 14.4 26.4 16.2 16.0 17.4 31.3 19.6 23.1 17.8 19.5 26.5 20.9 28.3 30.9 17.7 25.2 20.4 22.4 19.3 22.9 23.6 44.8 31.2 23.0 21.5 18.1 21.0 19.3 14.4 22.0 35.1 26.7 19.1 32.8 24.7 19.8 10.7 12.3 22.9 7.1 6.8 10.1 5.0 15.0 12.3 11.3 10.7 16.9 19.0 11.4 14.2 14.3 16.1 16.2 11.1 6.2 23.4 9.1 16.4 8.5 20.1 15.4 15.2 17.0 10.1 12.3 30.0 12.4 20.6 21.8 13.6 17.7 25.8 13.8 34.8 9.8 18.6 20.4 16.8 10.6 14.0 20.5 18.3 13.9 15.1 12.3 12.7 10.9 14.5 15.7 11.0 14.2 15.3 8.1 8.9 21.8 12.3 13.2 11.1 9.5 15.4 11.0 9.9 23.2 14.5 11.0 7.5 22.9 4.2 7.9 8.4 7.1 8.9 10.7 9.0 9.0 7.1 9.1 10.1 9.9 3.0 6.8 5.5 12.3 6.1 5.0 17.6 26.3 33.0 26.7 16.2 16.0 17.8 19.5 25.2 22.0 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 10.7 21.5 16.4 15.4 16.0 11.6 21.7 14.4 15.0 30.7 24.9 21.1 19.9 26.9 10.6 13.1 18.8 32.5 17.8 36.2 17.8 17.2 24.1 13.1 65.4 21.8 31.8 17.2 14.5 22.6 24.2 28.8 15.5 26.6 19.2 15.0 25.7 23.6 24.0 20.8 29.0 19.4 19.7 13.7 19.6 20.6 16.8 19.1 17.0 20.4 23.5 12.6 20.4 11.7 14.5 17.2 13.6 20.8 24.1 41.7 39.0 6.2 16.3 15.5 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell line enhanced" "Detected in many" "A-431: 25.0;HDLM-2: 21.1;PC-3: 27.5;T-47d: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Uncertain "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.0 7.3 0.2 0.1 0.1 4.1 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.5 5.1 3.3 5.6 1.4 0.2 21.1 1.8 0.0 10.2 7.8 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.9 0.1 0.1 0.2 1.8 0.0 0.0 0.6 27.5 0.0 0.0 0.0 0.5 0.6 0.9 0.2 3.1 1.6 0.0 15.5 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.8 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "RH-30: 54.7;WM-115: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" 100000 Nucleoplasm "Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavourable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 5.8 0.0 0.1 0.4 0.0 0.0 0.0 7.9 0.1 0.0 0.0 1.0 0.0 1.0 54.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.9 0.1 2.7 0.0 0.0 0.0 0.0 0.5 60.7 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.2 9.6 15.1 8.4 3.7 1.2 4.1 3.2 3.9 2.9 3.5 1.7 4.6 2.8 4.9 4.8 9.3 2.3 5.7 1.9 8.6 4.4 4.4 5.3 5.4 5.1 3.3 5.0 8.5 3.7 4.7 3.5 5.5 5.7 2.3 3.5 4.8 2.1 4.5 4.3 7.4 5.4 2.2 4.1 12.8 9.6 12.1 8.0 6.3 3.5 2.6 7.3 5.7 9.4 4.0 6.1 7.3 3.7 19.6 4.9 4.1 5.3 7.6 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 NHEJ1 "Cernunnos, FLJ12610, XLF" ENSG00000187736 "Non-homologous end joining factor 1" Q9H9Q4 2 219075317-219160865 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012334, HPA043869" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB012334: , HPA043869: " "unprognostic (5.66e-2)" "unprognostic (3.01e-2)" "unprognostic (3.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (5.92e-2)" "unprognostic (5.16e-2)" "unprognostic (6.04e-2)" "unprognostic (3.51e-2)" "unprognostic (6.87e-2)" "unprognostic (1.58e-3)" "unprognostic (4.52e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (8.90e-2)" "unprognostic (8.29e-2)" 11.0 9.6 5.7 9.3 6.6 4.4 14.5 9.7 6.9 9.5 14.1 6.1 7.0 11.0 10.2 6.1 7.7 6.9 10.9 5.9 6.3 3.7 12.9 8.4 7.5 7.4 9.4 4.3 10.7 13.2 6.6 7.5 6.5 5.3 13.3 18.4 6.4 6.4 6.3 17.5 8.4 20.5 10.2 4.4 8.9 9.4 28.7 5.3 13.5 8.1 5.2 10.6 11.1 15.4 15.0 11.2 7.5 21.1 12.8 18.9 10.1 5.1 7.3 13.8 11.0 15.5 17.9 8.3 10.8 9.9 13.0 12.8 23.6 6.4 10.6 9.4 11.1 7.1 18.8 9.0 11.8 15.0 9.3 20.8 8.7 19.3 13.7 9.9 14.4 16.0 20.2 11.4 13.3 10.1 20.5 13.4 9.2 6.1 10.4 10.6 15.3 7.8 13.4 8.9 9.9 11.9 7.4 11.0 11.6 6.8 7.8 17.9 5.3 8.9 9.9 9.9 8.8 4.7 9.6 7.7 7.5 13.5 7.0 17.5 8.1 4.9 14.0 7.5 9.3 21.1 14.2 15.0 13.9 11.8 11.2 12.9 18.9 13.7 3.5 12.8 16.5 5.5 14.6 10.1 5.7 6.6 9.7 6.9 6.3 3.7 9.4 4.3 5.3 5.3 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA055238: " "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149460-178153967 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavourable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavourable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 35.4 41.0 42.5 37.5 46.4 44.2 37.9 26.2 54.2 27.1 37.3 23.7 26.2 29.0 31.9 34.4 59.4 37.6 33.6 52.3 37.7 33.6 31.3 57.1 24.9 60.3 37.1 29.3 38.2 62.1 15.1 25.3 25.0 26.7 28.0 22.4 18.6 40.0 35.5 50.9 39.1 26.7 34.2 34.1 29.9 30.4 26.9 25.6 40.6 34.5 61.9 32.9 26.8 33.4 50.8 78.2 7.1 38.9 37.9 43.8 51.2 32.3 48.9 15.8 45.8 10.8 14.3 55.2 25.2 12.2 27.0 23.5 28.6 27.6 46.4 46.8 14.0 20.3 23.7 52.3 14.4 88.2 79.8 24.5 38.1 32.1 18.5 41.8 26.5 17.2 24.7 21.2 19.1 25.3 24.6 30.0 15.1 140.2 57.8 29.0 24.4 75.7 39.2 21.8 69.3 20.2 20.6 40.8 47.3 19.0 51.2 44.0 26.3 29.6 25.6 28.4 31.9 23.9 56.6 37.8 76.0 55.2 29.6 55.3 31.1 7.1 35.3 4.8 31.6 38.9 43.8 50.8 39.2 36.3 48.7 50.0 40.8 42.0 2.7 37.9 27.0 78.2 36.3 51.2 42.5 46.4 26.2 54.2 37.7 33.6 37.1 29.3 26.7 25.6 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell line enhanced" "Detected in many" "Hep G2: 22.1;TIME: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: " "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.4 6.9 4.8 5.9 6.1 2.3 1.1 0.8 0.8 3.0 1.5 0.0 3.0 2.0 6.0 9.9 6.1 0.4 0.2 6.6 1.6 1.1 22.1 7.1 5.8 1.1 8.5 3.5 0.4 7.1 11.5 0.0 0.9 3.6 5.1 0.6 0.4 6.5 4.3 6.7 1.7 0.5 5.6 6.7 6.2 0.0 2.5 5.1 16.5 1.6 1.8 31.5 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.6 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Group enriched" "Detected in some" 4 "AF22: 16.5;EFO-21: 19.5;HUVEC TERT2: 18.0;TIME: 10.4;U-937: 13.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" "Cell Junctions" "Plasma membrane" "HPA049771: " "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.5 0.0 0.2 0.7 0.1 0.5 3.0 0.1 0.2 0.1 0.0 0.1 19.5 1.6 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 18.0 0.0 2.7 0.1 0.1 0.1 1.3 3.1 0.0 0.0 0.9 0.0 0.1 1.8 0.4 3.8 0.0 0.0 0.0 0.0 1.1 10.4 0.0 1.0 1.3 0.0 0.0 0.0 0.1 0.7 13.1 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Centrosome "Nucleoplasm, Nucleoli" "HPA005939: , HPA070691: " "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.2 8.7 18.1 15.4 7.0 11.2 7.6 10.5 9.1 8.9 7.5 5.6 6.5 28.8 7.2 14.1 12.9 14.5 6.6 18.7 13.9 4.5 10.6 5.3 5.3 4.1 18.4 30.6 7.7 5.3 15.5 6.4 14.1 2.6 11.8 13.4 13.4 13.9 7.4 2.5 9.6 15.8 33.5 2.0 8.0 13.9 8.4 9.5 13.2 4.0 11.3 7.5 16.4 20.5 22.6 31.4 8.6 11.6 9.5 4.8 19.9 5.9 15.0 12.2 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 NINL "KIAA0980, NLP" ENSG00000101004 "Ninein like" Q9Y2I6 20 25452705-25585517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.7;Hep G2: 23.1;SCLC-21H: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 10 "T-cells: 2.2" "Low region specificity" "Detected in many" HPA000686 Uncertain Approved "Cytokinetic bridge,Cytosol" "Cytokinetic bridge, Cytosol" "HPA000686: AB_1079193" "unprognostic (7.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (4.84e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (8.56e-2)" "unprognostic (2.50e-1)" "unprognostic (7.56e-2)" "prognostic favourable (1.47e-4)" "unprognostic (3.39e-1)" "prognostic favourable (1.03e-5)" "unprognostic (3.95e-2)" "unprognostic (2.72e-1)" "unprognostic (1.51e-1)" "unprognostic (6.26e-2)" 3.8 7.5 5.9 7.6 10.7 0.8 4.2 17.2 4.2 10.3 6.7 5.5 3.9 4.1 13.0 9.7 4.7 4.1 7.5 4.0 5.8 6.3 17.1 5.9 5.3 2.7 4.5 4.2 18.5 5.0 14.8 12.1 2.0 7.5 8.8 2.8 13.8 4.7 5.2 5.2 2.7 3.6 9.7 5.5 5.3 6.5 10.5 2.0 17.2 8.2 2.6 3.9 2.8 6.6 0.2 0.0 0.0 0.0 0.0 2.2 0.2 0.6 6.7 14.7 9.6 1.7 4.9 4.6 2.2 2.0 2.0 2.9 1.7 4.7 0.3 3.2 3.5 0.5 2.1 0.4 1.7 0.3 3.0 1.0 3.1 23.1 3.5 0.3 0.0 6.1 0.4 2.3 0.0 4.3 1.1 0.1 2.4 5.9 13.0 0.4 4.1 0.7 0.3 11.4 0.5 1.0 0.8 14.6 10.3 5.1 1.9 5.5 3.1 3.9 0.2 0.1 5.7 0.0 0.1 1.5 2.6 0.0 0.1 0.3 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.2 5.9 10.7 17.2 4.2 5.8 6.3 4.5 4.2 7.5 2.0 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "NIP7, nucleolar pre-rRNA processing protein" Q9Y221 16 69339430-69343111 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA040856: , HPA059850: " "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavourable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 17.8 15.5 8.1 16.4 8.7 20.4 14.0 7.0 12.4 10.2 13.7 9.5 11.1 11.8 15.6 13.1 24.0 13.0 11.3 9.1 9.0 7.8 18.0 18.0 10.7 17.6 12.6 9.6 11.6 18.4 9.6 10.2 14.3 10.9 10.1 14.2 8.8 13.1 13.2 12.1 14.7 14.2 11.7 8.3 15.4 12.3 14.8 9.5 27.1 19.2 23.8 21.0 10.6 11.8 16.6 14.2 8.4 11.7 15.3 19.0 9.5 14.9 10.7 9.1 12.0 11.9 10.8 13.5 13.5 10.9 23.7 17.5 17.2 16.2 27.3 15.2 12.5 15.0 17.1 21.5 30.2 7.2 13.7 14.2 7.6 22.4 11.7 31.2 9.3 11.6 17.2 21.8 24.2 13.0 28.1 4.9 16.4 18.3 18.8 22.9 26.4 12.4 27.2 9.3 24.9 14.6 11.2 11.6 16.5 27.1 8.7 16.7 11.8 19.1 11.3 17.3 15.3 13.0 24.9 15.1 11.4 66.8 10.0 18.6 17.2 8.4 8.1 5.7 16.8 9.2 18.1 16.6 15.6 19.0 14.2 12.1 15.1 18.3 4.0 15.3 11.7 12.5 14.8 9.5 8.1 8.7 7.0 12.4 9.0 7.8 12.6 9.6 10.9 9.5 NIPBL "DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2" ENSG00000164190 "NIPBL, cohesin loading factor" Q6KC79 5 36876759-37066413 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Activator, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040834, HPA058239" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA040834: AB_10796562, HPA058239: " "unprognostic (4.92e-2)" "unprognostic (9.77e-2)" "unprognostic (5.28e-2)" "unprognostic (8.10e-2)" "unprognostic (9.38e-2)" "unprognostic (6.02e-2)" "unprognostic (7.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.85e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (1.04e-1)" "unprognostic (3.40e-2)" 16.8 13.9 13.3 21.9 15.7 22.7 15.8 22.9 15.9 17.3 19.2 10.8 20.1 10.4 18.7 16.5 16.6 14.3 15.9 12.4 13.5 7.1 12.6 13.2 16.0 16.0 17.2 11.1 21.2 14.6 30.0 20.9 17.4 13.5 15.1 13.2 8.5 17.1 24.7 18.9 18.2 18.4 13.2 11.9 18.5 14.7 14.1 19.0 42.5 18.1 14.0 16.9 17.6 29.2 4.8 4.6 11.1 4.3 3.8 4.9 1.9 10.1 6.0 15.7 7.4 10.0 11.0 11.6 8.2 9.1 9.0 7.5 8.4 10.5 15.4 5.3 10.1 8.9 13.4 7.5 13.0 12.6 7.0 18.7 26.7 6.1 6.9 21.8 12.5 8.1 9.3 10.1 13.4 11.3 17.8 11.6 8.4 4.9 14.9 8.3 7.5 5.2 12.8 24.7 5.9 6.4 14.5 11.7 8.2 39.5 10.6 8.4 10.8 12.7 12.2 11.9 13.0 10.1 6.1 8.4 11.2 18.3 6.6 15.0 8.9 10.0 4.1 5.7 4.8 3.2 4.4 4.0 3.9 4.2 3.3 4.8 4.3 4.9 11.1 3.8 4.3 4.6 2.9 1.9 13.3 15.7 22.9 15.9 13.5 7.1 17.2 11.1 13.5 19.0 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334701-100361635 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036999 Approved Supported Centrosome,Cytosol 960000 Cytosol Centrosome "HPA036999: AB_10672105" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavourable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 9.9 7.4 6.7 5.4 9.9 5.9 12.4 3.7 10.5 6.4 7.2 6.1 10.6 5.5 6.6 13.3 9.2 7.9 7.1 7.4 5.8 6.3 29.8 41.1 5.6 8.9 5.9 8.0 7.2 8.5 4.7 7.6 4.9 7.7 7.2 6.8 11.3 8.2 10.2 14.7 7.7 5.3 7.0 5.4 5.7 6.8 3.3 3.3 4.4 10.8 14.5 10.5 8.2 5.6 4.2 5.9 1.5 2.4 3.0 4.3 1.3 9.9 9.9 1.2 5.1 8.9 12.1 6.2 4.1 6.0 9.7 9.2 8.4 11.2 9.9 6.2 5.8 7.5 4.5 11.0 11.6 3.1 2.3 7.2 3.2 4.3 10.8 4.7 4.9 7.6 16.7 5.1 8.5 6.1 3.3 8.0 11.8 9.4 3.1 4.3 4.4 15.0 3.5 4.2 9.7 16.0 6.2 6.9 3.2 5.6 9.6 6.1 7.1 4.4 4.4 6.1 2.5 2.9 3.5 4.9 5.4 8.5 9.6 7.9 7.6 0.4 2.4 1.1 3.3 2.1 4.3 4.2 3.1 2.5 5.9 3.7 3.6 3.5 1.5 3.0 1.6 1.8 3.1 1.3 6.7 9.9 3.7 10.5 5.8 6.3 5.9 8.0 7.7 3.3 NKAP FLJ22626 ENSG00000101882 "NFKB activating protein" Q8N5F7 X 119920672-119943772 "Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000916 Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000916: AB_1079486" "prognostic unfavourable (4.20e-4)" "unprognostic (4.28e-3)" "unprognostic (9.14e-2)" "unprognostic (1.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.42e-2)" "unprognostic (3.49e-3)" "unprognostic (4.18e-3)" "unprognostic (3.70e-2)" "unprognostic (1.05e-2)" "unprognostic (1.05e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-3)" "unprognostic (1.72e-1)" "unprognostic (1.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" 13.9 17.5 12.2 11.2 16.8 15.9 14.0 11.6 16.9 13.0 13.2 15.6 9.9 10.1 16.2 12.4 12.0 15.2 14.0 15.5 12.9 14.0 14.8 19.5 12.6 14.1 14.5 9.7 23.9 13.5 14.1 21.7 18.1 16.6 16.0 8.5 10.3 13.9 15.0 23.9 13.5 13.7 12.0 19.5 15.8 12.3 11.8 16.7 20.1 16.4 11.6 12.2 17.9 15.3 11.8 9.7 16.5 8.0 7.0 8.1 4.4 6.2 7.5 6.1 5.4 4.9 8.2 8.2 4.8 4.5 6.1 4.6 4.5 4.9 6.4 7.7 4.4 4.5 11.3 4.5 5.4 8.8 10.8 3.0 5.3 4.0 6.4 7.2 6.2 5.7 7.9 5.8 4.9 4.2 7.4 6.2 4.7 7.7 7.9 10.3 5.9 9.7 8.2 6.6 8.3 3.4 2.4 6.8 8.3 9.6 4.6 9.9 4.1 6.5 6.4 4.4 2.2 10.3 6.2 7.9 6.3 7.3 6.1 6.8 6.4 11.3 8.0 10.8 6.9 5.9 6.8 9.7 8.1 6.5 6.0 11.8 8.1 7.5 16.5 7.0 6.6 9.7 7.5 4.4 12.2 16.8 11.6 14.6 12.9 14.0 14.5 9.7 16.6 16.7 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA062861: " "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 15.3 10.9 6.7 11.5 8.4 12.5 12.9 9.2 10.3 12.0 14.6 11.0 10.3 8.7 15.4 12.5 22.0 10.5 14.1 27.5 6.1 5.6 14.0 16.1 11.7 10.4 8.5 3.6 14.9 10.7 8.4 9.0 30.8 7.2 12.5 9.9 14.6 12.3 11.1 31.5 16.1 15.6 15.7 8.3 12.4 11.3 17.1 6.0 17.7 9.5 15.4 19.1 14.5 12.7 8.2 23.0 21.0 25.5 12.0 7.4 10.4 9.0 15.6 24.1 12.5 17.0 11.4 14.3 15.5 11.7 24.3 18.2 17.1 12.8 15.1 24.4 15.6 19.2 19.5 11.6 12.4 12.5 21.3 13.5 14.6 12.5 26.6 17.9 11.1 16.9 20.6 16.1 12.4 29.4 19.0 15.2 13.7 8.9 34.5 11.1 14.2 12.0 27.3 27.7 14.1 15.7 9.3 28.9 37.8 11.3 34.2 15.3 21.7 21.7 21.2 15.3 16.5 16.4 17.2 20.1 32.4 12.4 10.3 10.7 21.5 21.0 25.5 20.5 7.0 20.5 6.9 7.8 7.1 7.0 20.5 8.2 7.4 7.1 14.4 12.0 21.5 23.0 6.0 10.4 6.7 8.4 9.2 10.3 6.1 5.6 8.5 3.6 7.2 6.0 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavourable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 10.8 11.1 6.6 7.6 5.7 5.8 10.0 6.6 5.4 9.0 9.7 11.8 9.4 19.4 11.7 5.7 12.8 27.4 10.2 11.0 9.7 18.7 10.2 13.2 7.8 5.4 19.7 7.9 6.1 8.4 10.4 12.2 9.1 11.0 8.2 8.0 16.8 12.6 15.8 14.6 12.5 9.9 9.4 19.9 11.9 8.1 10.8 9.0 9.3 14.5 9.8 6.1 12.0 7.4 5.8 6.2 12.2 16.6 6.7 8.1 20.5 5.9 22.2 6.4 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600614-42648741 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: " "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favourable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavourable (6.01e-4)" "prognostic unfavourable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favourable (1.05e-5)" 12.9 14.4 9.8 18.8 22.2 16.3 15.9 42.0 12.3 18.8 10.4 18.5 15.4 11.8 27.2 17.4 11.0 12.0 13.1 11.2 10.9 10.5 9.5 9.7 14.6 15.5 14.5 11.3 22.7 18.4 19.2 26.9 11.1 14.1 12.9 11.1 20.4 13.2 19.5 12.0 20.0 13.3 19.4 15.0 18.5 10.1 17.8 13.8 20.6 14.9 10.9 19.4 12.9 13.9 9.3 8.5 11.7 10.0 11.1 10.2 3.6 8.9 5.1 17.1 7.0 10.2 12.5 9.6 14.5 3.7 6.0 8.2 9.0 7.2 14.1 7.0 4.4 7.9 10.1 3.6 12.4 7.1 8.4 18.1 16.2 14.5 4.4 13.9 11.9 5.1 7.2 11.9 4.5 10.6 18.2 10.9 11.4 3.7 9.5 13.6 14.7 7.5 10.1 7.7 5.8 8.4 6.8 6.0 3.6 15.6 6.5 2.4 9.5 10.1 17.0 10.9 7.9 11.8 14.0 9.5 13.2 9.8 5.8 17.1 6.6 9.2 6.2 11.7 10.2 7.7 9.4 8.9 9.8 8.5 4.7 9.3 10.0 8.7 9.1 11.1 10.0 8.5 8.3 3.6 9.8 22.2 42.0 12.3 10.9 10.5 14.5 11.3 14.1 13.8 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "lung: 51.5;thyroid gland: 122.8" "Cell line enriched" "Detected in some" 28 "SCLC-21H: 47.6" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in some" 6 "basal ganglia: 2.4;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.4;hypothalamus: 12.0" "Group enriched" "Detected in some" 13 "basal ganglia: 6.4;hypothalamus: 16.1" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 51.5 0.1 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 122.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 47.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.1 0.2 2.5 0.0 0.1 0.1 0.4 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.3" HPA047561 Uncertain Uncertain Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA047561: " "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 6.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell line enhanced" "Detected in some" "HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA065034: " "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 20.5 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.1 0.0 0.0 0.0 3.9 16.9 5.2 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in some" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA062879: " "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 9.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678693-23682927 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 95.3" "Cell line enhanced" "Detected in many" "SiHa: 17.5;U-138 MG: 17.8;U-251 MG: 15.2" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "eosinophil: 23.5;neutrophil: 23.4" "Lineage enriched" "Detected in many" 19 "granulocytes: 23.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: " "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 0.6 1.3 0.3 0.6 0.9 0.6 1.5 0.1 0.8 1.1 0.6 0.2 0.5 0.5 0.7 0.5 1.2 0.7 0.8 2.4 0.8 0.3 0.4 1.6 0.8 0.7 0.6 0.2 1.6 0.6 0.5 0.4 0.3 1.2 95.3 0.2 0.5 17.9 0.7 2.0 0.2 0.4 0.7 0.6 0.3 0.5 12.3 0.7 0.0 0.6 3.2 20.5 0.7 2.5 1.0 0.0 23.5 0.0 0.2 1.2 0.1 3.2 2.4 0.0 5.9 2.2 0.5 4.9 4.4 2.8 9.5 11.2 1.4 3.7 0.0 0.6 3.3 0.8 2.3 5.1 7.5 0.0 1.2 2.2 1.8 3.5 4.2 0.0 0.8 0.8 1.3 9.6 0.5 0.5 0.1 0.0 3.7 1.0 7.6 0.6 1.4 1.7 0.0 3.8 0.3 0.5 3.8 1.1 0.3 17.5 3.3 0.3 2.3 0.3 0.6 17.8 6.3 1.3 15.2 0.0 0.0 0.0 8.7 1.7 2.1 3.4 0.0 23.5 0.5 0.0 0.1 1.0 0.2 0.5 0.0 0.9 0.7 1.2 23.4 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.8 0.8 0.3 0.6 0.2 1.2 0.7 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128753-35142315 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 40.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavourable (6.39e-4)" 6.3 6.9 7.0 8.2 7.6 6.4 11.4 7.6 9.1 5.6 5.8 5.4 3.3 5.1 10.0 5.5 7.9 10.0 8.3 4.8 6.0 6.4 4.8 6.9 4.5 9.1 5.6 7.7 16.3 40.3 5.1 4.2 6.1 5.4 9.2 5.3 6.2 9.1 7.5 8.8 7.6 5.1 10.2 5.1 8.3 6.8 7.2 6.4 10.0 10.0 6.6 8.3 6.3 5.4 6.4 4.5 0.4 3.2 2.4 9.1 3.0 8.1 19.9 6.7 11.9 4.2 6.2 10.7 7.3 6.9 13.1 10.9 13.7 7.9 18.1 10.2 6.1 10.9 15.1 18.8 9.1 2.9 23.6 8.1 9.5 17.1 5.6 15.6 6.5 7.0 10.1 13.6 20.8 8.5 21.8 6.6 7.7 11.2 23.9 12.7 12.6 8.8 19.3 11.7 19.9 7.7 7.9 13.8 8.4 7.0 7.1 8.7 17.4 11.3 7.5 7.1 10.0 6.8 24.5 5.2 4.0 15.1 5.0 12.9 13.6 0.1 3.0 0.0 5.7 3.2 9.1 4.8 5.4 6.0 4.5 6.4 7.4 5.1 0.4 2.4 1.6 1.0 3.0 3.0 7.0 7.6 7.6 9.1 6.0 6.4 5.6 7.7 5.4 6.4 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 15.9;HUVEC TERT2: 15.5;RH-30: 16.6;WM-115: 16.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680" Approved Uncertain "Nuclear bodies,Plasma membrane" 40000 "Plasma membrane" "Nuclear bodies" "HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 7.6 8.1 0.0 3.2 8.0 0.4 0.5 0.0 0.3 0.0 0.1 15.9 0.0 2.3 0.0 0.8 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 15.5 0.0 1.0 0.1 0.0 0.0 0.0 4.5 1.1 0.0 16.6 3.8 3.0 0.0 1.6 1.0 0.0 0.0 7.7 0.4 0.0 1.9 8.6 0.8 6.2 7.0 7.4 0.0 0.0 2.9 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: " "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 1.4 8.9 16.3 1.6 19.4 2.2 1.3 11.5 45.9 3.2 1.6 30.0 0.1 1.1 4.2 8.1 1.5 6.0 2.4 2.1 15.7 9.7 1.2 0.9 1.3 1.2 12.7 13.1 6.1 1.2 1.4 1.1 1.5 15.2 7.9 1.4 1.6 1.6 16.0 0.8 1.6 1.6 2.9 12.9 1.4 1.5 3.8 12.3 0.0 1.0 0.0 1.1 1.5 1.3 0.2 0.1 3.3 0.3 0.3 0.5 0.0 0.1 0.8 10.9 0.3 2.6 1.1 1.9 0.3 0.1 0.0 0.2 0.1 0.5 0.8 0.8 0.1 0.2 0.4 0.0 0.2 0.7 1.3 0.5 0.5 0.1 0.0 0.2 0.9 0.6 0.1 0.3 0.0 0.1 0.7 2.1 0.1 0.6 0.7 1.7 7.9 0.0 0.9 0.4 0.5 0.0 1.2 2.7 4.3 0.3 0.0 0.9 0.0 0.5 0.3 0.2 1.3 0.4 0.0 1.7 1.5 0.6 0.3 0.4 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 3.3 0.3 0.0 0.1 0.1 0.0 16.3 19.4 11.5 23.1 15.7 9.7 12.7 13.1 15.2 12.3 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: " "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.7 4.6 4.7 7.8 6.0 27.0 4.2 6.3 7.1 3.8 4.4 9.1 8.5 9.0 14.5 5.8 24.7 5.0 4.6 4.7 5.2 25.5 4.7 5.2 5.1 6.1 9.1 9.5 7.6 7.1 5.4 13.3 6.0 5.0 2.7 11.2 8.4 4.6 14.1 5.7 9.5 3.5 7.1 6.8 29.0 10.6 8.3 9.3 5.6 7.5 4.6 9.3 9.0 8.6 6.1 5.4 5.6 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell line enhanced" "Detected in some" "HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" Cytosol "Vesicles, Centriolar satellite" "HPA048062: " "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.2 0.1 0.0 0.0 12.9 6.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 5.4 13.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 19.9 0.1 9.7 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 NLRP1 "CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1" ENSG00000091592 "NLR family pyrin domain containing 1" Q9C000 17 5499427-5619424 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;Karpas-707: 41.2;U-266/70: 20.6" "Cancer enhanced" "Detected in all" "glioma: 20.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB009189, HPA064431" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009189: , HPA064431: " "unprognostic (4.40e-2)" "unprognostic (1.02e-1)" "unprognostic (3.16e-2)" "unprognostic (3.65e-2)" "unprognostic (4.00e-2)" "unprognostic (1.23e-3)" "unprognostic (4.13e-2)" "unprognostic (1.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "prognostic favourable (7.57e-4)" "unprognostic (2.99e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (6.69e-2)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "unprognostic (1.34e-2)" 19.5 2.5 2.4 39.9 3.1 15.1 16.4 0.9 2.8 19.1 6.1 5.3 5.6 4.0 16.2 10.2 12.4 7.6 15.5 8.6 4.9 1.8 6.3 3.4 19.1 31.2 4.2 1.9 4.5 2.3 2.2 2.9 8.3 5.2 10.2 5.7 6.3 8.1 11.3 17.8 35.2 18.3 13.1 6.8 34.4 4.4 6.9 3.2 15.9 13.7 11.9 30.8 17.5 16.8 5.3 4.6 16.8 7.5 3.8 7.0 3.7 6.2 0.0 0.0 0.0 3.3 4.6 0.7 2.6 2.5 1.0 2.2 0.1 2.4 2.2 9.7 2.5 2.8 0.0 10.1 1.6 23.3 0.0 0.6 2.0 0.2 3.1 0.0 0.7 2.8 6.4 8.5 6.2 10.8 5.4 41.2 5.0 0.0 0.0 1.8 0.0 0.1 2.4 1.6 9.7 0.0 2.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 10.5 2.1 1.3 1.3 0.4 20.6 6.6 1.6 3.5 0.2 0.1 13.8 6.3 4.4 6.0 4.5 6.6 4.4 4.9 6.1 4.6 5.3 5.5 5.0 16.8 3.8 7.5 0.4 7.0 3.7 2.4 3.1 0.9 2.8 4.9 1.8 4.2 1.9 5.2 3.2 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Cell line enhanced" "Detected in some" "A-431: 17.6;BJ: 5.3;HBF TERT88: 7.6;LHCN-M2: 3.4" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 17.6 0.0 0.0 0.0 0.0 0.2 0.0 5.3 2.6 1.2 2.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Group enriched" "Detected in some" 4 "HMC-1: 7.5;THP-1: 6.6;U-87 MG: 7.2;U-937: 6.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 6.0 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.3" "Cell line enhanced" "Detected in some" "BEWO: 25.1;K-562: 10.4;U-266/84: 11.4" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles, Cytosol" "HPA021183: " "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.6 0.9 1.1 5.0 3.8 1.7 1.4 0.6 2.7 2.6 2.6 0.9 0.2 2.5 2.1 3.7 10.8 1.0 3.7 0.7 2.0 1.8 4.7 0.9 2.2 5.0 0.8 0.8 1.0 6.1 0.3 1.7 8.1 2.9 2.1 1.2 2.4 4.1 1.6 1.4 3.5 2.9 1.1 1.0 3.0 3.1 14.3 0.9 4.2 3.1 0.2 3.5 4.7 5.6 3.8 1.8 0.6 0.9 3.4 2.6 0.8 2.3 3.9 2.0 0.4 0.1 0.1 25.1 0.1 0.0 0.2 0.1 5.0 0.5 2.6 0.2 0.1 4.1 0.0 4.3 0.2 2.5 0.2 2.5 0.3 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.1 0.0 10.4 0.3 0.0 0.3 0.2 1.0 3.0 0.0 2.8 0.0 1.5 2.3 0.9 2.4 0.6 0.1 1.1 0.0 3.4 0.8 0.0 0.2 0.5 0.3 0.3 2.7 11.4 0.9 0.3 0.7 0.1 0.6 0.7 0.3 2.6 0.9 1.5 3.8 1.1 1.0 0.6 2.6 0.8 1.5 0.5 3.4 0.5 1.8 1.2 0.8 1.1 3.8 0.6 2.7 2.0 1.8 0.8 0.8 2.9 0.9 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: " "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favourable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favourable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.0 12.0 1.3 9.6 4.1 4.8 1.9 5.4 6.3 2.7 4.7 0.6 10.1 7.3 16.7 6.9 10.2 3.7 3.1 0.9 9.4 3.9 9.6 4.1 6.5 6.3 3.3 5.6 5.3 13.0 3.5 6.9 5.5 0.1 4.9 2.8 10.8 5.6 8.1 5.9 6.8 11.1 1.6 2.4 6.5 5.2 1.8 6.3 8.0 4.3 3.5 13.9 9.9 6.4 5.4 4.9 4.8 2.8 1.7 1.9 2.4 0.8 10.3 3.8 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell line enhanced" "Detected in many" "A-431: 27.5" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favourable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 27.5 10.5 1.9 0.4 5.5 2.4 0.2 1.7 3.3 3.7 5.1 3.7 7.6 1.2 4.4 4.4 4.9 10.6 2.1 2.1 10.3 13.3 4.2 4.1 17.1 1.4 2.8 4.6 2.5 0.8 5.8 2.2 5.4 0.0 0.4 2.0 16.1 2.6 9.3 7.8 3.0 8.3 0.0 12.2 3.5 2.2 1.0 12.0 2.7 1.6 12.5 1.8 11.0 1.3 0.7 3.7 3.5 2.6 0.2 3.0 2.6 8.5 15.9 4.4 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.8 15.7 16.2 10.7 16.5 34.7 20.3 26.6 21.8 23.1 14.4 13.2 10.9 10.8 23.4 17.7 22.9 14.3 14.2 24.1 15.5 13.6 25.7 46.7 19.4 12.5 16.7 18.2 27.9 29.0 13.4 27.5 20.1 21.6 21.7 13.5 14.1 19.7 13.3 31.8 15.5 16.3 22.1 16.3 17.1 25.3 12.1 13.1 19.6 21.7 21.3 15.0 32.1 16.0 12.1 13.2 15.9 11.8 22.8 18.7 13.6 21.7 12.7 12.5 12.8 15.7 21.7 17.3 24.9 18.9 18.6 21.8 21.4 18.0 27.7 31.9 17.4 14.3 20.0 18.3 29.2 28.7 12.2 28.5 11.2 13.4 17.4 34.2 17.3 18.1 13.6 13.2 43.6 20.2 20.8 15.4 22.0 49.7 15.5 13.1 15.7 20.3 19.1 18.2 28.0 17.8 49.4 20.0 12.5 14.2 34.8 20.6 25.9 15.7 17.6 14.9 10.7 17.1 30.0 25.3 17.1 28.4 18.6 22.4 20.3 15.9 10.8 5.7 11.8 11.8 18.3 12.1 13.9 14.5 13.2 10.4 18.7 14.5 2.5 22.8 7.3 7.4 17.1 13.6 16.2 16.5 26.6 21.8 15.5 13.6 16.7 18.2 21.6 13.1 NME1 "NDPKA, NM23, NM23-H1" ENSG00000239672 "NME/NM23 nucleoside diphosphate kinase 1" P15531 17 51153536-51162428 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008467, CAB040571, HPA041113" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 28000000 Cytosol "Nucleoplasm, Plasma membrane" "CAB040571: , HPA008467: AB_1079492, HPA041113: " "unprognostic (2.24e-1)" "unprognostic (2.01e-1)" "unprognostic (3.48e-3)" "unprognostic (5.96e-2)" "unprognostic (9.71e-2)" "unprognostic (2.33e-3)" "prognostic unfavourable (2.60e-5)" "unprognostic (4.54e-2)" "unprognostic (3.35e-1)" "unprognostic (2.33e-3)" "unprognostic (2.90e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.07e-9)" "unprognostic (9.01e-2)" "unprognostic (1.51e-1)" "unprognostic (1.83e-1)" "unprognostic (9.46e-2)" 25.0 29.5 38.0 28.1 30.1 27.9 29.0 19.6 41.9 16.4 25.4 13.1 10.1 15.1 17.3 22.5 30.1 22.2 13.4 14.1 41.7 39.4 19.6 56.0 14.2 28.5 34.2 34.2 15.6 43.6 13.7 17.3 16.9 38.9 14.5 36.8 14.9 34.3 14.7 14.8 22.4 12.4 29.6 20.5 22.4 13.4 11.6 11.3 19.0 18.8 32.7 41.4 22.8 15.2 24.9 36.2 0.6 19.5 17.2 20.3 18.4 47.6 95.2 32.9 45.9 13.8 22.1 55.3 37.2 25.8 77.1 58.5 74.9 28.9 83.9 38.8 34.4 25.6 62.8 63.2 66.0 40.7 84.6 55.0 73.9 103.9 28.0 60.2 25.2 21.0 39.8 58.0 54.3 46.4 81.1 27.9 45.6 80.7 71.5 69.3 39.4 86.8 43.9 64.9 77.2 59.2 33.3 45.7 52.6 19.5 53.4 34.6 55.6 40.8 29.2 49.8 45.2 30.9 76.3 36.0 83.0 98.8 30.1 51.1 37.8 0.2 15.2 0.6 13.4 19.5 20.3 24.9 14.4 14.6 36.2 17.3 16.4 17.8 0.4 17.2 11.5 20.7 12.1 18.4 38.0 30.1 19.6 41.9 41.7 39.4 34.2 34.2 38.9 11.3 NME2 "NDPKB, NM23-H2" ENSG00000243678 "NME/NM23 nucleoside diphosphate kinase 2" P22392 17 51165435-51171747 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Nucleotide metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB036213, CAB036214, CAB036215, HPA041113" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB036213: , CAB036214: , CAB036215: , HPA041113: " "unprognostic (7.21e-3)" "prognostic unfavourable (4.74e-4)" "unprognostic (4.85e-2)" "unprognostic (1.15e-2)" "unprognostic (8.86e-2)" "unprognostic (1.42e-2)" "prognostic unfavourable (7.09e-4)" "unprognostic (6.62e-3)" "unprognostic (5.68e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (6.41e-2)" "prognostic unfavourable (1.55e-6)" "unprognostic (2.82e-1)" "unprognostic (9.09e-2)" "unprognostic (8.87e-2)" "unprognostic (3.19e-2)" 62.1 54.6 42.3 58.2 44.1 44.2 188.9 20.1 43.7 58.9 74.0 16.3 67.7 52.5 65.0 52.0 104.3 56.8 65.3 115.1 38.2 32.1 77.3 115.7 59.0 174.7 45.0 23.7 90.7 234.3 17.5 30.4 37.9 34.0 64.0 62.7 29.9 109.4 65.8 105.3 63.3 45.1 88.3 34.6 69.4 50.2 32.3 24.4 42.5 66.9 102.0 56.6 81.3 140.8 49.3 71.3 8.3 43.7 32.6 34.5 38.2 91.8 135.0 32.3 56.4 72.3 105.5 89.2 63.7 66.3 97.5 74.3 108.9 48.9 77.3 103.2 65.2 58.8 67.8 86.9 80.3 93.1 200.5 65.0 94.2 157.6 79.0 102.5 45.5 95.5 101.5 62.9 110.7 58.0 88.9 52.1 70.2 163.4 51.3 128.2 48.2 207.4 49.2 107.1 123.4 105.6 116.1 73.7 45.7 39.2 98.5 95.6 67.9 78.7 58.8 94.0 68.0 66.8 101.2 91.1 118.3 88.5 50.8 52.2 47.1 8.3 35.1 2.0 24.7 43.7 34.5 49.3 33.0 26.9 61.5 36.2 23.8 25.6 2.1 32.6 38.0 71.3 29.9 38.2 42.3 44.1 20.1 43.7 38.2 32.1 45.0 23.7 34.0 24.4 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 7900000 Nucleoplasm Cytosol "HPA041113: , HPA052733: " "prognostic favourable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 20.6 45.6 18.0 12.9 19.8 6.6 20.0 21.9 18.2 16.6 18.0 11.0 31.6 25.7 14.4 19.1 12.9 14.3 21.5 11.8 17.5 16.1 17.7 11.2 17.3 11.3 18.4 15.9 22.1 26.8 15.1 24.1 9.7 14.4 26.9 6.4 13.8 34.3 41.4 15.2 9.2 24.6 14.6 14.1 20.4 17.5 7.2 14.6 5.1 24.1 11.7 8.8 11.5 17.9 19.3 34.1 15.5 25.6 20.1 24.4 20.0 0.7 11.6 0.2 9.5 2.7 1.4 1.1 6.8 2.0 1.2 0.9 0.0 13.8 0.1 18.9 0.9 9.8 0.6 3.8 0.1 13.5 30.8 0.0 5.4 5.5 5.1 2.3 4.3 6.3 3.4 1.2 0.6 2.4 4.6 1.9 1.1 16.8 0.2 4.5 12.3 9.4 6.4 0.1 18.0 2.0 0.5 13.5 10.4 20.4 15.4 1.6 14.7 5.6 8.5 2.5 9.6 8.1 4.6 4.9 1.5 1.0 3.5 0.4 5.8 4.9 25.6 15.5 17.5 22.9 17.1 19.3 24.4 16.4 22.0 16.3 21.4 16.8 5.3 20.1 24.5 34.1 21.8 20.0 18.0 19.8 21.9 18.2 17.5 16.1 18.4 15.9 14.4 14.6 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115172-138139443 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.1;testis: 36.2" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555" Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035648: , HPA044555: AB_10960286" "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favourable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favourable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.3 5.2 12.3 0.6 18.4 0.3 3.7 3.5 13.9 7.1 1.2 3.9 4.7 0.5 4.1 18.2 1.0 28.1 6.8 2.9 12.0 10.7 15.4 0.6 3.6 0.6 9.4 9.9 4.5 3.5 12.1 8.9 0.4 13.1 4.2 1.1 4.8 3.1 3.9 0.4 0.4 0.5 2.6 4.2 0.4 2.2 36.2 4.8 0.0 9.6 0.3 0.4 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.6 0.0 0.0 0.0 0.6 0.4 0.6 0.2 0.1 1.5 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.0 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 25.1 0.0 5.7 2.1 0.0 0.7 3.7 0.4 1.3 0.0 0.6 0.0 0.0 0.8 0.4 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 18.4 3.5 13.9 12.0 10.7 9.4 9.9 13.1 4.8 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270465-151290057 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell line enhanced" "Detected in many" "NB-4: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 75.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008588 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavourable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 12.0 14.2 5.0 18.6 7.1 26.4 14.0 1.3 5.8 8.9 15.0 3.4 11.1 13.2 8.6 10.4 16.1 9.8 14.7 8.7 5.9 3.8 13.0 20.4 18.5 26.9 5.1 2.7 14.8 8.4 2.9 6.5 24.6 6.9 13.6 10.5 5.0 9.8 7.9 5.1 7.3 26.0 13.1 7.7 30.2 10.2 5.3 6.4 36.7 14.9 10.2 14.2 10.4 10.3 10.8 17.0 75.1 26.9 14.3 12.5 14.9 10.7 5.3 0.2 0.0 3.0 8.4 10.5 3.1 7.4 15.1 23.0 1.1 24.6 10.5 11.7 4.7 6.1 1.1 2.8 3.9 22.3 0.6 29.5 5.5 0.6 12.9 28.0 8.5 5.4 3.8 9.0 2.0 18.7 14.7 2.6 2.8 8.3 23.4 41.8 6.2 7.9 25.3 0.6 9.0 12.5 9.3 1.5 0.0 6.6 7.2 4.0 1.1 32.0 10.1 2.2 5.0 7.1 4.5 0.4 0.3 0.6 5.2 33.7 2.3 31.6 19.7 21.6 10.8 26.9 12.5 10.8 11.3 10.7 17.0 9.1 9.2 9.4 75.1 14.3 24.4 6.9 9.7 14.9 5.0 7.1 1.3 5.8 5.9 3.8 5.1 2.7 6.9 6.4 NMNAT1 "LCA9, NMNAT, PNAT1" ENSG00000173614 "Nicotinamide nucleotide adenylyltransferase 1" Q9HAN9 1 9943428-9985501 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059447 Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA059447: " "unprognostic (1.94e-1)" "unprognostic (3.81e-3)" "unprognostic (7.54e-3)" "unprognostic (1.01e-1)" "unprognostic (3.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (4.45e-3)" "unprognostic (4.55e-2)" "unprognostic (1.12e-1)" "unprognostic (3.57e-1)" "prognostic favourable (3.85e-14)" "unprognostic (3.11e-3)" "unprognostic (1.17e-1)" "unprognostic (1.47e-3)" "unprognostic (5.16e-2)" 7.2 13.2 8.1 7.2 9.0 4.0 8.8 4.1 8.1 8.8 12.8 9.3 11.9 8.9 10.1 8.8 8.7 7.4 7.3 13.9 7.6 6.8 11.5 12.6 5.3 5.6 10.3 8.3 5.1 14.1 10.3 9.3 5.6 13.0 7.0 13.6 10.1 17.7 8.4 29.1 8.1 9.2 8.3 9.0 8.6 7.1 10.7 8.3 6.8 10.8 11.5 6.8 6.2 10.4 5.3 4.3 12.8 4.9 3.1 2.7 2.3 3.7 4.7 6.5 6.3 12.4 11.3 1.5 7.4 6.1 8.7 5.6 2.0 6.5 4.0 4.8 11.3 3.9 7.9 10.6 10.5 8.3 4.0 6.6 2.9 6.1 9.9 5.4 6.5 11.9 12.0 10.5 15.1 9.0 7.7 2.7 9.6 6.4 3.0 3.5 0.8 8.4 3.5 4.0 2.1 10.1 2.1 4.7 2.4 9.8 8.4 8.4 3.1 5.8 8.5 3.6 3.2 7.3 3.4 3.9 3.7 3.9 6.1 11.4 7.3 6.6 4.9 3.9 2.4 3.3 1.1 5.3 2.3 2.7 4.2 3.6 2.1 2.5 12.8 3.1 4.5 4.3 1.9 2.3 8.1 9.0 4.1 8.1 7.6 6.8 10.3 8.3 13.0 8.3 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.6;Karpas-707: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049795: " "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favourable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favourable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.0 1.1 1.5 3.5 12.1 16.3 8.3 7.4 11.7 1.9 3.0 0.0 13.5 3.0 4.5 7.1 8.9 1.6 5.0 6.0 29.6 1.8 2.1 2.4 2.6 10.8 2.0 0.4 11.3 12.7 3.1 6.4 12.9 0.2 36.5 13.1 3.8 1.9 1.8 1.9 4.7 0.6 13.4 19.2 15.2 9.1 1.0 0.2 3.2 3.3 4.1 8.4 2.1 8.9 6.4 1.2 5.9 2.0 16.2 12.9 1.8 10.5 2.2 6.5 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 271.6;skeletal muscle: 103.2" "Group enriched" "Detected in some" 7 "BEWO: 22.4;NTERA-2: 18.5" "Cancer enhanced" "Detected in some" "renal cancer: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA049909: , HPA054792: , HPA072450: " "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favourable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.0 0.0 271.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 1.0 1.9 0.1 103.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 18.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NMT1 NMT ENSG00000136448 "N-myristoyltransferase 1" P30419 17 45051610-45109016 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022949, HPA022963" Supported Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA022949: AB_1854534, HPA022963: AB_1854535" "unprognostic (1.40e-1)" "unprognostic (2.87e-1)" "unprognostic (1.30e-2)" "unprognostic (6.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (4.94e-4)" "unprognostic (4.96e-3)" "unprognostic (3.86e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (3.77e-3)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (4.17e-3)" "unprognostic (9.45e-2)" 28.8 32.6 44.9 28.2 37.3 12.0 26.1 34.5 64.3 23.7 24.4 17.2 22.9 23.4 27.3 29.3 26.6 30.9 17.3 26.8 37.7 29.6 28.8 36.6 26.7 27.2 27.7 43.6 29.3 21.8 41.6 23.7 32.7 38.1 23.7 23.1 18.1 34.9 30.1 75.5 28.8 24.8 30.1 36.6 28.2 23.4 26.1 34.0 20.7 29.4 18.6 30.9 25.1 43.3 10.2 18.2 7.6 9.3 7.4 10.0 3.3 16.9 22.4 19.4 17.1 35.1 22.7 20.4 18.9 25.0 36.8 30.4 25.0 14.6 20.4 27.4 26.0 16.0 33.3 26.5 34.2 51.8 23.2 20.3 15.0 24.7 23.1 26.1 24.5 28.6 24.1 27.4 21.8 24.7 32.2 10.4 20.5 14.5 31.7 17.8 18.1 23.5 21.7 28.9 15.5 29.1 15.7 16.2 14.6 11.9 10.9 17.1 23.6 20.7 19.8 22.5 17.3 18.1 25.1 16.1 22.8 20.4 24.1 14.7 23.8 6.5 8.1 7.6 7.9 9.3 7.2 10.2 7.8 9.3 6.6 7.6 10.0 7.6 5.3 7.4 6.9 18.2 7.5 3.3 44.9 37.3 34.5 64.3 37.7 29.6 27.7 43.6 38.1 34.0 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.5;HMC-1: 28.0;TIME: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 29.3 5.4 18.9 6.5 17.3 3.8 19.2 35.6 25.3 12.0 9.9 6.0 4.7 7.4 14.5 5.0 8.2 8.9 8.1 9.6 12.8 9.2 10.8 18.5 7.2 9.0 8.8 15.0 18.2 7.1 28.5 7.9 5.1 10.3 10.7 10.7 8.3 5.8 9.4 18.8 11.5 11.9 12.5 10.3 10.1 8.8 14.5 9.9 23.7 6.9 4.5 8.9 10.1 20.1 1.9 0.3 8.7 0.5 12.9 17.5 3.9 2.7 3.6 4.1 3.1 11.4 12.3 0.8 6.1 5.0 5.6 7.7 3.5 12.6 0.1 4.3 33.5 3.5 3.7 3.4 9.6 3.7 4.8 7.5 1.7 4.7 7.6 0.5 28.0 10.9 3.6 8.0 2.4 21.8 3.5 0.5 21.0 3.4 5.7 1.4 3.0 3.5 4.3 6.1 0.5 4.2 0.6 1.2 4.8 7.4 1.2 2.0 3.8 2.3 48.6 5.6 8.3 24.8 4.4 4.3 4.5 0.3 6.9 2.0 4.1 8.7 0.3 7.9 7.2 0.4 12.9 1.4 11.5 8.3 0.3 1.9 14.7 9.3 1.2 12.9 0.5 0.2 17.5 3.9 18.9 17.3 35.6 25.3 12.8 9.2 8.8 15.0 10.3 9.9 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313285 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 97.7" "Cell line enhanced" "Detected in many" "HSkMC: 67.4;LHCN-M2: 40.0;RPTEC TERT1: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" 15000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA059180: " "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-6)" "prognostic unfavourable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 23.7 1.4 0.6 8.8 0.9 0.1 14.6 0.6 1.7 13.1 8.5 0.7 4.9 0.5 15.8 8.7 12.0 8.3 15.3 8.2 1.6 0.0 4.7 97.7 10.0 3.4 1.1 0.6 11.2 2.0 0.6 2.6 8.6 3.3 9.6 3.3 1.6 3.6 6.7 18.3 8.2 4.3 12.4 1.5 5.8 5.1 7.3 0.6 1.3 5.3 2.2 3.1 10.9 35.3 0.6 0.1 0.7 0.2 0.0 0.9 0.0 0.0 4.7 0.0 4.2 24.3 31.6 0.0 6.0 15.9 9.6 19.1 0.0 6.5 0.0 21.4 12.2 0.0 0.0 2.1 9.7 0.0 0.0 0.0 7.4 0.0 33.1 0.0 0.0 67.4 23.3 6.8 10.1 13.2 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.1 0.0 26.8 0.0 103.7 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 9.3 5.5 22.1 8.5 1.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.9 0.2 0.0 0.2 0.1 0.6 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.6 1.7 1.6 0.0 1.1 0.6 3.3 0.6 NOB1 "ART-4, MST158, NOB1P, PSMD8BP1" ENSG00000141101 "NIN1/PSMD8 binding protein 1 homolog" Q9ULX3 16 69741867-69754940 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041522, HPA049430, HPA067411" Approved Approved "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "HPA041522: , HPA049430: , HPA067411: " "unprognostic (5.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.15e-1)" "unprognostic (8.61e-3)" "unprognostic (9.45e-2)" "prognostic unfavourable (4.21e-5)" "prognostic unfavourable (8.16e-4)" "unprognostic (3.26e-2)" "unprognostic (3.04e-1)" "unprognostic (7.51e-2)" "unprognostic (1.04e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.16e-1)" 18.2 31.6 9.9 14.5 18.0 17.4 18.9 13.4 16.2 18.8 19.4 12.5 12.4 20.3 21.3 15.5 25.4 29.2 19.0 13.3 9.6 9.7 18.4 23.4 13.3 21.3 12.9 7.5 37.5 68.5 13.9 10.1 13.1 13.5 21.5 12.7 13.0 20.4 14.8 26.3 25.1 15.5 18.0 10.1 21.5 20.5 11.6 15.4 23.7 28.9 25.8 29.0 25.6 18.4 21.0 20.3 2.0 15.0 24.5 26.1 17.3 14.6 32.2 7.6 21.5 16.9 26.7 15.1 11.8 16.5 22.2 20.2 36.4 24.2 32.8 18.4 13.1 21.9 20.8 26.4 13.1 8.2 24.3 12.7 15.2 46.7 30.0 23.5 10.8 33.8 22.5 25.5 32.6 18.6 29.0 10.2 11.0 38.4 29.5 47.2 23.3 19.2 32.8 7.8 41.4 16.4 14.4 19.8 9.8 37.1 13.1 18.4 14.2 21.3 14.1 15.1 13.7 13.7 19.2 16.8 12.8 57.7 15.1 21.5 16.6 0.1 15.0 2.0 17.6 12.7 24.6 19.4 21.4 16.1 20.3 21.0 23.1 21.0 0.7 24.5 9.5 10.5 26.1 17.3 9.9 18.0 13.4 16.2 9.6 9.7 12.9 7.5 13.5 15.4 NOC3L "AD24, C10orf117, FAD24, FLJ12820" ENSG00000173145 "NOC3 like DNA replication regulator" Q8WTT2 10 94333226-94362959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063958, HPA067638, HPA070981" Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA063958: , HPA067638: , HPA070981: " "unprognostic (1.29e-1)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.49e-1)" "unprognostic (1.27e-3)" "unprognostic (4.58e-2)" "unprognostic (6.49e-3)" "unprognostic (3.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-1)" "unprognostic (9.93e-2)" "unprognostic (5.50e-2)" "unprognostic (1.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.30e-1)" 16.7 13.2 9.2 11.2 14.5 3.7 14.4 10.8 12.7 13.5 8.9 6.0 8.4 6.7 14.1 8.5 14.3 12.1 7.3 8.8 9.3 6.6 11.0 15.0 9.7 14.9 16.4 7.7 15.4 7.8 12.5 18.2 11.0 14.5 12.5 8.2 6.3 9.7 8.9 18.8 11.6 8.4 9.8 16.6 19.8 8.1 14.1 13.1 12.8 15.7 13.6 16.0 16.1 10.6 13.7 4.3 0.5 4.1 7.5 5.8 3.1 17.6 9.7 6.6 21.2 6.9 11.2 7.8 14.2 11.3 19.5 22.7 16.4 12.6 19.2 10.4 7.1 12.8 18.7 8.5 31.7 13.1 14.0 13.0 8.1 10.5 13.8 20.6 5.9 6.4 8.4 20.5 20.7 8.6 20.1 9.7 19.1 6.0 12.9 15.3 13.9 10.7 5.8 15.1 10.6 11.5 5.5 4.7 11.7 10.1 5.1 15.7 13.2 8.0 8.3 12.5 12.6 11.3 23.8 9.3 18.5 26.7 11.4 20.0 9.3 0.0 2.4 0.5 4.3 3.9 5.4 13.7 4.4 5.4 4.3 12.6 5.8 5.1 0.1 7.5 4.1 3.8 4.0 3.1 9.2 14.5 10.8 12.7 9.3 6.6 16.4 7.7 14.5 13.1 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144448-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA053424: " "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 11.9 10.3 9.0 14.2 11.6 18.8 11.1 11.5 17.2 9.9 9.2 14.1 7.8 14.8 11.5 6.4 12.0 10.7 10.4 8.6 8.0 7.5 11.2 15.6 9.2 13.7 14.7 8.5 13.6 16.8 7.1 10.4 9.7 12.1 9.8 6.9 10.3 16.2 8.8 22.5 15.7 11.9 8.2 9.2 15.5 12.5 28.4 10.6 15.7 10.5 13.2 12.3 9.5 9.5 13.9 18.8 5.9 16.1 7.4 11.4 8.1 12.3 22.9 5.1 7.9 2.5 2.7 26.0 8.5 4.3 10.5 5.8 18.6 5.9 18.9 9.4 4.3 11.1 9.0 9.3 2.3 7.4 24.7 12.7 7.6 12.2 6.8 14.8 14.9 4.0 6.5 8.2 6.6 7.4 21.5 4.4 4.3 14.5 14.0 34.8 14.9 18.2 18.3 5.7 16.5 5.4 9.2 12.5 9.9 7.3 9.9 6.3 13.9 9.2 9.8 6.3 15.9 10.0 14.2 11.1 6.8 16.6 9.6 12.8 13.2 2.5 11.8 5.9 11.4 16.1 11.0 13.8 10.6 11.3 15.8 13.9 9.3 8.9 1.7 7.4 12.1 18.8 8.7 8.1 9.0 11.6 11.5 17.2 8.0 7.5 14.7 8.5 12.1 10.6 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: , HPA053714: " "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavourable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavourable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavourable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.8 5.6 2.2 4.2 5.0 2.1 13.7 7.2 5.2 10.3 7.4 7.5 2.0 16.0 5.8 5.3 3.5 11.5 6.3 9.7 7.2 4.7 7.4 3.4 6.5 4.6 10.8 4.4 2.4 3.1 11.4 7.8 4.5 13.3 5.3 4.5 5.5 7.4 5.7 7.1 6.0 6.1 6.5 5.6 6.9 3.1 8.3 5.5 4.5 5.2 4.1 3.8 8.4 6.7 5.5 7.2 5.2 8.6 4.3 4.0 10.1 5.1 21.5 7.0 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 NOD2 "BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1" ENSG00000167207 "Nucleotide binding oligomerization domain containing 2" Q9HC29 16 50693588-50734041 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;T-47d: 5.5;THP-1: 6.7;U-266/70: 15.4;U-266/84: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8" "Group enriched" "Detected in many" 6 "dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041985, HPA054494" Enhanced Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA041985: AB_2677780, HPA054494: AB_2682505" "unprognostic (1.01e-1)" "unprognostic (4.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-3)" "unprognostic (9.91e-3)" "unprognostic (5.84e-2)" "unprognostic (5.90e-3)" "unprognostic (1.23e-1)" "unprognostic (4.17e-1)" "unprognostic (3.88e-2)" "unprognostic (6.94e-3)" "unprognostic (1.48e-2)" "unprognostic (2.31e-9)" "unprognostic (4.38e-2)" "unprognostic (1.08e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 2.6 0.6 0.9 6.2 0.5 13.2 1.7 0.5 1.5 5.7 1.0 0.7 0.9 1.5 1.8 2.6 12.6 1.1 3.7 3.2 1.2 0.5 0.8 1.9 7.6 8.0 1.6 0.0 1.4 0.4 0.0 1.0 2.6 1.4 1.8 1.0 1.2 5.5 0.4 1.4 14.2 1.3 1.9 3.2 4.7 1.4 2.2 0.9 1.0 0.9 12.1 8.3 4.0 10.6 0.0 15.5 6.3 15.3 1.9 1.0 6.8 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 11.6 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 1.4 0.0 5.5 6.7 0.0 0.0 0.0 0.0 0.0 15.4 6.6 0.0 0.2 0.1 0.0 2.0 15.3 3.9 0.2 9.1 0.5 0.0 1.0 0.9 15.5 0.0 0.1 0.3 6.3 1.9 5.8 0.6 0.6 6.8 0.9 0.5 0.5 1.5 1.2 0.5 1.6 0.0 1.4 0.9 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003547 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favourable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favourable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavourable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favourable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 17.0 15.7 11.8 13.4 3.8 4.1 14.8 8.5 3.9 3.9 4.1 8.9 7.1 14.5 5.1 3.8 18.6 6.7 22.5 1.4 15.2 24.5 12.3 12.7 20.2 10.3 29.1 18.1 5.9 7.3 15.3 5.9 7.3 9.1 13.2 3.3 14.8 15.9 21.8 13.5 21.2 21.8 7.6 10.9 8.5 6.0 9.6 18.7 9.9 9.1 13.5 13.0 13.8 10.2 16.2 16.4 11.8 15.7 11.0 13.4 18.7 15.4 21.7 19.0 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.1" "Cell line enhanced" "Detected in many" "T-47d: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavourable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavourable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 16.3 22.6 13.0 3.2 19.6 1.3 9.4 7.3 14.1 8.4 7.1 10.8 19.7 5.3 7.5 10.5 15.4 7.8 15.7 29.1 11.1 8.3 10.1 12.8 10.1 2.6 15.9 12.3 6.8 12.3 22.8 14.8 8.6 12.7 19.8 6.1 13.8 18.0 13.3 76.1 39.7 5.2 10.6 11.6 3.7 11.1 2.7 15.8 0.6 9.6 27.7 6.3 9.4 9.2 0.0 2.1 1.5 6.8 0.7 3.4 2.5 6.1 10.1 1.7 9.5 8.5 6.5 9.5 5.0 5.3 5.4 3.2 2.1 16.3 0.1 16.6 5.8 10.3 2.3 7.7 1.3 5.5 3.5 0.2 8.0 3.2 5.3 0.5 1.2 3.9 14.4 4.3 3.0 2.3 2.2 6.6 10.2 16.1 0.1 0.8 1.6 24.9 5.5 3.5 12.3 9.2 1.9 13.5 7.2 21.0 15.2 2.2 32.5 1.7 5.2 7.2 6.2 7.0 4.3 9.6 3.0 1.7 20.4 1.5 2.4 0.0 6.8 0.0 0.3 0.6 0.1 0.0 3.4 0.3 2.1 0.0 0.0 0.5 1.5 0.7 0.2 2.1 0.0 2.5 13.0 19.6 7.3 14.1 11.1 8.3 15.9 12.3 12.7 15.8 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461441-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA055891: , HPA061002: " "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (9.49e-4)" "unprognostic (4.09e-1)" 15.3 14.9 13.3 17.7 19.7 21.0 14.9 16.8 30.8 16.0 11.4 14.6 9.0 10.3 15.3 11.9 21.1 12.8 18.2 13.1 12.4 10.6 13.8 41.6 13.5 15.8 10.1 11.4 20.5 20.5 22.7 18.2 15.4 19.2 17.5 14.8 12.5 15.5 15.5 23.4 23.5 11.3 17.0 7.3 17.6 13.0 19.0 7.8 13.8 13.2 19.7 20.9 12.4 14.5 4.2 7.1 0.3 8.4 3.9 6.0 3.4 15.5 22.5 8.6 19.4 13.5 9.3 14.7 17.4 13.1 20.4 17.2 24.8 5.7 27.2 8.0 19.5 10.9 24.9 25.0 21.6 17.2 10.3 14.0 26.2 13.7 13.3 31.8 20.5 10.2 20.8 27.0 26.1 13.3 22.7 10.5 16.2 13.7 17.8 32.0 31.0 20.6 15.4 8.5 14.1 15.8 18.7 10.2 14.0 14.5 18.8 6.2 7.6 18.6 14.9 12.6 17.0 15.8 30.3 10.0 13.9 23.0 11.1 16.9 14.4 0.0 4.0 0.3 5.4 8.4 6.0 4.2 4.1 5.2 7.1 3.6 5.1 4.8 0.2 3.9 7.9 3.8 4.0 3.4 13.3 19.7 16.8 30.8 12.4 10.6 10.1 11.4 19.2 7.8 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554535 "Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA036347: " "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 12.7 11.3 10.4 10.3 15.1 19.3 11.0 16.4 19.3 14.7 11.2 14.1 6.8 7.7 13.3 11.6 12.1 11.4 8.8 8.3 10.8 9.7 9.6 15.2 9.4 14.4 8.6 9.6 16.8 14.7 15.5 10.5 9.8 12.0 13.0 10.0 9.4 9.1 10.3 17.9 18.0 11.4 12.4 7.2 22.0 11.0 9.4 9.2 20.9 9.4 8.9 14.9 11.0 9.3 6.9 5.8 5.0 4.8 2.8 8.4 1.9 5.1 7.3 4.1 12.4 5.5 3.3 4.5 5.0 3.3 5.3 5.6 10.0 7.0 14.2 6.1 5.6 6.8 8.3 6.9 9.1 5.7 4.5 9.6 11.3 7.8 5.6 8.1 5.3 4.9 2.1 11.2 9.8 6.2 11.2 6.0 5.4 8.8 7.9 7.3 5.6 7.1 10.1 9.7 6.6 4.1 4.7 8.0 3.7 7.8 9.9 6.2 6.4 3.7 8.0 8.4 6.9 5.9 8.4 5.0 4.7 25.9 7.8 9.1 3.9 5.0 3.5 2.6 5.7 3.2 5.7 5.1 8.1 5.2 2.3 6.9 8.4 7.0 2.2 2.8 4.8 5.8 5.1 1.9 10.4 15.1 16.4 19.3 10.8 9.7 8.6 9.6 12.0 9.2 NONO "NMT55, NRB54, P54, P54NRB, PPP1R114" ENSG00000147140 "Non-POU domain containing octamer binding" Q15233 X 71283192-71301168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022069, HPA054094, HPA054559" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles" 150000 Nucleoplasm "Nucleoli fibrillar center, Nuclear speckles" "CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522" "unprognostic (2.39e-3)" "unprognostic (2.22e-2)" "unprognostic (2.64e-1)" "prognostic unfavourable (9.29e-4)" "unprognostic (8.87e-2)" "unprognostic (5.54e-2)" "unprognostic (1.02e-3)" "unprognostic (9.34e-2)" "unprognostic (2.32e-2)" "unprognostic (1.41e-2)" "unprognostic (3.12e-1)" "unprognostic (2.07e-1)" "unprognostic (7.29e-3)" "unprognostic (6.79e-2)" "unprognostic (5.73e-3)" "unprognostic (2.76e-2)" "unprognostic (3.04e-2)" 37.2 55.9 30.2 37.7 30.8 51.2 37.2 54.8 38.6 45.4 33.4 36.0 38.4 29.9 52.4 40.5 41.0 40.5 37.2 30.5 27.5 29.0 40.1 43.3 37.3 45.7 28.8 31.7 69.2 61.0 39.4 48.2 42.4 27.5 40.8 37.5 42.5 39.8 41.4 37.2 38.4 35.2 40.5 38.3 45.9 40.3 34.4 29.0 98.4 51.0 39.1 57.4 43.6 36.8 44.1 47.3 35.3 51.8 45.4 51.8 58.9 58.5 64.8 89.7 49.2 36.6 37.8 49.1 48.0 44.7 65.0 57.4 51.4 43.5 66.6 53.5 44.2 43.8 133.8 41.7 71.6 50.7 89.4 54.6 68.0 51.1 31.0 76.6 48.0 40.0 29.8 65.7 44.1 53.3 69.6 69.9 59.9 52.0 99.0 69.8 111.6 52.6 89.1 94.0 57.1 49.8 51.8 62.3 77.3 62.2 40.6 55.1 38.2 49.6 48.9 42.1 63.2 58.8 55.5 40.3 76.3 75.8 31.4 89.1 60.1 35.3 44.8 34.9 45.8 47.6 51.8 43.7 46.6 44.9 47.3 44.1 50.8 50.2 20.8 45.4 51.8 41.2 50.1 58.9 30.2 30.8 54.8 38.6 27.5 29.0 28.8 31.7 27.5 29.0 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963385 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: " "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favourable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.3 16.8 9.8 22.4 13.2 19.0 16.2 21.1 15.2 12.0 12.6 9.0 12.6 12.0 14.3 11.7 19.0 12.1 14.7 14.8 8.9 7.1 13.6 34.0 12.9 20.8 10.0 8.7 20.7 26.8 13.9 15.5 12.8 10.6 12.3 12.8 11.1 14.7 14.6 38.6 21.4 13.1 12.4 9.8 18.0 15.1 9.8 11.4 17.9 15.4 16.3 20.9 18.1 18.9 5.2 4.9 1.3 3.8 4.4 8.4 3.0 16.1 13.7 8.2 16.9 11.0 12.6 14.4 14.9 10.6 15.6 12.9 17.9 17.1 45.8 10.6 12.1 11.2 22.6 19.4 16.8 8.7 21.6 36.4 13.0 16.2 14.6 39.5 15.9 12.7 17.5 17.6 16.1 13.1 32.9 16.3 11.7 11.6 41.6 29.8 21.3 22.6 27.0 12.4 15.2 7.8 26.1 17.0 10.0 12.4 9.2 11.6 17.6 15.6 16.2 13.1 7.6 15.9 27.4 12.2 19.7 39.5 13.6 29.3 13.5 1.3 3.2 0.6 4.8 3.8 8.4 3.4 5.8 7.0 4.0 5.2 7.0 5.2 0.5 4.4 2.5 4.9 3.8 3.0 9.8 13.2 21.1 15.2 8.9 7.1 10.0 8.7 10.6 11.4 NOP58 "HSPC120, NOP5" ENSG00000055044 "NOP58 ribonucleoprotein" Q9Y2X3 2 202265716-202303666 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018472, HPA021062" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA018472: AB_1854564, HPA021062: AB_1854565" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (9.20e-2)" "unprognostic (2.15e-3)" "unprognostic (2.39e-1)" "unprognostic (3.94e-2)" "prognostic unfavourable (1.97e-6)" "unprognostic (6.64e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.86e-4)" "unprognostic (4.52e-3)" "unprognostic (5.20e-2)" "prognostic unfavourable (3.38e-9)" "unprognostic (1.79e-2)" "unprognostic (3.10e-1)" "unprognostic (1.33e-1)" "unprognostic (2.60e-1)" 25.1 26.5 16.7 41.6 24.6 47.1 32.2 30.2 24.2 28.8 21.6 13.7 19.5 20.3 31.0 25.9 31.9 26.4 17.7 21.7 21.4 20.3 23.4 36.2 21.7 40.4 16.9 19.1 32.9 31.5 22.3 47.8 24.0 21.9 26.7 27.0 17.1 25.5 29.5 36.9 22.7 25.2 24.1 19.3 33.0 23.5 17.5 17.8 40.0 24.6 32.8 41.4 31.1 41.3 23.5 22.2 4.3 15.2 21.2 26.7 13.5 26.6 18.9 18.7 23.3 14.0 12.7 44.4 25.7 13.8 19.9 18.6 41.8 24.1 41.3 21.4 15.5 24.7 37.1 31.6 35.1 16.1 34.1 49.8 28.5 41.1 20.8 49.2 24.0 16.3 18.8 27.6 63.5 17.7 54.3 31.5 24.7 28.3 44.8 54.4 46.9 32.9 37.9 28.4 54.4 23.4 32.3 29.0 21.4 23.8 34.2 29.5 23.4 38.9 15.3 25.4 29.8 22.6 43.8 25.7 46.9 59.1 18.7 35.1 30.1 4.3 10.2 3.1 16.8 15.2 24.5 23.5 24.0 22.7 15.9 18.7 26.4 26.7 1.0 21.2 10.9 22.2 23.7 13.5 16.7 24.6 30.2 24.2 21.4 20.3 16.9 19.1 21.9 17.8 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favourable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.1 10.2 8.3 10.4 7.2 6.2 8.3 9.1 6.8 10.8 8.5 7.6 9.0 13.1 5.2 8.3 13.3 16.4 11.3 11.3 8.3 6.2 9.6 14.1 17.5 5.8 22.0 11.0 6.2 8.9 7.9 7.4 10.0 8.1 6.5 7.5 8.8 10.1 8.3 3.7 13.1 12.8 5.0 8.4 6.6 11.7 8.4 6.4 12.8 15.0 2.8 6.3 5.8 10.2 7.3 6.0 6.0 8.6 9.2 8.1 9.9 4.0 10.1 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell line enhanced" "Detected in some" "HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: , HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 6.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 12.8 0.1 8.0 0.0 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Cell line enhanced" "Detected in many" "A-431: 6.7;HEL: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: , HPA055561: " "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.7 0.0 3.2 1.8 0.1 0.0 0.5 0.6 0.7 0.9 0.8 1.5 1.7 0.0 4.3 0.2 5.1 1.0 0.2 0.3 0.1 3.1 8.1 1.1 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.7 0.6 0.1 0.1 3.5 0.6 0.0 2.3 3.0 0.1 1.2 0.2 1.5 2.3 2.6 1.8 1.5 0.3 1.2 1.9 0.4 0.7 0.1 0.8 0.0 1.2 4.6 0.0 0.0 1.0 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 51.2" "Group enriched" "Detected in some" 4 "BEWO: 6.8;HEL: 26.1;K-562: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol Cytosol Vesicles "HPA044384: , HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 27.1 11.6 4.4 7.6 5.6 0.2 17.4 2.7 6.0 20.5 11.0 2.3 10.3 10.4 11.9 12.1 7.8 9.0 20.5 9.8 4.8 4.1 27.9 7.8 19.6 3.5 5.8 3.7 11.2 14.8 2.3 4.2 18.5 7.9 9.4 12.5 2.8 51.2 13.6 7.6 4.2 22.3 9.7 5.1 5.6 16.5 11.2 3.9 0.7 8.5 8.6 2.6 7.6 12.8 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.0 0.0 0.0 6.8 0.2 0.0 0.0 0.0 4.0 4.3 0.0 2.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 26.1 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 2.2 0.9 0.0 0.1 0.1 1.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 4.4 5.6 2.7 6.0 4.8 4.1 5.8 3.7 7.9 3.9 NOTCH2 ENSG00000134250 "Notch 2" Q04721 1 119911553-120069626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" 67000000 "Nucleoplasm, Plasma membrane" "HPA048743: " "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavourable (5.24e-4)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 12.0 7.3 6.0 9.4 6.8 4.4 10.6 3.0 5.6 14.5 7.6 4.4 11.3 1.6 12.3 11.8 13.4 11.4 12.8 7.9 6.8 2.3 5.5 11.4 10.6 5.7 5.3 7.6 15.5 27.6 6.1 3.3 10.3 6.5 9.9 5.2 9.4 17.7 10.0 9.3 17.2 6.1 12.4 6.2 11.5 5.8 15.7 4.4 8.0 11.4 8.6 6.6 9.6 13.0 4.2 5.2 7.7 9.6 1.5 1.7 2.0 14.9 5.0 7.8 6.0 32.7 28.0 7.8 11.4 15.7 15.2 16.5 4.6 4.0 0.3 9.6 21.5 5.7 12.4 10.1 24.3 17.9 7.9 8.6 13.6 0.4 12.2 9.0 2.3 22.4 6.6 45.6 30.4 7.7 0.1 19.0 18.3 16.7 3.8 2.5 10.1 5.6 2.5 27.6 9.6 8.0 9.5 0.3 3.9 15.4 14.5 8.2 8.0 3.1 27.1 19.9 13.7 29.8 17.8 7.9 3.9 4.4 29.2 8.3 18.9 5.6 6.4 6.4 1.5 6.6 1.7 4.2 1.3 1.1 5.2 3.9 1.0 1.7 7.7 1.5 9.6 4.2 0.8 2.0 6.0 6.8 3.0 5.6 6.8 2.3 5.3 7.6 6.5 4.4 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch 3" Q9UM47 19 15159038-15200981 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 27.9;MCF7: 27.4;U-87 MG: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" 18000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: " "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavourable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavourable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 35.9 3.7 4.7 6.4 6.4 0.5 53.7 2.7 7.5 25.9 7.3 6.2 9.2 3.7 22.9 23.1 33.8 14.6 22.7 25.0 4.6 3.6 9.2 1.6 16.2 11.7 5.0 6.4 14.1 6.9 10.1 4.9 37.3 6.4 13.4 3.0 8.3 11.4 11.4 16.6 48.3 6.2 11.0 2.8 11.8 5.5 10.1 3.9 44.4 14.9 36.7 10.3 14.9 24.6 0.1 2.4 1.0 0.1 0.1 0.1 0.0 5.2 3.3 27.9 12.7 3.9 3.2 12.6 4.2 0.2 0.2 0.1 6.3 5.5 0.1 3.3 7.7 6.2 5.0 0.1 0.2 0.0 1.3 0.1 5.2 1.4 1.9 0.0 0.5 3.6 3.1 6.5 0.7 0.3 0.2 0.2 0.5 27.4 6.3 0.0 16.3 0.0 0.0 1.6 0.1 0.0 16.9 0.8 9.0 0.0 15.9 0.0 16.9 0.0 0.0 0.8 9.1 0.1 0.1 0.0 0.3 0.0 19.5 0.1 0.4 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 2.4 0.0 0.0 4.7 6.4 2.7 7.5 4.6 3.6 5.0 6.4 6.4 3.9 NOVA1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443093-26597754 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell line enhanced" "Detected in many" "AF22: 25.6;ASC diff: 13.9;HAP1: 12.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 17.8 6.7 17.5 3.4 17.4 1.3 32.9 54.7 49.2 12.2 6.3 13.3 5.0 2.5 9.4 6.9 4.0 6.2 6.2 3.0 17.1 25.1 7.0 2.2 2.7 4.4 19.2 17.8 6.3 2.7 4.4 14.1 1.3 26.4 5.4 6.5 4.0 2.8 17.5 6.9 3.1 3.4 9.9 22.5 2.1 3.3 10.3 14.9 0.0 4.1 2.7 5.2 5.6 9.4 0.3 0.3 0.6 0.4 2.2 0.5 0.0 0.0 6.0 25.6 0.0 13.9 7.5 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.4 0.1 12.5 0.1 0.0 0.0 1.0 0.0 0.0 0.2 5.2 0.0 1.2 9.3 0.0 1.9 1.9 5.4 0.0 0.0 4.1 0.0 5.2 0.1 7.5 6.1 0.7 8.5 0.1 3.5 4.9 8.1 4.7 0.0 0.0 0.0 0.7 0.0 0.0 3.6 4.1 3.1 0.7 0.0 0.0 0.0 5.0 0.0 3.7 0.6 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.5 0.6 2.2 0.4 0.3 0.4 0.0 17.5 17.4 54.7 26.9 17.1 25.1 19.2 17.8 26.4 14.9 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Cell line enhanced" "Detected in some" "AF22: 8.1;HDLM-2: 8.6;HUVEC TERT2: 13.9;TIME: 20.7;U-2 OS: 5.1" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.6 0.0 0.0 0.0 0.0 0.0 20.7 0.0 5.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222642 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA045908: , HPA066370: " "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 15.7 9.8 8.5 18.6 11.5 7.1 12.0 24.6 12.8 13.1 9.3 7.5 8.9 7.1 12.0 10.7 10.3 10.7 8.2 9.4 7.8 8.7 10.1 9.5 11.5 23.1 10.7 8.9 15.2 9.1 14.6 21.5 18.3 13.1 10.7 11.0 7.9 11.6 8.4 8.8 12.2 12.2 9.0 13.7 17.1 10.0 11.3 11.1 26.7 14.4 7.5 21.6 15.4 10.7 5.2 2.2 7.4 3.1 5.8 11.6 3.6 4.9 4.0 6.3 7.8 7.8 5.7 5.1 7.4 9.4 6.6 9.9 8.2 10.8 8.5 10.0 4.6 9.3 8.6 7.5 11.8 7.6 3.4 14.1 4.4 4.2 3.4 10.5 9.4 5.4 4.4 11.5 7.4 9.2 13.0 4.2 9.1 2.4 12.9 5.7 5.2 5.6 8.9 8.9 11.7 4.3 7.2 6.7 6.2 9.5 5.7 7.3 6.5 5.2 7.5 11.5 6.1 6.7 6.6 2.9 3.7 33.3 2.8 7.8 8.8 7.4 1.7 3.2 6.2 3.1 6.9 4.9 7.2 7.8 2.2 5.2 11.6 9.2 2.2 5.8 3.0 1.7 5.2 3.6 8.5 11.5 24.6 12.8 7.8 8.7 10.7 8.9 13.1 11.1 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (2.01e-5)" "prognostic favourable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favourable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.7 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 35.6 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 11.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 19.0 5.6 0.0 36.0 7.7 6.1 22.7 15.7 5.4 18.2 12.2 39.3 4.7 20.2 3.4 6.2 24.2 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 NPFFR2 "GPR74, NPFF2, NPGPR" ENSG00000056291 "Neuropeptide FF receptor 2" Q9Y5X5 4 72031804-72148067 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4;seminal vesicle: 10.1" "Group enriched" "Detected in some" 10 "NTERA-2: 8.8;RPTEC TERT1: 11.4;SH-SY5Y: 13.5;U-2 OS: 13.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 4 "olfactory region: 5.3" "Low region specificity" "Detected in many" HPA026825 Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" "Plasma membrane" "Actin filaments" "HPA026825: AB_10603123" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (6.07e-2)" "unprognostic (4.68e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.51e-1)" "unprognostic (2.40e-5)" "unprognostic (5.75e-2)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-1)" 0.9 0.2 5.5 0.7 2.6 0.2 1.4 0.2 3.5 0.5 0.5 0.0 0.0 0.5 0.1 2.8 0.3 0.8 0.4 0.4 0.9 2.9 0.6 0.2 0.2 0.6 0.5 4.0 0.3 1.2 0.1 1.0 4.6 1.5 3.2 0.9 1.4 0.3 10.1 0.3 0.7 0.5 0.2 0.6 0.5 0.4 1.6 0.0 15.4 1.2 0.0 0.6 2.5 0.7 0.6 0.3 2.3 0.3 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 11.4 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.2 1.1 0.8 0.3 0.3 0.2 0.1 5.5 2.6 0.2 3.5 0.9 2.9 0.5 4.0 1.5 0.0 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: " "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.5 4.2 5.6 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.0 4.5 7.1 2.8 6.8 2.8 4.9 6.4 3.3 7.7 3.6 3.5 6.6 5.2 5.9 3.4 6.6 4.2 3.9 6.1 4.3 2.5 5.6 8.0 6.6 0.9 4.5 6.9 3.6 6.5 2.5 1.0 17.9 5.5 6.2 4.6 6.6 6.1 7.2 3.5 8.1 3.4 13.3 4.8 5.2 6.8 4.0 3.4 8.3 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.0" "Cell line enhanced" "Detected in many" "Karpas-707: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.0" "Group enriched" "Detected in many" 36 "granulocytes: 76.0;monocytes: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavourable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 14.9 6.8 10.9 14.2 12.3 12.4 5.3 3.5 10.2 3.9 5.3 15.0 11.4 2.4 2.5 23.7 8.0 4.1 10.1 4.7 9.2 8.7 37.4 15.4 14.3 20.4 16.0 8.6 2.8 3.2 2.5 2.5 32.9 15.4 4.4 7.4 3.9 5.7 5.8 2.4 6.5 4.8 5.8 15.3 32.1 4.0 4.0 14.4 3.1 3.4 1.3 10.9 11.8 5.5 0.7 1.3 76.0 23.6 0.0 1.3 10.3 2.7 0.5 0.8 0.0 2.4 2.4 0.7 0.9 1.8 1.0 0.5 0.0 1.2 7.3 1.3 0.0 1.1 1.6 2.0 0.2 0.0 1.2 11.6 0.3 0.1 1.3 4.3 6.9 1.9 7.7 0.2 0.0 0.1 8.7 11.7 1.8 0.9 0.2 2.9 9.3 0.9 1.1 0.6 8.9 0.2 6.1 2.6 3.9 4.2 0.2 3.7 2.4 7.1 0.2 1.0 2.0 0.6 0.1 8.4 10.1 7.4 2.1 7.8 3.0 3.6 23.6 18.0 1.0 20.8 0.9 0.3 0.8 0.9 1.3 0.7 0.7 0.9 76.0 0.0 16.0 0.2 1.3 10.3 10.9 12.3 3.5 10.2 9.2 8.7 16.0 8.6 15.4 14.4 NPLOC4 "FLJ20657, KIAA1499, NPL4" ENSG00000182446 "NPL4 homolog, ubiquitin recognition factor" Q8TAT6 17 81556887-81648465 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021560, HPA023295" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021560: AB_1854586, HPA023295: AB_1854587" "unprognostic (3.17e-1)" "unprognostic (2.98e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (1.16e-5)" "unprognostic (1.06e-2)" "unprognostic (4.42e-1)" "unprognostic (2.97e-1)" "unprognostic (4.15e-3)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.95e-7)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.72e-1)" 21.7 23.0 15.3 18.7 16.1 22.0 15.4 14.7 24.1 13.2 15.9 18.6 14.2 14.7 18.9 16.3 25.1 14.7 14.4 35.4 16.2 13.5 20.2 28.2 18.4 18.3 16.4 15.5 13.9 18.2 17.8 17.1 25.6 17.2 16.7 13.3 21.0 16.4 14.9 89.8 24.2 16.4 19.4 14.9 22.0 17.6 31.0 13.4 19.7 14.7 17.1 20.6 15.7 16.6 4.6 5.9 5.7 18.1 2.5 4.6 7.8 28.6 37.8 15.1 23.5 18.7 15.6 18.8 23.8 26.6 39.6 36.8 28.7 26.0 21.3 19.1 27.8 23.3 14.8 20.0 34.5 13.4 19.6 24.7 30.7 25.4 17.9 26.0 31.6 15.3 19.4 36.9 13.2 40.4 26.0 32.5 23.9 18.6 35.0 14.1 17.7 23.9 23.1 24.3 17.4 14.2 27.8 20.3 23.4 29.9 41.8 27.0 32.7 19.2 28.9 52.1 36.2 28.3 38.2 24.8 17.5 26.3 41.5 17.5 33.4 3.0 18.1 3.9 4.6 4.6 2.8 4.6 3.2 3.6 5.9 3.7 2.9 3.8 5.7 2.5 2.8 4.6 3.0 7.8 15.3 16.1 14.7 24.1 16.2 13.5 16.4 15.5 17.2 13.4 NPM1 "B23, NPM" ENSG00000181163 "Nucleophosmin 1" P06748 5 171387116-171411137 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011384, CAB012983" Supported Enhanced Nucleoplasm,Nucleoli 810000 Nucleoli Nucleoplasm "CAB012983: AB_2533084, HPA011384: AB_1854692" "unprognostic (1.84e-3)" "unprognostic (2.59e-1)" "unprognostic (2.23e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (7.48e-4)" "prognostic unfavourable (4.82e-6)" "unprognostic (1.86e-2)" "unprognostic (5.25e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-3)" "unprognostic (1.27e-1)" "prognostic unfavourable (2.89e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.24e-2)" 56.8 44.7 29.9 61.1 33.6 76.0 67.0 37.7 34.6 113.5 57.8 24.8 39.3 36.7 78.2 50.5 81.6 65.0 44.0 48.5 28.8 31.6 64.9 78.8 59.5 128.1 36.1 27.9 177.4 102.0 27.1 57.9 65.2 36.1 87.2 49.3 29.5 47.3 48.2 67.9 42.7 52.8 92.4 43.2 85.9 54.0 56.7 31.3 111.3 112.6 66.5 82.1 116.8 65.7 85.3 54.1 12.3 29.1 59.0 126.6 91.4 118.4 80.2 97.5 138.1 59.6 108.9 145.4 107.8 98.5 146.1 131.6 191.5 83.7 317.2 85.7 62.3 69.5 135.3 245.1 190.4 98.7 107.3 111.9 78.7 141.0 88.4 225.3 92.8 96.0 86.4 99.1 195.6 109.0 136.0 73.0 106.0 147.1 147.0 160.3 122.0 98.6 132.0 107.6 162.6 124.6 83.6 76.9 61.8 64.4 105.4 195.1 129.3 100.0 68.0 48.9 107.8 56.2 181.5 58.5 106.3 190.8 73.9 183.5 97.4 12.3 26.9 8.4 45.7 29.1 84.6 85.3 85.1 66.2 54.1 62.8 126.6 99.0 4.0 59.0 23.1 48.7 73.2 91.4 29.9 33.6 37.7 34.6 28.8 31.6 36.1 27.9 36.1 31.3 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell line enhanced" "Detected in some" "HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041070: " "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favourable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favourable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.8 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.8 3.7 1.2 2.7 0.0 0.9 0.0 13.1 0.3 0.0 1.1 0.1 0.3 10.6 0.7 23.4 2.4 1.4 1.0 0.4 1.8 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 2.8 0.5 0.3 0.2 1.0 0.6 4.4 0.0 2.8 0.2 0.0 0.0 3.5 0.5 8.3 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 9.8 17.0 14.3 20.9 8.5 17.2 14.3 1.5 16.8 13.3 12.3 2.4 6.2 6.0 15.7 15.0 22.7 11.7 12.4 8.9 9.9 7.3 13.6 13.7 8.8 26.3 7.3 11.4 17.7 39.0 11.3 11.1 12.0 9.1 11.5 15.1 3.7 13.2 7.1 11.7 14.0 8.7 15.0 4.8 14.7 11.0 16.4 7.7 18.5 9.8 23.7 18.8 13.0 13.9 4.5 8.3 0.1 3.7 7.0 10.4 5.7 17.1 21.8 6.5 42.7 14.9 15.7 6.9 9.3 14.2 14.5 12.4 23.4 22.0 28.5 17.4 10.3 18.5 36.2 39.5 11.4 12.0 37.6 22.8 10.2 37.4 16.8 51.9 16.7 13.6 19.2 20.0 80.4 18.9 28.1 15.8 11.9 31.7 21.6 67.6 11.5 16.8 17.0 34.2 28.9 14.1 8.5 13.4 8.6 5.8 13.7 25.9 17.8 10.8 7.4 5.7 18.4 8.5 17.2 6.8 7.1 32.7 8.0 48.3 5.9 0.0 2.7 0.0 3.8 3.7 7.0 4.3 6.3 7.2 6.3 4.5 10.4 10.4 0.1 7.0 0.8 8.3 2.6 5.7 14.3 8.5 1.5 16.8 9.9 7.3 7.3 11.4 9.1 7.7 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell line enhanced" "Detected in some" "BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: " "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favourable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 14.9 0.1 0.0 0.0 0.0 7.4 9.7 0.1 0.4 0.1 0.9 3.7 0.0 0.0 0.0 3.8 0.3 16.8 13.5 0.0 0.0 0.1 1.6 1.3 0.0 0.0 0.0 0.0 0.2 0.0 12.0 0.2 0.7 0.1 6.0 0.0 0.0 0.1 19.6 0.8 0.8 0.3 0.9 7.2 0.0 26.3 0.6 0.0 0.3 0.2 0.2 0.5 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell line enriched" "Detected in some" 6 "ASC diff: 59.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in many" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 59.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 7.1 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Cytokinetic bridge,Mitochondria" 21000 Mitochondria "Cytokinetic bridge" "HPA051497: , HPA072453: " "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.7 32.0 18.4 13.5 37.7 34.1 25.8 41.0 67.3 47.4 42.2 21.7 57.1 10.3 24.5 58.9 73.9 29.6 34.2 27.3 18.4 19.6 8.2 16.3 19.2 26.8 12.5 22.9 27.8 30.2 30.6 18.6 25.1 4.6 11.8 33.8 14.2 5.5 7.7 17.0 11.4 9.1 21.1 8.7 64.5 26.3 11.3 3.5 39.7 22.2 26.3 20.0 17.2 28.3 36.9 24.8 21.1 23.8 10.3 19.2 8.9 34.2 19.6 25.2 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617297-98629868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" 2488000 320000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: , HPA058320: " "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavourable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 4.3 24.0 7.1 2.3 8.4 1.0 1.4 0.2 45.6 8.2 3.8 3.2 0.1 1.1 1.8 3.9 2.2 1.5 1.6 3.2 9.2 11.0 0.9 0.9 0.8 0.7 9.4 2.2 1.5 19.5 0.8 71.6 0.8 7.0 2.1 1.4 1.3 1.5 2.2 2.9 4.0 1.3 2.9 2.9 6.1 1.9 20.7 5.0 0.0 1.6 0.1 0.9 1.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 125.7 0.0 0.9 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 10.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 7.1 8.4 0.2 24.6 9.2 11.0 9.4 2.2 7.0 5.0 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favourable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 5.9 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.4 0.5 0.4 0.8 0.1 1.2 0.2 1.0 0.0 0.1 4.4 0.6 0.0 0.1 1.9 0.1 3.4 0.0 0.1 3.5 0.1 0.1 4.4 0.0 0.2 3.5 1.0 0.7 0.0 6.9 0.9 7.9 14.8 0.9 11.0 0.0 0.3 4.7 1.1 0.2 6.8 4.2 0.0 0.3 1.0 0.0 0.0 42.5 8.6 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323961-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.2" "Cell line enriched" "Detected in some" 18 "HEL: 50.2" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029903 Approved Nucleoplasm,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoplasm "HPA029903: AB_10601276" "prognostic favourable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 18.0 15.9 5.2 1.5 17.1 0.2 17.5 0.9 11.4 6.2 3.1 0.7 3.9 0.7 5.0 5.4 2.3 4.3 2.4 2.6 7.1 4.2 16.6 8.3 1.2 7.2 1.5 5.8 1.8 14.5 1.1 3.9 2.7 3.5 1.9 2.4 2.0 11.0 4.5 1.5 5.0 0.9 3.1 3.7 55.2 1.2 2.7 6.0 0.0 4.4 1.4 0.6 3.4 3.3 0.5 0.3 1.2 0.4 0.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.9 0.7 0.4 1.2 0.5 0.1 0.6 0.4 0.7 0.9 0.0 0.5 0.7 1.2 1.1 0.3 0.2 0.3 0.3 0.0 5.2 17.1 0.9 11.4 7.1 4.2 1.5 5.8 3.5 6.0 NQO2 "DHQV, DIA6, NMOR2, QR2" ENSG00000124588 "N-ribosyldihydronicotinamide:quinone reductase 2" P16083 6 2987987-3028869 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021283, HPA021332" Enhanced Supported Nucleoplasm,Cytosol 6500000 Cytosol Nucleoplasm "HPA021283: AB_1854600, HPA021332: AB_1854601" "unprognostic (7.11e-3)" "unprognostic (1.43e-3)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.00e-2)" "unprognostic (3.58e-1)" "prognostic unfavourable (8.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (4.90e-2)" "unprognostic (6.59e-2)" "unprognostic (3.60e-2)" "unprognostic (8.28e-2)" "unprognostic (2.03e-1)" "unprognostic (3.32e-2)" "unprognostic (3.96e-1)" "unprognostic (2.02e-1)" 24.7 45.6 18.2 11.0 17.6 27.2 21.9 44.3 28.1 12.9 11.5 8.9 8.8 15.6 10.4 15.4 12.1 11.2 12.8 38.2 16.0 13.3 82.9 47.0 11.7 17.5 17.0 23.5 13.5 18.4 12.1 9.3 12.1 24.5 12.7 9.0 18.0 24.5 13.5 41.3 20.2 15.5 10.7 11.8 15.3 12.8 7.7 12.5 7.0 11.9 13.9 7.9 10.4 11.0 3.2 16.6 62.1 25.2 7.3 9.3 13.1 12.6 21.4 13.0 28.7 23.1 13.7 14.0 12.3 15.8 11.3 12.8 22.5 4.8 11.1 44.9 21.1 9.7 13.4 8.5 8.9 25.8 11.4 6.8 26.3 22.5 18.8 6.8 21.8 8.4 10.2 13.8 12.8 11.0 38.9 6.6 9.4 28.1 7.8 12.7 17.7 17.8 14.6 15.6 32.4 17.1 6.8 2.8 5.1 18.6 8.0 39.0 10.9 4.7 19.0 10.7 4.2 14.3 5.3 14.5 32.8 3.4 12.6 20.8 21.1 5.6 25.2 13.5 9.2 15.7 6.6 3.2 8.3 8.3 16.6 2.1 5.0 5.7 62.1 7.3 13.9 1.7 9.3 13.1 18.2 17.6 44.3 28.1 16.0 13.3 17.0 23.5 24.5 12.5 NR0B1 "AHC, AHCH, DAX1, DSS" ENSG00000169297 "Nuclear receptor subfamily 0 group B member 1" P51843 X 30304206-30309598 "Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Receptor, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 23.9;testis: 36.0" "Group enriched" "Detected in some" 4 "A549: 34.3;RT4: 10.8" "Cancer enhanced" "Detected in many" "lung cancer: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA061948, HPA067207" Supported "Nuclear speckles,Vesicles,Centriolar satellite" "Nuclear speckles" "Vesicles, Centriolar satellite" "HPA061948: , HPA067207: " "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" "unprognostic (9.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (7.45e-3)" "unprognostic (4.83e-2)" "unprognostic (9.00e-2)" "unprognostic (1.33e-3)" 0.4 23.9 1.0 0.0 0.8 0.0 0.2 0.4 1.1 1.3 0.1 1.7 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.5 0.6 3.5 2.1 0.0 1.6 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.6 0.1 0.7 36.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.4 1.1 0.9 0.9 0.5 0.6 0.6 0.7 NR1H2 "LXR-b, NER, NER-I, RIP15, UNR" ENSG00000131408 "Nuclear receptor subfamily 1 group H member 2" P55055 19 50329653-50382982 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005446, HPA056838, HPA070212" Uncertain Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA005446: , HPA056838: , HPA070212: " "unprognostic (1.31e-1)" "unprognostic (5.35e-2)" "prognostic unfavourable (9.86e-4)" "unprognostic (1.34e-3)" "unprognostic (1.68e-1)" "unprognostic (5.24e-3)" "unprognostic (2.26e-2)" "unprognostic (9.69e-2)" "unprognostic (6.45e-2)" "unprognostic (5.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.88e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (5.12e-2)" "unprognostic (1.69e-3)" 30.1 27.5 24.5 24.7 27.5 98.0 24.4 20.6 33.5 25.1 30.9 23.1 25.2 30.9 31.2 23.1 27.9 26.9 28.7 36.8 23.8 19.4 27.1 31.4 28.3 23.3 31.7 25.9 26.5 37.6 22.0 18.6 30.5 28.1 27.9 10.5 23.2 33.8 33.8 76.2 25.3 30.3 29.9 22.9 29.9 26.7 21.2 29.1 20.4 27.1 24.4 21.7 33.2 27.6 34.1 34.2 63.0 37.7 22.3 28.6 32.5 16.0 42.2 4.1 10.3 12.1 12.8 13.2 22.2 18.9 13.2 15.1 8.7 15.6 10.3 19.9 13.3 15.0 2.6 12.1 3.2 25.7 22.7 9.9 14.2 9.0 23.3 16.3 27.1 13.4 16.6 13.5 9.2 12.0 16.1 21.5 7.4 17.8 11.6 13.4 8.3 36.3 7.0 10.7 17.9 11.3 18.0 4.6 16.1 14.4 17.9 13.9 12.3 13.6 15.1 17.7 14.4 18.0 19.7 26.9 22.2 7.5 35.3 10.8 17.7 39.1 35.9 63.0 27.7 35.0 27.0 34.1 27.4 25.9 34.2 34.1 28.6 24.9 55.4 22.3 37.7 29.5 24.4 32.5 24.5 27.5 20.6 33.5 23.8 19.4 31.7 25.9 28.1 29.1 NR2C1 "TR2, TR2-11" ENSG00000120798 "Nuclear receptor subfamily 2 group C member 1" P13056 12 95020229-95073703 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035040, HPA035041, HPA067767" Supported Supported "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "HPA035040: , HPA035041: , HPA067767: " "unprognostic (2.44e-1)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.51e-1)" "unprognostic (3.56e-3)" "unprognostic (3.01e-2)" "prognostic unfavourable (5.18e-5)" "unprognostic (1.30e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-1)" "unprognostic (3.83e-2)" "unprognostic (4.56e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (2.31e-1)" "unprognostic (1.42e-1)" "unprognostic (2.16e-1)" "prognostic favourable (5.62e-5)" 11.6 15.8 15.9 11.8 14.7 15.5 12.4 38.3 23.9 12.5 11.2 12.5 12.9 11.2 17.6 20.2 8.3 15.5 11.1 14.8 14.6 9.3 10.3 14.0 14.2 9.9 11.7 15.2 16.3 12.5 16.4 15.4 11.2 13.7 10.7 12.7 14.6 8.0 17.4 19.6 11.0 11.2 15.7 14.2 14.3 10.5 22.2 14.9 12.3 18.0 9.0 10.2 12.3 10.7 4.5 6.2 3.5 4.2 3.5 9.0 3.9 8.0 10.0 15.9 7.4 3.7 6.6 22.6 7.9 5.7 7.9 7.4 8.8 4.5 9.7 2.8 5.2 8.6 7.8 6.1 6.0 4.2 16.6 11.8 8.0 10.5 8.4 7.9 5.2 7.6 5.0 5.4 6.7 8.4 9.0 3.8 9.2 5.3 8.5 18.3 10.7 17.5 8.2 11.1 5.8 8.8 9.3 8.2 6.5 12.6 5.4 5.8 9.5 5.0 7.9 6.4 6.3 7.8 4.4 5.6 9.1 9.4 1.6 9.2 3.0 0.5 4.1 3.5 7.1 4.2 9.0 3.7 5.7 6.0 6.2 4.5 7.2 5.0 2.6 3.5 3.7 6.2 3.7 3.9 15.9 14.7 38.3 23.9 14.6 9.3 11.7 15.2 13.7 14.9 NR2F1 "COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583224-93594615 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 57.8;AN3-CA: 22.9;HHSteC: 44.5;PC-3: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB019281: , HPA058974: " "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavourable (1.47e-4)" 15.8 22.9 22.5 5.0 13.7 1.2 9.1 27.4 25.1 31.7 4.6 12.9 10.8 3.3 20.6 24.1 9.4 32.3 30.7 7.2 20.9 13.7 16.4 10.6 18.0 12.7 13.4 23.0 40.4 4.4 1.8 10.3 46.0 14.6 20.5 3.8 44.4 7.2 38.9 1.2 1.6 4.4 14.2 26.7 6.7 12.9 5.9 11.4 0.0 7.5 4.8 4.2 20.9 18.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 4.7 2.3 57.8 22.9 12.3 3.8 2.7 2.8 1.1 1.7 1.8 0.3 0.8 0.0 0.1 1.1 1.2 1.4 0.0 0.7 5.8 11.1 2.2 14.0 3.5 44.5 0.4 0.2 17.7 0.0 0.8 0.3 6.4 0.0 0.0 5.2 0.0 0.0 0.6 0.0 47.8 0.6 0.4 0.0 0.3 0.2 5.9 12.1 1.2 0.0 0.1 0.4 0.9 6.4 9.8 0.4 5.1 7.0 0.0 0.0 0.0 16.1 0.2 4.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 22.5 13.7 27.4 19.8 20.9 13.7 13.4 23.0 14.6 11.4 NR2F2 "ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058974: " "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 30.8 15.0 19.6 13.8 5.3 0.2 81.2 3.7 6.2 85.7 21.9 2.9 22.3 7.0 70.0 32.6 27.7 32.4 50.8 30.1 12.5 8.4 39.8 15.0 25.0 35.4 7.8 3.4 105.1 7.3 12.3 9.6 24.0 7.1 28.6 9.0 30.5 7.7 43.5 18.4 8.3 10.8 27.2 9.8 63.4 26.9 32.5 4.8 1.1 18.5 16.2 7.0 32.6 34.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 31.1 8.0 26.5 16.4 53.8 18.6 8.8 22.6 17.4 23.5 20.2 27.7 31.9 0.0 18.5 11.3 18.7 4.6 16.2 29.7 0.1 18.1 10.1 10.4 5.0 15.0 7.7 3.8 13.2 5.6 19.5 4.2 43.2 26.8 0.0 14.8 21.5 0.0 5.5 0.2 11.0 0.0 6.5 0.0 51.4 34.1 3.3 0.0 2.5 0.7 3.4 12.8 0.5 44.4 25.6 8.4 5.9 7.9 0.0 0.0 0.0 14.3 3.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 5.3 3.7 6.2 12.5 8.4 7.8 3.4 7.1 4.8 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.0 20.5 1.5 0.0 13.5 15.1 1.8 15.8 18.9 13.6 15.8 1.5 13.5 8.9 7.2 23.1 9.6 0.1 12.4 16.9 5.0 7.0 2.3 27.8 4.4 12.7 9.2 7.1 10.9 16.1 22.4 21.9 5.1 3.3 34.0 12.0 3.6 5.4 6.6 4.1 4.3 1.9 14.3 18.9 4.0 0.7 2.7 2.1 27.6 4.0 6.6 1.8 13.3 12.1 33.2 6.6 15.8 11.9 6.9 6.2 14.0 17.4 9.5 11.5 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 NR4A1 "GFRP1, HMR, N10, NAK-1, NGFIB, NUR77, TR3" ENSG00000123358 "Nuclear receptor subfamily 4 group A member 1" P22736 12 52022832-52059507 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 25.3;MCF7: 28.8;SK-BR-3: 27.3;SK-MEL-30: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "intermediate monocyte: 18.2;non-classical monocyte: 24.4" "Lineage enriched" "Detected in many" 13 "monocytes: 24.4" "Group enriched" "Detected in many" 5 "amygdala: 35.3;basal ganglia: 43.1;cerebral cortex: 77.4;hippocampal formation: 65.3;olfactory region: 79.3" "Low region specificity" "Detected in all" "HPA059742, HPA070142" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA059742: AB_2684119, HPA070142: " "unprognostic (2.40e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (1.74e-1)" "unprognostic (1.65e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-2)" "unprognostic (2.22e-3)" "unprognostic (1.90e-1)" "unprognostic (1.16e-1)" "prognostic favourable (6.99e-4)" "unprognostic (3.41e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-2)" "unprognostic (8.89e-3)" 69.1 111.3 4.0 58.1 12.9 5.7 25.0 5.4 10.9 32.3 23.3 21.1 46.0 5.6 49.8 33.9 28.1 63.3 99.9 76.7 4.8 5.0 17.9 12.1 50.1 8.3 7.5 5.9 177.3 16.1 28.9 51.8 7.6 13.1 88.3 13.8 43.7 66.8 203.2 32.3 23.4 24.3 98.4 6.8 5.1 32.8 11.8 6.4 11.9 34.7 35.8 14.9 71.4 54.5 0.4 1.8 0.2 24.4 0.1 0.2 0.7 1.8 9.5 1.8 3.4 1.3 0.4 7.2 1.8 3.6 1.4 2.0 9.3 1.8 2.0 0.8 3.2 1.0 5.6 0.8 0.8 0.1 2.0 2.6 25.3 2.6 1.4 1.0 8.9 0.3 1.1 1.4 0.1 0.4 2.5 0.4 0.1 28.8 0.7 2.7 5.2 1.0 0.8 0.3 4.7 0.0 0.7 1.5 4.7 5.9 27.3 47.6 1.7 3.0 0.0 1.4 4.6 0.9 1.5 16.1 7.6 4.1 0.9 0.7 7.9 0.1 0.6 0.0 0.1 18.2 0.1 0.4 0.0 0.0 1.8 0.4 0.2 0.0 0.2 0.1 24.4 0.1 0.1 0.7 4.0 12.9 5.4 10.9 4.8 5.0 7.5 5.9 13.1 6.4 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell line enhanced" "Detected in some" "BEWO: 47.0;CACO-2: 10.8;Hep G2: 10.5;K-562: 13.8;NTERA-2: 16.7;U-266/84: 10.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA031461: , HPA045145: " "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.2 0.8 0.1 0.1 47.0 0.0 0.4 0.3 0.5 10.8 1.2 2.1 0.4 0.0 1.1 0.6 0.5 0.7 0.5 2.0 1.6 1.7 10.5 0.0 0.9 3.1 0.0 0.6 0.5 0.6 0.1 13.8 0.3 0.2 0.2 0.0 1.3 16.7 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.1 1.9 0.3 0.9 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Cell line enhanced" "Detected in many" "HaCaT: 23.3;HEK 293: 11.7;NTERA-2: 17.1;T-47d: 11.9;TIME: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.7 1.4 0.0 6.4 0.0 23.3 6.4 0.2 0.1 0.2 11.7 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 5.3 6.9 0.1 0.0 7.7 0.1 2.7 17.1 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 11.9 1.9 17.0 0.0 0.0 0.1 0.9 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 100.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 100.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021670: , HPA059477: " "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 15.1 10.0 10.7 16.1 10.2 22.1 21.6 10.9 13.9 12.3 12.3 7.0 9.0 12.4 13.9 9.9 13.9 10.0 13.2 13.6 10.9 9.5 10.6 50.2 19.1 29.4 13.1 8.9 9.2 10.3 6.9 11.5 21.3 11.7 8.7 12.8 6.0 14.8 11.0 46.2 14.6 15.0 10.8 11.7 22.9 10.5 10.0 8.9 16.4 14.2 13.9 14.6 14.6 13.5 7.0 10.0 100.9 13.3 4.3 5.7 7.2 8.7 8.0 8.0 7.3 19.2 29.6 8.0 12.6 21.6 10.1 14.4 16.9 9.4 11.4 6.2 14.1 6.9 7.7 10.6 13.8 10.2 7.8 8.4 4.2 13.5 24.6 11.1 9.9 27.4 22.9 16.4 40.4 10.3 8.5 13.3 12.8 6.5 9.4 19.8 9.3 33.3 9.2 7.2 6.6 11.6 5.0 4.6 7.9 7.5 14.6 21.9 9.1 11.1 10.5 7.0 10.4 10.9 13.3 16.8 12.8 13.8 19.6 17.9 5.6 13.8 11.8 22.8 4.5 13.3 4.7 7.0 4.6 4.9 10.0 5.9 5.7 5.3 100.9 4.3 12.5 4.9 5.1 7.2 10.7 10.2 10.9 13.9 10.9 9.5 13.1 8.9 11.7 8.9 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell line enhanced" "Detected in some" "A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.0 25.2 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.5 0.0 0.0 47.1 0.2 0.1 0.5 0.4 0.2 0.0 3.3 0.0 0.2 0.2 0.0 0.2 50.3 4.2 0.0 0.0 0.1 16.2 0.0 0.2 0.4 9.7 0.1 0.0 3.4 0.0 0.0 7.4 8.5 5.8 0.0 4.9 31.0 0.3 0.0 0.5 0.0 0.0 17.2 1.1 0.2 0.0 4.2 0.0 0.1 0.2 0.1 0.0 14.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047050: , HPA050583: " "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 3.4 2.0 3.4 3.6 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 1.6 1.4 3.6 1.7 2.5 3.6 3.4 1.2 2.1 3.2 5.3 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 3.1 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 NRF1 "ALPHA-PAL, EWG" ENSG00000106459 "Nuclear respiratory factor 1" Q16656 7 129611714-129757082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029329 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029329: AB_10601240" "unprognostic (2.80e-2)" "unprognostic (2.20e-3)" "unprognostic (4.51e-1)" "unprognostic (4.04e-2)" "unprognostic (2.01e-1)" "unprognostic (4.20e-3)" "prognostic unfavourable (6.02e-4)" "unprognostic (1.09e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-3)" "unprognostic (1.83e-2)" "unprognostic (2.06e-1)" "unprognostic (6.52e-2)" "unprognostic (4.20e-1)" "unprognostic (2.06e-3)" 14.8 7.3 10.9 18.9 13.0 20.3 18.2 22.2 11.1 15.4 10.3 12.6 16.0 9.0 15.7 10.4 10.1 18.7 10.0 12.3 11.5 11.1 10.0 7.8 11.2 18.7 12.1 7.7 24.4 15.2 13.5 10.9 12.5 11.5 11.5 9.9 11.7 13.8 13.9 19.3 12.2 10.7 14.0 9.6 14.2 8.7 17.2 15.2 29.2 13.8 11.4 16.1 12.8 19.2 8.8 7.0 13.1 7.0 5.8 13.3 6.2 11.6 9.6 13.8 12.2 8.4 6.7 11.0 8.1 8.5 12.5 9.8 11.6 7.8 13.4 6.0 9.2 8.9 14.9 8.2 12.8 12.8 10.6 11.1 8.1 7.8 6.1 13.5 11.1 5.7 7.8 12.3 11.9 9.2 13.4 10.4 7.6 10.6 26.5 12.8 12.9 8.5 17.0 11.2 11.9 7.1 8.5 12.0 13.1 12.3 12.8 8.2 7.9 13.0 7.0 7.1 9.8 8.2 14.9 11.3 11.2 23.8 7.5 12.6 13.6 6.1 5.5 13.1 11.4 6.9 13.3 7.7 8.7 10.5 7.0 8.8 9.6 8.2 11.4 5.8 7.0 4.7 9.1 6.2 10.9 13.0 22.2 11.1 11.5 11.1 12.1 7.7 11.5 15.2 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;Karpas-707: 5.5;PC-3: 14.5;RPTEC TERT1: 7.4;SCLC-21H: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: " "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 1.9 0.2 8.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 2.4 0.4 0.2 0.1 4.7 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.2 0.0 5.5 0.0 0.4 0.0 0.0 0.1 14.5 0.1 0.0 0.0 7.4 1.7 5.5 3.3 0.0 3.2 3.3 0.0 0.0 0.2 2.5 0.4 0.0 1.6 1.1 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: , HPA060036: " "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.6 20.4 16.1 0.0 8.1 5.2 5.7 11.5 5.1 7.6 5.8 3.8 7.6 0.0 6.5 10.9 5.0 1.0 6.8 15.4 0.0 4.4 14.5 7.1 11.7 4.8 7.2 3.2 6.4 9.5 7.9 9.3 5.6 10.3 8.0 5.0 5.4 3.3 0.0 6.5 6.1 40.9 12.6 0.3 4.4 16.6 1.4 0.0 9.5 5.0 3.8 12.2 5.5 9.7 6.2 4.2 9.6 4.6 3.8 0.0 0.0 13.6 0.0 3.1 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favourable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.7 2.1 0.0 0.0 0.0 4.4 2.2 2.3 0.6 0.0 1.7 0.0 0.0 0.0 1.6 2.6 3.7 4.6 0.5 0.0 4.5 2.8 0.1 0.0 0.0 0.0 0.0 2.1 5.4 0.0 1.8 2.8 2.4 3.0 0.8 1.7 3.1 1.4 0.0 3.0 2.3 3.4 1.6 2.4 0.5 1.7 0.8 2.3 1.2 1.5 1.8 3.1 0.9 0.2 3.5 3.0 2.2 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 7.3 0.0 19.9 0.4 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026066: , HPA064599: " "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 1.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Supported "Vesicles,Plasma membrane" "Secreted in other tissues" 15000000 "Vesicles, Plasma membrane" "HPA039980: AB_10795517, HPA054974: " "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavourable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.6 14.1 9.0 0.0 8.2 2.6 2.6 2.2 4.3 2.8 2.7 13.3 34.2 0.0 3.4 7.1 5.4 0.4 4.3 4.6 0.0 1.9 0.1 0.6 0.1 22.2 0.0 0.5 19.5 3.3 3.9 3.5 30.0 0.0 0.0 1.9 0.0 0.0 0.0 11.3 2.5 0.0 0.5 3.1 5.7 0.0 8.1 0.3 0.3 0.0 20.2 0.0 0.1 28.6 12.4 0.1 3.2 58.5 0.0 0.0 0.8 27.6 0.0 25.9 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.3;SH-SY5Y: 11.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019681: , HPA061006: " "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.6 0.1 1.6 0.0 0.3 0.1 0.0 0.1 1.6 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.9 1.2 0.1 0.2 0.3 0.9 0.7 2.5 0.5 0.2 0.5 0.0 0.0 14.3 11.4 0.0 0.1 0.9 1.7 3.4 0.2 0.4 0.6 0.1 0.4 0.8 2.2 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favourable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.7 22.9 13.8 13.0 18.3 20.5 5.4 12.5 24.2 22.7 22.9 12.6 0.4 0.0 4.4 23.1 8.3 11.1 1.9 14.5 0.1 11.2 6.8 10.9 23.8 18.5 0.2 1.1 23.2 1.5 16.2 2.7 15.6 13.4 12.2 19.9 3.3 0.3 5.8 10.6 11.8 10.7 7.7 0.9 22.7 0.1 28.2 20.3 14.9 4.4 21.4 18.3 7.0 10.4 24.4 12.9 0.9 15.2 2.2 0.4 5.1 3.2 0.2 12.8 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2, ribosome biogenesis homolog" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA043487 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA043487: " "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 25.4 32.6 17.4 26.8 29.3 28.3 24.0 14.0 29.4 31.8 25.8 8.0 18.0 26.2 26.5 22.6 27.9 22.9 13.5 27.7 20.8 13.6 27.4 35.4 27.0 42.5 16.7 19.1 54.2 31.2 13.5 35.4 25.4 20.3 27.8 20.6 10.4 33.8 17.9 51.1 17.3 22.2 23.1 28.5 28.5 24.3 44.5 15.7 26.4 27.2 21.7 26.1 36.7 26.1 17.0 11.1 4.4 11.9 13.1 19.3 6.1 20.3 11.1 13.8 18.5 8.6 15.8 21.0 14.6 7.6 9.3 7.4 18.4 20.0 16.5 31.1 8.0 12.6 10.8 16.1 13.2 11.2 16.8 8.6 21.7 21.1 8.0 14.9 20.2 10.4 15.2 12.4 9.2 7.7 8.5 13.9 9.9 15.4 25.1 37.6 9.1 9.7 18.0 16.1 31.0 11.7 22.5 14.8 19.3 8.8 17.1 39.3 16.0 42.6 8.9 7.1 21.7 13.5 41.8 13.9 18.5 26.9 18.0 26.5 10.7 4.4 7.2 4.2 10.5 11.9 15.1 17.0 16.0 15.8 11.1 12.4 19.3 19.1 1.3 13.1 8.8 10.4 15.8 6.1 17.4 29.3 14.0 29.4 20.8 13.6 16.7 19.1 20.3 15.7 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300215 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA048431: , HPA070333: , HPA073705: " "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 11.8 13.2 11.9 25.4 15.7 23.9 14.0 28.9 16.7 15.6 14.2 18.5 17.0 10.6 19.0 13.9 17.8 13.6 15.8 11.7 12.8 11.5 14.4 10.5 12.3 19.4 12.9 11.7 16.6 27.1 24.6 19.3 16.0 13.4 14.2 14.3 13.8 13.5 18.7 20.6 16.1 14.5 15.6 13.2 16.1 13.1 28.1 16.1 27.3 20.1 10.6 22.7 13.4 20.2 10.2 8.9 18.7 10.8 10.9 7.8 2.9 9.7 12.6 13.1 11.3 6.4 8.3 0.4 8.8 8.9 12.4 11.6 2.8 8.2 20.1 10.0 12.1 8.4 20.8 19.6 15.1 34.0 12.6 8.9 14.2 0.1 10.7 19.2 10.6 7.8 11.9 14.7 13.8 18.0 12.1 7.1 12.5 20.4 13.3 6.2 14.2 11.1 14.8 1.7 6.2 8.0 11.8 15.9 11.0 22.9 10.0 6.9 10.0 16.0 13.3 8.7 12.6 5.5 10.9 8.3 7.2 14.4 5.0 9.4 9.3 10.7 9.1 9.4 7.5 6.1 6.3 8.5 6.3 5.0 6.7 10.2 7.8 6.3 18.7 10.9 10.8 8.9 5.7 2.9 11.9 15.7 28.9 16.7 12.8 11.5 12.9 11.7 13.4 16.1 NSD3 "FLJ20353, KMT3F, WHISTLE, WHSC1L1" ENSG00000147548 "Nuclear receptor binding SET domain protein 3" Q9BZ95 8 38269697-38382272 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005659, CAB013721, HPA018893" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833" "unprognostic (6.21e-2)" "unprognostic (3.73e-2)" "unprognostic (2.18e-2)" "unprognostic (4.12e-1)" "unprognostic (2.25e-1)" "unprognostic (1.53e-2)" "unprognostic (4.35e-2)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.72e-2)" "prognostic unfavourable (7.48e-4)" "unprognostic (5.06e-2)" "unprognostic (5.60e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.60e-2)" 19.2 11.3 31.1 15.8 31.4 36.3 20.1 51.5 37.7 18.5 15.5 16.7 14.0 16.2 16.0 12.5 17.0 16.8 17.0 12.7 24.4 16.6 14.2 11.2 17.9 22.3 25.0 26.8 26.5 16.3 21.0 24.2 22.5 21.9 16.4 18.7 12.3 18.3 17.9 12.3 16.2 17.7 16.0 15.3 17.2 19.7 9.3 25.6 16.7 19.2 6.9 20.4 19.6 23.3 26.7 5.6 26.2 5.1 8.6 18.0 2.9 23.9 13.8 23.7 16.0 16.6 19.2 17.6 20.1 22.3 17.4 20.3 7.3 13.3 28.6 18.5 13.7 14.4 18.7 16.1 24.9 11.3 11.0 36.4 11.1 8.6 17.1 16.0 13.2 10.3 16.4 15.7 32.1 20.0 25.8 19.0 16.5 8.6 46.7 13.6 16.1 6.5 21.4 25.9 9.0 12.4 18.6 13.4 18.1 16.3 14.3 14.0 18.1 12.2 19.0 18.2 18.9 27.0 11.8 17.0 20.2 27.6 15.3 16.2 13.1 13.9 5.1 9.1 8.0 2.4 5.3 16.5 12.0 7.1 4.1 26.7 15.0 6.3 26.2 8.6 1.5 5.6 18.0 2.9 31.1 31.4 51.5 37.7 24.4 16.6 25.0 26.8 21.9 25.6 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favourable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favourable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 17.4 24.8 11.0 7.7 10.5 6.0 20.4 7.7 15.0 13.4 23.4 13.9 20.5 13.3 10.4 35.7 36.2 11.9 7.4 16.7 14.3 11.4 11.6 38.1 9.9 8.7 9.7 10.4 9.8 7.9 9.8 6.9 7.9 18.9 12.0 10.7 7.9 12.2 17.7 6.9 14.5 24.0 9.9 14.2 7.3 9.6 8.6 9.3 6.0 11.0 22.2 17.0 7.5 16.1 16.2 17.5 16.4 17.7 17.0 17.3 13.0 43.6 16.1 21.9 11.4 18.9 14.4 12.4 8.7 11.7 15.9 20.3 22.2 23.9 21.6 29.4 11.8 22.5 28.5 40.2 14.1 7.2 16.3 8.8 15.7 22.4 13.8 8.8 7.2 17.6 15.6 31.1 7.9 14.7 14.6 9.8 12.0 19.3 8.7 11.5 8.7 19.4 6.5 15.9 17.7 33.0 18.1 7.9 9.0 7.8 11.7 9.2 7.7 11.3 12.4 7.4 12.3 17.8 16.7 13.9 9.3 37.2 13.7 13.8 7.0 16.4 17.7 15.8 15.6 16.2 15.7 16.2 15.6 13.5 17.5 12.9 11.4 12.6 1.9 17.0 12.1 15.6 17.3 13.0 11.0 10.5 7.7 15.0 14.3 11.4 9.7 10.4 18.9 9.3 NSFL1C "dJ776F14.1, p47, UBX1, UBXD10, UBXN2C" ENSG00000088833 "NSFL1 cofactor" Q9UNZ2 20 1442162-1473842 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047108, HPA050628" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 920000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA047108: AB_2679935, HPA050628: AB_2681194" "unprognostic (7.55e-2)" "unprognostic (5.26e-2)" "unprognostic (2.51e-2)" "unprognostic (2.47e-1)" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.10e-2)" "unprognostic (1.59e-1)" "unprognostic (4.67e-2)" "unprognostic (2.58e-1)" "unprognostic (4.97e-2)" "unprognostic (6.90e-2)" "unprognostic (5.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.44e-2)" "unprognostic (7.50e-3)" 15.7 22.7 20.2 10.2 23.5 15.8 15.3 18.2 26.5 16.6 14.7 17.1 9.3 11.1 17.4 21.2 19.8 19.9 12.2 21.9 16.7 18.2 14.8 19.8 12.7 9.6 17.1 22.4 22.7 10.8 12.4 9.9 21.5 24.2 16.8 13.9 20.1 13.6 21.8 49.7 25.6 12.4 18.9 15.8 12.2 12.6 11.1 15.3 12.8 13.1 14.8 12.4 15.9 13.7 14.5 12.0 32.4 10.9 5.9 11.0 9.4 21.2 24.6 15.8 15.0 14.3 13.3 11.7 9.9 17.9 24.3 18.0 20.8 17.2 11.8 8.1 18.0 20.1 9.7 26.0 18.7 4.4 10.5 11.9 4.4 23.8 15.1 11.5 7.2 11.3 9.5 25.3 8.5 17.2 15.4 10.6 16.9 10.2 12.0 22.0 16.9 27.2 5.7 19.7 11.5 28.2 14.9 9.1 11.2 12.0 23.9 10.8 14.6 8.0 16.0 18.9 13.9 10.9 16.2 8.5 15.2 9.8 14.0 16.1 13.3 10.7 8.9 32.4 8.5 10.6 8.5 13.9 9.2 8.3 12.0 14.5 10.5 9.2 29.1 5.9 10.9 9.5 11.0 9.4 20.2 23.5 18.2 26.5 16.7 18.2 17.1 22.4 24.2 15.3 NSMCE1 NSE1 ENSG00000169189 "NSE1 homolog, SMC5-SMC6 complex component" Q8WV22 16 27224991-27268794 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041567, HPA043091" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041567: AB_10964260, HPA043091: AB_10962722" "unprognostic (6.27e-2)" "unprognostic (8.17e-2)" "unprognostic (2.52e-2)" "unprognostic (2.48e-3)" "unprognostic (4.17e-1)" "unprognostic (4.52e-3)" "unprognostic (1.59e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.91e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-3)" "unprognostic (3.58e-1)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 24.0 37.3 26.7 33.3 27.4 16.9 30.1 16.9 27.2 22.2 24.7 31.4 30.8 14.1 23.1 32.5 34.7 36.0 36.7 21.7 24.3 26.3 30.9 37.4 27.1 36.7 31.9 20.9 29.5 45.3 46.7 20.5 21.4 27.1 33.8 21.2 26.0 37.2 31.5 22.5 19.5 23.8 35.4 32.4 20.9 26.2 55.4 19.3 41.5 33.9 25.7 29.3 27.6 20.4 42.0 38.9 31.8 27.7 60.4 41.6 32.6 14.4 20.8 14.3 15.5 23.2 31.2 11.5 15.5 15.8 11.8 12.3 16.1 35.3 28.5 37.2 23.5 15.6 26.7 46.4 15.3 34.8 18.5 13.1 19.3 30.8 40.5 15.3 9.9 30.5 32.4 29.6 56.7 15.8 17.5 9.0 21.7 24.4 20.0 17.0 12.6 14.4 17.6 17.6 44.5 34.1 9.4 15.1 13.7 10.5 14.7 26.4 24.3 18.4 9.8 14.3 9.0 16.3 14.8 27.0 19.4 21.9 30.8 15.2 6.1 31.8 27.7 25.0 25.2 24.3 27.8 24.1 36.0 30.6 38.9 42.0 41.6 32.6 9.0 60.4 22.5 37.7 32.8 32.6 26.7 27.4 16.9 27.2 24.3 26.3 31.9 20.9 27.1 19.3 NSMCE2 "C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7" ENSG00000156831 "NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase" Q96MF7 8 125091679-125367120 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway" Transferase "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051614, HPA065734" Supported Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA051614: , HPA065734: " "unprognostic (1.14e-3)" "unprognostic (1.29e-1)" "unprognostic (6.56e-2)" "unprognostic (1.22e-3)" "unprognostic (8.65e-2)" "unprognostic (8.89e-3)" "prognostic unfavourable (7.54e-4)" "unprognostic (3.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.09e-2)" "unprognostic (1.17e-1)" "unprognostic (7.53e-2)" "unprognostic (2.61e-2)" "unprognostic (6.85e-2)" 22.4 22.3 17.6 16.4 20.2 26.2 23.8 21.0 22.6 18.2 19.9 17.1 17.6 12.3 28.3 19.5 18.6 14.3 16.5 22.9 13.7 12.7 18.5 17.2 16.3 19.4 20.2 17.3 21.3 14.9 11.2 32.0 19.1 16.1 15.0 17.8 16.7 19.3 17.4 36.5 18.1 13.4 21.9 18.3 16.6 18.9 19.1 20.6 18.5 18.2 16.8 24.9 18.8 21.2 12.6 12.6 35.3 12.6 11.1 18.8 12.5 16.1 14.0 16.7 10.5 13.2 20.0 8.1 13.0 24.5 23.1 26.9 8.9 15.5 20.3 15.3 12.3 12.1 13.0 10.9 23.6 22.7 12.7 28.6 8.5 12.9 19.1 8.5 8.7 14.7 15.3 13.3 17.0 20.8 16.5 13.4 20.1 27.9 21.9 7.9 3.7 18.8 12.3 11.6 18.3 13.9 12.3 11.1 11.8 15.5 46.8 21.6 19.9 9.8 12.9 8.9 25.3 11.0 18.4 17.9 31.9 25.5 13.9 16.6 13.8 5.1 12.6 35.3 12.2 10.9 13.5 12.6 13.0 13.7 12.6 11.5 13.4 14.6 6.1 11.1 10.9 7.4 18.8 12.5 17.6 20.2 21.0 22.6 13.7 12.7 20.2 17.3 16.1 20.6 NSUN3 FLJ22609 ENSG00000178694 "NOP2/Sun RNA methyltransferase family member 3" Q9H649 3 94062916-94128545 "Disease related genes, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036181, HPA057979" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA036181: AB_10602715, HPA057979: " "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.13e-1)" "unprognostic (7.35e-4)" "unprognostic (1.44e-1)" "unprognostic (9.50e-2)" "unprognostic (1.22e-1)" "unprognostic (8.63e-3)" "unprognostic (6.94e-3)" "unprognostic (6.47e-2)" "unprognostic (2.67e-1)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.33e-2)" 9.1 11.3 8.7 17.4 14.1 10.9 10.3 9.3 11.6 11.5 13.3 10.4 8.7 10.7 10.9 13.7 9.1 10.4 9.0 9.2 9.0 9.4 10.3 15.0 11.7 15.4 8.8 10.6 12.5 11.7 11.8 19.8 8.7 13.0 11.6 14.9 8.6 10.3 8.2 4.8 9.4 18.2 10.2 9.7 14.1 11.4 11.2 10.6 19.5 11.8 7.6 10.7 10.3 9.3 5.5 4.4 10.4 7.9 8.3 6.5 3.5 4.3 6.0 6.4 4.9 3.8 6.0 2.9 6.9 5.5 8.4 8.8 3.6 4.9 6.7 8.7 4.6 6.2 7.4 5.1 11.7 11.6 5.4 10.9 7.5 4.8 5.1 10.7 9.2 5.7 6.1 6.1 7.0 7.1 4.6 10.3 7.4 4.4 9.9 5.1 5.3 6.7 7.8 11.1 7.2 6.3 4.3 11.7 8.3 7.1 4.6 7.0 8.1 6.8 6.3 5.9 6.6 3.1 7.6 8.2 9.5 12.9 7.4 9.1 8.7 10.4 4.9 5.8 4.1 4.7 6.5 5.5 4.6 5.2 4.4 4.3 5.2 6.0 8.5 8.3 7.9 3.9 5.3 3.5 8.7 14.1 9.3 11.6 9.0 9.4 8.8 10.6 13.0 10.6 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase family member 5" Q96P11 7 73302517-73308867 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: , HPA046867: " "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavourable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavourable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 9.0 7.7 11.2 13.1 12.8 40.9 8.7 12.9 14.4 8.5 10.3 15.0 4.8 12.6 12.3 6.9 10.8 12.0 8.1 9.4 10.8 9.3 9.4 9.8 8.0 16.1 19.4 11.9 10.6 19.6 9.5 8.3 8.3 13.6 9.7 6.2 7.7 13.6 9.7 27.1 11.8 12.1 10.9 11.6 15.8 9.6 14.6 13.6 23.5 10.6 11.2 12.1 10.6 8.9 33.5 21.2 18.7 14.4 16.8 22.3 15.3 12.0 16.7 4.7 10.3 2.0 2.5 17.9 5.8 3.4 9.0 9.6 22.6 9.0 19.9 3.9 2.9 10.4 8.8 5.8 2.9 13.1 20.6 7.5 12.2 12.9 7.6 16.6 10.2 3.3 9.7 7.7 6.5 1.1 24.5 4.7 4.3 29.0 14.0 34.0 19.0 12.9 17.1 3.5 28.5 3.9 6.0 12.2 20.4 10.2 27.2 13.1 17.5 13.2 1.9 0.1 13.1 13.0 3.9 19.0 24.5 28.4 0.2 23.3 0.9 14.2 14.4 15.0 14.0 12.5 11.0 21.5 15.9 14.3 16.5 33.5 22.3 18.8 18.7 16.8 9.3 21.2 17.3 15.3 11.2 12.8 12.9 14.4 10.8 9.3 19.4 11.9 13.6 13.6 NT5DC3 "FLJ11266, TU12B1-TY" ENSG00000111696 "5'-nucleotidase domain containing 3" Q86UY8 12 103770453-103841197 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041634 Approved Mitochondria,Cytosol "Secreted - unknown location" "Mitochondria, Cytosol" "HPA041634: AB_10795597" "unprognostic (2.61e-2)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (2.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.31e-4)" "unprognostic (1.57e-1)" "unprognostic (2.19e-1)" "unprognostic (2.45e-2)" "unprognostic (5.43e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (5.72e-6)" "unprognostic (8.60e-3)" "unprognostic (7.42e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (8.11e-4)" 4.2 5.4 14.8 3.2 10.5 23.9 5.4 2.7 16.2 12.2 52.0 2.9 9.4 2.0 17.9 8.4 8.9 3.5 2.6 2.2 13.3 5.7 2.2 4.0 2.8 2.3 2.8 11.7 3.8 3.5 1.8 4.2 4.5 10.4 9.8 12.5 3.7 3.9 9.1 7.0 2.8 4.2 32.9 2.1 1.9 6.6 3.5 2.7 0.0 2.9 0.9 2.4 22.4 5.2 4.1 4.9 2.4 1.6 1.5 3.3 0.8 3.2 5.9 3.4 3.9 4.9 3.8 6.4 5.4 3.2 3.8 2.5 4.0 0.9 5.5 1.1 6.4 3.8 4.8 10.7 5.6 4.1 3.9 6.9 2.2 4.7 2.7 3.6 1.8 3.4 2.4 5.0 21.6 2.2 10.8 2.8 8.6 2.9 3.2 5.9 4.2 6.4 4.4 6.0 2.1 6.1 2.2 4.6 1.9 4.6 5.1 6.4 2.9 3.5 2.9 3.8 4.6 5.2 10.8 2.5 3.1 4.1 3.6 5.6 5.5 0.8 1.5 0.1 1.7 1.6 3.3 3.5 2.4 1.4 3.8 4.1 2.1 1.8 2.4 1.5 1.0 4.9 0.6 0.8 14.8 10.5 2.7 16.2 13.3 5.7 2.8 11.7 10.4 2.7 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.4 2.9 5.0 0.1 11.5 36.7 0.0 35.5 38.9 17.5 32.9 0.0 54.5 0.0 12.8 31.0 2.8 0.0 35.7 41.7 0.0 0.0 0.0 0.8 0.6 5.7 0.0 0.0 9.4 0.4 35.7 22.8 14.5 0.0 0.1 108.8 0.9 0.0 0.0 0.1 3.9 0.1 1.1 0.1 37.9 2.4 0.0 0.6 0.4 2.2 12.0 0.0 0.9 63.0 14.3 0.1 18.0 57.7 2.7 1.7 0.0 98.1 0.0 44.8 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037853-15056079 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavourable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 24.2 8.3 11.7 8.1 11.7 11.9 48.2 5.2 12.1 16.1 18.0 5.4 8.6 6.8 14.4 24.5 14.6 10.2 12.2 23.2 8.0 6.0 10.6 16.9 13.5 12.4 7.4 8.0 13.0 13.3 7.6 5.0 7.8 9.8 15.9 15.7 17.9 11.1 7.7 14.4 13.6 9.7 19.8 7.4 13.7 12.9 14.0 6.4 8.1 10.5 12.7 11.7 18.8 19.9 9.4 12.0 31.2 5.7 5.3 12.3 5.2 9.8 7.2 8.7 7.5 11.1 21.4 3.3 12.0 16.4 12.3 21.2 3.3 7.4 6.8 9.5 22.9 4.2 6.9 14.1 17.3 6.5 9.5 3.9 6.5 18.5 11.4 2.9 2.2 11.1 8.4 11.9 4.5 27.9 4.6 7.8 22.9 8.3 5.8 12.1 6.3 8.0 11.6 11.8 9.1 8.9 13.7 2.6 9.8 5.0 1.8 8.5 3.3 4.4 15.6 17.8 7.1 7.5 10.5 7.6 15.0 8.9 10.7 6.4 8.0 2.5 4.1 31.2 5.5 5.7 6.5 9.4 7.2 7.3 3.8 6.1 5.9 3.7 1.9 5.3 5.5 12.0 12.3 5.2 11.7 11.7 5.2 12.1 8.0 6.0 7.4 8.0 9.8 6.4 NTMT1 "AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1" ENSG00000148335 "N-terminal Xaa-Pro-Lys N-methyltransferase 1" Q9BV86 9 129608884-129636131 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020092, HPA058420" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA020092: AB_1853831, HPA058420: " "unprognostic (4.74e-3)" "unprognostic (1.77e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (4.17e-3)" "unprognostic (4.92e-2)" "unprognostic (1.24e-1)" "unprognostic (8.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.35e-2)" "unprognostic (1.00e-3)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (3.50e-3)" 10.2 25.7 11.9 11.5 13.1 13.8 10.0 13.2 15.3 8.9 10.7 9.0 14.4 11.7 8.8 13.6 10.2 7.8 16.6 31.8 11.5 11.5 11.7 16.8 8.9 11.5 15.7 11.3 8.8 19.5 9.4 10.8 12.1 13.8 10.2 7.4 9.4 13.0 11.4 54.6 10.7 10.2 13.6 10.3 13.1 10.5 56.2 10.7 10.8 12.3 22.1 9.8 12.3 14.5 27.1 28.4 20.3 34.2 14.8 26.6 19.4 16.6 34.5 14.3 24.2 9.1 13.6 15.4 31.7 18.8 32.1 27.8 28.3 21.9 21.4 16.3 22.6 32.5 30.0 27.9 20.2 16.5 16.1 8.9 31.1 28.5 29.3 18.0 13.6 14.5 14.2 33.6 16.8 17.5 32.8 16.1 16.7 55.1 20.3 24.3 18.7 30.2 19.3 16.9 43.0 12.9 9.5 29.1 15.2 15.6 29.3 21.6 24.4 9.4 11.8 38.6 19.6 35.8 33.2 12.7 15.1 32.6 17.6 18.7 22.1 15.1 27.3 20.3 25.2 28.7 24.8 23.4 25.5 26.6 26.4 27.1 26.4 22.0 7.6 14.8 34.2 28.4 23.4 19.4 11.9 13.1 13.2 15.3 11.5 11.5 15.7 11.3 13.8 10.7 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244534 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.9;brain: 32.0" "Cell line enhanced" "Detected in some" "HL-60: 4.7;HMC-1: 11.9;NB-4: 27.0;U-937: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065089, HPA071290" Approved Approved "Plasma membrane,Cytokinetic bridge,Midbody ring" "Intracellular and membrane" "Plasma membrane" "Cytokinetic bridge, Midbody ring" "HPA065089: , HPA071290: " "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favourable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 1.2 1.4 11.9 1.6 10.9 38.9 0.6 4.4 32.0 1.0 0.8 11.5 0.2 1.8 0.7 0.9 0.8 0.7 1.4 4.6 11.4 3.1 0.8 0.8 2.0 1.9 4.4 7.4 0.6 1.8 11.9 1.0 1.1 11.7 7.4 0.7 10.7 1.3 1.8 0.9 0.8 1.1 0.8 5.3 2.8 1.2 1.8 2.8 0.0 0.7 0.0 1.0 1.1 0.9 0.1 0.1 4.0 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.6 4.7 11.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.2 27.0 1.0 0.1 0.3 0.3 0.1 0.0 0.0 3.3 3.0 0.1 0.0 0.0 0.0 0.4 0.1 0.6 2.1 2.6 0.1 0.1 0.0 0.0 0.9 7.0 0.7 0.6 0.2 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.0 0.0 0.1 0.1 0.1 0.0 11.9 10.9 4.4 32.0 11.4 3.1 4.4 7.4 11.7 2.8 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.1" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: , HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 0.0 6.6 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell line enriched" "Detected in some" 8 "U-138 MG: 47.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli" 11000000 Nucleoli "Nuclear membrane" "CAB009233: AB_632555, HPA027484: , HPA048065: " "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 5.9 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.9 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell line enhanced" "Detected in many" "AF22: 23.0;EFO-21: 23.0;Karpas-707: 16.8;RH-30: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: " "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavourable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavourable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.9 3.4 23.0 0.2 9.2 1.0 10.6 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.0 10.3 4.8 4.8 4.6 2.0 0.0 1.3 0.0 3.6 1.8 1.9 0.0 0.0 4.7 3.1 2.5 0.8 8.3 0.0 16.8 3.1 0.5 0.1 0.2 4.5 1.4 0.0 33.0 4.0 2.5 5.9 2.7 0.1 2.6 0.7 0.2 1.2 0.1 6.2 3.8 12.8 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell line enhanced" "Detected in many" "BEWO: 24.3;CACO-2: 12.9;RPMI-8226: 18.7;RPTEC TERT1: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008958 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favourable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.2 12.3 7.5 0.3 0.2 0.3 24.3 2.9 3.0 8.1 3.3 12.9 0.4 3.7 1.8 0.8 4.5 1.7 4.4 3.5 0.0 0.2 0.0 0.7 2.2 5.2 0.0 0.0 1.4 3.3 4.7 2.8 0.3 0.5 0.9 1.5 0.5 0.0 0.0 4.8 0.4 0.0 0.5 18.7 22.2 0.0 1.1 0.1 0.8 3.5 0.3 3.6 0.0 0.9 2.9 1.4 0.3 4.6 6.6 1.0 2.3 0.4 0.0 1.1 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341699-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA021220: , HPA050722: , HPA053648: " "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavourable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 20.1 17.3 17.1 22.1 15.5 13.2 20.5 20.5 20.0 22.2 25.0 17.6 17.3 30.9 24.4 17.6 18.1 19.8 17.0 16.5 14.8 12.9 17.1 18.9 21.2 28.7 14.3 15.4 25.4 21.7 28.0 26.4 23.7 18.5 21.6 15.3 16.2 19.8 15.7 30.3 16.9 38.3 20.8 19.8 26.5 17.7 56.0 16.0 32.3 26.5 15.9 19.8 25.3 22.3 21.1 18.9 28.9 24.0 24.5 24.7 17.1 26.6 12.1 16.4 9.6 17.1 20.9 13.6 21.5 19.8 16.4 18.9 11.8 23.6 28.8 28.5 13.4 13.5 9.7 14.0 10.5 25.4 16.5 10.4 11.6 7.5 23.9 24.2 13.6 13.3 16.4 11.7 11.1 10.7 27.3 0.8 13.1 14.3 42.8 18.5 25.6 16.0 23.8 17.0 4.3 12.1 13.2 15.4 25.6 40.3 17.3 20.5 11.9 14.0 21.6 13.9 4.9 18.5 20.3 28.1 21.4 25.3 28.1 20.9 22.7 10.4 15.7 20.7 20.9 20.3 24.7 21.1 18.3 21.1 13.6 19.9 20.4 19.0 28.9 24.5 24.0 18.9 14.3 17.1 17.1 15.5 20.5 20.0 14.8 12.9 14.3 15.4 18.5 16.0 NUBP2 CFD1 ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782901-1789191 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favourable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 16.9 22.8 12.9 15.4 12.4 19.5 14.7 16.3 19.8 13.9 15.1 14.9 16.1 21.6 14.1 14.2 20.3 15.6 15.2 13.8 12.0 10.4 16.5 32.3 12.1 18.0 14.4 17.4 14.6 37.6 8.3 13.8 14.7 12.9 17.7 6.4 14.8 26.9 16.3 30.2 17.2 19.1 16.4 12.0 17.9 18.8 14.5 13.2 22.7 19.4 20.7 16.6 15.3 13.6 25.8 44.1 28.8 29.7 25.8 41.3 31.1 9.2 30.2 5.2 15.9 4.3 3.1 17.0 11.2 4.8 6.9 7.8 17.0 14.1 14.9 12.3 2.4 10.8 3.6 10.2 1.3 12.4 29.0 6.3 22.4 26.7 8.3 9.4 13.0 4.5 8.9 5.3 4.0 8.6 15.5 9.5 2.8 34.1 18.9 15.4 14.3 17.6 24.9 11.4 33.2 5.5 7.1 20.0 23.4 11.2 16.4 11.3 25.1 11.2 9.6 10.9 14.4 10.9 10.9 21.9 13.9 17.3 6.6 11.8 14.3 25.6 29.1 28.8 34.7 29.7 31.7 24.3 30.9 30.5 30.2 25.8 25.8 24.2 14.4 25.8 28.2 44.1 41.3 31.1 12.9 12.4 16.3 19.8 12.0 10.4 14.4 17.4 12.9 13.2 NUCB1 "Calnuc, NUC" ENSG00000104805 "Nucleobindin 1" Q02818 19 48900050-48923372 "Plasma proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008176 Supported Supported "Golgi apparatus,Microtubules" "Secreted to blood" 15000000 "Golgi apparatus" Microtubules "HPA008176: AB_1845923" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (4.36e-3)" "unprognostic (6.28e-2)" "unprognostic (1.06e-2)" "unprognostic (2.95e-1)" "unprognostic (6.86e-2)" "unprognostic (1.98e-1)" "unprognostic (9.51e-2)" "unprognostic (8.14e-3)" "unprognostic (2.34e-3)" "unprognostic (9.89e-2)" "unprognostic (5.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (8.90e-3)" "unprognostic (3.41e-1)" 49.5 32.2 18.1 30.5 20.2 19.3 50.1 17.9 36.0 31.0 42.5 24.8 32.5 51.6 36.7 46.8 33.1 30.7 47.2 58.8 16.8 20.3 56.7 144.7 42.6 48.4 20.5 25.2 40.0 37.4 42.7 21.3 46.9 29.1 36.6 15.3 31.0 37.8 29.7 46.7 26.0 51.8 36.7 20.7 32.4 33.4 19.0 15.9 17.1 48.0 29.0 23.2 36.4 58.2 19.1 42.3 39.2 47.7 24.4 40.2 40.1 10.1 32.9 15.8 34.0 57.4 44.4 18.2 39.3 34.7 19.1 26.9 16.5 36.8 9.8 29.9 47.8 24.1 9.0 19.2 8.1 35.7 16.4 25.5 23.4 21.3 27.8 15.4 33.9 52.2 8.5 18.2 12.1 29.3 31.0 52.3 18.6 12.1 7.4 9.6 7.8 17.1 13.9 23.7 20.6 14.1 24.2 11.3 23.4 45.9 28.4 15.6 14.5 20.3 44.1 32.4 22.1 20.0 18.5 39.5 90.7 6.7 24.9 9.7 37.9 31.6 39.6 37.6 40.2 47.7 30.4 19.1 27.3 30.5 29.9 15.5 22.9 22.7 39.2 24.4 40.7 42.3 27.0 40.1 18.1 20.2 17.9 36.0 16.8 20.3 20.5 25.2 29.1 15.9 NUCKS1 NUCKS ENSG00000069275 "Nuclear casein kinase and cyclin dependent kinase substrate 1" Q9H1E3 1 205712819-205750276 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062351, HPA063843" Supported Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA062351: , HPA063843: " "unprognostic (1.68e-1)" "unprognostic (3.92e-1)" "unprognostic (3.38e-1)" "prognostic unfavourable (1.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (5.16e-3)" "unprognostic (1.18e-3)" "unprognostic (1.37e-1)" "unprognostic (5.82e-3)" "unprognostic (7.45e-3)" "unprognostic (1.44e-1)" "unprognostic (2.25e-2)" "unprognostic (7.57e-2)" 25.6 25.3 46.9 17.3 55.5 12.1 31.3 45.0 49.2 33.0 24.2 38.3 18.8 12.5 36.5 27.8 25.3 32.1 22.5 40.6 43.8 35.6 30.9 43.9 20.6 29.4 43.6 47.6 49.1 17.4 50.3 21.0 20.8 32.8 31.9 21.1 21.9 19.0 32.7 43.1 21.7 14.6 42.9 49.1 22.6 17.9 14.2 38.9 35.3 42.5 20.6 24.8 32.0 22.6 7.8 7.4 4.5 4.9 10.7 11.8 4.0 40.6 25.0 67.4 26.6 18.7 25.9 31.8 29.3 30.3 41.2 33.3 13.7 46.9 45.1 17.0 28.5 30.1 51.2 24.6 47.4 21.5 25.6 29.3 22.1 14.9 13.8 46.0 10.5 20.5 22.3 24.5 42.7 32.2 47.0 14.5 32.1 47.0 41.7 23.2 68.8 18.7 43.6 83.1 25.9 23.1 25.1 28.1 51.9 43.3 34.7 23.5 53.0 34.8 32.1 31.7 28.2 36.1 51.8 13.3 15.7 36.4 21.7 26.0 42.6 4.5 3.4 3.7 9.9 4.9 9.6 5.8 9.2 8.6 4.7 7.8 11.5 11.8 0.6 10.7 4.0 7.4 5.5 4.0 46.9 55.5 45.0 36.6 43.8 35.6 43.6 47.6 32.8 38.9 NUDCD1 "CML66, FLJ14991" ENSG00000120526 "NudC domain containing 1" Q96RS6 8 109240919-109334385 "Predicted intracellular proteins" Immunity "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023183 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023183: AB_1854695" "unprognostic (5.08e-3)" "unprognostic (3.73e-2)" "unprognostic (2.52e-2)" "unprognostic (9.03e-3)" "unprognostic (7.52e-2)" "unprognostic (3.62e-3)" "prognostic unfavourable (1.39e-5)" "prognostic unfavourable (4.37e-5)" "unprognostic (2.13e-1)" "unprognostic (9.49e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (8.22e-2)" "prognostic unfavourable (8.71e-6)" "unprognostic (1.95e-1)" "unprognostic (1.63e-1)" "unprognostic (3.35e-1)" "unprognostic (1.65e-1)" 22.1 9.2 9.4 10.2 12.7 3.2 17.1 16.4 12.2 14.0 9.1 4.4 9.0 5.0 14.4 9.8 10.9 12.3 9.0 10.9 9.9 8.4 13.6 10.8 12.3 14.1 12.6 8.9 12.0 13.1 9.1 15.2 25.4 9.7 10.7 12.1 4.8 11.4 12.7 10.9 7.5 8.6 13.8 8.6 19.0 10.3 20.1 8.4 19.5 15.6 11.0 14.0 13.8 13.4 4.4 4.4 1.2 4.2 5.1 5.2 2.3 13.2 7.9 11.3 6.4 6.6 8.8 6.2 9.7 11.6 27.2 25.7 8.8 10.4 8.9 6.2 10.2 7.9 17.1 15.7 37.9 11.3 6.2 13.6 5.4 8.9 13.1 5.9 5.2 5.8 8.7 13.4 18.9 24.6 15.0 4.7 22.9 11.2 15.8 6.9 8.0 10.9 10.0 9.4 8.7 16.7 6.9 9.4 8.3 4.3 11.6 9.3 9.2 4.6 6.7 13.4 8.1 6.2 8.3 3.5 4.4 10.5 5.1 10.1 11.3 0.0 1.9 1.2 3.3 4.1 4.4 4.4 3.7 4.9 4.4 3.8 4.6 5.2 0.1 5.1 4.2 3.2 4.0 2.3 9.4 12.7 16.4 12.2 9.9 8.4 12.6 8.9 9.7 8.4 NUDCD2 "DKFZp686E10109, NudCL2" ENSG00000170584 "NudC domain containing 2" Q8WVJ2 5 163446526-163460140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037384, HPA037385" Uncertain Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Microtubules "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA037384: , HPA037385: AB_10673630" "unprognostic (3.96e-1)" "unprognostic (3.69e-2)" "prognostic favourable (2.80e-4)" "unprognostic (1.46e-1)" "unprognostic (9.12e-2)" "unprognostic (3.75e-3)" "unprognostic (1.84e-1)" "unprognostic (4.74e-1)" "unprognostic (3.47e-2)" "unprognostic (7.63e-3)" "unprognostic (1.81e-1)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" "unprognostic (6.86e-2)" "unprognostic (3.40e-2)" "unprognostic (7.85e-2)" 18.3 17.3 19.1 17.4 20.2 14.0 16.6 10.4 21.8 8.5 15.1 23.2 12.7 20.2 12.5 9.7 15.0 14.3 9.9 10.1 19.9 15.1 16.2 20.1 11.8 18.9 27.0 14.5 13.4 24.4 9.6 13.2 14.5 19.3 12.7 9.1 9.3 19.4 10.6 25.7 11.7 18.0 14.1 30.5 16.6 15.9 12.5 20.9 16.9 14.6 11.0 13.4 12.8 11.5 34.3 30.3 14.1 21.6 28.5 36.5 24.4 23.2 12.0 9.2 14.4 5.6 4.2 12.2 9.4 2.7 3.4 5.5 10.8 17.9 13.3 22.7 1.5 11.7 4.9 5.3 4.0 26.4 13.6 12.2 15.3 9.7 6.1 13.7 13.9 1.5 3.2 3.3 4.8 3.7 12.9 16.6 3.4 9.5 20.3 30.3 10.0 13.3 17.2 15.3 23.5 3.0 5.4 23.4 13.2 14.9 9.6 24.4 18.4 14.3 8.4 11.7 17.4 12.8 21.5 13.7 22.9 22.3 13.5 23.8 12.1 14.1 18.9 11.8 23.8 21.6 30.3 34.3 34.0 28.4 25.4 24.4 36.5 31.9 2.4 28.5 17.9 30.3 30.0 24.4 19.1 20.2 10.4 18.1 19.9 15.1 27.0 14.5 19.3 20.9 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favourable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.1 5.0 5.9 6.3 4.0 2.2 10.0 3.8 6.7 3.7 5.9 6.8 3.5 5.7 6.3 2.8 3.6 2.9 5.0 4.8 1.8 3.9 4.6 4.4 5.2 7.3 7.1 3.2 4.4 2.8 2.1 4.5 5.4 7.8 3.2 4.7 3.7 3.4 4.8 4.7 13.4 3.0 5.6 2.3 4.2 6.9 7.0 4.2 4.4 2.7 4.1 9.2 9.5 5.1 4.5 5.7 7.3 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: " "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favourable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favourable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 18.2 12.6 22.4 5.0 16.0 3.1 14.3 2.5 23.4 6.5 11.0 7.9 5.9 16.7 4.7 11.7 7.1 12.6 9.8 20.9 15.4 13.5 16.7 11.2 12.6 9.4 16.1 14.8 4.0 26.0 4.7 27.6 4.8 11.2 10.5 4.6 14.7 16.7 9.9 28.7 6.2 13.8 3.1 13.2 6.3 12.7 8.9 7.8 3.1 17.9 9.2 5.7 4.9 4.7 5.8 15.1 1.7 27.3 6.1 5.8 8.9 8.2 11.3 1.0 4.4 1.3 1.6 18.1 2.3 3.1 3.8 5.5 8.0 8.8 0.6 11.6 1.2 10.4 0.5 6.3 0.3 4.3 8.3 1.8 4.9 5.5 9.7 2.2 22.3 2.3 8.0 0.9 0.7 7.5 2.8 1.4 1.3 24.0 0.2 0.0 5.9 15.8 4.3 10.4 4.8 4.1 23.8 15.7 2.3 4.1 0.1 9.6 8.9 10.7 17.6 6.4 2.8 4.5 2.3 0.7 0.4 1.0 9.3 2.5 2.3 1.7 18.5 0.5 5.8 17.4 3.6 5.8 4.6 3.8 15.1 4.0 4.5 5.2 0.6 6.1 27.3 7.3 2.5 8.9 22.4 16.0 2.5 23.4 15.4 13.5 16.1 14.8 11.2 7.8 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5" "Group enriched" "Detected in all" 4 "dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA060452: , HPA062492: " "unprognostic (4.85e-3)" "prognostic favourable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favourable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 25.9 13.4 22.1 13.1 22.0 8.7 13.1 13.5 20.5 11.1 32.8 23.9 13.9 20.2 11.7 11.6 8.7 14.0 13.6 22.2 21.1 19.6 25.9 23.1 16.2 31.1 27.7 16.9 23.0 18.3 32.9 9.7 7.6 20.1 13.4 18.4 13.6 11.7 13.6 20.3 6.8 37.5 18.5 30.4 22.2 13.8 9.5 21.6 2.2 17.1 11.5 9.1 12.4 8.4 4.3 13.6 18.8 24.5 3.7 4.3 6.7 12.7 6.8 11.2 5.8 22.6 20.5 5.2 10.4 9.6 7.0 7.3 10.4 5.7 2.1 9.1 9.6 9.3 9.9 6.5 11.3 6.3 7.2 5.4 8.7 10.0 14.5 9.1 9.9 18.3 5.8 4.6 12.7 10.9 6.1 11.1 6.8 13.2 0.0 2.4 8.7 10.1 7.1 8.1 16.0 7.0 10.3 5.5 9.7 6.2 6.3 9.5 13.8 7.2 10.7 11.5 5.0 21.0 8.0 11.0 10.8 0.3 7.4 7.0 6.3 2.2 18.2 18.8 2.6 21.9 2.7 4.3 2.7 2.4 13.6 4.2 2.4 2.4 14.6 3.7 24.5 1.8 4.3 6.7 22.1 22.0 13.5 20.5 21.1 19.6 27.7 16.9 20.1 21.6 NUDT16L1 SDOS ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: " "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favourable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favourable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 11.2 21.7 19.3 13.2 22.1 19.3 11.0 25.3 33.1 13.6 20.6 15.9 25.5 21.7 10.4 17.1 14.0 16.5 16.8 31.8 19.7 17.5 20.1 27.2 15.2 18.5 18.3 15.8 13.9 14.8 15.7 19.6 10.5 13.4 19.7 12.2 16.3 16.8 16.3 22.4 10.9 18.6 8.9 16.2 15.9 15.3 13.0 15.9 18.2 21.6 14.2 15.9 10.5 9.8 30.1 40.4 44.9 27.0 28.5 39.6 42.7 7.3 12.2 11.1 14.9 8.4 6.5 10.2 8.8 6.7 10.7 6.8 13.6 5.9 7.7 12.9 10.5 8.6 11.9 12.0 5.0 11.3 20.1 8.5 10.5 16.4 9.2 12.1 10.1 10.0 11.2 9.0 5.6 7.9 15.4 9.7 10.4 28.6 18.2 18.0 17.6 14.0 25.5 11.8 12.1 12.8 9.2 22.0 16.5 12.9 13.5 5.8 20.0 28.5 10.2 8.8 13.4 20.8 8.0 16.9 10.0 12.9 5.5 16.3 18.0 23.1 27.0 44.9 27.2 22.5 32.6 28.8 33.3 32.4 24.5 30.1 39.6 33.6 33.3 28.5 24.0 40.4 36.7 42.7 19.3 22.1 25.3 33.1 19.7 17.5 18.3 15.8 13.4 15.9 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845629-145848953 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 5.8;eosinophil: 11.5;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 8 "dendritic cells: 18.4;granulocytes: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavourable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 4.6 3.3 8.3 3.9 13.5 6.7 4.9 8.9 10.9 3.8 3.4 5.1 1.5 1.2 4.6 3.1 3.5 7.0 4.4 8.4 6.6 7.7 3.8 2.6 3.4 9.0 5.9 8.1 6.8 6.2 6.2 4.7 2.2 5.4 4.2 2.9 8.0 6.3 5.8 6.7 4.3 3.3 11.1 5.5 6.0 3.3 7.1 2.2 3.5 5.7 3.4 7.7 4.1 3.2 0.9 18.4 11.5 1.8 0.2 1.1 0.7 4.3 3.1 2.9 1.6 1.6 2.5 3.0 2.1 3.4 2.2 3.0 1.9 3.2 6.3 2.3 3.5 0.8 2.1 1.2 1.5 0.7 3.7 2.4 2.5 2.9 4.7 2.0 8.2 2.6 2.0 1.5 2.4 4.3 5.3 5.9 3.9 6.9 2.1 3.7 2.4 0.3 5.5 1.2 2.0 3.4 1.0 1.4 3.3 1.3 2.6 3.5 14.8 8.8 2.6 2.6 1.7 1.3 0.8 5.2 2.4 1.6 2.4 2.7 1.9 5.8 0.6 11.5 0.6 1.8 0.4 0.9 0.5 0.3 0.6 0.6 1.1 0.8 0.1 0.2 1.1 18.4 0.5 0.7 8.3 13.5 8.9 10.9 6.6 7.7 5.9 8.1 5.4 2.2 NUDT18 "FLJ22494, MTH3" ENSG00000275074 "Nudix hydrolase 18" Q6ZVK8 8 22106872-22109419 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028581, HPA030125" Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA028581: AB_10601381, HPA030125: " "unprognostic (9.90e-3)" "prognostic favourable (1.43e-4)" "unprognostic (4.88e-3)" "prognostic favourable (2.49e-6)" "unprognostic (1.29e-2)" "unprognostic (6.82e-3)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (5.30e-2)" "unprognostic (1.67e-1)" "prognostic favourable (2.47e-4)" "unprognostic (1.43e-1)" "prognostic favourable (8.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.05e-1)" "unprognostic (6.84e-2)" "unprognostic (2.32e-1)" 3.6 2.7 2.9 4.4 6.4 2.9 3.6 5.3 6.8 2.0 6.1 4.3 5.4 5.3 1.6 11.9 3.7 4.3 3.8 2.5 1.7 2.9 2.9 4.5 6.3 3.2 3.3 1.2 8.6 2.1 5.2 1.8 3.7 3.6 3.8 3.8 5.6 11.0 1.0 3.6 5.4 2.7 2.5 6.0 5.6 2.8 3.4 7.1 5.0 2.3 5.8 3.2 0.0 3.6 3.6 5.0 3.2 7.8 4.7 1.5 6.9 14.8 0.5 3.2 11.8 4.4 8.1 4.1 11.4 5.6 6.4 3.5 5.6 5.2 6.7 5.0 12.2 2.1 6.9 1.9 6.4 2.0 4.4 4.2 3.4 7.7 1.3 13.8 8.0 6.5 2.3 5.8 7.0 3.2 8.8 5.3 7.3 5.8 3.9 0.8 3.6 2.6 1.3 5.6 8.1 6.1 1.6 2.5 3.0 3.6 3.6 8.4 7.4 5.6 3.6 2.0 4.8 2.1 3.9 0.4 1.7 6.3 4.0 8.8 0.1 2.9 5.0 4.7 3.2 4.3 2.6 3.7 2.7 2.0 3.6 4.0 2.2 0.7 7.8 2.3 3.6 1.4 1.5 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favourable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.6 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 8.9 8.9 10.9 9.0 7.7 15.8 6.6 17.7 6.4 3.3 7.6 13.3 5.5 5.8 12.0 4.9 12.0 8.5 13.6 10.2 10.4 9.1 0.1 12.2 1.9 7.6 0.1 3.5 7.7 9.5 10.2 7.2 10.3 13.8 11.8 9.8 6.5 16.3 6.8 8.1 5.2 8.0 13.8 11.9 10.1 4.5 9.7 12.8 7.3 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 NUDT21 "CFIM25, CPSF5" ENSG00000167005 "Nudix hydrolase 21" O43809 16 56429133-56452199 "Predicted intracellular proteins" "Differentiation, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019863, HPA074228" Uncertain Supported "Nuclear bodies,Centriolar satellite" "Nuclear bodies" "Centriolar satellite" "HPA019863: , HPA074228: " "unprognostic (4.95e-2)" "unprognostic (4.42e-2)" "unprognostic (4.25e-3)" "unprognostic (1.31e-1)" "unprognostic (5.85e-3)" "unprognostic (1.29e-2)" "unprognostic (8.80e-3)" "unprognostic (6.87e-3)" "unprognostic (4.09e-2)" "unprognostic (3.19e-1)" "unprognostic (3.76e-3)" "unprognostic (4.27e-2)" "unprognostic (1.39e-2)" "unprognostic (2.85e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" 26.8 33.0 31.6 33.3 36.0 41.9 31.9 41.7 58.2 32.6 29.4 24.5 21.7 37.7 30.7 22.4 36.6 28.8 22.2 28.9 31.8 39.1 33.6 27.7 23.0 40.8 30.3 38.9 44.9 33.2 34.5 31.2 29.0 34.8 23.8 31.6 24.1 26.1 34.5 27.6 25.6 25.8 27.1 30.2 26.1 25.7 54.0 20.9 46.4 29.3 29.0 47.9 28.9 26.7 17.2 18.9 23.1 19.8 17.5 35.8 15.7 32.2 18.2 33.9 27.2 18.8 26.7 30.9 22.3 26.1 32.1 22.5 38.3 33.9 44.0 23.4 20.7 30.1 44.1 26.9 48.9 15.1 18.3 28.7 17.6 32.9 15.4 41.0 29.5 15.7 19.5 26.8 19.0 29.5 30.5 16.1 25.8 19.9 43.6 29.2 41.8 30.9 64.6 46.2 37.3 22.2 27.9 38.2 25.2 42.8 20.6 17.7 25.0 24.5 17.2 25.5 36.4 21.9 23.9 24.3 26.1 82.8 16.9 26.8 23.2 19.4 18.1 23.1 21.8 19.1 21.7 17.2 23.5 20.4 18.9 16.5 22.0 21.6 20.8 17.5 19.8 14.8 35.8 15.7 31.6 36.0 41.7 58.2 31.8 39.1 30.3 38.9 34.8 20.9 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavourable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 37.3 27.6 33.0 30.7 32.0 31.6 29.3 27.7 17.7 32.7 35.1 39.6 35.7 37.4 24.1 22.4 37.6 46.0 42.9 30.0 30.6 45.0 31.1 33.9 58.1 33.4 20.6 21.9 33.2 25.6 35.6 18.2 41.6 41.6 25.6 29.7 34.3 38.6 24.2 28.7 17.2 35.3 12.0 43.4 30.5 12.9 15.9 23.9 33.6 25.9 38.5 44.4 21.3 26.0 13.9 26.7 38.8 33.8 21.6 37.9 50.3 29.3 26.9 10.3 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.1" "Cell line enhanced" "Detected in many" "ASC diff: 16.7;THP-1: 27.5;U-698: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favourable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 8.7 19.0 5.4 4.8 8.3 1.4 6.2 4.2 8.6 4.6 8.4 5.7 5.9 7.1 6.2 12.4 8.6 7.1 5.7 24.8 4.8 7.3 14.8 45.1 5.0 6.8 6.3 6.2 5.2 8.5 9.1 4.7 4.2 7.8 6.4 8.3 11.6 5.9 5.3 5.0 6.0 9.4 7.1 7.2 5.5 5.4 6.7 3.5 6.1 19.7 6.5 5.9 6.3 6.0 13.6 7.9 2.5 11.0 2.3 20.6 6.0 1.1 3.9 3.5 2.0 16.7 4.2 3.3 1.0 5.2 1.6 2.0 1.1 4.9 5.7 3.8 3.8 3.9 2.7 4.2 0.9 1.8 3.6 0.0 0.2 5.2 1.8 3.9 0.8 7.2 5.4 0.8 3.1 2.7 4.1 2.5 0.6 10.5 2.0 9.1 3.7 0.9 4.3 0.4 1.7 7.9 0.0 2.9 2.9 3.6 1.5 3.0 10.6 27.5 2.1 1.8 0.2 0.8 0.2 0.0 0.0 22.1 7.0 4.9 0.0 2.5 8.5 1.0 9.1 11.0 10.1 8.8 10.8 10.8 6.8 13.6 14.3 9.9 1.4 2.3 10.6 7.9 20.6 6.0 5.4 8.3 4.2 8.6 4.8 7.3 6.3 6.2 7.8 3.5 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629930 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favourable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 5.5 2.0 3.0 4.1 4.1 2.1 10.8 4.1 2.7 3.9 8.1 3.5 10.1 10.6 1.7 4.8 22.0 2.4 5.9 32.5 2.6 3.0 16.0 21.4 3.8 4.3 4.9 2.3 2.2 7.7 4.3 1.3 2.5 5.9 4.2 4.2 2.0 28.3 8.2 38.2 12.4 12.2 2.4 4.1 1.9 6.9 1.4 2.3 2.0 13.6 25.0 15.3 1.6 4.7 7.1 11.8 1.0 11.2 8.1 3.4 2.1 10.3 4.2 1.6 2.7 1.5 1.9 2.6 2.1 1.0 0.9 0.9 3.4 2.7 10.8 3.4 1.6 5.1 1.9 1.3 0.1 10.5 4.5 0.6 1.8 10.5 0.4 3.4 5.2 1.2 2.6 1.1 0.3 1.9 3.0 9.7 0.7 17.3 5.7 4.9 0.9 8.6 3.5 0.8 67.9 2.7 1.8 0.8 1.1 0.5 6.0 2.1 3.3 1.4 0.5 2.3 3.3 14.7 0.4 6.9 4.6 2.1 1.6 4.6 1.3 0.0 1.0 1.0 3.1 3.9 2.6 3.3 1.8 3.4 4.3 7.1 1.6 1.9 0.0 8.1 11.2 11.8 1.1 2.1 3.0 4.1 4.1 2.7 2.6 3.0 4.9 2.3 5.9 2.3 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422582-87459454 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" 9000 "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: , HPA078535: " "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favourable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favourable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 14.2 25.6 19.5 10.0 22.7 4.0 31.1 22.5 22.3 17.9 19.6 11.8 18.0 27.0 17.3 24.5 12.8 16.2 11.4 18.0 21.8 19.4 28.1 30.9 15.8 12.2 22.9 16.5 18.4 64.1 35.4 33.1 17.5 20.0 22.5 18.3 11.3 20.2 18.7 23.8 10.2 30.0 16.0 17.0 9.9 14.1 14.1 22.6 7.6 22.7 16.0 9.7 13.6 35.9 13.9 13.8 3.7 13.9 9.3 18.3 10.6 10.6 11.5 12.8 6.4 25.4 16.0 10.4 20.5 13.3 7.9 7.9 8.1 18.4 15.6 21.0 16.6 7.3 11.8 14.4 12.7 11.7 9.1 5.1 13.4 14.1 16.0 9.3 8.4 15.4 19.2 9.4 8.9 15.8 14.3 10.5 14.9 14.0 13.0 10.1 10.3 4.7 15.3 11.4 9.1 59.7 9.8 15.5 10.6 13.2 23.4 10.4 13.4 13.5 16.2 12.8 12.4 9.3 10.0 8.1 6.3 12.7 18.4 8.8 16.1 0.9 11.7 3.7 13.4 13.8 12.4 13.9 13.4 13.2 13.8 12.0 15.9 18.3 1.3 9.3 13.9 13.0 12.3 10.6 19.5 22.7 22.5 22.3 21.8 19.4 22.9 16.5 20.0 22.6 NUFIP1 NUFIP ENSG00000083635 "NUFIP1, FMR1 interacting protein 1" Q9UHK0 13 44939249-44989483 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 8.9 9.8 10.4 10.7 16.4 17.4 11.6 11.0 17.2 9.8 7.8 10.8 4.8 7.1 11.7 14.4 9.2 9.2 6.3 6.4 12.7 9.6 10.2 13.7 11.2 8.5 8.9 12.6 13.7 11.5 9.3 9.6 7.7 7.9 9.1 7.9 6.3 8.6 8.8 17.0 10.1 6.4 10.3 10.0 8.4 8.6 14.1 8.8 11.4 10.1 6.8 9.3 8.9 8.3 6.6 6.3 1.1 3.7 8.3 6.9 2.5 5.4 4.3 7.3 6.0 5.0 5.2 8.7 6.4 5.6 12.0 7.7 11.5 8.7 15.9 5.4 6.0 8.6 13.5 9.1 15.7 4.8 10.6 12.1 2.9 10.3 8.3 15.5 4.9 5.4 8.5 8.1 12.3 5.9 9.6 2.7 8.4 6.2 12.8 9.8 17.2 7.1 12.7 6.9 9.7 7.2 4.7 4.0 8.9 5.5 7.6 6.9 5.7 8.7 4.5 6.2 5.3 7.9 8.8 3.7 5.7 20.0 6.9 11.0 8.6 0.0 3.7 1.1 3.9 3.7 6.9 5.9 4.3 4.1 4.7 6.6 6.8 5.1 0.2 8.3 2.3 6.3 2.4 2.5 10.4 16.4 11.0 17.2 12.7 9.6 8.9 12.6 7.9 8.8 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "NUFIP2, FMR1 interacting protein 2" Q7Z417 17 29255836-29294118 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: " "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 21.6 20.6 25.0 25.4 28.6 83.5 25.1 38.8 39.0 17.3 18.0 15.5 17.4 19.6 17.8 15.9 27.1 17.0 17.7 21.8 24.1 15.6 16.9 28.9 31.5 22.2 24.2 15.5 20.0 19.8 26.2 40.8 44.4 28.9 18.4 16.6 13.9 25.4 27.5 43.7 17.9 20.3 13.3 30.5 24.6 22.0 17.0 27.2 18.3 20.2 15.6 22.9 19.0 42.6 6.9 9.8 21.2 6.9 4.1 6.1 1.6 15.0 24.6 14.4 10.0 12.5 14.6 24.2 15.0 9.1 11.6 10.7 27.1 8.3 24.5 22.5 10.3 21.4 11.5 10.5 14.8 26.2 20.6 18.5 22.4 7.0 11.5 23.5 20.1 12.6 12.9 12.7 13.8 8.5 30.1 18.3 11.8 12.5 24.7 10.7 14.8 9.1 20.3 24.8 10.5 9.7 24.7 13.9 8.8 26.9 50.6 16.4 17.4 15.9 13.9 22.3 22.3 12.9 25.6 25.6 23.5 28.4 14.7 12.6 18.9 8.8 5.2 6.2 4.9 5.0 3.7 6.8 4.7 5.2 4.1 6.9 6.1 5.0 21.2 4.1 6.9 9.8 2.4 1.6 25.0 28.6 38.8 39.0 24.1 15.6 24.2 15.5 28.9 27.2 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686734-68745809 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: " "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavourable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 18.3 12.6 10.2 16.5 13.2 18.7 17.4 20.7 15.2 19.0 12.2 12.1 12.2 9.2 18.6 18.0 14.0 16.6 8.5 12.1 12.2 6.6 12.1 11.1 12.5 21.4 13.2 10.2 19.8 12.5 14.2 16.2 23.5 12.2 12.6 15.3 11.3 13.0 11.8 13.9 14.8 15.8 13.7 12.5 19.7 12.0 20.5 15.9 40.6 12.5 13.1 22.5 17.8 13.1 13.6 7.0 9.5 14.2 20.6 17.0 8.0 17.0 22.0 26.3 19.0 7.8 10.0 28.5 18.7 10.8 28.2 23.6 22.1 14.5 31.3 18.3 8.9 19.7 29.5 13.8 37.6 29.3 21.9 35.7 15.8 18.5 4.9 31.4 12.1 5.2 6.6 22.5 14.8 16.8 42.5 22.6 17.6 20.7 25.8 27.5 28.9 21.6 26.5 31.6 18.8 12.2 18.2 15.5 15.9 20.7 15.6 11.2 23.4 15.2 10.2 15.4 15.7 17.8 22.7 9.9 19.7 37.9 11.8 23.0 18.1 6.3 6.5 9.5 13.1 8.5 17.0 13.5 13.0 14.0 7.0 13.6 16.2 14.5 1.7 20.6 14.2 5.5 13.4 8.0 10.2 13.2 20.7 15.2 12.2 6.6 13.2 10.2 12.2 15.9 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA061750: , HPA063942: " "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favourable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.8 20.7 17.2 23.4 13.0 13.0 15.4 15.2 12.0 27.9 18.6 24.9 8.7 19.0 5.7 16.7 32.1 38.5 18.8 20.9 15.2 18.5 16.9 38.7 19.7 8.3 28.8 17.1 9.0 8.9 29.3 15.0 16.0 37.0 13.5 19.7 27.4 24.6 11.8 23.0 19.9 22.6 37.2 19.3 8.6 12.3 24.2 11.7 39.4 15.0 5.8 16.5 10.6 12.9 23.2 16.5 23.3 27.2 11.6 21.3 25.7 13.5 18.5 17.1 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell line enhanced" "Detected in all" "K-562: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: " "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favourable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.7 9.6 8.2 4.9 6.6 6.4 8.6 6.0 6.2 7.8 6.3 7.8 4.9 10.9 4.8 8.2 15.4 11.0 7.8 7.6 7.9 5.4 6.8 13.7 15.2 5.8 10.6 7.3 7.0 7.2 10.0 8.1 8.0 71.4 6.3 8.0 12.5 13.9 16.0 8.9 8.5 4.8 10.3 10.9 9.0 6.2 7.0 7.2 10.0 9.2 5.2 12.1 26.4 6.8 13.8 7.8 9.0 9.6 5.5 10.7 10.5 6.7 6.4 8.3 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavourable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favourable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 8.8 10.9 9.1 13.7 21.4 4.1 15.3 18.9 12.6 9.2 8.6 5.6 5.8 7.3 9.6 9.0 11.7 10.6 9.1 7.9 11.1 6.8 11.9 16.4 9.5 9.3 11.5 5.1 13.1 17.2 8.9 13.1 9.0 8.8 9.3 10.7 7.3 9.7 9.6 9.1 10.9 7.1 10.5 7.6 7.8 9.3 25.8 9.7 19.1 10.3 12.6 12.7 8.0 10.2 8.9 3.8 1.7 6.8 5.9 10.5 5.0 9.9 10.7 16.8 9.9 6.1 5.9 12.2 12.1 9.8 18.3 17.5 19.7 12.2 17.1 11.3 6.3 8.7 23.0 13.4 29.6 15.2 15.3 16.0 9.0 21.0 4.6 11.6 10.9 4.3 7.1 15.5 14.9 10.7 14.4 12.6 13.9 11.6 13.4 13.8 28.5 33.3 16.4 13.2 12.1 16.8 12.3 14.8 10.4 11.2 13.1 12.7 8.5 8.1 5.6 14.4 10.2 11.6 13.4 8.5 18.4 18.1 9.8 8.5 19.3 0.0 4.8 1.7 6.1 6.3 10.5 8.9 7.8 7.5 3.8 7.9 9.6 8.4 0.1 5.9 6.8 3.6 7.7 5.0 9.1 21.4 18.9 12.6 11.1 6.8 11.5 5.1 8.8 9.7 NUP50 NPAP60L ENSG00000093000 "Nucleoporin 50" Q9UKX7 22 45163841-45188015 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047162, HPA048328" Enhanced Enhanced "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA047162: AB_2679963, HPA048328: AB_2680360" "unprognostic (2.64e-1)" "unprognostic (1.21e-2)" "unprognostic (4.96e-2)" "unprognostic (1.22e-1)" "unprognostic (2.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.46e-3)" "unprognostic (5.83e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "unprognostic (7.22e-2)" "unprognostic (5.31e-2)" "unprognostic (1.97e-2)" "prognostic favourable (4.06e-4)" "unprognostic (1.43e-1)" "unprognostic (3.17e-2)" "unprognostic (3.63e-2)" 9.0 12.0 8.0 12.3 9.3 26.4 12.8 11.3 11.4 8.7 13.2 6.6 15.8 9.0 9.1 11.0 18.1 10.4 8.0 5.3 7.4 8.6 10.8 13.6 10.4 17.6 7.1 8.4 9.9 11.7 8.2 16.1 12.9 16.8 11.9 9.6 8.2 11.3 15.0 6.5 10.8 18.1 6.2 6.3 19.3 13.4 20.0 7.5 41.3 12.2 5.5 19.5 10.7 15.3 8.2 10.3 37.6 16.2 11.8 12.5 12.3 24.0 11.5 22.2 14.4 10.4 10.9 23.6 20.2 13.5 15.6 15.9 24.9 10.7 26.4 9.5 13.2 17.0 27.2 16.4 22.6 14.1 28.8 23.1 18.1 15.2 10.8 61.0 24.6 13.1 11.4 20.0 15.2 17.2 23.9 27.8 16.0 16.1 27.6 15.8 16.5 11.9 29.4 13.4 18.5 12.1 23.4 13.8 13.4 20.0 12.5 23.7 7.7 16.2 15.6 33.2 29.9 17.0 16.9 19.5 15.7 38.8 12.5 15.8 23.0 19.7 15.7 31.0 8.8 16.2 12.0 8.2 10.6 10.0 10.3 7.4 12.5 8.5 37.6 11.8 9.2 5.7 10.1 12.3 8.0 9.3 11.3 11.4 7.4 8.6 7.1 8.4 16.8 7.5 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavourable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavourable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.1 25.7 15.8 29.1 18.5 19.8 16.1 28.3 21.7 18.2 17.1 21.0 13.4 20.0 24.1 13.7 21.5 22.1 20.9 16.9 14.3 15.1 16.8 27.5 16.2 29.0 15.2 14.2 26.6 18.6 14.0 21.3 24.1 17.4 19.8 17.7 16.2 18.8 20.2 27.1 18.8 20.2 23.3 14.2 26.0 16.4 70.9 17.6 45.5 16.8 17.3 29.6 18.9 19.4 10.7 21.1 6.2 22.3 13.7 16.9 12.5 31.5 30.1 22.3 18.9 7.0 8.0 20.8 23.9 16.4 25.2 25.2 20.2 18.6 35.5 13.1 15.2 18.8 27.1 16.6 24.5 51.4 28.9 28.5 15.1 18.7 8.4 26.1 28.5 8.2 11.5 16.7 13.9 18.5 34.8 34.8 17.2 15.2 47.3 20.0 21.1 26.7 42.7 26.0 30.2 12.1 24.5 24.9 17.7 22.8 26.1 11.9 21.2 13.4 14.3 39.7 23.3 12.8 38.8 25.2 68.7 32.7 16.4 22.9 29.5 6.2 20.7 4.2 12.0 22.3 16.9 10.6 12.0 13.2 21.1 10.7 8.2 10.5 3.3 13.7 11.8 18.3 10.7 12.5 15.8 18.5 28.3 21.7 14.3 15.1 15.2 14.2 17.4 17.6 NUP85 "FLJ12549, NUP75" ENSG00000125450 "Nucleoporin 85" Q9BW27 17 75205659-75235758 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061910, HPA062595" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA061910: , HPA062595: " "unprognostic (2.30e-1)" "unprognostic (5.10e-2)" "unprognostic (5.12e-3)" "unprognostic (2.52e-3)" "unprognostic (2.25e-1)" "unprognostic (1.01e-2)" "prognostic unfavourable (1.73e-7)" "unprognostic (3.46e-1)" "unprognostic (1.09e-2)" "unprognostic (9.93e-2)" "unprognostic (2.94e-1)" "unprognostic (3.33e-2)" "prognostic unfavourable (3.32e-6)" "unprognostic (1.03e-3)" "unprognostic (2.16e-1)" "unprognostic (9.10e-3)" "unprognostic (2.11e-1)" 21.6 12.9 13.7 22.1 14.2 17.9 19.1 43.0 17.9 17.1 17.2 17.2 12.5 16.1 24.1 16.9 19.6 19.0 15.8 14.7 12.7 8.8 14.9 19.8 17.5 25.4 17.5 12.7 21.4 18.5 12.0 13.5 18.8 13.9 17.3 21.8 15.3 16.8 16.3 17.0 23.5 18.4 20.1 15.6 24.6 16.1 24.5 14.1 28.5 17.8 14.0 26.2 15.8 18.2 17.1 19.0 17.6 20.8 12.6 20.5 13.5 22.3 25.4 18.7 12.9 7.2 11.3 26.1 16.2 12.9 38.1 35.9 21.7 21.5 20.6 9.4 13.9 19.3 30.5 17.2 34.0 6.4 24.7 17.1 29.3 19.0 5.9 17.6 14.4 10.8 10.6 26.6 11.6 29.2 21.0 13.3 18.5 24.6 33.0 21.7 14.0 23.4 23.1 40.5 18.7 14.5 16.3 14.2 13.6 20.0 25.7 14.2 29.0 20.1 10.7 28.6 26.5 18.3 25.7 8.2 6.8 26.4 14.7 16.1 17.5 5.2 20.8 17.6 14.6 18.1 20.5 14.2 15.7 14.0 17.1 17.1 15.5 11.8 6.7 12.6 12.9 19.0 13.3 13.5 13.7 14.2 43.0 17.9 12.7 8.8 17.5 12.7 13.9 14.1 NUP98 NUP96 ENSG00000110713 "Nucleoporin 98" P52948 11 3671083-3797792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074810 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA074810: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (7.41e-2)" "unprognostic (2.13e-1)" "unprognostic (7.71e-3)" "unprognostic (3.40e-1)" "unprognostic (4.08e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (7.76e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (5.09e-1)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" 20.2 13.5 8.7 23.5 11.7 40.8 23.5 14.2 13.2 18.0 15.3 14.6 17.8 11.2 19.2 17.5 18.6 17.3 17.1 18.2 7.8 8.0 12.8 20.1 20.7 17.4 11.4 8.7 25.5 19.0 25.7 23.6 20.7 12.7 18.6 15.2 17.8 17.4 25.0 35.2 18.5 15.7 20.8 10.4 18.3 16.0 57.0 10.6 27.5 20.9 15.0 26.6 22.6 19.3 8.9 9.9 24.9 10.0 6.1 13.2 8.7 29.8 23.4 19.3 21.3 21.4 17.6 17.0 21.3 24.9 29.3 26.4 25.7 37.1 29.2 10.1 25.5 32.2 33.9 21.0 40.0 20.7 24.5 31.3 19.2 17.6 18.0 39.9 26.4 20.0 14.5 16.1 29.4 22.7 38.9 23.5 31.1 12.2 40.1 13.0 24.4 18.0 24.5 23.5 14.0 16.7 23.6 17.8 11.9 30.9 25.1 14.2 15.4 15.7 16.6 23.5 20.4 25.6 19.4 14.2 24.2 31.0 15.9 17.2 24.7 19.1 7.9 15.5 11.0 10.0 11.0 8.9 10.7 9.7 9.9 7.8 12.2 10.5 24.9 6.1 6.3 2.7 13.2 8.7 8.7 11.7 14.2 13.2 7.8 8.0 11.4 8.7 12.7 10.6 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675502-117710640 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavourable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 8.4 10.2 14.7 9.3 14.7 7.0 10.0 8.8 13.4 29.6 9.2 6.8 2.0 7.1 9.6 13.5 9.5 8.8 7.1 8.2 12.7 9.9 13.1 17.4 9.5 8.4 16.4 15.7 8.8 28.9 15.0 20.0 10.6 16.2 9.6 9.3 7.1 13.8 14.9 7.9 6.1 14.4 8.5 7.3 9.1 10.6 5.6 12.2 7.2 16.5 3.1 8.7 9.1 18.0 2.4 8.1 3.3 4.9 4.1 4.5 2.3 10.0 7.4 16.1 18.0 16.3 21.4 39.6 18.5 19.3 15.5 17.9 16.8 11.3 23.9 20.1 17.0 9.2 23.9 18.1 28.9 17.9 22.0 27.3 12.5 30.1 25.1 34.4 16.1 18.7 20.6 16.9 34.7 15.9 32.6 21.3 23.1 11.4 16.1 21.9 18.7 13.6 15.6 11.6 17.1 30.7 10.1 19.1 15.1 11.1 14.5 13.6 9.2 36.1 13.9 9.6 11.9 15.3 26.5 29.6 22.1 25.4 22.7 26.5 19.1 3.3 3.0 1.8 3.1 3.0 4.5 2.4 3.7 4.1 3.2 2.1 3.1 4.0 0.2 4.1 4.9 8.1 3.4 2.3 14.7 14.7 8.8 13.4 12.7 9.9 16.4 15.7 16.2 12.2 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA042904: , HPA074847: " "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavourable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavourable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.0 12.4 41.3 19.6 2.2 3.6 13.7 29.6 17.5 32.7 31.7 16.8 19.3 19.2 16.5 11.1 35.7 31.8 14.5 31.4 34.4 15.6 48.7 30.9 15.8 0.6 31.0 21.9 1.0 1.7 17.4 13.4 19.6 26.7 65.4 25.3 9.8 38.3 20.8 21.2 15.4 41.4 44.1 20.7 11.7 11.6 29.9 20.5 40.8 24.0 8.5 36.1 23.0 11.8 25.4 31.9 28.7 52.1 24.3 47.1 61.4 13.3 46.6 43.6 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 NXN "FLJ12614, NRX" ENSG00000167693 Nucleoredoxin Q6DKJ4 17 799313-979770 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 31.2;HHSteC: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023566 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA023566: AB_1854737" "unprognostic (1.68e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (3.48e-2)" "unprognostic (7.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.75e-2)" "unprognostic (6.98e-2)" "unprognostic (1.65e-3)" "unprognostic (2.27e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-1)" "unprognostic (5.76e-2)" "unprognostic (3.56e-2)" "unprognostic (2.34e-1)" "unprognostic (2.68e-2)" "unprognostic (2.05e-3)" 11.9 4.9 5.8 11.5 5.9 1.0 12.8 5.0 5.0 21.7 27.1 4.7 16.9 4.0 21.5 19.2 14.0 13.8 14.5 7.6 6.0 4.2 5.1 3.8 15.8 7.2 3.9 3.1 13.9 23.1 1.1 3.2 10.0 5.6 18.9 3.6 12.3 10.9 19.0 48.9 10.6 8.1 25.8 4.4 2.9 13.0 6.4 4.3 6.0 5.7 17.4 11.8 20.8 26.3 0.9 1.2 1.5 0.2 1.8 1.6 0.3 4.3 6.5 25.7 16.5 1.7 0.3 1.4 13.8 9.1 14.6 23.5 15.4 4.6 0.1 26.5 17.6 31.2 16.5 25.8 11.7 0.2 9.6 0.0 4.1 13.5 34.4 0.1 0.7 10.4 23.9 1.9 11.5 13.1 2.2 0.0 3.8 1.7 0.8 0.3 12.3 0.4 1.9 0.6 0.1 10.3 6.3 6.6 4.3 6.5 0.0 0.3 4.6 3.9 0.0 0.3 6.2 0.1 3.8 2.3 1.5 0.1 0.1 0.5 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.2 1.2 0.3 1.6 0.2 1.5 1.8 0.1 1.2 1.4 0.3 5.8 5.9 5.0 5.0 6.0 4.2 3.9 3.1 5.6 4.3 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell line enhanced" "Detected in many" "Karpas-707: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavourable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.7 11.8 10.2 3.7 11.0 11.6 2.2 8.6 10.9 10.3 15.1 2.7 0.8 11.4 25.5 9.7 1.7 11.3 9.2 12.9 14.1 3.6 8.7 7.5 7.3 14.6 7.4 8.2 6.6 1.6 8.6 3.1 11.1 1.8 37.3 17.1 4.0 9.8 1.8 5.8 7.3 4.5 12.4 4.8 7.6 1.9 8.1 9.6 3.7 0.9 6.4 1.7 10.6 9.6 11.5 13.7 1.3 8.9 17.7 17.6 13.4 9.8 32.8 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 NXT1 "MTR2, P15" ENSG00000132661 "Nuclear transport factor 2 like export factor 1" Q9UKK6 20 23350736-23354777 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047471 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047471: " "unprognostic (6.44e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.02e-3)" "unprognostic (1.99e-1)" "unprognostic (2.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.89e-2)" "unprognostic (1.17e-1)" "unprognostic (6.89e-2)" "unprognostic (5.54e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (1.15e-7)" "unprognostic (2.07e-1)" "unprognostic (1.98e-1)" "unprognostic (9.11e-3)" "unprognostic (9.31e-2)" 16.0 9.7 6.2 11.9 6.8 35.0 16.7 5.9 7.1 14.0 11.1 6.0 11.9 6.2 14.0 15.8 16.7 16.7 11.6 15.1 5.7 6.4 12.8 18.0 13.7 15.4 8.1 5.2 23.8 15.0 5.8 13.9 17.6 7.5 19.2 9.4 11.0 12.7 14.0 18.1 14.9 9.5 13.6 7.6 17.4 11.1 17.2 5.7 18.3 24.7 15.9 16.3 20.5 24.1 41.8 34.2 9.9 19.9 30.5 32.0 25.6 14.0 15.7 9.5 9.9 6.7 6.5 8.9 8.7 9.7 14.1 14.3 10.4 13.9 16.9 13.0 8.6 16.5 11.2 22.6 13.9 8.1 10.4 12.4 3.5 18.3 10.1 13.2 9.4 5.8 15.1 13.6 19.4 11.2 16.4 16.7 10.9 18.2 27.3 23.3 8.0 34.9 18.9 15.5 19.7 8.5 11.9 15.5 9.1 7.9 21.2 16.1 11.9 15.4 7.0 14.4 11.8 12.0 16.6 11.5 11.0 19.2 4.0 61.5 10.6 9.7 14.5 9.9 25.7 19.9 31.4 41.8 26.0 26.7 20.8 37.2 32.0 28.9 3.5 30.5 14.2 34.2 17.7 25.6 6.2 6.8 5.9 7.1 5.7 6.4 8.1 5.2 7.5 5.7 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544690 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.7" "Cell line enhanced" "Detected in all" "HL-60: 47.8;U-937: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: " "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 10.1 6.5 10.4 6.0 9.7 12.3 12.9 3.7 8.4 8.1 6.2 9.0 1.3 7.4 4.7 6.1 10.1 5.8 5.0 3.3 9.9 6.9 7.7 9.6 6.4 9.2 10.1 6.3 5.5 7.9 5.5 2.6 17.4 10.6 6.9 7.0 3.8 8.8 3.6 2.6 10.0 9.1 5.9 11.4 7.6 6.7 38.7 9.1 14.0 7.3 6.3 11.1 7.4 7.2 7.4 11.4 4.2 11.6 12.3 11.6 9.3 4.3 3.8 3.7 6.5 5.6 4.5 8.2 2.8 4.7 3.6 4.7 3.0 6.2 5.6 8.8 3.4 3.3 4.9 4.3 5.5 7.2 3.0 4.7 3.7 4.9 2.3 47.8 19.7 3.3 3.8 3.4 2.1 3.1 4.9 23.0 3.5 4.5 7.2 5.1 5.9 5.7 2.9 5.3 6.6 3.3 4.3 1.5 4.7 11.9 6.8 3.7 2.9 16.2 2.4 5.2 3.0 6.8 2.9 4.8 5.8 8.6 4.5 52.6 5.3 3.9 8.5 4.2 11.6 11.6 7.5 7.4 8.7 9.5 11.4 6.8 8.6 8.4 1.8 12.3 9.2 7.0 9.9 9.3 10.4 9.7 3.7 8.4 9.9 6.9 10.1 6.3 10.6 9.1 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8" "Cell line enhanced" "Detected in some" "AF22: 4.4;HUVEC TERT2: 5.6;SH-SY5Y: 13.6" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 3.1 6.3 11.8 1.6 15.2 1.3 1.4 15.4 32.8 1.8 1.6 3.8 0.0 1.6 2.8 1.3 1.5 1.9 1.6 1.2 13.2 12.8 1.9 1.1 1.3 1.4 7.4 13.4 5.7 2.1 1.1 10.2 1.7 11.4 2.9 1.4 1.0 2.3 3.2 1.2 1.9 1.8 2.1 3.9 1.6 2.3 9.0 4.4 0.0 1.2 0.0 1.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.4 2.0 2.9 1.9 0.4 0.1 1.4 0.2 0.6 0.6 0.3 0.0 1.5 0.4 0.2 0.9 0.2 0.1 1.9 0.3 0.2 0.4 0.2 2.1 0.0 1.2 1.9 0.0 0.6 0.7 5.6 0.7 0.1 0.1 0.5 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.3 13.6 0.5 0.3 1.3 0.2 0.0 2.0 0.0 2.8 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.2 15.4 20.6 13.2 12.8 7.4 13.4 11.4 4.4 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.1;U-2 OS: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045531 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045531: AB_10960749" "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 2.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.0;HEL: 9.0;HUVEC TERT2: 22.3;RT4: 18.4;TIME: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 2.9 0.0 4.1 8.5 0.2 1.3 1.4 0.9 1.0 2.0 9.0 0.2 0.4 5.3 0.0 4.7 0.1 1.0 0.0 0.5 9.0 1.2 0.2 3.0 0.0 0.0 8.6 0.3 0.6 0.0 22.3 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.0 1.1 0.0 0.0 0.0 18.4 0.4 6.4 0.0 0.8 0.1 1.6 1.3 10.8 0.1 5.4 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favourable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 14.6 19.1 19.1 15.8 19.3 15.3 19.3 13.2 20.2 13.6 17.4 18.8 30.3 19.1 12.6 26.6 15.8 20.1 15.9 13.5 19.1 18.6 27.8 35.4 16.2 24.8 21.4 19.6 22.5 25.3 21.6 22.4 13.8 20.9 16.8 20.4 17.6 15.9 24.2 16.7 14.9 17.9 15.8 21.4 16.2 22.7 44.7 20.9 21.4 24.6 14.2 20.7 16.0 14.1 27.6 16.5 23.4 16.2 27.4 24.4 13.2 14.3 9.3 20.1 13.5 11.6 13.3 11.9 8.8 12.6 10.5 11.7 13.9 10.6 19.9 9.8 5.4 10.6 12.4 11.9 15.7 17.5 6.7 24.1 9.8 26.0 10.9 16.5 15.8 10.4 17.5 10.2 34.9 7.3 30.5 17.1 11.3 21.4 26.9 19.4 18.9 6.1 12.5 17.5 19.3 20.8 7.9 21.1 14.1 8.3 8.4 28.9 14.8 15.3 7.5 11.0 13.0 7.0 15.2 22.5 22.4 44.2 9.1 16.8 9.3 20.4 13.8 23.4 17.2 14.2 21.6 27.6 19.7 17.0 16.5 25.8 24.4 23.2 13.4 27.4 16.2 16.0 21.8 13.2 19.1 19.3 13.2 20.2 19.1 18.6 21.4 19.6 20.9 20.9 OAS1 "IFI-4, OIAS, OIASI" ENSG00000089127 "2'-5'-oligoadenylate synthetase 1" P00973 12 112906777-112933222 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 51.4;BJ hTERT+ SV40 Large T+ RasG12V: 73.9;U-266/70: 72.5;U-266/84: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 83.9" "Low lineage specificity" "Detected in all" "HPA003657, CAB021104" Uncertain Supported Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "CAB021104: AB_10057722, HPA003657: AB_1854747" "unprognostic (1.03e-1)" "unprognostic (6.59e-2)" "unprognostic (8.56e-3)" "unprognostic (2.20e-3)" "unprognostic (2.78e-1)" "unprognostic (1.30e-1)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.20e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (6.91e-2)" "unprognostic (3.68e-2)" "unprognostic (5.67e-2)" "prognostic favourable (6.12e-6)" 31.2 7.3 6.1 16.6 7.1 5.7 8.4 2.1 6.0 16.4 25.4 11.0 2.6 23.6 5.8 21.0 39.1 5.1 10.7 5.1 4.2 5.7 18.3 23.3 20.7 17.3 5.9 5.3 7.4 3.2 4.3 6.1 18.8 8.6 11.5 20.5 11.7 31.8 4.2 2.9 6.3 27.2 7.6 9.4 30.1 22.7 4.2 6.2 21.6 9.4 13.5 27.3 20.9 13.0 18.2 24.4 4.1 83.9 4.5 16.8 29.0 1.0 5.8 0.0 0.0 2.0 1.6 0.4 0.0 7.6 51.4 73.9 3.3 6.2 8.0 2.3 0.0 2.6 0.0 0.7 0.7 5.9 0.0 0.2 10.5 1.3 0.6 0.1 0.4 0.1 2.2 1.9 0.0 2.7 0.0 3.5 0.0 0.1 0.2 3.6 0.3 5.1 1.7 0.0 3.3 2.6 16.6 0.1 0.3 0.8 1.0 19.6 0.2 1.3 10.1 0.0 0.1 0.7 0.1 72.5 55.0 5.5 0.6 2.3 0.4 1.0 40.9 0.5 4.9 63.6 4.6 18.2 6.5 6.1 24.4 13.6 2.5 3.3 4.1 4.5 83.9 22.1 16.8 29.0 6.1 7.1 2.1 6.0 4.2 5.7 5.9 5.3 8.6 6.2 OAS3 ENSG00000111331 "2'-5'-oligoadenylate synthetase 3" Q9Y6K5 12 112938352-112973249 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 64.0;BJ hTERT+ SV40 Large T+ RasG12V: 70.0;RT4: 17.5;U-266/84: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA041253, HPA041372" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" 21000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041253: AB_10794990, HPA041372: AB_10795590" "unprognostic (8.47e-2)" "unprognostic (9.13e-2)" "unprognostic (1.27e-2)" "unprognostic (4.39e-3)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.14e-3)" "unprognostic (8.06e-3)" "unprognostic (3.19e-1)" "unprognostic (1.73e-2)" "unprognostic (2.29e-3)" "unprognostic (2.48e-1)" "prognostic unfavourable (2.23e-5)" "unprognostic (4.25e-2)" "unprognostic (1.37e-2)" "unprognostic (3.29e-2)" "unprognostic (2.93e-2)" 36.9 4.9 5.1 11.2 5.4 18.3 7.0 2.9 5.5 10.5 6.8 5.5 3.2 7.3 10.0 11.8 17.9 4.2 9.4 6.7 4.5 5.3 10.3 7.1 19.9 13.3 5.1 5.1 6.1 3.2 3.3 4.6 19.3 8.7 5.6 6.9 8.9 24.7 3.4 3.3 6.0 9.3 8.3 6.2 22.0 9.5 3.0 3.3 21.3 9.9 6.7 13.5 9.9 8.2 2.6 4.8 10.1 14.7 5.0 3.8 3.9 6.3 9.5 0.0 1.5 0.3 1.4 0.8 1.2 8.3 64.0 70.0 7.2 5.8 0.4 2.3 2.9 5.4 1.2 7.7 5.4 4.7 0.3 4.9 4.4 2.3 1.2 1.7 2.7 0.5 2.5 9.1 0.5 3.3 0.1 1.0 0.8 4.1 2.7 0.9 0.5 5.5 3.9 3.4 0.1 3.0 17.5 0.2 0.0 5.8 2.2 5.7 7.6 0.5 2.2 1.7 1.2 1.5 2.6 0.5 19.1 0.1 1.4 4.8 5.2 0.9 7.9 1.6 2.0 8.6 2.5 2.6 3.0 3.0 4.8 1.3 2.2 2.6 10.1 5.0 14.7 0.2 3.8 3.9 5.1 5.4 2.9 5.5 4.5 5.3 5.1 5.1 8.7 3.3 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121019111-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;bone marrow: 33.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 51.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;hTEC/SVTERT24-B: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavourable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavourable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 20.5 0.5 1.0 8.3 1.4 33.1 2.7 0.4 1.9 3.6 5.9 1.7 0.1 1.6 1.7 1.3 4.7 0.6 3.1 2.2 0.7 0.9 4.0 22.6 16.5 1.9 1.3 1.2 1.4 0.4 0.2 0.8 3.6 2.3 2.5 3.0 2.3 3.4 0.3 1.1 0.8 2.0 1.1 1.9 5.2 15.7 2.1 0.6 6.0 3.2 3.7 7.6 2.9 1.5 0.8 3.2 44.5 10.8 6.9 23.6 10.8 1.0 0.2 0.0 0.3 0.3 0.9 0.0 0.1 0.5 51.5 26.5 0.0 4.9 0.3 1.5 0.0 2.7 0.0 0.3 3.8 9.1 0.0 0.0 5.2 0.0 0.3 0.0 0.7 0.3 0.2 20.6 0.0 0.1 0.0 1.8 0.2 0.4 0.0 2.6 0.0 1.1 0.0 0.1 0.6 0.2 4.8 0.0 0.0 0.4 0.2 8.1 0.1 0.8 0.0 0.2 0.4 0.6 0.1 1.9 3.7 0.0 7.7 0.4 0.1 4.2 10.3 22.4 20.4 10.8 5.3 0.8 14.1 23.6 3.2 0.3 4.0 15.7 44.5 6.9 7.4 0.1 9.9 10.8 1.0 1.4 0.4 1.9 0.7 0.9 1.3 1.2 2.3 0.6 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: " "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 41.4 7.5 4.9 17.6 50.3 48.5 16.8 25.1 51.3 22.5 24.7 19.2 5.4 0.0 18.3 42.4 44.2 22.5 47.0 24.5 7.3 31.2 46.4 5.3 14.3 25.9 0.0 30.6 31.7 24.3 20.2 23.6 26.1 79.8 8.9 31.3 10.7 12.2 2.6 9.8 10.6 11.4 18.8 11.2 21.5 0.6 10.3 11.0 15.8 42.1 35.3 14.0 11.4 20.1 12.8 12.0 21.2 15.6 7.6 8.0 11.2 17.7 12.5 6.1 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 OAZ1 "AZI, MGC138338, OAZ" ENSG00000104904 "Ornithine decarboxylase antizyme 1" P54368 19 2269509-2273490 "Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009291 Uncertain Approved "Vesicles,Centriolar satellite" Vesicles "Centriolar satellite" "HPA009291: AB_1079519" "unprognostic (2.37e-1)" "unprognostic (9.69e-3)" "unprognostic (1.72e-1)" "unprognostic (6.04e-3)" "unprognostic (9.41e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (3.75e-2)" "unprognostic (3.19e-2)" "unprognostic (6.22e-2)" "prognostic favourable (4.10e-5)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (8.37e-2)" "unprognostic (1.72e-1)" "unprognostic (2.44e-2)" "unprognostic (6.01e-2)" 50.7 56.5 73.3 47.5 68.2 84.6 67.4 41.5 68.6 27.2 37.8 22.9 31.1 47.8 32.7 33.7 38.6 40.1 34.0 73.7 67.2 53.3 31.8 45.7 50.3 71.4 60.4 52.3 31.2 86.0 11.9 34.6 53.5 39.9 32.1 24.0 27.1 65.6 33.7 137.4 30.4 55.3 37.3 37.0 66.0 41.4 25.0 29.4 31.8 43.8 59.3 40.1 37.2 45.3 69.7 83.1 150.4 136.3 24.4 54.4 160.8 72.9 15.2 11.7 20.0 24.6 39.4 30.5 52.2 36.3 26.4 36.3 21.6 23.7 49.9 28.2 24.2 21.3 11.5 15.7 17.5 66.3 39.8 38.5 15.1 34.0 25.2 53.7 61.0 26.2 27.5 9.9 15.1 29.9 37.3 58.0 29.7 26.7 44.5 56.1 38.5 27.7 37.0 23.4 65.8 24.0 21.2 27.7 29.4 34.3 31.3 57.3 26.1 114.2 38.0 18.8 23.2 80.9 54.7 56.6 23.3 60.9 85.6 84.4 28.4 109.3 116.3 134.1 36.1 117.5 36.0 69.7 39.5 38.3 83.1 66.6 36.9 36.4 150.4 24.4 136.3 56.0 54.4 160.8 73.3 68.2 41.5 68.6 67.2 53.3 60.4 52.3 39.9 29.4 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208130-228378874 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 180.2;tongue: 48.4" "Cell line enhanced" "Detected in many" "HeLa: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavourable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.5 0.9 0.5 0.9 4.4 0.6 0.7 3.1 0.6 0.6 0.8 0.5 0.5 0.6 0.8 4.4 2.4 1.0 0.6 21.2 0.5 0.7 1.6 0.5 1.0 1.0 0.5 0.5 1.7 1.4 0.4 2.4 0.5 0.9 1.7 0.3 5.2 2.6 1.1 180.2 1.1 0.8 0.5 0.6 1.4 0.5 0.7 0.6 0.5 2.2 48.4 3.5 0.6 0.7 1.0 1.1 0.1 0.4 0.6 3.2 0.7 2.9 2.8 8.0 4.5 0.2 0.1 5.6 1.5 0.5 1.0 0.9 2.0 2.1 5.7 8.1 0.5 1.0 0.4 1.1 0.2 2.1 5.1 1.9 16.0 0.0 2.0 1.3 6.1 3.0 1.0 0.4 0.2 0.4 5.3 1.3 0.3 5.0 2.0 1.6 8.8 1.7 8.1 0.1 1.3 4.6 1.5 3.0 9.0 0.2 2.9 1.1 8.0 3.7 0.7 0.0 9.3 0.2 0.1 4.7 0.9 1.4 0.0 0.8 2.1 0.1 0.4 0.0 0.9 0.1 0.9 0.5 0.9 0.7 0.9 1.0 3.2 0.5 0.1 0.6 0.1 1.1 0.8 0.7 0.5 4.4 3.1 0.6 0.5 0.7 0.5 0.5 0.9 0.6 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.8;SK-MEL-30: 22.2" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.8 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 58.1" "Cell line enhanced" "Detected in many" "CACO-2: 20.9;CAPAN-2: 27.8;HaCaT: 22.4;MCF7: 22.1;RPTEC TERT1: 17.3;RT4: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: , CAB068213: , CAB068214: , HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favourable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.8 3.4 3.8 3.7 0.5 7.6 3.9 2.9 4.3 15.5 3.2 21.9 10.2 1.7 7.4 10.6 7.9 17.1 1.1 4.0 2.9 15.3 31.7 29.2 0.4 4.0 1.7 2.3 33.2 12.0 3.2 9.0 6.7 5.7 10.9 7.7 7.1 25.0 0.5 8.7 24.5 1.2 3.8 2.1 15.1 2.0 1.5 0.4 58.1 9.8 8.6 5.0 6.5 1.2 1.2 1.8 0.3 2.0 0.9 0.1 15.0 6.1 0.1 0.5 0.2 0.3 12.2 0.0 1.5 2.0 3.0 20.9 27.8 0.1 5.3 0.3 22.4 6.2 3.0 5.6 0.1 10.8 1.1 0.2 6.3 0.1 0.5 1.5 0.0 3.1 4.7 0.2 1.2 0.0 0.1 0.0 22.1 0.6 0.4 2.4 2.5 0.0 4.6 0.5 17.3 18.9 2.0 0.9 0.1 16.5 0.2 9.3 1.9 0.2 0.1 6.2 1.2 1.5 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.7 0.8 0.2 0.2 0.8 0.9 0.3 0.1 1.2 0.7 0.9 1.8 2.0 0.2 1.2 0.4 0.1 3.4 3.7 3.9 2.9 4.0 2.9 4.0 1.7 6.7 1.5 OCRL OCRL1 ENSG00000122126 "OCRL, inositol polyphosphate-5-phosphatase" Q01968 X 129539849-129592561 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" Hydrolase "Cataract, Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012495 Approved Approved "Microtubules,Centriolar satellite,Cytosol" Cytosol "Microtubules, Centriolar satellite" "HPA012495: AB_1851804" "prognostic unfavourable (2.93e-5)" "unprognostic (3.17e-2)" "unprognostic (2.30e-1)" "unprognostic (6.34e-3)" "unprognostic (9.88e-2)" "unprognostic (1.35e-1)" "unprognostic (2.82e-2)" "unprognostic (2.68e-1)" "unprognostic (3.08e-3)" "unprognostic (2.56e-2)" "unprognostic (6.30e-3)" "unprognostic (1.74e-1)" "unprognostic (4.61e-3)" "unprognostic (4.10e-1)" "unprognostic (5.83e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" 12.1 20.5 10.7 6.0 18.2 5.3 10.8 13.4 23.1 12.7 13.4 10.1 28.8 9.1 15.8 19.7 13.3 12.8 13.8 8.6 13.0 20.5 10.9 11.3 8.6 6.0 12.9 15.1 33.0 12.4 37.3 20.3 13.2 17.8 21.7 14.1 15.3 8.5 27.7 11.4 9.6 9.8 21.5 8.0 6.3 11.4 23.2 6.4 4.3 19.0 5.6 4.1 18.0 9.2 0.4 2.4 0.3 6.6 0.0 0.7 0.7 9.6 11.2 9.2 10.4 16.4 13.6 9.0 14.9 11.9 15.4 14.3 7.5 7.1 0.8 25.7 12.6 6.1 17.0 11.3 16.1 0.0 11.5 3.0 10.1 7.5 12.2 3.0 0.3 11.4 15.0 15.1 15.1 11.4 4.0 7.4 16.0 12.7 2.2 4.2 3.3 16.7 2.2 9.6 5.8 8.8 10.1 11.3 14.3 7.0 10.0 7.8 7.2 5.3 9.6 12.6 5.8 13.1 14.8 2.1 1.6 2.0 8.8 11.1 9.9 0.0 2.1 0.0 0.2 2.4 0.7 0.3 0.1 0.1 2.4 0.4 0.6 0.2 0.3 0.0 6.6 0.9 0.1 0.7 10.7 18.2 13.4 23.1 13.0 20.5 12.9 15.1 17.8 6.4 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "salivary gland: 157.7" "Cell line enriched" "Detected in some" 17 "Hep G2: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 2.5 0.2 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.4 0.1 0.0 157.7 2.6 0.0 0.0 0.3 1.9 0.1 0.0 2.5 0.0 0.0 0.0 5.1 10.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448504 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 13.2 8.2 11.6 33.5 11.1 41.8 9.1 7.2 11.8 11.7 17.4 11.5 33.8 8.6 22.9 21.6 16.5 16.5 30.0 33.8 9.7 10.6 31.5 48.7 14.2 42.3 11.3 6.5 29.2 48.7 13.4 35.4 6.9 11.2 26.3 20.7 18.2 11.0 27.2 64.2 9.6 14.9 26.2 10.2 20.4 19.2 54.6 6.3 31.0 16.4 19.8 39.6 16.1 14.6 13.4 10.8 2.4 2.4 1.2 4.4 3.0 18.6 15.0 20.9 24.7 3.7 11.2 48.5 27.0 13.4 25.6 11.9 79.7 8.7 98.9 13.6 16.5 3.4 63.9 30.7 31.2 37.6 26.7 45.1 25.8 48.6 30.4 76.2 10.8 7.5 8.3 57.9 72.7 20.5 75.0 32.2 14.2 12.3 75.4 30.0 38.1 49.0 53.8 65.7 66.6 15.5 13.7 29.2 24.9 33.9 10.4 13.7 7.0 34.2 14.3 20.8 42.9 26.8 58.0 15.0 45.4 89.9 18.7 50.5 12.8 0.0 1.3 2.4 2.7 2.4 3.2 13.4 3.8 4.4 3.0 11.0 2.7 4.3 0.5 1.2 1.5 10.8 3.8 3.0 11.6 11.1 7.2 11.8 9.7 10.6 11.3 6.5 11.2 6.3 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: " "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favourable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 8.0 9.1 10.2 8.0 12.4 11.9 19.3 13.2 8.4 8.6 8.6 17.9 18.7 5.8 15.9 6.5 20.9 7.4 7.1 8.4 5.1 7.6 5.4 11.6 10.1 11.5 8.9 6.7 9.0 14.4 10.0 16.2 9.2 20.2 11.7 10.4 8.5 6.3 8.8 14.0 3.1 7.2 6.9 15.8 17.1 8.3 7.3 11.4 10.0 21.7 15.4 18.9 7.7 8.4 12.1 7.6 8.3 12.3 14.3 8.6 9.0 6.7 4.8 10.9 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 OGFOD1 "FLJ10826, KIAA1612, TPA1" ENSG00000087263 "2-oxoglutarate and iron dependent oxygenase domain containing 1" Q8N543 16 56451490-56479100 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003215, HPA003722" Approved Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003215: AB_1078881, HPA003722: " "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (3.80e-3)" "unprognostic (2.86e-2)" "unprognostic (2.48e-3)" "prognostic unfavourable (6.65e-4)" "prognostic unfavourable (7.02e-4)" "unprognostic (5.51e-2)" "unprognostic (6.87e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-2)" "unprognostic (4.59e-2)" "unprognostic (7.49e-2)" "unprognostic (7.20e-2)" "unprognostic (6.11e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-2)" 8.8 13.4 10.0 8.0 11.6 3.3 9.4 10.3 14.3 10.8 7.0 12.4 6.0 7.4 9.5 8.4 18.1 10.1 7.8 12.9 7.7 11.1 12.9 13.9 7.5 7.5 9.1 10.4 10.2 6.5 13.7 13.1 8.3 15.6 8.0 8.9 8.5 8.4 10.0 56.1 8.8 5.8 15.1 11.1 8.6 7.4 8.2 6.2 10.6 9.3 12.6 13.0 9.6 8.3 7.8 7.5 11.8 8.9 8.7 12.1 6.5 11.1 13.2 13.0 16.1 14.7 17.8 12.2 18.2 14.7 25.9 18.8 16.1 8.2 20.4 9.3 14.5 16.1 27.5 12.4 29.3 6.3 14.8 14.8 11.5 16.5 11.3 16.0 17.5 11.8 14.1 19.2 16.0 21.0 20.6 3.9 21.8 7.2 12.7 9.2 22.0 22.8 23.8 19.9 23.8 11.6 8.0 10.4 11.6 22.5 14.6 12.2 13.3 13.3 13.6 14.4 11.5 11.1 16.0 8.0 15.5 30.1 11.5 11.6 11.4 11.8 4.7 4.8 8.8 6.3 11.9 7.8 11.2 10.4 7.1 6.1 12.1 10.0 1.7 8.7 8.9 7.5 9.3 6.5 10.0 11.6 10.3 14.3 7.7 11.1 9.1 10.4 15.6 6.2 OGFOD2 "FLJ13491, FLJ37501" ENSG00000111325 "2-oxoglutarate and iron dependent oxygenase domain containing 2" Q6N063 12 122974580-122980043 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039448, HPA040306" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA039448: AB_10795035, HPA040306: AB_10794026" "unprognostic (2.14e-1)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" "unprognostic (3.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.57e-2)" "unprognostic (6.12e-3)" "unprognostic (1.14e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.07e-3)" "unprognostic (2.48e-3)" "unprognostic (1.13e-3)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" 6.2 15.0 8.9 11.7 11.7 10.0 7.5 13.4 10.6 7.5 13.4 11.6 14.1 18.5 9.6 14.9 11.2 12.8 13.1 8.5 8.0 8.8 12.9 18.9 8.0 13.4 14.5 9.3 11.6 24.3 10.9 13.5 10.6 13.4 11.4 7.8 9.7 20.1 14.6 13.2 15.9 17.9 8.7 8.0 14.4 11.5 25.1 13.8 10.9 13.3 10.8 12.0 7.4 8.0 16.4 13.4 18.0 16.6 8.8 15.6 9.3 7.2 11.7 4.9 8.0 3.4 3.7 13.2 4.4 4.6 6.2 5.6 11.0 6.5 8.1 9.2 3.8 10.5 3.5 6.0 2.3 5.6 7.7 12.9 10.0 11.3 7.4 12.8 10.1 5.4 9.1 5.7 5.1 6.5 14.9 6.0 3.1 13.9 10.7 24.1 3.0 15.1 12.0 4.7 14.3 4.7 6.5 6.3 5.8 6.0 8.7 8.3 21.9 11.0 4.1 8.5 8.7 10.0 4.5 15.2 9.1 7.7 11.7 6.7 8.2 12.5 12.2 18.0 10.1 13.1 8.7 16.4 8.2 9.8 13.4 11.4 9.3 8.5 10.0 8.8 16.6 8.0 15.6 9.3 8.9 11.7 13.4 10.6 8.0 8.8 14.5 9.3 13.4 13.8 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavourable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.0 0.0 11.0 10.1 1.5 17.1 10.6 6.9 7.0 1.4 0.7 23.3 23.5 7.3 1.9 3.1 11.7 24.6 4.9 2.5 5.1 4.1 0.6 9.0 2.4 1.8 10.2 10.2 5.1 16.1 5.5 0.3 1.8 23.7 3.2 0.0 3.8 1.6 0.9 1.6 12.4 5.3 16.0 0.3 13.9 6.3 5.0 3.1 1.1 5.4 18.9 8.4 17.0 8.6 1.8 5.6 2.5 0.1 3.0 5.7 16.2 2.9 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533083-71575897 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: " "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavourable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favourable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavourable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favourable (6.85e-7)" 26.1 24.0 33.3 39.7 36.6 38.7 33.7 75.7 43.8 25.0 23.0 22.0 31.1 22.5 36.7 48.3 24.3 33.4 21.2 25.1 29.3 15.4 27.4 20.3 31.0 47.9 30.2 25.6 42.8 46.1 26.5 34.5 19.5 26.6 34.2 30.3 29.9 35.9 30.9 35.0 45.4 38.4 31.1 32.3 56.7 28.2 11.8 36.6 35.7 34.1 27.6 41.4 24.9 31.0 9.7 7.6 3.2 7.2 12.5 9.9 6.0 14.3 13.5 17.5 15.3 18.9 17.4 11.8 11.0 19.9 12.0 18.5 14.2 16.5 17.1 7.8 13.5 17.9 19.1 10.8 14.8 14.6 19.6 10.8 32.1 10.1 14.3 22.2 17.9 16.6 22.0 13.1 24.8 11.1 10.9 59.5 11.4 12.2 17.1 26.7 11.6 18.4 17.0 19.6 21.9 18.5 16.7 9.0 7.9 17.1 11.4 10.6 8.4 15.1 12.9 13.0 10.6 13.5 6.4 16.3 11.7 20.6 9.1 23.4 7.9 3.2 5.3 2.3 9.9 7.2 9.0 9.7 8.3 8.0 7.5 8.5 9.7 9.5 2.4 12.5 6.5 7.6 7.6 6.0 33.3 36.6 75.7 43.8 29.3 15.4 30.2 25.6 26.6 36.6 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" "Nuclear speckles, Vesicles" "HPA052271: , HPA059602: " "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavourable (1.79e-4)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.0 10.2 0.7 0.9 13.4 8.2 3.8 9.9 10.7 12.6 6.6 7.9 7.2 3.0 20.8 14.2 6.3 7.8 17.1 16.4 16.8 20.7 13.1 0.1 18.3 9.5 0.3 1.3 5.6 5.9 8.4 23.0 15.4 6.6 6.4 10.7 13.7 12.7 15.5 13.3 11.7 12.0 4.4 6.1 22.3 7.4 13.6 13.9 3.8 13.8 10.5 4.1 10.2 15.8 10.1 14.6 7.3 32.2 28.2 2.9 22.4 14.6 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell line enhanced" "Detected in some" "HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: " "unprognostic (6.77e-2)" "prognostic favourable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.5 3.1 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 21.2 0.1 0.0 28.3 0.0 0.0 0.0 11.9 0.0 0.0 40.8 5.4 33.8 0.1 2.1 52.4 0.0 0.0 2.0 4.5 22.8 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: " "prognostic favourable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 21.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777158-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.9;HeLa: 14.6;WM-115: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 17.3 2.1 1.0 7.4 1.7 0.1 10.9 1.9 3.4 34.2 18.9 3.1 6.3 2.3 29.2 8.3 11.8 4.2 7.6 12.5 1.2 1.0 3.0 0.6 10.3 1.5 2.1 1.5 13.2 3.4 3.6 2.1 5.0 4.0 16.1 4.6 18.9 4.7 9.5 9.8 11.6 5.0 33.7 1.6 23.8 4.0 3.1 0.6 3.7 20.0 11.9 5.0 22.0 10.4 1.4 0.7 2.6 0.9 0.6 0.6 0.4 0.3 5.2 0.4 0.1 6.0 57.9 0.0 0.8 2.8 1.2 1.2 0.0 0.7 0.0 1.5 0.0 9.7 0.1 0.3 1.4 0.0 0.0 0.0 14.6 0.0 0.3 0.0 0.0 4.1 0.9 3.6 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 0.5 0.0 3.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 1.4 1.3 0.1 0.0 1.8 1.9 2.0 0.2 0.7 0.0 0.0 5.5 0.3 22.6 1.9 0.9 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.7 1.4 0.4 0.6 2.6 0.6 0.3 0.6 0.3 0.4 1.0 1.7 1.9 3.4 1.2 1.0 2.1 1.5 4.0 0.6 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Cell line enhanced" "Detected in some" "HMC-1: 29.3;NB-4: 21.2;THP-1: 18.4;WM-115: 6.0" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 4.2 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.2 1.9 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.0 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Cell line enhanced" "Detected in some" "CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Low region specificity" "Detected in all" HPA050798 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavourable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.4 3.1 0.5 1.9 0.7 32.0 0.0 0.3 0.0 4.1 16.8 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 33.8 0.0 0.0 0.2 15.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 64.4 25.6 0.0 7.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA055120: " "prognostic favourable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favourable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favourable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 10.2 22.4 13.8 21.5 18.1 9.2 15.8 10.6 14.6 14.5 16.4 14.1 20.1 12.1 15.4 15.1 17.1 15.9 12.1 15.8 12.6 10.0 23.0 23.8 19.1 17.9 16.7 9.6 15.0 18.2 15.7 20.9 8.9 13.0 17.8 16.1 11.3 20.6 22.7 20.9 10.2 16.1 24.2 18.2 17.2 13.9 6.9 19.4 18.4 18.3 14.5 16.4 17.0 20.6 22.5 9.5 18.6 19.5 18.6 22.8 10.2 13.5 5.7 3.8 3.5 19.2 18.0 10.9 5.6 6.1 4.9 6.2 1.6 8.2 30.7 11.9 5.8 13.9 13.4 13.7 5.9 23.5 7.5 9.6 4.4 6.6 9.6 23.3 6.7 17.0 15.3 4.8 10.0 4.3 18.0 9.2 13.4 8.3 7.9 8.3 5.6 12.4 9.9 12.5 12.8 10.7 9.1 4.0 1.9 11.4 18.9 15.8 8.5 9.0 2.5 2.5 5.1 12.6 5.8 7.5 9.8 20.2 7.8 18.3 6.2 10.8 9.2 18.6 12.8 14.5 16.5 22.5 15.7 15.0 9.5 21.4 22.8 20.8 10.6 18.6 19.5 5.0 13.9 10.2 13.8 18.1 10.6 14.6 12.6 10.0 16.7 9.6 13.0 19.4 OMD "osteoadherin, SLRR2C" ENSG00000127083 Osteomodulin Q99983 9 92414245-92424461 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 14 "ASC diff: 12.3;ASC TERT1: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069948 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Secreted in other tissues" 14000000 "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA069948: " "unprognostic (1.18e-1)" "unprognostic (2.33e-3)" "unprognostic (5.04e-2)" "unprognostic (2.26e-1)" "unprognostic (9.42e-2)" "unprognostic (1.87e-2)" "unprognostic (4.31e-3)" "unprognostic (6.42e-2)" "unprognostic (4.53e-1)" "unprognostic (3.89e-2)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-3)" "unprognostic (6.35e-2)" "unprognostic (2.84e-3)" "unprognostic (2.08e-3)" 14.0 7.9 2.2 1.2 4.3 0.0 14.6 3.7 3.4 20.3 8.3 1.0 8.0 0.8 8.2 19.3 14.0 8.7 8.9 20.2 2.8 1.7 2.9 0.8 12.2 0.8 7.0 5.4 15.3 1.8 1.5 4.2 11.5 6.0 13.6 2.2 14.2 2.3 4.2 2.8 3.5 3.7 13.9 19.3 0.7 5.0 12.8 1.3 0.2 9.2 14.5 3.2 22.1 7.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 12.3 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.2 4.3 3.7 3.4 2.8 1.7 7.0 5.4 6.0 1.3 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435685-57491297 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;gallbladder: 60.7;intestine: 18.0" "Cell line enhanced" "Detected in some" "HDLM-2: 18.2;HeLa: 11.6;RT4: 6.2;SCLC-21H: 9.5" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA057058: " "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.3 0.4 0.3 0.3 18.6 0.2 0.3 3.0 3.7 0.2 16.5 0.0 0.0 15.0 0.3 0.3 0.3 0.2 60.7 0.2 0.5 0.9 0.3 12.8 0.3 0.3 0.5 0.9 0.3 4.3 3.2 5.1 0.2 1.1 0.3 0.3 0.7 0.3 0.3 0.3 0.3 18.0 0.3 0.3 0.3 0.5 0.6 6.6 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 2.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 3.2 0.0 0.1 18.2 2.9 0.7 11.6 2.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 3.5 0.6 0.0 0.4 1.7 0.0 0.1 0.7 0.0 1.1 0.0 1.6 6.2 9.5 1.6 0.1 0.0 0.2 0.4 0.6 0.0 1.0 1.2 0.2 0.2 0.3 2.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 3.0 3.7 0.5 0.9 0.5 0.9 1.1 6.6 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: " "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavourable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favourable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 25.9 8.3 8.5 9.3 7.5 11.9 9.0 12.6 11.6 13.9 13.6 20.3 8.8 17.3 27.3 11.8 16.9 14.8 14.3 24.6 20.8 12.0 29.9 7.4 10.1 11.7 24.5 13.8 13.2 12.8 13.4 19.0 11.7 12.6 17.0 13.8 20.5 9.5 13.6 11.9 27.9 12.5 18.6 18.5 10.4 16.2 18.5 11.2 18.9 21.1 13.4 27.7 19.4 11.7 12.9 9.8 13.8 26.5 15.3 17.8 33.8 14.2 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 OPA3 "FLJ22187, MGA3" ENSG00000125741 "OPA3, outer mitochondrial membrane lipid metabolism regulator" Q9H6K4 19 45527427-45602212 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavourable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 21.6 14.8 8.5 9.4 15.9 7.9 21.8 8.5 13.1 6.2 8.9 7.2 5.7 8.4 10.5 7.7 11.3 7.6 9.8 21.8 9.8 9.6 15.9 16.4 19.3 9.7 11.0 4.5 8.9 9.3 23.9 12.3 11.4 18.4 7.9 8.7 12.1 8.2 9.4 19.7 12.5 9.7 10.2 12.4 12.0 9.2 15.7 11.1 5.3 11.8 9.7 9.6 9.5 30.3 6.7 7.8 7.4 13.0 10.9 6.2 4.5 11.3 14.5 5.8 5.8 3.9 4.8 8.9 7.4 6.9 8.0 8.5 6.7 8.2 9.8 5.4 7.4 9.1 9.7 10.2 7.0 17.9 9.8 15.2 8.1 6.9 7.0 10.7 19.8 7.2 7.9 8.8 9.7 5.6 12.9 11.1 5.4 7.0 8.3 4.4 5.1 10.0 8.3 5.2 5.3 6.2 20.6 4.4 5.2 9.5 8.8 4.0 4.9 6.1 12.1 6.8 7.8 5.6 12.6 7.5 13.8 8.2 6.6 7.7 10.2 6.0 7.4 3.8 5.3 10.5 5.6 6.7 4.8 4.5 7.8 5.6 6.0 5.9 7.4 10.9 13.0 7.3 6.2 4.5 8.5 15.9 8.5 13.1 9.8 9.6 11.0 4.5 18.4 11.1 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 68042344-68433913 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 5.8 8.2 21.9 2.4 22.6 3.6 7.1 12.3 21.6 9.9 4.9 10.7 3.2 3.5 9.7 4.8 6.1 5.3 4.5 4.1 19.5 9.7 7.0 1.7 6.6 2.0 9.6 12.2 7.1 4.0 6.6 4.8 20.7 9.1 16.2 5.1 7.9 7.2 8.0 7.8 8.6 4.1 6.3 6.2 2.9 5.9 2.9 12.4 0.1 7.2 2.0 2.3 3.9 6.2 2.7 3.3 4.1 1.7 1.7 1.2 0.3 15.1 3.8 2.4 5.9 5.5 5.7 3.9 2.8 3.9 5.3 6.4 2.4 3.1 0.7 10.8 3.4 4.1 2.1 1.2 8.2 0.4 1.5 3.2 4.3 2.4 1.8 0.8 3.8 3.2 3.9 4.9 4.8 4.3 2.1 1.4 3.1 7.8 0.5 0.8 4.6 3.2 0.4 4.8 0.7 6.9 5.8 0.9 2.3 5.5 7.0 12.4 4.7 1.3 4.7 3.6 5.8 12.7 3.6 2.1 2.5 0.5 2.7 1.9 2.6 1.1 1.7 0.6 1.2 0.9 1.0 1.3 1.0 0.8 0.7 2.7 1.1 1.2 4.1 1.7 1.2 3.3 0.7 0.3 21.9 22.6 12.3 18.6 19.5 9.7 9.6 12.2 9.1 12.4 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell line enhanced" "Detected in many" "U-87 MG: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavourable (2.26e-8)" "prognostic unfavourable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavourable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.6 2.2 5.1 1.7 0.0 0.0 1.5 9.6 0.0 0.0 0.0 5.0 2.0 2.5 1.4 0.0 1.4 0.0 0.0 0.0 0.3 3.6 1.5 3.0 2.5 0.0 1.9 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.6 1.0 0.7 2.0 3.5 4.6 2.9 1.0 5.3 2.9 0.0 0.6 0.7 6.8 2.3 5.2 4.3 0.5 1.9 4.0 9.8 1.0 7.6 8.6 2.0 2.1 1.5 36.9 4.5 9.1 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Cell line enriched" "Detected in some" 5 "U-937: 21.6" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: " "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 21.6 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949066-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 13.4 22.9 5.5 13.0 5.6 12.4 14.8 6.0 8.1 17.0 12.8 9.1 13.3 7.5 12.4 16.9 19.9 13.6 16.5 10.8 4.9 5.1 16.5 39.6 15.4 20.7 5.9 3.6 16.9 14.5 13.5 12.1 14.8 5.8 26.2 7.3 13.3 10.3 15.3 9.4 10.2 9.9 16.4 5.1 20.0 10.4 19.7 5.2 14.2 25.6 6.3 13.7 29.1 15.2 5.1 6.8 17.9 8.5 8.1 2.8 2.2 1.0 5.8 3.0 4.0 26.1 23.5 0.2 3.4 23.0 2.5 6.5 0.5 9.6 1.4 7.8 6.5 4.7 0.5 6.4 1.7 4.4 1.9 3.7 1.8 5.7 36.5 4.0 11.5 25.2 17.3 4.9 9.7 4.3 4.1 7.7 8.2 3.8 0.2 15.0 2.4 1.6 3.1 2.3 10.9 9.7 2.5 0.7 5.0 3.1 0.9 5.2 7.3 16.5 3.1 1.9 1.3 4.2 0.8 19.0 1.3 1.1 9.6 9.5 2.9 14.1 6.5 17.9 2.5 6.3 2.8 5.1 1.4 2.0 6.1 4.8 1.7 2.3 10.9 8.1 8.5 6.8 1.9 2.2 5.5 5.6 6.0 8.1 4.9 5.1 5.9 3.6 5.8 5.2 ORC2 ORC2L ENSG00000115942 "Origin recognition complex subunit 2" Q13416 2 200908973-200963680 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003693, HPA073881" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB003693: AB_425574, HPA073881: " "unprognostic (3.04e-1)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (8.12e-3)" "unprognostic (3.40e-2)" "unprognostic (1.52e-2)" "unprognostic (2.37e-3)" "unprognostic (3.28e-1)" "prognostic unfavourable (8.42e-4)" "unprognostic (6.18e-2)" "unprognostic (4.56e-2)" "unprognostic (4.63e-3)" "prognostic unfavourable (1.97e-4)" "unprognostic (9.67e-2)" "unprognostic (3.74e-1)" "unprognostic (1.42e-1)" "unprognostic (5.31e-3)" 11.7 10.6 8.3 15.9 14.0 9.0 14.0 19.0 14.6 12.6 16.1 11.8 15.1 15.7 18.4 12.9 12.3 10.3 10.7 14.6 9.8 9.2 10.8 9.5 9.5 13.5 8.6 10.4 14.6 14.3 13.7 18.0 14.4 12.9 11.8 12.3 10.3 18.1 22.0 16.1 14.6 16.9 8.9 9.0 14.1 12.1 33.2 6.8 20.3 14.7 12.7 14.2 10.9 11.7 8.1 6.9 5.1 3.6 4.6 8.9 2.2 11.2 8.0 8.9 8.9 3.6 6.3 15.2 11.6 7.3 10.6 10.5 16.4 9.0 6.9 8.4 6.7 9.1 19.4 13.0 16.0 15.5 18.3 16.2 14.1 20.0 7.2 12.8 11.6 5.9 7.7 10.7 13.2 12.1 25.7 8.6 9.2 10.6 17.7 12.1 21.7 19.0 12.7 9.1 10.2 11.0 9.0 14.4 10.8 10.0 8.9 6.3 6.4 6.4 9.2 9.3 9.7 7.9 11.5 6.2 14.7 11.4 7.3 12.4 8.7 0.3 3.6 5.1 5.0 1.4 6.3 8.1 6.8 4.7 3.0 7.2 8.9 6.0 1.8 4.6 2.4 6.9 4.6 2.2 8.3 14.0 19.0 14.6 9.8 9.2 8.6 10.4 12.9 6.8 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930397-148021604 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: " "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavourable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavourable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favourable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 11.5 14.3 19.0 11.4 20.5 19.6 17.3 29.8 27.2 13.6 14.6 11.0 12.0 13.9 14.8 13.5 13.1 17.3 11.9 13.8 18.1 22.3 24.5 15.5 10.9 11.9 18.1 18.1 21.2 12.1 18.9 29.5 14.3 30.9 14.9 16.8 12.7 15.2 14.6 16.0 11.6 15.6 13.8 18.1 11.0 10.9 17.3 11.8 20.4 19.0 12.7 13.6 13.3 12.6 16.1 18.1 21.5 19.1 20.2 16.6 13.1 12.2 10.7 21.0 11.5 8.2 8.1 22.9 14.0 11.8 17.7 17.8 26.4 12.5 15.9 15.4 8.2 12.5 23.8 13.8 18.5 11.1 20.2 21.9 11.6 17.8 10.9 13.8 8.3 6.8 16.8 19.3 7.7 11.9 20.8 8.4 11.5 13.0 10.7 11.3 23.9 15.7 11.8 14.2 14.3 19.6 25.5 19.9 15.6 12.6 13.9 16.8 10.7 6.7 8.6 13.5 13.3 9.8 12.8 8.4 19.7 15.0 11.0 10.8 8.2 21.5 15.0 19.8 16.2 19.1 16.6 16.1 15.8 16.6 18.1 15.4 16.6 16.3 21.1 20.2 14.8 9.2 16.0 13.1 19.0 20.5 29.8 27.2 18.1 22.3 18.1 18.1 30.9 11.8 ORC5 "ORC5L, Orc5p, ORC5T, PPP1R117" ENSG00000164815 "Origin recognition complex subunit 5" O43913 7 104126341-104208047 "Predicted intracellular proteins" "DNA replication, Photosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019730 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019730: AB_10696205" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (4.77e-2)" "unprognostic (7.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" "unprognostic (3.47e-2)" "unprognostic (9.26e-2)" "unprognostic (2.33e-1)" "unprognostic (1.77e-1)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (2.53e-2)" "unprognostic (7.73e-2)" 12.4 13.7 10.6 9.3 17.9 6.2 16.3 18.7 21.6 12.9 14.2 12.1 9.0 10.1 14.4 17.5 14.1 11.3 8.5 8.2 13.0 12.9 12.6 20.3 10.2 13.7 10.1 11.8 13.8 17.4 10.8 15.9 11.4 17.6 21.5 16.0 14.0 11.8 13.8 10.9 14.8 11.0 14.2 8.6 12.0 12.3 27.3 10.0 20.5 12.6 7.9 15.8 13.4 12.7 14.0 7.2 6.8 7.4 12.5 18.6 8.2 16.3 17.1 9.9 18.0 10.6 10.6 8.9 14.5 13.8 16.4 13.7 11.1 10.7 24.1 12.2 9.0 15.5 19.9 13.9 19.6 13.1 12.9 8.8 9.8 11.3 14.7 16.8 7.9 10.0 13.3 18.8 17.4 15.3 28.9 14.0 13.8 23.2 23.4 17.0 10.7 17.9 9.8 18.0 23.9 12.6 12.2 13.4 11.2 13.6 27.8 18.5 9.3 13.0 8.9 14.9 17.4 24.2 18.2 15.5 33.3 31.8 10.7 22.8 18.7 6.8 6.3 4.5 13.1 7.4 17.1 14.0 13.6 15.0 7.2 11.9 17.2 18.6 0.8 12.5 6.0 7.0 11.3 8.2 10.6 17.9 18.7 21.6 13.0 12.9 10.1 11.8 17.6 10.0 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: " "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavourable (3.53e-4)" "prognostic favourable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.8 1.4 4.1 8.9 7.0 14.2 1.1 3.8 6.1 1.3 2.8 1.2 1.4 2.7 1.5 1.9 6.7 0.9 1.2 2.3 4.4 3.5 0.8 1.6 1.5 10.6 3.1 4.5 0.9 0.6 0.3 1.2 5.2 2.4 0.8 3.1 0.5 1.4 0.6 0.4 1.9 2.7 1.7 2.9 4.1 1.5 23.1 1.4 12.8 0.9 4.2 10.7 2.6 2.0 4.1 3.4 1.0 2.6 2.8 4.1 2.5 10.7 10.0 15.9 12.4 2.0 2.5 11.8 19.3 7.2 21.3 11.2 14.0 6.6 12.5 10.1 3.6 11.0 20.4 5.3 18.1 6.4 16.5 10.4 5.3 14.1 2.4 16.9 10.9 0.7 0.9 11.6 6.1 7.0 12.5 6.4 12.9 9.5 22.7 21.2 17.6 27.4 27.4 29.2 12.7 5.2 3.7 19.1 11.3 9.8 10.9 6.7 5.8 13.4 4.2 19.7 13.3 12.4 18.1 4.9 6.6 43.6 8.3 11.1 15.2 0.0 1.1 1.0 3.5 2.6 1.4 2.7 2.0 2.0 2.2 4.1 2.9 1.4 0.5 2.8 2.5 3.4 4.1 2.5 4.1 7.0 3.8 6.1 4.4 3.5 3.1 4.5 2.4 1.4 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 834.6" "Cell line enriched" "Detected in some" 11 "Hep G2: 157.9" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Cell type enriched" "Detected in some" 45 "neutrophil: 53.4" "Lineage enriched" "Detected in many" 45 "granulocytes: 53.4" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 945333333333 120000000000 Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: , HPA047725: , HPA057726: " "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 834.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 157.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.2 0.0 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333252 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 404.1" "Cell line enriched" "Detected in single" 237 "Hep G2: 133.4" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Cell type enriched" "Detected in single" 35 "neutrophil: 13.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 13.2" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 422277500 61000000000 Vesicles "Golgi apparatus" "HPA046438: , HPA047725: , HPA057726: " "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 404.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 133.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.1 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59616144 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: , HPA043625: " "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favourable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favourable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 15.6 36.6 12.3 10.6 16.3 13.8 16.5 14.7 18.0 16.1 18.8 13.7 35.4 17.3 15.9 19.9 15.9 13.8 19.5 14.7 10.3 11.6 26.3 54.8 12.9 9.7 12.4 12.7 16.6 30.2 31.4 14.7 29.4 17.9 16.1 17.3 12.6 27.7 26.2 32.5 20.9 22.3 15.1 9.5 12.5 19.1 11.3 12.1 18.8 19.6 12.5 13.8 16.7 13.7 4.6 7.9 3.5 3.1 4.0 6.1 2.1 17.5 14.7 10.9 14.7 25.9 24.3 12.1 14.3 18.7 17.3 15.6 16.6 17.8 17.7 19.3 16.5 18.4 20.1 19.1 19.5 17.1 9.3 11.9 11.5 11.1 27.7 15.2 23.7 18.5 23.8 16.2 42.8 18.4 20.5 16.6 15.3 8.1 14.3 11.2 12.4 14.5 13.9 17.6 12.3 20.5 20.4 13.0 9.2 17.0 21.3 19.6 29.8 9.8 19.9 14.8 10.4 22.1 9.6 23.2 18.8 18.1 16.7 11.0 11.9 3.5 3.1 2.8 5.9 2.9 5.5 4.6 6.1 4.6 3.2 3.4 5.6 4.7 3.0 4.0 2.5 7.9 2.6 2.1 12.3 16.3 14.7 18.0 10.3 11.6 12.4 12.7 17.9 12.1 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657890-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 39.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 31.4;RPTEC TERT1: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.6" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favourable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavourable (4.85e-4)" 11.7 3.5 3.8 8.7 4.3 1.0 6.7 1.4 7.6 8.6 5.6 0.4 5.9 2.5 11.8 6.7 10.0 5.5 16.7 2.9 2.6 2.6 14.5 1.6 4.6 8.2 3.1 3.6 4.1 2.5 1.3 12.0 16.5 2.5 12.8 6.0 8.5 7.3 16.6 2.0 5.5 7.3 39.6 1.2 9.5 4.4 24.0 1.2 0.4 4.3 4.3 15.1 25.2 11.8 11.5 0.1 0.5 0.0 0.0 0.0 0.2 6.1 3.5 0.6 12.4 1.1 2.3 20.9 1.7 1.9 1.6 2.3 8.6 4.5 14.6 16.7 0.4 3.7 2.7 14.6 1.9 0.1 2.7 0.0 8.6 5.5 0.9 0.0 0.1 2.4 12.4 2.5 31.4 7.1 0.0 0.0 6.8 5.1 0.0 0.0 7.8 8.9 0.1 0.2 0.2 33.1 2.5 0.9 0.1 3.1 5.4 1.7 3.6 0.0 5.0 2.0 21.5 0.2 8.2 1.4 1.0 14.0 2.8 0.0 12.6 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.8 4.3 1.4 7.6 2.6 2.6 3.1 3.6 2.5 1.2 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595090 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 8.1 5.1 12.6 8.1 16.9 4.7 13.2 5.7 9.7 5.4 7.2 14.1 4.9 5.1 6.1 6.1 6.8 5.0 5.2 5.3 11.0 7.7 6.8 22.4 10.9 11.1 11.2 8.3 4.5 3.8 8.5 5.1 9.0 8.7 4.6 6.6 4.6 5.1 9.7 48.9 6.3 6.0 7.0 10.3 11.4 5.2 7.8 10.9 8.3 5.9 6.0 9.4 6.3 5.3 3.5 11.8 12.8 9.5 1.9 2.2 3.2 12.8 7.0 13.4 7.5 15.2 8.1 17.4 9.7 7.8 12.4 14.2 13.5 4.6 21.3 12.2 8.0 9.7 14.8 8.6 16.6 5.7 6.4 9.8 8.5 8.9 8.5 7.3 13.3 6.6 10.5 10.3 9.1 8.9 10.0 9.7 11.2 7.6 14.4 3.5 18.4 6.3 12.7 7.7 24.8 10.3 8.0 3.0 7.9 12.0 6.9 10.3 7.1 3.8 9.2 9.9 9.0 14.4 7.5 6.1 6.5 26.1 6.9 2.6 9.5 10.8 9.3 2.4 1.8 9.5 1.5 3.5 1.0 1.8 11.8 2.7 1.2 1.4 12.8 1.9 7.8 4.5 2.2 3.2 12.6 16.9 5.7 8.4 11.0 7.7 11.2 8.3 8.7 10.9 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162044-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 18 "basophil: 33.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favourable (4.98e-13)" "prognostic unfavourable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 32.3 14.3 33.3 5.9 28.9 7.0 23.8 6.2 43.1 27.7 13.8 33.9 6.2 10.2 24.4 9.0 15.5 15.2 10.6 24.7 37.6 22.6 21.7 6.6 11.9 5.0 40.6 27.7 14.3 8.3 21.0 8.8 4.2 29.9 12.0 11.5 16.6 23.3 13.9 73.2 8.7 9.8 20.4 49.0 4.8 9.7 6.9 29.0 1.0 14.6 9.9 4.1 12.0 29.7 0.2 1.8 33.7 1.8 0.1 0.4 0.6 15.2 4.6 11.0 20.4 25.7 21.1 10.3 5.7 16.7 5.2 4.3 2.9 16.0 0.0 6.8 10.2 15.6 4.3 10.0 4.8 0.0 8.1 4.8 3.3 0.0 12.8 12.0 2.5 27.2 14.4 3.9 16.2 6.5 0.0 0.1 6.4 6.4 2.7 3.6 9.0 15.2 0.0 8.8 1.3 1.4 11.3 7.1 7.0 13.3 15.6 18.2 5.7 8.7 1.4 19.4 4.0 6.2 5.5 0.1 2.1 0.4 9.4 3.5 11.0 33.7 1.8 0.4 0.1 0.9 0.0 0.0 0.4 0.2 1.7 0.2 0.2 0.2 0.7 0.1 0.3 1.8 0.3 0.6 33.3 28.9 6.2 43.1 37.6 22.6 40.6 27.7 29.9 29.0 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796539-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: " "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavourable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 3.7 2.2 3.9 18.2 9.5 3.8 6.6 1.2 16.0 12.1 6.1 6.2 0.7 9.8 3.8 3.7 10.2 6.2 10.4 5.3 4.3 4.3 14.4 1.9 9.0 10.9 4.2 7.4 8.4 3.9 23.1 4.2 6.3 3.1 4.3 6.7 3.7 6.9 2.9 6.7 12.8 10.4 4.0 6.7 10.2 8.7 3.5 4.1 13.9 16.8 7.2 14.7 12.4 9.6 3.7 3.5 6.3 2.1 8.1 9.8 2.4 14.4 3.9 2.9 5.4 6.6 13.4 6.6 16.4 18.3 7.7 12.2 9.8 19.2 8.0 2.3 17.5 12.7 8.8 12.3 11.9 4.8 3.6 1.9 5.8 7.3 9.4 5.4 43.0 6.5 10.3 10.0 12.1 11.5 10.0 11.2 13.0 0.0 3.3 6.7 5.7 5.1 2.7 8.1 3.3 7.7 10.3 0.6 6.1 11.1 8.0 2.4 4.1 0.5 13.6 3.4 6.8 18.5 12.2 7.8 11.3 20.2 7.4 9.0 37.9 6.3 2.1 1.5 9.8 1.8 8.4 3.7 6.2 6.3 3.5 1.7 2.1 4.2 0.4 8.1 1.2 2.5 9.8 2.4 3.9 9.5 1.2 16.0 4.3 4.3 4.2 7.4 3.1 4.1 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell line enhanced" "Detected in many" "HaCaT: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036076: AB_10601042, HPA053083: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favourable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.9 4.7 2.0 2.3 2.3 3.3 1.7 1.5 2.2 2.5 2.9 4.6 12.0 4.0 5.9 2.1 29.2 1.1 3.2 0.8 13.2 1.6 2.9 8.7 3.1 2.1 6.1 0.1 5.1 0.6 1.7 1.1 5.1 2.8 5.4 3.9 5.0 6.1 6.5 1.2 5.9 5.6 3.1 5.4 3.4 3.0 2.1 4.8 2.4 0.8 2.3 4.3 3.9 6.0 3.9 3.4 0.0 1.2 10.0 3.6 3.9 4.2 5.2 1.5 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 29.3 11.4 13.9 18.4 41.9 23.1 17.2 13.7 20.2 20.0 11.5 6.8 8.4 7.5 18.5 10.7 20.1 10.4 15.0 19.3 13.4 12.9 30.2 15.2 20.5 22.7 12.1 13.2 14.9 11.2 12.4 16.5 14.4 13.9 16.2 9.7 9.2 15.8 11.1 21.5 22.9 12.6 15.5 14.8 24.9 12.4 12.8 14.7 41.0 11.7 10.6 24.8 18.0 24.5 11.7 15.8 57.2 15.0 9.9 10.9 8.1 12.3 7.9 17.6 12.5 24.6 34.8 11.2 19.1 26.7 12.2 11.2 11.4 5.1 17.3 10.9 22.6 5.2 13.1 11.0 18.5 14.8 11.6 46.5 7.8 6.8 15.2 29.4 19.0 18.3 21.0 18.2 22.8 10.5 31.8 8.0 20.1 8.5 19.6 14.0 8.6 7.9 10.3 24.1 9.9 9.4 10.5 9.7 10.1 16.3 6.0 11.8 4.5 18.0 24.6 19.9 9.9 20.4 10.2 8.0 12.6 19.1 7.5 16.6 11.5 27.5 15.0 20.1 9.0 10.8 8.5 11.7 9.6 7.3 13.2 11.6 8.7 7.1 57.2 9.9 11.7 15.8 10.9 8.1 13.9 41.9 13.7 19.9 13.4 12.9 12.1 13.2 13.9 14.7 OSBPL9 ENSG00000117859 "Oxysterol binding protein like 9" Q96SU4 1 51577179-51798427 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027378, HPA027397" Supported Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027378: AB_1854816, HPA027397: AB_1854817" "unprognostic (5.99e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-2)" "unprognostic (2.43e-3)" "unprognostic (3.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-1)" "unprognostic (4.17e-3)" "unprognostic (1.58e-1)" "unprognostic (8.36e-3)" "unprognostic (8.61e-2)" "unprognostic (3.64e-2)" "unprognostic (7.53e-3)" "unprognostic (2.55e-1)" "unprognostic (4.95e-2)" "unprognostic (3.37e-1)" 35.7 28.8 12.6 19.0 20.7 20.3 27.4 30.3 17.6 29.4 15.4 29.8 20.0 13.1 36.3 29.7 18.8 19.4 15.0 27.2 13.5 16.1 35.4 52.6 25.7 18.2 25.1 14.0 29.4 26.9 43.2 27.6 20.8 22.2 37.1 16.6 29.9 18.2 22.4 55.6 15.2 16.4 25.3 28.2 22.5 22.5 20.0 24.8 19.4 28.2 18.5 24.6 27.7 31.6 23.4 19.9 28.7 13.6 12.8 23.2 12.6 21.7 11.2 22.8 5.0 16.3 8.1 40.8 11.2 18.8 18.1 21.6 16.3 16.4 31.8 19.6 12.3 10.1 19.2 19.4 25.8 22.6 14.1 25.1 21.9 33.5 15.8 25.8 13.0 16.3 18.8 20.4 13.5 23.8 47.5 10.4 10.1 15.5 7.4 28.0 31.0 5.2 18.7 33.1 33.7 24.2 17.0 11.3 15.0 9.5 26.1 31.0 12.6 26.0 14.3 5.2 17.4 6.5 19.9 25.4 16.1 37.1 12.8 12.0 8.0 28.7 13.6 25.0 16.1 11.4 23.2 23.4 16.0 16.6 19.9 16.4 17.1 18.1 15.9 12.8 8.6 15.7 15.3 12.6 12.6 20.7 30.3 17.6 13.5 16.1 25.1 14.0 22.2 24.8 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Cell line enhanced" "Detected in some" "EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavourable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.1 0.7 0.0 0.0 0.2 0.6 4.7 0.0 0.0 0.4 0.1 0.1 0.0 5.3 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.8 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.5 16.5 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favourable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favourable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.1 4.9 6.1 7.1 7.3 7.2 1.1 3.1 7.7 7.8 5.4 0.1 4.6 1.1 5.9 5.7 4.1 0.2 5.9 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.7 11.0 4.8 5.3 0.1 1.3 6.1 3.7 2.7 1.9 6.2 2.1 2.9 2.5 0.9 12.8 1.8 16.5 7.3 5.9 2.8 4.1 6.0 0.8 4.6 5.7 2.1 10.2 5.3 2.3 2.3 0.5 10.9 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 OSER1 "C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1" ENSG00000132823 "Oxidative stress responsive serine rich 1" Q9NX31 20 44196496-44210791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045125 Approved Approved "Nucleoli,Nuclear speckles" "Nucleoli, Nuclear speckles" "HPA045125: AB_10961629" "unprognostic (2.77e-2)" "unprognostic (3.01e-2)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.58e-5)" "unprognostic (1.18e-1)" "unprognostic (6.07e-2)" "unprognostic (8.44e-3)" "unprognostic (3.31e-1)" "unprognostic (1.14e-1)" "unprognostic (8.78e-2)" "unprognostic (8.01e-3)" "unprognostic (9.87e-2)" "unprognostic (3.96e-1)" "unprognostic (2.14e-1)" "unprognostic (2.45e-1)" "unprognostic (8.39e-2)" "unprognostic (1.06e-1)" 18.7 11.8 11.9 18.4 13.3 62.5 20.0 17.8 13.3 19.1 17.2 13.0 13.0 15.1 17.5 17.6 23.5 14.2 13.7 16.9 12.4 10.0 15.0 16.3 17.7 16.9 16.3 10.9 21.4 10.9 19.3 12.5 31.7 13.1 22.6 14.1 12.4 17.0 13.2 46.3 22.3 18.9 23.5 16.9 18.2 14.7 47.4 13.3 15.1 19.0 15.4 17.4 29.6 16.7 28.4 14.6 74.3 21.9 15.1 17.6 19.8 20.5 16.1 11.6 9.2 31.3 22.3 13.6 19.0 28.6 29.9 27.5 38.5 21.3 20.6 18.8 17.3 28.0 13.2 17.4 25.2 6.9 8.7 6.6 34.6 26.1 18.1 11.4 11.1 26.4 29.4 19.6 36.0 13.6 9.8 25.4 16.4 30.7 9.1 13.9 10.6 16.5 12.8 19.8 14.2 14.9 14.1 11.8 11.8 27.1 35.9 24.0 18.3 10.2 11.9 24.7 19.0 14.7 16.3 17.3 18.4 20.0 17.5 8.5 12.8 50.2 16.8 27.7 12.7 15.7 13.7 28.4 14.8 12.5 14.6 26.9 17.6 15.9 74.3 15.1 21.9 9.5 17.1 19.8 11.9 13.3 17.8 13.3 12.4 10.0 16.3 10.9 13.1 13.3 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446411-20455105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favourable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavourable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 11.2 14.2 13.2 13.1 14.5 10.7 14.4 21.3 18.3 14.3 15.6 18.6 11.6 8.8 16.0 19.2 12.9 13.1 13.6 15.8 13.4 10.2 12.3 22.2 12.4 16.9 13.4 12.5 12.4 12.4 10.6 20.8 13.6 15.5 10.8 14.0 14.5 12.4 18.6 19.6 9.9 12.4 16.8 12.3 18.8 13.6 5.7 15.2 16.2 15.7 9.6 18.7 16.6 11.0 24.5 28.8 23.4 19.1 13.0 14.2 15.7 6.3 10.3 3.4 10.0 5.9 4.1 10.5 5.0 6.6 12.8 12.4 14.2 7.5 13.3 6.5 6.3 5.6 10.3 10.1 8.0 10.5 13.2 8.4 8.7 18.2 4.4 14.4 12.0 3.1 3.1 15.3 8.1 8.4 8.1 7.6 10.0 11.9 14.1 6.3 5.1 20.4 22.5 6.4 7.5 7.2 7.3 13.3 2.6 8.9 9.4 6.8 6.3 13.7 3.9 5.4 13.2 6.8 6.0 2.3 12.5 18.2 3.3 22.5 6.5 5.1 19.1 23.4 13.7 17.6 11.9 20.5 14.2 12.0 28.8 24.5 11.3 12.9 8.7 13.0 13.6 12.4 12.9 15.7 13.2 14.5 21.3 18.3 13.4 10.2 13.4 12.5 15.5 15.2 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83948282-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.5" "Cell line enhanced" "Detected in many" "A549: 25.2;Hep G2: 37.9;T-47d: 28.2;WM-115: 23.6" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 4.5;monocytes: 12.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019239 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favourable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 4.0 9.8 1.7 3.0 6.5 0.8 28.2 0.6 3.7 1.7 17.4 2.1 0.7 18.1 1.3 1.7 5.6 1.8 5.1 6.9 1.3 1.4 13.8 63.5 8.2 1.6 13.4 0.0 3.2 5.2 2.5 1.4 1.2 6.6 2.1 1.8 5.1 2.0 1.7 7.8 1.6 21.3 5.5 13.7 5.4 5.0 5.6 1.9 0.0 5.2 13.5 2.9 6.0 10.6 0.0 1.0 4.5 12.3 0.0 0.0 0.8 1.7 25.2 0.2 1.1 1.6 2.3 1.9 2.9 2.7 2.6 0.9 6.2 9.2 0.0 6.8 2.4 4.6 1.0 1.8 1.0 0.3 0.3 0.4 5.6 37.9 5.5 0.8 9.9 1.4 1.5 6.9 1.6 2.5 2.2 2.5 3.4 11.7 0.3 0.3 0.2 5.8 0.8 2.6 1.2 1.8 2.1 0.1 0.6 6.1 1.9 12.3 28.2 1.0 8.7 4.1 6.2 6.0 1.9 1.1 0.4 0.0 13.7 1.3 23.6 0.1 2.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 0.0 12.3 0.0 0.0 0.8 1.7 6.5 0.6 3.7 1.3 1.4 13.4 0.0 6.6 1.9 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Cell line enriched" "Detected in some" 17 "ASC diff: 111.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA052425: , HPA063486: " "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favourable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.1 0.8 0.0 0.8 111.2 3.5 0.8 3.4 6.6 2.7 2.7 0.6 0.7 0.0 0.5 5.2 2.4 0.5 0.9 1.3 0.2 2.5 0.1 0.6 0.3 1.8 0.1 0.1 3.5 1.9 0.4 0.3 0.0 0.7 0.0 0.1 2.8 0.5 1.0 0.0 0.5 2.6 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.4 0.0 0.8 1.4 0.0 0.4 0.0 2.7 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavourable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavourable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.34e-6)" "prognostic unfavourable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.2 6.5 7.8 11.3 23.3 7.6 11.0 16.2 16.3 11.9 19.8 3.9 3.7 5.1 13.4 11.3 4.2 7.6 5.5 18.4 11.7 6.0 10.7 4.2 4.8 18.1 11.8 25.1 11.1 13.8 14.6 11.7 6.0 8.5 18.7 19.2 3.1 2.5 2.7 3.1 5.0 4.2 11.2 2.7 8.5 5.9 0.8 4.6 13.1 3.3 29.0 3.8 17.1 7.3 10.4 3.8 23.0 22.9 7.2 12.3 4.4 30.8 8.0 23.0 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol 630000 "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 19.8 24.7 41.9 24.1 61.6 32.6 20.8 41.8 101.9 24.3 25.0 31.9 22.3 24.7 21.9 23.6 37.8 34.5 21.6 31.6 46.9 37.8 27.2 27.6 23.0 31.9 33.1 45.4 23.4 23.0 26.0 21.6 30.7 60.4 23.8 24.1 24.2 30.4 27.7 26.7 36.9 26.0 23.1 26.7 25.7 23.9 22.1 21.2 27.8 29.9 24.5 32.8 27.1 22.9 46.0 60.8 56.1 71.3 44.8 64.5 78.2 30.5 55.2 30.5 26.9 20.6 22.8 23.4 18.4 27.4 41.0 30.3 37.0 29.3 16.3 35.0 29.5 38.2 39.3 45.8 25.5 18.8 30.5 27.1 33.1 46.8 28.9 26.9 29.8 24.2 29.8 31.3 20.0 38.6 18.9 18.5 27.5 62.8 29.3 35.6 35.7 26.3 24.1 11.9 27.8 42.6 44.7 23.1 33.3 20.8 32.0 33.6 49.6 23.8 27.9 21.9 21.3 29.3 24.1 21.8 13.7 23.3 28.3 17.5 20.9 55.1 56.3 54.3 53.1 71.3 41.4 46.0 49.1 48.6 60.8 41.9 38.4 42.6 56.1 44.8 60.9 42.1 64.5 78.2 41.9 61.6 41.8 101.9 46.9 37.8 33.1 45.4 60.4 21.2 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439458-23442390 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.8;tongue: 61.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 24.7;HaCaT: 23.3;SiHa: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: , HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favourable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 9.2 5.9 8.5 6.9 39.3 14.7 9.7 9.5 13.8 8.8 9.3 6.9 4.9 9.8 10.0 8.2 9.0 9.9 25.9 6.0 5.9 14.7 7.3 26.6 11.0 6.2 6.7 10.9 6.5 12.8 7.8 11.5 5.4 8.0 5.8 9.8 6.4 6.2 60.8 17.5 7.9 7.3 6.5 13.1 16.9 9.9 5.8 8.1 14.9 61.1 12.3 12.7 10.5 3.5 1.0 5.1 4.0 0.2 3.5 0.5 2.9 1.4 1.6 0.7 6.3 3.2 2.0 1.2 2.7 2.9 2.6 0.6 24.7 1.4 2.6 1.5 23.3 1.7 2.9 1.9 10.5 4.5 0.0 3.6 0.9 5.4 0.2 2.0 3.2 12.9 0.8 4.1 0.9 0.3 9.9 1.6 1.4 0.9 0.9 1.2 0.8 1.5 7.1 1.3 3.8 2.6 0.7 1.7 15.1 2.7 6.8 1.1 2.1 1.7 1.6 2.4 4.5 0.5 4.8 9.0 0.7 2.5 0.9 0.6 5.1 1.6 2.6 0.8 1.7 1.0 1.9 1.5 0.8 1.0 3.5 1.2 1.7 3.6 0.2 4.0 0.6 3.5 0.5 5.9 6.9 9.7 9.5 6.0 5.9 6.2 6.7 5.4 5.8 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.0 1.9 8.6 10.3 3.7 3.3 8.5 5.4 3.1 2.8 2.7 9.0 4.8 8.0 4.4 11.9 5.0 8.0 3.1 5.5 5.2 10.7 7.7 10.2 6.2 2.0 5.6 7.1 2.7 3.1 4.4 5.7 3.7 5.4 3.4 4.8 2.7 4.3 5.6 4.1 5.1 10.0 22.0 3.0 4.7 5.5 7.6 5.4 3.9 3.1 4.2 4.7 4.2 4.4 6.7 8.6 7.4 4.6 4.0 3.4 5.0 4.7 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922028-48958386 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/70: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favourable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favourable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favourable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 23.5 27.5 32.4 26.8 40.9 38.4 21.9 35.0 52.4 21.3 22.9 28.2 23.4 30.5 25.5 26.8 20.5 25.1 20.9 16.6 29.8 31.3 22.6 24.5 25.2 30.8 25.4 29.8 30.0 25.4 29.6 26.8 23.1 29.4 24.0 17.8 20.4 26.9 27.4 24.4 24.5 29.1 27.1 21.4 34.5 22.3 12.7 24.0 34.8 24.5 14.4 27.2 22.1 22.7 7.8 6.3 8.6 5.1 18.6 7.5 3.5 6.1 9.3 4.3 10.7 7.4 6.6 5.0 5.4 6.3 6.8 7.4 4.6 6.8 6.9 3.5 6.8 7.5 6.5 5.4 6.4 8.0 7.9 5.2 9.4 5.3 6.2 4.9 5.8 7.3 5.1 7.1 4.8 5.4 6.5 10.9 4.8 6.1 7.7 10.7 7.8 7.3 6.1 6.4 8.9 4.8 5.5 4.2 7.4 7.1 4.6 7.1 6.1 4.5 7.6 4.4 5.6 11.7 4.4 182.8 45.6 6.6 6.9 6.9 3.0 5.2 3.4 7.0 7.0 5.1 5.8 7.8 5.5 6.0 4.8 6.0 5.2 7.5 8.6 18.6 4.7 6.3 7.0 3.5 32.4 40.9 35.0 52.4 29.8 31.3 25.4 29.8 29.4 24.0 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU domain containing 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavourable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 11.4 11.3 14.6 14.1 18.2 8.9 13.2 13.8 19.6 12.3 11.3 9.9 10.3 9.2 12.1 9.0 13.2 9.1 8.6 14.0 14.9 13.7 11.0 10.5 10.0 13.8 18.5 15.5 12.5 9.9 11.2 14.4 14.9 16.2 11.6 11.3 6.0 9.5 14.8 35.3 11.2 9.1 12.4 19.9 11.3 8.8 11.9 17.4 13.9 11.8 11.0 11.9 11.9 14.0 7.2 12.9 8.8 7.8 7.8 6.8 2.9 16.0 9.3 8.3 6.2 3.7 2.8 8.7 12.7 4.8 11.9 7.7 7.9 10.1 17.1 6.2 6.7 5.5 17.2 10.4 18.5 13.7 10.5 23.2 9.6 6.0 8.0 11.8 12.3 4.7 5.0 9.6 22.7 9.6 23.2 10.7 10.1 8.7 19.8 7.7 4.5 18.4 8.9 8.0 15.2 9.3 11.6 2.0 7.5 1.2 28.3 12.3 14.5 5.7 9.8 7.1 10.7 10.8 12.1 10.7 20.4 25.0 10.4 14.8 13.6 8.8 6.5 4.3 5.9 7.8 6.8 7.2 4.8 5.7 8.1 6.8 6.7 5.9 0.9 7.8 5.8 12.9 3.6 2.9 14.6 18.2 13.8 19.6 14.9 13.7 18.5 15.5 16.2 17.4 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 2.6 2.0 12.4 1.7 13.9 5.9 1.5 13.2 17.0 1.8 3.4 16.0 0.0 1.5 1.9 1.9 1.9 2.0 2.3 2.1 10.0 4.6 2.3 1.0 1.5 3.5 20.4 7.1 2.0 2.5 4.6 1.7 0.9 10.5 1.2 3.1 0.7 1.6 2.0 1.8 3.2 2.1 2.9 9.1 2.2 2.3 8.2 17.4 0.0 2.3 0.0 2.4 1.9 1.3 0.1 3.2 0.3 1.4 0.1 0.7 0.4 3.6 4.1 4.5 6.0 0.4 1.3 3.2 2.5 1.3 3.9 1.9 2.5 3.2 2.9 2.2 0.9 4.6 4.8 2.0 3.2 5.9 6.6 3.7 8.3 2.0 0.3 4.0 5.7 0.0 0.2 3.8 4.3 3.5 6.0 5.4 1.8 2.9 3.1 3.9 2.0 2.0 5.6 3.0 1.4 1.6 3.9 10.9 6.0 3.4 3.0 1.0 2.5 4.3 2.3 5.3 5.2 3.0 6.2 3.3 2.4 3.0 2.9 5.8 4.5 0.0 0.4 0.3 0.6 0.5 0.3 0.0 0.3 0.7 0.2 0.1 0.2 0.2 0.0 0.1 1.4 3.2 0.0 0.4 12.4 13.9 13.2 13.8 10.0 4.6 20.4 7.1 10.5 17.4 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010676 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027045 Supported Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA027045: AB_1854847" "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favourable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favourable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 8.8 6.2 5.8 2.6 12.3 0.3 6.2 8.5 8.9 8.6 6.3 20.6 4.0 4.6 8.5 4.1 6.1 7.6 4.3 5.3 6.0 4.5 8.6 5.6 0.9 12.7 5.1 9.2 4.5 12.5 4.3 5.3 11.6 5.3 5.6 7.4 5.4 6.3 13.2 4.3 5.1 8.9 8.5 2.3 5.2 9.6 12.5 0.0 8.3 2.3 2.1 6.3 7.1 0.6 0.6 4.7 0.3 1.4 2.3 0.2 11.4 9.2 6.5 10.8 8.6 8.0 6.1 8.1 11.9 9.7 6.7 6.8 9.3 0.1 5.3 14.6 9.2 9.1 8.9 10.3 11.0 4.7 4.4 12.8 4.5 9.2 5.0 4.8 8.8 6.9 16.5 14.5 7.9 12.0 12.5 7.0 11.7 0.8 1.4 8.2 9.0 1.2 8.9 2.9 3.8 15.7 4.2 7.9 14.2 10.5 12.8 8.7 2.6 9.5 10.1 9.4 6.8 9.4 13.4 12.9 1.3 9.0 1.5 16.5 4.7 0.3 1.3 2.3 0.2 1.7 0.6 1.0 1.4 0.1 0.6 0.9 1.0 1.2 1.4 0.3 0.6 0.6 0.2 OTULIN "FAM105B, FLJ34884" ENSG00000154124 "OTU deubiquitinase with linear linkage specificity" Q96BN8 5 14664664-14699711 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051074 Uncertain Approved "Plasma membrane,Mitochondria" Mitochondria "Plasma membrane" "HPA051074: " "unprognostic (4.81e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (1.19e-2)" "unprognostic (7.48e-2)" "unprognostic (1.91e-2)" "unprognostic (7.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.02e-1)" "unprognostic (7.13e-2)" "prognostic unfavourable (2.59e-7)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (5.02e-2)" 10.0 7.4 5.9 22.6 7.8 32.3 8.4 7.2 6.6 8.2 9.3 8.3 8.9 10.7 9.5 7.7 13.8 6.1 10.8 15.5 6.7 4.9 8.5 19.5 11.1 16.0 9.6 2.8 9.1 12.2 7.5 9.8 11.8 7.0 11.1 7.0 7.7 10.6 10.8 16.5 18.1 11.7 8.1 10.5 12.5 7.1 11.5 7.4 15.0 7.8 9.7 19.3 8.5 15.8 3.4 2.9 3.1 3.0 1.0 4.6 0.9 6.3 7.4 7.4 8.4 6.9 7.2 8.2 6.4 4.5 9.1 6.9 9.9 4.7 11.4 12.6 4.1 7.2 9.2 8.4 6.3 19.7 7.6 8.2 23.5 5.3 5.9 7.8 14.1 4.1 10.3 7.5 6.4 7.7 8.1 18.3 6.5 3.9 7.7 6.8 4.5 7.8 11.9 6.7 4.6 6.0 6.6 3.4 5.5 22.8 5.1 4.9 5.6 9.0 7.1 11.9 13.4 8.9 8.4 8.3 12.5 13.0 6.8 14.9 6.1 0.4 2.0 3.1 1.0 2.2 3.0 0.9 2.5 3.4 2.9 3.4 1.8 3.9 2.2 1.0 3.0 2.5 4.6 0.9 5.9 7.8 7.2 6.6 6.7 4.9 9.6 2.8 7.0 7.4 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3" "Cell line enriched" "Detected in many" 9 "THP-1: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 113 "neutrophil: 11.3" "Lineage enriched" "Detected in single" 113 "granulocytes: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012341, HPA052122" Uncertain Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "CAB012341: AB_2157155, HPA052122: " "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.5 0.4 8.2 0.4 4.3 0.4 1.1 0.2 7.2 0.4 0.4 5.8 0.0 0.6 0.4 0.4 1.4 0.5 0.5 0.4 9.0 1.4 0.4 0.5 0.8 0.4 2.0 3.4 0.6 0.6 0.4 0.1 0.4 0.1 2.3 0.4 18.9 19.6 0.4 0.4 14.3 0.4 0.4 0.1 0.6 1.0 0.9 4.4 0.0 0.4 4.4 5.6 0.6 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.4 0.8 2.7 1.6 0.0 0.1 3.8 0.0 0.2 0.2 0.2 2.8 1.4 0.1 0.5 0.0 1.9 1.8 1.2 0.3 0.6 1.6 1.7 1.4 3.1 0.0 1.2 1.3 0.0 0.5 0.0 0.5 0.0 1.5 0.0 0.1 1.3 1.6 2.9 0.0 1.0 1.4 2.3 0.4 0.7 0.5 0.3 0.3 1.1 0.1 0.9 0.6 33.9 0.1 0.6 1.1 0.0 0.5 1.0 0.7 2.5 0.2 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 8.2 4.3 0.2 7.2 9.0 1.4 2.0 3.4 0.1 4.4 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 545 "HAP1: 62.7;NTERA-2: 52.5" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 OVCA2 ENSG00000262664 "OVCA2, serine hydrolase domain containing" Q8WZ82 17 2041936-2043430 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059002 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA059002: " 17.0 25.7 13.6 22.3 16.4 23.1 14.4 11.2 17.2 15.4 20.5 12.1 12.1 20.0 12.2 19.1 23.6 12.0 28.4 17.6 12.2 11.3 31.0 46.4 15.6 37.2 11.5 11.8 14.2 25.5 9.6 21.7 26.5 13.3 16.6 17.5 24.5 30.2 21.1 20.4 18.5 32.1 12.4 8.3 28.9 19.0 28.1 9.6 29.7 22.3 34.8 30.3 22.0 12.6 26.2 30.7 12.5 30.7 29.9 43.0 28.4 21.2 21.0 8.8 17.8 10.9 14.5 14.3 14.1 15.4 15.6 14.7 24.1 14.0 4.6 14.4 19.1 16.6 9.4 22.6 11.4 11.2 23.9 10.5 12.8 8.9 29.8 7.1 21.6 18.8 20.4 15.0 10.2 26.0 5.8 22.7 23.1 14.9 10.3 11.9 7.6 13.4 8.7 8.9 7.2 23.7 14.1 5.8 21.6 9.2 14.5 19.0 16.9 14.2 20.5 22.7 7.3 16.3 27.4 13.7 14.0 4.0 20.4 15.9 22.3 8.5 30.7 12.5 26.8 26.6 26.9 26.2 26.7 28.3 26.5 21.5 18.5 18.0 8.6 29.9 20.4 30.7 43.0 28.4 13.6 16.4 11.2 17.2 12.2 11.3 11.5 11.8 13.3 9.6 OVOL2 "bA504H3.3, CHED, CHED1, HOVO2, ZNF339" ENSG00000125850 "Ovo like zinc finger 2" Q9BRP0 20 17956979-18059188 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 6.7;CACO-2: 5.2;CAPAN-2: 8.9;HaCaT: 6.6;SCLC-21H: 10.3;SK-BR-3: 6.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 10.5;hippocampal formation: 6.8" "Group enriched" "Detected in some" 5 "cerebral cortex: 7.6;hippocampal formation: 5.8" HPA038531 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038531: AB_10673012" "unprognostic (2.85e-2)" "unprognostic (5.13e-2)" "unprognostic (2.41e-2)" "unprognostic (7.35e-2)" "unprognostic (2.14e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.40e-1)" "unprognostic (2.61e-1)" "unprognostic (2.63e-2)" "unprognostic (1.62e-1)" "unprognostic (1.84e-4)" "unprognostic (4.77e-3)" "unprognostic (2.92e-1)" "unprognostic (2.57e-2)" "unprognostic (3.76e-2)" 0.0 0.0 0.0 3.4 0.0 0.0 3.7 0.0 0.6 3.0 9.8 0.0 18.2 5.0 1.0 3.3 7.6 1.6 8.9 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.6 8.7 1.0 1.8 2.5 0.0 7.0 2.6 0.0 10.5 14.2 0.1 7.6 8.7 0.5 0.0 0.0 14.7 1.5 0.0 0.3 18.1 5.0 4.4 2.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 5.2 8.9 0.0 1.2 0.0 6.6 1.6 1.7 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.1 3.2 10.3 0.0 0.0 6.9 0.1 3.5 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA056878: , HPA057019: " "unprognostic (1.08e-1)" "prognostic favourable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 13.7 12.2 11.0 10.1 11.5 16.0 8.4 6.0 15.1 6.4 12.4 7.0 16.0 14.0 6.5 11.8 10.3 8.7 9.2 11.4 10.2 8.5 9.2 11.9 7.7 9.9 9.6 6.5 4.2 19.6 2.7 4.6 8.2 8.0 8.2 1.9 9.4 27.7 10.8 17.3 12.9 10.3 4.7 7.1 15.1 11.2 18.5 7.1 11.6 10.2 7.2 11.4 7.8 5.6 22.8 23.7 13.3 18.5 25.1 27.9 18.7 7.9 29.3 0.3 6.9 1.8 0.5 5.1 3.2 0.1 0.1 1.1 7.8 7.8 2.4 6.5 0.0 7.0 0.0 4.5 0.0 4.0 14.5 2.2 13.5 19.0 12.5 1.5 6.0 3.1 3.9 1.7 1.8 2.9 3.7 4.1 0.6 19.3 5.8 6.1 3.9 12.7 4.8 0.2 10.3 1.5 4.4 1.5 6.5 1.6 10.5 14.6 15.8 9.0 2.1 6.0 4.2 6.5 4.5 10.5 3.7 3.2 8.2 6.1 6.1 12.9 18.5 13.3 19.1 15.1 20.0 19.7 25.9 22.2 17.2 22.8 27.9 21.5 13.1 25.1 15.6 23.7 21.8 18.7 11.0 11.5 6.0 15.1 10.2 8.5 9.6 6.5 8.0 7.1 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favourable (1.35e-4)" "prognostic favourable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favourable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.2 13.7 6.7 9.8 10.5 3.7 10.3 8.3 11.9 6.0 11.8 6.2 13.7 10.1 6.4 16.2 10.3 7.7 7.9 13.5 6.6 6.4 14.9 26.1 10.0 7.7 6.6 6.5 6.4 18.7 8.3 13.0 7.3 7.0 8.0 13.8 10.4 15.5 15.6 19.4 8.3 8.9 5.8 6.7 9.6 8.9 19.9 8.0 8.1 11.7 12.3 11.3 7.9 6.4 8.4 9.0 3.7 6.5 10.3 11.8 6.6 7.6 12.9 2.7 7.6 8.0 8.8 7.9 6.2 9.0 11.6 8.3 9.8 9.2 14.3 8.4 5.6 8.1 11.3 11.8 11.0 8.5 11.5 15.7 10.9 11.8 9.8 12.7 10.0 8.2 14.8 9.3 9.7 10.0 16.1 11.6 9.8 11.5 9.2 9.8 0.5 14.8 12.4 7.2 23.3 17.1 4.8 3.9 7.2 9.8 16.9 12.6 18.5 11.8 6.1 7.3 8.7 9.5 8.9 11.1 12.7 4.5 10.3 11.2 7.4 2.1 5.4 3.7 9.4 6.0 10.8 8.4 9.7 11.6 8.6 8.2 11.4 11.8 0.9 10.3 6.5 9.0 6.0 6.6 6.7 10.5 8.3 11.9 6.6 6.4 6.6 6.5 7.0 8.0 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell line enhanced" "Detected in some" "LHCN-M2: 8.2;RH-30: 5.1;U-87 MG: 14.6" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA028776: , HPA028777: " "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.8 0.3 0.1 0.0 1.0 0.1 2.0 0.8 1.5 0.0 0.0 0.0 1.4 0.5 1.7 0.0 0.1 0.1 0.3 0.0 2.2 0.8 0.0 3.6 0.0 3.0 0.4 0.0 1.5 0.1 0.0 2.4 0.7 8.2 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.2 3.8 1.5 0.1 0.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.3 0.0 0.0 14.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" 13000 Vesicles Nucleoli "HPA012113: , HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 11.9 11.2 7.1 8.6 6.3 5.2 9.7 6.4 5.3 14.0 7.1 6.0 7.7 2.6 13.8 11.1 6.4 8.8 12.1 8.8 3.8 2.9 7.9 19.9 10.8 10.1 6.1 3.3 13.1 6.8 5.8 15.2 36.1 4.6 7.8 5.7 10.5 6.4 6.5 4.3 7.2 6.6 19.7 3.4 13.3 6.6 13.1 4.7 10.2 7.4 5.3 7.8 11.4 8.5 3.1 16.2 11.0 16.2 11.7 7.9 6.1 2.2 5.8 13.0 30.4 30.8 23.6 5.3 26.8 34.9 19.4 33.1 2.9 4.9 3.3 21.5 50.5 2.0 5.5 6.8 13.4 4.9 6.9 7.8 9.2 8.3 17.9 7.8 9.0 20.1 4.6 19.5 8.4 27.3 4.4 4.2 12.9 1.2 5.0 4.4 14.2 4.2 5.0 19.2 4.5 10.2 1.2 2.7 4.6 16.3 0.4 11.5 0.9 32.8 22.2 14.5 12.8 11.5 10.6 3.8 4.3 3.0 16.6 10.6 20.1 3.5 13.2 11.0 6.0 14.0 6.4 3.1 4.6 5.1 16.2 2.6 3.9 3.9 1.2 11.7 16.2 7.6 7.9 6.1 7.1 6.3 6.4 5.3 3.8 2.9 6.1 3.3 4.6 4.7 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;RPTEC TERT1: 36.7;RT4: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" Nucleoplasm "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.9 5.9 11.7 0.0 0.2 0.4 14.0 15.9 6.3 2.6 4.2 4.8 5.9 0.0 9.1 2.8 36.0 0.0 21.3 5.5 0.1 2.0 0.0 4.0 0.0 12.1 0.0 0.1 5.7 7.2 5.0 1.8 0.4 0.0 0.1 4.0 0.3 0.0 0.1 3.6 1.2 0.0 2.3 0.8 36.7 25.1 0.8 0.1 21.6 1.2 9.5 0.0 0.2 7.9 15.5 5.8 0.1 2.8 1.1 0.0 0.1 3.6 0.0 19.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 22.2;NTERA-2: 15.8;U-251 MG: 15.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favourable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.9 4.2 8.0 4.9 6.0 0.1 22.2 12.8 7.1 7.8 0.3 0.0 0.0 0.3 8.3 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.5 0.5 0.0 6.5 0.2 3.4 1.9 7.4 2.0 0.0 3.3 0.0 0.0 0.2 15.8 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.5 0.1 0.1 13.0 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavourable (9.01e-4)" "prognostic unfavourable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavourable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavourable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 17.3 4.5 13.0 25.3 40.2 30.9 10.9 51.0 46.2 19.7 47.4 7.4 13.5 5.9 19.5 50.4 19.7 8.2 18.6 43.3 7.5 3.1 5.0 4.3 8.8 16.7 9.2 3.5 18.7 10.9 16.8 22.3 9.3 7.8 3.1 17.0 4.6 3.6 8.9 4.6 19.8 3.4 8.7 10.6 11.1 7.5 1.2 7.3 10.4 30.8 12.1 4.7 8.7 8.8 24.2 10.0 6.7 11.8 17.7 6.4 2.8 43.4 13.5 11.7 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 61.3;U-87 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavourable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavourable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.1 6.2 2.0 9.9 27.9 33.3 11.3 47.5 40.6 20.2 50.0 14.0 8.9 0.2 14.0 50.8 12.8 6.2 24.8 32.0 7.5 2.1 0.0 9.1 8.4 61.3 0.0 6.1 20.1 36.7 23.9 22.0 10.6 3.6 0.6 24.7 4.0 0.0 0.0 0.5 5.1 0.1 0.6 1.5 5.6 1.9 1.0 2.8 12.1 4.0 8.0 5.0 0.7 16.3 30.7 12.0 9.3 10.2 4.3 4.6 2.0 59.2 0.0 8.5 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favourable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favourable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.8 10.5 2.0 0.0 5.9 7.0 0.1 6.9 9.1 5.2 5.6 2.3 20.7 3.3 7.2 8.4 2.0 4.4 2.3 1.5 12.3 7.8 0.0 15.6 0.0 15.7 3.2 0.1 4.0 2.3 5.2 0.4 5.8 0.0 14.3 2.5 16.4 0.4 0.4 2.8 12.4 0.0 0.0 19.2 9.2 5.9 8.2 0.1 7.7 8.3 0.0 7.3 5.3 4.0 3.1 2.7 7.7 5.4 20.4 11.2 0.0 23.0 0.3 3.2 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: " "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 11.7 21.0 14.7 14.4 11.0 14.3 16.9 5.5 10.3 13.3 31.8 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.4 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910062-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 3.3;granulocytes: 3.9;T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066650 Approved "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA066650: " "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavourable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favourable (8.84e-4)" 4.7 8.1 9.8 29.3 20.4 14.0 16.0 3.4 6.0 8.4 5.7 6.2 20.4 6.9 8.3 26.1 7.6 9.1 13.0 3.7 8.6 4.2 21.7 29.2 14.6 16.3 5.6 9.3 16.9 29.3 7.7 23.7 5.1 7.1 15.2 6.4 7.6 10.2 14.7 0.9 10.3 10.0 6.2 10.9 12.5 10.0 9.2 6.5 20.3 28.1 6.3 12.9 9.0 12.1 3.3 0.4 3.9 0.5 0.3 1.9 0.1 6.5 8.5 11.4 16.6 4.4 9.3 26.3 14.4 2.9 5.6 7.5 23.3 12.0 8.5 24.3 5.7 15.2 5.1 13.2 4.6 5.1 10.4 6.8 23.4 21.5 9.9 5.8 2.8 9.7 23.4 11.9 21.1 1.3 7.6 12.4 6.7 18.6 7.3 14.0 4.5 15.0 9.4 2.5 4.5 7.9 8.1 7.1 7.1 5.7 18.0 19.5 35.1 4.7 4.6 25.0 16.8 10.9 6.9 16.3 16.2 4.3 8.1 2.4 8.2 0.1 0.5 0.1 0.9 0.1 1.9 1.4 0.2 0.7 0.2 3.3 0.3 0.5 3.9 0.3 0.2 0.4 0.5 0.1 9.8 20.4 3.4 6.0 8.6 4.2 5.6 9.3 7.1 6.5 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favourable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 41.1 46.0 67.4 39.8 73.7 57.1 34.0 79.5 80.2 36.1 42.2 39.4 51.2 55.1 55.3 67.7 38.3 43.2 43.4 35.3 64.4 44.7 46.6 47.1 33.2 46.4 62.4 45.8 48.6 35.2 44.8 54.0 40.6 60.3 46.2 52.8 39.4 42.3 45.2 46.6 53.7 55.9 50.2 47.4 46.0 41.4 54.1 69.3 53.5 51.0 29.6 54.6 33.3 46.5 11.4 15.6 13.1 9.8 12.0 9.0 2.8 25.3 28.5 63.0 49.7 29.6 33.3 41.0 26.4 26.0 36.1 34.6 34.0 47.7 45.5 14.2 33.3 40.3 70.2 36.4 50.2 38.8 26.8 35.1 40.7 87.9 33.1 54.4 48.3 38.7 36.5 26.8 31.6 39.5 32.8 35.7 34.5 48.3 57.2 66.6 68.9 32.5 57.2 24.4 27.4 40.8 52.7 43.5 34.0 33.8 31.5 26.8 23.8 39.5 33.3 25.2 32.2 24.6 33.4 42.7 29.5 53.9 15.0 44.7 29.3 13.1 9.8 8.9 7.3 7.0 5.9 8.7 7.3 6.3 7.6 11.4 9.0 8.5 11.9 12.0 7.7 15.6 7.9 2.8 67.4 73.7 79.5 80.2 64.4 44.7 62.4 45.8 60.3 69.3 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA054666: " "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favourable (4.85e-4)" 7.9 8.7 12.2 10.7 15.6 3.2 16.5 7.8 19.0 9.1 8.9 9.3 14.6 6.6 13.9 15.1 9.6 14.2 10.0 9.5 14.1 12.4 8.7 4.7 7.7 7.3 12.1 12.9 14.0 6.7 9.7 13.7 7.4 10.5 11.2 9.4 8.4 7.7 11.4 10.1 14.3 7.7 13.1 15.1 6.8 7.7 37.3 10.7 4.5 15.8 10.0 6.3 11.1 8.9 4.3 7.0 1.4 4.7 4.1 6.1 2.9 8.9 7.0 12.3 9.3 16.7 15.5 6.0 11.5 9.1 10.6 12.9 6.3 19.1 9.5 7.7 6.5 4.3 6.9 8.6 18.2 2.9 6.1 6.0 10.5 10.0 8.8 12.3 6.4 10.7 12.9 13.3 12.4 10.7 10.3 5.5 9.0 6.5 12.3 11.4 15.6 9.9 6.6 13.4 5.8 10.6 5.9 20.4 13.4 8.5 4.3 8.6 7.9 7.0 8.3 10.4 9.6 14.3 15.9 5.7 1.6 8.8 15.2 8.3 17.9 0.0 3.1 1.4 2.7 4.7 6.1 4.3 3.0 2.7 5.3 4.0 4.7 3.0 1.2 4.1 3.7 7.0 3.5 2.9 12.2 15.6 7.8 19.0 14.1 12.4 12.1 12.9 10.5 10.7 PACS1 "FLJ10209, KIAA1175" ENSG00000175115 "Phosphofurin acidic cluster sorting protein 1" Q6VY07 11 66070363-66244747 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038914 Approved Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA038914: AB_10672831" "unprognostic (7.03e-2)" "unprognostic (3.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.40e-1)" "unprognostic (3.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.80e-3)" "unprognostic (1.40e-2)" "unprognostic (3.55e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (5.31e-2)" "unprognostic (5.23e-2)" "unprognostic (3.46e-1)" 20.0 14.6 18.0 33.7 23.1 17.7 25.5 33.6 25.5 17.7 16.6 12.5 12.8 10.5 17.4 16.9 19.6 18.1 19.8 33.1 17.3 15.0 17.7 7.4 20.7 42.3 12.8 19.0 26.2 16.7 19.9 16.9 14.6 12.8 21.3 8.5 19.0 66.8 18.8 15.2 16.2 15.1 23.5 11.7 24.0 16.0 28.4 13.6 33.9 21.6 15.6 33.7 21.9 17.7 7.2 1.9 11.2 3.7 2.9 5.8 3.6 16.7 17.8 8.3 5.5 15.9 19.0 9.7 22.8 16.8 16.9 10.5 10.9 13.9 10.6 15.4 40.2 11.0 6.2 17.3 21.5 16.9 7.0 17.1 15.6 15.7 19.3 2.4 14.2 19.4 8.1 15.3 19.2 15.8 6.4 20.9 18.2 31.8 18.2 6.6 3.9 8.5 12.2 8.5 18.7 11.8 16.9 11.9 13.6 23.8 14.2 11.8 15.9 3.3 20.8 21.7 9.5 28.9 9.8 10.6 6.8 2.8 18.3 4.0 10.6 5.2 2.0 3.9 5.2 1.5 3.5 4.6 4.9 4.5 1.9 7.2 5.6 5.0 11.2 2.9 3.7 1.2 5.8 3.6 18.0 23.1 33.6 25.5 17.3 15.0 12.8 19.0 12.8 13.6 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Cell line enhanced" "Detected in some" "MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: " "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 9.7 0.5 0.0 2.4 0.0 0.1 0.0 11.3 0.0 0.3 3.6 0.2 0.0 1.8 0.0 18.0 1.9 0.0 0.0 0.3 0.0 0.0 3.0 13.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 PACSIN2 SDPII ENSG00000100266 "Protein kinase C and casein kinase substrate in neurons 2" Q9UNF0 22 42835412-43015145 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049854, HPA056520" Enhanced Supported "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" 83000 "Nuclear speckles, Vesicles, Cytosol" "Plasma membrane" "HPA049854: AB_2680915, HPA056520: AB_2683163" "unprognostic (5.62e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-3)" "unprognostic (1.63e-2)" "unprognostic (3.96e-1)" "prognostic unfavourable (7.33e-4)" "unprognostic (4.48e-2)" "unprognostic (3.40e-2)" "unprognostic (2.82e-3)" "unprognostic (3.09e-2)" "unprognostic (1.00e-1)" "prognostic favourable (1.09e-13)" "unprognostic (2.87e-1)" "unprognostic (1.11e-1)" "unprognostic (6.20e-2)" "unprognostic (2.95e-1)" 20.1 42.0 19.4 19.4 20.7 14.3 22.9 32.3 21.3 18.7 28.4 17.5 21.1 22.5 20.8 18.9 19.3 17.5 33.3 28.0 17.9 19.5 32.5 20.7 25.8 16.9 20.6 15.7 17.4 77.3 14.3 21.5 33.8 32.4 24.6 23.5 26.6 31.7 16.6 23.9 19.4 25.6 25.1 17.8 22.5 27.8 12.6 19.2 13.1 31.0 15.8 18.4 17.7 17.6 4.7 8.3 37.9 12.6 6.7 4.5 5.0 24.7 26.0 21.9 14.0 11.3 12.1 18.0 22.6 13.7 20.5 17.1 27.0 14.6 11.5 19.2 16.7 17.6 14.3 24.0 13.5 11.7 14.2 18.5 13.3 38.4 16.1 13.0 40.4 11.6 23.7 26.9 11.8 16.7 16.0 8.4 17.5 16.2 13.8 20.5 12.0 11.0 17.0 32.8 7.7 23.5 14.7 14.3 6.4 27.0 18.7 50.7 13.5 17.4 24.7 15.3 19.5 16.9 13.3 6.3 8.6 12.6 14.6 11.6 33.2 7.9 7.0 17.4 2.8 12.6 3.0 4.2 3.2 2.4 8.3 4.7 3.2 2.4 37.9 6.7 12.1 3.1 4.5 5.0 19.4 20.7 32.3 21.3 17.9 19.5 20.6 15.7 32.4 19.2 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177525-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6" "Cell line enhanced" "Detected in many" "T-47d: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favourable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 4.1 17.0 3.9 2.2 5.7 0.4 4.3 3.5 4.7 6.5 8.5 8.6 7.1 1.6 6.7 7.6 12.6 4.8 5.8 40.6 4.0 2.4 2.9 10.0 3.9 0.8 7.6 3.6 6.3 14.6 4.8 1.0 8.0 4.4 8.6 1.1 4.6 11.3 6.7 121.6 11.9 1.9 7.4 8.3 1.5 6.0 1.6 6.5 0.3 8.5 44.6 7.1 6.4 5.7 0.0 0.1 0.0 0.9 0.0 0.2 0.9 16.4 8.3 3.8 16.6 3.3 3.3 18.6 5.1 7.4 10.8 6.1 12.3 2.3 0.1 1.6 2.8 27.1 7.6 12.5 4.3 2.5 12.9 2.5 31.3 28.2 6.5 0.5 2.6 9.3 16.8 5.7 9.1 4.8 5.4 0.2 4.4 32.6 0.3 12.1 4.7 16.6 10.1 14.4 2.6 4.5 15.6 0.1 13.0 8.1 5.8 7.6 41.0 2.2 2.3 18.9 19.0 2.4 14.1 2.8 1.3 1.5 6.1 5.7 9.7 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 5.7 3.5 4.7 4.0 2.4 7.6 3.6 4.4 6.5 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205126-17246005 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 48.7;lymphoid tissue: 60.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.3;EFO-21: 4.5;HaCaT: 2.8;LHCN-M2: 3.6;RPTEC TERT1: 4.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Low region specificity" "Detected in some" HPA062294 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA062294: " "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavourable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.3 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.1 0.0 4.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 60.2 1.3 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.1 9.3 0.0 4.5 0.4 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;RT4: 15.8;T-47d: 11.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 3.2 10.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 6.4 0.0 2.3 0.0 9.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 28.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.2 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 15.8 0.0 0.0 0.0 2.3 0.1 11.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: " "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavourable (9.44e-4)" "prognostic unfavourable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favourable (4.25e-4)" "prognostic unfavourable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 14.8 17.0 19.7 28.3 22.0 15.4 15.3 25.0 21.9 13.9 12.7 31.0 32.8 16.1 35.9 29.9 23.9 28.5 32.3 18.4 14.3 11.0 41.3 15.6 19.9 19.7 14.2 15.8 17.0 25.6 27.8 35.1 22.8 21.9 12.3 21.3 9.5 13.7 21.0 18.0 13.4 15.4 22.3 17.6 21.3 23.3 21.9 29.1 28.8 21.8 9.5 24.3 12.3 36.4 25.5 16.9 12.4 17.7 3.9 5.9 21.6 10.3 27.4 21.4 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.1;HMC-1: 25.6;SK-MEL-30: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: " "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 5.5 3.8 5.3 20.2 6.1 12.2 4.1 22.3 7.6 2.7 12.3 5.4 2.3 8.6 3.5 2.8 2.9 3.2 12.1 5.5 6.4 4.3 3.2 6.4 20.3 21.2 7.5 4.2 2.6 16.6 0.8 4.2 17.7 7.7 3.9 10.1 10.6 5.0 4.4 3.8 6.2 14.9 3.5 9.9 12.1 5.1 1.4 7.4 15.2 3.4 0.4 15.3 6.2 4.4 2.2 4.1 10.9 13.3 1.6 6.8 2.4 0.0 0.0 2.7 0.1 5.1 4.9 0.1 1.1 8.6 0.5 1.1 0.1 0.0 19.1 0.1 0.3 0.8 0.0 1.0 0.5 0.5 2.5 11.2 0.2 0.0 5.2 1.8 25.6 2.3 0.6 5.0 4.7 0.0 0.1 0.1 8.2 0.1 6.7 0.1 0.2 0.7 5.1 1.3 0.0 0.9 4.1 0.5 1.0 0.0 0.2 19.9 0.6 1.9 0.1 0.6 0.3 0.0 0.6 3.2 0.8 6.8 5.5 6.4 4.7 10.9 1.4 1.9 2.6 6.3 6.5 2.2 6.6 4.6 1.8 1.4 5.4 4.0 2.3 1.6 13.3 4.1 6.8 2.4 5.3 6.1 22.3 7.6 6.4 4.3 7.5 4.2 7.7 7.4 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Group enriched" "Detected in some" 7 "A-431: 47.9;Karpas-707: 37.0;U-266/84: 57.0" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49833973 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 129.2;placenta: 199.4;prostate: 58.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.2 0.7 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.6 0.1 0.2 5.7 0.0 6.6 129.2 0.1 6.8 0.1 0.1 0.4 0.5 0.8 0.1 0.2 0.1 0.1 0.2 0.9 0.1 0.0 0.6 199.4 0.2 58.4 0.0 0.1 0.1 9.8 0.8 0.1 0.1 2.4 0.2 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.2 0.2 0.4 0.5 0.1 0.2 0.2 0.1 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836885-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 65.1;liver: 220.0" "Cell line enriched" "Detected in some" 31 "Hep G2: 71.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favourable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 1.3 0.5 0.0 0.5 0.0 0.1 0.2 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 20.3 0.1 0.8 0.3 65.1 220.0 0.0 0.0 0.3 0.7 0.1 1.7 0.0 1.6 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 1.0 0.8 0.3 0.3 0.7 0.8 0.4 PAIP1 ENSG00000172239 "Poly(A) binding protein interacting protein 1" Q9H074 5 43526267-43557758 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073653, HPA076187" Approved Approved "Plasma membrane,Cytosol" 18000 "Plasma membrane, Cytosol" "HPA073653: , HPA076187: " "unprognostic (4.70e-2)" "unprognostic (4.30e-2)" "unprognostic (5.37e-2)" "unprognostic (2.65e-2)" "unprognostic (1.62e-2)" "unprognostic (4.74e-2)" "unprognostic (1.13e-3)" "unprognostic (2.98e-1)" "unprognostic (3.17e-2)" "unprognostic (1.62e-2)" "prognostic unfavourable (4.79e-4)" "unprognostic (3.54e-1)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" 30.1 26.6 26.9 15.4 26.0 20.6 35.9 22.7 32.6 30.2 27.8 25.0 19.6 18.3 28.4 26.0 26.1 22.8 23.3 45.6 26.8 24.4 34.0 38.3 21.3 20.8 28.6 21.5 24.8 23.5 30.9 24.0 29.0 23.0 32.1 24.3 21.3 23.4 31.7 62.8 16.6 24.2 38.7 33.4 21.0 23.8 44.3 27.3 29.9 38.5 20.6 18.6 31.5 36.8 14.1 35.0 23.4 12.4 12.5 16.4 10.9 22.6 20.2 39.7 38.4 41.7 33.0 32.5 20.0 44.7 38.3 33.4 18.8 28.0 15.1 34.8 28.3 14.9 61.9 24.1 39.1 12.5 24.0 11.9 40.5 29.6 36.8 17.7 18.8 34.9 46.9 25.8 48.8 36.4 27.5 20.5 38.1 24.4 19.5 24.5 19.7 26.1 15.3 30.0 21.2 47.5 28.0 22.6 34.3 64.2 24.8 44.4 35.3 25.8 20.2 34.8 28.8 17.3 25.1 15.5 26.3 22.7 20.3 27.5 29.9 17.4 12.4 23.4 10.5 10.4 14.0 14.1 13.1 14.5 12.4 13.2 16.4 13.0 4.6 12.5 11.1 35.0 11.4 10.9 26.9 26.0 22.7 32.6 26.8 24.4 28.6 21.5 23.0 27.3 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77321707-77474635 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0;brain: 71.4" "Cell line enhanced" "Detected in many" "U-266/70: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4" "Group enriched" "Detected in all" 11 "dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" 200000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favourable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 5.4 6.0 30.5 13.8 39.5 22.9 7.8 49.1 71.4 9.8 18.2 8.4 2.3 18.2 9.1 13.3 9.9 9.8 13.2 5.3 19.0 16.9 11.3 6.0 6.9 7.5 12.8 40.6 10.4 9.2 11.8 10.8 11.9 39.2 12.2 20.2 5.4 10.4 8.8 34.0 6.7 18.9 11.6 7.8 11.7 17.1 11.1 6.6 7.6 17.7 3.9 9.4 10.5 10.4 2.7 42.3 70.0 30.4 4.3 2.4 12.2 11.8 8.0 17.4 7.8 7.1 11.9 13.9 13.6 9.7 12.9 15.2 11.4 15.9 10.6 5.0 11.7 6.1 12.1 14.4 20.4 12.2 9.8 11.2 5.4 0.7 4.7 18.9 16.6 8.8 8.7 15.1 22.5 3.0 7.4 18.7 23.4 0.8 12.0 8.7 25.7 6.9 18.5 22.5 0.4 3.3 9.9 7.5 7.4 7.3 3.1 5.7 13.9 8.6 0.2 8.6 14.9 45.9 11.3 51.4 26.4 7.0 7.2 12.6 9.3 0.3 29.3 45.0 1.9 28.7 1.5 2.7 1.4 1.8 42.3 1.9 1.3 2.4 70.0 4.3 30.4 3.6 1.1 12.2 30.5 39.5 49.1 71.4 19.0 16.9 12.8 40.6 39.2 6.6 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles 590000 "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.36e-4)" "prognostic unfavourable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 28.7 18.9 22.4 27.6 23.5 21.4 56.5 17.4 20.7 19.5 23.0 27.8 17.4 19.0 22.6 19.2 23.4 17.9 20.7 29.0 22.6 22.0 19.5 34.3 35.7 50.2 26.8 13.5 19.9 16.6 30.5 13.0 27.6 22.8 17.7 23.0 12.9 19.6 21.2 34.2 16.3 25.2 23.0 32.1 34.6 18.4 15.9 24.8 44.9 16.9 19.1 31.9 24.1 32.7 6.6 13.7 25.9 12.6 6.6 10.8 7.0 35.2 12.6 17.8 13.0 12.6 16.7 26.4 17.9 14.8 19.5 17.8 29.9 18.1 22.6 51.2 18.1 18.1 18.8 17.0 30.2 10.1 9.1 33.5 14.5 23.5 25.6 32.5 32.2 13.3 14.0 17.4 37.1 19.2 16.1 28.2 18.9 37.2 30.9 16.8 10.6 19.0 28.3 10.1 20.5 17.0 24.8 10.4 11.8 23.9 16.9 13.5 59.3 23.6 19.8 16.2 9.0 16.9 26.3 19.2 33.9 55.7 13.4 32.6 15.3 16.5 10.3 24.5 6.3 12.6 8.5 6.4 7.3 7.1 13.7 6.6 5.4 6.3 25.9 6.6 10.8 5.1 10.8 7.0 22.4 23.5 17.4 20.7 22.6 22.0 26.8 13.5 22.8 24.8 PAK4 ENSG00000130669 "P21 (RAC1) activated kinase 4" O96013 19 39125770-39182816 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.6;MCF7: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025747, CAB044670, HPA070175, HPA072220" Uncertain Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (5.86e-2)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (8.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.13e-3)" "unprognostic (3.90e-2)" "unprognostic (4.04e-2)" "unprognostic (7.29e-2)" "prognostic unfavourable (9.85e-4)" "prognostic favourable (5.29e-5)" "unprognostic (2.39e-1)" "unprognostic (7.05e-2)" "unprognostic (2.02e-1)" "unprognostic (4.85e-2)" 6.8 11.1 11.0 12.7 12.3 4.8 11.9 13.7 12.4 17.3 19.6 13.7 19.9 26.0 12.2 17.3 20.1 15.3 16.5 8.1 10.9 8.1 19.4 17.0 18.7 5.4 13.7 7.7 13.8 29.6 11.2 17.0 23.0 10.3 29.6 8.1 19.7 40.9 18.5 10.3 18.6 25.1 9.0 8.3 7.9 18.6 22.3 12.5 8.8 15.2 10.1 14.7 11.5 15.0 2.8 3.4 4.2 2.5 3.6 4.5 1.9 17.6 44.6 6.6 10.1 2.1 2.2 20.1 8.4 3.4 5.7 5.7 29.2 15.0 4.0 12.8 5.3 6.5 3.6 6.7 2.1 10.7 10.2 4.8 8.1 14.2 3.4 4.8 7.0 2.7 3.0 5.3 3.8 7.4 9.5 3.2 3.4 49.1 5.1 5.3 12.1 10.7 5.2 5.2 3.0 5.5 19.4 21.3 14.7 8.6 38.3 9.5 17.0 8.0 12.3 9.7 16.7 11.1 15.0 3.6 3.4 3.3 11.9 2.9 11.6 1.0 2.5 4.2 2.6 1.4 3.6 2.2 2.9 4.5 3.4 2.8 2.2 2.2 2.1 3.6 2.1 2.9 3.0 1.9 11.0 12.3 13.7 12.4 10.9 8.1 13.7 7.7 10.3 12.5 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell line enhanced" "Detected in many" "CACO-2: 14.5;HaCaT: 22.5;hTCEpi: 13.8;SK-BR-3: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.6 0.0 0.2 0.1 0.0 0.0 4.3 0.0 0.1 0.6 0.4 14.5 2.0 0.1 2.3 0.0 22.5 3.2 4.8 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 13.8 0.2 3.2 0.0 1.1 0.2 0.0 3.1 0.0 0.3 0.4 2.0 0.2 0.1 1.8 1.1 5.9 5.2 1.3 1.8 7.6 0.2 0.8 7.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.3 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497066-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 203.3" "Cell line enhanced" "Detected in many" "LHCN-M2: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Actin filaments" Cytosol "CAB070159: AB_1726016, HPA035905: " "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.28e-4)" 17.3 8.9 8.5 19.6 7.5 0.1 28.1 2.1 6.7 58.4 71.9 5.7 46.4 6.7 82.2 25.6 84.3 31.3 30.8 95.0 9.2 3.2 12.7 3.6 24.9 17.0 4.6 4.7 28.0 3.0 25.6 3.9 14.0 6.0 71.4 17.9 9.2 11.4 50.9 30.5 8.9 16.8 203.3 6.7 25.8 31.4 14.1 6.9 2.2 12.7 17.2 5.8 140.3 82.7 0.2 2.2 13.6 3.2 0.6 5.1 1.5 17.6 8.7 19.4 12.0 17.9 19.5 27.3 12.1 30.5 10.7 15.2 0.2 1.0 7.6 3.1 5.2 3.7 11.8 30.8 13.7 16.0 3.6 0.1 25.1 2.2 31.3 0.0 0.2 29.7 19.2 19.1 28.7 4.5 0.0 0.1 64.4 0.8 5.1 0.3 5.6 5.2 1.7 18.0 0.1 1.2 3.5 2.0 10.5 22.8 1.7 1.6 10.8 0.1 14.5 11.2 42.4 4.7 19.6 10.9 0.1 0.3 9.4 0.2 3.1 13.6 3.2 0.0 5.1 1.9 0.2 0.1 0.6 2.7 2.2 0.2 0.6 2.0 0.8 0.6 1.2 0.2 0.5 1.5 8.5 7.5 2.1 6.7 9.2 3.2 4.6 4.7 6.0 6.9 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell line enhanced" "Detected in many" "AN3-CA: 16.2;EFO-21: 15.0;REH: 26.6;SH-SY5Y: 17.1;U-2197: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favourable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.3 8.4 16.2 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.0 0.1 1.5 4.2 0.0 0.2 0.0 8.3 0.0 3.4 5.3 5.9 0.0 0.1 3.8 0.0 0.7 0.0 0.6 2.9 0.0 1.1 8.5 0.6 5.0 3.4 2.4 26.6 0.0 0.1 0.4 0.0 0.9 17.1 4.3 0.0 0.1 1.5 4.0 0.0 0.0 8.8 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Cell line enhanced" "Detected in many" "ASC diff: 15.4;hTEC/SVTERT24-B: 14.8;RH-30: 29.1;U-251 MG: 13.0;WM-115: 17.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: , HPA074153: , HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.4 5.5 1.3 5.4 5.3 1.6 3.6 0.0 0.1 0.0 0.5 5.6 2.0 0.0 1.2 4.5 0.2 1.6 0.0 5.0 0.1 0.1 0.0 0.0 7.0 0.1 14.8 2.4 0.1 0.0 0.0 5.7 0.0 0.0 0.0 4.3 1.4 0.0 29.1 0.0 4.0 0.0 1.7 0.0 2.1 0.2 7.4 0.6 0.0 0.1 3.4 8.5 0.3 13.0 0.0 0.2 0.0 4.2 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in some" 4 "AN3-CA: 21.7;CACO-2: 23.2;HAP1: 19.4;NTERA-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: , HPA056119: " "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavourable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.6 21.7 0.3 0.1 4.4 0.4 0.1 1.2 0.6 23.2 0.5 0.0 0.2 0.4 0.1 19.4 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.1 4.5 0.0 0.0 3.6 0.2 0.1 14.0 1.3 0.0 0.0 0.0 0.0 1.8 2.7 3.6 0.1 0.0 0.0 1.3 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 PALMD "C1orf11, FLJ20271, PALML" ENSG00000099260 Palmdelphin Q9NP74 1 99645943-99694541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 84.9;skeletal muscle: 106.9" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 42.5;LHCN-M2: 13.7;TIME: 59.6;U-87 MG: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017959, HPA030549" Supported Supported "Plasma membrane,Actin filaments,Focal adhesion sites" "Actin filaments" "Plasma membrane, Focal adhesion sites" "HPA017959: AB_1854949, HPA030549: " "unprognostic (1.48e-2)" "unprognostic (1.15e-2)" "unprognostic (2.05e-2)" "prognostic favourable (9.42e-4)" "unprognostic (7.67e-2)" "prognostic favourable (5.90e-5)" "unprognostic (1.54e-2)" "unprognostic (2.10e-1)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (8.32e-2)" "unprognostic (6.18e-2)" "unprognostic (5.19e-2)" "unprognostic (1.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.70e-1)" "unprognostic (8.08e-2)" 84.9 18.6 8.3 6.2 4.3 0.0 46.4 1.1 3.7 17.1 6.5 3.9 4.0 1.3 18.6 10.1 16.2 8.7 5.3 59.0 5.6 3.4 5.1 20.9 10.6 3.4 3.9 3.8 17.4 2.2 4.4 4.7 16.8 19.0 8.1 2.6 7.9 34.0 4.4 106.9 18.0 3.5 12.2 4.1 2.3 2.8 7.5 2.2 2.1 3.4 48.2 6.2 6.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.7 2.9 0.0 0.1 0.0 0.0 0.0 0.0 5.5 7.1 0.0 0.0 0.0 1.1 0.5 0.0 0.0 42.5 6.0 0.0 13.7 0.1 0.0 0.0 0.0 1.8 0.0 10.6 0.0 0.0 2.2 0.2 0.1 0.0 2.7 0.0 0.6 0.0 59.6 0.0 0.1 4.6 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 4.3 1.1 3.7 5.6 3.4 3.9 3.8 19.0 2.2 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 304.2" "Cell line enhanced" "Detected in many" "ASC diff: 76.6;fHDF/TERT166: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" 59000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: " "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favourable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavourable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 16.5 24.5 8.2 6.5 16.4 0.8 17.3 6.6 16.5 74.9 14.0 5.4 9.5 5.8 21.3 83.8 11.7 10.6 11.5 304.2 8.8 23.5 13.7 2.1 13.2 5.8 10.0 7.6 17.0 16.4 49.5 18.3 26.3 15.5 13.4 9.5 8.7 53.8 29.4 22.0 8.5 8.5 18.5 4.8 8.9 17.2 7.2 4.6 1.8 21.7 13.2 7.3 15.8 15.3 0.5 2.0 10.1 5.3 16.2 14.1 6.3 14.9 2.2 27.6 12.2 76.6 45.9 11.0 42.6 63.8 12.6 38.5 7.3 19.9 0.0 9.2 98.2 5.1 1.5 18.7 34.9 1.8 6.2 3.1 9.0 2.3 11.6 0.9 3.4 25.1 8.1 9.2 7.0 26.0 0.1 2.1 35.7 3.0 0.0 0.4 4.9 8.3 1.1 15.4 8.3 48.7 1.7 13.1 9.0 18.1 1.1 11.1 4.7 1.0 20.0 40.1 10.4 18.8 12.6 4.7 1.1 0.0 46.0 4.2 34.5 1.9 5.3 0.1 14.1 0.9 10.0 0.5 8.5 10.4 2.0 0.3 2.9 4.8 10.1 16.2 1.9 1.1 12.1 6.3 8.2 16.4 6.6 16.5 8.8 23.5 10.0 7.6 15.5 4.6 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Cell line enhanced" "Detected in all" "U-2197: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria "Nucleoplasm, Mitochondria" Microtubules "HPA062721: " "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavourable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favourable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.8 7.6 4.1 10.1 2.8 3.9 10.7 9.3 2.3 3.5 2.8 5.3 5.8 11.4 10.5 2.8 8.0 3.8 4.1 1.6 11.0 25.0 11.9 7.1 3.7 4.5 8.3 8.9 5.7 5.4 4.3 4.6 2.8 13.9 5.4 2.9 10.5 7.5 14.5 6.7 17.0 14.3 3.5 10.9 3.7 3.8 15.8 12.2 8.1 6.9 9.5 9.1 10.0 3.5 7.1 9.1 35.9 10.2 8.1 8.7 14.1 2.6 8.1 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579600 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062358 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA062358: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favourable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 9.1 16.6 11.6 17.5 10.4 10.5 17.6 22.8 11.9 8.9 23.9 9.0 8.5 28.0 10.2 8.8 12.8 7.8 6.9 7.4 11.7 9.1 13.2 39.2 12.5 8.2 8.4 7.5 10.7 8.8 14.6 11.2 9.4 10.8 9.1 17.9 6.7 11.0 9.6 8.2 11.9 63.0 8.0 10.3 9.6 10.9 10.2 11.0 10.2 10.5 13.4 8.2 9.9 11.6 4.1 2.7 3.5 4.7 0.9 2.5 1.1 13.8 7.8 32.3 17.2 12.1 14.1 13.7 8.3 8.9 11.2 16.5 12.9 12.9 21.3 13.7 11.7 10.0 21.6 16.7 20.1 19.8 10.5 10.9 7.4 9.5 14.1 14.7 14.8 11.2 22.6 14.0 15.8 13.1 10.0 21.6 15.2 7.7 14.6 6.7 13.8 5.7 10.7 22.1 8.7 14.0 20.5 15.1 32.3 9.6 15.8 23.6 20.6 18.6 13.4 15.1 21.2 8.9 17.7 15.1 20.7 15.9 8.9 15.0 11.7 3.5 3.2 1.6 1.9 3.8 2.5 4.1 1.9 1.9 2.0 1.6 1.3 2.3 1.3 0.9 4.7 2.7 2.4 1.1 11.6 10.4 22.8 11.8 11.7 9.1 8.4 7.5 10.8 11.0 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379234-133391694 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Cell line enhanced" "Detected in many" "A-431: 6.2;U-266/70: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047782 Uncertain Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA047782: " "unprognostic (3.67e-3)" "prognostic favourable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favourable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favourable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 6.7 4.1 4.3 5.8 6.7 1.5 4.7 6.8 8.7 3.7 6.0 10.8 5.6 5.6 3.7 1.8 7.4 3.4 2.4 2.5 5.7 2.7 8.9 9.2 2.8 5.2 10.0 3.4 3.6 3.2 1.9 2.5 2.1 4.2 4.8 1.5 2.8 9.9 5.1 3.5 4.4 8.5 2.8 4.7 8.2 7.5 36.7 7.6 0.7 2.4 2.1 5.4 4.6 4.2 4.3 1.1 1.0 1.0 1.7 0.3 0.4 6.2 0.0 0.2 1.2 0.0 0.7 1.6 2.8 1.2 1.4 0.2 1.1 0.1 0.0 0.9 0.6 3.5 0.4 0.8 0.6 4.1 0.5 0.5 0.0 0.2 1.7 0.0 1.0 0.1 0.3 0.9 0.4 0.1 4.9 0.3 0.0 0.1 0.0 0.1 1.2 3.0 4.6 0.0 0.0 0.1 0.0 0.3 2.2 0.9 0.1 0.0 1.3 0.0 2.7 0.3 1.4 1.2 0.0 18.1 3.3 1.7 0.0 0.0 0.1 1.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.2 1.1 4.3 0.0 0.0 0.0 1.7 0.9 0.8 0.0 0.4 4.3 6.7 6.8 6.5 5.7 2.7 10.0 3.4 4.2 7.6 PAPD7 "LAK-1, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Poly(A) RNA polymerase D7, non-canonical" Q5XG87 5 6713007-6757048 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavourable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favourable (8.55e-4)" 13.5 7.9 9.6 13.9 11.1 25.8 16.3 22.7 12.3 15.1 16.6 10.6 14.8 9.5 13.2 8.0 12.2 11.3 11.4 8.6 10.7 7.3 9.7 19.9 13.2 14.1 14.8 5.8 18.5 13.3 13.2 12.2 10.0 9.0 11.6 8.3 10.2 17.0 10.6 10.4 16.7 13.1 13.9 7.9 14.8 10.1 11.1 11.7 25.4 11.3 11.3 11.6 12.5 34.9 1.9 3.8 0.7 0.7 0.5 2.3 0.8 16.3 11.1 13.7 16.8 9.9 8.9 19.7 11.1 14.0 13.9 15.8 11.5 9.1 12.0 8.6 13.7 12.2 11.1 8.6 12.8 13.4 7.1 6.1 35.1 6.2 6.2 9.2 9.3 6.0 7.5 15.5 10.0 8.1 8.2 15.9 11.3 9.0 12.5 12.0 7.4 8.7 11.3 11.6 3.0 5.5 9.4 13.6 10.4 26.6 12.9 7.6 7.8 5.1 7.1 16.7 17.5 14.6 15.5 15.2 6.3 10.6 10.8 8.6 10.3 0.0 0.7 0.7 2.1 0.4 2.3 1.9 1.7 1.6 1.2 1.5 1.9 1.7 0.4 0.5 0.6 3.8 1.8 0.8 9.6 11.1 22.7 12.3 10.7 7.3 14.8 5.8 9.0 11.7 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 20.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 4.5 2.2 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 20.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA049781: " "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favourable (9.14e-4)" "prognostic favourable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.6 16.3 20.4 20.2 25.5 13.1 13.4 25.4 13.2 17.7 14.7 15.3 16.5 8.6 24.7 13.3 15.4 26.6 17.0 38.7 11.7 19.2 20.9 32.9 11.1 29.1 33.3 21.1 13.8 15.2 12.5 29.2 4.2 32.1 36.9 16.1 23.4 9.0 17.5 10.7 19.7 25.9 4.7 19.8 14.7 18.6 26.9 13.9 21.1 16.4 12.5 4.5 17.2 16.5 17.0 11.0 11.3 25.8 17.1 15.4 20.1 22.3 25.9 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell line enhanced" "Detected in many" "U-266/70: 20.7" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" HPA073505 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA073505: " "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.99e-4)" "prognostic unfavourable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.7 2.0 3.3 3.4 0.6 0.5 8.1 0.2 0.5 0.0 0.2 0.9 6.3 3.2 1.5 0.5 5.7 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 0.2 1.5 9.4 0.5 6.7 0.2 1.0 3.7 0.9 1.4 0.7 1.5 2.3 10.6 2.8 5.7 0.7 0.7 3.8 10.7 1.1 0.5 1.0 5.3 1.7 0.5 20.7 4.5 2.0 0.2 7.4 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell line enhanced" "Detected in many" "Hep G2: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA064625: " "prognostic favourable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favourable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.6 0.6 7.0 3.0 4.3 7.0 4.8 2.1 7.9 1.3 2.9 2.6 2.4 0.7 0.8 1.4 0.3 0.9 3.4 2.1 9.4 1.2 4.2 0.6 26.5 1.2 1.1 0.6 1.9 0.4 0.9 5.0 7.5 0.9 4.2 5.4 0.9 2.7 3.8 3.6 0.3 7.3 1.1 1.7 8.2 2.0 2.7 5.7 0.5 0.2 8.0 0.2 9.4 3.1 2.7 1.1 0.8 1.2 1.2 1.6 1.0 2.5 10.9 14.0 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 PARD3 "ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118" ENSG00000148498 "Par-3 family cell polarity regulator" Q8TEW0 10 34109560-34815325 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 9.0" "Lineage enriched" "Detected in single" 73 "granulocytes: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030443 Approved Supported "Cell Junctions,Cytoplasmic bodies" "Cell Junctions" "Cytoplasmic bodies" "HPA030443: AB_10600926" "unprognostic (9.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.62e-1)" "unprognostic (2.83e-2)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "prognostic unfavourable (1.73e-5)" "unprognostic (3.48e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (5.82e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.54e-1)" "unprognostic (9.20e-2)" "prognostic unfavourable (4.41e-4)" 16.4 12.9 13.8 7.0 15.8 0.3 16.8 4.4 8.3 24.8 20.3 7.4 19.7 7.1 21.4 13.6 34.5 14.7 13.2 17.1 10.7 6.3 18.0 15.9 15.2 3.0 7.8 4.3 28.4 26.2 19.0 15.8 14.4 8.8 20.5 15.3 11.7 15.5 17.3 28.3 34.4 14.9 21.1 8.7 3.3 14.2 9.1 9.2 12.8 15.6 14.6 13.4 20.7 29.5 0.0 0.0 9.0 0.1 0.0 0.0 2.1 18.9 46.1 15.7 10.6 11.8 10.1 22.4 8.6 10.4 15.3 17.3 16.8 16.1 0.1 12.5 18.0 13.8 13.3 22.3 19.9 0.1 9.9 0.0 5.8 17.2 15.0 2.0 0.0 12.2 21.4 20.0 15.2 9.6 12.8 6.0 18.4 13.2 21.3 1.4 6.6 16.4 17.0 15.9 8.3 31.8 14.6 8.1 8.1 10.2 14.7 15.9 8.2 2.5 11.0 7.7 22.4 14.3 9.0 4.9 6.0 0.0 8.3 0.0 8.4 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 2.1 13.8 15.8 4.4 8.3 10.7 6.3 7.8 4.3 8.8 9.2 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662778 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.8;pancreas: 31.0" "Cell line enhanced" "Detected in many" "REH: 17.6;RPMI-8226: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: " "prognostic favourable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favourable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 2.7 6.1 11.7 3.5 12.4 2.1 2.8 26.8 16.1 2.0 3.0 2.2 3.7 2.0 2.4 3.6 2.7 2.5 3.1 2.3 13.8 7.2 5.5 3.1 3.5 4.0 7.9 5.7 3.3 31.0 5.3 13.9 1.5 7.4 2.7 2.0 1.4 3.8 4.6 7.0 1.5 2.5 2.7 3.7 3.7 3.2 16.9 3.4 2.5 2.3 1.4 3.4 2.9 3.1 11.4 5.3 3.7 1.0 1.2 8.5 2.1 5.6 6.1 1.7 14.9 1.2 0.2 3.1 0.1 0.7 2.2 2.1 3.0 2.4 9.5 2.9 0.1 4.5 3.4 0.7 0.5 4.4 3.2 3.8 2.8 3.5 1.6 1.6 9.0 0.1 0.3 2.1 0.8 1.1 0.3 2.2 0.4 5.5 9.7 2.0 2.0 4.0 17.6 1.1 15.3 5.9 3.3 14.5 7.8 0.9 2.1 2.3 13.1 0.6 0.9 0.2 0.5 1.4 2.9 2.3 7.4 8.4 1.7 3.4 0.6 2.1 1.0 0.4 4.5 0.5 8.5 11.4 6.4 5.9 1.2 7.4 3.2 2.4 3.7 1.2 0.1 5.3 6.1 2.1 11.7 12.4 26.8 16.1 13.8 7.2 7.9 5.7 7.4 3.4 PARG ENSG00000227345 "Poly(ADP-ribose) glycohydrolase" Q86W56 10 49818279-49970203 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021819, HPA053007" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021819: AB_1854974, HPA053007: " "unprognostic (5.77e-3)" "unprognostic (6.74e-2)" "unprognostic (3.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.22e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.57e-5)" "unprognostic (1.21e-1)" "unprognostic (3.97e-1)" "unprognostic (8.34e-2)" "unprognostic (1.47e-1)" "unprognostic (4.06e-2)" "unprognostic (5.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (8.54e-2)" "unprognostic (1.13e-1)" 4.0 5.6 4.3 4.2 5.4 1.4 5.3 7.8 6.3 4.8 5.1 6.7 4.9 3.0 6.2 4.3 3.6 6.6 4.6 5.9 9.2 5.2 3.5 5.8 4.5 4.7 3.5 8.1 4.7 5.8 4.9 6.1 4.7 5.1 8.1 6.7 5.1 4.7 4.0 5.9 4.7 5.8 4.9 6.9 4.4 4.8 6.9 7.0 12.5 7.7 8.3 9.4 5.5 12.7 10.6 18.7 13.7 9.0 11.2 13.7 12.7 14.0 14.8 14.2 8.5 11.9 9.6 8.3 10.8 14.5 15.7 8.0 16.0 14.7 14.6 9.8 8.7 9.3 10.2 14.1 8.2 7.2 15.5 12.4 20.5 9.0 16.6 8.5 11.1 7.1 15.6 12.7 18.4 24.3 18.6 21.2 11.1 12.0 8.2 12.9 16.3 10.3 16.4 13.3 18.9 7.9 9.1 9.3 11.3 9.6 14.2 9.4 14.1 20.5 15.9 15.0 6.7 12.5 6.2 3.0 5.2 5.5 7.9 6.9 7.1 6.7 7.0 6.9 9.4 9.1 3.0 8.3 7.7 5.4 5.5 5.5 PARK7 "DJ-1, DJ1, GATD2" ENSG00000116288 "Parkinsonism associated deglycase" Q99497 1 7954291-7985505 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response" "Chaperone, Hydrolase, Protease, RNA-binding" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004190, CAB005870" Supported Supported Nucleoplasm,Cytosol 69000000 "Nucleoplasm, Cytosol" "CAB005870: AB_444361, HPA004190: AB_1079566" "unprognostic (6.88e-3)" "unprognostic (7.50e-2)" "unprognostic (3.48e-2)" "unprognostic (1.16e-2)" "unprognostic (4.08e-2)" "unprognostic (5.68e-2)" "unprognostic (7.45e-2)" "unprognostic (9.63e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-3)" "unprognostic (8.17e-2)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" "unprognostic (7.43e-2)" 44.6 67.9 69.3 38.1 64.9 33.7 45.4 57.2 62.7 34.0 36.4 33.4 43.2 27.3 35.8 56.6 40.9 39.0 41.6 71.7 56.9 57.2 60.5 77.1 28.6 46.1 61.6 57.2 45.9 60.4 66.6 48.4 44.6 41.2 44.7 39.5 38.6 46.5 39.4 128.7 19.8 27.5 48.1 52.5 37.5 37.2 38.2 32.2 38.8 71.6 43.3 46.5 41.3 43.4 49.5 141.8 38.8 61.0 52.8 87.2 90.6 68.2 61.5 61.3 70.4 66.0 63.5 30.1 63.6 59.6 62.6 50.6 56.0 74.8 84.7 71.9 68.2 49.0 66.1 85.0 81.4 75.3 71.4 91.0 91.9 83.1 57.0 86.8 56.1 59.8 36.3 63.8 76.7 65.6 88.3 63.1 86.8 63.9 60.4 110.3 50.0 63.5 46.5 82.3 116.1 98.2 35.1 71.7 60.2 63.6 98.3 99.2 54.8 64.7 62.1 57.8 46.1 53.3 69.7 61.3 98.3 120.5 76.2 132.9 81.8 22.7 61.0 38.8 52.6 55.4 49.7 49.5 52.7 62.2 73.9 38.6 45.6 52.4 21.0 52.8 44.1 141.8 87.2 90.6 69.3 64.9 57.2 62.7 56.9 57.2 61.6 57.2 41.2 32.2 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;Karpas-707: 23.4;U-266/70: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 23.9 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 23.4 0.4 0.2 2.5 0.1 2.2 1.4 0.0 2.1 5.9 0.1 4.8 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 1.5 0.1 2.1 26.2 2.5 6.6 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 PARP10 FLJ14464 ENSG00000178685 "Poly(ADP-ribose) polymerase family member 10" Q53GL7 8 143977153-144012772 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.4" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA028122, HPA052427" Approved Supported "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA028122: AB_10601979, HPA052427: " "unprognostic (9.80e-3)" "unprognostic (5.89e-2)" "unprognostic (2.63e-3)" "unprognostic (9.10e-2)" "unprognostic (1.74e-2)" "unprognostic (1.46e-2)" "unprognostic (7.37e-2)" "unprognostic (3.61e-1)" "unprognostic (9.05e-2)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (4.69e-3)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (8.69e-2)" "unprognostic (5.30e-3)" 14.2 18.8 8.8 27.4 9.5 15.7 18.6 5.3 8.7 14.4 16.5 9.3 20.7 20.5 20.3 18.3 15.8 18.0 21.8 6.4 8.9 4.1 20.5 19.1 21.4 23.6 10.4 6.8 22.4 15.3 9.3 14.2 10.4 9.2 17.7 3.8 12.7 27.7 14.9 12.5 14.3 21.8 9.6 8.9 31.1 13.1 15.8 9.8 27.8 15.4 10.4 21.6 8.8 12.9 2.4 16.4 3.2 2.8 1.9 4.6 2.4 8.4 0.8 0.6 1.5 4.2 3.8 4.6 1.4 1.8 9.5 10.7 0.4 14.8 10.5 20.2 4.5 3.2 0.2 5.0 0.4 23.7 0.0 11.6 4.9 5.3 4.1 4.5 14.0 2.4 5.0 4.7 1.9 1.4 0.2 8.4 1.8 10.3 15.7 7.9 0.5 6.8 14.8 1.7 14.1 3.9 10.7 0.5 0.5 9.8 1.0 18.6 11.0 6.8 6.5 4.9 7.4 8.2 5.2 14.3 8.4 2.4 7.1 15.4 2.6 0.0 1.9 3.2 4.6 2.8 3.0 1.2 2.2 3.7 2.3 2.4 1.6 2.3 1.1 1.9 2.7 16.4 1.6 2.4 8.8 9.5 5.3 8.7 8.9 4.1 10.4 6.8 9.2 9.8 PARP11 C12orf6 ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 7.1 14.5 11.2 8.6 9.2 3.7 8.3 11.0 9.1 6.4 5.4 5.6 4.8 4.9 10.2 7.5 5.0 6.3 5.6 5.1 6.1 5.7 5.7 5.7 6.3 12.8 5.0 5.7 13.1 6.6 10.0 10.4 4.1 7.6 12.0 5.7 7.2 6.6 6.0 4.1 3.9 6.5 7.2 6.1 9.2 4.2 12.8 5.6 16.9 12.3 2.7 12.1 8.3 5.8 10.7 10.2 18.3 10.2 8.2 12.5 7.1 2.5 2.1 13.6 2.1 4.3 6.9 3.8 3.0 5.1 5.3 5.3 7.8 2.0 7.4 1.9 6.6 2.1 4.5 4.5 8.6 14.9 4.5 10.6 0.0 5.7 4.9 7.1 4.0 5.5 3.5 4.2 11.8 3.9 2.8 6.0 7.4 3.5 3.8 2.7 5.0 0.3 7.6 9.3 1.7 2.5 5.7 0.9 3.1 2.9 2.6 3.9 0.5 6.5 7.7 4.6 4.5 7.0 4.0 2.9 6.3 10.5 4.4 4.0 1.2 18.3 10.2 10.2 9.2 8.5 12.5 10.7 10.2 6.7 10.2 10.1 11.7 9.4 10.2 8.2 6.4 8.9 4.3 7.1 11.2 9.2 11.0 9.1 6.1 5.7 5.0 5.7 7.6 5.6 PARP2 ADPRTL2 ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343582-20357905 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA052003: " "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavourable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 11.5 16.6 23.6 8.9 28.5 20.9 15.2 36.7 31.3 12.0 11.7 16.8 9.3 11.2 18.8 16.8 10.7 14.7 8.9 14.0 19.2 17.8 14.0 15.0 12.0 11.8 16.6 30.8 20.2 11.8 11.6 14.6 11.3 22.1 11.3 12.9 10.8 10.5 12.9 25.9 15.1 10.8 14.6 13.9 11.4 11.6 20.4 17.4 6.0 11.7 13.9 15.2 9.3 10.4 6.7 5.6 1.8 5.0 6.9 12.3 4.9 20.2 14.8 22.8 17.1 7.6 7.2 16.6 22.5 12.3 28.6 35.5 13.9 19.4 15.0 10.2 7.1 19.0 30.3 10.3 33.9 12.0 14.8 13.7 17.9 23.3 6.8 28.3 7.9 5.0 8.8 17.8 19.7 14.7 14.5 20.5 19.6 12.5 14.5 12.2 12.5 23.1 18.2 31.0 9.7 11.4 10.6 15.8 10.9 25.1 14.0 6.6 12.9 9.6 10.0 17.5 26.5 12.0 18.2 19.2 24.5 19.9 7.3 12.6 19.3 1.8 5.0 0.5 9.5 4.5 12.3 6.7 8.9 8.3 5.4 4.6 9.6 9.3 0.1 6.9 2.5 5.6 5.2 4.9 23.6 28.5 36.7 31.3 19.2 17.8 16.6 30.8 22.1 17.4 PARP3 "ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: " "prognostic favourable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favourable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 15.2 29.2 11.2 14.6 17.1 2.8 13.6 5.7 18.8 7.5 17.3 10.6 14.3 26.9 10.3 14.1 10.8 12.1 16.2 12.4 11.6 12.3 17.3 22.3 13.3 9.7 12.0 14.2 8.2 3.9 34.2 9.8 6.2 12.2 12.1 10.7 13.2 14.0 18.1 14.6 6.1 26.3 18.9 8.7 12.8 15.8 4.5 10.2 2.9 17.0 9.6 10.3 15.1 8.9 9.0 2.9 1.7 4.1 6.6 4.9 2.3 6.0 3.3 1.0 9.0 8.7 16.5 2.5 9.8 15.9 12.2 13.7 1.9 15.9 8.2 2.6 16.2 0.9 2.5 8.9 5.9 20.0 0.6 4.2 6.7 6.3 9.5 2.5 5.8 13.1 5.5 7.7 5.2 6.1 1.7 7.7 9.3 1.5 2.2 6.3 1.3 9.6 3.5 1.5 7.0 7.4 6.6 1.0 3.4 9.9 2.8 5.3 3.4 2.8 13.7 24.5 5.1 3.6 5.9 11.8 14.3 3.5 15.8 7.4 7.6 0.0 2.6 1.7 3.6 4.1 3.4 9.0 4.2 2.8 2.9 4.3 4.9 4.9 0.1 6.6 2.0 1.2 4.3 2.3 11.2 17.1 5.7 18.8 11.6 12.3 12.0 14.2 12.2 10.2 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Nucleoplasm "Midbody ring, Cytosol" "HPA049183: " "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favourable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.7 0.0 5.4 8.6 1.5 2.7 8.6 1.9 7.0 1.9 5.6 0.3 15.4 6.9 8.2 0.2 5.8 0.9 5.9 4.5 9.7 7.5 5.1 4.7 0.5 2.9 11.9 0.1 3.3 4.9 3.8 2.7 0.1 0.7 4.2 2.6 3.8 14.3 15.1 5.8 2.9 7.2 11.5 8.0 3.5 5.8 6.0 9.3 6.3 10.3 1.6 0.4 42.2 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.5 6.5 3.4 8.0 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 PARP9 "BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 34.9;BJ hTERT+ SV40 Large T+ RasG12V: 41.8;SK-MEL-30: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA066708: " "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favourable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 27.1 20.2 8.7 17.2 12.4 9.1 13.8 2.9 13.9 13.1 13.1 9.9 7.4 10.4 23.3 10.1 15.6 12.3 14.9 8.5 7.4 6.0 17.8 38.6 18.9 17.5 8.5 6.0 12.1 14.4 16.0 20.3 11.9 10.3 15.1 10.1 11.5 19.1 6.6 8.6 5.7 21.2 14.8 16.3 27.3 11.1 5.4 10.3 21.8 17.5 9.0 19.1 13.7 9.8 7.3 11.9 38.2 18.0 13.0 10.6 9.1 8.0 2.7 1.0 0.7 6.2 13.0 0.9 2.7 14.7 34.9 41.8 4.2 8.9 1.8 6.0 5.4 8.9 2.3 4.8 7.3 13.9 1.6 8.7 2.8 2.2 6.7 2.8 5.8 10.5 4.7 4.9 1.2 7.4 0.8 7.5 1.4 3.5 8.9 3.5 0.4 7.6 9.5 9.9 0.6 13.4 4.6 0.6 2.4 7.1 1.2 32.3 3.8 3.1 4.4 1.5 4.4 0.3 1.6 4.6 2.4 3.3 5.2 3.0 2.7 14.4 12.7 15.3 9.2 17.7 8.6 7.3 9.8 10.3 11.9 5.0 7.5 9.1 38.2 13.0 18.0 1.4 10.6 9.1 8.7 12.4 2.9 13.9 7.4 6.0 8.5 6.0 10.3 10.3 PARS2 DKFZp727A071 ENSG00000162396 "Prolyl-tRNA synthetase 2, mitochondrial" Q7L3T8 1 54756898-54764514 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028308, HPA028314, HPA028518" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center, Mitochondria" "HPA028308: , HPA028314: AB_10603981, HPA028518: " "unprognostic (1.95e-1)" "unprognostic (1.10e-1)" "prognostic favourable (1.26e-5)" "unprognostic (1.93e-2)" "unprognostic (1.19e-2)" "unprognostic (1.79e-3)" "prognostic unfavourable (2.34e-4)" "unprognostic (6.48e-2)" "unprognostic (2.72e-1)" "unprognostic (1.14e-1)" "unprognostic (9.42e-2)" "unprognostic (1.10e-1)" "prognostic favourable (1.24e-6)" "unprognostic (2.72e-2)" "unprognostic (9.77e-2)" "unprognostic (1.73e-2)" "unprognostic (9.64e-2)" 6.8 8.4 4.7 4.0 8.2 0.5 6.2 5.2 7.9 6.5 9.0 9.5 8.3 6.0 7.9 7.5 7.0 10.4 4.1 6.6 6.5 4.4 9.6 11.3 4.1 5.8 4.5 5.3 11.5 13.6 7.0 6.6 5.6 4.9 7.1 8.3 5.0 7.2 6.9 8.7 6.7 5.1 4.9 4.3 4.9 6.2 11.5 9.4 8.7 6.7 5.9 5.2 6.0 5.2 7.3 8.9 5.3 11.6 8.1 10.5 6.0 4.7 7.8 5.1 6.7 6.3 5.4 11.5 4.0 5.0 7.2 5.2 9.0 3.1 8.3 6.4 3.6 7.7 9.2 6.4 5.4 5.4 8.4 8.0 4.8 6.7 9.8 4.6 2.8 5.8 9.8 9.3 8.4 5.3 14.0 1.1 5.5 5.0 6.4 6.1 11.8 10.1 5.0 10.1 9.6 6.1 3.5 5.3 5.4 5.8 7.7 10.5 4.4 5.9 2.8 5.4 5.6 7.6 5.0 8.2 6.9 3.3 4.1 5.5 3.1 1.5 6.6 5.3 6.4 9.7 7.6 6.1 7.0 6.8 8.9 7.3 10.5 7.0 0.6 8.1 11.6 7.1 9.3 6.0 4.7 8.2 5.2 7.9 6.5 4.4 4.5 5.3 4.9 9.4 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" 11 12377185-12530801 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 4.0;memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favourable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 30.5 8.3 7.1 14.4 6.5 0.0 44.0 3.9 8.3 29.2 39.2 3.5 25.8 6.9 40.5 17.6 27.0 17.2 35.2 21.3 6.4 5.3 15.3 10.7 13.2 8.5 5.3 7.8 22.7 16.2 10.1 6.3 16.3 5.5 31.7 16.4 18.3 13.4 35.1 6.4 7.7 13.1 55.9 5.0 8.4 24.2 8.4 2.8 0.4 10.5 8.1 5.0 38.8 33.4 0.0 0.0 0.0 0.0 0.0 4.0 0.1 7.6 7.6 7.1 9.2 36.4 28.3 16.6 29.4 30.3 20.8 19.5 5.6 12.0 0.0 9.8 53.4 4.7 0.0 15.3 24.8 0.1 3.8 0.0 10.8 4.2 28.0 0.0 0.2 22.3 6.2 8.7 13.7 25.8 0.0 0.0 30.9 4.6 0.0 0.0 3.3 6.6 0.0 17.8 0.0 11.5 7.5 1.1 0.0 22.6 9.1 15.1 4.3 0.2 31.9 25.1 10.5 13.5 8.0 0.0 0.0 0.0 13.9 0.0 27.6 0.0 0.0 0.0 0.5 0.0 4.0 0.0 1.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.1 6.5 3.9 8.3 6.4 5.3 5.3 7.8 5.5 2.8 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Cell line enhanced" "Detected in many" "A-431: 19.3;BEWO: 16.4;RPTEC TERT1: 16.9;RT4: 18.1;SK-BR-3: 16.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Enhanced "Cell Junctions,Centriolar satellite" "Cell Junctions, Centriolar satellite" "HPA066352: , HPA066960: , HPA069079: " "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favourable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.3 3.9 1.3 1.7 0.7 1.9 16.4 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 6.0 1.7 0.0 0.1 0.7 10.9 2.0 4.6 0.6 0.0 0.0 1.0 6.8 0.0 0.0 6.7 1.0 0.0 1.5 2.7 16.9 18.1 3.4 1.1 4.9 16.1 4.2 12.8 0.2 0.1 1.0 2.5 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 PAWR "par-4, PAR4" ENSG00000177425 "Pro-apoptotic WT1 regulator" Q96IZ0 12 79574979-79691097 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 5.0;naive B-cell: 6.2;NK-cell: 2.9" "Group enriched" "Detected in many" 8 "B-cells: 6.2;NK-cells: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012640, CAB020779" Approved Approved "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "CAB020779: , HPA012640: AB_1855748" "unprognostic (2.42e-1)" "unprognostic (5.58e-2)" "unprognostic (9.77e-3)" "unprognostic (5.39e-2)" "unprognostic (9.44e-3)" "unprognostic (4.21e-3)" "unprognostic (9.21e-2)" "unprognostic (1.37e-1)" "unprognostic (4.78e-1)" "unprognostic (3.03e-1)" "unprognostic (2.42e-3)" "unprognostic (4.97e-3)" "unprognostic (2.22e-2)" "unprognostic (2.58e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-1)" "unprognostic (4.23e-2)" 10.3 6.1 3.4 16.1 8.9 2.1 16.4 6.2 3.3 27.4 16.6 3.8 20.1 9.4 35.0 19.3 20.8 20.4 20.2 5.6 5.5 3.3 14.4 15.5 14.6 5.0 5.7 2.6 22.1 15.1 14.6 19.0 24.8 5.3 21.8 12.6 7.9 14.3 21.1 2.7 14.5 15.0 31.5 3.6 6.1 10.8 15.4 4.9 6.7 24.5 8.4 8.6 27.5 26.2 6.2 0.3 0.5 0.0 2.9 0.4 0.1 19.7 18.4 3.3 0.1 1.7 0.7 22.1 12.6 3.7 6.4 3.9 22.7 7.5 13.2 23.5 7.0 22.0 11.5 9.5 9.2 5.4 15.5 0.0 10.6 9.8 9.2 0.2 0.3 1.6 20.2 5.0 29.0 10.7 0.7 1.8 7.0 15.0 3.1 0.0 16.0 10.1 0.0 7.5 8.5 12.2 15.0 9.7 0.0 22.6 12.0 2.0 10.7 0.1 15.6 9.8 8.7 0.3 8.4 5.9 7.5 9.6 1.6 0.0 4.2 0.5 0.0 0.1 0.1 0.0 0.0 5.0 0.3 0.2 0.3 6.2 0.4 0.4 0.5 2.9 0.0 0.2 0.0 0.1 3.4 8.9 6.2 3.3 5.5 3.3 5.7 2.6 5.3 4.9 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735603-100829941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1" "Group enriched" "Detected in some" 9 "AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Group enriched" "Detected in some" 6 "cerebellum: 1.0;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebellum: 1.5;pons and medulla: 3.5" "Group enriched" "Detected in some" 6 "cerebellum: 7.9;pons and medulla: 8.1" "CAB013024, HPA047704, HPA070751" Enhanced Supported "Nucleoli,Golgi apparatus" "Intracellular and membrane" Nucleoli "Golgi apparatus" "CAB013024: AB_2533990, HPA047704: , HPA070751: " "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavourable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 1.0 0.1 3.1 0.1 0.0 30.5 0.0 1.5 93.7 0.1 9.1 0.0 0.1 0.1 0.1 43.1 0.1 0.1 0.0 0.2 0.0 1.5 0.3 0.6 0.7 0.0 1.8 0.8 0.0 0.5 0.1 19.4 0.1 0.1 0.1 0.0 1.7 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 14.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.1 0.1 0.1 0.2 0.0 1.8 0.1 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Group enriched" "Detected in some" 8 "Daudi: 21.0;REH: 61.0;U-698: 27.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: , HPA068498: " "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 61.0 0.1 0.1 0.0 0.0 4.3 1.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1" "Cell line enhanced" "Detected in many" "HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB016239, HPA038462" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB016239: AB_2159984, HPA038462: AB_10672594" "unprognostic (3.09e-1)" "prognostic favourable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.1 3.7 0.4 0.0 0.0 0.0 0.2 0.1 58.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.0 0.1 0.1 34.6 1.4 0.0 0.1 2.7 0.0 0.1 86.1 0.0 0.1 0.3 0.1 0.4 0.1 0.1 0.2 0.2 0.0 11.8 0.5 27.1 33.2 0.4 3.4 0.1 0.0 0.0 0.0 0.0 2.7 0.1 3.4 0.9 0.0 1.7 1.4 2.3 1.2 0.0 0.1 0.0 0.0 0.7 1.1 0.7 0.4 0.0 8.0 1.2 8.0 0.0 30.0 5.3 0.5 0.5 0.0 0.0 0.0 2.7 0.5 3.7 0.0 1.2 0.0 2.0 0.8 0.1 4.5 0.5 0.0 0.1 12.9 0.0 0.0 0.0 0.0 4.5 2.2 0.0 0.8 4.0 0.9 3.4 0.0 0.0 0.0 0.5 1.3 0.6 0.0 0.0 3.0 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771858 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavourable (9.43e-4)" "prognostic unfavourable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 8.9 10.6 11.9 16.6 19.6 42.0 11.6 25.7 20.0 13.5 14.1 11.3 10.1 15.8 16.3 12.4 10.3 11.6 10.1 8.3 11.2 9.7 11.3 10.3 10.1 13.7 22.7 10.0 19.8 12.3 11.6 19.3 13.2 14.7 11.2 12.6 6.9 10.2 10.5 15.2 12.6 12.8 10.8 19.0 11.2 9.5 12.9 19.7 18.5 11.3 5.0 12.3 11.2 18.9 2.2 1.6 0.3 1.3 0.7 3.1 0.4 7.3 6.1 12.3 9.6 4.8 3.9 17.5 5.5 3.5 7.2 5.3 12.8 6.7 8.8 4.3 3.1 7.6 12.3 5.1 7.6 7.1 10.1 15.1 10.0 9.3 2.3 17.0 9.0 2.1 7.7 8.4 3.7 4.7 17.6 8.1 5.3 6.5 11.6 9.9 34.7 6.2 10.8 11.7 12.8 5.6 6.8 10.1 5.7 7.9 9.1 6.2 5.8 9.5 4.2 5.4 7.4 6.2 8.5 8.0 10.0 16.3 3.9 15.5 5.4 0.0 1.3 0.3 2.2 0.6 3.1 1.6 2.5 1.9 1.6 2.2 2.7 2.6 0.0 0.7 0.8 1.1 1.4 0.4 11.9 19.6 25.7 20.0 11.2 9.7 22.7 10.0 14.7 19.7 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003084 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 32.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 6.0 5.4 5.7 6.2 5.0 9.7 6.3 32.3 5.7 7.8 5.5 5.8 4.5 5.2 6.5 6.7 7.1 5.7 5.0 4.7 6.0 3.4 5.7 6.9 4.7 9.4 5.7 1.4 7.1 8.4 7.2 8.7 7.9 5.6 7.7 5.7 6.9 6.6 5.4 7.1 7.4 6.9 9.3 4.2 6.4 5.9 10.4 6.2 31.2 6.4 4.7 6.9 6.1 5.9 2.2 3.3 1.4 3.1 2.9 6.5 2.5 9.8 8.1 10.7 18.2 4.7 3.9 9.6 4.4 4.6 6.0 7.1 8.9 7.8 12.9 5.5 5.2 7.8 13.7 6.9 7.5 12.9 10.7 9.8 5.8 7.6 3.3 13.3 13.1 3.8 5.2 6.0 2.4 5.7 13.4 8.7 6.0 13.7 28.3 11.1 17.4 5.5 16.2 11.0 14.0 6.2 8.3 8.6 5.5 11.6 8.7 5.4 6.6 11.5 2.9 5.1 0.9 7.2 10.4 8.9 5.2 17.8 12.5 15.7 13.6 0.7 2.3 1.4 2.5 2.6 3.8 1.3 4.0 2.9 2.6 2.2 6.5 1.7 1.0 2.9 3.1 3.3 3.2 2.5 5.7 5.0 32.3 5.7 6.0 3.4 5.7 1.4 5.6 6.2 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favourable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.8 15.2 10.4 19.5 19.5 13.1 21.6 18.6 20.0 17.2 17.0 16.9 16.7 14.6 21.8 17.6 25.4 24.2 26.1 12.3 16.1 12.3 10.0 25.4 30.7 36.2 18.1 15.5 20.0 27.3 23.3 25.3 17.4 8.3 24.3 14.3 17.0 26.5 42.3 27.9 14.6 16.0 2.1 29.1 22.6 8.9 11.5 9.6 15.9 0.1 9.7 13.7 21.8 14.9 15.0 17.7 19.8 14.7 25.8 9.9 16.6 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 30.5;NTERA-2: 29.9;SK-BR-3: 61.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 13.2 17.3 14.9 8.3 15.0 1.4 16.4 14.1 17.4 73.4 26.3 11.2 15.9 13.6 67.2 15.3 20.8 35.1 25.8 12.6 10.9 9.7 15.4 4.2 10.4 2.3 11.6 14.6 35.2 29.4 21.3 12.4 9.6 8.1 27.6 9.3 10.2 19.6 25.1 16.8 6.0 14.6 56.8 8.0 5.1 13.9 9.7 8.7 2.7 17.4 8.5 6.6 32.2 24.7 0.0 0.1 2.9 0.0 0.3 0.2 2.5 1.1 22.3 22.1 5.9 14.9 7.2 1.3 9.3 6.1 2.5 1.8 4.3 4.0 0.0 1.9 12.7 7.8 8.6 2.4 1.0 1.1 9.3 30.5 17.9 0.0 9.8 0.0 7.8 7.1 0.0 1.6 0.7 0.1 0.0 0.0 0.6 14.7 0.0 0.1 29.9 1.1 0.0 7.3 8.9 1.8 13.3 0.8 13.1 10.8 61.6 0.0 23.4 0.0 0.1 1.3 3.1 8.7 2.7 2.8 21.1 0.0 0.1 0.0 0.1 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.1 0.0 2.5 14.9 15.0 14.1 17.4 10.9 9.7 11.6 14.6 8.1 8.7 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell line enhanced" "Detected in many" "THP-1: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in many" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.6 4.5 20.5 19.0 5.7 9.3 3.7 12.3 7.0 8.6 6.2 5.8 9.3 4.6 1.5 9.8 3.6 11.5 5.0 17.0 4.9 8.2 3.9 3.5 2.3 7.3 4.4 7.2 4.8 5.6 6.7 4.3 9.6 0.2 4.4 17.7 2.5 4.0 2.0 15.1 3.1 7.6 30.6 0.5 6.5 2.8 11.0 19.2 8.5 1.6 3.7 7.0 36.0 11.5 17.4 4.8 10.2 22.9 3.2 4.9 4.9 8.3 6.2 8.9 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "Karpas-707: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favourable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favourable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favourable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favourable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 25.3 48.1 35.4 24.9 54.9 13.7 19.9 18.3 31.4 26.8 36.2 26.1 28.1 25.5 28.3 29.8 23.6 22.8 31.1 21.9 46.6 28.6 18.1 13.3 22.6 28.6 41.8 34.4 50.1 17.6 42.4 56.7 21.2 47.8 26.4 14.3 38.6 20.7 48.3 57.2 13.2 28.6 52.6 29.0 27.5 28.1 15.9 33.8 27.9 33.1 22.4 26.8 37.5 25.7 9.2 4.0 42.9 6.6 13.0 46.8 14.4 0.9 2.6 4.2 2.8 14.8 4.6 3.1 3.5 7.8 1.7 3.4 0.7 3.5 4.3 11.4 4.2 3.7 1.0 2.2 1.2 2.3 1.6 0.9 3.5 2.7 6.8 1.1 12.0 7.0 3.7 2.1 0.4 6.4 0.5 156.1 4.2 1.5 2.3 3.7 1.6 2.0 2.7 6.1 9.3 4.7 1.9 0.7 5.4 4.5 1.4 3.5 4.4 5.0 6.0 1.7 1.2 1.0 1.0 21.4 17.9 1.0 6.1 1.7 1.3 26.7 2.5 42.9 11.0 3.6 30.4 9.2 29.5 17.2 2.2 5.7 19.7 12.1 23.7 13.0 6.6 4.0 46.8 14.4 35.4 54.9 18.3 31.4 46.6 28.6 41.8 34.4 47.8 33.8 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888784 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.0" "Cell line enhanced" "Detected in many" "CACO-2: 67.5;Hep G2: 66.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Approved Enhanced Nucleoplasm,Cytosol 210000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: " "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 18.3 25.5 18.1 9.6 15.6 4.3 19.7 13.2 14.8 13.9 18.4 7.8 24.3 12.6 13.9 21.4 26.5 25.6 22.9 32.5 10.8 23.7 38.7 99.0 14.0 7.8 16.7 12.3 18.5 73.0 15.8 15.5 11.7 16.4 26.9 20.3 16.3 16.2 20.7 23.1 5.8 17.2 18.1 14.5 10.2 19.2 7.0 8.7 4.3 36.8 16.2 12.3 22.4 31.8 11.8 20.9 3.5 19.4 8.0 16.9 7.5 20.4 48.5 2.9 30.1 11.0 10.3 3.9 6.6 11.0 10.3 8.2 67.5 36.2 4.2 19.2 7.2 13.6 18.3 10.6 7.0 10.9 33.1 3.7 7.7 66.3 11.6 3.6 13.6 10.0 11.6 10.2 4.8 27.6 7.2 0.3 7.1 34.1 0.4 12.2 4.1 45.4 2.0 4.0 13.4 43.2 21.1 12.7 21.5 5.5 37.6 14.3 10.9 7.1 11.4 1.7 14.4 2.5 16.2 0.1 0.8 0.1 9.4 11.9 2.6 0.0 10.7 3.5 8.8 19.4 6.9 11.8 11.6 12.6 20.9 4.1 3.8 7.9 0.6 8.0 13.3 15.3 16.9 7.5 18.1 15.6 13.2 14.8 10.8 23.7 16.7 12.3 16.4 8.7 PCBP1 "hnRNP-E1, hnRNP-X, HNRPE1, HNRPX" ENSG00000169564 "Poly(rC) binding protein 1" Q15365 2 70087454-70089203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037113, HPA043803, HPA068497" Supported Enhanced "Nuclear speckles,Cytoplasmic bodies" 12000000 "Nuclear speckles" "Cytoplasmic bodies" "CAB037113: AB_1840915, HPA043803: , HPA068497: " "unprognostic (1.63e-1)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (7.08e-2)" "unprognostic (5.37e-1)" "unprognostic (1.63e-2)" "unprognostic (8.33e-2)" "unprognostic (9.94e-3)" "unprognostic (2.01e-1)" "unprognostic (2.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.71e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-1)" "unprognostic (5.90e-2)" 52.7 57.6 34.4 49.7 36.7 79.5 149.6 33.3 39.9 38.8 47.2 32.4 45.7 41.1 54.1 39.3 55.6 39.3 45.4 55.1 34.0 31.2 41.6 69.5 46.3 77.8 43.5 29.8 42.3 88.3 42.8 30.5 52.7 37.5 36.3 31.2 29.6 47.9 42.0 149.0 41.5 39.6 59.7 39.1 52.0 43.2 31.6 42.1 91.0 43.8 59.9 48.4 49.6 148.0 15.1 29.2 49.6 32.1 31.6 30.3 28.9 61.4 63.5 54.9 42.8 59.3 45.4 88.5 46.1 42.7 45.8 38.6 73.5 41.4 84.6 23.8 52.3 55.1 64.4 67.2 47.0 60.3 49.7 67.6 38.9 112.2 66.9 55.9 65.1 39.5 43.9 37.7 52.7 58.1 69.1 62.7 57.4 76.4 72.0 84.1 55.4 42.0 58.3 60.1 84.8 62.2 63.7 52.2 42.0 37.9 77.8 54.5 46.2 50.9 53.3 43.1 54.1 36.4 58.1 83.6 85.8 85.9 45.6 77.7 52.9 12.6 30.8 45.5 30.3 32.1 27.8 15.1 23.7 26.0 29.2 14.4 24.2 26.9 49.6 31.6 26.7 21.0 27.7 28.9 34.4 36.7 33.3 39.9 34.0 31.2 43.5 29.8 37.5 42.1 PCBP2 "hnRNP-E2, HNRNPE2, HNRPE2" ENSG00000197111 "Poly(rC) binding protein 2" Q15366 12 53452102-53481162 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038356 Uncertain Supported Nucleoplasm,Cytosol 2000000 Nucleoplasm Cytosol "HPA038356: AB_10697248" "unprognostic (1.44e-1)" "unprognostic (2.08e-1)" "unprognostic (9.89e-2)" "unprognostic (2.92e-3)" "unprognostic (4.34e-3)" "unprognostic (2.69e-2)" "prognostic unfavourable (1.82e-5)" "unprognostic (2.52e-1)" "unprognostic (2.05e-2)" "prognostic favourable (8.23e-4)" "unprognostic (3.53e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.35e-1)" "unprognostic (1.99e-1)" "unprognostic (8.20e-2)" 105.3 106.7 110.8 85.7 93.4 158.1 180.8 136.5 131.5 84.1 67.2 50.5 75.7 69.2 101.7 84.5 75.3 89.5 71.0 112.1 105.0 53.1 112.6 108.3 83.8 118.8 94.5 88.9 124.5 148.2 98.1 88.7 62.4 93.2 61.7 71.0 65.0 88.3 61.2 96.5 94.4 71.3 90.8 115.4 73.0 86.2 98.7 104.2 106.8 91.2 57.1 93.5 76.8 132.5 20.9 31.5 17.2 18.5 12.4 28.8 13.7 57.4 89.5 87.5 70.4 127.5 98.7 67.1 61.2 84.0 100.5 72.0 104.1 86.6 103.1 59.9 91.7 56.5 96.4 83.4 96.2 63.8 69.5 103.6 69.9 102.1 128.6 101.1 68.4 113.5 70.0 84.9 136.7 96.3 88.4 185.2 89.7 156.3 94.9 113.9 111.8 62.9 76.4 79.5 120.8 79.4 90.0 86.4 75.9 83.8 75.5 59.8 105.7 88.1 70.2 52.1 71.5 47.5 62.1 103.1 71.0 95.3 61.2 64.9 56.6 8.3 18.1 13.1 15.9 18.5 26.1 20.9 24.5 20.5 22.5 20.9 28.8 23.6 17.2 12.4 17.0 31.5 27.4 13.7 110.8 93.4 136.5 131.5 105.0 53.1 94.5 88.9 93.2 104.2 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" HPA030247 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244" "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.7 14.5 0.0 0.8 0.2 1.5 0.6 0.0 0.0 0.0 0.3 3.9 0.0 0.8 0.0 0.2 26.6 0.0 0.0 0.0 0.0 6.9 0.0 0.0 20.4 0.1 0.2 0.4 0.0 0.0 0.1 0.9 0.3 7.6 1.5 0.4 1.3 0.0 0.0 1.1 0.0 0.0 2.5 23.1 0.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 6.0 0.0 0.3 1.4 0.0 12.3 14.8 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.7;HaCaT: 37.1;HUVEC TERT2: 19.5;RT4: 25.4;TIME: 25.3;WM-115: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: " "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavourable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favourable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.3 0.3 2.7 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.7 0.0 15.3 0.2 37.1 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.5 0.0 0.1 0.0 6.2 0.0 0.4 19.5 0.0 3.2 0.0 5.1 0.1 0.0 11.3 5.1 0.1 0.0 4.3 2.2 25.4 0.3 0.6 0.1 8.1 6.5 6.5 0.1 25.3 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: " "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.1 0.0 0.0 4.9 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.2 0.0 2.4 0.0 13.2 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 31.4 8.5 0.0 0.0 7.2 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in some" "AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.7 0.0 0.0 1.8 0.0 0.0 0.0 9.9 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 35.0;ASC diff: 42.3;ASC TERT1: 47.1;BJ hTERT+: 20.7;fHDF/TERT166: 33.4;HHSteC: 31.2;HSkMC: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" 1200000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavourable (4.71e-4)" 28.4 3.5 4.2 7.2 4.0 0.0 16.2 2.0 2.7 30.4 13.3 2.1 9.8 6.0 34.0 8.7 11.2 8.6 14.9 8.9 2.7 3.6 5.4 3.0 5.9 2.6 5.2 1.4 14.9 2.4 1.8 3.5 29.0 5.4 23.3 9.5 21.8 6.3 9.5 10.3 5.1 9.0 25.4 5.4 4.0 5.5 9.7 4.0 1.0 8.2 7.7 1.9 17.5 16.3 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 35.0 0.0 42.3 47.1 0.0 6.3 20.7 1.2 1.8 0.0 0.0 0.0 0.0 33.4 0.0 8.1 0.1 0.6 0.0 0.2 0.0 0.0 0.0 31.2 0.0 0.0 47.9 0.0 2.2 0.9 0.2 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.6 2.6 1.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 16.4 1.0 3.3 0.1 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 4.0 2.0 2.7 2.7 3.6 5.2 1.4 5.4 4.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "HPA062669: " "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 33.8 0.0 0.5 1.2 0.0 2.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 16.4;RH-30: 46.0;RT4: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: " "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavourable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavourable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.5 7.6 11.5 11.2 0.0 1.4 0.0 0.7 0.3 0.7 9.9 0.0 0.0 0.0 5.7 0.4 14.4 1.3 0.0 16.4 0.0 10.4 0.0 11.9 0.2 0.0 6.7 3.4 0.3 4.1 2.8 0.0 0.0 3.4 0.0 0.0 0.0 3.3 1.5 0.0 46.0 0.0 0.3 24.2 0.3 0.1 0.1 0.4 0.5 0.7 2.5 0.0 9.3 2.4 2.5 0.0 0.0 0.0 0.0 7.2 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell line enriched" "Detected in some" 4 "AF22: 22.5" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 1.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.3 12.4 0.0 3.3 2.6 0.0 1.8 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.0 1.0 0.3 0.6 0.0 4.9 0.1 0.1 0.0 3.2 0.3 0.1 6.1 0.3 1.5 2.5 1.0 0.3 0.1 20.3 0.7 5.6 0.0 0.1 1.2 8.5 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.0 0.0 23.6 0.7 0.6 2.9 0.9 3.6 0.0 31.0 5.3 0.0 2.4 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: " "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 16.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.1 0.0 4.4 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 5.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell line enhanced" "Detected in some" "A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA035812 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035812: " "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.4 7.6 0.0 0.0 0.0 0.3 7.5 0.3 4.3 0.0 0.9 0.1 1.6 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell line enhanced" "Detected in some" "A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: " "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 8.9 8.7 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.6 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.3 0.6 0.3 0.1 0.3 0.5 0.4 2.3 0.2 0.4 0.5 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.2 0.2 0.2 0.3 0.3 0.4 0.4 3.7 0.1 1.9 0.8 7.6 0.3 0.9 1.9 1.2 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 7.5 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA076190 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA076190: " "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.7 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.7 3.9 0.0 0.0 0.1 0.0 8.2 0.0 0.5 0.0 0.0 0.1 5.3 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.4 0.0 0.0 0.0 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell line enhanced" "Detected in some" "AN3-CA: 11.9;T-47d: 6.6;U-138 MG: 26.3;U-2197: 7.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014668 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 11.9 5.3 3.8 0.3 0.5 2.7 0.0 0.2 0.0 0.2 0.0 4.4 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 6.4 0.3 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.0 6.6 0.0 0.3 26.3 1.3 7.0 1.3 0.0 0.0 0.0 6.3 0.0 3.3 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 12.7;SH-SY5Y: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 12.7 8.5 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell line enhanced" "Detected in some" "EFO-21: 16.5;SH-SY5Y: 7.0;T-47d: 5.3;U-2197: 7.5;WM-115: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029566 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA029566: AB_10601385" "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavourable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.0 0.0 0.1 3.5 5.3 2.1 0.0 0.6 1.3 7.5 0.0 0.0 0.0 0.0 3.8 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.0 0.3 1.7 1.1 0.5 1.0 0.4 0.2 0.5 2.8 1.0 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.7 0.5 0.0 0.7 0.1 0.2 0.8 6.9 0.1 0.2 0.8 0.3 0.3 3.0 2.6 0.3 0.3 0.3 1.7 2.1 0.2 0.9 1.7 11.3 0.4 0.8 3.2 0.7 1.6 0.4 0.3 1.0 0.2 3.8 0.2 5.1 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell line enhanced" "Detected in many" "AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.0 6.1 5.3 2.3 5.7 2.0 0.1 2.9 4.7 0.2 0.7 0.6 7.9 2.9 0.3 2.8 1.9 2.3 0.7 0.0 0.0 0.3 0.0 2.1 1.2 0.2 13.5 0.3 2.0 0.8 1.1 0.0 0.1 7.3 0.0 0.1 0.3 1.1 0.1 0.1 1.0 0.0 2.0 0.0 1.6 0.6 0.3 0.0 0.3 16.0 1.5 2.6 5.5 0.3 9.4 0.1 0.2 0.9 0.1 2.8 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.4 14.9 16.1 0.5 3.2 6.2 2.5 4.0 0.0 0.1 0.3 5.4 3.2 2.1 0.1 0.3 4.0 0.1 1.4 0.0 0.0 0.0 2.5 0.2 0.0 11.5 0.1 4.4 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 9.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.3 1.8 4.5 0.5 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell line enhanced" "Detected in some" "BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.6 12.6 0.0 0.0 0.0 0.0 0.4 0.0 18.7 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 14.0 0.0 3.7 0.0 4.4 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 6.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA038625: " "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.9 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.4 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.1 0.2 0.1 0.3 2.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AF22: 11.0;BJ: 3.6;EFO-21: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.2 1.5 0.0 3.6 0.3 0.0 0.1 0.0 0.0 0.1 8.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.2 0.0 5.6 4.5 0.3 1.1 0.0 0.1 0.9 1.9 4.7 0.1 0.1 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 5.9 0.2 0.1 0.0 5.6 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.2 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.2 0.3 1.1 2.1 0.0 3.6 2.4 0.7 3.1 0.4 0.2 0.3 0.2 8.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Group enriched" "Detected in some" 7 "ASC diff: 18.4;ASC TERT1: 7.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.4 0.3 0.1 18.4 7.3 0.0 0.8 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.6 0.1 0.6 0.7 0.3 0.5 0.7 0.1 0.3 0.9 0.6 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 1.6 0.0 1.0 0.6 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.7 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell line enhanced" "Detected in some" "SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.3 3.1 0.5 1.5 5.3 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.1 3.0 3.6 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.8 0.1 0.1 5.7 0.4 0.3 0.1 1.8 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 1.5 0.4 0.0 0.4 0.1 11.0 0.9 0.1 0.3 0.7 6.4 0.1 5.4 0.9 0.4 0.8 0.8 0.4 1.8 0.4 0.9 0.7 13.7 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 1.4 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.6 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.4 0.2 0.9 0.2 0.2 0.5 0.7 2.7 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.7 0.3 0.9 0.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.3 1.0 2.5 0.2 0.5 0.4 1.2 0.0 1.0 1.1 0.4 0.6 2.0 5.9 3.1 0.1 0.2 0.3 1.1 0.1 0.5 0.0 0.2 0.0 1.8 0.1 0.4 6.6 0.3 0.6 0.5 1.6 0.1 0.3 0.5 0.6 0.3 0.7 0.3 0.1 0.3 0.7 0.0 0.3 0.3 0.7 1.8 0.6 0.1 0.8 1.5 0.7 7.2 0.5 0.5 0.1 3.9 0.3 0.1 0.1 8.3 0.2 1.4 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: , HPA076182: " "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.1 1.8 0.0 14.9 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.2 0.2 3.3 1.9 0.4 0.3 0.2 0.0 0.0 2.8 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: , HPA077526: " "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavourable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 1.7 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: " "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.4 0.3 13.2 10.7 0.2 1.4 2.4 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.6 0.6 0.2 0.1 1.2 0.3 1.0 0.3 0.4 0.7 1.0 0.1 0.1 1.8 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.0 0.3 0.8 0.0 6.7 0.6 0.1 0.7 0.7 0.3 2.0 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.5;TIME: 14.3" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.0 0.0 4.6 5.9 0.8 6.8 28.5 2.8 1.9 0.0 0.0 0.2 5.5 0.2 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 4.3 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 2.6 14.3 3.8 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.1 0.1 0.0 32.2 24.3 0.6 8.5 0.0 13.9 15.6 1.3 4.6 4.8 11.1 9.4 6.4 0.0 3.5 7.8 0.0 1.4 0.0 0.0 0.0 3.3 0.0 3.1 8.5 0.7 0.8 4.5 4.2 0.1 0.0 0.4 3.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell line enhanced" "Detected in some" "AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.2 0.1 0.6 0.7 0.9 1.6 0.0 0.4 1.0 0.2 0.2 1.5 6.2 1.0 0.3 0.0 0.3 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.2 2.0 0.9 0.1 0.6 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.2 0.1 0.1 2.9 0.2 0.2 0.3 0.0 0.1 0.1 1.4 0.4 2.9 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.8 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AN3-CA: 42.5;HSkMC: 13.5" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 42.5 1.0 0.2 0.4 2.8 0.3 1.0 2.1 0.0 2.6 0.3 2.3 5.6 0.7 0.1 0.5 1.0 0.0 0.3 0.0 0.0 0.0 3.2 0.2 0.0 13.5 0.3 0.8 0.4 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 4.7 0.9 0.0 0.1 0.0 4.6 6.3 0.1 0.0 0.0 0.4 0.4 5.5 5.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell line enhanced" "Detected in some" "REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.2 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.9 0.9 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.5 0.0 9.7 0.6 0.0 0.0 0.1 8.2 15.9 0.1 0.0 0.2 0.1 0.3 0.1 0.9 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Cell line enhanced" "Detected in some" "U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 16.3 0.2 0.2 7.0 0.0 0.0 0.0 10.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050816: " "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavourable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favourable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 18.0 17.3 25.5 21.9 29.1 13.1 14.4 18.7 29.0 17.6 13.4 27.6 18.8 17.1 23.8 20.3 12.6 22.4 23.0 9.7 24.2 17.1 23.1 21.0 16.4 23.5 30.0 20.8 28.4 16.1 38.2 27.0 16.4 25.1 25.4 9.1 21.6 23.7 18.3 6.9 12.7 18.2 15.2 14.5 33.1 20.0 9.4 28.7 14.2 36.0 4.8 16.7 15.8 17.6 9.4 8.2 3.1 7.4 14.2 12.0 6.8 12.4 16.4 16.7 9.2 17.5 24.2 12.1 12.0 13.7 12.9 14.0 11.4 22.9 3.7 8.3 8.1 20.5 4.0 11.2 6.0 18.0 12.2 14.3 18.2 15.8 14.2 2.7 4.8 32.1 23.9 15.8 21.0 9.2 11.2 17.2 9.4 8.6 1.9 18.1 18.4 9.8 9.9 5.5 7.5 14.5 10.4 15.5 24.0 11.9 15.7 20.6 20.1 9.7 8.8 12.6 8.7 13.0 5.7 28.3 14.1 1.0 3.1 10.2 14.8 2.9 7.4 3.1 11.0 6.6 10.6 8.6 6.4 9.3 8.2 9.4 12.0 10.6 0.6 14.2 6.1 7.1 4.5 6.8 25.5 29.1 18.7 29.0 24.2 17.1 30.0 20.8 25.1 28.7 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 40.2" "Cell line enhanced" "Detected in many" "A549: 32.0;K-562: 23.9;SK-BR-3: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavourable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favourable (5.36e-5)" 5.7 28.4 4.1 25.9 3.9 7.1 4.4 0.6 3.6 5.1 6.4 5.7 1.2 1.8 7.6 4.6 4.5 6.9 5.8 2.4 2.8 2.3 4.1 2.7 7.8 25.6 3.8 2.9 19.6 2.1 0.6 2.0 3.2 3.7 6.0 2.3 3.3 6.5 2.8 1.0 2.0 8.5 11.7 7.7 20.8 2.9 9.1 3.3 5.7 2.6 1.3 40.2 10.0 4.2 16.5 12.5 1.5 0.8 9.1 32.1 10.9 1.7 32.0 0.8 0.0 0.2 0.0 1.5 1.0 1.7 0.4 0.1 1.6 6.3 5.7 1.8 3.2 4.6 0.0 4.7 0.0 6.6 0.0 0.2 0.3 0.6 0.6 1.3 0.2 0.1 2.1 0.5 3.7 1.4 23.9 5.4 2.2 0.7 0.3 1.1 5.5 0.4 0.1 0.8 4.0 4.9 2.6 0.2 0.0 2.9 15.9 0.0 2.9 2.0 0.4 0.1 0.4 0.0 1.1 5.9 4.1 10.4 1.5 4.4 0.1 0.4 0.3 0.8 14.9 0.7 16.9 16.5 17.9 18.8 2.1 10.1 32.1 29.1 1.5 9.1 0.8 12.5 18.9 10.9 4.1 3.9 0.6 3.6 2.8 2.3 3.8 2.9 3.7 3.3 PCF11 KIAA0824 ENSG00000165494 "PCF11 cleavage and polyadenylation factor subunit" O94913 11 83156988-83187451 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040779 Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA040779: " "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (3.99e-2)" "unprognostic (1.18e-1)" "unprognostic (3.24e-3)" "prognostic favourable (1.34e-4)" "unprognostic (3.74e-2)" "unprognostic (4.89e-3)" "unprognostic (1.12e-3)" "unprognostic (9.53e-2)" "unprognostic (6.07e-2)" "unprognostic (5.63e-2)" "unprognostic (1.55e-1)" "unprognostic (3.91e-3)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "prognostic favourable (2.03e-5)" 17.6 15.2 21.8 33.5 23.3 32.1 21.1 29.7 21.3 22.1 19.7 13.6 30.8 14.0 25.6 36.8 21.9 23.4 20.8 14.0 21.7 10.0 15.7 14.5 24.0 25.8 26.6 15.4 28.9 16.1 22.4 32.5 18.9 19.2 25.6 17.9 13.8 22.5 28.5 27.0 32.5 21.2 21.4 20.6 27.2 17.7 20.1 27.4 29.4 23.4 22.5 25.1 24.8 29.3 11.4 6.8 17.5 7.2 13.0 10.5 5.3 11.0 7.9 12.9 11.0 15.5 15.2 10.4 10.6 7.9 10.3 7.9 13.5 11.1 25.0 8.1 7.7 11.2 18.8 7.3 9.9 17.7 6.4 14.6 10.3 9.5 8.7 17.1 16.3 10.8 14.2 7.8 11.4 10.3 16.9 12.2 9.6 11.8 16.0 19.1 13.5 8.9 15.3 16.3 14.9 8.9 16.5 10.8 12.0 13.0 10.4 10.4 10.4 11.9 10.6 14.7 7.6 10.8 7.0 11.0 18.4 53.1 6.4 11.4 11.3 12.0 7.2 14.2 10.5 6.9 9.1 11.4 7.4 7.6 6.7 10.4 8.6 8.5 17.5 13.0 5.1 6.8 5.1 5.3 21.8 23.3 29.7 21.3 21.7 10.0 26.6 15.4 19.2 27.4 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177539-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA069107: , HPA073074: " "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 17.6 22.6 13.7 14.6 16.0 11.3 21.0 33.5 15.9 20.9 18.2 14.6 20.4 10.3 24.0 20.7 15.6 22.5 14.7 31.3 12.8 10.8 15.4 18.1 14.8 19.6 16.9 13.0 30.6 28.6 12.1 37.6 13.4 14.9 20.0 16.3 14.4 21.4 19.3 21.6 15.0 15.2 19.7 13.4 20.1 19.2 43.4 16.5 19.4 25.4 11.6 20.6 18.0 21.2 15.1 9.7 8.1 12.5 7.6 32.4 19.0 22.3 9.5 14.6 12.8 26.9 20.2 10.2 17.3 26.0 24.1 22.3 18.7 21.2 18.0 11.5 23.4 14.3 23.1 15.6 26.9 15.6 22.8 23.1 24.8 16.4 26.8 39.2 9.5 16.6 17.5 15.1 26.9 18.9 17.7 7.4 27.2 10.8 20.9 27.7 14.4 12.2 19.0 16.2 17.2 21.9 11.4 19.5 12.0 10.7 26.8 19.7 14.8 48.0 12.2 7.2 25.8 10.3 12.9 11.3 10.6 25.1 24.7 26.7 16.3 8.1 9.6 7.1 27.6 12.5 32.4 15.1 23.6 28.7 9.7 14.2 21.5 22.3 1.5 7.6 11.5 9.2 23.5 19.0 13.7 16.0 33.5 15.9 12.8 10.8 16.9 13.0 14.9 16.5 PCIF1 "bA465L10.1, C20orf67, PPP1R121" ENSG00000100982 "PDX1 C-terminal inhibiting factor 1" Q9H4Z3 20 45934628-45948023 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049517 Enhanced Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Nucleoplasm "Microtubules, Cytokinetic bridge" "HPA049517: " "unprognostic (5.42e-3)" "unprognostic (7.76e-2)" "unprognostic (7.69e-2)" "prognostic unfavourable (8.86e-4)" "unprognostic (1.39e-2)" "unprognostic (4.20e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.57e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.50e-6)" "unprognostic (1.01e-1)" "unprognostic (4.44e-2)" "unprognostic (9.14e-3)" "unprognostic (1.24e-1)" 18.5 15.7 12.7 18.4 17.8 26.2 19.2 33.7 27.9 26.0 19.4 26.7 15.9 14.7 29.8 17.0 19.4 28.8 16.9 23.7 12.9 12.4 16.3 13.2 18.9 23.9 17.7 13.6 37.5 23.5 21.5 18.9 18.7 14.4 20.0 10.8 23.9 20.6 20.8 27.1 24.2 17.1 19.6 16.1 22.8 16.3 17.6 16.2 36.0 24.8 15.3 22.2 18.7 20.4 31.8 28.1 42.4 26.4 38.3 32.7 31.9 11.4 15.8 12.3 15.2 8.6 10.6 13.7 4.6 14.0 14.1 13.7 26.9 15.4 12.3 15.6 12.3 13.0 8.8 16.0 6.1 7.6 6.3 15.8 12.7 18.0 16.3 14.1 15.9 14.6 16.8 8.6 13.9 11.7 11.0 17.3 10.0 23.9 27.8 26.5 4.4 13.9 17.4 11.4 15.1 11.4 12.0 16.9 16.9 17.5 16.5 8.8 17.3 16.6 10.0 17.3 13.9 15.3 9.1 20.1 11.5 11.3 21.8 13.1 10.1 37.2 26.4 42.4 32.7 25.7 25.6 30.2 28.3 29.5 28.1 31.8 29.8 25.9 42.3 38.3 24.8 22.6 29.1 31.9 12.7 17.8 33.7 27.9 12.9 12.4 17.7 13.6 14.4 16.2 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Group enriched" "Detected in some" 28 "REH: 61.0;U-2 OS: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 1.3 0.5 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 1.1 61.0 1.0 0.0 0.4 0.2 1.1 0.8 0.0 0.6 0.1 0.7 0.1 0.0 0.0 70.0 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 PCM1 PTC4 ENSG00000078674 "Pericentriolar material 1" Q15154 8 17922840-18029944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023370, HPA023374, CAB058695" Enhanced Enhanced "Nuclear membrane,Centrosome,Cytosol" Centrosome "Nuclear membrane, Cytosol" "CAB058695: , HPA023370: AB_1855072, HPA023374: AB_1855073" "unprognostic (1.52e-2)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (3.35e-2)" "unprognostic (9.52e-2)" "unprognostic (1.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.74e-3)" "unprognostic (1.09e-1)" "unprognostic (2.26e-1)" "unprognostic (2.84e-1)" "unprognostic (2.83e-1)" "unprognostic (1.76e-2)" "unprognostic (2.16e-1)" "unprognostic (4.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.45e-1)" 19.6 19.0 26.2 26.7 40.4 25.1 25.1 29.2 29.0 25.0 21.1 21.6 22.8 12.4 23.3 27.3 16.4 26.4 17.8 23.0 22.9 18.4 18.8 22.0 19.1 21.1 24.5 24.9 29.1 27.0 42.0 35.8 19.8 26.4 20.2 16.3 16.2 19.4 25.3 63.1 17.6 18.3 26.7 27.2 20.8 17.9 80.0 28.0 40.2 28.2 19.1 20.4 27.0 22.6 11.5 14.9 19.9 7.5 11.2 13.0 4.3 20.3 21.7 33.4 44.2 18.9 19.7 17.3 17.2 21.2 18.4 20.8 14.7 12.2 26.7 11.9 17.1 14.8 21.3 15.8 31.4 8.8 8.2 45.8 15.4 29.8 21.1 20.0 11.8 17.1 16.9 21.3 23.7 21.1 30.9 20.8 22.4 10.2 42.9 33.2 27.5 6.3 25.9 29.9 9.5 15.2 28.3 25.6 19.3 18.4 10.1 26.4 15.9 29.3 18.8 16.8 13.7 20.5 14.5 8.9 19.6 23.9 14.2 22.1 17.1 19.9 6.0 14.4 11.5 3.8 12.0 11.1 10.4 13.0 5.9 11.5 11.6 11.6 6.4 11.2 7.5 14.9 10.3 4.3 26.2 40.4 29.2 29.0 22.9 18.4 24.5 24.9 26.4 28.0 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: " "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 22.0 24.1 13.1 18.2 17.1 9.0 41.1 24.3 21.7 22.8 24.4 11.7 33.2 14.8 29.0 24.5 21.6 21.5 22.1 26.1 13.5 12.6 21.5 16.7 29.2 21.0 18.4 11.4 33.3 53.8 57.9 34.2 19.2 15.6 22.8 14.8 15.0 39.8 38.8 45.7 18.0 18.7 38.5 18.9 24.3 19.6 10.4 16.9 27.8 33.6 23.6 15.5 28.4 28.6 16.5 15.4 32.4 12.1 22.3 15.2 10.6 6.5 4.2 14.5 2.5 21.4 20.0 8.2 8.6 15.4 3.7 5.9 1.9 15.1 6.3 12.2 11.6 16.2 2.5 10.1 6.5 8.0 4.9 7.2 7.5 4.4 28.3 2.6 7.4 19.9 19.5 4.6 12.7 17.4 5.5 20.6 5.8 2.7 15.1 6.6 5.6 1.9 4.7 2.8 8.0 15.0 13.0 9.5 8.1 6.1 8.0 8.7 7.9 4.0 14.3 3.3 4.4 5.0 3.1 12.6 9.4 2.2 9.9 6.2 4.0 19.6 9.6 22.9 10.2 12.1 12.4 16.2 13.0 12.1 9.7 16.5 15.2 13.4 32.4 22.3 12.1 15.4 13.8 10.6 13.1 17.1 24.3 21.7 13.5 12.6 18.4 11.4 15.6 16.9 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA057849: " "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favourable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 16.0 12.4 15.4 19.2 15.3 6.8 7.5 9.9 6.1 9.5 17.7 16.5 12.1 8.1 13.6 8.7 11.0 13.4 3.5 11.9 7.9 18.0 15.8 13.0 8.2 12.2 27.1 15.3 5.2 9.1 14.4 14.6 14.9 8.1 7.1 18.8 27.2 11.7 17.0 15.8 6.3 19.6 15.1 12.7 25.4 30.0 13.0 15.0 17.6 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.1 14.6 15.9 9.9 8.7 8.7 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574095-101594437 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 27.9 30.4 40.0 25.8 48.5 30.7 34.0 48.6 40.2 33.8 32.2 25.0 25.0 24.1 34.1 34.4 30.5 28.3 25.5 35.6 35.1 36.9 32.0 29.7 29.0 32.2 41.1 35.7 45.9 25.2 34.6 32.9 30.7 39.8 36.9 28.6 26.8 25.4 32.8 37.2 24.1 22.8 48.6 32.3 24.3 24.8 17.8 38.0 25.1 38.7 22.4 34.6 40.1 44.3 19.8 15.8 31.0 22.1 23.6 22.9 25.6 38.6 21.3 30.3 24.2 28.5 41.1 34.0 26.7 35.6 27.3 31.0 25.4 21.3 41.1 19.8 28.5 21.0 40.6 34.0 57.5 29.7 23.1 44.1 26.4 30.3 21.2 40.5 21.5 24.2 33.4 23.0 30.9 37.7 41.2 24.1 33.6 16.3 34.8 34.3 49.1 34.2 20.4 28.5 31.2 36.1 22.9 40.8 32.2 24.8 24.4 35.6 22.4 30.7 24.2 25.1 34.9 13.1 28.2 18.3 28.3 50.4 25.1 43.2 30.9 31.0 15.1 24.7 15.6 17.7 20.3 19.8 20.5 18.9 15.8 16.0 21.1 19.4 13.7 23.6 22.1 12.5 22.9 25.6 40.0 48.5 48.6 40.2 35.1 36.9 41.1 35.7 39.8 38.0 PCOLCE "PCPE, PCPE1" ENSG00000106333 "Procollagen C-endopeptidase enhancer" Q15113 7 100602177-100608175 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 83.4;BJ hTERT+: 62.1;HSkMC: 95.6;SH-SY5Y: 66.7;U-2197: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017623, HPA042927" Approved Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" 1300000000 "Golgi apparatus, Vesicles" "CAB017623: AB_2251882, HPA042927: " "unprognostic (4.14e-1)" "unprognostic (1.79e-1)" "unprognostic (1.34e-1)" "unprognostic (2.92e-1)" "unprognostic (1.70e-2)" "unprognostic (4.48e-2)" "unprognostic (1.33e-2)" "unprognostic (3.93e-2)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.16e-2)" "unprognostic (1.73e-1)" "unprognostic (6.13e-2)" "prognostic unfavourable (1.68e-5)" "unprognostic (1.04e-2)" "unprognostic (3.21e-2)" "unprognostic (1.63e-2)" "unprognostic (1.43e-2)" 29.5 16.7 0.6 18.1 1.3 0.0 29.3 1.0 2.0 90.4 11.2 1.6 22.8 2.0 42.1 89.9 23.1 29.6 34.3 47.3 0.7 0.7 14.6 73.0 24.5 51.1 3.7 1.9 38.8 7.9 1.2 11.4 23.8 2.9 49.4 4.5 54.6 16.0 19.8 10.0 16.0 7.4 26.1 6.9 10.5 9.1 20.8 0.5 2.4 17.8 20.1 18.4 28.2 34.0 0.8 1.0 1.6 1.0 1.1 1.1 0.1 0.0 0.0 0.1 0.2 29.5 83.4 0.2 34.2 62.1 15.5 13.6 1.2 0.0 0.0 0.0 36.1 0.0 0.0 0.0 1.3 0.2 0.2 0.0 0.5 1.7 8.2 0.0 0.2 95.6 0.0 8.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.2 6.8 0.3 0.0 0.1 0.0 0.0 0.0 0.1 66.7 0.0 0.1 0.1 0.1 0.0 0.2 38.5 10.7 117.7 0.0 0.0 0.0 0.0 13.4 0.0 6.4 0.0 0.3 1.6 0.5 1.0 1.1 0.8 0.9 0.6 1.0 0.2 0.6 0.3 0.4 1.1 0.8 0.0 0.4 0.1 0.6 1.3 1.0 2.0 0.7 0.7 3.7 1.9 2.9 0.5 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889203 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 55.6" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;RPMI-8226: 13.2;U-2197: 28.4;U-266/70: 28.2;U-266/84: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavourable (1.08e-4)" 35.2 1.2 1.0 2.0 0.5 5.5 29.0 0.3 0.7 12.4 3.6 0.5 9.1 0.0 3.9 6.0 16.8 2.1 3.8 55.6 1.4 1.2 7.3 7.9 6.9 1.6 0.6 0.7 2.5 0.6 0.1 13.8 20.1 0.4 14.2 2.1 2.5 2.7 3.9 6.3 2.7 1.5 41.6 0.8 1.2 2.0 1.9 0.3 0.0 3.5 6.2 0.9 28.2 30.6 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.5 4.2 1.4 0.0 25.4 7.0 0.0 0.3 0.1 1.1 1.5 0.2 0.5 0.0 1.2 1.9 0.0 5.0 0.0 1.4 0.0 8.4 0.8 2.8 0.0 0.0 0.5 0.0 2.8 0.0 2.6 0.6 0.0 0.2 0.0 0.5 0.7 1.5 0.4 2.1 8.8 0.0 3.2 13.2 1.2 0.0 2.7 1.7 6.6 0.0 2.4 0.0 1.7 0.0 2.2 5.1 28.4 2.1 28.2 13.0 0.0 6.3 0.7 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.5 0.3 0.7 1.4 1.2 0.6 0.7 0.4 0.3 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell line enhanced" "Detected in some" "HMC-1: 8.9;Karpas-707: 4.5;NB-4: 18.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in single" 19 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" "Nuclear speckles" Vesicles "HPA057428: " "prognostic favourable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favourable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.6 0.7 1.1 0.0 1.3 0.0 0.2 0.0 0.8 0.6 2.7 2.5 0.1 0.0 0.3 8.9 0.0 0.6 0.0 0.0 0.0 0.2 4.5 0.0 0.3 0.3 18.0 0.4 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.4 1.5 0.0 3.9 3.3 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867317-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 177.9;seminal vesicle: 234.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 56.4;SK-BR-3: 9.5;T-47d: 17.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 177.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favourable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favourable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 2.1 11.0 5.6 1.4 177.9 1.0 2.6 15.8 15.8 39.3 10.6 11.4 50.8 1.9 11.4 65.7 38.4 2.9 1.7 1.7 8.3 14.0 9.7 1.0 1.1 1.0 11.6 3.7 1.2 2.1 3.4 1.0 1.3 20.0 60.9 6.9 49.0 1.7 234.5 1.0 1.4 1.5 93.5 3.7 1.5 1.1 1.2 37.5 0.0 39.2 0.0 1.2 65.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.5 0.0 0.0 0.0 56.4 0.0 0.0 0.1 0.1 0.0 9.5 0.0 17.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 177.9 15.8 15.8 8.3 14.0 11.6 3.7 20.0 37.5 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Group enriched" "Detected in some" 6 "RT4: 15.7;T-47d: 10.3" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA052833: " "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favourable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 15.7 2.2 0.0 0.0 0.3 0.0 10.3 0.4 0.2 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55750979-55842830 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.4;liver: 53.2" "Cell line enhanced" "Detected in all" "HDLM-2: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 56.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022979 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA022979: " "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 8.2 5.6 4.9 8.2 8.2 5.1 8.4 3.1 5.3 6.2 11.9 3.0 29.8 9.3 5.2 15.8 6.6 4.9 10.1 12.1 5.1 4.7 17.0 53.2 11.6 7.8 6.2 4.9 5.2 7.5 4.2 5.3 19.4 5.5 7.5 12.7 5.3 7.1 32.1 10.8 4.1 9.8 8.3 5.0 10.0 12.5 8.0 3.9 3.0 5.7 5.8 5.2 8.1 9.9 2.0 12.1 56.4 15.3 6.2 2.7 6.5 8.6 7.9 6.0 2.2 8.1 7.9 15.5 3.4 4.5 5.4 5.3 8.9 11.2 2.4 26.5 5.3 4.8 3.5 5.7 4.9 38.3 8.0 21.4 2.4 16.7 7.2 8.1 17.0 6.5 7.6 3.2 5.9 10.5 15.3 8.6 5.9 7.5 6.4 6.6 6.5 7.1 3.3 8.7 1.9 5.7 6.4 3.0 6.8 1.7 3.7 14.3 10.0 14.1 7.6 6.2 4.4 6.9 4.4 24.6 7.7 1.5 5.7 13.5 10.7 15.1 15.3 56.4 2.5 12.6 1.5 2.0 1.6 2.5 12.1 1.4 0.9 2.2 15.9 6.2 13.2 0.9 2.7 6.5 4.9 8.2 3.1 5.3 5.1 4.7 6.2 4.9 5.5 3.9 PCYOX1L MGC3265 ENSG00000145882 "Prenylcysteine oxidase 1 like" Q8NBM8 5 149358007-149369653 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037463, HPA038402" Approved Approved Nucleoplasm,Mitochondria "Secreted - unknown location" 930000 "Nucleoplasm, Mitochondria" "HPA037463: AB_10673632, HPA038402: " "unprognostic (1.34e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (7.83e-2)" "unprognostic (5.73e-2)" "unprognostic (4.18e-3)" "unprognostic (7.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.25e-1)" "unprognostic (3.05e-3)" "unprognostic (8.77e-2)" "unprognostic (4.90e-2)" "unprognostic (2.86e-1)" "unprognostic (2.49e-1)" "unprognostic (2.26e-3)" "unprognostic (3.28e-1)" 4.8 6.6 4.5 7.2 13.5 6.9 4.0 15.9 19.0 6.5 4.4 8.2 2.7 2.3 6.2 2.7 4.6 7.9 5.8 5.2 4.6 8.9 3.7 1.2 4.2 9.6 5.5 9.9 7.9 6.7 27.0 6.4 6.2 13.7 6.4 2.1 9.4 3.4 6.6 1.6 6.6 5.6 6.0 4.6 6.3 5.8 11.5 2.4 5.8 3.3 3.1 7.4 5.0 4.7 1.8 13.5 3.9 9.6 4.5 7.2 4.5 2.1 1.4 2.9 6.2 2.4 1.5 2.1 5.0 1.0 2.5 5.3 0.4 3.5 9.7 15.4 1.6 4.3 3.2 7.1 0.3 4.7 4.7 4.4 0.0 0.3 6.9 2.9 4.1 6.3 1.2 5.0 4.3 7.9 2.6 19.1 0.2 3.4 2.6 4.2 2.7 9.2 5.2 2.3 25.6 1.0 0.6 5.9 7.7 10.0 3.6 7.8 9.4 5.5 4.6 2.8 3.0 7.2 2.0 11.2 15.2 5.5 6.1 17.7 7.3 3.0 7.1 3.9 3.0 9.6 4.0 1.8 5.7 2.3 13.5 1.2 6.8 4.7 1.2 4.5 9.1 1.3 7.2 4.5 4.5 13.5 15.9 19.0 4.6 8.9 5.5 9.9 13.7 2.4 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900965-81911464 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Cell line enhanced" "Detected in all" "Hep G2: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Supported "Intermediate filaments,Centrosome" 7000 Centrosome "Intermediate filaments" "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favourable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 13.6 5.5 13.3 5.7 12.7 5.3 10.4 12.2 17.0 6.5 16.2 13.4 6.4 30.7 5.8 8.6 7.6 12.2 8.0 17.7 14.0 11.8 21.7 46.5 7.2 6.3 13.4 16.0 7.8 11.5 8.2 4.6 6.0 15.9 10.1 8.5 5.8 10.8 6.6 13.5 4.5 26.5 5.0 14.3 4.1 11.5 70.8 11.0 5.6 6.7 6.8 5.8 7.5 4.4 7.3 6.6 2.1 3.5 4.7 8.4 4.0 12.1 7.0 5.6 15.8 28.2 14.9 8.3 8.7 18.8 12.3 14.6 27.4 12.7 4.2 4.8 9.1 10.0 8.5 16.2 7.1 1.2 6.9 9.2 9.6 62.6 30.2 9.2 7.7 12.2 9.4 11.1 8.6 11.3 17.0 8.8 9.1 10.3 10.9 11.4 4.5 7.5 7.2 6.0 15.0 14.7 23.0 7.2 6.6 6.6 36.4 8.5 10.1 21.9 7.6 9.1 6.0 6.8 7.2 5.7 2.4 4.1 9.4 12.4 8.9 2.1 3.5 1.2 7.1 3.4 4.6 6.0 8.4 7.2 6.6 7.3 7.0 7.2 1.0 4.7 3.0 6.5 5.0 4.0 13.3 12.7 12.2 17.0 14.0 11.8 13.4 16.0 15.9 11.0 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408829 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" 40000 Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: , HPA060836: " "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 26.7 25.7 25.5 25.0 23.9 23.0 22.4 23.4 28.5 22.8 25.9 18.3 21.6 21.1 25.8 21.6 32.2 20.5 23.4 30.2 23.4 20.4 25.2 31.8 20.5 20.2 23.2 23.5 23.4 28.2 23.3 18.0 28.8 24.2 23.0 22.0 19.0 27.8 26.4 103.5 24.8 19.6 26.9 22.2 20.5 22.6 19.7 24.3 20.1 22.4 37.2 25.2 24.1 28.2 11.3 15.8 24.2 11.9 20.4 14.2 4.6 30.7 26.9 18.2 23.2 14.1 14.7 11.8 25.6 14.8 20.7 17.5 27.2 15.4 13.6 22.7 24.1 16.7 21.9 25.6 20.2 19.3 24.3 13.7 26.0 23.6 20.7 25.7 13.6 15.4 19.3 22.7 37.3 20.6 32.3 24.8 20.2 64.2 35.7 35.1 23.3 29.2 16.5 18.2 23.5 20.9 23.7 18.7 37.4 19.1 30.5 13.0 13.4 13.5 18.6 27.9 30.9 33.0 39.9 23.9 27.3 30.1 22.4 23.1 29.1 7.6 9.4 8.6 12.4 11.9 11.1 11.3 11.5 8.9 7.4 11.1 8.3 10.3 24.2 20.4 10.6 15.8 14.2 4.6 25.5 23.9 23.4 28.5 23.4 20.4 23.2 23.5 24.2 24.3 PDCD11 "ALG-4, KIAA0185, RRP5" ENSG00000148843 "Programmed cell death 11" Q14690 10 103396648-103446292 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017924, CAB026472" Approved Supported Nucleoli,Vesicles Nucleoli Vesicles "CAB026472: , HPA017924: AB_10601045" "unprognostic (1.34e-1)" "unprognostic (6.84e-2)" "unprognostic (1.48e-1)" "unprognostic (2.31e-2)" "unprognostic (1.80e-1)" "unprognostic (8.94e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.16e-1)" "unprognostic (6.49e-2)" "unprognostic (3.25e-2)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (1.77e-1)" "unprognostic (6.28e-2)" "unprognostic (5.59e-2)" 11.3 11.8 11.6 13.9 12.5 9.6 13.8 12.6 12.0 11.0 10.4 10.6 8.9 8.5 17.3 10.6 17.3 14.3 9.9 10.3 10.5 7.0 11.0 14.0 11.3 14.7 9.9 8.6 16.5 17.2 17.7 14.4 10.9 10.5 12.1 12.0 9.2 11.3 13.0 42.8 22.3 11.1 13.6 9.5 14.7 10.8 22.8 12.4 20.7 10.9 13.8 17.0 11.2 16.8 5.6 5.4 1.4 4.4 3.4 9.1 3.5 10.1 15.1 10.5 29.6 9.2 8.3 11.8 11.2 7.9 11.3 9.3 20.5 10.0 28.0 8.0 8.0 18.2 27.0 14.1 12.8 12.9 18.2 16.3 9.6 16.4 11.0 32.4 11.2 8.6 13.0 17.4 39.8 12.1 26.1 12.6 10.9 11.5 16.2 18.5 21.6 14.6 16.4 15.1 12.7 7.1 10.0 7.1 13.3 7.5 8.9 12.4 8.8 9.2 13.1 8.4 10.6 11.2 20.9 16.1 22.4 26.6 7.4 31.4 6.2 0.1 4.4 1.4 5.7 4.3 9.1 5.6 5.4 4.6 4.7 4.1 4.8 5.6 0.6 3.4 3.6 5.4 3.8 3.5 11.6 12.5 12.6 12.0 10.5 7.0 9.9 8.6 10.5 12.4 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: " "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavourable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 22.8 24.2 18.1 25.4 16.7 20.0 73.3 14.2 20.2 19.6 25.6 12.0 26.6 21.6 23.1 28.5 29.8 23.3 28.3 32.0 17.0 15.6 28.5 33.4 27.5 52.9 16.5 12.8 24.3 53.4 19.9 16.4 21.2 15.4 21.6 26.8 18.0 27.0 32.0 30.8 19.1 26.1 20.7 20.8 30.3 26.3 17.2 10.5 44.3 31.9 28.5 32.9 25.2 22.3 13.8 15.3 9.6 12.3 16.4 17.5 10.6 13.4 9.8 15.0 35.1 21.7 23.8 16.6 16.0 18.4 19.0 21.3 17.6 11.8 24.4 13.1 17.6 19.3 32.1 26.6 28.0 19.9 35.1 34.5 12.7 31.9 26.4 42.9 23.4 21.6 26.2 24.1 39.2 26.4 68.6 16.0 23.2 29.3 29.7 31.0 21.5 15.2 21.2 11.6 31.6 28.7 8.0 27.6 28.8 18.3 29.9 18.7 15.2 44.0 19.9 9.4 20.2 22.3 28.3 21.5 25.0 26.5 17.5 42.0 24.0 3.7 11.0 9.6 13.4 10.6 15.7 13.3 15.3 14.1 15.3 13.8 15.2 14.1 4.7 16.4 12.3 14.2 17.5 10.6 18.1 16.7 14.2 20.2 17.0 15.6 16.5 12.8 15.4 10.5 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581068-32587452 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol 31000 Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 34.1 40.6 42.1 32.3 35.9 18.9 28.9 28.7 33.0 21.2 31.7 16.4 27.0 31.4 22.9 24.8 33.8 21.4 23.1 63.7 33.0 34.2 37.0 52.0 20.6 25.9 32.9 31.9 25.8 47.6 14.7 38.8 29.5 31.0 23.2 27.6 14.7 27.3 24.5 107.4 23.9 27.1 32.1 26.4 26.8 28.0 52.4 23.5 15.2 25.4 42.7 26.6 30.6 31.8 34.6 29.1 11.2 44.8 24.2 49.8 26.9 69.1 86.1 20.8 22.3 35.1 54.2 26.8 51.0 32.9 41.5 35.8 69.7 26.6 37.7 74.6 24.9 18.5 28.7 38.9 31.8 67.9 46.1 56.9 37.8 41.6 41.8 72.5 22.9 34.4 37.1 28.1 46.2 27.6 51.7 41.4 34.9 44.3 32.4 37.7 22.7 29.2 31.9 31.9 45.6 31.8 18.0 43.8 24.9 48.5 47.2 35.2 20.6 42.5 42.6 37.3 41.7 40.2 82.3 40.2 56.9 65.5 44.3 66.5 32.9 6.9 23.1 11.2 26.7 34.9 33.9 34.6 42.9 33.0 28.5 25.5 30.4 29.3 3.2 24.2 44.8 29.1 49.8 26.9 42.1 35.9 28.7 33.0 33.0 34.2 32.9 31.9 31.0 23.5 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133836 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA049388: " "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavourable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 16.0 16.8 22.4 17.6 26.9 13.1 23.8 43.7 28.5 19.0 19.4 21.3 12.6 14.6 23.8 19.8 23.2 18.6 12.7 14.4 21.0 16.3 13.7 15.6 21.5 19.5 22.9 24.7 26.5 16.6 16.5 15.7 17.4 20.6 17.4 14.3 15.0 14.2 19.0 17.5 16.4 15.4 20.4 17.5 18.7 15.1 27.4 32.1 19.7 18.0 12.7 21.5 18.4 18.6 5.9 4.0 4.0 3.2 7.1 4.5 1.4 8.6 7.2 12.3 12.7 12.4 17.6 7.5 10.0 11.1 12.3 9.5 8.7 9.7 16.7 10.9 8.0 16.5 31.4 7.1 8.9 10.1 8.4 16.2 6.2 7.6 11.5 22.0 11.0 10.1 11.0 6.7 12.8 9.7 20.6 13.7 10.7 6.6 23.1 15.8 14.9 6.6 20.4 15.9 18.6 7.5 13.9 10.2 12.2 11.2 9.5 14.6 7.6 18.2 9.8 12.8 12.5 7.4 15.3 24.6 28.0 12.1 11.5 24.4 6.4 4.0 3.2 1.8 4.5 2.6 3.8 4.8 4.3 4.1 2.8 5.9 4.5 4.5 0.8 7.1 2.5 4.0 3.1 1.4 22.4 26.9 43.7 28.5 21.0 16.3 22.9 24.7 20.6 32.1 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828631 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favourable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 20.7 14.8 17.5 14.1 21.0 23.8 23.0 20.5 21.9 19.6 15.1 23.7 11.4 13.2 21.5 12.8 18.4 15.9 14.9 14.6 18.4 17.3 13.7 10.1 19.7 17.5 20.2 17.1 15.5 13.0 17.5 13.7 20.6 22.2 17.1 15.9 13.9 21.7 14.7 8.1 15.4 14.7 17.2 22.8 18.4 15.5 12.1 18.8 19.1 17.3 13.3 17.6 15.8 16.4 12.6 14.7 20.6 16.3 16.2 25.3 10.8 9.4 13.1 22.6 8.4 20.6 13.9 12.5 13.3 14.1 12.3 12.6 8.7 12.6 15.8 10.9 15.9 18.5 13.9 13.0 13.7 15.4 7.1 16.2 17.5 14.4 10.6 13.7 32.3 11.9 9.5 12.0 6.1 25.2 16.3 9.3 13.8 14.6 14.6 12.4 16.6 10.3 15.4 21.5 11.6 14.9 0.0 18.2 16.2 17.9 10.2 7.9 15.4 9.5 27.4 11.5 13.6 16.7 12.8 7.2 14.3 16.8 9.8 11.0 10.9 20.6 11.9 19.6 13.9 10.4 15.0 11.4 16.7 12.8 12.3 12.6 17.5 15.2 9.8 16.2 16.3 14.7 25.3 10.8 17.5 21.0 20.5 21.9 18.4 17.3 20.2 17.1 22.2 18.8 PDCL3 VIAF1 ENSG00000115539 "Phosducin like 3" Q9H2J4 2 100562690-100576735 "Predicted intracellular proteins" "Angiogenesis, Apoptosis" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018469, HPA027094" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018469: AB_1855116, HPA027094: AB_10601387" "unprognostic (1.34e-1)" "unprognostic (8.30e-2)" "unprognostic (2.20e-1)" "unprognostic (3.32e-2)" "unprognostic (5.07e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (6.07e-5)" "unprognostic (1.44e-1)" "unprognostic (5.46e-2)" "unprognostic (1.66e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.55e-5)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (8.22e-2)" "prognostic favourable (4.23e-4)" 12.9 15.9 14.7 16.4 16.2 12.0 18.0 10.7 16.5 12.7 18.8 14.3 15.3 10.5 20.1 23.5 22.5 14.9 13.1 17.6 14.6 15.8 20.9 12.2 13.5 14.0 24.4 15.9 15.4 10.4 10.8 11.4 17.1 17.4 19.6 17.9 10.2 12.0 15.4 35.7 22.0 12.1 49.6 18.3 14.5 13.3 14.0 14.5 13.4 13.0 18.8 19.6 29.9 16.8 26.5 33.4 22.2 43.6 25.6 31.4 23.3 13.2 18.5 19.5 16.9 6.3 8.8 21.8 16.5 10.2 29.8 18.6 23.2 8.2 21.3 25.1 19.3 11.1 24.1 15.9 23.7 34.2 20.8 22.5 10.0 27.2 16.7 23.8 24.1 9.8 29.1 26.4 16.9 18.3 18.7 14.5 22.1 22.5 23.8 36.5 25.6 27.3 23.3 20.9 14.9 18.3 30.7 18.4 16.1 12.9 17.7 18.1 13.9 16.5 14.3 18.8 19.9 14.5 22.6 8.8 16.3 22.4 11.6 27.8 14.7 18.6 19.3 22.2 19.4 34.9 22.1 26.5 29.7 21.5 33.4 20.8 31.0 23.8 2.1 25.6 43.6 18.4 31.4 23.3 14.7 16.2 10.7 16.5 14.6 15.8 24.4 15.9 17.4 14.5 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.2" "Cell line enhanced" "Detected in many" "AN3-CA: 23.9;HUVEC TERT2: 35.9;NTERA-2: 21.8;SK-MEL-30: 21.6;TIME: 20.0;U-266/84: 18.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 36.6" "Group enriched" "Detected in all" 5 "B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavourable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 14.9 2.9 21.5 28.4 29.0 48.2 15.0 12.7 31.9 6.4 6.6 39.2 0.7 3.9 6.7 2.1 3.9 3.5 8.1 16.1 20.7 18.8 3.7 8.7 10.0 15.9 36.3 14.2 2.0 1.7 1.7 3.4 13.1 32.2 18.3 8.6 6.6 15.9 10.3 28.2 6.2 8.5 9.5 37.4 18.5 4.2 3.2 36.9 2.3 5.5 5.5 14.7 16.1 3.9 16.1 2.6 36.6 2.8 4.4 13.3 3.7 0.0 6.8 13.5 23.9 0.7 0.7 0.0 4.4 5.2 4.2 5.5 0.0 0.0 2.0 0.1 8.2 0.0 0.1 0.0 4.1 5.8 0.0 0.1 1.9 0.0 0.5 4.8 0.0 1.4 0.2 2.1 0.1 35.9 0.0 1.3 1.8 0.1 0.0 2.8 21.8 0.3 0.9 2.4 1.3 3.3 0.0 0.1 10.4 0.0 1.1 21.6 0.1 1.7 20.0 3.3 0.8 1.8 0.7 0.6 18.8 7.3 3.4 5.0 1.4 2.7 2.8 8.4 4.4 2.4 8.4 15.4 8.3 6.2 2.4 16.1 9.4 6.5 36.6 4.4 2.1 2.6 13.3 3.7 21.5 29.0 12.7 24.6 20.7 18.8 36.3 14.2 32.2 36.9 PDE4D DPDE3 ENSG00000113448 "Phosphodiesterase 4D" Q08499 5 58969038-60522120 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell line enhanced" "Detected in many" "A549: 24.8;AN3-CA: 28.5;HeLa: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 28.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045895 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA045895: AB_10960275" "unprognostic (1.14e-1)" "unprognostic (8.73e-3)" "unprognostic (4.35e-2)" "unprognostic (7.87e-2)" "unprognostic (5.97e-2)" "unprognostic (2.03e-1)" "unprognostic (8.10e-4)" "unprognostic (1.17e-1)" "unprognostic (6.59e-2)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "prognostic favourable (4.00e-5)" "unprognostic (1.51e-1)" "unprognostic (8.20e-2)" "unprognostic (1.77e-2)" "unprognostic (2.56e-2)" 8.2 1.9 4.4 6.8 8.6 46.2 5.3 4.2 13.0 13.5 18.6 1.4 14.7 4.1 17.1 14.0 10.3 6.6 12.7 15.5 4.5 5.8 12.8 3.4 11.1 3.7 5.2 6.6 5.3 2.9 7.0 9.0 11.8 2.7 18.2 11.2 8.6 24.4 16.5 60.0 5.1 7.5 35.8 5.0 3.8 10.2 2.6 2.8 4.4 6.2 11.3 9.5 20.0 11.2 6.1 0.7 28.1 1.1 0.1 0.8 0.5 0.0 24.8 5.2 28.5 0.9 1.8 4.1 0.6 0.7 1.4 2.0 9.7 0.8 1.9 0.1 0.2 4.2 0.0 1.1 2.4 1.1 2.8 3.6 41.0 2.1 3.8 1.7 0.2 3.8 0.9 3.9 0.7 2.9 0.0 0.6 2.4 1.7 1.3 4.0 0.9 1.3 0.4 6.5 4.1 6.5 9.3 0.9 3.3 6.5 11.0 5.6 0.8 3.7 3.4 0.3 0.1 4.9 1.3 1.4 0.0 0.2 4.2 6.8 1.1 2.0 1.1 28.1 0.8 0.0 0.8 6.1 0.7 0.3 0.7 6.1 0.5 0.4 1.5 0.1 0.1 0.0 0.4 0.5 4.4 8.6 4.2 13.0 4.5 5.8 5.2 6.6 2.7 2.8 PDE5A ENSG00000138735 "Phosphodiesterase 5A" O76074 4 119494395-119628991 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;HHSteC: 35.0" "Cancer enhanced" "Detected in all" "thyroid cancer: 27.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004729, HPA012873" Approved Approved "Centriolar satellite,Cytosol" 3100000 Cytosol "Centriolar satellite" "HPA004729: AB_1079588, HPA012873: AB_1855124" "unprognostic (6.95e-2)" "prognostic favourable (5.20e-4)" "unprognostic (1.28e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (7.36e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.54e-1)" "unprognostic (2.16e-2)" "unprognostic (1.52e-2)" "unprognostic (8.98e-2)" "unprognostic (8.71e-3)" "prognostic unfavourable (1.17e-4)" 12.3 4.9 2.0 28.2 2.3 0.4 8.1 3.0 2.3 21.3 28.0 1.7 20.1 6.5 17.3 21.4 30.7 10.7 13.3 5.3 2.0 2.8 3.8 1.2 11.4 4.1 2.4 3.4 10.0 7.8 5.1 3.4 8.9 4.4 31.8 11.7 20.2 8.5 23.7 6.8 4.2 15.6 45.6 2.0 2.1 9.1 7.6 1.2 0.9 9.1 8.1 2.2 25.9 15.9 1.5 0.5 1.4 0.4 0.6 2.1 4.2 8.0 0.4 5.7 0.6 1.9 2.9 1.0 5.4 24.3 0.2 0.5 0.5 0.7 0.8 0.2 6.7 2.9 1.8 0.8 0.7 0.2 3.7 9.0 1.4 0.4 35.0 1.9 0.9 3.2 1.7 0.6 0.0 0.7 1.0 1.5 0.8 0.4 2.4 0.3 1.2 1.4 0.3 2.9 2.1 2.1 2.4 2.2 4.5 6.3 7.9 0.6 1.4 1.0 1.2 3.2 2.8 1.7 0.7 2.1 1.0 0.7 3.1 0.5 0.4 0.0 0.3 0.0 0.6 0.1 2.1 1.5 1.3 0.4 0.2 1.0 0.6 0.9 1.4 0.6 0.4 0.5 0.4 4.2 2.0 2.3 3.0 2.3 2.0 2.8 2.4 3.4 4.4 1.2 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.1;HeLa: 27.8;SK-BR-3: 7.4" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036911: , HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.3 1.3 0.3 1.2 0.0 0.5 1.1 12.1 0.2 0.1 1.3 0.2 0.5 0.2 0.1 0.9 0.1 0.0 0.2 0.2 1.0 0.7 27.8 0.3 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.1 0.8 1.4 0.7 0.0 0.3 3.7 1.0 1.6 7.4 0.8 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.1;EFO-21: 16.2;MCF7: 12.0;NB-4: 17.9;NTERA-2: 22.1;SCLC-21H: 12.3" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011380 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011380: AB_1855132" "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.1 1.9 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.7 9.7 0.0 16.2 0.0 0.0 1.4 5.2 0.0 0.0 5.5 0.0 0.0 3.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.0 0.8 17.9 22.1 0.0 0.0 0.0 0.6 11.0 4.4 12.3 7.3 2.7 0.0 0.2 0.1 9.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69328621-69330595 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA063409: " "unprognostic (4.28e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavourable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favourable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 6.6 7.9 4.8 7.8 4.5 5.3 4.8 3.1 6.9 3.6 7.6 3.8 3.3 7.1 5.3 5.6 8.4 4.4 6.5 3.8 4.6 3.3 14.9 30.2 3.7 7.0 3.0 5.2 5.0 14.2 8.2 3.9 4.9 4.4 5.3 4.1 4.3 12.8 4.6 10.4 6.0 5.2 3.4 2.3 5.0 8.3 3.7 2.0 10.2 7.3 9.2 6.2 3.7 4.0 10.3 3.2 2.5 2.8 1.7 6.9 1.5 8.9 6.0 1.2 2.9 1.8 1.3 10.6 7.5 2.0 5.4 4.7 14.9 6.4 16.6 10.0 2.6 12.9 3.7 4.0 2.2 4.0 30.8 8.4 5.7 21.3 3.7 11.7 6.7 2.8 7.1 4.8 2.3 3.1 20.2 1.9 2.9 11.5 9.1 12.3 7.7 11.1 21.6 1.9 15.4 4.3 5.6 10.3 8.2 13.0 2.2 6.3 12.8 3.8 4.6 4.6 8.8 5.4 8.7 15.7 10.4 19.6 3.1 8.7 6.0 0.0 2.8 2.5 1.2 1.6 3.1 4.3 3.9 3.9 3.0 10.3 6.9 2.5 0.0 1.7 1.5 3.2 3.0 1.5 4.8 4.5 3.1 6.9 4.6 3.3 3.0 5.2 4.4 2.0 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.1" "Cell line enriched" "Detected in many" 4 "WM-115: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005579 Approved Approved "Vesicles,Centriolar satellite" "Secreted to blood" 300000 "Vesicles, Centriolar satellite" "CAB005579: AB_2161916" "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.75e-4)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (8.67e-4)" 9.5 6.1 13.1 6.6 20.4 2.1 16.5 9.0 16.6 11.1 14.8 33.4 5.8 16.3 15.5 11.2 8.5 12.1 10.0 14.0 14.9 14.2 10.4 5.4 16.5 8.1 29.8 12.5 6.6 54.7 5.7 6.1 21.5 21.1 14.4 12.7 7.4 16.6 10.2 63.1 10.6 20.3 10.7 26.4 11.8 20.9 4.5 22.7 1.6 6.0 8.6 2.7 11.0 12.7 3.0 3.3 11.6 4.6 5.3 3.6 2.9 5.7 3.9 0.4 5.6 1.1 0.2 13.3 1.3 0.7 1.7 1.1 6.0 6.5 0.1 2.3 1.1 14.6 0.4 17.7 0.9 3.2 0.6 0.1 3.2 2.1 7.2 0.6 0.7 0.8 7.0 0.8 5.6 3.2 0.5 0.8 4.1 7.2 0.8 1.3 10.4 0.8 2.9 0.4 0.6 2.3 1.3 0.6 0.4 19.7 1.1 3.3 2.8 0.6 9.5 3.6 10.0 2.1 7.8 0.2 0.3 0.2 3.3 1.8 80.7 11.6 2.6 3.5 2.7 2.9 3.6 3.0 2.7 2.5 2.3 3.0 3.3 3.3 7.6 5.3 4.6 3.3 2.8 2.9 13.1 20.4 9.0 14.5 14.9 14.2 29.8 12.5 21.1 22.7 PDGFC "fallotein, SCDGF" ENSG00000145431 "Platelet derived growth factor C" Q9NRA1 4 156760454-156971394 "Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 18.4;fHDF/TERT166: 28.1;U-138 MG: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 11 "monocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009134 Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" "Plasma membrane, Cytosol" "HPA009134: AB_10601981" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (5.79e-2)" "unprognostic (3.67e-2)" "unprognostic (3.97e-1)" "unprognostic (3.41e-2)" "unprognostic (8.78e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" "prognostic favourable (1.35e-5)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "prognostic unfavourable (3.17e-4)" 11.5 9.1 3.2 6.5 3.4 0.7 7.9 1.3 3.5 21.8 6.1 1.9 8.4 2.2 21.3 9.4 6.1 9.0 12.7 3.6 2.4 2.0 9.7 10.3 6.9 4.3 2.2 3.8 10.4 9.8 28.0 2.2 4.9 1.9 17.7 2.4 5.5 26.6 9.3 6.5 4.1 5.4 11.9 2.0 4.1 5.6 4.3 1.7 2.2 10.4 4.4 1.5 8.3 4.7 0.0 0.2 0.0 2.1 0.0 0.0 0.7 1.0 1.6 18.4 12.1 3.4 6.7 0.4 9.6 10.2 5.8 7.8 1.0 4.3 0.0 1.7 28.1 1.1 5.1 6.3 8.0 0.0 2.3 11.2 1.7 1.0 9.0 1.7 0.1 6.9 3.2 14.7 10.6 2.8 0.0 0.0 14.3 0.0 0.0 0.0 0.2 0.7 0.0 3.8 0.0 11.0 0.4 0.0 0.0 0.0 0.0 0.1 1.4 0.5 12.4 20.0 0.2 5.0 7.8 0.0 0.0 0.0 7.6 0.0 0.7 0.0 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.7 3.2 3.4 1.3 3.5 2.4 2.0 2.2 3.8 1.9 1.7 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907186-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 48.2" "Group enriched" "Detected in some" 6 "ASC diff: 55.5;HHSteC: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6" "Group enriched" "Detected in many" 27 "granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 24000 "Golgi apparatus, Vesicles" "HPA046183: , HPA066271: " "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavourable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 26.1 48.2 1.1 10.1 1.5 0.1 21.2 0.6 1.8 13.8 5.6 1.1 15.0 1.5 9.8 10.2 2.7 5.3 20.6 13.9 0.9 1.9 4.3 1.8 2.3 3.5 0.8 1.6 33.4 32.8 5.0 14.4 8.5 6.4 8.5 4.0 16.7 6.0 16.2 9.8 5.1 2.2 4.0 2.1 2.3 8.6 5.4 0.0 1.1 11.5 4.4 4.6 13.5 10.0 0.4 0.0 7.1 0.0 12.6 13.6 2.9 0.0 2.9 1.5 0.0 55.5 1.6 0.0 0.3 0.3 0.2 0.3 0.0 0.5 2.7 0.5 2.7 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.6 0.1 16.9 0.0 0.0 5.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.8 0.0 2.6 0.0 0.0 3.7 0.0 5.3 1.2 0.0 0.7 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 7.1 13.6 0.0 1.1 0.4 1.5 5.8 0.0 0.0 0.1 5.1 0.2 12.6 0.0 0.0 0.1 2.9 1.1 1.5 0.6 1.8 0.9 1.9 0.8 1.6 6.4 0.0 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Cell line enhanced" "Detected in some" "ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: " "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favourable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 81.0 37.9 0.1 4.2 47.0 0.0 0.1 11.2 0.0 0.1 0.1 32.7 0.1 3.2 0.0 0.0 0.4 0.1 0.1 0.1 0.2 27.4 0.0 0.0 68.9 0.0 5.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.6 0.0 0.1 0.0 0.1 0.0 0.1 14.8 0.5 16.2 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113837-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 169.0;ASC TERT1: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 8 "monocytes: 4.1;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" 35000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavourable (8.11e-4)" 61.8 10.4 8.3 11.0 9.1 0.5 66.1 4.6 10.4 73.1 15.7 6.7 6.9 5.1 44.3 17.3 21.7 26.1 51.7 24.2 8.2 3.9 17.0 4.6 28.9 21.5 7.9 8.1 46.5 7.5 10.4 7.7 46.4 7.7 24.2 6.3 22.9 11.2 19.3 29.8 20.3 11.2 29.8 5.0 19.6 9.2 21.5 6.7 1.4 21.4 16.0 7.3 23.6 35.1 0.4 0.1 0.0 4.1 0.0 2.9 0.6 0.0 0.0 1.0 0.0 169.0 58.5 0.3 5.9 24.5 4.1 7.0 0.6 0.0 0.0 0.7 16.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.4 24.0 0.0 0.0 26.3 0.0 5.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.2 2.8 0.3 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 2.9 0.6 0.0 0.4 0.1 0.8 0.1 0.1 0.0 1.3 0.0 0.0 4.1 0.0 0.0 0.6 8.3 9.1 4.6 10.4 8.2 3.9 7.9 8.1 7.7 6.7 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Group enriched" "Detected in some" 5 "AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" "Nucleoli, Golgi apparatus" Nucleoplasm "HPA052801: " "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.4 0.2 48.4 1.5 0.6 3.1 0.9 39.2 1.8 7.8 0.2 0.0 0.0 0.2 0.6 0.0 2.6 0.2 0.9 0.0 2.9 0.0 1.4 1.0 3.7 0.0 0.0 21.4 0.0 2.2 0.0 3.2 0.0 0.6 0.2 3.1 0.0 0.1 2.4 0.6 0.0 0.0 0.1 0.2 2.8 0.1 0.3 0.3 0.3 0.8 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 beta subunit" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria 6500000 Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favourable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 21.8 34.3 22.5 19.5 28.4 8.6 17.1 15.1 26.2 18.0 21.6 18.4 19.2 16.2 17.2 18.2 22.8 15.0 16.5 64.2 24.1 20.8 38.7 41.8 13.9 18.2 23.7 23.3 11.0 17.2 26.0 20.0 21.6 26.4 19.5 23.9 16.1 17.6 22.1 92.2 14.3 17.3 24.5 22.8 23.2 21.4 21.8 17.5 20.9 16.1 33.8 20.6 17.9 14.4 37.0 50.1 33.6 39.8 43.4 38.6 38.3 19.0 26.7 27.7 20.8 28.2 34.7 33.2 24.1 30.2 35.6 36.7 48.1 18.5 40.7 13.6 30.4 11.1 33.7 22.1 27.3 23.5 24.7 36.3 50.4 36.3 28.5 29.4 20.4 30.2 20.4 28.7 16.9 30.6 18.7 18.4 38.6 18.2 27.8 31.0 38.1 30.3 13.3 21.6 39.2 56.2 26.1 19.2 21.2 22.3 32.1 23.9 47.5 31.6 22.4 19.1 25.4 20.0 27.2 25.7 36.5 28.7 29.3 35.0 18.0 16.4 35.4 33.6 31.5 39.8 33.2 37.0 31.2 30.0 50.1 33.3 35.1 31.4 7.0 43.4 35.9 33.7 38.6 38.3 22.5 28.4 15.1 26.2 24.1 20.8 23.7 23.3 26.4 17.5 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favourable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 23.9 13.8 5.5 10.2 12.0 13.5 17.0 13.9 19.3 18.7 30.8 8.4 12.5 11.2 14.4 17.7 26.7 14.3 19.2 11.2 22.4 11.8 25.2 35.4 22.0 22.2 13.9 12.3 17.8 10.5 14.4 13.9 25.2 11.6 15.1 15.5 13.7 13.7 11.3 14.3 12.1 24.7 10.9 28.8 24.0 14.6 10.6 15.0 22.7 23.3 25.5 13.7 9.6 14.4 16.2 14.7 18.8 11.1 21.9 15.5 11.2 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067062-123225227 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" 2900000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favourable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavourable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 11.6 17.1 2.6 11.2 3.1 6.3 9.3 1.0 4.0 10.0 11.0 2.4 10.9 5.6 12.2 17.1 6.7 9.1 22.2 7.2 2.5 1.2 11.0 66.0 14.4 7.1 2.2 1.8 11.4 18.3 5.2 12.1 29.1 1.9 14.3 10.8 12.7 10.8 7.6 8.1 6.1 8.2 9.5 2.3 8.6 17.6 18.0 2.5 3.2 18.2 5.5 7.9 7.8 6.9 3.2 12.8 0.3 9.0 0.5 2.4 2.3 8.1 5.0 6.3 7.6 28.9 26.2 33.6 15.5 26.0 8.7 24.0 16.0 7.5 0.0 20.3 24.0 4.3 2.7 9.4 9.2 0.2 3.1 3.6 1.5 19.1 12.0 8.9 0.5 22.5 14.2 5.9 12.4 29.4 4.5 21.3 5.9 9.9 2.4 10.5 4.6 5.2 2.3 4.5 22.5 7.3 4.8 6.8 4.1 7.5 8.5 13.3 7.4 11.0 16.3 2.2 7.1 10.5 4.2 6.3 1.6 3.6 7.2 7.1 7.5 0.0 9.0 0.3 1.4 2.2 2.4 3.2 1.0 0.9 5.4 0.8 0.6 0.6 0.2 0.5 0.4 12.8 0.0 2.3 2.6 3.1 1.0 4.0 2.5 1.2 2.2 1.8 1.9 2.5 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 53000000 "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavourable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (1.20e-4)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 26.9 32.7 16.7 25.0 29.9 19.9 28.7 11.3 16.8 33.4 26.1 13.9 53.7 20.4 30.4 76.1 27.1 25.5 22.4 32.7 14.2 13.9 42.1 118.4 30.4 36.3 17.8 12.7 26.5 141.6 24.9 23.3 39.5 19.0 22.6 30.1 14.6 53.4 45.0 15.7 16.1 28.4 26.5 14.3 35.1 30.9 12.4 19.5 18.1 97.9 20.1 29.7 21.9 30.6 45.2 61.0 52.0 46.2 51.5 52.2 59.7 33.9 36.9 52.9 82.9 68.1 58.9 94.0 82.7 76.8 43.4 58.5 52.3 67.1 55.2 58.2 80.8 27.9 39.7 69.2 46.7 43.2 31.3 44.7 28.9 84.9 73.7 45.8 33.6 42.5 53.2 42.0 75.8 97.8 38.4 119.1 42.8 40.2 17.6 47.5 44.1 29.2 42.3 53.9 99.9 61.8 41.1 33.9 67.9 32.6 47.8 46.4 16.9 77.7 48.0 40.8 52.1 36.7 47.8 112.4 69.3 35.8 55.1 57.6 57.0 52.0 44.4 20.5 47.5 46.2 52.2 45.2 37.7 44.7 48.6 33.1 18.4 31.0 8.1 51.5 33.9 61.0 37.7 59.7 16.7 29.9 11.3 16.8 14.2 13.9 17.8 12.7 19.0 19.5 PDK1 ENSG00000152256 "Pyruvate dehydrogenase kinase 1" Q15118 2 172555373-172608669 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 31.3;U-87 MG: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8" "Low region specificity" "Detected in all" "CAB017554, HPA027376, HPA059083" Approved Approved Nucleoli,Mitochondria 22000 "Nucleoli, Mitochondria" "CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: " "unprognostic (2.14e-1)" "prognostic unfavourable (7.30e-5)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "unprognostic (6.47e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (9.69e-3)" "unprognostic (6.44e-2)" "unprognostic (5.44e-3)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.10e-8)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" "unprognostic (2.56e-2)" "unprognostic (5.34e-2)" 9.9 16.2 6.8 11.0 10.5 13.4 16.7 7.1 15.6 7.3 15.3 3.3 2.9 15.5 5.4 8.0 11.2 4.4 5.8 27.6 6.9 5.2 6.8 14.2 6.1 21.4 7.2 5.2 19.5 7.2 3.4 7.5 7.9 7.2 6.5 13.1 7.6 14.1 7.6 9.6 24.7 8.4 5.2 10.7 14.2 12.5 11.0 6.7 10.3 5.1 5.0 20.8 18.0 9.8 5.9 2.3 16.0 2.2 1.4 15.8 6.2 14.1 0.6 3.7 9.1 1.5 2.3 5.2 12.5 10.1 6.3 13.4 3.6 3.0 13.5 6.9 3.8 6.2 2.5 7.8 20.1 2.7 5.0 16.4 3.3 4.2 2.7 8.1 6.1 2.9 2.8 4.3 7.3 3.3 3.4 9.3 8.3 1.4 5.1 10.2 8.9 3.9 5.4 6.0 21.7 3.2 4.6 6.9 7.9 3.2 3.8 4.7 2.4 3.4 3.8 10.0 3.2 5.2 3.3 31.3 18.1 11.1 32.0 5.9 2.0 12.2 2.2 16.0 2.5 1.5 3.0 4.7 4.2 2.8 2.3 5.9 15.8 9.6 8.5 1.4 1.9 0.4 8.0 6.2 6.8 10.5 7.1 15.6 6.9 5.2 7.2 5.2 7.2 6.7 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favourable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favourable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.4 11.3 10.1 11.9 9.0 1.2 7.1 10.5 10.6 10.3 0.9 7.1 8.2 11.9 19.8 3.1 7.5 2.8 10.5 16.5 10.4 7.3 9.2 6.9 6.4 0.0 8.0 18.9 11.0 6.9 0.5 9.2 2.9 8.2 6.0 8.3 6.1 0.0 2.4 9.1 9.2 25.2 11.1 5.8 5.5 7.5 11.4 10.0 3.2 4.7 18.5 7.3 4.7 12.5 10.3 8.5 5.1 16.2 15.3 4.4 18.3 2.6 8.0 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465221-24539837 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria Mitochondria Nucleoli "HPA046583: , HPA072492: " "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavourable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 9.6 5.6 5.7 9.8 17.3 16.3 12.8 3.3 23.6 8.0 14.7 5.5 5.6 13.6 7.3 15.7 9.5 13.2 7.0 16.9 12.5 6.8 13.7 11.1 11.2 13.4 6.2 13.7 11.0 7.3 12.8 14.1 7.7 14.9 8.3 10.1 9.9 19.3 5.2 3.9 14.2 15.6 8.6 6.1 17.9 12.7 23.1 4.8 12.5 6.2 4.1 14.9 10.3 9.2 4.5 7.2 36.4 10.9 7.1 11.0 6.7 9.0 4.6 3.9 6.5 0.1 0.0 4.1 2.7 2.4 3.7 6.5 0.4 11.0 9.1 1.8 0.7 2.0 11.3 6.9 9.9 7.8 5.4 4.9 5.3 2.6 1.3 4.1 4.8 0.7 3.0 0.9 0.9 5.5 0.9 13.9 0.5 16.9 7.8 5.4 7.0 5.4 4.0 7.0 13.4 3.2 17.6 2.5 3.2 14.7 6.0 4.5 8.2 1.6 0.1 2.6 3.8 4.8 3.2 8.9 6.8 11.0 7.1 6.4 5.3 9.4 8.9 21.3 7.6 10.9 11.0 4.5 6.2 6.2 7.2 4.1 4.9 5.7 36.4 7.1 10.4 2.3 5.1 6.7 5.7 17.3 3.3 23.6 12.5 6.8 6.2 13.7 14.9 4.8 PDLIM1 "CLIM1, CLP-36, CLP36, hCLIM1" ENSG00000107438 "PDZ and LIM domain 1" O00151 10 95237572-95291024 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 95.1;HHSteC: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9" "Group enriched" "Detected in many" 6 "B-cells: 49.1;granulocytes: 39.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017010, CAB072838, CAB072840" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" 210000000 "Actin filaments" "Plasma membrane, Cell Junctions" "CAB072838: , CAB072840: , HPA017010: AB_1855147" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.58e-2)" "prognostic favourable (1.14e-5)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (2.07e-1)" "unprognostic (8.99e-2)" "unprognostic (2.26e-1)" "unprognostic (2.82e-3)" "unprognostic (5.77e-2)" "unprognostic (6.56e-2)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.97e-1)" "unprognostic (4.21e-3)" "unprognostic (1.11e-1)" 60.9 6.4 2.9 32.3 3.7 2.7 69.9 3.6 3.7 30.6 78.8 3.0 24.3 27.8 30.0 35.6 48.3 28.0 38.4 107.5 3.0 2.4 19.8 49.0 78.8 91.6 6.3 2.2 23.3 20.5 11.7 6.7 53.0 16.5 34.7 34.7 12.8 34.5 27.4 150.1 26.4 96.3 27.2 8.6 52.9 28.3 14.3 3.6 23.4 76.9 54.9 41.9 65.0 38.9 49.1 6.8 39.1 0.5 1.7 3.2 9.2 33.9 21.9 1.5 0.0 8.1 5.5 35.3 10.4 32.4 27.1 44.5 46.2 52.7 0.0 2.9 28.1 95.1 11.1 60.2 27.5 0.0 17.2 33.8 6.5 74.9 92.7 0.0 1.7 15.8 31.7 13.8 50.0 48.4 7.3 8.6 6.4 6.0 0.1 0.5 3.1 17.7 28.5 1.2 11.9 13.9 32.3 6.1 2.5 11.2 10.3 0.1 8.4 14.9 42.6 10.6 2.5 0.0 0.0 4.1 0.0 11.1 11.6 0.0 5.0 0.0 0.5 39.1 2.8 0.1 0.0 49.1 0.5 3.2 6.8 44.9 0.1 2.0 1.7 1.7 0.3 0.7 0.4 9.2 2.9 3.7 3.6 3.7 3.0 2.4 6.3 2.2 16.5 3.6 PDLIM2 ENSG00000120913 "PDZ and LIM domain 2" Q96JY6 8 22578279-22598025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003880 Approved Supported "Actin filaments,Focal adhesion sites" "Actin filaments, Focal adhesion sites" "HPA003880: AB_1855149" "unprognostic (1.04e-1)" "unprognostic (3.53e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-3)" "unprognostic (9.33e-2)" "unprognostic (3.69e-2)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-3)" "unprognostic (1.52e-1)" "unprognostic (3.37e-1)" "prognostic unfavourable (1.37e-7)" "unprognostic (6.14e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-2)" "unprognostic (3.08e-3)" 10.4 7.0 5.4 10.9 5.9 6.0 10.4 16.2 7.9 19.8 27.6 8.4 7.7 17.8 11.1 11.0 41.1 9.0 19.9 10.1 6.3 5.0 20.9 16.4 26.5 17.2 6.9 7.1 13.1 15.6 2.2 5.7 42.3 10.8 11.2 3.2 11.3 12.4 10.0 53.5 48.8 32.2 16.2 10.1 81.6 5.6 8.5 5.0 7.5 5.5 23.4 21.0 12.7 23.2 9.6 12.4 49.3 20.2 8.7 16.4 10.2 22.6 14.0 9.5 16.6 18.7 32.1 10.7 35.8 26.8 25.8 26.1 16.0 3.8 9.3 10.1 32.3 11.6 5.3 24.4 5.0 0.0 3.6 2.9 9.1 11.5 23.8 3.2 22.7 34.2 3.0 12.6 3.5 14.1 0.8 6.1 17.4 11.9 4.1 3.8 7.8 1.4 3.3 1.8 1.0 4.5 4.6 2.9 7.1 7.5 20.5 32.4 7.2 6.6 17.5 28.1 29.0 33.5 16.4 0.1 0.2 3.0 28.9 13.0 20.6 22.7 15.5 49.3 16.4 20.2 14.6 8.4 12.4 16.1 12.4 9.6 8.6 12.2 32.9 8.7 19.4 8.0 12.8 10.2 5.4 5.9 16.2 7.9 6.3 5.0 6.9 7.1 10.8 5.0 PDLIM4 RIL ENSG00000131435 "PDZ and LIM domain 4" P50479 5 132257671-132273454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 27.5;HBEC3-KT: 32.1;HHSteC: 31.9;hTEC/SVTERT24-B: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011912 Uncertain Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA011912: AB_1856277" "unprognostic (1.36e-3)" "unprognostic (1.93e-1)" "unprognostic (1.62e-2)" "unprognostic (8.08e-3)" "unprognostic (4.70e-3)" "unprognostic (2.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.39e-1)" "unprognostic (1.34e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-2)" "unprognostic (4.20e-2)" "unprognostic (5.84e-3)" "unprognostic (1.13e-2)" "unprognostic (2.61e-1)" "unprognostic (3.57e-2)" "unprognostic (3.40e-3)" 11.5 5.0 7.1 12.8 13.1 0.6 30.4 2.4 5.9 11.5 32.9 7.4 8.9 5.0 33.4 28.7 27.9 16.2 19.1 21.8 12.2 6.9 6.9 0.6 3.4 8.2 6.5 3.8 15.0 4.8 4.6 10.1 19.8 35.9 17.3 3.7 9.6 19.8 21.9 3.8 21.2 8.7 44.8 23.4 2.8 13.4 6.9 3.8 3.5 4.8 25.2 10.6 22.6 13.8 0.0 0.0 0.0 0.0 1.3 0.0 0.3 13.3 0.0 2.9 0.0 4.0 11.3 1.0 3.9 1.8 3.8 1.2 0.0 1.2 0.1 2.7 19.9 27.5 0.0 32.1 1.8 0.0 1.4 0.0 0.0 0.6 31.9 0.0 0.0 14.3 2.3 35.3 13.2 21.9 5.6 0.0 17.0 0.0 0.0 0.1 1.0 8.2 0.6 19.8 0.0 8.6 0.0 0.0 12.1 8.7 0.0 0.0 0.0 1.4 13.9 14.0 15.4 14.7 21.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 7.1 13.1 2.4 5.9 12.2 6.9 6.5 3.8 35.9 3.8 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 129.6;skeletal muscle: 173.0" "Low cell line specificity" "Detected in all" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 51.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" 2200000 "Nucleoplasm, Plasma membrane, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 11.6 4.8 6.2 4.2 6.1 8.7 9.8 3.4 5.8 12.7 11.0 3.7 7.1 5.6 37.5 12.9 14.0 10.2 11.0 129.6 5.3 5.2 12.9 13.9 5.6 5.3 5.4 4.5 10.3 8.1 3.4 6.8 18.9 10.2 15.3 5.4 12.6 15.3 12.5 173.0 5.6 15.8 22.1 4.9 7.0 5.6 5.5 3.7 1.0 5.3 52.9 9.5 17.7 7.1 3.2 5.6 51.1 12.2 2.7 3.9 3.8 8.6 25.7 10.0 3.9 22.1 15.2 3.9 21.2 17.6 12.2 9.8 23.7 19.3 3.4 21.7 21.2 9.0 13.6 19.8 20.4 6.1 5.7 12.7 16.8 8.9 31.9 4.1 11.4 20.4 17.5 29.1 22.7 27.3 5.4 3.8 25.8 8.5 4.2 1.4 3.4 10.8 2.0 7.4 3.1 13.6 27.8 5.0 6.7 11.5 26.5 5.9 3.1 1.3 34.2 31.8 5.0 13.7 12.8 2.6 3.4 3.5 17.3 3.0 7.4 51.1 6.8 5.9 3.8 11.8 3.1 3.2 3.7 3.9 5.6 2.5 2.5 3.2 6.8 2.7 12.2 1.9 3.4 3.8 6.2 6.1 3.4 3.9 5.3 5.2 5.4 4.5 10.2 3.7 PDLIM7 ENIGMA ENSG00000196923 "PDZ and LIM domain 7" Q9NR12 5 177483394-177497606 "Predicted intracellular proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 80.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018794, HPA048815" Approved Enhanced "Actin filaments,Focal adhesion sites" 7600000 "Actin filaments, Focal adhesion sites" "HPA018794: AB_1855155, HPA048815: AB_2680530" "unprognostic (7.70e-3)" "unprognostic (3.75e-2)" "unprognostic (9.27e-3)" "prognostic unfavourable (5.45e-4)" "unprognostic (1.40e-1)" "unprognostic (3.48e-2)" "unprognostic (9.18e-3)" "prognostic unfavourable (4.07e-4)" "unprognostic (5.01e-2)" "unprognostic (3.10e-1)" "unprognostic (7.24e-2)" "unprognostic (1.88e-1)" "prognostic unfavourable (6.19e-10)" "unprognostic (6.72e-3)" "unprognostic (3.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.68e-2)" 12.4 5.6 3.7 21.1 9.3 12.5 8.3 0.5 5.9 54.6 76.0 3.2 42.6 9.0 85.0 35.8 33.9 35.5 52.3 11.1 3.8 5.0 8.3 2.4 11.6 8.9 3.5 5.8 28.2 3.1 2.1 10.3 11.5 5.6 42.0 7.6 17.6 9.1 61.7 159.6 5.3 16.5 129.5 3.1 12.7 27.0 11.7 2.4 3.7 5.4 24.9 6.5 67.8 19.6 1.8 4.8 80.6 8.4 0.4 1.4 3.9 24.8 4.9 23.7 18.7 6.4 11.8 24.1 47.6 26.0 27.1 19.5 9.6 22.5 4.5 49.2 29.1 12.0 3.9 32.3 6.3 6.2 5.7 14.6 16.3 9.0 17.6 7.8 49.3 25.7 5.4 21.7 10.4 16.2 10.8 3.2 19.6 19.2 1.4 17.2 16.4 21.4 29.0 21.2 2.8 18.1 5.1 3.6 7.8 18.6 3.5 9.1 5.1 7.0 58.3 32.7 35.5 12.4 43.4 0.8 0.9 5.3 15.5 8.4 7.4 27.2 8.4 20.5 0.9 3.9 1.1 1.8 0.6 1.4 4.8 1.0 0.6 0.7 80.6 0.4 4.9 0.3 1.2 3.9 3.7 9.3 0.5 5.9 3.8 5.0 3.5 5.8 5.6 2.4 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.2;TIME: 33.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavourable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favourable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 8.9 4.4 9.6 4.0 8.0 14.6 3.2 7.0 7.8 8.3 9.8 4.6 33.2 5.0 23.7 11.2 19.9 4.1 5.9 12.3 0.5 2.0 2.3 5.5 1.6 9.1 1.1 3.3 9.4 11.8 14.1 22.6 18.7 0.8 8.2 10.1 2.1 6.9 3.6 4.4 5.7 1.7 5.7 0.9 5.7 6.2 0.8 4.2 4.6 0.5 21.6 1.5 1.4 33.2 10.1 6.5 23.6 8.3 4.6 1.9 4.2 12.9 4.2 8.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 91.1" "Cell line enhanced" "Detected in all" "T-47d: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA047369: , HPA049121: , HPA051484: " "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favourable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 10.5 13.2 11.0 11.7 10.7 6.0 27.8 15.4 16.9 13.8 21.6 9.0 11.8 27.7 10.9 16.5 14.2 11.0 16.6 15.5 11.5 8.1 21.9 33.8 11.2 12.7 10.2 10.0 11.2 37.4 17.2 26.0 19.6 12.8 19.6 25.3 13.7 25.2 14.7 22.1 8.8 30.9 13.1 14.9 10.6 24.6 91.1 8.7 6.9 16.3 8.2 9.5 13.4 11.1 11.0 12.8 12.0 8.3 7.7 12.6 7.8 7.8 11.6 12.0 10.0 6.7 8.1 19.8 7.4 6.6 5.5 7.7 14.2 17.2 15.1 16.3 9.9 12.9 8.4 7.6 8.0 9.2 11.5 9.1 19.5 37.2 17.5 7.2 21.8 8.5 7.9 9.6 8.1 5.8 6.7 9.9 13.0 19.3 4.7 3.8 5.8 4.4 7.3 4.9 18.0 8.8 12.8 12.3 8.8 20.0 11.5 19.0 46.4 11.2 9.0 4.3 3.9 4.7 9.5 9.3 9.0 14.6 8.8 6.1 13.6 3.2 8.0 12.0 11.0 8.3 12.6 9.2 8.0 8.9 12.8 11.0 10.0 9.4 1.1 7.7 6.6 5.9 7.0 7.8 11.0 10.7 15.4 16.9 11.5 8.1 10.2 10.0 12.8 8.7 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639410-32110931 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell line enhanced" "Detected in some" "BEWO: 8.9;SiHa: 12.4;SK-BR-3: 11.5;T-47d: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane" "CAB020784: , HPA036503: , HPA036504: , HPA064387: , HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.3 1.3 7.8 1.0 28.8 0.3 5.6 3.6 18.1 2.9 1.9 5.1 2.4 0.8 3.0 7.4 6.1 2.8 1.2 19.6 6.6 4.8 9.5 0.4 10.0 0.5 5.4 8.8 16.7 1.5 0.8 2.6 11.9 11.5 2.0 1.1 4.3 2.3 2.5 2.6 11.1 1.1 2.9 3.2 0.5 2.0 6.2 6.1 0.3 1.3 0.7 2.0 1.1 2.9 0.4 0.7 0.7 0.6 0.2 1.0 0.0 0.1 0.0 3.4 0.1 0.0 0.0 8.9 0.0 0.0 0.6 0.6 0.0 0.0 0.0 5.0 0.0 4.7 1.8 1.0 0.0 0.0 0.4 0.0 2.7 0.0 0.0 0.0 2.7 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.8 0.0 0.0 0.0 3.9 0.1 0.1 0.8 12.4 11.5 0.0 6.0 0.0 0.0 0.0 2.4 0.0 0.5 0.0 0.0 2.9 0.0 0.0 1.2 0.4 0.5 0.4 0.5 0.1 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.7 0.2 0.6 0.7 0.0 0.0 7.8 28.8 3.6 18.1 6.6 4.8 5.4 8.8 11.5 6.1 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375467 "Predicted intracellular proteins" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.7" "Cell line enhanced" "Detected in all" "HEL: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: " "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavourable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 8.1 7.8 12.2 5.1 13.3 61.7 8.2 8.7 12.9 9.1 14.8 11.4 32.8 14.0 10.7 15.1 11.4 7.7 10.3 7.0 12.0 10.4 13.5 21.1 7.4 3.7 14.7 7.4 10.1 20.1 18.9 8.6 6.0 12.9 7.3 12.0 6.3 12.4 21.3 6.7 6.6 13.7 7.6 14.8 5.0 10.6 23.2 12.4 8.9 7.5 5.4 4.2 8.0 15.3 1.0 1.7 5.7 2.0 2.5 2.5 0.5 5.1 8.8 3.2 6.2 5.6 5.0 1.8 4.9 4.3 2.2 1.8 4.4 6.9 6.0 4.5 7.5 7.7 5.6 5.3 4.4 3.8 4.9 51.0 3.6 4.3 4.1 21.2 4.8 4.9 6.3 4.0 12.0 3.9 4.6 6.3 5.5 2.0 4.1 2.7 2.5 7.9 3.3 12.4 2.6 6.6 3.7 2.5 4.1 5.3 2.2 3.9 1.5 3.1 6.3 3.7 4.1 6.7 8.4 3.4 2.9 4.4 4.6 9.7 3.2 2.7 1.4 5.7 2.2 1.1 2.5 0.9 1.8 1.8 1.7 1.0 1.5 2.0 5.6 2.5 2.0 1.3 0.8 0.5 12.2 13.3 8.7 12.9 12.0 10.4 14.7 7.4 12.9 12.4 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 42.1;T-47d: 109.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favourable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.2 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.5 0.1 0.1 0.2 1.1 0.5 0.0 0.0 0.1 1.7 0.3 0.1 0.4 7.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.2 0.2 0.5 0.0 1.2 0.2 42.1 0.0 0.1 1.2 0.2 0.3 0.0 109.4 0.1 0.1 0.2 0.2 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Group enriched" "Detected in some" 6 "EFO-21: 30.8;RPTEC TERT1: 102.0" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavourable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.4 0.0 30.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 102.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Approved Nucleoplasm,Cytosol 240000 "Nucleoplasm, Cytosol" "HPA028356: AB_10602814, HPA070820: " "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.7 5.8 24.3 10.5 45.1 25.3 8.1 72.8 63.6 60.6 42.6 12.8 9.1 7.8 26.4 90.8 18.3 9.0 22.8 47.4 4.2 5.0 6.4 4.1 3.2 55.7 2.1 7.9 21.2 12.9 33.3 42.5 45.5 6.6 14.3 81.0 8.3 2.5 5.0 16.1 16.8 4.2 25.6 5.3 22.0 8.8 4.8 12.9 38.6 26.4 22.2 16.2 15.1 60.6 40.3 31.6 30.0 31.2 11.3 6.9 14.8 37.1 4.1 57.0 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavourable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.3 0.0 0.0 1.7 0.0 5.2 8.9 2.2 1.3 0.1 0.2 0.0 0.2 3.9 0.1 0.0 13.5 0.6 0.0 0.0 6.5 0.2 0.3 10.2 0.0 0.0 5.3 0.0 3.0 0.7 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 PEF1 PEF1A ENSG00000162517 "Penta-EF-hand domain containing 1" Q9UBV8 1 31629862-31644896 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061608 Approved Nucleoplasm,Vesicles,Cytosol 660000 "Nucleoplasm, Cytosol" Vesicles "HPA061608: " "unprognostic (2.92e-2)" "prognostic favourable (3.95e-4)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-1)" "unprognostic (8.40e-2)" "prognostic unfavourable (2.88e-4)" "unprognostic (5.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.79e-2)" "unprognostic (1.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.35e-1)" "unprognostic (8.85e-3)" "unprognostic (2.38e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-3)" 34.0 27.0 26.9 15.3 28.7 17.0 27.1 22.5 40.8 26.6 23.4 25.9 21.1 16.2 27.1 46.5 29.7 29.0 26.1 26.4 24.3 23.8 28.3 38.7 24.9 20.8 25.0 17.3 31.1 20.8 31.6 21.6 44.2 28.6 29.8 24.2 25.7 24.8 33.4 25.5 32.5 20.7 31.9 22.4 23.6 20.5 17.8 16.5 27.4 85.9 20.3 30.7 23.7 21.9 39.1 40.4 60.9 39.5 42.0 49.2 48.7 17.3 20.4 17.0 13.1 20.1 21.1 16.4 16.6 28.4 40.1 35.4 12.0 26.3 18.5 23.2 36.9 18.2 32.9 42.3 32.5 23.2 35.6 15.3 16.4 24.0 35.5 14.9 14.5 21.7 48.9 39.2 36.7 38.7 15.8 19.2 28.7 20.5 22.7 14.6 23.6 23.2 22.2 16.6 20.2 31.3 18.9 24.4 14.1 18.9 17.8 24.7 15.8 11.0 20.4 17.4 15.0 29.6 21.8 12.4 12.5 20.0 21.9 22.1 20.8 60.9 39.5 46.2 49.2 35.3 47.5 37.8 42.1 44.6 40.4 39.1 39.9 40.0 40.1 42.0 32.7 37.4 41.9 48.7 26.9 28.7 22.5 40.8 24.3 23.8 25.0 17.3 28.6 16.5 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Cell line enhanced" "Detected in many" "AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: , HPA051038: " "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.1 93.1 39.3 1.9 3.5 5.4 7.1 4.2 5.1 7.0 21.8 4.3 0.2 0.2 8.2 0.8 120.8 5.0 7.2 0.3 12.7 0.0 15.0 93.1 1.4 14.8 0.0 7.8 1.6 12.7 8.9 3.0 0.0 29.1 10.0 0.6 0.0 0.0 42.6 8.4 5.6 29.8 7.8 23.4 9.7 59.1 3.4 0.0 2.0 7.0 12.6 0.0 0.0 4.1 0.2 0.5 5.4 7.8 5.2 11.6 9.3 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;U-698: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavourable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.2 1.0 13.7 9.1 1.6 1.2 3.1 1.7 2.0 1.6 2.6 21.3 1.5 17.5 4.3 0.6 2.1 4.1 3.8 3.2 4.3 3.3 1.6 0.6 3.4 4.8 1.7 3.1 1.6 3.0 2.4 8.2 9.0 0.9 4.4 1.3 0.1 3.7 2.5 8.9 0.6 4.7 4.7 9.9 6.6 3.9 6.3 8.8 1.3 2.0 4.7 1.1 1.2 6.4 1.5 2.2 1.5 2.5 10.1 0.9 53.0 0.8 1.5 4.0 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favourable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.9 5.5 0.0 3.1 4.6 0.1 0.7 2.5 0.5 0.0 0.1 0.4 0.1 2.6 1.5 0.5 4.2 0.0 0.2 1.3 1.5 4.7 8.5 0.0 2.6 0.7 20.7 2.9 0.2 0.0 0.0 1.0 3.5 0.1 0.6 0.0 23.2 0.2 9.0 0.7 11.4 0.3 1.0 2.2 9.3 10.9 0.0 0.5 0.0 6.1 0.0 3.8 0.3 1.6 2.8 0.5 2.6 0.4 0.0 0.6 2.9 3.2 1.6 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: , HPA062281: " "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favourable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.3 6.5 5.3 4.1 8.5 3.3 4.2 4.9 6.4 4.7 4.0 9.5 3.5 3.8 4.9 5.4 8.2 3.5 6.2 1.9 7.5 3.0 1.0 5.4 2.8 5.4 0.8 7.5 3.1 7.0 4.8 1.7 0.9 1.8 6.1 2.0 9.4 3.1 2.4 3.3 6.7 10.7 3.9 4.0 2.6 4.9 6.4 3.5 2.5 7.1 16.7 8.3 4.2 2.7 4.2 6.4 18.1 4.1 5.6 3.2 2.0 8.7 2.5 3.4 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053966: , HPA056028: , HPA060760: " "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favourable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.0 12.3 19.8 13.8 22.0 10.5 10.9 22.9 28.0 12.6 11.8 25.5 8.4 12.9 14.3 9.8 17.4 17.3 11.4 18.2 19.9 18.8 9.6 10.6 11.2 17.2 20.2 18.6 21.0 18.9 18.2 17.0 12.4 18.3 13.8 8.6 13.8 16.5 14.7 38.2 17.2 11.6 12.2 18.7 13.6 12.4 21.3 18.1 17.0 14.5 12.3 13.3 11.2 10.6 3.8 3.5 5.8 3.4 3.8 4.5 1.9 15.7 34.6 13.7 21.6 10.7 7.9 30.8 11.4 8.0 15.9 17.0 33.7 11.7 38.0 17.6 9.0 24.3 25.5 17.9 9.0 19.6 36.4 16.9 17.4 27.1 13.8 13.6 22.8 9.7 11.1 19.6 16.5 11.8 20.3 16.7 8.7 21.6 25.6 16.1 22.5 11.6 27.1 12.1 18.7 11.1 12.0 13.8 18.4 19.7 14.5 14.7 17.5 9.2 11.8 12.3 17.4 18.6 22.0 9.0 15.4 15.8 13.9 14.1 15.8 0.9 2.4 5.8 3.1 3.1 3.1 2.6 3.0 2.4 2.4 3.8 3.3 4.5 1.4 3.8 3.4 3.5 2.0 1.9 19.8 22.0 22.9 28.0 19.9 18.8 20.2 18.6 18.3 18.1 PER1 "PER, RIGUI" ENSG00000179094 "Period circadian regulator 1" O15534 17 8140472-8156506 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.2;hTCEpi: 27.1;hTERT-HME1: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047947, HPA067064" Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA047947: , HPA067064: " "unprognostic (7.64e-2)" "prognostic favourable (3.89e-4)" "unprognostic (5.54e-2)" "unprognostic (1.20e-1)" "unprognostic (2.59e-1)" "unprognostic (9.44e-2)" "prognostic favourable (2.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.67e-2)" "unprognostic (6.21e-3)" "unprognostic (6.87e-2)" "unprognostic (4.68e-2)" "unprognostic (7.09e-3)" "prognostic unfavourable (1.94e-4)" "unprognostic (2.08e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-2)" 39.4 33.4 13.2 21.6 15.0 27.3 31.3 19.5 23.9 27.8 24.6 20.9 27.8 6.9 19.5 17.2 31.6 25.2 36.9 24.0 13.3 6.3 14.2 18.6 25.8 10.8 15.6 11.3 50.1 61.8 19.3 29.8 12.7 20.1 23.1 8.1 36.6 23.3 43.5 70.3 47.9 16.9 29.3 17.5 16.7 23.6 13.8 17.1 4.6 28.5 33.1 12.1 30.2 25.0 1.6 4.9 3.3 3.6 0.5 2.1 1.2 1.0 3.8 4.4 6.3 14.5 10.7 2.5 1.5 2.7 1.9 2.3 3.8 2.5 7.1 1.2 2.2 3.1 4.4 23.2 1.3 2.2 5.5 3.7 8.3 1.1 20.0 1.5 5.7 16.0 27.1 3.3 26.5 4.2 4.7 9.9 3.5 3.5 4.3 2.9 3.8 2.5 6.0 2.5 3.7 4.6 0.8 1.9 4.7 3.2 3.7 3.0 2.7 1.1 7.2 2.2 4.3 0.8 1.3 5.8 2.2 2.5 3.0 1.8 1.6 0.0 3.6 1.7 1.9 2.5 2.1 1.0 1.7 1.2 4.9 1.6 1.6 1.1 3.3 0.5 1.2 0.7 1.1 1.2 13.2 15.0 19.5 23.9 13.3 6.3 15.6 11.3 20.1 17.1 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavourable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 24.4 28.1 26.0 26.1 30.1 28.2 29.6 19.0 31.8 19.7 21.9 27.2 18.1 20.4 28.0 21.3 31.2 28.0 22.7 18.1 26.3 18.5 24.2 34.9 19.8 30.0 27.2 26.6 30.5 49.0 31.3 17.0 20.2 23.6 24.2 19.2 18.6 22.2 22.1 34.1 32.3 19.8 22.9 24.3 26.4 25.2 34.5 27.2 21.2 25.3 23.1 24.9 21.8 22.6 14.4 17.8 3.9 19.4 12.4 16.2 16.3 34.2 39.2 14.4 30.7 16.7 16.4 22.3 22.8 18.8 39.0 30.5 45.4 14.8 46.6 20.4 25.9 23.9 44.5 40.8 28.8 19.9 42.8 22.5 22.5 39.0 41.6 54.4 23.8 23.1 25.7 40.5 40.9 25.1 37.1 19.0 23.6 43.2 26.4 55.2 28.1 28.7 33.7 25.2 45.5 21.4 23.8 25.0 26.0 22.5 25.8 30.2 18.1 28.0 19.8 45.9 34.8 23.2 38.1 24.2 20.6 47.6 32.1 25.0 29.3 3.9 15.8 3.9 13.3 19.4 16.2 14.4 12.4 12.7 17.8 13.8 14.2 12.7 0.6 12.4 13.9 15.4 9.5 16.3 26.0 30.1 19.0 31.8 26.3 18.5 27.2 26.6 23.6 27.2 PET100 C19orf79 ENSG00000229833 "PET100 homolog" P0DJ07 19 7629737-7631956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 106.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA067288: " "unprognostic (7.02e-2)" "prognostic favourable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favourable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favourable (2.44e-4)" 18.7 27.8 24.9 21.3 23.3 42.3 22.9 16.1 27.8 13.2 21.9 9.7 29.3 22.2 13.4 27.4 18.0 11.0 24.0 47.3 31.6 18.3 24.7 36.8 14.9 20.5 19.8 25.3 11.9 24.7 11.0 20.7 18.0 21.0 16.4 16.4 14.7 29.9 30.1 41.1 14.8 18.8 12.9 21.3 18.2 25.6 14.4 12.4 16.4 17.5 29.9 17.5 10.2 13.6 52.6 86.9 106.6 82.2 33.8 60.1 72.1 18.1 16.3 30.0 17.9 14.6 10.5 11.0 15.5 8.9 10.7 10.5 14.6 12.3 12.1 27.4 11.7 16.2 13.5 14.1 8.9 27.6 27.3 17.3 34.5 23.2 7.3 29.4 16.6 11.9 9.2 7.2 7.6 15.1 12.4 46.9 11.2 19.7 31.6 46.3 19.4 35.7 20.0 17.0 28.1 21.5 22.1 16.7 20.0 20.6 18.6 16.7 13.5 39.1 16.4 8.5 10.4 16.9 23.1 42.2 32.9 22.0 15.5 22.8 10.0 106.6 82.2 89.2 41.9 63.7 39.0 52.6 48.6 43.8 49.8 51.0 45.4 47.7 77.2 33.8 56.1 86.9 60.1 72.1 24.9 23.3 16.1 27.8 31.6 18.3 19.8 25.3 21.0 12.4 PEX14 ENSG00000142655 "Peroxisomal biogenesis factor 14" O75381 1 10472288-10630758 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046104, HPA049231" Supported Supported "Nucleoli fibrillar center,Peroxisomes" Peroxisomes "Nucleoli fibrillar center" "HPA046104: , HPA049231: " "unprognostic (7.23e-3)" "unprognostic (7.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-2)" "unprognostic (3.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (5.32e-2)" "unprognostic (2.32e-1)" "unprognostic (5.85e-2)" "unprognostic (1.31e-1)" "unprognostic (3.05e-3)" "unprognostic (9.67e-3)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (3.75e-2)" 14.9 11.6 14.3 12.2 22.3 8.3 13.1 15.7 35.0 11.8 14.8 18.6 8.3 18.0 14.4 10.4 22.6 14.8 12.2 17.8 14.4 16.2 13.3 25.9 13.6 11.6 13.0 16.1 15.7 15.3 13.6 14.2 17.7 22.4 21.9 10.5 14.8 20.0 31.0 22.1 14.6 20.9 10.7 11.1 11.2 12.8 18.7 11.4 11.4 13.5 11.6 17.3 38.7 13.6 4.2 5.0 7.3 3.8 4.2 8.4 3.6 15.4 14.6 12.5 13.7 9.2 8.7 8.1 17.9 15.1 20.0 19.1 15.4 28.9 11.3 18.0 13.7 18.6 13.0 17.3 9.6 15.8 21.2 13.9 15.9 21.1 13.9 15.6 20.0 10.5 14.0 15.1 14.0 12.8 21.7 11.7 9.0 12.8 14.9 20.6 12.8 17.2 16.2 10.4 16.2 15.8 10.3 14.9 17.0 17.3 14.5 16.1 13.3 11.2 12.3 14.7 15.5 14.1 15.2 16.8 13.6 22.1 16.1 21.7 15.6 1.9 3.8 7.3 8.4 2.8 5.3 4.2 4.4 6.2 4.7 3.9 5.8 5.2 0.6 4.2 2.5 5.0 5.2 3.6 14.3 22.3 15.7 35.0 14.4 16.2 13.0 16.1 22.4 11.4 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Supported Nucleoplasm,Peroxisomes "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favourable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.4 3.6 7.6 16.0 12.7 12.5 9.6 13.0 10.6 18.0 22.0 23.4 9.4 25.4 15.5 13.9 12.3 10.5 18.4 22.3 14.7 12.9 17.9 7.3 15.0 11.7 28.9 7.3 15.2 12.6 17.3 13.0 9.9 15.2 11.7 17.2 10.2 14.6 11.7 4.9 13.0 11.2 17.2 10.9 22.1 6.3 11.8 4.2 17.3 15.0 11.5 7.5 9.6 9.0 12.9 11.1 22.0 15.4 8.4 10.6 25.4 16.9 20.0 10.1 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 PEX5 "PTS1R, PXR1" ENSG00000139197 "Peroxisomal biogenesis factor 5" P50542 12 7188685-7218574 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039259, HPA039260" Enhanced Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA039259: AB_10673419, HPA039260: AB_2676417" "unprognostic (7.44e-2)" "unprognostic (2.54e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-1)" "unprognostic (1.27e-1)" "unprognostic (4.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (5.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.63e-2)" "unprognostic (2.92e-1)" "unprognostic (5.70e-2)" "unprognostic (7.31e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (1.13e-1)" 24.8 20.7 24.5 13.4 27.3 7.8 16.9 23.4 28.8 14.4 12.2 20.8 13.2 12.3 15.1 12.6 13.7 17.3 20.2 15.6 25.5 22.2 22.5 27.0 14.4 17.6 28.3 21.0 25.2 26.7 22.0 26.5 10.6 17.4 13.3 12.5 13.1 16.5 15.4 41.4 17.3 12.4 16.6 26.3 9.7 11.4 31.4 15.1 22.3 15.7 13.5 19.4 12.3 18.4 4.5 9.2 4.6 7.3 5.2 7.8 4.2 6.6 13.5 5.8 15.2 13.8 9.1 11.5 6.8 8.7 8.4 8.5 16.9 10.4 67.5 3.5 8.1 9.0 10.7 9.5 8.2 10.1 10.0 6.3 8.8 11.6 7.3 8.9 6.2 11.4 15.7 6.0 16.7 6.8 12.3 2.5 6.5 8.6 22.4 8.5 18.6 7.1 10.6 12.3 9.8 6.3 9.5 5.2 11.1 9.4 20.8 8.6 4.9 5.3 6.3 8.6 14.8 6.9 7.7 4.2 4.8 24.0 8.4 9.4 5.6 0.1 3.3 4.6 6.5 2.9 7.8 4.5 4.8 5.7 5.3 3.7 6.5 5.8 2.9 5.2 7.3 9.2 1.9 4.2 24.5 27.3 23.4 28.8 25.5 22.2 28.3 21.0 17.4 15.1 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 17.7 8.5 4.3 16.1 16.1 15.5 4.5 3.1 4.9 2.6 5.4 5.4 5.2 7.2 4.4 7.4 16.8 15.0 16.2 2.7 14.0 7.9 2.4 12.0 3.1 10.9 2.4 5.0 19.3 18.8 10.6 2.9 12.9 12.6 7.4 5.6 2.0 6.3 8.0 5.3 7.5 13.6 7.6 2.9 6.5 5.2 13.6 5.9 2.9 11.6 16.3 22.7 10.9 7.2 8.2 1.6 4.0 7.1 11.1 9.8 9.9 2.8 12.6 6.5 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913937 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049202: " "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favourable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favourable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.5 17.8 8.1 7.0 8.9 4.0 13.5 7.0 10.7 8.7 8.5 7.9 14.0 6.1 5.5 18.9 9.1 8.9 17.0 14.5 7.2 6.7 16.3 10.0 9.2 4.7 8.9 9.5 6.1 43.6 15.5 10.2 6.7 6.9 11.7 9.2 13.6 15.4 18.9 11.7 12.0 6.6 7.5 9.6 4.7 14.5 19.4 5.4 5.9 11.5 7.5 6.8 6.9 7.0 4.6 5.4 4.3 5.3 2.9 6.9 1.8 4.7 4.6 4.6 6.5 6.0 8.9 2.5 6.6 8.3 7.1 7.5 5.7 5.6 1.7 12.6 7.1 6.1 3.3 12.3 8.8 4.9 8.0 6.4 4.6 0.8 14.4 8.0 3.7 8.5 13.0 5.1 10.2 5.3 11.9 5.1 9.7 11.3 3.5 9.9 4.7 7.9 4.7 4.7 4.9 15.4 6.4 8.7 12.6 6.1 8.7 8.5 5.7 10.1 4.0 4.6 2.2 7.2 5.1 7.2 4.7 0.0 3.7 7.3 5.6 0.2 3.0 4.3 2.6 2.5 2.0 4.6 3.4 4.2 5.3 2.9 6.9 4.1 0.5 2.9 5.3 5.4 6.4 1.8 8.1 8.9 7.0 10.7 7.2 6.7 8.9 9.5 6.9 5.4 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavourable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 38.5 18.1 32.4 18.6 21.2 21.8 31.3 52.8 26.3 40.7 45.3 38.6 24.7 26.0 53.4 28.1 14.4 23.4 51.9 47.9 27.5 23.6 23.1 18.6 24.9 24.9 47.5 18.1 23.2 27.6 34.5 36.4 44.6 20.7 17.1 34.1 17.2 32.3 32.6 21.4 27.2 22.8 46.1 19.1 45.4 17.7 18.3 19.4 39.6 34.8 30.2 23.7 28.1 57.3 28.7 28.5 16.9 47.2 16.6 42.7 67.5 29.0 31.4 33.3 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 PFDN5 "MM-1, PFD5" ENSG00000123349 "Prefoldin subunit 5" Q99471 12 53295291-53299450 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008587 Approved Supported "Intermediate filaments,Cytosol" 110000 "Intermediate filaments, Cytosol" "HPA008587: AB_1079597" "unprognostic (3.56e-3)" "unprognostic (2.31e-2)" "unprognostic (2.87e-2)" "unprognostic (4.02e-3)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.12e-1)" "prognostic favourable (5.45e-4)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.54e-6)" "unprognostic (5.34e-2)" "unprognostic (9.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-3)" 75.9 73.7 105.0 82.3 85.4 119.3 142.4 53.8 66.7 97.0 77.1 56.3 102.5 39.7 94.3 156.8 80.3 94.6 91.0 77.0 82.7 76.7 81.8 83.5 64.9 117.2 94.3 69.2 134.5 155.8 49.6 81.2 67.3 63.3 96.1 65.4 60.1 116.4 99.9 87.0 71.6 54.1 108.1 91.0 83.8 64.7 60.5 64.9 60.5 128.1 108.9 101.1 91.8 144.9 163.9 98.0 63.7 127.8 69.4 158.4 329.0 35.4 54.7 53.0 47.7 102.9 143.2 38.7 88.9 121.1 82.9 56.1 50.0 54.7 48.0 53.7 95.5 32.6 46.1 63.7 80.3 45.4 64.5 43.7 67.7 68.6 66.2 71.0 47.8 136.5 93.6 58.5 45.8 73.6 51.0 64.8 82.2 125.4 49.7 106.0 50.0 84.6 40.6 57.5 56.8 94.5 52.5 44.9 51.2 57.1 50.5 64.5 65.6 90.8 64.4 46.9 35.8 22.1 39.7 48.6 51.8 70.6 51.4 56.9 42.8 63.7 127.8 46.5 80.9 97.0 110.9 163.9 123.2 97.6 98.0 156.8 158.4 125.9 38.3 69.4 100.2 91.0 95.8 329.0 105.0 85.4 53.8 66.7 82.7 76.7 94.3 69.2 63.3 64.9 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus" 110000 "Nucleoplasm, Golgi apparatus" "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favourable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavourable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 12.5 19.1 29.2 15.4 27.8 15.0 15.6 13.2 33.9 12.0 17.7 12.9 13.1 13.8 14.4 22.4 15.1 12.5 11.4 16.2 31.6 24.8 19.1 23.2 10.8 15.7 27.0 31.9 14.5 21.3 15.3 14.6 14.0 20.7 12.5 16.2 8.2 15.8 16.0 43.6 10.8 13.7 13.4 20.7 11.3 12.2 33.1 17.5 10.7 12.2 22.5 18.9 11.8 9.8 6.8 5.0 3.4 7.1 3.9 7.5 4.3 14.8 9.9 6.9 14.2 7.7 6.6 11.3 11.4 5.8 10.0 9.5 9.3 7.3 21.9 13.9 6.4 10.9 11.3 13.1 15.1 14.7 12.0 19.6 11.0 15.5 8.7 15.0 12.8 5.9 15.1 14.1 10.1 9.8 23.8 9.4 10.7 10.1 17.9 15.8 11.6 8.7 15.5 10.1 22.1 16.2 7.1 16.0 19.4 9.9 26.0 16.5 14.9 21.6 8.2 7.1 10.6 8.8 18.8 19.0 51.8 24.4 6.9 19.9 10.1 3.2 5.1 3.4 4.1 6.5 4.2 5.9 5.6 7.5 4.9 6.8 3.3 4.6 2.7 3.9 7.1 5.0 5.3 4.3 29.2 27.8 13.2 33.9 31.6 24.8 27.0 31.9 20.7 17.5 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: , HPA060173: " 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 4.2 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "SK-BR-3: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favourable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favourable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 1.4 3.8 3.1 2.9 3.3 3.4 3.2 1.7 4.1 2.7 2.5 2.2 9.6 1.6 8.1 3.3 5.0 1.0 1.1 1.3 3.4 3.1 2.0 2.2 3.6 4.5 5.0 5.2 6.3 6.2 1.3 2.8 0.9 1.9 3.8 2.4 3.4 1.0 4.5 3.1 0.8 1.2 1.9 4.6 4.4 4.8 2.9 1.9 4.7 54.7 2.7 4.6 4.9 1.3 2.9 3.1 1.4 1.3 3.4 0.7 0.5 3.3 1.9 3.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 PGBD1 "dJ874C20.4, HUCEP-4, SCAND4" ENSG00000137338 "PiggyBac transposable element derived 1" Q96JS3 6 28281572-28302549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5;plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007267 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007267: AB_1079601" "unprognostic (2.26e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-1)" "unprognostic (1.96e-3)" "unprognostic (1.28e-2)" "unprognostic (8.81e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.71e-4)" "unprognostic (5.38e-3)" "prognostic favourable (6.79e-4)" "unprognostic (7.32e-3)" "prognostic unfavourable (4.97e-4)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (5.23e-2)" "unprognostic (2.68e-1)" 6.1 4.5 7.4 3.8 7.2 2.8 8.5 9.6 12.8 6.1 7.4 4.0 1.3 3.0 9.2 6.0 4.5 4.3 4.0 7.0 7.1 6.3 5.9 5.1 5.4 3.1 7.0 7.7 6.0 4.0 6.6 8.6 4.3 5.1 6.0 4.6 4.4 3.8 7.4 4.1 3.0 4.0 11.7 7.0 4.9 4.8 5.2 3.6 8.9 4.0 3.1 3.4 5.2 3.8 1.0 4.4 3.5 0.2 1.2 1.2 0.3 5.1 2.8 9.1 12.9 7.3 5.3 3.0 6.8 4.6 8.6 9.8 3.2 2.2 3.4 4.3 4.6 2.3 9.9 5.5 11.2 3.7 5.7 6.2 5.7 4.0 3.5 7.7 0.8 4.3 2.6 8.4 2.9 10.5 8.0 0.4 9.5 1.5 6.5 9.7 3.4 5.7 11.2 11.6 0.0 4.2 2.8 6.3 12.0 4.6 0.8 5.1 2.5 4.8 7.4 12.9 8.6 0.9 10.6 3.3 3.3 4.4 2.9 4.5 6.0 3.5 0.1 0.0 0.6 0.2 0.3 0.5 0.2 1.2 0.7 1.0 0.1 0.5 0.0 1.2 0.1 4.4 0.5 0.3 7.4 7.2 9.6 12.8 7.1 6.3 7.0 7.7 5.1 3.6 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: " "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.6 3.1 3.0 2.0 2.5 2.5 2.7 4.2 2.6 2.4 5.6 1.5 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 2.2 4.6 5.0 4.1 1.4 3.8 5.5 1.0 2.7 5.6 3.5 2.1 2.6 4.3 3.7 3.4 1.6 3.6 1.1 3.5 3.6 2.6 6.1 3.5 3.2 2.1 5.9 3.8 2.3 5.4 5.3 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 115.1;esophagus: 123.8" "Cell line enhanced" "Detected in all" "A549: 177.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4" "Group enriched" "Detected in all" 5 "granulocytes: 115.1;monocytes: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" 59000000 "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 29.8 12.7 10.9 14.2 11.8 85.5 23.7 8.0 19.1 16.0 14.1 13.8 8.1 22.9 6.3 12.5 123.8 8.4 24.9 14.3 10.3 12.1 15.4 23.2 25.6 34.9 12.4 11.4 14.3 8.3 16.2 10.8 17.0 19.3 7.9 12.9 19.7 31.8 6.8 8.5 10.6 25.3 9.5 12.6 27.6 13.4 27.0 7.4 16.8 21.2 68.8 49.9 14.8 26.1 3.9 15.9 115.1 32.0 2.0 3.0 19.0 22.6 177.4 44.2 47.5 67.3 41.7 9.6 15.3 27.2 21.2 29.1 26.0 26.1 22.2 18.9 15.7 19.2 32.3 27.5 14.3 15.3 28.2 30.0 31.9 54.6 20.5 49.6 33.4 29.7 13.8 33.5 8.3 50.1 40.1 19.7 27.2 25.7 40.9 24.8 26.6 15.6 31.8 40.6 40.9 29.7 12.2 23.8 20.8 13.1 20.8 18.1 22.9 42.6 46.9 11.2 20.0 13.3 16.9 14.9 27.3 39.9 24.5 53.9 10.1 98.6 32.0 115.1 2.6 15.3 3.0 3.9 2.5 2.4 15.9 2.3 2.4 2.6 38.4 2.0 10.9 11.4 2.4 19.0 10.9 11.8 8.0 19.1 10.3 12.1 12.4 11.4 19.3 7.4 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in some" 6 "BEWO: 91.3;HUVEC TERT2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" 12380 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavourable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.2 0.4 0.0 91.3 0.8 0.8 0.4 0.5 2.1 0.1 0.0 2.0 0.6 0.1 0.4 4.1 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.0 1.0 1.6 0.4 43.0 0.0 0.0 12.1 0.1 0.0 0.1 0.4 0.7 0.0 11.3 0.0 0.1 0.2 6.9 3.7 0.0 0.1 1.6 0.0 0.1 8.7 0.0 2.3 0.0 3.6 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262872 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 10.5 12.4 7.3 13.3 10.1 10.9 13.9 8.8 22.1 10.8 13.8 7.7 7.9 12.3 9.2 4.6 14.9 7.3 7.0 13.5 9.5 5.9 8.2 13.7 22.2 22.2 10.2 10.0 9.6 10.1 12.0 13.4 7.8 8.2 8.4 15.1 5.7 10.6 8.4 10.2 9.9 10.4 9.5 6.9 10.4 11.0 5.1 10.5 10.2 8.8 9.9 10.1 9.6 10.5 8.0 11.5 21.8 16.7 6.7 6.3 6.4 10.1 11.1 12.6 16.3 7.4 6.2 6.2 12.6 7.4 10.5 10.8 12.0 10.9 20.7 17.1 8.8 8.0 16.6 16.5 15.8 22.8 9.2 11.9 14.4 9.6 9.9 16.3 17.6 9.3 10.2 10.3 10.8 10.5 9.6 8.9 12.0 15.8 14.3 5.4 9.4 8.6 15.7 16.9 20.9 11.0 19.2 12.4 9.4 14.9 11.4 12.0 15.3 12.2 12.0 10.8 10.2 7.4 14.6 14.8 16.5 10.9 7.8 17.0 14.9 8.3 12.8 21.8 5.0 16.6 5.6 6.8 5.7 6.3 11.5 8.0 5.4 5.0 13.1 6.7 16.7 10.3 4.9 6.4 7.3 10.1 8.8 22.1 9.5 5.9 10.2 10.0 8.2 10.5 PGLS 6PGL ENSG00000130313 6-phosphogluconolactonase O95336 19 17511629-17521288 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040744, HPA042032" Approved Supported Nucleoplasm,Cytosol 10000000 Nucleoplasm Cytosol "HPA040744: AB_2677111, HPA042032: AB_2677809" "unprognostic (3.68e-2)" "unprognostic (8.98e-3)" "unprognostic (1.25e-1)" "unprognostic (9.64e-3)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (2.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.30e-1)" "unprognostic (4.75e-3)" "unprognostic (2.39e-1)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (9.26e-3)" 27.3 31.5 15.6 23.6 13.9 29.3 33.7 9.0 20.1 23.8 29.5 16.0 17.9 21.9 16.6 18.7 38.0 25.9 27.8 18.5 13.9 11.6 25.9 42.7 27.5 60.0 14.3 11.8 32.0 42.1 19.1 16.4 26.5 10.9 23.5 13.5 16.8 31.5 20.7 10.9 27.2 30.8 13.3 16.8 31.4 20.8 15.8 12.2 46.6 26.7 19.2 27.6 18.5 21.6 17.6 46.4 45.8 44.5 17.4 14.9 22.4 18.6 16.8 10.6 7.2 16.2 27.0 20.3 12.8 20.9 12.9 16.6 8.0 28.3 20.7 14.4 20.0 12.9 5.9 20.0 3.9 10.3 23.2 9.7 7.8 14.3 27.9 10.3 10.8 31.7 27.7 7.7 23.2 17.3 11.0 5.1 15.8 20.5 22.6 29.0 14.1 70.6 15.3 6.8 13.1 17.4 15.1 13.5 16.2 8.2 9.1 18.0 13.2 18.7 16.2 13.4 3.7 26.7 7.2 9.0 6.3 8.8 19.1 26.5 13.1 15.2 40.8 45.8 14.9 44.5 12.1 16.4 13.2 13.2 46.4 17.6 12.5 12.6 39.6 17.4 41.5 34.4 14.0 22.4 15.6 13.9 9.0 20.1 13.9 11.6 14.3 11.8 10.9 12.2 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348840 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5" "Cell line enhanced" "Detected in some" "HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3" "Group enriched" "Detected in some" 9 "cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB025879 Supported "Vesicles,Plasma membrane" "Secreted in other tissues" "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.0 0.1 2.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.2 0.2 0.0 1.5 0.0 0.1 19.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 13.7 6.5 0.0 8.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 5.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol 73000 "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavourable (8.78e-4)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favourable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 15.5 16.7 11.2 10.4 13.7 4.8 12.3 19.1 13.3 15.4 10.1 9.0 30.7 8.9 10.6 26.2 10.3 8.8 14.2 12.2 11.0 8.6 12.2 44.9 13.4 6.3 13.5 9.9 15.5 36.3 9.3 36.2 27.6 18.1 30.9 13.7 7.4 29.2 23.4 5.5 7.5 11.6 11.1 9.7 8.1 14.4 16.8 11.3 4.0 14.9 7.6 8.7 11.1 10.0 8.2 7.4 11.1 6.5 5.3 8.7 3.9 10.0 6.6 12.9 15.4 21.0 22.4 14.9 34.3 24.9 16.6 26.2 17.2 4.7 5.3 7.3 34.2 6.4 11.7 14.4 31.9 3.9 11.4 6.8 13.1 28.8 23.8 6.6 3.4 14.2 11.9 29.3 37.1 19.5 22.1 5.8 17.9 10.4 1.1 4.4 5.7 9.1 4.7 28.8 3.1 12.9 9.9 5.1 8.0 9.9 8.8 6.8 7.7 7.4 28.5 11.5 6.3 23.0 18.4 11.3 4.4 3.8 9.0 5.3 17.9 11.1 6.4 3.8 5.0 6.0 6.7 8.2 5.2 6.2 5.5 5.0 8.7 8.2 2.7 5.3 6.5 7.4 3.6 3.9 11.2 13.7 19.1 13.3 11.0 8.6 13.5 9.9 18.1 11.3 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Enhanced "Nucleoli,Endoplasmic reticulum" 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 26.8 17.0 33.4 38.4 72.2 34.7 21.7 40.6 47.3 21.6 26.9 20.5 33.0 7.7 44.5 42.1 21.5 36.4 17.0 29.1 8.2 41.8 8.7 16.3 23.0 12.0 14.3 4.7 35.7 9.6 26.2 13.6 13.9 9.2 4.8 25.3 28.7 10.7 10.5 87.5 28.7 12.8 20.9 11.2 28.5 20.5 31.2 13.9 29.7 49.4 15.9 11.4 9.2 10.7 15.1 22.2 53.2 38.2 5.1 9.3 8.4 41.1 22.8 28.6 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" 64000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favourable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favourable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 47.9 29.5 18.3 13.3 20.4 12.8 38.3 17.7 19.3 27.3 46.6 14.8 42.5 46.8 26.1 20.2 32.8 21.1 31.2 27.2 18.4 18.4 36.5 64.7 22.4 13.6 17.4 18.5 24.1 41.6 25.6 34.4 95.6 18.0 29.4 24.8 22.0 29.8 33.4 17.9 46.0 69.1 29.5 16.3 16.7 35.1 19.3 19.2 15.3 33.1 15.7 16.2 35.1 33.8 3.2 6.0 4.7 2.5 2.6 4.8 1.4 23.5 8.7 16.0 12.9 69.6 36.7 16.1 32.3 36.1 24.0 32.1 9.0 24.3 16.6 37.9 41.5 13.7 14.6 16.0 30.2 9.5 8.4 11.1 22.9 17.0 88.1 16.1 8.3 28.8 32.4 20.1 24.9 21.5 18.5 21.0 34.4 7.3 14.8 7.5 12.6 7.8 11.9 12.8 11.4 35.4 8.3 12.7 12.0 18.1 20.5 18.3 15.8 7.3 39.8 20.3 16.6 20.7 14.9 24.3 19.7 17.8 22.2 14.4 13.8 4.7 2.5 4.6 3.9 2.1 1.9 3.2 4.8 3.9 1.4 2.7 4.4 4.0 2.2 2.6 1.8 6.0 4.7 1.4 18.3 20.4 17.7 19.3 18.4 18.4 17.4 18.5 18.0 19.2 PGS1 DKFZP762M186 ENSG00000087157 "Phosphatidylglycerophosphate synthase 1" Q32NB8 17 78378640-78425114 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022526 Approved Approved "Vesicles,Cell Junctions,Intermediate filaments" "Vesicles, Cell Junctions, Intermediate filaments" "HPA022526: AB_1855271" "unprognostic (1.19e-2)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (1.86e-3)" "unprognostic (1.35e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (5.76e-3)" "unprognostic (3.17e-2)" "unprognostic (8.46e-3)" "prognostic favourable (7.33e-5)" "prognostic unfavourable (9.94e-4)" "prognostic unfavourable (1.16e-5)" "unprognostic (9.94e-2)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" "unprognostic (2.72e-2)" 16.4 11.6 14.5 20.8 20.3 41.4 28.2 17.6 17.4 14.4 13.1 18.4 13.2 13.7 17.3 13.2 14.5 16.9 17.2 14.0 15.7 16.1 14.3 8.0 25.5 19.1 21.6 17.0 18.3 14.0 16.0 13.3 24.0 15.3 13.9 10.2 12.9 13.1 16.8 13.8 11.9 15.1 13.4 18.0 22.6 12.6 13.9 18.8 17.7 18.6 7.8 14.3 16.9 32.3 8.0 14.0 26.0 12.6 6.7 11.3 8.4 13.1 11.6 11.3 8.5 10.0 16.0 13.4 12.4 11.9 13.3 14.7 10.8 10.4 13.6 7.5 7.0 10.2 13.4 8.4 10.5 20.4 15.2 14.9 13.8 10.8 9.8 11.2 12.1 16.3 11.1 9.6 8.7 25.4 17.3 9.5 9.0 7.2 25.3 10.1 11.8 11.2 13.3 20.3 11.6 13.0 12.1 15.0 22.8 10.6 11.7 11.3 12.3 13.6 15.9 17.3 12.0 9.2 10.4 10.5 6.2 10.3 13.1 12.6 12.8 1.5 12.6 13.2 8.4 10.4 9.8 7.8 8.8 8.8 14.0 8.0 11.3 8.1 26.0 6.7 4.6 6.6 10.4 8.4 14.5 20.3 17.6 17.4 15.7 16.1 21.6 17.0 15.3 18.8 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500369 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favourable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 11.0 12.3 10.0 17.2 17.4 11.5 11.6 18.7 15.2 17.2 14.2 16.5 11.7 9.9 22.7 12.1 37.0 15.1 12.6 10.7 11.4 7.9 16.4 18.7 13.8 10.4 15.3 8.9 15.3 15.4 22.3 18.1 11.6 12.1 13.7 15.8 15.4 18.1 10.3 14.9 19.1 15.4 15.7 13.6 14.4 12.1 15.7 18.5 17.8 15.2 18.1 30.0 12.1 20.6 5.3 5.6 4.0 6.3 4.8 7.7 3.4 12.2 8.4 19.0 13.6 4.8 5.4 2.8 8.8 9.0 19.4 20.2 8.1 13.9 11.8 8.1 10.5 8.7 13.1 8.8 17.4 8.8 7.3 24.6 14.5 12.5 7.3 14.6 28.4 4.8 8.2 12.4 21.9 25.5 12.4 8.2 12.3 3.8 10.3 3.7 14.4 5.8 10.9 18.1 8.8 10.0 11.1 10.1 12.6 19.8 8.2 10.3 11.1 5.4 16.5 9.5 17.7 6.6 17.0 6.3 9.0 10.0 9.1 12.4 9.9 3.4 4.6 4.0 7.7 4.1 6.8 3.3 5.9 7.2 4.5 5.3 4.0 5.4 3.5 4.8 6.3 5.6 2.7 3.4 10.0 17.4 18.7 15.2 11.4 7.9 15.3 8.9 12.1 18.5 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404049-49414905 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 189.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Vesicles,Mitochondria "Intracellular and membrane" 3800000 Mitochondria Vesicles "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.58e-4)" "prognostic unfavourable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favourable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 27.4 31.6 21.8 19.9 24.9 19.0 30.6 12.9 25.9 21.6 38.9 24.0 17.0 26.9 24.1 17.7 28.6 24.3 18.6 41.6 21.9 20.9 54.0 53.7 19.2 18.5 27.6 21.4 27.1 24.1 27.8 18.8 24.1 22.0 25.3 40.7 24.7 41.8 20.2 41.7 19.5 32.7 26.6 20.5 22.7 25.0 16.6 18.2 23.3 42.5 35.6 22.3 22.4 24.0 33.4 84.6 6.3 28.0 28.4 34.7 40.2 36.1 67.5 16.2 31.8 21.8 17.3 45.1 26.7 17.8 43.4 28.5 189.6 32.5 67.0 49.0 24.6 23.6 44.0 38.6 45.0 29.1 57.9 33.8 43.8 85.7 16.1 66.6 20.9 19.2 26.8 46.9 17.3 31.6 60.2 18.1 28.1 61.5 46.2 41.7 30.1 64.5 37.0 61.6 55.0 29.5 38.3 32.8 27.9 20.2 23.6 37.5 40.2 31.1 27.5 41.2 31.8 32.1 57.3 23.2 63.4 64.8 27.0 44.4 35.6 6.3 25.3 6.2 32.3 28.0 34.7 33.4 28.7 31.0 38.1 29.9 30.4 30.9 2.5 28.4 21.0 84.6 28.1 40.2 21.8 24.9 12.9 25.9 21.9 20.9 27.6 21.4 22.0 18.2 PHF11 "BCAP, IGER, NY-REN-34" ENSG00000136147 "PHD finger protein 11" Q9UIL8 13 49495610-49528987 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016566, HPA016708" Uncertain Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA016566: , HPA016708: AB_1855286" "unprognostic (1.65e-2)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "prognostic favourable (7.98e-6)" "unprognostic (3.49e-3)" "unprognostic (6.29e-2)" "unprognostic (5.50e-2)" "unprognostic (6.91e-2)" "unprognostic (3.05e-2)" "unprognostic (1.64e-1)" "unprognostic (2.37e-1)" "unprognostic (8.48e-2)" "prognostic unfavourable (4.46e-7)" "unprognostic (9.81e-2)" "unprognostic (5.36e-3)" "unprognostic (1.05e-1)" "prognostic favourable (3.46e-4)" 25.2 32.3 16.8 37.8 23.7 23.3 27.6 6.1 18.8 18.9 20.6 18.0 13.7 17.8 22.0 21.5 19.4 17.2 22.9 19.5 15.2 17.9 22.4 17.1 20.7 38.0 23.3 12.5 19.2 23.1 10.1 13.6 20.8 18.0 21.4 16.2 12.7 27.1 20.5 11.3 19.2 23.1 32.1 22.9 31.3 20.0 9.7 22.2 37.1 25.7 17.8 28.1 25.8 20.3 21.4 20.7 26.2 27.0 14.4 39.3 21.7 5.4 2.2 0.8 0.0 11.3 21.6 6.9 13.1 15.0 18.9 20.0 0.0 13.1 13.1 3.6 14.7 3.7 4.8 4.5 11.2 26.5 4.0 6.4 4.4 5.7 14.0 4.7 10.1 13.0 7.2 7.6 4.2 12.0 1.3 5.8 14.1 4.4 14.8 11.1 2.6 1.5 14.4 0.0 3.9 17.0 10.0 0.4 0.1 3.4 7.4 0.2 4.3 10.7 10.6 4.6 1.8 6.5 3.7 4.2 2.1 8.1 9.5 6.7 6.9 13.9 22.3 15.2 23.7 27.0 27.4 21.4 30.3 27.9 20.7 19.3 25.0 27.4 26.2 14.4 24.4 18.0 39.3 21.7 16.8 23.7 6.1 18.8 15.2 17.9 23.3 12.5 18.0 22.2 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: " "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.5 9.9 5.0 9.5 18.4 6.3 7.1 9.6 7.0 13.1 12.5 16.3 6.7 28.9 12.4 6.4 6.8 7.5 13.8 9.3 17.3 9.5 7.7 8.7 11.4 12.8 17.3 10.1 19.4 13.3 8.3 6.7 13.2 18.6 26.0 8.2 28.1 8.9 14.9 21.3 8.6 9.1 12.1 5.7 10.4 12.1 20.9 18.5 6.3 24.6 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 PHF2 "CENP-35, JHDM1E, KDM7C, KIAA0662" ENSG00000197724 "PHD finger protein 2" O75151 9 93576407-93679587 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010831 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA010831: AB_1855294" "unprognostic (9.42e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (9.34e-4)" "unprognostic (1.30e-1)" "unprognostic (2.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.44e-1)" "unprognostic (8.48e-2)" "unprognostic (1.07e-1)" "unprognostic (5.89e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "prognostic favourable (1.12e-5)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.17e-1)" "unprognostic (4.19e-2)" 16.8 14.6 17.4 17.7 22.2 16.7 23.2 33.1 19.0 19.8 18.1 27.8 18.6 11.3 22.0 15.9 14.5 18.4 16.7 19.1 15.3 14.5 10.8 9.3 17.8 20.7 23.1 15.6 27.1 18.5 22.6 21.7 17.6 16.6 18.6 10.6 16.9 19.0 21.9 27.8 21.4 13.3 24.9 18.5 21.4 15.9 9.6 18.2 19.8 18.8 12.0 12.1 16.4 32.5 2.5 3.8 5.0 2.6 1.0 4.0 2.2 9.2 7.7 16.2 13.3 10.4 8.1 8.4 7.3 9.8 10.6 7.6 3.6 5.4 6.6 5.4 9.4 18.0 10.2 7.0 5.6 17.7 6.7 5.4 8.8 5.6 9.3 10.4 18.4 8.1 12.2 5.0 8.4 8.4 7.7 11.3 7.3 20.4 20.0 11.7 4.2 6.7 22.5 12.5 2.6 6.7 11.6 21.3 10.5 7.6 12.6 6.6 8.4 18.5 9.7 10.0 8.7 11.0 10.4 9.2 1.5 4.9 5.5 6.5 11.2 1.1 2.6 2.5 3.3 1.4 3.1 1.8 3.3 2.1 2.7 2.5 3.6 4.0 5.0 1.0 2.0 3.8 1.9 2.2 17.4 22.2 33.1 19.0 15.3 14.5 23.1 15.6 16.6 18.2 PHF20 "C20orf104, dJ1121G12.1, TDRD20A" ENSG00000025293 "PHD finger protein 20" Q9BVI0 20 35771974-35950381 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029619, HPA029620, HPA029621" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201" "unprognostic (1.21e-3)" "unprognostic (7.30e-2)" "unprognostic (3.20e-2)" "unprognostic (2.35e-3)" "unprognostic (1.36e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (2.76e-1)" "unprognostic (2.17e-1)" "unprognostic (2.64e-2)" "unprognostic (4.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (7.23e-2)" "unprognostic (1.01e-2)" 19.1 11.6 14.0 16.8 19.0 14.1 17.2 25.1 19.2 15.9 15.9 16.1 8.1 8.1 19.1 11.6 16.5 14.2 14.8 15.2 14.1 13.8 11.2 11.1 16.5 17.3 14.9 13.0 18.9 9.4 17.9 20.0 15.6 15.0 14.7 11.7 14.7 15.3 15.7 46.6 12.9 12.3 17.2 18.9 20.8 12.7 17.4 15.2 19.4 14.2 14.5 20.8 18.7 21.8 12.0 8.2 23.6 11.9 13.0 12.4 6.5 9.6 7.7 13.5 19.9 9.8 11.3 12.6 11.0 10.5 11.1 9.7 22.4 7.3 16.1 10.0 14.6 6.0 12.4 15.3 13.6 7.2 5.3 30.0 14.7 8.3 9.9 14.3 11.7 8.8 21.6 11.7 18.1 12.1 12.2 10.4 12.7 5.7 14.5 8.4 6.7 9.6 10.6 20.0 9.5 8.8 6.7 12.3 10.0 19.6 22.8 10.1 18.0 10.7 16.9 24.6 5.6 12.7 11.2 9.6 11.4 11.8 18.2 10.5 12.6 11.9 8.6 23.6 10.6 9.0 11.3 12.0 10.5 11.9 8.2 9.8 12.0 12.4 20.5 13.0 11.9 7.7 5.5 6.5 14.0 19.0 25.1 19.0 14.1 13.8 14.9 13.0 15.0 15.2 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 14.5 19.9 15.3 15.7 26.6 27.1 17.6 22.2 22.0 15.7 14.2 12.6 11.7 11.6 17.6 13.0 16.0 12.4 13.6 22.5 15.9 10.5 13.6 16.4 12.9 13.5 11.8 14.8 16.9 12.7 22.4 18.6 15.1 12.9 13.1 12.9 10.0 14.9 14.6 27.0 9.5 12.9 14.5 12.9 15.4 12.8 15.9 13.7 38.9 28.5 9.2 14.7 14.7 16.9 2.4 4.0 14.7 4.3 3.0 3.4 1.6 9.9 10.0 16.5 9.5 13.0 15.5 5.9 14.7 11.6 10.1 10.0 5.6 6.9 11.4 12.9 14.7 5.9 11.1 7.8 12.7 19.2 7.9 12.3 11.9 3.9 13.6 9.8 8.8 11.5 9.8 10.5 15.8 11.2 15.1 18.1 15.0 10.0 31.8 4.4 7.3 13.4 15.6 11.0 9.8 8.3 8.6 40.9 12.0 9.3 6.7 11.9 13.1 11.1 14.4 16.5 13.2 10.7 14.0 10.8 14.0 14.7 14.6 17.4 14.6 3.7 4.3 7.5 2.5 2.5 2.5 2.2 2.3 2.9 4.0 2.4 3.4 2.7 14.7 3.0 3.8 3.3 2.6 1.6 15.3 26.6 22.2 22.0 15.9 10.5 11.8 14.8 12.9 13.7 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45009999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.9" "Cell line enhanced" "Detected in some" "AF22: 8.1;AN3-CA: 7.2;NTERA-2: 5.1;SCLC-21H: 6.3;SH-SY5Y: 27.9;U-2 OS: 6.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Uncertain "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA053834: , HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.7 3.5 8.4 0.8 7.4 0.5 0.8 3.7 10.9 10.1 0.7 3.6 0.9 0.7 8.6 1.7 1.6 2.3 0.8 1.3 7.8 3.4 2.2 0.5 0.6 0.6 4.7 3.2 5.6 1.8 2.0 17.9 0.6 4.2 4.8 0.6 6.5 0.8 2.1 0.7 0.5 0.7 2.3 4.4 0.6 1.0 8.5 7.3 0.0 3.0 0.0 0.6 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 7.2 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.6 0.9 0.0 5.1 0.3 0.0 1.9 0.1 0.0 0.1 6.3 27.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.3 0.0 0.2 0.3 0.0 3.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.4 3.7 7.3 7.8 3.4 4.7 3.2 4.2 7.3 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373253-134428791 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavourable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 7.4 19.3 10.2 14.1 12.2 6.5 9.7 18.2 13.5 8.7 8.0 11.6 20.3 7.8 9.0 30.1 11.5 7.3 6.1 7.2 11.0 11.1 9.9 7.5 8.4 20.4 12.5 9.3 30.7 10.4 24.1 18.1 8.2 13.3 8.6 9.5 5.4 11.3 16.8 6.2 7.4 10.2 8.1 17.1 17.8 8.1 8.3 14.4 30.2 11.8 6.0 25.0 8.9 9.8 18.4 11.0 5.3 7.4 9.6 9.9 5.0 11.3 9.4 41.3 16.9 7.7 9.9 7.8 11.4 9.1 12.2 15.2 5.6 11.8 18.2 26.2 6.9 10.2 28.8 12.9 20.6 14.8 13.4 17.6 16.1 6.4 8.3 17.5 9.8 6.5 9.8 13.3 16.6 17.0 12.9 9.0 14.9 7.4 28.2 8.7 12.6 12.7 27.9 15.1 13.8 13.0 13.7 14.3 16.9 8.7 8.1 11.9 7.5 9.7 12.9 11.4 8.2 14.3 17.4 4.6 10.7 24.6 7.5 20.9 14.2 5.3 6.1 3.7 7.9 6.0 8.5 18.4 8.2 7.1 8.8 12.8 9.9 8.2 2.5 9.6 7.4 11.0 8.3 5.0 10.2 12.2 18.2 13.5 11.0 11.1 12.5 9.3 13.3 14.4 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410657-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 260.7" "Cell line enhanced" "Detected in many" "Karpas-707: 14.0;U-266/70: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: " "prognostic favourable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favourable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favourable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 0.9 0.6 0.3 0.6 1.5 0.8 0.9 1.0 1.4 0.5 1.0 1.2 0.4 0.7 0.5 2.0 0.6 0.6 0.4 1.9 0.6 0.4 0.6 0.9 0.6 0.5 1.1 0.7 0.4 0.9 0.6 0.5 0.5 0.7 0.7 1.0 1.2 1.0 0.7 1.5 1.0 1.0 0.5 0.9 0.7 0.6 260.7 0.4 1.7 0.5 0.6 0.6 0.9 0.5 6.7 2.6 3.9 2.5 2.2 4.9 1.7 2.0 0.6 1.5 6.4 1.1 1.6 2.7 2.0 2.1 1.6 2.0 1.0 0.8 3.3 0.2 1.5 1.1 1.1 3.1 2.8 4.1 1.5 3.8 0.4 2.3 1.1 4.1 7.2 0.9 3.5 1.5 3.3 2.3 2.3 14.0 1.2 0.9 4.9 1.6 0.7 4.3 2.2 1.4 4.0 1.7 0.9 1.1 1.2 1.8 0.1 1.6 0.9 2.1 1.7 2.7 1.9 2.9 4.1 16.6 7.9 2.0 1.1 9.6 1.6 0.7 2.2 3.9 2.1 2.5 2.5 6.7 2.5 3.7 1.1 3.8 1.7 3.5 0.5 2.2 1.4 2.6 4.9 1.7 0.3 1.5 1.0 1.4 0.6 0.4 1.1 0.7 0.7 0.4 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavourable (1.48e-4)" "prognostic favourable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.5 5.5 14.5 34.9 8.3 11.0 27.1 12.3 22.2 17.6 29.2 28.7 2.4 0.0 5.3 32.9 18.3 26.9 25.6 12.4 0.1 24.5 4.3 19.5 19.8 17.3 27.4 0.1 15.8 42.8 16.8 20.0 12.6 7.8 32.5 7.7 53.3 18.3 8.4 36.3 42.3 16.1 25.2 2.3 1.1 16.2 15.7 14.3 9.0 6.0 98.9 12.2 46.8 0.1 2.9 15.3 17.9 13.7 26.8 6.7 27.4 35.6 38.3 22.6 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell line enhanced" "Detected in many" "hTERT-HME1: 43.3;RPTEC TERT1: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: " "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 13.5 16.3 12.8 7.0 6.0 12.4 0.9 11.5 31.1 5.2 7.3 9.0 16.6 0.0 3.5 4.8 7.0 0.3 19.3 11.3 2.0 0.2 0.3 0.8 15.2 8.7 0.3 3.5 3.8 14.2 21.8 43.3 12.5 1.1 0.4 26.8 1.7 0.0 1.7 4.6 25.2 0.0 3.3 0.4 54.9 30.8 0.9 2.4 2.0 0.1 37.4 8.2 0.1 11.6 17.9 1.7 20.8 11.3 0.2 0.0 0.0 30.2 0.2 22.3 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: " "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavourable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.3 5.0 38.5 39.1 3.6 7.6 9.4 4.5 2.6 3.9 11.2 0.0 14.5 15.4 6.5 2.3 15.7 0.7 0.2 1.5 2.9 1.9 1.8 10.0 0.0 5.6 20.4 3.4 6.3 4.4 12.9 2.5 0.1 5.8 1.1 0.0 0.1 3.6 1.3 0.4 2.6 0.2 4.5 2.4 2.3 5.1 19.5 1.7 5.4 7.1 0.9 15.7 9.3 8.5 4.7 6.0 0.0 0.0 0.0 2.7 0.5 10.5 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell line enhanced" "Detected in many" "A-431: 31.9;HaCaT: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: " "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favourable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 31.9 3.5 20.1 0.0 6.5 10.8 8.2 18.5 9.1 12.3 14.6 10.0 2.3 0.0 19.5 7.1 33.3 0.3 11.9 22.5 0.4 0.4 0.0 8.6 3.3 7.1 0.0 0.1 12.6 7.1 8.4 15.8 19.7 0.0 0.1 3.7 0.0 1.3 0.0 8.1 6.2 2.8 25.9 0.0 7.3 7.7 0.5 1.5 18.3 0.3 1.9 0.6 0.1 17.2 3.3 28.2 8.8 4.5 1.7 0.0 0.0 3.4 0.0 6.3 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 PHLDB3 FLJ40193 ENSG00000176531 "Pleckstrin homology like domain family B member 3" Q6NSJ2 19 43474954-43504935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043425 Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles" "Plasma membrane, Cytosol" "HPA043425: AB_10797142" "unprognostic (2.50e-2)" "unprognostic (4.22e-3)" "unprognostic (3.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.22e-3)" "unprognostic (4.43e-1)" "unprognostic (1.93e-1)" "unprognostic (2.15e-1)" "unprognostic (3.60e-2)" "prognostic favourable (6.36e-6)" "unprognostic (4.62e-2)" "prognostic unfavourable (4.11e-5)" "prognostic unfavourable (5.77e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (2.37e-1)" 2.7 8.5 6.6 11.7 5.9 3.6 6.0 2.1 5.2 8.7 4.8 1.8 7.1 5.8 8.8 6.5 28.4 7.3 15.9 4.5 5.2 2.9 4.8 9.6 4.0 7.8 3.5 5.8 9.5 7.7 6.8 7.9 6.4 3.2 11.7 2.2 6.7 11.1 7.6 9.0 28.7 9.4 7.5 3.0 6.4 5.4 18.7 3.0 12.2 5.7 15.2 23.2 9.3 14.8 4.4 8.1 0.9 3.3 2.6 5.5 2.3 5.3 5.6 2.4 5.9 2.1 4.4 15.3 3.8 3.4 3.9 2.7 5.7 5.6 3.2 12.2 2.3 6.2 1.7 6.7 0.7 7.5 5.3 3.5 5.4 6.8 5.3 1.3 6.8 3.7 8.6 4.1 2.5 3.4 6.2 4.9 1.9 8.4 5.4 0.3 1.4 4.6 6.4 3.1 2.1 1.8 18.1 0.1 5.1 4.9 10.7 4.6 7.6 4.5 4.3 2.5 6.7 3.0 3.6 12.6 13.7 3.5 2.3 2.6 4.1 0.3 3.3 0.5 4.0 2.3 2.9 3.7 3.7 3.0 6.9 4.4 5.5 4.8 0.9 2.6 0.2 8.1 3.6 2.3 6.6 5.9 2.1 5.2 5.2 2.9 3.5 5.8 3.2 3.0 PHOSPHO1 ENSG00000173868 "Phosphoethanolamine/phosphocholine phosphatase" Q8TCT1 17 49223362-49230766 "Enzymes, Predicted intracellular proteins" "Mineral balance" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 80.0;testis: 52.3" "Cell line enhanced" "Detected in some" "Daudi: 9.2;EFO-21: 6.2;HDLM-2: 6.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 10.2;pons and medulla: 8.2" "Group enriched" "Detected in some" 171 "eosinophil: 30.6;neutrophil: 80.0" "Lineage enriched" "Detected in single" 248 "granulocytes: 80.0" "Low region specificity" "Detected in all" HPA065025 Approved "Plasma membrane,Actin filaments" "Actin filaments" "Plasma membrane" "HPA065025: " "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (7.53e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-1)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-2)" "unprognostic (2.04e-1)" "unprognostic (6.88e-2)" "unprognostic (1.02e-2)" "unprognostic (2.88e-1)" "unprognostic (2.03e-1)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" 2.5 1.3 1.1 2.9 1.9 15.3 0.7 1.0 10.2 0.6 0.6 0.2 0.2 2.5 0.9 2.7 0.9 1.3 2.1 1.0 1.7 1.3 1.0 0.9 2.5 2.0 2.1 1.5 1.1 1.0 0.1 0.8 7.6 8.2 0.9 0.0 1.6 0.9 0.5 2.2 1.1 2.6 0.3 1.5 12.6 0.7 52.3 0.1 0.0 0.8 0.1 0.1 1.4 1.3 0.0 0.0 80.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 2.1 0.1 0.2 0.0 0.3 0.4 0.0 0.2 2.9 0.0 9.2 6.2 0.0 0.0 1.7 0.5 0.1 6.5 0.2 1.2 1.2 0.4 0.0 0.0 1.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.4 0.0 1.7 1.8 3.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.2 3.7 0.5 3.0 2.0 0.0 0.3 0.3 0.6 2.7 3.5 0.3 0.0 0.1 30.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.0 0.0 0.3 0.0 0.0 0.1 1.1 1.9 1.0 10.2 1.7 1.3 2.1 1.5 8.2 0.1 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 112.7" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Low region specificity" "Detected in some" "HPA053810, HPA065621, HPA078004" Enhanced Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" Nucleoplasm "Nuclear membrane, Vesicles, Cytosol" "HPA053810: , HPA065621: , HPA078004: " "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 112.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nuclear bodies,Cytosol" 430000 Cytosol "Nuclear bodies" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 15.8 26.4 31.5 12.1 28.0 11.7 15.3 14.7 27.2 19.2 15.7 18.5 13.7 14.7 11.2 21.7 13.7 21.1 14.2 59.1 22.7 19.3 18.4 12.6 12.1 12.7 27.0 21.0 13.7 46.5 15.6 21.2 14.7 20.8 20.2 11.6 14.1 30.5 22.6 86.0 9.2 16.3 16.9 24.3 10.3 13.4 13.8 18.6 7.5 20.7 19.8 10.4 12.0 9.8 24.9 48.8 3.3 35.4 20.0 24.3 32.1 7.1 52.2 29.8 19.0 19.3 35.0 43.8 16.7 21.3 20.4 18.1 19.0 16.3 15.2 20.3 20.6 19.0 6.5 37.7 6.4 13.6 13.2 4.8 34.3 41.7 24.0 9.5 19.6 43.6 31.0 11.7 14.1 26.7 11.5 14.2 31.6 40.7 13.9 20.1 23.6 22.5 11.5 13.0 25.1 32.2 11.9 14.6 13.9 17.9 21.1 8.7 16.0 26.5 21.7 42.6 13.2 11.8 15.4 9.4 9.1 9.3 24.1 6.9 25.5 2.9 35.4 3.3 24.3 34.2 20.9 24.9 21.1 21.9 37.5 16.5 15.0 21.3 1.7 20.0 24.0 48.8 22.9 32.1 31.5 28.0 14.7 27.2 22.7 19.3 27.0 21.0 20.8 18.6 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.7 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.1 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.1 3.1 19.5 5.3 17.0 12.8 19.0 0.1 11.0 15.1 10.9 11.5 28.7 7.3 17.0 5.6 13.4 12.4 13.2 6.5 7.0 2.6 8.8 20.5 8.3 11.5 15.3 11.4 23.8 24.2 6.9 20.5 9.5 22.6 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA012312: " "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.0 6.9 9.5 19.3 8.3 9.2 7.9 26.7 24.5 16.0 18.2 11.8 12.3 13.6 2.2 20.6 12.5 13.5 6.9 22.8 9.1 10.8 5.5 7.6 3.4 9.0 7.3 15.3 5.4 6.6 9.3 14.1 5.7 9.0 24.1 17.0 9.5 6.0 4.8 8.6 8.2 6.0 19.3 11.0 4.4 20.4 9.2 12.8 14.9 17.0 9.7 18.0 5.7 5.6 27.6 14.9 15.4 15.6 11.4 13.3 16.9 8.7 11.8 23.7 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.7;SH-SY5Y: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" HPA069318 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA069318: " "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.4 0.0 0.3 0.8 1.1 0.3 1.2 0.4 0.4 0.1 1.9 0.0 2.1 0.6 3.7 0.0 0.6 0.1 0.0 0.2 0.0 3.9 1.4 1.6 0.0 0.0 0.9 0.0 0.8 0.0 2.5 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 12.7 0.0 0.0 4.3 4.9 2.9 0.0 3.3 0.0 0.3 1.1 0.0 2.1 1.5 0.7 1.0 0.2 0.0 2.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 PI15 P25TI ENSG00000137558 "Peptidase inhibitor 15" O43692 8 74824537-74855029 "Predicted secreted proteins" "Developmental protein, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 15.7;SH-SY5Y: 15.6;SK-MEL-30: 20.7;U-266/70: 5.4" "Group enriched" "Detected in many" 7 "breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006593, HPA030057" Uncertain Approved Vesicles,Cytosol "Secreted in other tissues" Vesicles Cytosol "HPA006593: AB_1078568, HPA030057: AB_10602143" "unprognostic (2.77e-1)" "unprognostic (1.57e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-2)" "unprognostic (3.22e-1)" "unprognostic (3.24e-1)" "unprognostic (2.94e-2)" "unprognostic (2.33e-3)" "unprognostic (1.87e-1)" "unprognostic (2.25e-1)" "unprognostic (3.65e-2)" "unprognostic (1.85e-2)" "unprognostic (8.63e-14)" "unprognostic (2.54e-3)" "unprognostic (1.34e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" 4.2 1.4 3.7 33.4 6.5 0.2 23.4 0.5 2.2 17.3 8.8 0.0 6.5 0.3 26.5 33.8 1.8 18.5 1.2 18.8 1.3 0.9 2.5 0.4 2.3 4.6 3.5 0.0 28.7 0.5 0.2 0.7 0.4 5.9 21.4 3.3 0.0 1.9 5.2 0.6 0.5 8.3 30.7 6.0 15.2 1.0 2.6 1.7 0.1 0.8 0.9 0.3 7.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 15.6 0.0 0.0 20.7 0.3 0.4 0.0 0.0 0.3 0.0 0.1 5.4 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.5 0.5 2.2 1.3 0.9 3.5 0.0 5.9 1.7 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Cell line enhanced" "Detected in all" "K-562: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: " "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favourable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favourable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.7 8.2 7.3 10.9 20.8 12.6 10.4 8.9 13.5 13.1 12.8 6.4 4.2 18.4 5.3 17.8 8.6 13.8 8.5 8.0 15.6 21.2 18.9 11.2 7.3 10.4 18.7 15.2 11.2 5.4 11.1 6.2 10.6 51.5 15.6 10.1 13.5 16.3 6.4 5.7 8.5 16.4 15.9 3.4 7.3 15.6 17.9 13.1 11.6 13.5 9.2 11.4 8.6 10.7 23.9 12.4 8.8 7.4 12.0 12.2 14.6 15.8 13.5 9.9 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 PICK1 "dJ1039K5, MGC15204, PRKCABP" ENSG00000100151 "Protein interacting with PRKCA 1" Q9NRD5 22 38056311-38075701 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067384, HPA072674" Approved Approved Mitochondria,Cytosol Mitochondria Cytosol "HPA067384: , HPA072674: " "unprognostic (1.97e-2)" "unprognostic (4.61e-3)" "unprognostic (7.79e-2)" "unprognostic (9.26e-2)" "unprognostic (1.29e-2)" "unprognostic (1.81e-1)" "unprognostic (6.04e-2)" "unprognostic (1.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "unprognostic (1.68e-3)" "unprognostic (1.20e-1)" "unprognostic (8.56e-2)" "prognostic favourable (5.26e-5)" "unprognostic (1.36e-1)" "unprognostic (2.74e-1)" "unprognostic (4.61e-3)" 7.7 11.9 16.9 5.7 32.7 5.3 14.9 18.4 26.2 8.9 12.5 21.3 18.6 10.8 11.3 15.5 13.0 18.1 10.0 14.7 17.2 14.8 12.4 14.5 10.8 8.1 47.4 21.5 15.6 16.1 36.6 22.7 8.7 24.7 25.5 13.4 11.4 19.1 18.9 18.0 11.5 9.8 12.5 17.6 8.1 15.0 18.6 36.5 2.5 13.4 6.8 8.5 8.9 8.6 2.5 4.6 1.9 2.7 1.4 3.2 1.7 10.5 7.6 4.3 5.6 3.0 2.4 6.4 5.9 7.2 12.8 13.0 8.0 6.7 4.7 6.6 7.2 11.6 11.7 24.0 11.0 2.9 18.8 1.7 9.2 9.2 11.2 5.4 11.6 7.7 14.1 8.4 12.5 4.9 3.4 3.4 2.6 6.7 3.2 0.5 6.8 8.3 2.8 0.2 4.2 14.8 17.2 17.9 9.1 6.7 16.3 6.0 9.5 4.0 1.3 3.6 6.9 4.9 3.5 7.8 1.8 1.3 7.9 1.8 5.3 0.0 2.7 0.0 1.8 1.5 0.6 1.1 1.8 3.2 4.6 2.5 3.1 1.8 1.9 1.4 1.5 0.9 1.7 1.7 16.9 32.7 18.4 26.2 17.2 14.8 47.4 21.5 24.7 36.5 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.9" "Cell line enhanced" "Detected in many" "BEWO: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB012647, HPA055473" Supported Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: " "unprognostic (1.38e-1)" "prognostic favourable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favourable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favourable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.4 3.0 3.3 6.7 3.7 15.0 3.9 7.7 10.0 4.4 4.3 2.2 0.4 7.1 3.2 4.1 6.8 3.3 3.0 2.2 4.7 2.9 2.9 5.6 3.1 7.0 4.4 10.9 2.9 5.6 3.0 2.8 10.1 3.2 5.2 2.0 2.7 6.1 3.5 7.1 7.9 6.5 2.0 5.9 5.3 5.9 5.0 1.9 21.9 3.9 4.3 9.2 3.3 2.8 1.9 3.1 0.1 1.8 0.4 3.3 1.2 4.1 4.8 2.3 4.9 0.5 1.8 21.3 5.9 1.6 2.2 2.9 4.4 8.0 3.4 1.8 0.8 6.2 1.7 2.3 0.4 6.9 9.8 2.9 3.3 9.0 5.6 3.2 7.5 6.9 4.2 1.1 0.3 3.9 3.4 2.6 0.9 1.9 9.1 5.4 3.2 3.4 14.9 3.3 6.6 0.8 1.4 4.0 5.4 2.5 6.5 1.6 4.8 5.6 2.2 2.8 6.2 2.0 3.8 8.4 4.7 6.6 3.5 2.7 4.4 0.0 1.7 0.1 1.9 1.8 1.8 1.5 1.4 1.5 3.1 1.9 1.7 1.7 0.0 0.4 1.6 0.8 3.3 1.2 3.3 3.7 7.7 10.0 4.7 2.9 4.4 10.9 3.2 1.9 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA031975, HPA040616" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: " "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.0 0.0 0.5 2.7 10.5 14.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.7 0.0 0.3 0.0 23.4 5.5 3.3 0.0 0.0 0.0 0.1 2.7 0.7 3.2 0.0 0.2 1.6 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.1 0.0 3.2 8.1 0.0 0.1 0.0 0.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 14.9 0.1 9.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.3 8.6 3.9 3.1 4.3 8.8 5.6 6.2 12.5 7.0 11.2 3.8 7.7 7.2 8.3 8.6 12.5 2.5 6.5 5.9 7.2 5.6 7.1 10.7 4.7 7.8 20.1 6.2 9.2 8.0 5.5 7.1 8.7 8.4 6.1 9.2 6.5 2.5 7.9 2.5 4.3 3.2 3.8 16.4 10.9 8.2 2.3 4.4 5.7 9.2 10.8 9.9 14.7 6.6 9.5 3.1 2.4 12.5 6.1 11.0 6.4 8.4 22.7 6.8 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 PIGG "FLJ20265, GPI7, LAS21" ENSG00000174227 "Phosphatidylinositol glycan anchor biosynthesis class G" Q5H8A4 4 499210-540196 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015997 Uncertain Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA015997: AB_2164679" "unprognostic (3.87e-2)" "unprognostic (5.32e-2)" "unprognostic (5.78e-3)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (3.48e-2)" "unprognostic (4.68e-1)" "unprognostic (2.64e-1)" "unprognostic (7.01e-3)" "unprognostic (6.61e-3)" "unprognostic (9.09e-2)" "unprognostic (1.83e-2)" "unprognostic (1.51e-1)" "unprognostic (4.27e-3)" "unprognostic (2.97e-2)" 16.2 22.0 12.8 19.8 19.7 11.3 17.1 21.3 23.2 13.3 15.6 23.2 21.5 18.8 23.2 28.7 16.7 15.6 17.4 11.5 13.6 12.5 15.5 13.0 15.5 16.5 20.3 16.0 22.1 18.6 31.1 22.9 16.7 17.2 16.9 16.5 19.5 20.9 19.1 10.7 26.6 17.5 19.3 21.8 17.7 17.5 19.9 17.6 16.2 21.9 9.6 15.1 19.5 15.0 4.2 9.2 16.4 7.5 8.1 9.0 4.5 11.0 12.3 11.2 9.4 20.5 14.8 17.6 14.7 17.7 15.7 18.7 12.5 26.3 4.5 10.7 18.5 14.8 10.6 14.3 14.4 4.3 11.3 11.5 15.0 9.7 14.4 15.8 17.3 16.5 24.0 14.5 8.0 11.9 12.6 10.6 13.9 6.7 8.8 13.7 17.9 16.8 9.8 6.9 6.9 14.9 15.3 11.1 14.2 10.6 11.1 10.2 17.8 14.3 18.3 16.3 7.6 8.0 22.6 8.5 11.1 7.3 13.8 11.7 19.9 16.4 5.9 4.7 7.2 7.5 8.3 4.2 5.7 6.9 9.2 3.6 6.2 5.0 4.3 8.1 5.3 8.0 9.0 4.5 12.8 19.7 21.3 23.2 13.6 12.5 20.3 16.0 17.2 17.6 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavourable (2.57e-4)" "prognostic unfavourable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 8.2 11.8 8.0 6.6 11.5 10.8 3.3 4.6 5.5 7.7 13.8 12.0 10.6 4.0 9.4 4.4 12.1 9.8 5.8 11.1 8.6 25.7 8.0 8.2 14.3 12.3 3.4 5.2 9.1 15.2 13.5 15.4 8.8 9.5 5.1 6.1 8.2 6.2 8.0 3.1 6.1 6.1 6.7 11.6 8.7 4.5 4.2 6.0 4.8 3.4 9.4 3.7 3.1 5.7 7.0 4.3 4.6 13.0 3.6 0.1 6.5 8.8 8.5 4.4 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favourable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.8 10.1 10.1 12.8 12.6 17.1 13.5 16.8 13.2 11.0 13.2 13.1 17.2 18.7 24.6 12.7 23.3 13.5 14.2 17.5 15.5 9.1 11.4 15.6 10.2 9.0 23.3 13.3 10.0 9.5 11.1 13.0 13.9 13.4 28.0 12.1 15.3 11.6 7.1 17.1 9.4 12.5 18.8 18.1 13.6 26.0 11.5 11.8 22.4 15.9 7.1 25.2 14.9 15.7 22.4 16.4 8.8 12.5 29.7 27.6 9.3 12.3 13.3 21.8 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favourable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 9.4 16.6 7.2 8.7 11.7 5.4 11.6 12.6 15.6 10.8 11.5 17.8 15.6 14.1 14.0 13.6 12.6 15.8 13.4 9.5 7.4 6.4 16.1 15.2 10.6 13.8 9.0 10.1 15.9 17.5 47.3 13.4 27.6 11.5 13.1 13.2 18.0 17.5 17.4 7.6 10.0 12.9 10.7 11.0 14.2 13.9 16.5 9.7 11.3 20.0 8.3 13.4 13.6 9.9 7.4 13.7 8.0 8.8 7.1 10.0 4.1 15.9 27.3 7.8 11.2 7.0 7.8 14.0 6.8 11.8 16.4 13.5 10.0 16.2 9.0 12.4 8.1 11.6 13.0 21.3 9.9 9.9 8.4 5.4 17.8 7.6 13.7 7.2 9.4 9.6 23.5 14.6 24.0 8.5 5.9 12.9 13.4 8.8 8.5 8.3 5.0 11.2 8.9 6.3 9.8 18.1 11.1 6.6 8.8 9.4 23.3 5.3 17.5 4.8 5.1 12.1 10.7 6.4 12.4 7.9 11.6 3.8 13.0 5.4 14.9 7.0 6.7 8.0 9.2 8.8 9.3 5.0 5.1 10.0 13.7 7.4 6.5 7.6 2.4 7.1 5.9 9.5 7.6 4.1 7.2 11.7 12.6 15.6 7.4 6.4 9.0 10.1 11.5 9.7 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: " "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favourable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.5 12.9 4.6 6.4 3.0 1.8 8.7 9.0 3.5 3.9 4.2 9.0 8.0 4.5 11.8 2.0 13.7 2.1 4.0 0.8 13.0 18.9 6.9 14.0 6.4 5.8 6.0 6.5 3.2 6.0 6.5 1.3 3.6 15.4 2.6 1.3 11.1 11.1 6.9 6.2 13.3 21.5 3.8 10.4 3.5 3.4 8.3 13.2 10.2 4.7 6.5 10.7 4.1 8.7 6.6 8.4 7.4 6.2 9.9 2.9 3.6 2.2 3.2 6.4 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041706: , HPA046766: " "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 16.8 17.6 18.9 12.9 23.6 10.0 15.2 15.7 26.5 14.7 21.5 43.0 10.8 13.3 21.8 22.8 20.0 28.2 12.7 17.4 21.4 20.2 18.4 16.3 11.3 11.6 21.5 11.9 23.9 16.2 34.4 21.7 17.3 26.9 14.1 24.9 20.1 17.9 15.9 16.4 14.0 14.2 19.6 30.5 11.1 11.5 22.1 18.1 16.5 14.7 15.9 19.5 14.2 15.0 10.0 10.8 9.4 6.3 12.1 15.0 6.7 11.7 15.0 19.1 13.9 12.6 15.1 19.2 12.1 14.4 20.6 18.1 27.7 25.0 15.2 19.7 11.9 21.9 17.4 22.9 21.0 6.2 9.4 34.2 9.9 31.1 11.6 20.7 8.2 13.4 14.7 11.8 13.5 14.8 17.1 13.5 17.4 13.2 17.6 21.2 9.6 22.7 12.8 24.0 24.2 18.2 11.0 12.3 11.6 22.6 41.2 14.7 22.7 14.6 8.7 33.9 12.0 18.2 12.1 9.1 12.7 10.1 20.7 21.7 14.6 9.4 4.4 1.9 13.4 6.3 12.2 9.2 12.4 15.0 10.8 10.0 12.7 12.5 0.9 12.1 5.3 10.6 11.2 6.7 18.9 23.6 15.7 26.5 21.4 20.2 21.5 11.9 26.9 18.1 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favourable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.3 5.6 4.5 3.9 8.8 10.9 3.8 6.5 15.3 6.1 7.5 3.1 19.3 5.5 5.9 8.0 16.7 2.4 7.5 7.6 9.4 4.0 4.8 7.5 7.7 9.9 8.8 12.0 11.2 31.2 8.4 10.3 4.6 8.8 8.9 11.0 5.2 4.3 5.0 6.8 4.5 3.1 5.3 10.5 9.7 2.4 6.5 3.5 6.3 3.2 6.2 10.8 4.4 7.7 11.1 4.8 5.4 2.2 3.1 2.1 3.0 9.1 9.4 6.5 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029409 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029409: AB_10610280" "unprognostic (8.83e-2)" "prognostic favourable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 21.9 10.0 13.1 9.2 13.9 10.6 7.5 9.9 12.0 12.2 12.7 9.7 14.3 10.8 33.3 9.9 12.1 11.2 9.4 15.1 9.8 10.4 8.9 6.9 6.5 12.9 10.0 16.7 7.9 14.8 9.8 9.3 6.6 6.1 21.7 11.1 19.9 25.8 13.0 5.9 11.3 14.0 15.5 15.6 12.6 7.4 12.7 14.1 16.7 11.5 13.6 39.8 9.4 3.4 11.7 5.1 12.8 15.2 27.4 31.5 20.4 10.6 12.3 12.0 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112064010-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.9" "Cell line enhanced" "Detected in many" "T-47d: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.7 1.0 1.5 0.3 3.3 0.2 1.6 0.9 2.0 1.6 0.8 3.2 2.3 0.4 1.5 8.1 1.0 14.4 1.2 0.9 2.6 2.0 4.9 0.5 2.8 0.3 1.1 1.8 2.5 1.2 4.4 10.5 0.5 9.7 1.4 0.7 2.7 1.1 1.5 0.9 0.9 0.5 0.9 0.8 0.4 0.8 41.9 1.2 0.1 5.8 0.6 0.3 0.9 0.8 1.2 1.0 0.7 1.2 0.3 0.3 0.2 2.9 1.4 4.5 2.0 2.3 2.5 3.1 1.1 3.7 3.7 3.6 5.6 9.2 1.3 3.9 2.1 3.7 1.0 2.4 3.7 1.4 3.8 2.1 2.5 2.4 2.1 2.2 1.3 1.6 2.8 6.9 3.9 1.9 2.7 0.8 2.2 1.1 0.9 2.7 1.3 2.5 1.8 2.9 3.1 9.6 1.4 5.7 1.5 3.7 1.3 1.9 12.3 0.6 1.1 2.1 2.4 1.3 1.0 1.1 0.4 1.6 3.1 0.3 1.7 0.0 0.3 0.7 0.0 1.2 0.3 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 1.5 3.3 0.9 2.0 2.6 2.0 1.1 1.8 9.7 1.2 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell line enhanced" "Detected in some" "Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" Nucleoplasm "CAB026136: , HPA038452: " "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.1 2.5 0.0 0.0 5.1 0.0 0.2 13.4 0.8 3.7 0.0 0.4 0.0 10.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 17.4 0.2 0.3 51.7 1.2 5.6 0.0 0.0 1.0 0.6 0.0 0.0 0.3 0.0 26.4 0.0 0.0 0.8 0.0 0.2 0.2 0.0 32.9 0.0 27.1 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 PIK3C2B "C2-PI3K, PI3K-C2beta" ENSG00000133056 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta" O00750 1 204422628-204494724 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.9;RT4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030515, HPA050360" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030515: AB_10670043, HPA050360: " "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.45e-1)" "unprognostic (2.19e-3)" "prognostic unfavourable (5.42e-4)" "unprognostic (3.35e-3)" "unprognostic (3.57e-3)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (5.36e-2)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "prognostic favourable (1.16e-4)" 12.9 4.5 11.0 16.0 19.3 5.3 11.0 9.1 17.5 7.4 17.0 36.0 9.6 15.5 10.5 5.8 14.6 7.7 14.7 10.7 14.4 9.1 7.6 5.8 18.0 23.9 24.2 11.2 3.9 6.1 4.7 4.3 20.4 14.5 7.3 14.5 6.3 8.0 14.1 20.0 22.6 15.7 11.2 16.2 14.2 20.7 2.4 23.0 31.8 9.8 8.1 23.1 13.1 11.8 7.4 0.3 0.5 0.2 1.6 2.0 0.4 3.2 6.5 5.8 5.3 3.4 0.3 31.9 0.4 1.3 1.3 0.9 3.8 8.5 5.5 1.2 0.7 8.1 3.4 2.3 0.5 3.3 0.9 0.1 12.9 1.4 0.2 1.9 4.2 0.4 2.4 0.3 0.2 8.5 2.0 3.7 0.1 7.2 6.6 5.5 5.3 4.1 7.2 1.4 1.0 1.6 33.3 6.4 3.5 11.5 16.2 3.7 7.2 1.0 0.3 0.2 2.1 0.6 0.1 4.0 1.1 7.2 0.2 2.9 0.8 0.1 0.2 0.0 1.2 0.0 1.0 2.9 1.3 0.8 0.3 7.4 0.7 0.6 0.5 1.6 0.0 0.1 2.0 0.4 11.0 19.3 9.1 17.5 14.4 9.1 24.2 11.2 14.5 23.0 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652699-138834938 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 41.2;HMC-1: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: " "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavourable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 12.5 9.9 10.6 9.7 20.6 17.4 11.5 29.9 25.0 12.4 14.6 11.9 11.7 13.7 9.6 6.9 15.2 10.9 8.7 12.7 12.2 14.2 22.6 9.3 9.5 9.1 11.9 15.2 8.8 20.3 20.2 10.9 18.1 24.1 13.4 15.7 12.2 14.9 15.9 33.4 19.6 16.4 8.3 12.5 9.9 11.0 6.4 10.7 14.4 37.4 7.1 11.9 13.4 11.0 4.6 9.1 11.3 7.8 1.3 6.5 2.6 22.6 9.8 4.2 3.5 3.9 5.2 28.7 5.3 5.1 5.4 5.8 10.5 8.6 9.1 14.5 5.2 9.7 5.5 8.4 9.7 11.6 6.2 41.2 6.7 6.3 4.0 10.0 65.3 4.4 6.5 3.8 7.7 8.1 15.7 6.8 6.7 10.3 5.8 7.0 6.0 9.2 4.2 4.4 6.5 8.3 12.5 3.7 2.7 14.7 6.4 18.9 16.0 23.9 8.5 3.5 4.4 7.5 7.4 11.5 7.5 8.3 8.5 9.7 4.8 7.0 7.8 11.3 4.0 4.5 2.7 4.6 5.2 3.0 9.1 4.1 6.5 4.4 10.0 1.3 4.3 1.4 2.2 2.6 10.6 20.6 29.9 25.0 12.2 14.2 11.9 15.2 24.1 10.7 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651732-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5;NB-4: 21.8;REH: 22.7;THP-1: 22.0;U-937: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: " "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 4.5 2.1 3.4 34.8 7.1 32.8 2.9 3.3 4.3 3.2 3.3 5.5 0.7 3.1 3.7 3.4 3.5 4.0 6.5 2.9 4.2 3.1 4.6 3.3 8.2 40.3 7.4 1.8 5.3 2.2 2.3 2.2 3.3 4.6 3.2 2.1 3.1 11.2 1.8 0.9 2.0 11.4 2.9 5.3 35.5 3.3 3.0 5.7 23.5 4.1 2.3 36.0 5.8 3.6 8.4 14.5 35.0 15.0 14.5 13.7 16.6 2.6 1.7 0.1 0.5 0.4 0.4 0.2 4.1 8.4 9.0 7.4 0.1 1.1 7.1 1.7 3.3 0.8 0.7 3.7 5.7 50.5 0.1 0.8 0.4 3.0 1.8 18.4 6.4 1.5 1.5 10.1 3.4 1.3 2.6 0.0 5.1 0.2 1.7 21.8 0.7 0.5 22.7 4.5 0.2 3.8 0.0 0.5 0.5 0.9 1.7 4.0 0.2 22.0 3.3 2.7 2.8 0.0 3.8 1.6 1.6 10.0 5.8 26.3 1.5 9.6 11.8 21.1 12.9 13.1 13.7 7.8 9.8 11.8 12.5 8.4 12.9 13.4 35.0 14.5 15.0 14.5 7.4 16.6 3.4 7.1 3.3 4.3 4.2 3.1 7.4 1.8 4.6 5.7 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106907145 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8" "Cell line enhanced" "Detected in some" "Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA069976: " "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 5.0 1.8 2.2 16.0 3.1 27.8 2.3 0.8 1.7 1.7 4.1 2.7 0.0 2.8 1.7 2.0 2.0 1.8 3.5 1.7 1.7 1.5 1.9 1.5 4.3 13.1 3.0 1.0 1.7 1.5 0.6 1.4 2.0 2.5 2.2 2.6 1.9 3.1 0.5 1.1 1.3 6.1 1.9 6.4 17.4 2.5 7.6 3.0 40.8 2.3 0.9 21.2 4.1 1.5 6.2 5.6 14.2 24.5 5.3 5.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 11.9 15.2 0.0 0.0 0.0 0.0 4.7 8.5 12.6 0.0 0.0 23.0 4.6 0.0 0.0 6.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.1 0.0 0.0 30.9 0.0 11.5 0.0 21.8 2.9 4.6 3.4 14.2 5.6 10.6 5.1 4.7 2.6 4.2 5.6 6.2 2.8 3.8 13.9 5.3 24.5 4.9 2.6 3.6 2.2 3.1 0.8 1.7 1.7 1.5 3.0 1.0 2.5 3.0 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Group enriched" "Detected in many" 8 "granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: " "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favourable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favourable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 33.7 10.9 7.4 7.0 8.2 0.8 24.7 36.4 11.0 16.9 6.3 3.5 9.1 3.3 15.8 11.0 8.4 7.6 10.9 28.7 6.8 8.5 10.4 4.1 20.0 6.0 8.7 3.1 4.6 4.0 18.7 10.2 13.4 10.4 9.0 5.3 13.6 9.4 8.0 14.8 4.6 6.0 12.3 7.1 10.9 7.4 24.0 4.5 5.9 12.7 6.2 5.3 12.3 8.7 0.5 0.6 8.6 3.1 0.1 3.5 0.9 4.6 1.6 21.4 10.8 2.1 0.9 6.8 2.8 2.0 3.7 4.6 0.9 1.4 6.1 8.5 1.0 2.8 7.4 2.5 2.4 4.8 6.7 3.8 19.2 0.7 0.7 3.5 5.3 2.6 1.5 3.9 1.4 7.6 1.4 4.4 5.2 7.1 14.0 2.1 7.5 4.3 18.0 5.7 7.3 9.2 33.3 15.5 11.2 9.0 23.9 2.5 6.6 3.1 14.2 3.9 3.7 0.6 2.7 6.3 6.5 3.7 3.1 4.7 2.0 0.0 0.3 8.6 3.3 0.5 3.0 0.5 0.8 2.9 0.0 0.0 0.3 1.9 0.1 0.1 3.1 0.6 3.5 0.9 7.4 8.2 36.4 8.9 6.8 8.5 8.7 3.1 10.4 4.5 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678935-130746829 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: " "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favourable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 15.5 16.2 11.6 11.6 15.9 10.6 14.9 14.7 17.2 16.5 13.1 14.9 9.5 10.3 18.8 12.0 12.9 15.6 12.0 12.2 9.7 10.0 14.9 28.2 13.7 12.4 12.0 11.4 17.8 12.0 40.7 20.6 14.4 17.3 14.1 11.6 14.1 14.0 15.4 14.8 16.0 13.4 14.6 12.1 18.5 13.3 14.9 11.8 29.7 18.1 10.2 13.6 16.5 13.9 8.4 9.6 12.0 8.5 11.5 13.7 7.0 14.1 9.0 13.2 9.5 19.6 15.6 9.2 10.5 12.7 14.6 16.9 11.6 12.1 16.7 13.3 10.6 20.2 21.7 16.4 23.0 10.0 8.0 13.6 10.3 8.0 9.0 20.6 6.8 10.8 11.8 15.5 9.9 13.4 15.7 8.5 12.8 12.4 16.8 6.3 16.6 8.8 11.8 15.4 15.0 9.6 11.6 12.2 8.9 15.1 9.6 10.6 13.2 9.1 10.6 11.2 9.8 12.6 8.4 9.9 9.0 22.0 12.3 7.9 10.4 12.0 7.2 9.2 9.4 8.4 13.7 8.4 8.6 6.9 9.6 5.7 10.1 9.0 6.0 11.5 8.5 3.4 9.3 7.0 11.6 15.9 14.7 17.2 9.7 10.0 12.0 11.4 17.3 11.8 PIK3R5 "p101, P101-PI3K" ENSG00000141506 "Phosphoinositide-3-kinase regulatory subunit 5" Q8WYR1 17 8878911-8965712 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.0" "Group enriched" "Detected in some" 4 "HDLM-2: 28.0;U-937: 8.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044505, HPA052247, HPA052412" Uncertain Supported "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA044505: , HPA052247: , HPA052412: " "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (9.89e-3)" "unprognostic (1.42e-1)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (7.95e-2)" "unprognostic (1.33e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" "unprognostic (6.89e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.24e-1)" 13.8 4.1 2.0 13.0 3.4 51.0 7.2 0.6 1.8 2.1 5.6 3.6 0.0 2.5 1.9 3.1 3.1 3.8 5.7 3.1 3.4 1.6 2.7 2.4 16.4 22.9 5.0 0.6 2.5 1.8 0.7 1.3 2.3 3.0 2.7 2.1 2.4 3.1 1.0 1.0 1.8 10.4 2.9 5.3 23.8 2.6 4.0 2.5 17.6 2.2 1.9 12.4 4.5 2.8 3.6 8.0 23.8 12.1 5.7 13.6 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.3 1.0 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.8 0.4 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 4.9 10.6 3.7 13.6 10.0 8.8 3.2 7.5 11.4 8.0 3.6 5.8 8.9 23.8 5.7 12.1 6.4 9.2 9.5 2.0 3.4 0.6 1.8 3.4 1.6 5.0 0.6 3.0 2.5 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell line enriched" "Detected in some" 8 "HMC-1: 57.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 7.3 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 PIM1 PIM ENSG00000137193 "Pim-1 proto-oncogene, serine/threonine kinase" P11309 6 37170203-37175426 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 34.8;HMC-1: 64.9;U-698: 116.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 64.6" "Group enriched" "Detected in all" 5 "granulocytes: 64.6;T-cells: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003941, CAB017040" Uncertain Supported Nucleoli,Cytosol Cytosol Nucleoli "CAB017040: , HPA003941: AB_1079618" "unprognostic (1.25e-2)" "unprognostic (4.77e-1)" "unprognostic (3.61e-2)" "prognostic unfavourable (9.73e-4)" "unprognostic (1.91e-2)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (4.64e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (7.32e-2)" "unprognostic (2.14e-3)" "unprognostic (8.16e-3)" "unprognostic (1.04e-1)" "unprognostic (5.26e-3)" "unprognostic (2.90e-1)" 39.3 5.4 7.4 18.5 8.9 80.9 20.1 8.1 9.9 23.0 17.9 4.7 4.2 17.9 15.4 9.8 56.3 21.6 24.7 20.8 8.2 3.7 7.5 24.5 14.5 35.7 7.4 2.2 20.0 9.6 2.0 5.6 28.7 12.7 15.6 8.8 6.9 12.8 4.5 26.5 31.3 26.1 31.6 10.7 21.4 12.1 6.8 7.6 15.0 7.2 20.1 28.8 32.6 31.2 1.7 1.4 64.6 1.7 8.4 19.0 8.5 3.0 1.2 2.0 1.1 4.6 2.4 23.5 1.0 3.3 2.2 3.6 4.5 4.2 6.0 1.7 1.2 3.5 2.0 3.2 2.0 27.5 1.3 34.8 1.3 5.8 4.7 0.6 64.9 8.3 4.0 2.0 1.3 0.6 29.9 9.8 0.3 0.7 1.9 3.1 3.7 1.9 4.6 3.6 7.1 0.6 18.4 9.7 1.9 2.3 0.2 0.6 0.5 1.0 1.1 1.3 3.9 5.8 1.3 4.6 2.4 116.6 0.5 8.8 1.3 64.6 1.7 24.4 14.7 1.6 19.0 1.7 13.1 12.9 1.4 1.3 11.9 9.0 14.1 8.4 0.9 0.4 9.4 8.5 7.4 8.9 8.1 9.9 8.2 3.7 7.4 2.2 12.7 7.6 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849682 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Approved Enhanced Nucleoplasm,Cytosol 30000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: , HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favourable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favourable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 24.5 36.3 40.0 18.7 38.8 25.6 9.3 27.4 66.0 9.2 15.8 18.1 8.5 22.9 14.0 8.3 11.3 16.4 10.1 25.9 38.0 35.2 17.4 14.5 13.2 14.8 38.7 37.2 13.9 21.1 9.5 13.6 13.3 57.3 23.2 6.5 14.1 21.3 15.7 50.2 10.2 21.7 11.1 19.6 15.4 19.6 24.8 15.0 19.7 9.9 8.1 9.3 11.1 9.7 36.4 72.8 88.2 44.9 40.7 53.8 46.2 25.9 23.8 17.8 16.5 6.2 5.6 10.5 19.4 8.4 14.5 14.0 22.1 8.3 16.1 31.0 7.2 13.3 12.2 11.7 4.6 34.3 52.0 41.8 29.3 19.0 10.1 19.5 24.6 7.6 7.9 9.4 4.4 11.8 18.9 24.5 8.7 18.2 29.5 76.2 17.0 36.6 27.0 18.5 27.0 10.4 12.8 22.4 26.4 18.7 9.4 21.7 12.0 23.4 19.9 20.1 16.1 31.1 31.1 31.6 29.7 21.7 21.5 25.0 24.7 52.2 43.4 88.2 42.0 44.9 39.2 35.6 41.5 42.1 39.7 36.4 33.1 37.2 26.8 40.7 41.7 72.8 53.8 46.2 40.0 38.8 27.4 66.0 38.0 35.2 38.7 37.2 57.3 15.0 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA054483: , HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favourable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favourable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favourable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.1 17.8 18.6 12.7 12.8 10.7 9.9 10.4 11.9 12.8 13.1 9.0 11.3 4.6 30.4 10.7 10.8 16.5 18.3 15.8 11.5 37.1 7.8 21.2 23.4 7.1 12.3 6.6 7.2 10.1 13.9 4.8 12.9 13.1 20.2 9.5 18.3 10.7 20.7 13.3 16.1 10.7 14.8 13.4 16.2 10.6 11.9 21.3 12.2 5.7 10.7 8.8 11.2 13.0 5.8 8.9 15.9 7.5 6.9 7.5 7.6 16.7 12.3 6.3 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favourable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.5 8.8 9.6 9.0 8.1 6.6 11.0 10.0 4.5 11.1 7.5 9.3 5.8 17.7 3.5 5.4 13.3 24.2 18.6 14.4 7.2 7.2 7.4 6.2 10.0 9.1 7.9 4.6 5.5 11.8 8.7 16.4 15.3 23.5 11.0 10.8 7.8 25.9 9.9 21.9 9.9 21.2 11.7 16.1 8.2 8.1 7.9 8.3 6.7 8.0 22.1 8.5 9.9 9.3 6.7 14.5 8.5 12.9 4.9 12.9 32.2 6.9 15.0 15.1 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534849-22714555 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" 8800000 "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: , HPA068771: " "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 13.0 7.3 43.8 20.3 63.8 17.3 6.9 6.6 41.4 13.2 7.8 75.5 1.0 5.9 9.9 5.6 9.2 7.2 15.1 5.9 56.0 31.7 7.6 8.3 11.5 33.4 65.7 22.9 4.3 4.9 29.5 4.2 10.5 36.5 4.4 9.0 5.7 3.9 6.3 2.6 4.0 8.1 14.4 92.0 26.6 8.4 5.4 59.8 10.1 5.9 1.0 38.5 11.5 5.8 14.7 12.0 26.3 16.6 38.4 46.7 39.3 8.7 8.7 10.1 3.2 16.3 22.2 7.7 16.4 17.5 8.9 11.0 8.1 14.2 18.5 6.0 32.9 3.1 8.8 4.6 9.0 40.9 9.1 34.7 6.4 17.9 28.9 6.6 27.3 11.1 4.1 12.1 11.7 13.1 19.3 36.1 16.4 3.6 26.6 6.0 4.1 6.2 10.7 14.5 25.1 13.2 1.7 1.8 4.3 5.2 2.7 26.1 2.3 11.6 15.8 6.9 10.1 12.7 10.0 23.0 13.0 13.5 18.6 20.2 5.3 16.1 8.8 26.3 34.5 15.6 46.7 14.7 27.5 40.0 11.6 8.6 18.6 34.9 10.9 38.4 16.6 12.0 19.6 39.3 43.8 63.8 6.6 30.3 56.0 31.7 65.7 22.9 36.5 59.8 PIP5K1A ENSG00000143398 "Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha" Q99755 1 151197949-151249536 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029366 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA029366: AB_10602116" "unprognostic (1.05e-1)" "unprognostic (2.36e-2)" "unprognostic (8.64e-2)" "unprognostic (7.94e-3)" "unprognostic (1.17e-1)" "unprognostic (3.28e-2)" "unprognostic (1.26e-2)" "unprognostic (3.01e-1)" "unprognostic (8.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.16e-7)" "unprognostic (1.44e-1)" "unprognostic (8.14e-2)" "unprognostic (2.93e-1)" "unprognostic (1.59e-1)" 18.1 19.5 15.7 15.4 21.0 9.6 20.2 22.6 27.6 19.8 18.0 20.3 14.7 16.4 24.8 22.6 20.7 19.4 20.7 18.9 17.3 13.4 17.8 18.3 21.7 17.1 12.7 17.5 20.4 16.6 21.8 25.3 44.6 14.6 17.3 15.6 29.5 17.8 15.2 26.1 20.4 20.4 27.2 16.1 20.1 16.8 42.1 14.0 19.3 20.1 13.9 22.3 16.2 17.7 9.1 8.7 11.7 6.2 4.7 5.9 6.3 17.7 13.8 21.4 24.6 14.1 14.9 21.0 23.4 33.0 43.8 39.3 25.1 17.2 16.1 25.0 24.9 15.1 27.7 16.1 38.4 24.3 19.8 12.8 18.2 11.9 26.7 22.9 16.2 19.9 14.9 27.2 34.5 17.8 12.5 13.8 22.0 24.8 22.8 11.4 31.7 21.4 22.1 18.7 12.0 22.5 10.3 14.3 19.0 31.6 24.4 20.6 25.5 21.7 17.0 17.4 24.4 16.0 28.1 19.3 32.1 36.4 16.9 6.7 20.8 0.1 5.5 7.3 5.3 6.2 4.1 9.1 5.0 5.9 8.4 4.6 5.4 4.2 11.7 4.7 4.8 8.7 3.9 6.3 15.7 21.0 22.6 27.6 17.3 13.4 12.7 17.5 14.6 14.0 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705414-69009176 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 30.3;HEL: 11.3;Hep G2: 9.2;Karpas-707: 6.4;U-266/70: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 22.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favourable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 4.0 9.5 9.4 8.4 6.5 10.2 4.2 33.4 14.6 5.6 26.9 4.1 10.8 26.1 6.1 2.0 1.2 5.0 7.6 24.6 8.1 11.7 6.1 0.8 12.6 2.1 10.4 6.4 1.4 6.7 21.3 8.5 16.8 32.8 3.3 23.1 28.7 11.6 13.6 3.0 2.4 39.7 2.6 3.7 3.1 19.9 17.6 1.5 0.0 1.6 1.9 3.3 3.5 2.9 3.9 0.9 22.1 0.3 0.0 1.0 0.2 0.0 0.0 30.3 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 3.2 0.0 2.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 11.3 0.2 9.2 0.0 0.6 2.8 0.0 1.3 0.0 0.0 0.1 0.5 6.4 0.2 0.7 0.0 0.1 1.5 0.9 0.9 0.1 0.1 0.2 2.3 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 11.7 2.2 1.4 0.0 2.1 0.0 3.1 0.3 22.1 0.0 0.0 0.0 3.3 0.2 0.0 0.1 3.9 0.5 0.0 1.2 0.0 0.1 0.9 1.0 0.2 9.4 6.5 33.4 14.6 8.1 11.7 10.4 6.4 32.8 1.5 PIP5K1C "KIAA0589, LCCS3, PIP5Kgamma" ENSG00000186111 "Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma" O60331 19 3630183-3700479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017168 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017168: AB_1855395" "unprognostic (1.20e-1)" "prognostic favourable (1.79e-4)" "unprognostic (1.36e-3)" "prognostic favourable (7.28e-5)" "unprognostic (7.03e-2)" "unprognostic (4.02e-3)" "unprognostic (5.80e-3)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (2.57e-3)" "prognostic favourable (2.32e-4)" "unprognostic (1.51e-1)" "prognostic favourable (3.00e-4)" "unprognostic (2.25e-1)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" 16.1 10.2 20.5 12.8 25.8 4.5 8.0 58.6 46.3 10.7 23.5 8.5 14.8 10.9 19.8 10.0 12.3 12.8 12.7 13.8 22.8 10.7 7.5 3.8 11.5 7.5 11.3 17.1 11.5 17.2 10.0 9.2 13.7 19.0 16.7 6.4 16.9 20.0 33.4 13.5 10.2 11.5 19.2 6.3 15.8 13.6 23.9 8.7 5.3 9.3 3.9 6.0 17.3 19.0 2.5 3.2 3.6 3.0 1.7 2.8 2.0 9.0 8.6 6.8 8.8 13.3 10.8 10.2 17.5 11.1 7.5 6.1 7.6 2.6 3.8 6.7 18.8 8.1 3.2 5.6 3.1 13.5 5.7 4.4 7.1 6.2 11.0 4.4 13.5 12.0 5.4 6.1 2.3 12.8 6.6 7.1 7.1 7.5 5.3 3.3 7.0 12.0 10.0 5.2 5.2 5.6 7.8 6.8 5.9 9.1 4.9 5.3 3.9 6.6 28.0 10.6 6.0 37.3 8.1 8.2 6.5 1.7 14.3 9.3 7.6 3.6 2.8 0.0 2.8 2.6 1.2 2.5 2.1 2.0 3.2 1.3 1.0 1.6 2.2 1.7 3.0 2.2 1.4 2.0 20.5 25.8 58.6 46.3 22.8 10.7 11.3 17.1 19.0 8.7 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain Uncertain "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favourable (5.27e-5)" 38.3 12.3 9.5 15.1 10.9 20.9 18.5 34.5 12.3 5.9 7.3 6.2 7.4 11.4 9.6 14.4 7.0 10.0 9.5 6.9 6.4 6.9 11.9 8.4 12.9 14.6 8.3 10.1 7.5 10.9 6.0 11.7 38.1 8.6 8.2 3.3 7.7 7.9 7.9 6.4 10.2 8.0 6.2 5.8 16.5 9.7 17.8 7.7 4.2 10.6 5.3 9.8 6.2 7.0 6.9 11.0 28.6 12.9 5.7 6.8 7.9 10.4 9.6 2.9 2.9 8.9 3.4 6.7 8.5 6.8 6.0 6.5 13.9 3.3 6.3 9.1 4.3 11.8 3.9 7.6 1.0 6.9 8.4 6.6 5.9 11.4 18.5 13.7 17.3 6.4 4.3 10.7 4.6 5.3 19.0 3.7 3.4 39.0 5.9 5.9 2.8 4.0 8.4 3.2 6.3 3.8 9.2 7.2 4.2 4.9 16.0 5.5 13.2 7.5 10.3 7.6 9.0 4.8 7.9 4.5 6.2 7.8 7.2 9.2 6.0 9.9 12.9 9.3 6.8 9.5 6.5 6.9 4.9 5.7 11.0 6.3 6.7 5.5 28.6 5.7 5.0 5.4 4.7 7.9 9.5 10.9 34.5 12.3 6.4 6.9 8.3 10.1 8.6 7.7 PITPNA "PITPN, VIB1A" ENSG00000174238 "Phosphatidylinositol transfer protein alpha" Q00169 17 1517718-1562816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol 100000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (1.54e-1)" "unprognostic (6.63e-2)" "unprognostic (2.43e-1)" "prognostic favourable (2.29e-4)" "unprognostic (7.88e-2)" "unprognostic (8.89e-3)" "unprognostic (2.37e-1)" "unprognostic (1.37e-1)" "unprognostic (7.33e-2)" "unprognostic (3.17e-2)" "prognostic favourable (1.80e-6)" "unprognostic (7.41e-2)" "prognostic favourable (9.35e-4)" "unprognostic (1.72e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-2)" "unprognostic (6.81e-3)" 20.2 22.2 31.1 28.1 34.0 38.5 20.8 43.5 54.1 27.5 22.3 21.0 35.0 27.0 29.2 29.8 37.7 33.1 22.2 18.7 30.2 34.2 20.4 22.7 22.5 17.5 34.0 37.5 18.0 17.4 29.3 21.1 31.2 60.7 27.6 27.7 88.0 38.7 33.2 14.3 44.1 42.4 27.0 26.4 21.9 19.7 25.0 18.8 12.4 31.9 15.4 26.8 21.0 23.5 6.4 5.2 12.3 4.0 5.3 7.5 2.5 20.6 23.1 23.6 20.3 26.1 29.0 37.2 23.2 27.0 24.6 18.2 26.6 8.5 26.8 21.1 32.1 26.1 22.5 23.4 34.7 21.9 22.8 14.4 19.9 11.8 26.0 10.0 17.8 21.0 32.0 24.7 26.2 41.9 20.0 14.9 26.4 11.7 25.4 9.1 16.5 11.3 20.4 9.1 15.0 24.6 24.4 8.5 18.6 27.3 20.3 16.6 17.3 8.1 38.3 15.2 13.4 43.6 31.6 9.1 15.4 9.1 26.5 15.7 19.3 5.0 3.7 4.6 3.4 4.0 6.4 6.4 5.1 4.6 5.2 4.2 4.8 4.1 12.3 5.3 2.8 4.1 7.5 2.5 31.1 34.0 43.5 54.1 30.2 34.2 34.0 37.5 60.7 18.8 PITPNB VIB1B ENSG00000180957 "Phosphatidylinositol transfer protein beta" P48739 22 27851669-27920134 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000528 Uncertain Approved Vesicles,Cytosol 150000 Cytosol Vesicles "HPA000528: AB_1079622" "unprognostic (9.29e-2)" "unprognostic (1.64e-1)" "unprognostic (4.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "prognostic unfavourable (5.28e-4)" "unprognostic (1.34e-1)" "unprognostic (7.52e-3)" "unprognostic (4.78e-2)" "unprognostic (8.22e-3)" "unprognostic (1.56e-3)" "unprognostic (2.42e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (6.28e-2)" "unprognostic (2.89e-2)" "unprognostic (1.64e-1)" 32.5 22.2 29.6 24.8 29.3 14.8 25.0 20.8 38.0 23.9 37.8 16.2 24.5 17.1 32.9 23.8 42.2 21.7 28.4 31.3 24.7 24.5 20.5 43.8 23.9 24.6 25.7 29.0 24.8 22.3 21.8 26.9 38.1 27.2 26.5 24.6 15.1 20.2 31.2 16.1 23.5 21.2 49.6 22.6 20.6 28.8 14.7 21.1 19.9 20.0 15.2 30.9 45.3 43.3 24.4 17.1 20.4 14.7 17.7 27.2 16.9 29.9 13.0 23.9 17.8 21.2 25.7 18.2 29.1 25.5 32.0 31.0 20.5 14.2 20.8 15.5 27.9 31.7 34.0 29.0 45.1 35.5 32.1 21.2 21.1 18.8 22.9 48.3 34.5 22.9 28.4 38.7 40.4 31.1 30.0 43.4 29.2 16.0 20.4 23.8 18.1 17.2 26.1 37.8 30.4 26.5 28.6 28.1 35.2 19.9 24.1 23.5 13.0 17.2 30.4 32.1 47.0 24.3 30.3 17.8 20.8 40.9 27.6 24.0 27.1 20.4 12.8 12.4 22.7 14.7 25.0 24.4 22.2 23.6 17.1 20.8 21.6 21.1 11.6 17.7 13.7 15.4 27.2 16.9 29.6 29.3 20.8 38.0 24.7 24.5 25.7 29.0 27.2 21.1 PITPNC1 "RDGB-BETA, RDGBB, RDGBB1" ENSG00000154217 "Phosphatidylinositol transfer protein, cytoplasmic 1" Q9UKF7 17 67377281-67697261 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026563, HPA031250" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA026563: AB_1855409, HPA031250: " "unprognostic (1.33e-1)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.14e-3)" "unprognostic (4.17e-2)" "prognostic favourable (4.85e-5)" "unprognostic (6.57e-2)" "unprognostic (6.32e-3)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "unprognostic (5.70e-2)" "unprognostic (2.31e-2)" "unprognostic (1.34e-2)" "unprognostic (9.83e-2)" "unprognostic (7.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.16e-2)" 20.8 10.0 22.9 18.0 31.0 11.3 16.6 18.9 33.5 12.0 7.5 18.7 7.0 4.6 10.7 11.7 11.0 22.4 12.5 11.7 23.4 19.1 17.3 14.3 13.5 24.3 21.4 17.0 16.7 23.3 5.4 12.3 19.0 22.7 11.2 9.1 31.2 18.3 13.1 5.1 5.2 8.1 11.7 14.8 13.9 11.8 5.1 17.8 14.5 10.4 6.0 27.0 12.0 16.8 1.6 1.6 16.1 5.5 7.2 16.4 5.0 5.8 2.2 5.9 11.4 5.1 7.0 6.8 6.6 5.3 1.3 1.0 0.0 8.7 7.2 2.2 6.1 2.4 10.3 9.9 1.4 13.2 6.0 0.8 9.7 4.7 1.3 1.4 13.6 5.5 4.4 0.8 5.3 5.1 0.6 26.2 5.0 12.7 16.8 6.1 9.9 12.0 21.3 1.3 6.4 12.5 7.1 7.2 19.0 2.6 5.0 5.9 3.7 7.2 5.1 3.1 1.2 4.0 3.1 17.1 8.5 5.6 19.9 5.9 2.5 1.1 2.5 16.1 16.4 4.0 9.6 1.0 10.7 15.5 1.6 1.6 12.3 13.0 3.1 7.2 5.5 0.4 4.0 5.0 22.9 31.0 18.9 25.3 23.4 19.1 21.4 17.0 22.7 17.8 PITPNM1 "DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1" ENSG00000110697 "Phosphatidylinositol transfer protein membrane associated 1" O00562 11 67491768-67506263 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060227 Approved Supported "Cytosol,Cytoplasmic bodies" "Cytosol, Cytoplasmic bodies" "HPA060227: " "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" "unprognostic (1.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.83e-2)" "unprognostic (8.68e-2)" "unprognostic (8.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.77e-1)" "unprognostic (2.26e-2)" "unprognostic (4.61e-1)" "unprognostic (3.27e-2)" "unprognostic (2.32e-2)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (4.62e-2)" "unprognostic (5.69e-2)" 6.5 14.3 20.1 19.6 17.6 20.4 3.5 23.2 30.7 6.0 12.1 6.4 11.0 16.0 7.0 7.2 10.0 20.5 8.0 10.6 16.6 21.6 14.7 7.3 8.6 21.9 17.8 14.2 3.0 6.4 9.3 15.0 6.9 18.6 5.6 6.7 15.6 5.2 9.9 4.6 3.5 17.7 5.2 6.3 15.2 13.6 4.9 8.0 9.3 11.1 4.5 14.6 12.1 4.7 1.6 2.1 2.9 6.8 0.2 2.5 2.0 5.6 14.3 8.8 6.4 9.7 5.8 14.3 5.6 9.9 6.9 3.9 12.8 10.4 5.6 13.5 7.9 14.8 6.7 12.3 2.3 40.6 2.7 7.6 24.7 4.8 7.7 8.5 16.6 7.2 7.9 10.4 6.9 8.3 5.8 5.1 5.7 8.5 14.6 20.3 8.9 6.2 10.6 2.8 7.6 11.6 11.4 8.5 5.4 12.4 17.5 13.6 3.4 7.6 8.1 12.5 9.6 7.9 3.9 7.5 3.5 5.0 17.6 10.3 4.9 0.0 2.6 1.8 2.5 6.8 2.2 1.6 1.7 2.2 2.1 1.2 0.7 1.7 2.9 0.2 5.3 0.8 1.5 2.0 20.1 17.6 23.2 30.7 16.6 21.6 17.8 14.2 18.6 8.0 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell line enriched" "Detected in some" 5 "NB-4: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036587: , HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.2 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.2 0.1 43.9 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 9.6 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 98.7" "Cell line enhanced" "Detected in many" "HAP1: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favourable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 12.6 9.9 21.6 5.5 35.7 2.6 7.9 13.4 23.7 12.2 5.8 8.9 19.3 4.7 9.2 98.7 5.7 10.2 7.1 7.5 18.4 23.4 7.5 4.4 7.4 5.9 14.9 16.7 16.2 6.0 27.1 12.5 10.7 11.7 9.9 5.3 7.2 6.4 20.3 4.7 7.1 4.4 9.8 12.0 5.9 6.5 13.7 9.5 3.0 13.8 2.9 7.4 7.8 7.9 11.2 4.3 2.7 4.5 14.8 17.8 9.0 10.4 8.0 25.1 17.5 8.8 9.3 7.5 7.0 8.4 6.6 8.9 6.5 9.9 1.6 10.9 11.0 9.1 38.5 13.6 8.3 7.8 13.7 3.1 6.6 4.3 11.0 1.8 6.0 9.7 9.1 11.2 6.7 7.4 2.9 1.1 6.7 5.6 0.8 3.5 17.1 13.1 7.5 11.2 2.5 10.6 8.8 18.6 12.1 11.2 1.9 8.5 3.1 2.6 6.7 5.7 9.2 16.9 3.2 0.0 0.1 3.8 6.2 5.1 7.6 2.7 3.3 1.0 15.5 4.5 17.8 8.7 13.7 14.2 3.6 11.2 14.4 16.6 1.1 14.8 2.9 4.3 8.3 9.0 21.6 35.7 13.4 23.7 18.4 23.4 14.9 16.7 11.7 9.5 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Cell line enhanced" "Detected in many" "Karpas-707: 5.8;U-266/70: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA041903: , HPA043634: " "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.7 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.4 0.0 0.7 0.1 0.0 0.1 1.5 1.0 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.6 1.5 5.8 0.8 0.5 1.1 2.3 0.6 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.4 0.2 0.9 0.4 0.5 0.5 1.0 1.8 0.6 1.0 4.6 3.3 0.4 2.2 0.7 1.7 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 PKIG ENSG00000168734 "CAMP-dependent protein kinase inhibitor gamma" Q9Y2B9 20 44531785-44624247 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 102.0;HSkMC: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "memory B-cell: 58.2;naive B-cell: 62.1" "Lineage enriched" "Detected in many" 10 "B-cells: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042703, HPA063690" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042703: AB_10797018, HPA063690: " "unprognostic (3.15e-2)" "unprognostic (5.65e-2)" "unprognostic (8.07e-2)" "unprognostic (1.44e-3)" "unprognostic (3.16e-1)" "unprognostic (9.49e-2)" "unprognostic (3.96e-2)" "unprognostic (6.46e-3)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "prognostic favourable (4.90e-5)" "unprognostic (6.26e-2)" "unprognostic (9.08e-2)" "unprognostic (1.19e-2)" "unprognostic (1.35e-2)" "unprognostic (4.22e-1)" "unprognostic (3.96e-2)" 21.1 25.1 39.2 22.7 31.9 7.5 18.4 12.9 37.7 28.0 44.0 13.5 15.4 12.5 31.8 19.3 31.7 31.4 29.3 107.1 23.0 17.2 22.9 14.4 39.0 17.9 16.7 25.9 17.2 13.3 13.8 19.5 32.6 14.3 30.2 13.3 26.2 18.8 32.5 25.6 8.0 17.9 52.8 11.9 13.2 24.1 41.5 11.4 3.2 25.8 18.6 18.2 42.2 20.3 62.1 6.2 0.4 0.3 0.7 1.6 3.1 5.1 5.3 8.7 5.6 13.1 26.8 1.2 12.5 102.0 14.2 10.7 12.2 2.4 20.1 10.3 10.9 2.0 1.7 2.7 4.6 10.1 3.2 3.1 0.8 8.6 12.2 0.4 0.2 41.4 5.5 6.9 1.5 31.6 2.4 0.5 1.3 6.6 3.1 5.1 4.6 7.7 0.5 0.2 0.4 7.8 1.0 3.5 11.5 3.2 1.5 8.4 4.0 2.5 20.4 19.5 8.7 8.6 6.0 2.7 7.5 14.1 9.7 0.3 8.3 0.4 0.3 0.1 0.2 0.2 0.2 58.2 0.3 0.3 1.5 62.1 1.0 1.6 0.4 0.7 0.2 6.2 0.1 3.1 39.2 31.9 12.9 37.7 23.0 17.2 16.7 25.9 14.3 11.4 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301434 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.2;kidney: 12.4;liver: 47.8" "Cell line enriched" "Detected in some" 9 "K-562: 47.4" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.7" "Low region specificity" "Detected in some" "HPA006653, CAB034376, CAB034378" Enhanced Approved "Golgi apparatus,Cytosol" 2900000 "Golgi apparatus, Cytosol" "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: " "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.1 0.0 0.1 0.3 0.1 7.2 0.1 0.9 0.2 0.1 4.9 0.1 0.1 5.8 0.1 1.3 0.1 0.0 0.7 0.1 0.1 0.4 12.4 47.8 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 17.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: " "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (8.33e-4)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.6 17.3 6.8 9.7 0.1 0.3 18.3 19.2 4.6 12.2 11.7 13.4 14.7 15.4 8.6 2.1 31.7 4.7 6.1 2.2 19.8 15.6 7.8 15.6 11.7 0.0 8.7 22.3 0.2 0.5 7.2 1.9 2.5 22.4 27.4 3.9 37.0 24.4 24.2 11.1 9.2 26.6 15.1 29.8 2.3 5.4 12.9 13.6 9.3 24.2 7.2 13.8 17.4 2.3 16.4 20.8 23.9 20.0 20.8 15.4 26.5 6.2 11.7 19.0 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 PKN1 "DBK, MGC46204, PAK1, PKN, PRK1, PRKCL1" ENSG00000123143 "Protein kinase N1" Q16512 19 14433053-14471867 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003982, CAB010278" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB010278: AB_2163965, HPA003982: AB_1855440" "unprognostic (3.83e-2)" "unprognostic (2.14e-1)" "unprognostic (4.13e-2)" "unprognostic (1.13e-2)" "unprognostic (1.94e-1)" "unprognostic (4.58e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" "unprognostic (8.55e-3)" "unprognostic (4.08e-3)" "unprognostic (2.11e-1)" "unprognostic (1.45e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (4.08e-1)" "unprognostic (2.24e-2)" 28.8 19.5 19.1 27.6 26.7 39.6 25.3 21.9 19.2 19.2 26.0 20.9 16.5 10.0 25.4 19.7 16.6 22.2 22.5 38.3 17.1 17.6 17.9 16.3 27.9 42.2 19.5 16.3 21.7 32.3 15.8 18.7 22.7 19.2 22.6 6.9 21.5 22.6 22.7 43.2 7.6 16.9 22.5 19.4 39.7 24.2 21.5 18.9 39.2 17.8 13.8 24.0 22.1 30.5 11.5 17.0 24.1 30.6 13.5 20.7 15.2 37.2 22.2 8.3 17.2 13.4 15.8 13.7 13.4 16.1 14.2 13.6 8.6 21.4 35.6 34.8 23.0 8.6 13.2 6.0 5.5 28.8 17.1 42.6 14.2 18.4 44.5 16.7 26.8 11.4 4.3 8.6 13.5 32.9 18.8 24.7 10.4 15.3 25.2 15.5 15.0 25.4 33.9 11.3 25.6 7.0 6.1 30.2 42.8 8.3 10.6 21.7 9.6 29.2 49.2 28.3 12.1 34.1 20.3 32.5 29.6 19.4 18.5 33.6 22.1 15.4 17.3 24.1 20.7 24.2 15.7 10.7 14.0 14.2 17.0 11.5 13.1 14.3 21.3 13.5 30.6 11.1 15.9 15.2 19.1 26.7 21.9 17.3 17.1 17.6 19.5 16.3 19.2 18.9 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: , HPA057913: " "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.3 9.2 18.2 10.9 12.2 13.9 11.8 13.8 12.8 15.6 16.2 9.7 16.8 9.2 16.5 13.1 18.4 17.7 10.5 21.3 3.3 12.9 6.8 19.0 8.3 10.7 6.7 2.0 11.4 11.0 12.2 14.8 17.7 11.3 6.7 16.7 4.7 7.7 5.8 9.1 10.7 7.4 27.7 3.8 13.8 46.0 8.8 5.8 20.7 12.0 17.8 8.9 6.1 16.5 13.2 11.9 16.9 14.4 3.7 3.2 6.3 5.5 6.6 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 PKNOX2 ENSG00000165495 "PBX/knotted 1 homeobox 2" Q96KN3 11 125164687-125433389 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 26.7;AN3-CA: 6.6;hTEC/SVTERT24-B: 5.3;LHCN-M2: 7.8;SK-MEL-30: 5.3;WM-115: 14.5" "Cancer enhanced" "Detected in many" "melanoma: 8.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028867, CAB034342, HPA055368, HPA066962" Supported Enhanced "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB034342: AB_2164138, HPA028867: , HPA055368: , HPA066962: " "unprognostic (2.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-2)" "unprognostic (7.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.44e-2)" "unprognostic (7.66e-2)" "unprognostic (3.70e-1)" "unprognostic (4.10e-6)" "unprognostic (1.76e-3)" "unprognostic (7.11e-2)" "unprognostic (1.71e-2)" "unprognostic (6.48e-3)" 5.8 4.1 10.0 3.3 12.4 0.7 1.7 16.3 25.7 5.1 2.8 3.6 0.2 2.0 5.6 4.7 2.7 9.8 3.4 7.9 7.3 6.9 2.9 1.1 9.6 2.4 5.2 12.3 23.6 6.3 0.9 7.3 12.8 6.9 10.2 2.8 24.3 2.5 8.7 19.5 4.0 2.4 4.6 4.6 3.4 2.5 7.2 3.1 0.0 18.3 8.4 2.2 3.3 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.7 6.6 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.3 0.0 5.3 0.0 0.0 0.0 0.0 7.8 0.2 0.0 0.0 2.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.4 16.3 25.7 7.3 6.9 5.2 12.3 6.9 3.1 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in some" 5 "HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 44.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.0 1.0 25.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790745-32896840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 134.7" "Cell line enhanced" "Detected in many" "CACO-2: 60.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 10.4" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 4 "hippocampal formation: 22.1" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favourable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 3.1 0.7 1.4 7.9 5.2 1.1 3.3 2.2 1.8 6.1 14.2 1.4 6.9 6.5 1.2 2.0 3.3 21.6 4.4 134.7 3.9 0.9 3.6 13.6 1.1 3.4 0.7 2.0 9.5 5.4 9.6 14.7 24.1 3.8 3.5 13.3 12.6 24.6 5.0 3.4 1.9 13.3 1.3 1.3 2.4 4.8 3.4 0.4 2.7 0.6 2.3 4.3 2.0 2.1 0.6 3.9 10.4 2.1 1.5 1.0 0.6 16.9 3.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 60.7 15.3 0.0 10.4 0.0 15.1 2.1 13.4 0.0 0.0 4.8 0.1 0.7 15.9 9.5 0.9 0.2 0.0 12.7 0.0 14.7 0.5 3.0 4.8 1.4 4.4 0.0 0.1 9.3 2.9 0.0 7.4 5.0 4.5 8.0 1.9 1.6 0.7 3.5 0.0 7.7 0.2 0.1 0.0 6.8 0.0 4.1 4.0 0.0 0.1 0.0 0.0 0.8 5.1 1.4 10.4 0.4 1.6 1.0 0.2 0.6 0.4 3.9 0.6 0.9 0.5 1.2 1.5 2.1 0.8 0.6 0.6 1.4 5.2 2.2 1.8 3.9 0.9 0.7 2.0 3.8 0.4 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.0;skin 1: 48.4;tongue: 59.0" "Cell line enhanced" "Detected in many" "A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;NK-cell: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 2.3;T-cells: 1.6" "Region enriched" "Detected in single" 37 "cerebellum: 10.0" "Low region specificity" "Detected in many" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: " "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavourable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavourable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.6 0.0 0.2 3.7 0.3 0.0 3.3 0.2 0.3 14.5 14.6 0.3 5.0 11.2 1.9 6.2 69.0 2.6 8.9 0.5 0.3 0.1 0.6 0.2 4.3 0.2 0.2 0.2 1.1 10.2 3.9 3.8 23.2 0.2 4.5 3.6 0.2 12.5 2.5 0.6 48.4 25.4 1.0 0.2 0.3 10.4 0.5 0.2 2.2 5.8 59.0 29.9 2.8 21.5 0.3 0.0 0.0 0.0 2.3 1.6 0.1 37.0 7.2 0.0 0.1 0.0 0.0 15.5 0.3 0.2 0.8 0.4 14.7 26.0 0.0 1.5 0.2 50.0 0.0 18.9 0.1 0.0 9.3 0.0 4.3 10.2 0.1 0.0 0.0 0.1 32.7 0.1 8.0 0.1 11.0 0.2 0.1 23.3 0.1 0.0 0.0 12.5 0.1 0.0 0.1 0.4 7.4 10.6 0.1 10.7 37.9 0.0 13.7 0.1 1.3 0.2 1.3 0.6 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.8 0.0 0.3 0.0 0.7 0.0 2.3 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456964-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: , HPA070648: " "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favourable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favourable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 7.3 3.9 42.7 3.7 42.1 4.2 15.5 14.5 26.6 19.8 7.1 49.9 6.9 7.1 8.3 8.9 10.7 11.8 8.9 12.1 47.7 31.2 34.2 9.7 7.3 3.0 66.9 14.7 8.3 8.7 12.2 6.6 3.4 28.4 7.8 8.1 10.4 19.3 13.1 4.0 9.4 6.4 8.5 111.7 3.2 7.7 5.6 31.6 3.3 18.2 2.4 5.5 9.1 6.9 0.1 0.7 1.0 5.3 0.0 2.1 0.5 16.5 9.2 12.7 14.4 5.9 6.4 12.1 13.8 7.4 20.8 18.1 30.9 15.7 10.6 10.3 16.0 13.4 16.4 13.8 34.9 15.9 8.4 10.0 10.4 25.2 9.9 15.8 2.2 2.8 13.3 14.3 21.9 10.5 13.6 16.9 15.8 18.3 6.9 6.8 13.5 7.0 9.2 19.0 9.1 30.8 12.0 22.2 3.9 9.6 14.4 11.3 17.1 14.5 4.8 12.5 14.0 9.2 17.3 9.7 8.1 7.8 7.3 8.7 12.1 0.0 1.0 0.0 0.4 0.3 0.7 0.0 1.5 0.6 0.4 0.1 1.2 0.4 1.0 0.0 5.3 0.7 2.1 0.5 42.7 42.1 14.5 26.6 47.7 31.2 66.9 14.7 28.4 31.6 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: " "unprognostic (1.35e-1)" "prognostic favourable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.7 0.2 0.5 0.1 0.0 0.2 0.0 0.0 23.4 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261062 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 20000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 23.8 9.1 9.6 6.6 9.4 5.6 19.7 16.4 16.1 5.4 6.2 10.0 4.7 5.0 7.7 11.2 5.7 7.2 8.5 31.3 7.9 8.6 24.1 11.8 15.9 23.1 7.5 9.2 7.4 6.4 11.3 9.2 24.4 7.7 6.2 5.7 8.5 7.6 5.8 39.9 10.0 5.3 8.2 6.8 16.2 6.2 9.3 6.2 11.3 10.4 6.8 4.9 9.1 5.0 3.7 8.8 9.4 18.2 1.3 4.5 7.7 4.7 5.0 4.0 12.7 19.2 14.1 9.3 11.8 15.7 17.8 15.0 11.7 8.8 8.6 14.8 16.7 7.3 4.3 5.0 8.2 2.4 6.5 2.5 4.9 9.3 10.3 2.3 12.7 9.6 5.7 17.8 2.8 10.8 3.6 4.6 11.4 10.2 3.2 7.0 2.5 5.8 4.7 5.8 26.6 8.9 4.4 1.3 2.6 15.7 4.7 9.7 12.3 11.5 8.8 15.5 7.6 20.1 7.3 17.2 14.6 10.4 14.2 6.6 5.9 9.4 14.4 9.3 3.1 16.8 3.2 3.3 3.4 4.5 8.8 3.7 4.5 3.7 0.6 1.3 18.2 7.8 3.2 7.7 9.6 9.4 16.4 16.1 7.9 8.6 7.5 9.2 7.7 6.2 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell line enriched" "Detected in some" 4 "RT4: 13.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: " "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 3.2 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 13.2 0.7 0.1 0.0 1.4 0.0 1.4 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2G6 "iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9" ENSG00000184381 "Phospholipase A2 group VI" O60733 22 38111495-38205690 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" "Calmodulin-binding, Hydrolase" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 31.4;HMC-1: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001171 Approved Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA001171: AB_1079145" "unprognostic (5.26e-2)" "prognostic favourable (7.29e-4)" "unprognostic (8.74e-2)" "unprognostic (6.27e-2)" "unprognostic (3.83e-1)" "unprognostic (3.70e-3)" "unprognostic (8.67e-3)" "unprognostic (9.55e-2)" "unprognostic (3.48e-1)" "unprognostic (1.91e-1)" "unprognostic (2.37e-3)" "unprognostic (4.95e-2)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (3.00e-1)" "unprognostic (1.48e-1)" "prognostic favourable (1.55e-4)" 16.2 17.7 15.6 8.5 20.5 13.1 15.6 15.9 26.3 14.8 7.9 36.9 18.5 9.8 16.3 20.5 8.7 21.6 25.3 6.3 19.7 7.2 18.1 8.6 9.0 12.4 19.3 16.7 21.3 12.8 24.2 12.7 6.8 19.5 17.6 6.3 12.9 20.2 17.4 7.4 18.1 8.7 7.8 14.9 12.1 9.5 30.0 23.2 16.3 45.7 4.1 11.3 12.1 11.2 1.8 5.4 4.1 0.9 8.8 5.7 1.9 0.7 2.8 3.0 7.7 10.0 4.9 8.1 0.9 0.9 0.8 1.1 3.1 1.8 5.8 6.6 2.3 3.6 3.4 1.9 1.0 8.9 13.1 31.4 3.8 3.5 2.8 3.5 20.1 16.1 4.3 2.8 4.4 1.0 5.1 10.6 1.5 4.6 6.5 2.1 2.5 1.8 4.8 1.1 4.5 2.9 6.9 5.7 2.4 1.3 3.1 7.1 3.2 2.5 1.2 2.6 4.4 1.1 0.5 17.4 3.1 3.1 3.7 4.0 1.5 4.1 0.9 0.4 3.8 0.3 1.9 1.8 3.1 5.7 1.5 1.5 1.4 3.9 3.3 8.8 0.6 5.4 3.7 1.9 15.6 20.5 15.9 26.3 19.7 7.2 19.3 16.7 19.5 23.2 PLAA "DOA1, FLJ11281, FLJ12699, PLA2P, PLAP" ENSG00000137055 "Phospholipase A2 activating protein" Q9Y263 9 26904083-26947463 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005035, HPA020994, HPA020996" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 5300 "Plasma membrane, Cytosol" Nucleoplasm "CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (4.00e-3)" "unprognostic (5.00e-1)" "unprognostic (1.61e-1)" "unprognostic (4.06e-2)" "unprognostic (4.50e-3)" "unprognostic (2.48e-1)" "unprognostic (5.54e-2)" "prognostic favourable (7.87e-4)" "unprognostic (3.24e-2)" "unprognostic (1.44e-1)" "unprognostic (9.29e-3)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (1.39e-2)" "unprognostic (5.10e-1)" 13.6 20.1 9.4 12.4 13.1 29.6 11.9 12.9 18.0 13.4 12.3 11.1 13.5 10.5 15.6 12.8 16.2 10.8 13.6 26.2 10.1 10.2 15.0 19.6 14.4 16.4 9.6 10.9 12.3 12.9 15.0 10.0 17.4 13.4 12.1 13.1 9.5 13.4 11.6 52.6 13.5 12.3 16.1 10.0 16.1 12.0 15.7 7.9 27.0 13.0 18.2 14.6 14.9 12.7 13.2 12.2 19.2 17.9 13.5 16.5 8.6 27.2 16.2 20.5 20.7 13.9 17.8 15.4 25.7 14.7 19.7 19.3 5.7 13.1 24.7 21.5 19.6 11.0 20.3 20.3 21.8 32.5 8.6 15.3 26.6 10.9 14.2 12.3 20.9 15.8 12.2 24.0 17.6 19.6 9.3 25.1 21.1 11.4 23.7 12.0 29.7 14.1 16.9 12.9 14.6 15.3 16.4 13.2 22.5 13.8 16.3 8.0 11.3 9.5 23.7 0.0 24.4 12.7 20.7 8.3 17.9 25.7 13.9 17.6 10.2 19.2 11.9 18.7 11.2 16.8 12.5 13.2 11.6 11.3 12.2 11.5 10.7 12.2 11.2 13.5 17.9 6.3 16.5 8.6 9.4 13.1 12.9 18.0 10.1 10.2 9.6 10.9 13.4 7.9 PLAG1 ZNF912 ENSG00000181690 "PLAG1 zinc finger" Q6DJT9 8 56160904-56211324 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 13.0;ASC TERT1: 17.2;HSkMC: 12.2;hTERT-HME1: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA072290 Supported "Nucleoplasm,Nuclear speckles,Centrosome,Cytosol" "Nucleoplasm, Nuclear speckles" "Centrosome, Cytosol" "HPA072290: " "unprognostic (1.89e-2)" "unprognostic (1.93e-2)" "unprognostic (1.22e-3)" "unprognostic (1.63e-4)" "unprognostic (6.81e-2)" "unprognostic (1.07e-1)" "unprognostic (5.63e-3)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (7.99e-2)" "unprognostic (3.42e-2)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (2.83e-2)" "unprognostic (3.94e-1)" "unprognostic (1.21e-2)" "unprognostic (6.14e-2)" 1.9 3.6 2.4 3.5 2.9 2.1 2.5 11.0 2.7 7.6 3.8 4.1 9.0 3.4 3.4 9.8 2.0 7.5 2.1 6.8 1.9 1.8 3.7 1.2 4.6 6.7 4.8 2.1 11.6 2.2 2.1 17.8 8.0 4.6 5.1 1.6 7.9 7.5 9.2 1.4 3.4 5.5 2.5 6.3 6.2 3.0 5.2 4.5 11.7 3.5 1.5 5.2 4.8 7.0 3.5 0.2 1.1 0.5 0.7 4.6 1.0 1.5 0.0 9.5 0.1 13.0 17.2 3.0 4.2 5.5 2.0 0.9 0.6 4.9 0.2 4.1 2.3 0.3 2.6 5.6 2.0 0.1 5.8 6.0 0.5 1.4 2.7 1.9 1.8 12.2 3.1 1.1 12.6 3.7 2.5 0.1 4.2 0.0 0.5 3.6 2.7 1.4 4.7 0.7 3.7 2.6 0.5 0.1 0.0 0.1 0.0 0.3 0.1 1.8 5.6 2.9 3.8 4.7 1.0 1.5 1.1 2.2 3.3 0.7 0.8 1.1 0.1 1.1 0.3 0.1 0.2 3.5 1.0 0.6 0.1 2.0 4.6 4.3 1.0 0.7 0.5 0.2 0.2 1.0 2.4 2.9 11.0 2.7 1.9 1.8 4.8 2.1 4.6 4.5 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 95.0" "Cell line enhanced" "Detected in many" "AF22: 35.0;RH-30: 35.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: " "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavourable (4.94e-6)" "prognostic unfavourable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 14.6 28.5 2.3 14.8 4.3 7.7 12.3 2.0 7.6 12.9 8.9 4.6 10.0 3.9 19.5 16.3 12.4 7.7 13.0 9.0 5.1 1.5 6.8 1.5 12.1 8.2 2.6 2.2 16.0 11.2 5.2 45.6 95.0 3.6 12.6 8.6 19.3 11.7 7.3 4.5 23.1 7.9 16.8 3.8 6.8 10.9 6.8 2.0 3.9 5.6 24.2 12.0 14.2 18.4 4.1 10.3 16.4 8.1 1.7 1.4 2.3 0.0 1.5 35.0 0.0 13.9 28.6 0.1 12.0 7.7 6.0 12.5 0.1 1.9 0.8 5.9 10.4 0.0 0.2 4.2 11.8 0.9 1.6 14.9 17.5 0.2 4.6 13.3 3.0 21.5 1.5 5.2 4.6 11.8 1.4 0.2 7.1 2.0 5.5 6.2 5.8 1.1 6.7 35.6 0.0 11.2 0.3 3.1 3.4 17.3 0.0 0.0 0.0 16.5 6.8 0.0 12.8 27.7 12.9 3.1 3.0 0.1 9.2 5.5 0.6 3.4 8.1 16.4 1.0 6.2 1.0 2.7 0.9 1.4 10.3 4.1 0.7 1.2 14.8 1.7 1.9 4.6 1.3 2.3 2.3 4.3 2.0 7.6 5.1 1.5 2.6 2.2 3.6 2.0 PLAGL2 ZNF900 ENSG00000126003 "PLAG1 like zinc finger 2" Q9UPG8 20 32192503-32207791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "intermediate monocyte: 11.7;non-classical monocyte: 20.7" "Lineage enriched" "Detected in many" 14 "monocytes: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005900 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005900: AB_1079629" "unprognostic (9.40e-2)" "unprognostic (1.67e-1)" "unprognostic (6.95e-3)" "unprognostic (1.09e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-3)" "unprognostic (8.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-2)" "unprognostic (2.26e-1)" "unprognostic (3.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (7.90e-2)" "unprognostic (1.09e-1)" 5.9 5.1 6.1 9.0 7.8 30.2 5.8 10.5 7.7 6.9 10.6 6.8 5.6 11.5 9.6 6.6 17.9 10.9 5.8 5.6 6.2 4.0 7.0 6.1 9.3 9.0 5.8 4.9 11.7 11.6 8.5 12.9 5.4 7.2 7.6 9.2 9.8 10.2 6.7 10.1 10.4 24.8 8.3 4.2 10.4 10.1 33.2 7.4 16.4 7.9 13.7 12.9 6.8 11.4 0.9 1.4 1.4 20.7 0.3 1.0 1.2 7.8 4.5 12.0 4.3 4.5 3.4 7.5 3.1 4.9 6.7 6.2 33.5 3.9 8.0 4.3 3.2 7.7 14.9 7.1 9.0 4.7 6.7 32.5 3.6 16.0 5.4 14.2 7.2 4.2 6.4 5.4 3.8 4.8 11.4 7.3 3.5 4.4 15.5 9.8 5.6 5.1 10.1 15.5 5.1 2.9 6.0 5.4 6.0 7.6 4.1 6.7 6.2 17.4 3.6 8.2 8.8 5.9 6.3 20.1 11.1 10.4 4.8 30.1 5.0 1.4 2.1 0.5 0.5 11.7 1.0 0.9 0.6 1.0 1.4 0.6 0.8 0.4 0.6 0.3 20.7 0.3 0.5 1.2 6.1 7.8 10.5 7.7 6.2 4.0 5.8 4.9 7.2 7.4 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA007951: " "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favourable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.0 0.0 0.0 0.1 0.0 13.3 3.8 4.0 2.5 1.1 0.9 0.0 0.2 38.0 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.5 0.0 0.0 0.9 1.2 5.1 18.6 0.0 1.5 0.1 30.6 1.9 0.0 0.0 3.2 3.8 0.0 0.0 0.2 39.1 2.8 10.2 7.0 0.0 9.2 5.6 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607765-218637184 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009914, HPA038139, HPA038140" Enhanced Approved "Nuclear membrane,Plasma membrane,Cytosol" Cytosol "Nuclear membrane, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.1 2.5 1.5 1.0 1.6 0.5 1.0 0.9 2.4 0.6 6.4 0.3 3.8 0.9 0.8 1.1 3.7 0.6 0.9 0.9 1.0 1.5 3.9 0.5 0.7 0.7 1.6 1.0 0.7 0.4 1.4 4.7 0.6 2.6 6.4 1.5 23.0 1.4 0.6 62.5 0.8 1.4 33.1 1.1 0.5 3.5 3.9 0.5 0.0 1.4 6.8 0.5 9.6 5.3 0.9 1.2 0.3 0.4 0.9 0.9 1.0 0.6 1.5 2.1 0.4 0.2 1.4 1.2 1.2 2.6 0.4 1.4 2.4 0.3 1.4 1.8 0.4 1.0 0.0 1.5 0.3 0.5 1.8 1.2 3.5 1.9 0.2 1.2 0.6 3.0 0.1 1.9 0.5 2.7 1.0 1.1 2.2 1.8 0.4 1.2 0.7 3.4 0.9 0.8 0.5 4.3 3.0 2.3 21.1 1.0 0.8 0.3 2.5 0.5 6.0 1.5 1.2 0.7 0.7 0.5 0.8 0.9 4.6 0.3 1.6 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.3 0.9 0.3 0.9 0.7 0.8 0.3 0.9 0.0 1.2 0.7 1.0 1.5 1.6 0.9 2.4 1.0 1.5 1.6 1.0 2.6 0.5 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Supported "Endoplasmic reticulum,Cytosol" 490000 "Endoplasmic reticulum, Cytosol" "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favourable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favourable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 13.9 43.2 28.0 44.0 77.9 37.1 21.3 34.7 35.4 25.2 28.9 8.2 15.8 6.1 36.4 30.1 6.5 6.7 13.6 11.0 22.6 24.6 6.5 14.8 10.3 53.2 2.7 75.0 70.6 28.5 19.2 13.2 21.1 23.0 24.6 18.1 18.3 4.7 13.0 18.2 8.9 6.0 21.3 24.9 12.9 10.5 20.1 33.4 16.6 10.3 18.5 14.2 47.0 37.2 21.3 10.2 18.0 7.7 25.6 27.3 6.3 34.2 10.9 13.1 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell line enhanced" "Detected in some" "A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: " "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 3.9 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.5 2.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915147-143976734 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.9" "Cell line enhanced" "Detected in many" "PC-3: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Enhanced "Intermediate filaments,Focal adhesion sites,Cytosol" 7100000 "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavourable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavourable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 20.9 11.0 15.9 16.5 13.3 27.9 13.1 15.0 20.7 20.7 17.7 14.6 16.7 13.1 20.2 16.8 25.1 18.2 29.0 23.4 18.9 10.7 11.2 10.9 16.6 15.0 9.9 13.0 18.0 14.0 8.8 12.0 24.2 13.2 17.5 9.8 13.0 17.8 14.8 144.9 36.4 24.1 24.7 11.0 16.9 21.4 6.7 12.7 16.3 9.2 44.2 24.5 20.2 19.2 1.5 3.4 0.8 4.1 0.7 2.9 3.2 16.3 51.2 3.3 4.1 6.0 13.4 11.7 24.0 10.7 6.4 3.6 7.1 17.1 1.6 18.7 35.1 19.4 2.2 33.6 2.5 12.2 1.8 6.2 52.0 5.8 9.5 2.0 5.2 15.4 6.6 17.2 33.6 7.4 3.0 5.3 7.4 28.7 1.2 3.4 2.2 72.1 0.3 9.4 4.4 10.7 30.3 3.4 3.4 40.9 8.7 3.9 10.7 2.4 23.8 24.8 44.9 21.8 28.4 0.8 0.6 1.2 23.6 2.6 35.2 0.0 4.1 0.2 1.4 3.8 2.8 1.4 2.7 2.0 3.4 1.5 2.0 1.1 0.8 0.7 2.7 2.8 2.9 3.2 15.9 13.3 15.0 17.3 18.9 10.7 9.9 13.0 13.2 12.7 PLEK2 ENSG00000100558 "Pleckstrin 2" Q9NYT0 14 67386983-67412200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.4;CAPAN-2: 28.2;HBEC3-KT: 52.6;PC-3: 19.2;TIME: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in single" 8 "T-cells: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA001208 Enhanced Uncertain Vesicles,Cytosol Vesicles Cytosol "HPA001208: AB_1079631" "unprognostic (4.41e-3)" "unprognostic (3.77e-1)" "unprognostic (1.15e-1)" "unprognostic (6.23e-2)" "unprognostic (6.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.18e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.97e-1)" "unprognostic (9.21e-3)" "prognostic unfavourable (8.26e-5)" "unprognostic (1.06e-1)" "unprognostic (3.09e-3)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (8.98e-2)" "unprognostic (4.59e-2)" 1.7 28.8 0.5 7.6 1.1 4.1 1.5 0.5 0.8 2.4 14.9 1.4 1.6 12.4 1.1 14.9 9.7 0.4 7.4 0.5 0.5 0.2 6.0 29.1 1.9 0.5 0.5 0.5 1.0 16.5 2.5 0.9 2.6 0.7 5.1 12.7 0.9 6.9 2.3 1.4 12.1 28.1 1.2 0.7 0.6 8.5 2.4 0.5 13.9 28.6 6.5 6.5 4.8 4.4 0.0 0.8 0.0 0.1 0.0 6.5 1.2 26.4 4.0 0.0 0.0 0.0 0.3 2.6 5.3 0.8 1.2 1.5 14.4 28.2 0.0 5.2 0.7 12.6 0.0 52.6 3.0 0.0 0.2 0.0 6.1 0.1 1.1 0.0 0.0 0.6 3.8 1.4 16.9 4.4 0.1 0.1 0.9 8.4 0.0 0.0 0.1 19.2 0.0 0.0 4.1 9.0 0.7 0.2 0.0 5.0 2.3 1.5 3.5 0.2 20.5 0.0 16.5 0.1 0.1 0.0 0.0 0.1 3.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.7 0.8 0.0 6.5 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.5 1.1 0.5 0.8 0.5 0.2 0.5 0.5 0.7 0.5 PLEKHA1 TAPP1 ENSG00000107679 "Pleckstrin homology domain containing A1" Q9HB21 10 122374696-122442602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002043, HPA064795" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002043: AB_1079632, HPA064795: " "unprognostic (1.79e-2)" "unprognostic (3.18e-2)" "unprognostic (2.70e-1)" "unprognostic (5.44e-3)" "unprognostic (7.41e-2)" "unprognostic (1.69e-1)" "unprognostic (5.50e-2)" "unprognostic (4.07e-2)" "unprognostic (3.88e-1)" "unprognostic (2.69e-1)" "unprognostic (7.98e-2)" "unprognostic (7.63e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (7.42e-2)" "unprognostic (4.31e-2)" "unprognostic (5.23e-2)" 11.7 7.4 18.2 8.7 30.2 2.6 13.6 15.8 37.9 13.6 14.9 25.4 11.4 17.1 17.9 14.5 26.7 8.8 16.3 19.4 19.8 16.6 27.1 25.4 24.4 9.0 15.6 24.4 13.9 18.1 18.8 22.9 30.6 20.7 12.7 13.9 9.5 16.0 13.6 22.5 43.9 17.2 16.0 19.6 8.7 14.0 25.5 15.0 3.4 18.7 13.9 11.7 16.1 16.1 6.9 1.8 1.3 1.6 11.6 16.5 6.2 7.7 7.1 7.2 5.0 10.5 12.0 8.7 8.6 15.1 5.2 5.7 6.0 9.7 4.8 4.2 7.7 17.0 6.8 26.3 4.8 3.4 6.7 0.0 7.0 7.0 6.9 0.8 2.3 6.5 21.8 4.3 18.4 17.5 7.1 0.0 4.8 2.9 4.3 0.7 5.6 4.8 1.2 10.3 0.9 63.5 8.6 9.9 4.8 11.1 8.3 8.7 4.6 0.0 16.6 4.4 3.6 4.8 4.3 0.0 0.0 1.6 6.8 0.0 2.7 0.1 1.5 1.3 16.5 1.4 10.8 2.9 10.0 13.2 1.8 6.9 15.9 13.5 0.5 11.6 1.6 0.9 6.6 6.2 18.2 30.2 15.8 37.9 19.8 16.6 15.6 24.4 20.7 15.0 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavourable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 7.7 9.7 8.8 19.1 6.6 14.2 6.4 3.4 6.9 8.6 8.2 4.8 11.8 3.7 9.0 11.5 6.7 6.9 8.9 17.7 7.0 4.7 7.3 4.0 9.7 29.9 6.6 6.9 10.5 4.5 15.3 6.9 6.9 4.8 9.0 5.0 16.7 5.9 10.3 5.4 5.4 8.8 9.9 8.0 16.3 6.4 5.0 5.7 5.2 7.8 3.2 26.2 12.8 8.6 14.2 5.3 7.5 2.0 3.8 2.7 0.9 9.4 2.2 1.4 3.4 3.6 7.1 1.5 11.5 9.1 8.8 7.5 1.2 6.5 52.8 13.7 10.5 6.0 3.7 7.3 13.3 13.3 0.3 26.9 18.7 1.3 13.0 8.6 11.0 16.2 5.0 4.6 8.2 1.5 2.6 15.3 8.2 1.2 17.6 4.1 1.3 3.3 4.5 7.4 11.2 10.7 8.2 0.1 2.1 13.4 2.5 9.2 5.7 4.3 2.1 6.4 5.0 1.1 9.1 4.8 4.5 24.6 10.2 9.4 1.4 5.2 1.5 7.5 2.0 2.0 2.1 8.9 2.3 2.3 1.8 14.2 1.5 2.7 3.4 3.8 2.0 5.3 1.9 0.9 8.8 6.6 3.4 6.9 7.0 4.7 6.6 6.9 4.8 5.7 PLEKHA4 PEPP1 ENSG00000105559 "Pleckstrin homology domain containing A4" Q9H4M7 19 48837097-48868632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 27.4;ASC TERT1: 18.7;BJ hTERT+ SV40 Large T+ RasG12V: 21.8;SK-MEL-30: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA042978, HPA048473" Uncertain Approved "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Cytokinetic bridge, Centriolar satellite" "HPA042978: , HPA048473: " "prognostic favourable (1.97e-4)" "unprognostic (4.39e-1)" "unprognostic (8.16e-2)" "unprognostic (2.85e-2)" "unprognostic (3.98e-1)" "unprognostic (4.20e-2)" "prognostic unfavourable (8.68e-4)" "unprognostic (5.09e-2)" "unprognostic (1.01e-2)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.84e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-3)" "unprognostic (6.38e-2)" 14.0 10.2 5.0 10.1 7.7 0.3 11.4 4.5 5.5 9.4 14.6 6.1 3.5 4.7 13.2 5.6 8.7 10.2 9.7 19.3 3.9 3.0 9.7 10.8 9.6 5.7 28.9 2.6 22.8 11.4 3.1 13.3 5.2 12.4 9.7 3.4 12.5 6.0 8.1 8.9 5.9 5.1 23.3 13.5 8.0 7.9 6.2 4.4 7.4 12.9 5.8 6.3 11.0 7.3 7.4 2.0 1.4 0.7 1.2 5.3 1.6 3.7 0.2 4.3 27.4 6.3 18.7 3.5 3.0 10.7 11.7 21.8 2.5 1.0 0.1 5.2 4.1 1.1 1.5 1.5 1.8 0.0 1.4 0.9 0.6 2.7 4.9 0.0 6.2 9.6 0.9 6.8 0.4 3.4 3.9 2.3 3.2 2.3 1.3 0.2 0.6 0.3 0.1 13.7 0.2 3.6 0.0 0.0 4.8 1.2 1.1 31.5 1.7 1.2 0.5 3.7 3.0 4.8 0.7 12.4 10.3 2.2 4.4 0.3 9.9 0.0 0.6 1.4 3.1 0.7 2.3 3.0 3.0 2.0 0.2 7.4 5.3 4.7 0.3 1.2 0.5 2.0 1.0 1.6 5.0 7.7 4.5 5.5 3.9 3.0 28.9 2.6 12.4 4.4 PLEKHA5 "FLJ10667, KIAA1686, PEPP2" ENSG00000052126 "Pleckstrin homology domain containing A5" Q9HAU0 12 19129752-19376400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 28.0;NTERA-2: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 14.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035923, HPA035924, HPA041455" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: " "unprognostic (3.16e-1)" "unprognostic (8.35e-3)" "unprognostic (1.30e-1)" "unprognostic (4.85e-3)" "unprognostic (6.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.35e-2)" "unprognostic (3.62e-1)" "unprognostic (2.55e-1)" "prognostic unfavourable (5.41e-5)" "unprognostic (3.71e-1)" "prognostic unfavourable (7.42e-5)" "unprognostic (1.27e-1)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (1.07e-2)" 7.7 52.3 13.8 7.8 22.0 2.9 11.9 13.0 22.4 23.5 9.8 7.2 19.4 10.0 23.1 25.7 16.0 16.0 16.7 25.2 11.2 11.5 32.2 12.1 9.9 2.4 10.7 16.3 26.1 11.3 27.2 14.4 10.2 15.0 17.6 10.8 22.2 11.4 22.7 2.0 13.2 10.0 23.1 23.7 2.8 13.7 14.8 13.0 6.1 11.5 5.9 4.3 18.1 18.1 0.4 2.7 14.8 0.4 1.7 6.4 0.4 11.0 5.4 20.0 0.2 6.8 9.2 7.1 4.7 10.3 2.9 4.6 8.1 10.0 0.2 1.6 5.2 4.7 13.4 8.8 6.0 28.0 4.8 6.5 12.1 3.9 6.3 0.2 0.9 5.3 9.2 8.2 15.7 3.0 2.8 0.4 3.0 3.4 4.3 0.8 28.6 2.8 0.1 9.3 0.1 20.1 13.1 1.8 4.1 4.6 2.7 16.9 3.3 1.5 4.6 1.9 7.9 0.5 0.2 0.3 0.2 0.2 4.4 0.1 3.6 14.8 0.4 0.3 2.7 0.3 6.4 0.2 2.5 2.3 1.8 0.4 0.4 1.9 1.0 1.7 0.2 2.7 2.1 0.4 13.8 22.0 13.0 22.4 11.2 11.5 10.7 16.3 15.0 13.0 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218851-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.1" "Cell line enhanced" "Detected in many" "A-431: 20.6;BEWO: 33.5;CAPAN-2: 28.0;RT4: 23.2;SK-BR-3: 20.7;T-47d: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028152 Enhanced Approved "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA028152: AB_10601048" "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favourable (3.57e-4)" 2.4 4.6 18.2 4.1 27.8 0.4 10.6 60.1 34.5 3.4 23.2 13.4 1.4 18.2 2.6 10.0 13.0 7.4 9.8 11.8 14.2 11.4 20.9 13.9 2.4 0.6 11.5 23.3 2.8 7.6 3.7 17.6 6.3 18.9 9.4 21.9 21.7 5.2 11.2 2.6 2.0 20.8 4.8 19.0 1.9 29.1 2.7 14.2 0.0 2.2 1.3 1.9 7.3 6.1 0.9 1.4 0.1 0.2 0.0 0.4 0.0 20.6 13.0 8.2 0.0 0.1 0.2 33.5 0.7 2.3 0.0 0.1 6.2 28.0 0.1 6.2 0.4 2.3 0.1 2.2 0.1 0.0 1.3 0.0 5.1 8.8 1.2 0.0 0.0 0.3 6.9 0.0 1.8 3.7 0.0 0.0 8.5 9.2 0.0 0.0 2.6 15.9 0.0 0.0 0.0 8.3 23.2 1.7 17.2 9.4 20.7 0.1 19.7 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 18.2 27.8 60.1 34.5 14.2 11.4 11.5 23.3 18.9 14.2 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;RT4: 39.3;SK-BR-3: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: " "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favourable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 0.0 0.5 0.1 0.7 3.3 3.0 0.1 2.7 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 PLEKHA8 "FAPP2, MGC3358" ENSG00000106086 "Pleckstrin homology domain containing A8" Q96JA3 7 30027404-30130483 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072314 Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA072314: " "unprognostic (5.49e-3)" "unprognostic (8.62e-3)" "unprognostic (2.39e-1)" "unprognostic (5.14e-2)" "unprognostic (1.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.70e-4)" "unprognostic (5.96e-2)" "unprognostic (2.86e-1)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.96e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (3.07e-2)" 7.3 5.6 9.7 7.2 11.6 3.2 7.5 16.3 13.0 8.5 7.8 8.3 4.8 8.3 8.6 10.0 9.2 5.4 7.7 6.0 8.2 7.5 14.0 6.1 7.1 8.7 9.9 5.8 9.3 9.0 10.5 8.8 21.0 9.9 7.6 8.4 9.1 8.5 9.0 4.8 7.9 9.0 8.7 7.8 5.2 6.9 8.1 9.6 6.9 6.6 1.7 10.2 8.7 8.6 1.2 0.5 2.8 0.9 1.0 1.7 0.3 6.5 4.5 20.7 21.9 5.9 4.7 14.4 4.8 3.8 3.8 5.0 8.5 2.9 15.4 6.6 4.8 4.8 10.8 5.7 5.5 2.9 7.2 8.9 7.6 7.9 5.1 3.9 3.1 2.3 4.4 5.2 7.4 8.2 8.1 5.6 5.5 4.4 7.7 2.8 13.8 5.1 0.0 5.9 10.3 4.3 5.3 2.7 15.8 5.3 17.3 6.9 6.0 4.0 7.0 3.4 14.5 3.5 5.5 11.6 20.2 9.0 6.7 2.5 8.1 2.8 0.6 2.5 1.7 0.6 0.9 1.2 1.0 1.1 0.5 0.8 1.2 1.6 0.1 1.0 0.9 0.1 1.0 0.3 9.7 11.6 16.3 13.0 8.2 7.5 9.9 5.8 9.9 9.6 PLEKHG2 "ARHGEF42, CLG, FLJ00018" ENSG00000090924 "Pleckstrin homology and RhoGEF domain containing G2" Q9H7P9 19 39412585-39428415 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 31.9;REH: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017973, HPA048054" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017973: , HPA048054: " "unprognostic (3.55e-1)" "unprognostic (6.73e-2)" "prognostic unfavourable (3.53e-4)" "unprognostic (3.97e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.24e-2)" "unprognostic (4.48e-2)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (2.10e-1)" "unprognostic (4.99e-1)" "prognostic unfavourable (3.79e-8)" "unprognostic (8.01e-2)" "unprognostic (3.90e-2)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" 15.7 6.1 2.9 30.8 4.4 14.8 14.2 2.8 4.0 18.7 12.4 3.9 5.6 5.9 20.3 10.1 9.7 12.6 17.6 13.5 3.5 2.6 10.7 5.1 21.4 20.2 4.5 2.2 17.5 4.4 5.8 7.6 17.4 7.4 12.3 3.9 13.6 6.8 15.0 7.1 4.4 9.6 14.1 6.9 24.8 8.8 8.7 3.6 49.3 11.1 9.5 24.6 13.0 10.1 3.9 4.2 2.8 1.8 1.4 4.4 2.7 3.5 17.5 31.9 17.3 3.0 4.0 4.6 9.4 7.4 6.5 5.6 11.2 6.4 6.2 6.9 12.2 1.2 4.8 8.3 3.5 20.5 4.4 8.1 9.1 5.1 5.3 0.9 10.1 9.2 1.4 7.8 3.8 8.3 5.4 7.3 10.4 7.1 10.0 3.1 7.5 1.7 36.1 3.9 1.8 5.6 6.6 0.8 10.3 2.1 0.7 3.1 9.4 9.2 10.6 17.2 13.5 6.3 6.0 5.4 1.6 9.1 9.5 3.6 9.5 2.8 1.4 0.4 4.4 0.8 2.6 3.9 2.1 2.5 1.0 3.6 2.8 3.5 2.6 1.4 1.8 4.2 3.9 2.7 2.9 4.4 2.8 4.0 3.5 2.6 4.5 2.2 7.4 3.6 PLEKHG3 "ARHGEF43, KIAA0599" ENSG00000126822 "Pleckstrin homology and RhoGEF domain containing G3" A1L390 14 64704102-64750247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063455, HPA065323, HPA073702, HPA074734" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Cytokinetic bridge, Centrosome" "HPA063455: , HPA065323: , HPA073702: AB_2732238, HPA074734: AB_2732265" "unprognostic (8.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.38e-2)" "unprognostic (4.04e-2)" "unprognostic (2.18e-1)" "unprognostic (7.22e-2)" "unprognostic (7.21e-2)" "unprognostic (5.53e-3)" "unprognostic (1.49e-1)" "unprognostic (3.34e-3)" "unprognostic (3.63e-1)" "unprognostic (3.54e-2)" "prognostic favourable (7.39e-8)" "unprognostic (2.29e-1)" "unprognostic (2.67e-1)" "unprognostic (4.24e-2)" "unprognostic (2.67e-3)" 12.8 2.9 17.2 7.8 36.9 11.4 19.8 7.3 29.4 15.2 15.9 67.3 9.3 10.2 31.6 9.9 26.4 19.8 17.5 12.5 24.2 12.8 19.5 16.5 8.4 4.0 40.7 21.6 16.8 22.7 17.9 3.7 22.3 19.5 12.3 12.1 13.6 19.6 31.6 5.9 19.6 10.0 20.7 24.5 16.0 11.5 5.1 40.9 1.2 14.5 6.4 5.3 16.6 17.1 0.0 0.7 16.7 1.9 6.4 12.2 2.9 28.5 13.3 11.1 16.8 1.2 0.0 19.3 3.2 3.8 5.1 4.1 14.0 12.6 0.0 5.8 3.1 27.6 7.5 25.4 1.7 0.0 6.5 12.7 16.4 3.3 1.5 0.4 6.1 1.5 14.8 1.0 9.2 3.3 0.0 0.1 1.7 13.5 0.0 11.6 3.7 14.2 0.1 5.5 1.9 14.0 20.9 3.8 6.8 6.6 9.9 9.5 10.8 2.8 6.4 2.2 23.0 0.1 4.4 0.0 0.0 0.0 0.2 1.3 3.9 4.5 1.9 11.7 12.2 1.1 8.6 0.0 3.7 5.2 0.7 0.0 0.4 2.7 16.7 6.4 0.7 0.0 1.1 2.9 17.2 36.9 7.3 29.4 24.2 12.8 40.7 21.6 19.5 40.9 PLEKHG6 "FLJ10665, MYOGEF" ENSG00000008323 "Pleckstrin homology and RhoGEF domain containing G6" Q3KR16 12 6310436-6328506 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.4;placenta: 39.6" "Cell line enhanced" "Detected in some" "BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.9;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041459, HPA058230" Uncertain Supported "Cell Junctions,Centrosome" "Cell Junctions" Centrosome "HPA041459: AB_10794518, HPA058230: " "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" "unprognostic (1.44e-1)" "unprognostic (8.03e-3)" "unprognostic (5.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.20e-2)" "unprognostic (1.22e-1)" "unprognostic (3.13e-1)" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (4.18e-2)" "unprognostic (5.73e-2)" 7.5 0.2 0.3 8.9 0.7 1.0 15.8 0.3 0.4 4.4 30.3 0.4 1.1 19.4 0.6 1.6 19.9 0.5 6.7 1.2 0.3 0.0 1.1 2.5 1.8 0.3 0.3 0.3 0.6 4.5 1.9 3.3 39.6 0.5 2.6 9.6 0.7 8.8 2.3 0.3 6.7 43.4 0.5 0.3 0.4 5.7 0.5 0.3 0.5 3.4 11.3 8.6 6.8 8.6 0.3 3.9 2.5 0.2 0.1 0.4 0.1 0.2 2.1 0.2 0.0 1.1 0.1 55.6 0.1 0.0 0.1 0.1 17.6 9.7 0.1 0.1 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 3.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.2 4.6 0.3 0.0 0.0 0.1 0.0 18.7 0.1 0.0 0.4 8.3 0.1 2.7 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.4 2.5 0.1 0.1 3.9 0.1 0.1 0.3 0.7 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637273-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.1;RPTEC TERT1: 8.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: " "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 10.1 2.7 3.7 9.2 6.5 0.3 7.5 5.4 5.6 27.2 8.5 2.9 3.6 4.1 30.0 9.5 5.2 9.8 8.1 3.7 4.2 2.7 8.7 1.8 21.7 3.0 3.4 3.3 19.4 2.5 9.6 1.8 4.2 8.3 7.9 5.0 7.4 3.8 7.8 5.4 6.9 5.7 13.1 9.7 4.7 4.1 4.2 4.0 0.0 4.7 4.7 4.3 11.1 8.6 0.8 0.6 1.4 0.4 0.7 1.0 0.0 0.6 5.1 2.1 0.1 4.2 10.1 0.4 0.7 2.6 1.0 2.7 0.0 1.8 1.3 0.3 0.8 3.4 0.6 0.8 2.0 0.1 1.5 0.1 0.7 0.2 0.6 0.0 0.7 2.9 0.8 2.6 0.1 2.3 4.8 0.2 0.9 1.4 0.9 0.2 1.1 5.1 0.0 6.1 0.1 8.3 0.3 1.6 0.8 0.5 0.0 5.1 0.7 0.2 0.2 6.0 1.7 0.3 1.8 1.2 0.3 0.0 2.4 0.0 0.6 0.8 0.4 0.4 0.4 0.2 0.4 0.3 0.7 0.5 0.2 0.8 1.0 0.6 1.4 0.7 0.3 0.6 0.5 0.0 3.7 6.5 5.4 5.6 4.2 2.7 3.4 3.3 8.3 4.0 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: " "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favourable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavourable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 8.0 3.6 2.5 3.6 4.5 10.9 5.3 7.6 5.6 6.1 4.1 2.6 0.9 2.2 2.9 2.0 17.2 3.7 3.8 3.9 4.2 1.7 1.7 3.1 4.5 7.3 10.5 2.9 2.5 4.2 3.5 3.6 2.8 4.7 2.6 3.0 3.4 7.6 2.7 6.3 5.8 3.4 2.5 5.3 4.5 3.0 2.4 3.4 6.7 3.8 6.5 10.4 5.2 6.7 2.4 1.3 9.8 1.4 1.3 1.4 0.9 5.8 8.5 1.5 2.8 6.0 2.9 5.3 1.7 3.9 3.0 3.1 2.6 3.2 3.0 5.1 5.6 1.5 3.5 2.1 0.9 11.8 4.1 0.0 3.1 3.5 6.3 0.0 4.4 11.3 6.7 4.8 7.9 9.0 2.9 3.5 4.7 3.6 5.8 1.1 0.9 6.0 2.6 3.1 2.7 4.4 9.0 2.6 2.4 3.0 2.3 3.2 5.2 2.5 10.3 7.3 2.7 5.5 3.0 3.6 3.8 1.2 4.1 1.5 3.0 3.8 1.4 1.3 1.4 1.0 0.8 2.4 1.0 1.1 1.3 1.0 0.7 0.6 9.8 1.3 1.3 1.0 1.2 0.9 2.5 4.5 7.6 5.6 4.2 1.7 10.5 2.9 4.7 3.4 PLEKHM3 "DAPR, PLEKHM1L" ENSG00000178385 "Pleckstrin homology domain containing M3" Q6ZWE6 2 207821288-208025560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035046 Uncertain Approved Vesicles,Cytosol Cytosol Vesicles "HPA035046: AB_10603128" "unprognostic (3.62e-1)" "unprognostic (1.58e-2)" "unprognostic (8.27e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (4.77e-2)" "unprognostic (6.06e-2)" "unprognostic (8.20e-2)" "unprognostic (4.13e-2)" "unprognostic (2.92e-3)" "unprognostic (2.17e-1)" "unprognostic (1.09e-1)" "unprognostic (4.86e-4)" "unprognostic (2.42e-1)" "unprognostic (3.12e-1)" "unprognostic (5.72e-2)" "unprognostic (1.33e-2)" 6.5 10.9 10.0 4.1 11.2 11.1 5.1 11.8 16.8 5.6 5.0 10.6 2.1 3.3 6.2 3.4 4.2 4.5 4.5 6.6 7.3 7.8 5.1 6.8 6.2 4.3 6.2 11.4 9.1 4.8 17.3 7.2 4.6 13.1 6.4 4.9 6.5 5.4 4.8 5.1 5.2 3.9 5.9 8.6 4.9 4.6 5.3 7.5 4.1 10.6 2.3 4.5 4.8 5.4 2.3 1.9 6.7 2.1 2.0 2.7 0.6 1.5 1.3 3.4 1.9 5.6 5.7 5.1 3.1 3.3 2.5 2.3 1.7 1.3 1.3 3.1 3.5 1.6 3.4 4.4 3.3 2.4 5.3 2.6 4.2 2.7 3.4 2.8 1.5 4.8 5.5 2.8 3.3 2.6 1.6 3.6 3.1 0.8 3.4 1.9 3.3 1.6 2.7 2.9 2.7 1.3 1.7 7.2 3.8 2.8 0.3 3.0 0.9 2.3 3.7 3.9 2.4 2.4 2.0 4.0 4.7 1.3 4.5 1.7 2.9 3.0 2.1 0.9 2.5 0.8 1.0 2.3 2.3 2.2 1.9 1.7 2.7 2.3 6.7 2.0 1.7 1.9 1.3 0.6 10.0 11.2 11.8 16.8 7.3 7.8 6.2 11.4 13.1 7.5 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" HPA040055 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.4 3.4 30.8 17.7 8.1 8.0 12.0 8.5 8.8 2.1 1.7 7.3 4.2 16.2 0.9 3.9 3.2 5.0 11.2 1.2 7.3 0.8 2.5 23.7 8.1 10.9 12.8 2.9 10.6 3.4 11.8 2.1 26.1 11.3 0.8 1.7 8.8 6.6 1.6 6.3 8.3 5.2 1.3 1.9 0.2 3.0 3.3 1.1 10.9 1.2 11.1 15.2 6.6 6.1 6.2 3.3 9.7 15.2 2.5 7.1 10.6 3.8 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751454-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037583 Approved Vesicles,Centrosome Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favourable (1.03e-4)" 0.2 0.1 0.2 1.6 0.2 0.0 11.7 0.2 0.2 26.8 18.5 0.2 10.2 17.0 1.0 2.2 0.8 3.4 6.4 0.2 0.2 0.1 0.6 0.2 4.8 0.2 0.2 0.2 1.3 26.6 0.0 1.9 0.3 0.3 3.5 1.8 0.4 53.1 4.9 0.2 0.7 38.8 0.2 0.2 0.2 2.9 1.1 0.2 0.2 0.2 1.3 2.0 0.8 0.2 0.8 0.5 1.3 0.3 0.7 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.3 0.2 9.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 4.3 0.1 1.4 16.9 0.1 0.2 0.1 1.4 0.1 5.8 0.0 0.0 0.3 0.1 0.0 0.3 3.4 0.1 0.0 0.0 0.0 2.0 0.8 0.1 0.2 0.3 0.1 0.1 0.8 0.2 0.2 0.0 0.5 0.2 0.3 1.3 0.7 0.3 0.5 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell line enriched" "Detected in some" 9 "ASC diff: 75.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Supported "Vesicles,Lipid droplets,Plasma membrane,Cytosol" 11000 "Lipid droplets, Plasma membrane" "Vesicles, Cytosol" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (8.31e-4)" "prognostic unfavourable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 75.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.4 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 PLIN5 "LSDA5, LSDP5, MLDP, OXPAT" ENSG00000214456 "Perilipin 5" Q00G26 19 4522531-4535224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8" "Cell line enhanced" "Detected in some" "BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 14.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA077050 Supported "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA077050: " "prognostic favourable (7.68e-4)" "unprognostic (1.01e-1)" "unprognostic (4.22e-2)" "prognostic unfavourable (8.56e-4)" "unprognostic (1.24e-2)" "unprognostic (6.06e-3)" "prognostic favourable (2.81e-4)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-1)" "prognostic favourable (1.97e-4)" "unprognostic (3.18e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "prognostic favourable (2.16e-4)" 20.9 1.7 8.0 2.9 5.2 3.9 6.5 4.2 5.8 1.8 3.3 2.0 10.5 1.6 1.6 5.5 1.9 3.1 1.9 12.0 7.8 1.4 5.8 44.6 2.8 1.5 3.4 2.6 25.8 30.1 0.5 6.2 0.6 3.7 4.5 0.9 3.4 40.3 4.6 40.8 1.7 1.3 1.5 1.7 1.8 11.5 1.4 4.2 0.0 2.2 6.0 1.1 3.7 5.7 0.6 0.4 14.7 0.5 0.8 0.4 0.1 0.5 0.3 1.1 3.8 2.8 0.1 5.5 0.2 0.2 0.2 0.1 0.4 1.0 0.3 1.2 0.2 0.4 0.0 0.0 0.0 0.5 0.4 0.3 1.4 1.7 0.6 0.4 0.9 0.7 0.0 0.0 0.1 0.3 1.2 0.5 0.3 0.9 0.3 0.9 0.7 0.5 0.3 0.2 3.4 0.3 5.0 0.7 4.7 0.5 0.8 0.0 10.4 0.7 1.0 0.6 0.5 0.5 0.3 0.6 0.2 0.2 0.5 1.1 0.2 1.5 0.5 0.8 0.3 0.4 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.4 14.7 0.8 0.3 0.4 0.2 0.1 8.0 5.2 4.2 5.8 7.8 1.4 3.4 2.6 3.7 4.2 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 42.9;T-47d: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 22.9 20.7 7.2 0.5 3.8 6.2 2.8 4.9 8.2 16.3 9.5 1.5 20.3 0.0 32.3 17.6 28.8 0.3 11.3 14.9 0.0 0.6 0.0 9.3 1.7 20.7 0.1 0.6 3.6 15.7 6.3 17.6 32.8 0.0 0.8 32.2 8.3 0.0 0.0 1.3 3.4 1.1 20.0 0.0 42.9 4.6 0.4 0.9 15.1 3.0 13.2 72.3 0.3 41.8 4.5 12.2 2.0 39.1 0.0 0.0 0.0 3.5 0.0 20.0 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880861-127899195 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol "Centrosome, Cytosol" "HPA017327: , HPA035026: AB_10602080, HPA043198: " "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favourable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavourable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavourable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.4 1.3 1.5 4.7 2.4 16.5 2.2 0.5 2.2 2.0 3.2 0.3 0.6 2.3 1.3 1.3 5.4 1.1 1.2 2.0 1.2 1.3 1.5 0.9 1.5 5.9 1.2 1.4 1.5 0.9 0.3 0.6 5.0 2.6 1.4 3.7 0.8 1.7 0.7 0.4 2.7 3.2 1.9 1.8 2.7 1.6 21.7 1.0 21.7 1.0 2.1 6.0 1.5 2.2 0.7 0.7 1.5 0.8 1.4 4.0 0.8 11.6 5.5 20.7 10.6 0.7 2.0 9.4 11.4 8.1 15.2 15.8 7.7 12.0 15.7 4.2 6.3 7.7 14.6 9.1 23.5 12.2 6.0 14.2 8.8 7.2 0.2 20.0 16.9 0.6 0.9 13.9 6.4 11.7 16.5 21.0 12.8 8.1 30.8 9.0 9.6 6.3 16.1 14.5 5.4 5.0 7.4 11.5 9.4 7.2 6.6 3.5 5.3 8.7 5.0 12.0 11.6 8.1 14.2 10.9 11.9 22.4 6.1 15.3 13.2 0.0 0.4 1.5 1.6 0.8 1.1 0.3 1.8 1.7 0.7 0.7 0.6 2.3 0.0 1.4 0.3 0.4 4.0 0.8 1.5 2.4 0.5 2.2 1.2 1.3 1.2 1.4 2.6 1.0 PLOD1 "LH1, LLH, PLOD" ENSG00000083444 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" Q02809 1 11934205-11975538 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049137, HPA055799" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" 2700000 Vesicles Nucleoplasm "HPA049137: AB_2680649, HPA055799: AB_2682924" "unprognostic (1.00e-1)" "unprognostic (2.69e-3)" "unprognostic (9.21e-3)" "unprognostic (5.43e-2)" "unprognostic (7.53e-3)" "unprognostic (1.12e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (1.13e-3)" "unprognostic (1.23e-1)" "unprognostic (1.79e-1)" "unprognostic (4.15e-3)" "unprognostic (2.32e-1)" "prognostic unfavourable (1.91e-12)" "unprognostic (2.79e-1)" "unprognostic (7.12e-2)" "unprognostic (5.92e-2)" "prognostic unfavourable (2.43e-4)" 29.0 19.5 14.9 16.8 24.0 7.1 32.1 12.1 17.6 35.8 21.7 17.0 17.7 19.1 34.2 21.1 16.5 24.7 21.3 31.2 17.6 14.8 27.5 51.3 22.2 19.7 24.5 9.9 31.8 30.3 18.2 16.3 41.5 20.8 21.1 12.0 25.1 39.3 22.0 18.3 13.3 20.8 39.0 13.2 21.1 18.6 10.0 22.4 1.7 34.8 11.1 8.2 19.5 69.7 1.6 16.3 17.7 19.4 2.6 9.1 9.3 17.6 15.1 8.3 38.9 56.9 31.9 6.7 52.5 69.7 27.7 47.1 17.2 11.6 10.2 55.5 57.9 14.9 12.1 18.3 19.1 10.6 12.9 5.5 24.3 21.8 35.3 3.4 26.8 38.7 9.6 33.4 13.4 49.0 15.4 5.0 28.8 11.4 0.8 9.2 3.7 22.5 4.1 16.9 22.1 15.9 4.0 3.2 13.2 22.9 15.7 26.4 7.9 8.8 48.4 31.7 23.8 39.6 25.7 11.7 19.1 6.1 70.2 12.1 51.6 0.0 19.4 0.9 9.1 17.2 1.6 1.0 1.6 4.4 16.3 1.6 0.6 3.4 17.7 2.6 15.0 2.4 1.0 9.3 14.9 24.0 12.1 17.6 17.6 14.8 24.5 9.9 20.8 22.4 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell line enhanced" "Detected in many" "HBF TERT88: 85.3;U-87 MG: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavourable (7.64e-10)" "prognostic unfavourable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavourable (4.99e-11)" "prognostic unfavourable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 17.0 12.2 3.8 1.2 13.9 15.0 9.7 60.4 18.5 32.9 62.1 0.9 1.7 0.0 11.8 10.2 3.6 4.4 51.9 85.3 0.0 7.0 4.2 11.9 8.4 35.8 0.0 0.0 26.2 7.5 28.5 13.9 45.4 5.6 0.2 58.1 6.2 0.0 0.0 2.4 5.2 0.0 2.5 0.0 13.8 0.8 1.9 0.0 48.1 5.2 5.1 14.1 0.5 57.0 40.8 12.4 12.9 36.0 18.5 2.6 0.0 76.0 0.0 7.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell line enhanced" "Detected in some" "BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045188: " "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.1 2.3 1.4 0.1 1.3 0.0 0.0 10.7 0.1 0.9 0.2 1.2 1.4 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 8.7 0.9 2.1 0.9 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 4.4 0.0 0.8 0.2 0.7 0.0 0.7 1.9 0.0 12.0 9.6 5.3 0.5 46.4 0.0 0.0 0.0 8.9 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.8 4.0 4.3 5.3 3.5 3.9 4.3 2.6 3.4 2.1 2.5 1.0 2.6 3.7 1.1 2.6 4.8 3.0 3.7 2.3 46.6 2.8 7.4 3.8 5.3 3.1 2.7 5.6 4.3 3.0 1.6 3.7 3.2 1.2 3.9 2.7 4.1 2.5 7.0 4.0 1.4 2.5 0.0 2.8 3.7 4.4 10.9 5.5 3.1 2.8 1.6 4.0 6.0 3.7 1.9 1.6 2.6 1.7 0.8 2.9 0.9 3.0 1.9 1.7 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell line enhanced" "Detected in some" "AN3-CA: 10.7;ASC diff: 11.3;ASC TERT1: 8.7;SCLC-21H: 11.1;SH-SY5Y: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA070252: " "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 10.7 11.3 8.7 2.2 1.6 1.1 0.3 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.4 2.8 0.0 0.0 2.9 0.0 3.1 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.1 2.5 0.0 0.0 0.0 0.0 2.4 0.0 11.1 8.5 0.0 0.1 0.0 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.8 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 7 "PC-3: 12.0;SH-SY5Y: 21.5" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: " "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.0 0.0 0.0 0.0 0.5 0.1 0.4 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535006-154550435 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: " "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favourable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 20.2 18.1 23.3 14.9 30.9 17.5 25.2 29.3 28.6 22.7 19.5 24.7 16.7 15.6 24.4 19.3 24.4 22.8 16.0 16.2 22.9 22.2 26.0 34.9 17.1 20.4 28.9 24.3 23.9 14.2 28.2 21.9 17.8 29.4 18.4 22.7 13.3 19.4 23.3 23.0 16.5 22.1 29.2 32.5 19.1 16.8 13.3 25.9 22.0 24.8 22.3 31.5 18.3 16.5 25.2 25.2 23.2 30.9 34.0 28.8 23.7 23.4 19.2 24.9 26.5 29.4 25.6 21.0 30.2 37.0 41.3 33.8 22.6 20.8 25.6 15.5 35.8 17.3 32.4 40.4 45.9 25.8 16.2 30.7 15.3 21.9 30.2 30.6 25.8 27.5 37.5 48.8 38.4 35.3 31.3 32.9 35.9 16.8 23.5 14.6 18.8 20.9 23.3 12.9 15.5 28.6 15.1 14.5 16.4 18.4 19.9 28.8 19.1 21.5 22.7 24.7 28.0 21.7 26.8 17.2 22.3 32.2 23.2 14.8 32.8 23.2 19.4 15.2 23.7 22.5 28.2 25.2 24.8 25.6 25.2 19.2 26.6 24.8 5.2 34.0 30.9 24.8 28.8 23.7 23.3 30.9 29.3 28.6 22.9 22.2 28.9 24.3 29.4 25.9 PLS3 T-plastin ENSG00000102024 "Plastin 3" P13797 X 115561174-115650861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 13.1" "Group enriched" "Detected in many" 6 "dendritic cells: 13.1;NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020433, HPA076083" Approved Approved "Plasma membrane,Cytosol" 110000000 "Plasma membrane, Cytosol" "HPA020433: , HPA076083: " "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "unprognostic (6.10e-2)" "unprognostic (4.37e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (6.07e-5)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (4.59e-4)" "unprognostic (2.23e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (5.15e-2)" "unprognostic (1.54e-1)" "prognostic favourable (3.72e-4)" "prognostic unfavourable (7.04e-4)" 41.9 11.0 11.8 9.8 12.5 0.2 24.6 3.6 16.7 43.8 14.3 13.9 24.1 6.0 37.4 27.6 54.4 21.5 23.6 18.8 12.2 8.2 40.7 100.5 64.7 6.0 14.7 13.7 44.4 8.9 2.7 4.6 21.9 22.7 21.6 9.2 10.6 16.6 31.4 17.7 38.4 8.2 34.6 14.5 31.6 13.3 14.9 13.0 5.1 64.8 34.7 12.5 38.7 29.0 0.0 13.1 0.4 0.1 4.2 1.5 0.2 27.8 28.7 25.1 7.3 25.4 23.8 38.3 29.1 32.9 27.9 33.8 31.1 23.2 0.1 84.2 23.9 35.9 26.6 47.3 45.4 0.4 33.3 2.7 35.6 13.0 23.0 0.0 1.3 15.0 22.8 43.2 30.4 60.4 0.0 0.0 26.6 8.1 0.0 0.3 33.3 34.4 0.0 16.8 0.6 33.3 15.1 0.0 5.2 61.1 15.2 12.2 8.4 0.4 66.0 45.3 7.7 46.1 58.1 1.1 4.0 0.5 19.8 0.1 18.7 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.1 4.2 0.0 13.1 1.5 0.2 11.8 12.5 3.6 16.7 12.2 8.2 14.7 13.7 22.7 13.0 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544864 "Predicted intracellular proteins, Transporters" "Antiviral defense" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 54.7;BJ hTERT+ SV40 Large T+ RasG12V: 72.7;HHSteC: 50.1;SK-MEL-30: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB070421: AB_11153452, HPA068923: " "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.9 14.9 11.9 39.7 21.4 27.0 31.1 5.7 19.0 20.9 29.6 7.2 22.1 18.4 19.6 25.7 25.4 19.5 30.8 22.7 16.1 12.7 32.0 36.5 33.8 38.6 17.6 4.9 40.0 26.1 10.3 18.4 25.7 22.1 25.0 28.0 12.6 32.3 34.2 16.4 9.9 24.6 19.4 29.8 46.0 20.5 15.4 14.8 16.4 27.5 14.9 19.5 27.5 48.0 6.5 27.5 26.2 41.2 14.3 8.1 17.6 17.0 6.9 4.4 2.0 6.6 11.2 6.7 5.4 14.7 54.7 72.7 5.4 14.3 1.3 12.8 3.4 14.1 3.5 5.1 9.2 5.2 3.5 11.0 2.2 4.1 50.1 6.3 5.8 17.7 8.6 6.0 30.8 8.0 7.0 17.1 11.1 6.6 4.8 2.4 4.2 6.1 4.4 4.8 0.4 15.4 4.7 2.7 0.0 6.9 3.3 90.5 3.4 7.7 4.8 4.4 3.8 9.8 8.9 13.1 2.4 0.0 4.4 4.6 3.8 8.2 41.2 11.0 5.6 40.4 8.1 6.5 3.7 5.0 27.5 4.9 2.6 3.8 26.2 14.3 22.7 7.3 2.1 17.6 11.9 21.4 5.7 19.0 16.1 12.7 17.6 4.9 22.1 14.8 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192339-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.8;ASC TERT1: 19.5;HUVEC TERT2: 20.0;TIME: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavourable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 40.5 29.6 19.4 5.9 20.4 1.7 53.3 19.1 23.4 25.1 17.7 14.8 10.8 4.6 21.9 13.9 15.8 28.0 29.4 20.3 23.1 13.8 16.9 43.4 24.2 16.7 13.7 14.6 25.2 13.0 3.8 11.7 35.9 21.8 17.9 16.9 15.9 14.8 18.2 8.7 11.1 9.3 25.0 28.7 18.4 11.0 16.8 16.6 0.9 25.1 8.9 4.5 23.3 28.7 0.0 0.2 0.0 0.2 1.3 0.0 0.5 0.0 3.6 0.6 0.0 24.8 19.5 0.1 4.4 6.0 2.0 4.3 0.4 4.8 0.0 4.8 8.2 0.5 0.9 0.4 1.1 0.0 0.0 1.9 3.0 0.5 11.3 0.0 0.5 11.8 0.6 4.1 1.2 20.0 0.1 0.3 2.9 0.1 0.0 0.0 0.8 1.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.5 0.0 1.4 0.3 0.2 41.2 4.2 1.0 9.2 0.8 0.1 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.5 19.4 20.4 19.1 23.4 23.1 13.8 13.7 14.6 21.8 16.6 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell line enriched" "Detected in some" 28 "EFO-21: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol 2600000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavourable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 4.6 2.1 4.4 3.8 2.5 0.0 3.1 5.2 9.3 3.6 2.5 2.5 2.5 1.6 3.8 5.2 3.7 3.3 2.7 10.2 6.2 5.3 2.5 5.3 6.3 3.1 2.9 5.0 5.0 4.9 18.7 2.5 4.9 3.9 3.7 0.7 2.5 7.9 4.1 5.6 8.8 2.5 2.9 2.5 5.6 2.3 5.2 2.5 2.5 3.2 2.5 2.5 3.5 12.6 0.6 0.0 0.0 0.9 0.0 1.1 0.5 17.7 8.4 9.3 7.4 12.3 13.8 14.9 10.6 9.1 6.1 6.1 27.9 8.3 2.0 16.0 11.4 27.5 4.8 20.8 2.5 2.8 7.5 0.2 4.9 7.2 8.1 2.1 1.5 13.8 14.6 11.3 8.8 3.0 10.2 3.7 6.5 10.3 4.1 3.9 9.0 7.5 5.5 23.9 5.5 5.3 35.8 8.3 9.1 7.7 7.3 10.1 11.7 13.5 11.2 9.8 12.6 17.8 11.1 2.2 1.5 3.9 14.1 4.0 10.3 0.0 0.0 0.0 0.7 0.1 1.1 0.5 0.6 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.9 0.0 0.8 0.5 4.4 2.5 5.2 9.3 6.2 5.3 2.9 5.0 3.9 2.5 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: " "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.1 1.6 4.8 12.2 5.1 6.5 6.5 11.7 2.5 2.7 3.8 6.1 3.5 1.5 6.3 12.5 7.2 4.9 5.7 1.0 0.7 3.6 1.5 19.1 3.3 4.0 0.7 6.8 8.8 4.2 4.1 0.3 3.1 3.8 1.3 4.3 10.1 1.4 6.2 1.5 3.7 5.3 0.4 0.5 3.7 5.4 10.2 5.3 4.3 7.8 1.9 4.7 1.7 7.7 6.0 5.5 0.6 4.9 0.9 0.1 2.1 11.2 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 431.8" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: " "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favourable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.4 0.0 6.5 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 431.8 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 20.6 21.7 18.2 19.8 20.4 40.8 23.3 24.3 23.7 27.4 20.3 26.1 25.2 20.1 25.2 27.5 26.4 20.4 24.4 37.9 16.4 15.5 38.0 32.4 21.3 30.5 23.9 17.4 25.1 28.0 23.6 22.8 35.5 17.1 25.5 18.0 27.6 26.8 20.5 65.7 28.9 20.1 20.9 21.3 29.9 22.8 13.4 22.4 23.6 30.5 48.3 29.5 21.6 22.7 22.8 41.1 26.2 36.5 19.9 31.1 29.0 21.1 26.2 28.2 21.3 5.3 11.1 22.0 11.0 15.7 29.9 24.8 32.1 30.6 19.5 24.0 14.1 14.2 28.3 18.4 15.4 13.9 33.7 14.5 20.0 28.6 11.1 20.3 20.1 10.0 18.6 13.4 14.2 22.5 21.5 22.7 14.4 43.2 21.2 26.3 49.1 23.3 23.4 15.1 38.6 31.2 16.0 25.8 32.6 18.3 21.1 14.3 34.3 25.0 12.9 13.0 16.6 14.4 21.6 17.0 17.5 38.3 10.4 19.7 17.9 7.9 36.5 16.4 20.2 25.2 18.1 22.8 19.9 18.8 30.0 21.6 19.4 19.5 26.2 19.9 22.1 41.1 31.1 29.0 18.2 20.4 24.3 23.7 16.4 15.5 23.9 17.4 17.1 22.4 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 9.8 15.7 16.2 10.3 16.2 12.1 7.8 18.1 14.6 14.6 13.0 13.9 13.4 8.6 13.1 16.3 11.7 15.0 12.9 24.6 14.1 14.2 20.6 17.4 11.0 16.4 12.6 9.0 15.6 15.0 10.4 16.2 19.2 8.8 15.7 7.0 14.8 21.5 13.2 31.8 10.7 10.5 10.9 11.2 14.0 9.5 7.4 11.8 12.5 16.4 26.4 15.8 9.8 11.1 9.8 7.1 10.2 8.9 5.1 10.7 8.1 6.9 7.2 9.5 6.5 2.6 6.7 4.2 6.3 4.1 6.2 5.1 5.4 6.5 6.1 10.6 5.6 4.8 8.9 8.1 3.2 10.5 15.0 4.2 7.0 9.9 12.2 4.1 7.6 8.2 7.6 5.7 5.0 5.9 4.1 9.9 4.4 8.5 3.7 8.9 19.6 13.2 7.0 3.8 9.0 4.8 3.4 6.6 8.4 4.1 1.7 10.9 9.7 16.7 6.4 3.1 3.1 3.9 5.7 6.0 7.2 9.3 4.4 5.5 6.1 3.6 8.9 4.4 4.9 5.8 4.8 4.8 7.7 7.1 6.6 9.8 10.7 6.0 10.2 5.1 6.1 7.1 8.4 8.1 16.2 16.2 18.1 12.8 14.1 14.2 12.6 9.0 8.8 11.8 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849331 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "basophil: 52.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 52.2" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favourable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavourable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 14.8 13.1 6.8 15.4 9.0 4.3 13.6 8.2 8.2 11.4 19.4 7.0 11.6 18.9 9.7 13.1 22.7 10.0 13.9 10.7 4.7 2.9 14.6 43.3 11.8 11.2 6.6 4.3 7.8 40.4 7.8 28.3 19.9 6.6 12.0 20.4 8.8 21.2 13.5 12.5 13.2 19.6 9.5 5.7 12.0 15.2 9.7 7.8 7.6 10.0 12.0 22.0 10.5 12.2 2.9 3.5 52.2 4.9 1.6 3.6 3.0 10.9 24.5 5.4 14.2 9.7 15.3 12.1 17.1 20.7 17.2 18.6 18.3 13.6 17.5 7.2 29.8 15.2 11.1 20.9 17.6 13.0 13.0 5.8 14.8 31.2 18.4 15.3 13.9 22.8 14.9 18.3 16.9 17.5 7.8 17.1 11.4 28.7 15.6 14.1 23.0 15.9 19.9 12.1 34.8 19.1 19.4 10.3 19.5 14.1 31.1 10.2 20.2 13.4 20.3 12.4 14.0 33.4 16.7 21.2 17.7 22.0 10.3 19.3 16.4 52.2 4.9 0.9 2.5 3.7 3.6 2.9 2.2 3.2 3.5 2.4 2.5 2.4 7.8 1.6 2.3 3.2 1.6 3.0 6.8 9.0 8.2 8.2 4.7 2.9 6.6 4.3 6.6 7.8 PMS1 "MLH2, PMSL1" ENSG00000064933 "PMS1 homolog 1, mismatch repair system component" P54277 2 189784085-189877629 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031013 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA031013: " "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (9.31e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-3)" "unprognostic (1.49e-2)" "prognostic unfavourable (2.38e-6)" "unprognostic (5.31e-2)" "unprognostic (1.60e-2)" "unprognostic (7.29e-3)" "unprognostic (3.55e-1)" "unprognostic (2.30e-1)" "prognostic unfavourable (1.86e-6)" "unprognostic (1.29e-1)" "unprognostic (3.77e-2)" "unprognostic (1.92e-2)" "prognostic favourable (3.73e-4)" 9.8 8.2 9.6 9.8 12.4 9.9 10.1 14.6 13.2 10.6 7.5 6.9 17.3 6.6 11.8 14.5 7.3 11.4 7.5 7.1 9.7 8.0 6.3 8.6 7.1 11.1 10.1 9.9 12.2 9.8 7.6 18.2 7.6 14.2 8.9 8.2 6.7 8.4 15.0 8.4 9.9 8.5 9.6 10.7 11.1 11.5 38.8 10.9 9.6 9.6 7.3 9.2 8.2 8.4 14.0 8.1 2.9 5.5 9.0 13.2 3.7 7.9 7.2 18.4 14.5 10.1 15.3 16.2 15.2 7.5 12.9 15.7 11.8 10.9 23.7 8.7 6.3 11.8 17.9 11.2 18.4 17.7 10.4 23.6 13.1 17.6 14.0 13.6 10.7 9.8 11.4 12.0 24.6 13.4 19.6 12.9 15.9 5.5 16.1 19.1 18.2 16.6 18.7 12.6 22.7 12.4 11.7 17.2 12.0 11.3 7.1 10.8 8.1 11.2 10.4 14.1 9.7 8.8 13.4 10.3 12.6 20.5 8.2 12.1 8.9 2.2 5.5 2.9 12.0 3.3 11.2 11.7 8.8 13.2 5.0 14.0 8.9 11.4 2.8 9.0 4.1 8.1 8.2 3.7 9.6 12.4 14.6 13.2 9.7 8.0 10.1 9.9 14.2 10.9 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell line enriched" "Detected in some" 8 "AN3-CA: 26.5" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 26.5 0.0 0.0 2.8 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.1 0.0 0.1 2.1 0.2 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 PNISR "bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130" ENSG00000132424 "PNN interacting serine and arginine rich protein" Q8TF01 6 99398051-99425331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038796, HPA075076" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles" "Plasma membrane, Cytosol" "HPA038796: AB_10672652, HPA075076: " "unprognostic (2.95e-1)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (9.72e-3)" "unprognostic (1.68e-2)" "unprognostic (8.55e-3)" "unprognostic (4.41e-2)" "unprognostic (1.58e-3)" "unprognostic (5.82e-2)" "unprognostic (4.32e-3)" "prognostic favourable (5.27e-4)" "unprognostic (1.47e-2)" "prognostic unfavourable (1.41e-4)" "unprognostic (3.43e-2)" "unprognostic (2.59e-1)" "unprognostic (8.89e-2)" "prognostic favourable (1.09e-4)" 24.7 28.5 48.9 28.3 49.8 53.7 29.9 123.3 69.7 35.5 38.3 22.8 39.9 26.7 43.1 58.7 19.8 29.4 22.3 31.0 46.9 17.5 25.5 21.7 26.6 42.2 48.0 29.8 49.3 24.7 34.7 83.9 21.7 41.0 34.1 28.2 24.1 30.8 34.5 39.4 31.9 34.4 31.5 61.0 39.3 28.2 17.4 57.1 32.1 44.7 18.0 30.7 29.5 30.3 18.0 13.1 20.4 7.4 15.6 12.3 2.2 11.3 7.7 41.3 28.3 14.7 21.9 19.1 18.0 9.9 10.8 13.4 13.8 20.7 34.9 12.1 10.1 17.4 20.7 15.7 21.9 28.6 23.1 20.2 38.3 13.8 11.2 28.0 28.7 21.5 22.4 12.0 15.7 15.7 23.5 22.9 14.2 11.4 13.3 32.2 23.1 7.1 26.9 11.6 12.4 21.2 19.7 16.7 22.1 9.0 11.7 15.4 15.6 24.7 17.3 10.9 12.8 10.6 15.4 15.9 11.0 32.0 16.4 28.9 12.6 6.9 7.4 6.6 8.6 4.2 8.5 12.0 8.4 6.8 3.3 18.0 12.3 11.8 20.4 15.6 4.8 13.1 7.7 2.2 48.9 49.8 123.3 69.7 46.9 17.5 48.0 29.8 41.0 57.1 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favourable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 13.1 32.4 11.2 22.0 11.8 24.3 15.0 18.0 13.8 14.0 17.4 17.0 26.4 15.6 16.7 25.3 13.6 18.1 18.2 16.8 12.3 9.5 20.1 16.8 15.9 21.0 13.9 14.2 17.1 22.5 19.7 26.8 17.1 12.9 18.7 15.0 19.6 20.3 22.4 12.8 15.3 15.7 13.2 10.1 30.7 17.9 17.2 13.9 22.3 23.0 17.0 20.6 14.6 12.4 7.9 7.5 19.3 12.7 2.7 7.7 3.8 12.8 8.7 8.8 13.8 8.4 6.5 14.3 20.8 10.6 9.6 8.4 6.9 16.9 8.3 6.6 6.3 10.5 3.1 11.7 5.7 10.7 13.3 14.1 16.4 6.0 6.3 13.3 19.0 6.1 6.2 8.7 5.7 12.6 6.9 16.8 12.5 8.2 13.5 10.7 8.2 17.7 11.5 8.1 16.8 9.9 27.5 10.4 16.8 9.1 27.4 4.6 4.7 8.3 17.8 18.8 11.5 4.5 17.1 18.6 7.5 6.7 17.0 6.0 14.9 1.4 8.8 12.2 7.7 8.5 6.4 6.5 6.6 5.8 7.5 7.9 4.9 4.4 19.3 2.7 12.7 4.3 6.8 3.8 11.2 11.8 18.0 13.8 12.3 9.5 13.9 14.2 12.9 13.9 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Cell line enhanced" "Detected in some" "HHSteC: 7.9;HMC-1: 6.8;SK-MEL-30: 6.6;U-2 OS: 15.2;U-266/70: 5.8;U-698: 8.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria Mitochondria Nucleoli "HPA045007: , HPA052115: " "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favourable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.8 0.4 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 7.9 3.2 6.8 1.2 0.0 0.1 0.0 0.2 1.3 0.0 0.1 0.4 1.1 0.0 3.4 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.2 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Cell line enhanced" "Detected in many" "HAP1: 17.7;K-562: 18.7;LHCN-M2: 19.4;SH-SY5Y: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012956 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.7 10.6 3.1 7.1 1.9 0.7 0.1 1.3 0.6 0.1 0.8 0.0 10.0 0.5 0.1 17.7 2.8 0.9 0.0 6.6 0.0 0.2 0.2 5.2 0.1 0.1 1.8 3.5 4.5 0.0 1.0 18.7 0.1 19.4 0.0 0.1 0.1 9.0 0.0 0.0 11.7 0.0 4.5 0.0 8.7 17.1 0.0 0.2 0.0 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.1 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157844-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavourable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 18.5 19.2 13.0 17.2 19.0 21.8 15.4 10.0 12.8 10.8 13.1 9.1 10.2 9.9 15.3 15.4 14.9 13.8 13.2 24.5 19.1 9.6 16.6 27.4 12.9 15.0 15.0 11.9 20.0 27.0 13.2 15.7 16.3 13.1 14.4 12.2 8.9 12.7 15.0 48.8 12.4 9.5 15.1 11.7 13.6 13.2 11.4 13.9 9.7 16.6 15.1 15.2 15.8 21.4 14.7 12.6 2.0 13.2 10.6 15.5 14.4 15.1 16.6 7.7 12.6 9.5 7.9 19.4 14.5 9.4 16.3 11.6 31.8 9.0 20.8 12.2 9.6 13.0 24.8 17.1 25.7 14.4 17.4 20.2 7.9 23.3 14.8 16.1 9.3 10.2 12.6 16.5 18.9 11.9 27.8 11.3 14.6 11.2 15.7 15.2 21.7 18.1 13.3 19.0 22.1 12.4 12.9 13.8 10.3 10.8 13.4 23.2 9.5 9.0 8.9 18.8 20.3 16.7 40.1 9.1 13.1 32.1 15.4 24.1 25.5 0.4 9.4 1.9 10.1 13.2 15.5 14.7 11.4 11.5 12.6 11.1 13.3 12.2 2.0 10.6 9.4 9.0 11.7 14.4 13.0 19.0 10.0 12.8 19.1 9.6 15.0 11.9 13.1 13.9 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Cell line enhanced" "Detected in all" "ASC diff: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" "Lipid droplets" Nucleoplasm "HPA055173: , HPA062602: , HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.4 8.2 1.7 4.4 64.1 5.7 11.0 11.1 9.0 7.0 6.2 6.9 10.5 6.2 6.6 8.3 9.4 2.5 4.6 2.1 7.9 22.7 8.5 3.6 11.1 21.0 5.8 10.8 11.2 6.0 4.7 5.4 5.7 7.2 6.3 6.2 6.1 7.8 12.9 4.9 17.6 7.6 3.7 13.8 6.8 2.4 6.3 8.4 20.6 17.6 6.4 7.5 6.8 10.2 6.3 4.9 4.1 5.0 24.3 15.0 5.2 15.8 8.4 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Cell line enhanced" "Detected in many" "AF22: 13.3;LHCN-M2: 15.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol Nucleoli "Mitochondria, Cytosol" "HPA058058: " "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.2 13.3 5.4 3.8 4.2 0.4 2.4 1.4 3.3 7.1 3.8 7.0 0.0 2.0 4.0 3.3 8.3 3.9 2.7 0.0 0.7 0.2 3.1 7.1 6.1 0.0 0.2 4.8 3.0 10.4 0.5 0.4 0.0 0.0 15.0 0.6 0.2 0.0 9.1 0.0 0.0 7.2 0.1 1.4 0.2 1.2 0.1 2.7 1.0 3.7 4.2 4.5 0.4 1.3 4.0 0.1 0.1 0.0 0.0 0.0 11.4 0.0 4.7 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459953-137550534 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "HMC-1: 42.8" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;T-reg: 3.5" "Group enriched" "Detected in many" 5 "B-cells: 3.6;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favourable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.3 5.6 10.6 2.8 11.0 2.8 6.3 17.0 11.4 6.4 4.5 6.7 3.8 3.1 7.6 2.1 2.2 5.8 4.7 4.8 8.4 2.6 2.3 7.4 4.1 5.4 9.7 9.7 9.7 17.7 3.3 7.1 1.1 6.6 14.7 2.1 5.4 18.7 4.8 19.1 15.4 4.8 7.2 6.7 5.4 9.6 1.8 11.6 0.4 7.6 4.2 2.8 7.8 3.7 3.6 0.7 0.0 0.4 0.0 3.5 0.5 0.0 0.5 0.1 0.2 0.4 0.3 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.4 0.4 0.1 0.2 0.2 42.8 0.6 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.8 0.1 0.7 0.0 0.4 1.0 0.7 1.3 0.0 0.1 0.8 0.2 0.0 0.3 0.1 1.9 0.6 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.8 0.5 0.4 0.7 3.6 1.2 0.9 0.0 0.0 0.1 0.4 3.5 0.5 10.6 11.0 17.0 11.4 8.4 2.6 9.7 9.7 6.6 11.6 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.0 6.3 11.2 10.0 25.0 17.2 16.6 13.4 23.7 11.0 18.4 6.1 8.1 7.8 16.9 13.1 5.3 19.0 8.5 16.8 11.7 5.2 5.3 10.4 4.5 18.3 3.7 11.1 15.6 16.2 14.8 13.7 14.8 6.3 22.5 13.7 9.2 8.6 8.8 4.9 9.0 3.2 11.8 16.6 13.2 17.8 9.3 13.1 12.8 13.9 16.0 5.8 6.3 12.0 18.2 8.1 27.0 7.3 19.1 19.3 11.6 17.3 5.7 11.7 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 PNPO PDXPO ENSG00000108439 "Pyridoxamine 5'-phosphate oxidase" Q9NVS9 17 47941506-47949308 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridoxine biosynthesis" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023204, HPA027776" Enhanced Enhanced Nucleoplasm,Cytosol 150000 "Nucleoplasm, Cytosol" "HPA023204: AB_1855506, HPA027776: AB_10601246" "unprognostic (1.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.62e-1)" "unprognostic (1.97e-2)" "unprognostic (6.65e-2)" "unprognostic (8.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.47e-3)" "unprognostic (8.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.74e-1)" 6.0 13.1 9.9 5.1 13.0 2.9 8.6 8.3 16.5 6.2 7.0 8.6 6.9 8.5 4.2 9.6 8.1 8.4 10.1 10.2 8.7 12.0 26.0 64.7 5.3 7.7 11.2 9.9 8.0 13.7 17.3 7.4 5.8 11.1 6.9 7.4 8.4 8.3 7.1 14.7 5.5 9.6 5.2 7.1 6.8 6.7 6.4 6.0 5.2 14.4 8.2 6.1 5.4 5.2 6.8 12.2 2.4 16.4 7.7 8.2 8.7 17.5 14.5 1.1 2.7 7.4 5.7 0.0 5.9 3.9 6.7 5.8 23.8 13.0 16.7 28.5 5.9 10.6 9.1 16.2 9.7 20.3 7.8 11.8 6.8 24.7 8.0 10.4 8.1 7.6 12.7 12.4 15.4 8.7 11.1 5.8 7.8 13.1 10.5 3.4 2.1 18.0 8.9 5.1 12.2 18.5 9.1 5.9 4.9 5.4 8.8 5.0 15.6 3.8 9.1 10.8 6.3 10.7 12.4 13.8 15.2 8.8 8.8 9.1 5.5 2.1 11.0 2.4 6.8 16.4 8.0 6.8 6.2 7.4 12.2 5.7 8.2 7.9 1.1 7.7 10.4 8.9 6.4 8.7 9.9 13.0 8.3 16.5 8.7 12.0 11.2 9.9 11.1 6.0 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 53.8;hTCEpi: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: " "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavourable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 70.5 58.1 21.3 46.1 28.3 105.4 48.1 30.8 31.8 55.9 51.5 30.3 27.0 23.6 60.3 30.9 45.4 73.6 45.0 48.5 20.8 17.9 32.9 97.9 59.5 87.1 23.1 22.3 83.4 41.3 31.3 29.5 38.8 20.4 56.6 26.0 46.5 35.5 40.8 154.1 49.0 32.4 63.6 31.1 46.9 38.2 35.5 20.8 91.2 38.4 30.8 45.4 113.2 41.0 9.6 7.3 37.5 7.1 6.9 10.4 3.8 2.9 2.8 6.0 10.2 24.6 41.6 4.2 3.8 26.6 7.1 16.8 2.4 8.2 6.3 18.6 4.6 10.0 3.2 5.7 11.0 7.9 9.9 1.1 16.4 7.6 53.8 5.9 14.8 29.8 57.2 4.8 22.1 11.7 0.9 19.6 7.9 2.8 1.5 31.1 1.7 6.1 7.0 7.4 5.0 16.8 5.2 3.8 10.9 9.8 13.5 9.9 6.7 29.7 11.1 5.7 3.4 3.9 1.4 30.8 15.1 2.1 11.4 5.1 3.5 10.3 6.6 36.7 7.5 7.1 7.8 8.3 8.9 7.8 4.2 9.6 10.4 10.4 37.5 6.9 6.3 7.3 7.1 3.8 21.3 28.3 30.8 31.8 20.8 17.9 23.1 22.3 20.4 20.8 PNRC2 ENSG00000189266 "Proline rich nuclear receptor coactivator 2" Q9NPJ4 1 23959109-23963462 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027820, HPA045837" Uncertain Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA027820: AB_10602147, HPA045837: AB_2679467" "prognostic favourable (6.02e-4)" "unprognostic (5.99e-2)" "unprognostic (3.15e-3)" "unprognostic (2.10e-2)" "unprognostic (3.58e-1)" "unprognostic (4.45e-3)" "prognostic unfavourable (7.97e-5)" "unprognostic (4.05e-2)" "prognostic unfavourable (1.41e-4)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.92e-3)" "unprognostic (1.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-1)" "unprognostic (4.44e-2)" "prognostic favourable (4.05e-4)" 35.6 32.8 21.1 39.3 21.4 39.0 36.8 22.3 21.0 38.6 40.6 17.1 25.9 32.0 37.5 24.4 28.7 24.9 32.7 41.9 20.9 19.4 33.3 21.3 37.2 40.6 21.8 20.2 39.7 25.2 29.2 28.5 36.2 18.6 37.1 30.8 23.8 26.2 30.1 32.8 18.7 38.4 37.9 26.1 34.4 29.3 16.9 18.7 44.6 56.0 23.0 34.4 49.1 35.6 46.8 38.9 69.5 40.5 36.6 48.9 52.8 23.6 9.4 41.3 28.5 28.6 26.3 15.8 26.3 23.5 30.7 24.7 27.4 30.0 64.7 25.9 16.7 21.1 27.6 22.9 34.2 45.9 17.8 61.4 28.9 28.7 24.4 59.5 28.2 19.7 29.0 25.1 23.5 29.6 51.9 36.4 17.9 19.3 36.8 22.7 55.9 17.5 41.8 26.9 27.4 30.8 25.5 24.8 21.7 22.8 19.6 26.8 21.3 37.5 23.6 19.9 19.2 19.4 16.7 30.8 35.3 44.2 13.5 57.7 20.3 69.5 40.0 44.0 39.6 40.5 41.3 46.8 43.3 42.6 38.9 46.7 48.9 41.2 26.7 36.6 37.1 27.9 44.6 52.8 21.1 21.4 22.3 21.0 20.9 19.4 21.8 20.2 18.6 18.7 PODXL "Gp200, PC, PCLP" ENSG00000128567 "Podocalyxin like" O00592 7 131500262-131558217 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.0;NTERA-2: 48.7;TIME: 54.4;U-251 MG: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 43000000 "Plasma membrane, Centriolar satellite" Vesicles "CAB016169: AB_628165, CAB062558: , CAB068219: , CAB068220: , HPA002110: AB_1855512, HPA045507: AB_2679356" "unprognostic (1.26e-1)" "unprognostic (7.68e-2)" "unprognostic (8.28e-3)" "unprognostic (6.46e-3)" "unprognostic (5.16e-3)" "unprognostic (5.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (7.95e-3)" "unprognostic (3.52e-1)" "unprognostic (9.20e-3)" "unprognostic (3.40e-1)" "prognostic favourable (2.89e-4)" "unprognostic (2.56e-1)" "unprognostic (8.78e-3)" "unprognostic (3.55e-2)" "unprognostic (1.03e-1)" 8.8 4.9 8.2 3.8 8.9 0.8 7.6 4.8 13.5 11.7 5.0 4.6 16.0 2.8 14.5 2.7 4.4 22.1 7.9 19.3 6.7 6.7 30.6 3.0 14.7 2.6 7.2 5.9 6.1 20.4 7.5 4.0 12.5 15.2 4.5 3.7 15.5 9.1 27.8 5.7 3.8 4.8 12.8 8.1 2.9 4.6 3.5 6.6 0.0 14.0 5.2 2.5 6.1 8.3 1.1 0.3 2.2 0.3 0.4 0.8 0.3 5.0 2.4 4.1 1.8 0.1 0.0 0.3 0.6 0.5 1.8 0.7 12.3 7.9 0.0 11.8 36.0 3.6 4.0 0.0 1.2 0.6 2.0 0.0 15.0 0.2 0.1 0.4 0.4 0.0 0.0 6.5 0.0 14.5 1.2 0.2 1.5 1.4 0.0 0.0 48.7 4.9 2.0 7.3 1.5 0.2 2.2 3.7 0.9 4.4 0.5 0.0 0.4 0.1 54.4 0.7 2.9 7.4 21.6 0.3 0.5 0.1 2.8 2.0 4.3 0.7 0.3 2.2 0.6 0.2 0.5 0.3 0.5 0.8 0.0 1.1 0.4 0.4 1.1 0.4 0.2 0.3 0.4 0.3 8.2 8.9 4.8 13.5 6.7 6.7 7.2 5.9 15.2 6.6 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.0;SCLC-21H: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB024934: , HPA042265: " "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.8 10.6 25.1 0.0 0.0 15.7 1.2 0.0 2.2 0.4 7.9 0.4 9.3 9.5 0.1 0.0 8.6 0.0 0.2 0.0 17.7 0.1 8.8 7.9 0.3 21.0 21.6 0.4 1.8 0.0 0.0 0.6 12.2 0.0 0.8 4.7 0.1 0.0 15.9 18.7 0.0 0.3 32.0 3.1 1.0 47.6 26.8 11.3 24.4 20.7 6.2 10.7 0.1 0.0 4.9 0.4 7.4 0.0 0.0 7.3 0.2 13.7 7.0 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B, actin binding protein" Q8WVV4 X 85277396-85379743 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.8;skin 1: 55.6" "Cell line enhanced" "Detected in some" "A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.0;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 7 "B-cells: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" 430000 "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavourable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.5 0.4 0.3 9.9 0.3 0.0 3.7 0.4 0.4 7.0 41.8 0.0 0.5 10.9 0.8 1.6 21.4 1.6 10.0 6.3 0.3 0.3 2.5 0.5 1.4 0.4 0.3 0.2 1.0 2.9 0.0 2.5 3.4 0.1 3.9 16.9 0.1 5.6 0.9 0.4 55.6 55.8 0.7 0.4 5.5 7.6 0.4 0.0 0.3 0.7 20.3 9.2 4.9 6.9 6.0 0.0 0.0 0.0 0.0 0.8 0.1 1.7 11.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 11.3 5.8 1.6 0.0 11.5 2.5 0.1 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 1.9 0.0 4.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 38.6 0.0 0.0 0.0 2.9 0.0 1.2 0.5 0.1 0.0 0.0 0.1 0.1 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.2 0.1 0.0 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856344 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA007838: AB_1079651, HPA031630: AB_10601490" "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavourable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 12.1 10.3 24.3 15.1 27.3 10.4 24.2 18.4 23.6 17.6 13.1 27.6 8.4 10.2 17.6 12.6 16.1 13.5 12.4 11.1 24.4 18.4 15.7 12.0 20.9 13.5 27.7 17.7 19.9 14.8 30.0 10.0 15.1 21.1 12.0 15.4 12.2 12.9 15.2 6.6 20.2 12.1 16.8 30.5 14.5 14.9 6.8 25.6 9.2 13.0 5.2 17.7 16.9 24.2 9.4 10.0 6.3 10.8 9.9 7.3 5.6 15.6 13.3 14.6 17.9 15.5 12.9 8.3 10.9 11.1 14.0 10.6 10.1 13.4 17.6 16.4 11.2 15.7 18.1 14.4 12.8 21.4 12.4 6.9 12.1 7.1 13.2 24.7 19.6 9.7 22.9 15.7 22.5 12.4 23.8 12.0 13.4 7.5 15.3 6.2 23.8 15.3 17.5 8.0 15.5 14.6 38.3 19.1 23.0 15.5 21.5 20.1 20.4 23.1 11.5 14.9 14.8 11.7 19.6 16.9 21.8 23.1 8.3 12.4 14.0 2.8 7.7 6.3 6.7 9.9 7.3 9.4 6.5 7.1 10.0 5.8 6.1 6.3 1.1 9.9 10.8 5.0 5.6 5.6 24.3 27.3 18.4 23.6 24.4 18.4 27.7 17.7 21.1 25.6 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468938-119494708 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" "Endoplasmic reticulum" Cytosol "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favourable (2.23e-4)" 11.9 12.1 7.6 10.7 12.0 3.9 10.9 13.9 10.6 10.1 9.5 9.8 27.4 5.9 13.7 11.7 9.3 10.1 6.9 8.3 7.3 8.9 8.3 10.3 9.1 14.3 15.0 5.6 10.5 29.2 12.1 14.5 11.5 10.9 9.4 10.9 8.7 7.8 25.7 5.1 14.0 12.1 15.2 14.0 14.9 8.2 4.7 8.9 11.7 8.6 4.1 15.6 10.6 10.2 9.9 14.3 9.4 11.5 19.8 16.0 10.3 7.4 5.0 8.7 9.6 22.0 12.6 6.2 11.9 12.2 9.7 13.3 8.1 4.9 11.5 16.2 15.0 8.8 11.6 11.8 15.4 9.9 7.5 13.5 7.9 8.8 14.3 14.8 15.9 12.9 7.7 9.6 13.5 11.0 7.3 14.1 9.8 7.5 8.4 14.3 8.9 9.2 8.4 8.8 16.9 8.4 9.6 9.5 14.6 5.7 3.6 9.2 9.5 12.4 13.9 9.5 5.9 2.8 6.1 19.4 16.8 15.7 8.3 15.0 13.4 1.9 11.5 9.4 12.0 10.8 13.8 9.9 13.6 12.5 14.3 7.0 16.0 15.2 0.9 19.8 7.0 8.0 14.7 10.3 7.6 12.0 13.9 10.6 7.3 8.9 15.0 5.6 10.9 8.9 POLA1 "NSX, p180, POLA" ENSG00000101868 "DNA polymerase alpha 1, catalytic subunit" P09884 X 24693919-24996986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication, Host-virus interaction" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002947, CAB012274" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB012274: , HPA002947: AB_1079652" "unprognostic (6.92e-2)" "unprognostic (4.43e-3)" "unprognostic (3.27e-3)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (4.80e-5)" "unprognostic (1.87e-1)" "unprognostic (9.25e-3)" "unprognostic (2.48e-2)" "unprognostic (8.41e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-2)" "unprognostic (3.08e-1)" 10.5 5.5 8.0 15.0 10.2 14.3 10.9 12.0 9.6 10.1 9.7 11.8 5.8 5.7 11.2 7.7 10.2 8.9 5.5 9.3 7.8 6.6 6.1 4.9 7.2 12.7 10.3 4.5 12.9 7.3 8.5 8.5 10.7 8.7 7.3 11.0 7.5 7.9 9.3 22.4 9.3 7.5 9.7 13.1 9.0 7.9 5.7 10.0 30.1 7.0 8.5 14.7 9.9 10.6 4.6 2.5 1.2 4.6 2.7 3.8 1.7 14.0 10.5 13.9 11.2 2.6 3.1 3.1 10.5 5.8 11.3 13.0 8.7 7.4 18.0 3.6 4.5 11.6 26.4 8.5 15.3 9.3 11.2 13.4 20.5 6.5 1.1 17.5 7.2 2.0 1.8 14.1 4.1 5.8 12.3 9.2 7.8 9.8 19.0 5.9 13.5 8.8 17.1 36.5 13.6 4.1 9.3 12.6 7.8 12.4 5.9 5.6 11.6 5.8 4.6 10.0 6.9 19.1 10.0 5.5 7.9 14.5 5.8 8.3 11.1 0.0 2.0 1.2 3.0 4.6 2.9 4.6 3.4 3.8 2.5 3.2 2.4 2.4 0.6 2.7 1.3 1.6 3.6 1.7 8.0 10.2 12.0 9.6 7.8 6.6 10.3 4.5 8.7 10.0 POLDIP3 "KIAA1649, PDIP3, PDIP46, SKAR" ENSG00000100227 "DNA polymerase delta interacting protein 3" Q9BY77 22 42583721-42614962 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018419, HPA048790" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA018419: AB_1856928, HPA048790: " "unprognostic (2.00e-1)" "unprognostic (1.55e-1)" "unprognostic (1.32e-1)" "unprognostic (7.05e-3)" "prognostic favourable (7.79e-4)" "unprognostic (2.82e-1)" "unprognostic (1.17e-2)" "unprognostic (5.44e-2)" "unprognostic (8.16e-2)" "unprognostic (4.49e-3)" "unprognostic (2.48e-1)" "unprognostic (5.96e-2)" "prognostic favourable (3.36e-4)" "unprognostic (3.73e-2)" "unprognostic (3.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" 17.7 24.5 25.8 22.9 31.6 43.8 25.3 30.9 33.2 28.4 23.2 36.2 23.4 19.2 31.3 27.8 28.1 41.4 28.8 20.6 25.9 19.2 24.4 19.7 25.1 24.4 38.0 24.9 71.5 24.1 27.7 24.4 30.8 27.4 27.5 22.5 24.0 28.1 27.0 23.8 28.5 21.2 27.2 24.5 26.9 28.0 28.2 38.3 37.9 33.5 17.4 33.2 21.2 27.0 22.2 33.0 22.7 28.5 20.9 26.8 27.0 17.1 17.6 39.7 18.4 17.9 20.7 25.5 19.8 16.8 30.5 22.8 20.5 11.9 29.1 12.8 23.4 20.0 41.3 22.6 23.9 14.0 30.4 23.1 20.7 21.2 16.7 35.9 23.7 14.3 25.8 22.4 23.4 21.4 24.7 19.4 24.0 19.1 29.9 26.0 22.0 16.6 38.0 36.1 19.7 25.4 11.1 13.1 11.2 24.0 21.0 21.1 19.3 26.4 19.4 19.4 23.5 13.1 19.8 18.9 23.0 27.0 15.8 22.3 27.3 18.1 28.5 22.7 25.7 26.5 26.8 22.2 23.0 21.8 33.0 22.2 25.6 22.5 16.6 20.9 22.7 16.9 23.7 27.0 25.8 31.6 30.9 33.2 25.9 19.2 38.0 24.9 27.4 38.3 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687365 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 34.8" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA058210: , HPA067385: " "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 6.1 3.4 6.7 10.2 4.4 29.3 6.2 34.8 14.4 7.0 6.6 2.0 7.6 7.3 6.1 4.4 7.5 6.2 6.5 4.7 5.6 1.6 3.8 8.6 5.4 8.2 3.3 4.3 8.7 6.8 3.6 3.1 6.5 5.1 6.8 7.7 4.3 8.7 7.4 8.9 17.9 8.5 6.8 3.7 16.7 7.8 25.6 4.4 29.8 5.1 6.0 10.3 6.7 8.7 0.5 1.7 0.8 0.8 4.8 0.7 0.5 11.1 14.9 22.1 10.6 4.7 3.6 19.7 11.4 5.2 13.7 10.0 18.0 6.6 12.8 4.8 6.2 15.5 15.4 7.7 8.4 5.9 19.5 20.2 19.2 8.8 0.9 15.8 11.6 2.8 3.0 14.2 4.7 4.8 22.6 7.2 6.7 18.1 25.9 28.9 17.2 8.9 21.5 12.5 5.8 4.3 18.3 18.5 10.6 13.3 10.9 2.5 16.1 9.8 4.3 12.5 12.8 9.4 11.5 9.6 6.5 20.1 6.8 21.9 8.8 0.0 0.3 0.8 0.5 0.1 0.7 0.5 0.3 0.4 0.7 0.3 0.5 0.3 0.1 4.8 0.8 1.7 0.6 0.5 6.7 4.4 34.8 14.4 5.6 1.6 3.3 4.3 5.1 4.4 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.1 8.8 16.7 7.7 0.8 4.9 8.5 9.8 5.0 15.6 18.1 8.8 13.5 10.7 5.6 5.5 10.6 16.7 6.0 18.5 12.5 9.2 15.9 9.7 10.9 0.4 18.9 6.9 1.4 0.4 8.5 1.4 9.0 13.9 6.9 15.6 15.0 19.2 12.4 9.8 20.6 16.4 15.4 9.7 5.6 9.7 12.0 6.9 9.9 5.8 3.1 11.7 6.7 3.2 2.5 18.6 10.4 7.7 5.0 10.2 24.7 4.7 14.0 10.0 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 POLE3 "CHARAC17, CHRAC17, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410672 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047945: " "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 16.9 23.9 18.2 22.0 18.5 56.3 19.3 36.0 25.0 17.0 17.6 15.8 12.5 15.1 18.2 16.5 27.8 17.6 17.0 17.9 16.1 14.8 14.3 29.5 15.8 29.0 15.1 18.5 15.4 20.8 13.1 8.4 21.2 20.0 15.9 20.3 12.4 17.9 16.3 48.3 24.7 17.3 16.9 16.9 26.8 17.2 29.9 15.9 35.0 16.3 27.3 32.4 18.8 16.7 34.9 33.5 34.3 34.4 28.0 44.0 47.7 15.7 19.7 13.9 20.8 7.9 7.1 12.2 21.1 10.8 23.9 18.9 18.2 14.4 57.4 13.1 12.3 27.1 27.0 23.2 22.1 10.9 16.3 29.8 20.4 18.6 8.5 61.7 18.0 8.1 16.0 20.7 26.8 16.5 41.5 32.1 16.6 40.1 42.3 33.2 17.9 35.7 43.4 57.9 32.2 10.4 15.1 30.1 17.4 30.6 19.4 16.5 29.0 27.8 13.6 17.8 24.1 22.4 36.0 16.8 54.9 77.4 16.2 36.5 21.2 25.4 34.0 34.3 35.5 34.4 44.0 34.9 34.0 33.7 33.2 33.5 36.9 34.3 7.2 28.0 26.6 33.5 39.0 47.7 18.2 18.5 36.0 25.0 16.1 14.8 15.1 18.5 20.0 15.9 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958492-74970128 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054979: , HPA071815: " "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.2 14.5 23.6 15.2 17.3 27.1 21.4 4.4 15.5 18.4 13.4 8.6 7.0 9.0 10.4 9.0 10.0 9.7 13.1 18.1 15.9 10.6 11.6 18.8 10.7 17.0 13.9 12.6 12.8 12.5 2.8 3.9 9.6 12.2 12.0 8.8 13.9 16.2 11.2 28.1 8.1 12.4 14.1 11.7 12.2 12.5 11.0 10.0 5.5 13.1 15.1 10.4 13.9 31.9 14.7 14.7 8.0 22.2 4.4 9.9 12.3 11.7 11.2 1.0 1.0 3.8 8.6 0.0 8.0 9.9 12.8 10.9 14.9 5.2 11.5 6.7 9.0 5.3 5.3 6.6 15.0 5.2 14.4 8.9 6.5 14.7 13.9 12.6 14.1 8.7 13.0 5.3 11.8 5.5 10.9 6.8 9.7 11.4 3.7 35.6 7.8 21.1 4.5 9.6 9.3 10.6 0.3 3.5 5.3 11.0 4.6 6.3 3.4 4.1 6.2 2.9 3.3 2.0 7.6 2.4 1.6 4.2 10.5 18.9 14.1 2.3 22.2 8.0 6.3 13.2 7.0 14.7 8.9 7.8 12.9 13.7 9.9 6.9 1.6 4.4 12.4 14.7 8.5 12.3 23.6 17.3 4.4 15.5 15.9 10.6 13.9 12.6 12.2 10.0 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497036 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017030, HPA023202" Approved Approved "Nuclear bodies,Mitochondria" "Nuclear bodies" Mitochondria "CAB017030: , HPA023202: AB_1855523" "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavourable (6.59e-4)" "prognostic unfavourable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 6.7 9.3 5.4 17.5 10.0 8.1 8.2 10.9 8.7 7.7 7.8 7.0 11.1 7.9 10.2 6.8 6.4 7.5 7.9 7.3 5.6 4.4 7.8 7.8 10.4 12.2 10.8 5.2 13.0 9.4 5.0 9.9 6.9 8.7 8.0 5.7 5.8 8.6 11.9 10.7 10.5 8.4 9.3 5.6 11.5 6.9 24.2 7.9 9.8 9.6 5.4 13.3 6.6 11.5 12.2 10.5 6.5 8.2 6.0 12.2 4.4 6.7 8.3 6.0 7.4 5.7 4.6 7.3 4.0 3.8 6.1 5.3 8.6 5.4 12.4 4.9 2.1 5.6 8.2 3.8 7.7 3.5 9.4 8.4 10.0 8.5 6.4 11.9 9.4 4.6 4.4 4.9 7.3 4.4 14.7 4.8 5.9 9.0 12.6 15.7 6.3 9.3 11.8 19.6 13.1 5.6 2.0 8.4 9.4 3.2 7.3 7.4 7.1 10.0 4.9 6.6 8.9 5.7 10.4 8.5 5.7 9.4 5.2 11.1 4.6 6.5 5.9 6.5 7.9 3.5 7.5 12.2 8.8 7.6 10.5 12.1 12.2 11.6 1.2 6.0 8.2 4.8 8.4 4.4 5.4 10.0 10.9 8.7 5.6 4.4 10.8 5.2 8.7 7.9 POLH "RAD30A, XP-V" ENSG00000170734 "DNA polymerase eta" Q9Y253 6 43576150-43615660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006721, HPA026762" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006721: AB_1847785, HPA026762: AB_10601248" "unprognostic (1.79e-1)" "unprognostic (7.29e-2)" "unprognostic (2.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.61e-1)" "unprognostic (5.11e-3)" "unprognostic (9.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (7.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.24e-1)" "unprognostic (9.50e-2)" "unprognostic (6.73e-2)" "unprognostic (8.77e-2)" "unprognostic (7.91e-2)" "unprognostic (6.02e-2)" 7.4 9.4 7.5 9.7 10.4 4.6 7.2 10.5 10.5 8.5 8.4 12.7 8.0 5.7 9.6 7.1 11.4 7.8 6.2 6.7 5.3 4.4 7.2 7.5 9.8 16.3 8.9 8.1 7.4 13.0 7.1 9.7 5.1 7.9 6.9 10.1 8.9 8.6 5.6 9.5 11.7 7.9 11.8 6.9 9.2 7.6 24.7 6.8 22.1 9.9 6.2 18.3 8.6 8.4 8.6 4.3 4.5 2.6 6.8 7.2 3.2 20.2 4.7 6.3 9.2 9.0 14.9 15.0 21.7 6.8 12.7 14.7 5.3 3.6 22.5 5.5 8.8 5.1 6.4 13.7 15.8 11.3 4.9 6.6 13.1 15.4 6.7 11.2 8.9 10.0 16.7 10.4 5.6 12.0 10.4 13.5 16.0 6.7 10.2 2.9 1.9 3.5 11.2 6.5 5.6 4.8 15.2 7.1 2.4 6.9 5.8 3.4 8.2 5.0 16.2 11.8 11.4 5.5 10.9 12.7 8.8 40.6 5.6 6.6 12.8 4.5 2.6 4.1 7.2 2.5 6.4 7.8 6.0 5.2 2.1 8.6 5.0 5.2 2.0 6.8 1.9 4.3 7.0 3.2 7.5 10.4 10.5 10.5 5.3 4.4 8.9 8.1 7.9 6.8 POLI "RAD30B, RAD3OB" ENSG00000101751 "DNA polymerase iota" Q9UNA4 18 54269404-54321266 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012000, HPA064696" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA012000: AB_1847786, HPA064696: " "unprognostic (1.64e-1)" "unprognostic (5.79e-3)" "unprognostic (9.72e-3)" "unprognostic (4.92e-2)" "unprognostic (3.04e-1)" "unprognostic (4.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.04e-3)" "unprognostic (2.22e-2)" "unprognostic (2.07e-3)" "unprognostic (1.30e-3)" "unprognostic (1.55e-1)" "unprognostic (4.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (6.99e-2)" 16.5 11.1 10.2 9.5 14.0 5.2 15.8 9.6 14.7 12.9 9.9 13.4 13.7 6.6 13.2 13.1 6.6 10.3 8.3 9.1 8.7 7.6 12.9 6.4 9.0 7.4 10.9 9.0 16.4 11.8 17.6 21.3 17.4 15.3 12.7 7.7 9.6 11.3 14.7 7.2 8.2 7.6 10.9 12.0 8.2 9.0 30.5 10.9 17.3 27.3 1.5 7.0 12.7 10.5 9.9 10.3 10.9 10.7 7.9 12.7 7.1 7.7 2.8 21.3 12.9 7.2 14.1 6.9 6.4 13.8 7.4 12.4 2.1 7.4 3.7 2.1 9.3 6.4 5.0 7.3 8.3 8.8 2.5 4.6 3.2 5.4 11.8 7.3 3.8 15.2 11.2 6.4 13.4 15.6 3.1 10.5 12.3 6.1 5.2 6.4 7.3 3.1 3.3 4.3 9.1 8.4 10.3 10.0 10.2 4.6 4.1 6.8 14.8 3.3 7.5 13.9 3.8 2.1 5.3 8.5 1.9 5.2 9.9 6.6 10.1 5.4 10.7 10.9 8.3 5.7 7.7 8.6 8.8 8.6 10.3 9.9 12.7 7.6 6.7 7.9 5.8 8.1 9.8 7.1 10.2 14.0 9.6 14.7 8.7 7.6 10.9 9.0 15.3 10.9 POLK "DINB1, DINP, POLQ" ENSG00000122008 "DNA polymerase kappa" Q9UBT6 5 75511756-75601144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012035, HPA057303, HPA068117, HPA069375" Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA012035: , HPA057303: , HPA068117: , HPA069375: " "unprognostic (9.66e-2)" "unprognostic (5.29e-2)" "unprognostic (5.37e-2)" "unprognostic (2.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.65e-2)" "unprognostic (6.29e-3)" "unprognostic (2.42e-1)" "unprognostic (5.93e-2)" "unprognostic (1.80e-2)" "unprognostic (9.96e-3)" "unprognostic (1.58e-1)" "unprognostic (9.64e-2)" "unprognostic (2.02e-1)" 14.7 12.7 10.1 8.6 12.9 6.3 13.4 17.0 13.4 18.1 10.7 8.8 13.6 6.3 21.3 12.1 11.7 10.5 9.5 11.4 14.1 10.5 12.6 12.3 12.2 9.2 14.1 12.9 15.5 11.1 18.5 23.9 15.2 17.2 13.9 8.1 6.5 10.2 10.5 15.2 10.3 9.2 15.4 16.9 13.1 9.0 9.8 12.4 12.1 18.8 9.3 8.9 12.7 10.2 7.0 7.5 6.0 13.3 4.6 4.5 2.5 6.4 6.6 4.1 5.2 5.4 10.9 3.5 12.3 8.7 9.6 10.0 4.2 5.2 6.6 10.1 8.1 2.5 3.8 4.2 11.5 7.3 4.4 6.0 5.8 1.9 10.4 3.8 4.9 5.0 5.2 7.7 5.3 8.0 5.3 3.9 9.0 0.5 7.5 3.1 1.5 3.9 3.2 10.5 4.6 5.8 2.2 4.2 4.6 9.2 2.5 3.3 3.6 3.7 10.0 7.0 3.6 3.3 7.0 4.5 4.1 5.9 4.7 6.1 12.0 5.7 7.1 3.4 3.3 7.9 2.9 7.0 3.7 4.0 6.1 5.4 4.5 3.0 6.0 4.6 13.3 7.5 4.1 2.5 10.1 12.9 17.0 13.4 14.1 10.5 14.1 12.9 17.2 12.4 POLL ENSG00000166169 "DNA polymerase lambda" Q9UGP5 10 101578882-101588270 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066704 Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus" "HPA066704: " "unprognostic (3.71e-3)" "unprognostic (6.93e-3)" "unprognostic (1.73e-2)" "unprognostic (2.47e-2)" "unprognostic (9.52e-2)" "unprognostic (1.80e-2)" "unprognostic (2.11e-2)" "unprognostic (1.24e-1)" "unprognostic (8.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.12e-2)" "unprognostic (7.19e-2)" "unprognostic (4.74e-2)" "unprognostic (1.06e-2)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" "unprognostic (1.64e-3)" 11.0 15.1 14.4 16.0 17.1 9.2 13.4 11.2 22.1 13.7 12.6 16.4 15.6 14.3 15.1 22.1 15.4 18.1 17.7 12.3 11.1 10.4 16.4 16.5 11.8 13.0 9.6 13.0 20.9 30.7 21.7 23.7 11.7 12.7 17.2 15.0 19.5 17.8 14.7 26.1 12.8 11.9 12.7 9.4 15.6 16.7 53.2 11.2 4.6 18.3 10.2 14.2 14.8 11.6 8.5 10.7 1.1 8.5 8.4 11.9 7.1 12.5 11.5 9.1 12.6 9.2 17.2 12.7 8.3 14.5 12.8 13.5 8.4 15.2 3.1 13.2 7.5 15.8 10.0 12.3 10.3 11.1 13.6 9.8 10.8 9.5 17.0 10.2 9.0 15.6 16.8 14.1 29.4 13.7 10.9 10.9 8.0 10.0 0.0 11.2 4.8 6.8 0.0 8.1 5.1 10.7 7.6 6.4 9.3 5.1 8.6 14.3 26.2 5.9 7.3 4.6 9.3 5.2 9.1 15.8 7.9 4.7 9.9 8.9 3.4 0.5 8.5 1.1 6.7 5.9 10.6 8.5 7.4 6.8 10.7 7.1 11.9 7.9 0.9 8.4 5.7 0.2 8.9 7.1 14.4 17.1 11.2 22.1 11.1 10.4 9.6 13.0 12.7 11.2 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" "HPA048931, HPA053359" Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048931: , HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favourable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.3 9.1 7.8 5.5 0.7 0.9 7.1 6.3 2.4 7.5 10.1 7.2 5.0 15.9 2.9 3.4 10.6 9.2 4.1 12.8 4.6 5.0 10.2 5.6 4.5 0.0 11.0 9.3 0.1 0.3 6.8 4.2 3.7 6.7 12.1 7.8 5.2 9.9 6.4 7.4 4.4 8.4 9.4 5.6 2.4 7.7 4.3 3.8 7.3 4.0 2.6 3.7 10.9 2.8 6.6 8.7 2.6 8.2 6.1 4.9 16.5 3.2 8.2 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: , HPA049700: " "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavourable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.3 21.3 9.5 18.3 9.3 7.5 13.8 8.6 5.7 12.4 7.7 26.7 7.4 21.5 9.2 8.8 10.9 24.5 12.7 11.1 8.9 12.6 18.5 9.1 17.9 6.6 17.5 10.0 5.7 8.0 18.4 14.4 9.6 24.5 5.4 8.5 8.3 12.9 7.5 17.3 14.1 15.6 20.9 10.0 5.5 15.4 14.8 7.7 9.5 12.6 6.8 7.4 6.1 15.2 15.1 11.9 12.8 17.3 7.7 7.4 18.8 7.8 15.1 13.3 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 POLR1B "FLJ10816, FLJ21921, RPA2, Rpo1-2" ENSG00000125630 "RNA polymerase I subunit B" Q9H9Y6 2 112541915-112577150 "Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037528 Supported Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA037528: AB_10671627" "unprognostic (1.66e-1)" "unprognostic (3.17e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (2.71e-5)" "unprognostic (2.07e-1)" "unprognostic (1.16e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "unprognostic (2.05e-1)" "unprognostic (1.13e-1)" "prognostic unfavourable (5.52e-4)" "unprognostic (6.12e-2)" "unprognostic (1.29e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" 8.8 11.0 6.4 10.6 6.8 4.9 15.7 8.0 8.2 7.6 7.0 7.7 8.6 5.8 9.3 7.4 12.8 9.2 9.2 6.1 5.7 6.1 11.3 20.5 8.0 11.3 6.8 3.7 11.3 25.2 20.7 11.5 7.2 5.2 7.7 8.5 7.3 10.0 8.3 14.7 9.2 8.0 7.9 4.8 11.4 8.1 15.7 5.0 9.6 15.7 11.5 14.6 8.9 11.8 9.4 11.0 2.5 6.3 10.2 17.1 7.3 9.4 9.9 6.3 13.0 6.8 6.6 11.8 7.1 5.4 12.0 10.5 22.2 5.6 22.7 10.6 4.7 13.3 26.4 14.5 13.9 10.2 13.3 13.1 9.9 16.7 7.2 20.9 9.1 6.2 10.5 12.5 19.3 9.3 23.7 8.2 6.3 8.3 9.4 13.6 30.6 19.7 14.2 10.4 24.1 8.3 9.0 15.9 14.8 6.5 16.5 9.0 7.6 7.4 8.4 7.4 10.9 6.8 10.4 11.1 18.3 19.6 5.6 13.4 6.2 0.2 6.0 2.5 8.3 6.3 17.1 9.4 8.4 8.9 11.0 9.3 10.3 10.4 0.4 10.2 4.8 2.6 11.3 7.3 6.4 6.8 8.0 8.2 5.7 6.1 6.8 3.7 5.2 5.0 POLR1D "MGC9850, RPA16, RPA9, RPAC2, RPO1-3" ENSG00000186184 "RNA polymerase I subunit D" "P0DPB5, P0DPB6" 13 27620742-27744237 "Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039337 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039337: AB_10672961" "unprognostic (1.33e-3)" "unprognostic (5.96e-2)" "unprognostic (4.35e-2)" "unprognostic (8.50e-3)" "unprognostic (1.98e-2)" "unprognostic (3.71e-3)" "unprognostic (5.33e-3)" "unprognostic (2.04e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-2)" "unprognostic (2.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (2.56e-2)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" 30.5 43.8 17.0 35.4 22.1 46.5 36.5 41.2 23.7 34.6 40.8 15.9 34.4 30.9 26.0 29.9 58.9 21.4 32.3 28.5 16.7 14.4 27.3 29.9 32.6 36.5 14.8 20.6 43.6 115.9 16.7 24.3 24.7 15.6 37.4 32.7 20.9 46.2 39.5 38.1 44.8 36.4 41.2 17.4 31.9 41.7 23.7 13.0 50.9 32.3 40.7 40.7 56.8 54.0 29.2 42.7 21.4 39.3 27.9 56.6 26.2 20.0 18.9 21.8 22.3 25.1 45.1 29.3 19.9 34.4 26.3 26.2 30.5 40.9 65.0 15.1 22.4 31.0 40.0 63.5 31.4 20.1 23.8 46.2 20.6 51.0 37.9 41.9 36.3 40.5 67.2 21.4 40.0 36.4 25.2 11.6 25.5 20.8 41.2 51.1 52.5 20.1 28.3 37.5 29.2 41.5 31.2 37.2 29.1 13.3 26.8 71.7 16.4 39.2 25.2 11.7 18.3 20.0 21.7 19.0 21.5 36.7 10.2 30.4 22.7 21.4 38.4 17.3 24.9 39.3 32.8 28.4 40.2 31.4 42.7 29.2 43.6 34.2 13.7 27.9 34.2 31.2 56.6 26.2 17.0 22.1 41.2 23.7 16.7 14.4 14.8 20.6 15.6 13.0 POLR1E "FLJ13390, FLJ13970, PAF53, PRAF1" ENSG00000137054 "RNA polymerase I subunit E" Q9GZS1 9 37485935-37503697 "Predicted intracellular proteins, Predicted membrane proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022527, HPA052400" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA022527: AB_1854924, HPA052400: " "prognostic favourable (2.27e-4)" "unprognostic (2.09e-1)" "unprognostic (9.90e-3)" "unprognostic (1.10e-2)" "unprognostic (7.16e-3)" "unprognostic (2.07e-1)" "unprognostic (1.09e-2)" "unprognostic (7.14e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (2.80e-1)" "unprognostic (2.48e-1)" "unprognostic (1.07e-1)" "unprognostic (4.96e-2)" "unprognostic (5.23e-1)" "unprognostic (1.58e-1)" "unprognostic (4.24e-2)" 15.4 12.2 10.5 20.2 11.6 9.3 19.7 10.7 9.0 19.0 13.9 10.0 14.9 7.0 20.5 14.7 15.1 17.3 13.7 14.9 9.1 9.2 7.6 23.9 10.1 15.5 9.0 9.2 36.9 25.9 10.3 9.6 8.7 9.5 17.3 9.3 9.5 19.5 18.4 17.2 13.1 9.0 22.4 10.2 10.8 13.0 11.2 11.5 16.0 15.3 13.3 17.1 21.9 16.8 8.1 3.9 1.4 4.3 9.0 16.9 5.5 19.4 18.3 10.1 16.0 19.0 24.4 6.6 17.2 6.7 17.9 15.9 15.7 6.5 28.3 8.4 19.9 8.2 24.6 20.5 22.7 27.3 11.5 13.5 23.2 11.1 14.2 25.9 9.6 25.9 7.3 35.1 30.3 9.1 35.3 12.5 15.7 9.3 17.9 8.9 17.9 15.0 16.0 9.3 13.5 9.3 7.2 14.5 11.9 11.5 9.2 14.8 9.0 17.3 6.2 21.3 32.5 18.2 34.4 6.8 9.6 29.8 7.3 16.5 17.6 0.0 2.5 1.4 10.6 4.3 16.9 7.4 10.2 10.8 3.9 8.1 12.8 11.1 0.8 9.0 3.4 2.7 5.4 5.5 10.5 11.6 10.7 9.0 9.1 9.2 9.0 9.2 9.5 11.5 POLR2C RPB3 ENSG00000102978 "RNA polymerase II subunit C" P19387 16 57462387-57472010 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040919, HPA041826" Enhanced Supported Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA040919: AB_10795483, HPA041826: AB_10793935" "unprognostic (2.10e-2)" "unprognostic (4.42e-2)" "unprognostic (7.52e-3)" "unprognostic (1.82e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (1.48e-4)" "unprognostic (2.90e-1)" "unprognostic (9.54e-2)" "unprognostic (1.95e-1)" "unprognostic (2.48e-2)" "unprognostic (2.60e-2)" "unprognostic (6.63e-2)" "prognostic favourable (3.03e-6)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.20e-1)" "unprognostic (5.43e-3)" 26.2 30.1 24.2 18.4 26.9 23.9 25.8 34.1 37.6 27.2 22.9 28.8 23.1 21.5 26.0 45.0 26.2 30.3 29.9 32.6 24.5 25.9 38.3 44.8 29.9 30.2 25.0 30.1 37.2 39.4 33.7 35.0 29.2 25.5 29.2 26.0 29.6 30.4 31.4 47.5 23.7 27.9 26.1 24.1 22.4 25.2 26.4 21.9 30.5 35.8 27.3 27.1 27.5 22.2 21.8 16.2 41.7 19.8 26.2 28.6 21.9 17.4 28.8 24.1 21.9 21.9 19.7 21.4 23.0 25.1 37.0 24.5 36.8 22.1 19.7 27.1 25.3 18.3 31.9 24.2 41.2 9.1 23.7 15.1 17.2 42.0 24.9 27.4 29.1 17.6 20.0 28.2 26.1 22.2 26.2 11.1 24.1 24.1 30.3 29.0 36.1 43.9 44.3 28.6 34.9 29.9 17.3 30.7 35.8 37.3 20.8 24.1 15.9 25.3 17.1 23.4 23.8 17.7 26.2 25.8 22.0 40.1 23.5 23.7 30.8 24.8 17.3 29.0 20.7 16.4 22.6 21.8 23.6 19.1 16.2 20.9 28.6 26.8 41.7 26.2 19.8 13.2 22.5 21.9 24.2 26.9 34.1 37.6 24.5 25.9 25.0 30.1 25.5 21.9 POLR2D RBP4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843551-127858157 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA034694: , HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 8.2 9.4 8.1 8.9 9.1 17.9 7.9 9.3 12.6 6.9 7.7 12.3 6.9 6.3 7.5 6.2 9.8 7.7 7.6 7.3 7.8 6.3 6.3 13.5 7.2 11.8 9.9 7.5 10.3 17.4 7.4 9.4 10.2 8.7 7.2 9.9 7.3 7.6 6.5 21.9 8.9 7.8 9.8 8.8 11.1 7.8 46.4 9.9 16.7 6.3 9.1 16.8 8.0 7.2 16.7 20.6 11.4 22.1 16.7 21.0 14.3 18.2 11.9 22.2 15.5 8.3 9.1 17.8 17.5 8.3 21.1 18.9 26.9 15.1 28.4 15.1 11.7 9.7 31.8 15.1 32.8 16.6 17.3 28.0 11.9 24.7 9.7 30.0 15.6 6.4 11.4 28.2 16.2 13.7 39.0 25.5 12.0 14.5 29.8 13.7 31.1 13.8 28.7 23.5 25.5 7.0 12.5 13.8 18.5 11.8 14.6 14.7 16.3 20.8 13.8 18.3 25.8 10.3 20.1 30.1 48.7 51.0 15.9 15.0 18.0 5.7 15.8 11.4 19.4 21.5 18.1 16.7 15.6 16.9 20.6 15.1 21.0 17.8 5.0 16.7 22.1 13.5 13.9 14.3 8.1 9.1 9.3 12.6 7.8 6.3 9.9 7.5 8.7 9.9 POLR2F "HRBP14.4, RPB6" ENSG00000100142 "RNA polymerase II subunit F" P61218 22 37952607-38041915 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in single" "melanoma: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000827, CAB009882" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB009882: AB_2299942, HPA000827: AB_1079834" "unprognostic (8.27e-2)" "unprognostic (7.50e-2)" "unprognostic (1.51e-3)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (2.73e-3)" "unprognostic (2.85e-1)" "unprognostic (5.87e-2)" "unprognostic (4.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.11e-4)" "unprognostic (9.08e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-1)" "unprognostic (7.86e-2)" 31.7 31.4 37.5 23.4 43.8 23.0 28.2 32.6 54.5 25.2 27.8 57.3 20.4 26.3 24.2 18.7 24.6 23.2 20.3 37.8 33.5 31.2 25.1 58.5 17.9 19.8 44.8 44.1 30.2 26.1 43.5 28.8 21.2 38.4 21.4 21.0 21.0 38.0 29.6 67.9 19.0 25.7 20.8 39.6 16.8 26.9 21.9 48.3 13.1 28.5 23.4 18.0 19.0 26.8 36.1 49.5 52.4 36.7 40.1 38.5 29.3 34.0 40.3 28.5 30.4 34.3 20.1 25.4 31.9 18.7 32.8 30.9 46.7 12.1 26.3 23.1 27.6 24.6 39.2 30.9 16.2 32.1 66.3 24.5 41.4 63.4 29.9 47.8 15.8 26.6 23.5 44.2 17.1 28.0 46.8 22.2 23.7 48.4 37.2 57.7 41.0 30.7 37.1 26.2 30.7 18.1 21.2 42.8 16.0 29.4 21.1 46.1 14.7 33.2 25.6 28.9 41.1 35.7 36.1 25.1 38.8 54.9 29.4 24.4 32.5 34.5 36.7 52.4 34.3 33.3 32.1 36.1 30.0 33.2 33.4 28.9 27.3 27.2 46.2 40.1 28.1 49.5 38.5 29.3 37.5 43.8 32.6 42.7 33.5 31.2 44.8 44.1 38.4 48.3 POLR2K RPB10alpha ENSG00000147669 "RNA polymerase II subunit K" P53803 8 100150584-100154002 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047477 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoplasm, Nucleoli fibrillar center" "Intermediate filaments" "HPA047477: " "unprognostic (3.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-3)" "unprognostic (2.75e-2)" "unprognostic (4.68e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" "unprognostic (9.75e-3)" "unprognostic (5.73e-2)" "unprognostic (5.65e-2)" "unprognostic (3.46e-2)" "unprognostic (3.07e-2)" "unprognostic (9.16e-2)" "unprognostic (3.43e-2)" 31.4 43.7 51.1 22.0 38.7 32.9 41.5 34.7 53.0 33.8 28.5 24.7 20.8 21.2 29.3 42.7 33.1 23.8 23.9 35.3 46.2 51.0 47.5 46.6 27.3 29.7 49.0 35.0 26.2 20.2 28.2 36.8 27.1 46.0 37.8 31.8 21.5 32.7 33.3 23.3 21.8 28.4 34.8 40.4 31.9 26.6 22.6 23.7 24.9 36.6 22.3 31.5 39.3 23.1 29.0 30.0 24.2 19.2 25.0 30.9 24.2 39.3 19.9 25.7 18.1 27.7 25.3 17.4 29.2 24.1 29.8 36.3 12.3 27.1 26.4 58.0 23.1 18.1 27.6 24.1 39.5 42.0 30.6 35.8 25.1 25.9 22.0 23.1 26.1 20.5 32.2 23.7 24.3 27.0 28.0 25.9 29.1 25.0 58.4 34.3 26.8 39.6 23.0 14.9 38.1 37.1 22.2 54.3 35.7 19.8 17.8 42.3 36.3 35.3 20.4 17.6 25.3 27.2 31.0 26.7 42.2 41.5 33.4 40.7 27.4 24.2 15.2 22.1 23.7 19.2 28.2 29.0 30.9 29.4 19.0 19.7 27.1 29.3 5.8 25.0 18.2 30.0 30.9 24.2 51.1 38.7 34.7 53.0 46.2 51.0 49.0 35.0 46.0 23.7 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell line enhanced" "Detected in all" "WM-115: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB010109: AB_2165718, HPA052658: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.5 6.1 7.2 1.9 2.2 4.1 3.3 5.3 1.7 8.4 6.9 3.5 7.9 29.0 1.8 2.2 4.4 9.0 8.5 30.3 13.3 8.1 10.6 2.9 5.4 3.8 7.4 2.7 2.7 3.9 14.1 10.7 10.4 15.1 2.6 3.0 5.2 7.7 4.7 34.4 27.3 6.9 3.2 16.3 2.5 1.0 9.2 2.5 2.1 4.0 14.6 2.2 2.1 12.4 4.6 8.9 6.5 19.9 6.6 17.2 21.3 10.2 9.9 36.7 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 POLR3H "KIAA1665, RPC8" ENSG00000100413 "RNA polymerase III subunit H" Q9Y535 22 41525804-41544606 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046787 Approved Supported Nucleoplasm,Vesicles,Centrosome Nucleoplasm "Vesicles, Centrosome" "HPA046787: AB_2679806" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (9.57e-2)" "unprognostic (1.26e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.05e-2)" "unprognostic (1.33e-2)" "unprognostic (5.43e-2)" "prognostic favourable (5.41e-4)" "unprognostic (6.40e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (1.49e-1)" "unprognostic (4.00e-2)" "unprognostic (1.70e-1)" 16.8 14.0 30.0 9.1 28.8 5.5 13.5 21.0 27.4 12.1 7.5 15.8 12.6 6.1 10.5 11.7 17.0 19.0 10.3 14.8 24.0 20.5 10.0 18.9 14.7 10.9 22.2 17.6 22.4 13.7 13.1 11.5 7.9 17.2 11.0 6.8 12.1 12.2 14.2 7.7 14.6 6.2 14.4 14.2 7.2 7.9 14.2 16.5 7.0 15.4 8.2 9.3 8.1 9.1 11.6 11.2 0.6 13.8 3.9 10.2 7.5 16.1 10.9 10.1 14.7 11.1 10.1 6.7 13.6 12.7 23.2 18.7 22.0 5.3 13.8 10.7 22.8 7.4 18.5 22.2 14.6 12.5 22.8 8.2 17.3 10.5 11.5 34.1 14.1 12.6 14.5 30.5 8.2 11.3 17.3 8.9 12.9 15.4 8.7 9.3 7.1 14.2 13.4 7.9 14.3 10.8 9.5 9.8 5.8 17.7 18.0 8.6 7.2 9.7 10.1 13.9 15.0 24.0 18.0 6.7 12.5 20.8 24.2 12.2 13.1 0.0 10.0 0.1 7.3 13.8 10.2 11.6 7.1 8.6 11.2 10.1 10.0 8.1 0.6 3.9 12.7 10.8 4.4 7.5 30.0 28.8 21.0 26.9 24.0 20.5 22.2 17.6 17.2 16.5 POLR3K RPC11 ENSG00000161980 "RNA polymerase III subunit K" Q9Y2Y1 16 46407-53628 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA005891 Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005891: AB_1079653" "unprognostic (3.00e-1)" "unprognostic (1.50e-3)" "unprognostic (1.53e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-1)" "unprognostic (1.40e-1)" "unprognostic (8.03e-3)" "unprognostic (9.06e-2)" "unprognostic (7.40e-2)" "unprognostic (5.72e-2)" "unprognostic (9.96e-2)" "unprognostic (1.84e-1)" "unprognostic (7.36e-3)" "unprognostic (2.68e-2)" "unprognostic (3.63e-2)" "unprognostic (3.53e-2)" "unprognostic (9.63e-2)" 7.3 12.4 15.4 16.6 17.6 11.3 8.3 14.3 18.8 8.0 9.1 9.0 11.9 9.8 8.3 9.3 9.8 9.3 7.4 12.0 13.7 15.4 9.1 10.3 7.6 19.6 11.9 15.5 9.1 11.0 12.1 7.5 8.0 9.0 10.0 9.2 5.9 11.1 12.7 21.8 5.7 9.3 8.2 9.8 14.0 9.1 5.7 7.9 13.7 11.5 12.4 18.6 9.9 8.6 39.6 25.3 32.2 18.9 13.5 30.0 18.2 10.7 18.5 11.8 12.2 4.9 2.9 9.4 15.3 4.9 13.7 9.0 23.8 11.6 27.9 11.7 5.4 10.7 27.4 7.1 9.8 16.7 25.2 20.5 13.9 16.9 3.7 18.4 20.2 2.9 6.2 15.1 7.7 6.7 29.1 8.9 8.8 26.7 22.1 12.2 19.3 17.7 26.9 13.6 29.1 7.7 7.7 17.3 10.2 10.5 19.7 9.0 11.6 16.7 6.3 8.8 10.8 11.8 18.5 5.7 13.7 54.9 3.8 13.5 13.1 9.0 13.6 32.2 15.8 18.9 16.2 39.6 20.3 18.2 12.4 35.1 18.4 17.2 9.8 13.5 17.3 25.3 30.0 18.2 15.4 17.6 14.3 18.8 13.7 15.4 11.9 15.5 9.0 7.9 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: , HPA049817: " "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 19.4 15.2 14.5 16.0 17.7 35.0 14.4 25.9 22.0 13.1 16.6 16.0 14.2 19.5 17.9 14.8 15.8 15.8 14.9 11.8 11.7 10.0 14.0 16.6 13.3 18.7 10.8 12.7 18.6 23.3 14.9 20.6 15.4 13.4 18.6 11.4 20.2 17.4 11.7 18.4 17.0 19.1 12.1 12.7 19.0 16.3 17.3 13.5 24.5 19.5 15.2 22.3 15.8 14.5 3.7 4.3 3.7 3.6 4.5 5.2 2.6 16.9 12.4 15.5 34.9 8.4 6.9 12.9 12.2 10.3 12.1 10.6 21.9 10.8 23.5 4.0 10.5 13.0 15.4 11.8 13.6 20.3 30.7 17.4 12.5 14.5 8.6 36.2 22.3 9.1 8.4 16.1 14.8 9.0 47.8 17.5 11.9 13.0 21.6 23.1 16.3 15.1 19.7 12.1 19.7 6.2 14.9 22.2 19.6 10.7 20.5 10.9 17.1 19.1 12.7 21.8 13.5 17.1 24.3 21.1 19.6 34.0 12.7 23.2 21.6 0.1 2.3 3.7 5.2 1.4 3.0 3.0 3.3 3.8 2.6 3.7 3.0 4.3 2.6 4.5 3.6 4.3 1.7 2.6 14.5 17.7 25.9 22.0 11.7 10.0 10.8 12.7 13.4 13.5 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" 7 75416787-75486271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA043809: , HPA049817: " "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 5.5 5.5 6.5 9.9 8.4 11.0 4.5 11.2 7.4 5.9 5.1 5.8 6.5 4.5 7.0 7.5 6.6 5.9 6.0 5.3 6.8 6.9 6.3 5.0 10.3 4.3 4.4 8.4 7.5 7.7 10.1 6.6 5.4 5.4 5.2 9.3 6.5 5.3 5.7 5.5 6.2 6.2 4.6 6.7 5.3 4.6 6.3 13.1 7.0 7.3 12.0 6.6 5.0 3.5 3.4 3.9 1.6 2.7 3.8 1.7 15.5 13.0 18.0 34.5 6.8 7.6 11.9 11.3 10.5 9.3 9.0 15.6 10.1 27.5 4.7 12.3 14.1 15.3 14.0 15.4 18.6 21.1 13.6 15.0 10.4 9.0 36.0 19.4 6.5 8.9 14.1 10.6 9.4 38.1 15.5 15.0 15.7 21.9 18.3 14.3 14.7 19.8 12.0 14.1 5.1 21.2 20.2 26.5 13.1 21.0 9.2 18.3 12.9 10.4 22.6 12.2 16.4 23.4 16.6 19.3 34.0 14.7 18.5 20.8 0.6 1.2 1.3 3.8 1.6 3.3 2.6 2.9 1.1 0.9 3.5 1.5 1.9 3.9 2.7 1.0 3.4 0.5 1.7 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.5 5.8 15.1 2.8 3.4 5.5 2.1 3.1 5.5 4.0 5.5 9.1 4.9 4.6 3.8 5.8 8.2 6.3 5.3 1.9 1.4 13.9 5.5 2.4 2.0 4.7 7.8 3.8 2.7 7.3 5.3 5.4 3.2 14.8 3.7 1.6 9.9 2.0 11.8 1.0 6.8 6.8 2.8 1.5 9.8 5.6 4.1 9.1 3.1 3.0 9.7 3.2 7.4 8.4 8.4 8.6 4.2 4.8 8.5 9.3 3.5 3.2 9.9 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049817 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA049817: " "unprognostic (2.23e-1)" "prognostic favourable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favourable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 4.0 3.0 4.7 3.4 5.6 6.6 4.5 6.0 5.3 4.7 4.6 2.4 5.8 5.2 3.8 2.8 2.1 3.8 4.7 3.5 4.4 2.2 3.6 3.1 3.5 5.8 4.7 2.0 3.1 1.7 4.5 3.7 4.3 5.1 14.2 5.3 3.0 7.0 4.0 2.5 3.9 9.5 3.9 3.6 4.0 3.9 4.2 3.5 5.7 3.3 3.0 4.8 1.1 1.9 8.1 13.1 16.8 8.6 3.4 2.0 2.9 4.5 2.1 2.7 4.7 3.7 1.2 0.8 2.6 1.2 3.0 1.3 2.0 5.0 4.7 5.4 4.4 2.8 2.0 2.4 3.6 2.9 5.4 7.2 2.5 1.3 2.9 9.4 9.3 2.5 4.3 10.0 5.8 4.1 1.8 9.5 2.0 1.6 3.0 6.8 12.4 2.5 11.9 4.3 4.5 3.2 5.0 6.7 0.9 16.5 6.8 2.4 2.1 8.8 1.3 9.8 9.2 1.4 3.3 5.7 2.4 1.5 3.5 2.5 3.9 4.0 3.3 4.2 4.8 2.7 3.8 3.0 1.6 3.5 3.4 1.1 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581398 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047598: , HPA069204: " "unprognostic (1.50e-2)" "prognostic favourable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 16.3 33.8 16.2 25.6 14.4 14.1 23.9 8.7 16.7 18.6 17.5 13.6 24.2 11.8 14.5 27.1 15.9 14.6 19.5 25.8 18.1 13.9 24.1 24.1 18.3 19.7 16.9 15.9 11.7 18.9 25.0 17.5 8.2 14.2 15.6 18.0 15.1 20.9 22.6 13.3 12.7 15.1 19.5 14.4 20.3 15.2 9.0 12.1 24.2 19.8 18.9 19.6 13.7 19.2 32.0 33.5 3.6 19.7 18.2 28.2 22.8 20.1 34.5 12.3 15.0 23.3 12.6 19.5 17.0 11.0 20.7 15.9 29.7 9.3 11.8 25.8 13.6 21.4 20.5 32.3 18.6 28.0 31.1 14.4 22.5 33.6 16.4 20.4 15.2 15.8 18.6 23.9 11.0 17.3 17.6 7.6 20.6 44.3 16.5 18.4 14.6 29.8 19.5 15.0 32.4 29.0 20.7 9.6 10.5 28.7 8.4 21.8 39.3 19.6 12.4 10.8 16.3 17.3 18.5 19.9 33.4 20.9 21.1 24.9 17.3 3.6 16.2 3.5 24.7 19.7 22.6 32.0 22.6 23.0 19.0 22.4 28.2 26.8 1.1 18.2 16.7 33.5 21.4 22.8 16.2 14.4 8.7 16.7 18.1 13.9 16.9 15.9 14.2 12.1 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706053-100707495 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 12.3 16.6 20.5 15.1 21.0 25.3 16.1 25.1 33.2 11.3 14.7 8.7 14.0 17.5 13.9 12.5 20.4 13.4 13.9 19.6 18.3 18.1 13.1 31.4 11.7 18.2 16.8 22.0 13.2 21.2 6.6 11.5 18.1 13.3 16.0 8.1 10.0 24.2 15.8 46.4 22.6 17.6 12.3 12.9 12.3 15.5 7.0 9.4 11.0 11.6 20.5 11.8 11.5 12.5 32.1 30.4 46.4 35.6 42.1 37.0 32.0 24.3 24.2 9.8 17.3 5.2 5.0 19.2 13.8 6.5 15.3 15.2 35.4 15.8 19.8 23.3 6.0 15.5 14.3 16.2 7.6 17.9 43.2 8.9 15.8 34.0 8.8 13.6 10.9 5.8 6.1 15.7 15.5 8.5 31.5 17.7 8.0 69.0 34.1 46.7 30.1 33.5 25.8 10.4 33.5 9.1 13.4 19.7 20.0 11.1 34.4 16.3 11.3 13.8 8.3 21.3 25.6 41.8 27.1 7.5 20.4 35.4 13.4 23.5 23.1 46.4 35.6 38.2 32.4 34.1 29.4 32.1 32.5 31.6 30.4 26.4 29.9 31.1 21.9 42.1 35.3 27.9 37.0 32.0 20.5 21.0 25.1 33.2 18.3 18.1 16.8 22.0 13.3 9.4 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavourable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.6 0.4 0.1 2.7 6.9 0.6 2.7 2.8 4.7 5.8 0.0 1.5 0.1 1.1 5.4 0.0 1.3 1.2 3.9 0.0 2.9 0.0 1.0 0.0 0.1 0.0 0.0 2.7 0.2 7.6 1.0 0.3 2.8 8.1 13.2 0.0 0.0 1.0 3.0 4.6 0.4 14.7 0.0 0.0 0.0 6.7 12.2 0.0 0.0 9.5 0.0 5.2 6.0 2.9 0.0 1.9 9.9 0.0 0.0 0.0 13.3 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.7 27.9 12.8 23.7 48.5 18.4 21.4 5.3 17.5 10.1 14.1 20.9 56.7 12.2 4.9 11.6 6.2 16.8 8.4 4.3 10.4 12.4 5.6 8.2 38.7 33.7 5.6 10.1 37.8 10.6 13.3 9.7 9.4 16.9 5.3 9.1 18.7 6.1 10.1 15.9 15.8 8.7 8.4 13.1 11.4 15.4 13.4 12.8 14.4 73.3 19.3 21.0 9.6 8.4 9.5 10.5 14.3 10.5 5.2 8.0 8.3 13.4 8.6 12.2 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 POSTN "OSF-2, periostin, PN" ENSG00000133110 Periostin Q15063 13 37562583-37598844 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hTEC/SVTERT24-B: 77.4;U-138 MG: 98.9;U-2197: 67.3" "Cancer enhanced" "Detected in all" "breast cancer: 231.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012306 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to extracellular matrix" 740000000 "Golgi apparatus" Nucleoplasm "HPA012306: AB_1854827" "unprognostic (7.73e-2)" "unprognostic (1.44e-3)" "unprognostic (2.19e-2)" "unprognostic (2.57e-2)" "unprognostic (4.73e-2)" "unprognostic (2.22e-2)" "unprognostic (4.19e-3)" "prognostic unfavourable (2.93e-4)" "unprognostic (3.05e-3)" "unprognostic (7.10e-2)" "unprognostic (1.32e-2)" "unprognostic (5.93e-2)" "prognostic unfavourable (1.83e-7)" "prognostic unfavourable (4.86e-4)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (8.32e-3)" 60.9 2.0 5.3 12.7 4.0 0.0 26.9 0.5 2.7 17.6 14.1 0.6 11.7 0.6 29.0 20.0 16.5 20.3 14.5 34.1 6.2 0.5 47.5 3.0 28.4 19.5 0.5 1.1 21.0 3.1 8.2 1.7 17.3 2.5 12.4 19.7 0.8 10.8 10.2 14.2 46.1 9.6 14.5 1.7 0.7 37.3 21.5 0.1 3.1 8.0 5.5 1.7 23.5 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.2 13.7 8.3 0.0 3.5 0.0 0.8 0.1 0.0 0.2 0.0 0.0 2.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 14.6 0.0 77.4 0.3 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 98.9 0.0 67.3 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.0 0.5 2.7 6.2 0.5 0.5 1.1 2.5 0.1 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: , HPA064323: " "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.3 5.1 13.3 4.0 1.6 1.6 5.4 0.8 1.4 1.6 1.6 7.4 3.7 7.2 3.4 1.3 4.9 8.1 2.4 2.3 2.9 3.1 5.0 3.5 6.0 1.0 5.5 3.4 1.1 1.4 1.8 3.3 2.1 5.4 4.1 2.1 3.3 5.0 3.6 15.5 2.0 7.3 4.8 3.2 2.8 3.6 8.1 6.1 4.9 3.6 3.3 4.1 6.8 3.4 3.0 4.9 1.8 3.1 4.0 1.8 16.6 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: , HPA062096: , HPA064404: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.1 2.8 18.1 1.8 3.5 0.1 0.5 38.2 1.0 1.0 0.3 0.2 2.9 8.2 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.7 0.8 0.5 15.0 1.0 1.1 0.4 8.8 0.4 0.2 0.1 2.0 0.1 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.2 0.0 4.8 1.4 7.8 0.8 0.0 0.3 26.6 25.7 30.3 14.6 0.9 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favourable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.4 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.6 0.0 0.0 0.1 7.1 0.3 2.6 0.0 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.3 0.6 0.0 0.0 0.1 0.0 1.8 0.4 0.1 0.1 5.2 0.0 9.4 0.4 0.8 0.0 0.2 0.3 0.1 0.1 0.0 0.0 1.1 0.1 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 POU5F1 "MGC22487, OCT3, Oct4, OTF3" ENSG00000204531 "POU class 5 homeobox 1" Q01860 6 31164337-31180731 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HAP1: 52.5;NTERA-2: 139.7" "Cancer enriched" "Detected in many" 34 "testis cancer: 355.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "CAB025600, CAB026380, HPA058267, CAB079773" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: " "unprognostic (3.25e-2)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-2)" "unprognostic (2.11e-2)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (2.59e-1)" "unprognostic (9.27e-2)" "unprognostic (2.27e-2)" "unprognostic (4.79e-2)" "unprognostic (1.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.35e-1)" "unprognostic (3.86e-2)" "prognostic favourable (2.04e-5)" 1.2 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 2.3 2.3 1.2 1.2 4.9 3.1 5.7 1.2 5.2 4.3 1.2 1.2 0.0 11.1 5.0 2.0 1.2 1.2 1.2 1.2 8.8 0.0 1.2 1.2 1.2 4.7 1.0 1.2 1.2 3.0 1.2 1.8 5.9 1.2 1.2 1.2 6.3 2.2 1.2 1.2 1.2 1.2 1.2 11.2 1.2 3.0 1.8 1.8 1.0 1.1 0.9 0.3 0.6 0.2 8.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.7 52.5 0.6 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 139.7 0.0 0.1 0.1 0.1 1.0 1.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.1 1.4 1.0 0.5 0.8 0.7 0.5 1.0 0.4 0.4 0.2 3.0 0.9 0.6 1.8 1.1 0.5 1.8 0.3 0.3 1.2 1.2 1.2 1.2 1.2 0.0 1.2 1.2 1.2 1.2 POU6F1 "BRN5, MPOU, TCFB1" ENSG00000184271 "POU class 6 homeobox 1" 12 51186936-51217708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA047021, HPA050411" Enhanced Supported "Nuclear bodies,Actin filaments" "Nuclear bodies" "Actin filaments" "HPA047021: , HPA050411: " "unprognostic (4.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.48e-3)" "unprognostic (1.45e-2)" "unprognostic (2.72e-1)" "unprognostic (6.58e-2)" "unprognostic (9.70e-2)" "unprognostic (7.11e-3)" "unprognostic (4.45e-1)" "unprognostic (2.05e-1)" "prognostic favourable (6.61e-4)" "unprognostic (2.48e-2)" "unprognostic (9.36e-2)" "unprognostic (2.09e-3)" "unprognostic (1.74e-1)" "unprognostic (2.02e-1)" "unprognostic (2.33e-1)" 8.2 6.9 8.4 5.1 11.6 2.8 5.7 17.6 21.8 8.5 5.6 6.4 2.4 3.7 7.1 2.3 3.9 5.9 5.6 3.5 8.2 4.6 5.2 2.8 5.5 4.1 10.0 8.3 12.4 6.1 3.1 6.2 3.3 8.1 6.9 2.2 5.0 8.4 6.9 13.6 5.6 5.7 6.6 6.6 6.3 3.8 2.4 10.1 0.0 7.5 1.2 3.0 4.7 6.2 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.6 1.3 1.8 2.4 0.6 2.1 1.0 0.8 1.0 1.1 1.3 0.3 0.9 3.1 0.3 0.7 0.0 2.2 0.1 0.0 4.8 3.1 0.8 1.6 0.0 1.7 0.8 4.3 1.2 0.9 1.8 0.3 3.5 1.1 8.5 0.5 0.0 0.4 1.1 3.0 0.0 0.9 1.0 0.0 0.6 0.0 2.3 3.9 2.0 0.0 4.3 0.9 2.8 2.7 1.9 1.6 0.6 2.2 5.5 4.4 0.4 1.7 0.7 0.7 0.0 0.0 0.0 1.0 0.0 0.1 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 11.6 17.6 21.8 8.2 4.6 10.0 8.3 8.1 10.1 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Cell line enhanced" "Detected in some" "U-266/84: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: " "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.5 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.3 0.8 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.2 1.3 0.7 0.8 0.2 0.0 0.3 0.3 0.5 0.6 4.0 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 PPA2 FLJ20459 ENSG00000138777 "Pyrophosphatase (inorganic) 2" Q9H2U2 4 105369077-105474081 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Nucleoplasm,Mitochondria 8300 Mitochondria Nucleoplasm "HPA030888: , HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavourable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favourable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favourable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 9.2 18.0 18.4 17.2 15.4 24.0 20.6 12.3 17.6 10.2 19.8 9.3 20.3 18.1 13.3 20.7 14.8 10.7 18.7 42.5 15.6 15.3 23.7 21.2 23.1 34.8 17.2 12.1 9.5 25.0 10.4 15.0 9.3 15.4 16.1 16.7 12.6 21.4 26.8 29.6 15.0 16.8 22.8 12.4 12.1 15.0 9.7 10.7 9.4 14.3 28.2 10.6 12.2 9.5 20.0 35.3 14.7 20.8 22.0 17.0 14.6 11.5 5.5 10.7 18.1 6.8 5.5 7.8 6.5 8.6 8.0 5.7 12.1 17.0 9.5 8.7 5.3 5.8 21.4 10.3 9.5 13.4 7.6 8.5 8.9 11.0 5.4 20.1 8.2 5.3 10.7 5.5 4.3 7.7 14.1 13.1 7.3 14.6 17.1 14.5 7.8 18.7 15.2 6.6 9.3 26.5 8.9 11.0 6.6 4.5 26.7 9.4 14.0 16.4 4.1 5.8 11.3 6.2 11.3 11.6 14.6 9.9 10.1 10.9 7.8 14.7 15.0 9.7 15.3 20.8 13.3 20.0 16.0 16.2 35.3 16.6 15.5 17.0 6.4 22.0 16.2 17.7 15.9 14.6 18.4 15.4 12.3 17.6 15.6 15.3 17.2 12.1 15.4 10.7 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 97.6;breast: 102.1" "Cell line enhanced" "Detected in many" "ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: , HPA063663: " "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavourable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favourable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favourable (5.52e-5)" 97.6 1.6 1.9 17.1 1.2 0.7 102.1 1.5 1.3 3.1 24.9 0.8 2.1 7.5 3.5 2.2 2.8 2.4 8.7 12.5 1.4 0.9 6.7 5.9 24.8 11.4 1.1 0.9 6.7 1.2 2.8 0.3 26.8 0.9 10.4 13.9 1.1 5.8 1.5 5.0 2.7 9.6 7.4 1.2 7.0 11.9 3.5 0.6 0.9 6.2 4.3 2.1 30.2 14.1 0.0 0.4 0.0 2.3 0.0 0.7 0.3 9.6 8.6 0.0 0.0 47.4 27.0 55.9 0.9 10.4 1.3 0.5 1.8 25.0 0.0 0.0 0.9 3.9 3.4 0.1 0.2 23.2 4.8 0.0 1.9 2.3 12.6 0.0 0.0 27.8 2.3 2.3 9.0 0.1 0.0 0.0 2.0 2.4 0.0 0.1 0.1 24.9 0.0 0.0 0.0 7.1 34.1 0.0 0.2 4.0 1.5 0.5 0.0 7.7 7.8 1.8 2.6 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 1.9 1.2 1.5 1.3 1.4 0.9 1.1 0.9 0.9 0.6 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Enzymes, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" 16000 "Nucleoli fibrillar center, Mitochondria" Nucleoplasm "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavourable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 23.4 36.3 18.9 20.5 21.9 10.7 30.7 12.0 26.0 23.2 32.0 12.4 27.3 25.5 18.2 34.4 31.6 14.5 30.9 22.1 17.8 16.4 41.4 43.9 26.5 28.1 19.3 14.9 19.6 47.0 22.8 16.1 37.6 17.2 27.2 27.3 19.6 36.6 35.0 19.6 21.9 41.0 27.6 18.9 24.4 27.2 13.5 13.4 22.6 31.3 26.0 20.5 24.0 19.4 41.9 44.4 76.1 55.7 42.0 41.0 52.0 22.5 9.4 5.5 8.5 17.1 17.8 20.5 11.4 13.1 15.4 13.7 7.9 27.6 6.8 22.5 14.4 13.3 3.6 17.3 13.0 17.9 10.9 11.4 10.4 9.4 23.5 11.7 20.2 15.7 31.4 10.8 20.0 14.3 4.6 4.9 15.7 13.5 5.7 11.5 6.3 14.6 6.5 5.6 12.1 33.7 21.3 6.5 7.1 14.0 34.2 35.4 16.1 51.8 8.9 8.5 11.3 12.9 13.0 16.2 10.1 4.9 3.5 13.5 17.3 58.1 55.7 76.1 30.7 55.1 35.7 41.9 37.0 33.0 44.4 39.9 41.0 34.9 41.2 42.0 51.8 33.2 36.4 52.0 18.9 21.9 12.0 26.0 17.8 16.4 19.3 14.9 17.2 13.4 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favourable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.0 13.7 9.4 19.0 10.7 18.0 30.3 27.2 8.8 35.5 14.0 25.1 26.6 9.5 36.6 18.1 46.7 4.7 31.0 5.7 16.9 9.3 3.9 12.8 4.7 29.3 0.0 20.4 17.7 62.6 9.0 12.5 13.9 15.9 22.4 12.9 60.0 45.1 0.4 10.1 79.8 20.6 21.2 19.2 25.4 18.2 32.2 24.5 27.0 43.5 18.6 62.2 25.8 22.9 30.1 34.1 39.7 22.4 17.8 14.0 6.4 21.2 11.2 19.5 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Cell line enhanced" "Detected in some" "A549: 3.5;HeLa: 5.1;SH-SY5Y: 2.9;SK-MEL-30: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.5 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270700-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 78.4;SK-MEL-30: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: " "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavourable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favourable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 28.9 18.6 20.9 17.5 20.8 20.8 40.5 22.8 24.1 15.9 18.3 27.7 18.5 15.5 26.2 20.4 19.4 16.9 23.9 19.3 19.7 12.0 18.1 15.5 25.4 15.9 18.9 17.8 21.0 17.7 21.2 34.1 24.9 20.7 13.8 16.3 21.9 19.0 18.5 38.7 24.2 17.8 18.4 30.0 14.7 15.6 29.8 22.5 17.0 25.2 10.0 13.6 18.7 18.6 2.6 2.8 10.0 4.8 1.1 2.2 1.0 78.4 10.6 9.7 6.6 9.1 5.7 10.3 9.2 7.5 11.5 7.6 20.0 7.0 7.3 12.0 7.4 11.4 8.2 7.9 9.9 4.9 5.7 5.9 11.1 6.4 9.3 7.7 7.2 7.2 12.7 14.7 12.1 7.4 9.9 6.0 9.9 10.7 5.3 4.6 5.8 9.1 6.1 24.5 6.4 5.6 10.8 9.5 6.4 13.7 17.3 45.1 11.6 8.2 10.1 11.5 9.0 15.9 9.7 7.3 4.6 10.3 9.5 5.4 13.4 0.0 3.6 1.7 1.3 1.9 2.2 2.6 2.2 1.9 2.8 2.3 1.7 1.0 10.0 1.1 4.8 2.8 2.1 1.0 20.9 20.8 22.8 21.4 19.7 12.0 18.9 17.8 20.7 22.5 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119389-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.1;pituitary gland: 14.9;skin 1: 25.3" "Cell line enhanced" "Detected in many" "PC-3: 23.0;SK-BR-3: 18.8;U-266/70: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA043567: , HPA050340: " "prognostic unfavourable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favourable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favourable (6.46e-7)" "prognostic unfavourable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.6 3.9 13.9 1.6 9.3 0.9 2.2 22.1 20.8 1.2 4.3 1.6 1.7 5.1 1.6 1.1 4.4 1.3 1.4 1.4 12.8 12.2 1.1 1.6 1.8 1.6 7.4 13.7 1.0 4.9 4.1 14.9 1.1 7.3 3.4 2.0 1.6 2.7 1.6 1.7 25.3 4.6 1.2 2.4 1.3 2.3 2.1 1.8 0.0 1.8 1.2 2.2 1.1 1.9 0.0 0.0 0.0 0.0 0.2 1.1 0.3 1.9 2.0 2.0 5.1 0.0 0.0 3.9 0.2 0.2 1.0 1.4 1.4 0.8 4.5 2.7 0.2 1.0 3.1 0.4 0.2 4.8 6.8 2.8 1.8 1.0 0.2 1.1 7.3 0.2 1.1 0.6 0.3 0.0 5.4 7.1 0.1 8.7 1.4 1.9 0.9 23.0 4.6 4.0 2.2 0.3 1.0 4.2 5.8 0.8 18.8 2.0 10.4 2.7 0.4 1.1 4.0 0.7 0.1 13.3 10.9 3.3 1.1 4.5 2.6 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.4 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 13.9 9.3 22.1 19.8 12.8 12.2 7.4 13.7 7.3 1.8 PPFIBP1 "hSGT2, hSgt2p, L2, SGT2" ENSG00000110841 "PPFIA binding protein 1" Q86W92 12 27523431-27695564 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001924 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA001924: AB_1079665" "unprognostic (5.27e-2)" "unprognostic (5.71e-2)" "unprognostic (3.10e-2)" "prognostic unfavourable (6.29e-4)" "unprognostic (4.73e-2)" "unprognostic (6.94e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (5.11e-4)" "unprognostic (7.33e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (2.56e-4)" "unprognostic (1.92e-2)" "prognostic favourable (5.11e-7)" "unprognostic (8.54e-2)" "unprognostic (7.54e-2)" "unprognostic (2.64e-1)" "unprognostic (4.09e-2)" 21.3 17.1 15.5 8.0 16.8 2.2 22.6 4.9 25.0 18.3 15.4 13.3 13.0 7.1 28.1 9.3 17.1 16.5 12.2 43.3 17.1 9.0 23.8 15.7 25.0 7.8 13.1 16.4 53.1 13.7 12.7 22.2 34.5 15.3 15.3 11.1 8.1 14.2 18.4 13.7 17.8 10.0 20.5 11.2 16.6 15.1 7.1 13.3 6.2 23.9 14.9 6.2 17.2 18.4 7.0 2.0 1.5 0.6 0.3 1.8 0.6 4.5 9.2 7.5 6.4 12.5 34.9 13.4 16.6 18.7 9.8 14.2 24.2 13.9 3.4 19.4 33.6 11.4 4.0 15.2 17.7 7.8 2.2 7.6 7.0 3.5 5.4 2.3 4.3 27.1 10.6 28.5 29.3 33.5 4.0 3.5 34.8 3.5 2.1 0.6 13.4 7.1 3.5 18.7 1.3 14.5 10.1 0.6 3.1 8.3 4.4 23.1 5.7 3.5 32.5 27.7 9.3 15.1 16.9 0.0 0.0 0.2 30.7 3.3 43.6 1.5 0.6 0.3 0.7 0.2 1.4 0.7 1.3 0.7 0.6 7.0 1.3 1.3 1.5 0.3 0.2 2.0 1.8 0.6 15.5 16.8 4.9 25.0 17.1 9.0 13.1 16.4 15.3 13.3 PPHLN1 ENSG00000134283 "Periphilin 1" Q8NEY8 12 42238447-42459715 "Predicted intracellular proteins" "Keratinization, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038902, HPA038903" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA038902: AB_10674844, HPA038903: AB_2676263" "unprognostic (4.06e-2)" "unprognostic (1.66e-1)" "unprognostic (6.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.80e-1)" "unprognostic (7.92e-2)" "prognostic unfavourable (1.28e-7)" "unprognostic (2.85e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-2)" "unprognostic (1.58e-1)" "unprognostic (4.42e-3)" "prognostic unfavourable (5.06e-5)" "unprognostic (3.16e-1)" "unprognostic (3.08e-1)" "unprognostic (3.22e-3)" "unprognostic (2.04e-2)" 25.6 32.4 29.0 37.2 34.2 37.6 27.8 43.0 32.2 24.3 23.7 18.9 27.7 19.2 35.3 27.7 27.0 25.3 24.5 29.0 25.6 28.7 25.2 25.2 23.0 44.3 23.8 35.0 30.6 21.3 20.7 39.9 24.2 26.3 22.6 27.1 21.6 31.1 24.9 32.0 26.1 26.9 28.3 24.6 30.5 23.1 48.4 24.9 51.4 23.1 28.6 47.2 28.1 25.3 25.0 24.1 23.1 14.5 23.7 33.2 12.2 14.6 13.7 16.3 13.5 14.7 16.4 14.4 17.3 19.7 18.2 15.1 22.1 18.6 25.0 22.0 18.4 13.7 16.7 18.1 22.5 21.5 17.4 39.2 14.1 19.9 15.5 46.1 22.6 19.5 18.6 14.4 13.9 22.7 19.1 19.4 19.9 11.2 25.8 27.8 14.1 13.6 22.1 18.6 22.9 28.4 13.0 11.6 17.0 15.2 12.4 14.8 18.8 23.2 15.6 10.6 19.0 10.2 14.8 22.4 31.1 40.4 18.0 85.3 7.0 21.0 12.8 23.1 19.3 14.5 23.2 25.0 24.7 25.9 24.1 21.1 22.7 22.6 8.3 23.7 13.4 22.9 33.2 12.2 29.0 34.2 43.0 32.2 25.6 28.7 23.8 35.0 26.3 24.9 PPIB "CYPB, OI9" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155812-64163205 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Isomerase, Rotamase" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" 120000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favourable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavourable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 56.9 64.3 23.9 49.3 26.9 54.9 48.1 15.1 32.1 75.3 44.1 35.4 102.8 42.0 64.2 106.9 48.0 54.8 58.1 44.5 23.8 27.3 89.5 285.9 57.2 63.8 29.7 19.6 67.5 193.7 26.7 71.8 120.2 27.5 51.0 47.7 36.2 123.3 95.4 19.5 33.1 57.5 54.3 30.7 78.0 47.7 27.2 29.5 53.7 154.3 45.7 69.1 49.2 51.7 63.5 191.6 41.0 51.1 44.9 71.6 87.1 39.3 49.5 44.7 101.6 156.7 91.0 39.3 94.0 123.5 74.4 88.5 71.2 73.1 37.6 76.4 145.5 64.2 81.7 63.1 38.4 23.8 30.8 53.0 54.7 93.1 164.3 52.9 48.0 83.8 68.1 43.4 105.8 89.8 37.0 131.0 56.4 62.8 16.1 81.1 39.0 31.8 30.9 47.5 191.8 77.2 61.4 25.3 39.9 43.0 74.0 68.4 44.2 161.8 55.2 74.4 61.7 41.6 63.4 71.2 68.9 39.5 69.5 85.2 74.2 41.0 51.1 33.9 71.6 39.2 71.5 63.5 50.5 58.1 67.4 38.0 33.0 44.2 25.5 44.9 25.2 191.6 40.1 87.1 23.9 26.9 15.1 32.1 23.8 27.3 29.7 19.6 27.5 29.5 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709134-158723396 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 16.8 25.8 20.1 15.5 21.4 14.9 22.3 26.7 26.8 12.6 16.8 14.4 18.2 33.4 14.6 13.6 16.5 15.4 13.0 28.8 19.4 22.1 21.5 45.3 11.0 17.4 22.6 18.9 14.6 17.5 11.3 30.3 14.5 26.0 16.1 14.2 9.1 15.4 13.7 53.3 24.0 29.2 13.1 22.7 16.5 15.5 16.9 23.4 22.7 21.7 16.0 16.8 15.4 55.0 15.6 17.2 33.4 22.2 23.9 24.4 17.1 15.3 14.3 14.4 19.7 21.4 16.1 21.8 15.2 8.3 14.0 10.6 18.5 10.5 16.2 6.8 14.1 11.8 43.6 17.4 17.1 53.7 15.2 29.0 12.9 25.5 16.6 18.2 21.8 10.1 14.2 12.0 17.9 15.2 36.2 29.0 15.5 14.7 26.0 16.5 19.8 19.1 11.8 7.1 13.9 15.4 7.7 24.4 16.3 11.4 23.7 21.6 10.9 17.4 14.7 14.0 15.8 15.4 20.0 16.7 34.6 20.7 17.8 19.7 14.0 33.4 15.3 33.2 21.2 22.2 24.4 14.6 20.7 19.6 16.7 15.6 21.5 22.0 20.9 23.9 22.0 17.2 22.4 17.1 20.1 21.4 26.7 26.8 19.4 22.1 22.6 18.9 26.0 23.4 PPIG "CARS-Cyp, SCAF10, SRCyp" ENSG00000138398 "Peptidylprolyl isomerase G" Q13427 2 169584340-169641406 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021788, HPA057469" Supported Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA021788: AB_1847408, HPA057469: " "unprognostic (2.70e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (3.49e-2)" "unprognostic (1.55e-3)" "unprognostic (3.66e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-3)" "unprognostic (2.47e-2)" "unprognostic (2.28e-1)" "prognostic unfavourable (4.56e-4)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (3.41e-2)" "unprognostic (3.39e-2)" 26.2 25.3 28.5 23.8 45.3 39.2 26.7 45.0 40.7 33.1 27.1 14.6 26.0 25.3 27.1 28.1 29.4 24.3 21.2 24.2 30.0 20.3 26.0 41.1 25.5 30.4 27.7 35.9 29.5 22.8 39.4 56.7 26.0 38.0 29.3 23.9 13.8 28.6 28.8 27.8 24.5 30.8 31.9 39.7 29.7 24.1 19.8 33.7 24.1 28.4 22.6 29.9 37.4 27.6 36.4 23.7 41.7 24.7 18.7 29.6 13.3 19.1 9.1 25.8 14.1 14.3 17.6 24.3 21.9 16.5 16.2 16.8 24.9 22.1 33.1 20.2 15.8 18.5 20.2 18.0 24.0 23.0 16.3 49.8 13.6 30.3 13.8 46.8 22.2 14.8 20.4 22.0 24.7 17.8 48.0 27.6 18.5 15.5 34.5 28.7 37.0 9.3 31.8 25.8 32.3 20.1 28.9 22.6 14.9 23.6 17.6 23.8 16.4 27.1 20.4 21.2 16.2 14.1 18.0 16.1 23.1 46.2 15.6 25.1 19.4 20.7 20.0 29.9 20.3 20.1 23.2 27.6 27.0 23.8 14.9 36.4 29.6 23.7 41.7 18.7 24.7 23.7 22.9 13.3 28.5 45.3 45.0 40.7 30.0 20.3 27.7 35.9 38.0 33.7 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.1 1.2 6.6 10.6 13.2 1.2 0.0 2.4 0.6 0.2 0.1 1.8 0.0 0.5 0.6 1.2 1.0 0.0 0.4 0.5 0.9 0.5 0.1 0.0 5.3 0.6 0.3 2.7 6.3 0.2 4.0 0.8 0.9 0.4 0.4 0.6 0.1 0.6 0.2 1.3 0.8 0.0 0.6 5.1 0.1 1.5 2.5 0.2 0.3 4.4 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.2 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavourable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favourable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 1.7 5.2 3.4 1.8 6.4 1.1 3.4 28.4 7.0 2.8 6.1 9.1 2.2 5.6 3.7 3.1 2.5 2.1 3.6 5.0 2.5 1.4 1.4 2.0 3.3 3.0 2.9 13.4 7.6 0.9 3.4 6.5 4.7 2.7 6.3 7.2 8.8 2.3 2.8 2.3 5.3 4.5 5.0 3.0 3.3 2.7 5.3 3.2 4.3 2.8 3.5 3.8 3.0 8.5 5.6 4.9 9.1 3.0 1.9 8.5 4.2 5.4 6.1 9.0 6.5 8.1 8.0 6.5 5.8 23.2 9.6 18.5 6.2 7.8 7.6 12.0 17.0 3.5 6.9 13.6 12.5 3.4 16.3 7.4 11.5 6.5 8.6 11.9 4.5 6.6 4.5 7.7 2.4 6.1 9.8 5.0 4.0 6.7 15.4 14.9 4.6 11.0 10.5 4.2 19.3 11.5 2.8 5.4 6.4 6.7 10.3 2.6 3.2 9.9 10.1 15.7 5.1 4.3 1.4 0.0 2.7 2.8 3.8 5.3 3.3 3.6 3.2 3.6 2.7 2.5 1.0 3.5 2.1 2.4 0.8 3.0 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: , HPA059859: " "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.8 2.5 0.0 0.0 18.3 26.6 8.8 0.0 0.4 0.0 0.1 11.3 17.4 0.1 4.0 0.3 55.8 0.3 6.7 0.0 0.0 0.3 0.0 13.5 2.0 1.1 0.0 0.0 1.3 6.2 0.0 2.1 0.0 0.0 0.0 0.0 20.4 0.0 0.0 1.7 5.3 0.0 0.0 8.6 13.3 10.9 9.2 0.1 29.9 10.0 0.1 5.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" 850000 Cytosol "Plasma membrane" "HPA029209: " "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 16.2 11.7 13.8 15.0 18.3 64.0 15.1 20.5 28.6 15.5 32.4 13.3 9.4 19.1 17.4 12.7 15.2 10.7 10.8 37.1 13.5 16.1 22.8 26.7 14.6 11.8 15.6 19.1 12.1 13.3 18.2 12.2 15.8 24.3 16.5 19.4 12.3 18.7 13.5 56.1 16.7 25.2 15.0 13.8 11.6 14.9 29.7 12.7 23.4 13.3 11.6 13.4 15.2 16.5 4.0 2.7 8.0 2.1 4.7 4.5 1.9 47.8 10.8 9.4 8.0 14.4 13.4 12.0 13.2 15.5 9.8 9.3 6.1 14.1 28.8 12.6 14.9 10.7 9.7 13.6 17.2 25.9 5.5 17.7 7.7 9.5 12.1 20.0 12.7 11.3 16.3 11.5 15.8 9.6 9.8 23.0 11.9 21.0 26.0 4.7 8.8 9.1 9.4 21.8 9.3 11.8 23.0 16.0 12.0 13.7 16.0 11.1 16.1 8.8 13.2 20.5 20.5 8.9 9.3 17.9 10.1 33.7 9.4 7.9 10.3 6.7 1.8 5.1 3.5 1.8 3.8 1.7 2.8 3.1 2.7 4.0 2.2 2.1 8.0 4.7 2.1 1.6 4.5 1.9 13.8 18.3 20.5 28.6 13.5 16.1 15.6 19.1 24.3 12.7 PPM1B "PP2CB, PP2CBETA, PPC2BETAX" ENSG00000138032 "Protein phosphatase, Mg2+/Mn2+ dependent 1B" O75688 2 44167969-44244384 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016745 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA016745: AB_1855622" "unprognostic (5.49e-2)" "unprognostic (2.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.96e-3)" "unprognostic (1.92e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-2)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (2.25e-1)" "unprognostic (6.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (1.75e-2)" 23.7 13.8 31.2 12.2 33.8 24.7 15.2 32.6 25.2 16.3 18.2 26.0 13.6 13.2 15.7 20.4 14.9 12.7 14.3 21.1 29.6 24.6 19.4 27.7 13.4 16.6 34.6 22.4 15.8 20.9 34.6 17.9 12.1 22.9 20.7 19.0 24.3 16.4 16.4 72.0 12.5 14.3 21.1 27.3 16.1 14.8 13.3 34.1 19.1 15.0 13.1 16.8 18.2 15.9 6.5 5.5 11.1 5.0 4.7 9.5 1.6 17.3 15.5 20.7 15.1 25.9 12.1 23.5 13.5 15.6 14.0 12.4 20.9 11.3 19.1 21.2 15.5 9.5 23.1 8.8 20.8 19.3 9.0 20.2 9.3 14.3 20.9 18.0 16.9 11.6 15.5 11.1 18.9 11.4 14.7 20.3 12.5 14.4 17.8 29.0 25.5 5.2 19.0 23.1 12.8 32.6 17.6 16.7 21.0 12.1 18.2 15.6 9.8 12.6 10.4 12.3 17.7 10.1 12.9 17.8 11.6 17.9 6.5 30.0 8.8 8.3 3.3 11.1 7.2 4.5 6.2 5.8 6.9 6.1 5.5 6.5 9.5 6.4 9.2 4.7 5.0 5.3 6.2 1.6 31.2 33.8 32.6 24.9 29.6 24.6 34.6 22.4 22.9 34.1 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell line enhanced" "Detected in some" "AF22: 10.0;HAP1: 16.2;MOLT-4: 7.6;SCLC-21H: 7.5;SH-SY5Y: 15.5;THP-1: 6.9" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.5 0.0 0.0 0.7 0.0 0.0 0.8 1.1 0.0 0.0 6.3 0.1 0.1 0.0 16.2 0.0 0.4 0.1 4.8 0.0 0.1 0.0 1.1 0.5 2.1 0.3 1.3 0.0 0.0 0.0 1.6 0.0 0.0 2.8 7.6 0.0 2.8 0.8 0.0 1.3 0.0 0.0 0.0 7.5 15.5 0.2 0.0 1.0 0.0 6.9 0.0 0.0 1.9 0.0 2.3 0.0 0.1 4.3 0.2 0.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919420-21952837 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" 780000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavourable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 25.0 15.6 14.0 21.8 14.3 24.3 18.4 16.9 16.3 18.1 13.2 7.6 12.5 9.6 17.6 9.7 23.6 12.3 13.1 17.0 13.9 14.9 13.2 8.5 21.6 15.1 11.6 10.1 14.4 10.7 8.3 7.7 28.1 14.5 15.6 4.9 11.2 11.2 16.5 15.8 15.5 11.1 15.4 15.5 31.4 10.5 6.7 10.9 6.2 10.9 15.1 10.2 15.8 37.6 0.7 5.5 17.7 13.9 1.7 1.4 2.8 9.1 9.8 6.3 6.1 3.5 6.2 7.9 10.4 6.2 9.2 6.3 4.4 3.7 5.5 13.0 7.3 11.0 2.7 6.4 3.3 7.8 8.8 21.3 4.5 4.2 5.8 7.8 5.8 5.8 1.9 9.0 4.2 35.8 54.2 2.3 11.8 8.4 4.6 6.1 2.6 10.7 7.0 16.2 1.6 3.1 3.9 2.5 9.8 9.9 3.3 8.5 4.1 5.5 30.1 11.1 11.3 10.1 9.9 4.6 3.7 6.1 11.2 15.0 21.2 0.0 7.7 3.3 1.0 12.9 0.7 0.7 0.7 0.6 5.5 0.6 0.7 0.8 17.7 1.7 13.9 1.4 1.4 2.8 14.0 14.3 16.9 16.3 13.9 14.9 11.6 10.1 14.5 10.9 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HDLM-2: 34.9;U-266/70: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavourable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.1 0.7 4.0 2.1 2.3 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 3.6 3.3 0.2 0.1 34.9 3.5 3.4 3.3 0.4 0.1 2.1 4.0 0.4 1.6 0.1 0.2 0.2 0.1 5.5 0.0 1.8 0.8 0.2 2.3 0.8 4.1 0.7 0.8 0.1 3.7 4.8 4.1 2.0 2.3 0.1 2.7 2.1 0.2 0.4 0.4 0.3 1.3 34.9 0.1 1.9 0.6 1.7 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 PPME1 PME-1 ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171099-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 69.0" "Cell line enhanced" "Detected in all" "RH-30: 90.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" 16000 Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: , HPA064396: " "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavourable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 9.4 16.1 13.3 6.2 27.6 8.4 9.3 27.4 38.5 11.4 9.2 13.5 9.4 7.1 13.1 16.5 13.5 15.2 8.9 12.8 14.6 18.3 12.3 6.5 8.2 5.5 13.6 18.6 12.4 10.4 69.0 13.6 15.5 22.4 15.1 9.8 9.6 11.9 15.9 21.0 16.2 7.4 13.4 12.7 5.0 8.3 22.9 9.3 8.6 14.9 7.9 8.5 11.4 10.2 7.5 11.3 10.9 9.6 12.2 14.0 8.4 9.9 13.0 8.9 9.4 9.3 7.7 8.8 14.6 9.6 27.7 22.0 28.6 6.6 5.3 10.2 10.8 16.6 13.2 10.0 26.1 7.4 5.0 7.9 14.1 12.2 18.6 5.7 7.0 7.4 8.2 14.7 6.4 8.1 18.4 4.5 48.4 6.6 6.7 6.1 7.0 10.4 8.0 90.6 8.0 10.4 6.9 12.2 10.4 17.5 8.0 20.5 14.7 5.9 4.9 11.1 13.3 10.6 11.2 8.5 10.8 9.4 8.2 5.2 9.0 1.3 8.6 10.9 10.8 9.6 13.3 6.9 13.8 12.7 10.8 7.5 14.0 11.2 5.0 12.2 8.5 11.3 9.7 8.4 13.3 27.6 27.4 38.5 14.6 18.3 13.6 18.6 22.4 9.3 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166410-161178013 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030123, HPA054287" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA030123: AB_10603987, HPA054287: " "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavourable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 7.3 14.8 11.6 9.1 12.1 31.7 10.2 23.5 16.5 11.0 9.9 13.2 8.5 6.0 11.7 13.5 7.5 33.2 9.5 9.5 11.5 12.5 12.0 9.1 10.2 11.2 14.2 16.1 13.0 13.1 10.5 12.3 10.1 12.1 11.0 6.7 14.4 11.3 14.6 8.5 15.9 7.1 10.0 10.6 12.0 8.2 6.9 13.7 9.2 11.0 6.1 8.7 8.7 8.2 9.8 11.5 6.9 7.7 12.3 16.7 8.9 7.0 6.5 9.8 6.4 7.4 7.9 3.3 4.9 5.7 6.0 8.1 7.7 6.8 5.5 11.8 3.4 4.9 7.5 7.9 5.5 3.8 14.9 6.7 14.7 17.5 7.9 2.2 3.7 6.3 7.9 5.9 8.3 11.4 19.7 8.6 4.4 6.6 8.9 7.0 7.0 14.0 10.8 6.8 13.1 11.4 3.1 7.8 12.5 5.9 8.7 9.8 15.6 10.4 4.0 5.6 6.2 4.8 6.2 15.4 11.2 8.5 5.7 4.9 4.3 6.9 7.7 5.5 12.7 7.7 8.4 9.8 9.8 8.8 11.5 8.6 8.6 8.8 1.6 12.3 5.3 7.2 16.7 8.9 11.6 12.1 23.5 16.5 11.5 12.5 14.2 16.1 12.1 13.7 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: " "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favourable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 46.2 53.4 31.7 46.6 15.8 19.4 32.3 22.9 26.9 46.3 35.2 76.3 55.9 39.8 39.1 34.8 40.5 36.6 47.7 28.5 41.8 24.8 38.2 25.2 40.0 34.5 48.5 49.4 21.8 31.6 39.4 23.2 46.4 35.5 33.0 37.4 105.5 61.5 95.4 52.5 42.3 43.7 43.9 34.5 45.4 38.3 24.8 41.2 26.6 47.8 70.7 57.2 33.6 33.0 35.7 36.6 42.1 29.6 33.1 30.6 45.2 42.8 33.4 37.6 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 PPP1CB "PP-1B, PP1B, PP1beta" ENSG00000213639 "Protein phosphatase 1 catalytic subunit beta" P62140 2 28751640-28802940 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022558, HPA065425, CAB069426" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 7700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB022558: , CAB069426: , HPA065425: " "unprognostic (2.90e-1)" "unprognostic (5.03e-2)" "unprognostic (5.49e-2)" "unprognostic (2.00e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (6.52e-6)" "unprognostic (3.47e-2)" "unprognostic (2.44e-1)" "unprognostic (3.15e-2)" "unprognostic (1.54e-3)" "unprognostic (3.95e-1)" "unprognostic (1.68e-1)" "unprognostic (3.66e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-1)" "unprognostic (2.26e-2)" 28.5 22.6 30.0 20.5 37.6 29.5 32.4 19.1 29.8 51.1 39.3 21.1 30.7 24.4 58.0 31.8 86.0 37.0 33.3 67.1 27.8 27.9 32.0 20.0 35.3 22.3 27.4 24.4 39.7 21.9 48.9 28.7 42.3 22.0 46.4 27.7 25.2 36.5 38.6 99.6 25.1 30.0 100.8 27.5 25.2 31.4 25.5 21.4 28.1 27.5 32.9 25.3 82.1 50.5 15.6 25.4 41.5 42.7 23.5 28.3 17.9 36.4 23.0 80.2 24.8 27.5 25.6 46.7 19.6 22.4 19.1 18.9 20.4 21.6 29.2 24.7 20.3 22.6 22.8 26.2 22.8 46.3 11.8 22.0 28.2 22.0 59.9 24.9 10.4 19.6 37.3 20.6 43.2 23.1 20.0 29.0 25.0 18.3 26.4 21.6 26.3 18.2 26.0 71.1 22.2 62.2 44.1 22.0 27.2 30.5 33.9 26.6 16.4 14.0 27.6 25.6 28.2 18.3 23.6 20.7 32.5 59.8 27.2 26.9 18.9 22.5 24.8 32.1 16.8 37.8 21.3 15.6 25.5 19.6 25.4 13.4 22.7 25.5 41.5 23.5 42.7 19.6 28.3 17.9 30.0 37.6 19.1 29.8 27.8 27.9 27.4 24.4 22.0 21.4 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600400-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favourable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favourable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 11.5 19.1 10.8 19.6 12.6 5.2 17.4 18.8 16.2 20.4 13.0 24.2 17.0 12.6 14.7 13.0 14.7 15.2 16.4 9.7 15.9 10.3 14.0 20.4 14.6 14.1 14.5 12.4 16.0 21.6 28.8 17.9 10.1 10.4 14.9 15.5 19.6 12.8 21.0 14.1 12.8 13.0 15.4 14.1 17.4 15.6 21.6 11.8 33.5 16.6 12.5 17.0 14.7 13.2 4.8 6.1 6.2 5.4 1.8 5.7 3.5 5.4 6.7 8.6 7.0 7.9 5.4 4.6 5.4 6.9 7.8 6.5 7.3 3.3 5.3 4.0 4.5 8.4 10.2 10.0 5.9 5.8 5.5 6.5 5.8 3.5 8.1 5.7 6.4 6.3 5.8 6.9 14.3 7.1 6.0 6.7 6.9 6.8 7.3 4.9 4.4 4.8 7.6 9.0 10.2 7.9 6.8 12.1 5.2 7.0 6.7 6.0 6.7 7.0 4.4 6.1 5.3 6.7 4.3 12.3 6.6 5.7 5.6 6.6 5.2 6.2 5.1 5.6 5.3 4.5 5.7 4.8 3.7 4.3 5.6 4.0 3.5 3.9 6.2 1.8 5.4 6.1 3.9 3.5 10.8 12.6 18.8 16.2 15.9 10.3 14.5 12.4 10.4 11.8 PPP1R12A "M130, MBS, MYPT1" ENSG00000058272 "Protein phosphatase 1 regulatory subunit 12A" O14974 12 79773563-79935460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041296, HPA071956" Approved Supported "Actin filaments,Cytosol" 300000 "Actin filaments, Cytosol" "HPA041296: , HPA071956: " "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-1)" "unprognostic (5.60e-3)" "unprognostic (6.19e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (1.61e-1)" "unprognostic (9.69e-3)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-3)" "unprognostic (5.50e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (1.38e-1)" 20.1 8.9 17.2 19.4 17.2 23.8 15.9 18.3 18.3 28.0 45.2 6.5 20.9 10.1 36.6 16.5 34.2 28.1 17.0 13.7 12.6 8.8 8.7 6.6 15.8 13.3 9.9 15.4 17.3 7.0 11.0 15.2 18.9 10.4 33.1 17.2 24.0 11.4 42.1 13.7 12.9 19.3 73.7 8.8 14.6 23.2 10.8 10.4 18.8 14.2 9.9 12.4 47.6 29.3 14.9 11.0 50.6 16.9 25.5 18.7 10.8 15.5 12.9 19.1 10.9 14.8 14.6 16.7 32.0 17.9 20.7 13.9 12.1 7.8 13.6 13.1 43.4 12.4 14.8 12.4 25.5 18.3 9.0 37.0 15.4 8.8 11.5 24.0 23.3 12.0 9.5 20.9 19.5 14.3 15.0 16.6 22.2 9.9 26.4 12.7 14.8 9.6 21.8 21.2 10.1 12.3 25.6 9.1 6.7 24.7 8.7 10.8 12.1 11.6 21.0 22.2 11.6 15.2 17.8 10.6 10.0 18.4 7.6 13.6 18.9 35.6 11.7 50.0 17.9 12.5 16.1 14.9 17.1 18.7 11.0 13.5 13.8 17.7 50.6 25.5 16.9 9.3 18.0 10.8 17.2 17.2 18.3 18.3 12.6 8.8 9.9 15.4 10.4 10.4 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 105.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 10.6 2.8 6.9 8.1 9.0 1.8 7.7 13.9 10.5 55.3 62.0 15.0 31.0 5.8 105.2 9.4 37.4 21.9 17.4 83.1 5.8 4.5 5.0 2.9 8.1 4.2 10.1 9.2 18.7 2.3 2.0 4.5 8.4 9.5 36.4 16.3 13.7 5.7 50.3 17.6 5.3 14.1 59.5 7.3 6.9 20.8 3.4 11.1 1.3 5.0 11.2 3.5 35.1 11.4 2.3 1.7 15.9 1.8 0.7 1.7 0.5 2.7 5.4 4.2 3.9 5.9 4.3 6.8 2.1 2.2 2.2 2.1 2.3 4.8 3.0 1.1 3.9 8.6 6.2 3.3 2.4 3.9 3.8 3.0 7.9 1.5 1.4 6.5 3.5 3.4 3.8 3.2 3.3 1.8 4.5 3.6 3.9 2.0 4.8 4.1 2.8 1.1 3.2 10.7 4.4 1.8 9.8 5.1 3.9 4.1 4.9 2.4 4.3 3.0 2.3 3.2 1.9 2.3 1.8 5.3 5.0 3.3 3.0 5.3 12.6 1.8 1.8 1.3 1.7 0.9 1.4 1.7 1.1 1.0 1.4 2.3 1.4 1.0 15.9 0.7 1.4 1.7 1.6 0.5 6.9 9.0 13.9 10.5 5.8 4.5 10.1 9.2 9.5 11.1 PPP1R13B "ASPP1, KIAA0771, p53BP2-like, p85" ENSG00000088808 "Protein phosphatase 1 regulatory subunit 13B" Q96KQ4 14 103733752-103847590 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006394, CAB015454" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB015454: AB_2252775, HPA006394: AB_1079668" "unprognostic (1.20e-1)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.45e-1)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (1.25e-2)" "prognostic favourable (1.41e-4)" "unprognostic (3.22e-3)" "unprognostic (5.13e-2)" "unprognostic (5.39e-2)" "unprognostic (1.62e-3)" "prognostic favourable (3.28e-11)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (1.97e-2)" "unprognostic (2.23e-1)" 7.1 5.5 12.1 5.0 13.2 1.0 7.7 23.3 16.6 8.6 9.0 7.8 6.4 8.7 9.1 4.5 13.5 12.3 5.8 24.5 10.0 6.5 8.3 5.9 11.9 3.3 5.3 9.8 13.3 13.2 12.2 15.6 7.1 10.5 13.3 7.3 13.9 11.6 8.2 7.6 12.9 11.2 6.7 5.2 13.0 11.9 21.2 6.3 1.1 28.4 4.3 7.9 10.1 7.3 0.7 0.0 0.0 0.0 0.2 2.0 0.3 3.9 3.4 0.4 4.6 0.8 0.3 1.7 2.5 1.9 3.5 1.6 2.6 3.6 1.0 9.7 2.1 8.3 4.8 3.6 2.9 2.0 3.3 0.0 1.2 4.4 3.2 0.4 3.7 0.9 4.2 0.3 4.0 6.7 0.5 1.7 2.2 16.1 0.0 0.3 0.8 4.3 10.1 2.7 2.3 7.1 9.9 5.5 14.6 7.8 6.2 1.9 15.3 0.6 5.6 2.5 3.3 2.0 2.4 3.7 4.4 6.7 1.5 2.5 1.2 0.0 0.0 0.0 1.4 0.0 2.0 0.7 1.3 0.0 0.0 0.5 0.2 0.5 0.0 0.2 0.0 0.0 0.9 0.3 12.1 13.2 23.3 16.6 10.0 6.5 5.3 9.8 10.5 6.3 PPP1R14A "CPI-17, PPP1INL" ENSG00000167641 "Protein phosphatase 1 regulatory inhibitor subunit 14A" Q96A00 19 38251237-38256591 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "A549: 39.7;EFO-21: 34.2;K-562: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3" "Group enriched" "Detected in many" 29 "B-cells: 46.4;dendritic cells: 39.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005044, CAB009803, HPA042097, HPA054534" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: , HPA054534: " "unprognostic (5.40e-2)" "unprognostic (4.00e-3)" "unprognostic (4.02e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-1)" "unprognostic (8.92e-3)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (1.25e-5)" "prognostic unfavourable (7.12e-4)" "unprognostic (4.13e-1)" "unprognostic (5.81e-2)" "unprognostic (2.22e-2)" 45.4 34.9 22.5 15.1 28.7 2.6 20.1 4.4 37.9 21.1 56.1 60.9 16.6 13.9 39.6 10.8 32.6 20.1 31.7 13.0 34.4 19.0 8.9 4.0 21.1 2.8 43.6 19.2 22.7 17.1 1.7 1.6 24.2 28.4 29.7 10.0 4.4 10.4 70.3 13.9 3.5 16.5 79.9 76.0 31.1 22.9 18.7 38.2 0.0 3.3 3.4 2.1 51.6 15.6 46.4 39.3 1.1 0.1 1.4 0.1 3.7 0.0 39.7 0.1 0.0 0.2 0.0 1.7 3.7 0.0 0.0 0.0 3.1 0.0 0.0 34.2 0.2 0.1 3.4 0.0 0.0 0.5 0.0 7.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 16.5 0.1 0.0 0.2 0.0 0.1 1.3 0.0 0.0 1.0 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.1 0.0 46.4 0.0 0.0 6.8 42.7 0.1 0.0 0.3 1.4 0.0 39.3 0.0 3.7 22.5 28.7 4.4 29.7 34.4 19.0 43.6 19.2 28.4 38.2 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805705-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4;lymphoid tissue: 35.0" "Cell line enhanced" "Detected in some" "Daudi: 22.2;HMC-1: 24.0;HUVEC TERT2: 14.1;U-266/70: 39.0;U-266/84: 15.6;U-698: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049571 Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA049571: " "unprognostic (2.62e-2)" "prognostic favourable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favourable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 11.2 3.2 26.3 15.9 44.4 13.0 4.4 19.7 35.1 3.6 4.5 25.6 0.0 3.6 3.5 1.9 3.3 5.8 5.3 4.9 25.5 9.1 24.4 2.6 7.3 30.1 15.0 18.8 1.6 1.5 1.2 1.8 3.7 10.9 2.1 5.1 1.6 2.3 2.3 3.4 1.8 9.2 6.8 18.6 14.4 4.9 1.2 15.1 5.1 3.2 0.5 35.0 7.5 3.7 8.4 4.9 3.5 1.3 3.9 5.2 1.6 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.3 0.0 0.0 0.4 0.0 0.0 0.5 0.1 1.7 0.0 0.0 0.0 0.1 24.0 0.0 0.0 0.0 0.0 14.1 0.3 4.7 0.0 0.0 2.8 3.7 3.1 0.0 1.9 0.0 0.0 0.0 0.0 7.1 8.0 0.0 0.0 0.0 0.0 1.2 2.1 0.0 0.3 0.0 0.0 39.0 15.6 15.3 0.0 0.0 0.0 0.0 0.3 3.5 5.2 0.7 2.8 8.4 3.7 5.1 1.1 5.4 2.2 3.0 0.0 3.9 1.3 4.9 3.7 1.6 26.3 44.4 19.7 35.1 25.5 9.1 15.0 18.8 10.9 15.1 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 34.6;U-937: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 9.9 1.6 5.9 7.2 4.3 11.5 0.2 5.9 6.9 5.3 3.6 1.2 2.0 9.7 5.4 10.4 6.6 2.9 6.5 2.7 8.1 0.6 23.3 2.9 1.2 3.4 6.1 34.6 7.0 7.6 13.0 11.7 4.2 4.3 4.9 6.2 1.0 8.6 12.0 0.0 0.4 27.5 5.2 7.9 3.1 0.6 0.4 2.0 5.5 2.1 11.0 1.6 8.3 14.1 20.8 5.3 0.0 14.7 1.8 9.5 12.0 6.0 36.0 24.2 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: " "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514425-195543386 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043729: , HPA059420: " "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 16.4 12.7 19.9 17.7 26.0 45.2 18.3 16.2 22.9 16.1 21.2 11.4 17.4 19.5 18.9 20.7 25.6 15.3 15.8 23.3 18.6 21.7 16.7 13.0 21.7 30.4 16.5 15.4 17.1 12.0 9.5 17.6 16.1 21.2 17.0 16.0 13.7 15.0 19.0 57.1 14.1 22.6 17.7 15.4 24.2 13.9 21.8 7.0 38.1 19.1 25.2 23.5 26.5 15.5 26.0 26.6 63.2 16.9 22.8 50.2 30.1 11.4 2.5 4.2 4.8 7.1 7.7 7.7 7.1 10.4 7.6 6.6 38.6 5.1 4.5 28.6 8.7 5.1 4.4 7.2 9.4 8.9 8.3 5.1 4.2 12.9 11.0 5.4 5.4 9.3 5.6 5.7 11.6 6.5 3.9 9.7 6.7 8.0 9.6 6.0 4.4 11.6 4.5 7.4 13.4 9.1 8.7 10.0 5.5 8.6 9.5 12.8 15.0 5.5 7.2 4.9 5.7 8.0 9.7 66.1 28.7 21.7 6.9 9.9 9.5 26.3 16.7 63.2 19.6 16.9 26.9 26.0 41.2 27.0 17.6 23.6 50.2 34.0 39.4 22.8 16.4 26.6 41.7 30.1 19.9 26.0 16.2 22.9 18.6 21.7 16.5 15.4 21.2 7.0 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: " "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favourable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favourable (9.87e-4)" "unprognostic (6.60e-2)" 9.0 10.4 16.4 8.9 18.7 8.1 7.9 16.2 21.6 8.3 8.8 15.0 7.9 7.0 15.8 18.8 11.2 13.5 9.8 8.9 13.2 12.2 25.6 10.4 10.0 10.9 17.7 13.6 12.7 7.3 35.5 11.9 11.3 14.4 10.8 9.8 8.4 6.8 10.2 6.4 9.5 9.0 11.9 12.0 11.0 9.4 8.4 15.9 10.4 19.5 2.4 10.8 12.7 8.8 7.7 5.6 14.1 6.0 3.8 7.9 2.3 13.8 6.7 5.8 7.1 14.6 10.8 15.2 8.3 9.3 5.0 6.1 3.7 8.7 9.4 13.7 11.5 7.7 4.8 7.4 10.6 12.0 4.1 10.1 5.7 8.9 10.1 4.5 8.1 13.5 6.8 9.1 11.2 12.7 4.1 15.8 13.8 7.6 8.6 7.3 14.6 7.1 7.2 15.5 10.2 10.6 9.2 7.7 4.8 15.3 4.0 14.7 7.2 7.3 11.3 5.4 6.7 4.8 6.5 11.8 3.3 8.6 8.6 10.2 7.1 14.1 5.4 8.5 4.4 6.0 3.5 5.9 5.2 5.1 5.6 7.7 7.9 6.4 13.0 3.8 5.1 3.5 5.0 2.3 16.4 18.7 16.2 21.6 13.2 12.2 17.7 13.6 14.4 15.9 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043729: , HPA059420: " "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favourable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.4 1.7 3.5 3.8 4.0 14.2 5.3 5.8 6.5 3.1 3.8 5.5 1.7 6.6 4.4 11.8 3.5 3.8 4.2 3.9 2.7 4.4 3.3 2.0 3.5 1.8 12.5 2.8 10.4 2.3 2.0 3.5 0.8 0.4 4.1 6.1 1.5 5.8 1.2 5.9 1.9 0.8 2.5 4.3 6.4 3.2 2.0 6.6 20.0 5.7 7.3 6.5 3.8 3.8 1.6 4.0 0.8 1.4 3.4 0.4 2.8 6.4 2.3 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295643-23302848 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: " "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavourable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favourable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 4.2 7.6 14.5 8.2 22.5 5.5 6.8 27.3 22.9 6.5 5.8 17.5 8.4 9.7 8.2 16.6 4.3 6.5 5.4 4.7 12.4 12.6 9.3 6.9 5.1 13.6 27.0 20.7 11.8 7.1 11.7 14.3 4.4 20.8 9.3 9.6 7.4 6.3 10.4 13.6 16.9 8.8 5.8 21.6 11.0 7.8 11.5 25.9 5.9 13.8 4.9 12.3 5.2 7.0 3.0 1.1 1.6 4.7 0.9 1.7 1.0 0.7 2.1 2.6 1.8 5.1 2.2 1.3 0.9 1.5 1.4 1.3 1.2 4.1 7.9 0.6 1.1 5.5 1.5 0.8 1.8 2.8 1.5 1.4 4.1 2.8 1.4 1.6 3.2 1.8 3.2 0.9 4.5 0.6 1.3 7.1 1.2 1.8 1.4 2.5 0.6 2.0 2.3 1.8 5.0 0.8 1.8 3.2 0.9 1.3 1.1 0.8 1.4 0.6 1.2 1.8 1.0 3.0 0.6 30.0 3.1 3.6 1.4 2.8 1.1 0.5 1.3 0.5 1.5 3.9 1.7 3.0 0.5 0.7 1.1 2.3 1.7 1.0 1.6 0.9 4.7 1.0 1.0 1.0 14.5 22.5 27.3 22.9 12.4 12.6 27.0 20.7 20.8 25.9 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000244: , HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favourable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.6 5.4 4.8 5.3 6.6 4.7 2.3 3.1 4.8 2.1 3.3 3.8 3.1 3.1 0.6 2.3 4.2 1.8 1.3 1.1 17.0 5.9 0.3 3.1 0.3 4.3 0.4 1.9 3.3 3.9 2.2 1.7 0.5 0.8 1.3 2.5 9.3 1.2 4.2 14.7 10.2 6.9 4.1 1.0 2.1 1.2 5.6 4.8 1.6 0.6 8.0 4.8 2.7 2.5 5.9 1.2 5.2 2.3 3.9 4.8 2.1 2.0 6.6 7.5 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 PPP1R8 "ard-1, ARD1, NIPP-1, NIPP1, PRO2047" ENSG00000117751 "Protein phosphatase 1 regulatory subunit 8" Q12972 1 27830778-27851676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027406, HPA027417, HPA027452" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490" "unprognostic (5.61e-2)" "unprognostic (2.55e-1)" "unprognostic (4.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-2)" "unprognostic (9.09e-3)" "prognostic unfavourable (2.19e-5)" "unprognostic (4.82e-2)" "unprognostic (2.14e-3)" "unprognostic (2.20e-1)" "unprognostic (3.16e-2)" "unprognostic (9.16e-2)" "unprognostic (6.26e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-2)" "unprognostic (4.86e-2)" "unprognostic (2.58e-2)" 18.0 14.5 28.6 15.5 37.0 23.2 19.4 23.1 29.7 18.9 16.0 18.2 12.0 13.3 24.0 15.6 19.6 19.4 14.6 16.2 23.4 17.7 13.9 14.8 17.6 28.6 24.6 25.7 24.6 18.5 14.2 18.9 17.4 24.4 15.3 18.0 11.7 15.1 19.5 17.8 17.8 15.1 21.8 24.6 16.9 14.3 21.4 25.6 20.7 17.9 9.4 24.6 18.6 16.0 11.9 9.7 17.0 11.4 14.0 16.5 14.9 20.9 14.9 32.5 21.1 20.5 21.5 18.7 22.6 23.9 38.9 31.5 16.7 24.2 30.1 16.0 25.7 19.0 38.2 21.2 28.3 25.2 23.2 39.3 20.3 24.5 20.7 36.1 28.0 18.7 23.2 35.2 31.5 23.0 33.2 20.6 23.1 13.7 39.4 21.3 40.2 17.4 32.3 26.9 28.6 20.9 19.4 22.8 20.7 27.8 21.8 26.9 19.1 22.7 18.9 19.2 17.5 30.0 21.0 19.1 29.1 38.0 18.7 47.1 24.4 17.0 10.0 9.1 14.0 10.0 16.5 11.6 11.6 15.8 9.7 11.9 12.8 12.1 5.9 14.0 11.4 7.3 11.4 14.9 28.6 37.0 23.1 29.7 23.4 17.7 24.6 25.7 24.4 25.6 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Cell line enhanced" "Detected in all" "U-698: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" Cytosol "Nucleoplasm, Plasma membrane, Centrosome" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favourable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 12.8 8.6 12.4 8.4 12.5 6.8 12.5 12.7 8.9 9.5 8.7 29.2 13.5 16.3 9.6 8.2 12.2 18.4 10.4 12.2 11.2 5.7 15.9 5.1 12.7 6.2 18.5 12.7 7.7 6.3 10.7 7.9 11.7 19.2 21.7 10.4 4.2 20.0 7.5 15.3 9.4 15.4 8.3 19.9 14.1 14.2 4.1 11.0 11.4 10.5 2.1 12.1 6.9 12.6 11.1 13.4 5.5 8.1 2.3 5.7 59.6 3.9 21.7 14.0 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: " "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 14.5 12.5 19.1 15.5 23.8 26.4 12.2 17.9 22.1 12.9 13.8 11.4 9.5 14.1 10.9 11.0 8.9 10.0 12.5 14.8 17.9 11.4 10.1 10.5 12.1 18.9 28.4 17.2 12.6 9.5 11.3 30.8 12.7 20.6 11.8 14.7 6.8 10.2 9.7 20.0 6.5 15.3 14.5 22.8 21.5 13.1 46.8 24.1 18.9 8.7 7.5 16.4 14.7 10.4 12.2 12.7 32.1 19.2 13.9 14.7 11.4 15.5 8.5 14.8 13.2 9.8 19.7 11.1 12.6 10.7 14.8 18.2 6.7 11.3 16.7 5.0 12.0 6.7 6.7 4.8 22.1 18.3 7.8 9.3 4.6 24.8 14.3 17.3 18.4 15.1 4.5 11.1 6.9 20.1 9.8 17.0 21.3 11.3 18.2 16.2 13.5 9.9 18.1 11.4 13.7 5.2 9.1 16.0 13.9 15.4 11.1 20.2 7.4 20.7 17.0 16.2 6.9 13.6 14.4 15.2 20.0 34.0 8.2 16.6 18.4 20.0 15.0 32.1 10.7 19.2 11.7 12.2 10.8 13.8 12.7 11.0 9.6 11.7 28.1 13.9 16.4 8.1 14.7 11.4 19.1 23.8 17.9 22.1 17.9 11.4 28.4 17.2 20.6 24.1 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 20.7 14.3 24.3 23.4 22.0 31.0 23.5 19.7 26.0 24.7 23.7 14.3 36.3 56.9 19.0 25.5 21.9 22.1 20.8 32.2 25.6 10.4 16.5 16.9 13.9 16.3 25.2 35.4 20.4 27.0 16.9 15.8 22.1 34.2 24.1 23.5 31.7 25.3 27.9 14.1 23.9 21.5 27.3 14.0 23.6 23.6 19.0 35.6 26.7 17.7 33.2 32.4 19.4 21.8 15.6 14.9 59.9 19.4 33.7 50.3 94.8 23.4 18.7 17.3 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 PPP2R5D "B56D, B56delta" ENSG00000112640 "Protein phosphatase 2 regulatory subunit B'delta" Q14738 6 42984499-43012342 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029045, HPA029046" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029045: AB_10598912, HPA029046: AB_10600988" "unprognostic (2.25e-1)" "unprognostic (7.14e-2)" "unprognostic (4.73e-2)" "unprognostic (6.89e-2)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (3.89e-4)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (9.44e-2)" "unprognostic (2.59e-1)" "unprognostic (2.71e-1)" "unprognostic (1.21e-1)" "unprognostic (9.96e-2)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (6.05e-2)" 17.9 14.4 19.7 17.0 31.5 15.1 14.2 28.3 41.0 20.2 24.5 13.7 15.9 31.1 20.7 11.4 18.1 19.0 14.3 22.0 17.7 18.4 15.7 15.8 15.0 16.2 16.6 25.1 20.7 16.5 17.4 11.2 16.6 26.3 18.4 18.6 16.5 13.7 19.2 41.0 17.9 36.4 20.8 11.2 14.4 14.9 27.1 13.1 35.5 13.4 11.1 14.7 19.1 18.5 9.2 12.5 17.9 11.3 11.8 19.7 15.3 26.6 14.0 21.5 28.0 13.3 18.4 12.1 14.8 10.5 29.6 26.2 22.8 7.3 20.0 14.4 17.9 15.1 28.9 17.0 26.5 17.0 25.2 23.8 17.4 21.4 9.3 16.4 17.6 10.1 11.2 23.6 10.7 22.5 24.9 15.5 17.0 11.4 42.2 15.0 9.6 13.4 29.6 26.7 13.0 9.0 12.6 27.3 17.9 20.1 13.4 15.9 18.7 15.4 21.3 21.4 19.8 22.3 23.5 16.0 20.1 40.9 8.4 15.3 18.4 14.8 11.3 17.9 16.8 9.8 17.6 9.2 15.3 19.0 11.6 9.0 11.8 14.1 6.9 11.8 7.4 12.5 19.7 15.3 19.7 31.5 28.3 41.0 17.7 18.4 16.6 25.1 26.3 13.1 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell line specificity" "Detected in all" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavourable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.4 21.6 16.4 7.4 21.4 19.7 8.7 9.2 7.9 24.3 9.2 9.0 19.3 9.7 13.9 28.5 14.8 22.6 6.4 14.7 19.7 10.2 15.8 23.5 7.5 16.9 15.0 18.9 21.7 16.3 5.7 25.5 13.9 23.3 4.9 17.7 6.4 8.9 9.0 34.9 10.7 8.4 15.4 30.3 11.5 17.7 15.2 10.2 13.6 13.4 18.9 20.6 23.4 18.8 14.1 11.9 12.2 16.4 11.4 13.3 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: " "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.4 14.9 20.2 13.9 14.0 16.2 20.6 25.5 21.7 28.7 25.4 21.5 15.9 24.4 8.8 17.2 11.9 21.3 18.4 35.1 17.2 15.2 79.3 12.2 19.8 27.6 31.1 26.8 16.3 16.7 22.3 22.9 19.2 19.1 27.9 20.9 15.1 26.3 27.4 23.7 12.7 19.2 26.7 38.9 17.8 18.7 26.7 18.8 14.6 20.8 18.3 9.8 14.5 20.2 24.8 22.8 18.7 21.9 15.8 17.4 36.2 18.1 32.7 15.5 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA047157: " "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085377 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: " "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 24.7 26.6 13.5 26.1 14.1 26.7 18.6 16.0 15.9 19.2 28.4 14.5 20.5 22.5 19.2 28.4 39.1 17.7 31.9 28.5 12.6 12.1 28.9 52.3 27.4 25.3 12.5 12.8 22.5 26.3 23.9 16.2 51.6 11.9 18.3 17.4 18.8 22.0 14.9 26.0 26.1 38.8 15.9 11.9 36.2 22.6 39.0 9.5 59.7 27.1 26.5 37.9 22.2 21.1 19.5 30.3 57.3 28.2 12.4 23.6 12.0 30.3 34.1 22.8 31.8 21.6 18.2 35.4 27.1 30.2 35.7 39.7 30.0 39.7 23.7 34.9 31.9 24.8 28.2 33.6 21.1 29.6 50.5 16.1 21.2 66.2 32.8 22.6 30.5 26.4 29.8 32.5 20.6 41.4 31.3 21.7 27.2 87.6 39.3 41.2 43.3 18.2 44.0 23.7 41.2 33.7 31.3 22.2 32.8 13.3 40.2 23.1 37.0 38.5 26.3 20.9 21.9 16.8 20.8 37.2 40.9 27.7 29.8 29.1 25.2 21.4 26.9 57.3 18.3 28.2 13.1 17.0 19.2 20.6 30.3 19.5 17.2 15.2 56.9 12.4 24.5 23.5 23.6 12.0 13.5 14.1 16.0 15.9 12.6 12.1 12.5 12.8 11.9 9.5 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457611-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: " "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.0 14.2 22.1 25.7 19.7 48.5 20.1 33.2 22.6 20.6 22.7 15.0 22.0 19.8 22.0 17.7 22.7 21.0 23.4 15.7 19.4 14.2 20.7 27.8 21.4 29.0 20.8 16.8 23.4 21.7 25.6 24.0 25.1 16.3 21.6 20.9 14.7 20.5 29.1 34.8 25.4 27.1 19.9 18.0 29.1 21.2 25.3 18.3 44.6 19.6 20.3 27.5 19.9 25.6 9.0 7.4 8.5 4.7 12.1 10.0 3.6 14.6 17.5 22.1 15.5 12.1 12.1 30.2 12.6 12.4 14.3 14.2 15.1 19.2 33.0 16.1 11.1 15.9 21.5 16.3 22.5 26.8 8.8 16.9 12.3 12.4 13.7 33.1 18.5 8.4 25.2 11.1 16.9 14.5 15.2 24.5 15.9 23.6 24.9 16.0 16.2 12.4 28.9 23.8 14.1 14.4 23.8 25.9 14.2 18.7 45.8 15.8 24.0 19.2 14.3 12.8 11.5 13.1 16.0 18.9 28.3 38.0 15.3 15.6 19.9 8.5 3.1 3.6 7.2 3.5 10.0 7.1 7.3 6.5 2.9 9.0 9.0 7.3 3.4 12.1 4.7 7.4 9.3 3.6 22.1 19.7 33.2 22.6 19.4 14.2 20.8 16.8 16.3 18.3 PPP4R3B "FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2" ENSG00000275052 "Protein phosphatase 4 regulatory subunit 3B" Q5MIZ7 2 55547292-55618880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001233, CAB017185" Approved Supported "Nucleoplasm,Nuclear speckles,Centrosome" "Nucleoplasm, Nuclear speckles" Centrosome "CAB017185: , HPA001233: AB_1080033" "unprognostic (9.60e-2)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-2)" "unprognostic (6.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (3.27e-2)" "unprognostic (8.27e-3)" "unprognostic (7.62e-2)" "unprognostic (1.07e-2)" "unprognostic (3.69e-1)" "prognostic unfavourable (6.03e-4)" "unprognostic (9.73e-2)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" 11.9 10.4 12.1 10.6 13.1 8.1 10.9 17.5 13.1 11.2 11.4 8.6 7.4 11.5 8.8 7.8 12.0 12.5 9.1 5.3 12.8 12.7 18.1 8.3 13.0 13.3 7.9 10.8 13.6 10.7 11.7 11.1 11.4 9.5 10.6 7.8 9.6 9.1 6.0 11.0 14.4 10.3 11.1 10.8 11.0 8.0 12.3 18.7 12.6 6.2 14.3 11.3 10.0 17.6 16.9 23.9 19.6 20.0 25.3 21.6 19.7 15.4 17.0 14.3 18.2 19.2 23.4 15.9 17.4 13.8 11.8 18.1 19.1 26.8 32.4 15.7 17.2 19.3 13.1 20.7 38.5 8.1 26.7 14.5 24.2 29.5 30.4 22.2 14.8 31.7 16.8 29.1 21.6 25.3 27.2 18.2 23.1 19.6 20.0 16.7 12.2 18.3 25.7 20.2 19.0 20.7 21.2 12.9 17.3 24.0 25.8 15.1 24.7 16.9 21.2 27.2 10.4 21.9 28.1 21.1 10.3 19.8 29.0 22.5 21.2 15.6 23.9 20.4 19.6 23.0 17.6 21.5 21.2 16.9 16.9 25.3 22.0 18.1 20.0 19.3 9.2 21.5 21.6 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46346994-46392981 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol 47000 "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: " "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 18.9 24.7 23.0 18.1 28.8 13.4 15.9 25.2 50.8 20.4 21.1 19.4 15.2 18.0 23.0 15.2 20.1 27.8 20.5 48.2 20.8 23.9 22.6 22.1 17.4 19.3 21.9 29.8 16.7 21.5 26.3 23.9 17.3 34.5 19.5 17.5 19.7 21.0 21.4 40.8 16.4 15.3 23.5 16.2 21.7 20.6 19.0 15.3 15.6 18.1 20.5 16.1 17.1 18.1 10.6 11.1 1.9 14.1 14.0 19.8 8.9 19.5 36.8 22.0 16.6 16.6 17.8 10.2 24.3 19.8 29.6 26.7 26.4 15.6 30.0 13.3 17.7 16.1 28.9 28.7 8.9 20.8 39.2 25.0 27.0 18.7 18.5 33.8 17.5 16.2 13.6 20.8 15.5 25.4 24.0 15.5 16.8 21.2 18.9 63.4 16.6 20.1 28.2 19.0 24.0 17.7 26.8 31.3 23.0 20.4 26.0 8.7 16.3 21.6 21.1 13.0 21.6 9.6 25.4 12.5 28.7 36.0 13.9 28.4 21.6 0.0 6.8 1.9 19.8 12.1 12.7 10.6 9.2 15.3 11.1 8.7 8.9 12.0 0.1 14.0 14.1 7.9 9.3 8.9 23.0 28.8 25.2 50.8 20.8 23.9 21.9 29.8 34.5 15.3 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favourable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favourable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 16.8 22.1 21.3 19.6 20.7 17.9 32.2 39.0 52.7 13.0 15.8 18.5 20.6 23.1 17.2 13.3 18.6 16.2 17.3 25.6 19.8 18.3 18.7 40.6 19.0 32.8 19.8 22.4 16.8 23.7 19.7 26.7 14.9 19.4 19.8 11.7 20.2 26.3 18.2 47.3 25.8 20.0 21.2 20.4 21.2 22.5 37.8 17.3 21.1 21.1 11.7 18.5 15.6 13.6 9.8 12.3 16.0 10.3 6.4 14.3 8.5 16.1 9.5 14.9 18.9 11.0 11.8 13.4 16.2 17.3 17.3 17.6 8.0 10.0 19.5 8.0 16.0 13.2 9.1 12.0 6.5 10.0 16.9 10.4 18.3 19.7 14.4 24.3 28.6 17.5 13.1 10.4 5.6 15.1 10.6 17.1 12.5 26.1 16.6 17.7 6.1 11.9 23.4 11.4 12.7 12.7 19.2 9.4 12.6 16.6 25.9 13.1 9.3 18.6 17.3 16.2 14.7 13.4 10.6 18.4 4.4 17.2 16.9 12.0 22.2 4.0 9.6 6.3 10.8 10.3 12.7 9.5 7.6 11.5 9.8 9.8 7.4 9.5 16.0 6.4 7.4 12.3 14.3 8.5 21.3 20.7 39.0 52.7 19.8 18.3 19.8 22.4 19.4 17.3 PPP6R3 "C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3" ENSG00000110075 "Protein phosphatase 6 regulatory subunit 3" Q5H9R7 11 68460731-68615334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017183, HPA038467, HPA038468" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB017183: , HPA038467: , HPA038468: " "unprognostic (9.46e-3)" "unprognostic (1.45e-1)" "unprognostic (4.62e-2)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (6.19e-2)" "unprognostic (1.97e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.33e-2)" "unprognostic (1.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.20e-3)" "unprognostic (3.29e-1)" "prognostic unfavourable (8.23e-4)" "unprognostic (1.54e-2)" "unprognostic (6.43e-2)" 33.0 29.8 16.7 25.7 24.1 36.5 26.8 35.7 25.8 33.2 29.6 27.9 24.9 21.5 43.8 24.3 29.9 26.6 24.6 27.5 17.3 16.5 28.8 28.2 27.9 26.8 25.0 18.5 36.4 23.8 49.0 48.1 40.0 23.7 28.3 27.5 28.2 28.2 29.2 46.4 25.8 31.5 35.5 24.3 31.1 27.7 28.2 24.0 45.5 39.2 34.8 31.8 34.3 26.9 14.8 15.0 16.9 16.7 11.7 17.7 7.1 24.9 29.6 30.6 21.4 16.4 16.7 23.8 21.9 21.3 25.5 23.5 51.2 25.4 28.8 21.6 20.4 23.6 33.7 24.8 33.8 27.8 14.1 33.3 30.0 17.3 15.7 31.5 29.7 16.5 16.7 26.2 28.4 23.2 28.0 21.5 18.2 33.4 31.6 24.3 15.3 17.6 29.7 41.8 28.0 17.0 36.3 17.4 20.7 31.1 24.7 45.2 36.6 16.9 23.0 25.2 23.9 26.7 18.6 17.0 23.7 37.8 18.2 14.0 26.7 14.6 11.5 14.4 14.7 15.2 14.0 14.1 15.6 14.4 7.4 14.8 17.7 16.1 16.9 11.7 16.7 15.0 15.0 7.1 16.7 24.1 35.7 25.8 17.3 16.5 25.0 18.5 23.7 24.0 PPT1 "CLN1, INCL, PPT" ENSG00000131238 "Palmitoyl-protein thioesterase 1" P50897 1 40071461-40097727 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 86.0;THP-1: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021546 Supported Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 130000 "Golgi apparatus, Vesicles" "HPA021546: AB_1855667" "unprognostic (5.02e-2)" "unprognostic (2.73e-1)" "unprognostic (1.64e-1)" "unprognostic (2.06e-3)" "unprognostic (6.68e-2)" "unprognostic (2.83e-2)" "prognostic unfavourable (6.98e-8)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.16e-2)" "unprognostic (2.39e-1)" "unprognostic (5.20e-3)" "unprognostic (1.75e-1)" "unprognostic (2.30e-1)" "unprognostic (2.93e-2)" "unprognostic (2.08e-2)" 33.3 27.1 37.6 31.0 41.5 33.3 39.7 35.2 41.0 30.3 21.0 31.5 17.2 12.9 31.3 19.4 18.5 20.7 23.2 18.1 32.7 35.8 29.4 18.4 47.3 48.5 35.3 29.1 24.7 17.4 30.4 21.2 25.9 34.6 28.0 26.0 26.3 22.1 23.6 8.3 13.8 16.6 36.5 33.6 61.3 17.9 13.8 29.1 19.8 18.7 14.4 30.0 23.0 19.8 9.3 77.4 59.9 90.0 7.2 19.1 91.6 10.0 6.8 11.0 6.2 13.3 11.4 21.6 5.6 10.2 13.6 16.8 39.2 16.9 11.5 11.0 5.9 17.7 17.1 10.1 18.7 14.5 17.6 6.0 16.8 19.3 15.1 13.5 14.5 10.7 11.1 10.8 10.1 18.3 13.9 16.8 7.6 20.1 7.7 10.1 20.8 10.6 8.7 14.8 20.0 9.5 18.0 8.8 9.3 11.0 86.0 34.2 12.5 159.9 6.4 6.6 14.2 6.2 16.7 15.1 31.6 11.1 8.5 33.0 12.0 6.2 90.0 48.2 9.9 77.6 11.8 9.3 14.7 11.5 77.4 9.2 19.1 14.7 59.9 7.2 58.3 7.6 16.8 91.6 37.6 41.5 35.2 41.0 32.7 35.8 35.3 29.1 34.6 29.1 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavourable (1.43e-5)" "prognostic unfavourable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favourable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.0 6.9 5.9 6.2 14.8 13.1 8.5 5.6 7.4 6.1 6.2 7.8 4.8 21.2 5.8 5.4 11.8 11.9 12.9 12.4 15.4 9.8 18.8 7.4 8.4 14.1 20.7 15.5 11.2 21.3 8.6 25.5 11.6 13.9 6.1 9.9 3.1 18.3 17.8 8.4 12.9 15.3 8.0 12.9 25.4 13.6 9.6 7.5 10.5 14.6 12.3 6.9 11.1 13.2 5.6 6.0 17.1 9.3 17.6 19.4 23.7 9.5 11.5 11.0 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell line enhanced" "Detected in some" "ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA054395: " "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.6 18.6 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.7 5.3 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 12.1 0.6 5.2 0.3 5.3 0.3 0.0 16.9 0.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 62.1;prostate: 40.3" "Cell line enriched" "Detected in some" 33 "PC-3: 90.3" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" HPA047871 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047871: " "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.6 2.0 30.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 40.3 62.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 9.9 5.1 0.8 0.0 2.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 90.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.5 0.0 0.2 0.5 0.0 0.4 0.0 0.8 0.1 0.1 2.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071156-49074071 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 125.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: " "unprognostic (1.50e-1)" "prognostic favourable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavourable (1.66e-6)" "prognostic favourable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favourable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavourable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 13.5 17.5 25.0 12.3 26.9 6.7 9.0 18.0 39.7 28.1 11.8 26.3 12.6 6.0 22.1 125.1 7.3 15.6 12.3 12.9 25.3 29.9 12.4 6.9 11.5 11.3 26.1 18.9 20.1 6.2 19.7 31.0 9.8 25.5 12.2 10.0 13.0 7.5 29.4 6.8 7.6 6.6 33.2 23.1 10.9 9.2 17.7 17.0 14.4 13.3 3.8 11.9 12.6 10.7 14.6 6.7 16.4 6.4 16.8 29.4 11.1 4.5 9.5 11.1 14.1 40.0 24.3 1.4 16.1 16.9 11.0 12.1 0.5 1.4 0.4 3.9 34.9 4.2 0.4 8.7 12.2 8.3 12.6 3.6 12.3 0.4 41.0 2.3 7.0 30.9 7.5 20.8 15.2 16.8 0.5 1.2 19.1 8.3 14.9 2.8 6.2 0.6 8.2 6.1 0.9 16.3 1.3 7.4 18.5 13.5 7.0 9.2 6.8 1.6 10.1 8.5 11.3 18.2 4.7 20.1 5.1 3.6 20.4 4.1 13.1 16.4 5.9 7.9 18.3 6.4 20.7 14.6 20.1 16.1 6.7 13.6 18.1 19.4 15.4 16.8 4.8 2.6 29.4 11.1 25.0 26.9 18.0 39.7 25.3 29.9 26.1 18.9 25.5 17.0 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell line enriched" "Detected in some" 5 "K-562: 139.9" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.1 0.0 19.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 13.9 0.0 0.0 0.6 0.0 0.0 8.4 2.0 4.9 3.6 0.1 0.0 0.4 26.7 0.0 0.0 0.0 0.0 0.0 139.9 2.2 0.0 1.2 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.1 28.7 0.0 0.0 0.0 4.2 3.4 0.7 0.0 25.2 0.0 0.0 0.4 1.9 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavourable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.4 39.7 33.2 22.6 3.5 6.0 17.8 46.8 27.7 51.9 39.7 26.5 31.7 12.4 18.6 29.8 44.3 37.8 20.0 49.1 22.9 41.9 25.6 51.9 24.3 0.8 12.6 22.2 1.5 2.6 29.4 30.2 29.0 21.3 26.6 48.2 28.2 12.9 19.3 13.0 17.0 13.6 41.5 16.6 23.1 24.7 30.3 24.0 44.5 24.8 16.1 29.7 25.0 17.3 34.3 30.3 28.3 67.4 8.6 22.8 15.3 15.0 31.4 52.3 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 106086320-106109939 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Cell line enhanced" "Detected in some" "Karpas-707: 66.9;RPMI-8226: 12.5;U-266/70: 25.1;U-266/84: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;T-cells: 19.3" "Region enriched" "Detected in single" 6 "olfactory region: 4.4" "Low region specificity" "Detected in all" HPA030033 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030033: AB_10601050" "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavourable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 11.6 1.5 1.6 26.3 3.2 10.4 7.0 5.3 1.6 14.0 16.5 1.9 1.4 5.4 11.6 2.2 33.4 3.8 8.1 2.3 1.9 2.0 3.1 2.4 18.8 33.3 2.1 0.5 4.2 1.8 1.2 2.1 9.0 4.9 3.6 11.0 4.3 10.6 3.0 2.0 8.9 18.2 3.4 7.4 24.2 8.6 3.0 1.5 3.1 7.7 35.7 49.9 12.8 18.0 1.5 0.2 6.8 0.6 2.5 19.3 1.3 0.4 0.1 0.3 0.0 0.5 0.6 0.0 2.3 7.0 0.7 1.3 0.4 2.7 0.5 0.1 4.5 0.1 0.0 1.0 0.8 6.3 0.0 0.1 1.4 0.0 1.1 0.2 0.5 0.7 3.5 1.0 3.0 0.8 0.4 66.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 12.5 0.6 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.7 0.4 1.1 0.6 0.6 2.1 25.1 16.2 1.4 1.5 0.4 0.6 1.2 0.4 5.6 12.6 0.6 19.3 1.5 12.0 11.6 0.2 0.5 1.1 6.8 6.8 2.5 0.1 0.2 15.4 1.3 1.6 3.2 5.3 1.6 1.9 2.0 2.1 0.5 4.9 1.5 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026997 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681" "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 5.8 5.4 7.6 7.2 8.9 14.2 8.5 20.3 10.4 7.4 7.8 6.4 5.8 6.6 8.2 6.8 8.4 5.4 5.5 4.6 7.7 6.2 5.0 7.3 6.3 6.9 6.6 6.5 7.3 6.2 9.7 11.2 8.3 6.4 7.1 8.0 5.5 6.7 5.4 12.9 12.1 7.0 6.1 6.3 6.7 7.8 5.6 6.3 14.4 6.5 4.7 9.9 6.2 7.0 8.8 3.3 9.4 3.8 7.1 5.0 1.8 2.9 4.0 5.0 3.3 2.3 2.8 3.3 2.5 3.2 2.1 2.7 4.1 3.2 11.9 3.1 2.9 4.0 4.2 2.1 3.4 4.6 4.1 7.8 4.9 3.1 1.5 7.1 32.6 1.9 4.7 3.1 2.0 3.7 4.3 4.5 3.0 3.5 4.7 3.5 3.8 2.9 4.4 3.2 1.8 3.0 5.4 5.5 2.9 3.6 4.2 1.1 2.9 3.0 3.6 4.9 2.2 2.5 3.2 1.1 1.9 16.5 2.2 3.8 4.4 3.9 3.4 8.5 4.5 3.4 4.1 8.8 3.5 3.5 3.3 6.0 5.0 2.4 9.4 7.1 3.8 3.2 4.1 1.8 7.6 8.9 20.3 10.4 7.7 6.2 6.6 6.5 6.4 6.3 PRDM15 "C21orf83, ZNF298" ENSG00000141956 "PR/SET domain 15" P57071 21 41798225-41879482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 17.5;U-266/70: 16.1;U-698: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024268, HPA029255, HPA029256" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA024268: AB_1855688, HPA029255: , HPA029256: " "unprognostic (8.73e-2)" "unprognostic (1.32e-2)" "unprognostic (2.43e-2)" "unprognostic (6.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.85e-4)" "unprognostic (4.22e-4)" "unprognostic (6.50e-2)" "unprognostic (4.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.52e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-8)" "unprognostic (1.34e-1)" "unprognostic (2.70e-1)" "unprognostic (9.72e-2)" "unprognostic (4.86e-3)" 4.8 4.7 9.0 8.1 7.0 4.6 5.5 10.4 7.5 4.8 5.4 7.3 8.4 7.9 5.4 4.5 6.7 5.9 4.9 4.4 4.3 3.4 3.9 5.1 4.7 17.0 8.0 4.8 6.7 5.9 5.6 6.4 3.3 6.0 6.3 5.0 4.3 7.6 7.3 9.3 8.3 7.7 5.1 6.6 9.4 5.4 6.2 7.8 10.8 6.1 6.9 16.8 4.8 7.7 3.0 1.5 1.2 2.5 0.1 1.3 1.3 1.3 2.9 2.5 3.2 0.7 1.3 2.6 1.1 0.9 1.3 1.0 1.9 1.7 17.5 1.2 1.3 2.9 2.2 1.4 1.2 1.7 2.3 3.2 6.7 2.1 0.7 2.7 2.1 0.7 1.7 1.4 1.2 1.7 2.9 1.0 1.6 3.6 2.6 2.0 2.7 1.9 4.5 1.7 2.0 1.3 2.3 4.1 2.5 5.3 2.1 1.0 2.1 1.5 2.2 2.0 0.7 1.3 2.0 16.1 1.9 31.9 1.6 3.3 2.7 0.0 1.4 1.2 1.3 2.5 0.1 3.0 0.2 1.1 1.5 1.0 0.8 1.2 0.0 0.1 0.6 0.7 0.8 1.3 9.0 7.0 10.4 7.5 4.3 3.4 8.0 4.8 6.0 7.8 PRDM2 "HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2" ENSG00000116731 "PR/SET domain 2" Q13029 1 13700198-13825079 "Enzymes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005809 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA005809: AB_1079673" "unprognostic (2.22e-1)" "unprognostic (3.28e-1)" "unprognostic (5.34e-2)" "unprognostic (1.28e-2)" "unprognostic (6.70e-2)" "unprognostic (2.72e-3)" "unprognostic (1.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.20e-2)" "unprognostic (2.53e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (9.63e-3)" "unprognostic (3.81e-1)" "unprognostic (2.45e-1)" "unprognostic (1.85e-1)" "unprognostic (5.85e-3)" 15.2 14.5 26.0 17.2 28.1 64.1 17.2 32.3 44.9 16.2 18.1 19.8 12.6 12.4 18.8 16.4 19.6 14.4 16.4 14.3 19.8 14.5 10.8 9.3 15.6 23.4 18.9 27.8 30.7 12.8 16.0 26.7 15.7 18.0 17.7 13.6 10.3 15.8 18.9 45.2 21.6 16.8 16.8 21.6 16.9 14.2 17.1 17.8 14.4 23.3 11.7 22.7 19.8 19.3 16.0 5.4 9.7 5.1 5.7 5.7 2.5 6.7 3.9 14.1 5.4 11.2 8.6 6.8 8.9 5.4 6.1 6.8 6.1 7.7 20.8 7.8 8.5 8.4 10.5 5.2 6.7 12.8 7.5 13.9 4.5 2.8 6.1 4.6 12.0 9.1 9.2 6.4 5.4 6.0 12.3 24.1 7.6 3.4 7.4 7.4 4.2 5.2 10.4 7.6 6.2 3.5 7.7 12.3 7.9 7.1 4.5 9.7 6.4 7.5 10.6 7.8 8.5 7.1 4.8 35.4 24.0 29.8 6.9 10.9 10.0 3.9 4.8 6.8 5.7 3.1 3.8 16.0 4.5 5.2 2.9 12.5 5.2 4.5 9.7 5.7 5.1 5.4 4.1 2.5 26.0 28.1 32.3 44.9 19.8 14.5 18.9 27.8 18.0 17.8 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: " "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.7 2.8 6.5 0.1 3.9 8.1 7.7 3.8 8.4 3.9 3.5 3.6 1.0 0.4 1.0 5.1 0.0 0.0 0.8 5.2 0.0 1.1 2.3 2.5 0.2 4.2 7.9 0.1 5.7 2.5 2.8 3.5 2.9 0.0 11.9 4.8 0.3 1.2 0.0 4.8 2.2 0.0 7.5 4.9 1.4 0.0 1.2 5.2 0.0 0.1 0.7 5.4 3.4 1.1 0.2 2.3 4.0 3.8 11.0 15.3 0.0 3.0 0.0 2.9 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686399 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 127.6;pancreas: 320.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 11000000 "Endoplasmic reticulum, Cytosol" "CAB008659: AB_1620984, CAB027389: , CAB047362: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 11.6 14.8 3.8 7.0 6.4 3.9 11.2 3.3 5.4 13.2 10.7 6.5 17.4 8.9 11.5 10.5 13.1 9.6 12.9 17.6 3.8 4.0 11.8 127.6 8.9 16.9 7.2 4.0 14.6 320.8 6.1 15.8 21.9 7.4 9.3 11.4 8.0 25.4 14.1 7.8 7.2 10.6 8.8 8.1 12.6 12.8 25.2 6.1 4.7 12.0 10.0 15.0 10.8 8.7 27.9 31.4 2.0 39.3 24.1 22.7 21.3 24.2 33.5 14.2 27.4 77.4 39.6 20.0 32.7 35.7 29.7 43.4 35.1 30.6 20.9 15.4 42.4 29.4 40.8 20.3 28.5 12.7 78.5 14.8 29.6 44.3 32.3 19.0 14.1 41.9 26.3 28.9 29.0 37.2 28.5 77.1 27.4 36.1 9.7 29.8 49.0 49.2 13.5 35.5 117.8 26.5 8.5 20.8 17.7 30.1 35.8 24.1 37.8 24.3 24.5 21.2 14.0 54.7 24.5 25.3 30.6 22.3 38.0 24.7 30.2 1.7 20.6 2.0 17.8 32.2 21.8 27.9 22.7 18.6 31.4 16.2 16.4 16.7 1.5 24.1 39.3 22.0 22.1 21.3 3.8 6.4 3.3 5.4 3.8 4.0 7.2 4.0 7.4 6.1 PRDX6 "1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX" ENSG00000117592 "Peroxiredoxin 6" P30041 1 173477266-173488807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006983, CAB008663" Supported Supported "Plasma membrane,Cytosol" 180000000 "Plasma membrane, Cytosol" "CAB008663: AB_1620994, HPA006983: AB_1079595" "unprognostic (9.92e-2)" "unprognostic (1.50e-1)" "unprognostic (3.67e-1)" "unprognostic (2.99e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (5.71e-3)" "unprognostic (2.80e-2)" "unprognostic (5.27e-3)" "unprognostic (3.96e-3)" "unprognostic (3.19e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (9.51e-4)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (1.15e-1)" "unprognostic (4.73e-3)" 80.0 42.1 32.8 30.8 38.9 21.8 106.3 19.8 32.8 27.2 46.7 37.4 35.8 12.1 30.8 54.1 39.9 40.2 22.3 70.5 29.0 23.9 45.9 116.1 29.2 37.5 34.0 28.2 31.5 39.3 63.9 19.1 36.9 30.3 40.0 56.0 21.3 22.6 35.4 128.0 25.7 20.2 40.5 19.7 23.1 33.2 44.9 24.1 17.4 46.9 68.6 25.7 36.5 46.2 17.2 37.9 14.3 23.9 12.0 25.0 30.6 51.2 15.8 26.2 29.0 101.5 49.6 22.1 104.7 35.7 43.7 31.1 29.7 34.5 33.4 33.5 85.8 29.9 34.2 33.7 35.6 29.3 31.6 22.1 27.0 33.5 57.3 23.1 7.3 41.1 34.2 24.0 33.7 42.8 49.2 6.9 49.6 10.5 15.7 30.5 57.5 97.9 18.8 30.3 34.0 65.5 11.7 12.2 22.6 36.1 42.5 24.0 35.9 32.7 28.8 17.1 19.5 25.8 28.4 10.5 15.4 27.4 20.4 20.1 15.5 13.9 23.9 12.9 17.0 20.6 18.9 17.2 17.6 21.1 29.3 13.6 23.2 25.0 14.3 12.0 17.5 37.9 20.4 30.6 32.8 38.9 19.8 32.8 29.0 23.9 34.0 28.2 30.3 24.1 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303774-177306959 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavourable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 18.9 25.0 21.9 33.9 20.3 30.3 21.6 12.0 31.1 16.9 44.6 14.8 15.4 43.5 18.3 15.5 35.6 17.4 20.6 16.8 19.3 18.6 46.1 62.3 18.9 43.0 20.2 14.7 20.3 91.6 12.3 17.7 29.4 21.0 19.8 35.0 18.9 40.1 16.4 11.9 26.2 70.6 19.0 14.8 43.5 24.6 12.9 13.5 25.2 29.3 27.2 33.7 18.0 18.9 27.1 77.4 111.7 94.2 30.4 26.4 49.2 31.8 30.0 18.3 48.7 16.4 17.8 60.8 22.8 15.9 33.3 32.2 67.1 36.6 27.1 26.9 21.4 18.1 32.5 60.9 22.8 116.1 45.0 23.4 31.1 44.6 17.3 36.8 33.0 16.0 21.9 26.3 22.5 41.2 25.8 39.3 32.4 82.8 23.6 53.9 37.2 49.6 7.6 36.9 48.7 21.7 26.7 29.2 36.7 21.3 42.5 39.6 27.4 45.3 22.7 30.5 26.7 25.0 54.5 22.0 37.7 39.4 26.3 49.7 31.7 31.5 75.7 111.7 26.4 94.2 25.8 27.1 21.9 26.2 77.4 21.1 19.3 21.1 55.2 30.4 90.3 28.3 23.3 49.2 21.9 20.3 12.0 31.1 19.3 18.6 20.2 14.7 21.0 13.5 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827883 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;brain: 35.5" "Cell line enhanced" "Detected in many" "MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favourable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 10.8 8.1 20.5 25.1 24.9 32.7 12.4 11.4 25.0 9.6 5.1 35.5 0.2 4.6 3.2 2.7 4.8 3.7 9.5 4.9 21.8 15.5 4.1 4.0 17.7 28.3 26.2 12.1 2.2 3.9 5.2 5.8 8.4 17.4 3.9 4.6 7.7 4.0 2.8 4.6 2.7 8.6 5.6 27.6 28.7 6.1 4.5 23.9 2.8 6.7 1.0 15.1 10.3 2.5 2.0 2.1 11.7 2.7 2.1 9.3 2.2 0.6 1.6 22.0 0.0 0.3 1.6 7.7 0.7 0.9 3.1 0.8 0.1 0.0 4.4 14.0 1.9 0.2 1.1 0.0 2.1 1.0 0.5 0.6 2.5 0.0 1.3 2.3 14.4 1.8 0.0 7.2 0.0 19.0 0.0 0.1 4.1 43.2 0.0 6.8 0.8 1.8 6.4 6.4 2.6 0.1 0.0 4.6 0.7 4.0 45.3 5.0 40.5 18.5 21.2 1.2 4.5 0.0 1.2 0.2 0.9 5.4 20.6 4.8 6.7 5.2 2.3 2.5 5.0 2.7 3.0 2.0 2.7 4.2 2.1 1.7 0.4 1.5 11.7 2.1 2.3 1.7 9.3 2.2 20.5 24.9 11.4 17.7 21.8 15.5 26.2 12.1 17.4 23.9 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092242-64445476 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 18.1;ASC TERT1: 11.3;HSkMC: 16.6;U-87 MG: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.1;NK-cell: 1.1" "Group enriched" "Detected in many" 6 "B-cells: 2.1;NK-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 26.5 4.9 15.2 6.9 14.2 1.3 19.8 2.6 23.0 24.4 20.4 5.2 13.8 3.9 24.8 13.7 11.2 14.3 12.6 7.8 15.7 8.4 6.0 4.9 13.2 1.8 7.0 13.2 12.7 5.5 13.3 8.7 8.1 8.9 11.0 7.1 8.7 6.1 19.9 2.6 5.3 7.4 22.8 6.2 2.7 11.4 2.9 5.5 0.0 9.9 3.6 2.2 14.9 18.2 2.1 0.0 0.2 0.0 1.1 0.1 0.1 0.0 3.4 0.9 0.0 18.1 11.3 0.0 2.5 3.2 2.1 3.1 5.9 0.1 0.0 0.3 2.4 0.1 0.0 2.3 2.1 2.3 0.1 0.0 0.3 0.0 5.1 0.0 0.0 16.6 2.9 6.0 2.6 1.2 0.0 1.3 2.8 3.2 0.0 0.0 2.2 0.0 0.0 0.1 0.1 3.3 8.3 0.9 0.1 0.0 0.6 0.1 1.2 0.1 0.1 8.9 4.1 2.1 4.9 2.7 0.0 0.5 11.5 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.1 15.2 14.2 2.6 21.6 15.7 8.4 7.0 13.2 8.9 5.5 PRICKLE4 "C6orf49, DKFZp761H221, OEBT" ENSG00000278224 "Prickle planar cell polarity protein 4" Q2TBC4 6 41780762-41787372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 7.0;HeLa: 7.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "HPA031240, HPA055593" Approved Approved "Mitotic spindle,Centriolar satellite" "Centriolar satellite" "Mitotic spindle" "HPA031240: AB_10600929, HPA055593: " "unprognostic (1.16e-2)" "unprognostic (2.08e-2)" "unprognostic (2.56e-2)" "unprognostic (6.86e-2)" "unprognostic (1.58e-1)" "unprognostic (2.15e-2)" "unprognostic (6.41e-2)" "unprognostic (1.93e-2)" "unprognostic (3.47e-4)" "unprognostic (4.25e-2)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (1.56e-5)" "unprognostic (3.64e-3)" "unprognostic (5.74e-2)" "unprognostic (1.50e-1)" "unprognostic (2.17e-3)" 4.5 2.2 0.5 3.9 1.2 0.0 8.9 0.0 2.1 6.8 3.0 0.4 5.4 1.8 10.8 4.7 4.1 4.8 5.5 2.1 0.9 2.1 1.6 12.2 0.6 0.6 0.2 2.6 1.0 3.7 1.6 2.5 1.9 5.6 2.6 2.0 2.3 8.4 2.7 1.9 0.4 4.4 0.5 8.8 5.0 1.3 0.2 0.0 5.8 4.4 4.2 3.6 13.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 1.4 4.3 2.3 0.4 3.0 7.0 0.3 0.4 0.1 0.2 1.8 1.5 0.8 2.8 1.9 3.8 0.0 0.2 0.0 0.6 0.6 0.3 7.8 1.7 0.0 0.0 0.1 2.7 0.4 0.1 0.0 0.1 2.4 0.9 0.9 1.2 0.2 1.2 0.5 0.5 2.4 1.2 0.1 2.7 4.2 0.5 0.9 0.0 5.0 0.4 1.2 1.2 3.2 1.6 1.7 0.8 0.0 0.5 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell line enhanced" "Detected in some" "HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: , HPA060047: " "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavourable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavourable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 0.0 0.0 0.2 0.4 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.0 0.0 0.0 0.0 0.3 0.0 0.0 12.9 7.3 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 PRIMPOL "CCDC111, FLJ33167" ENSG00000164306 "Primase and DNA directed polymerase" Q96LW4 4 184649613-184694963 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054372 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA054372: " "unprognostic (1.68e-1)" "unprognostic (1.27e-3)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (2.67e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-2)" "unprognostic (3.34e-2)" "unprognostic (3.32e-3)" "unprognostic (5.86e-2)" "unprognostic (2.52e-2)" "unprognostic (5.02e-1)" "unprognostic (3.04e-1)" "unprognostic (3.04e-2)" "unprognostic (3.81e-1)" "unprognostic (1.49e-1)" "unprognostic (1.05e-1)" 12.3 12.6 8.3 17.0 11.5 9.1 13.5 14.6 11.0 17.7 14.3 15.4 18.1 6.9 25.4 13.1 12.0 15.1 14.6 12.0 8.0 8.3 8.6 9.9 11.3 10.8 8.4 11.5 18.7 9.0 9.8 14.0 10.8 10.2 14.8 13.2 12.0 11.0 17.9 10.3 10.0 11.2 14.8 14.7 11.9 11.0 8.0 10.2 15.0 12.1 6.4 10.8 16.3 15.9 3.3 2.5 18.6 4.1 3.6 4.9 2.6 9.3 3.8 9.5 10.9 12.7 16.6 6.5 9.1 15.1 16.1 14.1 3.0 9.1 5.3 3.5 7.1 5.6 7.7 9.7 17.0 10.8 3.9 5.6 5.4 3.6 8.2 4.8 8.4 10.4 8.0 14.7 9.7 8.4 11.2 18.6 11.4 3.1 9.3 4.2 3.1 3.4 8.5 6.9 6.0 8.1 5.6 7.2 9.0 5.7 1.6 10.3 4.9 8.5 4.5 5.4 7.2 4.4 6.2 9.4 6.7 2.7 7.9 6.2 13.3 7.8 2.0 18.6 3.5 1.9 4.9 3.1 3.2 3.4 2.5 3.3 2.7 2.7 1.0 3.6 4.1 2.2 3.7 2.6 8.3 11.5 14.6 11.0 8.0 8.3 8.4 11.5 10.2 10.2 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645322-56715335 "Enzymes, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;skeletal muscle: 40.2" "Cell line enhanced" "Detected in many" "HEK 293: 8.5;RPTEC TERT1: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA044540: " "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavourable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavourable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favourable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 2.4 2.1 3.7 1.2 6.3 0.7 4.1 7.2 8.1 2.2 5.5 1.2 2.4 1.2 3.0 3.2 6.3 3.5 2.6 39.1 4.2 2.9 14.5 1.4 2.0 0.8 2.4 6.2 2.5 2.6 10.4 2.6 1.2 5.0 4.6 2.2 6.0 4.5 3.5 40.2 1.4 2.1 7.2 1.9 1.9 3.2 1.7 0.8 0.0 4.0 12.3 0.8 4.4 2.1 0.2 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.7 2.0 0.0 0.7 0.5 2.3 1.8 1.4 2.5 4.3 3.8 4.7 0.0 0.6 0.6 0.0 7.8 0.0 7.1 0.0 8.5 0.0 6.9 5.2 0.0 0.0 0.1 0.6 0.0 3.5 0.3 0.8 0.0 0.0 1.0 0.1 0.0 0.0 5.5 5.4 0.0 0.0 0.0 14.0 1.2 2.0 5.4 5.7 0.1 0.0 3.2 0.0 0.0 1.5 2.3 2.7 6.3 0.0 0.0 0.0 4.5 0.0 1.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.7 6.3 7.2 8.1 4.2 2.9 2.4 6.2 5.0 0.8 PRKAB1 ENSG00000111725 "Protein kinase AMP-activated non-catalytic subunit beta 1" Q9Y478 12 119667753-119681630 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004247, CAB005058" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005058: AB_562038, HPA004247: AB_1078149" "unprognostic (1.20e-1)" "unprognostic (3.08e-2)" "unprognostic (7.42e-2)" "prognostic favourable (8.66e-4)" "unprognostic (2.33e-1)" "unprognostic (2.89e-2)" "unprognostic (8.97e-3)" "unprognostic (1.46e-2)" "unprognostic (6.26e-2)" "unprognostic (3.63e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "prognostic favourable (5.40e-9)" "unprognostic (5.60e-2)" "unprognostic (2.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.32e-2)" 16.3 17.2 8.1 16.6 11.9 23.4 13.8 12.5 20.7 16.8 22.8 14.6 6.7 20.4 13.6 13.2 17.9 11.6 19.3 9.2 8.3 7.2 40.1 12.3 21.4 20.6 8.9 9.8 14.2 21.7 11.7 10.8 19.1 11.1 9.7 22.7 20.6 15.3 10.7 12.0 10.6 23.9 12.5 10.5 20.7 25.0 33.4 8.3 20.0 17.5 9.4 16.6 16.3 10.6 26.4 17.4 38.8 19.9 22.1 20.9 18.3 4.7 12.8 10.1 9.6 8.7 7.5 13.4 7.7 10.0 12.5 9.6 13.4 10.8 15.9 10.2 10.5 6.7 10.2 15.9 11.6 10.1 9.4 24.9 5.6 19.4 15.7 11.5 31.6 11.3 13.5 11.4 15.3 9.3 37.9 6.2 9.7 13.1 26.0 12.9 14.3 14.3 15.1 8.7 9.2 14.3 15.1 8.1 13.8 10.2 3.9 10.5 12.5 15.1 11.0 7.7 8.2 5.9 7.7 20.0 17.5 11.8 7.6 7.8 11.0 24.8 16.4 38.8 17.2 18.4 20.9 26.4 18.3 18.3 17.4 21.7 19.9 18.6 19.1 22.1 19.9 15.4 19.7 18.3 8.1 11.9 12.5 20.7 8.3 7.2 8.9 9.8 11.1 8.3 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49019197 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA077805: " "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavourable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favourable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 23.8 30.3 18.5 13.6 18.6 22.6 25.5 14.2 27.0 19.2 18.8 19.6 18.0 13.3 16.0 23.9 26.8 14.1 14.2 39.4 15.2 18.2 27.1 30.8 13.9 14.9 19.7 18.4 18.9 19.6 19.2 22.2 18.9 22.1 19.1 17.0 20.3 18.4 21.0 58.4 21.7 19.8 20.4 15.9 18.7 17.4 19.2 10.7 22.5 22.5 24.9 23.0 23.2 15.7 29.2 41.0 44.0 35.9 40.1 36.9 37.9 21.5 13.4 15.3 24.1 39.2 40.2 8.7 23.7 31.2 24.3 15.6 13.2 19.3 13.9 21.4 27.3 18.9 11.1 30.6 23.5 15.9 18.3 18.9 20.8 10.5 32.5 25.0 14.9 31.6 24.1 17.6 37.1 23.3 14.3 20.0 32.5 13.9 10.3 9.5 9.4 28.2 5.8 13.5 17.6 32.5 18.2 12.8 16.3 16.8 31.0 36.0 37.8 14.0 21.6 11.4 15.4 26.0 17.9 32.9 32.1 9.3 27.7 18.0 10.3 41.1 35.9 33.6 31.5 34.2 30.3 29.2 28.4 29.4 41.0 26.4 25.9 26.8 44.0 40.1 33.0 27.6 36.9 37.9 18.5 18.6 14.2 27.0 15.2 18.2 19.7 18.4 22.1 10.7 PRKCA PKCA ENSG00000154229 "Protein kinase C alpha" P17252 17 66302636-66810743 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003844, HPA006563, HPA006564, CAB016290" Enhanced Approved Enhanced "Plasma membrane,Cytosol" 1900000 Cytosol "Plasma membrane" "CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625" "unprognostic (3.06e-1)" "unprognostic (3.56e-2)" "unprognostic (1.38e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (7.41e-3)" "unprognostic (7.43e-2)" "unprognostic (6.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.35e-3)" "unprognostic (8.77e-2)" 4.0 19.6 26.5 9.0 22.8 2.5 3.0 10.8 33.9 7.0 13.8 19.0 3.5 14.6 14.8 6.7 4.7 6.1 10.8 5.8 31.6 15.6 16.7 6.5 6.0 8.4 18.7 15.6 20.4 5.5 1.7 6.0 6.5 17.6 17.2 11.2 7.0 3.1 22.3 6.6 3.8 12.7 13.7 15.0 7.9 7.9 3.7 14.4 0.4 4.5 1.3 5.9 9.5 9.5 0.0 1.4 0.1 2.7 0.1 4.0 1.0 2.3 12.3 2.5 2.6 6.2 15.9 0.3 13.3 8.7 9.6 8.2 1.4 1.5 3.1 3.6 21.4 0.3 1.3 1.5 20.9 5.1 3.0 0.0 7.3 6.4 8.5 3.8 20.9 6.9 0.6 12.0 10.3 8.2 8.0 0.0 14.8 0.7 7.7 2.3 1.0 6.6 1.4 18.8 0.0 3.4 2.0 1.5 8.5 4.4 2.5 0.1 0.3 5.4 24.5 16.7 9.7 10.4 8.3 0.0 0.0 0.3 53.0 0.0 8.2 0.1 0.6 0.0 0.5 0.8 1.5 0.0 2.5 1.2 1.1 0.0 4.0 2.3 0.0 0.1 2.7 1.4 0.5 1.0 26.5 22.8 10.8 28.2 31.6 15.6 18.7 15.6 17.6 14.4 PRKCB "PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835946-24220611 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in some" "HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol 3400000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: , HPA054203: " "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.0 1.9 13.9 20.8 55.6 20.4 1.8 14.1 57.2 4.1 4.7 4.4 0.6 4.9 3.5 1.2 3.2 2.6 3.9 1.5 23.4 7.8 1.8 3.7 5.4 31.0 11.0 20.4 1.2 1.4 0.9 1.4 2.5 8.3 6.2 4.4 3.5 1.9 8.4 1.2 4.6 9.1 5.8 7.3 31.2 3.8 6.4 6.4 24.1 3.9 0.0 27.7 7.6 1.7 23.6 18.5 21.8 14.6 20.1 19.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.8 40.8 1.9 0.0 0.0 5.9 40.9 0.0 0.1 0.0 0.0 0.0 58.1 0.1 0.0 0.0 12.9 12.9 0.3 0.0 12.3 0.1 2.3 0.1 3.6 7.1 0.0 0.0 0.0 0.6 0.0 18.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 16.4 0.0 17.5 7.6 14.4 14.5 10.7 6.7 23.6 9.5 17.2 6.2 22.1 7.8 19.0 21.8 20.1 14.6 18.5 6.7 7.5 13.9 55.6 14.1 57.2 23.4 7.8 11.0 20.4 8.3 6.4 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 63.3;THP-1: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5" "Group enriched" "Detected in all" 7 "dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9" "Group enriched" "Detected in many" 5 "basal ganglia: 124.2;thalamus: 366.1" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" 300000 Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavourable (2.24e-4)" "prognostic favourable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 27.8 33.4 9.4 29.7 11.5 30.3 17.6 5.7 10.7 10.3 27.8 10.1 43.7 21.4 5.5 21.3 18.3 16.1 33.7 11.9 8.3 3.7 16.5 4.5 29.2 24.5 10.2 5.6 8.1 13.4 6.1 5.1 7.5 7.1 17.9 16.1 10.3 14.1 40.7 3.9 17.1 42.9 17.4 10.2 32.1 24.8 9.6 8.0 10.5 26.9 13.4 26.3 22.9 12.7 3.1 17.6 20.7 22.9 2.4 1.5 6.4 7.7 3.0 1.2 2.0 9.0 5.2 11.2 4.7 5.9 5.8 5.7 7.3 7.6 20.0 2.1 10.2 3.5 7.9 11.5 4.7 17.4 6.0 11.1 4.1 7.8 5.7 14.6 25.1 4.1 8.4 5.9 5.5 5.0 2.2 2.9 8.3 19.1 1.6 24.9 3.1 5.5 1.7 3.0 4.7 6.3 16.7 2.0 1.4 3.6 63.3 9.7 5.3 45.2 7.2 2.8 3.6 3.7 4.4 4.4 6.8 10.2 6.7 25.2 5.4 17.7 22.9 17.0 1.5 22.2 1.0 3.1 1.1 1.2 17.6 2.9 0.8 0.7 20.7 2.4 15.3 8.5 1.1 6.4 9.4 11.5 5.7 10.7 8.3 3.7 10.2 5.6 7.1 8.0 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.9;HUVEC TERT2: 39.2;MOLT-4: 26.0;RT4: 16.5;TIME: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6" "Group enriched" "Detected in many" 14 "NK-cells: 27.3;T-cells: 35.3" "Group enriched" "Detected in many" 6 "basal ganglia: 25.0;thalamus: 19.5" "Low region specificity" "Detected in many" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: " "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favourable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 17.5 5.4 5.0 21.6 22.0 11.2 14.7 2.8 6.1 13.6 10.3 6.2 6.9 5.1 19.1 7.0 20.1 8.6 12.7 10.1 6.8 4.4 8.1 5.5 24.1 27.6 5.9 2.5 7.1 5.9 8.8 15.5 22.7 7.2 9.8 5.0 9.1 24.7 10.8 9.1 15.9 16.0 10.5 5.7 25.9 6.0 4.3 6.4 54.6 15.1 10.6 34.6 13.2 14.4 0.4 2.2 1.5 0.7 27.3 35.3 17.9 6.2 2.2 0.3 1.7 1.0 0.2 29.9 0.1 0.5 0.3 0.3 0.6 3.7 0.1 4.5 0.0 4.4 0.2 4.8 0.5 0.7 2.8 0.0 0.7 0.2 0.4 0.0 0.9 0.8 5.0 0.2 3.4 39.2 0.0 0.1 2.2 11.5 26.0 0.2 0.5 3.0 2.2 1.1 0.0 0.0 16.5 1.1 1.9 0.7 5.8 3.6 5.7 0.5 25.7 0.7 5.2 0.7 0.3 0.5 0.1 0.2 1.1 0.3 1.2 0.1 0.7 0.5 30.0 0.4 23.9 0.4 23.0 35.3 2.2 0.3 28.5 27.6 1.5 27.3 0.2 0.7 18.6 17.9 5.0 22.0 2.8 6.1 6.8 4.4 5.9 2.5 7.2 6.4 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222365-170305981 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: " "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavourable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favourable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 10.3 7.5 11.4 5.9 15.5 2.1 9.5 14.8 16.6 12.5 11.1 7.0 6.0 10.4 13.1 8.4 20.6 15.1 10.5 10.1 9.5 7.7 13.0 6.7 14.8 3.9 5.6 9.4 15.2 7.7 12.4 14.7 9.8 11.0 16.3 12.2 7.3 25.8 12.6 12.7 11.0 11.6 12.5 6.8 6.1 30.2 15.0 5.3 12.6 23.1 8.4 9.9 16.3 13.0 1.9 1.8 1.0 1.3 5.8 4.8 1.4 35.9 9.1 9.2 9.8 8.2 11.4 14.9 9.2 13.7 12.3 13.3 13.3 17.6 11.0 30.5 13.0 16.9 17.3 18.1 21.1 8.0 10.7 10.2 11.6 7.4 13.0 9.2 4.6 10.2 12.7 10.4 16.5 9.5 11.2 9.1 12.3 12.4 13.3 3.6 19.3 10.2 9.6 14.2 18.2 19.3 11.0 14.6 11.9 20.0 26.3 9.0 28.9 6.3 10.1 12.8 9.9 11.9 15.2 15.7 15.1 15.7 9.2 7.2 5.0 0.1 1.3 1.0 2.6 1.2 4.0 1.8 3.6 4.8 1.8 1.9 3.9 2.2 0.7 5.8 1.1 1.8 2.3 1.4 11.4 15.5 14.8 16.6 9.5 7.7 5.6 9.4 11.0 5.3 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Cell line enhanced" "Detected in many" "BEWO: 23.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favourable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.5 4.8 1.7 8.9 0.0 0.0 23.5 0.5 0.2 5.6 0.3 12.1 16.4 0.0 14.9 1.9 13.2 10.1 12.5 4.0 0.5 11.2 0.0 7.7 16.1 1.6 0.0 5.8 0.3 7.5 0.0 4.3 0.0 3.3 0.1 0.1 9.2 0.4 0.0 3.4 11.7 0.0 0.0 2.6 9.6 7.9 12.3 9.9 6.1 13.7 2.6 9.6 2.0 0.0 0.0 7.1 0.1 0.0 3.5 0.6 0.1 0.6 0.1 8.5 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 PRKD1 "PKC-mu, PKCM, PKD, PRKCM" ENSG00000184304 "Protein kinase D1" Q15139 14 29576479-30191898 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018367, HPA029834" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB018367: AB_2253119, HPA029834: AB_10602821" "unprognostic (5.35e-2)" "unprognostic (3.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.70e-2)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-3)" "unprognostic (8.88e-2)" "unprognostic (2.37e-2)" "unprognostic (5.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.56e-1)" "prognostic favourable (2.44e-5)" "unprognostic (9.45e-4)" "unprognostic (1.99e-1)" "prognostic unfavourable (2.91e-4)" "unprognostic (3.89e-1)" 7.4 10.6 8.0 5.3 9.7 0.7 19.0 4.9 8.9 5.1 8.7 5.1 24.1 3.1 8.3 9.0 3.5 6.8 9.0 6.3 9.8 5.9 15.1 2.3 14.9 1.6 5.6 6.6 15.7 7.3 35.7 9.2 4.5 10.8 20.1 3.5 4.9 3.5 24.4 3.1 2.7 3.5 19.7 16.4 2.4 4.8 16.1 8.6 0.5 8.2 2.9 1.8 14.1 12.2 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.6 4.0 17.8 16.7 0.1 12.1 9.3 12.4 6.7 0.0 0.5 0.0 1.2 19.0 0.1 5.9 1.4 6.8 0.0 4.1 0.0 0.1 0.4 9.0 0.0 0.1 17.7 0.6 0.8 1.4 2.5 1.2 0.4 11.6 1.3 0.0 0.0 2.5 6.2 0.0 7.0 3.2 13.2 5.6 3.6 7.1 2.1 0.0 4.7 0.0 0.1 6.3 11.7 4.8 1.0 3.5 0.0 0.0 0.0 3.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 8.0 9.7 4.9 8.9 9.8 5.9 5.6 6.6 10.8 8.6 PRKD2 "DKFZP586E0820, HSPC187, PKD2" ENSG00000105287 "Protein kinase D2" Q9BZL6 19 46674275-46717127 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Cell adhesion, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021490, HPA056727" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021490: AB_1855708, HPA056727: AB_2683217" "unprognostic (3.01e-2)" "unprognostic (1.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.06e-2)" "unprognostic (8.91e-2)" "unprognostic (1.99e-2)" "unprognostic (8.79e-3)" "unprognostic (2.61e-1)" "unprognostic (6.22e-2)" "unprognostic (4.21e-3)" "unprognostic (8.89e-2)" "unprognostic (2.74e-1)" "unprognostic (3.45e-3)" "unprognostic (1.04e-2)" "unprognostic (7.19e-2)" "unprognostic (4.34e-2)" "prognostic favourable (9.15e-4)" 17.1 7.6 7.0 25.8 6.5 18.1 18.0 2.5 6.8 16.8 13.7 5.8 18.7 13.7 14.8 16.5 23.4 15.6 17.4 7.4 6.3 3.1 13.2 9.1 21.3 24.8 7.5 2.7 17.0 12.5 10.3 17.2 20.1 6.6 14.8 7.7 11.9 15.6 21.5 7.5 26.8 19.8 11.7 6.8 34.8 15.2 6.6 7.2 41.5 18.7 10.5 33.0 17.4 37.5 6.6 0.4 7.3 1.0 2.9 6.1 1.9 8.6 13.4 5.3 6.5 4.4 3.6 6.8 4.5 7.1 9.4 10.3 7.4 8.5 10.1 7.9 6.0 12.9 4.7 12.0 2.9 8.6 7.0 10.6 4.2 3.9 5.8 7.7 15.7 4.3 5.8 5.4 4.6 16.5 6.8 14.6 3.9 9.1 14.8 25.0 4.5 6.8 9.7 2.5 16.3 5.8 12.9 3.4 10.8 8.4 7.0 1.8 5.6 3.1 7.8 4.0 8.0 3.4 3.6 14.3 56.9 5.0 4.2 6.4 4.2 0.9 1.0 3.4 5.6 0.9 4.9 6.1 5.7 6.1 0.4 6.6 5.1 4.9 7.3 2.9 0.7 0.0 4.0 1.9 7.0 6.5 2.5 6.8 6.3 3.1 7.5 2.7 6.6 7.2 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324808 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favourable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 16.1 22.1 9.5 20.7 10.7 5.3 35.1 4.8 9.2 17.2 18.0 7.2 7.2 6.0 19.2 16.0 9.8 11.3 10.0 11.6 12.7 6.1 9.9 8.4 20.4 22.3 11.4 3.7 15.0 7.6 12.9 20.7 11.1 10.3 14.4 8.3 27.8 11.1 13.3 19.1 11.5 12.1 16.5 15.4 22.0 10.5 16.8 10.8 16.2 11.8 9.3 21.2 12.4 17.7 16.4 8.2 5.7 8.3 6.3 11.5 3.4 12.6 5.4 14.3 11.8 10.9 18.4 10.5 8.2 15.3 9.3 9.5 8.6 4.5 18.6 6.9 12.3 5.0 9.7 10.1 12.6 24.0 14.2 12.2 8.3 5.8 4.5 8.7 7.5 8.6 5.2 14.7 9.7 16.5 10.2 22.9 10.8 2.1 3.8 6.8 15.1 5.2 12.8 22.6 15.9 6.2 14.3 10.8 28.0 7.9 4.5 48.2 4.9 8.0 15.9 26.7 13.9 10.6 9.2 26.2 48.5 21.7 9.3 3.7 16.0 5.7 8.3 5.5 10.5 6.6 9.1 12.4 8.8 8.4 7.8 16.4 10.4 11.5 1.5 6.3 3.3 8.2 4.1 3.4 9.5 10.7 4.8 9.2 12.7 6.1 11.4 3.7 10.3 10.8 PRKG1 "PGK, PKG, PRKG1B, PRKGR1B" ENSG00000185532 "Protein kinase, cGMP-dependent, type I" Q13976 10 50990891-52298350 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "basophil: 8.0" "Lineage enriched" "Detected in single" 24 "granulocytes: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007699, CAB009629" Enhanced Approved Vesicles,Cytosol 33000 "Vesicles, Cytosol" "CAB009629: AB_2170663, HPA007699: AB_1079677" "unprognostic (3.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.44e-2)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (5.54e-1)" "unprognostic (2.23e-1)" "unprognostic (4.94e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (3.40e-1)" "unprognostic (9.26e-2)" "unprognostic (5.50e-3)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (3.78e-4)" 8.0 10.9 5.2 6.6 7.3 0.8 6.9 2.8 5.4 19.2 14.4 2.1 6.8 2.9 22.8 10.7 6.0 9.9 12.6 14.8 7.0 4.9 4.4 2.1 19.5 2.6 3.1 4.8 8.9 2.6 13.7 8.4 11.0 4.6 9.5 6.2 6.2 6.4 9.4 24.9 2.8 5.3 28.2 2.7 2.7 5.9 5.0 3.1 0.2 9.2 12.7 1.2 13.4 15.8 0.1 0.1 8.0 0.1 0.3 0.0 0.1 0.0 0.1 1.4 11.3 5.4 5.2 0.0 4.9 15.5 1.6 2.3 0.1 0.7 0.2 0.0 12.9 0.1 0.0 0.0 1.4 0.0 4.2 0.8 0.3 0.0 4.7 0.0 0.0 6.6 0.0 4.1 0.1 0.0 0.0 0.1 4.3 0.1 0.0 0.0 3.2 1.9 0.0 3.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.1 0.0 0.0 9.5 1.7 4.8 2.9 1.2 0.5 0.0 8.4 0.0 2.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.1 5.2 7.3 2.8 5.4 7.0 4.9 3.1 4.8 4.6 3.1 PRKN "AR-JP, PARK2, parkin, PDJ" ENSG00000185345 "Parkin RBR E3 ubiquitin protein ligase" O60260 6 161347420-162727771 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.8" "Cell line enhanced" "Detected in some" "AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016257, HPA036012" Enhanced Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB016257: AB_628104, HPA036012: " "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.69e-3)" "unprognostic (9.85e-2)" "unprognostic (5.85e-2)" "unprognostic (7.07e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-3)" "unprognostic (8.16e-2)" "prognostic favourable (6.75e-12)" "unprognostic (9.93e-2)" "unprognostic (1.51e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-1)" 6.8 7.1 7.9 2.3 12.2 1.5 4.2 7.2 13.4 5.3 4.3 6.3 4.6 2.8 7.8 4.4 6.1 3.4 4.3 17.7 9.2 6.2 17.4 3.6 2.6 3.0 5.8 5.2 6.4 3.0 5.6 8.6 2.0 5.5 4.0 2.4 8.3 3.5 4.8 41.8 4.0 3.3 6.6 5.9 2.7 3.5 10.3 6.8 0.6 3.8 4.7 2.7 4.9 2.1 4.6 1.2 4.2 0.8 1.8 4.6 1.3 0.0 0.3 1.2 3.6 0.9 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 0.0 0.2 0.2 0.0 0.4 0.6 9.0 0.2 0.0 0.8 0.2 0.1 3.1 0.1 0.0 0.5 0.0 0.4 5.7 0.9 0.5 0.1 0.1 0.2 0.8 0.0 0.0 5.7 0.6 0.1 0.9 2.5 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.3 0.1 0.3 0.8 0.1 0.0 0.1 0.1 2.2 2.8 0.8 4.2 2.1 0.5 3.5 1.5 2.0 2.2 1.2 4.6 4.4 4.6 1.5 1.8 0.4 0.3 0.2 1.3 7.9 12.2 7.2 11.7 9.2 6.2 5.8 5.2 5.5 6.8 PRKRA "DYT16, HSD14, PACT, RAX" ENSG00000180228 "Protein activator of interferon induced protein kinase EIF2AK2" O75569 2 178431414-178451512 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, RNA-mediated gene silencing" RNA-binding "Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004648, HPA034996, HPA034997" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (5.38e-2)" "unprognostic (4.02e-3)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (8.33e-5)" "unprognostic (9.66e-2)" "unprognostic (7.10e-3)" "unprognostic (2.32e-3)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-3)" "unprognostic (8.99e-2)" "prognostic favourable (5.45e-4)" "unprognostic (1.38e-1)" "unprognostic (6.78e-2)" 15.7 14.5 18.3 11.3 20.3 13.0 31.2 17.1 30.9 15.7 18.7 16.9 10.8 11.0 18.0 19.4 16.6 13.9 13.1 22.2 17.4 17.5 18.0 14.5 13.7 12.1 18.3 17.2 14.9 19.8 17.4 21.5 8.7 18.8 17.4 14.8 13.2 13.8 18.1 55.3 18.2 10.9 33.1 20.2 9.4 15.2 23.5 15.7 13.8 16.7 14.8 14.1 18.5 17.7 19.4 29.2 13.5 13.9 13.5 20.1 16.4 10.8 8.3 24.6 12.0 22.7 26.0 19.3 16.8 16.3 21.1 23.1 23.1 15.6 22.2 19.0 19.1 10.2 19.2 13.2 23.6 19.8 12.5 13.6 10.0 22.0 26.4 10.7 7.6 15.0 30.4 19.8 22.2 20.0 12.5 19.0 28.5 11.3 21.0 27.5 22.3 16.8 18.5 41.2 22.4 23.7 12.4 15.4 19.3 10.9 10.6 21.7 14.8 14.0 11.6 17.7 20.1 16.1 13.9 26.2 16.3 27.0 20.5 16.4 10.4 3.1 13.9 13.5 11.0 13.5 15.9 19.4 17.2 13.4 19.9 15.3 19.5 15.9 3.7 13.5 13.2 29.2 20.1 16.4 18.3 20.3 17.1 30.9 17.4 17.5 18.3 17.2 18.8 15.7 PRKRIP1 "C114, FLJ13902, KRBOX3" ENSG00000128563 "PRKR interacting protein 1" Q9H875 7 102363872-102426676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051146 Uncertain Supported "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA051146: " "unprognostic (4.78e-3)" "unprognostic (7.23e-3)" "prognostic unfavourable (3.65e-4)" "unprognostic (8.25e-2)" "unprognostic (2.99e-3)" "unprognostic (3.15e-2)" "unprognostic (1.99e-2)" "unprognostic (4.38e-3)" "unprognostic (1.57e-3)" "unprognostic (1.50e-2)" "unprognostic (2.61e-3)" "unprognostic (9.79e-3)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (4.88e-1)" "prognostic favourable (1.94e-4)" 14.9 19.3 20.1 21.1 22.6 31.0 15.2 28.0 23.0 15.9 14.0 19.2 24.2 14.9 17.6 20.4 15.0 16.2 13.9 16.5 19.0 21.2 16.7 12.3 14.6 22.4 19.1 20.3 18.9 17.0 26.6 18.9 18.1 17.9 17.7 11.6 17.1 21.5 17.8 20.7 27.0 14.5 16.6 20.1 19.1 14.6 43.7 19.0 15.8 16.8 12.4 19.6 14.1 14.4 15.3 18.5 21.7 15.7 14.7 15.1 10.7 12.5 8.7 10.8 13.7 6.4 5.6 10.4 9.6 8.1 14.4 13.6 12.0 12.3 11.7 16.5 7.7 11.0 6.9 8.4 9.2 13.4 12.7 5.8 9.6 8.8 9.8 8.8 7.9 5.3 8.9 11.6 8.5 8.1 13.8 26.8 11.1 26.1 22.6 27.3 10.8 8.9 15.0 8.9 18.8 7.8 8.6 8.8 17.5 15.2 21.1 12.9 10.1 11.2 9.1 16.5 16.1 18.6 12.4 23.3 19.1 22.4 12.3 14.0 19.9 5.3 12.7 20.1 13.8 12.4 13.0 15.3 13.1 14.2 8.1 15.1 15.1 14.1 21.7 14.7 15.7 18.5 13.4 10.7 20.1 22.6 28.0 20.8 19.0 21.2 19.1 20.3 17.9 19.0 PRMT2 "HRMT1L1, MGC111373" ENSG00000160310 "Protein arginine methyltransferase 2" P55345 21 46635167-46665124 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018976, HPA029591" Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA018976: AB_1855719, HPA029591: AB_10601250" "unprognostic (1.82e-1)" "unprognostic (2.96e-1)" "unprognostic (8.61e-3)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.58e-2)" "unprognostic (1.29e-3)" "unprognostic (1.34e-1)" "unprognostic (2.23e-1)" "unprognostic (6.78e-2)" "unprognostic (4.34e-3)" "unprognostic (1.72e-1)" "unprognostic (4.62e-3)" "unprognostic (8.76e-3)" "unprognostic (2.86e-2)" "unprognostic (1.91e-3)" "unprognostic (2.23e-1)" 19.9 14.7 37.1 21.8 43.6 18.7 28.4 21.4 37.2 25.5 25.2 35.4 12.0 14.7 24.5 15.9 30.7 27.1 23.4 29.4 37.4 53.1 19.9 8.5 21.7 28.7 44.8 32.2 48.5 15.1 19.9 20.1 26.2 44.9 22.0 17.1 20.6 21.0 28.0 9.5 28.1 20.0 28.5 69.6 25.6 17.4 10.1 40.3 13.8 20.1 7.4 28.3 23.1 26.0 18.9 27.6 64.2 26.1 50.8 60.2 41.6 22.7 19.5 39.5 14.7 28.8 28.2 9.7 21.5 24.2 24.4 22.3 27.4 18.6 13.4 27.3 38.3 6.7 18.4 27.1 14.2 33.4 17.7 34.7 16.5 20.4 13.9 10.3 16.5 17.4 27.0 29.6 21.2 35.2 22.0 25.2 37.3 25.4 14.8 19.4 21.6 23.0 19.1 10.0 8.8 19.0 19.5 28.6 17.8 22.7 10.4 41.0 14.0 10.7 31.8 23.9 16.4 12.6 14.1 6.7 6.1 8.5 21.9 28.1 34.4 44.2 19.6 64.2 60.2 26.0 43.6 18.9 40.5 51.0 27.6 16.7 49.9 56.9 26.3 50.8 26.1 23.8 29.0 41.6 37.1 43.6 21.4 37.2 37.4 53.1 44.8 32.2 44.9 40.3 PRMT5 "HRMT1L5, SKB1, SKB1Hs" ENSG00000100462 "Protein arginine methyltransferase 5" O14744 14 22920511-22929585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005525, CAB012459, HPA064708" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB012459: , HPA005525: AB_1079679, HPA064708: " "unprognostic (8.34e-2)" "unprognostic (5.14e-3)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (4.56e-3)" "prognostic unfavourable (1.82e-4)" "prognostic unfavourable (4.77e-5)" "unprognostic (3.64e-2)" "unprognostic (6.80e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (2.61e-4)" "unprognostic (4.69e-2)" "unprognostic (1.99e-3)" "unprognostic (1.21e-1)" "unprognostic (7.04e-2)" "unprognostic (6.28e-2)" "prognostic unfavourable (1.04e-4)" 17.0 21.6 18.3 17.8 22.8 12.0 21.2 18.4 24.9 20.3 25.0 18.1 24.9 16.1 24.9 19.6 33.1 28.0 16.6 22.3 15.3 13.2 25.7 22.2 15.8 15.6 17.2 15.2 30.2 30.9 30.8 17.4 24.3 15.9 21.1 22.6 16.9 19.0 21.7 42.0 21.7 14.5 22.2 13.4 17.9 19.5 22.1 17.3 22.7 30.9 19.6 22.1 20.8 22.0 17.6 23.8 4.3 17.6 9.8 15.6 15.5 40.0 38.7 28.0 27.7 13.3 15.2 30.5 27.6 20.5 42.9 36.4 35.4 37.3 39.1 22.6 20.3 32.0 55.4 46.4 49.6 25.1 26.8 24.3 26.1 54.4 25.6 51.0 21.2 15.0 24.8 33.2 60.6 20.3 34.4 21.4 22.1 36.2 36.4 22.8 25.0 49.0 43.1 34.0 28.4 20.8 27.5 30.2 19.8 30.1 32.4 14.1 21.8 19.3 19.0 18.2 26.0 25.9 35.1 29.4 62.6 52.0 11.5 24.8 28.4 1.7 16.8 0.2 8.2 17.6 13.4 17.6 11.3 13.5 23.8 15.5 15.6 12.5 4.3 9.8 13.2 14.1 9.4 15.5 18.3 22.8 18.4 24.9 15.3 13.2 17.2 15.2 15.9 17.3 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056679-107059294 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059424: " "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavourable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 6.6 16.1 14.4 10.5 13.4 4.6 10.8 12.6 13.9 8.9 10.3 11.5 10.4 8.1 9.7 11.3 10.9 12.2 9.8 5.0 11.8 16.2 16.7 16.3 5.9 11.5 12.2 14.1 12.3 16.8 15.0 13.8 9.6 13.2 11.8 9.7 12.6 8.3 11.4 2.1 7.6 9.3 8.0 13.6 11.5 9.5 9.4 10.6 18.2 9.5 3.4 11.1 10.1 7.3 9.7 14.7 1.8 10.1 14.6 10.9 7.6 3.5 0.0 7.1 3.1 4.7 5.2 1.9 4.8 3.6 4.7 4.8 4.6 2.5 8.8 6.7 4.4 5.1 6.5 7.1 3.7 0.0 6.9 5.3 10.0 6.6 4.7 10.9 3.3 4.9 3.9 4.2 4.3 4.0 7.1 1.3 4.2 81.7 6.4 3.8 3.0 6.7 8.1 15.5 3.3 11.3 7.3 13.3 16.2 6.5 9.5 3.1 6.6 8.2 4.6 3.5 7.1 7.2 7.1 1.5 1.0 1.5 5.1 5.1 2.8 1.8 8.9 1.6 7.5 10.1 8.4 6.9 7.6 6.8 11.9 9.7 10.9 10.9 0.5 14.6 9.2 14.7 7.8 7.6 14.4 13.4 12.6 13.9 11.8 16.2 12.2 14.1 13.2 10.6 PRMT7 "FLJ10640, KIAA1933" ENSG00000132600 "Protein arginine methyltransferase 7" Q9NVM4 16 68310974-68358563 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044241 Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA044241: " "unprognostic (9.33e-2)" "unprognostic (5.33e-2)" "unprognostic (1.52e-1)" "prognostic favourable (2.31e-5)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (4.12e-2)" "unprognostic (1.22e-1)" "unprognostic (3.74e-1)" "unprognostic (1.19e-1)" "unprognostic (4.74e-3)" "unprognostic (3.09e-2)" "unprognostic (7.72e-2)" "unprognostic (1.75e-1)" "unprognostic (9.23e-2)" "unprognostic (3.57e-1)" "unprognostic (1.31e-1)" 14.8 14.4 15.6 12.7 22.0 11.1 12.9 29.4 20.5 11.4 11.7 20.2 13.9 7.0 18.9 11.9 12.7 18.1 9.3 23.1 14.4 13.1 9.5 12.2 9.7 17.0 11.2 18.7 21.9 14.8 12.0 14.0 11.4 13.3 12.8 7.6 20.8 17.3 16.2 34.0 16.9 9.9 18.5 11.6 12.4 9.9 17.0 13.1 24.4 11.1 12.0 14.9 13.3 10.4 10.8 26.2 9.9 8.5 18.6 18.1 11.5 10.1 16.5 7.8 19.7 7.5 7.1 26.3 10.2 5.5 12.9 10.7 41.6 10.2 21.6 17.1 8.6 13.2 11.1 10.3 7.1 7.7 16.7 6.4 18.5 18.8 5.5 11.8 10.0 7.8 4.4 10.6 10.0 7.7 15.1 1.2 7.0 17.0 14.5 18.2 12.9 11.2 19.5 11.5 14.6 6.0 9.3 10.8 8.4 34.0 8.6 6.9 14.3 11.7 9.2 9.2 8.1 10.9 9.0 6.6 12.3 22.1 11.6 12.6 9.4 9.9 7.0 5.9 15.8 8.5 18.1 10.1 10.6 13.9 10.2 10.8 16.1 14.1 0.8 18.6 7.7 26.2 11.7 11.5 15.6 22.0 29.4 20.5 14.4 13.1 11.2 18.7 13.3 13.1 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684230 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: " "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favourable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 6.0 17.2 6.0 5.2 8.6 12.4 6.9 8.0 8.9 5.6 4.5 4.2 7.9 2.5 8.6 7.6 5.0 7.5 8.4 6.5 5.6 5.0 7.5 5.8 7.6 5.3 5.8 5.3 22.6 7.2 16.3 10.0 5.0 7.1 6.0 4.5 9.8 5.8 11.3 6.7 5.6 4.3 6.1 4.6 4.5 5.9 11.2 3.9 11.6 15.8 2.8 5.4 5.5 5.2 9.6 6.0 10.8 6.1 5.1 10.4 2.7 3.5 2.3 5.6 4.3 4.4 7.4 4.9 3.9 6.2 5.9 6.3 1.8 3.9 12.1 1.8 3.3 2.4 6.5 3.3 8.2 4.4 3.8 6.7 4.4 3.0 3.3 9.7 3.7 5.1 3.5 3.6 3.2 4.9 6.5 7.0 5.0 2.0 8.2 3.8 2.9 4.2 5.6 4.8 4.4 4.8 2.8 3.5 5.3 6.2 4.9 3.2 2.1 2.1 4.2 3.8 3.1 4.2 4.2 8.0 6.4 7.9 4.3 6.0 2.8 7.4 6.0 10.8 6.7 6.1 6.5 9.5 8.1 8.2 4.0 9.6 10.4 9.0 4.2 5.1 4.4 6.0 6.8 2.7 6.0 8.6 8.0 8.9 5.6 5.0 5.8 5.3 7.1 3.9 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: " "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.96e-4)" "prognostic unfavourable (4.64e-4)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavourable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.2 20.0 4.6 7.1 37.3 22.8 4.1 40.2 57.9 19.5 19.9 6.6 18.8 4.4 9.3 78.3 56.5 5.0 54.7 36.6 3.6 4.3 0.0 2.3 20.6 45.9 7.9 1.8 20.6 78.9 83.4 65.2 16.7 2.3 15.8 22.4 5.4 3.1 4.8 3.7 29.8 3.8 12.2 4.0 9.8 4.3 5.4 0.8 11.4 16.0 57.1 3.3 4.1 25.1 31.8 14.6 17.7 32.6 7.3 14.7 14.8 25.6 5.8 114.4 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Cell line enriched" "Detected in some" 18 "Hep G2: 25.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051287: " "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 23.2;CAPAN-2: 41.1;HaCaT: 22.2;hTCEpi: 24.1;MCF7: 18.2;RT4: 25.0;SK-BR-3: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: " "prognostic unfavourable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.2 0.0 0.0 0.2 0.1 0.0 11.8 0.0 0.0 0.1 0.1 0.2 41.1 0.0 0.0 0.0 22.2 0.0 12.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 25.0 0.2 0.0 0.0 35.9 0.0 11.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 PROSER1 "bA50D16.2, C13orf23, FLJ12661" ENSG00000120685 "Proline and serine rich 1" Q86XN7 13 39009866-39038076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034225, HPA055687" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB034225: AB_1564157, HPA055687: " "unprognostic (6.75e-3)" "unprognostic (9.56e-3)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (7.06e-2)" "unprognostic (2.92e-2)" "unprognostic (3.73e-3)" "unprognostic (5.98e-2)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-1)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (9.31e-3)" "unprognostic (2.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.95e-1)" 10.8 9.9 10.6 12.8 13.3 26.8 11.3 22.6 14.3 8.5 13.7 17.4 9.6 12.9 11.9 11.8 14.5 9.2 8.0 8.8 10.7 6.9 12.6 11.3 15.0 15.2 14.8 9.0 10.0 19.0 7.0 19.5 35.4 12.2 13.4 17.3 11.0 17.9 8.3 11.8 18.5 15.0 9.9 16.3 16.6 12.8 19.0 15.0 26.1 14.3 8.2 17.3 10.8 11.2 4.1 4.8 6.0 4.4 7.5 6.4 4.2 7.1 5.6 17.6 12.1 6.0 4.8 27.9 6.8 6.0 6.9 7.4 17.7 11.3 16.8 5.5 6.6 12.5 18.8 12.2 11.3 25.4 15.4 24.8 6.1 12.2 13.8 25.8 15.3 6.4 14.8 10.9 24.9 11.2 12.2 10.2 7.3 12.5 15.6 13.8 26.2 6.1 16.5 18.6 10.6 6.9 11.3 9.9 11.4 4.8 12.5 10.1 13.5 14.9 10.2 4.0 6.5 7.8 8.6 9.6 9.8 18.3 6.5 14.4 7.8 6.0 3.4 0.6 5.7 3.2 6.4 4.1 5.5 6.1 4.1 3.1 4.9 5.3 0.9 7.5 4.4 4.8 3.0 4.2 10.6 13.3 22.6 14.3 10.7 6.9 14.8 9.0 12.2 15.0 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell line enhanced" "Detected in many" "A-431: 32.3;CAPAN-2: 38.7;HBEC3-KT: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.3 4.6 0.2 0.1 1.0 1.2 1.9 1.4 0.7 1.1 0.6 10.7 38.7 0.0 6.0 0.1 8.5 3.3 24.7 0.6 0.0 7.9 3.7 2.0 6.8 5.8 0.0 2.3 1.4 5.4 7.0 8.0 3.6 5.5 0.0 1.6 4.4 0.0 1.2 2.0 2.6 5.2 4.2 0.0 2.6 1.6 0.0 0.4 2.4 9.8 4.1 5.1 2.0 2.4 0.0 7.9 12.9 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell line enhanced" "Detected in some" "Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA000842, HPA001030" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000842: , HPA001030: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.3 0.0 15.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.8 2.7 0.0 0.2 0.0 0.2 0.0 0.8 0.7 0.0 8.3 1.2 0.1 0.2 1.2 40.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 PRPF18 hPrp18 ENSG00000165630 "Pre-mRNA processing factor 18" Q99633 10 13586927-13630868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA037599, HPA047950" Supported Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA037599: AB_10795137, HPA047950: " "unprognostic (5.82e-2)" "unprognostic (7.86e-3)" "unprognostic (4.07e-2)" "unprognostic (1.20e-2)" "unprognostic (3.00e-2)" "unprognostic (6.36e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (6.12e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-3)" "unprognostic (2.82e-2)" "unprognostic (2.20e-1)" "unprognostic (8.09e-2)" "unprognostic (1.63e-1)" 21.7 20.4 22.8 21.1 21.3 40.5 22.6 29.3 22.9 18.5 18.5 15.9 25.3 18.3 20.8 32.1 20.7 15.6 17.1 19.5 17.1 14.8 22.8 23.5 17.9 17.9 17.2 21.4 18.4 19.8 20.1 40.8 20.2 21.6 16.4 20.5 9.8 22.3 28.5 34.1 20.9 20.1 20.9 21.9 17.4 18.6 19.4 22.0 25.6 26.2 16.0 20.7 18.0 21.9 20.0 19.9 30.3 25.0 27.0 25.8 11.6 16.5 12.4 11.0 9.5 15.5 15.2 13.9 19.4 9.7 21.3 20.5 11.8 25.5 13.9 10.9 17.7 13.8 14.6 16.0 24.7 20.4 14.6 16.3 10.6 9.2 18.6 12.7 19.5 11.7 26.1 18.5 9.0 20.6 16.7 18.8 19.3 17.1 23.5 8.7 10.4 6.2 16.9 13.5 17.2 14.0 7.1 7.8 19.4 15.2 11.0 16.4 17.0 20.8 17.4 13.3 15.6 21.4 14.5 18.5 19.7 19.9 19.6 16.0 9.0 16.9 20.4 25.9 21.6 18.1 18.6 20.0 19.7 18.5 19.9 18.2 21.0 25.8 30.3 27.0 25.0 17.4 23.6 11.6 22.8 21.3 29.3 22.9 17.1 14.8 17.2 21.4 21.6 22.0 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 6.2 12.3 16.6 5.8 12.6 1.5 9.7 15.6 20.3 12.8 8.8 11.7 13.2 5.5 14.7 13.8 8.5 15.2 8.3 16.3 12.6 10.6 12.9 5.5 6.6 4.1 13.3 14.5 22.0 10.3 30.3 17.5 11.8 12.0 11.0 4.9 10.4 14.2 17.9 22.3 13.1 4.7 10.4 9.6 7.3 8.9 25.1 12.9 2.3 19.4 5.5 5.2 9.9 9.1 1.8 1.5 0.0 0.4 3.1 3.5 0.8 5.1 7.5 7.6 7.4 6.3 4.1 7.0 4.2 5.9 4.5 2.3 8.7 11.5 4.1 9.0 5.5 3.0 4.6 14.6 2.3 3.0 1.8 4.3 2.8 3.1 8.0 1.4 5.8 5.8 12.4 4.5 16.4 3.5 2.1 2.2 5.4 4.8 1.0 2.9 3.2 2.8 3.6 1.2 3.3 9.5 4.7 8.1 9.8 3.4 9.5 5.1 18.0 4.0 1.5 2.8 11.3 3.6 1.8 5.3 3.0 1.6 8.4 1.1 2.5 0.0 0.4 0.0 2.4 0.3 3.5 1.1 2.3 1.1 0.6 1.8 2.7 2.9 0.0 3.1 0.2 1.5 1.0 0.8 16.6 12.6 15.6 20.3 12.6 10.6 13.3 14.5 12.0 12.9 PRPSAP2 PAP41 ENSG00000141127 "Phosphoribosyl pyrophosphate synthetase associated protein 2" O60256 17 18840085-18931287 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021881 Approved Approved Nucleoplasm,Cytosol 28000 "Nucleoplasm, Cytosol" "HPA021881: AB_1855782" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.78e-2)" "unprognostic (1.18e-1)" "unprognostic (2.01e-2)" "unprognostic (1.90e-1)" "unprognostic (3.25e-2)" "unprognostic (9.82e-2)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.71e-4)" "unprognostic (4.57e-2)" "unprognostic (8.98e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-1)" "unprognostic (9.08e-2)" 9.5 15.5 18.9 22.7 20.0 16.0 12.7 42.9 23.0 13.6 16.1 27.2 13.7 19.0 16.3 14.6 15.9 16.6 16.6 13.9 20.5 22.0 22.9 16.2 13.7 35.9 23.6 19.4 20.9 16.2 18.5 24.9 10.4 20.2 13.1 19.1 16.2 13.4 13.6 9.8 15.3 16.4 13.5 35.0 14.8 17.0 22.7 22.6 28.1 20.5 10.3 41.1 12.7 13.5 26.0 18.9 17.0 14.7 21.4 29.9 16.7 15.9 17.5 25.5 18.3 11.2 7.1 26.2 12.0 9.4 15.7 14.8 22.0 7.6 40.7 12.4 10.3 19.5 29.9 15.1 17.3 18.3 24.0 12.7 14.7 18.3 15.5 8.1 11.5 8.1 10.2 19.9 15.3 14.7 18.8 6.8 14.0 17.6 17.1 9.5 18.2 11.7 24.1 42.1 18.0 9.7 10.1 15.0 19.5 18.3 7.2 18.5 20.2 11.8 9.7 6.6 12.9 22.0 14.8 11.1 13.0 16.9 13.4 11.9 13.3 12.7 13.8 17.0 16.7 14.1 18.5 26.0 21.2 17.1 18.9 24.3 29.9 22.3 5.8 21.4 14.7 13.1 21.1 16.7 18.9 20.0 42.9 20.1 20.5 22.0 23.6 19.4 20.2 22.6 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563811-29567295 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.1" "Cell line enhanced" "Detected in many" "BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enhanced" "Detected in single" "B-cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA040996: , HPA048121: " "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favourable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favourable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.8 0.5 0.7 14.4 0.4 0.0 3.1 0.4 0.8 22.8 58.9 0.8 2.6 24.8 6.8 13.3 0.7 2.9 12.1 1.0 0.6 0.5 12.7 0.5 3.7 0.6 0.4 0.4 4.0 2.0 0.0 2.7 19.0 0.5 2.7 18.5 0.3 4.6 0.9 0.5 0.3 66.1 1.1 1.1 0.4 16.6 1.4 0.4 0.3 1.0 1.0 1.9 7.0 1.9 1.6 0.0 0.0 0.5 0.0 0.0 0.6 7.2 10.3 0.0 0.0 4.0 5.0 13.2 0.3 0.5 0.2 0.1 9.0 17.2 0.0 1.9 2.4 19.9 2.2 0.0 0.0 0.0 1.4 0.5 1.9 9.8 1.3 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.2 1.4 1.6 8.2 0.0 0.0 9.1 11.9 15.2 0.2 0.1 1.0 33.5 0.0 2.4 0.0 8.8 0.2 0.0 0.0 0.4 0.8 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.4 0.8 0.6 0.5 0.4 0.4 0.5 0.4 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.9;BJ hTERT+: 25.9;fHDF/TERT166: 31.2;HSkMC: 20.0;LHCN-M2: 30.2;U-138 MG: 37.2" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Nucleoplasm "Midbody, Cytosol" "HPA049254: " "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.1 0.0 2.5 0.0 7.1 24.9 0.0 11.2 25.9 16.2 12.4 0.0 0.0 0.0 0.0 31.2 0.0 2.5 0.2 17.0 0.0 0.6 0.0 0.3 0.0 6.8 0.0 0.0 20.0 2.8 4.8 15.2 0.5 0.0 0.0 30.2 0.0 0.0 0.0 0.2 0.4 0.0 1.9 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.1 37.2 4.3 1.2 5.8 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Mitochondria" Nucleoli "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: " "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.0 3.3 4.4 0.2 0.3 3.5 2.3 1.8 5.3 5.1 2.5 3.7 0.7 6.9 1.9 1.3 1.5 1.7 1.2 2.6 1.5 4.1 3.5 1.4 1.2 1.1 2.5 1.8 2.3 3.5 0.7 0.9 2.2 2.0 2.4 9.2 3.9 2.0 3.5 0.0 1.5 0.6 0.4 1.8 3.4 7.5 3.0 3.2 2.3 0.9 3.0 1.4 1.2 3.5 5.2 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Cell line enhanced" "Detected in many" "HMC-1: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.1 1.3 6.6 0.0 0.2 6.5 1.3 0.5 1.0 1.6 3.1 1.8 2.9 3.7 0.2 2.3 1.0 1.3 0.2 4.5 10.2 1.3 1.3 1.1 0.5 3.1 15.9 0.8 1.1 1.4 0.4 0.2 7.1 0.0 0.8 6.8 3.5 3.8 8.1 3.2 3.4 1.2 4.5 0.2 2.1 1.7 3.2 0.3 2.4 3.6 2.7 2.5 1.0 2.4 6.7 8.6 1.6 9.3 7.2 5.5 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30556886-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;HAP1: 12.6;U-266/84: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064061: " "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favourable (6.49e-6)" "prognostic favourable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavourable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 7.6 5.6 9.7 5.5 7.4 4.0 3.5 15.0 13.8 5.4 4.5 5.6 3.1 2.5 7.3 15.3 3.6 6.2 4.0 3.2 10.1 12.1 4.3 3.8 4.9 6.1 5.9 7.6 13.5 5.4 10.6 8.8 3.4 8.0 4.4 5.3 6.9 2.6 6.9 3.1 6.5 3.4 3.8 4.6 5.0 5.9 8.6 5.7 11.1 4.9 1.7 5.6 6.4 4.0 2.0 2.3 1.5 1.2 1.3 1.9 0.4 0.6 1.6 5.3 10.0 2.6 0.9 0.0 0.0 0.0 0.0 0.0 4.6 0.5 4.6 3.9 0.9 0.6 12.6 1.0 0.0 2.7 4.6 6.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 0.0 7.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 6.8 2.3 0.6 0.0 0.0 3.1 0.7 4.0 0.0 0.0 0.0 7.6 8.5 4.5 0.0 2.6 2.9 1.5 1.2 0.3 0.5 0.3 1.0 1.0 1.6 1.2 1.0 2.0 0.9 1.9 1.0 1.3 0.6 2.3 0.0 0.4 9.7 7.4 15.0 13.8 10.1 12.1 5.9 7.6 8.0 5.7 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell line enhanced" "Detected in some" "REH: 21.8;SCLC-21H: 6.3;SH-SY5Y: 14.2;T-47d: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062741: " "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favourable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 5.2 4.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 2.3 0.0 1.5 0.0 0.1 4.0 0.0 0.0 0.0 5.0 0.0 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.4 21.8 0.0 0.2 2.9 4.2 6.3 14.2 0.0 0.2 0.0 7.1 0.0 0.0 0.0 2.6 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1" "Cell line enhanced" "Detected in many" "HeLa: 16.3;HMC-1: 27.1;hTERT-HME1: 28.2;SiHa: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" "Cytokinetic bridge, Cytosol" "HPA070174: " "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favourable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavourable (7.71e-8)" "prognostic unfavourable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 2.9 1.5 4.2 8.1 15.5 3.1 2.4 1.7 9.5 9.5 25.7 34.1 1.1 2.5 2.6 1.6 1.4 4.9 5.3 1.6 7.2 5.1 3.8 2.3 10.4 6.2 24.9 3.8 11.4 2.0 1.0 2.7 2.8 16.6 2.3 21.4 3.3 6.3 1.6 0.7 1.6 9.3 4.8 22.8 26.1 2.6 1.2 19.7 1.1 3.0 0.2 2.6 3.6 3.6 1.1 4.2 16.9 12.3 4.6 20.1 7.2 0.0 2.8 4.9 0.1 0.7 0.0 0.0 5.9 4.6 12.6 13.0 0.0 0.0 0.0 1.9 7.3 0.2 0.9 3.0 6.1 2.3 1.7 0.6 16.3 0.0 1.6 0.0 27.1 2.0 4.3 1.2 28.2 5.2 0.0 0.0 6.4 1.5 0.3 0.0 0.3 1.1 1.7 0.5 0.5 12.8 3.0 0.0 0.2 18.6 0.0 1.1 0.0 0.2 3.6 10.7 3.3 0.0 7.4 0.1 0.0 0.0 4.6 0.6 3.2 16.9 1.1 13.3 20.1 11.8 4.6 0.0 7.2 16.8 1.3 1.1 1.6 10.8 6.5 4.6 12.3 4.2 0.0 7.2 4.2 15.5 1.7 9.5 7.2 5.1 24.9 3.8 16.6 19.7 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell line enhanced" "Detected in many" "PC-3: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046636 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: " "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavourable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.1 2.8 0.8 5.6 0.0 0.4 2.4 3.4 0.6 1.0 1.3 0.6 3.8 6.9 8.9 0.5 6.0 0.4 3.0 0.4 6.0 8.9 2.1 2.6 2.1 0.6 4.1 5.0 0.6 1.3 0.4 0.2 0.4 1.0 4.9 0.9 9.6 3.4 10.6 1.3 17.1 9.8 2.6 6.9 1.2 0.5 13.9 9.9 1.3 3.3 15.9 3.0 0.6 2.6 5.7 9.5 5.0 8.1 2.7 1.5 3.3 5.5 6.7 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 PRRC2A "BAT2, D6S51E, G2" ENSG00000204469 "Proline rich coiled-coil 2A" P48634 6 31620720-31637771 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 25.9;HEK 293: 47.2;U-266/70: 24.3;U-266/84: 25.8;U-698: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026383, HPA046791, HPA066501" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "CAB026383: , HPA046791: , HPA066501: " "unprognostic (2.07e-1)" "unprognostic (6.84e-2)" "unprognostic (3.82e-1)" "unprognostic (2.25e-3)" "unprognostic (5.04e-2)" "unprognostic (4.63e-1)" "unprognostic (2.42e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-3)" "unprognostic (2.38e-1)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.57e-1)" "unprognostic (5.40e-2)" "unprognostic (3.10e-1)" 10.9 18.4 20.7 28.9 22.1 5.0 12.2 25.2 29.1 15.0 24.6 18.4 11.9 4.8 19.7 51.5 47.2 32.3 13.8 24.2 18.4 13.2 16.0 10.2 41.7 14.9 14.3 20.4 29.3 12.2 4.8 18.5 8.6 15.9 30.9 7.1 15.0 12.3 15.9 35.1 28.8 23.0 12.8 11.5 43.5 34.6 46.3 16.7 27.1 16.8 10.4 14.4 16.0 13.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 11.7 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.4 13.1 0.0 0.0 25.9 0.0 0.0 47.2 0.1 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 24.3 25.8 24.6 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 22.1 25.2 29.1 18.4 13.2 14.3 20.4 15.9 16.7 PRRC2B "BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526" ENSG00000130723 "Proline rich coiled-coil 2B" Q5JSZ5 9 131373636-131500197 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021022, HPA064301" Uncertain Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA021022: AB_1852324, HPA064301: " "unprognostic (4.78e-3)" "unprognostic (9.21e-2)" "unprognostic (5.40e-2)" "unprognostic (5.87e-2)" "unprognostic (1.22e-1)" "unprognostic (6.86e-3)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (1.62e-1)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (4.02e-1)" "prognostic favourable (5.42e-9)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-2)" 27.4 29.1 43.3 30.3 44.1 30.3 22.1 54.6 56.3 29.4 26.3 32.7 27.3 18.9 33.8 19.7 35.7 36.1 27.5 28.0 39.0 34.1 24.7 18.1 22.5 31.8 26.8 36.8 51.4 30.2 42.0 35.5 23.6 28.9 28.2 15.1 31.8 23.0 29.9 29.4 42.4 23.0 27.2 21.4 27.4 22.2 21.9 26.9 28.1 29.9 18.3 28.1 26.0 29.5 10.3 6.9 4.1 4.5 5.8 7.4 3.0 17.5 34.1 36.5 25.2 27.9 28.8 36.5 17.8 17.5 20.8 17.3 32.0 15.0 30.5 21.1 20.4 42.4 36.4 15.2 15.8 31.3 19.7 19.0 60.1 14.0 18.8 25.1 25.1 28.2 20.2 22.5 26.3 24.0 34.4 22.8 18.7 36.9 21.0 16.2 26.5 14.0 40.8 37.2 29.3 15.1 27.6 49.3 31.0 43.2 26.4 17.9 53.4 15.6 34.7 46.7 21.7 20.6 23.3 10.1 25.0 41.0 16.4 13.6 23.1 4.1 4.5 2.7 7.4 1.9 5.5 5.5 4.4 6.6 2.3 10.3 7.2 6.3 3.2 5.8 1.1 6.9 3.6 3.0 43.3 44.1 54.6 54.7 39.0 34.1 26.8 36.8 28.9 26.9 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: " "unprognostic (8.82e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favourable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 14.7 3.4 2.7 2.7 9.2 7.5 1.2 6.2 8.4 2.3 4.0 8.1 9.5 0.0 10.9 4.9 4.8 7.4 4.7 3.9 0.0 2.4 2.6 3.5 2.7 11.3 0.0 3.4 11.6 4.0 4.4 3.7 11.7 1.2 0.0 7.8 1.1 0.0 0.0 3.3 7.0 0.0 6.1 0.0 38.6 0.7 0.0 0.0 4.6 7.3 2.8 0.0 1.6 8.3 3.5 2.1 6.8 1.9 0.0 0.0 0.0 3.5 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favourable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.6 0.3 0.2 0.7 1.1 0.0 3.7 0.2 0.0 0.3 0.3 1.7 12.0 0.5 1.3 0.1 7.0 0.2 6.8 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 6.0 0.2 0.2 2.7 0.2 0.6 0.0 1.9 0.1 0.7 0.5 1.1 0.2 0.3 6.7 5.3 9.2 1.9 0.2 1.0 10.8 0.1 11.6 0.1 0.4 0.7 0.5 0.3 0.1 4.2 14.0 0.4 0.1 0.3 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 18000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA035127: AB_10602822, HPA035128: , HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.5 3.3 12.5 1.7 0.8 1.2 2.4 1.4 3.3 0.2 2.4 1.3 0.3 2.9 0.2 0.9 3.1 0.6 6.7 1.4 0.5 1.3 0.0 1.2 0.3 1.2 3.2 0.2 1.2 0.5 0.6 0.7 3.3 1.8 15.8 3.0 0.2 6.1 1.5 1.8 0.3 1.3 0.7 0.2 4.8 3.2 1.2 23.8 0.4 6.4 0.2 0.6 0.3 3.4 0.6 0.9 4.3 4.4 0.4 7.9 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 70.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: , HPA052681: " "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 13.8 0.3 0.0 3.8 0.2 0.3 0.0 0.0 0.1 70.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665641-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.9;BJ: 16.7;BJ hTERT+: 12.0;fHDF/TERT166: 24.0;U-2197: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA006607: , HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 8.4 2.1 0.4 2.5 0.4 0.2 7.3 0.2 0.6 15.6 2.4 0.5 3.5 0.7 4.6 5.4 5.3 2.1 2.3 8.6 0.4 0.2 0.6 0.4 2.8 1.8 0.3 0.1 3.2 2.2 0.3 2.8 2.6 1.7 15.1 0.7 12.8 4.6 5.2 6.6 15.8 1.1 10.2 1.2 0.4 1.6 6.7 0.0 0.6 7.9 9.3 6.5 10.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 2.0 7.9 0.0 16.7 12.0 2.1 2.4 0.0 0.0 0.0 6.1 24.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 2.6 3.7 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.8 0.0 0.0 1.6 0.3 0.0 0.0 5.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.4 0.2 0.3 0.1 1.7 0.0 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1708 "pancreas: 3057.4" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7" "Low lineage specificity" "Detected in many" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 26000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: , HPA063471: " "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavourable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favourable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favourable (4.91e-4)" "unprognostic (3.12e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3057.4 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 1.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 1.5 0.0 2.5 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.5;testis: 31.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favourable (2.66e-4)" "prognostic favourable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.9 0.5 2.1 4.1 1.4 0.0 1.9 0.5 2.8 16.5 6.0 2.0 1.3 2.2 3.0 2.7 3.6 9.8 27.5 0.3 2.2 0.9 1.1 0.8 8.0 0.0 0.7 2.4 1.9 9.8 0.0 0.9 20.4 4.1 2.0 5.8 20.0 3.1 3.2 0.3 5.9 8.6 1.0 0.5 0.3 8.1 31.3 0.2 0.3 0.6 7.7 7.7 3.1 16.2 0.3 0.4 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.5 0.0 0.0 4.1 0.0 13.5 12.2 2.9 4.8 0.0 5.5 0.0 0.0 20.4 0.2 9.1 2.7 3.8 0.0 2.1 0.0 1.1 0.0 0.4 0.0 0.0 1.2 5.2 1.0 3.0 0.0 0.0 0.0 2.3 0.0 0.1 2.7 0.6 0.8 0.0 11.5 0.0 0.0 2.0 1.5 64.8 0.0 0.0 0.8 0.0 29.0 0.0 5.8 0.8 3.6 2.6 0.3 0.0 0.0 0.3 0.9 3.3 0.0 0.1 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 0.5 2.8 2.2 0.9 0.7 2.4 4.1 0.2 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 708 "pancreas: 6267.9" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 37.2" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Group enriched" "Detected in some" 6 "basophil: 5.6;T-reg: 5.1" "Group enriched" "Detected in many" 6 "granulocytes: 5.6;T-cells: 5.1" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 27000000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "prognostic favourable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6267.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.6 0.0 0.7 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.5 2.1 0.0 1.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.3 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750466-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "pancreas: 984.9" "Cell line enriched" "Detected in some" 8 "PC-3: 121.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 82 "basophil: 39.0" "Lineage enriched" "Detected in single" 82 "granulocytes: 39.0" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 490000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 0.3 0.3 1.6 1.7 1.5 0.2 0.2 2.8 4.2 0.9 8.2 0.0 0.0 2.8 0.2 0.2 2.9 0.2 4.8 0.4 1.2 0.7 0.3 0.4 0.2 0.2 0.3 1.6 0.7 984.9 0.2 0.1 0.2 2.3 0.2 2.3 0.0 0.6 0.2 0.2 2.0 23.9 0.3 0.2 0.2 0.8 0.3 0.0 0.0 0.2 6.6 3.5 0.2 1.3 0.0 0.1 39.0 0.4 0.1 0.3 0.1 1.7 2.0 0.1 0.0 0.0 0.9 0.0 4.8 1.1 0.5 0.2 4.7 0.4 0.0 0.0 2.1 2.1 0.0 4.4 1.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 15.9 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.2 0.0 12.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 39.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 1.5 2.8 4.2 1.2 0.7 0.3 1.6 2.3 0.0 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell line enhanced" "Detected in many" "CACO-2: 29.6;CAPAN-2: 37.3;HEL: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.4 16.2 12.1 4.9 2.0 10.1 0.0 7.9 6.0 5.7 7.8 29.6 37.3 0.0 1.2 9.3 4.2 13.7 0.0 8.9 0.0 0.5 21.7 3.0 0.0 6.0 0.0 0.0 2.9 0.1 3.1 0.0 8.9 7.0 4.2 2.7 0.2 3.3 0.0 8.3 0.3 3.7 0.0 0.0 5.1 0.2 8.7 0.4 7.6 0.0 0.0 0.4 1.7 4.8 2.5 6.4 9.2 4.7 0.4 0.0 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Cell line enriched" "Detected in many" 6 "AF22: 57.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 1.2 57.4 1.2 0.0 0.0 5.8 0.4 1.7 1.4 2.1 9.6 0.3 0.0 2.4 0.0 0.0 0.2 0.1 2.0 0.0 3.0 0.4 0.4 3.6 0.4 0.4 0.0 0.2 0.0 0.6 1.0 1.0 1.0 0.0 0.8 0.8 0.0 0.0 2.3 1.4 0.0 9.1 0.0 1.1 0.1 0.7 3.3 0.5 0.7 3.1 0.2 0.1 0.1 0.8 0.6 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.4 2.7 3.3 4.2 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.3 1.1 0.9 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 4.9 4.9 1.9 1.6 1.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 2.5 4.8 2.7 2.4 0.5 1.3 0.3 1.5 3.9 3.3 3.0 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Cell line enhanced" "Detected in some" "HSkMC: 10.1;MOLT-4: 5.4;SCLC-21H: 9.4;SH-SY5Y: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: " "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.8 3.4 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.6 0.4 0.3 2.4 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.1 0.0 0.1 10.1 0.3 0.6 0.1 0.0 0.5 0.9 0.0 2.0 5.4 0.3 0.5 0.0 1.4 0.0 0.1 0.0 0.2 9.4 8.3 0.1 0.1 0.2 0.6 0.5 0.0 2.8 4.6 0.2 0.0 2.4 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;LHCN-M2: 22.4;U-87 MG: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA002455: " "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favourable (7.55e-4)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 5.0 2.6 11.9 0.0 4.3 26.6 0.6 2.7 4.2 2.4 5.1 1.5 2.0 3.0 1.7 10.9 0.4 3.4 4.7 4.7 0.0 3.1 0.2 2.1 0.2 7.8 0.0 0.1 7.0 3.0 13.5 2.4 3.2 0.3 2.4 22.4 1.7 0.0 0.5 2.3 7.0 2.3 10.4 1.3 6.2 6.5 5.1 5.7 1.1 0.5 1.8 0.0 1.2 13.1 7.6 5.3 17.9 2.3 0.2 0.3 6.9 24.0 1.2 2.6 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: " "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favourable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.2 21.9 20.5 8.1 28.7 20.5 18.7 21.0 24.1 21.5 27.2 27.2 35.7 9.3 13.9 19.9 38.0 17.2 15.9 23.6 21.2 10.7 10.6 14.9 13.2 26.5 10.7 20.8 21.0 28.9 17.8 22.0 17.2 11.8 19.0 20.1 28.3 8.1 13.9 8.9 16.3 10.3 17.4 11.8 30.0 30.3 11.4 15.2 22.9 21.5 18.7 26.6 23.9 18.2 21.9 18.1 17.9 9.9 12.4 18.2 9.4 18.4 13.0 13.3 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell line enriched" "Detected in single" 18 "HEL: 13.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015095, HPA056839" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome subunit alpha 4" P25789 15 78540405-78552419 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol 12000000 "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: , HPA060613: " "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 41.2 38.8 24.9 36.7 25.8 33.4 33.0 25.3 37.5 32.4 38.0 17.9 23.7 39.4 35.3 32.5 49.9 27.1 24.4 37.7 29.8 27.6 55.7 76.3 37.4 45.1 25.5 26.9 31.2 24.4 20.2 25.9 55.4 33.8 35.3 41.3 19.1 26.0 25.0 60.3 26.3 49.1 36.6 28.1 45.5 31.5 36.5 21.4 61.6 42.6 75.0 44.8 41.3 28.3 29.4 61.9 31.4 75.6 37.7 40.0 61.4 40.1 58.2 50.4 44.4 31.8 30.1 39.5 37.8 30.4 46.6 50.0 60.5 58.7 87.7 55.9 34.8 55.0 101.6 41.0 45.1 35.9 70.8 73.6 43.6 48.7 51.6 74.8 45.5 24.3 25.7 39.2 39.1 50.2 78.9 34.4 38.0 57.8 50.4 70.2 47.4 34.2 43.9 66.7 29.4 47.2 70.4 44.5 32.5 60.6 44.3 46.1 40.9 61.6 39.9 34.8 46.5 38.3 64.3 31.5 74.2 82.7 32.6 112.5 38.3 18.8 47.4 31.4 27.8 75.6 28.5 29.4 29.2 29.0 61.9 22.9 23.3 28.3 21.7 37.7 69.7 35.3 40.0 61.4 24.9 25.8 25.3 37.5 29.8 27.6 25.5 26.9 33.8 21.4 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome subunit beta 10" P40306 16 67934502-67937087 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 117.3" "Cell line enhanced" "Detected in many" "REH: 36.0;U-266/70: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030224, HPA030225, CAB034384" Enhanced Supported Vesicles,Cytosol 1400000 Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: , HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favourable (5.44e-4)" 11.5 13.0 9.1 24.9 11.8 23.9 11.4 4.0 7.8 8.0 21.6 5.6 8.5 42.4 9.3 9.5 10.6 12.4 16.6 12.0 6.9 4.9 16.9 17.2 19.5 38.3 9.5 5.6 8.7 61.5 0.9 6.9 11.2 8.5 13.5 6.3 5.8 27.9 11.6 6.9 7.0 35.6 7.7 6.5 49.7 23.8 2.5 7.8 39.2 13.1 10.4 20.5 13.2 8.4 50.8 75.2 100.0 98.1 69.1 68.8 117.3 5.9 5.3 0.4 0.8 0.4 3.5 21.0 2.0 8.5 6.9 9.8 2.7 29.1 21.6 3.7 2.7 8.7 0.1 1.9 0.5 9.6 0.5 7.7 1.8 3.0 12.0 14.3 23.6 5.3 1.2 3.0 0.0 4.0 0.7 8.3 1.9 7.4 28.1 14.7 0.3 2.0 36.0 2.2 29.5 4.7 10.4 0.3 0.4 6.7 11.8 2.6 2.4 31.0 6.7 4.4 1.2 1.9 2.3 40.3 7.2 14.4 10.9 18.7 9.5 57.1 89.4 67.1 68.8 98.1 50.2 50.8 54.0 57.3 74.6 49.1 45.3 50.1 100.0 69.1 71.4 75.2 60.8 117.3 9.1 11.8 4.0 7.8 6.9 4.9 9.5 5.6 8.5 7.8 PSMB5 "MB1, X" ENSG00000100804 "Proteasome subunit beta 5" P28074 14 23016543-23035230 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049518, HPA061796" Approved Supported Nucleoplasm,Centrosome 8200000 "Nucleoplasm, Centrosome" "HPA049518: , HPA061796: " "unprognostic (3.03e-1)" "unprognostic (1.99e-2)" "unprognostic (8.35e-2)" "unprognostic (6.13e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (2.85e-4)" "prognostic unfavourable (2.90e-5)" "unprognostic (2.55e-2)" "unprognostic (9.95e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.19e-1)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (4.95e-2)" "prognostic unfavourable (4.73e-4)" 28.1 38.8 33.6 19.3 35.5 9.6 29.0 19.4 42.9 24.7 28.3 26.8 25.4 21.0 24.2 49.2 31.6 31.6 22.0 37.7 32.9 33.3 35.3 45.4 20.6 18.3 37.5 35.4 22.2 36.6 35.4 26.6 32.5 33.9 27.2 32.2 21.1 28.4 28.7 101.2 22.3 17.2 34.9 32.5 16.7 25.1 27.6 27.3 15.7 29.0 47.3 22.7 20.6 25.2 32.3 53.4 24.6 39.9 19.4 46.8 39.5 22.1 47.1 33.7 31.9 45.4 39.2 33.3 31.6 37.6 55.8 47.4 39.6 35.2 27.5 29.5 42.9 30.2 53.8 39.4 53.9 16.8 37.2 17.4 34.4 139.6 35.9 21.1 21.0 43.7 37.0 41.3 34.5 57.6 26.2 15.6 45.6 65.1 12.0 29.0 37.4 76.4 16.2 25.4 18.3 43.3 32.1 43.0 33.5 22.2 45.2 30.3 21.8 27.5 30.9 27.3 27.8 25.2 31.0 13.5 26.8 20.6 21.3 17.1 33.8 24.6 39.9 17.3 29.3 39.0 34.2 32.3 35.1 28.1 42.6 30.1 46.8 35.6 15.5 19.4 27.9 53.4 28.7 39.5 33.6 35.5 19.4 42.9 32.9 33.3 37.5 35.4 33.9 27.3 PSMB6 "DELTA, Y" ENSG00000142507 "Proteasome subunit beta 6" P28072 17 4796144-4798503 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023312, HPA063656" Supported Supported Nucleoplasm,Cytosol 2800000 Nucleoplasm Cytosol "HPA023312: AB_1855828, HPA063656: " "unprognostic (2.71e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (3.32e-3)" "unprognostic (8.80e-2)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-2)" "unprognostic (7.47e-2)" "prognostic unfavourable (5.93e-4)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (5.27e-2)" "unprognostic (5.66e-2)" 28.6 35.0 33.7 23.2 36.4 31.7 34.0 24.2 41.5 29.6 31.7 26.7 26.8 22.6 33.4 47.1 41.9 30.3 24.2 72.0 30.4 30.5 41.4 67.1 25.7 35.3 33.4 34.0 25.3 41.8 40.8 26.6 49.6 35.9 26.4 36.1 23.5 30.6 36.6 97.4 33.6 23.2 40.5 29.7 29.0 31.2 27.0 28.0 35.8 34.6 53.8 39.6 27.9 26.0 93.9 96.3 51.1 95.3 60.4 81.2 107.9 46.0 80.6 43.5 37.1 37.1 33.4 50.2 24.4 51.1 74.7 58.6 59.9 37.6 35.8 48.5 58.4 46.7 66.1 68.4 72.9 46.6 69.7 21.2 53.0 69.6 42.8 21.9 33.9 31.5 52.5 65.2 62.1 72.5 32.4 54.5 57.2 54.8 38.7 36.6 36.9 56.0 43.4 30.9 47.4 56.0 31.1 25.5 31.3 35.0 27.4 25.1 33.4 24.6 34.5 36.9 27.9 49.5 59.0 22.8 30.3 21.8 52.8 40.1 44.3 51.1 95.3 50.5 57.1 87.5 57.8 93.9 62.3 62.6 96.3 79.8 53.7 56.1 32.9 60.4 78.0 89.7 81.2 107.9 33.7 36.4 24.2 41.5 30.4 30.5 33.4 34.0 35.9 28.0 PSMB7 ENSG00000136930 "Proteasome subunit beta 7" Q99436 9 124353466-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Supported Nucleoplasm,Cytosol 2700000 Nucleoplasm Cytosol "HPA052408: , HPA054902: " "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 36.9 56.9 51.0 32.8 55.1 53.4 41.9 33.7 52.7 26.6 33.3 34.0 27.9 32.5 33.6 52.1 41.9 32.6 29.2 59.6 44.5 41.3 53.7 87.1 27.0 33.6 43.6 46.9 32.7 67.1 38.5 24.1 53.2 47.3 28.8 37.1 31.1 48.2 26.9 76.7 48.7 32.2 31.4 39.9 28.6 33.1 50.3 36.5 48.2 32.7 67.7 39.5 32.3 30.8 53.4 67.9 45.2 62.7 53.6 66.2 69.0 51.9 63.5 43.5 52.5 30.7 36.7 62.7 50.6 69.8 73.4 50.7 83.4 50.8 59.3 40.9 47.3 74.4 54.1 53.6 67.4 57.0 46.7 37.1 101.0 69.2 69.5 73.6 37.1 43.9 47.3 76.4 76.6 61.5 75.7 42.2 56.6 90.4 52.8 49.5 64.3 90.9 46.8 64.9 69.3 51.9 34.0 51.3 41.8 48.1 61.7 74.9 71.1 32.4 48.7 47.5 38.3 60.6 75.7 45.8 128.3 59.8 79.4 45.4 66.7 40.4 61.7 45.2 41.8 62.7 45.0 53.4 48.1 46.1 67.9 47.5 46.3 44.9 27.3 53.6 58.4 57.8 66.2 69.0 51.0 55.1 33.7 52.7 44.5 41.3 43.6 46.9 47.3 36.5 PSMB8 "beta5i, D6S216E, LMP7, PSMB5i, RING10" ENSG00000204264 "Proteasome subunit beta 8" P28062 6 32840717-32844703 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046995, HPA050327" Enhanced Approved "Vesicles,Cytokinetic bridge" 3300000 Vesicles "Cytokinetic bridge" "HPA046995: AB_2679896, HPA050327: AB_2681088" "prognostic favourable (5.08e-4)" "unprognostic (4.22e-2)" "unprognostic (2.39e-2)" "prognostic favourable (7.16e-4)" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (7.78e-2)" "unprognostic (1.09e-1)" "unprognostic (5.71e-2)" "unprognostic (1.17e-2)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (1.97e-3)" "unprognostic (7.11e-3)" 17.0 21.9 7.9 34.8 11.7 14.0 14.9 3.6 7.5 10.0 20.8 5.1 8.8 20.1 12.5 15.3 16.6 13.2 23.8 10.6 6.6 5.7 20.9 30.0 29.0 46.3 9.9 5.1 11.3 12.7 3.6 8.2 9.7 8.8 13.5 24.4 9.2 14.6 11.2 5.1 14.7 37.3 11.5 9.0 42.8 19.4 3.9 9.0 32.2 18.7 18.7 29.0 13.9 12.5 28.9 27.4 37.6 33.2 23.3 29.9 52.2 6.3 2.0 0.1 0.0 2.7 7.0 4.4 1.5 10.1 12.4 17.9 0.0 11.2 24.8 4.8 4.1 4.5 1.4 6.0 3.4 10.2 0.0 10.9 1.3 0.4 14.8 0.2 4.1 7.9 2.8 6.9 2.3 8.4 0.3 5.2 3.1 0.0 5.7 6.0 0.0 1.6 15.5 0.8 12.2 10.1 1.8 0.1 0.1 2.2 5.3 3.3 2.4 20.3 2.5 3.7 1.9 3.5 0.2 8.8 8.3 5.5 1.3 14.3 4.6 19.4 29.0 37.4 25.5 33.2 22.1 28.9 21.7 26.4 27.4 26.3 15.1 21.6 37.6 23.3 28.6 23.3 29.9 52.2 7.9 11.7 3.6 7.5 6.6 5.7 9.9 5.1 8.8 9.0 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256495-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000872 Approved Enhanced Nucleoplasm,Cytosol 46000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705" "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 23.7 21.6 28.2 16.7 26.6 26.9 24.6 17.1 39.1 18.4 21.0 11.8 14.3 12.7 23.7 27.9 23.4 18.0 13.7 34.5 37.8 19.1 22.8 29.7 17.9 16.2 19.8 29.3 16.1 20.4 21.8 15.9 25.3 37.2 19.0 23.0 12.1 18.9 22.8 178.0 22.9 17.2 23.2 31.3 19.3 20.0 42.1 15.6 14.4 18.0 29.2 25.4 23.3 17.2 21.4 37.7 57.0 38.1 28.7 36.4 37.8 31.8 30.2 34.8 36.3 30.6 28.2 36.6 30.9 43.3 68.3 51.6 27.9 36.0 27.2 47.2 37.3 33.1 42.5 36.0 80.0 32.4 18.6 21.3 20.3 23.9 26.4 32.2 28.6 25.2 28.6 44.4 32.7 41.1 30.0 16.4 46.9 60.4 24.0 42.0 30.7 37.5 28.8 45.1 22.2 38.4 33.2 36.6 24.5 25.2 65.6 25.8 41.2 28.5 31.1 26.3 23.6 28.2 44.6 28.4 44.7 40.3 38.1 29.4 40.1 30.9 37.6 57.0 26.6 34.1 26.2 21.4 27.5 27.2 37.7 20.7 25.3 24.8 41.7 28.7 38.1 26.4 36.4 37.8 28.2 26.6 17.1 39.1 37.8 19.1 19.8 29.3 37.2 15.6 PSMC2 "MSS1, Nbla10058, S7" ENSG00000161057 "Proteasome 26S subunit, ATPase 2" P35998 7 103344254-103369395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019238, HPA049621" Supported Supported "Cytosol,Cytoplasmic bodies" 39000 "Cytosol, Cytoplasmic bodies" "HPA019238: AB_1855834, HPA049621: " "unprognostic (4.00e-2)" "unprognostic (6.66e-2)" "unprognostic (2.55e-1)" "unprognostic (3.58e-1)" "unprognostic (1.57e-3)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (6.08e-2)" "unprognostic (7.73e-2)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" "unprognostic (4.71e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (9.76e-2)" "unprognostic (1.41e-1)" 29.3 35.8 29.4 27.2 35.3 41.6 24.4 25.9 39.7 23.2 23.4 26.2 22.0 22.8 28.2 26.6 29.9 22.5 19.5 38.5 30.1 24.7 36.9 58.8 24.4 26.2 32.0 29.9 23.7 18.5 27.8 33.6 31.1 37.0 23.1 24.8 23.2 24.1 24.8 83.5 31.2 23.2 29.2 31.5 28.4 24.9 23.4 34.3 27.5 25.5 35.2 31.8 26.5 22.2 25.7 40.7 65.7 52.3 29.6 50.2 35.1 51.5 36.2 31.0 45.6 33.4 25.0 28.6 38.5 35.7 44.9 45.1 43.9 45.9 34.8 82.5 33.8 31.8 39.1 27.4 47.2 55.4 26.4 31.1 30.0 31.9 29.4 50.7 38.8 22.2 22.4 44.8 15.0 33.5 72.0 47.4 38.4 73.8 50.1 33.6 38.6 38.2 28.2 38.8 40.7 30.5 32.3 28.2 25.3 36.1 53.6 33.6 24.7 25.9 35.7 39.5 47.9 74.4 60.7 42.6 99.0 68.1 43.7 53.5 60.6 65.7 30.5 28.1 26.5 44.2 30.1 25.7 31.0 28.2 40.7 20.1 27.5 27.6 4.6 29.6 52.3 23.8 50.2 35.1 29.4 35.3 25.9 39.7 30.1 24.7 32.0 29.9 37.0 34.3 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Supported Nucleoplasm,Cytosol 180000 "Nucleoplasm, Cytosol" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 27.9 25.9 37.3 24.1 49.3 31.8 26.2 25.6 39.7 25.1 28.2 24.9 21.1 20.3 27.2 26.0 29.4 25.0 21.8 45.7 32.8 28.0 30.7 60.2 21.5 22.8 36.1 27.3 21.0 25.2 31.0 16.8 39.8 28.2 22.6 24.0 21.3 32.1 29.8 134.7 34.8 20.9 30.8 24.3 25.7 24.9 24.0 22.9 33.5 27.1 38.3 28.8 25.5 25.3 39.2 45.1 32.6 54.7 45.0 51.1 61.3 39.0 44.5 42.8 31.5 20.6 22.2 41.7 32.6 48.5 82.1 58.3 39.6 22.9 31.7 20.3 41.0 39.3 37.5 42.7 37.1 47.2 48.4 30.5 54.5 38.2 26.6 35.5 32.6 24.7 23.1 33.3 37.6 46.0 43.1 30.0 50.0 87.1 44.7 45.2 41.9 53.8 47.3 84.2 27.8 38.2 29.5 31.3 27.1 26.7 37.7 20.5 46.5 37.1 32.5 47.1 59.6 66.6 83.5 32.5 37.5 36.7 48.6 35.6 58.8 24.4 43.5 32.6 47.9 53.1 43.7 39.2 40.4 43.8 45.1 32.8 35.6 36.2 9.8 45.0 54.7 45.1 51.1 61.3 37.3 49.3 25.6 39.7 32.8 28.0 36.1 27.3 28.2 22.9 PSMC4 "MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7" ENSG00000013275 "Proteasome 26S subunit, ATPase 4" P43686 19 39971005-39981441 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002044, HPA005471" Approved Supported Nucleoplasm,Cytosol 66000 "Nucleoplasm, Cytosol" "HPA002044: AB_1079707, HPA005471: AB_1855838" "unprognostic (1.66e-1)" "unprognostic (9.08e-2)" "unprognostic (1.69e-1)" "unprognostic (1.83e-2)" "unprognostic (7.46e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.53e-2)" "unprognostic (4.45e-1)" "unprognostic (4.42e-2)" "unprognostic (9.90e-2)" "unprognostic (8.45e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.81e-1)" "unprognostic (2.32e-1)" 24.0 31.3 23.4 26.1 26.9 15.0 20.3 23.9 37.1 22.8 25.0 26.1 24.9 26.4 29.8 34.0 29.9 25.1 22.2 35.9 24.1 25.4 40.4 65.6 20.1 21.3 25.6 27.4 22.7 19.6 33.1 22.1 29.7 32.3 22.5 24.6 21.8 21.1 28.1 57.3 25.8 24.8 27.1 26.0 25.2 24.1 29.7 25.5 27.9 30.2 28.0 28.5 28.9 20.1 18.1 34.4 16.0 43.1 19.8 28.1 25.8 22.4 72.9 14.8 19.3 12.7 10.6 17.0 13.3 16.3 29.6 23.0 42.1 16.3 11.2 26.0 15.7 12.1 19.8 18.0 22.5 19.8 20.8 16.5 13.7 34.2 18.7 17.1 19.8 11.1 14.6 24.1 16.5 19.3 21.1 17.1 18.1 33.9 20.3 9.9 26.7 22.2 17.8 17.8 16.1 19.7 33.8 19.2 24.7 15.1 24.0 12.0 16.6 15.1 12.8 19.4 19.4 17.7 32.3 20.7 35.9 17.2 24.6 18.2 21.4 14.8 20.5 16.0 23.6 32.2 20.0 18.1 21.1 23.9 34.4 16.9 17.1 17.6 11.1 19.8 43.1 17.1 28.1 25.8 23.4 26.9 23.9 37.1 24.1 25.4 25.6 27.4 32.3 25.5 PSMC5 "p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1" ENSG00000087191 "Proteasome 26S subunit, ATPase 5" P62195 17 63827152-63832026 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017871, HPA064293" Enhanced Supported "Plasma membrane,Cytosol" 100000 "Plasma membrane, Cytosol" "HPA017871: AB_1857638, HPA064293: AB_2685234" "unprognostic (9.65e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-1)" "unprognostic (2.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.35e-1)" "unprognostic (8.29e-3)" "unprognostic (1.24e-2)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" "unprognostic (2.17e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (3.13e-6)" "unprognostic (9.54e-2)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" 36.8 43.1 44.8 35.8 42.6 26.7 30.3 47.7 48.3 29.5 36.5 30.3 40.8 26.2 32.0 42.4 46.0 32.2 42.0 41.7 38.6 42.9 52.3 48.7 26.3 33.5 50.1 42.2 28.2 36.7 77.0 32.6 42.9 41.8 32.7 36.7 26.7 36.0 41.7 94.2 45.2 28.9 41.8 39.3 33.4 33.2 32.7 35.7 33.0 37.8 60.4 43.9 33.3 32.4 30.4 31.2 30.9 40.9 34.2 57.7 40.5 41.6 62.8 43.9 28.4 30.8 32.6 36.2 42.5 30.5 51.5 40.9 67.5 26.1 28.1 29.3 42.4 31.1 44.1 39.4 73.9 25.2 46.6 61.9 51.5 55.0 30.8 61.9 41.4 32.5 29.6 52.7 48.8 46.4 46.4 36.1 47.7 73.1 45.7 23.4 38.6 54.3 42.9 87.1 40.8 36.3 49.1 36.9 50.3 29.1 51.4 24.0 50.7 30.0 43.5 63.2 59.4 29.1 85.2 38.3 59.1 45.5 37.9 44.6 40.1 22.8 25.6 30.9 37.8 37.2 51.4 30.4 44.8 40.4 31.2 24.4 37.7 42.2 8.1 34.2 40.9 22.4 57.7 40.5 44.8 42.6 47.7 48.3 38.6 42.9 50.1 42.2 41.8 35.7 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: " "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 46.5 30.2 36.4 26.9 25.4 26.6 39.3 36.7 35.3 59.7 45.0 37.8 38.3 40.6 46.0 31.8 35.6 46.2 32.1 62.8 38.9 20.1 29.7 24.8 40.3 30.8 42.1 28.9 19.7 32.2 30.1 30.5 37.4 44.1 17.6 43.4 42.7 32.8 29.2 29.3 41.6 28.0 63.8 18.1 39.3 47.5 26.2 19.4 32.6 20.5 31.3 42.1 30.8 28.6 33.3 46.7 25.7 37.6 12.5 31.6 45.4 21.5 28.9 30.1 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056864-231172827 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" 49000 Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavourable (8.63e-12)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 21.9 25.5 21.5 19.0 27.8 14.4 18.4 22.3 29.0 17.3 20.6 16.2 15.3 21.7 24.3 17.6 25.3 16.1 13.0 34.9 31.8 22.1 20.9 27.8 16.8 16.3 20.3 27.2 16.4 10.9 73.9 24.6 28.5 34.0 18.7 23.7 15.0 16.7 21.1 75.5 20.2 17.9 27.2 17.5 18.7 17.4 16.8 17.8 20.6 17.3 23.7 22.3 17.8 16.4 14.3 21.2 23.5 26.7 25.6 21.6 15.4 28.8 31.5 35.5 27.7 37.0 26.7 34.4 38.5 40.1 39.0 39.7 38.2 28.9 22.7 36.3 42.9 27.8 49.3 35.9 53.3 34.3 26.4 41.9 25.9 43.8 19.1 36.9 36.4 23.0 17.8 41.9 22.3 45.9 57.9 17.2 46.2 28.1 28.8 21.2 45.7 25.2 24.5 54.5 21.7 28.7 30.0 23.7 21.3 30.8 27.9 18.8 22.1 21.8 42.8 31.1 32.8 37.5 36.5 14.9 21.9 40.4 48.0 28.5 35.5 23.5 19.2 14.6 19.2 25.9 19.0 14.3 18.3 16.9 21.2 12.0 14.9 16.8 10.8 25.6 26.7 12.1 21.6 15.4 21.5 27.8 22.3 27.6 31.8 22.1 20.3 27.2 34.0 17.8 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091618 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" 82000 Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 15.8 23.6 35.5 14.3 32.1 14.2 20.9 27.4 31.1 21.7 19.0 30.3 13.4 14.8 22.4 29.8 21.6 27.1 15.1 14.7 32.0 50.2 20.5 19.0 16.5 18.0 38.9 29.6 19.9 11.1 20.3 20.9 26.1 39.0 19.4 19.8 17.1 14.6 19.0 13.3 15.3 17.4 21.6 38.9 14.8 15.7 15.6 23.8 21.2 24.3 12.2 21.8 22.0 16.1 28.1 30.7 40.2 38.8 32.2 32.4 35.1 31.0 31.6 21.7 19.5 33.0 24.9 19.7 25.6 21.3 23.2 20.3 18.8 20.0 26.5 39.3 24.4 16.9 34.1 24.7 35.8 28.7 29.4 15.5 30.7 23.6 16.8 24.0 17.4 18.9 27.0 21.5 26.1 57.2 29.9 36.0 28.9 40.7 22.6 21.0 39.4 43.1 22.9 31.1 28.0 24.9 20.2 14.0 13.4 39.2 16.3 25.7 17.6 20.8 41.0 18.5 10.7 31.1 18.9 28.8 39.5 28.1 25.6 33.5 21.7 38.3 26.9 40.2 28.2 33.0 30.2 28.1 28.6 30.1 30.4 27.2 28.8 32.2 13.2 32.2 38.8 30.7 32.4 35.1 35.5 32.1 27.4 31.1 32.0 50.2 38.9 29.6 39.0 23.8 PSMD11 "MGC3844, p44.5, Rpn6, S9" ENSG00000108671 "Proteasome 26S subunit, non-ATPase 11" O00231 17 32444261-32483318 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042275, HPA067433" Approved Approved "Nucleoplasm,Golgi apparatus" 78000 "Nucleoplasm, Golgi apparatus" "HPA042275: AB_10794793, HPA067433: " "unprognostic (1.16e-1)" "unprognostic (2.71e-1)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.33e-6)" "unprognostic (2.64e-2)" "unprognostic (3.97e-1)" "unprognostic (8.10e-2)" "unprognostic (5.88e-2)" "unprognostic (9.17e-3)" "prognostic unfavourable (5.73e-6)" "unprognostic (9.39e-3)" "unprognostic (6.65e-2)" "unprognostic (2.90e-1)" "unprognostic (2.17e-2)" 26.0 22.4 20.7 19.9 22.3 19.9 17.4 22.2 27.1 16.3 19.2 23.8 14.9 19.2 24.2 17.2 28.5 17.6 16.5 24.7 18.3 18.7 21.7 38.2 19.1 19.5 24.4 16.9 19.1 25.8 30.1 19.1 27.5 28.1 18.6 23.7 17.3 19.2 16.7 69.0 25.3 18.8 25.4 19.1 20.0 18.3 22.8 19.8 27.7 19.5 26.9 26.8 18.9 18.9 24.4 30.8 22.8 28.0 30.1 33.1 26.8 35.7 39.7 29.0 31.2 19.7 14.7 31.0 20.4 26.5 45.4 36.9 40.0 32.8 28.1 32.6 22.1 41.6 33.0 28.4 44.7 14.1 22.5 22.7 20.1 30.9 19.2 26.9 24.4 13.1 15.0 39.4 27.4 31.8 43.0 33.0 26.6 22.2 40.2 15.9 39.8 20.0 25.0 37.6 38.0 22.3 26.8 25.7 17.4 25.9 18.8 20.6 45.5 12.9 21.8 25.4 29.6 31.3 47.1 18.4 28.7 37.2 36.8 21.1 42.6 22.8 27.4 16.7 28.3 27.1 31.0 24.4 27.7 28.4 30.8 23.7 24.9 26.0 12.6 30.1 28.0 25.1 33.1 26.8 20.7 22.3 22.2 27.1 18.3 18.7 24.4 16.9 28.1 19.8 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366627 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol 44000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favourable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavourable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 16.4 18.0 16.0 12.3 16.0 11.8 14.1 19.5 26.7 11.7 11.8 8.8 11.5 9.4 12.5 13.3 16.4 9.9 11.4 14.9 17.0 19.7 17.1 31.4 10.8 11.3 23.6 15.3 12.6 17.6 15.7 12.9 13.7 32.5 12.8 13.8 8.1 12.5 11.0 42.3 11.6 10.8 15.7 13.4 12.0 12.4 15.5 11.3 12.7 12.2 18.9 16.7 17.2 19.6 8.8 10.8 12.1 18.1 11.4 14.0 8.9 28.1 17.2 13.6 14.9 10.5 12.7 18.7 20.1 12.9 22.4 19.9 17.8 12.5 16.2 13.0 16.3 16.7 23.6 20.6 33.6 7.8 17.6 18.9 14.3 18.3 13.6 19.6 11.7 14.1 13.7 21.2 16.7 22.0 25.1 9.7 20.9 19.3 17.9 18.9 16.4 22.8 9.2 35.1 14.6 16.7 23.5 13.1 18.9 14.8 29.1 19.4 20.8 16.7 22.5 23.8 16.0 17.8 36.2 9.9 15.2 13.7 28.1 20.8 13.7 12.1 10.6 8.8 9.9 17.4 14.0 8.6 13.0 11.1 10.8 8.8 11.7 12.3 7.6 11.4 18.1 7.0 12.1 8.9 16.0 16.0 19.5 26.7 17.0 19.7 23.6 15.3 32.5 11.3 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236546-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" 49000 "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favourable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 24.2 17.9 18.4 20.9 21.3 29.1 28.6 22.1 25.6 24.0 23.6 19.2 20.0 15.6 25.3 20.3 26.8 20.6 19.1 31.8 19.6 20.4 23.4 34.9 23.0 29.8 17.1 19.1 18.1 26.5 15.1 18.0 31.7 21.8 24.0 19.5 16.8 20.9 21.1 56.5 25.5 20.5 21.3 17.0 26.9 18.8 21.2 12.9 32.8 23.3 30.0 27.0 20.5 17.9 20.8 33.5 25.1 32.6 26.4 26.6 39.0 30.9 18.5 22.1 22.7 22.3 20.3 12.7 21.3 30.2 46.7 34.5 16.3 41.8 29.4 20.7 25.9 29.4 27.8 32.1 37.1 23.7 21.2 13.0 7.2 11.2 24.8 31.7 27.6 17.9 23.0 23.3 20.2 42.3 32.9 23.0 35.7 12.2 26.4 19.5 29.5 26.8 20.5 21.7 20.7 27.4 8.3 17.9 14.1 15.6 16.7 16.5 10.2 19.6 27.8 13.7 13.1 6.9 24.8 20.8 24.1 38.2 24.7 25.4 22.6 22.2 31.4 20.5 23.5 30.6 26.3 20.8 24.1 23.6 33.5 18.5 21.3 23.3 25.1 26.4 32.6 22.7 26.6 39.0 18.4 21.3 22.1 25.6 19.6 20.4 17.1 19.1 21.8 12.9 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980797-39997960 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Supported Nucleoplasm,Cytosol 380000 Nucleoplasm Cytosol "CAB017038: , HPA048972: " "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 25.1 27.7 20.0 25.0 26.1 22.0 21.3 30.0 40.3 22.5 28.1 22.4 16.8 23.2 26.8 21.2 27.7 22.7 23.7 36.1 20.6 21.4 23.8 54.4 20.8 22.3 19.2 23.7 24.0 23.6 28.1 20.8 33.8 24.5 23.2 25.4 21.4 22.5 21.9 93.2 33.2 23.5 24.7 17.6 26.9 21.1 19.9 17.5 35.7 24.3 39.2 26.3 20.7 21.2 15.6 24.3 14.4 17.0 13.1 17.7 12.0 32.1 40.2 22.1 31.7 18.0 11.7 26.3 23.8 24.7 42.9 33.3 33.2 27.8 38.8 59.8 25.4 50.5 39.1 31.0 29.1 38.9 43.6 22.4 20.6 32.8 16.4 30.1 25.2 15.5 26.5 45.3 19.9 24.2 45.6 24.2 19.8 23.4 46.6 20.8 30.6 23.9 34.4 30.7 36.3 21.4 21.8 29.2 22.1 22.7 139.3 19.5 31.3 26.1 21.5 18.6 32.9 27.4 42.4 26.4 33.5 43.2 28.4 22.8 29.9 6.6 16.8 14.4 15.1 17.0 15.1 14.4 14.6 17.7 24.3 15.6 13.7 16.5 5.5 13.1 14.3 16.7 12.6 12.0 20.0 26.1 30.0 40.3 20.6 21.4 19.2 23.7 24.5 17.5 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254703-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 27.5 28.0 44.3 24.4 46.4 25.5 29.9 25.7 50.4 21.9 28.6 28.3 16.5 22.7 25.1 41.5 26.7 31.4 21.8 38.7 37.5 36.8 25.3 44.7 20.2 28.2 47.5 44.8 26.7 27.7 27.4 19.3 30.0 43.2 23.0 28.1 24.3 25.6 31.2 86.7 28.0 20.5 39.3 29.6 26.3 25.8 35.9 29.1 23.1 23.7 25.7 36.2 28.0 19.8 62.7 65.1 111.6 76.0 54.2 74.2 88.2 41.8 50.5 37.3 30.5 40.7 30.2 40.7 28.5 34.9 45.5 36.3 66.0 48.0 34.1 69.9 40.1 43.9 47.9 43.0 38.9 55.5 41.8 33.2 43.0 68.0 45.0 39.0 38.8 32.7 35.8 51.9 48.0 39.6 51.7 43.3 38.1 123.6 35.9 47.5 70.9 51.1 30.5 36.3 61.5 44.6 36.0 29.3 50.0 31.6 46.4 37.6 48.5 77.2 34.8 22.7 35.7 27.8 48.5 51.9 64.5 72.7 37.6 36.8 41.3 59.6 71.5 111.6 43.0 76.0 48.4 62.7 50.5 47.3 65.1 61.1 46.4 46.0 95.8 54.2 75.5 39.2 74.2 88.2 44.3 46.4 25.7 50.4 37.5 36.8 47.5 44.8 43.2 29.1 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842984 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol 12000000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 14.1 20.1 10.2 12.2 16.2 14.7 32.5 20.7 21.8 14.6 12.9 10.2 12.3 10.3 14.8 14.1 17.3 13.8 10.6 12.7 11.7 12.3 11.5 21.0 34.8 23.6 9.8 14.1 16.7 32.2 13.3 11.7 10.5 14.5 16.1 12.5 8.8 15.1 15.7 10.0 16.7 11.2 24.5 9.9 12.3 14.4 11.3 8.1 13.0 12.6 9.2 15.5 14.9 13.5 17.5 14.4 15.2 17.9 14.2 25.2 14.2 13.2 17.3 8.4 15.6 18.8 18.7 9.9 19.7 15.5 18.7 17.1 15.3 8.8 13.6 9.0 20.0 19.9 0.0 19.4 21.8 12.4 1.9 11.3 24.0 8.5 14.2 3.9 4.3 15.6 12.6 18.1 19.4 10.8 41.4 9.1 17.4 16.5 12.1 8.2 12.4 12.4 11.1 18.3 10.7 17.2 11.7 11.5 7.4 23.8 20.3 9.4 24.3 9.7 16.7 0.0 10.1 7.8 17.4 5.5 5.5 14.9 11.6 13.1 16.4 15.2 14.9 12.3 17.1 16.5 18.6 17.5 19.9 20.5 14.4 13.2 19.4 15.1 8.1 14.2 17.9 10.5 25.2 14.2 10.2 16.2 20.7 21.8 11.7 12.3 9.8 14.1 14.5 8.1 PSMD6 "KIAA0107, p44S10, Rpn7, S10" ENSG00000163636 "Proteasome 26S subunit, non-ATPase 6" Q15008 3 64010549-64024010 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "MCF7: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036921, HPA036922" Uncertain Supported "Golgi apparatus,Vesicles" 8600 Vesicles "Golgi apparatus" "HPA036921: , HPA036922: AB_10670850" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (4.76e-3)" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (1.82e-1)" "prognostic unfavourable (1.68e-4)" "unprognostic (8.65e-2)" "unprognostic (1.38e-1)" "unprognostic (1.95e-3)" "unprognostic (6.69e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (4.20e-2)" "unprognostic (1.89e-1)" "unprognostic (9.55e-2)" "unprognostic (8.22e-3)" 17.1 27.4 16.1 16.3 19.3 33.8 18.4 15.8 24.2 14.5 16.0 13.2 21.4 12.1 17.9 23.1 23.5 14.5 18.7 31.4 16.2 16.8 24.5 29.1 14.2 20.0 18.4 17.7 13.6 100.6 21.9 16.3 22.2 21.1 15.8 16.2 12.3 20.3 20.1 55.9 20.3 12.9 18.0 16.2 17.0 17.4 41.7 16.2 23.5 14.9 32.4 21.8 15.9 15.1 54.1 53.5 62.3 58.1 47.2 59.6 65.6 12.2 12.7 18.9 13.2 13.3 11.9 16.0 16.9 17.0 29.8 22.0 23.7 10.5 16.7 7.5 17.2 8.4 21.9 19.0 28.1 17.1 13.0 22.3 10.3 15.8 19.6 25.3 14.6 12.8 13.5 24.6 10.8 18.6 22.4 11.3 20.9 176.8 17.4 16.0 23.6 9.0 14.6 12.9 16.6 23.5 17.7 6.8 11.0 12.6 11.2 16.8 9.8 16.1 15.5 13.3 14.1 18.9 27.7 13.7 20.4 25.5 19.5 24.1 15.2 41.0 51.7 60.2 48.8 58.0 51.0 54.1 55.8 53.1 53.5 49.4 56.2 54.3 62.3 47.2 58.1 37.3 59.6 65.6 16.1 19.3 15.8 24.2 16.2 16.8 18.4 17.7 21.1 16.2 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374536-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavourable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 53.0 35.1 30.0 23.9 35.6 32.9 43.0 28.1 49.4 26.5 31.8 25.8 30.1 31.5 30.9 40.9 39.1 32.5 28.0 75.3 32.2 29.3 40.9 71.1 28.8 28.8 27.1 37.0 24.4 48.2 30.6 29.2 56.6 30.0 33.6 32.9 24.6 32.6 29.7 157.1 42.2 33.2 34.5 25.0 27.6 28.9 55.8 21.4 38.1 35.4 50.1 33.9 28.3 27.1 40.4 60.8 32.0 68.1 38.8 65.6 68.7 61.1 97.6 38.5 43.9 62.8 50.6 20.2 44.6 60.9 68.7 71.9 66.9 36.9 43.2 46.6 59.3 21.3 64.3 55.4 62.1 71.1 42.4 46.9 32.2 41.2 81.2 47.2 41.7 50.9 55.4 59.1 78.8 53.9 58.4 48.6 75.4 60.9 44.5 26.6 29.9 53.3 46.5 61.9 34.3 48.6 51.0 40.3 41.0 46.2 59.9 43.2 31.3 44.6 39.6 52.6 48.6 55.0 65.2 49.2 56.8 57.6 79.1 48.6 58.3 32.0 55.2 29.2 46.1 59.9 39.1 40.4 40.4 44.2 60.8 37.0 33.6 32.6 20.8 38.8 68.1 42.3 65.6 68.7 30.0 35.6 28.1 49.4 32.2 29.3 27.1 37.0 30.0 21.4 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888731-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" 330000 Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 25.6 10.7 11.5 12.9 12.1 27.8 18.7 15.3 12.0 9.6 22.1 9.2 14.8 19.5 14.4 13.6 12.3 10.7 12.5 13.9 10.6 11.2 19.2 19.8 12.3 14.8 10.6 9.0 13.0 28.6 4.9 8.3 8.7 12.7 9.5 4.8 9.4 15.3 14.2 28.6 12.4 16.3 15.7 11.6 14.8 24.7 13.6 8.7 13.8 10.9 17.1 9.2 8.2 11.8 24.5 36.7 29.6 26.3 14.9 25.9 27.3 20.5 31.6 2.6 4.8 4.4 4.5 5.5 21.0 6.8 10.5 6.0 23.0 2.5 15.3 17.8 10.8 8.4 7.5 11.0 6.3 29.6 16.6 12.5 14.7 11.4 11.0 8.8 8.9 8.0 5.2 11.8 4.5 6.3 11.2 2.2 6.6 24.1 17.5 6.6 5.5 24.7 13.4 7.2 9.4 5.1 20.7 5.5 7.7 21.1 3.1 11.3 9.1 4.4 16.6 10.1 11.6 19.7 14.6 12.0 25.9 22.3 18.1 11.5 9.2 20.3 26.3 29.6 20.9 25.4 16.7 24.5 20.1 18.9 22.2 19.5 15.8 13.6 24.1 14.9 22.0 36.7 25.9 27.3 11.5 12.1 15.3 12.0 10.6 11.2 10.6 9.0 12.7 8.7 PSME1 "IFI5111, PA28alpha" ENSG00000092010 "Proteasome activator subunit 1" Q06323 14 24136158-24138967 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006632 Approved Approved "Nuclear bodies,Cytosol" 8600000 Cytosol "Nuclear bodies" "HPA006632: AB_1079686" "prognostic favourable (8.87e-5)" "unprognostic (1.02e-2)" "unprognostic (9.90e-2)" "unprognostic (2.84e-1)" "unprognostic (2.65e-1)" "unprognostic (1.97e-1)" "unprognostic (5.16e-1)" "unprognostic (7.04e-2)" "unprognostic (9.63e-3)" "unprognostic (5.06e-3)" "unprognostic (1.49e-2)" "unprognostic (1.38e-2)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (4.50e-1)" "prognostic favourable (4.60e-4)" "unprognostic (1.62e-3)" 37.6 59.1 19.1 64.4 23.0 37.2 59.7 9.9 16.9 34.8 53.9 15.3 47.4 48.2 40.3 50.4 45.4 39.4 53.4 59.1 19.6 17.2 67.7 70.3 61.7 114.2 24.8 17.4 46.7 47.2 26.4 30.6 42.7 21.3 39.2 44.8 28.4 38.0 57.0 38.0 33.7 82.3 45.0 20.4 82.8 38.9 14.5 22.5 70.5 58.4 54.3 52.0 35.8 40.4 68.2 72.2 112.1 93.3 81.2 87.8 132.3 17.4 14.6 11.1 21.3 24.2 28.0 17.0 11.2 36.5 35.9 51.6 9.3 42.7 45.1 8.4 18.6 25.4 15.8 23.2 24.1 37.6 9.7 20.0 7.2 51.5 53.3 25.5 25.6 24.4 14.9 16.2 14.3 27.1 3.1 40.3 14.0 44.4 65.5 31.1 1.0 25.2 52.1 22.8 32.4 45.3 46.4 7.1 12.6 14.2 37.1 21.6 24.3 25.1 15.2 9.9 11.7 11.2 16.6 37.7 38.7 21.3 13.4 22.8 15.9 53.2 74.4 89.4 87.0 93.3 87.0 68.2 82.0 82.6 72.2 61.6 59.4 72.7 112.1 81.2 89.4 68.5 87.8 132.3 19.1 23.0 9.9 16.9 19.6 17.2 24.8 17.4 21.3 22.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA057193: , HPA070225: " "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 26.8 8.8 6.4 8.8 3.2 3.6 17.1 14.9 6.5 11.6 7.5 16.1 7.1 29.1 7.9 4.2 7.7 10.1 7.9 7.6 12.4 15.9 54.9 13.7 20.9 5.8 26.1 11.0 5.0 5.9 12.3 12.5 6.1 40.4 16.7 6.9 14.2 16.1 14.1 22.2 13.7 26.2 8.0 29.6 4.8 8.0 20.5 6.0 18.7 10.5 14.7 10.0 13.1 6.9 13.4 4.6 18.0 20.9 12.8 20.3 25.2 11.4 44.2 10.3 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 PSMG2 "CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1" ENSG00000128789 "Proteasome assembly chaperone 2" Q969U7 18 12658043-12725740 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041517, HPA046741" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA041517: AB_2677530, HPA046741: " "unprognostic (2.28e-2)" "unprognostic (9.44e-3)" "unprognostic (9.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.40e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "prognostic favourable (3.09e-4)" "unprognostic (5.91e-2)" "unprognostic (2.27e-1)" "unprognostic (1.73e-1)" "unprognostic (9.04e-2)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (6.75e-3)" 37.3 31.0 24.1 25.2 25.2 42.0 37.4 26.2 27.4 30.5 30.3 24.7 20.6 25.6 34.8 39.6 43.4 27.8 39.2 28.5 23.5 23.4 38.7 46.8 30.9 41.8 24.0 18.9 35.7 44.8 9.9 26.4 35.4 23.0 32.5 35.2 24.8 31.9 28.5 29.0 32.2 34.6 38.1 27.0 35.1 31.0 71.6 20.6 49.0 40.3 37.1 41.3 38.1 29.9 28.8 31.2 33.0 40.9 27.6 41.5 33.2 21.0 13.6 15.8 20.5 29.6 43.3 21.1 20.2 33.2 38.1 43.1 23.0 23.7 24.4 16.6 24.5 13.5 25.6 27.8 33.3 12.6 12.2 13.4 12.2 27.9 28.3 45.2 20.8 34.6 22.0 22.4 30.8 26.6 19.9 31.3 29.5 21.0 28.6 62.6 12.4 16.0 19.5 23.8 35.0 34.3 29.7 19.3 14.8 19.9 23.5 19.1 20.5 37.9 17.0 42.4 54.4 35.6 23.6 26.1 36.2 28.7 24.9 23.5 17.0 29.0 35.8 33.0 27.5 36.3 32.7 28.8 36.1 31.6 31.2 26.1 33.1 31.0 12.0 27.6 40.9 25.8 41.5 33.2 24.1 25.2 26.2 27.4 23.5 23.4 24.0 18.9 23.0 20.6 PSMG4 "C6orf86, PAC4" ENSG00000180822 "Proteasome assembly chaperone 4" Q5JS54 6 3231403-3303373 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067652 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA067652: " "unprognostic (3.13e-3)" "unprognostic (6.00e-2)" "unprognostic (3.60e-1)" "unprognostic (4.11e-2)" "unprognostic (4.11e-1)" "unprognostic (2.20e-1)" "unprognostic (6.52e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-2)" "unprognostic (6.74e-3)" "unprognostic (7.40e-3)" "unprognostic (3.02e-2)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.59e-1)" "unprognostic (8.18e-2)" "unprognostic (2.54e-1)" "unprognostic (3.48e-2)" 13.9 12.7 12.6 13.0 26.1 14.3 16.0 18.5 14.4 15.8 15.1 11.8 11.3 17.3 16.7 23.1 16.9 13.4 18.7 12.9 11.4 14.0 13.1 18.1 11.0 15.2 10.7 12.2 13.8 30.9 8.9 16.2 9.6 10.7 15.5 8.9 13.6 21.0 18.8 36.6 17.9 16.8 18.1 10.6 11.9 17.4 13.3 9.8 13.5 17.2 16.5 14.6 13.1 11.3 25.6 18.5 12.2 20.1 16.2 24.4 13.2 21.1 10.4 6.3 15.5 5.7 8.4 10.8 9.6 7.2 9.2 15.1 8.8 7.3 7.1 26.3 5.7 10.0 5.2 6.4 6.0 12.0 22.4 5.7 10.7 22.6 6.8 16.5 6.1 7.1 7.2 6.7 10.0 11.5 22.1 5.5 4.9 20.2 9.4 30.5 7.6 20.5 12.5 3.4 39.4 7.3 8.4 27.0 7.8 4.3 6.1 20.5 7.8 7.4 10.9 7.9 7.4 8.7 9.2 17.9 25.3 13.1 5.5 11.9 10.6 6.2 20.1 12.2 14.8 18.4 17.0 25.3 24.4 17.8 15.5 25.6 24.4 20.9 4.8 16.2 18.1 18.5 20.5 13.2 12.6 26.1 18.5 14.4 11.4 14.0 10.7 12.2 10.7 9.8 PSPC1 "FLJ10955, PSP1" ENSG00000121390 "Paraspeckle component 1" Q8WXF1 13 19674752-19783019 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038904 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA038904: AB_10673291" "unprognostic (2.13e-3)" "unprognostic (3.48e-1)" "unprognostic (1.52e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-3)" "unprognostic (2.14e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (1.13e-3)" "unprognostic (9.57e-2)" "unprognostic (1.09e-1)" "unprognostic (1.69e-3)" "unprognostic (3.04e-3)" "unprognostic (2.92e-1)" "unprognostic (3.69e-2)" "unprognostic (8.61e-2)" "prognostic favourable (1.46e-4)" "unprognostic (7.72e-2)" 10.6 14.6 17.8 14.1 18.7 45.0 16.8 24.6 24.7 13.9 15.0 15.3 11.7 12.6 16.0 23.3 15.6 17.1 12.8 11.4 18.9 19.8 13.1 9.2 10.2 19.0 14.6 18.4 16.3 11.2 8.4 23.6 25.7 15.9 11.9 16.4 17.6 11.4 9.4 20.3 14.7 13.1 15.0 12.2 13.8 12.3 23.9 13.6 27.5 12.9 10.7 21.2 12.3 10.9 18.2 17.8 14.8 18.7 9.6 18.2 12.1 18.2 7.6 17.9 8.9 7.4 7.9 23.3 9.8 13.0 18.7 17.0 25.2 10.6 24.4 10.6 10.4 9.3 20.7 11.9 19.6 10.5 10.2 28.0 5.5 30.6 14.5 20.1 18.0 12.1 2.5 11.3 12.7 15.8 15.2 10.1 16.3 19.9 23.5 19.6 25.1 10.1 16.2 17.9 12.7 19.2 27.8 16.5 8.5 13.4 22.7 8.6 13.2 21.2 9.3 11.3 10.8 10.7 9.4 8.7 5.1 42.2 5.1 12.1 13.4 10.6 18.1 11.0 10.2 18.7 11.1 18.2 13.7 9.4 16.6 18.0 13.8 10.4 14.8 9.6 13.5 17.8 18.2 12.1 17.8 18.7 24.6 24.7 18.9 19.8 14.6 18.4 15.9 13.6 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" "HPA049315, HPA056561" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA049315: , HPA056561: " "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavourable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.4 9.5 39.1 18.9 1.5 3.1 10.7 14.7 11.9 20.1 19.3 14.7 7.7 9.4 5.4 7.2 13.3 21.1 12.0 16.9 3.6 10.1 5.9 12.8 12.0 1.8 6.2 6.7 3.5 1.1 7.9 5.6 9.8 13.3 4.3 16.0 16.8 9.5 4.2 16.2 10.9 14.7 37.7 3.1 6.7 4.8 16.5 9.5 8.3 12.7 15.0 7.6 6.0 5.0 12.4 20.6 8.7 24.1 3.4 2.2 3.2 10.0 15.0 34.5 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: , HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 2.8 5.6 7.0 2.5 8.8 12.5 8.8 4.3 10.4 5.8 4.3 10.5 4.7 4.6 5.4 11.4 3.7 5.6 3.5 4.7 7.5 7.3 5.5 10.6 2.8 4.0 8.8 8.7 3.8 5.4 4.2 7.2 3.7 9.3 5.6 4.3 3.8 4.3 3.6 6.8 3.8 3.8 5.4 8.7 2.9 3.0 11.1 8.6 2.9 6.8 1.4 3.6 4.8 3.2 6.5 7.4 6.3 5.5 6.6 10.0 6.0 5.4 3.8 2.0 1.0 2.5 4.7 2.6 2.0 5.2 4.6 5.5 5.6 4.8 5.5 5.0 3.7 2.9 1.0 4.6 5.3 2.9 10.2 3.7 0.9 4.4 6.0 7.6 4.6 5.2 8.0 4.1 7.9 3.2 5.1 8.5 6.7 8.1 2.6 4.7 4.7 5.5 5.5 3.6 5.0 6.9 3.3 2.2 2.4 4.6 5.2 7.6 2.4 0.6 3.8 3.6 3.4 1.4 5.2 3.1 1.7 7.5 3.3 5.2 1.4 0.0 5.5 6.3 8.9 3.3 10.0 6.5 6.9 8.4 7.4 5.8 9.2 9.4 0.6 6.6 3.9 7.0 4.2 6.0 7.0 8.8 4.3 10.4 7.5 7.3 8.8 8.7 9.3 8.6 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell line enhanced" "Detected in many" "HEL: 37.1;HMC-1: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.8 5.5 2.7 2.0 1.7 4.2 1.5 0.0 0.3 1.8 13.5 7.6 10.4 2.5 0.0 1.2 37.1 1.8 0.0 2.2 2.1 41.2 1.9 13.0 1.9 6.2 3.9 8.8 0.0 8.6 1.3 0.3 0.0 0.8 0.0 0.0 2.8 1.8 4.2 13.6 0.1 0.8 0.9 3.8 0.1 12.2 4.3 2.8 0.2 3.1 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.3;HMC-1: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.5 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 2.1 0.5 0.0 0.0 5.2 0.2 14.3 0.3 0.1 0.2 2.8 0.0 0.3 0.0 0.7 52.4 0.0 2.3 0.1 0.1 0.0 0.2 0.2 0.0 0.5 0.0 7.1 0.2 0.1 0.1 0.0 0.0 3.5 0.8 0.1 0.0 0.0 7.1 0.0 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 PTAR1 ENSG00000188647 "Protein prenyltransferase alpha subunit repeat containing 1" Q7Z6K3 9 69709522-69759959 "Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021248 Uncertain Approved "Centriolar satellite,Rods & Rings" "Centriolar satellite" "Rods & Rings" "HPA021248: AB_1855872" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (9.40e-2)" "unprognostic (1.71e-1)" "unprognostic (4.16e-1)" "unprognostic (6.99e-2)" "prognostic favourable (4.65e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" 16.2 11.2 18.9 13.8 16.8 40.6 18.6 18.7 21.3 17.4 15.8 17.7 13.1 10.2 20.3 11.1 14.8 16.0 13.0 15.8 20.1 8.8 22.2 19.9 19.1 15.9 18.8 12.6 21.5 19.1 27.1 21.5 17.0 14.9 12.4 21.5 17.4 17.8 13.6 23.3 15.8 17.6 15.3 16.5 16.2 13.1 14.9 20.3 38.9 16.2 8.9 14.0 17.4 18.2 4.0 3.4 13.2 6.3 4.8 6.8 2.5 7.7 9.9 12.8 6.4 12.2 15.7 7.4 18.3 13.1 6.3 7.0 3.3 5.2 7.7 8.9 14.4 12.4 29.4 7.0 14.4 7.9 7.8 12.7 17.7 7.1 12.1 10.7 10.8 9.6 6.6 11.6 16.7 10.6 8.0 17.3 16.2 2.0 8.8 3.8 16.9 7.2 9.2 20.8 5.7 14.5 7.5 9.8 11.8 12.6 5.3 9.4 3.8 4.8 19.0 15.7 14.4 12.5 14.9 11.6 11.8 5.1 10.6 10.3 27.8 6.8 4.6 6.3 5.2 6.3 4.7 4.0 4.3 3.7 3.4 2.7 4.9 5.3 13.2 4.8 3.5 2.0 6.8 2.5 18.9 16.8 18.7 21.3 20.1 8.8 18.8 12.6 14.9 20.3 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell line enhanced" "Detected in some" "AF22: 10.8;BEWO: 14.4;Hep G2: 24.0;LHCN-M2: 11.4;TIME: 12.1;WM-115: 10.5" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favourable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.8 0.0 1.8 5.3 14.4 1.6 3.4 0.1 0.4 0.0 0.7 0.0 0.0 0.9 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 24.0 0.5 0.0 0.0 7.9 7.7 0.0 0.1 1.6 0.0 0.0 11.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 12.1 2.6 1.7 0.0 0.2 0.0 0.0 0.0 3.6 0.0 10.5 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261715-96336995 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavourable (1.08e-5)" "prognostic unfavourable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 8.2 7.9 8.0 8.1 14.7 10.2 10.4 10.2 15.0 9.7 8.3 5.1 22.5 10.6 8.4 7.8 9.6 7.0 7.9 20.1 8.6 9.9 9.5 12.8 7.8 21.8 7.1 8.0 9.6 12.1 23.2 4.9 10.8 9.6 5.7 7.4 5.2 8.8 29.8 10.1 10.4 8.3 9.0 6.0 11.8 8.1 5.1 3.6 20.7 11.0 7.7 11.8 9.3 6.8 3.6 6.1 9.4 3.7 5.0 4.6 7.8 10.4 8.1 1.4 3.9 2.9 6.1 2.4 7.6 10.5 7.3 5.1 3.0 3.0 17.2 7.0 7.1 4.3 9.9 7.6 11.4 8.8 7.1 16.9 15.6 1.6 3.0 12.4 5.9 5.1 7.3 10.2 7.2 4.7 8.4 8.9 6.6 3.0 9.6 1.9 2.2 7.6 7.7 7.3 13.0 4.1 8.9 6.1 2.5 2.8 2.5 1.1 5.9 4.2 8.3 6.6 4.1 4.5 8.7 1.8 9.2 8.4 4.1 13.1 5.3 9.4 3.7 2.1 2.8 2.5 4.0 2.6 4.6 3.4 6.1 3.6 4.0 2.9 1.3 5.0 2.4 1.8 2.6 7.8 8.0 14.7 10.2 15.0 8.6 9.9 7.1 8.0 9.6 3.6 PTEN "BZS, MHAM, MMAC1, PTEN1, TEP1" ENSG00000171862 "Phosphatase and tensin homolog" P60484 10 87863113-87971930 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Lipid metabolism, Neurogenesis" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004076, HPA031335" Approved Supported Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "CAB004076: AB_390810, HPA031335: " "unprognostic (8.72e-2)" "unprognostic (2.45e-1)" "unprognostic (5.43e-1)" "unprognostic (1.50e-2)" "unprognostic (3.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (2.07e-1)" "unprognostic (6.87e-2)" "unprognostic (9.77e-2)" "unprognostic (2.71e-1)" "prognostic unfavourable (7.35e-4)" "unprognostic (1.57e-1)" "unprognostic (2.73e-1)" "unprognostic (6.54e-3)" "unprognostic (2.41e-1)" 42.4 24.1 17.7 20.9 17.7 13.5 32.8 39.9 19.7 43.1 26.7 9.9 19.0 15.1 29.8 22.8 26.8 30.3 21.0 19.1 16.0 17.4 19.6 32.4 27.2 30.4 15.7 19.5 29.1 21.3 16.4 23.6 36.4 14.2 35.3 17.7 21.6 16.8 20.8 16.8 20.4 25.4 26.0 11.7 40.9 17.8 18.7 12.5 49.7 25.2 13.3 18.6 29.6 30.9 4.3 5.1 29.6 11.0 4.3 4.7 2.0 10.4 4.9 5.7 5.1 13.1 9.0 5.1 5.6 12.5 6.6 9.3 5.0 12.9 12.3 3.8 9.2 6.3 7.5 6.4 10.5 6.2 2.1 4.1 12.8 6.1 14.0 13.8 7.1 6.1 17.9 8.3 10.8 9.3 3.1 33.6 6.0 8.0 7.7 25.1 2.1 0.0 12.0 3.0 9.1 10.3 6.0 2.0 9.2 7.5 3.5 9.4 9.9 20.0 8.1 21.9 5.1 8.5 4.5 11.1 14.3 14.1 6.8 13.1 1.3 8.3 7.9 12.2 3.6 11.0 3.9 4.3 4.0 3.5 5.1 3.7 4.7 4.5 29.6 4.3 7.2 4.2 3.5 2.0 17.7 17.7 39.9 19.7 16.0 17.4 15.7 19.5 14.2 12.5 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038044: , HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favourable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 11.1 5.4 21.6 10.6 2.9 1.3 8.7 8.9 30.8 6.2 12.1 1.6 14.5 9.2 5.8 8.1 6.9 3.4 3.8 7.8 22.7 8.9 31.3 21.9 9.2 12.6 4.2 1.3 5.3 17.9 11.1 3.4 11.2 3.1 11.3 5.4 6.8 10.6 12.9 6.2 4.0 21.9 5.7 2.6 11.8 9.2 2.9 1.5 17.2 12.0 3.9 9.6 7.7 10.9 15.3 11.7 6.9 16.7 7.6 19.5 9.4 16.1 9.7 0.1 2.9 4.1 8.1 9.7 4.8 0.5 1.8 2.7 8.9 15.3 17.0 4.0 3.2 7.4 5.5 3.2 2.7 16.6 7.2 15.8 4.6 3.6 4.9 5.1 4.8 5.9 10.4 5.5 0.9 0.8 10.8 6.0 2.8 5.4 11.9 5.1 3.9 2.4 8.9 1.3 8.9 25.5 5.1 12.3 0.8 8.5 2.4 14.0 5.7 16.2 2.1 0.1 4.3 3.9 0.1 4.5 5.6 18.0 2.0 9.4 6.0 3.5 11.7 6.9 12.7 16.7 13.5 15.3 14.6 12.6 11.7 8.8 11.0 10.9 2.2 7.6 14.5 9.9 19.5 9.4 21.6 2.9 8.9 30.8 22.7 8.9 4.2 1.3 3.1 1.5 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 358.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol 580000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavourable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavourable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favourable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 44.7 41.4 56.0 41.2 55.7 39.6 175.0 44.2 51.7 49.0 51.9 38.1 49.5 46.4 57.7 52.0 52.6 69.8 36.0 46.0 54.6 57.2 52.1 67.1 46.4 62.0 67.0 41.4 82.3 55.1 43.2 49.2 50.3 57.0 60.7 55.3 24.0 36.6 49.4 64.2 37.0 46.7 64.7 72.5 42.7 36.6 39.7 65.1 53.5 72.5 36.7 55.1 72.7 358.9 40.6 36.9 27.3 74.8 29.2 42.5 60.5 79.9 69.8 56.6 33.7 41.7 37.9 86.3 52.4 40.1 67.5 50.5 59.1 84.4 88.7 79.7 44.7 51.6 106.1 68.5 85.6 65.1 70.6 69.2 44.1 68.2 30.6 82.2 50.3 27.4 50.1 51.0 61.9 69.4 111.0 85.0 65.9 49.9 81.6 78.1 96.7 81.5 71.4 53.4 119.0 59.4 62.6 73.4 42.9 53.5 77.2 45.4 88.9 69.1 41.6 40.6 47.2 48.7 72.4 35.8 98.6 71.3 44.2 67.9 73.0 27.3 37.5 23.2 32.0 59.0 42.0 40.6 42.5 38.1 36.9 28.5 42.3 36.4 14.8 29.2 74.8 31.3 42.5 60.5 56.0 55.7 44.2 51.7 54.6 57.2 67.0 41.4 57.0 65.1 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 46.6" "Cell line enhanced" "Detected in many" "RH-30: 6.6;THP-1: 13.0" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 5.3" "Lineage enriched" "Detected in single" 28 "dendritic cells: 5.3" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.7 0.1 0.7 1.2 4.5 1.2 0.5 0.6 1.6 1.5 5.5 0.3 0.1 1.7 4.7 2.4 2.2 1.6 3.6 13.8 0.5 0.7 0.3 0.2 0.6 0.7 0.6 0.8 0.7 0.3 0.4 1.5 0.4 0.4 2.0 3.2 1.6 0.7 3.1 46.6 0.2 1.6 10.6 0.2 0.4 2.4 3.8 0.2 0.5 0.5 14.4 0.8 5.1 1.4 0.1 5.3 0.0 0.0 0.0 0.0 0.4 1.0 0.0 2.7 2.6 0.3 0.0 0.8 2.2 1.9 1.2 1.1 1.7 0.3 0.3 1.7 0.2 0.0 0.4 1.1 1.8 1.0 0.4 5.5 2.2 4.0 0.0 0.5 3.9 0.1 0.7 1.9 0.1 0.6 1.9 0.4 2.2 0.0 1.8 1.4 0.7 0.5 1.5 6.6 0.7 0.3 0.5 1.3 3.4 1.4 0.5 1.4 0.9 13.0 0.0 0.9 1.7 0.0 0.7 3.6 1.1 0.3 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.7 4.5 0.6 1.6 0.5 0.7 0.6 0.8 0.4 0.2 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 211.4;urinary bladder: 163.9" "Cell line enhanced" "Detected in some" "ASC diff: 28.1;ASC TERT1: 22.3;BJ: 27.3;BJ hTERT+: 37.3;HEL: 17.1;HMC-1: 72.7" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" 25000000 "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (9.35e-4)" 4.5 1.1 1.8 9.1 3.1 2.6 2.5 0.5 2.7 2.6 35.3 4.6 3.0 3.9 2.5 1.6 25.7 16.7 9.4 4.9 1.9 1.6 3.9 1.8 4.0 1.4 3.5 0.7 3.6 1.0 0.7 2.4 0.8 2.5 60.9 9.3 1.5 1.9 2.3 0.7 55.9 6.5 211.4 4.9 3.6 7.8 1.0 3.1 0.4 1.5 5.3 4.2 163.9 19.5 2.5 13.0 14.4 8.5 1.9 0.1 13.7 0.0 0.1 0.1 0.0 28.1 22.3 0.0 27.3 37.3 0.2 0.2 0.0 0.0 0.9 1.3 4.6 1.7 0.0 2.5 0.2 0.0 0.0 17.1 0.1 0.0 8.1 1.1 72.7 11.4 0.2 1.4 0.0 10.1 0.0 0.0 0.5 0.0 0.0 1.5 0.3 0.1 0.0 0.3 2.0 3.5 0.0 0.1 0.1 0.1 2.3 0.0 0.0 1.9 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 7.4 0.0 12.0 7.6 14.4 0.0 8.5 0.0 1.7 0.0 0.0 13.0 2.5 0.0 0.0 3.5 1.9 6.1 0.9 0.1 13.7 1.8 3.1 0.5 2.7 1.9 1.6 3.5 0.7 2.5 3.1 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972705 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.6" "Group enriched" "Detected in some" 4 "HaCaT: 63.2;HBEC3-KT: 78.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "T-reg: 3.0" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavourable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavourable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 2.9 1.0 6.5 3.5 5.3 0.0 20.2 1.4 8.7 11.0 2.3 1.4 2.1 2.4 11.2 2.0 17.0 1.2 45.6 4.0 4.3 3.5 0.4 0.2 1.3 1.1 1.4 4.3 2.6 1.7 0.7 2.3 3.6 3.1 5.5 1.8 2.4 5.3 2.6 0.7 1.5 1.6 13.4 0.8 3.6 1.9 1.3 1.0 0.1 1.4 15.8 3.4 8.0 12.3 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.3 2.1 0.0 0.0 0.6 0.6 0.0 0.0 0.2 0.1 0.2 0.0 1.7 0.0 0.1 0.5 63.2 0.2 78.1 0.0 1.5 0.3 0.1 0.4 0.0 0.1 0.0 0.1 0.0 4.3 2.0 7.7 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.3 0.1 7.6 0.0 0.0 0.0 3.5 0.0 0.4 0.1 0.0 1.2 0.3 1.9 1.1 16.6 1.0 0.0 2.5 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 6.5 5.3 1.4 6.2 4.3 3.5 1.4 4.3 3.1 1.0 PTK2 "FADK, FAK, FAK1, PPP1R71" ENSG00000169398 "Protein tyrosine kinase 2" Q05397 8 140657900-141002216 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001842, CAB004036, HPA029671" Approved Supported "Vesicles,Focal adhesion sites,Cytosol" 32000 "Focal adhesion sites" "Vesicles, Cytosol" "CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288" "prognostic unfavourable (3.21e-4)" "unprognostic (3.86e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.93e-1)" "unprognostic (2.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.96e-2)" "unprognostic (1.06e-2)" "unprognostic (2.38e-1)" "unprognostic (2.80e-2)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" 22.6 20.4 36.0 14.4 42.3 3.1 19.3 20.5 40.8 24.9 17.9 55.7 23.5 14.5 20.2 29.9 14.6 18.7 18.4 20.0 43.5 23.9 22.3 17.0 21.5 13.0 41.4 31.4 19.4 18.2 33.1 13.0 42.1 30.0 19.2 20.7 11.0 21.9 25.5 17.9 13.5 16.3 21.9 38.0 12.2 17.5 21.2 46.1 2.8 22.5 10.2 14.0 22.2 17.8 8.6 7.2 1.8 3.9 5.2 5.7 4.1 14.6 23.4 32.5 11.7 13.7 14.7 21.0 14.5 20.2 13.6 13.4 10.2 12.2 8.9 33.0 18.6 17.4 19.1 33.3 20.6 0.1 8.9 19.7 12.9 14.0 18.7 0.0 9.4 10.0 16.4 17.0 24.0 40.1 19.8 0.2 18.2 25.5 0.2 0.2 12.6 26.2 13.1 17.8 0.4 28.7 33.5 12.9 16.1 22.7 7.3 14.7 17.2 0.3 24.2 13.4 25.3 15.8 16.3 0.0 0.1 0.9 17.4 0.1 18.1 1.8 3.9 0.0 0.3 1.6 0.0 6.8 0.8 0.1 5.3 8.6 5.7 2.0 1.7 5.2 0.9 7.2 0.2 4.1 36.0 42.3 20.5 40.8 43.5 23.9 41.4 31.4 30.0 46.1 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.7;brain: 65.2" "Cell line enhanced" "Detected in many" "Daudi: 37.0;REH: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5" "Low region specificity" "Detected in many" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" 84000 "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favourable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favourable (5.11e-4)" "unprognostic (3.33e-3)" 7.2 4.7 20.4 24.3 30.0 46.7 4.9 65.2 48.3 5.4 14.5 7.8 5.0 16.6 4.3 4.7 7.9 6.8 6.4 4.7 30.5 7.0 6.8 5.0 11.5 35.6 4.3 25.4 2.4 5.4 5.2 5.3 4.1 3.9 10.1 11.9 8.3 12.6 6.7 2.2 15.1 18.4 5.5 4.8 32.0 10.8 4.3 3.7 37.8 5.6 2.9 35.4 13.0 6.0 26.9 18.7 24.0 25.8 14.7 19.0 21.5 10.9 3.0 0.8 0.9 23.5 1.7 6.4 0.8 0.5 0.6 0.8 2.9 6.3 37.0 1.2 1.7 10.1 0.3 9.2 0.3 2.5 0.2 7.6 2.9 0.5 4.8 8.2 13.8 12.7 13.8 0.8 5.3 0.3 8.9 25.7 0.6 1.1 14.0 16.5 0.6 0.8 41.0 0.2 25.3 2.6 8.6 5.8 1.0 3.9 2.7 1.4 3.3 21.2 5.2 0.4 0.8 0.7 0.3 20.7 8.9 20.0 1.6 17.8 0.7 22.3 23.7 18.0 19.0 22.4 12.5 25.5 9.6 13.3 18.7 26.9 12.1 14.2 24.0 14.7 25.8 6.2 9.5 21.5 20.4 30.0 65.2 48.3 30.5 7.0 4.3 25.4 3.9 3.7 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell line enhanced" "Detected in some" "A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavourable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 11.3 1.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 21.8 0.0 3.9 0.0 17.7 0.0 0.0 0.0 2.8 0.2 0.0 4.5 0.0 0.0 0.0 3.6 0.0 24.0 0.0 0.1 0.0 0.1 1.3 0.1 6.3 0.0 0.1 0.1 8.2 0.0 0.6 0.2 0.0 13.8 0.2 1.2 1.3 4.3 0.0 13.3 0.8 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.2 0.2 0.6 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 PTMA TMSA ENSG00000187514 "Prothymosin alpha" P06454 2 231706895-231713541 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047183 Approved Supported Nucleoplasm,Cytosol 610000 Nucleoplasm Cytosol "HPA047183: " "unprognostic (1.49e-3)" "prognostic favourable (6.56e-4)" "unprognostic (3.73e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.52e-2)" "prognostic unfavourable (3.61e-4)" "unprognostic (5.99e-2)" "unprognostic (1.56e-2)" "unprognostic (3.72e-3)" "unprognostic (2.35e-3)" "unprognostic (9.24e-2)" "prognostic unfavourable (1.99e-7)" "unprognostic (5.54e-2)" "unprognostic (6.07e-2)" "unprognostic (3.81e-3)" "unprognostic (8.64e-3)" 72.8 37.7 60.0 78.4 65.2 161.4 76.1 38.2 64.2 75.0 80.9 53.9 33.9 56.3 84.8 59.9 83.7 66.7 47.2 38.7 66.3 48.3 67.3 73.5 63.5 104.0 68.7 59.6 80.5 79.5 31.3 97.9 59.1 54.2 50.0 82.7 42.2 55.5 53.4 60.6 92.5 62.8 58.4 86.6 90.1 69.2 113.9 67.2 127.5 73.4 50.4 118.6 70.0 69.9 189.1 134.7 114.4 126.9 117.0 167.3 255.0 97.8 58.8 83.9 74.8 25.5 34.1 86.2 66.8 56.1 58.4 61.3 56.9 114.7 155.0 76.6 52.1 51.8 118.0 82.3 74.3 122.8 92.8 199.7 48.5 91.9 31.7 226.6 85.5 49.3 30.9 51.7 42.8 95.2 116.0 66.0 50.9 139.8 318.2 309.0 126.3 49.1 219.3 59.8 105.4 71.5 87.5 171.3 105.4 76.8 76.9 58.4 57.9 180.2 70.6 49.3 87.5 60.2 71.8 80.0 39.3 310.3 33.7 139.0 78.9 114.4 113.6 75.3 99.1 114.0 143.5 189.1 143.8 120.6 126.3 160.4 160.6 134.8 23.1 117.0 126.9 134.7 167.3 255.0 60.0 65.2 38.2 64.2 66.3 48.3 68.7 59.6 54.2 67.2 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" HPA038186 Approved Approved Nucleoplasm,Nucleoli 31000 Nucleoli Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.0 26.9 46.2 43.3 25.0 21.0 16.7 26.5 29.7 24.2 20.8 17.0 24.9 2.3 19.9 48.1 12.7 26.8 24.6 9.6 83.3 36.4 2.9 15.8 5.8 28.3 0.7 7.1 19.9 10.0 17.4 35.8 27.0 21.1 6.1 22.0 15.3 1.1 4.9 44.0 29.1 0.5 12.1 5.0 19.0 1.2 14.2 46.0 29.0 10.9 22.7 9.9 3.0 36.6 33.3 46.3 4.6 24.1 5.3 2.5 3.1 25.9 2.0 24.2 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol 4800000 Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favourable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 16.5 35.1 41.6 19.8 41.2 18.1 23.9 32.0 74.2 27.5 27.4 27.2 30.1 18.3 26.7 26.0 31.8 30.1 28.7 42.1 38.0 32.4 32.6 41.0 22.1 19.8 30.8 35.5 23.2 22.4 55.0 22.5 21.4 37.0 33.4 21.7 20.8 36.0 41.5 110.7 27.2 18.8 35.3 21.9 24.4 23.8 62.4 17.6 23.7 27.2 37.0 21.3 22.1 23.9 12.6 19.2 7.8 15.5 17.7 18.4 14.9 24.8 44.1 27.2 50.4 18.4 22.6 27.2 26.0 29.5 35.8 25.0 23.6 30.7 25.9 19.7 44.1 40.5 28.4 32.1 30.8 46.0 15.5 16.0 46.7 22.4 54.8 27.6 34.8 27.0 31.7 26.1 24.9 36.4 23.7 28.8 30.0 64.5 25.1 17.1 42.7 43.9 25.1 25.1 47.6 37.5 31.2 29.5 20.9 52.7 54.4 32.5 57.7 12.0 26.7 29.7 26.9 30.6 36.7 26.3 67.3 23.4 36.6 18.0 40.9 5.8 15.5 7.8 18.4 15.5 17.6 9.6 14.0 16.4 19.2 12.6 13.1 13.1 5.4 17.7 14.4 13.8 14.0 14.9 41.6 41.2 32.0 74.2 38.0 32.4 30.8 35.5 37.0 17.6 PTPN11 "BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2" ENSG00000179295 "Protein tyrosine phosphatase, non-receptor type 11" Q06124 12 112418351-112509913 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005377 Approved Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" 160000 Nucleoli "Nucleoplasm, Actin filaments, Cytosol" "CAB005377: AB_632401" "unprognostic (2.18e-3)" "unprognostic (1.73e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "unprognostic (4.25e-2)" "unprognostic (3.55e-2)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (8.85e-2)" "unprognostic (3.75e-3)" "unprognostic (1.66e-1)" "unprognostic (2.46e-1)" "unprognostic (3.62e-2)" "unprognostic (1.80e-2)" 25.4 16.8 38.6 14.4 39.0 17.7 30.8 17.5 39.5 18.3 14.7 26.9 9.9 11.9 19.1 13.3 17.6 11.1 13.1 30.1 38.0 32.2 18.0 23.1 15.1 14.5 45.3 22.5 13.1 14.0 29.3 12.9 16.6 26.2 16.2 13.9 9.4 12.0 20.0 34.0 14.1 11.1 28.0 45.7 10.9 12.8 7.6 32.1 10.9 21.2 8.2 13.7 17.4 15.4 17.3 17.1 22.0 11.8 11.3 15.4 6.3 34.8 33.3 24.3 23.0 35.4 34.6 28.8 42.4 46.3 33.4 25.2 33.1 13.5 36.9 22.1 39.2 20.9 31.2 37.6 55.7 28.0 25.7 53.7 31.0 18.1 35.4 43.0 34.3 28.0 37.9 35.9 51.1 27.6 40.7 13.0 32.2 25.2 30.2 20.9 29.4 21.8 31.1 35.9 21.2 30.8 39.2 16.9 20.8 40.8 31.3 26.0 36.0 29.9 33.6 39.4 35.3 23.4 37.1 25.2 41.5 36.9 32.7 30.2 36.8 22.0 11.0 15.0 14.8 9.5 14.1 15.5 13.4 12.1 12.6 17.3 15.4 11.8 10.3 11.3 11.8 17.1 9.8 6.3 38.6 39.0 17.5 39.5 38.0 32.2 45.3 22.5 26.2 32.1 PTPN12 "PTP-PEST, PTPG1" ENSG00000127947 "Protein tyrosine phosphatase, non-receptor type 12" Q05209 7 77537275-77640071 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007097 Approved Approved "Plasma membrane,Cytosol" 1100000 "Plasma membrane, Cytosol" "HPA007097: AB_1079689" "unprognostic (2.28e-1)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.35e-1)" "unprognostic (3.35e-2)" "unprognostic (1.40e-3)" "unprognostic (4.48e-3)" "prognostic unfavourable (8.78e-4)" "unprognostic (1.29e-1)" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "prognostic unfavourable (2.01e-4)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.27e-6)" "unprognostic (4.99e-2)" "unprognostic (2.97e-1)" "unprognostic (1.81e-1)" "unprognostic (3.21e-1)" 29.6 15.1 14.3 20.5 19.6 29.7 25.1 15.7 22.7 20.0 28.9 8.1 13.8 8.8 20.7 9.6 22.0 18.1 19.8 45.6 17.3 12.6 16.9 14.8 34.7 17.4 15.3 13.4 19.0 10.7 12.4 19.8 36.0 18.6 14.1 13.8 9.9 12.8 17.1 17.6 17.6 14.6 23.0 24.0 25.0 14.4 13.9 17.7 9.7 16.7 11.9 12.9 23.2 61.2 2.5 3.9 9.9 4.9 12.8 3.8 2.8 17.5 10.8 25.7 13.1 18.1 18.9 13.8 18.4 23.4 14.5 20.7 5.3 27.6 2.1 5.9 21.5 12.6 8.6 18.4 29.3 5.1 4.8 11.0 10.9 21.7 17.7 6.2 7.4 15.4 20.6 31.5 40.8 30.6 13.2 3.1 46.2 12.0 0.8 17.4 20.7 12.4 3.7 20.6 1.1 24.9 9.5 3.2 17.1 22.6 20.7 17.9 10.0 23.0 22.2 31.4 19.0 11.4 34.6 3.2 1.7 5.4 18.5 16.3 54.4 3.7 4.2 6.6 3.6 2.9 1.4 2.5 1.2 2.7 3.9 1.1 0.6 3.8 9.9 12.8 4.9 0.3 1.5 2.8 14.3 19.6 15.7 22.7 17.3 12.6 15.3 13.4 18.6 17.7 PTPN13 "PTP-BAS, PTP-BL, PTP1E, PTPL1" ENSG00000163629 "Protein tyrosine phosphatase, non-receptor type 13" Q12923 4 86594315-86815171 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 44.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.0;MAIT T-cell: 2.3;memory CD4 T-cell: 2.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002213, HPA063119" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "CAB002213: AB_564089, HPA063119: " "unprognostic (5.36e-2)" "unprognostic (4.46e-1)" "unprognostic (1.11e-1)" "unprognostic (2.54e-3)" "unprognostic (4.02e-1)" "unprognostic (9.03e-3)" "unprognostic (4.43e-2)" "unprognostic (4.38e-2)" "unprognostic (2.46e-1)" "unprognostic (7.05e-2)" "unprognostic (3.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-3)" "unprognostic (3.95e-3)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "unprognostic (2.85e-2)" 10.3 5.9 10.8 2.7 16.9 0.7 9.9 5.7 11.6 15.9 4.1 13.0 7.6 1.2 10.8 21.2 18.7 11.4 6.5 5.3 10.4 5.7 22.1 1.6 18.0 4.3 16.9 7.9 24.1 4.3 26.6 38.3 3.0 14.2 12.0 2.4 39.0 5.9 9.4 1.0 43.0 2.3 8.7 10.3 3.5 3.6 12.2 17.6 1.9 16.9 12.4 11.8 15.7 17.6 0.0 0.5 0.1 4.9 0.1 2.3 0.1 5.0 2.5 44.4 4.3 18.8 16.4 0.0 9.3 19.1 3.5 4.5 0.0 2.5 0.0 2.0 10.3 16.7 7.7 14.1 6.9 0.1 5.7 4.2 5.5 0.0 2.3 7.4 0.0 10.5 4.5 2.6 8.6 0.0 0.0 7.2 0.0 2.2 0.6 2.7 10.1 1.9 1.5 0.0 0.0 13.5 21.2 2.6 3.7 2.8 6.2 5.1 3.6 0.2 0.0 3.4 2.7 0.0 1.2 7.6 0.0 0.0 3.6 0.0 1.5 0.0 0.2 0.0 0.2 3.0 2.3 0.0 2.2 0.3 0.5 0.0 0.0 0.0 0.1 0.1 4.9 0.0 0.1 0.1 10.8 16.9 5.7 11.6 10.4 5.7 16.9 7.9 14.2 17.6 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase, non-receptor type 21" Q16825 14 88465778-88554733 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centriolar satellite" "CAB011468: AB_442979, HPA073999: " "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favourable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.5 4.7 5.3 8.6 7.3 0.0 13.2 4.4 5.8 10.7 8.7 10.7 7.4 4.9 10.6 10.7 8.9 8.3 12.7 17.4 7.4 4.2 8.1 6.0 15.3 1.6 6.6 4.2 15.8 7.8 10.6 3.9 15.6 6.4 11.9 6.5 12.6 6.5 10.5 8.8 24.2 10.5 15.7 7.3 3.7 7.4 15.2 6.5 0.8 16.0 8.4 3.1 12.0 26.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 3.5 2.9 7.6 2.9 8.1 7.0 7.8 9.6 7.4 5.7 7.9 5.1 6.5 0.0 2.3 12.2 3.4 1.1 3.4 8.4 0.2 1.7 0.0 3.1 2.1 9.0 0.0 0.1 4.7 6.7 4.8 5.7 4.6 1.1 0.1 14.6 2.9 0.0 0.1 2.2 5.6 0.0 22.7 0.0 4.9 2.6 0.5 8.8 5.5 13.8 3.2 6.8 1.4 9.0 10.6 8.4 4.3 6.5 0.3 1.1 0.0 3.9 0.1 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.3 4.4 5.8 7.4 4.2 6.6 4.2 6.4 6.5 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell line enhanced" "Detected in some" "Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 32.9 0.0 0.1 0.0 0.0 0.0 0.2 3.1 0.0 4.6 0.0 0.0 0.1 13.0 10.3 2.9 0.0 1.4 0.1 5.1 0.0 7.5 5.0 0.1 9.2 7.4 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 2.3 7.8 0.1 0.1 0.2 14.2 3.0 17.6 5.4 13.4 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase, non-receptor type 23" Q9H3S7 3 47381011-47413441 "Enzymes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favourable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 15.9 18.5 23.1 17.4 22.3 19.2 21.6 22.8 25.0 18.1 12.5 21.4 14.6 20.7 20.0 15.1 17.2 17.2 12.8 13.2 17.9 11.7 16.4 13.0 16.8 17.8 24.6 23.7 23.4 19.4 53.4 29.9 17.1 20.5 16.9 10.4 15.2 20.8 19.0 25.7 25.9 16.0 16.0 20.3 19.2 17.9 17.8 22.7 9.7 24.8 9.7 11.1 17.7 18.1 1.4 1.1 3.7 1.2 0.9 1.5 0.8 13.1 18.7 10.4 13.5 13.6 10.5 10.0 11.9 11.9 11.2 9.5 15.8 13.0 9.4 11.0 13.5 11.8 9.0 13.0 5.4 8.6 9.6 12.8 13.7 14.6 15.0 7.5 17.5 14.0 13.3 14.5 14.9 13.7 9.6 12.9 11.9 18.3 7.1 6.3 11.1 13.1 4.4 5.1 11.2 8.4 25.3 5.6 13.1 10.5 22.5 8.7 12.8 7.3 13.8 17.2 14.5 23.8 16.9 18.4 12.1 5.4 18.6 7.1 12.1 3.7 1.2 0.0 0.8 0.5 0.6 1.4 0.6 1.3 0.4 0.7 0.6 0.8 1.4 0.9 0.5 1.1 1.5 0.8 23.1 22.3 22.8 25.0 17.9 11.7 24.6 23.7 20.5 22.7 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favourable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.3 4.3 5.7 7.6 5.1 5.3 9.7 3.3 9.4 1.9 5.2 6.4 11.4 5.3 8.0 3.7 6.5 4.4 5.2 5.1 12.3 3.7 3.6 4.1 6.1 3.4 3.7 2.7 4.8 9.8 8.8 4.0 8.3 6.2 5.4 5.0 5.6 5.1 4.3 7.5 7.1 3.5 9.8 7.4 6.9 10.0 7.4 9.2 4.6 5.9 3.8 2.8 2.4 10.4 0.2 6.5 2.2 4.0 9.3 13.0 6.7 4.9 0.2 3.1 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase, non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.1;lymphoid tissue: 69.0" "Cell line enhanced" "Detected in many" "HEL: 28.1;HL-60: 24.9;HMC-1: 110.1;THP-1: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli 7400000 Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favourable (1.87e-4)" "prognostic unfavourable (5.42e-4)" "prognostic favourable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favourable (2.64e-8)" 6.6 8.8 2.4 42.9 4.4 27.7 4.6 1.2 2.7 2.8 7.0 5.1 4.7 7.5 3.7 8.8 7.0 5.0 9.8 2.9 3.1 2.3 7.0 6.8 25.4 58.1 5.2 1.8 2.3 6.7 2.7 5.6 7.7 3.9 5.6 5.2 3.6 10.6 7.0 1.3 6.1 21.0 2.6 4.9 69.0 6.6 1.5 3.3 31.4 6.3 4.1 50.7 8.5 4.2 63.9 38.0 107.1 103.2 22.2 28.2 63.2 2.8 5.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 2.9 6.4 2.0 1.5 0.0 3.3 0.0 3.8 0.0 1.2 1.1 28.1 0.6 2.4 0.0 24.9 110.1 0.0 2.8 0.0 1.2 0.0 0.0 0.2 0.0 6.0 9.0 14.6 1.5 0.9 8.2 0.0 14.2 3.0 5.4 0.5 0.0 0.9 4.5 0.0 1.4 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.9 0.1 54.4 35.9 107.1 28.2 71.3 18.2 62.3 13.7 21.0 38.0 63.9 15.8 19.9 66.7 22.2 103.2 10.0 14.4 63.2 2.4 4.4 1.2 2.7 3.1 2.3 5.2 1.8 3.9 3.3 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: " "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favourable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 20.5 12.6 36.3 11.1 40.2 73.4 7.7 15.5 30.3 19.2 23.5 15.0 28.6 13.5 12.2 20.7 22.1 14.6 22.1 21.7 20.8 9.4 19.2 5.3 19.0 14.4 19.2 9.1 32.8 22.9 15.8 16.7 26.5 19.2 17.3 19.0 8.4 22.2 21.8 14.0 10.1 17.0 17.6 16.8 16.4 16.0 20.1 19.3 15.0 25.5 23.0 15.9 16.5 18.9 17.1 8.5 19.1 13.6 12.7 17.6 17.8 7.9 18.2 16.0 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: " "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favourable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.1 0.3 6.8 0.1 0.3 3.5 0.5 0.3 0.1 0.7 0.4 0.1 0.3 0.0 0.0 0.3 2.7 0.0 27.5 1.5 0.4 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.7 0.3 5.1 0.7 0.0 0.4 0.7 0.0 1.6 0.0 0.6 40.2 0.4 0.4 0.1 2.3 0.5 0.3 0.3 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell line enhanced" "Detected in some" "Daudi: 51.0;HEL: 28.8;HL-60: 26.0;MOLT-4: 38.5;THP-1: 21.4;U-266/70: 23.9;U-266/84: 21.6;U-698: 30.6;U-937: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: , CAB068221: , HPA000440: AB_1078468" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavourable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 28.8 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 38.5 15.7 0.1 0.1 1.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 21.4 0.3 0.0 0.2 0.1 0.1 23.9 21.6 30.6 0.0 23.3 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell line enhanced" "Detected in some" "AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" 2500000 Vesicles Nucleoplasm "HPA054829: " "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.6 4.7 0.6 0.0 0.0 0.0 0.2 7.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 2.7 0.0 5.6 1.4 2.8 8.5 0.0 2.1 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: , HPA054822: " "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favourable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.4 4.8 2.9 0.2 6.1 8.2 2.9 12.1 23.5 5.0 4.6 8.0 3.7 0.0 3.7 11.1 12.7 3.0 9.6 7.1 13.4 4.9 0.1 7.4 11.1 7.5 0.0 0.4 6.0 8.9 10.5 14.4 13.7 0.0 0.2 12.3 9.0 6.8 0.0 3.0 6.2 24.5 6.2 0.8 12.4 9.2 15.3 0.0 12.5 14.0 0.7 3.8 0.3 23.1 7.9 5.5 15.3 10.9 0.1 1.6 0.0 10.1 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 5 "HDLM-2: 14.0;RT4: 26.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: " "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favourable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 26.7 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 40.7;HaCaT: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" 92000000 "Plasma membrane, Cytosol" "HPA054747: " "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favourable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.6 20.9 18.9 40.7 8.7 7.1 2.5 6.3 7.5 7.7 6.3 0.2 2.0 0.0 15.0 10.6 41.3 5.0 0.0 3.4 0.4 8.0 0.0 8.6 13.0 4.0 0.0 4.7 7.5 1.8 1.6 0.3 0.2 5.8 0.0 3.1 15.4 1.6 3.9 10.6 8.9 0.0 4.2 0.0 1.5 7.3 14.5 19.9 6.0 1.1 11.5 7.3 1.5 0.8 6.9 11.9 15.7 7.6 2.1 0.0 12.0 3.5 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Group enriched" "Detected in some" 9 "AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavourable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.1 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "Pituitary tumor-transforming 1" O95997 5 160421822-160428744 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.5;testis: 100.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 54.5" "Lineage enriched" "Detected in all" 7 "T-cells: 54.5" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: " "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 1.5 1.7 2.1 16.2 5.5 34.1 2.9 1.4 4.6 3.8 8.2 1.0 0.7 5.8 1.3 2.6 24.1 1.0 1.9 2.3 5.1 2.7 1.7 1.4 3.8 19.2 1.5 2.2 1.1 1.2 0.2 2.0 5.0 2.2 1.6 11.3 1.5 4.5 1.1 1.2 8.7 5.8 4.5 1.4 7.5 3.4 100.1 1.0 29.8 23.9 23.2 35.1 3.3 7.2 8.1 6.1 2.4 2.1 3.3 54.5 4.7 45.5 23.7 53.6 38.4 9.1 8.9 16.7 24.2 55.5 64.3 70.5 45.8 40.1 49.8 21.6 27.5 23.9 33.2 67.3 92.3 56.9 30.2 26.2 32.1 27.5 1.8 23.8 23.1 4.2 11.3 43.6 26.5 45.3 21.0 38.8 66.0 21.4 28.4 58.5 27.0 34.5 26.5 63.0 42.7 32.8 9.3 33.4 21.2 34.9 21.3 71.9 43.5 26.1 19.3 29.1 38.9 22.7 70.6 33.4 29.8 56.9 31.3 41.2 51.5 1.9 0.7 2.4 7.0 2.1 2.5 8.1 14.4 16.2 6.1 5.5 3.6 8.9 0.8 3.3 1.4 5.8 54.5 4.7 2.1 5.5 1.4 4.6 5.1 2.7 1.5 2.2 2.2 1.0 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960435-37961125 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8" "Cell line enhanced" "Detected in some" "Daudi: 1.5;MOLT-4: 3.0;U-698: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.4;T-reg: 1.0" "Low lineage specificity" "Detected in many" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: " "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 1.0 0.4 0.9 5.2 1.2 5.0 0.5 2.2 2.4 1.1 3.9 0.2 0.0 0.0 1.6 2.2 3.3 1.8 1.5 2.5 1.0 0.4 0.7 0.5 0.9 1.0 0.7 0.4 1.2 1.0 1.4 0.4 1.8 0.3 0.8 0.7 0.0 0.2 1.4 1.9 0.6 3.1 2.0 0.9 2.3 1.0 5.3 0.0 15.8 1.3 7.5 7.3 1.8 0.7 0.4 0.0 1.4 0.4 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.7 0.5 0.9 0.0 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.9 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 1.0 0.1 0.9 1.2 2.2 2.4 1.0 0.4 0.7 0.4 0.3 0.0 PUM1 "KIAA0099, PUMH1" ENSG00000134644 "Pumilio RNA binding family member 1" Q14671 1 30931506-31065991 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" RNA-binding "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027424, HPA027449" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027424: AB_10602918, HPA027449: AB_2672281" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-3)" "unprognostic (1.10e-1)" "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" "unprognostic (2.44e-2)" "unprognostic (3.19e-3)" "unprognostic (4.42e-2)" "prognostic favourable (7.62e-8)" "unprognostic (1.57e-1)" "unprognostic (5.41e-2)" "unprognostic (1.19e-1)" "unprognostic (2.74e-1)" 25.1 26.3 30.1 17.1 35.0 36.3 27.0 38.1 35.9 24.0 20.8 28.1 16.5 17.6 27.6 24.5 22.6 29.1 18.3 22.0 24.2 29.7 23.6 20.3 20.4 18.8 22.8 25.5 33.9 21.8 38.1 31.7 31.4 33.1 22.8 24.0 25.8 25.4 23.9 40.7 29.7 22.8 25.9 20.1 19.1 20.6 15.9 22.1 27.9 28.3 15.6 27.1 23.4 24.1 18.9 25.2 27.6 24.8 28.5 27.1 22.0 17.2 23.1 37.7 23.9 29.7 25.7 25.8 20.8 25.3 21.5 24.6 24.2 29.9 20.4 21.9 27.9 25.4 30.9 22.9 27.9 16.9 26.8 22.0 27.1 28.8 20.8 26.7 21.2 27.4 29.0 28.6 30.4 29.4 30.3 19.3 24.6 14.4 26.1 19.3 38.5 16.2 27.2 25.7 21.7 31.5 26.2 31.2 23.8 28.6 22.2 24.5 22.3 20.4 30.6 18.0 16.3 23.9 20.5 15.5 14.2 22.5 16.1 19.9 22.7 27.6 24.8 18.5 25.7 23.8 26.3 18.9 23.2 25.0 25.2 18.8 26.6 26.9 14.8 28.5 24.6 14.6 27.1 22.0 30.1 35.0 38.1 35.9 24.2 29.7 22.8 25.5 33.1 22.1 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Cell line enhanced" "Detected in some" "AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: " "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 1.1 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 4.3 0.4 0.5 0.2 0.0 0.9 0.0 6.9 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.3 0.0 0.0 0.0 0.0 0.0 2.7 3.0 3.7 0.0 0.4 0.3 0.0 0.2 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 PUS1 ENSG00000177192 "Pseudouridylate synthase 1" Q9Y606 12 131929200-131945896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051636, HPA057593" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051636: , HPA057593: " "unprognostic (2.72e-1)" "unprognostic (9.13e-2)" "unprognostic (1.81e-1)" "unprognostic (2.69e-2)" "unprognostic (8.12e-3)" "unprognostic (8.07e-2)" "unprognostic (4.57e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (2.06e-1)" "unprognostic (5.30e-2)" "prognostic unfavourable (3.49e-8)" "unprognostic (1.80e-3)" "unprognostic (8.06e-2)" "unprognostic (8.59e-2)" "unprognostic (1.56e-2)" 12.7 15.8 18.8 19.5 23.3 26.2 11.2 8.8 16.9 8.7 11.9 9.4 11.0 12.4 13.6 18.7 16.5 12.9 25.1 8.6 15.6 8.3 10.7 22.8 11.0 21.4 11.7 15.8 10.1 19.8 7.2 9.5 8.3 11.7 11.7 10.5 7.6 11.4 15.7 13.5 15.4 13.9 9.7 6.2 17.4 13.6 11.9 16.4 11.6 10.3 11.6 15.8 10.8 12.8 5.9 4.6 1.9 2.0 9.1 4.0 1.3 15.2 20.0 4.7 8.4 4.6 7.9 29.2 11.8 5.0 9.0 5.8 22.1 10.0 18.3 13.7 6.4 19.4 15.6 11.2 5.9 8.1 31.6 18.4 9.7 19.3 12.4 31.4 16.9 7.9 9.1 10.3 8.8 8.8 22.8 5.6 5.2 26.6 20.6 28.2 25.1 30.5 19.7 6.8 18.9 7.3 21.3 13.3 7.4 9.9 13.6 10.9 14.9 34.0 7.7 7.2 15.4 15.3 17.1 15.5 11.6 21.7 7.4 25.2 9.9 1.2 2.0 0.4 3.2 1.4 2.2 5.9 2.7 3.3 1.6 5.5 4.0 2.1 1.9 9.1 1.3 4.6 2.4 1.3 18.8 23.3 8.8 16.9 15.6 8.3 11.7 15.8 11.7 16.4 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridylate synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: " "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 7.0 8.7 7.4 5.0 7.3 3.9 7.3 6.8 7.9 4.8 10.0 5.1 3.0 9.2 7.7 9.1 5.0 5.4 6.4 4.6 6.5 6.9 8.5 17.6 6.3 6.5 8.5 4.6 6.8 7.2 6.3 10.3 4.2 5.9 6.6 6.0 6.7 6.2 3.9 6.7 4.3 19.8 3.6 7.1 5.9 4.2 7.8 8.0 9.1 10.4 4.1 8.3 4.4 4.4 5.2 4.9 9.8 6.9 4.8 4.3 1.8 2.7 1.6 4.4 7.6 3.9 4.3 5.2 5.6 5.2 5.5 5.2 4.2 3.9 8.7 5.8 3.1 3.0 5.1 4.5 6.7 8.8 2.5 7.9 2.1 13.3 7.1 8.7 5.0 5.2 5.4 3.9 9.4 6.9 8.0 6.1 3.8 2.5 6.9 7.0 4.0 3.0 6.7 5.9 4.4 3.2 5.2 2.6 3.6 4.5 8.0 9.0 3.1 5.5 5.3 5.4 4.2 3.5 4.0 7.3 3.2 18.4 4.6 5.1 6.0 9.8 1.9 2.0 3.9 2.2 4.3 5.2 2.5 2.6 1.6 3.2 3.0 3.4 4.1 4.8 6.9 4.9 1.5 1.8 7.4 7.3 6.8 7.9 6.5 6.9 8.5 4.6 5.9 8.0 PUS3 FKSG32 ENSG00000110060 "Pseudouridylate synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: " "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.6 8.8 5.9 7.4 7.7 2.3 8.7 9.0 8.4 7.4 9.2 3.6 4.6 9.9 8.4 8.6 8.1 6.4 5.9 7.6 8.0 6.4 9.6 36.6 6.1 11.0 8.7 7.2 7.7 17.9 8.2 21.1 7.6 7.7 10.4 7.4 5.4 10.6 5.1 15.2 8.2 11.5 13.9 9.7 8.9 9.3 5.3 7.3 9.6 12.4 10.6 9.2 11.1 7.3 13.0 8.8 9.9 12.3 13.0 16.5 7.1 3.5 4.3 13.3 14.9 13.7 17.5 6.4 11.9 10.0 6.8 7.6 14.1 13.4 18.1 19.6 5.2 12.4 21.6 11.0 6.9 15.4 10.4 18.6 5.5 10.1 14.5 11.7 5.5 13.8 13.3 8.1 17.4 12.5 18.9 9.5 7.3 2.1 13.0 12.5 11.5 8.5 2.6 12.2 10.2 11.2 5.6 15.5 13.8 8.1 11.4 6.5 24.3 7.6 8.4 14.4 5.9 6.8 9.8 7.1 10.6 19.1 3.9 18.8 9.8 9.9 9.7 7.8 13.0 9.4 15.2 13.0 12.8 12.5 8.8 12.2 16.5 15.6 3.7 13.0 12.3 7.8 12.9 7.1 5.9 7.7 9.0 8.4 8.0 6.4 8.7 7.2 7.7 7.3 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 130.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in many" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: " "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.9 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell line enhanced" "Detected in many" "TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" HPA012568 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248" "unprognostic (2.90e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavourable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavourable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.5 15.1 1.5 6.1 1.8 2.2 2.6 36.4 10.2 12.0 13.7 8.8 9.2 0.0 21.0 10.5 14.2 5.1 13.8 8.0 2.6 9.9 3.8 9.5 5.9 12.7 1.4 8.3 2.9 6.8 10.5 20.7 13.0 1.8 0.0 5.5 1.9 1.3 1.3 3.4 11.2 0.0 6.9 2.0 25.7 6.6 6.5 7.6 23.1 14.5 5.1 8.2 3.7 52.7 14.5 17.9 10.7 28.4 0.0 2.1 0.0 11.6 7.4 8.2 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 28 "Daudi: 37.2;MOLT-4: 40.5;U-698: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA047497: " "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 40.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 PWP1 IEF-SSP-9502 ENSG00000136045 "PWP1 homolog, endonuclein" Q13610 12 107685732-107713167 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038708 Approved "Nucleoli,Golgi apparatus" Nucleoli "Golgi apparatus" "HPA038708: " "unprognostic (7.06e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (9.65e-4)" "prognostic unfavourable (1.40e-5)" "unprognostic (1.97e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.89e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.00e-1)" "unprognostic (6.95e-2)" "unprognostic (6.13e-2)" "unprognostic (1.10e-2)" 33.2 25.4 29.4 29.3 32.2 27.9 35.1 32.9 38.7 25.6 29.2 20.3 26.1 17.9 32.9 26.8 33.9 27.5 21.1 18.7 32.9 25.3 31.5 32.3 22.0 29.6 22.9 38.6 35.2 31.1 31.6 23.0 29.8 37.6 27.1 27.5 16.6 26.0 30.5 43.5 32.7 24.2 33.6 33.3 28.7 27.0 36.3 22.1 32.5 27.1 26.8 36.5 30.0 28.1 31.7 21.6 10.9 14.7 18.8 23.8 12.7 23.5 29.6 18.0 17.1 25.4 27.9 23.9 24.8 28.3 35.4 30.0 29.7 11.2 36.4 13.5 38.4 20.7 24.3 26.2 35.1 18.1 27.8 27.7 18.2 34.5 26.1 33.5 19.9 25.0 24.2 32.6 29.3 41.2 36.3 10.3 37.8 26.0 23.4 33.1 21.5 48.6 19.4 21.2 34.0 22.0 33.5 20.4 16.4 20.3 14.7 34.1 26.1 16.7 32.2 27.0 13.7 21.9 28.1 14.8 20.4 28.7 12.0 18.7 23.5 10.9 9.8 7.1 20.2 12.4 18.6 31.7 20.2 21.2 15.9 28.5 17.3 23.8 3.1 18.8 14.7 21.6 21.5 12.7 29.4 32.2 32.9 38.7 32.9 25.3 22.9 38.6 37.6 22.1 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2, small subunit processome component" Q15269 21 44107290-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 30.5;Daudi: 26.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA024573 Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 6.1 6.1 11.3 7.7 14.6 3.6 6.3 9.7 12.8 4.0 9.0 9.6 2.4 4.4 7.8 9.2 8.2 5.9 4.8 4.6 6.8 4.8 6.9 8.7 5.0 7.9 15.4 5.7 5.0 12.8 1.4 4.0 7.6 8.9 8.1 1.8 4.9 8.2 5.2 8.0 14.7 5.6 2.2 6.4 8.8 10.6 5.3 17.2 3.6 4.8 8.6 16.8 5.0 5.7 6.8 2.6 2.9 4.3 3.4 6.9 5.0 1.1 0.4 0.3 1.2 3.5 3.6 9.2 11.8 6.2 15.7 10.6 30.5 0.5 26.4 0.4 0.0 1.3 0.5 8.9 9.1 6.4 19.0 3.1 5.5 7.0 2.3 2.3 0.9 0.2 0.0 10.9 0.0 0.5 10.1 10.6 5.2 0.3 0.1 0.7 0.3 1.1 1.5 0.1 13.6 0.0 0.4 9.2 1.6 0.6 1.0 7.4 0.0 1.0 6.0 6.4 1.1 14.2 1.4 14.3 17.0 1.2 0.4 2.8 9.1 0.2 2.2 2.9 6.0 3.1 6.6 6.8 4.9 6.9 1.6 4.1 4.9 6.1 1.2 3.4 4.3 2.6 3.5 5.0 11.3 14.6 9.7 12.8 6.8 4.8 15.4 5.7 8.9 17.2 PWWP2A KIAA1935 ENSG00000170234 "PWWP domain containing 2A" Q96N64 5 160061801-160119423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046733, HPA058233" Supported "Nucleoplasm,Focal adhesion sites" Nucleoplasm "Focal adhesion sites" "HPA046733: , HPA058233: " "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (5.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.18e-2)" "unprognostic (7.86e-3)" "unprognostic (1.40e-3)" "unprognostic (6.24e-2)" "unprognostic (2.42e-2)" "unprognostic (7.08e-2)" "unprognostic (7.25e-2)" "unprognostic (8.24e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (3.88e-2)" "unprognostic (1.08e-1)" "prognostic favourable (3.51e-4)" 8.4 9.3 9.5 12.7 22.3 11.9 9.1 52.7 16.0 14.4 13.6 19.9 5.3 9.6 10.8 7.2 8.7 9.5 8.1 7.4 15.9 8.8 10.3 8.6 9.8 12.0 25.2 8.9 10.5 10.5 10.6 15.1 11.2 17.0 11.9 14.7 10.3 8.8 8.4 7.0 14.7 10.6 9.3 13.8 12.5 11.8 6.3 21.3 18.6 9.8 5.8 11.4 10.7 10.1 6.0 2.9 6.0 4.4 1.1 4.9 0.9 10.6 5.1 13.4 11.4 14.9 11.7 18.9 8.5 7.0 7.6 7.8 16.6 20.8 17.2 13.1 6.5 7.7 11.6 13.3 12.6 17.8 12.9 12.3 9.5 8.5 11.4 12.4 9.4 8.3 6.7 15.3 11.7 12.2 9.4 11.2 12.9 8.9 10.6 12.1 15.7 6.7 16.7 11.9 11.0 9.3 7.6 15.8 11.0 14.4 14.5 15.4 11.2 13.8 16.2 13.3 9.2 9.9 16.5 12.8 11.5 15.3 8.8 12.6 13.1 6.0 4.4 2.4 2.8 2.0 2.2 6.0 3.0 3.3 2.9 3.7 4.9 2.7 5.0 1.1 2.6 2.7 2.5 0.9 9.5 22.3 52.7 16.0 15.9 8.8 25.2 8.9 17.0 21.3 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 7 "AF22: 10.8;Daudi: 8.1;SH-SY5Y: 8.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavourable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.6 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426126 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.1" "Cell line enhanced" "Detected in many" "U-937: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Approved Supported "Plasma membrane,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favourable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 9.3 9.4 20.7 17.0 51.4 33.6 7.6 22.6 31.4 28.9 8.9 81.1 2.4 6.3 14.2 5.3 6.6 8.0 9.6 7.5 33.7 19.9 10.4 5.7 8.2 23.8 68.6 23.4 11.1 8.5 13.7 6.1 17.5 43.9 6.0 6.4 4.4 8.8 7.7 7.6 7.5 7.7 11.8 55.9 13.5 8.3 6.7 56.6 3.7 40.3 2.5 26.1 9.8 13.1 31.3 18.8 31.8 22.5 8.7 11.2 13.4 4.2 2.5 1.9 3.5 26.6 23.6 5.6 6.9 14.6 6.6 9.3 1.2 0.9 22.6 1.6 11.6 1.3 6.0 4.3 7.0 5.6 3.8 3.9 3.0 1.7 31.0 33.5 6.9 20.2 10.5 8.3 14.4 5.8 4.7 7.4 11.8 1.6 7.3 34.6 2.3 6.3 12.6 3.3 4.0 4.2 2.4 1.7 1.2 4.7 3.3 5.4 11.4 34.7 5.9 8.3 3.4 15.7 7.2 5.8 5.7 22.5 12.0 47.6 3.4 14.6 20.1 29.4 11.2 16.2 9.9 29.0 8.1 9.4 18.8 31.3 7.1 8.4 31.8 8.7 22.5 13.5 8.7 13.4 20.7 51.4 22.6 31.4 33.7 19.9 68.6 23.4 43.9 56.6 PXMP4 PMP24 ENSG00000101417 "Peroxisomal membrane protein 4" Q9Y6I8 20 33702754-33720319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.3;SK-BR-3: 35.3;T-47d: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050077 Approved Approved "Nucleoli fibrillar center,Peroxisomes" Peroxisomes "Nucleoli fibrillar center" "HPA050077: " "unprognostic (3.41e-2)" "unprognostic (1.11e-1)" "unprognostic (2.59e-1)" "unprognostic (1.75e-1)" "unprognostic (5.08e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-1)" "prognostic favourable (3.88e-4)" "unprognostic (3.53e-1)" "unprognostic (4.47e-2)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "prognostic favourable (4.03e-10)" "unprognostic (3.84e-2)" "unprognostic (2.20e-1)" "unprognostic (6.08e-2)" "unprognostic (2.20e-1)" 6.2 20.0 6.4 5.4 10.0 3.9 15.6 4.7 12.6 7.8 7.8 12.5 16.9 10.1 7.1 7.1 10.0 8.0 9.1 7.9 6.7 5.3 6.7 13.4 27.5 9.3 6.1 9.2 9.2 9.5 24.4 5.3 5.0 6.5 11.5 7.5 10.8 27.6 13.2 9.9 14.4 11.8 7.1 7.6 6.4 9.0 4.2 5.9 8.4 19.0 6.9 5.9 10.6 9.0 6.2 6.2 12.0 21.9 5.8 8.5 5.5 1.2 5.5 1.5 5.5 2.7 4.0 4.0 4.0 2.2 3.1 1.3 19.3 6.1 0.0 7.6 3.3 5.8 4.2 4.6 2.2 1.6 1.5 6.3 4.7 0.1 2.5 0.3 4.8 3.0 5.1 4.2 1.4 2.0 3.5 4.0 2.2 11.8 5.7 4.4 0.2 0.0 3.0 7.6 0.7 1.9 4.1 5.0 2.5 11.1 35.3 3.5 29.8 2.1 3.9 2.2 2.5 5.6 3.7 2.6 5.7 0.1 4.3 2.1 3.7 1.4 8.0 12.0 8.1 14.9 8.5 5.5 8.3 8.1 6.2 6.2 6.3 8.5 2.1 5.8 21.9 3.8 5.7 5.5 6.4 10.0 4.7 12.6 6.7 5.3 6.1 9.2 6.5 5.9 PXN ENSG00000089159 Paxillin P49023 12 120210439-120265771 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 49.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003841, HPA051309" Supported Enhanced "Focal adhesion sites,Centrosome,Cytosol" "Focal adhesion sites" "Centrosome, Cytosol" "CAB003841: AB_562188, HPA051309: " "unprognostic (4.00e-2)" "unprognostic (1.94e-2)" "unprognostic (3.51e-2)" "unprognostic (3.55e-3)" "prognostic unfavourable (1.09e-4)" "prognostic unfavourable (3.72e-5)" "prognostic unfavourable (7.12e-5)" "prognostic unfavourable (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (9.19e-3)" "unprognostic (2.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-2)" "unprognostic (3.35e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 35.4 26.2 17.9 26.7 16.5 31.6 45.9 15.5 18.6 25.0 29.0 12.4 31.7 25.6 27.6 30.9 16.0 29.8 31.8 26.2 18.0 7.6 27.6 13.1 35.8 42.9 15.7 8.1 14.8 16.3 17.6 13.9 34.0 15.8 24.9 23.5 24.7 22.1 40.1 98.5 19.7 34.7 44.4 20.3 34.0 20.6 19.8 14.4 9.9 26.7 22.8 11.6 30.1 45.7 0.5 7.6 49.5 12.3 14.4 26.3 14.5 32.6 16.2 5.8 5.8 11.7 30.4 39.3 27.6 24.1 22.5 11.9 18.9 20.5 2.2 18.2 28.1 23.3 4.0 50.3 18.0 1.8 3.6 0.4 11.9 6.7 16.9 0.5 0.7 14.8 33.0 23.6 26.8 40.0 5.7 3.7 44.0 21.6 2.0 0.7 8.2 56.3 4.8 9.6 2.0 23.1 31.4 9.5 2.8 24.8 7.6 14.9 18.8 2.7 52.7 15.7 17.2 19.5 32.9 4.0 2.2 0.8 45.1 4.9 30.6 9.8 12.3 13.4 26.3 4.4 14.2 0.5 12.1 17.2 7.6 0.4 9.6 12.8 49.5 14.4 0.2 1.2 9.1 14.5 17.9 16.5 15.5 18.6 18.0 7.6 15.7 8.1 15.8 14.4 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell line enhanced" "Detected in many" "MCF7: 33.9;NB-4: 53.4;THP-1: 39.4;U-937: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavourable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.6 13.3 0.1 0.0 1.3 3.0 0.1 2.8 3.9 1.8 1.2 0.0 7.1 2.3 0.0 2.7 15.7 0.6 10.5 0.0 17.0 0.0 2.2 1.6 4.3 4.6 19.8 15.7 3.9 5.5 0.8 0.1 3.8 9.7 3.6 0.5 33.9 0.0 53.4 3.6 0.0 17.2 0.0 7.4 0.1 5.5 0.1 0.0 2.4 0.0 2.7 3.3 39.4 2.5 0.1 0.2 2.3 0.0 0.1 0.0 0.0 1.3 24.4 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603913-143609773 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063416, HPA069706" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA063416: , HPA069706: " "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 6.1 8.1 11.5 6.7 9.7 4.8 5.6 5.3 13.4 6.9 5.4 6.1 10.8 4.4 4.7 5.2 6.1 10.1 6.3 4.4 12.2 8.5 7.7 20.5 5.9 6.7 7.6 12.1 6.7 10.6 4.3 9.1 3.5 9.7 7.5 4.0 4.5 13.7 9.1 4.8 4.7 4.9 4.0 4.4 5.9 7.0 8.6 4.5 3.8 9.5 6.3 6.1 3.6 3.1 11.1 5.4 0.4 1.4 3.2 3.2 2.1 5.8 11.0 2.0 4.2 1.9 1.2 4.1 5.2 2.2 4.2 2.4 4.8 5.8 7.7 7.0 3.7 4.9 1.9 6.1 0.8 5.2 6.7 3.8 4.2 3.2 1.9 1.7 1.1 2.1 1.6 4.8 2.7 2.4 5.9 2.4 2.0 18.0 7.3 1.3 1.8 17.7 5.1 1.9 11.5 3.9 3.8 7.1 2.4 8.4 10.8 1.9 13.3 2.2 2.1 3.8 7.9 5.9 4.9 4.2 1.0 4.8 4.4 2.4 3.5 0.3 1.4 0.2 3.2 1.1 3.1 5.8 2.1 2.6 2.1 11.1 3.0 3.0 0.4 3.2 1.0 5.4 1.8 2.1 11.5 9.7 5.3 13.4 12.2 8.5 7.6 12.1 9.7 4.5 PYGL ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944736 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 56.1;HMC-1: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 36.0;neutrophil: 41.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" 17000000 "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavourable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavourable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 47.6 9.9 4.9 9.7 6.8 40.0 28.1 1.3 3.9 17.2 10.1 3.0 23.7 1.7 10.9 7.3 24.8 7.8 5.5 15.0 3.9 3.4 6.8 58.8 19.6 25.6 6.5 1.6 15.4 4.1 12.5 3.7 23.3 5.3 11.4 10.3 17.8 11.8 55.2 7.1 15.3 3.5 11.2 8.7 38.8 4.5 6.8 5.4 2.4 7.1 9.1 7.3 18.4 24.3 0.0 7.3 41.4 13.8 0.1 0.0 5.5 28.3 8.0 2.1 13.2 9.8 11.8 23.0 5.7 4.8 15.7 24.0 21.1 3.6 0.0 11.1 33.8 56.1 21.4 28.8 27.3 0.1 9.0 5.4 12.8 16.4 17.6 20.6 62.0 25.1 11.8 21.3 9.0 13.9 2.2 0.1 11.1 28.3 0.0 28.4 7.9 29.7 0.5 7.3 1.1 21.8 19.0 0.9 0.9 25.8 9.0 0.3 4.2 40.4 0.6 6.1 10.2 11.4 18.3 0.2 0.0 0.0 5.6 21.3 3.2 11.3 13.8 36.0 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 41.4 0.1 3.9 0.3 0.0 5.5 4.9 6.8 1.3 3.9 3.9 3.4 6.5 1.6 5.3 5.4 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538890-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.6" "Cell line enhanced" "Detected in many" "U-698: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 3.0 3.8 3.8 1.6 8.2 0.6 3.1 10.1 5.1 10.8 5.1 2.8 8.2 0.9 9.8 5.8 3.3 4.2 3.9 2.6 5.2 4.3 1.8 0.6 3.2 1.0 4.2 2.8 14.2 2.3 26.6 6.9 3.2 5.0 7.9 1.9 5.5 1.9 9.4 18.7 1.5 1.8 7.9 5.2 0.8 2.8 6.0 3.2 0.0 10.1 5.7 1.0 7.6 9.2 0.6 0.2 0.9 0.2 0.3 0.4 0.0 2.7 5.0 8.8 4.6 3.3 7.6 3.7 6.0 6.6 4.8 5.5 3.3 0.0 0.0 1.8 3.8 0.0 9.0 0.0 6.1 0.0 3.0 1.3 1.4 0.2 4.8 4.9 0.0 4.0 4.7 4.3 0.6 2.4 0.0 0.0 7.4 0.1 0.2 0.0 2.4 2.6 0.0 11.2 0.0 1.5 1.9 4.8 5.7 5.4 0.0 4.2 1.7 1.4 0.0 11.9 5.4 0.2 7.0 0.1 0.1 25.5 3.7 0.0 2.7 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.0 0.6 0.3 0.4 0.9 0.3 0.1 0.2 0.1 0.0 3.8 8.2 10.1 2.8 5.2 4.3 4.2 2.8 5.0 3.2 PYM1 "PYM, WIBG" ENSG00000170473 "PYM homolog 1, exon junction complex associated factor" Q9BRP8 12 55901413-55932618 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012803, HPA039717, HPA046200" Supported Supported "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" "Nucleoplasm, Nucleoli, Cytosol" "Cell Junctions" "CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556" "unprognostic (3.03e-2)" "unprognostic (1.00e-1)" "unprognostic (5.65e-2)" "unprognostic (8.82e-2)" "unprognostic (1.97e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (3.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.29e-1)" "unprognostic (1.32e-2)" "unprognostic (1.59e-2)" "unprognostic (2.22e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.34e-4)" 17.5 21.4 16.2 21.2 14.8 13.2 20.3 16.3 17.1 15.2 21.2 14.2 27.1 21.8 16.1 30.8 46.7 16.3 21.5 13.6 14.0 14.7 19.4 31.3 14.4 28.6 14.7 14.0 13.3 24.8 15.3 19.8 21.5 12.8 20.7 21.5 18.3 22.9 24.5 18.2 27.2 29.9 16.3 13.2 25.5 15.8 21.1 14.1 26.3 22.5 31.2 39.1 16.5 19.9 29.5 35.9 21.6 27.2 14.4 53.6 24.1 17.4 13.9 20.4 11.3 12.4 16.2 33.5 12.8 15.5 12.2 10.3 20.3 20.8 21.9 19.6 12.4 13.7 15.7 27.5 9.8 16.9 11.7 17.8 11.9 25.0 15.2 20.6 16.3 14.5 17.8 13.7 20.6 12.9 15.2 24.4 14.2 26.2 13.2 36.8 35.6 7.3 11.9 8.1 25.1 24.9 24.8 13.8 15.9 16.4 22.1 11.5 26.9 43.7 10.0 7.4 10.4 11.4 9.3 12.9 19.5 33.8 12.6 14.3 11.4 3.9 24.5 21.6 18.7 27.2 22.9 29.5 34.0 26.1 35.9 25.2 22.6 22.6 5.8 14.4 18.5 19.6 53.6 24.1 16.2 14.8 16.3 17.1 14.0 14.7 14.7 14.0 12.8 14.1 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: " "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.1 2.5 4.7 5.3 2.6 2.3 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.3 0.5 6.2 1.1 2.0 1.8 3.8 0.5 1.7 5.7 1.3 0.8 2.9 2.1 1.0 1.9 0.1 2.0 3.4 1.2 0.5 3.7 3.4 0.7 1.9 5.1 7.5 3.9 0.2 0.8 2.3 4.3 4.3 1.1 0.6 2.6 1.9 2.7 2.1 1.4 5.0 6.7 2.6 1.7 1.6 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 QRSL1 "DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA" ENSG00000130348 "Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1" Q9H0R6 6 106629578-106668417 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Ligase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "memory B-cell: 32.6;naive B-cell: 26.1" "Lineage enriched" "Detected in all" 7 "B-cells: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029585, HPA029587" Approved Approved Vesicles,Centrosome Vesicles Centrosome "HPA029585: AB_10599823, HPA029587: AB_10602311" "unprognostic (1.86e-3)" "unprognostic (5.58e-2)" "unprognostic (6.19e-3)" "unprognostic (3.45e-1)" "unprognostic (2.11e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.97e-5)" "unprognostic (8.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (4.03e-2)" "unprognostic (1.66e-1)" "prognostic favourable (3.83e-4)" "unprognostic (2.06e-1)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.46e-1)" 9.8 10.8 12.4 17.0 14.7 8.5 15.6 10.1 15.6 7.6 11.7 10.1 11.9 11.3 9.5 10.8 10.3 8.5 8.3 13.9 10.4 9.1 15.5 12.5 7.7 21.0 15.8 8.3 10.2 10.8 10.9 11.9 8.7 9.9 8.3 13.7 7.5 10.6 12.5 35.7 8.8 14.8 8.8 11.9 16.7 11.0 10.6 13.7 13.8 13.7 14.6 21.3 8.9 8.6 32.6 4.0 1.6 4.5 2.6 3.1 2.2 6.1 6.4 8.8 12.7 5.7 7.2 12.4 7.0 7.2 9.4 9.4 7.4 5.1 20.5 6.4 7.8 10.9 13.1 8.5 11.9 9.7 10.0 10.0 6.8 7.6 9.0 22.5 9.0 7.0 13.3 10.0 14.8 6.6 18.0 6.7 7.7 6.9 7.2 11.0 9.2 7.5 19.7 11.3 5.2 10.2 7.1 7.7 7.9 5.6 13.1 10.3 8.6 17.5 6.5 6.7 5.5 7.1 10.8 3.9 5.5 12.0 9.1 15.3 9.9 1.6 2.4 0.4 2.6 3.6 2.5 32.6 2.9 2.2 4.0 26.1 2.7 2.6 0.7 2.6 4.5 3.2 3.1 2.2 12.4 14.7 10.1 15.6 10.4 9.1 15.8 8.3 9.9 13.7 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32893178-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavourable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavourable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 10.8 8.3 13.6 9.1 11.3 8.3 22.0 21.3 14.9 13.1 8.7 9.8 9.5 5.4 13.8 13.1 15.9 11.2 8.9 10.0 12.5 7.1 9.3 9.5 9.1 8.2 13.1 10.9 21.4 15.6 16.5 11.4 9.0 11.5 11.5 9.2 10.9 16.7 9.7 9.8 20.1 7.9 10.4 11.5 10.1 9.3 14.2 12.8 14.2 14.2 14.0 10.1 11.8 24.8 2.0 2.2 0.3 2.4 1.7 1.1 0.4 11.2 13.9 16.3 15.0 6.3 12.4 7.8 9.8 8.8 7.2 8.8 12.1 5.3 11.8 6.3 11.9 14.7 14.9 8.8 15.3 5.0 9.6 11.0 13.4 10.0 4.8 13.2 6.0 5.9 9.4 9.1 14.9 9.8 16.8 5.3 11.1 10.0 6.3 5.3 17.2 8.5 10.6 32.2 4.9 7.4 12.4 8.5 12.2 18.5 9.9 6.2 10.2 7.0 9.7 17.4 17.5 31.3 21.0 3.6 4.9 12.3 11.2 6.3 11.2 0.0 1.2 0.3 1.1 2.4 0.5 2.0 0.7 1.0 1.1 0.9 0.6 0.7 0.0 1.7 0.6 2.2 0.2 0.4 13.6 11.3 21.3 14.9 12.5 7.1 13.1 10.9 11.5 12.8 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell line enhanced" "Detected in many" "HHSteC: 194.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042127, HPA056243" Uncertain Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" 3200000000 "Golgi apparatus" Vesicles "HPA042127: , HPA056243: " "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavourable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 41.5 5.9 1.4 17.7 18.1 37.5 70.5 44.2 44.7 37.8 26.7 0.6 13.4 0.6 27.5 35.3 9.0 1.7 11.9 18.5 2.4 2.7 1.3 3.5 1.8 194.6 4.5 12.8 20.0 5.4 40.3 48.4 55.6 1.8 6.5 24.9 7.2 0.9 8.4 4.8 17.0 1.8 3.2 1.0 6.2 11.9 5.1 5.2 12.9 17.6 8.5 3.2 21.5 65.4 47.4 18.6 31.7 37.3 4.8 7.8 1.1 18.0 14.6 14.2 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245841 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 5700000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: " "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.2 8.0 8.4 15.9 14.1 16.0 7.3 30.3 10.6 5.8 5.8 9.4 8.9 6.0 8.1 13.2 5.6 8.1 5.5 7.0 7.6 7.1 7.0 9.2 6.5 19.1 11.0 6.7 9.4 21.7 12.1 29.2 5.8 9.6 6.1 6.7 7.9 6.5 4.9 5.1 12.4 10.3 8.1 7.1 14.6 7.6 11.7 10.1 8.3 12.1 6.0 16.7 5.4 6.4 3.4 0.8 1.6 0.3 0.4 0.8 0.2 7.2 17.7 14.7 19.5 8.3 10.1 18.6 9.3 10.4 18.1 16.7 13.2 15.8 11.2 15.3 12.4 23.6 17.4 13.4 14.7 16.5 8.7 6.0 29.3 14.5 11.8 17.8 9.2 8.0 13.6 17.9 21.8 13.2 14.4 30.3 9.6 12.3 6.6 11.9 17.4 11.3 12.2 19.1 18.3 6.2 6.6 15.8 11.9 14.6 11.6 7.8 8.3 10.4 7.5 22.0 16.0 18.0 21.1 10.7 14.3 24.7 14.7 9.4 20.5 1.6 0.3 0.7 0.5 0.0 0.8 1.9 0.6 0.2 0.1 3.4 0.2 0.4 0.1 0.4 0.0 0.8 0.3 0.2 8.4 14.1 30.3 10.6 7.6 7.1 11.0 6.7 9.6 10.1 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036827: , HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavourable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 17.1 13.9 8.7 12.4 10.4 13.3 14.1 6.4 10.3 11.0 11.2 14.9 7.9 10.4 16.1 9.2 13.7 13.1 13.6 7.5 6.7 6.7 15.8 15.7 12.2 14.9 11.0 7.6 12.6 15.3 10.7 16.9 11.6 9.4 11.2 12.5 17.7 11.8 9.8 7.5 12.4 12.9 10.8 11.3 19.9 10.7 14.1 10.0 17.3 13.2 10.9 21.6 11.6 10.9 13.9 15.8 5.3 12.9 6.4 6.6 5.0 13.3 13.9 11.6 12.8 5.1 6.3 11.0 7.0 4.4 12.0 11.1 13.2 9.7 24.9 10.3 6.4 13.4 22.5 10.6 15.8 4.7 10.2 11.2 8.3 9.4 7.3 20.3 10.5 4.9 9.6 10.9 15.6 12.4 11.7 8.9 6.8 10.6 16.9 7.9 22.2 15.2 15.4 8.2 13.3 9.4 9.3 15.8 7.5 10.2 10.1 12.9 11.2 10.3 8.1 10.5 11.5 4.1 13.6 6.3 9.1 34.8 9.2 15.0 21.1 0.3 12.4 2.9 5.6 12.9 5.3 13.9 4.8 5.5 15.8 9.5 6.6 5.3 5.3 6.4 9.1 6.6 5.9 5.0 8.7 10.4 6.4 10.3 6.7 6.7 11.0 7.6 9.4 10.0 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favourable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favourable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favourable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 14.8 14.2 21.4 14.8 20.9 18.4 24.6 16.5 36.3 13.9 18.4 26.0 14.8 14.5 16.4 18.2 12.5 17.9 16.4 23.8 21.5 16.9 13.2 16.6 18.8 15.9 30.1 16.3 22.1 50.3 16.0 14.7 10.4 20.7 14.8 12.0 15.3 24.8 20.7 36.6 16.3 14.4 18.3 33.7 13.0 16.9 17.4 21.4 15.8 13.6 14.7 13.9 12.9 12.6 28.5 29.7 41.6 27.1 29.7 36.5 25.7 20.9 26.3 21.2 20.5 9.1 12.4 14.4 13.9 13.4 23.8 17.4 18.3 9.9 21.2 14.8 17.0 15.8 22.3 25.9 16.1 13.6 21.9 19.7 18.1 15.3 21.5 13.4 14.8 14.6 20.5 20.3 9.6 18.1 22.8 17.9 13.9 17.2 30.3 22.5 16.9 19.2 20.7 25.8 12.6 11.4 23.0 27.2 23.3 15.8 18.8 22.6 17.1 16.1 15.4 21.9 18.2 18.2 28.2 13.3 11.8 21.8 16.9 18.8 27.1 17.8 27.1 41.6 36.5 22.6 31.5 28.5 29.6 30.4 29.7 21.0 23.2 26.6 16.6 29.7 24.2 27.7 30.5 25.7 21.4 20.9 16.5 36.3 21.5 16.9 30.1 16.3 20.7 21.4 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 14.5 8.2 9.5 14.9 12.9 19.1 13.0 16.4 11.4 11.1 12.9 8.9 10.3 8.0 11.4 13.0 12.0 8.0 7.7 8.1 10.2 6.2 9.6 10.8 10.9 13.8 11.9 5.4 9.3 10.1 15.6 20.7 14.4 11.8 13.7 13.1 12.9 12.0 9.5 10.0 14.1 15.0 10.1 16.7 13.2 9.4 25.2 12.5 17.1 11.0 6.9 15.7 11.5 16.0 10.2 6.0 18.6 12.9 10.2 13.9 5.5 10.5 6.9 10.6 9.3 9.1 9.7 8.8 12.0 16.8 11.8 13.1 9.4 7.6 14.9 6.5 7.1 12.1 10.6 7.2 13.3 11.2 7.2 8.8 5.4 10.5 11.2 12.0 10.8 8.9 8.3 10.3 15.4 7.5 7.6 9.3 9.1 10.1 9.5 12.5 7.6 9.1 9.7 12.1 6.0 8.5 6.3 3.6 7.8 6.2 4.5 23.4 8.2 7.6 8.3 7.9 8.5 8.8 9.0 9.5 10.0 25.6 11.3 12.6 5.8 10.7 6.9 18.6 9.9 9.4 8.8 10.2 10.2 10.0 5.3 9.5 9.0 8.8 8.5 10.2 12.9 6.0 13.9 5.5 9.5 12.9 16.4 11.4 10.2 6.2 11.9 5.4 11.8 12.5 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavourable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.5 12.6 17.9 20.7 9.6 13.2 10.6 12.9 13.5 13.0 14.3 22.6 14.3 32.7 10.3 18.3 9.3 23.4 24.0 22.9 20.5 11.7 26.3 16.1 22.5 11.6 22.4 17.1 12.4 10.7 22.9 29.5 20.9 27.2 28.1 14.9 21.2 38.8 15.4 13.8 14.9 23.2 12.4 19.5 12.9 18.2 18.3 14.2 20.8 8.5 9.3 11.4 12.0 15.2 12.1 12.1 15.2 16.2 22.5 30.8 30.7 13.6 18.4 15.4 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 93.1" "Lineage enriched" "Detected in all" 12 "granulocytes: 93.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043025: , HPA048638: " "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favourable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 15.4 11.7 23.3 33.2 19.5 57.7 15.4 12.7 26.6 15.9 16.5 16.3 10.0 17.1 15.3 13.2 33.0 15.7 20.1 12.5 20.2 11.9 18.8 24.1 22.7 43.3 14.8 11.9 19.2 34.9 10.0 16.2 18.5 12.8 17.7 12.6 15.5 24.2 14.5 21.6 22.4 18.0 13.4 10.3 41.1 24.1 8.1 12.5 31.9 14.6 19.6 43.0 20.6 19.0 6.4 2.2 93.1 2.0 1.2 7.7 3.8 17.9 10.5 11.3 15.2 7.2 12.7 18.5 12.2 9.7 12.3 10.9 11.1 15.4 13.0 10.2 13.8 16.4 6.5 14.5 5.6 19.9 13.8 17.9 9.2 19.5 21.6 9.7 31.7 16.9 28.0 8.0 16.8 14.1 33.0 26.6 11.4 32.1 13.9 18.8 14.5 17.3 13.8 5.4 24.7 20.3 18.9 19.9 19.3 10.7 23.8 19.9 20.9 23.6 14.2 22.5 12.5 26.2 12.1 29.6 15.4 19.0 14.4 14.1 19.6 14.6 2.0 16.2 2.5 1.5 3.9 6.4 5.0 3.4 2.2 3.8 4.8 3.3 93.1 1.2 2.0 0.9 7.7 3.8 23.3 19.5 12.7 26.6 20.2 11.9 14.8 11.9 12.8 12.5 RAB11A YL8 ENSG00000103769 "RAB11A, member RAS oncogene family" P62491 15 65726054-65891991 "Predicted intracellular proteins" "Cell cycle, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013097, HPA051697, HPA060686" Approved Enhanced "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "CAB013097: AB_2533987, HPA051697: , HPA060686: " "unprognostic (4.15e-2)" "unprognostic (5.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.85e-2)" "unprognostic (6.07e-2)" "unprognostic (3.17e-2)" "unprognostic (7.12e-2)" "unprognostic (8.60e-2)" "unprognostic (4.83e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (4.29e-2)" "prognostic favourable (1.46e-5)" "unprognostic (9.93e-2)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (1.21e-1)" 43.3 64.1 32.4 27.0 49.6 25.1 35.4 34.9 57.3 41.3 49.9 27.7 30.5 31.4 36.4 31.7 131.6 34.2 42.8 34.5 35.0 40.5 52.4 28.7 38.1 32.8 34.3 36.6 35.6 24.5 32.3 36.6 60.5 60.5 35.8 52.2 33.7 58.3 31.2 27.3 79.8 35.2 34.3 33.1 55.3 47.9 47.4 25.1 32.4 46.2 60.7 62.1 51.7 60.6 18.1 31.5 54.0 33.3 15.1 24.5 59.5 42.0 49.9 51.0 36.9 46.7 43.9 66.7 45.0 45.9 41.1 49.1 45.8 75.8 55.3 46.0 51.5 65.2 80.2 59.6 38.8 36.0 47.9 66.2 36.1 40.5 35.6 31.0 39.4 44.7 67.9 40.3 33.6 90.9 53.1 33.0 57.9 41.8 30.6 24.6 42.5 28.4 26.1 38.7 51.2 110.3 110.6 36.8 39.1 32.4 51.6 41.7 68.2 36.3 68.6 32.6 46.5 31.3 39.7 17.4 41.3 43.0 30.2 52.7 34.9 32.4 32.1 51.8 14.0 29.8 14.3 18.1 21.0 16.6 31.5 14.1 19.8 15.5 54.0 15.1 33.3 20.3 24.5 59.5 32.4 49.6 34.9 57.3 35.0 40.5 34.3 36.6 60.5 25.1 RAB11B H-YPT3 ENSG00000185236 "RAB11B, member RAS oncogene family" Q15907 19 8389981-8404434 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054396 Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA054396: " "unprognostic (5.81e-3)" "prognostic favourable (2.08e-4)" "unprognostic (1.13e-2)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (4.78e-2)" "prognostic favourable (7.58e-5)" "unprognostic (1.23e-1)" "prognostic favourable (2.06e-4)" "unprognostic (3.66e-1)" "unprognostic (3.87e-1)" "unprognostic (8.85e-2)" "unprognostic (3.29e-3)" 41.1 38.7 38.1 34.3 51.9 36.5 32.5 43.7 89.0 27.9 29.3 70.8 27.6 46.1 31.0 26.8 38.8 31.0 31.7 56.7 39.6 37.5 40.6 35.9 32.3 32.3 43.6 34.4 35.1 60.5 27.6 35.3 37.9 62.2 32.9 15.0 40.1 57.8 32.7 47.8 40.7 46.4 26.4 48.4 42.9 45.8 25.9 38.5 30.8 71.1 22.1 28.0 33.2 27.1 20.8 28.2 45.6 24.5 24.9 23.8 16.6 21.8 28.9 20.8 19.1 10.7 10.6 15.4 13.0 8.9 9.8 10.3 18.9 18.4 12.8 36.9 10.9 17.2 7.0 18.6 3.2 25.5 33.7 13.6 24.2 23.4 10.3 15.9 25.6 14.7 12.3 10.7 7.1 12.2 14.3 34.4 10.1 20.9 26.8 75.6 29.2 26.2 17.9 13.8 21.5 10.2 32.4 22.5 28.9 16.1 13.4 16.7 17.0 18.0 23.4 37.1 21.4 28.5 20.7 35.6 23.6 15.1 27.8 17.8 24.8 19.9 20.8 45.6 22.6 21.1 15.7 19.1 20.6 23.8 21.8 20.8 20.0 18.6 32.1 24.9 24.5 28.2 19.8 16.6 38.1 51.9 43.7 89.0 39.6 37.5 43.6 34.4 62.2 38.5 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046603 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favourable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.8 7.1 11.8 6.4 21.6 12.0 7.2 13.3 19.9 11.4 9.7 7.9 19.0 3.8 23.0 29.8 6.8 12.9 8.6 7.2 10.5 7.1 12.8 5.6 7.7 8.5 8.0 12.9 10.7 7.0 8.6 6.6 8.3 11.5 12.7 5.3 6.9 6.2 27.2 6.5 6.3 6.7 20.0 7.5 7.7 15.5 8.6 8.8 10.0 11.8 3.8 5.6 10.5 13.7 2.3 2.6 1.9 1.2 0.9 2.3 0.4 5.2 6.7 5.6 7.1 9.4 12.0 6.1 10.4 12.1 6.4 6.7 5.4 5.6 10.8 8.4 10.6 3.7 7.8 4.6 10.0 2.7 8.2 3.9 6.9 3.7 13.6 7.1 4.2 11.7 8.7 9.1 20.0 3.9 2.8 9.2 8.3 1.9 5.4 5.3 4.8 4.7 4.7 19.9 3.6 9.6 4.2 1.3 10.4 7.3 3.0 12.8 2.3 6.7 5.7 8.6 7.0 10.1 10.3 6.7 5.6 7.0 8.9 12.3 5.3 1.5 1.2 1.4 1.5 0.8 1.4 2.2 1.2 1.5 0.6 2.3 2.3 1.3 1.9 0.9 0.7 2.6 0.6 0.4 11.8 21.6 13.3 19.9 10.5 7.1 8.0 12.9 11.5 8.8 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Approved Supported "Vesicles,Cytokinetic bridge,Centriolar satellite" "Vesicles, Cytokinetic bridge, Centriolar satellite" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favourable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favourable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favourable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.1 9.7 8.5 14.3 9.4 8.4 8.4 7.9 7.7 5.6 7.4 2.1 12.2 9.9 12.3 4.6 6.0 8.9 2.7 9.0 8.6 5.5 9.4 21.5 15.3 5.4 6.8 9.0 6.1 7.9 6.9 11.7 2.8 4.8 9.7 13.6 8.8 10.8 8.1 4.1 18.3 7.8 3.2 7.8 2.7 10.1 9.4 8.6 10.5 5.3 5.9 10.1 19.0 11.3 7.5 10.5 5.5 6.7 5.3 14.4 4.3 3.9 8.3 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 RAB11FIP5 "GAF1, KIAA0857, pp75, RIP11" ENSG00000135631 "RAB11 family interacting protein 5" Q9BXF6 2 73073382-73156721 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell line enhanced" "Detected in many" "TIME: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6" "Lineage enriched" "Detected in single" 18 "T-cells: 2.6" "Low region specificity" "Detected in all" "HPA036406, HPA036407" Enhanced Enhanced "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA036406: , HPA036407: AB_10669778" "unprognostic (1.49e-1)" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.58e-3)" "unprognostic (4.08e-3)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.87e-4)" "unprognostic (3.23e-3)" "unprognostic (1.45e-1)" "prognostic favourable (2.26e-5)" "unprognostic (1.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "unprognostic (9.66e-3)" 8.4 5.4 5.3 3.8 9.3 1.5 6.3 9.5 16.7 5.2 4.2 2.8 4.6 3.5 7.9 7.3 5.3 5.6 8.2 7.2 4.9 6.3 14.9 2.3 4.8 2.1 5.6 6.5 6.7 8.4 22.3 4.3 11.4 16.0 5.3 2.1 5.1 9.5 5.9 9.0 5.8 2.6 5.2 2.9 18.9 4.9 46.4 2.5 0.0 3.9 4.7 2.7 5.3 7.4 0.1 0.0 0.0 0.0 0.0 2.6 0.5 12.0 5.4 0.4 3.8 4.0 4.8 7.0 18.2 10.0 6.2 4.8 3.9 3.0 0.0 9.6 9.2 4.9 2.3 5.6 2.8 20.9 6.7 4.4 2.3 2.5 4.9 0.0 0.8 5.8 5.3 7.6 5.0 8.5 3.4 2.4 4.4 0.3 0.0 0.1 2.9 8.6 4.1 4.9 10.2 5.4 1.5 1.8 1.9 6.0 2.5 2.7 1.4 0.2 25.0 15.1 8.8 11.2 9.5 7.9 2.3 0.0 11.8 4.7 1.4 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 1.9 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.8 0.5 5.3 9.3 9.5 16.7 4.9 6.3 5.6 6.5 16.0 2.5 RAB13 ENSG00000143545 "RAB13, member RAS oncogene family" P51153 1 153981617-153986358 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 115.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0" "Group enriched" "Detected in many" 9 "dendritic cells: 12.0;monocytes: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003996 Approved Supported "Plasma membrane,Cytosol" 4600000 "Plasma membrane, Cytosol" "HPA003996: AB_1079728" "unprognostic (4.39e-3)" "unprognostic (1.20e-1)" "unprognostic (2.51e-2)" "unprognostic (4.11e-2)" "unprognostic (4.28e-3)" "unprognostic (3.20e-2)" "unprognostic (1.18e-3)" "unprognostic (2.80e-1)" "unprognostic (3.53e-2)" "unprognostic (2.11e-2)" "unprognostic (2.10e-1)" "unprognostic (5.93e-2)" "unprognostic (1.06e-3)" "unprognostic (2.45e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (1.28e-2)" 49.0 40.4 18.1 28.7 30.2 29.7 52.1 13.6 23.5 33.1 33.6 13.7 46.6 17.8 28.5 47.1 43.2 25.0 46.7 36.9 21.9 17.0 61.3 51.5 40.8 36.7 22.9 11.1 39.2 65.6 28.4 11.1 29.0 29.1 41.5 24.5 21.6 47.4 44.4 26.8 25.0 28.7 35.3 31.3 44.8 34.5 24.0 24.7 5.9 54.8 35.0 24.9 41.0 78.4 1.0 12.0 0.9 7.7 0.0 0.7 2.4 17.1 21.1 19.2 20.1 64.4 115.1 6.2 20.9 49.5 18.9 19.3 21.3 14.6 0.0 31.5 24.9 11.8 11.3 19.0 26.3 11.0 8.8 14.3 13.3 11.9 27.0 0.0 10.1 83.7 16.5 32.6 14.5 32.9 3.0 0.0 32.1 35.6 0.0 7.3 30.8 20.2 4.1 24.9 0.0 42.6 18.1 1.2 15.8 27.3 23.7 42.1 38.9 11.4 60.9 34.4 20.4 21.3 22.6 0.1 0.0 0.2 53.6 2.4 52.2 0.0 7.7 0.1 0.0 1.4 0.1 0.8 0.1 0.1 10.7 1.0 0.1 0.7 0.9 0.0 0.2 12.0 0.0 2.4 18.1 30.2 13.6 23.5 21.9 17.0 22.9 11.1 29.1 24.7 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.4" "Cell line enhanced" "Detected in many" "HAP1: 37.4;RH-30: 44.7;RT4: 32.7;SK-BR-3: 34.3" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavourable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.3 4.0 16.7 4.2 19.2 0.6 6.3 40.4 32.9 5.7 9.9 2.2 3.2 9.1 2.4 4.5 1.8 1.9 4.7 14.1 21.2 10.8 7.5 11.4 4.3 2.6 7.8 12.6 1.4 5.6 16.2 4.0 11.9 10.2 4.3 15.4 1.9 27.2 3.8 3.9 2.8 9.6 8.6 4.2 1.2 5.3 1.0 2.5 2.4 2.9 0.6 2.2 13.4 1.8 0.0 5.2 0.0 0.1 0.8 0.7 0.1 3.0 16.2 6.0 5.9 1.3 1.9 16.8 1.9 2.7 4.0 3.5 7.6 8.2 0.1 1.1 4.7 3.1 37.4 0.3 2.8 1.0 1.8 3.5 0.3 6.6 0.2 0.1 2.2 1.3 0.7 1.7 0.3 12.4 0.1 0.5 7.0 17.3 4.2 3.1 13.4 2.3 5.2 44.7 0.2 4.6 32.7 19.3 3.7 0.9 34.3 4.3 9.7 3.3 3.1 3.4 14.8 1.6 2.4 0.1 0.1 1.6 0.7 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 5.2 0.3 0.1 16.7 19.2 40.4 32.9 21.2 10.8 7.8 12.6 10.2 2.5 RAB1A "RAB1, YPT1" ENSG00000138069 "RAB1A, member RAS oncogene family" P62820 2 65070701-65130106 "Plasma proteins, Predicted intracellular proteins" "Autophagy, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005331, HPA056141" Approved Supported "Endoplasmic reticulum,Cytosol" 19000000 "Endoplasmic reticulum, Cytosol" "CAB005331: AB_632290, HPA056141: " "unprognostic (4.78e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "prognostic unfavourable (4.19e-4)" "unprognostic (1.55e-3)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (4.30e-3)" "unprognostic (2.79e-1)" "unprognostic (4.81e-2)" "unprognostic (2.77e-1)" "unprognostic (7.80e-2)" "unprognostic (1.83e-2)" "unprognostic (8.63e-2)" 53.0 57.6 54.6 34.8 58.4 80.8 54.0 47.7 63.2 49.2 50.3 24.8 53.8 52.7 46.7 75.8 58.8 40.7 40.9 49.9 48.1 52.8 77.8 75.4 48.2 40.7 44.0 55.3 37.1 53.5 38.5 59.7 108.6 47.3 40.5 52.2 34.0 68.7 57.1 43.8 35.5 51.6 47.6 49.6 34.5 53.2 30.9 42.4 21.5 56.9 53.1 34.9 52.2 45.1 19.1 33.2 45.0 37.1 24.4 25.1 22.2 39.2 29.1 35.8 20.8 86.6 51.0 56.4 58.4 39.7 25.9 27.5 50.2 26.0 15.9 33.6 57.6 25.2 32.5 51.9 41.0 19.6 19.5 20.1 23.2 73.6 55.0 20.8 18.3 45.0 53.0 33.9 30.3 50.8 28.6 18.5 50.8 35.1 12.2 25.1 28.2 26.2 12.5 33.9 25.3 50.0 44.0 25.8 23.0 26.8 43.9 49.2 27.3 19.6 48.7 33.4 42.6 35.2 32.6 28.9 17.8 38.3 44.4 32.2 32.3 35.3 37.1 32.2 19.5 36.8 21.5 19.1 21.1 21.0 33.2 13.9 20.5 20.4 45.0 24.4 31.6 27.6 25.1 22.2 54.6 58.4 47.7 63.2 48.1 52.8 44.0 55.3 47.3 42.4 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268533-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" 26000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: " "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favourable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 47.5 47.7 36.2 32.5 42.4 33.1 47.8 35.6 60.6 42.0 45.6 38.0 35.7 46.5 42.0 37.2 61.2 45.8 48.4 50.2 34.5 31.5 47.3 67.8 43.0 51.8 34.8 38.6 44.4 52.9 55.0 42.5 63.6 34.6 49.5 38.4 45.3 62.2 48.6 82.8 50.6 58.0 49.2 38.7 47.3 45.6 36.5 30.9 49.2 54.7 50.4 55.9 40.1 41.2 26.3 36.4 84.7 44.2 36.3 47.3 59.7 39.0 45.4 22.9 31.1 39.3 29.4 21.3 32.5 40.0 44.2 31.2 25.8 41.6 16.3 43.0 47.8 37.9 26.1 46.7 24.3 32.6 23.5 25.9 29.5 22.4 26.2 22.0 47.8 30.7 40.3 37.3 19.4 41.6 26.6 29.8 42.0 78.8 38.1 35.5 24.2 43.1 23.6 18.9 42.6 44.4 37.0 23.0 25.3 24.4 59.9 23.7 91.3 25.5 41.9 42.3 28.6 49.8 28.8 16.3 12.9 21.3 48.0 18.8 38.6 27.2 38.8 61.2 47.3 40.8 35.7 22.7 28.5 38.4 31.6 26.3 25.0 29.7 84.7 36.3 44.2 36.4 30.7 59.7 36.2 42.4 35.6 60.6 34.5 31.5 34.8 38.6 34.6 30.9 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561733 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.5;SK-BR-3: 35.9;T-47d: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003621, HPA052111, HPA068647" Uncertain Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003621: , HPA052111: , HPA068647: " "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favourable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favourable (4.48e-4)" 30.9 23.5 3.7 11.9 5.3 11.9 27.5 1.3 4.0 6.9 20.2 5.2 3.0 15.7 6.0 8.8 4.1 6.8 17.8 17.0 5.3 2.5 15.9 38.2 27.8 21.9 7.1 1.8 17.0 14.5 3.2 5.8 12.6 9.1 9.4 8.3 8.5 10.9 3.2 8.8 2.6 23.8 5.0 13.4 32.9 15.0 6.3 3.6 2.5 13.6 1.9 4.2 13.2 13.6 1.9 8.3 13.4 19.4 0.0 3.6 5.6 8.0 1.2 0.8 1.6 5.3 1.4 13.1 0.7 2.5 3.4 5.3 19.5 16.5 0.0 5.8 0.7 3.1 1.6 5.0 1.8 9.0 1.2 8.0 1.5 9.0 3.3 1.1 2.4 2.9 0.8 1.8 0.5 1.3 1.5 0.0 0.7 9.7 0.0 11.6 1.7 3.5 0.7 0.0 3.6 5.9 10.7 0.2 0.9 1.5 35.9 10.9 22.6 12.4 0.9 0.8 1.8 0.0 1.1 0.0 0.0 0.0 11.7 15.8 1.7 2.8 19.4 3.5 0.6 17.0 0.7 1.9 1.6 0.5 8.3 1.2 3.6 1.2 13.4 0.0 12.7 0.4 0.4 5.6 3.7 5.3 1.3 4.0 5.3 2.5 7.1 1.8 9.1 3.6 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222314 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 62.4;urinary bladder: 48.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.0;U-2197: 56.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 6.0 3.0 6.7 5.7 5.1 0.2 4.0 7.3 4.8 23.1 32.9 5.1 9.6 3.0 34.1 8.0 9.7 8.1 12.4 7.0 7.4 4.5 3.3 1.8 4.9 1.7 6.4 5.4 8.2 1.6 2.9 3.5 12.3 6.7 24.9 7.5 3.6 2.8 26.9 4.7 3.1 7.0 62.4 6.6 1.1 8.7 4.3 7.2 1.4 15.1 3.9 1.7 48.9 11.2 0.3 1.5 1.3 0.6 0.9 2.0 0.3 4.7 1.9 6.8 4.8 10.5 32.0 6.3 14.0 24.3 12.3 12.8 4.1 2.3 0.9 4.4 22.4 1.7 7.1 5.1 14.7 3.5 3.3 3.4 3.1 3.2 6.5 1.8 0.5 11.9 5.9 15.3 14.4 6.4 5.2 2.9 13.6 4.0 1.5 1.9 2.5 2.6 1.7 10.1 1.4 8.5 3.3 3.5 2.4 7.0 3.3 3.6 3.0 2.0 8.5 19.2 6.0 56.4 8.1 2.5 2.8 2.3 10.8 3.8 9.4 0.3 0.4 1.3 0.3 0.4 0.0 0.3 1.1 0.5 0.3 0.3 2.0 0.8 0.0 0.9 0.6 1.5 0.0 0.3 6.7 5.1 7.3 4.8 7.4 4.5 6.4 5.4 6.7 7.2 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070514 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.3" "Cell line enhanced" "Detected in some" "BEWO: 26.9;CAPAN-2: 26.2;HaCaT: 23.8;hTCEpi: 23.5;MCF7: 36.3;RT4: 33.0;SK-BR-3: 53.7;T-47d: 50.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 24 "T-cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favourable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.3 0.3 10.9 0.3 0.0 10.8 0.5 0.4 23.6 28.4 0.3 28.1 14.8 4.0 15.9 98.3 9.7 33.3 0.3 0.3 0.3 18.2 1.0 19.1 0.6 0.3 0.2 2.3 27.4 8.6 9.5 19.1 0.3 13.3 16.2 0.4 44.1 26.8 0.4 48.0 43.0 2.1 0.4 0.3 16.2 1.1 0.2 3.7 36.1 74.6 60.9 13.0 31.8 0.1 0.0 0.0 0.0 0.0 3.4 0.8 19.7 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 19.3 26.2 0.0 0.0 0.0 23.8 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 33.0 2.9 0.0 0.0 53.7 0.0 50.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 2.8 0.8 0.0 0.0 3.4 2.9 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.3 0.5 0.4 0.3 0.3 0.3 0.2 0.3 0.2 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Cell line enhanced" "Detected in many" "A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favourable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.6 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.7 0.2 0.9 0.8 2.2 0.7 0.2 0.0 1.5 1.4 0.5 14.9 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 0.3 0.3 0.0 1.6 8.9 0.0 0.6 0.8 1.2 1.1 1.1 2.3 5.2 0.9 18.9 3.7 0.3 17.1 0.6 5.6 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell line enhanced" "Detected in many" "HEL: 20.5;hTCEpi: 15.6;hTERT-HME1: 19.0;U-87 MG: 55.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavourable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.3 0.2 0.0 0.5 6.7 0.0 0.5 4.4 0.6 0.4 0.0 2.8 0.4 0.0 1.2 4.8 0.0 2.9 0.1 0.0 0.1 20.5 1.7 0.0 0.8 1.1 2.2 5.3 15.6 8.6 19.0 0.2 0.0 1.3 5.4 2.5 0.0 2.4 0.1 4.9 0.0 0.0 0.1 1.3 9.4 0.0 3.5 0.7 4.4 0.0 2.7 0.1 0.1 6.4 0.2 3.3 0.6 0.1 0.0 0.0 55.6 11.6 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113242-88175467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;tongue: 38.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.9;hTCEpi: 68.0;hTERT-HME1: 60.6;SK-MEL-30: 36.6" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Region enriched" "Detected in single" 5 "pons and medulla: 3.2" "Group enriched" "Detected in many" 5 "NK-cell: 15.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;NK-cells: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA071701 Uncertain "Nuclear bodies,Mitochondria" "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favourable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 15.6 0.4 1.2 0.4 0.4 4.6 0.3 0.6 10.8 1.6 1.2 2.8 1.0 7.0 8.7 29.9 2.8 8.2 1.7 0.6 0.5 2.6 0.8 5.3 0.4 0.5 0.2 3.0 2.3 0.9 4.6 7.7 3.2 4.0 0.4 35.5 4.9 5.2 0.5 24.9 2.4 2.7 0.7 1.3 0.9 5.3 0.1 1.6 6.6 38.1 21.0 4.2 13.3 0.0 4.2 0.5 1.3 15.3 1.8 0.6 2.2 0.3 0.0 0.1 0.0 0.5 0.1 1.4 5.7 2.3 4.2 1.0 1.0 0.1 1.4 1.5 15.6 1.2 18.9 3.1 0.2 1.1 11.4 1.5 0.0 0.2 0.1 0.1 0.5 68.0 0.3 60.6 2.7 0.0 0.2 0.0 0.0 0.1 3.8 1.8 0.0 0.1 0.0 0.1 4.4 8.7 0.4 0.2 0.0 0.0 36.6 3.4 1.0 1.5 0.0 1.0 0.0 0.2 0.3 1.4 0.0 0.3 0.4 0.2 0.0 0.6 0.1 1.6 0.6 0.9 0.0 0.5 1.8 1.5 0.0 0.1 0.9 0.5 15.3 1.3 4.2 0.9 0.6 0.4 0.4 0.3 0.6 0.6 0.5 0.5 0.2 3.2 0.1 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell line enhanced" "Detected in many" "PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favourable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.3 3.2 3.8 1.0 1.4 2.0 1.2 1.4 1.9 0.9 0.5 3.3 2.2 1.6 2.7 10.7 1.3 0.7 0.7 3.4 1.3 3.9 3.7 0.9 2.2 4.1 3.1 1.3 0.8 0.4 0.4 0.7 1.1 1.3 3.2 5.0 0.6 1.9 13.5 3.5 0.2 2.8 1.5 0.5 24.7 11.8 1.0 4.3 2.3 0.9 0.4 0.4 1.2 0.9 17.1 1.1 2.1 4.5 0.8 3.2 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 RAB3GAP1 "KIAA0066, RAB3GAP, RAB3GAP130, WARBM1" ENSG00000115839 "RAB3 GTPase activating protein catalytic subunit 1" Q15042 2 135052265-135176394 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034494, HPA034495" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034494: , HPA034495: AB_10670158" "unprognostic (1.02e-2)" "unprognostic (2.43e-2)" "unprognostic (5.73e-2)" "prognostic unfavourable (2.96e-4)" "unprognostic (2.18e-1)" "unprognostic (9.57e-2)" "unprognostic (2.96e-2)" "unprognostic (7.00e-2)" "unprognostic (3.18e-1)" "unprognostic (1.13e-2)" "unprognostic (3.15e-2)" "unprognostic (2.05e-1)" "unprognostic (8.40e-3)" "unprognostic (2.41e-2)" "unprognostic (3.75e-1)" "unprognostic (4.11e-1)" "unprognostic (2.15e-1)" 24.1 18.4 22.1 20.8 32.9 27.3 21.8 27.1 37.2 25.1 24.0 21.2 20.0 15.7 42.2 27.0 26.1 20.1 18.3 28.4 21.4 29.1 20.1 16.9 18.6 19.7 24.5 28.1 31.3 29.4 31.7 50.0 33.0 34.5 26.0 24.0 23.2 37.3 25.4 37.4 25.1 19.4 26.4 26.0 17.5 22.7 19.6 21.3 28.8 26.2 20.9 24.6 25.2 24.8 9.1 5.4 9.3 7.1 3.6 10.7 2.4 19.4 7.9 14.0 11.5 27.5 23.5 12.9 29.9 24.7 23.8 23.6 17.5 16.0 29.0 18.6 30.5 16.5 14.7 27.6 29.2 13.8 14.9 14.4 10.0 15.2 19.2 17.7 15.7 20.5 36.5 21.9 39.7 17.1 18.6 16.9 21.6 11.5 9.0 6.9 10.7 13.3 15.6 17.9 12.1 14.0 17.4 11.3 8.9 20.3 12.2 14.1 10.7 12.9 20.6 24.2 18.4 10.3 12.5 12.0 6.8 21.8 15.8 10.7 13.4 9.3 5.0 7.6 2.0 6.7 1.8 7.0 5.0 2.8 5.4 9.1 10.7 5.3 2.0 3.6 7.1 2.9 6.5 2.4 22.1 32.9 27.1 37.2 21.4 29.1 24.5 28.1 34.5 21.3 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272454 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavourable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 16.7 16.2 14.9 19.6 18.7 14.3 17.8 24.2 22.4 15.6 13.5 14.3 13.9 12.2 16.8 14.9 15.6 12.8 12.8 15.3 16.5 18.8 18.9 15.6 14.3 18.2 17.1 15.6 16.2 14.5 35.6 28.3 19.8 21.9 14.2 13.5 11.6 15.6 15.8 19.9 13.1 15.0 14.9 15.2 14.9 14.5 10.1 15.5 26.1 20.5 11.9 21.7 16.0 15.8 7.1 5.2 12.3 5.1 3.6 8.9 4.6 13.8 10.6 12.8 9.6 14.8 17.6 14.6 14.3 13.6 13.0 15.3 9.7 11.6 17.3 10.1 13.8 13.3 13.3 10.9 15.1 14.4 8.7 13.5 14.1 9.0 19.5 19.2 13.9 13.9 12.5 12.6 19.6 11.8 23.2 11.2 14.6 3.9 14.7 6.8 27.6 6.3 8.1 17.7 15.4 11.0 11.5 12.8 15.5 14.8 14.5 23.2 15.1 18.4 17.1 14.2 6.6 9.7 15.2 10.0 12.1 15.2 12.2 16.3 16.6 12.3 3.9 7.5 7.1 4.9 8.6 7.1 7.0 8.9 5.2 5.5 6.3 7.4 2.5 3.6 5.1 3.3 8.0 4.6 14.9 18.7 24.2 22.4 16.5 18.8 17.1 15.6 21.9 15.5 RAB3IL1 GRAB ENSG00000167994 "RAB3A interacting protein like 1" Q8TBN0 11 61897301-61920269 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 18.7;K-562: 20.2;RPMI-8226: 20.9;U-2197: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039723 Uncertain Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA039723: AB_10795406" "unprognostic (1.62e-1)" "unprognostic (3.59e-2)" "prognostic unfavourable (6.08e-4)" "unprognostic (1.97e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-2)" "prognostic unfavourable (1.61e-7)" "unprognostic (7.93e-2)" "unprognostic (2.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.86e-1)" "unprognostic (3.43e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (1.42e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.59e-3)" 24.1 7.1 8.2 6.8 8.0 12.9 13.3 4.0 6.5 18.5 7.8 6.8 4.5 4.3 18.0 9.5 7.2 13.3 10.0 11.2 8.2 3.4 10.0 7.4 6.2 5.9 10.1 3.8 28.6 3.2 6.1 5.4 14.0 8.7 11.9 2.6 13.4 6.7 5.1 9.1 8.5 5.0 8.5 7.7 22.7 5.4 22.1 6.9 6.6 8.8 6.5 2.4 13.4 26.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 3.2 6.9 0.2 3.5 13.4 9.9 0.7 2.6 6.7 3.9 2.7 0.9 0.7 0.0 4.9 4.0 1.7 4.6 0.2 0.7 0.0 1.0 6.6 2.5 3.3 18.7 0.2 0.1 5.6 3.4 2.0 4.4 0.4 20.2 0.2 2.2 5.8 0.0 0.0 2.0 6.9 0.3 0.9 20.9 0.3 0.3 0.2 2.4 1.6 1.4 11.9 1.1 0.7 0.5 14.5 6.6 27.6 1.1 0.2 0.9 0.0 2.8 7.5 6.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 8.0 4.0 6.2 8.2 3.4 10.1 3.8 8.7 6.9 RAB8A "MEL, RAB8" ENSG00000167461 "RAB8A, member RAS oncogene family" P61006 19 16111629-16134234 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041945 Supported "Nucleoplasm,Plasma membrane" 16000000 "Nucleoplasm, Plasma membrane" "HPA041945: " "unprognostic (1.10e-1)" "unprognostic (3.95e-3)" "unprognostic (1.98e-2)" "unprognostic (2.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (2.57e-1)" "unprognostic (1.14e-2)" "unprognostic (2.52e-3)" "unprognostic (1.29e-2)" "prognostic unfavourable (6.56e-5)" "unprognostic (6.60e-2)" "unprognostic (7.25e-2)" "prognostic favourable (1.71e-4)" "unprognostic (9.99e-2)" 23.4 22.8 15.6 24.5 14.1 32.5 15.9 16.6 13.6 18.2 23.1 18.5 15.0 37.6 17.2 11.8 22.9 18.0 17.1 10.6 13.6 11.2 24.8 57.8 19.3 24.9 14.2 8.4 23.3 24.7 8.8 15.5 30.9 13.6 16.3 20.1 16.5 27.4 14.7 5.2 22.3 56.2 14.1 16.7 43.4 20.1 15.9 14.7 33.4 18.5 12.7 36.1 19.7 17.9 34.3 45.4 55.2 81.1 39.0 31.8 75.5 28.9 19.6 16.2 13.5 13.1 11.7 25.3 17.6 15.2 23.5 24.7 22.3 33.5 20.0 20.1 17.2 19.2 21.6 21.7 15.0 41.0 12.6 41.9 18.2 22.9 15.0 36.3 41.8 12.1 11.3 22.1 9.6 19.3 19.4 30.6 18.6 33.4 30.2 31.9 20.2 31.5 34.5 17.8 35.4 17.3 22.2 14.9 14.7 17.8 21.2 11.1 17.1 13.6 19.0 19.8 12.8 38.4 30.0 16.7 34.1 30.1 19.1 36.4 21.3 36.0 50.6 55.2 31.8 69.8 28.4 34.3 28.4 28.6 45.4 31.8 22.5 26.5 53.8 39.0 81.1 32.5 26.6 75.5 15.6 14.1 16.6 13.6 13.6 11.2 14.2 8.4 13.6 14.7 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189469-63267782 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074534 Supported Nucleoplasm,Vesicles 5200000 Vesicles Nucleoplasm "HPA074534: " "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 21.8 12.1 15.2 20.9 12.9 50.8 22.6 10.1 12.2 15.8 17.7 11.8 7.6 13.6 14.2 8.6 10.9 12.7 18.4 17.5 19.2 14.4 13.7 11.4 27.7 30.8 15.3 12.9 25.2 5.7 6.6 11.7 22.0 16.9 14.3 9.0 9.8 9.3 11.3 7.5 8.2 21.1 14.3 19.5 33.7 9.8 11.8 11.5 38.8 16.4 4.7 27.8 24.4 23.7 10.7 10.4 30.8 14.5 13.1 19.2 14.3 4.7 4.0 15.4 6.3 29.4 24.3 4.6 4.7 10.7 8.5 16.7 4.3 3.9 12.9 4.3 10.1 2.4 13.2 6.4 14.4 19.4 2.6 16.2 3.6 2.8 27.4 6.1 10.3 14.6 3.3 16.1 9.4 21.6 6.3 12.5 15.6 3.1 9.9 3.3 9.6 3.9 8.5 20.5 1.8 6.8 22.4 1.3 3.3 7.1 0.9 13.1 3.4 6.2 24.3 15.9 10.3 8.4 6.3 8.1 8.1 12.3 10.2 17.3 43.2 27.1 14.5 11.9 15.8 13.1 14.4 10.7 12.8 15.0 10.4 10.6 10.0 12.2 30.8 13.1 11.6 1.3 19.2 14.3 15.2 12.9 10.1 12.0 19.2 14.4 15.3 12.9 16.9 11.5 RAB9A RAB9 ENSG00000123595 "RAB9A, member RAS oncogene family" P51151 X 13689125-13710506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003094, CAB016411" Supported Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016411: AB_630176, HPA003094: AB_1079736" "unprognostic (3.40e-2)" "unprognostic (1.36e-2)" "unprognostic (3.56e-3)" "unprognostic (3.08e-2)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.77e-2)" "unprognostic (8.23e-2)" "unprognostic (1.27e-2)" "unprognostic (4.88e-2)" "prognostic favourable (3.35e-5)" "unprognostic (3.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.46e-1)" "unprognostic (2.68e-2)" 17.1 36.0 17.7 20.3 17.1 30.6 48.4 16.2 24.1 14.8 17.6 20.2 19.7 9.3 18.8 14.3 19.7 11.9 14.5 23.1 16.9 14.3 19.6 15.6 17.3 21.0 24.7 13.8 18.9 23.6 19.1 11.3 17.8 18.1 13.5 16.2 8.0 22.8 17.6 12.0 21.2 12.3 15.3 25.5 15.1 14.2 6.4 23.4 9.8 16.8 13.2 19.3 16.1 19.7 13.1 19.1 17.7 25.7 19.8 27.3 13.9 12.4 6.7 8.6 20.3 28.9 23.2 7.7 7.0 24.6 10.7 15.7 7.2 14.0 11.3 17.4 10.9 12.8 12.8 14.9 10.6 25.0 19.9 3.6 14.8 8.2 17.4 6.3 9.8 24.9 26.4 13.5 14.5 9.9 6.9 16.8 11.5 8.6 5.9 10.3 9.2 12.7 8.2 9.1 33.8 29.5 11.6 7.1 5.0 14.8 21.1 24.1 11.7 6.7 7.7 8.2 4.2 28.9 4.2 13.3 23.1 4.5 8.2 5.4 8.0 17.7 25.7 11.1 27.3 16.6 21.1 13.1 15.0 22.4 17.6 10.0 11.3 19.4 15.3 19.8 14.5 19.1 11.7 13.9 17.7 17.1 16.2 24.1 16.9 14.3 24.7 13.8 18.1 23.4 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported Approved "Nuclear membrane,Nucleoli fibrillar center" "Nuclear membrane" "Nucleoli fibrillar center" "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 44.2 45.4 42.3 36.7 42.5 29.6 43.5 30.9 53.1 43.6 40.5 32.0 45.3 47.8 46.8 32.4 36.2 30.4 39.8 32.2 39.5 45.9 46.0 92.3 35.7 53.0 44.7 33.4 37.5 88.1 18.5 48.6 51.0 39.9 33.8 19.1 23.3 68.8 40.5 52.2 31.6 43.4 32.0 38.4 32.2 60.6 28.3 31.9 38.8 56.1 28.7 32.4 31.4 47.5 54.5 59.6 114.0 58.1 33.2 57.2 64.1 17.0 46.9 6.8 17.6 46.3 26.6 9.0 50.9 27.0 12.5 17.7 8.3 11.2 49.4 26.4 30.1 12.8 4.2 16.0 5.2 18.2 27.5 7.2 13.8 14.3 24.8 6.3 20.0 25.8 15.9 8.4 6.2 17.4 3.1 64.4 11.5 26.3 11.0 5.7 8.3 30.5 15.0 14.5 9.5 11.9 12.8 12.5 18.2 13.4 29.2 12.3 10.9 5.3 33.8 22.5 14.8 21.7 7.3 57.3 19.1 17.1 32.5 11.8 24.1 86.2 58.1 76.4 57.2 30.5 48.1 54.5 52.0 49.8 33.8 49.9 35.3 47.6 114.0 33.2 29.6 59.6 55.8 64.1 42.3 42.5 30.9 53.1 39.5 45.9 44.7 33.4 39.9 31.9 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA047641: " "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favourable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favourable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 4.7 13.7 5.4 19.8 10.0 8.5 6.0 4.4 8.6 5.6 7.8 9.9 17.3 14.3 5.9 7.3 11.6 5.3 14.1 8.7 6.5 5.8 10.8 6.6 6.7 35.5 11.9 6.0 5.5 11.3 10.3 11.2 9.1 8.1 17.3 4.1 11.2 16.7 13.9 5.1 17.8 17.5 7.1 6.9 31.5 9.3 8.8 8.4 8.3 9.2 7.5 23.0 10.2 7.6 14.9 3.6 2.4 3.0 5.1 3.5 2.7 8.2 14.0 3.5 6.4 1.9 3.0 6.3 10.1 6.1 7.2 7.0 9.6 7.5 16.0 15.9 3.8 10.5 1.3 5.9 1.2 6.1 5.8 6.2 10.0 13.6 4.3 4.3 19.6 5.0 5.1 8.5 1.4 9.9 3.0 5.8 5.2 19.4 5.6 10.0 4.6 6.5 19.7 3.2 10.8 4.8 11.0 5.5 7.0 4.5 21.6 4.4 17.5 9.7 16.3 11.3 5.4 7.5 9.8 9.0 2.8 12.1 11.8 11.4 8.0 0.5 2.5 2.4 3.5 2.8 2.6 12.2 2.5 3.3 3.6 14.9 2.3 2.1 0.7 5.1 3.0 2.1 2.1 2.7 5.4 10.0 4.4 8.6 6.5 5.8 11.9 6.0 8.1 8.4 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favourable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 18.4 15.2 13.0 14.7 14.4 59.2 12.0 22.4 16.8 16.9 14.1 12.6 9.4 9.1 16.4 9.5 20.6 12.0 13.5 10.8 13.5 15.6 14.9 17.2 10.5 10.6 12.8 12.1 14.7 13.2 13.3 10.2 18.8 13.5 13.1 11.0 13.8 10.6 16.1 12.1 21.9 15.5 15.3 11.9 15.3 11.9 21.5 9.8 13.1 22.3 20.7 18.2 19.1 16.3 15.7 10.4 18.1 13.5 15.4 10.9 7.6 20.2 6.1 5.3 8.9 14.4 20.2 5.3 17.8 22.9 18.8 17.9 5.6 13.2 9.9 7.0 25.8 8.5 7.3 9.7 26.3 6.7 5.8 5.3 7.1 5.6 11.5 9.1 7.5 10.0 12.5 24.3 26.9 4.9 9.7 7.2 18.7 10.2 6.0 12.6 7.0 8.8 5.4 9.3 7.4 16.4 9.3 6.1 9.5 8.3 18.3 9.6 10.5 5.7 6.4 30.6 6.4 18.7 13.9 9.4 12.2 11.7 14.2 10.1 9.7 18.1 7.8 9.4 8.6 6.9 9.3 11.2 8.1 10.9 7.3 15.7 8.8 8.2 15.1 15.4 13.5 10.4 6.7 7.6 13.0 14.4 22.4 16.8 13.5 15.6 12.8 12.1 13.5 9.8 RABIF "mss4, RASGRF3" ENSG00000183155 "RAB interacting factor" P47224 1 202878957-202889135 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027715, HPA054936" Approved Approved "Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" "HPA027715: AB_10602151, HPA054936: " "unprognostic (4.87e-2)" "unprognostic (3.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.37e-1)" "unprognostic (3.51e-1)" "unprognostic (1.36e-2)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.70e-1)" "unprognostic (5.62e-3)" "prognostic favourable (5.64e-5)" "unprognostic (4.40e-2)" "unprognostic (2.94e-1)" "prognostic unfavourable (2.61e-5)" "unprognostic (1.23e-1)" "unprognostic (5.21e-2)" "unprognostic (8.54e-2)" "unprognostic (2.47e-1)" 7.1 7.0 13.4 10.3 13.8 14.0 7.9 11.5 17.9 8.9 10.4 10.9 3.1 9.9 6.3 8.2 13.8 6.2 8.4 6.7 12.7 15.4 11.2 10.9 8.9 11.7 13.4 10.4 4.0 5.7 6.0 9.2 11.2 14.5 8.6 11.7 6.6 7.9 6.8 7.4 10.6 12.0 9.3 18.2 10.2 7.0 30.2 10.6 8.9 6.3 8.8 15.8 9.4 7.5 15.7 17.7 31.1 21.0 14.9 18.7 15.6 12.3 13.3 9.5 10.9 15.0 11.6 10.4 13.7 7.6 14.3 13.3 9.2 10.8 10.1 6.8 10.9 11.6 7.6 8.7 10.8 12.0 13.9 8.4 10.9 9.6 12.1 11.5 14.6 9.6 12.6 17.9 4.7 18.6 13.2 11.3 13.8 20.6 12.8 12.4 7.7 16.5 9.2 12.8 13.9 14.5 12.8 13.6 11.8 11.8 20.9 10.6 13.5 8.4 14.4 10.0 9.2 4.6 12.1 5.9 13.1 10.9 9.8 10.7 9.2 24.1 20.0 27.6 18.3 21.0 13.3 15.7 17.4 17.2 17.7 15.5 15.9 16.7 31.1 14.9 18.8 16.9 18.7 15.6 13.4 13.8 11.5 17.9 12.7 15.4 13.4 10.4 14.5 10.6 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.3" "Cell line enhanced" "Detected in many" "MOLT-4: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome Centrosome Vesicles "HPA042642: , HPA042700: , HPA044007: " "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.2 1.7 6.0 5.9 9.5 1.7 3.3 6.3 20.9 4.3 3.4 4.2 0.4 2.4 4.7 9.0 2.7 29.3 2.8 3.3 7.0 6.0 3.5 3.4 12.9 1.8 4.0 7.5 7.4 2.6 1.2 6.3 1.6 6.4 3.8 2.0 3.8 5.2 12.2 2.2 2.1 2.2 3.6 4.8 2.7 2.1 4.8 4.3 2.0 5.5 2.0 3.1 2.1 2.7 8.8 9.8 2.5 7.6 12.2 10.4 5.5 2.5 4.3 5.9 4.7 4.9 7.2 4.5 2.4 2.0 3.4 2.5 3.7 1.6 3.6 10.3 0.8 2.7 3.0 0.3 2.3 5.0 5.7 1.8 0.1 0.5 4.0 0.7 1.3 2.5 5.1 0.7 1.5 2.5 1.7 0.9 2.1 2.1 12.0 0.9 3.3 1.5 2.2 2.3 1.6 2.4 0.6 2.4 8.3 2.3 2.5 2.1 0.5 3.4 0.6 0.4 0.8 0.9 1.6 3.6 3.7 0.8 7.0 2.7 1.2 0.0 4.8 2.5 7.1 7.6 7.7 8.8 10.4 7.2 7.5 8.0 8.6 6.8 0.5 12.2 7.2 9.8 5.0 5.5 6.0 9.5 6.3 20.9 7.0 6.0 4.0 7.5 6.4 4.3 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783663 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 59.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome Centrosome Vesicles "HPA042642: , HPA042700: , HPA044007: " "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favourable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavourable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 8.2 8.2 12.4 11.1 22.1 8.1 12.9 19.7 21.2 13.0 8.4 12.7 12.6 7.9 13.9 59.0 8.1 41.9 9.4 5.8 13.1 15.3 10.6 7.0 14.4 13.3 9.9 16.5 17.8 9.6 10.9 16.7 7.4 14.3 10.0 11.0 9.5 9.5 11.6 5.1 13.8 8.6 10.2 9.5 11.5 9.1 12.2 14.5 12.6 17.9 3.5 12.3 9.4 9.2 13.6 13.2 9.2 19.4 10.8 16.8 10.3 13.4 12.3 21.0 16.4 23.6 18.8 15.4 10.1 11.3 8.2 11.3 3.4 11.9 8.7 9.0 14.5 17.7 9.6 11.8 8.9 7.5 13.6 7.5 21.1 8.9 9.8 21.1 8.1 16.0 16.2 10.8 13.6 9.1 5.7 11.0 16.3 17.0 10.5 9.3 8.0 9.2 17.8 12.1 9.1 15.9 13.4 9.0 16.4 12.4 11.0 7.6 10.8 6.6 14.0 7.9 15.8 6.7 6.8 9.3 4.3 4.2 14.9 5.3 11.0 1.0 10.9 9.2 16.8 17.4 12.2 11.2 13.0 13.7 11.6 13.6 15.2 14.7 4.3 10.8 19.4 13.2 13.0 10.3 12.4 22.1 19.7 21.2 13.1 15.3 9.9 16.5 14.3 14.5 RABL6 "bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1" ENSG00000196642 "RAB, member RAS oncogene family like 6" Q3YEC7 9 136807943-136841187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044037 Uncertain Approved Centrosome,Cytosol Cytosol Centrosome "HPA044037: AB_10966437" "unprognostic (3.10e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "prognostic favourable (4.00e-4)" "unprognostic (9.23e-2)" "unprognostic (2.44e-2)" "unprognostic (1.90e-3)" "unprognostic (7.55e-3)" "unprognostic (1.65e-1)" "unprognostic (4.92e-2)" "prognostic favourable (1.46e-4)" "unprognostic (5.23e-2)" "unprognostic (1.03e-3)" "prognostic favourable (9.14e-4)" "unprognostic (4.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.15e-1)" 20.8 17.7 31.0 21.6 42.8 32.9 17.9 43.6 41.4 12.5 25.1 18.0 14.8 29.4 13.7 14.6 17.9 12.8 22.2 29.4 28.2 22.2 17.1 7.3 17.2 18.5 22.7 21.6 13.9 39.6 17.4 23.3 16.0 16.7 24.3 16.6 13.1 24.8 16.9 98.6 21.5 29.4 15.6 20.6 20.0 24.5 16.5 17.2 20.9 13.9 22.6 13.9 13.8 19.9 4.7 4.1 2.9 5.7 6.1 5.2 1.4 19.0 25.3 18.1 21.2 7.4 8.4 47.7 17.3 11.1 16.8 12.3 28.2 20.2 27.0 10.9 13.4 41.7 20.2 15.2 5.8 28.0 26.0 16.5 31.6 32.9 13.4 30.5 21.2 9.3 15.8 10.4 11.6 17.4 35.8 13.2 11.5 38.0 32.6 21.1 34.0 21.8 42.7 21.7 26.3 11.1 16.9 59.8 24.8 30.5 35.9 21.3 30.8 30.8 21.1 21.8 19.0 22.9 27.9 11.3 12.9 21.9 18.3 14.9 20.3 1.2 4.8 2.9 3.7 5.7 3.8 4.5 3.9 3.6 3.3 4.7 3.2 4.1 2.3 6.1 2.0 4.1 5.2 1.4 31.0 42.8 43.6 41.4 28.2 22.2 22.7 21.6 16.7 17.2 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: " "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavourable (1.74e-5)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 73.9 33.6 34.7 37.7 41.2 52.7 20.7 41.7 51.3 55.7 56.8 32.9 70.0 20.9 27.1 58.2 52.8 37.0 50.6 71.4 9.7 30.7 21.0 27.2 23.8 49.6 18.9 17.2 35.1 45.3 40.1 45.0 49.0 37.4 16.5 60.0 53.9 10.4 44.4 62.2 40.3 18.4 35.3 30.6 71.6 46.9 26.3 44.3 29.4 107.9 33.5 60.8 56.9 51.4 36.6 55.1 44.8 48.1 12.6 13.8 19.6 33.7 36.1 69.3 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 RACK1 "Gnb2-rs1, GNB2L1, H12.3" ENSG00000204628 "Receptor for activated C kinase 1" P63244 5 181236909-181248096 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004288, HPA021676" Uncertain Supported Nucleoplasm,Vesicles 130000 "Nucleoplasm, Vesicles" "CAB004288: AB_2247471, HPA021676: AB_1849868" "unprognostic (4.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.03e-2)" "unprognostic (1.07e-2)" "unprognostic (7.43e-2)" "prognostic unfavourable (2.98e-6)" "unprognostic (4.19e-1)" "unprognostic (3.04e-1)" "unprognostic (2.00e-1)" "unprognostic (2.07e-1)" "unprognostic (3.81e-1)" "unprognostic (1.05e-3)" "unprognostic (3.67e-1)" "unprognostic (1.78e-1)" "unprognostic (3.50e-1)" "unprognostic (2.62e-1)" 100.5 72.1 32.2 92.0 32.8 74.9 185.3 45.0 34.3 102.3 85.7 36.2 66.0 43.0 86.0 82.9 128.1 98.3 81.8 102.5 29.8 29.2 80.6 113.7 95.7 223.3 38.2 27.6 189.2 330.4 48.8 68.3 72.3 31.8 102.6 61.2 57.8 119.7 66.9 133.8 115.5 72.1 92.8 37.6 107.8 70.5 52.9 32.4 197.4 115.4 117.0 141.8 99.7 113.5 92.9 69.4 19.2 50.8 47.1 81.4 138.7 66.0 56.4 85.7 107.1 131.7 242.1 86.6 59.6 162.6 140.0 141.4 121.0 58.7 134.8 78.1 103.4 45.7 97.8 331.2 103.6 134.1 105.5 46.0 62.4 60.2 164.8 105.8 46.7 231.6 178.6 105.2 146.6 142.3 60.9 99.1 107.4 102.5 104.5 68.0 59.7 51.1 81.6 53.1 112.5 147.8 63.4 71.3 84.1 30.5 101.7 150.0 69.4 92.3 75.0 48.6 44.3 42.7 90.0 74.4 107.0 84.1 46.6 82.7 49.5 19.2 50.8 16.3 45.9 43.6 69.5 91.9 70.3 53.8 69.4 92.9 81.4 65.2 7.8 47.1 37.1 53.3 68.6 138.7 32.2 32.8 45.0 34.3 29.8 29.2 38.2 27.6 31.8 32.4 RAD1 "HRAD1, REC1" ENSG00000113456 "RAD1 checkpoint DNA exonuclease" O60671 5 34905264-34918989 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006692 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA006692: " "prognostic unfavourable (6.30e-4)" "unprognostic (1.85e-2)" "unprognostic (9.40e-2)" "unprognostic (1.98e-3)" "unprognostic (2.00e-1)" "unprognostic (2.38e-2)" "prognostic unfavourable (1.06e-5)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.61e-3)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (3.12e-3)" 3.1 6.5 3.4 3.2 4.9 4.8 4.4 5.2 4.7 5.4 3.2 2.9 4.6 3.8 3.7 3.5 3.3 6.6 3.5 4.4 3.7 3.5 5.6 6.1 2.9 4.0 3.3 3.0 3.4 6.0 5.3 3.1 4.3 3.7 7.4 4.5 3.6 3.3 2.6 3.1 3.7 5.8 5.2 4.7 3.8 4.7 9.4 7.6 7.2 3.1 4.8 9.3 2.6 5.8 6.8 7.2 14.0 5.1 5.9 10.4 9.2 9.0 9.7 8.0 6.4 8.0 15.2 3.3 8.2 5.4 7.9 5.6 10.9 6.8 6.8 8.1 20.7 4.3 8.7 11.1 7.5 5.3 4.8 10.5 7.0 4.6 14.4 9.0 8.2 7.2 11.3 7.9 9.4 10.3 10.4 15.2 5.3 4.7 6.2 7.5 7.9 19.0 13.0 8.5 8.0 9.3 4.2 12.7 9.6 6.5 9.6 5.0 9.1 13.4 6.6 16.8 8.8 7.2 3.0 6.8 5.9 3.1 7.7 8.7 6.5 8.0 2.9 9.4 9.3 8.0 2.3 4.8 2.9 7.6 5.3 2.6 RAD18 RNF73 ENSG00000070950 "RAD18, E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA006716: , HPA006724: , HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (3.73e-4)" "prognostic unfavourable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 6.2 5.7 7.4 5.6 12.7 7.9 9.5 16.4 11.4 5.5 6.6 3.9 5.4 17.7 6.5 3.7 7.6 4.9 5.6 4.4 4.7 3.3 4.3 5.7 5.9 7.6 8.4 6.9 7.1 4.2 3.4 6.9 6.9 5.7 7.4 9.0 3.5 7.5 3.5 3.7 8.5 10.5 6.0 7.8 8.5 5.1 9.5 9.8 16.6 6.7 4.7 7.5 6.1 6.8 3.7 6.3 8.7 3.0 4.3 5.5 1.5 9.7 9.3 7.8 4.6 1.9 4.2 9.5 15.5 5.3 15.0 10.3 8.4 6.3 12.1 3.0 8.8 3.4 8.2 8.0 15.3 7.4 10.3 10.3 9.3 5.0 1.2 13.5 8.9 1.5 2.9 14.8 10.1 4.8 10.9 12.0 13.0 11.3 13.7 9.6 10.8 17.1 10.9 8.6 9.5 4.3 7.5 3.2 7.4 6.9 6.6 5.0 6.9 6.0 4.0 12.4 6.8 10.6 13.2 6.1 9.3 26.3 9.2 15.0 9.1 7.4 2.7 8.7 3.0 3.0 5.5 3.7 4.0 5.2 3.4 3.7 4.3 3.2 1.2 4.3 1.8 6.3 5.0 1.5 7.4 12.7 16.4 11.4 4.7 3.3 8.4 6.9 5.7 9.8 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol 3100000 Nucleoplasm Cytosol "HPA026418: , HPA053901: , HPA057003: , HPA065599: " "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.4 11.6 13.5 13.9 22.5 25.8 22.6 15.4 31.0 36.6 33.3 13.0 22.7 26.8 35.5 23.1 24.4 18.4 32.0 13.9 37.8 23.4 10.8 15.0 12.5 43.8 23.3 31.7 26.3 48.0 26.4 50.6 25.1 27.7 24.7 32.9 30.7 29.0 28.9 18.5 28.8 15.3 14.0 43.5 28.5 12.6 25.0 19.7 17.0 31.1 34.0 24.2 40.5 19.7 52.7 14.0 62.5 47.0 35.8 29.9 19.5 43.4 44.1 43.2 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 RAD23B "HHR23B, HR23B, P58" ENSG00000119318 "RAD23 homolog B, nucleotide excision repair protein" P54727 9 107283137-107332194 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029718, HPA029720, CAB033868" Enhanced Supported Nucleoplasm,Cytosol 8200000 "Nucleoplasm, Cytosol" "CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008" "unprognostic (3.95e-3)" "unprognostic (1.01e-2)" "unprognostic (2.28e-2)" "unprognostic (8.14e-2)" "unprognostic (4.71e-2)" "prognostic unfavourable (2.58e-4)" "unprognostic (2.94e-1)" "prognostic unfavourable (6.71e-4)" "unprognostic (1.34e-1)" "unprognostic (3.72e-1)" "unprognostic (3.31e-2)" "unprognostic (1.20e-1)" "unprognostic (2.94e-3)" "unprognostic (2.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" 41.0 30.1 21.9 23.5 24.5 37.0 28.9 33.3 28.1 28.9 31.4 18.4 28.2 21.8 27.0 38.0 45.3 22.6 24.1 45.5 22.2 23.0 29.7 82.0 27.7 20.7 20.8 23.3 31.6 45.9 21.0 24.8 66.1 25.6 31.1 25.9 17.3 28.7 25.8 98.2 38.2 29.1 29.4 22.6 29.8 23.0 38.5 18.6 32.8 30.4 34.0 27.1 42.1 32.6 5.2 2.5 7.1 2.7 5.0 4.9 1.2 33.3 29.7 42.1 27.0 29.0 46.0 47.5 51.8 42.7 46.2 31.8 49.2 36.6 46.9 21.0 56.6 47.0 58.0 46.1 46.7 31.8 19.0 24.4 31.3 37.5 38.6 43.6 21.0 38.5 43.1 44.1 66.6 32.1 39.3 35.3 41.6 54.5 42.4 22.2 44.8 34.7 31.7 55.3 22.2 39.7 31.6 38.5 26.1 35.8 50.7 31.9 51.7 17.9 29.4 34.5 33.9 42.5 38.7 24.3 44.4 25.3 36.8 26.0 36.1 1.7 2.7 2.3 4.4 2.7 4.9 4.0 2.6 3.7 2.2 5.2 4.4 3.5 7.1 5.0 1.7 2.5 4.6 1.2 21.9 24.5 33.3 27.4 22.2 23.0 20.8 23.3 25.6 18.6 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.9;testis: 24.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB010381, HPA039310" Enhanced Supported Nucleoli,Cytosol Nucleoli Cytosol "CAB010381: AB_2253533, HPA039310: " "prognostic unfavourable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 1.0 0.9 0.4 6.6 0.9 5.3 1.0 0.7 0.9 1.1 5.7 0.4 0.3 1.7 0.8 2.0 4.9 0.5 1.7 1.8 0.5 0.5 1.0 1.0 1.9 7.4 0.5 0.3 0.9 0.7 0.0 0.4 6.2 0.7 0.8 7.6 0.4 1.4 0.3 1.3 2.1 2.6 1.2 1.1 5.0 1.5 24.0 0.5 27.9 0.6 3.7 9.7 1.0 1.9 3.1 1.7 2.7 2.2 2.2 8.8 1.7 12.5 5.6 13.4 5.0 1.4 3.6 12.1 22.3 6.1 19.8 19.9 13.1 8.6 7.1 11.0 7.9 26.7 25.2 10.4 19.3 14.8 8.6 17.8 10.9 10.0 0.1 14.4 12.2 0.5 1.8 13.3 5.9 10.7 23.3 20.0 17.1 11.0 20.5 13.3 15.3 7.0 23.5 18.9 11.9 7.2 17.0 6.0 11.2 9.8 17.3 3.5 10.5 12.0 4.5 14.3 9.1 20.0 11.4 5.0 24.9 23.7 6.2 30.1 12.5 2.0 0.9 2.7 4.1 2.0 0.8 3.1 4.3 5.5 1.7 1.6 1.2 2.1 1.3 2.2 2.2 1.2 8.8 1.7 0.4 0.9 0.7 0.9 0.5 0.5 0.5 0.3 0.7 0.5 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: " "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 5.1 4.9 4.2 4.6 10.1 9.2 8.2 2.0 5.6 8.2 4.3 11.6 11.2 1.7 10.8 13.8 7.0 6.0 6.4 3.4 5.6 3.2 4.3 3.2 5.0 6.6 9.2 4.0 10.0 5.7 8.0 10.0 8.0 7.5 7.0 4.0 9.4 18.7 3.8 2.4 7.1 5.8 6.7 7.3 6.9 3.7 3.4 7.3 12.6 4.9 4.6 12.1 7.7 8.3 13.6 6.6 14.0 5.9 7.8 10.1 4.8 12.2 4.8 5.4 3.3 5.1 8.7 3.4 6.2 4.8 6.9 8.9 3.4 16.7 15.1 4.1 3.8 11.1 3.4 9.9 9.5 6.7 3.5 7.2 4.4 2.7 2.7 6.0 7.3 4.4 7.7 7.9 8.4 6.2 5.8 7.0 5.6 9.5 11.8 2.1 3.2 4.9 13.3 6.5 5.5 5.4 3.5 3.7 2.4 5.0 1.8 10.7 8.4 5.5 1.6 8.5 8.2 6.6 5.1 3.4 3.4 12.0 4.6 10.7 4.7 14.0 5.9 5.4 8.6 4.7 7.1 13.6 8.2 9.2 6.5 11.5 10.1 9.7 0.7 7.8 4.5 6.6 9.1 4.8 4.2 10.1 2.0 5.6 5.6 3.2 9.2 4.0 7.5 7.3 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: " "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favourable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 11.1 22.7 22.1 10.1 20.8 19.4 15.4 20.8 31.0 12.3 13.7 16.0 11.1 7.3 14.3 23.1 13.2 11.8 10.9 24.9 20.2 17.4 13.7 13.9 8.9 19.6 17.2 21.4 13.4 11.2 20.0 18.3 15.1 28.9 18.3 15.0 13.2 10.6 12.7 15.5 10.3 9.6 14.4 14.0 14.4 13.2 18.9 12.7 23.8 12.6 11.7 18.6 12.6 11.8 14.4 13.0 18.8 11.3 11.2 21.7 9.2 15.4 18.0 11.1 12.2 6.1 5.3 25.4 8.5 3.9 11.4 14.5 7.6 10.0 9.1 12.6 5.8 5.9 14.9 12.0 21.3 22.2 30.7 12.8 20.2 28.9 6.0 16.5 11.5 3.1 10.8 12.7 10.3 12.7 19.9 12.5 9.7 77.6 23.3 23.0 3.0 16.7 15.1 17.6 17.2 6.9 9.7 13.8 12.8 6.8 3.3 12.8 10.1 17.5 4.0 9.6 25.6 8.7 10.3 11.8 43.8 26.7 9.8 16.3 11.0 18.8 7.5 9.8 13.7 11.3 13.3 14.1 15.0 14.9 13.0 14.4 16.4 15.4 4.6 11.2 9.8 11.7 21.7 9.2 22.1 20.8 20.8 31.0 20.2 17.4 17.2 21.4 28.9 12.7 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 912077-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA028957: " "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavourable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 7.4 8.5 12.4 8.1 15.1 5.0 10.0 18.8 15.9 12.6 11.7 14.5 13.6 9.4 12.5 14.2 8.2 11.0 9.0 7.8 14.3 7.3 9.9 10.5 6.9 8.9 15.0 9.6 17.6 11.4 9.6 15.6 8.5 15.0 10.5 11.7 9.5 8.4 11.0 16.5 14.9 10.4 12.8 17.0 10.3 8.8 6.8 20.9 9.4 14.6 4.3 9.7 9.7 13.3 7.0 9.6 7.4 3.8 4.0 6.0 1.4 3.1 12.2 9.6 10.7 10.5 7.9 10.3 6.4 5.9 7.0 7.0 11.7 11.2 10.0 2.0 6.3 9.4 7.3 4.3 6.3 13.5 6.5 11.2 11.8 8.1 5.9 12.0 3.4 4.6 7.5 7.4 22.8 5.9 7.4 5.8 6.8 6.7 8.1 11.9 12.4 8.0 8.3 9.4 3.7 7.3 5.8 3.4 3.9 8.2 8.9 4.5 8.2 5.9 5.8 9.9 11.9 7.7 6.6 2.2 3.5 10.5 5.1 5.1 3.6 7.4 3.4 2.0 4.6 2.9 6.0 4.8 4.9 4.0 4.4 7.0 5.7 5.2 2.8 4.0 3.8 9.6 4.4 1.4 12.4 15.1 18.8 15.9 14.3 7.3 15.0 9.6 15.0 20.9 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: , HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.4 4.1 3.3 3.5 4.3 5.2 4.1 7.8 4.3 3.6 4.4 2.2 5.3 4.6 3.6 3.9 2.5 3.1 3.4 3.5 3.4 8.8 4.2 3.8 3.4 5.6 5.0 5.3 3.9 4.9 3.8 3.5 3.7 4.2 7.3 4.6 4.1 4.3 4.1 4.7 4.4 4.7 4.2 5.2 3.8 3.5 6.9 5.2 6.5 7.1 6.3 8.3 4.0 5.6 4.4 11.4 11.2 6.4 4.6 6.0 4.8 6.8 6.6 6.3 7.8 3.3 14.8 1.4 8.4 4.4 17.9 6.0 8.2 7.8 4.0 12.7 9.5 5.1 5.8 14.1 7.6 5.2 4.8 10.1 9.8 7.3 8.3 8.1 5.2 4.3 12.6 6.4 9.0 4.8 5.8 8.8 2.0 3.3 7.3 4.7 8.9 7.6 7.3 4.9 4.8 8.5 9.5 7.0 8.0 7.1 9.3 8.7 8.8 15.0 7.5 8.0 8.8 6.5 4.8 4.7 8.1 6.0 8.3 4.3 7.1 6.6 5.2 6.9 4.7 5.4 2.2 6.3 7.1 5.2 6.3 4.0 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;HEK 293: 5.9;NTERA-2: 6.6;SCLC-21H: 9.3;SH-SY5Y: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA051776: " "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.7 7.6 0.2 1.8 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.4 2.1 0.0 0.0 6.6 1.3 4.9 0.2 0.0 0.0 0.0 9.3 20.1 0.1 0.0 0.0 3.0 0.6 0.0 0.0 0.0 5.4 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 RAE1 Mnrp41 ENSG00000101146 "Ribonucleic acid export 1" P78406 20 57351010-57379211 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048795 Uncertain "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA048795: " "unprognostic (1.20e-1)" "unprognostic (5.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (3.23e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (2.12e-7)" "unprognostic (1.88e-1)" "unprognostic (8.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.50e-3)" "unprognostic (3.88e-2)" "unprognostic (7.48e-2)" "unprognostic (3.55e-1)" "unprognostic (9.49e-2)" "unprognostic (2.89e-1)" "unprognostic (2.01e-1)" 9.2 10.0 9.4 11.1 15.2 28.6 12.0 18.1 18.3 9.5 9.7 11.5 9.3 8.0 13.0 13.9 14.0 12.2 7.9 8.1 9.8 11.0 9.2 10.7 7.1 12.5 8.1 12.6 12.1 9.1 12.3 13.7 13.5 10.4 9.2 11.4 9.4 8.9 11.0 9.6 14.8 8.8 11.3 7.3 12.1 8.6 64.8 8.3 19.4 11.7 11.5 17.3 10.0 11.5 17.0 16.6 39.1 21.5 11.8 20.2 17.8 12.6 15.6 15.6 8.9 9.4 8.6 14.1 10.3 14.5 50.6 19.6 49.6 10.2 20.3 14.4 14.8 16.8 29.2 25.2 41.7 6.1 13.2 13.9 14.0 22.0 17.7 16.7 12.5 12.7 22.7 21.7 24.4 15.3 24.3 9.8 15.9 34.1 24.8 14.6 9.9 27.6 13.9 15.1 13.4 11.8 13.3 17.0 14.0 17.5 39.8 18.0 21.6 14.5 8.8 21.6 19.4 12.7 17.0 10.7 23.0 23.2 15.1 10.4 10.8 9.1 21.5 39.1 15.6 18.1 18.9 17.0 15.2 15.5 16.6 16.3 20.2 18.4 19.4 11.8 17.9 12.6 12.9 17.8 9.4 15.2 18.1 18.3 9.8 11.0 8.1 12.6 10.4 8.3 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" "Focal adhesion sites" Cytosol "HPA054022: " "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.6 0.5 0.2 0.5 0.2 0.0 1.4 0.2 0.2 10.4 0.3 0.2 0.2 0.2 0.8 0.6 39.7 0.6 0.2 0.2 0.2 0.0 2.8 0.2 0.6 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.5 0.2 0.4 0.3 0.2 7.0 0.2 0.7 14.6 0.3 0.3 0.2 0.6 0.2 0.5 0.3 0.3 0.2 19.8 22.5 1.3 12.6 0.6 0.4 2.3 0.6 0.5 0.7 0.1 1.5 0.9 0.0 0.0 0.1 1.3 0.1 0.1 0.9 0.1 0.3 0.0 3.7 0.0 2.1 3.0 1.6 0.0 15.5 0.2 0.4 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.3 15.5 0.9 3.2 0.1 0.0 1.3 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.7 0.2 0.0 7.4 2.0 0.0 1.1 0.0 2.9 1.1 0.4 0.1 0.9 0.0 0.0 0.0 6.7 0.3 0.0 2.0 0.6 0.4 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.6 0.7 0.4 2.3 0.5 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavourable (9.75e-4)" "prognostic unfavourable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.4 8.3 6.6 23.4 15.9 32.5 26.2 18.8 18.9 8.1 3.5 0.6 13.0 15.9 1.8 14.1 24.0 40.8 0.0 6.7 4.4 10.1 4.9 20.7 0.1 0.4 21.8 7.5 33.7 26.9 59.5 6.2 0.2 24.4 2.1 0.4 0.1 9.7 10.4 3.9 19.0 0.1 21.8 15.5 3.3 1.8 19.2 2.8 8.7 3.3 0.5 38.3 30.6 16.4 7.5 14.1 0.7 0.0 0.0 25.9 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 RALA RAL ENSG00000006451 "RAS like proto-oncogene A" P11233 7 39623483-39708124 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047037, HPA065232" Approved Supported "Plasma membrane,Focal adhesion sites" "Plasma membrane" "Focal adhesion sites" "HPA047037: , HPA065232: " "unprognostic (1.20e-3)" "unprognostic (1.03e-2)" "unprognostic (2.91e-1)" "unprognostic (7.73e-3)" "unprognostic (1.98e-2)" "unprognostic (9.14e-2)" "prognostic unfavourable (5.32e-5)" "unprognostic (7.71e-2)" "unprognostic (2.17e-1)" "prognostic favourable (7.46e-4)" "prognostic unfavourable (6.30e-4)" "unprognostic (3.32e-1)" "unprognostic (4.95e-3)" "unprognostic (5.38e-2)" "unprognostic (7.15e-2)" "unprognostic (2.79e-1)" "unprognostic (2.95e-2)" 19.2 25.2 24.7 14.3 24.6 4.8 24.4 16.1 22.0 18.4 22.3 17.2 8.0 23.5 15.7 15.5 44.9 15.0 20.0 13.8 24.7 20.2 15.9 15.4 30.3 14.8 27.6 18.9 17.4 11.6 12.8 14.2 23.7 20.3 12.9 23.6 9.1 18.5 12.7 16.8 19.5 25.5 15.7 36.0 16.0 24.4 12.2 21.9 19.9 13.8 31.0 28.9 15.2 20.8 13.3 16.3 21.5 11.2 15.7 20.4 11.5 19.7 4.5 11.2 9.7 21.4 17.8 7.7 17.3 25.1 15.8 17.6 11.3 9.7 10.1 6.5 13.4 20.5 15.8 11.3 27.3 9.7 7.5 7.9 7.4 8.3 34.7 13.7 11.3 14.0 13.8 28.1 40.1 76.6 15.8 6.8 16.0 6.4 9.7 16.3 31.4 9.0 12.1 10.1 8.8 16.1 9.2 20.1 19.5 10.7 17.2 11.8 16.0 15.1 24.5 9.3 8.3 11.7 12.3 12.1 9.3 12.4 10.5 14.3 16.9 21.5 9.8 11.0 9.7 11.2 12.0 11.5 15.7 12.4 16.3 13.3 20.4 17.9 4.5 15.7 8.6 10.6 19.7 11.5 24.7 24.6 16.1 20.8 24.7 20.2 27.6 18.9 20.3 21.9 RALBP1 "RIP, RIP1, RLIP76" ENSG00000017797 "RalA binding protein 1" Q15311 18 9475009-9538116 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transport "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 10 "neutrophil: 55.1" "Lineage enriched" "Detected in all" 10 "granulocytes: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046010, HPA046651" Approved Approved "Nuclear membrane,Vesicles,Cytosol" Cytosol "Nuclear membrane, Vesicles" "CAB046010: AB_11126824, HPA046651: " "unprognostic (1.23e-1)" "unprognostic (5.84e-3)" "unprognostic (1.58e-1)" "unprognostic (1.74e-2)" "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (5.72e-2)" "unprognostic (9.90e-2)" "unprognostic (1.53e-1)" "prognostic favourable (8.47e-4)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "prognostic favourable (5.39e-6)" "unprognostic (1.28e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (1.26e-1)" 19.7 14.6 23.2 14.8 24.3 17.9 19.1 27.1 27.2 17.1 20.7 14.0 54.7 12.5 15.9 16.7 33.7 17.5 13.7 21.4 24.7 19.6 30.6 14.2 15.1 14.6 23.1 13.7 18.8 10.4 19.8 15.3 28.8 19.6 24.3 17.4 9.8 17.6 44.8 24.3 47.5 13.4 22.7 20.6 19.3 17.4 8.5 23.1 15.4 15.7 23.4 16.4 24.3 26.3 2.5 5.5 55.1 4.5 4.3 3.2 1.2 22.7 15.4 13.7 15.5 15.8 24.9 18.1 27.6 15.0 14.2 15.3 17.0 22.6 29.0 20.2 25.2 13.1 18.9 20.7 17.8 28.8 18.3 15.4 14.2 12.7 12.9 45.0 17.8 17.3 20.8 19.8 19.8 23.9 21.9 26.8 22.3 18.0 27.0 19.8 10.6 15.7 36.4 24.5 21.3 19.6 31.7 18.5 15.1 23.9 20.9 12.2 12.9 20.9 28.5 42.1 32.4 29.1 32.7 16.6 16.5 31.4 18.3 21.4 15.9 3.1 2.8 4.3 3.2 2.9 2.7 2.5 2.7 2.6 2.4 2.4 2.3 2.9 55.1 4.3 4.5 5.5 1.7 1.2 23.2 24.3 27.1 27.2 24.7 19.6 23.1 13.7 19.6 23.1 RALGAPA1 "DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1" ENSG00000174373 "Ral GTPase activating protein catalytic alpha subunit 1" Q6GYQ0 14 35538352-35809304 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000851 Approved Approved Mitochondria,Cytosol Cytosol Mitochondria "HPA000851: AB_1078945" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (8.90e-2)" "unprognostic (6.76e-2)" "unprognostic (1.85e-1)" "unprognostic (1.19e-2)" "unprognostic (7.65e-2)" "unprognostic (1.17e-2)" "unprognostic (2.88e-1)" "unprognostic (3.38e-2)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "prognostic favourable (9.76e-5)" "unprognostic (2.75e-1)" "unprognostic (2.46e-1)" "unprognostic (3.09e-2)" "unprognostic (1.46e-1)" 13.9 21.8 19.5 13.1 25.6 8.3 22.5 31.7 28.3 20.2 18.3 23.2 13.6 10.7 21.0 19.2 15.1 15.0 13.0 11.7 21.8 22.2 17.1 13.9 13.4 11.7 21.5 17.9 28.1 15.4 43.6 42.6 10.1 28.1 20.4 20.2 14.2 15.0 15.2 15.9 27.0 13.8 17.5 23.6 11.6 14.1 13.7 21.3 14.9 21.3 12.2 13.0 15.0 19.2 1.6 1.5 0.1 1.1 2.3 3.3 0.5 5.7 6.7 9.0 7.9 13.7 10.6 5.8 4.3 4.8 5.4 5.0 4.2 5.1 5.7 6.4 5.6 9.5 10.8 8.2 5.5 12.1 4.7 5.2 8.6 20.1 7.1 8.6 8.4 7.6 14.9 4.8 12.0 7.5 5.0 14.4 5.0 9.1 6.5 4.1 3.9 10.7 5.3 6.4 3.4 10.9 9.1 8.4 13.7 9.1 15.2 7.3 14.6 4.2 6.9 5.5 4.1 6.2 5.2 11.7 10.6 7.2 2.6 5.7 5.9 0.0 0.6 0.1 2.4 1.1 3.3 1.6 2.5 3.1 1.1 1.3 1.8 2.5 0.1 2.3 0.9 1.5 2.7 0.5 19.5 25.6 31.7 26.0 21.8 22.2 21.5 17.9 28.1 21.3 RALGAPA2 "AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2" ENSG00000188559 "Ral GTPase activating protein catalytic alpha subunit 2" Q2PPJ7 20 20389552-20712488 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "RT4: 46.9;SCLC-21H: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042707, HPA043622" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042707: , HPA043622: " "unprognostic (7.40e-2)" "unprognostic (1.71e-1)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.34e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-2)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "prognostic favourable (3.77e-5)" "unprognostic (6.52e-2)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (5.33e-2)" 26.5 7.0 7.3 9.9 8.1 19.4 16.9 11.4 8.7 10.6 12.7 9.6 14.9 10.5 15.2 9.6 8.9 10.7 13.0 7.8 8.3 4.2 11.0 26.4 26.5 13.0 10.8 4.4 8.0 18.5 14.1 20.9 18.5 7.4 13.2 13.5 8.2 22.6 12.8 26.0 15.3 10.0 9.6 8.4 8.2 18.1 8.6 9.3 8.2 23.2 6.0 10.2 13.9 15.7 1.7 2.0 7.0 2.1 2.6 2.4 0.6 3.4 2.2 4.6 2.4 2.3 1.8 5.2 0.9 0.9 1.1 1.5 1.8 4.8 1.5 3.1 1.4 3.6 4.8 4.0 2.2 7.0 2.3 5.3 1.1 3.3 0.9 6.8 3.2 1.6 3.0 1.8 0.8 6.6 1.1 3.0 1.8 2.3 2.5 9.0 1.9 2.1 3.8 3.1 2.1 4.1 46.9 26.2 2.3 3.5 2.6 3.0 1.8 6.5 1.7 1.8 1.8 1.4 1.2 1.7 1.2 0.7 1.6 4.5 2.6 5.9 2.1 6.0 1.7 0.7 2.4 1.4 1.1 1.6 1.0 1.7 2.1 1.5 7.0 2.6 1.6 2.0 1.4 0.6 7.3 8.1 11.4 8.7 8.3 4.2 10.8 4.4 7.4 9.3 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell line enhanced" "Detected in many" "U-266/84: 61.3;U-698: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 17.8;naive B-cell: 14.6" "Lineage enriched" "Detected in many" 12 "B-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 6.4 5.0 27.9 10.5 6.2 5.4 8.9 5.1 8.0 9.9 1.2 7.2 5.8 8.2 7.3 14.0 8.7 4.7 4.7 6.0 3.2 6.1 16.4 3.7 25.3 2.2 4.1 11.5 5.0 6.2 8.4 4.6 3.8 5.3 6.4 9.9 9.2 7.4 2.1 10.0 19.7 6.1 3.2 26.1 6.8 37.7 2.1 16.0 4.3 4.7 29.4 7.5 8.4 17.8 0.5 1.4 0.1 0.3 0.5 0.8 10.1 3.3 10.3 0.1 11.5 16.9 4.0 8.8 19.7 7.2 6.5 4.0 10.0 21.5 3.0 26.1 8.4 4.5 2.2 9.5 0.0 2.7 0.0 2.2 3.7 1.9 2.8 0.1 7.5 2.0 9.3 6.6 6.2 5.1 0.8 4.7 1.6 4.2 0.8 7.0 3.5 6.0 10.6 0.1 2.4 6.4 1.6 4.6 5.8 6.5 12.5 7.7 1.4 4.6 3.3 3.2 12.1 4.2 24.5 61.3 50.2 1.9 1.4 3.7 0.5 0.1 1.4 0.2 0.0 0.2 17.8 0.1 0.1 0.2 14.6 0.5 0.1 0.8 0.3 0.0 0.5 0.0 0.8 5.0 10.5 8.9 5.1 6.0 3.2 2.2 4.1 3.8 2.1 RALY "HNRPCL2, P542" ENSG00000125970 "RALY heterogeneous nuclear ribonucleoprotein" Q9UKM9 20 33993646-34108308 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040971, HPA043614" Enhanced Enhanced Nucleoplasm,Vesicles 12000 Nucleoplasm Vesicles "HPA040971: AB_2677230, HPA043614: AB_2678581" "unprognostic (2.06e-1)" "unprognostic (9.54e-3)" "unprognostic (3.72e-2)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (3.60e-4)" "unprognostic (3.06e-1)" "unprognostic (1.27e-1)" "unprognostic (3.66e-1)" "unprognostic (4.20e-2)" "unprognostic (8.59e-2)" "unprognostic (3.29e-2)" "unprognostic (2.88e-2)" "unprognostic (8.61e-3)" "unprognostic (1.64e-2)" "unprognostic (8.80e-2)" 37.7 23.4 26.3 39.9 30.7 65.2 55.4 22.4 33.9 35.0 43.7 37.6 35.1 41.9 36.4 31.0 41.6 35.2 38.9 51.9 27.3 24.4 39.3 30.3 40.9 53.9 33.0 23.4 38.3 38.5 21.9 20.7 41.9 26.5 34.9 34.9 32.0 38.7 32.7 62.0 39.8 48.8 41.7 40.9 40.4 36.0 56.8 28.9 76.0 76.7 43.6 42.6 33.5 49.7 30.8 40.9 61.6 54.1 54.1 48.4 40.4 36.3 25.2 40.8 31.1 18.3 19.5 33.1 25.5 21.2 34.3 29.6 67.8 33.1 28.7 37.6 21.2 41.1 19.2 39.8 19.5 18.8 19.9 68.0 14.8 67.7 25.4 35.0 34.7 20.7 24.3 25.3 26.0 33.2 28.1 49.2 21.8 35.3 87.1 56.6 21.1 48.7 51.6 55.8 39.0 20.9 23.1 38.9 43.6 42.6 40.8 57.9 41.6 37.3 26.0 70.9 42.9 34.4 31.8 49.3 41.3 51.1 35.6 26.6 32.5 32.9 32.4 61.6 44.3 39.9 33.1 30.8 40.1 48.4 40.9 30.7 35.6 33.6 52.9 54.1 54.1 33.8 42.0 40.4 26.3 30.7 22.4 33.9 27.3 24.4 33.0 23.4 26.5 28.9 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.8;HDLM-2: 37.1;PC-3: 43.2;SH-SY5Y: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057814: " "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favourable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavourable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.7 0.0 0.1 0.0 3.4 5.2 0.3 0.5 0.9 0.5 0.4 0.0 12.8 0.0 0.1 0.2 0.0 2.0 0.0 0.0 37.1 1.0 0.0 0.0 0.2 10.4 0.0 0.0 4.0 6.1 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 43.2 0.0 0.4 0.2 0.0 0.0 0.4 54.4 0.8 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.4 4.5 1.5 0.5 3.4 3.9 1.8 2.8 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 1.7 5.7 0.0 4.3 1.1 2.1 0.0 1.5 0.0 0.0 4.4 0.3 0.3 0.0 2.6 0.4 0.0 1.6 2.7 0.0 0.0 0.4 0.5 0.0 3.5 0.0 0.9 1.4 0.3 2.0 0.0 5.4 2.8 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719481-108785811 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Enhanced "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.5 24.3 14.4 17.0 18.6 35.5 24.4 23.1 22.2 19.8 17.1 12.8 25.5 13.3 19.9 21.5 17.0 19.1 14.8 20.2 12.9 12.5 18.9 19.5 17.7 19.2 15.1 17.0 32.4 24.1 48.5 37.5 18.8 16.5 21.8 15.8 14.3 20.0 31.6 37.5 17.3 17.4 23.2 17.8 16.3 20.9 20.6 15.9 26.6 28.7 18.0 17.5 20.5 19.7 5.6 5.1 8.3 6.3 4.2 8.7 2.3 18.2 11.2 16.1 14.6 18.8 16.9 15.6 16.5 13.1 13.6 12.0 27.8 8.8 28.8 12.8 17.1 15.4 27.5 17.1 19.9 17.5 13.3 30.0 13.9 19.6 11.0 35.0 10.1 14.1 13.1 21.3 16.6 20.8 32.1 16.0 18.0 10.1 15.5 14.3 20.3 13.4 14.6 24.8 13.9 12.1 22.9 23.5 10.8 14.6 12.6 16.0 8.0 16.1 24.8 14.3 18.9 10.0 18.4 13.3 19.6 26.2 11.1 15.8 11.0 8.3 5.3 5.1 7.6 3.4 8.7 5.5 6.3 6.9 4.2 5.6 6.2 6.7 8.3 4.2 6.3 5.1 5.1 2.3 14.4 18.6 23.1 22.2 12.9 12.5 15.1 17.0 16.5 15.9 RANBP9 RanBPM ENSG00000010017 "RAN binding protein 9" Q96S59 6 13621498-13711564 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033767, HPA050007" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB033767: AB_2176959, HPA050007: " "unprognostic (3.59e-2)" "unprognostic (6.57e-2)" "unprognostic (4.37e-2)" "unprognostic (2.67e-1)" "unprognostic (1.78e-1)" "prognostic favourable (9.97e-4)" "unprognostic (1.30e-1)" "unprognostic (4.61e-2)" "unprognostic (5.87e-3)" "prognostic favourable (2.47e-4)" "unprognostic (1.61e-1)" "unprognostic (6.74e-2)" "unprognostic (3.51e-1)" "unprognostic (7.19e-3)" "unprognostic (1.52e-1)" "unprognostic (3.49e-1)" "unprognostic (3.09e-1)" 12.4 12.7 15.1 14.0 13.6 30.1 24.8 13.1 24.0 14.5 14.4 9.8 9.8 8.3 13.2 14.3 40.8 9.7 15.5 12.2 15.0 16.0 11.8 16.0 17.9 10.5 18.0 14.3 12.4 11.9 14.7 10.6 15.7 13.7 13.9 11.4 8.3 14.4 11.4 31.8 16.9 9.1 14.7 12.4 9.5 11.0 60.1 12.6 20.9 10.7 20.0 18.0 14.4 21.0 2.0 2.3 3.8 2.0 2.7 8.1 1.2 16.4 7.2 17.5 17.6 23.8 22.1 18.5 20.2 22.8 21.2 22.4 11.0 9.8 14.6 33.0 23.5 9.0 13.4 11.7 29.3 24.5 12.5 14.7 14.3 20.3 32.9 22.9 11.0 22.3 15.2 25.1 20.8 17.2 31.0 11.7 23.5 16.6 26.1 19.1 7.7 10.2 21.0 13.7 20.7 16.8 19.1 22.1 15.5 16.3 30.3 29.9 16.1 19.5 16.9 19.4 13.7 15.8 20.7 28.2 34.3 19.8 8.9 14.6 35.7 0.8 1.3 3.8 1.9 1.8 3.8 2.0 4.0 2.0 1.4 1.7 3.8 2.6 1.8 2.7 2.0 2.3 8.1 1.2 15.1 13.6 13.1 24.0 15.0 16.0 18.0 14.3 13.7 12.6 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41245611-41286251 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favourable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 12.2 30.7 23.5 16.9 28.4 28.5 16.1 17.6 41.1 8.5 11.8 23.1 7.3 12.7 9.5 9.4 26.1 11.5 13.7 11.5 26.9 30.4 12.0 25.1 11.5 19.5 31.7 28.6 10.6 20.2 11.0 17.7 16.1 28.1 11.4 9.6 7.1 16.3 13.3 12.5 51.6 12.8 12.3 22.0 14.2 16.0 64.3 28.3 22.1 12.7 14.4 21.7 13.3 29.2 8.7 7.6 8.2 14.8 7.1 13.1 9.7 58.7 30.9 20.1 21.0 10.9 9.0 24.5 51.0 27.9 51.4 27.0 37.5 19.4 31.7 41.1 37.3 54.7 36.6 40.1 31.1 25.6 56.8 26.8 30.1 29.2 13.6 43.3 20.2 8.7 19.1 36.6 32.5 26.9 34.4 22.6 29.2 50.4 25.2 35.2 22.0 36.8 31.0 19.9 33.4 20.1 33.7 18.3 12.2 36.2 32.1 18.6 18.9 17.5 41.6 39.4 37.8 21.7 41.8 16.8 22.4 30.2 27.5 30.8 22.7 2.8 9.5 8.2 11.2 11.2 13.1 7.9 11.3 10.3 7.1 8.7 10.5 8.0 2.7 7.1 14.8 7.6 11.6 9.7 23.5 28.4 17.6 41.1 26.9 30.4 31.7 28.6 28.1 28.3 RANGRF "HSPC165, HSPC236, MOG1, RANGNRF" ENSG00000108961 "RAN guanine nucleotide release factor" Q9HD47 17 8288497-8290092 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057280, HPA057888" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057280: , HPA057888: " "unprognostic (2.87e-2)" "unprognostic (2.93e-2)" "unprognostic (7.41e-2)" "prognostic favourable (1.65e-4)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.90e-3)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (2.01e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" 14.5 14.7 24.7 11.7 29.1 11.8 26.5 10.9 19.2 31.5 15.4 7.9 13.5 10.5 20.0 22.5 10.6 21.5 10.9 23.4 15.1 17.8 17.0 11.5 18.9 26.9 16.2 19.2 21.0 6.3 16.2 17.1 14.6 18.8 15.9 10.8 17.2 6.0 19.4 11.4 9.8 11.9 18.8 12.2 15.4 16.7 70.1 15.9 16.8 11.6 9.1 20.3 14.1 10.5 26.8 22.3 25.3 16.3 21.8 40.2 18.2 15.9 18.9 13.9 14.2 10.1 12.9 11.7 9.4 18.5 25.9 24.3 10.1 6.4 30.6 10.2 11.3 18.2 25.5 12.6 18.7 21.3 32.3 15.2 14.8 13.9 23.0 9.5 22.3 12.5 23.1 22.1 21.2 20.5 6.6 8.6 15.8 0.4 29.3 31.3 9.7 7.3 25.8 10.8 18.2 14.1 7.1 5.4 15.1 7.6 11.3 19.9 0.9 9.3 11.3 5.7 9.9 11.0 18.9 14.8 11.6 36.8 12.0 19.1 8.2 4.9 16.2 25.3 24.2 16.3 22.6 24.2 29.3 27.4 17.3 26.8 26.2 22.4 2.1 21.8 12.5 22.3 40.2 18.2 24.7 29.1 10.9 19.2 15.1 17.8 16.2 19.2 18.8 15.9 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037739 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;pancreas: 26.0" "Cell line enhanced" "Detected in many" "SH-SY5Y: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" 110000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favourable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.2 4.6 6.7 2.9 13.5 16.8 3.1 27.5 22.9 2.7 5.3 2.2 0.0 5.9 3.7 1.0 2.5 5.8 2.7 9.9 6.5 6.3 3.9 0.7 3.4 3.4 4.3 16.4 3.3 26.0 4.5 8.0 3.3 15.8 2.6 5.6 2.6 9.0 3.5 0.8 2.7 5.5 2.3 4.3 3.2 15.4 2.3 3.1 1.6 2.1 0.3 3.0 1.6 2.2 0.5 3.0 7.2 6.3 2.9 5.2 2.0 4.4 5.6 1.1 4.6 0.0 0.0 9.2 6.0 2.8 0.8 0.7 12.3 2.0 1.6 1.7 0.7 6.2 3.6 11.3 0.2 0.0 3.9 2.0 7.8 5.5 1.1 0.4 2.2 0.2 9.8 3.2 8.1 0.1 11.6 0.8 0.0 5.0 1.6 1.1 6.7 5.4 7.4 4.0 4.3 3.4 2.3 12.5 30.3 8.7 9.1 3.9 4.5 1.3 1.3 5.3 8.4 0.9 5.0 0.0 0.0 0.6 0.3 3.8 8.6 1.5 2.3 3.3 5.2 4.7 2.0 0.5 1.7 3.7 1.8 0.4 0.3 1.9 7.2 2.9 6.3 3.0 1.6 2.0 6.7 13.5 27.5 22.9 6.5 6.3 4.3 16.4 15.8 3.1 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.4;NK-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057169 Supported Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles, Centrosome" "HPA057169: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favourable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 16.7 8.0 28.4 8.8 23.8 51.0 16.3 21.5 34.1 12.6 14.5 11.3 10.4 10.9 12.7 7.3 9.9 10.2 14.1 14.9 23.4 15.3 16.4 20.9 18.1 8.5 14.1 29.6 10.2 13.4 20.7 13.8 26.1 16.9 9.3 14.8 10.0 18.7 9.4 15.7 12.7 11.9 14.0 13.9 19.2 13.7 6.7 14.3 9.3 27.5 8.9 7.8 11.9 13.8 0.4 1.4 9.4 1.4 5.2 1.5 0.3 3.2 4.4 21.1 6.5 8.3 9.4 32.4 6.3 8.0 5.8 4.2 13.6 7.3 18.6 2.3 6.3 3.0 7.1 8.1 6.9 3.1 5.0 28.9 9.3 7.8 6.0 3.5 40.0 5.4 4.6 13.9 4.9 16.5 6.3 17.4 7.1 5.7 8.7 0.5 9.0 4.4 7.1 5.3 0.7 5.2 7.5 6.0 8.0 9.3 4.5 7.7 2.2 2.3 17.5 9.2 9.7 11.7 5.2 19.4 11.5 0.3 10.9 1.5 5.5 2.7 1.4 1.0 0.8 0.8 1.0 0.4 0.7 0.5 0.8 0.3 0.9 0.4 9.4 5.2 0.9 1.4 1.5 0.3 28.4 23.8 21.5 34.1 23.4 15.3 14.1 29.6 16.9 14.3 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118238-22357144 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 67.0;parathyroid gland: 258.2" "Cell line enhanced" "Detected in many" "Daudi: 11.6;HUVEC TERT2: 24.6;SCLC-21H: 19.0;TIME: 13.9;U-698: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" Nucleoplasm "Nuclear bodies" "HPA057821: , HPA076772: " "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavourable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favourable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 10.8 5.8 12.6 3.6 22.6 1.8 6.2 5.2 25.1 4.5 4.6 47.6 0.6 3.9 4.4 3.1 6.1 4.2 7.0 6.7 21.3 10.1 7.3 8.5 14.1 5.7 41.8 13.3 3.7 7.9 258.2 3.3 23.2 31.5 2.8 5.2 0.9 3.4 3.4 2.7 4.4 4.1 5.6 67.0 17.1 3.7 3.5 29.5 3.9 5.4 1.8 4.9 3.9 4.9 0.7 0.0 0.0 0.0 0.0 0.2 0.4 1.5 0.0 2.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.7 11.6 0.6 0.1 7.2 1.5 1.0 0.0 0.0 2.3 0.1 0.0 2.9 0.0 0.0 0.0 0.3 1.3 0.7 0.4 24.6 2.6 0.1 0.0 0.6 1.6 0.0 2.0 2.3 2.8 0.0 3.9 2.3 1.0 19.0 5.0 0.2 3.3 0.0 1.6 0.0 13.9 0.0 0.6 0.2 0.6 6.4 1.3 20.7 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 22.6 5.2 25.1 21.3 10.1 41.8 13.3 31.5 29.5 RAPGEF6 "PDZ-GEF2, PDZGEF2, RA-GEF-2" ENSG00000158987 "Rap guanine nucleotide exchange factor 6" Q8TEU7 5 131423921-131635236 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA037982, HPA037983" Approved Approved Centrosome,Cytosol Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: " "unprognostic (1.86e-1)" "unprognostic (5.16e-2)" "unprognostic (5.64e-2)" "unprognostic (2.69e-1)" "unprognostic (3.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (3.72e-3)" "prognostic unfavourable (3.87e-4)" "unprognostic (3.57e-1)" "unprognostic (4.10e-2)" "unprognostic (6.31e-2)" "unprognostic (2.81e-4)" 7.2 7.3 8.4 15.2 11.2 15.7 9.9 34.1 12.7 7.2 6.7 13.7 6.1 5.0 6.9 5.9 6.5 6.1 7.7 6.6 9.4 10.5 6.2 8.4 9.5 24.6 13.1 9.0 8.6 6.2 12.5 9.5 8.0 17.1 7.2 7.8 5.4 6.9 7.9 6.9 8.1 7.3 6.9 10.9 11.3 6.5 19.7 14.5 21.2 7.1 5.5 22.0 7.7 7.2 5.4 1.6 8.7 2.0 5.3 14.2 5.4 6.9 5.0 7.1 6.6 3.7 4.2 6.8 7.7 6.1 6.6 10.0 9.1 4.9 16.2 5.2 5.1 5.6 9.9 8.0 13.4 7.9 5.4 10.2 7.3 4.9 3.0 7.1 10.8 3.1 3.8 9.6 9.3 5.8 5.8 9.8 5.8 3.5 7.3 5.7 3.1 3.8 10.9 10.2 8.6 4.8 5.5 24.5 5.6 8.0 3.6 9.5 5.1 6.2 5.7 8.7 6.2 7.0 8.8 5.7 6.8 17.7 5.0 9.4 7.4 1.4 1.7 6.3 6.3 2.0 10.7 4.5 8.5 6.8 1.4 5.4 14.2 10.1 8.7 5.3 1.5 1.6 9.6 5.4 8.4 11.2 34.1 12.7 9.4 10.5 13.1 9.0 17.1 14.5 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell line enhanced" "Detected in many" "HaCaT: 38.2;hTCEpi: 19.2;T-47d: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favourable (8.43e-4)" "prognostic favourable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.0 5.7 4.2 0.6 1.4 2.7 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 38.2 1.1 1.3 1.6 3.1 2.8 1.0 1.2 2.3 0.7 2.0 3.5 1.6 19.2 1.1 0.5 1.7 0.7 1.1 0.8 5.8 1.9 2.5 1.7 1.0 3.5 0.6 1.0 0.7 11.2 11.0 2.2 1.3 13.0 0.5 33.4 1.5 3.2 1.4 2.9 1.4 1.2 1.9 1.8 1.4 3.3 1.2 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.8;non-classical monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.0 6.1 7.3 6.3 7.6 2.7 17.6 8.4 12.7 9.8 7.9 3.7 6.8 6.9 6.8 8.4 9.2 6.3 12.5 8.3 5.2 5.0 8.2 51.1 17.2 6.8 4.2 8.4 3.6 5.8 4.0 9.9 11.1 6.0 7.2 6.7 8.5 11.2 4.4 8.3 10.2 10.2 7.1 4.8 26.7 7.8 7.9 3.1 1.7 25.8 7.9 5.6 9.6 8.7 0.0 1.1 0.0 2.8 1.1 0.6 0.3 5.4 3.8 8.0 4.6 6.3 8.2 7.0 7.6 5.6 7.9 10.0 17.5 5.8 0.0 1.8 11.5 2.7 4.1 6.5 16.5 1.1 2.3 0.0 9.1 3.0 15.8 0.0 0.1 11.3 5.5 14.5 15.3 12.3 0.4 4.2 15.7 3.0 0.0 0.0 4.7 4.8 0.1 11.3 3.0 5.7 17.6 2.8 3.8 5.2 5.0 6.3 2.8 0.2 14.5 19.5 6.3 9.3 8.0 2.0 3.4 0.0 16.1 0.1 4.3 0.0 0.8 0.0 0.2 2.8 0.6 0.0 0.5 0.1 1.1 0.0 0.4 0.1 0.0 1.1 2.6 0.1 0.5 0.3 7.3 7.6 8.4 12.7 5.2 5.0 4.2 8.4 6.0 3.1 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437757-47449178 "Disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skeletal muscle: 45.3;tongue: 14.8" "Cell line enriched" "Detected in some" 4 "RH-30: 71.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 1.7 0.8 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 2.7 0.7 0.1 0.1 1.4 0.4 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.4 0.0 0.3 0.8 0.0 45.3 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.4 14.8 0.4 0.0 0.0 0.2 0.1 2.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 71.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.7 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.7 0.0 0.3 0.1 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309192-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 63.1;SK-BR-3: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 26.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058282 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058282: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favourable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 27.6 13.5 5.0 18.6 7.6 32.3 23.7 11.5 15.2 30.2 29.6 5.0 16.8 18.0 23.8 23.9 17.3 23.3 30.2 24.3 5.9 6.1 14.6 24.0 32.0 23.4 4.6 7.8 50.0 9.3 7.4 18.1 16.6 6.5 22.9 8.5 26.8 12.1 32.7 43.1 14.3 31.6 18.6 3.7 31.1 14.3 21.8 2.9 9.7 16.3 15.4 20.2 31.5 20.3 1.0 6.1 26.6 9.3 2.5 2.6 1.9 5.0 11.9 3.6 6.0 7.0 10.8 3.6 4.2 6.3 6.2 4.0 8.2 4.4 2.7 6.6 9.4 14.9 4.1 9.9 3.5 20.2 6.1 7.7 6.0 8.0 11.3 2.7 24.4 15.1 2.9 6.5 8.3 9.1 4.8 5.9 6.9 63.1 1.7 9.4 3.1 3.8 3.6 21.1 10.2 3.6 4.0 1.5 12.2 8.9 40.1 12.2 37.8 11.1 10.6 7.7 13.2 13.5 4.5 14.2 4.7 2.3 12.9 5.5 22.8 8.7 4.2 15.7 1.6 6.9 2.6 1.0 1.7 1.7 6.1 0.9 0.8 1.3 26.6 2.5 9.3 1.8 1.4 1.9 5.0 7.6 11.5 15.2 5.9 6.1 4.6 7.8 6.5 2.9 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 105.0;vagina: 111.3" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 49.4 6.1 0.4 26.5 0.5 0.0 54.5 0.3 0.4 18.5 29.9 0.6 10.0 2.1 6.8 24.2 11.5 40.6 8.3 105.0 0.6 0.3 26.8 2.7 13.4 13.3 0.5 0.5 75.5 3.9 0.0 19.7 1.6 2.0 46.2 15.7 19.4 49.0 17.9 10.5 3.3 9.3 20.7 2.4 3.2 6.6 19.0 0.2 1.0 31.5 1.7 5.9 39.6 111.3 1.0 1.2 0.0 0.9 0.2 0.7 0.1 2.4 0.8 0.0 0.1 0.5 1.5 0.0 0.2 0.7 0.1 0.1 0.1 158.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 17.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 2.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.4 1.0 0.7 0.3 0.0 0.2 0.9 1.2 0.3 0.1 0.4 0.5 0.3 0.4 0.6 0.3 0.5 0.5 2.0 0.2 RARS DALRD1 ENSG00000113643 "Arginyl-tRNA synthetase" P54136 5 168486445-168519299 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (7.59e-5)" "prognostic unfavourable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 21.8 26.3 16.0 18.3 15.3 6.2 22.6 17.1 18.4 21.2 29.4 9.1 20.4 33.3 22.9 21.4 34.7 19.5 14.4 21.7 19.8 12.3 29.8 33.5 18.7 18.6 13.9 15.2 21.3 33.0 19.9 34.5 30.3 15.8 18.9 27.4 15.5 34.0 15.4 27.8 27.9 48.7 21.5 14.5 22.1 24.4 17.2 11.8 20.5 21.5 32.3 23.7 22.4 22.6 11.1 21.8 5.2 17.7 16.8 16.3 11.7 27.1 32.2 23.9 26.4 33.1 37.9 41.1 40.0 34.4 41.7 48.8 54.7 29.6 28.9 32.8 38.0 26.4 31.2 53.8 54.4 30.0 21.5 19.4 29.4 34.3 28.7 45.7 20.7 29.1 28.8 45.4 21.8 33.3 28.9 14.7 44.6 25.1 19.0 18.3 39.2 22.0 8.4 34.8 27.4 37.1 31.0 22.8 28.0 30.6 35.4 41.2 32.1 19.2 33.0 30.2 27.8 23.3 46.6 14.6 26.8 29.6 32.9 32.7 28.7 3.4 14.4 5.2 12.5 17.7 14.3 11.1 12.6 13.3 21.8 6.6 15.6 16.3 4.0 16.8 16.4 10.3 12.8 11.7 16.0 15.3 17.1 18.4 19.8 12.3 13.9 15.2 15.8 11.8 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102482445-102517781 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 47.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 20 "dendritic cells: 6.2;monocytes: 3.7" HPA043010 Uncertain Uncertain "Vesicles,Cell Junctions" "Cell Junctions" Vesicles "HPA043010: " "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 2.9 1.1 2.3 1.4 1.2 0.0 2.1 0.5 4.4 3.2 2.4 2.5 4.1 0.0 0.6 1.5 1.3 0.5 1.8 2.0 0.9 0.1 0.8 1.3 1.1 2.2 0.9 0.0 1.1 1.7 1.5 0.0 0.7 3.7 47.4 1.8 3.0 0.5 0.5 1.9 0.8 0.2 0.3 0.2 1.4 2.3 0.1 6.2 0.0 3.7 0.0 0.2 1.8 0.2 0.9 3.2 0.2 0.5 1.9 0.1 5.7 3.0 1.2 2.9 0.2 0.4 2.2 6.4 6.5 7.6 0.0 0.0 0.0 0.2 0.7 0.3 1.7 0.5 0.0 0.0 0.2 2.1 0.3 0.0 0.0 0.8 0.6 8.1 0.7 2.1 0.0 1.1 0.0 0.9 2.3 1.1 3.6 0.0 0.8 2.2 11.8 0.9 0.2 0.2 0.2 1.5 1.0 16.5 14.1 1.3 0.5 2.7 1.8 0.2 1.9 0.4 2.6 0.0 3.7 0.0 0.2 3.7 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.6 3.9 0.0 1.8 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell line enhanced" "Detected in some" "Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Approved Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: " "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavourable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.1 8.3 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.3 0.0 12.0 0.0 26.8 10.7 0.0 0.3 0.0 0.0 4.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 RASAL2 nGAP ENSG00000075391 "RAS protein activator like 2" Q9UJF2 1 178094141-178484147 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018805, HPA020453" Enhanced Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA018805: AB_1856085, HPA020453: AB_1856086" "unprognostic (5.55e-3)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (6.33e-2)" "unprognostic (3.40e-2)" "unprognostic (5.59e-2)" "unprognostic (5.91e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (2.92e-2)" "unprognostic (3.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-2)" "unprognostic (4.98e-2)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" "prognostic unfavourable (2.05e-4)" 13.5 3.8 4.2 2.8 5.1 0.4 7.1 2.7 8.5 9.5 4.2 3.7 4.2 2.4 10.9 5.5 24.4 5.8 9.0 15.5 3.8 5.9 7.1 2.7 9.2 1.5 4.0 6.5 6.3 5.0 6.1 6.7 21.2 5.6 5.0 4.3 10.7 9.6 4.5 8.3 7.5 3.3 7.1 3.8 2.9 3.7 9.0 2.7 0.0 5.0 13.1 4.8 5.6 13.2 2.1 0.5 1.4 0.6 0.3 0.1 0.0 16.1 5.3 7.0 2.3 4.7 6.4 9.7 8.1 7.9 6.9 5.2 8.5 8.6 0.0 13.5 7.9 13.6 5.6 12.9 6.4 0.0 3.1 0.0 5.6 3.3 5.6 2.3 0.3 20.1 2.5 8.2 29.6 6.2 0.5 0.0 9.5 1.6 0.0 1.9 5.2 1.0 0.1 2.8 0.0 3.7 2.1 5.4 2.6 6.3 4.9 4.9 5.7 2.6 11.7 9.2 9.3 9.5 10.8 3.5 0.0 0.0 7.2 1.2 6.5 1.4 0.4 0.1 0.1 0.3 0.0 0.6 0.0 0.0 0.2 2.1 0.1 0.1 0.8 0.3 0.6 0.5 0.0 0.0 4.2 5.1 2.7 7.1 3.8 5.9 4.0 6.5 5.6 2.7 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464571 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.9" "Cell line enhanced" "Detected in some" "HDLM-2: 14.1;HEL: 11.7;HMC-1: 22.6;Karpas-707: 25.2;NB-4: 12.8;RPMI-8226: 10.6;TIME: 16.7;U-937: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA043417: " "unprognostic (2.72e-2)" "prognostic favourable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favourable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favourable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavourable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.8 2.1 3.1 19.2 3.8 16.7 1.7 0.5 1.9 1.4 3.4 4.6 0.7 3.6 1.7 1.1 3.0 1.9 4.5 1.1 4.1 1.8 3.3 2.8 8.0 23.5 4.5 1.3 0.9 1.3 0.3 1.4 0.8 3.7 2.3 1.9 1.5 7.5 1.1 0.7 1.2 14.5 0.9 5.1 29.9 4.0 0.6 4.6 27.3 3.1 1.6 28.9 4.5 2.0 2.9 3.2 8.8 9.3 8.9 16.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 11.7 0.0 0.0 0.2 9.3 22.6 0.0 0.0 0.0 0.0 0.1 0.0 25.2 0.0 0.1 4.9 12.8 0.0 0.0 1.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 16.7 0.0 0.0 0.0 0.0 0.2 4.5 6.9 0.0 15.8 0.0 4.3 1.7 8.8 14.9 3.4 8.9 2.2 9.5 16.4 2.6 2.9 8.0 9.6 2.5 8.9 9.3 3.2 6.4 3.5 3.1 3.8 0.5 1.9 4.1 1.8 4.5 1.3 3.7 4.6 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 33.7;HSkMC: 8.2;REH: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 47 "plasmacytoid DC: 48.0" "Lineage enriched" "Detected in many" 47 "dendritic cells: 48.0" "Group enriched" "Detected in many" 5 "basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 79.6 24.3 14.0 6.2 23.2 8.3 30.4 11.6 32.0 49.1 7.1 8.5 18.6 5.9 19.9 17.1 10.9 11.6 11.8 20.1 14.7 15.5 30.2 85.9 5.6 3.7 10.0 22.5 33.5 17.5 7.2 81.3 2.6 22.2 17.8 6.9 6.6 49.4 51.8 37.2 9.1 6.1 4.3 19.6 12.2 6.1 13.8 8.9 9.1 37.7 9.2 2.5 6.2 5.5 0.0 48.0 0.0 1.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 33.7 1.8 0.1 0.4 0.6 0.0 0.1 1.3 0.0 0.0 3.8 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 3.7 0.2 0.0 0.1 8.2 0.0 0.3 0.0 0.1 0.0 0.0 0.1 3.4 6.1 0.5 0.6 2.0 32.2 0.0 0.0 0.7 0.0 6.1 0.2 0.5 0.4 7.0 0.0 0.0 1.8 0.0 0.3 0.2 0.1 6.9 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.0 0.0 0.3 14.0 23.2 11.6 32.0 14.7 15.5 10.0 22.5 22.2 8.9 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavourable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.5 0.0 0.6 0.0 0.0 0.1 0.9 0.3 1.4 1.1 0.2 0.7 0.0 0.2 3.0 0.2 0.2 0.0 1.3 0.0 0.9 0.0 0.2 0.0 1.7 0.0 0.1 0.2 4.0 2.7 0.4 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.2 0.4 1.5 0.0 1.1 0.0 0.0 2.4 0.4 2.6 9.2 0.0 0.7 0.3 0.1 2.2 5.3 0.2 1.0 2.3 0.7 0.0 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 12.2;Daudi: 15.6;Karpas-707: 10.5;NTERA-2: 7.2;SCLC-21H: 7.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0" "Group enriched" "Detected in many" 5 "B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favourable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favourable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favourable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 11.7 5.3 12.2 8.4 18.9 22.2 14.3 3.5 8.4 7.6 8.0 10.0 2.6 10.8 3.0 9.9 10.9 6.6 10.1 4.9 6.2 8.2 9.4 32.8 19.1 9.2 13.0 3.5 3.3 2.5 1.7 12.6 10.3 38.3 3.8 6.0 6.1 9.7 4.2 3.5 20.3 10.7 5.0 8.7 13.2 12.2 1.9 19.3 8.0 3.9 4.7 8.5 4.8 5.6 8.8 18.0 0.8 12.4 2.5 2.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 12.2 0.3 15.6 0.0 0.0 0.3 1.0 0.1 0.0 0.1 2.3 1.3 1.0 0.5 0.5 0.3 0.7 0.2 0.5 0.0 0.5 0.0 0.2 10.5 0.0 0.5 5.0 0.5 7.2 3.2 1.5 0.1 5.9 0.5 0.2 7.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 4.7 1.1 0.2 0.2 0.4 2.1 0.2 1.4 7.7 1.5 6.4 1.1 1.1 1.7 8.8 2.0 1.9 0.8 2.5 12.4 18.0 0.3 0.7 12.2 18.9 3.5 8.4 6.2 8.2 13.0 3.5 38.3 19.3 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.1;lymphoid tissue: 55.8" "Cell line enhanced" "Detected in some" "HDLM-2: 28.8;MOLT-4: 27.2;REH: 7.6;U-698: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039389: " "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.7 1.0 5.7 9.9 17.0 7.8 1.9 33.1 18.5 1.4 1.6 0.8 0.0 2.5 1.6 1.6 6.7 4.7 2.7 1.6 6.1 3.2 5.9 1.2 4.2 20.0 3.0 6.2 0.8 2.0 0.3 1.2 4.9 22.3 1.0 2.3 1.4 2.5 1.0 0.8 7.3 3.7 0.7 1.6 8.6 4.8 2.2 1.1 55.8 1.2 1.6 16.3 4.3 2.4 1.2 0.0 0.8 0.0 2.4 10.4 1.4 0.0 0.2 0.5 0.1 0.0 0.0 0.0 2.2 0.7 1.1 0.9 2.4 0.0 6.1 0.5 0.1 0.1 1.3 0.0 1.0 28.8 1.2 0.4 0.2 0.0 0.3 0.2 0.4 0.0 0.1 0.6 0.0 0.0 0.2 1.9 0.0 0.9 27.2 0.0 0.4 0.0 7.6 0.1 0.0 1.1 0.0 2.6 0.9 1.4 0.1 0.1 0.6 0.0 0.1 0.2 0.9 3.1 0.4 4.8 2.3 7.3 0.1 0.0 0.3 0.0 0.0 0.8 5.7 0.0 4.2 1.2 6.4 5.7 0.0 0.7 6.0 6.0 0.3 2.4 0.0 0.0 10.4 1.4 5.7 17.0 33.1 11.7 6.1 3.2 3.0 6.2 22.3 1.1 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.4;skeletal muscle: 28.7" "Group enriched" "Detected in some" 6 "Daudi: 29.3;HEL: 30.9;U-266/70: 48.4;U-266/84: 18.4;U-698: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4" "Group enriched" "Detected in many" 16 "B-cells: 13.4;granulocytes: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058937: " "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.6 9.4 13.6 13.3 3.2 4.9 2.0 9.6 3.1 3.5 35.0 0.0 5.7 2.6 1.3 2.0 2.1 5.0 24.3 13.4 8.8 5.1 4.1 5.8 19.8 25.2 5.5 1.6 3.7 9.3 3.1 8.2 19.9 2.1 5.3 6.7 5.4 1.7 28.7 2.3 4.5 3.7 42.4 10.1 5.4 1.3 26.3 1.9 6.7 5.0 25.0 5.4 2.1 13.4 0.2 11.4 0.1 0.2 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.5 4.4 0.8 0.2 29.3 0.1 0.2 0.0 0.0 0.0 0.4 3.0 0.3 30.9 0.2 0.0 0.4 0.1 4.2 0.0 0.0 0.0 0.0 1.7 0.1 1.6 0.6 0.0 0.2 2.3 0.1 0.0 0.0 1.4 0.0 0.3 1.8 0.2 0.0 0.0 0.1 1.4 0.0 0.1 0.5 0.1 0.1 0.1 0.2 48.4 18.4 12.9 0.0 0.1 0.1 11.4 0.0 0.0 0.3 0.0 0.4 10.4 0.5 0.5 0.2 13.4 0.7 0.2 0.0 0.2 0.1 0.0 0.7 0.9 9.4 13.3 2.0 9.6 13.4 8.8 25.2 5.5 19.9 26.3 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 5 "HEL: 18.9;HMC-1: 18.9;U-937: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.9 0.0 0.0 0.0 0.1 18.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Group enriched" "Detected in some" 5 "A549: 9.3;CAPAN-2: 8.3;HaCaT: 12.8;HMC-1: 6.4;RPTEC TERT1: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol Vesicles Cytosol "HPA040406: " "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favourable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favourable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.6 0.0 12.8 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.0 13.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell line enhanced" "Detected in many" "AN3-CA: 19.2;BEWO: 20.1;Daudi: 20.5;HL-60: 24.1;NB-4: 31.2;U-937: 38.4" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: " "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavourable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.8 11.9 19.2 0.1 0.0 20.1 1.1 3.3 0.2 0.0 1.1 0.0 20.5 1.9 1.0 0.0 1.7 0.0 0.3 7.3 0.7 13.4 0.0 0.2 0.0 24.1 13.7 0.0 0.0 0.4 0.0 7.8 0.0 8.1 0.0 0.0 3.5 31.2 2.6 0.3 5.5 1.3 7.8 0.0 9.5 0.1 0.9 0.0 0.3 0.6 0.0 15.4 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.6 0.1 38.4 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 RASSF3 ENSG00000153179 "Ras association domain family member 3" Q86WH2 12 64507001-64697567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 44.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022664, CAB034035, HPA038469" Supported Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (2.55e-3)" "unprognostic (3.73e-1)" "unprognostic (2.37e-1)" "unprognostic (6.21e-2)" "unprognostic (3.66e-2)" "unprognostic (1.49e-1)" "unprognostic (1.45e-3)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.59e-2)" 22.4 13.8 4.2 24.0 4.5 5.9 48.4 2.5 4.5 15.3 64.1 6.5 21.6 8.3 18.5 12.5 27.0 9.4 30.1 37.4 4.6 4.4 5.8 6.4 19.4 22.2 7.4 2.9 13.6 10.0 1.0 4.3 16.0 7.6 26.5 17.8 14.1 18.9 21.2 16.0 5.0 18.0 80.1 10.8 25.7 25.6 6.9 5.5 7.6 5.3 6.3 14.5 57.4 30.9 5.5 3.2 44.4 6.6 4.1 7.9 0.9 9.7 11.0 3.5 6.7 3.8 5.5 21.4 4.3 22.3 5.8 6.8 7.9 10.4 15.4 9.1 3.0 4.3 10.6 4.4 7.0 12.6 4.1 10.0 4.9 8.9 10.5 10.6 7.1 3.7 3.9 13.2 9.9 24.5 5.3 7.6 6.7 9.3 6.9 6.9 7.8 6.7 11.2 11.3 6.5 7.5 11.9 7.9 8.3 7.2 1.4 50.9 6.3 6.7 35.4 4.7 5.8 4.9 4.6 7.1 7.5 10.0 5.7 9.3 13.6 5.9 6.6 4.2 5.1 6.3 4.2 5.5 7.6 5.6 3.2 3.7 7.7 7.9 44.4 4.1 5.9 3.0 7.7 0.9 4.2 4.5 2.5 4.5 4.6 4.4 7.4 2.9 7.6 5.5 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.0;RH-30: 53.4;RPMI-8226: 17.4;U-937: 27.3;WM-115: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038834 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA038834: AB_10795576" "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 1.9 3.8 6.0 0.3 1.3 0.2 0.3 0.6 1.1 1.5 0.1 0.0 0.7 0.2 0.0 0.8 0.9 0.9 11.9 0.0 0.0 0.0 12.4 6.3 0.8 0.0 4.4 0.0 0.6 0.0 0.9 0.0 21.0 0.9 0.0 0.9 13.6 0.3 0.4 2.5 53.4 17.4 0.1 0.3 0.3 0.2 0.0 0.1 0.6 0.3 10.4 0.2 0.1 1.2 1.0 2.0 0.2 0.2 0.0 6.3 27.3 17.7 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.9" "Cell line enhanced" "Detected in some" "Daudi: 31.6;hTERT-HME1: 9.5;RPTEC TERT1: 10.1;RT4: 29.4;U-266/70: 8.7;U-698: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "memory B-cell: 6.4" "Lineage enriched" "Detected in single" 13 "B-cells: 6.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA037712: " "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.5 0.3 0.3 12.9 0.3 0.0 4.8 0.3 0.3 1.8 12.1 0.4 3.7 5.8 0.4 3.7 3.7 1.3 7.7 0.3 0.3 0.5 13.4 1.2 4.2 3.0 0.3 0.1 1.8 11.3 0.0 2.2 11.2 1.1 6.4 7.8 0.4 5.1 6.3 0.4 3.1 23.2 2.1 0.5 0.6 21.5 0.9 0.1 77.9 3.3 2.0 8.2 11.0 2.5 6.4 0.0 0.4 0.0 0.0 0.4 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 5.1 31.6 0.5 0.0 1.6 0.0 2.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 10.1 29.4 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 25.8 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 6.4 0.4 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.1 1.1 0.1 RASSF8 "C12orf2, HoJ-1" ENSG00000123094 "Ras association domain family member 8" Q8NHQ8 12 25959029-26079892 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038163, HPA038164" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA038163: , HPA038164: AB_10672621" "unprognostic (2.77e-1)" "unprognostic (1.71e-1)" "unprognostic (3.10e-1)" "unprognostic (6.10e-3)" "unprognostic (3.88e-1)" "unprognostic (3.15e-1)" "unprognostic (6.10e-3)" "unprognostic (8.28e-2)" "unprognostic (2.86e-1)" "unprognostic (6.29e-3)" "unprognostic (2.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.00e-2)" "unprognostic (1.32e-3)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" 9.8 14.1 14.6 6.4 14.0 1.3 14.6 8.0 10.4 20.9 12.7 10.3 7.0 2.5 23.9 10.5 6.7 10.0 14.6 11.9 16.0 8.5 19.7 5.2 12.5 2.2 15.1 8.0 26.3 5.2 4.3 16.1 10.6 14.8 14.2 4.6 14.7 4.4 12.7 12.0 3.3 4.4 17.3 19.9 5.0 7.0 44.7 13.6 0.3 9.7 5.2 2.2 10.1 18.8 0.6 4.1 0.9 0.3 1.4 0.6 0.1 3.2 2.6 11.5 1.4 18.0 20.4 16.1 17.9 26.2 7.6 8.4 5.7 1.0 0.2 14.2 19.3 1.3 2.5 2.1 9.7 1.2 3.3 0.5 6.5 0.3 9.0 2.0 0.1 12.1 2.1 16.8 11.3 9.0 0.6 2.3 8.7 4.4 2.3 0.4 11.5 24.8 3.0 11.2 0.1 4.6 4.9 0.5 8.3 9.4 0.1 8.8 1.7 1.7 10.6 15.0 7.8 38.0 13.4 1.0 0.6 0.3 13.9 0.2 21.0 0.7 0.3 0.2 0.6 0.1 0.2 0.3 0.2 0.2 0.0 0.6 0.3 0.2 0.9 1.4 0.1 4.1 0.1 0.1 14.6 14.0 8.0 10.4 16.0 8.5 15.1 8.0 14.8 13.6 RB1CC1 "ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131" ENSG00000023287 "RB1 inducible coiled-coil 1" Q8TDY2 8 52622456-52745843 "Predicted intracellular proteins" "Autophagy, Cell cycle, Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024391, HPA053049" Approved Supported "Nuclear membrane,Cytosol" Cytosol "Nuclear membrane" "HPA024391: , HPA053049: " "unprognostic (1.58e-2)" "unprognostic (7.51e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (3.22e-1)" "unprognostic (4.21e-2)" "unprognostic (7.39e-2)" "unprognostic (1.38e-2)" "unprognostic (9.34e-2)" "unprognostic (1.21e-1)" "unprognostic (8.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.56e-3)" "unprognostic (7.67e-2)" "unprognostic (4.41e-1)" "unprognostic (8.00e-2)" "unprognostic (2.42e-1)" 16.2 13.7 36.6 9.8 19.8 38.0 15.0 21.8 36.8 14.5 13.3 7.9 11.9 11.0 15.5 11.9 15.0 11.0 12.2 22.7 31.1 17.0 15.2 18.3 13.5 10.5 16.5 22.5 18.4 14.6 21.5 15.2 13.3 17.0 14.2 10.1 7.6 12.9 11.4 35.9 13.2 13.2 13.4 12.2 11.7 12.0 28.2 17.0 21.6 15.7 10.3 10.9 16.4 14.1 7.1 7.6 25.5 9.7 8.5 8.4 6.6 13.7 12.3 15.2 13.2 16.9 19.3 8.7 10.5 21.5 11.1 13.9 8.5 15.6 10.1 17.7 15.4 18.4 18.7 9.8 21.1 7.6 16.4 17.2 12.8 11.8 20.9 6.1 9.7 18.0 20.3 11.0 30.3 15.0 20.4 16.5 13.5 9.0 15.5 9.1 15.0 6.3 8.0 7.3 10.2 10.2 10.8 14.7 15.3 10.9 12.6 23.2 14.3 11.2 17.6 10.7 15.0 16.8 9.2 16.4 14.1 10.1 16.9 10.7 11.9 22.3 8.0 14.7 7.8 7.6 7.8 7.1 6.5 7.9 7.6 6.2 8.0 7.4 25.5 8.5 9.7 3.9 8.4 6.6 36.6 19.8 21.8 36.8 31.1 17.0 16.5 22.5 17.0 17.0 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA049042: , HPA058085: " "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 12.9 17.0 13.7 10.9 23.1 13.5 13.0 20.9 23.3 13.7 11.2 16.4 6.7 11.3 16.4 12.8 11.9 12.6 9.9 10.4 13.2 12.9 20.6 17.3 10.5 16.5 13.5 12.5 16.2 16.8 15.9 21.5 10.3 15.0 11.8 13.2 12.7 14.6 12.0 18.8 14.9 12.7 11.6 10.5 14.0 10.7 9.5 13.7 22.5 17.4 8.9 19.8 11.7 16.7 8.6 6.1 19.1 7.7 7.7 9.6 3.3 10.5 11.2 10.8 12.8 15.1 8.7 11.8 10.0 8.6 12.9 12.9 11.8 12.8 16.5 7.7 7.3 12.2 18.0 6.7 15.4 14.0 9.7 13.8 11.4 9.5 9.8 17.2 11.3 7.0 8.7 12.0 10.3 10.3 26.5 17.0 10.7 9.7 16.6 7.3 17.6 18.7 14.9 23.1 20.6 9.0 7.7 17.0 13.7 14.2 15.0 12.8 16.2 9.8 7.8 10.7 11.5 15.7 13.2 8.3 11.5 20.3 9.5 10.8 16.4 19.1 5.2 7.5 8.6 6.3 9.2 8.6 8.1 8.8 5.4 7.1 8.0 9.6 11.9 7.7 7.7 6.1 8.1 3.3 13.7 23.1 20.9 23.3 13.2 12.9 13.5 12.5 15.0 13.7 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell line enriched" "Detected in some" 15 "RH-30: 24.5" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 24.5 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 RBFOX2 "FOX-2, HNRBP2, HRNBP2, RBM9" ENSG00000100320 "RNA binding fox-1 homolog 2" O43251 22 35738736-36028425 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 4 "T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006240 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006240: AB_1079750" "unprognostic (3.17e-1)" "unprognostic (4.80e-2)" "unprognostic (9.30e-2)" "unprognostic (3.21e-3)" "unprognostic (3.42e-1)" "unprognostic (2.74e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-1)" "unprognostic (5.78e-3)" "unprognostic (2.13e-2)" "unprognostic (1.53e-2)" "unprognostic (6.08e-2)" 14.0 11.6 25.7 7.6 30.5 0.4 12.7 58.4 37.2 26.4 23.2 7.4 11.2 7.9 38.5 13.8 22.9 20.4 16.7 20.8 19.6 15.9 10.2 10.6 12.7 3.7 12.0 26.3 43.3 9.3 20.5 20.6 21.3 22.8 18.3 13.6 9.7 10.3 20.5 40.7 12.6 10.6 32.6 9.7 5.4 13.3 10.4 10.1 1.8 18.7 5.7 5.3 18.1 15.9 0.0 0.7 0.0 0.0 0.1 3.1 0.1 14.8 9.7 31.8 18.6 20.0 33.7 13.1 28.0 37.5 20.9 23.0 18.7 6.4 9.6 13.5 31.7 14.5 11.6 12.8 26.7 7.6 13.3 5.3 8.7 6.9 6.0 1.5 4.0 24.4 16.6 19.9 22.7 25.4 4.0 1.2 22.8 5.8 1.4 0.8 12.4 13.5 2.2 28.3 2.2 14.4 16.7 9.8 37.4 31.9 5.0 9.9 5.9 1.8 31.3 29.9 17.6 17.7 12.9 1.0 3.1 11.8 14.0 2.2 16.8 0.0 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 25.7 30.5 58.4 37.2 19.6 15.9 12.0 26.3 22.8 10.1 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favourable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.5 10.6 30.2 29.2 5.4 9.3 13.3 11.6 4.0 5.6 15.9 18.5 14.1 15.7 15.9 8.6 14.4 18.5 6.6 11.9 8.3 8.7 10.4 13.0 11.5 26.1 18.5 17.7 7.9 11.3 17.9 6.7 11.6 12.9 3.7 22.9 15.5 4.7 7.8 16.7 21.0 21.2 11.4 12.9 9.4 7.8 21.1 9.3 9.1 12.0 15.2 14.8 14.4 7.7 11.9 6.9 17.9 10.5 21.7 18.0 14.4 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047849 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047849: " "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 7.3 5.9 5.7 7.4 7.7 13.9 5.0 12.3 8.2 5.4 7.5 6.9 7.5 2.8 8.1 11.4 6.4 4.9 7.1 12.2 5.9 5.4 6.2 14.7 6.3 6.4 8.5 4.9 6.0 7.9 2.8 9.1 5.9 5.5 7.6 4.8 7.5 5.8 5.8 9.3 4.0 6.3 7.3 5.3 7.5 7.7 11.9 6.5 13.2 7.2 4.9 9.2 6.7 5.7 8.6 10.8 7.5 6.4 4.3 5.4 4.4 2.1 1.4 0.8 1.8 1.5 0.2 1.1 1.1 0.5 2.0 0.4 3.4 0.6 0.7 1.2 0.2 3.6 1.4 0.4 0.5 0.0 0.6 3.2 1.3 2.3 0.6 1.8 1.7 0.0 0.3 0.9 0.2 0.0 4.6 1.5 1.1 3.7 2.5 12.1 1.2 4.6 1.8 5.1 0.6 0.4 2.3 2.6 0.9 0.6 1.7 6.8 0.8 1.3 0.0 2.6 2.5 1.7 1.4 0.2 0.6 1.5 0.9 1.1 0.8 6.4 6.4 7.5 5.4 5.6 3.8 8.6 3.6 4.1 6.7 8.0 1.3 3.1 3.5 4.3 5.3 10.8 2.3 4.4 5.7 7.7 12.3 8.2 5.9 5.4 8.5 4.9 5.5 6.5 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Midbody, Cytosol" "HPA057281: , HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favourable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.3 12.5 15.4 7.4 13.3 11.0 9.2 8.5 7.0 5.8 10.2 5.8 8.6 13.8 13.1 13.9 11.6 10.5 6.0 7.6 10.2 5.9 14.0 15.2 10.6 13.1 15.8 9.6 19.7 13.1 10.4 8.1 13.7 6.4 7.9 9.4 6.5 10.2 7.0 17.5 13.9 12.8 6.6 17.7 9.3 10.0 14.2 15.1 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.8 21.7 8.6 14.2 9.4 10.3 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Low region specificity" "Detected in many" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytokinetic bridge" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.0 0.0 0.0 0.4 1.3 0.0 15.5 0.0 0.0 0.0 0.1 14.3 0.1 0.0 0.6 8.7 0.0 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893206-22919184 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favourable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 18.7 26.9 22.0 22.1 29.3 28.1 24.8 33.7 35.7 28.6 22.5 26.9 25.9 18.3 35.0 24.7 25.9 36.9 24.2 20.3 19.9 24.2 27.8 27.0 25.2 25.0 19.7 23.7 40.8 23.2 56.6 37.5 43.9 23.9 27.2 25.7 35.4 25.3 25.8 18.0 22.3 24.8 28.2 22.6 32.7 25.3 23.5 26.7 44.0 42.4 19.7 31.2 24.8 34.9 14.0 17.8 49.9 17.2 20.5 14.3 9.8 19.7 31.4 32.0 16.7 17.6 15.1 13.4 21.7 29.8 42.4 33.3 14.1 24.4 33.2 17.2 20.1 28.2 35.9 18.2 34.6 26.0 29.6 15.6 24.5 1.0 27.7 30.0 25.7 19.3 25.3 24.4 16.2 23.6 19.7 21.6 20.8 25.3 32.8 13.5 14.2 29.5 28.3 26.6 20.2 16.5 28.1 22.1 24.7 32.6 25.3 13.7 18.7 17.8 21.8 7.4 12.6 17.6 20.1 20.5 26.2 31.4 12.3 17.3 26.3 11.3 17.2 17.6 14.3 13.3 9.8 10.8 10.2 12.3 17.8 14.0 12.5 10.9 49.9 20.5 16.4 9.3 10.4 9.8 22.0 29.3 33.7 35.7 19.9 24.2 19.7 23.7 23.9 26.7 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281346-17293875 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3" "Cell line enhanced" "Detected in many" "HBF TERT88: 11.1;LHCN-M2: 28.6;RH-30: 29.5;T-47d: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA066927: , HPA067231: " "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 3.4 0.2 1.4 0.9 2.2 0.1 1.1 0.3 1.9 7.0 2.7 0.1 3.0 0.5 9.7 7.3 3.4 7.8 1.7 41.0 1.5 1.7 0.3 0.4 0.4 0.2 0.5 1.1 2.1 0.2 0.1 1.8 0.2 0.3 3.6 2.4 1.6 2.5 2.2 153.8 0.4 1.2 9.3 0.5 0.4 0.8 1.3 0.1 0.1 1.4 37.3 1.9 5.1 2.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.7 4.5 5.9 0.0 0.0 0.0 0.0 9.0 3.3 6.1 6.5 0.0 0.5 0.0 2.8 6.4 0.0 5.6 0.2 11.1 0.0 0.2 0.0 0.5 3.0 0.2 0.0 0.5 3.2 0.0 1.2 0.2 0.7 0.0 0.0 28.6 1.3 0.0 0.0 2.0 0.7 0.0 29.5 0.0 0.0 0.0 3.9 0.4 0.0 0.0 0.1 13.8 0.2 0.0 2.1 4.9 0.0 7.7 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.3 1.9 1.5 1.7 0.5 1.1 0.3 0.1 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.0 7.1 12.9 23.5 12.7 8.9 11.4 11.0 12.3 13.7 20.6 13.8 7.6 18.0 11.2 11.6 11.0 18.7 18.2 15.4 6.4 8.5 14.3 24.4 15.2 11.3 13.4 10.6 7.3 9.1 21.9 10.6 14.3 6.9 21.2 21.0 27.4 6.4 19.9 10.4 23.9 11.8 9.2 11.7 21.3 17.5 11.3 28.6 24.4 26.6 9.5 11.6 10.1 16.0 25.4 12.9 20.8 21.8 13.6 16.4 18.1 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391407-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.3;skeletal muscle: 107.9" "Cell line enhanced" "Detected in many" "Daudi: 38.8;U-698: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB017036 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favourable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favourable (1.63e-4)" "unprognostic (1.83e-1)" 4.4 3.5 4.5 22.8 4.9 64.3 4.3 10.0 5.2 9.2 28.1 6.4 7.1 5.9 13.0 6.7 16.3 10.4 6.5 24.4 4.2 3.9 5.3 6.7 9.8 23.3 4.7 2.3 17.2 5.9 1.9 4.4 9.9 5.0 12.2 3.4 10.9 11.6 8.3 107.9 2.7 12.9 27.4 3.4 22.0 8.1 16.7 4.1 26.8 4.1 18.9 28.0 25.1 11.4 6.4 2.2 3.5 2.9 5.5 7.6 3.4 5.4 5.6 2.8 7.1 0.0 0.4 16.1 1.8 0.4 3.9 1.0 23.0 5.9 38.8 15.4 0.5 5.0 2.3 2.2 0.6 7.8 9.6 32.9 2.1 14.5 1.7 15.8 15.5 0.5 1.1 1.6 0.3 2.6 26.8 7.1 0.4 23.6 11.4 16.3 10.4 7.1 22.2 7.0 31.5 2.9 2.5 11.7 7.5 4.3 14.3 7.2 7.9 22.3 4.6 1.3 12.4 1.6 7.5 17.0 22.5 40.8 0.3 11.4 1.2 0.0 1.0 3.5 5.4 2.9 3.5 5.6 4.5 3.7 1.8 6.4 5.7 5.0 1.3 5.5 2.7 2.2 7.6 3.4 4.5 4.9 10.0 5.2 4.2 3.9 4.7 2.3 5.0 4.1 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavourable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 41.4 44.1 37.5 41.5 41.4 120.8 38.5 57.5 41.8 43.4 35.0 30.7 46.3 29.5 51.9 34.3 42.8 35.3 40.7 40.2 35.8 29.9 39.2 32.4 40.4 41.8 41.1 31.4 52.3 35.6 40.9 71.5 45.2 37.4 39.2 27.0 28.9 37.1 46.0 44.1 32.1 30.6 40.2 43.0 38.4 33.5 22.9 46.4 52.4 40.7 28.2 40.5 39.9 46.1 27.6 32.5 88.9 25.1 24.2 22.5 16.8 28.7 26.7 27.8 24.6 21.9 24.9 30.3 38.6 19.3 25.2 23.8 38.6 26.7 39.7 30.1 14.9 27.2 41.2 24.4 29.1 26.6 29.5 52.8 27.0 44.6 24.8 48.6 33.0 10.1 42.4 21.1 24.0 23.5 54.4 35.4 21.6 24.9 56.5 35.0 33.5 32.0 34.5 44.1 29.9 22.9 20.8 27.1 23.5 30.2 38.5 33.7 25.9 34.3 27.0 32.8 28.1 30.4 34.6 22.8 46.3 58.3 22.5 39.1 24.0 41.2 25.1 38.2 22.5 22.1 22.1 25.3 19.8 20.7 22.4 27.6 18.9 18.0 88.9 24.2 19.4 32.5 22.1 16.8 37.5 41.4 57.5 41.8 35.8 29.9 41.1 31.4 37.4 46.4 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638617-66666682 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042174: , HPA047849: " "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 41.6 50.3 37.1 34.4 37.2 57.5 38.3 55.5 43.9 40.6 39.1 35.5 43.4 33.9 42.2 48.3 44.5 37.4 33.6 33.0 32.1 31.0 40.9 37.2 34.3 44.7 30.1 32.7 51.1 63.9 44.9 41.5 42.5 31.1 42.7 33.2 41.3 54.6 33.2 40.8 37.4 36.2 36.7 26.9 48.5 42.1 47.3 32.2 68.2 59.5 37.9 48.7 36.5 37.2 51.4 45.0 61.7 51.9 57.5 72.7 54.3 26.5 35.2 53.5 30.1 19.7 21.4 32.5 28.1 22.8 29.6 21.3 58.7 34.7 34.4 38.8 28.1 29.7 57.1 33.4 31.8 34.1 29.7 46.8 36.0 34.9 39.0 32.0 20.4 31.3 29.1 34.1 48.4 39.2 36.8 25.5 30.9 54.9 52.6 32.9 67.2 38.8 49.2 50.2 38.0 39.3 43.1 45.1 32.5 49.5 36.3 78.7 69.0 32.2 39.8 31.0 27.3 19.1 22.7 32.0 33.4 55.6 24.8 25.3 44.2 61.7 45.7 48.6 56.8 46.8 51.0 48.0 59.0 61.8 45.0 51.4 63.8 63.5 53.6 57.5 51.9 40.6 72.7 54.3 37.1 37.2 55.5 43.9 32.1 31.0 30.1 32.7 31.1 32.2 RBM41 FLJ11016 ENSG00000089682 "RNA binding motif protein 41" Q96IZ5 X 107064420-107118823 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042881 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA042881: AB_10794536" "unprognostic (1.07e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.39e-1)" "unprognostic (2.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-2)" "unprognostic (1.98e-2)" "unprognostic (2.19e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" "unprognostic (2.80e-2)" "unprognostic (1.92e-1)" 10.0 10.3 9.2 9.1 10.8 5.0 9.5 23.7 14.2 13.4 11.9 10.1 8.2 12.7 12.2 11.5 11.1 12.4 7.6 8.8 8.7 6.8 11.8 13.7 8.3 8.9 9.7 9.4 9.7 10.6 21.0 14.1 12.0 11.6 10.8 11.2 9.0 10.7 9.0 14.6 11.6 15.5 11.2 14.2 11.5 8.2 15.6 12.8 12.2 15.7 8.0 9.9 12.4 9.8 6.3 4.8 10.6 7.0 8.6 6.3 3.4 14.1 11.4 7.3 5.9 4.9 8.6 8.5 8.4 8.3 6.2 8.4 7.5 11.9 7.8 15.9 6.1 11.8 10.6 7.8 9.5 9.6 15.7 9.5 20.6 9.2 5.5 9.6 7.5 6.0 15.6 7.5 7.6 9.3 16.3 10.9 7.5 6.8 8.1 5.5 10.8 13.1 6.6 6.1 6.7 9.2 9.0 6.1 9.6 10.5 7.6 6.7 6.9 5.0 9.0 8.7 5.1 10.3 6.6 5.1 9.4 8.7 4.9 4.4 6.5 10.6 7.0 10.6 6.3 3.7 3.9 6.3 5.5 6.3 4.7 6.3 4.1 2.8 1.0 8.6 3.7 4.8 4.9 3.4 9.2 10.8 23.7 14.2 8.7 6.8 9.7 9.4 11.6 12.8 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 26.0 22.0 16.6 20.3 16.0 29.2 23.6 12.1 23.4 20.4 27.3 22.6 18.8 24.2 25.5 21.8 25.5 18.3 23.6 24.9 13.7 12.0 22.2 33.3 19.3 19.2 15.7 17.6 27.6 17.7 20.7 15.0 41.3 16.0 19.5 9.9 15.9 25.1 24.6 44.6 31.5 24.7 18.6 18.1 25.4 22.0 23.7 16.0 41.1 25.8 21.9 21.3 21.2 22.4 43.6 49.1 61.3 48.9 38.9 45.6 33.9 32.4 51.1 11.4 15.5 10.4 8.3 31.2 22.3 12.4 26.4 20.8 30.1 21.2 18.1 40.9 14.2 13.4 13.1 15.7 7.7 46.8 23.4 24.9 17.0 24.6 27.1 22.0 24.1 11.7 12.6 19.4 10.7 14.4 25.9 14.9 11.9 36.9 27.8 29.1 13.0 21.1 30.4 15.6 18.0 12.5 15.1 15.0 21.7 25.4 20.9 17.0 16.7 34.7 21.9 18.8 25.8 24.9 38.8 36.5 38.4 27.8 18.2 21.0 26.3 46.1 42.1 61.3 45.6 48.9 39.3 41.0 37.9 45.5 49.1 43.6 34.2 37.7 38.6 38.9 45.4 45.4 41.9 33.9 16.6 16.0 12.1 23.4 13.7 12.0 15.7 17.6 16.0 16.0 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261879 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0;HSkMC: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 10.7 14.8 5.2 7.6 6.4 6.0 7.9 1.6 4.9 14.4 8.1 5.4 7.4 3.1 14.6 14.6 8.4 13.6 7.2 4.4 6.0 4.8 7.8 7.0 14.3 13.6 4.5 5.3 17.6 6.8 8.7 7.8 6.0 4.3 14.4 4.7 14.3 6.2 8.9 4.5 6.2 6.3 11.5 5.6 8.4 5.9 6.5 4.1 11.0 13.4 3.6 6.9 20.5 6.6 3.2 1.1 5.9 4.6 5.3 4.9 1.2 2.9 1.8 3.0 4.0 8.2 18.0 2.0 3.4 7.8 4.3 6.2 0.1 4.8 2.3 1.3 6.0 1.5 0.9 3.9 2.2 3.4 2.1 5.4 0.7 0.2 8.0 6.6 1.9 16.2 4.3 3.4 2.5 9.0 2.2 2.5 5.8 2.9 3.8 3.2 1.1 3.5 2.6 3.5 1.3 7.2 2.5 1.1 3.6 3.2 2.4 6.3 3.5 4.3 5.1 3.2 2.9 2.7 1.4 0.9 0.6 0.0 8.4 2.7 1.9 1.9 1.7 5.9 2.8 2.1 4.6 2.8 3.9 3.5 1.1 3.2 4.9 3.4 2.0 5.3 4.6 0.5 1.9 1.2 5.2 6.4 1.6 4.9 6.0 4.8 4.5 5.3 4.3 4.1 RBM47 "FLJ20273, NET18" ENSG00000163694 "RNA binding motif protein 47" A0AV96 4 40423267-40630875 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.6;BEWO: 49.6;CAPAN-2: 21.8;SK-BR-3: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 42.4" "Group enriched" "Detected in many" 11 "dendritic cells: 11.3;granulocytes: 42.4;monocytes: 14.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA006347 Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA006347: AB_2181208" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.49e-3)" "unprognostic (2.38e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-2)" "unprognostic (7.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.33e-16)" "unprognostic (1.62e-2)" "unprognostic (9.81e-2)" "unprognostic (1.72e-1)" "unprognostic (5.77e-2)" 8.2 33.6 1.9 8.2 2.4 2.6 10.9 0.8 1.2 5.4 22.9 3.3 28.7 24.1 2.6 15.4 27.3 5.3 12.7 4.0 2.4 1.1 37.0 16.1 14.5 11.3 3.0 0.3 4.6 19.2 8.0 2.9 27.2 6.6 13.2 17.3 9.2 60.8 36.0 0.9 6.0 42.8 2.2 4.1 15.0 22.2 7.1 2.2 1.6 31.5 13.7 20.6 7.8 9.7 2.0 11.3 42.4 14.2 0.1 0.1 4.8 11.5 16.6 0.0 0.5 0.0 0.0 49.6 0.3 0.3 0.1 0.1 9.7 21.8 0.0 8.7 0.3 4.6 0.3 3.3 0.1 0.0 2.7 0.0 1.2 2.6 0.2 0.1 0.1 0.2 2.0 0.0 0.0 0.0 0.6 2.5 0.0 6.5 0.0 0.3 5.1 0.9 0.0 0.0 12.8 15.3 14.6 0.5 0.1 6.6 16.6 0.1 7.3 3.0 0.0 0.1 0.6 0.1 0.3 8.8 13.0 1.4 1.5 1.3 0.0 0.1 14.2 0.1 0.0 10.9 0.1 2.0 0.0 0.0 11.3 1.2 0.1 0.0 42.4 0.1 8.1 4.6 0.0 4.8 1.9 2.4 0.8 1.2 2.4 1.1 3.0 0.3 6.6 2.2 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677921 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042174: , HPA047849: " "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favourable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 7.1 12.3 17.6 9.6 17.3 4.0 10.2 35.9 19.3 13.4 10.0 22.8 13.5 9.3 19.0 20.2 10.1 18.3 9.8 9.2 17.5 17.4 9.9 9.8 8.8 13.8 15.4 16.2 29.8 11.8 15.7 25.6 12.2 17.3 14.6 11.5 14.5 14.1 15.0 13.9 17.4 10.3 14.0 16.4 11.8 9.8 17.0 18.7 8.5 12.3 7.6 15.5 11.3 11.5 21.8 11.4 26.8 15.1 13.2 12.5 8.4 13.5 13.6 29.8 24.9 14.7 15.1 10.1 13.0 13.1 14.6 15.0 19.0 14.2 15.1 18.7 16.4 17.6 19.6 17.9 15.5 14.6 13.3 16.5 17.1 20.2 10.8 16.6 16.3 15.7 12.3 14.9 12.7 14.0 12.5 15.2 19.6 21.7 10.3 12.8 17.8 18.3 21.1 23.8 15.5 13.3 13.7 18.4 16.8 15.6 8.0 29.1 21.3 15.8 12.9 16.2 16.6 15.7 11.6 7.5 12.6 15.5 14.9 11.8 14.2 12.7 9.6 26.8 10.8 14.1 10.4 21.8 10.1 10.4 11.4 18.6 12.5 9.2 6.1 13.2 15.1 9.4 7.4 8.4 17.6 17.3 35.9 19.3 17.5 17.4 15.4 16.2 17.3 18.7 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favourable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favourable (5.13e-5)" 24.4 30.2 30.2 51.3 37.1 30.0 25.1 49.4 41.1 31.2 31.0 28.9 38.5 30.3 51.4 34.3 21.8 28.8 32.6 25.3 32.1 19.8 29.2 30.6 26.8 39.8 38.1 26.0 42.6 35.9 41.9 36.9 21.9 30.5 40.1 29.8 25.6 28.1 38.3 25.3 35.9 32.4 36.7 40.9 42.6 28.0 29.7 38.0 24.9 32.6 21.9 35.9 25.1 36.6 12.8 9.9 14.7 8.6 7.3 15.6 5.9 9.6 6.1 25.1 16.7 25.7 14.1 8.9 16.3 14.2 14.4 15.2 10.6 10.9 49.5 9.6 16.2 8.0 21.4 14.4 18.3 19.8 8.0 22.9 14.1 13.7 14.6 24.1 23.8 13.1 17.8 16.3 18.4 18.1 18.8 12.5 13.7 9.1 22.6 35.8 20.1 11.2 8.7 10.8 12.6 14.3 18.8 9.9 17.9 14.9 10.8 10.2 8.4 19.0 16.8 14.4 17.2 11.7 16.5 17.2 40.7 29.8 8.3 20.2 14.1 14.7 8.6 5.0 15.6 4.7 12.1 12.8 10.2 8.5 8.8 11.9 10.5 11.5 6.1 7.3 7.7 9.9 6.7 5.9 30.2 37.1 49.4 41.1 32.1 19.8 38.1 26.0 30.5 38.0 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521929-56596196 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: " "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favourable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 24.5 7.2 5.7 5.8 10.0 3.6 31.3 8.5 8.7 12.2 9.9 6.0 6.1 4.7 17.5 11.9 9.3 10.4 10.4 19.3 8.6 5.1 12.4 4.4 53.1 8.0 7.5 5.2 12.6 7.5 11.5 12.1 24.8 11.4 9.6 9.6 14.3 10.3 9.8 9.3 7.5 7.5 12.9 19.2 13.2 8.0 4.8 7.4 2.7 16.5 8.1 5.3 11.7 19.2 1.1 4.9 3.0 8.3 2.1 2.3 1.5 11.5 9.7 4.2 6.1 10.2 9.9 4.2 14.7 15.2 11.3 10.0 7.6 20.6 0.2 17.6 14.9 8.4 3.8 23.4 12.7 3.8 3.1 1.4 7.5 2.3 6.6 1.6 2.7 8.8 5.9 11.8 13.9 20.8 0.7 2.8 19.2 1.5 1.6 1.9 2.5 3.6 0.9 4.6 0.2 14.0 2.8 0.4 3.2 17.1 6.2 2.1 6.6 3.1 31.8 7.1 15.1 3.9 3.4 2.5 1.1 0.8 2.5 0.4 9.8 1.0 8.3 2.6 1.6 2.6 1.7 0.6 0.7 2.3 4.9 1.1 1.8 1.2 3.0 2.1 0.6 1.3 0.9 1.5 5.7 10.0 8.5 8.7 8.6 5.1 7.5 5.2 11.4 7.4 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein, X-linked 2" Q9Y388 X 130401969-130413343 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (7.04e-4)" "prognostic favourable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 19.4 16.7 22.3 16.7 20.0 17.1 25.0 22.7 22.9 25.1 19.9 18.9 19.1 17.0 29.4 29.5 18.7 19.8 18.8 17.8 21.0 18.7 17.7 21.1 16.9 21.2 18.6 22.1 28.2 21.9 17.9 24.4 17.3 21.0 23.0 20.0 16.3 20.5 23.7 21.0 21.4 15.9 23.0 18.9 21.1 18.4 10.8 19.0 26.4 23.0 17.9 26.7 27.2 20.2 12.6 10.5 11.0 9.5 9.4 19.3 5.4 13.8 14.5 14.6 15.1 14.6 27.4 14.9 13.0 13.4 14.9 16.2 10.8 17.0 13.4 31.4 9.9 15.1 23.3 12.0 21.7 12.2 20.7 12.0 13.4 11.3 13.2 18.5 14.3 19.8 17.3 16.6 23.2 16.6 10.4 11.7 16.6 24.1 21.2 23.1 11.0 23.7 16.4 14.5 18.1 15.1 11.1 17.1 20.4 8.2 17.6 23.0 11.4 13.7 10.8 12.0 9.8 28.0 27.2 15.5 16.9 19.1 14.6 30.3 15.2 11.0 9.4 10.8 11.1 9.5 11.1 12.4 13.8 14.0 7.8 12.6 15.1 14.2 8.0 9.4 9.4 10.5 19.3 5.4 22.3 20.0 22.7 22.9 21.0 18.7 18.6 22.1 21.0 19.0 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 134.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 8.6 0.0 0.0 6.0 0.1 0.0 0.0 0.7 0.0 0.4 11.0 25.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 5.1 0.0 0.0 0.0 3.1 134.2 5.5 0.0 0.0 0.5 0.1 0.0 0.0 19.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7123684-7128942 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3" "Cell line enhanced" "Detected in many" "HEL: 6.8;Hep G2: 15.2;K-562: 31.3" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 12 "granulocytes: 1.3;T-cells: 2.4" "Low region specificity" "Detected in all" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA038723: " "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favourable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favourable (3.68e-4)" 1.5 2.6 0.3 18.2 0.3 0.7 1.3 0.6 0.3 2.8 1.7 0.1 2.3 1.4 5.3 13.3 2.3 1.5 3.6 2.3 0.3 0.3 99.9 74.2 3.6 54.3 0.2 0.0 3.5 1.3 0.2 1.6 0.1 0.1 2.6 1.6 0.7 5.9 3.3 0.4 0.7 4.4 1.8 0.2 44.3 1.2 1.2 0.0 6.2 2.0 0.7 10.1 2.3 1.4 0.1 0.0 1.3 0.0 0.0 2.4 0.1 1.8 3.1 0.0 1.0 0.0 0.0 0.7 1.1 0.0 0.0 0.2 1.7 1.9 1.1 0.5 0.0 2.2 0.1 0.0 0.0 2.7 0.0 6.8 4.9 15.2 0.0 0.4 2.0 0.3 0.1 0.0 0.0 0.0 31.3 1.4 0.0 0.0 0.1 0.4 0.4 0.1 0.4 0.0 0.1 0.1 2.6 0.1 0.3 2.7 1.1 0.0 0.6 1.1 1.1 1.3 1.3 3.7 0.5 0.6 0.2 0.2 0.9 1.4 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.4 0.1 0.3 0.3 0.6 0.3 0.3 0.3 0.2 0.0 0.1 0.0 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016020 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.1;breast: 210.2" "Cell line enhanced" "Detected in some" "EFO-21: 10.3;SK-MEL-30: 6.9;T-47d: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6" "Group enriched" "Detected in many" 30 "granulocytes: 60.6;monocytes: 54.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 68.1 3.7 3.8 3.0 11.4 7.5 210.2 2.1 5.5 4.3 10.9 8.7 2.7 0.5 6.4 4.5 7.2 2.4 14.7 29.7 5.3 2.8 7.6 2.5 2.5 4.5 7.6 3.0 2.6 3.7 14.7 3.5 4.4 6.2 4.7 1.2 3.5 4.8 2.7 5.9 6.6 2.0 4.4 8.9 21.5 3.0 2.6 5.2 1.2 11.3 1.8 1.4 4.5 17.5 0.0 1.8 60.6 54.1 0.0 0.1 15.0 0.0 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.8 1.8 2.3 0.0 10.3 1.0 0.0 0.0 0.7 3.3 0.0 2.5 0.0 0.1 0.9 1.2 0.0 0.0 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 4.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 1.9 0.1 6.9 26.2 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 54.1 0.4 0.0 23.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 60.6 0.0 11.1 0.3 0.1 15.0 3.8 11.4 2.1 5.5 5.3 2.8 7.6 3.0 6.2 5.2 RBPMS HERMES ENSG00000157110 "RNA binding protein, mRNA processing factor" Q93062 8 30384479-30572261 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 71.5;RPTEC TERT1: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056999 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056999: " "unprognostic (1.65e-1)" "unprognostic (7.81e-2)" "unprognostic (1.53e-1)" "unprognostic (2.23e-3)" "unprognostic (8.66e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-2)" "unprognostic (3.47e-3)" "unprognostic (4.63e-2)" "unprognostic (2.32e-1)" "unprognostic (4.67e-2)" "unprognostic (2.88e-2)" "unprognostic (1.76e-2)" "unprognostic (4.76e-2)" "unprognostic (2.52e-1)" "unprognostic (4.91e-2)" "unprognostic (2.16e-3)" 71.3 20.4 2.3 28.4 6.9 0.2 112.8 1.4 2.9 81.7 66.1 4.4 46.3 6.9 90.8 31.8 66.2 35.7 50.4 53.8 2.8 2.7 69.1 34.5 36.7 19.3 5.4 3.4 65.5 15.0 12.2 10.4 29.2 9.3 77.3 13.7 41.2 22.9 59.8 14.5 11.8 22.3 181.8 10.3 28.9 38.1 27.4 2.9 4.8 54.1 8.5 10.9 155.4 88.9 0.5 3.9 0.3 0.2 0.7 0.3 0.0 0.1 11.1 12.6 0.1 71.5 21.5 31.5 15.8 21.7 19.5 16.2 16.2 6.6 0.1 8.5 20.2 6.3 14.4 11.4 23.6 0.0 3.0 0.3 5.2 16.6 30.8 0.1 2.5 24.8 2.9 18.7 2.5 11.2 0.1 0.0 9.5 6.8 0.0 0.2 32.4 7.3 0.7 3.5 0.9 49.4 18.8 0.2 2.5 1.6 11.8 7.8 2.5 0.0 10.3 9.7 0.9 16.6 2.6 0.0 0.0 0.0 15.9 0.0 4.3 0.0 0.1 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.3 0.7 0.0 3.9 0.1 0.0 2.3 6.9 1.4 2.9 2.8 2.7 5.4 3.4 9.3 2.9 RC3H1 "KIAA2025, RNF198, roquin, RP5-1198E17.5" ENSG00000135870 "Ring finger and CCCH-type domains 1" Q5TC82 1 173931214-174022297 "Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027428, HPA027434, HPA027448" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683" "unprognostic (6.91e-2)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" "unprognostic (2.33e-2)" "unprognostic (7.73e-2)" "unprognostic (1.61e-2)" "unprognostic (5.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.75e-1)" "unprognostic (1.13e-2)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (5.25e-2)" "unprognostic (2.15e-1)" "unprognostic (3.43e-3)" "unprognostic (6.83e-3)" 10.4 7.8 11.8 8.0 10.3 32.6 10.6 26.7 14.0 9.9 10.3 12.3 8.3 6.9 10.9 8.4 11.8 9.4 8.1 9.0 11.9 7.4 8.1 11.2 11.3 8.8 10.4 7.1 10.8 9.8 10.2 14.6 9.1 12.4 8.7 8.6 13.3 9.0 7.6 19.1 14.0 10.6 8.4 9.3 13.6 9.1 9.7 9.0 15.2 9.9 7.7 13.6 8.4 9.8 2.8 1.6 10.4 3.9 2.3 2.7 1.1 7.3 10.2 5.7 8.8 10.8 8.4 7.8 5.0 7.1 5.8 5.1 9.3 8.2 10.4 9.0 8.1 7.1 8.5 7.0 8.2 7.2 2.1 9.0 7.6 7.8 6.6 11.6 10.5 8.0 5.5 8.4 5.7 8.9 10.2 6.4 7.0 5.5 7.0 10.6 9.7 1.1 7.7 10.2 7.6 10.3 14.2 6.8 6.1 9.5 12.2 4.8 8.2 11.8 12.8 7.6 7.6 6.4 6.4 8.0 8.0 13.4 5.1 5.3 7.5 4.5 3.2 4.0 2.0 3.2 2.1 2.1 1.9 2.3 1.6 2.8 2.7 2.3 10.4 2.3 3.9 1.3 1.5 1.1 11.8 10.3 26.7 14.0 11.9 7.4 10.4 7.1 12.4 9.0 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 24.7;HDLM-2: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053880: " "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favourable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 5.9 0.4 0.0 0.0 0.0 0.0 0.3 24.7 0.0 0.0 0.0 0.1 49.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.1 5.5 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.0" "Group enriched" "Detected in many" 4 "MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2" "Lineage enriched" "Detected in many" 7 "T-cells: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: " "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.2 1.5 2.7 15.8 4.0 4.7 7.6 37.0 3.7 3.9 5.0 7.6 3.2 5.2 3.2 7.7 12.6 11.2 6.5 3.1 3.3 7.8 5.3 2.1 8.1 27.2 5.5 1.9 2.0 15.0 5.5 15.0 7.0 7.6 27.7 5.2 6.1 17.4 4.8 1.6 10.0 6.7 2.6 7.9 7.9 13.2 2.6 2.9 17.2 11.7 8.6 23.2 6.0 6.3 2.8 1.5 1.4 0.9 1.9 19.2 4.2 10.3 8.1 0.1 2.5 2.2 5.2 9.5 7.0 3.8 5.6 5.3 2.3 13.8 7.7 6.4 11.8 9.8 7.3 8.9 6.1 7.4 4.4 0.8 2.1 7.1 1.4 2.5 6.8 1.8 6.7 1.9 2.9 1.2 1.1 0.3 2.5 3.4 6.7 4.0 10.9 6.0 2.7 0.1 0.2 4.2 8.9 22.2 5.5 5.6 7.3 21.7 7.6 5.3 8.1 6.7 8.0 0.4 4.8 10.5 12.6 9.9 2.8 10.6 7.7 1.4 0.9 1.1 0.7 0.5 5.6 2.6 14.0 5.0 1.5 2.8 19.2 9.9 0.3 1.9 0.2 1.1 19.2 4.2 2.7 4.0 37.0 3.7 3.3 7.8 5.5 1.9 7.6 2.9 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488959-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 12 "MOLT-4: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favourable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 15.8 10.6 9.1 10.3 8.9 3.8 9.7 7.3 12.1 14.2 7.3 19.0 15.2 4.3 22.3 11.1 11.9 11.7 10.5 11.6 9.0 8.6 14.8 8.0 8.8 8.5 15.8 6.2 18.0 6.1 4.7 25.8 14.9 11.4 14.6 7.0 20.0 27.4 18.5 6.1 4.6 6.1 11.9 16.3 14.9 8.0 5.8 12.8 4.4 23.9 6.9 10.6 10.3 11.3 0.5 13.1 25.9 19.0 6.7 7.3 9.1 0.4 0.3 6.3 0.4 5.0 4.4 0.0 1.9 2.3 1.1 0.8 0.2 0.4 1.3 1.4 3.0 0.8 0.9 0.7 1.2 1.5 1.2 3.3 0.8 0.3 1.9 1.5 2.1 4.5 1.8 1.4 0.7 3.4 0.2 2.0 4.0 0.1 76.5 4.3 3.5 1.0 6.5 0.6 5.4 2.1 1.0 1.4 1.2 1.5 0.3 2.3 0.1 3.8 2.9 1.3 0.5 0.3 0.7 0.1 0.1 1.5 0.7 3.4 2.5 2.2 19.0 2.1 7.1 13.7 4.3 0.5 6.0 7.3 13.1 0.5 3.6 5.4 25.9 6.7 12.0 0.2 7.1 9.1 9.1 8.9 7.3 9.7 9.0 8.6 15.8 6.2 11.4 12.8 RCC1 CHC1 ENSG00000180198 "Regulator of chromosome condensation 1" P18754 1 28505943-28539300 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015413, HPA027573, HPA027574" Enhanced Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236" "unprognostic (6.23e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.91e-5)" "unprognostic (3.93e-2)" "unprognostic (2.03e-3)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (8.50e-2)" "prognostic unfavourable (2.43e-11)" "unprognostic (1.04e-2)" "unprognostic (2.78e-1)" "unprognostic (3.02e-1)" "unprognostic (6.23e-2)" 12.3 11.2 7.5 21.1 10.9 32.0 13.9 5.8 10.4 11.6 17.9 5.0 8.0 17.5 12.1 10.1 30.1 12.6 8.6 6.9 8.0 4.6 9.5 23.0 15.3 22.7 14.8 4.0 16.3 21.0 4.7 12.4 17.0 9.8 10.2 19.0 6.0 20.6 7.8 13.6 11.7 14.7 12.7 17.7 23.0 11.8 46.7 10.2 34.2 47.9 28.4 34.2 16.4 16.7 8.4 16.0 4.6 8.7 6.2 11.5 6.9 47.7 20.7 18.0 21.3 12.9 16.7 20.2 18.7 11.4 30.5 23.9 20.6 38.5 61.4 11.5 18.0 28.8 58.7 29.8 24.0 24.8 35.0 54.2 25.3 27.0 9.7 59.0 32.5 21.1 19.9 29.4 24.2 20.8 40.4 19.0 12.3 25.9 47.0 21.4 38.7 20.3 46.7 31.8 29.9 11.3 22.4 29.0 14.8 20.3 32.3 15.6 13.6 18.5 15.9 15.7 31.1 19.2 36.4 11.5 16.3 46.9 15.3 87.3 16.9 4.6 8.7 3.2 6.2 8.7 11.5 8.4 9.2 9.6 16.0 7.7 8.3 9.1 1.9 6.2 6.2 9.1 8.4 6.9 7.5 10.9 5.8 10.4 8.0 4.6 14.8 4.0 9.8 10.2 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA052184: , HPA060643: " "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavourable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 7.4 8.5 4.4 7.0 5.1 4.2 3.3 4.3 5.6 5.8 6.4 7.0 7.2 6.4 5.0 4.8 7.4 4.8 7.7 11.5 3.7 7.9 12.0 3.9 5.5 5.6 4.0 7.1 9.1 4.9 3.3 6.5 3.8 7.2 3.2 7.3 7.8 6.4 33.4 4.3 6.0 9.5 2.3 6.8 4.8 5.4 5.7 3.6 8.7 8.4 6.8 5.8 7.7 6.8 5.5 4.8 4.9 6.7 9.2 2.6 15.1 23.4 12.4 20.9 8.8 7.2 17.0 14.9 10.7 12.8 10.6 23.5 18.8 16.1 6.8 12.0 18.0 10.4 10.0 5.3 17.8 16.6 12.0 15.6 21.9 12.6 19.0 19.4 9.0 8.2 11.1 9.1 11.3 38.1 10.5 9.9 32.4 0.8 28.9 28.8 18.3 9.2 10.0 33.8 11.1 13.8 13.4 20.1 19.9 42.3 18.2 29.8 19.9 12.7 16.9 14.2 15.1 19.3 11.8 9.4 25.5 13.0 20.2 22.3 4.8 3.8 2.2 7.3 4.9 5.7 5.7 7.8 6.4 5.3 6.8 7.5 9.2 1.4 6.7 3.5 5.5 5.9 2.6 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 5.2 9.9 6.1 12.5 8.1 6.1 17.3 14.3 7.0 5.3 9.2 3.3 5.8 8.0 6.4 5.9 9.2 6.2 8.7 6.2 5.5 6.7 8.5 11.3 6.6 5.7 8.4 1.5 8.2 12.1 9.3 3.2 9.4 6.0 5.6 7.4 3.1 8.2 6.2 5.2 11.8 9.7 8.6 5.6 10.1 6.5 18.9 7.2 21.9 11.0 8.3 14.5 6.4 5.7 3.1 2.3 0.1 2.0 1.7 2.9 0.8 4.8 7.2 1.7 3.6 4.2 5.1 12.8 5.6 1.0 1.6 1.7 3.4 9.3 17.1 9.1 3.4 10.5 5.5 1.5 2.8 14.3 11.3 12.3 12.2 4.9 3.5 5.9 4.9 3.7 5.0 1.7 2.3 2.7 9.3 11.3 4.9 1.6 7.0 6.1 6.5 3.0 8.4 8.6 18.2 7.6 2.2 5.6 6.4 9.7 6.3 6.6 7.2 11.4 4.2 1.0 7.2 4.1 0.2 20.3 8.3 10.2 1.9 13.0 4.8 0.1 0.7 0.1 0.8 2.0 2.1 3.1 1.7 2.7 1.6 2.1 2.9 1.0 0.1 1.7 1.1 2.3 2.1 0.8 6.1 8.1 14.3 7.0 5.5 6.7 8.4 1.5 6.0 7.2 RCHY1 "ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363" ENSG00000163743 "Ring finger and CHY zinc finger domain containing 1" Q96PM5 4 75479037-75514764 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030338, HPA030339" Approved Supported Nucleoplasm,Vesicles,Cytosol Cytosol "Nucleoplasm, Vesicles" "HPA030338: , HPA030339: AB_10603232" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "prognostic favourable (9.09e-4)" "unprognostic (1.90e-1)" "unprognostic (3.45e-3)" "unprognostic (1.19e-2)" "unprognostic (7.87e-3)" "unprognostic (5.82e-2)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.60e-2)" "prognostic favourable (3.62e-5)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "prognostic favourable (7.89e-5)" 8.8 12.1 15.7 9.9 20.1 15.6 17.8 20.7 16.8 10.2 12.7 9.8 8.7 9.0 11.0 7.5 8.4 12.9 7.2 17.6 14.1 16.2 17.1 12.5 10.4 12.2 15.9 15.7 16.2 10.6 14.9 13.0 10.5 17.1 12.0 14.2 7.7 12.3 11.3 29.7 5.9 9.2 12.4 16.7 12.2 10.3 13.4 15.4 14.9 20.3 8.0 12.7 9.7 12.1 4.4 7.4 18.9 8.8 4.6 7.4 4.3 6.0 3.1 9.4 8.7 9.9 8.7 5.4 4.1 9.6 8.5 10.0 8.6 7.5 10.1 7.8 5.9 3.6 23.8 7.2 13.0 8.2 7.8 13.1 5.9 11.0 8.5 17.6 7.2 8.0 9.1 9.7 9.2 17.1 12.0 10.3 19.8 9.8 16.1 7.1 15.6 5.5 8.7 22.1 8.5 13.2 10.4 14.5 8.0 6.7 15.8 17.4 8.9 8.0 6.7 5.6 5.6 5.0 6.8 10.9 7.8 14.3 6.8 12.5 8.8 18.9 8.8 8.5 4.3 5.2 7.4 4.4 5.3 5.0 7.4 2.2 3.9 5.5 3.7 4.6 4.7 3.8 5.2 4.3 15.7 20.1 20.7 16.8 14.1 16.2 15.9 15.7 17.1 15.4 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49527618-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.2;ASC TERT1: 36.1;BJ: 57.0;BJ hTERT+ SV40 Large T+ RasG12V: 33.0;fHDF/TERT166: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "HPA043134: , HPA050402: " "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 19.6 10.9 3.7 18.2 5.3 3.2 15.6 7.2 6.6 36.3 10.7 2.0 9.6 22.2 28.2 33.9 11.4 10.7 26.2 18.2 3.4 3.5 12.6 18.6 12.6 4.4 3.3 2.8 29.5 5.1 2.1 9.0 18.0 6.0 19.4 7.0 10.7 6.2 8.2 10.6 8.2 23.7 16.8 2.9 21.3 7.8 17.3 4.2 1.8 9.9 9.8 7.9 21.5 21.6 0.6 0.5 3.9 0.4 2.3 9.7 1.6 0.5 0.8 0.5 30.3 52.2 36.1 0.3 57.0 14.8 21.5 33.0 0.7 0.2 0.2 3.4 49.8 0.0 1.4 0.1 10.3 0.0 0.4 3.2 0.2 1.6 18.3 0.0 7.5 20.3 0.0 15.0 0.0 8.2 1.4 0.1 17.5 0.6 0.0 0.3 0.2 3.9 0.1 0.7 0.9 0.2 0.0 0.3 1.9 0.0 0.2 0.0 0.2 2.0 19.2 0.3 9.6 24.9 0.0 2.8 8.3 0.5 1.4 1.8 2.4 0.0 0.3 2.2 0.9 0.0 1.0 0.6 2.5 0.9 0.5 0.4 9.7 3.2 3.9 2.3 0.4 0.4 1.9 1.6 3.7 5.3 7.2 6.6 3.4 3.5 3.3 2.8 6.0 4.2 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell line enhanced" "Detected in some" "AF22: 17.7;NTERA-2: 22.8;SCLC-21H: 35.8;SH-SY5Y: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 17.7 1.2 0.2 1.5 5.3 0.1 0.3 0.2 0.6 0.6 0.1 0.1 0.2 0.4 0.2 7.7 0.0 0.2 0.2 0.9 0.2 0.1 5.6 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.1 0.9 0.0 0.0 1.5 1.6 6.2 22.8 0.0 5.7 1.0 0.5 0.0 0.0 35.8 23.9 0.1 1.6 0.8 1.3 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favourable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favourable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.1 15.0 17.2 14.9 19.6 25.8 18.9 33.7 21.7 17.3 16.2 17.3 26.8 11.8 19.1 21.9 13.5 16.0 17.1 20.8 16.3 14.4 15.7 13.5 15.8 15.3 18.8 20.8 27.5 18.2 21.4 23.8 14.1 18.6 23.7 13.4 17.3 18.0 35.5 55.3 17.7 16.5 23.6 18.1 17.5 14.4 31.4 21.3 20.6 30.0 16.4 13.4 17.9 16.3 10.0 9.5 27.3 8.5 11.8 10.7 5.4 9.8 7.7 15.8 8.8 13.7 12.8 17.5 11.2 11.2 12.7 13.2 7.6 12.9 14.5 7.9 14.4 14.8 12.6 11.0 9.8 14.8 7.4 13.1 13.9 10.0 15.3 19.9 12.7 14.2 10.5 13.7 17.0 7.8 13.6 18.1 18.3 6.5 10.2 11.5 17.3 9.5 11.2 30.5 16.5 10.5 17.0 10.1 22.0 28.7 15.0 20.9 18.7 14.3 10.7 11.3 12.8 14.5 12.5 16.0 10.5 18.1 9.4 11.9 9.9 15.3 8.1 27.3 6.0 7.5 7.9 10.0 6.5 6.2 8.5 8.0 10.7 7.6 13.7 11.8 8.5 9.5 7.6 5.4 17.2 19.6 33.7 21.7 16.3 14.4 18.8 20.8 18.6 21.3 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favourable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 3.2 3.8 2.3 0.2 1.6 10.2 2.0 4.7 3.8 0.9 4.8 1.4 1.3 0.9 1.9 1.4 2.8 4.0 1.0 0.7 5.2 0.8 3.2 0.8 4.7 2.5 1.0 10.1 1.3 5.5 2.2 2.7 2.8 8.0 3.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056686 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056686: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.3 5.8 4.9 4.0 14.8 15.8 16.6 11.2 11.6 10.2 10.2 4.5 9.6 18.1 6.7 6.7 10.0 7.1 13.1 11.9 10.0 19.5 7.1 6.4 13.6 12.7 8.6 9.6 12.0 13.4 9.8 15.5 9.3 12.6 6.2 16.6 5.9 7.4 15.1 13.3 16.6 10.8 13.4 7.8 19.9 12.0 7.6 13.2 6.1 13.5 15.9 6.7 4.9 9.4 14.5 8.9 11.4 13.3 17.6 14.5 13.4 10.3 5.9 11.3 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Cell line enhanced" "Detected in many" "CACO-2: 10.6;T-47d: 17.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: " "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 6.0 7.1 1.3 2.5 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.6 6.0 6.6 2.9 0.4 0.9 4.1 1.7 4.1 1.5 8.3 4.2 1.8 0.0 0.0 0.2 3.0 0.0 0.8 0.5 0.4 0.1 1.8 0.0 0.6 2.4 2.3 2.3 0.9 2.6 0.8 0.0 0.0 1.6 3.4 4.8 0.8 1.9 1.8 2.6 17.4 0.4 0.0 0.1 2.1 0.0 0.4 5.5 2.0 2.3 3.4 2.4 1.1 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296722 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 81.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" 77000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 15.9 81.0 17.9 7.0 29.2 4.2 22.3 9.3 20.2 14.7 10.1 19.5 11.1 2.9 12.7 9.1 11.9 8.8 11.6 16.9 20.8 17.0 21.7 28.6 20.4 8.7 27.5 15.2 23.7 22.0 16.0 16.1 16.4 31.6 11.3 4.9 7.4 9.0 11.9 35.5 5.5 5.3 14.9 50.4 10.6 8.3 13.9 30.6 3.5 19.7 11.8 5.9 13.4 11.9 9.4 9.6 17.1 11.4 13.1 15.8 5.6 17.1 9.1 36.3 14.3 21.3 23.8 20.7 21.8 12.4 14.4 15.9 25.5 30.0 0.0 33.5 26.9 15.8 20.1 20.8 21.6 10.3 11.1 12.7 30.4 18.8 20.0 4.6 8.8 24.2 11.9 17.9 32.2 39.1 18.1 7.7 33.3 30.3 2.7 3.8 11.5 14.9 7.9 25.4 7.4 18.3 8.6 9.9 10.7 38.3 17.4 13.7 22.3 7.6 24.1 24.0 17.8 11.5 16.9 2.5 4.1 16.6 9.1 2.8 55.1 17.1 11.4 16.5 9.4 9.4 12.5 9.4 8.4 6.9 9.6 6.1 5.7 4.6 1.3 13.1 7.1 7.8 15.8 5.6 17.9 29.2 9.3 19.0 20.8 17.0 27.5 15.2 31.6 30.6 RECQL5 "FLJ90603, RecQ5" ENSG00000108469 "RecQ like helicase 5" O94762 17 75626845-75667189 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029971 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029971: AB_10611389" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "prognostic unfavourable (1.73e-6)" "unprognostic (8.39e-2)" "unprognostic (2.34e-2)" "unprognostic (3.57e-3)" "unprognostic (5.83e-2)" "unprognostic (3.15e-1)" "unprognostic (5.84e-2)" "prognostic favourable (4.34e-4)" "unprognostic (4.07e-2)" "unprognostic (7.01e-2)" "unprognostic (6.37e-2)" "unprognostic (1.42e-1)" "unprognostic (4.78e-1)" "unprognostic (1.81e-2)" 7.4 12.9 12.6 11.7 16.0 10.0 9.8 11.4 17.7 9.4 10.6 24.4 17.4 22.9 10.5 13.2 20.4 11.8 12.4 6.7 12.9 8.6 14.9 15.8 8.4 16.8 14.5 11.0 14.3 10.8 17.6 21.9 32.3 14.3 12.2 9.8 13.2 15.6 14.0 6.8 21.1 23.2 9.6 13.2 16.6 23.8 21.0 17.0 12.1 21.4 6.2 16.0 12.1 12.8 5.2 16.4 6.0 3.9 3.8 4.2 3.2 11.0 20.5 8.3 11.7 11.6 7.8 19.1 8.2 6.9 10.7 9.5 9.0 11.8 13.1 8.9 7.2 10.5 8.6 9.8 10.2 7.0 16.1 23.9 24.8 13.0 11.6 7.7 11.9 11.0 12.1 10.6 12.8 13.9 12.0 11.7 7.9 9.8 15.8 10.5 5.4 15.9 12.8 19.4 13.2 9.0 13.2 10.0 9.7 8.9 16.1 11.0 28.9 6.2 7.0 13.8 15.9 7.5 8.4 16.7 9.5 12.6 11.3 7.7 9.9 6.0 3.1 4.4 4.2 3.9 2.7 3.6 2.7 3.1 3.8 5.2 4.1 2.9 2.1 3.8 1.9 16.4 2.2 3.2 12.6 16.0 11.4 17.7 12.9 8.6 14.5 11.0 14.3 17.0 RELB REL-B ENSG00000104856 "RELB proto-oncogene, NF-kB subunit" Q01201 19 45001430-45038198 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.0;HDLM-2: 31.8;U-698: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007753, HPA040506" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB007753: AB_562340, HPA040506: " "prognostic favourable (1.55e-4)" "unprognostic (1.20e-1)" "unprognostic (7.13e-2)" "unprognostic (5.52e-2)" "unprognostic (1.12e-2)" "unprognostic (3.41e-2)" "unprognostic (1.71e-2)" "unprognostic (4.30e-2)" "unprognostic (5.81e-3)" "unprognostic (1.02e-3)" "unprognostic (6.01e-2)" "unprognostic (6.48e-2)" "prognostic unfavourable (2.99e-6)" "unprognostic (2.68e-2)" "unprognostic (4.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.20e-2)" 8.0 6.8 2.2 27.6 3.6 27.8 6.8 1.2 3.1 4.9 12.2 2.1 1.6 8.8 8.5 4.7 6.4 5.2 10.9 11.9 1.8 1.6 10.1 7.4 12.8 18.2 3.6 0.9 7.8 12.3 1.9 2.1 4.7 2.8 9.9 3.4 3.6 7.3 4.8 8.1 8.3 13.0 8.4 3.9 17.2 8.3 3.7 1.7 17.7 5.6 7.2 24.8 8.8 6.1 8.2 3.9 14.5 5.0 2.1 2.2 1.7 8.7 5.3 0.5 2.3 1.1 3.9 1.8 1.6 11.4 2.5 4.0 1.8 9.7 25.0 4.6 2.6 4.0 0.2 3.6 2.1 31.8 0.8 0.9 0.3 1.0 10.2 1.9 14.9 6.4 1.5 5.1 6.0 1.6 0.2 16.3 0.9 2.1 0.4 5.9 0.8 0.9 1.9 1.3 3.0 4.1 13.6 0.0 0.8 1.6 4.7 4.5 1.6 4.8 5.1 6.0 3.0 2.2 5.8 20.6 12.1 26.8 6.6 0.7 3.3 0.0 5.0 2.1 1.4 3.2 2.1 8.2 2.2 2.0 3.6 7.9 1.8 0.9 14.5 2.1 2.6 3.9 1.1 1.7 2.2 3.6 1.2 3.1 1.8 1.6 3.6 0.9 2.8 1.7 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 21.1 3.0 5.5 6.2 9.7 28.8 19.3 6.4 6.5 8.4 10.4 6.5 2.8 7.2 8.3 7.8 9.8 7.3 9.7 12.1 5.1 5.0 4.9 5.5 10.4 14.6 9.1 2.1 8.9 4.0 2.6 3.2 20.7 17.9 6.2 7.5 8.1 5.3 5.0 10.1 11.5 8.6 11.1 28.2 10.9 14.7 4.1 5.3 6.0 18.1 9.6 6.6 15.6 13.3 0.1 3.2 16.1 4.0 0.9 1.7 1.3 2.8 3.7 9.0 6.4 6.2 5.2 7.1 5.1 5.3 4.5 5.7 11.4 3.5 0.6 3.9 4.7 2.7 2.9 5.4 7.1 0.0 1.5 1.1 3.1 9.8 3.7 4.2 2.9 7.0 4.4 5.5 5.5 18.0 2.2 2.9 3.3 2.4 4.4 2.2 1.8 1.1 1.6 32.6 1.5 4.4 4.2 2.0 5.6 4.7 3.5 4.5 12.1 1.4 21.4 9.1 5.3 6.9 5.7 1.5 1.6 4.8 8.3 6.7 6.9 0.0 4.0 2.5 1.3 0.8 1.2 0.1 1.2 1.1 1.6 0.0 1.1 1.7 16.1 0.9 0.5 3.2 1.1 1.3 5.5 9.7 6.4 6.5 5.1 5.0 9.1 2.1 17.9 5.3 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471784-103989516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 73.4;liver: 35.8" "Cell line enhanced" "Detected in some" "Hep G2: 33.6;PC-3: 6.8;SCLC-21H: 8.2;SH-SY5Y: 8.9;TIME: 19.5" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Region enriched" "Detected in many" 11 "cerebellum: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046512 Approved "Plasma membrane,Focal adhesion sites" "Secreted to extracellular matrix" 59000000 "Focal adhesion sites" "Plasma membrane" "HPA046512: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 2.7 5.9 5.7 1.2 5.3 0.5 6.3 73.4 6.7 2.9 2.1 0.8 0.0 1.1 1.0 3.0 1.7 4.4 1.9 3.2 5.7 5.3 1.2 35.8 1.6 7.9 1.8 2.5 1.3 1.0 0.3 0.8 0.4 5.1 1.2 2.1 10.6 1.1 2.1 0.4 1.1 1.9 2.4 3.2 1.1 0.8 1.5 0.0 0.0 2.6 1.7 0.9 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.2 0.0 0.1 0.0 0.0 2.4 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 1.4 0.0 0.0 0.0 8.2 8.9 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 5.3 73.4 6.7 5.7 5.3 1.8 2.5 5.1 0.0 REPS1 ENSG00000135597 "RALBP1 associated Eps domain containing 1" Q96D71 6 138903493-138988261 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029961, HPA029962" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA029961: AB_10603233, HPA029962: " "unprognostic (1.72e-3)" "unprognostic (9.61e-2)" "unprognostic (5.82e-3)" "unprognostic (2.77e-2)" "unprognostic (6.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavourable (9.47e-4)" "unprognostic (3.79e-1)" "unprognostic (2.49e-1)" "unprognostic (9.71e-3)" "unprognostic (4.29e-3)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.27e-1)" "unprognostic (3.83e-2)" "unprognostic (2.69e-2)" 9.5 9.4 18.9 11.5 22.0 15.5 18.4 25.9 25.5 12.9 12.9 14.8 15.3 11.7 17.5 32.5 20.9 14.6 14.0 17.7 17.7 17.6 12.1 23.1 11.5 13.3 15.1 19.4 17.0 13.9 32.8 28.3 14.0 20.0 13.6 13.7 13.6 21.6 13.4 12.1 22.6 12.2 16.3 10.8 15.8 12.4 27.7 11.7 30.7 13.9 13.5 18.4 14.7 14.3 4.6 6.2 8.0 7.5 5.2 6.9 2.0 12.7 10.1 19.4 24.1 10.9 19.6 21.2 12.5 13.8 14.7 17.7 24.0 11.2 15.5 10.6 17.3 15.1 22.0 18.8 19.5 16.4 18.9 13.0 6.1 14.5 16.6 41.1 21.1 15.9 15.5 26.8 32.6 15.1 17.3 16.0 18.7 21.6 23.2 22.5 18.4 9.6 27.3 11.9 8.8 12.1 19.4 17.3 17.1 11.5 17.6 16.4 8.4 28.4 14.7 8.2 13.7 22.2 17.1 15.8 14.3 21.7 9.7 17.0 11.9 8.0 2.3 3.2 4.2 6.5 6.9 4.6 5.4 5.8 3.4 3.4 5.5 6.5 1.5 5.2 7.5 6.2 5.4 2.0 18.9 22.0 25.9 25.5 17.7 17.6 15.1 19.4 20.0 11.7 REST "NRSF, XBR" ENSG00000084093 "RE1 silencing transcription factor" Q13127 4 56907876-56966678 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006079, CAB068222" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB068222: , HPA006079: AB_1079801" "unprognostic (7.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (1.39e-1)" "unprognostic (7.47e-3)" "unprognostic (2.30e-1)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (4.32e-3)" "unprognostic (1.73e-1)" "prognostic favourable (9.50e-5)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" 14.4 11.4 6.0 15.6 8.9 21.5 39.7 2.1 6.3 13.7 11.0 5.6 13.0 6.5 14.2 13.7 14.5 11.2 13.8 22.1 6.1 4.5 13.9 12.0 18.2 35.6 8.2 3.0 13.9 15.9 22.4 4.5 14.4 11.8 17.3 7.6 7.2 14.0 27.6 13.8 11.6 12.0 16.3 15.2 18.7 10.4 15.3 8.2 43.4 13.4 8.3 14.0 15.6 19.5 16.7 10.7 9.0 8.4 16.7 15.3 4.2 7.0 9.0 12.5 12.4 9.4 11.9 15.8 10.5 9.4 11.3 10.3 8.9 10.9 16.9 16.9 11.4 6.5 9.2 11.1 17.8 8.9 5.5 15.4 7.1 7.9 11.5 19.4 9.2 11.7 10.0 10.8 11.2 13.9 9.8 18.2 13.0 11.2 22.3 13.2 10.6 5.9 19.8 10.7 5.2 12.8 12.8 0.2 5.7 12.7 12.4 9.4 13.2 12.7 19.6 14.4 12.8 8.0 9.4 7.3 5.4 10.2 9.2 11.0 7.4 9.0 3.6 7.7 10.6 5.3 8.9 12.0 10.5 10.4 8.1 16.7 15.3 9.3 3.7 16.7 8.4 10.7 10.3 4.2 6.0 8.9 2.1 6.3 6.1 4.5 8.2 3.0 11.8 8.2 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell line enhanced" "Detected in some" "MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavourable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 11.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 89.7 0.0 0.0 0.0 1.2 26.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favourable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.4 20.2 8.9 14.4 22.9 12.7 12.7 9.3 12.7 11.1 13.1 9.5 14.1 14.3 13.1 15.1 25.5 11.4 14.0 10.8 15.3 10.9 5.8 12.3 16.9 15.7 9.9 15.0 19.4 19.2 12.1 12.4 11.9 11.8 14.3 8.7 11.2 14.5 14.5 5.6 5.0 7.9 13.8 14.6 12.7 21.0 16.0 11.0 10.0 8.2 14.1 23.2 7.8 14.9 12.1 7.4 11.9 8.8 24.6 29.2 12.7 11.0 6.4 9.1 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 REXO1 "EloA-BP1, KIAA1138, TCEB3BP1" ENSG00000079313 "RNA exonuclease 1 homolog" Q8N1G1 19 1815246-1848463 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042155, HPA042552" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA042155: AB_10806233, HPA042552: AB_10794280" "unprognostic (1.36e-1)" "unprognostic (3.86e-3)" "unprognostic (7.52e-2)" "unprognostic (3.70e-3)" "unprognostic (4.21e-2)" "unprognostic (2.38e-3)" "unprognostic (7.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-3)" "unprognostic (3.75e-2)" "unprognostic (2.87e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-2)" 10.9 17.6 15.6 11.9 19.5 19.3 11.5 13.0 25.4 6.2 9.3 10.3 3.4 12.1 9.5 5.5 8.3 7.7 7.8 7.7 14.0 5.9 8.3 10.3 9.0 14.2 8.6 10.3 9.7 16.1 5.1 6.6 13.7 8.9 7.8 5.6 7.6 11.1 7.1 13.8 14.2 11.7 9.4 5.7 20.0 10.4 31.7 11.6 9.6 7.8 6.2 9.7 7.8 9.0 1.4 1.2 2.0 0.8 0.7 1.4 1.0 11.9 7.7 7.1 11.0 2.8 3.7 14.4 8.7 4.7 6.4 5.7 10.0 6.7 10.3 5.9 6.0 10.6 5.3 9.7 2.8 16.3 8.3 10.8 8.4 5.8 6.5 9.5 17.8 6.5 5.6 8.4 5.6 5.8 16.2 17.9 3.3 7.5 15.7 10.7 16.0 7.6 14.1 5.9 9.7 4.2 6.8 10.5 11.5 5.4 9.2 11.2 8.0 14.1 10.0 10.1 8.8 16.8 14.5 29.2 14.0 8.9 8.1 11.5 13.0 1.3 0.8 0.5 1.0 0.7 0.8 0.6 0.8 0.6 0.6 1.4 1.1 1.4 2.0 0.7 0.8 1.2 0.3 1.0 15.6 19.5 13.0 25.4 14.0 5.9 8.6 10.3 8.9 11.6 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favourable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavourable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.4 16.0 6.2 16.6 49.9 53.0 14.8 46.5 36.4 23.5 30.0 41.9 47.0 15.1 46.9 41.1 17.5 13.9 41.2 38.9 14.6 10.8 16.6 22.1 26.0 65.6 12.1 5.3 36.6 39.5 29.7 31.6 42.0 30.7 9.3 52.6 6.5 8.8 15.2 19.1 28.3 7.8 20.2 54.9 33.7 22.3 11.0 6.9 21.4 16.5 19.6 33.6 6.3 39.7 30.3 36.3 23.3 28.5 7.3 8.7 25.5 20.9 28.6 16.1 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047006: " "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavourable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favourable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 9.9 13.7 16.9 15.1 18.4 10.9 14.5 21.6 18.3 12.7 11.9 11.9 13.2 13.8 14.5 10.7 15.5 13.5 11.2 14.6 13.8 11.8 12.0 19.3 9.7 18.3 18.0 13.2 22.2 21.4 13.3 14.6 14.1 15.4 13.7 10.1 8.8 14.9 13.1 36.4 15.1 13.5 11.9 16.1 16.9 13.0 18.7 18.4 15.0 15.2 9.1 16.3 12.5 21.3 5.5 3.6 3.3 2.5 7.2 5.2 1.8 5.7 13.5 6.3 9.3 6.6 6.9 11.3 10.0 5.7 10.6 7.0 16.0 7.5 18.9 6.8 5.4 15.8 13.2 10.5 6.1 12.2 12.3 10.2 14.3 12.5 8.3 23.3 10.0 6.4 8.9 11.1 15.3 7.7 22.4 8.3 6.7 16.7 16.3 14.0 12.8 19.5 11.6 10.4 18.8 6.7 5.5 18.2 9.9 10.6 12.4 11.4 15.2 9.4 6.7 19.4 10.1 9.2 12.2 5.5 6.7 13.0 7.2 13.5 11.5 0.7 2.5 3.3 3.9 2.5 4.3 4.7 4.0 4.0 2.0 5.5 5.1 5.2 0.1 7.2 2.0 3.6 3.4 1.8 16.9 18.4 21.6 18.3 13.8 11.8 18.0 13.2 15.4 18.4 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell line enhanced" "Detected in many" "K-562: 24.1;U-266/70: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Low region specificity" "Detected in all" "HPA040755, HPA040868" Enhanced Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549" "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.3 3.5 5.7 2.5 2.3 4.8 1.9 4.2 4.7 4.7 5.3 2.6 5.5 3.9 6.8 3.6 3.2 4.3 1.9 5.0 4.0 3.1 6.4 5.4 3.6 0.5 9.5 9.4 2.2 0.8 5.5 7.2 1.6 24.1 17.3 11.5 8.2 1.5 7.2 3.1 3.7 7.7 10.6 6.9 1.4 2.1 5.1 5.7 4.0 5.4 1.3 9.2 8.1 0.8 3.5 3.1 4.6 5.1 24.9 16.8 1.5 7.3 12.3 3.3 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favourable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavourable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 11.0 9.5 16.1 15.8 15.4 23.0 15.3 13.9 16.6 10.1 12.8 10.0 5.0 8.6 10.0 9.4 17.9 10.1 9.0 9.1 12.1 9.1 10.1 23.0 10.6 20.4 12.3 14.0 11.7 15.1 10.9 8.6 17.5 15.1 11.0 15.0 8.9 12.2 8.1 16.5 18.8 10.0 12.7 14.8 14.2 12.2 13.5 14.0 22.1 10.4 14.7 28.5 9.9 11.6 22.4 18.7 27.5 24.2 24.8 13.6 15.8 23.1 18.0 21.0 20.8 4.3 5.1 9.6 13.6 15.0 27.7 33.4 19.9 21.6 21.8 3.8 9.6 15.9 17.1 22.7 28.8 15.6 29.7 13.3 25.1 14.7 3.4 20.0 8.3 5.2 5.1 26.0 18.0 14.8 27.6 13.5 21.3 27.3 19.8 38.8 23.9 15.2 29.6 23.4 27.3 14.8 18.7 17.1 21.7 16.1 30.5 11.1 22.1 18.4 5.7 27.4 18.2 21.1 30.3 8.3 10.7 37.9 13.9 30.9 28.5 19.5 22.0 15.6 11.4 24.2 11.7 19.0 9.9 10.4 18.7 22.4 12.6 9.5 27.5 24.8 22.4 10.0 13.6 15.8 16.1 15.4 13.9 16.6 12.1 9.1 12.3 14.0 15.1 14.0 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818049-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 8.0 17.7 5.7 19.1 7.2 14.4 10.9 19.9 10.2 7.9 7.5 5.6 5.9 6.9 11.6 8.9 10.3 7.0 6.5 6.2 5.2 5.5 5.4 6.2 6.6 19.1 4.7 5.6 9.6 7.6 3.7 5.9 14.2 8.6 5.7 10.3 7.0 7.8 4.6 6.1 7.5 7.0 6.6 5.6 11.8 6.3 17.8 3.7 34.7 6.1 9.7 19.2 5.2 7.0 8.2 7.9 8.5 7.5 3.3 8.3 4.1 11.4 11.5 22.0 17.7 1.7 2.7 11.9 16.0 7.4 21.5 18.7 15.1 17.8 43.1 6.7 6.2 17.7 27.7 11.3 29.1 16.5 16.6 24.9 13.4 16.3 1.9 30.1 12.0 2.5 1.5 18.5 12.8 7.1 17.3 10.9 12.9 13.4 25.4 14.4 25.8 10.0 9.5 25.6 9.9 6.4 10.3 11.4 20.1 12.0 16.2 8.4 13.0 16.7 3.7 11.4 12.7 14.4 17.0 6.1 8.3 69.1 8.2 17.9 21.7 1.6 5.7 8.5 4.5 7.5 4.9 8.2 5.5 4.7 7.9 7.8 7.4 6.3 1.3 3.3 6.5 3.3 8.3 4.1 5.7 7.2 19.9 10.2 5.2 5.5 4.7 5.6 8.6 3.7 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "stomach 1: 118.3" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 10.0;HUVEC TERT2: 14.2;LHCN-M2: 24.8;RH-30: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058911: , HPA078021: " "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavourable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 5.5 3.0 6.4 5.2 8.6 2.6 8.2 10.8 6.6 11.7 20.9 9.7 7.0 19.5 4.8 4.8 3.0 5.5 3.7 5.1 6.3 6.3 5.4 5.3 3.2 2.8 9.8 5.2 5.2 7.6 2.7 9.4 3.4 9.0 6.3 15.4 6.3 8.7 5.4 8.5 4.2 20.7 3.4 8.3 2.8 118.3 2.7 8.3 1.9 9.6 2.3 2.8 3.3 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.3 1.2 0.9 0.0 0.1 3.5 0.0 1.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.5 0.0 10.0 0.0 14.2 0.0 0.0 24.8 0.0 0.0 0.0 2.1 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.6 10.8 6.6 6.3 6.3 9.8 5.2 9.0 8.3 RFLNB "Cfm1, FAM101B, MGC45871, RefilinB" ENSG00000183688 "Refilin B" Q8N5W9 17 439978-445939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 48.4;bone marrow: 40.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.4;HMC-1: 66.0;NB-4: 21.1;U-937: 18.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 48.4" "Lineage enriched" "Detected in many" 16 "granulocytes: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030879, HPA060388" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" "Actin filaments" "Plasma membrane, Cytosol" "HPA030879: , HPA060388: " "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (3.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.87e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (3.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-3)" 6.8 1.6 1.9 4.1 2.3 40.9 5.6 1.1 1.5 2.6 4.9 1.8 4.2 2.2 1.1 2.1 2.7 3.7 2.1 1.5 2.7 1.7 5.2 2.9 1.8 1.8 1.0 0.8 1.3 6.3 3.6 1.1 1.2 1.7 2.8 1.9 3.2 3.6 2.3 4.1 3.2 0.9 3.0 2.7 4.5 1.4 0.0 2.5 48.4 2.1 0.5 3.0 1.0 8.6 2.3 1.1 5.5 3.9 2.8 6.1 14.1 6.2 4.7 2.3 0.1 0.3 0.0 0.3 27.4 0.8 3.2 0.3 4.3 0.0 1.9 0.3 0.4 0.6 5.7 3.2 66.0 1.5 0.1 1.4 0.5 4.7 1.3 0.1 5.2 0.1 0.1 21.1 2.5 0.0 0.9 2.5 0.0 0.8 0.0 0.1 12.9 5.7 0.0 5.0 0.1 9.9 0.9 3.7 3.3 2.2 0.0 2.1 2.1 0.0 0.0 18.3 5.7 48.4 2.1 21.6 1.8 1.4 1.8 0.0 1.8 1.5 0.6 0.0 3.0 2.7 10.2 0.5 1.8 2.5 1.1 1.0 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 0.7 0.0 1.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.7 2.7 0.0 0.0 0.0 5.2 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell line enhanced" "Detected in some" "A549: 2.4;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: , HPA072380: " "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.4 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;NB-4: 4.7;U-266/70: 5.5;U-266/84: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA048320: , HPA072380: " "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 2.3 1.1 0.1 0.1 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.8 1.3 4.7 0.2 0.1 2.4 0.5 0.6 0.0 0.4 1.7 0.5 0.1 0.4 1.3 0.0 0.4 0.0 0.0 0.9 0.3 0.0 5.5 5.4 0.1 0.1 1.6 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 RFPL4A "RFPL4, RNF210" ENSG00000223638 "Ret finger protein like 4A" A6NLU0 19 55759014-55763175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8" "Cell line enriched" "Detected in some" 17 "U-2 OS: 43.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.9" "Cell type enhanced" "Detected in some" "classical monocyte: 12.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 12.7" HPA046368 Uncertain Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA046368: " "unprognostic (3.74e-1)" "unprognostic (2.96e-2)" "unprognostic (9.20e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.2 0.0 0.1 0.2 0.0 0.0 0.0 0.4 7.1 0.0 0.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.4 3.8 0.0 0.1 0.0 0.0 0.0 3.8 1.7 12.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 43.7 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 12.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.7 0.0 0.8 0.0 0.0 2.8 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769141-55773179 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5" "Cell line enriched" "Detected in some" 24 "U-2 OS: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;myeloid DC: 2.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.5;monocytes: 5.4" HPA046368 Uncertain Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA046368: " "unprognostic (8.87e-2)" 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.0 0.0 0.3 3.0 0.0 0.4 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 2.3 0.2 1.5 0.3 0.0 0.3 0.0 0.0 2.5 0.4 5.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.2 RFWD3 "FANCW, FLJ10520, RNF201" ENSG00000168411 "Ring finger and WD repeat domain 3" Q6PCD5 16 74621394-74666881 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048258, HPA075649" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA048258: , HPA075649: " "unprognostic (4.79e-2)" "unprognostic (6.45e-3)" "unprognostic (6.35e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-3)" "unprognostic (5.04e-2)" "unprognostic (3.64e-2)" "unprognostic (1.01e-1)" "unprognostic (4.03e-3)" "unprognostic (2.53e-3)" "unprognostic (1.73e-3)" "unprognostic (2.84e-1)" "unprognostic (4.31e-1)" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" 7.3 5.2 4.2 12.2 6.1 33.9 7.8 7.8 5.6 7.4 6.7 8.4 8.4 5.5 9.7 10.0 12.8 6.3 5.5 5.4 3.9 3.7 6.5 5.6 6.5 12.0 6.1 4.8 7.7 9.6 8.5 7.5 11.5 5.3 6.5 8.1 7.2 8.0 8.4 4.5 11.6 7.8 5.6 4.8 9.7 6.2 35.1 7.2 40.5 7.0 7.5 18.0 7.2 8.6 9.3 7.1 13.8 10.9 9.1 11.7 6.5 13.9 17.9 13.5 9.8 2.8 3.9 15.3 12.6 9.7 20.2 17.6 23.3 14.7 19.5 10.3 9.8 16.8 22.1 13.1 24.8 6.1 13.2 17.2 14.6 13.1 2.5 17.3 18.0 2.8 4.2 25.4 15.7 8.5 26.0 8.8 15.1 22.2 25.2 15.9 26.6 8.7 39.3 9.2 17.2 7.2 14.8 10.1 10.7 20.3 7.2 9.0 13.2 14.8 8.3 14.8 14.2 8.3 15.8 11.9 22.1 58.4 10.6 13.4 17.9 13.8 6.8 9.9 9.3 6.3 10.2 7.8 7.7 8.6 7.1 9.3 11.7 8.1 7.7 9.1 10.9 5.5 10.9 6.5 4.2 6.1 7.8 5.6 3.9 3.7 6.1 4.8 5.3 7.2 RFX1 EF-C ENSG00000132005 "Regulatory factor X1" P22670 19 13961538-14007039 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048722, HPA052966" Approved Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048722: , HPA052966: " "unprognostic (6.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.55e-3)" "unprognostic (2.63e-1)" "unprognostic (5.45e-2)" "prognostic favourable (2.42e-4)" "unprognostic (2.62e-1)" "unprognostic (1.71e-1)" "unprognostic (2.88e-1)" "unprognostic (1.61e-2)" "prognostic favourable (4.92e-4)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-2)" "unprognostic (2.96e-1)" "unprognostic (1.50e-1)" "unprognostic (1.56e-2)" 7.4 7.4 13.1 8.7 13.1 9.8 7.0 36.2 19.3 10.3 6.0 6.2 10.2 10.6 8.0 4.6 8.0 8.5 6.3 7.0 11.7 5.9 7.9 8.6 7.0 7.2 8.6 9.5 10.2 12.5 11.9 18.9 8.0 9.5 8.5 3.1 9.8 12.7 12.4 11.0 7.0 9.2 4.4 6.8 12.0 11.2 21.0 10.8 11.6 10.9 3.4 9.3 6.8 13.6 3.9 3.5 10.8 3.5 3.4 2.0 1.1 6.1 6.3 3.4 4.1 2.0 2.6 10.2 3.4 2.3 4.0 3.5 6.4 6.2 3.5 6.9 1.8 8.1 2.4 2.5 1.4 3.5 13.9 4.0 7.0 5.7 3.8 4.0 8.5 1.9 2.7 3.6 2.1 3.1 10.1 3.9 2.1 9.4 7.3 8.8 7.6 9.5 6.4 3.5 4.9 4.0 3.3 14.1 7.4 5.9 5.2 4.8 5.5 4.2 3.7 7.0 5.7 7.6 5.9 9.3 4.1 2.4 5.6 4.0 6.2 0.7 3.5 1.6 1.4 1.1 1.3 2.9 1.6 1.5 1.7 3.9 1.7 2.0 10.8 3.4 2.0 3.5 1.0 1.1 13.1 13.1 36.2 19.3 11.7 5.9 8.6 9.5 9.5 10.8 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell line enhanced" "Detected in many" "HMC-1: 16.0;SCLC-21H: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favourable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favourable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favourable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 3.9 3.2 5.2 10.2 2.7 1.6 3.1 2.5 3.6 2.2 3.5 1.4 5.0 4.5 2.8 3.3 6.2 1.3 5.1 3.0 1.1 0.7 7.1 3.2 1.4 3.1 3.1 16.0 1.8 4.5 4.8 2.5 3.3 4.5 0.2 2.1 2.0 6.1 4.2 1.4 2.0 1.6 3.1 0.5 2.8 7.8 19.8 2.5 2.5 1.9 1.3 3.3 3.4 4.7 0.9 4.6 3.6 2.5 6.6 2.1 2.5 2.7 11.5 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell line enhanced" "Detected in many" "AF22: 21.9;HDLM-2: 12.9;SCLC-21H: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favourable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 1.9 2.7 21.9 5.3 0.9 1.0 2.2 0.8 2.3 1.9 1.4 0.8 2.5 3.1 0.9 1.1 1.1 5.3 2.2 3.3 12.9 1.4 5.9 2.9 1.8 1.1 1.2 0.8 1.3 1.0 2.3 3.7 3.2 1.1 3.2 2.0 1.5 3.7 4.3 5.8 1.1 3.9 1.5 0.8 3.0 1.6 11.8 5.2 1.3 0.6 2.0 1.1 3.1 2.0 1.4 3.2 0.7 1.3 1.1 0.5 6.3 1.5 1.4 1.4 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.2 4.8 4.3 10.2 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 7.1 6.1 5.8 6.6 4.6 8.9 4.3 6.9 2.3 9.9 9.4 10.1 5.7 10.2 8.1 10.2 3.7 4.3 5.2 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 RFX8 FLJ42986 ENSG00000196460 "RFX family member 8, lacking RFX DNA binding domain" Q6ZV50 2 101397361-101474703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "basophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA059745: " "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 2.1 0.6 0.4 0.8 0.7 10.0 7.5 0.2 2.3 0.9 0.5 0.8 1.3 0.4 0.7 1.7 0.7 0.2 1.0 0.8 0.4 0.9 0.6 0.7 0.7 0.9 0.7 1.6 0.7 0.6 1.0 2.2 0.9 1.6 0.5 0.1 0.8 0.9 0.1 0.5 1.4 0.3 0.8 0.8 0.4 0.4 2.6 0.0 7.8 1.5 0.0 0.3 0.6 2.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 2.0 1.4 1.3 1.4 0.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.0 0.0 15.4 0.1 0.0 0.0 0.0 7.3 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 1.9 2.8 0.0 0.0 0.0 10.1 4.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 2.3 0.4 0.9 0.7 1.6 1.6 0.0 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: " "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavourable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 8.8 0.0 1.7 15.0 0.3 0.2 78.9 0.0 0.3 10.9 0.1 25.7 0.2 1.0 0.2 0.3 0.5 0.1 2.6 1.2 0.0 1.9 0.8 0.8 0.9 0.3 1.1 1.7 0.3 11.0 9.0 1.9 0.0 0.2 0.0 5.7 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 4.9 6.0 0.0 0.9 0.5 0.1 0.0 0.0 27.0 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928531 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 18.4;HSkMC: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.49e-5)" "prognostic favourable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 22.1 15.7 22.1 16.9 24.8 1.5 19.7 14.2 23.2 18.1 9.9 25.5 8.8 7.9 17.4 11.5 9.9 14.4 20.3 15.0 21.5 15.0 25.7 14.3 18.4 17.4 18.2 16.3 18.7 6.3 10.5 9.7 14.2 19.1 12.5 11.9 21.0 7.8 11.1 3.0 8.4 9.4 19.8 19.6 37.5 7.6 13.0 20.4 1.7 9.1 2.9 8.9 18.1 12.6 0.0 2.4 0.2 5.2 0.0 1.1 1.2 0.1 0.7 13.5 2.0 18.4 8.5 13.8 6.2 10.5 2.8 3.5 6.0 0.4 0.1 5.8 4.4 0.3 0.9 1.5 2.8 0.2 1.0 0.1 1.4 6.1 4.9 0.2 0.7 28.9 0.3 7.2 1.7 10.5 0.0 10.0 6.0 0.0 1.4 0.1 4.9 0.4 11.7 0.8 11.9 0.7 3.8 1.7 4.0 1.9 2.1 1.0 0.1 0.1 7.7 4.1 1.6 12.7 3.3 1.0 0.2 0.0 4.3 0.1 11.2 0.0 2.1 0.0 0.2 5.2 0.4 0.0 0.8 0.0 2.4 0.0 1.1 0.6 0.2 0.0 1.8 0.0 0.6 1.2 22.1 24.8 14.2 21.9 21.5 15.0 18.2 16.3 19.1 20.4 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419342 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.1;thyroid gland: 38.2" "Cell line enhanced" "Detected in some" "BEWO: 14.5;CACO-2: 8.2;RT4: 17.0;SK-BR-3: 7.6;T-47d: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Region enriched" "Detected in single" 6 "cerebellum: 10.1" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favourable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favourable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 4.3 6.2 5.3 1.2 7.9 0.7 4.3 1.9 6.8 7.6 1.9 3.4 23.3 1.8 4.9 14.5 1.1 5.3 6.5 5.2 8.2 1.3 20.7 6.0 7.5 1.2 6.7 3.0 1.6 12.1 65.1 9.1 5.8 7.9 4.1 1.8 7.3 3.5 23.9 5.0 1.1 1.2 1.4 9.5 5.1 6.8 1.1 7.3 0.0 38.2 0.4 0.9 4.5 4.5 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.1 14.5 0.9 1.1 0.5 1.6 8.2 5.9 0.0 5.2 1.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 3.0 2.5 2.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.6 1.6 5.0 17.0 0.8 4.3 0.2 7.6 2.5 12.5 0.0 0.0 2.6 0.0 2.0 0.6 0.0 0.4 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 5.3 7.9 1.9 6.8 8.2 1.3 6.7 3.0 7.9 7.3 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Cell line enhanced" "Detected in some" "AF22: 30.4;BEWO: 8.9;MOLT-4: 9.0;NTERA-2: 13.6" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: , HPA044222: " "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favourable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 30.4 0.5 6.4 3.6 8.9 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 2.0 5.0 0.1 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.1 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 9.0 0.1 13.6 0.0 7.9 7.0 0.0 0.0 0.3 3.2 1.8 0.3 0.1 0.0 2.4 1.6 0.0 0.0 6.6 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 RGP1 KIAA0258 ENSG00000107185 "RGP1 homolog, RAB6A GEF complex partner 1" Q92546 9 35749287-35758575 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020414, HPA021085" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA020414: AB_1852289, HPA021085: AB_1852291" "unprognostic (2.10e-1)" "unprognostic (3.22e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (7.09e-4)" "unprognostic (2.22e-1)" "unprognostic (5.42e-2)" "unprognostic (1.51e-3)" "unprognostic (1.81e-3)" "unprognostic (9.77e-2)" "prognostic favourable (8.55e-13)" "unprognostic (2.46e-2)" "unprognostic (1.68e-1)" "unprognostic (3.03e-3)" "unprognostic (1.18e-1)" 13.4 18.2 12.0 11.4 16.8 7.1 12.3 13.7 24.8 12.2 17.7 18.3 23.8 14.9 15.3 12.5 14.0 12.3 12.1 17.6 11.6 11.2 16.7 14.2 13.2 9.8 10.7 14.8 15.0 17.6 32.6 18.3 14.1 13.0 12.9 19.1 15.4 18.3 22.5 25.8 13.1 17.2 14.1 10.6 12.8 16.5 13.2 13.7 11.2 17.3 11.9 13.0 13.5 10.6 4.0 2.1 3.4 1.9 3.7 3.7 0.9 11.7 11.0 12.9 10.7 12.1 13.1 7.6 9.3 13.5 12.9 12.1 9.4 4.5 9.1 6.7 11.8 6.7 12.3 17.5 10.7 12.1 7.3 7.8 21.1 7.0 11.4 8.4 11.1 13.1 22.5 13.6 16.6 15.3 5.3 5.1 11.7 5.5 2.6 3.0 5.4 13.0 8.6 9.2 6.4 11.3 8.2 9.5 10.2 8.2 11.6 7.5 9.6 4.0 19.3 10.4 13.2 7.1 7.7 7.6 10.5 9.7 14.8 3.6 13.3 3.4 0.9 1.4 2.6 1.5 3.7 2.8 1.9 3.0 0.6 4.0 2.3 2.4 2.3 3.7 1.9 2.1 1.6 0.9 12.0 16.8 13.7 24.8 11.6 11.2 10.7 14.8 13.0 13.7 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell line enhanced" "Detected in some" "BEWO: 9.0;MOLT-4: 13.5;NTERA-2: 4.1;RPMI-8226: 3.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 13.5 0.2 4.1 0.0 0.1 0.1 3.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2-like and GRIP domain containing 2" P0DJD1 2 87755955-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;testis: 12.3" "Cell line enhanced" "Detected in some" "BEWO: 11.9;K-562: 4.1;MOLT-4: 13.6;NTERA-2: 5.9;SiHa: 4.8;THP-1: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "T-reg: 11.3" "Lineage enriched" "Detected in single" 12 "T-cells: 11.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 0.7 2.1 0.1 0.6 0.2 7.1 0.8 1.3 0.3 4.6 0.8 1.2 1.1 0.0 0.3 2.4 0.0 0.5 0.0 0.2 0.4 0.8 1.2 1.3 0.1 1.7 6.3 0.1 2.7 7.5 0.6 0.1 0.8 0.1 0.6 0.6 1.8 0.0 0.1 0.9 1.7 12.3 0.9 1.6 0.3 0.9 0.9 0.0 0.5 0.1 0.0 11.3 0.4 0.0 0.0 0.7 0.0 0.0 0.0 11.9 0.5 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.1 2.8 0.3 0.0 0.0 4.1 0.3 0.0 0.5 13.6 0.0 5.9 0.0 0.3 0.0 0.3 0.0 0.0 0.0 3.0 4.8 0.1 0.0 0.0 5.5 0.2 0.9 0.1 0.0 0.0 2.7 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.4 0.9 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.0 0.0 0.0 11.3 0.4 RGPD3 RGP3 ENSG00000153165 "RANBP2-like and GRIP domain containing 3" A6NKT7 2 106391290-106468376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.6" "Group enriched" "Detected in some" 4 "HEL: 3.2;MOLT-4: 10.1;RPMI-8226: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.3 0.0 0.5 0.4 0.4 0.3 0.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.4 1.4 0.7 0.1 0.1 0.6 0.2 0.2 0.7 0.7 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.4 0.7 0.1 11.6 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 1.2 0.2 0.4 0.5 0.4 0.4 0.3 0.5 0.1 0.4 0.5 0.4 0.3 0.5 0.0 0.0 0.1 0.3 0.3 1.2 0.1 0.7 0.3 0.1 3.2 0.3 0.5 0.3 0.1 0.1 0.1 0.3 1.1 0.4 0.3 0.6 0.0 0.5 0.2 10.1 0.1 0.4 0.1 0.0 0.1 3.2 0.1 0.5 0.5 0.1 0.4 0.0 0.2 0.1 0.3 0.2 0.3 0.2 0.6 0.5 0.6 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.5 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.2 1.2 0.2 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA049497: , HPA051675: , HPA067564: " "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 RGPD5 "BS-63, DKFZp686I1842, RGP5" ENSG00000015568 "RANBP2-like and GRIP domain containing 5" Q99666 2 109792758-109857695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 10.5;PC-3: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (2.50e-2)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.23e-1)" "unprognostic (4.23e-2)" "unprognostic (3.19e-1)" "unprognostic (3.19e-3)" "unprognostic (3.19e-1)" 4.9 5.0 5.2 2.5 11.7 11.4 9.4 8.2 6.3 6.4 5.2 7.5 6.0 12.3 6.8 6.1 2.6 4.0 3.4 4.4 4.7 4.8 5.3 5.1 5.6 3.0 5.1 4.9 6.0 11.9 3.8 15.1 4.9 5.6 6.4 2.0 8.3 8.5 4.9 7.4 5.2 5.8 6.9 4.9 3.7 8.7 15.7 3.7 1.0 6.8 3.2 2.6 6.3 15.3 6.9 4.3 9.2 3.5 2.8 6.7 0.9 8.3 4.7 1.7 1.8 0.4 0.1 1.6 4.2 1.3 1.6 2.4 9.0 1.0 0.6 5.3 0.7 3.4 1.4 0.3 0.3 1.9 10.5 3.7 3.6 0.2 0.2 0.6 0.5 0.7 2.3 0.9 0.6 0.9 2.3 2.1 0.7 2.3 0.4 1.2 2.4 11.0 3.6 5.8 0.0 0.5 3.0 5.7 3.2 5.0 0.0 1.4 0.1 0.9 5.8 1.8 6.4 0.4 2.3 4.0 0.3 0.6 3.2 0.1 0.7 6.8 3.5 4.1 4.1 1.6 6.7 4.0 3.8 4.0 2.3 6.9 4.9 3.7 9.2 2.8 3.0 4.3 2.9 0.9 5.2 11.7 8.2 6.3 4.7 4.8 5.1 4.9 5.6 3.7 RGPD6 RGP6 ENSG00000183054 "RANBP2-like and GRIP domain containing 6" Q99666 2 110513812-110577185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (1.11e-2)" "unprognostic (6.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" "unprognostic (4.14e-4)" "unprognostic (2.04e-1)" 5.6 4.1 3.2 2.4 4.9 6.9 5.5 5.6 8.1 4.5 3.8 2.1 4.9 10.1 2.3 3.8 3.4 4.7 3.8 4.4 3.3 4.7 5.1 2.8 3.4 6.4 6.9 8.5 9.5 5.3 6.0 3.5 3.3 4.4 5.2 6.2 4.1 3.5 2.6 3.2 4.0 19.9 7.5 2.4 3.8 3.7 5.7 3.8 8.1 2.6 2.9 4.1 0.3 13.8 3.4 16.6 12.5 5.0 6.1 1.7 10.1 9.2 8.3 5.9 11.3 5.1 0.3 7.4 8.7 6.1 10.2 5.6 11.0 3.3 5.8 14.6 1.2 7.7 6.2 1.9 1.9 5.5 5.7 10.6 10.9 5.3 6.2 3.4 6.9 4.0 4.4 0.4 11.1 4.3 2.1 8.4 0.1 8.2 7.4 23.5 4.2 5.2 1.1 9.7 0.6 5.6 7.7 9.1 12.2 2.3 10.9 7.7 0.3 0.3 7.2 0.8 3.9 6.8 2.6 3.2 2.4 1.3 4.1 2.5 3.1 2.7 1.7 5.7 3.1 2.5 8.1 2.9 1.6 3.8 0.9 0.3 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2-like and GRIP domain containing 8" O14715 2 112370092-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell line enhanced" "Detected in many" "HEL: 14.4;hTEC/SVTERT24-B: 12.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA045704: , HPA049497: , HPA051675: , HPA067564: " "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 2.4 0.9 0.5 1.3 0.9 6.2 2.3 2.6 2.7 1.7 1.5 0.4 1.9 2.1 1.1 1.6 1.4 1.7 0.6 0.8 1.3 2.8 2.4 0.9 0.6 2.2 2.3 2.0 2.8 2.0 1.4 1.0 1.3 1.6 1.5 2.4 1.3 1.5 0.8 1.3 1.2 14.0 2.1 1.4 1.9 1.5 2.9 2.1 3.1 2.4 1.4 5.1 1.2 6.1 2.9 4.5 2.7 1.4 3.0 0.1 2.9 2.2 2.2 1.6 5.2 0.4 0.0 1.9 3.4 2.7 10.7 1.5 2.3 7.5 3.5 14.4 3.8 2.8 1.7 0.1 0.2 0.5 2.0 12.1 3.0 2.0 7.3 0.4 3.3 2.2 6.5 0.8 2.8 3.2 0.0 0.7 0.0 1.0 2.7 2.9 0.6 7.1 0.1 1.6 0.7 3.1 8.5 1.5 2.2 4.8 4.2 0.1 0.0 0.0 0.4 1.7 0.3 3.1 1.3 1.3 3.5 1.0 5.1 1.7 2.3 2.9 1.4 2.9 3.2 2.2 1.0 1.4 2.4 2.1 1.3 1.2 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499828-119542708 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.9;lymphoid tissue: 96.9" "Cell line enhanced" "Detected in many" "HMC-1: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" 1400000 "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: " "unprognostic (1.64e-2)" "prognostic favourable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favourable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 9.6 7.7 11.9 28.2 12.1 23.6 15.4 2.8 12.4 25.8 44.0 17.0 5.3 12.5 15.3 13.1 21.9 10.8 18.8 11.7 12.0 10.5 8.3 3.9 13.5 47.6 17.4 6.7 10.3 3.9 0.8 6.6 16.9 10.5 17.8 18.9 6.4 18.1 8.2 13.2 9.3 23.1 19.1 28.5 18.7 12.8 3.7 11.1 96.9 14.7 11.1 34.3 17.9 20.0 6.9 40.2 20.5 26.3 7.6 77.9 63.0 29.6 5.5 0.4 52.1 7.5 48.1 4.9 13.8 21.0 8.4 13.5 1.7 7.1 12.7 7.4 10.7 6.6 7.7 8.4 22.2 6.2 8.9 34.0 1.6 4.0 12.0 6.9 92.5 18.7 11.2 16.2 15.1 15.9 8.7 10.3 9.6 13.4 40.2 24.0 2.4 15.0 7.8 0.0 4.7 4.3 6.9 2.1 1.7 2.6 34.0 48.7 6.5 12.3 20.9 4.8 4.1 6.8 11.8 0.5 7.9 4.6 1.4 30.2 2.1 20.5 21.5 0.2 15.0 26.3 15.7 6.9 32.5 25.8 40.2 3.6 77.9 58.5 9.9 7.6 21.6 23.9 35.0 63.0 11.9 12.1 2.8 12.4 12.0 10.5 17.4 6.7 10.5 11.1 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA054646: , HPA067421: " "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favourable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 3.9 5.0 10.1 7.3 3.4 2.7 4.2 4.3 3.4 4.4 3.3 4.0 2.4 0.9 2.7 3.7 3.9 2.0 13.6 1.4 0.1 1.6 0.4 2.8 9.8 3.1 0.3 5.6 2.3 9.3 2.3 3.1 9.7 4.6 0.2 4.0 3.4 0.7 10.6 4.8 4.8 10.0 3.9 3.2 2.3 11.8 11.4 11.8 2.7 1.9 9.0 4.6 6.7 7.3 8.6 5.6 1.7 4.5 5.0 3.9 2.2 5.1 5.9 6.1 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell line enhanced" "Detected in many" "HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Group enriched" "Detected in all" 5 "amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: , HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.8 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.1 3.7 4.7 2.6 0.0 3.8 0.0 1.2 0.0 39.8 0.1 7.4 0.1 1.5 0.2 5.7 35.6 0.6 0.3 0.2 0.2 0.2 1.2 9.6 0.0 0.1 7.6 15.7 0.6 1.0 3.5 0.0 20.5 0.4 0.1 0.1 0.7 0.0 0.1 3.0 1.3 9.0 0.3 0.0 0.7 0.0 3.4 5.1 2.4 2.0 0.6 10.8 0.8 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 RGS19 "GAIP, RGSGAIP" ENSG00000171700 "Regulator of G protein signaling 19" P49795 20 64073181-64079988 "Predicted intracellular proteins" Autophagy "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1" "Cell line enhanced" "Detected in many" "HMC-1: 48.8;NB-4: 38.4;THP-1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056384, HPA069984" Enhanced Supported "Nucleoli fibrillar center,Cell Junctions" "Cell Junctions" "Nucleoli fibrillar center" "HPA056384: , HPA069984: " "unprognostic (3.98e-2)" "unprognostic (2.32e-1)" "unprognostic (4.26e-3)" "unprognostic (8.42e-2)" "unprognostic (2.03e-1)" "unprognostic (9.94e-2)" "prognostic unfavourable (2.75e-4)" "unprognostic (1.25e-2)" "unprognostic (2.41e-2)" "unprognostic (3.91e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "prognostic unfavourable (2.06e-9)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (4.66e-3)" 7.0 4.8 6.0 19.0 7.5 36.7 12.7 2.5 5.0 3.3 3.5 6.8 1.9 5.5 2.9 2.9 4.4 4.1 4.5 5.1 5.4 4.9 4.0 7.2 10.4 27.2 9.1 2.6 2.7 3.9 0.8 2.6 5.6 5.7 3.9 1.8 2.2 6.1 2.2 1.6 4.3 10.6 3.2 7.1 43.1 5.7 2.8 7.2 15.2 3.7 1.2 19.5 6.1 3.6 17.3 29.9 95.0 55.5 9.1 13.8 22.0 4.8 7.4 2.1 3.8 0.9 1.6 3.6 3.0 2.1 6.4 2.6 10.9 6.7 8.5 8.5 1.9 4.7 2.1 3.9 1.5 4.1 4.1 12.1 3.8 4.4 1.2 24.7 48.8 1.0 2.4 2.7 0.9 4.1 4.6 4.5 1.9 8.6 18.2 38.4 2.2 9.4 15.3 1.2 6.1 1.8 2.4 4.1 3.8 3.1 1.9 4.0 2.6 32.6 4.3 6.0 3.0 1.0 2.9 2.8 2.2 10.3 3.3 18.9 3.9 33.1 35.5 95.0 13.4 50.4 13.8 17.3 12.7 12.7 29.9 17.1 8.9 9.2 79.6 9.1 55.5 17.1 13.5 22.0 6.0 7.5 2.5 5.0 5.4 4.9 9.1 2.6 5.7 7.2 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 7 "HEL: 8.1;Karpas-707: 29.3" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 29.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775515-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.5;brain: 38.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.0;HaCaT: 6.8;hTERT-HME1: 8.3;RH-30: 7.3;SH-SY5Y: 6.4;U-2 OS: 7.3;U-251 MG: 7.9" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.7 11.5 9.1 0.8 18.3 0.7 0.9 27.6 38.1 0.9 0.8 1.6 1.7 1.0 1.0 0.8 0.9 0.7 1.3 0.7 11.5 8.3 4.2 0.8 0.9 1.1 3.6 8.9 1.3 1.4 0.7 2.8 0.7 4.7 0.8 0.9 1.3 0.7 1.4 0.7 0.9 0.9 0.7 1.4 1.0 4.6 7.8 1.8 0.0 0.7 0.0 1.0 0.7 0.1 0.7 3.6 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.3 0.9 0.0 2.7 5.2 7.0 0.5 0.0 0.0 0.0 0.4 3.6 6.8 0.0 0.1 3.5 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.3 0.5 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.2 0.0 7.3 0.0 0.0 0.0 5.9 6.4 0.4 0.3 0.3 0.0 0.0 2.8 0.0 7.3 0.4 7.9 0.0 4.2 0.0 1.1 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 9.1 18.3 27.6 20.7 11.5 8.3 3.6 8.9 4.7 1.8 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 15.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: " "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in some" 8 "HDLM-2: 22.9;HEL: 9.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in many" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: " "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favourable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.0 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.1 0.0 0.1 0.2 22.9 0.5 9.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell line enriched" "Detected in some" 5 "HEL: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.1 0.0 0.1 0.1 0.2 0.0 43.6 0.0 0.0 0.5 0.0 0.3 0.9 0.7 0.3 0.2 0.0 8.5 0.2 0.2 0.4 0.0 0.3 0.8 0.2 0.0 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.4 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Group enriched" "Detected in some" 6 "HEL: 27.6;K-562: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.1 27.6 0.6 0.2 0.0 0.3 0.2 0.1 0.1 0.1 0.1 0.1 8.5 0.7 0.0 0.1 0.2 0.2 3.1 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.2 0.4 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.4 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 16.3;U-266/84: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA053111: , HPA061001: " "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 1.9 1.2 2.8 0.7 0.1 1.1 0.9 2.7 5.0 5.6 1.8 1.6 2.8 0.8 0.2 0.7 0.8 1.0 2.2 16.3 0.1 2.7 1.4 0.9 0.6 1.0 5.7 0.3 0.4 2.5 0.8 1.9 3.4 7.9 1.9 0.8 1.2 6.6 1.8 2.8 2.6 1.7 4.3 0.4 0.1 0.6 1.7 0.7 0.7 4.4 0.3 1.8 1.0 1.5 2.6 3.0 0.9 9.6 32.6 1.6 1.3 4.0 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 RHOA "ARH12, ARHA, Rho12, RhoA, RHOH12" ENSG00000067560 "Ras homolog family member A" P61586 3 49359145-49412998 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Host-virus interaction" Hydrolase "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005052 Approved Supported "Plasma membrane,Cytosol" 65000000 "Plasma membrane, Cytosol" "CAB005052: AB_562216" "unprognostic (1.50e-1)" "unprognostic (3.38e-1)" "prognostic favourable (3.08e-4)" "unprognostic (8.75e-2)" "unprognostic (1.63e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.15e-4)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (9.44e-3)" "unprognostic (2.21e-2)" "unprognostic (4.29e-2)" "prognostic favourable (3.21e-6)" "unprognostic (5.14e-2)" "unprognostic (7.50e-2)" "unprognostic (1.57e-1)" "unprognostic (4.52e-2)" 141.1 89.5 63.0 79.8 60.6 91.4 93.1 34.3 77.3 80.3 79.1 100.4 48.9 63.6 84.4 66.4 116.7 67.8 74.2 72.5 57.6 54.8 104.0 80.7 104.6 102.4 74.0 43.8 102.7 64.9 45.8 48.2 105.3 68.8 76.0 80.3 81.6 66.5 72.0 86.0 73.9 90.8 88.9 97.3 116.0 73.4 57.3 60.3 127.1 108.1 80.1 99.8 103.4 75.7 42.6 78.4 124.2 125.7 38.3 50.5 151.5 54.9 42.4 53.2 57.0 61.1 92.6 41.6 119.6 76.7 83.6 77.2 35.9 57.6 80.6 34.4 143.6 31.3 58.4 65.2 85.9 62.1 34.8 77.0 57.0 42.1 65.5 75.8 57.7 72.3 46.4 68.4 55.1 107.0 41.0 50.7 99.1 26.2 82.6 74.0 50.8 54.0 38.2 53.5 63.4 72.3 62.8 19.5 44.4 71.8 52.0 53.8 33.7 85.5 115.5 67.1 60.8 88.6 86.0 50.4 102.2 92.6 65.5 74.7 76.7 52.5 99.7 106.8 49.1 125.7 41.6 42.6 41.4 47.6 78.4 37.5 32.2 40.1 124.2 38.3 120.4 58.7 50.5 151.5 63.0 60.6 34.3 77.3 57.6 54.8 74.0 43.8 68.8 60.3 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Cell line enhanced" "Detected in many" "Hep G2: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040205: , HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.1 9.3 0.0 4.4 3.9 0.0 2.7 2.5 2.2 3.4 0.3 0.1 0.0 11.5 14.3 0.1 2.7 0.8 2.7 0.0 2.5 0.5 4.5 33.9 4.9 0.6 0.2 5.7 1.5 1.4 1.4 10.7 5.0 0.0 9.9 0.2 2.5 0.0 4.0 4.0 2.2 13.1 3.2 7.4 0.3 2.6 10.0 3.2 3.6 3.5 0.7 1.2 9.5 4.4 11.5 0.1 2.9 0.0 0.0 0.0 2.1 2.0 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 36.7;HDLM-2: 51.6;PC-3: 36.2;RPTEC TERT1: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Approved "Nucleoplasm,Golgi apparatus" 58000 "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: " "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 5.0 13.8 13.3 19.2 15.6 29.3 5.8 53.2 19.3 16.5 17.8 8.9 15.9 24.7 12.7 17.5 13.7 10.9 10.3 13.5 13.8 9.8 16.4 6.9 18.7 28.6 20.2 8.7 8.8 7.5 9.1 14.7 4.7 14.2 8.3 14.1 12.4 9.6 12.1 8.5 7.3 26.5 9.9 11.2 28.4 20.9 9.0 18.9 27.2 18.3 6.2 24.4 14.2 10.2 17.4 24.2 13.4 21.0 18.5 32.9 13.6 16.1 18.7 3.5 4.1 1.2 1.9 1.6 1.6 1.5 0.7 1.3 7.5 36.7 1.6 12.5 1.6 2.3 6.2 9.6 0.5 51.6 2.0 8.6 12.7 7.1 2.8 9.6 7.2 2.5 2.0 1.5 0.8 4.9 1.4 2.6 0.3 10.3 13.4 14.5 2.9 36.2 7.1 0.2 2.9 29.3 1.4 2.9 2.4 9.7 1.2 0.7 5.5 4.2 6.0 1.2 11.2 3.5 0.4 3.7 1.9 4.9 1.4 11.0 0.7 6.2 3.5 13.4 32.9 11.1 31.0 17.4 26.0 28.1 10.9 14.8 20.1 24.5 7.7 18.5 21.0 24.2 27.3 13.6 13.3 15.6 53.2 19.3 13.8 9.8 20.2 8.7 14.2 18.9 RHOH "ARHH, RhoH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.8;lymphoid tissue: 94.7" "Cell line enhanced" "Detected in some" "Daudi: 35.6;HMC-1: 27.4;MOLT-4: 49.6;U-266/70: 19.2;U-266/84: 15.4;U-698: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 1.8 0.6 0.6 33.8 1.1 21.7 5.2 0.4 0.4 1.3 2.4 0.5 0.4 1.6 2.0 0.9 2.5 1.5 4.1 1.1 0.6 0.7 1.6 1.7 4.8 43.2 0.8 0.2 0.7 0.8 0.0 0.9 0.3 0.8 2.1 2.0 1.0 7.8 0.6 0.5 1.2 15.1 0.7 1.2 33.1 2.7 0.7 0.6 94.7 1.6 1.9 41.0 5.1 1.5 41.2 4.7 32.2 0.2 12.3 54.8 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.3 0.0 0.0 0.0 5.8 27.4 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 49.6 3.7 0.6 0.1 5.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.1 0.1 0.0 0.1 0.0 0.0 19.2 15.4 32.9 0.0 1.2 0.0 32.2 0.2 29.6 21.6 0.1 19.4 30.5 34.6 29.1 0.3 41.2 54.8 43.3 1.6 12.3 0.2 4.7 47.0 21.1 0.6 1.1 0.4 0.4 0.6 0.7 0.8 0.2 0.8 0.6 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;HUVEC TERT2: 88.4;TIME: 23.5;WM-115: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 2.5 10.2 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 23.5 0.0 0.2 0.1 1.4 0.0 0.0 0.0 0.0 0.0 25.4 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 RHOQ "ARHQ, RASL7A, TC10" ENSG00000119729 "Ras homolog family member Q" P17081 2 46541806-46583121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 62.0;ASC TERT1: 48.5;SK-MEL-30: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044938 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA044938: " "unprognostic (1.24e-1)" "unprognostic (1.30e-2)" "unprognostic (5.82e-2)" "unprognostic (2.07e-2)" "unprognostic (3.61e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.60e-5)" "unprognostic (2.01e-2)" "unprognostic (9.24e-2)" "unprognostic (2.11e-2)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (3.88e-3)" "unprognostic (1.39e-2)" "unprognostic (1.87e-1)" "unprognostic (7.68e-2)" "unprognostic (3.52e-2)" 43.3 13.1 20.9 14.1 19.4 4.9 16.7 6.5 15.1 16.4 16.6 12.7 11.7 4.9 15.5 32.9 9.8 13.8 15.0 65.2 16.8 13.0 13.9 6.0 14.2 10.0 19.5 14.9 16.0 12.9 20.4 8.2 13.8 20.4 14.6 6.9 16.0 9.6 19.2 63.8 7.2 8.9 19.3 15.4 13.2 9.3 6.3 13.4 8.0 18.0 17.2 9.1 17.7 12.1 3.9 2.9 8.9 4.8 0.7 0.8 1.3 4.1 4.3 7.2 10.1 62.0 48.5 0.9 11.9 30.1 5.8 9.1 2.0 1.3 10.1 13.0 21.0 1.7 7.5 3.5 10.6 3.4 5.1 2.3 3.2 7.0 30.3 3.0 3.6 42.9 6.1 7.7 8.3 6.8 4.0 16.8 12.5 2.8 2.3 5.4 7.5 5.4 1.6 13.1 3.4 7.9 8.0 5.7 18.5 4.4 5.9 52.7 3.2 6.9 4.7 19.0 17.7 18.5 4.8 17.3 6.2 10.6 27.7 7.4 6.7 2.7 4.6 7.8 0.7 4.8 0.6 3.4 0.4 0.8 2.9 3.9 0.1 0.6 8.9 0.7 3.4 1.3 0.6 1.3 20.9 19.4 6.5 15.1 16.8 13.0 19.5 14.9 20.4 13.4 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favourable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favourable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.1 10.6 16.3 5.3 5.5 18.8 15.8 7.4 13.5 10.3 25.2 14.5 10.5 11.3 6.4 17.7 7.5 15.0 3.4 15.0 31.0 12.6 22.4 18.0 9.8 11.5 17.2 8.9 12.9 10.0 5.8 9.5 22.8 8.9 7.1 38.5 12.1 12.8 26.0 12.5 28.2 11.8 22.0 8.6 17.9 22.9 27.1 14.8 19.6 8.6 20.2 18.1 15.3 10.5 16.9 8.9 11.3 23.8 15.0 14.7 6.9 11.0 14.9 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Cell line enhanced" "Detected in some" "K-562: 60.7;NB-4: 45.0;THP-1: 16.9;U-266/84: 27.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Group enriched" "Detected in some" 348 "HL-60: 46.0;K-562: 46.1;NB-4: 74.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: , HPA036888: " "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 13.7 9.0 12.1 11.7 18.2 31.1 16.6 23.6 17.1 12.7 10.9 12.4 8.7 7.2 15.5 7.3 10.2 11.5 9.8 8.5 11.7 8.5 9.8 11.2 10.9 13.0 15.7 11.6 19.4 12.1 16.3 17.3 13.4 13.6 10.8 10.6 9.6 12.0 9.3 18.3 13.9 10.4 13.5 11.6 10.2 10.1 17.8 15.9 18.4 15.5 9.4 12.9 11.6 11.9 6.2 2.6 7.9 4.7 10.7 7.8 2.3 9.8 8.4 13.2 10.0 5.5 6.9 12.7 12.0 8.9 10.9 13.1 13.7 8.1 18.9 10.9 8.4 10.2 20.2 8.5 18.5 13.2 9.6 30.1 10.3 9.8 5.7 30.2 10.0 5.2 5.5 19.5 14.9 10.5 24.3 16.1 11.1 6.6 17.8 10.5 21.0 11.5 18.3 20.9 12.3 5.6 12.2 12.0 9.2 15.6 7.2 8.1 6.3 11.0 13.0 16.5 11.6 10.0 12.7 7.9 13.7 27.6 7.6 12.2 10.9 7.9 3.6 4.3 6.8 2.5 7.8 6.2 5.8 4.9 2.6 5.2 7.7 5.9 4.2 10.7 4.7 2.4 4.0 2.3 12.1 18.2 23.6 17.1 11.7 8.5 15.7 11.6 13.6 15.9 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 43.4;pituitary gland: 29.2" "Group enriched" "Detected in some" 9 "CACO-2: 6.4;SCLC-21H: 3.5;SH-SY5Y: 6.9;SK-BR-3: 11.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favourable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.5 2.7 4.0 0.5 9.3 0.5 1.1 0.5 5.6 1.6 1.1 0.8 1.2 0.6 2.1 6.1 0.7 43.4 0.9 0.5 4.6 5.1 0.6 0.5 3.1 0.5 2.5 5.2 2.6 1.2 1.1 29.2 0.5 3.6 1.0 1.3 1.2 0.5 1.9 0.5 0.6 0.8 1.1 0.5 0.5 2.0 14.7 2.1 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 3.5 6.9 0.0 11.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.3 0.5 5.6 4.6 5.1 2.5 5.2 3.6 2.1 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 6.0 8.5 7.7 6.0 8.7 8.2 8.1 10.9 6.1 6.0 5.3 5.3 1.4 0.3 5.5 10.6 6.6 5.7 5.2 2.4 6.1 10.4 0.8 5.5 7.7 15.2 0.3 2.3 9.3 10.4 6.7 9.7 6.0 4.8 0.4 6.0 10.0 0.7 1.9 5.6 9.0 1.0 4.2 0.3 4.2 6.3 1.2 7.2 5.8 5.1 13.0 6.8 0.2 12.0 7.8 3.9 11.3 6.9 1.3 0.6 0.2 8.0 0.1 4.9 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.2;SH-SY5Y: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: " "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.2 4.1 0.0 0.0 17.2 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Cell line enhanced" "Detected in many" "MOLT-4: 5.9;THP-1: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.1 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.7 0.6 0.0 0.3 2.8 0.9 1.2 0.7 1.1 0.1 3.9 0.1 0.3 0.1 0.6 0.0 0.0 0.5 0.7 1.2 1.3 5.9 3.1 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.3 6.4 0.2 2.1 1.4 1.1 0.5 0.2 0.8 0.6 1.1 1.3 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.4;THP-1: 4.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.4 1.9 3.4 0.0 0.1 0.0 0.5 0.0 1.5 0.0 0.5 0.1 4.8 0.0 0.4 0.4 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.8 0.7 0.3 0.1 0.3 0.0 1.5 0.6 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.5 0.6 0.0 0.2 0.5 0.1 0.3 0.1 0.0 0.1 0.7 1.7 3.2 0.3 0.2 1.4 0.9 0.1 0.1 0.1 0.7 0.2 0.5 0.4 0.2 0.0 3.5 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 RIMKLB "FAM80B, KIAA1238, NAAGS, NAAGS-I" ENSG00000166532 "Ribosomal modification protein rimK like family member B" Q9ULI2 12 8681600-8783095 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 53.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059552 Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA059552: " "unprognostic (5.29e-3)" "unprognostic (2.26e-2)" "unprognostic (1.89e-5)" "unprognostic (2.40e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-2)" "unprognostic (6.56e-2)" "unprognostic (8.52e-2)" "unprognostic (8.67e-3)" "unprognostic (1.76e-1)" "unprognostic (3.25e-1)" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-2)" "unprognostic (3.02e-1)" "unprognostic (3.74e-1)" "unprognostic (3.99e-1)" 22.5 10.7 15.9 10.7 19.2 15.8 20.1 23.3 21.2 18.1 17.6 16.4 11.2 5.1 35.9 18.2 10.4 25.4 12.5 10.7 17.6 12.8 9.2 3.2 13.9 7.6 10.2 19.0 22.7 7.3 36.2 10.1 21.2 19.9 11.7 6.5 18.0 9.0 13.5 9.5 8.8 8.7 25.5 14.0 11.5 7.7 27.8 12.1 13.6 15.6 4.8 6.4 11.8 18.4 4.0 1.3 5.3 2.9 2.8 3.9 2.5 1.2 7.2 16.6 17.7 2.3 2.0 23.8 6.9 3.4 5.9 4.0 0.6 7.6 10.5 6.6 4.5 2.7 8.4 9.3 6.5 0.1 5.1 4.8 20.3 0.0 2.6 1.4 4.9 4.4 4.2 5.5 9.7 7.6 6.6 0.0 3.6 4.3 9.6 0.6 19.6 0.4 15.1 22.7 0.0 9.0 3.7 0.5 10.9 7.6 9.9 6.8 2.1 4.8 14.3 6.2 20.7 3.2 2.2 0.1 0.0 53.0 5.4 0.9 4.3 5.3 2.9 1.2 2.4 1.1 3.0 2.2 2.4 3.5 1.2 4.0 3.9 1.5 0.7 2.8 1.4 1.3 0.1 2.5 15.9 19.2 23.3 19.5 17.6 12.8 10.2 19.0 19.9 12.1 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.7;U-2 OS: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: " "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 0.0 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.6 0.0 0.0 0.0 0.0 8.4 20.7 5.0 0.0 0.1 0.5 0.3 0.2 0.0 0.0 5.5 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell line enhanced" "Detected in many" "Daudi: 37.0;SH-SY5Y: 17.5;U-87 MG: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA055285: " "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.8 3.0 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.0 0.0 0.0 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 1.8 1.4 0.0 3.3 5.4 0.2 1.8 0.2 2.5 2.6 6.8 0.5 0.5 9.9 17.5 0.4 1.8 1.2 0.4 10.3 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.1 16.1 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330242-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 31.5" "Cell line enhanced" "Detected in many" "hTCEpi: 26.2;U-2197: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.7;non-classical monocyte: 19.1" "Lineage enriched" "Detected in many" 6 "monocytes: 19.1" "Group enriched" "Detected in many" 6 "amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6" "Group enriched" "Detected in many" 6 "amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favourable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavourable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.9 5.1 11.1 7.1 22.7 3.9 3.4 13.0 13.5 5.9 5.2 1.5 2.4 8.0 4.2 2.3 15.8 5.8 8.7 3.3 9.7 2.3 2.3 2.7 3.8 5.4 1.4 5.8 4.8 6.6 1.5 5.0 4.5 2.2 4.7 3.6 2.5 4.8 3.5 10.3 31.5 5.8 2.8 0.8 4.6 11.1 2.8 2.5 0.0 1.5 8.7 8.6 3.4 7.0 0.1 3.3 0.0 19.1 0.0 1.5 2.0 1.6 4.4 1.3 2.7 1.5 8.6 1.0 9.9 9.1 7.6 3.7 2.7 5.0 0.3 5.0 7.2 10.5 0.0 13.4 1.0 0.5 0.0 0.4 4.3 2.3 3.0 0.1 4.6 8.3 26.2 7.8 4.7 1.6 0.2 0.1 3.3 0.3 0.1 11.3 0.6 19.8 0.1 3.8 0.0 2.2 1.7 9.9 2.6 2.6 1.3 13.6 0.9 0.8 4.3 12.3 7.3 28.8 2.5 0.2 0.5 0.0 17.1 2.6 4.9 0.0 4.3 0.0 0.2 9.7 1.5 0.1 1.0 0.3 3.3 0.0 1.1 0.5 0.0 0.0 19.1 0.0 0.1 2.0 11.1 22.7 13.0 13.5 9.7 2.3 1.4 5.8 2.2 2.5 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19886521-20002457 "Disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favourable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 19.2 6.7 9.9 6.1 8.7 4.0 24.4 4.3 10.2 11.7 21.6 9.5 7.6 10.5 12.7 6.6 11.1 9.7 14.7 13.7 10.0 6.2 12.2 4.6 26.8 4.3 8.3 4.4 12.7 5.1 4.2 4.9 16.7 9.3 8.0 10.4 16.5 12.0 11.3 10.9 6.6 23.4 13.2 7.7 17.5 6.5 3.5 9.9 0.3 13.1 5.5 3.7 9.9 15.6 0.3 1.2 2.2 3.3 0.1 0.3 0.4 3.4 11.2 2.1 6.7 12.3 7.5 6.9 2.7 11.5 2.9 1.7 5.3 3.1 0.0 12.2 7.0 12.4 0.1 17.8 3.3 1.4 0.0 0.0 1.9 0.4 2.7 0.0 0.0 11.0 3.0 5.6 6.2 15.9 0.0 0.2 8.8 2.5 0.0 0.2 0.3 24.8 0.0 7.4 1.8 3.8 4.8 1.8 0.4 2.7 11.0 0.0 1.0 0.9 17.2 6.2 1.4 3.7 4.6 0.0 0.0 0.0 4.0 0.0 0.9 0.6 3.3 0.2 0.2 2.7 0.2 0.2 0.2 0.2 1.2 0.3 0.3 0.3 2.2 0.1 2.8 0.6 0.1 0.4 9.9 8.7 4.3 10.2 10.0 6.2 8.3 4.4 9.3 9.9 RING1 RNF1 ENSG00000204227 "Ring finger protein 1" Q06587 6 33208495-33212722 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008701 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA008701: AB_1079814" "unprognostic (2.12e-3)" "unprognostic (7.98e-2)" "unprognostic (3.77e-2)" "unprognostic (1.37e-1)" "unprognostic (3.91e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (4.75e-2)" "unprognostic (7.76e-2)" "unprognostic (1.26e-2)" "unprognostic (3.70e-2)" "unprognostic (1.62e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.55e-1)" "unprognostic (2.13e-1)" "unprognostic (9.88e-2)" 26.7 22.6 17.8 15.9 21.3 12.0 14.6 27.6 24.2 22.2 17.6 22.0 21.0 18.2 31.9 17.3 14.5 18.8 21.4 14.4 17.3 18.2 19.3 21.6 16.8 14.5 24.0 15.4 25.0 18.3 24.0 34.0 14.9 17.0 21.8 7.6 20.0 19.0 20.5 18.0 21.7 19.5 22.9 18.5 23.2 24.1 16.9 20.8 25.5 29.3 13.1 14.3 13.9 17.1 1.2 2.2 0.8 1.5 0.2 2.2 0.2 4.2 3.5 4.2 4.0 4.2 1.4 9.7 11.1 6.8 4.5 4.6 3.8 3.1 6.9 4.6 4.4 7.6 3.6 3.3 3.2 8.5 2.9 8.3 5.8 7.1 9.6 4.7 6.8 0.0 3.4 4.0 7.5 1.6 11.9 5.3 4.7 0.0 0.3 3.7 1.9 4.6 4.5 6.9 7.6 5.0 3.7 8.3 5.2 4.0 4.3 11.5 4.9 8.3 2.3 5.0 3.8 0.0 9.1 6.0 6.2 6.6 3.7 4.3 3.1 0.0 1.5 0.8 2.2 0.4 0.4 1.1 0.7 1.0 0.7 1.2 1.7 0.9 0.3 0.2 0.5 2.2 0.4 0.2 17.8 21.3 27.6 24.2 17.3 18.2 24.0 15.4 17.0 20.8 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867834-38878279 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.0;Karpas-707: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favourable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favourable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.5 3.7 6.3 10.2 10.3 5.4 10.4 6.5 5.8 2.6 3.9 4.2 6.2 3.4 1.8 2.4 5.3 4.6 6.1 3.9 5.1 6.4 5.0 6.0 7.0 20.4 5.5 3.8 1.7 17.4 4.9 5.7 3.3 5.5 2.6 3.5 5.9 7.9 4.5 3.0 3.2 6.3 2.6 4.5 13.0 6.1 1.4 3.5 7.6 6.4 3.1 15.7 4.3 2.9 16.6 12.3 3.1 2.1 4.1 8.7 2.9 0.0 1.3 0.4 0.2 0.6 0.3 2.6 0.3 0.2 0.3 0.4 2.3 6.9 7.7 3.6 0.4 0.2 1.3 2.9 0.4 1.7 0.8 9.6 2.0 4.9 1.6 5.4 17.0 1.6 0.5 0.9 0.6 3.4 1.9 20.0 0.0 1.2 1.7 3.8 0.6 0.3 1.1 0.1 5.8 1.9 0.2 2.6 1.1 3.1 5.1 2.7 0.6 6.6 2.2 0.1 1.5 0.4 0.0 8.6 7.1 6.1 0.6 3.0 0.4 3.1 0.9 1.5 8.7 2.1 5.5 12.4 5.8 6.3 1.6 16.6 4.6 5.4 2.8 4.1 2.0 12.3 6.1 2.9 6.3 10.3 6.5 5.8 5.1 6.4 5.5 3.8 5.5 3.5 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389496-7418037 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA017866: , HPA051446: " "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 13.8 10.6 7.7 13.2 13.0 17.5 13.1 12.2 13.5 12.7 11.6 7.3 4.0 7.3 15.4 6.0 15.6 12.3 8.5 11.8 8.0 8.1 8.7 11.7 10.1 14.2 11.6 9.4 13.8 15.3 7.7 17.8 13.9 13.3 10.7 9.6 7.2 10.2 10.3 18.8 12.5 9.9 15.5 9.4 14.4 10.3 21.3 9.2 19.2 10.1 14.7 16.8 10.9 12.6 15.4 14.9 7.7 11.1 18.6 15.0 8.2 7.5 4.4 7.1 16.7 11.1 9.1 10.9 9.5 6.4 8.9 7.4 12.8 3.9 19.7 16.9 7.7 7.7 17.9 7.6 11.4 13.0 19.3 10.5 7.1 13.7 9.4 30.2 13.8 6.7 10.6 9.6 19.8 7.8 26.8 4.6 8.3 9.9 20.5 14.3 15.3 10.4 15.8 9.3 21.4 5.0 7.4 23.7 11.7 8.0 4.8 13.8 7.3 10.0 7.8 9.8 7.4 6.4 14.3 6.4 12.1 29.3 3.0 15.6 14.9 7.7 8.5 5.9 11.5 11.1 13.8 15.2 11.9 12.1 14.9 15.4 13.7 15.0 1.7 18.6 9.7 12.4 11.3 8.2 7.7 13.0 12.2 13.5 8.0 8.1 11.6 9.4 13.3 9.2 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 22.2 20.1 14.8 17.1 17.5 24.4 19.7 26.3 18.6 19.1 17.0 8.9 14.0 17.3 17.5 17.1 17.0 15.0 10.7 19.6 15.7 13.4 21.0 23.6 13.3 17.6 20.0 11.1 20.7 21.5 15.1 37.5 15.8 19.7 19.5 17.3 10.3 18.7 16.6 24.9 13.3 20.2 16.3 20.7 22.5 16.4 14.8 18.6 25.8 21.7 20.7 17.4 20.7 21.0 15.2 17.8 9.4 18.7 17.8 24.1 13.5 8.8 10.4 9.7 18.8 12.8 14.0 15.5 22.3 13.8 15.8 21.0 14.2 15.6 19.6 25.4 10.0 10.5 16.5 13.0 21.7 13.8 9.1 9.8 20.1 19.8 11.5 18.6 13.8 9.2 10.2 19.3 19.6 12.8 14.8 12.7 18.1 14.8 21.7 22.2 11.5 11.2 24.5 18.9 28.8 12.4 8.1 12.1 9.0 13.5 14.0 15.3 14.7 17.7 13.7 20.3 14.1 16.1 24.2 12.5 16.2 44.0 12.1 19.1 18.4 7.0 16.0 9.4 16.3 18.7 22.3 15.2 20.7 17.8 17.8 11.0 22.5 24.1 3.2 17.8 13.4 17.8 18.5 13.5 14.8 17.5 26.3 18.6 15.7 13.4 20.0 11.1 19.7 18.6 RIOK3 SUDD ENSG00000101782 "RIO kinase 3" O14730 18 23452823-23486603 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001620, HPA024184" Approved Approved "Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus, Centriolar satellite" "HPA001620: AB_1079815, HPA024184: AB_1856289" "unprognostic (7.99e-2)" "unprognostic (1.71e-2)" "unprognostic (2.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.05e-1)" "unprognostic (7.48e-2)" "unprognostic (8.98e-3)" "unprognostic (1.01e-1)" "unprognostic (5.10e-2)" "unprognostic (4.20e-1)" "prognostic unfavourable (4.10e-4)" "prognostic unfavourable (5.80e-4)" "unprognostic (3.90e-2)" "unprognostic (1.46e-1)" "unprognostic (5.44e-2)" "unprognostic (1.39e-1)" "unprognostic (2.71e-2)" 10.1 8.7 6.9 11.7 7.7 52.4 10.9 8.9 10.1 14.7 21.4 8.5 5.9 15.6 8.8 9.3 41.0 7.8 10.7 11.5 6.1 5.5 10.5 19.9 10.1 10.7 9.1 6.2 7.6 10.7 7.5 11.6 21.4 11.6 6.8 14.7 6.0 14.9 7.0 40.0 13.3 36.5 15.2 10.5 8.9 12.9 22.7 7.6 11.1 7.3 16.0 16.5 13.7 21.5 11.7 11.0 21.7 21.5 8.3 11.2 10.0 14.7 5.8 6.0 7.8 11.0 12.3 10.9 14.8 10.9 10.5 10.1 6.6 15.9 10.2 19.4 16.4 19.3 10.2 16.8 16.2 10.1 4.2 9.5 10.8 8.3 27.5 26.7 8.3 14.7 32.0 18.6 25.8 14.5 13.7 12.9 15.7 7.8 9.2 4.4 5.6 11.6 10.4 12.6 12.4 12.0 19.3 14.0 10.1 18.9 8.6 10.8 7.6 14.5 22.9 17.3 4.3 7.6 9.6 23.2 19.6 15.2 10.2 12.4 12.9 21.7 13.5 8.0 9.1 19.6 6.9 8.2 7.6 7.9 11.0 11.7 6.1 6.9 9.3 8.3 21.5 5.1 11.2 10.0 6.9 7.7 8.9 10.1 6.1 5.5 9.1 6.2 11.6 7.6 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavourable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 13.9 9.6 12.7 13.6 16.7 2.2 14.1 8.1 11.1 9.8 11.0 12.2 14.5 8.1 10.7 11.3 20.4 11.3 12.1 8.2 10.9 12.6 13.1 14.2 9.1 13.1 13.9 11.9 14.2 22.5 13.8 15.0 27.1 14.1 11.2 13.9 10.2 20.3 11.3 27.1 14.9 8.3 11.2 14.7 12.1 10.5 6.6 11.2 6.3 48.4 12.8 15.6 14.7 12.5 13.1 21.8 1.6 11.1 8.2 13.6 9.1 20.2 12.2 4.3 9.4 10.3 15.7 11.5 9.9 7.6 11.7 9.6 8.2 10.7 27.1 11.4 11.2 11.8 13.8 14.1 18.4 51.3 6.4 8.5 5.3 9.8 16.6 17.4 4.0 12.0 19.1 8.9 21.9 11.8 11.8 12.1 11.8 5.9 13.8 5.7 9.4 16.2 0.0 14.7 27.0 11.8 11.9 23.3 8.4 10.6 14.6 16.5 13.0 7.3 9.5 11.7 12.9 6.3 20.4 17.9 9.2 27.2 13.7 17.4 12.5 1.6 10.9 0.6 8.7 9.4 13.3 13.1 13.6 10.6 13.4 10.3 13.2 10.8 0.7 8.2 11.1 21.8 12.0 9.1 12.7 16.7 8.1 11.1 10.9 12.6 13.9 11.9 14.1 11.2 RIPK1 RIP ENSG00000137275 "Receptor interacting serine/threonine kinase 1" Q13546 6 3063991-3115187 "Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010302, HPA015257" Supported Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB010302: AB_2178118, HPA015257: AB_1856294" "unprognostic (1.24e-1)" "unprognostic (6.83e-2)" "unprognostic (1.87e-1)" "unprognostic (7.75e-2)" "unprognostic (6.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (1.96e-1)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (5.00e-2)" "unprognostic (3.29e-1)" "unprognostic (9.65e-3)" "unprognostic (3.44e-1)" "unprognostic (9.01e-2)" "unprognostic (1.38e-2)" "prognostic favourable (6.71e-4)" 24.5 12.0 6.9 15.7 12.4 10.5 28.0 11.9 11.0 16.4 18.9 9.6 22.9 14.5 16.8 17.7 17.1 13.5 17.9 12.3 7.5 6.8 18.5 36.7 16.7 19.8 11.8 6.6 13.2 19.9 14.4 17.9 24.4 10.2 17.8 16.6 10.9 21.1 18.7 11.4 18.9 24.8 21.3 6.9 19.4 15.8 9.0 9.4 18.6 18.5 15.2 19.2 15.0 20.4 4.1 3.2 6.6 3.9 6.6 7.6 2.1 9.5 6.9 10.4 10.7 22.2 14.2 5.7 15.1 20.5 16.0 18.4 9.3 6.6 9.0 14.6 21.6 11.0 12.9 12.4 17.5 18.6 7.0 11.5 4.5 6.7 12.5 10.0 14.8 19.2 11.1 14.8 10.7 13.8 13.0 5.2 15.4 12.4 6.9 10.9 6.5 8.6 8.4 7.7 10.1 14.3 19.2 9.0 8.8 9.9 6.3 16.7 11.4 7.1 16.7 17.5 9.4 6.6 11.1 8.0 10.3 9.6 7.3 5.5 19.4 1.1 3.0 6.4 6.1 3.7 4.9 2.0 4.9 7.6 3.2 4.1 4.1 5.4 6.6 6.6 3.9 2.9 5.7 2.1 6.9 12.4 11.9 11.0 7.5 6.8 11.8 6.6 10.2 9.4 RIPOR1 "FAM65A, FLJ13725" ENSG00000039523 "RHO family interacting cell polarization regulator 1" Q6ZS17 16 67518418-67546788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 8.2;eosinophil: 6.4;intermediate monocyte: 12.0;memory B-cell: 12.3;myeloid DC: 7.6;naive B-cell: 8.1;neutrophil: 4.9;non-classical monocyte: 10.4;plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005923 Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA005923: AB_1078809" "unprognostic (7.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.56e-3)" "unprognostic (3.71e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (6.53e-4)" "unprognostic (1.10e-2)" "prognostic unfavourable (5.00e-5)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.38e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.82e-8)" "unprognostic (8.51e-2)" "unprognostic (3.52e-2)" "unprognostic (1.19e-1)" "unprognostic (7.46e-2)" 26.6 16.7 21.2 20.8 28.5 21.9 23.7 31.8 35.1 18.8 16.6 13.1 8.4 8.7 24.2 11.4 15.1 17.6 20.4 35.6 21.2 15.8 30.8 11.7 27.8 17.6 12.8 18.6 20.6 22.4 20.4 14.4 27.9 16.9 15.7 7.6 27.1 15.8 20.7 24.3 12.1 15.6 24.0 10.0 37.5 13.4 11.6 12.5 6.7 19.0 13.1 16.2 17.0 22.6 12.3 10.8 6.4 12.0 1.1 1.4 3.7 15.5 13.2 6.0 9.4 15.2 13.7 13.3 16.6 16.5 19.3 16.2 27.2 11.6 2.1 23.3 28.5 8.9 12.0 15.1 12.5 6.8 6.1 20.7 18.3 6.1 17.2 1.6 10.5 13.5 7.0 26.0 17.6 20.3 2.2 2.3 14.2 17.0 4.8 5.1 1.6 10.7 16.7 10.8 11.1 14.7 8.0 4.5 11.9 31.0 5.2 10.4 11.1 3.9 35.1 22.0 13.0 18.5 11.5 3.3 2.3 6.4 14.7 4.0 11.7 0.0 8.2 6.4 1.0 12.0 1.4 12.3 0.8 0.4 7.6 8.1 0.6 0.5 4.9 1.1 10.4 10.8 0.5 3.7 21.2 28.5 31.8 35.1 21.2 15.8 12.8 18.6 16.9 12.5 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.4" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA042051: , HPA044083: " "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 RLF "Zn-15L, ZNF292L" ENSG00000117000 "Rearranged L-myc fusion" Q13129 1 40161373-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA054653: , HPA057300: " "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavourable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 14.8 8.1 12.6 11.3 12.6 44.5 13.9 20.8 17.1 12.4 11.1 11.6 7.1 8.6 14.1 8.6 12.4 9.9 11.2 12.3 11.0 8.3 8.7 12.7 12.8 11.8 12.8 11.8 14.6 9.4 12.5 15.1 11.9 15.4 13.2 9.2 10.2 9.4 9.9 13.4 17.7 9.9 14.3 14.1 10.1 9.3 15.9 11.8 14.9 10.0 8.4 13.5 18.1 14.8 4.1 3.5 10.1 4.1 4.1 4.9 2.4 12.3 4.7 9.4 9.8 8.4 6.9 11.2 4.6 7.0 8.0 10.7 9.7 6.6 12.4 6.1 5.9 11.7 11.9 8.2 14.7 5.8 8.0 10.2 5.8 5.9 6.7 8.4 6.2 6.8 8.7 8.6 9.7 5.5 15.4 7.6 7.3 3.9 7.1 5.1 12.6 5.5 5.5 15.5 7.2 5.1 12.6 6.7 9.4 8.7 11.7 8.3 5.5 30.6 4.6 9.5 10.2 7.8 8.6 7.0 6.5 11.6 8.2 7.9 5.9 10.1 2.8 5.5 3.7 3.9 4.9 4.1 3.7 3.8 3.5 4.1 4.8 4.0 6.3 4.1 4.1 1.6 3.3 2.4 12.6 12.6 20.8 17.1 11.0 8.3 12.8 11.8 15.4 11.8 RLIM "MGC15161, NY-REN-43, RNF12" ENSG00000131263 "Ring finger protein, LIM domain interacting" Q9NVW2 X 74585217-74614617 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018895 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018895: AB_1856323" "unprognostic (1.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-1)" "unprognostic (1.31e-3)" "unprognostic (1.25e-1)" "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-1)" "unprognostic (3.82e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (6.04e-4)" "unprognostic (1.20e-1)" 11.8 14.3 17.5 10.6 25.6 37.4 12.4 12.6 20.5 12.2 7.4 8.3 5.6 6.4 10.6 8.0 10.2 9.5 10.7 10.5 17.1 16.6 11.6 9.7 13.8 9.2 12.4 13.7 12.4 9.7 19.5 18.5 10.5 28.6 11.9 7.6 5.2 8.9 8.7 11.2 10.2 7.1 10.1 13.9 9.8 8.4 6.9 12.4 9.7 13.0 6.2 10.1 10.5 9.3 3.5 4.8 16.3 7.4 5.2 4.6 3.0 13.5 13.8 13.4 11.2 13.5 14.3 13.2 13.1 15.2 11.7 14.5 10.7 14.2 7.3 15.3 16.4 11.8 26.9 15.7 18.0 6.6 14.2 12.8 24.3 6.5 12.0 19.3 22.9 13.8 9.9 16.7 28.7 13.6 11.1 13.3 15.4 10.3 14.3 10.9 20.6 13.3 13.7 28.4 12.3 10.9 16.2 9.9 11.5 24.5 11.9 15.2 6.7 15.2 18.0 14.2 13.8 14.5 11.4 7.1 13.6 11.7 15.5 19.6 13.8 16.3 5.9 5.6 3.2 7.4 3.3 3.0 4.1 4.0 4.8 3.5 4.5 4.1 11.4 5.2 5.4 2.6 4.6 3.0 17.5 25.6 12.6 20.5 17.1 16.6 12.4 13.7 28.6 12.4 RMDN1 "CGI-90, FAM82B, FLJ20665, RMD1" ENSG00000176623 "Regulator of microtubule dynamics 1" Q96DB5 8 86468257-86514357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026495 Approved Supported "Actin filaments,Centrosome" Centrosome "Actin filaments" "HPA026495: AB_1848414" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.02e-1)" "unprognostic (2.09e-1)" "unprognostic (1.60e-1)" "prognostic favourable (8.51e-4)" "unprognostic (2.08e-1)" "unprognostic (7.15e-2)" "unprognostic (4.71e-3)" "unprognostic (3.47e-1)" 20.4 20.1 19.0 19.5 18.4 12.2 16.9 10.8 13.3 13.8 22.5 13.9 7.7 16.3 11.6 13.3 21.1 12.4 14.2 44.3 17.6 16.7 35.0 32.5 21.0 23.6 22.2 10.7 11.6 13.0 14.5 15.6 12.7 19.1 12.6 17.2 13.6 12.2 18.9 45.2 18.5 29.0 17.7 23.1 19.2 16.9 14.4 15.3 25.6 29.3 27.1 18.0 14.3 11.2 17.8 22.1 38.6 27.9 15.5 18.0 12.6 21.3 9.3 10.9 6.2 21.5 35.3 13.3 15.7 14.2 12.5 12.3 11.0 13.7 25.6 13.4 13.0 20.9 13.9 15.7 15.0 21.7 10.9 13.4 11.0 27.5 11.5 6.0 0.3 19.1 14.9 16.7 25.9 28.1 14.1 14.1 19.8 19.3 21.3 2.8 5.5 23.4 12.2 15.3 26.3 14.8 13.5 5.1 11.5 13.0 51.9 22.1 29.2 11.3 15.2 14.0 22.7 17.7 9.4 18.3 15.1 19.9 18.3 9.7 18.9 5.6 17.1 38.6 12.3 21.6 14.3 17.8 12.8 14.4 19.5 12.3 10.6 13.7 6.8 15.5 27.9 22.1 18.0 12.6 19.0 18.4 10.8 12.5 17.6 16.7 22.2 10.7 19.1 15.3 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Cell line enhanced" "Detected in many" "HSkMC: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: , HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favourable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.3 3.9 2.6 1.7 11.9 12.2 1.5 7.1 9.2 3.6 3.7 1.0 11.2 2.3 3.1 10.6 3.9 0.9 4.8 4.5 4.6 2.6 4.0 1.5 3.4 6.2 0.0 4.1 17.4 3.8 4.9 0.7 2.0 4.7 2.0 6.4 1.3 0.7 4.0 5.1 3.9 0.0 0.6 0.4 9.3 3.0 2.0 7.8 5.6 0.6 6.3 1.2 5.4 2.8 5.0 5.3 2.6 2.8 3.9 6.7 4.7 5.9 0.9 5.0 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favourable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.3 22.1 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.4 29.2 10.3 16.4 0.6 19.0 14.7 23.2 22.7 13.6 29.0 15.5 18.5 14.1 14.8 11.1 9.2 10.5 24.2 20.0 5.9 17.1 11.6 10.0 7.4 15.4 18.3 11.2 16.8 11.5 14.3 22.5 8.2 17.5 23.7 8.2 18.6 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.2 16.6 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980711-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavourable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 9.3 9.9 6.2 16.6 7.5 3.9 5.1 13.1 6.1 5.7 7.6 2.9 5.9 7.6 4.1 6.3 7.7 7.5 3.5 3.8 5.3 8.5 5.5 6.3 7.0 13.2 7.4 3.5 5.4 10.0 9.1 7.5 11.0 9.6 6.6 9.1 3.9 7.7 6.3 6.4 5.4 10.5 4.0 8.1 21.0 7.1 11.7 4.8 35.7 7.3 6.3 11.4 5.6 4.5 4.3 9.8 14.4 8.1 5.1 3.9 3.7 13.8 9.5 20.1 7.0 3.1 4.9 18.9 13.9 7.9 12.7 11.7 4.6 9.4 29.3 5.0 6.8 20.2 13.4 6.7 14.8 16.8 3.4 12.3 7.7 5.8 4.5 22.7 12.7 4.3 4.3 10.1 7.5 6.0 9.2 15.1 13.2 9.8 28.3 7.9 17.2 9.1 26.2 19.7 10.9 5.8 5.9 17.2 10.6 13.0 9.9 5.4 10.6 10.1 4.2 13.2 8.6 13.0 11.0 6.6 13.8 11.2 8.4 9.9 14.2 14.4 6.1 11.2 2.8 7.3 3.3 4.3 3.3 2.9 9.8 4.0 3.2 3.7 10.6 5.1 8.1 2.8 3.9 3.7 6.2 7.5 13.1 6.1 5.3 8.5 7.4 3.5 9.6 4.8 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favourable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavourable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.0 12.8 25.1 10.7 1.1 5.5 10.5 11.1 8.8 10.5 17.6 4.9 22.7 26.5 9.6 5.2 11.2 10.7 10.6 17.1 5.2 10.0 14.5 7.6 32.4 0.4 5.6 6.5 1.2 2.0 4.5 4.4 5.7 20.0 21.1 5.5 22.0 19.2 26.0 21.1 5.1 23.3 27.1 28.3 6.2 12.4 14.5 11.5 9.4 15.8 8.2 26.7 8.4 1.8 8.5 7.9 16.2 1.6 5.8 9.5 31.4 7.9 18.4 15.5 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 73.2 7.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 28.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 38.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favourable (1.18e-4)" "prognostic favourable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favourable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavourable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.8 11.2 6.8 6.8 1.0 1.9 8.4 6.9 2.9 10.4 12.1 8.8 5.7 15.9 10.5 1.6 8.9 5.5 6.8 5.7 8.6 15.0 7.6 11.9 6.8 0.7 7.0 7.1 1.0 1.7 8.8 3.2 4.0 10.5 4.7 4.9 25.5 12.8 6.9 6.7 19.6 13.8 9.8 11.4 2.6 5.9 14.1 8.2 7.5 2.7 3.1 7.4 4.3 3.8 12.4 6.2 17.6 11.4 11.5 12.7 12.6 7.3 11.2 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.2;THP-1: 6.1;U-87 MG: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.1 3.5 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.1 2.3 1.0 1.8 0.2 0.0 0.6 0.7 5.2 0.7 0.0 4.3 0.0 2.9 1.0 2.7 0.0 0.6 0.0 0.0 1.6 0.0 0.7 0.6 0.0 0.0 1.2 1.9 2.2 2.2 1.2 1.4 0.0 0.0 0.7 0.7 0.5 1.8 0.0 0.0 0.2 0.6 6.1 0.0 0.0 0.2 3.5 0.9 0.0 0.8 0.2 6.8 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;liver: 50.6" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" "Vesicles, Plasma membrane, Actin filaments" "HPA077800: " "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 2.9 1.3 9.9 2.6 15.0 2.0 2.8 2.6 21.8 1.4 2.8 1.4 0.2 2.6 4.4 1.5 1.8 1.1 13.3 2.5 7.4 7.6 1.8 50.6 12.3 1.4 7.1 8.6 0.9 2.0 3.2 3.2 1.6 8.6 3.7 2.3 1.0 4.0 1.5 0.6 0.6 2.3 2.6 5.6 0.9 6.1 0.8 2.3 0.0 5.5 2.1 2.4 6.9 2.0 1.7 1.7 0.0 0.0 0.5 1.6 0.2 0.6 4.2 2.1 1.1 0.4 0.0 0.3 0.0 0.2 0.6 0.7 2.6 0.9 3.2 0.8 0.0 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.0 1.6 0.2 0.9 0.6 0.0 0.1 0.3 0.4 1.1 0.1 3.3 0.0 5.4 0.4 0.2 5.0 0.2 1.0 0.2 1.5 0.6 0.8 0.0 0.5 0.1 38.6 0.1 3.8 0.1 0.2 0.0 0.4 0.0 0.5 1.7 2.8 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 1.7 0.2 0.1 1.7 1.1 0.7 0.1 0.0 0.5 0.0 0.0 0.4 0.2 9.9 15.0 2.6 20.4 7.4 7.6 7.1 8.6 8.6 2.3 RNF10 "KIAA0262, RIE2" ENSG00000022840 "Ring finger protein 10" Q8N5U6 12 120533480-120577594 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052643 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA052643: " "unprognostic (1.54e-1)" "unprognostic (3.04e-1)" "unprognostic (5.40e-2)" "unprognostic (2.83e-3)" "unprognostic (1.09e-2)" "unprognostic (3.58e-2)" "prognostic unfavourable (5.30e-5)" "unprognostic (5.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.40e-1)" 26.2 37.7 32.6 23.0 34.5 64.3 64.2 33.4 44.0 27.7 30.5 25.3 30.1 23.8 24.1 41.4 40.2 22.5 32.2 79.6 32.4 27.0 36.0 37.9 43.8 44.8 27.2 27.0 25.2 34.0 36.0 27.0 26.5 21.9 25.2 27.7 23.8 26.6 33.8 118.9 26.6 29.5 32.1 26.9 29.0 28.1 46.0 23.5 23.9 25.7 45.0 27.0 28.4 51.7 11.3 17.7 49.7 15.2 13.1 17.2 14.0 29.5 39.2 19.3 30.6 37.8 30.0 22.8 27.9 31.8 23.2 24.7 32.2 13.7 35.1 25.5 46.0 20.5 35.3 37.8 33.2 34.4 19.8 35.9 21.9 33.2 50.8 32.1 25.4 30.5 43.8 32.5 44.8 46.9 35.7 24.3 34.7 34.0 21.1 35.3 29.2 39.1 19.0 24.7 50.1 45.8 60.9 19.0 20.7 38.8 25.1 21.3 40.4 18.7 37.2 16.9 18.9 26.9 18.0 21.1 37.7 24.9 28.0 22.0 18.1 41.0 15.2 49.7 14.3 13.2 15.5 11.3 14.1 16.3 17.7 10.0 12.8 12.8 35.1 13.1 14.8 9.1 17.2 14.0 32.6 34.5 33.4 44.0 32.4 27.0 27.2 27.0 21.9 23.5 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 12.8 11.2 15.3 15.6 19.3 21.2 12.7 24.1 21.9 15.1 9.8 18.8 10.9 11.4 16.4 9.8 16.2 12.6 13.0 11.0 13.0 13.0 12.9 14.8 13.3 13.9 15.7 15.5 16.8 14.8 20.8 19.2 16.7 17.8 12.7 10.3 12.9 14.9 12.5 15.0 14.1 10.9 11.7 14.2 14.3 12.0 15.7 16.9 14.9 16.4 6.5 17.8 15.8 14.8 7.9 5.2 26.7 9.9 3.3 6.1 2.0 9.7 22.7 14.5 12.4 12.6 14.2 12.4 12.8 15.0 12.8 16.5 9.9 6.5 12.0 14.5 17.8 19.2 3.9 9.5 16.0 12.4 8.1 14.9 9.2 7.6 13.7 8.6 16.8 11.1 10.4 13.8 15.3 14.2 13.7 12.1 15.7 4.7 11.4 5.6 11.9 8.8 11.5 20.7 9.8 9.8 17.5 11.9 17.4 11.5 11.4 11.1 8.9 10.7 16.3 20.5 17.2 10.7 12.2 8.7 11.9 14.3 12.5 14.0 15.4 6.4 9.9 9.3 4.8 7.0 4.8 7.4 4.9 4.3 5.2 7.9 5.5 4.2 26.7 3.3 7.6 4.9 6.1 2.0 15.3 19.3 24.1 21.9 13.0 13.0 15.7 15.5 17.8 16.9 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953892 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavourable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavourable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favourable (3.01e-4)" "unprognostic (1.36e-2)" 23.2 21.3 24.4 18.3 25.7 31.2 20.6 26.7 23.1 24.0 29.7 32.6 21.1 29.5 20.3 23.4 20.2 23.6 20.1 21.9 23.0 25.3 30.3 31.6 24.4 24.0 28.3 19.4 28.4 36.8 16.1 21.6 40.6 23.7 24.5 21.3 27.1 27.8 24.1 43.8 15.2 33.9 17.6 29.3 36.3 24.2 101.9 24.1 28.3 37.9 20.0 24.1 22.6 25.0 28.5 32.5 43.4 44.6 23.7 29.4 34.9 15.6 15.4 7.9 8.3 16.3 11.3 23.3 14.0 15.9 29.0 12.3 45.7 12.9 7.6 28.0 7.4 12.6 11.8 14.1 10.0 13.7 8.6 9.6 10.3 32.1 14.3 17.4 11.6 9.8 13.0 11.1 7.6 6.9 18.0 8.9 8.5 52.6 14.6 18.1 8.2 22.1 16.0 8.3 13.7 15.3 12.8 12.1 8.7 17.1 108.1 21.6 28.8 16.2 9.1 26.3 12.2 13.8 16.1 18.3 19.1 14.4 14.9 11.4 14.5 38.5 42.5 35.7 22.0 39.2 24.6 28.2 24.6 22.4 32.5 28.5 29.4 23.7 43.4 23.7 44.6 26.7 28.8 34.9 24.4 25.7 26.7 23.1 23.0 25.3 28.3 19.4 23.7 24.1 RNF115 "CL469780, ZNF364" ENSG00000265491 "Ring finger protein 115" Q9Y4L5 1 145738868-145824077 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019130 Approved Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA019130: AB_1859220" "unprognostic (3.44e-2)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (2.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.64e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" "unprognostic (3.23e-1)" "unprognostic (4.77e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" 7.2 5.2 6.8 4.8 6.8 6.4 7.7 16.2 7.0 6.3 3.4 4.6 5.7 3.5 8.9 5.0 5.8 4.3 4.8 23.5 5.8 5.6 5.1 3.9 5.6 4.7 6.2 4.7 4.5 5.8 5.9 3.5 5.2 6.5 3.8 7.3 3.6 5.6 27.6 3.8 3.1 10.9 4.5 4.2 3.8 3.4 4.5 6.0 5.0 5.4 4.5 4.1 6.3 2.7 2.4 9.0 2.2 3.2 3.2 1.4 11.1 4.6 5.7 4.2 10.4 13.7 4.6 8.4 15.7 6.2 7.6 5.0 4.1 7.8 9.6 12.0 7.8 6.3 5.8 6.8 7.8 4.1 6.2 5.9 4.6 6.6 9.7 14.5 7.9 5.1 6.3 7.6 8.0 6.1 12.8 11.3 8.4 7.1 6.2 7.2 9.8 6.8 5.7 6.5 12.2 3.8 5.7 7.9 6.8 8.5 6.2 9.3 9.3 9.8 9.1 7.1 5.4 8.9 10.8 10.2 8.3 4.6 6.6 5.7 9.0 2.2 3.2 3.2 1.5 2.7 2.7 2.2 3.2 1.8 2.4 2.3 3.1 1.7 3.2 1.6 2.4 2.0 1.4 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favourable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 5.0 10.9 11.3 8.3 11.0 8.6 7.9 9.3 10.1 14.8 15.6 21.3 11.2 4.7 8.2 10.5 11.9 12.4 11.2 16.0 6.7 7.2 7.9 10.7 10.5 8.2 6.8 6.7 8.1 10.1 16.0 9.7 26.4 11.8 5.0 13.0 11.4 4.6 7.8 7.8 11.1 5.9 23.9 4.3 16.8 9.9 8.0 8.6 12.1 10.4 17.0 12.0 5.0 16.4 10.5 10.0 7.0 7.8 6.1 5.5 5.3 9.2 4.4 9.3 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018372-32073213 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavourable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 21.9 2.3 4.1 9.1 5.7 18.2 20.4 1.2 6.6 5.0 8.9 12.2 3.3 12.3 7.2 5.5 3.9 4.3 6.0 5.4 6.1 4.1 2.1 14.1 10.3 13.5 7.7 3.1 2.4 4.2 2.5 1.3 4.4 7.0 3.1 7.8 1.6 5.0 1.9 4.4 6.0 26.0 4.1 12.0 7.4 4.2 3.3 8.3 14.8 3.2 2.9 7.2 4.5 6.2 2.1 3.4 9.0 3.8 11.7 12.5 5.1 0.7 0.1 0.1 0.2 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.5 0.9 0.7 0.1 3.9 1.6 0.2 0.2 0.2 0.1 5.1 31.8 1.0 1.5 0.0 1.7 0.3 0.1 1.1 0.0 1.1 1.3 4.8 2.6 0.9 5.4 0.3 0.1 0.3 0.3 0.5 0.2 0.1 0.1 7.8 0.8 2.5 0.1 0.1 0.5 0.1 0.0 3.7 0.1 0.1 0.4 6.8 4.2 9.0 3.8 3.3 12.5 2.0 8.2 2.0 10.1 10.5 3.4 2.1 8.2 10.6 1.5 11.7 1.9 3.4 10.0 5.1 4.1 5.7 1.2 6.6 6.1 4.1 7.7 3.1 7.0 8.3 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663277 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 14.2 14.2 13.4 17.0 13.7 18.7 14.5 12.2 24.7 9.8 16.0 14.8 7.4 24.3 10.4 9.2 19.8 9.5 13.1 14.2 13.1 10.2 11.6 27.9 10.4 19.9 11.4 11.6 12.1 22.4 5.9 10.0 14.1 12.3 10.0 6.3 10.1 13.2 9.3 50.3 21.9 20.3 9.9 10.0 18.6 21.0 33.6 9.3 16.1 8.6 19.5 18.6 13.1 11.2 15.9 13.6 7.5 13.8 17.1 17.3 9.2 25.9 8.6 7.3 10.4 1.7 2.4 12.5 13.7 5.2 7.9 7.5 17.4 9.1 21.5 8.9 5.7 17.5 4.4 10.2 2.2 14.2 31.8 10.9 9.0 14.4 6.6 21.7 16.1 4.1 8.1 6.5 5.1 7.2 21.9 21.7 4.1 20.9 22.1 10.2 19.5 17.0 16.1 6.3 33.9 6.0 14.5 17.5 13.6 10.3 13.6 14.0 8.7 17.1 9.4 14.4 10.4 21.1 23.3 38.4 19.0 25.2 18.3 12.7 14.8 0.6 9.8 7.5 17.3 11.5 14.2 15.9 15.7 16.7 12.4 15.6 12.2 11.4 2.2 17.1 13.8 13.6 16.8 9.2 13.4 13.7 12.2 24.7 13.1 10.2 11.4 11.6 12.3 9.3 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA064784: " "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favourable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.4 12.1 8.2 9.3 32.3 19.8 13.7 10.8 27.8 10.4 15.5 10.6 28.0 8.1 15.8 13.2 18.5 11.0 13.8 14.7 9.9 8.0 9.7 5.6 10.3 21.5 10.4 13.9 20.9 26.3 8.8 23.9 11.5 3.0 16.5 9.3 10.9 7.5 6.9 5.5 9.5 5.4 8.8 34.3 20.2 9.1 4.3 12.5 8.9 13.4 34.7 25.5 11.1 12.0 14.2 5.7 15.0 6.9 28.0 18.4 16.7 11.9 9.8 7.6 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511678-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favourable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 14.0 17.6 27.9 14.8 39.0 10.0 15.8 10.2 28.8 10.9 10.0 44.4 6.0 12.5 8.2 11.8 33.7 9.7 8.4 12.8 30.1 23.6 14.2 12.4 12.3 9.4 44.7 18.7 6.5 8.2 19.4 9.5 8.5 33.7 13.6 9.9 7.3 20.6 8.8 23.9 24.2 17.5 7.8 56.2 15.1 12.3 42.2 39.3 7.7 13.3 12.8 15.4 10.6 12.9 19.1 8.2 43.5 29.2 2.4 4.2 8.6 17.3 9.1 12.6 7.6 19.3 18.8 9.3 11.9 9.3 4.5 5.5 13.6 62.3 7.2 10.9 9.1 12.6 5.4 13.6 6.9 7.8 7.3 4.9 5.8 7.0 7.5 7.7 5.9 12.4 15.9 2.4 15.0 12.2 13.2 6.8 11.2 7.3 7.7 2.9 6.3 5.1 9.8 5.7 7.8 7.3 18.8 3.9 8.3 11.5 13.4 7.3 8.6 4.1 12.9 11.3 7.0 9.3 3.6 3.0 5.8 8.0 13.9 11.0 13.6 8.5 15.0 25.2 2.5 29.2 4.2 19.1 2.9 2.4 8.2 18.4 3.3 2.2 43.5 2.4 27.0 7.6 3.4 8.6 27.9 39.0 10.2 28.4 30.1 23.6 44.7 18.7 33.7 39.3 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;hTCEpi: 17.4;HUVEC TERT2: 16.1;TIME: 16.1;U-698: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: , HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.6 3.2 3.5 0.0 0.1 54.7 15.0 0.6 4.7 0.0 4.6 4.6 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.4 1.2 3.9 16.1 0.0 0.0 0.8 0.5 0.4 0.0 0.4 0.3 0.2 0.5 3.3 9.8 3.0 0.5 0.0 0.3 7.0 5.2 8.2 0.1 16.1 2.5 0.5 0.2 0.3 0.0 0.0 46.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavourable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.1 20.0 30.7 36.8 32.5 14.5 6.0 16.2 28.3 15.0 24.4 6.9 16.8 6.9 29.1 14.2 26.5 24.2 21.3 26.5 28.5 8.6 14.6 22.7 5.7 13.9 9.6 14.0 8.9 38.5 13.9 20.5 14.7 14.5 26.8 14.0 0.5 10.9 3.0 13.2 10.2 14.6 13.4 13.8 20.0 7.0 11.2 20.7 16.3 17.5 26.6 12.3 8.8 15.6 16.8 15.5 13.4 28.6 5.9 8.3 6.5 19.6 12.0 36.0 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266610-127288567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favourable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favourable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 27.3 20.9 28.5 16.6 29.1 5.1 23.9 63.7 34.5 22.7 18.6 29.2 10.5 11.8 32.0 35.2 14.2 17.9 21.3 25.2 26.3 21.7 20.9 16.8 21.0 17.3 30.0 27.7 28.5 12.6 26.5 27.4 27.8 31.3 18.6 17.6 17.5 16.7 20.3 55.9 16.0 15.2 26.1 28.7 24.6 15.5 16.3 27.7 9.2 26.7 15.5 17.6 19.2 18.7 11.7 14.2 22.8 22.8 11.5 10.3 9.1 5.5 7.0 26.7 23.5 24.7 24.8 9.7 18.9 30.2 10.1 14.5 9.1 8.4 10.0 13.4 15.4 7.1 7.9 8.8 14.8 11.5 6.9 12.7 8.4 12.7 24.5 7.5 9.0 21.6 18.7 11.4 22.8 17.7 13.6 9.8 22.2 10.6 7.3 13.6 9.7 7.3 9.4 6.9 5.0 14.4 6.1 16.0 16.1 7.3 10.4 11.6 7.1 26.0 20.8 17.8 5.9 18.4 13.3 14.2 8.8 6.6 13.6 13.2 16.8 16.8 18.9 16.1 9.3 20.0 9.7 11.1 8.0 10.3 14.2 11.7 7.3 10.2 22.8 11.5 22.8 7.1 8.6 9.1 28.5 29.1 63.7 34.5 26.3 21.7 30.0 27.7 31.3 27.7 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favourable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.6 5.7 4.3 5.5 16.3 16.4 25.5 12.0 15.8 16.2 18.3 14.4 25.6 2.8 14.5 11.8 19.7 6.1 12.2 15.1 8.4 8.4 6.0 5.1 24.3 21.8 6.4 9.7 15.0 20.1 19.2 12.7 29.5 5.2 9.0 16.2 8.2 8.6 6.5 3.0 10.4 5.6 7.2 11.1 19.1 23.7 5.7 4.2 7.2 17.9 17.3 4.8 8.7 19.5 8.2 4.7 12.2 2.6 18.3 10.7 0.1 2.6 9.0 6.0 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142453-76240373 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;skeletal muscle: 52.2;testis: 24.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.3;U-266/70: 21.9;U-266/84: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.5;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 10.5 3.5 21.0 3.4 19.4 2.3 2.5 10.7 36.5 1.5 7.6 8.0 0.4 8.2 1.9 3.6 1.5 2.4 1.8 3.6 26.4 15.5 5.1 1.4 1.4 4.5 19.7 12.0 1.4 3.6 8.8 2.7 2.1 25.3 1.8 6.6 6.8 1.9 2.0 52.2 1.5 7.3 2.2 11.3 3.0 2.4 24.7 5.9 0.0 3.8 1.5 2.8 1.5 0.5 0.7 0.4 2.5 0.3 1.1 8.5 1.4 0.1 3.4 12.4 4.5 4.0 2.0 5.7 0.1 3.9 0.8 0.4 1.4 1.3 0.0 1.8 0.3 0.1 10.9 0.0 0.7 41.3 3.7 0.0 1.2 1.9 0.6 0.5 4.7 1.1 0.0 1.5 0.0 0.1 6.4 0.1 1.5 3.3 1.8 0.3 2.0 8.8 0.0 0.1 0.0 1.5 1.3 2.2 10.2 2.2 0.0 4.9 0.3 2.1 0.0 0.8 1.0 6.1 3.9 21.9 17.6 0.0 0.3 0.0 6.3 2.5 0.3 0.4 2.3 0.2 4.9 0.3 5.1 4.0 0.2 0.7 8.5 5.5 1.7 1.1 0.3 0.4 2.1 1.4 21.0 19.4 10.7 36.5 26.4 15.5 19.7 12.0 25.3 5.9 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Cell line enhanced" "Detected in some" "AF22: 12.5;HaCaT: 6.8;HeLa: 6.7;RPMI-8226: 6.5;SCLC-21H: 12.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041615: , HPA047798: " "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.5 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 6.8 0.5 1.0 0.0 0.0 1.0 0.1 6.7 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 1.0 1.7 1.2 2.4 0.5 6.5 0.8 2.1 12.9 14.7 2.3 0.0 0.0 0.3 0.5 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell line enhanced" "Detected in all" "NB-4: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favourable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavourable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.1 6.7 5.2 8.2 2.5 2.2 9.9 4.2 2.7 5.0 2.3 4.5 2.7 5.0 5.5 2.4 4.6 3.0 2.8 2.0 2.6 9.0 6.8 4.9 7.6 6.8 6.7 8.7 2.6 2.7 4.0 3.2 5.2 11.3 3.7 2.0 8.2 15.6 43.8 8.5 9.0 14.7 3.3 13.0 2.2 1.9 4.8 5.4 9.6 2.0 5.2 5.7 22.9 7.2 3.8 5.6 5.6 5.1 8.4 4.9 12.2 3.3 25.5 5.2 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046109: " "unprognostic (6.15e-3)" "prognostic favourable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavourable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 20.8 9.3 8.9 10.7 11.1 31.6 18.7 21.1 13.0 13.6 11.2 10.7 12.3 11.1 13.9 8.5 14.3 10.1 10.9 12.0 10.2 10.2 7.5 18.8 14.3 12.0 13.8 11.0 14.6 9.2 12.0 8.1 9.9 15.3 10.1 10.8 9.1 11.0 13.6 20.8 20.1 10.1 12.9 10.5 11.7 10.7 18.4 13.4 17.6 9.6 13.9 15.2 14.7 17.1 6.2 5.8 21.8 10.0 7.7 11.6 5.7 12.3 4.9 8.9 11.6 8.3 6.1 12.7 7.6 4.8 5.1 8.1 9.6 6.1 13.1 17.6 6.3 12.6 12.4 9.0 7.9 6.2 6.1 24.9 12.5 11.9 4.3 7.6 6.2 6.0 3.5 8.0 7.1 7.4 7.4 13.8 5.1 20.9 25.1 4.5 10.5 6.5 11.3 10.3 10.6 4.3 17.1 7.4 7.5 8.6 10.6 6.5 16.0 6.8 7.3 8.9 7.0 9.4 10.0 11.8 11.1 19.9 8.7 9.2 7.0 21.8 6.6 7.5 11.6 7.1 10.4 5.7 9.8 8.3 5.8 6.2 8.7 9.1 7.3 7.7 10.0 5.5 6.2 5.7 8.9 11.1 21.1 13.0 10.2 10.2 13.8 11.0 15.3 13.4 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748868-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA058368" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA038505: , HPA046138: , HPA058368: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavourable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 12.3 7.0 12.0 11.6 14.0 23.1 12.0 22.6 15.6 13.1 11.2 12.2 6.3 7.4 14.2 8.2 20.6 10.7 10.8 9.2 12.6 5.9 8.9 9.3 16.9 11.3 15.4 9.1 14.6 10.7 17.5 10.4 8.6 13.9 10.5 10.0 8.4 12.4 8.8 15.0 14.1 10.3 14.2 10.1 12.6 10.3 7.2 14.9 12.6 11.5 7.4 12.5 13.1 15.8 0.6 0.8 5.0 1.9 1.2 1.6 0.6 8.1 6.3 7.6 7.5 5.0 6.6 3.1 6.4 6.1 7.2 6.3 10.5 6.2 14.6 6.6 7.7 7.9 10.3 7.7 9.5 7.3 6.6 10.1 11.6 4.1 5.7 5.3 8.5 6.1 6.1 8.2 18.7 11.6 8.9 11.8 7.2 6.9 9.1 9.6 3.0 4.1 8.6 18.2 8.0 4.6 8.6 3.4 6.2 8.7 6.6 13.9 8.2 6.9 7.7 12.0 10.1 7.5 5.7 8.6 4.5 17.4 2.4 5.9 6.9 2.8 1.9 1.5 1.6 1.1 1.2 0.3 1.5 0.9 0.8 0.6 1.1 0.9 5.0 1.2 1.0 0.8 1.2 0.6 12.0 14.0 22.6 15.6 12.6 5.9 15.4 9.1 13.9 14.9 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597613 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046112: , HPA062121: " "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavourable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favourable (4.59e-5)" "unprognostic (1.49e-2)" 32.9 41.5 42.2 26.4 36.2 32.8 40.4 19.0 38.7 34.4 40.5 33.0 36.0 34.5 28.1 44.5 40.2 33.3 34.8 52.4 34.5 32.9 57.8 85.1 36.0 33.1 41.2 29.3 31.6 85.1 21.8 20.2 50.7 36.0 34.2 35.4 32.1 42.1 45.7 47.0 30.4 46.5 33.2 42.2 37.2 35.7 36.3 31.3 31.0 43.7 39.2 42.6 43.8 29.4 53.2 80.2 78.6 94.7 39.3 54.4 83.3 32.2 32.7 25.5 27.6 26.1 32.3 41.2 27.3 53.8 58.3 55.4 49.9 34.3 30.8 53.7 40.5 30.3 22.0 43.7 62.7 35.0 27.1 23.4 16.9 59.9 45.8 25.9 32.1 33.7 58.1 38.8 65.0 48.4 27.4 32.1 78.6 51.7 24.4 60.3 17.8 49.4 26.1 53.6 43.7 54.4 30.1 15.2 20.1 23.1 33.6 44.8 33.3 34.3 41.8 28.6 20.4 57.2 38.9 44.8 37.3 38.6 44.7 39.1 25.1 40.4 94.7 71.6 40.7 69.3 37.7 53.2 42.6 39.1 71.0 44.3 36.7 36.8 78.6 39.3 51.8 80.2 54.4 83.3 42.2 36.2 19.0 38.7 34.5 32.9 41.2 29.3 36.0 31.3 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Cell line enhanced" "Detected in many" "HeLa: 36.3;RPTEC TERT1: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 5.2 0.0 1.8 2.2 0.3 2.6 3.6 7.4 7.1 0.1 0.0 0.0 0.0 2.8 0.0 6.1 0.0 13.5 0.0 2.0 0.1 36.3 0.0 0.0 0.0 0.0 1.2 0.0 11.3 0.1 0.1 0.2 0.0 5.1 0.0 0.0 0.9 2.9 10.1 1.5 1.2 0.4 29.1 0.0 6.3 6.0 0.2 0.0 10.2 0.0 1.0 2.7 9.0 1.9 0.1 6.0 0.0 0.0 0.0 6.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 RNF187 "RACO-1, RACO1" ENSG00000168159 "Ring finger protein 187" Q5TA31 1 228487061-228495766 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030098 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030098: AB_10602923" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (2.83e-4)" "unprognostic (4.90e-3)" "unprognostic (1.13e-1)" "unprognostic (2.93e-2)" "unprognostic (3.46e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (5.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.92e-3)" "unprognostic (1.59e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" 15.7 30.3 25.6 12.5 28.1 12.3 10.3 33.2 54.7 11.4 10.7 15.5 12.5 14.7 12.9 12.2 18.0 14.2 14.5 17.7 25.2 24.9 16.2 20.4 11.5 9.8 20.2 29.3 20.2 19.4 22.3 16.4 8.8 22.7 15.0 6.6 12.3 30.3 12.6 55.5 15.5 13.2 8.6 16.3 19.0 14.2 9.5 11.4 11.1 27.9 19.4 11.2 10.0 13.1 2.0 1.7 8.7 2.1 1.0 2.3 0.6 9.3 7.0 4.9 10.3 5.4 3.5 9.5 7.8 4.8 4.9 3.7 3.6 6.5 21.2 16.3 8.9 7.4 6.2 6.6 1.8 9.6 8.0 6.4 5.2 4.6 14.7 7.3 12.6 6.1 11.8 3.8 5.1 4.3 10.2 41.5 3.5 5.2 11.6 6.5 11.0 7.2 9.9 4.5 20.0 3.5 5.9 10.9 11.0 7.9 16.5 21.0 11.6 17.5 9.9 6.1 6.3 6.6 7.4 75.5 22.6 11.6 16.4 7.7 10.2 0.0 1.1 8.7 1.3 2.1 1.5 1.2 1.5 2.3 1.4 2.0 1.4 1.2 0.3 1.0 1.4 1.7 1.3 0.6 25.6 28.1 33.2 47.3 25.2 24.9 20.2 29.3 22.7 11.4 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045364-185102608 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavourable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 17.8 15.0 14.3 13.9 12.4 15.3 29.7 15.6 23.6 16.6 12.0 7.8 20.7 10.4 16.2 12.6 15.2 11.5 13.1 12.0 16.0 13.1 13.7 11.1 16.7 20.7 9.4 10.4 19.9 15.0 12.3 26.5 28.4 11.4 13.2 13.5 10.1 17.3 20.6 13.1 12.5 9.8 14.8 11.2 16.2 12.2 27.8 9.4 17.2 15.1 11.5 16.1 17.6 16.9 14.7 19.9 20.6 22.1 17.4 19.4 12.0 13.9 7.7 28.5 11.3 8.1 13.9 27.1 9.9 12.6 15.7 12.6 12.3 23.4 4.2 12.4 12.1 4.9 19.5 14.3 19.1 12.2 10.2 22.5 4.7 10.7 11.9 23.0 12.7 13.0 8.8 12.8 16.5 15.7 17.8 10.0 11.3 8.7 19.9 6.8 38.2 4.2 22.9 17.7 4.0 11.9 9.9 8.4 14.4 6.9 4.2 20.2 8.8 12.4 11.1 11.3 14.7 10.7 12.6 16.5 10.7 15.6 7.0 10.9 12.6 19.3 17.0 20.6 13.5 21.1 19.4 14.6 12.5 12.6 19.9 14.7 12.8 12.6 7.9 17.4 22.1 10.0 13.2 12.0 14.3 12.4 15.6 23.6 16.0 13.1 9.4 10.4 11.4 9.4 RNF214 DKFZp547C195 ENSG00000167257 "Ring finger protein 214" Q8ND24 11 117232625-117286445 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 17.2" "Group enriched" "Detected in many" 5 "granulocytes: 4.3;T-cells: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039332 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA039332: AB_10671874" "unprognostic (7.36e-2)" "unprognostic (4.91e-2)" "unprognostic (9.90e-2)" "unprognostic (1.66e-2)" "unprognostic (6.34e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (6.03e-5)" "unprognostic (2.06e-1)" "unprognostic (6.47e-2)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (8.48e-2)" "unprognostic (1.25e-2)" "unprognostic (3.04e-1)" "unprognostic (1.82e-1)" "unprognostic (2.33e-1)" "unprognostic (2.28e-2)" 12.9 14.0 13.3 10.5 18.5 11.8 12.3 19.7 21.3 15.4 11.2 22.3 11.7 11.0 17.6 11.8 10.1 11.5 9.6 11.3 13.9 11.3 11.1 12.7 11.6 12.1 14.9 17.4 17.1 28.0 21.5 16.3 12.8 16.6 10.8 12.1 16.8 13.4 13.3 18.4 10.9 10.7 22.2 17.7 12.5 12.9 22.3 14.9 10.9 15.5 11.1 13.6 13.3 12.6 1.8 2.2 4.3 2.1 0.9 17.2 1.3 6.4 8.2 18.4 10.8 9.8 11.1 9.5 12.4 10.4 11.1 12.0 12.9 16.5 8.8 18.2 12.9 9.5 20.3 9.3 14.0 14.7 5.4 27.4 7.1 9.8 18.7 14.5 10.4 8.9 11.0 13.9 20.6 13.9 16.3 9.3 13.6 5.2 10.8 12.9 9.8 7.0 11.7 12.6 11.9 11.3 11.6 11.4 12.8 13.2 8.6 6.1 15.9 11.1 13.7 11.0 9.4 7.3 8.4 5.3 4.2 11.1 4.7 11.6 14.4 4.3 2.1 2.2 2.1 2.0 1.2 1.8 7.2 3.6 1.7 1.7 1.9 1.9 0.9 0.9 1.8 2.2 17.2 1.3 13.3 18.5 19.7 21.3 13.9 11.3 14.9 17.4 16.6 14.9 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules Microtubules Nucleoli "HPA029427: , HPA056498: " "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavourable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 9.8 7.1 17.5 7.3 12.6 8.0 8.0 20.7 24.5 10.1 7.8 7.3 11.9 10.4 14.0 13.0 6.4 10.6 13.3 7.7 11.3 14.4 8.5 8.0 6.9 6.5 10.4 15.2 10.8 15.4 12.6 7.9 9.0 10.7 12.3 5.2 11.2 8.8 11.8 7.4 7.9 5.5 10.9 8.1 8.8 6.9 10.0 5.5 2.2 10.3 1.6 5.0 7.9 8.0 4.8 3.5 3.5 2.1 6.1 4.8 0.9 4.5 9.6 10.1 16.3 9.9 10.4 10.0 7.8 7.1 7.8 4.9 2.6 5.1 1.8 14.2 6.3 5.7 6.1 9.0 6.4 10.6 7.4 3.2 10.4 3.4 13.6 2.4 13.0 14.1 11.1 13.5 7.3 9.2 2.6 8.8 9.4 7.3 1.7 5.7 3.1 10.7 8.2 5.8 7.2 10.3 7.0 4.4 11.4 7.8 5.8 5.8 5.3 2.7 12.7 21.4 9.5 6.1 4.6 9.4 2.3 2.4 12.6 1.8 8.2 1.9 2.1 3.5 2.5 1.9 2.5 2.7 2.6 2.0 1.1 4.8 4.8 4.3 1.6 6.1 1.7 3.5 1.3 0.9 17.5 12.6 20.7 24.5 11.3 14.4 10.4 15.2 10.7 5.5 RNF216 "TRIAD3, UBCE7IP1, ZIN" ENSG00000011275 "Ring finger protein 216" Q9NWF9 7 5620047-5781739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018955, HPA021123" Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018955: AB_1858500, HPA021123: AB_1858501" "unprognostic (3.31e-2)" "unprognostic (4.24e-2)" "unprognostic (1.28e-2)" "unprognostic (1.58e-2)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.35e-1)" "unprognostic (2.40e-1)" "unprognostic (1.40e-2)" "prognostic favourable (6.24e-5)" "unprognostic (2.88e-2)" "unprognostic (9.01e-2)" "unprognostic (3.49e-1)" "unprognostic (1.73e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-3)" 16.9 14.9 22.0 18.8 24.8 22.2 18.4 33.5 27.8 17.8 26.9 22.0 13.4 11.5 26.9 13.3 18.7 19.6 14.2 29.1 20.5 17.4 12.7 11.8 14.9 23.8 23.8 14.8 25.6 21.3 23.2 24.9 14.6 20.4 17.7 11.8 18.9 16.2 21.5 22.5 15.1 20.1 25.0 18.7 23.3 18.3 34.3 26.3 18.5 19.8 9.6 24.1 17.7 30.7 8.8 6.7 24.5 8.4 10.0 9.7 6.5 14.4 15.6 12.8 21.8 15.3 13.3 8.8 15.5 16.3 16.1 14.9 11.3 8.3 12.7 8.0 17.3 10.4 13.3 10.9 13.2 7.9 11.6 9.8 9.5 11.4 18.4 16.0 16.8 13.7 14.0 12.3 15.1 12.7 19.6 8.9 17.8 22.2 6.0 25.5 17.6 13.0 15.3 18.1 7.1 9.6 12.2 9.8 15.6 9.8 24.6 8.8 9.7 16.4 13.8 16.3 29.4 16.6 13.9 7.2 5.4 10.3 12.2 14.9 25.9 1.3 7.7 24.5 9.0 8.4 9.0 7.3 7.9 6.7 6.7 8.8 9.7 9.1 13.1 10.0 7.7 5.4 7.0 6.5 22.0 24.8 33.5 27.8 20.5 17.4 23.8 14.8 20.4 26.3 RNF219 "C13orf7, FLJ13449" ENSG00000152193 "Ring finger protein 219" Q5W0B1 13 78614291-78659179 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavourable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 17.6 7.7 10.7 8.9 15.5 3.4 10.6 24.2 16.3 11.9 8.0 4.7 7.3 7.4 11.3 7.8 8.7 9.1 7.1 10.6 10.7 10.3 7.6 6.7 8.0 13.9 11.9 12.1 12.3 6.6 5.0 11.5 12.2 12.7 10.2 8.5 4.0 7.1 10.1 8.7 8.5 8.7 12.7 13.4 13.6 6.8 21.7 13.4 21.8 9.5 8.5 16.7 12.8 9.2 10.5 7.0 8.2 10.6 12.3 13.3 7.8 11.0 4.3 19.0 11.1 6.7 6.5 8.7 9.2 6.9 9.1 11.5 8.6 8.3 18.6 4.5 5.8 11.0 14.9 7.2 16.0 11.6 10.9 28.5 5.5 7.5 5.6 27.5 8.9 6.1 8.1 7.6 8.2 7.5 7.3 2.5 11.8 3.0 16.6 9.4 0.0 4.8 19.5 15.6 7.2 6.1 5.9 13.9 7.8 6.4 8.1 6.9 4.1 22.2 6.1 7.9 7.2 5.2 7.6 2.7 3.0 17.9 12.7 16.8 8.5 4.8 6.0 8.2 9.5 9.7 11.3 10.5 10.7 11.6 7.0 10.1 13.3 11.9 2.0 12.3 10.6 5.9 10.4 7.8 10.7 15.5 24.2 16.3 10.7 10.3 11.9 12.1 12.7 13.4 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663864-218672411 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA036420: , HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 13.4 12.7 13.9 11.1 16.1 6.2 13.7 13.4 27.6 17.3 13.3 17.1 9.8 4.3 16.6 16.2 12.2 16.8 11.8 17.2 13.1 16.5 13.7 15.6 11.9 12.1 12.1 11.6 17.8 13.0 19.3 14.8 17.7 15.4 14.7 9.0 15.3 13.6 17.9 16.9 15.7 10.3 16.0 10.0 12.9 11.8 18.4 9.1 15.3 16.8 12.7 16.8 14.0 11.8 13.3 8.2 23.3 11.2 14.8 15.0 13.9 5.9 7.6 6.9 8.0 10.5 6.4 7.4 6.7 17.0 23.2 21.7 12.6 4.0 3.9 5.4 14.2 5.4 7.9 13.2 10.1 4.3 10.9 5.4 5.6 11.9 12.9 4.7 5.9 14.2 12.4 21.1 14.2 12.7 9.0 6.2 14.9 16.9 5.3 5.8 10.9 8.7 7.5 4.3 5.8 14.2 6.3 7.0 7.9 5.2 5.8 10.0 6.9 8.8 7.3 13.2 6.3 5.1 9.6 5.3 4.2 6.6 11.1 5.9 8.0 23.3 10.6 14.9 13.9 10.3 12.6 11.9 13.7 13.6 8.2 13.3 15.0 11.7 8.9 14.8 11.2 7.4 11.5 13.9 13.9 16.1 13.4 27.6 13.1 16.5 12.1 11.6 15.4 9.1 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favourable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavourable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.6 17.3 16.2 19.1 16.0 12.7 17.3 17.0 18.4 19.9 15.8 29.2 32.8 13.8 23.6 20.2 28.5 23.0 25.6 12.5 16.5 12.6 36.4 8.1 24.1 12.3 15.2 15.2 13.1 13.2 24.8 22.4 15.1 17.6 21.7 13.6 34.1 13.9 15.8 16.2 22.2 14.5 16.7 11.0 12.2 11.3 11.6 11.2 13.7 17.5 4.5 39.5 12.8 9.9 24.1 16.1 12.6 15.5 5.2 8.5 0.1 8.0 25.8 18.7 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 RNF34 "FLJ21786, RIF, RIFF" ENSG00000170633 "Ring finger protein 34" Q969K3 12 121400041-121430623 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074151 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA074151: " "unprognostic (3.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.90e-1)" "unprognostic (6.10e-2)" "unprognostic (9.92e-2)" "unprognostic (2.55e-2)" "prognostic unfavourable (6.72e-8)" "unprognostic (3.39e-1)" "unprognostic (9.99e-2)" "unprognostic (1.60e-2)" "unprognostic (5.87e-3)" "unprognostic (2.80e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.55e-3)" "prognostic favourable (3.02e-4)" 11.9 10.6 18.2 19.6 23.4 10.4 12.3 25.2 26.9 11.2 17.3 21.5 10.0 17.0 15.0 12.7 14.4 11.7 15.5 16.0 17.6 17.7 10.8 11.1 11.6 27.2 19.3 19.4 14.0 12.2 11.1 17.1 10.2 19.3 10.2 14.2 12.7 12.4 12.9 45.7 13.8 16.0 15.0 21.3 19.4 16.3 20.8 17.2 21.7 12.7 9.1 22.5 16.4 11.5 31.8 16.9 36.5 20.3 29.9 42.8 25.8 18.4 22.4 14.6 15.3 11.6 10.7 18.4 19.7 17.7 19.7 15.1 27.7 7.1 26.6 15.2 21.2 13.4 22.0 12.4 17.6 38.7 13.0 30.8 15.5 25.4 14.0 26.5 21.7 9.5 16.8 17.1 14.9 20.6 23.2 12.5 19.3 14.6 23.3 38.9 18.8 20.4 22.3 19.2 15.6 13.6 22.1 21.7 14.1 24.8 9.3 15.0 16.1 20.2 16.5 17.0 12.3 14.7 15.5 22.2 36.7 29.0 12.1 18.7 17.0 26.9 17.9 36.5 32.4 19.9 33.0 31.8 37.8 34.1 16.9 25.5 32.8 32.6 27.4 29.9 20.3 14.3 42.8 25.8 18.2 23.4 25.2 26.9 17.6 17.7 19.3 19.4 19.3 17.2 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Cell line enhanced" "Detected in some" "A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 6 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: " "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.9 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 1.6 0.0 1.4 0.0 0.5 2.6 1.1 0.3 0.0 0.0 0.1 0.3 0.0 1.9 0.0 0.2 0.0 0.7 0.6 0.0 1.0 0.0 1.3 0.0 0.0 0.3 0.4 0.0 1.9 0.3 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.5 0.6 0.0 0.3 1.9 8.0 0.7 0.6 0.1 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: " "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavourable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 28.6 29.1 25.4 32.2 39.4 36.4 28.6 35.9 50.3 28.2 25.1 34.8 28.4 27.0 32.2 28.0 30.3 27.8 27.1 24.6 22.7 22.8 32.3 25.6 27.4 41.9 23.5 23.4 32.1 31.0 31.2 30.0 29.4 36.7 28.5 26.7 29.2 36.1 28.5 26.0 28.5 29.3 31.8 23.1 41.9 28.9 36.8 23.7 50.4 29.3 19.1 51.5 27.7 26.3 36.9 35.3 41.8 39.9 39.7 43.7 45.8 19.8 18.9 19.8 13.8 17.2 18.0 22.1 24.3 27.4 25.9 23.5 21.4 18.8 25.2 14.5 24.5 13.0 20.9 19.0 24.7 11.8 12.6 30.5 19.5 20.4 25.9 21.4 26.7 20.8 23.1 24.0 20.1 23.9 16.1 34.9 26.4 13.6 34.3 29.9 30.4 23.7 25.0 18.8 13.0 17.6 25.4 18.4 17.4 17.0 13.3 16.9 21.0 16.2 19.9 22.6 11.1 21.3 37.2 45.2 60.1 27.9 22.0 23.4 23.4 14.6 29.6 41.8 43.7 39.3 43.7 36.9 37.5 43.0 35.3 27.2 36.2 36.3 32.9 39.7 39.9 23.6 39.9 45.8 25.4 39.4 35.9 50.3 22.7 22.8 23.5 23.4 36.7 23.7 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202175-56221933 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favourable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 22.2 17.6 18.6 11.8 30.2 12.0 14.3 30.9 47.1 16.2 15.0 16.9 12.3 8.5 16.4 9.7 16.5 17.7 18.0 22.6 17.3 22.4 14.1 10.5 16.5 14.8 15.3 18.2 17.0 16.0 17.9 16.7 14.6 25.3 25.2 13.6 14.6 10.5 15.6 21.2 10.1 10.8 20.3 11.8 13.5 12.2 10.1 12.1 11.3 20.5 10.1 17.0 16.2 11.5 24.6 13.1 41.1 11.5 13.4 12.5 12.3 7.5 11.6 12.6 20.0 26.5 19.3 9.4 25.3 25.1 22.8 18.5 14.2 9.9 14.6 13.5 21.4 8.7 17.0 12.2 16.6 15.2 9.3 19.6 8.3 8.1 55.6 21.4 21.4 24.6 28.7 19.0 33.6 22.1 13.8 15.0 12.6 12.2 12.2 9.6 15.2 13.6 13.3 9.1 8.8 12.1 11.1 23.1 14.0 22.1 12.7 20.0 17.8 25.2 13.3 11.5 12.3 14.8 9.7 10.8 12.4 13.3 13.7 12.9 13.7 21.0 11.5 41.1 12.5 11.4 11.2 22.7 10.6 10.9 13.1 24.6 11.0 11.2 15.8 13.4 11.2 10.2 12.1 12.3 18.6 30.2 30.9 47.1 17.3 22.4 15.3 18.2 25.3 12.1 RNF8 KIAA0646 ENSG00000112130 "Ring finger protein 8" O76064 6 37353972-37394738 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050731, HPA064925" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA050731: , HPA064925: " "unprognostic (1.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.39e-2)" "unprognostic (8.20e-2)" "unprognostic (5.17e-2)" "unprognostic (3.99e-2)" "prognostic unfavourable (3.33e-5)" "unprognostic (2.36e-2)" "prognostic unfavourable (1.91e-4)" "unprognostic (2.26e-3)" "unprognostic (3.38e-1)" "prognostic unfavourable (4.99e-5)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (3.41e-2)" "unprognostic (3.66e-3)" "unprognostic (1.09e-1)" 8.0 11.7 13.1 8.2 17.8 8.9 11.5 25.7 18.7 9.2 9.5 10.6 6.8 6.9 13.5 5.7 18.3 12.0 8.8 17.6 13.4 14.8 11.8 7.5 10.8 8.3 12.0 16.0 13.2 6.5 11.9 16.4 10.2 13.7 8.6 8.2 8.0 10.2 11.9 15.2 9.9 8.4 10.7 9.6 7.7 7.6 19.8 13.8 6.6 8.0 9.4 13.3 12.9 15.2 8.8 8.3 2.6 8.1 7.6 10.8 5.5 6.5 3.9 9.5 11.3 7.7 11.1 2.7 6.8 8.4 12.9 14.2 5.8 3.7 8.1 4.2 6.6 6.2 13.2 8.6 13.6 8.5 12.8 14.0 6.9 8.7 4.4 7.4 10.3 5.5 8.3 7.7 9.0 12.4 9.4 2.8 7.4 4.3 9.0 9.2 6.6 5.2 7.1 8.8 5.6 6.6 4.6 18.8 6.3 5.1 5.8 9.4 5.2 7.3 5.6 8.5 7.6 8.0 10.0 8.4 11.1 40.0 4.2 10.6 9.8 1.0 4.6 2.6 10.8 6.0 10.0 8.8 8.1 10.2 8.3 6.0 7.1 9.4 0.6 7.6 8.1 3.6 9.3 5.5 13.1 17.8 25.7 18.7 13.4 14.8 12.0 16.0 13.7 13.8 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064161: " "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.0 4.7 15.3 0.2 0.0 7.9 0.6 0.7 1.9 1.7 3.6 1.7 7.9 2.2 0.1 1.9 10.0 0.7 1.8 7.5 5.0 1.5 7.3 4.8 2.0 0.6 4.6 0.2 0.2 3.1 1.0 0.3 6.0 2.9 0.2 7.6 7.7 1.9 4.7 1.8 5.0 2.7 4.1 3.7 1.8 7.3 6.6 2.2 1.2 2.2 7.2 1.7 0.5 1.3 5.2 3.1 3.1 3.6 12.0 8.3 5.7 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol 27000000 "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favourable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 39.8 35.7 18.5 27.6 25.7 40.8 57.9 14.7 33.1 34.9 27.8 43.0 25.9 27.3 36.6 34.2 51.4 30.5 32.8 49.5 20.4 16.5 32.6 46.2 36.1 36.6 37.1 25.3 36.2 32.4 25.7 21.1 35.1 24.3 30.7 8.7 25.6 37.5 33.2 41.6 60.7 26.0 37.7 31.7 29.8 25.3 37.9 29.6 17.1 41.4 41.9 25.8 35.5 38.6 12.9 47.8 10.3 53.3 9.8 12.1 35.3 21.1 30.1 3.3 11.2 18.3 26.1 12.4 19.9 13.8 18.1 15.7 16.8 25.9 11.7 15.4 37.8 19.9 5.7 19.9 2.8 14.9 27.4 7.9 8.3 15.4 61.8 10.4 25.4 22.2 29.6 10.5 13.1 12.3 10.3 19.9 10.3 21.1 8.0 19.7 5.5 30.7 10.2 7.3 15.0 11.1 7.7 9.6 6.6 11.9 17.3 19.8 12.4 32.8 22.0 31.1 9.1 11.2 13.3 12.7 13.5 8.6 33.9 23.6 20.4 5.7 44.4 10.3 10.4 53.3 12.1 12.9 11.2 10.4 47.8 9.5 10.5 9.3 3.2 9.8 48.7 13.9 10.7 35.3 18.5 25.7 14.7 33.1 20.4 16.5 37.1 25.3 24.3 29.6 RNMT RG7MT1 ENSG00000101654 "RNA guanine-7 methyltransferase" O43148 18 13726660-13764558 "Enzymes, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039409 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA039409: AB_10795289" "unprognostic (3.02e-1)" "unprognostic (1.07e-2)" "unprognostic (3.48e-1)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (3.04e-1)" "unprognostic (6.17e-3)" "unprognostic (1.43e-1)" "unprognostic (3.76e-2)" "unprognostic (1.42e-3)" "unprognostic (9.45e-2)" "unprognostic (9.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.78e-1)" 18.9 10.1 13.3 12.7 20.4 40.1 16.6 19.7 27.3 14.0 11.5 10.3 12.1 9.1 15.4 13.1 12.6 12.2 9.9 21.2 14.9 18.2 12.9 12.0 12.4 14.6 14.5 21.8 19.6 13.3 16.6 21.2 16.1 28.5 14.7 11.6 10.8 12.8 12.2 29.1 14.3 11.3 15.1 16.1 12.3 11.4 17.1 12.6 12.2 19.2 15.8 15.8 26.5 11.4 20.1 20.8 21.6 13.1 9.4 15.7 4.1 11.4 6.8 13.2 9.9 9.8 12.5 9.2 9.4 11.7 9.8 13.3 8.0 5.5 12.8 11.6 9.6 4.6 15.5 13.5 16.6 7.1 8.3 9.6 7.0 7.5 10.8 25.0 8.2 9.5 14.7 10.3 29.1 7.5 14.4 12.9 11.1 7.1 15.9 9.0 10.1 5.3 10.4 13.9 17.4 9.0 9.0 10.2 15.3 10.6 7.8 18.1 6.8 10.5 7.7 19.7 27.7 16.0 10.0 26.0 28.3 26.6 14.5 9.6 9.8 21.6 13.1 8.5 12.5 10.3 10.1 16.2 11.9 10.3 8.1 20.1 15.7 12.2 7.1 9.4 11.4 20.8 12.8 4.1 13.3 20.4 19.7 27.3 14.9 18.2 14.5 21.8 28.5 12.6 RNPEP APB ENSG00000176393 "Arginyl aminopeptidase" Q9H4A4 1 201982372-202006147 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036074, HPA036075, HPA061487" Approved Supported "Nucleoplasm,Golgi apparatus" "Secreted - unknown location" 6600000 "Golgi apparatus" Nucleoplasm "HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: " "unprognostic (8.57e-2)" "unprognostic (3.43e-2)" "unprognostic (2.81e-1)" "unprognostic (5.45e-2)" "unprognostic (2.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-3)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-1)" "unprognostic (3.50e-3)" "unprognostic (1.91e-1)" "unprognostic (6.00e-2)" "unprognostic (1.97e-2)" "unprognostic (1.68e-1)" 18.5 22.0 6.4 14.9 8.2 9.5 16.7 9.2 11.0 17.8 34.2 13.5 21.2 31.1 17.4 18.7 33.2 19.2 21.8 11.5 6.1 4.6 22.5 18.3 21.5 14.1 7.0 5.4 18.0 19.5 11.6 10.4 26.3 9.0 18.4 26.8 16.4 25.1 13.6 10.0 18.3 66.6 12.8 8.1 22.7 15.7 21.2 6.0 13.9 28.4 19.1 24.7 17.6 17.5 2.3 12.1 12.3 17.0 1.6 3.1 2.2 19.0 20.7 12.3 18.5 20.2 19.0 31.1 14.7 28.5 18.4 20.8 14.8 24.4 4.1 18.9 25.8 34.6 15.7 28.7 12.9 11.3 20.3 10.4 9.9 13.9 17.2 26.4 36.8 17.3 29.7 16.4 18.9 33.1 23.6 6.2 18.6 17.4 3.6 11.2 17.4 10.3 13.9 17.4 29.4 38.3 17.3 14.3 12.1 36.3 45.4 14.6 34.5 15.1 23.6 8.7 11.7 8.4 17.8 13.8 11.1 3.7 8.6 22.5 17.3 10.8 9.2 12.3 1.9 15.7 2.6 1.6 2.0 2.2 12.1 2.3 1.8 2.1 6.7 1.6 17.0 4.5 3.1 2.2 6.4 8.2 9.2 11.0 6.1 4.6 7.0 5.4 9.0 6.0 RNPEPL1 ENSG00000142327 "Arginyl aminopeptidase like 1" Q9HAU8 2 240565804-240581372 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036772 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA036772: AB_10670848" "unprognostic (3.92e-2)" "unprognostic (7.28e-2)" "unprognostic (1.20e-2)" "unprognostic (2.39e-1)" "unprognostic (5.24e-3)" "prognostic favourable (7.43e-4)" "prognostic unfavourable (5.06e-4)" "unprognostic (3.72e-3)" "unprognostic (9.10e-2)" "unprognostic (1.66e-3)" "unprognostic (3.10e-1)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (5.31e-2)" "unprognostic (9.86e-2)" 17.2 13.7 10.1 13.7 8.8 17.2 48.4 7.2 10.5 11.0 21.0 9.5 11.8 18.6 8.0 8.9 22.1 8.0 22.3 28.3 9.2 6.0 18.2 26.7 32.2 54.1 12.9 8.2 7.1 40.0 7.7 4.3 10.1 8.1 14.9 9.1 7.0 21.5 13.5 26.5 22.5 31.0 11.4 9.7 25.7 20.0 5.9 7.6 23.1 8.8 16.7 12.1 14.4 18.8 7.0 7.6 22.4 9.1 7.6 12.4 5.4 6.8 11.5 2.5 6.8 9.4 9.8 8.7 4.4 11.0 5.0 6.2 3.1 20.2 2.0 2.3 11.1 7.5 2.9 8.2 0.5 12.0 4.0 4.5 3.7 18.6 23.7 2.9 8.2 11.6 13.4 2.6 5.1 17.0 3.3 13.4 3.3 9.7 3.7 11.1 3.4 4.6 7.8 3.8 16.6 20.2 9.5 2.4 5.1 3.0 10.3 20.0 7.2 13.6 11.6 5.4 5.6 7.5 5.0 12.7 1.9 2.3 11.1 8.3 8.1 5.8 9.1 22.4 12.4 7.8 10.6 7.0 9.6 11.1 6.4 6.8 5.4 8.1 16.0 7.6 7.6 7.6 11.1 5.4 10.1 8.8 7.2 10.5 9.2 6.0 12.9 8.2 8.1 7.6 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 14.9;HEL: 40.7" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 4.2 0.0 0.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.8 40.7 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.6 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell line enriched" "Detected in some" 11 "AF22: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.7 1.0 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell line enhanced" "Detected in many" "HSkMC: 17.8;U-266/84: 18.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028910 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA028910: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favourable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavourable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.6 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 2.7 1.0 2.8 0.8 3.6 1.8 1.8 5.3 2.5 9.2 0.7 0.6 17.8 4.1 3.1 6.4 4.7 2.6 4.6 6.2 5.3 1.1 1.5 0.5 3.2 1.1 1.8 12.7 3.4 1.2 2.3 3.3 3.5 4.0 1.6 5.6 0.9 5.4 5.1 1.9 5.9 1.6 2.0 18.7 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2, ARL3 GTPase activating protein" O75695 X 46836940-46882358 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" 77000 "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: " "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 17.2 10.6 5.0 10.7 6.6 31.4 8.2 5.6 4.3 6.3 10.1 5.5 3.5 7.4 8.4 7.1 17.2 5.8 9.3 5.9 5.7 4.8 10.2 17.1 14.0 18.1 8.1 2.8 6.9 4.7 5.6 4.1 28.0 8.5 6.9 7.7 4.9 8.3 6.1 2.9 5.0 18.6 6.3 10.6 24.3 6.4 5.7 6.7 12.1 5.9 8.7 11.7 7.0 8.7 5.0 10.7 23.0 15.9 3.4 3.3 5.3 11.3 5.4 11.0 6.0 8.7 10.8 26.1 14.5 11.5 12.9 13.1 23.4 9.7 13.5 5.9 15.4 7.4 10.5 10.6 17.6 5.9 6.1 7.2 6.9 5.6 9.9 15.0 25.3 8.4 7.0 10.2 5.5 16.2 3.1 7.1 14.4 1.0 9.2 13.8 6.8 10.5 11.9 15.1 7.1 8.3 11.6 4.0 5.4 12.9 8.0 6.5 9.0 14.2 14.3 10.0 7.5 15.8 5.1 2.7 3.4 8.0 5.2 10.7 10.4 23.0 10.6 16.6 3.2 14.4 2.6 5.0 2.6 2.7 10.7 4.6 3.3 3.0 20.9 3.4 15.9 3.8 2.8 5.3 5.0 6.6 5.6 4.3 5.7 4.8 8.1 2.8 8.5 6.7 RP9 PAP-1 ENSG00000164610 "RP9, pre-mRNA splicing factor" Q8TA86 7 33094797-33109401 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031523, HPA050778" Uncertain Enhanced Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA031523: AB_10603235, HPA050778: " "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (1.07e-2)" "unprognostic (1.82e-1)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "prognostic unfavourable (2.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.22e-2)" "unprognostic (7.53e-2)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (2.65e-5)" "unprognostic (4.19e-2)" "unprognostic (2.63e-2)" "unprognostic (2.70e-1)" "unprognostic (1.61e-1)" 10.1 13.8 11.7 9.4 16.0 20.7 14.9 17.1 16.0 10.9 12.2 13.0 7.0 10.3 14.6 18.8 8.1 10.0 10.7 19.2 11.1 10.1 11.4 11.5 9.7 19.4 17.4 8.6 14.2 16.9 10.4 14.2 11.7 11.0 14.0 11.8 12.8 15.0 14.4 34.7 10.7 12.5 15.7 11.8 17.2 10.5 15.2 12.6 13.6 15.6 9.0 18.2 13.4 16.0 34.1 11.7 8.1 5.0 5.9 8.4 3.3 9.7 14.0 14.8 16.9 9.4 8.9 7.0 12.4 10.6 14.5 11.6 12.4 7.2 12.4 8.2 10.3 9.8 17.9 10.7 18.6 5.6 11.1 9.1 11.1 11.6 16.6 12.1 6.3 8.9 10.1 16.4 32.5 11.8 16.2 11.4 14.4 20.2 12.9 33.2 12.4 10.1 13.0 12.9 8.2 10.4 9.4 14.3 19.7 8.7 19.6 21.2 10.3 16.8 9.4 14.3 20.1 12.7 20.2 18.6 16.8 24.7 10.1 17.2 27.6 6.4 5.0 8.1 6.6 3.6 6.1 22.0 7.0 7.4 5.3 34.1 8.4 7.8 0.9 5.9 4.6 11.7 5.9 3.3 11.7 16.0 17.1 16.0 11.1 10.1 17.4 8.6 11.0 12.6 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favourable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favourable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 18.6 17.1 33.6 24.3 38.8 20.5 26.6 23.6 30.5 20.0 15.4 17.2 17.6 9.9 19.5 26.3 18.7 28.8 19.2 22.5 31.4 22.1 19.5 18.4 19.3 37.1 22.0 26.7 32.6 15.3 16.4 27.0 17.2 25.4 17.2 19.0 18.0 16.2 19.8 45.0 22.6 16.8 18.6 22.1 28.4 15.3 34.6 27.7 25.4 30.7 17.2 37.9 20.3 17.1 46.2 31.5 48.4 18.1 49.3 55.9 65.9 13.0 12.5 21.0 15.7 14.3 13.2 12.7 24.3 16.5 31.1 27.1 17.7 16.2 33.3 15.6 9.6 12.2 29.6 13.7 30.4 24.6 27.5 38.7 16.9 15.2 7.2 51.3 27.3 5.7 7.7 30.0 15.5 13.4 40.4 29.0 18.0 13.3 36.5 22.5 41.1 26.7 24.4 31.1 15.5 11.1 14.2 17.9 17.3 26.8 10.8 21.2 11.2 15.2 8.5 7.7 16.7 41.5 15.9 23.6 52.5 28.9 19.0 45.5 13.9 42.8 18.1 48.4 51.6 14.0 55.9 46.2 48.8 47.3 20.4 39.0 55.8 53.9 18.1 49.3 18.1 31.5 42.5 65.9 33.6 38.8 23.6 30.5 31.4 22.1 22.0 26.7 25.4 27.7 RPAIN "hRIP, MGC4189, RIP" ENSG00000129197 "RPA interacting protein" Q86UA6 17 5419641-5432876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023924, HPA031526" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA023924: AB_10601890, HPA031526: AB_10601555" "unprognostic (1.68e-1)" "unprognostic (9.31e-3)" "unprognostic (2.32e-1)" "unprognostic (7.88e-2)" "unprognostic (5.41e-2)" "unprognostic (3.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.87e-3)" "unprognostic (3.98e-2)" "unprognostic (4.25e-3)" "prognostic favourable (5.20e-4)" "prognostic unfavourable (4.41e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.67e-2)" "unprognostic (1.00e-3)" 12.4 19.5 24.4 12.1 26.4 14.9 22.1 18.3 24.0 14.6 13.4 12.1 18.4 12.1 13.8 21.6 11.9 17.0 12.2 25.4 20.2 21.0 17.1 19.3 11.5 12.8 18.0 24.9 17.4 15.8 10.9 25.5 12.0 19.7 14.5 14.6 12.9 11.9 14.0 41.6 12.3 9.5 13.5 17.5 10.5 14.6 11.4 18.9 16.2 12.1 15.8 15.0 12.2 10.5 25.3 19.3 22.3 13.4 12.1 24.7 13.0 8.9 20.3 21.2 17.4 16.1 12.3 9.3 9.1 17.3 20.1 18.1 12.0 3.2 10.9 12.9 5.9 9.7 27.4 8.6 17.5 11.2 19.8 8.4 10.0 15.1 20.8 10.9 19.6 10.5 17.7 12.3 24.9 17.7 9.0 7.0 11.0 7.8 25.0 19.8 10.9 10.4 12.0 15.2 9.7 14.8 10.5 14.1 25.1 8.2 6.5 23.5 9.4 15.1 8.7 6.3 8.6 5.1 17.6 6.9 11.4 10.9 9.3 11.2 9.5 11.2 13.4 22.3 12.5 12.0 15.8 25.3 17.0 16.2 12.8 21.4 20.4 18.2 2.4 12.1 10.5 19.3 24.7 13.0 24.4 26.4 18.3 24.0 20.2 21.0 18.0 24.9 19.7 18.9 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041739: " "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (9.32e-4)" "unprognostic (4.30e-3)" 10.1 10.2 12.8 8.5 12.4 4.7 8.1 7.8 15.6 7.8 10.2 12.6 7.9 8.5 10.7 6.0 12.3 10.4 6.9 9.5 10.9 6.1 6.7 10.8 7.3 9.8 12.3 10.1 12.4 9.4 12.9 9.4 8.7 11.9 9.4 7.1 9.5 9.8 9.2 27.0 10.3 8.0 10.1 8.0 9.1 9.4 12.6 11.8 11.2 8.3 7.9 10.7 11.2 8.4 5.9 4.5 0.0 5.9 4.9 7.2 3.3 7.1 8.5 11.7 12.3 9.8 7.1 9.9 7.0 6.1 9.1 9.0 23.1 6.5 5.6 11.6 7.8 16.9 21.1 10.3 7.8 9.8 10.2 10.6 11.9 10.1 6.2 8.6 6.7 7.2 13.1 10.9 7.6 10.2 24.6 6.4 8.4 4.5 9.3 5.3 20.6 7.9 16.9 10.1 6.0 4.0 16.8 10.7 14.4 9.0 9.5 4.8 15.6 10.8 9.3 14.4 9.4 14.3 11.2 10.8 29.6 6.3 10.3 9.4 13.5 0.0 2.6 0.0 7.2 3.5 6.6 4.8 4.3 4.5 4.5 5.9 6.1 5.3 0.0 4.9 5.9 2.9 4.4 3.3 12.8 12.4 7.8 15.6 10.9 6.1 12.3 10.1 11.9 11.8 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92298965-92402056 "Enzymes, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA046443: " "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 6.8 7.0 7.8 7.3 10.5 12.0 7.6 27.2 11.6 8.4 6.3 7.1 7.2 6.6 11.1 11.5 5.6 6.3 5.5 5.9 8.1 8.6 8.1 10.6 5.2 8.2 7.7 6.7 8.2 8.6 9.4 16.1 6.7 11.7 7.6 5.8 6.4 7.2 7.1 10.5 10.7 6.3 7.4 9.9 7.6 6.4 6.7 8.7 12.8 9.4 6.5 6.3 6.6 7.6 4.4 3.5 4.9 2.4 4.0 4.8 1.2 6.2 3.8 6.7 6.1 5.5 7.1 5.7 4.9 3.4 3.2 2.7 2.7 2.8 9.3 8.5 3.6 4.3 5.5 3.2 5.0 6.3 4.0 5.7 6.9 3.6 3.3 9.8 5.7 3.6 3.9 4.2 4.1 3.4 5.8 6.2 4.9 3.2 8.3 6.2 5.2 4.3 6.2 8.9 4.0 4.2 5.6 6.2 4.6 8.0 7.3 4.0 3.9 7.5 6.0 4.9 6.2 5.6 6.9 6.0 7.0 4.9 3.4 6.2 3.3 4.8 2.4 1.9 4.1 1.7 4.8 3.4 3.2 3.5 1.8 4.4 3.5 3.8 4.9 4.0 1.9 3.5 2.8 1.2 7.8 10.5 27.2 11.6 8.1 8.6 7.7 6.7 11.7 8.7 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: , HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 21.0 27.2 17.7 17.8 28.8 27.9 30.4 27.7 22.2 26.3 35.4 39.2 32.2 14.2 18.2 21.4 20.7 26.0 29.5 40.3 17.0 18.4 26.2 40.0 36.5 39.3 27.8 20.2 19.5 29.4 30.2 39.4 34.2 26.4 19.8 21.6 33.5 15.1 24.2 26.0 20.0 19.0 21.1 20.3 30.4 31.4 21.3 12.2 23.4 22.9 18.5 19.7 32.0 28.0 35.4 23.5 17.2 25.5 11.8 15.0 30.4 25.6 27.5 22.8 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: , HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.0 0.7 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavourable (2.04e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavourable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 21.1 17.1 13.9 14.1 19.2 15.4 20.7 16.7 17.3 14.5 13.8 9.0 10.3 10.3 15.4 12.1 19.2 15.8 14.4 19.6 16.5 11.0 18.8 30.7 12.2 15.3 16.8 11.3 20.9 25.9 13.7 21.6 15.5 19.3 15.5 14.1 9.5 14.0 11.5 46.3 16.7 10.6 19.8 17.4 16.3 14.2 18.1 18.7 10.0 20.4 29.3 15.8 22.1 15.1 10.3 9.3 0.8 7.7 11.1 12.4 6.1 7.9 3.8 4.3 17.0 7.6 11.9 11.3 11.4 6.8 10.1 10.1 15.4 5.7 18.6 10.9 5.7 9.1 14.3 10.8 22.9 7.9 13.1 12.2 4.8 8.9 9.1 18.4 5.9 7.2 8.7 14.0 28.7 8.0 32.3 10.3 12.6 7.7 13.6 19.4 12.5 6.9 13.1 8.2 13.3 9.7 7.9 7.3 9.5 5.0 6.7 18.7 6.1 15.7 5.2 8.3 7.4 81.5 30.4 4.4 6.8 23.2 11.1 23.3 16.7 0.3 6.9 0.8 5.9 7.7 12.4 10.3 8.4 7.7 8.1 7.8 11.1 10.5 0.2 11.1 4.9 9.3 7.3 6.1 13.9 19.2 16.7 17.3 16.5 11.0 16.8 11.3 19.3 18.7 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: " "prognostic unfavourable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavourable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 3.0 6.5 8.0 3.8 13.8 2.7 6.1 5.3 12.7 6.3 3.3 2.4 6.8 2.4 7.3 7.8 3.9 11.7 4.9 3.3 9.1 9.9 5.5 2.2 3.5 3.1 5.9 13.2 6.5 3.2 18.5 25.8 3.8 9.0 5.2 3.5 1.7 3.4 5.3 2.3 3.6 2.0 6.3 3.5 1.9 3.5 20.9 4.7 3.1 7.6 2.3 3.1 4.4 3.6 4.9 2.0 1.8 1.0 2.1 5.6 1.3 8.9 11.2 10.1 9.2 12.1 11.8 4.4 10.0 6.6 9.4 2.7 6.1 7.3 6.0 7.2 10.3 10.5 8.4 9.6 16.7 3.6 5.9 2.2 9.4 6.1 5.0 5.4 4.1 7.4 5.9 10.5 6.5 7.0 5.5 3.5 13.8 3.4 8.9 3.8 6.4 5.3 15.1 13.8 7.2 12.1 2.4 17.5 6.6 12.4 5.2 4.6 7.9 4.3 6.3 10.2 7.3 8.4 8.9 4.6 5.2 10.7 15.5 3.3 6.0 1.7 0.9 1.1 3.6 1.0 3.5 3.2 2.6 3.3 0.8 4.9 2.6 5.6 1.8 2.1 1.0 2.0 2.1 1.3 8.0 13.8 5.3 12.7 9.1 9.9 5.9 13.2 9.0 4.7 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: " "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavourable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.0 7.2 7.4 22.3 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 5.2 12.6 4.0 12.5 20.7 16.5 17.5 3.2 17.5 7.3 32.0 12.9 6.8 3.4 7.0 11.0 11.1 18.7 7.6 7.4 13.4 35.1 28.0 9.2 8.2 18.4 12.1 10.6 6.5 13.8 7.3 8.3 5.7 7.4 11.0 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.7 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 RPL10 "DXS648, DXS648E, FLJ23544, L10, NOV, QM" ENSG00000147403 "Ribosomal protein L10" P27635 X 154389955-154409168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB010339, HPA011311" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" "CAB010339: AB_2181277, HPA011311: AB_1856431" "unprognostic (2.46e-3)" "unprognostic (3.57e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.25e-2)" "unprognostic (2.06e-1)" "unprognostic (6.11e-2)" "unprognostic (9.01e-3)" "unprognostic (1.91e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (3.37e-1)" "prognostic unfavourable (7.67e-6)" "unprognostic (6.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.65e-2)" "unprognostic (5.68e-2)" 103.6 65.3 41.4 108.0 48.5 103.7 152.6 82.4 70.7 118.2 80.6 44.6 107.8 51.3 100.4 75.5 105.2 122.3 52.6 82.5 38.2 31.9 112.1 155.0 97.6 190.2 48.2 37.4 223.5 242.3 35.0 51.9 87.4 53.1 83.6 77.1 66.7 109.9 101.5 125.9 121.8 108.9 78.7 51.4 93.9 90.5 33.9 47.2 158.9 198.9 137.9 134.4 86.9 119.3 252.9 168.6 64.4 124.1 149.1 304.9 445.3 187.8 87.1 87.3 66.8 198.2 375.4 77.2 72.2 167.6 139.1 177.0 77.2 84.5 372.4 175.0 120.5 73.0 170.8 173.0 119.6 81.8 135.4 50.2 62.4 84.6 233.1 107.9 74.4 283.3 274.0 83.6 261.3 218.2 70.7 119.0 135.8 94.3 117.5 105.0 68.7 150.6 140.9 82.7 206.9 151.8 67.1 70.0 117.0 17.4 153.8 213.5 56.0 150.9 105.0 48.7 92.6 109.6 159.9 283.6 204.8 370.4 74.0 155.8 60.8 64.4 124.1 18.1 149.9 107.7 256.2 252.9 251.6 186.2 151.2 243.2 304.9 231.1 13.0 149.1 94.9 168.6 178.0 445.3 41.4 48.5 82.4 70.7 38.2 31.9 48.2 37.4 53.1 47.2 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468408-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 360000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: " "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 55.0 41.7 35.5 80.8 28.0 79.0 96.9 25.3 37.6 71.5 76.4 22.8 62.3 35.0 91.2 62.5 88.7 91.0 72.6 45.2 28.1 23.1 45.4 71.1 44.8 94.0 28.5 38.0 155.3 141.2 18.6 35.6 56.6 25.6 86.5 55.2 34.7 104.5 66.1 98.5 92.9 47.2 56.8 27.3 51.4 55.5 33.2 20.1 70.6 62.0 121.6 76.5 77.4 86.4 165.3 104.4 8.5 62.8 101.1 186.5 235.1 65.8 68.0 77.4 72.7 116.0 211.6 87.7 68.3 140.6 96.3 76.8 98.4 63.8 197.7 63.0 92.5 58.5 104.2 155.8 80.1 68.5 91.8 75.9 63.0 137.4 171.8 110.6 63.3 245.9 182.7 70.6 237.0 141.0 89.4 97.8 109.2 116.4 116.7 134.5 81.2 60.1 92.4 74.6 153.0 121.7 109.0 54.6 80.0 42.0 96.6 192.8 104.5 201.8 81.3 31.5 56.9 41.8 85.9 61.8 100.6 130.6 39.5 129.1 56.3 8.5 62.8 5.9 82.7 61.2 146.9 165.3 137.8 106.1 104.4 146.8 186.5 145.8 6.1 101.1 52.4 98.5 104.4 235.1 35.5 28.0 25.3 37.6 28.1 23.1 28.5 38.0 25.6 20.1 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651821 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 45.5" "Cell line enriched" "Detected in single" 45 "U-2 OS: 29.6" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.6 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.3 0.5 1.0 0.6 0.8 0.2 0.7 0.9 0.9 0.0 0.4 0.2 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: " "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favourable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavourable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 66.8 74.4 52.9 85.7 95.2 158.6 110.8 42.3 91.7 88.4 35.9 112.3 103.8 94.1 87.4 71.7 93.1 62.8 111.2 44.1 26.3 174.3 32.0 41.5 148.9 203.8 38.9 39.1 192.1 237.1 56.6 142.9 92.1 97.8 53.7 67.9 209.5 106.4 305.2 108.1 79.1 158.7 56.0 132.2 107.3 56.2 74.6 109.1 58.6 76.5 126.9 150.5 231.1 53.7 57.1 61.7 50.3 57.9 81.4 76.5 96.0 74.6 137.3 60.0 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 RPL13A "L13A, TSTA1" ENSG00000142541 "Ribosomal protein L13a" P40429 19 49487554-49492308 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038751 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA038751: AB_10962004" "unprognostic (2.35e-3)" "unprognostic (2.15e-1)" "unprognostic (4.08e-2)" "unprognostic (2.02e-1)" "unprognostic (2.95e-3)" "unprognostic (2.55e-1)" "prognostic unfavourable (9.97e-4)" "unprognostic (1.21e-1)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (7.81e-2)" "unprognostic (7.85e-2)" "unprognostic (3.22e-1)" "unprognostic (1.87e-1)" 85.4 87.0 45.7 114.3 46.9 132.5 106.4 38.9 41.2 103.8 145.5 38.8 89.2 84.1 129.4 80.7 117.7 83.5 119.9 112.5 37.2 31.2 65.4 113.9 71.8 265.3 41.5 37.0 203.8 334.9 21.8 54.2 76.7 44.1 114.3 46.8 65.4 169.0 95.4 216.0 122.9 77.0 121.1 44.2 121.4 87.8 54.5 27.8 124.0 119.8 147.0 115.0 112.7 196.5 284.6 144.9 40.5 81.3 148.0 268.3 354.3 119.8 147.3 70.1 204.6 133.7 211.9 83.5 104.9 129.9 75.6 82.1 124.9 92.1 304.0 84.4 78.4 79.5 87.4 151.7 44.8 85.1 205.9 153.4 95.9 178.0 163.0 230.4 122.0 245.0 253.4 53.6 182.2 121.9 132.1 114.7 87.0 104.2 161.0 234.1 135.5 132.6 156.6 160.0 132.5 102.7 203.6 120.2 158.1 54.8 244.2 231.7 107.7 265.9 150.1 95.5 103.1 59.2 138.0 116.1 157.4 137.2 59.7 158.0 87.6 40.5 81.3 20.7 132.2 70.3 194.3 284.6 226.2 180.3 126.7 264.8 268.3 212.3 13.6 148.0 60.4 144.9 165.3 354.3 45.7 46.9 38.9 41.2 37.2 31.2 41.5 37.0 44.1 27.8 RPL14 "CTG-B33, hRL14, L14, RL14" ENSG00000188846 "Ribosomal protein L14" P50914 3 40457292-40468587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 92.6;hTCEpi: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004136 Approved Supported "Endoplasmic reticulum,Cytosol" 210000 "Endoplasmic reticulum, Cytosol" "HPA004136: AB_1079839" "unprognostic (1.36e-3)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (2.54e-1)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (2.11e-1)" "unprognostic (1.54e-1)" "unprognostic (2.90e-2)" "unprognostic (6.14e-3)" "unprognostic (1.15e-1)" 49.9 33.5 28.3 57.4 43.8 47.2 134.4 28.7 57.6 85.4 68.2 21.4 48.0 29.8 87.0 30.9 66.0 61.0 56.7 46.7 40.8 22.8 42.5 69.8 44.6 61.7 24.7 22.2 151.9 117.3 48.4 34.4 60.8 40.6 81.8 42.0 36.2 162.9 73.6 72.3 66.7 39.0 59.1 24.7 69.6 52.4 23.8 11.7 42.9 63.3 100.2 58.5 48.7 77.0 26.6 16.0 4.6 11.6 14.3 38.3 47.9 9.5 5.3 32.5 11.5 26.3 92.6 18.9 14.7 49.3 55.5 42.1 11.1 3.8 41.9 12.4 14.5 2.9 16.5 25.7 32.7 14.2 18.2 20.1 9.2 10.6 40.3 28.5 10.8 44.8 96.7 15.8 33.5 50.8 23.6 5.9 38.4 9.2 9.4 26.0 9.3 17.3 4.4 12.3 20.3 41.1 7.1 10.1 16.3 7.7 7.5 22.3 11.7 15.7 16.9 11.3 8.2 14.3 18.6 18.3 22.0 22.9 5.0 21.5 10.4 3.7 11.6 4.6 21.1 11.6 35.5 26.6 31.7 27.7 16.0 24.1 38.3 34.9 1.8 14.3 9.9 14.6 24.9 47.9 28.3 43.8 28.7 57.6 40.8 22.8 24.7 22.2 40.6 11.7 RPL17 "L17, rpL23" ENSG00000265681 "Ribosomal protein L17" P18621 18 49488453-49492523 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043724, HPA046385" Supported Supported "Endoplasmic reticulum,Cytosol" 28000 "Endoplasmic reticulum, Cytosol" "HPA043724: , HPA046385: " "unprognostic (1.11e-1)" "unprognostic (8.77e-2)" "unprognostic (1.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (3.34e-3)" "prognostic unfavourable (3.60e-5)" "unprognostic (2.69e-1)" "unprognostic (3.29e-3)" "unprognostic (2.11e-1)" "unprognostic (4.35e-3)" "unprognostic (2.72e-2)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (6.54e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-3)" 59.6 60.0 40.5 57.8 58.1 101.1 127.2 41.7 42.9 66.7 64.4 26.3 67.8 40.9 64.1 65.5 84.9 76.7 79.7 49.5 32.2 31.1 99.4 184.2 48.0 106.0 42.9 32.3 177.4 203.2 21.7 72.5 77.1 43.6 60.7 53.1 39.8 83.3 83.8 67.6 76.3 69.7 43.7 38.1 78.5 66.8 92.7 32.9 66.6 81.7 146.2 75.2 58.2 70.4 140.6 102.8 22.2 59.2 95.1 158.9 142.2 98.1 62.5 91.1 107.5 150.7 308.0 86.8 110.5 128.7 104.8 79.5 84.0 47.9 170.4 76.3 109.2 117.9 123.5 198.2 112.3 70.6 127.7 89.9 74.3 114.4 131.4 291.6 72.3 293.3 224.7 109.1 258.9 143.1 87.9 125.1 130.0 79.8 105.2 187.3 92.7 51.4 104.6 118.7 219.3 141.9 117.7 69.8 84.2 40.8 85.1 170.8 80.5 191.1 113.6 77.8 66.2 38.1 115.9 112.9 105.2 157.8 74.4 177.7 74.0 22.2 59.2 15.2 82.8 53.2 158.9 140.6 134.5 109.0 93.7 117.9 150.4 127.9 12.7 95.1 43.8 102.8 104.8 142.2 40.5 58.1 41.7 42.9 32.2 31.1 42.9 32.3 43.6 32.9 RPL17-C18orf32 ENSG00000215472 "RPL17-C18orf32 readthrough" 18 49481681-49492479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043724, HPA046385" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA043724: , HPA046385: " "unprognostic (1.62e-1)" "unprognostic (1.67e-2)" "unprognostic (1.70e-3)" "unprognostic (3.83e-4)" "unprognostic (1.95e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" "unprognostic (2.38e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (5.42e-2)" 7.8 34.4 16.3 17.1 12.5 7.2 8.5 23.6 28.6 9.7 10.7 3.5 11.5 22.8 10.4 9.9 14.8 5.9 13.8 13.7 11.8 14.8 17.6 34.0 8.9 18.9 14.8 4.6 10.5 37.7 3.4 13.7 13.3 6.8 9.6 5.3 6.1 12.6 14.6 11.4 5.6 15.2 5.8 14.1 13.5 10.4 16.3 4.7 11.2 14.2 26.7 12.9 9.1 7.0 6.7 10.6 9.7 9.3 5.8 9.7 10.2 6.6 3.2 13.3 15.7 15.2 9.7 0.3 6.8 5.7 2.6 7.8 2.1 13.7 3.9 3.6 7.2 7.6 10.6 2.2 9.3 8.3 3.5 7.3 2.1 2.8 3.4 7.4 17.2 16.1 5.7 4.1 9.5 3.6 1.5 17.6 15.9 3.2 11.2 5.8 5.9 0.3 6.3 6.1 12.1 22.7 0.7 12.7 23.9 3.1 11.8 15.9 14.8 17.2 1.5 7.6 3.5 8.0 3.8 6.7 8.7 6.5 11.1 4.7 9.7 3.5 9.3 4.9 7.1 6.4 9.2 6.7 9.2 9.4 10.6 6.2 6.3 9.7 9.7 5.8 6.1 7.1 8.4 10.2 16.3 12.5 23.6 11.7 11.8 14.8 14.8 4.6 6.8 4.7 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 548.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: " "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 57.1 89.2 32.9 57.0 33.5 66.1 48.0 26.3 43.8 54.5 45.9 80.4 53.2 83.7 27.6 25.1 47.4 29.8 59.7 20.8 35.6 103.8 30.3 41.7 76.8 67.8 42.1 47.3 77.9 87.7 29.2 39.4 53.6 42.7 73.7 34.2 72.6 66.2 548.2 52.3 44.5 69.4 26.4 75.8 44.1 70.7 46.7 60.9 23.7 83.6 79.3 47.1 82.1 30.5 40.5 45.0 25.0 60.2 61.3 71.4 49.9 25.4 65.1 47.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859876-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 430.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA055259: " "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavourable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 48.8 33.8 24.9 42.2 43.0 85.7 53.6 27.8 61.1 49.9 46.0 26.5 28.1 40.4 47.8 36.4 65.5 56.5 38.9 31.5 22.6 16.2 50.0 85.9 34.8 83.7 22.3 26.1 109.2 106.6 9.3 30.5 46.9 30.9 41.8 26.8 30.4 99.8 31.6 157.7 90.1 43.3 36.6 21.9 57.6 50.1 67.3 17.6 59.5 65.3 107.9 54.0 45.0 57.1 395.8 193.6 24.8 110.7 126.0 278.4 430.5 126.2 98.4 65.8 92.7 98.8 162.8 166.6 77.5 98.6 102.7 97.9 135.8 127.2 191.2 179.9 66.7 95.2 77.5 165.1 35.9 97.7 208.8 89.3 94.7 154.6 171.1 128.4 97.8 203.2 217.7 56.8 122.4 112.2 113.4 124.0 64.8 197.0 173.7 169.6 154.7 151.8 156.3 69.8 226.6 93.7 120.2 95.3 143.0 27.5 192.2 240.0 91.2 249.6 86.0 63.6 74.1 127.0 130.0 166.3 151.2 123.4 83.6 205.6 78.9 24.8 110.4 16.5 134.8 110.7 234.6 368.3 232.2 167.1 166.6 395.8 278.4 212.5 11.3 126.0 85.6 193.6 195.9 430.5 24.9 43.0 27.8 61.1 22.6 16.2 22.3 26.1 30.9 17.6 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204727 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "SK-BR-3: 937.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol 100000 "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: " "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 72.3 57.7 51.3 56.7 56.9 122.5 94.7 41.8 88.6 72.2 64.5 42.2 62.7 48.7 67.0 56.7 77.7 78.1 65.9 87.3 49.2 37.0 62.3 124.4 70.7 229.5 50.5 53.0 156.4 124.4 33.1 51.7 57.3 58.7 60.0 52.5 48.1 113.8 67.6 91.4 95.8 58.8 57.5 57.1 74.4 66.1 45.2 34.1 53.0 63.3 94.9 103.4 63.1 75.9 208.2 143.4 40.4 108.7 116.2 236.3 325.8 47.0 64.0 46.4 56.3 85.0 107.5 48.1 44.3 90.4 91.7 73.8 69.7 44.5 115.2 78.0 63.2 80.0 69.8 91.6 47.3 46.7 122.5 41.1 47.8 90.7 132.6 100.6 56.9 119.7 100.6 70.6 127.9 79.1 71.4 67.4 63.3 46.4 133.2 140.6 47.5 47.7 79.0 66.1 115.1 82.7 59.0 56.5 62.8 26.6 937.7 138.3 90.8 128.1 46.5 35.9 48.5 54.6 81.4 89.0 88.1 84.7 48.7 76.8 46.1 36.7 108.7 40.4 116.1 90.3 180.1 208.2 187.2 146.8 143.4 193.1 236.3 190.8 17.1 116.2 72.6 132.4 146.2 325.8 51.3 56.9 41.8 88.6 49.2 37.0 50.5 53.0 58.7 34.1 RPL21 "DKFZp686C06101, FLJ27458, L21, MGC104274, MGC104275, MGC71252" ENSG00000122026 "Ribosomal protein L21" P46778 13 27251309-27256691 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047252 Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 22000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA047252: " "unprognostic (4.79e-2)" "unprognostic (3.69e-2)" "unprognostic (1.99e-1)" "unprognostic (2.31e-1)" "unprognostic (3.57e-1)" "unprognostic (1.90e-3)" "unprognostic (2.55e-2)" "unprognostic (7.72e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (1.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.47e-2)" "unprognostic (4.53e-2)" "unprognostic (4.83e-3)" "unprognostic (1.28e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-1)" 54.7 44.0 57.3 52.2 68.7 133.6 105.9 39.8 50.7 63.7 61.7 46.3 32.7 42.7 57.8 53.0 59.3 57.7 55.0 63.9 48.0 36.8 64.3 148.7 44.8 100.9 53.6 44.4 142.9 109.8 19.0 48.2 57.8 61.2 52.5 57.2 36.5 85.7 47.2 68.0 72.2 66.3 64.4 48.7 72.8 58.0 46.4 50.0 60.5 58.3 87.6 92.6 59.1 64.9 178.1 103.2 34.8 57.9 95.6 224.2 258.9 56.3 47.4 83.9 67.7 87.5 166.6 71.1 102.5 94.0 80.5 52.3 114.2 105.2 216.5 39.6 81.4 75.6 96.1 104.3 95.2 68.3 87.5 169.2 48.2 88.2 82.8 230.9 67.2 148.0 171.2 52.6 134.1 90.1 69.8 53.9 91.2 80.5 116.3 143.6 109.5 79.6 87.0 161.2 90.8 75.1 67.9 72.7 67.7 47.6 95.8 83.1 64.4 206.6 99.5 35.8 46.7 56.1 83.6 36.5 51.2 161.3 45.8 147.7 60.6 34.8 55.8 22.1 101.6 56.9 162.9 178.1 153.1 125.7 75.9 164.1 224.2 177.8 11.9 95.6 57.9 103.2 104.1 258.9 57.3 68.7 39.8 50.7 48.0 36.8 53.6 44.4 61.2 50.0 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6181269-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068294 Approved Nucleoplasm,Nucleoli 320000 Nucleoli Nucleoplasm "HPA068294: " "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 75.5 71.5 54.3 79.7 42.8 124.7 75.0 46.7 39.5 95.8 73.9 39.2 53.9 66.5 133.6 63.9 103.9 59.1 61.8 50.8 47.4 38.6 58.8 90.2 55.3 142.6 50.6 39.7 163.1 154.8 30.4 57.0 49.8 37.4 90.8 46.4 57.0 140.3 66.8 114.0 79.7 62.6 106.6 58.3 79.1 62.0 38.2 35.0 95.3 91.0 112.8 81.1 101.5 91.9 75.6 62.3 11.0 38.9 42.2 98.8 73.9 88.0 25.1 53.5 54.6 37.7 59.3 42.3 76.9 30.9 28.3 24.2 49.8 76.6 136.7 63.3 28.5 50.9 40.2 40.0 37.3 66.9 65.4 132.8 57.2 61.7 37.4 175.7 53.3 52.3 33.1 25.2 52.2 35.3 109.4 82.8 32.5 38.8 76.8 143.4 33.3 55.7 74.1 111.0 105.8 41.4 30.6 74.0 67.9 62.6 181.4 140.8 58.4 139.3 86.3 40.4 44.5 53.3 72.2 66.7 91.4 206.8 26.7 181.7 25.0 11.0 38.9 8.8 38.0 34.3 66.9 75.6 71.1 52.3 59.8 72.4 98.8 78.1 2.9 42.2 27.8 62.3 54.0 73.9 54.3 42.8 46.7 39.5 47.4 38.6 50.6 39.7 37.4 35.0 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA048060: , HPA056207: , HPA068294: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favourable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavourable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.5 17.5 5.7 66.3 17.0 100.0 17.5 15.8 36.5 12.9 8.4 7.5 3.6 48.1 3.6 14.7 4.0 14.1 40.4 7.2 2.9 2.5 4.3 2.1 16.8 68.7 8.9 6.4 72.6 82.5 4.1 43.8 43.7 3.0 3.1 70.5 19.7 64.5 5.0 89.3 3.2 86.6 2.0 7.4 31.9 34.7 0.9 4.8 1.6 7.9 6.8 11.1 7.8 20.2 2.4 19.0 4.9 22.0 5.0 3.4 7.6 45.0 5.4 51.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 RPL23A L23A ENSG00000198242 "Ribosomal protein L23a" P62750 17 28719393-28724359 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 261.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051754, HPA077474" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 15000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA051754: , HPA077474: " "unprognostic (1.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (9.79e-2)" "unprognostic (7.76e-2)" "unprognostic (1.91e-3)" "unprognostic (1.23e-1)" "unprognostic (9.64e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.78e-1)" "prognostic unfavourable (5.16e-6)" "unprognostic (3.91e-2)" "unprognostic (1.54e-1)" "unprognostic (3.98e-3)" "unprognostic (2.68e-1)" 49.1 38.5 48.6 43.3 62.1 67.9 87.0 40.6 75.5 63.8 47.0 27.3 48.5 34.8 53.2 44.0 56.5 64.1 35.1 48.8 56.6 28.7 39.5 93.2 62.3 108.0 42.6 39.6 142.1 63.3 21.4 45.3 51.0 40.5 44.9 48.8 27.6 61.3 41.7 64.9 70.5 44.6 39.8 63.4 59.1 47.8 108.1 35.7 56.1 44.4 78.8 84.9 51.1 61.0 261.4 139.2 30.6 75.3 142.1 254.7 206.1 58.8 120.4 72.8 90.3 96.5 155.5 71.0 55.4 97.1 93.8 79.3 122.4 57.2 133.3 52.2 76.8 80.6 95.9 123.5 97.3 70.5 265.1 63.7 118.3 130.3 87.9 132.2 66.7 151.2 159.1 74.6 118.0 101.5 82.6 90.5 93.8 97.4 147.6 174.4 69.3 73.4 87.5 131.6 157.5 101.6 120.5 75.3 87.8 39.3 285.5 123.9 141.9 155.4 60.1 51.6 73.6 60.1 97.8 112.9 104.2 77.9 81.8 73.2 56.9 30.6 66.3 19.4 156.5 75.3 232.3 261.4 227.4 203.4 108.7 227.4 254.7 229.5 9.4 142.1 59.6 139.2 154.0 206.1 48.6 62.1 40.6 75.5 56.6 28.7 42.6 39.6 40.5 35.7 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686782 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" 19000 "Endoplasmic reticulum, Cytosol" "HPA051653: " "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavourable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favourable (8.25e-4)" "unprognostic (5.37e-2)" 61.3 58.9 60.6 99.3 68.8 87.9 135.5 73.0 90.1 94.7 64.0 15.8 84.3 49.6 74.2 98.0 75.5 65.4 82.9 110.0 45.6 43.8 58.3 70.3 122.0 256.0 50.7 46.3 174.7 211.4 25.9 65.5 68.2 53.4 69.0 54.7 30.4 133.9 109.9 175.9 66.2 46.2 98.7 80.7 51.4 60.5 30.2 44.1 61.3 84.7 134.3 71.7 105.1 175.4 128.2 107.7 29.6 65.6 85.5 173.8 214.1 163.5 54.4 83.4 92.0 91.5 164.0 126.3 94.3 105.4 127.5 93.5 108.2 72.5 180.5 117.0 72.1 87.1 96.6 116.8 127.8 96.7 96.9 107.0 47.2 80.9 89.9 120.3 56.7 159.1 149.9 80.2 143.3 107.9 97.9 90.1 117.2 109.3 128.2 184.3 150.1 118.2 113.1 82.3 172.4 130.1 73.0 178.7 83.1 49.1 88.3 209.1 107.9 221.4 78.8 55.6 103.2 30.4 114.6 79.2 101.1 315.6 74.5 127.4 93.2 29.6 65.6 16.3 86.1 57.1 125.2 128.2 136.4 104.2 90.5 127.0 173.8 132.3 10.9 85.5 56.9 107.7 121.1 214.1 60.6 68.8 73.0 90.1 45.6 43.8 50.7 46.3 53.4 44.1 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 101.9 93.8 92.3 109.2 174.4 287.2 90.3 88.6 131.8 120.3 90.9 99.1 52.5 178.2 101.9 104.9 113.3 117.4 181.5 141.7 66.5 211.4 69.5 103.6 114.3 203.9 103.2 90.2 244.7 363.4 99.6 299.5 148.1 78.7 53.7 126.3 70.1 113.8 141.3 86.8 62.3 113.7 93.8 110.8 161.7 76.6 38.4 82.0 47.7 89.2 204.8 91.2 138.3 92.8 48.7 60.8 67.1 155.0 43.2 50.4 77.9 79.7 146.9 72.1 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.7 28.4 16.7 41.1 36.7 32.8 32.0 22.4 73.0 38.9 19.3 40.2 56.4 38.0 28.5 52.3 16.5 31.6 40.1 33.3 24.0 14.7 22.3 23.9 42.3 29.7 23.5 22.6 18.9 29.2 65.9 29.3 38.0 15.5 42.9 21.4 37.8 29.7 23.9 18.7 24.6 15.1 26.0 23.9 37.7 29.3 25.9 24.7 47.0 26.1 27.4 21.3 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682411-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 555.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA060776: , HPA063379: " "prognostic favourable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavourable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 65.9 58.8 49.6 116.1 81.5 146.4 149.4 47.8 80.5 69.7 69.9 25.1 64.2 60.1 73.2 74.9 98.4 76.4 88.5 103.5 59.9 33.9 57.0 71.3 111.1 316.9 44.5 49.3 132.2 278.5 10.4 54.6 64.8 64.0 70.1 75.7 42.1 115.8 70.1 124.6 97.9 69.2 109.2 47.1 92.0 72.4 56.8 28.5 74.6 89.3 127.5 120.5 71.0 128.7 341.9 188.5 71.3 122.3 161.9 351.8 555.6 168.0 117.0 74.8 89.7 103.0 197.1 113.1 109.3 138.1 125.4 96.4 147.9 157.1 238.4 86.4 95.6 123.0 98.6 152.4 94.5 87.0 212.0 105.0 114.3 182.4 171.0 190.1 123.6 215.3 272.6 19.7 209.3 124.2 108.0 75.3 105.9 126.6 141.6 286.6 121.5 122.6 124.0 78.6 144.9 117.8 168.5 85.6 153.9 40.5 155.7 169.7 68.8 217.9 112.7 40.8 110.2 105.0 138.0 85.8 187.9 195.0 93.9 130.3 74.1 71.3 122.3 37.8 208.1 119.1 266.8 341.9 295.7 244.4 188.5 301.2 351.8 290.3 29.7 161.9 108.1 180.0 198.2 555.6 49.6 81.5 47.8 80.5 59.9 33.9 44.5 49.3 64.0 28.5 RPL28 "FLJ43307, L28" ENSG00000108107 "Ribosomal protein L28" P46779 19 55385345-55403250 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050459 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA050459: " "unprognostic (4.70e-3)" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (6.53e-2)" "unprognostic (9.73e-2)" "unprognostic (3.38e-2)" "unprognostic (2.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.93e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.61e-5)" "unprognostic (4.28e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-1)" "unprognostic (8.93e-3)" 91.7 86.3 81.9 112.8 68.3 166.7 88.9 32.8 84.1 117.1 107.7 86.7 71.1 89.9 144.6 81.3 224.2 105.0 118.0 72.9 66.2 54.4 87.1 228.8 133.0 398.1 70.4 50.7 200.5 198.5 25.5 73.7 88.7 53.2 122.7 61.2 88.0 143.3 77.9 102.1 136.4 108.1 76.8 70.7 205.5 85.8 75.9 27.4 375.5 144.6 108.5 269.6 131.8 121.7 139.5 93.6 27.8 77.2 66.7 146.6 190.9 119.3 139.0 48.4 96.1 86.5 139.3 81.7 81.1 77.6 71.0 65.9 135.4 63.8 179.5 58.4 73.4 75.2 55.0 104.2 31.5 69.4 312.4 110.7 87.9 164.7 143.9 128.7 97.6 195.4 149.9 52.7 106.9 76.2 85.6 147.8 63.2 138.0 143.8 119.7 115.9 152.1 146.0 69.8 136.6 89.9 239.2 61.7 102.0 51.6 170.2 122.1 70.7 138.0 92.3 63.5 71.6 50.8 128.5 121.9 175.6 112.0 81.1 157.6 53.5 27.8 77.2 21.9 77.0 67.8 119.7 137.8 129.9 101.2 93.6 139.5 146.6 130.8 24.4 66.7 56.3 88.3 117.7 190.9 81.9 68.3 32.8 84.1 66.2 54.4 70.4 50.7 53.2 27.4 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: " "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.2 90.1 69.5 105.9 123.9 194.9 98.1 77.5 95.8 106.5 88.7 107.2 106.5 193.8 33.8 78.7 63.1 100.2 164.9 51.0 78.8 136.3 100.3 116.5 178.9 147.0 145.5 96.8 238.2 234.6 78.5 139.9 119.2 78.2 148.9 78.5 158.2 126.2 189.2 115.4 153.0 58.7 76.6 187.9 136.2 144.9 56.2 109.7 58.0 133.9 132.4 100.2 248.9 103.3 59.8 80.4 92.2 115.5 97.1 137.7 137.8 79.1 174.5 79.0 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol 120000 "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: " "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 71.7 71.8 51.3 72.3 50.3 107.0 134.5 50.8 49.3 102.2 94.4 42.7 78.1 63.1 207.5 79.6 126.9 101.6 96.2 54.5 41.4 38.8 66.6 102.5 74.5 205.9 47.4 57.7 217.8 453.1 50.9 75.0 74.5 58.0 138.7 57.0 74.8 216.3 68.5 48.9 118.1 62.6 115.6 50.7 84.3 74.4 76.4 23.3 105.5 158.5 82.3 109.8 119.9 105.7 198.9 114.8 18.9 56.4 150.3 249.0 326.4 86.4 80.1 91.6 101.3 117.3 254.3 123.5 67.0 127.6 67.1 60.3 100.6 66.1 357.7 92.9 80.7 57.6 97.7 143.3 44.7 60.8 96.3 90.0 95.8 150.5 173.2 127.9 76.0 245.7 194.2 58.0 206.7 130.4 101.3 124.4 96.9 111.3 129.8 186.2 95.8 55.9 104.3 88.9 179.5 123.9 128.2 83.9 99.1 42.0 137.6 219.3 103.7 208.6 129.2 45.1 71.3 47.2 76.3 95.6 72.2 158.4 101.6 113.1 50.9 18.9 56.4 11.9 132.5 51.7 205.6 198.9 192.1 153.7 101.2 175.8 249.0 195.2 8.1 150.3 44.5 114.8 126.1 326.4 51.3 50.3 50.8 49.3 41.4 38.8 47.4 57.7 58.0 23.3 RPL30 L30 ENSG00000156482 "Ribosomal protein L30" P62888 8 98024851-98046469 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002651 Approved Approved "Endoplasmic reticulum,Cytosol" 52000 "Endoplasmic reticulum, Cytosol" "HPA002651: AB_1079842" "unprognostic (3.28e-2)" "unprognostic (2.19e-1)" "unprognostic (7.36e-2)" "unprognostic (2.42e-2)" "unprognostic (3.48e-3)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (3.34e-1)" "unprognostic (2.89e-1)" "unprognostic (2.49e-2)" "unprognostic (4.76e-2)" "prognostic unfavourable (1.41e-9)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (5.97e-3)" 146.2 68.8 77.6 75.4 56.2 153.1 195.1 54.3 62.0 158.8 123.2 64.1 96.3 57.5 146.1 120.3 164.9 126.6 113.5 147.3 64.5 53.1 75.7 140.6 121.2 383.2 78.6 46.4 284.8 344.3 44.6 62.1 97.5 49.3 154.7 96.3 66.2 172.7 131.4 191.2 144.8 90.1 164.3 85.2 146.6 96.3 79.5 58.7 168.1 170.4 102.5 176.5 153.6 197.4 180.4 94.5 42.1 70.0 94.2 238.2 179.6 146.7 100.8 108.6 104.1 156.6 290.4 104.6 86.7 151.6 146.4 128.6 111.2 138.8 192.1 227.0 123.7 96.3 135.2 161.0 152.5 75.8 112.9 167.3 100.9 145.7 230.5 89.1 83.7 246.3 255.8 108.4 311.0 150.2 119.4 127.5 124.2 195.2 207.8 167.2 97.1 146.4 112.6 82.7 176.7 119.4 136.4 157.0 134.5 50.2 125.5 197.9 165.2 212.1 83.4 57.3 61.7 85.5 103.7 134.5 108.9 157.3 80.5 182.3 83.7 42.1 70.0 31.6 104.4 63.1 154.1 180.4 181.2 138.9 94.5 171.7 238.2 186.0 26.3 94.2 55.6 94.0 117.8 179.6 77.6 56.2 54.3 62.0 64.5 53.1 78.6 46.4 49.3 58.7 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841588 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 406.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" 140000 "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 80.5 42.2 62.9 55.4 44.5 106.7 109.0 33.2 50.8 101.5 58.9 34.9 38.3 37.3 63.1 91.5 94.8 82.3 49.5 53.5 46.5 36.5 68.4 132.9 63.7 117.4 50.1 41.1 167.0 406.2 20.4 38.6 48.6 32.8 62.6 68.4 41.8 67.9 43.3 121.4 90.5 48.6 78.0 48.4 77.7 52.0 55.9 30.7 103.9 66.9 87.7 121.5 91.2 68.9 230.3 119.2 38.8 86.1 104.4 281.7 293.2 73.3 88.3 77.1 98.2 121.3 217.4 254.8 60.7 113.1 128.3 88.0 116.6 75.3 128.1 55.5 87.1 46.1 87.4 126.1 105.6 59.1 146.3 74.4 112.0 126.0 181.4 119.9 75.6 195.0 275.4 97.8 189.2 111.9 91.3 119.1 104.7 221.5 134.7 207.3 129.9 167.7 107.7 69.3 166.7 129.6 122.3 49.0 98.0 40.8 109.8 130.4 160.7 231.2 64.5 55.7 71.2 73.1 111.3 80.6 126.5 223.9 70.9 172.2 82.9 38.8 86.1 22.9 99.1 66.7 178.3 230.3 197.2 143.1 119.2 214.7 281.7 213.1 12.7 104.4 53.6 118.2 147.0 293.2 62.9 44.5 33.2 50.8 46.5 36.5 50.1 41.1 32.8 30.7 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favourable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 58.6 42.9 77.9 110.7 169.1 267.7 76.7 90.7 115.2 74.8 62.7 108.6 104.4 178.5 54.6 88.1 41.9 83.7 141.4 98.3 65.8 134.1 74.5 90.1 166.2 142.4 186.8 83.5 238.0 202.1 61.1 139.0 134.5 130.5 102.5 123.2 114.0 114.4 228.2 89.3 86.8 105.2 83.7 108.1 156.2 99.0 83.6 107.1 37.0 216.2 127.0 71.9 170.9 99.3 51.3 69.6 53.6 80.1 76.6 99.9 143.9 69.9 116.8 62.7 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 RPL35 L35 ENSG00000136942 "Ribosomal protein L35" P42766 9 124857880-124861981 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA006047 Approved Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA006047: AB_1856443" "unprognostic (1.16e-2)" "unprognostic (5.42e-3)" "unprognostic (3.04e-2)" "unprognostic (3.69e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" "unprognostic (2.67e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-3)" "unprognostic (6.58e-2)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" 91.6 70.1 81.9 116.6 59.2 178.1 156.1 49.2 55.6 109.3 118.5 45.8 86.8 63.0 95.1 98.9 158.5 98.4 89.9 97.0 60.2 55.0 77.5 140.3 89.1 228.4 65.9 48.1 189.1 492.3 25.7 67.0 71.8 45.8 118.3 56.6 63.9 150.9 98.5 247.1 142.7 75.6 131.5 60.8 113.4 78.2 60.5 46.0 113.3 128.4 154.6 130.1 125.5 176.4 201.4 172.2 31.1 82.2 105.1 165.8 281.7 93.3 145.8 82.8 113.5 90.5 192.0 113.6 73.7 119.1 153.8 105.0 240.5 92.6 140.1 76.7 82.0 181.0 96.0 161.3 56.5 85.7 166.0 56.6 198.0 155.3 161.6 125.8 75.7 176.7 252.5 90.9 161.8 112.8 121.3 177.8 115.2 303.3 148.1 288.7 155.1 179.8 126.5 127.7 311.6 131.9 110.8 112.1 91.0 66.9 158.7 149.3 161.3 207.8 57.8 68.6 72.6 119.0 149.5 100.3 233.6 208.8 96.4 132.6 115.2 28.5 82.2 31.1 116.6 72.1 155.1 201.4 156.5 133.8 121.0 189.4 165.8 143.9 10.8 105.1 58.8 172.2 122.6 281.7 81.9 59.2 49.2 55.6 60.2 55.0 65.9 48.1 45.8 46.0 RPL36 "DKFZp566B023, L36" ENSG00000130255 "Ribosomal protein L36" Q9Y3U8 19 5674947-5691876 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047153 Supported Uncertain "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA047153: " "unprognostic (2.81e-2)" "unprognostic (5.70e-3)" "unprognostic (8.16e-2)" "unprognostic (6.28e-3)" "unprognostic (2.25e-2)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (5.48e-2)" "unprognostic (1.29e-1)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (4.65e-2)" "prognostic unfavourable (2.32e-4)" "unprognostic (7.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" 52.2 101.2 56.3 80.9 43.1 120.2 88.4 40.8 71.1 59.7 63.4 21.2 58.0 60.4 72.2 64.9 79.6 63.2 66.2 69.6 39.7 33.9 48.4 59.7 58.6 201.6 38.7 52.9 225.0 196.1 12.9 48.0 38.6 34.9 65.0 36.7 29.4 129.4 70.4 78.7 101.9 61.4 60.8 39.5 75.3 64.7 53.8 32.3 39.9 40.9 106.1 55.5 48.4 103.1 163.2 79.0 29.1 57.6 68.6 180.7 220.0 100.2 50.3 35.3 87.3 42.2 81.6 52.3 55.3 36.2 56.4 46.5 93.3 51.2 68.5 134.1 26.1 70.8 31.7 65.8 17.1 51.8 223.2 43.1 51.7 76.8 93.6 92.8 60.6 69.5 108.2 34.9 73.4 47.5 55.2 223.1 32.8 107.1 115.1 128.8 118.7 171.3 71.6 41.5 185.9 54.3 67.2 62.9 84.3 32.6 93.6 154.5 72.2 159.9 50.8 37.2 49.9 54.3 120.6 110.1 100.0 107.3 70.7 149.0 51.8 29.1 57.6 21.4 77.3 48.3 125.2 161.4 157.2 113.1 79.0 163.2 180.7 146.6 8.0 68.6 40.4 74.6 120.6 220.0 56.3 43.1 40.8 71.1 39.7 33.9 38.7 52.9 34.9 32.3 RPL36A "L36A, RPL44" ENSG00000241343 "Ribosomal protein L36a" P83881 X 101390824-101396154 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA063979, HPA077586" Uncertain Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA063979: , HPA077586: " "unprognostic (3.38e-2)" "unprognostic (2.11e-2)" "unprognostic (7.04e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (4.19e-3)" "unprognostic (4.15e-3)" "unprognostic (1.28e-1)" "unprognostic (2.86e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (8.81e-11)" "unprognostic (1.87e-2)" "unprognostic (4.50e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" 62.9 40.7 50.7 81.5 53.8 139.8 136.1 27.7 46.8 65.3 71.0 25.1 53.4 45.6 67.5 71.4 77.1 59.0 60.6 54.9 43.1 31.1 47.3 60.1 43.4 190.1 42.1 50.6 165.3 171.4 15.0 35.1 44.7 41.8 55.9 68.3 26.1 158.1 71.5 125.7 96.5 54.1 65.5 44.6 67.9 54.6 26.3 32.6 60.8 69.3 118.6 104.0 71.9 74.0 162.9 113.2 13.7 74.2 86.7 175.5 199.2 121.7 65.9 101.3 49.9 124.9 224.1 64.8 93.8 103.0 123.1 188.2 78.1 62.6 236.0 93.9 77.9 82.3 151.4 131.4 128.4 83.0 166.1 109.1 116.3 71.9 179.6 198.4 105.2 212.6 248.2 99.7 185.0 113.9 131.8 126.9 99.2 175.4 91.8 236.7 134.6 134.1 86.2 221.7 184.9 112.6 50.8 68.0 135.8 87.6 98.4 167.9 47.5 224.6 105.1 36.6 89.6 101.1 95.1 108.0 154.2 186.5 45.0 295.8 39.0 12.5 74.2 13.7 86.6 73.6 140.3 162.9 162.3 120.6 111.4 134.0 175.5 156.7 7.2 86.7 70.4 113.2 84.9 199.2 50.7 53.8 27.7 46.8 43.1 31.1 42.1 50.6 41.8 32.6 RPL36A-HNRNPH2 ENSG00000257529 "RPL36A-HNRNPH2 readthrough" X 101391011-101412297 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: " "unprognostic (3.69e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.65e-3)" "unprognostic (1.63e-1)" "unprognostic (2.96e-1)" "unprognostic (1.79e-1)" "unprognostic (5.34e-2)" "unprognostic (2.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (1.49e-3)" "unprognostic (2.04e-4)" "unprognostic (1.56e-1)" "unprognostic (4.81e-2)" "unprognostic (3.94e-1)" 6.7 6.0 3.7 8.5 5.0 7.2 6.1 15.3 5.2 5.9 9.9 1.4 4.9 1.5 6.7 7.2 6.9 4.5 5.8 5.1 3.7 5.4 4.3 5.8 4.5 22.1 4.6 4.6 12.7 19.7 1.5 3.6 4.2 3.5 5.2 4.5 1.5 18.1 7.2 14.0 5.3 4.4 6.4 5.0 6.5 4.3 2.5 2.3 5.9 6.9 13.1 6.2 7.3 7.5 16.2 19.8 13.6 16.1 10.6 14.3 22.4 3.7 0.0 5.1 1.0 2.3 5.1 1.7 14.6 0.7 3.0 2.2 0.0 2.2 3.4 4.5 2.0 0.4 4.3 0.6 1.0 4.3 1.7 4.1 2.7 1.3 3.9 3.5 1.7 5.5 2.8 1.6 1.1 1.8 1.4 4.3 3.9 0.6 5.6 2.2 0.3 2.0 7.1 5.3 2.8 1.3 0.6 3.1 4.5 1.8 1.6 1.8 1.7 2.0 2.1 0.5 2.8 2.5 2.5 3.7 6.3 1.2 1.4 3.4 3.1 7.5 14.9 13.6 13.1 16.1 11.5 16.2 12.3 12.4 19.8 15.4 14.3 13.6 4.7 10.6 9.9 10.7 9.0 22.4 3.7 5.0 15.3 5.2 3.7 5.4 4.6 4.6 3.5 2.3 RPL36AL RPL36A ENSG00000165502 "Ribosomal protein L36a like" Q969Q0 14 49618519-49620685 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA077586 Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA077586: " "unprognostic (1.55e-2)" "unprognostic (2.44e-2)" "unprognostic (8.73e-2)" "unprognostic (3.15e-3)" "unprognostic (1.52e-1)" "unprognostic (2.55e-2)" "unprognostic (1.31e-1)" "unprognostic (6.37e-2)" "unprognostic (4.18e-2)" "unprognostic (1.38e-3)" "unprognostic (2.29e-1)" "unprognostic (4.72e-1)" "unprognostic (1.16e-3)" "unprognostic (8.32e-2)" "unprognostic (2.80e-1)" "prognostic favourable (2.83e-4)" "unprognostic (1.00e-1)" 60.3 55.8 45.9 46.5 40.9 68.2 66.5 35.9 37.7 69.3 74.3 29.2 56.6 52.1 54.9 102.1 61.8 45.9 31.5 48.2 38.0 34.4 69.9 139.2 54.8 63.6 45.3 34.1 105.3 131.9 35.7 62.0 56.9 40.3 62.9 50.5 30.8 85.2 68.6 82.4 40.8 99.8 71.1 48.0 78.8 61.8 36.7 41.8 65.4 72.5 67.6 71.0 87.6 63.9 105.8 112.7 119.5 66.7 84.5 132.0 139.8 72.2 54.5 39.5 22.8 56.8 78.5 23.1 59.7 66.0 56.0 63.5 56.7 50.1 95.3 57.0 49.4 52.2 33.4 50.9 65.6 32.7 38.5 59.8 57.6 73.2 72.0 95.3 51.4 80.3 78.2 42.8 57.9 70.8 37.9 84.9 43.0 93.3 56.1 85.7 22.2 56.1 35.5 62.1 51.1 84.9 110.0 34.6 21.4 52.6 41.7 59.9 90.4 53.1 54.5 35.1 55.9 45.6 45.9 51.8 52.9 96.3 25.4 43.2 33.4 119.5 66.7 99.6 98.6 63.2 132.0 105.8 129.3 123.0 68.7 79.9 120.7 112.6 74.0 84.5 55.9 112.7 118.2 139.8 45.9 40.9 35.9 37.7 38.0 34.4 45.3 34.1 40.3 41.8 RPL37A L37A ENSG00000197756 "Ribosomal protein L37a" P61513 2 216498189-216579180 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065327 Approved Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA065327: " "unprognostic (9.94e-3)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.19e-1)" "unprognostic (5.12e-3)" "unprognostic (6.92e-2)" "unprognostic (1.76e-2)" "unprognostic (2.67e-1)" "unprognostic (8.26e-2)" "unprognostic (2.33e-1)" "unprognostic (2.62e-1)" "unprognostic (8.84e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.49e-1)" "unprognostic (4.92e-2)" "unprognostic (1.05e-2)" "unprognostic (1.67e-1)" 115.0 109.4 130.0 114.9 104.2 153.1 252.9 78.4 82.8 134.5 129.9 66.0 80.5 79.8 188.5 123.9 154.9 131.5 90.7 154.0 91.2 81.7 81.0 116.7 100.7 283.5 108.6 91.0 281.8 423.2 47.3 84.3 74.1 89.0 134.7 115.2 77.9 265.7 107.8 307.2 159.0 76.6 171.8 98.6 97.6 99.0 130.3 60.1 117.2 123.7 186.1 154.7 137.2 195.1 215.6 197.7 39.6 103.3 119.1 222.5 229.2 82.4 70.6 153.4 103.2 160.5 282.9 114.0 112.5 151.2 114.8 98.3 178.9 80.5 91.2 158.0 138.0 86.7 144.9 165.8 118.9 103.7 153.6 149.0 128.0 252.5 274.9 163.5 93.9 306.4 349.5 99.3 280.6 158.2 116.0 134.0 148.5 166.4 155.0 336.8 177.5 80.7 112.6 115.3 111.0 159.9 145.4 99.6 112.1 41.5 130.2 256.2 82.3 283.2 106.0 83.1 90.8 81.4 122.8 142.5 200.7 174.0 92.7 114.6 84.0 39.6 103.3 24.2 122.9 77.1 168.0 215.2 190.4 151.9 143.0 215.6 222.5 198.2 13.5 119.1 63.9 197.7 136.5 229.2 130.0 104.2 78.4 82.8 91.2 81.7 108.6 91.0 89.0 60.1 RPL38 L38 ENSG00000172809 "Ribosomal protein L38" P63173 17 74203582-74210655 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052543 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA052543: " "unprognostic (1.68e-3)" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (7.71e-3)" "unprognostic (4.95e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (6.17e-8)" "unprognostic (1.89e-1)" "unprognostic (6.00e-2)" "unprognostic (1.18e-1)" "unprognostic (3.39e-2)" 105.7 85.6 114.6 92.9 94.2 140.7 148.5 58.8 142.3 91.1 107.6 42.6 88.1 74.9 88.2 104.6 89.3 88.2 86.2 152.3 87.3 69.2 67.5 83.5 132.5 313.8 111.4 104.1 258.2 305.8 26.7 59.9 62.8 95.4 73.0 79.4 41.2 118.9 101.8 283.6 108.0 73.8 150.8 162.9 108.0 77.7 99.6 108.3 77.1 67.7 143.5 133.2 92.9 195.6 174.9 141.2 54.0 106.3 80.4 217.6 213.6 95.1 94.6 91.2 93.0 125.0 148.2 90.4 103.7 67.0 95.0 66.6 106.1 73.1 168.5 72.7 88.6 86.1 108.7 134.6 74.5 46.9 174.4 96.3 80.3 136.9 146.0 179.7 86.1 284.4 189.4 89.1 145.3 138.8 118.1 94.0 79.3 100.2 174.0 217.4 106.6 143.4 126.0 193.5 149.6 112.5 74.7 82.7 154.3 43.3 181.3 224.3 138.1 187.3 90.7 79.5 129.5 73.1 135.3 127.8 197.0 173.9 65.1 119.2 75.5 54.0 106.3 37.3 112.2 84.4 132.9 174.9 190.5 140.5 115.2 174.7 217.6 185.8 34.0 80.4 74.5 141.2 117.4 213.6 114.6 94.2 58.8 142.3 87.3 69.2 111.4 104.1 95.4 108.3 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Supported "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" 830000 "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 63.6 33.4 37.0 59.0 40.4 70.6 88.2 34.5 42.2 73.6 60.5 33.5 42.3 18.8 67.3 49.8 81.3 65.7 39.4 38.8 31.7 26.4 53.2 84.5 46.1 103.9 35.1 26.3 139.1 159.9 33.1 42.0 52.0 34.1 67.6 50.9 35.9 66.2 51.0 87.2 77.1 36.4 67.3 47.9 60.3 46.3 42.8 20.0 81.3 66.1 91.7 102.8 74.2 55.9 72.5 58.7 5.9 40.9 45.0 97.0 135.7 44.2 89.4 37.8 63.7 170.4 309.9 66.8 54.1 111.7 83.8 65.1 98.8 77.7 175.4 61.7 128.8 80.6 270.2 209.1 92.7 48.4 162.0 107.5 80.1 82.0 240.2 112.6 53.9 304.0 272.6 91.0 363.9 133.9 98.4 69.0 125.2 73.0 75.0 50.1 82.7 64.0 84.1 86.3 170.2 115.1 87.9 67.3 70.4 33.3 94.9 133.6 70.1 162.8 78.4 43.8 66.2 40.7 85.9 67.9 105.2 117.3 53.9 151.6 49.3 3.5 40.9 5.9 38.2 36.2 71.1 72.5 74.6 53.7 58.7 60.5 97.0 75.7 2.7 45.0 33.5 37.4 57.0 135.7 37.0 40.4 34.5 42.2 31.7 26.4 35.1 26.3 34.1 20.0 RPL5 "L5, PPP1R135" ENSG00000122406 "Ribosomal protein L5" P46777 1 92831983-92841924 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043717: AB_10964719, HPA054444: " "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 119.4 80.3 50.0 70.0 50.1 113.8 140.5 46.9 46.8 158.6 111.4 45.0 75.1 61.7 135.2 114.6 159.4 100.5 73.1 73.0 43.5 43.1 99.7 114.9 89.9 148.2 54.5 36.2 296.8 306.5 40.8 90.3 90.2 44.3 175.4 78.8 64.3 121.5 73.2 109.1 97.8 95.3 153.4 61.9 130.1 90.0 68.8 45.7 156.6 210.0 97.7 118.9 191.2 146.6 104.5 85.2 12.8 45.9 72.4 143.0 142.1 116.8 50.2 89.5 75.5 116.4 235.3 143.6 69.9 93.6 87.1 62.4 133.0 51.1 220.5 112.3 78.5 74.7 102.6 131.0 111.3 69.8 140.4 114.4 83.6 122.4 139.7 175.1 48.2 192.4 206.7 77.3 170.2 120.2 141.6 116.3 99.7 66.3 139.4 198.6 138.2 94.9 128.1 173.4 142.4 105.6 97.3 76.3 91.3 45.5 127.1 203.3 70.0 240.9 73.0 44.0 80.4 83.1 126.0 72.0 68.3 149.2 29.8 151.0 29.8 12.8 45.9 7.2 60.9 44.8 122.1 104.5 111.5 91.6 85.2 88.4 143.0 123.9 4.4 72.4 38.3 71.1 83.2 142.1 50.0 50.1 46.9 46.8 43.5 43.1 54.5 36.2 44.3 45.7 RPL6 "L6, TAXREB107, TXREB1" ENSG00000089009 "Ribosomal protein L6" Q02878 12 112405190-112418838 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060903, HPA068418" Approved Approved "Microtubules,Cytokinetic bridge" 270000 "Microtubules, Cytokinetic bridge" "HPA060903: , HPA068418: " "unprognostic (5.95e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (5.49e-2)" "unprognostic (1.10e-2)" "unprognostic (2.50e-1)" "unprognostic (1.02e-2)" "unprognostic (3.74e-1)" "unprognostic (5.63e-2)" "unprognostic (1.07e-2)" "unprognostic (4.19e-3)" "unprognostic (2.52e-2)" "prognostic unfavourable (6.95e-4)" "unprognostic (2.45e-1)" "unprognostic (2.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.90e-2)" 63.6 60.2 58.0 55.5 72.9 102.2 94.0 42.0 87.8 63.8 65.1 39.4 50.5 39.8 68.9 83.2 86.5 64.9 38.9 45.8 50.0 38.7 78.8 111.9 45.2 84.5 45.3 72.6 149.8 113.7 39.3 78.7 69.2 91.1 56.9 63.5 32.9 81.5 51.8 73.6 80.0 50.9 52.5 46.0 68.0 67.6 60.0 42.3 71.2 62.9 122.7 106.4 61.9 68.1 164.0 158.0 28.3 98.8 125.5 191.9 287.6 97.6 92.6 113.5 116.2 142.1 234.9 152.0 96.2 134.1 126.4 72.7 144.5 61.7 212.5 81.7 99.8 95.9 121.0 165.0 126.6 83.7 154.1 114.6 82.2 128.6 149.6 204.0 89.2 217.7 230.1 96.2 221.7 141.4 150.3 58.2 145.0 130.4 147.1 328.3 160.6 107.6 135.7 124.8 203.9 156.5 160.3 106.6 138.2 66.8 177.2 160.3 186.1 208.6 85.0 63.6 78.1 81.5 105.5 80.5 125.0 170.5 82.3 147.4 95.1 28.3 98.8 20.9 114.5 84.1 189.8 164.0 174.1 147.8 136.0 145.4 191.9 162.2 12.7 125.5 73.3 158.0 137.8 287.6 58.0 72.9 42.0 87.8 50.0 38.7 45.3 72.6 91.1 42.3 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 627.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: " "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 98.1 71.3 76.7 92.3 156.6 200.7 75.5 107.9 86.8 73.7 58.3 85.7 102.8 292.0 88.3 87.0 94.2 101.2 137.7 115.1 78.5 84.0 159.8 93.3 88.2 94.1 112.6 82.0 187.8 162.8 68.2 213.6 119.5 142.4 110.8 104.6 83.3 178.7 172.3 89.4 76.7 120.9 87.9 113.8 114.9 98.5 106.2 77.4 50.7 627.9 151.0 158.7 148.1 112.1 56.7 86.8 72.1 99.6 64.1 90.8 188.4 59.3 139.9 93.1 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348214-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles 160000 Nucleoli Vesicles "HPA046794: " "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavourable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavourable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 58.8 72.8 34.9 64.0 39.6 78.6 96.3 33.1 43.2 70.1 66.6 27.6 66.9 38.9 137.4 81.5 96.0 94.8 74.4 48.2 29.5 25.7 51.0 59.3 48.1 159.6 32.7 45.2 164.9 193.1 29.1 50.6 42.4 34.1 90.1 67.6 47.3 204.8 70.0 85.2 91.9 48.6 91.0 35.5 68.1 61.4 78.2 24.0 80.5 77.9 70.1 93.2 75.1 109.7 79.7 56.4 12.1 35.8 50.2 80.4 94.0 45.2 69.0 78.9 78.5 138.7 230.3 75.3 57.1 116.9 103.0 57.6 104.8 59.8 142.1 35.3 99.6 111.1 116.5 137.2 83.2 60.3 65.9 50.0 102.6 101.9 92.0 118.3 59.3 231.6 205.4 74.5 129.3 130.7 95.6 75.0 118.2 153.8 91.7 123.8 85.7 68.1 80.7 98.9 180.8 132.7 58.1 74.1 65.4 46.7 120.5 72.9 131.3 125.4 71.4 68.1 49.0 61.2 67.7 29.3 58.3 87.3 53.1 82.7 52.8 12.1 35.8 7.7 52.2 33.6 77.3 79.7 71.2 64.3 56.4 71.8 80.4 73.5 5.5 50.2 29.3 56.1 54.6 94.0 34.9 39.6 33.1 43.2 29.5 25.7 32.7 45.2 34.1 24.0 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879618-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: " "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavourable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 17.5 22.1 19.9 14.4 27.5 9.0 19.9 20.5 35.9 14.8 14.2 16.9 16.4 11.9 15.7 17.4 18.9 17.2 10.2 14.4 17.6 16.5 18.8 23.5 11.9 16.5 14.9 20.4 17.4 16.9 22.9 22.4 15.1 17.9 17.0 17.0 13.2 17.4 14.4 19.9 16.3 12.8 16.5 13.9 15.4 13.7 33.0 14.5 25.1 17.8 15.6 20.3 13.7 13.3 15.4 12.5 10.2 13.6 16.4 18.6 10.6 35.4 11.3 20.1 32.2 19.0 24.6 13.7 28.4 20.7 27.6 22.9 28.0 13.6 53.3 25.8 23.9 17.0 45.6 34.5 45.9 27.9 34.3 28.4 15.9 25.3 20.9 43.7 22.0 25.1 26.6 36.1 35.0 27.0 54.8 18.5 25.1 26.1 24.9 28.4 20.3 16.7 28.6 22.6 33.7 21.5 22.5 38.5 23.5 24.3 18.6 29.8 24.9 42.4 25.8 26.8 22.3 21.1 49.0 23.2 36.3 81.1 14.9 41.6 27.8 5.6 11.4 10.2 14.9 13.6 18.6 13.3 14.6 15.5 10.8 15.4 15.5 14.9 2.6 16.4 11.9 12.5 12.0 10.6 19.9 27.5 20.5 35.9 17.6 16.5 14.9 20.4 17.9 14.5 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 240000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavourable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 65.9 45.5 32.1 53.7 34.7 120.1 115.2 31.0 61.9 63.9 78.4 26.4 51.1 95.2 106.4 57.1 76.0 51.2 68.9 78.7 27.2 23.6 48.2 62.6 54.5 169.4 29.0 28.8 125.7 349.6 11.8 45.2 38.4 28.8 61.3 15.7 45.6 174.7 57.3 202.1 89.0 82.8 84.9 29.2 79.7 96.4 48.9 17.0 61.2 73.2 103.2 72.8 64.7 100.0 174.8 117.5 31.1 82.7 77.9 136.8 251.3 120.4 142.3 10.2 44.2 11.4 26.0 97.8 87.3 16.5 26.7 19.0 124.2 65.2 162.1 126.4 10.3 73.0 13.3 30.4 4.9 70.4 161.9 96.2 109.6 87.5 28.6 63.0 52.5 28.0 34.7 12.0 20.6 19.6 129.5 37.6 11.3 322.1 89.9 85.4 95.0 161.3 88.2 58.9 152.4 14.2 91.4 62.3 104.0 83.8 45.7 119.9 105.8 61.0 78.4 35.5 135.2 74.1 104.9 68.8 58.7 140.2 70.7 104.8 48.6 24.1 80.3 31.1 70.5 82.7 117.9 166.8 119.3 86.9 117.5 174.8 136.8 105.0 9.8 77.9 78.5 64.5 113.8 251.3 32.1 34.7 31.0 61.9 27.2 23.6 29.0 28.8 28.8 17.0 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.4 2.8 6.6 9.0 4.7 57.6 87.0 71.9 54.6 8.0 65.4 142.9 6.6 57.9 65.1 5.4 6.2 78.7 52.0 115.0 4.5 24.1 7.8 8.5 9.3 37.8 11.9 180.9 4.4 82.7 5.4 109.2 66.7 5.0 4.3 77.5 9.8 109.2 3.8 71.6 122.7 4.9 89.4 3.7 4.6 48.8 1.9 47.3 7.3 104.4 6.7 4.1 3.0 4.6 83.7 7.9 102.5 143.9 124.1 83.1 86.9 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 RPLP0 "L10E, LP0, P0, PRLP0, RPP0" ENSG00000089157 "Ribosomal protein lateral stalk subunit P0" P05388 12 120196686-120201235 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 408.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003512, HPA073501" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA003512: AB_1079844, HPA073501: " "unprognostic (2.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (8.49e-3)" "unprognostic (2.99e-2)" "unprognostic (2.44e-1)" "unprognostic (2.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.67e-1)" "unprognostic (4.82e-2)" "unprognostic (2.34e-1)" "unprognostic (3.35e-1)" "prognostic unfavourable (7.66e-12)" "unprognostic (2.74e-1)" "unprognostic (2.39e-1)" "unprognostic (3.06e-1)" "unprognostic (1.47e-1)" 67.3 59.5 20.6 76.6 31.6 100.5 119.8 26.8 26.0 58.4 76.8 22.0 61.8 50.5 95.9 66.0 128.3 74.8 88.6 49.8 28.9 16.2 47.1 121.7 55.4 59.7 21.9 26.6 117.5 408.6 13.5 36.6 70.1 41.5 72.4 60.8 32.8 138.5 54.6 101.0 113.9 57.3 63.8 23.4 60.0 69.0 73.0 18.7 89.6 90.8 162.5 82.8 64.2 116.6 135.9 143.3 10.7 63.4 82.7 172.4 193.3 126.0 109.1 92.8 158.8 189.6 312.3 132.4 97.1 168.7 152.0 99.1 120.6 77.6 276.3 98.2 169.9 100.2 164.3 201.7 96.3 106.7 125.2 131.8 72.4 103.0 204.5 177.0 99.7 281.5 345.4 106.5 316.4 179.5 161.4 80.1 144.5 136.4 178.2 119.7 176.8 146.2 130.0 130.6 216.4 152.0 145.6 99.1 120.7 70.0 104.8 190.8 187.1 214.1 120.6 71.7 109.4 90.8 120.4 181.1 190.6 137.9 128.8 127.4 60.3 10.7 63.4 5.3 71.5 58.3 172.4 135.9 131.9 97.1 137.0 123.2 131.4 104.4 5.0 82.7 35.1 143.3 83.4 193.3 20.6 31.6 26.8 26.0 28.9 16.2 21.9 26.6 41.5 18.7 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452784-69456194 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 1030.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" 1000000 "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavourable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 59.6 57.2 47.5 76.8 42.9 171.7 451.2 68.8 103.3 70.1 79.0 20.8 57.9 87.5 73.5 76.3 100.7 65.7 80.6 341.6 35.5 29.7 55.8 69.9 290.9 1030.2 42.4 33.3 134.3 209.0 8.6 36.0 52.3 45.6 71.0 33.3 61.3 102.8 60.7 262.9 155.2 74.3 128.2 38.8 77.4 77.1 45.7 32.7 73.0 50.8 146.9 71.8 72.3 95.5 329.0 226.3 79.6 176.1 169.8 267.2 368.8 82.7 84.7 38.0 87.6 54.5 65.8 81.7 72.9 43.3 40.8 32.7 85.9 84.4 115.9 109.0 38.3 113.3 58.5 57.3 8.9 116.2 179.0 97.6 97.3 83.8 95.5 86.4 89.2 82.7 100.5 29.7 55.7 49.2 91.8 98.9 28.8 77.6 94.2 254.8 142.1 81.7 96.7 124.2 169.6 39.3 89.7 60.9 118.7 73.2 90.6 297.4 74.7 199.0 86.3 59.2 132.5 70.6 118.3 202.7 323.2 98.3 70.9 220.7 48.8 79.6 176.1 60.4 119.5 124.7 220.2 329.0 247.2 162.7 215.0 278.5 267.2 223.0 26.2 169.8 70.2 226.3 202.7 368.8 47.5 42.9 68.8 103.3 35.5 29.7 42.4 33.3 45.6 32.7 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306247-58324695 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favourable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (5.78e-2)" 7.1 8.5 8.3 5.7 12.9 5.3 7.1 15.8 10.7 6.6 8.6 5.9 6.6 10.2 8.2 7.8 8.5 7.4 6.2 11.8 7.2 6.8 11.2 15.0 5.6 7.6 6.5 9.9 8.4 11.9 10.8 9.4 6.0 7.2 7.4 8.2 9.0 8.5 7.0 53.5 7.4 9.1 11.7 5.5 7.7 7.7 9.1 5.9 6.3 8.1 18.5 8.5 7.2 7.0 4.6 6.6 4.7 9.8 9.8 6.4 3.5 10.1 8.0 9.4 7.4 7.8 8.4 10.3 8.6 9.2 12.3 13.9 12.2 6.7 12.1 2.0 11.5 6.2 14.0 12.7 12.0 8.4 7.4 11.5 9.6 6.6 7.7 19.8 9.6 9.2 12.3 14.6 14.0 9.7 9.9 8.7 11.9 5.5 13.4 7.0 12.3 15.3 5.5 7.4 11.7 9.0 14.5 5.9 10.4 8.0 9.6 11.5 9.2 9.6 8.8 9.3 10.4 9.8 16.2 13.0 22.2 17.5 10.7 13.9 6.6 3.0 5.7 4.7 4.2 4.9 5.6 4.1 5.5 5.8 6.6 4.6 6.4 6.2 2.6 9.8 9.8 6.2 3.0 3.5 8.3 12.9 15.8 10.7 7.2 6.8 6.5 9.9 7.2 5.9 RPP25 FLJ20374 ENSG00000178718 "Ribonuclease P and MRP subunit p25" Q9BUL9 15 74954416-74957464 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 18.6;SCLC-21H: 17.1;SK-MEL-30: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 4 "dendritic cells: 16.7;monocytes: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046900 Approved Supported "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA046900: AB_10962049" "unprognostic (9.36e-2)" "unprognostic (7.17e-3)" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "prognostic unfavourable (2.24e-5)" "unprognostic (7.18e-2)" "unprognostic (5.73e-3)" "unprognostic (5.50e-3)" "unprognostic (7.78e-2)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.71e-3)" "unprognostic (5.50e-3)" "unprognostic (5.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.53e-1)" 3.9 7.3 3.0 1.9 4.6 0.0 2.2 3.2 14.0 3.4 6.7 3.7 1.2 6.0 1.7 1.3 3.3 1.8 3.7 2.5 2.5 6.8 2.6 1.9 5.1 2.7 8.0 5.1 12.0 4.9 9.0 2.8 6.1 10.6 2.1 4.1 3.2 2.4 1.3 1.9 2.1 4.6 2.0 7.9 6.2 5.6 1.9 1.8 3.1 4.9 2.6 2.5 4.1 2.4 2.3 16.7 0.3 6.4 0.3 2.7 1.4 8.9 6.8 1.7 0.0 0.6 0.4 2.9 1.7 2.0 0.5 0.4 9.2 8.2 0.0 7.8 1.7 2.7 5.3 0.3 0.1 3.3 0.2 0.0 7.9 0.2 18.6 0.0 5.3 2.4 0.2 3.4 0.0 7.9 6.0 0.0 1.7 3.4 1.4 2.3 8.2 2.7 0.0 0.0 6.0 1.6 0.1 17.1 12.8 12.8 11.3 25.5 2.2 7.1 1.8 0.0 0.7 1.6 0.0 0.1 0.0 0.0 0.9 13.9 10.0 0.0 3.3 0.0 1.5 6.4 0.9 2.3 1.1 1.3 3.3 1.9 2.7 2.1 0.3 0.3 4.8 16.7 0.4 1.4 3.0 4.6 3.2 14.0 2.5 6.8 8.0 5.1 10.6 1.8 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871716-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 24.2 19.0 20.9 16.8 20.3 27.2 22.3 26.0 24.0 18.9 19.0 16.2 16.3 11.5 25.2 18.6 23.8 19.2 16.0 26.6 19.8 16.8 20.6 18.4 17.1 23.2 18.5 20.4 23.9 17.7 37.7 23.6 23.6 19.3 18.8 19.3 18.7 19.2 16.5 35.9 23.5 16.4 20.6 19.2 21.3 19.2 32.0 21.6 31.2 18.1 24.0 26.3 21.7 18.9 19.4 22.2 16.2 19.5 14.2 20.3 16.2 28.0 18.7 19.6 23.6 12.8 13.8 6.9 20.1 18.1 33.7 35.4 31.6 22.6 16.6 15.4 12.8 19.7 26.1 17.8 34.7 26.6 18.0 11.1 12.0 24.9 12.1 22.5 14.1 11.3 11.6 25.3 28.8 19.1 22.1 15.2 22.2 17.3 26.1 30.7 12.1 21.3 14.6 16.7 17.4 12.7 13.3 10.6 10.7 11.7 8.5 23.6 23.0 14.3 10.8 16.8 16.8 9.5 41.4 10.3 26.3 35.6 21.1 12.2 12.9 4.3 19.5 16.2 17.1 18.7 18.6 19.4 19.6 18.7 22.2 16.7 17.0 18.5 2.2 14.2 15.3 20.7 20.3 16.2 20.9 20.3 26.0 24.0 19.8 16.8 18.5 20.4 19.3 21.6 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 88.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 16.8 27.0 32.1 12.0 32.0 7.8 19.0 28.5 36.9 16.9 18.1 22.8 26.3 14.4 20.0 88.6 18.4 19.7 14.4 21.3 30.2 27.6 20.8 16.5 14.5 13.8 27.5 31.3 19.3 17.6 20.2 24.0 13.7 30.2 23.3 16.1 13.2 20.2 23.4 36.1 15.3 13.5 21.2 27.8 16.0 14.9 20.3 23.5 10.2 24.4 11.1 14.3 20.6 20.1 8.6 10.7 5.0 8.4 9.3 7.6 4.3 12.0 13.4 22.8 24.2 12.5 14.8 14.2 22.0 21.6 12.7 18.0 3.6 13.5 17.0 23.1 15.8 20.2 25.3 22.1 18.1 15.0 14.5 18.0 20.1 14.2 22.1 30.0 9.8 11.3 29.6 12.1 34.6 18.2 16.2 18.6 16.3 15.0 15.9 12.8 18.3 9.7 13.3 7.3 27.2 19.5 26.1 39.9 33.7 18.2 10.2 18.7 14.0 21.6 22.1 13.4 8.4 7.1 17.8 21.1 29.1 17.6 13.6 24.9 13.4 0.9 6.3 3.0 4.4 8.4 6.5 7.5 5.8 5.0 10.7 8.6 7.6 5.8 5.0 9.3 5.5 7.4 3.1 4.3 32.1 32.0 28.5 36.9 30.2 27.6 27.5 31.3 30.2 23.5 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles 91000 "Nucleoplasm, Vesicles" "HPA061693: " "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 14.0 16.9 16.8 12.0 21.6 13.2 14.0 40.1 22.1 20.2 17.9 21.4 16.6 11.5 21.0 16.4 17.0 24.2 12.2 14.1 16.3 14.1 18.3 12.5 14.0 13.8 16.3 14.1 34.2 17.9 27.5 29.4 10.7 15.2 18.3 16.3 19.8 14.5 19.2 28.5 15.6 13.9 20.1 13.8 16.7 14.2 16.2 17.4 25.6 25.4 10.4 17.3 21.6 17.1 8.0 4.2 6.0 8.6 5.1 9.1 2.5 15.7 12.1 16.0 16.2 16.7 14.2 15.2 11.4 13.7 12.6 12.5 10.4 19.4 25.0 13.2 14.0 17.6 22.5 17.0 13.9 11.5 9.4 14.4 14.3 12.5 12.0 21.5 17.8 15.0 13.0 17.6 23.3 15.6 14.0 27.3 12.8 22.7 18.8 7.0 20.0 13.7 17.4 11.9 25.2 18.6 14.6 17.1 17.3 23.4 20.0 15.2 15.7 19.1 14.2 11.7 12.2 9.8 16.2 16.7 18.4 18.9 11.7 16.2 11.5 6.0 3.6 4.4 8.1 2.4 7.4 7.6 7.6 6.4 3.5 8.0 8.9 8.8 2.0 5.1 8.6 4.2 9.1 2.5 16.8 21.6 40.1 22.1 16.3 14.1 16.3 14.1 15.2 17.4 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499689 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: " "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 103.0 76.8 80.6 187.8 68.7 161.8 165.7 50.4 75.3 138.6 134.1 43.2 105.8 67.0 149.4 132.4 142.8 132.3 133.0 135.9 63.2 53.5 84.3 105.7 101.9 354.2 71.5 64.2 242.4 490.0 41.7 89.7 72.2 63.4 116.6 103.4 72.7 193.2 104.0 223.4 140.8 88.1 198.4 69.9 132.6 96.3 67.2 48.3 137.3 119.0 190.7 169.5 145.6 230.6 232.4 173.3 45.1 96.7 91.3 161.6 231.8 110.2 171.9 130.6 201.7 188.9 286.0 87.5 93.8 185.4 133.7 128.2 119.0 92.1 270.6 58.6 127.7 74.3 154.0 185.9 131.9 115.3 267.3 163.6 113.1 171.0 176.5 289.0 121.6 283.7 303.3 89.3 230.0 192.9 161.5 144.3 144.2 123.2 134.8 217.7 120.6 177.3 130.1 165.4 143.9 191.9 260.5 139.6 186.3 63.9 215.3 139.5 70.0 300.6 110.4 106.2 95.5 51.5 123.4 144.4 219.6 192.4 44.2 199.1 90.6 45.1 96.7 29.9 95.6 82.8 127.6 232.4 137.5 110.9 144.1 221.1 161.6 135.7 25.9 91.3 70.6 173.3 109.8 231.8 80.6 68.7 50.4 75.3 63.2 53.5 71.5 64.2 63.4 48.3 RPS12 S12 ENSG00000112306 "Ribosomal protein S12" P25398 6 132814441-132817564 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA006124, HPA006365" Approved Supported "Golgi apparatus,Vesicles,Cytosol" 280000 Cytosol "Golgi apparatus, Vesicles" "HPA006124: AB_1856460, HPA006365: " "unprognostic (6.58e-2)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (6.37e-2)" "unprognostic (4.95e-3)" "unprognostic (1.46e-1)" "unprognostic (3.95e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (7.04e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-1)" "unprognostic (5.66e-2)" 95.6 65.1 66.4 169.3 53.2 199.6 187.3 49.6 66.9 98.4 83.8 42.5 93.7 73.1 106.1 99.2 129.4 88.0 113.7 152.2 56.1 44.6 78.0 108.8 182.0 515.8 67.8 42.0 222.2 403.5 23.2 46.3 87.7 44.5 94.4 82.1 56.5 220.6 71.5 100.5 153.8 79.5 162.6 71.8 122.9 85.4 62.6 52.5 139.6 116.7 155.1 130.9 109.7 196.8 159.2 101.3 17.4 54.3 70.9 211.8 222.0 66.7 50.8 78.9 122.4 152.4 193.7 93.8 85.2 114.9 90.6 87.7 104.4 64.1 148.0 118.2 108.9 65.2 85.6 142.6 83.2 96.9 110.2 100.9 66.6 147.4 170.8 283.6 78.8 207.4 233.9 78.3 277.5 119.0 165.2 98.5 110.0 136.2 119.4 165.2 97.3 83.0 135.2 63.1 93.7 120.4 69.5 67.2 54.8 28.7 184.7 227.9 78.3 288.7 103.5 38.7 111.1 129.7 157.1 148.0 120.5 110.4 127.9 161.1 55.2 17.4 54.3 7.8 95.6 50.7 147.0 159.2 168.0 123.1 73.4 139.3 211.8 174.2 5.7 70.9 40.7 101.3 90.8 222.0 66.4 53.2 49.6 66.9 56.1 44.6 67.8 42.0 44.5 52.5 RPS14 "EMTB, S14" ENSG00000164587 "Ribosomal protein S14" P62263 5 150442635-150449756 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 708.0;pancreas: 483.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018504 Approved Supported "Endoplasmic reticulum,Cytosol" 540000 "Endoplasmic reticulum, Cytosol" "HPA018504: AB_1856463" "unprognostic (5.70e-3)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (8.17e-3)" "unprognostic (7.51e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (3.26e-1)" "prognostic unfavourable (8.69e-4)" "unprognostic (1.47e-1)" "unprognostic (8.81e-2)" "unprognostic (2.29e-1)" "unprognostic (8.14e-2)" 60.9 43.2 50.1 64.3 39.1 92.8 111.6 22.6 37.2 85.1 70.3 28.0 50.6 33.6 59.6 86.4 79.4 91.7 57.2 59.2 35.7 30.3 53.6 74.7 57.0 96.6 39.8 32.5 115.1 483.0 17.4 38.9 62.0 35.3 69.7 61.5 41.1 61.8 50.8 93.4 95.0 60.6 67.0 37.0 68.4 58.3 48.5 33.8 84.5 93.9 71.2 83.6 87.1 65.2 360.5 205.3 51.0 166.0 157.4 465.9 708.0 87.6 160.8 83.7 170.4 128.2 241.2 137.4 67.4 113.0 110.0 100.4 219.1 113.1 199.0 99.3 127.2 70.3 125.2 299.6 74.8 92.3 151.2 72.3 149.2 164.5 182.4 206.4 74.9 183.1 117.3 112.0 264.2 152.8 95.4 78.8 139.2 236.7 89.1 174.1 86.2 136.6 87.5 96.4 213.1 143.9 161.3 92.3 105.1 48.8 244.4 193.4 107.7 226.5 94.7 59.5 50.0 50.3 90.6 107.0 150.4 130.7 74.2 202.4 39.2 51.0 166.0 36.7 186.2 114.2 261.9 360.5 313.3 226.8 181.1 299.4 465.9 319.4 25.7 157.4 97.0 205.3 196.8 708.0 50.1 39.1 22.6 37.2 35.7 30.3 39.8 32.5 35.3 33.8 RPS15 "MGC111130, RIG, S15" ENSG00000115268 "Ribosomal protein S15" P62841 19 1438358-1440494 "Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054510, HPA057793" Enhanced Approved "Endoplasmic reticulum,Cytosol" 170000 "Endoplasmic reticulum, Cytosol" "HPA054510: AB_2682510, HPA057793: AB_2683528" "unprognostic (4.47e-3)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.08e-3)" "unprognostic (5.98e-2)" "unprognostic (2.05e-1)" "unprognostic (4.33e-3)" "unprognostic (4.42e-2)" "unprognostic (2.58e-1)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (5.00e-2)" "unprognostic (1.44e-3)" "unprognostic (5.21e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.61e-2)" 61.7 61.2 63.0 67.5 51.4 123.6 74.2 46.0 87.5 56.2 66.4 46.1 41.2 69.0 73.6 52.3 80.9 61.2 73.7 72.1 50.4 40.5 64.8 103.7 43.0 95.3 52.1 52.6 144.8 136.0 21.6 59.3 60.9 45.2 66.9 37.1 61.2 123.7 53.2 154.9 102.4 67.6 51.8 51.0 76.2 63.5 60.8 24.9 70.7 74.2 127.6 82.9 47.6 70.9 237.3 149.5 48.6 106.7 103.8 218.1 269.2 103.1 110.2 48.5 65.9 45.5 66.3 83.6 54.1 43.2 64.9 50.9 176.9 36.5 128.1 48.7 34.7 65.8 47.2 67.0 25.5 106.5 246.9 41.9 101.0 167.0 48.2 106.6 80.0 81.4 81.0 43.9 43.1 57.1 85.0 184.5 40.5 181.6 88.0 143.3 109.7 141.8 91.7 57.9 167.3 58.9 113.7 78.1 92.7 45.6 78.7 155.1 60.2 143.7 57.6 55.0 63.0 109.6 119.3 160.3 158.6 124.5 54.6 97.4 62.8 48.6 106.7 44.5 116.2 89.5 160.8 237.3 179.3 146.1 149.5 222.5 218.1 177.4 21.6 103.8 68.2 124.2 162.9 269.2 63.0 51.4 46.0 87.5 50.4 40.5 52.1 52.6 45.2 24.9 RPS16 S16 ENSG00000105193 "Ribosomal protein S16" P62249 19 39433207-39435948 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064222 Approved Supported "Endoplasmic reticulum,Cytosol" 36000 "Endoplasmic reticulum, Cytosol" "HPA064222: " "unprognostic (4.63e-3)" "unprognostic (4.78e-2)" "unprognostic (2.73e-1)" "unprognostic (9.49e-2)" "unprognostic (2.20e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.96e-1)" "unprognostic (1.89e-3)" "unprognostic (4.40e-2)" "unprognostic (5.28e-2)" "unprognostic (5.73e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-2)" "unprognostic (2.06e-1)" "unprognostic (4.62e-2)" 89.8 60.8 49.0 123.2 46.1 127.3 126.9 39.8 46.8 124.8 120.7 48.6 80.0 67.2 97.9 80.8 150.1 108.1 105.9 118.7 41.7 35.7 81.5 147.6 103.7 243.2 49.2 29.9 248.1 457.6 19.9 48.8 97.0 35.5 129.5 52.8 73.8 130.5 87.6 205.5 113.4 110.9 126.3 52.2 136.7 92.1 57.4 37.7 153.9 125.1 183.6 151.0 143.8 159.8 153.7 106.4 17.6 71.8 71.7 179.1 225.5 138.3 296.6 79.7 90.4 120.1 148.1 74.0 63.8 74.7 83.4 76.9 188.7 76.9 117.3 82.9 79.6 46.3 93.2 155.3 52.8 137.0 220.6 92.6 101.0 194.9 122.6 135.1 62.9 172.7 242.1 73.5 117.4 106.9 118.2 132.7 86.9 213.9 184.6 136.3 98.4 108.6 123.8 82.4 141.9 91.5 156.3 81.1 116.8 47.9 215.8 164.1 61.9 262.6 64.2 69.6 91.3 73.7 138.8 185.0 191.5 148.7 72.0 129.3 67.1 17.6 71.8 11.0 84.5 57.9 120.9 153.7 140.8 105.6 91.9 143.2 179.1 143.0 13.2 71.7 48.2 106.4 94.7 225.5 49.0 46.1 39.8 46.8 41.7 35.7 49.2 29.9 35.5 37.7 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540564 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: " "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 40.1 37.3 23.9 41.5 28.0 78.5 93.7 20.5 39.7 41.3 35.4 18.0 32.7 12.0 34.4 69.6 58.2 48.5 36.3 36.2 24.9 16.0 33.0 56.8 30.4 75.5 22.2 22.4 100.0 160.7 8.0 28.1 28.7 29.1 32.2 54.1 21.2 64.2 38.1 47.5 60.8 33.0 54.2 26.6 40.9 38.1 29.3 19.2 36.1 38.5 85.2 82.2 34.1 55.8 42.1 34.6 12.5 19.7 26.5 48.5 63.4 10.2 74.1 23.9 15.5 40.5 56.4 18.6 5.6 10.4 17.7 16.3 105.6 33.8 14.7 10.5 22.6 32.5 57.7 57.2 32.0 8.9 146.2 2.6 76.6 70.9 55.3 12.9 14.1 72.5 105.7 21.9 75.0 37.5 10.0 39.1 27.3 82.5 16.6 45.7 36.0 59.2 11.1 6.1 26.3 52.9 93.5 17.4 11.2 2.2 31.4 30.9 38.2 39.9 9.7 27.7 20.2 17.1 12.3 11.8 18.2 12.8 22.6 33.5 15.1 12.5 19.7 4.5 16.6 17.2 43.6 39.9 41.3 26.8 27.2 42.1 48.5 42.4 2.5 26.5 14.8 34.6 23.7 63.4 23.9 28.0 20.5 39.7 24.9 16.0 22.2 22.4 29.1 19.2 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 21.2 26.3 12.6 17.8 14.2 9.3 26.6 24.4 19.9 21.4 17.0 29.0 14.0 26.6 25.5 14.4 17.2 19.9 25.0 7.4 38.2 63.5 25.5 22.3 25.6 20.9 37.3 33.3 13.9 18.9 18.3 22.5 14.5 28.5 19.2 13.5 23.5 17.8 37.2 22.0 50.3 28.4 16.5 39.9 22.3 21.0 28.2 15.8 19.8 31.5 43.8 22.7 30.2 17.2 17.8 40.7 19.9 31.8 33.5 30.7 41.2 24.2 25.9 41.6 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962052-1964860 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 284.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" 140000 "Endoplasmic reticulum, Cytosol" "HPA055133: " "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavourable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 46.1 41.0 28.0 101.8 40.4 97.6 65.9 34.7 30.7 48.2 47.0 22.2 28.8 39.9 45.7 27.1 100.7 61.7 55.7 38.2 19.5 16.0 34.2 107.4 71.1 104.2 36.6 18.6 112.6 284.3 9.6 32.2 45.4 30.1 43.6 32.5 18.3 53.6 28.9 67.3 78.3 47.5 25.8 22.4 131.9 47.8 18.9 28.1 115.2 50.3 114.5 78.3 51.6 77.6 137.5 69.0 18.2 44.9 53.6 125.4 54.7 81.0 117.7 68.2 219.3 99.1 244.6 120.8 55.7 133.9 146.3 103.9 209.6 56.8 155.5 89.2 96.2 101.9 98.5 186.8 55.0 98.1 194.8 52.4 131.3 187.7 242.1 123.0 86.5 326.4 267.9 122.2 203.4 141.8 107.1 88.4 100.8 376.2 154.3 215.6 216.7 106.4 189.2 110.5 185.9 133.5 77.2 122.3 111.1 54.5 171.3 132.0 115.5 216.0 64.7 78.9 104.0 18.9 116.4 34.4 56.6 197.9 42.5 106.6 99.0 4.9 37.6 18.2 50.7 44.9 84.6 137.5 99.9 78.4 68.7 117.9 125.4 93.8 7.6 53.6 36.0 69.0 68.1 54.7 28.0 40.4 34.7 30.7 19.5 16.0 36.6 18.6 30.1 28.1 RPS20 S20 ENSG00000008988 "Ribosomal protein S20" P60866 8 56067295-56074581 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003570 Approved Supported "Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" "HPA003570: AB_1856466" "unprognostic (2.57e-2)" "unprognostic (6.91e-2)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.99e-1)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (6.75e-2)" "unprognostic (9.78e-2)" "unprognostic (4.83e-2)" "unprognostic (3.46e-1)" "prognostic unfavourable (1.21e-8)" "unprognostic (3.64e-2)" "unprognostic (8.80e-3)" "unprognostic (2.33e-3)" "unprognostic (2.19e-2)" 164.6 74.7 74.1 177.3 61.8 191.2 193.8 30.4 57.8 148.1 118.9 49.5 104.1 58.3 100.6 108.4 161.3 91.2 108.3 140.0 57.3 47.0 88.0 136.5 124.0 280.9 67.7 41.8 267.4 218.0 28.5 69.2 77.9 48.1 136.7 60.5 70.2 165.9 104.1 161.5 132.2 86.1 152.5 75.9 157.1 98.5 79.6 47.5 168.0 141.7 143.6 140.8 179.7 157.7 214.3 142.6 64.0 77.1 78.0 248.9 267.6 142.9 128.2 126.5 122.9 181.6 209.9 107.4 96.4 143.2 114.7 105.5 132.8 139.0 211.1 119.3 101.4 90.4 78.8 152.1 97.1 91.3 109.5 175.0 118.1 165.6 174.5 97.6 115.2 205.0 159.3 75.0 216.9 138.8 139.9 126.5 112.9 176.5 266.9 195.4 169.6 55.4 146.7 46.6 109.0 137.7 155.4 42.3 131.5 41.6 113.3 188.5 164.3 203.1 90.8 86.7 149.1 114.2 152.2 138.0 118.7 154.1 131.6 171.2 77.2 64.0 77.1 31.3 101.6 64.5 144.7 214.3 189.1 135.6 100.5 180.9 248.9 181.3 14.6 78.0 59.0 142.6 125.7 267.6 74.1 61.8 30.4 57.8 57.3 47.0 67.7 41.8 48.1 47.5 RPS21 S21 ENSG00000171858 "Ribosomal protein S21" P63220 20 62387116-62388520 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003371 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA003371: AB_1079846" "unprognostic (1.92e-2)" "unprognostic (1.41e-1)" "unprognostic (1.31e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (8.46e-4)" "unprognostic (6.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "unprognostic (4.60e-1)" 69.0 66.0 93.6 140.3 61.5 191.6 177.7 59.2 89.7 93.5 105.1 24.3 84.0 72.0 121.5 85.7 99.6 93.3 97.8 66.0 65.6 47.3 62.9 86.1 66.4 199.9 74.0 86.6 189.4 321.2 12.8 49.2 53.0 52.7 76.3 61.9 33.1 164.2 97.3 172.3 129.6 71.5 120.0 51.1 94.9 73.3 92.9 60.0 92.9 86.3 175.2 90.8 84.4 229.7 170.4 122.5 18.1 59.8 71.0 175.9 158.2 99.5 104.1 53.1 100.4 59.2 105.1 70.1 64.4 51.6 161.6 61.6 347.1 133.6 122.4 133.4 49.6 139.9 58.8 179.3 55.8 30.4 153.0 201.5 149.2 263.9 120.8 154.8 90.9 116.8 251.0 61.1 111.3 74.9 102.9 102.0 55.3 151.5 173.8 220.5 81.3 318.5 118.0 135.0 185.0 75.8 112.7 97.8 96.9 66.2 296.6 134.7 126.1 203.4 78.7 95.6 126.4 80.9 125.9 163.2 185.3 133.2 114.3 94.6 50.6 18.1 59.8 13.9 85.7 50.5 122.2 170.4 146.0 112.6 87.6 170.0 175.9 152.7 9.4 71.0 40.0 122.5 92.7 158.2 93.6 61.5 59.2 89.7 65.6 47.3 74.0 86.6 52.7 60.0 RPS23 S23 ENSG00000186468 "Ribosomal protein S23" P62266 5 82273358-82278577 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" "HPA054853: " "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 114.6 62.1 72.6 129.7 54.8 139.2 191.8 45.1 53.7 141.2 118.9 46.5 83.5 62.2 131.8 94.1 145.2 118.3 114.4 79.4 61.4 52.9 92.8 134.8 90.1 200.7 74.4 34.7 269.5 211.6 41.6 65.6 94.6 51.9 134.3 89.8 52.9 126.7 84.7 205.4 134.3 97.0 129.6 77.7 150.1 83.8 61.4 51.5 194.5 141.5 171.9 173.8 160.7 165.8 140.7 110.8 11.1 56.6 63.8 136.1 158.2 91.4 36.1 104.0 79.7 175.1 236.9 106.1 87.9 133.4 133.1 132.4 50.6 62.6 215.9 61.7 113.8 47.2 155.5 252.9 138.3 78.3 87.8 88.3 53.4 49.1 231.4 127.4 64.1 227.3 301.0 101.5 266.8 171.4 91.7 68.0 114.9 59.5 140.4 129.4 66.5 84.1 94.1 149.1 194.0 129.2 38.7 66.9 87.5 45.3 78.9 178.1 59.9 197.7 121.6 19.0 73.9 46.2 138.0 97.9 143.0 151.7 44.8 165.1 41.6 11.1 56.6 8.7 60.1 52.4 92.2 140.7 103.0 81.1 97.6 130.8 136.1 112.3 6.0 63.8 43.3 110.8 73.4 158.2 72.6 54.8 45.1 53.7 61.4 52.9 74.4 34.7 51.9 51.5 RPS24 S24 ENSG00000138326 "Ribosomal protein S24" P62847 10 78033732-78056813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003364 Approved Approved "Nuclear bodies,Endoplasmic reticulum,Cytosol" 70000 "Endoplasmic reticulum, Cytosol" "Nuclear bodies" "HPA003364: AB_1079847" "prognostic favourable (1.50e-4)" "unprognostic (1.58e-1)" "unprognostic (4.95e-2)" "unprognostic (1.09e-1)" "unprognostic (6.95e-2)" "unprognostic (8.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.25e-1)" "unprognostic (9.48e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.10e-10)" "unprognostic (3.18e-2)" "unprognostic (1.38e-1)" "unprognostic (6.65e-2)" "unprognostic (8.22e-2)" 171.6 122.0 127.7 80.8 79.0 186.2 231.3 56.2 68.4 242.4 201.1 37.9 112.4 86.2 159.2 148.8 277.8 125.1 128.5 123.9 90.4 83.8 134.4 176.6 147.0 263.8 100.6 70.2 369.4 279.3 49.1 86.1 139.3 64.6 251.6 130.0 49.8 176.0 139.5 320.4 192.3 148.9 182.4 111.7 175.8 85.3 87.9 79.5 197.1 221.4 130.0 123.5 271.7 237.7 171.5 180.5 49.6 123.2 156.4 187.3 213.6 110.2 43.1 108.6 169.5 134.6 237.7 97.9 118.6 163.4 125.4 110.3 62.0 77.9 229.3 65.2 102.6 86.0 125.0 152.8 115.0 76.3 141.7 93.4 28.7 59.1 152.7 223.1 53.2 225.2 229.1 88.6 322.0 148.8 126.7 45.9 135.1 44.9 119.0 368.0 76.1 403.5 80.9 130.0 110.2 160.0 51.8 54.9 107.5 59.7 200.8 146.5 113.2 248.1 126.1 38.0 90.6 51.5 156.9 60.5 122.2 176.7 46.9 311.1 31.1 49.6 123.2 46.5 102.4 118.3 167.4 171.5 140.6 129.8 180.5 145.4 187.3 168.2 16.9 156.4 91.0 155.4 112.3 213.6 127.7 79.0 56.2 68.4 90.4 83.8 100.6 70.2 64.6 79.5 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031801 Approved Approved "Endoplasmic reticulum,Cytosol" 54000 "Endoplasmic reticulum, Cytosol" "HPA031801: AB_10610419" "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavourable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 38.9 22.4 48.3 48.3 65.1 100.7 39.7 52.8 47.6 31.2 27.2 59.3 68.5 98.7 92.3 36.7 54.2 42.7 56.8 35.5 48.5 46.6 140.6 19.8 49.8 50.5 99.8 43.9 90.6 101.3 29.8 74.4 56.6 73.0 59.6 43.3 80.3 78.0 137.1 49.8 54.3 68.4 50.7 107.2 57.5 34.3 35.5 67.5 28.1 87.5 54.6 70.3 108.9 53.8 30.6 35.6 30.9 50.6 50.5 41.2 81.5 21.2 99.3 36.1 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: " "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 52.8 65.1 74.2 27.5 102.8 152.5 74.4 53.9 80.1 89.9 52.6 99.9 24.0 118.0 34.1 56.9 24.9 83.3 46.4 61.6 46.6 133.6 62.3 43.4 59.6 94.9 40.4 34.2 92.3 148.7 47.4 54.0 68.2 42.4 39.4 72.7 82.0 30.3 73.5 72.8 147.4 41.3 22.3 72.6 75.1 53.6 27.9 48.2 21.1 46.6 30.6 41.2 45.3 22.1 22.4 45.8 28.5 43.2 33.9 64.9 63.7 24.8 80.8 28.6 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: " "prognostic favourable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavourable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 104.0 122.0 161.3 87.8 379.9 374.5 100.0 126.2 302.5 170.0 153.7 244.4 115.1 236.9 106.0 182.0 104.8 142.1 208.9 143.7 115.1 183.2 93.3 161.8 158.5 251.8 207.4 123.1 363.6 410.9 135.2 249.1 139.3 113.9 128.9 161.3 261.5 223.2 131.3 195.4 178.0 143.0 118.2 184.3 157.0 210.8 85.8 191.2 72.3 254.7 219.3 141.9 416.9 82.3 58.8 97.3 93.6 126.1 258.9 263.9 287.2 102.0 116.5 80.6 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: , HPA049132: , HPA054087: " "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavourable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 54.1 45.0 46.8 66.0 85.5 111.5 120.1 33.3 77.9 74.5 60.0 21.4 43.0 37.3 66.0 57.8 68.3 61.4 51.2 47.1 57.0 32.7 71.1 172.7 43.9 84.3 42.4 68.3 167.1 88.9 20.7 53.7 57.1 52.1 57.7 52.5 25.3 70.5 46.9 101.9 69.1 52.5 46.3 40.4 77.1 58.9 48.6 36.4 62.8 64.0 144.0 82.1 52.1 71.1 194.8 130.9 42.2 62.9 122.8 253.3 267.6 104.8 61.0 66.9 111.2 93.4 178.5 127.9 82.7 95.2 90.9 57.6 113.8 119.1 146.9 139.9 78.9 99.7 96.6 113.1 106.3 124.5 111.8 135.3 65.6 152.2 135.9 201.7 92.7 160.5 225.1 61.0 166.4 123.2 120.6 134.9 103.8 82.1 117.9 243.0 160.7 78.2 112.5 170.5 173.6 102.8 100.4 88.5 70.2 56.8 247.2 184.4 109.9 172.3 117.3 83.4 126.9 74.3 140.0 121.5 84.2 95.5 119.3 171.7 83.0 42.2 62.9 24.1 129.3 59.1 183.5 194.8 197.3 154.8 91.1 179.3 253.3 206.8 14.4 122.8 52.5 130.9 120.7 267.6 46.8 85.5 33.3 77.9 57.0 32.7 42.4 68.3 52.1 36.4 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: " "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favourable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 46.8 64.2 21.3 19.8 29.7 18.2 53.6 16.3 23.4 29.4 58.5 15.5 30.4 46.0 30.2 49.3 40.4 27.0 38.3 47.1 22.8 22.2 61.0 75.2 31.7 23.4 32.6 19.2 26.5 65.9 19.2 38.8 35.6 43.9 56.2 55.3 18.3 99.8 46.0 47.1 18.1 80.4 54.8 39.9 28.2 41.9 15.7 27.3 19.4 53.9 25.7 19.8 55.0 36.3 34.5 30.9 51.5 47.6 27.2 75.4 38.3 17.1 48.0 43.5 11.7 63.7 75.5 43.6 54.2 38.7 11.9 29.2 8.8 23.9 16.1 19.4 51.8 6.6 14.7 26.7 20.1 11.9 19.9 13.3 40.5 62.7 73.4 10.5 36.9 59.0 35.9 26.9 20.5 67.5 12.2 16.2 99.3 23.7 13.5 16.5 12.8 14.0 10.6 20.9 18.2 33.5 34.7 6.3 9.6 19.7 8.3 38.3 18.4 24.5 71.4 63.3 59.6 13.6 24.0 18.3 15.6 14.3 67.1 29.2 57.0 51.5 34.3 40.0 27.5 35.9 33.9 34.5 41.6 32.0 30.9 26.9 32.9 33.1 11.4 27.2 47.6 30.8 75.4 38.3 21.3 29.7 16.3 23.4 22.8 22.2 32.6 19.2 43.9 27.3 RPS29 S29 ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 526.9;pancreas: 892.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004107 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favourable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 59.9 53.6 54.5 108.8 58.9 140.0 155.5 34.4 88.2 68.6 89.6 17.9 67.6 71.4 54.9 67.9 75.3 56.1 63.5 108.2 43.1 33.8 54.5 75.3 74.3 232.1 64.3 56.2 128.3 892.4 8.5 41.6 44.5 53.1 50.6 58.9 29.2 86.0 67.9 177.4 102.6 70.9 76.3 74.6 98.1 63.3 94.0 60.6 53.2 45.6 136.9 101.6 47.1 83.8 303.1 164.3 62.9 102.0 123.1 363.7 526.9 147.8 98.1 102.7 91.9 118.1 201.4 135.9 101.5 86.7 92.8 76.1 98.9 137.2 135.0 116.3 85.2 129.7 117.9 144.4 103.3 88.0 213.0 105.7 89.0 172.2 144.7 269.6 91.9 208.2 236.5 60.9 177.8 132.0 117.8 177.5 89.8 196.7 184.0 168.0 125.2 277.2 154.7 127.9 154.5 111.8 132.6 77.8 89.8 72.0 133.3 235.1 173.8 235.9 121.7 71.1 190.8 66.0 89.6 205.0 227.5 182.7 50.1 111.4 68.4 62.9 102.0 46.1 175.8 81.1 219.7 303.1 322.1 227.3 122.6 281.3 363.7 295.6 24.4 123.1 73.4 164.3 181.8 526.9 54.5 58.9 34.4 88.2 43.1 33.8 64.3 56.2 53.1 60.6 RPS3 "FLJ26283, FLJ27450, MGC87870, S3" ENSG00000149273 "Ribosomal protein S3" P23396 11 75399486-75422280 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063339 Uncertain Supported "Endoplasmic reticulum,Cytosol" 430000 "Endoplasmic reticulum, Cytosol" "HPA063339: " "unprognostic (3.62e-2)" "unprognostic (6.94e-3)" "unprognostic (2.64e-1)" "unprognostic (1.44e-2)" "unprognostic (5.55e-2)" "unprognostic (1.08e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-2)" "unprognostic (3.27e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (6.92e-6)" "unprognostic (3.22e-1)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (2.19e-1)" 72.2 52.7 36.6 108.4 41.2 122.2 136.6 32.1 33.8 105.1 102.0 32.5 65.2 65.8 102.4 84.7 136.5 92.2 107.7 58.5 29.7 26.5 52.9 78.1 71.0 218.6 47.6 30.6 224.7 288.7 13.8 51.3 75.9 35.0 105.7 65.7 47.6 151.0 61.8 86.9 117.6 78.0 110.6 42.1 121.4 75.4 54.1 36.5 126.5 119.4 134.7 130.1 110.3 118.9 104.5 69.7 22.6 44.5 64.6 144.2 213.9 85.5 53.1 75.5 83.1 95.5 170.4 97.7 82.1 105.8 109.0 71.1 153.1 102.5 299.4 100.6 73.7 124.1 97.4 152.7 100.5 79.2 76.1 122.6 53.0 67.6 142.6 197.9 80.4 199.9 208.7 74.5 207.1 142.9 122.1 85.3 97.9 94.0 118.7 95.2 94.8 63.0 112.8 264.9 218.1 107.0 71.6 65.0 92.2 60.5 143.9 83.5 146.9 151.7 114.4 52.7 87.8 71.8 74.1 78.3 96.5 331.7 31.6 111.1 53.2 22.6 44.5 14.7 94.2 31.6 129.1 104.5 123.0 99.4 69.7 95.6 144.2 111.8 11.2 64.6 30.1 60.8 78.2 213.9 36.6 41.2 32.1 33.8 29.7 26.5 47.6 30.6 35.0 36.5 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavourable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 79.4 58.5 111.6 109.6 143.6 281.1 113.9 84.8 130.9 120.2 74.4 113.0 116.2 360.7 42.4 92.4 52.8 113.1 141.5 114.2 79.4 109.4 77.9 72.3 130.5 166.3 184.8 80.8 208.5 292.1 73.9 196.6 142.5 125.2 188.9 142.6 118.7 199.5 219.6 104.7 45.3 146.2 108.9 120.6 139.1 96.6 107.3 106.2 38.1 139.5 186.6 93.3 224.7 86.5 58.8 77.8 64.8 93.2 146.9 236.3 220.8 75.5 135.0 69.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 RPS5 S5 ENSG00000083845 "Ribosomal protein S5" P46782 19 58386400-58394806 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 495.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055878, HPA061979" Enhanced Supported "Endoplasmic reticulum,Cytosol" 860000 "Endoplasmic reticulum, Cytosol" "HPA055878: AB_2682954, HPA061979: AB_2684650" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-1)" "unprognostic (1.53e-1)" "unprognostic (2.37e-2)" "unprognostic (2.49e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (4.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.77e-1)" "unprognostic (1.81e-1)" "unprognostic (5.06e-1)" "prognostic unfavourable (4.75e-4)" "unprognostic (2.79e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (1.01e-1)" 93.2 62.4 40.6 71.7 36.4 118.0 111.7 28.4 34.9 105.3 100.7 34.6 69.1 51.1 108.4 66.2 159.0 103.7 81.4 50.9 33.3 28.9 63.1 160.1 79.1 162.1 37.8 30.9 199.2 376.8 19.4 45.0 72.5 31.9 112.3 50.9 45.5 145.6 54.9 162.7 122.7 63.3 81.1 39.0 103.1 66.0 66.8 34.0 136.8 134.5 144.1 129.6 104.5 131.0 150.0 86.6 16.9 44.9 64.8 138.0 156.5 75.0 110.5 42.2 67.1 82.3 106.6 66.1 42.0 69.9 51.8 33.1 82.3 55.5 156.3 53.0 59.5 49.0 67.0 103.5 21.5 42.4 495.1 61.8 61.5 103.8 102.1 103.6 52.7 135.2 172.2 53.7 122.8 67.5 78.5 83.7 55.2 61.0 100.1 71.2 70.0 149.3 97.3 60.5 137.0 57.2 95.0 63.4 79.1 29.4 84.6 86.3 48.8 125.9 42.5 78.3 57.5 31.2 91.4 112.5 190.6 115.2 49.0 77.6 42.9 16.9 44.9 8.6 54.2 41.1 99.7 150.0 94.6 70.4 82.9 141.7 138.0 106.0 6.5 64.8 30.1 86.6 74.7 156.5 40.6 36.4 28.4 34.9 33.3 28.9 37.8 30.9 31.9 34.0 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favourable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 90.0 65.3 64.1 110.2 70.2 166.3 152.8 37.0 50.4 125.4 149.9 38.8 57.4 73.0 91.6 97.7 166.8 87.7 81.5 70.0 51.5 44.4 88.5 91.3 104.0 243.5 66.0 36.2 206.6 441.2 26.1 64.0 67.9 64.7 152.5 83.9 53.3 109.1 72.1 129.5 139.9 96.3 157.8 84.5 137.8 87.5 67.2 53.2 127.9 147.0 119.7 125.8 207.4 143.4 237.2 135.7 30.1 75.5 129.7 274.9 399.9 106.2 69.9 71.1 83.2 120.6 186.1 85.4 71.9 93.8 86.4 72.3 58.1 49.3 244.4 71.2 68.6 52.3 79.6 110.6 93.9 127.3 76.2 161.1 90.5 105.3 147.3 85.3 80.5 154.3 202.4 57.5 169.7 103.8 67.6 99.8 93.2 64.0 180.6 573.5 133.3 47.6 141.4 71.9 116.2 119.6 91.5 71.1 95.6 27.2 115.8 148.5 75.4 311.8 76.1 49.8 53.3 51.5 112.3 47.2 91.4 165.9 33.7 128.3 29.0 30.1 75.5 23.3 111.6 67.1 193.2 237.2 205.0 150.5 135.7 196.8 274.9 215.8 12.8 129.7 60.6 126.1 152.7 399.9 64.1 70.2 37.0 50.4 51.5 44.4 66.0 36.2 64.7 53.2 RPS6KA1 "HU-1, p90Rsk, RSK, RSK1" ENSG00000117676 "Ribosomal protein S6 kinase A1" Q15418 1 26529761-26575030 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.2" "Cell line enhanced" "Detected in many" "HMC-1: 29.6;U-937: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 60.4" "Low region specificity" "Detected in all" "CAB003852, HPA007981" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003852: AB_289590, HPA007981: AB_1079850" "unprognostic (1.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.61e-3)" "prognostic favourable (7.20e-7)" "unprognostic (7.35e-2)" "unprognostic (3.69e-1)" "unprognostic (6.93e-3)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (9.64e-2)" "prognostic favourable (1.84e-4)" "prognostic favourable (4.58e-4)" "unprognostic (4.77e-2)" "unprognostic (7.61e-2)" "prognostic favourable (8.33e-4)" 11.0 8.2 6.3 24.2 9.7 15.8 5.0 14.4 6.3 4.9 23.2 11.1 4.4 24.5 2.1 3.6 8.9 6.0 8.0 3.4 5.3 5.1 13.6 5.4 26.1 32.7 10.3 3.5 2.1 10.1 10.0 7.4 3.3 8.6 8.6 15.8 3.6 19.0 5.5 1.1 9.0 45.2 2.8 7.9 27.0 9.7 2.7 9.0 15.9 13.9 4.9 17.3 6.2 4.5 5.0 22.0 40.1 18.0 7.9 8.3 17.1 9.7 3.4 2.8 3.7 0.1 0.0 3.7 0.8 1.5 4.2 4.0 4.0 8.1 18.3 4.5 0.5 11.5 6.3 22.7 3.0 15.1 4.1 20.1 8.5 7.0 1.3 23.7 29.6 0.7 8.3 3.8 6.9 1.8 3.4 6.7 0.2 5.4 0.8 23.3 7.2 11.0 12.6 3.6 8.0 12.0 2.7 4.1 1.6 6.9 6.6 3.2 4.2 20.3 1.2 0.2 5.3 0.7 3.3 4.1 4.9 10.0 2.5 31.8 4.0 9.6 18.0 40.1 8.3 16.4 6.9 4.9 6.1 7.3 22.0 5.0 3.9 5.5 34.5 7.9 17.3 8.6 6.0 17.1 6.3 9.7 14.4 6.3 5.3 5.1 10.3 3.5 8.6 9.0 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.6 22.2 8.4 4.3 8.2 14.5 2.5 11.0 16.8 8.2 11.3 25.1 16.4 8.3 3.8 11.5 9.0 9.6 9.3 15.3 7.0 7.6 9.8 14.0 67.5 8.4 19.0 10.2 9.2 7.5 12.9 16.3 29.8 6.4 23.9 8.6 6.0 12.3 5.8 6.0 13.4 6.6 17.8 9.6 7.1 10.6 3.9 3.8 14.8 4.5 16.0 0.0 5.7 16.6 9.0 6.3 28.5 6.2 19.1 11.6 9.3 17.0 9.5 21.2 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 RPS6KA4 "MSK2, RSK-B" ENSG00000162302 "Ribosomal protein S6 kinase A4" O75676 11 64359148-64372215 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.6" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008649, HPA023225" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB008649: AB_1619460, HPA023225: AB_1854144" "unprognostic (2.30e-1)" "unprognostic (7.05e-2)" "unprognostic (2.03e-1)" "unprognostic (4.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.47e-2)" "prognostic unfavourable (8.17e-4)" "prognostic unfavourable (9.27e-4)" "unprognostic (2.45e-1)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-3)" "unprognostic (1.98e-2)" "unprognostic (3.93e-3)" "unprognostic (5.25e-2)" "unprognostic (1.09e-1)" "unprognostic (2.85e-1)" 14.9 9.1 13.3 15.7 17.1 13.2 7.6 37.6 22.7 7.7 12.4 13.1 5.8 14.0 11.0 6.9 18.5 8.1 10.5 7.8 10.9 10.1 8.7 9.6 10.9 15.0 16.7 9.9 6.5 9.2 5.7 4.7 16.6 9.8 8.3 8.4 10.0 10.9 8.9 16.3 17.3 15.4 9.8 11.5 22.2 18.3 3.3 13.5 7.6 6.7 16.7 16.4 9.7 8.8 0.5 12.6 1.4 3.0 0.3 1.0 2.1 27.7 15.5 2.2 5.7 5.0 4.7 32.1 14.7 7.8 11.6 5.8 15.4 14.6 2.8 17.3 8.5 25.7 2.7 12.0 5.7 8.7 5.2 6.5 13.3 7.8 5.0 6.6 12.2 4.7 11.3 9.8 8.1 7.0 2.6 4.0 5.9 25.4 5.9 10.3 2.5 32.9 11.7 9.3 9.3 8.0 12.9 3.3 2.6 15.3 9.4 12.9 11.0 8.2 13.9 15.8 19.9 28.6 13.2 4.8 3.7 2.9 10.5 7.6 8.0 1.1 3.0 1.4 0.9 2.4 1.0 0.5 0.7 0.7 2.7 0.4 0.4 0.4 0.2 0.3 1.4 12.6 0.6 2.1 13.3 17.1 37.6 22.7 10.9 10.1 16.7 9.9 9.8 13.5 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell line enhanced" "Detected in many" "NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.6 3.5 0.0 3.4 3.4 0.0 7.5 4.0 3.4 2.8 2.7 3.0 0.0 0.0 4.1 0.1 9.0 6.0 7.9 0.0 4.5 0.0 0.1 0.0 3.0 0.0 0.0 1.9 0.0 0.0 3.7 0.8 0.0 0.1 2.7 0.0 1.3 0.1 10.8 11.7 0.0 14.4 0.0 0.5 8.3 0.0 11.5 0.0 4.2 0.0 1.9 0.0 0.0 0.1 4.3 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 RPS6KC1 humS6PKh1 ENSG00000136643 "Ribosomal protein S6 kinase C1" Q96S38 1 213051233-213274773 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026531, HPA031565" Approved Enhanced Endosomes,Lysosomes "Endosomes, Lysosomes" "HPA026531: AB_10601497, HPA031565: " "unprognostic (3.90e-2)" "unprognostic (5.90e-2)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (2.42e-1)" "unprognostic (9.81e-2)" "unprognostic (1.32e-2)" "unprognostic (1.64e-1)" "unprognostic (4.10e-2)" "unprognostic (3.34e-1)" "unprognostic (4.18e-1)" "unprognostic (5.11e-2)" "prognostic unfavourable (2.70e-4)" "unprognostic (8.10e-2)" "unprognostic (5.48e-2)" "unprognostic (2.98e-2)" "unprognostic (4.44e-2)" 12.0 14.1 15.6 10.0 19.4 6.4 17.1 13.5 19.4 14.1 13.1 12.6 8.8 9.2 15.9 8.4 10.3 11.8 11.6 9.4 17.3 15.6 9.8 10.8 13.6 7.5 17.8 16.8 14.4 13.5 19.9 16.7 12.3 15.3 17.6 10.1 7.3 8.9 17.7 14.1 6.7 8.7 18.5 22.3 11.0 12.5 26.5 13.2 6.8 10.4 6.1 7.8 14.6 16.0 2.5 8.7 13.7 6.8 4.0 3.3 2.2 7.4 6.4 10.6 11.4 10.6 15.7 9.3 9.8 14.4 15.2 17.5 5.2 8.3 4.7 6.6 14.7 6.1 12.8 8.0 11.6 9.9 4.7 12.7 7.6 7.2 9.8 8.0 15.1 10.3 6.9 13.3 7.3 12.6 16.3 7.3 15.5 4.0 3.3 2.6 15.3 7.3 4.0 10.0 4.6 7.0 7.5 6.2 16.1 10.6 8.4 14.0 12.0 3.4 11.7 10.4 9.6 11.9 6.4 4.3 8.3 3.6 4.4 3.1 10.6 13.7 4.6 3.3 2.8 6.8 2.3 2.5 2.3 2.4 8.7 1.9 1.5 3.3 0.5 4.0 6.3 1.0 1.6 2.2 15.6 19.4 13.5 19.0 17.3 15.6 17.8 16.8 15.3 13.2 RPS7 S7 ENSG00000171863 "Ribosomal protein S7" P62081 2 3575205-3580919 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056586 Approved Approved "Endoplasmic reticulum,Cytosol" 1000000 "Endoplasmic reticulum, Cytosol" "HPA056586: " "unprognostic (3.28e-3)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.00e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (5.27e-4)" "unprognostic (6.41e-2)" "unprognostic (6.02e-3)" "unprognostic (7.08e-2)" "unprognostic (5.60e-2)" "unprognostic (6.27e-2)" "prognostic unfavourable (1.34e-8)" "unprognostic (3.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" 54.0 42.1 41.7 57.4 47.8 91.9 112.1 35.1 52.6 57.9 54.4 22.5 35.3 38.3 49.4 70.5 75.2 60.6 80.9 42.7 35.6 28.9 88.1 184.7 40.5 73.8 35.4 49.9 128.7 94.3 19.0 42.3 56.0 46.5 49.6 61.0 27.5 61.1 46.8 96.7 74.9 53.8 46.2 35.2 74.2 55.7 120.7 30.3 59.0 49.0 129.1 89.6 54.8 62.3 124.7 91.6 22.4 53.7 83.8 117.9 145.9 62.2 61.0 94.0 100.9 93.5 205.2 154.4 75.6 132.1 125.9 73.5 105.4 98.5 208.4 126.5 87.4 68.7 106.2 122.8 111.3 65.2 143.3 76.1 44.8 151.5 225.7 131.6 79.2 172.2 185.4 78.0 169.7 147.0 117.3 105.9 127.3 83.9 145.8 293.8 138.7 94.7 116.5 95.9 185.3 142.2 76.6 107.2 161.3 40.0 154.2 230.1 84.8 191.0 68.6 75.8 49.9 52.1 121.1 119.0 216.7 204.2 79.7 158.7 84.4 22.4 53.7 19.9 74.4 47.3 109.5 124.7 107.1 94.6 91.6 107.1 117.9 103.2 11.4 83.8 44.3 87.8 90.6 145.9 41.7 47.8 35.1 52.6 35.6 28.9 35.4 49.9 46.5 30.3 RPS8 S8 ENSG00000142937 "Ribosomal protein S8" P62241 1 44775251-44778779 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029266 Enhanced "Endoplasmic reticulum,Cytosol" 52000 "Endoplasmic reticulum, Cytosol" "HPA029266: AB_10601611" "unprognostic (9.70e-3)" "unprognostic (2.26e-1)" "unprognostic (3.02e-1)" "unprognostic (9.75e-2)" "unprognostic (1.62e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.36e-5)" "unprognostic (1.02e-1)" "unprognostic (6.17e-2)" "unprognostic (7.30e-2)" "unprognostic (9.31e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (9.05e-9)" "unprognostic (1.94e-1)" "unprognostic (8.55e-2)" "unprognostic (8.83e-2)" "unprognostic (5.57e-2)" 55.7 60.7 44.8 44.4 46.3 100.1 82.0 50.1 65.5 69.6 47.8 33.8 37.0 40.7 61.9 48.4 78.0 66.7 43.9 36.8 34.6 23.7 41.6 74.1 36.5 77.7 34.8 34.6 195.0 98.3 13.1 37.2 45.4 36.8 53.5 42.5 32.3 61.0 72.7 53.7 91.2 45.6 39.4 35.6 57.0 47.4 71.9 29.0 64.8 40.9 97.3 72.0 52.7 71.2 146.1 98.0 15.3 50.2 61.2 128.4 168.5 100.6 50.4 81.1 106.7 141.0 221.9 132.7 74.1 117.5 104.8 84.4 86.5 110.3 191.0 81.7 89.7 69.1 103.9 129.0 77.6 69.1 181.5 71.2 71.8 114.9 200.4 141.4 69.8 176.5 214.1 69.8 187.5 125.1 105.7 134.3 97.4 79.7 155.4 151.4 177.1 87.3 125.3 99.3 213.1 117.5 86.6 86.8 100.2 40.0 224.7 293.7 78.5 284.6 85.3 52.1 91.4 79.9 125.8 106.0 103.9 144.4 63.7 169.9 62.4 10.3 50.2 15.3 55.1 49.1 94.1 146.1 101.4 76.7 79.2 124.5 128.4 106.7 5.0 61.2 38.1 98.0 84.2 168.5 44.8 46.3 50.1 65.5 34.6 23.7 34.8 34.6 36.8 29.0 RPSA "37LRP, LAMR1, LRP, p40, SA" ENSG00000168028 "Ribosomal protein SA" P08865 3 39406689-39412542 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB009561 Approved Supported "Plasma membrane,Cytosol" 710000 "Plasma membrane, Cytosol" "CAB009561: AB_2182543" "unprognostic (3.67e-3)" "unprognostic (2.92e-1)" "unprognostic (3.97e-2)" "unprognostic (3.72e-2)" "unprognostic (5.38e-2)" "unprognostic (5.10e-2)" "unprognostic (5.84e-3)" "unprognostic (2.54e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (8.56e-2)" "unprognostic (7.50e-2)" "unprognostic (2.91e-2)" "unprognostic (3.18e-1)" "unprognostic (2.77e-1)" "unprognostic (1.73e-1)" "unprognostic (1.46e-1)" 47.5 42.9 48.8 88.4 56.9 107.0 76.7 26.3 56.2 50.9 63.6 29.1 65.6 48.4 73.5 50.1 93.4 82.4 52.2 67.3 43.2 33.7 44.1 63.8 67.5 300.2 41.7 37.7 145.1 264.7 35.7 42.2 45.0 43.5 58.9 71.5 31.4 148.1 50.2 60.4 70.5 53.0 73.9 48.1 76.8 58.4 60.2 26.8 83.5 72.8 105.2 112.4 53.8 80.4 92.4 64.0 6.9 24.8 61.5 101.2 114.8 92.6 84.9 73.9 121.8 65.0 148.4 116.2 66.2 107.5 151.0 88.5 92.9 80.8 209.9 40.7 130.3 37.1 159.7 152.9 130.2 75.7 83.6 95.0 80.7 90.1 126.0 133.4 89.6 164.7 254.9 116.1 186.3 155.4 98.6 101.8 109.0 64.8 154.9 99.8 247.1 146.1 73.2 105.9 154.0 105.6 42.9 53.5 109.2 36.1 279.0 114.8 81.4 185.7 61.2 46.4 85.6 77.1 161.0 78.7 119.6 125.2 74.4 130.0 61.3 6.9 20.6 4.8 53.8 24.8 93.5 92.4 89.8 71.4 58.1 89.5 101.2 88.4 3.0 61.5 20.4 64.0 66.1 114.8 48.8 56.9 26.3 56.2 43.2 33.7 41.7 37.7 43.5 26.8 RPTOR "KIAA1303, KOG1, Mip1, raptor" ENSG00000141564 "Regulatory associated protein of MTOR complex 1" Q8N122 17 80544819-80966371 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013514, HPA064306" Approved Enhanced Vesicles,Lysosomes "Vesicles, Lysosomes" "CAB013514: AB_2533523, HPA064306: " "unprognostic (5.09e-3)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "unprognostic (9.75e-2)" "unprognostic (3.34e-3)" "unprognostic (1.17e-2)" "unprognostic (9.63e-2)" "unprognostic (8.80e-2)" "unprognostic (4.40e-3)" "unprognostic (8.46e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-2)" "unprognostic (1.77e-2)" 13.6 12.3 10.5 11.1 14.5 10.2 9.3 17.5 21.0 12.6 13.1 19.0 9.6 12.2 15.0 9.3 14.2 12.5 8.0 15.5 10.8 10.5 8.3 12.9 11.0 9.0 12.2 9.9 12.8 9.8 14.3 14.1 9.7 12.7 12.0 7.4 15.2 10.4 13.9 23.7 12.3 11.0 13.6 9.5 11.6 11.1 10.3 12.7 16.7 10.2 11.1 11.9 14.3 10.5 2.1 1.9 3.1 2.4 1.7 3.8 1.2 9.6 19.3 4.6 8.2 6.6 5.7 8.6 7.3 6.7 11.6 8.7 15.1 8.6 8.1 5.8 8.9 5.9 7.4 9.8 6.6 2.9 12.0 12.5 10.7 13.6 6.7 11.2 8.9 8.4 6.7 11.9 6.9 11.5 15.5 3.3 6.5 5.3 10.7 4.7 4.9 15.5 5.1 8.4 6.6 3.4 11.0 9.1 9.2 8.9 14.3 8.1 9.3 8.2 5.2 24.5 10.4 7.7 9.3 5.2 1.9 8.0 14.9 5.9 14.9 3.1 0.9 0.0 3.8 2.4 2.5 2.1 1.6 1.8 1.9 1.1 2.3 2.2 0.0 1.7 1.3 1.1 3.6 1.2 10.5 14.5 17.5 21.0 10.8 10.5 12.2 9.9 12.7 12.7 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridylate synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 9.5 9.7 12.0 16.5 14.8 20.9 10.4 15.3 23.8 7.4 11.2 9.4 6.2 17.6 10.5 14.0 13.9 8.6 11.2 8.1 12.7 10.4 10.7 13.4 8.2 18.2 9.5 11.3 10.0 15.3 9.9 8.9 8.2 11.2 11.3 5.1 10.9 19.8 10.5 11.1 16.8 12.8 8.3 7.0 17.4 15.1 6.2 9.2 15.5 8.5 15.1 15.6 10.8 10.7 17.3 23.1 17.7 19.9 18.0 20.4 15.8 10.5 12.5 3.1 13.9 2.7 3.2 14.3 8.8 5.1 11.6 8.5 29.1 10.0 14.8 9.7 4.2 18.2 7.1 8.9 2.1 13.4 28.8 7.3 19.2 10.5 4.4 13.4 12.3 4.7 8.6 10.0 2.6 8.0 17.0 6.7 3.9 33.6 16.7 14.1 15.7 21.6 29.8 8.3 30.4 4.2 6.5 16.1 11.6 10.2 16.7 9.7 8.6 16.8 9.0 11.6 15.1 12.1 12.7 10.7 10.7 17.0 5.6 10.5 9.5 17.5 19.9 17.7 18.3 18.0 18.1 14.9 15.5 20.4 23.1 17.3 16.2 16.3 12.7 18.0 17.4 21.2 18.7 15.8 12.0 14.8 15.3 23.8 12.7 10.4 9.5 11.3 11.2 9.2 RPUSD2 "C15orf19, C18B11, FLJ31409" ENSG00000166133 "RNA pseudouridylate synthase domain containing 2" Q8IZ73 15 40569300-40574943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favourable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 6.6 9.8 7.8 7.7 15.3 14.2 9.3 7.7 14.6 7.7 9.3 7.7 8.1 8.3 10.9 9.9 9.9 8.5 6.4 11.4 7.6 7.4 7.0 12.2 6.5 10.6 6.8 8.8 11.0 9.8 6.9 7.5 7.5 8.4 8.5 7.3 7.7 13.3 8.9 19.8 10.6 8.8 6.5 5.0 11.0 7.9 7.9 6.6 13.7 10.4 10.5 10.5 8.2 6.3 20.1 8.9 2.9 8.9 17.8 16.0 8.1 7.6 8.7 7.4 12.2 6.4 4.9 14.0 6.9 8.2 11.9 9.5 10.7 4.8 7.4 10.0 7.9 20.8 17.1 12.0 6.8 8.5 11.7 13.0 12.0 12.5 9.6 10.7 9.4 6.8 11.4 7.8 10.8 7.4 16.0 8.8 5.9 9.3 12.8 13.7 9.5 9.5 16.5 8.2 11.3 7.6 6.7 8.5 9.7 9.2 10.6 5.6 10.1 14.8 4.6 8.2 9.6 10.5 7.8 9.1 18.0 19.8 7.1 17.0 6.4 0.0 3.5 2.9 13.5 4.1 12.4 15.6 13.3 14.3 6.8 20.1 16.0 13.3 0.4 17.8 8.9 8.9 13.6 8.1 7.8 15.3 7.7 14.6 7.6 7.4 6.8 8.8 8.4 6.6 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favourable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.6 7.9 9.5 12.5 16.3 5.7 7.5 10.4 8.1 7.2 20.4 13.1 15.5 7.3 6.6 11.6 18.2 11.4 8.6 13.0 10.1 36.3 7.1 19.0 8.2 19.0 8.3 15.0 17.3 8.8 11.1 16.2 22.6 11.5 9.6 6.4 11.9 22.0 8.7 11.7 13.9 12.1 14.4 12.4 9.6 13.8 9.4 9.5 14.2 7.0 21.2 10.1 9.8 9.2 6.3 6.8 8.7 4.9 5.1 13.4 4.1 21.7 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Group enriched" "Detected in some" 8 "HDLM-2: 60.8;U-87 MG: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: " "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.6 1.9 0.0 1.6 0.1 0.1 0.0 0.1 0.2 60.8 0.1 0.0 0.0 0.7 2.7 0.0 0.2 0.8 0.3 4.9 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 RRAGA "FIP-1, RAGA" ENSG00000155876 "Ras related GTP binding A" Q7L523 9 19049395-19050983 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (6.30e-2)" "unprognostic (4.65e-1)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (7.43e-4)" "unprognostic (6.74e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (3.13e-1)" "unprognostic (2.65e-1)" "unprognostic (1.74e-2)" "unprognostic (4.88e-2)" "unprognostic (2.10e-3)" "unprognostic (1.05e-1)" 39.0 39.0 38.0 21.5 44.9 14.6 33.8 40.1 67.7 36.9 30.4 39.0 39.8 21.8 45.9 46.6 33.7 43.6 28.6 48.3 39.5 46.5 39.0 38.3 27.7 28.4 38.0 41.7 50.2 26.9 38.4 33.3 40.1 43.4 35.7 26.9 25.1 29.5 45.3 57.1 31.6 24.9 47.9 34.3 25.5 27.1 26.1 31.6 27.0 34.3 32.6 26.2 37.3 28.1 20.9 30.9 54.1 38.5 29.5 36.6 35.1 26.0 21.5 17.8 18.5 64.3 41.0 12.3 26.3 31.6 23.0 28.4 8.2 8.1 5.2 14.6 44.2 10.0 15.2 24.8 24.4 22.2 17.1 33.2 30.9 31.6 42.2 4.5 12.6 36.2 24.1 19.6 13.4 27.2 7.4 7.6 47.6 16.5 12.6 27.0 9.9 16.6 9.8 11.6 7.3 34.9 22.9 14.7 18.3 14.4 13.1 13.5 16.8 12.4 21.1 28.0 10.8 19.8 19.5 5.3 8.7 11.7 30.8 7.0 10.1 48.3 32.5 54.1 30.5 35.9 29.7 19.6 31.6 30.1 30.9 20.9 29.4 28.8 22.8 29.5 38.5 22.3 36.6 35.1 38.0 44.9 40.1 67.7 39.5 46.5 38.0 41.7 43.4 31.6 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717739-55758774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavourable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favourable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favourable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 11.8 14.8 18.8 8.6 25.8 7.1 14.7 21.2 22.2 14.7 11.4 11.5 11.7 7.1 18.7 36.3 9.2 20.6 12.9 14.5 19.0 24.5 16.0 7.9 10.8 7.5 19.6 20.7 22.8 8.4 21.4 23.7 11.1 17.6 16.6 9.7 12.9 8.9 18.8 13.6 12.0 8.7 17.1 15.8 10.7 9.9 8.9 17.4 7.3 22.6 8.3 8.4 12.3 14.9 12.2 9.1 8.7 8.3 7.7 10.4 5.1 5.9 4.5 5.2 3.9 17.6 17.1 1.3 5.1 9.7 4.5 6.1 2.3 3.9 1.7 37.5 7.0 3.8 4.7 2.8 4.4 2.9 6.2 2.6 5.6 5.3 13.0 4.1 4.1 20.0 11.4 3.4 4.2 6.1 3.5 4.2 7.8 4.2 2.2 5.4 5.3 7.1 8.3 5.7 4.9 7.3 7.5 5.2 4.5 7.1 2.3 7.7 6.6 4.2 3.4 5.5 2.7 5.4 2.7 5.8 7.8 3.3 4.4 8.7 2.5 8.7 6.1 5.2 6.9 8.3 10.0 8.9 8.7 9.4 9.1 12.2 10.4 10.0 1.8 7.7 4.7 5.8 9.6 5.1 18.8 25.8 21.2 22.0 19.0 24.5 19.6 20.7 17.6 17.4 RRAGC "FLJ13311, GTR2" ENSG00000116954 "Ras related GTP binding C" Q9HB90 1 38838198-38859823 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018247, HPA055489" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA018247: AB_1856475, HPA055489: " "unprognostic (2.04e-2)" "unprognostic (1.58e-1)" "unprognostic (2.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.40e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (9.97e-9)" "unprognostic (2.14e-1)" "unprognostic (3.61e-2)" "unprognostic (4.98e-2)" "unprognostic (2.23e-2)" "unprognostic (1.71e-1)" "unprognostic (5.13e-2)" "unprognostic (6.38e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-1)" "unprognostic (3.82e-2)" 27.8 14.0 18.6 11.9 24.1 20.1 36.5 15.9 22.3 13.4 19.4 13.3 11.0 14.1 14.9 11.1 20.7 11.8 13.6 19.0 16.7 13.8 18.8 13.9 15.0 14.2 18.9 14.1 17.6 12.9 13.9 8.9 27.6 21.4 12.6 13.3 11.9 12.7 13.8 15.5 24.6 13.0 17.0 15.6 12.8 12.9 12.7 15.9 11.2 12.9 8.2 16.0 16.0 14.9 4.9 11.3 7.7 3.3 2.0 4.0 2.0 12.0 5.5 7.2 7.9 38.6 26.2 11.2 11.2 23.0 15.3 16.3 4.2 8.0 7.5 6.5 17.4 7.3 13.4 7.4 12.7 12.2 9.5 7.2 6.7 4.7 47.4 8.4 8.2 23.2 18.8 16.3 21.3 15.9 7.3 15.2 22.1 3.3 6.0 4.8 9.2 9.4 5.9 12.8 5.0 10.8 14.1 3.8 5.6 9.0 6.7 23.4 6.2 6.4 14.1 18.7 7.7 20.4 9.5 12.0 19.2 8.9 17.4 9.5 9.6 0.5 3.3 6.7 2.5 3.0 4.0 4.6 3.7 3.0 3.1 4.9 3.3 3.1 7.7 2.0 2.3 11.3 3.3 2.0 18.6 24.1 15.9 22.3 16.7 13.8 18.9 14.1 21.4 15.9 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell line enhanced" "Detected in many" "Karpas-707: 27.8;SCLC-21H: 14.5;U-266/70: 35.2;U-266/84: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA068664: " "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavourable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favourable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 10.5 0.0 0.0 0.0 5.2 2.4 0.0 0.0 0.8 7.0 8.3 0.1 0.6 0.0 0.0 0.0 0.2 27.8 0.0 0.7 3.3 3.5 1.5 0.7 7.0 10.1 0.1 2.5 0.2 14.5 0.8 0.2 0.9 11.8 0.3 5.6 0.0 0.8 1.2 5.0 1.3 35.2 16.3 0.0 2.7 5.3 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277926-14364506 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.3" "Group enriched" "Detected in many" 5 "B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: " "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (7.80e-4)" "prognostic unfavourable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 22.3 11.8 8.3 27.5 7.8 2.3 22.6 9.5 7.0 14.1 16.9 6.4 7.8 11.9 16.2 9.8 13.5 11.1 12.9 29.8 8.7 8.1 25.6 33.0 18.1 15.2 6.5 7.6 16.6 18.5 13.5 7.4 50.8 8.4 16.7 11.0 14.5 15.1 12.9 31.4 9.2 37.7 31.4 7.6 17.6 13.7 21.0 5.2 11.3 26.2 14.4 20.8 27.3 15.0 12.3 0.4 1.5 0.0 3.5 6.2 0.9 15.1 6.5 6.2 5.5 22.4 22.0 9.4 53.3 27.9 46.0 58.5 13.3 18.8 17.4 9.0 35.8 17.4 10.6 19.1 46.4 15.4 10.3 1.1 3.9 10.5 24.1 0.0 0.1 23.3 36.2 18.3 59.0 22.8 7.6 0.0 39.9 7.3 3.7 0.9 17.9 6.2 3.6 20.8 0.3 23.6 8.3 1.7 3.2 12.8 8.2 7.2 5.3 1.1 52.1 24.9 13.8 47.8 14.4 0.0 0.0 8.2 10.0 0.0 5.0 1.5 0.0 0.0 6.2 0.0 2.6 12.3 1.1 3.2 0.0 6.9 0.6 2.5 0.4 3.5 0.0 0.4 0.0 0.9 8.3 7.8 9.5 7.0 8.7 8.1 6.5 7.6 8.4 5.2 RREB1 HNT ENSG00000124782 "Ras responsive element binding protein 1" Q92766 6 7107597-7251980 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001756, HPA034843" Approved Supported "Nucleoli fibrillar center,Nuclear speckles" "Nuclear speckles" "Nucleoli fibrillar center" "HPA001756: AB_1856477, HPA034843: " "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (2.93e-1)" "unprognostic (5.05e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-3)" "unprognostic (2.53e-1)" "unprognostic (1.32e-2)" "unprognostic (2.45e-2)" "unprognostic (6.51e-2)" "unprognostic (3.31e-2)" "unprognostic (1.16e-1)" "prognostic favourable (1.41e-4)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.92e-1)" 17.4 13.3 3.4 17.9 3.6 24.1 15.9 1.4 3.3 15.8 16.8 3.6 13.5 9.7 18.5 16.3 26.6 9.4 19.1 8.5 3.8 2.1 12.7 18.5 14.4 15.9 4.2 1.8 12.5 26.4 14.6 11.2 15.9 4.6 13.7 8.3 15.2 23.6 18.5 30.5 16.5 20.3 14.5 5.2 20.0 9.6 10.6 4.4 12.8 15.9 17.1 24.9 12.5 17.5 3.0 7.8 8.6 3.6 5.2 2.3 2.0 6.8 6.6 5.5 6.4 5.2 3.3 22.7 2.7 3.8 3.1 4.2 10.2 5.4 3.2 5.8 5.1 5.0 7.9 8.5 3.4 4.6 6.4 12.9 4.6 12.8 7.1 7.1 9.8 5.7 7.0 4.9 7.5 4.1 22.6 0.0 3.5 8.3 4.2 19.8 2.5 5.8 6.7 6.8 5.2 5.2 13.2 1.5 1.3 6.0 8.8 5.7 6.6 16.6 6.4 6.1 3.9 4.3 3.5 2.2 2.4 5.0 1.7 5.9 4.9 6.0 3.6 8.6 2.2 3.1 1.7 3.0 1.3 1.4 2.4 1.6 2.3 2.1 2.8 5.2 3.2 7.8 0.8 2.0 3.4 3.6 1.4 3.3 3.8 2.1 4.2 1.8 4.6 4.4 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.1 12.0 7.1 17.0 16.4 9.6 13.2 16.0 7.1 8.3 3.6 4.6 36.4 12.5 14.6 2.1 5.8 13.4 10.1 5.9 6.3 9.1 4.3 7.6 13.8 2.8 19.5 20.8 25.3 7.8 11.9 19.8 6.7 5.6 22.7 5.6 4.8 5.3 6.7 7.5 3.1 4.9 7.3 16.5 6.5 3.0 6.0 6.9 3.7 7.9 9.9 6.3 15.1 11.0 21.4 7.6 3.6 5.9 5.4 33.1 16.2 4.3 11.6 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA047426: " "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 14.1 19.4 12.4 22.6 19.0 8.7 19.1 15.3 18.8 17.6 25.7 20.8 31.2 22.5 20.3 22.9 18.4 24.4 20.2 12.5 13.3 10.9 15.9 25.8 14.5 14.4 19.9 14.5 24.5 29.2 24.3 18.8 20.5 16.1 21.8 14.8 20.2 22.5 24.5 21.9 23.9 26.6 12.9 14.7 18.5 19.3 25.9 17.7 11.9 30.3 13.5 15.9 21.7 27.9 4.9 5.9 7.0 4.0 6.5 8.6 2.9 5.9 11.8 8.7 8.5 23.6 10.8 13.3 4.5 13.8 7.8 5.9 6.3 27.5 10.2 13.5 7.1 25.5 12.2 10.6 3.1 20.1 10.2 6.1 11.1 4.7 14.8 9.0 16.8 16.7 20.3 7.7 14.8 6.5 14.6 22.9 4.1 14.4 4.6 10.7 10.1 3.6 7.6 5.8 23.5 9.2 6.4 11.4 16.4 8.0 16.4 9.7 21.7 19.5 6.2 4.8 6.0 7.5 6.0 26.8 26.2 12.5 5.4 10.2 5.8 6.7 3.3 4.7 6.8 2.5 6.9 3.4 6.6 4.8 5.9 4.9 5.3 6.0 7.0 6.5 4.0 2.2 8.6 2.9 12.4 19.0 15.3 18.8 13.3 10.9 19.9 14.5 16.1 17.7 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: , HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.8 21.1 5.6 12.1 4.3 5.1 12.4 10.0 6.0 10.4 8.1 22.9 14.7 17.4 13.0 6.3 20.4 15.4 11.6 7.0 9.4 18.5 13.4 7.9 17.8 7.2 20.9 17.7 5.3 16.4 25.6 23.7 5.8 19.2 11.7 5.9 20.5 14.1 13.5 24.2 14.3 15.6 7.7 17.2 7.2 8.8 7.6 16.2 8.0 7.7 10.0 18.6 10.9 7.6 7.0 12.0 15.6 31.5 23.9 20.8 20.5 10.0 26.9 7.4 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285287-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoli "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 10.3 7.2 8.9 8.0 9.9 8.5 11.6 11.6 10.4 8.4 8.0 5.5 5.4 5.3 10.1 7.1 8.7 8.9 5.0 11.4 8.6 6.3 9.3 10.7 7.5 8.3 8.0 5.0 9.8 8.4 12.1 10.0 8.7 8.6 7.8 7.2 5.8 7.9 6.4 33.5 8.5 6.8 11.8 9.4 10.3 7.6 6.3 9.0 6.5 8.9 10.5 8.3 8.5 9.4 5.1 3.3 0.6 2.4 3.1 5.7 1.6 8.0 6.1 6.8 4.9 5.0 6.9 5.9 8.3 6.3 8.7 6.3 11.8 7.5 11.7 11.4 6.4 7.4 11.6 11.0 14.6 4.7 8.7 9.1 5.7 6.5 10.3 14.0 4.9 4.7 6.8 11.3 15.2 5.6 18.5 3.8 9.7 7.4 9.2 6.8 13.5 12.7 6.5 4.2 11.5 7.0 7.5 7.9 11.5 7.1 13.2 12.2 9.5 10.1 7.8 7.1 6.5 12.4 15.3 4.7 7.2 12.2 8.0 6.9 11.1 0.6 1.6 0.2 3.5 2.4 4.8 4.7 4.2 2.9 2.4 5.1 5.7 5.5 0.5 3.1 2.1 3.3 2.5 1.6 8.9 9.9 11.6 10.4 8.6 6.3 8.0 5.0 8.6 9.0 RRP1B "KIAA0179, Nnp1, PPP1R136, RRP1" ENSG00000160208 "Ribosomal RNA processing 1B" Q14684 21 43659548-43696079 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA017893, HPA020324" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA017893: AB_1852274, HPA020324: AB_1852276" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (4.03e-1)" "unprognostic (1.32e-3)" "unprognostic (1.24e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-2)" "unprognostic (7.19e-2)" "unprognostic (1.98e-2)" "unprognostic (5.55e-3)" "unprognostic (1.08e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (2.95e-9)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (4.24e-2)" 12.7 10.3 10.7 20.0 13.7 7.6 14.5 13.9 12.5 13.1 11.1 11.5 9.4 9.5 16.1 9.2 15.7 14.0 12.2 8.4 9.5 8.6 7.5 17.7 10.4 22.8 13.1 7.5 20.0 20.6 11.8 11.4 8.4 10.3 11.3 10.9 15.0 13.9 12.8 21.6 14.1 11.1 12.9 9.9 16.9 11.8 32.5 12.6 25.6 9.6 12.6 20.5 13.5 14.1 6.0 3.2 2.1 2.7 5.8 9.8 5.3 16.6 9.9 10.6 15.9 6.9 7.4 8.7 8.8 6.3 9.8 8.1 22.4 7.3 32.7 5.8 6.9 7.5 26.0 15.2 11.7 11.0 20.7 19.3 11.4 14.0 9.5 30.1 7.7 7.6 9.7 11.7 13.6 10.9 30.2 9.6 8.6 8.7 23.9 9.1 36.0 11.0 31.5 10.7 22.9 7.1 8.0 21.0 11.2 16.5 12.2 12.2 8.0 9.4 9.6 3.0 9.6 7.9 16.0 13.1 16.7 39.1 9.6 32.5 9.9 2.1 2.6 0.7 7.2 2.7 8.5 6.0 9.1 8.6 3.2 5.3 8.6 9.8 0.1 5.8 2.3 2.6 7.0 5.3 10.7 13.7 13.9 12.5 9.5 8.6 13.1 7.5 10.3 12.6 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: " "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 42.6 24.1 24.0 35.0 25.9 24.3 20.2 33.8 30.7 43.4 42.7 43.7 18.6 19.8 27.6 35.1 22.9 40.0 41.0 48.1 25.0 40.7 31.7 26.7 46.6 30.1 26.3 24.7 24.5 25.1 51.8 22.2 35.2 38.3 21.6 40.1 45.0 31.6 28.8 26.6 25.0 29.9 23.7 22.8 26.5 40.3 30.7 26.9 24.9 22.9 38.6 31.5 32.5 28.2 40.1 30.6 26.4 53.0 20.3 30.5 52.8 17.5 33.3 37.2 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: " "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 12.8 18.1 10.0 11.7 6.4 4.3 20.2 11.0 6.6 14.2 12.1 23.1 7.4 21.4 5.6 7.8 14.3 11.4 15.2 6.1 5.4 23.4 11.7 12.7 12.4 6.1 27.9 10.1 5.4 7.7 19.2 9.8 8.6 16.4 6.2 8.4 26.1 26.8 11.4 8.3 13.2 46.7 10.2 9.5 7.4 15.8 5.4 3.9 8.0 23.2 10.6 9.5 12.6 6.4 10.9 14.0 8.3 11.1 9.5 7.1 25.3 9.0 10.7 15.5 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038487: AB_10672518, HPA057562: " "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.2 10.2 4.1 5.3 8.6 7.5 5.8 5.3 6.6 12.3 11.6 10.5 12.0 14.4 5.2 5.0 10.4 11.7 9.3 13.1 6.9 16.8 6.8 12.3 11.8 9.8 12.3 9.5 6.4 12.2 5.8 10.7 12.6 13.4 8.4 9.7 12.7 11.9 18.4 10.1 9.3 10.7 3.3 3.2 11.5 8.2 6.3 7.4 7.6 15.5 8.6 8.4 10.8 6.5 11.7 5.4 11.3 10.2 9.4 8.5 13.7 9.9 12.4 7.5 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA022436: AB_2180789, HPA022967: AB_1856484" "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favourable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 6.2 21.4 10.3 16.9 17.6 14.5 3.7 11.0 10.8 14.2 12.1 21.1 8.0 17.1 24.5 7.7 6.0 11.6 15.4 12.3 18.8 21.1 22.9 9.6 20.5 12.3 13.8 16.1 10.5 17.0 9.4 18.3 13.8 17.6 16.3 11.9 14.7 23.0 10.1 4.1 23.1 9.5 11.8 15.3 17.2 9.6 5.6 19.3 2.8 13.3 14.2 19.9 14.1 9.7 14.9 15.9 11.3 12.9 25.4 17.8 6.6 11.1 19.8 10.3 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 RSAD2 "cig5, vig1, viperin" ENSG00000134321 "Radical S-adenosyl methionine domain containing 2" Q8WXG1 2 6865806-6898239 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 31.8" "Group enriched" "Detected in some" 5 "BJ hTERT+ SV40 Large T+: 30.4;BJ hTERT+ SV40 Large T+ RasG12V: 46.9;HMC-1: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 24.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041160, HPA049409" Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA041160: AB_10795489, HPA049409: " "unprognostic (8.91e-2)" "unprognostic (3.85e-2)" "unprognostic (7.89e-2)" "prognostic unfavourable (4.60e-4)" "unprognostic (3.27e-1)" "unprognostic (3.25e-1)" "unprognostic (1.95e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (3.66e-3)" "unprognostic (9.47e-3)" "unprognostic (4.06e-2)" "unprognostic (1.27e-2)" "unprognostic (3.98e-2)" "unprognostic (4.54e-3)" "unprognostic (4.47e-2)" "unprognostic (1.79e-1)" 31.8 3.1 4.8 10.1 8.7 12.5 4.1 1.1 7.8 7.2 5.6 4.7 2.1 3.4 4.8 7.8 2.9 5.5 6.2 5.3 5.3 5.8 6.1 3.6 15.3 7.7 4.8 5.6 3.5 2.1 1.2 6.2 10.1 12.5 3.7 3.1 7.5 20.2 2.5 5.5 1.0 4.9 5.2 6.1 10.8 7.2 2.3 2.0 11.5 10.2 3.5 2.8 4.0 2.0 0.4 2.7 24.3 5.1 1.6 3.2 2.2 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.4 30.4 46.9 0.0 0.9 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 2.0 0.0 0.0 0.5 0.4 0.0 0.0 2.8 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 0.1 14.6 3.6 24.3 1.8 5.1 2.2 0.2 1.9 1.7 2.7 0.4 3.2 2.4 14.4 1.6 4.5 0.2 0.9 2.2 4.8 8.7 1.1 7.8 5.3 5.8 4.8 5.6 12.5 2.0 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: " "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 10.4 8.4 8.6 9.4 14.6 35.8 10.3 23.9 12.0 17.0 14.4 6.9 8.1 7.7 13.4 8.6 9.7 10.9 8.4 8.1 8.9 9.1 10.4 7.9 11.5 11.8 8.1 7.3 18.3 13.3 17.6 15.1 8.2 8.4 11.5 10.9 9.6 10.1 10.7 17.1 10.7 10.9 11.5 7.2 12.8 8.8 12.4 10.0 22.6 11.8 5.7 12.7 16.6 10.7 20.7 16.4 25.7 9.2 14.3 20.8 7.3 11.8 3.4 11.7 6.9 7.0 8.1 5.6 4.2 9.1 8.6 9.1 4.0 3.6 10.4 6.8 5.2 5.2 8.3 5.2 14.2 10.1 6.0 7.9 3.7 4.5 5.3 14.7 8.5 6.1 5.7 7.4 7.0 6.8 11.8 6.6 6.3 12.2 11.8 8.8 9.9 5.9 21.5 11.4 5.4 5.2 5.1 11.9 9.4 8.1 8.0 7.2 3.8 10.0 8.1 7.8 8.5 11.5 6.8 8.8 6.5 13.2 8.0 9.0 13.0 25.7 9.2 14.6 18.6 6.9 18.8 18.3 20.1 17.1 7.6 20.7 20.8 16.9 17.9 14.3 7.5 16.4 17.4 7.3 8.6 14.6 23.9 12.0 8.9 9.1 8.1 7.3 8.4 10.0 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696443-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favourable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 12.9 10.6 15.0 22.1 14.6 9.5 15.5 28.7 17.0 22.8 23.5 8.9 12.1 11.1 17.2 13.6 15.0 14.2 13.4 10.6 12.4 10.3 12.0 14.9 15.7 18.2 11.1 11.0 19.2 14.9 19.5 16.2 12.2 11.8 18.8 15.1 13.9 14.0 15.4 13.6 11.7 14.9 18.0 11.0 20.7 14.3 29.8 13.8 34.5 21.1 6.7 18.0 23.6 28.2 7.2 7.0 31.5 4.0 3.0 5.2 1.2 8.8 6.8 11.4 20.0 8.0 10.3 5.6 6.6 7.1 9.4 10.8 8.4 15.9 18.2 2.6 6.8 7.7 15.5 8.5 13.5 9.8 8.3 14.5 10.8 8.3 6.8 17.8 13.7 7.3 6.2 8.6 9.5 7.7 19.6 19.2 9.7 10.2 15.2 17.9 8.1 6.1 15.9 11.4 19.1 5.9 11.7 13.5 14.1 10.0 18.2 7.2 11.1 9.5 7.4 14.1 13.0 8.4 10.0 8.6 9.1 29.3 6.7 16.5 9.2 9.1 4.0 6.4 5.2 2.9 3.9 5.4 4.5 3.8 2.2 7.2 4.3 4.7 31.5 3.0 3.2 7.0 4.5 1.2 15.0 14.6 28.7 17.0 12.4 10.3 11.1 11.0 11.8 13.8 RSC1A1 RS1 ENSG00000215695 "Regulator of solute carriers 1" Q92681 1 15659869-15661722 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027813, HPA028676" Approved Supported "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA027813: AB_10600308, HPA028676: AB_10600895" 3.0 0.9 0.3 1.7 0.4 2.8 2.6 0.1 0.6 2.2 0.6 0.0 1.2 0.0 3.5 1.2 1.1 2.9 0.3 0.5 4.0 7.7 2.7 2.0 0.4 4.6 0.2 2.1 1.3 2.3 3.9 1.3 0.1 0.8 0.6 2.1 0.6 3.0 0.8 0.1 0.6 4.7 1.7 3.2 1.1 2.2 1.1 2.8 0.5 3.5 1.7 2.3 1.5 3.3 3.8 4.7 3.1 5.9 4.1 6.3 2.8 4.6 7.7 7.3 6.3 5.4 7.3 2.7 6.2 2.2 12.3 3.9 9.6 4.8 3.1 6.8 7.6 6.7 1.3 10.0 3.5 3.2 0.0 13.3 7.4 4.8 18.6 6.9 5.6 3.3 5.2 0.0 5.1 2.2 4.5 6.6 3.0 1.8 6.1 3.8 1.5 5.2 2.3 4.5 3.3 0.9 4.7 4.0 7.3 3.5 2.0 2.1 3.9 12.7 1.5 2.7 2.8 0.0 1.2 0.5 0.4 3.5 1.4 1.1 0.5 2.3 2.8 0.2 0.6 0.5 0.0 1.7 0.1 0.7 2.3 1.5 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197067 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 27.7 24.3 26.7 23.4 28.8 76.1 47.8 35.7 29.9 40.6 32.2 10.0 25.6 18.1 34.5 26.6 34.2 26.4 21.4 25.3 25.1 25.3 24.3 26.7 27.0 35.8 25.4 25.8 54.7 37.8 15.0 23.2 22.4 24.1 44.3 20.5 11.2 25.8 21.3 47.2 19.3 21.1 50.4 27.5 28.6 28.8 24.2 20.6 39.5 43.1 36.9 27.4 61.9 49.6 29.1 27.0 11.4 24.1 22.7 45.1 47.7 15.8 16.2 17.8 23.4 14.0 26.4 14.4 16.9 18.9 14.2 18.1 15.4 9.8 49.6 15.2 12.1 19.5 23.4 19.4 19.0 24.1 14.5 25.3 13.0 19.1 32.2 47.7 16.6 22.3 41.3 14.2 41.2 17.6 47.9 36.0 16.4 16.2 26.1 42.1 22.0 14.5 20.8 22.3 74.7 21.2 14.8 25.3 30.3 7.8 21.9 54.5 21.0 70.7 12.2 11.7 13.7 13.6 24.0 34.7 53.0 49.3 18.2 47.3 19.5 11.4 23.8 11.4 19.6 23.4 31.1 29.1 29.5 24.3 27.0 22.5 45.1 34.0 6.0 22.7 24.1 21.1 32.4 47.7 26.7 28.8 35.7 29.9 25.1 25.3 25.4 25.8 24.1 20.6 RSPH3 "dJ111C20.1, RSHL2, RSP3" ENSG00000130363 "Radial spoke head 3 homolog" Q86UC2 6 158972871-159000187 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039109, HPA040230" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA039109: AB_10794423, HPA040230: AB_10796119" "unprognostic (6.18e-3)" "unprognostic (3.62e-3)" "unprognostic (4.54e-2)" "unprognostic (6.20e-2)" "unprognostic (1.88e-1)" "unprognostic (9.18e-2)" "unprognostic (1.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.15e-1)" "unprognostic (6.74e-3)" "unprognostic (6.98e-2)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (5.89e-2)" "unprognostic (1.67e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" 4.9 9.0 7.1 3.8 9.8 3.1 6.2 6.3 12.7 6.8 8.2 7.0 14.3 11.3 7.4 12.8 15.5 10.7 6.0 6.6 8.0 6.8 10.7 5.4 8.5 2.6 4.8 10.6 7.3 8.6 25.9 14.4 5.5 10.4 8.9 6.5 5.5 10.3 14.9 3.8 7.6 12.2 6.6 6.0 3.9 7.5 24.3 7.0 2.1 12.8 5.1 3.9 9.1 8.4 2.3 5.8 13.0 7.7 1.8 1.8 1.6 9.9 5.1 2.3 5.4 5.4 6.9 2.9 7.1 8.2 2.8 3.7 2.0 6.0 2.1 6.5 7.5 7.6 1.5 6.6 3.2 4.8 4.4 2.7 5.0 3.4 5.2 2.5 1.9 8.5 11.8 4.6 8.9 2.7 3.1 3.4 4.6 5.6 1.5 3.1 1.5 3.4 2.4 0.4 2.1 8.8 3.2 3.5 4.4 13.2 4.4 2.5 5.4 6.2 6.4 2.9 7.4 5.6 3.8 3.6 6.9 1.8 12.5 3.3 4.6 0.7 5.2 0.6 0.8 3.6 1.8 1.3 1.2 1.6 5.4 2.3 1.0 1.4 13.0 1.8 7.7 5.8 1.4 1.6 7.1 9.8 6.3 12.7 8.0 6.8 4.8 10.6 10.4 7.0 RSRC2 FLJ11021 ENSG00000111011 "Arginine and serine rich coiled-coil 2" Q7L4I2 12 122503458-122527000 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040070, HPA048183" Uncertain Approved "Nucleoli fibrillar center,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli fibrillar center, Cytosol" "HPA040070: AB_10673430, HPA048183: " "unprognostic (4.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "unprognostic (6.42e-3)" "unprognostic (6.90e-2)" "prognostic unfavourable (2.05e-4)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (2.74e-2)" "unprognostic (3.26e-1)" "unprognostic (3.19e-2)" "unprognostic (1.06e-2)" "unprognostic (2.23e-2)" "unprognostic (8.87e-2)" "unprognostic (4.84e-2)" "unprognostic (1.53e-2)" 18.5 19.4 24.8 20.2 31.9 82.6 20.1 34.9 45.9 19.3 21.0 16.0 19.9 14.3 21.4 21.4 26.9 19.6 21.0 20.2 28.9 21.4 20.6 18.2 19.1 23.0 24.9 24.1 25.2 19.0 11.3 43.2 20.6 28.1 20.0 18.6 10.7 19.1 21.3 36.8 18.7 19.2 20.4 45.1 18.6 16.0 20.7 29.4 21.1 23.5 17.7 15.7 25.0 28.0 24.6 16.3 22.3 18.4 16.4 19.3 9.8 11.7 14.2 13.5 5.7 10.7 7.0 9.7 21.8 7.0 9.4 5.3 19.9 5.0 13.4 18.6 7.6 7.6 14.7 6.1 9.2 12.6 13.6 23.4 17.2 21.2 5.9 20.1 14.3 8.7 7.2 8.0 13.6 6.6 14.9 8.4 8.2 9.4 14.5 15.0 11.1 11.7 11.1 12.2 8.7 12.1 22.1 10.9 9.8 17.0 5.7 12.0 9.2 7.4 9.9 9.6 11.6 10.6 11.9 9.6 22.3 21.6 6.1 11.6 5.4 19.8 16.6 22.3 16.4 13.5 13.9 22.8 15.0 13.3 16.3 24.6 19.3 15.2 17.7 16.4 18.4 15.4 19.0 9.8 24.8 31.9 34.9 45.9 28.9 21.4 24.9 24.1 28.1 29.4 RTCB "C22orf28, FAAP, HSPC117" ENSG00000100220 "RNA 2',3'-cyclic phosphate and 5'-OH ligase" Q9Y3I0 22 32387582-32412255 "Enzymes, Predicted intracellular proteins" "tRNA processing" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000535, HPA001103" Supported Supported Nucleoplasm,Vesicles,Cytosol 43000 Nucleoplasm "Vesicles, Cytosol" "HPA000535: , HPA001103: AB_1078351" "unprognostic (1.84e-1)" "unprognostic (6.48e-2)" "unprognostic (1.07e-2)" "unprognostic (2.71e-3)" "unprognostic (7.21e-3)" "unprognostic (1.43e-2)" "unprognostic (1.75e-3)" "unprognostic (1.49e-1)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (5.07e-2)" "prognostic favourable (4.25e-5)" "unprognostic (6.91e-2)" "unprognostic (5.35e-2)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" 26.4 30.1 20.1 20.4 29.7 15.1 29.2 22.9 34.5 25.7 35.6 35.2 32.7 51.6 29.7 25.8 30.8 26.9 22.9 26.4 19.6 24.6 42.4 55.1 23.1 22.7 29.1 26.2 29.0 29.4 38.4 29.9 33.7 36.7 27.0 42.3 27.1 29.9 28.6 40.9 46.6 61.7 31.8 24.4 29.3 29.7 30.8 25.5 32.0 32.7 30.1 46.6 26.5 24.2 44.6 51.5 29.0 47.7 37.0 40.5 44.0 31.7 28.6 35.9 26.9 31.4 23.5 28.6 27.9 33.7 44.7 42.5 37.1 13.0 7.9 18.7 32.5 21.7 41.0 40.5 57.9 39.8 41.2 22.5 24.3 33.7 21.6 52.5 20.6 23.0 26.9 44.1 43.0 40.1 26.6 22.5 32.5 26.5 22.3 18.2 20.5 26.2 34.7 38.8 40.6 30.7 27.7 37.1 20.5 30.2 19.6 35.4 21.5 20.5 30.1 24.7 36.4 21.4 26.7 15.7 12.5 28.5 25.5 23.8 32.1 29.0 43.5 27.4 31.7 47.7 35.5 44.6 33.3 33.0 51.5 43.6 39.9 34.6 4.3 37.0 35.5 28.9 40.5 44.0 20.1 29.7 22.9 34.5 19.6 24.6 29.1 26.2 36.7 25.5 RTEL1 "bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL" ENSG00000258366 "Regulator of telomere elongation helicase 1" Q9NZ71 20 63657810-63696253 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA020622, HPA067329, HPA078328" Approved "Nuclear speckles,Nuclear bodies" "Nuclear speckles, Nuclear bodies" "HPA020622: , HPA067329: , HPA078328: " "unprognostic (3.63e-2)" "unprognostic (8.08e-3)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.27e-1)" "unprognostic (9.30e-3)" "unprognostic (2.59e-1)" "unprognostic (3.64e-2)" "unprognostic (3.30e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (9.50e-2)" "unprognostic (8.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" "unprognostic (8.84e-2)" 8.4 14.3 9.4 11.5 12.4 14.2 7.9 25.6 11.8 9.1 11.1 11.2 10.9 9.8 15.4 7.4 7.0 9.5 9.3 6.2 8.0 6.9 7.1 7.2 8.9 7.8 7.5 12.1 10.6 17.8 7.2 18.2 9.8 8.2 10.2 4.8 10.2 12.9 10.2 10.2 8.2 10.1 8.8 4.4 11.6 10.4 17.6 8.9 9.1 11.9 4.9 9.5 9.3 9.0 1.7 3.6 0.0 3.3 0.4 3.0 2.4 5.2 7.2 5.2 10.0 1.1 1.2 9.6 10.9 2.9 17.0 4.5 14.4 4.5 7.1 5.7 3.3 9.9 3.5 7.1 4.1 3.5 7.3 8.7 12.5 13.7 3.8 8.5 16.0 1.5 4.0 4.2 5.2 5.8 10.8 6.7 3.8 5.6 13.2 11.0 5.1 15.2 10.6 4.9 7.3 2.7 6.5 10.3 6.2 6.1 17.8 1.3 4.7 9.6 7.7 19.3 6.3 6.6 8.3 6.2 2.6 4.4 4.7 6.0 6.7 0.0 2.7 0.0 3.0 3.3 1.6 0.9 1.7 2.0 3.6 1.7 2.9 1.1 0.0 0.4 2.6 3.2 1.4 2.4 9.4 12.4 25.6 11.8 8.0 6.9 7.5 12.1 8.2 8.9 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006714 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 20.4 27.8 27.6 21.6 33.8 34.3 20.4 40.5 34.5 23.7 22.5 14.3 17.6 16.9 25.7 18.4 22.4 18.5 18.4 24.8 26.5 21.4 17.6 19.6 17.2 23.0 17.0 35.1 27.7 15.2 37.0 20.3 36.9 27.2 22.0 20.6 15.4 19.5 23.2 55.2 24.8 20.7 24.7 14.9 23.5 19.0 25.4 13.5 25.3 26.7 15.6 21.6 27.8 20.2 8.0 7.4 11.6 4.3 8.6 5.7 1.4 15.2 10.0 33.0 26.8 18.8 22.3 15.6 20.4 23.0 28.0 23.4 19.4 9.7 14.5 16.6 21.3 27.1 19.1 16.9 24.0 22.0 17.8 30.4 22.6 14.5 13.2 27.0 17.8 16.0 17.2 14.9 15.2 22.5 23.0 16.8 22.9 11.5 25.8 16.7 17.8 13.8 28.1 25.8 13.8 18.2 32.7 17.0 22.5 18.3 23.4 9.2 19.2 26.2 18.4 27.5 17.5 27.3 22.3 19.4 29.9 24.1 19.8 25.8 16.7 5.9 4.3 8.4 4.8 2.8 4.4 8.0 4.7 4.1 3.0 6.5 5.7 4.7 11.6 8.6 3.3 7.4 5.4 1.4 27.6 33.8 40.5 34.5 26.5 21.4 17.0 35.1 27.2 13.5 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053986: " "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 33.4 34.2 43.5 29.1 43.9 52.6 28.9 27.4 48.7 28.8 29.4 53.0 20.1 28.0 31.4 24.1 30.5 31.6 23.2 38.7 40.6 35.6 31.8 30.3 24.2 29.7 49.6 35.7 35.2 27.5 26.0 29.3 30.5 46.6 28.5 26.0 26.0 25.8 31.7 74.6 27.9 29.8 34.1 59.7 30.2 25.3 29.1 45.2 31.4 29.1 28.9 34.4 29.0 23.9 20.0 35.1 91.6 31.8 29.4 23.0 33.2 28.5 20.5 20.8 20.3 26.0 23.3 19.4 44.6 33.7 64.4 37.0 41.9 27.8 24.5 52.9 36.1 32.1 20.8 34.3 44.6 11.4 16.1 30.6 22.4 32.3 29.9 43.5 42.3 20.6 35.7 28.7 25.0 27.6 23.6 25.6 31.5 54.5 36.4 37.1 15.4 39.1 25.0 56.7 32.2 26.8 18.8 21.5 23.3 46.8 79.4 41.9 36.8 41.6 29.5 55.1 35.7 29.9 36.0 21.4 24.6 34.8 43.4 29.6 30.0 39.2 31.8 84.1 20.9 29.6 17.6 18.6 18.0 20.3 35.1 20.0 20.5 18.8 91.6 29.4 28.8 29.9 23.0 33.2 43.5 43.9 27.4 48.7 40.6 35.6 49.6 35.7 46.6 45.2 RTKN B5 ENSG00000114993 Rhotekin Q9BST9 2 74425836-74442422 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030259 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA030259: AB_10601484" "unprognostic (4.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.20e-2)" "unprognostic (2.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-3)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (2.57e-2)" "unprognostic (9.43e-3)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (2.96e-2)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.23e-3)" 3.2 4.9 17.1 3.9 24.2 0.4 7.1 3.9 23.6 5.6 8.7 29.7 7.3 21.2 5.1 4.0 8.0 9.0 9.7 7.2 22.2 13.7 27.0 39.0 6.3 1.9 34.8 7.7 3.6 16.3 12.8 5.3 7.9 17.2 6.5 8.8 6.0 17.3 7.0 7.5 21.1 16.4 4.4 36.3 2.2 6.0 1.4 29.4 1.9 7.4 5.3 4.3 3.1 5.6 1.7 9.7 0.0 0.0 3.1 0.4 0.6 16.8 5.2 6.7 19.8 4.1 4.8 28.9 2.6 3.3 3.8 2.8 26.1 9.4 0.1 7.5 2.5 23.1 2.5 16.8 1.8 3.3 10.9 4.0 0.9 32.8 2.5 0.0 0.0 2.9 13.4 3.2 10.7 1.9 2.0 0.1 5.6 12.0 0.6 3.3 7.3 10.5 3.7 20.9 2.5 18.5 0.1 6.8 6.5 7.2 28.0 14.9 15.6 1.5 0.2 7.2 4.9 3.2 3.5 1.7 1.1 0.6 6.9 0.0 6.6 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.2 0.3 0.9 1.7 0.0 0.1 0.0 3.1 0.0 9.7 0.0 0.6 17.1 24.2 3.9 14.9 22.2 13.7 34.8 7.7 17.2 29.4 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell line enhanced" "Detected in many" "A-431: 24.9;HaCaT: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 24.9 1.4 13.4 6.2 0.0 0.1 3.3 3.6 4.2 4.1 6.5 10.4 5.0 0.0 1.6 1.4 20.0 7.5 0.6 4.3 3.5 5.1 4.1 3.0 4.3 0.0 5.5 3.2 0.2 0.3 5.1 0.5 0.6 0.2 0.2 5.5 3.1 10.8 7.2 5.6 5.1 9.3 14.3 0.0 2.6 10.9 7.3 8.4 2.4 8.4 3.4 7.6 3.1 0.0 1.9 12.2 0.1 9.1 0.1 0.0 9.5 2.4 0.0 2.9 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: , HPA053174: , HPA075136: " "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Cell line enhanced" "Detected in single" "NTERA-2: 2.0" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL6 "dJ1033E15.2, DKFZp761O17121, LDOC1L, Mar6, Mart6, SIRH3" ENSG00000188636 "Retrotransposon Gag like 6" Q6ICC9 22 44492572-44498298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005697 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA005697: AB_1079244" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.71e-3)" "unprognostic (1.57e-1)" "unprognostic (9.64e-3)" "unprognostic (5.40e-2)" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.57e-2)" "unprognostic (1.65e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" 11.6 14.1 19.3 7.7 17.4 3.2 10.2 16.2 30.0 13.6 12.2 14.7 15.2 9.7 17.8 14.2 9.4 19.1 12.4 16.7 17.1 16.1 10.9 4.9 10.4 6.3 16.9 11.4 22.6 12.1 18.9 9.9 5.9 11.9 11.5 10.4 9.2 7.7 16.3 15.5 3.7 9.2 19.0 16.5 7.9 10.7 12.6 9.5 14.4 11.6 7.2 5.3 11.8 10.2 0.2 1.1 0.1 1.4 0.9 4.5 2.1 6.9 9.7 12.6 16.7 9.9 8.1 3.3 9.2 11.0 13.0 10.3 3.2 4.1 0.0 5.8 17.2 6.1 8.5 9.1 8.1 3.3 16.5 0.0 18.7 0.0 12.2 0.9 4.6 8.7 8.9 11.9 9.2 11.6 3.9 0.0 8.8 12.3 22.1 2.0 7.7 10.4 6.1 6.7 0.0 11.2 8.1 13.6 15.9 15.1 7.3 9.3 7.3 9.8 11.9 10.2 13.9 13.5 7.4 4.4 1.7 0.0 15.2 2.3 15.2 0.0 1.4 0.1 4.3 0.6 4.5 0.0 2.5 3.6 1.1 0.2 1.0 2.5 0.0 0.9 0.8 0.1 0.4 2.1 19.3 17.4 16.2 27.8 17.1 16.1 16.9 11.4 11.9 9.5 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Group enriched" "Detected in some" 4 "HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: , HPA044249: " "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favourable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 22.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 28.1 45.0 5.5 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.0 2.0 0.0 0.0 0.0 7.5 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Predicted membrane proteins" Receptor "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.0;brain: 33.2" "Cell line enhanced" "Detected in many" "NB-4: 20.0;REH: 28.2;SCLC-21H: 17.2;SK-MEL-30: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" 1300000 "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 0.8 1.1 10.9 1.2 7.0 1.3 0.7 33.2 24.6 0.8 1.7 1.2 0.3 3.9 4.9 0.5 0.9 1.3 0.6 1.4 8.8 3.1 0.9 4.0 1.7 1.1 1.4 6.8 1.1 2.7 0.6 1.6 1.1 4.9 1.2 0.6 0.7 1.3 1.2 0.8 5.2 1.8 0.7 2.8 5.9 2.3 1.1 0.5 0.1 1.1 0.4 0.7 0.7 0.7 0.1 1.3 0.0 0.0 0.7 12.0 1.7 4.1 2.0 1.2 3.0 0.0 0.0 0.6 0.4 0.0 0.3 0.1 3.2 1.1 0.2 1.4 0.0 6.8 0.7 1.7 0.0 0.1 7.3 0.1 1.8 0.4 0.7 0.1 0.2 0.0 2.2 0.0 0.2 0.0 0.2 0.2 0.0 5.8 2.1 20.0 4.7 3.6 28.2 0.0 0.2 0.2 1.7 17.2 2.8 2.0 1.4 13.4 1.6 0.5 0.0 0.2 8.1 0.0 0.1 0.0 0.5 0.5 0.2 4.1 0.0 0.0 0.0 0.0 5.1 0.0 12.0 0.0 4.5 5.1 0.2 0.1 2.7 5.7 0.0 0.7 0.0 1.3 3.1 1.7 10.9 7.0 33.2 20.1 8.8 3.1 1.4 6.8 4.9 0.5 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "RUN and cysteine rich domain containing beclin 1 interacting protein" Q92622 3 197671393-197749727 "Disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA050908: , HPA054497: " "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavourable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 10.7 8.4 19.3 15.5 24.0 10.7 6.8 30.0 24.6 7.9 9.8 12.4 6.4 10.7 9.1 6.5 14.5 7.7 10.4 10.3 18.1 18.8 7.8 5.7 12.4 19.8 14.6 19.4 14.0 11.0 13.3 16.6 8.5 18.3 7.4 8.8 8.3 7.1 11.2 9.7 11.7 12.0 11.4 15.1 22.3 11.3 22.0 15.8 7.9 7.4 7.0 22.3 9.6 8.0 7.8 14.7 12.8 4.1 1.5 4.4 1.2 14.8 3.5 4.2 8.5 7.4 4.2 4.3 6.9 4.5 8.2 7.0 6.2 4.1 17.1 13.5 7.4 8.1 7.8 3.8 6.7 4.4 6.9 10.4 6.0 2.3 4.3 5.9 8.7 3.5 4.9 7.2 8.6 5.1 5.7 42.7 5.5 12.0 7.0 3.7 3.6 11.5 7.0 4.3 10.6 4.8 6.5 17.0 4.1 5.0 9.8 5.5 14.5 3.9 6.8 5.0 4.8 13.6 9.1 20.2 16.2 13.0 6.6 10.9 4.3 0.6 2.4 12.8 3.6 3.5 2.3 6.6 3.0 4.4 1.4 7.8 2.2 3.0 2.7 1.5 4.1 14.7 3.6 1.2 19.3 24.0 30.0 24.6 18.1 18.8 14.6 19.4 18.3 15.8 RUFY1 "FLJ22251, RABIP4, ZFYVE12" ENSG00000176783 "RUN and FYVE domain containing 1" Q96T51 5 179550558-179610026 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038804 Approved Supported "Nuclear speckles,Vesicles,Cytosol" 9600 "Vesicles, Cytosol" "Nuclear speckles" "HPA038804: AB_10673290" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.50e-1)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (9.74e-2)" "unprognostic (1.31e-1)" "unprognostic (2.73e-2)" "unprognostic (3.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" 20.9 27.9 19.7 24.7 22.4 21.1 36.9 22.4 18.9 18.2 20.2 16.9 27.9 16.9 22.5 16.9 25.9 18.8 20.7 14.8 19.7 14.8 23.9 17.5 20.8 23.1 18.8 17.1 19.4 19.8 22.6 21.5 17.3 19.7 20.9 15.5 16.4 21.2 18.3 26.7 24.2 18.8 17.5 14.7 27.9 18.6 12.2 20.5 20.1 27.3 14.1 20.1 20.7 34.3 3.2 3.4 7.9 4.5 1.2 2.9 21.5 7.1 11.8 6.3 8.3 12.2 10.1 7.2 12.7 9.1 7.5 8.8 11.4 16.7 11.6 7.2 15.4 6.6 11.5 16.6 8.9 36.6 8.7 20.2 9.0 8.2 12.5 11.2 11.1 10.2 9.2 5.1 14.6 8.2 8.2 11.1 6.7 21.6 11.9 7.8 6.7 5.5 10.7 4.5 10.7 12.6 11.7 6.3 9.0 18.6 12.0 6.6 9.6 13.8 9.8 10.0 3.3 5.3 9.9 6.9 10.6 20.8 9.2 20.3 9.1 7.4 3.4 7.9 1.7 3.6 1.0 2.7 2.0 1.7 3.0 3.2 1.4 1.8 5.9 1.2 4.5 3.4 2.9 21.5 19.7 22.4 22.4 18.9 19.7 14.8 18.8 17.1 19.7 20.5 RUNDC1 DKFZp761H0421 ENSG00000198863 "RUN domain containing 1" Q96C34 17 42980565-42993690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023726 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA023726: AB_2184078" "unprognostic (4.24e-2)" "unprognostic (1.26e-1)" "unprognostic (9.39e-2)" "prognostic favourable (6.93e-5)" "unprognostic (9.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.40e-2)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (3.84e-2)" "unprognostic (1.22e-1)" "unprognostic (1.53e-3)" "unprognostic (2.87e-3)" "unprognostic (1.25e-1)" "unprognostic (1.12e-2)" "unprognostic (4.77e-3)" 7.3 11.0 23.4 8.7 23.1 8.4 14.7 18.6 24.6 13.0 12.9 7.9 12.2 9.0 12.3 17.9 9.0 20.9 9.5 8.7 17.2 13.0 12.1 6.6 9.6 9.3 9.2 16.9 7.7 14.2 17.7 17.2 6.7 12.2 17.9 11.0 8.9 11.1 12.9 14.5 9.1 10.0 12.3 7.5 10.7 13.9 11.9 12.5 9.6 14.5 4.4 10.4 12.7 8.1 5.6 7.5 10.0 5.2 1.4 2.6 1.2 11.3 19.8 8.0 10.9 13.8 8.3 8.6 10.9 11.4 15.7 11.8 12.5 6.6 7.6 10.0 10.8 14.2 10.2 11.1 17.6 8.6 16.1 5.1 11.2 11.9 8.9 11.0 10.9 6.2 13.6 13.9 9.3 8.4 9.7 4.9 9.0 8.2 13.5 7.8 9.0 12.6 9.8 11.3 7.6 13.2 15.2 11.8 10.9 8.6 8.3 9.0 15.9 12.3 6.9 14.4 9.0 8.5 13.0 11.6 11.2 6.7 10.2 5.9 8.9 5.0 3.3 10.0 1.9 5.2 2.4 4.6 2.3 1.6 2.5 5.6 2.3 2.5 7.6 1.4 3.6 7.5 2.6 1.2 23.4 23.1 18.6 24.6 17.2 13.0 9.2 16.9 12.2 12.5 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "Runt related transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 54.3;lymphoid tissue: 58.6" "Cell line enhanced" "Detected in many" "HEL: 65.0;HMC-1: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: " "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavourable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 11.5 3.2 5.2 14.8 7.3 29.8 54.3 1.0 4.3 12.5 4.7 3.8 4.0 3.8 2.9 7.4 6.5 4.6 12.4 7.6 6.1 2.0 4.2 6.7 17.9 13.9 8.5 1.1 6.5 5.8 1.6 5.5 6.4 6.0 9.9 5.1 3.5 29.8 8.8 14.4 8.3 5.1 6.8 12.3 10.6 12.7 2.9 6.6 58.6 4.6 5.7 14.2 11.0 9.1 3.2 3.4 17.0 3.9 1.3 4.8 2.0 13.0 1.0 0.0 0.1 3.4 4.4 8.6 7.4 7.5 4.1 3.1 0.6 10.0 6.4 0.5 6.5 11.8 0.8 8.8 6.0 9.9 1.0 65.0 2.6 3.0 6.3 7.5 39.2 8.5 5.3 12.5 12.4 2.3 4.4 3.8 8.7 2.8 30.3 11.9 0.6 3.8 30.7 22.8 3.9 5.5 5.2 0.3 0.0 7.6 1.9 2.7 3.9 17.6 9.7 6.8 8.8 10.1 11.1 12.5 5.1 6.1 8.5 16.5 9.9 17.0 3.2 6.3 3.4 1.4 3.3 3.2 3.1 3.2 0.9 3.1 4.8 3.8 3.5 1.3 3.9 3.4 4.0 2.0 5.2 7.3 1.0 4.3 6.1 2.0 8.5 1.1 6.0 6.6 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell line enhanced" "Detected in some" "HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB025416: , HPA004195: , HPA059006: " "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavourable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavourable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.2 6.1 5.3 0.1 3.6 0.0 0.2 38.7 0.6 0.1 0.6 0.0 0.0 1.4 13.4 0.0 0.0 0.0 0.3 0.0 0.0 52.1 0.0 0.0 0.4 12.0 0.2 1.0 0.0 0.0 7.3 0.0 0.1 1.2 0.0 2.4 0.0 28.9 0.0 8.3 0.0 0.0 0.5 0.0 0.1 18.1 12.5 5.9 0.0 13.5 1.4 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 RUVBL1 "ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a" ENSG00000175792 "RuvB like AAA ATPase 1" Q9Y265 3 128064778-128153914 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019947, HPA019948" Enhanced Supported Nucleoplasm,Cytosol 47000 "Nucleoplasm, Cytosol" "HPA019947: AB_1856516, HPA019948: AB_1856514" "unprognostic (7.40e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (4.73e-2)" "unprognostic (3.55e-1)" "unprognostic (2.66e-2)" "prognostic unfavourable (1.21e-8)" "unprognostic (2.43e-2)" "unprognostic (3.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (7.39e-2)" "unprognostic (2.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 17.6 15.1 10.7 15.8 14.2 11.9 13.9 7.9 14.0 12.5 11.6 12.9 14.3 8.4 19.2 11.4 19.2 37.3 11.3 18.6 11.4 13.6 20.9 13.7 12.9 18.7 10.0 9.8 15.4 13.6 26.5 14.2 19.9 13.0 12.0 14.1 11.5 10.2 12.0 12.9 11.8 10.2 16.1 8.8 21.9 10.9 44.7 10.3 33.4 15.2 18.1 23.9 12.6 15.0 10.6 8.7 1.5 7.9 10.9 20.2 7.2 26.7 24.3 14.9 24.3 11.7 11.4 19.6 13.1 11.3 25.3 17.5 25.4 15.9 38.0 13.1 12.5 21.3 39.8 27.8 29.5 15.5 19.5 31.5 14.1 17.0 12.1 29.4 10.1 11.6 14.7 21.3 27.4 16.9 25.8 8.9 14.4 38.1 31.5 22.3 37.6 20.8 25.9 18.1 26.4 15.1 10.1 25.1 22.5 14.5 12.0 20.1 21.8 21.8 10.9 11.5 14.1 17.3 19.8 9.1 14.5 37.3 14.2 18.1 14.4 0.8 4.8 1.5 11.3 7.9 14.6 10.6 13.6 14.0 7.7 10.2 11.5 12.8 0.2 10.9 7.4 8.7 20.2 7.2 10.7 14.2 7.9 14.0 11.4 13.6 10.0 9.8 13.0 10.3 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.8 29.7 3.5 20.0 1.5 2.7 9.4 15.6 6.8 17.9 11.8 15.4 12.5 27.1 12.1 3.1 15.3 2.1 10.2 2.1 16.4 12.2 17.7 8.9 7.8 5.0 34.7 12.4 3.1 2.0 4.0 2.1 6.6 30.6 11.5 1.6 5.9 30.6 4.1 10.7 4.4 25.4 16.0 17.4 3.2 11.1 14.2 20.5 15.7 13.1 5.6 11.6 13.3 9.7 11.4 16.7 7.5 38.6 23.4 26.7 28.0 8.4 17.0 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 RXRA NR2B1 ENSG00000186350 "Retinoid X receptor alpha" P19793 9 134317098-134440585 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.9;non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 14.9;monocytes: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004565, CAB005352" Supported Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB004565: AB_2184877, CAB005352: AB_2184874" "unprognostic (2.68e-1)" "unprognostic (7.94e-2)" "unprognostic (3.67e-2)" "unprognostic (7.22e-2)" "unprognostic (2.07e-2)" "unprognostic (6.69e-2)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.65e-3)" "prognostic favourable (7.02e-4)" "unprognostic (7.72e-2)" "prognostic unfavourable (5.58e-4)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "unprognostic (1.49e-2)" "unprognostic (2.59e-1)" 18.5 10.1 9.9 10.4 6.7 19.6 36.8 4.6 9.8 11.0 9.3 4.9 8.1 14.0 10.1 6.1 24.2 9.3 12.9 14.2 9.0 3.7 11.7 49.3 12.8 10.4 6.0 7.0 11.7 20.6 8.0 10.7 9.6 9.4 9.7 2.0 9.5 9.3 9.7 45.8 19.0 15.2 10.6 9.5 11.5 8.8 5.9 8.1 1.5 13.6 18.3 5.9 16.0 23.7 0.1 1.7 14.9 12.3 1.3 1.1 1.8 5.5 15.6 2.0 5.0 3.5 3.3 24.0 3.0 3.5 4.3 2.5 8.6 8.7 0.0 8.2 4.3 27.0 0.7 10.6 0.2 7.9 2.0 0.0 19.0 13.1 4.5 6.5 2.4 5.3 4.5 5.4 2.5 3.7 10.7 0.5 1.0 14.9 0.5 1.4 3.8 5.4 2.8 7.4 10.8 0.2 24.1 4.4 2.0 9.5 9.1 2.4 12.6 8.9 4.8 5.3 6.4 5.7 2.6 0.7 0.0 0.1 4.0 6.6 3.4 1.1 5.2 2.8 1.1 9.3 0.0 0.1 0.7 0.7 1.7 0.0 0.2 0.9 14.9 1.3 12.3 0.1 0.9 1.8 9.9 6.7 4.6 9.8 9.0 3.7 6.0 7.0 9.4 8.1 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400917-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 28.3" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 89.8" "Low region specificity" "Detected in all" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: " "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favourable (9.40e-5)" "unprognostic (5.03e-2)" 1.9 3.9 5.4 1.0 14.9 0.6 1.0 0.3 5.9 4.0 2.5 5.3 0.6 1.3 1.8 1.3 1.7 3.6 1.2 5.8 7.5 8.9 0.7 0.8 3.4 0.8 4.1 4.3 1.7 2.7 0.8 29.8 1.3 14.1 1.1 2.7 13.5 1.9 2.1 44.8 2.9 2.0 1.8 8.9 1.0 1.1 1.5 5.4 0.0 1.1 2.5 0.6 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 14.9 0.3 5.9 7.5 8.9 4.1 4.3 14.1 5.4 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779803-63809558 "Disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA064014: " "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 9.7 19.6 10.3 9.8 11.3 5.7 14.7 8.2 13.6 10.3 9.3 10.6 11.3 7.8 9.2 20.8 9.6 10.9 9.6 21.1 9.8 11.4 15.2 20.1 11.9 14.8 10.7 8.0 17.4 33.4 20.2 19.0 10.5 9.5 12.1 10.1 12.4 17.0 14.5 14.7 11.1 8.2 12.2 13.1 10.6 8.1 16.1 9.0 9.1 17.2 10.7 9.7 11.8 8.1 6.6 7.2 1.8 3.6 4.7 7.0 2.2 7.5 14.1 9.9 8.4 8.7 11.7 11.5 8.5 12.4 12.8 8.5 5.1 7.3 16.4 14.9 8.9 7.0 12.0 10.9 15.3 17.0 12.2 8.9 4.0 8.1 13.2 13.5 7.8 10.4 10.9 12.4 16.2 7.1 9.9 14.0 19.3 12.2 7.3 5.6 6.0 18.0 7.4 11.6 8.8 12.2 10.1 24.6 4.3 8.9 6.8 16.9 14.4 6.8 8.1 11.5 11.8 7.1 11.7 9.3 13.3 11.5 7.8 8.2 15.1 1.2 3.1 1.8 4.0 2.9 6.9 6.6 4.4 4.8 3.0 4.2 5.9 4.8 0.6 4.7 3.6 7.2 7.0 2.2 10.3 11.3 8.2 13.6 9.8 11.4 10.7 8.0 9.5 9.0 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor-like tyrosine kinase" 3 134065303-134250744 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: , HPA075430: " "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 23.8 13.2 8.5 12.1 9.3 6.3 27.5 10.6 9.5 26.5 19.3 12.7 18.2 8.8 25.8 19.1 21.1 16.7 15.8 17.1 8.1 6.7 12.9 12.7 12.4 9.1 10.8 7.3 39.7 17.7 14.1 17.9 18.8 8.6 26.9 12.1 16.4 15.2 21.5 15.3 15.5 13.3 28.6 8.4 13.8 14.3 20.3 10.0 13.6 23.2 11.4 15.2 27.5 31.9 2.8 0.7 6.7 1.6 3.1 4.3 1.1 25.6 6.8 21.6 16.5 27.9 29.7 16.7 17.0 39.7 22.8 25.7 21.6 19.7 5.0 28.4 21.0 24.1 15.3 21.5 32.7 8.4 6.9 13.3 7.4 13.9 21.8 6.5 11.8 19.6 25.3 14.1 28.4 19.0 4.6 2.5 22.3 12.2 9.0 8.4 18.2 8.2 4.4 16.6 10.5 18.7 19.0 10.6 15.7 20.7 15.1 25.8 18.9 11.8 14.0 18.9 17.2 19.7 13.7 1.1 1.3 2.7 12.0 10.9 13.3 6.7 1.6 3.1 2.5 1.6 2.9 1.5 4.2 3.0 0.7 2.8 4.3 3.4 0.6 3.1 1.6 0.0 1.0 1.1 8.5 9.3 10.6 9.5 8.1 6.7 10.8 7.3 8.6 10.0 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell line enhanced" "Detected in some" "HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" Cytosol "HPA056416: " "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.7 0.0 13.7 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 11.3 1.0 0.6 0.0 0.0 1.1 22.3 0.0 0.0 0.5 4.2 0.0 0.0 9.4 0.2 0.0 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.3 0.5 0.0 0.0 7.7 10.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 2.7 3.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 99.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavourable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 22.1 18.6 21.5 13.6 19.0 55.8 7.7 30.8 48.9 18.7 21.5 18.0 24.8 0.5 58.6 52.3 21.2 8.9 19.2 16.5 0.0 8.3 1.4 23.3 15.3 12.6 0.6 4.8 44.8 7.3 16.7 18.1 42.2 7.1 0.0 58.0 78.7 0.0 0.4 17.3 56.1 3.5 22.3 0.1 99.4 17.0 6.6 0.2 66.0 34.0 66.6 27.7 0.8 59.7 12.9 7.2 17.2 37.1 0.2 0.5 1.0 23.1 0.3 7.5 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Group enriched" "Detected in some" 10 "A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.8 11.4 0.0 0.1 0.0 86.8 0.0 123.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 183.4 0.0 1.7 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 4.1 0.0 0.0 0.1 129.6 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 118.0;SK-BR-3: 143.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavourable (3.18e-4)" "prognostic unfavourable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavourable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.5 27.2 1.4 3.2 9.4 35.7 3.7 32.4 29.8 26.6 23.7 25.5 31.6 0.0 52.0 48.4 41.5 0.0 72.6 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 118.0 0.7 0.0 58.5 75.0 0.0 0.1 6.0 73.7 0.0 16.4 0.1 100.3 20.3 0.0 0.1 23.8 143.0 4.7 44.4 0.3 63.3 16.0 25.7 15.4 73.1 0.0 0.2 0.1 47.6 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Group enriched" "Detected in some" 5 "HBEC3-KT: 656.0;RT4: 256.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: " "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavourable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 24.8 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.2 0.5 61.7 0.0 656.0 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 87.4 0.7 99.7 0.4 0.0 0.0 1.4 0.1 0.0 0.0 0.0 4.8 0.0 15.6 0.0 15.5 256.5 0.5 0.0 1.0 0.1 0.2 0.1 0.1 0.1 0.3 21.7 2.9 8.4 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 44.7" "Cell line enhanced" "Detected in many" "A549: 33.4;HBEC3-KT: 17.8;HeLa: 21.7;U-2197: 19.5" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 10 "dendritic cells: 8.9;monocytes: 6.9" "Low region specificity" "Detected in many" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" 390000 Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: " "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavourable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 4.7 0.6 0.6 3.3 3.1 1.5 2.2 0.6 1.7 3.7 1.2 1.3 0.1 0.4 2.4 1.6 7.4 1.6 1.6 7.9 0.5 0.7 10.2 0.1 14.2 4.6 1.7 0.1 1.2 5.3 0.0 0.3 5.6 3.5 3.6 1.0 0.3 2.0 1.6 2.5 44.7 1.0 1.8 1.5 2.1 0.7 1.4 0.4 0.5 1.7 2.1 4.9 3.7 4.0 0.7 8.9 0.0 6.9 0.0 0.3 0.4 2.8 33.4 0.0 0.0 3.2 2.1 0.0 2.3 12.2 2.9 4.9 0.9 1.0 0.0 7.5 5.8 8.8 0.0 17.8 1.6 0.1 0.0 0.1 21.7 6.0 0.8 0.0 0.1 1.5 9.1 7.1 8.0 0.6 0.0 0.0 15.7 0.2 0.0 0.0 0.2 4.1 0.0 2.4 1.8 9.7 7.2 0.5 0.0 2.1 2.5 0.7 0.1 0.2 3.0 1.2 1.9 19.5 2.4 0.5 0.6 0.0 15.6 0.2 7.4 0.0 0.2 0.0 0.0 3.6 0.3 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.9 8.9 0.1 0.4 0.6 3.1 0.6 1.7 0.5 0.7 1.7 0.1 3.5 0.4 S100A6 "2A9, CABP, CACY, PRA" ENSG00000197956 "S100 calcium binding protein A6" P06703 1 153534599-153536244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 375.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002601, HPA007575, CAB040549, CAB047354" Enhanced Enhanced "Plasma membrane,Cytosol" 5100000 "Plasma membrane, Cytosol" "CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859" "unprognostic (8.80e-3)" "unprognostic (6.96e-2)" "unprognostic (2.31e-1)" "unprognostic (2.47e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-1)" "unprognostic (6.86e-3)" "unprognostic (1.66e-1)" "unprognostic (3.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.88e-1)" "unprognostic (1.46e-2)" "prognostic favourable (7.56e-4)" 126.4 32.6 14.8 104.9 29.9 73.8 223.6 13.3 14.6 95.4 176.8 10.1 51.2 70.2 65.0 135.5 126.5 42.2 264.5 112.3 13.0 22.5 103.4 6.0 151.9 61.5 45.6 7.9 38.1 13.5 0.5 17.7 100.1 27.3 85.1 85.5 28.5 58.7 55.2 59.1 45.1 98.1 88.9 35.5 27.5 69.9 29.6 17.8 4.9 76.9 183.0 36.2 150.9 145.0 30.7 130.1 303.7 180.7 9.1 69.2 201.7 77.6 86.9 0.0 7.2 146.3 189.8 0.2 95.2 237.8 48.3 63.4 6.0 162.4 0.1 30.2 141.3 33.7 1.5 136.7 22.8 31.9 0.0 16.2 58.1 5.3 55.4 0.7 11.2 88.5 113.7 51.7 89.5 107.1 0.0 0.1 120.3 11.7 0.2 6.6 0.1 143.0 0.0 10.8 28.1 375.0 72.1 22.4 3.9 129.5 131.9 97.9 18.1 25.2 156.4 46.7 12.2 95.3 154.5 0.2 0.2 0.2 181.3 17.4 99.6 139.8 180.7 74.1 62.0 96.8 67.3 30.7 58.5 60.3 130.1 17.2 37.3 49.5 303.7 9.1 86.9 68.3 69.2 201.7 14.8 29.9 13.3 14.6 13.0 22.5 45.6 7.9 27.3 17.8 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391188 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1" "Group enriched" "Detected in some" 28 "hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 320.7;neutrophil: 720.9" "Group enriched" "Detected in many" 8 "granulocytes: 720.9;monocytes: 320.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" 10876880 530000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavourable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 14.0 0.8 0.8 30.5 2.6 718.8 1.1 0.5 1.6 123.0 2.8 0.7 0.4 0.4 12.0 1.2 532.3 5.5 2.1 36.7 1.5 0.5 1.4 4.3 26.2 37.3 3.3 0.4 2.1 2.7 0.1 0.9 4.7 3.3 1.4 0.4 1.3 92.4 0.3 2.5 6.2 1.0 9.0 1.8 72.4 2.0 1.9 0.9 2.6 4.6 597.1 257.6 5.0 224.1 0.6 63.7 720.9 320.7 0.3 0.6 244.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.6 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 27.5 0.0 0.9 0.0 1.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 100.9 0.0 0.6 53.6 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.6 0.0 8.2 320.7 38.9 0.4 26.5 0.6 0.6 0.3 0.2 63.7 0.3 0.3 0.3 720.9 0.3 6.4 2.5 0.4 244.7 0.8 2.6 0.5 1.6 1.5 0.5 3.3 0.4 3.3 0.9 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 227.6" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" 10597950 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavourable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 35.7 0.0 2.1 0.0 14.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.4 0.0 0.8 0.0 0.6 0.3 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.4 7.5 0.0 9.2 0.1 0.0 0.3 227.6 0.1 3.6 28.9 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.5 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 81.0;WM-115: 159.2" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 81.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 159.2 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 S1PR2 "AGR16, DFNB68, EDG5, Gpcr13, H218" ENSG00000267534 "Sphingosine-1-phosphate receptor 2" O95136 19 10221433-10231331 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 14.3;Daudi: 25.2;U-266/70: 18.9;U-698: 27.3;WM-115: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 23.7" "Group enriched" "Detected in many" 7 "granulocytes: 23.7;T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014255, HPA014307" Approved Uncertain "Nuclear speckles,Golgi apparatus" "Golgi apparatus" "Nuclear speckles" "HPA014255: , HPA014307: AB_1847989" "unprognostic (5.38e-3)" "unprognostic (1.83e-3)" "unprognostic (1.20e-1)" "unprognostic (1.26e-2)" "unprognostic (3.31e-2)" "unprognostic (1.05e-3)" "unprognostic (8.50e-2)" "unprognostic (8.71e-2)" "unprognostic (2.84e-1)" "unprognostic (1.70e-1)" "unprognostic (7.40e-3)" "unprognostic (1.47e-2)" "prognostic unfavourable (4.36e-10)" "unprognostic (4.91e-2)" "unprognostic (4.56e-2)" "unprognostic (3.11e-1)" "unprognostic (8.09e-2)" 17.1 2.3 1.4 13.7 1.3 0.9 7.2 0.9 1.5 13.3 4.1 1.7 3.9 1.8 8.3 9.2 6.4 7.9 6.5 6.1 1.3 1.5 2.4 9.5 11.2 10.6 1.3 0.0 12.9 2.6 3.9 2.2 31.3 1.7 9.8 2.5 3.2 9.4 5.7 3.4 4.0 3.9 8.7 1.7 2.2 4.2 21.8 1.0 2.0 3.3 6.3 15.6 8.0 12.0 0.3 1.6 23.7 1.9 2.1 7.4 1.2 1.4 0.2 1.6 3.3 9.2 11.2 14.3 2.1 4.3 0.9 2.0 0.9 0.8 25.2 2.5 3.9 0.8 0.6 1.0 0.6 2.5 1.3 0.6 0.6 0.6 3.0 0.7 0.5 6.1 0.5 1.8 0.6 0.1 0.6 5.5 0.6 1.1 0.3 1.2 1.7 0.8 1.7 0.7 0.9 0.8 1.2 1.2 2.3 1.2 0.7 1.7 0.6 0.6 0.2 3.5 1.1 7.8 0.6 18.9 8.9 27.3 1.3 1.3 18.7 23.7 1.9 0.4 4.9 1.5 5.9 0.2 6.2 4.6 1.6 0.3 2.6 2.6 0.5 2.1 0.6 0.2 7.4 1.2 1.4 1.3 0.9 1.3 1.3 1.5 1.3 0.0 1.7 1.0 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745424 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" 8400000 "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: " "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favourable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 18.4 24.9 22.0 18.9 23.3 14.9 18.2 23.3 26.3 19.0 19.4 16.4 21.2 18.9 22.6 19.3 17.0 18.1 16.6 15.6 21.8 22.8 31.9 22.7 23.2 19.9 20.5 24.9 15.7 18.3 25.1 31.9 21.2 28.7 21.1 20.1 17.7 20.0 18.2 12.7 14.7 20.4 17.0 22.2 20.9 20.5 11.0 19.6 26.8 35.8 8.5 19.7 20.9 20.9 5.8 13.7 13.4 8.7 30.1 14.9 13.4 10.8 8.1 15.2 8.5 25.9 17.8 11.7 16.6 17.7 15.7 13.5 10.8 8.8 17.7 9.6 16.0 8.5 18.7 11.3 20.2 11.1 11.3 18.2 13.4 10.4 14.0 27.3 22.4 11.7 17.8 15.9 12.2 10.7 20.0 18.3 25.6 5.3 23.2 15.0 16.2 16.6 6.1 7.9 16.7 17.2 15.9 6.0 14.4 11.5 15.2 17.6 11.4 26.4 12.1 14.3 7.9 14.4 17.1 10.5 25.5 12.7 16.7 42.3 14.3 4.3 8.7 13.4 13.6 7.0 14.9 5.8 9.8 13.6 13.7 5.3 10.1 13.1 7.1 30.1 6.0 5.7 8.2 13.4 22.0 23.3 23.3 26.3 21.8 22.8 20.5 24.9 28.7 19.6 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: " "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favourable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favourable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favourable (2.12e-4)" 25.7 29.6 31.0 29.6 33.7 35.4 17.4 50.8 46.2 27.4 21.6 28.4 23.1 25.8 30.2 27.4 15.7 26.8 19.4 21.0 30.3 24.6 32.2 20.0 18.2 26.8 30.5 26.5 42.8 24.2 31.0 38.4 17.3 28.6 28.4 20.9 21.3 23.6 34.8 38.1 18.9 25.7 24.8 43.4 29.4 20.1 23.4 34.3 23.5 26.9 11.1 25.2 24.1 32.7 11.4 9.3 24.3 9.5 6.4 13.3 5.6 17.8 23.3 17.0 12.5 16.6 10.7 19.8 17.0 9.2 10.6 10.1 29.6 12.9 34.1 15.5 8.5 16.4 20.6 10.6 17.6 23.7 22.1 25.9 23.7 22.9 9.7 21.6 24.5 10.6 11.3 15.6 12.1 10.4 24.8 17.3 12.5 19.9 25.8 20.7 29.0 24.7 32.8 14.7 19.0 12.0 30.5 16.0 14.9 22.5 10.3 13.7 15.3 13.3 16.4 13.2 13.8 16.5 23.1 23.0 20.4 24.8 13.5 18.8 21.5 24.3 9.5 15.8 11.9 8.2 13.3 10.3 10.5 9.2 8.3 11.4 11.7 9.1 18.3 6.4 8.5 9.3 9.5 5.6 31.0 33.7 50.8 46.2 30.3 24.6 30.5 26.5 28.6 34.3 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 10.9" "Cell line enhanced" "Detected in some" "AN3-CA: 14.7;K-562: 10.6;Karpas-707: 18.4;U-2 OS: 5.2;U-266/70: 6.4;U-266/84: 16.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.4 16.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Cell line enhanced" "Detected in some" "AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: , HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favourable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favourable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 14.8 0.1 0.4 0.3 0.0 4.9 12.7 0.3 0.7 0.0 0.0 0.0 5.7 6.9 0.0 9.2 0.0 0.4 0.0 5.6 0.0 0.0 8.9 0.3 0.0 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 1.8 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 23.5 0.0 4.9 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell line enhanced" "Detected in many" "AF22: 46.1;NTERA-2: 34.8;SCLC-21H: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004162: " "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favourable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.1 11.5 0.8 0.7 0.0 1.0 1.4 3.6 3.0 0.8 0.6 0.0 1.0 1.3 0.1 11.2 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 0.9 7.5 0.0 2.9 0.8 7.1 0.0 34.8 0.2 6.7 1.1 0.0 3.3 4.8 15.7 8.8 0.0 0.2 0.1 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087840-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" Cytosol Mitochondria "HPA041662: , HPA049059: " "unprognostic (2.93e-2)" "prognostic favourable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavourable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavourable (7.98e-5)" "prognostic favourable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 16.0 9.5 23.5 17.4 20.2 19.6 47.9 17.2 21.2 15.3 21.3 19.7 12.2 20.6 14.7 9.8 18.2 14.0 12.8 16.8 21.2 17.9 13.1 11.1 15.9 20.1 20.9 10.3 14.5 20.3 7.2 7.3 11.3 16.5 12.7 15.5 7.8 15.4 16.1 27.2 25.9 21.5 12.4 21.3 18.0 16.7 11.4 16.1 79.1 14.8 10.8 17.9 12.9 20.5 3.5 2.3 4.5 2.9 8.0 2.7 1.5 22.6 17.3 15.2 21.5 9.6 9.8 23.2 12.5 3.0 12.7 10.3 13.0 11.2 39.5 17.0 8.1 18.4 16.6 9.3 6.5 26.4 13.7 17.2 22.9 23.4 8.6 10.1 10.8 6.8 15.5 8.8 3.0 7.5 20.9 10.8 7.4 34.1 21.5 39.9 31.3 15.3 29.3 13.5 28.3 10.8 11.0 28.0 28.0 11.0 15.0 8.3 9.4 21.8 8.1 22.4 20.6 22.4 15.7 20.5 17.6 32.6 13.4 27.7 9.0 0.3 2.9 4.5 1.7 0.9 2.0 3.5 1.9 2.0 2.3 2.1 2.7 2.0 0.5 8.0 1.0 1.8 2.1 1.5 23.5 20.2 17.2 19.6 21.2 17.9 20.9 10.3 16.5 16.1 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923928-944581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEK 293: 37.9;HeLa: 41.9;SCLC-21H: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 10 "NK-cells: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA030110 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 2.1 10.0 2.4 5.0 3.0 1.0 1.6 1.6 4.7 4.4 3.0 7.2 2.5 5.1 9.5 7.4 4.2 13.6 4.5 8.5 5.7 4.0 10.0 2.9 2.4 2.1 6.9 2.0 5.9 1.8 0.6 21.9 0.6 5.9 12.4 1.4 16.9 2.4 22.1 1.4 0.3 5.6 6.0 8.8 11.7 5.5 2.7 5.1 0.3 4.6 0.6 0.5 7.2 22.8 0.3 0.0 0.0 0.2 4.7 0.4 0.0 0.1 2.6 0.0 2.4 0.1 0.0 0.8 4.1 0.2 0.2 0.1 0.1 0.8 0.0 8.0 8.5 5.3 2.7 0.0 0.0 0.3 37.9 0.0 41.9 0.1 0.7 0.0 0.3 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.0 0.0 1.6 0.3 0.2 0.5 2.2 0.4 0.0 27.3 8.4 8.6 4.1 0.0 4.8 0.2 0.5 1.4 6.3 0.0 0.9 0.5 0.0 0.1 1.8 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.3 0.2 0.2 0.0 0.1 0.1 0.4 0.0 4.7 0.1 0.0 0.0 0.0 2.4 3.0 1.6 4.7 5.7 4.0 6.9 2.0 5.9 5.1 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189459-118621995 "Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.2;U-266/70: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 6.8;dendritic cells: 4.3;T-cells: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favourable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 2.1 3.0 14.1 3.1 16.2 1.1 5.0 13.8 20.2 4.6 6.9 7.7 8.9 7.1 2.7 8.0 9.7 8.8 6.7 10.8 10.8 7.0 8.3 4.0 6.2 2.3 9.6 13.7 2.1 4.7 12.7 20.8 0.9 13.7 6.3 8.1 2.6 5.7 12.8 2.0 2.3 4.8 1.9 10.9 4.2 9.5 3.2 8.6 0.7 15.8 2.5 4.5 10.8 3.0 6.8 4.3 0.2 0.0 1.1 3.7 0.9 7.4 0.3 0.6 0.0 0.0 0.0 2.0 3.5 5.4 6.2 3.2 1.6 7.0 10.3 0.7 4.3 1.8 2.4 4.0 9.0 0.2 0.8 0.1 4.6 0.0 0.0 0.0 0.3 0.2 1.3 4.5 0.7 0.2 0.0 6.1 3.1 1.8 2.2 0.0 1.0 1.1 0.0 0.0 7.2 2.8 11.2 3.2 0.0 2.2 23.2 0.3 1.7 0.0 0.0 0.1 3.0 1.3 0.8 11.9 9.7 0.8 1.4 0.0 1.2 0.1 0.0 0.0 0.6 0.0 3.7 6.8 2.6 1.7 0.3 2.9 3.7 1.8 0.2 1.1 0.0 4.3 2.4 0.9 14.1 16.2 13.8 20.2 10.8 7.0 9.6 13.7 13.7 8.6 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: " "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 3.9 0.0 1.0 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.6 1.0 0.1 0.2 0.0 0.1 10.6 0.1 6.7 0.2 0.0 0.6 0.0 22.7 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 3.6 10.7 0.0 0.0 0.0 0.2 0.1 0.1 0.4 1.4 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Cell line enhanced" "Detected in many" "MCF7: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.5 4.8 1.9 4.0 0.5 2.1 1.8 1.4 1.3 3.9 3.5 3.5 3.2 3.9 1.6 1.4 3.4 1.4 2.0 5.4 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.2 1.9 1.3 3.3 0.4 2.6 0.4 1.2 1.6 10.6 0.9 0.4 0.8 1.5 1.7 1.8 0.2 6.8 1.9 4.2 2.6 5.0 0.8 0.7 6.3 1.2 1.0 3.7 2.2 3.8 1.9 0.6 3.2 2.6 4.6 0.2 1.8 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54567097-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.7;testis: 44.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.9;non-classical monocyte: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" "Cell Junctions" Cytosol "HPA043061: , HPA065309: " "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 7.5 2.9 7.8 9.0 6.0 0.5 4.0 5.6 7.0 8.9 10.1 8.0 3.0 2.3 11.1 5.5 5.4 4.2 6.5 28.2 5.5 7.3 2.5 7.6 6.4 2.9 10.6 5.2 2.1 4.1 4.8 2.0 6.0 10.8 7.7 3.3 3.4 2.4 6.3 48.7 2.6 3.3 23.8 26.5 4.6 3.9 44.6 6.1 0.7 2.4 1.3 4.8 15.9 5.8 0.9 2.6 0.0 3.9 0.0 0.4 0.8 16.7 1.7 3.3 1.7 7.1 11.3 6.2 14.6 21.0 11.6 11.9 17.3 4.0 1.0 7.5 20.2 11.7 3.2 7.3 16.4 9.6 1.6 0.0 2.0 3.5 4.0 0.0 0.1 6.3 2.5 8.3 12.4 9.0 1.3 0.0 5.4 1.1 0.2 0.0 1.6 4.1 0.5 6.7 0.0 5.4 5.4 0.5 5.5 2.3 2.8 7.6 11.1 0.2 18.3 13.8 22.8 3.4 4.5 0.1 0.0 0.0 3.9 0.3 4.4 0.0 2.3 0.0 0.0 3.9 0.0 0.3 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.8 7.8 6.0 5.6 5.7 5.5 7.3 10.6 5.2 10.8 6.1 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.6;lymphoid tissue: 35.4" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavourable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavourable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavourable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 9.6 4.0 2.3 9.2 2.4 5.2 2.6 1.0 1.6 9.3 6.8 0.6 0.9 4.3 2.8 3.0 34.6 2.7 4.3 2.5 1.3 1.5 6.3 3.5 7.8 10.8 2.5 1.1 6.3 2.3 0.1 6.4 11.3 3.1 5.3 7.0 0.7 5.7 1.6 2.4 1.5 12.7 2.2 2.5 21.7 6.3 2.5 1.7 35.4 3.3 9.9 9.5 4.8 9.7 5.5 3.0 15.6 9.8 7.4 7.6 2.6 12.2 1.6 0.4 0.1 5.5 7.0 0.1 4.8 20.1 23.0 30.5 0.1 13.6 5.1 7.6 11.8 14.5 0.0 4.4 7.8 17.4 0.6 7.4 8.2 0.0 2.5 8.3 10.4 3.1 6.4 7.6 2.1 3.4 0.5 12.8 4.8 0.0 12.3 6.8 0.0 3.5 4.1 4.1 5.8 0.1 1.5 2.0 0.2 3.7 1.4 3.9 0.4 4.1 14.8 5.4 1.9 16.1 2.6 7.6 1.4 4.7 5.6 4.9 5.3 15.6 3.6 12.7 7.6 7.0 7.3 5.0 5.9 6.5 3.0 5.5 6.3 5.7 15.5 7.4 9.8 2.1 7.2 2.6 2.3 2.4 1.0 1.6 1.3 1.5 2.5 1.1 3.1 1.7 SAMHD1 "AGS5, HDDC1, Mg11, MOP-5, SBBI88" ENSG00000101347 "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" Q9Y3Z3 20 36889773-36951901 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity" "Allosteric enzyme, Hydrolase" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 57.2;BJ hTERT+ SV40 Large T+: 24.3;BJ hTERT+ SV40 Large T+ RasG12V: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 46.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047072 Enhanced Supported "Nucleoplasm,Plasma membrane" 100000 Nucleoplasm "Plasma membrane" "HPA047072: " "unprognostic (1.09e-1)" "unprognostic (7.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (4.07e-2)" "unprognostic (2.03e-1)" "unprognostic (3.63e-1)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.44e-1)" "unprognostic (9.06e-2)" "unprognostic (3.18e-2)" "unprognostic (2.72e-2)" 54.3 18.6 8.7 31.8 13.0 9.9 35.9 4.9 9.7 14.5 21.2 9.0 8.7 15.8 13.5 20.2 24.1 33.4 15.3 25.4 8.7 6.0 12.5 12.4 25.7 48.3 14.5 4.9 22.1 18.1 4.9 22.4 13.7 10.2 14.0 13.2 11.6 14.7 9.7 9.2 11.4 20.6 21.3 13.7 40.7 19.2 15.1 15.0 9.7 14.9 10.7 18.5 23.2 50.2 0.4 46.7 2.8 23.4 6.0 10.9 19.1 3.8 1.5 0.7 1.5 57.2 10.9 0.7 2.3 4.2 24.3 26.0 4.8 1.3 8.2 3.3 1.5 3.0 6.0 2.8 5.1 2.4 2.0 0.4 2.1 2.5 5.0 4.7 1.4 13.3 0.1 8.5 0.2 3.1 1.5 1.9 0.5 1.2 0.0 1.7 0.7 3.2 0.2 3.9 3.1 0.9 0.6 2.9 0.4 3.0 1.1 2.9 1.4 7.5 0.8 1.9 2.1 2.0 3.4 1.1 3.0 3.4 1.6 0.4 0.6 0.2 19.4 0.6 6.1 23.4 5.6 0.4 6.9 6.4 46.7 0.4 8.5 6.3 2.8 6.0 20.4 11.0 10.9 19.1 8.7 13.0 4.9 9.7 8.7 6.0 14.5 4.9 10.2 15.0 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6" "Group enriched" "Detected in some" 4 "HEL: 59.5;K-562: 70.8;Karpas-707: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 53.6;eosinophil: 49.9" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in some" 7 "olfactory region: 25.4" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: " "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 14.4 3.9 5.8 33.0 10.4 72.1 4.2 1.1 5.1 2.9 4.7 4.9 0.0 3.1 3.4 4.6 4.1 6.8 10.1 5.1 4.4 3.4 5.9 7.2 27.9 28.3 11.1 1.4 3.3 2.3 1.0 2.7 6.7 6.7 4.1 7.0 3.4 3.4 1.2 1.6 1.9 13.6 4.7 17.5 43.6 5.0 2.4 7.1 12.6 2.6 2.8 16.7 11.8 4.5 6.5 5.6 53.6 17.3 3.7 12.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 59.5 0.0 0.0 0.0 7.0 2.9 0.0 0.0 0.0 8.8 0.8 70.8 30.9 0.0 0.0 3.3 8.5 0.0 0.0 5.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.7 0.0 0.0 0.0 0.0 13.3 0.1 0.0 0.3 4.5 0.0 53.6 8.8 49.9 5.3 11.6 3.6 6.5 10.3 7.8 5.6 2.6 6.6 4.6 11.0 3.7 17.3 0.2 12.9 6.8 5.8 10.4 1.1 5.1 4.4 3.4 11.1 1.4 6.7 7.1 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 35.3 67.0 55.2 45.3 57.4 81.0 38.0 35.2 49.1 30.0 44.8 43.9 37.6 53.1 37.5 40.3 59.5 32.4 33.0 66.3 68.4 61.3 63.2 47.5 34.8 41.7 64.9 50.2 37.3 52.3 16.2 38.8 43.1 54.9 34.4 23.8 26.4 50.1 34.5 121.6 31.4 48.6 48.1 73.5 31.6 41.6 79.2 49.3 34.0 34.9 51.0 24.4 37.3 48.6 90.1 107.4 97.9 96.4 70.0 94.1 143.8 30.0 17.0 27.5 29.7 29.9 25.1 42.7 38.5 28.6 35.7 26.4 30.6 58.3 31.2 47.6 31.8 31.6 33.8 24.1 40.4 47.6 17.1 44.4 22.4 50.6 34.0 60.3 36.0 25.2 27.6 27.2 32.7 26.8 21.0 17.8 32.2 38.4 68.0 99.1 34.6 18.7 43.2 43.5 31.0 50.0 27.0 32.1 28.0 24.7 36.8 47.6 35.6 88.5 32.5 22.0 24.5 39.8 44.8 27.7 38.5 85.9 21.4 35.9 40.3 69.6 82.9 97.9 70.0 89.0 70.6 90.1 86.2 82.4 81.2 77.6 84.2 83.2 83.4 70.0 96.4 107.4 94.1 143.8 55.2 57.4 35.2 49.1 68.4 61.3 64.9 50.2 54.9 49.3 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762799-31764851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.8;skin 1: 14.7" "Cell line enhanced" "Detected in some" "HeLa: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA071699 Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA071699: " "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 0.8 0.3 0.7 1.6 1.0 4.8 1.8 0.7 1.3 2.0 1.0 1.3 0.7 0.2 1.2 0.8 0.7 1.8 2.5 0.7 0.7 0.8 3.2 0.9 1.4 2.5 1.9 0.7 1.6 0.7 0.2 2.9 3.3 3.9 2.6 1.1 8.8 0.7 1.6 0.7 14.7 1.5 0.7 3.1 2.1 0.8 1.2 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.0 0.5 0.2 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.5 0.4 0.8 0.8 0.5 0.2 0.2 0.0 2.9 1.0 0.8 0.1 0.2 1.7 0.0 0.8 0.1 0.0 3.2 3.9 7.7 1.1 0.2 0.4 0.1 0.2 0.0 1.2 1.4 0.5 0.5 1.2 0.0 3.9 2.9 2.4 0.0 0.9 0.4 0.9 0.0 0.6 0.7 1.2 0.6 0.3 0.7 0.5 0.3 0.0 0.3 0.1 3.1 0.0 0.3 2.2 2.1 2.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.7 1.0 0.7 1.3 0.7 0.8 1.9 0.7 3.9 0.7 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavourable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.4 8.9 3.5 10.5 0.1 0.2 19.0 2.7 1.8 2.9 1.3 16.9 7.6 17.2 8.9 1.3 23.5 11.1 3.1 0.6 11.9 12.8 7.5 9.9 18.9 0.0 8.5 13.1 0.0 0.5 1.0 1.9 4.7 10.4 7.8 0.8 38.9 2.4 23.1 6.6 20.4 26.4 13.5 19.2 3.6 4.8 18.5 10.9 10.5 29.4 4.0 23.7 16.3 3.0 2.6 9.1 8.0 13.4 2.7 7.8 8.3 6.2 10.2 8.4 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063012-30083208 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" 17000 "Endoplasmic reticulum" "Rods & Rings" "HPA040400: " "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favourable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 30.7 80.7 58.1 37.3 69.0 57.8 62.1 45.8 89.0 40.9 32.8 35.8 49.3 26.9 35.0 65.9 20.2 42.9 39.5 34.3 57.5 80.9 38.7 67.0 39.1 77.7 59.1 49.8 60.6 67.8 44.6 48.9 61.6 53.4 45.6 28.1 26.1 69.4 45.5 29.7 18.4 30.7 30.4 62.4 36.4 38.7 21.3 35.4 50.3 50.0 16.0 36.0 35.4 37.3 36.9 30.2 96.2 36.9 29.0 99.7 91.0 21.7 15.5 19.7 13.0 33.8 23.5 15.0 26.9 38.7 23.4 30.3 8.3 24.4 14.7 39.6 29.2 19.3 19.8 22.3 19.3 7.8 14.4 20.2 11.0 10.7 34.0 6.4 24.1 36.6 41.9 26.3 21.7 32.5 23.6 31.6 17.7 8.2 23.6 10.6 17.4 16.8 19.0 13.0 20.2 32.5 8.9 8.5 30.3 23.5 23.4 30.1 20.2 13.6 23.1 15.7 45.0 7.1 8.8 22.3 20.3 13.4 38.9 17.5 25.4 96.2 30.1 50.8 41.3 28.9 45.2 27.0 59.4 47.5 30.2 36.9 99.7 67.4 58.4 29.0 36.9 25.1 53.5 91.0 58.1 69.0 45.8 89.0 57.5 80.9 59.1 49.8 53.4 35.4 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA052730: , HPA056957: " "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.6 17.3 6.9 4.1 2.9 6.0 9.6 4.0 5.4 9.4 7.5 14.1 7.1 6.4 5.8 5.6 5.4 7.3 11.4 2.4 5.5 9.3 12.8 7.5 12.1 6.9 11.0 12.8 9.0 6.2 6.2 4.2 6.6 11.0 6.4 4.8 12.2 8.2 10.0 7.0 3.5 11.9 6.2 7.0 10.0 13.9 11.9 7.6 5.3 14.4 3.6 7.4 7.4 4.2 5.9 6.7 4.6 3.9 4.6 2.7 5.1 3.7 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "SART1, U4/U6.U5 tri-snRNP-associated protein 1" O43290 11 65961689-65979828 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 22.3 17.5 26.4 25.0 27.8 50.7 21.7 28.5 27.2 21.4 19.6 17.7 20.9 22.7 26.3 17.4 19.0 20.3 20.7 19.5 23.8 16.8 15.8 18.2 19.0 26.2 23.0 25.7 26.8 28.4 22.5 19.2 22.4 25.2 18.1 12.0 15.9 27.1 27.2 34.6 26.2 19.9 27.9 29.2 29.2 20.3 20.4 25.6 24.0 20.5 19.1 19.0 20.6 41.3 5.9 5.8 12.1 5.3 4.1 8.1 2.7 22.5 27.3 12.5 16.8 12.3 9.8 19.2 17.5 12.4 20.3 13.3 19.7 15.7 25.7 20.2 15.2 22.2 15.7 16.0 10.3 20.6 15.6 29.7 19.4 18.2 18.5 25.6 25.0 12.3 12.3 18.8 16.9 12.6 18.7 18.3 11.6 40.7 32.9 36.9 21.3 26.1 36.2 18.2 27.0 8.4 15.1 14.2 20.1 16.6 17.1 20.3 19.1 20.9 18.7 25.4 25.1 24.9 24.5 28.0 21.8 22.5 21.1 13.0 21.5 2.0 4.5 12.1 7.1 5.3 6.0 5.9 8.0 7.4 5.8 5.4 5.9 6.6 6.3 4.1 3.1 4.9 8.1 2.7 26.4 27.8 28.5 27.2 23.8 16.8 23.0 25.7 25.2 25.6 SASH1 "dJ323M4.1, KIAA0790, SH3D6A" ENSG00000111961 "SAM and SH3 domain containing 1" O94885 6 148272304-148552050 "Predicted intracellular proteins" "Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.9;ASC TERT1: 22.3;WM-115: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 32 "monocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029947, HPA029949" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029947: AB_10598915, HPA029949: AB_10602280" "unprognostic (9.71e-2)" "unprognostic (4.74e-2)" "unprognostic (5.32e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (3.55e-2)" "unprognostic (4.79e-3)" "unprognostic (6.69e-2)" "unprognostic (4.76e-2)" "unprognostic (2.06e-1)" "unprognostic (8.65e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-1)" "unprognostic (2.13e-3)" "unprognostic (5.45e-2)" "unprognostic (3.53e-1)" "unprognostic (8.04e-3)" "unprognostic (1.54e-1)" 41.4 5.4 19.6 5.3 21.7 0.7 25.7 9.9 28.1 16.8 9.2 22.2 4.4 5.6 11.2 9.3 35.6 10.0 15.6 13.2 21.9 14.2 13.5 7.7 16.7 4.7 26.3 11.4 5.3 7.7 15.0 3.5 23.5 22.8 9.8 8.3 9.2 12.2 8.1 10.6 17.5 6.7 13.2 28.6 10.3 6.0 4.8 22.3 0.2 30.9 10.4 8.2 13.2 17.9 0.0 0.0 0.1 5.5 0.0 0.1 0.6 1.3 0.8 6.8 2.2 58.9 22.3 1.1 7.7 18.7 5.9 9.0 1.7 1.6 0.0 4.1 20.6 1.6 2.0 1.8 4.9 0.0 1.5 0.0 3.9 1.5 1.8 0.0 0.3 10.3 1.9 8.8 2.4 21.3 0.1 0.0 5.5 1.5 0.0 0.0 2.0 1.0 0.0 4.9 0.0 4.3 4.2 0.2 0.0 2.3 8.8 6.1 0.6 3.9 18.5 5.7 1.1 18.2 1.6 0.0 0.0 0.0 9.2 0.0 27.2 0.1 2.9 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.6 19.6 21.7 9.9 17.9 21.9 14.2 26.3 11.4 22.8 22.3 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell line enhanced" "Detected in some" "Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favourable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 31.3 23.8 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.9 40.0 0.0 31.1 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 SASS6 "DKFZp761A078, FLJ22097, SAS-6, SAS6" ENSG00000156876 "SAS-6 centriolar assembly protein" Q6UVJ0 1 100083563-100132955 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028187 Uncertain Supported "Centriolar satellite,Cytosol" "Centriolar satellite" Cytosol "HPA028187: AB_10602220" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (3.07e-2)" "unprognostic (2.06e-2)" "unprognostic (1.31e-1)" "unprognostic (3.02e-3)" "unprognostic (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (8.43e-3)" "unprognostic (4.73e-2)" "unprognostic (6.56e-2)" "unprognostic (3.71e-2)" "unprognostic (7.76e-8)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (1.20e-1)" "unprognostic (2.54e-1)" 6.2 3.8 3.8 6.1 5.4 10.9 5.9 17.8 6.9 6.4 6.1 5.0 8.3 6.4 4.8 5.5 6.2 4.3 2.5 3.2 5.4 3.5 3.3 3.5 3.3 8.5 5.5 3.3 5.3 4.2 10.2 12.0 5.9 5.8 6.9 6.4 3.1 5.1 4.8 3.8 4.5 7.0 4.9 6.2 7.3 4.6 15.0 6.9 17.1 4.6 5.0 7.7 4.5 4.8 5.1 1.4 8.1 2.3 2.3 3.6 1.4 11.2 3.8 9.3 8.9 1.1 2.0 13.5 7.1 3.5 9.4 11.3 5.9 6.1 12.1 6.2 2.9 10.5 12.5 4.3 12.7 6.7 12.6 10.3 8.2 7.6 0.6 17.4 10.4 1.0 2.0 7.8 6.9 4.9 16.6 12.0 4.3 3.3 15.5 8.4 12.0 7.7 11.1 18.1 6.3 4.5 5.2 6.6 9.9 7.1 11.6 6.0 5.7 10.5 2.4 6.5 8.3 7.6 10.0 6.0 12.2 17.0 5.4 11.5 3.6 8.1 1.2 4.8 3.5 2.3 3.6 5.1 3.4 2.9 1.4 3.9 3.1 3.0 3.5 2.3 1.7 1.4 3.1 1.4 3.8 5.4 17.8 6.9 5.4 3.5 5.5 3.3 5.8 6.9 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345387-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "lymphoid tissue: 331.6" "Cell line enhanced" "Detected in many" "HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 37.9" "Group enriched" "Detected in many" 6 "NK-cells: 18.6;T-cells: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favourable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favourable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 6.7 5.3 11.8 11.7 11.0 16.4 5.9 10.1 22.7 5.6 15.1 3.6 16.1 6.8 5.9 11.1 5.3 8.0 7.7 10.9 10.8 8.1 5.4 7.2 7.6 25.9 10.0 15.6 6.2 14.8 22.4 12.9 1.8 6.6 10.1 8.2 5.9 17.9 26.2 35.7 9.2 11.3 12.1 8.1 11.5 10.4 2.9 4.5 331.6 11.3 4.6 11.8 18.7 11.0 4.7 1.2 4.7 0.6 18.6 37.9 7.9 0.4 0.0 2.6 0.0 3.7 3.6 0.3 0.7 2.5 0.6 2.1 0.1 4.7 0.9 0.0 0.8 0.0 9.6 1.1 1.2 92.0 5.8 0.0 0.2 0.0 0.5 5.3 0.8 1.6 0.8 0.0 0.1 0.6 0.1 5.1 0.4 0.0 21.5 6.8 3.9 0.3 25.7 1.3 0.9 1.0 3.2 1.2 7.3 0.0 0.8 0.0 20.6 39.3 0.3 2.7 1.7 1.2 0.7 0.2 0.0 2.0 2.2 20.7 1.2 4.7 0.5 1.3 14.3 0.6 25.8 0.5 9.7 7.4 1.0 4.7 37.9 22.6 1.2 18.6 0.3 1.2 1.7 7.9 11.8 11.0 10.1 22.7 10.8 8.1 10.0 15.6 6.6 4.5 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.8" "Cell line enhanced" "Detected in many" "HaCaT: 12.0;K-562: 11.0;SCLC-21H: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.3 4.1 1.3 5.4 0.7 2.8 4.4 5.3 2.7 1.2 3.5 5.0 0.9 2.1 14.8 0.7 46.8 1.9 1.4 5.5 2.8 2.3 1.1 9.1 1.1 3.1 2.8 9.2 2.6 4.7 11.5 0.7 5.6 2.4 1.8 1.6 2.3 3.0 1.2 1.9 1.6 0.9 2.3 1.3 2.3 18.0 3.7 1.0 3.1 0.1 1.6 1.0 1.2 6.7 1.3 5.3 0.2 3.2 2.7 0.5 1.6 2.1 1.3 4.8 1.1 2.2 0.6 0.5 0.4 0.9 1.8 0.2 2.6 1.6 1.2 0.0 12.0 2.1 1.8 2.1 1.1 7.8 0.5 3.7 0.0 0.1 0.4 0.5 1.5 2.6 1.7 1.4 1.9 11.0 0.9 1.2 1.1 0.6 0.0 3.2 0.9 1.5 0.6 1.0 0.9 1.1 9.2 1.4 1.3 0.0 1.7 4.6 0.4 0.2 2.3 1.4 4.9 0.9 2.5 2.7 1.0 2.2 0.6 1.5 0.0 0.1 5.3 1.1 0.0 1.4 2.5 0.4 2.7 0.1 6.7 1.8 0.8 0.1 3.2 0.2 1.3 0.1 0.5 4.1 5.4 4.4 5.3 5.5 2.8 3.1 2.8 5.6 3.7 SBDS "CGI-97, FLJ10917, SDS, SWDS" ENSG00000126524 "SBDS, ribosome maturation factor" Q9Y3A5 7 66987677-66995601 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028891 Approved Supported Nucleoplasm,Cytosol 55000 "Nucleoplasm, Cytosol" "HPA028891: AB_10601500" "prognostic unfavourable (1.49e-4)" "unprognostic (1.87e-2)" "unprognostic (5.73e-2)" "unprognostic (1.71e-3)" "unprognostic (8.06e-3)" "prognostic unfavourable (3.65e-4)" "unprognostic (1.07e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (6.99e-2)" "unprognostic (7.84e-3)" "unprognostic (4.59e-1)" "unprognostic (1.04e-2)" "unprognostic (9.38e-3)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (5.06e-3)" 40.9 34.5 37.7 18.7 44.0 41.7 44.5 23.6 43.2 30.7 37.5 35.3 20.2 39.1 35.6 27.3 40.8 27.7 34.0 70.0 39.2 40.9 36.9 38.4 32.1 16.7 50.6 36.6 31.9 27.5 50.4 26.9 38.6 44.6 35.1 35.7 20.1 23.5 40.5 130.7 26.1 34.4 52.0 63.2 16.7 32.8 15.9 48.2 7.2 33.9 38.7 15.6 54.0 38.0 21.6 15.5 20.8 12.6 16.6 39.1 19.4 31.0 13.2 11.7 10.6 42.7 31.9 13.1 52.9 43.6 40.5 31.2 27.1 16.0 11.5 40.2 48.3 15.1 19.7 31.4 43.6 11.0 26.0 5.7 24.6 16.2 38.0 14.4 7.9 28.8 42.3 30.8 53.6 24.9 41.7 12.6 62.9 18.6 7.6 21.0 13.0 31.4 5.8 25.2 24.2 42.7 13.9 18.0 12.4 26.5 45.9 35.1 34.2 12.2 33.1 54.8 18.7 27.7 38.5 7.8 9.2 26.4 18.8 23.7 30.3 20.8 11.1 20.2 23.4 12.6 29.6 21.6 30.6 27.2 11.3 18.7 39.1 31.5 4.7 16.6 11.2 15.5 25.9 19.4 37.7 44.0 23.6 43.2 39.2 40.9 50.6 36.6 44.6 48.2 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: " "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favourable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.6 5.9 9.4 6.6 12.6 16.8 48.2 5.1 9.4 6.2 8.7 3.9 8.1 2.5 2.8 9.1 4.4 5.6 4.2 10.8 2.6 4.0 1.0 4.3 5.3 5.1 2.3 3.5 8.6 5.6 3.2 12.0 10.0 2.1 2.4 7.2 1.9 3.4 0.7 4.0 6.0 3.2 6.6 3.3 5.5 6.0 3.1 6.9 7.1 10.0 4.4 3.0 1.7 10.9 11.1 5.5 10.9 4.2 0.8 1.9 3.6 8.2 1.1 7.7 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell line enhanced" "Detected in all" "AF22: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: , HPA070248: " "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavourable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 7.1 3.6 53.9 11.5 21.0 18.2 7.6 8.0 15.1 5.4 9.6 22.5 26.6 6.7 25.4 8.7 26.7 16.8 20.3 5.3 3.3 22.9 10.0 23.5 17.9 17.1 6.3 3.4 14.9 16.7 17.1 17.6 8.2 6.5 9.8 24.9 7.4 2.5 8.2 16.8 11.4 3.5 13.6 5.7 38.0 32.0 14.2 8.0 18.4 4.2 10.5 16.8 10.9 15.5 5.2 8.4 9.2 3.7 1.8 3.1 9.0 2.0 13.9 9.0 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642125-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: " "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavourable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 21.6 15.6 22.2 17.0 30.5 14.4 12.9 24.9 48.3 14.1 15.0 27.0 7.4 18.2 18.9 7.4 27.2 24.0 17.2 21.3 21.4 18.9 12.4 13.9 13.9 17.7 17.5 21.6 24.1 21.1 13.7 17.5 18.4 26.1 15.0 8.6 14.1 20.8 11.8 28.4 18.5 17.0 14.6 14.8 20.2 17.0 15.9 15.7 19.7 18.4 8.4 13.1 16.9 13.6 5.1 5.1 7.8 2.9 1.9 4.2 3.2 26.2 46.2 12.7 20.9 6.0 5.8 15.5 19.9 6.5 9.3 7.9 25.0 16.4 15.4 13.6 7.3 20.3 9.1 12.2 2.7 23.7 26.0 17.2 22.9 12.5 10.4 16.3 17.1 9.6 7.7 11.2 8.0 7.5 22.1 15.8 7.3 16.9 16.3 8.7 16.2 27.7 20.3 17.6 15.8 6.1 38.1 18.9 20.6 20.5 21.6 7.3 15.1 9.2 20.5 34.0 19.7 12.1 29.1 22.4 33.3 14.6 20.5 10.4 19.2 4.0 2.9 2.7 4.2 2.5 2.7 5.1 2.4 2.8 2.3 4.7 2.2 2.4 7.8 1.9 2.2 5.1 0.5 3.2 22.2 30.5 24.9 48.3 21.4 18.9 17.5 21.6 26.1 15.7 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: , HPA046345: " "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 34.4 17.0 17.5 34.1 19.5 46.1 25.8 19.1 17.9 29.0 24.5 12.4 29.0 17.0 25.1 25.9 25.8 21.0 21.1 33.6 15.8 16.6 27.9 32.2 27.8 29.9 19.2 12.5 31.7 21.3 32.7 26.8 23.0 20.6 26.5 21.4 15.3 24.3 31.0 35.4 24.1 30.7 25.5 21.7 38.1 17.4 22.7 20.6 42.3 27.8 21.9 28.6 29.1 33.9 18.4 19.2 32.8 13.6 12.9 15.3 7.9 15.0 13.7 17.0 14.1 11.7 16.1 15.8 17.8 14.5 15.4 11.2 49.0 16.5 31.5 20.1 18.8 14.9 17.4 14.3 17.5 17.3 11.8 29.4 18.2 12.8 9.2 30.8 19.8 13.3 15.4 13.2 20.0 15.8 22.4 17.4 19.4 14.2 23.0 17.2 13.2 18.7 18.8 22.8 15.9 14.6 19.2 9.8 10.1 19.7 16.9 9.5 15.6 33.3 19.5 15.9 13.1 11.9 9.4 12.6 9.3 51.6 13.3 66.3 6.0 20.9 13.0 17.3 14.7 12.5 13.3 17.7 13.9 14.1 9.8 18.4 15.3 13.7 32.8 12.9 13.6 19.2 12.4 7.9 17.5 19.5 19.1 17.9 15.8 16.6 19.2 12.5 20.6 20.6 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 4.5 6.5 9.5 6.4 14.3 6.8 5.4 9.5 19.1 5.0 4.5 3.5 3.1 3.3 5.9 4.6 4.1 6.1 3.7 3.7 7.1 7.9 4.4 3.8 8.5 7.2 4.6 12.0 7.6 4.6 5.7 4.6 2.7 4.8 5.5 5.0 12.4 3.7 3.3 4.2 6.6 4.0 4.0 4.0 5.0 4.4 5.2 5.1 34.4 5.3 2.1 6.2 4.2 4.5 2.9 3.1 1.5 1.7 2.5 2.6 1.3 3.8 3.0 4.0 3.8 2.2 5.4 6.7 2.4 5.1 2.6 3.7 3.8 3.7 6.9 1.8 2.4 6.5 5.1 2.6 5.3 4.9 1.9 4.5 5.5 3.3 3.1 4.8 3.5 2.1 2.3 4.0 2.7 3.7 6.4 8.1 3.9 4.2 15.3 3.3 3.9 3.3 9.7 6.4 5.9 1.8 5.3 4.1 2.6 5.7 3.1 3.0 7.8 2.1 3.8 2.4 4.4 4.0 4.2 4.5 8.5 6.6 2.9 4.0 3.5 0.8 1.2 0.2 1.1 1.7 1.2 2.0 1.9 1.3 0.8 2.9 2.6 1.8 1.5 2.5 0.6 3.1 2.6 1.3 9.5 14.3 9.5 17.0 7.1 7.9 4.6 12.0 4.8 5.1 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.7 10.1 10.1 31.3 14.0 18.1 15.9 11.8 17.3 9.8 22.3 3.8 24.0 18.9 13.4 17.3 10.4 14.3 22.2 17.5 6.7 13.6 8.7 8.0 7.7 9.0 5.5 6.7 11.9 20.6 11.1 17.7 15.0 3.3 13.6 18.6 15.0 9.5 11.8 8.2 10.4 11.7 16.7 21.6 17.8 15.3 28.8 17.5 10.9 15.5 11.2 21.6 10.1 15.2 10.9 8.0 11.9 9.9 9.5 11.4 11.8 21.2 20.7 9.0 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" 110000 "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 28.8 27.9 15.7 32.2 21.9 22.6 38.7 7.6 16.5 20.9 37.8 27.6 24.6 37.7 22.5 27.9 54.7 24.7 27.0 18.8 14.8 10.1 34.2 37.8 28.8 42.1 24.2 11.6 20.5 32.1 42.7 17.6 47.8 17.4 20.3 37.1 17.5 56.4 31.9 18.5 36.1 47.5 17.1 20.1 39.4 33.2 29.2 20.1 25.8 29.2 28.3 38.4 21.4 25.8 37.8 59.5 46.9 51.3 36.6 47.0 47.4 12.6 16.7 7.2 11.1 21.9 11.4 21.5 13.1 16.7 14.0 15.1 23.9 30.1 10.5 17.3 19.7 46.3 21.3 16.3 5.8 41.4 20.9 26.6 9.7 16.4 16.6 13.6 51.2 14.6 29.1 13.2 9.6 13.5 8.8 19.9 9.8 19.4 6.9 15.7 7.1 10.8 12.1 6.6 36.1 16.1 18.3 7.4 7.5 10.7 19.0 12.0 26.1 21.9 12.6 12.1 7.2 13.0 15.2 13.8 20.2 10.7 11.3 32.2 8.8 46.9 51.3 39.4 46.6 48.3 37.6 37.8 42.7 46.9 37.8 32.5 35.6 38.2 34.6 36.6 50.3 59.5 47.0 47.4 15.7 21.9 7.6 16.5 14.8 10.1 24.2 11.6 17.4 20.1 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favourable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavourable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 22.8 22.9 10.4 25.4 21.0 13.1 12.5 14.9 13.9 16.3 19.9 18.6 22.1 9.4 14.5 11.9 27.4 9.9 15.1 6.1 14.8 8.9 6.5 8.1 17.8 27.0 6.5 10.1 20.1 9.6 14.2 8.6 11.1 14.8 10.7 9.4 27.4 8.7 12.7 17.1 7.7 10.9 7.6 14.2 20.1 20.3 14.8 19.5 9.4 22.7 12.4 22.1 17.1 11.8 20.1 13.9 35.9 15.7 26.0 25.6 8.4 26.6 11.0 12.9 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 SCAND1 "RAZ1, SDP1" ENSG00000171222 "SCAN domain containing 1" P57086 20 35953617-35959472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047138 Supported "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments" Cytosol "HPA047138: " "unprognostic (3.88e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-2)" "unprognostic (4.09e-3)" "unprognostic (2.67e-2)" "unprognostic (1.56e-2)" "unprognostic (7.15e-3)" "unprognostic (3.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.48e-2)" 38.7 31.8 23.5 25.4 22.0 50.3 21.6 13.7 37.7 18.1 30.3 12.3 22.4 45.3 19.3 32.8 21.0 17.0 27.1 19.8 21.6 22.7 30.7 39.6 18.0 26.5 21.0 18.4 19.8 30.7 8.8 21.2 16.9 14.5 26.8 7.2 19.1 36.2 27.8 50.7 19.5 35.4 15.4 16.5 31.9 40.6 23.8 13.4 34.8 26.8 26.2 15.9 14.8 17.3 42.0 60.9 70.6 61.6 30.4 47.2 43.2 13.0 9.7 3.8 7.3 2.0 2.4 24.4 9.1 3.6 4.0 4.7 8.9 9.7 10.1 23.6 1.5 12.2 0.8 4.3 0.4 3.6 21.7 24.9 5.3 19.0 7.0 7.8 10.3 4.2 3.4 3.3 0.7 6.4 10.8 8.1 2.4 13.1 21.8 55.4 12.8 38.3 16.6 11.8 16.5 3.8 5.2 18.8 27.8 15.0 24.0 20.2 16.3 14.8 12.8 13.4 12.0 12.9 8.9 24.3 11.9 14.2 15.6 8.4 10.4 70.6 61.6 57.3 35.1 40.9 27.7 36.6 35.0 30.9 45.8 42.0 29.7 29.0 53.3 30.4 39.6 60.9 47.2 43.2 23.5 22.0 13.7 37.7 21.6 22.7 21.0 18.4 14.5 13.4 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Predicted intracellular proteins" "Disease mutation, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA061180" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046253: , HPA061180: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favourable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 9.0 10.9 17.0 9.3 15.6 8.8 9.4 26.0 20.7 10.3 8.3 10.7 9.8 8.9 10.0 10.8 12.1 9.0 7.5 17.8 15.9 17.2 12.6 9.9 8.4 7.1 17.3 13.2 16.8 10.9 24.1 36.3 24.6 15.6 9.9 6.3 7.7 9.7 9.5 17.9 9.8 8.3 10.4 20.6 7.5 7.9 25.7 14.7 12.6 16.3 8.7 7.7 9.4 9.5 13.2 6.6 20.4 4.6 12.0 14.3 2.8 5.0 4.7 6.6 3.7 3.3 6.1 5.4 6.9 4.9 3.2 4.5 4.9 4.1 5.0 6.1 2.3 5.5 15.3 2.8 4.8 11.7 7.5 2.7 5.7 2.4 4.2 7.1 6.3 5.0 5.1 3.8 6.1 4.2 3.8 14.5 5.4 2.1 6.9 2.2 1.9 2.7 6.3 10.4 1.7 2.9 5.1 15.5 7.5 9.1 3.2 7.4 4.7 5.9 5.1 7.3 6.9 3.4 6.0 8.8 18.4 7.5 4.3 9.0 4.8 20.4 4.6 11.5 8.6 2.5 9.8 11.0 8.7 7.6 2.5 13.2 14.3 9.1 7.7 12.0 2.9 6.6 6.6 2.8 17.0 15.6 26.0 17.1 15.9 17.2 17.3 13.2 15.6 14.7 SCARA3 "APC7, CSR, CSR1, MSLR1, MSRL1" ENSG00000168077 "Scavenger receptor class A member 3" Q6AZY7 8 27633868-27676776 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 52.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.6;HeLa: 54.6;HUVEC TERT2: 37.8;U-2 OS: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029861, HPA047386" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA029861: , HPA047386: " "unprognostic (2.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.68e-3)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.17e-1)" "unprognostic (4.31e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (3.41e-2)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (6.31e-3)" "unprognostic (6.03e-3)" 7.5 4.6 16.4 9.0 27.3 0.4 10.6 10.3 26.8 19.9 11.2 7.7 14.2 3.4 33.8 9.4 14.5 52.2 18.4 4.8 16.2 13.0 3.8 2.7 7.8 7.4 16.4 10.3 13.1 2.8 2.2 3.6 11.8 21.2 12.4 5.4 8.6 13.7 42.6 1.1 6.0 5.1 40.5 21.8 2.0 5.9 3.9 12.1 3.2 19.2 4.7 13.2 11.3 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.1 2.5 0.0 13.5 49.6 11.3 6.5 10.2 7.0 5.2 5.9 4.2 0.0 15.3 13.0 12.1 0.0 12.0 3.3 0.0 1.4 4.7 54.6 0.2 1.4 0.0 0.0 20.8 0.7 10.8 0.5 37.8 0.0 0.0 3.9 2.9 0.0 0.0 3.4 6.2 0.0 0.0 0.0 2.2 7.2 0.0 1.6 1.5 8.6 0.0 8.4 0.1 13.4 5.8 35.0 21.4 3.4 0.0 0.0 0.0 9.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.3 10.3 22.5 16.2 13.0 16.4 10.3 21.2 12.1 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 13.9;SH-SY5Y: 15.5;SK-MEL-30: 15.4;U-138 MG: 21.4;U-2 OS: 22.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavourable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavourable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.1 5.4 1.9 2.6 1.2 13.9 5.7 3.3 1.7 0.0 0.0 0.2 8.1 6.7 0.1 1.8 0.0 0.4 0.4 11.7 1.1 0.2 2.5 11.6 0.0 0.6 4.6 0.0 1.6 0.8 1.7 0.1 0.1 1.2 0.5 0.0 0.2 4.2 1.8 0.3 8.9 0.0 0.0 0.0 1.3 15.5 0.0 0.0 15.4 0.5 0.0 2.0 21.4 22.4 0.5 3.1 0.6 0.2 0.2 0.1 0.3 10.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 145.6;skin 1: 70.8;tongue: 62.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavourable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavourable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favourable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavourable (1.73e-5)" 0.4 0.0 0.1 0.2 0.4 0.0 4.9 0.1 0.2 15.2 0.2 0.2 0.1 0.0 0.8 0.2 145.6 0.0 0.3 0.1 0.1 0.0 0.4 0.1 27.8 0.1 0.1 0.1 0.2 0.1 0.0 0.1 3.7 0.2 0.1 0.4 0.1 11.8 0.1 0.3 70.8 0.2 0.1 0.2 0.1 0.0 0.5 0.1 0.4 0.5 62.2 35.1 0.4 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.8 0.0 24.3 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 47.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622112-30735812 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved Approved Nucleoplasm,Cytosol 59000 Nucleoplasm Cytosol "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 22.4 22.7 20.6 17.6 29.7 15.5 21.7 21.9 28.1 27.7 20.0 12.6 19.3 17.1 20.5 23.3 25.9 19.0 13.4 20.9 19.2 17.8 24.5 33.9 18.8 16.6 16.5 19.4 21.8 33.8 28.5 68.5 29.4 26.0 20.3 21.9 14.5 34.5 22.3 24.7 15.7 22.0 19.6 15.6 20.4 18.8 18.8 17.1 24.4 31.0 18.0 19.0 17.2 22.3 14.3 16.3 18.8 17.2 19.4 15.9 9.2 24.1 10.5 13.4 8.9 22.2 25.0 19.6 18.1 25.2 26.7 31.7 17.0 18.2 13.4 8.7 28.5 14.0 16.5 19.1 31.2 18.7 9.1 9.2 14.7 57.3 27.8 17.2 11.9 18.5 14.7 16.4 27.9 18.1 15.1 25.5 26.2 28.5 10.6 10.0 12.8 18.5 9.3 14.7 16.1 21.5 20.9 14.0 11.7 17.5 17.4 17.9 25.6 12.8 14.5 18.5 14.2 15.4 15.1 17.6 16.4 18.2 8.7 13.3 19.1 18.8 13.4 15.6 9.6 14.4 12.4 14.3 11.1 12.0 16.3 12.3 10.5 10.7 4.3 19.4 17.2 13.3 15.9 9.2 20.6 29.7 21.9 28.1 19.2 17.8 16.5 19.4 26.0 17.1 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favourable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavourable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.9 4.1 1.1 26.2 0.1 0.2 0.9 1.9 4.9 0.2 0.4 0.0 0.4 0.3 0.1 0.1 0.0 2.5 0.0 0.2 0.0 0.3 0.0 0.3 0.3 2.2 22.4 0.1 2.7 0.9 0.0 0.1 0.2 2.4 0.1 0.0 0.1 3.5 0.0 0.0 0.1 0.0 0.3 0.0 22.8 9.9 0.0 0.2 1.1 0.0 0.0 0.0 2.6 1.0 0.1 1.7 0.0 0.0 0.1 0.7 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: " "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favourable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.3 0.1 3.9 20.0 0.0 0.0 1.2 0.0 0.0 0.0 10.3 0.0 0.0 1.9 0.0 0.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: " "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favourable (5.80e-4)" 12.5 13.1 14.7 18.2 15.3 11.2 21.3 15.9 13.9 15.8 27.9 6.7 23.4 9.0 21.4 16.7 11.1 16.5 17.2 27.2 12.6 8.8 14.8 9.5 11.4 10.5 7.6 12.5 24.8 30.2 26.5 23.0 7.8 10.7 22.7 12.6 16.8 19.2 23.8 28.4 8.4 12.7 36.9 7.4 8.7 18.5 26.6 6.7 11.3 14.3 11.1 8.3 22.7 25.7 4.3 7.6 2.2 2.2 2.9 4.2 1.7 8.9 6.0 14.3 13.1 6.6 12.6 0.0 7.2 12.6 12.1 12.6 5.7 11.6 16.4 5.5 13.1 2.2 11.0 9.7 10.5 11.3 8.4 7.6 8.1 14.3 28.7 16.3 12.6 13.6 9.9 8.0 19.5 12.1 7.1 12.8 11.8 4.8 16.3 14.1 13.2 6.4 18.1 15.0 9.7 9.7 11.2 10.1 10.8 12.5 10.0 10.4 8.9 42.0 8.9 12.8 10.0 7.8 13.1 13.1 7.3 17.9 8.0 14.7 11.6 1.3 1.2 2.2 3.3 2.2 4.2 4.3 3.9 3.1 3.7 2.1 2.9 2.4 0.0 2.9 0.5 7.6 2.7 1.7 14.7 15.3 15.9 13.9 12.6 8.8 7.6 12.5 10.7 6.7 SCML2 ENSG00000102098 "Scm polycomb group protein like 2" Q9UQR0 X 18239314-18354727 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 20.0;REH: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 7 "dendritic cells: 7.0" "Low region specificity" "Detected in all" "HPA001662, HPA064713" Enhanced Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA001662: AB_1079879, HPA064713: " "unprognostic (5.15e-2)" "unprognostic (2.57e-2)" "unprognostic (7.93e-2)" "unprognostic (7.26e-5)" "unprognostic (1.24e-1)" "unprognostic (2.24e-2)" "unprognostic (4.95e-5)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (1.18e-1)" "unprognostic (6.15e-4)" "unprognostic (1.83e-1)" "unprognostic (2.35e-4)" "unprognostic (3.30e-1)" "unprognostic (2.54e-1)" "unprognostic (1.97e-2)" "unprognostic (3.31e-3)" 2.4 7.7 3.1 2.1 4.1 8.6 3.1 3.4 3.8 3.7 3.7 3.7 2.0 2.1 4.9 2.5 2.3 2.9 2.8 2.0 2.3 2.0 1.5 2.6 1.3 2.0 3.6 0.5 9.5 3.9 3.2 8.0 7.1 2.3 2.9 2.3 3.6 10.0 2.2 2.0 3.4 2.0 6.5 2.2 2.3 1.7 19.0 4.2 12.5 4.3 2.3 2.1 2.7 4.2 0.8 7.0 0.2 0.2 0.9 0.7 0.2 0.9 3.3 11.8 3.0 0.9 1.5 3.5 2.0 1.4 4.0 4.5 4.8 0.7 0.0 0.4 0.9 0.0 16.5 0.2 4.9 0.0 13.5 0.0 3.0 2.1 0.5 10.3 2.7 0.6 0.6 2.9 3.4 0.2 7.7 0.0 2.8 1.5 16.5 5.5 20.0 4.2 17.8 5.9 2.4 0.0 0.2 7.2 8.4 3.5 3.3 0.0 4.2 4.6 0.3 3.6 2.6 8.0 1.8 0.0 9.4 16.5 1.2 7.1 2.7 0.0 0.2 0.2 0.7 0.2 0.7 0.2 0.3 0.2 0.9 0.8 0.2 0.1 0.2 0.9 0.1 7.0 0.0 0.2 3.1 4.1 3.4 3.8 2.3 2.0 3.6 0.5 2.3 4.2 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.3;Hep G2: 6.0" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: " "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Group enriched" "Detected in some" 4 "CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA041707: " "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 2.9 0.1 0.3 1.4 0.4 0.2 1.0 0.1 0.1 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.5 0.4 9.4 0.1 0.1 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.1 0.2 4.2 0.0 0.0 0.2 9.4 7.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Group enriched" "Detected in some" 11 "REH: 9.8;RH-30: 30.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053992 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA053992: " "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 9.8 30.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Group enriched" "Detected in some" 4 "LHCN-M2: 21.5;RH-30: 17.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.3 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.8 2.7 0.0 0.3 0.0 1.1 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 3.5 0.0 0.0 21.5 1.0 0.0 0.0 2.0 0.0 0.0 17.9 0.0 0.0 2.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell line enhanced" "Detected in many" "AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.3 1.0 11.8 0.1 1.6 12.4 0.2 6.7 11.0 7.7 7.2 1.9 1.3 0.3 1.5 8.7 0.0 1.9 0.0 9.1 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.1 1.1 8.2 0.1 0.1 4.8 0.8 1.9 0.1 4.0 3.8 0.0 0.6 0.0 0.0 0.4 4.7 1.9 3.4 1.7 0.2 0.3 0.1 2.2 7.5 5.0 2.7 4.2 0.1 0.1 0.0 1.5 1.6 10.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 SCN9A "ETHA, Nav1.7, NE-NA, NENA, PN1" ENSG00000169432 "Sodium voltage-gated channel alpha subunit 9" Q15858 2 166195185-166376001 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 17.3;BJ hTERT+: 12.9;HHSteC: 14.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 17 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in single" 24 "dendritic cells: 18.6" "Region enriched" "Detected in some" 5 "hypothalamus: 10.9" "Low region specificity" "Detected in many" "CAB013679, HPA061843" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" "Plasma membrane, Actin filaments, Focal adhesion sites" "CAB013679: , HPA061843: " "unprognostic (2.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (8.98e-5)" "unprognostic (1.47e-3)" "unprognostic (9.43e-3)" "unprognostic (2.28e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.64e-1)" "unprognostic (1.45e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (2.30e-5)" "unprognostic (1.69e-3)" "unprognostic (6.74e-2)" "unprognostic (2.46e-2)" "unprognostic (2.46e-1)" 6.6 4.2 3.8 2.8 9.1 4.2 2.7 0.9 4.4 1.8 10.2 0.5 0.1 1.4 0.9 3.8 2.6 1.2 5.8 2.9 2.8 15.9 4.8 8.3 4.5 3.5 4.1 2.3 2.1 4.8 0.6 11.3 9.2 7.3 2.0 7.0 1.7 1.8 1.9 0.9 1.8 4.2 5.2 2.5 12.4 1.7 16.2 0.4 10.3 1.4 1.9 1.2 3.6 1.8 0.0 18.6 0.7 0.1 0.4 0.0 0.0 0.0 1.9 0.1 0.0 7.5 6.5 0.0 17.3 12.9 4.0 1.4 0.5 0.1 0.0 0.0 2.1 0.0 5.0 0.6 6.7 0.0 1.6 1.3 1.5 1.4 14.9 0.0 0.0 0.4 0.2 6.9 1.3 0.8 4.3 5.0 0.6 0.0 2.6 0.0 1.5 0.5 0.7 2.5 6.5 1.8 7.3 0.8 7.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.1 0.0 0.0 2.5 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.4 0.1 18.6 0.0 0.0 3.8 9.1 0.9 4.4 2.8 15.9 4.1 2.3 7.3 0.4 SCNN1D "dNaCh, ENaCdelta" ENSG00000162572 "Sodium channel epithelial 1 delta subunit" P51172 1 1280436-1292029 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA026884 Enhanced Supported "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA026884: AB_10601501" "unprognostic (2.08e-2)" "unprognostic (2.08e-1)" "unprognostic (7.39e-4)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic favourable (1.60e-4)" "unprognostic (1.44e-2)" "unprognostic (1.81e-1)" "unprognostic (2.08e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.32e-4)" "unprognostic (5.27e-2)" "prognostic unfavourable (6.67e-5)" "unprognostic (3.13e-1)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (7.06e-2)" 3.2 3.8 4.0 1.9 5.1 3.6 1.2 12.8 6.3 1.7 2.0 7.0 3.2 1.1 1.1 3.9 1.5 1.5 4.1 3.3 1.4 3.2 1.5 2.5 3.1 4.6 3.0 0.8 5.9 1.3 2.3 0.2 8.6 2.4 3.9 4.6 5.1 1.0 3.2 3.8 2.4 10.2 1.3 0.7 0.7 1.8 0.5 0.9 0.0 0.2 0.0 0.8 0.2 0.6 5.0 1.9 5.2 1.4 0.8 0.9 3.3 1.0 1.7 1.9 0.9 2.8 3.5 1.8 1.5 0.8 0.9 0.8 0.3 6.6 3.0 0.4 5.9 1.3 1.4 0.1 3.6 2.3 1.1 2.6 0.0 0.5 2.4 8.4 0.4 1.8 1.4 2.4 1.0 3.7 9.3 0.4 0.8 0.7 0.2 2.7 3.8 1.4 1.5 2.2 6.6 1.8 1.4 3.1 2.6 4.9 1.1 11.3 0.7 2.9 2.8 6.1 3.5 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.2 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Group enriched" "Detected in some" 7 "hTCEpi: 30.7;RT4: 13.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071194: " "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 13.8 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 SCOC "HRIHFB2072, SCOCO, UNC-69" ENSG00000153130 "Short coiled-coil protein" Q9UIL1 4 140257286-140385726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061198, HPA070321" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA061198: , HPA070321: " "unprognostic (2.27e-2)" "unprognostic (2.26e-2)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (7.34e-3)" "unprognostic (1.37e-3)" "unprognostic (8.99e-3)" "unprognostic (1.13e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-1)" "unprognostic (4.03e-1)" "prognostic favourable (4.82e-12)" "unprognostic (2.98e-2)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-2)" 16.2 26.6 49.3 9.7 45.0 4.5 27.7 36.3 57.1 17.7 16.1 25.0 15.0 16.5 18.8 32.2 20.4 17.3 15.3 38.3 47.1 66.9 38.6 27.9 13.7 9.7 59.7 32.5 16.6 19.0 29.6 30.5 18.5 74.5 24.2 19.2 15.0 17.9 20.1 13.5 11.0 16.0 19.9 61.8 9.9 19.6 11.1 25.0 6.0 26.0 13.0 11.8 14.8 11.8 18.8 14.3 18.5 12.4 19.2 27.9 19.2 14.7 10.0 27.6 14.4 24.7 34.4 19.8 24.1 23.6 19.5 22.0 6.7 22.0 6.1 21.6 24.8 6.4 16.8 34.4 29.8 20.8 12.0 9.5 5.2 15.8 21.9 19.1 12.1 22.9 46.6 17.4 19.6 26.0 14.7 18.0 34.1 9.7 23.7 11.6 8.6 17.3 14.5 11.5 8.9 57.4 13.5 19.5 20.3 16.4 24.6 26.5 18.0 11.8 19.9 30.0 17.4 24.5 23.4 27.7 47.2 16.1 34.8 8.7 29.2 18.5 9.0 11.7 15.7 12.4 20.1 18.8 19.0 15.5 11.2 15.2 27.9 21.4 5.2 19.2 12.0 14.3 16.6 19.2 49.3 45.0 36.3 57.1 47.1 66.9 59.7 32.5 74.5 25.0 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribbled planar cell polarity protein" Q14160 8 143790920-143815379 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: , HPA064312: " "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 13.0 6.1 15.1 10.8 12.2 9.4 15.9 10.1 13.9 15.1 18.4 17.5 9.8 14.8 9.4 5.9 36.6 11.6 11.9 8.0 12.2 7.7 10.2 13.6 11.5 12.9 13.5 12.8 10.9 17.2 11.2 9.6 9.5 11.8 10.9 7.6 7.5 22.9 11.2 36.8 33.3 16.3 11.2 9.7 11.2 17.0 10.1 16.4 14.0 9.1 11.9 9.6 11.6 17.8 0.6 0.5 0.2 0.4 0.2 1.5 0.6 18.5 15.0 6.9 8.7 2.5 3.2 11.6 10.4 3.0 4.8 4.0 6.6 12.1 7.3 12.7 3.0 19.4 3.7 14.0 0.9 8.1 20.6 10.2 12.9 11.5 5.7 4.2 5.8 2.7 13.6 4.7 4.0 5.3 12.9 2.6 3.7 36.9 11.0 9.1 5.2 19.0 13.3 6.4 8.2 2.5 18.7 15.0 11.0 11.8 13.0 11.0 16.4 10.2 10.1 5.3 22.2 9.4 14.6 9.2 9.0 7.5 5.5 4.3 8.3 0.1 0.1 0.1 0.6 0.4 1.5 0.6 0.4 1.2 0.5 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.6 15.1 12.2 10.1 13.9 12.2 7.7 13.5 12.8 11.8 16.4 SCRN2 ENSG00000141295 "Secernin 2" Q96FV2 17 47837692-47841333 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022934, HPA023434" Enhanced Supported "Nucleoplasm,Golgi apparatus" 350000 Nucleoplasm "Golgi apparatus" "HPA022934: AB_1856638, HPA023434: AB_1856639" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.86e-1)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (1.73e-1)" "prognostic favourable (3.86e-4)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (5.77e-2)" "unprognostic (1.28e-3)" "unprognostic (8.72e-2)" "unprognostic (3.43e-2)" "unprognostic (5.28e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "prognostic favourable (5.83e-4)" 43.4 10.3 8.3 14.2 14.1 6.7 20.8 17.7 13.1 10.6 17.3 11.2 23.6 25.1 11.4 18.1 8.9 15.4 13.3 17.9 8.6 8.9 29.3 17.4 8.3 8.7 8.1 9.6 11.8 25.3 11.4 14.5 7.8 10.5 13.6 6.1 14.8 20.1 19.2 20.0 10.9 20.1 9.7 7.3 15.0 9.8 4.0 10.9 8.5 18.1 9.0 11.0 10.7 10.0 16.9 19.2 25.9 13.4 16.5 22.1 10.8 11.9 19.0 5.3 5.1 15.5 12.0 16.1 6.0 12.3 9.3 9.5 14.2 14.3 6.6 12.2 3.1 6.5 1.7 10.6 3.2 15.8 13.1 6.7 13.9 12.3 5.5 3.1 5.4 11.5 8.0 5.7 4.4 10.4 2.2 7.5 12.7 10.8 10.6 5.5 2.6 7.6 14.2 4.0 26.7 7.4 5.4 4.1 17.1 3.4 7.3 8.0 16.4 6.3 4.8 8.5 9.1 2.3 2.8 31.2 4.0 3.1 23.1 5.6 1.9 12.3 12.8 25.9 16.9 13.4 16.3 16.9 14.0 16.4 16.3 15.6 22.1 12.2 3.2 16.5 6.5 19.2 13.9 10.8 8.3 14.1 17.7 13.1 8.6 8.9 8.1 9.6 10.5 10.9 SCRN3 FLJ23142 ENSG00000144306 "Secernin 3" Q0VDG4 2 174395730-174429575 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034689, HPA034690" Approved Approved Vesicles,Cytosol 9300 "Vesicles, Cytosol" "HPA034689: , HPA034690: AB_10670574" "unprognostic (5.39e-3)" "unprognostic (4.58e-2)" "unprognostic (2.06e-2)" "unprognostic (3.58e-1)" "unprognostic (1.91e-1)" "unprognostic (1.89e-1)" "unprognostic (9.89e-2)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (5.85e-2)" "unprognostic (8.81e-2)" "unprognostic (1.30e-1)" "unprognostic (6.62e-3)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" 12.4 15.9 19.2 7.6 18.4 3.7 11.4 13.2 27.0 8.4 10.4 16.7 12.5 15.4 10.3 10.1 14.2 9.1 9.4 21.2 20.2 20.0 17.4 18.0 10.1 10.5 23.5 21.1 11.7 12.1 26.6 20.6 10.9 25.9 13.4 11.3 8.7 10.6 12.3 30.3 11.5 11.5 11.8 27.9 9.3 10.2 8.4 20.2 10.4 17.3 6.2 9.5 11.2 9.1 9.9 6.9 18.5 4.6 5.5 7.5 2.2 9.0 5.6 14.5 13.4 11.3 12.8 8.2 14.0 10.8 10.9 13.0 5.5 6.7 1.7 9.2 13.9 9.1 11.2 12.1 14.0 19.7 10.1 16.9 12.2 4.3 17.0 12.9 8.9 14.3 15.1 20.0 14.7 12.5 11.1 6.6 14.7 10.1 10.6 12.5 7.1 23.8 5.3 15.2 9.9 12.1 9.3 9.4 26.5 9.6 9.6 17.6 12.8 12.5 9.1 12.6 6.6 14.8 11.7 17.5 18.1 0.2 13.8 6.4 12.7 4.8 4.6 1.9 4.6 2.7 3.3 7.0 4.7 4.3 4.3 9.9 7.5 5.9 18.5 5.5 3.6 6.9 4.8 2.2 19.2 18.4 13.2 27.0 20.2 20.0 23.5 21.1 25.9 20.2 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favourable (8.85e-4)" 10.8 11.4 8.5 15.4 10.6 5.0 15.8 10.5 11.9 12.1 14.6 11.0 14.6 10.7 12.6 14.0 14.4 10.6 11.0 7.8 7.3 6.5 12.1 18.0 11.8 13.7 9.3 7.8 13.0 12.8 22.7 14.4 15.8 9.5 13.2 13.9 12.3 15.5 13.8 14.6 14.1 14.9 13.0 7.3 12.6 11.3 9.1 8.9 17.2 13.3 9.5 16.0 16.0 12.7 8.3 13.6 12.3 4.3 11.8 10.5 5.9 3.9 5.1 8.0 5.5 10.3 7.5 9.2 6.2 8.1 7.3 6.9 4.7 7.7 8.2 4.6 6.4 9.3 4.7 5.5 6.5 15.0 4.4 5.6 5.7 3.0 7.3 8.1 7.4 7.2 5.5 5.1 7.0 6.8 9.0 10.9 6.9 3.0 6.6 6.3 6.4 2.5 6.1 4.4 9.7 7.7 7.2 6.0 8.7 4.9 16.4 9.7 9.1 7.6 5.1 5.2 3.5 6.2 5.0 14.6 12.9 9.8 4.0 6.1 5.7 12.3 3.7 9.7 8.0 3.9 10.5 8.3 10.4 8.7 6.0 7.3 9.2 7.5 8.2 11.8 4.3 13.6 9.5 5.9 8.5 10.6 10.5 11.9 7.3 6.5 9.3 7.8 9.5 8.9 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavourable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favourable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 17.0 17.9 19.6 16.5 30.2 7.3 21.5 17.6 26.7 19.9 17.9 9.6 14.0 14.0 26.2 23.2 19.5 18.9 10.6 16.4 18.2 15.4 21.9 23.9 14.6 22.8 16.4 19.1 22.7 26.9 20.4 30.6 17.5 22.6 18.5 18.6 9.4 18.3 20.8 32.3 19.6 16.1 24.9 16.2 23.5 18.1 24.1 19.9 21.5 25.8 17.1 22.9 21.3 17.5 13.2 10.3 5.6 16.8 15.4 17.8 10.5 14.4 5.9 14.5 19.3 17.2 15.6 15.2 20.6 17.9 17.3 15.0 18.0 20.8 22.8 15.5 18.9 15.0 22.0 19.9 21.7 20.0 11.6 19.5 12.9 14.9 16.3 32.9 22.2 13.5 22.6 18.2 20.1 15.0 34.7 18.8 17.6 16.0 33.4 11.6 23.5 9.0 20.3 27.2 19.1 16.5 16.2 21.9 18.2 14.1 28.8 23.3 13.2 19.4 14.2 18.6 18.8 22.2 17.1 17.3 18.0 31.1 20.9 14.9 22.9 5.6 9.9 2.7 14.2 12.7 17.7 12.1 17.4 16.1 10.3 13.2 17.8 14.9 1.6 15.4 16.8 9.0 14.7 10.5 19.6 30.2 17.6 26.7 18.2 15.4 16.4 19.1 22.6 19.9 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell line enhanced" "Detected in many" "AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB025123: , HPA044416: " "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 101.9 0.0 36.8 34.4 0.1 14.7 17.5 8.6 9.5 3.0 0.0 0.0 47.8 44.1 0.0 17.6 0.2 7.4 0.0 6.9 0.0 9.8 37.4 1.1 0.2 0.4 13.3 0.4 19.4 0.5 0.3 9.6 0.0 3.5 0.8 0.0 2.5 10.8 0.1 0.1 16.0 0.3 53.2 8.7 3.0 7.9 0.0 0.0 0.7 4.3 11.4 8.0 49.4 15.1 0.2 8.2 0.9 0.0 0.1 15.7 0.0 15.4 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 51.6;WM-115: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: " "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favourable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.1 7.5 12.4 3.0 3.1 6.7 9.5 3.2 1.9 0.3 2.5 0.2 17.0 18.7 3.6 1.7 1.5 2.0 1.4 1.3 0.0 0.8 0.4 11.9 0.0 1.8 7.1 7.3 0.2 3.1 3.9 1.3 0.2 6.1 2.9 0.1 0.1 8.1 2.3 0.1 15.3 0.6 3.9 2.9 6.3 4.0 8.4 1.1 51.6 1.2 1.1 4.4 4.0 6.8 0.5 1.5 0.0 0.1 0.2 0.4 0.0 71.8 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favourable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favourable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 22.6 2.9 1.6 0.1 40.4 24.9 69.8 29.0 39.6 32.8 23.6 34.5 57.9 0.0 13.0 36.4 29.4 1.1 73.7 40.0 6.5 1.0 0.7 2.4 13.4 44.1 0.1 1.2 33.5 49.4 13.5 33.1 4.3 1.1 0.0 18.9 22.5 0.0 2.0 2.9 9.1 0.0 14.6 0.0 54.0 30.2 0.6 2.3 39.8 24.7 7.1 17.9 1.3 8.1 25.1 20.9 2.5 18.6 1.2 0.9 0.1 39.5 2.3 14.9 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 SDCBP "MDA-9, SYCL" ENSG00000137575 "Syndecan binding protein" O00560 8 58552924-58582860 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 99.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 166.5" "Group enriched" "Detected in all" 5 "granulocytes: 166.5;monocytes: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012245, HPA023840" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" 1500000 "Nucleoplasm, Cytosol" "Nuclear membrane" "CAB012245: , HPA023840: AB_1857712" "unprognostic (2.39e-2)" "unprognostic (3.34e-2)" "unprognostic (1.84e-2)" "unprognostic (4.45e-2)" "unprognostic (9.15e-2)" "unprognostic (2.60e-3)" "unprognostic (7.14e-2)" "unprognostic (1.04e-3)" "unprognostic (1.11e-1)" "unprognostic (5.68e-2)" "unprognostic (3.05e-2)" "unprognostic (3.01e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.92e-1)" 106.2 32.0 28.5 37.6 45.2 51.5 67.4 20.9 29.0 42.7 28.4 18.8 22.2 19.7 38.4 28.2 37.8 28.0 47.9 36.9 32.1 25.8 41.4 41.7 73.1 49.7 33.4 16.9 35.5 20.1 36.4 16.4 68.5 47.6 35.5 33.6 53.0 41.5 20.7 22.5 24.7 34.3 37.9 39.0 70.1 31.0 25.4 22.2 34.3 44.4 23.4 21.4 50.0 44.2 5.9 21.7 166.5 44.8 3.4 9.8 29.7 14.4 22.4 23.9 12.4 89.4 77.1 10.5 14.9 53.2 21.6 28.5 8.9 30.3 0.0 24.0 19.9 6.0 12.9 17.1 26.8 2.6 11.0 21.7 19.9 7.1 99.4 5.5 35.4 52.6 23.2 21.7 65.3 51.8 10.7 12.7 49.0 3.8 12.2 6.5 14.9 6.4 5.9 7.3 2.8 34.4 15.2 10.4 18.9 15.9 6.8 73.0 6.2 15.2 44.5 20.9 9.0 24.6 9.5 3.8 5.1 8.7 53.2 0.0 18.7 52.9 44.8 43.7 5.7 30.0 7.1 5.9 7.6 6.0 21.7 5.4 9.8 7.4 166.5 3.4 26.4 6.0 8.5 29.7 28.5 45.2 20.9 29.0 32.1 25.8 33.4 16.9 47.6 22.2 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.4;HBEC3-KT: 12.8;RT4: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054554, HPA064490" Enhanced Approved Vesicles,Cytosol Vesicles Cytosol "HPA054554: , HPA064490: " "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavourable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 8.7 0.4 1.2 0.4 5.1 4.5 0.8 2.7 5.3 2.5 2.4 1.9 15.4 0.9 1.8 1.0 6.8 0.4 12.8 1.2 0.3 0.9 0.7 0.6 1.2 5.2 0.9 1.0 1.6 9.1 1.9 1.9 8.4 1.2 0.7 0.9 2.1 1.4 2.5 1.2 0.6 1.3 0.6 1.7 1.0 11.9 2.1 1.6 1.3 7.8 3.0 0.4 0.7 5.6 1.3 0.5 2.4 1.0 2.4 2.2 0.9 0.6 3.4 0.8 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 SDE2 "C1orf55, FLJ35382" ENSG00000143751 "SDE2 telomere maintenance homolog" Q6IQ49 1 225982702-225999331 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028467, HPA031255, HPA031256" Approved Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" "Nuclear speckles" "Golgi apparatus, Plasma membrane, Cytosol" "HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568" "unprognostic (9.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.36e-2)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (9.59e-2)" "unprognostic (2.68e-1)" "unprognostic (3.63e-2)" "unprognostic (1.84e-2)" "unprognostic (3.34e-2)" "unprognostic (9.01e-2)" "unprognostic (1.41e-3)" "unprognostic (3.90e-2)" "unprognostic (3.51e-1)" "unprognostic (3.98e-2)" "unprognostic (3.84e-2)" 25.6 11.2 10.7 13.3 12.8 33.6 21.6 10.8 11.5 12.3 10.6 17.9 9.0 11.0 15.1 11.5 14.3 12.8 13.4 12.2 10.8 11.0 11.9 17.9 16.2 13.9 14.1 9.8 16.2 14.2 15.6 13.9 14.5 12.5 12.9 11.6 11.1 12.0 11.2 20.9 18.0 12.9 12.7 13.5 14.4 11.5 14.1 14.4 33.9 15.8 11.0 14.1 15.6 16.9 8.2 7.8 17.9 7.2 12.5 11.2 6.3 8.4 6.2 10.1 10.7 7.0 7.9 12.5 9.1 8.6 12.5 9.6 8.9 9.8 12.5 14.2 7.6 11.0 12.6 7.9 15.2 9.5 10.2 13.7 5.3 8.2 12.9 13.5 16.7 8.6 11.5 13.2 16.8 8.5 25.0 15.2 9.2 2.5 18.7 10.7 14.0 6.6 15.8 13.0 16.1 7.5 6.0 9.0 15.0 10.3 11.3 17.1 11.2 16.6 8.3 10.6 7.5 13.7 19.8 9.1 6.5 15.4 11.0 8.4 21.0 16.3 6.0 5.5 8.2 6.2 11.2 8.2 8.3 7.9 6.7 7.1 8.6 8.0 17.9 12.5 7.2 7.8 6.4 6.3 10.7 12.8 10.8 11.5 10.8 11.0 14.1 9.8 12.5 14.4 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavourable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favourable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.4 29.9 12.3 20.1 21.2 15.9 33.4 14.2 18.1 24.5 25.0 32.4 25.1 22.8 45.0 16.2 23.9 21.7 29.0 14.5 48.6 19.9 11.6 82.6 42.0 13.1 14.4 15.1 15.8 18.7 18.3 9.7 26.5 18.6 19.0 11.5 28.2 19.1 39.0 4.2 37.9 24.7 17.9 44.2 52.2 24.5 13.6 7.8 67.0 43.3 17.6 26.3 18.3 19.2 18.2 17.9 10.8 11.7 20.2 8.6 16.8 17.6 20.9 11.5 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.3 22.0 13.1 9.1 19.0 15.5 10.2 11.9 17.2 16.1 12.4 20.6 16.5 15.4 21.8 17.1 16.6 17.0 16.9 17.3 22.8 16.1 13.3 18.1 29.6 19.8 15.6 18.5 19.2 20.7 17.5 17.1 25.9 15.2 19.9 19.4 33.8 15.9 35.5 20.2 32.4 17.2 16.9 28.5 22.9 22.7 14.0 17.5 16.3 19.1 33.0 29.7 18.7 16.1 16.4 13.3 19.4 14.1 12.3 19.0 19.6 15.9 13.9 17.1 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 SDHAF3 "ACN9, DC11, LYRM10, Sdh7" ENSG00000196636 "Succinate dehydrogenase complex assembly factor 3" Q9NRP4 7 97116590-97181763 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020523 Approved Approved Microtubules,Mitochondria Mitochondria Microtubules "HPA020523: " "unprognostic (3.94e-2)" "unprognostic (9.11e-2)" "unprognostic (6.51e-2)" "unprognostic (2.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.61e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-2)" "unprognostic (3.74e-2)" "unprognostic (3.07e-3)" "unprognostic (4.27e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-3)" "unprognostic (2.82e-1)" "unprognostic (3.79e-3)" "unprognostic (2.34e-1)" "unprognostic (8.45e-2)" 8.2 16.0 11.8 11.6 12.0 11.4 9.6 5.4 15.5 6.7 12.3 7.9 11.1 15.2 8.3 11.8 12.0 8.8 12.5 22.0 11.3 12.8 17.6 20.1 10.2 14.6 12.9 11.5 7.4 16.2 5.8 13.7 5.8 16.6 8.4 12.8 9.4 16.8 12.4 18.3 9.7 13.2 9.8 15.7 11.5 12.1 14.9 9.6 15.6 14.6 11.2 8.7 9.6 7.9 12.0 25.9 11.3 8.7 6.4 15.0 12.2 7.3 6.0 3.2 20.4 2.0 1.7 3.2 2.2 1.5 2.4 4.0 1.1 5.9 11.9 7.5 2.1 2.6 7.8 6.5 5.2 8.5 10.9 8.1 6.1 11.0 3.7 16.9 3.3 3.5 4.1 4.2 5.7 2.2 21.1 0.3 4.8 0.0 20.0 23.9 6.9 6.6 4.1 2.9 17.2 3.0 5.4 15.2 8.0 8.7 11.5 10.2 0.1 4.6 3.5 0.8 11.4 18.6 2.3 7.0 16.7 31.7 3.3 30.0 11.6 5.4 6.9 2.7 9.1 8.7 12.1 12.0 11.6 14.3 9.5 9.8 15.0 14.9 11.3 6.4 8.2 25.9 10.2 12.2 11.8 12.0 5.4 15.5 11.3 12.8 12.9 11.5 16.6 9.6 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favourable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 13.4 14.5 18.1 6.5 20.1 6.1 14.3 15.7 25.7 8.3 9.5 7.9 10.3 7.9 9.0 14.6 9.8 16.0 8.5 17.6 18.0 21.2 14.9 10.7 8.4 10.6 14.7 17.4 9.7 14.2 10.5 18.3 10.2 15.5 10.6 10.6 11.1 9.7 8.9 30.5 9.7 7.9 8.8 13.0 6.9 8.8 7.3 9.7 7.4 11.5 10.2 7.8 8.1 6.9 10.5 13.4 9.1 10.5 9.6 9.3 6.2 9.9 3.2 14.1 8.7 7.2 10.7 2.8 5.3 4.1 2.6 3.9 2.9 8.4 6.8 10.2 2.8 1.8 4.8 4.7 3.9 14.2 3.2 4.7 1.3 2.9 12.2 4.6 3.8 7.7 15.2 1.9 11.6 6.4 3.1 10.6 8.4 6.8 4.1 11.6 6.7 3.3 4.7 9.6 7.9 11.2 3.3 13.0 9.4 3.2 1.5 6.7 7.2 12.0 4.7 2.7 2.0 2.2 5.8 4.9 3.3 2.2 2.9 11.1 6.4 6.0 10.5 9.1 7.7 9.2 8.0 8.7 8.5 9.0 11.3 10.5 9.3 8.5 7.1 9.6 9.5 13.4 9.1 6.2 18.1 20.1 15.7 25.7 18.0 21.2 14.7 17.4 15.5 9.7 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: , CAB068234: , CAB068235: , HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favourable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 25.5 25.4 14.5 18.5 28.2 28.1 16.5 22.4 28.8 51.4 46.5 35.7 30.8 35.1 28.0 30.2 30.2 57.7 44.7 58.0 20.6 47.3 31.6 26.4 27.4 34.6 49.4 23.6 28.8 29.5 44.4 75.3 36.3 26.4 40.7 35.7 21.1 32.8 28.2 12.0 51.1 23.6 27.9 43.5 47.3 14.5 27.3 15.0 30.4 38.1 63.9 22.3 27.9 18.0 19.8 22.3 36.3 29.5 17.0 20.9 35.9 30.3 75.3 21.8 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044294 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044294: AB_10961400" "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favourable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 19.5 29.3 21.6 12.4 24.1 21.4 15.6 47.7 26.9 13.9 13.5 23.0 17.1 14.8 16.3 16.5 12.0 19.6 10.4 37.1 21.7 18.5 22.2 18.6 11.8 17.0 32.5 19.6 19.2 22.3 17.2 27.9 12.9 22.0 17.2 8.7 19.5 31.1 21.9 64.2 16.2 14.9 13.9 18.8 22.4 16.5 15.2 29.8 13.3 18.0 17.0 12.2 13.9 14.7 25.8 30.6 17.2 19.5 27.5 24.5 15.6 10.9 18.2 12.9 15.1 18.0 13.9 13.2 6.5 8.2 13.5 15.6 14.1 13.7 14.8 16.0 6.6 19.1 11.5 14.5 5.9 20.1 20.2 12.9 13.5 35.8 8.8 11.8 13.1 15.4 17.5 9.6 13.9 14.3 11.6 12.7 13.1 19.1 19.4 19.1 12.4 16.9 25.0 6.7 10.3 23.6 13.7 22.6 19.6 15.9 28.4 13.9 19.6 17.5 7.6 4.2 14.1 12.2 8.0 21.8 13.7 17.7 11.0 15.0 11.2 17.2 19.5 11.5 21.9 11.6 21.0 25.8 16.6 17.1 21.9 25.2 23.7 24.5 6.0 27.5 9.5 30.6 19.3 15.6 21.6 24.1 47.7 26.9 21.7 18.5 32.5 19.6 22.0 29.8 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 276.9" "Cell line enhanced" "Detected in some" "HMC-1: 5.4;SK-BR-3: 3.3" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "myeloid DC: 12.8" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.8" "Low region specificity" "Detected in single" HPA039230 Uncertain Approved Mitochondria,Cytosol Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favourable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 0.9 0.9 2.2 1.4 5.9 0.5 0.4 0.6 2.1 0.5 0.9 0.8 0.0 0.7 0.4 0.2 0.2 0.2 1.4 0.2 1.7 2.5 0.2 276.9 0.6 0.6 4.2 0.7 0.3 0.4 0.1 0.0 1.0 2.8 0.3 0.8 1.3 0.3 0.2 0.2 0.2 0.7 0.3 1.3 0.5 0.9 0.3 0.8 0.1 0.3 0.0 0.3 0.8 0.0 0.0 12.8 0.6 0.8 0.2 0.0 0.3 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.2 0.4 2.3 0.0 0.4 0.0 0.0 0.0 0.5 0.5 1.3 0.6 0.6 0.1 0.8 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 1.4 0.1 0.4 0.8 0.9 0.0 0.8 0.1 0.2 0.5 0.1 0.1 1.6 3.3 0.7 1.2 1.7 0.6 0.0 0.9 1.1 0.3 0.7 0.4 0.2 1.1 0.8 0.3 0.1 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.6 0.2 0.1 1.3 0.0 0.3 2.2 5.9 0.6 1.6 1.7 2.5 4.2 0.7 2.8 0.8 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" 7400000 "Nuclear membrane" "Golgi apparatus" "HPA047533: " "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favourable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavourable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favourable (2.95e-4)" "unprognostic (7.89e-2)" 65.5 43.6 18.7 23.3 17.3 36.4 42.6 11.2 15.5 44.4 38.5 23.0 38.8 20.7 41.8 57.9 40.3 27.3 33.2 30.8 18.7 18.4 56.5 68.2 44.7 41.1 24.7 12.6 55.7 70.9 21.2 41.7 46.0 18.4 44.4 28.0 28.5 43.5 36.2 51.9 23.3 33.3 39.7 31.5 38.4 29.5 28.2 19.7 33.2 74.6 39.3 32.1 49.8 37.8 29.1 44.3 32.6 48.4 34.3 45.9 46.3 23.6 51.1 37.7 58.3 47.8 59.7 29.0 37.8 44.1 31.1 37.2 54.7 58.7 11.8 24.9 46.5 51.6 52.3 31.7 33.8 28.9 38.6 34.3 58.2 51.3 41.5 25.8 38.9 41.1 39.9 21.4 34.8 43.9 34.1 31.6 41.9 55.5 10.5 56.1 40.1 22.0 13.2 48.8 38.3 69.8 66.3 18.5 41.6 31.4 35.2 85.1 34.4 60.0 29.9 31.5 23.7 26.9 46.0 31.1 58.9 16.6 34.2 45.5 24.6 20.7 43.8 24.1 28.4 47.3 28.5 29.1 35.4 30.4 43.8 26.6 30.2 30.9 32.6 34.3 48.4 44.3 45.9 46.3 18.7 17.3 11.2 15.5 18.7 18.4 24.7 12.6 18.4 19.7 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139477-59158836 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 132.6" "Cell line enhanced" "Detected in many" "HDLM-2: 58.2;Karpas-707: 62.8;RPMI-8226: 127.1;U-266/70: 64.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: " "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 5.9 18.4 30.1 18.6 29.7 11.3 16.0 14.9 25.2 12.2 18.7 24.4 27.8 27.5 9.1 58.0 10.7 9.2 11.1 7.2 27.7 33.9 19.0 66.8 13.0 22.0 41.8 21.3 7.0 96.8 14.6 46.6 8.1 27.1 48.8 16.4 10.0 132.6 34.1 4.3 7.9 21.1 6.6 51.3 23.6 28.4 6.4 25.3 7.3 35.9 8.6 23.4 18.9 5.9 33.6 50.0 10.6 17.6 17.3 34.4 32.6 8.6 10.4 5.7 8.8 3.5 0.6 7.3 7.9 6.7 9.7 5.9 7.3 4.7 19.9 12.4 4.7 9.3 8.9 5.9 5.6 58.2 12.2 6.4 7.3 22.4 10.6 21.0 9.7 2.0 14.1 6.0 16.2 3.2 7.3 62.8 3.4 10.2 8.6 8.4 5.7 6.4 7.9 5.6 127.1 6.3 7.3 26.6 10.5 4.7 19.1 26.6 8.6 15.5 2.5 11.8 4.9 4.1 9.4 64.0 47.1 19.5 11.7 14.3 14.4 10.6 13.1 9.4 25.9 15.5 33.1 33.6 27.3 25.2 13.5 17.4 14.3 19.5 2.0 17.3 17.6 50.0 34.4 32.6 30.1 29.7 14.9 25.2 27.7 33.9 41.8 21.3 27.1 25.3 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321178 "Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles 15000 "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: " "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavourable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 25.2 30.7 19.0 24.2 24.7 20.6 25.5 16.2 24.9 37.9 47.0 22.6 38.1 47.7 29.6 30.8 30.1 24.7 41.6 30.6 19.5 20.7 33.2 58.3 27.0 19.9 24.7 17.5 24.7 66.8 22.3 48.1 44.1 20.2 23.2 27.9 22.3 63.5 33.4 42.6 25.5 57.1 32.0 21.9 25.9 27.2 26.4 20.5 29.0 38.2 32.8 28.6 25.8 24.2 26.9 60.8 29.1 44.6 23.2 27.7 41.2 20.8 31.7 25.5 9.8 41.5 46.1 84.7 42.7 52.2 49.9 57.7 26.1 17.1 19.1 19.6 67.6 8.5 32.7 38.0 25.6 16.6 34.0 23.3 25.7 63.1 56.9 26.5 20.6 40.8 30.7 52.2 32.6 59.2 24.9 28.3 38.5 43.0 25.9 29.2 28.9 38.4 25.2 18.3 33.9 30.4 15.7 14.3 17.8 18.7 17.4 16.6 22.5 25.9 44.2 20.6 23.5 30.6 36.6 23.5 32.7 44.2 38.9 37.3 33.9 28.0 44.6 28.1 24.5 38.4 27.2 26.9 24.6 23.7 60.8 22.2 20.3 21.2 29.1 23.2 29.5 54.2 27.7 41.2 19.0 24.7 16.2 24.9 19.5 20.7 24.7 17.5 20.2 20.5 SEC14L1 "PRELID4A, SEC14L" ENSG00000129657 "SEC14 like lipid binding 1" Q92503 17 77086716-77217101 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 90.8;TIME: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 71.8" "Lineage enriched" "Detected in all" 11 "granulocytes: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021463, HPA028703" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021463: , HPA028703: AB_10602300" "unprognostic (1.19e-1)" "unprognostic (8.61e-2)" "unprognostic (1.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (7.37e-2)" "unprognostic (1.21e-1)" "unprognostic (7.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (1.37e-1)" "unprognostic (1.33e-3)" "unprognostic (3.09e-1)" "unprognostic (4.30e-2)" 40.8 34.0 25.4 25.3 39.1 33.4 40.6 42.3 33.2 27.7 11.1 21.9 12.2 13.3 15.8 18.9 18.8 15.9 21.2 18.2 27.0 19.5 25.1 15.8 38.4 25.8 31.6 20.6 12.6 18.3 17.3 18.6 49.3 22.5 10.8 10.5 24.2 21.4 12.9 51.0 11.9 12.2 16.2 25.8 33.9 18.4 35.4 24.4 10.0 24.0 14.4 26.0 15.7 14.7 2.4 2.3 71.8 6.2 1.5 2.0 1.9 11.7 8.6 15.2 23.3 6.4 7.9 5.4 10.7 9.2 12.6 10.9 11.4 7.7 31.4 21.5 14.7 4.5 6.7 10.4 16.4 5.8 6.1 16.4 6.6 14.8 10.8 3.3 7.7 11.1 4.2 10.5 11.0 90.8 10.0 26.5 17.7 5.9 5.7 4.4 5.5 7.8 4.4 24.4 23.3 21.4 4.7 11.7 9.1 11.8 6.2 6.6 5.2 3.6 56.7 14.3 13.5 7.8 7.6 15.2 11.9 16.5 6.2 3.4 4.2 4.2 3.2 9.2 0.7 5.5 0.6 2.4 0.7 0.5 2.3 1.2 0.8 0.5 71.8 1.5 6.2 0.8 2.0 1.9 25.4 39.1 42.3 33.2 27.0 19.5 31.6 20.6 22.5 24.4 SEC14L2 "C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1" ENSG00000100003 "SEC14 like lipid binding 2" O76054 22 30396857-30425317 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 43.0;liver: 112.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 38.3;hTCEpi: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" HPA064466 Approved Supported Nucleoplasm,Cytosol 190000 Nucleoplasm Cytosol "HPA064466: " "prognostic favourable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (5.59e-3)" "unprognostic (6.51e-2)" "prognostic unfavourable (7.63e-6)" "unprognostic (1.25e-3)" "unprognostic (3.76e-3)" "unprognostic (2.23e-1)" "unprognostic (2.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.63e-3)" "unprognostic (1.17e-3)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-3)" "unprognostic (2.01e-1)" 1.9 1.2 13.6 1.9 14.2 2.4 22.7 7.3 15.0 2.2 5.7 12.6 7.3 10.1 2.4 43.0 8.0 2.3 4.3 1.1 10.8 10.4 3.6 112.3 1.8 2.1 16.1 10.4 1.3 1.9 3.7 5.0 1.5 10.6 25.7 1.4 24.2 4.0 7.8 1.0 2.9 13.5 2.4 8.9 1.0 3.4 1.2 10.4 1.1 4.3 0.6 2.7 1.8 2.9 0.8 0.9 0.5 0.2 0.1 7.1 1.5 9.9 2.4 2.0 2.7 3.0 7.5 0.1 8.1 6.5 4.8 5.0 0.6 6.7 0.2 2.4 9.8 7.7 1.2 38.3 5.3 0.9 1.9 0.2 2.4 3.6 4.1 0.0 2.6 5.2 20.9 4.4 7.9 12.0 0.0 0.2 9.6 1.7 1.0 0.2 0.0 3.4 0.4 3.5 0.2 8.5 3.3 1.2 1.4 5.0 1.1 4.5 6.5 0.1 18.2 6.7 4.3 2.7 4.9 0.1 0.0 0.3 14.7 0.0 5.3 0.1 0.2 0.4 0.9 0.2 0.4 0.8 2.6 0.6 0.1 0.6 7.1 4.7 0.5 0.1 0.1 0.9 1.1 1.5 13.6 14.2 7.3 13.4 10.8 10.4 16.1 10.4 10.6 10.4 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958317-5019158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;RPMI-8226: 4.1;SCLC-21H: 6.4;T-47d: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 1.1 1.7 7.4 1.3 17.5 1.5 1.2 2.2 22.1 2.8 1.7 29.4 0.0 1.4 0.9 1.2 2.0 2.2 1.1 7.5 13.5 6.1 1.1 0.8 1.0 1.4 25.8 8.8 1.7 1.8 0.8 1.7 1.3 15.2 1.7 2.1 0.3 1.9 1.1 11.0 2.9 1.1 0.9 25.2 1.2 3.7 1.4 15.6 0.0 0.9 0.5 1.7 0.9 0.4 0.1 0.4 1.6 0.0 0.1 0.2 2.9 0.0 0.4 0.6 0.3 0.6 4.1 0.5 0.1 0.0 0.1 0.0 0.5 0.2 0.2 0.3 0.5 0.6 0.2 0.1 0.0 0.0 0.5 1.9 0.4 1.0 0.2 0.0 0.4 0.6 0.8 0.1 0.1 0.1 0.2 0.4 0.1 0.3 0.0 0.2 1.3 0.3 0.1 0.4 4.1 0.3 0.1 6.4 0.2 0.4 0.3 0.4 4.2 0.0 0.5 0.2 0.4 0.3 0.0 0.2 0.0 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 1.6 0.1 0.0 0.4 0.0 2.9 7.4 17.5 2.2 20.0 13.5 6.1 25.8 8.8 15.2 15.6 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favourable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favourable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 9.7 11.2 13.4 10.6 16.4 21.5 10.1 36.8 21.0 11.4 9.4 9.2 10.7 10.0 11.7 8.9 10.9 10.4 9.0 8.7 13.3 5.4 10.0 23.8 11.6 10.5 12.3 11.5 10.7 20.2 11.9 26.3 7.6 13.2 13.2 7.2 10.4 16.3 9.7 14.3 13.4 11.3 7.3 6.7 13.4 19.1 46.7 12.9 19.6 15.8 5.7 8.1 10.0 8.4 5.9 6.1 4.7 7.2 3.3 7.1 4.5 10.9 24.3 12.3 20.2 13.1 13.5 14.5 13.6 11.9 10.2 7.8 17.5 9.4 11.0 9.6 16.5 30.2 13.6 19.5 5.5 23.2 8.8 11.2 22.7 13.9 12.7 19.0 19.9 14.5 14.1 14.1 16.7 13.8 13.9 15.3 10.7 47.3 12.7 10.2 10.8 17.3 18.3 15.2 18.6 10.4 14.7 17.4 11.5 17.6 26.7 8.3 27.3 15.0 19.8 16.4 12.4 13.2 10.4 7.3 11.1 14.2 12.8 8.6 16.3 3.9 5.9 2.8 6.3 7.1 6.5 5.9 6.4 7.1 3.6 3.8 4.2 6.7 4.7 3.3 7.2 6.1 4.5 4.5 13.4 16.4 36.8 21.0 13.3 5.4 12.3 11.5 13.2 12.9 SEC16B "LZTR2, PGPR-p117, RGPR, Sec16S" ENSG00000120341 "SEC16 homolog B, endoplasmic reticulum export factor" Q96JE7 1 177923956-177984303 "Predicted intracellular proteins" "ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 43.4;liver: 47.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4;CAPAN-2: 8.8;EFO-21: 6.7;HDLM-2: 6.8;RPMI-8226: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054292, HPA072913" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Actin filaments" "Endoplasmic reticulum, Plasma membrane" "Actin filaments" "HPA054292: , HPA072913: " "unprognostic (2.31e-1)" "unprognostic (1.90e-1)" "unprognostic (6.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-2)" "unprognostic (1.50e-2)" "unprognostic (4.76e-3)" "unprognostic (2.43e-1)" "unprognostic (7.34e-4)" "unprognostic (6.67e-2)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 1.4 1.8 1.1 3.2 0.9 0.0 1.5 0.9 2.3 1.7 19.6 0.9 0.9 14.3 1.3 0.9 0.9 1.6 2.5 2.2 0.9 0.4 2.5 47.4 0.9 0.9 0.9 0.9 1.8 4.8 0.1 1.4 0.9 1.0 0.9 1.6 0.9 1.4 0.9 3.9 0.9 43.4 0.9 0.9 2.7 4.0 0.9 0.9 0.9 1.4 0.9 1.0 0.9 1.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 2.3 1.9 0.1 1.9 2.4 8.4 0.1 1.9 0.6 0.1 0.8 1.2 8.8 0.7 6.7 1.5 0.0 0.4 0.2 0.1 6.8 0.1 0.0 0.0 4.1 0.2 0.1 0.0 4.9 0.6 0.3 0.1 2.6 0.0 6.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 7.7 0.1 0.2 0.8 1.5 0.1 0.2 1.0 0.1 1.6 0.9 1.3 0.2 0.8 0.0 1.9 0.8 0.1 3.3 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.1 0.9 0.9 2.3 0.9 0.4 0.9 0.9 1.0 0.9 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavourable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favourable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 25.3 20.9 27.6 13.4 30.5 28.0 28.8 19.0 30.5 24.1 21.1 32.8 17.4 28.4 26.2 25.8 16.4 22.2 17.4 22.6 27.5 25.4 22.5 14.1 24.6 18.9 34.7 24.6 29.0 26.6 23.8 23.7 17.7 27.6 36.4 14.5 25.7 23.3 25.1 15.4 14.5 31.6 24.9 49.2 15.8 20.7 32.0 25.6 14.5 23.5 11.8 15.2 18.4 17.6 11.5 10.3 18.8 10.7 9.9 19.4 9.2 12.1 11.5 16.0 14.4 32.1 30.3 4.4 22.2 20.4 21.3 22.5 8.1 18.2 11.9 9.1 23.0 6.5 12.4 18.7 19.2 16.5 14.0 18.5 19.4 9.2 25.5 10.2 19.0 18.0 22.9 26.6 28.4 24.2 18.3 20.9 20.9 7.9 12.2 9.4 10.1 17.1 6.3 11.4 10.4 17.5 10.0 9.4 13.5 16.9 12.5 15.6 24.2 9.5 22.1 19.4 15.5 29.4 21.4 17.6 26.6 11.2 21.1 13.0 18.0 8.7 10.7 18.8 13.7 7.7 19.4 11.5 17.7 16.1 9.9 9.8 15.2 13.4 6.0 9.9 8.0 10.3 14.2 9.2 27.6 30.5 19.0 30.5 27.5 25.4 34.7 24.6 27.6 25.6 SEC23A ENSG00000100934 "Sec23 homolog A, coat complex II component" Q15436 14 39031919-39109646 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles 54000 "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: " "unprognostic (2.40e-1)" "prognostic unfavourable (5.75e-4)" "prognostic favourable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.69e-4)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 23.9 23.5 10.2 16.8 19.1 7.1 22.1 18.6 20.6 21.4 29.6 8.4 14.0 30.2 30.0 16.8 20.3 19.0 17.2 26.5 11.0 14.8 14.4 55.7 13.5 15.5 12.5 12.8 24.3 8.5 4.7 17.2 15.5 19.8 18.6 18.6 16.2 9.8 31.0 31.7 9.6 38.3 52.8 8.3 11.8 16.9 12.3 6.9 12.9 11.8 11.3 11.3 31.9 18.9 15.6 19.8 38.1 21.6 26.0 26.1 17.9 10.6 20.1 17.5 15.5 32.1 36.8 5.3 43.0 37.1 30.6 38.3 20.1 9.0 2.5 10.5 59.9 8.6 22.0 17.3 44.8 8.1 7.6 4.4 16.0 65.2 24.5 7.4 6.8 28.1 9.3 21.1 15.6 25.6 3.2 6.2 23.8 9.9 6.6 3.0 3.9 19.2 9.6 24.2 3.8 16.1 16.2 1.8 4.2 29.8 8.8 9.5 10.9 2.3 28.5 16.2 12.4 23.6 10.8 6.0 7.3 12.0 11.0 6.3 15.5 38.1 21.6 24.2 18.2 18.6 26.1 15.6 23.0 23.4 19.8 14.5 24.2 19.6 19.6 26.0 16.3 17.4 24.0 17.9 10.2 19.1 18.6 20.6 11.0 14.8 12.5 12.8 19.8 6.9 SEC24A ENSG00000113615 "SEC24 homolog A, COPII coat complex component" O95486 5 134648789-134727823 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038901, HPA056825" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA038901: AB_10674843, HPA056825: " "unprognostic (9.10e-3)" "prognostic unfavourable (3.70e-4)" "unprognostic (2.76e-2)" "unprognostic (4.98e-2)" "unprognostic (2.08e-1)" "unprognostic (4.53e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-2)" "unprognostic (2.41e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-2)" "unprognostic (3.54e-1)" "unprognostic (1.18e-3)" "unprognostic (4.77e-2)" "unprognostic (3.00e-2)" "unprognostic (9.37e-3)" "unprognostic (8.97e-2)" 12.5 18.6 7.8 12.9 8.8 15.2 19.9 10.9 8.9 12.9 19.7 6.7 17.7 20.8 12.4 11.0 18.1 9.6 11.9 11.6 7.2 6.7 10.5 43.5 12.7 19.8 6.6 5.8 11.7 18.1 16.6 25.1 22.2 9.7 10.9 13.2 9.8 27.2 25.6 19.7 10.1 33.1 10.8 10.2 14.2 15.4 7.4 7.3 10.7 12.8 11.5 14.3 14.7 12.3 5.6 6.1 8.1 5.8 4.8 7.2 3.0 11.0 6.3 12.0 9.2 17.9 18.2 13.0 17.2 21.4 13.8 24.1 23.4 6.8 8.4 11.7 20.0 6.3 15.0 13.3 24.3 10.2 7.1 7.1 9.9 17.3 12.8 8.3 14.3 11.3 7.6 13.4 9.8 12.6 9.5 13.0 13.8 6.0 7.9 6.1 7.8 4.0 8.1 10.6 9.7 9.2 8.8 5.1 5.2 11.2 5.4 13.7 9.5 6.9 13.7 11.5 4.4 14.5 10.3 23.0 20.1 13.9 13.6 8.9 21.9 8.1 4.9 3.5 4.2 5.8 7.2 5.6 4.6 4.2 6.1 3.7 4.4 5.0 3.0 4.8 5.7 4.1 4.2 3.0 7.8 8.8 10.9 8.9 7.2 6.7 6.6 5.8 9.7 7.3 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favourable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 25.5 20.2 15.8 18.3 16.5 26.6 34.5 26.9 18.9 21.4 20.0 16.8 19.9 15.5 26.2 19.2 22.6 18.9 18.7 20.5 14.2 12.1 18.9 49.5 20.4 17.8 15.7 11.8 24.9 20.4 30.7 27.7 22.3 15.1 19.1 18.3 22.5 20.2 28.3 37.0 25.8 17.4 25.5 14.8 17.4 18.0 12.1 16.7 31.7 20.8 18.3 21.9 24.9 31.1 13.9 15.7 14.6 13.7 15.7 16.1 10.6 11.9 11.0 17.4 13.0 21.2 21.3 10.0 15.7 19.2 13.4 11.9 10.0 13.9 11.1 8.3 23.8 10.2 19.5 15.7 19.9 13.6 9.7 11.6 10.0 10.9 14.3 15.2 13.7 21.0 20.2 15.3 18.5 19.7 17.6 10.2 19.8 9.7 22.0 7.1 6.6 8.8 14.3 15.4 6.4 16.3 15.0 12.3 9.9 12.1 25.9 9.3 7.6 5.9 18.2 15.8 10.6 13.7 11.2 9.9 12.4 10.6 14.0 6.1 12.6 8.2 12.3 14.6 12.3 13.7 13.7 13.9 13.7 12.8 15.7 11.6 16.1 13.2 12.3 15.7 13.2 6.2 11.9 10.6 15.8 16.5 26.9 18.9 14.2 12.1 15.7 11.8 15.1 16.7 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818661-82901166 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol 22000 "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavourable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (2.69e-4)" 41.3 40.6 22.5 28.0 29.2 30.6 34.5 27.4 30.6 46.4 36.0 26.4 39.2 35.7 53.6 50.2 37.7 34.8 36.1 42.8 23.7 23.8 47.3 57.8 33.9 26.6 25.3 25.3 67.1 79.1 42.7 62.7 54.1 36.0 37.2 38.1 32.6 47.8 46.0 38.7 34.1 51.4 46.2 24.5 28.4 35.9 23.3 23.3 35.7 50.0 31.0 39.5 47.1 37.6 29.4 34.6 34.8 36.0 40.5 40.0 30.5 24.8 11.3 32.7 23.1 58.3 72.7 23.8 46.4 52.0 26.1 32.4 19.5 32.0 32.3 20.4 92.5 11.9 32.2 30.7 36.2 32.9 12.8 19.7 19.4 51.1 58.0 21.0 25.1 69.5 39.0 39.9 45.9 42.3 29.9 32.1 46.4 21.8 27.7 17.0 22.4 10.3 20.7 17.7 23.9 42.1 14.4 21.1 23.5 18.4 32.1 29.9 25.0 23.8 43.2 34.4 17.9 30.1 29.0 24.1 10.3 44.4 34.4 25.4 39.5 34.8 31.1 23.3 32.6 34.8 40.0 29.4 29.2 31.8 34.6 24.4 29.3 28.0 9.5 40.5 36.0 28.9 24.0 30.5 22.5 29.2 27.4 30.6 23.7 23.8 25.3 25.3 36.0 23.3 SEC31B "DKFZP434M183, SEC31B-1, SEC31L2" ENSG00000075826 "SEC31 homolog B, COPII coat complex component" Q9NQW1 10 100486642-100519864 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035882, HPA040819, HPA060052" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: " "unprognostic (1.23e-1)" "unprognostic (3.13e-3)" "unprognostic (3.39e-3)" "unprognostic (1.03e-2)" "unprognostic (4.85e-2)" "unprognostic (1.42e-3)" "unprognostic (1.97e-3)" "unprognostic (6.63e-2)" "unprognostic (2.22e-1)" "unprognostic (2.25e-2)" "unprognostic (1.10e-4)" "unprognostic (8.23e-3)" "prognostic unfavourable (6.41e-7)" "unprognostic (2.31e-2)" "unprognostic (2.54e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-4)" 2.8 2.4 3.3 3.2 5.0 6.4 2.6 12.1 11.8 2.7 2.8 5.4 4.3 1.9 3.0 3.5 1.4 2.9 2.6 5.6 3.1 3.6 2.7 3.4 2.4 4.3 3.3 5.6 3.9 0.8 3.9 5.0 2.4 6.3 2.9 2.7 6.1 2.8 2.5 13.6 2.4 2.9 3.2 3.4 4.9 1.9 16.2 3.4 0.0 2.6 5.2 3.6 2.3 1.9 0.9 0.0 0.1 0.2 0.0 2.1 0.1 0.4 0.4 4.5 1.5 1.4 2.5 0.4 0.9 2.0 0.4 1.4 0.4 0.7 1.0 1.3 0.0 0.5 2.4 0.6 1.2 5.5 1.3 2.2 2.9 0.5 1.9 1.6 1.9 3.8 2.3 0.3 2.7 0.8 0.6 2.7 0.1 0.0 2.8 4.9 0.0 0.9 4.3 0.1 1.8 1.4 0.0 0.3 1.5 0.5 0.1 0.9 1.2 0.6 0.0 0.6 0.7 0.4 0.3 2.1 1.0 1.2 0.1 5.3 0.7 0.0 0.1 0.0 0.5 0.2 2.1 0.0 0.0 0.4 0.0 0.9 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.1 3.3 5.0 12.1 11.8 3.1 3.6 3.3 5.6 6.3 3.4 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: " "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 33.2 30.8 43.1 18.8 46.0 27.3 22.5 30.3 51.7 28.7 26.6 19.7 33.1 19.6 26.1 47.7 25.5 18.7 20.2 21.0 41.7 40.7 41.7 65.7 25.7 19.5 53.2 25.9 31.9 39.5 37.3 34.7 37.8 53.9 34.0 19.9 10.5 39.7 30.8 22.1 11.2 24.4 32.5 55.1 35.3 30.1 16.3 40.2 17.6 42.3 12.2 21.8 43.7 28.3 38.5 14.9 25.0 15.5 12.7 23.6 11.0 33.9 23.9 18.9 16.6 56.5 30.0 11.8 43.6 32.2 20.4 21.2 25.5 35.9 38.3 48.8 31.1 32.5 23.1 21.1 32.1 29.9 22.4 26.5 14.9 25.6 41.2 26.8 17.4 29.9 20.3 22.3 21.9 20.0 16.2 37.1 24.1 28.4 14.0 14.2 19.3 15.7 18.8 27.3 51.5 29.1 21.8 19.3 18.3 35.7 39.2 29.7 58.7 24.7 26.7 29.0 13.1 24.1 35.0 42.9 32.2 59.8 30.3 21.0 27.0 6.4 14.1 25.0 19.4 15.5 22.2 33.2 18.4 19.4 13.0 38.5 23.6 20.9 22.2 12.7 11.6 14.9 16.0 11.0 43.1 46.0 30.3 51.7 41.7 40.7 53.2 25.9 53.9 40.2 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" 1 86862445-86914424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" Nucleoli Cytosol "HPA054937: " "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favourable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (8.17e-4)" "prognostic unfavourable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 41.5 48.9 34.7 32.4 33.2 27.1 41.4 20.4 33.9 44.3 37.0 28.9 42.7 32.9 34.9 62.0 36.9 36.8 36.1 31.4 33.4 35.8 68.4 85.3 47.8 45.4 36.0 25.1 47.6 38.5 20.6 46.9 65.6 34.3 41.5 37.4 30.8 35.8 33.7 22.0 21.7 51.1 30.2 45.0 58.7 32.3 36.4 29.0 57.0 100.7 22.8 33.7 40.0 29.7 68.9 57.5 44.3 41.8 26.8 41.3 51.1 38.5 26.5 22.1 24.5 72.6 86.4 36.2 48.7 55.7 45.8 46.7 37.4 47.0 47.6 62.5 43.1 24.3 25.0 27.1 54.0 44.4 35.3 48.5 25.3 35.4 45.9 63.3 33.1 55.4 43.0 30.5 46.0 38.5 44.8 49.8 44.4 17.3 46.0 42.6 32.5 36.7 38.5 41.0 46.5 63.5 39.9 28.8 23.8 48.4 44.2 64.1 19.3 55.2 40.1 33.6 25.0 64.6 53.1 30.0 30.4 48.8 19.6 52.4 39.3 44.3 40.0 36.8 32.8 38.4 41.3 56.7 35.8 34.7 39.0 68.9 37.1 37.5 36.7 26.8 41.8 57.5 38.3 51.1 34.7 33.2 20.4 33.9 33.4 35.8 36.0 25.1 34.3 29.0 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA048362: " "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favourable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 27.5 49.3 34.8 35.6 49.9 36.2 30.4 17.0 52.5 23.6 30.6 14.8 23.3 38.5 22.1 38.1 36.3 26.9 28.7 32.7 29.7 31.9 33.8 49.5 26.4 40.1 29.3 40.0 28.4 41.5 9.7 30.7 28.9 22.2 32.8 16.2 22.8 48.2 26.0 52.7 21.1 37.8 15.5 19.5 49.3 36.8 30.8 18.7 44.4 43.2 25.4 35.5 21.6 23.3 61.7 83.7 39.6 71.7 29.9 53.1 71.6 31.8 23.3 25.2 14.5 3.8 12.3 4.6 12.9 10.9 11.0 6.5 6.3 16.2 15.4 36.0 7.1 14.2 11.7 15.6 7.4 22.3 25.3 20.3 14.8 15.3 22.6 30.0 39.9 12.9 13.3 13.0 12.2 19.1 19.4 14.5 13.1 30.6 25.9 46.1 44.6 30.6 33.0 24.3 29.2 10.5 14.8 13.5 27.7 11.3 10.6 33.0 29.2 22.5 19.1 12.5 27.5 24.6 18.5 73.1 52.4 10.1 26.9 23.9 29.6 39.6 71.7 34.5 29.9 71.0 28.2 59.7 39.7 31.3 71.2 61.7 53.1 37.6 5.4 29.9 65.4 83.7 29.4 71.6 34.8 49.9 17.0 52.5 29.7 31.9 29.3 40.0 22.2 18.7 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favourable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favourable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.6 5.9 12.9 9.6 19.9 12.2 15.2 12.5 14.6 14.8 18.3 13.2 13.3 13.1 5.6 8.1 5.4 14.4 8.3 13.6 22.9 20.4 8.1 26.5 31.2 17.7 10.7 19.7 7.0 14.8 10.7 14.6 13.3 7.9 35.5 14.3 9.8 6.9 13.1 13.4 22.2 4.5 8.1 24.4 18.5 15.1 7.0 20.2 8.0 11.9 12.4 7.8 17.6 8.4 10.1 11.6 25.0 17.6 24.5 28.7 11.5 15.2 14.1 15.1 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 39.6;BJ hTERT+: 38.0;HHSteC: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7" "Group enriched" "Detected in all" 6 "B-cells: 32.4;T-cells: 51.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 110000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavourable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 35.9 19.5 19.8 31.3 20.6 2.4 33.4 13.5 20.8 83.5 66.2 9.1 38.3 22.0 67.5 34.2 53.4 46.1 67.2 25.5 19.1 20.6 19.2 6.6 18.2 35.1 20.7 11.7 49.9 38.1 18.1 27.2 22.1 15.9 59.5 10.7 41.4 57.3 89.1 29.4 11.6 24.0 76.2 14.1 18.2 35.2 21.9 8.8 1.4 45.7 12.2 12.8 92.5 36.1 32.4 1.3 2.4 7.5 7.5 51.6 21.9 3.2 6.7 1.9 11.2 18.7 22.0 21.9 39.6 38.0 18.5 13.4 0.2 0.5 0.4 8.2 23.2 0.3 1.8 2.4 1.2 1.7 6.7 0.7 2.1 3.3 50.1 0.0 3.5 21.3 7.2 8.8 3.3 2.3 0.6 3.8 4.6 1.7 0.1 0.4 2.5 7.1 0.0 0.0 4.5 2.9 0.0 4.3 9.5 12.3 11.0 0.1 15.2 0.2 8.0 5.6 15.8 20.6 0.0 3.5 1.6 0.2 22.3 0.0 3.6 2.4 2.2 0.9 23.0 3.8 29.7 32.4 38.3 27.4 1.3 24.2 51.6 30.4 1.6 7.5 7.5 0.4 34.7 21.9 19.8 20.6 13.5 20.8 19.1 20.6 20.7 11.7 15.9 8.8 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Group enriched" "Detected in many" 4 "Hep G2: 90.8;HSkMC: 79.4" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" 2223100000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favourable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.3 0.1 7.5 2.1 1.3 0.6 1.9 0.0 0.0 2.0 10.7 0.3 6.7 0.2 0.3 0.0 0.0 0.0 0.4 8.7 0.5 0.0 90.8 4.6 0.5 0.0 79.4 0.1 0.0 0.0 0.0 1.0 2.2 3.9 0.2 0.1 1.1 5.2 0.1 0.2 0.3 15.6 2.1 1.2 0.3 0.5 0.4 2.7 0.2 21.2 0.1 0.1 0.5 0.3 0.9 0.1 1.4 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 24.5" "Cell line enhanced" "Detected in many" "AF22: 42.0;BJ: 32.6;fHDF/TERT166: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 15 "monocytes: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" 1200000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: " "unprognostic (1.20e-1)" "prognostic unfavourable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 9.6 1.1 2.9 5.2 14.6 0.3 3.7 1.0 6.0 7.4 17.8 1.4 0.7 2.3 1.5 3.3 8.6 3.5 8.6 3.7 2.0 2.1 1.3 1.1 4.9 12.9 1.6 6.5 1.4 1.0 1.3 12.0 14.7 11.1 5.0 8.7 8.2 1.5 0.8 1.0 2.7 5.3 24.5 3.3 17.9 5.4 1.8 1.8 0.0 4.2 1.4 2.4 11.9 2.1 0.0 0.2 0.0 4.7 0.3 0.3 0.0 3.6 10.0 42.0 0.0 1.3 1.0 2.7 32.6 19.2 2.7 1.7 3.5 9.8 0.0 1.5 35.5 18.1 0.1 7.8 3.9 0.0 1.3 0.0 1.8 0.0 1.1 0.8 0.0 1.3 0.0 5.9 1.4 10.2 0.0 0.0 1.1 0.1 0.0 0.0 15.7 3.7 0.7 17.9 1.0 6.1 0.2 3.2 1.7 0.2 0.0 0.3 0.1 0.3 5.7 3.7 3.9 10.5 4.7 2.4 1.6 0.0 3.8 1.4 7.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 4.7 0.0 0.0 0.0 2.9 14.6 1.0 6.0 2.0 2.1 1.6 6.5 11.1 1.8 SEMA3C "SEMAE, SemE" ENSG00000075223 "Semaphorin 3C" Q99985 7 80742538-80922359 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 46.6;T-47d: 52.8;U-2197: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "basophil: 25.8" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042418 Approved "Golgi apparatus,Plasma membrane,Cytosol" "Secreted in other tissues" "Golgi apparatus, Cytosol" "Plasma membrane" "HPA042418: AB_10797389" "unprognostic (1.93e-2)" "unprognostic (2.54e-3)" "unprognostic (4.94e-1)" "unprognostic (9.86e-2)" "unprognostic (6.74e-2)" "prognostic unfavourable (5.72e-5)" "unprognostic (9.28e-3)" "unprognostic (1.91e-3)" "unprognostic (1.39e-2)" "unprognostic (9.01e-2)" "prognostic unfavourable (4.08e-5)" "unprognostic (2.07e-2)" "unprognostic (1.55e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-2)" 27.1 4.1 3.7 11.9 5.6 0.2 25.1 1.2 6.8 37.0 31.7 7.6 21.6 4.3 26.9 25.1 20.0 7.1 16.4 12.4 5.2 6.1 5.8 1.1 12.3 0.3 13.1 3.0 23.5 1.5 0.0 4.1 5.9 25.5 29.6 14.1 27.4 13.6 19.7 7.3 9.7 10.6 48.8 8.5 8.9 13.3 11.6 6.0 0.2 2.5 15.2 1.5 35.5 14.5 0.0 2.0 25.8 3.2 0.0 0.0 0.8 1.2 15.0 31.3 0.1 7.0 17.1 0.0 10.2 11.8 5.2 6.6 2.4 28.4 0.0 0.4 3.4 6.1 0.1 9.2 8.5 0.0 3.1 1.9 13.5 0.1 8.5 0.1 0.0 7.4 6.1 12.7 12.6 0.1 0.1 0.0 8.7 21.8 0.0 0.0 0.2 2.4 0.0 15.1 0.2 27.1 46.6 0.1 16.1 28.6 7.4 1.7 52.8 0.0 24.5 28.4 13.0 68.4 17.9 0.2 0.0 0.0 10.7 0.0 28.1 25.8 3.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 1.0 1.8 0.0 0.8 3.7 5.6 1.2 6.8 5.2 6.1 13.1 3.0 25.5 6.0 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.3 4.5 4.9 5.4 2.6 0.0 0.0 0.0 1.4 16.8 17.1 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 4.5 1.2 5.4 3.9 1.7 0.0 0.1 0.6 0.0 0.0 0.2 0.2 0.0 26.2 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649113 "Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.0;SK-BR-3: 20.2;U-2 OS: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: " "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 4.0 1.1 2.4 1.0 12.2 0.6 7.8 2.0 12.2 5.5 6.4 1.9 0.5 2.2 5.4 1.4 4.7 2.3 6.5 0.9 4.0 4.7 1.0 1.0 6.1 0.6 5.9 6.4 0.9 9.6 0.7 1.4 1.1 5.1 15.0 4.9 2.4 6.2 9.1 1.0 2.2 3.6 10.3 6.6 0.7 3.8 0.9 3.1 0.9 2.2 0.5 0.8 9.8 3.3 0.5 0.3 1.4 0.6 0.7 0.5 0.2 0.2 1.1 0.2 0.0 0.5 3.2 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.0 1.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 20.2 0.0 1.6 0.0 0.0 0.8 6.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 1.4 0.3 0.5 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.5 0.5 0.8 0.7 0.6 0.3 0.3 0.2 2.4 12.2 2.0 8.7 4.0 4.7 5.9 6.4 5.1 3.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.8;RPTEC TERT1: 32.1;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.8 15.9 1.2 3.8 1.1 0.8 8.8 1.8 3.9 2.2 2.4 1.9 51.8 4.1 20.1 1.3 27.8 1.0 25.8 1.8 23.6 3.3 5.4 3.9 2.6 4.4 0.6 2.5 3.1 11.3 2.4 5.1 2.5 2.6 6.6 1.2 4.3 1.4 2.3 5.4 14.6 1.7 0.9 9.0 32.1 34.9 3.8 3.9 6.3 10.2 2.4 7.1 1.6 5.6 1.8 3.4 3.7 4.0 9.6 11.5 2.0 17.1 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved Supported "Endoplasmic reticulum,Vesicles" 4100000 Vesicles "Endoplasmic reticulum" "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favourable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favourable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.5 0.4 0.2 0.8 0.6 2.0 4.6 15.5 1.7 0.0 2.1 2.5 1.2 0.3 42.9 2.5 6.5 1.0 0.2 0.5 8.6 33.1 0.1 0.9 0.2 0.1 1.6 1.5 10.6 0.0 6.7 38.9 10.8 6.9 0.1 12.4 0.9 4.3 5.5 4.2 6.7 4.4 1.1 3.6 0.1 3.4 4.7 1.0 0.0 2.6 0.3 2.0 11.9 5.1 2.2 2.0 10.5 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: , HPA065969: " "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavourable (5.94e-5)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favourable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 7.1 4.9 5.3 7.5 8.7 4.8 3.3 5.0 10.4 9.1 8.4 2.0 4.1 2.4 5.4 7.9 2.1 7.7 8.5 10.1 6.3 6.6 4.2 2.0 4.0 3.1 0.9 6.7 4.4 7.4 6.1 3.2 3.9 0.3 0.1 5.3 2.1 3.8 0.7 2.9 4.7 0.0 6.9 0.0 7.1 3.4 3.3 8.0 7.2 3.0 9.0 3.5 0.5 4.2 15.5 7.5 3.7 9.1 5.8 5.8 0.3 18.9 0.3 8.3 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Group enriched" "Detected in many" 4 "A549: 13.7;CACO-2: 13.1;Hep G2: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.7 3.5 1.5 2.2 0.7 3.0 0.5 1.5 0.7 0.7 13.1 2.2 0.2 1.8 0.6 0.9 3.4 0.6 0.6 0.3 2.1 0.7 1.1 47.9 5.7 0.5 0.4 3.7 0.8 0.7 0.4 1.9 1.3 0.1 1.1 0.8 0.2 0.5 0.5 0.8 1.3 0.3 0.6 3.2 0.4 1.1 5.5 0.5 0.9 1.4 3.8 0.6 1.3 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell line enhanced" "Detected in some" "AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 14.5 17.3 0.1 0.0 15.1 0.2 0.1 0.0 0.1 0.8 0.6 0.6 0.6 0.2 0.1 20.3 0.0 0.0 0.6 3.0 0.2 0.2 4.9 0.2 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 1.4 45.2 0.1 2.6 9.5 0.6 7.5 12.9 4.1 1.5 0.1 0.2 7.7 5.6 1.0 0.3 1.4 1.2 0.1 0.5 0.2 0.2 0.3 0.2 0.7 5.3 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell line enhanced" "Detected in many" "AF22: 11.7;HUVEC TERT2: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavourable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favourable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.7 0.8 11.7 4.5 4.9 1.6 1.0 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.1 1.1 0.4 0.7 1.0 3.4 6.1 0.5 0.9 0.6 0.1 2.3 2.8 1.4 1.0 0.5 20.4 0.5 0.6 1.9 0.4 1.0 0.8 5.2 1.3 7.2 2.6 0.2 0.4 0.3 5.9 7.7 1.1 0.5 0.9 1.3 1.0 9.5 2.0 2.8 2.9 0.4 4.9 0.9 5.0 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favourable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.3 0.0 1.3 1.1 0.2 0.5 13.9 0.3 0.0 0.3 0.1 1.9 0.0 3.5 7.2 2.9 0.9 0.1 0.9 1.7 0.0 4.2 0.0 3.7 0.0 0.1 1.0 7.6 0.0 0.5 0.9 0.1 3.0 0.4 0.7 2.3 0.6 4.4 0.0 1.4 0.1 2.1 1.0 0.9 12.3 11.4 0.1 0.9 3.8 0.4 0.0 0.0 6.4 0.3 0.2 0.0 9.1 0.0 2.1 1.7 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 SENP1 ENSG00000079387 "SUMO1/sentrin specific peptidase 1" Q9P0U3 12 48042898-48106308 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011765, HPA046491" Supported "Nucleoplasm,Focal adhesion sites" Nucleoplasm "Focal adhesion sites" "HPA011765: AB_1079907, HPA046491: " "unprognostic (2.66e-2)" "unprognostic (6.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.69e-2)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.72e-5)" "unprognostic (6.48e-2)" "unprognostic (2.44e-3)" "unprognostic (8.20e-3)" "unprognostic (2.57e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (8.37e-4)" "unprognostic (7.61e-2)" "unprognostic (3.02e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-1)" 5.7 3.3 3.0 9.0 4.0 8.4 5.2 5.3 3.2 5.5 4.9 3.8 3.5 3.4 6.2 4.3 5.7 5.2 3.8 3.6 2.7 3.3 3.8 3.9 4.3 7.3 3.0 2.3 6.2 4.4 6.1 11.4 8.1 3.0 4.4 4.7 5.1 20.0 4.7 6.8 6.6 4.5 5.8 4.3 6.4 4.5 60.2 3.6 15.0 5.2 4.8 8.3 5.7 6.3 5.3 3.8 7.1 2.6 3.8 5.5 2.3 7.0 9.1 11.3 8.5 3.4 5.0 8.4 7.6 8.5 13.1 10.6 11.1 11.4 19.2 6.6 6.9 6.9 14.0 6.7 13.3 17.4 6.3 16.8 8.8 5.3 5.6 15.6 11.4 4.1 5.5 11.7 10.5 6.8 14.7 9.1 6.8 5.6 19.5 5.0 10.3 6.9 18.4 12.0 9.4 3.6 8.6 11.9 8.2 11.0 6.7 4.5 10.6 7.5 6.2 11.1 9.9 6.5 8.0 9.5 15.3 18.7 6.8 36.3 5.0 2.0 1.8 7.1 4.3 2.6 5.5 2.4 4.2 3.9 3.3 5.3 3.6 4.1 3.8 3.8 2.0 3.8 5.0 2.3 3.0 4.0 5.3 3.2 2.7 3.3 3.0 2.3 3.0 3.6 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO1/sentrin/SMT3 specific peptidase 3" Q9H4L4 17 7561875-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA060290 Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA060290: " "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favourable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 16.3 16.0 22.3 20.9 23.4 16.6 18.0 29.2 38.4 15.9 22.5 18.4 16.8 16.2 18.6 22.7 18.6 19.9 17.0 26.1 21.0 19.2 17.5 15.1 18.7 18.8 20.0 23.3 19.6 17.8 29.5 17.3 23.6 17.2 16.0 20.5 17.3 18.6 21.9 22.0 20.8 17.6 23.1 15.3 18.9 17.2 28.8 16.4 18.9 19.0 14.2 23.4 16.8 32.8 0.8 0.7 1.1 0.7 1.1 1.7 0.3 26.2 31.8 18.9 29.2 21.4 15.7 19.7 19.3 19.8 33.6 31.6 19.0 11.5 31.4 19.1 25.3 25.3 40.6 30.1 28.3 22.1 37.1 16.3 27.0 19.4 29.0 15.0 20.8 20.1 30.8 38.3 37.6 26.9 20.8 8.8 25.9 17.6 36.3 11.4 23.4 19.4 33.3 17.7 18.1 22.4 15.4 18.9 24.4 19.3 18.7 20.5 15.7 9.8 14.1 19.3 16.8 18.3 41.3 13.0 13.5 19.9 19.5 15.9 28.5 0.1 0.7 0.2 0.4 0.4 0.1 0.4 0.2 1.3 0.1 0.8 1.7 0.5 1.1 1.1 0.1 0.7 0.3 0.3 22.3 23.4 29.2 38.4 21.0 19.2 20.0 23.3 17.2 16.4 SENP5 MGC27076 ENSG00000119231 "SUMO1/sentrin specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006684 Supported "Nucleoli,Plasma membrane" Nucleoli "Plasma membrane" "HPA006684: " "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavourable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavourable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 13.8 13.5 20.0 15.3 20.0 25.7 16.1 28.3 23.8 15.0 15.1 16.1 14.5 11.3 14.6 16.2 16.3 12.9 14.4 15.9 18.9 21.7 13.6 19.5 15.2 15.9 19.4 18.4 17.5 15.7 19.8 21.5 17.8 23.5 15.1 14.0 12.0 13.2 15.9 17.8 16.4 13.0 16.8 18.2 17.1 14.0 36.6 16.4 19.3 14.1 9.2 21.1 14.9 20.1 8.9 7.8 15.8 8.7 7.6 8.9 4.2 13.1 6.0 9.6 8.6 8.1 9.8 7.6 8.4 9.0 9.1 14.7 10.4 5.2 12.3 23.4 9.2 9.1 9.9 4.5 14.9 6.6 6.5 16.7 8.9 7.3 9.5 13.7 7.9 8.4 12.1 9.3 9.9 8.9 11.0 19.1 10.6 11.3 12.9 8.1 7.4 11.9 8.3 7.7 8.3 4.5 7.5 6.0 8.0 9.4 10.6 10.3 17.8 10.5 10.0 8.9 9.2 12.2 17.1 20.4 35.7 26.5 12.0 11.1 10.1 15.8 7.6 7.1 8.9 8.1 8.1 8.9 8.6 8.8 5.0 8.5 8.0 8.6 14.9 7.6 8.7 7.8 6.9 4.2 20.0 20.0 28.3 23.8 18.9 21.7 19.4 18.4 23.5 16.4 SENP6 "KIAA0797, SUSP1" ENSG00000112701 "SUMO1/sentrin specific peptidase 6" Q9GZR1 6 75601509-75718278 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024376 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024376: AB_1856678" "unprognostic (9.86e-2)" "unprognostic (1.20e-2)" "unprognostic (4.84e-2)" "unprognostic (1.87e-2)" "unprognostic (6.38e-3)" "unprognostic (7.33e-2)" "unprognostic (1.13e-2)" "unprognostic (2.97e-1)" "unprognostic (3.93e-2)" "unprognostic (5.32e-3)" "unprognostic (7.81e-2)" "unprognostic (9.24e-2)" "prognostic unfavourable (6.09e-4)" "unprognostic (1.78e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (2.83e-5)" "unprognostic (1.72e-1)" 25.9 20.0 24.3 21.8 24.5 27.1 25.9 35.0 24.3 32.5 27.7 23.5 24.9 16.8 37.7 21.2 21.0 27.4 21.5 20.0 22.8 19.8 24.1 22.5 22.5 21.1 29.6 20.3 38.7 21.8 40.1 44.2 26.8 27.0 27.7 21.8 23.0 20.4 25.7 27.8 22.0 24.1 43.0 27.2 24.7 21.3 26.1 28.6 28.5 34.8 15.8 23.9 27.1 34.0 9.9 10.9 19.4 13.1 9.8 11.2 5.5 10.7 11.3 25.7 18.4 20.0 26.7 19.1 19.4 21.7 16.4 20.6 15.5 10.4 18.3 18.4 22.4 13.8 24.1 12.9 25.5 26.8 20.8 27.7 13.6 14.4 27.8 24.0 20.4 20.6 21.6 15.4 34.4 27.1 33.4 20.3 20.1 13.1 9.5 13.0 15.6 9.6 18.0 13.6 26.6 17.6 16.1 22.5 23.2 16.6 14.7 16.8 13.2 23.0 22.6 14.7 16.1 7.5 20.0 23.3 23.1 14.6 7.4 23.0 15.5 5.2 7.4 19.4 7.7 7.9 11.2 9.3 7.8 10.2 8.7 9.9 11.2 9.9 14.7 9.8 13.1 10.9 6.5 5.5 24.3 24.5 35.0 24.3 22.8 19.8 29.6 20.3 27.0 28.6 SENP7 ENSG00000138468 "SUMO1/sentrin specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027259 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027259: AB_1856679" "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 17.0 9.0 11.0 19.1 14.5 19.5 16.5 35.5 19.5 21.7 13.1 11.8 8.2 6.4 24.3 15.2 11.9 18.6 12.8 10.0 13.2 9.1 10.5 7.7 11.5 19.0 12.9 10.8 27.9 15.9 22.4 24.4 17.0 18.7 15.1 10.0 9.2 10.2 11.1 11.1 18.6 13.8 16.0 17.3 14.1 13.6 7.9 16.8 32.1 16.0 9.4 15.4 17.2 14.0 6.8 3.2 24.5 4.1 6.2 7.6 3.8 6.9 4.7 23.4 12.9 4.5 6.9 4.3 4.1 3.0 6.8 8.4 3.1 6.5 5.4 6.3 3.9 7.1 7.3 3.7 13.7 10.0 2.1 9.8 3.7 4.2 3.7 5.6 9.6 5.2 6.8 3.4 7.8 9.7 8.0 13.9 6.4 4.6 10.3 6.6 4.8 5.1 11.6 6.2 4.9 8.1 4.1 9.1 7.0 3.8 3.8 5.1 6.3 7.6 7.9 9.5 5.8 3.1 4.0 9.9 5.9 12.7 3.3 7.5 7.7 24.5 4.1 3.8 4.2 3.6 5.2 4.2 5.6 4.2 3.2 6.8 7.6 5.1 12.6 6.2 3.8 2.8 4.5 3.8 11.0 14.5 35.5 19.5 13.2 9.1 12.9 10.8 18.7 16.8 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO/sentrin peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143688 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 2.5 4.8 6.4 3.4 8.1 5.0 4.4 5.7 8.0 4.0 4.0 3.9 6.4 3.8 3.9 6.7 4.8 5.1 4.2 7.7 7.3 6.9 9.3 5.0 3.3 3.1 6.2 7.7 5.3 6.2 3.9 12.7 3.7 8.0 5.9 4.3 4.2 5.6 6.6 11.0 3.5 3.3 4.2 5.0 3.1 4.3 26.5 4.3 2.2 12.0 4.5 2.7 4.9 3.0 3.0 5.7 2.1 5.6 7.1 3.7 2.1 1.9 3.2 6.3 5.0 7.6 9.2 3.5 5.0 3.1 3.0 2.8 2.7 4.5 1.9 7.4 3.2 4.5 9.6 7.7 4.4 2.1 5.3 3.0 4.5 2.2 5.3 3.6 1.7 4.5 7.8 1.9 8.4 2.8 4.6 3.6 7.1 4.9 3.6 4.7 5.0 3.3 2.4 5.4 4.0 7.9 3.4 7.7 2.5 5.3 4.4 5.2 6.7 2.7 2.9 6.1 2.2 10.1 2.5 3.0 3.6 2.3 2.9 5.0 4.3 2.1 1.9 1.4 1.6 3.9 2.3 3.0 2.8 2.5 5.7 1.4 3.1 3.7 0.7 7.1 5.6 1.7 2.1 2.1 6.4 8.1 5.7 8.0 7.3 6.9 6.2 7.7 8.0 4.3 SEPT2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" 8800000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favourable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavourable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 64.2 46.4 76.5 42.9 69.9 29.1 58.7 34.9 61.8 69.3 48.4 85.2 57.4 37.8 59.5 59.8 46.8 48.2 54.0 56.2 65.8 55.4 64.6 31.4 51.2 51.3 76.5 52.7 63.4 73.0 56.6 56.3 58.9 60.7 53.7 53.3 48.8 43.6 64.7 39.5 32.0 42.2 81.8 100.8 51.5 45.6 67.7 57.2 36.2 64.2 39.0 47.5 56.5 42.6 25.5 51.2 38.5 50.5 51.3 36.9 59.4 31.9 28.8 78.5 51.3 73.1 79.8 40.6 70.8 69.8 45.5 58.0 16.1 34.8 13.0 16.9 80.9 28.5 51.2 47.9 74.9 32.8 36.4 52.2 28.8 59.4 44.8 49.7 31.9 71.0 31.4 37.9 36.6 79.2 46.5 19.1 66.9 23.0 29.4 30.4 57.1 21.1 29.1 98.7 27.5 67.5 48.9 56.3 37.9 49.0 33.9 46.7 20.3 44.9 74.8 55.8 23.7 53.8 41.8 37.7 32.8 45.8 48.0 30.4 77.0 38.5 46.0 26.3 30.3 50.5 36.9 25.5 29.6 31.2 51.2 21.6 26.2 27.4 16.3 51.3 37.2 38.6 29.5 59.4 76.5 69.9 34.9 52.3 65.8 55.4 76.5 52.7 60.7 57.2 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell line enhanced" "Detected in many" "AF22: 13.5;SCLC-21H: 36.5" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.5 10.1 0.1 0.0 6.7 0.1 0.1 0.9 0.4 0.2 1.5 10.9 0.4 0.1 0.0 7.0 0.0 0.3 4.5 2.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.7 0.0 1.1 1.8 0.1 9.2 0.3 8.7 0.0 0.6 0.0 1.3 36.5 7.6 5.4 0.0 8.9 1.3 3.3 0.0 0.0 4.8 0.4 0.5 7.2 6.2 0.1 0.1 4.4 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell line enhanced" "Detected in many" "K-562: 65.7;THP-1: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: , HPA063885: " "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavourable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.0 12.0 18.5 1.1 3.9 0.1 4.6 5.8 5.2 3.0 0.2 1.6 0.4 1.8 10.2 1.7 8.7 1.7 2.6 3.1 1.0 0.2 0.6 0.0 4.8 0.2 12.7 5.2 2.1 1.7 0.7 2.1 65.7 0.1 8.1 1.2 1.3 7.3 1.6 3.2 13.3 0.3 2.0 0.3 0.4 19.2 15.6 0.6 0.9 0.8 4.8 21.1 0.8 13.7 18.4 0.5 0.9 1.3 0.0 0.1 1.7 0.6 4.4 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 SEPT7 "CDC10, CDC3, SEPT7A" ENSG00000122545 "Septin 7" Q16181 7 35800932-35907105 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023309, HPA029524" Enhanced Enhanced "Nucleoli,Actin filaments,Midbody,Cytosol" 16000000 "Actin filaments" "Nucleoli, Midbody, Cytosol" "HPA023309: AB_10600093, HPA029524: AB_10601573" "unprognostic (7.91e-3)" "unprognostic (6.89e-3)" "unprognostic (9.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (2.22e-2)" "prognostic unfavourable (2.37e-4)" "unprognostic (2.00e-2)" "unprognostic (4.43e-2)" "unprognostic (7.13e-2)" "unprognostic (3.56e-2)" "unprognostic (7.66e-2)" "prognostic unfavourable (2.78e-4)" "unprognostic (2.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.43e-3)" 35.5 28.5 89.0 26.8 77.8 31.9 29.5 41.9 81.5 35.1 28.7 54.3 11.5 15.7 37.8 36.2 31.7 25.4 34.2 47.5 86.4 58.1 24.3 21.5 28.3 38.8 79.6 66.2 42.8 11.2 22.9 31.9 41.0 72.0 28.4 28.2 9.6 14.9 29.9 21.7 29.1 20.1 42.6 76.8 29.5 18.1 19.3 98.2 33.0 22.6 17.3 41.4 36.9 24.0 40.4 24.0 47.3 24.8 69.1 56.8 48.6 36.6 17.7 45.1 29.6 50.8 52.6 23.1 47.3 43.7 40.4 34.8 27.4 28.5 34.7 32.2 48.1 27.9 31.8 31.5 57.7 23.7 16.7 27.9 24.7 14.8 29.7 33.6 30.9 34.1 24.7 31.7 31.3 42.1 21.9 27.5 65.5 17.1 33.9 56.5 48.3 25.0 35.1 42.9 19.9 39.1 27.4 24.2 42.5 33.0 42.6 28.3 31.4 37.3 35.5 40.8 48.4 25.0 52.0 32.4 29.5 87.6 26.1 56.3 86.1 47.3 20.7 34.9 55.4 24.0 56.8 40.4 39.6 50.5 24.0 37.4 35.6 44.9 39.3 69.1 24.8 17.2 34.2 48.6 89.0 77.8 41.9 81.5 86.4 58.1 79.6 66.2 72.0 98.2 SEPT8 "KIAA0202, SEP2" ENSG00000164402 "Septin 8" Q92599 5 132750817-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 150.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Approved Approved "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: " "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavourable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 9.5 8.4 43.1 7.0 49.4 2.9 7.1 27.8 74.9 9.3 10.2 66.8 5.2 10.7 6.7 8.2 13.4 7.0 10.7 13.1 56.3 37.0 9.2 4.3 8.4 5.6 76.1 29.3 10.9 9.4 15.9 5.0 18.5 45.8 8.1 11.5 7.9 13.6 9.3 4.1 20.4 10.5 9.0 150.3 5.9 11.0 2.9 64.1 1.5 9.5 5.2 7.5 18.3 6.2 0.8 2.4 1.1 2.0 0.3 5.2 1.7 17.1 8.3 12.0 24.4 16.7 16.4 39.4 18.6 17.8 17.7 21.7 14.5 12.4 0.1 16.6 17.9 13.3 22.4 30.4 19.5 21.9 16.1 16.8 10.5 12.5 12.2 5.9 24.5 11.8 9.8 8.1 11.6 24.5 25.7 3.3 9.4 16.3 19.1 5.5 6.3 5.4 17.6 14.0 1.4 10.3 44.2 16.1 10.0 15.7 3.6 10.4 32.1 7.8 25.4 19.7 12.9 4.8 13.2 4.6 4.3 0.6 12.6 8.8 14.8 1.1 2.0 0.0 4.1 1.1 4.2 0.8 3.4 5.2 2.4 0.3 0.9 2.2 0.0 0.3 0.5 0.0 3.6 1.7 43.1 49.4 27.8 44.6 56.3 37.0 76.1 29.3 45.8 64.1 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43802589 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favourable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 78.4 109.1 61.4 103.2 58.1 110.6 115.0 33.0 45.9 71.2 107.6 45.1 99.7 59.2 65.1 121.7 109.6 60.0 128.9 166.4 56.1 48.2 97.5 153.1 79.7 81.4 72.9 42.6 51.8 125.4 23.5 62.5 102.9 89.4 84.7 87.6 63.0 134.3 106.7 98.7 59.9 86.4 68.5 66.7 79.5 79.5 65.5 45.8 77.0 122.5 116.7 82.9 84.8 116.3 146.1 259.3 225.7 218.7 91.4 142.8 413.5 34.5 57.7 43.0 58.6 149.8 110.4 33.2 61.8 77.5 40.3 51.6 74.0 34.8 18.0 51.2 106.0 46.1 33.6 46.4 20.2 49.2 39.8 43.4 83.9 141.8 73.4 40.5 93.9 104.2 60.2 32.6 35.0 58.6 44.7 118.9 78.9 106.2 51.7 95.8 36.7 67.2 53.0 28.5 82.5 109.8 126.8 32.3 34.7 33.1 139.3 31.6 116.6 173.3 49.6 68.9 35.2 103.5 45.2 43.9 58.8 124.8 74.4 73.6 71.4 127.3 218.7 225.7 113.6 194.5 103.1 142.2 125.7 116.0 185.9 146.1 116.7 118.3 129.1 91.4 166.0 259.3 142.8 413.5 61.4 58.1 33.0 45.9 56.1 48.2 72.9 42.6 89.4 45.8 SERGEF "DelGEF, Gnefr" ENSG00000129158 "Secretion regulating guanine nucleotide exchange factor" Q9UGK8 11 17788048-18013162 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037811, HPA037812, HPA074086" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037811: AB_10672726, HPA037812: , HPA074086: " "unprognostic (2.67e-2)" "unprognostic (7.15e-2)" "unprognostic (7.00e-2)" "unprognostic (9.04e-3)" "prognostic unfavourable (5.67e-4)" "unprognostic (6.94e-2)" "unprognostic (1.30e-3)" "unprognostic (1.87e-1)" "unprognostic (3.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.74e-3)" "unprognostic (5.56e-2)" "unprognostic (4.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.43e-1)" "unprognostic (1.24e-2)" "unprognostic (5.82e-2)" 8.2 14.2 30.1 7.5 22.3 4.7 15.2 24.4 31.4 13.1 10.7 9.5 4.3 6.1 11.8 17.7 9.6 13.9 10.3 9.9 28.6 24.1 15.6 12.3 10.0 8.0 27.9 18.1 26.1 17.4 17.7 19.3 4.8 23.0 13.6 11.5 10.1 12.3 17.1 11.8 11.1 6.2 14.4 10.4 7.6 10.1 3.9 10.7 7.8 25.3 8.8 11.8 9.5 15.6 15.4 14.4 8.9 11.8 11.3 22.0 14.1 6.6 7.7 7.3 13.7 12.7 13.1 4.4 5.3 12.0 6.2 8.2 5.5 2.2 6.0 7.0 6.7 8.7 25.9 17.0 5.4 13.1 21.1 9.2 7.0 22.7 14.2 8.1 10.6 11.7 18.7 3.0 13.4 6.7 5.5 11.6 9.5 10.3 7.8 17.7 5.6 9.2 11.3 8.0 6.6 15.1 10.0 17.1 4.0 9.9 9.9 10.0 4.7 7.6 3.4 6.5 7.6 8.4 6.3 8.0 9.6 7.7 10.0 9.4 6.2 7.2 11.8 8.9 21.1 9.3 17.4 15.4 21.3 16.0 14.4 11.1 21.7 19.2 1.2 11.3 9.4 5.9 22.0 14.1 30.1 22.3 24.4 31.4 28.6 24.1 27.9 18.1 23.0 10.7 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.5;HaCaT: 53.0;HBEC3-KT: 83.7;hTCEpi: 47.6;RT4: 57.3;SK-BR-3: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favourable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavourable (2.11e-4)" "prognostic unfavourable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 12.8 3.0 2.7 8.7 5.9 8.0 7.4 24.7 18.4 1.6 2.0 4.6 46.5 8.5 32.6 23.2 53.0 0.3 83.7 0.3 0.8 2.0 0.0 2.7 2.4 6.6 0.0 9.9 7.3 47.6 10.2 22.5 1.0 0.3 0.0 2.7 2.1 0.3 0.3 2.8 6.5 0.0 5.3 2.8 8.8 57.3 1.1 6.6 6.3 47.9 1.0 28.0 1.4 6.1 0.4 2.0 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.0 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 SERINC5 "C5orf12, TPO1" ENSG00000164300 "Serine incorporator 5" Q86VE9 5 80111651-80256079 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.6;RT4: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037898, HPA037899" Supported Supported "Vesicles,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Centrosome" "HPA037898: AB_10673649, HPA037899: " "unprognostic (2.95e-1)" "unprognostic (1.80e-1)" "unprognostic (4.98e-3)" "unprognostic (1.08e-2)" "unprognostic (5.05e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-2)" "unprognostic (8.00e-2)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" "unprognostic (7.71e-2)" "unprognostic (1.62e-1)" "unprognostic (1.40e-2)" "unprognostic (4.81e-2)" "unprognostic (8.09e-2)" "unprognostic (4.93e-2)" "unprognostic (9.17e-2)" 6.9 21.1 9.0 7.8 11.2 3.0 6.7 5.3 15.6 10.2 16.3 28.8 11.2 5.1 6.9 12.9 9.7 9.6 8.4 4.1 9.5 7.3 5.3 26.3 8.0 9.3 13.4 7.0 9.8 7.8 4.2 5.3 24.7 12.1 20.3 17.5 3.6 9.8 8.4 3.1 10.9 9.5 4.4 9.7 8.3 9.7 18.9 15.0 7.8 5.2 6.7 12.3 9.3 7.7 0.8 4.0 6.2 6.9 0.4 17.5 4.7 5.1 9.2 3.1 2.0 4.3 4.6 9.3 4.2 2.8 1.8 1.9 18.5 26.6 0.8 4.3 5.4 14.9 4.2 11.1 2.7 0.7 2.2 0.6 1.1 9.9 1.6 0.6 1.9 5.2 6.2 4.8 12.6 3.4 1.6 4.4 4.9 8.8 10.3 2.5 4.3 3.2 12.3 2.7 1.4 5.5 25.4 0.2 3.0 3.7 8.7 16.3 3.8 3.2 3.7 5.4 1.5 5.4 5.2 5.7 1.6 13.3 10.2 1.8 22.0 6.2 6.9 4.4 1.6 3.4 1.2 0.5 13.9 4.2 4.0 0.8 17.5 10.5 3.6 0.4 1.0 0.9 4.5 4.7 9.0 11.2 5.3 10.9 9.5 7.3 13.4 7.0 12.1 15.0 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell line enriched" "Detected in many" 8 "Hep G2: 20.7" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" 3955000000 5900000000 Nucleoplasm Cytosol "HPA048739: " "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favourable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.0 0.7 0.8 0.7 0.5 0.5 0.6 0.9 0.9 2.5 0.6 2.2 0.3 0.4 0.3 2.4 0.5 1.4 0.9 1.4 2.1 0.7 20.7 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.1 0.5 1.4 1.1 0.3 1.4 1.1 0.9 0.6 0.9 1.1 0.9 0.5 0.7 1.0 0.9 0.5 0.5 0.2 1.5 0.9 0.5 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 43.9;tongue: 15.3" "Cell line enriched" "Detected in some" 7 "U-937: 47.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 9 "dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2" "Low region specificity" "Detected in all" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol 42000 Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: " "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 1.3 0.1 0.0 2.3 0.2 43.9 0.1 0.3 0.1 1.1 0.7 0.0 0.0 0.1 0.2 0.3 3.1 0.1 0.1 5.5 0.0 0.0 0.0 0.2 3.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 4.8 0.2 0.1 0.1 0.0 1.0 0.1 1.3 2.5 0.1 0.1 0.0 2.8 0.1 0.1 0.1 4.0 0.9 15.3 1.5 0.1 1.3 0.3 2.1 3.3 4.2 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.2 4.2 3.3 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.1 0.1 1.8 0.3 0.0 2.1 0.1 0.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 132 "HaCaT: 64.1;hTCEpi: 24.4" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" 59000 "Nuclear speckles, Cytosol" "HPA052630: , HPA057129: " "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661963 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3" "Cancer enhanced" "Detected in many" "cervical cancer: 186.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" 11000000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: , HPA055992: " "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.7 0.2 0.2 0.2 0.0 3.8 0.2 140.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 5.4 0.2 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 1.1 0.0 0.2 13.0 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.2 21.3 3.1 13.1 80.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.1 8.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SERPINB7 MEGSIN ENSG00000166396 "Serpin family B member 7" O75635 18 63752935-63805376 "Disease related genes, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6" "Cell line enhanced" "Detected in some" "BJ: 45.7;fHDF/TERT166: 32.2;HaCaT: 78.8;HBEC3-KT: 25.0;HBF TERT88: 43.8;hTERT-HME1: 25.5;U-138 MG: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024200 Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Endoplasmic reticulum" Mitochondria "HPA024200: AB_1856730" "unprognostic (8.66e-3)" "unprognostic (6.31e-3)" "unprognostic (6.55e-2)" "unprognostic (4.03e-4)" "unprognostic (9.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (9.99e-2)" "unprognostic (4.70e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (2.02e-1)" "unprognostic (6.81e-2)" "unprognostic (1.62e-1)" "unprognostic (3.37e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-3)" 0.2 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 2.0 0.2 0.0 0.0 0.0 0.5 0.0 2.6 0.1 1.3 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.4 0.0 0.1 0.0 0.0 0.6 0.0 0.9 54.6 0.1 0.0 0.1 0.0 0.3 0.3 0.0 6.7 0.1 22.6 16.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.7 0.0 45.7 9.2 7.0 5.2 0.0 0.2 0.0 0.0 32.2 78.8 0.0 25.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.5 1.0 25.5 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 1.6 0.9 4.3 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63969925-64019779 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.6" "Cell line enhanced" "Detected in many" "HL-60: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 12.4 7.4 2.9 9.3 4.2 16.0 6.1 1.3 5.5 7.7 7.4 7.1 0.0 3.7 4.1 4.3 20.6 3.7 13.7 4.5 3.1 3.3 7.1 23.7 8.2 10.1 4.7 4.0 8.1 4.2 1.1 5.0 9.5 7.4 4.2 6.1 3.4 8.1 2.1 4.5 36.6 8.7 4.4 6.0 9.8 4.2 2.9 3.5 4.2 5.0 17.5 11.3 9.6 11.0 5.1 25.3 5.9 20.5 2.1 4.2 5.0 7.4 1.5 1.3 9.2 4.6 6.5 0.6 24.3 23.6 15.4 15.4 0.3 3.4 0.1 8.9 14.5 12.2 0.2 15.4 22.1 10.3 0.3 0.0 2.8 0.8 10.5 37.3 3.2 6.2 13.4 20.8 6.8 16.4 0.2 4.3 10.6 0.6 0.6 4.1 0.5 7.5 0.5 3.4 0.6 6.9 8.5 0.7 0.7 4.8 0.7 8.9 0.3 14.0 25.4 23.6 5.0 2.8 9.7 1.9 0.3 0.0 24.2 21.7 20.3 1.1 20.5 0.8 3.8 16.1 3.4 3.6 3.1 2.3 25.3 5.1 1.7 2.6 5.9 2.1 8.0 13.7 4.2 5.0 2.9 4.2 1.3 5.5 3.1 3.3 4.7 4.0 7.4 3.5 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887266-2903280 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.0;lymphoid tissue: 39.6" "Cell line enhanced" "Detected in many" "BEWO: 66.8;HUVEC TERT2: 14.6;TIME: 15.2;U-266/84: 13.7;U-698: 28.7" "Cancer enhanced" "Detected in all" "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol 4900000 Nucleoplasm Cytosol "HPA030067: " "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavourable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 5.6 5.1 3.3 15.9 4.1 7.2 2.6 3.6 6.7 3.9 2.1 4.4 1.3 1.7 1.9 1.9 4.6 4.1 5.3 4.9 3.4 3.6 2.5 7.6 13.7 39.6 4.8 3.9 3.8 1.3 4.7 4.9 24.5 4.7 2.6 2.9 3.5 7.5 1.3 2.0 1.0 5.5 2.4 7.1 14.4 2.0 4.4 2.0 6.4 4.2 2.1 18.9 3.4 3.8 10.3 6.4 2.9 38.0 18.8 17.9 12.3 0.0 2.8 0.1 0.0 0.2 0.1 66.8 0.5 0.1 0.6 1.0 0.8 5.4 10.9 6.8 0.6 0.0 8.0 0.0 0.6 3.5 0.8 1.0 1.0 1.5 3.9 0.0 0.0 3.0 0.0 1.2 0.0 14.6 4.9 0.1 0.5 0.2 0.0 0.0 9.3 0.0 1.0 0.0 0.1 0.4 0.0 0.4 0.1 6.5 0.0 0.0 0.0 0.1 15.2 0.0 0.1 0.0 0.0 0.0 13.7 28.7 0.0 0.0 0.0 1.7 18.3 0.1 17.9 38.0 14.7 8.3 13.0 16.8 6.1 10.3 12.1 17.5 2.9 18.8 22.0 6.4 13.0 12.3 3.3 4.1 3.6 6.7 3.4 3.6 4.8 3.9 4.7 2.0 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421592-40426025 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA063323: " "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 17.3 10.6 5.7 11.3 6.2 30.4 9.6 4.4 9.0 11.4 10.8 5.3 5.3 7.9 10.7 4.4 18.2 13.1 16.1 13.8 8.0 5.4 10.3 14.3 20.8 7.9 8.1 2.8 10.3 17.3 2.8 7.3 19.5 10.3 15.3 3.9 5.8 10.0 6.8 11.4 10.9 13.7 8.4 6.3 8.9 14.2 5.5 8.6 6.6 19.1 23.7 10.0 10.5 18.9 10.6 20.2 14.4 17.2 12.1 10.5 9.7 11.4 13.5 1.9 4.7 5.5 3.9 5.3 18.4 5.6 10.0 9.9 6.0 9.3 2.3 8.8 6.1 4.7 1.5 16.6 3.1 6.3 3.3 2.0 3.3 5.1 6.2 0.7 7.2 6.3 10.2 10.9 2.0 5.6 4.1 3.6 9.0 17.1 1.0 3.7 1.5 9.1 1.4 3.1 5.7 5.2 8.0 0.6 0.9 9.7 9.1 8.9 9.0 1.9 10.2 10.0 11.2 8.0 12.2 5.3 2.2 3.0 13.9 3.0 4.6 14.4 17.2 11.0 8.1 14.9 4.8 10.4 8.0 7.6 20.2 10.6 9.4 6.5 13.9 12.1 14.0 18.4 10.5 9.7 5.7 6.2 4.4 9.0 8.0 5.4 8.1 2.8 10.3 8.6 SERTAD2 "KIAA0127, Sei-2, TRIP-Br2" ENSG00000179833 "SERTA domain containing 2" Q14140 2 64631621-64751005 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019021, HPA020904" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019021: AB_1856740, HPA020904: AB_1856741" "unprognostic (1.40e-2)" "unprognostic (7.41e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (4.03e-4)" "unprognostic (2.15e-2)" "unprognostic (8.15e-2)" "unprognostic (3.39e-3)" "unprognostic (1.06e-1)" "unprognostic (9.55e-2)" "unprognostic (5.95e-3)" "unprognostic (1.98e-3)" "unprognostic (7.04e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.21e-3)" "unprognostic (6.78e-2)" "unprognostic (4.98e-2)" "unprognostic (3.84e-1)" 14.3 5.5 4.3 11.3 5.5 52.1 10.4 6.4 5.9 12.4 8.6 9.1 5.6 4.6 9.6 7.6 24.7 7.8 8.4 10.9 4.7 3.5 6.7 11.0 11.8 12.5 7.2 4.4 12.1 5.8 8.4 6.2 17.4 6.0 8.6 6.5 10.2 18.4 7.5 10.8 18.8 9.9 9.5 6.7 24.5 7.2 7.4 8.4 53.8 7.6 16.7 25.7 22.0 16.7 5.4 8.8 3.8 3.1 2.6 4.2 1.4 14.3 4.2 8.0 8.0 6.9 17.6 9.2 11.5 11.1 6.8 6.5 10.8 11.0 12.2 6.4 18.8 5.7 5.2 7.0 14.6 1.1 7.9 8.0 4.0 7.8 1.5 7.0 4.1 11.9 9.3 15.7 10.2 4.1 5.0 6.8 15.9 3.4 7.5 7.7 4.4 11.3 6.6 13.7 4.7 9.3 13.2 9.3 3.6 8.1 5.7 14.4 3.8 5.7 12.4 37.2 19.2 21.7 9.3 11.7 4.4 14.1 13.8 13.0 14.5 2.3 2.7 3.8 1.8 2.8 1.1 4.7 1.8 2.0 2.8 5.4 4.2 3.1 3.8 2.6 3.1 8.8 0.9 1.4 4.3 5.5 6.4 5.8 4.7 3.5 7.2 4.4 6.0 8.4 SESN1 "PA26, SEST1" ENSG00000080546 "Sestrin 1" Q9Y6P5 6 108986437-109094819 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 6 "B-cells: 21.0;NK-cells: 21.8;T-cells: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073659 Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA073659: " "unprognostic (2.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.02e-1)" "unprognostic (3.52e-2)" "unprognostic (1.17e-1)" "prognostic favourable (6.47e-5)" "unprognostic (2.68e-1)" "unprognostic (6.91e-2)" "unprognostic (1.01e-1)" "unprognostic (8.33e-2)" "unprognostic (1.83e-3)" "prognostic favourable (2.07e-4)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (7.95e-2)" 23.5 14.2 14.5 11.0 23.7 22.7 39.3 21.2 18.9 13.2 16.9 10.2 17.3 10.3 17.1 14.4 11.9 15.2 10.0 32.4 13.0 11.3 8.8 14.1 17.5 54.1 12.2 14.6 33.0 16.1 18.1 25.6 26.8 13.0 15.2 12.8 9.5 10.0 17.2 69.2 19.7 18.6 17.9 13.7 19.3 14.9 20.8 13.6 9.6 18.2 15.4 16.4 16.1 15.3 21.0 2.1 3.9 3.0 21.8 30.6 7.8 1.5 2.5 11.6 5.4 14.8 18.9 36.4 6.1 7.0 2.1 4.1 4.7 1.6 12.7 5.1 4.5 1.8 3.1 12.2 2.6 1.1 15.5 5.6 3.2 17.7 9.1 2.2 5.8 20.4 19.5 3.8 6.2 10.9 4.1 9.2 10.4 3.0 4.8 7.0 4.7 1.6 3.9 3.3 5.8 4.5 7.6 2.8 5.8 3.3 2.1 2.4 2.0 14.6 6.7 1.6 3.2 1.5 1.9 9.3 5.3 5.2 3.6 5.6 3.5 3.9 1.0 1.2 14.2 2.3 30.6 4.4 13.3 11.1 1.0 21.0 16.6 8.8 3.9 21.8 3.0 2.1 5.6 7.8 14.5 23.7 21.2 18.9 13.0 11.3 12.2 14.6 13.0 13.6 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 14.6;ASC diff: 24.8;ASC TERT1: 27.1;HSkMC: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 7.3 14.2 22.3 10.4 38.6 11.9 11.6 10.2 20.8 10.3 6.8 11.1 3.3 5.2 9.3 11.7 7.6 7.0 9.9 5.1 15.9 12.9 8.7 6.0 7.2 17.3 12.6 12.0 18.4 3.3 27.7 10.7 6.6 13.9 8.5 5.4 19.7 9.1 4.8 5.4 8.4 10.6 7.6 11.6 12.7 3.9 41.6 14.1 11.3 17.3 4.0 18.3 10.0 7.7 4.2 1.1 1.0 3.5 0.8 4.5 0.8 0.0 0.5 14.6 0.0 24.8 27.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 3.8 1.7 0.0 2.9 8.8 6.3 0.0 3.1 4.6 1.9 7.7 0.5 0.5 1.6 0.3 14.9 11.1 0.0 3.3 0.5 0.2 0.7 1.2 0.1 1.2 4.5 5.9 0.6 2.8 0.9 0.3 3.3 9.6 1.9 4.1 0.1 0.1 0.8 0.0 5.5 0.1 1.7 3.8 0.3 0.5 0.1 0.0 0.5 0.7 2.0 3.5 1.0 0.8 0.6 0.7 1.7 0.8 4.2 2.3 1.3 0.7 2.7 4.5 1.7 0.8 0.8 3.5 1.1 4.0 0.8 22.3 38.6 10.2 20.8 15.9 12.9 12.6 12.0 13.9 14.1 SET "2PP2A, IPP2A2, PHAPII" ENSG00000119335 "SET nuclear proto-oncogene" Q01105 9 128683424-128696400 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005232, HPA063683" Supported Enhanced "Nucleoplasm,Lipid droplets" 880000 Nucleoplasm "Lipid droplets" "CAB005232: AB_2185634, HPA063683: " "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.31e-1)" "unprognostic (3.77e-1)" "unprognostic (7.15e-2)" "unprognostic (4.37e-3)" "prognostic unfavourable (9.41e-7)" "unprognostic (2.00e-2)" "unprognostic (1.88e-2)" "unprognostic (3.62e-1)" "unprognostic (3.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (7.57e-2)" "unprognostic (1.91e-1)" "unprognostic (2.09e-1)" "unprognostic (1.54e-2)" 47.2 49.7 66.5 59.3 65.8 71.8 56.5 64.2 61.2 54.4 51.3 55.3 45.6 40.1 64.8 33.1 71.6 51.6 48.9 81.6 63.6 57.3 51.7 57.8 51.2 91.1 65.4 56.1 76.5 61.3 55.0 38.7 65.4 47.3 59.2 56.4 36.3 52.1 46.9 76.3 53.6 45.7 59.0 73.5 62.8 46.8 34.8 58.6 152.9 69.1 46.2 92.7 74.4 84.1 72.2 66.4 43.2 56.5 78.8 77.9 69.7 50.4 57.6 82.9 65.6 24.8 38.9 76.5 41.7 46.2 60.3 41.6 79.2 62.0 130.6 35.3 42.9 94.7 122.5 62.7 69.0 59.5 52.2 75.1 89.7 64.4 55.4 137.0 49.2 32.3 49.1 51.3 103.0 56.3 145.7 53.0 49.3 85.2 114.7 50.6 138.4 61.4 105.0 103.1 105.7 46.5 57.0 84.5 53.1 91.8 61.7 49.8 76.9 42.7 53.9 71.3 53.5 43.9 68.9 41.7 119.8 155.4 33.9 73.0 67.9 34.5 53.9 43.2 58.9 56.5 72.1 72.2 67.9 62.8 52.7 66.3 65.8 77.9 35.4 78.8 45.6 66.4 52.3 69.7 66.5 65.8 64.2 61.2 63.6 57.3 65.4 56.1 47.3 58.6 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "AF22: 9.3;Karpas-707: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9;naive B-cell: 7.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: , HPA057259: " "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favourable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 10.6 2.9 3.8 13.2 8.7 2.1 9.8 16.0 12.6 16.9 14.6 4.2 19.9 2.5 14.0 17.5 6.6 11.0 7.9 6.8 3.6 3.5 15.0 7.2 9.8 7.0 2.9 7.4 12.8 8.2 9.1 5.1 10.2 3.2 12.2 5.3 14.0 6.9 21.3 14.5 6.6 6.9 19.9 3.7 5.9 9.1 5.5 1.2 3.4 8.4 8.7 8.8 11.9 13.3 7.5 4.3 0.2 1.6 0.0 0.6 0.2 0.0 1.6 9.3 0.0 2.7 0.7 0.6 0.7 1.7 0.9 0.7 0.1 0.0 0.5 0.3 1.0 2.7 1.0 2.9 0.6 0.8 0.4 0.0 1.0 0.6 0.0 0.0 0.0 2.2 1.1 0.0 1.8 0.3 0.0 37.1 0.2 0.5 0.0 0.0 1.3 0.6 3.0 0.0 3.2 3.1 2.1 4.7 2.5 0.0 0.0 0.5 1.3 0.0 0.0 5.5 2.1 0.0 4.3 4.9 0.3 0.0 3.3 0.1 3.1 0.2 0.0 0.0 0.6 1.1 0.0 4.9 0.1 0.5 0.1 7.5 0.0 0.2 0.0 0.0 1.6 4.3 0.0 0.2 3.8 8.7 16.0 12.6 3.6 3.5 2.9 7.4 3.2 1.2 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2" Q9BYW2 3 47016429-47163967 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favourable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 13.2 10.5 12.2 15.2 15.4 20.0 11.7 22.4 16.4 13.4 14.0 9.1 12.9 9.5 15.8 7.5 10.8 11.4 8.7 8.8 10.6 6.8 11.4 10.3 10.4 11.8 11.7 9.5 16.0 13.4 21.4 16.3 10.7 11.3 12.4 10.9 7.7 12.7 14.8 27.6 12.5 11.5 11.9 9.8 13.8 10.4 12.8 12.8 23.2 15.8 5.5 12.8 16.1 15.5 4.8 2.6 6.0 2.3 7.1 3.9 1.0 11.4 9.0 15.2 7.8 9.1 10.6 6.4 10.6 10.3 12.4 11.3 9.5 7.5 25.3 6.6 14.5 7.0 16.4 10.1 16.8 14.5 6.5 25.9 15.1 7.3 6.8 19.4 15.0 9.1 9.7 12.2 15.2 11.4 16.6 9.6 10.1 6.0 14.2 2.6 11.5 7.5 9.4 14.7 13.1 6.2 15.1 6.6 10.5 17.8 7.0 6.6 7.4 14.4 14.6 13.6 10.2 11.6 16.8 12.2 13.6 25.5 7.9 11.1 7.9 2.4 2.2 5.2 3.9 2.3 2.4 3.7 2.4 3.0 2.5 4.8 3.5 3.0 6.0 7.1 1.9 2.6 1.0 1.0 12.2 15.4 22.4 16.4 10.6 6.8 11.7 9.5 11.3 12.8 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017093: , HPA035574: " "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavourable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavourable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 18.9 21.9 33.1 18.2 29.1 13.2 40.9 58.0 38.9 21.7 20.7 15.4 22.1 14.0 24.0 27.0 20.7 22.0 18.4 18.3 29.6 13.8 15.4 22.1 26.5 29.8 23.0 30.1 29.7 22.7 25.6 31.4 23.0 25.1 20.6 20.4 16.7 22.3 22.7 16.6 29.0 19.8 24.1 22.8 22.5 18.7 21.3 26.6 21.0 25.9 14.8 24.2 20.4 37.5 3.7 4.0 4.7 2.0 4.3 4.1 1.0 9.8 11.8 24.4 11.0 14.4 15.0 58.1 9.7 13.1 14.1 16.2 11.7 12.2 21.4 5.8 14.1 8.2 22.7 12.8 15.6 15.0 11.3 20.9 19.9 10.9 14.6 15.9 13.9 14.5 20.9 21.3 25.3 14.9 20.4 14.1 12.0 14.4 14.0 13.3 18.4 9.6 16.4 19.2 9.5 11.0 15.8 9.7 15.2 14.1 11.7 8.7 15.6 11.7 17.6 14.8 17.0 8.0 11.5 10.2 12.8 35.7 10.6 11.5 13.9 2.3 2.0 1.7 3.8 1.2 2.5 3.4 2.5 4.1 1.3 3.7 2.4 2.2 4.7 4.3 1.4 4.0 1.0 1.0 33.1 29.1 58.0 38.9 29.6 13.8 23.0 30.1 25.1 26.6 SETD6 FLJ21148 ENSG00000103037 "SET domain containing 6" Q8TBK2 16 58515479-58521181 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041481, HPA053546" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041481: AB_10804004, HPA053546: " "unprognostic (1.32e-1)" "unprognostic (2.98e-3)" "unprognostic (3.35e-1)" "unprognostic (2.81e-1)" "unprognostic (7.90e-3)" "unprognostic (1.95e-1)" "unprognostic (1.93e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (3.54e-4)" "unprognostic (3.74e-3)" "unprognostic (2.14e-1)" "unprognostic (3.73e-1)" "unprognostic (5.93e-3)" "unprognostic (1.55e-1)" 7.8 11.3 7.7 7.4 8.8 4.3 12.6 18.6 11.8 8.4 7.1 6.6 17.0 7.0 10.2 14.0 11.5 10.3 9.6 8.6 8.8 7.0 11.7 12.1 7.9 7.9 8.9 9.0 9.0 20.0 22.1 17.1 7.0 8.3 12.2 8.2 7.2 15.5 19.7 14.7 14.4 7.8 9.2 7.7 9.2 9.6 10.2 9.7 5.5 13.6 9.5 8.8 7.4 10.3 3.2 3.9 3.8 3.0 8.6 4.9 2.7 1.8 3.7 0.8 7.2 2.8 2.0 13.5 3.1 3.4 4.4 2.5 6.4 3.7 13.5 4.9 3.1 5.7 5.7 4.1 3.2 1.7 20.3 0.6 6.2 11.5 2.9 9.8 6.1 2.5 8.2 3.7 5.6 3.1 10.7 1.7 0.9 6.6 0.2 11.8 15.3 8.3 0.2 1.7 18.3 4.6 0.2 13.5 9.4 13.4 10.2 5.0 6.6 1.2 2.7 1.7 4.8 2.0 5.1 9.3 5.6 10.0 3.4 4.8 3.3 3.8 2.4 0.2 4.6 3.0 3.3 3.2 3.9 4.9 3.9 3.1 4.8 4.8 0.1 8.6 2.9 3.8 3.2 2.7 7.7 8.8 18.6 11.8 8.8 7.0 8.9 9.0 8.3 9.7 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: " "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavourable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.7 6.7 9.8 6.4 4.7 6.3 16.3 4.8 5.5 6.9 5.9 4.5 8.0 11.4 6.6 5.3 7.3 9.1 5.1 5.5 5.5 11.3 6.4 6.9 5.2 6.7 11.3 6.1 8.2 5.8 5.7 9.2 8.1 10.8 9.3 4.9 11.1 7.8 6.6 13.4 5.4 9.1 6.3 8.4 5.3 6.6 7.1 13.0 7.3 8.6 5.8 9.3 15.4 5.4 4.0 4.2 4.4 6.7 9.7 10.4 88.6 4.2 4.0 3.9 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 SETSIP SETP18 ENSG00000230667 "SET-like protein" P0DME0 1 92074533-92075441 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell line enhanced" "Detected in some" "MOLT-4: 2.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA063683 Approved Supported "Nucleoplasm,Lipid droplets" Nucleoplasm "Lipid droplets" "HPA063683: " "unprognostic (2.31e-2)" "unprognostic (3.79e-3)" "unprognostic (7.59e-2)" "unprognostic (5.74e-2)" "unprognostic (5.60e-2)" "unprognostic (7.74e-2)" "unprognostic (1.88e-8)" "unprognostic (3.43e-1)" "unprognostic (1.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.35e-4)" "unprognostic (1.63e-2)" "unprognostic (2.58e-1)" "unprognostic (3.10e-2)" "unprognostic (4.93e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.2 0.6 0.3 0.1 0.2 0.1 0.6 0.7 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 1.3 0.5 0.4 0.0 1.2 0.0 0.0 0.3 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.9 1.2 0.0 0.0 2.3 0.0 1.6 0.5 1.2 1.0 1.4 0.0 0.6 1.5 0.6 1.3 0.9 0.5 0.7 0.2 0.0 0.7 0.4 0.2 0.2 0.7 0.6 1.2 0.0 0.1 1.8 0.0 0.0 0.6 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 SETX "ALS4, AOA2, KIAA0625, SCAR1, Sen1" ENSG00000107290 Senataxin Q7Z333 9 132261356-132354985 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis" "Helicase, Hydrolase" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024105, HPA057269" Approved Supported "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA024105: , HPA057269: " "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (3.23e-1)" "unprognostic (2.03e-1)" "unprognostic (9.99e-2)" "unprognostic (2.14e-2)" "unprognostic (4.86e-2)" "unprognostic (1.64e-2)" "unprognostic (2.06e-2)" "unprognostic (1.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.32e-1)" "unprognostic (6.76e-3)" "unprognostic (2.47e-1)" "unprognostic (1.13e-1)" "unprognostic (5.64e-3)" "unprognostic (6.42e-2)" 20.3 12.3 13.0 23.5 15.0 14.0 16.1 16.7 14.8 14.7 16.0 11.2 14.5 9.9 18.3 15.2 13.2 17.5 12.3 13.8 13.0 8.3 12.5 15.8 18.5 23.5 19.8 12.6 15.8 11.0 24.0 24.6 13.4 16.9 13.8 12.6 8.6 16.2 16.1 18.4 15.2 19.4 16.9 20.6 25.7 13.2 34.5 18.1 26.3 31.6 10.8 24.0 18.8 16.3 8.0 5.5 16.9 5.0 5.3 6.5 2.3 9.2 12.3 14.3 15.4 18.5 22.4 8.6 12.3 13.8 10.0 9.4 13.0 10.5 15.7 6.0 22.8 18.9 14.3 10.6 11.0 14.9 6.2 16.4 13.9 11.2 17.3 25.2 20.0 15.7 16.8 17.0 15.2 16.0 19.0 12.7 11.5 13.3 15.5 9.6 15.3 9.7 14.8 20.8 10.4 11.1 12.1 8.9 13.7 20.2 9.0 11.2 12.4 13.0 18.2 21.0 9.1 14.0 11.7 7.8 13.1 24.4 9.6 10.1 11.2 7.7 4.9 4.8 6.1 4.5 6.5 6.2 4.6 4.6 3.6 8.0 5.0 4.3 16.9 5.3 5.0 5.5 3.4 2.3 13.0 15.0 16.7 14.8 13.0 8.3 19.8 12.6 16.9 18.1 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990921 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: " "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavourable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 7.0 6.4 5.3 6.3 5.9 13.6 7.6 7.4 5.5 6.3 6.5 4.3 9.4 8.7 6.8 7.7 4.1 4.3 4.8 4.9 5.9 6.2 6.1 8.4 5.3 8.7 6.7 6.4 5.7 5.6 6.1 7.2 5.9 7.2 15.3 7.7 5.9 7.7 4.3 7.9 6.2 5.8 6.3 10.3 6.2 6.1 23.6 19.0 10.6 20.6 18.7 27.8 20.6 15.7 12.0 21.7 18.5 13.6 12.6 26.3 15.4 14.1 27.0 21.9 19.7 16.7 29.9 13.5 14.9 13.6 27.6 22.4 33.2 13.6 26.9 38.0 19.2 17.0 12.5 46.2 18.4 11.9 15.7 28.0 18.5 18.7 33.4 11.8 19.5 10.5 24.3 26.7 53.6 18.7 29.1 37.3 21.5 12.4 16.4 19.0 14.1 19.7 9.2 16.2 10.9 18.3 16.8 14.2 15.6 13.0 30.5 11.4 16.1 30.5 13.6 42.6 17.6 10.6 15.3 9.8 21.8 18.9 21.2 20.4 25.8 22.0 19.0 23.6 27.8 23.6 2.0 18.7 20.6 11.8 26.3 20.6 SF3B3 "KIAA0017, RSE1, SAP130, SF3b130" ENSG00000189091 "Splicing factor 3b subunit 3" Q15393 16 70523788-70577670 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041134, HPA042986" Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041134: , HPA042986: AB_10960386" "unprognostic (3.39e-2)" "unprognostic (1.53e-1)" "unprognostic (7.47e-2)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (1.06e-2)" "unprognostic (7.67e-2)" "unprognostic (2.07e-1)" "unprognostic (2.29e-1)" "unprognostic (6.97e-2)" "unprognostic (2.29e-1)" "unprognostic (3.28e-2)" "unprognostic (1.60e-1)" "unprognostic (8.76e-2)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" 23.8 21.1 11.8 22.1 23.2 24.7 22.4 24.9 26.9 23.4 20.6 20.9 15.6 17.1 27.5 13.9 31.8 22.1 15.6 20.1 14.0 12.8 17.0 19.0 18.4 28.5 16.9 15.0 33.3 22.5 34.0 26.8 19.9 16.5 18.4 16.4 20.2 22.6 17.3 30.9 28.9 18.8 20.1 15.4 21.0 17.9 15.5 15.9 47.7 25.1 17.2 31.9 23.7 25.0 23.2 21.4 16.4 18.8 21.0 25.9 19.7 18.4 19.4 25.2 17.6 12.5 11.6 19.0 17.5 15.0 22.9 18.6 19.8 14.8 24.8 14.2 13.7 21.8 26.5 15.0 37.0 8.0 18.6 19.3 15.9 20.9 8.5 27.1 22.8 11.0 10.9 25.5 18.9 13.7 26.3 8.9 18.2 22.8 23.8 13.4 23.1 11.2 42.1 19.6 27.8 7.4 25.5 21.9 16.2 57.1 9.1 8.8 19.6 13.5 14.0 17.0 18.6 13.1 18.4 10.0 21.9 66.5 11.3 17.4 15.8 11.5 15.8 16.4 23.1 18.8 25.4 18.6 21.8 24.2 21.4 23.2 25.9 22.0 5.4 21.0 17.9 12.0 24.0 19.7 11.8 23.2 24.9 26.9 14.0 12.8 16.9 15.0 16.5 15.9 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 16.2;REH: 14.5;RPMI-8226: 13.5;THP-1: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA035447: , HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.0 4.2 9.6 5.9 11.7 6.1 6.2 6.6 13.7 2.5 2.8 26.7 1.1 2.0 4.3 3.7 2.3 3.7 3.6 3.9 12.6 6.9 2.7 1.1 4.1 7.2 14.6 7.4 11.2 3.8 10.1 6.6 3.7 10.8 6.5 3.4 3.9 4.6 3.6 3.9 1.2 3.5 3.4 10.6 9.0 2.9 1.5 9.7 2.0 7.8 1.1 6.2 3.7 4.1 0.1 5.4 1.7 7.4 1.3 1.8 0.4 0.0 3.4 0.2 0.0 0.0 0.2 3.1 0.1 0.0 0.0 0.0 0.0 0.8 5.3 0.0 0.1 1.5 5.9 0.0 0.0 0.3 5.3 0.0 8.8 0.0 0.4 5.7 0.7 0.8 0.2 0.0 0.1 0.0 8.9 16.2 0.0 2.3 4.5 9.0 1.0 0.0 14.5 1.7 13.5 0.0 0.4 1.3 11.1 0.0 0.0 0.0 0.8 17.4 0.0 0.0 1.8 0.2 0.1 6.9 9.9 0.0 0.7 10.9 0.1 0.1 0.4 1.7 1.4 3.8 0.8 0.1 0.5 0.9 0.7 0.1 1.8 1.1 0.2 1.3 7.4 5.4 0.0 0.4 9.6 11.7 6.6 13.7 12.6 6.9 14.6 7.4 10.8 9.7 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Cell line enhanced" "Detected in many" "A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported Nucleoli,Cytosol "Secreted in other tissues" 54000000 Cytosol Nucleoli "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favourable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavourable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavourable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 68.6 11.6 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.2 36.2 0.6 3.0 0.0 108.3 0.0 166.7 0.0 16.4 0.5 0.0 11.6 12.2 0.0 0.0 0.1 0.0 111.9 0.0 29.3 0.0 0.1 0.4 0.0 14.6 0.0 0.0 0.2 19.3 0.0 0.0 3.8 25.9 15.8 0.0 0.0 16.6 2.9 0.1 7.7 0.1 0.0 0.0 31.7 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261958-41309497 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 105.4;BJ hTERT+ SV40 Large T+: 30.5;HBF TERT88: 43.2;hTCEpi: 39.4;NTERA-2: 31.5;RPTEC TERT1: 64.8;WM-115: 42.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" 1600000 Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: " "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favourable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavourable (3.12e-4)" 20.1 3.4 4.6 2.4 7.5 0.3 73.2 10.8 5.6 58.4 6.1 15.2 8.0 3.0 35.6 19.3 9.7 25.9 15.5 43.9 7.8 2.5 30.6 1.5 1.8 0.9 4.5 6.7 12.5 1.5 0.6 0.7 9.9 24.1 12.8 7.8 19.3 73.2 27.1 1.9 20.8 5.4 21.4 2.8 5.0 11.0 11.1 13.7 0.0 3.3 18.4 5.1 10.9 41.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 11.6 0.3 10.6 0.6 2.2 20.0 105.4 30.5 29.1 0.0 2.6 0.0 0.1 0.1 0.1 1.6 8.0 43.2 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.1 1.8 39.4 3.0 3.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 31.5 0.0 0.0 2.4 0.0 64.8 0.0 0.6 2.8 0.8 0.0 6.1 0.0 0.3 0.2 0.0 3.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.5 10.8 5.6 7.8 2.5 4.5 6.7 24.1 13.7 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.7 12.4 8.8 9.3 7.1 5.9 19.8 10.7 7.4 12.7 8.7 12.1 6.7 16.9 10.0 7.9 12.9 12.4 9.8 7.4 5.2 19.5 15.3 6.7 14.1 7.6 19.7 15.2 6.6 11.3 11.4 13.8 7.8 21.2 6.7 5.6 17.2 16.6 30.0 23.0 20.7 19.4 8.9 13.3 7.3 10.1 13.8 15.6 10.1 8.5 12.7 12.3 15.5 10.0 10.5 13.8 8.1 11.8 19.3 21.0 17.1 10.4 13.6 14.0 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavourable (7.47e-4)" "prognostic unfavourable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favourable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.2 13.0 10.6 22.2 19.5 17.4 16.7 20.6 17.8 14.6 22.1 27.0 27.3 11.7 15.8 16.9 16.2 15.5 17.0 22.3 16.2 28.3 13.8 10.9 37.9 17.6 34.9 28.2 16.3 20.2 16.8 14.7 7.8 25.6 11.8 22.5 21.4 10.2 59.7 10.4 12.7 7.2 12.3 27.4 35.7 13.9 2.0 9.3 14.1 23.1 18.4 12.5 63.3 7.2 9.1 17.6 24.2 21.4 11.3 8.2 12.8 19.4 22.0 22.3 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: " "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favourable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.3 11.6 8.9 2.8 1.8 4.2 6.9 3.9 11.0 5.8 11.2 8.7 2.0 7.2 7.2 3.0 9.0 9.9 5.2 8.3 5.8 8.4 7.2 14.7 3.5 4.3 9.2 4.8 2.7 7.7 0.9 6.4 7.3 1.7 2.9 6.6 1.2 6.5 14.3 4.7 8.0 9.6 2.5 6.4 8.0 7.5 2.1 6.4 3.3 2.6 1.7 2.2 4.6 3.3 11.0 4.7 7.9 3.0 2.9 2.4 11.5 7.9 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: " "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.8 12.0 12.2 19.7 19.4 36.5 2.2 14.5 29.3 12.4 18.8 7.5 22.8 3.6 20.7 25.6 2.5 18.3 6.4 16.9 0.6 9.9 0.3 11.8 8.1 15.2 1.1 0.0 29.4 9.0 18.2 23.8 8.7 0.0 28.8 14.4 12.0 0.0 0.0 9.3 9.5 5.4 15.1 7.6 24.0 3.8 7.7 6.2 0.0 16.1 18.4 5.6 0.1 0.0 39.2 13.1 3.6 22.4 14.9 18.5 4.4 14.6 0.0 22.0 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA052590: , HPA053608: " "unprognostic (1.38e-2)" "prognostic favourable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favourable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favourable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 11.1 11.4 7.9 11.8 12.5 9.9 15.5 20.9 11.0 19.5 17.1 10.6 16.9 11.6 21.4 10.2 9.0 17.6 11.1 10.7 7.9 6.8 9.8 12.9 11.1 17.2 16.5 7.1 31.5 17.7 8.6 9.4 8.4 10.8 13.1 6.9 12.1 14.8 20.0 36.1 12.2 13.4 21.4 13.4 11.6 13.5 35.6 14.4 17.6 19.5 9.0 10.4 17.1 25.1 25.4 27.6 18.8 18.2 19.5 36.1 20.4 6.9 11.9 9.1 5.9 6.3 6.2 16.6 4.7 5.4 12.5 11.8 13.6 6.3 21.2 11.9 3.7 8.3 7.0 8.3 3.5 6.8 13.2 13.1 7.3 18.1 15.5 11.7 14.8 6.6 11.4 7.4 7.6 4.6 11.0 10.8 4.4 23.4 13.3 23.1 12.6 11.6 20.8 5.9 18.3 6.2 10.6 14.8 6.8 7.4 14.1 7.9 11.6 9.7 3.2 8.7 7.4 5.0 8.3 12.6 18.3 12.3 6.2 19.9 6.9 5.0 18.2 18.8 22.3 15.6 26.9 22.2 31.2 27.2 18.3 25.4 36.1 27.8 5.6 19.5 12.5 27.6 29.6 20.4 7.9 12.5 20.9 11.0 7.9 6.8 16.5 7.1 10.8 14.4 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66667596-66862022 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006699, HPA027146" Supported Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favourable (5.52e-6)" "prognostic favourable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favourable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 6.5 5.9 13.9 8.7 20.9 7.7 23.9 9.8 14.8 12.0 10.0 24.0 8.7 8.6 8.0 10.3 7.6 7.8 7.8 5.4 16.1 10.2 14.9 13.6 9.9 8.5 28.8 9.3 9.8 15.6 29.2 14.8 5.9 14.6 7.8 10.7 17.2 7.0 7.7 6.1 12.4 10.8 6.0 32.8 8.2 7.2 8.9 21.9 8.3 17.3 4.3 6.8 6.1 8.0 5.8 13.8 21.4 15.7 6.9 13.3 8.0 11.4 2.9 0.5 1.8 3.5 6.8 6.5 7.3 6.9 4.0 4.2 5.2 7.7 8.6 1.8 8.0 3.7 6.0 4.3 5.0 4.8 10.2 7.8 2.1 5.1 3.5 7.0 9.3 3.3 3.8 1.9 6.7 6.4 1.5 4.2 7.6 1.8 5.5 4.3 1.6 4.0 9.7 4.3 5.8 5.4 2.6 2.5 1.9 3.3 4.9 11.0 23.1 14.0 7.6 3.8 3.4 3.3 2.7 5.2 9.9 9.9 4.4 11.8 3.9 21.4 15.7 6.2 8.1 9.3 13.3 3.7 8.4 8.5 13.8 5.8 9.0 6.9 2.5 6.9 4.4 7.7 5.3 8.0 13.9 20.9 9.8 14.8 16.1 10.2 28.8 9.3 14.6 21.9 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.2 6.2 5.7 2.0 2.5 4.5 0.8 0.4 2.1 1.9 6.2 0.7 7.1 0.9 2.9 3.1 4.6 2.5 2.7 4.0 6.8 7.4 4.0 3.6 0.2 9.9 5.2 1.2 7.4 7.5 4.2 2.3 7.1 0.6 1.3 7.2 2.5 6.6 6.2 1.0 7.2 8.8 4.7 1.2 6.8 3.8 3.5 4.4 2.4 3.7 3.7 5.5 3.1 4.2 3.6 4.2 5.0 3.9 3.6 8.6 3.1 7.3 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favourable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 15.8 7.5 2.2 4.9 8.0 10.6 10.4 10.6 10.7 7.5 7.0 6.2 16.5 11.7 6.2 13.9 10.1 5.2 11.1 7.8 10.2 5.5 16.9 10.1 4.8 9.3 3.8 4.2 6.8 13.1 9.9 12.1 10.5 32.5 17.7 8.0 6.7 1.7 2.2 5.0 7.2 2.8 10.2 4.5 10.9 16.8 3.4 2.7 7.7 7.8 4.0 11.7 1.4 14.6 8.1 9.9 7.7 7.7 6.0 4.7 3.3 10.1 6.4 6.6 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035501: , HPA069302: , HPA069857: " "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.4 10.8 14.7 9.0 0.7 1.3 10.0 10.2 5.2 14.9 16.3 7.6 11.7 14.5 5.1 4.2 5.5 13.9 5.6 18.8 18.4 9.2 16.4 7.4 6.1 0.1 14.9 14.2 0.1 0.4 16.3 6.9 8.8 14.0 25.9 12.3 9.3 23.4 8.4 15.7 8.2 15.0 18.9 8.4 3.7 6.9 7.3 7.7 11.2 13.9 6.7 9.0 10.5 2.4 11.3 13.5 10.0 20.3 11.1 25.9 16.8 6.2 15.1 16.9 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200583782 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.6;lymphoid tissue: 25.7;testis: 27.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: " "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 5.3 1.7 1.5 8.6 2.3 5.3 3.5 4.0 3.1 1.6 2.7 0.7 0.3 2.1 1.6 1.0 3.7 1.6 1.3 1.4 1.9 1.5 1.8 1.0 1.9 6.5 2.7 3.7 2.2 1.2 1.1 0.9 2.2 3.2 1.4 2.9 0.1 1.7 1.5 1.0 2.0 2.8 1.7 3.5 3.9 1.7 27.9 2.3 25.7 1.5 4.1 7.0 2.0 1.8 3.8 2.1 12.6 1.9 2.4 4.2 1.4 15.5 7.3 17.6 7.9 2.4 3.9 10.9 17.9 7.5 15.4 15.5 11.2 10.5 10.1 8.3 8.5 11.6 15.5 9.3 26.4 20.3 7.7 19.1 10.5 8.0 0.7 19.9 15.5 1.5 1.1 15.5 8.0 13.6 14.7 15.0 29.1 6.9 16.0 8.2 12.5 18.2 12.7 23.3 9.3 6.4 6.1 10.3 7.1 13.1 6.4 7.8 6.8 11.7 8.2 16.2 16.1 14.8 15.6 6.8 14.2 22.1 10.2 13.4 23.1 12.6 1.8 5.1 2.8 1.7 1.9 3.0 3.2 2.8 1.0 3.8 2.4 3.0 1.3 2.4 1.9 2.1 4.2 1.4 1.5 2.3 4.0 3.1 1.9 1.5 2.7 3.7 3.2 2.3 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 8.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favourable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favourable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 11.1 15.3 51.8 13.3 45.8 17.3 15.9 14.4 43.7 11.6 12.1 12.6 14.9 10.8 13.3 38.6 16.5 12.7 15.1 12.3 43.2 24.9 12.6 6.6 14.7 15.4 13.9 34.8 11.3 14.8 25.4 30.7 11.1 18.9 20.6 7.4 13.6 23.0 18.1 13.4 23.0 13.0 14.2 13.7 16.6 14.2 10.0 17.6 9.4 15.7 6.0 10.8 16.1 10.9 0.6 0.9 8.6 0.4 1.3 2.1 0.7 10.1 15.7 14.4 20.0 8.2 9.9 21.4 8.8 10.4 12.3 12.5 15.8 19.6 4.9 9.6 12.8 14.4 8.8 10.4 4.3 7.2 18.0 8.6 23.8 16.7 7.0 5.1 13.0 10.6 6.9 12.4 7.2 12.7 5.1 7.4 7.3 21.6 10.9 6.9 7.0 6.9 24.0 7.3 3.9 15.8 21.4 7.0 16.6 11.0 8.3 6.6 21.5 6.2 14.8 9.9 11.3 14.5 11.6 6.1 0.9 4.5 8.6 6.8 8.7 8.6 0.4 2.1 1.7 0.3 1.5 0.1 0.7 1.0 0.7 0.6 2.1 1.1 0.2 1.3 0.0 0.9 1.0 0.7 51.8 45.8 14.4 43.7 43.2 24.9 13.9 34.8 18.9 17.6 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.5;HaCaT: 15.9;HBEC3-KT: 30.6;SK-BR-3: 15.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: " "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavourable (6.21e-4)" "prognostic favourable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.5 0.2 0.4 9.2 0.9 1.9 5.3 0.6 0.5 4.7 19.7 0.5 8.7 10.9 3.8 6.7 20.0 3.0 15.8 0.4 0.4 0.0 9.6 1.7 13.4 5.4 0.6 0.4 1.1 18.8 4.9 3.4 14.3 0.9 11.0 4.3 1.6 24.0 13.3 0.8 15.3 18.0 2.2 1.0 3.8 11.0 2.5 0.4 5.0 10.9 11.0 17.2 9.0 9.4 5.6 0.4 0.0 0.1 1.9 9.2 1.0 18.5 2.7 0.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 6.7 14.4 2.9 8.5 0.0 15.9 1.1 30.6 0.0 1.3 2.7 0.1 2.3 1.0 0.0 0.2 4.0 0.0 12.8 0.0 3.1 0.0 3.1 7.0 0.0 6.5 1.3 0.0 0.6 5.3 0.5 0.0 11.3 5.5 11.8 0.0 0.0 1.0 15.4 0.0 10.3 0.1 0.3 0.3 1.0 0.2 0.1 6.1 6.6 3.5 0.1 2.0 0.1 0.0 0.0 0.0 3.0 0.1 5.2 3.9 6.8 6.2 0.1 5.6 9.2 4.7 0.0 1.9 0.1 0.4 3.3 1.0 0.4 0.9 0.6 0.5 0.4 0.0 0.6 0.4 0.9 0.4 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell line enhanced" "Detected in many" "U-266/70: 15.3;U-87 MG: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: " "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.0 1.3 1.7 2.5 3.7 4.3 0.5 1.9 0.9 0.9 0.7 0.7 2.2 3.3 5.1 5.0 0.1 0.9 1.5 1.4 2.0 3.4 3.3 0.6 1.3 7.6 1.2 0.7 3.5 6.2 3.2 6.3 1.0 2.5 4.3 3.5 4.1 2.2 1.9 1.7 2.9 3.5 6.4 2.1 4.6 0.8 4.8 2.0 2.9 2.4 3.1 9.0 0.6 0.8 2.5 0.3 1.5 3.7 15.3 3.2 3.3 47.5 2.9 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793023-2841098 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036790 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavourable (5.42e-6)" "prognostic unfavourable (9.52e-4)" "prognostic favourable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favourable (2.67e-4)" 17.5 7.0 9.7 20.4 14.5 30.2 13.1 6.1 10.1 9.0 11.6 9.8 7.5 8.9 7.9 18.7 10.8 8.7 9.5 9.9 9.3 8.8 26.3 18.3 20.2 18.5 12.0 3.5 8.8 10.1 3.6 7.6 20.8 15.4 8.4 7.4 11.6 9.3 7.8 11.0 31.2 14.2 8.9 14.5 46.8 10.8 5.0 12.2 5.2 8.0 6.9 17.4 11.6 10.9 4.4 8.6 16.7 21.9 3.8 7.0 5.4 5.2 3.2 3.7 5.1 3.1 7.7 3.5 8.3 6.9 6.5 5.8 2.3 16.3 8.2 9.6 6.9 2.5 0.2 5.5 3.9 4.2 3.3 19.3 6.5 2.7 10.1 7.9 13.7 14.6 5.2 3.7 3.3 14.2 1.1 19.2 7.7 4.2 1.2 9.5 5.9 6.2 0.3 3.3 3.6 11.0 8.2 11.1 8.2 6.1 5.8 4.1 8.8 13.3 17.9 6.3 4.8 2.2 6.2 8.1 3.8 1.7 7.3 21.5 6.7 1.8 10.5 6.7 7.0 18.6 4.4 1.4 1.9 4.6 8.6 4.4 1.0 2.7 16.7 3.8 21.9 3.5 3.5 5.4 9.7 14.5 6.1 10.1 9.3 8.8 12.0 3.5 15.4 12.2 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254853-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: " "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 38.6 72.5 12.7 20.0 13.4 29.9 35.7 34.8 22.3 30.5 12.7 20.7 42.0 7.5 33.9 20.4 11.9 32.2 29.0 9.6 17.2 11.2 19.6 9.9 38.8 25.1 13.0 18.9 49.6 7.1 30.0 14.7 19.5 15.1 13.5 4.9 12.4 22.4 45.1 61.7 10.1 10.3 21.0 19.0 14.8 7.2 17.0 10.8 9.3 20.8 7.7 18.9 25.3 44.3 13.3 4.8 8.0 3.9 13.0 28.9 9.5 7.2 3.6 1.7 3.4 15.7 13.3 92.0 4.0 2.7 2.2 2.7 2.3 3.3 6.1 1.7 10.5 0.9 0.8 3.4 1.9 4.7 3.4 4.1 16.5 0.4 6.0 1.1 2.1 10.6 2.5 10.0 2.1 30.7 4.5 2.0 3.0 26.0 14.4 6.8 3.6 5.5 0.2 8.2 27.5 2.6 12.2 4.1 2.2 5.5 5.0 5.8 4.5 3.0 23.6 5.9 8.2 5.6 3.1 0.8 1.7 4.2 11.2 4.0 7.9 3.5 3.9 4.5 28.9 1.3 9.1 10.9 13.7 19.9 4.8 13.3 7.5 9.8 8.0 13.0 2.1 2.2 5.7 9.5 12.7 13.4 34.8 19.2 17.2 11.2 13.0 18.9 15.1 10.8 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248826633 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 4.1 5.0 5.3 4.0 4.8 3.0 3.3 10.3 8.7 4.1 4.9 6.2 4.9 2.5 7.2 4.7 3.3 6.5 5.5 4.0 4.1 4.5 3.9 4.2 4.2 3.9 4.2 5.9 2.4 5.0 3.9 2.9 5.1 5.7 13.6 8.0 5.6 4.3 5.0 5.4 4.3 3.6 3.6 4.0 4.1 3.7 1.1 1.2 6.2 1.8 0.4 1.5 1.0 9.8 6.2 8.2 9.4 11.8 8.0 10.9 22.3 7.7 13.1 9.9 6.0 8.8 5.0 13.6 18.7 10.6 7.8 9.6 6.3 11.3 2.8 8.1 6.7 4.8 7.2 8.8 9.8 6.5 10.3 14.5 5.6 8.6 13.8 5.2 8.7 3.2 8.3 6.0 14.5 16.0 9.4 5.8 10.0 8.9 4.4 9.6 13.2 6.9 8.6 7.4 9.2 18.1 11.9 16.1 6.9 6.5 34.0 13.0 14.5 4.5 12.0 10.1 6.8 5.5 1.8 5.4 1.1 1.0 1.1 0.5 1.5 0.9 1.2 1.1 0.5 0.4 6.2 0.4 0.4 0.8 0.2 1.0 SH3D19 "DKFZp434D0215, EBP, Eve-1, EVE1, Kryn, SH3P19" ENSG00000109686 "SH3 domain containing 19" Q5HYK7 4 151102751-151325632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 54.3;ASC TERT1: 46.4;HSkMC: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016424, HPA058562" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA016424: AB_1856814, HPA058562: " "unprognostic (1.09e-1)" "unprognostic (6.14e-2)" "unprognostic (1.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (5.09e-1)" "unprognostic (7.37e-2)" "unprognostic (1.48e-1)" "unprognostic (6.40e-3)" "unprognostic (1.86e-1)" "prognostic favourable (1.38e-5)" "unprognostic (7.90e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.64e-2)" 56.0 9.5 6.8 11.2 14.2 0.0 24.2 4.4 9.2 19.2 28.5 20.1 10.7 20.3 22.8 13.9 23.6 17.3 29.6 31.7 7.8 5.1 12.8 23.1 26.1 3.7 13.6 5.5 27.2 7.8 15.4 6.0 16.8 12.7 18.8 23.0 12.4 14.1 19.8 12.8 17.4 35.9 26.6 7.7 3.1 14.6 12.3 15.1 0.3 15.6 12.8 6.7 27.7 23.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 7.0 5.2 3.3 2.6 54.3 46.4 7.2 8.7 9.3 3.9 4.0 6.7 8.7 0.0 3.5 8.1 5.2 3.5 10.0 3.8 0.0 2.8 0.0 6.3 7.1 13.1 0.0 0.0 36.8 7.7 5.8 9.0 22.5 0.0 0.0 10.1 2.9 0.0 0.1 6.7 7.6 0.0 0.2 0.1 4.8 4.9 0.2 4.6 6.2 6.4 5.1 2.0 0.0 16.3 12.3 4.4 5.4 3.4 0.0 0.0 0.0 6.3 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.8 14.2 4.4 9.2 7.8 5.1 13.6 5.5 12.7 15.1 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306387-36324886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 26.2" "Cell line enhanced" "Detected in many" "HaCaT: 16.1;SK-BR-3: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "HPA042212, HPA042456, HPA066168" Approved Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: " "prognostic favourable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavourable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.6 1.1 11.6 3.4 9.5 1.9 10.1 12.2 11.3 4.4 5.3 1.1 1.4 16.6 2.8 2.7 7.1 1.9 3.0 2.2 5.2 2.2 8.6 1.4 4.5 2.8 1.9 7.0 4.0 1.0 1.3 2.2 19.4 7.4 7.0 6.0 12.4 12.7 2.6 1.0 16.2 24.3 2.0 2.4 1.6 2.3 6.6 1.9 0.0 26.2 4.1 4.5 3.7 6.7 0.1 0.3 2.0 0.5 2.7 0.6 0.0 9.9 0.3 1.9 2.2 0.6 1.2 10.8 4.8 1.0 3.6 1.6 5.6 4.0 1.8 5.3 2.0 16.1 1.7 3.6 3.0 0.5 0.7 1.6 3.4 4.4 1.6 0.9 2.4 0.6 3.0 2.4 1.8 1.3 0.2 3.1 1.7 5.9 1.6 0.9 1.2 1.9 2.4 0.1 1.2 4.1 1.2 4.0 2.0 1.1 12.1 3.8 0.4 0.4 2.8 1.5 0.8 4.8 0.5 3.5 1.1 2.1 4.1 0.9 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 11.6 9.5 12.2 11.3 5.2 2.2 1.9 7.0 7.4 1.9 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;RT4: 26.7;SCLC-21H: 17.4" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: " "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favourable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.5 0.0 0.0 0.0 0.0 26.7 17.4 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favourable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favourable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favourable (4.28e-4)" 9.3 18.8 36.9 11.7 27.0 30.4 16.6 31.3 47.2 15.8 16.4 33.0 43.7 25.7 14.4 14.2 29.5 21.0 13.6 14.8 34.2 24.4 15.8 6.6 14.9 13.6 28.8 37.9 20.0 35.9 29.1 26.8 45.2 26.3 21.3 10.1 13.4 30.0 33.8 19.4 46.6 20.4 16.6 30.9 14.9 25.8 7.8 24.1 16.9 16.4 15.0 15.8 27.8 18.1 7.7 7.6 6.6 4.6 5.0 4.9 2.8 13.2 11.2 5.5 7.5 3.3 4.2 16.5 4.6 10.5 9.2 8.5 7.0 22.9 14.0 3.7 8.2 32.7 1.7 10.0 2.6 8.9 7.5 3.5 18.0 6.1 7.0 3.1 8.6 3.0 11.5 4.7 4.2 7.7 4.7 18.7 4.6 32.6 18.0 8.4 4.9 7.9 36.6 10.4 62.6 10.3 16.1 17.4 14.1 6.7 17.5 7.2 25.1 4.7 7.0 4.3 7.4 10.9 10.1 18.2 8.9 8.9 10.0 3.9 2.3 4.4 3.3 6.6 4.1 1.6 4.9 7.7 4.7 3.8 2.7 3.8 3.4 3.0 2.7 5.0 4.6 7.6 3.9 2.8 36.9 27.0 31.3 47.2 34.2 24.4 28.8 37.9 26.3 24.1 SH3PXD2B "FLJ20831, KIAA1295" ENSG00000174705 "SH3 and PX domains 2B" A1X283 5 172325000-172454523 "Disease related genes, Predicted intracellular proteins" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.8;ASC TERT1: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "classical monocyte: 1.3;myeloid DC: 1.7" "Group enriched" "Detected in many" 15 "dendritic cells: 1.7;monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036471 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036471: AB_10670799" "unprognostic (3.32e-1)" "unprognostic (1.95e-2)" "unprognostic (4.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.84e-1)" "unprognostic (2.38e-1)" "prognostic unfavourable (7.51e-5)" "unprognostic (5.38e-3)" "unprognostic (3.11e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.87e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-2)" "prognostic unfavourable (8.45e-4)" 26.9 17.8 6.9 12.4 10.1 0.7 28.0 13.3 8.7 28.0 10.0 16.6 13.4 3.1 26.4 19.6 12.3 14.6 21.4 5.8 7.6 4.1 2.8 2.6 13.2 11.4 16.0 4.5 18.1 7.9 16.7 4.3 10.2 10.9 10.6 6.9 15.9 14.8 16.8 5.1 15.0 8.2 25.8 10.0 7.7 11.1 10.9 9.6 1.8 6.5 4.3 4.2 17.0 14.9 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.3 5.2 19.7 12.9 36.8 31.1 16.7 3.1 11.0 2.0 4.1 1.4 0.4 0.0 4.3 12.2 3.0 6.9 3.6 2.0 0.3 1.3 0.0 5.0 1.0 11.8 0.0 13.8 19.9 5.7 8.4 2.4 14.1 0.0 0.1 8.9 1.1 0.0 1.6 7.5 1.2 6.2 3.2 1.8 2.1 0.5 1.7 11.0 2.2 1.4 4.0 0.5 0.7 15.1 12.7 5.1 7.8 1.3 0.0 0.0 0.0 8.6 0.8 10.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 10.1 13.3 8.4 7.6 4.1 16.0 4.5 10.9 9.6 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094256-169271105 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;monocytes: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074783 Approved Supported "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA074783: " "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favourable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 15.2 4.8 13.8 7.2 11.8 3.7 11.1 2.5 12.7 7.5 17.2 15.9 10.8 15.7 6.8 7.2 7.1 6.9 19.7 7.8 17.8 9.3 14.6 9.6 11.3 3.7 13.0 10.9 11.9 12.0 5.2 7.8 8.6 10.3 17.2 16.0 10.7 20.9 10.7 16.2 6.8 17.2 8.8 11.7 4.5 27.6 7.0 11.3 0.9 23.1 7.6 5.5 9.4 6.3 0.4 3.4 0.0 8.5 0.3 0.0 0.7 7.3 6.2 5.6 16.2 6.1 7.6 7.3 20.6 10.0 15.4 7.1 6.1 8.9 0.0 1.0 21.4 4.9 4.5 8.1 17.0 0.0 2.6 4.3 14.1 3.2 13.8 1.5 0.1 4.5 4.5 13.1 10.4 9.4 0.0 0.0 14.2 3.0 1.5 1.4 2.8 5.3 2.3 1.8 0.3 7.0 5.8 4.2 5.1 5.2 8.0 2.0 2.6 0.6 8.5 7.3 5.7 12.1 7.2 0.5 0.0 0.0 8.2 1.5 8.7 0.0 1.4 0.0 0.0 5.9 0.0 0.4 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.3 8.5 0.2 0.0 0.7 13.8 11.8 2.5 12.7 17.8 9.3 13.0 10.9 10.3 11.3 SH3RF3 "FLJ00204, POSH2, SH3MD4" ENSG00000172985 "SH3 domain containing ring finger 3" Q8TEJ3 2 109129348-109504632 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 13.8;RPMI-8226: 13.2;TIME: 15.3;U-266/84: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA044822, HPA048444" Approved Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA044822: , HPA048444: " "unprognostic (1.97e-1)" "unprognostic (8.84e-3)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (2.55e-1)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (2.33e-4)" "unprognostic (4.57e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-2)" 17.4 5.6 2.7 3.4 4.4 0.6 18.3 1.7 5.4 5.3 3.6 3.3 2.5 1.0 5.5 2.2 3.4 4.8 5.6 6.4 3.0 2.1 2.5 0.8 6.0 2.9 4.3 1.5 3.0 1.8 0.6 2.6 6.5 3.8 3.4 1.6 4.6 2.4 5.9 6.4 2.9 2.3 4.6 2.8 2.0 2.7 4.3 2.9 1.5 3.4 3.6 4.0 4.6 3.4 0.4 0.4 1.8 0.2 0.0 0.6 0.3 0.0 0.0 0.1 1.4 6.3 4.8 0.0 2.8 8.2 2.1 0.8 0.7 0.0 0.0 2.1 2.0 0.0 0.1 1.2 0.9 0.0 2.8 0.0 0.1 0.0 13.8 0.0 0.0 8.3 1.9 9.6 4.3 7.6 0.0 7.9 4.8 0.0 0.0 4.2 0.7 7.9 1.7 0.0 13.2 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.1 0.0 15.3 2.7 8.2 7.8 3.6 2.7 17.8 0.0 0.0 4.1 3.7 0.0 0.2 0.7 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.6 1.8 0.0 0.0 0.4 0.0 0.3 2.7 4.4 1.7 3.3 3.0 2.1 4.3 1.5 3.8 2.9 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: " "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.1 3.4 0.1 0.0 0.0 0.3 2.5 0.2 0.2 0.3 0.4 1.7 1.3 3.0 3.0 0.0 1.3 0.0 6.4 0.0 7.9 0.1 0.0 2.7 2.8 2.6 0.0 0.4 0.1 8.0 0.1 6.5 15.0 0.4 4.2 0.3 2.4 26.0 2.1 0.1 2.8 1.7 0.8 0.8 0.3 0.4 0.2 1.4 0.9 0.3 14.9 0.0 0.5 6.1 0.0 1.7 11.3 0.2 0.1 0.6 2.6 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037683: , HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.2 0.5 0.2 6.1 5.0 0.0 5.5 0.3 4.2 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 5.5 0.0 3.8 0.0 2.0 9.7 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.2 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nuclear speckles" "Nucleoplasm, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favourable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.7 4.2 0.0 0.4 0.7 3.1 0.6 0.3 0.0 0.0 8.1 2.9 5.1 1.5 0.0 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 1.7 0.2 1.5 0.0 0.0 0.0 0.0 16.6 1.6 9.5 0.0 0.0 3.3 0.3 0.0 7.6 7.5 3.9 15.4 2.5 1.0 0.0 6.2 0.0 11.8 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell line enhanced" "Detected in some" "HEL: 6.3;TIME: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.6 0.0 1.2 0.2 0.6 0.9 0.4 0.0 0.0 0.0 6.3 0.4 1.7 1.5 0.8 0.3 1.5 1.0 0.1 0.3 2.0 0.1 0.1 0.1 0.9 0.5 0.2 1.3 1.8 1.7 0.0 0.7 0.3 0.5 1.2 1.9 1.7 0.0 0.8 0.3 0.3 10.0 0.2 1.7 0.6 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 99.4" "Cell line enhanced" "Detected in all" "PC-3: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044453 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 12.0 14.5 15.8 7.9 11.7 13.2 10.9 9.0 15.3 11.3 12.3 13.7 17.3 11.5 11.4 14.7 11.4 12.9 10.3 14.7 14.0 8.9 14.1 25.7 10.0 9.3 14.6 11.3 11.9 14.0 11.7 10.2 9.6 13.3 12.2 7.2 10.5 16.8 11.8 25.5 13.5 10.7 9.4 9.2 12.5 12.0 99.4 12.3 6.1 10.9 10.8 7.1 10.1 9.5 12.7 22.4 26.1 21.2 17.3 22.1 11.0 8.5 12.6 7.1 5.6 11.5 11.9 8.1 8.0 9.5 10.7 10.6 8.9 13.9 3.7 14.7 9.7 9.8 3.5 12.1 3.0 11.2 9.5 9.3 14.5 10.5 20.4 3.2 8.7 13.3 20.0 8.9 10.2 11.4 6.2 8.8 9.7 14.1 11.0 9.2 2.9 46.0 7.7 5.4 12.4 11.3 9.8 7.2 11.1 13.7 20.7 13.2 21.7 12.0 9.6 8.4 13.3 12.0 10.7 10.8 8.2 5.0 12.2 8.0 6.6 12.5 18.1 26.1 16.7 21.2 18.6 12.7 16.6 22.1 16.6 12.3 13.8 15.0 9.3 17.3 18.4 22.4 16.5 11.0 15.8 11.7 9.0 15.3 14.0 8.9 14.6 11.3 13.3 12.3 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37919134-38069211 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 71 "basophil: 8.1" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.1" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: , HPA052108: " "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 8.6 5.6 7.5 5.3 15.9 7.2 8.0 1.4 12.5 8.2 8.4 16.1 3.2 10.1 6.1 5.6 19.6 5.9 29.4 20.2 8.9 5.0 13.6 34.2 11.6 3.1 17.9 5.3 5.6 17.8 13.7 13.1 7.7 12.6 12.9 7.0 7.6 18.9 11.3 6.4 13.0 9.5 11.9 7.6 6.7 14.1 3.5 16.3 2.7 7.7 10.3 11.1 10.7 11.9 0.0 0.0 8.1 0.0 0.0 0.1 0.0 9.2 14.7 1.5 0.2 1.7 4.1 2.6 10.2 12.5 7.1 5.5 3.5 6.4 0.0 12.4 8.8 8.9 5.8 15.0 5.1 7.8 11.7 0.0 5.1 10.8 11.3 0.4 0.5 3.6 4.8 11.2 8.6 7.3 3.7 3.1 8.3 6.2 1.1 0.4 3.8 14.0 0.5 4.3 0.5 14.8 3.3 15.7 12.6 1.3 11.2 2.5 7.0 0.5 9.0 3.3 12.0 1.7 16.2 0.9 0.3 0.1 19.7 0.9 3.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 15.9 1.4 12.5 8.9 5.0 17.9 5.3 12.6 16.3 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46580554-46621626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Uncertain "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: " "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 1.5 0.8 1.0 17.3 3.0 18.9 0.9 2.4 1.3 0.8 2.2 0.6 0.3 1.3 1.5 2.0 5.7 0.4 1.1 1.5 1.0 0.7 5.0 0.3 1.7 11.2 0.7 0.7 1.2 0.3 0.2 0.8 2.8 0.7 0.9 2.5 0.3 2.6 0.3 1.4 3.8 2.3 1.9 1.1 9.9 1.4 14.1 0.9 22.9 0.6 3.0 12.9 2.0 1.6 4.6 2.0 1.8 5.4 0.3 3.4 2.1 15.2 16.2 6.1 7.4 1.3 3.1 8.5 31.0 12.2 30.4 14.1 7.7 10.0 13.3 14.0 14.1 10.1 13.4 10.1 37.6 8.5 9.0 14.6 12.2 13.1 0.0 12.8 18.7 0.6 0.6 22.3 9.0 15.9 6.0 14.1 32.9 10.1 11.5 10.7 4.8 17.3 21.0 41.1 21.3 6.2 4.7 2.6 3.3 21.4 11.4 4.9 6.2 10.5 9.1 22.3 14.4 21.4 24.6 11.2 14.8 21.4 10.2 13.9 22.4 0.3 0.8 1.8 0.5 1.3 0.1 4.6 0.8 0.4 1.2 1.9 0.1 0.3 0.8 0.3 5.4 2.0 3.4 2.1 1.0 3.0 2.4 1.3 1.0 0.7 0.7 0.7 0.7 0.9 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4278601-4290724 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 14.8;brain: 23.1;heart muscle: 17.3" "Group enriched" "Detected in some" 46 "RH-30: 18.8;SH-SY5Y: 60.6" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 148 "plasmacytoid DC: 14.8" "Lineage enriched" "Detected in single" 148 "dendritic cells: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.5 0.7 4.0 1.4 2.5 1.2 0.4 4.1 23.1 0.4 0.9 2.4 0.0 0.7 0.4 0.4 0.4 0.4 0.6 17.3 3.3 4.5 0.4 1.7 0.5 1.2 4.7 2.3 0.4 0.5 0.4 0.2 0.4 6.1 0.5 0.7 0.0 0.5 0.4 0.8 0.4 0.6 0.4 2.5 0.6 0.4 0.5 1.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 18.8 0.0 0.0 0.0 0.1 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 4.0 2.5 4.1 20.4 3.3 4.5 4.7 2.3 6.1 1.1 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: " "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.6 1.0 0.0 0.0 1.2 0.7 0.0 0.0 13.8 0.7 1.4 0.3 10.0 5.0 0.0 32.0 0.2 1.2 4.5 0.3 0.0 0.2 0.0 3.5 0.4 0.1 1.1 0.0 0.5 20.0 4.3 0.0 0.0 0.0 0.0 0.0 2.7 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 7 "AN3-CA: 69.1;PC-3: 40.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" Cytosol "Lipid droplets" "HPA054754: " "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 7.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 3.1 40.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell line enhanced" "Detected in some" "SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA051178: " "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.5 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 6.1 0.0 16.7 0.0 0.1 0.0 0.1 0.0 6.2 0.9 37.9 0.2 0.0 0.0 0.0 22.0 0.0 12.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023314 Enhanced Supported Nucleoplasm,Cytosol 240000 "Nucleoplasm, Cytosol" "HPA023314: AB_1856830" "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favourable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favourable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 23.7 24.1 7.6 12.0 19.5 12.2 28.3 5.0 6.2 16.9 18.7 23.9 10.6 18.5 15.0 4.3 23.5 16.0 20.2 9.6 11.0 23.3 8.3 18.9 18.0 4.9 5.5 9.0 10.1 8.0 13.1 5.9 11.6 7.0 4.2 6.0 17.5 27.4 7.6 9.6 7.9 22.5 30.3 15.7 26.9 16.2 10.5 5.5 34.2 6.5 8.6 26.6 7.8 2.7 3.3 9.8 29.9 15.8 8.6 8.2 7.4 6.4 13.0 7.8 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell line enhanced" "Detected in all" "RH-30: 208.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Enhanced Microtubules,Mitochondria 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavourable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 24.6 11.4 11.6 30.6 9.1 14.0 23.0 13.4 21.8 17.9 16.5 16.4 11.9 45.7 22.2 16.5 15.8 20.9 21.7 9.7 25.5 18.6 18.8 7.0 11.6 67.4 31.1 16.7 17.9 31.6 14.4 48.2 17.8 19.7 43.5 13.6 16.2 24.7 17.0 9.9 18.6 16.7 208.3 42.3 9.0 11.4 24.9 11.9 7.0 16.5 48.4 22.4 38.3 11.2 7.3 14.8 9.4 18.1 58.3 31.9 38.8 15.7 29.0 13.0 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2, leucine rich repeat scaffold protein" Q9UQ13 10 110919547-111013667 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 22.9 13.2 22.3 17.2 32.4 31.2 18.0 24.9 25.2 19.3 16.7 8.9 12.1 12.5 17.3 17.4 19.1 14.1 15.8 14.6 19.0 24.8 20.9 18.2 16.8 20.9 22.3 20.1 21.9 15.7 26.5 33.4 17.9 17.7 18.1 17.0 9.8 13.9 14.4 21.7 15.8 24.2 25.0 23.3 23.2 13.9 26.7 17.7 29.4 21.5 9.4 23.3 23.7 17.1 16.4 11.3 34.6 13.7 9.8 9.6 11.2 11.2 7.1 9.1 15.2 20.9 21.4 5.9 13.8 20.7 12.9 15.7 6.4 10.2 24.6 6.9 24.7 9.6 11.0 9.9 18.9 13.4 6.5 11.2 11.0 6.2 15.2 19.0 20.1 23.6 15.7 14.9 28.1 13.0 6.9 17.6 18.3 6.0 9.3 15.3 5.6 7.4 13.4 18.2 6.9 13.6 7.7 4.8 9.5 12.0 6.0 13.5 30.8 16.2 13.1 10.4 9.3 13.1 9.4 16.3 16.6 39.4 12.4 19.7 7.4 20.9 12.0 16.7 7.0 13.7 8.4 16.4 8.3 8.1 11.3 13.0 8.8 8.5 34.6 9.8 13.5 8.1 9.6 11.2 22.3 32.4 24.9 25.2 19.0 24.8 22.3 20.1 17.7 17.7 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Group enriched" "Detected in some" 4 "BJ: 19.1;BJ hTERT+: 8.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035141: , HPA060931: " "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.1 8.8 2.9 3.1 0.3 0.3 0.3 0.1 0.4 0.3 0.2 0.0 0.9 0.2 0.1 0.1 1.3 0.1 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.5 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.2 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608262-3636322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" 150000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: " "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 8.9 12.9 7.6 6.2 10.6 5.9 8.9 17.3 12.3 8.8 14.1 14.9 8.8 18.5 10.7 6.1 11.6 7.6 5.3 5.9 7.0 5.5 14.3 26.7 6.3 5.3 12.0 4.5 10.2 13.7 11.8 6.2 8.6 9.8 7.4 8.6 12.3 8.9 9.4 7.5 12.1 22.8 5.1 6.7 6.1 9.7 5.2 13.0 7.7 7.7 4.0 7.6 7.5 9.6 5.2 7.1 5.1 4.8 6.4 7.5 5.4 5.2 10.7 11.5 7.3 4.8 4.8 6.4 3.5 3.2 6.9 4.2 18.5 4.9 6.2 7.9 6.8 10.3 15.2 11.5 5.1 10.0 14.8 6.8 9.2 13.2 5.7 5.9 9.7 8.1 5.5 7.6 5.2 13.0 9.0 8.0 6.7 9.4 7.5 4.6 5.8 7.2 10.4 6.0 9.9 9.8 6.8 3.3 8.8 12.9 12.0 3.6 10.7 3.5 9.3 10.6 5.1 10.2 8.5 2.7 3.4 4.1 11.5 5.3 5.4 3.3 4.7 5.1 4.6 4.8 4.7 5.2 4.2 3.7 6.5 4.0 7.5 4.7 0.9 6.4 4.1 7.1 3.6 5.4 7.6 10.6 17.3 12.3 7.0 5.5 12.0 4.5 9.8 13.0 SHROOM2 APXL ENSG00000146950 "Shroom family member 2" Q13796 X 9786456-9949443 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051646, HPA061435" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions" Cytosol "HPA051646: , HPA061435: " "unprognostic (8.65e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-2)" "unprognostic (4.06e-2)" "unprognostic (6.99e-3)" "unprognostic (8.05e-2)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.51e-1)" "unprognostic (6.54e-2)" "unprognostic (2.82e-2)" "unprognostic (9.73e-2)" "prognostic favourable (1.35e-7)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (1.93e-1)" "unprognostic (7.67e-3)" 1.3 3.6 6.8 1.3 7.7 0.5 2.5 2.8 17.0 4.7 3.2 3.7 4.6 1.8 3.3 5.8 7.2 3.6 6.3 1.5 7.4 5.5 5.3 7.6 8.1 1.0 5.7 9.1 13.8 7.2 5.5 6.1 14.3 5.8 10.6 3.0 3.6 6.0 5.8 0.7 7.9 1.4 2.1 7.9 1.7 2.6 5.8 2.5 1.8 3.1 3.4 3.4 6.4 4.3 0.0 0.9 1.1 0.0 0.0 0.2 0.0 4.0 0.5 7.6 1.0 0.4 1.2 4.3 0.4 1.3 1.6 2.7 5.0 0.0 0.0 1.4 1.0 3.3 3.9 10.8 1.9 0.0 2.9 0.0 0.0 0.8 2.5 0.0 5.2 0.2 7.5 12.4 0.5 9.3 0.0 0.0 2.6 4.3 0.0 0.0 6.6 0.0 0.0 8.3 0.0 7.0 12.9 1.1 0.6 0.3 0.1 12.0 4.4 0.2 4.3 12.1 1.5 0.0 0.4 0.0 0.0 0.0 7.9 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 6.8 7.7 2.8 17.0 7.4 5.5 5.7 9.1 5.8 2.5 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Cell line enhanced" "Detected in some" "EFO-21: 6.0;HUVEC TERT2: 22.8;RH-30: 4.4;RPTEC TERT1: 4.9;TIME: 8.6;WM-115: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Vesicles,Focal adhesion sites" "Focal adhesion sites" Vesicles "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.1 0.0 6.0 0.7 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 22.8 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.4 0.0 4.9 2.1 0.1 0.0 0.0 0.7 1.3 0.0 0.1 8.6 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.6 8.8 0.9 1.9 0.0 0.0 8.8 1.3 3.5 2.7 5.2 9.9 10.4 0.0 2.7 4.9 8.1 7.0 5.9 2.8 0.0 7.3 0.0 9.3 6.1 1.2 2.8 2.5 0.4 5.2 2.7 5.1 6.5 4.3 0.0 1.9 6.3 0.0 0.1 3.4 6.0 0.0 11.9 3.5 7.3 2.1 9.8 3.9 10.6 15.4 9.6 12.4 2.5 11.2 0.9 6.6 0.0 7.7 1.7 0.0 0.0 4.9 0.0 4.8 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.4 7.6 16.6 14.9 14.3 12.5 17.0 7.9 10.8 11.8 5.8 5.8 11.1 11.0 8.8 10.0 9.9 11.4 11.6 14.6 4.4 9.2 5.9 6.0 15.1 20.0 5.8 9.1 15.0 20.9 6.9 16.1 9.9 9.5 10.5 9.6 5.8 15.6 11.9 20.2 11.8 18.2 25.0 11.6 11.0 10.7 18.9 16.8 23.6 11.8 20.3 7.5 13.4 10.5 12.7 11.4 6.8 8.4 13.7 5.7 20.2 9.4 7.2 11.4 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741127-150763477 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: " "prognostic favourable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 9.6 48.0 7.6 11.8 10.3 22.7 23.5 10.9 17.2 30.0 10.5 8.4 20.3 7.9 23.5 13.9 28.8 14.9 11.0 10.7 7.2 7.3 8.4 35.5 11.8 19.1 9.9 7.5 19.0 14.6 6.4 8.1 31.4 7.9 18.8 9.2 8.3 11.2 21.7 8.3 19.3 9.5 17.4 9.4 16.9 12.0 8.7 8.6 23.6 11.4 10.6 25.1 22.7 25.6 3.0 3.1 10.0 2.7 1.6 3.6 1.1 16.6 4.1 3.2 6.4 11.1 8.4 13.1 6.9 8.0 8.4 10.3 8.4 7.5 9.3 10.2 7.2 10.3 8.7 6.2 7.9 7.8 6.2 18.2 5.0 27.9 15.9 10.0 5.4 7.6 14.5 5.0 11.5 6.5 4.5 36.7 5.3 20.0 18.3 5.1 10.5 8.2 13.5 7.0 33.3 5.3 5.8 12.5 5.9 5.2 4.9 12.3 32.9 15.1 4.5 5.8 5.2 12.6 9.3 43.7 16.6 13.0 5.5 14.5 2.9 9.5 2.7 10.0 2.1 1.5 3.2 2.5 3.6 3.2 2.4 3.0 1.9 1.9 5.9 1.6 1.5 3.1 2.0 1.1 7.6 10.3 10.9 17.2 7.2 7.3 9.9 7.5 7.9 8.6 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 67.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favourable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favourable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favourable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favourable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favourable (1.54e-5)" 11.0 3.2 11.8 19.3 12.3 18.1 17.7 2.4 12.3 10.7 16.9 11.2 16.2 18.6 11.0 14.5 13.7 16.3 12.8 12.9 11.1 10.1 29.4 67.0 14.9 25.6 11.7 8.5 9.6 22.7 10.0 7.3 6.2 15.6 14.2 9.2 15.2 22.1 13.4 6.4 4.5 20.4 11.2 17.7 28.7 17.7 7.4 10.2 12.4 15.4 8.8 18.0 11.3 13.3 11.4 12.9 17.4 16.7 27.8 38.9 22.8 7.8 21.5 1.3 7.5 1.2 6.4 15.7 1.2 1.8 3.6 3.2 9.9 49.4 2.2 5.8 6.8 11.3 3.5 4.0 0.6 6.7 13.1 4.3 4.3 0.2 4.0 3.5 7.5 3.4 0.8 0.6 0.5 10.5 4.4 0.1 1.0 26.4 10.4 12.2 7.8 11.8 13.4 0.0 7.7 2.6 5.3 13.3 6.5 0.1 7.3 9.4 9.3 2.9 12.1 1.2 1.5 1.8 0.0 2.7 4.5 5.4 4.9 8.3 4.2 17.4 13.0 11.2 38.9 13.9 30.9 11.4 32.5 33.7 12.9 8.6 29.8 28.9 7.0 27.8 16.7 4.9 29.9 22.8 11.8 12.3 2.4 12.3 11.1 10.1 11.7 8.5 15.6 10.2 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410021-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 99.9;lymphoid tissue: 74.6" "Cell line enhanced" "Detected in some" "Daudi: 20.8;HEL: 10.6;HMC-1: 8.5;NB-4: 6.5;U-698: 15.3;U-937: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7" "Group enriched" "Detected in many" 14 "granulocytes: 99.9;monocytes: 66.7" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavourable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 2.6 6.2 4.5 24.6 9.8 9.1 1.4 0.7 4.9 2.7 3.7 5.7 0.0 5.3 1.3 0.7 2.2 2.7 2.7 1.6 3.3 3.0 2.6 7.2 7.7 74.6 6.6 1.8 1.2 2.4 0.2 2.5 1.1 7.7 2.6 3.3 0.7 2.3 0.7 0.6 0.9 9.6 3.2 7.4 37.0 3.1 0.9 4.8 2.0 1.2 0.2 13.2 4.8 1.3 5.8 5.1 99.9 66.7 0.0 0.1 4.4 0.1 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 20.8 0.6 0.0 0.4 0.0 0.1 0.0 6.4 1.5 10.6 0.2 0.1 0.0 4.8 8.5 0.0 0.0 0.1 0.0 0.0 0.5 1.0 0.0 0.4 0.1 6.5 0.6 0.3 1.3 0.1 0.4 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.1 3.9 0.5 0.5 1.0 0.4 0.2 1.0 0.2 15.3 0.4 8.8 0.3 1.5 5.6 99.9 0.1 33.9 0.0 5.8 0.0 0.0 5.1 3.6 0.0 0.0 11.5 0.0 66.7 0.2 0.1 4.4 4.5 9.8 0.7 4.9 3.3 3.0 6.6 1.8 7.7 4.8 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell line enriched" "Detected in some" 15 "HEL: 15.0" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: " "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.2 15.0 0.2 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.5;U-87 MG: 25.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favourable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.8 0.1 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.0 0.0 0.0 25.7 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB023801: , HPA038211: , HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.7 0.9 0.3 1.6 1.3 2.4 0.0 2.4 0.7 0.2 11.1 1.6 16.7 1.0 0.1 0.5 0.7 27.8 0.9 2.3 0.7 0.1 1.0 21.5 0.4 5.1 0.3 0.1 0.5 21.6 0.1 0.4 1.7 0.8 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 10.9 1.8 0.4 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.7 0.4 4.6 2.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" 21 6111134-6123739 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 29.9;Karpas-707: 40.7;LHCN-M2: 28.0;SiHa: 29.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 6 "B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038211: , HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 9.7 13.7 0.4 3.0 1.7 8.4 5.2 0.4 3.1 2.9 3.0 1.3 4.6 0.9 3.1 1.9 6.8 1.0 15.5 6.2 1.5 1.7 12.3 8.5 1.2 1.8 0.6 10.2 11.2 1.6 2.2 3.2 2.6 5.1 2.3 7.6 3.9 14.3 9.1 2.9 6.1 1.7 2.1 2.0 5.0 1.7 1.0 1.0 0.9 5.6 3.2 7.1 2.7 1.6 5.0 0.0 1.7 0.3 0.5 0.1 3.1 15.7 1.2 1.0 0.2 0.1 2.8 0.4 0.2 0.6 0.3 17.6 2.3 1.1 0.5 0.0 0.3 1.8 0.0 0.2 2.8 0.6 2.4 29.9 3.3 1.1 0.4 0.2 0.4 13.9 1.6 9.1 0.6 0.9 40.7 28.0 1.5 0.3 0.7 1.7 1.8 0.6 7.2 4.7 1.6 5.4 1.5 0.7 29.4 1.9 1.6 0.3 1.3 0.8 0.4 1.6 0.6 6.5 5.6 12.2 0.5 4.5 1.0 1.9 0.0 0.1 0.0 0.1 0.8 0.5 1.6 0.0 0.1 0.7 1.6 0.1 0.1 0.0 0.3 1.7 5.0 0.0 0.1 SIKE1 "FLJ21168, SIKE" ENSG00000052723 "Suppressor of IKBKE 1" Q9BRV8 1 114769479-114780685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024177, HPA025726" Supported Approved "Vesicles,Focal adhesion sites" "Focal adhesion sites" Vesicles "HPA024177: AB_1848798, HPA025726: AB_1848800" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (3.53e-2)" "unprognostic (4.52e-3)" "unprognostic (4.10e-1)" "unprognostic (6.04e-2)" "unprognostic (3.37e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-2)" "unprognostic (2.52e-2)" "unprognostic (1.94e-2)" "unprognostic (7.91e-2)" "unprognostic (2.38e-2)" "unprognostic (3.86e-2)" "unprognostic (9.06e-2)" "unprognostic (2.95e-3)" "unprognostic (1.05e-1)" 18.3 15.4 14.5 17.4 15.9 15.3 16.4 23.5 16.3 18.3 17.3 14.5 14.2 16.7 17.2 13.4 18.1 14.3 13.4 20.3 14.2 15.1 24.4 22.2 12.3 19.7 21.1 11.2 17.2 17.5 15.4 22.5 17.1 23.2 15.2 17.3 9.3 17.2 13.9 21.1 21.9 17.5 16.4 19.2 20.6 14.5 11.8 17.9 26.0 19.3 17.1 21.2 17.2 14.2 8.1 9.8 12.3 7.6 9.2 10.3 5.3 8.4 2.4 11.2 10.7 13.6 10.8 12.0 7.0 6.6 10.3 13.9 7.4 4.5 15.8 6.9 5.9 8.2 12.3 8.4 14.0 10.6 7.2 8.7 7.5 7.6 12.8 9.8 7.1 10.5 9.7 7.4 12.0 9.2 13.3 10.2 7.8 37.6 17.3 8.8 25.4 7.3 10.4 23.1 8.0 7.5 7.7 8.5 9.6 11.1 10.9 12.7 6.6 33.1 6.5 8.6 11.4 14.3 9.7 8.6 7.4 15.5 12.3 15.0 18.4 12.3 6.0 7.4 8.6 6.4 10.3 7.9 8.0 7.4 7.8 8.1 9.3 9.9 4.0 9.2 7.6 9.8 6.2 5.3 14.5 15.9 23.5 16.3 14.2 15.1 21.1 11.2 23.2 17.9 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "Single-minded family bHLH transcription factor 2" Q14190 21 36699133-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7" "Cell line enhanced" "Detected in some" "PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 0.5" "Group enriched" "Detected in some" 4 "hypothalamus: 2.1;midbrain: 0.8" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavourable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favourable (2.88e-4)" 0.5 0.3 0.8 0.1 2.3 0.0 0.1 2.4 2.3 2.8 0.2 0.2 0.0 0.1 0.3 1.5 31.3 0.3 0.2 0.1 2.5 1.1 16.1 0.1 0.1 0.1 1.4 0.7 0.1 0.1 1.2 1.7 0.1 0.3 6.8 0.0 0.2 0.4 0.0 15.7 0.3 0.1 0.0 0.4 0.1 5.5 0.2 1.3 0.0 0.2 11.0 28.7 1.5 0.4 0.3 0.7 0.0 0.0 0.0 0.8 0.0 3.2 5.0 0.2 0.2 0.0 0.0 5.0 0.1 0.0 0.4 0.0 2.6 7.6 0.1 4.6 0.1 1.7 2.5 0.0 0.2 3.9 7.9 0.1 7.2 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.4 0.0 0.1 0.0 8.3 1.9 0.0 0.0 0.2 22.9 0.0 0.1 0.1 28.8 17.3 0.2 0.3 8.2 0.0 0.7 2.1 0.2 0.3 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 2.3 2.4 2.3 2.5 1.1 1.4 0.7 0.3 1.3 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 29.3;testis: 41.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA037889: , HPA037890: " "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavourable (2.32e-6)" "prognostic unfavourable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 3.1 15.1 5.4 5.0 3.9 2.0 3.3 10.2 5.4 7.5 4.5 2.0 2.9 3.9 8.0 6.8 3.1 9.3 5.3 2.0 6.2 4.4 1.8 5.1 3.1 3.5 2.5 3.0 29.3 3.4 4.2 7.6 3.3 3.4 6.1 4.9 4.0 3.8 4.7 5.5 2.3 5.1 6.2 3.0 5.5 5.1 41.5 3.7 4.5 2.1 2.7 3.4 4.4 5.4 7.1 8.1 10.5 5.3 10.8 6.3 3.5 1.8 5.0 16.2 12.9 8.5 8.3 8.2 6.9 6.8 7.2 8.9 17.4 5.4 0.0 8.6 8.0 1.7 17.5 12.3 9.0 3.1 13.1 8.7 3.3 2.2 19.0 9.6 6.8 5.6 5.1 4.8 8.6 6.6 21.9 8.4 8.5 8.5 9.3 7.6 5.9 5.5 13.9 10.8 12.0 4.7 3.7 10.6 11.6 7.5 1.1 6.6 4.4 18.3 4.7 8.8 4.7 7.9 5.9 2.1 2.3 13.7 3.5 6.4 5.0 7.0 5.3 10.5 5.2 5.2 6.3 7.1 6.3 4.0 8.1 6.9 5.3 4.1 0.7 10.8 4.0 3.9 4.1 3.5 5.4 3.9 10.2 5.4 6.2 4.4 2.5 3.0 3.4 3.7 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829400-16880353 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA050329: " "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favourable (4.37e-4)" "prognostic unfavourable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 19.1 17.9 22.2 17.2 28.1 9.8 21.5 25.1 38.6 24.4 16.0 20.8 50.0 12.8 37.5 21.5 14.5 23.3 17.3 15.7 24.2 20.8 15.9 9.8 21.7 20.8 16.5 30.4 32.5 16.2 60.8 17.7 53.2 24.8 22.7 11.0 15.5 20.2 54.7 17.1 22.7 17.7 26.5 14.8 25.1 13.7 30.2 13.4 9.3 22.5 9.6 15.8 17.2 22.2 4.8 2.6 6.1 6.7 1.9 2.0 2.3 14.5 7.8 13.2 16.9 10.9 10.1 41.8 12.4 10.3 17.2 15.3 19.2 13.7 13.1 14.0 14.3 12.6 10.9 11.1 16.0 13.6 19.7 14.0 17.1 8.7 14.4 8.2 11.4 16.6 14.7 11.6 10.0 15.6 11.4 8.1 12.0 17.4 11.1 13.2 16.4 25.0 14.7 12.2 8.6 9.8 12.4 9.8 12.3 15.7 12.1 9.7 8.5 7.7 20.4 16.8 10.2 24.2 13.8 11.6 8.5 13.1 11.6 10.8 12.4 0.1 6.7 6.1 1.8 6.0 1.2 4.8 1.7 2.0 2.1 3.8 2.0 1.4 3.3 1.9 5.3 2.6 0.5 2.3 22.2 28.1 25.1 38.6 24.2 20.8 16.5 30.4 24.8 13.4 SINHCAF "C12orf14, FAM60A, TERA" ENSG00000139146 "SIN3-HDAC complex associated factor" Q9NP50 12 31280584-31327058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 83.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038167, HPA057585" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038167: AB_10675629, HPA057585: " "unprognostic (2.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (2.80e-3)" "unprognostic (1.84e-2)" "prognostic unfavourable (5.78e-4)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (1.15e-1)" "prognostic favourable (7.89e-4)" "unprognostic (3.22e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" "unprognostic (9.75e-2)" 13.1 6.5 1.6 21.4 5.1 7.9 11.1 4.5 1.9 25.4 15.8 3.4 15.8 6.7 28.3 16.8 19.8 14.6 8.4 5.6 2.9 1.8 16.6 3.3 17.0 22.5 3.4 0.9 18.5 19.6 7.6 19.6 18.9 5.2 18.6 8.3 6.0 16.3 20.1 3.2 12.7 17.0 11.7 3.8 18.5 7.0 13.6 3.7 39.0 14.9 12.3 27.3 19.3 13.6 22.8 28.3 7.9 8.0 19.0 15.1 10.4 3.4 5.1 17.3 3.4 1.0 2.1 32.0 1.8 1.3 3.5 4.7 13.8 9.0 11.9 14.7 0.5 6.2 14.4 6.9 6.9 12.7 6.4 8.2 3.5 8.6 4.3 13.4 8.1 1.9 10.9 3.0 14.7 8.2 11.3 4.7 1.5 2.6 23.9 9.8 83.4 2.8 20.3 8.3 10.2 7.9 10.3 24.1 16.2 4.2 7.6 9.9 3.2 7.9 8.9 0.8 5.2 0.4 6.0 5.3 7.6 24.0 2.4 5.1 4.6 7.9 4.8 7.5 8.8 5.8 10.3 22.8 12.3 10.4 10.4 17.9 15.1 11.8 1.5 19.0 8.0 28.3 5.8 10.4 1.6 5.1 4.5 1.9 2.9 1.8 3.4 0.9 5.2 3.7 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: " "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.4 9.5 2.6 5.4 10.5 7.1 6.0 5.5 5.4 1.9 6.8 9.8 16.0 3.5 3.6 1.6 2.3 1.8 10.6 3.9 23.9 9.1 3.3 4.6 9.6 10.3 5.5 1.1 7.7 1.0 16.2 13.5 4.5 2.7 2.7 3.8 16.5 3.0 5.7 17.5 2.4 8.7 2.1 0.5 1.7 10.1 3.5 6.1 14.5 4.6 14.9 22.7 6.9 13.9 7.5 1.4 6.8 5.3 22.0 9.4 15.4 19.8 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 SIPA1L1 "E6TP1, KIAA0440" ENSG00000197555 "Signal induced proliferation associated 1 like 1" O43166 14 71320449-71741229 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002875 Approved Approved "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA002875: AB_1079974" "unprognostic (1.50e-3)" "unprognostic (2.99e-1)" "unprognostic (3.34e-2)" "unprognostic (5.64e-3)" "unprognostic (4.19e-2)" "unprognostic (4.14e-1)" "unprognostic (7.89e-2)" "unprognostic (4.86e-2)" "unprognostic (3.09e-1)" "unprognostic (8.62e-2)" "unprognostic (2.61e-1)" "unprognostic (5.27e-2)" "prognostic favourable (6.80e-8)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.42e-1)" "unprognostic (7.03e-2)" 4.5 12.0 27.1 8.2 36.4 7.8 6.8 21.7 35.7 7.7 8.9 5.3 1.0 7.6 5.4 8.7 11.2 10.6 11.8 2.4 17.5 10.4 11.7 9.3 8.6 7.6 8.1 23.9 3.6 9.5 23.6 13.0 3.6 10.1 6.2 9.0 7.3 7.6 6.9 2.2 6.4 8.0 8.0 6.8 18.1 13.8 14.5 7.2 3.1 11.0 3.2 11.5 7.7 4.8 6.8 1.0 18.7 5.3 1.6 3.3 1.6 10.2 3.2 7.5 5.6 2.2 6.5 13.6 14.0 16.6 5.7 7.3 18.5 5.8 4.8 3.6 22.9 10.2 5.4 12.6 10.9 4.3 2.5 10.1 21.2 4.3 18.9 1.2 3.9 4.7 10.6 8.8 20.9 6.1 4.4 12.1 7.8 15.4 4.0 1.1 4.3 8.8 6.0 8.1 5.1 4.1 15.9 9.3 24.8 14.3 11.3 1.0 6.7 0.5 16.8 40.8 15.1 4.6 8.0 9.9 11.2 7.1 7.0 3.3 13.5 4.0 4.0 0.8 1.5 4.7 3.3 2.6 1.3 2.0 1.0 6.8 0.9 1.0 18.7 1.6 5.3 0.3 1.2 1.6 27.1 36.4 21.7 35.7 17.5 10.4 8.1 23.9 10.1 7.2 SIPA1L2 KIAA1389 ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232561558 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 33.4;NTERA-2: 26.7;WM-115: 22.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nuclear membrane,Nuclear bodies,Golgi apparatus" "Nuclear bodies" "Nuclear membrane, Golgi apparatus" "HPA024181: AB_1856886, HPA027224: " "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 4.1 1.1 3.6 2.9 3.3 2.1 3.4 0.3 7.6 3.2 8.9 1.6 1.9 1.0 8.7 1.2 4.4 16.2 3.1 3.9 1.6 2.4 6.5 0.8 6.5 6.7 1.4 3.9 3.2 10.0 2.9 10.5 3.3 2.3 2.5 3.3 3.3 3.7 3.0 4.5 2.0 3.4 3.4 1.1 4.7 5.7 0.0 1.2 4.3 1.2 2.0 2.4 0.2 0.0 3.6 33.4 0.2 0.2 0.0 14.5 0.6 1.2 1.5 1.1 1.4 0.0 2.8 6.7 12.6 0.8 6.8 1.0 1.4 0.0 6.3 0.0 3.2 0.0 3.1 0.4 3.6 1.9 4.7 0.3 3.0 7.7 0.0 0.0 0.7 1.5 3.5 0.3 26.7 5.4 0.0 0.0 1.7 4.2 5.2 1.8 5.8 11.1 0.3 4.5 0.7 0.4 2.7 4.0 0.0 8.6 1.3 3.1 0.0 0.0 4.9 3.0 22.6 0.0 0.6 0.0 0.2 1.2 2.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 4.3 2.0 0.9 1.2 0.0 0.2 SIPA1L3 KIAA0545 ENSG00000105738 "Signal induced proliferation associated 1 like 3" O60292 19 37907228-38208372 "Disease related genes, Predicted intracellular proteins" "GTPase activation" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042072, HPA045480, HPA074988" Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA042072: , HPA045480: , HPA074988: " "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.86e-1)" "unprognostic (5.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-2)" "unprognostic (1.31e-2)" "unprognostic (5.48e-2)" "unprognostic (3.11e-1)" "unprognostic (6.05e-2)" "unprognostic (3.15e-1)" "unprognostic (5.43e-2)" "unprognostic (9.26e-3)" "unprognostic (6.45e-2)" "unprognostic (4.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.96e-2)" 6.2 6.2 10.8 15.3 11.9 5.4 10.0 18.1 13.2 9.8 18.3 13.0 13.9 31.1 6.7 6.4 9.0 9.3 7.6 11.1 15.8 7.7 12.4 6.9 10.5 11.4 10.5 7.8 6.0 17.1 7.4 7.8 3.4 8.5 9.7 12.8 11.2 14.1 9.1 11.4 19.0 29.7 6.2 8.7 12.2 16.4 8.1 12.4 11.7 18.2 6.7 20.2 10.0 11.8 4.6 0.9 1.1 3.5 0.9 1.4 0.3 16.6 29.5 3.7 4.6 2.2 2.2 2.5 7.2 6.1 4.7 4.5 10.1 9.7 9.5 6.2 6.1 3.8 3.3 13.5 5.3 3.2 1.6 2.6 2.8 3.1 4.3 1.8 2.8 1.7 7.1 8.9 19.1 5.4 1.8 2.0 8.3 5.1 2.3 2.4 3.0 7.9 5.2 3.0 1.4 10.5 14.3 8.8 4.7 7.9 13.6 1.1 9.0 1.7 11.5 8.0 2.8 24.5 11.0 2.7 4.6 3.2 10.3 2.4 10.3 0.2 0.4 1.1 0.5 0.7 0.2 3.0 0.4 0.5 0.2 4.6 0.4 1.4 0.3 0.9 3.5 0.9 0.3 0.3 10.8 11.9 18.1 13.2 15.8 7.7 10.5 7.8 8.5 12.4 SIRT1 SIR2L1 ENSG00000096717 "Sirtuin 1" Q96EB6 10 67884669-67918390 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003855, HPA006295, HPA052351" Approved Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: " "unprognostic (1.55e-1)" "unprognostic (2.78e-1)" "unprognostic (9.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-2)" "unprognostic (2.48e-1)" "unprognostic (4.95e-2)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (2.18e-2)" "unprognostic (2.83e-2)" "unprognostic (9.67e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" 17.2 32.3 12.6 21.1 17.8 17.0 18.1 22.6 14.5 24.2 20.5 15.7 14.0 9.2 19.0 12.7 12.7 15.1 15.2 14.7 14.1 10.4 13.9 17.3 12.6 16.1 17.0 10.1 26.6 14.4 16.4 13.3 14.7 12.1 21.7 12.5 12.1 12.3 16.1 19.9 12.9 15.0 21.0 17.7 13.5 13.2 25.4 16.3 28.1 15.2 9.3 14.7 21.6 37.5 4.9 3.9 3.8 3.5 3.6 7.1 1.8 8.2 9.4 15.0 16.7 14.3 11.1 9.4 11.5 11.9 15.8 14.1 10.4 7.1 17.4 6.2 7.6 6.6 18.6 3.8 17.0 9.3 10.8 9.2 7.1 8.1 13.1 9.9 7.1 10.2 9.3 9.5 16.4 6.3 11.7 9.5 11.5 6.6 9.2 13.7 18.6 15.2 16.7 11.8 6.8 7.4 5.1 9.7 13.3 21.0 13.9 14.5 10.1 9.2 5.3 12.3 11.5 10.9 11.1 8.0 9.5 34.5 6.3 15.1 5.0 3.8 2.4 3.2 3.4 3.0 4.9 4.9 3.7 4.7 3.9 3.3 7.1 4.2 3.1 3.6 3.5 3.5 2.9 1.8 12.6 17.8 22.6 14.5 14.1 10.4 17.0 10.1 12.1 16.3 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.1 5.1 4.4 11.0 25.3 17.4 3.0 6.0 10.7 9.4 12.2 9.2 5.2 2.8 13.1 11.2 4.4 8.0 12.9 5.7 13.0 8.3 5.5 5.8 5.5 17.8 3.8 12.2 18.1 15.6 7.7 9.2 16.4 5.2 22.6 14.3 4.6 7.7 3.0 0.7 7.2 10.2 12.4 7.8 7.5 7.3 11.1 5.0 7.0 9.4 6.6 4.2 9.9 15.6 12.7 2.8 19.6 8.9 9.3 4.5 6.5 10.2 9.6 11.7 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 SIRT7 ENSG00000187531 "Sirtuin 7" Q9NRC8 17 81911939-81921323 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 17.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037261, HPA053669" Approved Supported "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "CAB037261: AB_1079989, HPA053669: " "unprognostic (8.15e-3)" "unprognostic (3.24e-2)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.46e-1)" "unprognostic (3.36e-2)" "prognostic unfavourable (1.97e-5)" "unprognostic (3.03e-1)" "unprognostic (2.10e-1)" "unprognostic (2.46e-2)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "prognostic unfavourable (1.69e-7)" "unprognostic (4.34e-3)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (2.16e-2)" 6.2 5.9 6.7 10.1 12.8 22.6 6.4 17.0 11.4 8.2 12.9 7.0 9.0 14.3 5.5 4.6 28.8 7.2 10.6 3.9 6.7 2.6 7.9 9.8 7.9 11.3 11.0 6.6 4.8 18.7 4.9 7.8 8.8 7.6 7.1 6.7 3.7 12.7 7.0 5.3 15.7 15.3 5.1 5.7 14.1 18.4 8.9 8.8 8.3 6.7 7.3 16.4 8.3 12.3 3.9 1.8 17.4 3.4 1.3 2.6 1.2 16.0 13.4 1.6 5.8 4.4 4.2 10.8 8.1 6.8 9.6 9.0 11.5 12.8 7.1 6.3 4.5 11.6 6.6 5.0 3.1 6.1 14.2 6.3 6.5 18.0 13.3 8.1 12.9 4.2 15.9 9.1 7.6 7.1 6.7 3.5 4.5 12.6 8.6 11.6 4.2 13.9 5.8 3.5 6.7 9.3 10.5 7.0 9.2 9.3 22.6 10.4 9.4 19.5 5.6 4.2 9.5 8.0 14.7 5.9 1.8 5.2 10.5 11.1 7.0 3.0 2.3 17.4 2.6 3.4 0.9 3.3 2.0 2.1 1.2 3.9 1.8 0.6 3.8 1.3 2.6 1.8 1.0 1.2 6.7 12.8 17.0 11.4 6.7 2.6 11.0 6.6 7.6 8.8 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643415-60658259 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 52.7;RH-30: 28.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 1.2;pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB058690: , HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavourable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favourable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 7.1 0.4 0.3 0.1 0.5 0.1 4.7 0.3 0.6 7.4 0.2 0.2 0.0 0.1 0.2 2.1 1.3 0.5 0.4 0.4 0.3 0.3 0.3 0.2 1.8 0.3 0.4 1.2 0.3 0.3 16.8 39.1 0.1 4.5 8.7 0.1 2.0 55.1 0.2 59.0 0.4 0.2 0.7 0.5 0.2 0.5 1.6 0.0 6.5 2.4 22.5 3.0 1.4 9.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.2 1.9 0.2 11.7 6.8 8.0 0.1 2.0 4.5 2.3 2.0 0.0 3.7 0.0 1.1 0.4 2.7 3.9 3.6 0.8 0.0 9.4 0.9 0.8 2.7 0.0 0.0 0.1 6.0 1.7 1.6 0.3 0.1 2.6 0.0 52.7 1.3 0.0 0.2 0.0 4.7 0.0 28.8 0.0 2.2 6.4 1.1 0.1 2.3 0.1 2.4 1.3 0.2 6.7 3.1 3.2 3.6 2.9 0.2 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.3 0.3 0.4 1.2 4.5 0.0 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005161-45009430 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.3;skeletal muscle: 21.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.4;LHCN-M2: 21.5;RH-30: 14.8;SCLC-21H: 25.3;U-2197: 16.4;U-698: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056958 Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA056958: " "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 5.8 0.2 0.2 0.2 0.4 0.1 3.4 0.5 0.4 13.3 0.4 0.2 0.0 0.1 1.1 0.8 0.8 0.1 0.1 0.8 0.1 0.0 0.4 0.1 0.3 0.2 0.9 1.8 0.3 4.6 5.7 13.5 0.3 1.4 5.2 0.1 9.3 23.3 1.3 21.0 0.3 0.1 0.4 0.8 0.1 7.4 1.1 0.0 3.9 0.7 4.0 0.8 1.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 6.2 23.4 0.0 0.1 1.0 0.4 0.0 0.1 0.0 0.0 1.0 0.0 0.0 2.1 3.9 0.2 0.0 1.1 0.0 7.5 0.0 0.0 0.0 2.1 1.1 0.0 4.8 0.0 0.7 0.0 0.0 21.5 0.7 0.0 1.2 0.2 4.7 0.0 14.8 0.0 0.0 1.2 25.3 0.2 3.2 0.1 0.0 0.1 1.8 0.3 0.4 1.2 16.4 0.0 0.5 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.1 0.0 0.9 1.8 1.4 0.0 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Enhanced "Microtubules,Mitotic spindle,Centrosome,Cytosol" Microtubules "Mitotic spindle, Centrosome, Cytosol" "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavourable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.2 5.9 10.7 9.1 0.0 2.3 8.4 15.2 6.4 19.2 13.1 9.8 12.1 15.4 4.5 8.4 10.6 14.3 6.2 21.0 13.1 7.3 20.5 3.9 5.5 0.0 15.8 7.9 0.4 0.4 15.4 5.1 9.4 10.6 6.6 12.7 8.7 24.0 14.2 12.4 11.1 15.8 23.0 7.1 4.3 4.4 13.7 5.0 5.0 7.9 3.2 7.1 12.2 3.7 7.6 11.0 7.1 18.2 4.0 8.4 15.4 1.8 12.4 21.8 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.6;HDLM-2: 10.1;HMC-1: 8.6;Karpas-707: 10.7;RPMI-8226: 12.6;RPTEC TERT1: 15.6;U-266/70: 9.7;U-266/84: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favourable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favourable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 10.1 0.2 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.6 15.6 0.0 0.0 0.0 1.0 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 9.7 6.9 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 SKAP2 "RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R" ENSG00000005020 "Src kinase associated phosphoprotein 2" O75563 7 26667062-26995239 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005560, HPA024045" Enhanced Supported Nucleoplasm,Cytosol 3200000 Nucleoplasm Cytosol "HPA005560: AB_2667360, HPA024045: AB_2671416" "unprognostic (8.52e-2)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (5.62e-2)" "unprognostic (7.91e-3)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (4.15e-3)" "unprognostic (1.82e-1)" "unprognostic (1.41e-2)" "unprognostic (1.26e-2)" "unprognostic (3.80e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (3.51e-2)" 20.8 22.5 11.5 29.4 12.9 12.8 28.5 6.0 12.8 7.7 15.3 7.6 11.0 10.5 5.2 15.4 14.0 9.4 9.6 12.6 9.5 12.1 20.4 7.8 31.6 36.4 12.0 8.9 13.3 6.1 25.1 10.9 5.3 15.5 10.2 15.0 2.5 5.8 9.8 8.3 8.6 16.5 21.1 42.6 31.8 11.7 10.1 11.5 6.4 6.1 1.9 19.3 19.3 28.1 9.9 12.3 37.3 18.0 8.3 5.1 6.7 11.5 6.1 0.6 15.3 2.9 2.4 3.8 4.7 7.1 2.3 5.9 4.9 46.9 9.0 20.9 8.9 6.3 8.4 4.8 5.0 5.1 13.5 9.9 1.8 6.4 3.9 18.2 35.0 10.5 4.5 6.9 9.4 14.3 5.2 4.7 9.3 2.1 0.0 9.2 0.5 6.0 11.8 1.5 0.7 29.0 9.1 7.6 0.2 8.6 4.7 6.2 6.4 9.6 20.8 3.9 0.1 13.1 4.9 7.4 9.4 15.8 9.4 23.7 15.1 8.2 12.6 19.4 3.7 15.0 5.1 9.9 2.1 3.0 9.6 8.0 0.5 2.9 37.3 8.3 18.0 12.3 3.5 6.7 11.5 12.9 6.0 12.8 9.5 12.1 12.0 8.9 15.5 11.5 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228695-2310119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: " "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 12.5 4.7 11.8 7.1 22.5 4.8 8.1 34.5 21.2 9.8 8.2 5.5 3.1 4.6 11.9 4.4 5.9 9.1 8.0 9.0 11.0 4.1 4.4 6.1 11.1 6.9 6.2 10.1 10.4 9.6 4.2 6.2 7.4 8.5 8.4 3.5 4.0 12.0 11.9 6.8 11.7 5.9 9.3 5.3 9.3 6.0 7.2 5.3 3.6 6.9 8.1 5.1 7.6 7.8 0.8 0.3 3.0 0.6 1.3 0.6 0.4 10.3 6.0 14.6 14.2 24.4 14.7 9.6 15.6 8.7 9.7 7.2 9.1 8.1 6.6 11.7 20.0 12.3 8.1 12.6 9.0 7.2 17.7 16.6 9.1 12.8 16.3 9.3 17.8 15.7 7.0 14.6 11.0 11.9 9.3 5.1 11.9 6.6 1.1 10.3 14.7 11.7 5.1 9.2 5.4 8.3 4.1 21.0 13.7 15.2 13.6 15.1 4.6 12.0 21.5 16.8 10.5 23.6 12.1 4.0 2.8 6.1 8.9 16.2 6.8 0.6 0.5 0.3 0.5 0.6 0.5 0.3 0.4 0.5 0.3 0.8 0.6 0.5 3.0 1.3 0.3 0.1 0.4 0.4 11.8 22.5 34.5 21.2 11.0 4.1 6.2 10.1 8.5 5.3 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell line enhanced" "Detected in some" "AF22: 22.6;AN3-CA: 5.8;BEWO: 10.5;SH-SY5Y: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Cytosol "Nucleoplasm, Nuclear bodies" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 0.9 22.6 5.8 0.5 0.2 10.5 0.4 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 1.4 2.0 0.4 0.0 0.0 2.5 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.9 0.7 0.1 1.3 0.0 0.3 0.7 0.0 0.4 0.5 2.5 5.2 0.8 3.9 0.1 0.4 4.5 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.2 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008472 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008472: AB_1856933" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavourable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 16.2 15.0 10.5 21.1 14.7 22.8 12.4 5.0 18.2 14.0 11.8 12.2 13.4 15.9 17.1 12.7 14.4 12.0 26.8 21.7 11.2 11.4 15.0 18.0 23.8 15.2 11.6 10.6 17.8 11.4 9.6 21.1 26.6 16.0 15.8 11.7 14.8 14.2 17.0 19.5 10.3 28.0 13.5 17.3 12.6 17.9 14.4 8.3 14.0 18.9 13.5 21.1 15.3 16.3 5.7 2.9 5.4 11.3 3.2 2.6 2.3 8.2 10.2 6.8 4.4 8.8 3.9 12.6 8.3 5.7 5.8 4.6 2.1 18.0 10.3 26.8 7.6 19.0 4.2 3.8 9.2 17.8 4.1 13.7 9.9 4.5 7.6 5.7 7.6 6.6 3.8 8.5 6.6 14.6 6.0 11.7 12.1 8.8 2.3 1.8 26.7 3.6 5.6 23.1 2.1 8.8 13.1 5.1 6.2 20.7 21.1 4.4 14.1 6.3 27.9 16.8 15.6 14.2 15.4 15.6 7.2 19.8 6.4 3.0 7.8 3.4 4.3 2.0 1.6 9.8 2.3 4.6 1.4 2.1 2.9 5.7 2.5 2.6 5.4 3.2 11.3 2.0 0.5 2.3 10.5 14.7 5.0 18.2 11.2 11.4 11.6 10.6 16.0 8.3 SKP1 "EMC19, MGC34403, OCP-II, OCP2, p19A, SKP1A, TCEB1L" ENSG00000113558 "S-phase kinase associated protein 1" P63208 5 134148935-134177038 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB012982, HPA053745, HPA058134" Approved Supported Nucleoplasm,Cytosol 600000 Nucleoplasm Cytosol "CAB012982: AB_2533076, HPA053745: , HPA058134: " "prognostic unfavourable (7.53e-4)" "unprognostic (1.97e-1)" "unprognostic (9.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (5.72e-4)" "unprognostic (4.47e-2)" "unprognostic (1.33e-1)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (3.07e-1)" "prognostic favourable (5.20e-4)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (8.26e-2)" "unprognostic (2.40e-1)" 63.7 90.2 101.8 35.1 113.6 59.2 110.3 109.3 152.1 94.0 70.5 78.8 55.7 43.6 73.9 99.3 72.9 84.5 64.4 116.0 112.7 100.7 113.8 83.5 52.8 52.3 109.9 121.7 98.4 44.6 116.8 81.4 83.1 114.2 84.8 69.1 68.5 54.7 113.4 141.7 59.9 55.2 82.3 106.3 47.0 58.8 69.3 79.7 57.5 108.0 82.1 60.9 71.8 58.2 113.5 78.4 136.3 90.7 96.4 157.1 209.1 67.4 52.7 78.6 105.7 121.8 99.5 56.1 78.7 100.1 92.5 95.8 80.9 65.8 50.0 118.2 106.1 37.8 78.5 118.9 107.8 45.7 55.5 39.4 82.8 57.5 57.5 30.2 49.0 85.1 95.9 81.0 64.2 98.8 47.5 44.2 138.2 53.3 65.1 32.5 45.6 56.8 36.0 84.1 61.2 103.3 76.0 64.4 50.5 106.7 27.3 71.8 79.1 47.4 74.2 59.8 37.1 62.4 79.7 27.5 45.8 74.3 83.2 58.0 64.7 132.3 83.2 136.3 91.3 78.3 102.0 113.5 131.3 111.8 78.4 99.8 157.1 123.5 78.0 96.4 90.7 69.6 130.2 209.1 101.8 113.6 109.3 152.1 112.7 100.7 109.9 121.7 114.2 79.7 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36184319 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.1" "Cell line enhanced" "Detected in all" "BEWO: 73.6;RH-30: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavourable (3.72e-7)" "prognostic favourable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavourable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 6.5 6.9 7.8 8.0 7.5 12.9 6.5 11.5 9.0 7.5 7.7 10.3 3.7 10.2 9.9 6.3 13.5 8.1 4.9 4.1 7.3 5.1 4.2 14.0 5.8 9.4 8.8 7.4 7.7 6.1 3.9 12.5 49.1 6.5 7.2 9.5 6.1 6.3 5.4 3.4 7.6 7.7 6.4 7.4 9.4 5.3 3.9 7.4 19.5 5.0 7.5 11.7 7.9 8.4 6.5 16.0 14.7 7.9 7.7 8.5 5.0 7.4 3.7 15.8 17.6 3.9 6.2 73.6 9.7 7.3 24.8 18.8 20.6 5.9 10.8 2.6 7.8 7.8 17.7 12.3 26.7 4.8 10.1 6.3 13.8 9.7 1.9 13.9 2.9 5.7 3.2 4.5 3.1 6.8 10.8 2.5 8.9 3.6 16.1 8.0 14.4 5.7 16.0 92.3 6.9 1.8 7.9 13.6 16.3 30.4 6.6 4.3 6.7 7.9 3.1 9.3 10.8 3.5 6.7 3.1 3.0 13.4 4.2 17.1 6.7 10.3 7.9 14.7 5.4 7.2 8.5 5.6 5.7 5.8 16.0 6.5 7.9 6.0 1.5 7.7 4.1 4.3 5.3 5.0 7.8 7.5 11.5 9.0 7.3 5.1 8.8 7.4 6.5 7.4 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell line enriched" "Detected in some" 8 "HEL: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: , HPA058217: " "unprognostic (4.16e-3)" "prognostic favourable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.2 1.7 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.1 3.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 SLAIN2 "FLJ21611, KIAA1458" ENSG00000109171 "SLAIN motif family member 2" Q9P270 4 48341322-48426212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035824, HPA063599" Approved Enhanced Centrosome,Cytosol 13000 Centrosome Cytosol "HPA035824: AB_10602399, HPA063599: " "unprognostic (6.20e-2)" "unprognostic (1.80e-1)" "prognostic favourable (5.77e-4)" "prognostic favourable (7.98e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (1.33e-3)" "unprognostic (2.58e-1)" "unprognostic (1.59e-1)" "unprognostic (2.23e-2)" "prognostic unfavourable (6.71e-4)" "unprognostic (1.57e-1)" "prognostic favourable (1.50e-4)" "unprognostic (1.75e-1)" "unprognostic (5.72e-2)" "unprognostic (1.85e-1)" "unprognostic (8.00e-2)" 14.8 9.3 6.8 11.7 8.6 7.0 12.6 9.2 10.7 18.4 20.7 6.1 11.7 6.9 18.1 12.2 24.0 14.3 12.3 21.3 7.3 5.6 12.8 16.1 14.0 10.6 7.6 7.2 16.4 10.4 17.2 9.4 29.7 8.0 19.0 13.1 14.1 15.2 17.3 49.2 20.1 15.5 30.6 6.2 11.4 13.2 23.6 5.8 23.8 12.1 22.2 16.9 24.9 23.7 7.7 8.5 10.9 8.6 10.7 13.5 4.2 12.6 5.0 9.1 8.9 14.1 17.4 6.4 19.5 25.0 17.6 18.3 4.9 10.7 7.6 12.1 22.4 8.4 37.0 18.4 31.0 6.3 3.8 13.4 7.4 5.6 15.1 12.2 13.7 14.7 27.2 20.3 23.7 10.3 8.5 8.6 17.6 6.4 14.0 10.1 3.8 7.2 8.0 17.7 4.8 15.4 14.0 6.0 7.7 7.9 6.0 8.3 7.5 8.7 13.0 19.3 18.3 12.2 19.9 11.7 12.1 6.5 15.1 14.0 13.8 10.9 8.0 9.6 8.8 5.8 9.9 6.1 11.0 13.5 8.5 7.7 9.1 9.8 7.5 10.7 8.6 2.9 7.1 4.2 6.8 8.6 9.2 10.7 7.3 5.6 7.6 7.2 8.0 5.8 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Group enriched" "Detected in some" 5 "Daudi: 32.6;U-698: 48.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA051363: , HPA051903: " "prognostic favourable (9.42e-4)" "prognostic favourable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favourable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favourable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favourable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 48.1 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavourable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 28.8 11.9 17.1 18.0 15.2 17.4 17.8 25.4 21.7 30.9 31.3 24.5 33.7 38.2 15.2 21.0 17.7 34.4 23.0 36.2 15.6 18.6 47.8 14.8 24.6 18.8 44.2 23.4 12.0 18.5 23.5 15.6 17.5 34.2 37.7 37.8 10.4 68.0 40.3 21.3 21.1 51.3 28.0 24.1 29.7 22.0 19.5 15.0 21.5 14.0 15.0 23.2 29.2 14.8 25.9 14.9 27.3 39.5 22.0 39.9 91.2 24.3 37.9 25.5 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 23.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell line enhanced" "Detected in all" "A549: 31.1;AF22: 32.1" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: " "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favourable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favourable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 6.2 31.1 32.1 12.4 8.0 5.2 6.6 5.8 4.4 4.2 4.4 12.4 10.0 9.3 7.9 5.0 19.0 6.1 6.7 6.5 9.3 7.6 2.7 5.5 1.8 2.5 3.3 4.7 5.5 2.4 9.3 5.5 6.8 4.3 6.4 6.5 6.6 5.9 2.8 3.7 10.2 3.3 9.0 3.8 4.9 21.4 5.6 3.6 11.7 5.1 4.6 2.8 1.7 11.4 10.5 7.0 7.9 7.4 5.4 4.8 10.4 5.5 2.0 8.4 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229996-34338060 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 9.4;neutrophil: 18.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 18.5" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favourable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 8.7 5.8 7.4 12.4 11.1 27.5 7.0 10.2 14.1 14.7 8.0 12.7 3.6 8.3 6.3 8.7 24.9 4.7 6.3 6.9 6.8 6.9 18.6 4.9 11.5 10.9 9.9 8.4 5.8 5.1 5.4 10.9 5.2 12.5 5.0 7.4 9.7 9.3 4.9 10.5 8.6 10.2 6.0 9.2 11.1 8.0 38.5 10.9 18.2 10.6 8.2 13.6 8.2 21.2 2.0 1.0 18.5 1.4 0.6 2.3 0.7 2.6 3.1 2.0 2.8 6.3 7.4 1.3 3.9 9.1 3.0 4.4 1.8 4.3 1.8 3.7 4.1 26.7 4.7 3.2 3.6 0.7 3.2 14.2 8.0 4.1 3.9 8.5 15.6 4.3 5.7 8.9 18.0 9.2 3.1 4.2 4.1 0.9 0.9 6.8 1.5 3.4 4.3 3.4 1.8 3.4 6.7 4.3 3.2 4.3 0.1 0.9 1.9 2.9 5.7 3.5 2.6 12.2 0.9 3.7 4.1 1.1 4.2 6.3 1.5 9.4 1.1 2.3 0.5 1.4 0.3 1.2 0.8 0.7 0.7 2.0 1.3 1.1 18.5 0.6 0.6 1.0 2.3 0.7 7.4 11.1 10.2 14.1 6.8 6.9 9.9 8.4 12.5 10.9 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.0" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Group enriched" "Detected in some" 6 "CAPAN-2: 29.5;SK-BR-3: 29.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 29.5 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.6 1.7 0.6 0.1 0.3 0.0 29.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: " "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavourable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavourable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 19.9 4.7 14.4 12.3 10.0 8.5 47.4 10.8 8.2 8.5 13.7 15.8 11.6 21.9 15.1 9.7 19.1 20.1 20.1 16.1 13.7 20.4 18.0 12.8 18.3 17.7 22.9 1.9 11.9 24.6 12.6 24.7 20.5 22.7 14.6 9.5 3.9 13.5 11.5 46.6 15.0 12.0 22.8 15.1 10.5 0.3 16.0 8.4 20.9 0.6 16.0 0.9 8.7 13.8 8.2 14.5 16.1 15.9 7.7 6.7 22.1 23.8 14.5 10.1 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.1;skeletal muscle: 33.4" "Cell line enhanced" "Detected in many" "HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Low region specificity" "Detected in many" HPA016860 Approved Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 7.6 4.9 1.8 2.4 5.4 0.4 1.1 9.5 2.0 0.8 4.8 1.7 1.7 7.6 0.7 1.6 0.7 1.1 1.0 2.8 1.8 1.0 8.1 9.8 6.1 1.8 0.8 0.5 1.2 25.1 8.9 1.5 17.4 5.6 1.2 1.3 3.6 3.5 6.0 33.4 12.1 6.0 0.8 1.0 2.7 3.9 3.5 0.8 19.6 2.2 1.5 0.9 4.4 1.4 0.5 0.3 0.8 0.2 0.3 4.7 0.3 0.6 0.6 0.2 1.3 0.0 0.0 2.3 0.0 0.1 0.5 0.7 5.0 0.2 4.0 0.9 0.1 0.0 28.8 0.0 0.5 0.0 12.4 4.7 0.3 4.7 0.0 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.0 6.1 0.6 8.9 1.8 3.5 4.3 23.8 0.0 0.4 6.7 2.1 0.1 0.6 1.1 1.1 0.7 0.0 0.1 1.1 0.3 1.6 1.9 0.0 1.0 0.2 3.7 0.5 0.8 0.2 0.1 0.2 0.2 0.2 0.2 1.1 0.3 0.0 0.5 4.7 4.0 0.8 0.3 0.1 0.3 4.0 0.3 1.8 5.4 9.5 2.0 1.8 1.0 0.8 0.5 5.6 0.8 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036075-7040121 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 55.9" "Cell line enhanced" "Detected in many" "A549: 17.9;HaCaT: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA065245: " "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 2.5 1.3 1.4 3.5 0.8 0.2 1.6 1.5 1.0 1.8 4.9 0.7 1.2 8.0 1.1 1.4 5.0 1.5 3.2 1.3 1.2 0.7 12.0 55.9 2.9 7.6 0.8 0.5 1.7 2.8 2.7 1.0 3.3 0.7 1.5 1.3 1.8 3.5 1.5 0.5 4.5 10.2 0.7 0.6 4.8 1.6 0.7 0.3 3.6 3.0 2.4 5.8 1.8 2.4 6.8 2.8 2.4 2.2 2.7 3.9 1.3 10.0 17.9 4.2 2.6 2.6 1.5 1.8 1.0 2.6 2.3 5.3 5.8 11.3 6.4 1.7 1.6 15.9 3.3 5.5 0.9 7.9 2.2 2.6 1.4 13.8 3.0 0.9 6.2 1.7 6.3 3.4 2.8 9.5 3.0 1.8 2.4 5.0 3.8 1.6 1.7 1.4 1.8 1.4 1.1 2.2 2.8 0.2 1.1 3.1 1.8 1.4 4.8 1.4 3.5 1.5 3.5 2.4 1.5 3.2 6.6 0.4 4.4 2.3 0.7 0.0 2.0 2.2 3.2 1.9 2.3 2.3 2.9 3.9 2.1 6.8 3.1 2.9 2.4 2.7 2.2 2.8 3.0 1.3 1.4 0.8 1.5 1.0 1.2 0.7 0.8 0.5 0.7 0.3 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavourable (1.19e-7)" "prognostic unfavourable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.4 5.7 0.1 0.1 2.5 8.3 11.4 47.9 29.5 34.0 38.7 2.7 30.0 0.1 37.7 33.7 4.1 4.1 69.4 14.3 20.6 0.2 21.8 42.6 50.0 43.9 32.0 27.0 17.0 10.2 22.9 10.5 18.5 0.1 6.8 29.5 3.1 0.3 31.6 0.4 46.6 0.1 0.5 7.5 18.0 0.5 0.7 0.3 46.0 41.0 0.5 5.9 27.0 31.9 67.9 1.1 1.0 49.9 22.0 0.3 1.0 33.3 20.3 0.5 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Cell line enhanced" "Detected in many" "BEWO: 12.6;BJ hTERT+: 12.7;CAPAN-2: 18.8;HHSteC: 12.6;SK-MEL-30: 19.3" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: , HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favourable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 6.0 1.3 1.9 4.3 8.5 12.6 3.3 12.7 1.1 3.2 1.8 18.8 0.3 3.5 10.3 0.3 0.1 1.2 1.2 0.3 1.5 0.3 1.3 1.9 12.6 0.4 0.3 6.3 0.2 1.9 0.1 2.6 0.3 0.6 2.1 0.6 0.2 0.3 0.4 0.2 0.1 0.9 0.1 2.2 0.3 0.7 0.4 0.3 6.1 19.3 0.3 0.0 0.3 0.7 0.5 0.2 0.9 0.3 0.1 0.9 0.6 0.3 3.5 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favourable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.5 16.0 0.1 9.7 6.3 3.4 3.0 0.2 5.8 5.0 2.3 16.4 0.5 0.6 1.2 5.1 1.3 0.3 9.0 10.2 0.3 5.5 14.7 0.1 8.3 3.1 0.9 9.6 1.2 0.1 11.0 5.4 2.0 4.2 2.2 0.6 3.0 0.3 0.0 2.4 7.4 14.1 2.5 0.6 0.0 0.2 4.6 0.3 1.8 0.0 8.0 2.7 14.5 0.3 10.6 0.1 8.4 9.1 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell line enhanced" "Detected in some" "BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" "Focal adhesion sites" "Intermediate filaments" "HPA075017: " "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.3 0.7 1.1 0.2 0.0 0.0 5.9 0.5 0.0 0.0 0.0 1.2 3.5 0.4 1.7 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.9 0.0 0.0 1.4 0.1 2.0 0.0 0.0 0.0 4.4 1.9 0.3 6.4 0.3 0.9 7.7 0.2 0.0 0.0 3.5 0.3 0.0 11.3 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell line enhanced" "Detected in some" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.8;U-251 MG: 8.3;U-937: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA049286: " "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favourable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.3 6.1 0.1 0.4 3.3 2.3 0.0 16.4 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.8 0.1 0.3 0.0 2.7 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Cell line enhanced" "Detected in many" "ASC diff: 40.9;ASC TERT1: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favourable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.7 3.8 3.8 6.1 40.9 30.5 5.1 9.2 23.1 2.5 8.7 2.5 6.8 2.5 4.4 12.8 4.9 5.3 2.3 4.4 1.8 6.1 1.1 2.0 5.8 8.2 2.1 4.3 13.9 3.4 5.6 3.9 6.3 2.7 2.8 8.6 1.8 0.8 1.2 2.8 2.2 1.8 4.7 10.9 6.4 7.7 1.5 2.7 1.8 5.5 5.3 2.5 13.0 9.2 1.2 1.1 4.9 2.1 8.0 11.2 0.7 4.1 4.5 3.6 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell line enriched" "Detected in some" 20 "HMC-1: 89.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Supported Vesicles,Centrosome Vesicles Centrosome "HPA073224: " "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.2 89.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 SLC18B1 "C6orf192, dJ55C23.6" ENSG00000146409 "Solute carrier family 18 member B1" Q6NT16 6 132769370-132798553 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.4;RPTEC TERT1: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029747, HPA049659" Approved Supported "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA029747: AB_10600797, HPA049659: " "unprognostic (1.84e-2)" "unprognostic (3.94e-1)" "unprognostic (4.22e-2)" "unprognostic (2.85e-1)" "unprognostic (2.41e-2)" "prognostic favourable (3.55e-4)" "prognostic unfavourable (7.90e-4)" "unprognostic (1.53e-1)" "unprognostic (2.39e-1)" "unprognostic (4.09e-1)" "unprognostic (6.97e-3)" "unprognostic (1.13e-1)" "prognostic favourable (9.24e-4)" "unprognostic (7.20e-3)" "unprognostic (1.08e-1)" "unprognostic (2.08e-2)" "unprognostic (7.88e-2)" 9.3 7.3 26.2 6.0 21.9 4.5 11.0 13.1 20.6 9.4 9.5 18.8 3.1 14.4 7.0 7.8 10.7 10.1 11.5 4.2 21.6 15.8 11.8 6.0 5.7 7.2 19.5 10.8 7.4 7.8 13.0 6.9 15.5 17.0 5.0 11.4 7.4 11.7 4.9 4.8 10.5 10.4 5.8 21.7 7.0 14.9 2.3 16.3 8.3 10.1 5.9 8.6 10.6 5.5 7.5 15.6 0.6 11.3 2.8 9.4 6.5 3.9 3.7 6.4 0.0 0.8 2.4 3.9 1.4 4.5 2.9 9.2 8.3 8.2 0.1 5.8 0.8 11.1 8.7 9.7 2.3 5.8 16.3 2.1 6.9 10.0 4.9 1.9 0.2 6.5 9.4 4.5 9.8 9.2 23.4 1.5 2.4 5.6 6.0 0.2 8.5 5.3 9.7 7.0 6.5 23.7 7.0 12.9 0.0 7.7 15.3 12.2 5.3 0.0 4.2 1.3 3.4 1.3 3.8 5.1 0.4 0.2 7.0 0.2 1.0 0.0 11.3 0.5 3.7 2.5 6.7 5.5 5.7 5.2 15.6 7.5 8.2 5.6 0.6 2.8 0.2 12.1 9.4 6.5 26.2 21.9 13.1 20.6 21.6 15.8 19.5 10.8 17.0 16.3 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.1 0.4 7.2 0.1 0.2 0.3 0.6 18.4 0.5 0.4 0.2 0.1 0.5 0.5 0.5 0.8 0.1 1.2 0.1 0.9 0.7 1.7 0.2 0.2 3.2 0.4 0.1 0.9 0.0 0.2 0.8 0.0 1.8 0.1 0.6 3.2 0.3 0.3 0.2 0.2 0.2 0.3 1.0 0.1 0.5 2.0 0.5 0.3 0.2 0.5 0.5 0.5 4.1 0.3 0.2 0.1 0.6 1.4 0.3 0.4 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell line enhanced" "Detected in many" "AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.2 1.8 2.1 5.9 13.5 0.0 0.0 0.8 1.8 34.1 1.7 0.0 10.3 0.3 25.8 6.2 2.8 0.9 0.3 12.7 0.0 0.1 0.0 0.4 0.4 0.1 10.9 12.8 5.2 2.1 0.0 0.0 0.1 3.6 0.0 0.0 0.0 2.5 2.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 2.1 6.2 0.3 0.0 1.0 0.0 1.9 3.1 0.0 7.5 0.0 0.0 0.0 8.6 14.3 4.8 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell line enhanced" "Detected in some" "HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported "Plasma membrane,Intermediate filaments" "Plasma membrane" "Intermediate filaments" "HPA041505: , HPA044066: " "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.0 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 1.2 6.4 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.5 0.0 0.3 5.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.5 0.0 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.1 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favourable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.7 12.6 14.0 4.5 5.0 16.1 0.4 0.1 0.7 0.3 12.6 0.4 0.6 1.5 2.7 3.6 2.5 6.7 0.2 2.0 7.8 5.9 2.2 11.1 0.6 0.3 0.4 1.2 13.2 12.2 0.6 0.4 5.3 3.4 0.4 2.9 0.5 1.4 4.3 2.3 1.3 0.8 10.0 0.0 15.4 1.4 0.2 3.3 4.8 4.1 18.7 0.1 3.1 7.4 2.3 9.5 1.5 7.6 0.1 0.2 12.9 0.4 4.5 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell line enhanced" "Detected in some" "A549: 17.4;HeLa: 23.4;Hep G2: 14.5;RPTEC TERT1: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavourable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavourable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.0 23.4 14.5 0.8 0.0 0.0 0.5 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.9 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA052825: , HPA059314: " "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favourable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favourable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.5 12.4 16.8 6.3 11.8 6.7 21.3 4.5 6.2 5.4 5.0 6.4 12.1 4.8 4.9 6.2 10.3 4.6 12.3 10.2 3.0 8.3 6.7 2.1 24.0 6.7 9.3 4.0 5.6 7.2 13.4 8.1 7.8 4.5 4.1 7.1 3.9 10.2 5.2 5.9 7.7 9.4 11.1 7.2 2.9 17.3 5.6 6.3 8.7 9.2 32.2 5.1 5.5 6.7 12.1 5.6 14.4 8.7 5.8 10.8 13.0 4.3 5.6 18.9 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell line enhanced" "Detected in many" "hTCEpi: 8.9;U-266/70: 6.5" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Low region specificity" "Detected in single" HPA019059 Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 3.9 2.2 0.8 2.2 0.6 0.4 1.3 2.3 1.6 0.5 0.8 1.5 3.2 0.7 0.3 0.6 1.8 1.8 2.0 1.9 0.1 0.7 0.2 0.9 0.7 8.9 0.9 2.9 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.2 0.5 0.5 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.3 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.5 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell line enhanced" "Detected in many" "Hep G2: 49.6;SK-BR-3: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" HPA023048 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favourable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favourable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.0 26.0 2.5 12.4 0.9 0.7 5.0 6.0 1.9 7.7 5.8 15.7 6.0 6.3 4.7 1.4 9.0 3.5 6.2 1.4 4.6 20.1 5.1 15.8 49.6 1.1 11.5 6.3 0.5 3.2 5.4 1.0 4.4 8.6 7.9 2.6 26.4 16.8 12.2 2.5 19.6 12.8 5.3 19.9 6.8 12.7 16.4 11.1 5.6 38.2 1.3 16.3 6.4 1.9 5.9 19.5 8.6 10.8 4.9 2.5 3.6 2.6 12.2 5.1 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171784370-171999859 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favourable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 6.4 6.7 8.8 6.2 18.2 2.9 9.2 17.9 25.0 10.6 12.2 5.7 5.2 4.2 10.4 7.1 11.5 6.9 5.9 42.4 9.9 13.4 10.7 1.9 5.2 6.5 10.4 12.4 10.0 3.5 16.4 14.7 4.7 15.2 10.6 10.0 11.0 21.7 14.8 84.7 7.6 5.7 14.3 7.1 5.6 9.0 4.3 6.2 5.8 10.1 23.8 8.4 10.0 6.7 6.4 3.6 5.1 4.6 6.6 8.1 2.9 7.1 5.3 5.6 12.8 16.5 18.7 0.1 9.1 15.5 12.4 11.9 2.8 6.7 22.6 6.0 10.6 9.0 11.7 11.4 15.6 13.8 10.9 9.8 7.6 6.6 6.3 19.8 9.8 16.3 11.3 14.4 4.1 12.8 6.8 10.4 7.9 4.3 13.9 8.3 4.5 7.4 14.5 8.0 11.8 13.0 6.3 7.8 2.5 5.7 13.5 7.2 4.9 5.9 8.8 10.3 4.5 11.5 6.2 14.0 9.0 22.9 14.3 10.5 7.0 5.1 3.0 1.6 6.5 3.9 7.3 6.4 4.5 6.8 3.6 3.9 6.3 8.1 0.2 6.6 4.6 0.6 4.5 2.9 8.8 18.2 17.9 25.0 9.9 13.4 10.4 12.4 15.2 6.2 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell line enhanced" "Detected in many" "Karpas-707: 34.6;RPMI-8226: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Supported Mitochondria,Cytosol 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.4 3.5 4.9 11.3 4.3 0.7 7.8 4.2 5.5 5.7 5.5 6.8 6.5 5.5 12.3 1.4 8.7 3.5 4.1 16.4 4.1 9.0 6.9 6.9 5.1 9.4 17.4 5.5 4.0 7.4 1.2 7.0 8.0 34.6 7.2 3.7 10.3 4.7 1.8 9.9 3.7 2.1 47.7 5.9 3.4 1.4 5.0 7.2 0.0 4.0 11.0 4.4 5.7 6.2 1.1 9.1 5.7 12.9 8.9 7.5 9.0 6.7 8.2 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.2 15.1 8.9 7.9 3.7 6.8 8.4 11.1 9.4 12.4 7.9 14.9 16.0 7.0 8.4 9.3 20.6 9.8 13.4 2.8 13.1 17.9 6.4 7.4 9.1 16.1 10.3 10.8 6.8 8.1 9.4 10.1 5.7 13.0 11.0 5.5 14.1 10.7 9.7 19.2 23.2 12.7 4.8 16.5 7.4 3.9 43.9 19.7 6.4 15.4 7.9 7.4 5.2 5.5 13.9 9.3 6.4 10.4 9.7 5.6 8.9 16.7 9.2 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 SLC25A25 "KIAA1896, MCSC, PCSCL" ENSG00000148339 "Solute carrier family 25 member 25" Q6KCM7 9 128068201-128109245 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020381 Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" "Vesicles, Mitochondria" "HPA020381: AB_1857037" "unprognostic (4.62e-2)" "unprognostic (2.66e-2)" "unprognostic (2.56e-2)" "unprognostic (1.59e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-1)" "prognostic favourable (1.01e-4)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.60e-2)" "unprognostic (4.96e-2)" "unprognostic (3.70e-2)" "prognostic favourable (4.65e-6)" "unprognostic (1.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.66e-3)" "unprognostic (1.42e-2)" 29.2 15.8 7.3 8.1 12.8 5.5 10.6 8.8 20.0 14.4 7.2 6.3 20.0 7.9 14.6 8.2 22.7 17.5 31.6 5.6 7.6 9.0 9.5 48.4 12.4 6.7 7.5 8.0 13.6 52.6 12.1 19.0 7.6 15.0 8.5 5.5 13.6 7.6 63.5 31.3 9.5 10.0 17.3 8.7 7.8 10.5 7.3 5.3 5.4 10.8 20.2 9.7 8.6 9.6 2.9 4.6 3.8 8.4 1.5 7.6 3.9 5.8 6.1 8.7 12.6 6.6 5.7 5.8 12.1 11.3 10.2 6.8 11.0 6.1 7.6 3.7 5.6 10.4 6.8 4.0 3.9 8.8 5.6 4.4 12.4 6.5 10.5 5.0 10.1 7.2 3.8 10.0 7.4 6.9 15.8 16.4 6.4 14.1 8.9 5.1 8.8 9.6 8.8 7.5 15.9 3.9 6.1 21.7 9.3 12.7 8.2 16.9 9.0 2.9 4.4 11.6 6.9 8.7 11.9 14.4 25.1 8.1 7.8 2.7 9.5 3.8 2.3 1.2 4.8 7.3 2.4 1.7 5.3 4.8 4.6 2.9 4.5 7.6 0.4 1.5 8.4 1.5 3.9 3.9 7.3 12.8 8.8 20.0 7.6 9.0 7.5 8.0 15.0 5.3 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051720 Uncertain Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA051720: " "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favourable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favourable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favourable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.4 12.3 2.1 9.2 7.1 2.8 5.1 2.9 2.6 3.2 3.6 1.4 11.5 5.1 3.0 3.4 10.0 2.6 3.5 1.7 2.7 3.2 4.3 9.1 1.7 2.6 0.5 11.7 5.8 2.0 6.1 1.1 5.1 1.2 1.8 2.6 2.4 4.6 2.4 0.7 4.1 5.0 1.5 2.2 2.5 11.4 1.1 2.7 8.5 5.1 3.6 11.4 3.3 6.6 2.2 1.7 5.2 2.5 3.9 2.3 1.7 5.6 7.6 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favourable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.5 5.3 17.4 14.2 15.9 20.4 21.8 8.9 11.4 10.0 14.2 14.8 11.2 19.6 22.2 7.5 15.8 20.9 8.7 20.4 15.0 17.0 16.3 12.9 9.3 24.0 23.1 10.1 23.0 29.3 7.3 22.5 10.5 8.6 12.7 14.5 10.2 13.8 15.9 17.2 10.0 15.0 15.4 27.9 11.7 8.1 11.2 18.3 12.0 21.9 38.7 15.2 13.2 10.6 13.9 7.8 24.6 8.5 25.9 16.9 23.0 18.0 9.7 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528805-23575463 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.8" "Cell line enriched" "Detected in all" 4 "HEL: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 28.9" "Lineage enriched" "Detected in many" 18 "granulocytes: 28.9" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 8.2 18.3 5.8 13.7 8.3 88.8 13.1 4.2 8.2 13.4 16.4 6.5 11.7 39.7 10.3 6.8 8.2 9.5 8.5 16.8 6.2 5.2 9.4 11.8 25.7 18.5 12.2 5.1 17.2 14.8 15.6 8.8 23.9 10.3 17.1 5.8 7.9 21.1 17.4 13.8 7.6 17.6 7.9 10.2 28.7 8.0 15.0 8.6 1.9 9.0 5.9 5.7 13.9 33.0 1.2 1.4 28.9 1.6 0.7 1.2 0.8 3.9 4.3 4.6 4.2 6.1 7.5 6.9 3.1 4.1 2.3 2.6 4.3 8.5 6.4 3.8 2.6 5.1 4.2 8.5 3.2 1.0 2.2 49.4 7.2 1.5 5.1 2.7 1.9 6.4 8.3 5.0 5.0 3.6 10.8 3.2 3.6 1.7 3.3 11.7 2.4 3.4 3.5 2.3 2.5 7.1 2.2 1.4 2.0 4.3 6.6 3.1 1.8 4.3 5.7 11.2 1.7 6.6 6.0 2.6 1.0 4.0 10.6 6.8 7.0 0.6 1.6 1.4 0.6 0.6 0.6 1.2 0.4 0.3 1.4 0.8 1.2 0.7 28.9 0.7 0.8 0.4 0.7 0.8 5.8 8.3 4.2 8.2 6.2 5.2 12.2 5.1 10.3 8.6 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA065411: " "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favourable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.2 17.5 8.6 11.3 18.8 10.1 6.8 11.0 16.2 20.0 16.4 17.1 9.3 8.1 9.7 16.4 15.3 31.4 12.9 17.8 9.3 10.5 7.4 11.2 10.3 14.4 9.6 13.7 14.3 11.4 20.2 12.3 16.2 7.7 13.5 13.7 18.4 10.0 6.8 20.3 18.2 6.4 8.7 13.9 26.2 12.2 13.4 18.2 12.8 23.4 14.6 17.6 15.8 13.1 11.6 9.8 13.0 13.1 13.8 10.5 12.3 12.8 10.1 11.4 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;Karpas-707: 18.6;RPMI-8226: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA050821: " "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favourable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.6 0.2 6.8 1.3 0.6 3.4 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 0.5 0.5 0.3 0.0 13.7 1.0 4.4 2.5 0.3 0.8 1.4 4.7 1.6 0.1 0.5 0.4 0.7 0.6 18.6 0.7 1.5 3.2 0.1 0.3 2.1 6.0 0.9 13.4 0.7 0.0 2.3 3.0 1.4 3.6 0.7 1.8 0.7 1.3 0.5 1.7 4.4 0.3 7.7 4.8 1.1 1.4 1.0 2.6 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell line enhanced" "Detected in some" "HAP1: 4.9;HEK 293: 4.1;HEL: 4.0;RPMI-8226: 3.6;SCLC-21H: 3.8;U-2 OS: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.3 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.5 4.9 0.0 0.0 0.7 4.1 4.0 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.1 0.1 0.0 3.6 0.3 0.6 3.8 0.4 0.6 0.5 1.0 1.8 0.6 0.5 0.4 5.0 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavourable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favourable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.3 9.8 7.6 4.9 3.7 11.4 4.7 5.9 10.7 6.7 9.5 1.7 0.1 9.7 4.9 3.2 5.4 3.5 4.2 11.3 9.8 0.0 10.5 8.8 13.1 0.0 1.5 6.7 5.8 5.1 2.4 9.0 4.1 12.1 6.3 7.8 0.4 0.2 4.4 8.1 0.4 1.1 4.4 9.7 9.1 3.9 12.0 4.8 11.9 12.3 14.3 0.2 6.7 8.6 5.1 7.3 0.5 13.6 5.1 1.3 4.5 0.0 6.9 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 17.5;SK-MEL-30: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: " "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favourable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.0 17.5 9.8 2.1 2.6 6.9 3.0 4.5 0.2 11.2 1.2 5.0 4.3 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 2.0 0.4 0.7 1.9 1.5 1.9 2.9 0.7 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 28.9 3.2 0.9 1.2 5.9 3.8 4.6 1.8 2.5 1.8 0.4 6.0 3.1 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 SLC29A3 "ENT3, FLJ11160" ENSG00000198246 "Solute carrier family 29 member 3" Q9BZD2 10 71319258-71381423 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 19.5;Hep G2: 21.7;RT4: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046085, HPA054976, HPA057905" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA046085: , HPA054976: , HPA057905: " "unprognostic (1.73e-1)" "unprognostic (2.38e-3)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (6.07e-6)" "unprognostic (1.28e-1)" "unprognostic (4.71e-1)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (3.80e-2)" "prognostic unfavourable (5.53e-5)" "unprognostic (3.37e-1)" "unprognostic (1.36e-1)" "prognostic favourable (1.16e-4)" "unprognostic (3.43e-3)" 11.3 4.0 6.4 6.6 8.3 1.9 6.8 3.2 12.6 8.3 6.1 11.3 2.4 4.1 12.1 4.6 3.5 9.4 7.4 3.6 8.0 5.5 3.9 12.5 11.1 10.5 9.8 6.5 15.8 7.4 7.1 2.8 24.6 6.7 8.3 6.0 4.6 7.5 5.4 2.1 3.7 4.9 8.9 8.0 9.4 8.9 4.9 7.7 9.3 6.7 1.3 6.2 18.4 10.0 3.6 19.3 2.8 12.9 5.7 4.0 5.6 1.2 7.3 1.0 4.6 4.2 3.3 19.5 1.3 1.4 0.4 0.2 8.0 5.2 4.2 3.9 2.7 11.6 3.3 1.8 0.0 3.3 3.3 1.2 0.6 21.7 2.0 1.0 2.7 3.2 8.0 0.1 0.3 1.9 3.9 4.1 0.5 11.3 2.7 2.1 2.5 2.6 3.3 0.4 3.4 1.6 17.3 5.5 5.8 3.9 12.7 1.0 1.9 2.3 3.0 0.1 2.4 1.3 0.0 1.1 1.8 2.3 5.1 14.3 0.8 2.8 12.9 1.4 4.0 10.1 3.4 3.6 3.2 3.6 19.3 1.5 2.6 3.6 1.0 5.7 6.3 13.6 3.4 5.6 6.4 8.3 3.2 12.6 8.0 5.5 9.8 6.5 6.7 7.7 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306870 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.7" "Cell line enhanced" "Detected in many" "AN3-CA: 24.0;SH-SY5Y: 34.8;U-2 OS: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052829 Approved "Microtubules,Cytokinetic bridge" "Microtubules, Cytokinetic bridge" "HPA052829: " "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favourable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 35.7 8.3 7.6 2.5 6.4 0.8 6.5 4.2 9.7 2.0 2.5 2.0 0.3 4.5 2.4 5.3 1.3 4.2 1.8 1.7 9.4 15.7 3.4 3.8 1.2 1.8 12.2 5.4 3.2 13.0 0.5 1.6 0.8 7.0 3.0 2.0 11.5 1.1 1.0 2.1 1.4 5.4 2.0 3.1 1.1 7.1 1.3 1.1 0.3 4.3 0.3 0.7 2.3 0.5 1.3 1.1 4.3 1.1 4.3 1.3 0.3 0.0 10.4 6.2 24.0 0.3 0.1 1.1 0.9 0.0 0.8 0.4 5.8 0.2 0.0 1.2 0.9 0.1 2.3 0.2 0.2 0.0 1.3 0.1 0.3 8.5 1.9 0.1 1.4 0.7 8.0 0.1 0.4 0.7 1.6 0.1 0.6 5.0 0.9 0.4 7.8 0.6 3.9 1.0 0.9 1.6 0.2 4.1 34.8 0.6 2.1 0.4 2.6 2.8 0.3 8.6 12.0 0.8 0.2 0.5 0.0 0.0 1.1 0.3 3.8 2.0 1.1 0.6 0.8 0.5 1.3 0.7 0.5 0.7 0.4 1.3 0.7 0.9 4.3 4.3 0.5 1.1 0.3 0.3 7.6 6.4 4.2 9.7 9.4 15.7 12.2 5.4 7.0 1.1 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;HSkMC: 24.2;SK-MEL-30: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041015: " "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.6 16.7 14.4 9.1 12.5 4.3 5.1 0.3 16.0 0.0 6.9 16.5 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 1.7 0.1 0.0 7.2 16.6 0.0 0.4 1.8 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 2.3 3.7 1.0 9.2 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA042960: , HPA071184: " "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favourable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favourable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.7 3.5 0.8 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 2.2 3.2 0.9 1.0 2.4 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 0.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.4 0.8 12.1 2.7 6.3 0.8 0.5 0.7 1.2 0.7 0.8 7.2 2.0 3.4 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.6;CAPAN-2: 10.4;HaCaT: 7.9;HEK 293: 6.5;U-2 OS: 11.3" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: " "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 3.0 1.0 2.6 0.0 2.0 1.1 0.2 1.8 7.6 1.0 4.2 0.0 10.4 0.4 1.6 0.1 7.9 0.0 0.8 1.5 0.0 6.5 0.0 0.9 0.1 0.3 0.0 0.0 1.5 0.7 0.8 0.2 0.6 0.6 0.9 0.2 0.9 0.1 0.1 2.3 0.7 0.0 1.3 2.8 2.3 1.0 0.3 0.8 0.1 2.4 0.0 0.1 0.0 0.1 0.2 11.3 0.2 1.0 3.9 3.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: " "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.6 6.8 3.7 4.8 16.3 7.6 33.1 12.8 9.4 6.8 6.7 2.9 22.2 2.6 11.2 11.7 8.0 5.6 7.4 8.2 6.6 4.2 2.1 13.8 6.8 9.2 7.3 4.7 11.3 18.7 8.7 14.2 4.2 8.2 12.3 8.4 4.2 1.4 4.6 11.5 5.4 4.4 1.8 9.5 21.2 12.5 3.8 6.6 12.5 6.5 28.6 3.3 9.5 6.7 5.1 11.9 17.0 10.1 5.4 8.2 2.1 4.8 7.4 4.4 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: , HPA067637: " "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.7 1.4 0.0 0.1 3.8 0.0 0.3 1.4 0.0 18.9 9.8 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.7 0.0 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093646-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 19.4 22.1 14.4 19.4 15.7 13.3 29.7 14.9 18.5 25.0 20.9 13.2 33.7 19.7 24.3 32.4 20.5 20.3 23.5 25.4 14.5 15.4 28.6 39.2 24.3 23.7 15.5 13.1 25.4 50.5 29.6 38.1 34.3 13.9 24.5 19.8 17.6 36.8 35.3 17.1 21.2 25.0 18.1 13.2 20.1 20.3 18.1 12.7 22.1 33.5 18.8 19.6 18.2 28.9 8.3 13.2 12.4 6.9 5.6 9.1 3.3 15.6 12.2 11.3 19.9 29.9 23.1 36.0 24.9 22.6 15.7 24.1 11.2 19.8 20.8 31.7 16.9 17.0 15.7 18.9 26.7 24.8 18.1 23.2 15.4 18.2 24.1 14.5 25.8 15.6 25.0 16.2 19.3 15.2 13.9 24.9 20.0 19.8 19.1 30.3 12.9 13.9 15.4 14.4 37.5 23.5 14.7 20.3 16.1 19.7 19.8 33.7 19.1 32.4 13.8 10.3 13.3 25.6 24.6 22.6 27.7 16.2 20.2 26.5 25.2 12.4 6.7 10.7 6.1 6.8 6.5 8.3 9.1 8.9 8.4 6.3 8.4 7.1 5.9 5.6 6.9 13.2 6.1 3.3 14.4 15.7 14.9 18.5 14.5 15.4 15.5 13.1 13.9 12.7 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell line enhanced" "Detected in many" "hTCEpi: 33.0;hTERT-HME1: 22.6;LHCN-M2: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.4 2.4 1.3 2.0 21.7 8.9 4.7 4.1 5.3 5.0 4.8 1.8 1.6 0.3 0.8 3.4 20.2 1.9 11.7 4.7 2.7 0.8 0.3 1.2 2.8 8.3 2.1 1.2 10.0 33.0 11.7 22.6 2.6 1.5 3.0 26.1 5.2 2.1 1.2 0.7 2.3 0.4 19.7 0.3 1.7 3.3 1.2 2.1 5.6 17.5 1.6 6.2 1.9 2.4 2.7 1.9 9.0 3.5 1.8 3.8 0.2 8.7 2.9 2.7 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Group enriched" "Detected in some" 12 "HEL: 6.6;U-937: 4.3" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: , HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in some" 81 "BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037989 Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus" "HPA037989: AB_10670536" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: , HPA057418: " "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.5 22.7 17.0 26.7 15.6 9.8 19.2 14.3 23.3 30.5 24.5 46.7 15.8 9.4 33.6 19.8 10.1 26.8 17.1 33.4 11.5 19.5 11.9 14.9 27.3 27.2 22.2 11.2 10.0 18.8 22.0 27.5 18.8 11.6 27.0 20.9 27.5 16.3 14.4 7.6 25.5 11.0 18.3 25.3 15.0 14.3 14.7 18.9 8.4 6.8 9.8 21.5 15.2 8.0 23.3 10.3 24.9 18.8 14.3 23.5 14.0 15.2 16.9 20.4 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA027011: " "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 16.8 25.9 19.4 26.7 24.0 25.6 17.5 30.3 25.0 19.1 19.3 22.8 21.3 22.0 19.2 20.9 23.4 24.3 20.2 13.5 19.0 12.9 20.7 26.7 17.4 22.9 19.9 13.6 21.0 30.5 18.0 23.7 29.8 17.7 23.6 12.2 28.9 30.9 17.3 13.4 25.6 20.7 15.8 19.3 26.1 21.6 19.6 23.3 19.7 23.0 13.5 23.4 19.1 19.3 17.4 42.9 26.8 21.9 18.3 28.3 23.5 14.1 17.1 8.0 6.4 11.2 10.7 14.8 7.7 14.7 8.7 10.3 24.0 22.6 9.5 26.5 9.1 20.1 4.5 17.5 3.2 7.6 13.5 8.3 10.5 19.1 21.2 10.9 9.9 15.4 22.3 12.3 14.4 7.2 13.1 17.5 6.4 34.3 7.6 16.3 10.3 16.7 7.2 8.6 18.3 11.0 14.0 11.8 16.4 7.2 37.6 24.1 22.2 19.1 6.9 22.4 14.3 11.3 12.3 23.4 19.2 9.8 25.3 12.4 9.9 19.0 21.9 26.8 23.8 21.5 22.2 17.4 24.4 24.0 23.9 16.9 28.3 25.5 19.5 18.3 16.7 42.9 22.1 23.5 19.4 24.0 30.3 25.0 19.0 12.9 19.9 13.6 17.7 23.3 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Group enriched" "Detected in some" 9 "AF22: 23.3;WM-115: 39.2" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.3 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enriched" "Detected in some" 7 "HDLM-2: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" "Golgi apparatus" Nucleoli "HPA051327: , HPA061582: " "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.8 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 0.0 3.5 0.0 48.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 3.6 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 47.8;Karpas-707: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.11e-4)" "prognostic unfavourable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.1 14.5 4.4 11.2 15.2 6.9 6.8 4.7 7.2 6.0 5.5 9.1 15.8 2.2 7.9 6.5 10.3 6.3 9.3 4.3 3.8 3.1 2.4 5.6 7.6 47.8 2.7 12.6 10.9 9.6 6.8 22.8 6.9 4.6 42.1 6.0 13.3 3.3 2.4 2.4 3.8 3.0 12.7 3.4 15.9 6.6 3.3 4.4 7.8 12.9 8.4 4.8 2.8 6.3 7.8 8.4 10.7 5.1 8.1 10.2 4.3 8.4 4.6 7.1 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144171-93197964 "Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 8.0 11.0 16.0 12.6 19.3 24.1 6.5 20.7 20.2 8.0 7.3 8.7 2.1 3.0 10.4 3.6 7.8 6.2 8.4 9.2 14.2 14.8 13.7 11.0 8.2 7.0 16.8 10.3 8.6 8.0 8.0 17.2 8.7 17.6 7.5 9.4 5.4 5.4 9.1 3.4 5.9 4.2 11.5 20.0 5.7 6.4 6.0 13.4 5.6 12.7 2.3 9.2 8.6 7.7 1.6 2.9 8.1 7.7 0.8 2.6 1.8 5.1 9.1 18.7 3.7 6.6 13.6 10.5 8.8 14.8 13.2 16.1 7.3 16.8 6.2 5.1 8.2 6.3 5.7 3.2 12.2 10.3 6.7 7.1 19.2 4.8 5.2 17.9 10.6 6.5 10.3 7.6 4.8 7.1 0.6 0.1 13.5 1.3 7.8 13.5 7.5 9.3 3.5 11.1 2.5 4.4 7.6 17.4 22.6 12.9 5.0 3.2 9.2 5.2 7.8 25.0 7.7 14.7 12.9 2.6 5.2 0.0 5.6 7.5 12.9 0.2 7.7 8.1 1.3 3.9 1.8 1.3 1.0 1.6 2.9 1.6 2.6 1.7 2.5 0.8 2.5 1.1 0.8 1.8 16.0 19.3 20.7 20.2 14.2 14.8 16.8 10.3 17.6 13.4 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in some" 4 "Hep G2: 31.7;SCLC-21H: 10.5" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol Cytosol Microtubules "HPA031871: " "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.8 0.0 0.0 1.2 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.0 1.2 0.0 0.6 0.1 0.4 0.0 0.6 31.7 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.0 0.4 0.3 0.0 0.1 0.2 10.5 0.9 0.5 0.1 0.0 1.3 0.2 0.0 0.2 0.9 0.0 0.6 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 22.5 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 23.7 0.0 9.9 34.9 27.0 53.2 0.0 7.5 0.0 12.9 52.4 16.3 3.9 26.3 0.0 3.7 39.6 0.4 0.1 0.4 23.6 46.8 5.3 0.0 5.7 9.1 12.2 0.1 20.9 0.1 86.2 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.3 5.9 34.2 12.4 2.3 5.5 16.4 5.2 4.9 2.5 19.7 1.7 9.4 4.9 6.3 3.1 5.6 4.8 2.5 1.5 3.0 4.1 6.6 11.2 1.5 5.9 9.8 2.4 5.0 5.9 6.8 4.1 3.7 18.0 4.1 2.8 3.9 2.0 6.6 0.5 9.5 5.5 15.1 4.0 1.5 1.3 4.6 3.3 8.8 4.8 2.6 7.3 8.1 3.5 9.4 3.0 0.7 2.1 0.6 16.5 1.4 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favourable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favourable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.3 6.8 6.8 10.4 14.2 8.5 12.8 10.3 12.0 14.5 10.2 6.4 6.8 2.7 5.9 14.3 10.6 6.5 7.2 8.6 1.7 5.9 3.1 5.7 10.3 21.5 6.5 9.0 17.1 15.2 10.1 6.7 14.9 9.2 4.2 10.5 5.2 2.5 3.8 7.4 10.2 9.4 7.3 7.5 6.4 10.1 5.0 7.6 15.5 10.7 4.5 5.0 2.7 11.6 8.0 6.1 13.8 3.1 6.2 4.0 3.2 10.8 3.9 5.9 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: , HPA036513: AB_10670801, HPA066087: " "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favourable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 3.1 10.5 20.2 5.5 3.9 9.4 10.4 14.6 7.1 7.1 3.5 15.7 11.3 4.3 22.3 8.3 4.5 12.3 13.5 8.9 2.3 9.1 4.9 16.4 12.9 4.4 17.9 2.1 5.5 2.0 7.8 9.0 15.8 14.1 6.1 11.3 3.0 5.1 5.6 23.5 8.3 12.0 7.1 10.8 30.7 5.2 7.8 10.7 14.6 29.9 7.6 4.8 11.1 15.4 12.9 14.9 8.4 7.6 2.1 1.3 2.6 10.4 8.4 13.0 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell line enhanced" "Detected in all" "BJ hTERT+: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016508 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148" "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favourable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.6 14.3 4.0 8.0 14.3 12.1 8.7 15.4 68.2 24.1 38.0 47.3 10.1 10.7 8.7 18.0 11.8 19.7 19.2 39.7 11.1 11.2 8.5 11.4 47.7 34.1 5.8 9.4 12.9 15.6 42.7 29.8 10.7 7.4 10.9 12.2 4.9 8.8 3.7 24.3 11.0 12.6 7.5 22.8 8.8 4.6 6.8 10.6 15.7 6.7 31.8 5.4 8.5 5.9 30.0 15.2 18.8 15.7 6.3 5.7 14.0 42.4 7.8 17.4 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell line enriched" "Detected in single" 70 "HaCaT: 22.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 22.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in some" 60 "CACO-2: 22.2;Hep G2: 32.1" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Low region specificity" "Detected in many" HPA018423 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favourable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: " "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.2 13.0 31.2 18.3 33.1 24.5 8.2 28.1 33.4 18.9 22.2 7.2 11.5 11.2 14.2 27.0 25.1 27.3 26.3 28.7 24.8 9.9 4.8 18.3 10.5 21.0 16.3 12.2 22.3 58.3 28.6 25.0 2.8 2.5 22.5 26.5 15.8 15.9 3.6 7.5 7.4 16.6 17.9 14.6 21.0 34.8 32.9 29.0 34.6 10.2 47.5 13.8 7.7 4.5 46.0 7.7 8.7 14.1 21.2 20.6 8.5 15.9 11.5 24.2 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 48.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA038360: , HPA071102: " "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favourable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 48.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 129.8;SiHa: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 210000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB010455: AB_638288, HPA017980: " "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favourable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavourable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.1 68.1 6.9 21.6 8.4 6.8 64.4 28.1 10.8 14.8 13.0 65.1 30.6 17.8 31.2 16.5 56.0 12.7 55.1 7.9 32.3 12.0 12.7 49.6 28.7 78.4 14.9 18.6 14.8 129.8 18.0 55.0 8.6 24.6 39.4 9.0 77.8 15.3 19.0 11.6 23.0 15.9 10.5 34.7 10.3 9.0 11.9 5.7 132.3 49.6 95.4 17.8 19.6 15.7 15.0 22.4 22.0 19.8 49.0 54.3 56.4 14.7 23.5 42.8 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Cell line enhanced" "Detected in some" "ASC diff: 91.2;CACO-2: 20.8;HEL: 73.9;HMC-1: 19.5;T-47d: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA065634: " "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favourable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.2 0.1 0.0 91.2 0.6 4.4 0.0 1.1 0.3 0.5 20.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.3 73.9 0.3 7.6 0.3 0.2 19.5 6.4 0.0 0.2 0.0 2.2 7.5 0.2 1.1 0.0 3.0 4.8 0.2 0.3 0.0 0.8 0.4 0.9 3.0 0.1 0.9 0.1 6.1 0.0 36.0 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell line enhanced" "Detected in many" "Hep G2: 23.5;NB-4: 27.9;U-937: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favourable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 7.9 10.3 7.6 0.1 4.1 5.3 1.2 3.0 2.5 1.1 22.7 1.0 3.0 0.3 7.0 0.4 1.5 1.1 1.8 11.7 0.2 23.5 13.6 20.4 2.9 9.6 1.7 2.0 9.2 5.2 16.3 4.2 1.5 0.8 0.1 27.9 2.6 5.3 19.4 3.9 10.1 0.2 0.0 9.3 1.4 0.7 0.1 9.1 0.6 10.4 2.1 1.2 2.9 10.4 0.6 4.8 1.5 13.3 0.6 26.9 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell line enhanced" "Detected in many" "HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: " "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 39.3 0.0 2.3 0.0 7.7 11.3 0.1 3.0 13.1 4.5 7.8 0.0 8.6 22.8 1.4 7.2 22.7 6.6 4.0 9.1 0.1 0.0 35.4 13.5 0.0 15.6 69.9 61.7 33.9 0.1 43.9 0.5 12.6 40.4 22.0 17.5 0.0 14.6 44.9 3.4 0.7 30.4 0.4 78.8 10.8 0.0 5.4 0.0 8.7 0.2 36.7 3.4 10.6 6.7 0.2 11.8 29.9 8.6 0.0 0.1 5.7 27.1 25.4 75.2 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell line enhanced" "Detected in many" "ASC diff: 71.8;ASC TERT1: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064714 Supported Nucleoplasm,Mitochondria 270000 Mitochondria Nucleoplasm "HPA064714: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favourable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.7 5.7 1.5 1.9 71.8 56.8 4.9 5.7 14.9 3.7 5.0 6.0 18.0 9.0 2.9 21.5 13.5 4.6 8.2 6.4 7.8 3.8 11.2 4.0 7.5 4.8 2.2 5.8 31.5 6.8 7.1 6.5 11.7 0.3 18.8 4.2 9.6 8.9 2.5 8.7 5.5 1.8 6.0 6.8 5.1 15.9 7.5 2.9 8.0 8.9 8.0 8.8 6.8 10.0 3.7 3.4 4.0 4.1 14.5 9.5 6.8 7.2 4.9 4.9 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644559 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 61.1;SK-BR-3: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" 78000 "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: " "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favourable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 29.3 14.2 25.1 21.4 28.3 23.4 31.6 24.2 33.9 24.7 23.0 40.7 21.7 10.5 21.0 17.3 31.8 24.8 24.9 29.1 21.2 17.9 29.4 9.1 39.4 46.7 26.1 18.4 14.2 16.5 21.6 8.6 114.9 31.8 19.9 20.3 36.6 22.1 28.8 51.6 29.0 19.1 19.3 37.5 49.4 44.0 51.6 21.2 30.4 26.9 26.4 39.2 29.0 26.3 19.0 17.8 86.0 45.9 13.1 21.8 22.8 61.1 1.5 13.7 8.2 20.8 12.8 39.2 13.3 32.8 22.0 26.0 13.7 29.3 12.4 17.9 36.8 47.3 2.0 10.2 14.2 0.3 1.7 7.9 7.7 0.5 23.0 0.1 6.6 13.9 13.6 8.3 7.2 16.8 3.7 2.1 33.3 45.0 6.5 5.9 4.8 5.5 13.9 19.5 0.5 7.1 32.5 1.3 8.2 10.5 58.9 1.5 22.9 0.6 15.3 9.9 3.6 11.7 3.3 0.7 1.3 12.2 2.4 5.5 11.0 22.9 7.2 39.3 21.8 19.6 17.2 17.7 15.1 16.5 3.7 19.0 16.5 16.8 86.0 13.1 45.9 17.8 16.5 22.8 25.1 28.3 24.2 33.9 21.2 17.9 26.1 18.4 31.8 21.2 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Cell line enriched" "Detected in some" 30 "HMC-1: 138.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favourable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.4 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.2 0.5 0.0 0.6 0.4 4.6 0.1 0.3 0.3 0.7 138.2 0.0 0.1 0.3 0.0 1.5 0.7 0.2 0.2 0.3 0.1 1.3 2.0 1.7 0.1 0.6 0.2 0.6 2.1 0.2 0.4 0.2 3.4 0.6 0.7 0.2 1.5 0.2 1.5 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell line enriched" "Detected in many" 5 "CACO-2: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.3 2.4 4.0 2.0 0.4 7.6 2.0 1.5 1.7 1.9 66.1 2.1 0.2 1.2 1.1 5.6 2.7 4.6 1.4 4.2 6.4 0.0 4.5 5.6 0.7 0.0 3.3 0.9 8.5 1.8 5.3 0.1 2.8 0.4 0.3 2.3 0.0 0.2 1.4 0.9 0.1 2.0 0.8 1.3 3.8 6.5 3.4 14.2 6.6 0.9 5.1 1.1 0.2 0.2 2.9 0.4 2.1 3.0 3.4 0.1 0.4 0.4 1.5 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.4;T-47d: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favourable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 4.0 2.7 0.0 10.5 2.0 6.2 0.4 0.2 1.7 2.6 9.9 0.1 20.4 0.6 0.9 0.3 0.0 10.1 4.0 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell line enhanced" "Detected in many" "HaCaT: 35.2;Hep G2: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favourable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favourable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.3 7.6 0.9 4.0 2.6 0.7 10.9 2.7 1.7 1.4 0.8 0.5 7.0 0.0 3.1 0.9 35.2 4.2 8.3 0.2 0.0 1.7 0.3 3.3 20.6 1.6 1.9 6.9 0.3 3.4 1.7 1.6 3.5 0.7 4.9 1.4 3.4 0.2 0.2 6.1 10.3 1.2 5.2 1.7 8.5 15.0 0.4 2.5 1.4 8.8 0.2 3.4 3.3 5.9 1.0 3.6 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA036679: " "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavourable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavourable (1.79e-4)" 12.3 16.1 18.8 14.2 27.0 12.7 13.9 27.4 29.0 11.5 11.3 15.8 8.7 11.6 12.8 12.2 14.2 12.3 9.8 18.6 17.9 19.6 15.3 15.0 12.8 14.6 17.0 20.5 15.2 13.3 23.8 16.0 14.5 29.1 12.6 12.3 9.0 12.4 12.1 26.0 15.1 12.0 12.5 15.4 13.1 12.5 29.9 16.8 16.1 14.6 14.9 15.1 11.1 11.0 16.7 13.3 40.8 17.9 22.5 19.5 14.1 21.6 12.6 12.8 11.9 13.2 12.2 18.8 18.0 12.5 19.0 15.6 18.4 15.9 13.7 16.8 14.4 15.5 20.4 14.0 17.1 19.1 16.7 15.8 13.3 20.2 16.1 22.5 15.1 10.9 17.8 18.9 18.0 19.3 22.8 15.0 17.5 13.2 15.1 22.1 12.9 12.5 12.6 28.0 15.8 19.6 10.1 13.9 13.7 14.0 19.2 17.3 11.6 14.8 19.5 17.8 16.1 12.3 21.0 24.8 35.1 44.0 19.3 18.2 14.1 40.8 17.7 24.2 17.6 16.9 17.4 13.5 16.1 15.3 13.3 16.7 19.5 16.5 16.5 22.5 17.9 10.7 17.1 14.1 18.8 27.0 27.4 29.0 17.9 19.6 17.0 20.5 29.1 16.8 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favourable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.6 51.8 10.2 21.0 10.2 6.0 23.3 19.0 10.3 15.6 13.5 29.5 25.1 9.4 41.8 9.0 15.4 10.4 9.2 2.9 27.1 15.5 12.3 25.2 15.0 16.7 6.3 39.8 8.7 8.1 17.7 4.5 8.7 38.2 8.0 12.0 30.1 18.2 11.0 24.3 19.3 14.4 5.6 11.0 12.7 11.9 8.4 30.6 17.4 32.9 16.2 13.6 12.6 18.6 21.0 10.7 20.6 28.0 8.6 11.6 5.3 32.1 16.0 42.1 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 48.5" "Cell line enhanced" "Detected in all" "hTERT-HME1: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavourable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 14.5 5.0 3.2 10.5 4.6 3.3 17.0 4.0 4.8 10.8 38.2 5.0 8.8 48.5 8.1 12.6 8.4 6.5 12.5 9.3 5.0 3.8 15.3 3.7 9.3 10.3 4.8 1.9 9.0 3.3 2.4 4.4 5.6 4.5 10.3 6.9 20.0 8.3 8.4 5.6 5.6 43.4 18.2 5.8 9.7 7.8 6.1 5.5 6.8 6.3 14.7 15.5 15.0 14.9 1.8 2.0 0.1 0.9 2.4 3.9 0.7 5.8 10.9 9.9 4.6 4.6 8.3 7.1 20.0 9.3 7.7 6.0 3.0 3.0 13.4 1.7 7.7 2.5 9.4 9.7 12.3 11.3 3.1 6.1 7.5 3.2 8.0 13.8 5.4 6.6 4.2 11.7 37.8 12.6 4.0 4.7 15.8 2.1 13.8 3.2 6.5 10.9 9.4 7.9 2.6 18.1 4.2 2.5 6.2 9.1 6.8 3.1 15.4 5.4 8.8 18.2 5.1 12.5 15.4 1.8 1.9 7.7 15.9 9.8 8.3 0.0 0.5 0.0 3.0 0.6 2.0 1.2 3.8 3.9 1.4 1.8 1.5 2.7 0.1 2.4 0.9 2.0 3.2 0.7 3.2 4.6 4.0 4.8 5.0 3.8 4.8 1.9 4.5 5.5 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Group enriched" "Detected in some" 10 "CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favourable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.7 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.5 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 13.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Low region specificity" "Detected in all" "CAB015467, HPA051805, HPA055106" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB015467: , HPA051805: , HPA055106: " "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favourable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favourable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.0 4.8 0.0 0.1 1.8 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 6 "Hep G2: 18.4;Karpas-707: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073570-34106262 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 10.1 9.5 10.5 7.3 11.0 3.6 26.6 8.0 10.1 6.5 7.6 4.6 9.4 5.0 11.3 9.1 7.5 8.5 4.9 6.8 11.6 6.8 46.0 9.5 8.5 7.6 11.7 4.7 9.0 5.8 6.3 6.6 15.8 13.6 7.0 8.8 11.3 6.4 6.9 7.8 10.1 7.4 5.9 14.7 4.9 7.8 10.6 9.0 5.9 42.7 4.4 8.0 6.5 22.1 0.8 2.3 0.7 1.0 1.0 2.6 0.7 6.2 5.6 11.8 8.3 9.9 8.1 5.7 7.2 21.8 4.5 6.8 9.3 13.8 10.1 5.8 14.5 3.2 14.3 4.1 7.6 10.5 3.7 10.4 5.2 3.1 2.6 4.4 4.4 3.9 10.6 12.2 4.9 2.6 10.3 2.4 11.5 4.2 4.7 3.6 5.9 5.5 4.8 2.1 4.6 17.6 8.8 6.2 2.8 14.9 4.0 3.4 2.4 4.8 2.5 8.8 6.8 16.8 2.8 12.5 10.8 7.6 17.7 6.6 5.9 0.0 1.0 0.2 2.6 0.9 2.1 0.8 1.4 1.7 0.9 0.8 1.9 2.6 0.7 1.0 0.4 2.3 0.4 0.7 10.5 11.0 8.0 10.1 11.6 6.8 11.7 4.7 13.6 9.0 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 22 "RT4: 8.7;SCLC-21H: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Group enriched" "Detected in some" 15 "basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 77.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 17.8" "Cancer enhanced" "Detected in many" "liver cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 33.0 0.1 0.8 26.0 0.1 7.2 0.1 0.2 2.2 0.1 0.0 0.0 3.1 4.9 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 1.0 77.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell line enhanced" "Detected in some" "A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.2 0.2 0.0 14.3 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 2.8 1.8 4.3 3.6 0.1 0.0 4.7 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 10.1" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: , HPA052726: " "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 10.1 0.1 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell line enhanced" "Detected in many" "ASC diff: 30.4;ASC TERT1: 18.8;hTERT-HME1: 43.0;SCLC-21H: 29.3;SK-MEL-30: 21.6" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 30.4 18.8 0.0 0.0 6.4 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 8.1 0.0 0.0 9.3 0.0 1.5 0.0 11.2 0.0 0.2 10.5 15.7 4.1 43.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 7.6 0.0 9.7 21.6 0.0 0.0 0.0 4.6 2.5 0.0 0.0 0.0 0.0 0.0 8.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 27.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007663, HPA008044" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA007663: AB_1857194, HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.6 4.7 1.4 27.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.6 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 104.5" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol Cytosol Mitochondria "CAB078195: , HPA004057: AB_1080012, HPA076311: " "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.8 104.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.0;lung: 50.5" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CACO-2: 5.4;Hep G2: 14.4" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enriched" "Detected in single" 36 "pons and medulla: 11.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 5 "midbrain: 69.9" "Low region specificity" "Detected in all" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: " "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.1 6.3 0.1 0.3 1.6 0.9 0.1 0.7 0.1 0.1 0.3 0.1 50.5 0.1 0.1 0.1 0.1 0.6 0.0 0.1 11.3 11.2 0.1 0.0 0.2 0.7 0.1 0.1 0.4 25.0 0.4 0.1 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.0 0.1 1.0 0.2 0.4 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 14.4 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.0 0.4 0.2 0.1 0.0 2.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 11.2 0.1 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favourable (5.22e-5)" "prognostic unfavourable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavourable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.1 6.2 4.7 8.0 2.5 12.7 6.9 27.5 8.2 6.1 6.2 7.9 13.4 6.4 10.9 3.7 4.2 5.7 7.4 1.5 5.2 12.7 22.5 9.3 0.2 3.4 27.5 1.3 1.7 7.5 1.9 8.9 7.1 2.7 7.2 4.9 9.7 6.7 9.5 5.0 6.9 7.3 20.9 45.1 9.6 11.4 4.1 5.2 2.8 1.5 10.6 1.9 22.5 10.5 5.6 2.6 5.0 3.0 3.4 4.9 24.5 6.8 32.1 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell line enhanced" "Detected in many" "HaCaT: 23.5;hTCEpi: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavourable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.2 5.4 2.7 6.9 4.3 1.4 6.1 5.8 15.6 9.4 11.7 1.8 2.8 0.1 0.6 15.9 23.5 4.1 4.6 1.9 0.0 0.7 6.4 12.8 2.1 19.8 1.4 0.3 4.4 41.1 4.6 11.0 0.2 4.9 18.5 0.4 4.0 1.0 0.0 2.0 7.2 0.8 0.0 8.2 0.9 0.8 1.7 1.6 2.9 13.4 2.6 3.5 3.8 0.1 1.0 4.4 0.9 3.0 20.4 14.0 1.6 3.5 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: " "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.2 8.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.0;SCLC-21H: 7.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: " "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.2 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.0 0.1 1.2 0.2 0.0 0.2 7.0 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.1 7.0 2.0 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 SLC7A2 "ATRC2, CAT-2, HCAT2" ENSG00000003989 "Solute carrier family 7 member 2" P52569 8 17497088-17570573 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8" "Cell line enhanced" "Detected in many" "HHSteC: 66.3;RT4: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009277 Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "HPA009277: " "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-2)" "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (7.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.76e-1)" "unprognostic (4.49e-1)" "unprognostic (1.34e-2)" "unprognostic (1.11e-2)" "prognostic unfavourable (2.65e-7)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.46e-2)" "unprognostic (8.98e-2)" "unprognostic (1.79e-1)" 10.6 3.8 8.6 1.4 3.4 0.1 18.0 2.5 8.3 11.5 2.5 2.4 2.9 0.8 6.4 11.8 3.7 13.6 5.1 9.7 6.8 0.9 3.8 68.1 3.3 2.8 4.4 3.5 35.1 32.2 78.2 3.0 29.0 9.1 4.9 1.5 13.0 2.4 3.3 57.8 3.3 2.0 4.3 10.9 1.8 3.3 7.7 3.5 0.0 14.3 10.4 1.2 3.4 6.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.9 0.3 10.1 0.0 0.1 11.1 0.0 6.8 0.5 0.6 3.3 0.0 0.0 2.3 0.0 0.0 7.3 1.7 2.3 0.0 3.8 0.0 8.0 7.0 66.3 3.0 0.0 8.9 1.4 8.6 8.2 3.1 0.0 0.0 7.7 10.7 0.3 3.5 3.7 0.9 0.0 5.1 5.3 0.8 17.0 0.1 1.3 0.5 0.2 3.1 0.0 0.3 7.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.6 3.4 2.5 8.3 6.8 0.9 4.4 3.5 9.1 3.5 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA052673: , HPA056077: " "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.6 55.6 1.0 15.6 0.4 0.9 40.1 11.8 4.3 7.2 4.6 36.2 21.0 13.4 10.5 15.0 66.2 11.5 106.7 5.0 14.1 5.8 11.0 52.2 25.9 16.8 10.2 20.3 3.0 183.4 8.8 65.7 1.4 16.4 15.1 5.7 99.4 12.3 15.1 5.1 13.5 11.9 4.3 20.6 8.0 1.2 9.0 3.5 150.7 30.1 32.3 13.8 13.6 1.1 2.5 16.8 10.4 9.1 19.6 16.0 58.1 9.9 25.5 24.0 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA050713: " "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.3 9.5 7.1 7.6 21.1 12.7 20.0 11.0 8.0 16.4 13.8 40.8 7.1 18.6 8.7 14.1 14.3 13.8 13.7 17.9 3.8 9.9 9.9 18.8 12.9 3.9 11.6 9.0 8.5 12.0 12.8 6.4 11.0 14.5 3.3 8.9 5.0 15.2 8.1 5.3 3.5 19.3 4.5 15.6 5.7 8.2 10.5 5.7 31.7 8.9 3.7 13.3 6.3 16.1 10.9 8.3 9.1 13.7 7.1 13.3 21.2 6.9 8.6 7.3 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 SLC7A6OS FLJ13291 ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favourable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 19.8 14.1 15.7 16.1 20.0 20.1 17.4 29.1 18.2 13.2 13.1 20.2 10.9 13.9 15.5 18.0 12.4 13.4 10.7 16.5 14.6 11.7 13.4 9.3 13.8 24.7 19.8 14.2 17.0 14.7 18.8 13.1 15.9 18.1 13.4 13.4 14.2 14.1 15.0 24.5 15.5 16.3 12.3 17.4 20.3 13.7 12.2 24.5 17.0 15.7 8.7 19.8 14.0 21.6 13.3 11.2 21.8 13.3 12.7 14.9 10.6 7.9 8.2 12.0 9.0 7.1 9.7 13.8 10.1 5.8 12.1 10.7 20.8 11.6 14.0 9.3 6.7 14.5 11.3 8.6 11.0 5.2 6.9 9.3 13.1 17.1 9.1 13.1 10.2 7.4 9.6 9.9 16.1 9.0 14.4 6.3 11.0 12.0 16.9 13.3 8.6 7.0 20.1 7.4 17.1 7.6 10.5 12.8 9.3 19.5 4.5 11.4 12.2 12.2 13.2 9.7 8.3 9.4 8.0 15.6 12.6 20.9 10.0 15.9 9.9 21.5 11.4 21.8 13.4 13.3 14.9 13.1 13.4 12.0 8.7 13.3 14.5 11.4 10.3 12.7 10.8 11.2 13.3 10.6 15.7 20.0 29.1 18.2 14.6 11.7 19.8 14.2 18.1 24.5 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell line enhanced" "Detected in many" "BJ: 15.1;fHDF/TERT166: 36.6;hTERT-HME1: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: " "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.1 1.1 0.1 1.7 3.5 0.0 15.1 5.8 5.0 3.3 0.0 2.5 0.0 1.2 36.6 0.6 0.2 2.5 5.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.7 10.7 0.4 0.0 0.2 6.4 0.0 0.4 0.0 0.7 2.1 4.0 7.9 0.0 1.7 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.3 5.1 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 SLC9A3R1 "EBP50, NHERF, NHERF1" ENSG00000109062 "SLC9A3 regulator 1" O14745 17 74748652-74769353 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Wnt signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001962, HPA009672, HPA027247" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 9600000 "Plasma membrane" "Vesicles, Centriolar satellite" "CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162" "unprognostic (1.29e-1)" "unprognostic (4.58e-2)" "unprognostic (1.73e-2)" "unprognostic (5.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (9.83e-5)" "unprognostic (7.41e-2)" "unprognostic (5.61e-2)" "unprognostic (5.38e-2)" "unprognostic (7.53e-2)" "unprognostic (4.49e-2)" "unprognostic (1.56e-3)" "unprognostic (7.81e-3)" "unprognostic (5.53e-2)" "unprognostic (3.84e-2)" "unprognostic (2.08e-2)" 5.4 33.3 19.8 9.9 23.3 22.6 15.2 21.9 15.1 12.5 30.6 15.2 35.9 57.6 5.4 12.0 74.3 20.5 30.8 5.6 14.2 8.8 36.1 64.9 8.6 13.5 14.3 14.0 5.0 26.5 12.5 4.9 8.3 12.8 10.1 13.4 22.9 41.8 23.3 1.5 11.2 73.3 3.1 12.1 13.8 14.8 5.4 14.1 18.4 5.6 24.3 30.3 7.1 20.3 9.8 14.3 72.7 24.8 45.1 70.4 44.3 13.7 11.3 5.6 5.8 3.4 2.5 25.5 3.3 3.1 8.5 8.3 35.4 8.2 3.0 3.4 7.0 19.7 9.7 6.4 4.0 3.6 9.3 22.6 30.6 47.1 7.0 14.7 15.3 2.0 3.6 6.7 2.9 7.0 7.1 16.2 13.0 77.3 34.7 33.1 5.0 6.7 3.8 6.3 13.6 11.7 9.8 4.9 6.4 3.4 63.1 7.1 122.1 11.8 2.3 2.6 7.7 6.1 5.4 28.2 12.7 5.5 4.3 19.7 1.5 72.7 14.1 65.3 70.4 20.6 46.6 9.8 43.2 59.3 13.7 8.6 25.5 45.2 50.3 45.1 24.8 14.3 47.0 44.3 19.8 23.3 21.9 15.1 14.2 8.8 14.3 14.0 12.8 14.1 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;HDLM-2: 5.0;RT4: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Region enriched" "Detected in single" 5 "olfactory region: 1.7" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA036096: " "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.3 0.3 0.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 1.4 0.5 0.2 3.0 0.0 0.4 0.0 0.0 0.0 5.0 0.2 0.3 0.5 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.5 0.1 0.2 1.4 0.6 0.2 0.6 0.4 0.0 8.9 0.2 0.3 0.2 0.5 0.1 0.2 0.2 0.6 0.6 1.4 0.9 0.3 0.3 0.2 0.1 0.7 0.2 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 0.7 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" Mitochondria "Centriolar satellite" "HPA058971: , HPA065520: " "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.5 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 1.3 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA047008: " "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.4 15.5 13.0 0.0 11.9 4.7 2.0 1.8 1.3 1.7 16.8 2.1 13.8 0.8 7.0 5.0 2.8 14.7 4.9 16.8 4.2 12.1 8.3 11.7 5.3 11.4 6.7 4.2 14.5 8.5 5.6 12.3 6.2 1.0 9.4 7.2 2.3 3.8 0.0 3.4 7.3 5.7 1.0 10.7 9.7 5.4 1.4 3.5 1.4 7.8 10.5 4.4 2.7 6.9 4.1 10.5 7.6 12.2 5.3 10.3 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Cell line enhanced" "Detected in some" "Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favourable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.5 44.8 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.3 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Cell line enhanced" "Detected in some" "HAP1: 8.8;NTERA-2: 5.9;RPMI-8226: 5.5;SCLC-21H: 6.4;U-266/70: 3.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 2.3 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 5.9 0.9 1.0 0.9 5.5 0.1 0.0 6.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.1 1.2 3.4 0.5 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912569-100965136 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: " "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.8 20.2 19.5 17.1 26.6 12.1 11.3 21.4 21.4 12.2 10.7 22.0 13.0 9.4 20.9 56.1 9.4 17.3 9.6 11.6 17.8 14.2 10.9 10.2 11.6 15.6 29.4 17.3 29.4 12.3 11.6 26.8 17.4 18.3 14.5 12.1 7.8 10.3 16.0 17.9 15.1 11.5 12.9 22.7 22.0 9.9 26.7 31.3 14.7 11.3 10.5 13.2 10.8 19.9 13.8 9.5 8.6 8.9 10.9 14.0 5.6 9.7 8.0 11.8 12.2 6.2 8.5 4.5 10.3 7.3 9.7 11.8 5.8 6.8 9.0 6.4 4.3 9.9 8.1 3.4 11.8 10.2 6.5 8.4 5.3 11.4 4.6 10.7 9.9 3.9 5.0 7.4 8.0 6.2 5.8 9.0 14.1 6.5 7.2 5.9 5.3 6.0 7.1 58.3 3.1 3.8 5.0 2.5 5.1 6.5 1.7 11.8 10.3 3.9 8.0 11.4 9.5 7.0 11.7 7.2 10.7 7.5 7.8 12.4 5.9 6.8 8.9 8.6 14.0 8.8 12.2 11.1 10.8 11.5 6.5 13.8 12.0 10.6 4.6 10.9 8.8 9.5 9.8 5.6 19.5 26.6 21.4 21.4 17.8 14.2 29.4 17.3 18.3 31.3 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243036-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.1;hTERT-HME1: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8" "Group enriched" "Detected in many" 7 "NK-cells: 16.8;T-cells: 27.8" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 32.9 12.8 2.8 21.2 2.6 2.8 11.5 1.7 3.0 18.9 7.7 6.6 25.3 4.0 13.6 7.7 10.0 9.3 8.3 6.4 3.6 2.8 5.9 4.0 18.6 20.9 4.8 1.2 10.7 5.0 4.5 3.2 9.9 6.0 15.9 5.0 7.9 15.4 43.1 27.5 5.0 8.5 10.9 6.1 25.3 7.6 3.8 2.2 51.4 7.6 7.2 22.3 17.0 8.5 0.7 1.4 1.9 3.0 16.8 27.8 7.1 6.0 3.1 0.4 0.5 9.0 15.9 1.2 15.8 25.0 13.2 14.8 0.0 3.9 0.7 10.2 15.5 25.5 0.3 7.1 9.3 0.1 0.5 0.1 3.3 0.3 33.1 0.4 0.1 18.1 18.0 10.1 44.2 6.0 0.0 9.1 9.2 0.5 7.4 0.3 0.5 2.3 0.0 5.3 0.0 3.4 15.0 1.0 0.0 1.7 1.6 28.1 10.5 0.2 23.6 5.3 2.0 3.8 3.6 1.6 0.1 0.1 15.5 0.0 7.5 1.9 1.7 1.1 11.1 2.7 13.7 0.4 13.6 12.6 1.4 0.7 17.0 13.7 0.7 16.8 3.0 0.5 27.8 7.1 2.8 2.6 1.7 3.0 3.6 2.8 4.8 1.2 6.0 2.2 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.8 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967201-104029233 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" 17000 "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favourable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 15.2 11.2 13.7 11.0 36.7 14.6 16.1 16.7 13.1 16.6 19.0 9.9 10.9 9.1 17.0 12.1 40.2 12.1 13.6 17.2 10.6 7.1 14.9 12.2 17.1 10.1 11.2 13.4 17.2 12.5 22.6 13.1 17.4 12.8 19.3 13.6 11.4 19.8 12.7 19.3 16.6 15.5 29.8 13.0 12.1 15.7 10.2 12.8 12.0 15.8 21.6 12.5 24.9 23.6 1.4 2.2 6.5 1.4 1.3 3.6 0.7 21.2 12.4 14.9 10.6 16.1 22.5 6.3 13.3 17.7 9.9 9.3 7.9 22.9 11.3 8.3 13.7 23.2 7.8 16.8 14.5 9.0 10.8 11.5 10.2 6.6 12.1 13.7 10.0 11.5 22.1 13.4 39.2 17.8 14.3 7.8 13.0 7.4 9.6 7.6 3.7 8.0 9.4 18.3 5.8 13.0 24.5 3.5 6.1 11.5 11.2 11.0 5.8 9.9 26.9 7.3 7.6 13.4 15.5 9.5 11.6 7.2 10.8 18.4 4.7 1.2 1.4 3.3 3.6 1.2 3.6 1.1 2.2 2.2 1.2 1.4 1.5 2.5 6.5 1.3 1.0 2.2 1.4 0.7 13.7 36.7 16.7 13.1 10.6 7.1 11.2 13.4 12.8 12.8 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879045-58933653 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: " "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 32.1 20.2 26.1 37.1 27.6 46.9 35.9 38.0 28.8 32.6 28.2 25.9 27.6 27.4 27.4 25.2 35.3 25.0 25.6 24.6 27.2 24.2 29.5 32.1 25.9 35.9 34.1 29.3 29.0 22.4 40.0 40.9 38.2 32.4 26.6 30.5 20.6 38.1 45.6 39.4 32.0 29.2 29.0 34.3 38.2 34.9 24.4 34.6 50.5 32.9 30.5 38.8 31.3 32.8 31.2 32.4 32.6 21.1 27.2 29.8 12.5 27.3 30.1 26.6 13.5 18.1 13.8 22.4 19.9 23.3 18.4 18.0 20.8 16.7 51.7 18.7 18.2 24.6 26.3 22.7 25.7 33.1 17.1 37.5 31.6 15.7 15.9 29.4 29.0 12.8 22.7 19.4 16.4 17.0 33.2 30.1 21.3 19.7 29.2 22.8 29.7 14.8 22.6 24.2 24.9 22.4 35.8 21.9 18.9 20.7 20.3 20.2 16.2 32.2 17.6 22.6 33.0 24.6 26.5 21.3 41.9 37.5 17.9 36.4 22.4 32.6 18.9 25.6 29.2 18.0 29.8 31.2 23.4 24.8 18.6 27.6 25.7 23.0 26.9 27.2 21.1 32.4 20.9 12.5 26.1 27.6 38.0 28.8 27.2 24.2 34.1 29.3 32.4 34.6 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: " "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favourable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 19.4 18.9 25.7 14.1 30.7 32.9 22.0 30.4 32.9 18.0 16.2 14.2 14.2 12.9 18.1 21.4 17.8 14.6 14.8 19.3 23.7 23.6 19.4 19.0 18.1 19.4 25.7 28.1 17.5 15.4 18.4 21.6 18.5 28.4 17.5 16.8 10.3 18.6 16.6 33.8 17.7 17.0 18.6 26.2 20.6 17.8 20.3 25.8 21.4 26.0 20.2 23.5 20.6 17.7 18.4 13.2 33.5 20.1 20.6 17.9 12.2 12.3 15.6 13.4 19.0 17.7 18.8 17.4 17.4 25.4 19.3 23.3 20.7 15.0 20.1 17.8 18.6 13.7 11.7 19.3 24.3 32.3 17.3 14.9 21.3 13.2 17.8 25.1 18.4 20.2 18.1 17.6 20.1 13.2 13.5 18.8 17.2 10.8 12.2 16.1 9.8 14.0 10.5 27.9 19.8 17.0 20.0 16.3 22.5 20.4 18.7 30.7 25.1 23.8 16.7 18.8 9.7 13.6 18.4 21.0 24.0 17.9 27.1 16.7 17.7 24.7 13.2 22.5 17.4 14.8 16.3 18.4 16.3 17.1 12.1 16.6 17.9 17.1 33.5 20.6 20.1 13.2 17.4 12.2 25.7 30.7 30.4 32.9 23.7 23.6 25.7 28.1 28.4 25.8 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: , HPA066238: " "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 2.9 9.2 6.0 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.1 4.6 3.7 10.9 4.8 2.4 6.7 4.1 3.3 3.3 9.1 5.1 7.4 6.7 2.9 2.0 7.2 10.5 1.8 2.5 5.2 2.9 4.0 7.1 5.9 4.4 5.1 4.4 6.3 5.0 3.5 8.9 10.0 3.0 2.2 2.1 5.1 4.6 4.1 3.0 1.5 7.3 5.6 4.7 6.4 9.0 5.5 5.6 5.4 4.2 12.7 2.1 7.3 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 SMAD1 "JV4-1, MADH1, MADR1" ENSG00000170365 "SMAD family member 1" Q15797 4 145481194-145558079 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 22.2;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 4 "granulocytes: 22.2;monocytes: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005389 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB005389: AB_656608" "unprognostic (8.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-1)" "unprognostic (6.85e-2)" "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (2.30e-1)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (4.68e-2)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" "unprognostic (5.88e-2)" "unprognostic (1.14e-3)" "unprognostic (3.15e-2)" 20.4 7.8 19.9 7.9 21.3 3.8 21.1 17.9 17.8 18.5 15.5 14.3 13.6 11.9 33.2 22.7 16.2 20.3 13.7 10.3 13.5 10.3 12.7 37.4 11.0 11.9 9.3 10.0 12.3 13.1 33.7 14.7 8.7 12.2 13.6 16.9 7.8 17.5 16.0 22.6 20.2 15.3 24.6 12.6 10.1 11.4 10.5 14.3 15.3 15.2 14.9 10.3 16.5 21.9 0.0 4.0 22.2 11.9 1.2 0.7 0.8 3.8 5.0 9.5 11.4 3.7 5.4 4.7 5.5 13.3 9.0 6.9 2.4 14.2 3.3 3.3 12.6 5.6 10.7 12.3 5.4 0.0 5.4 0.0 4.2 5.0 9.9 6.4 1.0 7.4 14.6 4.8 9.5 45.6 4.3 0.1 11.4 3.7 9.6 0.1 8.8 6.2 18.5 8.8 11.5 9.8 6.8 14.8 7.1 7.8 17.1 3.4 5.8 0.0 13.7 4.4 6.1 4.5 3.4 12.6 0.0 22.3 7.0 0.1 4.5 22.2 2.1 0.8 0.0 5.3 0.0 0.0 0.4 0.0 4.0 0.0 0.2 0.0 0.0 1.2 11.9 0.0 0.7 0.8 19.9 21.3 17.9 14.9 13.5 10.3 9.3 10.0 12.2 14.3 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: " "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.4 32.2 19.7 19.0 31.5 38.5 22.5 24.5 29.4 25.6 29.9 12.3 21.5 34.9 17.6 31.0 24.8 22.1 27.3 34.3 37.9 11.3 29.6 48.7 19.9 36.7 41.1 30.3 28.4 35.3 21.9 50.7 28.2 13.7 29.3 31.4 14.6 28.2 19.8 9.6 7.7 20.6 28.7 23.8 57.4 38.7 18.2 21.4 29.5 20.2 24.0 15.3 27.4 31.5 38.0 21.9 10.3 17.8 28.7 27.5 30.4 26.3 28.1 27.7 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 SMAD3 "HsT17436, JV15-2, MADH3" ENSG00000166949 "SMAD family member 3" P84022 15 67063763-67195195 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008094, HPA046386, HPA067203, CAB069409" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: , HPA067203: " "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (1.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-2)" "unprognostic (8.40e-3)" "unprognostic (1.80e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (2.93e-1)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (5.97e-2)" 25.3 4.6 12.2 18.5 12.4 12.4 21.6 5.0 12.7 20.9 17.9 7.6 9.5 12.7 19.9 16.6 35.3 14.3 27.7 19.7 7.5 4.8 15.6 13.6 13.9 14.0 6.0 7.5 23.0 12.6 7.0 10.8 11.5 8.2 20.5 9.2 30.8 12.5 10.8 37.3 19.6 19.0 23.2 5.5 11.2 15.8 7.0 7.7 10.5 21.8 23.4 29.7 31.4 24.6 4.8 2.5 3.2 1.9 0.4 6.3 1.8 12.5 42.1 7.9 3.8 13.9 32.1 6.2 7.3 30.0 10.1 8.2 8.7 33.7 4.2 9.8 20.7 29.8 8.2 30.7 10.1 3.3 3.1 0.4 11.9 6.5 10.5 1.6 0.7 29.0 7.2 8.9 7.6 34.1 10.1 11.7 12.6 6.5 0.3 6.3 4.7 13.2 0.4 2.3 1.5 6.8 40.4 0.2 2.7 9.6 5.3 8.3 1.4 7.8 28.7 13.7 12.8 9.8 8.2 4.5 1.2 5.2 12.4 1.8 12.2 0.0 1.9 3.2 5.5 1.5 5.7 2.1 6.2 6.3 1.8 4.8 2.8 2.4 0.1 0.4 1.5 2.5 3.1 1.8 12.2 12.4 5.0 12.7 7.5 4.8 6.0 7.5 8.2 7.7 SMAD4 "DPC4, MADH4" ENSG00000141646 "SMAD family member 4" Q13485 18 51028394-51085045 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019154 Approved Supported Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA019154: AB_1853480" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (4.83e-2)" "unprognostic (1.17e-2)" "unprognostic (4.05e-1)" "unprognostic (7.29e-3)" "unprognostic (9.00e-2)" "unprognostic (4.01e-2)" "unprognostic (2.51e-2)" "unprognostic (1.03e-3)" "unprognostic (4.40e-2)" "prognostic favourable (1.92e-5)" "unprognostic (2.62e-2)" "unprognostic (4.23e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" 25.6 17.5 16.0 14.0 16.7 11.4 24.9 29.7 16.0 27.9 22.6 17.9 21.3 15.1 28.2 18.8 21.7 20.5 17.5 19.6 15.3 11.5 21.0 22.0 20.1 16.0 17.2 13.3 30.5 25.0 30.0 28.9 30.6 14.2 27.8 17.4 18.4 23.1 22.8 39.7 18.2 23.4 27.6 13.9 21.7 19.3 17.6 18.4 38.8 35.0 13.9 18.1 29.0 24.1 3.6 3.6 3.4 1.8 2.9 4.7 1.3 8.5 11.3 30.7 8.8 12.7 19.6 17.3 15.0 16.5 20.2 25.4 6.9 2.0 14.2 4.5 13.0 14.1 17.2 6.7 21.5 12.3 9.7 9.8 11.3 7.9 12.6 17.1 7.7 8.9 11.4 9.9 14.6 14.6 11.0 13.1 11.9 4.5 10.1 4.9 16.0 7.1 13.2 15.6 13.9 9.7 3.7 19.0 11.3 14.0 2.6 9.3 7.0 10.0 11.0 17.1 7.9 4.3 9.9 19.7 13.7 12.3 11.1 6.7 11.3 0.8 1.8 1.8 3.2 1.1 3.7 2.2 3.3 2.6 3.6 3.6 4.0 4.7 3.4 2.9 1.3 2.9 4.3 1.3 16.0 16.7 29.7 16.0 15.3 11.5 17.2 13.3 14.2 18.4 SMAD5 "Dwfc, JV5-1, MADH5" ENSG00000113658 "SMAD family member 5" Q99717 5 136132845-136188747 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 33.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058931 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058931: " "unprognostic (6.04e-2)" "unprognostic (4.16e-2)" "unprognostic (9.99e-3)" "unprognostic (3.23e-1)" "unprognostic (5.98e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (9.49e-2)" "unprognostic (4.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-1)" "unprognostic (3.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.40e-3)" "unprognostic (3.22e-1)" "unprognostic (5.95e-2)" "unprognostic (2.15e-1)" 22.6 14.2 13.7 10.2 14.6 8.6 18.2 27.5 15.7 27.9 16.7 19.8 15.9 12.4 33.5 15.8 20.8 17.3 14.0 15.9 14.9 12.4 15.7 20.2 16.7 10.4 18.0 12.2 33.5 15.3 25.2 23.0 24.1 16.4 23.0 16.9 22.0 16.9 18.8 19.3 27.5 12.7 25.7 16.7 16.3 14.4 11.5 19.0 8.4 19.2 15.2 15.7 25.6 27.9 7.3 7.4 33.1 6.1 9.3 7.2 2.4 13.8 11.7 14.4 12.7 15.7 24.1 15.2 19.3 13.6 12.9 20.0 51.4 10.1 15.3 16.2 14.9 12.8 16.8 22.0 21.1 6.6 10.4 10.2 12.7 9.6 13.1 6.2 10.9 17.3 13.4 20.3 14.1 16.0 9.7 10.6 14.2 5.6 5.0 6.3 8.6 5.9 10.6 27.9 9.0 7.8 14.3 13.0 13.6 16.8 4.4 16.8 9.8 7.6 18.4 19.6 12.5 14.4 19.1 12.0 14.3 19.4 12.6 8.0 14.8 33.1 6.1 13.0 7.2 3.9 5.5 6.5 4.2 4.6 6.1 7.3 1.4 4.3 1.0 9.3 4.4 7.4 1.1 2.4 13.7 14.6 27.5 15.7 14.9 12.4 18.0 12.2 16.4 19.0 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell line enhanced" "Detected in many" "EFO-21: 20.8;HaCaT: 12.3;HeLa: 17.1;U-2197: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: " "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favourable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.8 6.9 1.1 2.4 4.3 1.1 6.5 4.9 0.1 0.8 0.0 1.3 3.1 0.5 20.8 4.1 12.3 1.5 0.0 0.1 1.5 5.7 10.7 17.1 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 0.9 0.9 0.7 0.3 1.3 0.1 2.9 2.1 2.6 0.0 1.2 1.4 2.3 5.4 2.5 1.1 2.6 2.9 0.5 1.0 1.9 4.2 3.0 3.9 12.1 0.9 0.3 1.2 0.2 2.1 3.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 SMAD7 "MADH7, MADH8" ENSG00000101665 "SMAD family member 7" O15105 18 48919853-48950711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026212, HPA028897" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB026212: , HPA028897: AB_10600811" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (5.61e-4)" "unprognostic (8.15e-2)" "unprognostic (5.35e-1)" "unprognostic (2.76e-1)" "unprognostic (6.02e-2)" "unprognostic (2.37e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (2.09e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-2)" "unprognostic (4.44e-1)" 9.5 3.3 3.1 7.4 4.3 8.6 11.6 8.0 7.7 11.4 11.5 4.2 5.1 5.5 6.5 3.0 2.8 4.2 5.7 27.0 5.8 3.1 7.4 6.5 13.7 2.8 6.1 4.4 4.5 5.6 14.6 3.9 11.2 6.0 9.3 7.0 7.1 5.3 11.5 4.9 4.4 15.0 5.0 6.3 2.9 7.2 3.2 2.8 3.6 10.0 5.7 3.4 6.8 19.4 0.1 0.3 8.3 0.8 2.6 1.9 0.4 2.3 1.9 1.6 5.4 9.5 4.0 13.7 10.9 4.6 4.3 1.9 0.6 3.3 0.2 20.6 7.9 12.4 3.9 3.6 2.3 23.6 6.2 0.1 5.8 5.1 1.7 4.7 11.8 3.4 3.3 4.8 5.2 0.8 3.9 15.5 6.4 0.8 0.0 1.4 11.4 0.8 1.4 1.7 5.2 6.6 2.5 3.0 6.5 4.9 2.3 4.7 1.9 3.7 10.4 11.5 6.3 3.2 10.6 8.4 4.1 1.3 5.0 3.0 1.7 5.8 0.2 8.3 1.4 0.8 1.2 0.1 1.4 1.3 0.3 0.0 0.4 0.9 0.0 2.6 0.2 0.0 1.9 0.4 3.1 4.3 8.0 7.7 5.8 3.1 6.1 4.4 6.0 2.8 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.6;SH-SY5Y: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: " "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favourable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (2.47e-2)" 4.4 3.1 7.0 3.2 6.2 0.6 4.1 10.7 11.8 6.3 8.2 14.3 4.1 2.6 10.0 11.3 5.8 5.1 7.4 6.9 15.0 6.2 5.0 1.4 5.3 2.6 10.7 8.9 10.1 1.3 3.0 6.2 6.7 10.2 14.9 6.0 11.9 17.7 12.4 13.8 2.1 4.0 8.4 15.5 1.5 5.9 2.7 11.0 0.0 38.9 1.9 3.4 7.7 12.6 1.7 1.7 1.1 0.8 0.7 1.4 0.2 0.0 0.1 0.5 5.8 1.7 0.8 0.2 6.6 0.7 1.8 1.1 0.0 0.1 0.2 4.2 8.6 0.3 5.8 0.1 2.0 0.2 8.2 0.0 3.0 4.6 1.8 0.5 0.1 3.0 0.5 0.0 0.0 3.5 0.0 0.0 4.2 0.3 0.1 0.5 0.8 0.6 0.1 6.2 0.0 0.0 0.9 5.1 27.6 1.3 0.2 0.3 0.4 0.2 6.3 2.7 2.2 1.5 1.6 0.1 0.0 0.0 1.9 0.2 0.4 1.1 0.4 0.3 1.2 0.8 0.8 1.0 1.2 1.3 0.2 1.7 1.2 1.4 0.9 0.7 0.5 1.7 0.4 0.2 7.0 6.2 10.7 7.8 15.0 6.2 10.7 8.9 10.2 11.0 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavourable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavourable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favourable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 24.7 7.6 0.9 0.8 3.4 13.5 41.9 19.1 19.3 9.8 6.1 15.1 26.1 0.3 3.4 11.8 8.8 5.4 7.4 13.7 1.2 4.4 3.3 0.9 5.0 9.4 0.8 3.2 8.7 5.7 21.2 19.2 23.5 2.6 1.4 15.7 21.8 4.0 3.0 3.9 29.6 0.2 0.3 0.9 14.2 5.7 1.0 1.2 4.1 16.8 3.0 14.5 1.2 8.1 10.9 10.4 0.5 11.6 0.5 0.7 0.5 16.1 8.2 5.9 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862015 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 18.7 14.8 19.9 17.8 25.1 15.1 15.3 20.7 30.2 14.4 25.2 14.5 18.5 24.5 16.2 17.7 29.3 10.5 16.3 20.5 20.5 18.6 14.1 17.2 14.4 18.3 19.2 18.1 15.2 33.9 27.1 11.5 14.8 25.0 17.2 27.0 13.0 18.6 15.2 32.6 21.0 29.6 18.7 15.7 14.8 20.7 29.6 13.0 26.6 20.0 17.5 20.1 18.9 16.6 12.5 11.7 24.0 15.5 20.2 21.9 16.3 26.2 8.3 13.3 16.1 12.3 16.3 21.4 11.8 13.6 9.9 9.8 12.4 7.9 13.8 12.9 14.5 8.4 12.5 12.6 16.9 15.9 17.4 15.2 7.8 10.4 8.2 11.1 13.0 10.6 14.6 11.1 13.6 15.6 14.5 16.9 15.5 15.4 8.3 13.6 9.8 9.8 15.7 49.3 22.7 17.9 16.2 18.6 13.2 7.5 10.8 7.5 14.3 16.8 14.9 8.0 13.8 5.2 10.4 15.8 14.1 7.1 6.1 13.1 11.0 24.0 13.7 14.6 16.3 15.0 18.5 12.5 21.9 18.6 11.7 11.1 11.2 14.4 19.3 20.2 15.5 11.5 20.5 16.3 19.9 25.1 20.7 30.2 20.5 18.6 19.2 18.1 25.0 13.0 SMARCA1 "hSNF2L, ISWI, NURF140, SNF2L, SNF2L1, SNF2LB, SWI" ENSG00000102038 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1" P28370 X 129446501-129523500 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003335, HPA064712" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA003335: AB_1080024, HPA064712: " "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (6.21e-2)" "unprognostic (2.16e-2)" "unprognostic (5.44e-2)" "unprognostic (7.15e-2)" "unprognostic (3.41e-2)" "unprognostic (1.53e-1)" "prognostic favourable (3.03e-4)" "unprognostic (9.26e-2)" "prognostic favourable (5.09e-4)" "unprognostic (1.87e-3)" "unprognostic (1.28e-1)" "unprognostic (6.14e-2)" "unprognostic (2.33e-2)" 10.4 44.6 14.5 5.0 15.2 0.4 11.8 12.0 12.0 17.1 11.4 7.7 25.5 3.9 15.8 31.4 9.6 12.0 12.3 19.3 13.9 17.9 13.9 34.1 9.2 2.5 13.1 8.4 42.2 9.0 34.8 29.9 21.0 14.6 23.8 4.3 9.7 9.8 42.9 8.7 4.6 4.8 17.7 14.0 6.9 10.0 33.0 13.1 2.0 26.0 6.8 2.6 16.8 15.3 0.3 0.8 0.0 0.0 1.6 4.3 0.5 6.7 15.1 31.3 20.4 22.8 20.7 10.8 13.8 40.0 20.6 23.4 5.2 24.1 0.0 21.5 25.9 6.4 19.4 8.1 23.3 0.0 3.6 0.0 13.7 28.4 10.0 0.0 0.0 25.9 2.3 14.7 2.8 15.0 3.5 1.7 22.2 0.0 0.1 0.0 12.5 8.7 0.0 16.9 0.0 20.3 8.3 7.5 20.6 1.9 0.2 3.4 14.0 0.1 10.4 13.8 7.1 9.0 7.5 0.0 0.0 0.0 12.2 0.0 8.5 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.0 0.0 0.3 4.3 1.3 0.0 1.6 0.0 0.8 0.0 0.5 14.5 15.2 12.0 12.0 13.9 17.9 13.1 8.4 14.6 13.1 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favourable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 23.6 29.6 38.8 21.3 43.6 40.7 30.1 41.6 44.0 23.8 17.3 20.0 38.4 10.3 26.4 30.1 20.4 29.4 22.8 21.2 30.2 30.8 23.4 28.9 20.2 29.5 25.9 32.4 85.0 18.5 104.1 35.0 23.2 24.7 23.2 15.9 22.8 26.1 44.8 41.3 27.0 18.3 26.6 19.7 23.9 15.8 26.5 23.4 20.6 28.0 24.8 27.1 23.7 22.0 9.9 11.3 20.4 8.3 8.6 12.5 4.2 5.2 3.9 2.9 4.2 6.0 7.2 8.8 6.7 5.3 3.1 2.3 0.0 2.1 9.1 2.7 6.1 2.3 1.6 5.6 2.2 176.7 2.5 24.6 10.9 1.9 2.3 10.3 14.5 4.7 2.1 3.1 5.8 4.9 0.8 31.3 5.2 2.1 2.5 8.6 2.9 1.5 11.6 3.7 8.2 7.1 4.8 1.9 1.7 4.3 1.0 1.8 1.9 6.7 5.8 5.0 2.4 3.2 3.2 2.9 3.6 4.1 5.4 3.9 1.3 20.4 4.6 13.1 10.3 6.2 9.9 9.9 9.9 10.5 5.6 8.0 12.5 10.0 13.5 8.6 8.3 11.3 10.4 4.2 38.8 43.6 41.6 44.0 30.2 30.8 25.9 32.4 24.7 23.4 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513463-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268" "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavourable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 21.0 39.5 24.7 24.8 32.6 34.5 21.9 26.9 29.2 24.0 23.8 27.7 24.6 17.9 27.3 26.3 19.8 23.0 23.8 29.8 25.0 25.1 21.1 21.0 33.3 29.5 30.2 26.5 29.4 24.6 33.1 33.3 27.7 29.6 23.1 22.5 16.3 22.0 25.7 24.6 14.7 22.6 22.9 34.6 28.6 22.8 37.8 32.8 44.3 28.5 15.1 29.7 25.6 23.7 11.7 13.2 15.4 19.4 15.6 16.3 10.6 11.8 9.3 34.2 21.5 20.1 14.6 20.5 15.0 17.9 21.9 18.6 15.8 16.7 32.1 10.4 12.8 9.4 31.3 14.0 21.3 21.2 11.1 24.0 13.7 13.0 14.9 29.6 14.1 12.8 10.2 15.5 13.4 17.0 21.6 20.3 14.3 10.6 34.5 10.3 27.9 13.4 38.4 21.9 10.4 17.2 14.5 27.5 23.2 19.6 13.9 17.3 10.0 13.9 18.0 14.5 11.2 15.1 14.7 22.3 26.8 39.0 11.4 24.9 14.7 5.0 10.7 15.4 13.9 12.7 16.3 11.7 14.2 15.0 13.2 11.5 14.9 14.7 9.7 15.6 19.4 10.1 16.1 10.6 24.7 32.6 26.9 29.2 25.0 25.1 30.2 26.5 29.6 32.8 SMARCB1 "BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1" ENSG00000099956 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1" Q12824 22 23786931-23838008 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009196, HPA018248, HPA019127" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165" "unprognostic (2.15e-1)" "unprognostic (5.62e-2)" "unprognostic (6.60e-3)" "unprognostic (1.63e-2)" "unprognostic (4.01e-3)" "unprognostic (2.14e-1)" "prognostic unfavourable (6.52e-4)" "unprognostic (4.10e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.10e-2)" "unprognostic (4.43e-3)" "prognostic favourable (1.14e-6)" "unprognostic (1.24e-1)" "unprognostic (4.58e-2)" "unprognostic (4.57e-2)" "unprognostic (7.04e-2)" 11.0 15.2 14.6 33.2 15.4 16.9 12.1 30.4 21.9 13.4 25.1 16.4 11.4 41.1 17.2 11.0 15.6 12.3 15.0 12.6 13.2 14.2 14.6 11.7 14.0 32.8 13.0 13.8 21.3 16.1 7.9 15.7 20.8 12.8 11.0 9.4 16.7 40.9 13.1 28.1 14.7 27.4 10.6 12.8 19.8 24.1 37.7 12.9 29.4 15.7 12.0 16.0 21.1 12.2 19.5 9.9 4.8 11.6 7.0 7.5 5.9 1.5 1.0 19.0 1.7 1.8 0.5 3.8 6.0 1.8 1.8 2.9 2.2 1.8 15.5 5.2 0.8 2.9 4.5 2.9 3.0 2.5 6.6 12.9 1.7 1.3 2.0 13.6 3.8 1.1 2.2 2.1 4.7 0.9 3.5 8.6 1.1 3.8 11.1 3.1 5.7 3.8 7.0 15.3 7.0 1.5 3.0 9.0 6.8 1.4 0.4 10.2 1.4 2.1 1.6 1.6 6.6 2.6 1.7 9.5 8.7 10.3 1.3 7.5 4.6 4.0 10.0 4.8 3.8 10.2 5.2 19.5 4.6 4.6 9.3 6.4 3.8 2.5 0.8 7.0 11.6 9.9 7.5 5.9 14.6 15.4 30.4 21.9 13.2 14.2 13.0 13.8 12.8 12.9 SMARCD1 "BAF60A, CRACD1, Rsc6p" ENSG00000066117 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1" Q96GM5 12 50084972-50100712 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004101 Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA004101: AB_1080026" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "prognostic unfavourable (2.53e-8)" "unprognostic (3.62e-2)" "unprognostic (1.44e-1)" "unprognostic (4.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" "unprognostic (2.18e-1)" "unprognostic (3.45e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" 21.3 24.5 16.4 22.6 22.7 29.9 21.3 27.8 28.2 19.8 19.9 29.5 17.6 18.8 23.6 23.4 23.3 19.9 18.2 15.6 16.3 13.8 25.1 18.3 19.4 26.1 15.7 20.4 24.7 19.6 44.3 17.8 24.7 18.8 20.4 22.4 20.3 21.4 25.9 16.6 19.7 24.0 23.8 18.5 28.1 17.4 34.4 14.9 64.3 24.3 17.9 36.7 19.3 18.2 6.0 6.7 4.4 3.4 3.1 6.9 2.3 8.0 13.6 40.3 23.3 12.6 11.9 20.0 10.1 17.9 29.7 17.4 37.4 12.7 31.6 15.2 19.2 10.4 34.0 26.4 25.7 24.4 25.1 31.1 13.8 21.6 15.0 27.5 12.5 12.0 17.8 17.5 31.8 34.9 26.3 19.6 15.0 19.0 39.9 14.8 50.4 22.4 47.9 10.5 27.6 16.8 19.0 21.8 36.3 21.2 10.8 42.1 24.3 23.1 20.9 15.3 17.1 9.6 20.5 27.7 24.3 28.1 12.4 11.2 17.3 4.4 2.3 4.1 6.1 2.1 5.8 6.0 3.3 3.9 3.6 5.6 2.1 6.9 1.1 3.1 3.4 6.7 5.0 2.3 16.4 22.7 27.8 28.2 16.3 13.8 15.7 20.4 18.8 14.9 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Cell line enhanced" "Detected in some" "A-431: 9.0;EFO-21: 4.3;SiHa: 18.7;U-266/70: 4.2" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001500 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 18.7 0.1 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.2 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA071309: " "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.1 14.0 15.8 14.6 3.3 4.9 14.8 16.8 8.0 15.1 12.8 12.1 14.1 34.7 8.2 8.6 30.8 22.9 10.9 20.5 22.0 9.6 20.9 22.5 7.8 0.9 12.6 21.1 3.2 2.2 20.4 8.3 10.6 16.8 28.6 13.6 8.8 32.9 6.5 13.7 11.0 22.1 45.3 13.0 6.5 6.6 15.0 11.6 20.0 9.4 4.9 18.9 8.6 8.4 18.4 19.4 25.4 21.0 10.5 35.2 20.4 11.9 18.6 22.2 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434962 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavourable (4.20e-5)" "prognostic unfavourable (9.00e-4)" "prognostic unfavourable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 4.8 5.5 3.0 25.4 4.4 15.1 4.0 3.1 3.2 5.3 10.1 1.7 5.3 6.5 5.2 4.9 19.3 4.6 7.0 5.7 2.4 1.7 4.4 6.3 7.9 16.5 3.1 1.3 4.7 4.2 1.7 10.8 7.4 2.6 4.4 6.9 2.7 5.7 6.9 5.9 4.6 7.0 6.2 3.1 13.1 5.7 20.7 3.2 70.2 5.1 7.6 14.3 7.8 6.3 8.8 6.1 30.5 7.6 7.8 15.8 4.8 62.1 11.5 26.2 12.1 5.0 5.1 12.1 31.0 14.7 35.9 31.2 14.5 35.8 39.4 18.1 12.7 36.0 29.8 15.0 57.8 52.2 20.8 38.1 19.7 4.7 2.8 25.2 31.2 2.6 2.2 19.0 15.5 15.2 21.9 45.8 21.4 11.2 30.9 6.2 15.4 27.1 31.4 41.2 28.6 6.7 7.7 15.8 16.4 23.7 21.9 10.8 26.3 18.9 14.4 23.0 19.2 20.9 56.5 30.6 31.3 71.9 16.4 25.9 25.5 30.5 3.2 12.1 6.7 4.7 6.5 8.8 10.5 8.0 3.5 7.2 6.7 6.0 5.7 7.8 7.6 6.1 15.8 4.8 3.0 4.4 3.1 3.2 2.4 1.7 3.1 1.3 2.6 3.2 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655738-2805017 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 30.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavourable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 19.8 8.1 9.1 29.9 11.1 35.6 17.2 18.0 11.3 21.9 17.3 8.2 16.0 13.7 19.2 12.3 12.4 15.6 13.3 12.6 8.3 8.0 9.3 10.2 21.5 31.3 12.7 8.6 20.0 21.2 15.9 14.8 16.2 9.4 15.6 15.3 11.6 14.0 14.0 12.9 10.8 23.7 23.1 9.8 32.0 14.0 13.7 11.5 34.4 12.1 9.6 22.1 25.7 23.5 4.1 1.2 30.3 1.2 1.1 3.2 0.5 10.7 4.9 16.7 10.4 7.1 10.5 12.0 10.8 7.7 10.3 13.1 9.2 3.5 23.2 4.8 9.6 5.9 13.4 6.2 16.3 4.7 7.0 14.5 9.6 8.7 8.0 41.6 11.4 6.9 5.7 13.0 10.8 8.4 16.8 14.5 9.8 3.8 17.4 10.6 6.7 5.7 14.2 13.5 10.2 6.3 16.6 13.7 8.6 14.6 4.9 8.5 3.6 17.7 8.0 12.8 17.7 17.3 19.8 8.8 13.3 21.3 8.2 7.7 11.0 1.9 1.2 3.1 1.9 0.8 1.4 2.9 2.5 2.2 0.4 4.1 3.2 2.0 30.3 1.1 1.1 1.2 2.5 0.5 9.1 11.1 18.0 11.3 8.3 8.0 12.7 8.6 9.4 11.5 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: " "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favourable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favourable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favourable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.0 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 2.5 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.2 5.0 3.1 5.1 3.5 5.8 4.9 5.3 1.1 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6, nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303771 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favourable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.7 16.6 18.1 18.9 17.6 11.9 10.9 19.1 18.4 15.0 10.6 15.1 13.2 9.0 26.2 11.9 16.1 22.2 16.7 16.4 12.8 15.9 11.5 7.3 11.5 10.7 13.4 16.1 38.7 9.3 16.2 17.2 10.1 14.5 14.5 9.5 18.6 10.4 13.3 14.0 15.3 10.3 18.9 12.8 9.0 9.7 39.2 11.5 22.3 11.6 8.4 16.8 12.7 12.4 2.0 3.3 4.8 3.6 4.6 4.3 1.5 8.4 13.0 18.8 12.1 20.3 16.5 9.7 13.7 15.1 15.6 13.3 15.8 4.3 8.9 4.9 20.1 12.4 13.7 11.7 16.4 8.9 8.6 8.7 6.9 7.7 11.6 4.6 6.3 23.3 8.6 12.6 11.2 14.2 7.1 10.9 11.6 6.7 11.6 3.7 6.0 6.8 12.1 12.0 3.5 9.0 7.8 3.2 9.6 14.3 4.2 5.9 6.5 3.4 18.6 14.4 7.9 15.2 14.3 9.5 5.7 4.2 11.5 5.2 8.3 4.8 1.8 2.0 3.7 0.8 3.7 1.2 3.1 3.5 1.0 2.0 4.3 2.9 1.4 4.6 3.6 3.3 1.8 1.5 18.1 17.6 19.1 18.4 12.8 15.9 13.4 16.1 14.5 11.5 SMG7 "C1orf16, EST1C, KIAA0250, SGA56M, SMG-7" ENSG00000116698 "SMG7, nonsense mediated mRNA decay factor" Q92540 1 183472216-183598246 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029350 Supported Supported "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA029350: AB_10603031" "unprognostic (6.06e-2)" "unprognostic (1.79e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-3)" "unprognostic (1.98e-2)" "unprognostic (1.36e-1)" "unprognostic (5.44e-2)" "unprognostic (6.15e-2)" "unprognostic (1.46e-1)" "unprognostic (9.01e-2)" "unprognostic (6.17e-2)" "unprognostic (2.69e-1)" "unprognostic (6.47e-3)" "unprognostic (7.82e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 14.6 14.3 20.7 17.1 25.3 30.9 17.6 35.8 29.3 17.6 18.1 19.9 6.6 16.8 16.6 13.6 19.1 22.1 12.9 20.0 17.8 14.8 18.2 18.7 15.6 19.7 16.0 23.1 22.7 18.7 25.9 20.2 18.7 15.9 15.1 20.4 15.9 17.2 14.5 19.2 20.5 17.8 15.2 14.4 18.9 18.3 52.1 15.1 31.6 19.9 12.7 23.9 14.5 22.3 9.3 11.7 11.2 9.6 9.5 10.3 8.0 21.5 13.2 19.0 14.9 13.0 12.4 31.8 13.3 24.5 14.9 11.4 19.5 16.9 30.5 15.3 16.4 23.5 25.6 19.7 17.7 13.5 11.2 24.6 14.3 15.8 13.2 32.2 15.8 11.2 18.1 20.3 47.2 16.2 30.5 21.6 15.4 21.9 22.6 14.2 33.0 7.6 14.3 21.3 23.8 11.4 20.2 25.7 20.1 20.5 29.2 15.9 29.1 13.2 15.4 16.9 17.5 16.7 18.8 23.6 27.7 25.3 13.7 18.3 18.0 3.1 9.3 9.5 9.7 9.6 8.9 9.3 8.8 9.5 10.7 8.5 9.9 10.3 11.2 9.5 5.0 11.7 7.8 8.0 20.7 25.3 35.8 29.3 17.8 14.8 16.0 23.1 15.9 15.1 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9, nonsense mediated mRNA decay factor" Q9H0W8 19 43727992-43754990 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA041763: , HPA042096: " "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavourable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favourable (8.09e-4)" 10.0 14.6 18.1 16.9 24.5 12.4 14.9 25.0 24.8 13.2 12.0 21.6 11.5 13.4 11.6 13.8 11.2 10.9 11.7 9.4 16.5 15.6 10.2 8.5 11.9 19.3 36.0 14.2 10.2 8.1 14.9 14.2 16.6 23.1 14.7 11.0 9.2 14.0 12.7 9.1 12.3 11.7 13.9 20.4 17.1 14.2 40.9 29.6 13.2 10.8 4.1 19.3 11.1 12.0 9.2 8.0 3.6 12.2 4.6 8.3 10.7 12.5 13.9 10.2 6.5 7.2 10.2 6.8 18.0 10.8 20.2 15.3 9.7 16.8 13.8 8.9 12.3 5.5 11.9 10.0 13.2 10.6 6.7 24.9 9.9 6.5 8.4 18.7 13.6 5.4 8.6 14.6 15.8 8.2 18.6 12.3 9.3 9.0 19.8 5.3 4.9 9.4 10.6 8.4 6.2 10.7 10.4 17.1 8.4 18.8 14.3 10.6 8.6 10.4 9.9 31.7 18.6 11.6 13.7 6.0 12.9 16.5 9.5 14.4 25.7 1.0 6.1 3.6 6.3 9.0 5.6 9.2 6.4 5.3 8.0 6.7 8.3 5.7 1.5 4.6 12.2 7.0 4.6 10.7 18.1 24.5 25.0 24.8 16.5 15.6 36.0 14.2 23.1 29.6 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: " "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.6 4.9 7.6 6.4 7.9 9.1 8.0 15.9 6.8 8.2 9.2 6.5 1.8 7.1 21.7 5.1 5.0 15.8 5.6 14.9 3.9 11.5 7.4 5.5 5.1 10.6 13.7 1.7 10.8 15.6 8.4 11.1 8.7 10.4 3.0 15.6 3.1 5.8 8.0 3.6 4.3 7.7 14.1 9.9 5.0 4.5 17.8 9.8 3.3 11.0 18.6 2.7 5.7 12.3 12.5 9.0 5.1 10.6 5.5 18.4 10.2 2.9 5.8 19.1 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.2" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA066648: " "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.8;SiHa: 4.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 1.2 1.1 1.3 0.3 0.0 0.0 1.4 0.0 5.8 1.4 0.0 2.1 0.3 2.3 1.5 0.0 3.6 0.0 2.2 1.6 0.0 2.3 0.0 2.6 0.0 2.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.5 0.0 0.9 1.6 1.3 0.1 0.3 0.0 0.6 3.1 1.6 4.5 2.0 3.0 0.1 0.2 0.5 0.0 1.1 1.7 0.3 0.0 0.1 0.9 1.7 0.5 1.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favourable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.7 10.7 14.4 13.9 16.0 34.8 19.2 12.4 15.2 10.7 13.7 9.5 22.7 21.0 21.7 13.8 3.7 16.7 15.9 15.1 11.9 13.3 12.1 7.8 18.0 27.1 14.4 8.1 24.6 32.0 13.7 20.8 8.2 19.3 6.9 13.2 8.2 15.6 24.5 27.2 16.0 12.9 18.8 13.5 23.9 9.4 18.6 17.3 8.0 5.6 27.4 11.6 20.5 13.7 11.7 13.8 13.1 15.8 13.6 11.2 22.0 17.7 15.3 14.7 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Group enriched" "Detected in some" 7 "CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA077331: " "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 72.8 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.2 0.0 0.2 0.1 6.2 0.3 26.8 19.0 0.3 0.1 54.7 0.0 4.3 0.0 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell line enhanced" "Detected in some" "CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favourable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 45.8 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.2 34.2 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.6 4.6 0.0 0.0 17.9 0.0 1.2 0.4 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 25.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA068733: " "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favourable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.4 30.5 22.9 24.0 21.1 29.1 27.1 17.5 20.7 20.3 23.3 18.8 27.1 23.2 20.1 18.8 25.8 21.6 28.6 23.1 10.0 27.3 30.9 14.2 62.0 40.5 20.2 23.7 24.7 38.2 23.1 37.2 30.5 22.6 21.9 25.1 28.8 23.8 55.8 13.2 36.9 15.6 27.1 31.7 45.5 23.5 23.0 24.6 18.4 35.5 67.6 26.0 29.9 15.9 14.3 15.2 17.8 18.3 21.3 51.3 25.8 13.0 13.1 10.8 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047771: " "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favourable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favourable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favourable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 22.7 8.0 9.3 23.6 11.0 5.7 19.1 10.3 4.8 11.9 10.4 9.7 6.1 9.8 4.7 4.3 12.0 3.0 8.3 4.8 6.5 24.2 9.2 22.8 19.6 16.7 11.0 12.9 12.3 5.1 10.0 7.3 10.8 12.2 14.7 8.0 9.9 10.1 15.3 15.9 17.0 7.0 9.0 19.4 6.6 10.0 10.1 12.8 20.2 6.7 19.5 6.9 9.2 9.5 6.6 21.7 31.1 20.9 17.2 18.7 21.5 36.2 20.5 9.0 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2" "Cell line enhanced" "Detected in some" "HEL: 3.1;MCF7: 14.1;SK-BR-3: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 51 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 51 "dendritic cells: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA065332: , HPA071268: " "unprognostic (6.97e-2)" "prognostic favourable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favourable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 0.4 0.6 2.1 1.8 10.7 9.9 1.4 1.1 7.5 4.0 4.4 23.5 2.1 9.8 0.7 0.8 14.3 5.5 4.7 5.1 3.7 2.2 13.6 0.5 2.5 1.1 8.8 4.8 1.3 1.1 0.4 1.1 1.9 16.9 1.9 2.8 2.5 8.4 2.2 0.4 7.8 9.5 2.1 10.1 2.4 11.0 0.9 8.9 0.4 9.3 0.9 3.6 4.4 7.3 0.0 54.2 1.0 0.0 0.0 0.0 4.0 2.4 1.6 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 3.1 0.4 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 14.1 0.1 0.1 0.1 0.2 0.4 0.5 0.1 0.0 2.8 1.2 0.1 0.0 6.4 0.0 0.9 0.2 0.1 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.2 0.0 4.0 2.1 10.7 1.1 7.5 3.7 2.2 8.8 4.8 16.9 8.9 SMN1 "BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A" ENSG00000172062 "Survival of motor neuron 1, telomeric" Q16637 5 70925030-70953942 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.3;MOLT-4: 37.1;T-47d: 28.7;WM-115: 38.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB016324, HPA045271, CAB069888, HPA073601" Supported Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: , HPA073601: " "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.18e-1)" "unprognostic (2.09e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-3)" "unprognostic (2.10e-2)" "unprognostic (2.43e-1)" "unprognostic (9.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.01e-1)" "unprognostic (4.41e-1)" "prognostic unfavourable (6.62e-13)" "unprognostic (2.04e-1)" "unprognostic (2.17e-1)" "unprognostic (8.06e-2)" "unprognostic (4.14e-2)" 4.3 3.3 5.1 4.7 4.4 23.9 5.1 6.0 4.3 6.1 4.0 2.8 5.2 7.4 4.7 5.7 8.0 3.5 5.2 5.0 6.8 7.0 3.7 16.4 4.6 8.0 5.3 6.4 5.2 4.7 4.6 6.0 3.8 3.5 5.8 5.9 3.1 9.2 5.2 5.2 6.1 6.9 4.9 2.5 10.7 5.1 15.8 14.7 5.2 11.3 9.0 16.1 7.1 2.8 0.6 1.1 1.3 3.0 4.5 15.1 1.1 1.7 1.7 1.3 1.3 1.3 1.4 23.3 2.2 1.5 1.7 1.2 1.5 0.3 1.7 21.0 1.7 1.9 0.4 2.4 1.9 0.5 3.7 0.6 0.6 0.9 0.9 2.1 0.9 1.0 37.1 15.5 1.4 0.6 1.9 4.6 11.0 0.9 1.6 1.7 3.6 1.5 4.1 19.5 28.7 3.9 10.5 10.9 1.2 1.0 2.3 1.3 0.9 13.9 1.6 1.5 38.2 5.2 9.1 3.4 10.1 11.3 16.1 15.8 10.3 9.4 13.4 12.5 14.2 13.4 3.1 9.0 10.5 14.7 12.5 7.1 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049612-70078522 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 37.7;MOLT-4: 33.8;NB-4: 31.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: , HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 3.9 2.7 5.4 3.7 4.8 10.4 4.2 5.6 9.8 3.9 4.0 0.2 4.9 19.1 10.0 2.9 11.5 3.2 5.2 5.1 6.6 5.4 6.2 8.6 4.1 7.0 7.9 11.4 5.0 3.8 4.7 6.9 8.5 5.4 5.2 3.3 2.6 12.1 5.5 4.0 5.4 9.8 5.1 0.0 10.9 4.8 15.0 14.0 4.7 14.9 9.2 15.6 6.2 16.6 0.1 0.1 0.0 6.6 7.9 37.7 8.9 5.7 11.5 11.4 0.1 0.1 0.3 25.7 9.1 7.5 0.2 0.0 7.7 0.2 0.3 18.1 0.0 0.6 0.0 0.3 0.0 0.0 14.8 0.0 0.3 0.2 0.0 0.1 0.0 0.1 33.8 31.7 0.1 0.1 0.0 13.0 19.3 7.5 0.0 9.4 20.7 16.9 3.7 23.7 12.0 7.5 15.8 7.8 0.3 0.1 0.2 0.1 0.3 21.3 0.1 0.0 21.5 3.9 6.1 4.7 8.1 14.9 15.0 13.7 13.1 9.3 13.1 15.0 15.6 13.1 1.2 9.2 10.1 14.0 13.1 6.2 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304951 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA061214: , HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavourable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 21.3 18.0 16.7 20.0 17.5 38.3 26.6 24.0 20.1 19.0 18.1 17.5 13.5 13.9 23.6 13.1 24.1 18.4 16.7 19.4 15.0 15.4 19.3 20.8 23.5 32.7 15.0 14.4 23.4 15.3 18.0 24.3 25.2 16.5 18.0 16.1 19.6 18.0 17.4 34.3 19.0 16.6 21.3 22.7 21.8 17.0 19.8 16.9 30.0 18.9 14.9 24.7 25.4 22.4 6.2 9.2 17.4 9.7 6.3 8.7 4.5 15.3 11.7 17.2 19.7 13.4 16.0 12.8 17.8 18.6 23.7 24.4 15.0 19.0 21.8 11.6 11.1 16.7 25.2 12.3 26.8 12.3 13.5 21.7 10.0 17.5 16.0 23.8 21.0 12.4 13.2 18.8 31.8 13.1 19.5 20.4 18.3 7.2 25.4 23.2 19.1 8.1 22.0 34.5 11.4 13.2 11.1 8.6 11.6 11.5 9.8 20.4 12.1 13.7 14.3 13.9 15.9 12.7 22.6 16.9 17.5 33.1 14.0 33.5 10.7 5.7 9.6 14.7 6.1 9.7 7.5 6.2 7.9 7.6 9.2 5.5 7.1 6.8 17.4 6.3 9.7 5.5 8.7 4.5 16.7 17.5 24.0 20.1 15.0 15.4 15.0 14.4 16.5 16.9 SMOX "C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO" ENSG00000088826 "Spermine oxidase" Q9NWM0 20 4120980-4187747 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 34.7;Karpas-707: 59.3;RPTEC TERT1: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1;neutrophil: 3.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047117, HPA060198" Approved Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane" "Nucleoplasm, Vesicles" "HPA047117: , HPA060198: " "unprognostic (1.24e-2)" "unprognostic (6.55e-2)" "unprognostic (7.24e-3)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (3.33e-6)" "prognostic unfavourable (1.36e-4)" "unprognostic (4.92e-2)" "unprognostic (3.37e-1)" "unprognostic (7.18e-2)" "unprognostic (7.58e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (4.08e-2)" "unprognostic (2.64e-3)" "unprognostic (1.26e-2)" "unprognostic (3.07e-1)" 3.5 3.1 26.0 4.1 22.7 24.2 3.4 10.1 29.0 9.6 6.7 23.5 17.6 9.5 10.2 6.9 6.1 4.7 14.0 2.9 28.8 16.2 3.8 4.4 2.1 4.0 25.1 16.5 9.2 28.9 8.7 6.0 5.7 20.7 8.1 1.4 6.5 10.6 10.2 2.5 7.8 7.1 3.9 25.9 2.9 7.4 3.9 24.1 0.3 3.9 3.4 2.6 5.3 5.2 0.1 2.1 3.5 0.9 0.2 0.2 15.3 3.1 34.7 2.4 1.8 1.7 2.5 4.4 4.5 8.7 3.3 2.2 14.2 8.7 0.0 1.5 4.1 6.3 2.0 2.1 1.4 0.0 1.0 6.1 1.1 14.4 10.7 1.1 2.5 9.6 3.9 6.9 2.9 5.8 1.3 59.3 1.9 0.9 2.3 3.4 3.0 4.7 2.0 3.0 8.2 27.3 2.4 0.4 2.1 8.4 0.9 15.6 0.1 1.5 6.9 3.8 3.6 0.6 3.5 2.7 0.4 0.0 3.2 1.5 2.9 0.0 0.9 0.1 0.0 0.4 0.0 0.1 0.2 0.2 2.1 0.0 0.0 0.0 3.5 0.2 0.1 1.0 0.0 15.3 26.0 22.7 10.1 17.6 28.8 16.2 25.1 16.5 20.7 24.1 SMPD2 "ISC1, nSMase" ENSG00000135587 "Sphingomyelin phosphodiesterase 2" O60906 6 109440763-109443919 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018110, HPA018125" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane" "Cell Junctions" "HPA018110: AB_1857292, HPA018125: AB_1857293" "unprognostic (1.61e-1)" "unprognostic (8.01e-2)" "unprognostic (1.97e-1)" "unprognostic (8.79e-3)" "unprognostic (3.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.17e-4)" "unprognostic (7.08e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" "prognostic favourable (1.00e-3)" "unprognostic (3.60e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" "unprognostic (1.45e-2)" "prognostic favourable (1.70e-4)" 6.0 6.8 4.2 20.2 4.9 8.5 8.5 5.4 6.4 9.0 12.6 9.8 16.4 10.5 6.1 16.0 17.2 17.4 12.6 5.1 4.9 3.7 10.2 7.8 8.4 9.4 4.7 4.2 6.7 15.5 17.9 8.8 19.5 4.8 10.1 10.2 8.4 16.6 11.9 3.3 16.9 15.4 7.8 4.3 10.1 11.1 35.1 4.7 18.3 10.5 13.5 23.0 6.3 10.1 18.3 13.4 9.3 7.8 6.2 8.0 5.3 8.9 10.4 5.5 8.6 9.6 5.3 18.3 3.0 11.1 7.5 7.2 9.7 7.3 4.9 6.4 6.4 11.5 5.5 13.2 4.5 6.2 14.2 5.7 10.7 6.0 8.1 6.2 6.7 5.6 15.3 6.7 13.3 6.9 10.9 8.7 3.7 12.9 10.0 13.5 1.5 5.0 7.0 2.6 5.3 13.7 15.3 7.2 6.0 5.7 17.8 13.4 5.7 11.9 4.4 3.4 4.9 2.7 11.2 5.9 1.5 3.1 6.6 5.9 6.0 5.7 7.8 9.3 6.6 7.5 7.3 12.8 7.4 8.0 10.2 18.3 5.6 5.7 2.3 6.2 6.6 13.4 7.2 5.3 4.2 4.9 5.4 6.4 4.9 3.7 4.7 4.2 4.8 4.7 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA046279: , HPA049426: " "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavourable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.73e-4)" "prognostic unfavourable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 31.7 15.7 19.8 14.6 10.2 7.5 25.8 16.9 12.6 25.0 20.9 45.4 16.3 20.7 15.0 17.0 18.1 25.3 22.4 17.4 27.4 24.4 23.3 16.9 36.0 8.7 26.0 14.9 8.8 15.0 28.0 11.2 14.4 28.9 16.8 13.9 17.2 27.1 13.1 30.4 20.9 28.8 15.1 22.5 10.6 15.1 27.6 15.4 16.7 20.4 7.4 13.9 11.4 11.1 21.4 20.8 14.0 19.8 14.7 16.4 27.8 19.3 14.9 15.2 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 23.8;hTCEpi: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.3 3.2 1.5 23.8 10.8 10.3 5.4 14.5 1.6 3.5 1.7 1.4 0.0 0.8 3.4 2.5 0.9 2.7 1.3 0.0 2.8 1.2 5.4 4.5 15.3 0.0 0.1 13.1 19.5 1.5 2.8 2.8 1.9 0.0 6.6 4.7 0.0 0.1 0.5 4.2 0.0 5.7 0.2 7.9 2.1 2.4 0.0 0.7 9.7 13.6 1.6 0.7 5.6 3.2 1.9 0.3 3.5 0.0 0.0 0.0 4.6 2.5 7.1 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27934993-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4" "Cell line enhanced" "Detected in many" "BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.6" "Group enriched" "Detected in some" 7 "eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.7;granulocytes: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" 330000 "Golgi apparatus, Cytosol" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 1.3 0.2 1.1 2.7 1.4 0.6 2.7 5.6 1.2 1.3 14.0 0.5 0.5 12.5 1.1 8.6 1.1 3.5 3.6 0.5 0.8 0.5 5.8 0.8 7.3 2.0 0.3 0.9 1.3 48.0 5.0 1.5 1.0 1.0 2.3 12.6 1.3 25.5 0.5 0.3 0.9 25.0 0.8 0.8 1.6 9.1 1.0 0.3 0.7 24.4 1.4 3.5 1.4 0.5 0.5 2.7 6.3 0.3 0.5 0.2 0.2 2.5 1.2 0.0 0.1 0.0 0.0 22.6 0.0 0.5 0.3 1.7 5.7 17.4 0.8 4.1 0.0 2.8 1.8 1.5 0.2 0.0 11.6 3.7 0.2 1.4 0.0 1.2 0.0 0.1 1.4 3.4 0.2 0.4 0.5 0.2 0.0 9.2 0.0 0.3 13.5 2.1 0.2 0.1 14.0 12.2 4.5 11.7 0.2 0.0 22.6 0.6 16.3 0.7 0.0 0.0 3.9 0.0 0.0 0.1 5.9 0.3 0.3 0.0 0.0 0.4 0.3 6.3 0.0 0.3 0.0 0.5 0.1 0.0 2.7 0.5 0.2 0.0 3.8 0.5 0.0 0.1 0.0 0.2 1.1 1.4 5.6 1.2 0.8 0.5 0.3 0.9 1.0 0.3 SMS "MRSR, SPMSY, SpS, SRS" ENSG00000102172 "Spermine synthase" P52788 X 21940573-21994835 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Polyamine biosynthesis" Transferase "FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029849, HPA029852" Approved Approved "Nuclear bodies,Cytosol" 26000 "Nuclear bodies" Cytosol "HPA029849: AB_10602072, HPA029852: AB_10611521" "unprognostic (2.51e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (7.49e-4)" "prognostic unfavourable (7.79e-8)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.18e-3)" "unprognostic (3.95e-3)" "unprognostic (2.45e-1)" "prognostic unfavourable (7.85e-5)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (8.50e-2)" 21.7 48.1 29.7 18.7 25.0 18.6 28.4 36.6 35.4 20.8 23.1 8.1 26.0 23.5 20.8 31.3 19.2 13.3 20.9 26.3 22.3 25.0 55.1 19.5 17.6 18.5 25.6 28.5 42.4 16.7 13.6 19.2 63.6 24.2 61.3 24.4 15.7 20.7 20.6 18.0 9.7 25.1 36.8 17.4 18.9 18.8 18.4 11.0 19.6 27.6 11.7 20.8 28.2 16.5 13.2 19.4 37.0 25.7 11.7 20.3 12.3 90.6 23.2 39.6 15.0 10.5 17.8 12.3 24.9 14.9 38.3 36.7 28.8 29.7 32.9 8.6 25.4 19.9 38.7 45.4 75.8 15.2 18.1 17.0 28.0 20.4 19.3 32.9 15.0 11.7 13.9 39.3 73.9 36.6 36.2 4.6 52.1 19.3 24.3 33.0 67.1 34.5 24.3 27.2 25.0 51.0 12.9 18.9 15.3 19.9 25.6 65.5 23.1 13.7 32.3 27.8 28.0 57.6 40.4 3.5 7.0 19.6 54.2 14.7 38.5 2.9 21.4 37.0 7.6 22.1 9.4 13.2 12.0 13.2 19.4 8.3 7.9 9.3 21.1 11.7 25.7 4.0 20.3 12.3 29.7 25.0 36.6 35.4 22.3 25.0 25.6 28.5 24.2 11.0 SMTN ENSG00000183963 Smoothelin P53814 22 31064105-31104757 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 99.3" "Cell line enhanced" "Detected in all" "WM-115: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001721, HPA051778, HPA058590" Enhanced Supported "Nucleoplasm,Actin filaments" 11000 Nucleoplasm "Actin filaments" "CAB001721: , HPA051778: , HPA058590: " "unprognostic (1.36e-2)" "unprognostic (4.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (1.08e-3)" "unprognostic (2.05e-2)" "unprognostic (4.56e-1)" "unprognostic (2.15e-1)" "unprognostic (7.22e-2)" "prognostic unfavourable (2.73e-5)" "unprognostic (2.75e-2)" "unprognostic (1.84e-1)" "unprognostic (8.41e-3)" "unprognostic (6.34e-2)" 17.4 3.3 5.0 8.3 3.8 1.5 13.2 12.7 4.7 34.3 99.3 2.0 7.5 10.3 72.4 12.5 26.4 23.5 32.5 27.6 4.3 1.3 7.0 4.7 9.1 1.7 3.6 2.2 18.2 6.8 1.3 2.0 6.0 5.3 34.5 10.6 14.9 4.6 66.7 28.8 6.4 20.3 91.7 1.7 16.9 36.7 6.2 4.0 1.8 5.1 16.8 2.2 61.3 21.4 4.1 1.3 0.3 2.8 0.3 3.1 1.9 19.6 5.9 2.0 7.5 3.1 5.0 16.4 29.5 13.8 24.3 16.7 8.2 6.3 8.8 2.6 16.2 2.9 2.0 17.4 11.5 2.9 16.2 9.3 4.7 9.7 2.8 13.8 16.3 4.1 1.6 32.1 5.3 20.9 9.9 7.3 16.6 17.6 1.5 3.0 2.2 25.1 5.5 5.8 9.3 9.7 6.4 3.2 3.5 9.2 4.4 4.3 5.2 2.2 32.9 17.9 16.9 16.7 21.8 7.0 8.4 5.2 25.9 5.4 55.8 0.0 2.8 0.0 0.5 0.7 0.2 4.1 0.5 1.2 1.3 0.2 3.1 1.7 0.3 0.3 0.7 0.7 0.1 1.9 5.0 3.8 12.7 4.7 4.3 1.3 3.6 2.2 5.3 4.0 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favourable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 9.5 15.2 17.3 7.0 16.4 4.9 15.5 13.2 16.1 9.8 11.1 11.7 13.5 9.2 9.5 24.1 19.2 14.2 9.2 10.7 15.0 7.8 13.8 23.5 7.8 17.0 11.5 15.0 10.3 23.6 8.3 11.5 14.9 14.4 11.9 10.5 14.2 16.2 10.9 13.6 16.4 16.2 9.2 10.4 11.2 15.2 12.1 14.1 12.6 12.4 6.1 13.1 10.0 9.8 24.2 23.8 38.0 25.0 13.0 20.8 17.0 12.9 23.9 9.4 9.7 17.5 13.7 16.0 10.0 13.1 15.8 14.5 23.9 29.0 7.7 25.8 14.4 17.0 6.5 26.4 10.2 8.1 13.9 11.6 19.1 17.0 20.9 7.7 14.5 15.6 41.2 18.6 18.5 12.7 19.3 17.0 17.3 24.9 9.7 15.2 11.7 21.6 7.1 9.6 13.9 19.6 19.0 14.0 16.7 11.5 19.9 17.5 31.0 14.6 6.1 10.7 11.8 9.5 11.4 15.9 12.5 5.2 15.4 6.1 16.0 38.0 25.0 28.7 15.8 19.7 15.7 24.2 15.6 17.0 21.1 18.8 14.1 14.1 24.5 13.0 15.8 23.8 20.8 17.0 17.3 16.4 13.2 16.1 15.0 7.8 11.5 15.0 14.4 14.1 SMURF1 KIAA1625 ENSG00000198742 "SMAD specific E3 ubiquitin protein ligase 1" Q9HCE7 7 99027438-99144100 "Enzymes, Predicted intracellular proteins" "Differentiation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019671, HPA055245" Approved Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019671: , HPA055245: " "unprognostic (2.21e-1)" "unprognostic (6.15e-2)" "unprognostic (8.88e-2)" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (3.92e-3)" "unprognostic (2.58e-1)" "unprognostic (1.46e-1)" "unprognostic (7.83e-2)" "unprognostic (1.68e-1)" "unprognostic (3.81e-1)" "unprognostic (4.62e-2)" 15.0 11.1 8.7 10.5 15.0 23.8 12.4 12.1 16.5 11.8 10.9 20.9 6.9 9.5 11.6 5.7 19.3 10.2 12.5 7.9 9.3 8.4 10.3 10.1 16.0 8.1 15.4 9.4 19.6 22.5 9.0 15.1 15.4 14.9 11.7 10.6 14.3 13.4 9.6 10.7 17.3 10.3 9.8 10.6 9.1 19.5 26.0 11.8 6.6 7.8 6.6 12.7 11.5 13.3 1.2 1.2 2.4 1.9 1.0 2.1 0.6 13.8 7.9 6.4 4.6 5.1 5.4 9.6 7.8 7.5 6.3 5.9 4.0 11.5 4.3 8.4 7.2 7.6 3.6 10.0 6.6 3.3 3.0 2.3 4.6 3.8 4.8 2.6 5.7 4.9 7.0 9.9 11.5 6.0 7.0 7.7 5.8 11.2 4.5 5.5 7.5 8.5 4.3 6.0 2.6 6.9 11.4 2.8 6.4 7.4 9.8 6.8 3.1 5.0 8.7 10.0 10.3 17.9 15.4 6.9 4.7 4.6 5.0 5.2 15.5 2.0 1.4 2.3 1.3 1.5 1.6 0.9 2.1 1.3 1.1 1.2 1.2 1.0 2.4 1.0 1.9 1.2 2.0 0.6 8.7 15.0 12.1 16.5 9.3 8.4 15.4 9.4 14.9 11.8 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 75.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved "Intermediate filaments,Mitochondria,Cytosol" Cytosol "Intermediate filaments, Mitochondria" "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavourable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favourable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 5.9 5.7 8.8 5.6 7.3 2.7 10.0 5.0 23.9 4.9 4.7 2.1 3.1 4.8 3.8 6.7 7.3 10.4 4.5 75.7 7.0 8.4 7.7 9.7 8.1 8.0 5.3 10.0 4.7 7.8 2.9 7.5 10.6 6.9 4.6 5.8 3.1 6.2 3.0 29.5 4.3 4.7 3.8 4.7 6.2 6.2 8.9 2.2 8.0 7.8 5.1 5.6 5.2 4.0 9.3 5.5 8.1 5.9 17.6 14.5 7.3 24.1 7.0 9.5 6.7 9.9 17.2 40.6 13.6 11.3 17.3 19.7 27.5 20.7 12.5 14.1 15.4 11.4 9.0 25.4 16.8 10.4 10.5 4.0 11.8 21.9 8.9 17.6 2.8 18.4 14.3 12.0 9.6 12.5 12.7 3.2 15.5 12.6 12.2 11.1 8.6 9.5 7.6 23.1 10.6 17.1 17.7 9.4 22.0 10.6 38.3 28.2 29.8 11.7 14.4 13.5 19.9 7.4 21.1 12.9 4.8 14.4 17.5 14.0 15.3 6.7 5.9 8.1 9.5 3.2 11.2 9.3 14.5 12.7 5.5 4.8 12.7 11.6 0.6 17.6 1.2 3.8 14.5 7.3 8.8 7.3 5.0 23.9 7.0 8.4 5.3 10.0 6.9 2.2 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 92.9;K-562: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB012229: , HPA045821: , HPA054352: " "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 6.0 12.0 9.9 9.7 16.2 7.6 10.6 25.9 14.7 8.9 6.5 6.4 3.7 4.5 8.7 21.8 6.1 10.0 7.7 5.8 10.3 12.0 8.9 5.5 9.2 6.3 12.0 10.2 8.0 7.2 6.7 11.9 4.6 15.3 6.8 8.3 9.5 5.3 5.9 9.5 6.7 5.2 7.6 6.8 5.3 6.1 10.5 8.1 7.5 18.8 3.6 9.3 8.3 6.6 11.3 5.9 8.3 3.4 19.4 12.9 8.7 4.6 2.8 4.1 3.5 4.7 6.4 4.1 6.5 4.9 7.7 17.3 3.7 5.4 7.6 5.3 6.0 3.0 3.7 7.3 25.9 4.0 3.8 4.4 4.2 4.4 8.8 4.4 92.9 17.3 1.7 10.2 6.6 5.2 35.1 2.6 7.5 1.6 8.5 8.6 3.7 4.5 7.9 5.0 10.9 5.6 6.8 9.8 4.7 3.1 0.4 5.9 3.8 7.6 4.0 3.7 2.6 2.6 7.7 13.3 3.6 3.9 7.1 6.1 4.3 8.1 3.4 8.3 10.5 3.0 10.8 11.3 11.1 12.8 5.9 11.1 12.3 12.9 2.4 19.4 3.3 3.8 11.8 8.7 9.9 16.2 25.9 14.7 10.3 12.0 12.0 10.2 15.3 8.1 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.3 11.4 8.1 7.8 5.4 13.3 9.8 5.7 10.5 10.8 18.0 5.2 16.1 6.7 4.0 11.7 10.8 6.4 13.1 4.6 10.9 5.9 12.0 4.8 3.9 5.9 5.8 3.8 5.8 10.7 9.5 5.1 6.1 6.3 8.1 3.7 10.9 4.2 5.2 5.6 13.5 5.8 4.1 4.2 7.3 4.7 6.5 9.1 3.8 9.4 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.0 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 SNAI1 "SLUGH2, SNA, SNAH, SNAIL, SNAIL1" ENSG00000124216 "Snail family transcriptional repressor 1" O95863 20 49982999-49988886 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 17.6;TIME: 24.5;WM-115: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB005883, HPA056831, HPA069985, CAB078687" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB005883: AB_443967, CAB078687: , HPA056831: , HPA069985: " "unprognostic (4.60e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (4.76e-4)" "unprognostic (2.60e-2)" "unprognostic (1.15e-2)" "unprognostic (4.22e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.61e-5)" "unprognostic (3.34e-3)" "unprognostic (9.85e-3)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (2.63e-7)" "unprognostic (3.75e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (8.82e-7)" "unprognostic (1.88e-2)" 18.3 8.0 1.8 5.9 3.8 5.5 11.1 2.9 2.7 5.9 3.4 5.8 2.6 1.6 5.4 4.2 4.0 8.2 22.2 11.8 3.1 1.2 5.2 7.2 14.3 5.9 3.1 1.3 6.8 7.0 3.6 4.9 15.9 2.9 6.1 1.3 11.0 3.4 3.8 3.6 3.2 2.3 4.3 6.3 8.1 4.5 4.5 3.6 0.7 18.7 4.1 2.0 10.8 13.9 0.0 4.1 0.0 0.6 0.0 0.0 0.1 0.7 0.6 3.4 0.5 1.1 0.6 6.9 2.9 3.7 0.6 0.4 5.5 0.8 0.4 8.1 5.2 0.1 1.0 0.0 0.3 0.0 0.7 0.4 1.2 3.3 8.9 0.9 2.8 2.0 0.2 1.3 0.0 8.8 4.2 0.1 0.0 1.2 0.1 1.0 4.6 2.4 1.5 0.9 0.4 4.1 0.0 1.5 3.5 17.6 4.5 0.7 0.9 4.0 24.5 0.0 4.4 0.0 0.0 0.1 0.1 4.5 1.4 1.3 15.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 1.8 3.8 2.9 2.7 3.1 1.2 3.1 1.3 2.9 3.6 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Group enriched" "Detected in some" 4 "Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.7 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.0 0.4 0.2 0.0 4.4 0.2 0.1 0.0 2.9 0.3 1.6 0.0 0.2 2.0 0.0 1.8 0.0 0.0 0.0 10.8 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 35.7 21.3 0.3 0.0 0.0 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.5 0.0 25.7 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 SNAP29 "CEDNIK, SNAP-29" ENSG00000099940 "Synaptosome associated protein 29" O95721 22 20858983-20891218 "Disease related genes, Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" "Ichthyosis, Neuropathy, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031823, CAB037092, HPA056492" Supported Supported Nucleoplasm,Cytosol 34000 Cytosol Nucleoplasm "CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: " "unprognostic (1.76e-1)" "prognostic favourable (6.99e-4)" "unprognostic (3.72e-3)" "unprognostic (3.26e-2)" "unprognostic (7.83e-3)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (2.05e-2)" "unprognostic (1.34e-2)" "unprognostic (2.60e-2)" "unprognostic (3.68e-2)" "unprognostic (6.85e-2)" "unprognostic (1.22e-1)" "unprognostic (2.52e-1)" "unprognostic (1.45e-1)" "unprognostic (4.51e-3)" "unprognostic (6.08e-2)" 19.4 18.8 15.9 15.5 15.3 15.7 15.5 13.4 19.7 16.0 18.8 15.3 17.1 16.5 15.2 11.6 21.7 12.3 19.9 23.1 13.8 13.0 17.7 36.1 13.4 20.1 15.1 12.3 15.7 16.6 13.1 11.5 26.4 13.7 13.6 17.7 19.0 17.7 17.1 27.6 17.6 16.8 17.6 15.9 24.1 17.4 47.0 14.9 18.3 15.1 15.9 18.2 15.3 16.3 10.8 20.0 23.0 33.2 26.1 14.9 14.0 15.5 6.4 9.1 7.5 10.3 15.1 11.8 14.8 13.4 16.7 16.9 8.8 5.5 9.7 9.5 13.9 9.2 11.9 10.0 18.1 14.0 9.1 16.2 7.2 9.4 14.8 14.3 13.2 11.9 14.2 17.5 12.7 11.7 70.2 14.0 15.4 10.7 13.0 13.8 3.0 6.7 12.5 20.4 3.9 9.8 8.4 7.4 8.9 15.9 10.0 16.7 15.7 11.5 10.1 17.1 15.6 11.7 11.5 14.3 23.2 17.9 12.8 9.7 12.2 19.5 20.0 23.0 10.6 27.4 11.0 10.8 10.5 11.4 17.4 9.2 9.7 9.8 22.6 26.1 33.2 20.0 14.9 14.0 15.9 15.3 13.4 19.7 13.8 13.0 15.1 12.3 13.7 14.9 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 13 "SCLC-21H: 21.3;SH-SY5Y: 13.3" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 1.2 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.1 0.2 21.3 13.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762357-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 42.5;U-2 OS: 56.4;U-251 MG: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA067076: , HPA072276: " "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 9.9 12.3 7.5 8.6 10.3 7.0 8.4 12.1 8.0 14.4 6.8 5.6 11.6 4.9 10.3 15.8 9.2 8.7 10.4 11.2 7.8 7.6 8.7 7.0 10.5 9.7 11.8 5.4 12.1 5.0 8.8 27.2 11.3 14.2 10.3 4.2 5.7 7.2 19.8 5.6 8.7 5.2 6.9 14.5 9.5 5.4 24.9 9.4 9.1 9.8 8.2 8.9 17.4 14.3 12.0 9.3 7.5 7.0 9.6 13.1 5.1 14.9 2.9 2.9 6.1 3.2 3.8 3.4 12.7 8.4 14.6 8.7 1.0 3.1 3.1 16.9 5.4 4.7 2.8 3.8 24.1 3.4 2.0 1.8 1.5 2.1 8.6 1.9 4.1 3.6 2.6 12.3 42.5 5.5 2.0 2.9 13.9 1.9 4.7 3.1 2.8 9.7 3.6 7.7 1.1 11.9 2.3 2.1 5.0 8.3 1.5 10.0 3.0 3.1 8.5 16.1 56.4 10.4 38.8 1.9 2.0 2.7 10.9 2.5 9.5 7.5 7.0 5.8 6.4 5.9 8.3 12.0 8.1 5.5 7.0 12.0 13.1 8.5 7.1 9.6 4.9 9.3 8.7 5.1 7.5 10.3 12.1 8.0 7.8 7.6 11.8 5.4 14.2 9.4 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920316-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: , HPA077597: " "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 12.5 15.1 11.0 14.2 17.1 20.3 12.0 19.3 19.8 30.8 20.0 13.2 11.9 14.2 32.4 11.8 20.3 21.8 12.1 12.1 11.7 11.6 15.6 11.1 12.3 12.4 10.6 13.6 24.2 15.1 12.0 16.5 13.6 12.2 24.8 6.0 10.8 18.0 27.0 8.1 16.4 11.3 22.8 9.1 14.8 11.9 28.7 12.3 18.3 17.5 10.4 11.4 29.9 16.1 11.5 20.1 14.7 20.9 17.7 15.5 10.4 9.0 10.5 5.0 19.4 7.0 14.9 4.6 9.6 10.4 9.6 8.7 4.8 7.9 7.8 12.0 11.3 11.2 3.5 7.2 2.8 10.0 8.9 10.9 4.6 6.8 12.7 6.8 18.1 12.1 11.2 11.3 7.0 10.8 10.7 13.2 5.8 8.1 8.7 19.3 6.4 23.6 10.3 4.9 7.7 8.8 3.2 5.9 13.2 5.0 5.4 21.6 8.8 7.4 14.0 32.5 11.5 30.2 12.0 12.6 20.6 4.7 20.3 14.1 10.2 4.5 16.4 14.7 13.7 20.9 13.7 11.5 11.7 11.8 20.1 11.0 12.2 12.2 2.4 17.7 20.7 13.3 15.5 10.4 11.0 17.1 19.3 19.8 11.7 11.6 10.6 13.6 12.2 12.3 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: , HPA066031: " "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 4.1 5.3 11.2 4.2 9.0 9.4 6.5 6.5 2.8 3.8 4.5 2.5 1.8 2.9 2.5 4.0 2.5 5.9 3.0 4.7 13.5 6.9 10.4 11.1 3.4 4.5 2.3 8.1 6.1 6.1 2.7 3.1 7.0 2.9 4.8 8.7 1.3 2.8 7.4 3.6 13.9 5.7 1.3 1.6 6.6 2.5 11.9 8.5 2.2 2.0 1.5 4.8 4.8 5.8 6.4 2.5 2.7 8.1 6.3 7.5 3.6 4.1 3.1 2.9 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046627, HPA073243" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA046627: AB_10961152, HPA073243: " "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favourable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 6.8 5.8 7.6 9.5 15.4 12.7 7.6 20.1 19.4 8.0 6.6 10.9 8.7 9.5 9.9 10.1 6.6 14.5 9.2 6.3 10.1 8.0 8.6 11.5 8.0 10.8 7.7 10.1 11.2 17.8 13.4 13.3 6.7 10.4 9.1 7.2 11.8 10.8 8.5 7.2 13.5 7.8 8.0 8.2 11.7 8.1 20.0 10.2 11.2 10.0 5.7 10.2 9.4 7.1 3.4 1.7 3.7 1.6 2.3 2.6 0.6 6.0 7.1 7.3 10.1 4.7 9.2 13.4 7.9 5.3 8.3 6.7 16.2 5.6 9.3 5.7 6.2 19.7 8.8 10.2 5.0 13.1 13.8 6.3 18.0 7.7 4.2 13.2 7.5 7.3 8.6 7.2 6.9 7.3 12.9 6.9 5.8 13.6 7.6 15.0 15.1 9.3 12.6 7.4 13.2 4.8 11.0 21.1 14.7 7.9 13.2 4.2 13.5 7.7 10.4 8.6 7.9 15.4 11.2 4.3 5.1 7.6 6.0 6.2 5.0 0.0 1.6 1.3 2.6 1.3 1.2 2.0 1.1 1.1 0.6 3.4 0.9 0.7 3.7 2.3 0.5 1.7 0.9 0.6 7.6 15.4 20.1 19.4 10.1 8.0 7.7 10.1 10.4 10.2 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658654-153661830 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" 15000 "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 21.8 32.5 20.2 14.5 25.9 8.4 30.2 12.1 26.3 17.5 19.2 18.5 17.2 9.1 19.7 25.0 20.7 20.4 21.4 38.1 17.4 17.7 21.8 22.1 15.7 26.1 21.6 17.8 17.9 22.9 18.0 10.8 14.5 20.5 17.9 14.7 15.6 14.1 22.6 56.9 16.1 13.2 24.9 22.1 19.4 16.0 16.5 20.8 18.1 19.9 29.8 21.7 19.6 13.9 42.4 50.8 44.6 49.9 35.4 42.8 42.8 20.1 24.7 21.0 12.7 26.9 18.0 13.6 17.1 19.0 24.2 18.5 17.5 16.1 14.5 34.5 17.3 26.9 17.2 22.3 17.0 19.3 23.8 16.0 19.0 8.4 27.8 15.7 10.2 21.6 16.7 18.1 20.7 22.7 13.5 11.2 24.2 32.5 17.9 9.2 11.4 26.6 17.0 18.3 38.2 26.8 19.4 16.1 28.2 19.7 22.9 22.3 34.8 16.7 19.9 11.3 17.2 22.3 16.0 27.2 29.7 22.1 21.5 9.8 14.6 27.6 49.9 44.6 30.9 49.1 35.0 42.4 31.4 31.0 50.8 36.9 34.8 31.8 10.4 35.4 39.0 38.1 42.8 42.8 20.2 25.9 12.1 26.3 17.4 17.7 21.6 17.8 20.5 20.8 SNCAIP SYPH1 ENSG00000064692 "Synuclein alpha interacting protein" Q9Y6H5 5 122311354-122464219 "Disease related genes, Predicted intracellular proteins" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 22.6;ovary: 32.3" "Cell line enhanced" "Detected in some" "AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.8;RPMI-8226: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 9.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064687 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "HPA064687: " "unprognostic (7.28e-3)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (6.56e-2)" "unprognostic (2.18e-2)" "unprognostic (1.56e-1)" "unprognostic (1.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.95e-2)" "unprognostic (3.73e-1)" "unprognostic (3.52e-2)" "unprognostic (3.00e-1)" "unprognostic (5.98e-2)" "unprognostic (1.82e-3)" "unprognostic (5.77e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-1)" 3.9 1.2 2.2 2.1 5.8 0.7 4.1 15.4 6.4 16.0 1.6 3.7 4.0 1.6 22.6 4.3 0.9 4.5 2.4 1.5 3.4 2.2 1.6 0.4 1.4 4.5 1.6 2.4 32.3 0.7 0.3 1.6 2.1 3.2 2.6 1.1 2.3 0.8 2.7 0.7 1.9 1.1 10.6 1.5 6.1 1.2 11.6 2.1 0.5 1.2 3.3 1.4 4.6 4.1 0.4 0.4 9.9 0.3 0.1 0.4 0.0 0.0 0.1 7.7 0.2 0.0 0.5 0.5 3.5 7.4 1.3 0.4 0.5 0.6 0.1 0.3 3.4 0.2 3.0 0.5 4.8 2.8 1.0 0.0 0.6 0.4 0.1 0.0 0.4 0.6 0.1 0.6 0.4 2.3 0.0 2.0 0.0 0.0 0.2 0.1 3.7 0.6 0.2 0.0 7.9 0.3 1.0 1.5 0.3 0.0 0.7 0.0 0.6 0.2 0.8 0.4 1.0 0.5 0.8 0.2 0.2 0.3 0.4 0.0 0.5 9.9 0.3 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.4 0.2 0.4 1.7 0.1 0.1 0.4 0.1 0.0 2.2 5.8 15.4 4.3 3.4 2.2 1.6 2.4 3.2 2.1 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958618-86963260 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6" "Group enriched" "Detected in some" 4 "CAPAN-2: 93.7;RT4: 77.2" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 292.8" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581" Enhanced Supported Supported "Nuclear bodies,Centrosome" Centrosome "Nuclear bodies" "CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavourable (2.29e-8)" "prognostic unfavourable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 74.1 78.3 82.3 5.3 20.8 1.0 28.9 12.3 44.5 9.5 5.8 4.6 6.4 4.8 6.1 12.0 11.0 26.5 6.2 9.0 40.0 92.9 4.1 1.9 4.6 4.9 72.9 35.1 15.0 3.5 1.6 1.7 4.9 100.1 11.9 2.7 10.8 10.9 44.4 6.6 8.5 5.4 5.8 35.2 20.2 2.6 2.9 5.3 0.2 3.4 3.3 9.6 76.6 18.3 0.0 0.7 0.0 2.4 0.0 1.8 0.6 0.2 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 93.7 0.0 1.9 0.1 7.8 0.0 0.3 0.0 0.0 0.0 0.5 18.2 0.3 0.1 0.0 0.1 0.4 7.3 0.0 0.0 6.6 0.6 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 77.2 0.0 0.0 0.6 1.0 0.1 20.3 0.0 17.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.6 82.3 20.8 12.3 44.5 40.0 92.9 72.9 35.1 100.1 5.3 SNF8 "Dot3, EAP30, VPS22" ENSG00000159210 "SNF8, ESCRT-II complex subunit" Q96H20 17 48929316-48945117 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059320 Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA059320: " "unprognostic (7.85e-3)" "unprognostic (3.97e-3)" "unprognostic (2.25e-2)" "unprognostic (1.73e-1)" "unprognostic (4.39e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (7.64e-4)" "unprognostic (1.91e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-2)" "unprognostic (5.36e-2)" "prognostic unfavourable (2.81e-7)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.52e-1)" "unprognostic (1.38e-1)" 22.5 27.8 24.9 20.6 26.2 25.2 32.4 12.9 22.6 17.9 23.5 16.6 29.7 22.1 18.9 28.7 23.0 17.7 24.9 31.5 20.1 19.2 30.8 39.0 18.2 27.3 23.9 21.5 22.3 26.7 17.9 17.4 21.7 19.0 17.6 26.8 18.3 25.2 23.1 40.7 19.2 24.0 25.7 18.2 20.7 24.7 19.8 16.0 28.3 24.0 30.9 26.2 20.5 33.8 5.2 8.3 11.2 6.7 1.7 5.7 1.5 16.1 32.4 20.2 25.8 21.1 12.3 32.0 13.6 18.9 26.7 24.1 79.6 16.9 14.9 24.0 25.7 10.8 18.8 19.2 29.9 21.2 30.4 16.4 41.1 33.5 18.5 22.2 18.7 15.2 19.3 25.5 19.7 25.0 16.2 15.1 27.2 32.3 23.8 19.0 9.9 27.7 15.7 36.9 17.5 16.0 18.1 13.4 26.8 16.4 7.7 19.4 19.5 27.5 20.8 29.0 23.1 18.0 25.5 22.2 25.3 17.7 25.5 12.1 22.4 2.3 5.7 11.2 3.2 6.2 1.8 5.2 4.8 3.7 6.4 5.2 3.2 2.7 2.3 1.7 6.7 8.3 5.7 1.5 24.9 26.2 12.9 22.6 20.1 19.2 23.9 21.5 19.0 16.0 SNIP1 PML1 ENSG00000163877 "Smad nuclear interacting protein 1" Q8TAD8 1 37534449-37554344 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036896 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036896: AB_10670244" "unprognostic (1.37e-1)" "unprognostic (2.83e-1)" "unprognostic (1.65e-3)" "unprognostic (7.24e-2)" "unprognostic (5.83e-2)" "unprognostic (8.30e-3)" "unprognostic (3.26e-2)" "unprognostic (3.66e-2)" "unprognostic (7.74e-2)" "unprognostic (5.01e-2)" "unprognostic (9.30e-2)" "unprognostic (5.34e-3)" "unprognostic (3.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" 10.6 13.4 10.6 13.3 12.4 15.9 15.0 18.4 14.4 12.8 10.8 10.0 14.2 8.5 14.2 11.9 13.5 11.9 10.0 8.5 11.1 9.0 9.9 20.6 10.2 11.7 10.8 10.5 12.7 15.3 9.8 13.1 13.2 9.9 13.3 9.0 12.3 11.7 11.5 13.5 13.2 12.3 11.6 7.9 14.9 11.8 21.7 11.6 16.9 10.5 11.1 14.0 11.7 17.0 3.7 4.3 4.6 3.5 3.1 5.5 1.8 6.1 3.5 6.9 6.8 8.3 7.9 4.7 7.9 9.0 7.6 6.7 3.4 5.6 8.5 6.2 8.4 6.5 6.4 7.2 6.3 7.6 9.3 13.1 6.1 6.9 9.5 12.0 7.4 7.6 8.5 7.5 9.6 7.3 9.2 7.9 5.3 4.6 7.1 9.4 11.2 8.1 7.5 11.6 7.1 5.5 5.9 5.6 11.2 8.4 5.5 10.3 4.9 6.6 12.1 6.0 6.7 7.5 7.8 9.4 10.9 7.0 7.1 8.6 5.4 4.1 3.1 3.9 5.5 2.8 5.4 3.7 3.7 5.3 2.6 3.6 5.1 4.5 4.6 3.1 3.5 4.3 4.2 1.8 10.6 12.4 18.4 14.4 11.1 9.0 10.8 10.5 9.9 11.6 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Cell line enriched" "Detected in some" 14 "Hep G2: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA052824 Uncertain Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA052824: " "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.8 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 35.5 0.5 0.0 1.0 0.0 0.8 0.2 0.5 0.9 0.1 0.1 0.1 0.1 0.1 0.3 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.3 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA049393: " "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favourable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.8 0.1 6.9 8.2 4.5 0.0 4.1 5.4 4.6 2.1 0.2 0.7 0.4 2.4 5.0 1.2 1.1 5.8 0.9 1.5 1.9 4.4 1.1 0.1 4.3 0.0 7.1 2.9 2.8 4.7 0.9 5.8 0.8 0.2 4.2 0.0 0.4 0.2 2.4 5.8 0.0 1.4 0.1 6.2 3.2 0.4 2.1 4.0 0.2 5.9 0.4 0.1 10.0 7.5 5.5 6.5 1.2 0.6 1.2 0.0 4.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 50.8;TIME: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favourable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favourable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.2 2.0 3.7 3.5 11.1 4.0 3.5 3.5 5.9 3.8 3.8 2.7 4.7 5.1 2.8 4.4 2.1 4.3 7.5 4.0 5.9 3.5 5.9 3.7 3.1 5.8 6.6 6.6 4.4 5.2 4.3 7.4 50.8 2.6 6.0 3.5 1.7 6.6 5.8 4.1 9.1 4.6 2.7 5.4 9.9 5.6 2.6 5.5 3.0 3.3 4.2 2.2 8.4 29.5 3.4 3.4 3.9 4.1 9.7 6.9 4.4 2.4 7.9 4.8 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: , HPA044248: " "unprognostic (7.87e-2)" "prognostic favourable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favourable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.4 26.1 14.5 16.8 5.2 6.1 7.1 9.7 6.3 21.8 18.5 35.0 11.2 36.4 11.6 7.9 11.8 26.5 17.9 16.8 13.1 20.6 21.1 36.4 35.0 5.5 38.4 25.0 7.8 6.4 19.4 5.4 11.7 31.4 8.7 12.4 54.3 20.1 16.0 17.3 12.7 32.6 15.5 43.4 11.5 8.1 15.9 10.3 22.0 28.5 4.7 18.4 18.7 9.2 9.7 12.1 12.4 15.5 9.0 21.4 56.4 5.1 20.6 14.7 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 SNRNP48 "C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234" ENSG00000168566 "Small nuclear ribonucleoprotein U11/U12 subunit 48" Q6IEG0 6 7590199-7611967 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029234 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029234: AB_10604097" "prognostic unfavourable (8.30e-4)" "unprognostic (3.46e-2)" "unprognostic (2.65e-1)" "unprognostic (9.65e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (9.46e-3)" "unprognostic (2.55e-1)" "unprognostic (9.87e-3)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "prognostic unfavourable (4.16e-4)" "unprognostic (1.55e-1)" "unprognostic (8.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.03e-1)" 9.5 7.1 12.3 11.7 14.9 15.6 12.6 28.9 13.3 10.5 10.3 7.0 13.6 9.9 11.7 8.6 9.4 9.2 7.1 12.2 11.9 7.5 10.7 12.7 8.6 11.7 14.1 8.1 14.4 10.5 7.3 11.0 9.2 11.4 10.5 10.1 5.9 10.1 13.0 15.8 11.0 11.5 10.5 17.8 11.2 9.6 5.3 14.3 15.3 10.4 7.1 10.0 9.9 30.2 3.3 2.7 6.0 2.0 2.7 3.7 1.7 5.7 4.6 9.6 17.9 5.2 7.7 6.5 6.6 6.1 7.1 7.9 9.7 4.7 13.5 7.1 5.4 7.4 11.9 7.0 11.0 10.4 11.6 9.7 14.6 18.7 5.5 11.6 6.5 5.4 10.9 8.0 6.2 6.1 13.6 2.1 9.9 3.2 18.9 16.8 13.0 5.2 20.4 8.3 18.1 6.5 5.1 14.9 4.1 12.7 3.3 11.2 6.4 4.1 6.8 9.5 4.3 5.6 11.2 3.5 19.3 8.3 3.2 9.3 17.0 0.4 2.0 1.0 2.0 1.4 3.4 1.7 2.4 2.6 2.4 3.3 2.1 3.7 6.0 2.7 0.8 2.7 1.7 1.7 12.3 14.9 28.9 13.3 11.9 7.5 14.1 8.1 11.4 14.3 SNRPA1 Lea1 ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: , HPA048499: " "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favourable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 11.9 13.3 12.4 26.1 19.6 35.2 17.7 9.7 17.2 9.9 18.0 10.2 10.4 14.6 14.3 21.1 24.6 12.4 11.8 17.3 17.9 9.8 16.1 19.7 14.1 29.2 11.2 12.2 10.8 16.3 9.1 10.7 29.3 14.1 10.3 19.3 11.3 17.2 9.1 13.4 12.1 22.5 11.7 9.4 26.4 15.9 24.3 7.0 33.4 11.6 18.1 30.0 12.3 12.2 21.7 23.5 8.4 18.2 18.3 26.9 15.3 31.2 21.9 21.1 10.7 6.0 4.9 20.8 29.1 13.5 26.2 20.0 46.7 28.0 34.8 16.7 19.7 18.7 31.5 20.8 28.1 17.6 48.7 27.3 35.6 24.6 4.6 31.2 19.6 4.0 15.6 16.7 21.1 16.8 37.9 32.8 16.0 34.6 31.4 33.2 27.0 18.6 31.4 22.8 35.0 19.1 82.2 16.5 17.3 17.7 20.3 21.9 19.6 24.7 12.1 14.0 26.6 16.3 29.0 27.1 80.2 67.6 11.3 29.5 16.5 1.4 15.0 8.4 24.6 18.2 24.1 21.7 25.4 24.2 23.5 19.1 21.2 26.3 2.9 18.3 16.6 22.3 26.9 15.3 12.4 19.6 9.7 17.2 17.9 9.8 11.2 12.2 14.1 7.0 SNRPB2 "Msl1, U2B''" ENSG00000125870 "Small nuclear ribonucleoprotein polypeptide B2" P08579 20 16729961-16742563 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050814, HPA076104" Supported Enhanced "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA050814: , HPA076104: " "unprognostic (4.73e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (8.45e-2)" "unprognostic (8.36e-2)" "prognostic unfavourable (6.03e-7)" "unprognostic (4.23e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.06e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.14e-2)" "unprognostic (1.77e-1)" 27.1 29.4 30.8 29.9 31.5 46.6 32.4 23.2 33.3 25.1 28.6 18.3 19.5 24.7 33.5 37.9 25.4 28.2 22.8 30.9 31.0 29.7 45.4 30.2 24.7 39.9 28.7 33.0 33.4 21.5 19.7 41.9 35.2 25.5 25.9 28.1 16.9 23.0 25.5 34.7 18.4 30.1 31.8 30.8 36.0 27.0 24.3 28.3 40.8 33.1 31.1 35.7 34.1 22.7 21.2 29.8 29.0 24.5 19.8 30.6 18.1 17.8 17.6 23.2 14.4 11.6 14.7 25.9 17.7 14.8 19.3 19.0 20.2 20.3 28.7 13.9 15.1 16.8 18.2 20.6 27.7 9.4 15.3 26.5 5.8 37.1 13.6 30.9 18.3 14.5 13.8 17.6 13.8 18.1 21.8 13.1 19.6 18.6 35.4 37.5 20.6 23.7 20.3 27.9 20.1 18.7 12.2 12.3 35.3 13.1 36.2 87.1 22.9 25.3 15.3 17.7 17.6 15.8 29.1 11.6 23.7 32.1 8.4 18.4 38.2 26.5 19.5 29.0 19.3 24.3 24.8 21.2 24.5 21.8 20.5 19.6 21.5 23.5 8.4 19.8 24.5 29.8 30.6 18.1 30.8 31.5 23.2 33.3 31.0 29.7 28.7 33.0 25.5 28.3 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555503-24609980 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 23.7 31.8 23.8 28.9 23.3 29.7 29.5 27.1 27.4 29.3 38.3 24.7 29.8 27.9 31.6 30.6 41.8 30.8 27.1 31.6 21.8 24.2 38.5 61.6 26.5 36.4 24.3 26.8 33.9 34.0 27.8 31.8 33.3 22.6 27.8 33.1 27.9 42.9 27.3 59.0 26.7 35.5 29.6 25.5 32.3 27.8 22.4 23.1 46.8 39.2 61.0 42.7 27.1 30.2 42.5 39.0 38.1 34.9 36.6 33.2 29.8 40.7 14.0 44.0 15.9 16.5 14.2 16.6 39.8 18.3 39.7 37.0 19.9 15.8 36.4 18.8 24.9 30.8 55.8 48.8 40.5 27.7 57.0 39.1 28.2 30.0 18.0 96.4 24.6 16.3 22.7 43.0 22.6 28.9 26.8 18.5 16.2 20.8 41.0 24.0 24.3 20.2 39.5 46.0 18.9 35.4 31.7 20.6 22.9 25.5 16.7 21.2 25.1 26.2 30.4 33.1 33.3 16.6 29.4 19.1 36.9 66.9 16.3 33.2 22.3 12.2 31.4 38.1 28.2 34.9 31.3 42.5 30.7 30.6 39.0 36.3 29.4 33.2 15.7 36.6 34.7 37.1 28.9 29.8 23.8 23.3 27.1 27.4 21.8 24.2 24.3 26.8 22.6 23.1 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavourable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 30.5 23.4 20.3 24.0 24.8 59.5 28.3 32.1 26.2 26.1 27.6 29.6 21.5 24.6 32.5 24.3 29.1 25.4 20.5 26.3 20.6 18.3 23.5 25.3 24.8 31.5 23.9 26.7 32.1 26.5 19.8 31.6 32.3 26.8 29.8 24.9 22.3 23.4 17.6 41.8 33.3 30.7 30.8 23.7 32.3 24.2 36.3 24.3 37.5 34.1 24.2 30.4 33.0 25.0 32.5 38.2 47.8 44.1 47.6 47.1 35.5 39.4 29.2 30.0 31.8 24.8 27.9 34.9 27.1 23.9 29.9 27.6 29.0 36.2 38.5 24.9 20.2 38.9 36.0 25.8 40.7 30.6 28.5 31.1 26.4 29.0 35.6 21.7 36.9 21.4 34.5 27.1 37.4 29.0 44.5 29.0 22.8 40.4 38.7 37.0 33.6 39.4 41.9 38.8 26.4 27.7 36.6 32.3 35.0 37.4 33.1 37.3 47.4 41.8 30.6 32.8 37.6 29.5 32.4 28.7 40.6 42.9 29.8 35.1 36.2 42.0 38.0 47.8 32.1 40.6 36.0 30.9 36.2 36.3 38.2 32.5 38.3 36.0 36.1 47.6 44.1 22.7 47.1 35.5 20.3 24.8 32.1 26.2 20.6 18.3 23.9 26.7 26.8 24.3 SNX1 "HsT17379, MGC8664, SNX1A, Vps5" ENSG00000028528 "Sorting nexin 1" Q13596 15 64094123-64146090 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047373, HPA052761" Approved Enhanced Endosomes,Lysosomes "Endosomes, Lysosomes" "HPA047373: AB_2680018, HPA052761: AB_2681939" "unprognostic (3.99e-2)" "unprognostic (8.65e-3)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (7.13e-2)" "unprognostic (2.73e-1)" "unprognostic (7.15e-2)" "unprognostic (6.49e-3)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.47e-2)" "unprognostic (3.26e-1)" "prognostic favourable (9.88e-6)" "unprognostic (2.27e-1)" "unprognostic (3.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.95e-1)" 30.6 47.3 22.4 27.4 31.2 16.8 36.3 17.7 25.3 32.4 30.3 46.9 44.7 26.0 30.8 39.2 38.7 21.2 23.5 30.9 24.8 20.1 30.6 38.6 33.7 31.3 40.1 23.5 25.0 31.2 43.0 22.2 31.1 30.3 31.0 27.1 22.5 30.8 48.4 40.9 29.1 26.3 30.4 54.1 37.5 30.2 17.7 35.9 32.9 80.8 18.5 35.9 32.3 31.7 34.5 42.3 51.9 50.6 30.7 30.6 43.9 19.0 25.4 22.0 18.7 39.0 29.2 7.1 26.3 31.1 28.1 33.2 17.2 34.7 22.9 27.1 27.6 29.9 34.8 31.5 23.5 37.0 15.4 26.3 29.9 24.7 21.3 26.5 30.1 32.9 20.3 21.9 17.1 28.9 20.8 9.0 29.0 28.4 28.2 22.5 14.9 15.0 25.6 20.3 32.2 43.3 45.9 17.8 17.0 23.4 18.0 22.8 25.8 24.6 28.7 24.5 33.1 15.6 15.1 23.9 60.4 32.4 19.6 36.4 25.3 41.5 50.6 51.9 29.7 47.2 25.0 32.0 25.4 28.9 42.3 34.5 24.7 24.0 38.1 30.7 43.5 28.4 30.6 43.9 22.4 31.2 17.7 25.3 24.8 20.1 40.1 23.5 30.3 35.9 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: " "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.6 1.2 0.0 2.6 0.0 0.0 14.9 0.0 1.0 0.0 0.0 0.1 4.6 6.0 10.7 0.0 0.4 3.4 0.9 0.0 8.2 3.2 0.6 0.1 9.0 0.0 12.7 2.3 0.1 1.4 0.0 1.1 0.2 0.3 0.0 0.0 2.4 5.3 13.4 3.9 1.3 0.0 0.0 0.3 26.6 2.9 5.8 1.8 2.9 2.2 15.5 3.9 18.2 0.0 0.0 3.2 0.0 3.4 4.6 3.7 4.0 0.1 21.8 75.8 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027408-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.9 13.6 17.1 12.7 18.3 11.6 23.5 25.7 21.9 13.2 22.7 16.7 9.5 19.7 14.2 8.9 15.9 11.4 13.9 15.1 16.2 14.3 15.7 9.8 14.1 14.7 16.3 14.5 18.3 17.7 13.7 8.4 9.5 13.4 15.1 11.6 11.2 15.6 15.4 25.2 17.2 20.4 15.0 17.6 11.3 13.5 7.6 15.8 12.4 14.4 10.1 11.5 14.9 12.5 7.7 8.0 10.9 18.3 3.2 7.1 5.7 17.4 12.9 8.4 8.2 10.1 7.5 4.7 1.7 7.9 13.8 12.7 10.1 13.7 17.8 9.9 9.9 9.8 9.8 8.7 3.8 26.7 8.1 8.9 10.6 16.9 11.0 4.6 14.4 6.3 13.0 14.6 8.4 8.2 15.0 11.4 7.2 10.5 16.3 20.7 9.0 12.8 13.5 5.0 19.1 10.2 3.8 15.2 11.4 14.9 13.5 12.9 13.6 10.7 16.1 14.0 13.4 14.1 7.4 12.3 21.0 17.0 13.7 7.3 4.8 7.8 11.3 10.9 6.9 13.6 5.6 7.7 7.1 6.1 8.0 6.1 5.2 4.7 1.6 3.2 18.3 5.5 6.7 5.7 17.1 18.3 25.7 21.9 16.2 14.3 16.3 14.5 13.4 15.8 SNX2 ENSG00000205302 "Sorting nexin 2" O60749 5 122774996-122830108 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037400 Approved Supported Endosomes,Lysosomes 39000000 "Endosomes, Lysosomes" "HPA037400: AB_10670381" "unprognostic (9.26e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (7.90e-6)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "prognostic favourable (8.76e-7)" "unprognostic (8.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" 32.1 28.0 27.7 36.0 27.7 22.1 52.1 30.4 24.7 22.0 24.1 14.1 34.0 20.4 24.7 36.6 25.3 24.9 22.0 33.3 27.2 17.4 38.5 30.1 39.5 58.9 27.2 23.2 33.1 26.2 24.7 29.8 34.7 26.0 23.3 24.5 12.4 27.7 29.7 20.9 23.4 27.4 35.8 27.7 45.8 27.0 14.5 28.1 16.0 40.4 21.2 34.6 30.3 30.4 84.6 34.5 30.5 43.5 9.6 16.5 32.1 16.3 13.1 17.3 13.5 39.2 23.9 73.4 13.3 20.7 15.6 22.8 22.9 23.8 21.1 32.9 15.2 5.6 36.3 24.2 23.2 20.8 21.7 21.4 13.0 15.6 26.4 9.3 16.0 22.4 18.6 16.3 23.5 17.1 10.9 15.6 16.7 14.8 7.7 12.5 10.8 15.5 33.3 17.3 23.7 23.3 26.7 13.9 10.5 15.5 18.0 21.5 22.7 22.5 19.3 13.9 12.5 19.9 15.1 11.7 14.5 23.0 18.4 34.3 16.6 30.5 43.3 26.7 8.7 43.5 10.0 84.6 11.9 10.4 34.5 84.4 11.8 9.9 15.2 9.6 42.7 10.2 16.5 32.1 27.7 27.7 30.4 24.7 27.2 17.4 27.2 23.2 26.0 28.1 SNX21 "C20orf161, dJ337O18.4, SNX-L" ENSG00000124104 "Sorting nexin family member 21" Q969T3 20 45833810-45843275 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 16.1;PC-3: 19.6;U-87 MG: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.9;classical monocyte: 2.9;eosinophil: 7.3;intermediate monocyte: 5.0;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 6 "granulocytes: 7.3;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046359 Approved Approved "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA046359: AB_10963216" "unprognostic (1.97e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.24e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (4.96e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-2)" "unprognostic (2.18e-1)" 25.4 21.0 10.0 4.4 9.8 1.9 14.1 10.3 18.3 18.8 8.4 8.6 10.3 10.0 17.6 13.8 11.3 14.3 15.3 9.1 7.5 6.4 8.9 5.2 9.5 2.7 7.9 7.5 19.1 4.2 5.5 6.9 6.9 8.8 14.1 2.9 13.6 10.2 11.2 43.4 35.2 6.1 19.8 7.6 6.6 9.3 7.2 6.4 0.0 6.0 14.9 3.7 15.4 12.0 0.2 0.3 7.3 5.0 0.0 1.0 0.7 3.6 4.6 0.8 6.6 3.8 3.4 3.2 4.7 4.2 5.1 3.9 3.4 2.8 0.0 16.1 4.7 4.7 0.1 3.7 0.5 0.4 0.6 0.1 2.3 3.2 2.9 0.0 1.1 2.5 2.1 4.5 0.2 3.1 0.0 0.0 1.7 9.0 0.0 0.3 1.2 19.6 0.0 0.6 0.0 1.6 0.6 0.8 7.3 10.6 10.0 5.6 6.5 0.9 3.4 7.5 5.8 14.0 4.2 0.0 0.5 0.2 17.8 0.0 4.0 3.9 2.9 7.3 0.0 5.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 3.3 0.1 1.0 0.7 10.0 9.8 10.3 18.3 7.5 6.4 7.9 7.5 8.8 6.4 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell line enriched" "Detected in some" 4 "Daudi: 19.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038470: AB_10673174" "prognostic favourable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.5 0.5 0.1 0.4 1.7 0.0 0.0 0.1 2.3 0.3 2.2 2.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 3.3 0.0 1.1 0.2 0.0 1.3 0.3 4.0 0.3 1.2 0.8 0.8 4.5 0.9 0.2 0.7 0.0 1.9 0.0 0.0 1.1 1.4 0.2 0.5 4.2 1.7 4.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 SNX27 "KIAA0488, MGC20471, MY014" ENSG00000143376 "Sorting nexin family member 27" Q96L92 1 151612006-151699091 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045816 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045816: " "unprognostic (3.35e-1)" "unprognostic (4.76e-1)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (2.79e-2)" "unprognostic (3.42e-1)" "unprognostic (2.41e-2)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (5.92e-2)" "unprognostic (1.63e-1)" "unprognostic (5.45e-2)" "unprognostic (2.81e-1)" "unprognostic (4.15e-1)" "unprognostic (7.30e-2)" "unprognostic (1.04e-1)" 10.9 12.5 21.5 12.5 28.6 13.4 12.6 25.0 27.7 14.8 15.9 23.4 13.5 9.1 12.1 16.2 12.1 13.9 11.5 12.1 23.0 21.3 24.2 12.8 13.6 10.4 23.7 19.2 17.2 10.0 26.0 14.8 17.5 20.3 14.8 13.0 13.1 9.7 20.6 25.6 16.0 10.1 21.3 23.1 17.0 11.2 12.8 18.7 8.8 12.8 7.7 10.8 17.4 21.7 2.5 8.4 20.3 18.6 1.7 3.6 7.3 5.8 8.7 9.3 11.7 14.7 10.9 20.7 3.2 6.6 5.6 6.0 7.1 7.8 5.6 6.9 5.1 7.3 11.9 6.4 7.1 7.9 4.5 8.9 5.1 7.9 9.8 10.6 6.1 8.6 4.8 6.4 7.4 6.3 5.4 34.5 7.3 10.5 6.3 7.3 16.4 5.6 6.6 9.0 7.2 8.7 8.9 9.3 8.0 8.5 15.9 6.1 10.2 9.0 8.3 8.0 5.4 8.3 6.6 7.2 7.3 11.3 9.5 6.9 8.9 9.5 18.6 2.6 2.6 16.1 3.6 1.8 3.2 2.3 8.4 2.5 3.1 2.5 20.3 1.7 16.9 2.1 2.5 7.3 21.5 28.6 25.0 24.6 23.0 21.3 23.7 19.2 20.3 18.7 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.7 6.5 5.1 8.2 7.5 5.5 5.2 10.8 4.4 4.2 13.3 1.4 10.0 4.4 13.3 7.2 7.9 3.0 6.8 3.2 3.7 3.0 3.4 5.4 5.9 3.1 5.5 6.1 4.3 6.7 5.0 3.7 4.8 5.7 5.9 4.2 2.0 3.6 7.2 4.0 4.3 15.2 2.5 8.5 10.5 9.7 3.1 6.7 9.3 12.9 6.9 5.5 4.2 6.5 7.0 19.1 4.4 14.9 13.7 4.8 8.4 2.9 12.7 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell line enriched" "Detected in single" 50 "RT4: 41.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Group enriched" "Detected in some" 4 "basal ganglia: 0.8;olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: " "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favourable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell line enhanced" "Detected in some" "HHSteC: 6.0;HSkMC: 7.8;REH: 2.5;SH-SY5Y: 3.0;U-266/70: 9.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.6 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 2.5 0.0 2.2 0.1 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.1 1.5 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 SNX5 ENSG00000089006 "Sorting nexin 5" Q9Y5X3 20 17941597-17968980 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020679, HPA051187, HPA076450" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB020679: , HPA051187: , HPA076450: " "unprognostic (6.00e-2)" "unprognostic (2.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.00e-2)" "unprognostic (4.47e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (2.30e-10)" "unprognostic (1.67e-1)" "unprognostic (6.19e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.15e-2)" "unprognostic (6.50e-2)" "unprognostic (3.48e-2)" "unprognostic (2.99e-1)" 23.0 30.7 19.0 29.1 19.7 26.5 20.6 12.8 17.8 17.4 21.1 16.4 16.3 27.3 17.9 40.9 18.5 17.0 17.3 20.0 17.2 14.0 35.9 30.3 18.7 43.8 20.4 14.8 29.4 18.7 17.7 15.4 24.4 15.6 17.6 22.9 17.8 18.1 14.8 34.9 14.5 23.6 14.0 21.8 46.4 18.2 9.8 17.8 25.6 64.4 19.6 27.3 20.5 19.0 32.8 28.8 33.4 34.5 15.2 26.7 19.5 18.4 20.2 8.6 9.4 6.1 10.6 51.6 14.8 8.3 9.5 10.9 19.5 26.2 30.6 9.2 9.3 20.8 12.0 23.2 13.0 7.7 10.7 27.2 8.3 115.7 9.5 19.0 32.8 10.0 10.3 10.3 18.8 13.7 13.1 20.7 11.4 14.4 16.7 16.8 9.2 10.1 19.9 21.9 22.8 11.7 21.5 8.6 4.9 14.1 21.7 19.0 11.8 12.4 10.8 15.1 18.7 9.3 18.5 14.7 22.3 24.8 7.4 6.9 13.1 23.5 23.5 33.4 23.8 32.0 21.6 32.8 21.8 23.2 28.8 30.5 13.2 19.2 1.9 15.2 34.5 14.8 26.7 19.5 19.0 19.7 12.8 17.8 17.2 14.0 20.4 14.8 15.6 17.8 SNX6 ENSG00000129515 "Sorting nexin 6" Q9UNH7 14 34561094-34630183 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049374 Approved Supported Endosomes,Lysosomes "Endosomes, Lysosomes" "HPA049374: " "unprognostic (1.89e-1)" "unprognostic (6.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.06e-2)" "unprognostic (1.12e-1)" "unprognostic (2.36e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.23e-1)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (4.68e-4)" "unprognostic (1.91e-1)" "unprognostic (3.48e-2)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" 35.7 27.0 26.7 23.0 23.2 16.3 29.4 19.0 21.5 20.8 28.1 30.7 17.7 37.0 37.9 18.0 24.9 16.3 21.6 19.0 28.3 22.0 30.4 18.6 17.6 33.5 33.7 18.1 20.7 15.5 61.1 19.1 46.2 26.7 22.3 24.3 14.7 20.1 18.6 20.3 18.3 38.4 23.2 50.9 33.6 20.8 23.1 23.3 28.5 21.5 19.6 21.9 28.5 22.5 30.5 29.4 56.0 43.1 29.8 43.9 45.2 31.7 18.0 21.0 13.6 32.7 67.4 29.5 31.4 34.8 32.4 28.4 17.3 39.7 20.6 26.3 41.2 22.5 22.2 23.2 56.7 25.2 8.9 12.4 11.0 31.6 28.1 21.8 15.5 43.3 25.6 22.1 32.2 44.0 13.3 17.1 43.3 18.3 19.6 10.7 11.4 21.6 21.0 24.3 20.8 41.3 24.3 16.5 17.8 25.3 22.0 26.3 28.4 14.2 43.2 23.3 16.6 22.5 20.1 15.8 25.7 23.4 12.7 12.0 25.9 26.7 32.8 39.5 32.3 43.1 41.7 30.5 43.9 37.4 29.4 27.0 33.6 36.0 56.0 29.8 39.7 19.3 42.7 45.2 26.7 23.2 19.0 21.5 28.3 22.0 33.7 18.1 26.7 23.3 SNX7 ENSG00000162627 "Sorting nexin 7" Q9UNH6 1 98661701-98760500 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037419, HPA054338" Enhanced Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA037419: AB_10671754, HPA054338: " "unprognostic (3.19e-1)" "unprognostic (2.18e-1)" "prognostic favourable (5.10e-5)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (9.59e-7)" "unprognostic (1.53e-2)" "unprognostic (2.64e-1)" "unprognostic (1.41e-2)" "unprognostic (1.19e-3)" "unprognostic (1.88e-1)" "unprognostic (7.95e-3)" "unprognostic (1.68e-1)" "unprognostic (1.45e-1)" "unprognostic (8.65e-2)" "unprognostic (1.77e-1)" 19.2 13.6 12.0 8.2 11.3 0.2 22.4 3.1 9.8 18.6 24.7 9.7 12.5 19.4 18.7 18.7 17.7 13.5 15.4 18.0 12.0 15.6 22.1 13.0 9.6 4.7 13.6 9.3 13.8 13.7 14.7 13.2 13.9 15.6 17.7 25.4 6.6 15.0 14.8 5.8 11.5 27.2 21.8 17.3 6.4 13.9 14.7 12.7 2.0 13.9 10.3 7.4 18.7 21.9 0.6 0.3 0.0 1.4 0.0 0.3 0.3 16.1 8.7 5.3 7.2 18.9 30.0 3.0 10.3 18.8 15.5 20.2 5.0 6.1 0.0 13.4 25.2 4.7 5.6 14.6 15.5 0.0 10.7 0.0 13.9 8.7 11.2 0.0 0.0 15.0 15.7 12.7 5.6 21.5 0.0 0.0 24.4 3.3 0.1 0.0 5.1 12.6 0.0 11.9 0.0 15.4 13.0 2.6 31.7 13.7 13.0 7.4 0.0 0.5 14.7 15.2 8.5 11.7 20.7 0.0 0.0 0.0 21.5 0.0 7.3 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 12.0 11.3 3.1 9.8 12.0 15.6 13.6 9.3 15.6 12.7 SNX9 "SDP1, SH3PX1, SH3PXD3A" ENSG00000130340 "Sorting nexin 9" Q9Y5X1 6 157700387-157945077 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031410, HPA057203" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA031410: AB_10603339, HPA057203: " "unprognostic (1.63e-3)" "prognostic unfavourable (5.95e-4)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (8.09e-2)" "unprognostic (1.40e-2)" "unprognostic (4.06e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (7.93e-2)" "unprognostic (4.99e-3)" "unprognostic (4.45e-2)" "unprognostic (2.42e-1)" "prognostic favourable (9.95e-4)" "unprognostic (2.14e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" 44.7 18.9 13.0 16.5 14.7 17.2 35.4 6.7 16.2 27.4 24.6 19.8 43.5 18.1 32.1 19.5 31.4 17.2 26.4 20.4 12.2 10.8 17.8 25.4 14.6 22.5 19.7 11.4 19.8 22.5 17.7 10.8 45.0 13.3 25.0 17.7 11.1 25.2 41.7 16.5 21.2 28.0 44.6 16.4 19.8 21.5 10.9 18.4 5.0 18.4 17.9 20.3 34.0 40.2 4.1 11.2 1.3 7.3 0.5 6.7 1.0 7.8 5.1 5.5 6.4 27.4 24.4 11.6 15.7 44.3 10.7 14.4 4.5 8.0 0.0 7.8 24.3 5.2 6.4 10.5 9.0 6.4 7.5 4.9 7.9 6.8 13.7 2.6 10.0 14.4 9.4 11.0 10.8 14.8 24.9 0.0 5.2 4.4 0.0 3.9 4.3 6.7 0.0 5.5 8.9 17.3 4.6 3.5 6.4 10.0 4.6 24.0 2.2 5.6 12.0 11.9 5.4 38.0 8.3 0.0 0.0 0.0 23.8 2.0 6.9 0.0 1.0 1.3 0.6 3.2 2.4 4.1 1.7 1.3 2.0 3.4 6.7 2.1 0.1 0.5 7.3 11.2 2.8 1.0 13.0 14.7 6.7 16.2 12.2 10.8 19.7 11.4 13.3 18.4 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107489958-107660167 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 10.8;AN3-CA: 14.0;ASC diff: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.0;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 14 "B-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favourable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 7.6 12.0 19.3 4.4 15.6 1.3 3.6 15.1 30.2 12.7 12.8 11.0 2.5 3.7 9.0 5.5 5.6 6.2 7.6 17.0 18.0 12.4 5.8 3.6 5.0 2.9 12.5 14.9 21.6 3.9 10.9 12.0 6.1 9.6 13.0 4.2 7.4 21.1 7.0 22.1 1.5 3.4 14.3 9.6 4.7 5.6 9.1 11.1 1.0 6.1 4.1 3.3 14.8 8.0 4.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 10.8 14.0 13.2 5.1 1.2 0.0 0.0 0.3 0.6 0.0 0.0 5.7 0.4 0.0 0.0 7.2 0.2 0.2 9.1 6.8 0.7 0.0 6.7 1.7 2.9 0.6 5.3 0.0 5.2 0.0 4.3 0.0 0.3 0.0 2.8 1.3 0.3 2.5 0.9 3.2 1.3 0.0 0.0 0.2 3.5 5.8 1.3 0.0 0.1 0.4 2.0 0.1 3.4 1.2 5.9 0.5 2.7 0.5 3.7 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.2 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 19.3 15.6 15.1 20.6 18.0 12.4 12.5 14.9 9.6 11.1 SOCS1 "Cish1, JAB, SOCS-1, SSI-1, TIP3" ENSG00000185338 "Suppressor of cytokine signaling 1" O15524 16 11254405-11256200 "Cancer-related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.3;lymphoid tissue: 58.3" "Cell line enriched" "Detected in some" 5 "HDLM-2: 47.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 15.2" "Cell type enhanced" "Detected in many" "basophil: 12.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010355, HPA074108" Approved Supported "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "CAB010355: AB_2193144, HPA074108: " "unprognostic (4.50e-3)" "unprognostic (3.30e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-2)" "unprognostic (1.25e-2)" "prognostic favourable (1.10e-4)" "unprognostic (1.71e-2)" "unprognostic (4.09e-3)" "unprognostic (5.31e-3)" "unprognostic (4.82e-2)" "unprognostic (1.17e-1)" "unprognostic (5.39e-2)" "prognostic unfavourable (1.08e-6)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (6.08e-2)" "unprognostic (1.67e-1)" 10.9 2.8 0.7 19.2 1.5 13.9 37.9 15.2 1.1 15.8 6.3 0.3 2.2 3.3 4.9 7.6 5.6 4.2 11.0 3.6 0.6 1.0 11.1 42.3 9.6 25.8 0.8 0.0 9.3 3.8 0.7 16.8 9.3 2.4 5.3 1.8 3.2 3.7 3.9 2.3 6.0 11.0 6.5 1.1 14.7 6.6 7.1 0.4 58.3 5.1 4.8 14.7 5.4 8.3 4.4 1.3 12.9 0.1 5.5 2.7 0.4 1.2 0.2 0.5 0.1 1.6 0.2 1.8 1.0 7.3 0.4 0.6 0.3 0.2 2.8 2.2 0.4 0.5 0.2 0.1 0.1 47.2 0.3 0.7 0.0 3.8 0.6 0.0 8.7 0.6 0.1 1.0 0.0 0.1 6.3 0.8 0.0 1.1 3.1 1.8 5.3 0.8 0.3 0.3 0.3 0.5 0.2 0.7 0.1 0.2 1.7 0.5 0.0 0.4 0.0 0.6 3.1 0.4 0.6 0.2 0.2 4.4 1.2 0.3 0.6 12.9 0.1 8.8 2.2 0.0 2.0 1.4 2.5 2.7 0.0 4.4 2.7 2.5 0.3 5.5 0.0 1.3 2.6 0.4 0.7 1.5 15.2 0.6 0.6 1.0 0.8 0.0 2.4 0.4 SOCS3 "CIS3, Cish3, SOCS-3, SSI-3" ENSG00000184557 "Suppressor of cytokine signaling 3" O14543 17 78356778-78360077 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9;HSkMC: 24.9;U-266/70: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 11.6" "Group enriched" "Detected in many" 6 "granulocytes: 11.6;T-cells: 4.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB012220, HPA068569" Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB012220: AB_443287, HPA068569: " "prognostic favourable (4.80e-4)" "unprognostic (2.67e-1)" "unprognostic (5.05e-2)" "unprognostic (1.64e-3)" "unprognostic (4.41e-3)" "unprognostic (2.48e-3)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (9.61e-3)" "unprognostic (1.84e-1)" "unprognostic (2.00e-2)" "prognostic unfavourable (9.34e-9)" "unprognostic (1.08e-2)" "unprognostic (8.80e-2)" "unprognostic (7.59e-3)" "unprognostic (8.40e-2)" 94.9 16.8 6.3 42.5 21.4 33.9 25.7 3.0 12.8 27.6 26.6 5.6 1.9 6.2 13.9 9.2 22.7 88.0 59.6 23.5 11.4 5.1 13.5 30.4 52.1 30.2 13.9 0.1 31.2 14.5 13.9 13.4 23.5 38.0 20.8 9.2 10.3 9.2 6.7 26.0 12.1 15.6 39.0 29.6 36.7 32.2 12.1 8.7 5.6 14.2 40.9 10.3 38.1 41.1 0.0 1.3 11.6 1.3 0.4 4.3 0.6 2.0 3.3 2.4 1.2 0.9 15.2 6.3 10.2 9.3 10.7 4.5 2.1 1.4 0.0 2.2 2.4 0.6 0.5 1.0 4.2 48.9 0.3 1.8 7.2 0.4 4.9 0.0 0.9 24.9 0.8 8.3 3.1 4.6 5.4 19.2 4.9 1.0 1.0 0.3 1.7 4.2 0.0 12.2 0.3 17.0 2.0 0.1 1.5 3.1 0.8 0.4 0.9 0.4 2.7 21.1 6.0 7.3 5.9 25.3 14.2 0.0 17.3 0.2 1.3 0.0 1.3 0.3 1.0 0.1 2.6 0.0 2.8 1.2 1.3 0.0 4.3 0.8 11.6 0.4 0.0 1.2 1.6 0.6 6.3 21.4 3.0 12.8 11.4 5.1 13.9 0.1 38.0 8.7 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049488 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: " "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 14.5 11.1 12.5 16.0 21.2 12.7 12.2 12.6 19.1 11.4 12.0 14.0 8.7 11.1 13.6 9.3 13.2 13.9 15.0 13.9 15.5 10.9 17.6 10.6 16.7 18.0 22.6 10.5 12.6 10.2 12.8 18.5 12.4 17.0 11.7 12.8 7.2 11.9 10.3 12.3 10.5 13.2 17.5 29.6 16.4 15.1 9.5 19.6 16.2 15.3 6.5 16.0 16.1 18.9 3.8 4.1 4.5 5.8 6.0 4.9 2.0 10.7 9.3 12.7 14.8 8.4 9.7 10.1 12.6 9.3 8.0 13.2 7.6 11.6 16.2 8.9 9.4 15.1 17.2 10.2 18.8 16.6 7.0 9.6 12.1 4.5 8.6 11.0 17.0 7.7 10.6 14.4 10.6 14.4 5.7 16.3 14.6 10.7 16.4 8.0 10.0 10.1 15.2 19.8 6.2 11.4 11.9 16.9 14.5 12.7 7.7 12.0 10.7 8.1 14.7 20.6 20.9 10.1 10.7 5.9 6.2 15.7 13.3 8.9 15.8 1.7 4.2 4.5 3.2 4.9 4.9 3.0 4.0 3.0 3.1 3.8 2.2 2.4 2.6 6.0 5.8 4.1 3.6 2.0 12.5 21.2 12.6 19.1 15.5 10.9 22.6 10.5 17.0 19.6 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 44.9;fHDF/TERT166: 43.7;U-138 MG: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavourable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.1 3.9 3.4 5.0 11.0 15.9 4.2 24.2 44.9 11.9 7.0 3.7 2.5 2.6 4.7 43.7 2.5 3.7 3.8 15.2 2.6 3.4 4.1 3.7 4.4 6.8 2.4 4.6 12.6 5.8 10.1 4.0 4.0 3.6 2.9 7.5 1.8 2.1 3.9 3.8 3.2 2.7 5.8 3.3 4.8 3.9 2.7 7.4 5.9 3.9 4.6 1.6 3.4 4.5 29.7 6.6 9.8 4.7 3.6 2.2 2.2 13.5 4.7 9.2 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 SOCS6 "CIS4, Cish4, HSPC060, SOCS4, SSI4, STAI4, STATI4" ENSG00000170677 "Suppressor of cytokine signaling 6" O14544 18 70288901-70330200 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.0;myeloid DC: 6.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" CAB010189 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB010189: AB_661195" "unprognostic (1.76e-3)" "unprognostic (6.83e-3)" "unprognostic (8.90e-3)" "unprognostic (4.52e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.07e-1)" "unprognostic (7.93e-2)" "unprognostic (5.83e-2)" "unprognostic (1.75e-1)" "unprognostic (6.90e-2)" "unprognostic (8.19e-2)" "prognostic favourable (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (4.11e-2)" "unprognostic (1.80e-2)" 9.1 8.8 12.7 5.1 16.3 10.2 12.8 13.8 11.6 15.0 14.6 20.1 9.8 14.1 12.9 6.7 17.7 11.8 12.6 9.8 12.8 7.8 8.9 26.1 8.8 2.8 21.4 10.1 10.6 12.4 18.1 7.2 21.1 14.9 8.7 13.5 14.3 17.3 7.8 17.7 8.4 20.4 13.3 20.3 4.2 12.7 6.1 18.0 2.5 10.8 10.3 7.5 10.6 11.8 0.5 6.3 4.6 6.0 1.5 1.1 1.7 10.1 22.5 9.6 6.6 9.1 10.8 10.8 22.0 13.5 13.4 10.1 8.4 17.3 1.1 2.0 20.4 12.1 7.0 7.1 13.1 0.0 4.2 7.6 8.0 12.9 10.9 4.1 8.7 8.7 8.6 11.6 9.8 6.7 4.5 5.3 9.1 4.9 3.6 3.1 6.2 9.7 4.2 9.3 1.9 8.2 8.4 4.4 11.1 11.3 12.6 10.2 3.7 7.3 8.2 14.8 7.5 3.0 8.8 0.0 0.0 2.8 16.5 0.3 9.9 0.0 6.0 4.6 0.4 1.2 0.2 0.5 0.8 0.1 6.3 0.0 1.1 0.6 0.0 1.5 0.1 0.6 0.0 1.7 12.7 16.3 13.8 11.6 12.8 7.8 21.4 10.1 14.9 18.0 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 55.6 48.7 34.2 34.2 45.8 31.9 28.4 47.0 28.1 32.0 24.2 63.1 35.4 66.7 49.5 43.3 20.2 49.0 34.6 26.4 49.2 60.9 107.6 63.9 90.2 30.3 47.5 40.3 33.1 26.4 44.8 24.9 35.9 74.2 85.3 38.5 90.4 51.0 47.9 51.4 52.0 43.9 69.0 103.7 62.5 34.2 37.4 31.4 87.1 46.1 45.2 53.0 42.0 42.0 24.9 55.1 33.6 34.6 65.2 141.0 79.0 50.8 69.3 33.0 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" "Nucleoli, Cytosol" "HPA043992: " "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavourable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.4 10.2 12.4 13.3 7.2 6.6 3.2 6.6 7.1 9.3 5.6 4.1 1.2 3.3 2.4 11.5 10.1 9.9 6.1 9.8 0.5 1.9 5.3 9.5 5.4 3.8 1.2 5.2 3.7 7.5 8.9 6.4 6.1 3.7 0.7 10.2 7.2 3.7 2.8 3.1 7.9 8.9 11.5 1.2 5.5 2.2 14.8 9.2 13.6 15.0 4.3 19.1 8.0 9.2 23.5 4.6 11.5 14.3 1.4 0.3 3.3 10.0 1.6 14.8 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Cell line enhanced" "Detected in some" "AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035388: , HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.4 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.3 0.2 0.3 0.4 0.2 0.1 0.0 0.8 0.0 0.6 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.6 0.0 0.0 0.3 0.2 0.5 0.5 4.8 0.0 3.3 0.8 0.4 1.8 0.0 0.1 0.0 23.9 13.7 0.0 0.0 0.1 0.0 0.3 0.2 5.9 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.8 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 126.5" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;HMC-1: 26.0;SK-MEL-30: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.6;eosinophil: 2.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, HPA043084" Enhanced Supported "Focal adhesion sites,Centrosome" "Focal adhesion sites" Centrosome "HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favourable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 95.0 6.4 23.0 16.4 21.6 1.8 23.5 16.8 22.5 14.9 70.2 18.7 22.1 8.1 41.8 12.5 45.0 25.1 28.9 83.7 20.9 8.3 5.9 14.7 8.7 1.4 13.4 14.1 9.8 7.3 17.5 3.5 9.9 19.2 42.0 20.0 6.4 7.2 65.7 46.4 6.3 15.5 126.5 20.6 2.9 40.0 5.5 19.3 0.0 4.0 12.7 1.2 63.9 31.4 0.1 0.0 7.6 1.2 0.6 1.0 0.2 0.7 0.6 6.3 1.6 2.3 0.1 0.9 0.2 0.0 0.2 0.0 14.9 5.6 0.0 1.2 0.1 0.3 1.1 0.2 0.1 1.7 2.3 3.6 0.2 8.9 0.8 0.0 26.0 0.4 0.2 0.3 0.1 2.6 5.9 1.2 0.6 0.4 0.0 0.3 2.9 1.4 0.5 2.1 0.2 7.0 9.8 2.7 2.0 0.9 0.3 22.3 1.2 0.2 0.2 0.0 2.2 0.1 1.2 0.8 0.2 0.1 2.7 0.2 6.3 7.6 0.2 2.2 0.7 1.2 1.0 0.1 0.3 0.4 0.0 0.1 0.3 0.1 0.2 0.6 0.2 0.0 0.5 0.2 23.0 21.6 16.8 20.7 20.9 8.3 13.4 14.1 19.2 19.3 SORBS3 "SCAM-1, SH3D4, vinexin" ENSG00000120896 "Sorbin and SH3 domain containing 3" O60504 8 22544986-22575788 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015849 Approved Approved "Focal adhesion sites,Cytosol" 6600 Cytosol "Focal adhesion sites" "HPA015849: AB_1857365" "unprognostic (6.15e-3)" "unprognostic (2.09e-2)" "unprognostic (2.34e-1)" "unprognostic (3.90e-3)" "unprognostic (1.72e-1)" "unprognostic (9.30e-2)" "unprognostic (2.51e-2)" "unprognostic (2.44e-2)" "unprognostic (5.83e-3)" "unprognostic (1.70e-1)" "prognostic favourable (4.88e-4)" "unprognostic (4.21e-2)" "unprognostic (3.08e-3)" "unprognostic (7.41e-2)" "unprognostic (1.58e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.53e-5)" 52.2 22.6 25.0 16.8 23.2 3.3 56.5 31.4 27.0 49.3 28.9 21.9 19.2 19.6 40.6 32.0 27.5 33.8 42.8 32.8 27.3 12.8 28.1 41.8 38.9 28.7 21.3 18.0 49.0 21.7 27.0 24.1 43.3 22.8 38.0 23.7 45.8 36.6 34.5 29.5 32.0 34.5 41.9 24.1 28.6 20.4 36.0 21.2 3.4 29.7 36.2 15.7 38.4 44.7 0.8 5.6 0.4 3.2 4.0 17.4 3.3 22.4 28.3 15.5 17.4 25.1 33.6 15.8 23.1 35.9 27.1 16.9 28.7 10.1 0.1 15.8 36.0 19.4 23.2 21.1 14.1 15.8 10.1 1.9 16.0 13.1 28.6 0.2 0.1 21.1 15.8 9.4 13.9 20.9 4.9 0.7 19.2 8.8 1.9 0.7 5.4 11.9 21.5 10.5 2.1 12.3 4.4 0.9 13.9 11.3 2.7 14.3 4.7 8.0 32.5 24.1 17.3 17.5 16.2 0.4 0.6 3.0 14.1 5.3 16.3 0.0 1.6 0.4 8.6 3.2 17.4 0.6 9.4 9.9 5.6 0.8 9.7 5.6 0.4 4.0 0.7 1.9 0.4 3.3 25.0 23.2 31.4 27.0 27.3 12.8 21.3 18.0 22.8 21.2 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Group enriched" "Detected in some" 12 "RH-30: 33.2;SH-SY5Y: 43.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 33.2 0.0 0.0 0.0 0.0 43.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA061916: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.5 0.0 6.5 4.1 16.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.2 0.1 0.0 12.3 0.2 3.6 5.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.7 0.0 1.3 7.2 0.2 0.0 0.7 0.6 11.7 0.0 0.0 0.0 6.9 0.0 4.2 1.2 0.0 0.1 0.0 0.0 0.0 1.4 7.1 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favourable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.6 4.7 11.8 14.3 34.4 6.8 34.0 8.7 13.9 8.6 9.2 12.1 4.3 0.1 11.1 3.6 2.9 13.9 6.9 12.4 0.3 6.6 3.2 7.6 13.0 13.5 0.0 10.6 17.1 1.1 10.5 2.3 1.3 24.1 1.2 12.0 12.4 8.2 0.2 4.4 1.9 9.2 27.8 5.6 16.4 8.5 12.1 6.9 5.1 34.2 36.7 14.4 2.0 0.3 1.8 7.0 0.3 14.5 11.6 9.5 0.0 3.1 0.0 7.5 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117120-50231558 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: , HPA052689: " "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favourable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 16.0 12.9 16.9 10.5 17.8 25.2 13.4 15.8 14.5 12.9 20.1 19.8 23.4 15.5 14.9 17.3 12.7 11.2 11.4 15.3 17.7 13.4 18.4 9.4 12.5 15.6 19.9 9.8 11.8 11.6 38.6 20.5 30.1 15.1 13.0 13.0 11.1 14.3 14.7 37.1 13.0 26.7 18.3 23.1 17.0 12.1 19.2 16.8 14.7 18.7 14.6 10.3 15.3 15.0 1.2 2.1 8.5 2.8 2.4 1.8 0.6 9.5 7.1 14.4 9.6 11.1 12.1 6.8 8.6 9.5 6.5 8.2 3.1 12.7 10.0 7.8 10.9 8.8 7.7 6.5 11.7 16.8 2.8 10.1 5.5 5.3 12.2 11.8 10.8 12.5 16.1 6.1 14.2 14.0 7.7 25.3 15.6 7.9 9.7 9.4 4.4 6.2 10.6 20.0 7.5 10.6 9.1 10.4 12.2 9.5 11.4 11.2 12.6 14.5 15.3 18.0 11.8 8.1 5.6 17.8 19.3 12.5 4.7 6.6 10.6 8.5 1.8 4.1 1.8 1.4 1.5 0.9 1.1 1.3 1.2 1.2 1.3 1.2 7.2 2.4 2.8 2.1 0.1 0.6 16.9 17.8 15.8 14.5 17.7 13.4 19.9 9.8 15.1 16.8 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Group enriched" "Detected in some" 7 "A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: , HPA074049: " "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 40.8 1.0 0.6 0.3 0.0 0.1 3.2 0.4 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 45.9 0.0 18.3 0.1 1.1 1.2 0.1 0.5 0.1 0.0 0.0 0.9 0.0 18.2 0.2 4.1 0.0 0.9 0.3 0.0 0.3 0.2 0.5 1.2 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.4 0.5 1.5 0.5 1.0 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in all" HPA029901 Approved Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 15.6 0.1 0.0 1.1 4.3 47.6 4.5 9.9 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 SOX7 ENSG00000171056 "SRY-box 7" Q9BT81 8 10723768-10730512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.2" "Cell line enhanced" "Detected in some" "HaCaT: 9.2;hTCEpi: 17.0;HUVEC TERT2: 19.9;TIME: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 17.4 1.8 3.5 3.4 3.3 0.7 7.0 1.7 4.2 16.0 3.4 2.1 1.0 0.8 7.1 6.8 19.7 3.0 6.1 12.5 2.6 2.2 3.0 7.4 37.2 2.9 2.6 1.5 2.6 4.5 2.7 4.2 26.4 3.6 5.8 2.2 7.6 7.1 5.0 12.5 11.7 2.1 4.2 3.0 2.2 2.2 1.9 3.2 0.6 4.7 22.7 14.5 8.8 23.1 1.9 0.3 0.8 0.4 0.2 1.2 0.1 4.4 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 9.2 2.7 3.3 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 17.0 0.0 3.5 19.9 0.4 0.2 0.0 0.1 0.1 0.1 1.2 2.6 0.9 0.0 0.0 0.0 1.6 0.5 2.7 1.7 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.4 0.1 0.2 0.2 1.2 1.9 0.3 0.1 0.1 0.3 0.2 0.4 0.8 0.2 0.1 0.3 0.1 0.1 3.5 3.3 1.7 4.2 2.6 2.2 2.6 1.5 3.6 3.2 SP100 ENSG00000067066 "SP100 nuclear antigen" P23497 2 230415942-230544090 "Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA016707, HPA017384" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA016707: AB_1857398, HPA017384: AB_1857399" "unprognostic (8.04e-3)" "unprognostic (1.08e-2)" "unprognostic (3.34e-2)" "unprognostic (1.86e-3)" "unprognostic (5.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (6.25e-3)" "unprognostic (5.32e-3)" "unprognostic (1.11e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (1.61e-4)" "unprognostic (1.96e-2)" "unprognostic (1.48e-2)" "unprognostic (2.33e-2)" "unprognostic (3.25e-2)" 39.7 27.7 7.0 44.0 12.9 56.8 33.4 3.4 9.4 25.6 28.3 5.5 19.1 15.3 18.9 20.5 22.5 16.1 20.3 32.3 7.1 5.3 21.7 24.8 36.0 48.5 13.0 4.0 23.8 19.9 1.8 13.7 25.1 10.9 24.0 12.4 13.9 23.4 17.6 14.6 17.3 35.4 20.2 15.6 52.2 18.6 9.8 10.6 25.9 31.6 17.8 37.4 27.0 34.7 44.1 17.4 75.6 25.2 30.8 33.2 26.1 13.3 4.0 0.2 1.8 20.8 33.8 3.2 17.4 39.1 40.5 65.4 2.4 15.8 6.2 14.1 18.8 6.6 0.2 16.6 29.7 14.8 0.5 10.6 6.9 5.3 30.1 12.5 14.6 27.7 9.8 19.4 17.6 30.5 5.4 10.2 15.4 3.6 7.8 13.3 0.6 6.4 5.9 9.5 4.3 11.5 11.4 0.1 0.2 6.9 2.2 29.9 2.1 13.0 36.7 19.6 5.2 11.9 10.0 12.8 4.1 13.9 18.7 13.7 9.4 31.8 22.5 28.6 33.2 19.2 26.3 38.9 32.3 28.5 16.8 44.1 31.0 27.3 75.6 30.8 25.2 17.4 29.1 26.1 7.0 12.9 3.4 9.4 7.1 5.3 13.0 4.0 10.9 10.6 SP140 "LYSP100-A, LYSP100-B" ENSG00000079263 "SP140 nuclear body protein" Q13342 2 230203110-230313215 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.2;lymphoid tissue: 46.8" "Cell line enhanced" "Detected in some" "Daudi: 17.6;HDLM-2: 29.4;Karpas-707: 14.7;RPMI-8226: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 36.2" "Low lineage specificity" "Detected in all" "HPA006162, HPA067493" Enhanced Approved "Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center" Mitochondria "HPA006162: AB_1857403, HPA067493: " "unprognostic (8.15e-3)" "unprognostic (2.25e-3)" "unprognostic (3.90e-3)" "unprognostic (5.72e-4)" "unprognostic (5.66e-2)" "unprognostic (3.33e-4)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (6.05e-2)" "unprognostic (1.12e-3)" "unprognostic (3.89e-2)" "unprognostic (2.88e-1)" "unprognostic (1.20e-9)" "unprognostic (9.12e-2)" "unprognostic (8.50e-2)" "unprognostic (3.66e-1)" "unprognostic (9.30e-3)" 1.9 0.8 0.9 39.1 1.1 2.9 1.1 0.5 0.7 0.7 2.3 0.5 0.0 1.4 0.6 0.9 3.5 0.8 1.4 0.8 0.9 1.0 1.1 1.1 6.3 26.9 1.4 0.0 0.7 0.4 0.0 0.9 0.6 0.6 1.0 2.0 1.0 8.9 0.1 0.3 0.7 13.1 0.3 2.0 34.9 2.3 1.3 0.7 4.0 1.3 1.7 46.8 4.8 0.9 36.2 3.0 12.6 3.6 5.1 10.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 17.6 0.0 0.0 0.0 0.0 0.0 1.1 29.4 0.0 0.0 0.0 0.3 0.1 2.5 0.1 0.3 0.0 0.3 0.4 0.0 0.0 14.7 0.3 0.0 0.0 0.8 0.8 0.0 0.0 1.6 9.1 5.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.8 0.0 0.0 5.4 2.2 0.6 1.3 0.4 0.0 0.0 1.3 4.1 9.0 2.6 10.0 36.2 9.0 9.7 3.0 25.1 4.6 6.1 12.6 5.1 3.6 0.2 7.8 3.6 0.9 1.1 0.5 0.7 0.9 1.0 1.4 0.0 0.6 0.7 SP2 KIAA0048 ENSG00000167182 "Sp2 transcription factor" Q02086 17 47896150-47928957 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003357, CAB010245" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB010245: AB_2121523, HPA003357: AB_1080070" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (6.30e-3)" "unprognostic (5.85e-2)" "unprognostic (1.18e-1)" "unprognostic (6.91e-2)" "unprognostic (5.66e-2)" "unprognostic (2.46e-1)" "unprognostic (6.46e-2)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (5.39e-2)" "prognostic favourable (1.82e-5)" "unprognostic (5.34e-3)" "unprognostic (4.28e-2)" "unprognostic (3.37e-2)" "unprognostic (8.66e-2)" 18.8 15.0 16.9 21.9 20.5 19.1 21.0 28.5 23.4 17.3 16.3 26.9 12.5 16.9 20.5 16.2 19.9 18.3 14.9 20.2 13.8 11.8 17.2 13.3 17.4 22.3 14.1 13.0 20.5 19.7 31.0 14.5 21.4 18.5 16.2 15.8 26.9 18.7 18.2 30.2 19.2 20.8 16.6 17.6 22.2 16.5 23.2 16.3 31.9 21.7 16.0 28.3 18.9 18.0 8.3 6.3 14.3 9.3 12.7 11.5 7.8 16.3 18.9 13.0 11.0 6.4 6.0 12.4 9.6 7.1 10.0 9.1 20.6 8.3 14.2 8.7 12.6 12.6 9.0 8.4 10.6 20.6 12.7 14.4 12.7 10.6 6.0 12.8 17.1 8.7 9.9 11.8 11.1 9.5 15.5 24.2 9.6 22.2 31.6 8.1 5.9 12.6 14.4 17.8 8.9 7.0 26.5 13.0 15.6 8.4 8.9 9.5 12.9 12.2 15.5 17.6 9.4 12.3 14.8 21.6 23.8 12.7 9.6 8.7 14.2 14.3 8.0 12.1 11.5 9.3 10.1 7.0 8.8 10.7 6.3 8.3 10.2 10.3 14.3 12.7 8.1 6.1 8.8 7.8 16.9 20.5 28.5 23.4 13.8 11.8 14.1 13.0 18.5 16.3 SP4 "HF1B, MGC130008, MGC130009, SPR-1" ENSG00000105866 "Sp4 transcription factor" Q02446 7 21428034-21514822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010246, HPA040395" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB010246: AB_2194481, HPA040395: " "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" "unprognostic (6.04e-2)" "unprognostic (8.28e-2)" "unprognostic (9.14e-2)" "unprognostic (8.51e-2)" "unprognostic (1.09e-2)" "unprognostic (7.85e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.15e-3)" "unprognostic (1.89e-1)" "unprognostic (6.04e-3)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "unprognostic (6.18e-2)" "unprognostic (7.80e-3)" 5.8 4.7 7.9 8.9 11.0 10.2 6.3 25.9 9.5 8.6 4.4 6.4 3.8 3.1 9.2 5.8 4.1 7.8 4.6 6.5 8.3 6.1 5.4 3.4 6.0 11.7 8.6 6.9 19.8 5.2 17.1 11.8 3.7 6.7 7.3 4.3 6.0 5.0 5.7 10.5 5.0 5.6 5.3 6.8 9.1 4.9 6.0 10.0 27.0 13.1 4.8 11.2 6.8 6.3 5.4 1.5 7.2 1.8 3.5 8.3 3.1 2.2 1.7 5.0 7.9 1.5 0.9 1.4 2.3 1.6 2.6 3.6 3.4 2.6 9.0 1.4 1.5 2.8 7.4 2.1 5.3 2.6 2.8 4.8 3.2 1.4 1.1 3.9 5.6 1.1 1.9 2.8 3.3 5.3 5.9 6.9 2.2 1.0 9.1 2.9 12.0 2.1 20.5 8.5 3.2 0.9 1.6 6.5 8.1 5.2 2.4 1.8 2.6 2.9 2.3 4.3 5.4 2.7 4.1 9.1 7.1 14.2 2.5 6.3 6.0 4.3 0.8 7.2 6.8 0.9 8.3 3.7 6.4 6.6 0.9 5.4 7.6 7.1 1.9 3.5 1.8 1.5 7.6 3.1 7.9 11.0 25.9 9.5 8.3 6.1 8.6 6.9 6.7 10.0 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715351-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "Hep G2: 50.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Low region specificity" "Detected in many" HPA074123 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA074123: " "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 8.7 1.8 0.5 2.5 0.6 0.1 7.4 1.6 1.0 11.4 3.9 1.4 3.2 3.1 7.2 3.0 1.9 3.0 5.1 0.8 0.6 1.4 0.8 5.9 4.6 3.1 0.2 0.8 1.5 0.5 0.1 0.1 2.1 0.4 7.2 1.0 3.8 2.1 0.9 0.7 6.6 3.1 3.1 0.1 0.2 7.3 2.4 0.0 0.2 0.1 0.8 6.5 3.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 1.4 0.1 0.1 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.6 1.0 0.6 1.4 0.2 0.8 0.4 0.0 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Cell line enriched" "Detected in some" 5 "BEWO: 44.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favourable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favourable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 0.4 0.0 0.0 0.0 0.0 44.6 0.2 0.2 0.9 0.2 9.4 0.9 0.0 0.3 0.0 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 2.1 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 5.6 1.4 0.0 0.0 5.7 0.0 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037542 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (4.90e-4)" "prognostic favourable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 11.1 13.0 28.2 5.4 29.8 1.7 15.8 12.0 22.0 16.7 11.5 21.9 23.1 13.7 14.0 24.8 16.0 34.8 17.0 15.7 27.7 24.6 22.6 13.8 8.1 7.7 31.5 22.0 20.2 11.2 24.0 32.8 7.3 25.7 17.1 13.1 11.1 11.8 19.8 6.1 18.2 7.9 14.3 36.9 5.7 19.2 34.3 18.1 10.5 19.9 11.4 9.8 14.8 11.9 7.5 4.1 1.1 1.1 12.1 10.6 3.0 12.3 4.9 14.2 0.0 9.7 17.5 0.1 6.8 8.2 8.8 9.4 9.8 13.7 5.2 8.1 7.5 8.8 6.4 8.2 18.9 0.0 5.1 2.7 12.6 12.6 10.9 2.9 0.0 14.9 11.4 7.9 4.6 3.6 8.6 5.9 8.8 0.0 9.7 0.0 7.8 4.1 10.4 14.9 0.2 14.2 12.1 10.4 12.3 7.8 7.2 9.6 33.7 1.2 3.7 8.6 5.1 4.5 7.0 9.7 4.4 0.2 14.0 0.0 3.8 1.1 0.2 0.7 7.1 1.1 10.1 7.5 8.0 8.9 2.5 7.3 10.6 9.2 0.4 12.1 0.8 4.1 7.4 3.0 28.2 29.8 12.0 22.0 27.7 24.6 31.5 22.0 25.7 18.1 SPAG9 "CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1" ENSG00000008294 "Sperm associated antigen 9" O60271 17 50962174-51120865 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 6.3;neutrophil: 13.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040446, HPA061458" Enhanced Enhanced "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA040446: AB_10671691, HPA061458: " "unprognostic (1.36e-1)" "unprognostic (6.61e-2)" "unprognostic (6.04e-3)" "unprognostic (4.65e-2)" "unprognostic (3.52e-2)" "unprognostic (9.73e-2)" "unprognostic (8.13e-2)" "unprognostic (3.72e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.83e-2)" "unprognostic (9.71e-2)" "unprognostic (2.23e-3)" "unprognostic (2.27e-2)" "unprognostic (9.53e-2)" "unprognostic (7.67e-2)" "prognostic unfavourable (8.10e-4)" 21.6 16.4 32.1 12.5 42.6 15.8 13.8 32.7 46.6 15.9 15.6 44.8 7.6 14.0 19.6 9.1 20.7 12.3 18.8 15.1 33.1 25.5 23.6 22.8 20.5 8.7 55.7 25.9 22.2 21.0 25.8 14.6 21.8 37.1 13.2 14.1 12.2 9.9 14.4 39.6 14.2 14.2 19.1 50.2 12.1 10.5 33.3 55.2 8.5 28.2 9.5 10.6 15.0 13.6 1.0 1.3 13.4 1.3 0.5 1.8 0.4 17.5 19.7 25.4 12.3 24.1 21.4 22.4 14.5 14.2 16.3 20.3 17.7 12.1 9.5 10.1 23.7 15.2 16.6 12.1 30.3 14.4 19.7 7.9 15.6 13.1 18.1 11.4 9.3 15.4 14.2 21.9 39.4 13.3 17.5 10.6 22.9 8.8 7.2 4.8 6.7 25.7 8.2 28.3 8.4 14.9 33.5 19.7 27.5 12.7 11.9 13.1 9.7 13.7 18.5 45.4 10.7 34.9 21.1 15.1 21.7 15.6 15.5 6.8 15.7 6.3 1.3 0.8 1.4 0.8 1.0 1.0 1.2 1.3 1.3 1.0 0.7 0.9 13.4 0.5 0.5 1.1 1.8 0.4 32.1 42.6 32.7 34.9 33.1 25.5 55.7 25.9 37.1 55.2 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 14.1" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589435-141590772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 15.5" "Cell line enhanced" "Detected in some" "PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 26 "A-431: 40.4;U-2 OS: 14.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 40.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.1 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 27.3" "Group enriched" "Detected in some" 5 "A-431: 13.0;U-2 OS: 6.3" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 13.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 6.3 0.0 0.5 0.0 0.0 0.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 10 "A-431: 5.0;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.6 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 45.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: " "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 28.7 34.7 23.2 12.1 28.0 14.5 44.9 21.3 26.7 37.1 22.5 23.1 26.2 9.1 29.9 48.4 17.7 26.1 26.2 17.5 24.7 22.3 33.7 13.7 18.4 12.9 31.8 19.4 46.1 10.3 13.2 29.8 32.2 28.9 26.6 10.0 17.2 11.9 27.0 20.6 12.4 9.7 37.0 35.7 20.2 14.4 18.3 32.5 7.0 25.1 8.7 7.8 31.4 58.7 3.2 6.0 45.8 6.8 4.1 8.3 5.3 0.0 6.0 16.3 0.0 36.0 30.3 11.7 14.6 22.0 14.8 14.7 0.0 0.0 0.0 9.1 17.6 8.4 22.1 10.1 16.0 1.1 12.8 18.2 7.9 3.8 36.2 18.9 36.9 29.9 16.4 12.2 17.2 21.6 7.9 3.2 26.5 1.3 5.6 31.8 8.2 2.1 0.0 27.4 0.6 17.2 7.5 1.7 4.0 12.4 5.0 15.4 2.9 22.4 17.8 11.1 5.6 15.3 8.5 3.9 0.0 0.0 12.3 16.5 19.3 45.8 6.7 8.7 4.4 6.7 4.3 3.2 6.2 1.8 4.8 3.2 8.3 4.4 10.6 4.1 6.8 6.0 1.5 5.3 23.2 28.0 21.3 26.7 24.7 22.3 31.8 19.4 28.9 32.5 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.6 7.7 12.6 12.4 8.0 9.4 11.4 5.9 8.7 6.2 5.6 10.4 9.3 18.6 5.5 8.2 7.6 12.4 6.0 7.7 12.5 7.5 20.5 4.2 12.7 7.3 14.2 14.4 5.2 7.9 7.9 7.6 13.7 16.6 6.3 6.8 4.5 22.8 12.0 13.1 4.5 12.1 17.8 12.1 8.4 6.6 18.0 19.3 10.0 8.5 9.8 5.5 9.8 11.8 6.9 10.6 6.1 6.9 9.5 17.7 15.1 7.5 12.3 8.2 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.8;RH-30: 3.5;RPTEC TERT1: 2.2;U-2 OS: 2.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.5 0.5 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.0 1.3 0.2 0.5 0.0 0.1 2.8 0.0 0.7 0.2 0.1 0.0 0.0 1.7 1.7 0.0 3.5 0.1 2.2 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.9 0.1 2.3 0.4 0.3 0.0 0.3 1.1 0.7 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 SPATA13 "ARHGEF29, FLJ31208" ENSG00000182957 "Spermatogenesis associated 13" Q96N96 13 23979805-24307074 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.4;HDLM-2: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040185, HPA041208" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040185: AB_10795521, HPA041208: AB_10794193" "unprognostic (8.80e-2)" "unprognostic (9.32e-3)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-3)" "unprognostic (6.23e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-3)" "unprognostic (9.15e-3)" "unprognostic (1.78e-1)" "unprognostic (4.21e-1)" "prognostic favourable (1.16e-4)" 5.5 11.8 14.7 13.9 23.7 21.4 11.8 5.5 15.2 9.2 8.8 33.7 10.9 9.4 7.8 11.9 3.2 8.2 9.8 6.4 15.3 10.5 13.1 17.8 15.3 16.8 27.9 7.4 12.1 29.7 6.1 8.3 13.7 17.7 12.1 10.2 7.5 6.8 9.8 2.4 6.3 11.5 6.2 25.7 47.8 13.8 5.2 27.2 11.9 10.7 3.1 12.8 6.5 4.5 1.2 2.5 19.3 4.7 9.6 17.7 5.8 1.7 2.9 15.2 1.9 0.5 1.3 0.6 4.4 19.4 2.3 1.9 3.7 7.7 11.6 2.4 4.0 3.3 4.3 1.3 5.8 26.2 5.2 2.8 2.2 4.2 0.7 4.4 2.2 1.7 0.2 2.5 1.4 3.8 0.0 9.8 2.4 6.4 8.1 1.5 4.9 3.7 7.1 5.8 6.1 10.3 5.7 5.5 4.2 0.9 9.6 8.6 1.3 2.6 4.4 3.0 2.4 0.2 3.1 2.2 0.0 0.0 2.6 4.3 14.2 2.4 3.1 0.0 17.3 4.0 13.5 1.2 14.7 17.7 2.2 1.0 15.6 16.0 19.3 9.6 4.7 2.5 13.8 5.8 14.7 23.7 5.5 15.2 15.3 10.5 27.9 7.4 17.7 27.2 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.4 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.7 0.6 0.3 0.5 0.7 2.3 1.2 1.2 0.1 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.2 0.4 0.4 0.4 2.3 0.9 4.7 1.8 0.7 0.7 0.6 1.4 0.6 0.6 0.8 0.6 0.9 0.5 1.2 0.7 0.3 1.9 0.5 1.0 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 SPATA2 "KIAA0757, PD1, PPP1R145, tamo" ENSG00000158480 "Spermatogenesis associated 2" Q9UM82 20 49903391-49915508 "Predicted intracellular proteins" Necrosis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048581, HPA052224" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA048581: , HPA052224: " "unprognostic (4.02e-2)" "unprognostic (5.98e-2)" "unprognostic (8.26e-2)" "prognostic unfavourable (1.87e-4)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (3.25e-3)" "unprognostic (8.77e-2)" "prognostic favourable (9.08e-4)" "unprognostic (8.33e-2)" "unprognostic (6.45e-3)" "unprognostic (5.99e-2)" "unprognostic (4.89e-2)" "unprognostic (9.57e-2)" "unprognostic (4.38e-1)" "prognostic unfavourable (4.53e-4)" "unprognostic (2.52e-1)" 4.6 6.2 15.3 5.4 19.3 15.4 5.7 16.6 25.7 5.8 10.5 12.8 4.1 11.7 5.4 6.0 5.7 7.1 5.5 5.5 15.2 11.4 5.8 5.4 5.4 5.1 14.4 15.4 6.0 11.9 7.6 6.9 5.5 10.6 8.1 9.8 5.9 8.8 6.6 12.9 5.1 11.2 5.0 19.9 15.6 8.7 18.5 10.2 4.6 11.0 4.0 5.5 5.2 3.6 4.9 3.3 6.1 3.5 3.4 4.8 2.3 5.4 6.8 4.6 4.1 5.3 3.8 7.6 3.5 5.2 12.3 5.2 21.1 4.4 4.2 7.5 3.5 10.1 3.4 5.8 6.5 5.8 3.3 2.2 4.0 13.7 5.0 5.9 9.0 3.8 7.1 6.3 4.0 2.6 7.5 4.8 2.9 11.6 6.0 15.1 6.9 8.2 4.6 5.0 4.4 4.0 4.4 4.4 4.7 7.1 21.6 5.5 5.2 5.2 3.7 8.8 7.3 7.3 4.9 11.9 9.1 4.5 6.9 3.1 3.9 0.3 3.5 3.3 3.7 2.5 3.5 3.6 3.4 4.5 3.3 4.9 4.5 4.8 6.1 3.4 1.3 1.6 3.8 2.3 15.3 19.3 16.6 25.7 15.2 11.4 14.4 15.4 10.6 10.2 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 4.6;testis: 11.3" "Cell line enriched" "Detected in some" 7 "Hep G2: 10.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" HPA032080 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.2 0.0 0.0 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.2 0.3 11.3 0.0 0.0 0.3 0.0 1.3 0.6 4.6 0.8 0.9 0.8 0.4 0.2 0.7 0.3 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 1.5 10.7 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.1 0.5 0.2 0.3 0.4 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.5 0.2 0.3 0.2 0.1 0.4 0.0 0.4 0.4 0.2 0.3 0.3 0.0 4.6 0.5 0.9 0.7 0.8 0.5 1.1 0.7 0.6 0.4 1.3 0.8 0.3 2.3 0.9 0.5 0.6 0.7 0.4 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404088 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.2" "Cell line enhanced" "Detected in many" "HDLM-2: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044000 Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavourable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 1.0 2.8 3.6 1.0 3.2 0.3 1.4 1.5 2.7 1.3 1.6 2.7 1.8 2.5 1.6 9.4 1.4 6.4 2.9 8.5 3.4 2.6 6.2 1.9 1.9 2.5 2.4 2.1 1.6 2.2 6.1 7.0 1.0 3.2 2.2 0.9 1.7 3.2 1.5 8.7 0.9 2.6 1.9 2.7 1.9 1.5 52.2 2.1 1.8 2.9 3.4 1.9 1.8 3.5 5.7 3.6 2.0 3.1 2.4 7.7 2.5 6.4 4.1 5.8 3.1 1.7 3.2 4.7 1.6 3.1 3.4 6.0 9.3 8.6 10.3 4.8 3.1 3.6 4.4 7.2 3.8 41.2 5.1 3.1 7.7 7.0 6.4 0.7 5.7 2.8 3.6 5.1 6.2 4.1 3.1 18.2 4.6 3.7 6.5 4.9 4.2 3.5 15.2 3.8 13.9 8.1 3.3 4.5 4.1 6.3 12.2 2.9 3.5 7.1 7.6 2.0 2.8 3.9 4.6 4.4 4.2 9.5 4.0 5.4 1.7 0.0 3.1 2.0 4.6 2.3 6.5 5.7 4.9 5.5 3.6 3.3 5.5 7.7 0.2 2.4 0.9 2.1 2.4 2.5 3.6 3.2 1.5 2.7 3.4 2.6 2.4 2.1 3.2 2.1 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.2 4.2 1.4 6.9 1.1 1.2 8.1 3.6 1.7 1.7 1.1 7.8 4.5 1.8 4.9 1.1 9.1 1.3 2.0 0.3 1.7 14.8 1.2 1.4 10.6 3.8 0.9 3.7 1.2 2.5 2.7 0.8 1.8 5.4 1.2 1.2 23.8 3.1 5.6 4.2 5.6 6.7 0.7 5.1 2.4 1.8 8.1 5.3 3.8 3.9 4.5 10.1 4.0 4.7 1.7 6.3 0.3 1.7 3.1 1.9 1.6 5.2 2.9 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: " "unprognostic (1.05e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.1 9.7 12.1 4.3 3.2 2.8 4.2 6.9 2.8 10.0 4.3 9.1 8.5 1.0 3.7 4.6 13.7 5.3 3.7 7.6 2.0 7.5 1.7 11.8 13.4 1.4 2.1 4.1 2.9 4.4 6.9 3.0 2.2 10.8 1.4 6.5 11.9 6.4 5.5 6.6 7.4 13.0 6.7 3.4 5.9 3.5 11.3 6.2 15.3 2.8 3.7 12.5 2.9 2.1 7.7 9.7 6.4 5.5 3.5 5.2 4.1 7.5 12.2 2.7 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402331-45421419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavourable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 9.0 8.7 10.7 12.3 10.7 11.1 9.5 21.3 8.2 10.3 9.9 10.0 10.2 12.1 9.8 8.4 17.5 8.8 8.3 9.6 9.6 5.9 10.8 14.8 11.2 14.1 13.5 5.8 12.9 12.0 7.6 7.6 10.6 8.9 9.9 10.2 7.2 9.4 12.8 15.9 16.1 13.2 9.4 7.1 8.6 8.2 12.1 12.0 9.9 11.2 12.3 10.9 10.2 11.9 3.6 3.3 4.8 6.4 3.3 4.7 0.7 7.2 5.6 7.5 5.5 6.2 6.1 9.1 6.5 5.9 7.0 6.9 12.7 4.7 5.3 7.2 4.2 16.7 11.1 8.1 7.9 7.2 6.2 6.9 8.9 9.9 7.0 9.2 3.0 5.0 9.3 5.8 7.7 5.6 11.1 8.6 7.9 4.8 6.3 17.7 5.3 7.2 7.1 10.5 4.9 8.8 7.2 10.3 5.2 5.3 11.7 5.8 10.3 16.9 3.4 3.5 5.2 21.0 13.7 7.3 14.5 8.2 8.9 15.2 6.2 0.1 2.8 4.8 4.1 2.6 1.5 1.9 2.8 4.7 3.3 3.6 2.9 3.0 4.2 3.3 6.4 2.5 2.6 0.7 10.7 10.7 21.3 8.2 9.6 5.9 13.5 5.8 8.9 12.0 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Cell line enhanced" "Detected in many" "AN3-CA: 10.4;ASC TERT1: 17.6;HSkMC: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: " "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.4 10.4 8.8 17.6 1.3 1.0 3.9 0.8 0.7 0.1 0.7 0.0 0.6 1.7 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.5 1.8 1.5 0.5 3.7 0.1 0.0 3.9 0.3 0.1 0.1 4.0 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.0 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.2 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favourable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favourable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.4 5.1 7.1 8.5 16.0 5.2 3.9 8.7 4.9 3.2 0.9 4.2 1.5 2.3 5.2 2.2 2.4 3.7 4.6 2.6 1.7 0.1 1.7 1.2 12.6 3.6 0.3 7.6 6.1 2.0 3.7 8.9 1.2 2.5 4.4 2.6 1.6 3.3 0.6 4.3 3.7 5.3 0.8 7.8 1.4 3.0 4.6 4.9 6.7 4.0 5.7 3.8 4.6 3.0 3.9 5.0 2.1 2.5 1.2 0.5 6.0 1.1 2.5 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 SPATC1L C21orf56 ENSG00000160284 "Spermatogenesis and centriole associated 1 like" Q9H0A9 21 46161148-46184476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.6" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018979, HPA019165, HPA029394" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" "HPA018979: AB_1845696, HPA019165: AB_1845697, HPA029394: AB_10601148" "unprognostic (1.46e-2)" "unprognostic (3.88e-2)" "unprognostic (3.95e-2)" "unprognostic (4.86e-2)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "prognostic favourable (2.16e-4)" "unprognostic (5.56e-2)" "unprognostic (2.35e-3)" "unprognostic (1.07e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-2)" "unprognostic (2.58e-1)" 4.7 11.5 21.5 4.2 31.7 5.1 4.3 13.1 19.0 8.2 5.1 5.6 8.9 5.3 5.3 6.5 4.6 4.0 5.7 5.5 14.4 9.4 4.3 1.5 4.4 5.7 7.8 16.5 10.9 11.7 5.8 7.8 4.7 7.5 16.7 3.6 2.6 9.5 10.1 8.8 7.0 6.3 5.6 5.2 8.1 8.3 23.5 13.6 2.2 3.7 5.0 4.3 4.4 6.4 4.8 5.9 23.6 4.2 4.0 6.9 2.7 1.8 0.0 2.4 4.5 1.4 3.3 1.3 2.6 1.4 1.5 1.1 0.0 1.2 5.8 5.4 3.3 0.3 0.0 2.1 0.4 5.2 4.3 13.8 0.8 3.2 0.1 0.0 5.8 3.4 1.0 0.0 0.0 4.8 23.8 8.7 2.1 3.6 4.4 1.6 9.9 11.8 9.9 3.2 6.4 2.3 0.5 0.7 4.6 2.1 1.2 5.2 3.8 5.3 0.3 4.4 5.3 6.2 4.0 14.6 7.8 4.2 5.8 7.7 4.1 1.0 3.9 23.6 3.0 4.2 3.9 4.7 4.4 4.3 5.9 4.8 6.9 6.8 0.2 4.0 2.9 4.8 4.2 2.7 21.5 31.7 13.1 19.0 14.4 9.4 7.8 16.5 7.5 13.6 SPATS2L "DNAPTP6, SGNP" ENSG00000196141 "Spermatogenesis associated serine rich 2 like" Q9NUQ6 2 200305881-200482263 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055427, HPA066310" Uncertain Enhanced Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA055427: , HPA066310: " "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (9.35e-2)" "unprognostic (1.78e-2)" "unprognostic (4.39e-3)" "unprognostic (3.58e-2)" "unprognostic (2.17e-3)" "unprognostic (3.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (7.43e-4)" "unprognostic (3.95e-1)" "unprognostic (7.84e-3)" "unprognostic (3.71e-2)" "unprognostic (5.67e-2)" "unprognostic (6.01e-2)" "unprognostic (2.99e-1)" 25.0 13.5 22.4 14.3 20.1 4.2 46.1 15.7 25.7 33.1 34.5 14.5 27.2 34.3 20.4 20.7 28.0 34.8 46.9 46.4 18.4 18.8 37.7 44.9 22.4 14.7 21.9 20.9 30.0 24.3 17.1 24.7 26.9 20.3 27.3 34.6 14.9 63.4 28.8 26.5 15.6 44.6 20.6 23.4 22.1 42.2 11.5 16.7 14.3 21.6 17.5 12.3 25.4 46.5 2.2 9.8 22.9 3.3 4.2 17.0 1.6 27.1 15.7 18.5 2.3 12.4 15.9 6.9 48.7 16.3 31.7 23.8 42.4 29.9 0.1 11.3 30.9 27.0 5.6 28.4 20.9 16.3 7.8 0.2 14.3 50.8 22.3 4.6 2.0 19.5 28.3 21.2 20.3 12.3 6.3 19.6 42.1 8.3 0.7 1.3 4.5 36.2 0.1 65.9 1.9 76.5 22.2 0.5 5.2 12.7 7.1 19.8 3.8 6.5 20.4 21.1 21.3 6.5 27.7 5.8 5.6 0.3 18.0 2.2 29.6 22.9 3.1 4.2 3.6 3.3 8.3 1.6 3.9 3.6 9.8 2.2 1.7 2.0 3.1 4.2 2.5 7.6 17.0 1.6 22.4 20.1 15.7 25.7 18.4 18.8 21.9 20.9 20.3 16.7 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24, NDC80 kinetochore complex component" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051234 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA051234: " "unprognostic (1.57e-1)" "prognostic favourable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 2.8 3.2 1.1 9.0 1.0 19.4 3.8 0.4 1.9 2.8 4.0 0.8 0.9 3.5 2.2 2.8 8.4 1.4 2.4 8.2 1.0 0.4 1.8 2.6 4.2 4.9 0.6 1.0 1.1 1.0 0.1 1.0 5.9 0.6 1.4 3.5 0.8 2.4 1.5 2.7 3.2 4.4 6.7 0.7 5.5 4.0 13.3 0.7 58.0 0.9 12.8 12.2 2.3 3.2 1.9 1.3 7.2 1.4 4.2 3.7 0.7 26.0 9.8 13.6 11.1 1.9 3.6 6.2 15.3 5.7 14.5 16.5 10.3 8.9 20.7 17.5 6.8 14.2 10.6 10.9 10.8 10.9 9.1 27.8 22.9 15.3 0.4 19.4 12.5 0.7 0.4 10.3 4.8 12.8 14.8 43.7 10.1 17.2 26.6 11.8 9.6 15.9 21.3 20.9 6.7 4.3 8.6 14.3 10.3 13.4 8.4 3.5 8.2 7.1 12.0 13.8 14.6 18.4 18.3 26.7 13.7 19.9 10.1 19.3 11.1 4.1 1.4 1.5 1.4 1.2 1.2 1.9 2.3 3.4 0.5 1.9 2.7 1.7 7.2 4.2 1.3 1.3 3.7 0.7 1.1 1.0 0.4 1.9 1.0 0.4 0.6 1.0 0.6 0.7 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711146 "Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: " "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favourable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favourable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 31.0 53.4 39.7 28.5 41.5 27.5 42.2 24.2 55.3 39.1 46.3 40.8 46.3 47.8 34.9 53.2 39.1 33.9 35.6 39.4 38.0 47.0 62.3 98.7 37.1 68.9 47.2 38.1 34.7 112.1 30.5 48.8 50.9 41.7 41.0 41.6 38.4 87.7 57.8 43.2 34.3 53.4 34.2 48.3 37.4 45.7 57.1 25.5 42.6 55.2 38.3 52.0 36.6 30.2 40.2 123.4 48.5 27.8 22.2 34.1 43.1 21.2 20.1 19.2 24.8 31.0 25.3 32.0 29.5 27.1 26.8 24.1 21.1 31.1 22.8 13.0 26.7 20.5 19.4 27.6 26.1 30.3 23.3 26.8 33.5 29.4 35.1 37.3 44.5 20.7 36.2 29.5 32.2 21.7 22.8 72.3 27.3 20.6 29.4 37.8 36.5 41.9 12.0 17.9 114.5 39.4 26.2 13.9 31.3 29.1 31.2 39.2 34.9 42.7 20.4 24.2 22.7 43.3 34.8 79.8 118.9 32.1 37.6 41.2 31.5 45.3 26.0 48.5 27.8 26.0 32.8 40.2 34.1 30.5 28.4 29.0 32.2 32.8 19.8 22.2 27.8 123.4 33.9 43.1 39.7 41.5 24.2 55.3 38.0 47.0 47.2 38.1 41.7 25.5 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 55.8;salivary gland: 98.0" "Group enriched" "Detected in some" 5 "MCF7: 68.4;SK-BR-3: 47.3;T-47d: 37.8" "Group enriched" "Detected in many" 10 "breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 8 "midbrain: 2.1" HPA055707 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA055707: " "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favourable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.4 2.4 0.2 0.0 28.5 0.3 0.7 12.0 6.5 0.2 0.3 4.4 4.0 0.3 0.9 2.4 16.1 0.1 0.4 0.3 0.1 0.1 5.5 0.1 0.3 0.1 0.6 1.3 0.0 0.1 0.2 0.1 55.8 4.0 0.2 98.0 4.5 0.1 3.0 7.8 0.1 0.1 0.1 10.8 0.1 0.1 0.2 0.1 7.8 22.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 47.3 0.0 37.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.7 0.4 0.3 0.3 0.1 0.1 0.1 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell line enhanced" "Detected in many" "SiHa: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 17.2 18.0 9.8 3.2 7.4 3.8 21.1 7.0 5.8 7.1 8.8 29.3 15.4 1.0 22.9 6.0 12.9 7.4 16.7 3.5 5.2 7.9 7.1 19.7 3.2 2.7 0.7 4.2 4.0 17.0 10.0 11.3 0.1 0.8 8.7 5.5 14.7 0.2 3.9 7.8 4.3 4.2 19.7 9.9 17.3 8.7 3.2 3.2 36.8 17.7 7.8 15.6 4.6 0.5 0.9 10.8 1.0 19.0 3.4 4.3 1.4 10.4 5.9 4.1 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HDLM-2: 3.4;hTCEpi: 1.2;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.7 0.8 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favourable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.1 5.5 14.2 13.8 22.2 21.9 10.2 8.6 11.1 8.4 10.8 6.7 7.9 6.0 10.8 11.4 18.7 9.8 13.2 8.3 18.0 6.0 13.8 13.1 10.1 15.7 13.7 12.7 16.7 15.1 6.9 19.9 11.9 17.5 15.5 11.9 7.1 6.1 12.7 7.5 7.6 8.1 11.9 6.5 17.9 21.4 9.3 10.9 9.4 15.0 8.0 14.2 18.8 12.9 11.2 5.6 13.9 10.3 15.5 13.7 12.0 11.5 18.2 11.4 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 SPG21 "ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21, maspardin" Q9NZD8 15 64963021-64990310 "Disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 47.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA040407: , HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 34.2 34.0 22.4 27.6 24.3 28.2 48.6 12.6 23.7 31.1 28.7 25.1 38.7 23.8 31.6 73.3 29.4 34.9 30.6 25.3 23.4 22.9 39.2 66.3 33.3 40.4 25.7 17.8 35.6 25.3 26.3 28.4 48.2 18.8 30.0 28.3 33.7 31.9 47.0 35.4 28.9 37.8 30.4 29.3 31.7 31.1 26.8 19.3 33.5 50.1 28.9 26.1 31.4 24.7 9.4 20.4 47.7 35.8 3.9 5.5 11.5 22.3 33.5 16.9 32.0 43.8 43.4 21.2 14.0 47.8 28.0 32.7 15.0 34.9 25.8 21.9 32.8 30.0 48.5 32.9 26.7 10.6 15.6 22.3 22.7 27.0 55.6 21.0 19.8 29.5 37.7 22.2 42.1 33.4 18.5 21.0 34.1 31.9 19.3 18.5 18.7 17.6 20.1 18.1 45.1 28.7 27.2 20.8 18.6 16.6 35.3 31.8 24.1 35.9 16.3 23.8 24.8 33.8 20.9 15.1 25.6 15.1 30.8 56.0 20.0 2.1 35.8 3.8 4.0 21.3 3.7 9.4 3.8 4.1 20.4 8.1 5.5 3.1 47.7 3.9 17.2 6.6 4.3 11.5 22.4 24.3 12.6 23.7 23.4 22.9 25.7 17.8 18.8 19.3 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 33.7;U-251 MG: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 11.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavourable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 9.3 2.2 4.7 10.5 3.5 15.0 20.4 0.4 3.2 5.5 5.0 4.0 0.4 1.9 6.3 8.3 13.8 5.3 12.7 10.5 5.3 2.1 4.1 2.4 12.9 10.1 4.4 1.5 5.5 15.1 3.1 2.7 7.4 4.7 4.3 1.1 11.0 11.5 1.7 6.8 8.7 6.3 5.2 4.0 2.7 3.8 3.7 6.3 3.0 9.4 16.2 12.1 5.6 7.0 0.2 8.0 2.4 3.4 0.1 1.4 1.3 9.6 1.0 4.2 0.2 2.1 2.0 4.4 22.3 14.8 18.8 11.4 5.2 1.0 0.4 2.0 16.4 2.0 3.2 28.6 4.6 0.4 1.7 0.1 7.1 33.7 4.7 0.3 0.8 3.8 0.5 29.3 11.6 18.1 4.5 0.0 3.7 12.3 0.9 0.1 0.2 8.1 0.6 1.1 0.7 1.0 0.1 0.5 1.0 2.2 0.2 19.3 0.8 1.3 29.4 29.6 5.7 22.7 37.7 0.4 0.1 0.4 22.5 1.7 4.4 2.4 3.4 0.0 1.4 1.7 0.4 0.0 0.2 0.4 1.0 0.2 0.0 0.3 0.4 0.1 0.3 8.0 0.0 1.3 4.7 3.5 0.4 3.2 5.3 2.1 4.4 1.5 4.7 6.3 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 27.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044559 Uncertain Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavourable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 3.9 3.2 4.2 5.1 4.4 13.8 13.7 2.3 5.4 5.1 5.9 6.7 2.0 3.5 6.7 4.7 16.8 3.9 3.5 3.2 4.7 6.1 3.3 2.4 16.8 7.6 4.5 2.3 6.6 4.2 4.8 4.7 12.3 5.2 7.2 6.9 4.8 27.4 2.9 1.2 3.5 4.9 5.8 5.2 5.9 3.9 3.4 3.5 11.2 5.6 6.4 11.8 4.3 8.2 1.2 1.4 3.7 2.1 6.0 1.5 0.8 16.1 4.1 9.7 7.8 2.1 3.0 7.0 8.1 3.4 4.7 5.7 2.7 16.1 0.0 3.6 3.8 5.4 12.5 5.9 8.7 6.9 3.9 20.8 5.6 2.5 0.9 17.9 16.3 1.4 2.1 7.9 4.3 5.2 6.3 20.3 10.8 5.4 5.9 9.7 10.0 6.1 8.4 20.9 4.4 3.5 4.3 0.0 5.4 14.5 4.2 1.5 9.2 8.6 2.2 9.6 10.8 15.9 5.0 4.5 5.2 10.7 5.1 14.8 5.6 1.7 1.8 3.7 1.5 2.1 0.7 1.2 0.8 0.9 1.4 1.1 0.5 1.0 0.0 6.0 1.7 0.0 0.5 0.8 4.2 4.4 2.3 5.4 4.7 6.1 4.5 2.3 5.2 3.5 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Cell line enriched" "Detected in some" 20 "HeLa: 99.6" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 99.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell line enriched" "Detected in some" 6 "HMC-1: 61.9" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in many" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favourable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 10.0 0.4 0.0 0.0 61.9 0.0 0.0 0.0 0.1 0.0 1.3 0.1 0.0 1.3 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 5.2 1.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Cell line enhanced" "Detected in many" "EFO-21: 18.2;U-266/84: 19.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 10.9 2.0 2.8 3.0 0.4 1.0 2.4 3.0 0.1 0.2 0.5 4.5 8.4 3.2 18.2 0.2 2.3 0.9 0.6 0.8 4.6 2.2 6.3 6.8 2.0 0.2 2.2 2.6 0.1 0.6 0.3 0.1 0.0 3.8 14.1 0.4 9.4 2.2 3.3 11.2 4.4 2.9 2.8 3.5 1.4 9.0 5.1 5.8 2.9 6.4 1.9 10.4 2.1 6.9 3.3 10.6 3.2 3.4 8.9 19.3 3.2 2.7 1.9 4.5 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell line enhanced" "Detected in many" "BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: " "prognostic unfavourable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favourable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 18.8 0.1 0.0 0.1 0.0 0.0 51.3 0.3 0.4 0.6 0.3 30.0 31.5 0.0 22.5 0.0 58.6 4.8 28.2 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 14.9 0.0 41.7 0.6 2.6 2.3 0.4 0.1 0.0 14.6 0.1 2.5 5.8 2.7 1.9 0.0 3.7 28.4 47.5 12.6 0.6 1.4 88.0 2.3 42.0 2.4 0.0 0.0 0.3 0.1 0.0 0.1 3.5 0.1 0.1 2.4 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 81.3;CAPAN-2: 120.0;hTCEpi: 66.8;RPTEC TERT1: 89.5;RT4: 69.4;SK-BR-3: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favourable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 81.3 59.1 0.3 0.3 0.0 0.0 38.7 1.5 0.1 0.1 0.2 41.8 120.0 0.6 6.6 0.4 27.0 4.2 57.9 0.1 0.7 4.9 15.3 1.5 0.0 0.1 0.1 0.0 0.0 66.8 0.0 28.3 0.2 0.3 0.0 0.1 63.0 2.4 0.2 5.9 16.6 8.3 0.0 36.6 89.5 69.4 22.3 0.3 24.2 78.7 0.2 35.1 10.1 0.0 0.1 0.4 0.3 0.3 5.5 7.0 4.5 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 SPIRE1 "KIAA1135, spir-1" ENSG00000134278 "Spire type actin nucleation factor 1" Q08AE8 18 12446512-12658134 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 40.5;U-2197: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040737, HPA040942" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040737: AB_10960987, HPA040942: AB_10960492" "unprognostic (3.39e-1)" "unprognostic (4.77e-2)" "unprognostic (9.18e-2)" "prognostic unfavourable (2.07e-4)" "unprognostic (2.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (9.49e-2)" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (4.60e-1)" "unprognostic (3.66e-3)" "prognostic unfavourable (7.92e-4)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-1)" 8.4 20.2 20.6 4.7 16.2 1.7 10.6 20.5 35.3 10.8 6.5 15.0 3.4 2.5 9.2 7.0 8.8 5.6 8.6 22.0 21.6 14.8 12.7 5.5 12.2 3.3 21.3 20.5 9.8 8.5 15.7 8.2 7.5 17.3 10.1 4.3 9.4 10.0 9.9 17.5 7.7 3.5 9.9 17.7 5.3 5.5 34.8 17.5 0.4 15.0 3.6 4.9 8.8 10.7 1.0 1.0 0.0 1.1 0.9 0.6 0.2 7.4 3.3 7.3 8.0 8.2 7.3 0.4 8.1 8.4 8.0 7.6 0.3 1.6 3.5 9.2 10.4 1.6 9.7 7.2 10.2 5.3 4.8 2.2 6.9 4.2 16.9 1.5 5.6 5.0 13.8 13.8 40.5 10.7 5.5 0.1 11.9 9.9 0.4 2.0 3.0 8.2 0.0 8.9 7.4 9.7 10.2 10.7 4.4 8.8 7.3 18.3 2.3 4.6 13.0 13.3 3.9 31.0 9.6 2.7 0.2 0.2 10.7 0.9 3.5 0.0 1.1 0.0 0.4 0.8 0.2 0.0 0.2 0.6 1.0 1.0 0.0 0.4 0.0 0.9 1.1 0.0 0.0 0.2 20.6 16.2 20.5 24.3 21.6 14.8 21.3 20.5 17.3 17.5 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell line enhanced" "Detected in many" "BEWO: 14.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: , HPA049415: " "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavourable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.3 6.8 4.3 3.6 1.2 0.8 14.5 2.3 1.3 3.2 1.3 2.6 7.2 4.5 1.0 0.6 7.2 1.9 0.2 1.0 1.8 8.3 0.9 5.6 6.9 1.1 0.3 1.5 1.5 1.7 1.0 0.8 0.1 6.9 1.3 0.9 10.1 0.1 1.5 4.7 4.2 3.4 1.5 1.0 1.6 6.9 11.3 5.8 9.4 4.1 4.1 15.5 2.4 0.3 1.9 4.1 2.6 1.9 0.6 2.9 0.4 2.9 1.6 3.9 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.2 24.3 9.2 21.4 17.7 9.8 26.3 11.5 11.9 19.2 17.2 22.2 24.7 6.6 28.4 10.3 21.8 14.9 12.7 6.9 7.5 25.3 9.5 23.7 27.5 30.1 10.5 20.6 16.4 17.1 20.7 8.8 17.7 21.3 11.9 9.6 27.4 11.5 30.1 21.8 16.1 14.6 11.1 29.3 10.4 10.0 16.5 21.4 8.2 24.5 17.9 24.4 12.8 14.9 15.7 11.9 21.8 8.8 18.0 14.1 6.1 20.1 16.1 12.6 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: , HPA031715: " "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favourable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.6 0.3 0.0 0.0 0.2 1.5 0.5 13.9 18.6 13.5 9.0 0.2 0.6 0.1 1.9 15.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.8 0.2 19.3 0.6 9.1 0.2 0.2 7.9 0.0 0.1 0.0 0.2 0.3 0.0 1.4 0.0 0.0 32.6 0.0 0.0 0.3 0.0 0.9 8.0 0.0 16.9 14.2 1.4 9.2 5.2 0.0 0.1 0.0 32.1 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Group enriched" "Detected in some" 35 "EFO-21: 41.0;RPTEC TERT1: 115.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: " "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favourable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavourable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 115.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 SPPL2B "IMP4, KIAA1532, PSL1" ENSG00000005206 "Signal peptide peptidase like 2B" Q8TCT7 19 2328615-2354806 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005592, HPA039292" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" "Nucleoplasm, Plasma membrane" Centrosome "CAB005592: AB_325074, HPA039292: " "unprognostic (4.16e-2)" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "prognostic favourable (5.00e-5)" "unprognostic (2.34e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-1)" "unprognostic (7.93e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "prognostic favourable (1.33e-4)" "unprognostic (3.29e-3)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.26e-2)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (3.40e-2)" 5.4 4.6 5.0 11.7 5.4 11.7 4.0 6.9 6.9 3.4 9.0 7.9 9.6 19.3 4.7 10.0 3.2 5.2 9.8 3.3 5.6 4.2 3.9 3.5 10.3 7.1 4.7 3.4 13.8 6.3 11.0 6.8 7.1 4.7 3.9 6.0 10.5 8.7 7.5 8.7 16.2 5.0 7.0 8.1 13.8 20.1 6.4 9.3 3.0 3.7 5.7 2.3 2.0 14.4 17.4 9.3 7.7 6.2 8.2 5.9 8.3 13.3 5.7 10.2 4.7 4.8 14.7 10.9 3.2 4.0 4.3 9.3 9.5 8.0 10.3 5.1 11.2 1.9 3.7 1.2 9.3 8.3 5.3 20.9 12.5 8.9 9.3 6.9 7.0 4.3 3.8 2.7 5.6 8.5 20.4 2.4 9.2 10.0 11.8 10.7 5.5 16.8 3.0 21.9 4.3 21.0 10.2 9.7 10.9 6.7 8.4 11.1 15.6 12.4 7.3 5.3 18.5 8.5 26.9 9.6 8.3 9.2 10.9 12.7 9.3 7.7 7.0 6.6 7.5 4.8 9.0 6.0 6.5 9.4 14.4 7.8 8.2 3.4 6.2 5.1 17.4 5.9 5.9 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA004194: , HPA059958: " "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavourable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.3 12.3 18.7 11.7 24.8 16.8 13.2 9.5 28.4 20.5 16.5 12.8 12.7 11.4 0.1 16.5 15.2 19.1 20.5 21.3 9.0 11.7 9.8 7.4 9.7 26.2 11.2 12.7 16.8 32.9 17.6 16.5 20.1 10.7 5.7 17.6 10.9 14.9 9.0 12.5 8.8 8.9 15.8 8.1 16.1 35.2 12.8 13.8 18.1 8.4 14.3 25.2 7.8 14.9 9.5 13.0 5.8 7.1 13.4 24.0 11.1 14.2 9.4 15.7 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887360-72892158 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 61.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9" "Group enriched" "Detected in many" 13 "dendritic cells: 9.9;monocytes: 9.3" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol 52000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 13.3 22.6 6.3 6.1 8.2 0.0 36.2 2.0 6.4 6.0 17.1 3.1 8.9 11.4 5.7 19.1 13.4 13.2 11.4 16.1 6.4 6.0 20.3 43.5 7.2 5.3 7.9 5.0 8.7 61.7 16.7 5.5 3.9 7.9 17.3 16.2 4.5 20.9 8.8 16.0 3.3 15.1 9.5 4.9 4.7 15.4 4.9 7.2 1.0 31.7 6.2 3.6 9.5 41.4 0.0 9.9 0.7 9.3 0.0 0.4 2.5 13.9 39.2 0.2 6.1 16.1 5.8 9.8 6.6 9.6 4.9 4.6 24.9 14.5 10.2 7.9 7.8 13.2 17.5 10.5 4.1 2.9 13.6 15.3 9.7 25.5 6.0 2.4 4.2 5.2 11.8 5.4 6.1 12.9 15.7 2.0 6.4 29.4 0.9 9.1 3.3 37.5 0.0 25.5 6.0 26.0 21.9 2.4 4.6 12.1 27.3 8.9 12.3 2.9 15.8 5.4 13.2 9.4 11.5 2.2 4.9 0.7 7.7 5.2 9.3 0.0 9.3 0.7 0.4 2.6 0.4 0.0 0.2 0.1 9.9 0.0 0.2 0.4 0.0 0.0 1.0 0.9 0.0 2.5 6.3 8.2 2.0 6.4 6.4 6.0 7.9 5.0 7.9 7.2 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038256: , HPA064394: " "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 26.6 14.1 15.4 15.6 20.0 20.1 11.1 8.0 11.8 5.2 7.1 18.5 7.6 20.5 4.2 9.9 9.0 8.7 17.9 10.5 23.5 6.4 4.2 3.7 19.9 10.1 13.0 8.7 16.0 10.6 18.3 17.6 3.2 18.2 8.0 8.3 18.0 10.1 12.2 7.6 16.5 8.1 13.9 10.6 16.0 22.5 6.6 23.4 8.4 7.2 21.3 6.8 11.1 5.0 13.1 17.6 11.6 12.7 15.9 6.4 33.6 21.2 12.6 25.2 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell line enhanced" "Detected in many" "TIME: 15.0;U-87 MG: 9.6" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.9 3.2 0.6 1.9 2.2 7.7 5.1 2.6 2.4 0.4 0.8 0.2 2.8 2.6 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.4 2.1 0.1 1.3 0.9 6.0 1.8 8.0 0.6 1.4 7.8 0.4 0.0 0.1 1.8 3.9 0.9 1.4 0.1 5.6 0.6 0.2 3.0 0.1 0.2 0.3 0.6 0.1 15.0 2.8 8.8 2.3 4.2 0.6 0.2 0.5 9.6 0.3 4.8 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell line enhanced" "Detected in many" "AF22: 29.6;AN3-CA: 59.8;ASC diff: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: , HPA070554: " "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.8 0.5 29.6 59.8 24.3 16.5 1.9 0.1 1.5 0.1 0.6 1.8 3.1 0.0 13.3 0.8 0.3 0.7 1.4 0.2 0.0 3.0 0.6 0.0 9.2 6.9 4.1 0.0 6.7 0.7 0.2 0.6 2.5 0.5 0.5 1.4 0.2 4.8 10.3 7.1 9.8 2.1 3.2 0.0 4.0 4.3 4.5 3.8 0.0 6.0 5.7 0.6 0.0 6.1 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.4 0.8 0.9 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 SPRY2 hSPRY2 ENSG00000136158 "Sprouty RTK signaling antagonist 2" O43597 13 80335976-80340951 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 68.8;SK-MEL-30: 37.4;WM-115: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037205, HPA042198" Approved Supported "Actin filaments,Microtubules" "Actin filaments, Microtubules" "CAB037205: AB_261923, HPA042198: " "unprognostic (9.37e-3)" "unprognostic (3.71e-2)" "unprognostic (1.10e-1)" "unprognostic (9.12e-3)" "unprognostic (3.80e-2)" "unprognostic (8.99e-2)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (4.28e-2)" "unprognostic (1.56e-2)" "unprognostic (9.89e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.86e-2)" 44.5 20.4 23.2 9.8 21.9 20.8 45.0 41.2 29.3 26.5 22.7 18.6 10.5 14.3 17.1 15.5 16.9 23.8 25.4 28.2 22.7 15.0 15.0 22.3 21.8 9.2 20.8 22.7 14.4 22.1 7.1 10.2 11.5 33.9 16.2 23.0 19.0 28.0 16.8 25.4 14.4 18.1 19.7 30.4 23.6 14.5 6.0 20.2 3.7 15.6 13.1 5.3 16.7 20.5 0.6 1.8 3.9 0.0 7.5 1.7 0.4 0.4 1.9 21.8 68.8 28.9 19.0 1.5 17.5 8.0 4.0 4.8 8.7 2.6 0.0 3.0 7.2 1.6 1.2 3.5 4.5 0.0 3.9 3.0 1.1 2.2 6.6 15.6 1.2 8.4 3.8 6.8 16.7 7.7 1.0 0.0 9.0 0.3 2.1 7.1 8.6 5.0 6.3 29.0 0.0 7.5 2.9 0.2 12.1 1.4 0.8 37.4 1.6 14.0 11.2 3.7 1.4 7.8 3.3 0.0 0.0 0.0 25.6 6.0 35.0 0.0 0.0 3.9 0.8 0.0 0.3 0.6 0.0 1.7 1.8 0.0 0.1 0.3 0.1 7.5 0.0 0.3 0.0 0.4 23.2 21.9 41.2 29.3 22.7 15.0 20.8 22.7 33.9 20.2 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4;EFO-21: 4.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB013505 Uncertain Approved Nucleoli,Cytosol Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.3 8.4 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.1 1.1 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.1 0.1 0.7 0.4 0.4 2.0 1.1 0.8 0.5 1.3 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.0 0.5 0.2 2.0 0.9 0.7 0.6 0.6 1.0 0.0 0.5 0.5 0.6 2.1 0.6 0.9 0.3 0.6 0.6 0.1 1.8 2.0 1.0 1.1 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 35.2;WM-115: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: , HPA072661: " "unprognostic (9.54e-3)" "prognostic unfavourable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavourable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 27.3 20.8 9.0 6.8 9.0 0.7 32.9 6.2 8.3 7.1 8.0 4.9 3.6 8.7 8.3 6.2 4.9 6.5 11.3 17.1 7.4 8.0 12.5 11.5 24.3 3.7 6.5 7.6 5.7 7.4 10.6 28.7 21.8 8.5 13.0 7.5 10.7 4.6 7.3 10.6 3.6 11.7 8.8 6.7 10.7 7.8 2.4 3.9 0.2 17.8 4.0 2.4 12.7 29.1 0.0 0.9 0.0 0.0 0.2 0.1 0.0 1.1 1.8 17.1 35.2 10.2 7.4 4.7 12.8 4.4 2.1 2.2 1.8 1.7 0.0 9.5 3.1 0.9 0.0 3.7 2.5 0.0 0.0 0.0 0.0 7.5 3.5 0.0 0.0 6.1 0.0 5.6 3.1 2.0 4.3 0.0 7.5 1.4 0.0 4.6 8.0 12.2 0.4 2.4 0.4 6.1 11.0 0.2 5.4 0.2 1.6 14.6 0.1 0.7 2.8 4.5 0.1 0.9 11.5 0.0 0.6 0.0 7.1 0.0 49.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 9.0 9.0 6.2 8.3 7.4 8.0 6.5 7.6 8.5 3.9 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments, Cytosol" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favourable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 16.8 15.7 30.4 10.1 51.9 3.3 11.6 27.1 59.3 15.3 11.4 14.9 10.6 10.8 14.1 21.7 15.9 26.8 11.7 23.1 28.3 27.0 11.3 8.0 13.1 8.8 21.5 34.9 26.4 20.4 26.5 20.3 8.0 34.2 18.3 10.0 15.6 23.3 25.1 7.4 13.0 9.8 18.3 14.0 9.8 13.4 4.9 12.2 3.7 20.2 6.6 11.4 12.4 11.4 9.4 9.4 26.7 18.4 9.7 21.0 15.6 12.4 19.4 2.5 5.1 20.7 10.3 3.3 19.2 9.9 7.2 4.6 3.2 10.5 8.0 15.9 23.4 11.6 3.3 14.5 4.8 8.7 5.1 5.1 11.8 7.3 15.6 9.6 9.1 9.3 23.0 10.3 15.9 14.9 4.4 20.4 12.6 26.9 6.8 5.0 1.4 13.7 3.0 4.3 16.5 9.2 10.0 4.3 4.2 16.5 15.3 7.8 14.3 7.5 20.6 8.3 8.4 18.6 13.0 11.5 10.2 2.3 24.3 8.5 10.0 15.5 9.8 26.7 21.0 17.5 20.1 9.4 14.5 16.9 9.4 7.5 12.5 14.6 15.5 9.7 18.4 4.5 8.0 15.6 30.4 51.9 27.1 59.3 28.3 27.0 21.5 34.9 34.2 12.2 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051402-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 22.0" "Cell line enhanced" "Detected in some" "AF22: 15.9;NTERA-2: 4.5;RH-30: 5.4;SH-SY5Y: 4.5;U-2 OS: 3.7" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062793 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062793: " "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favourable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.8 0.9 1.0 0.2 1.5 0.2 0.2 0.2 2.0 0.1 0.3 0.7 0.0 0.2 0.1 0.3 0.2 0.1 0.2 2.2 1.1 1.1 0.4 0.3 1.3 3.2 1.5 0.6 0.1 22.0 0.1 4.6 0.2 1.2 0.2 0.1 0.0 0.1 0.1 1.7 0.2 0.2 0.2 1.9 2.5 0.1 3.6 0.2 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.9 0.3 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 4.5 0.0 0.0 5.4 0.8 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.3 0.4 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.5 0.2 1.2 1.1 1.1 1.5 0.6 1.2 0.2 SPTAN1 ENSG00000197694 "Spectrin alpha, non-erythrocytic 1" Q13813 9 128552558-128633662 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding, Calmodulin-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004581, HPA007927" Enhanced Approved Vesicles,Microtubules 270000 "Vesicles, Microtubules" "CAB004581: AB_671135, HPA007927: AB_1857435" "unprognostic (1.46e-2)" "unprognostic (2.73e-2)" "unprognostic (1.56e-1)" "unprognostic (9.06e-2)" "unprognostic (3.24e-1)" "unprognostic (4.02e-2)" "unprognostic (2.56e-3)" "unprognostic (2.20e-1)" "unprognostic (1.81e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "prognostic favourable (1.84e-12)" "unprognostic (2.94e-2)" "unprognostic (1.60e-1)" "unprognostic (4.18e-3)" "unprognostic (2.19e-3)" 27.8 18.0 46.4 21.3 54.0 14.7 18.0 80.9 74.7 21.1 22.3 33.3 17.0 14.5 27.5 20.5 22.2 33.1 19.4 37.2 42.6 46.2 19.5 13.8 32.1 20.6 41.8 59.8 32.4 14.2 47.2 18.2 33.1 75.1 20.2 22.0 26.9 16.7 29.3 12.7 40.1 17.9 35.1 31.8 24.2 18.2 26.1 29.9 18.0 22.2 11.4 21.7 19.6 27.5 5.5 2.5 3.2 1.2 5.7 12.8 4.2 23.2 25.8 17.0 18.7 24.9 28.3 13.9 20.0 16.8 22.5 17.0 36.6 16.6 20.4 17.9 30.2 42.9 18.0 20.1 14.0 11.5 10.7 3.4 70.0 20.5 14.1 15.1 11.6 13.5 16.2 37.7 12.8 30.1 1.9 24.2 22.0 16.1 29.1 6.4 21.7 16.2 19.7 20.4 12.9 18.3 20.1 13.2 20.7 65.6 9.1 9.5 15.7 4.3 51.5 15.7 23.2 22.6 15.5 14.8 17.4 11.6 19.1 6.9 14.7 2.5 1.2 3.2 8.9 1.1 12.2 5.5 11.2 8.2 1.9 5.3 7.0 7.2 1.3 5.7 0.9 2.5 12.8 4.2 46.4 54.0 80.9 74.1 42.6 46.2 41.8 59.8 75.1 29.9 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66685248-66729226 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7;skin 1: 36.9" "Cell line enhanced" "Detected in many" "HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Supported "Cell Junctions,Cytosol" 4800000 "Cell Junctions, Cytosol" "CAB009844: AB_2194521, HPA039293: , HPA043529: " "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavourable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 0.8 4.9 26.2 1.0 38.3 1.7 4.5 29.6 46.7 9.6 0.9 2.0 0.0 1.0 1.1 1.2 12.7 2.6 1.2 0.7 19.7 8.2 12.7 7.1 0.9 0.5 6.5 24.7 0.8 8.3 12.2 3.9 0.7 14.4 6.8 0.7 1.7 13.4 3.1 0.7 36.9 0.9 1.2 1.9 0.9 1.2 18.9 6.2 0.0 0.5 0.1 3.3 1.1 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.4 3.3 1.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.1 8.0 0.0 1.7 0.0 7.7 11.7 1.1 0.0 0.0 4.6 0.0 19.9 1.1 0.3 3.3 0.3 0.1 5.4 0.0 3.5 2.9 3.2 0.0 0.0 12.5 2.6 1.5 23.1 10.3 10.7 1.3 6.6 4.4 1.1 23.5 13.8 6.5 16.4 1.5 18.7 0.9 0.6 0.0 4.1 0.6 5.1 0.3 1.2 6.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.2 38.3 29.6 46.7 19.7 8.2 6.5 24.7 14.4 6.2 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA054481: " "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 1.9 0.4 0.0 0.0 0.0 0.0 0.4 2.3 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.0 3.5 5.0 0.0 1.3 0.0 0.0 0.2 0.8 0.5 0.0 1.1 0.0 0.0 7.9 4.8 0.1 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606401-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA039372: , HPA040177: , HPA047957: " "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favourable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 14.0 12.7 6.2 9.7 9.2 33.6 11.9 10.9 10.9 13.7 10.9 6.9 9.9 8.3 11.9 8.6 15.5 12.5 12.2 9.9 5.8 6.5 14.9 25.1 9.7 8.7 6.0 6.8 16.7 16.9 13.6 14.0 15.3 8.5 12.5 9.7 7.9 13.3 13.9 16.3 12.5 13.7 9.3 7.6 15.0 11.0 7.1 5.5 17.7 12.8 8.0 13.3 12.5 11.8 2.7 3.4 7.8 5.7 7.3 8.7 3.3 8.1 8.1 6.4 9.0 10.8 11.3 9.9 12.1 13.3 10.1 12.2 7.2 3.6 18.3 6.8 11.3 8.5 10.6 9.5 14.5 9.6 10.0 7.3 4.9 6.6 10.4 15.5 14.6 9.3 9.9 6.4 13.1 11.0 10.2 29.1 11.2 8.8 10.3 6.2 5.8 9.0 9.5 17.9 7.8 10.5 11.7 6.2 8.8 10.8 12.5 8.4 7.8 6.6 9.7 9.9 8.4 19.2 7.4 10.2 12.6 14.3 11.8 8.6 8.3 7.8 4.1 5.8 5.7 5.7 8.7 2.6 5.6 5.7 3.4 2.7 5.2 5.6 6.0 7.3 5.4 2.9 6.0 3.3 6.2 9.2 10.9 10.9 5.8 6.5 6.0 6.8 8.5 5.5 SQLE ENSG00000104549 "Squalene epoxidase" Q14534 8 124998497-125022283 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018038, HPA020762" Enhanced Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA018038: , HPA020762: " "unprognostic (1.37e-2)" "unprognostic (6.26e-3)" "unprognostic (5.12e-2)" "unprognostic (9.51e-3)" "unprognostic (4.63e-1)" "prognostic unfavourable (7.42e-4)" "unprognostic (4.76e-3)" "prognostic unfavourable (4.67e-4)" "unprognostic (3.45e-2)" "unprognostic (7.21e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (7.51e-2)" "prognostic unfavourable (5.70e-4)" "unprognostic (9.71e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-3)" "unprognostic (7.74e-3)" 4.6 15.7 11.1 9.9 13.9 10.4 12.1 8.9 19.9 15.1 11.5 28.8 4.4 15.8 8.9 5.1 40.3 10.0 6.3 4.2 15.4 14.5 7.8 38.1 16.0 8.6 10.8 9.7 17.5 6.3 16.5 9.5 24.7 28.5 13.8 10.1 9.3 10.4 4.7 1.3 23.8 8.7 6.6 36.0 5.6 11.5 29.3 18.7 9.8 5.7 24.2 15.0 5.3 21.6 15.1 12.4 1.2 9.7 9.5 9.0 6.1 25.5 9.9 59.4 17.0 18.5 31.4 6.0 6.7 20.7 9.2 16.9 13.4 37.3 17.6 9.7 8.3 19.5 24.7 37.2 10.7 14.5 52.3 50.2 6.7 34.2 27.2 5.9 14.8 21.4 39.8 27.4 22.6 10.0 28.6 34.3 7.4 42.1 20.3 7.4 24.6 6.8 8.9 10.9 23.9 64.7 29.4 18.6 9.4 13.8 44.4 13.8 11.8 15.4 9.8 3.8 13.4 4.5 6.0 6.2 12.6 24.1 6.4 17.9 6.5 1.2 5.1 0.5 9.0 8.5 4.4 13.6 5.4 8.3 12.4 15.1 7.5 7.8 0.1 9.5 9.7 8.8 5.6 6.1 11.1 13.9 8.9 16.4 15.4 14.5 10.8 9.7 28.5 18.7 SQSTM1 "A170, OSIL, p60, p62, p62B, PDB3" ENSG00000161011 "Sequestosome 1" Q13501 5 179806398-179838078 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Autophagy, Differentiation, Immunity" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 196.4;HHSteC: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004587, HPA064165, HPA068843" Supported Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "CAB004587: AB_628279, HPA064165: , HPA068843: " "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.45e-2)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.31e-5)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (5.65e-2)" "unprognostic (1.66e-1)" "unprognostic (1.70e-1)" "unprognostic (9.52e-2)" "unprognostic (3.21e-1)" "unprognostic (8.68e-3)" "unprognostic (4.41e-2)" "unprognostic (2.01e-1)" 47.8 74.5 12.4 21.6 16.0 19.5 60.4 26.2 23.4 25.2 31.7 20.9 39.8 22.9 29.4 27.7 30.8 23.1 45.2 51.9 13.9 12.8 38.6 88.3 33.3 33.4 23.2 16.3 32.3 51.8 22.7 33.6 72.7 15.6 36.2 15.2 28.9 39.0 36.2 102.8 15.3 22.0 36.3 15.5 25.6 40.0 18.9 17.9 18.8 60.4 45.3 17.5 47.9 64.0 27.8 34.2 100.4 58.3 28.2 38.7 52.4 13.9 79.8 3.8 11.4 56.5 39.0 57.4 20.4 61.0 16.2 20.8 15.6 57.7 2.2 56.7 31.2 17.3 7.5 17.2 7.6 196.4 11.7 6.6 28.9 24.4 135.4 6.7 36.3 32.7 21.9 30.3 46.9 16.6 7.0 46.9 34.6 11.0 2.6 6.5 9.4 24.9 5.2 8.4 21.8 24.0 61.1 8.4 7.4 30.2 29.5 72.8 14.7 11.6 36.9 28.4 12.6 26.9 26.1 70.2 73.5 7.3 64.7 11.4 31.5 90.0 58.3 59.9 32.7 39.6 38.7 27.8 28.9 29.2 34.2 27.1 24.0 24.0 100.4 28.2 36.6 14.8 38.7 52.4 12.4 16.0 26.2 23.4 13.9 12.8 23.2 16.3 15.6 17.9 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 26.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA044598: , HPA050153: " "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favourable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 4.8 9.9 2.5 4.8 3.0 5.6 2.7 13.3 3.5 2.5 3.3 3.1 3.0 4.1 2.5 2.6 3.5 4.3 2.7 3.0 3.5 14.4 4.4 3.5 2.2 4.9 2.7 4.5 7.7 3.7 3.7 3.0 5.5 4.4 4.4 3.9 3.4 3.4 2.1 5.7 4.6 6.8 4.1 3.1 2.3 2.3 9.0 15.6 26.9 16.4 7.5 11.3 14.2 6.1 14.8 7.9 8.2 3.8 5.3 11.0 10.6 6.1 6.9 7.3 27.1 3.9 5.3 7.8 4.0 4.2 1.4 7.8 2.8 8.1 9.2 4.6 16.1 10.2 8.2 8.3 6.3 10.1 4.1 3.7 1.9 3.1 4.7 8.1 4.5 18.8 6.8 13.1 2.4 11.9 7.5 6.7 5.0 3.6 7.4 5.6 6.6 6.1 5.6 7.1 7.0 9.5 4.9 6.6 3.4 5.7 8.5 10.2 6.7 5.5 8.1 10.9 4.3 8.1 16.4 12.0 7.0 14.3 6.5 9.0 6.8 6.7 15.6 7.4 5.6 6.4 26.9 7.5 13.3 9.3 11.3 14.2 SRBD1 FLJ10379 ENSG00000068784 "S1 RNA binding domain 1" Q8N5C6 2 45388680-45612165 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030567, HPA030568" Approved Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA030567: AB_10611244, HPA030568: AB_10601856" "unprognostic (1.16e-2)" "unprognostic (1.27e-1)" "unprognostic (4.97e-3)" "unprognostic (2.46e-1)" "unprognostic (8.20e-3)" "unprognostic (4.14e-1)" "unprognostic (8.69e-3)" "unprognostic (9.74e-2)" "unprognostic (7.11e-2)" "unprognostic (9.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.76e-1)" "unprognostic (3.42e-3)" "unprognostic (3.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (2.29e-1)" 11.7 9.8 5.5 12.2 7.5 6.8 10.9 6.3 6.8 13.8 10.4 6.3 15.7 6.7 19.3 14.9 8.0 8.6 7.4 9.4 5.5 5.8 11.6 13.2 8.7 11.0 6.4 4.7 11.2 14.9 25.1 20.9 11.5 8.7 12.7 9.9 8.4 16.6 14.5 9.5 8.4 10.7 8.3 7.3 13.9 9.9 12.2 8.0 16.5 12.5 6.1 11.3 9.7 9.4 6.1 7.0 14.3 13.0 9.2 7.7 4.9 13.7 7.1 14.7 9.8 5.4 12.0 11.6 10.6 9.3 10.2 9.4 6.0 5.9 11.9 7.9 7.6 6.5 14.4 13.4 18.9 16.2 8.0 15.8 5.7 12.7 6.4 13.1 9.3 7.2 5.6 12.0 14.1 12.3 11.2 9.1 15.1 12.5 17.5 10.0 16.8 7.8 12.1 21.1 10.8 11.6 9.0 13.0 10.6 9.3 10.1 10.3 6.2 4.8 11.3 14.3 11.4 6.9 9.1 9.6 3.5 7.2 8.0 13.1 10.2 3.4 7.2 14.3 6.6 7.9 5.8 6.1 4.9 7.7 7.0 5.3 6.9 6.2 2.6 9.2 13.0 6.7 5.0 4.9 5.5 7.5 6.3 6.8 5.5 5.8 6.4 4.7 8.7 8.0 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.3;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 6 "dendritic cells: 3.0;monocytes: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Plasma membrane,Cell Junctions,Cytosol" 20000000 "Plasma membrane, Cell Junctions" Cytosol "CAB004023: AB_2106059, HPA030875: " "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavourable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (1.63e-4)" "prognostic unfavourable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favourable (5.22e-5)" 6.9 17.5 12.8 11.1 12.0 5.4 9.9 6.4 16.0 16.0 16.4 3.5 15.1 29.5 20.3 9.7 16.2 14.2 42.1 5.8 11.3 6.6 13.4 2.9 10.4 7.0 3.3 9.9 15.8 19.1 6.6 11.3 6.3 5.1 19.9 13.1 13.1 7.5 22.5 3.4 7.7 28.1 27.2 3.6 12.2 29.8 27.3 4.8 4.0 6.6 10.5 10.4 26.4 20.0 0.3 3.0 0.1 5.3 0.6 0.1 1.6 7.6 35.5 8.1 7.3 3.1 4.9 17.0 7.1 6.1 8.6 5.5 13.3 6.9 0.2 4.4 12.8 14.0 4.9 33.0 3.4 0.0 4.4 1.9 1.2 20.7 7.4 0.1 3.0 5.3 11.2 5.6 7.5 7.8 0.2 0.0 1.4 5.2 1.8 0.2 3.8 32.1 8.3 2.1 0.2 3.6 34.0 7.6 27.5 8.0 11.3 8.8 10.1 2.8 11.5 10.4 7.0 3.8 6.3 0.1 0.2 0.1 7.3 0.0 7.7 0.0 2.6 0.0 0.0 5.3 0.0 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.1 0.6 4.4 3.0 0.1 1.6 12.8 12.0 6.4 16.0 11.3 6.6 3.3 9.9 5.1 4.8 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 13.5 15.5 15.4 17.1 15.6 23.6 13.6 24.8 18.1 14.8 16.3 20.4 14.0 14.1 23.6 12.0 13.0 15.1 16.0 11.9 11.5 9.3 10.5 9.3 11.6 13.9 18.2 10.8 17.2 17.8 31.2 18.2 16.3 13.0 14.1 10.3 17.5 17.2 13.4 23.5 14.8 18.0 13.4 12.6 16.0 15.9 22.4 14.0 20.5 17.4 10.1 15.1 21.4 12.7 3.2 2.3 6.2 3.2 1.7 2.4 1.5 13.9 27.6 16.6 16.9 13.1 9.3 18.0 10.6 9.8 12.2 9.7 13.1 10.3 29.0 14.6 13.4 14.0 17.2 13.2 10.0 18.7 39.6 18.5 24.2 11.2 5.9 21.4 22.3 9.7 6.6 18.3 15.0 12.4 28.3 16.5 8.8 17.2 18.3 8.5 17.3 12.4 25.5 13.1 16.6 3.8 16.1 16.1 16.7 11.8 15.4 4.5 17.4 12.1 20.0 17.3 12.7 9.7 14.1 18.7 15.8 21.4 13.9 11.2 13.2 0.7 1.8 6.2 2.4 3.2 1.9 1.8 1.3 2.4 1.3 3.2 1.3 1.1 5.4 1.7 0.8 2.3 2.1 1.5 15.4 15.6 24.8 18.1 11.5 9.3 18.2 10.8 13.0 14.0 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favourable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavourable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.9 3.3 6.0 5.7 20.0 12.8 3.0 5.4 6.3 2.3 3.7 3.3 10.4 11.8 6.1 8.5 3.9 4.2 5.0 2.8 3.4 7.5 6.4 3.7 8.8 5.3 11.9 3.6 11.7 9.3 3.9 3.6 9.2 10.9 26.5 12.9 6.5 17.4 5.2 7.5 4.4 5.6 1.8 6.6 7.6 5.4 9.2 5.1 5.8 43.6 3.9 5.3 10.5 4.5 14.6 2.6 1.0 4.1 14.1 7.7 4.3 18.5 16.4 14.2 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 SREBF1 "bHLHd1, SREBP-1c, SREBP1, SREBP1a" ENSG00000072310 "Sterol regulatory element binding transcription factor 1" P36956 17 17810399-17837002 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.7;SK-BR-3: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005406, HPA043343, HPA043878" Uncertain Supported "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "CAB005406: AB_2194226, HPA043343: , HPA043878: " "unprognostic (9.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-2)" "prognostic favourable (2.66e-4)" "unprognostic (4.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (3.14e-2)" "unprognostic (9.02e-3)" "prognostic favourable (9.05e-4)" "unprognostic (3.12e-1)" "unprognostic (9.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.20e-1)" "unprognostic (7.65e-2)" "unprognostic (2.36e-3)" 34.0 78.2 16.4 9.3 17.9 14.8 15.5 5.8 22.3 15.7 13.8 31.9 30.4 28.9 8.6 23.4 20.5 15.7 17.6 10.2 13.5 10.3 9.0 49.9 11.9 14.4 20.3 16.7 20.5 7.7 9.6 12.5 16.0 11.8 18.0 6.4 15.1 72.7 33.0 16.8 14.5 27.4 7.1 13.1 7.3 13.6 16.8 16.2 15.2 9.5 13.6 13.8 11.9 15.0 0.6 0.4 4.7 0.8 0.4 2.2 0.5 13.7 32.5 4.0 25.0 8.2 15.2 7.0 5.1 16.2 4.4 10.8 6.6 26.9 8.6 4.8 4.0 39.3 4.6 13.6 1.1 5.3 2.0 4.7 27.0 6.9 10.3 0.6 9.1 11.8 5.8 6.2 3.8 5.0 9.1 31.1 1.0 34.0 11.4 7.9 5.4 6.5 8.1 2.9 49.7 3.6 7.2 4.8 19.9 6.0 48.2 14.3 16.3 9.1 5.7 2.4 12.0 5.7 3.2 9.1 0.8 3.9 14.0 6.8 12.4 0.0 0.8 0.4 1.8 0.5 0.4 0.6 0.8 0.3 0.4 0.4 1.6 2.2 4.7 0.4 0.6 0.3 0.2 0.5 16.4 17.9 5.8 22.3 13.5 10.3 20.3 16.7 11.8 16.2 SREBF2 "bHLHd2, SREBP2" ENSG00000198911 "Sterol regulatory element binding transcription factor 2" Q12772 22 41833079-41907308 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031962, HPA031963" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "HPA031962: AB_10601266, HPA031963: " "unprognostic (6.53e-2)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (1.50e-3)" "unprognostic (3.41e-3)" "unprognostic (9.08e-2)" "unprognostic (5.04e-2)" "unprognostic (1.31e-1)" "unprognostic (4.78e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (9.85e-2)" "prognostic favourable (1.37e-4)" "unprognostic (4.68e-2)" "unprognostic (1.92e-2)" "unprognostic (3.22e-1)" "unprognostic (7.93e-3)" 13.9 45.2 42.9 19.6 41.7 18.2 16.3 51.9 66.5 16.5 27.7 32.7 22.3 26.1 19.4 41.5 42.4 18.9 28.7 33.9 37.3 33.6 18.9 20.4 27.9 21.1 21.7 38.4 22.7 29.7 34.2 17.4 15.8 34.2 22.8 20.9 25.4 29.0 20.0 17.2 32.9 22.3 19.8 24.7 16.0 30.2 13.5 21.0 15.6 14.3 20.5 26.1 17.1 19.0 9.6 8.4 2.0 5.5 1.8 6.4 4.9 18.0 12.9 34.5 32.0 20.2 27.1 19.3 6.0 20.4 7.2 14.8 15.2 24.0 32.3 8.6 14.8 31.1 19.6 40.1 5.1 9.1 21.4 16.1 22.8 15.1 33.8 23.5 11.0 25.4 22.8 18.8 23.6 14.1 16.5 39.0 7.5 23.0 17.0 17.8 21.8 10.0 19.7 19.7 51.8 29.9 19.0 14.0 10.5 13.9 25.6 25.7 16.1 42.0 15.0 9.7 18.2 4.5 7.1 28.5 14.5 25.7 9.5 17.9 14.8 0.0 5.5 2.0 6.4 4.9 4.4 9.6 3.5 4.6 6.6 7.3 3.2 3.6 1.0 1.8 4.0 8.4 2.1 4.9 42.9 41.7 51.9 66.5 37.3 33.6 21.7 38.4 34.2 21.0 SREK1 "DKFZp564B176, SFRS12, SRrp508, SRrp86" ENSG00000153914 "Splicing regulatory glutamic acid and lysine rich protein 1" Q8WXA9 5 66139971-66183615 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037673, HPA037674, HPA059332" Enhanced Enhanced "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA037673: , HPA037674: AB_10671376, HPA059332: AB_2683983" "unprognostic (1.38e-1)" "unprognostic (2.51e-1)" "unprognostic (6.16e-2)" "unprognostic (1.52e-1)" "unprognostic (9.40e-2)" "prognostic favourable (2.54e-4)" "unprognostic (1.29e-2)" "unprognostic (7.67e-2)" "unprognostic (5.66e-3)" "unprognostic (2.19e-1)" "unprognostic (2.66e-2)" "unprognostic (5.48e-2)" "prognostic unfavourable (5.77e-4)" "unprognostic (1.63e-1)" "unprognostic (3.08e-1)" "unprognostic (6.76e-2)" "unprognostic (6.69e-2)" 11.1 13.4 12.8 15.6 14.5 38.0 16.3 24.2 14.7 12.9 10.1 8.9 17.3 10.9 18.5 15.9 9.6 13.6 10.6 8.2 12.4 13.3 10.6 10.5 12.5 12.7 11.1 12.0 12.2 14.3 23.4 30.3 12.2 11.4 12.2 10.7 11.9 12.4 16.5 11.9 20.2 12.6 13.7 11.3 14.9 11.0 11.0 11.4 19.5 14.3 9.8 9.5 10.6 10.5 6.5 6.0 8.5 5.6 7.7 6.0 2.8 5.0 6.2 8.8 5.2 4.2 7.9 8.7 6.0 3.4 3.2 3.5 9.3 6.0 7.6 7.6 4.6 6.9 4.5 6.0 5.7 5.3 10.1 7.3 16.0 6.7 3.7 6.6 8.5 4.5 5.9 4.0 4.5 5.2 6.5 5.6 3.4 4.9 6.8 15.3 4.7 3.2 9.2 4.0 5.4 5.6 9.2 10.4 7.0 5.7 2.7 4.8 6.7 8.5 5.4 5.2 3.2 7.1 6.1 5.9 4.1 8.6 5.1 10.6 5.7 8.5 5.6 5.2 5.0 3.9 5.4 6.2 4.7 6.0 4.2 6.5 5.6 5.6 4.1 7.7 3.7 6.0 4.4 2.8 12.8 14.5 24.2 13.8 12.4 13.3 11.1 12.0 11.4 11.4 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718144-64768685 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: " "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 16.3 12.1 12.2 10.9 16.5 8.3 13.8 13.9 12.8 17.0 16.1 4.1 10.8 8.6 12.5 12.4 25.3 10.8 11.6 13.1 12.3 10.7 18.0 13.1 13.2 12.1 10.6 9.5 14.6 11.7 10.8 20.5 20.2 11.9 15.5 10.4 4.7 10.3 15.0 15.7 18.7 15.2 12.6 15.5 19.0 10.9 11.7 11.5 19.2 13.9 17.9 12.3 24.1 14.6 4.0 8.2 3.8 4.1 4.1 4.7 2.1 6.9 3.5 9.1 7.0 8.2 13.6 5.5 10.6 8.5 7.3 9.7 6.6 7.7 7.2 10.9 8.5 4.6 8.3 16.0 12.8 8.6 10.1 7.9 6.6 5.9 8.5 8.4 8.0 8.9 15.2 10.1 13.2 10.7 7.0 4.5 8.6 2.5 15.1 8.6 4.7 4.9 7.2 7.5 11.6 12.4 5.6 4.0 5.9 6.7 4.8 10.1 6.1 16.4 10.8 5.3 3.2 6.4 11.0 6.6 11.3 6.5 10.2 13.3 7.2 3.8 4.1 1.7 4.5 3.0 4.7 3.9 4.6 4.2 3.4 4.0 4.5 4.7 1.6 4.1 1.9 8.2 4.0 2.1 12.2 16.5 13.9 12.8 12.3 10.7 10.6 9.5 11.9 11.5 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961961-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042737, HPA058150" Approved Supported Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA042737: AB_10796583, HPA058150: " "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavourable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 21.8 9.4 11.6 11.1 15.2 10.1 17.2 15.0 14.8 12.7 10.2 6.1 8.5 9.1 13.0 12.1 14.2 11.1 9.6 10.7 11.8 8.0 14.3 12.6 11.2 12.5 13.1 11.9 17.1 10.6 15.5 20.2 11.5 14.2 12.8 10.9 5.1 13.0 9.5 19.7 10.7 9.5 11.3 16.0 15.4 10.1 9.3 14.9 12.5 15.6 13.8 11.6 14.4 17.5 10.3 9.6 2.6 12.8 7.4 11.5 4.3 10.8 8.0 7.4 11.6 8.5 7.9 12.3 10.4 7.6 11.5 13.5 6.5 10.8 13.7 12.2 6.5 8.0 12.0 14.2 21.5 19.4 6.8 13.1 5.8 6.6 9.1 15.1 11.0 9.5 11.0 14.4 14.3 12.4 12.0 11.2 12.0 4.9 10.4 4.8 10.8 5.3 10.8 17.4 14.3 12.6 11.2 7.6 7.1 9.6 9.5 17.9 9.7 9.1 9.0 17.8 10.9 12.6 15.1 6.0 11.2 15.8 10.2 12.3 15.6 0.6 7.3 2.6 6.6 12.8 8.4 10.3 7.3 7.2 9.6 8.9 8.6 11.5 1.2 7.4 10.1 9.1 6.7 4.3 11.6 15.2 15.0 14.8 11.8 8.0 13.1 11.9 14.2 14.9 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavourable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavourable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 3.5 2.4 2.2 3.3 0.7 4.3 1.3 0.0 0.0 1.4 2.0 1.2 1.7 1.5 0.5 0.7 0.5 2.4 1.9 3.1 0.5 7.4 3.4 0.1 0.1 0.0 0.9 0.0 8.5 0.0 2.3 4.2 0.6 1.0 0.0 1.8 1.1 4.8 12.7 14.1 9.9 1.4 3.0 2.2 19.0 12.8 43.6 11.1 20.7 18.7 17.1 16.4 12.3 14.4 15.8 8.7 14.6 7.4 9.5 18.2 15.5 12.9 10.9 14.5 9.2 10.5 15.3 23.0 13.1 8.6 10.5 17.2 17.0 9.4 18.5 12.9 24.9 12.6 24.3 9.1 13.2 8.3 9.3 14.0 14.8 19.0 17.8 17.6 6.2 3.5 14.5 6.6 14.0 10.5 20.5 13.0 18.7 24.7 14.2 17.2 17.4 15.1 16.1 14.4 7.0 17.1 14.7 34.4 0.6 9.3 0.5 2.6 9.4 1.0 2.2 2.1 2.6 6.3 4.8 0.8 1.8 14.1 1.4 9.9 12.7 3.0 2.2 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell line enhanced" "Detected in some" "AF22: 9.5;HBEC3-KT: 8.2;hTCEpi: 8.2;RT4: 10.9;T-47d: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.5 0.4 0.6 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.1 0.8 8.2 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.9 0.7 1.1 0.0 0.0 4.1 10.9 1.1 1.2 0.2 2.9 0.1 10.6 0.0 0.0 0.0 0.4 0.1 0.1 2.8 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 SRI ENSG00000075142 Sorcin P30626 7 88205118-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 140.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Supported Nucleoplasm,Cytosol 1400000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favourable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 20.6 22.0 47.7 24.6 53.5 18.7 22.4 18.9 43.6 24.1 140.7 32.5 7.0 45.3 18.1 33.1 15.6 39.4 14.2 19.4 35.9 40.2 21.7 14.6 21.9 16.6 45.0 44.8 23.3 18.4 12.1 18.3 21.2 36.9 19.5 115.0 11.1 17.7 18.4 8.7 11.1 62.8 25.2 41.9 14.6 16.2 10.0 28.0 9.2 19.7 9.4 19.4 27.0 18.7 29.7 34.5 95.4 42.1 36.3 36.4 32.7 34.1 13.1 35.5 36.5 57.6 48.6 17.8 20.5 33.3 23.2 27.6 12.2 77.6 38.0 21.7 31.1 34.6 44.6 46.5 30.4 30.6 20.0 19.7 36.2 0.0 34.9 26.2 21.1 49.7 42.6 24.5 35.7 69.5 17.4 33.0 31.8 21.6 38.2 18.0 31.2 26.5 15.9 50.3 21.0 43.2 34.2 25.7 30.5 62.6 36.0 28.6 17.0 11.7 43.4 43.5 36.5 39.9 36.5 30.9 14.3 40.7 42.7 25.1 73.7 86.5 26.1 95.4 31.0 36.5 36.4 29.7 34.5 35.2 34.5 24.9 25.8 29.8 16.3 36.3 42.1 27.5 34.7 32.7 47.7 53.5 18.9 43.6 35.9 40.2 45.0 44.8 36.9 28.0 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060024 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 107.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavourable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 26.7 17.7 20.3 29.0 35.4 15.2 16.9 10.2 30.8 14.3 13.3 14.0 11.5 10.8 18.8 9.8 17.7 15.8 14.2 24.9 19.6 16.9 13.9 45.3 14.0 31.0 15.3 15.0 22.8 107.4 8.0 14.5 14.8 15.6 13.1 11.7 15.0 36.0 17.6 43.6 18.2 9.8 22.9 11.7 21.1 14.5 14.4 14.1 17.9 11.9 21.2 20.8 20.2 19.8 10.7 10.2 0.3 6.0 5.0 10.3 2.0 24.9 36.3 12.1 40.4 24.1 26.1 19.0 38.8 19.9 55.5 29.8 44.7 15.1 48.2 22.9 33.6 19.6 38.6 31.2 18.4 23.7 58.3 30.4 40.2 50.4 35.5 50.9 27.9 26.2 22.6 53.7 47.1 23.4 49.4 40.9 26.9 54.7 43.4 44.5 26.3 70.4 32.7 12.5 78.7 19.7 9.9 23.3 22.3 20.0 43.3 30.3 15.1 25.9 19.4 36.2 28.5 62.7 43.5 33.0 33.2 72.2 25.2 68.5 41.7 0.0 5.4 0.3 7.0 6.0 10.3 10.7 7.1 9.1 6.4 9.3 8.4 9.7 0.2 5.0 3.1 10.2 7.5 2.0 20.3 35.4 10.2 30.8 19.6 16.9 15.3 15.0 15.6 14.1 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.7;HaCaT: 2.6;MCF7: 4.9;RT4: 10.1;T-47d: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 8 "B-cells: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: " "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.3 0.0 0.3 0.5 0.3 0.0 1.1 1.1 0.3 0.3 1.8 0.3 0.3 0.4 0.3 10.2 0.4 0.0 0.3 0.3 0.3 0.0 0.9 0.3 0.3 0.3 0.3 0.3 0.3 2.7 0.0 0.3 0.3 0.3 2.2 0.0 0.3 2.5 0.3 0.3 1.7 0.8 0.3 0.3 2.5 4.2 0.9 0.3 0.3 0.3 0.3 0.8 1.5 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.2 2.3 0.0 2.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.0 0.8 0.0 0.2 0.0 0.0 10.1 0.8 1.0 0.3 2.1 0.4 2.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035739-40039188 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli 400000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favourable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 63.0 81.2 100.0 46.0 102.8 85.9 75.4 65.4 91.3 87.8 62.6 67.9 54.7 50.7 83.0 115.7 75.6 87.8 64.2 114.2 80.7 95.4 107.2 79.6 52.2 60.8 103.5 86.3 99.1 59.1 69.6 82.3 68.8 84.3 84.1 65.0 61.0 71.3 66.4 107.5 44.4 65.7 67.2 86.5 67.5 56.0 43.4 68.9 58.7 98.9 56.6 65.0 80.9 72.7 78.7 151.5 111.2 69.3 63.6 96.4 135.1 24.7 31.1 75.4 56.3 56.5 51.3 36.8 45.7 48.5 39.7 40.8 55.9 21.2 20.8 47.6 55.4 40.2 59.9 47.5 37.6 49.7 42.8 49.7 99.3 65.4 43.3 44.2 40.6 53.2 54.4 32.8 40.3 66.6 51.9 38.3 63.4 37.6 65.2 52.1 41.1 56.4 44.8 34.4 35.0 85.5 74.0 55.0 49.0 46.1 45.8 29.9 62.9 82.0 57.3 46.2 31.4 43.5 33.3 31.2 87.0 51.6 44.9 48.2 42.8 76.2 69.3 111.2 68.5 62.5 66.4 78.7 77.7 76.3 74.5 66.1 75.4 72.8 60.7 63.6 56.5 151.5 96.4 135.1 100.0 102.8 65.4 91.3 80.7 95.4 103.5 86.3 84.3 68.9 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029567 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA048977: , HPA062044: " "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 18.4 27.5 18.6 21.3 21.0 13.6 22.5 18.2 26.0 24.6 19.2 23.2 31.2 19.3 24.1 25.5 22.6 18.0 17.1 21.8 18.7 22.5 34.4 67.8 19.4 24.0 23.7 17.1 21.1 43.2 30.1 47.1 26.4 29.4 23.2 21.7 19.2 48.1 31.2 28.4 19.6 24.4 20.0 22.3 23.5 22.3 30.8 19.4 32.3 23.6 22.5 27.9 23.9 17.6 20.5 23.4 26.3 30.1 29.5 33.4 19.7 20.3 22.0 21.1 19.8 21.8 22.5 25.4 29.2 26.6 30.2 38.8 26.5 22.9 29.7 29.8 27.8 21.5 28.9 23.0 43.9 29.5 14.5 24.0 21.0 62.1 33.9 25.6 24.3 18.8 22.7 22.2 39.6 30.4 21.2 32.5 31.4 33.8 27.4 14.4 16.2 21.4 21.9 25.8 23.7 36.0 31.1 20.1 21.6 20.9 27.2 26.6 36.1 17.8 23.0 18.4 19.8 21.9 20.1 28.2 37.8 37.2 13.1 16.5 21.9 15.9 19.8 26.3 23.6 24.0 29.3 20.5 23.6 26.0 23.4 18.6 22.3 21.7 19.3 29.5 30.1 16.0 33.4 19.7 18.6 21.0 18.2 26.0 18.7 22.5 23.7 17.1 29.4 19.4 SRPK1 SFRSK1 ENSG00000096063 "SRSF protein kinase 1" Q96SB4 6 35832966-35921342 "Enzymes, Predicted intracellular proteins" "Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016431, HPA056486" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA016431: AB_1857478, HPA056486: AB_2683148" "unprognostic (4.65e-3)" "unprognostic (6.82e-3)" "unprognostic (2.54e-3)" "unprognostic (1.01e-3)" "unprognostic (7.74e-2)" "unprognostic (3.31e-2)" "prognostic unfavourable (7.90e-6)" "unprognostic (1.23e-2)" "unprognostic (2.54e-3)" "unprognostic (2.36e-2)" "prognostic unfavourable (6.53e-5)" "unprognostic (7.28e-2)" "unprognostic (2.21e-3)" "unprognostic (9.24e-2)" "unprognostic (4.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.55e-3)" 13.5 7.1 8.1 15.4 11.7 32.1 11.7 22.5 17.8 12.8 23.8 7.8 10.8 20.3 15.2 7.9 24.9 8.9 10.8 8.7 8.9 7.8 17.8 18.9 14.9 14.6 8.0 8.3 9.5 26.0 11.7 17.7 27.9 9.6 10.5 28.7 12.4 17.6 9.4 19.9 26.2 25.7 11.3 7.9 19.0 13.9 32.7 7.6 21.0 8.5 17.0 19.8 15.2 15.7 4.3 2.8 24.6 3.4 5.0 6.7 2.9 29.3 11.1 16.4 24.5 9.2 12.0 20.8 18.0 17.4 16.9 18.0 31.3 9.9 39.2 15.3 11.1 15.1 32.0 21.5 30.3 26.7 23.1 20.6 13.1 27.1 8.2 30.4 10.1 7.7 11.7 19.4 25.4 21.1 43.6 16.6 14.1 10.4 31.3 23.7 13.4 12.2 22.1 19.7 24.2 16.9 49.3 35.1 12.9 18.5 17.6 12.5 9.9 20.3 15.2 15.9 12.4 10.7 22.6 9.8 21.6 36.8 6.3 35.4 14.1 24.5 2.1 13.7 4.3 2.5 6.1 4.3 5.7 5.7 2.8 3.3 4.8 5.2 24.6 5.0 3.4 1.6 6.7 2.9 8.1 11.7 22.5 17.8 8.9 7.8 8.0 8.3 9.6 7.6 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 9.9 12.1 24.8 10.1 27.6 7.1 13.3 28.4 47.1 12.7 9.4 21.0 7.8 8.2 13.2 11.9 11.9 10.9 11.6 10.4 26.4 28.6 10.3 10.1 9.2 11.5 27.2 30.2 13.0 10.5 11.9 15.3 12.0 27.3 14.0 10.9 7.9 10.1 11.1 7.9 16.9 8.2 13.3 23.1 12.0 11.3 69.3 32.3 22.1 11.3 4.7 14.0 13.6 9.7 12.2 7.3 58.2 8.1 10.0 11.9 6.0 13.1 8.7 13.9 27.6 14.9 16.9 7.8 12.8 15.1 12.9 15.1 6.8 11.2 8.3 16.4 16.6 7.9 14.1 13.6 16.5 14.4 12.5 11.8 8.2 5.9 17.3 11.2 17.7 11.7 25.3 10.9 20.6 22.1 11.6 34.2 14.2 24.8 41.5 8.5 11.5 9.6 13.5 15.4 18.2 18.6 20.4 20.5 14.2 14.6 22.0 13.5 8.2 7.8 14.5 23.8 17.4 22.6 12.0 37.6 37.0 20.5 9.3 11.6 17.7 11.2 8.1 26.0 11.9 5.5 7.1 12.2 9.0 8.9 7.3 11.6 8.5 9.7 58.2 10.0 6.2 6.4 10.1 6.0 24.8 27.6 28.4 38.7 26.4 28.6 27.2 30.2 27.3 32.3 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.1;SH-SY5Y: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 14.1 10.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 SRSF2 "PR264, SC-35, SC35, SFRS2, SFRS2A" ENSG00000161547 "Serine and arginine rich splicing factor 2" Q01130 17 76734115-76737374 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049905 Supported Approved Nucleoplasm,Cytosol 140000 Nucleoplasm Cytosol "HPA049905: " "unprognostic (2.50e-1)" "unprognostic (2.16e-3)" "unprognostic (2.73e-3)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "prognostic unfavourable (3.53e-8)" "unprognostic (1.19e-1)" "unprognostic (7.79e-3)" "unprognostic (7.03e-3)" "unprognostic (1.92e-1)" "unprognostic (1.07e-3)" "prognostic unfavourable (1.05e-7)" "unprognostic (3.85e-2)" "unprognostic (8.05e-2)" "unprognostic (1.95e-1)" "prognostic favourable (9.87e-4)" 35.4 40.2 20.6 56.6 30.3 73.1 35.3 33.3 36.2 42.1 37.7 34.0 19.5 41.8 37.0 33.6 51.1 35.1 34.8 32.4 19.9 22.6 36.9 66.7 37.3 64.3 21.6 24.0 47.1 34.2 29.1 33.8 51.2 29.5 31.3 36.5 35.5 35.6 40.5 44.9 41.1 46.6 25.5 23.9 52.5 35.6 29.2 18.9 105.3 41.1 41.3 64.5 30.6 35.7 11.1 30.2 4.2 23.5 15.6 12.7 12.2 47.7 38.5 45.7 31.9 11.2 9.5 47.5 30.9 22.9 35.9 33.3 40.4 33.5 73.6 22.6 29.0 43.3 45.3 35.7 36.1 30.8 79.0 55.2 37.3 46.9 12.7 61.0 33.1 10.5 8.1 29.7 8.6 28.0 56.1 32.5 28.0 38.2 66.9 66.6 53.5 55.0 67.8 49.2 54.3 24.0 34.4 39.0 55.7 35.2 30.3 16.6 37.1 44.6 29.2 33.1 42.7 22.0 49.9 42.8 32.2 85.2 29.8 48.5 27.3 1.0 17.5 4.2 12.3 23.5 12.6 11.1 8.5 12.7 30.2 9.8 9.8 9.0 2.1 15.6 14.7 22.4 10.6 12.2 20.6 30.3 33.3 36.2 19.9 22.6 21.6 24.0 29.5 18.9 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: " "unprognostic (2.08e-3)" "prognostic favourable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 69.2 20.2 49.6 22.3 30.7 26.5 27.5 33.4 36.0 27.3 29.0 25.4 44.5 71.8 17.7 45.3 33.1 37.5 47.7 32.3 61.3 20.6 54.1 54.3 27.8 35.7 50.4 41.0 55.1 30.4 31.5 33.8 37.8 37.5 42.8 16.9 56.2 57.9 34.2 29.1 18.7 49.7 23.6 27.6 34.7 85.3 25.9 37.0 56.7 34.4 43.1 37.4 42.5 46.6 16.0 42.9 17.4 31.2 41.7 27.2 116.1 37.7 43.0 22.0 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 SRSF8 "SFRS2B, SRP46" ENSG00000263465 "Serine and arginine rich splicing factor 8" Q9BRL6 11 95067197-95071224 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA049905 Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049905: " "unprognostic (2.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (1.55e-2)" "unprognostic (1.05e-1)" "prognostic favourable (9.99e-7)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (5.39e-2)" "unprognostic (2.75e-3)" 5.5 6.4 6.1 4.9 9.6 5.3 9.6 6.0 14.3 8.7 6.9 8.0 9.2 7.1 8.0 8.0 6.8 7.4 6.8 6.4 6.5 9.5 6.8 6.1 8.7 6.1 9.5 10.7 10.4 9.7 8.2 6.5 7.2 9.4 7.5 10.1 11.4 8.6 5.4 6.6 7.8 7.1 4.8 9.0 7.1 3.0 5.0 3.7 11.6 5.3 6.5 6.1 5.5 7.9 3.8 7.0 2.0 5.6 12.4 3.7 4.3 4.6 11.6 0.0 15.5 9.8 13.1 6.6 7.4 3.1 3.4 10.8 14.4 23.4 19.7 10.1 9.6 9.7 14.4 3.6 14.1 10.5 19.8 5.4 9.7 11.4 19.8 10.8 12.6 15.4 3.3 15.6 9.7 14.9 13.0 6.1 6.0 10.2 17.7 6.1 12.8 12.8 3.5 18.7 12.3 14.7 14.7 15.1 8.2 14.6 9.5 5.8 11.0 8.9 6.1 8.2 8.2 6.7 7.0 10.7 12.6 3.1 13.3 13.3 7.0 2.0 0.6 5.7 1.1 8.2 7.9 9.6 8.2 3.8 6.9 12.4 9.5 0.6 5.6 1.0 3.5 9.9 3.7 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461668-120469793 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA049849: " "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavourable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavourable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 25.8 50.7 29.5 37.9 28.5 33.8 31.2 24.9 30.6 31.5 36.4 21.7 35.5 29.8 26.7 37.4 53.6 32.6 42.3 20.7 26.7 27.9 37.2 42.5 27.2 41.4 31.6 25.3 37.1 68.5 34.9 36.5 49.3 27.9 33.1 35.8 29.3 33.9 30.4 17.0 32.4 31.0 25.1 23.8 39.6 33.0 52.5 25.0 53.1 43.7 36.8 51.0 26.5 35.7 22.1 18.7 28.8 15.4 15.7 14.8 5.1 54.8 38.4 59.0 38.0 27.0 27.1 63.2 37.8 34.0 48.5 41.8 46.1 25.9 53.6 44.2 31.6 32.9 53.1 53.7 53.6 40.1 54.5 45.7 25.8 45.0 34.9 56.2 41.8 28.7 34.7 42.1 36.8 44.1 57.3 16.2 41.7 76.9 55.4 109.9 73.9 33.6 62.0 24.8 51.7 42.0 70.2 52.4 37.4 44.3 23.6 43.6 71.0 49.7 38.4 36.1 42.8 27.1 40.8 50.0 37.4 67.0 38.0 42.5 37.6 12.3 10.7 28.8 14.8 11.7 11.2 22.1 11.7 13.0 13.9 17.7 11.5 12.8 12.2 15.7 15.4 18.7 11.9 5.1 29.5 28.5 24.9 30.6 26.7 27.9 31.6 25.3 27.9 25.0 SS18 "SSXT, SYT" ENSG00000141380 "SS18, nBAF chromatin remodeling complex subunit" Q15532 18 26016253-26091217 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055741, HPA059539" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA055741: , HPA059539: " "unprognostic (2.03e-2)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.95e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "unprognostic (4.59e-2)" "unprognostic (1.53e-2)" "unprognostic (1.63e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (2.47e-1)" "prognostic favourable (4.86e-4)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (1.40e-2)" "unprognostic (1.30e-1)" 26.1 40.5 18.7 30.4 26.4 15.5 26.6 17.6 20.2 24.8 21.4 31.8 32.1 14.0 31.7 32.7 29.8 27.2 23.4 22.4 21.6 16.1 30.0 30.9 21.9 25.8 32.6 16.3 39.4 20.6 39.4 41.8 43.2 25.3 28.6 18.7 26.1 26.0 33.5 10.3 31.3 22.6 31.0 23.7 24.7 22.5 28.3 32.6 27.8 35.6 24.7 35.2 25.5 25.9 15.9 13.1 19.9 17.1 20.7 17.6 13.1 19.0 13.8 33.9 16.6 27.0 24.5 17.1 23.4 21.3 20.7 19.8 9.0 15.8 33.2 18.7 27.4 24.9 18.4 22.7 25.6 21.2 8.8 16.4 20.3 14.6 21.4 25.2 25.5 31.4 26.8 26.0 28.5 15.5 12.0 17.1 28.6 19.1 10.3 14.6 6.4 13.4 12.0 26.4 15.9 21.9 22.5 14.5 21.9 35.8 16.6 10.1 16.9 14.9 17.7 43.6 8.7 10.0 22.9 30.8 20.6 24.0 20.4 17.5 23.1 19.9 11.7 16.5 15.1 17.1 17.6 15.9 14.6 15.7 13.1 13.0 15.5 17.4 5.6 20.7 16.7 7.4 15.7 13.1 18.7 26.4 17.6 20.2 21.6 16.1 32.6 16.3 25.3 32.6 SS18L1 "CREST, KIAA0693" ENSG00000184402 "SS18L1, nBAF chromatin remodeling complex subunit" O75177 20 62143795-62182484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011827, HPA059046" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB011827: AB_778216, HPA059046: " "unprognostic (4.12e-2)" "unprognostic (5.82e-2)" "unprognostic (1.54e-1)" "unprognostic (3.03e-2)" "unprognostic (6.57e-2)" "prognostic favourable (8.00e-5)" "unprognostic (1.39e-1)" "prognostic favourable (3.74e-4)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" "unprognostic (2.47e-3)" "unprognostic (6.43e-2)" "unprognostic (2.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (9.94e-3)" 6.6 8.9 11.9 7.7 12.7 7.7 8.6 35.9 15.8 7.0 7.0 9.9 12.2 9.5 9.7 10.9 9.3 6.9 7.2 6.4 11.5 10.9 11.5 33.3 8.2 7.4 11.2 14.5 10.0 10.4 8.4 10.7 8.8 13.1 8.7 7.8 7.4 8.6 11.8 19.2 23.7 9.0 7.7 9.9 9.2 8.8 10.7 10.9 6.0 8.3 6.7 7.1 6.8 8.6 3.6 1.3 2.5 2.7 1.6 2.8 0.5 6.4 7.7 10.7 9.7 4.8 5.6 7.8 6.1 2.4 10.2 5.1 26.3 6.0 3.9 8.1 3.4 16.7 6.6 5.8 9.3 2.7 4.3 17.5 16.1 13.6 3.6 6.3 15.6 3.4 12.8 5.2 4.4 4.6 11.7 7.6 5.7 7.6 9.6 9.9 4.3 8.8 10.7 13.9 4.4 7.6 8.2 20.4 11.3 10.9 13.3 9.1 12.5 10.2 5.4 19.5 11.8 7.2 8.5 8.5 7.6 3.5 9.7 6.3 6.4 0.3 1.6 0.6 1.7 1.1 1.1 0.7 0.9 1.4 1.3 3.6 2.8 0.9 2.5 1.6 2.7 0.8 0.8 0.5 11.9 12.7 35.9 15.8 11.5 10.9 11.2 14.5 13.1 10.9 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: " "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favourable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 15.8 7.3 14.6 13.2 18.8 15.3 9.1 10.3 11.8 15.4 17.4 13.9 14.5 21.7 9.5 7.0 8.9 17.5 14.4 17.0 10.8 20.4 23.5 14.2 23.3 13.6 30.7 18.6 12.0 9.3 12.4 11.6 16.8 21.2 32.7 12.4 15.0 21.5 38.1 23.1 17.9 11.4 10.7 30.1 17.0 20.0 8.2 11.8 8.7 13.7 13.9 18.0 28.7 9.8 9.1 14.8 21.7 18.7 23.8 37.6 36.8 13.3 33.7 8.6 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519098 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.2;BJ: 18.2;fHDF/TERT166: 18.4;U-87 MG: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" 44000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavourable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 10.7 2.1 3.3 4.9 1.8 0.1 8.1 3.5 1.9 33.0 18.4 1.6 6.3 2.1 33.1 15.2 9.8 11.0 30.9 10.6 1.4 0.6 2.5 1.8 5.8 1.2 1.2 1.6 17.0 1.8 0.3 13.4 2.5 3.0 6.8 3.2 4.7 1.9 15.7 4.7 3.8 5.8 23.8 3.2 7.3 6.9 5.7 1.4 0.5 2.4 4.2 1.6 19.3 10.9 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.3 19.2 0.0 18.2 4.1 2.6 3.0 0.2 0.0 0.7 0.2 18.4 0.0 0.0 0.0 1.4 0.0 0.1 3.2 0.8 0.0 3.7 0.1 5.7 9.0 0.0 3.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.9 0.1 2.0 0.0 2.0 0.2 0.2 0.0 0.3 0.2 0.7 7.3 0.8 1.0 0.7 2.9 0.2 0.0 0.1 19.6 0.2 4.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 1.8 3.5 1.9 1.4 0.6 1.2 1.6 3.0 1.4 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: , HPA039989: " "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favourable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavourable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.1 8.1 23.6 4.0 20.6 17.1 6.7 28.7 27.9 10.1 13.4 8.3 18.7 0.3 9.3 20.2 14.0 5.7 13.8 19.6 7.4 6.4 16.3 34.7 6.7 15.2 8.3 15.3 10.1 20.3 17.4 23.7 52.8 7.3 9.0 28.1 8.1 7.3 11.7 1.6 19.1 5.5 9.5 5.6 28.6 4.9 4.1 3.6 16.8 6.0 25.7 4.3 18.3 21.0 24.0 11.6 8.6 14.9 6.2 2.7 6.5 11.2 5.0 17.8 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 SSH1 KIAA1298 ENSG00000084112 "Slingshot protein phosphatase 1" Q8WYL5 12 108778192-108857590 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019845 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA019845: AB_1857497" "unprognostic (1.18e-3)" "unprognostic (3.00e-1)" "unprognostic (2.49e-1)" "unprognostic (2.70e-2)" "unprognostic (9.40e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (5.80e-5)" "unprognostic (3.28e-2)" "unprognostic (3.69e-2)" "unprognostic (1.72e-3)" "unprognostic (7.12e-2)" "unprognostic (3.42e-1)" "unprognostic (1.71e-2)" "unprognostic (1.41e-1)" "unprognostic (8.66e-2)" "unprognostic (9.55e-2)" "unprognostic (6.22e-2)" 7.3 7.8 8.5 7.4 8.1 10.6 9.3 20.3 8.8 7.4 8.5 6.8 13.1 4.4 9.8 7.9 7.6 8.2 8.3 10.1 8.0 6.9 5.8 7.4 10.1 8.7 7.7 5.2 7.9 8.0 9.7 6.8 7.8 8.4 6.5 6.5 15.0 5.9 8.0 21.4 7.1 6.5 10.4 8.1 8.6 7.1 5.2 6.6 2.0 7.0 7.9 6.6 10.0 13.3 1.8 2.0 5.7 4.0 2.1 2.9 1.2 5.1 6.8 4.5 3.5 8.5 7.2 4.0 6.6 14.1 6.0 5.4 3.4 2.5 2.4 4.7 15.5 5.1 2.7 11.1 4.9 4.9 2.6 5.7 3.1 2.1 4.5 2.9 15.1 9.9 3.8 5.5 12.2 5.5 1.3 2.0 15.8 2.9 3.3 4.2 3.1 5.4 2.4 5.3 3.2 2.4 9.2 3.3 4.5 5.8 1.5 12.7 2.1 2.6 4.3 10.9 4.6 6.5 3.7 3.9 3.5 3.0 5.7 2.4 34.2 4.2 2.4 4.8 2.9 4.0 2.7 1.6 1.5 2.5 1.6 1.8 1.4 1.6 5.7 2.1 3.2 2.0 1.7 1.2 8.5 8.1 20.3 8.8 8.0 6.9 7.7 5.2 8.4 6.6 SSH3 "FLJ10928, FLJ20515" ENSG00000172830 "Slingshot protein phosphatase 3" Q8TE77 11 67303448-67312607 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 23.6;RT4: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.8;eosinophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019949, HPA019957" Approved Approved "Nuclear speckles,Plasma membrane,Actin filaments,Cytosol" "Nuclear speckles, Cytosol" "Plasma membrane, Actin filaments" "HPA019949: AB_1857498, HPA019957: AB_1857499" "unprognostic (4.38e-2)" "unprognostic (1.37e-1)" "unprognostic (3.50e-3)" "unprognostic (3.73e-2)" "unprognostic (2.61e-3)" "unprognostic (9.30e-2)" "unprognostic (2.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-2)" "prognostic unfavourable (2.89e-4)" "unprognostic (1.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (6.78e-3)" 8.6 5.5 5.6 6.8 9.7 8.1 13.5 17.8 9.4 14.6 15.9 15.4 19.5 12.4 10.1 10.6 27.0 15.2 20.5 7.7 6.0 6.1 10.3 7.5 9.0 3.5 13.6 5.4 17.1 12.0 11.3 7.4 20.0 8.5 19.8 9.2 11.9 19.1 30.5 5.2 18.2 13.6 13.1 9.3 6.9 13.9 4.2 9.7 0.8 12.8 14.0 13.2 33.3 18.6 0.3 1.6 10.8 2.3 1.5 2.2 1.0 6.1 6.7 0.1 0.2 4.7 4.9 7.3 4.0 5.4 2.1 2.0 7.2 16.3 0.3 12.5 3.7 23.6 2.2 17.0 1.1 1.3 2.5 1.5 10.8 2.9 3.3 0.3 6.0 4.3 15.8 3.1 3.2 2.4 0.0 0.6 2.5 20.8 0.2 3.0 1.5 5.4 7.6 0.2 1.1 6.9 35.7 1.4 2.2 9.4 14.0 4.4 19.6 5.2 3.8 1.7 3.7 4.7 1.1 0.6 0.3 0.2 4.8 2.7 1.6 10.8 1.4 10.5 2.2 2.3 1.7 0.3 2.1 1.8 1.6 0.2 0.8 0.9 4.5 1.5 1.1 1.1 1.8 1.0 5.6 9.7 17.8 9.4 6.0 6.1 13.6 5.4 8.5 9.7 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.6;ASC TERT1: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA066432: " "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavourable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.6 1.1 3.1 0.0 20.6 11.9 0.2 6.1 8.5 0.8 2.4 0.0 7.5 0.0 1.3 8.3 2.4 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 7.4 0.7 2.7 0.6 0.3 0.0 0.1 6.4 1.4 0.4 1.8 6.9 2.0 0.2 8.5 2.3 1.9 6.3 0.3 6.0 2.3 0.4 5.9 0.6 0.3 2.2 2.9 1.5 2.9 1.5 0.2 0.8 0.1 4.5 0.0 7.4 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325985-57335877 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol 8300 Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 25.3 23.2 23.5 37.7 25.1 32.0 38.4 28.5 27.6 27.2 30.5 19.4 28.8 23.0 34.9 28.2 34.6 34.4 33.1 28.4 22.7 20.3 22.6 27.8 26.5 33.7 21.6 20.7 41.8 39.3 39.7 31.2 34.8 22.0 26.6 33.0 17.2 32.8 27.5 47.7 32.9 26.2 28.9 17.1 28.3 29.3 28.3 25.2 44.0 45.9 37.0 42.5 28.7 51.7 10.2 10.3 4.5 5.2 6.9 12.0 4.7 57.1 55.2 52.4 38.3 16.5 18.5 25.6 31.5 30.4 55.0 39.5 37.9 42.7 69.5 33.7 27.6 44.2 83.1 49.0 69.5 48.4 46.6 44.3 40.7 40.7 26.1 73.4 33.3 18.5 30.0 56.5 78.8 35.9 60.2 35.2 37.4 38.7 74.3 65.0 68.8 34.0 62.8 88.6 67.5 25.7 41.3 54.9 46.5 44.6 38.3 46.4 46.4 29.0 27.0 37.6 49.7 50.6 53.8 41.1 40.6 71.8 31.8 41.5 49.5 0.8 4.3 4.5 9.4 5.2 9.1 8.7 8.1 10.2 6.1 10.2 8.9 12.0 1.2 6.9 5.0 10.3 9.6 4.7 23.5 25.1 28.5 27.6 22.7 20.3 21.6 20.7 22.0 25.2 SSU72 HSPC182 ENSG00000160075 "SSU72 homolog, RNA polymerase II CTD phosphatase" Q9NP77 1 1541673-1574869 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069290, HPA070604" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA069290: , HPA070604: " "unprognostic (3.33e-2)" "unprognostic (2.79e-2)" "unprognostic (6.37e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "unprognostic (9.84e-2)" "unprognostic (2.40e-3)" "unprognostic (2.43e-2)" "unprognostic (3.23e-1)" "unprognostic (3.23e-1)" "unprognostic (6.75e-2)" "unprognostic (1.36e-1)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "unprognostic (8.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.06e-1)" 44.1 32.5 48.0 33.6 51.5 29.3 73.9 42.3 51.5 37.2 40.1 25.4 39.3 41.3 32.6 51.8 45.7 46.2 35.3 44.4 40.7 42.5 38.0 50.9 37.5 49.0 39.4 39.0 38.0 61.8 33.9 39.9 35.8 36.9 33.9 35.9 34.1 54.2 35.8 107.1 36.9 40.8 35.4 35.0 41.7 38.5 28.0 28.4 37.0 50.9 45.3 36.3 30.8 42.2 35.5 30.1 62.0 28.8 20.7 46.5 28.1 40.6 26.0 18.8 29.0 32.5 31.3 19.3 35.3 27.6 30.9 32.2 24.4 47.2 41.4 19.4 27.8 31.8 30.3 29.1 30.2 34.4 35.9 25.9 22.9 38.6 36.7 32.8 22.7 27.9 24.6 33.1 31.6 28.9 44.8 32.0 24.4 36.2 37.5 52.7 32.9 39.6 29.9 30.4 57.8 33.8 12.5 34.8 23.9 23.9 61.5 104.3 32.0 28.6 21.9 29.8 18.9 33.5 30.3 39.1 46.9 51.6 31.2 52.3 14.4 37.1 28.3 53.6 25.9 28.8 31.9 35.5 34.4 30.7 30.1 33.1 42.2 34.1 62.0 20.7 25.4 19.0 46.5 28.1 48.0 51.5 42.3 51.5 40.7 42.5 39.4 39.0 36.9 28.4 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Cell line enhanced" "Detected in some" "Daudi: 28.1;Karpas-707: 40.8;U-2197: 9.5" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 40.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 0.0 0.0 2.0 0.0 2.3 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell line enhanced" "Detected in some" "PC-3: 3.1;U-2197: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.3;PC-3: 5.1;T-47d: 2.2;U-2197: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.5 0.1 0.0 0.0 0.2 5.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 2.2 0.0 1.0 0.0 0.5 3.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196763 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3;thyroid gland: 2.9" "Cell line enriched" "Detected in some" 4 "BEWO: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.4 0.0 0.1 0.1 0.4 1.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.0 0.5 0.2 0.1 0.8 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.1 1.6 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.8 0.0 4.3 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.5 0.2 0.9 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.6 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.4 0.3 0.4 0.1 0.5 0.1 0.4 0.9 0.6 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644090-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 7.9;RT4: 4.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.29e-1)" 0.1 0.2 0.2 0.4 0.1 0.7 0.1 0.1 1.0 0.1 0.2 0.6 0.2 0.0 1.5 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.1 1.5 0.1 0.0 0.1 0.6 0.4 1.0 0.4 0.0 0.2 0.1 0.0 0.2 1.0 0.7 0.3 0.4 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.1 0.5 0.3 1.7 0.7 0.3 0.0 0.0 7.9 0.0 0.2 0.2 0.0 0.1 0.2 1.4 0.1 1.0 0.7 0.2 0.0 0.0 0.4 0.5 0.0 0.0 4.2 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.3 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.3 0.7 0.1 0.0 0.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell line enhanced" "Detected in some" "CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047014 Approved Nucleoplasm,Vesicles 220000 "Nucleoplasm, Vesicles" "HPA047014: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favourable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.2 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.0 0.0 0.0 35.7 72.1 26.0 2.7 0.0 50.5 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.2 0.1 0.0 0.0 47.3 4.7 21.5 2.9 0.0 0.2 33.4 0.0 50.5 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.4 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell line enhanced" "Detected in some" "A549: 5.7;NTERA-2: 4.9;PC-3: 6.5;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 6.5 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HaCaT: 6.8;HEL: 10.9;K-562: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favourable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.1 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.1 0.0 6.8 0.0 1.8 0.0 0.0 0.0 10.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell line enhanced" "Detected in many" "HDLM-2: 34.9;RPMI-8226: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.1 5.4 1.4 6.9 9.7 7.4 1.0 5.5 6.1 5.6 3.3 3.0 5.8 20.1 8.4 6.8 7.7 2.8 5.8 0.9 34.9 2.4 6.4 17.2 11.4 11.9 0.5 6.7 9.1 6.2 5.0 4.5 14.9 4.6 13.5 2.7 1.4 1.2 0.7 1.6 13.3 6.0 3.6 49.4 5.7 0.1 11.8 2.6 8.0 17.3 1.0 3.5 4.1 10.6 4.6 5.3 14.3 8.6 21.9 11.3 6.3 9.2 2.8 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 101.1" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favourable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 11.1 20.0 12.9 5.0 18.0 12.0 12.3 63.0 25.7 16.7 10.7 9.2 21.6 9.8 12.3 31.2 8.5 15.8 10.0 19.8 10.9 12.3 23.1 31.5 20.0 5.4 11.1 18.7 15.9 30.8 17.6 30.1 21.8 14.9 11.7 10.1 11.0 24.9 19.3 10.1 9.7 9.7 11.3 8.1 9.1 13.5 15.9 8.2 2.9 23.8 7.6 7.0 10.0 9.8 2.6 6.2 1.6 3.3 7.6 10.6 3.2 13.0 7.5 12.3 10.7 14.3 9.8 5.7 10.3 13.0 10.6 15.8 10.0 15.5 3.4 11.3 9.0 10.7 10.5 11.0 14.4 4.6 15.1 10.2 12.6 8.9 9.9 11.5 17.5 7.5 11.2 13.7 9.6 11.1 15.0 24.6 10.0 7.5 0.1 8.8 11.8 9.0 2.9 8.3 14.3 11.3 7.0 18.4 15.1 11.7 51.5 13.6 4.4 9.5 8.4 12.4 4.9 13.4 10.1 15.5 11.8 12.8 10.1 10.3 12.4 1.6 3.3 0.4 8.3 1.2 5.9 2.6 5.1 7.3 6.2 0.9 3.5 3.6 0.1 7.6 1.2 6.2 10.6 3.2 12.9 18.0 63.0 25.7 10.9 12.3 11.1 18.7 14.9 8.2 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell line enriched" "Detected in some" 8 "WM-115: 51.7" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" "Plasma membrane, Midbody" "HPA043813: , HPA046771: " "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 51.7 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380344-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.9;HaCaT: 16.1;SH-SY5Y: 23.1;U-251 MG: 14.0;U-87 MG: 23.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 21.3" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 3.7 6.4 1.4 1.1 5.4 0.6 5.7 21.3 0.8 9.2 4.6 1.2 4.7 0.3 9.0 2.2 3.3 4.0 5.1 0.7 0.9 3.9 3.3 1.8 15.0 0.7 1.6 0.2 3.2 0.6 18.8 1.8 0.6 5.2 17.2 1.1 1.9 1.8 5.7 4.0 1.6 0.6 12.5 1.2 0.9 1.5 2.4 0.2 0.7 1.0 4.4 0.5 8.4 15.5 0.0 0.6 3.2 0.4 2.8 3.8 0.2 3.5 1.5 0.8 0.0 3.2 1.0 0.0 8.9 0.2 1.9 2.2 0.0 0.0 0.0 3.7 21.9 16.1 1.1 3.9 2.0 0.0 2.8 0.5 4.8 0.1 0.0 8.9 0.1 1.2 0.1 0.0 0.3 0.0 0.0 0.2 0.2 0.0 1.8 0.1 6.7 1.4 0.0 0.0 0.0 5.1 0.0 3.0 23.1 3.6 2.5 0.0 0.0 0.9 4.0 0.2 9.3 0.3 14.0 0.0 0.0 0.0 23.8 3.5 3.9 0.0 0.1 3.2 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.1 0.0 3.8 0.2 1.4 5.4 21.3 0.8 0.9 3.9 1.6 0.2 5.2 0.2 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251193 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 222.7;tongue: 107.8" "Cell line enriched" "Detected in some" 23 "RH-30: 224.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 8.0" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039285: , HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favourable (2.01e-4)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 3.7 0.2 0.1 0.6 0.1 1.6 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 10.3 3.2 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.2 0.0 0.1 0.1 0.4 0.2 0.2 0.0 2.3 0.2 0.1 5.4 0.0 222.7 0.2 0.3 0.1 0.3 1.1 0.1 1.2 0.0 0.1 1.2 107.8 3.8 0.1 0.1 1.1 4.9 0.5 8.0 0.0 0.3 1.8 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.0 1.6 9.6 1.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.5 0.1 3.4 0.0 0.1 1.2 224.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 4.6 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.9 0.1 3.1 0.0 0.0 6.1 0.5 0.0 8.0 0.1 1.1 0.0 0.3 4.9 0.5 0.0 0.1 0.3 0.0 4.0 1.4 0.3 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336233-136752403 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035015: AB_10603117, HPA058653: " "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 26.0 10.9 13.3 12.9 15.6 12.9 17.9 46.5 14.3 24.8 14.9 11.2 12.0 9.1 21.3 10.8 12.8 16.8 10.5 12.3 12.9 7.4 12.0 10.2 13.3 12.9 14.0 7.2 22.6 13.8 17.3 20.4 20.5 14.3 16.3 14.3 13.0 14.5 14.0 20.8 17.2 12.7 16.8 9.5 14.5 12.2 9.5 18.9 29.7 15.6 11.7 18.6 17.0 29.0 8.9 6.7 13.2 4.8 8.0 7.4 2.9 17.3 9.0 15.3 13.1 11.5 20.0 8.2 19.5 25.1 18.4 17.5 15.3 7.7 13.6 12.4 20.2 12.1 16.4 8.9 25.2 16.6 7.7 14.5 13.1 8.4 8.8 25.2 14.6 12.6 10.1 13.5 15.2 14.2 9.2 27.5 11.6 14.8 16.6 8.2 9.9 7.2 14.9 16.6 18.1 10.1 12.5 7.5 12.0 20.9 8.4 8.8 11.9 10.7 11.9 21.3 15.5 18.9 17.2 20.6 14.1 30.9 13.1 8.6 13.5 4.8 4.4 6.5 7.0 4.6 7.4 8.9 5.9 6.3 4.1 7.3 6.7 5.2 13.2 8.0 4.8 6.7 6.9 2.9 13.3 15.6 46.5 14.3 12.9 7.4 14.0 7.2 14.3 18.9 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.2 4.9 5.9 12.9 15.4 5.3 11.3 13.0 7.3 9.3 5.2 5.2 7.1 9.0 16.0 5.5 5.4 10.4 11.8 8.7 4.3 5.1 3.7 7.8 14.8 7.4 10.0 11.8 10.0 13.6 18.4 7.8 3.3 5.0 14.9 5.3 3.9 5.8 3.0 7.6 3.2 6.0 3.8 11.4 9.3 2.6 4.0 6.2 5.6 9.3 7.5 6.9 10.2 16.3 5.3 12.8 6.8 4.2 4.3 4.6 12.4 6.0 8.9 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 158.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 11000 Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: " "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 12.9 12.8 22.1 13.9 23.0 10.5 17.8 20.1 21.8 18.1 18.4 35.0 13.6 17.8 23.1 15.4 22.7 16.5 14.7 19.0 23.3 21.2 19.6 16.9 13.4 15.3 33.0 14.3 16.3 15.1 20.9 17.8 20.6 26.3 20.2 20.7 14.6 18.3 15.7 30.1 14.4 25.2 19.0 54.7 13.8 15.6 13.3 22.3 18.4 20.1 15.9 19.0 16.8 16.4 17.6 16.9 27.8 17.8 16.7 20.7 12.3 5.3 6.2 4.9 4.5 4.6 5.5 5.6 3.3 4.5 6.0 5.8 10.3 5.1 4.4 5.2 2.7 4.2 5.2 11.5 6.9 7.8 5.9 6.0 4.3 8.0 6.4 4.9 7.2 4.4 8.3 7.1 10.3 3.5 6.5 6.8 158.8 6.5 7.6 4.4 7.8 3.3 5.3 12.9 6.3 6.5 6.0 9.0 6.6 4.0 4.9 6.9 4.6 2.9 3.1 5.4 6.5 3.3 5.8 6.5 6.2 3.4 6.7 5.3 6.3 22.6 16.2 27.8 14.4 17.8 15.4 17.6 16.7 14.0 16.9 16.2 17.5 13.2 24.1 16.7 15.7 16.4 20.7 12.3 22.1 23.0 20.1 21.2 23.3 21.2 33.0 14.3 26.3 22.3 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Group enriched" "Detected in some" 5 "Daudi: 62.1;U-698: 27.8" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 7.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 8.9 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavourable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.8 12.3 5.5 9.9 6.7 8.2 8.3 6.4 8.3 8.3 7.6 7.3 12.8 6.9 13.9 5.8 14.9 3.4 7.5 1.9 9.4 12.6 4.7 5.4 8.4 9.5 9.5 10.5 8.9 6.2 9.4 4.5 8.0 10.9 9.0 7.6 6.9 8.9 9.0 6.1 6.8 7.1 9.6 10.3 5.7 8.8 7.0 7.6 4.8 87.9 15.8 10.3 11.4 7.6 11.7 8.1 12.8 11.9 8.6 10.6 5.5 10.4 10.3 12.0 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.6" "Cell line enhanced" "Detected in many" "HMC-1: 7.6;RPMI-8226: 7.6;U-266/70: 9.3;U-937: 8.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 20.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 2.8 1.0 1.2 8.6 1.5 5.9 2.7 20.8 3.4 14.3 7.7 1.5 6.6 3.5 7.3 22.3 9.2 4.3 4.4 1.9 1.0 1.1 1.4 59.6 4.3 11.1 1.1 1.0 3.2 1.1 0.6 1.0 9.3 1.2 6.1 5.9 1.5 3.2 6.6 0.9 12.4 7.7 3.6 1.9 10.8 3.3 4.4 1.4 1.7 2.5 10.6 9.8 6.1 7.9 2.1 4.8 6.9 4.6 4.8 7.6 5.6 0.4 0.1 0.1 1.2 2.9 3.1 0.2 0.4 0.4 1.0 1.6 0.1 0.1 6.0 0.0 1.8 5.1 1.4 1.2 0.8 0.1 0.5 2.3 0.3 0.5 0.6 3.4 7.6 2.5 2.5 0.3 0.8 0.1 0.7 1.7 0.6 0.2 0.6 4.9 0.4 0.0 0.1 0.9 7.6 0.4 1.7 0.4 0.1 0.2 0.7 0.7 0.7 0.8 0.2 1.7 0.9 1.7 0.1 9.3 1.9 2.4 1.2 8.6 0.5 6.9 3.0 4.2 5.8 4.6 5.0 2.1 5.4 6.1 4.8 1.6 7.6 7.5 2.4 4.8 4.0 2.5 6.3 5.6 1.2 1.5 20.8 3.4 1.0 1.1 1.1 1.0 1.2 1.4 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190964358-191020960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 88.9;BJ hTERT+ SV40 Large T+ RasG12V: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol 22000 "Nucleoplasm, Cytosol" "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favourable (1.75e-4)" "prognostic unfavourable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 27.9 27.2 17.4 47.8 17.8 19.5 20.4 15.0 21.7 21.0 19.8 14.9 17.5 22.7 17.1 27.4 23.3 14.5 29.0 25.5 15.6 22.2 34.9 35.7 29.4 57.9 16.9 18.8 24.3 18.7 20.0 24.0 24.3 23.6 23.6 20.3 17.9 47.5 18.0 20.1 17.4 24.6 24.8 21.8 49.0 24.2 13.5 10.4 58.7 36.2 18.5 30.2 29.3 16.5 10.8 16.2 55.0 47.1 22.7 54.1 44.6 8.8 9.4 4.4 7.4 19.5 26.4 14.4 13.4 41.1 88.9 100.1 14.9 10.2 3.6 8.5 28.7 7.5 5.0 10.7 17.6 30.1 4.1 16.3 7.4 8.7 13.6 8.4 10.2 17.5 6.8 16.4 5.8 10.7 8.9 21.6 16.3 7.2 6.3 10.6 6.2 15.5 5.3 12.1 4.4 11.7 11.0 6.2 6.0 15.8 6.0 41.2 6.3 10.4 9.4 17.7 10.4 15.3 8.6 36.8 53.8 3.4 13.5 7.2 8.1 13.0 36.9 27.0 14.7 47.1 19.9 10.8 35.1 21.0 16.2 8.6 35.8 26.0 55.0 22.7 27.6 7.4 54.1 44.6 17.4 17.8 15.0 21.7 15.6 22.2 16.9 18.8 23.6 10.4 STAT2 STAT113 ENSG00000170581 "Signal transducer and activator of transcription 2" P52630 12 56341597-56360155 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003858, HPA018888" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB003858: AB_562227, HPA018888: AB_1857550" "unprognostic (3.03e-1)" "unprognostic (8.59e-2)" "unprognostic (6.92e-3)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (7.27e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (4.12e-3)" "unprognostic (1.56e-1)" "unprognostic (7.45e-3)" "prognostic unfavourable (4.78e-13)" "unprognostic (1.88e-1)" "unprognostic (5.56e-2)" "unprognostic (2.77e-1)" "unprognostic (1.46e-3)" 30.8 14.7 10.4 24.2 20.8 11.9 18.4 21.3 18.6 21.4 13.8 39.8 12.2 15.1 24.0 12.6 13.9 16.7 23.0 11.6 10.9 9.2 12.8 25.7 22.1 19.9 27.3 13.3 22.9 13.1 18.3 28.0 18.7 29.1 15.8 15.1 24.5 18.7 12.4 10.6 15.2 17.3 22.9 29.2 29.4 13.9 7.0 22.1 19.9 20.3 7.6 23.1 24.2 16.7 6.6 8.5 8.2 16.9 3.5 6.8 8.1 4.7 2.5 5.9 4.7 30.5 21.1 9.6 8.6 30.4 34.0 33.6 3.5 6.3 6.2 8.0 13.8 6.5 6.9 5.0 6.7 5.2 2.1 9.4 4.7 3.5 20.9 2.1 9.1 31.5 4.5 7.7 7.7 7.9 5.1 17.4 10.9 2.8 3.2 2.6 1.8 3.3 3.0 7.0 4.9 6.9 6.9 1.7 3.5 12.2 6.7 12.7 6.3 5.3 5.2 11.8 4.2 4.0 1.5 13.8 10.0 3.2 10.9 2.7 4.0 8.2 11.2 7.6 5.8 16.9 5.8 3.7 5.7 5.9 8.5 6.6 4.4 3.7 5.7 3.5 12.6 7.6 6.8 8.1 10.4 20.8 21.3 18.6 10.9 9.2 27.3 13.3 29.1 22.1 STAT3 APRF ENSG00000168610 "Signal transducer and activator of transcription 3" P40763 17 42313324-42388568 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001671, CAB003859, HPA058603, CAB068241, CAB068242" Supported Supported Nucleoplasm,Cytosol 220000 "Nucleoplasm, Cytosol" "CAB003859: AB_347629, CAB068241: , CAB068242: , HPA001671: AB_1080102, HPA058603: " "unprognostic (1.83e-2)" "unprognostic (2.42e-1)" "unprognostic (9.23e-3)" "unprognostic (2.91e-1)" "unprognostic (5.59e-3)" "unprognostic (1.78e-2)" "unprognostic (8.26e-2)" "unprognostic (1.51e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-1)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (6.47e-3)" "unprognostic (7.75e-3)" "unprognostic (2.21e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" 44.6 30.7 23.2 34.4 27.5 35.3 49.3 15.7 23.5 25.1 31.5 18.4 21.7 20.5 33.2 27.4 36.4 32.7 34.0 82.9 20.1 14.7 34.5 90.0 45.7 45.5 26.0 11.1 40.6 32.1 18.6 27.9 24.6 27.6 28.9 21.8 24.3 29.3 22.9 53.4 28.4 28.6 49.7 25.1 41.4 29.4 15.4 25.7 16.8 38.0 31.2 28.8 40.4 53.1 10.8 13.7 69.7 20.2 13.9 21.7 26.7 16.6 31.7 14.0 13.8 30.0 28.6 10.2 19.6 24.9 17.0 16.6 8.3 16.2 5.2 19.4 19.4 25.5 12.7 20.0 13.9 43.0 8.7 36.2 19.3 17.1 22.2 8.8 23.6 44.6 19.7 13.5 19.6 23.0 22.2 16.6 11.2 11.8 32.6 8.8 8.1 0.0 7.2 37.4 7.7 26.9 21.7 12.9 8.4 22.6 53.6 8.1 28.1 13.3 19.4 26.3 13.5 15.6 16.0 25.7 20.0 4.4 16.3 9.4 11.6 26.2 19.4 24.9 21.7 20.2 17.3 10.8 16.0 16.8 13.7 10.4 16.6 15.8 69.7 13.9 18.7 7.5 12.0 26.7 23.2 27.5 15.7 23.5 20.1 14.7 26.0 11.1 27.6 25.7 STAT5A "MGF, STAT5" ENSG00000126561 "Signal transducer and activator of transcription 5A" P42229 17 42287547-42311943 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Lactation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 25.3;HEL: 38.3;HMC-1: 22.3;K-562: 63.7;MOLT-4: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB003860, HPA027873, HPA042128, HPA049883, HPA051156" Approved Enhanced Nucleoplasm,Cytosol 140000 "Nucleoplasm, Cytosol" "CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: , HPA049883: , HPA051156: " "prognostic favourable (5.87e-4)" "unprognostic (3.09e-3)" "unprognostic (2.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.43e-1)" "unprognostic (3.41e-3)" "unprognostic (2.15e-1)" "unprognostic (6.22e-2)" "unprognostic (3.33e-1)" "unprognostic (6.82e-3)" "unprognostic (2.76e-1)" "unprognostic (2.11e-1)" "unprognostic (3.85e-2)" "unprognostic (5.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.98e-1)" "unprognostic (5.49e-3)" 44.0 21.5 3.6 16.5 8.1 30.0 24.1 3.4 4.0 12.6 12.8 6.3 10.5 5.1 11.0 11.4 11.6 9.6 15.3 9.8 3.9 4.7 8.9 5.5 12.8 26.7 9.1 3.2 15.6 8.3 1.9 7.0 11.3 6.1 13.9 5.8 11.9 11.9 11.7 18.3 9.7 11.6 13.6 7.4 17.3 7.9 8.5 6.1 21.9 8.6 9.1 17.0 19.9 20.2 7.2 15.0 15.2 18.5 14.3 16.2 8.8 1.0 1.2 0.1 0.0 9.1 4.4 0.0 0.5 2.0 1.0 0.6 0.1 1.0 0.0 2.3 2.0 0.0 0.2 0.0 0.2 25.3 0.0 38.3 2.9 0.3 3.7 3.2 22.3 10.2 0.7 0.3 0.5 3.0 63.7 0.0 0.5 0.1 46.2 18.2 0.3 0.0 1.1 0.3 3.3 0.3 0.7 0.1 0.0 2.3 1.1 4.2 0.7 4.1 1.7 2.3 0.6 1.1 0.0 0.0 0.0 0.0 0.2 6.2 0.5 6.8 11.8 5.9 9.1 15.1 12.8 7.2 15.8 13.2 15.0 6.7 16.2 13.0 15.2 14.3 18.5 5.7 11.2 8.8 3.6 8.1 3.4 4.0 3.9 4.7 9.1 3.2 6.1 6.1 STAT6 "D12S1644, IL-4-STAT" ENSG00000166888 "Signal transducer and activator of transcription 6" P42226 12 57095408-57132139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001861 Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA001861: AB_1080106" "unprognostic (3.43e-3)" "unprognostic (1.87e-1)" "unprognostic (1.37e-1)" "prognostic favourable (1.69e-4)" "unprognostic (4.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" "unprognostic (6.70e-2)" "unprognostic (1.88e-2)" "unprognostic (3.65e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.55e-1)" "prognostic favourable (7.76e-4)" "prognostic favourable (1.14e-4)" 33.6 34.9 10.4 35.9 12.8 12.8 27.9 4.6 11.6 37.8 47.3 6.2 28.4 23.9 44.5 26.6 40.8 31.8 33.8 20.9 10.2 3.9 35.0 31.0 34.9 25.2 13.3 12.0 41.9 21.2 18.1 9.2 22.0 9.8 42.3 26.2 23.3 30.1 26.5 11.4 39.1 59.4 43.8 12.2 48.4 32.1 13.3 7.9 29.3 31.1 24.4 42.8 43.1 34.0 6.2 9.6 27.6 13.0 4.7 5.9 14.0 16.8 16.8 4.1 6.8 41.0 39.8 11.9 13.4 29.5 14.9 10.9 7.6 22.9 40.4 21.0 29.7 23.5 5.1 26.0 11.0 18.1 1.9 9.3 17.9 9.4 24.5 10.7 30.5 55.4 21.5 18.1 16.1 26.3 6.5 5.7 19.2 5.7 11.7 12.0 6.3 3.4 13.6 0.3 13.7 25.8 28.1 0.1 0.4 12.5 10.5 12.6 15.6 24.7 21.8 0.3 8.8 15.5 0.2 0.1 0.4 10.1 13.5 10.5 17.9 9.8 12.5 6.8 5.9 13.0 5.2 6.2 4.8 4.8 9.6 6.2 4.7 4.3 27.6 4.7 11.0 4.6 4.9 14.0 10.4 12.8 4.6 11.6 10.2 3.9 13.3 12.0 9.8 7.9 STAU2 39K2 ENSG00000040341 "Staufen double-stranded RNA binding protein 2" Q9NUL3 8 73420369-73747708 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019155, CAB020836" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB020836: , HPA019155: AB_1857565" "unprognostic (5.75e-2)" "unprognostic (3.39e-1)" "unprognostic (2.31e-3)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (6.27e-2)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (6.36e-2)" "unprognostic (4.01e-2)" "unprognostic (3.31e-2)" "unprognostic (1.89e-1)" "unprognostic (3.62e-3)" "unprognostic (9.94e-2)" "unprognostic (2.98e-1)" "unprognostic (6.44e-3)" "unprognostic (4.25e-2)" 17.8 15.0 25.5 10.3 24.4 14.0 11.7 27.2 46.1 10.8 12.1 13.2 8.4 9.3 11.9 12.8 22.6 11.0 15.7 42.7 24.3 23.0 18.9 15.9 11.4 11.0 27.9 15.4 12.2 10.2 17.8 19.9 11.1 27.3 13.9 12.0 10.0 13.0 14.0 60.3 9.5 15.4 14.9 18.1 13.3 10.1 10.3 16.3 18.6 14.7 21.3 13.4 14.8 10.4 11.9 15.9 26.1 13.3 27.6 19.2 7.9 12.4 14.8 23.7 13.0 13.9 10.1 7.3 11.4 10.5 10.3 13.8 5.9 13.5 19.8 11.8 8.9 10.2 16.1 10.7 15.4 20.2 8.1 26.9 7.9 9.4 7.4 10.1 9.8 7.0 8.4 8.8 5.8 20.3 18.1 9.4 13.9 8.5 56.0 8.1 11.9 9.8 16.1 11.3 17.3 22.2 13.9 9.1 15.1 6.0 16.7 10.1 19.2 12.1 15.7 10.4 17.8 10.1 8.4 14.8 14.1 19.0 11.5 15.6 8.1 13.9 11.7 26.1 19.2 11.4 14.6 10.1 13.1 16.4 11.6 11.9 11.7 15.1 19.8 27.6 13.3 15.9 15.9 7.9 25.5 24.4 27.2 46.1 24.3 23.0 27.9 15.4 27.3 16.3 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.9;U-87 MG: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol 28000 Cytosol Nucleoli "HPA050510: " "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.5 7.9 0.0 2.7 3.9 36.9 7.0 2.1 2.3 4.2 3.8 6.0 9.0 0.0 15.9 11.9 11.2 3.4 6.9 4.7 0.0 11.2 12.8 7.1 11.7 9.7 3.1 2.4 21.8 12.2 24.7 8.9 3.6 6.2 1.3 11.7 6.2 0.0 1.8 10.8 16.5 0.0 4.6 5.6 5.1 16.7 13.3 2.4 5.8 20.2 1.5 4.0 4.2 15.3 26.0 15.3 5.5 11.4 0.0 0.0 0.0 47.8 8.1 5.4 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Group enriched" "Detected in some" 6 "HSkMC: 38.4;SiHa: 36.0;U-2197: 51.1" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065201 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favourable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavourable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 38.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.0 3.0 0.0 0.2 0.0 0.0 0.1 0.1 51.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA046543: " "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.3 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.4 11.3 15.3 7.8 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.1 11.5 0.8 1.3 14.4 9.4 11.1 15.9 19.0 12.6 7.7 17.6 5.7 15.8 7.5 11.5 21.3 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.7 7.7 10.4 6.5 15.8 16.1 11.4 20.2 6.3 13.0 19.6 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.23e-4)" "prognostic unfavourable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.0 76.6 48.4 40.3 27.0 18.0 43.6 44.6 24.0 64.8 37.8 56.1 42.1 58.7 52.5 35.3 52.1 121.3 44.7 71.3 46.1 49.5 82.7 51.5 51.5 23.5 43.6 52.3 18.2 28.1 53.6 40.5 45.6 81.6 33.8 37.2 71.8 65.6 59.5 58.3 64.8 64.5 46.1 59.5 45.2 43.5 39.5 35.1 50.9 53.9 41.4 57.2 30.2 40.9 41.2 51.0 53.8 60.0 30.8 66.5 62.0 53.4 43.9 59.3 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell line enhanced" "Detected in all" "WM-115: 51.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: " "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favourable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavourable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.7 7.2 4.5 6.7 5.2 6.5 11.5 10.1 8.4 7.3 6.8 3.7 10.2 9.3 5.4 12.4 9.0 2.0 12.3 4.8 12.2 3.3 11.2 3.0 2.1 7.5 11.3 13.3 6.4 2.6 9.9 8.3 6.3 1.0 13.1 5.1 12.4 8.1 25.5 1.8 5.7 13.4 3.5 6.2 3.0 9.8 3.0 3.7 5.8 8.1 27.6 2.9 24.0 8.7 8.2 4.1 5.7 5.4 11.1 16.3 5.9 10.8 17.5 51.5 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 STK11 "LKB1, PJS" ENSG00000118046 "Serine/threonine kinase 11" Q15831 19 1177558-1228435 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016231, HPA017254, CAB022105, HPA067481" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: " "unprognostic (8.60e-2)" "unprognostic (1.68e-1)" "unprognostic (5.00e-2)" "prognostic favourable (3.69e-5)" "unprognostic (2.04e-2)" "prognostic favourable (1.96e-4)" "unprognostic (9.11e-3)" "unprognostic (3.19e-1)" "unprognostic (9.08e-2)" "unprognostic (1.26e-1)" "unprognostic (1.95e-3)" "unprognostic (7.70e-3)" "unprognostic (3.54e-2)" "unprognostic (3.16e-2)" "unprognostic (1.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.12e-3)" 13.4 13.7 13.5 11.8 12.4 19.3 16.7 17.8 16.0 12.2 16.1 8.3 19.8 18.1 10.8 8.7 15.1 10.0 11.8 15.3 12.6 9.8 10.7 22.1 9.4 12.5 9.7 10.4 11.0 16.8 10.7 11.6 12.2 9.9 12.2 5.3 11.9 16.0 12.2 49.2 16.8 18.0 7.7 7.6 16.9 15.5 59.8 7.5 11.8 12.4 14.5 19.0 11.4 9.8 2.7 1.9 11.7 6.3 1.9 1.8 0.5 21.1 10.2 7.8 14.7 7.4 6.7 16.5 10.3 10.8 9.7 10.4 8.3 14.8 13.9 11.5 10.8 13.7 7.6 15.9 3.0 25.9 18.7 14.2 0.6 10.5 15.9 14.2 23.8 12.2 11.6 7.5 11.1 9.7 26.5 19.1 5.5 15.8 13.7 14.4 14.9 12.6 21.7 8.3 15.5 8.8 15.5 18.1 13.0 0.0 7.7 11.1 12.1 23.4 13.1 10.1 11.4 19.7 16.4 37.6 15.8 10.4 10.0 19.0 10.3 2.0 4.2 4.5 0.6 6.0 0.4 2.7 1.0 1.8 1.9 1.0 1.0 0.9 11.7 1.9 6.3 1.0 0.7 0.5 13.5 12.4 17.8 16.0 12.6 9.8 9.7 10.4 9.9 7.5 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA018138, HPA037979" Uncertain Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA018138: , HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.5 5.7 5.2 3.5 6.5 8.6 2.1 16.5 17.8 9.0 9.2 4.9 3.3 7.3 26.0 13.7 9.4 3.9 21.9 12.6 18.0 4.4 6.5 4.3 6.1 4.8 11.2 4.4 7.0 25.8 11.9 10.9 16.8 7.6 25.2 10.3 2.1 18.2 5.2 8.0 18.7 6.3 3.3 14.5 15.7 3.4 2.8 6.3 7.4 3.4 4.8 4.0 5.7 16.8 19.6 7.5 11.6 18.4 15.3 7.6 10.6 19.9 9.9 31.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell line enhanced" "Detected in many" "Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.1 2.2 3.3 1.2 14.7 5.6 3.7 7.6 11.4 8.3 8.7 6.6 1.1 35.5 7.0 4.3 2.2 1.4 3.2 10.2 6.2 3.8 3.3 2.8 0.6 4.4 13.4 36.0 7.1 3.2 10.3 5.4 3.4 2.6 33.4 20.6 1.7 17.4 30.4 1.9 5.1 2.9 20.3 10.7 4.9 7.5 1.2 1.3 1.9 1.9 1.6 1.3 7.0 4.1 8.1 4.0 5.8 4.2 13.7 22.2 38.7 6.1 4.6 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol 2800000 "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavourable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favourable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 28.6 14.2 15.0 29.7 16.9 19.1 34.8 12.2 21.0 36.3 37.4 12.1 23.0 31.9 24.6 26.5 68.4 20.4 41.3 30.0 14.7 12.8 30.5 14.2 23.9 31.2 10.6 10.1 20.0 20.6 12.4 13.9 38.4 14.7 28.3 28.8 36.8 30.8 21.6 18.8 60.6 67.9 34.8 9.2 31.7 30.2 22.1 7.6 38.2 28.2 41.6 48.5 39.2 45.4 8.1 11.2 11.4 13.4 1.5 13.7 6.7 36.0 11.2 20.0 18.5 30.8 18.4 28.4 16.9 23.8 23.7 23.2 32.9 49.0 25.7 8.6 21.1 32.7 18.5 37.2 22.7 64.0 9.5 27.4 14.4 18.8 43.5 27.6 19.5 11.9 59.5 18.6 54.8 20.3 9.9 17.8 15.5 15.7 20.6 11.4 17.9 8.5 26.1 12.3 13.9 22.8 32.6 11.7 16.8 10.7 17.2 22.8 20.8 26.9 27.4 15.1 11.0 12.3 19.4 17.4 9.1 9.6 23.5 16.7 24.8 5.8 13.4 6.1 6.1 10.6 7.2 6.6 11.4 8.7 11.2 8.1 7.8 6.1 11.4 1.5 12.7 7.5 13.7 6.7 15.0 16.9 12.2 21.0 14.7 12.8 10.6 10.1 14.7 7.6 STK26 "MASK, MST4" ENSG00000134602 "Serine/threonine kinase 26" Q9P289 X 132023265-132075943 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059921 Approved Uncertain "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA059921: " "unprognostic (6.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-3)" "unprognostic (4.42e-1)" "unprognostic (1.03e-2)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (1.31e-1)" "unprognostic (1.42e-3)" "unprognostic (2.49e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (4.76e-2)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" 5.4 1.4 1.1 13.5 5.1 25.9 3.3 3.8 1.1 18.0 6.4 0.3 34.8 3.7 42.3 29.6 11.7 6.0 5.2 1.9 1.2 2.3 3.5 3.2 6.7 12.8 1.2 0.3 4.7 4.0 10.2 5.8 50.7 1.2 11.5 4.8 2.2 6.3 22.4 1.2 5.1 6.1 19.1 1.5 8.5 4.7 5.2 0.8 44.7 2.3 6.8 10.2 18.0 6.6 8.4 6.2 26.4 11.6 22.0 13.3 10.2 9.0 3.1 0.3 0.0 1.5 1.4 20.7 0.3 1.1 0.1 0.1 8.3 8.2 12.3 5.6 2.0 10.3 23.0 14.4 0.0 10.6 18.8 17.7 7.8 7.8 1.4 37.0 1.4 2.0 8.6 0.0 9.8 4.0 7.8 11.6 3.4 7.9 38.0 34.4 18.4 1.2 27.5 11.4 15.8 9.3 14.5 7.7 8.5 5.4 4.9 0.2 6.3 9.8 0.1 3.7 4.0 11.2 13.2 8.9 14.0 13.7 3.4 40.3 1.8 26.4 5.1 16.6 13.3 6.7 13.0 8.4 9.1 11.3 6.2 7.3 11.8 12.2 10.0 22.0 11.6 2.3 4.0 10.2 1.1 5.1 3.8 1.1 1.2 2.3 1.2 0.3 1.2 0.8 STK3 "KRS1, MST2" ENSG00000104375 "Serine/threonine kinase 3" Q13188 8 98401403-98942827 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007120, CAB025316" Uncertain Approved "Intermediate filaments,Rods & Rings" "Intermediate filaments, Rods & Rings" "CAB025316: , HPA007120: AB_10601664" "unprognostic (7.88e-3)" "unprognostic (1.96e-1)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.53e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-3)" "unprognostic (9.68e-3)" "prognostic unfavourable (4.25e-4)" "unprognostic (6.71e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (9.21e-5)" "unprognostic (9.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (9.72e-2)" 16.5 16.6 6.5 8.1 12.4 2.5 20.5 2.6 10.6 17.2 13.1 10.5 14.2 4.6 22.2 13.1 9.0 16.0 12.6 10.0 7.4 4.1 14.7 12.0 16.2 10.8 12.8 3.6 22.8 10.7 15.1 18.9 53.1 9.9 15.0 6.0 8.2 10.8 16.4 11.6 10.0 10.8 23.5 12.9 8.2 9.5 10.1 11.4 3.4 10.6 7.9 5.9 16.4 24.3 1.9 8.3 9.0 8.7 1.8 1.8 2.9 37.6 7.1 7.5 9.9 24.4 12.2 7.5 13.1 11.8 12.3 10.7 5.2 16.0 0.0 11.4 13.0 15.3 5.2 11.3 19.9 9.0 6.7 10.1 3.5 3.5 8.3 3.3 8.8 8.1 19.5 6.3 17.2 5.2 4.2 5.5 8.9 4.7 8.4 4.0 2.2 2.8 7.4 6.5 3.2 14.0 4.7 1.9 4.4 8.3 9.6 8.1 7.9 5.5 3.9 8.3 5.3 12.5 7.2 4.4 6.5 2.7 7.4 4.2 13.1 2.1 8.6 4.5 1.3 8.7 1.4 1.9 0.8 1.8 8.3 1.3 1.1 0.7 9.0 1.8 5.4 3.4 0.1 2.9 6.5 12.4 2.6 10.6 7.4 4.1 12.8 3.6 9.9 11.4 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 11.5;REH: 10.1;U-2197: 18.5;WM-115: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058536 Approved Vesicles,Microtubules Microtubules Vesicles "HPA058536: " "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.7 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.8 8.1 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 11.5 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 10.1 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 2.9 0.0 1.1 18.5 0.0 0.4 0.0 0.0 0.0 0.0 47.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell line enhanced" "Detected in many" "Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: " "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favourable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.8 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.2 0.0 14.1 7.4 0.3 0.0 4.3 1.3 3.7 0.0 12.0 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 0.3 0.0 13.2 0.1 0.0 0.3 0.0 7.0 0.0 5.3 1.3 8.9 3.8 0.0 14.8 3.9 0.0 0.0 0.1 0.0 0.8 0.0 0.0 6.7 0.1 14.9 3.1 12.5 0.2 4.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 STK35 "bA550O8.2, CLIK1" ENSG00000125834 "Serine/threonine kinase 35" Q8TDR2 20 2101611-2177038 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 27.8;testis: 37.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026452, HPA051673" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA026452: , HPA051673: " "unprognostic (2.25e-2)" "unprognostic (2.97e-1)" "unprognostic (2.87e-2)" "unprognostic (1.30e-2)" "unprognostic (3.25e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (9.46e-6)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (3.05e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-1)" "unprognostic (4.39e-2)" "unprognostic (1.74e-1)" "unprognostic (4.67e-1)" "unprognostic (1.40e-1)" "unprognostic (4.99e-2)" 5.3 6.0 10.3 3.6 14.3 4.3 5.1 6.1 13.7 3.7 4.3 3.1 2.5 4.2 4.5 3.5 8.0 5.1 4.3 5.2 5.9 4.8 4.4 5.7 4.2 3.3 4.4 7.6 3.9 5.9 5.3 6.5 3.5 4.0 3.8 5.2 27.8 6.1 4.0 3.5 6.3 4.6 4.9 4.5 4.1 4.1 37.6 4.4 1.7 5.4 6.1 4.5 4.1 3.7 1.8 2.0 3.2 1.4 0.8 2.7 1.2 14.8 12.6 9.9 16.9 4.5 6.2 12.0 6.1 7.5 8.2 8.5 16.6 11.6 10.2 5.0 7.6 22.5 11.6 14.0 9.4 4.0 5.5 9.7 4.4 17.9 5.8 8.7 4.5 5.4 12.3 13.0 11.3 7.7 9.4 8.5 5.3 6.6 10.9 12.4 18.3 8.6 9.5 8.8 6.4 7.4 14.9 16.3 7.9 10.8 19.5 9.7 9.6 8.7 6.5 14.0 9.6 7.0 9.6 7.5 9.6 7.1 7.5 9.5 6.1 0.0 1.2 0.7 1.9 1.0 2.5 1.7 2.7 1.3 2.0 1.8 2.6 2.2 3.2 0.8 1.4 1.7 1.3 1.2 10.3 14.3 6.1 13.7 5.9 4.8 4.4 7.6 4.0 4.4 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: , HPA062802: " "prognostic favourable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavourable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.6 4.0 15.2 4.8 9.4 13.8 1.5 16.7 12.3 11.2 10.4 0.0 21.6 18.3 4.6 10.8 17.3 9.7 12.2 14.1 5.8 6.0 7.6 4.4 13.5 17.4 10.2 0.8 9.5 17.3 13.3 13.9 7.6 0.1 0.0 23.4 3.8 17.7 3.6 10.5 8.5 25.4 6.0 1.5 8.4 16.5 22.5 9.5 5.8 0.8 6.8 3.0 7.5 7.1 13.6 4.2 9.6 10.9 0.0 0.0 14.7 10.3 9.1 9.1 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966474-45079959 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 9.5 8.8 10.4 24.5 11.5 39.5 8.1 7.5 13.4 7.8 8.6 10.3 5.4 8.1 9.3 6.5 8.9 7.3 9.4 6.1 9.3 8.8 6.3 7.4 18.8 30.6 10.5 9.1 8.3 6.4 5.9 9.3 8.2 7.7 7.5 10.6 7.4 9.3 8.7 4.2 11.4 16.1 8.2 12.0 29.1 9.6 7.4 9.6 32.3 8.0 4.9 36.6 11.5 8.7 10.8 6.9 40.6 13.3 10.3 14.5 7.9 11.6 7.9 10.1 7.2 6.2 7.8 7.0 10.3 15.8 17.5 15.9 22.4 6.4 28.6 9.0 7.3 12.4 10.7 13.8 22.5 12.8 5.7 20.8 11.6 15.7 10.9 26.7 29.6 6.3 11.4 16.4 17.9 6.4 9.6 16.5 8.8 9.2 19.9 18.1 6.2 5.4 12.9 11.2 13.3 6.4 8.0 4.8 5.9 15.3 8.9 11.7 8.1 16.9 8.2 13.2 12.9 15.2 11.9 21.6 16.9 31.8 12.9 12.8 9.7 24.4 7.6 20.5 14.5 7.7 14.4 10.3 13.8 13.3 6.9 10.8 14.3 11.9 40.6 10.3 13.3 3.9 13.3 7.9 10.4 11.5 7.5 13.4 9.3 8.8 10.5 9.1 7.7 9.6 STK40 "MGC4796, SgK495" ENSG00000196182 "Serine/threonine kinase 40" Q8N2I9 1 36339624-36385896 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.2" "Group enriched" "Detected in all" 5 "granulocytes: 19.2;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008026 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA008026: AB_1857603" "unprognostic (3.32e-1)" "unprognostic (3.00e-1)" "unprognostic (6.47e-2)" "unprognostic (4.55e-1)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (2.69e-3)" "unprognostic (6.09e-2)" "unprognostic (2.09e-1)" "unprognostic (5.96e-2)" "prognostic favourable (5.59e-4)" "unprognostic (1.19e-1)" "unprognostic (2.75e-2)" "unprognostic (7.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" 22.9 7.2 9.8 15.3 9.4 9.2 26.5 8.9 11.1 10.2 19.1 7.4 16.7 9.4 11.8 12.2 22.3 11.3 18.2 25.6 10.0 7.1 14.3 23.5 16.6 15.4 13.1 7.4 22.2 34.4 9.2 14.7 19.2 12.1 15.7 9.1 9.0 25.1 17.7 53.9 17.2 10.8 26.0 10.3 17.2 17.0 32.0 8.9 9.2 14.6 20.7 16.6 19.5 26.6 2.4 2.7 19.2 8.5 1.6 2.9 2.4 7.0 3.1 15.6 16.2 11.1 6.4 8.8 7.2 9.8 8.7 9.4 17.1 10.2 30.0 5.9 6.7 7.1 14.2 3.1 6.4 13.0 11.1 19.6 2.9 21.8 11.0 11.4 26.2 5.8 11.8 6.7 3.5 5.4 24.0 10.9 5.4 11.1 11.8 15.1 10.0 4.3 13.6 10.6 19.9 5.4 8.0 19.1 9.7 5.5 8.7 23.9 5.9 13.5 9.0 5.5 11.5 16.1 15.8 11.4 6.4 25.3 28.6 10.0 18.0 1.0 3.0 4.9 2.6 6.7 2.9 2.3 1.7 1.7 2.7 2.4 1.0 1.5 19.2 1.6 8.5 2.6 1.0 2.4 9.8 9.4 8.9 11.1 10.0 7.1 13.1 7.4 12.1 8.9 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 120.5" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 44.0" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 104.0;hTCEpi: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.4 9.7 0.8 4.4 104.0 29.9 0.0 25.9 25.7 7.3 11.5 1.2 1.9 11.8 6.4 32.2 2.5 5.4 24.0 13.0 7.2 2.2 27.4 21.3 3.7 56.4 10.1 5.8 49.5 85.0 11.4 15.2 26.0 5.9 15.8 15.8 7.7 0.3 7.7 11.8 3.0 1.4 0.0 25.6 5.7 0.2 1.0 0.1 21.6 19.2 11.1 6.5 8.4 33.0 16.9 5.3 16.8 2.4 6.7 7.3 0.7 6.5 10.2 9.0 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 STOML2 "HSPC108, SLP-2" ENSG00000165283 "Stomatin like 2" Q9UJZ1 9 35099776-35103195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015944, HPA062016" Supported Supported "Plasma membrane,Cytosol" "Intracellular and membrane" 98000 "Plasma membrane, Cytosol" "CAB015944: , HPA062016: " "unprognostic (2.49e-1)" "unprognostic (2.69e-1)" "unprognostic (1.20e-2)" "unprognostic (9.43e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "prognostic unfavourable (4.77e-4)" "unprognostic (5.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.00e-5)" "unprognostic (2.74e-2)" "unprognostic (5.26e-1)" "unprognostic (2.67e-1)" "unprognostic (5.47e-2)" 23.2 38.6 20.5 24.8 20.7 26.9 25.3 20.9 30.3 22.1 30.8 19.9 17.4 26.6 26.6 25.5 32.9 28.2 35.4 49.6 18.6 19.1 38.6 67.1 17.1 31.7 18.8 18.8 30.9 48.3 20.4 17.4 28.5 20.7 25.6 33.6 25.0 32.1 25.5 59.2 26.3 39.0 26.7 13.8 23.1 28.7 23.2 14.3 32.4 34.8 46.3 33.8 24.8 21.1 34.7 44.4 20.5 27.1 33.8 40.3 37.7 46.5 54.0 29.0 43.3 21.4 25.7 31.1 23.0 34.0 65.8 48.2 60.8 21.9 39.4 16.3 29.4 20.0 44.3 51.7 44.0 33.6 40.5 24.1 45.8 57.5 62.5 45.6 27.7 32.5 40.5 53.3 64.2 42.9 39.1 24.2 32.1 37.6 40.5 80.9 45.4 34.2 35.5 24.6 42.1 35.6 28.1 27.0 32.8 13.0 35.0 29.8 24.3 29.4 23.1 22.5 31.8 18.6 40.6 17.0 29.0 37.1 29.9 29.0 30.2 20.5 27.1 14.8 25.5 23.1 30.0 34.7 28.8 28.7 35.8 30.2 27.8 25.3 4.7 33.8 16.6 44.4 40.3 37.7 20.5 20.7 20.9 30.3 18.6 19.1 18.8 18.8 20.7 14.3 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 3.6" "Lineage enriched" "Detected in single" 4 "monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003086 Enhanced Supported Nucleoli,Cytosol 9800 Cytosol Nucleoli "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 6.1 1.2 26.8 1.5 23.5 5.6 11.5 2.0 22.4 4.3 5.3 18.1 1.6 4.7 1.8 6.7 11.3 13.6 7.1 4.0 26.1 11.6 17.5 3.7 5.0 1.3 10.3 11.5 3.7 1.3 0.6 7.9 4.3 9.6 2.6 6.1 7.9 4.6 3.8 9.5 9.2 4.9 2.2 4.5 18.7 6.8 4.0 15.9 0.3 13.1 4.9 3.4 6.8 6.6 0.0 0.5 0.8 3.6 0.0 0.1 3.2 1.7 1.3 4.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 4.2 1.5 0.0 2.2 0.0 11.8 6.5 14.7 0.0 0.2 2.3 42.8 7.9 1.6 0.0 0.0 24.3 0.6 13.0 0.0 4.4 0.0 15.7 22.0 0.4 2.6 2.1 0.0 4.7 1.1 0.0 6.9 1.3 3.1 17.7 11.5 0.7 5.2 0.2 0.0 0.6 0.1 0.1 0.9 3.6 3.9 1.0 2.5 4.5 0.0 3.2 0.1 1.1 0.0 2.4 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 3.2 26.8 23.5 2.0 17.5 26.1 11.6 10.3 11.5 9.6 15.9 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: , HPA037845: AB_10671369" "prognostic favourable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favourable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.1 0.5 0.3 0.2 2.2 4.6 3.4 1.8 1.5 3.4 0.1 0.0 3.2 5.7 1.7 4.9 3.9 1.0 0.7 2.4 2.2 0.0 0.0 0.2 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 STOX2 DKFZp762K222 ENSG00000173320 "Storkhead box 2" Q9P2F5 4 183797692-184023526 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.4;HeLa: 9.7;NTERA-2: 14.4;SH-SY5Y: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049776, HPA065002" Uncertain Uncertain "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Cytosol" "Actin filaments" "HPA049776: , HPA065002: " "unprognostic (9.79e-3)" "unprognostic (3.46e-1)" "unprognostic (2.10e-1)" "unprognostic (6.57e-3)" "unprognostic (3.33e-1)" "unprognostic (6.41e-2)" "unprognostic (4.57e-4)" "unprognostic (8.97e-3)" "unprognostic (1.25e-1)" "unprognostic (1.86e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (1.64e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-3)" "unprognostic (2.49e-1)" 3.0 2.8 12.0 1.2 12.6 8.4 3.1 20.3 17.5 3.9 2.1 18.2 1.6 1.6 3.2 5.9 8.2 4.7 4.5 4.9 9.6 8.3 3.4 4.0 3.5 1.1 16.2 18.0 5.8 10.6 12.0 8.1 2.4 11.8 4.1 1.7 2.5 11.0 4.2 3.2 6.2 1.8 3.2 9.2 6.2 3.7 1.6 16.4 0.8 9.6 0.8 1.9 4.3 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.7 3.6 11.4 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 1.5 0.0 2.3 0.0 0.2 6.3 1.0 0.0 0.0 5.0 0.0 9.7 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.1 14.4 0.5 0.1 4.2 0.0 2.7 3.5 5.9 13.8 2.7 0.0 0.0 0.2 0.3 0.0 0.0 2.5 0.0 0.1 0.1 3.1 1.8 0.6 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 12.0 12.6 20.3 16.6 9.6 8.3 16.2 18.0 11.8 16.4 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Cell line enhanced" "Detected in some" "Karpas-707: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047366: , HPA052691: " "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.2 0.7 0.5 0.4 0.4 0.4 0.0 0.2 0.0 0.6 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.9 0.1 0.3 0.1 6.5 0.8 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 STRADA "LYK5, NY-BR-96, Stlk, STRAD" ENSG00000266173 "STE20-related kinase adaptor alpha" Q7RTN6 17 63682336-63741986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031637 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA031637: AB_10601718" "unprognostic (1.59e-1)" "unprognostic (2.19e-1)" "unprognostic (5.59e-3)" "unprognostic (5.52e-2)" "unprognostic (8.91e-2)" "unprognostic (7.56e-5)" "unprognostic (6.79e-4)" "unprognostic (3.68e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "prognostic favourable (5.34e-5)" "unprognostic (7.29e-2)" "prognostic unfavourable (6.08e-7)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "prognostic favourable (6.43e-4)" 13.3 17.7 19.4 14.6 23.7 17.5 13.0 25.0 28.4 15.2 13.2 27.1 8.7 9.5 16.1 20.6 14.3 20.9 14.5 15.1 18.9 20.2 14.7 13.0 13.9 19.6 20.9 21.7 18.5 12.5 21.9 17.5 14.4 26.0 13.8 13.1 22.2 12.6 16.7 10.3 20.1 12.0 19.1 19.4 20.7 12.6 55.4 21.4 16.2 13.3 8.9 21.3 12.9 12.8 11.2 16.2 18.6 10.0 15.6 11.7 7.5 7.2 21.7 18.9 19.0 18.6 13.9 7.4 13.8 12.7 19.9 17.8 5.6 8.4 11.0 8.6 11.7 6.0 12.5 13.3 19.8 12.2 12.1 21.8 15.2 13.4 13.2 20.6 15.7 14.5 11.5 22.6 13.0 22.0 13.9 11.8 18.8 13.4 24.2 14.1 9.4 12.3 15.8 30.1 13.5 17.8 14.3 20.7 23.2 9.4 15.5 15.1 11.4 15.0 17.6 19.0 13.5 15.3 11.4 11.8 12.5 13.9 14.1 12.5 14.9 18.6 9.5 8.6 10.5 7.1 9.7 11.2 9.7 11.7 16.2 9.0 9.6 8.5 11.4 15.6 10.0 13.7 7.2 7.5 19.4 23.7 25.0 28.4 18.9 20.2 20.9 21.7 26.0 21.4 STRADB "ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK" ENSG00000082146 "STE20-related kinase adaptor beta" Q9C0K7 2 201387858-201480846 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 59.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026549, HPA028520" Approved Supported Aggresome,Cytosol Cytosol Aggresome "HPA026549: AB_1844779, HPA028520: AB_10604100" "unprognostic (6.34e-2)" "unprognostic (2.48e-1)" "unprognostic (2.63e-1)" "unprognostic (3.56e-3)" "unprognostic (4.04e-2)" "unprognostic (7.64e-2)" "unprognostic (1.35e-1)" "unprognostic (1.58e-1)" "unprognostic (2.63e-3)" "unprognostic (2.65e-2)" "unprognostic (6.21e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.08e-1)" "unprognostic (7.83e-2)" "prognostic favourable (4.45e-4)" "unprognostic (4.93e-2)" 13.8 28.6 13.8 7.9 11.7 32.7 9.2 8.8 13.5 6.4 13.7 16.9 4.9 18.8 10.3 9.5 8.9 5.7 7.9 15.2 15.3 11.5 35.2 50.5 7.2 10.1 15.8 11.0 7.8 9.1 3.9 14.1 11.6 12.7 7.1 15.9 10.1 7.1 7.7 48.3 4.4 21.3 7.4 21.0 7.3 4.7 7.8 9.4 8.3 9.7 7.8 7.7 6.2 6.2 24.1 10.4 9.7 8.6 16.3 10.4 9.6 3.9 6.8 11.8 15.1 19.3 24.5 8.3 8.0 13.9 11.1 16.8 8.9 3.8 0.0 5.2 12.6 4.0 11.4 7.5 20.2 4.6 9.3 4.7 3.2 19.7 14.6 5.6 5.4 20.7 6.9 14.2 12.8 8.3 10.1 1.7 59.9 2.1 5.1 9.8 15.9 7.0 7.0 4.6 2.9 9.4 3.2 1.9 9.7 5.5 4.2 23.4 2.2 10.7 8.0 6.8 5.2 8.6 6.1 6.6 11.7 1.8 11.5 2.5 6.4 3.4 8.0 9.7 6.0 8.6 5.4 16.7 8.0 8.6 10.4 24.1 10.4 10.3 1.6 16.3 7.5 4.6 9.5 9.6 13.8 11.7 8.8 13.5 15.3 11.5 15.8 11.0 12.7 9.4 STRN "PPP2R6A, STRN1" ENSG00000115808 Striatin O43815 2 36843640-36966472 "Cancer-related genes, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017286 Approved Approved Nucleoplasm,Cytosol 11000 Cytosol Nucleoplasm "HPA017286: AB_1857618" "unprognostic (1.65e-1)" "unprognostic (1.65e-1)" "unprognostic (3.57e-3)" "unprognostic (2.23e-2)" "unprognostic (3.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.63e-3)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.77e-3)" "unprognostic (1.33e-1)" "prognostic favourable (2.27e-4)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (2.11e-1)" "unprognostic (3.43e-2)" 11.8 8.1 11.4 11.0 22.1 17.4 13.3 16.4 14.2 11.2 14.0 10.9 8.9 10.1 8.6 7.1 25.9 6.8 8.4 25.7 16.2 10.2 11.6 10.2 10.3 9.6 16.9 9.4 9.9 7.1 11.3 6.3 12.6 10.5 8.1 13.7 5.6 16.2 6.9 16.0 16.1 13.2 11.1 34.3 10.9 11.4 9.8 14.8 18.6 8.1 15.5 16.7 11.3 14.4 1.5 0.8 3.7 1.5 0.5 2.1 0.4 23.0 11.7 15.6 6.6 8.6 12.0 15.7 9.3 8.8 9.1 8.4 11.9 7.5 15.3 7.5 11.8 11.0 13.1 10.3 11.3 17.3 10.1 24.8 10.3 6.1 8.2 14.9 13.9 7.2 9.0 14.5 11.5 11.6 18.5 12.2 11.2 6.6 14.7 6.5 12.5 5.9 9.6 24.7 6.7 7.5 19.1 2.9 9.5 14.0 10.8 8.8 7.7 5.8 15.4 16.4 16.5 10.1 12.2 12.3 18.6 13.5 8.3 14.9 11.3 3.4 0.8 1.4 2.1 1.5 0.7 1.5 1.5 1.3 0.4 0.9 0.8 0.9 3.7 0.5 1.4 0.8 0.3 0.4 11.4 22.1 16.4 13.0 16.2 10.2 16.9 9.4 10.5 14.8 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" 15000 Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favourable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.5 14.3 15.9 12.1 16.2 10.9 13.5 23.4 17.7 15.8 17.4 11.5 16.5 8.8 14.7 14.8 16.5 10.8 14.0 21.5 14.4 12.1 15.2 22.7 11.6 7.2 12.9 10.1 12.6 13.1 18.0 20.2 14.1 13.9 16.2 14.0 11.4 12.6 17.2 52.0 12.6 11.3 22.0 11.8 11.9 12.9 22.4 14.6 9.3 14.9 13.5 9.7 25.1 20.5 7.0 10.5 8.5 7.9 7.4 10.0 2.4 17.7 15.3 17.1 12.3 14.6 11.1 14.2 16.9 12.5 14.2 14.4 20.4 12.0 10.3 12.4 12.3 9.8 19.0 10.8 21.1 8.9 6.4 10.2 10.5 39.4 15.8 8.7 11.4 11.7 11.4 11.3 13.8 11.4 12.3 9.8 13.7 12.1 11.3 8.5 8.4 14.2 8.3 20.1 2.7 21.3 25.5 10.8 8.9 18.8 13.8 9.2 15.8 7.5 13.7 14.0 12.5 8.8 6.7 9.3 10.7 10.2 6.9 6.4 11.1 6.3 7.1 8.3 6.8 7.9 8.9 7.0 8.5 7.7 5.8 6.9 8.6 10.0 8.5 7.4 6.2 10.5 6.4 2.4 15.9 16.2 23.4 17.7 14.4 12.1 12.9 10.1 13.9 14.6 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favourable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavourable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 20.7 18.9 24.2 33.2 45.6 35.4 26.0 38.0 45.4 31.0 38.8 57.5 56.2 27.1 46.2 55.9 38.4 33.5 33.3 41.2 21.1 17.8 63.8 13.1 39.7 50.5 38.1 29.9 27.3 24.2 42.8 83.7 34.5 26.8 40.6 39.0 15.3 15.3 12.2 15.5 20.6 18.2 20.6 40.7 33.8 32.3 15.1 13.0 26.9 44.0 13.5 51.5 27.5 30.8 44.6 16.1 18.8 29.8 12.8 14.9 20.9 17.2 38.6 35.4 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 STUB1 "CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1" ENSG00000103266 "STIP1 homology and U-box containing protein 1" Q9UNE7 16 680224-682870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037202, CAB037209, HPA041222, HPA043531" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533" "unprognostic (5.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.90e-1)" "unprognostic (3.89e-1)" "unprognostic (9.00e-2)" "unprognostic (3.06e-1)" "unprognostic (4.09e-3)" "unprognostic (2.21e-1)" "unprognostic (2.23e-1)" "unprognostic (8.31e-2)" "unprognostic (5.78e-2)" "unprognostic (6.77e-2)" "prognostic favourable (6.49e-9)" "unprognostic (9.67e-2)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.30e-1)" 29.4 43.7 52.2 20.1 43.2 19.3 40.5 39.1 53.3 25.1 24.8 18.1 27.6 24.1 19.7 34.9 35.2 31.1 25.5 45.2 43.2 38.6 24.0 25.9 23.6 28.1 42.0 42.5 29.4 43.4 39.8 27.2 12.1 35.0 23.4 17.7 18.6 37.7 29.7 92.5 33.7 20.9 24.5 34.5 19.7 22.8 13.8 25.4 13.1 29.1 30.2 19.4 22.3 35.9 18.0 21.0 19.4 14.5 10.3 16.9 6.9 17.8 24.2 16.4 27.7 37.5 34.4 9.4 24.4 28.7 29.0 25.8 30.1 22.8 18.1 17.3 40.8 15.3 20.2 36.7 12.1 19.9 66.8 11.2 35.0 25.1 54.1 18.9 22.4 40.8 39.4 33.9 21.5 29.3 18.1 30.3 44.8 70.7 20.5 18.6 18.3 26.5 31.7 10.7 44.5 38.7 17.9 28.6 23.2 19.5 43.0 30.6 27.4 36.3 23.2 26.6 23.3 22.0 29.3 30.0 31.0 29.2 21.0 17.2 30.0 11.9 14.5 19.4 16.9 11.9 15.4 18.0 14.6 14.7 11.7 17.3 13.6 12.9 14.0 10.3 12.4 21.0 12.2 6.9 52.2 43.2 39.1 53.3 43.2 38.6 42.0 42.5 35.0 25.4 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: " "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.6 4.2 11.3 7.3 21.5 26.2 5.8 18.3 27.1 16.9 19.2 5.1 11.3 9.5 19.8 24.5 7.3 7.4 9.1 17.0 8.3 8.8 5.4 4.6 5.1 16.9 5.9 11.3 24.5 11.2 23.7 13.6 27.1 7.0 9.5 18.4 3.1 5.1 4.5 4.7 5.9 3.2 9.0 5.7 14.9 14.3 12.7 6.9 8.6 7.4 13.2 5.1 5.3 29.1 8.6 4.9 19.5 6.3 5.7 4.1 5.4 14.0 9.1 12.0 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906633-99970341 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favourable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 15.1 15.8 13.5 16.4 16.3 13.6 16.1 10.8 17.8 19.4 18.5 14.2 29.3 13.4 21.7 25.2 19.9 12.0 14.9 14.5 13.8 13.2 14.3 26.0 13.2 11.9 15.4 14.2 18.2 17.8 25.5 37.1 17.6 14.1 18.2 14.6 16.3 20.6 28.7 28.5 20.6 18.9 20.4 19.1 13.3 15.0 12.0 10.4 17.0 21.8 18.3 15.9 18.8 17.8 7.4 4.9 15.5 8.1 14.3 10.4 4.5 10.6 9.7 10.0 11.9 11.4 11.6 19.9 8.2 12.2 9.2 7.9 12.2 14.4 20.9 8.2 8.7 12.3 8.3 11.5 7.4 18.3 6.8 13.5 12.8 7.4 13.2 19.8 4.9 11.4 13.3 10.0 15.1 10.8 18.6 11.6 6.9 13.1 11.7 5.4 8.8 7.9 10.1 17.7 9.6 12.3 12.5 5.8 10.3 16.5 12.7 8.1 12.6 5.4 8.5 6.2 8.8 9.9 6.6 16.5 20.1 4.2 8.7 8.3 6.7 15.5 4.2 7.3 7.4 4.5 10.3 7.4 9.1 8.2 4.9 5.9 10.4 9.8 4.3 14.3 8.1 3.1 4.9 4.5 13.5 16.3 10.8 17.8 13.8 13.2 15.4 14.2 14.1 10.4 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014369-94028610 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HaCaT: 2.2;hTCEpi: 7.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.4 0.2 0.3 7.0 0.4 0.0 4.0 1.8 3.5 3.9 11.7 0.1 1.5 5.7 0.5 13.6 12.8 0.8 2.3 0.3 0.5 0.3 1.0 0.4 7.1 0.1 0.3 0.7 0.5 7.7 7.1 0.5 0.7 0.1 4.3 10.6 0.1 9.8 3.2 0.2 6.9 20.9 0.1 0.4 1.0 6.0 0.4 0.1 0.4 0.4 5.0 1.5 0.7 4.1 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 10.4 0.1 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.1 7.1 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.4 1.2 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.5 1.2 0.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 1.8 3.5 0.5 0.3 0.3 0.7 0.1 0.1 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038189, HPA069176, CAB079007" Uncertain Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB079007: , HPA038189: , HPA069176: " "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 15.9 14.5 16.0 15.4 13.4 8.8 27.0 12.5 18.7 13.1 18.8 15.3 8.8 6.1 18.1 15.4 9.6 19.4 14.5 16.4 15.5 11.4 12.2 12.0 18.3 11.9 12.7 12.4 16.0 10.7 11.9 16.3 18.0 17.9 10.2 10.2 9.8 5.2 15.7 6.3 6.1 10.7 23.5 24.8 12.3 11.7 23.2 12.3 9.7 12.6 6.9 9.4 13.5 22.2 2.6 1.6 4.6 2.4 1.4 3.1 0.9 4.7 9.5 13.8 10.7 12.8 29.1 1.4 20.1 16.2 24.9 16.5 2.6 3.3 6.1 3.2 22.0 1.3 12.6 3.3 25.9 9.2 4.3 3.2 8.3 7.4 13.8 4.7 8.0 10.8 4.1 12.1 9.7 12.2 12.7 5.7 21.2 2.8 6.6 4.8 9.2 13.1 7.0 9.0 3.2 13.7 1.0 13.2 12.9 10.2 0.9 8.5 3.2 3.0 16.4 14.3 10.1 15.7 8.8 4.2 3.3 4.0 16.5 5.2 11.2 4.6 2.2 2.8 2.4 2.4 2.4 2.6 2.7 2.7 1.5 1.7 2.9 3.1 3.0 1.4 1.2 1.6 1.9 0.9 16.0 13.4 12.5 18.7 15.5 11.4 12.7 12.4 17.9 12.3 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA002191: AB_1080165, HPA069176: " "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavourable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favourable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 10.8 16.3 5.3 14.1 8.3 23.4 22.6 11.5 10.7 10.7 19.9 4.9 27.8 23.8 14.2 16.4 12.8 6.8 21.1 9.4 6.2 6.0 25.0 6.4 26.5 15.1 8.7 10.2 12.0 14.8 16.7 21.2 33.6 6.8 12.6 22.9 54.7 16.0 19.8 7.3 11.4 19.7 11.4 7.2 14.5 19.5 11.4 6.2 2.1 12.8 9.3 6.4 11.4 12.2 0.9 2.7 28.1 2.5 0.2 1.4 0.9 12.0 7.1 0.2 3.4 6.2 3.6 9.8 6.5 11.1 15.0 18.6 32.3 11.4 3.4 12.5 4.7 13.6 18.8 6.7 18.4 3.0 4.0 3.7 5.0 10.0 16.6 12.5 36.5 6.6 14.5 11.6 14.1 11.9 32.4 7.1 6.5 7.0 0.1 9.2 18.4 5.9 4.3 12.5 5.6 28.2 28.7 8.2 12.7 2.8 14.3 49.2 15.7 8.6 16.7 6.5 14.2 8.9 5.6 8.4 14.6 6.9 9.0 8.2 8.6 14.3 2.5 28.1 1.0 0.7 1.1 0.3 1.4 0.6 2.7 0.9 1.3 0.4 25.7 0.2 0.4 0.4 0.0 0.9 5.3 8.3 11.5 10.7 6.2 6.0 8.7 10.2 6.8 6.2 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806897-62832088 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 21.3 20.0 17.5 16.2 17.0 28.3 22.6 33.0 24.2 26.9 19.6 17.6 40.9 17.2 21.6 36.4 22.3 23.7 20.1 17.7 17.6 15.7 22.3 42.6 21.0 17.7 18.6 16.7 29.3 33.7 22.8 20.2 37.4 17.4 27.9 18.2 20.6 47.3 32.2 17.1 26.4 23.0 19.2 16.0 24.0 22.1 16.1 19.7 29.1 33.7 16.4 29.0 22.5 22.3 9.4 10.0 24.9 10.4 9.5 9.7 4.7 17.3 11.1 14.9 13.2 20.5 22.7 13.8 17.1 24.1 28.9 23.4 8.3 17.2 11.1 16.0 24.3 18.2 12.9 16.2 21.4 25.8 12.3 9.6 14.9 16.9 24.8 11.4 14.8 18.7 18.5 25.7 31.2 14.0 8.7 30.9 15.3 20.9 15.4 18.5 5.0 16.4 15.9 14.4 29.5 13.0 9.2 11.2 9.5 13.8 21.9 26.1 24.2 15.4 15.0 21.1 11.1 24.2 10.9 28.3 15.9 11.7 16.9 8.0 12.8 8.2 8.8 24.9 8.5 10.4 7.4 8.7 6.7 8.2 8.1 9.4 6.4 6.2 14.0 9.5 9.1 10.0 9.7 4.7 17.5 17.0 33.0 24.2 17.6 15.7 18.6 16.7 17.4 19.7 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavourable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 12.2 10.4 17.6 14.1 18.9 2.9 12.4 21.7 25.5 13.4 10.4 15.5 7.2 9.8 11.3 10.7 22.2 10.3 9.6 8.1 18.6 13.2 11.6 6.5 15.3 12.7 18.5 13.1 11.5 5.5 9.2 6.8 15.0 16.1 10.1 11.1 6.4 10.7 9.6 5.7 16.5 9.9 11.8 15.0 11.6 10.5 7.3 20.0 14.1 15.3 7.3 17.8 16.3 15.6 1.7 5.1 5.9 3.6 0.4 3.2 1.4 9.8 11.1 11.0 14.6 11.6 13.7 18.6 12.7 16.4 10.0 8.6 10.3 9.9 10.0 17.6 13.9 17.7 9.9 22.4 11.8 7.2 7.3 6.7 8.4 10.0 11.5 9.5 8.7 12.4 20.6 16.9 17.5 20.2 12.3 7.1 13.3 14.2 9.1 9.0 17.1 5.6 8.0 13.4 14.4 11.9 24.8 15.6 16.6 13.3 25.7 13.9 15.6 8.7 16.6 13.9 7.3 12.9 10.2 12.1 6.7 7.3 6.8 9.4 8.1 5.9 3.6 4.5 1.8 2.9 1.9 1.7 2.6 2.7 5.1 1.7 3.2 2.4 3.4 0.4 2.5 1.7 3.2 1.4 17.6 18.9 21.7 19.1 18.6 13.2 18.5 13.1 16.1 20.0 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" "Golgi apparatus" "Nuclear bodies, Cytosol" "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 28.6 24.7 26.0 16.5 25.9 23.7 28.1 20.2 33.6 28.3 28.9 23.7 21.9 15.8 36.9 42.5 26.3 19.9 18.1 28.4 20.8 21.1 29.6 29.9 18.7 19.4 23.9 22.4 24.4 30.0 14.9 21.0 20.0 29.0 24.5 23.7 25.8 40.6 26.0 38.4 20.9 20.3 28.4 25.3 19.7 23.2 43.9 20.2 30.0 29.2 17.8 21.4 23.3 23.0 35.4 45.2 48.5 46.2 49.0 59.3 55.7 11.2 19.5 22.4 9.6 27.5 31.9 7.9 16.7 17.9 15.2 19.0 6.8 8.9 13.4 12.8 28.2 14.7 11.4 23.7 23.1 22.9 16.4 8.3 4.9 14.4 36.6 6.6 17.9 29.0 35.1 15.2 22.7 18.9 3.7 6.9 16.6 6.1 13.2 11.5 5.0 10.9 21.2 16.4 8.3 21.1 10.2 2.0 11.5 9.5 6.0 15.5 6.6 8.8 23.7 14.8 9.0 8.0 18.1 6.5 6.3 5.8 21.5 14.7 13.7 31.7 46.2 48.5 42.2 38.4 38.4 35.4 45.6 46.5 45.2 32.2 29.2 34.3 14.0 49.0 39.2 38.0 59.3 55.7 26.0 25.9 20.2 33.6 20.8 21.1 23.9 22.4 29.0 20.2 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.1;SK-MEL-30: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.47e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favourable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.0 8.5 8.2 9.2 18.6 16.0 7.4 14.3 7.3 8.6 7.6 0.4 4.8 4.0 8.0 9.3 1.4 7.2 8.8 10.6 9.2 4.8 5.4 23.1 1.5 9.4 0.5 4.7 12.1 4.9 22.6 11.0 10.2 5.4 6.2 14.5 7.5 3.8 1.7 7.0 11.8 2.3 3.9 9.7 7.1 0.2 47.1 22.9 24.1 11.9 40.8 1.8 1.7 15.2 9.8 5.0 19.2 5.3 13.4 22.1 5.4 19.2 5.8 9.0 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 STXBP3 UNC-18C ENSG00000116266 "Syntaxin binding protein 3" O00186 1 108746674-108809526 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027225 Approved Approved Nucleoplasm,Cytosol 160000 Nucleoplasm Cytosol "HPA027225: AB_1857627" "unprognostic (3.14e-3)" "unprognostic (4.33e-2)" "unprognostic (7.18e-3)" "unprognostic (4.88e-2)" "unprognostic (6.54e-2)" "unprognostic (9.78e-3)" "unprognostic (2.00e-3)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "unprognostic (6.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.25e-2)" "unprognostic (1.65e-1)" "unprognostic (8.08e-2)" "unprognostic (1.08e-1)" "unprognostic (4.55e-2)" 18.3 18.4 29.8 18.7 42.1 15.2 20.9 21.9 27.1 19.4 20.5 26.3 15.6 18.7 20.3 19.9 18.8 16.0 20.8 14.3 30.4 22.1 30.2 17.8 16.8 18.2 48.0 28.0 16.2 20.5 31.9 18.0 20.3 31.4 18.1 21.9 9.8 17.5 21.3 15.4 19.7 23.8 18.4 56.6 19.8 18.0 11.3 42.5 20.0 27.8 14.6 17.8 20.2 18.3 5.9 8.3 26.2 11.6 8.7 10.2 5.9 21.9 8.7 15.0 7.9 18.3 17.8 21.2 20.4 18.9 13.8 14.1 8.0 8.9 19.5 13.9 16.5 13.2 10.1 12.0 19.4 21.7 14.0 16.1 11.9 10.4 14.5 25.1 27.7 13.8 17.1 15.4 16.9 17.0 11.9 19.3 19.1 14.9 15.8 20.2 16.0 13.8 13.3 21.9 10.7 22.4 18.4 9.0 8.3 25.1 24.3 29.7 9.7 23.9 19.1 18.1 10.6 25.0 17.5 12.9 11.2 16.2 32.5 19.3 27.4 26.2 8.8 20.8 7.8 10.6 9.9 5.9 9.2 7.8 8.3 5.4 7.9 7.5 24.3 8.7 11.6 3.9 10.2 5.9 29.8 42.1 21.9 27.1 30.4 22.1 48.0 28.0 31.4 42.5 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 36.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 7.7 6.4 5.5 4.3 6.0 3.4 5.2 10.6 4.7 9.9 6.4 4.2 7.5 6.3 12.0 7.2 5.1 7.3 6.6 5.9 6.7 4.7 14.5 3.8 8.0 3.2 4.2 4.5 9.9 5.4 19.3 36.3 4.7 6.8 9.5 4.6 7.6 4.5 9.4 4.0 3.7 5.1 13.2 8.6 5.0 5.5 5.6 5.1 7.2 7.9 2.7 3.5 9.6 8.2 3.2 2.9 4.0 1.2 5.1 2.9 0.7 5.4 8.2 7.5 6.7 6.4 6.3 3.1 4.3 4.1 5.6 5.5 4.8 3.0 3.7 9.1 4.2 3.3 9.7 4.3 10.3 5.6 5.5 4.9 5.6 9.8 2.7 3.0 1.5 7.2 1.3 8.0 1.9 5.5 7.8 3.0 6.6 2.4 10.0 1.9 5.4 5.9 4.3 8.8 2.2 9.9 3.3 7.3 5.5 6.6 1.1 3.6 9.6 2.1 4.3 7.8 6.2 4.8 4.5 2.6 2.5 6.4 5.1 4.0 4.7 4.0 1.1 0.1 2.6 0.8 2.9 2.1 2.3 1.7 1.4 3.2 2.1 2.7 0.3 5.1 1.2 2.9 2.1 0.7 5.5 6.0 10.6 4.7 6.7 4.7 4.2 4.5 6.8 5.1 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040468: , HPA048569: " "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 2.9 0.1 0.0 0.4 0.0 0.0 0.9 4.8 0.5 2.2 2.1 1.6 18.2 0.2 3.1 1.2 0.8 0.9 5.0 4.8 10.8 0.3 0.7 1.3 0.1 0.0 1.4 11.9 0.2 0.2 3.4 0.2 16.4 0.2 0.2 5.2 1.7 0.1 0.8 2.7 1.3 0.0 1.4 0.2 1.6 9.4 0.6 0.0 2.7 2.9 0.0 2.3 0.3 15.2 0.6 2.5 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 homolog, transcriptional regulator" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 54.4 40.8 64.1 50.9 69.8 87.6 52.3 28.2 82.4 48.9 44.4 21.5 23.2 36.2 36.8 36.3 52.7 27.4 31.3 46.9 79.3 53.5 54.7 60.7 36.3 58.4 45.8 57.5 30.7 26.9 26.5 49.0 47.0 51.6 34.5 46.0 17.4 32.3 29.1 39.6 26.8 47.5 33.2 39.6 67.2 38.7 28.1 29.8 72.4 42.2 54.2 54.6 39.8 29.7 61.1 69.4 92.0 24.6 25.9 59.5 49.2 21.6 18.0 35.8 33.4 21.8 38.7 22.5 38.0 27.7 34.4 31.8 26.0 34.4 11.0 26.5 26.2 14.8 30.0 31.1 46.4 45.9 27.5 37.0 43.9 49.2 30.9 64.3 50.7 27.1 26.9 36.5 26.1 25.7 42.9 162.4 30.3 19.3 60.7 102.8 23.5 36.8 27.0 46.7 70.3 34.2 19.7 19.4 16.1 58.8 27.7 26.9 30.7 59.9 26.5 37.3 40.5 31.4 28.5 63.5 109.5 19.2 34.3 69.9 22.7 92.0 23.9 54.9 31.5 24.6 28.4 61.1 41.4 41.2 46.8 35.1 32.9 37.6 29.2 25.9 21.9 69.4 59.5 49.2 64.1 69.8 28.2 82.4 79.3 53.5 45.8 57.5 51.6 29.8 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Supported "Plasma membrane,Mitochondria" "Intracellular and membrane" 330000 Mitochondria "Plasma membrane" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavourable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favourable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 23.5 25.9 20.5 25.0 38.6 26.0 35.5 26.9 23.0 34.6 25.3 59.3 19.5 32.4 18.6 32.1 34.4 42.1 31.6 41.2 31.3 38.3 28.1 22.4 33.7 32.6 28.6 23.0 30.9 26.0 29.1 39.8 30.8 28.5 26.7 31.5 36.0 40.6 26.2 10.7 46.4 25.8 47.5 35.5 46.4 28.6 24.9 13.9 21.4 44.5 42.7 27.1 22.6 24.8 27.2 26.3 33.3 32.9 23.5 33.3 28.0 31.7 39.7 23.9 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Supported "Plasma membrane,Mitochondria" 290000 "Plasma membrane, Mitochondria" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favourable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favourable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 13.8 12.1 12.0 14.6 20.2 35.1 14.7 16.6 24.4 19.6 21.9 13.4 31.0 17.7 5.4 23.4 7.1 9.3 23.0 25.5 7.5 6.4 16.1 11.0 20.8 26.1 21.1 11.3 26.2 20.0 15.3 35.3 20.8 12.2 16.3 42.6 9.7 7.9 6.7 11.2 7.5 5.5 18.6 26.5 33.2 21.6 2.3 8.2 26.4 30.6 22.0 23.5 13.6 18.1 19.5 12.8 21.4 19.7 11.1 16.2 12.5 28.6 16.5 22.9 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" 14000 "Nucleoli fibrillar center, Cytosol" "HPA047251: " "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavourable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 8.8 9.2 8.0 6.2 9.8 43.4 9.0 7.9 8.4 8.9 7.6 6.5 48.6 6.1 8.1 39.5 8.3 9.9 7.3 8.0 7.6 8.3 11.2 8.0 6.4 5.5 7.5 5.1 13.4 24.7 16.9 24.7 18.2 8.7 9.0 5.9 9.4 13.0 52.5 2.8 8.7 22.9 6.1 8.8 7.1 8.0 14.3 8.0 11.1 11.0 6.0 7.1 10.7 9.1 9.5 7.7 11.3 6.7 10.4 8.9 4.6 15.7 7.1 20.6 18.4 10.6 10.2 23.3 19.1 11.2 12.2 14.9 12.6 16.8 7.9 11.6 10.9 24.9 8.8 7.5 21.0 4.5 6.3 6.2 4.4 7.7 12.4 9.8 8.9 9.2 7.7 15.0 12.3 10.5 4.0 11.3 18.3 3.7 6.5 6.7 18.7 16.5 6.6 11.9 5.0 18.9 22.1 11.1 14.3 8.8 15.3 16.8 15.0 10.7 13.7 11.1 11.7 10.6 19.4 17.1 13.7 14.3 10.7 5.2 17.3 9.4 6.6 11.3 8.6 6.0 8.3 8.3 7.8 7.2 5.4 9.5 8.7 8.9 6.1 10.4 6.7 7.7 5.6 4.6 8.0 9.8 7.9 8.4 7.6 8.3 7.5 5.1 8.7 8.0 SUDS3 "FLJ00052, SAP45, SDS3" ENSG00000111707 "SDS3 homolog, SIN3A corepressor complex component" Q9H7L9 12 118376380-118418031 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040402, HPA041972" Approved Supported "Nuclear bodies,Cytosol" "Intracellular and membrane" "Nuclear bodies, Cytosol" "HPA040402: , HPA041972: " "unprognostic (1.49e-1)" "unprognostic (4.08e-3)" "unprognostic (1.09e-1)" "unprognostic (6.60e-2)" "unprognostic (7.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.05e-3)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.70e-1)" "unprognostic (8.71e-2)" "unprognostic (3.03e-1)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "unprognostic (2.37e-1)" 12.4 15.6 20.6 10.2 19.1 13.3 17.6 13.3 22.0 17.1 17.2 10.7 10.5 12.9 20.4 15.6 24.7 17.3 12.1 12.9 15.8 11.0 15.3 12.7 13.9 12.2 8.9 18.7 18.6 34.2 22.9 12.2 15.1 14.5 15.7 17.3 13.1 20.4 15.6 15.1 18.7 14.6 20.9 13.4 12.1 14.7 21.6 13.2 13.6 20.5 8.3 17.3 19.9 18.2 9.7 7.7 14.4 4.9 4.6 7.9 4.1 16.4 12.5 17.2 17.0 9.6 12.7 18.4 12.9 13.3 15.1 12.0 13.6 10.7 22.4 13.8 12.4 19.7 20.4 13.6 17.9 19.7 12.1 15.5 10.1 12.1 11.1 17.1 12.0 8.7 14.6 7.5 13.4 12.8 16.9 8.1 13.8 11.2 20.2 22.5 17.7 9.8 18.4 15.4 15.8 13.8 24.2 13.4 13.3 18.2 10.9 11.2 35.5 14.0 10.6 10.3 9.8 11.5 8.7 15.4 17.2 16.6 11.5 10.9 12.3 2.0 4.9 6.2 5.9 3.1 7.3 9.7 6.4 6.8 5.2 9.3 7.9 5.3 14.4 4.6 3.0 7.7 5.9 4.1 20.6 19.1 13.3 22.0 15.8 11.0 8.9 18.7 14.5 13.2 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavourable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 7.8 13.9 27.2 11.8 27.0 24.5 9.9 36.0 34.4 9.0 10.1 15.4 10.8 11.8 14.8 15.0 7.8 13.5 9.0 18.2 23.0 17.0 9.9 7.4 9.4 15.0 16.8 24.2 13.8 9.1 13.3 22.8 9.8 16.0 16.1 11.7 14.5 14.1 11.9 19.5 12.2 10.6 11.2 15.1 13.9 11.4 56.5 16.9 11.0 19.0 6.7 13.6 10.7 9.7 4.3 4.1 5.3 3.2 9.0 4.7 1.7 12.9 12.3 31.7 22.7 14.9 14.8 15.9 16.3 12.2 19.0 16.4 8.0 11.5 25.6 13.5 12.9 9.6 25.7 9.9 17.5 9.0 23.2 16.2 18.2 10.4 10.7 13.6 16.4 15.2 10.5 11.6 9.5 9.9 24.3 18.5 20.6 11.0 15.8 25.6 16.3 18.2 16.0 16.3 14.3 9.8 13.2 35.2 14.5 14.3 10.1 7.1 10.5 12.7 10.8 18.9 11.4 21.8 19.1 23.7 17.9 19.0 19.0 21.5 19.8 5.3 3.1 2.4 4.7 3.2 2.5 2.5 2.9 2.7 3.1 4.3 2.7 3.2 2.8 9.0 2.8 4.1 2.7 1.7 27.2 27.0 36.0 34.4 23.0 17.0 16.8 24.2 16.0 16.9 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: " "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavourable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 15.2 16.7 24.8 18.8 24.6 20.1 23.8 33.7 22.3 21.1 16.9 36.4 38.5 33.6 9.6 20.8 26.5 30.5 19.3 31.1 27.8 12.7 31.2 21.9 27.5 17.9 24.2 23.5 13.9 17.6 21.8 16.6 35.3 29.1 11.1 32.2 10.8 22.5 44.5 29.0 16.1 26.0 14.4 14.5 36.6 17.2 8.2 10.5 17.4 14.3 15.8 14.7 23.1 25.3 17.7 20.7 20.3 28.7 8.7 12.3 30.0 10.6 19.5 25.3 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721162-69787961 "Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 137.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA002107: " "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 1.2 0.6 0.9 9.3 1.8 1.3 1.1 0.5 1.5 1.1 38.6 0.5 0.7 31.8 0.8 0.6 1.0 1.5 1.2 1.2 0.9 0.9 1.1 24.8 2.4 12.9 1.2 0.7 0.7 0.5 0.0 0.4 0.6 2.0 0.6 20.3 1.3 0.6 0.2 0.4 0.4 137.6 1.4 3.6 13.3 13.9 0.5 0.7 2.0 0.6 0.3 2.0 0.7 1.2 0.2 1.8 21.9 3.2 1.8 3.6 1.6 0.3 0.2 0.3 0.4 0.8 0.9 0.6 0.4 0.2 0.1 0.1 0.3 0.3 0.5 0.3 0.4 0.5 0.0 0.1 0.3 0.6 0.4 0.5 0.4 0.2 1.2 0.6 0.7 5.5 0.0 0.1 0.2 47.5 0.2 1.1 0.4 0.3 0.3 0.5 0.4 0.2 0.2 1.6 0.3 0.1 0.8 0.7 0.4 0.2 0.2 0.2 0.7 0.3 15.4 0.4 0.8 13.7 0.3 0.8 0.4 0.2 0.2 1.4 0.6 5.8 3.2 0.8 0.7 1.9 0.2 0.1 1.1 0.3 1.8 0.2 3.6 1.7 21.9 1.8 2.2 0.2 0.5 1.6 0.9 1.8 0.5 1.5 0.9 0.9 1.2 0.7 2.0 0.7 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860152 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.8;liver: 26.2;vagina: 15.8" "Group enriched" "Detected in some" 19 "HHSteC: 37.1;HSkMC: 16.8;hTCEpi: 14.0;HUVEC TERT2: 10.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "pons and medulla: 3.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favourable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 9.8 0.1 0.1 0.3 0.1 1.1 0.1 0.4 13.1 8.9 0.5 0.1 19.8 0.4 3.7 0.4 0.1 1.2 0.1 0.1 0.0 1.5 26.2 2.0 0.1 0.3 0.3 0.2 0.1 0.0 0.4 0.1 3.3 1.0 0.1 0.3 4.7 0.3 0.1 10.9 37.8 0.5 0.3 0.1 1.3 0.4 0.1 0.6 0.2 0.1 1.0 0.4 15.8 0.6 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 37.1 0.0 0.0 16.8 14.0 0.0 0.4 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.6 0.2 0.1 1.7 0.3 0.3 0.2 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.3 0.3 3.3 0.1 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552075-48599425 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB033013, HPA041724, HPA043539" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540" "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 4.0 0.1 0.2 28.7 0.8 0.0 9.2 2.9 2.2 5.2 91.8 0.3 2.3 0.0 0.1 0.1 2.5 0.1 6.5 0.0 0.2 0.0 0.1 0.2 0.8 0.1 11.4 0.0 6.9 0.0 0.0 12.4 6.9 0.2 45.7 13.4 0.0 0.1 0.0 0.7 0.2 0.0 0.5 1.1 79.6 78.6 0.6 32.0 0.7 1.5 2.5 1.0 1.1 3.1 0.9 5.6 7.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 34.1 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.0 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 20.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 2.9 0.1 17.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.5 0.8 0.4 2.1 0.9 3.1 0.4 1.8 1.4 0.7 0.7 0.6 1.2 1.4 1.1 1.0 1.5 1.1 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavourable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favourable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavourable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 63.9 19.4 8.4 39.1 41.8 28.9 13.1 21.0 29.4 17.7 22.0 10.5 52.0 10.1 18.2 30.0 32.5 5.1 24.3 11.8 16.4 8.1 6.5 12.7 9.8 27.1 15.7 20.7 22.9 23.8 15.9 27.7 26.0 20.4 45.1 28.4 14.1 13.4 18.5 11.6 9.9 10.8 8.6 64.5 24.1 7.1 10.0 12.2 26.3 55.8 25.7 55.9 26.3 21.4 16.4 23.5 40.1 17.9 30.7 23.3 15.0 26.9 29.9 52.3 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin-like modifier 1" P63165 2 202206180-202238608 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: " "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favourable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 27.1 37.8 44.4 21.6 37.9 41.8 31.6 47.7 49.2 26.9 29.7 19.9 27.2 26.2 24.7 33.4 26.9 24.7 26.6 28.3 38.0 39.6 43.5 62.6 24.6 28.7 34.6 40.6 23.4 29.8 26.6 28.7 30.4 32.3 28.8 31.2 21.6 35.6 24.5 42.4 21.6 33.2 27.6 29.6 25.1 26.4 28.7 27.1 32.2 38.4 28.1 33.6 26.9 23.1 74.8 63.0 77.0 63.7 65.8 89.0 94.0 33.6 17.1 62.3 33.1 34.7 37.1 27.8 35.9 45.3 44.8 59.4 36.8 42.9 23.0 33.3 41.3 24.7 51.0 49.8 70.4 21.5 39.1 42.6 33.6 43.1 25.1 48.0 40.6 28.5 48.2 35.0 26.7 41.6 39.2 37.6 47.8 28.6 60.4 79.9 74.9 36.3 39.2 34.9 40.6 54.2 28.0 43.4 47.3 29.3 28.4 47.9 25.5 46.0 29.1 33.1 33.3 30.2 31.6 32.8 64.5 58.5 36.8 34.2 28.9 56.6 63.7 77.0 51.1 62.6 53.5 74.8 63.7 59.8 63.0 58.4 60.2 62.8 73.6 65.8 62.8 52.9 89.0 94.0 44.4 37.9 47.7 49.2 38.0 39.6 34.6 40.6 32.3 27.1 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin-like modifier 2" P61956 17 75165586-75182983 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: , HPA048064: " "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavourable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavourable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavourable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 69.0 70.0 77.8 62.6 70.9 63.5 62.6 105.3 73.1 75.4 55.4 50.4 44.5 52.3 69.5 55.7 77.2 58.8 64.3 51.7 68.2 59.4 67.8 60.9 58.0 63.4 57.5 48.3 81.0 62.3 27.9 51.0 60.4 41.5 65.6 48.8 49.7 54.7 53.8 66.9 51.0 53.9 69.9 59.0 69.2 65.8 59.7 44.8 92.6 65.5 50.7 72.1 80.3 61.6 90.7 107.4 130.6 89.3 73.9 119.0 122.6 80.0 33.1 117.4 60.1 34.5 33.3 55.2 63.4 31.1 43.9 40.8 37.8 44.2 70.1 45.5 36.2 39.2 52.7 39.1 51.9 40.5 80.0 70.2 33.4 64.8 22.6 92.0 63.2 33.6 22.3 39.0 21.4 45.2 57.7 57.4 32.3 34.6 140.2 79.6 71.5 50.0 98.0 111.9 58.5 43.9 67.6 72.2 84.5 76.9 64.0 50.9 69.2 72.6 50.7 64.0 66.5 48.7 101.8 40.4 36.5 107.4 40.3 55.1 51.1 113.4 76.1 130.6 73.2 84.7 75.9 90.7 92.3 84.5 78.8 77.6 85.6 83.0 68.0 73.9 89.3 107.4 119.0 122.6 77.8 70.9 105.3 73.1 68.2 59.4 57.5 48.3 41.5 44.8 SUMO3 "SMT3A, SMT3H1" ENSG00000184900 "Small ubiquitin-like modifier 3" P55854 21 44805617-44818779 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012180, HPA042123, HPA048064" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB012180: AB_304041, HPA042123: , HPA048064: " "unprognostic (2.77e-2)" "unprognostic (2.52e-1)" "unprognostic (5.79e-2)" "prognostic unfavourable (7.88e-5)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (6.81e-2)" "unprognostic (7.13e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (7.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.00e-2)" "unprognostic (1.62e-1)" "unprognostic (7.50e-2)" "unprognostic (1.80e-2)" 32.2 23.8 37.4 17.7 43.8 50.0 25.0 31.6 43.4 26.9 28.0 17.5 19.4 24.0 21.7 23.9 23.4 22.1 21.9 36.6 27.6 38.7 24.4 29.2 26.2 32.0 30.8 29.0 26.3 26.2 14.6 15.6 21.7 26.6 21.8 15.5 30.6 28.3 30.2 62.4 18.9 28.9 17.4 19.7 28.2 27.7 17.3 17.3 23.9 26.1 18.4 20.8 22.5 20.3 23.8 46.0 14.0 35.7 18.5 27.6 38.4 45.5 18.4 17.3 7.1 20.2 23.3 18.2 31.8 34.9 45.1 36.2 27.4 18.2 16.1 50.4 29.6 9.0 14.9 24.7 11.1 22.4 22.5 66.1 13.2 21.7 22.0 37.3 32.7 26.3 23.5 26.3 15.0 18.2 37.8 26.9 18.0 58.6 31.7 25.9 41.3 36.9 37.0 1.5 36.0 11.8 17.7 17.0 32.7 28.5 20.9 22.0 28.2 26.8 35.9 13.5 29.6 28.7 32.7 33.3 46.6 40.8 12.1 51.1 18.6 0.6 34.6 14.0 23.5 35.7 23.9 23.8 22.8 22.8 37.5 21.5 27.6 24.8 4.1 18.5 32.0 46.0 24.7 38.4 37.4 43.8 31.6 43.4 27.6 38.7 30.8 29.0 26.6 17.3 SUMO4 "dJ281H8.4, IDDM5, SMT3H4" ENSG00000177688 "Small ubiquitin-like modifier 4" Q6EEV6 6 149400227-149401292 "Predicted intracellular proteins" "Ubl conjugation pathway" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;HeLa: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042123, HPA048064" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA042123: , HPA048064: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-1)" "unprognostic (7.75e-2)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-2)" "unprognostic (2.44e-11)" "unprognostic (4.94e-3)" "unprognostic (5.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" 1.5 0.8 0.7 1.9 1.7 3.6 2.7 5.1 6.5 2.1 1.1 1.2 1.4 1.6 3.0 3.2 1.7 0.7 1.5 3.6 1.0 0.8 2.3 6.6 2.8 3.9 0.7 1.7 2.9 2.2 1.2 2.6 1.8 2.8 3.1 1.7 1.7 2.5 1.1 2.3 1.3 1.4 1.9 1.9 2.2 1.5 2.0 0.2 1.4 2.1 0.7 1.8 1.4 3.5 1.9 0.7 5.6 1.1 3.2 2.6 0.5 0.2 0.0 0.2 0.2 0.4 0.0 0.5 0.8 0.2 0.3 0.3 0.3 0.3 1.5 0.3 0.0 0.3 0.0 0.6 0.4 2.9 0.3 0.2 4.1 0.3 0.3 0.2 0.3 0.3 0.2 0.5 1.0 0.0 0.6 1.2 0.2 0.0 0.5 0.6 0.5 0.3 0.4 0.6 0.5 0.0 1.4 0.9 0.2 0.5 0.0 0.0 0.0 1.7 1.4 0.8 0.7 0.6 0.4 0.6 0.1 0.1 0.5 0.6 0.0 0.3 0.5 0.9 1.3 0.6 0.7 1.1 2.6 1.9 0.7 1.9 1.7 2.4 5.6 3.2 1.1 0.5 2.5 0.5 0.7 1.7 5.1 6.5 1.0 0.8 0.7 1.7 2.8 0.2 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351472-21384266 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: " "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 21.6 18.3 16.3 21.6 26.2 21.5 21.3 39.1 27.9 22.8 21.3 14.4 20.7 13.5 31.5 18.5 20.9 23.7 14.5 15.9 17.9 16.2 17.7 14.1 17.1 28.0 18.8 22.8 29.0 15.7 40.3 24.0 18.9 28.6 18.8 21.5 11.3 19.3 20.5 21.4 22.1 19.9 27.4 18.9 22.6 19.1 24.9 19.0 32.7 20.3 17.0 29.5 24.6 20.7 23.3 17.1 21.1 20.4 23.2 26.8 16.7 29.9 28.3 39.3 28.8 17.8 17.8 28.0 27.1 21.7 33.2 31.3 27.4 27.1 63.7 10.4 19.7 32.1 49.7 24.5 50.3 20.2 21.2 38.6 25.9 38.4 18.2 54.5 28.8 15.6 15.1 27.6 31.3 22.4 31.7 27.4 27.4 19.4 50.9 16.6 43.8 28.1 55.1 44.9 34.4 13.3 33.2 39.4 33.6 43.9 26.4 16.5 14.6 25.9 18.9 29.1 24.3 18.0 29.3 27.4 45.7 64.2 10.7 32.2 22.0 21.1 13.1 19.6 22.8 17.3 26.8 23.3 21.8 25.3 17.1 21.3 25.0 25.1 11.0 23.2 20.4 16.1 20.3 16.7 16.3 26.2 39.1 27.9 17.9 16.2 18.8 22.8 28.6 19.0 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: " "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavourable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favourable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 17.7 37.2 18.7 21.3 22.8 15.3 14.4 24.4 26.1 28.8 25.9 34.5 7.9 18.9 12.8 24.3 21.2 27.3 17.7 29.9 35.1 24.3 26.4 30.0 21.3 19.1 27.6 29.5 21.0 10.7 30.6 20.4 18.9 25.8 22.4 20.5 21.2 27.3 11.8 14.5 12.1 14.0 34.4 15.4 14.2 35.2 14.3 18.9 28.6 45.2 15.5 27.7 19.6 29.7 22.8 18.8 21.6 31.0 28.5 21.8 27.7 25.7 12.5 18.8 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell line enhanced" "Detected in all" "MCF7: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044340: , HPA052213: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.1 12.4 5.2 6.5 3.8 3.0 11.0 3.6 3.2 5.9 3.0 17.0 6.0 7.2 5.3 2.4 19.7 8.3 9.0 2.7 6.9 11.4 5.6 14.2 6.3 7.7 9.3 4.3 3.6 10.6 8.3 12.3 2.7 8.9 4.9 4.0 43.2 9.5 6.2 16.4 24.0 10.7 7.8 16.8 5.0 8.2 19.5 9.9 8.2 13.6 10.9 14.5 4.4 5.1 8.9 9.0 9.1 13.0 6.2 12.2 7.7 5.7 5.5 8.9 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328774-133336398 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA023608: AB_1857671, HPA074622: " "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favourable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 14.8 16.8 19.9 15.0 22.7 16.2 15.7 16.4 25.8 13.9 16.2 14.0 11.9 21.7 18.6 10.9 17.4 18.5 15.9 13.9 19.1 17.9 14.5 16.2 12.6 17.6 19.6 22.9 27.4 23.1 16.5 11.8 12.5 24.6 15.8 13.1 11.6 18.3 19.5 47.3 17.8 22.3 18.0 23.6 18.8 13.6 16.5 19.8 8.6 14.4 11.1 13.5 15.3 19.1 7.7 8.9 3.9 4.7 4.6 8.5 3.6 4.1 6.6 5.1 7.6 3.2 2.9 8.4 6.7 3.9 6.0 3.7 10.3 7.2 12.2 5.2 3.7 12.7 6.5 7.0 2.2 8.1 7.4 8.4 7.5 6.1 5.8 14.1 7.3 4.2 6.3 6.3 5.8 3.1 18.2 6.6 5.3 10.9 11.4 11.6 14.8 11.9 12.1 7.1 12.3 5.2 4.0 10.7 9.1 6.5 10.8 5.8 9.4 8.0 6.3 13.7 7.2 6.9 9.0 4.9 6.9 15.8 5.1 9.7 8.0 3.9 4.7 1.9 6.8 4.4 7.0 7.1 6.2 6.1 4.9 7.7 8.5 7.0 1.3 4.6 3.7 8.9 5.0 3.6 19.9 22.7 16.4 25.8 19.1 17.9 19.6 22.9 24.6 19.8 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150042-33219215 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.5;HUVEC TERT2: 36.0;LHCN-M2: 13.9;TIME: 14.2" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.9;neutrophil: 1.5" "Group enriched" "Detected in many" 9 "B-cells: 1.9;granulocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" 4300000 "Golgi apparatus, Vesicles" "HPA052788: " "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 7.6 2.5 7.0 1.5 6.1 0.4 2.5 2.0 13.2 11.0 2.6 4.6 2.3 1.5 7.0 6.5 2.3 7.9 13.1 5.7 6.4 8.1 2.6 1.1 3.0 4.4 6.9 6.9 6.4 1.2 1.0 1.3 0.5 6.3 1.9 2.2 3.7 1.3 10.7 2.2 2.8 2.7 7.7 4.6 3.9 3.3 4.7 3.3 0.0 5.3 2.9 8.1 3.0 3.5 1.9 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.8 0.1 0.0 4.4 1.5 14.5 4.9 0.0 0.0 0.0 4.1 1.1 0.0 6.3 2.0 6.0 0.1 7.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 1.1 9.3 1.8 36.0 0.0 0.0 13.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.1 0.8 0.8 14.2 0.0 6.9 0.5 2.1 0.0 0.3 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.1 7.0 6.1 2.0 13.2 6.4 8.1 6.9 6.9 6.3 3.3 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favourable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.6 2.8 4.0 3.7 8.3 6.1 7.4 6.1 12.8 3.5 3.4 3.3 9.5 12.6 6.9 7.6 15.0 2.3 12.5 3.3 21.5 1.7 10.2 2.2 5.4 13.4 1.6 26.5 9.8 12.4 5.8 10.9 7.1 3.1 11.2 4.8 5.2 2.4 4.4 0.8 2.9 4.2 3.5 5.0 6.7 5.5 1.7 2.7 5.0 14.6 2.2 5.9 4.6 10.9 8.1 4.8 5.1 2.4 7.8 1.7 8.9 5.2 5.7 4.2 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli, Nuclear bodies" "HPA057436: " "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.0 12.5 11.8 13.5 6.8 8.8 12.1 13.7 12.1 16.9 20.5 9.4 7.9 30.8 10.6 8.5 12.5 17.5 7.9 27.5 10.8 17.0 21.3 10.6 6.8 8.0 33.5 21.9 6.1 8.9 16.8 12.9 10.3 20.5 42.8 14.5 4.9 39.8 19.5 6.7 7.6 23.8 30.2 24.9 9.9 13.8 15.1 11.8 22.1 7.2 13.2 20.8 28.0 7.6 13.4 12.2 16.1 21.1 23.4 29.1 38.1 9.8 20.7 12.1 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 5 "Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 4.9 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favourable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.4 5.0 33.1 11.9 13.4 21.4 16.0 9.0 7.4 12.3 12.7 9.3 8.4 11.4 9.9 12.1 7.3 5.8 9.7 16.6 20.2 10.0 22.9 5.0 18.3 10.8 17.1 15.0 13.4 15.5 6.9 7.1 12.4 17.8 6.1 15.7 4.9 17.1 20.5 18.1 6.1 12.5 25.2 8.0 13.0 11.5 19.8 17.7 10.8 6.3 12.9 4.9 48.5 9.5 10.9 12.3 8.7 14.6 5.9 7.3 8.2 7.0 11.7 10.3 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736781 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 235.1;tongue: 93.5" "Cell line enhanced" "Detected in many" "HaCaT: 40.1;U-2197: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Group enriched" "Detected in many" 6 "granulocytes: 15.2;monocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavourable (5.70e-5)" 11.9 2.1 0.7 10.5 1.1 3.7 4.5 0.6 0.9 18.7 42.3 0.6 10.7 1.7 34.3 13.3 18.2 8.9 15.5 25.5 0.5 0.6 2.8 2.0 3.8 2.3 0.8 0.7 13.9 2.4 5.1 4.1 2.9 1.7 12.6 5.3 10.0 10.6 15.3 235.1 4.7 9.1 36.4 1.3 1.5 14.2 5.5 0.5 4.6 6.9 93.5 11.6 28.6 9.9 0.1 0.7 15.2 4.2 1.2 1.7 0.6 17.3 7.5 3.4 1.2 9.9 26.6 5.5 2.8 6.7 1.1 1.1 8.8 17.2 0.0 12.3 1.1 40.1 1.9 6.6 1.1 0.2 3.7 0.0 9.5 5.7 6.0 1.5 0.3 24.4 6.5 12.4 4.5 19.9 0.0 0.1 1.7 5.4 1.4 0.8 1.7 2.7 3.2 10.1 0.1 11.8 5.8 4.1 3.4 2.5 0.3 8.8 3.1 1.8 12.8 5.7 5.9 28.1 8.4 0.1 0.0 0.0 22.0 3.4 19.5 2.9 1.1 5.2 1.2 1.9 1.5 0.0 1.1 0.6 0.7 0.1 1.7 1.1 15.2 1.2 4.2 0.2 0.1 0.6 0.7 1.1 0.6 0.9 0.5 0.6 0.8 0.7 1.7 0.5 SWAP70 "KIAA0640, SWAP-70" ENSG00000133789 "Switching B cell complex subunit SWAP70" Q9UH65 11 9664077-9752991 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 29.5;naive B-cell: 29.6" "Group enriched" "Detected in all" 6 "B-cells: 29.6;granulocytes: 16.4;monocytes: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA006810, HPA006929" Supported Supported "Plasma membrane,Actin filaments" 7100 "Plasma membrane" "Actin filaments" "HPA006810: AB_1857683, HPA006929: " "unprognostic (4.16e-2)" "unprognostic (7.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.67e-1)" "unprognostic (3.38e-2)" "unprognostic (3.16e-3)" "unprognostic (1.26e-1)" "unprognostic (4.04e-1)" "unprognostic (3.33e-1)" "unprognostic (1.75e-1)" "unprognostic (3.85e-2)" "unprognostic (2.79e-3)" "unprognostic (5.00e-2)" "unprognostic (1.14e-1)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 30.8 7.3 10.6 24.0 12.0 10.6 25.8 4.2 13.7 14.5 12.9 10.5 10.4 9.0 19.0 10.8 14.5 11.5 13.2 12.5 12.7 8.2 11.4 5.8 20.6 36.0 12.3 7.9 9.2 8.8 17.5 8.4 25.4 11.9 15.9 7.8 13.1 15.8 11.3 9.7 21.2 16.2 14.0 14.7 32.6 9.9 5.2 12.0 7.5 16.4 10.2 42.2 20.6 26.5 29.6 2.9 16.4 9.7 2.8 1.4 1.7 11.4 6.4 9.1 0.0 19.0 16.6 16.0 12.5 15.3 11.9 13.2 7.0 9.1 45.8 12.4 24.0 13.8 11.0 7.0 15.4 4.1 4.4 12.1 7.7 3.4 10.6 9.3 22.6 11.6 8.8 8.7 15.6 36.2 1.1 0.1 12.4 1.8 2.7 4.5 8.3 3.3 6.6 8.5 1.3 9.9 30.5 0.4 4.6 11.9 15.4 10.0 6.1 7.1 41.4 21.0 7.5 17.5 11.7 1.2 3.4 32.3 8.3 10.5 8.5 5.7 2.0 16.4 0.4 4.8 0.2 29.5 0.5 0.4 2.9 29.6 0.4 0.5 0.4 2.8 9.7 0.8 1.4 1.7 10.6 12.0 4.2 13.7 12.7 8.2 12.3 7.9 11.9 12.0 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" Q1ZZU3 9 128275379-128288990 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA052032, HPA055472" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA052032: , HPA055472: " "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavourable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favourable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 10.2 11.7 14.7 11.8 15.9 6.0 17.9 18.0 13.2 18.2 9.0 12.3 48.0 9.9 13.0 44.8 13.5 20.4 12.7 14.8 12.5 13.2 14.2 18.0 12.5 8.7 16.7 11.0 19.6 13.2 26.5 23.8 10.7 13.6 14.6 8.1 14.1 15.2 50.7 14.1 10.3 9.5 12.8 13.7 7.7 9.2 57.1 16.2 8.9 27.8 12.5 10.5 12.4 17.1 12.6 14.2 28.1 9.6 13.4 15.3 10.0 9.5 17.1 10.1 11.7 27.5 25.1 11.4 16.8 22.4 21.8 14.8 21.8 11.3 9.1 22.4 27.3 16.0 16.1 22.4 14.9 13.6 12.0 6.9 32.6 17.0 35.4 4.4 6.5 21.1 10.8 36.5 19.7 20.9 16.2 14.7 22.2 38.8 9.5 6.3 6.8 35.5 9.0 14.0 14.4 14.6 5.0 11.7 6.5 20.9 13.4 19.9 22.3 4.7 12.9 15.9 13.2 30.8 14.1 15.6 23.4 12.1 21.7 6.9 17.1 28.1 9.6 16.4 10.2 5.7 12.0 12.6 10.1 10.2 9.8 12.5 12.2 15.3 6.4 13.4 5.6 14.2 10.0 10.0 14.7 15.9 18.0 13.2 12.5 13.2 16.7 11.0 13.6 16.2 SYAP1 "FLJ14495, PRO3113" ENSG00000169895 "Synapse associated protein 1" Q96A49 X 16719632-16765336 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000175, HPA000882, HPA048047" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA000175: AB_1080142, HPA000882: , HPA048047: " "unprognostic (4.66e-2)" "unprognostic (2.99e-2)" "unprognostic (1.25e-2)" "unprognostic (5.44e-2)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (9.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.82e-1)" "unprognostic (1.62e-2)" "unprognostic (1.95e-1)" "unprognostic (3.95e-3)" "unprognostic (1.14e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-3)" 17.6 31.3 13.1 12.9 12.3 26.2 16.5 10.2 14.0 17.1 23.8 12.2 16.1 20.6 17.0 13.7 18.5 14.4 20.7 25.7 13.5 13.7 28.7 51.4 17.6 11.4 15.8 11.0 19.9 14.3 22.8 15.9 18.9 18.4 16.2 16.1 10.7 15.9 21.3 22.5 12.6 33.0 12.3 17.3 13.7 16.9 10.1 11.2 15.3 16.2 13.3 15.1 17.9 13.5 12.6 11.1 17.8 15.0 13.8 15.2 9.1 16.0 13.6 9.8 18.3 13.4 15.2 4.5 12.8 9.2 10.8 10.8 12.7 13.4 12.6 18.9 12.5 9.6 11.9 16.8 14.4 8.2 23.9 5.0 14.6 12.1 9.6 8.5 7.8 10.4 8.0 18.6 15.8 14.8 10.8 7.1 14.5 18.9 4.6 9.2 11.4 15.0 5.0 12.4 12.6 15.9 10.6 10.1 12.4 23.9 17.1 12.7 22.6 7.7 11.6 13.9 7.3 28.1 10.4 7.8 6.6 14.6 13.6 4.3 11.3 9.2 10.5 12.7 15.2 11.3 12.3 12.6 13.0 13.9 11.1 10.8 13.1 13.6 17.8 13.8 15.0 9.2 14.4 9.1 13.1 12.3 10.2 14.0 13.5 13.7 15.8 11.0 18.4 11.2 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 8 "K-562: 17.0;U-2 OS: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.0 0.5 0.3 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.1 15.8 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.7;Karpas-707: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: " "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.3 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.7 0.4 3.2 0.0 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 3.9 0.0 1.6 2.3 2.0 0.3 1.4 0.0 0.0 7.3 0.4 3.3 0.0 0.0 0.3 0.0 0.0 0.0 3.8 1.2 2.6 0.8 2.3 0.0 2.2 1.4 2.1 1.7 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell line enhanced" "Detected in some" "CACO-2: 10.2;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: , HPA065613: " "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell line enhanced" "Detected in many" "U-138 MG: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.0 6.3 3.4 8.8 7.7 7.2 2.7 17.2 12.7 17.0 14.4 1.4 2.4 0.0 11.4 17.3 2.6 2.6 3.0 9.5 0.1 3.0 0.6 11.7 2.7 14.7 0.0 0.0 12.5 2.2 10.1 4.6 3.1 0.0 0.0 12.6 2.0 0.0 0.0 5.6 6.5 0.0 8.5 0.0 4.2 0.5 0.1 6.8 9.6 5.9 11.5 0.7 0.4 6.5 40.8 12.4 18.6 18.5 0.0 0.1 0.0 11.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 SYDE2 FLJ13815 ENSG00000097096 "Synapse defective Rho GTPase homolog 2" Q5VT97 1 85156873-85201046 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.1;SK-BR-3: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027138, HPA058378" Uncertain Approved "Nucleoli,Golgi apparatus" "Nucleoli, Golgi apparatus" "HPA027138: AB_1857686, HPA058378: " "unprognostic (1.68e-1)" "unprognostic (8.90e-2)" "unprognostic (2.34e-2)" "unprognostic (3.43e-3)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (3.84e-3)" "unprognostic (6.47e-3)" "unprognostic (4.39e-2)" "unprognostic (1.85e-1)" "unprognostic (3.88e-2)" "unprognostic (4.05e-1)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (7.51e-2)" "unprognostic (6.69e-2)" 2.5 1.8 1.1 2.6 1.7 0.6 3.8 0.6 2.2 3.5 11.4 0.5 2.0 2.5 3.8 2.6 5.6 2.3 7.7 5.4 2.8 0.9 4.7 6.4 9.1 3.4 0.9 2.4 3.3 9.9 8.4 5.1 5.0 0.9 5.0 2.6 7.2 3.9 2.5 2.4 1.9 9.2 13.3 0.9 1.0 6.0 3.3 1.0 0.6 5.2 1.0 0.8 6.0 9.6 0.3 0.1 1.4 0.1 0.3 0.7 0.2 2.2 0.6 0.7 0.8 2.5 0.7 16.1 2.5 1.6 1.5 2.3 4.2 0.7 0.0 0.8 1.6 4.2 8.0 1.0 2.4 0.9 2.2 2.0 1.7 1.4 2.9 1.3 0.5 1.1 1.3 1.1 1.1 0.3 2.5 0.0 1.1 3.0 1.2 0.2 4.1 0.9 0.0 4.3 0.5 1.1 5.6 0.1 0.0 1.8 8.7 2.6 2.0 1.7 0.3 1.9 4.2 0.0 2.5 0.0 0.3 0.8 0.2 0.8 1.7 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.7 0.3 1.4 0.3 0.0 0.1 0.0 0.2 1.1 1.7 0.6 2.2 2.8 0.9 0.9 2.4 0.9 1.0 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 38.7;HEL: 22.3;HL-60: 30.8;HMC-1: 20.5;REH: 25.8;THP-1: 23.7;U-698: 18.3;U-937: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 38.7 1.1 0.0 6.0 0.8 3.2 0.0 0.0 5.3 22.3 0.0 0.0 0.0 30.8 20.5 0.0 4.4 0.0 0.4 0.0 0.6 3.1 0.0 4.7 0.0 13.5 0.2 0.0 25.8 0.0 10.6 0.8 5.8 2.0 1.8 0.0 2.7 0.0 2.5 23.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.3 0.0 21.7 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 SYMPK "SPK, SYM" ENSG00000125755 Symplekin Q92797 19 45815410-45863290 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041756, HPA042449" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA041756: AB_10963544, HPA042449: " "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (2.59e-1)" "unprognostic (1.59e-2)" "unprognostic (3.11e-2)" "unprognostic (2.33e-3)" "unprognostic (9.93e-2)" "unprognostic (9.78e-2)" "unprognostic (1.23e-1)" "unprognostic (9.16e-3)" "unprognostic (1.67e-2)" "unprognostic (1.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (2.58e-1)" "unprognostic (6.38e-2)" 14.7 15.9 15.3 23.7 24.2 20.7 15.2 25.1 32.2 17.1 18.2 25.3 20.3 18.6 22.6 18.9 17.4 19.3 17.6 14.6 17.3 18.0 15.0 21.6 15.6 27.2 19.3 16.8 21.6 16.3 20.5 24.0 34.8 19.9 17.4 12.2 16.1 21.5 17.5 33.4 21.1 18.0 13.9 18.7 23.0 19.4 38.0 22.0 28.5 20.5 11.6 23.4 16.8 16.7 7.9 9.2 6.5 7.1 4.2 5.2 2.7 19.2 34.1 14.0 10.6 13.7 17.6 23.6 15.5 10.8 15.8 18.0 15.1 17.7 34.1 10.6 17.3 15.9 18.8 16.8 14.2 26.4 21.1 19.7 23.4 15.9 15.8 21.6 23.2 12.8 10.3 16.9 19.4 16.3 25.9 22.3 13.7 18.1 19.9 22.8 11.9 7.9 21.5 16.3 21.1 11.3 35.0 16.0 20.3 18.9 12.3 12.4 16.9 29.9 18.0 13.1 21.1 10.1 22.5 29.6 55.9 27.6 15.0 14.5 21.5 2.1 5.1 2.2 3.4 3.8 3.2 4.7 3.0 5.2 4.2 7.9 2.6 2.4 6.5 4.2 7.1 9.2 2.3 2.7 15.3 24.2 25.1 32.2 17.3 18.0 19.3 16.8 19.9 22.0 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32680360-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 51.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.8;fHDF/TERT166: 38.9;U-138 MG: 34.1;U-2197: 18.1;WM-115: 22.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 5 "monocytes: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028311 Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 4.2 3.2 3.7 5.8 3.9 0.1 6.8 1.1 4.2 5.9 7.2 3.7 1.2 1.5 7.7 7.7 15.6 5.3 4.8 7.9 3.5 3.9 1.4 1.1 4.6 0.6 3.6 2.6 7.9 0.9 2.7 2.8 1.1 3.5 6.1 4.8 4.6 4.1 8.4 51.0 1.6 4.0 28.5 4.5 1.9 6.5 5.4 1.9 0.0 1.9 23.6 2.3 7.8 2.5 0.0 0.3 0.0 1.8 0.0 0.3 0.0 0.0 1.3 0.1 0.0 6.5 10.2 0.0 10.5 26.8 9.1 6.6 0.1 0.1 0.0 0.5 38.9 0.4 0.3 0.2 5.5 0.0 0.0 0.2 4.4 0.9 5.2 0.0 0.0 15.7 0.9 10.1 0.3 2.9 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.9 0.0 2.0 0.0 10.6 0.0 0.1 0.1 10.6 2.2 0.0 0.6 0.0 1.7 34.1 1.5 18.1 2.7 0.0 0.0 0.0 9.6 0.1 22.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.7 3.9 1.1 4.2 3.5 3.9 3.6 2.6 3.5 1.9 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607785-85643792 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275" Supported Supported Nucleoplasm,Cytosol 77000 Nucleoplasm Cytosol "CAB010895: AB_261964, HPA041275: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavourable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favourable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 29.1 28.3 27.9 31.3 36.2 30.4 28.4 35.6 37.9 32.9 29.4 19.2 31.8 20.4 32.7 18.9 48.8 24.5 21.9 31.3 29.3 19.0 25.2 31.3 25.7 35.0 31.9 23.1 26.2 34.9 37.5 27.9 31.3 28.2 23.1 29.6 17.3 31.4 32.8 41.4 27.2 23.7 53.5 28.1 24.7 25.4 19.8 30.1 38.1 42.0 29.8 41.7 31.2 39.4 13.2 20.9 4.6 20.0 18.1 18.6 12.6 31.9 24.0 40.0 23.3 26.3 31.4 25.4 47.4 39.1 43.0 42.7 39.2 21.0 75.5 34.6 45.6 31.0 58.5 47.1 75.5 25.9 26.8 67.3 28.9 26.9 22.2 82.1 29.0 25.7 27.1 49.2 50.7 45.3 67.4 35.6 49.7 35.2 38.4 35.0 38.3 25.5 57.7 64.0 32.0 35.2 51.2 37.7 30.6 33.0 27.9 19.4 24.2 51.2 41.5 29.2 23.9 30.5 56.6 22.3 43.9 49.8 26.8 49.7 40.6 1.0 13.0 4.6 17.7 18.6 18.6 13.2 16.8 15.9 20.9 11.9 15.3 16.6 1.6 18.1 20.0 15.5 16.7 12.6 27.9 36.2 35.6 37.9 29.3 19.0 31.9 23.1 28.2 30.1 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 33.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.8" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 12.7 11.5 18.2 9.1 30.2 41.7 9.0 62.0 25.0 16.8 7.3 9.8 12.4 2.7 15.2 18.4 6.2 12.9 7.9 22.7 21.0 17.5 18.4 11.2 16.1 13.7 13.2 15.1 27.7 10.6 37.3 37.0 4.7 19.7 10.1 6.3 10.5 3.6 12.5 22.0 16.9 5.3 19.1 9.7 15.5 9.0 8.3 11.6 9.0 20.6 9.5 12.1 10.0 12.3 3.2 0.8 33.8 1.5 4.7 6.4 1.4 0.1 3.9 2.8 3.2 3.9 8.6 1.0 8.8 4.6 2.3 4.2 0.8 0.1 8.3 0.5 4.8 0.2 1.0 2.3 2.4 10.0 2.7 3.5 2.6 2.7 9.0 0.6 1.6 5.5 0.5 5.0 10.3 4.4 0.0 9.5 6.2 0.4 1.4 0.1 0.6 1.5 1.9 5.5 2.3 8.9 0.1 1.7 2.6 1.4 0.5 6.1 0.5 0.3 5.9 10.7 14.5 3.7 4.8 18.9 8.0 13.3 5.9 1.9 3.1 3.0 1.1 33.8 6.4 0.7 4.1 2.9 4.2 6.1 0.8 3.2 4.0 5.1 1.1 4.7 1.5 0.7 5.1 1.4 18.2 30.2 62.0 25.0 21.0 17.5 13.2 15.1 19.7 11.6 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell line enhanced" "Detected in many" "Daudi: 43.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Supported "Nuclear membrane,Intermediate filaments" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favourable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.3 5.9 8.7 2.8 8.7 2.6 11.5 1.2 1.2 2.0 3.5 1.9 3.6 43.5 1.8 1.1 8.4 5.7 2.2 2.5 6.6 2.2 0.2 4.3 0.5 1.7 0.7 0.2 3.7 8.2 2.5 2.3 4.5 0.2 3.5 1.4 9.7 4.6 0.2 3.9 1.8 5.4 8.2 1.4 13.2 8.3 8.1 6.0 13.8 3.3 3.7 3.8 0.1 3.9 3.2 5.2 1.0 3.6 4.8 2.1 16.5 0.9 0.0 4.6 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favourable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.5 2.8 5.1 5.6 8.9 7.2 10.3 11.5 6.6 7.0 5.9 6.3 2.6 2.0 3.9 6.9 5.2 9.1 6.7 8.4 6.5 8.7 13.8 9.0 3.5 4.8 5.7 12.3 4.0 5.0 12.2 6.2 10.9 10.3 11.9 9.0 5.6 5.3 4.7 3.6 6.3 5.8 11.1 7.2 7.4 4.0 5.8 4.5 14.1 9.0 5.5 7.8 7.4 12.1 10.9 5.4 8.7 6.3 6.2 7.2 4.3 8.2 10.8 8.6 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981887-158099176 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 62.0" "Cell line enhanced" "Detected in many" "TIME: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavourable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 2.8 3.9 12.2 4.9 25.1 15.3 6.7 3.0 18.7 3.9 8.7 50.5 3.7 5.8 5.2 9.4 6.0 4.6 8.0 8.5 17.8 10.9 3.2 4.0 2.8 4.4 46.8 8.8 2.9 6.6 1.1 2.9 2.6 33.0 5.3 8.9 1.4 13.5 5.1 4.3 3.1 5.6 6.6 62.0 3.3 7.0 6.5 24.4 3.0 4.4 1.4 5.3 5.9 3.0 3.2 1.1 9.3 1.3 2.4 3.8 0.8 5.9 20.9 1.7 2.7 1.3 4.3 9.3 11.0 22.4 13.2 15.6 10.7 5.1 0.2 7.5 21.2 5.7 3.7 6.9 15.4 8.3 3.4 11.6 10.9 11.3 2.5 4.0 12.6 2.2 3.7 20.1 4.7 22.9 8.8 2.6 6.0 2.8 5.0 4.5 2.0 11.7 2.2 7.2 5.3 4.4 6.9 13.3 0.7 8.5 5.4 2.1 4.2 2.5 40.5 10.0 10.3 23.1 13.3 1.1 2.8 0.3 18.8 6.4 6.9 4.5 1.3 1.1 1.9 0.6 3.8 1.9 2.6 1.7 1.1 3.2 2.2 1.7 9.3 2.4 0.8 1.1 2.1 0.8 12.2 25.1 3.0 18.7 17.8 10.9 46.8 8.8 33.0 24.4 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell line enhanced" "Detected in many" "BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: " "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.1 1.0 0.9 25.8 3.9 5.4 1.3 1.1 6.0 2.8 0.0 21.3 5.6 2.5 0.0 3.8 0.5 0.0 0.0 0.0 10.4 1.3 5.8 0.0 0.2 1.1 6.2 1.5 1.1 20.9 0.0 0.0 1.2 0.4 0.0 0.1 0.8 3.3 0.1 0.2 0.0 1.0 0.5 2.4 11.5 5.6 6.2 0.2 0.4 1.8 50.7 5.1 15.9 0.1 1.0 0.2 0.0 0.3 44.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 185.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 25.8;LHCN-M2: 9.2;SH-SY5Y: 39.3" "Cancer enhanced" "Detected in all" "stomach cancer: 27.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "thalamus: 64.1" "Low region specificity" "Detected in all" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: , HPA068563: " "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.91e-4)" 11.4 2.3 1.8 9.6 3.9 0.0 7.3 1.0 5.6 26.5 56.0 4.4 20.5 6.5 37.5 23.9 37.0 14.2 19.4 29.0 2.6 1.5 2.4 1.7 3.7 5.7 1.9 5.2 27.9 1.4 0.9 2.6 3.8 3.8 35.9 11.1 21.2 4.1 58.8 185.8 3.7 14.5 88.7 4.0 6.1 29.5 9.6 3.1 3.0 3.7 12.8 2.1 50.7 15.5 1.8 0.2 2.0 0.4 1.2 2.3 0.4 0.1 1.8 0.1 0.0 5.5 1.8 0.3 5.7 6.3 0.2 0.2 0.0 0.3 0.6 0.0 25.8 0.1 0.1 0.1 0.3 2.4 0.0 0.3 0.4 0.0 1.3 0.0 0.1 6.6 0.1 1.8 0.1 0.0 0.0 0.3 9.2 0.1 0.3 3.5 0.6 0.0 0.2 0.6 0.1 0.1 0.1 0.2 39.3 0.2 0.1 0.0 0.0 3.3 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.9 0.3 2.0 1.2 0.1 1.9 1.3 2.0 1.2 0.1 1.8 2.1 1.3 0.9 1.2 0.4 0.2 2.3 0.4 1.8 3.9 1.0 5.6 2.6 1.5 1.9 5.2 3.8 3.1 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: , HPA057142: " "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.2 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.5 0.7 0.3 0.5 0.9 0.1 0.1 0.0 0.4 0.1 0.2 0.3 0.6 0.4 0.6 0.2 0.2 6.0 0.1 1.2 0.1 0.0 0.3 0.3 0.3 0.3 0.2 1.8 0.2 0.7 0.2 5.8 0.2 0.0 0.6 0.3 0.4 0.1 6.1 0.1 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell line enhanced" "Detected in some" "ASC diff: 19.8;ASC TERT1: 8.3;BJ: 8.4;BJ hTERT+: 26.7;fHDF/TERT166: 13.8;HAP1: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076657 Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favourable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 19.8 8.3 0.0 8.4 26.7 2.6 1.0 0.0 0.0 0.0 0.0 13.8 0.0 7.1 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.6 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 2.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell line enhanced" "Detected in some" "AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA055426: " "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.9 3.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell line enhanced" "Detected in some" "BEWO: 10.2;CAPAN-2: 19.9;Daudi: 8.7;MCF7: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042059: " "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.3 0.1 0.0 0.2 0.5 10.2 0.0 0.0 0.0 0.0 0.3 19.9 8.7 2.4 0.0 3.5 0.5 0.3 0.0 0.0 1.4 0.0 7.3 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.8 4.1 0.0 0.8 0.6 2.5 4.4 1.5 0.9 2.8 7.9 0.4 7.8 1.8 0.0 0.0 5.2 0.1 0.0 1.4 0.0 8.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 72.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 72.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 65.2" "Cell line enhanced" "Detected in many" "MCF7: 26.3;RH-30: 53.0;RPTEC TERT1: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.5;MAIT T-cell: 17.9" "Lineage enriched" "Detected in many" 6 "T-cells: 17.9" "Low region specificity" "Detected in many" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favourable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favourable (9.07e-4)" 12.8 5.5 27.6 11.8 13.9 1.8 9.7 6.8 32.0 6.5 26.3 6.8 2.1 11.4 7.6 11.8 9.6 6.3 15.0 5.7 13.8 9.0 14.5 3.9 8.1 5.7 8.4 21.5 3.7 2.5 7.2 5.5 9.8 12.4 9.9 39.8 5.7 8.4 5.8 3.7 4.6 17.7 7.8 12.8 5.4 65.2 3.2 5.1 5.8 4.2 5.0 3.8 17.2 11.3 0.1 0.7 0.0 0.0 3.0 17.9 1.7 1.0 2.3 3.6 0.3 0.8 4.8 0.0 8.9 11.7 7.9 18.1 10.1 1.3 0.2 3.3 6.2 6.6 0.2 0.8 10.5 0.6 0.0 0.0 0.0 0.1 0.5 0.7 0.1 6.0 1.1 17.1 0.2 0.0 0.1 0.1 10.0 26.3 0.0 0.2 6.1 4.0 0.3 53.0 0.0 37.9 13.7 0.1 0.1 1.9 1.6 0.8 0.2 0.1 0.0 12.5 4.8 7.8 0.4 0.0 0.0 4.7 12.8 0.1 7.6 0.0 0.0 0.0 10.5 0.0 17.9 0.0 2.1 6.3 0.0 0.1 1.7 3.1 0.0 3.0 0.0 0.7 0.8 1.7 27.6 13.9 6.8 32.0 13.8 9.0 8.4 21.5 12.4 5.1 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.6" "Cell line enhanced" "Detected in many" "HMC-1: 16.4;U-138 MG: 12.5;U-2 OS: 13.6;U-266/70: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "basophil: 55.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 55.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favourable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 8.3 1.5 2.3 9.0 3.7 9.4 3.8 0.8 2.4 5.1 7.4 7.1 0.6 2.9 4.6 5.5 3.6 11.6 7.3 5.3 3.4 2.0 4.7 2.2 20.2 26.7 3.5 1.3 2.5 2.3 0.9 2.1 1.3 5.5 5.3 1.8 4.8 12.4 4.8 11.4 3.0 12.0 3.5 10.4 21.9 5.8 3.2 3.9 2.3 21.7 1.2 24.5 18.8 3.6 0.2 1.3 55.6 4.5 10.9 10.2 4.4 4.8 0.7 0.0 0.3 0.7 0.7 0.2 1.9 1.3 0.5 1.4 0.4 3.9 0.0 0.4 3.4 0.5 0.1 0.6 1.9 9.5 0.2 3.7 0.1 0.0 1.2 1.0 16.4 2.2 1.4 4.1 0.7 0.9 0.2 3.7 4.9 0.2 0.1 1.3 0.1 0.7 0.0 4.0 0.4 1.9 0.2 10.9 0.8 0.7 6.9 0.5 1.3 0.2 5.7 12.5 13.6 0.3 0.4 19.2 4.3 0.4 8.1 5.3 0.4 55.6 4.5 0.2 10.2 0.8 6.0 0.2 4.1 6.8 1.3 0.0 4.5 5.5 9.2 10.9 0.3 0.3 4.1 4.4 2.3 3.7 0.8 2.4 3.4 2.0 3.5 1.3 5.5 3.9 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 6.8 1.6 0.0 0.0 0.6 0.7 0.0 0.0 0.1 0.0 0.7 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.1 0.1 0.2 0.3 6.3 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.4 3.6 0.1 0.3 1.4 16.4 0.0 0.0 0.0 0.2 5.5 0.0 3.6 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134533 "Enzymes, Predicted membrane proteins" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favourable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 13.8 20.8 11.0 33.0 15.3 13.8 14.9 13.3 19.3 15.1 14.2 21.0 20.2 13.2 16.0 21.1 14.4 16.1 15.3 12.9 11.3 10.0 16.4 78.0 14.2 28.9 18.2 8.7 17.1 68.1 24.4 21.0 20.9 14.4 15.0 15.4 13.3 48.9 22.6 16.7 14.4 19.6 13.6 12.8 27.1 18.3 14.4 14.9 10.3 23.5 8.0 42.2 13.3 12.6 17.5 13.0 11.6 5.4 2.2 5.5 3.8 8.5 10.9 6.6 8.9 16.8 9.6 6.5 8.8 9.1 11.3 8.0 5.9 14.9 48.0 12.1 11.3 13.2 7.1 8.9 9.4 7.4 5.4 7.5 12.7 13.2 20.4 11.3 13.7 12.2 16.2 9.9 22.5 7.3 9.4 24.6 6.6 12.6 4.9 8.2 7.1 7.6 8.4 5.5 19.3 7.1 8.4 4.3 8.8 8.2 20.3 14.2 15.1 7.4 6.9 7.9 5.2 14.0 5.9 49.2 34.0 55.5 10.6 5.8 8.8 11.6 5.4 9.3 5.5 3.3 5.0 15.4 3.9 5.1 3.1 17.5 2.9 3.0 5.2 2.2 3.2 13.0 3.6 3.8 11.0 15.3 13.3 19.3 11.3 10.0 18.2 8.7 14.4 14.9 SZRD1 "C1orf144, DKFZp566C0424" ENSG00000055070 "SUZ RNA binding domain containing 1" Q7Z422 1 16352575-16398145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024221 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA024221: AB_10603450" "unprognostic (3.52e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (5.98e-6)" "unprognostic (2.53e-1)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "unprognostic (7.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" "unprognostic (7.60e-2)" 34.9 30.7 23.1 25.0 26.3 37.5 33.1 17.1 20.6 30.7 29.0 20.8 15.4 23.0 38.5 23.2 33.7 26.5 30.5 37.0 23.5 14.3 39.8 41.4 26.2 27.2 27.4 11.8 36.3 25.1 32.2 16.8 46.4 22.4 24.8 20.9 27.9 20.8 23.7 55.2 24.9 39.3 31.3 20.9 40.6 27.1 18.3 25.0 32.1 35.0 27.6 33.6 34.3 35.1 30.4 19.2 34.3 36.7 20.0 25.5 29.6 37.4 28.8 39.9 27.6 34.1 39.4 13.2 38.4 50.0 45.7 35.6 28.8 33.4 32.9 43.1 51.2 20.7 35.7 42.3 33.9 56.6 30.9 37.7 31.0 22.6 30.8 36.6 37.2 39.7 35.5 49.8 33.4 39.5 33.7 31.0 41.7 36.4 35.7 27.9 27.8 33.0 36.6 42.1 38.6 31.0 17.6 31.6 33.0 33.6 21.7 48.6 22.5 24.2 44.0 31.2 36.5 48.6 38.1 17.2 18.9 39.6 34.8 50.1 41.2 15.0 24.3 34.3 24.5 33.2 24.2 28.3 21.2 22.8 19.2 30.4 19.6 21.1 27.1 20.0 36.7 14.9 25.5 29.6 23.1 26.3 17.1 20.6 23.5 14.3 27.4 11.8 22.4 25.0 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2, KICSTOR complex subunit" Q5T011 1 43389882-43454247 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.47e-7)" "prognostic unfavourable (2.53e-4)" "prognostic favourable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 10.0 8.4 9.0 15.9 12.8 13.5 10.3 16.1 12.9 10.2 10.2 21.7 12.8 8.8 13.7 8.3 9.4 11.3 8.2 8.6 8.7 6.8 7.9 6.1 10.3 11.1 12.4 9.1 14.9 10.8 23.6 16.1 8.1 10.9 10.9 8.9 13.5 11.4 11.6 10.9 17.4 11.6 12.1 9.9 11.0 10.0 12.2 11.1 13.9 16.3 5.9 12.6 12.3 9.6 1.8 3.0 4.9 1.8 1.3 3.0 1.2 6.2 5.9 5.9 5.3 15.2 9.1 8.3 4.8 6.9 6.7 6.6 2.0 7.7 5.8 6.4 8.5 7.6 5.0 8.9 5.1 7.4 4.9 10.5 11.2 3.6 6.0 8.4 8.6 8.1 7.1 11.0 10.2 7.3 4.7 9.2 5.0 3.1 5.7 2.9 4.9 6.4 7.3 6.4 7.8 4.2 7.9 5.7 5.3 9.6 8.9 6.6 5.3 12.9 9.5 7.3 9.2 10.1 8.4 9.6 3.8 4.7 7.6 5.8 5.3 3.8 1.8 4.9 1.5 1.5 3.0 1.4 0.8 0.8 1.5 1.8 1.7 1.3 3.7 1.3 1.7 3.0 1.7 1.2 9.0 12.8 16.1 12.9 8.7 6.8 12.4 9.1 10.9 11.1 TAB1 MAP3K7IP1 ENSG00000100324 "TGF-beta activated kinase 1 (MAP3K7) binding protein 1" Q15750 22 39399741-39437060 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032328, HPA039988, HPA057104" Approved Enhanced "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB032328: AB_2281637, HPA039988: , HPA057104: " "unprognostic (1.76e-1)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (6.73e-3)" "unprognostic (9.23e-3)" "unprognostic (4.30e-2)" "unprognostic (6.44e-2)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (7.05e-2)" "unprognostic (1.63e-1)" "unprognostic (7.35e-2)" "unprognostic (7.80e-3)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" 12.2 14.9 18.3 13.6 20.8 13.6 12.5 24.7 28.1 16.9 16.2 32.0 10.9 16.9 18.8 10.7 13.6 17.9 19.2 18.9 17.9 15.7 12.4 14.8 13.7 15.8 22.7 18.8 26.7 19.5 16.3 12.5 13.8 15.9 16.9 9.1 19.6 21.6 19.1 27.8 17.3 15.7 14.3 17.2 17.2 14.4 11.9 20.6 13.0 13.3 10.9 13.0 16.8 14.3 5.9 8.2 6.1 8.7 5.2 7.6 6.3 12.0 12.5 12.8 14.6 13.6 11.5 11.3 10.1 12.6 15.6 14.8 11.5 8.7 18.3 8.0 9.8 14.8 12.9 14.8 6.2 14.1 20.7 8.0 15.4 11.3 11.9 15.0 15.4 11.6 13.2 11.7 12.8 11.3 14.6 12.6 7.7 7.8 11.5 12.5 8.9 12.8 20.9 18.2 18.2 12.0 12.9 11.4 8.4 14.4 17.9 12.6 14.6 16.6 9.7 10.9 17.3 8.3 8.2 19.9 12.8 13.3 12.8 10.7 10.6 1.4 8.7 6.1 7.6 7.2 6.2 5.9 4.6 6.1 8.2 5.9 7.5 6.7 1.3 5.2 6.7 3.8 4.6 6.3 18.3 20.8 24.7 28.1 17.9 15.7 22.7 18.8 15.9 20.6 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 and MAP3K7 binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: " "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favourable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 6.1 8.0 5.9 6.6 6.9 10.1 6.5 9.1 9.2 7.6 6.5 4.2 17.9 5.2 40.3 7.4 13.2 9.2 10.6 6.9 6.1 5.3 16.9 23.3 8.0 8.1 6.7 6.6 11.3 17.3 25.0 9.4 39.3 9.1 12.9 6.7 9.3 11.5 15.0 8.8 8.1 7.4 9.6 5.2 7.1 8.4 26.7 3.6 8.3 7.7 14.5 15.6 6.6 7.9 1.0 0.6 0.8 1.1 3.9 1.0 0.4 22.8 5.5 5.7 5.8 4.4 6.7 6.0 7.0 8.9 4.8 5.4 6.2 19.6 10.4 4.3 8.2 11.9 8.7 18.1 7.0 17.7 8.4 9.7 6.4 15.1 3.9 10.1 7.5 4.8 10.9 8.2 21.0 7.9 11.0 8.5 6.2 11.0 8.0 5.1 6.8 9.3 5.2 10.0 7.7 8.0 6.7 4.7 6.7 7.9 12.0 15.3 10.3 4.1 7.6 5.3 7.8 26.6 6.5 11.1 8.4 10.3 8.3 4.8 7.4 0.2 0.5 0.8 0.7 1.1 0.9 0.8 1.0 0.4 0.6 1.0 1.0 1.0 0.8 3.9 0.8 0.3 0.6 0.4 5.9 6.9 9.1 9.2 6.1 5.3 6.7 6.6 9.1 3.6 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell line enhanced" "Detected in many" "hTCEpi: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: , HPA061394: " "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favourable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.0 22.4 11.0 6.2 3.1 3.2 13.3 3.1 8.5 4.4 3.1 9.1 11.8 0.0 2.9 4.9 23.8 3.5 8.5 4.6 1.1 1.8 0.0 2.8 17.4 4.9 0.0 0.1 1.4 35.9 2.3 15.4 9.1 1.7 0.2 4.2 9.3 0.0 3.9 6.5 10.2 0.1 6.3 3.3 11.8 10.9 7.3 6.0 5.1 21.5 11.4 4.2 0.1 8.4 2.0 1.4 4.9 5.8 1.0 4.4 0.1 3.7 0.0 5.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: , HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.2 21.0 32.2 18.5 1.7 3.6 18.2 28.6 15.3 32.9 21.8 23.2 30.5 32.2 12.2 15.6 17.1 34.0 20.8 33.5 14.1 18.4 27.3 17.4 21.4 1.6 36.9 23.2 1.5 1.4 20.7 12.0 24.9 24.6 25.5 31.2 20.6 48.6 52.8 34.8 27.6 34.4 22.8 12.9 18.7 38.2 25.1 15.8 17.2 10.9 8.0 21.4 21.4 14.6 19.2 23.0 17.3 43.1 17.9 23.6 51.6 11.1 35.7 27.1 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell line enhanced" "Detected in some" "A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favourable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 74.1 0.0 0.0 0.1 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 100.5 0.0 9.7 6.3 100.7 0.0 18.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 1.1 4.2 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.5 34.8 0.0 0.0 3.2 26.8 0.1 17.5 0.1 4.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 TADA1 "ADA1, hADA1, HFI1, STAF42, TADA1L" ENSG00000152382 "Transcriptional adaptor 1" Q96BN2 1 166856510-166876327 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028651 Approved Supported "Nucleoplasm,Focal adhesion sites,Cytosol" Nucleoplasm "Focal adhesion sites, Cytosol" "HPA028651: AB_10602476" "unprognostic (9.53e-3)" "unprognostic (2.31e-1)" "unprognostic (1.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (7.09e-2)" "unprognostic (5.99e-3)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.98e-2)" "unprognostic (3.64e-2)" "unprognostic (2.73e-2)" "unprognostic (6.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-2)" 6.5 10.6 13.8 7.1 18.5 17.8 10.2 18.2 20.0 11.3 9.1 17.0 3.4 8.3 10.5 8.6 10.1 9.8 6.6 9.2 13.2 14.6 12.9 28.9 6.7 10.1 11.1 14.3 12.7 7.5 11.3 13.7 12.5 15.0 9.2 10.2 13.4 8.7 8.4 10.7 8.5 9.0 8.5 10.8 7.3 8.0 12.0 10.3 16.7 11.5 7.1 10.9 8.6 7.8 13.4 13.0 8.1 8.2 16.2 19.5 15.1 8.1 7.8 14.8 8.7 4.5 5.7 8.8 4.3 5.2 7.2 6.2 7.1 6.6 15.5 8.4 5.0 6.3 11.9 7.6 5.8 9.8 11.3 5.1 6.7 11.6 6.6 14.4 9.5 4.3 8.8 4.3 10.8 5.9 18.3 9.4 5.6 5.6 17.7 11.5 22.4 8.8 15.0 6.5 19.6 9.6 10.9 9.5 16.6 7.7 10.0 9.0 13.6 15.2 4.3 5.9 6.8 6.4 9.0 13.5 18.3 29.0 4.1 6.6 5.5 1.8 8.1 8.1 14.0 8.2 15.5 13.1 15.2 15.8 13.0 13.4 19.5 15.3 1.3 16.2 6.2 8.5 14.3 15.1 13.8 18.5 18.2 20.0 13.2 14.6 11.1 14.3 15.0 10.3 TAF11 "TAF2I, TAFII28" ENSG00000064995 "TATA-box binding protein associated factor 11" Q15544 6 34877778-34888089 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029326, HPA049127" Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA029326: , HPA049127: " "unprognostic (4.02e-2)" "unprognostic (5.36e-3)" "unprognostic (7.41e-2)" "unprognostic (5.18e-3)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (2.56e-3)" "unprognostic (1.45e-2)" "unprognostic (1.68e-3)" "prognostic favourable (5.87e-4)" "unprognostic (2.91e-1)" "unprognostic (6.77e-3)" "unprognostic (1.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.87e-2)" "unprognostic (4.92e-1)" "unprognostic (3.32e-1)" 20.6 25.5 22.2 26.8 28.1 43.1 27.2 30.1 29.8 23.0 23.2 17.5 26.7 21.1 23.6 24.2 23.5 22.7 22.0 33.3 21.5 17.9 20.7 28.7 23.2 28.6 24.8 22.1 27.9 25.4 16.7 18.8 30.6 26.7 23.8 25.3 20.4 20.3 31.0 39.3 31.2 24.2 26.8 23.4 31.1 22.6 32.7 29.0 29.4 23.3 24.6 28.7 22.8 22.6 14.9 20.1 26.5 23.6 13.2 16.7 12.8 14.6 6.5 21.2 37.3 13.3 14.2 18.7 11.8 10.0 20.4 19.7 14.8 9.5 20.2 15.8 11.2 9.4 26.0 10.9 16.6 12.2 20.9 22.6 13.4 24.8 18.7 28.6 15.9 15.8 17.9 13.7 11.3 24.8 35.6 15.6 9.7 26.8 18.2 23.9 18.9 11.0 19.9 18.8 15.8 15.0 9.6 25.6 23.1 14.0 15.4 26.7 24.8 35.9 14.2 14.1 18.6 8.1 14.3 14.2 34.8 29.0 5.3 34.2 20.4 26.5 23.6 19.3 12.6 21.0 12.1 11.6 13.4 13.5 20.1 14.9 15.7 14.0 14.6 13.2 16.8 17.7 16.7 12.8 22.2 28.1 30.1 29.8 21.5 17.9 24.8 22.1 26.7 29.0 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076002 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavourable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favourable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 23.5 13.4 24.6 14.3 23.4 27.7 14.7 14.0 33.7 18.0 16.6 19.5 15.3 10.0 13.9 14.7 22.1 9.9 18.0 19.2 25.3 26.9 22.3 21.0 11.5 8.6 32.2 22.6 6.6 15.9 14.6 21.2 21.0 35.8 16.9 18.2 7.7 14.5 11.7 40.9 13.0 12.8 22.2 36.1 7.7 14.0 10.3 20.7 4.1 18.2 16.6 14.8 16.4 11.0 1.3 3.0 7.9 4.6 0.5 2.3 0.8 20.2 5.3 8.2 11.9 23.6 22.1 13.6 48.3 20.4 19.7 19.9 8.5 4.6 7.7 18.5 32.1 8.6 14.3 17.4 29.7 13.2 3.2 7.8 12.9 8.7 18.7 13.7 11.9 19.7 20.9 33.0 18.0 16.8 14.9 7.6 26.6 11.7 7.1 3.7 16.3 11.1 5.6 14.7 3.1 23.2 17.7 8.5 10.7 23.7 15.4 17.4 5.2 9.8 21.9 32.6 12.4 23.0 26.4 9.2 23.3 10.4 34.6 7.2 48.3 2.6 4.6 3.7 1.7 3.3 1.5 1.2 1.1 1.7 1.5 1.3 1.1 1.6 7.9 0.5 2.8 3.0 2.3 0.8 24.6 23.4 14.0 33.7 25.3 26.9 32.2 22.6 35.8 20.7 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843354-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favourable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favourable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 13.4 11.7 10.2 10.7 11.1 7.8 12.1 14.0 12.7 12.3 7.4 8.4 15.9 7.1 19.2 14.5 16.5 13.6 9.7 8.5 9.3 11.7 17.9 9.9 11.5 13.9 9.2 9.5 12.7 8.9 22.6 19.5 20.2 10.7 12.6 8.1 11.6 10.1 20.1 7.2 11.3 7.5 11.1 8.5 13.9 8.4 17.1 9.2 23.3 14.9 10.9 15.8 9.9 14.4 9.8 11.3 4.9 13.1 8.5 12.9 4.6 12.0 12.0 16.7 5.1 8.4 12.9 26.9 13.2 13.2 14.4 12.5 11.1 9.8 14.2 7.0 10.7 6.9 14.5 16.3 16.1 13.8 15.8 15.3 5.1 14.9 10.9 12.0 17.1 10.1 9.6 10.6 15.7 21.6 10.2 15.1 14.5 8.0 9.0 10.2 20.1 8.8 5.4 14.1 4.4 14.7 10.8 7.1 18.2 11.4 15.3 11.6 5.3 9.6 10.0 17.4 20.5 17.0 18.2 7.4 8.8 20.2 10.5 13.9 14.9 2.6 8.4 4.9 11.5 13.1 10.9 9.5 9.5 12.9 11.3 9.8 6.3 9.4 0.4 8.5 10.0 9.4 9.4 4.6 10.2 11.1 14.0 12.7 9.3 11.7 9.2 9.5 10.7 9.2 TAF1C "MGC:39976, SL1, TAFI110, TAFI95" ENSG00000103168 "TATA-box binding protein associated factor, RNA polymerase I subunit C" Q15572 16 84177847-84187070 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072229 Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA072229: " "unprognostic (9.39e-2)" "unprognostic (1.13e-1)" "unprognostic (6.86e-3)" "unprognostic (8.20e-3)" "unprognostic (4.45e-2)" "unprognostic (3.47e-2)" "unprognostic (6.21e-2)" "unprognostic (1.26e-1)" "unprognostic (2.52e-1)" "unprognostic (3.53e-1)" "prognostic favourable (1.76e-4)" "unprognostic (1.06e-2)" "prognostic unfavourable (8.08e-6)" "unprognostic (5.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "prognostic favourable (3.22e-4)" 19.0 11.6 19.0 16.7 18.5 22.8 18.9 21.8 17.8 17.3 12.3 16.4 14.3 15.5 20.4 14.9 16.7 16.9 19.5 15.5 16.2 9.1 15.8 9.7 13.1 19.8 18.2 13.0 30.4 19.1 13.0 16.9 12.4 15.5 17.5 6.3 17.2 22.7 17.8 13.6 21.3 14.2 12.1 12.0 25.1 14.9 13.0 17.0 12.7 15.2 10.3 15.6 14.3 16.3 3.1 4.0 1.0 3.4 3.5 4.7 2.2 5.9 6.5 3.7 13.1 3.2 3.4 19.0 7.2 2.8 5.9 2.1 7.1 4.6 6.6 9.6 2.7 11.7 2.3 2.8 1.4 5.8 9.9 3.8 9.9 4.8 2.4 4.0 12.1 5.1 3.8 5.0 1.9 11.5 9.2 2.3 2.9 13.1 6.2 13.3 15.1 6.8 15.8 3.1 5.3 2.5 5.3 19.1 9.2 14.5 4.1 24.0 16.1 4.2 4.5 10.9 9.3 10.7 6.4 11.0 8.5 13.8 5.6 4.9 6.9 0.0 3.2 1.0 4.1 3.4 4.7 2.3 1.6 2.6 4.0 3.1 1.9 3.4 0.2 3.5 1.4 1.5 2.3 2.2 19.0 18.5 21.8 17.8 16.2 9.1 18.2 13.0 15.5 17.0 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: , HPA060385: " "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavourable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 13.9 10.6 12.5 19.9 18.4 14.2 12.9 17.3 20.1 15.1 14.7 4.3 17.3 16.8 15.2 9.7 16.0 11.5 18.1 11.1 12.0 7.6 13.6 18.7 15.8 19.0 14.4 13.6 20.9 30.5 9.3 24.3 18.5 13.6 16.4 13.4 3.9 12.3 11.4 31.5 14.5 17.8 18.1 22.1 18.4 13.0 8.0 13.6 13.1 13.2 12.9 12.2 28.1 17.1 24.1 14.3 22.3 9.2 9.0 16.3 2.7 3.8 3.0 4.1 4.1 4.1 16.0 7.5 4.4 3.2 5.6 4.0 10.5 10.6 9.4 8.4 4.2 11.6 4.8 6.9 6.2 2.5 2.0 9.6 17.3 6.2 4.0 8.7 5.2 4.4 7.4 4.5 7.3 7.0 6.5 18.6 7.7 1.2 7.3 16.8 3.2 2.4 3.5 4.7 8.0 6.5 6.2 2.9 6.2 2.6 9.5 3.0 11.8 2.2 6.8 8.4 5.6 12.7 6.4 8.3 9.4 7.9 3.1 9.3 2.8 17.4 9.2 14.8 10.0 6.5 10.0 19.5 13.8 10.9 6.2 24.1 16.3 13.6 22.3 9.0 5.2 14.3 9.4 2.7 12.5 18.4 17.3 20.1 12.0 7.6 14.4 13.6 13.6 13.6 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818504-8016627 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA066184: " "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavourable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 11.2 11.2 10.6 13.5 13.9 13.1 9.5 24.5 13.0 10.7 10.0 11.1 12.7 6.4 11.7 6.0 7.9 8.3 8.2 11.5 11.5 12.1 9.3 8.2 8.6 12.0 12.8 8.4 16.1 9.5 16.1 15.9 9.9 11.6 9.6 8.1 9.6 7.6 13.3 20.8 10.6 9.6 9.5 12.4 11.4 8.1 15.8 14.2 17.4 9.7 7.3 9.9 10.0 14.4 8.8 4.7 7.7 8.6 8.3 10.8 5.0 7.1 6.6 7.5 4.0 8.6 6.0 10.5 8.5 3.3 6.4 7.4 14.2 5.4 12.2 6.6 4.9 7.8 8.3 7.3 8.1 9.8 9.1 10.4 4.7 9.0 7.5 7.0 9.5 4.0 7.4 9.0 4.4 6.0 11.6 12.7 7.2 13.4 15.7 4.9 5.7 3.9 12.8 7.2 8.1 3.7 4.5 4.0 5.8 9.2 6.7 8.3 12.2 7.4 7.5 5.8 10.2 15.3 8.3 7.6 9.0 13.4 5.6 8.0 5.2 7.3 5.6 7.7 9.3 5.0 10.8 7.6 8.4 9.0 4.7 8.8 10.5 9.0 2.2 8.3 8.6 4.6 6.9 5.0 10.6 13.9 24.5 13.0 11.5 12.1 12.8 8.4 11.6 14.2 TAF4B "TAF2C2, TAFII105" ENSG00000141384 "TATA-box binding protein associated factor 4b" Q92750 18 26225936-26391685 "Disease related genes, Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.7;U-266/70: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028937 Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA028937: AB_10603034" "unprognostic (2.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-3)" "unprognostic (1.74e-1)" "unprognostic (2.13e-1)" "unprognostic (5.01e-2)" "unprognostic (2.67e-1)" "unprognostic (3.29e-2)" "unprognostic (2.21e-1)" "unprognostic (4.66e-3)" "unprognostic (3.14e-2)" "prognostic unfavourable (3.08e-4)" "unprognostic (7.38e-2)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (1.72e-4)" 5.0 5.0 1.9 7.8 7.0 5.7 5.8 4.9 7.1 3.5 3.6 1.7 0.6 1.5 4.8 1.7 5.1 4.2 3.4 2.6 2.0 3.1 3.5 0.9 2.6 11.8 2.3 3.4 8.1 5.2 2.3 2.7 11.5 5.8 2.8 3.3 2.6 4.1 2.1 6.4 5.6 3.9 2.8 1.9 12.8 4.7 9.9 1.4 6.5 3.8 2.4 9.1 4.6 3.5 4.4 1.8 0.0 1.0 0.8 4.0 1.0 1.8 0.2 0.1 0.3 0.5 0.8 0.9 0.5 0.4 0.3 0.5 0.3 0.8 24.7 2.2 0.1 1.8 1.3 1.2 1.2 7.5 5.0 2.7 0.6 0.3 0.6 6.8 1.6 1.3 0.5 0.2 3.8 0.5 4.4 3.2 0.1 1.2 3.8 1.2 1.3 2.9 0.0 2.9 6.7 0.2 0.1 2.6 1.2 1.2 1.8 0.9 0.8 1.2 0.2 1.0 0.8 1.2 1.9 11.8 7.8 9.1 0.4 4.2 0.9 0.0 0.6 0.0 0.2 1.0 1.9 3.9 1.2 1.8 1.8 4.4 4.0 2.2 0.0 0.8 0.4 0.8 0.2 1.0 1.9 7.0 4.9 7.1 2.0 3.1 2.3 3.4 5.8 1.4 TAF5L PAF65B ENSG00000135801 "TATA-box binding protein associated factor 5 like" O75529 1 229593111-229626047 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067941 Supported "Nuclear speckles,Cytoplasmic bodies" "Nuclear speckles" "Cytoplasmic bodies" "HPA067941: " "unprognostic (3.41e-1)" "unprognostic (1.34e-1)" "unprognostic (3.39e-2)" "unprognostic (1.93e-1)" "unprognostic (7.46e-2)" "unprognostic (1.94e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-1)" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (5.17e-3)" "unprognostic (8.16e-3)" "unprognostic (1.91e-3)" "unprognostic (3.21e-1)" "unprognostic (2.99e-1)" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" 19.5 8.3 13.0 14.4 12.8 23.0 25.6 13.5 14.7 12.1 15.3 14.7 9.9 12.7 15.8 10.6 15.0 14.1 16.3 12.9 10.5 9.0 9.5 18.6 13.6 15.7 12.1 8.0 12.2 10.4 12.7 11.6 25.0 12.9 15.7 15.8 9.2 13.3 12.3 24.9 10.1 17.0 16.5 12.8 15.6 13.8 8.5 10.5 15.9 13.5 11.9 15.3 17.1 13.2 1.1 1.6 0.2 1.3 2.1 2.6 0.8 16.7 9.7 14.0 11.6 9.7 10.2 36.3 11.4 13.7 14.3 13.4 13.0 13.8 18.9 12.2 12.3 14.4 15.4 14.0 13.8 14.1 22.1 14.8 9.9 8.3 10.9 19.6 17.2 11.2 13.6 14.1 12.1 13.9 19.7 17.6 13.4 8.1 22.1 10.6 19.8 7.7 19.7 15.7 19.5 10.0 15.6 14.1 17.2 9.8 13.5 15.7 16.0 20.5 12.0 11.9 14.6 15.8 24.0 9.4 7.1 21.7 9.1 11.9 18.7 0.0 1.1 0.2 2.1 1.2 2.6 1.1 2.2 1.7 1.6 1.0 2.2 1.9 0.2 2.1 1.3 0.7 1.9 0.8 13.0 12.8 13.5 14.7 10.5 9.0 12.1 8.0 12.9 10.5 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavourable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 14.1 19.8 21.5 15.4 23.6 13.9 12.0 23.5 35.8 19.4 17.5 12.7 12.6 12.1 24.1 17.6 16.8 23.6 16.8 17.2 20.5 16.3 16.1 10.2 12.9 14.3 13.1 15.9 26.2 16.6 22.6 21.7 19.5 19.3 15.8 13.7 15.6 17.9 23.3 23.1 17.9 13.2 23.7 13.1 14.6 14.0 27.3 14.7 21.7 21.3 11.5 17.0 19.6 14.9 15.3 14.3 13.2 25.7 14.0 18.7 13.1 17.1 32.2 20.8 34.2 27.5 14.6 29.2 18.9 21.2 24.3 22.6 23.9 20.9 15.7 21.6 28.9 14.5 28.6 22.5 26.2 25.6 18.6 15.1 31.2 15.7 27.3 14.5 14.3 14.8 14.1 35.7 39.5 19.7 26.1 29.0 21.9 60.9 30.9 23.7 30.8 25.9 22.9 25.6 23.2 17.3 14.0 19.0 27.6 23.8 37.1 15.8 13.5 14.5 19.5 37.0 38.0 47.8 24.4 17.9 31.0 26.4 25.1 20.5 31.8 12.7 11.0 13.2 15.6 11.4 18.7 10.2 15.0 15.7 14.3 15.3 15.3 14.3 6.4 14.0 25.7 8.5 13.9 13.1 21.5 23.6 23.5 35.8 20.5 16.3 13.1 15.9 19.3 14.7 TAF7 "TAF2F, TAFII55" ENSG00000178913 "TATA-box binding protein associated factor 7" Q15545 5 141260225-141320821 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006429 Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA006429: AB_1080196" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (4.79e-2)" "unprognostic (4.28e-2)" "unprognostic (8.17e-2)" "unprognostic (1.15e-3)" "unprognostic (1.66e-1)" "unprognostic (5.78e-2)" "unprognostic (6.75e-2)" "unprognostic (9.43e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (2.85e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-2)" 33.2 29.9 29.2 28.8 32.2 31.6 38.7 39.6 33.6 28.6 24.1 26.0 21.0 20.2 34.6 39.8 24.9 35.0 22.2 46.4 30.3 30.8 28.6 29.7 25.3 32.9 32.0 26.1 50.7 24.8 20.1 47.1 38.8 28.9 34.8 26.5 21.3 26.8 28.0 69.5 26.9 30.0 31.8 32.9 37.0 23.9 33.5 28.9 65.5 45.7 33.9 39.1 32.3 53.6 18.8 17.8 49.6 16.5 27.1 29.8 19.8 19.8 16.6 37.9 27.7 33.9 31.5 23.7 25.9 23.2 36.9 36.1 23.2 22.4 53.6 52.1 26.3 17.0 23.8 24.1 37.3 23.3 26.6 9.6 20.5 19.3 30.9 13.2 20.3 28.7 35.9 14.3 25.5 26.5 20.4 42.0 35.4 24.9 29.6 32.1 13.7 6.1 37.9 50.7 39.1 27.1 26.8 30.4 34.8 21.2 30.6 28.9 43.6 43.5 24.3 5.2 18.0 17.0 31.4 11.4 46.1 48.5 22.8 30.9 20.8 44.7 11.4 49.6 18.3 13.9 23.7 18.8 21.5 20.3 16.1 18.7 29.8 24.6 34.6 27.1 16.5 17.8 17.9 19.8 29.2 32.2 39.6 33.6 30.3 30.8 32.0 26.1 28.9 28.9 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199321-117204782 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 136.3;BJ hTERT+ SV40 Large T+: 129.6;CACO-2: 122.3;EFO-21: 162.6;fHDF/TERT166: 138.9;LHCN-M2: 95.9;U-138 MG: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 19.0;non-classical monocyte: 26.6" "Lineage enriched" "Detected in many" 10 "monocytes: 26.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 176.0" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol 8000000 "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 73.3 22.6 2.3 67.6 5.9 0.2 60.8 2.1 7.7 278.3 328.7 6.1 156.2 22.3 399.7 156.8 337.9 133.3 227.5 48.7 3.1 3.0 49.5 12.9 44.1 38.6 7.1 11.8 159.2 9.3 1.5 8.0 36.2 14.9 237.5 51.6 39.1 24.1 347.5 36.6 17.9 81.0 481.9 9.1 26.0 114.7 65.1 2.1 1.1 47.3 30.0 11.2 473.0 78.1 2.6 1.4 0.8 26.6 0.0 0.3 0.9 1.2 0.3 21.4 0.5 10.0 9.0 18.0 136.3 59.1 129.6 48.5 122.3 1.9 0.2 162.6 138.9 3.2 0.3 1.1 36.9 0.4 0.2 0.3 4.5 8.3 55.7 0.1 0.3 23.7 4.6 18.9 2.4 0.2 0.2 0.4 95.9 0.2 0.1 1.0 6.5 0.1 0.1 1.6 0.6 0.2 1.7 0.1 0.5 2.1 0.7 0.1 0.6 0.3 14.6 126.3 21.3 0.9 5.8 0.6 0.4 1.0 0.7 0.4 0.3 0.8 1.1 0.0 0.1 19.0 0.2 1.6 0.0 0.0 1.4 2.6 0.1 0.0 0.1 0.0 26.6 0.7 0.3 0.9 2.3 5.9 2.1 7.7 3.1 3.0 7.1 11.8 14.9 2.1 TAGLN2 "HA1756, KIAA0120" ENSG00000158710 "Transgelin 2" P37802 1 159918107-159925732 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001925 Approved Approved "Actin filaments,Cytosol" "Intracellular and membrane" 540000000 Cytosol "Actin filaments" "HPA001925: AB_1857756" "prognostic unfavourable (2.06e-5)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (7.07e-5)" "unprognostic (4.61e-2)" "unprognostic (1.50e-1)" "unprognostic (3.21e-1)" "unprognostic (3.56e-3)" "unprognostic (2.34e-1)" "prognostic unfavourable (1.92e-10)" "unprognostic (1.81e-1)" "unprognostic (9.22e-2)" "unprognostic (3.95e-2)" "unprognostic (2.50e-2)" 80.6 26.4 19.7 57.5 25.6 47.9 62.8 7.9 18.3 49.1 45.9 16.6 54.5 43.3 39.2 49.4 96.3 36.3 63.6 57.3 15.9 18.5 68.0 178.2 107.7 65.0 24.3 9.8 45.7 51.2 8.8 18.1 122.2 24.8 43.8 43.0 24.7 67.2 62.9 35.3 62.6 74.6 36.2 20.0 95.8 96.8 46.4 20.2 60.5 37.7 150.7 76.5 57.2 62.0 53.0 114.4 220.7 42.4 44.0 41.7 106.7 109.5 59.2 1.8 0.6 21.2 52.7 68.4 61.7 71.0 134.4 65.4 61.4 86.0 68.1 52.6 73.3 86.0 30.3 76.9 82.9 77.6 24.6 90.7 57.5 3.6 25.0 63.7 102.2 52.3 59.8 79.1 41.0 80.9 38.8 47.9 45.8 41.7 28.8 40.2 51.1 101.1 0.2 31.6 101.7 27.8 43.0 28.4 26.9 72.4 118.6 31.8 62.6 62.8 92.8 80.5 93.6 72.9 166.2 19.3 8.6 39.9 104.1 40.9 49.5 66.9 42.4 177.0 34.7 25.2 30.6 53.0 38.6 33.4 68.5 39.7 20.4 22.4 220.7 44.0 18.9 114.4 41.7 106.7 19.7 25.6 7.9 18.3 15.9 18.5 24.3 9.8 24.8 20.2 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747329-765024 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 148.6;neutrophil: 204.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol 39000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavourable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 39.0 24.2 26.6 34.8 31.3 117.4 44.2 20.6 38.3 27.7 28.5 51.2 18.8 34.2 20.4 20.7 90.0 23.2 33.2 37.5 29.2 23.6 45.8 48.4 37.9 60.0 46.5 26.6 23.4 31.9 14.6 15.8 34.3 30.7 28.3 23.7 15.5 38.3 19.5 31.2 38.4 29.4 40.4 47.5 45.6 35.8 14.8 33.0 34.1 42.2 82.4 43.1 51.4 37.5 8.5 36.1 204.6 60.8 5.9 10.4 45.3 41.9 53.1 15.4 29.1 31.9 18.6 45.4 31.9 41.1 31.6 26.1 22.6 91.6 23.4 43.4 41.8 45.4 24.3 34.4 16.5 30.6 49.3 40.5 20.6 78.8 34.1 64.7 60.5 15.2 27.8 21.2 17.2 43.4 52.5 39.2 29.3 40.1 37.6 76.8 24.2 43.1 31.4 18.1 83.9 57.4 24.5 38.0 13.3 29.7 61.5 30.9 29.2 49.3 57.6 14.5 13.6 11.4 29.9 16.6 16.1 27.8 32.1 56.6 58.4 64.7 60.8 148.6 5.6 23.2 6.1 8.5 7.5 6.8 36.1 6.8 6.1 5.7 204.6 5.9 23.2 14.8 10.4 45.3 26.6 31.3 20.6 38.3 29.2 23.6 46.5 26.6 30.7 33.0 TANGO6 "FLJ12688, KIAA1746, TMCO7" ENSG00000103047 "Transport and golgi organization 6 homolog" Q9C0B7 16 68843604-69085180 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041312 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA041312: AB_10796342" "unprognostic (8.55e-2)" "unprognostic (6.64e-2)" "unprognostic (4.66e-2)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (2.22e-1)" "unprognostic (9.82e-3)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "prognostic favourable (3.20e-4)" "unprognostic (1.55e-2)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (6.02e-2)" 12.5 7.7 8.0 9.6 13.1 7.0 10.7 10.9 15.0 10.2 8.2 14.7 7.2 6.0 12.8 5.6 8.5 8.3 8.0 7.8 7.3 7.7 13.1 27.6 8.4 10.8 9.8 10.6 10.0 11.2 21.6 13.2 7.9 9.3 9.7 7.1 12.1 7.7 10.3 18.5 9.2 7.0 11.1 9.4 9.7 9.1 9.3 12.1 14.5 7.9 5.8 12.6 12.8 12.7 4.0 6.6 2.6 9.0 2.5 6.5 3.8 5.6 11.7 3.9 8.3 6.6 7.5 2.8 7.7 6.5 9.7 7.9 7.5 4.7 12.9 4.3 10.9 4.7 8.8 10.4 12.1 3.0 5.3 2.3 4.7 6.9 5.4 6.3 5.9 5.5 5.7 13.7 12.5 9.3 8.4 2.2 9.0 5.7 6.6 5.1 8.4 6.3 7.0 5.7 14.4 7.2 3.2 4.1 4.7 19.0 1.1 5.1 3.7 7.2 5.3 9.2 3.3 9.2 5.5 4.0 3.5 8.8 5.7 2.4 6.0 0.0 4.8 2.6 4.9 9.0 5.2 4.0 4.9 5.0 6.6 3.7 3.1 5.0 0.3 2.5 7.9 1.7 6.5 3.8 8.0 13.1 10.9 15.0 7.3 7.7 9.8 10.6 9.3 12.1 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236221 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: , HPA037676: " "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavourable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 35.9 23.6 17.2 32.0 21.1 43.0 34.2 17.7 16.8 19.6 22.3 11.7 18.0 15.8 20.6 21.8 23.2 20.9 25.1 18.4 16.2 17.2 22.7 37.2 35.4 28.8 20.1 12.7 19.7 15.4 17.0 33.3 41.7 18.2 26.0 21.5 15.7 21.9 15.5 49.5 21.4 22.6 32.2 21.3 42.1 18.2 13.5 19.1 29.2 29.0 25.1 29.0 37.3 38.6 22.4 20.7 54.0 27.9 13.3 28.1 14.7 11.9 7.6 10.1 11.5 29.4 38.8 14.5 17.1 27.1 12.5 18.9 9.3 15.7 17.0 12.5 20.3 8.6 6.2 13.4 19.0 39.3 6.5 9.2 7.4 23.8 24.0 15.1 10.3 31.1 21.6 18.9 14.8 32.1 9.1 22.4 24.0 9.0 9.1 15.3 5.8 6.9 5.3 14.8 11.0 28.4 19.5 8.6 10.0 11.1 13.2 18.5 5.5 18.6 33.7 15.8 9.7 8.0 10.2 15.2 13.9 25.7 21.0 12.0 12.0 28.1 21.6 26.4 12.1 25.1 18.5 22.1 19.5 17.5 20.7 22.4 12.9 13.2 54.0 13.3 27.9 12.1 28.1 14.7 17.2 21.1 17.7 16.8 16.2 17.2 20.1 12.7 18.2 19.1 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.51e-4)" "prognostic favourable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favourable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favourable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.5 13.8 9.3 18.1 20.6 11.0 14.0 13.1 17.2 15.0 12.2 17.5 14.8 17.5 10.7 10.4 7.5 18.9 22.7 13.1 21.7 17.2 10.1 12.8 25.2 10.9 9.0 14.8 6.0 23.3 11.7 12.4 13.3 20.7 14.9 18.3 11.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.1 11.8 15.8 6.1 19.8 14.6 32.5 24.1 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.5 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853978 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Cell line enhanced" "Detected in many" "BEWO: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Supported "Endoplasmic reticulum,Centriolar satellite" 110000 "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: " "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favourable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favourable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavourable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 10.7 7.9 3.8 20.4 5.2 6.1 8.7 3.1 4.9 6.5 12.6 4.5 1.9 9.1 8.2 3.9 10.5 6.4 9.6 6.5 3.5 3.3 6.5 6.4 17.6 26.9 6.4 3.6 5.0 4.4 3.0 3.6 8.7 6.0 9.0 5.4 6.6 9.4 4.4 7.5 15.3 19.5 5.7 5.2 24.2 12.6 5.8 4.9 20.8 13.1 8.9 20.3 6.6 7.6 22.7 8.8 45.3 10.9 14.4 25.3 21.0 2.8 1.8 0.0 1.7 0.9 1.2 16.6 1.5 3.4 6.9 9.4 0.1 3.0 5.9 3.9 1.1 5.5 1.1 2.4 0.4 10.1 1.5 6.6 1.3 2.3 4.3 0.0 2.4 1.3 2.1 1.9 1.2 1.7 0.4 5.6 0.8 1.7 1.1 13.1 0.0 1.9 5.9 1.2 3.9 8.9 0.5 0.0 0.3 1.6 4.2 5.7 3.8 11.8 0.9 2.6 1.0 6.3 0.0 7.5 10.4 1.7 1.7 4.0 1.8 27.7 10.6 44.2 15.5 10.9 16.3 22.7 17.5 16.4 8.8 20.9 25.3 19.4 45.3 14.4 10.5 7.2 21.7 21.0 3.8 5.2 3.1 4.9 3.5 3.3 6.4 3.6 6.0 4.9 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.3;U-251 MG: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavourable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavourable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.8 0.0 0.0 2.3 2.2 3.0 0.0 0.5 1.6 6.2 8.4 2.1 16.1 15.4 3.0 3.9 8.2 7.1 28.3 2.4 10.4 0.9 1.8 6.0 0.7 1.0 0.0 12.2 0.3 0.4 8.4 13.0 4.0 8.5 5.2 0.0 0.6 2.0 1.0 0.3 3.9 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.6 16.2 1.6 0.8 0.0 2.3 8.7 2.0 2.3 28.0 8.0 13.3 14.4 8.0 10.8 1.5 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 TARBP2 Trbp ENSG00000139546 "TARBP2, RISC loading complex RNA binding subunit" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: , HPA061454: " "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavourable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 7.3 12.0 7.5 11.5 8.0 6.1 18.6 24.0 9.5 10.7 11.6 11.0 11.0 10.9 8.3 15.7 11.8 14.7 15.8 8.0 7.0 6.1 14.8 27.3 10.3 15.7 9.5 6.3 9.8 17.0 8.6 8.2 23.5 6.6 10.2 7.1 10.3 13.4 11.1 10.9 12.2 10.3 7.6 6.9 13.9 10.3 18.3 6.9 14.8 15.5 8.6 12.9 10.2 12.8 11.1 12.7 5.5 9.8 9.5 12.7 10.7 9.9 29.0 10.4 11.5 6.8 9.2 15.1 8.6 8.3 14.7 8.8 23.5 13.8 9.1 18.7 10.0 8.0 14.2 13.4 8.8 11.8 22.4 10.7 11.4 17.3 14.2 18.1 12.6 10.0 9.1 14.6 7.4 17.5 14.2 15.9 10.7 41.3 12.6 25.5 21.3 15.0 9.5 6.2 12.9 9.5 10.9 14.1 9.9 4.6 11.8 23.9 16.2 26.8 8.5 12.7 11.6 4.7 10.8 7.3 14.6 9.7 14.9 9.7 14.6 1.7 9.8 5.5 12.6 9.7 12.1 10.5 12.0 10.9 12.7 11.1 12.7 11.4 0.4 9.5 5.9 11.3 9.9 10.7 7.5 8.0 24.0 9.5 7.0 6.1 9.5 6.3 6.6 6.9 TARS ENSG00000113407 "Threonyl-tRNA synthetase" P26639 5 33440696-33469539 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037425 Approved Supported "Actin filaments,Cytosol" 170000 Cytosol "Actin filaments" "HPA037425: AB_10672279" "prognostic unfavourable (6.14e-5)" "unprognostic (5.13e-2)" "unprognostic (9.04e-2)" "prognostic unfavourable (5.17e-4)" "unprognostic (9.10e-2)" "unprognostic (1.07e-3)" "prognostic unfavourable (9.88e-7)" "unprognostic (1.43e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-3)" "unprognostic (5.97e-3)" "unprognostic (1.56e-2)" "prognostic unfavourable (9.63e-4)" "unprognostic (1.37e-1)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (7.25e-2)" 17.4 25.6 10.2 16.0 13.1 19.2 17.7 14.4 17.2 12.7 22.1 12.3 18.7 11.6 18.3 19.7 31.0 12.2 11.9 19.1 10.3 10.9 19.2 57.0 17.2 12.7 17.5 7.8 21.3 27.6 21.3 27.0 18.5 16.8 13.9 24.7 10.8 42.1 15.8 25.1 11.7 21.7 21.2 19.5 18.3 21.2 9.6 15.4 17.6 22.8 27.3 21.2 21.8 21.9 13.1 16.0 14.2 12.6 24.0 15.0 9.7 29.4 24.7 20.7 29.2 13.7 25.9 30.1 33.1 28.1 25.1 28.4 30.1 18.4 11.7 12.1 27.3 21.0 44.1 32.7 51.7 17.3 16.0 17.0 63.3 17.2 42.6 27.3 18.2 24.7 52.7 34.5 44.7 26.8 33.3 31.6 32.0 16.3 21.3 9.4 22.0 18.3 18.1 36.7 17.2 28.5 23.6 12.1 13.8 30.7 22.5 21.9 11.8 24.4 14.1 19.7 29.4 15.5 23.2 18.6 36.6 18.3 22.0 36.1 21.3 14.2 11.6 10.5 15.0 12.6 14.1 13.1 12.7 15.0 16.0 11.5 11.6 14.7 1.5 24.0 10.1 8.8 12.1 9.7 10.2 13.1 14.4 17.2 10.3 10.9 17.5 7.8 16.8 15.4 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 10.7 21.1 16.5 10.5 17.8 9.2 11.3 17.5 21.4 10.2 10.9 14.8 12.9 9.4 10.5 14.7 15.7 13.0 11.8 20.9 18.1 12.3 15.6 26.8 9.1 14.0 15.0 19.7 13.3 11.5 20.4 12.2 9.4 16.5 9.8 12.5 13.3 11.3 10.9 36.0 13.3 10.5 10.9 13.8 15.1 12.4 10.7 16.6 10.6 12.3 12.2 15.7 12.5 10.8 21.5 17.4 20.4 18.6 21.5 20.9 12.2 17.0 14.3 9.7 14.5 10.9 10.0 18.4 8.3 9.1 16.5 16.7 11.6 16.0 24.8 18.4 6.2 17.8 23.4 19.3 12.7 14.9 20.3 11.7 13.5 11.7 10.8 16.1 18.0 8.8 16.2 12.5 17.1 10.6 20.3 17.4 11.5 20.7 13.6 13.2 11.9 21.3 14.1 12.3 30.6 11.2 8.1 13.7 16.0 12.6 27.9 19.6 22.5 25.3 6.2 9.7 10.3 7.9 14.0 16.8 19.8 18.7 14.4 18.8 9.3 15.1 11.0 20.4 15.7 18.3 15.6 21.5 15.4 15.5 17.4 18.6 15.1 15.8 1.7 21.5 18.6 11.7 20.9 12.2 16.5 17.8 17.5 21.4 18.1 12.3 15.0 19.7 16.5 16.6 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Cell line enhanced" "Detected in many" "hTCEpi: 10.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.0 0.4 1.1 0.9 0.2 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.4 1.2 2.8 1.0 2.6 0.3 0.1 1.7 0.6 3.9 1.3 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.2 0.3 0.4 0.2 0.1 0.4 0.3 0.9 0.6 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816626 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favourable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 14.8 14.4 10.9 24.7 11.9 11.0 12.5 22.9 7.6 8.8 16.6 6.8 7.0 8.5 15.2 8.3 8.7 8.3 20.7 13.7 15.2 18.3 11.1 8.5 16.2 14.5 18.9 10.1 11.3 12.8 11.9 8.0 22.1 8.0 8.6 11.4 9.4 8.2 29.4 7.4 8.1 11.6 15.5 11.5 11.9 10.5 12.0 11.3 13.1 8.3 10.8 10.6 6.5 15.6 30.1 23.8 24.1 5.3 6.9 8.7 6.6 6.7 5.9 8.6 9.4 14.2 13.5 7.4 8.0 5.9 7.4 1.7 9.5 14.8 7.0 6.3 4.3 7.2 10.0 6.5 9.0 9.2 7.5 5.6 3.2 11.0 17.8 9.3 11.3 7.2 8.0 20.0 8.5 14.5 12.3 6.5 3.1 15.2 5.9 7.8 4.3 8.8 11.1 26.4 6.2 3.4 12.5 10.7 8.1 13.9 16.3 14.8 11.0 5.8 4.5 6.0 9.4 7.2 11.1 17.0 24.5 11.7 14.2 6.8 8.5 15.6 23.8 5.5 23.7 4.9 15.6 6.9 6.6 18.4 12.7 5.5 6.6 17.5 5.3 24.1 30.1 6.4 8.7 14.4 24.7 12.5 22.9 13.7 15.2 14.5 18.9 22.1 12.0 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favourable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 28.5 63.0 31.1 19.5 49.8 34.9 30.7 33.5 48.4 33.8 33.4 16.1 26.7 23.7 27.4 35.5 46.6 30.7 28.2 47.4 30.8 31.9 51.0 35.3 28.7 23.0 41.0 34.8 32.0 29.7 46.3 69.4 65.8 54.1 36.4 31.1 18.7 32.3 32.6 50.3 23.5 41.0 48.8 41.7 34.5 30.3 30.3 35.2 34.2 44.5 27.0 24.6 51.3 29.0 21.1 17.5 59.7 31.3 17.3 33.0 22.5 40.0 22.2 22.8 21.5 36.1 26.4 15.5 30.0 36.9 22.5 28.3 17.9 32.7 8.5 28.3 43.7 28.6 21.3 19.6 35.3 16.0 11.0 23.1 23.9 35.7 34.1 33.6 27.5 22.3 40.8 26.1 30.1 24.2 25.7 26.3 45.4 14.7 14.7 33.3 25.6 20.9 12.3 24.5 17.4 31.8 45.4 15.1 24.6 42.0 55.0 62.5 25.6 50.8 26.0 21.3 33.3 26.4 19.7 48.4 33.5 16.0 24.9 64.0 48.7 37.4 24.2 59.7 21.8 29.3 26.3 21.1 25.9 25.3 17.5 17.9 24.0 24.0 48.9 17.3 31.3 16.2 33.0 22.5 31.1 49.8 33.5 48.4 30.8 31.9 41.0 34.8 54.1 35.2 TAX1BP3 TIP-1 ENSG00000213977 "Tax1 binding protein 3" O14907 17 3662896-3668682 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046410, HPA063078" Approved Approved "Nucleoli fibrillar center,Vesicles,Actin filaments" "Nucleoli fibrillar center, Actin filaments" Vesicles "HPA046410: , HPA063078: " "unprognostic (6.15e-2)" "unprognostic (6.46e-3)" "unprognostic (3.37e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.68e-1)" "unprognostic (1.12e-3)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.80e-2)" "unprognostic (5.45e-3)" "unprognostic (5.19e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (7.90e-4)" "unprognostic (5.12e-2)" "unprognostic (2.10e-1)" "unprognostic (2.10e-3)" "unprognostic (1.92e-1)" 26.0 34.1 14.1 15.8 17.7 4.6 24.3 5.4 16.7 55.5 41.2 30.6 37.6 33.9 34.9 26.5 62.4 22.7 42.5 55.8 16.0 8.5 35.8 27.0 23.9 11.4 28.3 15.8 27.0 21.0 4.7 8.3 34.3 16.0 24.7 24.6 13.7 29.5 52.0 12.3 35.8 71.9 22.7 18.3 14.5 42.6 23.8 23.0 22.6 19.2 43.0 23.3 29.1 40.8 7.9 41.6 44.7 19.4 4.9 9.1 12.6 28.7 51.5 11.3 6.3 37.0 29.9 13.4 36.1 30.1 38.7 22.8 21.7 23.4 3.0 26.4 46.5 45.9 6.3 33.2 15.1 8.1 10.6 4.1 12.9 16.9 32.3 0.6 6.3 45.1 53.1 23.9 11.4 43.4 1.5 2.3 45.5 26.7 8.1 2.3 10.8 18.4 8.0 6.9 2.6 40.4 22.9 2.4 7.2 44.6 19.1 6.1 20.5 3.7 43.4 32.6 12.5 25.6 36.5 0.9 0.4 0.8 19.6 4.7 31.1 44.7 16.9 29.1 7.3 19.4 6.0 7.9 6.8 7.1 14.9 6.5 4.9 6.3 18.8 4.9 17.3 41.6 9.1 12.6 14.1 17.7 5.4 16.7 16.0 8.5 28.3 15.8 16.0 23.0 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favourable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 6.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: " "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favourable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.3 11.3 12.7 14.2 10.6 8.9 7.7 8.3 9.1 7.8 6.7 11.7 21.7 16.7 4.9 9.9 7.5 21.3 19.1 9.6 4.6 6.9 27.9 7.4 12.2 7.3 12.6 62.9 6.8 27.1 7.4 12.2 7.3 26.4 6.0 9.4 6.7 19.3 12.8 17.2 12.7 24.3 16.8 18.0 11.6 7.3 19.5 13.9 6.9 7.5 25.6 10.4 12.0 7.3 8.6 6.5 7.5 12.2 11.6 26.8 17.1 8.1 16.2 8.3 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 TBC1D15 "DKFZp761D0223, FLJ12085" ENSG00000121749 "TBC1 domain family member 15" Q8TC07 12 71839707-71927248 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013388, HPA015592" Supported Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA013388: AB_2199233, HPA015592: AB_1857789" "unprognostic (3.87e-2)" "prognostic favourable (7.06e-4)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (4.63e-2)" "unprognostic (6.13e-3)" "unprognostic (2.96e-2)" "unprognostic (3.10e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-2)" "unprognostic (4.07e-2)" "unprognostic (2.18e-1)" "prognostic favourable (5.34e-4)" "unprognostic (5.73e-2)" "unprognostic (4.34e-2)" "unprognostic (2.31e-1)" "unprognostic (2.78e-1)" 37.4 27.4 20.2 14.3 22.5 35.2 26.4 19.6 23.7 21.8 20.2 17.0 19.8 15.1 22.9 15.4 20.2 15.1 20.4 15.4 16.9 16.4 22.3 32.9 24.5 19.0 28.9 18.7 22.7 26.3 19.1 38.0 25.4 23.8 18.0 14.8 12.0 20.6 14.4 44.0 19.2 20.8 19.5 26.3 21.4 17.8 19.4 27.5 22.2 25.9 14.5 18.6 27.5 16.3 5.9 6.3 13.9 8.8 7.2 13.5 6.7 13.8 13.8 11.6 11.9 23.4 23.4 17.7 15.0 34.0 18.7 23.7 9.7 11.7 17.6 10.1 13.7 8.7 14.3 10.4 20.5 15.5 12.1 16.7 13.3 9.9 19.7 21.2 12.2 22.7 13.3 14.3 27.1 15.5 16.1 9.9 15.9 10.2 14.1 13.2 24.1 12.0 11.2 13.4 19.6 14.1 13.4 12.8 11.0 19.8 17.5 16.7 17.9 15.5 15.7 16.1 7.3 18.3 8.9 25.4 23.4 22.5 9.7 14.1 14.5 2.0 6.8 8.6 8.1 7.0 9.3 5.7 10.1 7.9 6.3 5.9 12.9 11.1 13.9 7.2 8.8 3.8 13.5 6.7 20.2 22.5 19.6 23.7 16.9 16.4 28.9 18.7 23.8 27.5 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26755351 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favourable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavourable (4.06e-4)" "unprognostic (3.51e-1)" 6.1 13.9 8.6 5.4 10.2 2.8 6.8 11.5 11.2 11.8 8.8 8.7 7.7 3.1 22.4 11.0 4.8 11.9 11.8 10.7 6.6 9.0 24.9 4.6 6.6 3.5 9.3 7.7 13.9 7.7 21.9 23.4 6.1 14.8 8.7 5.1 8.4 5.8 10.4 5.7 4.2 3.8 13.5 8.6 4.4 6.9 10.0 7.1 33.3 12.1 2.9 4.2 8.3 7.0 4.1 2.4 2.3 0.9 6.6 8.7 1.8 1.3 1.2 4.6 2.8 6.7 10.4 1.4 5.8 4.5 2.7 2.9 2.1 3.3 3.2 5.2 8.2 0.6 2.5 3.2 2.6 0.9 1.3 0.7 3.7 0.6 3.5 1.6 0.7 5.0 2.5 5.3 3.0 3.7 2.5 0.0 40.3 0.0 3.3 1.8 2.0 4.9 2.4 4.7 0.3 10.4 1.3 4.6 1.9 2.8 0.6 2.8 1.1 0.7 3.3 3.4 1.0 2.6 1.4 0.8 1.7 1.4 12.0 0.9 3.5 1.6 0.9 2.3 8.1 0.9 8.7 3.2 6.2 8.3 1.4 4.1 4.9 5.1 0.1 6.6 0.8 2.4 3.0 1.8 8.6 10.2 11.5 11.2 6.6 9.0 9.3 7.7 14.8 7.1 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 27.2;HaCaT: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030871 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030871: AB_10670046" "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.2 4.0 0.1 0.9 3.1 6.0 9.0 12.1 6.7 8.8 7.4 2.5 12.0 0.4 9.2 7.0 35.9 0.2 13.4 3.1 0.9 0.5 0.2 13.9 1.9 14.4 0.6 1.0 8.3 22.2 8.8 22.0 3.1 0.8 0.3 7.0 3.5 0.1 1.6 0.5 2.3 0.4 1.7 0.0 13.4 17.0 0.3 0.5 4.1 9.0 1.2 2.9 0.9 18.8 10.8 3.2 1.7 4.8 0.6 0.5 0.2 10.9 1.0 1.1 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 18.1 17.6 18.3 36.5 16.0 14.0 16.4 10.8 18.5 14.6 23.1 22.4 16.5 22.8 20.6 17.8 24.8 19.6 22.1 15.1 16.1 15.4 18.1 14.8 18.5 26.6 17.3 17.0 16.1 20.5 18.8 15.9 23.2 16.9 12.5 15.3 17.0 23.5 15.5 23.7 22.6 26.3 13.0 18.4 27.2 22.8 14.2 18.2 21.1 17.8 16.5 36.3 16.5 17.3 11.7 10.8 13.2 15.0 4.4 8.6 5.6 13.2 9.2 5.9 7.1 8.6 12.1 7.2 9.1 12.4 10.4 11.3 10.4 10.4 11.6 10.2 13.8 14.7 5.0 14.2 7.3 5.0 14.1 6.6 8.1 19.9 13.2 14.3 5.3 14.1 16.7 7.1 10.0 17.0 4.2 12.5 9.4 6.8 6.3 7.4 5.8 10.5 8.2 6.9 12.5 12.0 6.9 4.8 9.0 8.3 3.2 14.1 7.6 9.5 13.7 8.0 11.5 8.4 5.7 8.4 2.6 7.4 19.8 7.4 4.9 2.1 9.0 5.3 5.9 13.0 5.7 10.8 5.5 5.5 10.8 11.7 3.6 4.0 13.2 4.4 15.0 5.3 8.6 5.6 18.3 16.0 10.8 18.5 16.1 15.4 17.3 17.0 16.9 18.2 TBC1D22B "C6orf197, dJ744I24.2, FLJ20337" ENSG00000065491 "TBC1 domain family member 22B" Q9NU19 6 37257772-37332970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027908, HPA027909, HPA027910" Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203" "unprognostic (9.83e-2)" "unprognostic (5.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavourable (8.15e-5)" "unprognostic (2.70e-1)" "unprognostic (1.45e-1)" "unprognostic (2.29e-2)" "unprognostic (1.44e-1)" "unprognostic (9.48e-2)" "unprognostic (6.06e-3)" "unprognostic (3.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.53e-3)" "unprognostic (9.87e-2)" "unprognostic (2.71e-1)" "unprognostic (3.19e-1)" "unprognostic (9.73e-2)" 11.5 17.9 9.6 11.0 12.1 26.0 12.8 15.2 17.1 9.7 13.1 11.2 14.3 13.1 13.9 13.0 19.8 14.1 16.8 11.2 10.5 10.5 13.3 8.7 11.7 9.0 8.9 9.9 15.0 20.9 16.8 11.8 13.3 13.1 12.3 13.3 12.2 21.6 11.8 32.7 20.7 16.1 11.5 8.3 11.1 10.6 19.9 8.2 20.7 13.0 10.5 14.4 10.4 13.3 4.6 7.7 8.0 6.6 5.7 6.2 4.6 6.9 2.9 5.4 5.9 5.1 5.1 7.8 3.9 8.1 7.3 9.0 6.7 4.6 6.5 4.1 4.9 4.8 6.9 6.2 8.2 10.5 5.6 10.3 4.9 9.0 7.3 5.8 8.8 4.4 9.1 7.1 8.5 10.2 11.6 1.7 5.2 6.2 8.6 4.4 7.1 2.7 5.6 5.0 5.0 7.5 5.1 7.2 4.6 4.2 6.1 7.5 4.4 10.5 9.9 4.4 6.8 3.0 5.1 6.1 6.3 42.9 3.1 8.8 6.8 2.4 5.0 8.0 4.8 6.6 5.6 3.6 5.3 4.6 7.7 4.6 6.2 5.0 2.2 5.7 2.9 2.2 3.6 4.6 9.6 12.1 15.2 17.1 10.5 10.5 8.9 9.9 13.1 8.2 TBC1D24 "DFNA65, DFNB86, KIAA1171, TLDC6" ENSG00000162065 "TBC1 domain family member 24" Q9ULP9 16 2475051-2509560 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 33.4" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA044712, HPA068080" Uncertain Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA044712: AB_10795619, HPA068080: " "prognostic unfavourable (3.22e-4)" "unprognostic (5.23e-2)" "unprognostic (4.02e-2)" "unprognostic (6.41e-2)" "unprognostic (3.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.40e-1)" "unprognostic (2.03e-2)" "unprognostic (1.68e-1)" "unprognostic (7.37e-2)" "unprognostic (4.37e-2)" "unprognostic (1.28e-1)" "unprognostic (4.66e-3)" "unprognostic (2.02e-2)" "unprognostic (8.19e-2)" "unprognostic (7.78e-3)" "unprognostic (1.61e-1)" 6.0 5.8 11.0 2.9 9.6 3.7 4.9 15.8 17.7 4.2 3.5 2.8 6.7 3.8 3.3 5.0 2.2 4.3 3.5 4.9 9.0 5.4 7.6 6.6 6.4 3.0 3.8 12.2 2.1 16.6 5.2 5.6 3.6 7.5 4.5 1.9 5.4 33.4 6.4 6.1 3.5 2.8 3.1 3.7 3.4 3.8 2.4 4.5 0.8 5.5 1.0 2.3 4.0 2.9 0.2 1.3 0.0 0.9 0.2 2.2 1.0 2.6 5.0 3.3 6.8 4.0 4.0 2.9 4.7 2.4 3.1 2.6 4.7 2.2 6.5 4.3 3.6 4.7 5.2 1.4 2.2 7.1 6.2 5.9 6.5 4.0 2.4 4.2 2.5 1.5 2.1 2.7 1.1 3.8 7.1 3.6 2.8 4.6 2.9 8.5 3.0 3.3 15.1 6.4 4.5 2.2 1.7 26.5 6.4 3.1 11.6 1.9 3.7 3.8 4.0 6.1 6.6 5.9 4.6 2.4 2.1 8.1 2.6 6.2 5.4 0.0 0.7 0.0 2.2 0.8 0.7 0.2 0.5 0.7 1.3 0.1 0.5 0.3 0.0 0.2 0.9 0.6 0.0 1.0 11.0 9.6 15.8 12.4 9.0 5.4 3.8 12.2 7.5 4.5 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64781193-64881032 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell line enhanced" "Detected in many" "MCF7: 23.0;RPMI-8226: 13.6;RT4: 17.7;SCLC-21H: 16.6;SK-BR-3: 17.0;T-47d: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Group enriched" "Detected in many" 17 "granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favourable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favourable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.8 1.6 4.7 2.3 11.4 0.5 5.3 13.4 15.8 7.6 3.3 1.5 12.4 5.0 3.1 2.5 1.2 2.1 4.8 1.1 7.1 5.5 3.9 1.7 3.9 0.9 4.7 7.0 1.5 19.8 8.9 6.5 1.4 16.5 3.7 3.5 2.0 14.4 11.6 0.9 1.3 3.5 2.4 3.0 2.5 6.9 3.2 2.8 0.0 3.3 0.2 0.7 4.9 1.9 0.0 0.0 2.4 1.1 0.0 1.3 0.3 6.9 1.4 0.4 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.1 6.5 2.2 0.3 1.1 0.0 0.1 6.8 0.1 0.0 0.0 6.7 0.3 1.2 0.3 0.1 2.3 1.4 0.4 0.0 0.0 0.2 5.7 0.0 2.4 0.2 23.0 0.0 0.4 0.9 6.8 0.1 0.1 13.6 0.8 17.7 16.6 1.3 1.4 17.0 0.2 12.4 1.1 5.4 0.0 1.0 0.5 3.4 0.0 0.0 0.2 0.1 0.7 0.3 0.0 1.1 0.0 0.4 1.1 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 4.7 11.4 13.4 15.8 7.1 5.5 4.7 7.0 16.5 2.8 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 22.2 20.9 24.8 21.3 24.7 21.1 17.7 25.5 25.1 21.0 13.3 25.7 14.5 10.3 17.4 15.9 16.4 22.4 18.5 16.2 24.4 20.0 19.9 13.9 16.9 20.4 25.9 14.9 28.3 17.2 35.3 27.8 16.5 21.4 14.2 13.7 16.6 13.9 17.0 10.3 15.2 13.8 17.7 31.3 24.3 12.9 17.3 24.7 10.0 29.1 9.7 21.2 17.8 20.7 13.5 9.7 12.3 8.6 4.2 8.7 4.6 11.5 13.0 10.7 10.0 21.2 31.2 11.7 12.5 18.3 8.2 7.1 6.3 10.5 21.5 13.6 25.3 3.6 9.4 15.2 17.1 19.0 3.6 20.6 5.3 7.3 13.6 20.0 18.1 20.1 18.2 17.8 10.8 18.6 12.9 20.0 19.9 7.8 9.8 4.6 8.8 13.7 21.6 13.8 15.3 12.3 9.0 4.0 19.1 23.9 5.6 8.5 15.9 16.8 20.1 22.7 10.2 11.7 13.6 11.6 15.7 21.0 17.5 19.1 21.2 10.2 8.6 12.3 6.7 7.1 8.7 11.7 5.1 4.8 9.7 13.5 3.9 4.4 11.5 4.2 6.4 6.3 5.5 4.6 24.8 24.7 25.5 24.6 24.4 20.0 25.9 14.9 21.4 24.7 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620765-140756120 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.0" "Group enriched" "Detected in many" 38 "B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000262: , HPA006503: " "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favourable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 15.9 6.2 8.1 9.2 10.0 1.0 33.6 37.6 13.7 9.2 6.7 3.8 32.1 5.2 5.5 6.4 5.9 6.7 9.4 5.7 7.5 13.9 10.7 8.0 10.4 9.6 9.6 8.2 10.9 6.0 9.9 5.7 13.1 11.0 9.8 4.3 10.6 7.3 27.4 1.7 2.8 9.9 5.0 5.3 20.4 10.0 2.9 3.8 1.6 4.3 3.0 12.2 11.1 8.9 9.0 4.6 0.1 2.4 0.1 0.0 0.9 0.4 6.3 5.9 5.1 14.5 13.7 12.1 8.1 8.8 5.9 7.6 1.3 5.6 0.0 5.2 10.6 1.2 7.4 5.8 5.6 0.0 4.1 3.6 4.6 5.4 5.3 0.4 0.5 11.3 9.7 5.1 20.6 16.3 0.0 0.0 5.5 6.3 0.8 0.0 0.9 5.6 3.9 9.7 9.3 6.7 11.7 8.7 6.2 8.4 14.9 5.5 3.5 0.2 25.3 15.7 4.7 10.1 6.9 0.0 0.0 0.0 9.5 0.7 8.5 0.0 2.4 0.0 0.0 1.9 0.0 9.0 0.0 0.0 4.0 4.0 0.0 0.0 0.1 0.1 0.7 4.6 0.0 0.9 8.1 10.0 37.6 13.7 7.5 13.9 9.6 8.2 11.0 3.8 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907859 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (8.22e-2)" 30.4 28.7 31.2 14.3 29.8 17.0 21.2 27.0 37.9 21.7 17.8 36.7 20.6 16.4 18.9 24.5 21.7 20.7 19.0 15.2 31.4 26.6 20.7 22.4 18.3 16.8 34.9 23.3 24.8 24.6 22.7 13.3 14.8 29.0 18.2 14.5 17.5 25.6 21.9 20.3 24.0 18.9 19.1 42.3 18.0 16.1 12.2 24.1 12.0 23.3 12.5 17.2 17.4 19.7 5.4 9.4 5.0 8.1 3.7 5.5 4.9 10.6 16.4 7.4 17.3 22.9 14.7 17.4 12.9 13.3 13.0 13.0 11.0 10.7 7.3 16.0 15.6 10.2 8.9 30.1 6.0 24.2 10.0 6.5 12.0 7.3 12.3 8.6 22.7 16.9 13.1 10.2 7.3 14.3 4.3 8.5 11.6 26.5 5.5 7.1 5.2 9.3 9.6 5.7 7.1 12.2 17.3 10.7 7.9 12.2 14.6 14.8 11.5 13.9 14.5 19.0 8.5 9.0 11.4 4.4 5.7 5.7 18.0 11.0 13.4 4.5 5.9 5.0 5.5 8.1 4.5 5.4 4.0 4.7 7.8 5.1 3.9 3.1 0.8 3.7 7.9 9.4 3.4 4.9 31.2 29.8 27.0 37.9 31.4 26.6 34.9 23.3 29.0 24.1 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules 1000000 Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 40.5 77.3 50.0 32.5 66.7 41.2 108.9 46.8 86.9 33.0 35.7 22.1 34.1 31.8 37.5 78.5 44.4 43.0 27.1 76.7 69.2 56.5 57.7 85.1 59.8 69.6 51.0 50.8 62.3 80.7 24.0 57.9 36.7 77.9 39.1 33.2 30.6 37.3 36.8 43.4 24.6 31.0 62.4 117.9 30.3 38.9 31.2 29.0 26.7 39.8 35.2 40.7 33.3 35.4 53.6 63.1 20.9 39.2 30.9 57.8 34.8 60.8 42.4 77.9 76.8 34.7 49.4 42.6 51.8 44.6 56.5 65.0 58.0 67.2 94.1 94.9 29.0 37.9 48.2 66.1 55.9 43.8 77.1 44.7 45.6 63.8 50.9 38.7 37.3 49.6 52.2 40.2 62.2 48.2 46.6 59.0 50.7 54.0 81.2 92.9 47.8 38.9 55.0 65.1 100.6 54.6 54.5 75.2 49.0 49.7 35.2 93.0 50.0 98.0 44.9 29.1 32.3 51.0 81.2 48.8 47.1 82.2 66.2 66.8 57.6 13.9 34.9 18.2 35.9 36.7 40.4 53.6 43.0 42.4 42.4 49.0 41.3 52.0 20.9 30.9 39.2 63.1 57.8 34.8 50.0 66.7 46.8 86.9 69.2 56.5 51.0 50.8 77.9 29.0 TBCK "HSPC302, MGC16169" ENSG00000145348 "TBC1 domain containing kinase" Q8TEA7 4 106041599-106321495 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.6;HBF TERT88: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039951, HPA051611" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039951: AB_10795300, HPA051611: " "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (8.47e-2)" "unprognostic (1.12e-1)" "unprognostic (8.06e-2)" "unprognostic (1.13e-3)" "unprognostic (1.55e-1)" "unprognostic (3.81e-1)" "unprognostic (8.68e-2)" "unprognostic (1.85e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.20e-4)" "unprognostic (8.17e-3)" "unprognostic (1.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.29e-1)" 12.8 19.0 14.2 7.6 15.2 3.4 10.0 16.3 15.2 13.5 8.3 10.0 11.0 4.4 10.9 14.9 10.6 13.0 13.2 9.3 12.1 11.1 17.8 10.5 9.6 6.9 15.0 8.5 17.5 8.2 12.6 24.2 13.7 12.1 11.9 9.1 9.0 9.1 14.6 4.2 8.5 7.2 13.3 10.3 8.5 8.1 12.0 13.8 18.5 13.9 4.6 8.9 14.5 10.7 10.7 6.3 11.9 6.8 5.9 8.4 4.2 0.9 2.5 5.1 1.9 19.2 12.0 0.9 3.8 6.2 24.8 43.6 4.4 3.8 1.7 5.8 13.0 2.2 3.4 4.7 29.8 2.3 1.0 5.3 2.0 4.6 5.0 2.2 3.1 11.2 3.9 2.3 3.9 6.4 4.1 2.1 7.5 3.3 2.8 2.0 1.2 1.7 2.1 3.2 3.5 6.5 4.4 2.7 2.2 3.4 2.4 3.3 3.3 4.8 3.7 4.4 2.2 1.0 1.9 1.0 2.8 3.7 6.0 3.2 2.3 11.9 6.4 6.3 6.2 6.8 7.2 6.2 6.8 8.4 6.3 10.7 7.4 6.7 0.5 5.9 4.6 6.1 6.7 4.2 14.2 15.2 16.3 15.2 12.1 11.1 15.0 8.5 12.1 13.8 TBK1 NAK ENSG00000183735 "TANK binding kinase 1" Q9UHD2 12 64451880-64502108 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045797, HPA060211" Uncertain Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045797: , HPA060211: " "unprognostic (4.73e-2)" "unprognostic (8.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.90e-1)" "unprognostic (1.94e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (3.30e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.48e-4)" "unprognostic (1.69e-1)" "unprognostic (2.54e-2)" "unprognostic (1.24e-2)" "prognostic unfavourable (4.20e-6)" "unprognostic (4.35e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-2)" "unprognostic (9.56e-3)" 19.1 23.3 13.7 16.8 17.1 32.3 19.1 17.8 20.5 14.9 18.3 10.0 14.1 18.0 17.0 15.1 15.3 13.8 15.6 11.7 14.7 15.6 15.4 20.8 17.8 18.3 20.2 13.6 15.6 11.1 13.1 27.2 40.6 21.1 16.3 12.9 10.1 15.0 18.3 24.8 12.1 21.4 17.2 18.8 24.6 14.5 27.9 16.9 3.4 13.3 12.6 16.7 18.4 19.6 9.7 8.2 22.5 11.9 16.3 11.8 5.9 13.4 15.5 8.8 12.9 15.8 16.0 19.5 14.8 21.5 13.9 13.3 8.7 8.2 18.9 12.9 16.0 12.7 11.4 12.4 16.5 17.3 10.8 20.2 11.2 12.0 17.4 20.6 25.3 12.0 11.4 13.9 13.4 18.5 15.5 27.5 17.9 16.5 0.6 16.2 17.7 9.1 9.6 9.8 18.2 15.2 24.5 7.4 10.7 19.5 20.0 14.3 20.5 15.0 17.1 12.6 12.2 10.1 14.4 17.4 30.3 18.4 15.9 11.4 16.2 22.5 7.3 16.6 11.0 11.9 11.8 9.7 8.0 11.0 8.2 7.6 2.8 7.1 15.1 16.3 10.6 1.9 9.5 5.9 13.7 17.1 17.8 20.5 14.7 15.6 20.2 13.6 21.1 16.9 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.3" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: " "prognostic unfavourable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favourable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favourable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 6.5 7.1 10.1 6.0 12.3 4.5 8.1 3.3 8.1 21.4 7.9 13.2 18.0 2.1 33.0 26.4 8.3 12.4 6.7 5.2 8.6 9.0 12.5 11.0 5.2 9.5 7.6 6.0 13.8 11.3 21.0 24.3 14.5 7.5 24.7 4.1 9.8 5.5 33.0 4.9 5.8 4.2 22.4 9.0 5.7 7.0 9.9 8.5 14.7 9.4 3.4 7.1 15.3 24.5 3.2 3.1 17.3 4.2 0.3 3.1 1.7 0.0 13.5 8.6 23.0 8.0 8.4 8.5 5.2 11.6 10.0 10.5 10.1 9.3 14.4 0.3 10.3 3.1 18.8 4.1 14.7 5.9 9.3 9.0 16.5 11.9 11.4 3.2 32.5 7.5 4.7 10.4 5.5 9.2 15.8 25.1 5.7 11.4 7.8 12.2 17.1 14.6 17.6 6.8 17.6 13.6 7.7 11.1 5.0 12.5 3.1 7.5 6.1 7.1 13.3 3.5 8.7 0.3 2.0 15.3 11.9 11.4 12.9 7.9 3.3 4.4 4.2 4.9 2.1 2.6 1.7 2.0 1.6 1.9 3.1 3.2 3.1 2.8 17.3 0.3 1.7 0.3 2.5 1.7 10.1 12.3 3.3 8.1 8.6 9.0 7.6 6.0 7.5 8.5 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA071810: , HPA071813: " "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favourable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavourable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favourable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 7.1 7.7 10.8 8.9 11.7 19.3 12.2 16.4 16.6 7.3 7.3 5.2 7.8 8.1 7.9 5.6 7.1 8.5 7.4 7.9 15.9 14.2 5.7 8.5 6.6 12.0 10.0 11.8 8.3 6.0 4.7 8.2 9.2 11.1 8.0 9.3 4.6 5.7 9.2 4.4 5.9 7.7 7.2 8.5 7.6 7.2 71.2 8.0 11.7 10.7 5.0 10.2 9.2 12.0 27.8 14.7 43.1 14.9 21.1 30.8 25.3 6.2 7.6 17.6 11.4 13.5 13.9 9.9 11.8 12.6 15.9 20.9 9.0 5.0 19.4 8.2 9.4 8.2 11.2 12.8 19.2 14.8 13.9 34.1 4.6 9.8 13.7 17.8 13.3 8.6 13.1 17.7 19.3 15.0 49.2 13.4 11.3 14.2 14.9 10.7 19.6 10.0 10.4 10.6 7.4 9.3 5.6 22.9 22.8 7.0 9.2 14.6 4.2 7.2 13.5 9.1 13.3 20.1 13.0 10.8 11.7 12.6 15.3 11.7 10.9 43.1 13.7 32.7 28.5 13.8 30.8 27.8 24.1 29.9 12.4 25.0 23.4 27.3 31.4 21.1 14.9 14.7 24.6 25.3 10.8 11.7 16.4 16.6 15.9 14.2 10.0 11.8 11.1 8.0 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box 1" O43435 22 19756703-19783593 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 36.5" "Cell line enhanced" "Detected in some" "HEK 293: 9.9;K-562: 47.6;NB-4: 11.2;TIME: 15.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 3.0" "Group enriched" "Detected in some" 13 "basophil: 1.0;eosinophil: 2.7" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" "Nuclear bodies, Cytoplasmic bodies" "HPA029330: " "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favourable (8.90e-4)" 1.4 0.2 0.6 0.6 3.0 0.0 3.7 0.6 0.6 2.5 2.3 0.6 0.6 0.4 0.9 0.6 2.5 2.8 0.6 0.6 0.6 0.0 0.6 0.6 2.2 1.7 0.6 0.6 0.7 0.6 3.7 0.6 0.6 0.6 2.3 0.2 0.6 3.4 0.6 36.5 4.6 0.8 0.6 0.6 0.6 0.1 7.0 0.6 0.6 5.3 0.6 1.9 1.1 3.3 0.0 0.1 2.7 0.0 0.0 0.1 0.0 5.9 0.6 0.1 4.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.3 5.1 4.4 0.0 0.2 9.9 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 47.6 0.0 3.2 1.1 0.1 11.2 0.7 6.9 0.1 4.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 2.0 3.0 15.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.0 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 TBX15 TBX14 ENSG00000092607 "T-box 15" Q96SF7 1 118883046-118989556 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.3;skeletal muscle: 84.9;tongue: 37.5" "Cell line enhanced" "Detected in some" "ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA052245: , HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavourable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 18.1 0.1 0.2 0.1 0.5 0.1 12.5 0.4 0.8 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.2 0.1 0.3 1.2 0.5 0.0 0.1 23.3 0.2 1.3 0.2 0.2 0.1 0.1 0.2 0.5 0.1 2.1 0.7 0.0 0.2 2.8 0.1 84.9 3.6 0.1 0.2 0.6 0.0 0.1 0.4 0.4 0.0 1.9 37.5 2.4 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 27.7 11.7 0.0 2.4 3.2 6.3 10.6 0.0 0.0 0.0 1.3 14.1 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 19.9 0.1 0.1 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.1 1.2 0.1 0.0 14.9 0.2 1.5 0.7 0.3 0.0 0.8 0.0 0.3 0.0 0.3 0.0 3.4 2.1 14.0 0.1 0.2 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.8 0.5 0.0 0.2 0.2 2.1 0.4 TBX2 ENSG00000121068 "T-box 2" Q13207 17 61399896-61409466 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 47.6;MCF7: 27.9;SH-SY5Y: 22.2;SK-MEL-30: 15.1;WM-115: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008586, CAB013636" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013636: , HPA008586: AB_1080222" "unprognostic (6.18e-2)" "unprognostic (8.51e-2)" "unprognostic (4.50e-1)" "unprognostic (2.09e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (9.29e-2)" "unprognostic (2.10e-2)" "unprognostic (2.10e-1)" "unprognostic (2.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" "unprognostic (6.34e-3)" 11.5 3.4 2.0 2.9 3.1 0.4 9.9 1.3 2.3 14.8 4.4 1.9 30.4 4.9 12.2 37.0 5.9 11.3 16.8 6.8 1.8 1.8 28.9 4.6 35.7 1.3 3.6 1.5 8.3 1.8 1.8 3.7 30.4 3.6 15.1 2.2 33.7 2.2 38.1 5.8 2.9 5.5 16.4 1.7 8.8 8.1 9.6 1.5 0.0 8.6 5.0 1.8 19.5 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 47.6 1.5 1.7 5.8 7.3 7.7 0.4 0.1 1.3 0.1 0.0 0.6 1.2 0.0 0.8 0.0 0.1 0.0 2.8 0.8 0.0 2.3 5.3 0.1 0.7 3.0 0.1 8.7 0.5 0.0 0.1 0.0 0.5 27.9 0.0 0.1 0.0 3.3 0.0 1.9 0.2 0.0 11.3 0.1 22.2 0.0 0.0 15.1 0.6 0.9 0.0 1.1 0.0 2.7 1.6 0.0 0.1 0.0 6.6 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 1.3 2.3 1.8 1.8 3.6 1.5 3.6 1.5 TBX3 "TBX3-ISO, UMS, XHL" ENSG00000135111 "T-box 3" O15119 12 114670254-114684164 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 117.7" "Cell line enhanced" "Detected in many" "BJ: 33.8;BJ hTERT+: 32.2;RT4: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA005799, HPA075876" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005799: AB_1857817, HPA075876: " "unprognostic (3.27e-1)" "unprognostic (2.64e-1)" "unprognostic (2.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.40e-2)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-3)" "unprognostic (1.09e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "prognostic favourable (3.28e-4)" 4.3 60.5 0.9 3.3 1.9 0.0 19.9 0.7 2.3 18.2 12.2 1.7 69.6 14.2 13.1 18.7 1.9 7.5 5.0 6.2 1.2 1.5 4.1 15.1 12.6 0.8 1.2 0.5 15.6 1.1 0.3 5.3 67.8 1.6 32.3 1.5 2.6 7.3 117.7 4.2 4.8 19.4 9.7 1.4 2.6 2.2 3.5 1.2 0.5 36.3 7.3 3.5 24.6 25.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 5.9 0.0 0.0 8.9 12.3 13.4 33.8 32.2 13.1 13.0 5.3 1.4 0.0 0.5 5.8 1.5 2.8 1.2 16.2 0.0 4.0 0.0 1.5 15.4 2.9 0.0 0.0 5.4 0.8 4.4 9.1 0.1 1.2 0.0 1.1 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.8 0.0 42.2 2.2 6.5 4.8 2.2 1.1 1.6 0.0 0.0 4.0 2.6 2.2 10.9 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.7 2.3 1.2 1.5 1.2 0.5 1.6 1.2 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594506-3606840 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 11.7;U-2197: 8.4;U-937: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 12.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077366 Supported "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA077366: " "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favourable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 8.7 11.8 1.4 3.9 1.6 2.1 3.9 0.5 1.6 13.5 3.8 1.7 3.9 2.6 7.4 4.8 8.0 4.7 6.0 6.8 2.4 1.5 10.1 18.4 6.7 7.3 1.4 1.9 8.3 2.2 2.5 1.7 10.6 2.7 3.6 1.4 5.0 1.7 4.2 3.1 1.8 4.4 6.5 2.1 14.9 3.7 3.4 1.9 2.2 3.9 3.2 1.8 6.8 9.6 12.6 0.3 3.2 0.4 3.1 9.6 3.9 0.1 0.2 0.2 4.1 0.9 2.2 0.7 2.9 0.7 2.3 1.8 0.1 0.3 0.1 4.3 1.2 0.1 0.8 0.0 0.8 0.2 1.0 2.8 11.7 0.3 1.2 0.0 5.2 1.1 0.0 3.0 0.0 0.9 4.4 0.4 0.4 0.2 0.2 1.5 0.1 2.5 0.1 0.0 0.2 0.0 0.1 0.2 1.7 0.2 0.4 0.1 1.8 5.0 2.5 4.7 1.0 8.4 2.8 0.2 0.3 0.2 3.9 7.2 1.1 2.9 0.4 0.2 2.6 0.2 0.3 1.8 0.8 2.3 0.0 12.6 4.6 9.6 3.2 3.1 0.2 0.3 0.2 3.9 1.4 1.6 0.5 1.6 2.4 1.5 1.4 1.9 2.7 1.9 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779751-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 100.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;MCF7: 9.2;RT4: 21.0;SK-BR-3: 25.4;T-47d: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "MAIT T-cell: 32.2" "Group enriched" "Detected in many" 46 "NK-cells: 12.9;T-cells: 32.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favourable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 6.6 1.5 0.9 15.8 0.9 1.9 12.3 0.4 1.9 8.9 10.2 0.6 16.7 5.4 7.6 7.0 11.6 5.4 24.9 4.7 0.9 1.0 3.7 6.8 13.5 11.3 0.8 0.5 5.5 100.1 12.4 8.4 13.1 1.6 9.3 7.0 6.6 29.8 20.1 2.1 6.9 11.7 3.2 1.1 12.3 10.8 4.9 0.1 8.7 10.3 5.8 27.9 8.3 9.5 0.2 0.0 0.4 0.0 12.9 32.2 7.7 5.1 0.8 0.0 0.0 1.0 0.0 7.2 0.0 0.1 0.0 0.0 3.7 11.1 3.4 0.2 0.0 0.6 5.1 5.2 0.0 0.0 2.7 0.0 1.3 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.2 0.0 0.1 2.7 0.0 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.5 21.0 3.9 0.0 0.4 25.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.7 0.0 32.2 0.2 16.2 18.6 0.0 0.1 13.3 11.0 0.4 12.9 0.0 0.0 5.2 7.7 0.9 0.9 0.4 1.9 0.9 1.0 0.8 0.5 1.6 0.1 TCAF2 "FAM115C, FAM139A, FLJ40722, GATD9" ENSG00000170379 "TRPM8 channel associated factor 2" A6NFQ2 7 143620952-143730409 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 9.0;HUVEC TERT2: 9.6;TIME: 15.2;U-87 MG: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" "unprognostic (6.59e-2)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (8.86e-3)" "prognostic unfavourable (9.53e-5)" "unprognostic (1.89e-1)" "unprognostic (3.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.36e-1)" "unprognostic (2.04e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.17e-6)" "unprognostic (7.19e-2)" "unprognostic (4.02e-2)" "unprognostic (5.41e-3)" "unprognostic (2.85e-2)" 3.1 2.7 1.5 5.8 2.7 5.8 8.4 2.0 4.0 5.2 1.8 0.6 2.0 1.8 6.1 2.1 13.1 2.2 3.5 3.5 2.3 1.9 3.1 6.4 7.1 12.4 1.6 1.2 4.2 3.2 2.1 3.8 8.1 2.8 5.5 1.6 1.7 5.7 9.2 2.1 6.7 3.5 5.0 4.7 4.0 3.1 2.2 2.0 7.3 2.3 7.6 7.0 8.0 12.1 2.6 1.0 7.0 0.4 3.5 6.5 1.3 4.7 0.3 0.3 0.3 0.9 0.9 1.9 1.5 2.6 0.6 1.9 0.2 0.5 0.3 2.0 1.2 0.9 0.1 2.4 2.1 9.0 0.5 0.8 0.7 0.2 1.1 0.3 0.6 2.5 1.1 0.3 0.9 9.6 2.6 4.7 4.1 0.8 0.6 0.9 0.3 2.4 0.4 2.0 2.2 0.0 1.9 0.3 0.2 0.5 3.4 0.3 1.8 0.3 15.2 1.4 1.0 5.2 0.4 7.5 2.4 0.2 13.2 0.5 2.7 7.0 0.4 0.4 4.0 0.4 4.2 2.6 6.5 4.1 0.3 2.5 5.8 4.6 1.6 3.5 0.3 1.0 6.2 1.3 1.5 2.7 2.0 4.0 2.3 1.9 1.6 1.2 2.8 2.0 TCAF2C ENSG00000283528 "TRPM8 channel associated factor 2C" 7 143639230-143647646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.2;parathyroid gland: 1.9;placenta: 1.3" "Cell line enhanced" "Detected in some" "A-431: 1.1;U-266/70: 3.9;U-266/84: 1.8" "Cell type enhanced" "Detected in some" "basophil: 2.2;T-reg: 1.8" "Low lineage specificity" "Detected in many" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 1.8 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.9 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.1 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 26.7 25.3 30.7 40.5 31.5 29.6 31.1 26.1 27.4 26.0 28.3 21.9 26.6 20.3 27.3 20.9 27.5 23.6 24.7 21.4 27.8 24.2 26.5 56.8 22.3 39.2 29.7 17.6 28.5 38.4 32.2 28.7 21.1 27.1 31.3 22.5 20.6 25.4 25.4 21.8 22.8 22.4 38.9 36.8 30.0 26.1 17.3 31.3 39.9 54.6 18.6 46.9 39.6 37.3 60.0 31.9 20.5 17.8 25.2 40.1 17.8 26.8 27.2 24.3 25.0 17.3 21.5 17.4 21.3 25.0 25.2 28.2 15.5 22.5 65.9 24.3 24.4 20.7 30.7 19.5 36.8 37.7 15.4 49.8 13.3 22.9 54.3 19.5 21.5 15.4 52.8 23.7 104.8 21.5 31.6 57.3 22.9 12.7 40.4 13.7 39.6 8.1 31.3 8.5 11.8 34.8 18.3 22.8 16.6 17.6 15.5 57.2 22.4 21.9 19.0 18.6 17.1 20.8 19.1 35.4 22.1 44.7 32.7 22.4 26.1 18.1 17.8 20.5 30.1 16.8 28.6 60.0 31.4 27.7 22.1 44.4 28.0 29.1 6.4 25.2 15.6 31.9 40.1 17.8 30.7 31.5 26.1 27.4 27.8 24.2 29.7 17.6 27.1 31.3 TCEA2 TFIIS ENSG00000171703 "Transcription elongation factor A2" Q15560 20 64049836-64072347 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043836 Approved Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA043836: " "unprognostic (6.51e-2)" "unprognostic (2.02e-1)" "unprognostic (3.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.80e-1)" "unprognostic (4.91e-3)" "unprognostic (2.38e-1)" "unprognostic (2.91e-1)" "unprognostic (1.65e-3)" "unprognostic (9.03e-3)" "unprognostic (2.49e-2)" "unprognostic (9.67e-2)" "unprognostic (1.17e-1)" "unprognostic (3.81e-3)" "unprognostic (2.70e-1)" "unprognostic (2.28e-1)" "unprognostic (3.79e-1)" 14.8 19.5 31.4 7.9 32.8 6.6 9.3 34.7 40.4 18.3 11.7 17.7 11.0 5.6 18.8 10.9 8.4 24.5 13.5 19.1 27.7 30.0 14.8 27.5 10.9 9.2 27.2 32.8 30.3 16.1 18.6 17.9 14.7 26.5 16.9 3.2 14.5 17.9 22.3 30.7 10.4 7.8 11.7 18.3 16.2 10.5 32.0 18.9 8.7 15.0 6.1 5.2 10.9 15.4 9.7 3.0 4.4 2.6 3.6 5.5 1.6 7.5 8.2 13.1 22.2 11.7 7.3 5.3 7.9 8.8 14.0 6.7 4.8 13.4 8.6 17.8 9.1 20.2 5.2 6.7 2.7 5.3 10.3 3.2 14.3 12.6 17.4 3.6 4.6 11.3 6.0 3.6 4.6 9.5 5.6 16.2 4.2 16.5 14.7 17.5 8.4 19.8 14.3 9.9 22.2 7.0 5.0 12.9 21.8 8.0 5.5 19.8 15.0 9.0 13.5 25.2 13.3 14.2 4.8 18.9 12.4 4.6 22.4 4.2 5.0 2.4 1.7 4.4 3.6 1.6 1.6 9.7 3.2 2.6 2.1 5.0 5.5 3.4 0.8 3.6 2.6 3.0 5.4 1.6 31.4 32.8 34.7 37.6 27.7 30.0 27.2 32.8 26.5 18.9 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23381061-23424740 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 114.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.1;Hep G2: 33.5;SiHa: 11.1;T-47d: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3" "Lineage enriched" "Detected in many" 5 "T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: " "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favourable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 5.4 17.8 2.5 10.7 1.9 0.1 3.6 1.5 1.5 9.1 12.2 2.2 12.0 4.6 3.8 14.5 12.0 6.2 13.0 20.3 2.4 0.8 12.1 38.0 6.0 1.3 1.2 2.3 19.8 60.4 4.5 3.3 2.5 2.2 16.7 12.5 8.7 32.7 15.9 114.0 8.9 11.9 13.7 2.0 1.6 11.5 2.6 1.3 0.5 8.6 58.3 16.0 8.4 6.9 0.0 2.8 0.0 0.7 0.2 14.3 2.5 0.0 0.1 0.3 0.3 1.7 10.1 5.6 3.9 2.6 2.1 1.2 2.5 0.3 0.1 0.4 4.9 5.5 0.4 0.0 1.8 0.0 0.0 0.0 4.2 33.5 1.2 0.5 0.0 6.6 1.8 1.8 0.0 0.2 0.0 0.0 0.7 0.9 0.2 3.6 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 11.1 0.5 0.4 17.7 1.6 0.2 0.0 0.1 0.4 0.0 0.3 2.9 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.5 0.7 0.5 0.0 8.5 1.2 2.8 0.0 14.3 6.3 0.0 0.2 0.2 0.9 0.7 2.5 2.5 1.9 1.5 1.5 2.4 0.8 1.2 2.3 2.2 1.3 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Group enriched" "Detected in some" 4 "HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" HPA076317 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA076317: " "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.0 7.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276872 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;testis: 45.9" "Group enriched" "Detected in some" 7 "SCLC-21H: 7.3;SH-SY5Y: 22.8" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045564, HPA058982, HPA072199" Supported Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045564: , HPA058982: , HPA072199: " "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favourable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 2.0 11.2 21.9 2.1 31.8 1.3 3.3 32.7 56.4 4.7 2.2 6.6 0.0 1.9 6.0 7.8 1.5 1.6 2.0 2.0 22.3 23.1 1.5 1.3 1.5 1.3 13.0 24.0 5.0 2.1 1.3 23.1 1.3 19.8 3.7 2.0 1.4 2.3 5.4 1.4 1.3 2.4 4.3 11.0 1.3 1.5 45.9 8.4 0.0 3.4 0.0 1.3 2.1 1.1 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 21.9 31.8 32.7 31.9 22.3 23.1 13.0 24.0 19.8 8.4 TCEAL9 "DKFZp313K1940, WBP5, WEX6" ENSG00000185222 "Transcription elongation factor A like 9" Q9UHQ7 X 103356489-103358462 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011790 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA011790: AB_2214932" "unprognostic (1.26e-1)" "unprognostic (9.24e-2)" "unprognostic (3.35e-2)" "unprognostic (1.67e-3)" "unprognostic (5.52e-2)" "unprognostic (1.00e-3)" "unprognostic (1.31e-3)" "unprognostic (5.85e-2)" "unprognostic (7.64e-2)" "unprognostic (7.50e-3)" "unprognostic (1.59e-2)" "unprognostic (4.32e-2)" "unprognostic (1.10e-3)" "unprognostic (4.33e-3)" "unprognostic (1.26e-1)" "unprognostic (3.28e-2)" "unprognostic (2.58e-2)" 28.2 61.0 17.9 14.7 20.9 3.7 42.1 20.7 24.0 30.8 20.6 10.9 35.0 7.6 32.3 59.6 21.4 20.1 25.6 29.4 19.5 20.5 38.8 12.6 25.9 9.5 23.7 15.0 93.4 15.7 19.6 54.5 67.1 40.3 27.6 17.7 15.2 15.7 45.4 7.8 12.1 11.7 30.2 44.1 26.4 23.1 27.5 23.6 5.4 58.6 18.5 7.6 35.5 75.7 1.8 18.6 0.9 1.3 1.1 3.5 1.3 17.8 8.8 27.9 14.2 60.6 59.0 20.9 37.6 50.4 26.7 43.7 16.9 19.0 0.0 55.8 30.7 10.8 4.8 23.9 36.0 0.0 10.4 18.3 21.5 10.8 41.7 0.0 0.0 40.4 23.3 35.6 35.7 44.3 16.1 1.3 63.3 0.0 8.9 0.1 17.3 16.9 0.0 55.8 0.0 32.2 33.2 12.6 15.2 23.6 0.7 24.5 3.8 1.0 36.1 23.9 10.4 71.7 10.4 0.0 1.0 0.1 57.9 0.0 18.9 0.9 1.3 0.0 0.2 0.7 0.0 1.8 1.5 0.5 1.0 1.0 3.5 2.9 0.0 1.1 0.1 18.6 0.9 1.3 17.9 20.9 20.7 24.0 19.5 20.5 23.7 15.0 40.3 23.6 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053587-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046918: " "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 5.9 5.9 7.9 7.6 11.1 6.5 5.9 3.0 7.9 6.1 5.4 13.4 6.6 6.8 5.3 6.2 7.9 5.2 4.4 4.4 8.3 6.4 7.2 4.7 4.8 9.4 10.2 4.5 4.3 6.4 6.6 6.2 6.0 8.8 5.1 8.1 6.5 5.5 4.1 9.4 6.8 6.4 6.3 14.1 8.2 5.2 15.4 8.8 15.7 5.7 3.0 10.8 7.3 5.1 7.8 7.6 10.1 8.9 10.2 6.3 3.8 5.1 2.3 5.9 4.9 4.0 6.3 5.7 5.6 4.3 6.3 5.6 1.4 3.3 4.6 4.9 2.4 5.2 7.8 4.3 8.0 10.2 4.2 6.8 5.5 2.7 2.5 5.0 6.9 4.7 3.7 5.5 3.2 8.0 6.7 4.3 5.2 1.9 10.0 3.7 13.6 3.9 10.0 10.8 6.7 2.3 3.1 5.1 5.4 3.6 5.6 6.7 5.5 9.4 4.2 5.7 3.6 5.5 6.8 9.9 14.3 6.4 4.8 6.9 7.1 5.9 7.3 10.1 4.7 8.9 4.6 7.3 5.4 5.8 7.6 7.8 6.3 6.2 9.4 10.2 6.5 6.9 4.1 3.8 7.9 11.1 3.0 7.9 8.3 6.4 10.2 4.5 8.8 8.8 TCF12 "bHLHb20, HEB, HsT17266, HTF4" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: " "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavourable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 20.9 14.3 24.9 12.6 37.5 10.9 18.4 32.7 41.8 48.2 16.5 33.6 14.0 16.0 28.1 15.0 14.8 28.2 21.4 15.7 28.4 16.4 17.0 14.4 17.3 13.7 33.9 15.3 26.2 12.5 29.2 15.7 19.1 27.9 26.3 17.9 14.7 20.1 17.5 18.1 16.0 15.8 25.8 25.3 13.6 17.3 14.7 41.3 89.4 17.0 9.6 15.8 23.3 21.2 11.8 15.9 16.0 19.3 12.2 17.6 10.2 6.5 12.3 54.2 17.5 24.7 21.7 9.5 13.5 23.8 12.0 16.0 8.0 5.3 9.0 11.1 20.4 7.9 21.2 9.7 15.4 11.8 7.9 18.1 13.4 9.5 17.1 11.3 9.5 19.1 17.6 11.0 29.2 21.4 20.2 11.4 16.3 2.2 26.7 6.3 14.6 5.3 36.6 63.0 8.4 16.5 12.2 11.1 32.1 14.6 5.3 13.1 8.2 22.3 16.5 19.4 14.8 8.2 19.7 6.5 11.6 15.0 10.8 22.1 23.1 16.0 11.2 8.7 15.0 14.3 12.4 10.8 12.2 13.6 15.9 11.8 14.1 12.7 1.3 12.2 19.3 6.6 17.6 10.2 24.9 37.5 32.7 26.9 28.4 16.4 33.9 15.3 27.9 41.3 TCF20 "AR1, SPBP" ENSG00000100207 "Transcription factor 20" Q9UGU0 22 42160013-42343616 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017849, HPA036786" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "CAB017849: , HPA036786: " "unprognostic (2.17e-1)" "unprognostic (2.12e-2)" "prognostic favourable (1.88e-4)" "unprognostic (2.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (4.89e-4)" "unprognostic (1.77e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-3)" "unprognostic (7.30e-2)" "unprognostic (1.17e-3)" "unprognostic (3.07e-3)" "unprognostic (4.94e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 4.1 4.3 10.2 5.5 16.4 5.4 4.6 6.6 17.1 5.4 5.6 22.6 4.4 5.7 6.1 4.3 10.9 5.6 4.2 2.7 7.3 5.4 4.9 4.6 4.7 6.5 14.7 14.6 5.7 6.7 6.9 10.2 4.3 10.5 4.4 6.1 9.9 6.5 4.2 3.1 8.5 6.4 4.6 5.8 5.5 6.0 9.3 12.2 3.5 9.2 2.3 7.5 5.5 6.8 0.3 0.3 0.9 0.3 0.0 0.5 0.0 6.3 3.6 5.5 4.9 2.9 2.6 5.6 2.9 3.5 3.4 4.5 5.3 2.6 10.7 2.7 2.5 6.4 5.3 5.9 4.3 7.6 4.2 3.0 3.9 3.6 3.1 7.0 4.1 2.3 5.9 3.8 7.6 2.6 4.5 5.6 1.9 5.7 7.1 3.8 4.0 3.0 4.0 3.1 5.6 3.4 5.9 5.4 2.2 5.0 4.8 4.9 2.6 4.3 3.2 4.3 7.0 2.6 3.3 4.6 5.6 5.4 2.7 4.4 2.9 0.0 0.1 0.0 0.4 0.0 0.4 0.2 0.5 0.1 0.0 0.3 0.5 0.4 0.9 0.0 0.3 0.3 0.3 0.0 10.2 16.4 6.6 17.1 7.3 5.4 14.7 14.6 10.5 12.2 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222331-55664787 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.8" "Cell line enhanced" "Detected in many" "HDLM-2: 41.5;SH-SY5Y: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8" "Group enriched" "Detected in many" 36 "B-cells: 29.7;dendritic cells: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavourable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavourable (9.95e-4)" 34.6 16.0 20.3 14.4 17.0 10.7 23.5 48.7 32.4 35.4 13.5 14.9 12.0 6.6 27.4 9.6 12.5 16.9 20.4 19.9 23.5 11.9 6.0 6.2 21.9 16.8 16.7 20.3 31.8 7.2 16.2 15.7 32.8 16.1 9.5 10.1 9.2 9.4 13.2 12.1 12.2 10.7 28.4 15.0 14.6 7.4 17.0 17.5 6.4 16.4 12.7 17.0 18.3 14.5 29.7 85.8 0.3 1.2 1.5 0.1 1.7 0.0 1.1 11.7 3.6 2.8 4.9 0.0 5.9 13.1 4.2 5.6 7.3 1.1 9.0 0.0 13.0 1.5 5.4 5.2 2.9 41.5 4.1 3.5 0.0 0.0 1.3 1.5 0.9 6.4 1.6 5.9 0.2 15.3 5.8 6.8 3.6 0.0 2.2 0.0 3.5 0.7 13.2 4.9 20.1 0.0 0.2 4.2 52.7 0.0 0.5 0.0 0.5 0.4 15.4 16.0 5.6 0.6 4.6 5.1 9.6 8.0 3.5 1.6 4.6 0.1 1.1 0.1 0.1 1.2 0.1 29.7 0.0 0.0 3.3 22.0 0.0 0.0 0.3 1.5 1.1 85.8 0.1 1.7 20.3 17.0 48.7 26.9 23.5 11.9 16.7 20.3 16.1 17.5 TCF7L1 TCF3 ENSG00000152284 "Transcription factor 7 like 1" Q9HCS4 2 85133410-85310388 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.9;NTERA-2: 41.8;RH-30: 19.0;T-47d: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071298 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA071298: " "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (3.64e-3)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.05e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (6.16e-5)" "unprognostic (1.79e-2)" "unprognostic (3.59e-3)" "unprognostic (2.73e-1)" "unprognostic (5.17e-3)" "unprognostic (1.69e-1)" "prognostic unfavourable (2.06e-4)" "prognostic unfavourable (2.72e-4)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (5.38e-4)" 21.0 3.9 3.3 6.5 6.4 4.2 28.7 5.1 5.3 28.2 14.7 7.5 14.5 4.1 21.2 11.8 13.8 10.4 9.1 11.6 6.0 3.0 9.3 7.6 11.1 5.5 4.5 3.8 20.3 3.2 11.6 5.7 4.8 6.3 14.0 4.3 16.8 8.8 19.6 13.4 8.3 6.9 17.8 5.9 7.9 6.8 7.3 5.5 2.2 18.6 8.7 6.1 18.0 20.4 3.7 2.0 8.4 1.2 1.8 2.2 0.4 0.9 0.7 14.2 10.8 5.4 1.1 8.7 1.0 3.5 2.4 2.3 2.1 0.9 0.4 1.7 2.3 2.2 10.8 17.9 1.7 0.8 1.7 0.3 0.8 0.9 0.5 0.8 2.1 0.9 3.3 0.2 0.6 4.7 0.3 0.8 2.8 0.6 0.0 0.8 41.8 0.3 0.3 19.0 0.2 1.1 1.6 0.4 4.4 1.6 7.2 0.5 18.6 0.3 5.1 2.8 4.1 0.2 1.3 0.5 0.2 0.3 0.1 0.5 2.2 8.4 1.2 2.2 1.2 1.0 1.5 2.1 1.4 1.6 0.4 3.7 1.7 2.2 3.4 1.8 1.0 2.0 1.1 0.4 3.3 6.4 5.1 4.0 6.0 3.0 4.5 3.8 6.3 5.5 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.0 18.5 20.3 19.6 10.6 7.1 24.2 5.0 9.8 3.5 4.3 12.2 21.5 0.0 5.7 9.4 5.0 6.9 8.7 4.5 0.8 6.4 5.0 12.3 11.3 11.3 1.9 1.8 12.5 3.2 5.5 9.3 5.9 5.1 0.3 4.1 13.8 3.1 1.2 14.6 10.7 8.9 14.9 3.2 7.6 9.9 0.4 6.2 7.6 7.6 8.1 4.9 1.0 13.6 3.3 9.6 8.4 10.3 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084144-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 1.7;skin 1: 3.8;tongue: 7.0" "Cell line enriched" "Detected in single" 59 "SK-BR-3: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCHP "MGC10854, TpMs" ENSG00000139437 "Trichoplein keratin filament binding" Q9BT92 12 109900264-109983841 "Predicted intracellular proteins" "Apoptosis, Cilium biogenesis/degradation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038638, HPA061543" Supported Supported "Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Centrosome, Cytosol" "HPA038638: AB_10670785, HPA061543: " "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (2.58e-1)" "unprognostic (1.04e-1)" "unprognostic (2.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.59e-2)" "unprognostic (9.75e-2)" "unprognostic (1.15e-3)" "unprognostic (4.63e-2)" "unprognostic (1.22e-1)" "prognostic favourable (5.52e-4)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" 8.6 10.4 16.0 11.3 29.3 8.3 9.3 22.9 25.0 10.2 11.2 19.0 7.5 9.9 13.0 10.9 18.3 8.7 8.3 10.3 15.9 11.0 8.5 7.0 10.0 14.5 23.8 13.9 11.3 12.7 12.1 12.1 10.4 18.6 10.7 9.6 11.0 13.4 11.6 10.8 36.1 10.2 15.0 15.9 15.0 10.2 12.5 24.2 10.9 12.0 7.7 15.1 11.4 15.4 3.2 3.3 4.5 5.2 9.2 7.4 4.4 16.3 14.6 7.9 9.5 7.0 7.6 10.7 15.5 8.3 13.6 7.6 9.2 5.8 23.0 4.6 9.1 13.8 8.6 9.8 12.3 12.3 8.5 16.6 9.1 8.9 8.5 22.5 12.8 6.2 12.0 14.3 10.8 12.1 17.9 4.7 11.2 11.2 20.5 22.9 9.5 14.9 18.9 15.6 19.4 6.2 14.7 11.8 12.4 11.4 12.3 11.0 11.1 16.4 13.4 14.0 9.7 8.9 19.8 13.4 17.0 16.5 14.9 18.7 14.5 0.0 4.2 3.4 6.2 2.7 4.3 3.2 5.4 7.4 3.3 2.3 5.4 4.2 4.5 9.2 5.2 2.4 7.2 4.4 16.0 29.3 22.9 25.0 15.9 11.0 23.8 13.9 18.6 24.2 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 14.4;AF22: 40.9;BJ: 15.4;BJ hTERT+: 40.4;EFO-21: 26.8;HeLa: 25.7;RPTEC TERT1: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 40.9 0.0 0.0 0.0 0.0 15.4 40.4 0.0 0.2 0.2 0.0 0.0 26.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.7 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 12.9 0.0 0.3 0.1 0.2 0.3 0.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 157 "Daudi: 69.4;REH: 90.3;U-698: 92.2" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.5 92.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110649430 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Actin filaments" "Intracellular and membrane" "Nucleoplasm, Actin filaments" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favourable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 8.0 12.4 11.2 5.1 13.8 3.0 8.9 5.6 10.1 17.7 5.4 12.3 20.6 4.1 10.3 28.7 5.4 35.4 12.3 14.4 11.0 13.0 16.1 7.2 11.6 5.5 11.0 5.3 15.5 9.1 24.1 32.9 8.4 22.1 14.5 4.0 16.3 10.2 20.6 8.0 5.3 4.1 10.3 8.9 6.0 7.2 24.7 8.0 4.4 25.5 3.9 5.2 8.8 12.2 13.7 5.0 8.4 3.5 1.1 2.9 1.9 7.4 9.5 6.7 18.4 19.2 16.8 3.4 5.4 11.0 5.0 4.3 2.1 2.3 1.5 4.7 13.2 5.3 3.9 4.1 3.6 3.2 6.2 0.4 3.9 4.6 9.1 0.8 0.8 10.5 6.2 6.5 8.0 3.6 5.2 3.2 6.1 10.9 0.6 2.6 3.3 12.8 1.9 3.5 10.7 15.2 1.8 5.7 7.6 9.3 2.2 4.5 15.5 8.6 4.0 8.6 2.2 3.0 4.6 3.1 1.5 2.0 8.5 0.8 6.8 0.3 2.4 0.4 1.3 3.5 2.9 6.3 1.9 2.7 3.7 13.7 2.9 2.4 8.4 1.1 2.0 5.0 0.6 1.9 11.2 13.8 5.6 10.1 11.0 13.0 11.0 5.3 22.1 8.0 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671113-123708403 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.5 5.5 6.4 5.1 18.1 2.3 8.4 10.5 10.0 11.2 5.6 9.1 12.0 2.9 15.7 14.1 4.1 32.0 7.2 5.4 6.2 10.2 11.8 2.3 9.4 4.0 4.4 8.3 18.0 7.9 16.1 18.8 5.3 18.5 11.0 4.9 17.6 11.9 10.2 1.9 10.2 3.9 7.1 4.2 4.5 6.1 17.2 3.2 3.1 15.6 5.1 4.2 5.9 7.5 4.5 4.7 2.4 1.1 1.4 5.4 0.4 10.7 10.6 8.1 11.2 11.0 12.4 9.4 4.1 7.9 8.5 7.2 6.7 10.8 0.3 6.7 6.4 14.0 4.3 3.7 8.6 2.3 6.5 1.0 7.4 5.0 3.9 2.8 4.1 6.1 7.4 12.0 3.5 11.3 5.7 0.2 6.0 5.6 3.1 5.8 5.0 6.5 3.1 8.0 1.5 10.6 7.8 4.8 6.3 12.7 4.3 5.8 18.3 3.8 7.0 12.0 6.2 10.7 4.9 3.0 6.1 1.0 15.3 0.3 7.1 2.4 0.5 2.2 3.9 1.1 5.4 3.8 4.4 4.0 0.8 4.5 5.0 5.0 0.8 1.4 0.9 4.7 2.5 0.4 6.4 18.1 10.5 10.0 6.2 10.2 4.4 8.3 18.5 3.2 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell line enriched" "Detected in some" 5 "NTERA-2: 45.5" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 10.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 45.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell line enhanced" "Detected in some" "EFO-21: 8.4;HDLM-2: 16.4;U-87 MG: 9.6" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.1 0.3 0.4 0.0 2.6 0.0 0.0 9.6 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044768 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA071317: " "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavourable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 6.3 6.9 10.8 10.4 11.4 8.3 11.0 10.8 6.6 7.1 7.3 8.4 5.9 9.1 5.6 11.1 8.8 6.2 3.5 5.5 6.3 6.8 5.9 5.5 16.1 6.2 8.1 6.8 7.0 5.5 11.0 7.5 6.3 5.7 9.6 6.1 8.1 4.2 3.1 7.7 7.9 5.8 5.7 11.7 7.0 23.3 3.7 29.8 4.5 4.4 21.0 7.6 7.0 16.4 11.2 15.5 10.6 16.3 23.2 10.7 13.7 7.8 17.5 15.9 4.4 6.1 13.9 13.3 10.9 16.4 15.0 5.6 14.9 17.6 10.0 9.0 14.2 7.7 12.3 24.0 17.8 8.3 17.8 7.2 6.9 3.8 29.7 10.3 4.4 5.5 11.5 10.8 20.7 12.2 18.5 19.4 14.5 22.7 16.0 4.2 18.5 17.3 33.1 13.9 10.5 11.3 13.1 9.0 11.3 33.0 4.2 13.1 12.7 16.5 7.2 6.8 9.8 11.8 13.6 23.7 21.5 15.3 13.4 10.3 15.5 6.6 10.7 14.5 10.6 14.3 16.4 15.7 16.3 10.4 13.5 17.7 18.2 4.5 16.3 9.7 11.2 23.2 10.7 6.9 10.4 11.0 10.8 5.5 6.3 6.2 8.1 6.3 3.7 TDP2 TTRAP ENSG00000111802 "Tyrosyl-DNA phosphodiesterase 2" O95551 6 24649977-24667033 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Hydrolase, Nuclease" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.3;intestine: 55.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.6;neutrophil: 57.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB073398, HPA074011" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nucleoplasm, Nuclear bodies" "CAB073398: , HPA074011: " "unprognostic (2.46e-2)" "unprognostic (2.10e-3)" "unprognostic (1.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.58e-1)" "unprognostic (4.66e-3)" "unprognostic (4.13e-3)" "unprognostic (3.24e-1)" "unprognostic (5.78e-3)" "prognostic favourable (2.53e-7)" "unprognostic (1.20e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.70e-3)" "unprognostic (1.14e-1)" "prognostic favourable (1.47e-5)" 6.8 4.8 8.2 15.4 9.2 3.7 5.6 10.8 7.5 6.1 36.0 3.7 4.9 25.8 4.9 5.2 4.9 4.5 6.2 8.1 6.8 6.9 16.4 10.4 6.5 7.1 7.7 6.3 5.7 5.9 4.4 9.4 5.7 6.5 12.3 27.9 3.6 4.9 4.8 5.0 4.8 55.7 6.1 5.8 6.3 5.1 21.1 5.7 8.2 5.3 4.1 7.3 9.6 7.0 5.3 3.3 57.3 3.9 6.9 8.3 5.7 17.7 14.1 16.1 18.6 25.0 25.6 12.6 15.8 20.3 15.1 20.4 19.3 10.1 21.4 27.8 16.5 13.1 19.6 18.0 20.7 27.3 20.5 20.0 15.0 31.5 15.9 30.6 19.3 17.1 17.0 15.8 14.3 24.4 17.8 9.2 22.7 12.6 23.8 19.6 14.4 12.2 20.7 17.0 22.9 26.0 25.2 20.4 11.7 12.9 32.7 25.8 15.0 17.8 18.2 14.8 12.3 11.0 23.0 13.3 39.1 29.2 10.2 40.4 23.6 15.6 3.5 7.1 6.9 3.7 8.3 5.3 8.0 7.5 3.3 3.5 6.6 7.2 57.3 6.9 3.9 3.1 7.9 5.7 8.2 9.2 10.8 7.5 6.8 6.9 7.7 6.3 6.5 5.7 TDRD3 FLJ21007 ENSG00000083544 "Tudor domain containing 3" Q9H7E2 13 60396457-60573878 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034925, HPA067153" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "CAB034925: AB_2240523, HPA067153: " "unprognostic (8.52e-2)" "unprognostic (3.19e-1)" "unprognostic (2.23e-1)" "prognostic favourable (2.77e-4)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (7.37e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (6.18e-3)" "unprognostic (9.62e-2)" "unprognostic (9.95e-2)" "unprognostic (3.68e-2)" "unprognostic (4.40e-2)" "unprognostic (1.27e-3)" 13.7 12.0 13.0 10.3 14.7 6.9 16.9 13.8 14.2 16.7 17.2 11.7 14.2 12.9 15.2 14.2 16.5 14.4 12.7 16.7 12.9 10.6 16.2 13.5 16.9 11.3 13.5 14.8 20.6 21.3 15.3 15.4 12.4 17.7 15.5 15.5 11.1 12.5 14.8 42.4 15.2 16.7 19.0 16.8 12.9 14.8 15.9 15.0 18.7 16.9 18.6 12.1 19.0 15.4 3.8 7.2 2.3 3.5 3.0 6.9 2.1 4.4 4.9 10.9 25.4 4.4 9.5 6.4 5.1 5.8 6.0 3.9 3.2 7.4 10.9 2.1 7.5 6.3 8.9 7.5 6.5 8.1 6.8 20.2 9.4 6.2 8.5 14.2 10.6 6.4 10.7 3.5 10.6 8.1 4.5 6.6 6.4 4.8 12.6 7.4 8.3 3.8 6.7 5.2 7.2 8.1 5.9 9.6 11.6 7.3 9.0 18.4 4.6 6.2 6.8 3.8 3.9 4.3 5.6 13.3 11.5 9.4 3.6 7.4 11.6 0.5 2.3 2.3 5.5 3.5 3.8 3.8 6.2 6.2 3.3 2.7 5.2 6.4 0.1 3.0 2.5 7.2 6.9 2.1 13.0 14.7 13.8 14.2 12.9 10.6 13.5 14.8 17.7 15.0 TDRD7 PCTAIRE2BP ENSG00000196116 "Tudor domain containing 7" Q8NHU6 9 97411950-97496125 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.0;THP-1: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB020800, HPA022250, HPA024529" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "CAB020800: , HPA022250: , HPA024529: AB_1857869" "unprognostic (8.22e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-3)" "unprognostic (1.03e-1)" "unprognostic (2.88e-1)" "unprognostic (3.07e-1)" "prognostic unfavourable (5.91e-4)" "unprognostic (2.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "prognostic favourable (4.76e-5)" "unprognostic (4.03e-2)" "unprognostic (2.90e-1)" "unprognostic (1.17e-2)" "unprognostic (2.67e-1)" 9.5 7.1 10.6 9.1 11.5 8.9 7.7 7.1 10.2 8.8 12.8 8.9 3.7 14.0 9.8 6.0 10.5 8.2 9.2 5.7 8.6 6.6 6.4 7.3 9.8 7.0 10.2 8.8 8.3 9.7 12.5 9.3 7.9 11.6 7.1 12.7 19.0 8.8 7.0 5.1 6.1 16.5 9.6 12.6 8.8 7.6 31.1 9.8 9.3 7.3 4.7 7.3 12.1 8.6 4.3 4.6 9.8 6.1 1.6 2.9 1.8 8.0 5.6 0.0 1.9 4.3 5.7 4.8 5.1 12.9 17.6 19.8 7.2 6.8 0.5 2.5 7.2 6.2 4.7 2.6 4.7 26.0 4.0 3.6 2.8 5.2 4.0 8.2 8.9 1.9 5.2 5.8 0.6 7.6 2.0 0.4 4.6 4.8 4.0 4.0 0.8 3.0 1.8 2.9 0.1 4.3 5.4 0.9 2.3 7.1 3.2 19.4 1.9 25.8 7.7 2.2 2.2 5.6 3.9 2.7 3.1 0.5 5.2 4.5 5.7 2.4 3.1 9.8 1.7 6.1 2.4 4.3 2.4 1.8 4.6 3.4 1.8 2.9 5.7 1.6 5.8 0.9 1.6 1.8 10.6 11.5 7.1 10.2 8.6 6.6 10.2 8.8 11.6 9.8 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 3.6 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 8.0 6.4 7.4 14.0 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489792-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 41.9" "Cell line enhanced" "Detected in many" "BEWO: 29.5;HBEC3-KT: 14.2;hTCEpi: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favourable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 5.7 9.0 7.7 6.1 13.1 0.5 11.0 10.4 9.2 8.5 4.9 3.6 8.4 2.3 9.4 9.8 5.7 12.9 9.9 3.7 7.4 10.3 14.3 9.4 9.6 3.9 6.3 3.6 13.0 13.7 15.2 11.1 41.9 8.4 12.5 2.8 17.7 6.2 12.3 2.3 3.3 2.8 5.0 4.6 2.6 3.6 8.1 3.2 3.0 22.7 3.2 6.3 9.9 12.8 0.4 0.0 0.0 0.1 0.0 0.2 1.1 4.9 5.0 8.8 0.0 0.0 0.0 29.5 2.9 1.8 2.7 2.5 0.0 0.0 0.0 1.2 0.9 1.1 0.0 14.2 3.5 0.0 0.4 0.0 0.0 7.4 3.4 0.0 2.1 3.4 11.3 0.0 5.3 0.4 0.6 0.0 2.9 0.0 0.0 0.0 10.4 1.0 0.0 0.0 0.0 9.1 7.4 2.6 4.2 0.0 8.9 2.1 2.9 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 7.7 13.1 10.4 7.5 7.4 10.3 6.3 3.6 8.4 3.2 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: , HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavourable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 2.0 10.5 8.5 13.6 10.8 5.2 5.1 10.3 3.3 7.6 10.7 2.0 9.4 5.5 5.0 5.2 4.0 5.5 3.4 10.3 7.4 2.9 4.0 6.2 8.8 7.9 4.6 2.7 6.4 2.5 4.5 7.9 7.1 3.7 3.2 3.9 5.8 4.6 3.9 10.1 8.3 2.1 7.4 5.9 10.6 9.1 9.5 16.0 5.1 7.1 11.8 6.1 3.5 0.8 5.7 1.4 2.2 0.1 3.7 0.7 7.9 18.3 4.3 6.5 0.4 0.7 11.8 6.3 2.5 7.6 7.3 6.6 15.0 12.0 13.3 1.0 21.1 1.5 6.8 1.5 14.1 7.5 3.1 10.1 6.4 0.3 6.1 8.9 0.1 2.2 5.1 1.6 3.0 5.0 15.1 1.2 30.5 12.5 13.8 5.7 19.5 10.3 6.8 8.3 2.1 6.8 12.5 7.3 6.5 7.7 4.6 12.3 6.0 3.7 5.3 9.1 16.3 10.4 8.8 3.7 7.2 6.8 6.9 8.6 0.0 1.2 1.4 1.5 2.2 1.0 0.3 2.2 3.7 1.7 0.8 1.4 0.4 0.4 0.1 2.0 5.7 1.6 0.7 10.5 13.6 5.1 10.3 10.3 7.4 7.9 4.6 7.1 9.5 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460080-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3;testis: 12.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA051394: , HPA055389: " "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavourable (2.43e-5)" "prognostic unfavourable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.8 1.8 2.3 6.2 4.1 9.3 1.1 2.8 4.6 1.2 2.6 0.8 0.0 4.3 1.2 1.4 4.5 1.2 1.4 1.3 2.3 2.7 2.2 1.7 1.0 5.6 2.1 1.9 1.0 1.9 0.3 2.4 3.8 2.0 1.3 2.2 1.0 1.3 0.8 1.0 2.6 3.8 1.1 1.4 2.5 2.2 12.5 0.8 15.3 0.9 4.2 3.9 0.6 2.2 1.2 1.4 0.0 1.0 0.0 2.1 0.7 5.2 16.6 9.5 11.1 0.1 0.6 9.6 4.2 2.5 6.8 6.6 11.4 4.3 7.3 6.9 1.7 8.1 6.9 4.2 1.6 8.1 9.2 6.5 11.7 11.7 0.2 6.3 8.9 0.6 0.5 6.0 1.6 3.1 11.2 2.8 2.3 10.0 11.1 11.8 21.1 6.0 27.1 8.2 16.4 1.4 2.2 9.0 14.8 4.8 5.1 3.6 7.6 7.4 1.1 7.2 10.5 6.9 9.4 6.2 10.1 14.6 3.7 6.4 9.8 0.0 0.0 0.0 0.1 0.1 0.0 0.6 2.1 0.0 0.3 1.2 0.7 1.3 0.0 0.0 1.0 1.4 1.9 0.7 2.3 4.1 2.8 4.6 2.3 2.7 2.1 1.9 2.0 0.8 TEK "CD202b, TIE-2, TIE2, VMCM, VMCM1" ENSG00000120156 "TEK receptor tyrosine kinase" Q02763 9 27109141-27230175 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 35.8;NTERA-2: 17.8;TIME: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010359, HPA073265" Approved Supported "Plasma membrane,Centriolar satellite" "Secreted to blood" 7750000 8300000 "Plasma membrane" "Centriolar satellite" "CAB010359: AB_2203226, HPA073265: " "unprognostic (2.24e-1)" "unprognostic (1.74e-1)" "unprognostic (5.55e-2)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.26e-3)" "prognostic favourable (2.31e-5)" "unprognostic (7.48e-2)" "unprognostic (1.72e-2)" "unprognostic (1.41e-1)" "unprognostic (5.58e-2)" "unprognostic (2.72e-1)" "prognostic favourable (7.81e-4)" "unprognostic (7.50e-3)" "unprognostic (6.87e-3)" "unprognostic (1.83e-1)" "unprognostic (5.24e-3)" 28.6 7.8 8.1 4.6 5.9 0.4 17.9 3.4 5.4 10.8 4.7 4.6 3.4 3.2 14.5 5.3 6.7 5.9 9.1 13.0 7.1 6.1 25.4 8.7 27.8 2.9 6.9 3.4 6.1 4.5 3.5 4.0 36.3 6.9 5.4 4.7 12.4 3.4 5.5 7.8 3.0 5.3 10.6 5.3 23.4 4.0 3.7 3.5 0.3 9.7 8.4 2.4 6.4 12.4 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.6 0.0 0.0 0.7 0.0 0.8 0.3 35.8 0.0 0.0 0.3 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 8.1 5.9 3.4 5.4 7.1 6.1 6.9 3.4 6.9 3.5 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 13.8 11.7 9.2 14.2 9.0 19.3 14.3 21.9 14.9 11.1 11.3 15.7 11.4 17.3 11.7 14.8 12.9 11.8 13.4 9.6 9.9 9.1 9.6 11.1 8.8 14.4 10.2 15.9 12.1 18.5 8.6 10.3 12.1 10.9 12.3 3.6 11.1 18.6 11.0 18.9 23.5 16.2 10.4 8.3 20.7 14.0 9.0 10.4 17.3 10.6 11.2 14.8 10.6 10.5 8.3 8.2 3.2 11.4 3.8 5.1 5.0 8.1 12.2 3.8 7.2 1.5 1.6 14.7 13.0 2.5 6.3 4.6 15.6 7.8 12.0 11.3 2.0 8.6 2.7 4.9 1.2 7.0 23.6 6.9 14.1 9.0 2.5 8.7 10.4 3.1 1.9 5.8 1.2 3.7 17.7 4.3 2.5 27.5 10.2 23.3 12.2 10.3 30.6 5.3 12.2 2.3 7.7 16.0 9.0 11.2 10.7 4.0 9.9 10.5 5.8 13.7 9.6 13.2 10.7 7.9 5.0 21.9 4.3 12.3 11.4 0.0 6.8 3.2 5.1 8.6 5.1 5.4 3.6 4.3 8.2 8.3 4.2 3.2 0.5 3.8 11.4 5.0 3.3 5.0 9.2 9.0 21.9 14.9 9.9 9.1 10.2 15.9 10.9 10.4 TEP1 "p240, TLP1, TP1, TROVE1, VAULT2" ENSG00000129566 "Telomerase associated protein 1" Q99973 14 20365667-20413429 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029206 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029206: AB_10601271" "unprognostic (4.53e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "prognostic favourable (9.58e-4)" "unprognostic (2.27e-1)" "unprognostic (2.76e-1)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (6.81e-2)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.18e-1)" "unprognostic (6.18e-2)" "unprognostic (3.00e-1)" 14.7 10.4 5.4 22.0 8.7 4.5 11.4 5.8 6.6 8.9 24.1 11.2 7.7 27.7 12.9 11.3 9.4 7.9 15.7 9.3 6.3 3.5 9.4 9.2 14.1 15.0 7.7 3.0 9.2 8.7 28.2 11.7 7.0 7.3 10.8 18.1 8.1 11.4 8.3 13.4 10.0 38.3 10.9 12.2 19.5 11.1 3.6 8.7 14.2 11.2 6.6 20.8 9.7 10.9 4.2 8.3 7.8 4.4 0.9 1.8 0.5 7.3 2.9 3.4 3.6 20.7 8.6 5.8 4.9 4.6 3.0 4.2 6.3 7.7 5.7 3.4 14.0 7.2 2.7 9.9 5.3 7.2 2.8 6.9 6.4 4.2 6.2 5.7 12.6 12.0 9.4 6.2 4.8 14.0 2.4 4.6 11.0 4.4 4.3 4.0 1.3 2.7 9.5 8.1 2.0 10.2 10.5 1.0 1.4 3.9 10.1 3.2 5.5 3.9 14.3 12.0 8.5 4.4 1.4 10.3 5.9 3.7 2.8 5.4 4.4 4.1 4.0 0.2 1.8 4.4 1.7 2.9 0.8 1.6 1.3 4.2 0.9 1.1 7.8 0.9 4.4 8.3 1.3 0.5 5.4 8.7 5.8 6.6 6.3 3.5 7.7 3.0 7.3 8.7 TEPSIN "C17orf56, ENTHD2, FLJ31528" ENSG00000167302 "TEPSIN, adaptor related protein complex 4 accessory protein" Q96N21 17 81228277-81239091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063410 Supported "Nuclear membrane,Nuclear speckles,Golgi apparatus" "Nuclear membrane, Nuclear speckles, Golgi apparatus" "HPA063410: " "unprognostic (6.90e-3)" "unprognostic (1.03e-2)" "unprognostic (4.26e-2)" "unprognostic (3.64e-2)" "unprognostic (1.00e-1)" "prognostic favourable (9.96e-4)" "unprognostic (1.16e-2)" "unprognostic (4.85e-2)" "unprognostic (8.52e-2)" "unprognostic (2.29e-1)" "prognostic favourable (6.95e-4)" "unprognostic (4.99e-2)" "prognostic unfavourable (7.31e-8)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (3.58e-1)" "unprognostic (3.16e-3)" 8.5 6.7 8.0 11.9 8.5 17.3 21.3 11.9 9.8 6.0 9.9 9.0 7.3 14.9 7.9 8.6 8.8 8.0 6.6 4.9 8.8 4.7 9.8 13.3 12.5 13.5 12.5 6.3 6.8 11.1 5.3 9.2 7.7 9.8 10.1 6.5 4.8 9.1 9.3 12.4 15.8 12.4 9.8 8.5 17.0 9.7 9.1 9.8 12.2 12.6 7.5 9.0 7.2 7.0 3.0 2.7 7.6 2.9 0.7 1.8 1.2 8.7 12.9 5.0 8.1 3.5 5.8 10.0 7.8 4.4 7.8 7.2 8.3 6.2 6.3 4.4 5.2 11.4 5.2 6.6 3.8 3.8 17.1 5.2 7.2 11.9 5.2 5.6 10.9 3.0 8.6 3.6 4.1 12.4 6.4 6.2 5.0 7.6 10.5 13.0 5.5 11.1 6.6 6.6 6.9 3.0 5.6 6.7 7.8 9.3 10.2 10.7 6.9 10.1 7.9 10.6 6.1 8.1 7.4 8.4 5.8 4.7 7.8 4.8 5.2 4.2 2.4 7.6 1.8 2.9 1.1 2.5 1.2 1.4 2.7 3.0 0.8 0.8 4.3 0.7 1.9 2.7 1.6 1.2 8.0 8.5 11.9 9.8 8.8 4.7 12.5 6.3 9.8 9.8 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TERF1 "PIN2, TRBF1, TRF, TRF1" ENSG00000147601 "Telomeric repeat binding factor 1" P54274 8 73008864-73048122 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048379 Approved "Nucleoli fibrillar center,Nuclear bodies" "Nucleoli fibrillar center" "Nuclear bodies" "HPA048379: " "unprognostic (1.02e-2)" "unprognostic (1.66e-1)" "unprognostic (7.24e-2)" "unprognostic (2.42e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (6.53e-2)" "unprognostic (9.55e-2)" "unprognostic (1.52e-1)" "unprognostic (8.18e-2)" "prognostic unfavourable (6.68e-4)" "unprognostic (2.34e-3)" "unprognostic (1.04e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" 16.3 21.9 28.1 11.6 23.9 24.3 16.6 48.4 31.0 17.0 15.1 14.0 22.2 13.3 21.5 15.0 14.3 17.9 15.6 17.2 26.4 20.6 24.8 20.0 13.0 16.2 20.7 26.0 30.9 13.1 24.9 32.2 15.5 20.3 23.4 14.7 10.6 15.2 21.0 13.0 12.0 13.0 23.7 24.2 12.6 18.6 15.3 23.6 20.6 20.9 10.4 14.3 22.7 20.5 15.5 14.5 14.8 8.5 12.7 16.2 7.3 13.1 12.5 17.5 11.1 12.3 8.2 11.4 13.3 8.2 12.7 11.0 9.1 10.3 7.2 17.3 7.8 11.5 18.9 9.5 12.9 10.2 18.8 15.3 6.6 8.6 7.7 7.4 12.5 8.8 7.2 10.0 15.3 11.6 12.6 11.7 8.7 8.4 23.2 9.8 51.5 12.0 17.0 7.9 6.5 16.6 7.5 12.0 13.3 12.8 40.8 12.3 16.7 7.0 9.1 7.3 11.7 13.9 10.8 10.4 10.0 13.4 9.4 10.0 14.3 11.3 7.7 14.8 15.4 7.3 12.9 15.5 13.7 15.4 9.1 15.1 16.2 16.0 6.9 12.7 8.5 14.5 13.3 7.3 28.1 23.9 48.4 31.0 26.4 20.6 20.7 26.0 20.3 23.6 TERF2 "TRBF2, TRF2" ENSG00000132604 "Telomeric repeat binding factor 2" Q15554 16 69355561-69408571 "Predicted intracellular proteins" "Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001907, HPA002735, CAB010451" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898" "unprognostic (2.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.13e-2)" "unprognostic (6.07e-2)" "unprognostic (3.45e-2)" "unprognostic (3.42e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.00e-1)" "unprognostic (5.79e-2)" "unprognostic (2.92e-1)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" 15.6 14.9 22.1 18.2 24.4 16.1 14.1 32.2 30.0 16.2 15.2 20.0 13.3 13.4 19.2 16.4 15.3 16.1 14.0 14.7 21.2 22.1 13.2 14.9 12.6 32.6 19.6 21.6 20.5 22.2 26.9 13.4 15.8 17.1 15.5 15.0 14.5 12.0 15.3 28.9 15.3 13.6 19.6 17.3 14.9 12.6 15.8 16.5 23.0 16.9 9.6 42.2 17.2 21.5 15.2 5.4 11.2 4.1 4.9 7.5 2.9 8.0 13.2 11.9 12.0 11.4 8.5 10.2 8.3 10.4 19.7 15.3 12.0 11.1 37.2 11.3 10.2 13.1 14.5 10.1 18.5 6.9 11.5 10.7 7.0 10.9 9.7 10.6 9.1 8.6 10.3 15.7 19.3 13.5 20.2 5.4 12.7 11.0 21.0 13.6 13.8 6.4 29.5 7.9 21.4 8.5 6.0 13.6 10.6 27.5 6.3 7.4 11.9 12.4 8.2 12.4 10.9 8.5 9.8 14.5 15.2 47.0 10.7 9.6 11.9 11.2 4.1 4.5 6.8 3.4 5.1 15.2 6.8 5.9 4.1 8.7 7.5 7.5 4.7 4.9 3.5 5.4 5.2 2.9 22.1 24.4 32.2 30.0 21.2 22.1 19.6 21.6 17.1 16.5 TERF2IP RAP1 ENSG00000166848 "TERF2 interacting protein" Q9NYB0 16 75647786-75761872 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006719, CAB018660, CAB018749" Supported Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267" "unprognostic (3.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.06e-3)" "unprognostic (7.83e-2)" "unprognostic (3.30e-1)" "unprognostic (1.99e-2)" "unprognostic (2.33e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-2)" "prognostic favourable (6.14e-5)" "prognostic favourable (1.46e-4)" "unprognostic (1.81e-1)" "prognostic favourable (2.15e-5)" "unprognostic (6.26e-2)" "unprognostic (1.85e-1)" "unprognostic (5.30e-2)" "unprognostic (2.99e-1)" 22.5 45.0 51.0 17.9 71.8 35.3 18.2 70.1 64.9 20.9 12.6 30.5 12.5 12.5 21.7 28.3 13.6 17.4 17.2 30.0 44.2 68.4 21.5 19.6 17.2 28.4 47.5 53.5 30.9 16.7 37.6 41.8 12.6 48.3 23.4 13.0 18.9 15.5 22.3 18.5 15.1 12.7 18.5 39.4 22.3 14.0 24.3 32.5 20.5 26.2 10.5 27.6 16.2 15.6 20.4 8.9 40.5 12.4 17.1 23.9 7.2 6.4 6.1 13.8 10.6 15.7 16.5 4.3 19.7 17.0 16.8 12.5 6.7 7.1 33.1 26.4 13.2 9.4 13.6 5.6 14.3 12.4 19.8 16.8 9.5 15.3 20.6 22.6 24.1 14.0 16.0 13.4 20.9 11.2 19.6 14.0 19.2 19.0 27.3 29.0 6.9 14.2 31.0 8.9 27.2 12.5 6.0 33.6 20.3 25.6 6.0 15.6 13.8 22.3 12.3 16.1 8.5 13.9 15.0 58.6 51.0 46.5 16.9 15.5 15.2 20.2 9.1 40.5 13.1 8.0 16.3 16.9 20.1 21.6 8.9 20.4 23.9 15.4 14.6 17.1 12.4 8.7 18.6 7.2 51.0 71.8 70.1 58.6 44.2 68.4 47.5 53.5 48.3 32.5 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: , HPA065897: " "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 30.6 61.2 0.5 0.0 23.3 4.2 7.9 0.1 0.1 0.7 0.0 58.1 0.0 0.2 118.1 5.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.0 3.0 74.6 0.8 0.2 0.6 0.1 33.7 0.0 0.2 1.6 0.4 0.2 0.8 0.0 0.8 3.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 96.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 TES "DKFZP586B2022, TESS-2, TESTIN" ENSG00000135269 "Testin LIM domain protein" Q9UGI8 7 116210493-116258783 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 50.9;hTCEpi: 57.6;SK-BR-3: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA015269, HPA018123" Approved Supported "Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" "Plasma membrane, Cell Junctions" "HPA015269: AB_1857899, HPA018123: AB_1857900" "unprognostic (9.81e-2)" "unprognostic (5.53e-3)" "unprognostic (4.79e-2)" "unprognostic (1.31e-1)" "unprognostic (4.01e-1)" "unprognostic (6.08e-3)" "unprognostic (1.84e-3)" "unprognostic (4.81e-3)" "unprognostic (8.81e-3)" "unprognostic (6.19e-3)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.60e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.50e-1)" "unprognostic (5.47e-2)" "unprognostic (2.36e-2)" "unprognostic (3.86e-1)" 12.1 2.9 1.2 36.4 1.5 8.6 22.1 0.8 1.2 42.4 53.1 1.5 43.9 9.3 47.6 21.2 22.6 19.5 15.3 7.9 1.6 1.4 14.3 4.6 16.8 20.3 1.9 0.7 17.1 12.3 3.1 4.2 21.2 3.3 26.1 16.8 5.0 19.0 50.9 5.2 9.1 27.4 84.5 3.0 19.1 25.2 18.4 0.7 17.1 26.3 11.2 18.4 71.6 33.9 26.8 21.9 56.8 39.6 49.0 40.5 34.7 24.2 5.1 5.8 0.0 2.6 6.6 13.7 12.7 6.2 2.3 2.3 12.8 27.0 0.0 50.9 8.8 24.9 3.1 18.6 5.8 12.0 10.0 2.4 12.0 6.3 15.6 11.0 0.0 14.8 57.6 8.2 20.9 6.6 2.4 8.6 0.6 5.0 0.0 0.1 3.8 14.7 0.0 0.0 9.5 24.0 9.3 2.7 25.2 18.5 57.8 14.0 0.0 4.5 11.2 0.1 0.3 18.7 0.1 20.3 9.8 0.2 1.6 5.6 19.2 56.8 20.2 53.4 40.5 32.6 39.0 26.8 31.0 36.6 21.9 23.8 31.0 35.0 10.5 49.0 39.6 5.4 31.5 34.7 1.2 1.5 0.8 1.2 1.6 1.4 1.9 0.7 3.3 0.7 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.8;salivary gland: 92.6" "Cell line enhanced" "Detected in many" "HMC-1: 64.5;NB-4: 103.7;U-937: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 55.8" "Lineage enriched" "Detected in all" 5 "monocytes: 55.8" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053200: " "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 1.8 8.4 5.0 2.4 12.1 25.5 2.3 1.2 6.8 1.8 1.2 1.8 19.4 1.8 1.3 32.9 1.3 1.3 45.8 13.2 6.2 2.2 4.6 1.9 2.9 1.8 2.4 3.3 1.5 40.5 0.7 4.0 2.5 2.2 2.5 0.7 0.3 92.6 24.4 1.3 1.8 1.7 1.4 1.6 2.7 34.4 5.0 2.2 1.2 2.1 1.2 2.5 6.5 2.3 1.9 8.5 11.3 55.8 2.5 2.3 3.9 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.3 0.7 0.0 0.1 1.2 0.0 0.0 6.3 4.1 17.7 1.4 12.1 0.0 7.5 64.5 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.3 14.6 103.7 1.4 0.0 0.0 0.0 8.3 8.9 2.3 2.7 0.9 0.0 0.0 0.5 0.0 8.1 0.0 0.0 0.2 0.0 0.0 2.7 6.1 0.0 0.0 34.4 0.0 0.0 11.9 11.3 1.8 14.9 0.1 1.3 0.6 2.3 8.5 1.9 0.0 1.0 3.0 2.5 55.8 0.6 0.7 3.9 5.0 12.1 1.2 6.8 6.2 2.2 2.4 3.3 2.2 2.2 TET1 "bA119F7.1, CXXC6, KIAA1676, LCX" ENSG00000138336 "Tet methylcytosine dioxygenase 1" Q8NFU7 10 68560656-68694482 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 15.1;HAP1: 17.2;K-562: 9.6;NTERA-2: 10.1" "Cancer enriched" "Detected in some" 15 "testis cancer: 10.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019032, HPA057273" Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA019032: AB_1847363, HPA057273: " "unprognostic (1.60e-1)" "unprognostic (8.30e-2)" "unprognostic (9.85e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (8.15e-2)" "unprognostic (3.60e-3)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (7.90e-3)" "unprognostic (1.83e-1)" "unprognostic (1.71e-1)" "unprognostic (1.18e-3)" "unprognostic (2.88e-4)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (9.52e-3)" 4.4 1.6 3.3 4.3 2.6 1.6 3.1 4.4 4.3 5.1 2.4 5.8 3.2 1.2 6.0 3.4 2.4 2.9 3.5 2.4 3.5 2.3 1.8 1.5 1.6 1.7 2.5 2.6 6.1 1.6 7.4 2.2 5.8 2.9 3.2 2.0 8.1 15.9 4.8 4.0 2.2 1.8 6.5 3.6 1.7 2.2 1.4 5.9 1.2 3.2 3.2 1.8 5.1 5.4 1.3 1.1 1.0 0.0 0.9 2.3 0.2 0.6 0.7 6.8 7.7 0.7 0.6 15.1 0.3 0.8 0.6 1.1 4.6 0.2 0.0 0.2 0.7 0.0 17.2 0.0 0.7 0.2 2.7 1.8 0.0 4.0 1.0 1.5 0.9 0.9 0.1 0.4 0.0 0.1 9.6 1.2 0.6 0.5 2.7 1.2 10.1 0.9 2.6 2.2 0.2 0.3 0.7 1.9 3.0 0.3 0.4 1.4 0.9 1.2 0.2 0.6 1.4 0.0 0.5 0.5 0.5 2.7 0.1 0.0 0.1 0.0 0.0 1.0 1.5 0.0 2.0 1.3 0.8 1.3 0.2 0.5 1.4 1.1 0.0 0.9 0.0 1.1 2.3 0.2 3.3 2.6 4.4 2.6 3.5 2.3 2.5 2.6 2.9 5.9 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA050845: " "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.1 5.4 10.4 6.3 0.9 1.0 19.1 1.3 1.7 2.5 1.9 11.6 5.8 10.3 2.5 1.7 6.6 9.2 3.6 2.6 4.4 3.6 13.2 4.5 3.9 3.8 13.8 8.2 1.5 9.7 3.0 7.2 3.7 9.0 3.4 1.4 10.2 6.8 9.0 5.8 1.9 10.3 6.5 3.6 2.7 11.5 13.0 11.1 2.8 7.4 3.5 4.7 11.2 4.7 2.6 11.2 1.2 4.6 3.0 1.3 9.0 1.7 9.7 3.4 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell line enhanced" "Detected in some" "HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA030620: AB_10601598, HPA077020: " "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.5 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.2 8.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 0.1 11.6 0.0 4.7 0.4 0.1 0.6 0.1 0.5 0.4 1.7 0.0 0.1 1.4 0.2 0.0 0.0 0.6 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Cell line enhanced" "Detected in some" "HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036800 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 8.7 1.1 0.0 1.1 3.1 19.7 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.1 0.1 0.1 3.7 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 19.9 18.9 13.3 16.8 40.6 20.7 15.0 23.1 22.1 27.0 17.1 22.2 16.6 16.3 8.8 40.6 15.1 25.2 27.6 39.3 12.3 21.0 19.5 9.8 23.4 23.9 22.7 16.4 18.6 18.5 25.9 17.7 27.4 24.2 10.9 31.5 15.7 19.5 12.6 8.8 22.4 13.9 41.1 14.0 19.6 17.5 21.8 11.5 24.0 24.0 15.1 15.6 13.5 21.9 33.2 28.8 17.7 30.7 8.5 7.5 19.4 29.0 30.0 27.8 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Secreted - unknown location" "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favourable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favourable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 15.7 34.6 15.1 15.3 18.7 9.0 20.0 8.6 22.8 17.5 21.3 15.0 36.0 18.7 20.1 25.5 17.7 21.9 24.8 19.0 14.6 15.6 35.9 30.7 17.0 22.6 15.7 17.9 15.8 29.0 29.9 12.3 24.5 12.2 20.3 16.7 22.6 43.6 44.3 16.3 29.5 20.8 16.6 15.8 18.6 19.0 90.8 11.5 16.6 33.9 18.5 15.9 16.7 16.3 33.1 34.5 24.7 36.7 22.8 50.7 41.1 11.7 21.6 3.8 19.9 40.4 19.7 7.9 10.1 24.0 16.9 17.1 11.6 28.0 17.0 7.4 14.5 11.5 11.0 20.5 8.2 13.6 17.5 16.2 13.5 15.3 36.1 10.2 18.2 25.9 32.7 19.1 19.6 12.3 8.5 29.6 17.3 13.6 16.2 23.6 4.2 24.3 7.9 5.1 32.0 26.6 16.4 5.6 9.1 12.4 34.3 15.6 16.7 21.5 9.0 17.0 7.1 17.8 13.4 20.7 22.3 8.3 20.9 21.4 16.9 24.7 36.7 21.7 41.9 36.7 41.9 32.2 43.5 39.7 34.5 33.1 36.5 37.0 7.7 22.8 34.7 30.5 50.7 41.1 15.1 18.7 8.6 22.8 14.6 15.6 15.7 17.9 12.2 11.5 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 49.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8" "Group enriched" "Detected in many" 11 "B-cells: 14.4;granulocytes: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.7 5.4 5.3 9.0 14.8 2.0 7.6 4.0 2.3 7.0 4.6 7.8 6.0 8.5 5.7 11.6 7.3 21.6 6.2 1.6 6.1 7.5 11.9 1.2 5.8 4.1 4.0 3.2 7.5 4.1 13.5 49.7 1.0 25.2 5.4 3.5 9.2 9.0 4.5 0.9 4.1 9.6 2.3 4.9 5.5 9.0 19.3 4.0 2.0 14.8 2.0 8.2 2.7 2.2 14.4 0.3 4.1 0.6 0.4 0.8 0.8 5.7 5.2 11.6 10.3 2.9 8.4 1.5 1.3 4.8 3.6 4.4 1.4 5.1 11.5 5.5 0.9 5.2 4.9 5.4 4.2 1.4 6.0 6.6 5.3 3.8 0.9 3.0 1.3 4.6 10.1 4.1 3.1 0.1 3.7 1.3 1.9 3.2 4.7 2.6 5.6 2.3 1.9 5.4 4.2 12.1 3.3 18.5 7.4 6.4 3.9 4.0 11.0 3.4 0.6 15.5 4.7 5.0 4.6 1.6 11.7 8.8 6.1 1.3 3.0 4.1 0.1 0.1 0.3 0.6 0.1 14.4 0.4 0.3 0.2 6.8 0.2 0.8 0.3 0.4 0.3 0.3 0.5 0.8 5.3 14.8 4.0 2.3 6.1 7.5 4.0 3.2 25.2 4.0 TFAP4 "AP-4, bHLHc41" ENSG00000090447 "Transcription factor AP-4" Q01664 16 4257186-4273075 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001912 Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA001912: AB_1080251" "unprognostic (1.61e-2)" "unprognostic (1.36e-1)" "unprognostic (5.10e-2)" "unprognostic (4.42e-3)" "unprognostic (8.61e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (3.32e-4)" "unprognostic (8.05e-2)" "unprognostic (8.97e-2)" "unprognostic (4.60e-1)" "unprognostic (5.75e-2)" "unprognostic (7.68e-2)" "prognostic unfavourable (4.31e-6)" "unprognostic (1.08e-2)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "unprognostic (1.30e-1)" 8.2 7.0 9.6 11.8 9.6 3.4 7.3 31.6 15.6 10.0 6.8 6.6 5.7 11.1 10.1 3.7 9.9 12.5 7.0 4.8 8.0 6.3 4.4 6.3 5.5 11.1 11.1 7.1 18.7 22.2 6.3 6.7 6.9 8.8 9.0 3.9 6.1 13.2 7.0 8.6 12.2 10.1 5.5 12.8 10.2 8.3 3.1 14.9 13.0 8.4 4.5 7.3 7.4 11.0 1.7 0.5 0.9 0.1 0.1 1.2 1.0 7.0 7.4 6.4 9.3 2.7 7.2 10.6 2.7 7.2 4.8 5.2 3.7 11.1 24.1 7.2 2.6 10.4 11.7 9.4 1.5 14.1 8.3 7.4 6.9 9.9 3.8 12.9 4.3 6.7 6.1 5.2 14.6 3.1 13.6 6.4 1.8 11.0 18.2 21.4 14.6 9.8 16.0 14.3 25.0 1.8 5.3 13.2 10.0 9.2 9.7 9.0 4.8 10.2 2.0 6.5 5.1 22.8 7.1 10.6 8.7 20.3 4.4 12.9 4.5 0.0 0.0 0.9 0.4 0.0 1.2 1.7 0.2 0.0 0.3 0.4 0.3 0.7 0.0 0.1 0.1 0.5 0.2 1.0 9.6 9.6 31.6 15.6 8.0 6.3 11.1 7.1 8.8 14.9 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093663-51173134 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA070247: " "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 17.4 16.7 21.1 29.3 21.6 9.6 17.7 22.7 21.6 20.2 19.0 20.5 20.8 15.7 19.3 18.9 16.7 21.1 20.7 17.7 20.0 18.7 17.2 12.5 14.1 20.4 19.4 24.9 20.8 14.6 29.2 23.2 22.4 15.4 20.3 21.7 16.4 17.8 19.0 26.6 15.4 15.9 23.8 21.3 18.4 16.1 11.2 18.6 32.1 17.9 12.9 25.9 19.0 18.1 4.5 8.2 9.1 9.4 9.4 6.1 5.0 7.4 12.8 19.2 17.2 11.0 13.9 28.2 14.5 7.8 12.7 7.5 24.4 16.0 0.6 12.7 12.6 14.3 24.5 15.5 12.7 16.0 14.2 22.5 12.3 10.2 9.2 25.5 21.9 9.5 14.1 13.1 20.9 11.8 22.8 0.0 13.4 0.0 23.0 16.9 27.8 23.3 17.8 10.6 0.1 16.6 17.9 18.3 16.0 17.9 14.7 11.7 5.5 21.3 11.9 11.7 12.7 12.1 12.5 13.9 23.5 0.0 11.1 15.9 8.4 9.1 9.2 9.0 3.9 7.7 6.1 4.5 4.1 4.2 8.2 3.4 4.9 4.0 3.5 9.4 9.4 3.5 5.4 5.0 21.1 21.6 22.7 19.4 20.0 18.7 19.4 24.9 15.4 18.6 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell line enhanced" "Detected in some" "BEWO: 11.1;HEL: 9.2;hTCEpi: 10.6;RPTEC TERT1: 26.2;RT4: 18.9;SCLC-21H: 8.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favourable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.2 2.7 2.6 0.0 0.0 1.9 9.2 0.0 0.0 0.0 0.0 0.3 0.0 10.6 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.2 26.2 18.9 8.1 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 TFDP1 "DILC, Dp-1, DP1, DRTF1" ENSG00000198176 "Transcription factor Dp-1" Q14186 13 113584721-113641470 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.4" "Low lineage specificity" "Detected in all" "CAB033605, HPA044754, HPA068909" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB033605: AB_783105, HPA044754: , HPA068909: " "unprognostic (4.28e-2)" "unprognostic (9.50e-3)" "unprognostic (1.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.01e-2)" "unprognostic (2.10e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (5.50e-3)" "unprognostic (1.68e-2)" "unprognostic (3.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.43e-2)" "prognostic favourable (7.57e-4)" "prognostic favourable (6.17e-4)" "unprognostic (2.30e-1)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" 16.0 13.3 20.1 28.0 21.1 71.6 16.4 24.4 22.4 19.3 19.6 16.3 28.6 16.0 16.8 20.5 36.2 18.0 27.0 26.3 19.0 16.8 17.9 20.9 16.5 32.5 18.0 12.7 14.4 26.7 9.9 16.3 21.8 15.2 16.0 23.0 20.2 18.9 24.2 26.9 22.3 21.3 18.4 23.5 25.6 16.4 37.5 10.3 38.8 21.7 32.7 34.4 18.5 20.8 3.6 4.7 20.4 4.0 1.6 5.4 2.0 62.0 15.3 19.8 16.8 26.9 24.0 22.5 35.0 31.8 45.5 42.1 31.8 29.2 57.9 11.7 33.5 29.9 34.3 31.1 44.7 39.4 39.9 33.6 25.0 19.9 16.9 84.3 29.7 19.8 28.0 28.8 16.8 30.5 27.6 15.6 40.4 21.3 37.0 32.8 18.2 19.7 25.3 17.6 33.1 17.3 23.8 51.2 15.1 15.7 43.2 10.5 29.7 68.0 21.2 14.8 23.6 31.3 38.5 13.3 16.3 59.7 33.0 52.3 25.0 20.4 2.3 3.6 2.6 3.0 2.9 3.6 3.5 3.1 4.7 2.6 5.4 2.7 3.1 1.6 4.0 2.4 4.2 2.0 20.1 21.1 24.4 22.4 19.0 16.8 18.0 12.7 15.2 10.3 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell line enhanced" "Detected in all" "MOLT-4: 80.4;REH: 42.8;U-698: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favourable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favourable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.1 9.6 4.2 4.3 5.6 5.4 3.5 10.1 1.2 8.8 4.8 80.4 3.1 9.9 4.0 42.8 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.5 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 TFE3 "bHLHe33, TFEA" ENSG00000068323 "Transcription factor binding to IGHM enhancer 3" P19532 X 49028726-49043486 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023881 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023881: AB_1857931" "unprognostic (2.68e-2)" "unprognostic (2.89e-3)" "unprognostic (2.40e-2)" "unprognostic (5.36e-2)" "unprognostic (2.71e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (6.03e-5)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (4.32e-2)" "unprognostic (5.41e-2)" "unprognostic (1.16e-1)" "prognostic unfavourable (2.19e-8)" "unprognostic (1.93e-1)" "unprognostic (8.77e-2)" "unprognostic (4.19e-2)" "unprognostic (6.25e-1)" 31.3 20.9 12.6 18.2 14.4 22.6 53.1 16.5 18.1 22.6 17.7 16.6 30.0 9.9 22.8 21.9 20.5 18.8 16.4 15.1 11.3 11.8 21.6 14.1 22.8 10.3 13.2 9.4 24.4 15.9 16.5 16.3 22.0 15.9 21.2 10.4 15.7 12.6 30.6 13.6 14.1 13.5 21.2 14.8 23.0 14.7 10.4 15.2 4.2 21.7 10.8 10.5 28.6 20.5 1.2 1.9 10.5 4.4 0.4 1.4 1.6 11.9 15.3 5.1 14.8 16.7 15.1 5.1 15.7 18.2 16.1 13.8 9.4 9.5 4.5 6.7 23.1 9.8 9.7 14.2 13.0 9.8 5.2 4.1 11.4 8.7 22.5 4.3 10.2 13.1 9.2 26.3 18.9 7.7 7.9 19.7 13.7 7.0 2.8 4.0 13.9 13.8 4.3 8.9 10.2 10.2 5.5 4.9 4.9 16.8 7.2 5.5 10.3 3.9 16.3 17.6 18.9 17.6 8.6 12.1 11.4 3.7 21.0 5.3 12.0 0.0 3.5 1.6 0.5 4.3 0.9 0.6 0.9 0.5 1.9 1.2 0.6 0.4 10.5 0.4 4.4 0.4 1.4 1.6 12.6 14.4 16.5 14.9 11.3 11.8 13.2 9.4 15.9 15.2 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell line enhanced" "Detected in some" "MCF7: 32.1;SCLC-21H: 9.8;T-47d: 15.0;TIME: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Region enriched" "Detected in single" 8 "olfactory region: 1.0" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" 2090000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: " "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favourable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.1 0.0 0.5 0.1 4.8 0.0 3.6 0.4 0.0 0.0 9.8 0.1 0.0 1.0 0.0 15.0 0.0 41.7 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "TRK-fused gene" Q92734 3 100709331-100748966 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: " "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavourable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 36.4 40.3 27.2 21.9 33.8 29.7 31.0 28.1 40.5 31.2 34.7 33.3 44.2 52.5 31.2 45.8 46.7 29.0 40.8 46.2 28.1 30.7 44.6 68.6 29.9 25.4 28.2 21.5 33.5 49.2 52.3 45.1 63.3 33.7 27.5 40.7 31.9 39.6 45.8 38.6 31.0 67.1 37.5 31.7 28.3 28.9 33.5 23.0 27.6 43.6 42.9 41.2 29.5 30.1 25.8 27.8 43.2 28.4 27.7 26.8 21.8 48.4 26.4 32.9 20.9 41.6 47.2 40.7 35.1 47.3 45.9 54.8 33.3 24.2 6.5 25.8 43.6 36.4 35.4 40.1 54.7 29.8 20.8 24.4 20.3 30.9 46.5 18.0 14.6 38.6 54.1 27.5 48.5 40.6 17.5 18.1 47.4 33.9 15.8 14.3 31.3 39.8 14.0 19.3 21.1 55.7 32.7 26.0 23.8 23.1 30.1 40.9 35.4 24.4 27.1 27.8 33.6 12.8 25.4 15.4 15.5 23.3 44.4 19.7 32.6 43.2 28.3 27.0 21.8 28.4 26.4 25.8 22.6 24.4 27.8 22.9 21.6 21.6 18.7 27.7 26.4 19.4 26.8 21.8 27.2 33.8 28.1 40.5 28.1 30.7 28.2 21.5 33.7 23.0 TFIP11 "DKFZP434B194, Spp382, TIP39" ENSG00000100109 "Tuftelin interacting protein 11" Q9UBB9 22 26491225-26512505 "Plasma proteins, Predicted intracellular proteins" "Biomineralization, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027085 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027085: AB_1857964" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (4.87e-2)" "unprognostic (9.14e-2)" "unprognostic (3.24e-2)" "unprognostic (3.86e-2)" "unprognostic (6.28e-2)" "unprognostic (2.63e-1)" "unprognostic (1.76e-1)" "unprognostic (3.01e-1)" "unprognostic (4.38e-2)" "unprognostic (2.34e-1)" "unprognostic (2.96e-3)" "unprognostic (1.46e-2)" "unprognostic (9.24e-2)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" 11.8 13.5 12.7 12.7 13.8 43.9 10.9 13.8 15.4 9.4 9.5 13.1 8.9 9.9 11.8 8.9 14.5 10.7 10.3 11.8 13.2 9.6 12.3 24.7 11.0 17.7 15.5 12.0 10.3 16.3 11.1 12.0 11.5 12.2 10.5 9.8 11.9 10.9 8.7 34.2 16.3 12.7 10.2 10.6 17.8 11.1 40.6 12.3 23.8 15.4 11.0 19.0 11.1 11.5 23.8 15.5 35.4 23.8 19.6 25.5 17.8 10.9 12.9 11.2 12.6 18.0 10.9 11.3 13.5 17.2 21.1 20.0 9.8 8.0 21.4 8.4 16.7 16.3 16.0 13.0 15.7 15.6 15.2 13.1 8.3 9.9 16.5 30.4 16.9 13.9 17.6 20.0 15.8 16.1 17.7 20.5 14.1 13.4 13.8 16.7 10.8 10.8 21.0 17.3 18.9 12.2 11.1 8.5 12.3 16.1 11.6 15.8 9.4 14.5 15.8 17.8 29.2 11.2 12.3 15.1 19.3 42.4 14.1 12.3 13.2 35.4 16.9 28.6 23.8 18.2 22.1 22.9 21.1 22.2 15.5 23.8 20.2 18.4 26.8 19.6 23.8 9.7 25.5 17.8 12.7 13.8 13.8 15.4 13.2 9.6 15.5 12.0 12.2 12.3 TFPI "EPI, LACI, TFI, TFPI1" ENSG00000003436 "Tissue factor pathway inhibitor" P10646 2 187464230-187565760 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.2;placenta: 192.3" "Cell line enhanced" "Detected in many" "HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.5;plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005575, CAB020842" Supported Approved "Intermediate filaments,Cytosol" "Secreted to blood" 95000000 Cytosol "Intermediate filaments" "CAB020842: , HPA005575: AB_1080290" "unprognostic (8.75e-2)" "prognostic unfavourable (2.02e-4)" "unprognostic (7.95e-2)" "unprognostic (4.99e-2)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (3.05e-1)" "unprognostic (5.63e-2)" "unprognostic (3.86e-3)" "unprognostic (9.22e-2)" "unprognostic (2.43e-2)" "unprognostic (2.72e-2)" "unprognostic (7.05e-2)" "unprognostic (3.39e-3)" "unprognostic (4.05e-2)" "unprognostic (4.49e-2)" "unprognostic (5.81e-2)" 52.8 5.0 1.3 5.2 2.2 1.6 18.5 1.9 2.4 22.8 32.1 0.3 7.2 12.8 13.3 14.8 25.9 12.5 15.0 14.0 1.2 1.1 35.6 98.2 89.7 40.2 2.4 1.0 17.3 7.7 0.9 4.9 192.3 2.3 18.2 6.9 3.8 6.0 3.8 15.8 6.6 37.0 13.6 5.4 16.5 7.7 13.7 1.6 3.4 22.6 10.4 4.0 30.0 14.7 1.5 5.1 5.5 0.6 1.0 0.6 4.9 5.0 3.5 4.1 0.1 32.1 38.5 0.0 9.1 21.7 5.9 9.2 3.2 27.0 0.0 3.6 7.1 0.3 1.2 0.4 15.5 0.2 1.0 1.6 10.9 27.4 55.2 0.1 0.0 17.6 0.7 32.1 8.6 103.8 4.0 0.1 63.6 4.7 0.6 0.1 2.5 8.8 0.0 5.7 0.0 10.1 0.2 0.0 0.0 7.4 0.2 0.4 0.1 0.0 62.1 4.3 4.0 8.5 1.7 0.0 0.1 0.0 34.6 0.0 4.9 5.5 0.6 0.5 0.5 0.3 0.2 0.9 0.4 0.2 0.5 1.5 0.5 0.6 2.6 1.0 0.3 5.1 0.2 4.9 1.3 2.2 1.9 2.4 1.2 1.1 2.4 1.0 2.3 1.6 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107013-54115675 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA034958: AB_10603036, HPA058534: " "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favourable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 5.9 6.5 33.4 8.9 17.0 7.9 5.1 9.6 22.9 7.9 5.3 8.7 4.3 10.1 5.9 5.3 4.1 5.1 7.1 7.7 24.4 15.5 4.3 3.6 7.9 11.6 18.3 16.1 4.2 4.0 3.3 4.2 6.4 10.8 15.9 2.9 4.8 12.9 5.2 10.8 6.8 10.7 4.7 9.7 14.1 14.5 4.6 12.8 9.6 5.2 3.2 4.8 5.3 3.9 4.4 24.7 5.0 3.9 10.4 13.3 5.5 2.5 2.2 2.2 4.3 0.4 0.8 2.1 2.4 1.7 2.2 2.6 2.6 8.1 2.5 6.0 2.3 2.7 0.8 1.3 0.7 6.5 11.7 3.0 4.0 3.3 6.2 4.0 6.5 1.7 0.8 1.5 1.1 3.4 2.7 3.6 3.4 9.3 7.1 12.5 2.4 4.9 5.9 1.5 3.4 1.6 11.8 5.9 5.0 0.8 9.5 12.9 2.5 14.1 7.8 16.2 3.3 1.2 3.3 6.3 6.7 1.9 6.9 11.0 13.7 5.0 3.7 3.6 8.1 3.9 7.7 4.4 11.6 10.7 9.5 4.2 9.0 9.5 2.4 10.4 1.2 24.7 13.3 5.5 33.4 17.0 9.6 22.9 24.4 15.5 18.3 16.1 10.8 12.8 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082189 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" 1310000000 14000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavourable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavourable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (2.96e-4)" "unprognostic (2.62e-2)" 24.3 11.9 11.9 20.6 11.3 73.8 7.6 9.6 17.8 11.8 25.0 9.5 3.8 11.9 12.1 7.5 18.5 11.7 11.4 18.7 9.5 8.3 15.3 13.6 28.1 8.1 7.4 9.5 50.0 7.8 18.0 6.9 110.0 26.5 7.2 19.4 8.5 8.3 5.0 25.6 9.9 37.4 10.9 13.2 7.9 10.0 8.3 6.1 14.3 7.0 10.5 12.9 11.2 8.0 5.7 7.5 2.2 12.4 1.8 6.5 2.1 21.9 20.0 9.2 18.6 20.4 11.8 57.5 31.4 23.9 22.1 36.7 48.7 20.2 22.5 59.6 11.6 33.9 31.5 10.4 27.1 107.6 10.7 85.3 17.0 22.6 16.1 69.9 17.3 13.3 10.3 19.0 17.2 7.3 35.5 21.6 17.2 20.3 22.9 14.8 28.0 41.0 12.2 13.7 27.0 19.8 55.6 21.0 8.7 30.3 79.7 7.1 77.4 14.6 9.4 26.3 21.4 23.0 47.0 6.1 47.5 35.2 30.8 19.0 15.9 0.0 1.6 2.2 2.5 7.9 1.7 5.7 2.7 1.7 3.7 3.2 2.5 1.9 0.3 1.8 12.4 7.5 6.5 2.1 11.9 11.3 9.6 17.8 9.5 8.3 7.4 9.5 26.5 6.1 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.2 3.0 5.1 4.6 7.6 6.1 6.4 6.6 6.4 6.3 6.1 8.4 7.1 11.2 6.7 4.6 4.6 9.0 5.2 6.5 8.9 3.6 9.0 3.6 7.8 9.6 30.8 6.2 7.1 4.2 3.5 10.1 5.8 8.8 3.9 5.6 4.4 8.4 15.9 6.7 3.9 7.2 5.2 6.6 7.9 3.2 7.3 4.0 5.0 10.5 18.6 4.7 16.7 5.3 2.5 6.6 3.9 5.5 8.9 4.8 41.2 6.9 11.4 6.8 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 TGFB1 "CED, DPD1, TGFB, TGFbeta" ENSG00000105329 "Transforming growth factor beta 1" P01137 19 41301587-41353911 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000361, HPA073356" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" 1288167 38000000 "Golgi apparatus" Cytosol "CAB000361: AB_2201910, HPA073356: " "unprognostic (1.49e-2)" "unprognostic (5.43e-3)" "unprognostic (3.29e-2)" "unprognostic (4.90e-2)" "unprognostic (3.75e-3)" "prognostic unfavourable (3.38e-4)" "unprognostic (8.51e-3)" "unprognostic (5.63e-3)" "unprognostic (2.47e-2)" "unprognostic (5.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "prognostic unfavourable (1.19e-8)" "unprognostic (1.65e-3)" "unprognostic (2.79e-2)" "unprognostic (6.39e-2)" "unprognostic (4.86e-3)" 24.3 14.4 7.7 29.8 11.9 53.1 19.0 2.2 8.2 27.8 15.3 14.3 11.5 11.4 24.1 12.8 24.5 13.0 15.6 17.6 8.8 6.5 19.2 10.4 32.4 33.3 12.0 4.1 15.3 8.2 6.9 9.7 54.7 11.7 17.2 5.8 10.3 10.9 15.9 8.7 14.0 17.6 14.6 12.8 55.8 12.8 9.5 12.3 30.6 10.3 9.1 30.6 28.7 24.6 0.7 1.4 7.5 2.2 0.5 1.7 1.3 14.5 22.9 1.2 0.1 10.6 9.4 2.9 21.1 19.0 6.8 4.6 9.7 9.0 14.4 22.7 28.6 7.9 4.1 13.5 2.4 19.1 4.5 48.5 5.5 12.3 13.7 13.3 33.1 12.2 4.3 13.1 8.4 34.1 26.0 36.3 6.2 10.7 11.4 19.5 2.5 13.7 12.3 3.2 21.6 12.1 6.3 0.2 1.6 5.8 0.3 4.1 0.5 11.9 43.1 26.7 20.9 5.6 22.9 20.1 7.8 9.4 26.1 26.7 4.7 1.5 1.9 7.5 1.7 2.2 1.3 0.4 0.9 0.9 1.4 0.7 0.7 0.9 4.7 0.5 2.0 1.4 0.5 1.3 7.7 11.9 2.2 7.6 8.8 6.5 12.0 4.1 11.7 12.3 TGFB1I1 "ARA55, Hic-5, TSC-5" ENSG00000140682 "Transforming growth factor beta 1 induced transcript 1" O43294 16 31471585-31477960 "Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB020844 Enhanced Supported "Focal adhesion sites,Cytosol" 13000000 "Focal adhesion sites" Cytosol "CAB020844: " "unprognostic (5.80e-2)" "unprognostic (3.09e-2)" "unprognostic (5.34e-2)" "unprognostic (1.18e-1)" "unprognostic (6.64e-2)" "unprognostic (9.52e-2)" "unprognostic (1.89e-1)" "unprognostic (4.95e-2)" "unprognostic (4.19e-2)" "unprognostic (1.71e-2)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (6.06e-8)" "unprognostic (1.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (7.73e-5)" 16.8 4.1 1.0 14.4 1.4 0.3 18.5 1.2 1.6 42.9 51.1 1.8 22.1 5.8 80.7 22.7 34.1 28.9 36.2 11.8 0.9 0.7 8.6 2.8 11.2 10.6 1.1 1.3 40.3 2.2 5.1 1.8 11.5 2.3 37.7 10.4 11.1 7.1 34.7 5.7 5.9 12.8 71.9 1.8 11.5 19.6 10.9 0.9 0.7 5.8 7.8 3.6 69.9 23.5 1.3 0.5 8.8 0.0 0.0 2.5 2.3 4.3 5.4 9.0 0.0 8.9 16.3 0.1 23.5 22.0 14.7 10.0 2.3 1.5 0.0 22.1 20.1 6.5 1.8 4.3 19.4 0.0 0.0 5.2 10.1 1.2 22.6 0.0 6.7 10.5 6.4 9.1 5.4 9.7 0.5 0.0 17.9 0.0 0.0 0.6 0.4 5.6 0.0 10.7 0.0 4.1 2.2 0.0 6.4 9.1 0.0 4.5 0.0 0.5 26.1 26.5 6.5 7.4 10.2 0.0 0.0 0.0 11.7 0.2 16.3 8.8 0.0 0.1 0.3 0.0 0.5 1.3 1.4 0.2 0.1 0.5 0.2 1.0 0.2 0.0 0.0 0.5 2.5 2.3 1.0 1.4 1.2 1.6 0.9 0.7 1.1 1.3 2.3 0.9 TGIF2 ENSG00000118707 "TGFB induced factor homeobox 2" Q9GZN2 20 36573488-36593950 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053786, HPA064522" Enhanced Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA053786: , HPA064522: " "unprognostic (1.42e-2)" "unprognostic (8.27e-2)" "unprognostic (2.80e-1)" "unprognostic (2.10e-3)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (7.19e-2)" "unprognostic (4.88e-2)" "unprognostic (2.70e-2)" "unprognostic (1.77e-1)" "unprognostic (6.73e-2)" "unprognostic (1.51e-1)" "unprognostic (3.75e-2)" "unprognostic (8.53e-2)" "unprognostic (1.22e-1)" "unprognostic (8.79e-3)" "unprognostic (1.14e-2)" 14.0 6.1 2.8 20.0 3.1 4.1 7.8 1.3 3.5 13.7 8.8 4.0 3.5 3.2 23.7 7.9 6.8 18.0 10.2 7.6 2.7 2.5 9.2 13.2 13.7 16.6 4.4 1.6 17.9 33.3 10.5 3.4 9.1 3.9 9.3 3.7 12.1 14.9 5.7 4.1 5.6 8.1 13.7 3.2 20.3 7.0 16.9 2.8 26.7 12.9 6.9 22.1 10.0 7.2 8.2 7.7 14.7 5.4 4.2 7.6 3.8 6.9 1.7 20.0 22.6 2.9 2.7 7.3 4.0 4.6 9.6 7.2 10.2 8.9 18.7 10.6 3.9 7.2 16.2 10.4 9.4 8.8 5.9 23.4 4.0 13.5 4.6 9.9 5.7 4.2 6.9 2.0 7.4 9.4 11.2 11.5 4.6 9.9 16.8 18.9 16.7 5.0 14.4 23.9 10.2 6.3 4.6 6.0 17.8 1.2 10.6 10.0 12.7 22.1 6.8 1.5 6.3 0.1 7.5 13.2 4.9 17.6 0.1 11.9 7.5 14.7 5.4 1.7 4.8 4.9 5.2 8.2 4.4 4.9 7.4 6.5 7.6 6.3 2.2 4.2 3.4 7.7 4.2 3.8 2.8 3.1 1.3 3.5 2.7 2.5 4.4 1.6 3.9 2.8 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Group enriched" "Detected in many" 4 "CAPAN-2: 160.1;EFO-21: 53.8;HUVEC TERT2: 72.7;TIME: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavourable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavourable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.5 4.9 0.0 0.1 5.1 0.5 2.5 9.9 4.8 0.0 0.1 8.0 160.1 0.0 53.8 0.1 0.1 0.0 23.2 0.3 0.0 0.0 1.0 0.2 3.5 20.9 0.0 0.0 0.5 0.0 4.2 0.0 72.7 2.1 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.2 0.0 0.0 0.1 23.2 0.0 0.8 0.2 0.0 94.8 0.1 6.0 0.7 4.7 0.0 0.0 0.0 6.5 0.0 1.9 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328425 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" 9800000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 40.0 40.7 34.3 38.4 38.0 55.6 36.5 51.7 43.1 33.3 50.0 38.7 31.5 53.2 41.2 31.1 23.9 33.3 44.9 43.2 31.9 34.4 59.6 66.2 44.1 37.4 35.4 36.7 36.1 34.4 39.5 21.8 50.4 35.8 34.0 50.1 26.9 38.9 36.5 23.7 23.7 63.1 36.0 40.3 47.1 36.8 22.3 33.2 31.8 44.8 17.0 37.7 39.9 32.9 9.4 14.9 34.2 34.1 8.6 12.3 22.7 11.2 29.1 12.4 16.3 29.9 31.4 28.9 34.2 39.9 23.3 18.7 24.3 34.1 14.1 27.1 47.3 18.4 8.9 16.7 38.7 23.1 8.9 20.2 10.3 26.0 16.3 39.1 46.9 23.2 10.7 30.1 18.2 33.6 11.6 23.2 34.3 10.2 12.6 19.9 10.9 11.8 13.3 45.5 10.4 25.0 17.7 11.7 9.7 29.9 22.5 19.8 12.6 17.6 35.6 50.0 18.6 37.7 40.9 15.2 19.5 13.8 37.0 30.4 32.5 17.6 27.5 23.5 12.3 26.9 9.6 9.4 9.2 8.3 14.9 9.1 9.6 9.1 34.2 8.6 34.1 5.6 7.2 22.7 34.3 38.0 51.7 43.1 31.9 34.4 35.4 36.7 35.8 33.2 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892785 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 6 "monocytes: 7.3" HPA041416 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041416: AB_10795592" "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favourable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 3.3 4.6 7.5 2.5 10.9 0.3 3.9 13.4 16.0 4.8 4.1 9.9 0.8 4.3 4.2 4.0 3.9 6.3 3.0 9.4 7.8 10.3 5.8 3.7 3.6 1.8 9.5 6.5 7.8 3.7 8.7 4.6 3.6 11.7 5.7 3.8 7.0 3.7 6.5 3.8 2.4 2.4 4.1 11.6 1.8 5.1 6.2 7.6 0.2 7.0 1.8 1.6 5.5 3.8 0.6 1.1 0.0 7.3 0.8 0.4 0.2 4.6 8.2 5.2 6.8 2.7 3.2 0.1 9.1 4.0 7.9 9.3 1.2 6.4 0.0 5.7 2.4 7.2 11.1 2.1 7.0 0.0 5.7 1.7 4.6 0.5 1.4 0.4 3.4 1.1 3.4 4.3 4.2 3.7 0.5 0.0 5.1 3.6 0.0 1.6 7.7 3.2 0.0 6.6 0.2 3.1 3.9 5.6 6.0 6.2 2.7 3.9 3.1 3.8 2.9 5.6 3.7 27.3 6.3 2.3 2.6 0.0 3.3 0.6 7.7 0.0 0.6 0.0 0.1 0.9 0.1 0.6 0.4 0.0 1.1 0.3 0.0 0.3 0.0 0.8 7.3 0.0 0.3 0.2 7.5 10.9 13.4 16.0 7.8 10.3 9.5 6.5 11.7 7.6 THAP11 "CTG-B43a, CTG-B45d, HRIHFB2206" ENSG00000168286 "THAP domain containing 11" Q96EK4 16 67842082-67844195 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041434, HPA042189, HPA072537" Supported Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041434: AB_10960385, HPA042189: AB_10964636, HPA072537: " "unprognostic (1.43e-1)" "unprognostic (2.51e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-3)" "unprognostic (1.93e-3)" "unprognostic (1.40e-2)" "unprognostic (1.56e-3)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.66e-1)" "unprognostic (9.51e-2)" "unprognostic (2.97e-1)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (4.59e-2)" "unprognostic (5.87e-2)" 15.2 12.1 13.4 13.5 14.5 8.5 31.4 15.0 17.2 23.8 19.1 16.7 13.0 12.0 19.9 13.3 18.9 18.0 16.7 29.5 12.4 12.4 13.9 13.5 14.9 22.2 11.8 9.7 22.6 23.1 17.2 13.3 14.2 12.7 20.4 11.0 17.2 14.8 20.6 40.7 17.7 16.0 19.8 10.4 21.0 15.8 11.8 9.8 30.2 29.0 17.3 18.0 21.7 27.1 10.3 8.7 8.5 10.8 11.5 19.9 10.6 12.3 16.2 11.3 10.6 15.8 10.9 11.9 6.4 11.0 15.3 13.3 20.7 9.6 27.1 13.2 6.4 14.6 19.8 11.7 8.8 10.0 22.6 10.8 9.4 25.1 14.5 13.7 12.3 9.9 11.6 10.6 9.3 11.3 15.4 6.4 9.3 19.3 14.8 24.7 22.8 14.2 29.2 13.5 24.4 7.7 8.0 15.8 17.9 18.5 6.7 13.3 16.5 14.1 9.0 9.9 12.0 8.8 7.8 25.4 25.2 26.7 7.6 15.2 10.6 3.5 8.4 8.5 16.8 10.8 13.4 8.9 15.4 15.4 8.7 10.3 19.9 15.8 2.5 11.5 9.7 7.0 18.4 10.6 13.4 14.5 15.0 17.2 12.4 12.4 11.8 9.7 12.7 9.8 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71663009-71680639 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 19.8 31.3 10.9 9.9 13.3 14.2 6.1 24.1 14.1 7.7 6.4 7.3 6.2 6.6 7.1 20.0 10.0 6.9 10.2 7.9 11.6 8.1 6.7 5.9 6.8 7.9 16.3 10.4 9.9 6.1 5.5 20.6 7.9 12.6 8.4 6.8 2.5 5.4 5.5 5.7 6.5 6.3 5.3 18.2 7.4 8.2 21.0 16.0 7.0 8.0 4.2 7.7 7.8 11.6 6.5 3.8 2.8 4.1 8.4 11.4 3.1 3.8 4.9 11.5 8.7 8.6 7.1 5.7 6.1 5.5 5.9 5.0 4.7 5.0 2.6 4.2 4.0 6.9 11.0 3.4 7.7 11.3 6.0 7.5 8.3 7.7 7.6 4.5 3.5 5.3 14.7 5.7 12.4 9.1 5.5 5.6 7.8 1.2 3.7 4.5 5.7 8.1 5.3 3.8 12.9 6.8 6.0 8.0 12.7 6.4 3.9 5.3 7.2 4.7 4.0 6.1 2.9 5.2 4.0 7.1 8.8 6.1 3.5 5.3 3.7 2.0 2.8 2.8 5.0 3.9 8.2 5.7 7.0 4.8 3.8 6.5 11.4 7.6 2.5 8.4 4.1 1.9 6.8 3.1 10.9 13.3 24.1 14.1 11.6 8.1 16.3 10.4 12.6 16.0 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: " "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.8 9.3 8.5 12.3 14.1 12.7 8.2 8.9 11.7 23.8 14.9 12.5 6.2 8.7 12.0 9.8 7.8 13.5 7.9 8.3 15.0 22.1 10.0 12.5 11.1 17.7 7.1 10.4 11.9 10.2 14.9 13.2 10.2 10.1 11.2 8.7 6.8 12.2 16.0 7.3 15.8 11.8 10.3 12.5 10.6 2.3 11.2 12.7 10.9 15.0 20.6 9.6 12.8 9.2 12.6 7.6 8.6 13.8 12.7 13.5 11.4 10.7 15.2 7.1 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: " "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favourable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.1 19.1 11.5 21.3 15.5 16.2 18.1 10.0 15.4 17.2 15.3 17.3 14.2 13.6 5.9 17.8 17.6 23.1 25.5 6.5 10.2 27.1 13.9 13.1 49.2 20.7 16.5 9.8 16.7 20.2 18.4 25.5 15.8 23.8 4.7 13.2 29.7 16.8 40.2 19.8 16.2 19.3 16.1 18.2 35.7 20.2 27.4 18.0 8.4 27.5 22.8 13.7 19.4 13.8 18.4 12.8 17.4 20.3 11.1 6.5 14.0 14.1 14.1 14.0 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 15.7 14.9 11.5 18.7 17.6 14.4 18.6 21.2 17.0 18.4 17.0 24.4 16.5 14.9 20.2 23.8 15.5 15.6 13.5 17.2 12.0 11.9 17.8 21.9 13.1 17.9 21.9 14.0 19.3 14.9 19.9 30.9 24.3 17.8 18.3 14.5 17.3 17.0 13.3 20.3 20.8 21.1 18.8 19.2 17.8 13.1 26.5 21.3 18.0 20.4 16.9 15.2 16.5 14.3 10.7 7.1 18.5 8.7 6.8 13.6 6.5 6.8 4.9 10.9 7.6 12.4 12.3 6.2 16.4 8.4 8.6 8.9 6.2 17.1 10.0 8.4 5.3 7.3 9.8 7.8 10.5 11.3 6.8 7.2 8.0 7.9 17.2 9.7 8.2 10.3 13.6 9.8 15.1 4.6 12.4 20.5 9.0 8.0 8.7 6.6 6.2 5.1 8.5 12.0 6.8 8.0 5.8 8.4 8.6 7.7 10.5 9.1 11.4 8.1 5.6 14.7 9.7 16.9 8.4 18.4 9.0 9.4 10.2 7.8 12.3 14.6 8.7 12.2 9.8 7.5 13.0 8.9 11.9 9.2 7.1 10.7 13.6 10.4 18.5 6.8 8.0 5.9 13.0 6.5 11.5 17.6 21.2 16.5 12.0 11.9 21.9 14.0 17.8 21.3 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.4 11.8 3.2 5.4 2.8 3.5 7.1 6.0 5.3 7.3 6.9 6.0 6.1 8.8 5.7 3.4 7.2 2.7 5.5 1.1 8.3 17.4 10.3 9.0 7.0 8.8 9.9 6.4 3.3 6.9 6.4 5.9 3.8 49.2 9.0 4.0 13.4 10.5 6.6 4.6 11.9 8.8 6.4 4.7 3.8 5.4 7.2 6.0 6.9 8.9 9.3 10.2 6.7 2.4 12.0 9.5 7.1 6.0 13.2 7.4 6.7 12.9 6.3 10.3 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;CAPAN-2: 20.0;EFO-21: 17.5;HaCaT: 16.8;hTCEpi: 22.2;THP-1: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.9 0.7 0.1 0.1 0.0 0.0 0.0 0.0 20.0 0.0 17.5 1.7 16.8 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.1 0.6 22.2 0.3 1.4 5.6 2.1 0.0 0.5 0.4 0.0 2.1 0.0 0.8 0.0 0.0 2.4 0.1 8.2 0.3 0.0 4.7 0.6 8.7 0.0 12.5 11.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 84.6;urinary bladder: 67.4" "Cell line enhanced" "Detected in some" "ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 22000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: " "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavourable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 43.5 4.0 4.3 10.1 7.8 0.4 84.6 1.1 9.0 24.3 17.0 6.3 3.3 1.9 26.1 16.1 9.8 14.8 43.0 21.9 5.5 3.6 4.6 5.9 8.4 3.8 8.1 1.4 26.2 5.9 1.5 4.4 2.0 14.8 10.5 3.4 0.7 3.9 2.8 14.6 22.7 3.8 22.0 16.0 2.8 2.6 12.5 5.2 0.0 13.2 10.6 4.8 67.4 29.4 0.4 0.7 0.2 0.8 0.1 0.3 0.0 0.0 0.0 0.5 0.3 81.9 56.2 0.0 15.6 21.4 21.6 27.2 0.1 0.0 0.0 0.0 18.6 0.0 0.6 0.8 12.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 30.3 0.0 29.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 3.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.1 22.0 1.8 0.0 0.3 0.0 6.1 0.1 0.5 0.0 0.8 0.2 0.2 0.5 0.0 0.4 0.1 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.5 0.7 0.2 0.0 4.3 7.8 1.1 3.1 5.5 3.6 8.1 1.4 14.8 5.2 THEM6 "C8orf55, DSCD75" ENSG00000130193 "Thioesterase superfamily member 6" Q8WUY1 8 142727203-142736927 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 28.6;RT4: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023255 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted - unknown location" "Nuclear speckles, Cytosol" "HPA023255: AB_1845782" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (9.10e-2)" "unprognostic (5.33e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-2)" "unprognostic (1.74e-2)" "unprognostic (6.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.44e-1)" "unprognostic (4.91e-2)" "unprognostic (6.76e-2)" "prognostic favourable (6.66e-7)" "unprognostic (7.02e-3)" "unprognostic (3.55e-2)" "unprognostic (2.39e-2)" "prognostic favourable (4.49e-4)" 11.9 13.9 9.4 5.6 13.4 6.0 21.6 9.0 20.7 10.8 11.8 12.8 16.6 14.4 5.6 7.1 14.9 12.5 15.0 12.6 10.7 11.5 16.7 35.2 11.0 7.4 8.8 11.7 4.5 30.7 13.4 10.0 10.7 11.6 9.8 6.7 10.0 18.5 15.3 11.3 11.7 14.3 4.8 9.3 8.7 15.1 3.0 7.5 10.3 14.4 15.6 10.6 19.7 7.9 6.5 3.8 4.5 7.4 8.4 14.6 7.5 9.8 8.2 1.2 8.6 4.0 1.4 6.1 5.1 4.2 7.8 5.4 5.0 14.8 4.1 11.6 1.9 23.0 3.6 11.0 1.3 3.4 10.1 3.1 4.6 10.0 4.4 1.8 3.3 2.0 3.9 1.5 2.2 6.6 1.4 2.1 1.3 28.6 7.4 0.4 1.9 26.9 8.7 0.8 9.5 9.3 40.4 19.4 7.6 7.8 23.4 6.5 11.5 1.5 3.8 3.4 2.5 9.7 0.8 1.4 1.9 1.8 3.5 9.0 4.1 4.5 4.0 2.0 9.7 7.4 14.6 4.6 10.3 12.5 3.8 6.5 12.5 11.5 0.5 8.4 7.1 2.9 9.1 7.5 9.4 13.4 9.0 20.7 10.7 11.5 8.8 11.7 11.6 7.5 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016658-25026664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.0" "Cell line enhanced" "Detected in many" "Daudi: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" "Nuclear bodies" "Mitochondria, Cytosol" "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 2.2 8.0 8.6 2.4 10.1 0.8 4.7 4.6 10.4 5.5 3.5 5.4 3.6 3.3 4.7 6.5 2.6 7.2 2.7 4.6 8.9 6.6 12.3 26.0 2.1 5.5 9.5 5.5 9.6 8.7 7.9 13.0 2.3 8.5 3.8 4.0 2.8 4.4 3.7 5.2 2.9 3.0 3.0 9.1 3.2 3.5 7.0 7.7 5.1 10.5 2.1 3.3 2.9 3.9 5.2 3.8 0.6 0.7 11.5 10.4 3.3 5.3 6.1 3.9 7.8 4.0 5.0 1.0 2.6 1.0 2.9 1.9 4.0 6.8 24.6 8.4 1.2 3.0 5.6 4.9 3.0 3.3 3.1 9.0 1.7 2.5 4.5 0.0 1.5 3.1 9.1 2.1 4.5 2.0 7.7 2.9 6.2 8.3 4.9 1.7 7.2 3.0 2.6 1.0 10.5 8.3 1.2 6.5 3.7 5.2 4.7 9.3 4.6 0.5 1.9 3.5 3.1 4.6 2.4 2.1 2.8 0.0 5.8 5.0 2.7 0.1 0.4 0.0 3.0 0.5 5.4 5.2 4.4 4.0 2.2 4.0 10.4 6.8 0.6 11.5 0.7 3.8 2.0 3.3 8.6 10.1 4.6 10.4 8.9 6.6 9.5 5.5 8.5 7.7 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.1 12.4 13.1 28.9 12.7 11.4 48.2 13.4 12.5 29.6 34.4 17.5 18.2 28.9 19.4 7.7 19.1 20.0 57.0 31.4 19.8 29.2 15.6 12.3 19.0 4.2 25.5 14.0 9.6 24.3 25.4 12.9 16.2 23.6 13.1 18.7 26.7 17.1 15.6 11.3 45.4 29.9 16.7 30.1 21.1 16.6 25.5 14.8 27.7 13.6 13.7 15.5 23.4 12.4 10.2 11.7 15.7 23.9 6.6 11.5 17.3 7.6 24.8 7.9 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 THOC6 "fSAP35, MGC2655, WDR58" ENSG00000131652 "THO complex 6" Q86W42 16 3024027-3027755 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transport" "Developmental protein, RNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052953 Uncertain Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA052953: " "unprognostic (2.07e-2)" "unprognostic (4.13e-3)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (7.82e-3)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (3.44e-2)" "prognostic unfavourable (4.40e-4)" "unprognostic (3.59e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (9.43e-2)" 10.5 12.0 7.8 14.6 8.2 16.7 12.8 7.0 9.8 10.0 13.7 9.1 11.9 15.5 15.7 8.6 13.7 10.4 19.3 9.5 7.0 5.6 12.9 17.5 12.4 15.5 11.0 4.8 13.2 20.7 11.8 13.2 28.0 9.0 15.1 8.6 7.2 16.6 11.0 17.0 20.6 17.6 10.5 6.5 16.9 10.5 9.0 6.8 27.3 12.7 19.4 17.9 10.0 11.6 17.8 34.5 5.0 24.4 14.3 16.4 16.3 12.6 20.7 15.1 15.8 7.7 8.9 26.6 3.9 9.1 9.2 13.7 13.7 15.0 24.1 12.9 6.5 17.5 16.4 12.5 5.1 21.2 21.0 13.0 19.1 19.9 13.2 19.0 28.7 8.9 15.1 11.2 28.0 8.5 18.9 13.0 4.5 29.7 10.7 35.3 27.0 8.9 29.0 11.3 28.1 9.6 6.4 31.0 14.7 11.1 17.7 7.2 12.7 20.8 7.0 9.6 22.3 10.8 14.1 9.4 8.0 29.1 2.5 13.1 9.6 0.8 24.4 5.0 14.8 23.7 14.9 15.3 13.7 14.3 34.5 17.8 16.0 16.4 1.8 14.3 13.1 29.1 14.2 16.3 7.8 8.2 7.0 9.8 7.0 5.6 11.0 4.8 9.0 6.8 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863903 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 24.3 28.5 41.1 19.7 34.7 29.0 33.3 20.6 37.6 24.6 29.6 14.8 24.1 27.7 22.2 24.6 43.6 18.7 27.2 36.1 38.5 28.3 30.5 32.5 17.2 25.9 33.9 35.2 21.1 35.6 18.0 23.8 42.0 33.7 24.6 30.4 14.8 30.4 22.8 52.9 27.0 34.9 31.1 27.2 20.4 21.5 24.6 15.5 34.4 21.3 43.0 27.6 28.4 22.8 25.4 31.4 32.2 24.8 27.6 32.1 17.7 19.5 12.0 13.8 3.4 18.5 25.4 13.2 17.3 17.9 20.3 20.4 14.4 21.7 23.4 7.3 22.2 11.5 15.5 27.2 28.4 23.9 11.3 20.9 15.7 16.6 19.5 29.1 10.3 18.3 22.9 17.4 30.8 22.2 16.0 22.8 24.6 144.9 25.5 26.4 17.5 9.7 18.6 13.0 31.9 35.1 18.7 6.9 16.0 15.0 21.1 23.4 13.5 40.5 16.0 14.8 15.8 18.3 30.5 15.0 22.0 28.4 18.4 37.3 19.2 32.2 21.9 17.1 22.2 24.8 30.7 25.4 27.6 30.0 31.4 17.4 23.8 24.8 13.1 27.6 20.7 28.9 32.1 17.7 41.1 34.7 20.6 37.6 38.5 28.3 33.9 35.2 33.7 15.5 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 8 "Daudi: 10.1;SCLC-21H: 21.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051416: , HPA056745: " "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.1 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favourable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 14.9 19.5 27.7 12.2 23.3 7.6 12.9 16.4 24.3 12.3 14.0 20.7 15.9 15.7 13.3 18.4 10.1 17.7 16.8 16.3 23.3 17.4 16.3 12.1 10.7 10.7 21.9 13.3 15.4 12.7 25.0 12.4 7.6 16.1 18.8 12.3 17.1 18.0 23.5 21.9 7.4 11.7 13.7 19.5 11.3 11.6 18.8 14.3 14.1 15.9 12.3 11.2 9.9 7.9 14.3 17.0 11.1 14.4 6.9 11.6 8.7 2.7 17.2 8.5 9.1 19.4 11.0 4.7 8.0 7.1 8.0 7.9 3.5 11.4 5.2 7.1 9.6 8.5 8.9 10.0 5.9 11.0 9.6 7.1 12.1 9.4 9.8 6.5 6.4 14.8 7.4 12.1 9.0 9.5 5.3 11.5 11.5 8.2 10.2 2.7 3.0 14.6 7.0 5.7 9.5 14.0 5.5 16.3 7.8 7.9 16.3 4.7 10.9 3.2 7.5 5.2 5.6 10.8 4.7 13.6 8.2 2.9 5.5 2.9 8.0 11.1 14.4 7.3 9.6 10.6 9.5 9.6 6.9 7.5 13.2 14.3 11.6 9.9 1.5 6.9 13.4 17.0 5.4 8.7 27.7 23.3 16.4 24.3 23.3 17.4 21.9 13.3 16.1 14.3 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362842-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: " "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favourable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 17.4 17.2 13.3 12.9 14.8 22.2 14.2 13.4 19.6 15.2 14.4 13.8 12.5 12.8 14.0 15.8 16.5 12.3 10.9 19.3 12.3 13.9 20.7 23.9 11.1 13.5 18.3 11.0 14.3 14.8 22.2 27.8 14.4 23.2 15.9 15.1 14.0 16.1 14.9 29.4 13.4 14.9 12.3 15.8 14.5 12.5 42.8 14.8 22.3 18.2 17.5 13.2 16.2 11.7 13.9 15.4 12.5 19.3 11.7 22.3 10.1 12.5 17.2 12.0 6.2 15.9 15.3 48.4 15.4 12.7 15.7 12.0 12.9 13.4 12.9 12.1 13.9 8.3 21.9 15.8 16.0 14.4 12.7 16.3 17.4 11.2 15.5 20.7 11.7 12.2 17.8 18.6 19.4 10.3 25.4 18.9 20.7 17.9 24.3 8.9 23.1 16.7 15.5 20.6 18.5 10.4 19.1 5.0 16.2 12.8 9.2 13.7 14.9 13.4 7.3 15.1 13.1 18.2 16.9 24.1 56.2 41.7 18.3 19.4 21.7 10.6 13.2 12.5 16.2 17.4 21.1 12.3 14.1 16.8 15.0 13.9 22.3 16.8 2.7 11.7 19.3 15.4 13.2 10.1 13.3 14.8 13.4 19.6 12.3 13.9 18.3 11.0 23.2 14.8 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" 9800000 Nucleoplasm "Plasma membrane" "CAB068243: , CAB068244: , HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.3 0.0 52.6 38.1 0.0 82.2 92.1 29.5 32.7 0.0 0.0 0.0 0.0 144.0 0.0 0.4 0.1 22.6 7.0 0.0 4.4 1.5 0.0 16.3 0.0 0.0 28.2 0.0 37.4 1.3 0.0 0.0 0.0 22.7 0.0 0.0 0.0 19.7 0.1 0.0 5.8 0.0 0.0 0.0 2.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 42.4 14.1 12.2 12.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 THYN1 THY28 ENSG00000151500 "Thymocyte nuclear protein 1" Q9P016 11 134248279-134253370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038732, HPA038733" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA038732: AB_10697397, HPA038733: " "unprognostic (5.91e-2)" "unprognostic (6.22e-3)" "unprognostic (4.54e-2)" "unprognostic (3.48e-3)" "unprognostic (2.32e-2)" "unprognostic (8.99e-2)" "unprognostic (2.12e-1)" "prognostic favourable (1.01e-5)" "unprognostic (3.32e-2)" "unprognostic (1.99e-2)" "unprognostic (1.02e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" "unprognostic (1.71e-1)" "unprognostic (6.92e-2)" "unprognostic (1.66e-2)" "unprognostic (2.61e-2)" 20.1 22.4 36.7 13.3 39.3 21.4 26.1 29.6 43.6 22.8 22.7 16.0 20.8 16.8 22.8 45.2 16.0 27.9 17.3 27.8 30.2 30.4 22.4 31.6 15.8 20.4 24.9 38.1 37.6 15.6 13.6 25.2 12.3 24.5 29.7 26.0 17.5 14.3 32.7 14.3 15.5 16.7 24.5 23.2 17.7 18.7 24.3 23.1 35.0 29.9 15.6 23.9 22.6 15.7 27.8 30.6 74.0 24.4 29.7 50.7 34.4 8.1 5.0 18.5 14.8 18.0 20.6 10.9 7.0 15.6 16.6 15.7 27.6 20.1 15.2 23.8 9.8 12.7 28.0 21.4 16.3 15.6 7.8 42.4 7.1 24.8 25.8 33.6 14.0 15.5 11.5 19.7 13.0 26.0 19.5 7.4 14.9 4.5 39.0 62.0 21.5 18.5 18.5 13.7 12.9 22.7 14.4 17.7 14.3 14.6 3.6 8.3 20.7 17.1 13.7 7.2 11.1 6.5 10.6 8.3 8.6 32.4 10.6 43.9 8.2 37.6 21.7 74.0 36.0 24.4 43.1 27.8 38.3 36.2 23.1 21.8 44.3 50.7 11.3 29.7 22.5 30.6 44.7 34.4 36.7 39.3 29.6 43.6 30.2 30.4 24.9 38.1 24.5 23.1 TIA1 ENSG00000116001 "TIA1 cytotoxic granule associated RNA binding protein" P31483 2 70209444-70248660 "Disease related genes, Predicted intracellular proteins" Apoptosis RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056961 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056961: " "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "unprognostic (3.68e-2)" "unprognostic (1.07e-1)" "unprognostic (7.64e-3)" "unprognostic (2.51e-3)" "unprognostic (3.37e-3)" "prognostic favourable (6.79e-5)" "unprognostic (5.09e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "prognostic unfavourable (8.05e-7)" "unprognostic (4.00e-1)" "unprognostic (1.79e-1)" "unprognostic (1.25e-1)" "prognostic favourable (1.02e-5)" 15.6 20.4 15.9 29.3 20.5 14.8 28.2 36.3 22.0 30.2 23.6 25.3 24.6 20.6 42.1 43.5 15.9 28.4 21.6 16.0 17.2 14.7 20.7 18.0 19.1 26.4 21.9 16.5 46.9 24.3 26.0 48.7 21.2 19.0 26.2 24.1 27.1 27.8 24.2 13.2 23.4 25.9 24.9 21.0 30.8 20.8 13.4 25.2 65.3 29.3 15.1 21.2 23.1 23.5 9.7 11.6 12.4 7.9 10.9 9.8 5.6 7.2 8.1 42.3 23.6 12.0 20.5 20.4 12.9 9.2 12.6 12.5 10.8 11.2 16.5 11.2 9.6 11.9 20.5 7.0 17.9 15.3 9.0 16.9 14.0 25.8 9.7 16.9 9.6 15.2 10.5 7.1 8.0 23.2 13.1 15.1 17.6 6.2 31.2 26.9 34.4 9.7 38.2 23.0 16.8 19.2 14.3 25.7 22.0 15.3 18.2 12.4 10.8 12.6 18.9 15.5 16.3 7.2 12.7 12.6 12.6 30.4 9.1 21.6 20.5 12.4 7.9 10.8 8.3 6.5 7.8 9.7 8.0 8.2 11.6 8.0 7.3 7.9 3.0 10.9 3.8 6.0 9.8 5.6 15.9 20.5 36.3 22.0 17.2 14.7 21.9 16.5 19.0 25.2 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavourable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 30.0 29.6 31.4 29.4 44.4 39.2 46.6 72.8 47.3 27.7 27.3 26.7 26.9 23.8 35.0 37.9 43.9 27.1 27.9 30.1 32.5 20.4 25.7 35.3 30.2 39.5 48.2 25.0 34.6 35.5 40.2 30.7 33.2 33.6 27.7 34.3 20.3 33.6 32.0 51.5 31.7 32.5 30.3 39.3 33.3 32.5 28.1 47.8 38.0 33.3 23.6 40.9 29.5 45.8 5.7 6.6 4.9 5.9 7.8 8.6 2.6 35.7 23.7 40.5 44.2 24.5 33.7 27.0 31.9 40.3 39.1 37.6 28.2 43.2 35.6 19.7 29.0 33.9 39.7 25.9 51.1 34.8 17.7 26.8 26.2 29.4 29.3 40.4 32.8 28.8 31.9 31.0 52.2 38.1 26.7 38.2 36.3 30.9 35.5 37.3 20.3 19.8 30.6 31.8 23.6 32.4 20.3 14.5 17.2 21.5 20.7 28.4 21.4 24.1 26.4 24.8 21.0 20.3 33.6 25.1 31.5 28.7 23.4 38.5 18.1 3.7 4.5 3.9 7.2 3.6 7.3 5.4 7.4 6.7 4.6 5.7 7.9 8.3 4.9 7.8 5.9 6.6 8.6 2.6 31.4 44.4 72.8 47.3 32.5 20.4 48.2 25.0 33.6 47.8 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell line enhanced" "Detected in many" "BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 11.9 0.7 0.2 2.8 18.9 0.0 0.0 1.4 0.5 0.1 2.1 4.0 0.8 0.3 2.8 1.4 2.4 2.4 0.3 6.5 18.3 0.3 0.1 0.3 0.0 16.0 1.2 0.8 8.1 3.2 0.0 0.0 6.0 6.0 7.7 2.8 0.1 3.8 5.1 3.6 3.7 0.0 1.8 19.0 17.9 4.4 0.8 6.2 0.7 2.5 0.0 0.1 1.7 6.9 0.0 0.8 6.7 5.0 3.6 4.0 1.4 13.1 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Cell line enhanced" "Detected in many" "AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in many" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 34.4 4.0 1.5 4.2 0.4 1.8 1.1 1.7 2.9 0.5 2.5 1.0 1.8 3.1 0.6 1.2 0.0 1.2 14.7 1.9 0.2 0.6 2.0 0.9 0.3 1.0 2.8 0.1 0.6 0.1 2.4 0.5 0.1 3.8 0.4 0.4 0.9 2.5 0.9 4.4 22.4 0.4 0.1 0.2 0.9 7.9 0.1 0.4 0.2 0.3 0.5 0.8 0.3 8.7 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favourable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavourable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.1 4.2 0.0 3.6 3.2 4.1 1.9 7.0 7.2 5.6 6.3 4.2 7.6 14.4 4.0 8.0 14.4 2.0 7.3 2.2 15.4 3.9 3.6 8.4 4.1 8.8 1.3 9.4 6.6 9.2 7.0 5.1 5.8 7.7 3.1 3.0 7.9 3.6 0.7 0.6 16.8 8.0 0.9 9.3 5.0 6.7 2.9 5.4 4.3 12.9 7.1 5.8 3.0 11.5 6.9 4.7 17.4 10.5 12.5 11.0 10.0 8.0 4.9 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 45.1;U-698: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 6.8 1.7 2.6 4.3 3.2 2.6 5.2 5.5 10.4 3.5 6.0 0.9 6.2 21.1 4.5 2.1 2.0 3.5 4.2 7.4 17.1 2.1 2.1 4.2 1.9 2.1 6.6 2.9 3.5 2.3 3.7 4.1 5.5 2.1 45.1 4.6 3.4 11.6 3.6 0.5 2.2 20.1 6.5 14.0 7.7 4.7 6.0 6.2 4.4 9.3 2.1 4.0 9.5 4.1 5.5 6.6 4.6 4.3 28.2 25.9 38.9 5.2 4.4 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232547968-232550592 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA041717: " "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 3.9 5.9 13.3 9.2 15.3 19.4 8.9 10.1 11.7 5.4 5.1 10.7 2.0 5.9 8.5 10.1 5.6 7.4 6.9 4.9 13.8 8.2 10.1 5.0 6.9 12.5 9.1 8.0 13.2 5.8 6.3 21.2 6.5 8.6 8.3 6.7 8.3 7.3 7.9 7.5 13.6 6.8 4.3 8.8 11.1 8.1 9.7 10.8 14.2 9.6 4.8 10.6 5.5 5.9 7.1 3.8 7.0 4.8 4.5 9.8 1.9 6.9 5.2 11.3 16.7 4.2 5.5 8.5 5.0 2.8 6.1 6.9 6.5 7.8 11.5 3.8 3.7 6.6 9.3 2.8 9.4 7.0 8.1 10.2 15.2 7.4 2.6 8.5 6.8 6.1 2.7 6.4 4.0 3.8 8.0 12.2 5.3 10.4 10.5 17.3 6.7 6.3 9.7 10.1 5.2 3.6 8.2 13.5 13.5 5.4 4.8 5.2 7.1 8.3 6.5 10.2 10.4 6.4 5.1 10.8 7.5 10.7 5.9 8.6 6.3 4.0 4.8 5.3 6.7 4.3 6.1 4.9 6.5 4.3 3.4 7.1 9.8 7.7 7.0 4.5 4.8 3.8 4.5 1.9 13.3 15.3 10.1 11.7 13.8 8.2 9.1 8.0 8.6 10.8 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040016 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.3 2.6 2.2 5.9 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.0 0.3 1.0 1.0 0.2 1.4 2.2 0.1 0.2 1.7 2.3 0.4 1.3 4.6 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.3 1.4 3.0 0.0 3.4 2.8 1.9 1.3 1.1 4.1 1.0 4.0 0.1 1.3 6.6 4.2 1.7 2.6 1.0 4.2 1.4 0.0 0.2 1.1 1.5 1.0 6.3 4.0 1.3 0.1 1.8 0.6 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Cell line enhanced" "Detected in some" "Karpas-707: 4.5;U-266/70: 6.6;U-266/84: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035649 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA035649: AB_10670956" "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 2.9 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.5 1.3 1.0 0.1 0.1 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.1 0.4 4.5 0.3 0.3 2.8 0.3 1.3 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.8 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.6 12.9 0.6 1.0 1.5 2.1 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favourable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favourable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.2 4.2 9.1 12.1 10.0 6.6 6.6 7.0 5.2 5.2 4.0 4.1 1.1 5.9 7.7 4.1 3.7 4.8 6.1 4.9 3.1 1.9 3.2 2.1 10.8 2.7 5.0 10.3 9.2 6.7 8.8 4.0 2.6 5.3 6.3 5.4 3.6 1.2 1.7 5.3 4.1 4.8 2.9 4.9 3.3 3.3 4.2 4.6 7.5 9.3 8.3 4.8 5.3 4.2 3.3 4.6 4.8 3.9 1.5 3.0 6.7 3.0 6.5 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 TIGD7 Sancho ENSG00000140993 "Tigger transposable element derived 7" Q6NT04 16 3298832-3305729 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041357, HPA041474" Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041357: AB_10794992, HPA041474: AB_10795696" "unprognostic (7.69e-2)" "unprognostic (3.04e-4)" "unprognostic (6.56e-3)" "unprognostic (1.18e-3)" "unprognostic (1.79e-1)" "unprognostic (4.04e-2)" "unprognostic (6.50e-3)" "unprognostic (2.44e-1)" "unprognostic (2.78e-2)" "unprognostic (9.81e-2)" "unprognostic (8.56e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-2)" "unprognostic (8.87e-2)" "unprognostic (4.04e-1)" "unprognostic (5.90e-3)" "unprognostic (3.12e-2)" 3.7 5.6 7.7 8.2 7.6 1.3 11.7 8.6 6.8 8.5 5.9 5.3 5.8 3.1 9.3 8.2 5.2 8.8 4.7 7.7 7.1 8.3 6.8 3.9 4.6 4.8 7.1 3.7 17.4 4.4 16.9 17.6 5.3 7.5 8.4 3.6 3.8 4.1 8.9 5.5 3.5 4.0 6.9 6.7 6.5 3.7 12.5 7.3 8.5 11.0 2.8 5.0 11.0 6.1 4.9 1.1 6.3 2.8 3.8 5.7 1.5 0.8 2.0 5.5 2.9 2.9 4.2 4.5 2.9 1.7 4.4 4.1 0.3 1.7 2.0 4.6 2.1 0.5 1.9 0.8 5.6 0.1 2.8 5.7 1.7 0.1 3.3 0.9 7.6 4.4 1.4 4.1 1.3 3.3 2.8 3.6 3.7 1.2 1.8 8.7 6.2 4.9 10.1 1.3 8.3 2.4 0.5 7.5 2.8 6.7 0.9 2.5 3.2 3.3 1.1 2.6 6.4 2.7 1.6 7.6 7.7 6.3 1.6 3.3 3.0 1.0 1.4 6.3 3.3 1.0 5.7 1.6 2.8 4.8 1.0 4.9 5.5 3.6 3.5 3.8 2.8 1.1 2.9 1.5 7.7 7.6 8.6 6.8 7.1 8.3 7.1 3.7 7.5 7.3 TIMM13 "Tim13, TIMM13B" ENSG00000099800 "Translocase of inner mitochondrial membrane 13" Q9Y5L4 19 2425624-2427894 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048985 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA048985: " "unprognostic (5.47e-2)" "unprognostic (6.63e-2)" "unprognostic (7.15e-2)" "prognostic favourable (4.68e-5)" "unprognostic (8.67e-2)" "unprognostic (4.43e-2)" "unprognostic (1.37e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-1)" "unprognostic (1.53e-1)" "prognostic favourable (9.77e-4)" "unprognostic (4.91e-2)" "prognostic favourable (3.88e-5)" "unprognostic (4.00e-2)" "unprognostic (3.35e-2)" "unprognostic (4.33e-1)" "unprognostic (2.47e-2)" 18.5 38.2 21.7 21.3 19.9 25.0 15.7 15.9 28.6 14.6 26.4 18.5 19.8 43.0 14.2 20.4 32.5 17.1 22.9 28.1 20.6 19.1 29.4 49.8 13.6 20.7 23.1 19.3 22.5 57.0 9.7 16.9 21.5 21.1 20.6 14.7 16.7 32.7 26.1 56.6 22.3 34.5 13.7 17.3 21.7 25.6 33.3 17.4 23.6 20.0 44.6 18.5 15.7 17.4 21.1 72.7 10.5 36.1 19.6 21.0 24.5 28.7 30.2 11.0 21.7 6.2 6.3 15.1 16.8 5.9 12.4 9.1 43.5 14.6 17.3 6.0 5.5 21.3 17.0 22.8 3.4 15.9 59.9 14.4 29.4 33.1 17.8 28.0 15.8 14.6 12.4 13.6 9.3 14.8 29.3 26.1 4.9 12.0 32.9 38.4 30.8 44.4 24.9 8.8 46.7 12.0 24.7 41.0 37.7 7.6 31.1 19.4 20.7 31.1 13.8 14.7 16.2 27.4 33.5 41.2 21.1 18.1 15.0 38.3 22.2 6.3 36.1 10.5 14.5 33.2 17.8 21.1 16.6 15.2 32.6 19.9 21.0 17.9 2.3 19.6 19.5 72.7 16.3 24.5 21.7 19.9 15.9 28.6 20.6 19.1 23.1 19.3 21.1 17.4 TIMM17A "TIM17, TIM17A" ENSG00000134375 "Translocase of inner mitochondrial membrane 17A" Q99595 1 201955491-201970661 "Cancer-related genes, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010083 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010083: AB_10602899" "prognostic unfavourable (1.98e-5)" "unprognostic (3.28e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-3)" "unprognostic (7.58e-2)" "unprognostic (4.15e-2)" "unprognostic (7.45e-2)" "unprognostic (1.64e-2)" "unprognostic (8.54e-3)" "unprognostic (2.02e-2)" "unprognostic (2.01e-1)" "unprognostic (6.45e-3)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (2.81e-1)" 16.6 27.6 22.7 18.7 23.2 16.9 16.8 16.3 29.3 16.5 19.3 9.9 19.2 17.2 15.0 24.1 17.9 11.8 10.7 39.0 32.3 19.6 25.1 53.7 13.5 15.3 20.6 27.0 11.2 18.7 21.5 14.8 17.4 25.0 14.5 21.8 11.7 24.8 17.1 42.1 11.5 13.0 19.6 13.4 14.4 16.3 13.7 14.2 11.3 21.6 30.4 18.9 15.9 12.7 17.6 28.9 16.0 24.9 15.9 20.6 17.8 25.9 26.5 24.1 28.8 20.3 21.4 40.7 41.6 29.8 34.1 30.7 31.1 27.1 36.1 15.3 35.5 20.8 44.1 24.8 36.9 26.4 27.6 19.9 35.3 29.3 21.0 42.3 21.4 24.6 27.7 34.9 29.2 35.6 50.1 20.3 40.0 16.6 22.7 22.9 30.5 14.3 22.4 28.0 45.1 41.9 24.8 36.4 25.7 25.4 65.2 38.4 36.0 28.8 28.5 22.8 24.2 26.5 43.1 30.7 33.1 30.3 24.3 32.3 25.4 8.9 19.0 16.0 13.6 24.9 17.5 17.6 14.9 17.2 28.9 12.7 14.2 16.7 4.4 15.9 24.7 19.3 20.6 17.8 22.7 23.2 16.3 29.3 32.3 19.6 20.6 27.0 25.0 14.2 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favourable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favourable (7.88e-4)" 14.0 21.1 23.6 15.0 24.2 18.6 16.4 15.1 30.8 16.9 22.3 18.9 13.3 19.2 15.1 19.2 27.4 21.0 19.4 40.6 19.8 17.7 26.2 40.1 19.6 18.3 19.0 15.8 17.8 28.7 19.3 22.9 28.2 15.4 22.4 15.0 19.8 21.5 22.8 54.3 16.1 24.8 15.7 20.5 22.1 18.8 16.7 12.5 36.4 31.1 27.2 19.5 21.6 13.7 36.7 41.5 56.2 41.2 22.9 26.7 35.5 18.3 34.1 21.5 21.1 6.7 5.4 17.8 8.3 12.8 22.2 14.6 29.9 25.1 13.8 13.0 7.3 14.1 33.8 18.2 8.4 29.0 37.9 9.9 19.5 26.3 19.0 14.6 9.7 7.2 18.3 16.6 22.2 10.2 14.6 32.2 10.1 47.9 22.9 35.8 27.8 31.9 16.2 14.0 49.0 21.7 10.9 21.4 19.1 13.0 20.9 12.4 45.4 25.6 6.9 10.2 20.1 24.5 14.3 29.8 34.6 16.4 14.1 26.2 12.0 44.4 41.2 56.2 23.4 39.0 26.7 36.7 23.7 26.4 39.5 36.1 23.1 21.2 46.5 22.9 31.5 41.5 23.4 35.5 23.6 24.2 15.1 30.8 19.8 17.7 19.0 15.8 15.4 12.5 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favourable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favourable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.0 5.2 2.6 2.6 8.8 7.4 3.7 5.3 4.9 7.0 3.5 9.0 13.2 3.3 10.0 1.6 4.4 0.9 10.8 13.0 10.5 4.0 4.7 4.2 7.4 8.0 2.2 4.2 3.7 1.5 3.2 11.3 7.6 2.0 8.7 8.5 14.5 11.2 17.2 11.6 4.4 11.0 2.2 4.1 8.0 8.3 8.6 4.5 8.7 6.5 8.1 5.4 8.6 5.2 11.0 11.3 26.5 25.8 9.7 5.4 9.5 7.1 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: " "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.6 64.0 11.9 29.7 10.5 9.6 21.7 21.1 10.8 25.0 20.5 45.9 18.9 30.2 22.4 14.2 15.3 23.8 21.8 13.4 26.3 34.7 28.0 18.7 31.6 16.0 54.5 19.4 12.2 15.5 18.7 17.2 16.2 44.7 18.1 15.7 35.3 33.3 20.9 20.7 24.5 34.0 23.8 23.2 17.2 36.8 31.6 17.7 25.3 37.0 43.3 17.3 29.6 16.3 31.1 29.0 25.6 49.0 17.1 31.5 45.5 23.3 27.4 34.5 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498532-119525090 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053214: , HPA055846: " "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 13.6 17.2 18.1 10.4 16.7 5.9 13.8 8.6 16.2 16.4 12.2 20.4 21.5 9.2 13.3 19.4 18.5 13.6 14.9 43.9 15.9 15.4 22.8 20.5 13.0 15.9 20.9 11.9 11.8 12.5 20.4 17.4 21.4 16.4 15.2 14.5 14.0 14.3 21.6 37.2 16.0 15.3 12.7 21.9 14.3 12.3 13.3 15.6 9.9 19.9 20.3 14.5 16.7 11.1 12.4 13.8 16.3 15.5 8.5 15.8 15.5 14.0 13.2 6.6 5.6 25.7 17.3 14.9 4.1 13.8 12.0 13.8 8.9 8.7 10.3 7.1 14.5 6.6 16.5 13.4 19.6 8.6 5.9 7.6 6.2 10.0 13.5 5.9 5.0 15.1 20.7 9.6 12.5 16.9 10.3 9.9 22.0 17.5 6.1 12.5 8.8 16.5 5.2 4.6 13.5 18.0 7.0 8.8 16.3 4.2 6.4 15.8 10.6 16.2 8.4 6.8 5.1 6.1 7.1 6.4 6.0 14.0 11.5 15.0 10.6 6.8 13.8 16.3 8.4 13.0 10.1 12.2 8.3 10.3 13.8 12.4 10.4 9.0 3.4 8.5 15.5 11.9 15.8 15.5 18.1 16.7 8.6 16.2 15.9 15.4 20.9 11.9 16.4 15.6 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "parathyroid gland: 268.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" "Nuclear bodies" Nucleoplasm "HPA059061: , HPA069807: " "prognostic favourable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 15.8 27.8 10.4 17.0 11.3 13.3 18.2 10.1 16.7 14.5 13.1 17.9 12.9 9.5 16.8 16.1 22.4 12.6 13.7 12.4 9.3 8.9 14.8 11.4 18.8 27.0 13.7 9.8 15.4 17.1 268.9 11.9 15.3 10.9 13.5 12.5 11.3 14.8 15.5 14.9 13.9 12.9 15.1 11.7 21.0 14.5 7.7 12.4 26.1 16.6 12.6 19.5 14.9 14.2 27.3 17.7 46.9 21.4 25.4 27.4 28.8 11.6 10.7 15.5 8.1 17.1 12.8 7.9 12.0 15.2 17.6 16.5 4.6 13.1 17.1 6.9 16.9 11.5 8.7 10.7 11.2 21.7 4.4 10.7 9.8 18.3 14.8 11.3 15.5 14.0 17.3 14.1 13.5 19.0 4.2 21.9 14.2 12.8 17.0 5.6 3.6 13.3 14.0 9.9 12.4 15.7 16.8 9.5 8.8 12.5 11.9 10.7 8.5 7.3 15.2 8.3 10.1 14.0 9.3 16.9 12.0 9.7 9.9 6.4 12.2 41.6 20.6 46.9 27.4 21.4 21.8 25.7 21.6 25.5 17.7 27.3 22.8 22.8 26.0 25.4 19.6 15.0 25.2 28.8 10.4 11.3 10.1 16.7 9.3 8.9 13.7 9.8 10.9 12.4 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178933-168202114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: " "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavourable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 19.6 22.3 17.0 18.6 29.6 29.7 21.4 18.4 29.1 19.4 21.9 11.2 12.9 18.9 25.9 17.7 28.5 17.5 17.1 23.1 17.4 20.5 22.9 38.3 16.2 20.2 18.0 19.3 21.6 22.2 23.8 31.9 19.8 23.1 19.9 22.7 11.4 17.9 18.6 32.0 16.2 23.2 23.5 16.0 19.0 16.1 22.8 12.4 35.2 17.8 21.1 21.2 23.3 18.5 17.7 21.5 36.2 21.4 19.3 23.9 17.7 26.4 11.5 18.2 16.5 14.9 21.6 10.8 19.8 20.9 21.7 19.5 17.9 19.7 18.5 27.4 18.9 32.0 13.5 19.3 21.0 17.8 13.8 17.9 12.0 8.6 26.2 35.6 24.8 17.4 24.8 18.9 25.3 22.8 25.8 26.4 18.7 9.2 31.8 18.5 14.6 20.7 15.6 18.6 25.3 19.5 13.0 11.8 26.3 15.3 21.7 38.8 23.7 36.7 20.7 18.4 21.1 17.2 26.7 28.9 29.9 41.3 12.0 23.6 21.0 36.2 18.7 24.2 16.2 21.4 16.2 17.7 19.0 17.2 21.5 17.7 17.1 16.9 24.2 19.3 21.4 16.1 23.9 17.7 17.0 29.6 18.4 29.1 17.4 20.5 18.0 19.3 23.1 12.4 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: " "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 8.8 10.4 5.2 11.9 5.4 3.9 16.8 7.2 8.0 11.9 18.9 4.6 13.2 11.6 11.1 11.1 9.7 8.7 14.2 11.6 4.4 6.5 9.2 14.8 16.8 17.6 6.5 5.8 13.4 18.7 14.0 8.8 9.2 5.1 11.1 8.9 10.5 15.3 21.1 10.5 8.4 17.3 13.6 4.7 13.4 8.7 3.5 2.4 3.3 8.0 6.4 9.8 11.8 7.3 6.5 8.7 8.8 10.5 4.4 8.3 6.2 1.9 6.3 3.4 5.6 5.8 8.1 4.1 5.1 8.4 3.6 3.4 9.8 7.5 5.0 8.9 5.3 5.6 3.5 4.0 1.4 13.3 3.3 13.6 3.5 6.2 4.6 8.3 7.3 6.1 5.6 6.8 4.8 5.9 3.6 11.7 4.1 3.5 0.2 1.3 1.6 5.7 1.7 1.0 4.7 2.8 6.9 4.1 5.3 6.1 6.0 4.2 16.5 4.3 5.8 2.0 1.9 4.1 3.8 3.3 4.7 3.7 3.1 6.7 6.3 7.7 10.5 4.9 7.7 8.7 7.4 4.3 6.1 8.3 8.7 6.5 5.0 4.9 8.8 4.4 5.7 5.9 6.1 6.2 5.2 5.4 7.2 8.0 4.4 6.5 6.5 5.8 5.1 2.4 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: " "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favourable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.2 1.7 4.2 4.7 20.1 19.7 23.2 8.1 5.9 12.9 7.0 6.4 19.4 7.6 8.1 4.5 32.7 6.9 17.0 14.7 27.2 5.0 7.4 4.6 32.8 5.6 3.0 14.0 15.3 12.3 10.1 6.0 27.1 4.4 5.2 6.7 7.4 1.1 0.4 10.4 11.6 3.9 6.1 0.8 33.3 35.5 1.9 3.3 2.9 20.7 0.6 6.7 1.6 38.8 9.7 10.5 7.5 8.2 5.3 1.1 0.1 11.1 4.3 3.5 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708109-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell line enhanced" "Detected in some" "BEWO: 22.3;CAPAN-2: 22.4;MCF7: 9.9;SK-BR-3: 13.0;T-47d: 27.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5" "Lineage enriched" "Detected in many" 6 "T-cells: 6.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: , HPA053337: " "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favourable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favourable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favourable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.2 0.0 0.3 8.4 0.4 0.0 3.6 0.2 0.3 3.3 34.9 0.7 15.0 23.0 0.7 5.0 16.0 7.9 22.8 0.6 0.5 0.1 4.4 8.0 10.1 0.6 0.2 0.2 2.2 5.9 2.0 1.6 2.7 1.1 2.6 7.7 1.6 26.1 20.5 0.4 4.3 47.0 0.6 0.2 0.4 15.2 1.4 0.2 0.6 5.5 2.6 8.3 4.5 3.4 1.0 0.0 0.0 0.0 0.0 6.2 1.7 0.1 3.3 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 6.6 22.4 4.0 0.6 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.1 0.4 0.1 0.0 0.0 2.9 0.7 3.5 0.1 0.1 0.8 13.0 0.0 27.5 0.1 0.0 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 6.2 0.7 4.8 3.8 0.0 1.0 5.3 1.9 0.0 0.0 0.0 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 1.1 0.2 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell line enhanced" "Detected in all" "Hep G2: 39.8;RPMI-8226: 42.0;T-47d: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol 4800000 "Nucleoplasm, Cytosol" "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favourable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favourable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.0 15.3 2.7 9.3 3.4 3.7 7.6 3.5 3.8 3.3 2.1 6.9 14.6 7.5 12.4 2.5 8.5 5.0 6.6 1.1 12.9 6.7 4.6 8.1 39.8 5.8 3.9 7.8 5.8 4.5 3.1 11.0 3.3 8.1 14.5 2.4 27.4 3.4 3.6 7.4 10.5 6.1 4.2 42.0 5.3 10.7 10.4 9.3 6.5 11.4 5.9 42.0 2.8 3.9 6.6 6.9 5.2 2.1 26.9 22.2 6.7 6.8 3.6 6.0 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702790-1710438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.5;ASC TERT1: 7.6;SiHa: 8.1;T-47d: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 4.1;neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046063 Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA046063: " "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 11.3 9.2 0.5 4.7 1.4 1.7 18.4 0.1 1.5 2.7 9.6 0.3 1.7 7.9 1.8 3.1 6.8 2.7 5.6 4.0 0.6 0.4 2.3 14.8 4.6 0.5 1.2 0.4 4.6 1.2 1.5 0.9 1.6 1.9 4.1 5.4 3.0 2.9 3.6 2.2 2.2 18.4 4.3 1.3 1.1 4.5 0.8 0.5 0.3 2.6 1.2 2.7 4.8 6.3 0.7 0.4 4.1 0.4 0.6 0.5 0.1 0.7 1.4 0.8 2.4 6.5 7.6 0.5 1.3 1.2 0.7 0.5 4.6 2.1 0.1 1.3 2.1 6.2 1.0 0.6 0.5 0.2 1.0 0.6 2.0 0.4 3.7 0.0 1.6 6.1 2.2 0.8 1.5 0.5 0.5 0.3 0.6 1.3 0.0 0.3 0.1 0.4 0.1 3.7 0.1 0.4 2.2 0.1 0.3 8.1 0.7 1.2 6.5 0.6 1.7 0.4 2.0 1.4 0.3 0.1 0.0 0.1 0.4 0.2 1.0 4.1 0.4 0.6 0.4 0.2 0.2 0.4 0.5 0.2 0.1 0.7 0.4 0.4 2.7 0.6 0.2 0.4 0.2 0.1 0.5 1.4 0.1 1.5 0.6 0.4 1.2 0.4 1.9 0.5 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavourable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavourable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.4 10.2 9.0 4.8 4.1 7.2 4.2 10.7 9.6 11.0 3.2 5.8 17.5 2.0 5.8 20.6 16.1 2.5 28.7 14.6 1.0 2.1 1.6 5.0 5.0 5.1 1.2 5.0 5.0 12.5 10.3 13.6 4.6 2.6 2.5 7.4 3.4 1.1 1.2 2.7 3.5 4.5 2.3 0.6 9.8 8.1 2.9 2.1 9.7 6.9 4.8 10.0 1.9 11.2 7.8 3.5 4.1 4.4 2.0 3.4 5.3 4.6 0.6 2.6 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "Transducin like enhancer of split 2" Q04725 19 2997638-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.3" "Cell line enhanced" "Detected in many" "AN3-CA: 24.7;RT4: 19.6;T-47d: 14.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 85.3" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 3.1;T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" "Nuclear bodies" "Focal adhesion sites" "HPA049103: " "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favourable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favourable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favourable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favourable (8.88e-4)" 13.4 9.6 9.2 4.6 5.7 1.3 38.3 85.3 16.5 10.9 11.4 4.9 28.6 8.1 15.7 6.6 5.5 13.3 8.5 19.9 5.5 7.6 11.9 3.5 12.5 5.4 8.3 5.3 12.4 16.5 13.8 6.4 7.3 9.7 12.9 4.6 20.6 55.5 27.1 38.5 6.4 5.3 26.2 13.3 10.9 7.4 6.3 4.8 1.1 17.5 5.7 3.2 19.2 27.6 3.1 0.0 0.3 0.0 0.0 3.4 0.7 0.3 1.6 0.1 24.7 3.9 0.6 5.4 0.2 0.0 1.2 0.6 7.6 2.7 0.1 3.5 1.7 4.3 4.1 1.5 0.3 0.7 1.2 0.0 1.8 0.3 5.0 0.0 0.2 5.5 0.7 2.8 0.0 9.9 8.9 0.1 0.1 8.3 0.2 0.1 0.1 1.6 1.9 1.2 2.2 3.2 19.6 1.2 6.4 1.6 12.3 0.6 14.3 0.0 6.5 8.1 8.5 0.4 0.2 0.3 0.2 1.6 0.2 1.8 1.5 0.0 0.0 0.3 3.2 0.0 2.3 3.1 2.0 1.0 0.0 0.5 3.4 2.1 0.0 0.0 0.0 0.0 0.7 0.7 9.2 5.7 85.3 16.5 5.5 7.6 8.3 5.3 9.7 4.8 TLN1 "ILWEQ, TLN" ENSG00000137076 "Talin 1" Q9Y490 9 35696948-35732395 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002006, HPA004748" Supported Supported "Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol" 3600000000 "Focal adhesion sites, Cytosol" "Plasma membrane, Centriolar satellite" "CAB002006: , HPA004748: AB_1857760" "unprognostic (9.71e-2)" "unprognostic (2.02e-2)" "prognostic unfavourable (5.56e-4)" "unprognostic (1.96e-1)" "unprognostic (5.55e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-2)" "unprognostic (5.07e-2)" "unprognostic (1.94e-1)" "unprognostic (6.46e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "prognostic favourable (7.21e-4)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (7.83e-2)" "unprognostic (8.83e-3)" 47.4 23.7 10.9 29.3 16.6 25.1 38.1 9.6 11.8 34.7 64.0 18.8 22.8 13.0 57.4 20.6 41.2 38.3 48.4 30.3 11.1 7.1 30.5 36.1 33.0 26.0 17.9 7.3 39.0 12.8 19.6 14.6 30.4 14.4 39.5 15.5 22.8 14.9 43.6 24.5 16.5 27.6 87.0 12.4 54.1 38.2 17.3 14.1 33.4 20.7 12.5 20.7 72.5 49.6 3.3 6.8 12.7 9.2 4.8 7.1 7.1 11.3 19.0 11.8 16.2 40.6 30.9 13.5 31.7 34.9 30.8 27.9 15.7 5.1 13.8 10.5 58.5 6.2 13.8 19.7 22.6 31.1 8.9 31.3 24.7 13.9 25.2 18.9 52.4 37.3 9.4 45.3 21.5 47.2 10.7 14.2 40.6 5.0 12.7 4.9 9.6 14.7 17.1 6.9 8.0 15.4 9.1 2.6 11.3 15.4 8.6 10.1 7.3 13.1 56.9 49.2 19.1 15.0 25.5 4.9 4.8 9.6 38.1 10.2 44.3 6.7 7.0 8.4 7.1 7.8 5.9 3.3 4.2 5.4 5.3 3.2 2.0 4.2 12.7 4.8 9.2 6.8 2.8 7.1 10.9 16.6 9.6 11.8 11.1 7.1 17.9 7.3 14.4 14.1 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.9" "Cell line enhanced" "Detected in many" "ASC diff: 29.4;hTERT-HME1: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" 81000000 "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: , HPA054787: " "prognostic favourable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favourable (1.81e-6)" "prognostic favourable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 12.5 3.1 7.0 12.1 7.0 2.3 5.3 5.4 18.9 5.6 24.3 4.0 1.7 3.3 6.5 4.2 3.4 3.2 6.3 8.5 6.8 6.0 36.9 1.8 1.9 1.3 6.2 4.2 7.0 3.3 2.3 3.0 2.4 4.5 3.1 5.4 5.5 5.4 1.6 16.9 1.6 16.6 6.9 9.6 0.8 4.1 3.5 1.3 0.9 29.0 4.5 1.3 4.3 7.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.8 2.6 3.9 4.5 29.4 2.8 4.3 6.5 5.1 6.0 6.0 7.1 0.9 2.2 3.0 11.3 1.1 4.9 1.0 5.3 7.0 0.5 0.2 10.7 4.7 1.0 0.7 0.2 5.1 2.7 8.0 23.9 0.2 0.2 0.1 10.0 3.4 0.3 0.3 6.8 1.9 2.7 9.8 2.7 3.1 5.4 0.9 4.5 5.0 0.5 1.7 1.4 1.7 1.8 10.9 14.8 17.5 16.5 0.1 0.4 1.4 4.9 1.6 13.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 7.0 7.0 5.4 12.9 6.8 6.0 6.2 4.2 4.5 1.3 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000944-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 25.5;SK-MEL-30: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA071716: " "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavourable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 24.4 13.1 5.8 11.8 19.2 13.7 11.1 18.5 12.6 8.2 12.0 7.0 10.3 8.8 9.7 8.2 9.6 8.7 14.4 10.0 5.9 6.0 9.2 10.1 17.9 12.5 5.8 4.6 6.5 11.9 4.4 7.3 10.7 5.9 7.2 7.4 10.8 7.5 6.6 5.6 4.5 10.1 6.2 8.2 21.4 15.7 2.8 4.6 15.0 6.5 11.0 10.4 7.8 8.7 3.0 2.2 2.0 1.9 4.7 2.9 1.2 6.0 2.0 5.3 3.8 2.4 1.4 8.8 5.6 1.6 3.5 2.6 3.4 5.6 6.6 7.8 1.4 7.8 3.2 1.7 2.0 25.5 9.5 13.0 1.1 3.7 1.8 4.5 9.4 1.4 2.4 2.2 2.1 5.2 7.3 16.5 2.3 3.0 7.1 5.3 8.4 2.8 9.2 5.4 14.9 2.2 6.2 8.3 7.1 3.1 3.4 24.7 3.1 4.0 6.2 4.1 12.8 5.6 8.3 11.5 11.3 7.0 2.7 6.6 4.2 2.0 1.3 1.4 2.7 1.9 2.0 3.0 2.9 2.8 0.9 2.3 1.5 2.1 2.0 4.7 1.6 2.2 1.2 1.2 5.8 19.2 18.5 12.6 5.9 6.0 5.8 4.6 5.9 4.6 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Group enriched" "Detected in some" 55 "Daudi: 37.3;REH: 12.5;U-698: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Cell line enhanced" "Detected in some" "HSkMC: 7.4;hTCEpi: 7.4;RPTEC TERT1: 7.6;RT4: 9.3;THP-1: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 3.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 3.5 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.5 7.4 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.4 1.5 0.1 0.0 0.0 7.6 9.3 0.0 0.2 0.4 0.0 1.8 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724730 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" Receptor "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 29.1;TIME: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 30.1" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: " "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favourable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavourable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 29.2 12.1 15.5 23.5 12.5 17.8 21.9 9.4 10.3 6.9 6.8 10.6 3.0 4.4 5.8 7.7 5.0 6.8 10.6 10.9 19.9 7.5 9.0 16.5 16.0 30.9 12.4 11.4 6.7 3.0 2.9 3.8 22.8 10.5 5.7 7.4 7.2 9.0 3.6 7.4 5.2 6.6 10.4 11.1 41.4 4.5 2.4 13.0 1.1 8.3 5.6 7.5 12.1 16.1 0.6 7.5 30.1 21.4 0.0 0.0 6.9 0.0 0.0 12.5 0.0 5.8 11.8 0.1 5.0 8.7 1.2 0.7 0.0 1.2 1.7 0.2 12.8 0.0 0.0 1.1 1.8 0.0 0.0 2.6 2.6 0.1 4.4 9.0 0.0 7.3 0.0 2.7 0.3 15.2 0.0 29.1 15.2 0.0 0.0 1.8 1.5 0.6 0.0 14.1 9.1 0.5 14.6 0.0 0.0 3.1 0.0 0.5 0.0 4.9 21.1 0.6 9.5 0.0 2.3 0.0 0.0 0.0 0.4 9.5 7.4 17.6 21.4 7.2 0.0 19.6 0.0 0.6 0.0 0.0 7.5 0.2 0.0 0.0 30.1 0.0 20.2 0.3 0.0 6.9 15.5 12.5 9.4 10.3 19.9 7.5 12.4 11.4 10.5 13.0 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;SK-BR-3: 4.3;T-47d: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavourable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.2 0.9 0.0 0.0 0.6 1.0 0.3 2.5 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: , HPA050547: AB_2681168" "prognostic unfavourable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 13.9 22.5 10.6 14.5 24.7 16.6 14.5 29.7 18.3 22.5 20.5 17.1 12.1 4.9 23.4 21.9 15.2 11.1 17.9 24.6 5.8 8.6 11.2 13.3 18.5 21.8 3.3 14.6 20.1 17.7 17.7 8.6 28.9 12.3 14.6 30.0 8.6 8.1 11.3 13.3 9.0 7.0 13.6 8.2 25.7 11.1 3.5 6.9 11.3 8.0 14.6 19.5 7.0 25.9 18.3 13.7 26.6 14.9 10.3 22.5 8.6 13.9 7.6 12.7 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054064: " "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.7 21.8 11.7 21.1 33.6 25.1 14.3 11.6 19.2 13.8 15.5 11.7 25.0 14.3 16.1 15.7 20.6 18.2 15.0 11.0 13.6 40.0 21.4 18.9 19.8 22.2 16.6 25.6 20.7 30.4 8.3 17.3 19.0 17.5 21.7 21.7 17.7 12.1 17.6 18.0 7.3 14.8 14.8 22.2 27.9 23.2 15.8 14.4 16.0 17.0 23.1 16.1 22.0 15.1 14.6 15.0 9.7 12.7 20.6 30.4 15.5 12.4 20.9 12.0 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.1;EFO-21: 61.5;HUVEC TERT2: 20.3;NTERA-2: 14.6" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053639, HPA069378" Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA053639: , HPA069378: " "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favourable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 17.9 4.8 7.1 4.0 8.8 0.1 14.4 3.7 7.3 7.9 3.5 1.7 4.7 3.1 7.6 7.2 5.4 5.6 9.0 10.8 8.4 6.2 26.6 9.7 7.4 8.0 9.3 1.5 5.4 8.0 4.2 7.4 14.1 12.3 9.1 2.9 11.9 3.5 5.6 9.3 2.7 3.9 12.3 7.4 34.6 3.5 2.6 8.2 0.6 12.0 5.7 4.0 6.0 5.8 0.9 0.6 1.2 0.4 2.8 0.5 0.0 0.0 29.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.3 0.0 0.0 1.9 0.2 0.0 0.0 14.6 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.7 1.2 0.4 0.4 0.3 0.2 0.1 0.5 0.4 0.2 0.0 0.9 0.4 0.5 0.5 2.8 0.3 0.6 0.1 0.0 7.1 8.8 3.7 7.3 8.4 6.2 9.3 1.5 12.3 8.2 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell line enhanced" "Detected in some" "A549: 7.1;RPMI-8226: 4.4" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" "HPA051838: , HPA063184: , HPA065531: " "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.1 0.2 0.1 0.0 0.0 1.3 0.8 0.1 0.0 0.0 1.3 0.5 0.2 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.4 0.1 4.4 0.1 0.3 0.6 1.7 1.0 0.1 0.0 0.3 0.1 0.3 0.6 0.3 1.9 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Group enriched" "Detected in some" 6 "A549: 15.9;RPTEC TERT1: 24.6" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA046430: " "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.4 0.2 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.0 0.3 0.9 24.6 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Group enriched" "Detected in some" 14 "CACO-2: 24.3;Hep G2: 42.1" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 24.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell line enhanced" "Detected in many" "MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: " "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favourable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.5 8.3 12.0 3.3 0.2 5.3 0.6 1.3 1.0 1.1 8.6 12.2 5.3 9.4 0.4 4.3 3.7 5.8 0.7 5.0 1.8 3.3 1.0 17.3 6.8 1.3 3.6 1.5 1.8 4.8 0.6 0.9 1.9 4.1 0.3 21.6 2.2 5.7 4.5 4.0 7.1 0.4 12.4 24.9 3.8 9.5 10.6 0.4 9.1 2.1 48.4 3.5 0.6 0.1 1.2 1.2 0.8 9.4 5.9 3.0 0.8 2.0 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 TM7SF3 ENSG00000064115 "Transmembrane 7 superfamily member 3" Q9NS93 12 26973195-27014434 "Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057640 Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA057640: " "unprognostic (4.24e-1)" "unprognostic (1.90e-2)" "unprognostic (1.04e-3)" "unprognostic (8.80e-2)" "unprognostic (5.82e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-2)" "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "prognostic favourable (1.32e-4)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" 12.0 27.6 12.1 8.1 17.4 18.5 15.9 7.9 18.9 12.4 17.2 18.1 13.1 10.7 10.9 16.6 27.8 12.7 16.4 10.6 11.7 11.6 69.8 39.9 15.9 15.0 13.0 11.6 12.1 52.6 15.4 33.2 11.0 10.7 14.5 19.7 20.5 21.9 14.2 5.8 15.4 12.8 13.2 13.9 12.0 14.9 11.0 10.6 31.2 14.1 12.3 17.1 15.3 16.5 10.5 10.6 16.0 6.9 11.8 11.4 3.9 8.5 20.5 12.2 14.7 18.5 12.3 64.1 10.6 17.3 8.8 15.1 11.2 36.7 11.5 13.7 10.0 9.4 12.7 72.0 12.2 11.3 7.6 17.3 25.7 21.3 12.3 62.3 12.2 7.5 61.4 18.8 16.9 23.1 7.4 7.9 13.3 17.6 30.4 36.2 24.8 12.2 28.5 19.2 20.4 15.2 39.3 2.0 10.8 13.1 7.1 18.7 19.4 13.2 8.7 7.7 12.6 21.1 13.1 4.8 12.3 21.6 14.8 21.2 11.6 8.6 6.9 16.0 6.0 6.9 5.7 7.3 7.6 7.8 10.2 10.5 10.9 7.2 7.8 11.8 3.5 10.6 11.4 3.9 12.1 17.4 7.9 18.9 11.7 11.6 13.0 11.6 10.7 10.6 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518109-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" 320000 Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 28.4 23.9 19.6 31.0 19.3 12.8 24.5 16.0 18.9 29.3 54.2 16.5 49.9 42.9 31.5 27.3 28.4 23.7 57.7 37.3 19.5 19.2 28.7 50.8 25.2 17.0 20.8 13.5 31.3 33.6 27.4 20.3 50.7 18.7 35.6 35.7 18.5 43.0 57.9 18.4 22.4 60.0 21.4 26.3 25.6 69.6 15.4 18.3 27.1 33.1 16.1 26.6 34.7 34.4 3.3 11.2 7.7 3.6 5.5 6.5 2.4 37.0 25.3 28.2 39.4 41.3 30.9 33.9 51.3 38.0 22.3 18.4 30.3 73.4 27.4 28.5 45.2 35.1 25.5 28.2 41.9 30.6 21.9 24.3 22.4 23.7 31.1 49.6 28.4 28.4 28.6 31.4 54.6 24.4 24.1 31.6 33.9 16.9 19.2 19.2 17.9 15.6 23.9 35.7 21.4 31.7 27.6 13.1 29.5 27.1 26.1 26.1 44.9 18.9 42.7 27.8 23.6 27.7 46.8 32.8 37.2 25.4 37.7 34.8 19.3 7.7 3.6 5.5 5.8 3.5 6.5 3.3 6.2 6.3 4.3 2.2 4.8 6.0 4.2 5.5 3.5 11.2 6.0 2.4 19.6 19.3 16.0 18.9 19.5 19.2 20.8 13.5 18.7 18.3 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: " "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavourable (2.70e-5)" "prognostic unfavourable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.1 13.1 7.1 25.3 9.6 10.2 16.0 8.9 11.5 17.5 11.5 8.9 11.8 9.4 18.5 17.7 16.1 12.8 13.5 12.0 8.7 7.4 13.5 16.8 10.2 22.1 7.6 8.8 16.0 19.3 7.2 12.4 12.6 9.9 11.6 11.0 8.8 16.9 12.2 17.2 15.1 9.8 13.1 11.1 21.1 13.0 30.0 8.5 28.2 10.6 15.0 18.3 15.6 13.5 21.4 28.2 3.3 21.9 13.5 14.0 7.4 15.5 8.2 13.2 12.0 5.5 9.5 13.6 18.2 9.1 9.9 8.4 7.9 21.3 34.5 7.6 9.6 7.9 15.4 13.0 12.6 17.8 13.2 48.1 7.8 12.5 12.3 38.0 14.9 6.1 11.8 8.4 10.5 10.9 16.8 25.4 10.9 14.0 22.8 19.7 14.7 12.0 21.8 12.5 21.7 7.9 7.6 7.7 11.3 11.5 15.4 13.7 9.3 14.8 19.1 8.0 15.1 7.5 19.2 18.4 23.6 40.2 15.7 20.3 23.8 3.3 14.5 1.3 7.7 21.9 11.4 21.4 14.0 9.9 16.5 19.9 13.2 11.1 0.5 13.5 17.7 28.2 11.5 7.4 7.1 9.6 8.9 11.5 8.7 7.4 7.6 8.8 9.9 8.5 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favourable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 63.8 46.4 75.3 53.9 62.5 61.0 51.9 52.9 41.7 50.7 50.4 37.7 46.4 41.8 37.8 46.0 25.0 65.6 59.6 56.7 51.4 55.9 78.8 100.0 96.0 48.6 89.4 52.9 55.8 64.1 47.8 46.7 64.0 42.1 44.8 72.3 66.2 104.0 121.7 100.3 74.9 29.8 47.2 70.8 87.1 86.6 24.8 63.0 59.5 43.6 79.5 42.0 132.9 47.8 43.0 77.4 66.5 103.1 74.7 110.1 100.8 55.2 86.5 44.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.6 6.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 1.4 1.7 0.0 0.0 1.4 0.1 0.1 0.4 0.1 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567124-94650562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 17.9;Karpas-707: 24.2;U-266/84: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.2;neutrophil: 30.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 10.6 4.0 10.2 7.7 20.9 8.1 9.9 2.7 9.9 11.0 19.7 32.6 6.8 13.1 6.9 3.0 6.1 5.5 4.7 4.4 14.7 10.8 7.4 3.5 5.9 3.9 25.8 7.4 5.2 2.8 5.0 4.7 15.7 17.8 7.7 15.0 7.3 5.8 5.1 20.2 7.0 23.0 7.2 25.5 11.6 6.4 2.2 20.4 0.1 12.0 3.3 5.3 7.2 5.9 2.5 1.1 30.0 3.0 1.3 1.5 1.1 4.3 0.2 1.1 0.0 0.4 1.6 7.9 0.0 0.0 0.2 1.1 0.0 0.9 0.1 0.0 0.0 10.8 6.1 7.3 1.5 1.9 1.5 2.8 0.4 0.0 0.3 0.0 5.9 1.0 1.0 4.1 5.9 17.9 0.1 24.2 0.6 0.2 0.0 0.2 0.5 3.7 0.0 0.3 2.8 1.2 9.2 0.1 0.5 0.1 4.6 0.2 0.0 0.2 10.7 0.0 0.1 0.0 1.9 11.2 16.1 0.1 2.2 0.9 1.0 6.5 1.8 19.2 1.5 2.6 0.1 2.5 0.6 0.8 1.0 1.4 0.0 1.0 30.0 1.3 3.0 1.1 0.0 1.1 10.2 20.9 2.7 9.9 14.7 10.8 25.8 7.4 17.8 20.4 TMCO6 "FLJ39769, PRO1580" ENSG00000113119 "Transmembrane and coiled-coil domains 6" Q96DC7 5 140639427-140645408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037473, HPA037474" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037473: AB_10671049, HPA037474: AB_10671050" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (3.95e-2)" "unprognostic (1.38e-2)" "unprognostic (6.10e-3)" "unprognostic (1.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.11e-1)" "unprognostic (4.89e-2)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (6.24e-2)" "prognostic unfavourable (6.37e-4)" "unprognostic (7.21e-2)" "unprognostic (1.77e-1)" "unprognostic (1.96e-2)" "unprognostic (1.20e-2)" 9.0 15.9 4.0 10.2 6.0 4.9 9.1 9.9 7.9 10.0 10.3 9.6 5.8 5.6 9.6 8.0 9.6 11.8 9.0 5.2 4.4 5.2 6.1 21.4 5.8 9.9 6.1 5.8 13.2 9.9 6.1 7.2 10.5 6.0 7.5 4.3 6.0 16.9 5.9 5.4 7.4 8.5 5.6 6.6 12.0 6.7 19.0 5.2 14.7 8.4 5.5 11.4 7.7 7.7 9.1 7.6 13.4 10.2 4.3 11.3 4.8 3.0 5.9 3.9 5.8 3.9 4.1 14.7 2.4 2.7 3.0 3.2 9.0 5.5 12.0 6.4 1.8 6.0 3.1 6.6 1.4 4.3 11.1 9.2 2.6 6.3 5.4 5.2 3.5 6.8 1.5 3.7 6.0 7.0 3.7 4.0 3.6 5.8 12.0 11.9 4.5 9.2 10.2 8.3 12.1 3.5 2.7 6.9 2.9 6.9 13.0 6.1 10.5 6.1 3.3 0.1 2.9 1.1 0.9 7.0 4.1 5.5 1.9 8.2 3.6 10.6 7.3 5.8 6.1 9.9 6.8 9.1 8.1 6.2 7.6 6.4 11.3 4.8 13.4 4.3 10.2 2.1 8.7 4.8 4.0 6.0 9.9 7.9 4.4 5.2 6.1 5.8 6.0 5.2 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039739 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039739: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favourable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favourable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.6 23.7 8.5 7.0 20.3 19.6 8.5 10.1 15.4 20.1 19.2 17.6 25.3 10.9 2.8 10.4 14.9 9.8 17.6 15.4 11.8 19.8 8.2 19.0 35.6 17.5 13.1 14.3 17.5 20.1 14.2 20.2 17.5 16.8 21.5 12.5 12.9 14.1 15.1 4.0 26.8 12.3 18.4 19.8 16.7 7.9 11.1 8.8 6.5 0.2 24.1 11.7 25.3 10.5 18.5 12.4 8.0 19.8 22.4 15.4 5.0 19.4 12.5 16.4 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776483-74839779 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favourable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 11.5 15.5 10.6 11.6 12.1 15.4 7.7 10.5 13.9 8.1 7.9 19.1 9.5 7.6 7.4 8.9 9.3 6.8 9.6 9.0 11.4 8.2 10.9 19.9 14.7 19.0 17.3 9.1 9.4 18.7 21.0 14.7 12.5 13.1 8.0 6.7 10.0 15.1 9.1 7.5 9.7 7.7 9.4 18.5 10.4 8.3 17.4 14.2 7.5 11.7 6.5 10.2 10.6 6.1 4.9 8.8 5.7 7.7 3.9 7.9 5.0 6.2 15.4 8.3 9.3 11.7 7.3 4.9 10.8 11.0 13.9 15.5 12.6 6.8 3.3 3.5 12.3 7.1 8.3 6.0 7.4 2.4 11.7 8.3 6.3 8.7 8.6 13.6 7.7 5.8 6.7 14.1 3.1 9.9 4.8 5.2 9.4 6.0 8.1 5.5 4.5 12.4 5.1 13.1 5.5 6.2 5.5 7.0 9.2 6.0 7.8 8.0 10.0 21.1 7.8 29.4 7.5 11.1 14.0 3.6 3.1 3.8 11.3 14.2 11.1 2.2 7.7 5.7 7.9 6.5 4.0 4.9 7.6 7.2 8.3 1.6 6.3 4.4 3.6 3.9 6.6 8.8 7.5 5.0 10.6 12.1 10.5 13.9 11.4 8.2 17.3 9.1 13.1 14.2 TMEM106B "FLJ11273, MGC33727" ENSG00000106460 "Transmembrane protein 106B" Q9NUM4 7 12211241-12243367 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058342 Approved Supported Endosomes,Lysosomes "Endosomes, Lysosomes" "HPA058342: " "unprognostic (5.29e-2)" "unprognostic (2.34e-2)" "unprognostic (4.20e-2)" "unprognostic (6.20e-2)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (3.50e-2)" "unprognostic (5.89e-2)" "unprognostic (4.44e-2)" "unprognostic (1.30e-1)" "unprognostic (3.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.75e-3)" "unprognostic (5.52e-2)" "unprognostic (3.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-1)" 17.1 48.3 16.2 11.4 23.7 6.2 17.0 18.5 29.0 26.0 20.3 19.4 13.5 16.1 24.9 19.7 18.5 19.9 18.0 20.8 15.7 16.2 30.9 33.0 12.9 11.7 20.5 21.2 22.1 18.3 17.5 31.3 35.3 26.8 27.2 22.6 15.2 23.2 24.3 23.9 15.5 18.1 24.8 24.8 13.5 15.5 12.0 21.3 14.7 30.7 14.9 12.4 21.4 17.9 7.6 2.8 8.8 6.3 14.1 19.4 7.3 9.8 23.4 9.5 25.3 22.2 21.6 10.1 14.6 33.4 10.3 13.3 5.7 38.9 3.9 16.5 19.4 11.4 8.2 9.6 14.1 5.7 7.5 4.8 10.9 6.7 17.9 12.7 6.9 17.3 12.4 7.6 18.0 15.8 11.5 11.8 15.4 4.2 2.8 7.2 15.3 9.5 7.1 8.2 7.7 25.5 9.9 12.2 17.3 15.6 14.2 13.4 12.9 9.1 15.6 14.9 18.0 12.8 12.5 10.9 19.7 4.6 18.6 5.2 34.1 8.8 4.2 4.8 9.4 4.9 13.5 6.3 11.6 11.1 2.8 7.6 19.4 13.5 2.5 14.1 6.3 0.9 9.7 7.3 16.2 23.7 18.5 29.0 15.7 16.2 20.5 21.2 26.8 21.3 TMEM107 MGC10744 ENSG00000179029 "Transmembrane protein 107" Q6UX40 17 8173237-8176399 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052555, HPA059653" Approved Approved "Nucleoplasm,Plasma membrane,Midbody ring" "Nucleoplasm, Plasma membrane" "Midbody ring" "HPA052555: , HPA059653: " "unprognostic (2.87e-2)" "unprognostic (2.67e-1)" "unprognostic (2.85e-2)" "prognostic favourable (9.39e-5)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (5.70e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (6.02e-3)" "unprognostic (1.83e-2)" "unprognostic (1.87e-1)" "unprognostic (2.66e-3)" "unprognostic (1.26e-1)" "unprognostic (4.99e-1)" "unprognostic (2.66e-1)" "unprognostic (1.49e-1)" 8.6 11.8 13.7 7.1 19.6 17.5 13.0 7.3 23.2 11.7 8.3 9.9 10.7 4.2 10.0 30.1 8.8 38.7 9.4 8.8 11.0 13.4 12.1 4.0 12.8 17.7 10.9 17.1 7.5 9.6 17.8 20.8 10.0 15.6 5.9 7.8 12.6 8.7 10.1 1.7 12.7 6.0 10.1 10.5 11.9 7.1 15.9 8.2 7.8 19.1 4.3 9.6 9.5 7.8 33.1 18.7 28.4 29.9 14.5 20.8 12.7 31.2 9.8 15.3 7.0 9.2 14.0 3.1 7.3 6.9 6.4 8.4 1.2 17.9 8.5 9.4 7.3 21.8 6.3 14.3 10.1 10.6 7.3 4.6 17.2 3.3 3.7 1.8 5.2 6.8 9.1 16.9 8.2 10.6 3.9 16.9 15.1 9.3 4.2 4.9 1.6 4.6 7.8 4.2 12.3 11.8 2.4 4.5 7.0 8.5 1.8 6.2 5.4 6.3 6.7 3.2 6.2 5.1 3.9 6.6 3.6 3.4 18.8 7.1 5.2 10.5 13.3 28.4 18.8 15.8 16.3 26.7 18.1 20.0 11.8 33.1 20.0 20.8 10.9 14.5 29.9 18.7 14.3 12.7 13.7 19.6 7.3 23.2 11.0 13.4 10.9 17.1 15.6 8.2 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: " "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.4 0.8 3.9 0.0 0.0 0.0 0.0 11.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.3 0.0 0.1 1.8 0.0 0.0 2.2 0.0 0.5 0.0 10.0 44.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.8 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 TMEM109 MGC5508 ENSG00000110108 "Transmembrane protein 109" Q9BVC6 11 60913874-60923443 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011785 Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA011785: AB_1858075" "unprognostic (5.23e-2)" "unprognostic (9.02e-2)" "unprognostic (2.46e-2)" "unprognostic (2.69e-2)" "unprognostic (1.23e-1)" "unprognostic (2.40e-2)" "unprognostic (5.29e-3)" "unprognostic (2.95e-1)" "unprognostic (2.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.52e-1)" "unprognostic (3.63e-2)" "unprognostic (1.83e-1)" "unprognostic (2.82e-1)" "unprognostic (1.51e-1)" "unprognostic (2.84e-2)" "prognostic unfavourable (2.68e-4)" 40.2 21.2 7.7 22.4 11.5 10.4 45.4 13.4 17.4 39.7 28.8 17.0 17.7 12.0 43.1 25.9 38.0 30.0 32.0 32.7 9.9 8.3 27.0 31.7 30.0 26.0 16.5 9.5 42.6 28.5 23.2 18.9 36.2 12.4 38.5 11.8 44.1 43.4 27.5 41.9 28.4 19.2 38.0 10.5 28.8 25.1 16.6 12.1 21.5 36.9 35.2 33.0 35.6 44.7 25.5 83.1 9.5 13.7 19.9 36.2 21.9 24.2 21.4 13.8 23.1 35.2 16.2 11.6 22.8 20.6 24.2 21.0 19.1 25.8 28.0 42.6 25.3 31.9 14.4 9.8 14.7 21.8 19.1 19.8 10.1 4.2 10.4 40.1 17.7 11.0 12.5 18.8 9.4 29.3 10.2 73.7 17.2 44.1 29.5 17.2 23.7 21.9 29.4 27.0 40.2 11.9 12.4 5.7 10.0 18.1 43.9 21.6 24.6 7.3 30.0 31.2 15.0 39.4 20.7 25.3 18.6 15.0 27.8 17.3 36.1 6.2 13.7 9.5 35.8 12.1 36.2 22.3 20.8 30.3 40.8 25.5 19.0 24.3 1.5 19.9 8.8 83.1 15.5 21.9 7.7 11.5 13.4 17.4 9.9 8.3 16.5 9.5 12.4 12.1 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.1 4.4 6.2 6.9 6.2 4.9 4.2 3.4 5.5 4.5 4.9 3.3 3.5 4.8 2.2 2.5 4.3 3.4 3.6 3.9 11.6 2.8 3.1 4.2 4.1 9.9 1.2 0.5 6.0 6.3 5.7 10.0 1.5 5.9 3.9 4.5 6.2 1.8 9.8 7.7 2.9 4.9 2.5 8.3 14.0 23.6 5.9 3.9 3.7 3.2 5.7 11.8 16.3 1.1 4.2 1.3 3.8 1.5 4.7 8.1 4.6 5.9 3.8 5.9 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 23.1;cerebellum: 35.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 7.9 7.0 5.6 4.7 23.1 9.3 5.6 35.6 6.9 11.1 4.4 3.3 8.6 4.2 10.0 5.4 2.8 12.2 4.5 3.9 5.9 3.8 4.5 4.7 5.3 4.0 4.5 4.3 5.0 14.3 5.9 11.6 2.4 6.0 5.2 3.1 5.5 14.9 6.2 17.2 5.7 3.8 8.0 2.9 4.3 4.9 3.4 5.8 1.9 10.6 4.0 3.8 3.6 7.1 4.1 4.0 3.6 1.6 2.4 3.4 1.3 4.8 16.6 3.9 11.4 4.8 6.4 8.0 6.4 7.4 6.2 5.0 10.5 5.6 5.2 4.0 6.5 8.3 9.1 7.7 3.3 3.1 8.4 7.2 5.2 6.4 6.7 5.1 5.7 6.0 6.9 7.0 5.1 3.8 6.4 3.8 3.7 7.8 8.4 7.0 7.0 10.2 10.0 16.1 6.9 3.2 5.3 15.0 10.7 6.3 5.0 5.6 11.2 4.1 5.3 8.3 9.4 5.3 5.5 8.9 3.1 3.8 10.6 6.6 8.3 3.1 1.4 1.7 3.4 1.6 2.8 2.9 3.3 2.7 1.6 4.1 2.4 2.8 3.6 2.4 1.5 4.0 2.8 1.3 5.6 23.1 35.6 6.9 5.9 3.8 4.5 4.3 6.0 5.8 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: " "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 3.1 2.2 0.1 0.2 3.0 0.0 0.3 0.1 14.7 2.2 0.0 0.0 0.3 0.0 11.8 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 9.8 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: " "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 21.3 23.1 18.8 30.1 23.3 39.8 38.6 7.4 18.8 35.2 38.2 19.1 15.1 12.4 65.3 20.8 31.9 21.6 20.8 36.8 20.7 14.0 27.0 95.4 39.5 55.5 22.6 13.7 27.8 24.7 14.5 8.5 23.9 21.1 34.9 19.9 13.9 53.3 22.2 13.2 29.7 17.6 29.7 22.4 39.9 23.7 22.9 24.6 71.9 66.0 20.1 27.1 43.7 39.8 23.3 30.3 48.3 29.2 52.4 55.5 51.3 28.8 25.9 26.8 24.9 34.3 28.1 18.2 22.5 48.8 46.1 51.3 32.8 140.1 48.7 58.1 52.1 31.3 29.1 37.1 51.0 29.3 10.6 25.3 10.2 48.7 30.3 53.7 19.0 31.3 42.3 32.9 49.3 51.5 16.9 0.1 38.0 9.3 46.6 16.8 16.0 23.7 28.7 74.1 46.7 43.9 28.6 12.7 15.0 27.3 37.4 14.8 23.1 21.0 60.3 31.0 34.8 26.8 16.9 18.9 10.5 49.5 9.0 59.9 20.4 30.1 26.8 48.3 26.3 29.2 40.0 16.7 41.3 31.8 30.3 23.3 55.5 46.9 17.6 52.4 24.2 8.1 42.9 51.3 18.8 23.3 7.4 18.8 20.7 14.0 22.6 13.7 21.1 24.6 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell line enhanced" "Detected in some" "A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015796 Approved Midbody,Cytosol "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favourable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favourable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.5 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 10.6 25.2 0.0 0.6 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.2 4.3 6.6 0.0 0.0 21.7 0.0 17.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA046648: " "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 18.3 17.4 24.9 15.9 23.3 23.7 20.0 13.2 30.0 13.9 16.2 9.5 15.6 19.8 13.2 20.6 17.2 12.5 16.0 44.4 20.9 20.7 22.0 28.5 12.6 15.0 21.8 22.9 13.7 27.7 13.1 19.9 14.1 19.9 14.0 18.3 8.9 25.2 15.7 49.5 12.2 15.1 16.5 18.0 14.1 19.1 21.4 18.8 10.5 16.5 36.4 15.6 14.0 18.7 14.5 19.1 6.3 15.3 8.4 16.5 11.1 15.9 20.1 18.1 12.5 24.4 24.6 14.8 19.0 20.7 28.6 28.3 24.8 25.8 9.2 22.7 22.9 17.6 18.6 20.1 26.5 23.4 10.4 25.3 24.0 27.0 30.7 31.8 21.4 21.2 24.7 25.3 27.0 26.0 17.8 15.2 31.7 21.2 17.2 40.6 18.5 23.0 17.6 18.2 29.8 20.0 21.1 13.0 13.2 17.2 27.2 15.8 33.7 21.9 15.4 27.8 19.8 52.0 21.8 10.2 17.8 24.2 14.6 22.9 32.9 2.9 13.4 6.3 12.5 15.3 16.5 14.5 16.4 14.6 19.1 13.2 15.6 15.4 1.2 8.4 13.1 14.4 14.1 11.1 24.9 23.3 13.2 30.0 20.9 20.7 21.8 22.9 19.9 18.8 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.3 8.2 15.5 11.2 16.3 19.8 16.9 19.9 19.5 10.2 12.3 10.6 19.4 21.4 11.0 20.5 9.7 16.2 26.6 15.2 15.1 10.5 15.5 5.8 15.2 18.4 14.4 20.9 18.9 10.9 18.1 18.9 12.5 9.2 22.9 31.0 8.0 10.4 9.2 8.5 17.8 15.3 9.9 9.4 10.5 16.0 17.5 8.5 12.9 8.9 12.2 7.5 13.4 14.8 26.7 12.3 12.8 7.6 9.8 13.4 10.8 20.9 12.7 18.0 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.4" "Cell line enhanced" "Detected in many" "Daudi: 36.5;MOLT-4: 33.9;U-698: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" Vesicles "Nucleoli fibrillar center" "HPA043472: , HPA048443: " "unprognostic (1.12e-1)" "prognostic favourable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 7.5 1.9 2.1 37.9 6.0 27.3 6.6 0.5 3.0 6.5 5.6 2.3 3.5 1.5 11.9 7.9 6.6 5.0 4.3 5.6 2.5 1.6 3.4 13.0 6.1 27.6 2.2 1.6 4.9 23.0 0.8 6.4 2.5 2.1 5.3 3.1 5.3 10.3 3.2 17.5 5.2 10.0 8.1 3.0 26.5 6.0 3.2 3.9 69.4 4.1 5.5 36.8 7.1 5.8 18.5 13.3 13.6 23.7 14.9 17.9 10.3 2.0 1.3 5.6 5.9 3.3 2.9 0.1 2.9 1.4 2.0 2.6 9.0 1.3 36.5 0.7 3.8 2.0 4.3 5.0 3.1 3.3 3.1 7.1 2.5 2.3 2.2 7.8 0.4 2.7 3.1 2.6 2.5 5.1 6.7 0.1 2.0 3.7 33.9 5.7 5.0 1.9 11.8 5.4 2.3 1.3 0.8 4.2 3.3 2.3 5.1 3.0 1.9 5.8 4.0 2.7 4.9 3.2 2.4 4.0 4.1 43.3 0.8 4.7 2.2 6.1 12.4 13.1 8.5 23.7 11.2 18.5 10.7 7.9 13.3 17.3 17.9 12.0 13.6 14.9 18.6 1.3 12.9 10.3 2.1 6.0 0.5 3.0 2.5 1.6 2.2 1.6 2.1 3.9 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Group enriched" "Detected in some" 6 "AF22: 5.9;ASC diff: 8.5;Daudi: 9.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Supported Centrosome,Cytosol 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 5.9 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 30.9" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: " "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol Vesicles Cytosol "HPA074432: " "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.7 4.5 8.4 8.0 8.4 13.2 2.1 3.7 9.2 6.0 9.7 2.2 7.5 0.0 11.6 2.3 1.2 7.4 2.8 6.7 0.0 4.6 5.5 4.0 3.9 9.4 0.0 0.0 11.4 2.1 8.4 13.1 6.9 1.5 11.1 8.0 2.1 0.0 0.0 3.6 2.8 4.2 3.4 0.6 7.9 1.6 5.4 5.3 5.2 0.6 1.0 6.9 0.2 4.9 6.6 6.7 1.4 2.2 0.1 0.0 0.0 1.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell line enhanced" "Detected in some" "A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favourable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.5 0.7 0.1 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 2.2 17.9 0.1 12.6 0.0 8.1 0.0 4.1 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.6 0.4 0.0 0.7 0.1 0.1 0.0 31.5 2.4 0.1 0.0 0.4 11.1 0.0 30.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 TMEM141 MGC14141 ENSG00000244187 "Transmembrane protein 141" Q96I45 9 136791355-136793257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014615, HPA050244" Approved Supported "Cell Junctions,Mitochondria" Mitochondria "Cell Junctions" "HPA014615: AB_2204756, HPA050244: " "unprognostic (2.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (2.00e-1)" "unprognostic (8.53e-3)" "unprognostic (1.52e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.24e-1)" "unprognostic (8.45e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.49e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" 10.0 15.5 15.7 23.4 15.3 15.5 22.9 11.6 28.3 17.2 54.4 21.0 22.4 21.9 9.4 31.1 35.5 22.6 27.9 22.8 15.2 12.2 38.5 43.4 14.4 23.0 19.9 19.3 13.8 46.3 20.6 23.1 31.7 22.0 49.0 51.4 12.5 32.5 27.5 13.5 22.0 25.6 10.5 19.1 14.1 23.3 16.5 13.8 16.3 28.6 26.0 15.2 16.4 16.3 11.1 42.7 9.0 19.4 12.4 11.3 12.2 16.0 11.6 10.4 6.5 13.1 10.6 22.5 9.1 14.2 11.2 9.0 15.3 14.6 15.4 14.2 9.8 23.9 4.4 26.5 3.6 11.2 8.0 8.6 6.5 17.1 19.2 8.9 10.8 10.1 45.5 8.6 24.4 16.7 8.5 8.3 14.7 32.7 12.2 6.9 5.0 13.1 10.2 11.0 45.3 25.5 9.0 17.5 7.9 9.8 37.2 10.2 66.4 8.7 11.4 8.0 6.4 14.6 5.9 5.4 8.4 8.2 12.1 12.9 11.5 6.5 13.8 9.0 11.3 19.4 10.2 8.7 7.9 8.1 11.2 11.1 10.9 10.0 3.3 12.4 16.0 42.7 7.5 12.2 15.7 15.3 11.6 28.3 15.2 12.2 19.9 19.3 22.0 13.8 TMEM147 "MGC1936, NIFIE14" ENSG00000105677 "Transmembrane protein 147" Q9BVK8 19 35545595-35547526 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067837 Approved "Golgi apparatus,Actin filaments" "Golgi apparatus, Actin filaments" "HPA067837: " "unprognostic (6.98e-2)" "unprognostic (1.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (5.72e-2)" "prognostic unfavourable (4.98e-6)" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (7.34e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (4.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" 22.7 46.2 22.3 19.3 26.8 15.6 53.2 18.9 42.0 23.1 23.4 16.3 30.0 18.9 23.7 47.2 29.5 24.8 30.2 57.5 20.1 22.0 33.3 29.8 29.9 53.2 26.3 19.0 22.6 88.4 31.7 23.3 20.1 22.8 18.1 24.5 23.1 30.5 33.1 39.1 33.1 17.5 26.8 26.6 18.0 22.9 41.8 19.2 9.8 39.4 31.4 18.9 21.0 25.4 40.9 54.9 22.6 51.8 21.8 35.1 47.2 32.0 70.2 14.0 32.7 62.3 28.6 23.1 20.4 33.6 25.4 23.7 33.2 19.5 18.6 32.8 31.0 12.7 24.1 29.4 21.0 29.5 33.1 20.2 21.2 38.8 49.6 28.5 22.3 31.0 46.0 23.9 60.0 23.2 26.0 66.2 26.9 39.2 16.3 15.8 19.9 30.6 15.8 13.0 44.2 40.0 32.6 12.5 20.8 19.0 43.7 39.1 15.8 23.9 15.0 29.0 23.2 16.4 41.1 34.8 35.1 10.3 25.2 38.6 23.3 7.3 51.8 22.6 25.1 47.3 35.1 40.9 34.0 28.9 47.0 34.7 25.7 26.0 3.0 21.8 33.3 54.9 32.9 47.2 22.3 26.8 18.9 42.0 20.1 22.0 26.3 19.0 22.8 19.2 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671109-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA072536: " "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 8.7 24.4 26.7 6.2 32.0 4.3 12.9 25.7 40.0 13.9 12.5 13.5 5.8 18.9 14.3 19.3 18.0 16.3 12.6 8.1 25.5 40.7 25.8 52.7 9.0 8.8 28.3 22.6 21.0 23.8 9.2 12.9 7.9 31.7 19.0 13.3 25.7 9.6 11.7 2.0 6.8 17.4 13.4 29.1 6.5 20.3 8.4 10.7 5.8 14.6 11.1 11.6 14.1 11.6 22.3 14.3 6.4 0.2 4.0 25.7 11.9 68.3 10.4 7.7 21.8 21.2 16.3 6.5 13.8 19.0 12.8 19.9 15.8 17.7 8.4 15.5 17.4 26.2 17.1 23.2 21.6 33.8 14.0 12.4 17.0 25.9 6.9 6.3 15.5 14.6 16.3 14.0 3.1 17.3 2.6 24.0 15.2 13.9 12.3 7.2 4.5 18.1 9.7 11.0 6.6 24.8 13.2 40.2 19.5 15.4 12.4 25.7 19.1 12.2 12.6 17.8 23.9 6.9 22.2 11.6 9.8 12.6 25.0 4.0 14.1 6.4 0.2 6.4 16.4 0.0 10.6 22.3 21.2 17.2 7.8 13.2 16.4 17.5 0.9 4.0 0.0 14.3 25.7 11.9 26.7 32.0 25.7 40.0 25.5 40.7 28.3 22.6 31.7 10.7 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 18.2 4.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA019184: , HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.0 0.0 0.1 0.0 0.2 3.5 5.5 3.0 11.3 3.3 6.4 0.1 1.6 12.4 1.3 2.8 8.8 0.0 24.3 6.2 0.0 0.0 0.6 0.1 0.0 3.6 9.5 28.0 3.3 11.7 10.7 9.3 8.3 0.0 21.8 0.2 0.8 3.7 2.9 0.6 2.9 0.4 0.0 0.0 19.2 7.4 0.0 0.5 0.7 2.4 0.4 0.3 6.7 3.3 0.4 2.0 0.3 4.2 27.3 9.2 6.8 4.6 21.7 2.5 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell line enhanced" "Detected in all" "HMC-1: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favourable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.7 10.9 9.0 5.8 11.1 8.2 5.5 2.4 5.6 5.1 3.3 8.5 7.5 3.8 16.3 3.7 7.0 7.7 12.6 5.0 10.5 5.3 25.9 5.9 3.5 6.6 11.4 37.1 11.3 22.3 9.1 12.7 9.9 8.0 4.6 9.0 9.5 11.9 14.5 8.0 7.9 5.5 6.9 3.2 8.1 5.0 8.4 9.4 15.3 15.1 7.0 4.4 11.4 22.0 4.3 3.2 5.0 3.4 2.7 3.4 3.1 11.3 14.3 11.5 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 TMEM168 "DKFZp564C012, FLJ13576" ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762382-112790592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favourable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 14.4 14.9 9.0 11.4 14.6 5.6 15.4 6.9 15.7 15.7 21.2 17.9 17.6 13.2 17.4 18.3 19.1 15.0 12.1 18.9 11.8 8.2 18.8 11.8 13.5 21.3 12.6 7.8 17.5 9.9 28.2 12.7 26.3 15.5 16.6 24.3 18.4 19.6 14.5 11.0 25.5 18.4 19.7 15.7 16.4 14.3 13.9 12.4 17.8 17.5 12.6 17.4 14.7 16.9 15.4 17.9 16.5 16.9 13.7 22.4 10.0 9.1 7.8 7.3 6.6 12.6 25.8 10.4 10.2 9.6 3.8 3.4 9.9 9.8 9.8 6.9 10.1 10.0 7.4 8.9 10.0 15.3 7.6 8.2 9.6 5.6 8.5 9.4 10.8 12.5 23.2 4.4 6.6 11.2 11.3 9.0 13.9 14.7 8.0 5.9 5.9 6.0 5.4 3.6 14.2 9.7 17.6 5.5 10.9 13.4 18.4 7.8 10.3 8.3 15.9 18.7 9.4 8.6 13.1 15.4 13.0 11.0 12.1 8.3 23.4 16.5 16.9 12.5 14.2 13.7 16.9 12.4 15.3 13.8 17.9 15.4 22.4 15.5 9.4 13.7 13.5 12.2 13.7 10.0 9.0 14.6 6.9 15.7 11.8 8.2 12.6 7.8 15.5 12.4 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA062462: , HPA062797: , HPA070657: , HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.3 0.2 0.9 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.4 0.1 6.1 0.3 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 0.0 0.0 0.4 6.7 0.7 0.2 0.3 4.3 0.1 1.5 2.4 0.2 12.2 0.0 10.5 15.1 0.2 0.2 6.0 0.4 1.1 0.1 0.2 0.4 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.5 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 TMEM173 "ERIS, FLJ38577, MITA, MPYS, NET23, STING" ENSG00000184584 "Transmembrane protein 173" Q86WV6 5 139475534-139482935 "Disease related genes, Predicted membrane proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.8;EFO-21: 37.4;HDLM-2: 79.4;Karpas-707: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038116, HPA038534" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA038116: AB_2675841, HPA038534: AB_2676067" "unprognostic (1.45e-1)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (2.70e-2)" "unprognostic (1.71e-2)" "unprognostic (7.66e-2)" "unprognostic (2.77e-2)" "unprognostic (6.30e-2)" "unprognostic (1.01e-1)" "unprognostic (5.69e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (3.59e-8)" "unprognostic (9.18e-3)" "unprognostic (4.14e-2)" "unprognostic (4.45e-2)" "unprognostic (1.34e-1)" 22.9 6.5 6.3 17.4 6.7 18.1 15.9 1.2 4.5 22.5 9.4 6.0 13.3 6.4 16.7 18.1 16.0 24.4 13.5 26.3 3.8 3.1 12.5 8.1 32.0 41.3 7.9 2.3 30.7 3.9 1.9 8.1 13.9 6.8 20.3 8.8 14.7 16.6 14.6 10.3 9.6 10.9 16.2 7.1 35.8 8.0 11.1 6.3 15.8 13.0 16.5 29.7 17.7 17.9 0.3 26.9 5.8 29.1 39.8 28.9 26.1 1.1 0.5 0.0 0.0 1.2 4.0 0.1 6.4 24.8 3.2 10.3 0.0 8.9 0.0 37.4 19.3 4.7 0.1 9.5 1.2 79.4 0.9 5.4 2.5 0.3 2.2 1.6 0.1 5.7 0.4 2.1 2.6 11.0 1.6 24.9 11.5 0.0 0.8 8.3 0.0 1.8 0.3 2.3 7.4 2.8 2.4 2.5 0.0 2.2 2.3 6.2 0.3 21.5 8.0 0.8 0.4 2.5 1.9 0.0 7.5 0.0 0.1 23.2 2.8 5.8 29.1 0.0 28.8 19.4 14.2 0.3 28.2 23.2 26.9 0.2 19.4 17.5 2.4 39.8 7.8 9.2 28.9 26.1 6.3 6.7 1.2 4.5 3.8 3.1 7.9 2.3 6.8 6.3 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057160: " "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favourable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.0 3.5 4.8 16.7 8.8 8.1 8.1 5.9 5.0 7.4 2.8 13.2 2.5 5.1 8.5 5.5 3.2 6.4 2.2 6.2 7.4 5.1 8.8 2.8 9.7 2.7 9.6 12.4 7.8 4.4 3.0 3.1 5.2 20.7 4.3 10.8 6.8 11.1 2.2 17.0 4.8 2.1 7.1 4.7 3.1 9.5 8.4 5.7 3.6 5.4 15.8 7.4 4.0 9.2 2.1 10.6 6.2 14.1 3.7 4.8 8.9 5.9 7.4 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Group enriched" "Detected in some" 17 "HSkMC: 117.6;THP-1: 37.5" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: " "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 117.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 37.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 TMEM177 MGC10993 ENSG00000144120 "Transmembrane protein 177" Q53S58 2 119679167-119686507 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036689, HPA053816" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA036689: , HPA053816: " "unprognostic (1.24e-1)" "unprognostic (2.65e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (9.81e-3)" "unprognostic (2.05e-3)" "unprognostic (3.17e-2)" "unprognostic (8.05e-2)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-1)" "unprognostic (4.90e-1)" "unprognostic (6.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" 3.5 9.5 10.0 6.0 11.4 1.3 8.8 10.4 16.9 6.7 13.5 9.0 6.1 20.1 8.1 11.9 6.7 13.5 9.4 9.2 9.5 8.7 15.2 27.9 4.6 7.6 7.6 9.8 10.5 10.4 7.7 19.2 4.1 6.6 7.2 11.7 7.3 9.1 9.0 13.5 8.3 16.5 8.1 6.6 5.1 7.7 9.0 8.8 6.7 7.3 4.9 6.4 6.3 5.7 7.4 4.9 2.1 2.3 5.7 15.9 5.3 11.0 9.8 8.6 8.3 2.4 2.3 4.4 4.1 5.2 12.3 9.4 24.6 6.2 18.3 10.3 3.6 6.7 13.9 14.2 7.1 8.6 25.8 9.4 5.8 27.2 5.2 5.9 7.0 6.4 10.2 9.7 6.4 7.8 14.5 2.4 6.6 9.1 10.3 11.7 22.0 14.9 9.4 8.4 10.8 12.2 5.8 17.1 10.0 5.6 11.6 12.8 8.8 10.2 6.3 6.1 14.9 4.6 8.1 2.5 1.8 11.2 2.3 7.4 10.9 0.0 2.3 2.1 7.7 1.9 7.8 6.0 6.6 7.6 4.3 7.4 15.9 9.8 0.7 5.7 1.1 4.9 6.2 5.3 10.0 11.4 10.4 16.9 9.5 8.7 7.6 9.8 6.6 8.8 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Cell line enhanced" "Detected in many" "HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA048771 Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA048771: " "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favourable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.7 0.8 1.0 0.0 0.0 2.2 2.3 0.2 0.0 6.9 0.0 2.3 6.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 5.9 0.0 0.4 1.1 2.9 9.6 2.7 7.6 4.6 0.1 0.3 1.0 1.0 0.0 0.0 0.1 1.1 3.1 0.0 0.1 0.0 0.0 0.5 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040189 Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA040189: AB_10793959" "unprognostic (1.93e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.3 6.0 8.5 13.1 22.5 20.7 16.3 23.5 13.8 12.3 14.1 10.2 12.8 4.3 12.2 19.5 15.4 12.6 15.5 19.6 6.4 9.0 8.1 8.9 21.4 18.5 10.1 7.8 17.1 15.3 13.6 18.6 19.6 15.4 5.5 20.0 6.2 4.4 12.7 6.6 7.6 4.4 9.8 4.9 11.7 8.1 25.2 17.3 17.2 16.2 11.2 6.1 14.3 18.7 12.7 8.6 21.0 20.2 3.2 2.2 4.8 15.3 12.7 12.1 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045861 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045861: " "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.8 2.8 2.1 6.5 2.7 2.6 7.6 2.6 2.3 2.7 3.8 9.0 6.8 4.0 9.1 0.9 2.8 2.3 3.7 5.6 9.0 1.8 6.0 1.3 5.7 3.1 5.4 4.8 3.3 6.7 4.2 3.8 0.3 4.2 1.6 2.7 3.5 2.9 5.2 3.6 2.9 3.1 5.5 3.8 3.7 4.2 5.4 1.9 3.5 3.9 8.5 3.2 2.9 0.2 4.3 3.1 3.3 3.3 3.9 9.9 3.3 4.4 9.0 6.4 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: " "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.8 9.3 16.5 16.1 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.8 15.5 20.0 12.2 24.8 18.7 32.2 11.6 13.8 28.4 22.9 28.9 43.7 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.0 18.4 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.0 14.9 8.8 6.9 17.6 14.2 20.4 18.5 26.3 15.2 13.5 10.9 7.9 3.2 14.5 27.5 21.1 7.9 18.2 10.3 11.6 14.2 6.4 10.9 9.0 18.5 5.0 9.0 11.8 16.1 17.8 20.0 18.9 4.1 11.4 13.2 9.7 3.2 4.3 7.1 13.7 5.5 7.9 3.2 11.2 18.9 19.2 3.4 13.9 20.3 9.8 11.1 3.7 27.9 15.5 15.9 13.6 11.2 23.9 58.9 2.6 22.5 3.7 13.3 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054013: " "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favourable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.1 14.3 18.2 13.9 24.9 24.3 11.9 17.1 20.1 12.8 14.8 11.8 17.5 8.5 8.6 13.3 11.0 14.7 13.1 14.1 18.9 8.5 11.0 11.1 8.5 19.2 14.6 16.4 18.1 17.7 14.0 14.7 16.4 14.0 24.0 17.8 13.7 12.7 5.3 11.7 8.4 12.7 6.3 14.7 14.2 17.1 14.2 18.3 9.3 14.6 14.9 14.5 9.2 16.1 16.2 8.8 13.2 10.9 26.3 34.4 11.4 19.0 8.8 17.5 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038134 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favourable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.3 9.5 2.1 7.6 8.2 7.4 1.1 3.4 1.7 1.0 3.4 1.9 14.4 1.3 19.7 2.7 7.6 2.9 5.0 0.8 10.7 3.9 2.3 5.0 3.1 7.0 1.1 2.6 8.3 7.6 2.9 4.3 2.6 2.0 10.8 4.3 9.0 4.4 1.5 1.5 10.6 4.1 1.1 13.9 5.3 2.7 2.8 2.8 5.0 4.2 3.6 8.0 2.7 4.8 1.7 1.8 6.9 1.9 7.6 5.1 1.7 5.1 5.0 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavourable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favourable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.2 9.5 3.4 8.7 9.0 3.2 8.0 9.5 14.1 10.0 11.2 5.5 10.3 13.8 5.7 6.1 5.6 12.8 9.8 11.6 8.9 6.6 7.6 7.1 6.2 23.0 18.8 10.3 11.6 20.9 8.9 18.3 8.1 13.0 23.2 12.2 13.6 3.2 5.6 7.1 8.1 7.4 3.0 12.5 8.1 9.2 7.3 7.7 14.9 23.7 15.1 11.5 8.7 6.1 4.4 5.4 13.8 10.8 22.8 30.2 19.2 10.6 10.4 17.5 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Group enriched" "Detected in some" 9 "ASC diff: 8.6;ASC TERT1: 8.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.6 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell line enhanced" "Detected in many" "AF22: 37.7;BEWO: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.9 28.8 37.7 1.7 3.9 7.1 35.0 20.3 13.0 14.1 10.4 8.1 8.2 0.1 6.1 5.2 9.0 12.2 2.8 19.2 0.7 3.7 10.3 6.1 21.4 6.1 0.0 2.8 7.3 3.1 10.9 2.4 18.5 1.4 3.0 7.6 5.0 1.2 0.1 7.8 2.8 0.9 11.2 0.8 8.9 19.4 1.9 0.2 5.3 3.7 5.4 2.6 0.4 8.1 9.6 10.8 5.3 10.1 0.6 8.7 0.3 1.8 0.9 12.1 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favourable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavourable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.4 6.6 15.5 2.8 1.8 5.9 9.1 2.8 10.8 7.7 19.2 7.0 13.5 11.6 3.1 16.2 7.3 7.2 3.6 8.8 18.3 9.5 10.0 9.7 5.1 11.5 9.9 3.4 3.3 14.5 2.4 4.3 12.1 3.9 4.3 9.1 9.9 8.4 6.7 9.7 21.1 11.3 11.0 3.8 4.2 15.8 11.9 7.2 17.6 7.8 5.4 7.3 3.9 13.0 11.3 14.2 17.0 6.6 5.4 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.0 47.2 5.8 19.8 11.6 14.0 11.0 7.2 16.8 15.9 12.4 14.3 6.1 17.1 44.1 14.6 19.5 8.4 21.8 10.7 20.0 8.0 4.5 16.4 23.5 29.3 7.7 14.6 13.2 22.3 10.2 17.1 19.1 13.7 73.2 9.8 48.1 11.5 21.4 10.4 36.2 10.9 9.0 45.1 38.6 34.5 10.5 16.0 7.6 31.5 17.6 27.4 22.4 11.2 20.0 7.6 21.8 16.1 43.6 43.5 10.1 19.3 34.5 15.3 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.4 9.1 12.4 15.3 7.2 7.4 9.2 8.6 8.7 7.9 10.6 10.1 17.2 14.0 6.5 5.5 14.2 14.5 10.0 14.1 17.3 8.3 7.3 15.4 6.7 12.8 15.3 7.4 8.2 10.3 15.7 15.7 6.0 23.5 16.5 9.5 12.3 29.1 9.3 18.5 8.1 15.7 13.9 23.2 7.9 12.1 11.1 17.1 19.7 31.7 12.5 10.2 10.3 4.7 14.4 5.6 15.0 20.7 22.0 32.2 29.2 23.4 17.7 22.1 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: " "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.0 2.5 2.8 3.0 0.8 0.4 5.4 2.9 0.9 1.1 1.2 2.0 3.2 5.3 3.6 1.4 2.8 1.7 1.3 2.5 7.0 2.7 6.3 6.4 2.6 0.5 3.6 5.3 1.1 1.5 1.4 1.1 1.3 4.4 8.5 0.9 2.6 3.2 4.0 4.8 2.6 2.7 4.4 4.4 1.1 3.1 3.3 3.2 4.0 3.0 2.2 3.6 3.3 6.5 4.5 4.9 7.1 3.1 5.0 4.0 3.5 2.3 3.3 2.3 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 TMEM214 FLJ20254 ENSG00000119777 "Transmembrane protein 214" Q6NUQ4 2 27032910-27041695 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034551 Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Golgi apparatus, Cytosol" "HPA034551: AB_10602481" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.10e-1)" "unprognostic (4.12e-3)" "unprognostic (1.90e-2)" "unprognostic (2.42e-2)" "prognostic unfavourable (4.96e-4)" "unprognostic (1.96e-1)" "unprognostic (3.70e-1)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.74e-2)" "prognostic unfavourable (2.39e-10)" "unprognostic (1.54e-2)" "unprognostic (1.97e-2)" "unprognostic (2.04e-1)" "unprognostic (2.92e-2)" 21.8 20.8 9.9 16.3 13.2 9.4 21.0 10.4 13.6 23.2 19.8 11.6 34.5 13.7 23.0 33.4 15.8 18.2 22.6 22.3 8.7 9.7 22.1 47.5 18.9 10.5 10.8 9.4 24.0 57.7 29.1 31.8 30.8 12.7 19.1 20.4 16.9 56.0 36.8 16.9 18.0 20.2 21.7 8.5 19.4 19.4 13.5 11.7 11.4 23.3 10.8 21.1 22.5 16.9 4.1 7.6 8.7 5.7 8.7 8.1 3.1 24.5 16.4 9.9 21.0 32.4 33.4 21.7 32.4 44.0 23.7 26.8 15.6 20.5 11.3 16.4 47.5 17.7 12.0 22.9 19.3 10.7 13.6 14.9 13.0 32.2 40.9 13.6 25.3 28.9 16.4 20.6 35.2 25.6 13.4 23.2 26.5 17.6 6.9 10.1 7.1 13.2 9.3 18.3 27.1 17.8 17.2 8.6 10.0 15.1 25.8 11.6 14.1 8.2 21.9 17.2 16.9 17.4 18.1 31.3 21.1 17.8 22.3 17.0 23.9 8.7 5.1 3.9 6.3 5.7 8.1 4.1 4.9 4.4 4.3 3.8 2.4 3.6 0.9 8.7 3.2 7.6 3.6 3.1 9.9 13.2 10.4 13.6 8.7 9.7 10.8 9.4 12.7 11.7 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Group enriched" "Detected in some" 6 "NTERA-2: 6.4;SH-SY5Y: 1.9" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: , HPA063207: " "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favourable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.7 15.2 9.7 11.7 9.0 12.5 5.8 7.7 5.9 6.0 7.9 1.5 23.0 9.8 19.5 4.7 9.0 6.0 7.4 8.0 13.6 8.6 21.9 4.2 6.2 8.8 6.8 8.2 9.8 9.8 10.7 12.8 8.8 8.8 12.5 10.4 4.0 1.7 14.4 7.9 14.5 10.1 11.7 7.4 5.4 7.8 8.4 12.6 10.6 4.2 5.4 20.2 9.9 11.1 7.4 6.8 8.7 8.4 7.2 6.0 8.0 6.0 14.3 13.0 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA016579: , HPA059374: " "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.6 20.6 19.6 14.3 10.1 19.0 21.9 26.1 22.2 6.1 25.8 7.8 14.9 20.2 17.0 13.7 18.5 10.9 10.3 26.4 13.0 12.4 14.1 29.2 12.9 13.1 24.8 10.5 24.9 14.3 17.3 9.8 18.1 16.2 10.9 18.5 13.6 23.5 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.4 20.6 20.9 15.8 15.4 13.0 24.7 17.9 19.6 17.4 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.1 12.9 7.7 10.6 6.2 7.1 10.6 8.2 7.1 9.2 7.7 11.3 18.6 11.4 20.1 5.8 23.1 9.3 10.1 5.3 18.0 17.5 8.4 14.6 13.4 11.5 10.3 10.0 7.7 10.2 6.0 7.6 7.0 12.8 8.5 6.8 22.0 10.3 23.0 15.3 15.7 12.9 9.4 25.3 14.2 9.7 13.3 17.6 8.5 17.4 21.5 26.0 9.7 7.4 11.1 13.4 10.1 9.7 17.6 14.0 13.0 13.1 9.3 11.5 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA029489: , HPA059922: " "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavourable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 2.0 1.5 3.5 1.2 7.4 11.9 3.4 3.0 6.0 3.3 5.6 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 6.8 5.2 4.2 5.5 3.4 2.7 0.5 1.4 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 4.1 1.2 2.6 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.8 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favourable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.5 18.1 13.4 4.5 31.6 18.2 29.6 19.6 15.2 21.2 16.8 24.3 27.3 12.3 20.2 14.9 21.5 17.0 12.6 25.1 15.9 7.3 15.2 15.1 14.3 13.8 11.5 12.0 19.4 12.9 20.6 19.1 17.7 10.1 13.6 24.0 8.9 15.3 5.3 14.9 16.4 8.8 26.6 7.6 22.6 13.3 7.4 7.3 13.0 13.0 13.0 17.3 6.5 19.4 16.5 12.4 15.4 22.3 9.1 23.4 3.9 23.0 6.2 23.9 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 19.4;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 4900000 "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: " "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 4.8 15.0 15.0 3.7 23.3 1.7 12.0 28.0 36.5 9.4 19.4 9.5 6.7 35.5 10.1 21.2 9.0 9.2 7.1 6.4 11.9 17.0 14.7 10.6 8.0 3.5 10.7 19.5 19.4 14.1 17.3 15.9 4.9 14.0 12.5 3.2 14.4 16.1 15.5 12.7 6.2 26.2 8.7 9.7 4.0 6.7 3.9 5.1 1.5 12.7 4.3 4.6 8.3 6.1 3.8 3.4 0.5 0.2 6.6 11.1 3.8 1.8 0.4 3.3 5.4 3.5 0.5 3.2 3.0 5.6 2.8 5.7 15.1 10.6 0.2 11.6 2.9 8.4 0.0 10.2 2.5 6.5 6.2 0.3 2.9 3.4 9.2 0.1 0.3 4.3 6.3 3.0 0.5 4.0 1.4 6.7 2.8 2.2 3.2 0.2 2.8 7.3 4.4 2.3 6.6 14.4 0.2 10.0 6.7 2.9 19.4 0.0 25.2 0.3 1.4 1.2 6.3 0.2 0.9 6.7 4.4 1.7 0.2 0.1 0.1 0.5 0.2 0.2 5.6 0.2 7.5 3.8 7.9 3.1 0.5 3.0 11.1 5.8 0.4 6.6 0.2 3.4 6.1 3.8 15.0 23.3 28.0 36.5 11.9 17.0 10.7 19.5 14.0 5.1 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93187089 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" "Cell Junctions" "Golgi apparatus" "HPA048559: " "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavourable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favourable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 15.8 19.5 12.2 10.7 14.3 3.9 23.1 11.5 14.2 21.9 19.6 11.4 19.6 15.5 13.0 26.2 10.8 15.8 11.5 23.2 12.2 12.8 25.0 14.4 24.1 19.1 19.0 11.1 12.4 23.6 16.4 17.2 12.5 15.8 26.1 19.5 18.3 18.7 18.5 22.6 10.4 17.9 11.5 17.3 13.3 16.5 8.7 15.1 14.2 19.4 11.0 11.7 13.3 11.8 6.0 8.7 13.7 12.7 5.4 6.6 4.4 7.0 7.5 10.1 10.6 11.7 4.6 6.8 4.9 5.8 8.6 11.1 5.3 7.4 8.0 10.0 4.7 9.5 10.9 8.0 11.7 7.3 8.5 6.8 5.6 10.6 11.1 9.5 11.0 6.1 9.2 6.9 11.1 8.6 5.6 7.9 6.9 33.7 6.8 7.7 5.9 8.1 4.1 10.1 7.1 10.7 14.3 9.7 9.1 7.4 4.1 29.0 11.2 6.9 3.8 4.3 7.0 9.0 6.2 10.5 12.5 8.2 8.1 4.0 6.5 4.8 10.8 13.7 4.7 9.7 3.1 5.3 5.5 5.3 8.7 6.0 6.1 6.6 10.7 5.4 12.7 7.6 4.4 4.4 12.2 14.3 11.5 14.2 12.2 12.8 19.0 11.1 15.8 15.1 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA029105: , HPA072613: " "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.1 6.9 11.6 8.9 14.3 18.0 17.7 7.0 5.1 5.1 5.2 5.2 22.3 5.5 11.9 8.9 7.6 4.7 5.7 5.4 9.0 8.3 1.4 2.2 7.2 6.5 6.8 7.3 11.6 26.4 4.5 3.9 4.5 4.0 12.0 5.1 14.6 5.5 5.0 6.3 22.6 6.8 1.4 4.7 7.0 6.0 4.1 6.7 6.5 16.1 6.9 22.9 4.5 6.5 4.0 6.9 6.8 3.9 8.3 11.7 0.4 10.1 6.9 3.3 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell line enhanced" "Detected in some" "Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 10.8 0.0 0.0 3.4 0.1 0.3 0.0 17.7 0.0 0.2 0.0 0.0 7.6 0.0 2.8 0.0 3.2 2.4 19.3 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 TMEM258 C11orf10 ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favourable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 15.3 23.1 18.9 16.5 22.5 23.9 31.0 16.2 25.2 28.2 21.6 19.7 34.6 17.7 21.2 81.8 18.1 26.7 22.4 36.6 19.5 15.8 19.0 32.0 33.2 35.9 24.7 19.0 32.2 117.2 6.8 29.1 19.8 18.8 20.0 24.5 13.3 54.0 31.0 22.2 14.0 16.1 18.4 20.1 19.7 21.2 19.9 19.4 17.3 25.3 24.8 22.9 15.7 19.1 53.3 107.7 87.4 51.7 31.0 51.4 50.2 24.0 41.7 36.3 28.8 56.5 55.1 20.2 19.3 31.8 19.2 22.3 35.9 43.5 17.1 36.8 45.4 26.0 31.4 37.1 25.4 25.1 28.0 14.4 45.7 55.2 53.4 30.0 16.8 46.6 57.4 23.7 62.5 35.4 35.4 65.8 31.1 80.0 21.1 52.4 45.1 28.6 23.6 24.4 109.4 39.8 39.5 28.7 30.1 17.3 36.9 34.1 40.9 60.2 17.5 22.0 19.9 28.3 13.7 42.9 33.8 28.3 31.1 18.4 22.8 87.4 51.7 59.1 40.6 43.7 49.7 53.3 48.3 45.1 42.6 42.3 41.6 41.1 39.8 31.0 42.2 107.7 51.4 50.2 18.9 22.5 16.2 25.2 19.5 15.8 24.7 19.0 18.8 19.4 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: " "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favourable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 35.9 23.2 16.1 18.3 19.9 19.3 28.5 30.6 26.7 25.3 27.4 21.3 20.3 24.9 30.2 23.1 41.2 16.2 30.1 11.2 31.9 27.4 14.6 28.7 23.4 35.3 28.0 37.2 25.8 30.8 20.3 25.5 22.0 24.6 50.5 16.8 15.7 30.7 25.8 23.9 19.1 35.1 12.3 31.5 20.0 33.9 22.4 23.4 19.4 24.6 20.9 24.2 36.5 25.5 25.3 14.6 35.4 31.8 71.7 26.9 27.7 29.9 23.1 25.1 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favourable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.3 5.2 4.0 8.5 14.3 11.8 7.9 7.9 8.8 5.2 6.2 2.4 5.5 6.0 7.8 5.9 8.6 9.3 5.7 8.2 7.4 4.7 3.9 2.4 3.2 10.1 5.4 9.3 14.5 10.4 2.9 10.1 6.8 4.7 6.5 6.8 4.9 2.8 2.0 3.7 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.4 5.2 8.2 8.4 9.5 10.6 4.0 7.9 3.9 3.9 3.1 3.5 6.6 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell line enhanced" "Detected in some" "HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: " "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.8 0.0 1.9 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favourable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.5 4.6 2.2 4.6 6.2 4.6 1.7 2.5 4.5 3.5 3.6 3.4 1.0 11.5 2.2 2.9 4.5 4.3 2.1 3.0 5.8 2.9 3.6 3.4 2.1 10.7 7.4 1.7 4.0 3.7 4.9 5.2 2.3 7.1 30.1 2.5 7.7 8.7 2.2 5.7 4.5 9.9 2.5 9.7 2.0 2.1 7.5 4.7 8.5 11.1 22.8 14.8 6.9 1.3 3.4 4.1 1.4 4.6 16.7 15.6 12.4 1.9 6.3 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.3;HUVEC TERT2: 31.7;SH-SY5Y: 8.1" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported "Vesicles,Focal adhesion sites,Cytosol" Vesicles "Focal adhesion sites, Cytosol" "HPA048583: " "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.3 0.0 2.4 6.3 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 2.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 2.1 0.0 1.1 0.0 31.7 0.0 0.0 4.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 42.3;CAPAN-2: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051024: " "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 23.1 20.6 6.4 10.7 8.0 5.3 24.4 5.7 7.9 23.7 13.8 9.3 12.6 7.4 22.3 19.0 15.2 19.7 26.1 17.6 6.4 5.8 27.5 24.4 25.3 28.0 9.9 7.6 20.0 20.5 9.2 14.6 29.5 9.6 29.6 12.6 26.6 14.2 17.4 10.5 7.2 16.0 18.3 10.2 19.0 12.9 21.4 7.8 17.9 48.7 9.8 18.4 22.0 19.1 24.9 37.3 29.4 26.8 36.4 53.1 38.4 9.0 6.9 1.7 2.7 42.3 25.1 3.4 9.9 16.5 7.1 9.6 6.8 40.0 4.6 15.3 10.1 9.8 3.0 8.4 5.8 17.0 4.6 9.6 3.6 8.0 23.3 6.4 10.1 24.9 7.9 6.3 13.4 13.7 6.2 13.2 12.3 5.5 4.7 6.4 7.5 4.9 6.3 13.6 1.4 18.9 8.9 4.2 1.4 15.0 0.2 13.2 3.7 9.7 14.0 9.5 8.8 8.3 5.6 7.6 4.3 3.1 9.5 10.4 7.9 29.4 24.5 25.4 47.3 26.8 50.7 24.9 52.3 51.9 16.8 21.0 46.1 46.3 7.6 36.4 21.9 37.3 53.1 38.4 6.4 8.0 5.7 7.9 6.4 5.8 9.9 7.6 9.6 7.8 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Group enriched" "Detected in some" 5 "EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: " "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.4 0.3 0.1 2.1 0.2 0.5 0.1 0.0 0.0 0.0 5.3 3.0 0.0 13.1 1.6 0.8 1.4 0.0 0.0 0.0 1.3 0.4 2.0 34.4 2.9 0.0 0.0 4.8 0.0 0.0 0.0 2.8 0.1 5.2 0.0 0.3 0.0 0.3 2.5 0.1 0.0 0.0 4.5 28.8 2.3 0.4 0.2 0.1 1.4 0.0 0.6 0.8 1.8 0.0 5.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.7 7.9 14.1 10.0 28.2 26.4 14.9 15.6 26.8 16.9 23.6 13.9 12.1 6.6 14.8 14.4 16.4 14.6 6.2 18.7 6.5 5.6 8.1 6.0 14.1 19.0 15.0 12.2 16.0 10.3 12.3 30.0 11.2 8.0 19.1 9.4 7.3 7.9 5.5 13.6 15.8 8.6 7.4 14.2 4.9 6.1 6.1 8.6 14.7 8.5 21.1 8.1 14.1 9.6 10.5 10.0 7.3 9.8 22.0 6.2 15.7 15.7 10.9 14.9 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: , HPA059790: " "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavourable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.6 7.5 5.0 6.2 8.0 8.6 14.8 8.0 7.0 10.1 7.4 19.5 8.2 6.4 15.3 7.4 14.4 13.8 8.5 10.2 10.7 12.7 11.1 4.5 19.6 8.9 12.0 6.3 8.0 12.8 9.1 10.5 7.7 19.7 16.0 6.4 8.0 7.3 6.9 8.3 11.9 7.4 7.7 11.7 8.7 15.2 5.1 6.5 6.9 17.7 12.1 21.1 9.4 5.6 6.0 7.5 12.5 16.6 23.7 36.0 12.9 9.1 7.2 7.2 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861869-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA052569: " "prognostic favourable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favourable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 11.1 14.6 18.6 5.7 26.1 4.6 13.4 7.8 17.3 12.7 8.5 17.7 8.5 6.1 10.4 25.9 7.2 16.8 8.9 10.2 18.4 19.7 12.9 19.1 9.7 9.3 19.1 14.1 17.1 17.5 12.7 16.5 8.9 16.4 12.7 8.5 8.5 10.9 12.7 16.6 8.6 6.2 9.2 19.8 8.7 9.9 20.0 15.5 11.6 17.1 6.5 9.1 7.5 8.7 13.9 11.8 4.2 10.2 9.1 15.9 9.2 4.0 4.1 1.2 2.3 15.9 12.5 0.1 3.4 4.8 4.1 4.1 0.8 8.0 2.8 6.6 6.5 2.7 0.3 5.2 4.2 4.3 0.0 1.7 5.3 4.3 16.9 2.0 0.1 13.0 13.2 4.3 9.5 7.0 0.1 5.7 6.2 3.2 1.7 3.4 2.2 1.9 1.4 0.6 0.6 9.0 1.6 1.3 1.7 4.1 1.4 1.6 3.0 3.5 4.6 3.6 0.4 5.3 3.7 2.0 1.5 0.8 7.3 2.4 1.6 3.7 8.6 4.2 7.8 7.7 8.2 13.9 11.6 7.2 10.6 11.9 15.9 12.6 1.6 9.1 10.2 11.8 9.2 9.2 18.6 26.1 7.8 17.3 18.4 19.7 19.1 14.1 16.4 15.5 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 118.9" "Cell line enhanced" "Detected in many" "ASC diff: 92.2;ASC TERT1: 27.0;HSkMC: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3;myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA062101: " "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 5.3 5.2 1.6 3.0 7.3 0.6 12.5 0.3 1.9 8.6 2.7 1.9 2.5 1.0 8.5 5.7 4.4 5.2 5.7 5.7 1.3 0.9 1.4 45.2 5.8 5.2 4.4 0.7 6.4 20.2 0.3 25.1 20.2 2.1 5.9 1.8 3.1 23.9 2.2 2.4 118.9 1.7 6.6 2.2 2.2 2.0 5.4 4.4 0.0 6.5 3.7 12.2 7.7 18.5 0.5 2.9 0.9 3.3 0.0 0.5 2.0 6.0 0.4 0.5 2.1 92.2 27.0 0.0 14.5 13.5 2.0 19.0 0.5 0.1 0.0 7.2 9.5 6.9 0.5 2.8 5.2 1.5 1.8 5.0 2.2 1.7 5.8 0.0 0.3 28.4 1.6 3.7 5.6 0.7 0.1 0.7 4.9 0.0 0.0 0.1 0.7 3.6 0.0 5.1 0.0 0.1 0.2 0.6 4.3 3.5 1.8 1.5 0.1 2.8 2.0 14.1 9.9 0.1 3.2 11.9 6.8 0.0 11.1 0.4 9.3 0.0 3.3 0.9 0.3 0.0 0.0 0.5 0.2 0.3 2.9 0.0 0.1 0.5 0.4 0.0 0.5 1.6 0.0 2.0 1.6 7.3 0.3 1.9 1.3 0.9 4.4 0.7 2.1 4.4 TMEM50A SMP1 ENSG00000183726 "Transmembrane protein 50A" O95807 1 25337917-25362361 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065192 Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "HPA065192: " "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.17e-3)" "prognostic favourable (8.64e-5)" "unprognostic (1.45e-1)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.34e-4)" "unprognostic (7.39e-2)" "unprognostic (7.92e-3)" "unprognostic (2.53e-1)" "unprognostic (1.02e-2)" "unprognostic (2.44e-2)" "unprognostic (2.39e-3)" "unprognostic (6.66e-2)" "unprognostic (2.91e-1)" "unprognostic (3.91e-3)" "unprognostic (3.44e-2)" 36.2 45.6 29.2 23.2 39.1 19.4 43.4 30.5 29.4 29.7 32.7 21.5 25.6 26.5 29.4 31.5 36.7 23.5 30.9 32.6 30.9 23.6 39.1 31.8 34.2 36.3 29.3 18.5 22.6 29.7 21.7 13.6 40.4 19.9 32.8 38.6 19.1 56.5 33.0 21.5 25.7 39.6 27.8 38.1 39.4 26.5 17.5 20.4 32.7 39.2 29.6 28.1 37.1 31.0 13.0 14.0 56.5 26.8 19.2 25.0 23.1 8.4 9.6 16.1 8.3 30.3 27.3 5.7 17.0 27.3 32.4 36.4 7.7 21.1 9.7 9.6 60.6 12.2 12.6 13.9 35.4 25.5 18.1 20.7 10.5 11.8 22.4 15.8 16.8 29.8 20.5 24.0 13.9 23.3 13.8 15.3 30.6 5.9 10.3 19.3 18.9 7.9 9.1 17.7 17.2 32.6 6.2 13.5 8.6 17.6 12.4 13.6 6.4 10.4 34.4 18.1 7.6 29.6 7.0 10.7 11.6 9.0 23.6 23.7 10.0 56.5 19.1 26.3 24.0 23.0 25.0 13.0 21.1 24.4 14.0 10.1 15.5 21.1 39.7 19.2 26.8 13.0 23.4 23.1 29.2 39.1 30.5 29.4 30.9 23.6 29.3 18.5 19.9 20.4 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favourable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 18.9 10.1 5.8 1.4 1.0 2.2 0.0 2.2 9.2 6.8 9.2 13.3 21.4 0.0 7.2 1.4 18.4 2.0 7.1 3.9 0.0 5.1 0.4 0.5 13.2 8.5 0.0 18.6 0.7 6.4 8.8 9.7 6.2 2.9 0.0 3.4 6.5 0.0 0.0 1.0 3.9 2.6 3.7 3.3 17.2 19.7 0.9 17.3 1.8 7.5 18.2 1.0 2.0 4.3 7.1 6.2 3.1 6.8 0.2 0.2 0.0 7.0 0.2 8.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674555 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7;liver: 44.7" "Cell line enhanced" "Detected in all" "CAPAN-2: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 38.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favourable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favourable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 8.3 9.0 6.0 4.4 8.7 6.0 7.0 2.4 11.8 4.9 11.0 8.8 4.6 16.6 5.7 7.2 4.5 5.3 7.6 9.3 6.2 6.1 14.8 44.7 7.3 6.4 6.8 6.2 7.7 5.4 3.3 6.4 4.3 8.0 5.2 7.2 13.9 6.0 3.8 4.2 3.9 16.4 4.5 6.1 4.8 7.7 18.8 4.4 3.6 8.2 3.1 4.0 7.3 3.7 5.3 38.7 3.6 8.6 2.8 3.1 2.8 7.6 8.8 8.0 5.8 10.4 7.9 9.6 2.2 6.7 4.4 6.6 2.8 24.1 2.4 7.3 2.1 6.9 2.2 4.7 2.3 3.8 5.6 2.8 3.6 13.4 10.4 2.2 10.2 9.3 7.3 8.8 1.9 2.4 1.2 3.1 2.6 4.5 2.5 6.5 4.6 5.2 4.0 1.1 23.5 13.1 8.0 5.6 5.4 2.4 9.6 12.4 2.9 5.8 1.0 3.2 5.5 4.6 2.8 2.2 2.6 1.3 8.4 5.7 3.7 3.6 5.2 2.3 3.0 8.6 2.6 5.3 3.1 2.5 2.6 5.0 1.5 2.0 0.5 2.8 6.0 38.7 3.0 2.8 6.0 8.7 2.4 11.8 6.2 6.1 6.8 6.2 8.0 4.4 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185146 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: , HPA062359: " "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favourable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 11.6 8.6 7.6 9.5 12.0 9.6 28.6 21.1 13.9 10.4 15.5 15.1 9.8 15.5 9.9 15.4 10.7 9.4 14.0 7.3 7.8 9.8 9.5 12.3 13.0 10.5 10.2 8.2 6.1 12.0 16.5 10.8 12.3 12.7 8.6 17.6 11.9 16.9 9.2 14.5 8.5 17.3 11.0 11.9 9.6 12.0 3.1 7.8 4.6 10.5 8.9 13.7 13.2 9.0 2.5 4.6 2.6 1.8 3.8 5.0 0.9 7.4 4.0 1.8 3.5 2.2 3.0 19.3 7.2 9.1 12.9 17.9 6.4 14.8 7.6 4.2 6.8 14.4 7.7 5.7 4.7 8.9 3.4 6.2 8.9 4.7 5.0 6.4 5.6 2.1 6.8 5.6 3.9 7.0 5.4 6.6 1.4 1.7 0.0 1.5 0.6 1.7 3.8 2.0 4.0 6.8 9.5 11.7 5.0 5.7 14.2 3.4 7.6 6.5 4.1 6.4 2.6 4.5 11.6 5.5 33.2 5.4 5.9 7.1 5.5 1.5 1.8 2.6 2.4 0.8 2.9 1.9 3.2 2.7 2.0 2.5 1.9 2.6 0.5 3.8 1.0 4.6 5.0 0.9 7.6 12.0 21.1 13.9 7.8 9.8 10.2 8.2 12.7 7.8 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.7;SK-BR-3: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" 96000 "Vesicles, Centriolar satellite" "HPA066504: , HPA066936: , HPA068918: " "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favourable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.3 2.8 2.4 7.1 19.6 6.8 16.9 7.1 7.7 8.0 8.1 10.2 6.9 2.6 13.2 8.7 14.4 2.6 4.3 3.7 8.7 4.7 11.3 6.5 6.1 4.5 4.2 29.9 7.1 2.7 4.7 2.9 5.1 9.4 2.2 6.3 5.9 3.7 4.3 13.3 4.6 3.7 7.5 37.7 12.2 24.7 0.2 1.3 5.2 42.0 5.1 9.7 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.4 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 TMEM63B "C6orf110, dJ421H19.2, DKFZp434P0531" ENSG00000137216 "Transmembrane protein 63B" Q5T3F8 6 44126914-44155519 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029249, HPA029250, HPA029251" Uncertain Enhanced "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA029249: , HPA029250: , HPA029251: " "unprognostic (8.83e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-3)" "unprognostic (3.61e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.97e-3)" "unprognostic (1.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (8.60e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.67e-2)" "unprognostic (6.12e-3)" "unprognostic (3.15e-1)" 9.7 13.2 24.4 8.7 21.4 14.0 9.4 33.2 34.3 9.1 19.7 14.8 7.5 17.1 8.2 11.7 21.1 8.6 13.2 16.6 21.6 15.2 10.7 28.6 35.0 5.2 13.1 18.2 8.0 10.6 19.6 10.2 12.8 22.8 12.9 18.4 18.6 13.9 8.8 29.4 29.6 17.0 9.7 13.8 6.3 24.5 22.7 16.0 4.7 11.4 14.8 8.9 14.4 13.4 1.3 1.3 1.7 2.1 0.3 2.6 1.2 18.9 10.0 9.5 16.1 15.1 8.9 16.2 7.8 10.5 9.5 9.0 7.1 7.0 3.2 12.8 11.6 18.7 11.1 28.9 5.5 8.8 9.7 9.3 7.3 20.9 10.7 1.9 9.8 12.2 25.2 12.2 7.7 8.6 30.1 5.6 9.6 18.8 2.0 4.5 4.9 5.1 2.4 5.9 6.0 23.4 18.0 10.4 8.5 7.2 16.7 17.3 19.6 5.0 10.3 11.4 13.6 8.7 9.4 6.7 4.9 3.6 17.7 3.2 14.1 1.1 2.1 1.3 1.4 1.1 2.5 1.3 0.7 0.7 0.9 0.8 1.0 1.1 1.7 0.3 1.4 1.3 2.6 1.2 24.4 21.4 33.2 34.3 21.6 15.2 13.1 18.2 22.8 16.0 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: " "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.0 8.8 7.1 7.4 8.4 7.2 7.3 9.4 8.6 10.6 8.6 8.3 6.4 15.0 8.2 6.4 10.1 13.6 9.1 12.0 9.7 9.3 15.0 5.8 11.0 8.4 8.1 8.0 6.7 8.4 6.7 3.6 8.9 11.2 7.4 11.2 8.2 18.5 15.4 6.6 11.0 13.1 7.0 12.7 11.2 10.5 16.2 7.2 5.8 42.5 11.9 8.8 7.5 5.6 6.2 7.5 11.2 8.9 11.0 9.4 14.7 9.0 6.4 6.8 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favourable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 4.8 2.7 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.9 0.0 0.3 3.6 0.5 0.1 0.0 4.6 1.1 0.0 9.7 0.0 0.0 1.3 0.0 1.0 0.0 0.2 0.1 16.4 7.4 0.0 0.1 0.1 0.1 3.3 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 3.2 0.1 0.1 3.2 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.2" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA060282: " "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favourable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA057119: " "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.0 0.0 0.1 0.7 0.5 0.6 0.5 0.0 0.4 0.0 1.3 0.6 0.3 0.2 0.1 0.4 0.2 1.9 0.2 0.1 0.0 2.4 0.0 3.0 4.2 1.3 0.1 0.2 1.8 0.6 0.0 1.4 1.7 0.0 0.0 0.2 1.7 0.0 5.5 0.0 18.8 4.0 1.0 1.4 1.0 3.5 1.4 4.2 0.4 2.0 0.5 0.3 0.2 0.1 3.4 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057689 Uncertain Uncertain Midbody,Centrosome Centrosome Midbody "HPA057689: " "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favourable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favourable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.4 0.7 1.3 1.8 6.3 2.2 4.7 1.2 1.1 1.7 0.9 1.0 0.6 0.9 11.1 8.8 2.5 5.9 1.2 3.9 3.7 0.8 1.7 2.1 1.3 0.5 6.0 3.5 0.8 2.4 6.4 10.0 0.9 2.4 5.9 2.8 12.5 1.1 5.1 2.1 3.9 1.8 0.8 4.9 2.2 8.3 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055223-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.28e-4)" "prognostic unfavourable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.8 14.5 5.6 19.5 7.1 5.1 17.2 6.5 8.5 11.6 20.8 6.6 36.8 22.1 14.5 14.3 14.5 10.1 17.0 7.3 5.8 6.5 10.0 13.1 14.6 25.8 6.6 5.4 9.6 15.8 11.3 22.8 20.1 7.4 23.5 21.3 7.0 18.3 43.8 3.8 12.0 37.9 10.3 8.2 22.4 17.3 5.5 5.7 11.6 12.3 11.0 17.9 13.9 12.0 8.4 3.7 4.9 8.3 4.6 10.1 4.9 10.4 3.3 2.9 13.1 12.4 16.9 11.2 17.9 23.9 11.5 14.2 8.1 14.6 10.0 9.5 23.2 17.7 1.8 10.5 14.7 6.4 2.0 14.0 2.1 6.9 12.1 9.7 15.1 11.2 12.8 14.1 11.4 11.9 8.2 6.8 16.0 6.4 4.5 4.6 2.3 8.6 3.7 4.6 8.2 9.7 15.0 2.4 3.2 7.9 19.4 16.1 10.6 6.8 13.5 11.6 3.6 9.1 3.9 5.5 8.9 6.4 13.2 4.8 8.3 4.9 4.0 3.3 4.7 7.0 8.1 8.4 10.1 6.4 3.6 6.6 9.3 5.1 2.4 4.6 8.3 3.7 9.7 4.9 5.6 7.1 6.5 8.5 5.8 6.5 6.6 5.4 7.4 5.7 TMEM8A "M83, PGAP6, TMEM6, TMEM8" ENSG00000129925 "Transmembrane protein 8A" Q9HCN3 16 370773-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA051281: , HPA064673: " "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favourable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 8.4 9.3 6.9 9.5 7.8 15.2 13.5 7.7 7.9 6.8 16.6 7.3 24.1 17.7 7.3 29.6 11.8 6.5 15.2 10.0 5.6 4.3 28.7 33.5 13.0 10.7 7.1 3.2 8.3 44.2 11.5 10.7 45.5 6.7 11.4 6.0 8.8 22.5 8.8 12.8 3.7 25.0 5.0 4.7 13.2 17.5 26.3 6.0 12.6 12.3 5.2 14.6 9.3 8.8 2.0 2.9 24.3 5.5 0.9 7.6 3.3 4.4 11.7 6.7 12.3 9.2 8.3 13.4 12.7 13.3 6.5 9.3 45.8 20.8 4.7 17.3 12.2 6.3 3.0 14.0 1.8 13.4 11.2 7.8 7.9 26.1 21.3 5.9 14.8 9.6 4.2 10.0 2.9 15.0 12.5 7.3 8.1 27.4 8.2 11.5 10.6 4.6 17.9 7.7 10.8 10.5 11.4 8.0 9.2 7.1 7.2 37.4 12.9 11.8 21.8 18.5 20.0 12.8 6.7 14.7 7.3 9.3 9.4 6.3 11.7 4.6 5.0 6.3 7.4 5.5 5.9 1.8 5.8 5.8 2.5 2.0 7.6 5.5 24.3 0.9 3.8 2.9 4.3 3.3 6.9 7.8 7.7 7.9 5.6 4.3 7.1 3.2 6.7 6.0 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500090 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: " "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favourable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 14.6 25.6 26.6 11.2 32.0 13.9 9.8 24.4 32.7 11.7 16.7 30.3 8.2 15.4 13.0 8.5 14.5 27.4 13.7 21.1 21.7 13.3 14.0 9.6 17.0 10.6 24.0 23.0 17.1 13.9 17.2 18.6 18.6 21.9 12.5 11.5 25.4 11.8 12.5 40.4 16.2 15.2 9.4 15.9 14.3 14.8 16.5 23.4 10.7 18.4 9.6 9.2 13.7 7.1 4.6 6.2 5.5 4.6 4.3 7.1 4.5 7.5 19.7 16.3 25.6 8.2 9.3 23.4 4.5 10.0 7.7 7.9 6.6 11.8 10.6 15.1 7.9 9.9 7.8 12.5 4.3 9.5 11.1 10.8 8.8 9.9 11.1 12.0 23.5 16.1 7.0 7.7 6.7 14.0 11.2 12.4 10.1 8.8 24.8 7.5 6.8 7.7 17.6 19.3 9.8 7.6 19.9 14.5 15.4 5.4 23.5 13.5 14.5 14.3 8.1 7.7 9.8 8.0 6.4 27.0 7.7 5.8 9.1 11.1 10.5 0.2 4.6 5.5 7.1 2.9 5.4 2.0 3.3 4.7 4.6 4.6 2.8 4.4 1.2 4.3 2.7 6.2 4.1 4.5 26.6 32.0 24.4 32.7 21.7 13.3 24.0 23.0 21.9 23.4 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038298 Uncertain Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 2.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 6.3 0.0 5.6 0.0 0.2 0.4 0.5 0.0 0.0 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 3.8 0.0 2.5 1.0 0.0 0.5 0.0 0.3 0.1 0.0 0.4 0.3 2.4 0.0 0.5 0.2 0.1 0.7 4.8 0.7 0.8 0.1 0.2 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favourable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.8 0.3 4.5 1.5 3.4 3.7 0.0 0.4 3.6 0.1 3.5 2.3 7.1 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.4 0.5 1.0 0.7 0.0 0.1 4.2 0.6 2.9 0.5 1.1 0.8 2.2 1.0 0.1 0.5 1.2 26.3 6.4 4.2 0.0 1.2 1.0 0.2 1.6 9.3 0.7 5.8 3.2 0.0 0.0 0.0 2.9 9.7 4.2 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 TMOD3 UTMOD ENSG00000138594 "Tropomodulin 3" Q9NYL9 15 51829628-51947295 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001849 Approved Approved "Actin filaments,Cytosol" 21000000 Cytosol "Actin filaments" "HPA001849: AB_1080313" "unprognostic (6.31e-2)" "prognostic unfavourable (3.25e-4)" "unprognostic (2.39e-1)" "unprognostic (7.31e-3)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" "unprognostic (7.53e-2)" "prognostic unfavourable (6.25e-4)" "unprognostic (3.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavourable (3.38e-5)" "unprognostic (7.06e-2)" "unprognostic (7.97e-2)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (5.58e-3)" 23.0 9.6 7.3 14.2 9.7 7.7 14.1 7.5 7.7 16.4 16.0 4.6 32.4 13.3 13.4 11.8 53.1 12.0 12.0 10.5 7.7 6.3 16.6 14.6 25.4 10.3 8.1 4.2 12.7 9.3 8.0 9.2 20.2 8.5 11.0 13.9 6.9 20.8 21.4 5.9 15.4 21.7 11.1 8.7 20.5 14.4 6.6 8.0 19.6 11.4 21.9 22.7 16.5 27.2 14.4 17.6 28.3 21.9 10.7 15.1 9.4 23.1 23.3 9.4 2.4 9.3 15.7 10.7 10.8 14.8 11.3 10.2 9.0 17.6 5.6 8.8 11.5 34.1 8.6 24.3 14.5 9.4 3.8 8.4 25.7 7.2 10.4 10.7 9.2 10.5 23.7 9.1 28.3 19.9 8.8 8.7 13.6 17.2 7.1 7.2 5.2 3.8 8.5 11.1 14.6 18.4 16.0 2.3 6.1 18.0 12.1 6.4 8.2 8.6 21.7 14.5 9.6 11.7 12.5 5.2 15.2 6.3 9.3 19.6 8.5 22.7 17.7 24.0 14.8 20.9 13.1 12.0 12.8 12.9 12.4 14.4 11.1 10.3 28.3 10.7 21.9 17.6 15.1 9.4 7.3 9.7 7.5 7.7 7.7 6.3 8.1 4.2 8.5 8.0 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "BEWO: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.2 1.7 1.0 1.5 1.2 1.0 25.0 0.5 0.9 1.5 0.9 2.4 3.4 0.7 1.1 1.5 1.3 1.6 1.4 2.4 3.7 0.6 3.0 1.6 1.8 0.8 2.6 4.4 1.1 1.1 1.9 1.3 1.7 2.2 2.6 1.1 1.1 1.0 1.2 0.9 1.0 1.2 0.5 1.6 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 3.7 2.4 2.2 2.8 1.2 2.3 2.1 1.3 0.4 2.8 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Group enriched" "Detected in some" 20 "U-138 MG: 19.8;U-87 MG: 55.3" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: " "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.1 0.0 0.3 0.0 0.0 55.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell line enhanced" "Detected in some" "CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" "Cell Junctions" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favourable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favourable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.6 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.5 1.3 0.0 0.0 0.0 1.4 0.6 35.2 0.0 0.4 0.0 7.2 0.1 5.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavourable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 44.9 0.0 1.7 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 31.5 39.3 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033806 Approved Approved Nucleoplasm,Vesicles,Cytosol 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 141.5 118.6 233.1 367.2 285.8 313.3 0.5 75.1 196.5 58.3 100.5 24.4 119.2 33.9 72.6 227.8 62.4 34.5 50.3 78.5 198.2 1.9 42.2 70.3 0.3 66.6 164.9 350.9 145.8 72.2 69.0 60.4 350.3 5.3 0.5 206.3 50.4 196.0 357.9 83.8 81.8 151.1 82.5 138.5 347.1 41.5 24.8 10.5 108.8 5.1 13.8 136.7 167.5 281.7 85.2 42.2 482.6 74.5 110.6 80.3 65.8 130.3 68.4 61.3 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane and tetratricopeptide repeat containing 1" Q8IUR5 12 29500840-29784759 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 28.6;HSkMC: 19.4;hTERT-HME1: 35.0;LHCN-M2: 19.5;RH-30: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavourable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 29.3 12.8 12.9 4.6 30.8 0.5 25.8 2.2 9.0 11.4 8.4 2.9 4.3 3.0 7.4 2.9 6.1 12.6 6.2 15.7 15.2 8.1 13.1 2.4 6.7 2.4 5.4 7.8 8.7 2.9 10.0 18.7 2.7 9.1 6.4 5.4 7.1 3.7 8.3 13.7 2.9 4.6 12.7 4.9 34.1 7.4 2.8 6.2 0.8 3.7 4.4 2.0 8.9 10.5 0.1 0.1 0.4 2.3 0.1 0.1 0.3 0.0 0.0 5.1 0.0 16.3 10.9 0.0 5.3 10.9 1.4 1.1 0.0 0.0 0.0 2.7 3.3 0.0 0.1 0.1 0.0 0.1 1.5 0.0 15.3 0.2 28.6 0.6 0.0 19.4 1.9 13.5 35.0 0.7 0.0 0.7 19.5 0.0 0.0 0.0 3.9 7.0 0.0 40.9 0.7 0.0 0.1 0.4 0.4 0.6 0.0 1.3 0.0 0.2 2.1 1.3 0.8 0.7 4.2 7.1 0.0 0.0 9.3 0.0 0.1 0.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 2.3 0.1 0.0 0.3 12.9 30.8 2.2 7.6 15.2 8.1 5.4 7.8 9.1 6.2 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane and tetratricopeptide repeat containing 2" Q8N394 12 82686880-83134870 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 16.2;WM-115: 39.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favourable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 4.7 1.7 9.1 8.9 19.7 2.9 5.9 8.1 15.7 8.1 12.5 27.3 15.2 4.6 8.5 7.4 11.4 15.4 11.9 3.1 13.4 8.7 10.6 1.7 9.6 2.8 17.6 15.3 3.1 6.6 6.5 4.7 5.1 14.3 9.9 9.1 2.5 8.3 30.3 2.0 7.4 6.2 10.4 22.5 2.2 13.1 4.6 18.0 0.4 7.9 1.1 4.3 10.5 11.5 0.8 2.6 0.0 3.1 0.0 0.3 0.9 0.8 3.2 16.2 0.1 2.1 2.1 1.4 1.0 0.3 0.8 0.1 0.2 1.7 0.0 0.2 5.8 1.4 4.6 2.4 0.2 3.6 2.7 0.0 2.4 0.1 0.2 1.0 0.5 0.5 2.1 0.1 0.8 1.3 0.0 2.2 0.2 1.6 0.8 4.2 0.6 2.7 0.0 0.6 0.3 1.5 7.1 4.3 7.8 1.5 2.3 10.5 2.4 0.2 0.8 2.8 0.9 3.6 1.3 4.0 2.8 0.6 0.6 1.8 39.5 0.0 3.1 0.0 0.1 1.0 0.3 0.8 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 9.1 19.7 8.1 11.6 13.4 8.7 17.6 15.3 14.3 18.0 TMUB1 "C7orf21, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081080-151083546 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 10.6 15.2 10.3 16.1 11.0 13.7 17.8 9.1 16.0 9.7 27.5 9.0 17.0 31.8 10.4 15.4 21.6 9.6 18.0 17.3 10.6 9.6 25.5 35.5 12.9 15.6 10.2 10.0 13.1 51.5 9.5 21.1 18.9 8.3 16.1 6.0 12.7 29.6 12.9 33.8 15.1 39.2 12.8 8.7 16.1 24.0 11.5 8.5 23.9 23.6 12.9 19.1 18.7 11.8 8.0 4.2 18.2 3.6 3.1 9.5 1.8 24.1 21.8 5.1 26.5 3.4 4.2 19.3 9.9 8.3 8.8 9.9 18.8 29.5 16.2 21.3 4.8 16.5 5.7 8.7 1.9 29.6 20.2 6.9 20.2 28.4 8.6 8.5 24.5 6.4 7.3 7.4 2.0 6.5 43.0 22.1 3.9 39.0 28.3 36.7 22.0 13.2 17.7 6.5 29.9 9.1 18.8 18.9 21.0 8.0 12.4 12.9 9.7 11.9 7.9 11.3 8.2 14.1 16.3 34.9 19.1 11.1 26.0 16.0 14.2 3.5 2.7 18.2 5.4 3.6 4.7 4.4 8.0 5.8 2.8 8.0 7.8 4.5 4.7 3.1 2.2 4.2 9.5 1.8 10.3 11.0 9.1 16.0 10.6 9.6 10.2 10.0 8.3 8.5 TMUB2 MGC3123 ENSG00000168591 "Transmembrane and ubiquitin like domain containing 2" Q71RG4 17 44186970-44191731 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043137 Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043137: AB_10794388" "unprognostic (4.57e-2)" "unprognostic (1.58e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-2)" "unprognostic (6.37e-2)" "unprognostic (1.85e-2)" "unprognostic (6.43e-3)" "unprognostic (1.07e-1)" "unprognostic (2.05e-1)" "unprognostic (3.35e-2)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "unprognostic (9.75e-3)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.78e-3)" 22.5 27.0 21.2 22.6 26.7 39.9 37.6 32.4 39.0 27.3 24.0 25.9 30.5 25.2 27.4 26.4 31.0 24.2 26.6 21.2 21.2 20.4 28.9 29.4 22.9 24.7 19.9 23.1 27.9 33.5 30.7 25.2 38.9 21.0 30.3 23.6 23.3 30.7 34.1 22.9 29.0 29.6 23.4 18.8 40.0 25.8 46.0 19.6 21.1 34.6 20.9 23.1 26.0 25.0 10.0 10.2 29.9 13.3 5.5 8.1 8.2 11.3 22.5 14.3 13.3 22.6 18.0 11.3 15.1 16.4 28.2 28.9 11.6 21.4 7.9 16.4 18.7 21.8 10.1 14.3 17.8 19.4 20.9 8.2 20.4 17.7 23.5 9.2 18.6 21.7 21.0 19.2 12.0 19.7 9.4 23.8 18.4 8.1 12.8 12.4 4.7 19.0 11.7 17.4 12.8 17.9 12.9 11.5 11.7 7.9 7.5 14.9 21.9 12.0 16.2 23.6 14.5 16.5 13.4 17.5 12.7 7.7 18.1 7.9 15.9 29.9 13.3 24.1 8.1 11.7 6.8 7.7 6.7 7.7 8.5 10.0 6.5 7.3 29.3 5.5 11.7 10.2 7.6 8.2 21.2 26.7 32.4 39.0 21.2 20.4 19.9 23.1 21.0 19.6 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257546 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" 740000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 21.8 24.2 13.6 18.5 18.3 15.5 19.7 14.1 12.3 14.4 20.7 17.2 27.0 17.7 17.5 19.2 25.0 13.3 15.0 11.3 13.5 11.9 24.9 29.2 20.0 25.3 22.6 9.2 15.5 23.9 18.4 19.0 21.9 16.3 14.2 21.2 13.3 21.0 27.9 12.5 16.7 23.4 17.0 24.9 29.1 18.1 12.9 17.9 37.5 23.5 17.6 17.4 20.2 19.9 9.4 17.0 9.6 17.5 12.6 12.5 13.3 13.6 12.6 17.5 9.4 14.0 11.0 18.8 17.2 13.9 17.4 22.3 12.7 25.2 19.5 16.2 11.5 13.5 30.9 11.3 31.7 19.6 10.6 14.2 11.0 12.5 12.2 32.6 14.4 13.1 10.4 11.7 8.6 15.4 11.7 13.5 16.5 16.8 14.5 17.6 19.9 15.8 15.4 31.6 11.7 16.8 17.8 11.1 8.2 13.7 9.2 12.3 13.5 14.6 9.9 18.4 17.1 13.0 15.6 11.8 11.9 16.0 8.1 18.6 17.2 9.6 15.4 7.2 10.2 17.5 12.5 9.4 10.9 10.5 16.2 7.4 10.8 12.0 5.7 12.6 12.6 17.0 12.1 13.3 13.6 18.3 14.1 12.3 13.5 11.9 22.6 9.2 16.3 17.9 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712600-57740973 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: " "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (3.64e-4)" "prognostic unfavourable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favourable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavourable (3.37e-4)" 29.5 40.5 33.6 21.0 39.0 13.7 30.8 26.5 60.5 28.0 40.6 50.7 29.0 33.3 22.5 36.7 32.7 25.5 20.0 33.0 32.6 32.1 47.4 71.7 24.4 22.1 40.4 30.4 25.9 40.6 49.8 25.8 26.2 45.3 31.1 49.3 38.4 27.9 34.4 21.9 21.9 34.0 26.1 42.3 25.4 29.9 19.1 31.3 24.0 34.4 25.8 27.0 22.2 22.6 17.7 23.1 17.9 37.5 16.5 21.8 18.8 28.8 33.9 19.5 35.0 36.4 19.5 21.4 34.9 27.1 34.4 29.2 32.2 49.8 27.1 39.0 28.0 53.4 49.4 27.9 36.5 19.4 21.5 26.1 27.4 32.2 30.1 36.5 36.1 23.9 40.9 38.0 60.6 19.5 44.9 32.0 38.3 14.8 21.5 41.6 37.8 46.5 29.3 24.5 57.4 42.8 32.6 22.3 31.9 26.8 62.6 38.7 55.9 24.2 16.3 32.5 21.2 43.2 36.0 31.5 61.5 27.4 36.5 26.0 48.1 15.9 19.6 17.9 17.1 33.1 21.6 17.7 17.3 20.0 19.0 15.3 21.8 21.8 5.2 16.5 37.5 23.1 14.3 18.8 33.6 39.0 26.5 60.5 32.6 32.1 40.4 30.4 45.3 31.3 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "RT4: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: " "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (4.10e-4)" "prognostic favourable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favourable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.4 26.9 0.1 0.1 1.7 7.7 9.0 1.6 6.9 4.3 1.5 0.2 24.4 0.0 20.1 7.8 17.4 1.9 0.0 2.1 0.9 0.1 2.4 18.8 0.1 3.3 1.2 3.4 2.9 0.2 1.4 0.0 2.2 2.4 5.9 0.6 0.5 0.0 1.9 1.6 2.2 1.0 3.1 3.9 13.8 126.5 0.2 0.3 24.7 8.6 0.3 13.9 8.0 4.6 0.9 2.3 5.0 5.0 5.3 0.3 0.1 6.5 5.5 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.0;smooth muscle: 47.0" "Cell line enhanced" "Detected in some" "ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA077484: " "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavourable (3.51e-4)" 4.6 2.4 11.8 4.1 3.8 0.8 10.5 0.6 5.8 9.8 4.1 1.8 2.8 1.2 47.0 9.9 11.5 20.9 3.7 5.5 11.4 3.1 1.9 1.5 6.6 5.4 1.9 5.6 17.5 1.6 0.6 1.8 1.4 3.3 6.6 5.0 0.6 1.9 3.5 2.1 10.7 3.2 47.0 1.5 14.7 2.9 3.4 1.1 0.0 2.5 4.7 2.4 12.3 18.8 1.4 1.0 3.7 1.5 1.7 0.8 0.3 0.0 0.1 0.0 0.0 12.6 32.2 0.1 0.1 0.0 0.3 0.5 0.0 0.3 0.0 0.6 1.7 0.0 0.4 0.3 0.1 0.0 0.3 0.0 0.9 2.0 3.3 0.1 0.7 11.8 2.5 2.4 9.3 27.5 0.0 0.0 25.8 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 36.8 2.9 0.2 9.4 0.7 0.1 0.0 0.0 6.0 0.0 0.0 2.8 1.5 0.7 0.5 0.7 0.6 0.8 0.6 0.5 0.3 1.4 0.6 0.8 3.7 1.7 1.0 1.0 0.4 0.3 11.8 3.8 0.6 5.8 11.4 3.1 1.9 5.6 3.3 1.1 TNFRSF10D "CD264, DcR2, TRAILR4, TRUNDD" ENSG00000173530 "TNF receptor superfamily member 10d" Q9UBN6 8 23135588-23164030 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 24.1;LHCN-M2: 60.9;WM-115: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.0" "Low lineage specificity" "Detected in many" HPA070971 Approved "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA070971: " "unprognostic (1.49e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.69e-1)" "unprognostic (7.06e-2)" "unprognostic (3.56e-2)" "unprognostic (1.66e-1)" "unprognostic (1.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.12e-2)" "unprognostic (2.70e-1)" "unprognostic (1.35e-2)" "unprognostic (6.32e-2)" "unprognostic (1.72e-1)" 16.0 3.1 4.9 7.3 10.0 10.5 10.2 3.4 10.3 5.9 8.5 2.6 5.5 6.2 8.9 5.7 4.1 8.0 11.5 6.5 7.0 3.4 12.1 31.5 12.5 5.1 9.0 0.9 9.8 5.2 2.5 4.3 4.1 9.0 9.0 10.9 3.9 3.9 4.4 3.9 3.1 11.2 10.9 6.3 6.9 7.2 4.3 9.2 2.9 6.0 6.8 6.6 7.3 26.0 2.1 4.5 2.4 3.3 0.3 9.0 2.4 3.5 3.0 4.0 2.2 3.0 12.1 0.0 18.8 7.1 1.4 1.9 5.8 2.9 0.0 4.0 11.2 1.2 3.3 16.5 12.5 0.0 2.9 1.0 1.8 5.0 13.3 0.6 1.3 15.1 18.4 5.0 3.5 24.1 0.0 0.0 60.9 0.0 0.0 1.9 3.2 0.0 0.7 0.0 0.9 4.7 1.6 0.0 0.0 2.0 0.0 0.0 0.0 2.3 14.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 15.7 0.9 57.8 2.4 3.3 1.5 0.0 1.4 0.1 2.1 3.2 1.1 4.5 0.8 9.0 3.5 2.2 0.3 1.9 0.0 1.0 2.4 4.9 10.0 3.4 10.3 7.0 3.4 9.0 0.9 9.0 9.2 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell line enriched" "Detected in some" 6 "HDLM-2: 51.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: " "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.9 3.5 0.3 0.1 51.3 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.3 0.0 0.0 0.0 0.4 0.0 0.0 2.5 8.1 0.1 0.0 0.2 0.6 0.6 8.7 0.3 0.2 1.3 0.0 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA007853 Approved Approved "Plasma membrane,Cytosol" 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavourable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavourable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.3 19.8 2.2 4.1 4.0 9.2 13.1 51.3 37.2 44.0 28.3 8.5 43.5 0.1 68.0 34.1 27.0 0.5 37.5 16.9 0.9 1.3 0.1 6.6 7.2 27.8 0.4 1.8 8.5 26.0 46.2 55.4 12.7 2.7 0.3 46.3 46.0 0.0 3.2 10.7 43.4 0.2 24.7 1.0 44.5 4.8 2.5 0.8 36.6 17.0 30.3 8.9 0.7 22.3 79.3 36.6 52.4 84.2 0.8 0.3 0.3 24.7 2.2 62.3 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 TNFRSF14 "ATAR, CD270, HVEA, HVEM, LIGHTR, TR2" ENSG00000157873 "TNF receptor superfamily member 14" Q92956 1 2555639-2565382 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.3;HDLM-2: 14.4;HHSteC: 16.9;Karpas-707: 13.3;SK-MEL-30: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA006404, CAB026150, CAB030007" Approved Approved "Cytosol,Rods & Rings" Cytosol "Rods & Rings" "CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348" "prognostic favourable (4.39e-5)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "prognostic favourable (8.01e-6)" "unprognostic (1.11e-2)" "unprognostic (6.83e-3)" "unprognostic (9.62e-3)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (1.62e-1)" "unprognostic (2.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-2)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" "prognostic favourable (7.79e-6)" 15.9 24.9 4.9 38.9 2.8 11.0 21.9 2.0 4.5 16.8 36.3 3.2 18.5 36.3 15.2 20.5 13.7 12.3 36.7 12.7 4.9 2.5 19.3 20.5 30.3 33.2 3.6 5.7 12.8 7.3 3.5 9.3 8.3 3.9 21.5 8.2 44.1 20.9 22.6 5.2 8.4 41.9 14.6 4.1 36.7 16.7 5.9 2.7 23.5 10.8 10.6 25.0 15.4 17.2 18.2 9.7 30.2 25.8 8.1 25.1 14.2 1.3 0.1 0.1 2.3 5.0 2.7 0.7 0.7 2.3 1.3 1.9 0.2 14.3 0.8 0.1 2.1 1.3 0.0 0.8 0.2 14.4 0.0 8.4 0.4 2.6 16.9 1.1 10.4 2.6 1.4 0.7 0.1 3.7 1.1 13.3 1.2 0.0 4.6 1.3 0.0 1.2 3.8 0.0 4.1 0.2 2.0 0.4 0.0 0.5 0.1 27.9 0.4 0.3 9.4 0.2 0.6 0.2 0.1 10.8 2.6 0.4 2.3 1.2 1.0 3.0 15.1 8.2 17.2 25.8 14.9 16.6 18.0 14.8 9.7 18.2 17.3 14.9 30.2 8.1 24.1 8.7 25.1 14.2 4.9 2.8 2.0 4.5 4.9 2.5 3.6 5.7 3.9 2.7 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favourable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favourable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.1 0.0 1.6 16.1 1.1 1.2 26.3 0.6 0.9 7.6 0.0 0.0 0.0 20.0 0.0 1.0 0.9 1.2 0.0 0.9 0.2 0.8 27.3 0.7 0.0 0.3 7.7 0.2 7.6 0.1 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.7 1.6 0.0 4.5 0.0 2.7 0.1 10.5 1.8 0.0 0.0 45.6 0.0 0.1 0.0 3.8 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.4 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell line enhanced" "Detected in many" "RT4: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favourable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.9 9.7 9.5 3.0 26.1 7.7 10.8 3.5 6.9 1.1 0.4 16.8 21.2 2.2 14.2 2.5 18.1 1.4 12.9 0.6 0.0 2.9 0.0 1.2 16.9 15.3 0.4 0.1 13.7 15.5 0.6 11.8 5.1 0.7 0.0 0.3 5.9 2.6 0.2 7.4 10.1 5.6 2.9 3.2 18.1 102.3 6.8 1.5 3.0 2.8 2.4 2.2 2.1 1.0 2.8 2.6 0.1 3.2 0.0 0.0 3.1 4.7 2.1 7.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell line enhanced" "Detected in many" "HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavourable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favourable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavourable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.5 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.2 2.1 0.0 2.9 0.0 3.1 0.4 3.6 0.0 19.7 1.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.1 3.1 0.0 0.0 0.0 1.6 0.0 7.8 1.0 5.3 0.6 0.2 19.3 0.8 0.5 3.8 5.2 0.0 1.9 0.1 1.6 2.1 1.6 1.0 1.5 0.0 1.5 0.0 3.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Cell line enriched" "Detected in some" 8 "HDLM-2: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA071425: " "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.9 0.3 0.1 0.4 0.0 0.1 0.0 0.2 0.4 45.9 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.2 1.5 0.1 0.2 0.1 0.1 0.1 5.7 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell line enhanced" "Detected in some" "HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" 1112540 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: " "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.7 1.4 0.0 0.0 11.5 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.6 0.0 14.5 0.0 0.8 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.2 0.1 0.0 0.0 0.7 0.0 1.1 0.0 6.6 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.3;HHSteC: 7.9;HUVEC TERT2: 35.9;LHCN-M2: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA059579 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059579: " "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.2 6.5 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 7.9 0.1 0.0 2.8 0.1 0.9 0.1 35.9 0.0 0.2 29.9 0.0 0.3 0.1 0.1 0.3 0.8 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.1 3.3 1.9 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell line enhanced" "Detected in many" "AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.6 2.0 0.3 0.0 4.6 4.1 1.1 3.2 2.2 17.5 7.3 0.0 1.4 3.7 6.0 2.8 1.1 3.5 0.1 4.3 26.6 1.5 0.0 9.4 5.2 30.3 2.8 2.9 1.9 0.4 19.5 9.6 0.0 0.5 0.4 1.6 6.7 8.0 7.6 0.0 5.0 7.0 6.3 0.0 0.9 1.0 2.5 0.2 4.3 8.8 1.3 0.2 0.0 3.4 8.9 3.0 0.0 0.0 0.0 0.9 5.9 22.7 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 TNIP1 "ABIN-1, KIAA0113, NAF1, VAN" ENSG00000145901 "TNFAIP3 interacting protein 1" Q15025 5 151029945-151093577 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037893, HPA037894, HPA071950" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037893: AB_10672468, HPA037894: AB_2675723, HPA071950: " "prognostic favourable (5.69e-4)" "unprognostic (1.08e-1)" "unprognostic (1.10e-1)" "prognostic favourable (6.86e-5)" "unprognostic (7.45e-3)" "unprognostic (2.94e-1)" "unprognostic (5.35e-3)" "unprognostic (1.45e-2)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (2.25e-2)" "unprognostic (1.96e-1)" "unprognostic (7.68e-3)" "unprognostic (1.47e-1)" "unprognostic (4.69e-2)" "unprognostic (2.29e-1)" "unprognostic (9.84e-2)" 49.8 16.8 8.9 32.2 10.7 35.8 68.8 10.1 11.4 16.5 38.8 10.2 22.9 23.8 13.6 21.2 28.9 11.2 33.2 30.1 8.9 8.7 27.8 34.3 29.0 35.1 11.2 7.2 14.6 42.2 16.4 9.5 15.7 10.6 18.5 17.4 13.9 18.2 27.6 61.7 19.5 37.2 21.0 10.7 39.5 20.6 9.9 10.9 21.0 19.6 27.7 41.9 20.6 35.0 10.9 7.7 26.0 7.4 7.0 12.5 5.3 23.7 17.0 3.2 11.7 12.6 12.9 8.6 11.5 36.9 10.4 19.6 16.1 32.6 19.9 39.0 15.4 14.5 5.3 84.8 12.7 34.0 7.4 7.9 9.5 10.4 24.4 8.9 36.3 18.4 15.7 17.2 35.7 14.7 4.9 19.8 25.7 8.8 9.7 12.3 2.9 9.4 8.0 25.1 26.4 32.3 17.5 4.6 10.8 8.9 27.9 11.8 14.3 11.2 22.6 35.1 11.6 6.1 16.3 39.9 20.5 8.9 38.0 13.2 8.4 9.7 7.4 20.4 7.8 6.8 9.1 8.4 9.0 7.7 5.6 10.9 4.7 5.1 26.0 7.0 6.1 7.7 12.5 5.3 8.9 10.7 10.1 11.4 8.9 8.7 11.2 7.2 10.6 10.9 TNIP2 "ABIN-2, FLIP1, KLIP, MGC4289" ENSG00000168884 "TNFAIP3 interacting protein 2" Q8NFZ5 4 2741648-2756376 "Predicted intracellular proteins" "Apoptosis, Inflammatory response, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020818, HPA049886, HPA063197" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB020818: , HPA049886: , HPA063197: " "unprognostic (1.22e-1)" "unprognostic (2.09e-1)" "unprognostic (2.44e-1)" "prognostic favourable (1.13e-4)" "unprognostic (3.64e-1)" "unprognostic (9.87e-2)" "unprognostic (4.36e-2)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.77e-1)" "unprognostic (2.47e-2)" "unprognostic (8.34e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (2.94e-5)" "unprognostic (3.00e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-3)" "unprognostic (4.02e-3)" 16.7 10.3 7.8 14.5 14.0 18.9 32.5 3.4 12.4 9.8 26.4 7.3 7.1 16.4 11.9 10.1 14.5 9.6 13.7 26.6 7.4 6.5 23.4 16.6 16.0 17.9 11.2 4.7 12.3 24.2 3.5 11.4 15.3 12.4 13.6 10.1 9.7 10.7 13.5 21.9 10.5 37.2 23.9 12.2 17.8 15.3 11.7 11.1 8.1 14.2 12.3 18.2 15.1 33.7 9.8 7.3 20.9 11.8 4.4 11.2 4.7 12.3 17.0 5.4 8.1 17.3 11.9 23.4 13.6 12.2 12.7 12.4 19.4 20.2 11.4 15.5 14.8 8.2 9.6 15.6 7.5 8.9 12.1 13.6 10.0 21.4 21.6 11.1 17.3 15.3 14.2 14.0 12.7 18.0 13.8 16.1 8.8 25.8 14.6 27.5 14.1 29.1 9.6 8.2 5.9 13.6 14.0 8.1 9.1 10.6 11.1 14.9 12.1 16.4 20.9 9.8 10.9 15.4 20.8 16.8 11.3 8.2 18.0 20.1 10.6 6.4 7.2 20.9 6.7 11.2 7.2 7.8 10.2 11.2 7.3 9.8 8.4 7.0 7.1 4.4 11.8 3.4 10.2 4.7 7.8 14.0 3.4 12.4 7.4 6.5 11.2 4.7 12.4 11.1 TNKS "PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555914-9782346 "Enzymes, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 9.1 13.4 17.8 8.7 19.6 14.6 14.0 26.5 22.3 18.1 8.9 17.0 12.5 8.5 14.9 25.3 7.7 11.9 8.9 9.5 18.6 17.9 9.0 9.1 10.3 12.9 28.7 17.2 19.2 10.2 23.9 20.0 11.0 20.1 11.5 10.0 10.9 9.4 11.7 22.1 15.6 9.8 11.0 21.0 8.7 10.1 26.3 21.8 15.6 13.7 4.4 11.7 10.8 13.6 6.8 3.6 7.4 2.8 2.9 4.8 1.2 6.0 8.0 20.5 12.3 12.9 17.4 7.6 9.3 10.6 7.6 8.6 4.7 4.8 12.9 3.9 9.1 6.4 11.6 8.7 11.0 3.3 6.0 9.1 7.3 10.7 11.7 4.7 5.6 12.3 10.6 7.9 15.6 10.2 8.5 13.9 14.0 3.9 11.7 7.1 13.3 4.7 9.5 12.6 3.7 9.1 12.3 20.8 15.3 7.3 7.0 13.2 4.7 7.0 13.7 12.5 7.7 8.5 6.9 4.8 7.8 9.2 13.5 6.6 12.0 4.8 2.3 1.8 4.4 2.2 2.4 4.2 3.5 4.2 2.8 6.8 4.2 4.8 7.4 2.9 2.8 3.6 1.7 1.2 17.8 19.6 26.5 22.3 18.6 17.9 28.7 17.2 20.1 21.8 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell line enhanced" "Detected in some" "CACO-2: 23.8;EFO-21: 23.9;HeLa: 15.7;Hep G2: 15.9;HSkMC: 24.8;U-2 OS: 36.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Region enriched" "Detected in single" 7 "midbrain: 8.5" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 23.8 11.9 0.2 23.9 3.4 0.1 0.0 0.1 0.0 0.4 0.5 0.1 15.7 15.9 0.1 0.1 0.0 24.8 0.4 0.0 0.2 0.0 0.0 1.8 0.7 0.0 0.0 0.2 0.1 0.2 0.0 1.0 0.8 1.1 4.5 0.0 0.0 0.1 2.4 0.0 9.6 0.2 0.0 0.0 36.7 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in some" 7 "Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: " "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.2 0.5 1.7 1.2 1.7 0.2 0.4 0.0 0.1 0.2 1.1 0.4 1.2 1.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.9 9.7 0.4 0.3 0.2 15.3 0.2 0.1 0.7 0.0 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.6 0.2 0.6 0.2 0.3 0.0 11.5 0.5 1.7 0.1 0.4 1.3 0.4 0.5 0.3 0.4 0.9 0.2 1.5 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell line enriched" "Detected in some" 9 "RH-30: 103.8" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 103.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838989-1841680 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 635.0;tongue: 527.7" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.7;hTCEpi: 65.2" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.4" "Group enriched" "Detected in many" 4 "dendritic cells: 46.4;granulocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" 29000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: " "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 13.9 0.1 0.1 0.1 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 16.5 11.6 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.3 0.0 1.2 0.1 0.0 15.7 0.4 635.0 4.8 0.2 0.1 0.2 0.4 0.1 0.1 0.0 0.0 3.0 527.7 11.5 2.1 0.1 2.3 46.4 26.7 8.6 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 22.7 0.6 0.1 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 5.4 65.2 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.8 1.4 0.0 0.6 0.0 0.6 0.0 0.4 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 6.1 3.1 26.7 0.0 6.5 0.0 1.9 0.0 0.0 4.3 2.3 0.0 0.0 21.1 0.2 8.6 46.4 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 367 "heart muscle: 419.3" "Cell line enhanced" "Detected in some" "HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 1.0" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol 1700000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: " "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 419.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.2 1.1 4.5 0.0 0.6 0.9 0.2 0.0 0.0 8.6 2.0 0.0 1.2 0.4 0.0 14.4 0.0 0.4 0.0 0.2 0.0 26.2 0.5 0.0 0.4 0.1 0.0 0.5 0.3 1.1 0.3 0.0 1.3 0.0 0.0 1.5 0.0 0.0 0.2 2.0 6.6 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell line enhanced" "Detected in many" "HMC-1: 119.1;RH-30: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in many" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: " "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavourable (4.66e-4)" "prognostic unfavourable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.3 14.3 0.1 3.1 0.0 0.2 4.7 1.1 4.2 1.6 4.7 5.2 16.2 0.3 9.5 0.4 12.4 3.4 10.6 1.3 1.6 27.0 4.6 1.5 0.9 0.5 0.3 119.1 5.3 17.2 0.4 18.3 0.0 23.1 22.6 1.5 23.2 0.4 0.0 3.0 28.4 15.5 89.7 2.9 3.7 0.8 0.9 7.0 1.5 0.2 7.8 14.8 14.2 0.5 23.6 35.1 0.9 1.7 0.1 0.9 1.1 24.8 3.6 7.1 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell line enriched" "Detected in some" 26 "RH-30: 185.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.4 0.0 0.0 185.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" 47000 Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavourable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.9 29.3 20.1 26.2 24.5 20.7 52.3 18.5 21.9 18.5 21.6 15.7 32.3 16.4 25.4 25.4 26.5 17.9 22.8 21.9 22.5 16.5 26.2 20.8 24.2 22.4 22.9 16.4 22.5 28.9 54.1 36.5 34.9 27.0 21.2 24.4 19.4 26.1 35.3 38.0 15.9 19.9 32.0 31.2 21.7 25.3 30.9 20.8 25.2 32.6 18.0 23.6 27.5 30.8 11.1 10.7 8.9 13.3 14.1 18.3 10.6 21.6 28.6 41.6 24.9 31.0 38.5 24.6 25.7 35.0 25.6 26.4 24.3 18.6 25.3 17.6 40.3 15.8 28.3 22.9 37.1 14.7 15.7 15.6 38.0 12.3 21.0 17.2 11.5 27.8 16.6 34.2 48.8 62.1 23.3 13.5 72.7 10.3 15.7 6.6 22.3 21.9 19.0 37.5 15.9 15.8 29.0 21.6 22.3 41.3 13.2 30.3 16.3 14.2 58.8 21.7 25.6 32.7 28.7 12.4 19.4 33.8 17.3 17.7 39.8 7.3 8.3 6.9 13.4 11.5 18.3 11.1 12.2 10.0 10.7 11.0 13.4 13.4 8.9 14.1 13.3 5.0 8.1 10.6 20.1 24.5 18.5 21.9 22.5 16.5 22.9 16.4 27.0 20.8 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: " "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favourable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 21.7 19.8 37.1 16.0 35.7 17.8 13.5 33.1 44.7 17.9 13.9 23.2 12.7 13.4 20.7 20.9 22.9 22.4 15.9 20.0 31.1 24.9 14.3 10.1 13.7 16.6 24.8 36.6 32.9 16.0 26.6 19.1 16.1 22.2 16.8 15.9 18.2 15.1 20.0 15.2 36.6 12.5 23.3 25.2 15.3 12.9 24.1 20.9 14.9 17.8 9.9 17.8 18.9 14.7 1.6 4.3 2.6 1.2 0.4 3.3 0.7 17.4 13.3 20.6 26.3 12.5 16.6 13.4 20.2 13.4 29.3 20.7 18.2 9.5 11.9 15.8 17.0 23.4 36.5 20.0 16.4 14.7 29.2 18.3 21.0 22.1 14.2 32.3 17.7 14.8 15.8 19.4 20.7 13.7 28.5 11.4 16.2 30.3 27.0 22.3 23.9 40.4 26.1 16.1 21.8 17.4 12.8 50.5 25.1 16.4 20.9 10.0 14.6 11.5 13.7 45.0 11.9 24.0 29.6 22.7 21.8 20.3 13.4 29.4 15.9 0.6 0.9 0.3 2.1 0.8 3.0 1.5 1.5 1.7 1.2 1.6 2.7 3.3 2.6 0.4 1.2 4.3 0.5 0.7 37.1 35.7 33.1 42.1 31.1 24.9 24.8 36.6 22.2 20.9 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.6" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.6" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: , HPA024251: " "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 17.9 11.8 18.1 17.9 17.2 29.4 20.6 35.1 23.6 35.0 29.9 16.7 17.9 16.4 36.0 19.5 19.6 27.5 29.2 13.6 14.2 9.6 15.6 11.8 19.2 12.9 15.5 16.7 30.3 18.4 36.9 14.7 19.7 13.2 25.4 15.1 25.2 17.0 24.4 13.6 18.9 16.9 40.1 12.6 15.3 21.4 14.0 16.6 7.2 20.6 12.8 9.4 27.0 21.4 2.0 4.3 17.6 3.2 2.6 1.5 0.1 21.3 19.1 15.9 13.3 13.4 16.0 41.1 15.2 14.4 8.4 9.0 7.8 18.8 14.6 15.0 22.2 23.9 9.1 18.2 7.1 6.4 5.8 9.3 16.3 12.7 11.7 30.5 34.3 16.1 21.5 16.8 19.6 9.5 13.1 8.3 10.7 35.5 7.1 37.3 1.4 14.6 8.0 7.9 10.8 6.9 27.3 6.9 16.6 11.8 31.3 11.3 32.7 31.6 23.6 24.5 34.5 14.5 10.9 11.9 12.3 13.8 13.7 21.7 28.5 9.4 3.2 2.7 1.4 1.2 1.0 1.6 1.0 0.8 1.1 2.0 0.7 1.5 17.6 2.6 1.5 4.3 1.4 0.1 18.1 17.2 35.1 23.6 14.2 9.6 15.5 16.7 13.2 16.6 TNRC6A "CAGH26, GW182, KIAA1460, TNRC6" ENSG00000090905 "Trinucleotide repeat containing 6A" Q8NDV7 16 24610209-24827632 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015305, HPA017869" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA015305: AB_1850454, HPA017869: AB_1850456" "unprognostic (2.64e-1)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.86e-1)" "unprognostic (5.00e-2)" "unprognostic (1.10e-3)" "unprognostic (1.62e-1)" "unprognostic (3.22e-3)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (7.44e-3)" "unprognostic (2.63e-3)" "unprognostic (1.78e-1)" "unprognostic (9.18e-2)" "unprognostic (5.77e-2)" "unprognostic (2.31e-1)" "unprognostic (3.35e-2)" 17.3 23.6 14.7 23.2 15.1 10.2 17.0 25.0 19.3 20.8 17.0 15.6 17.2 10.5 26.6 23.1 12.5 20.2 12.6 13.4 11.3 9.4 13.0 17.0 14.0 16.7 14.5 10.9 26.7 20.1 42.6 25.4 12.6 16.2 16.4 12.8 17.8 16.6 18.6 26.5 16.5 16.0 27.5 19.4 14.2 15.8 11.4 14.7 15.9 19.6 14.9 13.8 16.4 16.4 5.4 5.2 2.3 2.7 3.3 3.9 1.3 11.5 16.1 19.1 10.3 16.6 22.0 10.9 19.8 16.1 14.5 15.9 11.8 9.7 11.7 8.6 19.8 13.1 23.7 16.6 21.8 11.8 12.3 11.7 17.8 16.2 14.3 11.9 8.2 22.1 8.7 18.9 12.5 19.8 17.7 7.5 18.6 13.6 9.9 7.9 27.4 8.1 19.6 14.8 10.5 11.0 10.8 9.4 13.0 13.9 8.6 7.6 9.9 7.9 18.1 18.6 12.7 9.1 13.8 16.5 12.9 19.5 17.3 7.5 13.3 2.3 2.7 1.9 3.0 1.6 2.5 5.2 2.9 2.7 1.0 5.4 3.9 2.7 1.5 3.3 1.6 5.2 2.9 1.3 14.7 15.1 25.0 19.3 11.3 9.4 14.5 10.9 16.2 14.7 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA047839: " "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (5.04e-5)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 14.3 68.4 10.5 10.4 15.7 19.6 29.5 11.3 13.4 20.9 24.2 23.6 24.2 16.9 7.9 12.9 30.2 17.4 42.7 21.7 12.0 11.8 22.5 57.5 17.7 7.5 12.0 10.2 21.5 74.4 30.2 20.0 5.6 13.9 24.5 18.3 36.5 32.4 56.0 60.4 44.7 26.3 23.7 11.9 6.1 28.8 9.0 13.1 8.9 30.3 31.0 13.8 38.8 22.9 7.8 21.3 63.0 25.1 4.8 51.2 25.2 10.9 22.5 7.3 3.0 13.8 6.9 5.6 8.2 20.4 5.4 6.6 9.0 14.1 10.0 15.8 11.2 15.6 4.9 13.9 5.6 5.0 7.2 1.2 26.4 14.9 19.3 5.1 4.9 14.7 17.3 6.2 31.9 2.5 4.1 8.8 11.3 29.8 3.9 4.8 2.6 8.6 3.5 9.3 11.9 21.1 22.8 4.3 10.5 14.0 41.7 4.9 65.7 6.8 3.4 6.2 4.4 6.8 3.9 13.4 14.0 4.7 5.0 2.6 2.3 63.0 10.5 49.9 46.6 18.6 51.2 7.8 43.4 36.4 21.3 6.2 38.4 46.2 23.6 4.8 25.1 6.9 35.9 25.2 10.5 15.7 11.3 13.4 12.0 11.8 12.0 10.2 13.9 13.1 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45339670-45343975 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA053775: , HPA069119: " "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favourable (9.05e-4)" "prognostic unfavourable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (2.71e-4)" "prognostic favourable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 7.4 9.2 8.9 8.0 10.6 9.7 8.1 11.6 9.4 7.4 8.9 8.7 11.2 9.8 10.8 11.0 8.3 8.9 8.7 7.5 6.4 5.6 7.1 7.9 9.4 8.7 5.1 7.4 9.4 7.4 10.8 7.8 8.2 7.7 8.8 9.2 10.0 9.9 7.7 4.3 6.9 9.4 10.0 9.4 11.0 9.4 18.7 5.0 14.6 10.3 6.1 8.8 9.1 7.3 8.7 6.0 13.8 6.8 3.2 9.6 4.7 8.2 4.5 6.3 7.5 3.8 3.1 11.4 6.6 6.0 12.3 11.7 5.5 4.4 14.3 6.7 7.9 7.4 9.9 11.5 8.6 9.1 8.1 15.2 8.7 6.1 3.2 9.1 8.3 4.5 2.0 12.4 7.9 9.8 11.8 7.9 8.4 6.4 16.2 7.7 14.0 6.1 11.7 11.2 6.3 4.9 10.9 6.7 6.9 6.8 17.3 12.8 4.3 14.6 6.7 5.2 11.1 9.5 11.8 5.6 7.5 9.1 7.8 12.0 6.7 13.8 5.7 5.7 7.9 6.8 9.6 6.2 7.7 8.4 5.5 8.7 6.9 8.3 0.8 3.2 5.9 6.0 8.5 4.7 8.9 10.6 11.6 9.4 6.4 5.6 5.1 7.4 7.7 5.0 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved "Plasma membrane,Cytosol" 34000 "Plasma membrane, Cytosol" "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavourable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favourable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 15.3 16.7 31.2 8.8 32.5 9.0 11.9 28.3 63.0 10.7 12.7 12.9 8.6 18.6 8.3 10.3 29.4 10.7 13.7 15.8 28.0 20.3 20.9 37.1 12.3 9.6 18.1 32.1 12.8 41.8 13.7 18.7 9.9 17.4 15.6 6.6 12.9 15.9 16.8 23.4 24.0 15.7 9.0 13.5 13.2 15.1 24.5 11.8 5.9 12.6 11.8 10.9 14.6 14.8 13.9 26.9 49.0 34.8 11.1 12.6 18.3 15.6 16.6 8.5 9.6 18.1 11.4 7.4 13.9 12.7 16.4 14.6 18.0 10.0 7.3 13.5 12.8 14.2 7.6 17.1 4.5 15.0 15.5 6.0 3.6 26.9 25.9 11.3 15.2 17.1 20.1 9.7 9.4 10.2 9.8 20.0 13.4 13.1 14.3 13.9 10.3 22.1 10.9 8.7 7.2 10.8 21.0 22.8 13.4 12.5 15.2 15.3 12.0 12.9 18.6 17.8 7.6 7.5 8.0 20.3 18.0 8.9 28.1 7.5 13.9 9.5 34.8 35.9 9.6 30.0 8.0 10.9 10.3 8.9 26.9 13.9 8.1 7.6 49.0 11.1 27.5 14.1 12.6 18.3 31.2 32.5 28.3 63.0 28.0 20.3 18.1 32.1 17.4 11.8 TOM1 ENSG00000100284 "Target of myb1 membrane trafficking protein" O60784 22 35299275-35347994 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000818, HPA001749" Approved Approved "Plasma membrane,Centriolar satellite,Cytosol" 14000 Cytosol "Plasma membrane, Centriolar satellite" "HPA000818: , HPA001749: AB_1080323" "unprognostic (3.75e-1)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "prognostic favourable (2.20e-5)" "unprognostic (1.11e-2)" "unprognostic (7.55e-2)" "unprognostic (4.07e-3)" "unprognostic (2.24e-1)" "unprognostic (9.92e-2)" "unprognostic (2.32e-1)" "unprognostic (3.71e-1)" "unprognostic (8.16e-2)" "prognostic favourable (3.72e-5)" "unprognostic (1.22e-1)" "unprognostic (1.30e-1)" "unprognostic (7.54e-3)" "unprognostic (3.31e-2)" 17.0 21.2 9.5 10.2 13.8 31.1 13.7 10.2 24.6 16.0 14.6 12.0 7.5 17.4 14.1 15.5 31.6 11.7 15.4 19.1 8.8 15.2 16.1 27.4 17.5 8.2 11.6 11.3 12.1 11.8 21.8 16.8 39.0 23.2 10.2 6.4 17.5 37.0 10.1 83.8 29.1 18.6 7.1 8.4 10.6 8.4 13.6 8.7 10.0 14.8 25.9 19.9 12.1 17.6 4.6 15.2 40.9 31.2 4.6 14.7 17.0 6.6 6.7 3.9 6.3 27.9 16.6 18.4 6.5 19.7 12.7 14.3 9.3 6.2 2.6 12.1 20.3 3.1 4.0 6.8 4.6 7.5 9.1 2.2 7.6 19.3 26.3 4.2 10.1 22.4 8.6 17.9 6.1 8.8 4.3 6.6 6.2 6.4 3.4 9.9 3.0 3.9 6.2 5.6 5.6 5.0 5.0 6.7 5.2 14.8 15.4 14.5 7.8 7.0 9.2 15.1 13.1 11.5 3.2 7.7 4.8 6.8 20.3 4.4 4.9 5.9 31.2 13.1 6.4 18.9 5.3 4.6 9.8 6.1 15.2 4.0 7.9 5.3 40.9 4.6 19.4 8.1 14.7 17.0 9.5 13.8 10.2 24.6 8.8 15.2 11.6 11.3 23.2 8.7 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.5" "Cell line enhanced" "Detected in many" "HaCaT: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Supported "Golgi apparatus,Intermediate filaments" 66000 "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favourable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavourable (2.58e-4)" "prognostic favourable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favourable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 11.8 14.8 24.7 7.3 27.4 3.5 10.4 23.2 38.2 10.5 12.8 32.3 8.7 8.8 12.8 8.2 35.9 12.7 8.8 81.5 25.9 21.8 13.1 4.4 14.4 4.8 24.4 23.8 15.7 12.2 28.7 14.4 6.3 42.3 21.1 9.7 19.5 9.7 19.3 32.0 29.0 10.5 16.0 16.4 7.7 10.9 14.7 20.9 4.3 24.8 13.7 10.5 12.0 11.0 2.7 2.2 14.6 3.9 1.4 5.3 1.8 11.1 13.4 3.6 2.8 8.9 9.0 5.7 19.3 9.1 10.9 9.1 12.3 8.1 2.0 25.3 18.9 46.8 2.9 11.3 6.5 3.1 5.2 3.4 12.1 2.3 5.5 0.7 2.3 10.6 7.8 9.9 7.4 10.9 1.2 3.0 13.8 11.7 1.4 1.8 0.6 8.2 1.9 8.7 5.0 14.2 21.9 4.1 3.8 8.6 11.2 6.9 5.7 1.5 13.9 10.1 2.7 20.3 7.0 2.6 2.1 0.8 11.7 1.0 24.2 7.1 3.9 5.1 3.5 1.2 2.5 2.0 3.2 2.8 1.8 2.7 5.3 3.9 14.6 1.4 3.4 2.2 1.5 1.8 24.7 27.4 23.2 38.2 25.9 21.8 24.4 23.8 42.3 20.9 TOMM40 "C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40" ENSG00000130204 "Translocase of outer mitochondrial membrane 40" O96008 19 44890569-44903689 "Predicted intracellular proteins, Transporters" "Ion transport, Protein transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036231, HPA036232" Supported Enhanced Mitochondria,Cytosol Mitochondria Cytosol "HPA036231: , HPA036232: " "unprognostic (2.14e-1)" "unprognostic (9.58e-3)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (2.37e-1)" "unprognostic (2.17e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-2)" "unprognostic (7.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (5.86e-3)" "unprognostic (5.30e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-1)" 16.0 25.3 13.6 16.9 15.6 19.7 20.6 17.7 27.0 10.2 20.5 10.9 10.1 20.0 11.8 10.5 22.9 13.5 11.4 21.5 15.3 14.9 16.5 36.9 15.1 22.3 15.6 13.3 18.2 19.2 16.2 11.9 15.3 20.2 11.2 16.7 11.5 11.5 13.5 32.3 14.7 15.1 11.6 11.9 12.7 12.6 12.3 8.8 14.2 11.6 18.6 15.6 10.9 12.5 7.3 7.0 5.1 6.8 4.7 8.7 2.0 30.8 52.3 19.1 26.3 7.1 6.4 24.3 22.2 12.3 42.1 30.2 56.8 21.4 45.6 23.9 14.6 33.4 49.5 31.9 19.2 17.6 44.9 30.6 20.5 44.7 15.2 39.0 27.5 10.1 18.1 32.6 20.7 14.5 48.2 15.9 16.4 38.5 42.3 28.7 33.4 32.6 43.3 21.7 26.5 19.3 42.9 29.8 19.1 23.6 49.8 15.8 16.7 39.6 11.9 29.2 29.6 20.3 57.9 17.2 35.6 44.7 21.7 41.5 30.7 0.7 5.5 5.1 4.7 6.8 5.2 7.3 4.5 6.5 7.0 4.2 7.9 8.7 1.1 4.7 5.9 6.9 4.8 2.0 13.6 15.6 17.7 27.0 15.3 14.9 15.6 13.3 20.2 8.8 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444444 "Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024679, HPA046494" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: " "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavourable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 1.4 2.8 1.4 11.0 1.8 11.7 1.9 6.1 2.7 1.9 5.5 1.4 3.2 5.5 2.2 1.8 5.6 1.7 1.3 1.6 1.2 1.1 2.0 2.3 2.6 3.7 1.9 1.2 2.4 2.3 1.1 1.1 2.6 2.9 2.1 1.7 0.8 3.1 2.2 1.0 4.0 6.8 1.4 1.9 5.6 3.5 4.8 2.1 10.3 3.3 3.6 5.3 3.9 5.1 0.6 0.1 0.0 0.2 1.9 0.6 0.1 6.9 6.2 4.7 7.3 0.3 0.5 11.3 5.9 1.1 3.5 2.8 5.0 6.0 6.4 6.0 0.9 4.7 4.5 3.6 0.8 6.6 9.0 15.2 7.9 5.1 0.2 4.6 9.6 0.6 0.5 3.7 0.7 1.7 17.1 4.8 1.4 14.2 11.5 7.9 6.6 9.1 14.0 3.0 6.7 2.0 7.5 7.8 4.4 6.1 4.1 2.6 6.0 4.3 1.9 4.4 18.2 4.9 7.1 1.7 3.1 3.9 4.2 9.9 5.1 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.2 0.6 0.1 0.6 0.5 0.4 0.0 1.9 0.0 0.0 0.2 0.1 1.4 1.8 6.1 2.7 1.2 1.1 1.9 1.2 2.9 2.1 TOP1 ENSG00000198900 "DNA topoisomerase I" P11387 20 41028818-41124487 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009058, HPA019039" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB009058: AB_2303554, HPA019039: AB_1858187" "unprognostic (1.46e-1)" "unprognostic (8.65e-2)" "unprognostic (1.33e-2)" "unprognostic (1.92e-3)" "unprognostic (5.05e-2)" "unprognostic (1.49e-3)" "prognostic unfavourable (6.42e-4)" "unprognostic (5.86e-2)" "unprognostic (1.51e-1)" "unprognostic (4.60e-2)" "unprognostic (3.74e-3)" "unprognostic (6.51e-2)" "unprognostic (8.65e-2)" "unprognostic (4.70e-2)" "unprognostic (5.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" 26.6 31.0 24.6 46.3 25.3 55.3 37.4 39.6 31.1 21.3 30.0 11.1 26.7 29.7 22.9 22.5 36.0 20.5 29.2 21.0 23.0 18.3 31.8 32.7 37.9 38.6 21.9 20.9 25.5 22.5 22.2 39.9 43.9 25.2 23.3 27.2 13.6 25.3 34.3 26.2 24.6 48.4 23.1 27.4 36.9 26.7 14.2 24.2 54.2 31.5 25.1 40.6 25.2 41.7 9.0 17.2 18.4 11.1 5.8 8.2 4.6 21.5 15.1 28.3 23.1 11.5 13.7 28.0 19.5 17.2 22.7 20.7 39.6 27.2 61.5 20.9 10.1 21.0 33.9 31.2 33.3 13.3 17.3 78.4 12.1 28.1 29.9 33.8 27.0 15.5 16.7 22.1 36.4 23.7 34.0 21.4 25.6 47.9 47.7 21.4 22.8 28.1 40.8 26.6 32.7 24.2 20.1 23.5 16.3 30.6 19.0 19.8 21.1 30.3 23.2 18.4 15.6 17.0 20.9 13.6 15.2 71.7 24.7 19.0 17.4 9.1 9.2 14.3 6.5 9.2 8.2 9.0 7.2 6.8 8.6 8.7 7.7 6.9 18.4 5.8 11.1 17.2 7.9 4.6 24.6 25.3 39.6 31.1 23.0 18.3 21.9 20.9 25.2 24.2 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.92e-6)" "prognostic unfavourable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 33.7 44.9 57.2 26.1 2.8 5.8 12.7 46.4 25.0 42.7 37.9 21.0 25.9 54.5 23.6 15.7 53.8 43.9 18.5 57.4 29.1 29.3 36.0 28.7 35.1 0.2 50.4 38.3 1.2 1.5 30.0 30.6 22.4 38.9 37.4 46.1 11.7 58.4 33.9 23.7 17.9 49.6 88.8 22.6 10.3 21.6 33.8 24.3 37.4 46.7 14.7 39.2 23.2 14.7 28.2 39.7 32.5 44.5 21.5 24.3 47.6 15.9 34.8 46.9 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812944-129824134 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: " "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavourable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 19.8 26.8 17.8 21.9 19.3 28.0 37.5 19.9 28.4 18.8 19.0 15.5 17.8 15.2 22.5 19.6 15.0 17.4 22.7 18.0 18.4 19.7 20.9 47.1 19.3 34.4 16.1 14.3 20.4 18.8 15.2 15.9 28.9 15.6 20.8 21.3 14.9 18.9 24.7 15.8 17.8 21.0 24.0 15.9 23.1 18.1 11.7 11.3 32.8 22.6 11.9 18.2 21.0 16.1 17.3 24.1 53.3 28.8 24.9 24.0 27.2 13.1 19.8 14.6 16.8 22.3 21.7 19.5 30.8 38.2 27.6 23.7 12.8 19.4 16.2 18.2 39.8 31.1 14.0 20.4 22.7 25.7 13.4 14.5 20.8 12.7 28.1 31.9 27.0 29.3 20.7 26.0 18.9 29.5 25.7 13.1 30.3 32.9 22.7 31.0 21.9 22.6 11.9 23.1 16.4 22.5 16.9 11.1 19.6 31.9 12.5 16.9 25.0 25.1 26.1 27.4 15.6 20.3 23.5 15.0 33.3 14.9 20.3 18.5 21.9 30.0 28.8 53.3 24.0 26.4 20.1 17.3 20.6 21.6 24.1 12.9 17.7 18.3 28.2 24.9 21.3 22.1 22.4 27.2 17.8 19.3 19.9 28.4 18.4 19.7 16.1 14.3 15.6 11.3 TOR1B "DQ1, MGC4386" ENSG00000136816 "Torsin family 1 member B" O14657 9 129803153-129811281 "Predicted intracellular proteins" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013403, HPA013697, CAB022709" Approved Approved "Nuclear speckles,Cytosol" "Intracellular and membrane" "Nuclear speckles" Cytosol "CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196" "unprognostic (2.91e-3)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (8.55e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-2)" "unprognostic (1.75e-1)" "unprognostic (5.73e-3)" "unprognostic (1.95e-1)" "unprognostic (7.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.13e-2)" "unprognostic (2.07e-3)" "unprognostic (4.09e-2)" "unprognostic (1.23e-1)" "unprognostic (5.40e-3)" "unprognostic (1.69e-3)" 14.2 14.4 9.7 13.8 12.2 14.0 18.4 23.6 11.9 11.3 22.5 10.5 11.6 12.3 14.0 8.2 13.5 10.5 15.0 13.3 11.7 11.5 11.8 35.3 13.0 10.8 9.4 9.0 10.8 21.1 13.3 13.6 20.0 10.6 12.9 25.8 10.8 12.8 13.7 13.5 13.0 18.1 14.2 8.9 12.4 14.9 19.5 8.3 16.8 16.4 10.0 11.9 14.9 18.0 4.6 6.2 17.2 14.6 7.3 12.3 8.4 5.3 12.3 5.2 13.8 26.0 19.5 12.0 19.3 12.6 13.2 13.2 10.2 12.3 3.8 12.3 18.9 22.0 5.6 7.9 13.6 14.0 5.9 3.4 10.5 7.2 11.2 6.3 15.0 11.0 14.0 18.9 9.4 11.7 11.6 8.9 12.3 15.0 8.6 10.0 10.9 9.8 3.6 9.1 11.6 10.2 5.6 7.2 8.3 12.4 14.4 7.6 20.7 6.2 10.7 25.1 12.0 29.8 16.5 6.5 24.3 3.2 13.8 8.3 17.0 6.3 11.5 17.2 12.2 14.6 12.3 3.9 9.5 10.5 6.2 4.6 7.1 7.1 14.2 7.3 8.5 3.8 9.1 8.4 9.7 12.2 23.6 11.9 11.7 11.5 9.4 9.0 10.6 8.3 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805418-59119208 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 88.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 9.8;MOLT-4: 53.9;SH-SY5Y: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: " "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favourable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 1.3 1.2 10.5 15.7 6.3 2.8 1.5 1.9 15.6 2.1 13.4 1.5 1.2 10.0 1.5 1.1 3.7 1.1 5.0 0.9 6.3 9.8 3.2 1.7 4.9 17.7 4.8 12.0 6.6 2.4 2.9 3.7 1.5 2.2 2.4 9.3 2.6 1.8 1.3 0.5 1.0 10.7 2.8 2.3 5.7 10.0 6.5 2.5 88.8 1.5 0.8 19.4 2.6 2.3 3.4 0.8 10.2 0.1 10.4 21.0 3.1 0.3 0.0 6.0 0.0 0.6 1.4 0.0 1.2 2.8 0.7 0.1 0.0 0.0 0.0 0.0 5.4 0.4 1.4 0.0 0.1 0.2 0.5 0.0 1.1 0.0 5.0 1.0 0.2 0.7 0.2 0.9 1.1 9.8 0.0 0.0 0.4 0.0 53.9 0.0 1.0 0.1 1.1 4.1 0.0 0.1 0.1 5.5 16.9 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.7 4.9 1.6 0.0 0.0 3.7 0.2 0.0 1.0 10.2 0.1 1.8 7.5 0.0 3.4 3.4 5.5 11.3 0.8 0.6 2.1 6.3 0.2 10.4 0.0 0.0 21.0 3.1 10.5 6.3 1.9 15.6 6.3 9.8 4.8 12.0 2.2 2.5 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52438005-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 18.7" "Cell line enhanced" "Detected in some" "AF22: 19.7;HAP1: 9.6;Hep G2: 8.6;RT4: 37.5;SCLC-21H: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favourable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favourable (3.95e-4)" 0.7 3.1 7.1 5.0 4.7 0.0 3.9 0.6 6.0 7.0 13.5 6.0 0.2 9.4 1.3 9.2 0.9 3.0 14.8 0.2 3.2 5.3 9.5 5.8 2.7 0.1 5.4 3.6 1.0 7.8 0.0 5.8 0.3 5.1 1.8 15.1 2.7 11.0 0.7 0.3 1.1 13.5 0.9 7.0 0.2 18.7 0.7 4.7 0.0 0.2 0.3 2.1 7.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.7 0.0 0.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 3.4 0.1 4.6 37.5 13.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.7 0.6 4.3 3.2 5.3 5.4 3.6 5.1 4.7 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favourable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 12.9 13.8 11.5 10.9 16.7 16.1 15.4 12.6 24.9 26.9 26.0 13.3 15.8 7.9 8.9 20.7 15.8 18.8 19.4 34.5 13.9 7.6 8.8 9.4 18.4 21.7 16.2 14.5 20.9 20.1 21.0 20.3 19.0 10.8 13.6 19.1 11.1 16.0 9.0 6.5 21.8 14.4 11.9 9.1 12.5 16.5 10.7 10.9 12.4 13.3 10.9 12.6 6.2 12.4 13.6 12.9 12.2 11.0 17.9 19.4 17.7 6.6 7.9 14.4 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 TP53BP2 "53BP2, ASPP2, PPP1R13A" ENSG00000143514 "Tumor protein p53 binding protein 2" Q13625 1 223779899-223845972 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021603, HPA050429" Supported Enhanced "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA021603: AB_1844384, HPA050429: " "unprognostic (1.29e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-1)" "unprognostic (1.38e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (7.37e-2)" "unprognostic (2.67e-1)" "unprognostic (7.99e-2)" "unprognostic (5.08e-2)" "unprognostic (1.24e-1)" "unprognostic (2.81e-2)" "unprognostic (1.83e-1)" 10.0 8.3 26.5 17.2 28.7 38.8 20.8 9.3 17.9 10.9 12.0 12.6 8.1 7.9 11.9 9.8 15.9 9.4 17.4 10.9 17.3 14.7 10.1 13.9 21.4 18.6 18.7 8.6 15.5 13.0 16.4 8.3 8.2 12.9 9.6 9.5 17.7 10.2 8.1 12.0 9.9 9.5 12.2 13.0 10.6 9.7 10.2 14.9 17.3 22.1 7.4 11.7 11.8 14.8 2.2 2.9 6.7 2.7 7.2 4.0 2.0 15.3 7.7 21.0 13.2 7.5 7.3 13.4 9.9 14.1 14.5 12.5 15.9 9.3 0.0 8.7 8.2 10.5 16.3 5.9 19.5 29.6 16.1 20.3 7.5 5.4 15.2 16.7 14.3 8.7 6.5 13.3 13.7 8.5 25.7 15.4 12.0 4.4 12.7 10.3 18.1 7.5 16.9 21.9 1.7 13.0 9.7 18.2 23.5 10.9 13.6 14.3 7.7 23.0 9.9 14.9 10.5 16.0 18.5 7.6 7.9 12.7 9.0 11.3 16.9 6.7 2.7 1.6 2.3 2.6 2.8 2.2 2.6 4.0 2.9 1.9 2.7 1.9 3.2 7.2 2.0 1.7 1.6 2.0 26.5 28.7 9.3 17.9 17.3 14.7 18.7 8.6 12.9 14.9 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 83.1;T-47d: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA059727: , HPA061276: " "prognostic unfavourable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 33.3 8.0 20.0 13.3 10.7 19.0 27.6 36.0 26.2 14.7 21.1 8.6 17.6 13.6 16.8 10.4 15.6 21.5 28.5 33.1 8.4 12.3 12.5 7.8 21.4 12.8 5.8 8.6 18.2 18.5 3.0 9.5 16.6 14.1 20.6 19.4 17.6 18.9 11.9 12.6 14.5 21.1 23.5 7.4 28.2 18.4 9.9 5.5 6.7 18.9 12.7 14.9 15.1 19.1 5.2 14.1 23.7 11.1 4.6 4.4 2.1 0.0 17.3 5.9 8.4 6.3 0.4 0.1 5.6 10.9 1.9 2.5 1.0 0.1 3.0 4.8 1.5 3.3 3.4 0.1 0.7 6.4 3.4 0.2 0.1 0.0 11.7 0.1 23.4 27.1 0.4 2.7 1.2 6.5 0.4 0.0 2.4 14.8 0.3 27.2 10.8 5.8 13.2 3.6 1.4 0.0 1.0 83.1 3.0 9.7 21.1 0.0 46.8 1.6 1.5 13.0 9.2 19.9 0.0 0.1 0.0 0.0 0.0 1.7 3.6 0.0 3.1 0.0 3.1 3.2 4.4 4.9 0.6 3.2 2.6 5.2 0.0 1.1 23.7 4.6 11.1 14.1 0.5 2.1 20.0 10.7 36.0 26.2 8.4 12.3 5.8 8.6 14.1 5.5 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652520-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell line enhanced" "Detected in many" "MOLT-4: 11.2;SCLC-21H: 14.3;U-698: 14.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 25.7" "Cell type enhanced" "Detected in some" "eosinophil: 1.2;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: , HPA044516: " "unprognostic (5.71e-3)" "prognostic favourable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favourable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favourable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.5 0.3 1.1 3.4 2.3 1.0 1.1 25.7 0.4 1.5 0.7 2.4 1.3 0.3 0.4 6.2 4.8 12.8 1.4 0.3 1.9 1.2 0.2 2.1 3.8 2.0 0.5 0.0 2.6 1.5 0.3 0.7 1.7 3.2 3.6 0.4 0.4 5.5 1.4 0.4 11.9 0.5 0.3 0.9 4.2 0.8 9.8 0.3 2.5 0.4 0.8 7.1 0.6 3.9 1.4 0.1 1.2 0.1 0.0 0.6 0.1 1.9 0.1 0.2 6.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.4 3.2 2.0 1.6 0.0 3.3 2.1 0.7 0.0 0.6 6.8 0.1 3.2 1.9 0.0 0.0 2.3 0.0 1.4 0.0 0.1 0.0 4.2 0.0 0.6 1.5 11.2 1.5 0.4 0.1 0.0 9.2 0.1 0.2 2.9 14.3 6.7 0.3 0.0 0.6 8.6 7.0 0.0 2.3 6.1 0.0 4.5 2.7 0.5 14.4 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 1.4 0.4 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 2.3 25.7 0.3 1.9 1.2 0.5 0.0 3.2 0.3 TPD52 "D52, hD52, N8L" ENSG00000076554 "Tumor protein D52" P55327 8 80034745-80231232 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 46.3;SK-BR-3: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 24.3" "Group enriched" "Detected in many" 6 "B-cells: 24.3;NK-cells: 6.8;T-cells: 11.1" "HPA028427, HPA062167" Enhanced Approved "Golgi apparatus,Cytosol" 42000 Cytosol "Golgi apparatus" "HPA028427: AB_10610561, HPA062167: AB_2684704" "prognostic unfavourable (1.11e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-2)" "unprognostic (3.77e-3)" "unprognostic (8.24e-2)" "unprognostic (3.75e-1)" "unprognostic (7.99e-3)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (4.77e-6)" "unprognostic (2.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (1.70e-2)" 3.2 3.9 33.9 20.2 23.2 3.2 30.9 37.5 43.3 8.3 45.2 19.7 7.3 38.1 4.1 23.2 18.1 6.3 13.2 4.5 35.4 26.9 18.4 15.1 7.8 15.8 27.4 24.0 1.5 26.0 19.1 19.1 13.6 20.3 42.5 51.3 17.4 33.5 8.0 3.1 18.2 40.3 4.4 31.4 9.8 32.7 2.1 19.8 3.5 25.8 7.3 22.2 9.5 10.0 24.3 2.4 2.5 0.0 6.8 11.1 4.1 23.1 6.2 0.2 4.2 0.0 0.0 9.5 1.5 2.3 6.4 3.2 3.2 6.8 33.8 8.4 0.1 9.5 9.6 6.5 4.6 4.1 8.0 4.7 8.9 5.2 0.0 1.5 0.1 0.0 4.6 0.0 2.2 0.3 0.0 46.3 0.0 7.6 7.4 6.9 2.1 15.7 0.0 0.1 21.4 11.1 5.6 12.0 8.2 7.2 105.2 19.4 10.2 6.0 0.3 0.0 6.6 0.1 5.4 17.4 15.0 27.7 4.2 0.0 0.4 0.2 0.0 2.5 6.4 0.0 11.1 24.3 6.4 5.5 1.1 22.4 4.2 4.8 0.2 6.8 0.0 2.4 4.1 4.1 33.9 23.2 37.5 43.3 35.4 26.9 27.4 24.0 20.3 19.8 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell line enhanced" "Detected in many" "AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favourable (3.97e-4)" "prognostic unfavourable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 6.9 7.9 0.0 51.4 0.4 0.1 12.2 1.1 1.1 0.0 0.1 12.5 8.9 0.0 26.4 5.8 15.9 1.5 11.0 0.0 0.1 11.0 0.1 11.0 0.1 1.1 0.0 0.0 1.4 45.3 0.0 5.9 0.0 5.5 0.1 0.9 67.2 0.0 0.1 0.8 4.3 0.0 0.0 0.0 52.1 1.8 1.7 0.0 13.3 36.3 0.8 31.0 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 TPD52L2 "D54, hD54" ENSG00000101150 "Tumor protein D52 like 2" O43399 20 63865228-63891545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047489 Approved Approved Vesicles,Cytosol 1500000 Vesicles Cytosol "HPA047489: " "unprognostic (1.17e-2)" "unprognostic (2.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.39e-5)" "unprognostic (3.63e-3)" "unprognostic (9.95e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (5.69e-2)" "prognostic unfavourable (1.74e-8)" "unprognostic (2.79e-1)" "unprognostic (7.07e-2)" "unprognostic (3.33e-2)" "unprognostic (3.15e-3)" 48.6 40.9 28.1 33.5 33.6 55.4 43.3 33.4 40.2 40.1 35.8 35.0 34.6 25.3 38.4 29.7 52.2 33.9 32.2 45.3 27.6 30.0 31.0 24.7 30.3 38.3 26.6 34.1 33.4 30.1 20.5 30.6 42.9 33.8 33.8 24.2 29.0 27.4 43.7 32.3 33.9 25.0 48.0 27.4 36.5 28.1 35.0 24.7 19.4 40.9 32.8 31.8 40.9 55.6 13.0 17.6 50.5 25.4 16.7 14.4 23.1 32.7 17.0 10.6 12.9 24.5 39.2 15.8 37.9 33.5 67.6 28.7 62.7 37.6 13.3 42.0 38.1 32.4 21.5 51.6 39.4 7.4 9.0 12.6 22.4 37.9 26.1 16.1 13.1 28.1 58.2 27.1 43.8 30.9 26.2 19.6 26.5 18.2 15.4 20.4 15.3 60.3 21.4 11.7 21.2 26.6 14.7 16.2 18.3 44.7 34.6 30.8 23.5 32.5 32.7 54.4 15.6 31.5 27.6 12.6 19.8 16.1 51.0 15.0 16.7 18.8 25.4 16.7 11.6 19.9 14.4 13.0 12.7 13.1 17.6 11.9 13.0 11.7 50.5 16.7 16.5 8.8 13.8 23.1 28.1 33.6 33.4 40.2 27.6 30.0 26.6 34.1 33.8 24.7 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.8;skeletal muscle: 211.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles 270000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 20.2 41.2 41.2 24.3 46.9 27.4 83.4 93.2 196.1 27.1 39.1 12.8 18.6 40.1 17.2 22.6 51.0 22.1 33.3 94.9 36.7 33.1 43.1 40.8 48.8 140.2 34.0 34.6 19.9 87.0 32.1 16.8 27.1 70.7 19.0 43.5 21.1 26.0 28.7 211.0 25.8 37.8 29.4 20.8 20.1 21.6 15.7 19.4 14.2 20.2 38.4 38.0 23.0 28.0 55.4 170.3 145.5 148.2 81.2 67.1 234.8 119.2 106.9 56.6 87.6 55.5 58.6 100.1 86.3 95.3 163.1 197.9 110.3 65.6 70.0 17.4 85.1 59.4 134.6 144.2 181.0 92.3 100.3 90.7 78.3 72.7 41.4 103.2 74.5 63.6 60.2 125.8 108.4 99.1 46.9 26.9 125.2 87.8 54.2 87.2 139.7 68.1 31.9 93.2 71.8 102.1 85.1 40.3 67.1 75.3 78.4 41.8 17.9 77.6 61.2 87.5 75.0 56.6 126.5 52.6 21.6 104.6 175.6 64.2 62.7 87.7 146.1 145.5 56.1 148.2 57.0 55.4 56.5 54.5 170.3 44.3 39.9 49.3 61.1 81.2 127.8 30.7 67.1 234.8 41.2 46.9 93.2 196.1 36.7 33.1 34.0 34.6 70.7 19.4 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 544.2;skeletal muscle: 589.5" "Cell line enhanced" "Detected in many" "BJ: 123.0;fHDF/TERT166: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 23.8" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" 280000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: " "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavourable (7.30e-4)" 17.9 5.7 5.5 32.4 5.2 1.2 15.2 5.6 5.1 48.1 119.7 2.4 84.2 14.6 72.4 38.3 121.6 36.2 75.3 544.2 4.1 2.6 14.5 4.4 10.5 3.3 3.3 7.0 27.0 29.3 1.9 3.2 17.7 4.1 72.5 28.0 19.1 12.9 81.3 589.5 6.5 39.5 245.2 2.7 6.5 51.7 9.6 2.3 0.4 7.7 121.7 5.9 193.8 38.7 2.7 8.4 23.8 11.6 1.2 3.4 9.9 43.6 28.8 34.8 1.7 12.2 7.7 114.6 123.0 45.3 75.7 56.3 20.2 8.7 0.1 56.5 122.9 24.2 29.5 19.7 50.4 1.1 4.1 6.4 31.0 9.8 34.2 0.2 1.4 10.7 11.4 62.2 16.6 19.8 0.6 1.5 57.8 22.5 1.9 0.5 41.5 5.0 0.7 12.3 1.2 108.1 24.1 8.3 5.7 14.7 23.3 5.2 17.0 1.2 91.2 100.1 49.2 14.9 87.2 0.4 0.3 0.5 28.3 1.7 69.3 23.8 6.1 2.9 2.5 11.6 2.0 2.7 2.4 2.7 8.4 2.6 2.6 2.3 6.7 1.2 7.9 1.7 3.4 9.9 5.5 5.2 5.6 5.1 4.1 2.6 3.3 7.0 4.1 2.3 TPM3 "NEM1, TRK" ENSG00000143549 "Tropomyosin 3" P06753 1 154155304-154194648 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 738.4;tongue: 203.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" 410000000 "Actin filaments" Cytosol "HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: " "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.39e-1)" "unprognostic (2.69e-3)" "prognostic unfavourable (6.73e-6)" "prognostic unfavourable (4.01e-4)" "unprognostic (2.80e-1)" "prognostic favourable (2.39e-5)" "prognostic unfavourable (3.65e-4)" "unprognostic (3.31e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.98e-2)" "unprognostic (1.00e-2)" 10.1 7.3 10.8 10.8 10.5 26.5 6.2 6.4 11.2 4.6 9.6 3.9 3.2 7.9 4.1 27.9 18.3 4.4 6.7 29.7 7.7 8.1 7.2 6.8 9.6 12.9 8.9 5.8 4.8 23.2 3.6 3.2 6.7 5.0 5.7 10.7 4.4 20.5 2.5 738.4 5.9 8.2 5.2 7.7 11.7 6.9 5.4 4.4 6.7 9.3 203.6 28.6 6.8 4.9 38.9 72.6 154.8 95.9 35.4 54.4 146.1 67.5 33.7 43.2 28.3 36.6 47.8 43.5 58.1 53.7 77.1 58.2 62.8 63.4 50.9 47.3 65.5 62.6 42.8 61.1 82.2 35.2 23.3 62.6 32.9 42.2 29.1 91.6 83.2 36.0 33.5 67.9 52.3 118.6 47.0 54.7 95.1 40.5 71.3 94.6 97.2 73.3 61.1 30.0 72.1 55.6 51.6 30.3 56.9 44.1 58.8 57.6 82.0 109.5 88.6 67.5 48.9 64.7 91.0 46.6 76.5 68.0 61.0 69.0 106.6 70.8 64.7 154.8 54.4 87.8 48.6 38.9 48.5 51.1 72.6 30.1 36.6 47.3 74.9 35.4 95.9 36.0 52.1 146.1 10.8 10.5 6.4 11.2 7.7 8.1 8.9 5.8 5.0 4.4 TPM4 ENSG00000167460 "Tropomyosin 4" P67936 19 16067021-16103005 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 225.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004685, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" 950000000 "Actin filaments" Cytosol "CAB004685: AB_425723, HPA047089: , HPA053624: " "unprognostic (1.27e-1)" "unprognostic (1.53e-2)" "unprognostic (3.62e-3)" "unprognostic (7.38e-3)" "unprognostic (3.80e-1)" "unprognostic (2.40e-2)" "unprognostic (3.11e-2)" "unprognostic (2.75e-3)" "unprognostic (1.38e-2)" "unprognostic (3.61e-1)" "prognostic unfavourable (3.07e-4)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.26e-10)" "unprognostic (3.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.78e-1)" 66.2 17.9 13.3 60.0 13.7 10.8 47.4 46.2 11.5 90.2 40.5 14.6 56.4 17.4 87.1 63.3 149.3 49.4 108.4 39.2 14.5 12.4 32.4 12.2 69.7 27.1 16.0 10.5 102.4 15.4 8.4 16.2 65.0 19.7 84.1 31.8 18.6 47.6 64.6 29.9 39.0 25.2 127.2 22.5 99.7 37.5 30.6 11.7 11.5 20.0 92.2 60.1 177.3 70.5 22.2 35.0 40.7 32.7 24.7 52.5 48.6 58.7 23.3 45.1 27.5 104.9 156.3 56.6 82.3 99.9 69.8 72.0 24.2 61.4 2.7 64.3 102.7 31.7 18.8 47.2 91.3 38.7 10.8 29.6 33.5 19.4 57.7 5.3 70.8 96.7 15.3 57.0 65.6 79.7 3.4 37.3 96.3 20.0 15.9 18.6 23.6 28.4 21.8 38.8 12.7 16.1 50.4 8.2 25.8 55.3 24.8 29.2 0.5 8.2 93.4 121.6 15.4 225.9 76.1 6.5 15.3 13.1 84.3 15.6 41.1 40.7 30.1 2.2 34.8 32.7 26.3 22.2 26.9 31.2 35.0 18.8 7.8 18.3 35.2 24.7 16.2 27.4 52.5 48.6 13.3 13.7 46.2 11.5 14.5 12.4 16.0 10.5 19.7 11.7 TPP2 TPPII ENSG00000134900 "Tripeptidyl peptidase 2" P29144 13 102597003-102679958 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021069, HPA049630" Approved Supported "Nuclear bodies,Cytosol" 410000 "Nuclear bodies, Cytosol" "HPA021069: AB_1858344, HPA049630: " "unprognostic (4.75e-2)" "unprognostic (4.78e-2)" "unprognostic (9.97e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-2)" "unprognostic (4.43e-2)" "unprognostic (2.45e-2)" "unprognostic (8.33e-3)" "unprognostic (5.02e-2)" "unprognostic (1.51e-1)" "unprognostic (3.12e-1)" "unprognostic (2.75e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.95e-2)" "unprognostic (3.43e-3)" 19.9 12.4 10.8 21.4 14.5 24.7 18.1 23.1 18.4 16.8 14.7 12.2 50.3 13.1 20.0 21.8 14.4 16.7 13.5 17.0 11.7 9.7 12.9 22.8 18.4 32.8 11.7 13.8 21.6 16.3 15.7 15.7 19.2 15.3 13.9 21.0 12.9 15.6 34.5 35.7 14.1 17.4 19.2 13.4 20.7 15.4 34.5 14.0 23.8 21.9 16.0 19.7 17.0 16.0 6.0 5.8 9.2 6.9 10.9 12.1 4.7 15.9 6.4 18.5 15.7 12.5 17.3 13.2 16.3 11.9 10.5 13.2 13.5 21.5 17.5 5.6 13.1 15.7 14.3 11.5 19.0 12.2 12.7 33.3 16.8 10.8 10.6 37.6 20.3 13.4 5.2 11.8 15.8 15.0 19.8 19.6 14.8 5.0 17.3 28.2 15.0 8.9 19.2 14.0 15.8 13.6 13.2 17.2 14.1 10.2 17.1 7.3 9.8 42.2 12.0 10.0 7.3 6.4 13.5 19.3 23.3 15.3 16.7 27.2 12.9 9.2 6.0 4.0 9.1 6.9 10.7 6.0 10.3 10.1 5.8 5.5 12.1 11.5 1.3 10.9 5.7 4.6 10.9 4.7 10.8 14.5 23.1 18.4 11.7 9.7 11.7 13.8 15.3 14.0 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell line enhanced" "Detected in some" "A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favourable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.4 0.4 6.2 0.9 0.0 1.1 0.2 0.0 0.0 0.0 0.3 0.9 0.2 0.6 0.0 3.3 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 0.9 0.3 0.4 0.0 0.8 0.0 0.2 0.1 0.1 3.1 0.0 0.3 0.2 0.5 0.2 0.8 0.3 0.1 1.2 0.3 1.1 15.5 1.9 0.9 0.4 4.1 0.8 0.2 0.1 0.2 3.3 0.1 0.2 1.2 0.3 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 TPRG1L "FAM79A, FLJ21811, RP11-46F15.3" ENSG00000158109 "Tumor protein p63 regulated 1 like" Q5T0D9 1 3625002-3630127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063163, CAB079051" Supported Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB079051: , HPA063163: " "unprognostic (1.92e-1)" "unprognostic (3.26e-3)" "unprognostic (4.46e-2)" "unprognostic (7.99e-2)" "unprognostic (4.50e-2)" "unprognostic (3.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (7.83e-3)" "prognostic favourable (1.76e-9)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" 18.3 19.1 34.3 9.7 46.6 14.5 17.4 23.1 57.7 19.3 24.0 12.9 17.2 24.5 16.5 21.2 28.7 24.8 19.3 25.0 32.9 32.8 32.1 34.9 16.8 14.6 25.7 41.7 25.9 17.4 11.7 20.5 12.7 41.4 17.1 23.4 19.1 18.7 25.0 29.5 25.4 28.3 18.1 13.2 13.4 17.4 8.7 13.6 8.0 21.9 17.3 18.2 17.1 16.3 5.1 7.9 17.0 3.2 2.6 7.1 3.2 11.3 8.1 5.0 8.9 38.1 26.5 4.6 16.9 23.4 15.7 10.4 15.2 10.4 4.2 15.1 23.0 17.9 6.0 15.6 13.3 13.3 9.6 5.8 9.5 17.6 23.1 8.5 6.9 19.9 23.0 13.0 13.3 22.1 4.1 15.0 21.8 5.2 6.1 8.8 6.7 19.1 5.1 7.5 10.0 16.2 11.9 14.1 13.9 9.0 18.8 17.9 11.7 7.4 25.1 13.2 3.9 30.0 4.7 13.6 17.6 4.7 7.8 18.7 1.7 12.8 3.2 4.9 5.6 2.6 7.1 4.2 6.4 5.5 2.8 5.1 5.9 6.8 17.0 2.6 2.5 7.9 3.4 3.2 34.3 46.6 23.1 57.7 32.9 32.8 25.7 41.7 41.4 13.6 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Cell line enhanced" "Detected in some" "BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA049690: , HPA068342: " "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 7.1 0.0 5.2 0.0 0.0 1.2 5.3 0.0 0.0 9.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.7 2.4 0.0 8.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Group enriched" "Detected in some" 4 "HDLM-2: 9.9;Karpas-707: 2.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA068342 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA068342: " "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.9 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavourable (8.07e-7)" "prognostic unfavourable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 69.6 23.4 28.3 22.1 2.2 4.2 27.3 29.3 16.6 42.6 32.2 49.6 30.1 32.8 17.3 16.3 36.8 32.3 26.6 48.6 14.1 12.5 64.3 22.4 33.8 0.7 24.6 16.6 1.4 1.4 26.7 19.5 22.9 47.5 30.0 33.3 28.6 41.2 19.2 31.5 25.3 23.4 76.4 19.8 11.4 11.4 20.6 13.8 44.8 17.0 13.2 29.5 15.0 15.4 47.8 29.4 21.9 44.9 12.0 20.7 29.4 14.9 87.9 31.0 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA054018: " "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavourable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.0 21.1 32.7 51.2 17.6 11.1 21.2 24.2 11.5 24.3 20.1 17.3 26.2 35.9 14.0 17.9 31.6 39.2 22.6 30.7 21.6 22.9 22.0 23.3 27.3 18.4 25.6 20.7 13.1 15.7 18.4 23.1 27.7 42.7 17.6 27.6 18.6 31.0 43.1 29.3 21.8 35.4 25.8 21.5 28.2 27.5 28.4 23.1 22.7 26.3 16.2 20.6 28.9 24.9 19.5 27.9 17.8 28.1 19.8 24.7 29.5 16.7 35.0 25.9 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185915906-185938136 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol 40000 Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: , HPA064972: " "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavourable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favourable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 36.2 38.0 34.9 52.5 32.4 34.5 34.1 29.8 29.1 30.5 39.5 20.3 31.7 22.4 37.8 32.3 36.5 27.1 31.0 26.4 29.9 30.1 33.0 37.1 27.1 36.9 29.8 21.9 28.9 31.0 28.6 31.3 38.0 20.9 31.6 27.5 26.1 26.6 32.3 50.8 22.7 24.9 35.7 27.1 31.9 28.7 38.4 25.1 57.2 29.6 47.3 42.8 34.0 50.3 34.5 37.0 30.7 21.0 20.6 25.0 10.7 31.3 13.0 32.6 16.6 9.5 7.5 17.9 25.5 16.4 28.2 22.3 20.8 16.6 30.4 30.7 13.0 20.5 35.6 24.8 33.1 25.5 22.6 28.4 11.7 27.6 12.7 30.1 23.0 7.2 12.3 16.6 16.1 21.5 27.1 19.4 21.5 16.5 74.5 43.7 48.5 20.2 45.2 26.3 35.5 27.3 13.7 24.2 24.1 16.8 23.7 30.0 23.9 33.4 12.2 19.1 25.0 15.9 38.2 35.8 87.2 56.7 19.6 35.0 30.0 30.7 21.0 16.1 20.2 17.1 18.1 31.7 19.8 18.7 18.3 34.5 25.0 22.7 22.1 20.6 18.6 37.0 18.5 10.7 34.9 32.4 29.8 29.1 29.9 30.1 29.8 21.9 20.9 25.1 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185915-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favourable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavourable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 8.9 10.3 8.3 28.8 13.4 45.5 12.0 15.3 11.4 10.6 14.7 7.4 19.9 15.9 9.3 15.6 19.9 9.2 18.1 10.0 9.0 4.9 13.4 20.0 13.1 25.6 12.4 6.1 10.2 42.9 5.9 12.0 9.6 9.5 14.8 6.0 8.4 24.6 19.5 14.0 13.0 18.3 9.3 9.6 19.5 16.5 9.7 11.8 21.0 13.2 13.2 33.1 11.5 13.1 6.9 33.0 23.0 14.2 14.7 13.6 9.2 22.4 14.9 5.4 8.8 2.9 3.4 13.5 7.8 5.1 6.6 5.6 9.4 10.8 13.9 7.7 3.6 14.1 6.9 13.8 1.3 9.7 32.2 8.0 23.0 15.9 11.6 16.2 16.0 5.5 8.5 4.8 6.5 6.4 9.8 22.8 2.8 24.8 11.2 18.4 7.9 14.2 31.4 7.3 29.3 5.0 21.8 6.3 10.6 6.7 24.3 11.1 10.4 16.4 7.1 5.5 13.7 7.1 8.7 27.8 4.9 16.6 6.8 11.3 8.6 7.0 14.2 23.0 10.9 12.5 10.2 6.9 9.8 9.8 15.4 3.6 6.7 7.7 19.5 14.7 7.6 33.0 13.6 9.2 8.3 13.4 15.3 11.4 9.0 4.9 12.4 6.1 9.5 11.8 TRAF3IP2 "ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522" ENSG00000056972 "TRAF3 interacting protein 2" O43734 6 111556454-111606278 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.4;U-2197: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036352 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA036352: AB_10672085" "unprognostic (1.94e-1)" "prognostic unfavourable (3.21e-4)" "unprognostic (1.79e-1)" "prognostic favourable (4.73e-5)" "unprognostic (2.81e-2)" "unprognostic (3.03e-2)" "unprognostic (1.01e-2)" "unprognostic (9.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.13e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (5.16e-5)" "unprognostic (1.11e-1)" "unprognostic (4.88e-1)" "unprognostic (2.34e-2)" "unprognostic (1.31e-1)" 16.0 13.3 11.9 12.4 12.0 13.4 18.2 3.5 12.5 15.7 16.4 6.0 27.1 16.4 22.4 16.1 24.3 22.5 13.4 7.9 10.2 5.0 9.2 5.6 11.7 8.3 6.1 4.8 8.9 15.5 9.1 11.7 17.9 18.8 11.9 15.8 11.2 19.1 32.6 10.6 30.4 13.6 13.7 13.8 6.3 16.6 3.9 7.7 12.9 16.2 21.0 18.5 11.9 15.9 5.4 2.0 8.0 1.4 2.9 11.8 2.0 7.1 2.4 0.6 3.2 9.4 10.1 4.1 7.2 18.9 3.4 4.4 1.5 4.1 1.1 2.8 9.2 15.7 2.8 28.2 3.9 8.9 1.9 1.3 3.2 3.1 3.2 1.8 5.5 14.7 20.3 8.3 35.4 6.4 3.4 0.3 3.3 6.2 5.4 4.5 2.2 2.6 9.3 3.3 0.7 8.9 11.5 5.5 0.4 3.4 18.8 12.1 8.8 4.9 1.7 4.9 1.8 37.2 7.8 0.2 1.9 3.7 10.3 3.0 11.0 8.0 1.4 3.5 2.9 0.3 10.0 4.6 5.6 3.8 2.0 5.4 5.9 5.5 1.5 2.9 0.1 0.2 11.8 2.0 11.9 12.0 3.5 12.5 10.2 5.0 6.1 4.8 18.8 7.7 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36487027-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Supported Nucleoli,Mitochondria Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favourable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 13.0 11.0 12.9 8.5 17.0 31.8 11.9 18.1 15.0 10.6 10.7 13.6 8.2 9.5 12.9 9.8 12.4 11.5 9.4 13.9 9.8 7.1 11.2 12.3 15.2 9.2 14.8 10.6 14.6 11.3 11.0 11.9 10.3 12.7 9.6 10.5 10.5 11.0 9.3 13.9 12.7 12.5 12.1 10.1 13.0 10.3 15.0 12.8 18.5 15.6 6.7 10.8 11.3 13.0 10.6 7.7 27.7 11.4 9.6 13.1 8.5 5.1 6.5 12.6 7.1 11.9 8.7 5.5 7.8 8.4 7.2 9.5 5.7 3.5 6.8 4.8 8.2 9.7 10.0 7.9 12.0 11.1 11.7 6.5 5.1 5.1 7.7 7.2 8.0 8.1 11.1 3.9 11.8 10.1 9.7 7.4 9.0 6.3 11.5 3.9 6.8 6.0 7.6 17.1 3.8 8.7 10.7 2.1 11.1 7.8 7.6 5.5 8.7 7.0 8.0 10.3 9.1 9.4 9.4 8.7 7.3 7.3 5.8 5.2 7.7 27.7 8.0 20.9 11.9 11.4 11.7 10.6 10.3 11.6 7.7 8.1 10.0 13.1 11.1 9.6 8.2 4.5 8.0 8.5 12.9 17.0 18.1 15.0 9.8 7.1 14.8 10.6 12.7 12.8 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 16.0 18.2 18.3 22.3 20.6 28.5 39.1 28.7 25.6 22.1 29.4 9.1 21.1 37.3 20.4 18.3 32.9 21.9 36.9 21.0 18.3 14.8 21.3 47.3 18.3 40.9 13.4 14.7 19.3 41.6 17.7 20.3 19.5 12.8 16.2 16.9 13.0 24.4 23.1 25.5 32.2 37.8 28.8 14.1 21.4 25.1 13.2 10.6 26.1 20.3 30.9 21.9 21.9 28.9 6.7 12.3 7.7 13.9 3.0 7.1 5.2 20.8 26.7 15.3 27.3 15.8 30.0 18.0 16.1 20.3 19.0 17.1 32.4 27.0 13.4 19.1 20.5 24.5 14.3 28.6 7.2 21.1 18.3 19.1 35.6 24.8 21.0 20.3 27.7 29.6 23.9 18.3 24.0 36.7 20.3 18.1 18.0 47.7 20.8 23.6 30.0 13.1 38.9 25.4 26.8 15.3 11.2 30.8 25.6 13.5 25.9 17.6 29.4 25.0 27.6 23.1 32.5 21.5 17.5 26.2 19.4 17.7 13.2 13.2 17.9 3.7 10.0 7.7 5.4 13.9 5.0 6.7 5.3 5.7 12.3 4.9 3.8 4.5 6.9 3.0 9.4 6.0 7.1 5.2 18.3 20.6 28.7 25.6 18.3 14.8 13.4 14.7 12.8 10.6 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125501-112153609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favourable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favourable (3.92e-5)" 15.1 13.1 11.0 21.9 19.2 20.5 16.6 11.9 19.8 15.6 31.6 42.1 15.2 12.7 15.1 12.8 26.0 12.8 14.0 16.9 12.2 10.8 12.7 12.5 21.2 25.5 26.2 10.7 15.3 10.2 15.3 14.9 15.5 22.2 18.5 16.8 22.7 16.4 16.7 10.3 28.1 16.0 20.5 25.0 25.0 15.2 30.9 23.4 28.2 13.0 13.0 29.7 25.6 17.4 13.2 11.4 59.1 21.4 14.8 13.8 19.3 10.6 12.1 19.6 18.2 13.3 12.8 10.1 12.1 17.7 17.3 13.7 12.9 9.7 12.1 10.5 12.8 21.6 19.0 11.9 11.6 21.1 18.1 19.6 17.1 7.0 23.2 12.1 30.7 16.4 20.3 12.3 16.8 15.1 21.9 7.5 10.9 17.9 13.3 16.7 16.0 14.3 19.0 12.0 20.4 11.2 40.1 16.6 12.8 25.3 25.0 6.7 16.2 16.9 9.6 7.9 5.7 7.7 6.4 18.3 16.1 13.0 8.4 9.6 8.5 59.1 21.4 48.3 10.7 19.4 7.3 13.2 10.5 9.6 11.4 12.2 9.7 8.9 42.8 14.8 20.0 7.5 13.8 19.3 11.0 19.2 11.9 19.8 12.2 10.8 26.2 10.7 22.2 23.4 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828599-49856574 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavourable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 4.8 1.6 3.4 6.0 10.7 9.5 3.0 7.4 3.0 3.5 3.7 2.0 3.2 2.3 3.8 2.4 4.5 3.0 2.9 1.5 2.7 2.7 1.6 1.2 1.3 8.1 2.0 2.8 3.4 1.6 1.6 2.0 2.5 3.0 2.9 4.8 2.7 3.1 1.7 2.8 6.7 3.4 3.4 5.1 3.7 1.9 25.0 3.4 11.5 2.2 3.1 6.8 1.9 3.0 5.1 1.6 0.6 3.0 2.7 4.9 1.6 6.4 7.9 11.3 11.3 1.0 1.6 9.3 7.8 3.7 16.5 15.8 9.5 7.4 15.9 5.5 4.5 8.5 11.8 8.9 12.4 9.1 7.8 11.9 9.6 8.5 0.4 9.7 10.0 1.1 1.3 13.2 7.0 4.3 8.6 11.5 7.3 9.3 16.1 12.4 9.0 13.0 8.9 7.6 9.2 3.0 9.0 5.5 9.4 8.6 7.3 5.5 6.6 13.9 3.3 10.6 12.6 14.5 15.2 8.5 20.2 17.0 5.3 13.2 9.4 0.0 1.5 0.6 2.3 0.8 2.0 5.1 1.3 4.9 1.3 3.8 1.7 2.6 0.3 2.7 3.0 1.6 0.8 1.6 3.4 10.7 7.4 3.0 2.7 2.7 2.0 2.8 3.0 3.4 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225889 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.9;skeletal muscle: 101.1" "Cell line enhanced" "Detected in all" "RT4: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: " "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favourable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 11.3 5.9 14.7 8.3 15.7 7.6 8.6 20.5 20.1 7.1 23.5 15.4 4.2 15.5 6.1 8.0 14.9 9.6 21.9 71.9 15.1 12.4 9.5 7.7 11.0 9.8 14.3 15.6 4.1 6.5 16.8 11.0 9.7 16.2 7.8 11.9 23.8 22.9 7.7 101.1 21.6 23.7 7.9 11.7 12.2 26.9 7.0 10.6 4.9 14.4 31.9 14.2 19.1 10.5 7.1 4.8 1.6 4.3 1.7 1.8 1.1 7.4 6.5 12.9 5.6 9.0 8.9 17.0 10.1 11.4 6.6 7.2 4.3 10.6 14.6 5.3 24.9 3.6 8.9 23.1 7.2 13.2 6.4 10.0 6.6 11.9 4.5 11.4 8.0 7.5 10.0 14.5 13.4 13.2 5.1 11.7 8.3 3.1 1.2 6.0 5.6 5.0 5.3 4.8 12.2 9.1 56.2 8.3 9.8 3.8 5.6 5.4 5.0 9.7 13.5 5.7 6.8 34.3 5.8 8.7 7.4 13.2 6.3 10.0 5.5 1.6 2.5 1.0 1.2 4.3 1.1 5.0 1.8 1.5 2.8 7.1 0.8 1.8 1.1 1.7 2.4 4.8 0.8 1.1 14.7 15.7 20.5 20.1 15.1 12.4 14.3 15.6 16.2 10.6 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: " "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favourable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.8 5.6 3.7 13.7 25.5 36.8 4.0 14.2 12.5 10.4 12.2 8.2 3.6 2.5 5.8 19.6 3.9 7.8 4.4 17.9 7.2 4.2 5.6 10.2 6.1 14.1 4.3 6.8 19.7 4.4 10.9 8.8 15.2 4.4 10.9 22.1 5.6 3.4 2.6 4.1 11.3 4.4 9.2 3.9 8.9 5.5 6.9 9.0 7.7 6.2 23.9 4.4 4.6 17.7 16.8 6.3 11.5 8.8 6.0 10.3 3.1 14.2 6.9 8.6 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 TRAPPC12 "CGI-87, TTC-15, TTC15" ENSG00000171853 "Trafficking protein particle complex 12" Q8WVT3 2 3379675-3485094 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034799, HPA043196" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA034799: AB_10600920, HPA043196: " "prognostic favourable (1.80e-5)" "unprognostic (9.21e-2)" "unprognostic (1.01e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-2)" "unprognostic (1.32e-2)" "unprognostic (1.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.27e-1)" "prognostic favourable (9.15e-4)" "unprognostic (3.23e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.53e-1)" "unprognostic (7.18e-2)" 18.2 17.3 15.2 19.7 19.7 14.6 12.8 18.3 25.3 20.3 16.4 21.1 15.2 15.8 19.7 14.4 16.7 14.8 17.9 26.8 16.0 15.6 16.1 29.2 16.8 22.0 15.4 15.6 19.3 16.4 16.5 20.4 12.8 20.6 18.5 8.3 16.3 24.4 16.9 40.7 41.3 17.6 16.4 13.1 19.9 17.1 50.8 12.2 23.2 16.8 17.3 18.6 16.9 14.1 1.0 7.5 6.0 5.5 1.4 3.9 1.2 8.4 14.7 4.8 5.5 10.9 13.6 12.8 13.9 3.4 4.1 2.2 9.1 7.1 9.6 15.4 4.7 10.8 5.6 6.2 1.6 11.6 20.9 8.3 4.2 31.1 4.9 10.4 14.9 9.9 4.8 4.5 11.5 3.5 12.8 5.3 7.1 11.7 10.4 17.8 11.8 20.8 7.9 6.6 7.7 4.4 7.0 12.4 20.2 5.5 6.3 9.1 7.3 8.4 8.9 10.1 5.7 10.0 12.2 15.2 11.2 7.6 11.7 8.2 5.5 1.2 1.8 6.0 1.4 4.1 3.6 0.9 2.3 3.8 2.4 1.0 1.6 1.9 1.7 1.4 5.5 7.5 3.9 1.2 15.2 19.7 18.3 25.3 16.0 15.6 15.4 15.6 20.6 12.2 TRAPPC13 "C5orf44, FLJ13611, FLJ26957, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65624716-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favourable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.4 12.9 16.1 10.3 22.5 7.5 14.0 14.5 22.7 12.1 11.3 12.8 10.2 9.8 11.9 10.4 13.4 9.7 9.8 17.7 17.1 17.7 21.6 16.9 11.0 10.2 17.3 14.2 10.1 8.2 20.6 22.4 11.8 19.5 20.6 14.3 10.5 9.9 12.4 15.2 8.0 13.3 13.9 18.9 10.7 11.0 10.6 15.1 18.0 18.7 11.7 10.8 11.5 9.9 6.6 10.1 14.7 13.7 9.1 13.1 9.8 12.9 8.8 13.9 25.0 10.8 13.8 13.4 15.4 14.0 19.1 21.0 7.5 18.3 13.2 17.0 12.4 12.0 15.7 16.0 22.6 9.2 11.6 8.5 10.9 6.9 14.7 10.3 12.8 9.8 12.7 14.8 19.1 16.8 10.1 12.6 16.8 13.7 17.1 4.0 6.4 4.8 15.0 17.5 15.4 13.9 14.8 17.6 12.6 18.8 11.4 14.1 16.5 13.5 11.5 6.7 9.4 14.9 15.5 8.3 16.2 21.1 14.2 18.6 12.8 14.7 9.4 3.8 10.1 10.1 13.1 6.6 9.9 8.4 10.1 5.4 9.9 9.9 3.6 9.1 13.7 7.6 10.4 9.8 16.1 22.5 14.5 22.7 17.1 17.7 17.3 14.2 19.5 15.1 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" "P0DI81, P0DI82" X 13712244-13734635 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: " "unprognostic (1.97e-1)" "prognostic favourable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favourable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.89e-5)" 6.5 6.4 15.6 9.5 13.7 9.5 9.4 24.1 16.1 10.5 9.4 10.1 8.8 8.2 16.4 8.7 8.5 9.4 7.6 6.4 14.4 14.2 10.1 10.1 7.8 16.1 10.4 13.0 11.7 11.2 8.9 19.5 7.2 11.5 8.9 9.1 10.2 8.1 8.3 4.9 10.3 8.8 16.0 11.5 11.1 10.7 4.3 11.1 4.3 8.8 4.2 16.4 8.1 9.4 11.2 10.7 13.7 6.6 18.5 16.1 9.0 6.7 5.2 8.0 20.6 6.2 4.8 3.3 6.3 5.4 5.0 5.4 4.4 8.3 11.4 10.2 5.2 8.9 10.7 9.0 6.9 11.5 15.9 8.5 12.3 3.5 4.7 11.6 16.4 6.2 5.1 10.7 14.7 4.4 10.7 19.6 5.1 11.1 11.4 15.4 7.7 9.4 11.3 10.7 11.1 7.9 5.0 8.6 11.4 11.6 9.3 8.0 11.6 7.7 5.8 5.1 4.6 9.1 4.0 10.2 9.9 14.3 4.7 8.3 5.2 13.7 4.9 8.6 16.1 6.6 16.0 11.2 12.8 15.8 4.3 11.1 10.8 15.5 10.0 18.5 5.4 10.7 15.3 9.0 15.6 13.7 24.1 16.1 14.4 14.2 10.4 13.0 11.5 11.1 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363511-57365353 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: " "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 14.6 23.3 13.4 9.9 17.1 11.6 17.2 23.8 16.7 11.5 12.5 6.7 12.1 7.0 12.2 15.1 15.4 11.4 13.7 26.5 18.0 14.0 12.9 14.5 12.4 15.0 11.6 14.5 15.8 9.7 12.2 16.4 16.9 18.1 14.3 7.9 9.0 11.4 10.4 28.8 11.5 8.6 12.7 15.1 14.3 10.2 31.2 9.6 12.7 17.6 16.8 13.7 15.4 9.5 26.7 21.5 32.2 13.2 22.8 15.5 13.4 9.1 7.6 10.3 6.6 9.6 10.9 9.5 6.2 14.5 9.5 28.9 3.6 7.1 7.0 8.9 8.4 3.3 5.2 10.4 10.3 3.4 36.2 7.4 12.3 8.0 10.1 7.7 11.4 11.7 13.1 7.6 5.2 7.0 2.2 0.1 11.2 2.6 11.4 6.8 3.5 14.9 5.7 9.8 10.5 10.7 14.4 11.0 8.5 6.5 6.7 5.7 10.5 10.0 7.5 8.8 7.8 4.4 10.3 11.4 14.4 14.1 12.7 4.8 9.0 32.2 13.2 16.3 7.5 11.6 14.7 25.0 15.5 12.3 14.8 26.7 15.0 12.0 15.3 22.8 10.3 21.5 13.4 13.4 13.4 17.1 23.8 16.7 18.0 14.0 11.6 14.5 18.1 9.6 TRAPPC2L HSPC176 ENSG00000167515 "Trafficking protein particle complex 2 like" Q9UL33 16 88856220-88862686 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041714 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA041714: AB_10793930" "unprognostic (1.27e-2)" "unprognostic (2.32e-3)" "unprognostic (1.46e-1)" "prognostic favourable (3.75e-4)" "unprognostic (2.77e-1)" "unprognostic (2.69e-1)" "unprognostic (5.24e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-1)" "unprognostic (6.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.81e-1)" "unprognostic (1.02e-2)" "unprognostic (1.18e-1)" "unprognostic (1.00e-1)" "unprognostic (5.81e-2)" "unprognostic (1.94e-2)" 22.7 46.1 29.5 18.6 29.2 19.8 22.4 15.9 37.4 18.5 21.8 25.5 16.0 16.2 15.8 40.4 17.4 19.0 25.0 26.0 22.9 24.4 20.2 21.9 13.9 24.3 24.9 22.5 21.5 25.6 8.7 16.0 13.7 22.1 15.8 15.7 20.0 17.3 17.3 53.8 19.0 14.7 14.1 27.3 18.3 21.5 33.9 18.1 11.5 19.2 25.1 16.6 16.1 16.4 41.2 45.6 10.8 39.0 24.6 47.7 40.9 15.8 11.1 18.9 14.3 14.2 18.2 19.5 14.3 16.4 22.2 8.5 30.9 21.0 12.2 25.4 18.2 17.0 25.7 20.6 16.1 10.6 15.4 8.1 11.2 39.0 21.0 22.9 6.5 17.6 13.0 29.9 15.2 17.8 24.2 9.8 15.1 49.5 30.5 70.9 19.0 20.8 29.4 15.7 12.6 17.0 18.4 20.5 10.1 48.6 15.0 13.1 38.5 24.4 14.0 14.7 16.1 19.3 16.2 13.8 23.3 56.7 17.6 34.2 17.5 10.0 39.0 10.8 34.0 31.2 34.2 41.2 39.2 36.6 37.7 35.2 36.9 31.4 6.8 24.6 29.7 45.6 47.7 40.9 29.5 29.2 15.9 37.4 22.9 24.4 24.9 22.5 22.1 18.1 TRAPPC3 BET3 ENSG00000054116 "Trafficking protein particle complex 3" O43617 1 36136570-36156053 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028408 Approved Approved "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA028408: AB_10601826" "unprognostic (3.54e-3)" "unprognostic (1.17e-1)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-2)" "prognostic unfavourable (2.70e-6)" "unprognostic (7.39e-3)" "unprognostic (1.15e-1)" "unprognostic (7.12e-3)" "unprognostic (7.38e-2)" "unprognostic (2.94e-1)" "unprognostic (9.25e-3)" "unprognostic (2.61e-2)" "unprognostic (9.47e-2)" "unprognostic (2.10e-3)" "unprognostic (6.53e-2)" 28.7 53.5 31.9 29.4 31.9 17.8 41.0 27.3 33.6 28.4 33.6 21.9 33.6 24.3 28.9 46.3 39.7 27.8 33.4 39.4 26.3 29.4 39.7 36.6 26.0 24.4 28.7 26.1 19.9 37.0 29.0 32.4 42.8 30.2 29.9 31.7 28.8 30.8 35.6 34.2 32.4 27.2 36.6 26.8 28.3 31.1 33.7 23.3 28.0 48.4 35.6 37.4 32.4 38.6 37.6 52.6 56.9 55.4 35.9 51.6 55.6 32.5 23.6 15.9 24.7 41.7 33.6 31.4 29.9 38.4 35.9 34.9 19.5 31.5 13.9 28.5 32.8 24.2 24.5 40.1 41.0 27.1 37.5 25.9 27.5 28.2 48.8 27.1 27.5 28.6 35.2 33.4 33.0 44.7 31.3 23.5 43.0 25.1 31.9 25.4 21.3 35.0 22.4 22.6 31.0 45.4 26.9 24.4 17.7 24.4 27.6 47.4 17.8 20.5 33.2 21.1 24.1 41.1 39.7 28.8 29.0 22.7 36.2 30.7 21.2 54.0 53.1 56.9 36.3 55.4 37.5 37.6 43.2 38.1 52.6 33.9 41.9 37.8 53.9 35.9 43.6 43.3 51.6 55.6 31.9 31.9 27.3 33.6 26.3 29.4 28.7 26.1 30.2 23.3 TRAPPC8 "GSG1, HsT2706, KIAA1012, TRS85" ENSG00000153339 "Trafficking protein particle complex 8" Q9Y2L5 18 31829173-31953136 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041107 Approved Approved Microtubules,Cytosol Cytosol Microtubules "HPA041107: AB_10793869" "unprognostic (4.04e-1)" "unprognostic (4.35e-2)" "unprognostic (2.62e-3)" "unprognostic (9.80e-2)" "unprognostic (8.18e-2)" "unprognostic (4.06e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (7.67e-3)" "unprognostic (4.42e-2)" "unprognostic (3.00e-1)" "unprognostic (6.35e-3)" "prognostic favourable (1.85e-9)" "unprognostic (3.55e-2)" "unprognostic (7.03e-2)" "unprognostic (4.26e-1)" "unprognostic (2.92e-1)" 16.2 17.0 12.9 18.1 16.5 13.6 15.4 20.8 19.5 16.0 18.1 16.3 15.3 15.0 16.9 13.0 18.8 14.8 13.8 15.5 12.9 12.1 20.1 26.4 14.1 17.5 15.6 12.7 14.5 15.7 24.1 19.8 19.3 19.2 14.8 16.6 17.5 17.0 17.5 25.0 20.5 25.5 15.1 14.6 19.8 15.7 40.7 13.6 28.2 18.7 13.3 19.0 16.1 18.7 2.7 2.8 9.9 2.8 3.0 4.3 1.1 8.5 7.4 8.5 6.5 12.9 12.3 9.4 11.3 12.1 10.7 10.6 5.0 6.5 12.1 9.1 11.0 13.2 12.3 6.4 15.0 13.7 5.8 10.0 7.3 6.1 9.9 29.1 11.8 10.9 8.9 9.9 14.4 12.1 14.5 11.2 10.7 5.8 12.4 10.0 8.6 6.2 13.1 10.1 12.8 10.7 13.5 6.6 7.8 14.5 8.8 10.2 9.7 12.9 14.6 11.4 5.7 4.1 6.9 14.3 15.8 18.1 11.0 12.7 11.7 9.9 2.7 2.8 2.0 2.8 4.3 2.5 2.7 2.4 2.8 2.7 2.4 2.6 4.5 3.0 2.7 2.1 2.9 1.1 12.9 16.5 20.8 19.5 12.9 12.1 15.6 12.7 19.2 13.6 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139730343-140458579 "Disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favourable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 9.7 12.0 13.0 14.7 17.9 13.8 8.3 18.3 22.0 11.3 10.3 17.2 12.5 11.3 11.4 9.8 12.1 17.4 12.8 14.7 13.0 13.7 12.2 10.0 9.5 10.6 14.5 11.7 11.5 15.4 42.0 28.2 14.1 15.1 10.4 9.0 17.2 12.7 12.7 38.3 8.8 12.7 10.5 13.2 10.5 11.1 7.9 9.1 24.8 14.2 10.0 15.3 10.1 8.3 6.3 6.3 14.2 5.0 7.5 7.1 4.6 6.9 12.4 5.7 15.3 12.1 7.2 3.8 4.4 7.5 2.5 4.0 4.5 8.2 8.4 10.7 8.9 8.9 7.5 7.1 2.6 12.2 4.6 13.4 7.3 4.4 8.5 3.4 10.8 6.9 6.8 1.9 6.3 9.8 4.8 7.4 4.0 19.2 20.4 4.3 1.7 10.9 8.8 2.1 13.8 8.4 8.5 14.2 8.0 7.3 3.5 7.6 11.2 4.9 5.7 3.4 6.1 8.0 3.5 10.5 7.7 5.8 7.2 7.3 5.5 14.2 4.9 4.0 6.5 5.0 7.1 4.5 4.5 5.1 5.1 6.3 4.7 5.5 7.8 7.5 4.7 6.3 3.3 4.6 13.0 17.9 18.3 22.0 13.0 13.7 14.5 11.7 15.1 9.1 TRDMT1 "DNMT2, RNMT1" ENSG00000107614 "TRNA aspartic acid methyltransferase 1" O14717 10 17142254-17202054 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009468, HPA036945, HPA036946" Approved Approved Nucleoplasm,Nucleoli,Centrosome Nucleoli "Nucleoplasm, Centrosome" "CAB009468: AB_2208432, HPA036945: , HPA036946: " "unprognostic (4.55e-1)" "unprognostic (3.22e-2)" "unprognostic (4.49e-6)" "unprognostic (7.07e-2)" "unprognostic (3.87e-3)" "unprognostic (1.33e-1)" "unprognostic (3.27e-4)" "unprognostic (3.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (3.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (2.64e-2)" 6.1 4.4 4.4 8.5 7.7 4.0 6.3 14.0 6.2 5.3 3.8 4.2 4.7 4.1 7.5 14.4 3.9 6.8 5.1 5.0 4.9 4.5 6.7 2.7 5.3 5.3 4.3 2.9 9.6 5.0 12.8 12.6 5.1 6.2 5.0 3.6 8.0 5.6 3.8 4.3 4.4 5.0 5.4 5.1 5.9 4.2 4.2 6.1 19.9 11.5 3.3 5.7 4.0 5.2 6.1 10.5 5.2 4.4 3.5 8.0 3.6 5.1 2.5 10.0 2.6 3.8 2.2 0.0 4.4 3.2 4.7 5.5 4.2 4.3 3.5 0.6 5.0 2.6 6.7 4.2 5.4 7.4 4.3 5.2 3.8 2.5 3.4 3.4 3.9 3.0 2.6 3.2 2.3 6.1 6.5 3.9 7.7 1.6 17.0 0.8 6.3 2.9 3.7 7.8 2.2 2.5 2.8 2.7 3.4 0.0 1.9 3.4 4.8 3.1 3.6 3.4 7.2 6.3 5.1 5.0 4.7 8.9 4.3 4.8 3.4 5.2 4.4 2.4 3.9 2.5 7.2 5.4 6.6 4.9 5.5 6.1 8.0 5.8 2.8 3.5 1.4 10.5 2.2 3.6 4.4 7.7 14.0 6.2 4.9 4.5 4.3 2.9 6.2 6.1 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Cell line enhanced" "Detected in some" "HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: " "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 TRERF1 "BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132" ENSG00000124496 "Transcriptional regulating factor 1" Q96PN7 6 42224931-42452051 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 53.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027771, HPA051273, HPA059943" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA027771: , HPA051273: , HPA059943: " "unprognostic (5.85e-3)" "unprognostic (4.38e-2)" "unprognostic (2.39e-1)" "unprognostic (3.28e-3)" "unprognostic (6.64e-2)" "unprognostic (3.92e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (2.05e-4)" "unprognostic (2.67e-1)" "unprognostic (1.16e-2)" "unprognostic (1.97e-2)" "prognostic unfavourable (3.67e-5)" "unprognostic (8.60e-2)" "unprognostic (5.39e-2)" "unprognostic (6.05e-2)" "unprognostic (2.78e-2)" 4.9 8.7 9.3 7.7 8.7 16.7 4.0 18.1 10.8 12.0 5.1 2.9 9.7 4.2 10.0 4.0 12.6 7.2 6.9 2.8 4.5 3.9 5.2 1.4 4.0 9.2 2.5 4.7 10.2 2.5 7.5 9.3 3.4 3.5 8.8 4.7 7.3 3.7 5.2 1.3 8.4 6.6 8.6 4.9 9.0 5.6 11.2 4.8 23.4 3.3 3.6 12.7 13.3 11.0 0.4 1.4 8.1 1.1 2.7 3.0 1.1 5.1 3.5 4.0 5.1 1.8 4.2 5.7 3.9 6.2 4.5 3.7 0.0 2.7 4.7 0.8 5.8 6.2 5.1 4.8 3.6 53.8 0.4 5.1 2.9 0.0 1.3 9.4 16.5 1.7 6.8 4.0 1.6 0.0 0.0 1.6 1.9 1.1 2.4 16.0 4.4 3.7 4.4 0.3 1.7 2.6 6.3 3.2 1.7 2.3 0.0 0.4 2.3 12.8 1.7 2.5 3.0 4.1 1.1 0.6 3.4 5.2 1.7 8.6 0.0 2.1 1.1 8.1 3.0 0.4 2.9 0.4 2.2 2.7 1.4 0.0 1.9 2.0 3.8 2.7 0.2 1.2 2.1 1.1 9.3 8.7 18.1 10.8 4.5 3.9 2.5 4.7 3.5 4.8 TRIAP1 "HSPC132, MDM35, P53CSV, WF-1" ENSG00000170855 "TP53 regulated inhibitor of apoptosis 1" O43715 12 120443961-120446412 "Predicted intracellular proteins, Transporters" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053640 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA053640: " "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (5.24e-2)" "unprognostic (4.06e-2)" "unprognostic (3.07e-1)" "unprognostic (1.40e-1)" "unprognostic (1.19e-2)" "unprognostic (3.31e-2)" "prognostic unfavourable (2.22e-4)" "unprognostic (9.87e-3)" "unprognostic (4.39e-2)" "unprognostic (9.93e-2)" "prognostic unfavourable (8.77e-4)" "unprognostic (8.81e-2)" "unprognostic (2.00e-1)" "unprognostic (6.44e-2)" "unprognostic (4.97e-2)" 11.7 16.8 10.6 12.5 13.1 14.6 20.6 9.1 12.4 9.4 12.5 8.0 12.0 10.0 9.9 11.6 15.4 9.3 12.7 17.3 13.6 8.3 12.5 34.5 14.2 13.6 15.5 11.9 7.7 36.5 5.7 8.6 17.8 13.5 12.4 17.0 6.8 19.3 8.6 29.1 16.8 12.1 11.1 10.4 12.3 12.3 11.2 11.6 11.7 11.2 21.5 13.9 12.0 10.0 17.4 28.2 9.0 24.8 22.2 25.5 19.6 15.8 21.7 20.0 13.6 17.4 26.9 47.8 20.9 14.9 18.6 15.4 18.1 8.9 31.4 17.8 17.0 10.9 23.1 34.4 19.7 13.9 25.9 19.1 15.2 47.5 26.0 32.0 14.8 27.8 43.5 18.2 26.1 38.3 30.5 8.2 27.0 19.9 24.0 43.2 28.5 17.7 20.0 18.8 32.6 23.8 17.8 19.7 12.9 24.0 8.3 17.7 27.6 18.8 21.7 12.0 18.1 12.0 12.6 21.0 33.2 33.7 18.4 24.8 20.8 9.0 22.0 8.0 20.7 24.8 24.9 17.4 20.3 19.7 28.2 15.8 25.5 22.0 1.9 22.2 16.5 25.4 17.6 19.6 10.6 13.1 9.1 12.4 13.6 8.3 15.5 11.9 13.5 11.6 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430321-125438405 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.2;thyroid gland: 90.7" "Cell line enhanced" "Detected in many" "HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1" "Group enriched" "Detected in many" 11 "granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA063982: " "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 26.7 6.5 5.9 17.6 6.5 84.2 13.3 4.3 6.1 10.4 12.4 4.4 6.6 4.9 6.2 6.7 10.9 10.9 21.0 11.1 4.3 4.0 16.6 63.5 28.9 14.6 4.2 3.9 6.4 23.6 20.9 7.2 15.5 4.5 12.1 13.3 15.0 14.5 9.1 22.3 10.4 16.9 11.3 3.1 15.9 18.5 5.6 3.1 9.2 90.7 17.6 12.1 12.4 9.0 0.2 0.5 10.8 3.7 0.0 3.1 0.1 4.0 4.6 0.6 1.3 1.3 2.6 7.3 2.6 3.7 1.9 0.6 6.2 5.4 7.4 2.5 1.9 3.1 2.0 2.6 1.7 3.2 9.7 54.0 2.0 12.0 3.4 27.0 4.9 2.5 3.9 8.1 18.4 5.7 4.7 23.5 0.2 4.3 2.5 4.2 4.5 9.0 5.1 0.9 8.0 15.9 15.5 3.9 1.4 6.5 7.1 25.7 1.8 1.3 2.9 2.1 2.8 2.1 3.3 33.1 33.0 10.3 3.8 0.1 5.0 0.0 0.9 10.8 0.0 1.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 5.8 0.0 3.7 0.3 3.1 0.1 5.9 6.5 4.3 6.1 4.3 4.0 4.2 3.9 4.5 3.1 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 40.2;HEL: 39.4;K-562: 53.6;SK-MEL-30: 39.1;WM-115: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 24.8" "Group enriched" "Detected in many" 9 "B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 19.6 30.9 13.2 17.7 13.3 7.0 23.2 23.2 23.0 10.8 12.3 10.5 6.7 8.7 23.0 22.6 8.1 11.6 14.5 18.2 15.0 10.8 24.8 10.6 18.9 33.0 13.4 16.2 52.3 14.4 6.6 11.3 23.0 15.5 16.3 6.9 35.7 9.9 13.6 6.9 8.2 11.9 17.6 10.4 38.9 19.5 13.9 10.1 37.3 12.1 6.2 33.4 21.9 23.2 7.1 0.6 1.5 0.1 9.5 24.8 4.5 0.0 0.0 30.6 40.2 11.0 10.2 0.0 1.7 1.6 1.0 1.7 0.1 3.3 3.4 1.2 3.6 0.5 2.2 3.4 0.9 3.8 6.3 39.4 0.1 0.5 13.7 2.2 15.1 9.4 3.5 4.4 1.2 4.8 53.6 0.0 1.7 0.3 5.0 9.4 14.5 3.9 0.0 10.2 1.4 7.0 5.0 26.4 12.6 0.2 1.6 39.1 0.0 0.2 3.0 14.6 7.3 0.1 3.8 0.0 0.0 4.9 7.8 7.7 53.8 0.8 0.1 1.5 7.3 0.0 8.8 5.3 14.4 7.7 0.6 7.1 8.5 5.2 0.3 9.5 0.1 0.0 24.8 4.5 13.2 13.3 23.2 23.0 15.0 10.8 13.4 16.2 15.5 10.1 TRIM11 "BIA1, RNF92" ENSG00000154370 "Tripartite motif containing 11" Q96F44 1 228393673-228406840 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028541, HPA043879" Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028541: AB_10600833, HPA043879: " "unprognostic (1.73e-1)" "unprognostic (9.73e-3)" "unprognostic (5.48e-3)" "unprognostic (7.73e-2)" "unprognostic (3.27e-1)" "unprognostic (2.33e-1)" "prognostic unfavourable (7.42e-5)" "unprognostic (1.08e-1)" "unprognostic (9.74e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.40e-2)" "unprognostic (4.89e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" 8.8 9.2 8.9 13.8 16.5 33.2 23.8 45.2 11.5 8.7 11.2 6.4 15.1 10.1 8.7 10.6 13.3 9.4 13.9 6.9 9.2 8.5 7.7 7.1 27.5 18.6 9.0 8.0 9.0 11.9 8.5 7.2 9.4 7.1 10.5 9.7 6.0 14.4 18.2 5.0 12.5 11.8 8.6 6.0 16.5 12.6 9.5 7.8 20.0 9.0 9.7 13.1 9.5 24.3 6.4 6.9 10.0 11.4 9.4 11.8 5.4 13.8 13.2 7.1 9.7 5.3 4.4 33.5 9.1 6.1 10.6 8.5 16.0 12.1 10.4 10.2 6.1 22.6 8.5 8.7 4.5 11.6 20.5 8.6 12.2 8.6 14.5 10.9 13.2 5.9 14.0 10.9 5.5 5.2 19.7 13.5 5.4 9.0 13.1 17.2 18.1 11.7 12.9 6.4 12.6 6.9 17.0 11.8 21.7 7.6 21.6 12.0 15.2 18.2 5.8 6.7 9.5 15.7 18.8 13.9 9.2 9.2 8.4 8.7 10.6 6.1 6.9 8.3 9.6 8.2 10.2 5.8 10.7 11.8 6.9 6.4 6.3 8.4 10.0 9.4 11.4 5.5 9.8 5.4 8.9 16.5 45.2 11.5 9.2 8.5 9.0 8.0 7.1 7.8 TRIM14 KIAA0129 ENSG00000106785 "Tripartite motif containing 14" Q14142 9 98069275-98119212 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053217 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA053217: " "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-1)" "unprognostic (9.80e-2)" "unprognostic (9.00e-2)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.55e-3)" "unprognostic (4.57e-2)" 9.2 3.3 6.4 20.2 7.6 6.4 6.2 1.4 5.4 5.2 15.4 4.2 1.1 18.1 3.8 4.9 16.8 3.8 10.8 4.1 5.9 4.4 13.4 19.8 14.3 24.4 5.2 3.5 4.5 3.9 15.0 5.0 5.7 5.6 8.2 10.7 4.7 7.7 3.5 1.0 6.0 31.8 5.3 5.8 30.4 7.0 6.2 5.7 35.2 3.2 3.7 19.5 8.9 7.4 4.4 8.0 2.4 27.7 6.2 11.5 7.5 10.2 5.3 0.2 4.8 0.0 1.7 3.6 6.0 11.8 33.8 29.2 10.2 6.2 13.7 5.0 6.6 11.8 10.4 6.9 10.4 17.4 8.5 4.0 8.5 10.0 7.4 21.4 4.5 1.0 3.4 4.9 6.4 4.2 15.8 6.5 3.0 13.3 16.8 6.8 6.0 16.7 10.8 0.6 6.9 2.7 6.4 1.7 1.4 8.6 18.2 5.8 4.8 12.4 2.9 1.4 3.6 0.5 8.3 2.8 3.3 4.6 3.9 16.9 4.7 0.4 7.4 1.0 8.1 14.5 8.9 4.4 9.3 8.4 7.9 3.3 7.4 6.2 2.4 6.2 27.7 8.0 11.5 7.5 6.4 7.6 1.4 5.4 5.9 4.4 5.2 3.5 5.6 5.7 TRIM15 "RNF93, ZNF178, ZNFB7" ENSG00000204610 "Tripartite motif containing 15" Q9C019 6 30163206-30172696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 12.1;intestine: 29.3;liver: 14.1" "Cell line enriched" "Detected in single" 24 "HEL: 19.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047527 Uncertain Approved "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA047527: " "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-1)" "unprognostic (1.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.92e-2)" "unprognostic (7.57e-4)" "unprognostic (5.27e-2)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (3.83e-1)" "unprognostic (1.63e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 8.6 0.0 0.2 0.2 0.0 12.1 0.0 0.0 0.0 4.3 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 52.9" "Cell line enhanced" "Detected in many" "A549: 64.1;HaCaT: 51.8;HeLa: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "T-reg: 25.1" "Lineage enriched" "Detected in many" 11 "T-cells: 25.1" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: " "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavourable (6.71e-4)" 6.1 13.5 7.4 4.8 12.8 7.0 6.7 7.4 11.7 16.0 5.0 7.8 6.6 10.2 7.0 2.8 52.9 4.0 7.5 6.5 8.0 4.4 5.7 2.2 6.2 10.9 11.3 5.6 3.7 6.2 1.9 5.7 15.8 9.8 4.1 5.2 5.0 14.7 5.7 11.4 15.6 5.5 5.4 5.9 4.6 14.4 5.5 7.8 4.7 7.4 5.3 16.3 11.7 23.3 0.4 1.5 0.6 2.3 0.5 25.1 1.3 20.1 64.1 2.0 4.4 9.5 11.0 2.1 3.3 11.8 4.1 5.8 3.8 26.3 2.1 12.7 14.5 51.8 5.8 14.9 2.8 26.6 3.7 1.0 46.7 2.0 15.9 1.1 2.2 6.0 9.4 9.0 5.2 8.8 1.2 10.5 11.2 7.1 4.4 2.6 3.0 3.9 1.9 16.6 1.5 21.3 26.1 1.4 4.1 14.6 16.6 5.0 2.5 2.8 13.7 5.2 6.2 2.5 11.4 2.5 2.7 0.2 8.1 2.8 13.2 0.1 2.3 0.6 0.8 0.6 0.5 0.3 3.0 0.9 1.5 0.4 0.8 1.6 0.5 0.5 0.3 0.3 25.1 1.3 7.4 12.8 7.4 11.7 8.0 4.4 11.3 5.6 9.8 7.8 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell line enhanced" "Detected in many" "A549: 48.6;CAPAN-2: 20.9;HaCaT: 24.8;HeLa: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA066431: " "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 5.2 48.6 0.3 2.0 5.9 2.4 3.8 0.4 4.0 1.8 3.7 0.8 20.9 0.5 3.8 13.9 24.8 0.5 1.1 0.9 0.2 0.7 0.3 38.8 0.5 14.6 0.0 0.5 2.5 1.4 2.7 1.0 0.5 0.0 0.0 4.7 5.1 0.1 0.5 0.5 1.0 0.5 2.5 0.0 3.5 3.0 0.1 1.1 5.5 1.1 2.9 2.5 0.4 10.9 1.2 6.3 1.9 7.0 0.6 0.6 0.0 4.1 0.4 9.2 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689689-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.3;BJ hTERT+ SV40 Large T+ RasG12V: 47.9;HSkMC: 42.0;TIME: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 34.3 6.9 8.8 32.8 13.3 22.2 17.3 3.2 10.3 14.4 12.2 10.6 15.1 6.5 20.0 18.9 17.6 17.2 20.2 12.4 10.3 6.6 13.9 19.3 29.8 62.2 15.5 6.5 21.9 5.6 2.1 8.1 9.4 13.3 20.4 13.7 15.0 17.2 14.6 7.1 7.8 28.7 13.5 22.9 65.4 11.2 6.3 12.0 35.6 15.5 13.4 40.6 19.8 13.5 49.0 55.2 33.0 50.3 18.0 58.1 47.3 0.8 0.2 3.4 0.6 18.5 37.3 1.0 10.9 19.1 20.8 47.9 0.3 2.2 23.0 3.3 15.4 2.3 7.6 11.4 2.0 0.5 0.0 1.3 1.2 0.4 24.3 3.5 2.2 42.0 10.8 4.1 1.9 25.6 0.5 1.2 22.6 0.4 12.0 3.6 9.8 1.2 14.9 0.8 0.5 10.9 3.5 0.4 0.8 1.0 1.0 0.4 1.2 3.9 33.4 12.9 7.0 0.6 0.6 1.3 1.1 2.5 16.2 6.4 1.7 27.4 35.7 23.8 35.8 43.5 47.0 46.5 39.0 37.8 42.8 49.0 35.2 33.7 33.0 18.0 50.3 55.2 58.1 47.3 8.8 13.3 3.2 10.3 10.3 6.6 15.5 6.5 13.3 12.0 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56887909-56914038 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 20.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 35000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavourable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favourable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favourable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 20.0 19.7 7.5 23.6 8.9 32.6 19.3 11.6 7.8 15.3 22.5 5.0 8.0 15.3 13.4 12.6 17.7 15.3 18.4 8.3 5.8 6.3 10.1 27.0 20.8 15.9 6.7 5.5 13.3 15.3 13.6 11.5 55.0 7.4 12.2 14.3 12.5 14.5 11.5 11.7 23.1 20.7 10.1 5.2 35.8 14.1 12.8 6.5 26.2 11.8 15.1 18.5 10.6 35.9 1.7 2.4 20.0 2.3 0.8 1.5 0.7 28.8 14.3 3.5 11.9 26.7 22.6 0.0 11.4 23.1 27.3 23.6 13.9 15.9 28.2 23.7 10.9 17.2 17.2 15.3 15.3 24.0 13.6 18.2 11.1 15.4 23.0 21.7 13.1 10.1 25.8 14.2 30.3 18.1 4.4 17.3 13.8 19.3 24.2 15.7 2.2 27.8 17.4 11.9 17.7 15.9 22.8 6.9 6.4 9.0 14.5 26.5 19.6 17.7 12.0 12.8 9.2 19.6 11.8 9.8 18.7 4.7 12.4 15.0 5.0 3.0 2.3 0.9 0.9 1.9 1.1 1.7 0.8 0.8 2.4 1.4 0.6 0.8 20.0 0.8 1.4 1.7 1.5 0.7 7.5 8.9 11.6 7.8 5.8 6.3 6.7 5.5 7.4 6.5 TRIM26 "RNF95, ZNF173" ENSG00000234127 "Tripartite motif containing 26" Q12899 6 30184455-30213427 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044975, HPA050456" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044975: , HPA050456: " "unprognostic (1.93e-1)" "unprognostic (5.41e-2)" "unprognostic (8.53e-2)" "unprognostic (1.96e-3)" "unprognostic (1.52e-1)" "unprognostic (5.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.40e-2)" "unprognostic (2.85e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (1.37e-2)" "unprognostic (1.63e-3)" "unprognostic (5.21e-2)" "unprognostic (8.82e-2)" "prognostic favourable (3.25e-5)" 11.9 12.6 10.6 20.0 12.2 13.8 13.2 17.6 14.9 10.7 16.1 15.9 14.5 18.5 12.9 18.4 21.5 21.1 18.6 8.4 10.8 11.3 19.5 19.2 12.2 21.3 13.1 8.1 10.9 15.3 16.3 11.5 10.8 12.3 13.4 9.8 17.7 18.4 20.6 9.9 21.5 21.9 14.2 13.1 17.6 15.2 10.9 14.0 13.7 15.8 10.7 21.7 14.7 24.6 3.6 3.8 1.7 4.2 2.1 4.1 3.6 10.2 2.2 0.0 14.5 4.8 2.8 4.7 2.8 3.3 7.2 7.2 0.0 0.4 22.9 8.2 7.1 11.7 0.0 10.0 2.3 0.0 6.7 3.5 1.6 8.3 4.5 4.5 2.9 3.0 3.5 7.3 4.6 4.5 1.6 0.0 0.0 0.0 7.5 11.1 0.0 3.9 9.9 6.9 3.3 6.0 9.6 0.4 6.2 10.5 4.6 2.9 3.6 1.5 7.5 5.6 3.9 0.0 0.1 9.2 16.4 12.1 0.0 13.0 8.9 1.7 3.1 0.5 3.9 4.2 3.2 3.2 2.9 3.8 3.8 3.6 1.8 2.7 1.7 2.1 2.6 1.9 4.1 3.6 10.6 12.2 17.6 14.9 10.8 11.3 13.1 8.1 12.3 14.0 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923989 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA048684: , HPA053408: " "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavourable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favourable (2.71e-4)" 11.5 10.6 8.8 25.5 9.7 7.9 9.3 10.1 12.2 11.2 10.2 8.7 20.2 23.8 12.1 13.2 7.8 12.1 11.4 8.1 8.2 9.6 10.1 22.5 10.4 17.4 12.6 8.3 14.7 31.0 7.4 13.9 13.7 10.6 13.7 4.6 7.7 17.0 25.2 12.2 9.7 19.4 9.2 8.4 18.6 18.5 9.2 9.2 16.7 12.5 7.9 12.1 9.9 11.8 12.5 12.5 13.8 13.9 11.2 15.9 13.8 3.3 2.3 0.9 6.0 0.8 1.7 0.6 4.6 1.1 1.4 1.7 1.7 1.4 7.7 7.9 1.3 7.4 1.1 2.7 0.1 3.0 12.9 10.8 0.5 2.3 1.3 4.5 1.7 1.3 1.6 1.2 0.5 1.2 10.5 3.3 0.4 1.3 6.3 2.4 0.0 7.3 9.0 6.9 14.2 1.1 1.1 3.2 12.9 5.5 3.4 7.3 3.3 3.5 3.9 3.4 7.1 6.2 2.7 12.0 14.4 12.0 1.8 11.5 5.2 12.6 13.8 8.8 12.7 13.9 15.9 12.5 12.6 14.4 12.5 10.5 11.8 12.1 13.8 11.2 12.1 9.8 10.4 13.8 8.8 9.7 10.1 12.2 8.2 9.6 12.6 8.3 10.6 9.2 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell line enhanced" "Detected in some" "HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA020053 Enhanced Supported "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA020053: AB_1858280" "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favourable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.3 0.0 0.8 0.0 53.0 0.0 12.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 70.5 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.2 0.9 39.6 5.6 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392777-114511160 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favourable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favourable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 15.2 12.8 16.9 18.4 19.9 27.1 17.1 38.3 21.8 16.9 14.3 11.0 21.9 10.9 19.8 38.3 16.4 15.0 15.6 10.8 18.1 12.5 17.3 15.0 14.3 15.2 12.1 18.0 19.8 15.7 21.8 22.4 27.2 15.2 16.5 13.0 10.7 16.4 19.1 14.3 19.5 14.8 20.2 12.9 14.9 14.1 29.0 16.3 20.5 17.9 9.8 16.6 17.9 28.7 3.4 4.0 12.2 2.8 4.7 4.4 1.0 12.9 7.0 13.2 9.9 5.6 5.9 22.5 6.6 7.0 9.2 9.8 7.9 5.5 13.8 6.8 7.7 7.5 12.0 7.7 12.7 10.4 7.1 13.3 9.2 9.1 6.2 16.8 11.1 5.6 5.7 10.9 11.2 7.7 16.6 9.8 8.8 48.5 16.9 7.1 17.8 7.1 14.6 20.2 4.5 6.6 20.4 9.2 9.7 12.5 15.1 11.9 6.9 9.2 8.6 6.4 10.5 14.8 9.2 6.9 6.4 14.5 9.1 9.8 18.2 12.2 1.6 7.4 3.5 1.8 3.1 3.4 3.7 3.7 2.0 2.2 2.9 4.4 4.8 4.7 2.8 4.0 2.0 1.0 16.9 19.9 38.3 21.8 18.1 12.5 12.1 18.0 15.2 16.3 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.2;SK-BR-3: 17.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA077996 Approved Nucleoli,Centrosome Centrosome Nucleoli "HPA077996: " "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 15.9 14.6 2.7 12.2 2.9 1.4 7.3 0.9 3.4 9.3 7.9 6.0 8.5 6.6 15.7 10.6 8.7 7.8 5.6 4.1 3.6 2.2 7.1 4.4 7.9 11.7 2.6 3.9 11.4 5.5 4.5 5.5 8.7 4.7 9.5 6.8 7.8 10.2 6.3 2.0 6.2 14.2 5.8 6.2 16.6 6.1 4.6 4.3 12.5 7.0 5.0 14.3 10.0 7.8 12.8 15.9 15.2 15.9 5.9 9.5 7.8 2.2 1.3 0.5 0.2 5.2 8.1 16.2 3.4 10.0 8.9 8.7 1.0 7.9 8.0 1.6 4.6 3.7 0.3 7.4 4.5 10.4 0.3 4.2 0.4 0.4 2.3 4.6 3.0 8.5 6.4 4.5 1.4 11.5 0.2 0.6 4.2 1.0 4.2 2.7 0.0 0.7 6.2 0.3 0.5 5.4 6.1 0.0 0.0 0.1 17.3 2.5 3.0 2.2 9.2 2.3 0.5 0.9 1.2 0.9 1.0 3.1 6.7 0.6 1.1 8.7 14.3 3.6 5.6 15.9 6.1 12.6 5.4 6.9 15.9 12.8 6.8 5.7 15.2 5.9 13.5 8.1 9.5 7.8 2.7 2.9 0.9 3.4 3.6 2.2 2.6 3.9 4.7 4.3 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA061321: " "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 0.0 0.1 5.9 1.7 3.3 1.1 3.8 4.9 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 4.2 5.3 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 TRIM38 "RNF15, RORET" ENSG00000112343 "Tripartite motif containing 38" O00635 6 25962802-25991226 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031685 Approved Approved "Plasma membrane,Cell Junctions,Centrosome" Centrosome "Plasma membrane, Cell Junctions" "HPA031685: AB_10603218" "unprognostic (6.62e-2)" "unprognostic (1.65e-3)" "unprognostic (3.34e-1)" "unprognostic (2.72e-2)" "unprognostic (1.25e-1)" "unprognostic (6.51e-2)" "unprognostic (7.79e-2)" "unprognostic (3.27e-2)" "unprognostic (2.78e-2)" "prognostic favourable (8.95e-5)" "unprognostic (2.81e-2)" "unprognostic (6.28e-2)" "unprognostic (2.73e-1)" "unprognostic (3.36e-1)" "unprognostic (4.49e-2)" "prognostic favourable (8.20e-5)" "prognostic favourable (4.94e-9)" 13.3 8.4 2.5 15.7 2.3 12.0 7.9 1.1 3.4 17.2 12.1 3.1 20.5 6.7 26.2 22.3 15.7 8.9 9.2 5.8 2.8 2.3 26.1 8.8 14.0 14.4 3.7 1.8 11.5 4.3 1.0 4.3 10.3 3.5 15.5 7.8 9.2 9.8 16.5 9.0 5.3 14.6 13.1 4.5 17.6 6.6 5.3 2.9 16.6 13.7 9.5 20.1 18.0 15.4 16.5 10.1 12.1 12.9 6.7 7.9 6.3 3.5 2.0 0.3 4.3 10.3 13.9 3.6 4.5 8.9 8.7 14.5 1.5 3.8 7.9 7.4 5.5 5.6 2.7 4.4 5.2 7.9 1.8 3.5 3.3 1.4 13.7 4.2 7.4 13.8 3.2 5.4 1.9 7.5 2.3 4.4 10.3 1.7 4.0 4.8 1.4 2.7 6.2 4.3 8.2 10.4 7.0 0.1 0.1 3.4 7.1 12.0 1.0 5.5 7.7 1.6 2.7 2.7 3.0 5.1 3.7 8.9 4.2 5.2 9.6 10.1 10.6 4.7 7.6 12.9 7.4 14.3 6.5 6.8 10.1 16.5 6.2 6.7 12.1 6.7 11.4 9.5 7.9 6.3 2.5 2.3 1.1 3.4 2.8 2.3 3.7 1.8 3.5 2.9 TRIM4 RNF87 ENSG00000146833 "Tripartite motif containing 4" Q9C037 7 99876958-99919600 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019356, HPA029461" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA019356: AB_1856376, HPA029461: AB_10600834" "unprognostic (1.88e-1)" "unprognostic (2.97e-2)" "unprognostic (3.37e-1)" "unprognostic (3.46e-2)" "unprognostic (1.80e-2)" "unprognostic (7.06e-2)" "unprognostic (1.22e-1)" "unprognostic (5.42e-2)" "unprognostic (3.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.48e-2)" "unprognostic (1.60e-1)" "prognostic favourable (7.36e-6)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (7.46e-2)" "unprognostic (5.65e-2)" 19.1 22.6 13.5 22.1 15.9 6.7 22.1 20.1 15.5 19.5 17.3 12.4 22.5 13.9 21.9 18.8 16.4 19.0 19.8 11.1 13.3 9.3 16.6 17.9 21.1 22.4 15.3 8.8 35.0 23.2 18.9 27.4 16.1 12.2 21.9 15.7 18.4 19.4 33.8 9.4 20.7 18.3 18.1 11.9 18.2 17.4 16.2 14.5 18.4 20.5 11.9 18.8 20.0 28.9 18.6 17.0 20.0 19.2 13.9 30.3 17.4 9.5 11.5 6.9 5.7 18.1 17.0 3.1 16.1 19.7 13.5 15.7 6.1 9.5 14.0 0.1 13.7 11.4 9.1 9.9 13.8 14.2 0.7 11.4 6.1 9.6 25.6 16.4 16.3 18.1 21.2 10.5 26.6 11.8 16.6 21.6 11.2 11.9 12.1 14.8 5.2 9.9 6.9 9.8 15.9 14.9 12.4 8.1 5.7 12.3 18.9 19.2 8.7 9.5 14.3 15.0 13.4 28.6 15.5 18.2 19.9 11.3 9.8 18.5 19.8 20.0 19.2 15.3 20.6 19.2 23.8 18.6 21.6 23.5 17.0 18.6 30.3 22.2 8.2 13.9 16.6 12.7 21.5 17.4 13.5 15.9 20.1 15.5 13.3 9.3 15.3 8.8 12.2 14.5 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235809 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.7" "Cell line enhanced" "Detected in all" "HDLM-2: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (2.68e-2)" 10.0 8.3 25.5 9.4 24.3 9.3 5.4 7.3 17.0 6.9 6.5 19.8 8.8 11.2 6.1 8.3 7.3 8.4 7.0 9.8 26.9 20.4 10.7 7.6 6.9 6.0 37.3 12.5 5.9 12.3 18.8 7.6 7.3 17.0 7.0 4.0 7.8 8.3 8.4 30.0 9.0 9.0 5.3 43.7 7.5 9.5 19.1 18.3 10.6 11.3 7.2 7.2 5.8 5.2 2.2 2.4 3.9 2.3 1.9 4.3 1.4 4.6 12.1 4.5 7.5 5.4 5.4 10.6 6.8 3.7 5.0 4.7 10.2 7.0 7.8 11.1 4.6 8.8 4.7 16.3 2.7 38.5 14.9 8.9 11.9 5.8 5.2 6.5 6.1 4.7 8.4 6.2 2.2 2.8 11.1 9.7 2.8 16.6 9.8 7.3 4.2 5.8 9.3 6.9 10.2 2.9 7.4 7.0 6.6 6.3 7.4 9.5 14.8 7.4 5.9 6.9 4.7 4.1 5.1 21.4 13.5 11.1 7.2 7.7 5.8 0.9 1.4 2.2 2.4 1.1 3.6 1.9 2.5 4.3 1.6 2.2 2.6 3.1 3.9 1.9 2.3 2.4 3.2 1.4 25.5 24.3 7.3 17.0 26.9 20.4 37.3 12.5 17.0 18.3 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662805-35818007 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA049053: , HPA057633: " "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavourable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 18.8 18.1 25.2 17.7 31.5 8.2 17.3 34.8 35.1 18.4 18.0 25.1 12.6 16.2 19.4 16.7 14.5 17.9 18.1 17.5 25.8 23.0 28.1 21.9 18.1 18.1 26.7 31.9 17.0 23.5 23.0 21.7 20.2 32.0 16.9 17.7 13.3 16.1 18.8 20.3 11.8 17.9 19.2 29.7 20.3 17.0 12.3 25.1 12.8 23.4 7.2 19.5 19.7 19.4 4.1 4.9 0.9 3.7 3.2 3.4 1.5 10.4 8.9 14.3 6.6 10.9 16.6 0.0 9.8 11.8 12.4 11.3 10.4 7.1 14.0 9.3 12.8 8.2 4.9 11.2 14.0 9.1 9.3 15.0 11.8 5.9 14.5 11.7 13.0 12.5 12.6 7.2 19.8 13.0 23.3 5.0 13.0 6.3 12.3 5.7 8.1 7.8 8.6 37.2 7.5 11.4 14.2 9.9 8.5 14.7 10.6 11.1 15.9 10.0 14.5 15.9 13.1 9.0 11.1 8.5 7.6 0.0 13.1 12.5 11.9 0.4 2.6 0.9 2.6 3.3 2.4 3.0 2.5 2.5 2.1 4.1 3.3 3.4 0.2 3.2 3.7 4.9 0.9 1.5 25.2 31.5 34.8 35.1 25.8 23.0 26.7 31.9 32.0 25.1 TRIM45 "FLJ13181, RNF99" ENSG00000134253 "Tripartite motif containing 45" Q9H8W5 1 117111060-117122587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030266, HPA054308" Uncertain Supported "Cytokinetic bridge,Cytosol" Cytosol "Cytokinetic bridge" "HPA030266: AB_10795476, HPA054308: " "prognostic favourable (1.58e-4)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (3.49e-1)" "unprognostic (5.70e-2)" "unprognostic (9.66e-2)" "unprognostic (2.19e-3)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.43e-2)" "unprognostic (3.05e-1)" "unprognostic (5.45e-2)" "unprognostic (7.09e-2)" "unprognostic (3.90e-2)" "unprognostic (4.85e-2)" "prognostic unfavourable (2.92e-4)" "unprognostic (1.27e-2)" 2.3 5.4 6.3 1.4 3.6 1.9 4.9 2.4 7.2 3.4 4.5 5.8 8.0 3.8 9.0 8.0 3.3 9.4 9.3 12.4 3.9 2.6 3.8 1.1 2.6 0.9 2.6 7.5 8.5 8.9 7.3 8.8 9.4 4.5 8.3 2.3 6.0 3.4 7.4 26.6 5.9 3.1 13.3 3.4 2.4 6.1 5.4 4.1 0.7 9.9 9.0 2.1 6.3 4.5 0.4 0.7 0.6 0.4 2.8 2.2 0.0 3.2 2.9 12.1 5.7 1.0 2.8 9.2 3.6 1.5 2.5 2.5 1.3 2.9 0.1 2.7 1.7 2.9 2.8 2.9 3.4 1.8 2.9 1.9 8.9 1.5 1.8 1.7 2.8 3.6 2.9 4.2 3.0 3.1 2.3 2.4 2.3 13.9 1.0 2.1 6.5 2.6 4.6 23.9 0.7 3.4 2.9 9.2 2.3 2.9 2.7 2.2 4.7 2.3 1.0 3.5 5.1 2.1 3.1 6.7 2.5 0.2 4.6 1.6 8.9 0.6 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.1 0.7 0.4 0.2 0.2 0.5 2.8 0.1 0.3 2.2 0.0 6.3 3.6 2.4 7.2 3.9 2.6 2.6 7.5 4.5 4.1 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 35.2;WM-115: 9.0" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles Vesicles Nucleoli "HPA044988: , HPA077883: " "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA054565: , HPA056819: " "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavourable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favourable (4.07e-4)" 9.2 13.0 17.8 15.3 19.7 10.9 11.5 42.3 24.2 10.9 10.9 9.8 15.4 11.8 12.1 14.3 6.6 10.3 8.2 9.1 15.0 10.5 11.2 9.7 11.0 18.8 18.0 12.0 17.7 14.6 15.3 19.4 8.6 16.2 13.8 10.2 8.1 14.0 15.6 9.8 14.5 12.6 8.3 14.0 16.9 11.3 11.7 20.8 15.3 16.8 5.0 13.9 10.3 15.1 5.4 2.7 5.6 2.5 5.5 11.2 3.7 3.5 4.2 6.8 8.7 12.4 7.9 6.1 4.0 3.5 3.9 3.4 6.0 6.7 7.8 4.3 4.3 6.7 3.7 5.3 4.6 13.4 7.7 3.0 15.9 5.0 3.0 9.1 7.0 7.9 4.5 4.2 2.4 4.6 3.2 18.6 4.0 6.8 5.0 8.4 2.4 5.4 6.0 3.7 5.3 3.2 4.8 7.8 6.3 5.7 4.1 3.6 7.7 6.3 5.5 7.8 4.1 3.6 3.7 13.7 6.6 5.4 8.9 8.1 3.0 5.0 2.5 5.6 8.4 2.2 9.3 5.4 9.0 9.2 2.0 4.2 11.2 8.9 2.6 5.5 2.0 2.7 5.9 3.7 17.8 19.7 42.3 24.2 15.0 10.5 18.0 12.0 16.2 20.8 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Group enriched" "Detected in some" 9 "HAP1: 8.2;NTERA-2: 17.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Group enriched" "Detected in some" 11 "cerebral cortex: 1.4;hippocampal formation: 0.8" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.2 0.0 0.0 0.0 0.3 0.0 1.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.6 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175487 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4" "Cell line enriched" "Detected in some" 15 "LHCN-M2: 96.9" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enriched" "Detected in single" 4 "cerebellum: 3.3" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 8 "olfactory region: 0.5" "Group enriched" "Detected in some" 9 "hippocampal formation: 0.8;pons and medulla: 1.1" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: " "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 2.1 0.0 0.3 0.2 0.2 0.0 0.1 3.3 0.1 0.4 0.1 0.1 0.3 0.0 0.0 6.6 0.8 3.0 0.1 34.3 0.4 0.1 2.7 22.0 0.1 0.4 0.1 0.1 0.5 0.1 0.0 2.0 1.4 0.8 0.3 0.0 0.1 1.0 0.0 37.0 0.3 0.1 0.0 0.1 0.1 0.1 3.8 0.0 0.0 0.9 24.4 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 96.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.3 6.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 3.3 0.1 0.4 0.1 0.1 0.1 0.8 0.0 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085439-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavourable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favourable (2.13e-4)" 14.3 12.0 6.2 15.7 9.3 4.7 24.5 3.2 11.1 14.9 15.0 6.8 22.3 9.7 14.3 13.1 12.9 12.8 13.7 8.7 7.5 5.2 10.8 10.4 23.7 11.7 15.8 5.2 17.3 10.8 10.7 15.2 14.0 8.8 12.5 8.3 7.5 12.2 22.1 8.7 13.2 12.8 15.2 8.5 17.2 10.3 5.6 12.0 9.7 14.0 9.1 12.0 13.6 22.0 3.3 2.1 7.4 2.4 7.7 3.6 1.0 9.9 12.5 5.4 6.9 12.5 13.0 6.5 8.3 7.4 13.5 12.6 5.9 14.5 11.8 9.0 6.9 11.5 2.2 7.6 9.1 11.8 3.5 7.4 15.7 4.4 11.2 13.1 16.9 8.2 11.1 8.8 14.4 7.1 12.9 15.0 9.3 13.6 11.0 14.6 5.4 10.4 10.2 8.8 7.7 7.1 10.4 0.3 0.2 9.2 25.8 7.0 5.9 8.6 13.4 19.0 16.9 14.2 8.9 7.4 7.4 9.3 9.4 10.7 14.8 2.5 2.4 2.1 3.6 1.5 2.6 2.0 2.7 2.3 0.8 3.3 2.6 3.4 7.4 7.7 2.1 2.1 1.1 1.0 6.2 9.3 3.2 11.1 7.5 5.2 15.8 5.2 8.8 12.0 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell line enriched" "Detected in some" 7 "A549: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA077996 Uncertain Nucleoli,Centrosome Centrosome Nucleoli "HPA077996: " 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 9.9 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.1;thyroid gland: 15.5" "Cell line enhanced" "Detected in some" "HHSteC: 9.9;HSkMC: 6.6;U-266/70: 13.1;U-266/84: 6.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: " "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.4 5.4 1.8 3.0 2.5 3.3 1.6 1.3 2.1 2.6 1.4 1.1 7.2 2.2 2.8 1.9 0.8 3.5 3.1 5.9 2.4 3.0 1.0 1.1 2.1 2.9 2.7 1.3 5.8 0.9 1.5 6.8 1.8 3.8 2.1 1.1 2.9 0.9 1.9 1.2 1.1 1.7 2.1 4.2 4.7 1.5 16.1 1.6 2.7 15.5 0.7 2.8 3.0 5.2 5.5 5.1 3.6 1.3 7.8 4.1 1.5 0.2 0.4 1.0 0.8 0.6 0.6 0.6 2.4 0.8 0.0 0.0 0.3 0.3 0.7 0.2 3.6 0.3 0.6 0.6 0.4 0.4 0.5 0.2 0.5 0.7 9.9 0.5 0.6 6.6 0.5 2.1 0.2 0.2 0.5 1.5 0.3 0.4 0.3 0.8 3.8 0.0 0.5 0.2 1.0 0.3 0.9 0.8 0.5 0.1 0.3 0.4 0.3 0.3 0.7 1.2 0.4 0.1 0.2 13.1 6.6 0.4 0.3 0.2 0.4 3.6 1.3 0.1 3.3 1.1 3.4 3.6 1.6 3.3 1.5 5.5 4.1 4.0 0.5 7.8 0.8 5.1 0.4 1.5 1.8 2.5 1.3 2.1 2.4 3.0 2.7 1.3 3.8 1.6 TRIM62 "DEAR1, FLJ10759" ENSG00000116525 "Tripartite motif containing 62" Q9BVG3 1 33145402-33182059 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050061 Approved "Vesicles,Focal adhesion sites" "Vesicles, Focal adhesion sites" "HPA050061: " "unprognostic (1.57e-1)" "unprognostic (4.39e-2)" "unprognostic (2.39e-2)" "unprognostic (2.62e-2)" "unprognostic (1.14e-2)" "unprognostic (5.80e-2)" "unprognostic (5.10e-5)" "unprognostic (2.05e-2)" "unprognostic (1.14e-1)" "unprognostic (4.32e-2)" "unprognostic (3.55e-3)" "unprognostic (3.66e-1)" "prognostic unfavourable (7.08e-5)" "unprognostic (2.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" 4.8 11.8 10.1 6.4 19.2 9.3 6.2 19.0 13.9 5.6 4.9 31.8 1.6 5.6 4.9 6.9 6.9 5.1 4.9 5.3 12.3 10.5 5.3 2.7 5.6 9.6 28.1 9.1 6.7 4.8 7.5 9.2 19.6 15.4 8.7 5.4 5.0 10.8 7.5 6.7 20.5 5.8 6.9 12.8 8.3 6.5 4.0 23.7 8.7 6.3 5.1 10.4 9.8 7.3 3.0 1.8 6.0 3.5 1.7 8.5 2.1 2.9 2.3 20.7 3.4 5.2 2.3 6.3 2.9 8.7 5.4 4.8 2.4 3.0 4.7 3.2 2.6 6.0 4.1 3.8 5.2 4.5 3.2 5.4 2.5 1.9 5.0 1.7 13.5 4.5 3.5 7.2 1.8 5.4 0.8 3.1 5.5 7.8 5.3 1.7 4.9 2.9 6.7 10.9 2.2 3.5 7.7 5.0 3.1 3.2 12.3 13.8 3.4 1.2 5.2 2.3 3.2 6.6 2.2 5.8 2.5 2.3 4.3 3.2 2.8 2.2 2.0 6.0 2.7 3.5 4.6 2.2 4.1 3.7 1.8 3.0 2.8 2.7 4.4 1.7 2.2 0.8 8.5 2.1 10.1 19.2 19.0 13.9 12.3 10.5 28.1 9.1 15.4 23.7 TRIM65 ENSG00000141569 "Tripartite motif containing 65" Q6PJ69 17 75880335-75897003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021575, HPA021578, HPA064820" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: " "unprognostic (1.82e-1)" "unprognostic (1.47e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-1)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "prognostic unfavourable (4.74e-6)" "unprognostic (5.36e-2)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-2)" "unprognostic (6.00e-3)" "prognostic unfavourable (1.82e-5)" "unprognostic (2.86e-3)" "unprognostic (7.18e-2)" "unprognostic (4.24e-3)" "unprognostic (7.50e-3)" 15.5 8.2 12.8 12.1 20.0 10.8 13.6 26.7 16.6 15.7 12.7 17.6 11.9 13.9 15.7 9.3 14.0 14.4 12.9 11.0 16.5 12.3 11.3 8.2 13.3 14.6 22.4 8.1 17.7 15.7 14.9 12.7 8.1 16.1 12.4 12.0 15.8 14.7 15.2 16.5 21.6 12.8 13.0 11.4 17.2 12.7 5.4 21.3 11.7 13.1 11.0 14.8 12.7 15.4 5.3 3.4 4.4 3.0 5.2 5.9 1.6 13.4 14.7 5.3 14.8 9.7 13.5 2.6 5.5 7.2 9.2 6.8 5.2 11.6 14.6 4.0 5.8 9.4 11.0 12.2 4.0 6.5 19.7 11.7 13.4 7.8 10.3 12.3 12.6 9.7 9.8 6.2 9.9 20.3 18.0 14.6 5.6 14.5 22.3 19.9 12.1 12.2 20.9 7.1 22.9 6.8 5.1 11.8 11.3 8.7 13.2 14.5 15.7 15.0 10.9 19.4 8.9 8.6 10.1 12.3 4.5 3.8 12.3 20.0 8.2 2.8 3.0 4.4 5.2 2.7 5.9 4.1 3.9 5.3 2.7 5.3 4.3 4.2 3.1 5.2 1.5 3.4 3.5 1.6 12.8 20.0 26.7 16.6 16.5 12.3 22.4 8.1 16.1 21.3 TRIM68 "FLJ10369, RNF137, SS-56" ENSG00000167333 "Tripartite motif containing 68" Q6AZZ1 11 4598672-4608259 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023455 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023455: AB_1858319" "unprognostic (4.77e-2)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (4.10e-2)" "unprognostic (4.13e-2)" "unprognostic (8.63e-2)" "unprognostic (2.01e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "unprognostic (7.78e-2)" "prognostic favourable (4.14e-6)" "unprognostic (4.23e-2)" "unprognostic (2.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" 7.7 11.3 11.1 8.0 11.1 3.1 10.6 15.2 12.8 16.3 10.9 12.6 18.2 10.3 10.6 12.2 8.0 12.6 10.3 9.4 9.6 7.9 14.9 12.7 11.7 7.6 13.1 10.5 17.3 9.9 12.6 10.5 9.8 10.0 16.8 10.1 9.9 12.0 17.5 8.7 7.6 9.8 9.8 11.9 10.7 12.4 13.2 9.5 10.0 17.8 6.7 8.9 11.7 8.4 9.1 5.9 8.9 5.2 5.5 12.8 7.6 8.3 9.3 3.9 6.3 6.3 10.3 0.0 9.2 6.7 8.3 7.6 1.2 8.6 5.7 5.6 4.6 9.8 3.8 6.4 7.2 14.1 7.4 6.9 2.4 0.0 7.3 11.1 9.8 7.9 9.4 4.9 7.4 10.5 6.4 3.0 7.4 2.0 9.1 3.0 4.5 7.7 7.3 5.5 0.2 5.4 3.7 2.0 3.7 0.0 9.3 5.8 4.0 5.6 8.4 11.2 7.7 11.2 4.0 11.7 12.6 8.3 7.7 4.9 10.5 6.4 2.7 8.9 9.0 5.1 10.1 9.1 9.9 10.0 5.9 7.9 12.8 10.1 0.3 5.5 5.2 4.0 8.7 7.6 11.1 11.1 15.2 12.8 9.6 7.9 13.1 10.5 10.0 9.5 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell line enhanced" "Detected in many" "HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 2.9 0.0 0.3 0.5 0.5 0.1 1.4 0.0 0.5 1.2 0.2 8.0 0.4 4.3 1.7 11.2 3.2 9.2 0.1 23.8 1.3 0.5 7.8 0.1 1.6 0.0 1.3 0.1 7.1 0.2 4.6 2.6 0.3 1.3 0.2 0.8 0.3 0.2 0.0 13.2 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.1 4.0 0.7 0.2 10.8 0.1 2.4 0.4 4.2 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32818018-32897826 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.5;testis: 11.1" "Cell line enhanced" "Detected in some" "AF22: 12.4;BEWO: 37.5;CACO-2: 8.8;Hep G2: 24.2;NTERA-2: 33.2" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: , HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.1 0.0 0.7 0.1 1.9 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.7 2.2 0.0 6.5 0.0 0.2 0.0 0.1 0.0 0.0 0.5 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 37.5 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 24.2 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 2.6 33.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.5 2.7 0.7 0.2 0.0 1.9 0.0 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214021-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 71.6;tongue: 37.7" "Cell line enhanced" "Detected in some" "HL-60: 4.7;LHCN-M2: 8.7;RH-30: 22.6;U-266/70: 14.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 12 "cerebellum: 3.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054909: " "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 2.3 0.1 0.1 0.1 0.2 0.3 0.1 3.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 5.5 1.8 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 71.6 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 37.7 1.9 0.0 0.0 2.0 1.9 4.9 1.3 2.1 1.3 0.4 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.3 0.2 4.7 0.2 1.0 0.1 0.0 0.1 0.0 0.3 0.5 8.7 0.2 0.1 0.4 0.2 0.3 0.3 22.6 3.0 0.0 0.3 1.9 0.2 0.2 0.3 0.1 0.2 1.9 0.1 0.2 0.3 0.2 0.1 14.1 1.2 0.2 0.2 0.3 0.2 4.5 1.3 1.5 1.1 1.2 1.0 1.3 1.0 0.9 0.8 2.0 1.3 1.3 4.9 2.1 1.2 1.9 0.8 0.4 0.1 0.2 3.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TRIM8 "GERP, RNF27" ENSG00000171206 "Tripartite motif containing 8" Q9BZR9 10 102642310-102660680 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023560, HPA023561" Approved Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA023560: AB_10600414, HPA023561: AB_10601861" "unprognostic (4.32e-2)" "unprognostic (6.90e-2)" "unprognostic (3.02e-3)" "unprognostic (1.45e-1)" "unprognostic (1.78e-1)" "unprognostic (5.03e-1)" "unprognostic (3.82e-2)" "unprognostic (1.03e-1)" "unprognostic (2.15e-3)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (1.52e-1)" "unprognostic (9.55e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (8.34e-2)" "unprognostic (1.36e-2)" 31.7 18.4 26.1 23.9 25.2 17.0 18.0 26.1 31.6 31.8 19.5 22.9 15.4 15.8 18.0 14.3 17.8 21.6 19.8 25.0 23.2 18.0 27.2 21.9 23.0 25.4 20.1 20.0 19.3 35.9 24.7 14.7 17.5 16.3 17.4 8.1 19.4 28.5 18.5 34.8 14.6 23.7 13.6 15.7 22.5 21.2 11.7 21.9 48.3 26.6 14.5 30.3 21.4 15.9 9.0 11.9 17.8 5.3 5.5 7.2 3.9 27.6 6.5 6.4 10.5 7.1 14.4 6.0 9.9 20.2 10.8 8.7 11.7 33.4 8.9 26.7 22.0 10.2 4.3 13.3 8.9 9.0 8.4 22.5 5.4 26.7 18.1 5.0 9.0 16.5 7.4 23.7 14.0 14.3 4.2 13.4 8.4 18.0 9.5 16.9 3.5 13.2 4.8 14.4 4.4 12.8 19.5 3.9 7.6 5.5 6.8 13.1 19.2 10.0 26.6 14.5 6.5 8.1 22.2 12.3 8.0 5.2 22.1 12.6 3.6 10.7 4.8 2.6 6.8 4.4 6.7 9.0 7.2 5.3 4.1 7.0 6.4 5.5 17.8 5.5 5.3 11.9 6.9 3.9 26.1 25.2 26.1 31.6 23.2 18.0 20.1 20.0 16.3 21.9 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell line enhanced" "Detected in some" "A549: 21.1;BEWO: 11.7;hTCEpi: 13.7;NTERA-2: 21.7" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 21.1 0.0 0.0 0.0 0.1 11.7 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 4.0 0.1 0.0 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 4.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 TRIO ARHGEF23 ENSG00000038382 "Trio Rho guanine nucleotide exchange factor" O75962 5 14143702-14532128 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008157, HPA064664" Supported Approved Vesicles,Cytosol Cytosol Vesicles "HPA008157: AB_1858327, HPA064664: " "unprognostic (6.65e-2)" "unprognostic (4.21e-3)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (9.39e-2)" "unprognostic (4.13e-1)" "unprognostic (2.18e-3)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" "prognostic unfavourable (3.11e-5)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (4.58e-3)" "unprognostic (2.23e-1)" 29.7 13.7 27.6 15.8 18.9 5.8 30.3 32.6 29.7 13.7 18.5 11.3 9.2 8.3 23.1 19.3 10.4 12.2 25.2 15.1 18.9 15.0 11.7 12.6 15.8 10.9 11.0 17.7 28.9 11.5 17.2 19.6 13.7 12.3 16.3 16.5 23.3 10.5 14.0 19.8 16.0 15.6 22.7 11.6 24.2 13.7 11.3 11.5 7.4 10.0 11.9 12.3 15.6 16.9 3.8 2.7 0.3 1.9 4.3 0.6 0.4 12.2 4.4 10.6 5.0 22.7 29.8 12.1 11.3 13.5 9.1 10.5 2.8 4.8 2.8 8.5 15.4 3.7 1.7 5.3 18.9 7.8 2.5 1.5 11.8 3.5 11.8 3.7 4.2 13.9 5.6 32.2 10.3 8.0 0.3 1.9 22.0 2.3 0.0 2.6 2.6 4.0 2.8 6.4 9.4 8.9 5.5 4.8 19.5 9.6 2.5 5.0 1.5 0.5 18.6 17.6 11.2 12.7 13.3 0.0 0.6 3.6 62.5 2.4 4.1 0.3 1.5 0.0 0.1 1.9 0.3 2.0 0.0 0.0 1.4 3.8 0.0 0.0 0.0 4.3 1.4 2.7 0.6 0.4 27.6 18.9 32.6 29.7 18.9 15.0 11.0 17.7 12.3 11.5 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751526 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 19.4" "Lineage enriched" "Detected in many" 12 "dendritic cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles 15000 Vesicles Nucleoplasm "HPA041934: , HPA072625: , HPA073886: " "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favourable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 19.7 10.7 6.0 9.2 7.2 2.3 16.8 3.7 5.4 25.6 19.1 4.5 20.6 9.7 17.8 16.7 44.8 12.0 17.6 18.1 6.5 1.9 14.0 4.5 19.5 5.4 6.7 3.5 22.4 12.9 7.0 4.8 25.4 7.0 19.2 6.6 20.2 16.1 18.3 103.7 10.4 10.1 20.9 6.7 7.1 11.3 8.7 5.4 2.8 31.7 21.6 21.7 24.3 26.5 1.5 19.4 0.1 0.7 1.6 0.9 0.4 26.6 16.2 5.7 8.6 22.4 23.5 20.5 17.2 19.9 19.7 17.3 21.9 15.4 0.5 23.4 14.5 19.9 12.8 25.1 11.8 16.8 5.1 8.7 15.3 16.7 18.4 0.4 2.7 27.1 17.1 17.5 13.5 20.2 12.7 7.3 14.4 9.0 2.3 6.0 12.1 13.8 3.9 11.7 7.8 16.6 13.3 0.0 6.6 22.7 10.2 6.4 10.7 4.7 39.4 13.3 23.9 34.7 18.1 7.7 4.2 2.6 21.5 2.5 8.7 0.0 0.7 0.0 0.5 0.1 0.7 1.2 0.2 0.9 3.8 1.5 0.3 0.2 0.1 1.6 0.1 19.4 0.0 0.4 6.0 7.2 3.7 5.4 6.5 1.9 6.7 3.5 7.0 5.4 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: " "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favourable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 13.0 15.0 10.5 10.8 12.5 7.7 12.1 18.5 14.1 17.4 13.0 8.8 15.2 11.1 13.3 12.7 14.7 11.4 11.2 12.9 9.2 6.7 15.5 16.1 10.6 9.4 12.2 11.1 16.0 27.1 27.1 34.9 24.4 15.2 14.5 11.0 9.4 15.1 15.3 24.0 12.4 15.9 11.2 10.7 15.2 16.2 14.0 13.5 16.4 18.4 11.1 11.9 15.8 12.5 20.0 12.7 17.0 13.0 12.1 14.1 3.9 12.4 12.6 8.2 8.6 14.5 22.5 12.5 19.8 15.2 9.8 11.3 7.6 20.3 8.7 14.6 17.4 16.4 10.8 9.6 21.5 13.2 3.3 9.8 11.4 7.2 11.1 11.5 9.8 8.6 11.8 17.3 14.9 15.6 6.4 10.1 15.3 17.4 6.5 2.8 3.7 9.0 8.1 15.7 4.3 8.8 20.4 6.0 5.4 16.0 9.4 6.1 20.5 5.8 20.6 11.4 8.1 11.9 8.9 9.0 13.8 7.8 13.4 6.5 14.3 8.2 8.8 17.0 13.3 8.0 12.8 11.8 14.1 12.1 6.9 20.0 13.5 14.1 8.7 12.1 13.0 12.7 12.2 3.9 10.5 12.5 18.5 14.1 9.2 6.7 12.2 11.1 15.2 13.5 TRIP4 "HsT17391, ZC2HC5" ENSG00000103671 "Thyroid hormone receptor interactor 4" Q15650 15 64387748-64455303 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016605, HPA050666" Approved Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA016605: AB_1858339, HPA050666: " "unprognostic (1.56e-1)" "unprognostic (1.14e-1)" "unprognostic (2.62e-1)" "unprognostic (4.50e-2)" "unprognostic (5.79e-2)" "unprognostic (1.08e-1)" "unprognostic (7.16e-2)" "unprognostic (3.01e-2)" "unprognostic (4.98e-2)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.37e-2)" "prognostic favourable (6.34e-6)" "unprognostic (2.41e-1)" "unprognostic (2.96e-1)" "unprognostic (2.61e-2)" "unprognostic (1.25e-1)" 17.1 14.7 14.2 18.8 15.1 13.7 18.3 15.9 19.6 14.3 20.8 16.6 23.5 17.5 17.1 14.6 22.6 15.3 15.6 15.5 12.4 11.2 28.5 15.8 15.3 15.0 17.1 14.6 15.9 19.9 22.9 19.6 19.3 15.3 15.7 20.4 12.7 16.5 13.6 14.6 20.6 26.2 17.3 15.7 20.0 17.4 15.0 14.4 28.0 27.1 17.4 18.6 16.8 17.5 8.6 10.4 30.9 19.7 9.7 11.5 8.3 10.8 16.2 14.3 10.1 11.8 15.6 13.4 11.6 15.0 20.1 19.6 13.5 24.5 7.8 3.9 17.6 15.5 23.1 13.2 19.2 15.8 6.5 11.4 11.6 14.1 21.1 12.3 21.7 19.4 17.4 15.9 16.7 17.5 13.1 9.9 18.4 12.5 7.7 12.8 8.3 8.7 11.9 10.8 13.0 19.7 20.9 7.7 12.2 10.4 12.6 20.9 15.9 18.5 15.4 14.4 9.8 9.5 16.3 8.3 14.8 7.8 11.9 12.7 17.9 30.9 11.4 26.6 11.3 14.6 9.6 8.4 10.8 11.4 10.4 8.6 9.2 9.7 16.1 9.7 19.7 8.2 11.5 8.3 14.2 15.1 15.9 19.6 12.4 11.2 17.1 14.6 15.3 14.4 TRIP6 "MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1" ENSG00000087077 "Thyroid hormone receptor interactor 6" Q15654 7 100867138-100873454 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046454, CAB046460, HPA052813" Approved Supported "Plasma membrane,Focal adhesion sites,Cytosol" 12000 "Plasma membrane, Focal adhesion sites, Cytosol" "CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: " "unprognostic (7.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.84e-3)" "unprognostic (3.52e-2)" "unprognostic (2.92e-2)" "unprognostic (3.18e-2)" "unprognostic (4.61e-3)" "unprognostic (8.48e-2)" "unprognostic (4.18e-2)" "unprognostic (5.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.25e-2)" "unprognostic (5.07e-2)" "unprognostic (9.71e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" 15.5 14.7 10.9 16.2 11.2 6.0 18.1 4.2 7.3 36.7 14.6 9.4 22.5 4.4 28.2 30.8 27.2 18.5 43.5 14.5 8.7 7.7 21.6 24.1 18.4 5.8 11.7 9.4 22.0 19.2 28.0 6.5 13.6 9.7 22.1 3.9 22.7 23.0 38.2 8.3 23.9 6.5 25.5 9.7 7.9 9.9 17.5 7.8 7.3 26.6 30.6 12.6 25.0 23.6 3.1 7.7 0.2 4.7 0.0 1.7 0.5 26.6 11.0 5.7 27.3 8.6 10.1 28.7 16.6 17.8 22.8 21.4 10.4 30.7 1.1 17.6 18.7 19.9 8.4 32.1 5.9 3.8 11.4 0.1 18.3 0.1 22.8 12.8 1.5 18.2 21.1 15.2 23.9 11.7 16.7 0.2 19.7 46.8 0.2 20.2 19.7 9.8 10.0 5.7 2.7 14.1 6.6 2.1 0.3 13.9 42.1 16.5 4.5 16.4 17.9 33.6 31.7 36.4 38.8 0.2 0.4 0.1 20.9 1.6 50.5 0.0 1.9 0.2 0.2 3.0 0.6 3.1 1.5 1.3 3.1 2.5 1.7 0.7 0.2 0.0 4.7 7.7 1.3 0.5 10.9 11.2 4.2 7.3 8.7 7.7 11.7 9.4 9.7 7.8 TRIT1 "FLJ20061, IPT" ENSG00000043514 "TRNA isopentenyltransferase 1" Q9H3H1 1 39841022-39883511 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024174 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024174: AB_1858346" "unprognostic (4.61e-2)" "unprognostic (1.77e-1)" "unprognostic (8.38e-3)" "prognostic unfavourable (8.80e-4)" "unprognostic (4.00e-2)" "unprognostic (8.55e-2)" "prognostic unfavourable (5.34e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-3)" "unprognostic (3.18e-2)" "unprognostic (3.54e-1)" "unprognostic (6.68e-3)" "prognostic unfavourable (7.08e-8)" "unprognostic (6.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (6.90e-2)" 9.5 10.3 12.9 10.4 19.1 8.0 19.8 25.8 18.4 15.1 13.4 15.9 22.7 11.4 19.3 21.3 19.8 18.4 9.1 15.9 12.5 12.0 14.6 13.2 11.9 14.8 13.9 10.4 16.7 27.7 14.1 26.7 17.6 14.4 21.4 15.8 13.5 15.1 23.9 10.1 22.9 11.7 18.0 9.8 14.0 12.9 17.3 17.9 15.4 19.2 9.4 14.7 17.2 17.5 3.9 13.4 0.9 6.6 2.4 5.2 2.8 14.5 6.7 14.6 14.9 7.3 11.0 22.0 9.7 13.0 15.6 17.6 12.9 19.2 8.4 12.8 8.2 14.8 21.0 16.7 21.9 10.3 10.6 18.0 15.6 8.0 16.9 17.5 9.9 9.3 15.1 19.5 19.3 12.5 24.4 10.2 9.7 7.1 13.3 18.8 19.6 6.1 14.2 18.3 19.3 14.8 18.7 16.6 11.1 13.9 9.5 10.6 10.5 30.0 8.9 10.4 12.8 18.0 16.0 13.8 10.8 17.1 13.2 17.9 9.0 0.0 6.6 0.9 2.7 4.9 5.2 3.9 2.6 2.9 13.4 3.2 3.4 3.5 0.1 2.4 5.8 11.6 2.7 2.8 12.9 19.1 25.8 18.4 12.5 12.0 13.9 10.4 14.4 17.9 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavourable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.3 10.4 11.3 19.1 11.5 14.7 16.2 17.3 8.7 19.1 16.6 11.1 12.7 19.3 22.7 9.3 14.3 18.8 15.2 8.9 12.6 26.3 15.3 26.7 18.6 20.8 30.7 18.1 20.8 20.5 19.9 18.7 14.0 33.2 6.2 11.8 17.0 12.4 33.2 26.7 24.4 21.0 14.5 26.6 11.9 15.7 26.8 12.2 10.8 22.5 18.0 8.7 17.2 15.6 27.6 10.7 16.6 30.3 10.7 20.7 17.8 12.9 32.5 14.3 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564032 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" "Nucleoli, Actin filaments" "Nucleoplasm, Cytosol" "HPA047601: , HPA058241: " "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavourable (2.14e-4)" "unprognostic (1.68e-2)" 7.0 8.9 6.5 7.5 8.9 3.3 13.1 6.1 8.7 4.6 6.0 9.3 7.5 7.3 5.5 7.2 9.2 10.1 6.1 5.0 7.9 6.7 9.1 16.8 4.9 7.4 9.2 6.1 6.6 12.4 6.7 12.2 10.0 9.7 7.4 6.9 2.5 7.3 4.7 9.3 6.5 10.4 5.1 10.5 7.0 7.6 16.7 10.1 10.7 10.8 5.1 8.0 7.2 10.8 8.8 10.0 9.2 7.6 5.8 7.1 4.0 6.6 4.7 9.2 4.7 5.5 7.7 6.7 8.1 3.1 5.7 4.3 3.9 8.3 9.2 3.1 4.8 3.9 10.7 5.1 8.8 11.7 4.7 6.3 4.1 6.4 5.2 16.0 6.8 4.9 13.2 5.7 12.5 5.8 14.6 8.3 4.8 7.7 13.5 3.3 5.5 4.6 7.8 8.8 5.9 7.7 5.5 5.8 5.0 4.4 24.6 8.1 8.0 6.9 4.2 5.8 6.0 4.7 9.2 5.8 9.7 8.4 4.4 9.4 4.1 4.0 7.6 3.7 3.8 7.1 3.1 6.3 6.5 6.4 10.0 8.8 6.7 6.2 9.2 5.8 6.2 5.6 7.1 4.0 6.5 8.9 6.1 8.7 7.9 6.7 9.2 6.1 9.7 10.1 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favourable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favourable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 7.4 10.3 9.9 10.9 10.3 10.1 9.8 13.7 12.3 10.6 11.8 12.7 12.8 8.3 17.3 9.5 10.4 9.6 10.6 7.0 9.9 9.2 8.2 8.0 8.6 13.1 16.4 9.8 15.4 10.5 9.0 13.8 7.4 10.0 14.8 7.1 12.1 10.3 12.1 7.8 20.4 9.7 11.8 12.7 12.1 10.8 5.0 10.4 10.0 12.4 5.6 13.6 14.8 10.1 9.2 4.6 6.6 5.3 4.6 7.6 2.7 5.4 6.4 8.3 7.3 5.1 4.1 3.9 5.4 3.8 5.4 4.7 3.9 4.8 10.0 4.0 4.0 6.3 3.9 6.4 5.0 4.3 6.9 8.8 15.7 4.0 9.3 8.9 6.3 4.7 6.7 4.7 9.2 5.5 7.0 4.4 4.1 3.8 9.2 7.1 7.4 7.9 9.3 2.9 5.2 5.2 5.0 11.3 10.8 4.3 5.4 4.7 5.9 6.6 5.5 4.3 6.1 6.8 4.6 5.0 6.9 8.0 2.5 7.2 8.6 6.6 5.3 2.8 6.7 4.6 7.6 6.6 6.0 6.3 2.5 9.2 7.3 6.7 5.4 4.6 3.2 4.6 3.9 2.7 9.9 10.3 13.7 12.3 9.9 9.2 16.4 9.8 10.0 10.4 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561862-101566446 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavourable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favourable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 18.0 21.2 13.1 13.6 14.1 14.4 19.7 16.4 19.1 16.1 15.3 5.5 12.9 11.6 14.6 13.1 20.9 15.0 10.7 20.4 13.0 13.4 26.6 34.6 10.0 19.3 12.5 16.7 18.8 12.1 9.9 19.9 18.2 18.5 16.2 14.2 5.5 14.5 13.0 35.2 15.2 16.5 15.3 14.3 19.6 15.6 14.7 10.6 23.0 16.6 30.5 18.5 15.6 11.3 21.6 15.4 27.4 14.8 12.2 23.1 11.8 20.8 10.2 13.6 13.7 12.5 10.7 12.7 12.4 12.2 16.3 18.2 15.5 14.1 43.4 16.3 7.7 21.1 26.2 19.0 22.4 15.5 12.9 29.1 8.1 11.2 9.6 25.5 12.4 12.5 19.8 14.2 13.3 15.8 24.6 9.7 17.5 14.3 20.4 18.7 25.2 22.1 15.2 11.1 19.4 20.8 17.7 33.9 19.4 9.7 20.7 27.4 27.3 28.2 10.4 8.9 16.8 5.9 13.1 11.3 20.6 41.6 15.0 18.4 13.3 27.4 11.2 7.3 13.6 14.4 18.8 21.6 16.8 15.8 13.5 20.4 23.1 21.1 4.9 12.2 14.8 15.4 15.0 11.8 13.1 14.1 16.4 19.1 13.0 13.4 12.5 16.7 18.5 10.6 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64318084 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 44.2 77.0 41.9 40.9 37.6 48.3 57.9 30.9 48.5 52.8 39.2 33.5 38.4 25.9 50.9 58.6 54.2 68.1 49.4 47.4 37.4 51.8 47.4 68.6 41.7 58.2 42.8 34.3 81.9 53.4 36.3 54.0 54.5 35.1 55.7 26.9 50.0 44.5 50.5 53.6 38.6 28.6 50.3 38.7 52.7 35.6 54.6 31.0 64.7 85.5 55.2 57.3 56.2 62.8 132.1 97.2 92.4 58.5 53.2 98.2 112.6 54.2 79.7 26.7 40.8 25.7 21.1 27.8 24.5 24.5 24.9 19.9 40.8 53.4 38.4 79.1 20.4 46.0 40.2 44.6 19.1 47.9 45.1 42.8 72.0 95.9 28.7 34.3 30.0 25.2 45.5 22.4 42.5 25.2 35.9 52.8 23.2 144.7 51.5 69.9 74.4 69.8 31.1 29.9 57.3 28.8 57.0 17.8 83.9 33.9 42.2 73.9 68.1 32.8 23.8 31.8 40.3 55.1 48.1 43.9 71.9 63.9 43.4 35.6 33.8 92.4 58.5 81.7 67.6 47.2 69.2 132.1 88.5 74.6 59.3 112.8 98.2 85.3 69.7 53.2 42.3 97.2 77.4 112.6 41.9 37.6 30.9 48.5 37.4 51.8 42.8 34.3 35.1 31.0 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavourable (2.99e-5)" "prognostic unfavourable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (9.25e-4)" "unprognostic (1.04e-2)" 10.8 11.6 16.7 8.4 20.9 4.1 15.0 13.8 18.3 11.8 9.5 8.0 6.8 7.5 11.9 10.7 9.6 13.2 8.6 9.9 19.4 9.9 12.9 9.8 9.8 11.8 13.6 14.3 8.8 10.1 14.7 17.7 8.9 14.7 12.0 11.2 7.8 12.0 11.0 18.0 9.9 9.6 14.3 12.9 11.0 10.6 11.7 13.4 9.1 14.9 12.0 10.7 10.2 8.5 5.8 5.0 6.3 6.1 5.1 7.6 4.4 7.4 6.5 5.4 4.2 10.3 5.3 1.3 4.7 5.5 7.0 6.0 3.9 5.2 7.6 6.5 4.8 5.2 7.7 7.7 8.3 7.5 5.8 7.3 6.2 1.3 8.1 0.0 5.9 6.5 10.4 6.8 8.7 5.8 10.2 5.3 4.3 37.1 8.5 3.1 0.0 6.0 2.7 3.6 5.0 6.4 8.1 9.2 7.3 6.9 26.1 9.7 7.4 3.1 4.6 4.8 12.7 3.6 5.3 5.5 7.7 2.9 4.4 2.6 3.9 0.5 6.1 6.3 4.5 4.9 5.6 4.0 6.1 4.6 5.0 5.8 7.6 7.4 2.4 5.1 5.5 1.5 3.7 4.4 16.7 20.9 13.8 18.3 19.4 9.9 13.6 14.3 14.7 13.4 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150497 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavourable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 13.0 12.2 13.9 21.7 24.1 5.9 18.3 26.5 22.5 17.4 13.1 18.2 24.2 13.6 17.4 15.4 13.7 13.9 9.6 12.0 14.4 9.0 12.1 13.0 9.6 20.9 23.1 12.8 21.4 18.1 23.8 26.8 13.2 15.6 14.9 14.4 10.8 14.3 17.4 16.9 17.9 14.2 14.3 19.4 16.5 12.6 11.1 25.8 17.8 16.5 12.0 17.6 13.9 15.8 15.1 9.6 2.2 4.5 5.4 13.6 3.9 10.6 6.2 10.5 7.3 5.7 11.2 11.5 11.3 4.5 8.6 7.2 7.4 4.4 17.6 14.1 9.0 9.7 19.3 8.7 15.0 17.7 15.3 10.5 13.8 7.1 10.3 18.1 9.9 7.8 10.0 16.3 21.5 7.8 22.0 11.4 8.6 4.0 14.8 9.6 14.6 12.6 15.9 15.9 9.6 7.1 8.5 6.9 11.5 10.4 10.0 13.3 5.9 16.1 8.1 11.5 7.7 9.6 15.0 14.6 11.8 20.9 13.0 14.6 4.4 0.1 4.5 2.2 8.5 4.4 10.4 14.8 9.0 8.3 5.2 15.1 13.6 11.1 1.9 5.4 3.5 9.6 6.2 3.9 13.9 24.1 26.5 22.5 14.4 9.0 23.1 12.8 15.6 25.8 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118098-185157072 "Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 7.6 12.9 9.4 10.1 12.8 5.9 8.9 14.2 11.3 10.5 10.0 9.6 9.6 9.6 9.3 11.3 10.5 12.6 8.2 13.2 10.3 10.6 15.3 16.0 10.3 11.1 11.2 9.1 13.7 8.3 18.0 26.9 9.7 11.9 11.7 8.5 5.2 7.6 10.0 27.4 5.5 8.7 8.5 12.4 12.8 8.4 29.4 12.8 16.5 12.4 7.6 13.0 11.8 12.2 16.2 12.1 19.0 15.8 11.0 12.7 8.1 8.0 14.8 10.2 7.6 15.1 13.9 14.5 7.8 7.0 10.7 11.2 13.4 15.5 8.8 19.5 5.3 10.4 17.1 10.2 10.5 10.4 7.4 8.4 11.2 13.6 10.5 12.4 14.0 6.7 13.9 10.9 11.0 11.7 22.0 12.1 12.7 6.8 9.4 7.2 16.9 3.1 11.1 14.7 14.0 10.3 8.9 9.1 8.1 15.2 14.8 10.5 15.1 7.0 11.2 9.8 7.8 6.7 10.4 19.5 26.1 14.0 6.4 11.0 9.4 16.8 9.8 19.0 7.4 13.4 7.9 11.7 9.7 8.9 12.1 16.2 12.2 9.5 11.1 11.0 15.8 5.1 12.7 8.1 9.4 12.8 14.2 11.3 10.3 10.6 11.2 9.1 11.9 12.8 TRMT2A HTF9C ENSG00000099899 "TRNA methyltransferase 2 homolog A" Q8IZ69 22 20111866-20117392 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001077 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001077: AB_1079092" "unprognostic (5.01e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (9.70e-2)" "unprognostic (1.17e-1)" "unprognostic (8.05e-3)" "unprognostic (2.19e-3)" "unprognostic (5.93e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (2.99e-8)" "unprognostic (4.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.80e-1)" "unprognostic (1.14e-3)" 14.3 22.5 12.6 18.8 13.6 14.3 13.4 16.3 19.7 13.9 16.6 17.4 15.4 18.2 13.1 15.6 16.1 15.3 17.1 12.8 13.1 11.4 13.2 22.8 11.1 22.8 12.4 14.4 15.2 23.6 10.8 18.5 15.8 11.2 16.8 6.1 14.2 36.5 16.1 14.8 18.4 16.2 12.4 12.7 23.2 16.7 16.9 13.4 26.8 15.6 12.7 18.3 13.1 11.0 9.7 14.0 7.0 14.9 9.5 15.2 11.5 6.3 7.4 2.8 4.6 2.9 2.1 9.8 5.7 2.9 4.6 4.1 8.7 5.5 8.8 4.9 2.6 10.0 2.1 3.2 0.6 9.1 24.0 10.1 9.8 7.9 7.9 15.8 10.2 3.8 4.3 4.8 1.8 4.7 37.9 6.1 3.1 10.1 8.9 10.0 5.4 9.4 10.4 4.9 3.6 2.6 7.2 7.6 5.8 3.5 9.1 9.1 6.3 13.5 4.4 5.6 7.5 4.3 4.9 21.9 9.7 6.7 7.5 6.7 5.6 6.6 11.5 7.0 10.5 14.9 15.2 9.7 10.9 12.1 14.0 6.8 12.2 11.5 1.5 9.5 12.0 12.4 8.5 11.5 12.6 13.6 16.3 19.7 13.1 11.4 12.4 14.4 11.2 13.4 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA003745: , HPA035120: AB_10601702, HPA040814: " "prognostic unfavourable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favourable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 7.6 10.4 6.9 8.9 10.3 9.1 8.5 7.0 14.2 9.6 11.4 6.9 10.7 8.1 8.1 8.6 12.9 7.4 7.3 13.0 10.7 6.6 12.3 9.5 9.4 12.6 9.5 6.6 11.3 10.4 18.5 17.6 5.9 10.7 10.1 12.6 13.4 15.3 10.4 17.6 9.5 13.5 7.9 8.4 16.6 11.4 4.0 7.9 18.2 12.8 5.3 17.7 9.9 9.5 16.5 8.1 14.8 8.2 14.4 19.2 11.5 15.6 13.6 2.8 6.4 6.4 3.4 8.6 8.1 11.0 9.2 13.7 14.6 12.5 13.9 16.3 7.5 9.8 12.5 11.3 11.5 12.0 7.9 8.8 11.2 6.9 5.7 15.6 14.4 4.3 6.7 13.2 6.1 17.6 9.0 13.3 8.4 15.8 19.4 8.3 3.8 10.1 15.9 13.4 13.3 6.7 9.3 4.1 5.4 13.9 10.1 8.1 6.6 7.5 10.3 11.6 7.0 10.8 7.2 8.5 12.7 13.0 9.0 18.0 8.9 9.6 8.2 14.8 13.8 6.5 14.6 14.9 16.1 13.3 7.4 16.5 19.2 16.1 4.8 14.4 7.0 8.1 13.0 11.5 6.9 10.3 7.0 14.2 10.7 6.6 9.5 6.6 10.7 7.9 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971451-60981358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 15.8 10.1 7.9 13.8 12.1 5.4 12.9 9.3 11.8 10.9 8.6 5.7 11.9 7.5 12.0 10.9 11.1 10.0 6.7 6.8 7.7 7.1 12.5 13.9 6.6 7.3 6.7 8.3 17.1 11.1 15.9 13.1 10.8 9.0 10.6 8.1 4.8 11.5 9.9 14.8 9.7 7.4 9.2 6.3 8.6 8.1 24.9 5.9 12.4 10.4 12.1 7.2 13.3 9.0 7.2 7.4 0.9 7.5 2.0 6.0 3.7 28.3 7.3 10.7 14.9 9.4 14.2 11.7 10.7 8.2 11.5 9.1 5.3 17.0 14.6 11.9 7.7 13.1 13.4 15.4 15.1 14.4 6.8 10.7 4.9 5.9 15.4 18.9 6.0 11.2 15.0 10.4 15.4 10.0 13.9 5.2 16.8 10.7 9.7 9.5 9.8 12.0 3.1 24.8 12.3 9.7 9.6 13.1 13.0 11.9 11.9 9.4 19.9 11.4 9.4 13.3 16.1 9.4 10.1 3.2 6.0 6.9 9.3 4.1 12.4 0.1 4.6 0.9 3.5 7.5 5.0 7.2 5.2 5.2 4.2 4.9 5.6 5.1 0.4 2.0 7.5 7.4 6.0 3.7 7.9 12.1 9.3 11.8 7.7 7.1 6.7 8.3 9.0 5.9 TRMT6 "CGI-09, GCD10, Gcd10p, MGC5029" ENSG00000089195 "TRNA methyltransferase 6" Q9UJA5 20 5937235-5950558 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047032, HPA050408" Approved Enhanced "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA047032: , HPA050408: " "unprognostic (1.78e-1)" "unprognostic (4.51e-2)" "unprognostic (1.65e-1)" "unprognostic (4.26e-2)" "unprognostic (2.11e-1)" "unprognostic (6.81e-2)" "prognostic unfavourable (4.70e-12)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.14e-1)" "unprognostic (6.27e-2)" "unprognostic (1.22e-1)" "unprognostic (7.65e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" 10.5 12.9 10.5 11.3 12.1 20.6 8.5 15.0 10.5 7.3 7.4 5.7 47.8 5.1 9.1 7.9 11.9 7.9 5.6 13.2 8.4 9.5 10.2 10.1 7.2 13.2 8.3 11.8 9.6 9.6 9.8 13.9 9.4 13.6 7.2 8.2 5.1 8.2 33.9 24.4 9.9 8.6 8.0 8.2 12.2 7.5 15.5 7.9 10.3 8.7 10.6 12.7 8.8 7.9 9.2 17.8 5.9 8.7 13.9 11.6 7.1 25.2 12.5 8.4 12.9 4.8 6.2 11.7 12.2 6.2 11.9 10.0 16.4 11.2 30.1 6.4 6.7 19.4 16.8 19.3 20.0 6.2 11.7 24.8 5.8 14.7 9.3 22.7 6.5 6.1 10.2 21.2 16.0 5.0 14.9 9.4 13.7 7.0 23.6 12.4 19.0 15.7 15.7 16.7 16.5 8.1 16.1 16.4 25.4 14.8 19.2 19.5 10.2 11.1 4.9 14.2 13.2 13.0 24.4 15.3 29.5 35.3 6.2 18.8 13.8 2.0 7.9 5.9 9.6 8.7 11.0 9.2 10.8 11.6 17.8 8.2 11.2 11.6 0.8 13.9 7.6 8.1 11.3 7.1 10.5 12.1 15.0 10.5 8.4 9.5 8.3 11.8 13.6 7.9 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell line enhanced" "Detected in some" "AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favourable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.0 0.0 0.0 0.0 1.7 10.0 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.4 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.5 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.0 1.1 0.1 0.1 4.7 0.2 5.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.9 1.0 0.1 0.4 4.8 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 TRMU "FLJ10140, MTO2, TRMT" ENSG00000100416 "TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA000824: , HPA035273: AB_10602901, HPA043300: " "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavourable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favourable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavourable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 8.5 16.1 11.5 9.9 16.0 6.4 7.5 17.8 16.0 9.7 8.7 11.5 10.2 10.9 12.1 18.0 10.9 6.2 7.3 16.8 11.3 11.9 20.5 18.8 7.1 10.2 15.7 11.8 8.0 22.7 20.0 13.6 9.7 11.2 8.7 10.2 9.0 12.5 15.5 17.8 9.8 7.6 9.4 11.4 8.7 9.2 8.3 13.9 6.5 9.6 8.3 9.8 7.1 9.1 6.2 7.6 3.9 9.6 7.5 11.3 6.3 10.8 9.9 4.3 9.6 8.0 5.7 10.7 11.3 8.0 16.1 12.5 14.0 2.7 7.1 8.0 10.1 9.7 18.1 10.1 13.8 4.6 24.4 8.4 15.2 16.5 6.9 16.1 5.8 5.4 11.4 16.6 5.3 10.3 11.7 1.7 9.7 11.4 6.2 13.2 16.1 17.5 7.4 9.2 13.1 8.0 7.5 10.2 12.3 10.0 11.8 18.9 6.7 6.7 7.5 7.2 12.8 10.1 12.6 4.2 4.5 7.6 10.1 11.7 14.4 0.0 6.8 3.9 11.1 9.4 9.4 5.7 9.4 10.0 7.6 6.2 8.6 8.0 1.4 7.5 9.6 6.0 11.3 6.3 11.5 16.0 17.8 16.0 11.3 11.9 15.7 11.8 11.2 13.9 TRNAU1AP "FLJ20503, SECP43, TRSPAP1" ENSG00000180098 "TRNA selenocysteine 1 associated protein 1" Q9NX07 1 28553085-28578545 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032068, HPA032069" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA032068: , HPA032069: AB_10603998" "unprognostic (4.06e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-2)" "prognostic favourable (2.22e-4)" "unprognostic (4.93e-2)" "unprognostic (2.28e-2)" "prognostic unfavourable (8.64e-5)" "unprognostic (5.79e-3)" "unprognostic (9.48e-3)" "unprognostic (2.24e-2)" "unprognostic (1.37e-1)" "unprognostic (2.28e-3)" "prognostic unfavourable (1.16e-5)" "unprognostic (1.84e-1)" "unprognostic (2.72e-1)" "prognostic favourable (9.45e-4)" "unprognostic (2.76e-1)" 11.4 10.5 12.6 11.3 14.7 9.3 13.4 19.6 14.1 12.4 10.9 15.4 12.0 7.0 11.7 14.8 10.8 13.2 8.7 12.3 11.7 12.1 11.4 8.7 13.2 15.7 19.3 13.3 12.8 11.6 14.0 9.2 10.8 13.6 10.3 11.6 10.7 10.5 14.0 7.9 17.3 9.4 14.0 12.8 11.1 10.2 7.2 17.1 15.4 8.4 9.0 16.9 12.9 9.5 4.8 4.3 9.1 5.9 12.9 7.5 2.7 4.4 2.7 7.9 5.3 7.2 13.8 3.7 6.1 12.3 11.2 10.1 4.1 7.0 6.8 2.4 6.6 3.4 8.5 9.6 11.3 6.0 9.7 5.1 9.4 2.8 6.7 3.9 4.4 14.8 8.4 8.7 6.9 15.8 5.9 5.6 10.9 3.0 6.6 4.6 5.5 5.9 4.9 5.5 4.8 12.2 4.6 4.6 6.0 7.2 6.4 6.6 7.0 4.8 4.5 3.0 2.8 4.6 5.4 7.3 9.2 4.2 7.1 8.6 8.2 6.9 3.5 9.1 5.7 5.9 6.0 4.8 6.2 7.2 4.3 4.7 7.5 4.8 2.2 12.9 3.5 2.8 4.0 2.7 12.6 14.7 19.6 14.1 11.7 12.1 19.3 13.3 13.6 17.1 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.1" "Cell line enhanced" "Detected in many" "AF22: 20.9;HEK 293: 12.9;HSkMC: 13.1;SCLC-21H: 14.0;SH-SY5Y: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053358 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA053358: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favourable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 4.5 4.2 21.7 2.1 15.5 1.6 3.7 11.3 23.8 8.0 2.5 7.9 1.4 1.7 16.3 8.6 2.4 7.1 5.6 2.9 17.9 15.6 5.3 13.2 2.5 2.3 10.5 13.2 21.7 5.7 7.6 20.2 5.5 22.3 7.4 3.2 5.0 1.5 6.9 32.1 1.5 1.8 10.9 8.9 1.4 2.0 3.6 14.2 4.2 9.2 0.1 2.4 3.6 5.0 0.7 2.6 0.0 0.2 5.2 1.2 0.4 0.0 0.2 20.9 0.0 4.1 5.7 0.0 1.1 7.2 1.1 0.4 0.0 0.0 0.0 3.0 7.5 0.1 0.1 0.3 0.6 0.0 12.9 9.6 0.0 0.8 1.5 0.0 0.1 13.1 0.0 6.7 0.0 0.5 0.0 0.1 7.7 0.0 0.1 0.0 10.7 0.0 6.1 9.1 0.1 2.0 0.1 14.0 18.8 0.0 0.3 1.8 0.0 1.2 0.0 8.8 9.2 0.1 1.1 3.3 0.4 0.0 1.3 0.0 7.6 0.0 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.4 0.0 0.5 0.3 0.7 0.0 5.2 0.2 2.6 0.0 0.4 21.7 15.5 11.3 23.8 17.9 15.6 10.5 13.2 22.3 14.2 TROVE2 "Ro60, SSA2" ENSG00000116747 "TROVE domain family member 2" P10155 1 193059422-193091777 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002835, HPA005142" Uncertain Approved Nucleoplasm,Cytosol 28000 Cytosol Nucleoplasm "HPA002835: AB_1857490, HPA005142: " "unprognostic (1.91e-2)" "unprognostic (5.11e-2)" "unprognostic (3.94e-3)" "unprognostic (7.34e-2)" "unprognostic (2.34e-2)" "unprognostic (1.41e-1)" "unprognostic (3.62e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-2)" "unprognostic (1.16e-2)" "unprognostic (8.45e-3)" "unprognostic (1.52e-1)" "unprognostic (1.05e-3)" "unprognostic (6.32e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (3.31e-4)" "unprognostic (5.62e-2)" 21.2 13.7 13.3 11.4 16.2 29.7 18.5 13.7 16.5 16.9 12.3 13.2 11.7 8.4 15.3 10.9 16.8 11.3 10.9 18.0 13.9 7.7 14.3 13.6 15.0 13.0 19.6 11.8 19.8 12.1 16.8 13.0 13.6 15.1 17.3 9.4 11.4 14.8 14.7 23.4 16.5 11.6 22.7 20.4 14.7 10.9 24.3 17.0 15.1 14.9 8.7 12.9 19.9 19.8 19.1 13.9 38.3 14.6 19.6 24.3 14.5 8.8 15.9 18.4 17.1 15.9 14.7 11.2 13.5 12.6 9.5 12.7 8.1 12.1 18.4 12.5 15.1 13.7 14.4 10.3 16.7 22.7 11.0 22.2 15.2 10.8 14.6 25.8 16.3 13.7 12.2 17.3 19.3 15.3 24.1 24.7 16.2 14.5 15.4 6.8 13.8 5.2 12.9 15.8 20.9 9.2 18.4 6.5 12.9 16.6 20.2 17.4 16.7 8.9 20.4 18.0 6.6 16.9 17.2 14.5 14.8 17.4 9.7 12.9 27.7 38.3 13.9 17.4 24.3 13.1 23.4 19.1 17.9 20.3 13.9 17.2 19.0 21.2 22.7 19.6 14.6 12.2 17.9 14.5 13.3 16.2 13.7 16.0 13.9 7.7 19.6 11.8 15.1 17.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell line enriched" "Detected in single" 122 "SK-MEL-30: 15.9" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: , HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 32.5;SK-BR-3: 21.4" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" 6500 "Nucleoplasm, Plasma membrane" "HPA041169: " "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favourable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favourable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.1 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 8.0 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 2.4 2.4 1.2 3.5 9.1 0.4 0.5 0.6 6.9 2.2 1.0 0.3 2.4 32.5 0.4 1.1 2.1 21.4 1.1 11.6 2.0 6.1 7.6 4.3 4.2 0.1 2.2 2.2 0.2 4.3 4.0 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Cell line enhanced" "Detected in all" "U-2197: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: " "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.3 8.3 7.0 7.7 20.2 15.2 8.5 10.6 14.7 6.7 8.9 11.4 4.6 18.2 5.2 12.2 14.1 9.3 7.8 9.7 10.1 5.6 14.5 12.8 6.0 18.4 15.0 11.3 14.1 9.2 7.6 14.4 5.4 16.4 14.0 12.2 13.1 9.6 7.3 5.3 5.1 10.6 9.7 8.9 9.4 19.8 5.8 7.4 7.3 11.6 14.2 7.3 16.3 8.2 10.7 5.1 49.9 12.1 9.5 21.0 17.5 11.7 30.7 9.9 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane" "Centrosome, Cytosol" "HPA069550: " "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.5 0.0 0.5 0.1 0.2 0.6 5.3 0.2 0.0 0.0 0.0 4.2 0.9 0.2 1.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.5 0.1 13.0 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 5.5 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.7 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 TRRAP "PAF400, TR-AP, Tra1" ENSG00000196367 "Transformation/transcription domain associated protein" Q9Y4A5 7 98877933-99050831 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054376 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA054376: " "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (2.21e-1)" "unprognostic (4.35e-2)" "unprognostic (2.02e-1)" "unprognostic (2.02e-1)" "prognostic unfavourable (8.77e-4)" "unprognostic (1.40e-2)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "unprognostic (9.45e-2)" "unprognostic (7.02e-2)" "unprognostic (2.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" 9.6 14.2 10.7 18.4 13.4 18.8 14.9 22.8 14.4 14.1 11.3 15.4 10.0 10.6 15.1 10.1 11.3 17.1 11.4 11.4 10.7 9.5 10.8 11.0 13.1 17.1 12.4 9.4 22.4 16.2 26.7 29.9 12.2 9.6 11.8 10.2 13.7 11.8 16.7 11.7 16.9 13.3 16.9 14.2 14.5 11.5 19.3 12.1 37.1 16.6 7.7 19.3 12.8 11.5 2.7 3.1 5.7 0.9 1.3 2.7 0.3 12.1 14.3 14.8 12.5 7.3 7.6 7.4 5.4 7.2 8.5 8.2 11.1 5.4 17.0 8.6 10.0 6.4 15.3 7.4 9.4 9.8 15.0 10.4 10.4 6.4 5.4 18.6 7.7 7.0 4.4 13.9 11.9 10.9 17.7 32.3 7.9 23.5 22.7 7.4 11.3 8.8 16.8 8.5 13.0 4.4 13.6 11.7 14.6 13.7 9.0 4.6 4.5 8.4 11.4 11.4 16.7 15.1 12.5 13.3 15.1 25.2 8.1 9.6 11.3 5.7 0.9 0.6 1.5 0.6 2.7 2.0 2.7 1.3 0.9 2.7 1.9 1.8 2.9 1.3 0.9 3.1 2.0 0.3 10.7 13.4 22.8 14.4 10.7 9.5 12.4 9.4 9.6 12.1 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938193-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Supported "Vesicles,Actin filaments" "Vesicles, Actin filaments" "HPA037914: AB_10672399, HPA057552: " "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.2 29.0 14.7 7.7 19.5 3.3 10.9 11.5 22.0 10.0 8.9 9.2 7.8 8.4 12.6 9.4 9.9 9.6 8.1 20.2 14.7 15.8 15.4 13.0 6.2 8.7 11.0 10.9 16.8 8.3 13.1 9.6 7.0 18.1 11.7 10.2 7.7 9.5 11.3 8.2 6.6 7.6 10.8 10.2 9.6 7.9 17.9 8.0 12.7 11.9 9.2 9.2 8.7 8.3 9.2 6.0 4.0 8.2 10.2 8.5 6.0 13.6 10.7 10.5 26.1 7.6 10.2 14.2 11.8 13.4 16.0 18.2 8.7 14.1 16.9 13.7 9.2 11.7 14.1 14.6 23.8 12.8 15.2 7.8 5.3 15.5 13.1 14.5 11.7 10.4 20.2 11.3 22.5 9.0 8.0 6.9 18.9 6.6 13.5 11.6 9.9 10.6 13.6 26.6 10.3 21.1 6.9 9.8 10.9 9.9 14.7 25.7 11.7 9.0 8.0 7.4 7.4 11.7 14.3 13.3 10.7 14.2 10.4 18.6 6.6 4.0 3.3 1.1 6.0 5.1 8.5 9.2 6.4 6.3 6.0 7.1 8.5 7.8 0.3 10.2 8.2 5.4 7.6 6.0 14.7 19.5 11.5 22.0 14.7 15.8 11.0 10.9 18.1 8.0 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 262.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "basophil: 12.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.0" "Low region specificity" "Detected in all" HPA029897 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 262.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.0 2.1 12.0 0.6 2.3 2.1 0.4 3.4 4.6 2.0 2.3 1.5 2.8 3.8 1.6 1.0 2.3 2.5 4.2 2.4 5.0 2.7 1.0 3.9 3.9 0.5 2.1 2.9 8.5 3.4 6.8 4.5 1.0 3.1 3.0 1.0 6.6 2.3 3.0 0.7 9.3 3.2 0.4 5.8 3.0 1.8 6.4 5.6 3.5 0.8 4.9 5.8 2.1 3.1 1.7 2.4 6.5 2.6 3.5 3.3 1.7 1.4 2.4 1.2 2.3 5.8 9.3 7.5 0.9 1.7 1.3 12.0 0.5 0.1 1.5 0.3 0.7 1.7 1.1 1.3 0.3 2.0 2.1 1.8 0.2 2.3 0.6 2.1 1.2 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 TSC22D1 "MGC17597, TGFB1I4, TSC22" ENSG00000102804 "TSC22 domain family member 1" Q15714 13 44432143-44577147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.7" "Group enriched" "Detected in all" 5 "dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077414 Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA077414: " "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (5.22e-2)" "unprognostic (4.78e-3)" "unprognostic (6.30e-2)" "unprognostic (2.04e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (7.97e-4)" "unprognostic (4.24e-2)" "unprognostic (9.08e-2)" "prognostic favourable (4.54e-4)" "unprognostic (8.14e-2)" "unprognostic (6.52e-2)" "unprognostic (1.83e-2)" "unprognostic (4.48e-2)" 43.1 38.6 71.6 23.7 82.3 6.6 56.6 32.6 94.8 73.7 49.9 27.9 14.1 27.3 68.3 62.5 46.4 67.6 49.7 54.1 64.2 63.9 46.3 36.7 37.7 14.1 71.2 49.2 63.7 15.5 44.7 36.4 40.8 54.6 72.6 47.7 56.6 31.0 39.5 49.6 20.4 48.6 64.4 46.0 11.1 36.7 27.9 38.6 31.7 38.2 24.3 17.4 39.7 31.6 1.1 8.9 17.7 2.3 7.9 2.5 24.6 5.3 17.1 16.7 6.8 10.7 13.3 19.4 5.9 24.5 6.5 6.9 19.1 19.1 8.9 12.5 14.2 13.6 7.2 48.4 9.1 1.7 5.6 61.0 31.2 5.8 9.9 3.5 7.8 19.9 21.1 17.3 42.4 14.6 1.6 0.0 12.2 5.4 11.0 2.8 11.8 16.0 7.9 3.3 2.6 12.9 8.9 8.7 11.8 16.3 16.2 4.7 7.9 4.9 12.7 7.3 6.7 15.0 8.7 0.1 1.6 2.8 18.4 2.9 16.8 17.7 1.0 2.7 2.5 0.9 2.4 0.7 0.8 1.1 0.9 1.1 0.9 1.3 4.8 7.9 2.3 8.9 1.5 24.6 71.6 82.3 32.6 94.8 64.2 63.9 71.2 49.2 54.6 38.6 TSC22D3 "DIP, DSIPI, GILZ, hDIP, TSC-22R" ENSG00000157514 "TSC22 domain family member 3" Q99576 X 107713221-107777342 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 57.8;ASC TERT1: 39.8;HHSteC: 95.7;hTCEpi: 85.2;Karpas-707: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001916, CAB034364" Approved Approved "Nuclear speckles,Golgi apparatus,Cytosol" Cytosol "Nuclear speckles, Golgi apparatus" "CAB034364: AB_2272198, HPA001916: " "unprognostic (3.67e-2)" "unprognostic (3.90e-3)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.43e-4)" "unprognostic (3.49e-2)" "unprognostic (3.21e-2)" "unprognostic (3.73e-3)" "unprognostic (4.40e-2)" "unprognostic (9.42e-2)" "unprognostic (5.32e-2)" "unprognostic (3.25e-1)" "unprognostic (7.47e-2)" "unprognostic (6.38e-2)" "unprognostic (1.37e-3)" "unprognostic (6.41e-2)" "unprognostic (4.14e-1)" "unprognostic (9.64e-2)" 69.1 48.4 18.2 72.7 21.0 72.4 142.4 31.8 32.7 53.3 49.0 10.6 36.7 16.7 37.2 26.6 58.7 45.4 47.8 42.6 18.8 12.2 33.8 20.9 83.3 98.8 22.0 16.2 54.6 20.0 7.1 18.8 31.3 20.8 51.8 37.2 39.8 172.4 40.7 163.5 65.2 54.6 45.4 22.9 55.7 49.3 20.3 19.2 29.7 59.8 36.1 62.7 75.3 89.6 47.9 31.7 191.5 62.4 69.0 82.4 105.1 1.5 2.6 1.3 3.7 57.8 39.8 0.5 2.4 2.0 1.1 1.2 0.0 5.2 3.3 6.0 1.9 7.8 2.8 7.8 0.5 1.0 1.3 1.6 11.0 0.1 95.7 0.3 5.6 36.2 85.2 0.9 23.8 4.3 0.5 53.8 9.8 5.3 0.1 5.7 2.4 1.7 0.1 3.4 7.0 3.8 1.0 0.3 3.0 2.4 13.2 18.1 2.5 7.5 6.4 3.5 1.0 0.7 0.4 11.8 5.1 1.5 1.8 6.7 0.9 42.7 34.0 126.9 55.2 40.4 40.6 47.9 63.4 53.6 31.7 45.5 59.6 55.4 191.5 69.0 62.4 6.4 82.4 105.1 18.2 21.0 31.8 32.7 18.8 12.2 22.0 16.2 20.8 19.2 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favourable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 14.2 17.5 20.6 13.2 22.1 16.2 17.3 14.0 34.0 16.4 16.8 25.4 7.8 11.2 16.7 24.5 12.7 13.9 12.3 17.2 22.1 19.0 12.8 14.2 15.9 16.3 27.6 16.6 15.0 19.2 13.0 13.4 16.0 20.7 16.3 11.8 13.2 13.9 14.5 31.8 13.7 10.3 15.0 34.5 13.4 13.9 12.4 24.2 20.8 19.4 15.4 15.2 13.7 12.5 14.0 20.2 15.9 14.2 28.2 21.9 17.6 22.5 7.5 9.8 12.1 8.2 7.8 28.0 10.8 19.5 16.4 16.2 7.1 9.9 14.7 11.9 12.1 10.4 10.6 9.1 16.8 21.5 6.8 6.7 5.7 9.3 15.1 26.2 9.4 5.3 17.7 7.2 15.0 9.1 14.8 41.2 14.5 10.9 26.1 13.3 21.0 8.6 16.5 16.4 31.0 10.4 7.6 10.2 15.1 14.1 11.3 27.3 14.3 16.5 4.6 10.9 24.6 7.4 17.3 56.0 38.3 22.4 10.4 14.7 23.7 15.9 9.8 13.5 20.4 14.2 17.6 14.0 19.3 20.9 20.2 10.4 15.0 20.4 1.8 28.2 13.0 18.1 21.9 17.6 20.6 22.1 14.0 34.0 22.1 19.0 27.6 16.6 20.7 24.2 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484432-12539623 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favourable (3.49e-4)" 8.8 10.6 9.7 8.8 19.1 6.7 10.9 16.5 14.0 10.4 9.8 12.7 8.4 5.8 14.0 9.9 7.9 12.8 10.3 14.3 10.5 12.3 9.8 7.3 7.3 10.9 11.5 7.6 18.0 11.9 14.3 15.3 4.9 10.2 10.5 10.9 13.5 7.2 13.1 16.7 15.3 6.1 12.3 12.3 6.1 8.5 11.3 9.1 9.9 12.5 9.6 8.1 8.6 8.3 8.5 7.1 2.6 4.2 5.0 13.7 5.6 8.0 14.0 7.5 9.9 12.8 13.6 17.4 7.6 6.7 8.1 5.9 7.9 8.6 9.7 5.3 6.2 7.5 12.5 13.0 9.3 7.6 15.6 10.6 18.8 8.1 9.9 16.6 4.1 11.7 15.1 14.8 18.2 6.5 15.6 5.3 9.4 15.1 12.6 7.6 10.6 16.9 9.6 5.2 19.3 12.2 8.2 4.9 8.6 7.0 6.3 5.9 11.4 11.6 5.8 5.2 5.1 7.1 11.7 5.0 12.7 12.0 7.0 16.7 6.5 2.4 4.2 0.3 6.4 4.2 10.9 8.5 9.8 7.4 5.9 8.3 13.7 11.7 2.6 5.0 3.6 7.1 3.5 5.6 9.7 19.1 16.5 14.0 10.5 12.3 11.5 7.6 10.2 9.1 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 153.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favourable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.2 9.6 5.8 8.6 5.4 5.4 8.4 6.9 6.2 11.3 7.9 11.2 10.9 20.7 13.3 6.1 9.8 9.7 10.0 8.6 8.4 11.8 12.6 8.1 9.8 8.2 16.0 7.6 6.2 10.2 8.6 4.9 7.0 16.2 11.2 8.5 9.5 9.5 17.4 8.8 12.8 11.6 153.6 18.5 10.7 9.4 12.5 7.7 7.4 13.1 12.6 22.7 11.7 5.1 6.2 8.7 9.0 7.4 8.3 17.0 16.1 8.7 9.7 7.3 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavourable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favourable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.3 23.7 21.0 14.6 24.9 26.0 19.5 22.3 30.1 27.3 27.0 16.2 7.6 19.4 13.7 24.8 22.0 20.9 20.2 30.4 27.2 25.5 12.0 12.5 23.8 32.0 18.0 20.8 22.4 41.1 14.2 38.8 22.4 19.5 16.5 33.0 25.9 11.4 19.6 12.9 24.0 10.3 21.2 16.1 18.3 20.5 15.0 26.9 21.4 18.0 28.5 17.9 18.1 12.0 18.3 11.2 38.2 16.5 10.6 20.4 15.4 18.9 10.0 23.4 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972407-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 19.4;ASC diff: 8.5;HeLa: 17.0;SiHa: 11.0;U-2197: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in many" 4 "T-cells: 6.1" "Low region specificity" "Detected in many" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 16.2 12.3 2.8 5.7 3.5 0.2 10.3 1.0 9.8 12.9 7.4 1.8 27.7 2.0 11.8 15.9 7.6 7.3 11.4 3.9 4.8 3.5 2.7 11.1 3.0 3.6 3.5 5.8 17.2 3.4 2.1 2.6 1.2 4.6 7.6 1.9 0.1 11.2 35.8 3.9 4.9 3.1 8.3 14.3 4.4 4.4 9.6 2.5 0.0 5.0 5.8 3.0 9.0 16.5 0.9 0.3 1.3 0.1 0.2 6.1 1.0 0.0 0.0 1.3 19.4 8.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.6 1.0 0.0 17.0 0.0 0.2 0.0 0.4 3.1 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 10.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.8 4.1 0.2 0.0 0.9 6.1 0.4 1.3 0.2 0.1 0.3 4.3 1.0 2.8 3.5 1.0 9.8 4.8 3.5 3.5 5.8 4.6 2.5 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31274945-31349547 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.7;RH-30: 26.1;U-138 MG: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 35 "granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 20.4;hippocampal formation: 16.8" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavourable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 5.7 3.3 4.4 4.0 6.6 1.0 5.2 1.1 17.3 13.0 11.6 0.7 2.4 2.5 19.4 8.5 5.6 9.5 11.5 4.6 3.3 2.0 2.8 1.3 4.9 1.2 1.6 8.0 28.0 1.5 1.1 7.2 4.8 2.8 9.5 3.7 4.9 2.8 8.9 1.6 2.5 4.3 16.4 3.3 4.5 6.1 3.3 1.2 0.0 8.5 1.7 0.7 11.1 11.4 0.0 0.0 4.9 2.2 0.0 3.2 0.7 0.0 1.1 0.4 0.0 5.8 12.7 0.0 3.3 4.8 2.1 3.7 0.0 0.7 0.0 0.0 8.2 0.5 1.5 3.1 4.6 0.0 1.3 0.0 0.0 0.0 11.2 2.8 5.2 7.5 2.8 7.6 3.9 0.0 0.0 0.0 9.6 0.5 0.0 0.0 0.5 0.0 3.2 26.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 2.5 0.0 1.9 0.0 18.5 5.9 2.1 4.7 0.0 0.0 0.0 12.0 4.8 0.5 0.0 2.2 0.0 3.2 0.8 0.1 0.0 0.9 1.0 0.0 0.0 0.3 0.8 4.9 0.0 0.4 0.0 0.7 0.7 4.4 6.6 1.1 17.3 3.3 2.0 1.6 8.0 2.8 1.2 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798154 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.8" "Cell line enhanced" "Detected in many" "A549: 42.5;ASC diff: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted - unknown location" 2100000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favourable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavourable (2.87e-4)" "prognostic favourable (1.66e-4)" "prognostic unfavourable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 33.1 2.8 1.0 3.6 1.4 0.6 26.9 1.5 2.0 38.8 16.1 1.8 6.4 11.5 13.2 25.5 17.8 15.3 8.6 9.3 1.2 0.3 31.8 86.8 5.1 3.7 1.7 1.3 27.8 12.2 2.6 4.3 43.0 3.4 15.7 4.5 48.5 9.3 10.8 7.0 15.0 21.4 13.0 0.8 3.0 8.7 9.0 0.8 1.5 12.2 16.0 12.4 18.2 27.9 1.8 0.7 2.1 0.4 0.7 1.3 0.2 0.8 42.5 4.7 4.6 72.7 9.3 8.7 1.4 8.0 3.1 3.0 5.5 11.7 0.1 8.3 5.3 17.0 2.7 10.4 1.0 8.7 1.4 2.0 11.0 15.2 13.7 0.7 3.2 9.5 11.5 5.6 4.6 3.9 4.6 0.3 2.9 19.6 0.1 1.5 6.2 1.8 1.4 4.5 6.7 7.4 7.4 4.3 7.1 8.1 6.4 3.8 8.5 0.6 1.2 8.9 7.1 21.7 3.4 0.3 0.1 0.3 4.2 2.2 1.6 1.8 0.4 0.5 0.9 0.2 0.4 1.8 0.8 0.7 0.4 1.8 0.9 1.3 2.1 0.7 0.4 0.7 0.8 0.2 1.0 1.4 1.5 2.0 1.2 0.3 1.7 1.3 3.4 0.8 TSLP ENSG00000145777 "Thymic stromal lymphopoietin" Q969D9 5 111070062-111078024 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.0;HHSteC: 13.6;hTCEpi: 8.1;hTEC/SVTERT24-B: 17.2;hTERT-HME1: 9.8;U-87 MG: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" HPA056350 Uncertain "Golgi apparatus,Vesicles" "Secreted to blood" 38400 "Golgi apparatus, Vesicles" "HPA056350: " "unprognostic (6.47e-4)" "unprognostic (3.26e-1)" "unprognostic (6.57e-2)" "unprognostic (1.93e-1)" "unprognostic (5.03e-2)" "unprognostic (7.72e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-2)" "unprognostic (5.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-1)" "unprognostic (1.88e-1)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (2.76e-1)" "unprognostic (1.74e-3)" 5.1 1.7 0.7 2.0 1.1 0.2 19.1 0.5 0.8 5.4 4.6 1.4 6.6 1.5 4.2 0.7 14.1 1.1 14.1 18.7 1.4 0.8 1.6 17.3 4.6 1.8 1.2 1.7 1.1 0.8 0.2 1.5 0.4 2.3 16.4 1.7 1.0 3.5 6.8 2.3 1.7 2.7 12.6 4.6 1.0 2.6 7.9 1.1 0.3 4.1 3.2 2.3 10.0 6.0 0.0 0.0 0.0 0.5 0.0 2.1 0.3 0.0 0.0 0.0 1.4 1.8 12.0 0.0 0.0 1.7 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.6 0.0 1.8 2.1 0.1 0.0 13.6 0.3 0.0 0.3 8.1 17.2 9.8 0.0 0.2 0.0 2.4 0.0 1.8 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 3.2 0.0 0.0 11.1 0.2 0.5 0.0 0.5 0.0 0.9 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.1 0.5 0.8 1.4 0.8 1.2 1.7 2.3 1.1 TSN "BCLF-1, REHF-1, TRSLN" ENSG00000211460 Translin Q15631 2 121737103-121767853 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059561 Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" 320000 "Nucleoplasm, Endoplasmic reticulum" "HPA059561: " "unprognostic (3.15e-2)" "unprognostic (1.83e-1)" "unprognostic (3.53e-1)" "prognostic unfavourable (7.05e-4)" "unprognostic (7.13e-3)" "unprognostic (3.12e-2)" "prognostic unfavourable (3.06e-4)" "unprognostic (2.32e-2)" "unprognostic (7.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.10e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (6.48e-2)" "unprognostic (1.04e-2)" "unprognostic (3.42e-2)" "unprognostic (3.18e-1)" 14.9 18.7 23.1 13.0 24.6 43.0 25.6 17.8 27.7 18.6 23.1 23.7 11.8 17.2 17.9 19.1 18.2 15.2 16.3 18.7 20.6 23.0 24.7 22.0 15.0 22.6 22.8 20.1 17.5 20.7 19.3 17.9 13.8 23.3 15.0 18.9 16.5 16.3 18.2 29.4 18.9 16.4 14.3 22.0 17.5 15.4 33.9 17.6 28.3 17.2 18.7 17.4 13.9 14.2 22.1 22.7 22.0 24.4 19.6 23.1 20.7 21.4 9.7 14.4 12.1 13.3 10.6 8.0 18.4 16.7 19.3 19.1 27.1 11.8 29.9 21.7 16.5 10.0 21.0 16.9 26.8 16.6 17.2 17.6 14.0 24.2 14.9 24.6 12.6 9.0 18.7 21.9 14.5 15.8 26.6 14.3 17.4 11.0 14.9 27.6 17.5 18.5 25.2 16.1 22.0 23.3 14.2 18.9 11.8 12.0 17.3 20.6 11.5 18.4 11.8 13.9 23.7 9.2 17.3 13.3 37.7 33.5 16.1 16.7 16.8 17.2 24.4 22.0 19.6 22.2 22.7 22.1 20.4 17.0 22.7 18.0 23.1 20.1 7.9 19.6 19.0 16.5 20.2 20.7 23.1 24.6 17.8 27.7 20.6 23.0 22.8 20.1 23.3 17.6 TSNAX TRAX ENSG00000116918 "Translin associated factor X" Q99598 1 231528653-231566524 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA024613, HPA031054, HPA031055, CAB034263" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" 100000 Nucleoplasm "Golgi apparatus, Cytosol" "CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314" "unprognostic (6.28e-3)" "unprognostic (5.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.12e-1)" "unprognostic (5.55e-2)" "unprognostic (2.27e-1)" "unprognostic (2.96e-2)" "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (2.42e-3)" "unprognostic (4.51e-2)" "unprognostic (1.91e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (4.98e-2)" "unprognostic (6.52e-3)" "unprognostic (2.70e-2)" 27.4 29.9 23.9 17.1 26.7 12.0 23.4 28.0 33.1 19.7 16.2 21.9 17.2 15.8 20.0 24.6 18.0 16.4 16.7 22.7 25.1 23.9 29.1 23.0 18.4 22.6 22.1 22.1 18.6 14.6 32.3 36.0 18.3 28.5 21.3 18.0 19.6 17.5 19.9 52.5 20.6 14.8 18.9 28.2 24.0 15.5 17.5 24.4 24.5 26.7 25.4 22.0 19.1 17.3 10.0 11.7 54.6 17.5 18.7 13.5 11.0 11.0 9.1 13.9 11.4 10.3 12.7 15.8 12.6 19.1 16.2 14.0 7.8 15.6 15.6 21.3 13.7 12.1 11.0 11.4 21.1 13.9 19.2 15.0 9.4 10.3 14.2 24.8 31.9 15.5 12.6 15.7 12.1 11.8 24.3 11.1 21.9 4.5 15.9 12.1 20.5 11.1 15.8 15.3 21.1 18.1 12.8 13.3 25.6 13.2 16.7 42.4 24.3 42.0 10.9 11.2 10.2 22.4 22.6 18.9 24.9 17.4 18.3 19.6 30.6 54.6 11.2 29.2 11.4 13.5 10.8 10.0 12.3 11.2 11.7 9.9 13.2 12.7 11.4 18.7 17.5 6.8 13.5 11.0 23.9 26.7 28.0 33.1 25.1 23.9 22.1 22.1 28.5 24.4 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 40.6" "Cell line enhanced" "Detected in many" "AN3-CA: 6.9;SiHa: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053516 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053516: " "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favourable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.9 1.9 4.8 1.1 9.2 0.6 0.9 2.0 3.9 1.3 0.9 3.3 1.9 0.5 1.8 3.6 0.7 14.2 1.2 0.7 3.8 3.3 1.6 0.8 2.1 0.7 1.2 3.7 2.5 2.2 2.9 6.9 0.7 6.3 1.0 0.7 1.0 1.0 2.0 0.5 0.8 0.6 1.2 0.9 0.8 1.2 40.6 2.5 0.0 1.1 0.0 0.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.4 1.1 0.4 2.5 6.9 3.5 0.9 0.9 0.0 1.6 0.5 2.4 0.7 0.8 1.0 1.0 0.2 1.3 1.0 1.1 1.5 0.3 0.9 0.0 0.8 0.1 1.1 1.6 0.2 0.8 0.9 3.5 0.5 0.0 0.5 0.3 0.0 0.0 0.3 0.6 0.7 0.4 1.7 0.7 0.1 3.5 0.6 2.0 2.1 4.4 0.1 0.4 1.8 0.1 0.8 0.4 0.1 0.3 0.2 1.2 2.1 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.8 9.2 2.0 3.9 3.8 3.3 1.2 3.7 6.3 2.5 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell line enhanced" "Detected in some" "A-431: 21.2;CAPAN-2: 36.7;HaCaT: 25.6;hTCEpi: 29.8;RPTEC TERT1: 107.6;RT4: 51.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.7 0.0 6.9 0.0 25.6 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.2 107.6 51.6 0.3 0.0 0.0 2.2 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 TSPAN12 "NET-2, TM4SF12" ENSG00000106025 "Tetraspanin 12" O95859 7 120787320-120858402 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 20.8;HUVEC TERT2: 23.2;RH-30: 21.3;RPTEC TERT1: 34.0;RT4: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051570, HPA058244" Uncertain Approved Vesicles,Microtubules Microtubules Vesicles "HPA051570: , HPA058244: AB_2683652" "unprognostic (2.40e-2)" "unprognostic (7.60e-2)" "unprognostic (3.66e-3)" "unprognostic (1.82e-2)" "unprognostic (3.97e-1)" "unprognostic (7.34e-3)" "unprognostic (1.60e-1)" "unprognostic (8.12e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (9.53e-2)" "unprognostic (7.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.18e-2)" "unprognostic (1.43e-1)" 6.8 40.9 3.1 4.3 3.9 0.0 4.5 2.2 3.3 8.1 19.3 2.1 36.8 13.5 6.1 8.7 3.6 3.7 13.6 22.2 3.2 2.7 40.7 12.6 16.9 1.6 2.7 2.3 2.5 12.8 1.1 10.3 9.9 3.3 7.9 7.1 2.9 33.7 15.1 2.3 1.2 31.0 4.1 1.8 18.4 7.6 3.0 2.2 0.5 18.7 3.5 3.2 10.4 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 6.1 0.1 1.3 0.4 5.9 0.1 0.2 0.5 2.0 0.9 1.5 0.0 4.2 0.1 0.1 3.1 0.6 0.7 0.0 20.8 1.1 6.1 0.8 3.3 0.0 1.0 0.1 0.0 0.1 0.1 23.2 0.2 0.7 2.7 0.7 0.0 0.1 9.7 3.7 0.0 21.3 0.7 34.0 25.9 5.0 2.9 0.2 0.5 0.0 3.1 0.7 1.0 5.0 1.5 0.0 2.5 6.4 0.0 0.0 0.7 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.9 2.2 3.3 3.2 2.7 2.7 2.3 3.3 2.2 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.8;EFO-21: 48.5;MCF7: 36.6;PC-3: 60.3;SK-BR-3: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044657 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044657: AB_10967927" "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavourable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.1 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 9.9 34.8 0.0 48.5 0.5 22.7 1.6 2.5 0.7 9.1 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 8.9 0.2 0.0 0.2 36.6 0.1 0.2 0.6 60.3 0.8 0.4 0.4 6.7 20.6 7.9 3.0 0.1 30.6 3.8 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 21.0 57.5 47.8 30.1 84.0 51.7 15.8 33.8 36.8 41.7 45.6 35.0 44.1 20.7 50.3 34.8 47.9 45.3 23.1 31.4 23.2 68.7 14.8 44.1 33.1 40.8 19.0 10.9 48.7 28.0 23.0 20.5 50.9 15.6 18.3 40.7 8.0 16.8 18.1 33.8 25.6 21.2 59.4 21.8 68.5 12.0 43.4 48.0 23.1 19.6 62.8 21.0 36.1 48.2 38.7 15.1 23.3 47.2 40.3 54.8 11.0 34.3 28.5 22.0 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 59.0" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: " "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavourable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favourable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.5 8.7 8.9 2.2 20.7 13.6 5.8 5.6 7.5 3.0 3.0 6.0 19.2 3.2 12.6 13.0 7.4 2.3 12.0 4.3 8.5 6.3 4.4 7.2 2.5 20.4 4.3 7.6 12.0 14.2 5.9 12.5 8.0 3.1 9.4 9.8 7.2 3.3 2.5 1.9 2.8 4.2 59.0 8.4 12.5 7.3 3.1 7.6 6.1 8.9 4.4 16.8 6.8 10.9 4.9 4.1 2.6 3.0 11.7 2.6 1.5 13.3 2.9 7.4 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Cell line enhanced" "Detected in many" "NTERA-2: 42.7;RT4: 64.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.8 10.5 28.3 14.3 12.4 6.7 11.5 4.5 7.0 8.9 20.8 23.5 13.7 0.0 18.8 4.6 6.4 0.1 8.5 10.5 0.0 15.2 1.4 6.8 26.1 6.9 0.0 1.1 13.2 4.1 7.8 3.0 18.9 0.0 0.0 9.1 8.1 0.0 0.1 42.7 7.9 0.0 13.4 0.0 13.9 64.4 1.8 7.7 4.4 3.9 6.0 5.7 1.0 5.3 5.6 8.5 9.1 2.9 0.0 0.0 0.0 4.9 0.0 3.9 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell line enhanced" "Detected in many" "RH-30: 62.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 5.9 5.0 4.9 4.6 13.9 6.7 20.3 4.3 5.7 8.1 3.1 0.2 6.7 3.9 0.9 2.3 2.5 2.6 1.0 2.6 9.1 2.7 5.7 13.3 0.0 0.7 5.9 2.1 8.9 4.2 14.8 0.2 0.2 3.8 5.2 0.0 0.2 8.3 1.8 2.7 62.6 0.8 18.1 1.5 10.5 7.1 4.4 11.3 4.3 3.9 0.0 8.7 2.4 7.2 3.8 6.3 0.0 0.0 0.0 6.0 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260" Uncertain Approved Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" Vesicles "CAB011232: , HPA046260: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.1 23.4 1.6 22.2 8.9 29.6 1.7 35.3 17.3 17.8 18.9 4.5 36.1 0.0 24.4 27.3 39.1 4.4 27.3 2.3 7.9 18.4 4.8 25.7 1.6 32.4 10.7 24.2 22.9 45.1 10.5 9.4 42.0 3.9 8.9 18.2 39.4 0.1 29.9 1.9 58.4 10.6 0.0 80.5 22.6 28.5 2.3 10.9 16.7 33.4 41.1 12.5 41.5 43.3 22.0 16.5 22.5 14.8 3.6 0.6 0.4 28.6 34.8 28.2 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116276578-116279903 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031970, HPA031971" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092, HPA031971: AB_10602484" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favourable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favourable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 14.0 34.1 38.3 9.8 67.2 18.5 14.4 49.1 64.5 15.2 12.8 9.8 20.1 14.7 13.9 21.4 15.4 20.3 12.9 21.4 34.6 36.6 31.5 23.5 12.9 11.8 21.8 49.8 22.9 17.6 41.3 17.2 9.7 31.1 27.1 11.3 13.3 17.2 22.6 61.6 11.2 12.9 17.1 11.5 15.6 15.3 12.9 12.2 9.8 25.0 15.5 15.2 14.6 12.9 30.7 24.6 52.9 29.4 17.4 36.2 17.0 13.0 12.8 16.5 30.1 29.3 19.4 13.9 20.9 20.9 19.2 22.1 16.5 9.5 27.9 26.3 24.1 23.1 13.0 35.7 20.6 11.3 33.8 11.2 18.9 29.9 18.6 18.3 6.8 22.6 28.0 19.8 19.3 18.2 19.7 21.7 26.7 28.6 12.2 10.8 8.2 12.0 11.3 14.3 15.2 33.2 25.4 14.5 14.3 17.4 23.4 10.0 30.7 22.9 22.0 12.9 11.6 10.4 22.6 11.9 12.9 15.3 21.5 11.9 8.4 52.9 17.8 27.2 24.2 27.7 36.2 25.9 31.7 26.7 14.3 30.7 31.3 30.4 13.5 17.4 29.4 24.6 23.7 17.0 38.3 67.2 49.1 64.5 34.6 36.6 21.8 49.8 31.1 12.2 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273474-97277964 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell line enhanced" "Detected in some" "K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6;U-2 OS: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favourable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favourable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 5.5 8.3 9.0 4.0 19.7 1.3 11.3 8.4 24.0 11.5 8.0 9.3 20.1 1.9 14.2 14.9 4.5 11.9 6.3 11.1 9.1 15.0 8.5 1.9 6.6 5.5 8.6 9.1 23.9 8.0 5.5 12.8 4.1 17.4 14.6 3.4 7.1 8.7 17.7 10.5 3.8 3.7 13.3 7.1 6.4 7.4 46.4 5.2 6.3 7.9 4.4 6.6 9.8 4.6 1.5 2.3 0.7 0.5 1.0 1.3 0.4 0.0 7.4 0.0 0.0 0.2 0.2 0.0 5.8 0.0 5.8 3.8 0.0 0.2 0.0 8.1 6.9 2.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 9.4 0.0 8.2 0.0 0.0 13.7 0.0 0.2 10.7 0.0 0.0 0.0 0.1 10.5 0.0 0.0 4.9 0.0 29.2 22.6 0.0 1.9 0.0 0.0 0.9 0.0 0.0 12.7 0.0 0.0 6.9 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.5 0.0 0.7 0.5 0.1 2.3 1.5 1.3 0.5 0.0 1.0 0.2 2.2 1.1 0.4 9.0 19.7 8.4 24.0 9.1 15.0 8.6 9.1 17.4 5.2 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Cell line enriched" "Detected in single" 131 "K-562: 13.1" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034699: , HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favourable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.4 26.2 19.2 17.4 17.3 12.5 17.1 20.3 16.5 18.9 16.3 24.7 22.4 22.4 14.1 17.7 21.2 46.9 28.1 25.3 29.1 23.2 18.2 19.6 19.2 10.7 31.5 19.1 11.6 15.4 26.4 27.3 13.2 18.5 16.8 19.2 37.5 24.0 24.8 30.5 29.8 21.6 35.7 18.9 20.1 18.2 24.2 16.8 38.6 19.3 21.5 39.3 11.0 17.9 13.9 24.5 29.2 17.3 18.0 27.1 26.8 20.5 25.1 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 TSR3 "C16orf42, MGC24381" ENSG00000007520 "TSR3, acp transferase ribosome maturation factor" Q9UJK0 16 1349240-1351911 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040760, HPA046265" Uncertain Approved "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA040760: , HPA046265: AB_10963942" "unprognostic (4.04e-1)" "unprognostic (2.00e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (4.74e-2)" "unprognostic (4.44e-1)" "unprognostic (1.40e-2)" "unprognostic (1.12e-2)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (6.07e-2)" "unprognostic (8.32e-2)" "unprognostic (3.92e-2)" "unprognostic (9.72e-2)" "unprognostic (3.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.14e-1)" 25.1 17.9 23.3 16.6 23.2 13.0 26.1 14.3 28.0 13.1 19.1 18.4 19.7 21.8 14.1 18.2 19.9 15.1 15.4 25.2 21.6 16.9 17.5 19.3 15.7 28.6 22.7 14.2 15.2 39.6 13.0 12.7 13.9 16.4 16.8 8.4 14.2 35.0 18.9 64.6 16.3 17.7 19.3 18.0 17.1 21.3 12.2 13.5 14.5 15.0 20.8 17.6 15.7 17.8 8.9 5.5 11.9 4.5 2.4 7.1 1.8 21.0 23.5 9.7 12.9 11.6 14.2 16.5 19.7 8.7 14.0 13.0 25.9 21.5 13.4 26.4 13.1 22.2 8.8 16.3 4.9 26.0 40.5 5.9 19.3 20.3 21.1 12.7 11.7 14.9 23.5 12.6 12.4 15.2 18.8 11.8 11.5 37.6 18.5 21.5 16.4 28.6 33.1 11.9 36.2 12.3 8.4 15.4 19.9 15.1 19.0 24.6 18.2 15.9 16.6 23.3 25.1 19.8 23.9 25.3 16.8 17.7 11.8 15.3 15.7 11.1 4.5 11.9 5.3 3.7 6.7 7.2 6.7 4.9 3.6 8.9 7.1 6.5 11.8 2.4 3.9 5.5 4.8 1.8 23.3 23.2 14.3 28.0 21.6 16.9 22.7 14.2 16.4 13.5 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: " "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavourable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 25.6 11.7 12.1 13.9 12.5 33.0 13.2 10.7 20.9 17.5 21.5 12.7 10.9 15.9 20.6 13.3 16.7 16.4 15.1 23.2 11.9 11.0 14.1 19.4 13.8 16.8 15.2 12.7 17.7 20.9 10.3 14.7 19.8 11.2 18.2 5.6 13.1 20.2 19.0 32.5 16.2 16.1 19.0 10.5 18.5 14.0 29.1 10.7 21.7 22.7 25.2 14.7 20.2 36.2 54.0 44.9 55.3 44.7 43.0 49.0 37.3 19.5 24.6 8.0 12.8 6.8 5.0 15.5 13.4 9.3 16.3 11.3 18.1 25.4 14.3 11.9 10.6 19.5 9.3 15.5 3.1 16.3 25.6 8.3 13.0 18.4 18.7 14.2 17.5 12.0 22.4 10.4 10.0 11.3 18.8 16.0 7.7 25.3 16.9 25.9 23.4 28.9 19.3 7.2 12.7 8.2 16.5 21.0 21.4 11.4 25.9 15.6 13.6 16.8 14.8 21.7 11.2 20.1 15.5 32.4 27.8 12.0 18.6 14.6 22.5 55.3 44.7 43.8 46.1 38.2 49.0 43.5 45.9 47.2 44.9 54.0 41.4 39.0 43.2 43.0 40.1 43.3 47.8 37.3 12.1 12.5 10.7 20.9 11.9 11.0 15.2 12.7 11.2 10.7 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: " "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.6 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 0.0 3.1 5.8 0.0 0.6 1.4 1.5 1.5 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 TSTA3 "FX, P35B, SDR4E1" ENSG00000104522 "Tissue specific transplantation antigen P35B" Q13630 8 143612618-143618048 "Enzymes, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol 600000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favourable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 9.4 12.0 7.0 9.5 10.1 16.3 10.2 6.1 13.8 8.6 18.7 8.4 16.6 24.8 8.4 9.9 28.0 7.7 23.7 15.7 8.1 7.8 11.7 40.0 8.9 16.5 6.8 8.1 9.7 60.1 6.4 14.2 21.9 12.2 13.9 14.9 9.5 35.4 14.2 16.8 28.4 20.2 6.9 4.7 11.3 35.5 24.6 5.6 14.7 13.0 17.8 24.8 9.8 10.4 18.7 25.6 17.7 21.0 28.1 26.9 20.5 17.5 12.8 6.5 19.3 5.4 5.2 12.0 14.6 14.3 10.4 7.8 15.7 18.8 7.7 14.3 10.3 12.6 9.7 19.8 4.7 19.9 14.1 11.4 22.7 18.1 11.1 7.6 13.0 6.5 10.2 7.0 25.0 16.8 12.6 11.2 7.8 53.3 9.9 11.5 8.8 17.6 11.3 4.9 23.7 20.9 17.6 13.3 10.4 10.0 19.7 14.6 25.0 11.1 14.1 6.9 27.4 8.2 14.0 8.4 6.0 5.6 10.6 17.4 10.3 10.5 15.9 17.7 21.0 21.0 21.2 16.1 22.7 22.6 18.0 18.7 16.9 18.7 16.3 28.1 16.3 25.6 26.9 20.5 7.0 10.1 6.1 13.8 8.1 7.8 6.8 8.1 12.2 5.6 TSTD1 KAT ENSG00000215845 "Thiosulfate sulfurtransferase like domain containing 1" Q8NFU3 1 161037631-161038990 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.4;SK-BR-3: 52.8;T-47d: 51.0;U-266/70: 59.6;U-266/84: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in some" 4 "olfactory region: 8.2" "Low region specificity" "Detected in many" "HPA006518, HPA006655" Approved Approved "Cytosol,Cytoplasmic bodies" "Cytosol, Cytoplasmic bodies" "HPA006518: , HPA006655: AB_10600919" "unprognostic (6.10e-2)" "unprognostic (4.70e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" "unprognostic (5.77e-2)" "unprognostic (1.63e-1)" "unprognostic (6.56e-2)" "unprognostic (2.51e-3)" "unprognostic (2.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (4.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (8.57e-3)" "unprognostic (8.88e-3)" 9.1 19.9 14.8 15.4 29.8 13.1 24.2 3.6 13.9 10.1 18.1 4.4 45.4 12.2 4.2 34.7 23.3 21.8 16.0 14.4 12.2 8.1 28.4 26.0 19.2 14.6 4.1 13.2 15.0 62.2 27.7 32.9 10.1 6.3 26.0 12.8 11.9 79.8 46.0 9.2 18.7 16.5 5.6 1.9 10.4 14.1 15.0 5.5 20.4 61.3 19.5 27.1 12.3 11.0 77.0 30.9 55.0 14.8 42.1 58.7 31.9 21.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 21.2 4.6 12.9 0.0 19.9 0.0 8.5 0.0 17.7 16.0 2.4 8.1 0.0 2.3 8.0 0.1 0.1 5.3 0.0 0.9 2.9 0.0 25.1 2.5 37.4 21.6 0.1 0.1 0.1 7.1 0.0 33.0 18.4 6.0 13.0 7.0 0.0 52.8 0.1 51.0 0.1 0.1 0.0 8.0 0.1 0.9 59.6 41.9 4.6 0.0 0.0 0.0 55.0 3.6 51.2 36.3 10.5 34.8 75.8 47.8 40.2 10.9 77.0 54.7 45.9 51.6 42.1 14.8 30.9 58.7 31.9 14.8 29.8 3.6 13.9 12.2 8.1 4.1 13.2 6.3 5.5 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Group enriched" "Detected in some" 9 "SCLC-21H: 20.8;SH-SY5Y: 7.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA031735: , HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 20.8 7.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358932-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 12.7 13.6 16.3 15.8 18.4 6.8 21.2 21.1 17.0 12.7 10.7 9.1 21.1 10.9 15.0 13.9 11.5 17.7 11.5 10.5 12.8 7.4 12.0 19.9 20.4 19.8 21.7 11.3 26.6 47.7 20.5 20.8 15.0 15.4 13.8 12.0 10.6 20.7 11.7 12.1 10.9 14.0 17.7 12.9 11.9 16.4 12.3 17.3 11.1 19.5 9.1 11.1 12.8 12.5 22.4 23.3 24.5 29.0 20.4 23.1 21.1 5.7 12.0 12.6 19.8 31.8 26.5 8.9 14.1 18.9 11.8 14.3 8.3 8.6 12.3 14.2 14.1 12.3 8.8 9.2 14.3 9.4 11.6 9.4 7.7 8.1 39.4 14.0 12.1 24.5 28.6 8.6 27.9 11.7 13.5 10.5 11.9 7.0 10.3 8.1 18.8 10.4 9.7 13.4 14.2 15.0 8.6 6.7 16.1 10.9 29.3 17.6 27.5 16.0 15.6 17.0 7.5 19.0 20.2 20.7 16.6 11.8 10.9 8.5 18.0 22.3 28.3 23.8 21.0 29.0 21.9 22.4 22.6 19.7 21.9 20.7 23.1 21.0 24.5 20.4 24.7 23.3 20.3 21.1 16.3 18.4 21.1 17.0 12.8 7.4 21.7 11.3 15.4 17.3 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favourable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favourable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 9.5 10.7 6.0 6.1 8.6 1.0 9.7 5.4 7.5 13.2 15.5 12.2 11.9 3.7 20.3 9.9 10.7 10.6 10.4 11.9 7.7 4.7 10.6 8.2 8.1 3.0 9.8 7.5 17.5 11.7 10.7 10.2 10.0 10.5 13.7 8.7 14.0 8.4 12.0 7.8 8.6 6.4 12.3 15.7 5.2 8.7 16.2 9.0 5.1 14.1 7.7 5.0 13.0 11.4 0.5 2.4 3.8 1.3 2.0 0.5 0.1 6.7 7.1 10.9 12.5 13.0 14.7 4.6 8.4 10.3 9.0 10.2 6.1 11.9 1.7 17.0 9.5 13.2 3.5 8.3 9.8 2.2 11.6 7.2 12.4 4.7 7.6 1.6 0.5 10.4 7.5 7.1 6.8 15.1 5.5 1.0 8.4 4.0 5.7 1.8 5.9 4.9 1.8 14.2 2.5 7.3 9.1 4.7 2.1 11.1 4.5 10.2 7.5 7.5 9.9 11.4 6.9 7.6 10.7 6.0 8.1 2.3 10.3 0.5 6.7 3.8 0.5 0.6 0.3 1.3 0.3 0.4 0.4 0.5 2.4 0.5 0.3 0.3 1.8 2.0 0.5 1.9 0.4 0.1 6.0 8.6 5.4 7.5 7.7 4.7 9.8 7.5 10.5 9.0 TTC26 "dyf-13, DYF13, FLJ12571, IFT56" ENSG00000105948 "Tetratricopeptide repeat domain 26" A0AVF1 7 139133744-139191986 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036338, HPA036339" Enhanced Approved "Nuclear speckles,Intermediate filaments,Cytosol" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA036338: AB_10673351, HPA036339: AB_10673386" "unprognostic (3.40e-2)" "unprognostic (8.88e-2)" "unprognostic (5.01e-2)" "unprognostic (6.72e-2)" "unprognostic (8.34e-3)" "unprognostic (1.45e-1)" "unprognostic (2.46e-7)" "unprognostic (1.72e-1)" "unprognostic (4.96e-2)" "unprognostic (5.27e-2)" "unprognostic (7.12e-2)" "unprognostic (2.75e-1)" "unprognostic (5.18e-2)" "unprognostic (1.16e-1)" "unprognostic (1.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" 3.5 6.5 6.9 2.5 8.1 3.3 5.6 6.9 8.3 6.1 3.1 4.4 7.4 1.3 6.6 7.6 3.1 20.9 4.5 3.5 5.7 5.1 8.3 1.9 5.1 2.8 2.7 4.8 8.8 3.2 13.0 20.1 3.8 8.4 5.6 2.8 5.4 3.6 5.5 2.3 3.2 2.2 4.6 2.7 2.6 3.1 17.4 3.9 3.8 7.3 2.8 3.1 3.7 3.9 3.6 2.5 5.3 1.5 1.6 2.3 0.9 11.3 8.6 7.6 9.0 9.5 11.1 3.8 5.5 5.8 9.1 9.3 5.5 8.2 2.5 9.3 4.3 5.7 8.5 6.5 13.3 7.1 7.3 3.1 6.9 4.7 4.7 8.8 2.1 6.3 5.9 13.6 6.2 6.7 6.8 1.6 7.2 10.7 14.9 10.3 7.6 7.6 5.2 9.0 4.0 7.9 3.4 11.2 8.0 13.7 5.8 7.8 7.0 4.7 4.6 8.5 7.4 7.7 10.2 3.7 4.6 1.9 14.9 4.3 9.9 1.2 0.5 1.2 2.1 0.5 1.1 3.6 1.5 1.4 1.1 2.4 2.3 1.7 5.3 1.6 1.5 2.5 1.0 0.9 6.9 8.1 6.9 8.3 5.7 5.1 2.7 4.8 8.4 3.9 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria 11000 Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavourable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 18.4 18.2 7.0 18.8 11.5 9.9 17.8 8.6 10.7 16.4 11.9 16.1 12.0 8.2 25.1 13.6 17.5 14.7 8.5 14.3 8.2 6.9 11.0 15.7 10.8 13.6 12.5 8.1 18.6 17.7 15.7 19.4 11.9 8.9 14.7 13.1 13.2 17.2 14.7 18.7 16.8 11.0 15.3 11.0 19.3 13.4 17.4 10.3 16.4 14.9 15.5 20.4 14.6 14.6 9.6 9.6 0.3 9.0 8.4 12.5 5.7 21.7 10.6 7.4 5.7 6.2 12.6 3.7 9.1 7.5 14.0 12.4 16.3 13.3 19.1 8.2 13.6 11.0 11.8 14.1 20.7 9.1 14.5 21.7 5.8 22.2 12.0 20.6 11.4 8.3 13.1 17.0 18.5 12.7 29.7 5.6 12.5 8.7 16.3 7.2 13.5 11.1 10.9 16.0 16.7 10.8 12.8 6.1 8.8 7.5 7.1 8.4 8.7 5.0 10.6 9.0 9.9 10.6 15.5 8.2 2.0 21.7 9.7 16.2 9.5 0.0 4.5 0.0 9.1 9.0 10.0 9.3 10.0 8.9 9.6 9.6 12.5 9.8 0.3 8.4 6.1 4.7 8.7 5.7 7.0 11.5 8.6 10.7 8.2 6.9 12.5 8.1 8.9 10.3 TTC28 KIAA1043 ENSG00000100154 "Tetratricopeptide repeat domain 28" Q96AY4 22 27978014-28679865 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003099 Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA003099: AB_1079195" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "unprognostic (8.55e-3)" "unprognostic (4.83e-2)" "unprognostic (5.20e-2)" "unprognostic (2.25e-1)" "prognostic favourable (4.30e-4)" "unprognostic (3.91e-2)" "unprognostic (1.18e-2)" "unprognostic (5.40e-2)" "unprognostic (5.10e-2)" "prognostic favourable (5.65e-5)" "unprognostic (5.54e-3)" "unprognostic (1.85e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (4.36e-1)" 4.6 3.0 1.4 1.1 2.0 0.0 4.2 0.6 1.3 6.0 4.1 1.4 7.6 6.5 3.0 5.7 3.7 2.8 1.2 1.0 2.8 2.1 4.7 0.5 0.9 11.8 2.7 3.2 2.4 5.4 3.3 1.3 3.7 4.4 2.6 1.6 2.1 5.3 1.0 1.6 3.1 5.0 4.3 0.2 4.3 3.4 1.0 2.5 0.4 0.2 0.9 0.6 0.5 0.0 5.2 13.6 5.8 8.1 12.1 0.3 3.9 7.3 5.6 4.9 0.4 0.0 0.0 5.5 11.5 0.8 8.7 0.2 3.0 0.5 5.8 0.8 6.6 4.9 3.7 0.1 5.4 12.1 0.3 3.7 2.5 10.2 3.4 0.4 1.3 1.8 0.1 0.4 2.4 3.4 5.3 3.4 0.1 2.7 0.1 3.8 8.4 5.5 0.2 3.6 2.7 0.5 9.5 6.7 3.3 4.3 2.9 1.8 0.2 0.1 2.4 0.1 2.8 0.4 0.2 0.1 0.5 0.1 0.3 0.3 0.4 0.3 0.3 1.0 0.6 0.5 0.4 0.9 0.2 2.5 0.1 0.5 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: " "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.4 7.6 35.7 6.7 34.5 50.2 12.4 23.6 29.4 10.7 14.5 10.1 10.8 18.5 8.2 39.5 7.0 10.7 14.5 15.1 19.6 7.7 37.4 11.5 13.1 12.6 20.8 12.1 25.9 9.0 10.8 9.7 15.8 22.5 21.8 20.0 16.6 20.2 5.4 10.1 13.0 27.1 17.1 9.7 12.4 16.6 27.3 20.8 29.3 16.8 15.2 19.0 8.2 20.5 15.3 6.1 18.7 8.8 21.9 15.7 18.5 25.2 20.9 11.5 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA051714: , HPA052100: , HPA052487: " "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.8 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.5 4.9 4.8 2.2 6.2 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.1 2.8 1.1 2.3 0.8 0.5 3.5 2.9 4.4 2.6 1.8 1.2 2.9 8.8 0.6 6.3 1.5 10.9 7.2 2.5 5.0 3.0 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.3 2.1 0.4 7.8 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 TTC30B "fleer, FLJ30990, IFT70B" ENSG00000196659 "Tetratricopeptide repeat domain 30B" Q8N4P2 2 177548998-177553014 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA051714: , HPA052100: , HPA052487: " "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (2.15e-2)" "unprognostic (9.10e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.89e-2)" "unprognostic (3.26e-1)" "unprognostic (5.45e-2)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (5.27e-2)" "unprognostic (9.77e-2)" "unprognostic (9.61e-2)" "unprognostic (9.25e-3)" "unprognostic (1.65e-1)" 2.4 4.6 4.4 1.9 4.9 0.7 10.5 3.2 5.1 4.8 4.0 7.7 3.8 3.1 4.9 8.9 3.7 13.2 4.5 2.3 3.9 3.8 10.8 4.3 5.5 2.5 3.1 1.5 6.0 5.2 8.0 7.0 3.3 3.4 3.5 3.7 4.5 4.4 4.2 1.2 3.0 3.7 3.1 5.2 3.1 4.7 11.5 2.9 7.7 10.4 1.6 2.8 3.3 2.2 3.2 3.9 6.5 3.4 1.9 2.2 1.6 2.8 4.2 5.7 1.1 5.1 5.9 3.8 1.7 5.3 4.7 5.0 2.4 7.1 1.1 4.7 3.2 7.0 6.8 7.2 4.5 1.6 3.4 2.0 2.7 2.1 4.2 2.5 3.5 4.9 6.8 4.6 3.5 3.7 2.6 1.0 2.7 4.8 5.0 3.9 2.6 1.1 3.9 4.9 1.1 7.0 3.1 13.8 7.8 2.1 4.9 3.3 5.0 4.8 3.2 2.6 1.4 3.3 1.5 2.6 2.9 0.3 5.9 1.0 4.3 6.5 3.4 2.8 1.7 3.3 1.1 1.4 1.2 1.8 3.9 3.2 2.2 2.2 2.0 1.9 2.2 2.8 1.0 1.6 4.4 4.9 3.2 5.1 3.9 3.8 3.1 1.5 3.4 2.9 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavourable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favourable (2.49e-4)" 9.2 8.9 7.4 12.3 11.7 11.5 8.6 13.8 9.3 9.0 15.7 8.6 5.3 10.5 11.6 9.4 8.7 7.9 14.5 7.4 8.9 3.7 9.9 23.6 8.2 10.4 10.4 7.7 9.7 13.4 13.2 10.0 13.7 8.3 8.0 9.5 10.5 8.1 7.5 6.5 11.1 16.2 9.3 7.0 13.6 11.6 8.6 12.2 11.5 7.7 9.7 11.5 10.6 8.5 9.3 9.7 8.1 10.2 7.5 9.0 7.8 10.9 10.0 6.5 3.4 3.8 11.2 7.6 6.1 8.5 11.1 7.7 8.4 8.2 15.5 4.9 4.8 8.0 6.0 6.6 5.5 17.0 6.2 16.5 8.9 14.5 7.4 6.7 10.9 8.1 8.9 9.5 5.9 7.5 11.0 6.6 6.9 10.2 9.9 3.9 4.0 4.9 9.8 17.1 7.3 6.1 8.1 3.2 12.0 5.7 9.0 6.2 6.7 3.8 13.8 7.6 12.8 4.7 9.0 9.7 7.8 10.1 9.5 7.7 7.1 6.4 10.2 8.1 8.4 10.2 9.0 9.3 6.5 8.0 9.7 7.3 6.3 6.8 1.4 7.5 10.2 5.7 8.3 7.8 7.4 11.7 13.8 9.3 8.9 3.7 10.4 7.7 8.3 12.2 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896643-19901986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favourable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavourable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 11.8 8.9 12.8 10.8 24.7 30.1 17.4 24.1 18.9 10.8 11.0 17.5 11.9 11.5 13.6 28.5 7.8 11.8 11.8 7.3 14.9 11.8 9.4 12.6 10.1 13.7 29.6 9.2 16.9 8.7 13.4 17.0 8.2 16.9 16.6 10.4 14.5 11.4 13.1 19.6 14.2 12.1 9.4 18.4 13.9 10.6 12.9 23.6 15.5 13.7 12.9 9.5 11.9 11.7 9.3 5.4 21.6 5.9 4.5 12.8 3.8 14.2 9.1 8.2 6.0 3.8 8.2 1.6 3.1 5.2 5.2 3.4 4.6 16.6 9.0 1.8 3.3 9.1 3.8 10.2 3.4 13.2 15.7 9.2 12.1 8.2 8.1 9.0 16.7 7.8 6.2 5.7 13.9 4.8 17.1 18.6 4.3 4.4 6.4 13.4 6.4 16.1 7.7 5.6 15.1 14.4 5.6 13.6 12.7 10.7 5.7 11.4 7.8 3.5 3.4 7.3 8.1 7.6 4.2 18.8 17.1 15.2 11.9 8.8 4.2 6.1 5.9 16.5 5.9 4.3 6.7 8.8 9.2 6.1 5.4 9.3 12.8 9.7 21.6 4.5 4.8 3.8 10.9 3.8 12.8 24.7 24.1 18.9 14.9 11.8 29.6 9.2 16.9 23.6 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.1 4.5 8.8 11.3 6.2 8.9 4.1 7.1 7.5 7.8 8.0 2.3 5.4 16.3 4.3 5.3 2.8 8.5 3.8 12.9 18.4 6.4 3.6 15.4 6.4 6.3 9.2 5.2 5.3 7.2 7.3 7.5 10.8 8.3 12.6 9.4 1.3 16.1 8.9 2.7 4.5 15.7 17.6 9.1 8.3 3.2 6.4 7.3 17.8 8.7 9.5 6.9 10.4 7.4 9.4 8.5 5.9 5.8 10.3 11.1 8.9 6.3 12.3 7.4 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 TTC37 "KIAA0372, THES" ENSG00000198677 "Tetratricopeptide repeat domain 37" Q6PGP7 5 95463895-95555007 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037905 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037905: AB_10673034" "unprognostic (5.99e-2)" "unprognostic (7.65e-3)" "prognostic favourable (2.62e-4)" "unprognostic (8.48e-2)" "unprognostic (9.49e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-2)" "unprognostic (2.18e-1)" "unprognostic (6.88e-2)" "unprognostic (5.97e-2)" "unprognostic (6.81e-3)" "unprognostic (2.51e-1)" "unprognostic (3.30e-3)" "unprognostic (6.88e-3)" "unprognostic (3.91e-1)" "unprognostic (3.98e-2)" "unprognostic (7.90e-3)" 29.6 21.8 18.9 16.1 19.4 6.9 19.2 35.7 37.9 21.1 19.7 8.2 20.7 15.6 17.3 15.5 27.5 14.8 13.7 17.5 20.2 14.1 28.2 25.2 17.1 13.8 21.5 21.5 21.3 22.2 40.2 42.1 20.7 26.5 21.1 16.8 6.6 16.8 17.4 33.1 23.9 22.7 21.5 29.8 16.0 18.8 9.1 25.0 25.2 19.7 23.5 15.3 28.1 16.1 10.3 14.8 3.5 7.4 8.2 12.0 3.7 12.4 13.3 16.9 5.8 28.3 38.6 15.1 23.7 19.3 15.5 23.4 14.1 9.1 22.0 15.7 22.6 12.3 21.3 28.7 26.1 12.8 17.4 14.7 27.0 9.3 24.3 9.5 10.7 25.6 14.8 19.7 27.7 24.5 11.5 14.5 29.2 7.1 12.4 7.7 9.5 11.3 10.6 23.6 23.1 17.2 9.8 21.2 16.6 19.6 9.7 21.7 15.1 8.2 33.6 21.2 12.2 16.7 18.2 14.0 17.6 20.5 21.5 14.1 27.2 3.5 6.0 2.1 9.9 7.4 12.0 9.6 9.7 8.0 7.2 10.3 10.0 10.4 0.2 8.2 6.7 14.8 8.8 3.7 18.9 19.4 35.7 37.9 20.2 14.1 21.5 21.5 26.5 25.0 TTC4 "CNS1, FLJ41930, MGC5097" ENSG00000243725 "Tetratricopeptide repeat domain 4" O95801 1 54715822-54742657 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041608, HPA042459" Approved Enhanced "Intermediate filaments,Cytoplasmic bodies" "Intermediate filaments" "Cytoplasmic bodies" "HPA041608: AB_10794485, HPA042459: AB_10797496" "unprognostic (4.89e-2)" "unprognostic (1.81e-1)" "unprognostic (2.05e-2)" "unprognostic (8.62e-4)" "unprognostic (8.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.21e-5)" "unprognostic (1.39e-4)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (2.42e-3)" "unprognostic (7.12e-2)" "unprognostic (2.85e-1)" "unprognostic (7.79e-2)" "unprognostic (5.86e-2)" "unprognostic (1.76e-3)" 10.9 10.6 14.5 13.4 17.6 3.5 17.1 13.7 14.0 18.2 10.9 12.8 12.7 9.1 14.9 14.1 11.9 15.7 8.0 13.4 14.6 14.0 13.2 16.4 8.9 13.0 13.5 9.3 18.5 16.6 15.6 14.6 12.5 12.9 13.5 10.8 9.2 13.1 14.7 33.3 14.7 8.5 12.8 20.4 10.3 11.2 13.3 12.0 11.7 11.5 15.1 14.0 11.4 13.6 11.5 11.3 8.6 11.7 15.0 14.9 10.5 9.8 7.5 8.8 4.5 14.3 7.3 7.8 13.6 6.8 17.7 10.7 9.3 2.8 18.3 7.3 9.1 5.7 19.8 13.4 17.9 15.5 15.6 17.6 3.4 5.3 12.6 13.3 4.3 6.5 13.7 25.8 15.8 7.2 18.8 2.3 9.6 4.7 11.8 8.0 18.6 14.3 10.9 18.8 8.3 8.7 2.8 5.8 4.1 11.6 6.1 11.4 5.6 7.3 7.0 8.7 9.6 8.7 18.3 6.6 11.6 14.5 11.1 15.2 8.8 5.9 10.3 8.6 12.5 11.7 13.3 11.5 10.3 11.8 11.3 11.0 14.9 13.2 0.2 15.0 11.3 9.6 9.3 10.5 14.5 17.6 13.7 14.0 14.6 14.0 13.5 9.3 12.9 12.0 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA054837: " "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 10.3 6.6 9.9 12.6 14.6 18.0 12.5 15.0 13.4 10.3 12.1 8.5 13.8 6.2 11.9 12.1 8.5 9.6 6.8 16.6 9.8 8.5 8.3 6.2 8.9 12.2 10.4 11.3 11.8 8.7 8.7 15.4 8.3 14.1 13.4 8.8 6.8 9.0 10.1 18.0 9.3 8.6 9.5 13.5 9.7 8.7 11.6 12.7 15.1 16.9 7.0 12.3 13.4 11.5 12.3 10.2 19.4 6.3 7.3 9.1 3.0 7.4 7.1 10.1 9.2 5.6 7.3 9.2 8.4 6.5 9.8 7.1 7.2 8.2 12.2 7.1 6.2 17.9 11.1 6.5 10.6 7.9 7.7 5.6 10.6 5.5 5.6 14.9 9.2 4.4 7.7 8.5 6.3 8.4 11.2 10.8 7.6 11.1 34.4 9.1 18.5 10.9 22.0 13.9 14.5 7.8 6.1 8.9 15.4 11.7 8.9 5.9 11.0 7.9 7.9 16.0 9.8 13.5 9.8 5.1 14.4 14.9 9.0 12.2 15.3 11.3 5.4 10.3 6.5 5.2 8.3 11.2 8.2 7.4 3.3 12.3 9.1 6.9 19.4 7.3 6.3 10.2 8.4 3.0 9.9 14.6 15.0 13.4 9.8 8.5 10.4 11.3 14.1 12.7 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: " "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavourable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavourable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 9.2 14.2 16.6 10.5 16.2 9.5 11.1 15.5 16.3 10.8 9.8 16.0 9.2 7.4 12.7 12.7 10.2 12.8 7.3 11.3 10.2 9.0 10.7 15.2 9.6 13.4 14.9 12.9 15.4 24.5 16.6 22.8 13.2 15.6 12.8 13.5 13.9 11.7 14.9 22.0 10.4 9.8 13.8 15.8 12.5 11.3 13.0 14.1 17.6 15.4 4.9 15.3 13.7 10.0 10.2 12.9 17.0 11.6 10.3 13.9 9.1 9.6 14.4 16.0 6.0 6.5 9.2 17.2 11.1 6.5 16.5 14.1 33.6 12.7 16.0 11.5 6.2 15.5 17.9 23.1 16.3 6.4 7.0 21.9 14.3 17.2 7.4 17.5 10.3 7.0 15.3 16.4 10.0 12.2 23.0 11.0 12.4 10.0 23.6 12.2 15.7 15.2 15.5 25.8 18.7 6.3 10.4 14.6 13.0 16.9 30.0 3.8 17.0 8.5 8.0 22.3 14.8 11.8 11.2 9.6 8.3 18.1 13.0 11.6 11.4 12.9 9.8 17.0 11.9 11.6 13.4 10.2 9.3 11.7 12.9 9.7 13.9 11.1 6.2 10.3 6.9 6.3 11.7 9.1 16.6 16.2 15.5 16.3 10.2 9.0 14.9 12.9 15.6 14.1 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.3;testis: 31.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavourable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavourable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavourable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 1.1 1.4 0.3 3.2 0.4 13.9 1.0 0.3 0.4 1.0 2.7 0.2 0.2 2.2 0.5 1.0 6.5 0.3 0.4 1.5 0.4 0.3 0.9 0.6 1.2 4.6 0.4 0.2 0.4 0.5 0.0 0.3 3.0 0.6 0.6 3.6 0.3 1.2 0.6 0.3 2.0 2.8 0.7 0.8 2.1 1.8 31.7 0.2 58.3 0.5 2.6 5.4 0.8 1.8 1.7 0.0 1.1 0.0 1.1 4.0 0.8 13.3 8.0 24.0 19.7 1.1 3.5 13.6 15.5 9.6 22.7 27.8 10.9 10.2 19.8 12.1 6.6 17.4 21.2 9.5 31.7 18.0 17.1 18.3 10.7 8.9 0.0 21.5 12.0 0.4 1.0 15.9 10.2 12.8 20.0 20.5 19.3 9.9 12.3 15.6 14.2 9.7 11.0 43.9 8.2 5.7 8.6 16.6 9.7 9.1 9.9 5.6 9.3 16.4 5.3 10.2 10.2 6.6 24.8 4.6 15.5 11.0 3.6 20.1 8.7 0.0 0.0 1.1 0.6 0.0 0.6 0.9 1.0 1.6 0.0 1.7 0.3 0.5 0.3 1.1 0.0 0.0 4.0 0.8 0.3 0.4 0.3 0.4 0.4 0.3 0.4 0.2 0.6 0.2 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482154-112541739 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA066819: " "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavourable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 4.4 4.0 9.9 4.2 11.9 7.1 11.3 5.0 12.5 3.3 4.1 9.2 2.5 3.1 4.6 4.2 5.2 3.2 4.9 10.3 9.4 6.5 3.9 3.3 5.9 4.4 8.1 5.3 3.2 3.8 4.1 2.4 5.3 5.9 3.2 3.9 2.6 3.0 3.7 13.1 6.0 3.2 5.8 5.4 4.0 3.2 3.0 6.5 5.1 4.2 5.2 3.8 4.8 2.9 1.8 1.2 2.7 1.3 1.0 1.3 0.5 3.7 2.8 3.6 8.1 4.4 6.2 1.4 6.4 5.3 6.8 5.9 3.5 1.3 3.5 3.6 5.5 2.6 6.3 3.3 8.3 2.4 3.6 2.9 4.0 4.4 1.9 4.1 1.5 2.8 2.3 9.9 5.3 5.8 4.8 2.8 5.3 1.9 3.5 2.3 3.1 5.8 3.8 4.1 1.9 2.1 2.9 7.7 5.4 5.0 1.7 8.9 1.7 2.4 5.7 8.1 5.9 6.3 4.7 1.5 3.1 2.9 9.0 3.1 3.4 2.7 1.3 1.0 1.3 0.8 1.1 0.8 1.0 1.0 0.4 1.8 0.9 1.1 2.4 1.0 1.1 1.2 0.8 0.5 9.9 11.9 5.0 12.5 9.4 6.5 8.1 5.3 5.9 6.5 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039644-43089428 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria Nucleoli Mitochondria "HPA048392: " "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favourable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavourable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favourable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.3 16.5 3.6 12.0 2.9 6.8 12.8 16.6 7.6 4.6 8.8 0.9 2.5 7.1 12.5 5.7 14.6 5.7 12.5 13.9 12.6 6.1 2.1 5.3 4.9 9.2 14.1 8.3 4.2 8.5 9.8 3.9 13.2 7.7 4.6 6.8 4.7 6.0 4.4 5.8 2.9 5.9 10.0 4.5 5.4 14.0 8.4 4.7 10.3 1.8 4.8 5.4 4.6 4.7 10.4 7.0 6.5 9.9 14.1 6.2 0.8 1.5 12.8 9.7 14.5 12.9 0.6 4.3 4.8 2.5 4.2 0.1 1.9 0.9 3.1 7.9 0.6 1.1 1.1 2.5 1.1 2.1 1.3 0.7 1.2 10.4 3.2 1.7 10.6 16.6 1.6 4.1 8.1 0.3 8.3 9.2 4.2 3.0 5.2 1.7 0.9 7.4 7.2 0.7 4.6 1.1 3.2 6.1 3.4 1.7 11.8 5.1 5.4 7.8 2.7 1.8 6.2 0.6 2.9 0.8 0.3 6.8 5.9 4.8 5.2 5.9 7.0 13.0 6.5 12.2 3.1 11.4 14.1 10.4 4.7 9.7 12.2 1.7 9.9 4.9 6.7 6.9 6.2 16.5 12.0 12.8 16.6 13.9 12.6 9.2 14.1 13.2 8.4 TTLL12 KIAA0153 ENSG00000100304 "Tubulin tyrosine ligase like 12" Q14166 22 43166622-43187133 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003054, CAB046029" Approved Approved "Plasma membrane,Cytosol" 2100000 Cytosol "Plasma membrane" "CAB046029: AB_11128395, HPA003054: " "unprognostic (2.45e-2)" "unprognostic (3.47e-2)" "unprognostic (7.37e-3)" "unprognostic (5.40e-2)" "unprognostic (2.65e-1)" "unprognostic (3.50e-1)" "prognostic unfavourable (2.84e-4)" "unprognostic (5.81e-3)" "unprognostic (2.24e-1)" "unprognostic (6.08e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-3)" "unprognostic (1.40e-1)" "unprognostic (6.66e-2)" "unprognostic (2.81e-2)" 7.3 13.8 7.2 14.7 8.3 14.0 11.2 13.6 12.3 10.9 21.5 5.5 8.9 15.0 7.1 8.7 46.3 9.0 36.0 6.9 7.3 7.1 8.4 19.4 5.3 9.2 6.5 5.9 16.5 29.8 4.4 7.0 6.8 7.1 9.4 12.1 7.0 13.5 7.9 5.5 16.4 13.9 5.9 4.0 9.7 20.7 18.3 5.3 10.7 7.6 23.7 23.5 8.3 15.2 3.5 3.8 1.3 4.7 4.3 5.6 3.3 31.5 13.3 5.4 13.3 8.3 5.7 17.5 10.4 3.7 10.0 5.2 21.6 18.0 30.4 12.6 8.6 22.5 22.4 19.0 2.5 3.8 35.6 7.4 21.4 18.5 13.0 33.4 7.7 9.0 23.2 11.9 12.8 10.5 45.8 7.2 4.6 29.3 23.2 18.1 19.6 13.3 23.6 18.6 43.7 8.4 10.4 16.5 6.8 22.1 32.4 11.7 12.7 14.9 10.0 6.7 9.4 12.8 14.4 12.2 15.0 22.5 7.6 17.2 9.0 0.0 4.7 0.7 5.6 2.4 5.5 3.5 5.5 4.1 3.8 2.7 5.5 3.7 1.3 4.3 3.1 3.3 3.5 3.3 7.2 8.3 13.6 12.3 7.3 7.1 6.5 5.9 7.1 5.3 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955078 "Disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.9 6.5 7.6 5.9 11.1 10.1 7.4 12.0 10.4 8.0 6.5 18.0 6.4 4.9 11.8 7.7 8.1 11.8 6.7 6.8 7.9 7.1 6.6 4.4 6.6 5.0 10.1 6.9 8.1 5.8 13.2 9.5 7.6 13.9 7.4 7.6 8.2 7.7 7.5 5.2 7.2 4.8 8.9 15.8 4.2 6.0 51.1 10.5 10.1 8.1 5.5 7.3 7.1 7.1 3.8 5.7 12.4 3.8 3.4 5.1 2.3 14.0 10.3 9.1 9.4 7.1 11.2 8.4 8.3 10.1 10.0 12.9 6.3 13.2 4.0 4.6 8.7 13.4 7.8 13.7 19.0 4.7 4.7 7.8 10.8 6.9 6.1 5.6 7.5 8.5 6.8 12.5 14.0 21.4 4.4 6.7 9.9 19.6 9.5 7.7 6.4 10.6 5.9 12.7 5.4 9.6 13.9 12.0 7.6 17.6 12.8 4.4 17.6 6.2 24.2 13.4 11.9 11.8 7.7 5.7 8.1 9.2 13.5 6.5 8.8 12.4 3.5 2.7 4.6 3.3 4.0 3.8 4.2 4.5 5.1 3.5 5.1 4.7 3.8 3.4 3.8 5.7 3.4 2.3 7.6 11.1 12.0 10.4 7.9 7.1 10.1 6.9 13.9 10.5 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.8;intestine: 5.0;testis: 17.6" "Cell line enriched" "Detected in some" 5 "HDLM-2: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules Microtubules Vesicles "HPA052397: " "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.5 3.3 0.5 0.0 0.1 0.1 1.1 0.2 3.6 0.1 1.3 1.6 0.8 0.1 0.1 4.8 1.4 0.1 0.8 0.4 1.8 0.1 1.1 0.1 0.2 1.1 0.8 0.6 0.0 0.3 0.1 0.9 0.1 5.0 0.3 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.1 0.1 17.6 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 1.1 0.8 0.4 0.2 1.1 0.9 0.1 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;REH: 2.0" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: " "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.6 0.3 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 TTPAL "C20orf121, dJ179M20.3" ENSG00000124120 "Alpha tocopherol transfer protein like" Q9BTX7 20 44475886-44494603 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 39.6;HSkMC: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046957, HPA066532" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA046957: AB_10959741, HPA066532: " "unprognostic (8.71e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "prognostic unfavourable (3.47e-5)" "unprognostic (1.69e-1)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (2.32e-1)" "unprognostic (5.06e-2)" "unprognostic (4.50e-2)" "unprognostic (9.55e-2)" "prognostic unfavourable (8.09e-5)" "unprognostic (2.09e-2)" "unprognostic (2.88e-1)" "unprognostic (2.24e-2)" "unprognostic (7.93e-2)" 9.5 6.2 6.3 7.2 8.3 9.1 7.6 6.5 13.1 8.2 4.6 4.8 5.1 4.3 6.3 9.2 7.0 6.9 5.3 4.2 5.8 7.9 5.7 32.0 4.0 9.7 5.9 11.5 6.6 7.6 11.1 12.8 5.0 9.8 6.4 5.0 6.4 6.2 7.3 3.8 14.7 5.3 6.6 3.6 5.7 5.5 6.4 3.0 5.8 9.3 5.5 9.2 5.9 7.9 5.9 3.1 4.2 3.5 7.9 7.6 3.4 8.5 4.5 3.5 6.1 39.6 15.4 3.4 9.3 13.0 9.0 7.8 16.5 5.2 5.3 8.0 8.6 8.5 4.4 14.6 9.8 5.5 2.0 2.5 4.6 4.8 11.0 3.7 6.0 34.1 9.6 8.9 15.0 3.0 3.2 5.6 7.2 9.8 3.6 2.4 4.1 7.5 1.1 3.7 2.9 3.5 6.2 7.7 3.6 12.9 5.7 5.7 6.2 2.4 3.1 20.3 8.1 6.0 8.0 8.4 5.7 5.8 9.8 2.7 5.9 0.7 1.6 2.6 6.7 3.2 7.1 5.9 5.7 6.7 1.7 5.8 5.1 7.6 4.2 7.9 3.5 3.1 5.7 3.4 6.3 8.3 6.5 13.1 5.8 7.9 5.9 11.5 9.8 3.0 TUB rd5 ENSG00000166402 "Tubby bipartite transcription factor" P50607 11 8019244-8106112 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4" "Cell line enhanced" "Detected in many" "HEK 293: 17.8;HeLa: 23.9;SCLC-21H: 27.1;SH-SY5Y: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Uncertain Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: " "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favourable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favourable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 5.0 18.3 18.9 2.8 16.1 0.7 4.5 12.4 36.4 18.2 4.2 6.3 2.8 2.5 24.3 10.7 3.6 20.8 5.5 10.2 20.5 17.9 11.7 1.0 3.4 2.2 25.1 22.6 17.9 5.1 11.0 18.4 4.6 17.7 8.7 2.9 11.3 5.6 9.0 3.1 6.5 2.4 12.0 9.2 2.1 2.4 5.1 9.1 0.5 10.5 2.9 1.3 5.2 8.7 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.8 7.0 8.7 6.5 2.2 0.0 4.7 1.2 5.1 6.7 0.0 0.0 0.0 0.4 6.3 0.0 13.0 1.0 4.5 0.0 17.8 0.0 23.9 2.8 1.0 0.0 0.1 3.4 1.1 2.3 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 4.8 0.0 6.4 0.1 0.0 0.0 0.2 27.1 20.2 3.4 0.0 1.3 0.7 0.1 0.0 2.8 6.8 0.4 2.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 16.1 12.4 36.4 20.5 17.9 25.1 22.6 17.7 9.1 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859482-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favourable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavourable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 8.7 8.0 9.3 8.1 13.8 6.8 12.4 19.9 12.2 12.3 11.2 13.5 16.6 6.7 13.6 16.4 18.2 10.0 8.3 8.4 8.9 7.2 8.5 9.3 8.8 10.2 16.1 8.5 16.3 13.2 10.4 18.7 7.2 12.3 12.3 8.2 11.7 11.4 12.2 9.9 11.6 7.5 9.3 13.4 9.3 9.6 9.2 16.4 16.2 15.5 10.3 13.8 14.1 13.0 10.1 8.8 14.1 7.6 8.1 17.6 6.9 5.9 8.1 6.4 6.7 3.6 2.6 5.4 4.6 2.7 6.1 5.1 8.8 3.9 5.4 7.9 1.0 5.0 8.9 2.8 5.9 3.1 10.9 6.3 6.9 10.4 1.9 3.7 3.4 1.4 4.4 5.3 2.0 4.8 13.5 3.8 2.1 41.9 7.6 4.3 5.6 3.6 8.2 9.4 8.4 2.4 2.7 6.0 3.6 3.3 2.6 3.2 6.3 3.6 1.5 4.4 9.8 3.1 5.0 4.4 6.6 8.2 2.1 4.3 3.9 5.6 7.6 14.1 10.9 5.0 12.4 10.1 13.5 11.5 5.2 8.6 17.6 14.2 8.2 8.1 5.3 8.8 14.1 6.9 9.3 13.8 19.9 12.2 8.9 7.2 16.1 8.5 12.3 16.4 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278630-133312337 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.3 26.7 16.7 17.3 25.6 29.4 21.4 28.6 33.4 20.3 19.3 22.5 25.2 19.2 23.2 18.9 19.8 35.1 21.7 18.6 21.9 17.2 24.4 22.2 22.8 27.7 16.3 26.5 28.3 30.9 31.9 23.0 17.0 22.3 20.8 16.0 19.0 26.8 22.3 30.4 24.1 19.7 17.6 16.7 25.6 20.1 33.5 15.4 25.6 23.0 18.3 19.5 19.3 18.2 6.1 14.3 17.3 11.9 12.1 10.4 8.7 18.2 25.4 9.4 9.5 10.0 10.9 12.0 14.3 23.3 17.7 17.9 26.4 12.8 13.8 8.1 16.3 12.3 12.5 11.7 7.8 12.9 24.0 8.8 12.5 14.5 12.6 18.8 16.3 11.3 10.3 16.4 20.4 11.6 10.7 11.2 14.2 25.0 10.3 20.9 8.2 20.2 8.2 10.9 6.0 11.6 9.5 6.4 12.7 10.2 11.5 11.5 8.3 9.7 14.0 8.6 7.8 11.3 12.7 11.2 7.6 16.1 34.7 8.5 5.5 5.0 11.9 11.9 7.6 11.2 8.5 6.0 7.6 8.0 14.3 6.1 8.7 9.0 17.3 12.1 11.8 6.5 10.4 8.7 16.7 25.6 28.6 33.4 21.9 17.2 16.3 26.5 22.3 15.4 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: " "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 5.1 5.7 5.7 5.1 8.4 5.5 7.3 4.0 10.4 7.9 4.6 6.0 4.6 4.2 7.4 8.7 5.9 4.9 4.7 6.6 7.7 6.3 6.8 5.6 5.5 6.0 11.0 5.0 10.0 10.2 6.3 4.8 12.9 7.5 5.3 5.3 4.0 7.4 14.5 7.3 3.0 9.3 10.0 4.8 5.3 12.9 5.9 5.4 8.6 7.0 6.1 4.6 0.8 5.3 4.0 1.5 3.3 5.4 7.6 2.5 12.1 12.9 15.3 9.0 11.8 7.7 8.8 15.2 16.8 16.8 14.6 9.8 5.8 9.2 6.5 13.9 12.3 10.0 11.8 14.1 14.2 4.0 16.6 13.0 5.2 3.9 16.9 7.4 12.6 4.5 11.2 10.4 10.0 11.7 15.0 10.6 8.0 11.3 7.3 9.0 11.8 14.0 16.8 1.8 9.7 19.0 5.2 8.9 12.4 8.7 7.9 14.1 7.9 8.6 11.6 7.6 8.9 22.5 11.8 11.8 24.9 15.2 11.2 10.8 0.2 2.3 0.9 4.5 3.3 4.6 3.7 6.7 7.2 3.6 5.3 6.0 7.6 1.5 5.4 3.3 4.0 5.4 2.5 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: " "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favourable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavourable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavourable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.2 7.9 15.0 12.5 15.2 22.7 14.2 14.6 24.5 15.8 17.5 10.0 8.6 6.9 2.2 21.5 7.8 8.9 9.4 18.3 8.9 6.6 4.1 9.8 6.4 19.6 4.4 4.8 13.3 11.1 23.8 32.7 12.1 3.9 6.5 13.2 8.3 6.5 3.9 20.3 5.8 6.9 14.7 2.5 9.9 7.8 3.8 10.1 12.7 7.6 8.3 9.5 4.3 9.7 11.6 14.1 23.6 14.1 2.0 2.4 6.0 11.7 2.4 17.7 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051426: " "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 19.8 13.1 10.9 6.2 12.2 3.6 13.8 9.9 17.4 15.3 13.2 10.7 9.7 11.3 17.6 14.0 9.3 15.0 11.0 11.0 10.4 10.5 13.8 12.2 9.3 4.3 12.3 11.3 16.5 10.3 9.6 9.1 17.9 10.4 15.8 8.4 10.2 14.9 14.2 15.6 14.8 11.9 12.1 8.6 7.5 11.8 32.0 11.9 2.9 20.0 11.4 6.7 11.0 14.9 0.6 1.8 0.0 0.8 0.0 0.1 0.0 6.5 1.4 1.4 0.0 4.9 4.1 0.0 5.0 0.0 1.9 2.3 0.1 2.3 0.0 1.5 5.9 0.0 3.5 6.3 1.2 0.0 7.0 25.4 7.5 0.0 2.4 0.0 0.0 4.9 8.9 2.1 5.0 2.1 0.0 0.0 2.2 3.3 0.0 0.1 1.2 6.5 0.0 0.9 0.1 2.6 3.1 0.5 11.5 6.2 5.2 5.1 4.6 7.1 4.4 0.0 9.4 0.1 0.0 0.0 0.0 0.0 6.1 1.7 6.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.8 1.8 0.0 0.0 10.9 12.2 9.9 17.4 10.4 10.5 12.3 11.3 10.4 11.9 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor candidate 2" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavourable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favourable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 13.4 16.3 28.5 12.2 27.2 9.2 15.1 18.9 38.1 11.9 15.9 11.1 13.9 11.1 10.3 26.2 10.8 18.6 15.5 22.0 26.4 25.8 18.9 18.0 13.5 13.2 26.2 17.0 12.0 15.3 21.3 12.3 15.3 27.3 13.2 15.0 12.2 13.5 17.0 29.9 8.8 12.1 12.3 13.2 14.2 13.9 15.2 8.1 12.0 21.1 15.0 17.2 9.9 8.5 19.5 20.4 26.3 17.3 17.1 22.0 22.9 12.0 10.0 14.1 15.3 15.6 8.1 15.5 9.9 13.3 18.7 15.9 17.6 11.1 20.6 10.8 9.1 7.8 17.1 12.8 16.4 12.1 15.8 10.1 9.4 18.9 13.7 17.8 17.8 8.8 20.8 18.7 9.3 19.2 12.2 9.9 10.7 9.2 18.6 22.9 19.2 14.5 6.5 6.8 16.8 18.7 13.1 7.5 15.6 7.2 12.9 14.2 12.3 21.8 15.1 5.6 13.7 12.7 19.8 24.5 38.0 14.4 12.5 11.9 8.8 10.2 17.3 26.3 20.4 15.3 20.4 19.4 18.1 21.2 11.3 19.5 20.9 22.0 24.5 17.1 13.9 20.4 19.5 22.9 28.5 27.2 18.9 38.1 26.4 25.8 26.2 17.0 27.3 8.1 TUT1 "FLJ21850, FLJ22267, FLJ22347, PAPD2, RBM21, TUTase" ENSG00000149016 "Terminal uridylyl transferase 1, U6 snRNA-specific" Q9H6E5 11 62575045-62592177 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA069055, HPA071838" Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA069055: , HPA071838: " "unprognostic (3.81e-2)" "unprognostic (3.54e-2)" "prognostic unfavourable (9.51e-4)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (1.83e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (2.71e-1)" "unprognostic (7.20e-3)" "unprognostic (1.03e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.97e-3)" 10.9 12.1 10.7 9.9 13.6 7.8 12.9 13.5 13.3 10.5 8.7 15.9 13.0 12.9 11.5 10.8 10.0 16.9 13.7 10.7 13.6 8.3 12.2 22.7 9.6 18.1 15.5 9.5 14.5 26.2 15.5 16.2 12.3 13.0 13.9 6.2 11.9 16.4 11.9 20.5 13.9 11.7 10.2 11.4 14.6 12.5 18.6 13.2 17.1 14.0 8.8 13.6 11.5 9.8 13.1 9.4 6.6 7.3 9.8 16.0 7.2 7.2 9.1 6.3 8.8 7.7 4.4 8.2 7.8 4.8 6.6 5.8 8.2 14.2 11.6 18.1 3.8 13.7 11.6 9.1 3.4 8.9 6.1 11.9 9.3 7.7 8.6 8.4 5.4 6.2 9.8 8.3 12.6 6.3 17.8 12.0 5.6 15.9 11.9 17.9 7.2 11.2 13.4 10.1 28.1 6.1 4.2 10.5 14.7 6.0 11.3 9.7 15.8 8.2 5.7 7.5 6.8 8.7 5.9 20.9 18.3 14.2 8.8 6.7 6.2 5.9 5.9 6.6 10.5 7.3 14.6 9.8 9.9 8.4 7.8 13.1 16.0 12.5 3.6 9.8 5.3 9.4 8.9 7.2 10.7 13.6 13.5 13.3 13.6 8.3 15.5 9.5 13.0 13.2 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910543 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 34.6" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 20.9;BJ: 26.6;BJ hTERT+: 83.9;fHDF/TERT166: 38.0;U-2197: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 21 "eosinophil: 11.2" "Lineage enriched" "Detected in single" 52 "granulocytes: 11.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062870 Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA062870: " "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 25.8 1.3 0.2 4.7 0.6 0.6 21.7 0.1 0.4 34.6 8.4 0.4 4.3 0.6 14.3 6.2 9.1 7.4 5.8 4.3 0.6 0.2 0.7 0.3 4.2 0.9 1.1 0.0 15.6 0.7 0.0 2.1 9.1 0.4 13.1 1.9 3.9 2.2 7.1 4.3 9.7 2.3 12.4 1.7 1.2 3.3 4.6 0.5 0.0 4.0 6.4 3.4 15.9 18.6 0.2 0.0 11.2 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 32.8 20.9 0.0 26.6 83.9 12.4 18.7 0.0 0.0 0.0 0.8 38.0 0.2 0.3 2.1 9.1 0.0 2.8 0.0 1.6 0.1 5.6 0.0 0.6 4.8 1.1 6.0 5.0 1.6 0.0 0.0 1.6 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 4.6 0.5 0.9 32.5 0.3 0.0 0.0 0.0 0.1 0.8 1.7 0.0 0.1 11.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.6 0.2 1.1 0.0 0.4 0.5 TWISTNB ENSG00000105849 "TWIST neighbor" Q3B726 7 19695462-19709087 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019071, HPA022416" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA019071: AB_1858465, HPA022416: AB_1858466" "unprognostic (5.66e-3)" "unprognostic (3.43e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.98e-3)" "unprognostic (1.85e-2)" "prognostic unfavourable (1.85e-4)" "unprognostic (1.16e-1)" "unprognostic (5.87e-2)" "unprognostic (2.03e-1)" "unprognostic (5.02e-2)" "unprognostic (4.93e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (9.06e-2)" "unprognostic (4.95e-3)" "unprognostic (2.96e-1)" 16.4 13.9 11.5 13.6 17.6 21.5 15.8 13.2 20.8 16.1 14.0 9.9 12.3 8.5 20.4 9.4 14.8 14.3 9.7 14.6 13.5 12.5 13.3 15.9 9.9 16.6 13.1 11.7 17.5 12.6 15.4 12.0 16.4 13.5 15.3 11.0 6.4 11.4 14.5 25.5 13.8 11.4 22.7 13.4 17.7 12.4 10.8 11.3 20.8 13.6 14.1 18.8 20.2 14.4 10.8 7.7 3.5 5.0 14.6 11.6 5.0 11.5 8.8 6.5 9.7 7.6 9.4 5.1 6.6 5.0 7.8 9.1 7.2 10.2 12.9 19.5 8.3 10.5 13.2 12.4 14.6 4.1 10.2 12.0 7.1 5.5 11.7 24.4 8.7 8.5 8.8 8.6 10.3 12.7 18.4 11.7 11.2 4.2 13.4 22.9 17.0 10.0 10.9 11.3 13.6 12.9 6.0 4.7 7.2 6.0 16.6 8.3 6.6 22.0 10.6 16.3 8.7 15.0 16.1 15.0 9.2 33.0 10.9 36.8 23.8 3.5 3.9 1.1 7.2 5.0 10.8 10.8 8.6 9.5 6.0 10.4 10.0 11.6 0.3 14.6 4.7 7.7 7.8 5.0 11.5 17.6 13.2 20.8 13.5 12.5 13.1 11.7 13.5 11.3 TWSG1 TSG ENSG00000128791 "Twisted gastrulation BMP signaling modulator 1" Q9GZX9 18 9334767-9402420 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014898 Uncertain Supported Centrosome,Cytosol "Secreted - unknown location" 6600000 "Centrosome, Cytosol" "HPA014898: AB_1858467" "unprognostic (2.55e-1)" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (8.95e-3)" "unprognostic (2.92e-3)" "unprognostic (1.83e-1)" "unprognostic (8.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" 13.0 8.9 8.3 6.9 8.5 2.9 17.3 5.0 6.2 21.9 17.4 9.3 56.2 4.7 33.0 21.5 19.0 14.4 16.4 9.2 8.4 7.1 19.8 4.8 12.6 6.6 11.0 6.1 20.4 4.4 12.7 11.4 10.7 9.1 26.5 10.2 10.6 9.4 34.8 6.1 7.6 8.6 36.0 12.3 9.4 12.0 13.0 8.1 4.3 20.5 8.7 6.8 26.0 17.9 3.3 7.8 7.5 4.1 4.1 7.5 3.1 14.8 5.4 15.6 7.7 30.8 27.9 7.2 28.4 35.4 15.6 22.5 5.7 19.6 2.1 14.4 37.5 5.2 15.2 11.2 28.9 5.8 4.3 3.8 4.6 2.8 27.4 2.7 8.0 28.2 9.2 13.1 6.3 24.2 5.8 3.9 40.0 4.5 3.0 3.4 5.1 4.4 5.3 16.0 1.3 17.7 19.9 2.0 5.4 22.3 6.2 6.0 7.0 6.5 20.0 28.7 14.4 26.9 17.7 5.8 5.1 4.0 17.6 3.9 10.1 7.5 4.1 5.8 6.7 2.2 4.4 3.3 3.2 6.8 7.8 2.8 3.8 7.5 2.0 4.1 0.7 7.8 1.4 3.1 8.3 8.5 5.0 6.2 8.4 7.1 11.0 6.1 9.1 8.1 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: " "prognostic favourable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favourable (5.53e-4)" "prognostic unfavourable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favourable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavourable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.7 16.9 17.7 19.8 22.9 30.3 14.3 28.3 22.5 27.4 26.3 18.8 21.5 22.6 11.5 27.4 22.4 24.0 18.6 25.0 25.8 18.6 35.7 24.6 24.6 24.4 25.9 28.4 30.3 25.0 28.9 13.7 21.6 14.5 23.4 22.3 10.9 18.9 16.7 25.7 15.6 22.3 26.8 19.9 18.7 25.2 18.5 19.1 29.3 18.6 30.0 17.2 15.8 22.4 29.0 25.1 38.2 36.0 35.0 27.0 20.5 30.0 35.4 26.7 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favourable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 61.9 85.2 23.1 25.5 58.3 76.0 34.0 75.5 70.5 52.6 40.1 55.3 74.8 55.3 32.5 69.7 140.2 32.9 100.6 51.7 81.9 73.0 27.7 79.9 95.6 66.7 68.7 84.6 53.9 66.4 77.0 58.3 46.2 46.5 53.3 71.9 50.2 57.2 103.1 49.1 104.0 24.0 78.3 64.4 67.3 44.0 50.3 18.0 81.4 66.2 51.2 63.5 47.6 55.4 54.3 35.1 101.8 93.5 27.0 76.2 47.0 78.8 60.0 75.3 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 TXNDC11 EFP1 ENSG00000153066 "Thioredoxin domain containing 11" Q6PKC3 16 11679080-11742878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041174, HPA041390" Supported Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041174: AB_10794191, HPA041390: AB_10796670" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (6.82e-3)" "prognostic favourable (2.12e-5)" "prognostic unfavourable (1.36e-4)" "unprognostic (2.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.68e-3)" "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (2.35e-2)" "unprognostic (9.96e-2)" "unprognostic (8.30e-2)" "unprognostic (3.23e-2)" "unprognostic (2.34e-2)" 12.5 12.5 6.1 10.9 8.1 24.1 12.3 12.8 9.9 12.7 20.8 8.3 13.2 19.2 12.9 16.0 12.6 12.7 17.5 11.4 7.3 4.4 21.2 47.2 22.4 21.3 7.4 4.4 13.9 22.9 28.6 11.4 15.0 7.1 13.2 15.4 18.6 24.1 14.3 23.2 9.9 27.4 7.8 5.0 23.6 17.6 5.6 6.7 15.9 28.6 11.6 33.2 15.0 10.2 5.7 3.6 9.6 3.3 7.8 9.2 3.5 8.7 6.1 2.8 3.9 7.7 6.5 5.0 8.7 11.9 8.0 10.3 3.0 14.0 22.1 14.7 10.9 7.9 3.5 7.3 6.6 9.8 4.6 4.7 7.0 14.7 11.4 6.8 9.5 4.9 8.3 8.9 14.2 10.0 7.1 28.5 7.0 7.9 5.3 2.6 3.7 3.1 6.9 5.8 47.3 9.1 4.7 4.0 3.8 17.0 13.3 9.2 8.1 9.5 10.3 3.7 4.3 17.4 5.0 38.9 21.2 13.3 7.9 8.7 6.2 4.9 3.3 9.6 2.7 2.5 6.6 5.7 4.9 6.0 3.6 4.9 4.8 3.1 1.0 7.8 2.8 2.8 9.2 3.5 6.1 8.1 12.8 9.9 7.3 4.4 7.4 4.4 7.1 6.7 TXNIP "ARRDC6, EST01027, HHCPA78, THIF, VDUP1" ENSG00000265972 "Thioredoxin interacting protein" Q9H3M7 1 145992435-145996600 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 110.2;HSkMC: 146.6;hTCEpi: 74.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031085, HPA053694" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA031085: AB_10601706, HPA053694: AB_2682232" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.92e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (2.51e-1)" "unprognostic (9.23e-2)" "unprognostic (1.20e-1)" "unprognostic (3.65e-2)" "unprognostic (1.19e-1)" "unprognostic (8.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (8.19e-2)" "unprognostic (2.22e-3)" 127.7 10.6 4.1 17.0 4.6 10.5 73.6 2.5 6.0 45.9 49.8 16.1 25.0 6.3 39.3 22.8 41.0 20.3 20.4 55.3 4.8 34.8 11.7 52.3 82.6 6.5 4.2 34.1 25.8 9.3 20.2 19.1 8.3 47.4 16.1 18.8 18.5 19.5 97.0 15.3 27.7 34.6 9.2 39.0 13.6 23.1 6.0 29.0 85.3 16.0 41.5 52.5 32.3 64.9 35.5 134.9 58.3 65.3 90.0 132.5 6.0 0.0 1.4 0.1 33.5 110.2 3.3 7.2 14.5 6.5 9.0 3.8 8.2 1.7 42.9 1.9 1.6 1.4 13.7 17.6 7.9 0.7 4.9 2.2 3.5 1.5 20.1 10.3 146.6 74.7 13.3 23.5 2.5 19.5 13.5 3.3 8.2 3.3 19.3 4.0 5.4 3.0 12.1 52.3 17.1 13.4 6.9 11.2 31.1 9.0 24.6 3.2 28.8 6.1 18.2 1.1 34.0 11.8 19.0 18.1 1.5 4.4 9.3 9.5 94.7 53.3 123.0 90.0 58.3 83.1 58.8 76.5 79.9 35.5 64.9 76.0 80.3 134.9 65.3 49.9 16.7 70.6 132.5 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: " "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.5 29.0 25.9 24.6 21.2 22.4 23.0 23.5 19.0 31.9 29.0 27.0 15.4 26.3 8.8 22.4 18.4 31.1 27.3 21.1 30.7 39.5 18.9 44.1 63.4 27.1 54.0 30.9 20.8 24.2 22.7 29.1 30.0 16.5 38.4 22.2 39.0 38.3 36.6 20.2 63.0 23.4 17.3 54.2 31.3 34.2 39.7 28.9 11.6 34.6 42.8 17.0 32.2 14.1 28.2 34.6 12.8 28.6 17.1 64.0 43.2 26.4 41.1 25.8 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 TXNL4B "Dim2, DLP, FLJ20511" ENSG00000140830 "Thioredoxin like 4B" Q9NX01 16 72044289-72094431 "Predicted intracellular proteins" "Cell cycle, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065865 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA065865: " "unprognostic (1.45e-1)" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (3.78e-2)" "unprognostic (8.72e-2)" "unprognostic (4.75e-2)" "unprognostic (2.65e-1)" "unprognostic (8.91e-2)" "unprognostic (4.75e-2)" "unprognostic (1.04e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.62e-1)" "unprognostic (2.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" 11.1 10.0 14.1 11.5 16.3 15.6 12.3 18.6 17.0 11.0 11.7 18.5 10.4 12.8 10.2 10.3 12.2 13.3 11.2 9.3 13.2 12.2 9.8 20.8 8.8 13.0 20.9 13.6 27.8 12.6 11.0 19.9 9.4 13.7 9.8 10.8 9.8 10.7 10.3 11.3 10.1 10.4 8.7 17.2 10.0 10.0 18.9 15.3 14.0 10.9 6.0 11.9 8.6 13.7 10.8 9.4 18.3 14.2 5.0 13.7 9.9 6.8 10.3 5.7 7.7 4.2 5.0 12.7 9.0 7.4 15.9 12.0 10.5 6.4 10.1 6.6 4.6 9.3 10.1 5.3 12.4 5.0 9.5 9.3 7.9 15.8 9.0 11.0 8.1 5.2 3.7 14.0 13.2 6.7 22.3 6.1 7.5 13.1 13.2 9.6 10.3 9.6 13.6 7.2 13.5 5.8 5.2 13.0 11.3 8.5 4.0 11.7 9.2 7.0 6.4 7.6 11.1 6.3 8.4 12.1 19.5 41.9 8.5 7.4 7.5 18.3 9.8 12.9 9.2 10.9 13.7 10.8 9.5 7.8 8.5 9.0 13.1 12.7 13.9 5.0 14.2 9.4 10.5 9.9 14.1 16.3 18.6 17.0 13.2 12.2 20.9 13.6 13.7 15.3 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2 OS: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Supported Mitochondria,Cytosol 410000 Mitochondria Cytosol "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favourable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.3 13.2 1.2 5.1 2.4 3.4 3.0 6.1 7.2 11.1 8.2 12.2 6.6 3.5 14.9 6.4 11.3 6.1 8.4 4.2 6.7 15.1 5.9 10.5 7.2 4.6 6.6 2.9 3.3 6.4 5.7 4.8 31.4 32.8 6.0 8.6 15.4 2.2 9.9 6.1 9.4 3.4 29.3 3.2 6.7 6.9 6.5 5.7 10.5 13.8 7.0 11.2 9.0 17.4 8.1 48.8 6.7 12.8 6.0 4.4 2.2 7.8 5.1 10.2 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 TXNRD3 "TGR, TR2, TRXR3" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126607052-126655155 "Enzymes, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.0" "Lineage enriched" "Detected in single" 4 "T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB020802: , HPA036109: " "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavourable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favourable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.4 5.9 4.9 2.4 4.7 0.9 7.2 5.5 5.7 7.3 4.2 4.6 5.5 1.6 8.3 7.1 6.4 4.7 5.2 4.9 4.0 2.9 6.7 10.0 7.0 5.2 4.6 3.5 8.8 7.1 12.3 8.5 3.3 7.0 5.2 3.6 6.4 5.7 5.1 7.3 4.8 2.6 8.1 5.1 3.3 4.9 27.8 5.8 5.0 7.4 3.6 2.1 6.6 5.3 0.3 0.7 0.5 0.9 0.9 4.0 0.3 13.7 3.5 4.5 7.1 8.4 12.7 2.3 6.1 5.5 5.0 7.1 6.3 7.8 0.0 7.8 8.4 5.5 5.6 6.3 6.3 0.0 4.1 1.6 3.3 4.8 7.2 5.5 0.5 11.6 5.5 1.7 11.6 3.6 3.3 0.0 8.0 9.9 1.1 3.0 6.4 2.7 0.4 3.9 2.2 5.3 6.9 7.8 4.8 17.4 5.1 8.8 7.0 2.1 6.0 6.1 1.5 8.3 2.8 3.6 1.5 0.0 3.3 1.9 5.2 0.0 0.9 0.5 0.5 0.8 0.1 0.0 0.2 0.6 0.7 0.3 4.0 1.3 0.0 0.9 0.2 0.0 0.0 0.3 4.9 4.7 5.5 5.7 4.0 2.9 4.6 3.5 7.0 5.8 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530056 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.9;HHSteC: 39.3;Karpas-707: 38.0;U-266/70: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9" "Group enriched" "Detected in many" 18 "dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0" "Low region specificity" "Detected in some" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus" 16000000 "Nuclear bodies" "Golgi apparatus" "CAB002518: AB_563953, HPA000530: , HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favourable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavourable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 25.2 7.9 2.8 41.6 8.4 12.1 19.0 1.5 4.4 10.7 10.7 3.8 2.3 10.4 4.4 15.7 22.0 13.7 9.6 15.0 7.0 2.6 18.6 38.1 28.8 57.8 6.5 0.4 7.5 5.8 1.7 3.9 11.5 9.1 7.9 4.9 5.4 16.5 3.8 10.0 8.8 13.9 7.3 15.2 43.9 12.4 3.0 5.0 13.3 12.5 25.5 28.8 12.4 9.4 0.9 12.2 18.2 23.0 0.8 0.9 2.6 6.5 0.7 0.0 0.1 0.9 1.2 0.6 1.1 0.1 2.4 5.3 0.0 15.9 0.5 0.8 2.7 5.8 0.2 0.2 0.0 2.8 1.4 0.3 1.1 0.4 39.3 0.1 7.6 2.4 2.4 3.2 0.0 0.0 0.2 38.0 0.2 0.1 0.0 1.0 0.0 2.1 0.2 0.0 7.6 0.0 0.0 0.0 1.4 6.1 8.3 0.5 0.6 4.8 1.5 0.0 0.6 0.1 0.2 18.2 3.7 0.4 0.2 0.1 0.2 2.5 23.0 18.2 0.3 22.4 0.2 0.8 0.3 0.2 12.2 0.9 0.2 0.1 6.7 0.8 15.9 1.1 0.9 2.6 2.8 8.4 1.5 4.4 7.0 2.6 6.5 0.4 9.1 5.0 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell line enhanced" "Detected in many" "HaCaT: 17.7;PC-3: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.4 6.7 0.5 4.0 0.7 0.6 2.4 1.2 0.8 1.4 1.3 4.3 6.0 8.4 4.0 0.3 17.7 0.7 2.6 0.3 5.3 6.0 0.5 1.9 2.1 1.6 0.7 0.0 1.2 5.1 1.2 2.1 1.0 0.0 2.6 0.6 4.2 3.2 3.5 2.2 27.2 5.6 1.6 3.7 0.6 1.6 4.9 2.5 4.1 9.3 3.6 6.0 0.7 1.7 1.6 1.1 3.0 5.3 9.6 5.8 4.1 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA015535: AB_1856487, HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.5 13.5 8.3 17.1 12.4 8.6 9.6 11.3 8.6 9.0 8.4 15.4 13.8 18.4 17.4 10.4 12.5 17.1 13.9 13.0 14.4 13.1 7.9 11.2 10.4 12.3 18.3 10.6 8.8 14.1 12.1 18.7 8.1 20.9 11.1 10.2 10.4 11.5 15.3 14.5 12.1 13.1 11.6 23.1 12.2 10.7 12.7 12.6 13.6 26.4 11.3 18.0 13.0 9.5 10.3 7.4 8.2 15.4 11.2 15.8 22.2 8.4 17.2 14.2 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.4 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.0 1.1 7.9 4.1 7.2 0.7 0.8 1.1 1.9 0.8 1.3 7.7 2.3 0.7 1.2 4.6 0.8 7.3 2.0 3.7 0.6 1.3 0.8 0.7 9.8 7.6 1.0 0.9 2.3 3.7 1.8 4.5 1.4 5.4 2.6 1.1 0.8 1.8 0.9 1.5 8.2 4.3 2.1 2.6 3.1 1.8 4.3 9.5 1.4 6.6 8.0 8.2 0.5 2.0 9.5 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavourable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 16.5 19.7 13.7 13.5 17.7 11.9 18.3 15.0 19.9 20.4 17.7 7.5 13.7 9.5 21.0 15.2 20.6 16.4 10.0 21.1 11.1 12.9 20.4 17.0 11.3 14.3 16.2 17.2 30.0 14.4 22.2 34.3 13.5 17.0 20.7 12.3 8.6 13.8 15.7 12.3 10.5 10.9 24.7 15.6 16.0 14.8 12.3 18.1 12.3 23.5 14.3 16.9 23.5 33.3 9.7 9.0 6.0 8.0 13.6 13.9 5.2 8.4 7.1 12.4 8.8 14.1 15.4 18.8 14.6 13.4 14.0 12.3 15.1 7.2 22.3 13.4 12.6 6.9 14.1 16.9 17.6 13.8 12.2 17.5 21.8 29.2 9.2 34.9 11.3 11.7 17.1 17.8 17.3 12.4 30.3 17.1 17.9 7.2 17.0 11.7 32.8 16.7 16.1 25.8 10.0 12.0 11.1 9.6 8.2 6.9 19.1 22.4 10.4 12.8 8.0 6.2 17.0 16.8 17.5 9.9 17.9 15.6 13.9 12.7 17.8 6.0 6.0 1.6 10.3 8.0 9.9 9.7 9.1 9.3 9.0 8.8 13.2 13.9 0.5 13.6 5.9 8.7 8.4 5.2 13.7 17.7 15.0 19.9 11.1 12.9 16.2 17.2 17.0 18.1 U2AF2 U2AF65 ENSG00000063244 "U2 small nuclear RNA auxiliary factor 2" P26368 19 55654146-55674715 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010910, HPA041943, HPA043562" Supported Supported Enhanced "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "CAB010910: AB_262122, HPA041943: , HPA043562: " "unprognostic (2.37e-1)" "unprognostic (2.22e-1)" "unprognostic (3.12e-1)" "unprognostic (9.60e-2)" "unprognostic (6.94e-2)" "unprognostic (4.01e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (9.46e-2)" "unprognostic (1.36e-2)" "unprognostic (8.00e-2)" "unprognostic (3.33e-2)" "unprognostic (4.25e-3)" "unprognostic (2.19e-2)" "unprognostic (4.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.08e-2)" 32.1 39.3 40.0 51.9 40.0 68.2 34.1 53.4 44.1 39.6 43.7 41.2 37.0 46.2 45.0 32.5 47.9 43.6 35.4 33.8 35.0 29.4 36.5 39.1 35.6 59.6 41.1 33.7 51.4 38.3 37.7 48.1 42.9 31.5 36.8 29.7 35.9 36.4 39.5 33.3 42.7 43.0 34.7 32.4 58.1 37.4 104.4 41.4 68.4 42.0 34.0 50.4 36.3 42.9 3.0 4.1 5.5 4.0 1.4 3.0 1.7 43.9 72.1 44.1 36.2 20.9 21.3 47.7 35.7 33.5 61.3 59.7 41.9 41.8 53.2 29.0 30.1 36.1 54.8 49.6 27.3 40.0 91.6 44.5 32.3 38.4 34.0 50.6 51.1 28.9 30.1 45.8 30.3 35.2 53.1 34.3 31.0 41.3 70.2 44.5 48.6 57.4 76.7 28.5 42.5 33.6 51.5 52.5 40.8 39.1 37.0 22.5 36.1 53.6 30.1 54.0 39.2 24.8 75.3 31.3 42.3 63.1 24.0 50.2 45.9 0.2 2.6 2.2 3.0 4.0 2.6 2.1 2.7 2.4 2.4 3.0 2.2 2.0 5.5 1.4 2.6 4.1 2.9 1.7 40.0 40.0 53.4 44.1 35.0 29.4 41.1 33.7 31.5 41.4 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.0" "Cell line enhanced" "Detected in many" "BJ: 61.3;BJ hTERT+: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 11 "B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavourable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavourable (1.03e-4)" 21.7 8.9 4.7 8.6 8.1 0.4 25.9 2.9 5.8 15.4 14.1 8.4 22.8 10.6 17.2 22.3 15.6 10.5 15.7 18.0 6.1 4.2 16.4 8.2 23.7 7.5 9.0 4.6 17.5 8.6 8.2 6.5 13.7 9.6 15.5 7.6 26.7 18.8 26.9 68.0 10.1 16.9 11.4 14.9 15.7 8.4 10.1 7.1 1.0 18.6 32.4 5.3 9.9 13.5 3.4 2.0 0.2 4.3 0.1 0.3 0.7 10.4 8.6 3.8 5.1 7.8 33.8 0.0 61.3 37.5 16.1 13.9 14.4 15.5 7.2 16.9 15.2 12.1 8.7 4.8 20.3 0.0 3.8 4.0 6.7 3.0 10.2 0.1 1.5 15.9 2.7 9.5 7.2 17.0 1.0 0.0 19.9 3.4 0.0 0.6 3.2 4.5 0.0 28.0 0.0 7.8 3.5 1.0 1.9 11.6 1.8 12.3 3.4 1.2 32.6 0.9 6.5 5.2 9.7 0.6 2.1 0.0 8.1 1.1 6.9 0.2 2.2 0.0 0.0 4.3 0.0 1.2 0.1 0.0 2.0 3.4 0.3 0.1 0.2 0.1 2.9 0.1 0.0 0.7 4.7 8.1 2.9 5.8 6.1 4.2 9.0 4.6 9.6 7.1 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 105.7;U-251 MG: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavourable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 29.9 2.1 6.0 4.8 29.2 23.4 4.1 44.1 16.2 34.0 27.8 5.7 14.1 1.1 9.9 33.8 5.2 6.7 12.8 56.1 4.7 10.1 5.3 6.9 11.1 13.7 9.0 3.6 10.8 6.1 37.3 105.7 20.8 29.9 12.4 45.4 5.5 5.2 5.8 4.4 9.8 4.7 11.7 14.6 5.3 3.5 6.4 6.7 19.2 12.0 10.2 5.9 10.3 35.3 17.2 15.8 43.2 68.8 20.8 7.3 9.9 9.8 4.2 10.8 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 UAP1L1 ENSG00000197355 "UDP-N-acetylglucosamine pyrophosphorylase 1 like 1" Q3KQV9 9 137077501-137084539 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044356 Approved Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA044356: AB_10959902" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (2.49e-2)" "unprognostic (3.80e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (3.01e-2)" "unprognostic (2.33e-1)" "unprognostic (5.65e-2)" "prognostic favourable (5.23e-4)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (1.67e-2)" "unprognostic (6.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.64e-3)" 10.5 14.7 13.6 9.8 20.6 5.0 16.3 3.4 17.5 13.0 8.8 22.1 8.6 10.0 7.3 9.7 5.9 5.8 9.4 11.3 14.7 8.1 12.5 3.1 11.6 12.2 24.9 9.3 3.9 10.5 8.5 14.7 10.9 14.2 12.8 6.7 14.1 15.2 10.9 2.5 9.0 9.4 6.6 13.5 20.3 10.8 3.5 29.1 1.4 13.3 4.9 10.3 11.4 13.9 2.1 1.8 0.6 3.7 0.3 3.0 1.2 0.4 2.8 0.0 7.6 13.1 6.1 2.2 3.8 10.1 10.9 7.6 5.5 1.3 1.7 2.3 3.9 5.8 14.2 0.9 2.2 4.6 1.3 3.7 4.2 5.2 29.2 0.0 15.4 4.5 1.0 6.2 5.1 8.5 1.1 8.7 7.3 6.2 0.3 3.8 1.2 4.0 6.0 0.1 5.3 4.3 0.5 4.5 2.8 0.9 21.3 8.6 11.5 10.3 6.7 19.7 4.3 13.7 1.8 9.5 13.6 3.7 17.1 4.0 5.6 0.4 3.7 0.1 0.8 2.0 3.0 2.1 0.4 1.3 1.8 1.0 1.0 1.3 0.6 0.3 0.0 1.1 1.7 1.2 13.6 20.6 3.4 17.5 14.7 8.1 24.9 9.3 14.2 29.1 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: , HPA065335: " "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavourable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 33.8 11.4 17.6 34.6 9.6 17.8 18.3 24.9 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.0 10.1 17.8 14.6 12.6 14.4 18.7 23.4 24.2 14.7 17.1 18.3 10.1 21.6 17.2 16.9 16.5 17.6 18.4 21.9 20.5 7.5 26.2 16.3 20.5 12.5 32.1 15.4 12.5 10.9 14.0 21.1 16.5 16.3 32.0 16.4 24.0 17.7 12.1 16.2 9.7 15.5 15.6 40.9 13.5 21.0 17.2 15.5 13.7 13.8 19.8 16.6 16.3 14.8 15.6 15.3 7.5 12.2 30.3 20.3 40.0 17.8 11.7 13.9 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: , HPA049132: , HPA056624: " "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 84.7 73.8 71.1 76.4 76.5 167.0 101.5 32.8 71.1 83.2 73.0 48.7 67.8 47.7 79.0 93.2 102.7 78.8 82.0 85.9 58.2 50.2 74.1 135.5 67.7 182.7 64.0 59.0 150.3 225.2 56.5 62.8 71.6 55.5 75.8 74.0 51.6 96.0 75.2 191.4 104.6 68.0 91.9 72.0 101.1 75.5 89.5 52.1 121.2 97.6 131.7 145.1 99.9 161.7 200.5 157.0 75.1 132.4 109.7 205.0 246.6 104.6 83.7 62.9 104.8 163.3 155.4 155.9 80.9 112.4 134.4 107.3 151.5 98.2 151.9 83.7 133.3 71.0 121.5 143.8 127.2 40.7 189.8 83.1 130.1 170.8 119.0 180.2 106.5 179.8 196.8 92.1 134.0 134.6 131.4 210.6 114.6 175.3 143.9 161.7 140.7 181.3 119.1 62.8 173.8 129.5 159.2 82.0 99.2 58.7 142.4 140.2 63.1 233.3 99.9 67.5 56.4 142.0 142.9 129.7 172.1 150.3 91.8 204.8 91.3 50.7 132.4 69.8 119.4 107.2 162.2 200.5 178.5 142.6 147.6 199.1 205.0 165.6 75.1 109.7 96.1 157.0 138.5 246.6 71.1 76.5 32.8 71.1 58.2 50.2 64.0 59.0 55.5 52.1 UBA6 "FLJ10808, UBE1L2" ENSG00000033178 "Ubiquitin like modifier activating enzyme 6" A0AVT1 4 67612652-67701179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037001 Approved Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037001: AB_10672787" "unprognostic (2.52e-1)" "unprognostic (4.89e-2)" "unprognostic (3.97e-3)" "unprognostic (2.81e-1)" "unprognostic (3.67e-2)" "unprognostic (4.92e-2)" "unprognostic (3.55e-3)" "unprognostic (6.06e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-2)" "unprognostic (3.38e-2)" "unprognostic (5.30e-2)" "prognostic unfavourable (7.01e-5)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.05e-3)" 16.8 12.6 14.1 14.1 16.6 22.7 13.0 18.0 16.0 17.0 10.5 14.6 7.0 12.2 16.7 10.0 20.5 9.9 12.4 9.5 12.0 12.0 10.2 16.4 14.5 17.3 18.7 11.2 14.3 10.9 17.4 44.8 18.5 17.7 12.7 13.2 7.5 13.7 10.4 10.1 12.6 15.3 13.4 20.7 16.9 13.9 14.6 18.6 27.1 12.3 13.3 19.9 15.7 19.5 5.6 5.1 9.3 4.0 9.7 5.8 1.9 14.8 8.3 13.8 10.8 6.8 8.1 9.3 30.8 12.1 14.1 16.5 8.7 20.1 18.8 11.0 12.6 8.8 14.2 15.3 21.3 21.6 4.0 12.0 14.7 8.1 5.8 21.1 9.2 5.7 4.9 18.2 11.1 12.4 28.6 11.2 16.6 5.6 21.9 4.8 8.1 10.1 13.0 28.3 6.9 11.5 16.9 6.7 8.5 17.4 12.4 5.8 8.2 5.7 17.9 13.1 14.7 10.6 13.4 8.1 6.3 19.0 23.3 5.9 12.5 9.3 3.0 4.6 4.4 3.9 4.8 5.6 5.1 5.8 3.7 5.2 3.9 4.5 2.2 9.7 4.0 5.1 4.2 1.9 14.1 16.6 18.0 16.0 12.0 12.0 18.7 11.2 17.7 18.6 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: " "prognostic favourable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favourable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.0 12.7 1.3 2.3 10.4 16.7 22.3 0.0 9.1 0.1 1.8 8.5 2.4 0.0 4.1 1.4 11.1 0.0 20.8 0.2 1.3 8.9 1.9 40.6 19.5 0.2 6.5 0.4 8.3 0.0 1.3 3.8 0.1 4.2 5.1 0.0 0.4 5.4 0.4 0.7 3.4 8.4 0.0 0.3 2.8 4.1 1.4 0.4 13.8 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.1 7.4 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961380 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 113.2" "Cell line enhanced" "Detected in all" "HDLM-2: 59.3;K-562: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" 54000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favourable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favourable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 7.6 5.7 12.4 5.8 13.4 27.1 6.2 10.9 12.7 6.1 11.0 8.0 6.8 9.9 6.2 10.3 10.0 9.4 5.1 22.2 11.0 8.6 8.8 7.6 6.4 5.8 11.6 7.4 7.8 6.7 6.9 6.6 9.3 8.7 7.4 7.8 7.7 9.2 9.2 113.2 15.7 9.6 9.3 10.1 5.7 6.1 10.9 7.8 3.9 6.1 21.9 9.0 7.6 8.3 3.2 9.7 5.1 18.8 2.2 3.6 4.0 8.9 10.5 7.5 10.8 5.6 6.6 14.0 7.9 6.7 9.8 7.9 14.5 11.5 10.8 7.6 6.4 30.7 10.4 9.1 4.4 59.3 9.8 9.0 18.9 8.1 5.9 11.7 8.7 6.2 12.0 6.2 6.0 8.1 75.2 8.8 7.7 18.5 9.6 12.1 17.7 17.9 10.8 14.1 14.3 7.0 5.8 11.6 12.8 11.4 10.3 8.0 8.7 12.7 6.6 5.6 8.4 6.6 9.7 5.1 9.6 12.9 10.3 10.7 7.6 3.4 11.3 5.1 3.1 17.2 3.3 3.2 3.6 2.1 9.7 2.0 1.9 2.2 2.5 2.2 18.8 1.0 2.7 4.0 12.4 13.4 10.9 12.7 11.0 8.6 11.6 7.4 8.7 7.8 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: " "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.7 3.7 5.9 2.5 3.3 16.8 8.2 3.4 3.2 4.6 7.7 6.4 8.1 9.2 2.5 15.0 2.4 8.4 0.9 17.0 23.9 7.6 16.4 11.9 5.2 4.7 13.0 4.6 6.3 4.9 2.4 3.4 11.4 8.5 1.2 26.8 7.8 25.7 14.0 13.9 11.3 4.6 26.2 2.8 7.9 10.9 10.0 9.7 15.0 12.9 9.6 7.7 10.0 6.5 7.3 25.8 5.3 16.6 13.3 9.1 2.6 6.4 3.3 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 UBAP1 UBAP ENSG00000165006 "Ubiquitin associated protein 1" Q9NZ09 9 34179005-34252523 "Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019804 Approved Supported "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA019804: AB_1858494" "unprognostic (1.83e-1)" "unprognostic (4.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-1)" "unprognostic (2.01e-2)" "unprognostic (6.53e-2)" "unprognostic (1.25e-2)" "unprognostic (3.63e-1)" "prognostic favourable (7.49e-6)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (1.17e-1)" 26.4 34.6 25.7 17.5 25.0 81.9 28.6 29.1 29.5 24.2 26.0 26.5 14.5 16.6 25.3 20.0 40.5 20.4 22.9 34.4 24.0 23.6 25.6 38.6 27.7 17.3 27.0 20.0 26.8 20.7 26.7 19.2 26.8 25.5 20.4 19.0 21.5 19.4 24.3 62.3 22.6 24.6 26.4 26.3 21.4 20.9 33.5 26.0 17.2 23.6 22.1 25.4 29.2 29.5 10.5 17.8 45.9 19.6 17.4 26.5 19.2 20.7 11.6 13.5 14.7 25.0 15.5 11.4 16.6 23.4 18.7 25.5 12.7 8.7 14.5 7.5 24.9 10.7 18.7 26.1 18.0 20.9 8.4 13.0 26.2 13.1 22.8 14.4 17.3 19.1 43.4 22.1 29.1 20.6 9.9 14.6 17.4 8.7 13.2 20.1 14.6 17.5 12.0 9.6 8.4 40.0 13.8 7.7 10.8 18.5 19.3 8.5 9.4 14.3 14.7 9.6 14.9 14.3 15.4 7.2 9.0 15.3 19.3 11.7 28.2 9.0 19.6 24.1 15.4 17.1 26.5 10.5 15.5 16.1 17.8 8.8 15.1 12.3 45.9 17.4 14.5 9.9 19.1 19.2 25.7 25.0 29.1 29.5 24.0 23.6 27.0 20.0 25.5 26.0 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavourable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 33.8 33.0 39.1 34.8 47.5 32.7 32.3 34.3 46.6 31.2 31.3 32.9 25.5 20.6 40.6 30.3 36.1 34.8 28.3 36.9 38.3 25.2 26.7 23.9 35.1 34.1 26.5 39.5 42.7 25.0 42.1 40.6 43.9 30.5 29.2 25.8 31.2 31.8 32.8 53.2 36.8 25.3 36.6 30.2 30.5 27.4 37.5 30.2 34.6 33.8 26.6 38.5 37.9 32.4 18.3 24.3 17.6 26.5 24.6 20.6 18.3 42.7 41.3 40.5 31.9 28.9 33.1 34.8 49.3 35.7 44.8 31.2 44.3 33.3 53.5 51.3 41.3 37.2 53.0 36.3 39.5 47.1 45.4 57.9 42.8 36.9 27.2 60.3 34.3 31.4 15.9 40.5 25.9 35.4 52.6 26.0 35.2 46.6 47.0 22.6 75.3 39.2 33.8 32.0 47.2 28.0 50.1 41.3 50.0 56.7 53.4 21.5 53.6 41.8 56.8 27.8 29.5 34.1 46.8 57.0 61.3 72.8 29.9 33.1 41.5 8.8 19.2 13.2 17.5 25.1 19.1 15.6 16.4 15.7 24.3 18.3 19.1 20.6 17.6 24.6 26.5 11.4 14.7 18.3 39.1 47.5 34.3 46.6 38.3 25.2 26.5 39.5 30.5 30.2 UBASH3A "CLIP4, STS-2, TULA" ENSG00000160185 "Ubiquitin associated and SH3 domain containing A" P57075 21 42403447-42447681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 17.6;lymphoid tissue: 62.3" "Group enriched" "Detected in some" 6 "HEL: 14.6;MOLT-4: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6" "Lineage enriched" "Detected in many" 15 "T-cells: 17.6" "Region enriched" "Detected in single" 13 "hippocampal formation: 0.5" "Low region specificity" "Detected in all" HPA035367 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA035367: " "unprognostic (5.14e-4)" "unprognostic (3.91e-4)" "unprognostic (1.57e-2)" "unprognostic (4.10e-5)" "unprognostic (4.33e-2)" "unprognostic (1.85e-6)" "unprognostic (5.54e-4)" "unprognostic (1.46e-3)" "unprognostic (6.17e-4)" "unprognostic (2.47e-3)" "unprognostic (1.94e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-6)" "unprognostic (1.65e-1)" "unprognostic (7.96e-2)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" 1.1 0.7 0.3 19.7 0.3 2.6 0.8 0.3 0.3 0.9 2.8 0.1 0.0 1.9 0.8 0.8 1.2 1.3 3.2 1.1 0.3 0.4 1.4 1.1 6.0 23.1 0.4 0.0 0.7 0.6 0.0 0.6 0.4 0.3 1.2 1.0 1.1 5.0 0.2 0.3 0.5 5.9 0.6 0.7 10.8 2.2 0.4 0.0 62.3 1.4 1.1 14.1 2.6 1.1 0.0 0.0 0.3 0.0 1.1 17.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 14.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 29.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 12.1 0.0 15.1 13.1 0.0 0.0 17.6 12.8 0.3 1.1 0.0 0.0 13.6 5.1 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.0 UBD FAT10 ENSG00000213886 "Ubiquitin D" O15205 6 29555515-29559925 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.2" "Cell line enriched" "Detected in some" 13 "RT4: 13.5" "Cancer enhanced" "Detected in all" "liver cancer: 75.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043710 Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA043710: AB_2756303" "unprognostic (2.99e-3)" "unprognostic (4.16e-2)" "unprognostic (6.37e-2)" "unprognostic (2.61e-2)" "unprognostic (3.93e-2)" "unprognostic (3.53e-3)" "unprognostic (1.60e-1)" "unprognostic (9.47e-2)" "unprognostic (1.44e-2)" "prognostic favourable (7.35e-4)" "unprognostic (1.28e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (2.40e-5)" "unprognostic (4.04e-2)" "unprognostic (6.02e-2)" "unprognostic (8.40e-2)" "unprognostic (1.21e-2)" 3.4 0.4 0.0 53.2 0.0 0.4 1.8 0.0 0.4 0.7 1.8 0.0 0.0 1.5 0.6 1.6 4.2 1.2 2.9 1.8 0.0 0.0 13.4 16.3 5.1 26.3 0.0 0.0 0.5 14.6 0.4 0.7 0.4 1.0 5.6 3.0 1.0 11.3 0.7 3.1 0.6 15.5 0.7 0.2 18.6 3.5 0.4 0.0 26.3 2.7 4.5 50.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 UBE2A "HHR6A, RAD6A, UBC2" ENSG00000077721 "Ubiquitin conjugating enzyme E2 A" P49459 X 119574467-119591083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: , HPA051765: , HPA065898: " "unprognostic (2.27e-3)" "prognostic favourable (2.16e-4)" "unprognostic (1.12e-1)" "unprognostic (9.09e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.07e-4)" "unprognostic (1.66e-3)" "unprognostic (1.96e-2)" "unprognostic (6.54e-2)" "unprognostic (2.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (2.20e-6)" "unprognostic (9.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.21e-1)" "unprognostic (7.92e-2)" 24.8 20.6 26.7 23.1 24.6 16.8 32.5 20.2 24.2 23.7 32.8 23.9 20.2 21.7 23.8 26.7 37.2 20.3 21.2 42.2 23.6 22.1 32.2 26.6 22.8 26.3 26.8 19.7 18.7 17.2 24.3 18.2 112.4 24.7 20.4 30.2 20.0 21.0 22.6 46.8 23.6 29.2 27.9 29.1 25.1 20.4 17.0 19.5 36.3 23.2 32.8 31.5 26.7 24.0 21.0 29.0 34.1 36.3 12.8 21.2 17.4 32.5 27.5 17.3 14.6 30.3 37.4 16.2 33.8 30.2 40.3 38.3 14.2 22.4 25.8 34.4 37.2 23.5 24.7 17.9 38.9 35.8 14.6 11.4 22.0 12.7 27.8 28.5 19.6 25.5 25.6 38.6 16.8 27.9 14.0 23.1 45.6 34.5 43.9 26.9 28.8 31.1 22.4 18.4 24.0 32.5 21.4 13.3 13.7 45.0 20.7 24.6 18.0 24.9 27.2 25.9 11.6 51.1 38.1 22.4 36.4 25.3 27.5 36.1 20.2 16.5 22.7 34.1 18.1 35.4 14.3 21.0 15.7 15.8 29.0 18.8 10.0 14.3 30.1 12.8 36.3 23.0 21.2 17.4 26.7 24.6 20.2 24.2 23.6 22.1 26.8 19.7 24.7 19.5 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371179-134391992 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 83.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: , HPA051765: , HPA065898: " "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 17.7 27.7 20.4 17.0 16.6 25.9 22.8 16.2 28.3 13.8 18.0 7.9 11.6 14.4 19.4 17.0 25.6 13.6 18.3 59.2 20.3 16.4 17.8 19.8 21.8 18.7 13.8 18.7 16.7 26.4 7.8 16.2 27.8 17.6 15.4 15.1 10.2 16.1 18.5 106.5 15.9 16.2 21.6 15.1 16.6 14.1 21.7 12.7 13.2 18.2 34.0 16.3 19.2 22.8 9.6 8.8 83.3 14.1 9.6 14.6 10.5 36.2 9.6 20.0 19.0 17.5 18.9 32.3 27.3 14.4 17.6 21.0 28.9 24.4 19.8 33.0 17.4 14.5 15.1 20.2 19.2 31.4 16.3 10.9 26.5 31.0 20.5 12.9 22.4 16.2 27.5 15.9 13.5 15.0 19.9 36.0 15.8 21.2 20.4 34.1 8.6 9.1 20.6 22.0 27.6 15.7 28.1 27.0 21.1 21.4 10.1 47.4 21.8 35.6 29.7 20.5 14.3 27.5 29.8 30.1 41.2 27.9 23.1 24.4 20.3 34.7 11.5 31.2 9.4 12.5 8.6 9.6 12.0 9.5 7.9 9.6 14.6 12.3 83.3 9.6 14.1 8.8 14.1 10.5 20.4 16.6 16.2 28.3 20.3 16.4 13.8 18.7 17.6 12.7 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: , HPA054975: " "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.2 28.8 52.0 24.9 1.4 3.2 29.9 31.2 15.8 51.4 36.9 94.6 45.4 41.6 30.6 14.8 38.8 0.2 33.4 52.5 17.7 27.4 12.8 22.1 24.8 0.4 18.3 32.2 1.0 3.6 34.8 34.1 25.0 0.2 35.4 42.3 64.6 30.2 5.2 31.2 69.0 32.1 47.1 0.2 17.3 13.6 30.0 25.0 49.1 36.0 19.7 36.3 27.0 9.1 46.1 40.3 31.3 60.3 11.2 0.3 46.4 28.0 13.1 43.7 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334975-58370753 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavourable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavourable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 8.2 10.6 8.1 10.0 7.9 17.1 7.5 7.7 9.0 6.3 7.3 5.5 4.8 4.7 8.5 5.5 8.2 5.5 6.4 25.6 7.6 7.2 5.5 5.4 7.0 13.7 8.1 6.7 5.9 4.8 5.3 7.4 6.8 7.4 6.5 7.9 3.5 6.4 5.0 74.9 4.6 5.8 8.8 8.4 11.0 5.6 3.2 8.4 5.5 6.0 25.1 7.1 9.5 10.0 3.7 7.2 41.0 13.7 2.8 3.5 7.1 10.6 5.8 10.8 13.9 22.2 17.9 7.0 7.0 12.0 8.1 11.9 11.7 9.2 0.0 11.1 10.5 9.7 20.9 10.2 11.4 11.0 12.3 2.8 2.1 6.7 14.6 8.4 6.8 20.7 11.5 8.4 15.7 16.1 5.5 4.5 10.9 3.3 9.0 9.4 13.2 9.1 7.6 9.8 5.9 12.1 6.2 8.2 11.0 13.8 23.3 11.2 8.5 5.7 12.9 3.1 10.9 10.6 7.7 11.5 8.9 9.4 9.8 17.5 3.5 2.8 13.7 6.2 2.4 9.5 2.8 3.3 2.9 3.0 7.2 3.7 3.0 2.3 41.0 2.8 7.9 3.0 3.5 7.1 8.1 7.9 7.7 9.0 7.6 7.2 8.1 6.7 7.4 8.4 UBE2D2 "UBC4, UbcH5B" ENSG00000131508 "Ubiquitin conjugating enzyme E2 D2" P62837 5 139526431-139628433 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.14e-1)" "unprognostic (2.75e-3)" "prognostic favourable (5.09e-5)" "prognostic favourable (5.90e-4)" "unprognostic (2.33e-1)" "unprognostic (8.19e-3)" "prognostic unfavourable (9.63e-7)" "unprognostic (7.41e-3)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (9.33e-2)" "unprognostic (1.41e-3)" "prognostic unfavourable (2.09e-5)" "unprognostic (8.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.20e-1)" "unprognostic (1.07e-1)" 35.6 25.0 41.2 31.5 39.9 44.2 35.9 31.9 49.6 43.9 50.4 35.5 31.5 22.2 35.5 52.2 44.8 47.6 27.1 34.8 39.5 40.5 37.2 39.5 34.8 55.6 40.5 36.1 35.3 41.7 23.8 35.3 33.6 35.9 30.8 46.4 30.7 30.5 37.9 80.6 33.2 37.4 39.3 41.9 41.3 29.1 68.0 29.3 71.0 34.4 31.2 64.5 42.2 36.1 34.3 39.3 40.8 23.0 22.5 41.7 19.5 36.5 24.4 42.8 29.9 28.9 37.1 27.4 38.7 36.2 45.6 53.4 62.8 34.8 52.3 51.0 39.9 23.2 42.0 65.2 61.1 33.7 24.5 29.6 27.0 36.0 56.6 28.9 26.4 29.1 33.7 45.2 67.7 48.6 25.6 44.8 42.2 36.7 44.6 41.2 23.5 26.6 34.0 44.5 37.8 47.9 43.3 39.0 25.8 33.8 43.5 61.4 27.2 25.7 31.8 34.8 19.4 28.9 47.2 32.2 52.3 73.3 24.9 47.7 27.7 14.8 20.9 40.8 22.6 18.8 24.7 34.1 32.7 31.7 23.4 34.3 41.7 35.2 34.5 22.5 23.0 39.3 40.0 19.5 41.2 39.9 31.9 49.6 39.5 40.5 40.5 36.1 35.9 29.3 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favourable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 67.2 70.6 39.1 52.7 44.6 132.7 70.4 36.9 50.9 45.5 51.8 37.5 38.4 49.3 46.3 39.1 63.2 45.7 47.5 72.5 37.3 39.5 63.0 91.9 67.5 68.1 43.4 36.9 60.6 53.4 42.8 49.1 66.5 45.2 49.6 48.5 38.4 46.7 43.3 91.1 53.2 58.9 48.4 44.4 68.2 49.5 40.0 42.2 88.8 66.3 55.4 61.4 74.6 81.4 24.7 31.2 118.0 36.2 29.7 33.2 50.9 52.5 30.1 50.3 40.6 53.7 77.6 43.3 53.6 71.4 47.8 45.2 45.2 75.1 56.4 35.1 54.3 30.2 53.6 71.9 65.9 52.3 27.0 51.3 31.0 36.8 56.4 72.1 44.2 58.9 45.6 52.7 73.9 62.0 64.4 57.6 63.6 42.5 105.7 41.1 36.4 30.2 55.8 49.4 40.7 48.2 50.3 50.8 42.8 32.9 84.5 60.4 35.1 42.7 56.9 50.1 42.9 32.8 48.6 51.1 65.8 86.2 53.4 40.2 53.7 71.1 35.9 54.6 25.1 36.1 33.2 24.7 31.8 29.6 31.2 20.1 32.6 29.7 118.0 29.7 36.2 21.5 32.6 50.9 39.1 44.6 36.9 50.9 37.3 39.5 43.4 36.9 45.2 42.2 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926438-43956136 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.6" "Cell line enhanced" "Detected in all" "SH-SY5Y: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favourable (4.86e-4)" "prognostic favourable (5.77e-4)" "prognostic favourable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 10.1 13.1 14.7 5.0 13.3 4.5 9.1 13.8 17.4 8.8 7.6 11.4 7.9 5.3 7.5 11.2 8.0 9.0 7.2 23.8 14.2 10.0 12.7 15.3 8.4 5.3 12.1 9.4 7.9 17.4 8.7 6.9 5.9 11.9 8.7 6.2 8.1 10.6 9.1 48.6 9.4 5.3 10.3 12.8 7.3 6.5 5.1 6.1 2.7 9.6 16.1 5.7 7.7 6.5 10.7 11.8 12.9 20.5 7.7 14.0 6.7 3.7 3.2 1.9 8.9 9.2 3.7 1.5 1.9 4.6 2.4 3.1 1.7 4.5 3.7 5.2 4.9 4.3 2.5 2.0 3.6 8.1 4.1 3.9 4.9 4.3 3.4 8.5 8.0 2.9 4.3 2.7 4.1 2.9 4.3 7.6 3.2 2.4 5.0 4.9 4.3 4.1 3.1 2.7 5.6 5.0 4.6 7.3 24.7 3.9 7.9 2.9 3.9 2.6 2.5 1.6 4.9 3.3 5.4 11.0 8.2 1.8 4.7 11.2 8.7 6.3 11.7 12.9 9.3 18.4 9.5 10.3 11.6 10.5 11.8 10.7 14.0 11.5 1.1 7.7 20.5 10.2 9.4 6.7 14.7 13.3 13.8 17.4 14.2 10.0 12.1 9.4 11.9 6.1 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045681: , HPA050551: " "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 10.8 11.1 12.6 17.8 13.5 14.3 11.2 11.6 15.3 13.0 19.4 17.8 8.9 11.9 13.3 8.5 27.4 9.2 9.7 26.9 13.5 11.2 14.6 17.7 8.9 18.7 15.2 9.7 9.1 17.1 12.0 6.0 11.4 14.5 14.0 13.3 8.8 11.9 12.0 95.6 14.1 16.6 14.6 19.4 15.0 11.9 11.8 13.6 21.3 12.5 20.7 23.3 17.7 16.5 23.7 13.1 24.4 11.5 20.5 20.6 13.1 21.2 23.0 21.5 15.7 17.6 18.7 30.7 20.7 16.7 19.8 17.4 15.8 10.9 33.3 21.8 20.3 23.0 26.7 19.2 31.9 17.5 21.8 12.4 12.2 18.0 17.3 18.0 23.6 15.9 28.8 18.7 27.3 26.4 21.8 36.1 16.2 9.5 22.9 16.6 23.7 12.0 29.8 11.4 30.4 23.0 14.0 9.3 17.4 19.5 17.0 16.1 16.7 11.8 19.8 19.9 15.2 23.2 23.1 14.0 16.4 47.1 15.3 16.9 15.2 8.1 10.3 24.4 15.4 10.8 20.6 23.7 20.1 20.1 13.1 15.5 20.2 20.5 18.6 20.5 11.5 9.6 18.3 13.1 12.6 13.5 11.6 15.3 13.5 11.2 15.2 9.7 14.5 13.6 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698044-39782792 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Supported "Intermediate filaments,Actin filaments,Cytosol" 150000 Cytosol "Intermediate filaments, Actin filaments" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavourable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 27.2 21.8 27.0 21.2 27.6 17.3 21.6 38.6 40.7 17.0 33.2 11.8 14.1 29.1 19.9 18.5 29.9 14.9 18.5 28.1 27.7 26.8 26.6 44.5 17.1 17.9 24.1 26.4 16.9 15.8 18.9 26.9 29.8 25.2 19.7 24.0 13.4 18.4 17.3 31.8 22.0 24.6 18.8 19.2 16.9 29.3 16.0 15.9 21.3 23.6 19.7 18.8 22.8 20.4 17.6 23.7 20.6 19.9 10.9 14.1 8.9 23.8 24.5 13.2 12.5 8.3 7.8 22.5 32.9 7.0 8.8 9.3 37.0 24.6 29.8 29.0 9.2 10.1 25.4 14.3 14.2 20.0 18.2 38.6 24.8 32.0 10.4 41.4 21.9 7.3 16.2 12.4 13.4 11.5 39.2 10.7 9.1 23.1 28.9 23.0 17.6 18.7 17.1 39.7 11.2 12.3 33.3 27.4 12.1 24.6 9.3 14.7 12.0 13.9 31.5 13.8 29.3 16.4 30.2 15.2 44.3 32.8 7.2 26.6 16.1 13.9 16.6 20.6 13.5 14.3 12.7 17.6 14.1 12.6 16.6 12.5 10.7 12.0 13.3 10.9 19.9 23.7 13.7 8.9 27.0 27.6 38.6 37.7 27.7 26.8 24.1 26.4 25.2 15.9 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol 8800000 "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: " "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favourable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 27.8 34.9 34.8 23.5 29.6 31.3 24.9 25.5 36.9 25.9 27.7 38.4 22.8 26.4 25.6 29.2 38.0 26.9 23.0 33.0 30.7 30.8 27.4 36.0 23.5 32.5 34.3 33.1 24.3 23.9 24.3 21.7 30.1 36.9 27.5 31.7 29.3 30.6 26.7 43.5 23.9 34.4 33.1 36.2 28.5 25.1 35.7 22.6 25.3 25.0 32.4 33.9 28.4 22.2 34.7 49.9 46.1 45.8 34.6 46.9 54.9 24.4 14.1 20.7 16.1 22.6 20.2 11.9 20.6 23.6 26.6 25.3 16.0 11.8 23.1 10.4 27.3 21.0 27.5 22.4 26.5 23.0 29.7 26.7 13.8 19.1 15.1 38.1 19.3 17.8 19.6 19.2 14.0 29.8 107.9 12.4 28.6 18.0 19.8 27.6 15.2 14.9 16.2 31.1 6.3 24.9 19.7 18.6 13.8 16.4 20.7 18.9 12.9 21.1 21.3 18.8 24.2 15.9 21.0 12.1 19.5 21.1 25.5 17.7 17.8 30.8 40.4 46.1 41.4 45.8 38.8 34.7 39.6 44.2 49.9 31.2 34.5 41.6 34.2 34.6 37.6 48.4 46.9 54.9 34.8 29.6 25.5 36.9 30.7 30.8 34.3 33.1 36.9 22.6 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Low cell line specificity" "Detected in some" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: " "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.6 0.3 1.2 1.6 0.6 0.6 0.6 1.1 0.6 0.4 0.2 0.0 3.0 1.4 0.5 1.3 0.6 0.8 0.4 1.1 2.4 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 0.9 0.7 1.3 0.3 0.0 1.6 2.5 1.3 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.1 38.6 19.6 18.6 10.5 12.5 14.3 22.1 19.5 16.0 13.8 23.3 16.5 22.3 16.7 15.6 13.9 21.7 21.8 12.0 25.3 131.9 32.4 24.8 15.1 25.6 29.3 25.7 13.3 17.1 24.4 29.0 19.2 15.7 28.2 21.2 21.7 23.3 26.6 12.4 33.8 21.8 16.3 28.6 18.4 26.7 34.4 28.2 19.1 23.4 20.6 14.1 26.9 14.4 50.2 10.2 15.7 39.1 34.1 51.6 23.9 31.9 26.0 32.7 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 UBE2N "MGC8489, UBC13, UbcH-ben" ENSG00000177889 "Ubiquitin conjugating enzyme E2 N" P61088 12 93405673-93442262 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044976 Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" 4600000 Nucleoplasm "Nucleoli fibrillar center" "HPA044976: " "unprognostic (1.74e-2)" "unprognostic (5.53e-1)" "unprognostic (1.26e-2)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (8.09e-2)" "prognostic unfavourable (2.41e-4)" "unprognostic (8.49e-3)" "unprognostic (2.72e-1)" "unprognostic (4.28e-3)" "unprognostic (1.07e-1)" "unprognostic (9.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (1.29e-1)" "unprognostic (1.48e-1)" "unprognostic (1.30e-3)" 24.7 25.0 29.0 28.7 39.1 29.0 21.2 29.2 44.3 18.4 26.6 15.6 15.1 20.7 23.2 20.0 30.4 19.7 17.0 27.7 31.0 33.7 25.4 22.3 19.3 36.1 27.6 34.5 17.4 17.6 13.9 18.2 24.2 34.9 23.4 22.6 13.7 18.0 18.5 35.7 19.1 20.4 21.3 24.6 21.5 19.3 83.7 17.4 32.2 15.5 16.8 35.1 22.7 18.8 53.8 35.5 29.9 39.2 29.5 57.3 51.9 35.8 26.0 43.9 28.1 17.0 16.9 30.6 50.2 26.8 40.3 33.8 46.2 15.6 73.0 11.4 29.3 28.6 48.4 36.8 38.4 60.7 25.1 49.1 14.3 40.7 21.7 58.6 32.8 17.7 15.2 24.0 30.0 31.0 54.5 11.4 41.8 29.5 57.8 54.5 57.1 36.4 45.0 35.6 35.7 33.5 54.3 42.9 39.1 26.5 31.2 24.5 40.8 36.1 32.0 27.3 22.8 24.6 36.1 19.7 53.3 62.0 10.7 31.3 33.3 29.9 27.1 28.9 31.7 35.4 36.9 53.8 40.2 39.2 35.5 38.6 36.0 34.4 8.2 29.5 39.2 26.7 57.3 51.9 29.0 39.1 29.2 44.3 31.0 33.7 27.6 34.5 34.9 17.4 UBE2O E2-230K ENSG00000175931 "Ubiquitin conjugating enzyme E2 O" Q9C0C9 17 76389451-76453206 "Enzymes, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023605 Uncertain Supported "Nucleoplasm,Nuclear bodies" 1600000 Nucleoplasm "Nuclear bodies" "HPA023605: " "unprognostic (8.75e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (8.68e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "prognostic unfavourable (6.84e-8)" "unprognostic (3.54e-1)" "unprognostic (2.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-3)" "unprognostic (1.18e-2)" "prognostic unfavourable (4.34e-9)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" 8.5 8.5 13.8 10.2 22.6 19.2 7.3 25.2 38.1 9.4 7.2 12.2 7.4 9.9 9.9 8.2 11.7 10.8 7.1 15.4 12.7 15.2 6.5 7.6 6.6 12.8 11.7 14.6 13.9 14.4 16.4 14.3 9.8 30.6 9.4 6.0 10.5 13.4 10.4 23.0 15.2 8.2 8.0 8.0 10.8 10.8 18.1 12.2 10.9 15.8 6.9 9.2 8.6 9.1 4.9 4.1 2.7 1.7 1.5 4.0 1.9 12.9 14.9 15.2 18.7 9.6 6.1 13.2 6.1 6.6 9.9 9.7 12.9 6.6 18.4 4.3 7.5 13.1 17.7 10.5 7.1 5.2 21.8 18.6 9.7 21.6 7.9 11.2 11.3 6.2 8.6 9.5 8.2 13.4 15.5 16.4 5.0 10.7 22.2 13.0 14.1 20.0 22.0 19.6 20.2 4.4 11.1 22.6 20.3 8.9 23.2 12.2 13.3 8.1 7.9 11.7 11.0 9.9 10.0 13.6 4.4 15.5 12.8 9.4 7.6 0.0 1.7 2.7 4.0 0.8 2.2 2.6 2.6 2.0 1.0 4.9 2.1 3.0 0.4 1.5 1.0 4.1 2.3 1.9 13.8 22.6 25.2 38.1 12.7 15.2 11.7 14.6 30.6 12.2 UBE2Q1 "NICE-5, PRO3094, UBE2Q" ENSG00000160714 "Ubiquitin conjugating enzyme E2 Q1" Q7Z7E8 1 154548577-154559028 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063368 Approved Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA063368: " "unprognostic (3.88e-1)" "unprognostic (2.13e-1)" "unprognostic (4.44e-3)" "unprognostic (3.64e-3)" "unprognostic (5.32e-3)" "unprognostic (6.10e-3)" "prognostic unfavourable (8.74e-4)" "unprognostic (2.92e-1)" "unprognostic (2.07e-1)" "unprognostic (9.92e-3)" "unprognostic (3.79e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (4.84e-7)" "unprognostic (2.20e-1)" "unprognostic (4.46e-1)" "prognostic favourable (1.86e-5)" "unprognostic (1.04e-2)" 17.3 18.7 26.5 16.2 29.4 24.2 19.4 26.4 29.0 20.0 21.2 18.7 8.2 16.2 18.3 25.4 20.9 21.8 18.2 17.6 24.5 25.8 25.7 27.4 23.0 26.3 22.8 21.0 21.7 27.2 21.4 29.3 24.5 27.2 21.4 25.7 18.5 19.0 19.8 19.1 21.6 21.4 21.9 19.1 26.0 20.5 30.0 22.0 25.1 21.0 14.0 29.9 19.3 18.5 3.2 5.1 8.1 3.1 4.7 6.2 1.6 18.0 15.7 22.2 16.9 22.8 23.6 19.2 17.9 27.4 23.2 18.8 17.6 19.4 22.3 25.9 25.0 15.8 26.1 20.8 20.0 22.4 16.5 17.7 14.0 17.0 28.8 28.7 28.5 22.7 27.6 18.7 21.7 29.7 14.8 27.7 29.5 28.0 17.5 21.1 30.3 26.7 20.2 15.5 23.4 25.4 19.3 22.6 31.6 18.2 34.3 29.4 20.9 43.8 20.6 15.0 16.8 17.7 19.1 33.8 25.0 29.5 16.8 20.3 22.7 8.1 2.8 5.6 4.8 3.1 4.3 3.0 4.5 5.9 2.5 3.2 5.0 5.7 4.4 4.7 2.6 5.1 6.2 1.6 26.5 29.4 26.4 29.0 24.5 25.8 22.8 21.0 27.2 22.0 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Cell line enhanced" "Detected in some" "Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favourable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 3.0 0.0 0.0 0.2 14.9 0.1 0.0 6.6 0.0 0.0 13.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 33.3 29.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061000 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA061000: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.3 18.0 34.6 15.0 19.1 31.2 10.6 14.6 20.3 17.1 17.1 14.4 12.3 14.0 6.0 20.3 7.3 18.1 16.6 18.8 23.0 9.6 12.0 19.8 18.3 27.2 14.3 13.1 26.4 24.7 14.0 26.5 28.7 11.3 15.1 16.9 9.5 26.9 37.6 19.7 14.9 25.0 10.5 7.2 18.1 12.4 16.2 19.5 17.0 15.2 10.9 13.4 17.4 21.4 16.5 15.0 11.4 13.5 9.6 9.0 19.5 15.8 8.3 35.5 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: " "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavourable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 59.4 32.2 28.3 22.6 1.8 2.6 5.0 48.4 14.7 29.9 27.3 21.8 21.3 57.9 20.1 12.1 17.5 28.4 12.6 13.3 45.3 94.2 34.6 18.5 7.0 5.4 41.3 33.7 2.8 3.5 22.0 21.3 11.7 34.3 40.6 18.7 15.7 56.0 21.5 71.1 54.7 49.3 21.8 20.8 8.0 12.7 72.0 39.0 61.7 15.3 27.4 10.9 22.5 17.9 18.1 51.3 15.3 115.2 32.7 78.5 67.9 18.9 29.3 65.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavourable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favourable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.3 29.0 43.2 20.4 4.0 7.4 24.7 33.2 18.6 38.0 26.8 20.6 37.3 35.4 13.2 12.1 24.8 39.9 19.5 34.3 32.1 22.8 21.6 15.8 23.5 1.8 25.9 26.4 2.6 4.7 29.9 12.4 22.0 27.3 29.3 29.7 28.3 46.3 33.0 16.7 14.8 35.9 46.0 30.8 14.5 14.6 34.0 34.7 23.2 28.6 11.1 30.1 16.4 10.8 17.1 27.4 29.9 39.4 14.9 29.0 45.1 17.0 27.0 35.5 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 UBE2Z "FLJ13855, USE1" ENSG00000159202 "Ubiquitin conjugating enzyme E2 Z" Q9H832 17 48908369-48929056 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007922 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007922: AB_1858551" "unprognostic (6.85e-2)" "unprognostic (5.72e-3)" "prognostic favourable (4.62e-4)" "unprognostic (9.11e-2)" "unprognostic (3.71e-3)" "unprognostic (1.76e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (2.32e-2)" "unprognostic (5.26e-2)" "unprognostic (8.66e-2)" "unprognostic (9.17e-3)" "unprognostic (3.48e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (2.63e-2)" "unprognostic (2.11e-2)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" 27.1 40.6 29.2 27.7 37.0 22.2 28.8 34.4 50.2 33.7 28.9 59.9 45.1 26.6 36.2 49.5 37.2 36.0 28.0 28.7 30.5 29.2 32.1 25.6 29.2 30.9 46.6 28.0 32.5 29.5 36.6 28.0 35.0 39.7 32.9 32.5 28.4 33.3 43.2 24.1 35.9 30.5 39.1 32.7 36.6 29.4 22.4 43.4 29.4 39.8 22.2 44.2 28.8 32.2 12.8 10.1 11.0 14.5 7.4 13.1 8.6 24.8 30.9 11.6 11.0 29.5 28.7 15.9 27.3 33.5 32.7 31.6 38.5 21.6 20.3 39.2 33.4 16.2 14.5 25.5 41.8 67.1 15.8 18.3 20.4 23.9 34.2 13.0 19.8 24.4 28.3 26.6 34.6 23.9 13.4 26.5 35.1 39.8 14.0 12.9 10.8 27.0 11.3 29.6 11.5 25.6 24.5 12.0 18.2 18.5 10.0 18.6 27.6 10.3 28.1 49.0 23.7 16.0 22.2 20.2 19.2 12.0 24.0 9.5 21.2 6.5 11.0 8.1 13.1 14.5 10.7 9.4 11.4 13.0 8.0 12.8 11.1 12.0 11.0 7.4 13.0 10.1 11.5 8.6 29.2 37.0 34.4 50.2 30.5 29.2 46.6 28.0 39.7 43.4 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 19.3 19.4 20.3 23.1 25.0 17.8 20.2 30.0 25.1 21.7 19.9 14.3 19.8 14.1 21.0 22.1 19.8 18.5 17.2 24.0 22.2 20.8 20.2 24.6 19.7 23.1 19.1 19.5 23.0 17.2 26.1 24.6 20.1 20.9 20.6 17.9 13.3 19.3 21.5 70.2 18.4 18.8 21.2 19.9 18.8 16.9 26.4 16.4 36.4 25.0 26.6 19.5 19.9 26.6 15.6 11.9 11.6 14.8 21.1 16.0 5.7 19.3 10.9 27.6 16.4 16.1 19.2 13.6 29.8 18.7 21.1 19.2 25.3 9.7 34.7 22.6 22.2 17.9 34.9 21.0 25.8 17.9 11.7 28.8 18.4 14.9 24.2 34.7 21.3 22.6 19.8 19.9 25.5 16.5 29.0 24.8 33.1 10.5 28.7 10.1 17.9 15.9 29.5 41.2 15.3 19.1 30.4 28.3 21.4 24.1 26.2 34.2 21.4 19.6 21.2 37.0 30.6 17.7 21.7 28.4 33.5 46.8 21.2 18.9 19.2 8.6 8.7 11.6 13.3 7.6 15.2 12.0 14.0 15.9 11.9 15.6 16.0 14.2 2.0 21.1 14.8 11.1 10.1 5.7 20.3 25.0 30.0 25.1 22.2 20.8 19.1 19.5 20.9 16.4 UBE3B ENSG00000151148 "Ubiquitin protein ligase E3B" Q7Z3V4 12 109477402-109536705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041012 Approved Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA041012: AB_10964435" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.12e-2)" "unprognostic (7.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.19e-2)" "unprognostic (2.93e-1)" "unprognostic (4.46e-3)" "unprognostic (9.39e-2)" "unprognostic (1.23e-1)" "prognostic favourable (2.49e-5)" "unprognostic (3.35e-1)" "unprognostic (3.35e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" 14.5 19.3 17.2 12.9 21.2 9.2 15.3 19.7 27.8 14.4 17.3 23.3 14.0 14.6 17.4 16.2 20.1 19.3 13.9 28.6 14.6 11.6 19.8 16.4 15.5 13.1 18.6 13.9 18.4 20.3 25.5 15.1 16.8 15.8 17.5 21.2 20.7 15.7 17.4 34.0 21.6 16.3 18.6 15.2 17.0 17.3 24.5 18.3 18.2 21.1 17.6 15.9 19.5 19.6 15.9 14.5 22.4 16.7 14.3 18.2 11.4 10.4 16.6 13.0 9.4 22.2 17.9 11.4 13.8 15.9 16.8 11.3 17.3 10.8 6.5 10.3 22.6 13.5 13.2 17.7 16.3 14.3 9.3 12.5 10.8 15.6 14.3 10.1 10.5 20.3 16.6 16.3 19.6 18.1 13.6 6.2 19.1 16.4 6.9 14.8 13.3 20.0 11.5 12.3 12.8 14.4 18.9 12.1 22.4 16.1 22.0 10.8 22.4 10.8 16.5 20.9 6.0 10.6 9.8 13.9 11.5 11.5 20.8 8.5 17.3 22.4 15.3 14.3 15.9 16.7 15.7 15.9 15.3 11.2 14.5 12.9 12.9 17.1 19.5 14.3 13.6 13.5 18.2 11.4 17.2 21.2 19.7 27.8 14.6 11.6 18.6 13.9 15.8 18.3 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favourable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.5 17.9 11.5 23.0 20.7 21.8 12.8 25.0 21.6 21.1 21.4 16.1 18.9 12.2 22.3 27.5 14.4 17.9 23.1 25.2 22.2 16.4 12.4 12.6 11.6 20.7 18.6 18.3 19.3 21.3 23.4 19.5 24.6 18.1 13.7 29.8 19.7 18.2 11.8 18.3 21.7 10.5 13.0 25.1 21.9 24.9 18.5 19.1 24.6 21.2 18.3 10.9 13.1 22.0 26.7 5.7 65.4 31.0 13.7 13.8 12.3 30.6 27.8 30.5 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557362-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA051746: " "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 10.2 16.2 11.9 8.9 13.0 7.1 10.0 23.1 19.5 11.7 9.2 9.4 15.2 6.1 16.4 14.9 9.6 13.9 11.8 21.2 11.3 17.6 12.3 15.4 7.6 8.7 13.0 11.8 14.5 17.5 28.5 17.2 16.5 13.6 12.5 9.4 12.3 12.3 12.6 52.8 7.6 7.0 14.6 7.4 9.1 8.1 27.6 7.0 16.2 16.4 11.1 11.7 10.9 12.9 2.8 4.1 1.0 1.9 3.0 4.0 1.1 6.4 14.6 20.8 15.0 24.0 29.8 19.5 20.0 16.4 15.9 15.0 11.1 11.1 14.3 31.2 24.4 8.9 32.8 13.3 20.6 23.7 19.3 7.4 13.2 24.1 12.8 7.8 14.4 21.2 10.0 15.5 14.6 15.4 18.8 7.9 17.5 13.4 11.1 14.1 49.7 6.5 20.3 12.8 11.8 14.9 5.5 20.7 19.0 6.6 12.9 11.7 17.7 11.5 16.2 9.0 10.4 9.6 10.4 11.9 11.9 8.7 16.4 9.3 13.6 0.0 1.3 1.0 4.0 1.9 2.3 1.6 2.8 3.9 3.0 2.8 1.7 2.3 0.0 3.0 1.0 4.1 2.3 1.1 11.9 13.0 23.1 19.5 11.3 17.6 13.0 11.8 13.6 7.0 UBL4A "DXS254E, GDX, GET5, MDY2, TMA24, UBL4" ENSG00000102178 "Ubiquitin like 4A" P11441 X 154483717-154486670 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003617 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003617: AB_1080450" "unprognostic (2.75e-2)" "unprognostic (3.39e-3)" "unprognostic (5.52e-2)" "unprognostic (2.88e-2)" "unprognostic (2.62e-1)" "unprognostic (2.13e-1)" "prognostic unfavourable (8.64e-4)" "unprognostic (4.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.24e-2)" "unprognostic (8.26e-3)" "unprognostic (4.50e-1)" "unprognostic (4.41e-2)" "unprognostic (2.74e-2)" "unprognostic (6.01e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-2)" 11.5 15.3 14.1 7.3 16.0 6.6 12.4 11.9 28.2 11.7 12.2 8.7 11.0 12.2 10.2 13.8 14.0 10.9 10.5 26.5 14.1 11.0 10.6 13.7 10.9 12.1 11.2 16.9 11.2 25.4 11.3 8.3 9.4 13.6 15.4 9.0 8.0 18.8 15.7 59.2 13.3 9.3 14.8 8.6 9.8 10.9 4.3 6.1 8.2 12.2 20.6 11.7 14.9 10.4 10.1 9.9 32.9 10.0 14.3 22.9 17.9 28.8 18.2 5.5 14.9 11.6 11.5 18.3 12.9 9.3 13.3 14.3 18.1 11.5 22.3 38.9 11.7 11.2 27.2 14.1 7.4 14.6 17.3 15.9 17.4 10.6 14.3 18.8 17.3 9.0 16.9 8.9 15.4 9.5 17.5 11.1 10.8 23.9 17.0 18.8 6.3 30.5 15.2 16.3 23.5 11.3 12.5 10.5 15.9 7.2 23.8 20.6 11.0 14.3 9.5 13.6 15.4 21.8 26.8 22.5 21.7 39.6 14.3 32.6 15.7 32.9 10.0 9.6 16.5 8.5 22.9 10.1 15.4 17.3 9.9 8.3 13.3 14.9 3.4 14.3 7.1 5.8 15.0 17.9 14.1 16.0 11.9 28.2 14.1 11.0 11.2 16.9 13.6 6.1 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: " "unprognostic (4.21e-2)" "prognostic favourable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 14.4 18.0 30.0 16.6 31.8 16.4 17.0 20.8 58.4 20.7 19.4 22.7 15.2 18.2 17.9 19.6 18.4 22.0 15.9 27.6 29.0 21.1 18.6 17.2 16.4 23.1 26.8 26.1 18.4 21.4 30.2 14.3 18.9 33.0 17.5 20.7 15.0 19.8 21.4 45.5 23.0 16.1 23.0 28.3 22.5 18.5 34.8 16.1 36.9 28.2 18.6 34.9 17.7 14.4 26.6 75.5 32.8 28.7 25.8 31.6 23.1 11.5 12.6 20.5 27.5 21.5 28.3 13.8 18.7 23.0 24.6 30.5 15.3 16.8 16.9 20.2 23.0 18.8 57.0 25.4 23.5 22.3 34.8 22.1 21.0 27.5 20.7 13.7 19.1 21.6 23.1 20.4 28.2 20.4 18.9 25.4 24.9 15.8 16.9 21.3 49.0 15.4 18.3 16.1 37.7 21.1 13.5 20.2 40.0 18.3 17.3 25.0 18.3 22.9 11.9 22.8 13.5 11.4 23.2 25.6 48.7 18.8 14.8 25.0 19.6 13.6 26.2 28.5 18.8 28.7 17.9 26.6 18.9 19.5 35.1 26.4 18.5 21.8 32.8 25.8 25.7 75.5 31.6 23.1 30.0 31.8 20.8 58.4 29.0 21.1 26.8 26.1 33.0 16.1 UBLCP1 "CPUB1, MGC10067" ENSG00000164332 "Ubiquitin like domain containing CTD phosphatase 1" Q8WVY7 5 159263081-159286040 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039615 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039615: AB_10674425" "unprognostic (1.25e-1)" "unprognostic (3.10e-1)" "unprognostic (6.04e-3)" "unprognostic (3.45e-2)" "unprognostic (7.08e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (4.46e-5)" "unprognostic (4.01e-1)" "unprognostic (2.14e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (1.87e-1)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (2.51e-2)" 17.1 16.0 16.7 18.4 19.7 16.7 16.3 20.2 33.0 18.5 12.5 12.2 11.4 9.8 22.5 13.1 22.2 14.7 14.5 13.1 20.9 19.1 17.5 14.4 17.8 24.1 19.7 22.7 16.8 12.6 18.0 23.9 19.6 36.7 14.7 14.7 10.9 15.4 17.6 15.3 14.2 13.8 19.5 20.4 22.2 13.3 24.2 15.4 26.8 14.4 16.1 30.1 18.8 16.8 11.9 10.8 21.9 13.9 25.5 19.2 8.2 14.5 10.6 22.0 23.8 22.9 21.2 13.0 15.9 24.2 16.3 21.8 8.6 10.1 13.0 17.6 19.8 11.1 13.6 30.5 28.5 25.9 13.3 10.0 9.3 7.8 28.9 22.6 15.8 18.7 28.7 14.8 29.6 15.5 13.7 17.6 22.7 4.7 12.2 6.9 15.2 6.4 15.5 21.5 15.2 16.1 11.2 11.7 15.5 16.0 10.7 37.4 11.3 15.1 16.5 16.8 14.1 8.7 20.0 14.1 14.2 19.8 17.8 15.6 24.9 21.9 6.5 16.1 16.6 13.5 18.6 11.9 15.8 17.3 8.5 10.9 18.5 19.2 19.4 25.5 13.9 10.8 16.9 8.2 16.7 19.7 20.2 33.0 20.9 19.1 19.7 22.7 36.7 15.4 UBN1 ENSG00000118900 "Ubinuclein 1" Q9NPG3 16 4846665-4882360 "Predicted intracellular proteins" "Host-virus interaction" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 15.1" "Lineage enriched" "Detected in many" 9 "granulocytes: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061029, HPA069045" Supported Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA061029: , HPA069045: " "unprognostic (8.20e-2)" "unprognostic (1.01e-1)" "unprognostic (8.99e-3)" "unprognostic (1.75e-1)" "unprognostic (1.65e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-3)" "unprognostic (6.53e-3)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (6.89e-2)" 14.1 12.4 10.5 16.6 11.5 38.2 19.8 20.2 15.4 12.6 12.4 11.0 18.1 13.4 13.1 11.8 24.5 11.7 16.6 15.5 11.2 6.5 10.4 15.3 19.1 16.5 9.4 10.8 14.4 12.9 17.6 12.3 10.4 9.1 11.7 13.4 15.9 15.9 14.5 20.9 15.1 15.2 12.8 6.6 21.2 12.5 36.7 10.1 27.1 12.0 13.8 13.7 11.6 15.8 1.2 1.7 15.1 1.2 0.9 1.6 0.9 9.1 11.3 13.1 13.0 11.6 10.8 10.8 11.5 10.7 13.2 12.7 9.4 10.9 17.0 10.7 10.9 12.3 16.7 10.2 11.2 16.7 8.8 13.8 15.1 7.3 11.2 16.7 15.3 7.3 13.7 15.3 16.5 17.2 22.9 14.4 9.7 13.1 18.3 7.8 11.3 8.8 29.5 16.4 16.0 7.0 10.4 18.0 9.9 19.6 16.1 9.9 15.9 15.0 17.5 14.1 13.6 45.7 14.1 14.1 14.6 33.9 8.3 10.7 23.7 1.4 1.2 0.9 1.6 1.2 1.1 0.9 1.2 1.4 0.8 1.2 1.3 0.8 15.1 0.9 0.9 1.7 0.8 0.9 10.5 11.5 20.2 15.4 11.2 6.5 9.4 10.8 9.1 10.1 UBQLN1 "DA41, DSK2, PLIC-1, XDRP1" ENSG00000135018 "Ubiquilin 1" Q9UMX0 9 83659963-83708203 "Plasma proteins, Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037256, HPA054143" Supported Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB037256: AB_1858556, HPA054143: " "unprognostic (4.72e-3)" "unprognostic (9.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (2.77e-2)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.80e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "prognostic favourable (1.07e-5)" "unprognostic (3.11e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-3)" "unprognostic (2.29e-2)" 26.8 33.9 27.2 26.2 38.7 41.1 38.1 35.0 42.2 24.9 24.4 21.2 27.8 21.9 29.1 22.2 30.5 21.4 21.0 34.5 28.9 32.1 31.6 40.8 23.3 25.8 30.0 27.8 21.5 28.1 36.0 29.5 30.4 37.2 26.5 23.7 15.2 23.8 28.9 79.1 27.8 27.6 26.9 33.9 28.6 23.1 22.9 23.3 59.8 25.7 16.2 34.8 24.8 27.3 16.0 19.2 23.4 25.0 24.7 18.8 14.9 43.5 40.3 29.6 22.9 24.7 26.3 49.1 40.7 36.1 43.3 32.9 16.5 31.1 43.3 26.3 34.0 50.1 41.0 28.9 45.1 22.8 19.1 26.5 31.0 25.6 32.6 32.1 29.2 21.8 36.4 36.5 50.8 32.3 28.6 31.0 35.3 25.8 44.9 17.8 38.8 37.0 33.4 33.2 22.6 28.2 19.0 26.8 29.9 37.6 37.9 29.1 18.9 23.4 32.0 27.7 25.9 45.8 40.7 43.5 61.4 21.2 41.2 23.7 33.5 23.4 17.1 17.6 16.6 25.0 16.2 16.0 14.5 15.2 19.2 15.5 14.7 16.0 18.5 24.7 23.1 8.2 18.8 14.9 27.2 38.7 35.0 38.7 28.9 32.1 30.0 27.8 37.2 23.3 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563639-56567868 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" 200000 Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavourable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.4 20.8 27.0 13.9 40.7 9.4 16.2 34.9 35.3 17.3 13.6 17.8 15.0 11.1 17.0 16.7 18.1 18.2 14.5 20.8 26.2 28.6 13.9 18.9 14.0 16.4 21.2 26.6 27.0 10.6 25.5 18.3 15.6 20.8 21.1 12.5 13.3 13.7 21.5 24.6 13.5 11.6 18.7 18.8 13.9 12.9 5.4 16.7 18.0 20.9 10.9 17.7 16.4 14.1 5.5 10.9 25.0 19.4 12.1 20.4 10.9 18.8 14.1 14.1 16.5 32.5 20.8 8.9 15.3 18.2 11.5 12.8 7.8 8.9 14.5 16.7 18.0 11.1 26.9 17.0 13.9 22.3 16.2 5.8 19.4 8.3 17.1 11.4 12.9 19.3 21.7 15.4 13.6 10.0 6.8 16.0 18.1 8.8 14.6 10.0 11.7 16.8 13.2 18.3 13.6 23.2 14.8 17.5 16.4 22.0 9.8 8.9 16.4 8.5 11.2 12.2 12.5 17.6 9.2 6.1 7.4 10.0 13.7 12.1 10.3 25.0 14.1 14.1 9.9 19.3 11.1 5.1 15.1 11.5 10.9 5.5 20.4 12.2 12.4 12.1 19.4 3.9 14.1 10.9 27.0 40.7 34.9 35.3 26.2 28.6 21.2 26.6 20.8 16.7 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038838 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038838: AB_10673120" "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 4.9 7.2 8.3 6.7 13.2 10.2 7.9 12.1 13.4 10.7 13.9 9.1 3.9 5.8 7.2 12.4 8.6 11.9 10.6 12.8 11.9 5.8 22.9 14.4 4.4 9.2 16.1 11.0 11.0 6.0 13.1 10.7 12.0 13.0 8.8 13.3 2.8 8.7 4.8 4.7 7.4 11.4 11.4 5.0 10.8 11.7 8.4 7.5 15.9 8.4 5.6 8.1 8.4 16.5 13.2 8.2 11.7 12.2 10.4 17.6 16.7 9.0 10.2 11.9 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564062-42693504 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favourable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 19.8 18.8 14.4 21.8 16.7 22.1 18.6 26.6 20.4 17.2 19.3 17.8 17.8 20.1 29.5 16.8 16.2 15.6 16.2 16.8 13.8 13.2 17.8 24.0 19.3 18.0 16.7 12.9 20.8 24.6 28.0 26.3 16.3 17.2 16.5 20.1 15.8 18.3 15.6 33.5 18.0 24.6 19.9 15.9 21.3 18.2 9.2 17.2 26.1 20.1 14.9 17.7 18.9 29.8 3.6 3.5 25.2 5.7 3.9 4.4 1.9 15.7 8.0 9.3 14.6 19.2 18.5 12.6 12.2 13.2 10.8 11.3 11.5 6.5 10.9 9.7 13.1 16.0 13.4 10.4 13.8 14.6 9.4 17.2 11.9 14.9 15.6 16.6 11.9 13.0 11.4 10.7 11.8 12.2 20.1 13.8 10.4 12.8 13.0 14.7 8.5 7.8 11.6 13.9 16.2 12.4 13.8 11.1 8.8 12.3 11.9 11.9 11.6 16.1 17.6 9.9 7.7 12.0 8.8 12.8 11.3 16.8 5.2 12.5 6.0 10.4 4.6 9.2 4.4 4.8 3.7 3.4 2.9 3.4 3.5 3.6 3.0 3.3 25.2 3.9 5.7 2.6 3.3 1.9 14.4 16.7 26.6 20.4 13.8 13.2 16.7 12.9 17.2 17.2 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.8 7.5 8.0 10.6 16.0 12.7 6.8 16.0 9.3 9.3 7.5 11.5 5.6 10.0 13.9 12.4 11.7 9.5 8.1 11.6 10.4 8.2 36.6 8.0 12.2 8.0 12.1 11.9 7.6 7.6 12.1 8.1 9.1 19.0 10.9 15.7 8.3 7.8 5.9 6.3 6.3 7.5 13.2 10.6 6.7 12.5 15.8 8.6 11.2 10.4 6.5 6.8 6.8 11.5 14.0 5.7 10.9 10.0 8.9 6.9 9.2 11.5 7.1 7.7 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 UBR4 "KIAA0462, KIAA1307, RBAF600, ZUBR1" ENSG00000127481 "Ubiquitin protein ligase E3 component n-recognin 4" Q5T4S7 1 19074506-19210276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" "Calmodulin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013394, HPA021046" Approved Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA013394: , HPA021046: AB_1858578" "unprognostic (1.37e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" "unprognostic (2.02e-1)" "unprognostic (8.78e-2)" "unprognostic (9.77e-2)" "unprognostic (1.14e-3)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (9.14e-3)" "unprognostic (7.48e-2)" "unprognostic (2.53e-1)" "unprognostic (7.68e-3)" "unprognostic (4.30e-1)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.52e-1)" 24.4 25.4 22.4 29.0 25.4 58.3 23.7 28.5 32.5 22.4 28.5 26.3 31.5 18.2 34.0 32.5 22.7 20.3 27.3 20.5 23.3 15.9 25.5 29.7 31.2 20.3 21.0 20.9 35.5 21.0 40.9 31.4 28.4 25.0 30.7 20.5 30.6 24.7 27.1 55.9 69.0 25.5 39.3 20.2 26.5 30.2 41.1 21.6 37.7 26.1 17.3 25.9 43.4 29.0 4.6 9.1 18.3 18.5 2.7 3.4 4.6 22.9 23.2 21.0 15.5 39.3 20.3 18.2 17.9 18.9 19.5 17.8 37.0 19.8 13.9 16.8 23.6 15.7 16.4 17.8 18.3 11.5 14.5 31.7 22.4 24.1 27.7 19.4 21.1 18.1 22.9 39.7 38.3 21.3 21.6 12.9 18.5 16.4 9.1 23.7 17.0 13.1 12.8 16.4 11.6 17.6 13.5 14.9 14.8 21.2 12.2 15.2 8.4 15.3 33.0 22.9 14.3 27.1 20.0 15.3 9.2 16.1 15.7 30.0 19.4 18.3 18.5 2.9 3.4 3.8 2.9 4.6 3.0 1.9 9.1 2.9 2.7 2.5 9.8 2.7 1.3 4.3 2.1 4.6 22.4 25.4 28.5 32.5 23.3 15.9 21.0 20.9 25.0 21.6 UBR5 "DD5, EDD, EDD1, HYD, KIAA0896" ENSG00000104517 "Ubiquitin protein ligase E3 component n-recognin 5" O95071 8 102253012-102412841 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053688 Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053688: " "unprognostic (3.79e-3)" "unprognostic (7.44e-3)" "unprognostic (1.25e-1)" "unprognostic (2.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (1.26e-4)" "unprognostic (2.50e-1)" "unprognostic (1.75e-2)" "unprognostic (7.54e-3)" "unprognostic (8.29e-3)" "unprognostic (3.84e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.69e-2)" "unprognostic (2.45e-1)" 27.0 16.7 27.1 29.5 31.7 30.3 29.2 40.8 32.8 24.9 25.0 19.1 21.1 14.4 26.8 24.0 23.8 22.0 17.6 22.7 25.5 15.3 17.9 17.0 24.2 29.6 21.9 20.6 29.7 22.2 32.4 25.5 25.0 23.6 20.2 17.1 19.7 22.9 21.8 39.9 29.7 22.4 29.3 17.5 21.9 21.1 39.7 28.3 37.9 20.3 15.9 27.0 27.5 28.6 5.0 4.0 6.3 5.5 2.4 7.1 2.1 23.2 10.4 20.2 10.3 19.9 20.3 18.6 17.6 15.6 13.8 12.1 10.4 15.7 46.4 15.2 16.5 14.2 17.2 15.3 19.4 20.0 8.4 38.7 14.2 18.7 17.7 12.0 21.4 23.2 15.3 14.2 24.8 16.5 18.6 26.4 13.5 21.0 30.5 14.4 15.2 11.8 17.8 11.9 22.0 12.6 22.9 14.9 12.4 12.3 12.0 12.2 19.2 12.8 16.5 14.7 17.2 13.2 12.2 14.1 13.6 47.7 14.6 18.8 11.9 3.1 3.4 5.0 5.6 3.4 5.6 5.0 6.0 5.9 4.0 3.9 4.8 7.1 6.3 2.4 5.5 3.6 7.1 2.1 27.1 31.7 40.8 32.8 25.5 15.3 21.9 20.6 23.6 28.3 UBTD1 FLJ11807 ENSG00000165886 "Ubiquitin domain containing 1" Q9HAC8 10 97498868-97571209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.5;neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034825 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" Vesicles "Plasma membrane, Cytosol" "HPA034825: AB_10602254" "unprognostic (1.52e-1)" "unprognostic (1.48e-1)" "prognostic unfavourable (5.54e-4)" "unprognostic (2.43e-1)" "unprognostic (1.78e-1)" "unprognostic (3.90e-2)" "unprognostic (3.63e-3)" "unprognostic (1.43e-2)" "unprognostic (1.66e-3)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "unprognostic (4.78e-1)" "unprognostic (6.62e-3)" "unprognostic (8.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-3)" "unprognostic (3.50e-3)" 16.0 5.6 7.7 7.3 7.1 10.2 20.5 5.1 9.0 11.5 4.6 5.8 9.7 2.9 6.6 13.9 8.1 8.3 9.0 23.8 6.8 6.5 15.6 11.2 26.0 8.3 9.1 4.8 8.9 12.9 3.1 7.8 5.3 6.4 6.5 1.5 8.9 10.7 10.8 24.2 22.7 2.5 7.0 6.7 5.3 4.1 30.3 5.7 1.0 12.9 10.9 4.4 10.3 8.6 0.3 1.7 8.5 3.4 0.0 0.4 0.5 9.0 9.0 2.4 11.9 10.1 9.6 2.8 10.4 15.3 11.2 8.6 6.0 7.9 1.1 12.7 7.0 10.9 2.4 13.9 1.5 2.8 4.7 1.1 2.8 7.5 14.6 1.0 3.1 13.1 4.7 12.2 3.0 17.8 0.6 1.7 7.1 4.3 0.4 9.2 3.9 16.6 0.9 4.2 1.0 8.6 3.4 0.8 2.5 4.7 2.9 13.4 10.8 6.8 19.1 14.2 8.7 14.8 13.5 2.2 2.5 0.4 12.0 6.2 7.4 1.3 3.4 7.5 0.2 0.8 0.2 0.3 0.1 0.0 1.7 0.0 0.1 0.0 8.5 0.0 0.9 1.2 0.4 0.5 7.7 7.1 5.1 8.1 6.8 6.5 9.1 4.8 6.4 5.7 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5" "Group enriched" "Detected in all" 4 "dendritic cells: 16.6;monocytes: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: " "unprognostic (1.78e-3)" "prognostic favourable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favourable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favourable (4.90e-4)" "prognostic unfavourable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 5.4 7.6 16.6 10.2 25.7 18.9 5.6 7.0 21.5 8.6 4.6 7.9 9.0 4.2 6.7 23.8 4.3 35.4 8.4 5.9 17.0 15.0 9.3 3.7 12.0 8.2 9.8 12.3 9.7 8.2 8.4 18.3 5.2 12.7 5.4 3.5 13.6 8.3 8.3 6.2 6.0 4.4 5.0 5.6 11.7 4.8 27.4 8.5 6.2 15.7 2.7 5.7 6.1 3.9 5.3 16.6 2.4 32.4 1.9 5.7 13.2 17.1 7.8 3.9 7.8 2.8 2.1 13.5 3.8 6.0 10.7 7.8 3.0 15.3 10.1 5.8 2.4 9.4 2.4 6.2 2.7 5.0 9.2 1.7 11.1 7.4 5.1 7.3 3.4 3.3 6.7 18.0 4.6 2.9 6.5 7.0 3.6 7.7 4.1 3.5 7.8 6.0 8.6 2.8 9.0 5.9 2.5 18.4 4.4 9.5 8.9 6.6 6.9 7.1 2.8 6.2 9.3 9.2 5.7 6.7 18.8 11.4 7.6 10.1 5.0 0.7 32.4 1.5 3.4 28.1 4.1 4.4 5.0 3.9 16.6 5.3 5.7 3.6 2.4 1.9 22.5 2.5 4.1 13.2 16.6 25.7 7.0 21.5 17.0 15.0 9.8 12.3 12.7 8.5 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457822 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: " "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favourable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favourable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favourable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 29.1 47.7 29.0 20.0 38.0 38.4 22.9 30.5 45.9 21.0 21.8 12.4 42.3 26.2 23.3 45.9 26.3 24.9 35.6 35.1 29.7 21.8 29.2 37.6 23.4 26.6 25.4 30.5 35.1 45.3 18.9 35.6 22.9 23.3 23.7 8.1 20.8 42.1 46.7 72.0 25.4 28.9 30.3 21.7 22.2 22.8 41.5 18.4 11.9 38.8 42.2 12.0 26.9 22.5 7.4 13.6 12.9 10.3 3.6 8.7 6.1 21.0 14.9 7.1 15.4 18.1 22.6 10.8 21.6 25.8 15.8 16.8 9.2 17.8 9.4 19.7 21.2 12.3 5.5 16.5 5.8 16.5 11.9 7.9 15.8 12.1 29.8 9.8 15.8 20.5 21.9 12.3 12.0 19.2 16.1 25.7 11.6 13.3 19.5 16.7 11.5 13.0 9.0 10.2 22.2 14.9 13.2 20.8 30.2 12.1 12.5 35.0 14.8 16.1 23.0 21.0 16.2 44.6 14.1 57.7 22.7 9.4 40.2 18.5 18.6 8.5 9.2 12.9 5.5 10.3 8.7 6.8 6.5 7.3 8.9 7.4 7.7 6.1 9.1 3.6 6.0 13.6 6.9 6.1 29.0 38.0 30.5 45.9 29.7 21.8 25.4 30.5 23.3 18.4 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: " "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favourable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.2 13.7 8.0 7.5 9.2 12.2 2.7 12.2 11.3 11.1 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.6 7.8 19.4 9.5 7.9 12.0 5.9 6.5 33.4 9.2 16.5 7.2 7.9 6.0 10.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell line enhanced" "Detected in many" "EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavourable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 55.0 11.4 0.0 1.5 1.9 0.0 57.6 29.7 20.4 20.6 11.1 0.0 0.0 97.1 29.3 0.1 21.0 0.0 8.3 0.1 8.6 0.0 0.3 0.0 44.0 0.0 0.0 10.6 0.2 16.3 0.0 0.1 0.0 0.2 10.8 0.0 0.0 0.9 32.9 62.2 0.0 24.4 0.0 30.8 0.0 96.9 60.9 0.3 0.2 0.1 0.0 0.4 0.3 1.3 0.4 0.0 88.7 45.5 85.5 0.2 94.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 UCHL3 ENSG00000118939 "Ubiquitin C-terminal hydrolase L3" P15374 13 75549480-75606020 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019678, CAB037139, CAB037208" Approved Supported Nucleoplasm,Cytosol 490000 "Nucleoplasm, Cytosol" "CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583" "unprognostic (4.16e-1)" "unprognostic (3.84e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (5.15e-2)" "unprognostic (6.46e-3)" "prognostic unfavourable (6.41e-4)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (9.71e-2)" "unprognostic (1.24e-1)" "unprognostic (7.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.97e-1)" "unprognostic (2.76e-2)" "unprognostic (8.84e-2)" "unprognostic (3.26e-2)" 13.7 39.1 23.6 11.9 37.6 17.4 21.4 17.5 18.7 10.6 21.2 11.4 12.8 12.8 9.0 40.5 37.7 8.1 12.4 15.5 20.6 12.6 20.7 36.8 10.3 12.2 18.2 13.5 7.7 20.8 9.5 28.9 26.3 14.7 12.4 25.0 6.1 24.0 14.9 31.7 28.8 15.0 16.9 13.3 15.3 14.5 24.6 18.6 18.9 28.1 29.8 20.2 16.0 16.2 17.4 46.0 15.8 43.5 20.5 23.4 17.3 53.2 8.9 7.8 5.4 14.6 17.4 22.5 20.2 20.0 26.3 29.5 49.3 25.9 27.6 14.6 21.2 29.4 18.2 49.0 40.0 14.7 15.9 17.4 14.8 31.5 21.1 41.5 13.1 15.5 34.1 20.5 33.1 25.6 19.0 7.9 39.5 19.2 16.8 27.2 11.6 26.9 13.5 12.6 18.1 30.9 21.7 23.5 6.9 11.5 22.4 9.3 12.9 11.8 19.8 11.5 13.7 12.2 26.9 11.1 12.3 32.1 23.2 45.0 8.2 15.6 24.1 15.8 10.9 43.5 14.2 17.4 19.9 15.5 33.6 16.0 19.8 18.3 5.4 20.5 36.2 46.0 23.4 17.3 23.6 37.6 17.5 18.7 20.6 12.6 18.2 13.5 14.7 18.6 UCHL5 "CGI-70, INO80R, UCH37" ENSG00000116750 "Ubiquitin C-terminal hydrolase L5" Q9Y5K5 1 193012250-193060080 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005908, HPA075383" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA005908: AB_1858585, HPA075383: " "unprognostic (3.66e-2)" "unprognostic (3.84e-3)" "unprognostic (5.17e-2)" "unprognostic (5.98e-2)" "unprognostic (1.20e-2)" "unprognostic (1.20e-1)" "unprognostic (3.50e-2)" "unprognostic (7.41e-2)" "unprognostic (1.96e-2)" "unprognostic (1.04e-3)" "unprognostic (3.44e-3)" "unprognostic (6.92e-2)" "unprognostic (6.41e-3)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "prognostic unfavourable (7.10e-5)" "unprognostic (4.33e-2)" 15.7 18.3 20.1 16.1 26.2 16.0 18.2 30.1 34.8 10.9 17.7 11.5 12.6 19.0 12.5 14.7 26.1 10.7 11.9 22.0 21.6 20.6 21.6 28.3 12.4 19.9 21.3 29.4 13.4 24.8 15.6 16.2 17.8 33.3 17.8 18.8 10.3 19.3 12.9 29.1 16.7 18.0 13.9 20.1 17.3 14.0 9.9 17.5 20.0 15.1 19.1 23.0 14.8 14.8 22.5 20.8 23.8 21.1 35.6 30.9 20.9 33.2 18.5 16.0 16.4 9.3 9.5 19.1 19.6 10.0 18.8 16.3 17.4 22.6 26.1 18.9 10.8 20.7 21.3 25.3 24.9 26.9 15.3 30.9 23.9 23.1 15.0 48.5 17.4 8.7 11.3 26.9 23.9 18.5 67.7 21.3 15.9 26.8 35.7 18.0 14.8 11.7 20.7 18.0 50.7 17.5 19.5 16.3 20.1 17.6 25.5 27.2 20.7 24.5 12.0 17.6 5.4 17.8 31.1 16.6 25.6 29.4 10.5 30.3 29.9 23.8 16.5 19.0 28.3 19.5 30.9 22.5 25.9 26.9 19.4 18.0 28.2 30.5 10.0 35.6 21.1 20.8 24.8 20.9 20.1 26.2 30.1 34.8 21.6 20.6 21.3 29.4 33.3 17.5 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Cell line enriched" "Detected in many" 4 "HDLM-2: 17.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB010771: AB_261839, HPA072225: " "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.0 2.0 1.7 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.0 0.3 0.4 2.2 0.8 0.4 0.8 17.8 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.6 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.4 1.6 4.2 0.6 1.1 0.6 1.2 1.2 0.5 0.9 0.7 0.2 1.1 0.4 0.3 1.4 0.6 1.2 1.6 1.7 0.8 0.3 1.1 0.6 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favourable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 17.3 15.0 13.3 11.6 12.9 5.5 20.8 9.7 13.3 17.1 18.2 16.4 12.9 15.1 15.0 16.3 17.8 12.6 13.0 13.2 13.1 12.1 21.8 17.2 13.3 12.3 15.6 10.9 13.8 11.8 19.1 14.2 16.2 15.5 17.9 20.0 11.4 14.8 13.9 20.4 20.2 15.9 18.3 23.0 12.5 13.4 10.0 15.0 14.3 15.2 11.8 11.5 16.5 13.5 5.2 7.1 11.1 8.5 8.7 7.6 3.8 9.1 11.0 5.2 5.0 17.1 15.3 5.1 10.0 14.1 13.3 12.8 4.6 2.6 2.8 5.6 11.7 14.2 4.7 10.2 15.2 8.3 6.2 4.0 5.2 5.0 7.6 6.3 6.2 10.5 11.0 6.4 9.2 12.3 3.0 2.8 16.9 6.9 0.2 2.1 1.4 11.4 1.0 12.2 3.5 16.0 14.5 2.2 4.7 11.0 14.1 8.7 11.2 3.8 9.2 12.3 6.5 20.3 9.8 0.6 6.2 0.6 10.6 5.0 12.5 6.9 8.3 5.0 7.6 8.5 7.1 4.5 5.5 6.1 5.5 5.2 3.6 4.7 11.1 8.7 6.6 7.1 3.8 3.8 13.3 12.9 9.7 13.3 13.1 12.1 15.6 10.9 15.5 15.0 UFC1 HSPC155 ENSG00000143222 "Ubiquitin-fold modifier conjugating enzyme 1" Q9Y3C8 1 161152776-161158856 "Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027481, HPA028722" Enhanced Approved "Nuclear speckles,Cytosol" 180000 "Nuclear speckles" Cytosol "HPA027481: AB_10599850, HPA028722: AB_10601674" "unprognostic (2.16e-1)" "unprognostic (6.17e-2)" "unprognostic (1.83e-1)" "unprognostic (8.25e-3)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-3)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (3.40e-2)" "unprognostic (5.04e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (2.62e-6)" "unprognostic (3.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.13e-1)" "unprognostic (6.22e-2)" 34.2 38.6 52.6 25.4 54.7 35.1 45.6 21.1 41.8 35.4 37.3 27.8 47.7 36.9 31.5 57.2 40.6 69.9 40.8 36.0 42.5 45.9 56.1 55.2 32.0 29.8 46.3 35.6 48.7 85.5 39.3 40.6 54.2 34.4 44.0 46.8 29.2 63.6 40.3 34.3 36.1 48.6 35.8 34.4 39.1 39.1 22.2 33.9 38.9 50.2 38.9 38.9 37.9 33.4 41.1 43.6 22.4 33.0 40.9 54.1 48.0 22.8 21.2 18.7 23.5 25.1 40.4 39.5 23.3 27.5 22.3 19.8 27.7 46.9 31.8 39.2 32.4 11.9 15.6 22.4 16.6 27.0 43.0 19.4 31.5 33.2 24.9 42.6 49.4 34.4 36.3 27.8 19.2 38.8 32.1 23.3 28.4 27.6 19.7 39.0 34.4 23.3 24.2 13.6 44.2 43.2 27.9 21.6 34.3 20.3 67.5 26.8 25.8 79.4 29.0 16.6 16.2 15.9 34.0 40.6 51.9 28.7 26.3 27.2 21.0 22.4 32.8 20.4 39.0 33.0 47.2 41.1 41.8 41.5 40.4 31.0 36.7 39.5 6.0 40.9 24.0 43.6 54.1 48.0 52.6 54.7 21.1 41.8 42.5 45.9 46.3 35.6 34.4 33.9 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.4 22.9 19.6 29.6 16.1 11.3 15.1 26.0 26.0 36.0 33.4 25.4 13.7 22.0 20.3 21.8 27.3 22.9 22.8 31.5 40.5 24.2 23.2 16.2 20.0 15.3 36.8 31.7 10.4 23.5 30.7 15.1 28.9 130.1 42.5 21.9 45.7 23.6 22.5 14.0 19.5 28.7 46.3 8.5 22.1 29.7 16.1 18.1 20.4 22.2 20.4 13.3 17.7 31.3 30.5 41.4 25.3 27.9 18.2 36.1 28.7 25.6 18.8 27.7 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 UFSP2 "C4orf20, FLJ11200" ENSG00000109775 "UFM1 specific peptidase 2" Q9NUQ7 4 185399540-185425985 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039985, HPA043298" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039985: AB_10794206, HPA043298: AB_10795037" "unprognostic (8.87e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (3.63e-2)" "unprognostic (3.19e-2)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.07e-8)" "unprognostic (1.92e-1)" "unprognostic (8.12e-2)" "unprognostic (9.36e-3)" "unprognostic (6.70e-3)" 15.8 20.3 12.5 10.3 14.9 4.1 18.7 11.3 20.3 17.3 17.4 16.3 17.0 11.0 19.4 17.4 20.1 17.3 13.5 24.2 11.4 11.7 28.1 19.2 13.2 11.6 14.6 11.3 30.5 20.1 18.3 22.8 12.3 17.0 18.4 12.6 13.7 14.4 20.3 40.8 16.6 13.6 16.9 20.2 14.2 17.3 23.7 14.6 15.8 23.5 19.2 12.2 20.8 13.3 15.6 13.0 5.5 7.9 13.9 17.9 8.2 12.0 7.4 20.8 15.0 18.8 19.6 11.5 12.5 12.7 15.0 14.2 12.4 15.5 12.2 5.8 15.1 9.6 16.1 20.3 15.6 13.0 9.4 6.4 7.2 11.2 20.8 9.7 8.0 11.5 15.9 13.1 13.6 24.0 16.3 24.6 19.4 7.3 13.0 7.3 5.4 10.7 12.9 8.2 14.6 14.4 7.0 12.4 11.6 7.8 12.7 15.2 9.8 6.9 13.9 6.3 11.1 4.3 9.7 22.4 8.6 5.8 20.3 6.1 15.9 5.5 7.9 5.4 16.3 6.8 17.1 15.6 16.5 17.6 9.8 11.0 17.8 17.9 0.4 13.9 6.6 13.0 14.0 8.2 12.5 14.9 11.3 20.3 11.4 11.7 14.6 11.3 17.0 14.6 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favourable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.3 14.4 13.8 9.3 47.2 61.2 58.0 35.4 29.0 19.1 22.8 36.9 23.3 28.7 10.7 38.0 12.0 16.7 22.2 31.0 19.2 7.1 18.2 10.2 25.2 22.5 16.0 16.1 40.1 40.7 17.9 18.5 26.5 9.1 11.7 79.6 10.8 21.7 15.1 33.1 10.1 17.8 27.4 16.6 33.8 16.0 7.3 6.0 28.3 36.4 13.4 10.4 11.4 36.1 20.0 31.6 29.7 18.6 20.9 9.4 36.4 24.0 25.1 61.0 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Cell line enriched" "Detected in single" 42 "RH-30: 24.7" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA047697: , HPA056290: " "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: " "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 5.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 4.0 0.0 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 UHMK1 "KIS, Kist" ENSG00000152332 "U2AF homology motif kinase 1" Q8TAS1 1 162497251-162529629 "Enzymes, Predicted intracellular proteins" "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071190 Approved "Nucleoplasm,Golgi apparatus,Midbody" "Nucleoplasm, Golgi apparatus" Midbody "HPA071190: " "unprognostic (6.69e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.08e-2)" "unprognostic (8.16e-2)" "unprognostic (9.63e-2)" "unprognostic (1.82e-1)" "unprognostic (7.81e-3)" "unprognostic (9.10e-2)" "unprognostic (3.11e-1)" "unprognostic (3.44e-2)" "unprognostic (9.08e-2)" "unprognostic (8.77e-2)" "unprognostic (4.66e-2)" 21.6 22.0 23.5 18.9 26.2 30.1 23.5 10.8 30.5 14.3 16.3 17.2 30.8 16.3 11.5 12.9 16.0 12.9 12.1 11.4 27.0 31.8 27.9 32.4 16.9 24.3 30.6 20.3 12.1 11.8 25.0 12.5 16.5 33.4 14.7 17.4 14.1 15.9 22.9 30.6 11.5 21.8 9.6 20.5 21.3 16.8 10.4 14.1 23.0 17.1 11.7 24.1 16.1 12.8 5.7 4.3 4.5 9.2 5.9 8.5 4.0 20.8 9.8 5.1 12.5 14.7 11.6 11.6 27.7 15.1 22.7 16.3 6.3 13.1 17.1 24.2 20.6 12.1 9.8 15.2 36.6 23.4 7.1 16.9 12.2 5.7 11.3 24.6 19.8 11.9 16.2 22.3 21.4 13.0 14.7 23.8 38.9 8.8 13.0 6.5 6.8 13.3 8.4 22.9 14.2 15.1 21.6 9.3 8.6 24.4 22.7 17.8 19.6 27.6 20.2 26.0 14.7 17.9 38.5 24.7 34.2 20.2 21.6 12.1 23.4 4.5 3.3 3.7 8.2 8.6 8.5 5.4 6.2 6.8 3.6 5.7 6.3 7.1 2.0 5.9 9.2 4.3 4.9 4.0 23.5 26.2 10.8 30.5 27.0 31.8 30.6 20.3 33.4 14.1 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.3 6.0 5.4 17.4 2.8 2.1 9.7 4.9 3.3 4.8 6.8 11.9 2.2 12.6 5.4 5.1 6.4 19.5 2.8 6.6 6.5 6.3 11.2 5.8 9.9 11.6 10.1 7.0 4.7 8.2 3.8 8.2 6.0 18.7 5.0 2.1 8.0 7.8 6.6 2.4 4.2 4.7 8.6 7.6 6.5 7.8 6.5 6.6 12.4 6.5 16.6 12.4 13.3 3.7 2.4 8.8 3.7 5.4 7.5 11.7 8.1 1.3 14.2 5.9 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.2 13.8 17.7 17.9 14.4 10.5 9.1 3.9 9.8 4.6 18.1 4.4 12.9 6.0 14.0 26.1 6.3 6.6 9.9 10.6 9.9 12.3 10.8 8.6 5.1 17.2 12.0 10.0 5.2 10.3 14.0 6.3 7.9 10.7 11.9 11.3 9.0 12.3 9.7 7.3 20.1 11.8 7.3 13.5 15.5 5.2 13.9 14.2 7.9 15.9 8.5 13.7 12.4 12.2 20.8 13.8 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 UIMC1 RAP80 ENSG00000087206 "Ubiquitin interaction motif containing 1" Q96RL1 5 176905005-177022633 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037503, HPA037504" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA037503: AB_10671373, HPA037504: AB_10671760" "unprognostic (2.96e-1)" "unprognostic (9.57e-2)" "unprognostic (2.48e-3)" "unprognostic (4.40e-2)" "unprognostic (1.69e-1)" "unprognostic (9.88e-3)" "prognostic unfavourable (7.67e-6)" "unprognostic (1.85e-1)" "unprognostic (1.12e-2)" "unprognostic (6.62e-2)" "unprognostic (1.30e-1)" "unprognostic (5.91e-2)" "unprognostic (1.33e-3)" "unprognostic (8.51e-2)" "unprognostic (5.52e-1)" "unprognostic (7.23e-2)" "unprognostic (1.44e-1)" 12.7 11.1 11.8 17.3 13.7 35.3 12.6 27.8 12.7 12.2 13.8 7.8 12.0 6.4 14.9 11.7 8.9 10.7 8.8 16.0 9.5 6.6 8.7 8.1 12.1 36.7 11.2 8.9 18.2 12.7 7.0 10.6 8.7 10.4 10.5 9.0 8.8 8.5 10.8 22.9 10.9 10.9 13.7 7.8 15.0 10.4 47.5 11.5 22.1 11.8 7.3 29.5 13.6 28.2 8.5 4.9 32.5 6.3 7.4 7.8 3.3 10.9 10.9 11.4 14.5 10.8 10.1 16.6 11.8 12.9 14.7 15.6 12.8 12.9 45.0 14.1 9.3 8.8 11.6 25.4 17.6 37.6 10.4 14.3 12.1 10.9 11.9 17.8 9.6 7.1 12.2 11.2 30.5 17.1 12.7 10.9 12.1 10.4 19.0 11.7 8.1 6.7 18.6 16.3 19.1 15.4 7.3 12.4 9.8 24.8 8.4 12.2 7.4 10.8 13.6 8.6 9.3 7.5 15.4 19.4 20.2 24.2 8.3 19.3 9.2 7.0 6.3 16.8 5.0 4.0 5.5 6.4 5.8 4.8 3.8 8.5 5.6 4.6 32.5 7.4 2.8 4.9 7.8 3.3 11.8 13.7 27.8 12.7 9.5 6.6 11.2 8.9 10.4 11.5 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell line enhanced" "Detected in many" "HAP1: 23.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: " "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.7 1.4 2.7 7.9 2.8 3.7 1.1 1.7 2.9 1.8 3.2 2.8 2.9 12.8 2.7 23.7 4.6 4.4 12.4 3.9 0.2 0.9 0.0 14.0 0.1 1.0 8.6 5.8 11.7 3.1 2.4 2.3 0.0 4.1 3.3 2.9 0.0 1.0 4.3 1.2 2.4 0.4 5.0 2.1 0.9 0.3 5.4 3.4 0.8 2.7 5.5 1.9 1.3 2.3 5.2 3.2 0.4 0.4 2.5 8.2 4.1 3.4 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell line enhanced" "Detected in many" "SiHa: 31.7;U-2197: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavourable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.5 5.6 10.0 8.2 3.5 5.2 0.0 14.6 10.8 6.6 3.6 8.7 5.8 4.2 1.8 0.5 1.4 0.0 3.5 0.0 0.7 1.3 6.7 8.9 3.9 5.7 1.1 0.0 7.4 6.4 0.8 0.0 0.0 4.9 1.4 2.2 0.0 14.2 2.7 0.3 0.0 31.7 0.6 0.9 0.9 3.9 8.9 6.6 8.2 22.9 11.0 0.0 0.0 0.4 9.4 5.0 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150063150-150069095 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.7" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" Vesicles "Centriolar satellite" "HPA056541: , HPA063007: " "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 8.0 3.6 1.0 0.4 1.2 0.2 8.2 0.3 2.0 1.9 2.8 0.4 1.1 1.4 1.1 2.1 3.6 3.6 4.4 1.2 1.3 2.3 5.5 2.6 3.1 0.3 0.7 0.6 2.0 1.1 1.9 0.7 1.4 0.8 1.3 1.1 1.7 1.2 0.4 0.7 1.0 1.0 0.8 0.5 0.5 2.9 24.3 0.3 0.3 8.2 5.3 2.1 1.8 3.1 0.3 0.0 0.0 0.0 0.0 2.7 0.5 3.8 1.6 4.6 5.1 1.5 8.7 1.4 4.1 1.9 5.3 5.9 8.3 3.6 0.0 9.3 6.8 6.4 13.7 15.0 5.3 3.4 6.9 0.1 2.3 0.4 2.1 0.0 0.6 7.7 2.9 11.3 6.0 7.0 0.2 0.0 4.7 5.6 0.0 0.0 2.1 12.2 4.4 4.7 0.2 10.6 8.9 0.8 0.1 9.7 6.1 2.1 1.8 1.0 3.7 0.9 7.0 13.8 9.6 0.0 0.0 2.7 7.4 2.0 3.8 0.0 0.0 0.0 1.5 0.0 2.0 0.3 2.0 1.1 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 2.7 0.5 1.0 1.2 0.3 2.0 1.3 2.3 0.7 0.6 0.8 0.3 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.2 1.7 2.6 3.0 1.1 1.7 4.5 2.5 2.6 3.0 2.6 0.9 2.1 8.4 1.4 5.7 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.3 2.8 3.9 5.5 1.7 1.6 2.2 14.7 3.0 2.1 1.8 7.0 2.2 5.8 6.9 4.4 3.2 3.0 1.5 8.4 3.7 6.4 7.0 1.3 9.7 2.5 1.2 2.0 2.9 1.8 6.1 1.9 2.2 13.0 2.0 4.2 7.9 3.5 10.8 5.8 2.3 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 UNC119B "MGC5139, POC7B" ENSG00000175970 "Unc-119 lipid binding chaperone B" A6NIH7 12 120710435-120723640 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077812 Enhanced Approved "Cytokinetic bridge,Mitotic spindle,Mitochondria,Cytosol" "Cytokinetic bridge, Mitotic spindle" "Mitochondria, Cytosol" "HPA077812: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.86e-3)" "unprognostic (6.71e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.26e-4)" "unprognostic (9.35e-2)" "prognostic favourable (6.69e-10)" "unprognostic (2.52e-2)" "unprognostic (7.73e-2)" "unprognostic (2.20e-1)" "unprognostic (5.42e-2)" 12.7 33.5 18.1 9.2 18.6 9.5 16.3 17.0 17.2 16.0 12.1 15.0 18.7 8.6 20.7 15.0 11.6 42.8 14.9 13.2 18.9 19.7 27.1 14.7 14.0 9.3 14.2 16.0 33.7 17.1 40.8 25.8 13.4 20.4 18.4 12.3 14.6 14.1 23.8 6.7 13.6 11.4 17.5 15.5 13.4 14.5 21.9 15.2 16.1 38.6 7.3 13.7 12.1 16.3 2.1 2.5 2.1 5.8 2.5 4.0 1.4 11.4 11.2 23.4 19.9 23.4 17.4 19.8 14.3 16.8 16.3 7.4 13.4 4.8 11.7 5.7 16.0 12.3 24.6 16.0 16.9 9.0 12.5 5.4 8.3 8.3 15.9 14.8 8.6 13.7 16.6 12.1 18.8 18.4 13.1 1.3 13.7 10.1 13.5 12.1 28.8 13.9 16.2 15.5 6.0 19.5 24.2 14.1 17.7 34.3 6.8 11.7 26.7 10.2 11.4 15.2 10.4 6.5 9.6 9.4 8.2 7.2 18.1 7.5 16.5 0.2 1.1 1.3 3.3 0.6 2.1 1.8 3.0 3.8 1.2 2.1 4.0 3.2 2.1 2.5 5.8 2.5 2.8 1.4 18.1 18.6 17.0 17.2 18.9 19.7 14.2 16.0 20.4 15.2 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: " "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favourable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favourable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favourable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favourable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.3 8.1 13.0 15.7 8.8 6.9 8.9 4.1 6.6 9.0 6.0 2.5 0.0 4.1 11.6 2.6 20.4 10.4 8.5 0.0 6.5 3.3 20.7 7.7 7.6 1.2 3.8 6.9 8.2 10.5 10.9 21.4 7.4 4.7 7.8 4.2 1.1 0.1 7.3 7.7 0.0 5.0 1.9 9.1 7.1 8.7 9.2 6.3 3.9 6.5 6.7 4.2 19.6 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.4 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" "Low region specificity" "Detected in many" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol 14000000 Cytosol Vesicles "HPA067117: , HPA073525: " "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavourable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 4.5 3.3 2.9 17.1 5.2 31.3 4.5 4.1 3.1 5.2 5.2 2.8 1.4 4.5 3.8 1.8 11.5 5.2 8.7 13.0 1.8 1.6 2.6 4.9 30.1 24.9 4.5 1.6 8.7 5.5 0.3 5.3 67.1 3.2 3.1 2.6 2.6 8.0 3.9 3.2 3.0 7.6 2.8 3.7 33.8 7.2 2.2 3.3 23.6 2.4 9.3 24.7 7.0 8.2 4.0 6.9 24.8 13.6 8.2 11.5 7.9 8.3 3.2 0.0 0.0 0.1 0.2 10.4 0.0 0.0 0.0 0.0 8.0 18.8 0.7 10.0 0.0 2.9 0.0 0.5 0.0 0.1 0.1 55.1 24.4 5.1 0.9 20.9 57.1 0.1 0.4 0.1 0.5 3.7 19.0 0.2 0.0 14.2 22.1 10.5 0.2 0.4 7.1 0.2 0.3 0.3 3.3 0.0 15.3 3.6 39.1 0.2 10.5 11.9 10.4 0.1 14.8 0.1 0.0 0.3 1.3 0.8 0.1 6.7 0.0 24.8 8.0 16.4 11.5 9.4 10.4 4.0 6.7 8.1 6.9 2.2 5.3 6.9 22.4 8.2 13.6 4.0 6.0 7.9 2.9 5.2 4.1 3.1 1.8 1.6 4.5 1.6 3.2 3.3 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" 21000000 "Nuclear speckles" Cytosol "HPA039228: " "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavourable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favourable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 19.1 21.0 10.1 14.4 10.1 11.9 20.6 21.8 14.6 20.3 27.6 10.7 23.2 13.0 29.7 15.5 24.9 20.4 24.8 12.8 9.5 7.3 16.2 15.9 15.2 13.2 11.9 12.3 22.1 19.4 25.8 14.1 22.8 11.5 23.8 10.9 15.3 20.2 29.6 6.9 26.6 16.9 35.8 9.7 15.7 22.4 18.4 10.8 18.0 20.8 12.6 16.9 33.2 30.4 10.1 12.0 12.1 11.9 10.8 14.5 9.8 15.1 30.9 12.8 11.1 35.1 16.3 11.4 17.2 14.9 23.5 18.9 24.6 20.1 17.9 23.2 21.7 33.7 21.7 22.2 11.1 19.8 31.6 34.5 32.3 17.6 19.9 8.5 23.5 20.1 27.2 23.0 16.9 31.8 15.2 14.7 17.6 24.4 10.9 7.3 17.3 15.7 21.8 19.5 19.0 16.0 36.1 18.1 16.4 23.2 23.2 21.5 21.0 17.7 31.3 20.1 14.5 16.9 18.0 14.1 19.5 8.4 19.7 20.0 20.4 12.1 9.0 5.4 14.5 8.3 14.0 10.1 11.9 11.2 12.0 8.3 10.0 9.1 1.8 10.8 11.9 10.7 10.5 9.8 10.1 10.1 21.8 14.6 9.5 7.3 11.9 12.3 11.5 10.8 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 43.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA071450: " "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavourable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 5.0 0.0 43.3 1.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Group enriched" "Detected in some" 5 "REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071881: " "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 8.3 0.0 0.0 0.2 0.2 6.1 3.9 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771993-209999300 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9" "Group enriched" "Detected in some" 5 "AF22: 5.1;SCLC-21H: 8.3;SH-SY5Y: 4.7" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.9 10.0 10.2 0.9 19.3 0.9 0.9 27.2 23.4 1.0 1.0 2.1 0.0 1.0 1.3 1.8 0.9 1.7 3.6 1.0 8.0 7.4 1.0 0.9 1.1 0.8 5.4 13.5 2.1 3.2 1.4 20.1 0.9 14.5 3.2 1.1 3.0 0.9 1.5 0.8 1.2 1.1 1.3 2.2 1.1 1.9 6.9 4.9 0.0 1.5 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 8.3 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 19.3 27.2 20.2 8.0 7.4 5.4 13.5 14.5 4.9 UNK "KIAA1753, ZC3H5, ZC3HDC5" ENSG00000132478 "Unkempt family zinc finger" Q9C0B0 17 75784771-75825799 "Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023636, HPA027962" Uncertain Supported "Cytosol,Cytoplasmic bodies" "Cytosol, Cytoplasmic bodies" "HPA023636: AB_10601774, HPA027962: AB_10611522" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (3.37e-1)" "unprognostic (1.04e-3)" "unprognostic (9.51e-2)" "prognostic favourable (2.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" "unprognostic (6.73e-2)" "unprognostic (9.78e-2)" "prognostic favourable (6.58e-5)" "unprognostic (5.31e-2)" "unprognostic (1.41e-3)" "unprognostic (6.69e-2)" "unprognostic (4.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.01e-2)" 11.6 11.7 13.0 17.8 14.6 13.9 15.5 19.5 14.5 17.8 11.2 15.0 17.6 12.5 18.7 16.1 13.5 17.0 15.4 10.6 13.0 8.7 12.3 11.8 18.4 17.6 14.5 14.3 24.5 18.2 18.5 20.7 13.4 11.2 15.6 6.8 22.2 19.6 16.3 15.0 25.1 13.7 14.3 9.7 21.2 12.9 22.1 16.4 15.6 17.5 8.2 16.1 13.8 15.2 2.8 1.9 0.4 1.1 1.3 2.3 1.5 6.3 10.2 11.4 9.6 3.6 3.4 9.3 4.3 4.6 4.8 5.9 3.7 7.4 13.7 3.7 4.6 5.9 5.7 5.1 2.2 7.0 18.8 8.5 8.2 7.9 4.9 6.5 10.9 6.7 3.1 4.1 4.5 6.3 4.4 6.8 3.8 12.7 14.5 9.0 4.9 6.8 15.4 11.4 6.9 4.5 6.9 10.6 20.7 5.6 7.8 15.0 9.5 10.1 4.5 11.5 6.3 5.0 5.5 11.8 3.4 7.5 8.3 4.2 7.0 0.3 1.1 0.4 2.3 0.7 2.3 1.1 1.3 1.4 0.7 2.8 2.1 2.0 0.4 1.3 0.9 1.9 1.3 1.5 13.0 14.6 19.5 14.5 13.0 8.7 14.5 14.3 11.2 16.4 UPF2 "DKFZP434D222, KIAA1408, RENT2, smg-3" ENSG00000151461 "UPF2, regulator of nonsense mediated mRNA decay" Q9HAU5 10 11920022-12043170 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067008 Supported "Cytosol,Cytoplasmic bodies" Cytosol "Cytoplasmic bodies" "HPA067008: " "unprognostic (1.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.61e-2)" "unprognostic (2.48e-2)" "unprognostic (1.41e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (5.48e-2)" "unprognostic (5.68e-2)" "unprognostic (9.27e-2)" "unprognostic (1.68e-2)" "unprognostic (3.01e-2)" "unprognostic (4.65e-3)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-1)" "unprognostic (8.48e-2)" 15.8 8.7 12.9 18.9 18.1 19.2 13.4 19.7 14.2 22.5 25.5 8.1 14.6 10.2 15.8 14.2 17.2 11.7 9.2 12.7 13.8 11.9 14.5 20.2 12.8 17.8 13.6 10.0 17.8 14.1 20.1 22.3 18.1 13.4 24.5 13.8 7.4 12.2 20.0 33.5 14.5 19.2 19.8 19.3 20.1 12.0 19.4 17.5 28.8 23.0 16.0 17.7 25.5 13.5 7.9 8.4 21.8 3.2 3.7 4.2 1.2 19.0 12.1 10.4 12.9 7.9 10.2 11.8 14.9 6.9 10.7 12.9 11.3 15.6 27.4 5.1 12.4 16.0 14.9 13.5 15.4 17.2 8.6 32.8 9.9 10.3 9.0 14.7 22.2 7.6 10.6 13.5 9.2 13.0 19.4 14.1 12.2 9.3 18.2 8.7 9.9 6.5 16.1 12.5 13.5 10.2 7.7 6.8 7.3 11.8 12.7 12.8 15.4 19.9 13.8 8.4 17.7 17.2 11.3 13.0 10.2 22.7 13.5 14.4 6.6 8.3 3.2 7.1 3.3 3.0 3.2 7.3 3.8 3.4 2.1 7.9 4.2 3.4 21.8 3.7 2.0 8.4 2.7 1.2 12.9 18.1 19.7 14.2 13.8 11.9 13.6 10.0 13.4 17.5 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: " "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favourable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favourable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.0 6.8 15.1 13.5 7.2 12.7 9.7 17.9 12.9 11.5 12.9 10.3 8.2 22.7 5.2 8.2 12.5 7.4 5.9 14.5 16.6 14.6 19.5 19.4 11.3 12.6 33.9 8.8 8.5 12.3 7.7 9.0 9.1 11.9 10.6 11.4 7.0 13.8 9.1 20.1 6.8 18.0 8.5 13.2 10.2 7.4 17.2 19.0 14.2 22.0 12.8 16.3 30.4 11.6 12.2 20.5 6.6 11.1 23.1 16.0 31.4 22.5 19.5 10.0 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavourable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavourable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.6 7.1 14.8 12.0 6.7 4.4 9.5 11.3 6.3 8.8 7.8 13.3 8.4 21.1 9.6 4.7 11.2 19.1 6.7 11.3 12.0 14.0 19.5 23.5 6.9 7.7 21.1 9.7 3.8 5.1 15.1 18.5 8.2 18.8 17.6 7.3 14.2 14.8 26.5 28.5 19.4 14.5 16.9 15.4 7.2 5.9 19.7 13.6 23.0 9.3 16.8 4.9 12.3 7.1 9.2 7.1 14.7 23.8 9.7 10.8 28.5 7.4 31.0 10.7 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Group enriched" "Detected in some" 5 "Hep G2: 18.3;RT4: 30.6" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 30.6 0.1 0.0 0.1 0.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;REH: 1.5" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 1.2 1.3 1.5 0.3 0.0 0.3 0.6 0.7 0.4 0.5 0.5 0.0 0.8 0.2 0.0 0.2 0.3 0.0 0.0 1.3 0.1 0.4 0.4 1.3 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75274085-75304600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favourable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 8.8 15.3 14.6 7.9 15.8 14.9 10.7 20.3 18.7 11.5 9.9 10.8 10.8 14.2 10.0 12.5 13.0 10.2 8.4 12.0 13.1 17.7 15.5 11.3 10.0 10.7 14.9 9.6 8.7 14.1 18.7 19.5 7.6 13.2 12.8 11.0 9.1 13.1 8.6 13.3 7.4 10.5 14.0 10.9 11.0 13.9 3.0 12.4 10.6 13.9 6.5 11.9 9.1 7.9 8.3 11.1 8.9 16.4 14.7 13.3 7.4 7.7 5.5 6.1 5.7 6.6 7.1 5.8 5.4 6.4 5.9 6.6 4.8 5.2 10.8 4.7 5.6 3.4 14.0 4.9 9.5 9.8 5.6 6.8 5.8 6.1 6.4 13.3 14.1 5.4 3.4 8.1 4.2 10.2 7.9 10.9 15.3 3.3 15.0 8.1 12.4 9.0 7.1 16.1 5.2 15.0 4.5 0.4 6.4 7.6 7.9 7.4 3.6 8.5 8.5 7.4 4.5 13.6 4.6 7.4 24.1 10.5 7.9 14.6 4.7 5.1 7.4 8.9 8.3 10.7 9.5 8.3 8.3 8.5 11.1 7.2 10.5 9.3 1.3 14.7 16.4 5.0 13.3 7.4 14.6 15.8 20.3 18.7 13.1 17.7 14.9 9.6 13.2 12.4 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.8 9.9 11.2 10.3 11.4 12.5 1.6 13.0 14.1 23.3 16.2 32.1 13.5 21.8 24.6 8.1 18.1 19.7 22.5 17.7 6.5 7.8 29.3 13.2 25.7 7.2 17.5 8.7 12.2 23.0 12.4 15.6 7.9 12.6 7.2 16.2 8.9 20.0 6.3 9.4 20.4 11.0 17.5 12.0 21.4 7.7 15.8 10.6 11.0 53.0 11.4 7.9 11.2 7.4 15.9 10.1 8.3 11.8 11.2 12.1 9.1 28.4 10.2 12.8 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA039111: " "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 13.4 22.9 26.1 13.3 31.4 14.6 17.7 15.0 22.9 12.4 15.8 12.0 12.3 12.8 17.4 23.4 15.2 10.9 9.2 71.0 19.2 23.0 18.3 23.4 8.9 12.3 22.8 22.6 11.5 25.3 7.9 24.5 14.4 20.6 15.7 17.2 18.9 19.6 14.3 76.4 12.2 10.4 20.0 20.0 12.9 15.9 30.9 18.3 12.3 19.0 22.0 14.9 10.9 11.0 39.7 38.9 7.2 39.6 21.9 31.5 34.8 42.4 30.6 34.3 29.7 28.5 28.8 27.0 24.3 24.4 33.8 33.5 49.1 18.0 17.1 39.2 29.2 22.9 23.3 33.9 30.1 21.8 38.3 33.5 20.3 67.8 46.8 31.2 27.5 29.3 54.6 27.1 43.9 25.1 35.6 35.5 39.7 45.7 30.2 64.9 20.8 34.9 21.9 28.1 58.0 23.9 40.4 59.0 20.9 26.8 41.0 33.5 36.0 79.5 23.2 38.9 33.0 25.0 49.9 27.4 38.0 28.9 11.7 47.3 44.8 7.2 27.0 5.2 24.0 39.6 29.1 39.7 30.3 27.4 31.9 32.8 31.5 28.4 2.6 21.9 32.7 38.9 31.1 34.8 26.1 31.4 15.0 22.9 19.2 23.0 22.8 22.6 20.6 18.3 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA046851: " "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavourable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 11.8 24.1 3.5 5.5 2.2 2.2 3.0 4.7 1.6 3.6 3.5 14.1 10.4 7.7 9.8 1.6 11.8 3.4 5.5 1.1 3.9 12.5 4.4 12.7 9.0 3.0 7.0 3.5 2.1 4.7 3.1 3.6 2.7 9.3 5.6 1.9 36.3 6.8 17.3 3.9 13.7 7.9 5.4 13.7 2.7 5.9 7.2 7.3 5.2 19.1 7.0 18.2 6.6 3.5 7.8 9.1 8.1 10.5 8.7 4.7 7.9 6.4 6.1 5.6 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell line enhanced" "Detected in all" "PC-3: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria,Cytosol 1300000 Mitochondria Cytosol "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favourable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.0 16.2 5.9 3.6 8.7 8.0 26.7 18.5 15.0 15.4 14.0 25.2 3.0 25.9 11.7 8.3 9.7 7.4 21.5 2.8 15.4 35.5 26.6 14.1 27.4 17.3 16.7 11.5 11.0 24.4 10.5 17.2 15.2 14.3 1.7 9.3 17.4 12.0 19.1 14.8 64.6 8.2 15.7 21.2 15.9 11.0 6.3 11.2 25.1 3.0 14.8 6.4 2.6 15.3 4.3 16.3 13.4 19.1 15.8 13.9 15.0 9.4 19.3 13.7 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 URI1 "C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI" ENSG00000105176 "URI1, prefoldin like chaperone" O94763 19 29923644-30016608 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Protein phosphatase inhibitor, Repressor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071709 Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA071709: " "unprognostic (4.22e-2)" "unprognostic (2.75e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (2.96e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-3)" "unprognostic (8.12e-2)" "unprognostic (1.26e-2)" "unprognostic (4.42e-3)" "unprognostic (1.57e-1)" "unprognostic (3.71e-1)" "unprognostic (1.33e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" 16.4 21.2 19.7 15.9 21.5 17.8 21.0 21.7 19.8 18.4 18.0 18.9 16.6 12.9 19.7 19.4 20.5 17.7 14.2 17.5 19.2 16.5 16.6 22.9 13.0 20.7 22.7 15.4 26.3 21.8 21.8 28.8 15.0 21.1 22.6 18.8 12.7 16.7 18.5 45.0 25.3 17.7 15.7 28.3 18.7 14.0 69.2 22.8 21.0 32.1 14.5 20.3 18.6 17.2 6.6 3.1 3.8 2.5 3.7 6.2 1.4 22.6 30.9 14.5 22.5 10.3 15.1 24.5 14.8 12.6 10.9 12.5 16.2 15.0 35.3 29.5 17.2 16.1 30.7 19.0 24.8 24.5 17.5 32.1 15.3 20.9 15.0 30.8 13.8 13.2 26.1 9.4 35.7 8.0 38.0 9.9 13.6 19.4 20.1 13.0 13.5 9.5 19.9 26.9 14.2 7.2 26.9 23.4 18.4 17.0 20.6 21.7 8.5 19.5 10.5 26.9 23.9 13.1 22.4 27.5 29.6 23.9 13.2 27.2 16.1 3.8 2.4 3.2 5.7 2.5 4.8 3.5 5.1 5.8 2.0 6.6 6.2 6.1 0.3 3.7 2.3 3.1 3.8 1.4 19.7 21.5 21.7 19.8 19.2 16.5 22.7 15.4 21.1 22.8 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371319-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA053645: , HPA065160: " "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 27.2 28.9 25.4 22.4 25.5 31.3 23.2 19.4 40.9 23.4 26.3 36.0 19.7 30.9 25.0 24.4 26.5 26.9 22.9 32.3 25.0 21.4 25.5 39.1 20.8 28.5 29.2 22.9 23.4 53.2 21.2 19.6 28.6 32.0 23.7 25.2 22.2 29.2 23.9 34.9 24.4 36.6 26.4 31.8 30.6 25.6 19.2 21.4 34.9 28.0 29.7 28.8 23.0 20.5 12.4 16.7 10.2 17.7 11.3 15.5 11.5 9.4 18.5 16.7 11.3 17.0 16.8 15.2 8.7 15.4 22.3 15.4 14.6 15.2 19.0 7.4 19.8 31.7 21.2 19.7 11.3 13.4 14.7 16.0 22.3 17.2 16.6 19.4 16.1 21.8 17.5 17.5 15.0 27.1 21.5 13.5 15.9 21.2 27.6 28.5 21.0 22.2 22.6 21.6 23.9 18.1 8.4 15.0 19.9 16.5 28.0 21.2 26.9 16.1 15.3 16.5 15.7 16.4 15.0 13.0 23.9 19.5 17.3 16.8 20.4 5.6 14.3 10.2 15.5 17.7 13.1 12.3 13.5 14.2 16.7 12.4 13.5 14.4 3.7 11.3 16.1 12.4 14.9 11.5 25.4 25.5 19.4 40.9 25.0 21.4 29.2 22.9 32.0 21.4 UROD ENSG00000126088 "Uroporphyrinogen decarboxylase" P06132 1 45012147-45015575 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027468, HPA028668, HPA030350" Uncertain Supported Nucleoplasm,Cytosol 5200000 "Nucleoplasm, Cytosol" "HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: " "unprognostic (5.90e-2)" "unprognostic (2.94e-2)" "unprognostic (2.49e-1)" "unprognostic (9.61e-2)" "unprognostic (7.94e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (2.48e-4)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (6.75e-2)" "unprognostic (7.72e-3)" "unprognostic (3.92e-1)" "unprognostic (1.24e-1)" "unprognostic (4.68e-2)" "unprognostic (1.41e-1)" "unprognostic (8.73e-2)" "unprognostic (8.12e-2)" 20.7 50.2 23.1 12.2 26.2 67.5 20.7 14.2 28.6 17.7 24.2 16.5 25.9 11.2 27.8 22.6 17.8 20.8 17.4 34.0 21.1 20.3 29.6 58.1 14.3 14.8 21.6 22.9 27.4 18.4 35.9 17.6 25.8 16.2 19.2 12.3 24.3 45.6 19.2 28.8 12.1 13.2 22.9 18.9 16.6 15.0 16.3 11.5 17.2 26.3 23.6 16.0 15.0 13.0 25.7 48.6 20.6 36.3 26.0 27.4 35.6 12.5 8.2 13.2 17.3 22.8 21.5 6.4 15.3 39.6 32.3 24.9 11.8 6.6 8.9 16.2 23.2 6.5 25.1 29.9 22.5 7.9 26.4 46.0 19.0 39.1 26.6 14.0 8.6 22.3 19.0 30.8 25.0 41.4 79.8 9.8 30.8 10.5 9.5 12.1 20.5 29.1 14.4 19.6 12.9 28.1 10.6 14.1 11.1 16.8 12.6 25.9 9.9 14.7 26.8 18.4 14.4 6.3 24.7 10.2 10.9 7.5 28.8 21.3 9.2 17.6 36.3 20.6 19.7 25.8 20.0 25.7 23.8 19.2 48.6 23.7 22.3 20.3 6.6 26.0 15.5 32.4 27.4 35.6 23.1 26.2 14.2 28.6 21.1 20.3 21.6 22.9 16.2 11.5 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823248 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol 15000 Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 13.8 16.1 48.6 9.0 46.6 33.2 13.9 12.8 35.3 8.9 11.4 15.7 12.8 13.2 9.3 41.2 10.5 11.3 11.5 31.4 36.9 20.4 22.6 25.5 10.0 16.8 22.7 23.4 14.5 14.1 14.4 12.0 7.9 20.0 12.9 12.4 14.0 18.1 14.0 45.6 9.8 12.0 13.0 12.5 11.7 12.5 13.8 13.8 10.8 16.4 14.4 12.7 9.4 6.3 17.3 27.1 2.4 15.6 24.7 21.3 17.8 17.4 18.9 13.8 30.7 18.5 18.8 18.6 22.6 39.1 15.9 15.9 8.2 21.3 24.4 10.6 28.0 10.0 8.0 16.1 15.0 30.1 15.2 51.8 10.7 13.5 26.1 21.8 12.2 23.5 9.2 11.1 29.8 14.5 8.9 23.2 26.5 20.8 19.1 24.6 15.0 19.8 13.5 15.3 14.5 20.8 10.9 10.8 18.6 22.6 17.4 30.7 15.6 20.8 14.4 21.1 7.9 16.2 19.1 21.4 15.5 16.6 29.4 8.9 10.0 2.4 15.6 2.2 16.1 15.4 18.5 15.7 16.0 20.4 27.1 17.3 21.3 16.3 1.2 24.7 14.6 12.9 14.2 17.8 48.6 46.6 12.8 35.3 36.9 20.4 22.7 23.4 20.0 13.8 USF2 "bHLHb12, FIP" ENSG00000105698 "Upstream transcription factor 2, c-fos interacting" Q15853 19 35268978-35279821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029764, HPA046567" Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029764: , HPA046567: " "unprognostic (6.10e-3)" "unprognostic (2.27e-1)" "unprognostic (1.06e-2)" "unprognostic (5.03e-3)" "unprognostic (4.60e-2)" "unprognostic (1.72e-1)" "unprognostic (2.45e-1)" "unprognostic (2.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.07e-2)" "prognostic favourable (5.12e-5)" "unprognostic (7.75e-2)" "unprognostic (8.12e-2)" "unprognostic (7.47e-2)" "unprognostic (5.75e-2)" "unprognostic (6.90e-2)" "prognostic favourable (3.28e-4)" 40.6 48.6 50.9 42.7 56.8 52.8 53.0 52.5 60.5 23.4 26.2 41.2 25.9 36.5 26.3 23.4 25.8 23.6 23.1 52.6 50.8 35.5 22.1 47.9 29.1 48.8 48.6 43.6 54.1 41.8 34.9 36.4 22.1 40.2 22.5 19.7 31.7 34.0 21.6 108.9 35.1 35.8 24.4 48.5 42.9 30.6 13.0 51.2 22.7 29.9 24.9 32.5 26.8 35.6 7.1 27.3 17.8 5.8 5.8 7.2 3.7 38.0 38.3 20.0 18.8 34.6 17.7 18.8 20.6 24.5 18.8 14.2 17.8 19.7 36.5 33.1 17.6 11.6 18.5 16.1 9.8 61.3 28.5 21.7 22.9 28.4 21.0 36.2 37.4 15.3 22.8 12.3 19.1 12.8 26.0 54.7 14.7 43.6 39.6 14.4 16.6 13.0 38.9 25.4 34.4 15.6 24.3 33.7 25.6 38.4 41.8 69.3 16.8 29.2 21.5 31.9 21.5 20.9 27.6 55.2 55.1 39.6 29.5 23.2 41.5 17.8 4.7 5.7 3.9 5.8 4.8 5.6 4.0 5.1 7.1 7.1 3.6 3.5 4.2 5.8 3.5 27.3 7.2 3.7 50.9 56.8 52.5 60.5 50.8 35.5 48.6 43.6 40.2 51.2 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 3.9 4.9 4.6 12.0 4.6 3.3 2.1 3.4 2.1 2.0 3.7 2.2 9.2 3.8 5.3 3.3 5.3 4.2 3.9 2.8 2.1 6.6 2.5 6.0 3.6 11.9 7.3 6.7 7.6 3.8 4.4 4.9 3.1 4.9 4.4 7.3 6.6 6.7 3.6 4.0 2.8 3.8 3.6 7.4 7.3 2.3 3.5 5.1 2.8 6.0 3.9 8.9 6.7 3.3 7.1 1.8 3.0 5.7 3.2 11.0 3.7 5.0 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724593-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 94.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" 43000 "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 18.1 22.1 9.9 14.9 11.5 4.1 14.6 13.8 13.2 18.1 16.5 9.1 24.9 13.0 18.6 25.3 20.1 15.8 12.1 35.4 10.9 10.4 18.7 38.8 13.6 10.8 11.5 11.7 23.2 23.6 16.8 32.1 23.1 16.1 19.4 14.0 11.4 20.8 22.2 94.4 13.2 17.3 19.1 14.7 13.5 14.8 15.3 10.6 15.0 20.7 27.0 14.1 23.8 18.8 10.1 14.6 16.8 21.2 19.1 20.7 11.2 14.2 11.3 15.9 21.3 39.0 51.8 14.6 33.5 41.1 18.5 22.6 11.2 22.1 18.8 20.7 30.7 16.6 23.8 20.8 27.9 20.6 9.2 12.9 10.1 23.5 30.7 17.0 14.9 29.4 25.7 19.2 37.8 27.6 22.3 21.7 27.3 9.3 16.8 9.0 21.7 6.7 11.2 15.2 15.0 27.6 16.6 12.7 12.4 12.3 26.1 21.1 19.1 14.0 21.2 17.0 10.5 30.7 12.6 20.5 11.0 9.1 25.3 10.3 20.0 16.8 11.4 10.1 15.2 16.5 20.7 9.3 12.9 14.5 14.6 10.1 13.6 13.1 7.0 19.1 21.2 11.8 12.9 11.2 9.9 11.5 13.8 13.2 10.9 10.4 11.5 11.7 16.1 10.6 USP10 "KIAA0190, UBPO" ENSG00000103194 "Ubiquitin specific peptidase 10" Q14694 16 84699978-84779922 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 105.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 105.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 105.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006731, HPA006749" Enhanced Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA006731: AB_1080495, HPA006749: AB_1080492" "unprognostic (4.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (6.93e-2)" "unprognostic (1.77e-3)" "unprognostic (1.03e-3)" "unprognostic (2.91e-3)" "unprognostic (1.75e-1)" "unprognostic (3.84e-2)" "unprognostic (2.56e-2)" "unprognostic (1.82e-3)" "prognostic favourable (1.00e-4)" "unprognostic (5.91e-2)" "unprognostic (4.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.38e-1)" 13.9 18.8 16.0 24.2 19.0 13.4 14.4 24.4 20.4 15.9 18.1 15.6 8.4 16.1 20.2 10.4 19.7 18.2 12.0 16.4 19.3 15.1 16.4 20.7 13.7 18.8 19.7 17.4 18.5 17.1 35.8 15.0 23.5 16.2 15.0 15.6 17.9 15.3 17.8 47.0 17.0 17.5 20.2 16.3 16.0 15.0 15.5 16.2 20.4 17.6 15.7 20.9 19.7 15.8 7.2 10.4 105.5 8.6 7.7 17.3 10.0 13.6 18.9 18.4 22.8 6.8 11.6 24.9 13.5 14.3 22.9 12.6 26.6 11.9 23.7 15.7 14.1 15.7 25.5 21.5 30.5 9.6 13.4 13.6 8.9 17.6 9.0 20.2 8.3 7.3 16.6 23.9 27.7 17.5 37.1 5.2 15.8 28.6 20.9 9.8 22.1 12.8 27.2 10.1 11.2 14.4 11.1 17.2 10.1 32.3 10.5 9.1 24.1 12.9 12.8 15.9 12.7 8.0 12.8 8.7 12.1 60.1 10.3 13.0 16.3 2.5 8.6 1.6 5.7 7.0 6.8 7.2 17.3 6.3 10.4 6.7 9.9 6.0 105.5 7.7 6.3 3.5 6.1 10.0 16.0 19.0 24.4 20.4 19.3 15.1 19.7 17.4 16.2 16.2 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179652755-179789401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.8;skeletal muscle: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "MAIT T-cell: 15.4" "Lineage enriched" "Detected in many" 8 "T-cells: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavourable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavourable (3.06e-4)" 6.4 7.5 2.0 2.3 2.8 0.8 3.5 2.9 4.1 2.7 2.1 4.6 1.5 0.7 3.2 3.8 2.6 2.5 2.5 34.8 2.0 2.3 2.3 3.4 6.0 2.5 2.1 2.1 7.2 3.0 3.3 9.8 1.9 3.0 3.0 1.8 3.1 3.3 2.1 90.3 1.8 1.7 3.7 2.5 1.6 1.6 5.6 1.3 1.7 5.5 17.1 3.2 2.6 1.9 2.0 1.9 0.0 0.4 0.0 15.4 0.7 12.3 5.3 10.1 7.7 4.6 6.4 4.9 7.3 8.4 10.8 9.1 7.8 4.4 15.3 8.2 8.8 0.9 11.3 4.4 12.9 36.2 4.8 4.0 8.0 7.3 3.3 11.2 0.0 6.8 1.6 8.4 10.7 8.6 1.9 19.8 8.9 8.1 6.8 2.0 7.8 4.8 11.7 10.0 12.5 7.3 3.5 5.7 7.4 7.0 9.4 4.2 16.2 8.1 9.3 13.0 10.4 11.1 28.1 9.6 8.0 31.4 6.0 7.6 12.1 0.0 0.2 0.0 1.3 0.4 15.4 2.0 1.3 2.9 1.5 0.6 1.0 1.0 0.0 0.0 0.4 1.9 0.6 0.7 2.0 2.8 2.9 4.1 2.0 2.3 2.1 2.1 3.0 1.3 USP16 Ubp-M ENSG00000156256 "Ubiquitin specific peptidase 16" Q9Y5T5 21 29024629-29054488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021140 Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021140: AB_1858668" "unprognostic (6.06e-2)" "unprognostic (3.14e-1)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (5.92e-2)" "unprognostic (5.79e-3)" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (5.78e-2)" "unprognostic (7.40e-2)" "unprognostic (8.73e-2)" "unprognostic (8.65e-2)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" 25.4 21.7 24.4 27.4 24.2 20.4 22.8 32.4 23.1 24.2 24.3 13.5 23.6 20.4 22.6 28.2 27.1 19.4 17.0 23.8 23.8 22.6 28.4 34.0 16.8 20.7 25.8 19.5 27.3 23.6 31.6 41.6 45.9 25.3 26.0 22.3 13.3 20.6 28.8 35.8 16.1 33.2 26.2 28.6 29.1 20.8 20.1 25.3 37.6 28.4 25.6 25.5 30.8 17.1 30.9 23.5 21.2 20.5 19.9 26.2 10.1 21.8 8.7 13.9 12.5 9.9 16.3 13.1 21.3 14.2 14.8 14.1 10.9 14.2 22.3 6.5 20.4 10.0 17.2 15.5 19.4 21.3 18.3 29.7 10.6 12.1 14.7 29.1 16.5 13.9 16.4 19.3 17.8 14.2 24.4 39.4 17.1 10.0 17.9 10.6 14.8 11.3 12.0 34.3 25.5 12.2 15.8 15.1 16.1 13.8 22.1 18.7 15.2 20.0 14.2 17.3 21.6 15.9 21.9 33.7 46.2 23.4 18.1 21.2 17.2 21.2 16.2 20.9 25.4 16.1 19.8 26.4 23.9 22.8 14.9 30.9 26.2 24.8 15.5 19.9 20.5 23.5 24.5 10.1 24.4 24.2 32.4 23.1 23.8 22.6 25.8 19.5 25.3 25.3 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381726 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.9" "Cell line enriched" "Detected in many" 4 "U-266/70: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favourable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 3.1 4.8 6.9 1.4 12.2 1.5 1.6 12.6 16.1 2.5 5.9 10.0 0.0 7.9 2.6 6.4 5.9 7.0 2.2 26.8 5.7 3.1 29.7 10.6 2.2 0.7 5.7 6.2 2.9 10.1 18.4 7.6 1.3 6.7 2.3 3.9 19.1 3.2 2.4 79.9 4.6 11.7 4.2 3.8 0.8 2.7 36.1 8.8 0.0 2.2 25.2 1.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 3.4 0.3 0.5 1.9 0.1 0.1 0.7 0.4 0.2 0.0 0.3 3.6 0.5 5.9 1.1 0.6 0.6 4.7 1.7 0.1 4.2 0.6 1.7 2.5 7.3 1.6 0.0 1.6 0.6 0.3 0.4 1.2 0.3 8.2 0.5 1.0 2.4 0.0 0.4 0.9 0.7 0.0 1.3 0.8 2.7 0.2 7.2 2.2 2.0 1.6 0.4 5.3 3.6 0.0 0.0 0.9 0.5 0.5 34.4 7.6 0.1 0.0 1.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.3 0.3 6.9 12.2 12.6 16.1 5.7 3.1 5.7 6.2 6.7 8.8 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 30.4;MOLT-4: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favourable (8.01e-4)" "prognostic unfavourable (2.48e-4)" "prognostic favourable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favourable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favourable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 3.0 2.9 5.2 7.0 6.8 5.8 7.4 4.9 4.1 3.7 2.6 2.4 3.3 4.1 4.2 4.7 7.6 3.1 3.5 1.5 22.2 4.1 7.6 8.0 1.6 4.8 7.1 5.7 5.1 5.1 4.9 3.7 4.0 30.4 5.1 2.2 8.0 27.8 16.9 4.1 7.0 4.7 5.8 7.0 2.9 3.3 1.1 5.8 5.7 7.2 4.6 7.5 10.0 5.9 4.1 1.9 5.5 3.2 5.1 7.4 2.9 8.2 9.4 3.8 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 USP21 "USP16, USP23" ENSG00000143258 "Ubiquitin specific peptidase 21" Q9UK80 1 161159450-161165723 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028397 Uncertain Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA028397: AB_10603227" "unprognostic (9.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "prognostic unfavourable (7.05e-4)" "unprognostic (1.22e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.68e-4)" "unprognostic (5.35e-2)" "unprognostic (6.73e-2)" "unprognostic (2.76e-2)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (9.50e-6)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (2.13e-2)" "prognostic favourable (3.35e-5)" 11.8 16.4 22.1 12.8 21.2 15.3 19.1 23.6 24.8 18.1 16.1 25.5 14.0 15.5 19.7 14.6 18.3 33.3 14.1 13.7 20.9 12.1 15.4 10.6 14.0 16.7 26.4 14.1 28.3 19.0 24.4 17.2 15.2 20.5 18.1 13.1 17.1 19.0 25.3 19.4 23.5 15.4 15.1 17.0 18.7 16.0 17.0 22.9 16.0 24.5 9.6 15.6 17.9 19.2 14.1 12.0 18.3 11.1 13.4 17.2 10.7 7.4 12.8 16.9 16.3 13.5 11.3 10.4 5.5 9.0 15.2 11.9 11.8 14.7 9.7 9.5 6.8 12.9 10.9 10.7 8.4 18.5 18.3 11.6 18.5 9.2 9.7 10.3 8.7 9.5 14.4 10.4 15.0 10.7 17.1 13.6 9.6 13.7 18.2 16.2 15.8 16.3 17.3 5.6 16.3 8.9 8.9 15.4 19.8 10.3 10.8 8.3 23.8 16.6 6.2 10.9 9.7 7.6 9.4 27.5 21.3 14.4 10.0 8.9 9.8 13.0 11.1 18.3 14.9 7.1 17.2 12.8 13.8 15.4 12.0 14.1 16.0 14.6 9.6 13.4 7.7 12.0 13.3 10.7 22.1 21.2 23.6 24.8 20.9 12.1 26.4 14.1 20.5 22.9 USP24 KIAA1057 ENSG00000162402 "Ubiquitin specific peptidase 24" Q9UPU5 1 55066359-55215113 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 46.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026723, HPA028428, HPA067124" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: " "unprognostic (2.28e-1)" "unprognostic (9.81e-3)" "unprognostic (4.70e-3)" "unprognostic (4.86e-3)" "unprognostic (9.31e-3)" "unprognostic (4.84e-3)" "prognostic unfavourable (1.34e-7)" "unprognostic (2.04e-1)" "unprognostic (6.93e-2)" "unprognostic (2.98e-1)" "unprognostic (5.08e-2)" "unprognostic (1.86e-1)" "unprognostic (8.12e-2)" "unprognostic (1.79e-1)" "unprognostic (6.42e-2)" "unprognostic (4.12e-2)" "unprognostic (1.64e-1)" 12.3 7.6 7.5 12.1 8.8 30.1 10.6 20.1 8.5 7.8 10.2 6.8 10.6 5.0 10.1 7.0 7.7 6.9 7.0 14.7 7.9 6.4 10.4 9.3 7.6 12.7 8.0 5.6 10.9 7.3 15.5 16.9 5.8 6.9 7.6 8.5 5.1 9.7 10.7 46.0 8.9 8.7 7.3 6.2 10.9 7.8 4.9 8.7 16.4 7.4 11.5 12.7 9.7 13.7 6.0 10.5 5.9 2.2 3.8 4.5 1.1 17.8 9.8 12.3 6.7 16.1 14.1 14.2 7.9 10.0 11.4 11.9 14.0 6.3 14.3 8.8 14.6 14.5 16.3 13.3 17.9 15.0 9.9 28.7 21.5 16.3 9.6 19.7 22.3 12.3 11.9 17.3 19.7 10.3 26.4 6.0 15.2 4.2 11.9 10.5 18.1 11.9 12.3 15.7 6.2 19.8 12.1 10.9 7.6 13.5 9.7 11.8 6.7 9.8 13.9 10.4 10.1 12.5 12.6 7.6 5.7 18.8 9.9 16.5 9.3 5.9 2.0 2.5 4.5 1.8 2.8 4.8 3.5 3.5 1.8 6.0 3.2 4.2 2.3 3.8 2.2 10.5 1.9 1.1 7.5 8.8 20.1 8.5 7.9 6.4 8.0 5.6 6.9 8.7 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27, X-linked" A6NNY8 X 49879948-49882565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA077264: " "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favourable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.8 3.3 1.8 5.9 2.9 0.3 7.7 1.7 7.4 3.9 5.9 4.8 2.2 1.1 12.7 4.1 3.1 4.7 3.8 3.9 2.2 3.5 3.5 6.1 1.9 1.3 3.2 8.8 3.2 4.1 0.8 15.5 2.8 4.1 1.7 4.1 5.2 3.9 7.5 2.6 4.7 3.9 1.3 2.0 1.9 3.8 1.9 2.8 3.2 3.6 2.2 3.7 3.1 1.7 1.0 0.7 0.7 0.3 1.3 0.4 2.1 5.6 6.5 7.5 6.2 5.0 5.4 2.4 4.1 2.8 2.3 10.0 2.5 1.4 2.3 6.4 3.6 9.3 6.2 4.1 2.9 4.3 2.3 1.6 9.2 4.2 0.7 5.1 7.0 4.2 4.0 4.0 3.9 4.6 2.4 4.5 5.3 3.5 2.0 7.0 3.9 3.7 5.6 0.5 4.6 2.1 1.7 4.9 4.8 4.5 5.8 5.2 1.7 2.9 3.3 6.4 5.7 0.9 2.2 0.5 1.0 3.8 2.0 3.6 0.7 0.4 0.1 0.6 0.4 0.8 0.6 0.5 0.3 1.0 1.7 0.8 0.6 0.7 0.3 0.7 0.4 1.3 0.4 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 40.1;skeletal muscle: 50.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 3.9 3.4 4.8 8.6 5.7 2.4 5.7 26.4 8.6 11.6 5.1 4.9 14.0 4.7 6.0 6.0 5.7 5.0 4.0 40.1 5.0 4.8 5.1 5.6 5.1 7.2 6.8 4.5 7.5 4.1 10.6 9.7 3.9 4.8 8.9 6.0 5.7 5.7 12.2 50.2 3.5 5.1 11.6 6.4 6.9 4.4 5.5 3.8 3.6 5.1 10.1 7.7 7.1 4.6 10.3 4.1 2.1 3.7 17.9 16.2 6.0 10.3 11.6 15.7 20.7 12.8 12.7 11.1 7.6 10.5 10.3 17.7 17.1 14.9 13.7 17.4 10.3 20.3 22.1 14.3 14.4 15.3 10.0 7.3 8.1 9.2 7.9 9.4 7.3 7.6 10.9 11.9 14.2 18.6 12.6 8.9 10.8 5.2 7.1 15.3 18.8 8.4 17.6 21.8 16.6 11.4 10.2 6.9 7.4 18.1 6.2 5.9 15.1 3.3 9.8 11.5 17.2 10.4 7.8 6.1 8.7 11.6 1.1 18.3 7.4 0.1 3.2 2.1 16.2 2.4 8.4 10.3 4.1 11.4 4.1 8.4 2.7 9.4 0.9 17.9 3.7 1.2 5.6 6.0 4.8 5.7 26.4 8.6 5.0 4.8 6.8 4.5 4.8 3.8 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60179094-60422470 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.4" "Cell line enhanced" "Detected in all" "MCF7: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 28.4" "Group enriched" "Detected in many" 10 "dendritic cells: 28.4;granulocytes: 13.5" HPA044365 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA044365: " "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 9.5 13.9 17.3 10.8 19.5 20.6 10.9 14.6 20.3 8.0 8.5 18.9 7.9 7.2 8.2 5.4 13.1 7.4 9.1 11.1 14.7 12.2 15.5 19.7 12.5 8.6 18.8 14.3 7.4 8.5 17.3 11.4 9.8 19.2 8.7 8.9 11.6 8.2 9.0 23.0 12.2 7.2 9.8 16.5 12.1 8.1 58.4 18.1 7.3 15.6 7.9 8.5 8.8 8.5 1.4 28.4 13.5 2.1 0.6 1.1 0.9 10.9 12.5 6.6 10.6 16.8 15.8 6.3 9.0 13.5 11.7 15.1 6.5 7.1 6.8 7.5 16.5 5.8 11.3 12.4 20.7 5.1 5.0 13.5 9.9 7.1 16.8 10.7 12.4 14.8 9.1 15.8 14.6 12.8 13.7 5.6 14.5 60.4 10.8 7.6 7.8 6.0 5.2 17.6 4.1 12.3 8.0 4.7 7.0 7.4 2.2 11.5 9.2 14.9 10.8 17.9 18.7 11.2 8.3 5.8 11.0 6.3 8.9 8.4 11.6 4.3 2.1 7.2 1.0 1.8 0.7 1.4 0.7 0.8 4.1 1.1 0.5 1.0 13.5 0.6 2.0 28.4 1.1 0.9 17.3 19.5 14.6 20.3 14.7 12.2 18.8 14.3 19.2 18.1 USP33 "KIAA1097, VDU1" ENSG00000077254 "Ubiquitin specific peptidase 33" Q8TEY7 1 77695987-77759852 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005719 Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA005719: AB_10601708" "unprognostic (2.31e-3)" "unprognostic (2.73e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (9.19e-3)" "unprognostic (1.88e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.59e-1)" "unprognostic (5.36e-3)" "unprognostic (4.89e-2)" "unprognostic (5.76e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" 30.8 27.1 28.1 18.8 32.1 24.6 28.6 55.3 37.5 21.6 20.4 20.6 18.5 20.2 23.3 23.0 17.8 19.2 21.7 17.0 30.7 30.6 26.0 20.3 21.0 20.7 26.0 25.4 25.3 17.0 28.8 23.4 34.6 38.7 24.6 21.0 21.4 19.5 19.8 16.3 19.4 23.8 19.8 21.4 22.3 19.5 19.9 21.6 27.8 25.1 12.9 20.3 21.0 20.0 15.7 12.2 33.2 18.4 12.3 17.8 10.6 16.3 7.5 25.9 17.9 37.3 32.6 22.3 17.9 17.1 21.9 24.6 9.9 14.1 12.2 17.0 17.4 12.9 18.8 12.3 26.8 11.2 14.7 43.1 18.3 8.6 23.2 14.7 10.9 24.0 9.7 21.1 15.5 19.4 16.8 10.7 16.4 6.3 13.2 14.7 25.0 14.8 12.8 27.3 8.6 20.6 16.8 21.8 16.8 12.5 16.7 25.0 9.3 16.0 16.2 20.2 14.4 20.3 16.9 8.7 11.1 11.9 15.3 17.4 10.2 33.2 15.4 20.0 15.1 15.0 15.3 13.4 14.7 15.2 11.5 15.7 17.8 15.6 20.9 12.3 18.4 12.2 13.2 10.6 28.1 32.1 55.3 37.5 30.7 30.6 26.0 25.4 38.7 21.6 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78214711 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 32.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA055213: , HPA058592: " "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 4.9 17.1 5.1 5.4 9.3 3.8 5.2 10.4 15.0 6.4 5.8 8.0 6.3 5.5 6.8 5.4 5.6 5.4 5.6 8.7 6.1 6.7 5.0 13.8 5.6 4.8 6.7 8.8 6.6 6.4 32.4 12.0 7.1 15.0 5.0 3.4 7.7 4.0 5.6 5.6 3.2 5.3 7.8 4.5 4.6 3.9 5.3 4.0 1.9 7.7 2.9 4.1 5.2 6.6 0.0 0.1 3.4 0.6 0.1 0.3 0.2 2.1 3.3 5.7 6.0 9.8 9.0 3.9 4.9 5.8 5.8 4.1 8.3 4.6 1.7 5.1 9.2 5.7 3.8 7.6 3.4 12.2 2.0 2.8 8.6 4.8 7.6 1.8 8.3 7.6 5.1 12.1 3.5 7.1 3.9 4.2 4.5 1.9 4.6 7.2 1.7 5.3 2.8 5.3 2.1 4.6 3.9 2.8 5.4 3.8 5.0 1.8 4.2 1.5 8.6 10.7 6.1 12.6 2.6 5.7 1.9 2.6 3.2 1.9 6.2 0.0 0.2 3.4 0.1 0.6 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.2 5.1 9.3 10.4 15.0 6.1 6.7 6.7 8.8 15.0 4.0 USP36 "FLJ12851, KIAA1453" ENSG00000055483 "Ubiquitin specific peptidase 36" Q9P275 17 78787381-78841441 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012082, HPA012395, HPA052860" Uncertain Supported Enhanced "Nucleoli,Nuclear speckles" Nucleoli "Nuclear speckles" "HPA012082: AB_1858682, HPA012395: , HPA052860: " "unprognostic (1.94e-2)" "unprognostic (2.80e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.18e-5)" "unprognostic (9.35e-2)" "unprognostic (1.98e-1)" "unprognostic (2.50e-3)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "unprognostic (1.68e-2)" "unprognostic (2.78e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (4.03e-3)" "unprognostic (1.78e-1)" 26.3 23.4 12.9 21.3 16.0 36.5 28.1 28.3 17.4 17.2 16.4 25.4 19.2 12.3 25.1 22.2 14.6 18.0 21.9 17.4 10.4 11.2 15.9 16.4 20.0 17.2 17.5 16.0 41.3 33.6 19.6 30.0 23.4 14.6 21.0 15.1 20.4 21.8 45.5 19.5 29.3 15.1 25.2 14.5 18.2 17.3 20.8 13.7 12.8 19.3 11.2 22.2 24.6 18.1 6.7 12.4 8.9 5.3 5.6 8.8 2.5 15.7 19.1 5.6 10.4 12.1 13.5 10.8 13.0 13.2 12.5 8.4 18.5 8.0 20.2 6.6 11.5 11.6 13.2 9.6 22.4 4.8 20.0 18.4 27.8 19.2 12.4 20.1 10.1 11.7 16.0 17.8 39.9 10.8 14.6 21.3 10.3 12.1 18.3 20.4 8.7 15.3 14.1 12.3 13.5 7.9 16.6 16.6 10.1 9.3 43.5 23.6 11.2 12.8 9.2 29.5 13.7 17.1 22.9 15.8 6.2 24.8 11.6 15.8 9.2 8.9 3.9 3.1 7.6 5.3 8.8 6.4 7.2 6.4 2.3 6.7 8.0 7.7 5.7 5.6 3.3 12.4 4.8 2.5 12.9 16.0 28.3 17.4 10.4 11.2 17.5 16.0 14.6 13.7 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568361 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favourable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 10.4 8.4 9.2 9.7 10.5 19.2 9.0 16.2 10.0 8.3 6.6 10.4 8.0 5.8 9.6 15.8 8.2 7.8 7.0 6.9 7.4 5.5 6.1 7.4 8.1 10.5 8.7 7.8 15.3 6.9 10.7 17.1 8.5 8.7 7.3 7.0 7.4 9.7 9.6 11.1 9.9 7.2 8.1 10.2 7.0 6.6 22.2 10.5 13.4 9.8 5.4 9.4 10.5 9.1 7.4 6.1 7.4 4.8 5.9 9.0 2.5 7.3 5.4 11.4 8.8 3.0 3.7 9.7 5.6 4.1 9.9 11.1 10.2 5.9 6.7 6.2 4.4 7.1 12.5 6.3 10.9 9.2 6.6 18.2 10.9 6.7 3.4 11.8 9.1 2.0 3.8 10.3 7.5 4.2 13.1 13.0 6.2 5.5 15.2 8.1 9.8 4.7 12.3 17.1 6.2 3.4 8.8 12.5 6.8 9.0 4.5 5.7 5.2 8.4 5.3 11.1 9.8 6.2 7.4 8.9 7.8 13.8 6.0 8.8 7.5 6.5 4.2 7.4 7.0 4.8 7.3 5.4 5.8 5.9 4.4 7.4 9.0 5.7 3.5 5.9 4.4 6.1 7.3 2.5 9.2 10.5 16.2 10.0 7.4 5.5 8.7 7.8 8.7 10.5 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Cell line enhanced" "Detected in all" "U-266/84: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA036990: , HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favourable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.7 4.5 4.0 6.8 5.2 5.2 2.9 7.6 7.4 7.0 6.0 12.9 7.0 5.9 5.4 6.4 3.8 9.3 7.5 5.8 14.4 6.0 5.4 5.3 2.7 7.2 10.9 5.4 6.3 6.9 7.2 5.8 7.0 11.7 18.5 4.7 7.5 14.2 2.0 3.6 8.7 9.4 5.9 5.6 4.5 5.5 8.1 7.3 5.9 10.3 6.6 6.3 4.1 8.3 6.5 5.3 5.6 7.9 20.7 35.1 10.7 6.6 8.4 5.4 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277831-49340712 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favourable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favourable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 22.1 18.4 21.4 22.4 29.3 41.4 23.1 30.3 32.5 20.7 20.1 26.8 16.9 16.1 23.6 20.9 23.5 19.3 17.5 22.8 22.2 18.0 20.2 18.5 25.7 25.5 20.2 17.5 23.6 17.1 23.6 19.7 22.1 24.3 20.9 21.9 23.6 19.1 21.3 25.7 27.6 19.4 25.9 20.4 30.6 17.7 25.0 19.7 36.8 21.2 14.1 42.4 22.1 22.0 17.0 24.1 59.4 27.3 21.5 18.6 22.2 6.2 7.2 10.1 13.4 18.7 20.1 6.8 17.2 15.3 22.3 20.1 7.7 15.9 12.2 6.8 25.0 8.5 13.4 24.4 20.8 18.8 4.0 27.0 14.4 8.5 27.4 14.2 15.6 20.6 10.7 24.4 20.1 25.7 9.4 19.4 20.6 10.7 16.8 24.2 8.5 12.7 6.9 6.3 10.6 17.5 13.1 8.4 11.2 12.5 8.8 6.3 6.1 22.9 22.8 15.0 8.2 18.7 10.0 15.5 7.5 17.8 13.5 22.6 17.2 18.0 27.3 30.0 16.9 22.1 18.6 17.0 17.6 16.9 24.1 14.1 17.1 15.0 59.4 21.5 24.4 9.6 18.6 22.2 21.4 29.3 30.3 32.5 22.2 18.0 20.2 17.5 24.3 19.7 USP44 FLJ14528 ENSG00000136014 "Ubiquitin specific peptidase 44" Q9H0E7 12 95516560-95551490 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.8" "Cell line enriched" "Detected in some" 5 "NTERA-2: 54.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Region enriched" "Detected in many" 5 "cerebellum: 10.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 39 "B-cells: 5.6;T-cells: 8.6" "Low region specificity" "Detected in all" HPA026543 Approved "Nucleoli fibrillar center,Microtubules" "Nucleoli fibrillar center, Microtubules" "HPA026543: AB_1858692" "unprognostic (2.12e-2)" "unprognostic (1.14e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-3)" "unprognostic (1.83e-4)" "unprognostic (7.18e-4)" "unprognostic (5.55e-2)" "unprognostic (1.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.97e-2)" "unprognostic (8.12e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.41e-2)" "unprognostic (7.07e-2)" 1.3 1.0 0.7 1.2 1.3 0.5 1.4 10.9 2.1 1.7 1.7 1.7 1.4 0.5 3.0 1.0 0.9 1.6 1.1 1.0 0.7 0.6 1.9 0.2 4.7 1.9 1.3 1.2 1.6 3.6 4.8 4.0 0.3 1.8 1.7 0.6 2.3 1.8 2.6 0.4 0.6 1.3 1.2 0.6 1.9 1.0 26.8 1.2 0.8 1.7 0.0 1.6 1.1 2.3 5.6 0.1 0.1 0.0 0.1 8.6 1.3 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.4 1.3 0.5 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 2.2 10.1 0.0 0.0 2.4 4.1 0.2 0.0 0.0 0.3 0.0 0.2 1.6 0.0 0.0 0.0 5.2 0.0 54.8 0.0 0.0 0.0 0.0 0.9 0.3 3.5 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.1 0.0 0.0 0.0 1.5 0.0 3.4 5.6 2.3 2.0 0.0 4.4 8.6 5.5 0.1 0.1 0.0 0.1 0.3 1.3 0.7 1.3 10.9 2.1 0.7 0.6 1.3 1.2 1.8 1.2 USP45 MGC14793 ENSG00000123552 "Ubiquitin specific peptidase 45" Q70EL2 6 99432379-99521728 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029602, HPA029604" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029602: AB_10600418, HPA029604: AB_10602283" "unprognostic (7.81e-3)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.15e-2)" "unprognostic (1.01e-1)" "unprognostic (2.77e-2)" "unprognostic (8.65e-2)" "unprognostic (2.95e-3)" "unprognostic (1.10e-1)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" "unprognostic (1.43e-1)" "unprognostic (6.91e-2)" 9.8 9.1 8.5 10.2 12.2 7.2 9.0 28.4 11.6 9.0 9.7 8.6 8.9 13.7 15.7 9.6 10.0 8.1 11.9 11.5 7.7 8.5 12.2 9.0 7.1 12.7 9.8 8.0 10.7 9.6 10.2 21.7 9.6 15.0 9.9 13.1 7.9 9.8 8.4 14.6 11.8 12.4 10.8 10.6 9.9 8.9 5.7 9.4 7.1 10.7 10.4 9.5 8.8 15.0 8.6 5.1 3.7 2.5 2.6 6.2 1.4 4.1 3.0 5.9 8.3 10.9 10.4 6.2 7.2 8.1 7.6 10.8 6.1 4.6 11.1 5.4 7.3 5.6 9.0 7.2 10.5 8.7 8.6 10.8 5.9 4.8 8.4 10.0 6.2 11.1 5.7 6.8 11.6 11.2 26.0 11.0 7.1 3.9 3.2 9.5 9.5 6.4 4.7 4.4 6.2 10.5 4.9 8.3 6.8 5.1 6.8 5.3 3.6 4.9 11.2 4.2 5.3 6.1 11.0 4.7 4.3 20.3 7.2 9.5 7.4 3.7 2.0 0.6 4.9 1.3 6.2 7.4 4.2 5.6 3.5 8.6 3.0 2.9 0.5 2.6 2.5 5.1 3.5 1.4 8.5 12.2 28.4 11.6 7.7 8.5 9.8 8.0 15.0 9.4 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavourable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.6 7.0 16.5 11.9 14.3 17.7 16.3 18.5 12.6 12.4 16.5 6.4 15.0 16.5 12.5 16.7 13.6 20.3 14.9 18.9 16.0 13.9 35.3 26.1 11.6 12.8 17.7 18.9 14.3 12.9 12.6 14.1 36.6 27.7 46.8 15.2 7.3 14.6 23.0 10.4 12.6 20.6 16.6 19.3 14.3 12.4 20.1 12.5 17.4 16.0 41.8 8.2 21.4 25.9 13.4 11.1 16.4 10.7 37.5 26.6 16.4 12.9 22.0 19.7 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852128-6866632 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol 820000 "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 18.6 28.7 23.1 17.8 32.6 13.6 12.9 24.6 50.9 15.9 21.5 26.8 13.8 17.6 22.3 12.8 27.7 19.1 14.7 22.4 23.9 28.6 14.9 24.8 14.4 18.6 23.6 33.2 14.4 13.2 29.7 19.6 21.7 36.8 19.5 16.1 11.6 14.1 22.7 41.2 33.5 18.1 25.3 23.6 14.1 15.9 30.9 18.7 22.8 19.2 20.4 19.9 21.3 16.0 10.8 18.6 5.3 16.6 10.8 17.1 16.6 25.3 39.7 26.7 30.2 18.2 16.8 34.1 27.6 21.2 33.0 24.1 37.5 25.2 30.7 14.5 28.6 22.4 29.3 27.4 21.2 57.5 24.8 28.1 31.9 20.3 14.2 25.4 29.6 16.9 15.9 28.5 19.8 28.2 24.1 12.3 27.2 27.8 38.1 12.6 52.0 16.8 30.0 34.8 21.2 18.8 24.7 14.7 29.7 18.8 28.7 12.0 11.5 20.8 27.3 28.0 33.9 21.3 34.3 14.9 34.2 46.7 31.2 16.2 27.2 2.3 12.3 5.3 17.1 16.6 16.1 10.8 15.2 14.4 18.6 10.0 14.6 14.8 0.9 10.8 14.7 13.6 12.9 16.6 23.1 32.6 24.6 50.9 23.9 28.6 23.6 33.2 36.8 18.7 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 34.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.4;naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favourable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favourable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 0.6 2.7 2.0 0.3 2.9 0.1 0.9 2.3 1.8 1.4 0.6 0.0 1.8 34.1 0.2 3.4 0.3 1.0 1.8 3.7 2.2 0.5 0.7 0.4 1.6 4.1 0.8 3.6 1.8 1.3 1.3 0.3 0.3 1.5 0.0 0.5 0.5 1.1 1.4 0.9 0.3 1.3 3.2 0.5 0.7 0.5 0.9 0.0 2.4 0.0 0.6 2.4 0.1 0.0 0.9 5.7 1.7 2.9 1.5 0.0 0.9 0.5 1.1 1.3 1.8 0.8 0.0 6.9 1.2 0.3 1.5 0.6 1.8 1.8 0.1 1.5 0.3 0.0 1.2 3.5 0.3 5.9 0.1 0.6 0.0 0.4 4.4 4.4 0.9 3.8 3.4 1.8 7.2 0.3 4.9 1.1 2.2 1.4 0.2 0.0 1.1 1.6 0.2 5.4 1.4 1.8 0.3 2.3 3.1 0.6 0.2 7.0 2.7 1.4 1.5 2.0 1.5 0.0 0.0 2.4 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.9 2.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 82.1;SK-MEL-30: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA035844: AB_10669532, HPA035845: " "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favourable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.54e-6)" "prognostic favourable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 26.7 11.9 4.6 11.2 7.9 0.7 20.7 10.9 6.2 16.5 15.0 2.9 27.4 4.5 11.6 16.1 17.9 24.7 8.2 18.6 6.4 5.3 20.2 6.6 26.1 8.7 8.8 4.0 11.4 19.3 6.2 33.9 10.4 13.4 10.7 13.1 17.2 17.7 25.8 33.7 11.3 11.2 9.0 15.5 14.1 13.6 10.2 4.9 4.8 10.7 15.6 8.0 20.5 27.0 1.9 0.8 3.1 0.0 2.2 5.1 0.9 2.7 1.6 0.6 0.0 15.7 15.8 3.4 17.6 82.1 1.6 2.1 1.8 2.6 11.3 0.6 5.2 1.3 1.3 1.3 4.1 1.4 1.1 0.7 1.2 0.6 12.3 0.9 0.1 5.2 3.8 5.5 8.0 7.4 1.7 0.4 2.1 0.6 0.6 1.2 1.7 0.9 0.2 2.9 2.2 4.1 1.7 0.9 0.7 0.9 6.9 25.4 1.7 0.6 8.0 0.5 1.8 6.6 1.5 0.8 1.2 1.9 8.0 0.4 2.0 3.1 0.0 0.2 1.3 0.0 1.4 1.7 2.6 2.0 0.4 1.9 5.1 2.7 0.6 2.2 0.0 0.8 2.2 0.9 4.6 7.9 10.9 6.2 6.4 5.3 8.8 4.0 13.4 4.9 USP8 "HumORF8, KIAA0055, SPG59, UBPY" ENSG00000138592 "Ubiquitin specific peptidase 8" P40818 15 50424380-50514419 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050215 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA050215: " "unprognostic (5.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "unprognostic (9.58e-2)" "unprognostic (2.35e-2)" "unprognostic (2.91e-1)" "unprognostic (1.42e-1)" "unprognostic (3.96e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.94e-1)" "unprognostic (3.99e-2)" "prognostic favourable (1.29e-5)" "unprognostic (4.89e-2)" "unprognostic (1.13e-1)" "unprognostic (3.79e-1)" "unprognostic (1.58e-1)" 19.4 21.9 21.0 20.6 20.6 21.6 18.1 27.3 21.6 21.4 23.9 13.8 19.5 20.2 22.1 17.4 22.3 17.4 15.5 17.4 19.7 18.2 28.2 26.4 17.0 25.4 21.8 15.2 21.9 16.7 42.6 43.2 29.1 29.7 16.7 18.9 10.7 19.9 17.9 24.3 17.8 32.1 19.2 29.3 30.3 17.7 27.5 26.1 28.9 24.1 12.7 20.9 22.3 18.4 16.7 10.6 38.1 15.1 9.5 11.9 6.9 11.0 15.9 8.9 15.7 16.3 18.3 12.4 15.9 18.9 15.5 18.4 10.6 7.3 11.7 12.3 18.2 21.5 12.2 11.9 18.4 10.2 8.1 21.6 14.8 10.9 16.8 14.4 14.6 14.2 14.3 13.7 23.3 15.0 12.3 14.2 14.5 22.7 9.2 5.7 10.2 7.3 8.4 16.6 17.5 14.7 26.1 11.4 10.4 16.8 25.1 20.8 13.7 17.7 17.0 16.1 9.1 49.6 21.0 11.1 23.1 12.9 12.9 29.2 15.5 38.1 13.3 22.4 11.1 12.4 10.7 16.5 11.4 11.1 10.6 16.7 11.9 10.7 22.7 9.5 15.1 9.9 8.5 6.9 21.0 20.6 27.3 21.6 19.7 18.2 21.8 15.2 29.7 26.1 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A, small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA047217: , HPA054023: " "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavourable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavourable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 15.1 11.4 8.2 13.3 11.2 10.2 15.8 12.7 13.8 13.3 13.4 8.4 8.5 8.5 17.6 13.9 16.9 13.9 9.0 10.0 7.1 7.2 13.2 14.9 10.7 14.8 7.6 9.8 17.4 22.7 13.1 13.8 12.5 10.6 13.5 14.7 8.6 13.2 10.6 19.6 11.8 11.0 15.3 7.7 16.1 13.3 4.3 7.7 20.7 12.4 16.3 19.5 16.0 13.5 11.1 11.8 16.2 14.3 15.5 14.6 7.7 14.2 15.9 8.6 22.5 14.4 14.7 14.4 15.8 12.1 15.9 12.7 16.2 14.1 33.8 31.9 11.4 18.3 34.2 17.2 19.6 11.2 17.0 19.3 13.6 12.3 16.3 27.2 14.8 18.0 15.2 21.6 22.9 12.5 19.1 10.6 13.7 23.4 19.6 20.8 17.8 17.9 15.4 12.9 23.1 11.0 10.9 9.0 23.6 9.0 16.6 18.6 8.9 15.9 10.8 7.0 9.2 19.6 30.3 13.3 15.4 30.1 10.6 33.8 15.8 16.2 8.0 4.0 12.7 14.3 14.6 11.1 10.7 11.8 11.8 10.9 13.5 12.4 1.0 15.5 12.0 9.4 14.4 7.7 8.2 11.2 12.7 13.8 7.1 7.2 7.6 9.8 10.6 7.7 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C, small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA047217: , HPA054023: " "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavourable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 4.8 4.8 5.3 3.4 5.9 0.5 6.2 6.6 5.9 6.8 5.3 4.6 6.7 4.6 3.6 5.2 3.9 5.5 5.1 5.2 8.0 7.9 4.5 3.5 5.5 6.1 5.8 8.9 4.8 6.6 7.1 5.9 5.7 5.5 5.3 2.9 4.5 5.3 6.2 4.4 5.7 2.3 9.1 3.8 4.6 4.2 4.1 5.8 6.7 4.8 3.5 6.8 3.1 4.3 6.9 14.3 11.2 14.7 10.6 11.0 12.4 9.7 8.4 7.8 6.8 9.1 10.6 3.4 11.8 10.1 12.6 6.9 11.2 10.8 9.0 20.4 4.9 6.6 10.0 18.1 14.2 9.3 13.2 6.4 12.6 6.9 11.8 5.4 12.6 3.2 11.0 10.1 13.0 5.0 10.9 10.0 4.6 14.3 7.0 4.7 9.6 7.4 11.1 8.5 10.0 14.4 10.4 7.8 8.2 8.7 8.5 5.5 7.9 12.9 4.2 6.8 14.6 6.7 3.7 5.4 4.6 4.8 3.9 3.0 4.9 3.7 4.4 4.1 6.8 6.7 2.4 3.5 3.9 5.8 5.2 3.1 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15, small subunit processome component" Q8TED0 5 73565443-73583377 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Supported "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA044697: " "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 17.1 11.8 6.5 9.4 11.7 38.6 13.2 8.7 12.5 7.5 8.6 10.4 9.3 7.0 11.3 8.7 13.6 10.4 6.7 8.8 12.9 5.6 9.3 12.9 10.2 12.1 11.0 8.0 11.0 9.7 11.8 16.4 8.8 12.5 10.1 10.9 7.5 10.9 6.6 14.5 18.3 10.7 9.9 10.3 11.4 11.9 10.1 10.0 11.4 10.3 13.2 12.8 9.5 9.4 8.3 9.0 4.6 8.0 8.8 10.8 5.4 10.7 11.7 7.9 23.9 6.9 8.2 15.0 12.8 7.5 14.6 16.2 13.0 14.4 24.3 13.0 8.7 9.1 13.5 23.9 22.6 11.9 9.8 11.2 12.4 10.6 8.5 10.1 9.2 8.3 10.8 16.5 18.5 10.0 17.0 13.4 12.3 13.6 15.4 7.2 10.7 6.7 12.3 12.2 23.5 8.7 14.7 8.2 8.8 11.6 9.5 13.5 12.2 7.5 8.1 8.7 12.0 10.1 25.0 9.9 13.1 31.4 13.7 17.5 12.6 2.5 7.0 4.6 9.7 8.0 9.7 8.3 9.8 10.6 9.0 7.2 10.5 10.8 3.8 8.8 7.3 6.5 7.9 5.4 6.5 11.7 8.7 12.5 12.9 5.6 11.0 8.0 12.5 10.0 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoli "Nucleoplasm, Nuclear membrane" "HPA052378: " "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favourable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.3 26.2 16.7 15.3 11.0 16.6 43.7 14.6 12.1 25.6 24.7 16.4 14.8 33.5 20.9 10.9 14.4 27.1 15.6 38.2 21.8 35.3 35.1 15.9 28.5 15.1 37.1 17.3 10.6 12.1 21.7 17.7 15.3 28.5 15.4 19.2 16.3 33.3 25.3 23.9 27.8 30.3 38.1 26.2 18.7 17.6 18.6 23.7 17.0 20.3 33.1 25.0 19.0 13.3 26.5 22.2 21.7 30.3 29.9 55.1 38.8 16.4 25.9 18.8 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20, small subunit processome component" O75691 12 101280109-101386616 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" Nucleoli "Plasma membrane" "HPA049341: " "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favourable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 14.7 11.9 8.4 10.7 9.7 8.3 15.3 8.4 9.6 14.1 8.0 11.8 7.0 5.0 12.5 8.4 10.9 10.3 5.8 8.3 6.7 5.8 8.0 12.0 12.0 17.8 9.0 6.3 16.3 14.2 17.9 9.5 9.7 8.2 8.8 10.1 9.9 13.8 8.5 13.1 10.8 8.0 9.4 7.1 11.3 8.6 12.6 9.7 11.9 9.8 11.0 12.9 9.4 13.8 3.1 2.8 0.1 1.1 2.0 2.8 0.6 4.4 11.2 8.5 3.9 7.6 8.9 10.4 7.7 6.1 12.4 6.9 12.8 3.2 11.9 4.1 8.6 9.3 18.7 8.0 16.1 5.3 7.6 12.6 6.0 9.5 4.3 20.9 5.8 5.8 4.2 17.2 5.9 8.5 19.8 2.4 9.0 5.8 9.0 5.9 22.2 11.7 10.3 13.9 9.3 5.2 13.6 9.8 6.6 14.5 9.2 8.7 9.7 4.7 9.6 14.7 7.2 10.2 15.0 4.5 6.7 20.0 8.0 9.6 22.4 0.1 0.8 0.1 1.9 1.1 1.9 3.1 2.1 2.4 1.4 2.4 2.3 2.8 0.1 2.0 0.7 2.8 1.8 0.6 8.4 9.7 8.4 9.6 6.7 5.8 9.0 6.3 8.2 9.7 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3, small subunit processome component" Q9NQZ2 4 70688479-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: " "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favourable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 19.9 23.4 17.6 21.3 17.9 14.5 17.1 20.1 20.3 15.7 16.1 12.1 12.1 14.3 19.4 14.2 23.5 19.4 13.3 18.9 17.0 12.1 24.5 27.5 16.4 26.7 15.5 16.2 17.2 17.0 16.4 21.2 22.9 18.4 14.5 15.2 9.9 16.0 16.7 18.1 20.1 22.8 18.2 14.7 38.7 19.5 11.5 20.3 33.3 16.5 21.6 27.2 15.5 17.6 7.3 13.6 6.3 12.7 6.5 8.6 5.2 12.0 11.8 15.9 13.2 22.7 17.2 13.7 25.2 16.3 14.5 14.1 15.4 16.2 53.4 15.9 21.5 10.2 23.3 34.5 21.1 16.5 13.3 20.3 15.9 16.5 24.7 30.6 18.1 23.2 20.8 17.7 17.5 19.4 23.1 18.0 23.4 25.1 28.3 17.2 11.1 17.3 12.2 21.9 21.8 26.1 19.6 13.4 18.3 10.7 24.5 15.6 13.5 12.4 21.5 14.8 25.1 14.0 16.1 26.4 19.4 38.8 18.0 15.1 12.9 6.3 11.1 5.5 7.0 12.7 7.3 7.3 5.8 7.8 13.5 6.8 8.6 7.2 0.9 6.5 10.8 13.6 7.0 5.2 17.6 17.9 20.1 20.3 17.0 12.1 15.5 16.2 18.4 20.3 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 57.2;TIME: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Supported "Nucleoplasm,Plasma membrane" 6000000 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favourable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 34.5 14.1 11.6 34.5 23.5 22.9 25.4 3.1 11.3 32.6 15.3 6.8 21.9 7.7 28.8 21.5 17.7 21.4 15.8 13.8 9.2 12.8 15.5 11.8 35.2 30.9 12.7 8.8 22.7 23.8 53.1 13.0 21.1 16.0 23.4 15.2 17.3 18.4 24.8 11.7 16.7 14.8 19.8 16.6 45.8 13.3 45.0 8.5 27.4 32.4 20.0 25.7 20.7 23.4 11.7 15.0 10.6 48.0 10.3 12.6 3.7 6.8 5.8 10.3 13.3 17.9 16.5 6.2 10.1 9.8 8.2 12.1 22.1 2.5 2.1 8.9 22.7 4.0 57.2 8.5 11.9 22.8 6.6 8.1 6.3 13.1 7.1 9.0 0.1 9.5 1.8 12.2 6.4 40.8 0.5 6.0 11.5 4.5 7.1 3.9 4.1 6.2 6.5 18.6 0.1 9.5 0.1 13.1 0.2 15.7 2.2 6.2 8.7 12.3 52.5 7.9 9.9 4.0 9.6 4.6 6.2 0.3 4.8 5.5 12.9 9.8 12.3 6.6 12.6 36.3 9.0 7.4 8.0 10.2 5.1 11.7 7.0 7.3 10.6 10.3 48.0 15.0 6.4 3.7 11.6 23.5 3.1 11.3 9.2 12.8 12.7 8.8 16.0 8.5 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell line enhanced" "Detected in many" "HEL: 14.7;U-266/84: 11.3;U-698: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA000568, HPA001165" Supported Approved Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoplasm Nucleoli "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.5 3.3 5.6 3.7 5.6 0.0 0.0 8.9 0.0 3.7 0.0 0.0 0.0 5.2 4.9 0.0 14.7 0.1 0.0 4.9 0.0 0.0 5.9 5.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 5.0 0.1 0.0 0.0 0.0 2.3 3.9 4.0 6.0 3.7 0.0 0.0 0.0 10.5 0.0 3.2 4.3 6.5 0.0 0.0 2.3 10.0 11.3 14.7 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 UXT "ART-27, STAP1" ENSG00000126756 "Ubiquitously expressed prefoldin like chaperone" Q9UBK9 X 47651798-47659161 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Chaperone, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050499, HPA058400" Approved Supported "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA050499: , HPA058400: " "unprognostic (1.12e-1)" "unprognostic (3.85e-3)" "unprognostic (9.08e-2)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (2.31e-3)" "unprognostic (1.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (1.44e-1)" "unprognostic (8.11e-2)" "unprognostic (8.64e-2)" "unprognostic (4.09e-3)" 30.9 37.4 21.7 33.7 23.6 54.4 38.9 20.0 27.3 26.7 31.9 24.8 33.5 23.2 26.8 39.8 30.1 32.4 31.3 47.3 20.9 16.5 34.7 66.8 24.9 46.1 23.6 24.9 50.5 54.1 21.4 29.6 39.0 26.0 30.0 31.1 19.5 46.5 30.5 42.1 36.2 29.1 21.1 27.6 37.1 31.9 24.7 22.6 50.4 37.0 33.2 41.6 24.5 32.5 58.2 60.2 26.2 35.8 36.0 73.5 52.0 44.8 49.8 21.2 28.2 48.6 58.7 37.3 29.1 42.6 50.0 47.5 42.7 42.8 51.5 21.2 41.5 36.4 30.1 39.8 35.7 33.6 59.8 25.9 56.7 42.2 56.7 57.1 51.0 41.2 51.1 42.1 45.3 40.2 28.2 49.8 42.3 49.4 38.9 79.5 30.5 56.9 34.7 43.1 70.7 40.2 33.1 20.2 26.4 32.3 35.3 45.0 41.4 52.9 29.3 35.0 38.2 48.1 31.9 39.4 34.7 46.2 44.6 63.5 35.3 18.7 35.8 26.2 40.2 35.5 54.1 58.2 57.7 43.2 47.4 56.7 73.5 60.2 23.0 36.0 32.4 60.2 52.9 52.0 21.7 23.6 20.0 27.3 20.9 16.5 23.6 24.9 26.0 22.6 VAC14 "ArPIKfyve, FLJ10305, TAX1BP2" ENSG00000103043 "Vac14, PIKFYVE complex component" Q08AM6 16 70687439-70801161 "Disease related genes, Predicted intracellular proteins" "Host-virus interaction" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027766, HPA075382" Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA027766: AB_1848651, HPA075382: " "unprognostic (9.25e-2)" "prognostic favourable (8.33e-5)" "unprognostic (2.83e-2)" "unprognostic (1.51e-1)" "unprognostic (8.94e-2)" "unprognostic (2.72e-1)" "unprognostic (2.21e-2)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.26e-1)" "prognostic favourable (1.56e-6)" "unprognostic (1.61e-1)" "unprognostic (1.10e-1)" "unprognostic (5.05e-2)" "unprognostic (1.80e-1)" 26.3 26.6 22.9 22.8 21.8 16.3 17.4 15.6 34.9 17.9 18.4 27.0 18.5 19.8 18.8 15.8 21.0 20.9 17.0 22.2 22.9 23.5 25.7 27.1 20.1 34.9 22.3 20.8 19.2 27.8 33.7 21.4 20.1 25.8 17.9 14.1 22.9 24.3 19.4 23.3 24.6 21.6 19.2 22.2 29.0 20.0 21.7 20.6 31.2 26.0 16.3 22.9 21.0 16.3 5.5 9.7 6.6 5.9 3.7 5.5 1.9 11.2 11.2 9.5 10.6 13.8 10.1 14.5 8.2 13.0 15.7 7.3 13.8 18.3 14.5 10.7 9.8 14.3 12.4 13.3 7.4 4.4 13.0 7.3 8.5 17.0 35.7 12.5 15.4 16.7 14.0 23.2 21.2 14.9 12.8 6.6 13.7 16.3 11.6 20.9 16.7 10.6 14.0 6.9 21.4 7.5 7.8 11.3 12.3 27.2 8.3 18.7 12.3 11.8 11.8 20.9 12.0 13.3 8.8 9.5 11.6 27.8 34.9 11.2 9.5 1.3 4.8 6.6 2.9 5.9 2.5 4.0 3.7 5.5 9.7 5.5 3.5 3.1 1.6 3.7 5.4 5.1 2.3 1.9 22.9 21.8 15.6 34.9 22.9 23.5 22.3 20.8 25.8 20.6 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.7;HUVEC TERT2: 63.0;LHCN-M2: 74.0;TIME: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.0 28.1 0.4 17.0 27.0 16.7 18.5 6.7 2.6 0.0 0.4 29.4 0.1 0.0 0.4 7.4 24.0 0.5 0.3 0.4 9.3 33.7 0.7 0.1 19.4 1.6 7.0 0.2 63.0 0.0 0.0 74.0 2.4 10.4 2.3 0.0 0.1 15.6 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.8 0.1 0.5 0.8 43.0 0.4 1.2 1.3 0.0 0.0 0.5 0.4 19.7 0.9 11.4 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Cell line enhanced" "Detected in many" "HL-60: 80.6;NB-4: 125.9;U-937: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Supported "Nucleoplasm,Golgi apparatus" 210000 "Nucleoplasm, Golgi apparatus" "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favourable (8.07e-9)" "prognostic favourable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.4 3.0 0.2 0.2 0.2 0.1 23.5 0.0 0.0 0.0 0.0 17.5 21.6 5.2 17.1 0.1 16.7 0.2 42.1 0.0 21.4 16.3 27.1 10.4 19.8 0.3 80.6 28.1 0.2 29.9 0.0 7.0 5.4 19.3 1.1 9.6 33.0 0.0 125.9 0.3 2.5 0.5 0.8 35.4 48.8 35.4 0.8 0.3 11.5 61.0 1.8 22.3 62.6 10.8 0.0 1.5 0.3 0.2 0.3 13.2 30.8 0.3 83.6 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "U-2197: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: " "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.7 3.1 1.1 5.2 5.1 1.6 2.6 0.3 0.5 0.0 1.9 3.4 0.0 0.0 0.1 0.2 1.1 0.1 0.1 1.4 1.6 9.9 0.0 0.0 3.2 0.0 3.9 0.1 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.9 2.4 4.1 0.0 0.9 0.2 0.0 4.8 1.2 123.8 0.6 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 VASP ENSG00000125753 "Vasodilator stimulated phosphoprotein" P50552 19 45506579-45526983 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 23.6" "Group enriched" "Detected in all" 6 "granulocytes: 23.6;monocytes: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004612, HPA005724" Enhanced Supported "Plasma membrane,Cell Junctions,Focal adhesion sites" 110000000 "Plasma membrane, Cell Junctions, Focal adhesion sites" "CAB004612: AB_2213431, HPA005724: AB_1858721" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (4.70e-2)" "unprognostic (7.85e-3)" "unprognostic (8.31e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (3.49e-5)" "unprognostic (1.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-2)" "unprognostic (3.64e-3)" "unprognostic (4.39e-1)" "prognostic unfavourable (5.91e-7)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (1.08e-2)" 29.1 10.3 4.9 33.3 5.9 40.3 19.0 3.9 4.7 22.6 38.2 5.3 15.4 28.8 37.5 13.3 34.3 23.8 32.2 21.1 5.2 4.3 17.9 21.1 30.5 44.5 7.7 2.2 22.5 10.5 2.9 7.5 31.5 6.2 26.8 9.8 8.9 12.9 20.3 10.4 13.0 43.7 36.7 4.8 69.2 33.4 14.4 6.6 28.3 11.7 12.8 33.2 39.2 17.5 1.8 2.6 23.6 10.4 2.0 2.1 2.2 15.3 16.1 4.7 8.1 2.4 4.1 12.1 15.8 12.2 10.9 9.5 7.3 32.2 7.1 13.4 12.6 14.3 1.4 15.6 3.7 20.8 3.7 40.7 8.0 12.3 13.4 14.9 63.9 6.3 8.8 10.2 6.6 16.3 24.3 15.5 6.7 12.8 6.8 12.8 8.3 11.1 5.1 2.9 2.6 9.3 49.1 5.6 3.9 18.8 9.6 11.1 10.4 25.5 24.1 17.5 17.7 5.6 24.9 8.3 9.9 12.1 12.2 18.1 21.0 5.6 4.0 23.6 2.1 6.5 1.5 1.8 1.7 2.0 2.6 1.7 1.1 1.3 17.1 2.0 10.4 1.0 1.2 2.2 4.9 5.9 3.9 4.7 5.2 4.3 7.7 2.2 6.2 6.6 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Group enriched" "Detected in some" 7 "A-431: 7.5;WM-115: 5.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 VBP1 "PFD3, PFDN3" ENSG00000155959 "VHL binding protein 1" P61758 X 155197007-155239817 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006260, HPA023230" Approved Supported Vesicles,Cytosol Cytosol Vesicles "CAB006260: AB_425740, HPA023230: AB_1858727" "unprognostic (1.55e-3)" "unprognostic (1.12e-3)" "unprognostic (3.35e-1)" "unprognostic (1.35e-2)" "unprognostic (3.78e-2)" "unprognostic (1.85e-3)" "unprognostic (5.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (9.80e-2)" "unprognostic (1.15e-1)" "unprognostic (5.76e-2)" "unprognostic (3.76e-2)" "unprognostic (4.54e-2)" "unprognostic (9.30e-2)" "unprognostic (3.80e-1)" 17.3 19.2 37.8 15.5 28.0 24.5 18.4 26.1 32.5 14.9 16.9 20.6 12.5 12.8 14.9 16.3 17.8 13.8 13.3 35.9 35.4 36.8 22.9 17.4 13.0 21.0 40.9 25.6 15.3 11.8 18.3 22.0 16.9 33.9 18.2 19.2 10.1 11.1 15.6 50.5 10.9 14.3 16.4 46.0 13.9 12.5 8.7 22.9 21.0 18.4 25.6 22.0 16.9 12.8 15.0 18.4 37.0 12.6 13.8 21.6 15.7 35.1 12.7 27.7 18.4 11.5 15.9 8.0 17.5 13.6 23.1 36.2 15.1 18.1 45.3 37.5 14.7 13.9 40.1 16.4 30.0 23.8 28.1 19.0 20.1 11.8 13.7 30.6 15.0 11.8 19.6 19.2 24.3 21.2 37.1 27.0 25.9 14.6 28.8 27.4 16.0 27.4 24.8 22.0 26.5 20.0 16.1 30.1 18.3 12.0 14.2 19.3 12.1 23.7 12.3 18.5 22.9 31.3 43.1 30.5 44.2 79.2 16.4 38.0 22.6 8.5 11.6 37.0 14.4 12.6 16.5 15.0 16.9 17.2 18.4 11.8 19.6 20.7 13.6 13.8 10.4 15.1 21.6 15.7 37.8 28.0 26.1 31.9 35.4 36.8 40.9 25.6 33.9 22.9 VCP "CDC48, IBMPFD, p97, TERA" ENSG00000165280 "Valosin containing protein" P55072 9 35056064-35073249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005593, HPA012728, HPA012814" Supported Enhanced Nucleoplasm,Cytosol 110000000 "Nucleoplasm, Cytosol" "CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.15e-2)" "prognostic favourable (7.30e-4)" "unprognostic (5.78e-2)" "unprognostic (1.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.13e-2)" "unprognostic (3.82e-2)" "unprognostic (1.81e-2)" "unprognostic (2.19e-2)" "unprognostic (3.24e-1)" "prognostic favourable (9.63e-7)" "unprognostic (1.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (9.11e-2)" 33.7 43.6 19.6 30.3 21.8 30.8 31.4 19.4 31.0 32.2 25.7 22.7 32.9 22.2 30.5 34.0 40.0 24.7 33.8 69.6 20.0 23.4 30.1 63.4 27.6 42.7 23.1 21.1 25.0 34.9 44.5 29.0 46.3 26.3 33.4 26.5 21.2 30.7 34.1 80.4 29.2 26.3 29.2 23.0 37.8 28.9 25.6 18.2 43.3 32.1 42.2 35.7 31.5 26.5 25.9 29.4 43.4 30.6 23.0 32.1 34.4 36.0 41.2 28.4 15.3 34.3 24.2 21.7 33.6 38.1 50.3 37.2 27.5 14.9 28.6 29.5 41.7 17.4 42.3 40.1 43.6 30.7 24.5 19.9 38.9 37.6 26.6 22.3 26.6 27.6 27.0 43.5 19.5 54.3 20.6 20.8 40.1 25.4 21.8 53.7 37.0 39.4 19.4 22.1 17.7 39.3 25.8 15.5 19.5 20.3 23.0 10.2 18.5 15.9 44.4 20.2 26.1 17.9 29.4 10.6 22.4 24.5 33.1 16.1 25.8 43.4 24.5 31.9 24.7 27.2 23.8 25.9 23.6 24.8 29.4 21.1 17.7 18.5 28.4 23.0 30.6 18.9 32.1 34.4 19.6 21.8 19.4 31.0 20.0 23.4 23.1 21.1 26.3 18.2 VCPIP1 "DUBA3, FLJ23132, KIAA1850, VCIP135" ENSG00000175073 "Valosin containing protein interacting protein 1" Q96JH7 8 66628487-66667217 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023932 Uncertain Approved "Plasma membrane,Centrosome" "Plasma membrane" Centrosome "HPA023932: " "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (4.01e-2)" "unprognostic (5.56e-2)" "unprognostic (5.23e-2)" "unprognostic (7.21e-2)" "unprognostic (2.80e-1)" "unprognostic (3.96e-1)" "unprognostic (5.23e-3)" "unprognostic (7.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-2)" "unprognostic (8.58e-3)" 9.5 8.7 15.7 12.6 14.5 30.9 8.9 14.4 15.1 7.5 8.4 7.0 3.8 7.0 7.8 8.7 8.1 6.9 7.0 6.7 10.2 9.2 8.3 12.3 10.5 13.6 10.3 13.7 7.8 9.0 14.0 5.9 8.0 12.3 7.0 7.8 6.0 9.0 7.1 14.8 7.3 10.0 6.3 9.6 14.7 8.0 10.8 11.7 11.6 8.0 2.8 13.3 7.9 7.0 2.6 3.4 11.3 8.8 2.8 4.3 1.7 8.8 8.0 4.2 5.5 12.7 9.0 4.0 7.1 7.2 5.5 6.3 4.7 8.4 11.9 2.1 9.5 7.9 6.7 5.9 7.9 8.9 4.8 13.3 7.9 5.9 7.7 4.4 14.3 9.7 8.8 5.9 10.8 5.9 8.9 11.6 8.0 4.3 9.5 7.6 7.9 5.6 6.1 6.5 6.0 7.9 7.0 2.4 4.7 5.5 8.4 6.1 8.6 7.3 11.8 7.2 5.4 6.3 4.7 10.3 5.0 12.8 7.2 6.4 5.4 9.2 3.2 6.7 4.3 5.2 3.6 2.0 2.7 3.1 3.4 2.6 2.2 2.9 11.3 2.8 8.8 1.3 3.3 1.7 15.7 14.5 14.4 15.1 10.2 9.2 10.3 13.7 12.3 11.7 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Low region specificity" "Detected in some" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: , HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favourable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.4 0.9 0.0 0.0 4.7 6.9 0.1 6.7 3.4 5.7 5.0 4.0 4.6 1.4 7.3 4.6 10.2 0.2 22.7 2.7 32.0 1.6 2.4 1.3 0.3 3.5 4.8 7.7 9.3 10.6 6.3 10.4 0.4 0.7 1.5 2.6 3.7 0.1 2.3 0.0 7.4 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.7 16.5 2.0 18.6 2.7 0.4 11.0 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.4 2.7 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 VENTX "HPX42B, VENTX2" ENSG00000151650 "VENT homeobox" O95231 10 133237404-133241929 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 24 "NB-4: 17.6;NTERA-2: 10.1" "Cancer enriched" "Detected in some" 15 "testis cancer: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1" HPA050955 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA050955: " "unprognostic (9.41e-2)" "unprognostic (8.89e-2)" "unprognostic (2.34e-1)" "unprognostic (4.26e-1)" "unprognostic (3.22e-2)" "unprognostic (2.01e-1)" "unprognostic (2.54e-1)" "unprognostic (9.62e-3)" "unprognostic (2.22e-1)" "unprognostic (3.00e-3)" "unprognostic (3.70e-4)" "unprognostic (4.22e-1)" "unprognostic (2.51e-3)" "unprognostic (3.43e-2)" "unprognostic (3.48e-1)" "unprognostic (7.54e-2)" "unprognostic (3.14e-1)" 5.6 2.4 1.2 6.6 1.2 4.4 2.0 1.2 1.2 1.7 1.7 1.2 1.2 0.4 1.7 1.2 1.2 2.0 2.5 1.2 1.2 1.5 1.9 1.2 4.4 1.2 1.2 1.2 1.7 2.1 1.0 1.5 1.2 1.2 1.2 0.4 1.2 1.5 1.2 1.2 2.0 1.2 2.1 2.2 7.3 0.9 6.3 1.2 2.9 1.2 1.2 1.2 1.5 1.2 0.5 3.1 2.4 5.1 0.6 0.3 1.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 17.6 10.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.4 4.6 0.6 0.3 5.1 0.1 0.5 0.2 0.2 3.1 0.5 0.2 0.3 1.8 0.6 3.9 0.2 0.1 1.0 1.2 1.2 1.2 1.2 1.2 1.5 1.2 1.2 1.2 1.2 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favourable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.2 0.0 2.5 9.3 0.0 11.0 24.3 3.2 4.8 0.3 1.7 0.0 4.3 11.8 0.0 0.1 0.2 18.2 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 13.9 2.8 64.8 0.6 0.0 8.8 0.2 0.0 0.0 1.7 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 18.8 0.0 38.5 13.0 0.4 4.5 15.0 0.0 0.0 0.0 10.4 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302790 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavourable (1.93e-5)" "prognostic unfavourable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 12.3 21.4 15.4 14.3 17.2 5.1 14.6 28.3 27.2 12.9 14.4 9.1 19.0 9.5 17.1 15.9 15.6 11.5 12.1 14.7 11.8 9.5 12.1 10.4 13.8 9.6 11.0 14.0 13.3 12.6 15.7 20.4 19.6 11.4 15.8 10.6 10.3 10.9 13.9 42.7 16.1 11.0 16.2 12.5 7.2 10.7 7.2 12.2 13.6 29.8 14.5 10.0 15.7 12.2 5.2 4.4 1.1 3.5 2.4 5.0 1.2 10.4 9.7 13.4 7.2 10.3 7.3 5.2 7.7 9.6 6.1 9.8 3.5 4.9 13.5 5.0 6.6 5.4 9.5 6.7 11.4 9.1 5.3 5.2 2.5 3.7 5.6 10.2 3.0 9.3 11.7 5.8 16.6 12.8 3.0 5.3 5.5 2.8 8.8 4.8 6.8 9.8 8.0 6.3 4.4 17.8 7.6 9.1 7.9 7.4 11.1 3.5 13.8 1.7 10.3 5.6 2.1 2.4 4.2 5.2 7.8 11.5 2.1 3.7 2.8 0.5 3.1 1.1 3.6 3.5 4.7 5.2 5.0 2.1 4.4 3.6 2.4 2.0 0.3 2.4 0.9 1.8 3.5 1.2 15.4 17.2 28.3 18.8 11.8 9.5 11.0 14.0 11.4 12.2 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165593 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 59.4;pituitary gland: 30.4" "Cell line enhanced" "Detected in some" "SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" 1273770 2800000 "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavourable (4.25e-4)" "prognostic unfavourable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 3.8 3.1 10.9 2.3 25.2 1.3 1.1 1.3 59.4 1.1 1.5 1.3 0.0 1.3 2.2 1.1 1.1 1.1 1.2 1.2 12.2 51.0 1.4 1.1 1.1 1.1 3.9 22.8 1.1 6.2 1.1 30.4 1.2 41.2 1.2 1.2 0.5 1.1 1.1 1.1 1.4 1.3 1.5 6.6 1.2 3.6 1.4 0.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 1.9 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.0 4.6 0.0 0.4 3.6 0.4 0.1 0.0 0.0 0.0 0.0 2.9 35.9 0.0 0.1 96.8 0.0 0.0 0.0 0.0 17.6 0.0 0.4 0.0 0.1 0.9 2.8 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 25.2 1.3 59.4 12.2 51.0 3.9 22.8 41.2 0.5 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Cell line enriched" "Detected in many" 4 "U-2197: 103.9" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA054983: " "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.5 13.9 0.0 18.6 23.2 0.2 9.6 6.7 8.2 10.3 2.9 0.6 0.0 0.0 15.0 1.3 0.9 0.9 11.3 5.4 0.0 0.7 0.9 0.0 8.5 0.1 0.0 17.7 1.5 12.0 5.4 1.2 0.0 0.0 10.2 0.0 0.1 0.0 0.2 0.0 0.0 18.4 0.0 0.0 1.6 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.5 18.3 2.7 103.9 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556070-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: " "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favourable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 22.3 29.3 26.6 20.7 25.1 10.5 28.2 18.0 23.8 32.3 18.6 22.8 17.8 18.9 35.6 23.3 23.6 36.0 28.9 20.7 23.3 13.2 22.5 10.6 20.4 15.2 22.4 14.9 65.4 18.4 27.2 19.6 19.9 19.7 21.8 14.7 28.8 28.7 23.5 13.8 24.2 18.6 24.7 28.2 15.8 18.6 25.4 23.3 30.0 37.5 21.3 19.9 23.4 30.3 5.6 5.3 16.2 5.8 6.3 11.3 5.8 10.5 7.1 20.4 6.2 25.9 14.1 38.3 7.0 14.5 6.2 6.1 6.0 10.5 14.3 16.2 11.1 7.1 9.3 11.7 4.4 8.7 14.2 15.3 7.1 10.0 20.2 12.0 10.1 17.5 24.3 8.4 10.8 23.1 5.5 2.5 9.6 9.0 14.2 13.8 12.6 12.6 18.4 13.8 18.7 14.2 15.2 9.0 25.8 8.0 8.6 17.9 8.4 11.9 12.1 16.9 8.2 10.9 17.7 3.9 11.1 31.4 18.5 20.6 32.6 16.2 4.4 1.0 11.3 2.5 7.3 5.6 6.2 9.2 5.3 4.0 8.5 8.9 2.6 6.3 5.8 4.5 3.1 5.8 26.6 25.1 18.0 23.8 23.3 13.2 22.4 14.9 19.7 23.3 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141008-10152220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005430, HPA031631, HPA031632" Uncertain Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB005430: AB_2241850, HPA031631: , HPA031632: " "prognostic unfavourable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favourable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 13.8 17.4 18.1 29.2 18.4 24.3 15.4 25.8 21.4 13.3 19.8 19.3 14.5 15.9 15.1 13.6 16.4 14.3 18.9 10.5 17.1 18.5 13.7 16.3 14.6 27.9 13.5 12.3 15.2 22.5 13.8 14.6 18.8 12.8 15.1 16.6 12.5 21.8 13.7 14.8 14.0 22.3 13.4 17.0 22.6 16.2 17.9 11.2 39.2 16.9 11.5 29.3 15.4 19.1 5.4 3.9 8.0 4.1 4.4 4.3 1.7 6.7 6.5 14.3 8.8 13.3 10.3 53.6 5.9 8.5 7.6 9.0 7.6 8.4 23.8 8.1 8.0 5.8 13.2 8.3 9.4 11.4 12.0 18.5 10.5 10.5 12.6 16.3 14.8 10.3 9.5 10.1 12.8 8.7 16.4 18.1 7.5 12.2 15.5 12.0 9.6 8.3 19.7 12.6 11.9 9.3 17.4 5.4 17.9 12.5 6.7 7.2 13.2 20.7 7.5 7.6 10.1 7.0 9.3 12.9 26.4 38.0 8.4 19.5 6.9 2.6 4.1 3.3 3.8 2.5 3.6 4.1 2.9 4.3 3.9 5.4 2.5 2.7 8.0 4.4 3.2 2.4 3.1 1.7 18.1 18.4 25.8 21.4 17.1 18.5 13.5 12.3 12.8 11.2 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487693-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavourable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 25.0 16.5 14.6 19.1 16.9 30.9 23.4 20.9 16.9 21.5 16.0 16.6 17.4 10.7 20.4 13.7 16.5 18.9 12.6 13.9 12.9 11.7 15.0 16.3 14.1 17.6 13.8 14.3 23.3 21.7 25.2 23.8 19.0 15.5 15.4 16.0 12.2 15.2 15.6 16.2 14.5 15.4 23.3 17.8 16.7 19.1 21.2 14.7 30.8 18.0 18.5 19.3 22.2 15.2 8.2 6.0 12.3 14.3 10.5 13.3 6.3 20.6 13.2 14.3 7.9 17.7 23.5 9.2 14.4 14.8 15.8 16.2 9.2 17.6 22.5 13.8 18.9 13.6 19.1 17.6 23.3 19.9 10.5 26.9 11.0 9.0 13.0 13.2 9.6 18.0 7.2 18.9 18.3 19.8 27.4 14.2 15.9 12.2 25.6 7.4 9.3 10.1 15.4 13.1 12.5 10.3 14.5 11.3 15.6 11.4 2.9 12.5 16.6 10.7 19.6 14.6 8.7 12.4 13.3 11.2 13.9 27.0 14.3 17.6 13.9 12.3 5.6 9.8 8.4 7.4 13.3 8.2 9.3 11.2 6.0 6.7 11.5 9.8 7.1 10.5 14.3 3.8 7.8 6.3 14.6 16.9 20.9 16.9 12.9 11.7 13.8 14.3 15.5 14.7 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell line enhanced" "Detected in many" "BEWO: 27.6;THP-1: 28.3;U-87 MG: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Approved "Vesicles,Cytokinetic bridge,Centriolar satellite" 180000 "Vesicles, Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favourable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 3.0 19.1 0.9 2.8 0.2 27.6 8.6 2.8 2.3 6.6 4.8 0.3 0.0 9.3 5.3 0.2 5.3 5.8 7.4 10.1 2.0 0.1 2.5 2.2 3.1 12.0 2.1 1.2 4.2 0.8 0.4 1.1 0.0 16.9 1.3 0.8 2.2 1.6 9.6 1.2 0.2 0.6 0.0 11.0 1.2 4.3 3.0 0.6 1.0 11.9 0.5 28.3 0.3 3.1 5.9 0.0 5.7 12.9 5.2 3.0 20.5 10.0 1.2 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: " "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.4 41.2 13.4 20.7 28.7 17.7 21.6 32.6 23.3 20.4 27.4 27.0 29.5 11.8 48.8 22.0 25.5 15.5 18.7 25.4 30.2 19.5 15.1 23.6 28.4 28.0 17.1 18.6 27.0 16.0 26.2 22.3 21.6 19.8 20.9 21.0 56.4 15.9 9.0 15.1 21.3 8.8 23.5 24.3 25.2 23.9 9.6 21.9 18.6 15.8 21.6 32.8 14.7 30.4 27.4 26.2 21.7 26.9 32.4 37.2 16.4 30.2 10.5 27.6 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" HPA062209 Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.4 0.7 0.4 1.8 0.0 0.2 0.2 0.9 0.2 0.0 0.4 0.2 0.7 0.0 6.1 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.6 0.1 0.4 0.2 0.3 0.9 0.9 0.3 0.4 2.0 0.5 0.6 0.4 1.2 0.9 0.6 1.0 3.3 1.4 0.0 0.5 0.1 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.5 6.5 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA027332: , HPA051621: " "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favourable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.0 4.6 5.2 4.0 14.0 11.2 2.4 4.0 6.9 6.8 6.5 3.1 5.7 7.6 5.0 11.2 7.4 9.1 7.7 9.5 4.1 3.0 6.5 7.2 2.5 5.9 9.4 3.4 9.4 11.0 8.7 8.5 10.7 13.3 3.9 6.2 3.7 5.5 3.7 2.1 5.9 4.8 6.3 2.2 4.8 4.8 2.5 3.5 11.5 8.5 8.1 7.3 3.1 11.6 4.2 4.4 10.9 3.2 3.5 2.8 12.0 4.8 6.7 6.4 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 VPS26A "Hbeta58, PEP8A, VPS26" ENSG00000122958 "VPS26, retromer complex component A" O75436 10 69123512-69172861 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011602, HPA057498, CAB075733" Supported Enhanced Endosomes,Lysosomes 19000 "Endosomes, Lysosomes" "CAB011602: AB_2215043, CAB075733: , HPA057498: " "unprognostic (1.17e-2)" "unprognostic (6.94e-2)" "unprognostic (5.58e-2)" "unprognostic (9.35e-2)" "unprognostic (5.95e-2)" "prognostic unfavourable (1.72e-4)" "prognostic unfavourable (1.70e-6)" "unprognostic (1.17e-1)" "unprognostic (1.35e-1)" "unprognostic (7.88e-2)" "prognostic unfavourable (9.18e-6)" "unprognostic (4.63e-2)" "unprognostic (2.15e-2)" "unprognostic (7.14e-2)" "unprognostic (6.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.72e-1)" 30.7 25.8 31.8 18.8 37.1 25.2 29.6 42.6 37.2 23.3 27.5 14.5 15.1 21.4 24.5 20.7 37.1 20.7 20.9 40.7 33.3 21.1 34.3 26.5 23.9 17.7 26.5 25.4 24.1 19.3 31.4 24.5 36.4 29.9 23.9 28.8 15.3 25.7 20.3 29.3 33.8 28.0 22.9 35.4 24.7 22.7 34.2 29.1 21.8 27.8 23.6 22.8 30.8 27.3 16.9 28.1 28.2 29.4 34.7 28.1 25.3 33.1 12.7 15.6 28.0 27.6 25.1 13.8 20.3 33.0 24.9 28.4 29.8 32.6 10.3 16.5 22.2 23.0 23.4 20.3 34.6 9.3 12.7 15.5 11.8 16.6 35.7 23.4 12.5 22.7 31.9 24.8 55.3 26.1 29.7 14.7 39.5 10.5 10.5 26.5 10.5 32.3 13.1 25.9 12.4 29.0 19.7 9.6 14.3 27.6 38.1 36.9 15.0 20.1 29.9 16.9 21.7 27.4 26.4 8.8 21.3 16.9 23.2 38.2 8.8 28.2 25.4 22.9 27.9 29.4 25.3 16.9 21.6 28.1 28.1 13.7 19.2 26.6 23.0 34.7 24.2 11.5 24.1 25.3 31.8 37.1 42.6 37.2 33.3 21.1 26.5 25.4 29.9 29.1 VPS29 "DC15, DC7, PEP11" ENSG00000111237 "VPS29, retromer complex component" Q9UBQ0 12 110491097-110502117 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039748 Uncertain Supported Vesicles,Cytosol 140000 "Vesicles, Cytosol" "HPA039748: AB_10674426" "unprognostic (9.46e-2)" "unprognostic (3.46e-3)" "unprognostic (2.16e-2)" "unprognostic (2.58e-1)" "unprognostic (3.08e-1)" "unprognostic (2.26e-2)" "prognostic unfavourable (2.79e-5)" "unprognostic (1.52e-1)" "unprognostic (3.37e-2)" "prognostic favourable (7.70e-4)" "unprognostic (1.64e-1)" "unprognostic (2.10e-3)" "unprognostic (2.96e-1)" "unprognostic (2.04e-2)" "unprognostic (2.11e-1)" "unprognostic (5.57e-2)" "unprognostic (4.29e-3)" 39.2 34.9 35.6 28.5 38.5 44.4 32.6 23.0 46.6 30.3 38.0 24.4 29.5 33.6 31.5 50.4 51.2 29.0 27.5 35.9 31.5 30.9 62.2 51.2 31.3 33.1 32.8 27.8 27.6 31.4 18.3 31.4 34.5 46.6 41.6 43.5 27.3 34.1 40.6 64.0 25.2 36.2 47.3 28.9 43.1 34.9 17.0 23.8 29.8 38.3 32.9 38.0 51.5 27.4 40.5 67.4 52.7 79.9 41.7 46.0 72.1 31.2 30.7 29.2 20.8 32.9 32.7 23.1 29.7 31.1 30.0 27.2 30.7 27.4 29.0 31.3 29.4 29.9 38.6 27.5 31.5 34.3 30.9 35.4 38.7 25.2 28.7 42.2 31.1 21.5 23.5 25.4 28.1 52.4 33.8 27.2 53.7 15.7 33.0 60.0 16.7 39.5 22.1 29.9 40.7 49.9 46.6 31.5 16.7 33.7 30.0 37.2 40.7 32.7 29.4 26.1 17.2 36.0 34.6 18.6 25.9 34.1 30.4 40.4 27.7 43.9 57.6 52.7 31.9 73.2 35.1 40.5 40.7 37.3 67.4 31.4 37.4 36.8 38.5 41.7 79.9 45.3 46.0 72.1 35.6 38.5 23.0 46.6 31.5 30.9 32.8 27.8 46.6 23.8 VPS35 "FLJ10752, MEM3, PARK17" ENSG00000069329 "VPS35, retromer complex component" Q96QK1 16 46656132-46689518 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040802 Supported Supported Endosomes,Lysosomes 320000 "Endosomes, Lysosomes" "HPA040802: " "unprognostic (1.11e-2)" "unprognostic (8.70e-2)" "prognostic favourable (7.74e-4)" "unprognostic (4.75e-2)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "prognostic unfavourable (2.10e-6)" "unprognostic (5.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-2)" "unprognostic (3.33e-3)" "unprognostic (2.49e-1)" "prognostic favourable (9.75e-5)" "unprognostic (3.68e-3)" "unprognostic (2.43e-1)" "unprognostic (1.34e-1)" "unprognostic (6.89e-3)" 14.1 12.6 15.1 11.8 21.1 18.3 15.7 13.1 23.6 14.3 15.2 11.9 10.0 11.7 13.0 19.3 16.4 14.8 11.2 14.0 15.1 18.6 13.4 9.2 14.4 11.6 20.4 17.0 16.2 11.7 22.8 18.0 15.3 31.7 14.5 12.2 8.4 12.3 12.7 11.9 19.5 21.9 12.7 16.5 14.0 12.3 12.1 10.9 14.0 12.2 11.8 13.0 17.1 11.6 2.4 2.9 3.1 9.2 1.7 3.2 2.0 8.5 8.7 10.0 6.3 12.1 16.6 5.4 8.2 10.2 11.7 6.2 8.5 6.0 9.1 8.7 10.0 8.4 10.2 12.3 13.5 2.5 11.6 6.7 4.9 6.5 11.3 9.5 6.7 11.0 13.8 10.1 5.9 11.6 6.4 2.5 12.4 6.1 10.9 9.1 3.0 11.4 11.3 14.3 16.6 11.3 7.2 7.2 8.3 8.1 9.1 7.4 3.8 8.8 11.6 8.9 2.9 9.2 9.7 5.5 5.6 9.3 15.4 12.3 4.9 2.2 2.7 2.6 1.6 4.5 1.7 2.4 1.9 2.1 2.9 2.4 3.2 2.4 3.1 1.7 9.2 1.7 2.7 2.0 15.1 21.1 13.1 23.6 15.1 18.6 20.4 17.0 31.7 10.9 VPS36 "C13orf9, CGI-145, Eap45" ENSG00000136100 "Vacuolar protein sorting 36 homolog" Q86VN1 13 52412602-52450628 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039734, HPA043947" Approved Supported "Vesicles,Lysosomes,Plasma membrane,Cell Junctions" "Vesicles, Lysosomes" "Plasma membrane, Cell Junctions" "HPA039734: , HPA043947: " "unprognostic (2.43e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-1)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-1)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" "unprognostic (3.96e-3)" "unprognostic (1.19e-2)" "unprognostic (9.37e-2)" "unprognostic (5.57e-2)" "prognostic favourable (9.91e-6)" "unprognostic (6.47e-3)" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (9.83e-2)" 16.4 14.5 16.5 15.9 22.3 7.0 23.5 36.8 27.7 17.1 21.1 13.6 12.8 23.8 22.4 12.9 24.6 16.6 18.0 20.3 15.4 13.0 22.6 20.2 17.5 15.6 16.2 18.5 20.0 19.0 14.4 20.1 21.7 25.9 20.1 24.7 18.2 21.6 18.3 23.4 44.6 27.9 23.7 13.8 22.3 15.7 4.2 13.8 18.1 20.0 16.8 18.1 20.3 21.7 14.4 14.9 13.9 19.2 19.4 19.3 11.8 3.7 6.3 11.2 7.3 11.6 16.3 9.6 8.7 6.7 8.9 5.4 7.4 12.6 13.3 4.6 12.5 10.7 8.8 10.5 9.9 9.9 8.5 15.6 10.0 6.6 13.9 21.0 17.0 11.4 20.6 6.0 9.9 8.9 11.5 11.8 17.0 4.9 15.3 21.1 10.6 3.3 16.0 6.3 8.1 15.6 9.9 5.7 12.0 6.2 14.8 13.2 8.6 35.0 13.8 5.7 6.9 5.6 9.8 8.8 11.0 14.1 5.9 14.9 13.2 13.9 13.5 10.9 12.1 14.8 19.3 14.4 13.3 15.1 14.3 12.3 12.4 13.2 3.7 19.4 19.2 14.9 14.3 11.8 16.5 22.3 36.8 27.7 15.4 13.0 16.2 18.5 25.9 13.8 VPS37A "FLJ32642, HCRP1, PQBP2, SPG53" ENSG00000155975 "VPS37A, ESCRT-I subunit" Q8NEZ2 8 17246571-17302427 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024705, HPA024781" Supported Approved Vesicles,Centrosome,Cytosol Vesicles "Centrosome, Cytosol" "HPA024705: AB_10601776, HPA024781: AB_10602100" "unprognostic (8.28e-2)" "unprognostic (1.84e-1)" "unprognostic (9.39e-3)" "unprognostic (3.91e-1)" "unprognostic (2.10e-1)" "unprognostic (6.31e-2)" "unprognostic (5.88e-3)" "unprognostic (2.28e-2)" "unprognostic (1.43e-1)" "unprognostic (3.17e-1)" "unprognostic (1.02e-1)" "unprognostic (2.88e-1)" "unprognostic (5.06e-2)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (2.18e-1)" 23.5 21.3 15.1 13.5 15.6 12.8 22.1 23.1 18.1 21.3 23.5 15.8 16.4 18.6 19.1 15.1 22.7 13.3 15.5 34.4 15.8 14.9 23.3 25.9 18.4 14.4 16.6 10.4 21.7 15.8 34.2 20.8 31.6 16.1 20.0 16.2 20.7 15.2 22.7 41.8 16.5 27.3 24.4 20.2 16.4 14.9 27.7 14.6 17.3 18.0 16.4 14.8 27.6 22.7 10.1 11.7 25.0 15.2 20.6 15.5 11.4 7.0 11.7 10.2 8.9 22.6 18.0 11.1 25.3 21.5 23.4 20.2 7.8 6.9 6.1 13.8 20.2 7.0 11.4 11.1 27.7 6.2 3.4 11.2 5.9 8.3 26.5 4.3 10.6 17.5 21.6 21.6 22.2 16.6 8.2 15.8 24.6 4.8 13.1 11.1 10.1 6.1 6.4 11.4 7.2 19.6 9.8 12.2 6.5 10.1 10.1 15.6 6.6 9.1 14.1 14.1 7.2 20.2 13.2 5.0 10.2 7.1 16.1 8.3 14.4 25.0 15.2 13.5 12.9 11.3 15.5 9.9 12.4 12.3 11.7 10.1 11.6 13.8 15.9 20.6 10.0 10.8 11.4 11.4 15.1 15.6 23.1 18.1 15.8 14.9 16.6 10.4 16.1 14.6 VPS37C FLJ20847 ENSG00000167987 "VPS37C, ESCRT-I subunit" A5D8V6 11 61130256-61161617 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavourable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favourable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 12.8 12.7 15.6 13.8 14.5 9.8 13.9 10.0 17.4 15.4 18.4 16.0 17.3 19.1 16.1 15.0 20.9 14.5 14.3 15.0 15.5 9.2 15.4 12.1 13.9 8.0 12.5 10.2 16.3 22.6 14.7 19.8 19.5 13.4 19.5 12.5 18.2 29.1 18.2 20.6 24.1 26.4 16.7 13.6 13.0 23.7 18.6 15.3 5.9 14.0 14.9 14.4 17.3 14.6 1.1 1.9 6.8 4.5 0.4 0.8 1.0 17.1 7.0 8.9 8.2 4.3 9.2 19.6 8.8 23.4 13.2 8.9 8.1 7.9 4.5 12.3 11.8 9.5 8.0 9.3 6.8 9.8 6.1 5.9 4.8 8.8 13.9 4.5 7.0 8.0 14.3 10.9 13.8 8.5 15.1 7.3 8.6 20.9 0.9 6.6 10.6 10.0 1.6 4.0 10.7 10.0 9.3 5.4 13.3 8.9 26.8 13.9 25.7 11.0 6.4 12.8 9.3 12.6 10.7 3.6 4.9 3.8 11.3 5.5 8.3 0.8 2.5 2.8 0.6 4.5 0.8 1.1 0.4 0.7 1.9 1.1 0.5 0.3 6.8 0.4 4.1 0.3 0.3 1.0 15.6 14.5 10.0 17.4 15.5 9.2 12.5 10.2 13.4 15.3 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" 34000 Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: " "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favourable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 16.8 13.0 14.3 14.3 17.2 28.0 17.2 15.4 19.1 19.8 24.0 21.8 15.5 20.0 16.7 12.1 55.0 13.1 15.1 9.9 13.7 16.0 15.6 20.5 14.3 21.6 17.0 14.7 11.9 14.0 17.5 17.4 27.4 23.4 14.3 22.2 9.3 21.8 15.0 9.9 22.1 28.7 15.2 20.2 17.3 18.7 9.0 14.6 27.8 17.0 17.6 31.8 18.6 24.7 20.7 13.6 56.4 20.6 19.1 18.9 15.4 18.4 6.8 7.6 8.3 11.8 16.7 13.2 16.2 15.3 12.4 13.6 5.0 13.2 17.8 10.6 11.8 40.1 9.1 17.7 16.5 12.9 7.3 8.9 9.6 7.7 16.9 30.6 19.5 15.1 27.6 10.9 19.5 11.5 4.4 16.7 17.6 6.4 19.1 9.6 7.9 10.7 16.0 16.2 17.1 15.6 21.7 13.0 11.5 12.2 12.0 18.1 11.5 16.7 17.6 19.2 9.4 7.2 10.6 56.1 26.9 22.9 11.0 14.5 14.2 39.4 16.8 36.0 16.5 16.6 15.4 18.9 17.4 17.0 13.6 20.7 15.8 16.6 56.4 19.1 20.6 13.6 18.9 15.4 14.3 17.2 15.4 19.1 13.7 16.0 17.0 14.7 23.4 14.6 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50, EARP/GARPII complex subunit" Q96JG6 7 93232340-93361121 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavourable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favourable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 15.9 16.3 16.4 15.3 24.2 6.9 21.6 26.1 28.3 13.0 16.0 9.9 13.3 11.5 17.7 17.5 15.7 11.9 10.4 12.6 19.8 16.0 20.0 12.1 13.2 15.3 16.4 22.2 15.4 13.5 23.9 30.8 12.8 26.7 14.3 18.5 7.5 15.0 14.2 18.7 16.8 12.8 14.8 15.9 15.5 14.1 13.8 19.2 15.8 15.8 14.0 15.3 14.2 12.9 5.5 10.4 4.2 8.1 5.2 11.2 4.3 11.0 6.7 8.6 13.4 16.2 11.6 8.7 10.5 9.0 10.9 12.0 9.4 13.0 9.8 11.9 9.0 9.6 12.9 10.0 15.2 11.5 9.0 18.4 13.0 5.9 9.9 9.4 10.1 9.8 11.6 13.2 13.3 14.1 14.5 12.8 14.5 11.0 8.8 8.4 6.0 9.4 7.0 11.4 13.4 10.1 8.9 6.2 13.3 12.1 26.8 10.7 9.2 7.0 12.7 15.9 9.4 29.0 10.7 7.0 15.5 11.9 11.7 9.2 12.6 4.2 7.0 3.4 6.2 8.1 11.2 5.5 6.9 7.6 10.4 5.5 5.5 7.4 1.7 5.2 4.8 5.1 8.1 4.3 16.4 24.2 26.1 28.3 19.8 16.0 16.4 22.2 26.7 19.2 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: " "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favourable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.7 24.0 11.8 14.4 5.3 13.1 22.0 8.6 17.6 17.5 13.0 17.4 28.8 38.0 24.7 16.6 18.7 12.4 19.3 6.4 22.1 18.8 22.6 24.4 16.7 17.3 24.4 20.7 22.6 13.2 13.0 10.8 19.2 23.0 27.3 7.1 29.6 32.7 24.4 19.1 18.4 20.4 5.7 45.8 11.9 24.4 19.7 27.1 6.4 36.6 21.3 29.8 12.2 15.5 11.9 10.4 14.7 12.3 34.9 27.0 21.3 13.2 8.9 8.4 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54, GARP complex subunit" Q9P1Q0 2 63892146-64019072 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA055894: , HPA067981: , HPA070582: " "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavourable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favourable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 15.5 14.2 10.1 11.1 13.2 12.6 14.3 22.1 12.9 18.6 17.1 11.4 17.3 12.9 16.3 14.4 13.3 14.4 13.7 12.5 11.3 8.5 15.8 15.5 15.2 9.6 14.3 10.6 18.0 21.0 34.2 32.1 13.0 12.1 17.3 13.5 14.3 31.9 19.4 12.2 13.1 16.9 17.5 10.4 13.3 13.7 12.2 12.5 18.3 17.5 11.3 11.3 13.5 26.2 3.1 2.8 4.1 3.2 3.0 4.3 1.0 16.5 9.2 16.9 13.1 12.4 13.1 12.3 10.8 16.2 11.5 11.4 16.7 10.8 11.6 8.1 14.2 7.7 16.6 9.7 20.3 16.4 11.0 11.0 7.1 28.2 11.6 7.5 4.7 12.1 14.7 8.1 17.7 17.2 12.0 9.8 14.4 7.3 7.6 7.3 10.1 6.6 7.7 16.5 6.5 12.6 9.7 9.7 14.5 9.3 12.0 12.3 8.6 14.6 12.3 14.8 11.8 8.9 17.5 22.5 6.2 14.8 10.8 14.9 12.4 4.1 3.2 1.3 2.1 3.2 2.6 2.4 2.1 2.5 1.8 3.1 2.8 2.2 3.0 3.0 2.5 2.8 4.3 1.0 10.1 13.2 22.1 12.9 11.3 8.5 14.3 10.6 12.1 12.5 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8, CORVET complex subunit" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 12.6 11.1 14.9 11.1 20.9 22.6 12.0 21.6 24.8 15.5 12.5 18.2 8.0 9.1 16.4 19.0 11.5 10.1 12.5 20.3 17.1 19.3 12.5 9.2 13.8 14.8 21.5 13.6 16.7 10.1 21.8 23.6 13.3 28.4 12.8 16.7 12.1 9.5 12.0 28.4 14.2 9.9 14.5 21.9 14.9 14.1 17.8 15.9 13.2 17.5 9.0 11.5 12.5 11.6 3.9 6.0 17.7 4.9 3.9 6.4 3.1 10.8 6.6 10.1 10.1 21.2 18.9 6.7 10.7 11.8 7.9 11.0 8.4 5.7 11.7 18.8 16.7 12.9 10.9 13.1 15.2 21.1 9.7 12.8 8.3 4.9 13.1 8.6 17.3 13.4 12.6 11.1 11.3 19.7 6.5 8.5 14.3 7.8 6.9 5.1 6.6 6.3 8.6 19.5 9.1 7.8 19.0 10.4 6.8 12.4 13.2 9.7 20.9 4.6 17.3 12.2 6.9 12.3 9.4 10.5 12.7 16.0 13.9 10.9 9.5 11.7 4.9 16.2 4.0 3.7 3.8 3.5 4.3 4.0 6.0 3.9 6.4 4.3 17.7 3.9 4.6 1.7 3.5 3.1 14.9 20.9 21.6 24.8 17.1 19.3 21.5 13.6 28.4 15.9 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720986 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 16.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favourable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 8.6 15.4 16.1 19.2 17.9 14.2 5.3 22.7 30.6 6.7 7.1 13.3 8.8 16.6 7.1 7.2 17.0 7.0 9.3 11.0 17.2 16.3 11.7 15.0 8.2 10.4 12.6 24.1 6.4 12.2 16.5 17.6 6.8 17.6 7.9 4.9 10.2 15.3 8.4 12.8 12.6 13.0 6.2 9.3 15.7 10.3 13.5 10.6 1.7 9.3 7.5 7.7 8.5 7.6 0.2 0.2 16.6 0.6 0.1 0.4 0.1 4.5 6.9 7.7 8.2 7.8 7.7 6.5 8.5 8.7 7.3 3.6 6.0 10.2 4.7 5.5 9.2 10.5 0.6 4.8 2.1 4.2 11.8 3.3 5.9 7.2 5.9 1.9 8.1 8.4 4.4 8.8 2.0 5.0 8.4 2.9 4.8 20.6 3.5 7.3 2.9 7.9 8.8 6.4 2.8 5.8 7.2 6.5 6.9 10.8 4.1 8.6 18.2 8.2 7.9 9.6 12.1 7.7 5.0 13.4 4.2 4.1 13.9 5.1 7.9 1.2 0.6 0.3 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.4 0.2 16.6 0.1 0.2 0.0 0.2 0.1 16.1 17.9 22.7 30.6 17.2 16.3 12.6 24.1 17.6 10.6 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.7 9.1 22.5 10.0 2.7 5.0 14.0 11.9 9.3 19.1 19.0 10.8 15.6 40.1 8.1 7.0 17.5 21.0 15.5 26.3 22.8 11.3 25.0 6.0 11.1 2.9 48.0 15.7 2.7 2.8 14.4 10.6 13.2 21.2 25.4 16.4 18.0 38.1 20.7 14.4 17.3 35.7 39.4 13.6 8.7 16.2 15.9 9.0 10.5 10.8 8.0 12.3 19.0 7.1 8.7 7.8 15.0 11.9 13.3 15.7 38.8 13.6 21.0 10.3 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 VRK3 ENSG00000105053 "Vaccinia related kinase 3" Q8IV63 19 49976467-50025946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 77.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA056489: " "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favourable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.66e-4)" 9.7 11.9 9.2 9.4 12.7 10.7 8.3 12.0 14.1 8.9 13.4 11.9 9.3 13.4 15.7 10.8 8.4 18.0 12.2 7.4 9.3 11.1 16.7 16.2 8.5 13.4 10.4 9.9 11.2 11.5 7.1 11.8 10.7 9.8 9.4 11.7 14.2 14.3 8.5 11.8 7.7 17.3 7.5 11.0 12.8 10.9 77.2 9.1 24.7 14.1 6.0 12.9 9.9 8.0 24.5 19.7 47.3 20.9 33.5 30.1 18.1 16.3 16.9 12.4 13.4 16.5 15.3 12.9 11.8 14.1 17.5 19.3 9.0 18.3 19.7 8.4 11.4 12.2 11.5 10.0 14.2 17.2 23.7 15.3 10.2 15.6 12.4 19.1 27.0 13.7 15.1 10.1 10.7 14.4 18.6 29.4 12.6 6.9 25.8 12.9 6.7 14.6 20.8 13.1 25.1 15.0 17.3 14.0 6.8 11.5 14.2 12.8 13.1 20.4 10.9 18.0 10.5 7.2 9.1 19.1 24.3 10.3 14.4 11.8 12.3 37.0 17.8 32.4 23.8 18.8 19.1 24.5 21.7 22.7 19.7 21.9 22.1 20.4 47.3 33.5 20.9 18.8 30.1 18.1 9.2 12.7 12.0 14.1 9.3 11.1 10.4 9.9 9.8 9.1 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.7;HUVEC TERT2: 11.6;PC-3: 3.9;TIME: 2.9" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 11.6 0.1 0.3 0.0 0.4 0.4 0.3 0.4 3.9 0.3 0.0 0.0 0.7 1.0 0.2 0.1 0.2 0.2 0.6 0.1 0.0 2.9 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell line enhanced" "Detected in many" "HAP1: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA062022: " "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.2 10.6 13.2 6.0 8.0 8.6 5.6 4.3 3.5 2.1 11.9 0.7 3.4 6.3 12.2 22.1 2.2 5.1 2.4 3.3 1.1 6.9 3.2 2.6 0.7 1.8 2.7 6.5 3.3 2.1 9.3 1.4 0.1 4.0 5.3 0.0 0.7 9.8 4.7 1.8 8.7 0.0 6.2 16.2 2.7 3.4 8.4 3.5 2.2 7.8 3.4 10.8 4.9 3.1 6.1 4.3 0.1 0.1 0.0 7.1 3.5 9.8 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavourable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.8;RH-30: 7.8;SH-SY5Y: 6.7;U-138 MG: 8.9;U-2197: 20.0;U-87 MG: 9.8" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.6 0.1 1.1 0.6 0.1 2.1 3.4 0.8 0.2 0.1 0.1 0.1 0.1 4.9 0.1 0.1 0.0 0.3 2.6 1.1 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.5 0.0 0.0 6.8 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 7.8 4.0 0.0 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.2 0.0 8.9 1.1 20.0 0.1 0.0 5.3 0.0 9.8 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavourable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.1 15.6 25.5 39.0 22.5 24.8 17.6 41.1 24.6 37.7 36.1 26.3 14.2 29.6 27.9 36.8 23.2 27.1 28.1 52.3 20.0 23.8 32.1 16.7 31.4 16.6 49.7 18.6 20.4 32.9 37.6 24.4 24.1 29.7 14.9 31.5 26.4 32.2 25.9 19.1 17.9 29.7 20.4 18.0 29.0 20.1 26.7 20.8 23.1 17.8 20.6 19.3 33.9 17.4 17.0 23.7 28.4 29.5 14.7 25.4 33.7 11.1 27.8 25.8 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 72.8" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: " "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 72.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 VTI1A "MVti1, Vti1-rp2, Vti1a" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA054108: " "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favourable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 16.8 12.8 14.5 17.9 17.9 25.2 14.6 16.7 18.6 10.0 13.8 14.3 14.4 15.2 11.8 11.6 21.1 9.5 10.3 13.1 13.4 11.1 15.4 11.8 15.7 15.4 12.8 12.2 10.5 12.8 17.4 13.7 11.0 14.6 11.4 17.0 11.2 14.3 13.6 18.4 17.1 16.5 12.8 12.7 16.0 12.3 9.8 13.0 18.8 14.2 9.7 19.6 13.1 15.6 7.3 6.8 14.8 11.7 7.3 8.8 5.5 10.8 9.1 8.7 11.7 13.4 11.9 5.2 11.6 14.8 9.5 10.7 10.2 11.3 11.3 4.5 13.3 13.0 7.4 9.3 13.0 14.1 6.5 9.8 6.6 10.7 9.5 13.5 14.3 9.0 12.1 10.7 22.4 10.1 8.9 14.2 12.5 7.4 10.7 10.4 3.6 5.3 11.3 12.4 5.0 10.0 9.7 3.9 7.6 8.3 7.3 7.6 6.5 7.6 14.0 7.4 6.4 9.0 12.9 6.2 8.7 13.3 12.2 12.5 7.2 8.9 8.9 11.9 7.5 11.7 7.0 7.3 6.3 6.0 6.8 6.7 6.2 6.4 14.8 7.3 10.4 6.4 8.8 5.5 14.5 17.9 16.7 18.6 13.4 11.1 12.8 12.2 14.6 13.0 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647075-67674831 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044121: , HPA048150: , HPA060118: " "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favourable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 37.5 21.4 49.3 14.9 39.3 14.3 32.1 12.6 32.9 11.3 22.8 16.8 16.1 21.3 12.5 42.5 34.1 14.6 22.0 49.6 36.9 30.4 39.0 30.5 14.8 16.3 38.1 20.5 12.7 27.9 20.3 11.3 21.0 24.2 16.2 27.4 15.4 25.7 18.8 31.0 21.8 20.2 22.9 37.1 15.6 20.7 15.4 20.2 8.2 25.9 18.8 19.5 19.4 24.2 18.7 22.4 52.1 29.6 20.1 21.7 18.9 38.3 19.4 11.3 6.5 22.6 13.5 16.4 17.0 10.6 8.2 8.5 9.6 13.8 11.5 14.5 18.9 10.9 12.9 12.9 13.4 11.8 8.2 11.6 11.7 12.3 9.7 7.2 8.4 13.1 14.0 9.1 9.4 9.5 7.6 9.0 12.0 45.5 9.0 26.7 7.3 31.3 10.9 12.8 4.2 12.2 23.1 6.3 13.1 12.0 16.3 24.1 15.2 20.3 13.6 22.9 34.2 18.4 15.7 8.5 9.1 17.7 19.3 13.5 10.5 28.6 23.4 52.1 19.8 29.6 16.9 18.7 17.5 20.2 22.4 16.4 16.7 20.4 10.6 20.1 24.7 14.7 21.7 18.9 49.3 39.3 12.6 32.9 36.9 30.4 38.1 20.5 24.2 20.2 VTN VN ENSG00000109072 Vitronectin P04004 17 28367276-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "liver: 321.7" "Cell line enriched" "Detected in some" 11 "CACO-2: 164.9" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" 224300000000 32000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favourable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.2 0.0 0.0 0.0 321.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.7 2.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 164.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 15.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.9 0.0 0.9 0.9 0.1 0.3 0.6 2.1 0.6 0.7 0.0 0.2 0.0 0.1 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 24.4;testis: 51.9" "Cell line enhanced" "Detected in single" "U-138 MG: 1.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036700: , HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.0 0.2 1.7 0.0 0.0 0.0 0.2 1.1 0.2 2.0 0.0 0.0 0.5 4.3 0.0 24.4 0.5 0.4 1.7 1.6 0.0 0.0 4.0 0.0 0.1 0.1 2.3 0.0 0.0 1.1 0.1 3.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 51.9 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.1 1.7 1.6 0.1 0.1 3.2 0.3 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115362-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.7;HEL: 20.0;HHSteC: 15.5;HUVEC TERT2: 18.4;RPTEC TERT1: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 25.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: " "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favourable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 14.8 20.2 13.8 7.5 13.4 1.6 16.0 2.3 9.3 15.5 23.9 7.5 10.0 16.7 16.6 17.0 12.6 9.9 19.9 6.5 14.1 24.6 16.0 4.3 19.4 6.8 12.5 6.6 9.6 15.3 5.5 34.2 25.9 15.2 22.5 28.4 10.3 31.2 13.2 3.0 17.9 24.0 13.6 15.0 6.0 17.8 6.3 7.6 3.9 13.7 7.1 9.8 14.9 11.8 4.5 4.8 25.6 5.3 4.3 7.5 3.6 0.0 0.2 3.6 0.2 3.8 3.5 1.3 0.5 0.2 0.3 0.1 0.2 27.7 0.0 3.4 0.5 0.1 0.7 6.3 0.0 9.4 0.0 20.0 5.0 0.6 15.5 0.2 9.4 10.5 0.7 0.6 2.1 18.4 1.0 3.4 1.1 0.0 0.4 0.3 5.6 0.7 0.0 12.3 0.1 20.2 0.2 3.1 0.3 0.5 0.2 1.0 2.5 0.9 0.4 0.1 2.6 0.1 0.0 1.2 1.1 0.0 11.5 0.4 0.2 25.6 4.8 0.5 2.9 3.3 0.7 4.5 3.2 1.7 4.8 2.3 4.1 2.6 0.3 4.3 5.3 2.6 7.5 3.6 13.8 13.4 2.3 9.3 14.1 24.6 12.5 6.6 15.2 7.6 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.2" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: " "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: , HPA061412: " "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 26.5 1.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;HeLa: 3.3;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" "Plasma membrane, Cytosol" "HPA046954: , HPA054262: " "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favourable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.4 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.1 0.5 0.7 0.3 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.3 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.0 0.2 3.0 0.0 0.2 0.0 0.5 0.0 0.1 0.3 0.0 2.0 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.4 1.2 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 VWA8 KIAA0564 ENSG00000102763 "Von Willebrand factor A domain containing 8" A3KMH1 13 41566837-41961120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039075, HPA045478" Uncertain Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA039075: , HPA045478: " "unprognostic (9.93e-2)" "unprognostic (4.12e-2)" "unprognostic (2.11e-1)" "unprognostic (2.57e-3)" "unprognostic (4.14e-2)" "unprognostic (1.50e-2)" "prognostic favourable (8.56e-4)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (3.31e-3)" "unprognostic (5.35e-2)" "unprognostic (2.44e-1)" "prognostic favourable (6.38e-14)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" 10.1 15.1 7.1 14.1 9.7 6.3 11.0 11.4 10.5 12.2 10.0 8.2 10.4 8.7 14.9 10.7 9.1 8.3 12.1 16.0 6.7 7.9 21.8 25.8 6.8 8.3 8.8 6.0 9.5 11.1 17.2 16.3 6.4 9.8 8.6 9.6 15.1 15.2 8.7 31.4 7.3 11.1 11.9 6.9 6.9 8.9 5.5 5.6 17.5 9.0 16.4 11.8 11.7 6.9 2.5 2.5 1.8 1.5 4.1 4.9 2.4 4.0 5.9 6.1 8.4 5.8 8.4 5.7 6.5 9.5 5.9 4.7 7.8 6.5 10.8 4.4 5.6 14.5 5.6 15.7 7.4 12.2 10.1 10.1 5.7 9.8 6.2 13.3 1.4 9.8 9.8 5.6 13.5 5.8 9.7 7.7 5.2 5.4 7.5 6.8 9.1 5.7 0.0 3.8 11.2 15.8 14.6 3.8 8.2 8.1 12.7 8.9 5.3 10.2 5.3 4.4 4.7 5.7 6.1 8.0 7.5 16.9 4.9 6.5 5.8 1.8 1.1 0.2 3.4 1.1 4.9 2.3 2.0 2.9 2.5 2.5 2.7 3.5 0.7 4.1 1.5 1.5 1.1 2.4 7.1 9.7 11.4 10.5 6.7 7.9 8.8 6.0 9.8 5.6 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: , HPA043921: " "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.7 0.0 0.2 5.6 0.0 0.3 0.0 0.4 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 18.9 1.0 0.0 0.1 11.1 0.5 0.5 0.0 1.7 0.2 0.3 0.3 0.0 4.1 0.0 1.6 0.0 10.6 0.1 0.0 0.1 0.1 0.4 0.8 0.0 0.1 0.5 0.7 0.0 0.4 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell line enhanced" "Detected in many" "K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" Cytosol Nucleoplasm "HPA026619: , HPA036044: " "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.7 0.0 2.0 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.4 2.1 1.9 0.6 3.9 2.2 3.5 4.7 0.0 0.0 1.0 2.3 0.1 0.3 0.0 1.2 0.8 10.6 0.0 0.0 1.2 0.0 0.0 5.3 0.6 0.0 0.0 1.6 0.0 1.3 8.5 1.3 0.0 1.7 0.0 0.0 1.1 0.1 0.0 1.0 0.0 0.8 3.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 WARS2 TrpRS ENSG00000116874 "Tryptophanyl tRNA synthetase 2, mitochondrial" Q9UGM6 1 119031216-119140671 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069692 Enhanced Supported "Plasma membrane,Mitochondria" Mitochondria "Plasma membrane" "HPA069692: " "unprognostic (1.00e-1)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (5.64e-2)" "unprognostic (3.42e-1)" "unprognostic (7.05e-2)" "unprognostic (7.73e-3)" "unprognostic (3.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.17e-2)" "unprognostic (3.96e-2)" "unprognostic (6.76e-3)" "prognostic favourable (1.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.83e-1)" "unprognostic (9.88e-3)" "unprognostic (4.71e-2)" 17.3 16.7 6.8 11.7 8.3 2.8 14.6 7.5 8.7 12.9 11.2 7.7 7.6 12.3 13.5 10.4 13.4 14.9 8.8 12.1 6.2 6.1 15.3 14.9 9.2 12.4 6.4 6.1 14.7 17.8 15.1 12.3 14.9 8.3 14.1 12.7 11.3 10.5 10.4 12.2 10.0 13.1 9.0 5.4 9.9 11.2 6.9 6.1 11.6 12.8 13.2 14.2 14.3 10.4 7.2 9.0 0.5 6.9 5.3 7.4 4.9 10.2 4.5 6.0 6.3 7.7 17.4 6.5 5.8 8.2 6.1 7.3 11.2 4.7 15.1 9.4 9.2 6.9 10.8 9.8 9.3 8.1 14.1 7.1 12.0 10.7 15.7 11.5 4.1 13.3 7.6 8.8 16.1 9.0 11.1 11.0 11.2 11.9 6.8 6.7 8.1 9.2 5.0 20.0 7.6 16.5 14.3 8.9 5.4 9.0 12.6 13.0 5.6 9.0 6.9 6.6 8.0 12.4 10.9 5.3 3.6 6.7 8.1 9.7 12.2 0.0 6.9 0.5 5.1 4.9 7.4 6.6 5.4 6.7 9.0 7.2 6.5 6.2 0.3 5.3 3.0 4.5 6.0 4.9 6.8 8.3 7.5 8.7 6.2 6.1 6.4 6.1 8.3 6.1 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "Wiskott-Aldrich syndrome" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 55.9" "Cell line enhanced" "Detected in some" "Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" 320000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favourable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favourable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavourable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 7.6 4.0 4.9 28.9 7.8 30.7 3.3 2.0 5.1 2.7 4.4 5.9 0.5 4.8 2.4 5.6 3.7 4.5 4.4 3.0 4.6 4.1 4.1 5.0 12.6 29.9 7.6 1.3 2.6 2.2 0.7 2.6 5.4 6.0 3.2 3.2 3.5 5.4 1.9 1.4 2.2 14.3 3.7 12.8 55.9 4.1 1.7 7.3 53.2 2.8 1.4 33.2 5.8 2.5 2.1 3.5 20.3 5.3 2.1 3.2 2.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 21.3 0.0 0.0 0.7 0.0 0.0 0.0 12.2 0.1 18.8 0.2 0.0 0.2 9.6 45.7 0.0 0.0 0.0 0.0 0.0 0.2 13.1 0.0 2.1 19.4 21.1 0.1 0.1 16.9 0.0 26.0 0.0 0.0 0.1 0.2 0.3 0.2 0.2 0.1 19.2 0.1 0.0 0.1 0.3 0.0 24.2 11.8 14.9 0.1 24.4 0.0 1.8 4.6 20.3 3.0 5.0 2.2 1.8 2.3 2.5 3.5 2.1 2.1 2.3 18.1 2.1 5.3 1.8 3.2 2.0 4.9 7.8 2.0 5.1 4.6 4.1 7.6 1.3 6.0 7.3 WASF2 "SCAR2, WAVE2" ENSG00000158195 "WAS protein family member 2" Q9Y6W5 1 27404226-27490158 "Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022632, HPA045288" Enhanced Approved "Plasma membrane,Cytosol" 470000 "Plasma membrane" Cytosol "CAB022632: , HPA045288: " "unprognostic (9.58e-2)" "unprognostic (8.93e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (4.40e-1)" "unprognostic (2.27e-2)" "prognostic unfavourable (5.29e-8)" "unprognostic (3.94e-2)" "unprognostic (4.14e-2)" "prognostic unfavourable (8.48e-4)" "unprognostic (7.60e-3)" "unprognostic (1.10e-1)" "unprognostic (9.15e-3)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.26e-2)" 36.9 23.3 22.0 23.8 30.0 30.0 28.6 13.6 24.0 31.9 28.8 33.2 13.2 15.7 36.9 16.0 55.3 28.8 22.3 20.5 22.8 13.1 20.2 11.6 29.4 31.1 32.5 12.6 38.8 24.0 21.3 14.8 29.7 23.2 26.4 23.3 22.2 25.6 26.1 11.4 35.1 26.7 42.9 31.5 34.0 26.4 20.7 32.7 32.3 21.6 22.2 35.2 39.1 30.3 18.9 21.8 36.9 38.4 8.5 12.9 16.8 24.1 11.6 26.9 24.4 19.6 25.7 15.6 19.7 18.4 21.8 19.7 10.0 26.1 16.8 19.1 30.8 19.4 21.7 32.4 26.2 23.5 13.6 36.6 20.5 11.8 26.5 29.2 21.2 23.5 35.4 23.7 44.4 27.3 29.1 8.7 29.5 8.7 21.7 13.5 21.7 17.8 45.5 33.1 17.1 15.6 13.7 13.4 14.8 34.4 15.4 25.8 12.8 17.8 35.7 18.1 18.8 37.5 15.5 18.0 23.7 22.5 21.4 36.3 20.3 14.8 23.3 18.5 12.9 29.1 10.5 14.1 10.2 8.9 14.8 18.9 10.7 8.1 36.9 8.5 38.4 21.8 10.2 16.8 22.0 30.0 13.6 24.0 22.8 13.1 32.5 12.6 23.2 32.7 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavourable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 10.9 5.3 9.1 10.6 37.1 20.8 7.4 12.9 27.4 19.2 20.6 12.4 16.5 9.7 8.1 19.2 12.0 13.1 10.9 19.0 9.2 9.5 6.9 10.7 12.4 25.9 11.7 12.0 21.3 13.7 21.0 13.3 14.5 11.2 9.8 23.1 7.8 6.4 19.2 7.4 25.2 9.8 13.2 5.7 13.2 12.7 3.1 9.8 12.0 11.2 17.2 13.8 8.1 21.3 9.8 8.3 27.8 10.6 10.1 20.1 8.3 21.6 21.6 3.9 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavourable (1.35e-5)" "prognostic favourable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.1 12.0 9.8 11.1 25.5 22.6 5.9 13.1 21.6 15.5 14.9 7.3 10.9 9.2 8.9 19.3 10.1 10.9 6.0 15.6 8.5 9.1 9.5 14.9 5.6 27.1 9.5 11.8 21.3 14.6 16.8 12.6 15.9 15.1 7.3 19.0 5.8 6.3 16.4 7.1 1.8 7.9 14.4 4.7 11.5 17.5 4.8 10.8 15.2 7.7 18.4 10.4 9.6 26.7 8.1 8.7 21.3 8.7 10.3 15.9 9.1 11.4 22.9 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "Wiskott-Aldrich syndrome like" O00401 7 123681935-123749067 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 44.3;U-2197: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favourable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 17.9 19.3 25.6 11.6 29.5 3.8 20.7 21.0 39.3 23.7 31.2 17.0 8.9 27.4 21.0 14.6 22.5 14.8 21.7 15.4 35.2 22.5 33.3 34.5 15.3 5.5 18.8 23.0 27.8 21.9 36.7 16.9 25.4 28.6 19.9 28.8 18.0 16.9 19.5 21.6 14.4 30.2 18.2 16.6 12.1 22.0 17.3 15.0 10.0 26.7 12.0 9.7 23.7 21.1 4.6 4.5 4.9 6.2 6.2 4.3 1.5 10.7 7.9 8.8 7.5 13.8 14.4 11.4 7.5 12.5 5.5 7.2 6.5 13.6 1.1 6.0 11.3 8.1 16.2 8.2 8.6 1.8 6.4 0.9 6.6 7.0 15.1 1.4 0.9 11.5 15.5 8.2 14.0 9.5 4.8 2.1 13.2 6.5 1.8 1.9 16.4 7.3 1.1 7.1 2.4 11.7 44.3 10.8 15.9 10.3 31.1 20.1 6.0 1.4 10.8 14.9 4.2 42.0 7.3 2.4 0.8 2.4 12.9 1.2 11.9 4.9 4.1 1.8 4.3 4.1 3.6 4.6 2.8 2.6 3.5 3.2 3.6 3.8 1.8 6.2 6.2 4.5 1.4 1.5 25.6 29.5 21.0 39.3 35.2 22.5 18.8 23.0 28.6 15.0 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favourable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favourable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.2 24.3 19.7 14.9 10.4 28.2 10.4 13.1 8.9 15.9 8.8 14.1 15.9 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.7 8.5 21.2 21.3 16.1 13.3 10.3 20.2 8.6 11.0 17.7 13.3 10.2 9.5 5.5 6.4 20.6 19.1 5.6 9.2 10.0 1.7 7.0 5.7 5.8 11.7 23.6 9.5 15.0 10.0 10.4 11.2 9.2 20.5 10.7 6.5 14.1 16.4 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Approved Nucleoplasm,Cytosol 870000 "Nucleoplasm, Cytosol" "HPA065682: , HPA068819: " "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 37.4 50.4 59.5 22.8 79.8 29.9 22.6 62.5 119.3 24.3 20.4 75.2 15.0 27.0 22.9 19.7 25.7 36.6 26.4 51.6 58.7 56.4 32.0 48.7 31.9 22.3 62.1 56.2 41.8 35.7 36.8 24.5 23.0 110.8 32.2 17.2 40.3 55.5 33.6 47.1 28.2 25.9 23.0 55.6 30.5 27.4 28.5 44.3 10.6 26.8 15.7 21.5 24.5 18.3 14.9 11.1 63.5 25.5 11.2 15.1 16.8 26.5 30.9 11.7 13.8 24.0 24.0 15.3 8.6 27.2 19.9 24.8 15.4 27.2 13.8 22.1 12.2 16.0 12.2 26.1 18.4 10.1 23.5 25.4 18.8 24.9 49.5 10.4 43.5 26.5 25.0 23.5 33.1 38.6 17.0 41.8 16.0 27.1 21.6 21.6 9.9 20.5 14.9 23.3 25.6 29.0 16.5 19.6 30.6 15.1 26.3 41.9 35.4 26.2 22.1 20.4 18.0 19.7 13.6 38.7 27.7 10.3 57.1 9.8 14.4 42.8 16.7 56.0 11.6 20.5 12.9 14.9 13.0 11.7 11.1 12.0 12.6 10.3 63.5 11.2 25.5 8.6 15.1 16.8 59.5 79.8 62.5 119.3 58.7 56.4 62.1 56.2 110.8 44.3 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: " "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favourable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.8 5.9 16.5 10.6 10.8 16.5 10.1 20.2 14.3 15.9 12.3 9.3 9.5 12.7 8.1 14.1 12.6 6.2 10.0 20.5 13.1 8.7 17.9 5.7 9.4 16.6 11.1 11.7 13.5 15.4 11.6 16.5 13.4 9.5 5.6 16.6 7.5 16.0 12.2 10.0 4.9 15.0 10.2 5.0 14.5 8.8 3.8 9.1 6.4 7.0 9.5 5.7 17.5 11.7 10.0 9.2 13.7 11.6 3.7 4.1 8.9 12.3 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 WDCP "C2orf44, FLJ21945" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029340-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavourable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 11.7 9.6 8.3 7.6 9.4 2.4 9.2 14.6 9.8 9.6 9.3 11.5 8.4 5.3 10.7 8.0 7.4 7.2 5.6 6.8 7.1 6.9 7.5 8.9 5.4 12.4 8.3 4.8 11.6 7.7 11.2 9.4 8.5 8.7 8.7 6.2 7.8 7.1 12.9 13.8 5.9 7.5 7.4 8.0 9.4 7.0 12.5 9.2 17.9 8.9 5.5 13.7 9.4 6.4 4.9 4.3 1.5 3.8 5.0 7.8 4.2 7.2 11.1 12.3 8.5 8.5 6.8 4.4 8.8 4.7 9.2 8.8 10.1 3.3 19.0 3.8 4.5 5.3 17.4 6.0 9.6 11.4 10.0 11.5 5.5 10.5 5.8 10.5 8.0 4.0 4.7 9.4 4.7 8.7 16.0 5.3 9.6 3.3 13.7 6.3 14.8 8.7 15.1 20.8 7.6 4.3 3.6 9.5 13.1 4.3 4.2 5.4 3.3 4.7 8.2 7.4 8.2 4.4 8.0 8.7 10.9 26.8 4.8 11.3 5.7 0.0 2.4 1.5 7.5 3.8 7.8 4.9 5.0 5.5 4.3 4.7 6.8 7.5 0.7 5.0 2.6 1.6 7.1 4.2 8.3 9.4 14.6 9.8 7.1 6.9 8.3 4.8 8.7 9.2 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" Cytosol "Nucleoli, Plasma membrane" "HPA042734: , HPA048572: " "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favourable (3.64e-5)" "prognostic unfavourable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.3 4.4 8.0 4.4 14.2 11.1 5.0 6.1 6.5 6.4 5.8 4.9 5.3 0.0 6.4 10.2 3.2 8.5 6.7 8.2 4.4 2.7 4.0 4.8 2.9 5.3 3.1 7.6 8.1 6.1 8.4 8.5 20.4 4.1 19.6 11.8 4.6 3.0 0.7 4.1 2.2 4.5 6.4 0.9 11.1 8.5 9.4 4.4 7.6 8.4 4.2 4.3 7.8 31.0 8.5 8.5 4.7 7.7 0.0 0.0 0.0 5.8 2.7 9.3 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in some" "Daudi: 29.4;HDLM-2: 26.9;HL-60: 10.2;THP-1: 9.1;U-698: 12.5;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 3.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 12.1 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 WDR1 ENSG00000071127 "WD repeat domain 1" O75083 4 10074339-10116949 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020804, HPA036434, HPA070293" Approved Supported "Plasma membrane,Cell Junctions" 280000000 "Plasma membrane, Cell Junctions" "CAB020804: , HPA036434: , HPA070293: " "unprognostic (1.35e-1)" "unprognostic (6.64e-2)" "unprognostic (5.31e-2)" "unprognostic (1.32e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (2.63e-3)" "unprognostic (6.83e-3)" "unprognostic (1.69e-1)" "unprognostic (9.00e-3)" "unprognostic (2.52e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.73e-5)" "unprognostic (1.11e-1)" "unprognostic (3.56e-1)" "unprognostic (3.46e-2)" "unprognostic (4.83e-3)" 40.2 23.7 19.0 49.4 18.1 33.5 35.0 8.1 22.6 53.5 53.3 25.8 38.4 39.2 80.9 54.2 59.6 54.9 57.6 49.5 19.6 20.5 55.4 41.3 41.7 57.4 22.1 17.1 51.5 22.2 19.5 18.6 40.4 26.8 47.1 38.3 37.6 38.5 49.1 32.1 31.6 54.5 88.0 19.5 46.9 41.1 38.0 16.0 74.5 49.9 36.4 50.2 69.6 41.5 22.9 40.2 54.2 61.2 32.5 55.6 64.1 30.2 30.3 27.2 22.8 20.6 34.3 43.0 76.4 70.5 69.1 54.3 36.2 38.2 21.0 24.9 91.2 19.8 29.5 55.9 73.9 32.8 10.1 60.0 31.1 25.7 48.4 19.0 69.6 32.9 28.7 70.1 35.1 74.2 17.9 35.0 66.9 17.3 83.8 26.8 32.2 30.5 39.6 24.9 17.8 43.1 48.2 9.2 10.0 32.6 18.1 31.4 15.2 20.7 111.6 53.3 22.4 44.1 66.9 22.1 35.4 27.6 56.4 28.9 66.1 37.1 29.0 54.2 48.3 51.7 37.4 22.9 40.6 48.2 37.8 16.9 41.7 44.4 54.1 32.5 61.2 40.2 55.6 64.1 19.0 18.1 8.1 22.6 19.6 20.5 22.1 17.1 26.8 16.0 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851175-120909524 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favourable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 18.6 21.9 10.6 17.4 17.2 6.2 16.4 17.1 18.9 17.3 15.5 21.5 18.0 14.5 22.6 15.9 19.6 21.0 15.7 10.6 11.5 12.7 25.2 19.8 14.9 17.0 13.9 10.6 19.4 16.1 33.9 17.7 18.4 26.0 16.5 17.3 19.0 20.3 21.5 8.5 14.8 19.9 17.5 20.0 19.7 18.9 12.8 12.9 20.6 24.0 11.7 19.8 22.0 17.3 6.4 6.8 15.5 16.3 3.9 3.3 3.4 11.9 11.8 11.6 19.1 16.3 20.8 8.1 11.6 23.2 12.9 16.4 6.6 13.4 8.7 6.0 17.1 11.8 13.4 16.0 16.0 11.8 11.5 9.4 9.5 6.3 15.4 13.0 10.9 17.0 12.8 11.7 19.1 24.3 7.4 10.9 13.7 5.1 8.1 5.1 5.6 7.5 3.3 19.6 7.5 15.0 10.0 5.8 10.3 10.0 11.2 30.6 8.2 8.4 17.9 8.9 5.4 1.3 10.7 5.5 3.4 10.8 12.7 10.8 4.6 15.5 5.9 2.5 3.3 8.0 2.6 6.4 2.3 3.1 6.8 3.8 2.4 2.5 0.5 3.9 16.3 1.6 2.9 3.4 10.6 17.2 17.1 18.9 11.5 12.7 13.9 10.6 26.0 12.9 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavourable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.3 4.6 5.3 10.0 10.0 8.6 9.7 6.6 5.3 8.2 8.0 11.6 6.1 7.9 6.1 5.3 5.5 14.3 10.6 13.2 4.0 8.9 13.4 7.4 13.7 6.5 17.4 8.2 7.8 7.7 9.7 19.4 8.5 20.9 5.2 9.0 5.0 11.9 10.2 12.1 11.7 8.7 8.3 12.4 9.0 5.2 9.3 8.2 5.2 6.8 8.1 4.0 11.5 6.8 7.4 6.0 6.1 7.3 6.8 10.3 13.3 7.3 11.9 7.3 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 WDR13 ENSG00000101940 "WD repeat domain 13" Q9H1Z4 X 48590042-48608867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000913 Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA000913: AB_1858795" "unprognostic (5.03e-2)" "unprognostic (6.53e-3)" "unprognostic (3.65e-3)" "unprognostic (2.10e-3)" "unprognostic (3.50e-1)" "unprognostic (1.54e-3)" "unprognostic (3.54e-2)" "unprognostic (6.76e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.58e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-1)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (4.32e-2)" 24.5 30.4 39.9 13.9 36.9 15.7 19.1 14.4 33.9 18.6 25.5 17.6 41.5 23.0 26.0 41.2 23.1 30.8 21.1 49.8 30.2 18.9 24.2 50.2 19.3 11.1 20.0 35.8 35.0 74.7 21.8 24.4 23.9 17.0 19.6 14.4 16.5 30.4 35.8 48.5 21.7 22.0 20.2 17.5 17.4 22.7 11.0 20.5 8.6 21.9 21.1 10.5 17.9 19.7 16.8 21.1 29.2 28.2 17.3 13.8 15.9 14.9 22.0 11.0 34.0 15.2 22.4 8.4 10.4 19.0 12.1 11.1 13.0 24.1 10.4 10.0 21.2 12.9 5.5 22.7 4.3 12.3 9.7 7.1 25.9 23.6 34.6 6.1 19.4 21.1 32.5 17.1 31.5 16.5 7.0 13.3 16.7 21.5 8.4 10.7 7.9 17.3 8.1 11.7 18.8 21.3 11.9 12.8 15.9 11.7 24.5 24.0 15.6 11.9 27.3 12.6 18.7 19.8 9.9 15.5 5.7 3.8 18.6 9.2 17.3 29.2 23.1 12.7 11.9 24.7 9.5 16.8 12.6 11.3 21.1 13.4 10.0 11.4 16.0 17.3 28.2 13.3 13.8 15.9 39.9 36.9 14.4 33.9 30.2 18.9 20.0 35.8 17.0 20.5 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favourable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 8.8 11.6 10.9 9.8 11.3 9.3 9.2 18.9 17.6 7.6 7.8 8.2 6.5 12.1 10.2 10.2 9.4 9.3 8.5 9.9 9.5 7.8 9.0 15.7 15.3 17.7 8.7 11.1 12.8 14.5 17.0 11.9 9.2 8.8 10.3 3.6 8.8 16.2 8.8 16.9 13.5 10.2 10.0 10.6 13.3 10.5 17.6 9.5 17.9 11.8 7.9 6.5 9.2 7.8 7.1 7.7 6.5 10.3 4.3 10.7 7.1 4.4 10.3 4.8 6.6 4.6 3.3 8.4 5.6 5.0 7.0 6.1 11.2 6.6 6.9 9.8 2.5 7.0 4.6 5.5 1.5 11.6 14.6 4.7 13.8 4.3 7.3 5.7 7.4 5.7 3.7 5.0 4.2 3.8 9.2 7.8 2.6 16.3 10.0 4.2 7.3 8.1 14.9 3.9 12.7 2.3 3.1 11.9 5.4 6.3 11.0 6.2 10.0 5.8 5.6 5.2 5.4 5.6 5.4 16.8 15.2 11.3 3.3 5.7 7.1 6.5 7.5 4.0 10.7 4.5 8.7 7.1 6.9 7.8 7.7 6.4 8.2 7.7 1.8 4.3 10.3 6.2 8.9 7.1 10.9 11.3 18.9 17.6 9.5 7.8 8.7 11.1 8.8 9.5 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028539: AB_10669752, HPA061094: " "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavourable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.8 12.9 14.7 21.1 6.6 10.5 9.9 18.6 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: , HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavourable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavourable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 12.5 13.5 7.7 10.6 10.7 3.3 12.2 8.4 9.7 10.5 7.7 6.8 9.7 7.3 12.6 6.5 13.3 10.5 4.6 8.7 7.1 6.4 8.5 14.8 7.3 15.5 6.9 6.2 12.1 21.4 16.3 14.8 8.4 8.3 8.4 10.8 6.6 9.8 8.1 25.4 10.5 6.8 11.7 6.2 8.5 9.3 14.9 6.9 15.2 11.1 9.5 15.2 10.2 9.1 8.7 11.9 0.5 6.6 7.9 12.4 6.3 15.0 9.6 9.6 14.5 10.4 8.6 11.1 10.5 6.9 12.3 10.8 10.0 5.0 17.8 14.5 7.8 10.1 23.7 12.1 19.6 14.6 12.3 16.7 10.2 8.1 8.6 31.3 8.9 8.4 8.7 15.5 23.6 11.7 20.3 8.8 10.7 8.7 14.9 7.2 34.4 15.3 14.2 33.2 13.5 6.1 10.0 14.8 13.5 12.0 14.9 17.0 5.9 13.1 10.3 9.2 14.7 16.8 23.5 12.9 15.1 27.9 13.5 20.2 23.8 0.1 6.0 0.5 8.8 6.1 11.4 8.7 8.0 10.3 11.9 7.9 12.4 11.3 0.5 7.9 6.6 6.6 10.7 6.3 7.7 10.7 8.4 9.7 7.1 6.4 6.9 6.2 8.3 6.9 WDR31 FLJ35921 ENSG00000148225 "WD repeat domain 31" Q8NA23 9 113313222-113340298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019340, HPA019347" Approved Approved "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA019340: AB_1858800, HPA019347: AB_2215267" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.78e-3)" "prognostic favourable (1.85e-4)" "unprognostic (4.54e-2)" "unprognostic (1.59e-1)" "unprognostic (2.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.48e-1)" "unprognostic (2.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.64e-1)" "prognostic favourable (1.90e-9)" "unprognostic (9.11e-2)" "unprognostic (1.65e-1)" "unprognostic (7.96e-3)" "unprognostic (8.50e-2)" 2.2 6.8 4.1 1.0 8.2 1.5 4.7 1.7 5.5 3.2 2.4 4.0 8.8 1.5 4.5 3.3 2.4 6.3 2.3 8.9 3.3 4.1 5.6 3.1 2.3 0.9 3.5 2.7 3.7 3.0 16.6 11.2 1.0 4.0 3.4 2.2 5.8 10.2 7.5 1.3 2.5 1.1 2.2 3.6 0.8 2.1 7.3 1.7 3.8 7.1 1.4 0.8 3.0 2.0 1.6 0.9 4.4 1.0 2.3 1.4 0.8 5.5 4.2 1.5 3.0 5.0 5.9 1.4 1.4 2.7 1.4 1.7 0.7 3.6 2.1 1.0 2.0 3.6 1.2 2.7 2.7 3.3 0.3 1.7 2.2 0.7 5.7 0.9 0.3 3.1 3.6 5.8 5.1 1.1 4.5 1.9 1.5 3.8 2.4 1.4 0.9 5.2 2.1 1.2 2.5 3.7 1.2 3.6 2.7 6.7 1.2 3.2 8.7 0.9 0.6 2.0 2.2 5.0 1.5 4.0 3.8 0.5 3.0 1.4 1.9 4.4 1.0 1.0 0.9 0.6 0.8 0.9 1.0 0.8 0.8 1.6 1.4 1.3 3.4 2.3 0.7 0.9 0.7 0.8 4.1 8.2 1.7 5.5 3.3 4.1 3.5 2.7 4.0 1.7 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701022-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavourable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.8 19.2 18.1 22.5 22.5 18.8 21.7 51.4 24.3 20.9 19.8 22.0 22.8 18.2 32.2 19.0 20.6 18.6 17.9 16.8 17.7 16.5 22.3 32.3 18.5 25.0 19.4 14.5 29.2 21.8 26.4 41.8 20.9 22.0 21.9 19.5 24.4 25.3 17.4 22.0 27.8 21.3 21.0 22.2 28.1 18.0 24.5 20.8 39.5 25.2 16.6 30.5 21.5 22.4 24.4 21.6 26.7 18.3 25.9 26.3 14.4 18.2 10.3 18.1 14.6 10.8 11.2 18.7 16.8 13.4 17.7 16.8 24.0 14.1 23.2 18.6 11.0 14.9 20.4 14.1 23.3 21.2 12.1 22.3 13.1 25.6 12.1 26.8 16.7 10.9 15.0 16.9 14.5 15.0 18.5 20.8 12.4 11.5 27.8 19.7 21.9 11.8 19.5 18.3 18.3 10.1 23.8 16.9 13.2 15.0 13.9 11.8 10.7 15.7 14.0 14.0 20.5 15.6 14.3 20.4 31.0 44.2 11.4 10.8 12.9 21.2 16.7 26.7 21.5 18.3 21.9 24.4 21.9 20.6 21.6 23.0 23.3 22.1 11.4 25.9 18.2 15.8 26.3 14.4 18.1 22.5 51.4 24.3 17.7 16.5 19.4 14.5 22.0 20.8 WDR4 "TRM82, TRMT82" ENSG00000160193 "WD repeat domain 4" P57081 21 42843094-42879568 "Predicted intracellular proteins" "DNA damage, tRNA processing" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017381 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017381: AB_1858807" "unprognostic (3.47e-2)" "unprognostic (2.15e-2)" "unprognostic (4.32e-2)" "unprognostic (2.13e-2)" "unprognostic (2.95e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (5.48e-7)" "unprognostic (2.85e-3)" "unprognostic (5.37e-2)" "unprognostic (2.27e-2)" "unprognostic (4.25e-1)" "unprognostic (4.78e-2)" "unprognostic (2.65e-2)" "unprognostic (1.74e-3)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.46e-2)" 9.1 9.3 8.4 14.2 8.4 12.1 7.5 9.3 11.1 7.6 7.2 6.7 6.5 10.7 12.5 5.1 17.4 8.2 8.1 6.1 8.3 4.9 7.3 12.2 7.8 18.2 8.9 8.4 9.7 22.0 6.9 8.4 8.9 8.5 7.0 7.0 6.8 11.8 8.4 13.1 10.2 7.5 7.4 6.6 11.7 7.3 10.9 9.6 10.1 9.3 11.3 17.0 8.5 11.1 7.5 9.1 0.2 8.8 4.4 5.5 4.4 14.4 20.4 5.5 7.8 3.3 3.6 13.2 8.4 3.0 7.1 4.6 20.4 7.5 24.2 4.9 6.0 8.1 18.9 10.7 5.1 7.8 18.0 24.3 21.3 17.2 5.8 14.9 6.1 2.0 4.7 9.7 7.1 9.3 29.3 9.0 6.2 12.1 15.4 8.5 13.7 20.0 16.9 3.3 23.9 5.4 8.9 12.9 8.4 8.8 13.1 4.2 8.6 11.6 6.8 11.1 7.4 5.1 16.8 12.4 8.6 19.6 5.4 23.8 13.0 0.0 5.4 0.2 3.5 8.8 4.7 7.5 4.7 4.3 9.1 7.2 4.8 4.9 0.0 4.4 5.0 4.4 5.5 4.4 8.4 8.4 9.3 11.1 8.3 4.9 8.9 8.4 8.5 9.6 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavourable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.2 12.8 18.8 13.1 21.7 17.3 16.2 19.5 23.3 15.1 12.6 17.7 9.4 9.4 13.3 13.3 20.6 17.5 12.2 16.9 18.8 17.5 15.8 14.8 14.0 13.9 21.4 20.0 9.4 21.3 14.4 15.8 11.4 28.9 12.0 13.8 11.5 13.7 12.0 19.7 12.8 11.2 19.2 23.3 12.5 11.5 26.6 19.8 8.1 23.1 12.9 16.6 13.5 13.6 8.9 24.8 24.0 18.1 15.8 5.7 7.3 6.7 11.6 16.4 23.9 17.1 24.4 12.9 21.5 23.3 10.2 18.9 10.6 11.4 20.5 9.9 20.3 8.8 12.3 29.4 11.0 24.7 14.1 8.2 13.6 9.1 26.2 17.3 20.4 15.5 37.9 11.5 25.2 16.3 8.1 22.4 16.5 14.5 9.1 11.1 6.1 4.6 21.9 22.4 14.4 11.1 5.7 9.6 11.8 18.4 11.6 17.9 11.5 21.7 14.2 13.8 11.2 7.6 15.7 20.4 16.5 36.7 18.9 7.8 23.0 11.4 14.0 24.0 5.7 16.3 5.5 8.9 3.4 5.1 24.8 5.4 2.3 4.2 6.8 15.8 18.1 11.1 2.6 7.3 18.8 21.7 19.5 23.3 18.8 17.5 21.4 20.0 28.9 19.8 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavourable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 28.7 19.8 16.7 15.2 15.5 14.4 19.9 21.5 24.3 35.3 30.3 23.6 15.4 8.3 13.5 19.2 16.0 16.0 18.3 32.5 5.2 31.9 16.8 11.3 18.3 20.4 13.2 12.9 15.5 19.3 18.8 17.7 28.4 12.5 7.8 19.6 18.5 9.4 9.1 21.3 26.4 10.3 30.1 8.5 19.1 28.9 21.8 32.1 21.3 21.8 25.1 25.9 10.1 19.3 36.7 28.8 25.8 38.4 20.1 8.6 12.2 23.8 13.4 26.8 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favourable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.1 7.2 17.7 5.1 24.0 10.1 6.4 19.9 42.6 8.0 5.6 9.5 3.4 3.7 9.4 5.8 13.7 8.4 7.1 7.5 20.1 20.6 7.5 3.6 6.7 5.0 14.8 21.0 7.6 5.6 10.4 4.4 6.3 24.8 7.3 5.4 5.8 4.7 7.2 14.2 20.3 4.1 9.8 12.7 5.3 5.6 19.9 11.3 5.5 6.1 4.8 7.0 6.8 6.3 3.5 5.6 18.8 5.0 2.2 4.6 2.0 10.6 3.2 6.2 7.8 12.4 10.9 3.4 12.2 7.5 8.2 9.2 3.2 1.6 4.8 6.6 11.6 12.0 8.8 5.3 10.8 8.9 4.9 4.0 7.2 3.5 7.1 6.2 6.0 6.7 8.9 12.7 6.2 9.6 2.4 6.8 13.8 6.3 6.0 4.9 2.6 6.5 8.5 15.9 2.6 13.6 9.2 11.1 10.1 10.7 5.7 8.5 2.6 6.4 16.4 10.9 5.0 19.0 10.0 4.4 3.6 3.9 12.7 6.2 16.2 11.4 4.7 5.8 3.2 5.0 2.8 2.0 2.9 3.4 5.1 3.5 2.6 2.2 18.8 2.2 4.5 5.6 4.6 2.0 17.7 24.0 19.9 32.4 20.1 20.6 14.8 21.0 24.8 11.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Cell line enhanced" "Detected in some" "AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: " "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.8 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavourable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 18.7 4.0 7.3 6.5 7.4 6.5 11.6 9.9 7.7 11.3 10.7 11.0 10.0 8.9 33.4 6.0 11.0 9.1 8.5 14.2 14.0 7.9 9.0 9.9 7.2 9.3 12.6 7.4 5.3 12.6 10.0 11.0 8.8 8.8 17.3 8.6 17.5 10.7 13.0 9.9 11.8 12.9 12.5 19.0 6.2 6.6 7.2 7.8 6.9 10.3 14.5 26.4 11.8 8.1 9.6 9.1 10.7 19.3 14.7 29.4 26.7 6.3 16.3 9.6 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 56.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 4.8 6.3 9.4 5.4 17.0 5.0 4.8 8.4 15.4 7.0 3.9 6.0 10.5 3.0 7.0 7.8 3.1 56.8 7.2 3.4 9.9 11.6 7.9 1.4 8.1 8.6 4.8 13.0 8.4 5.4 21.3 16.0 5.4 7.8 5.0 3.7 10.5 3.9 9.0 1.5 3.5 3.9 6.8 3.5 7.7 5.7 27.6 3.7 20.6 5.8 2.5 8.9 6.2 4.0 12.6 23.1 2.3 5.3 13.2 18.7 10.0 15.9 29.6 14.5 12.6 5.3 9.9 4.5 8.1 16.8 21.5 19.9 2.5 12.6 14.2 8.5 9.1 13.7 10.2 36.5 18.8 10.7 6.3 6.9 16.3 1.6 5.4 10.9 5.7 4.4 10.4 21.7 11.3 11.1 2.8 16.8 11.8 24.7 17.2 11.5 11.1 11.2 14.8 16.4 29.7 18.8 8.0 25.3 19.7 6.4 5.8 9.4 9.4 5.2 5.5 11.0 19.4 11.8 18.1 18.4 9.2 3.6 32.5 6.7 8.0 2.3 4.2 0.3 16.2 5.3 16.3 12.6 18.7 17.4 14.1 11.1 13.2 12.8 0.3 13.2 4.5 23.1 17.5 10.0 9.4 17.0 8.4 15.4 9.9 11.6 4.8 13.0 7.8 3.7 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: , HPA075133: " "prognostic unfavourable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 17.9 12.4 7.6 17.8 8.8 18.1 12.9 13.0 12.7 9.5 16.6 11.4 16.9 14.9 12.0 11.0 18.8 10.9 20.2 9.6 7.7 9.1 15.3 29.9 12.7 15.0 12.6 8.5 12.0 16.2 11.4 13.2 13.9 10.6 12.8 17.5 8.9 16.7 14.8 18.2 15.8 20.8 11.1 8.9 18.8 14.9 8.0 8.5 12.5 12.0 14.0 21.4 13.5 11.0 10.4 11.3 10.4 18.9 11.3 14.3 10.2 7.8 10.8 5.3 21.0 8.2 6.6 14.7 7.8 9.6 8.4 9.6 18.5 10.8 7.4 10.5 10.2 9.8 7.1 13.7 6.5 6.8 5.8 8.4 8.8 7.5 7.9 8.8 15.9 7.8 8.0 11.5 6.1 8.9 5.8 5.8 9.2 11.2 8.1 7.9 5.5 9.5 6.9 7.6 6.9 9.9 11.9 5.2 6.9 10.7 31.5 11.9 22.3 9.4 7.9 11.0 5.7 12.5 10.6 9.7 7.5 5.8 14.2 11.7 6.4 6.9 11.7 8.6 13.9 18.9 14.3 10.4 12.9 11.8 11.3 8.8 10.5 10.7 10.4 11.3 15.4 8.4 14.1 10.2 7.6 8.8 13.0 12.7 7.7 9.1 12.6 8.5 10.6 8.5 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favourable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 15.8 36.7 21.5 26.1 23.5 14.9 19.7 29.9 29.9 32.7 31.0 30.8 56.4 27.5 39.0 37.0 18.7 33.1 32.6 20.4 20.1 20.4 26.0 22.0 21.1 28.2 22.8 26.9 60.9 46.0 56.7 55.8 24.3 22.1 39.0 22.1 34.3 33.4 54.4 23.9 26.6 28.3 40.8 17.5 29.1 24.7 23.7 22.1 26.9 50.7 20.3 25.1 31.2 24.6 12.3 14.4 10.3 12.9 11.7 18.9 12.0 17.4 24.1 39.9 33.8 26.8 21.9 27.0 26.1 21.6 29.5 24.0 21.4 25.3 28.1 16.7 41.6 20.0 31.8 36.5 21.1 22.3 21.1 26.6 59.1 28.1 27.2 27.4 12.0 39.3 26.3 27.2 20.6 21.5 15.1 30.1 26.7 34.7 31.8 31.3 35.4 22.4 18.7 17.1 17.7 35.0 51.9 19.4 36.4 19.6 16.1 11.3 28.0 22.0 28.7 22.0 35.4 21.3 34.6 53.2 22.7 24.4 29.8 35.2 15.7 3.7 9.1 10.3 16.9 12.9 18.9 12.0 12.5 12.9 11.3 12.3 14.7 10.9 3.4 11.7 6.5 14.4 10.5 12.0 21.5 23.5 29.9 29.9 20.1 20.4 22.8 26.9 22.1 22.1 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299794 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favourable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 23.8 34.3 23.5 17.2 31.2 29.6 34.5 25.2 32.1 24.3 22.0 27.6 22.7 20.3 24.2 69.4 25.9 27.4 19.6 23.1 23.7 28.2 34.2 28.2 22.4 18.7 26.8 23.1 20.7 30.7 22.4 37.7 27.7 30.8 27.4 25.7 24.9 28.1 23.1 26.3 29.9 18.5 23.6 27.8 18.6 20.9 38.5 20.9 26.9 32.5 30.1 24.6 19.1 20.3 21.9 45.2 11.1 32.4 22.7 25.2 28.7 9.2 23.6 18.6 19.2 18.4 17.0 14.1 14.1 15.9 18.0 17.7 22.5 16.9 17.8 17.7 16.1 19.7 39.5 17.1 14.9 11.5 31.0 14.3 21.8 21.7 16.1 22.1 16.1 13.1 13.2 7.0 6.0 20.3 26.2 20.0 23.5 28.9 19.3 21.5 13.7 19.0 17.9 14.1 21.7 20.9 28.8 26.0 14.2 19.3 21.8 77.1 14.0 30.5 12.1 14.1 16.7 10.1 24.3 17.2 25.9 25.2 20.5 35.9 28.1 11.1 31.6 10.5 21.5 32.4 23.2 21.9 21.6 22.3 45.2 16.9 23.0 25.2 2.6 22.7 26.3 24.2 23.5 28.7 23.5 31.2 25.2 32.1 23.7 28.2 26.8 23.1 30.8 20.9 WDR62 "C19orf14, DKFZP434J046, FLJ33298, MCPH2" ENSG00000075702 "WD repeat domain 62" O43379 19 36054881-36105106 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 25.6;testis: 88.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 9 "monocytes: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043255, HPA043639" Enhanced Enhanced "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA043255: , HPA043639: " "unprognostic (1.77e-1)" "unprognostic (2.79e-3)" "unprognostic (3.16e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-1)" "unprognostic (4.22e-3)" "unprognostic (1.78e-4)" "unprognostic (2.00e-1)" "unprognostic (4.00e-2)" "unprognostic (5.82e-3)" "unprognostic (4.72e-2)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.73e-3)" "unprognostic (2.72e-1)" "unprognostic (1.50e-1)" "unprognostic (2.67e-1)" 0.5 0.2 0.2 3.3 0.4 4.3 0.6 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.4 0.8 1.0 0.2 0.5 5.5 0.5 0.2 0.5 0.3 0.5 1.4 0.2 0.2 0.4 0.2 0.0 0.3 0.7 0.4 0.3 0.3 0.3 0.6 0.2 25.6 1.4 0.7 0.4 0.5 1.1 0.3 88.4 0.3 10.3 0.2 1.3 3.0 0.3 0.7 0.1 0.1 0.0 3.7 0.0 0.3 0.2 10.7 21.5 8.4 7.7 0.5 0.7 4.2 9.3 4.4 13.0 11.7 11.2 4.2 14.0 6.4 4.9 3.7 7.8 3.0 7.7 8.8 5.5 9.5 12.2 7.2 0.1 10.3 14.3 0.2 0.2 9.8 3.9 3.2 12.2 19.2 6.5 13.4 18.0 6.2 4.6 4.5 15.1 7.8 5.6 1.9 4.9 9.4 4.8 7.6 8.7 1.5 5.9 7.5 2.6 13.0 12.8 9.8 15.4 9.3 11.6 16.6 5.2 9.9 14.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.3 0.2 0.2 0.4 0.4 0.5 0.5 0.2 0.2 0.2 0.4 0.3 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.4;hTCEpi: 20.2;hTERT-HME1: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favourable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.0 0.2 0.9 0.1 2.4 0.1 0.6 0.2 21.4 3.0 0.1 0.3 0.1 0.4 0.2 2.6 0.0 5.9 1.2 20.2 1.6 13.7 0.9 4.8 0.0 1.2 0.6 0.2 0.3 0.3 0.1 0.3 0.5 0.0 3.7 0.3 1.7 0.1 0.2 0.0 0.1 0.5 0.1 0.7 1.7 2.6 0.3 0.3 0.3 0.1 2.5 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57036606 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042074: , HPA051057: " "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favourable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 8.0 11.3 14.2 7.9 21.2 9.1 6.8 16.7 34.0 7.5 7.7 11.9 6.1 6.0 7.1 8.1 6.6 6.4 7.7 8.8 17.3 17.9 7.9 10.4 7.2 9.5 14.4 16.4 6.6 6.2 15.6 19.0 6.9 21.1 11.1 7.4 7.9 6.1 8.8 10.5 5.7 6.1 8.3 12.5 8.3 6.9 6.2 12.1 13.2 13.1 4.0 8.2 7.4 6.3 4.5 6.3 9.2 8.7 7.4 9.0 3.2 3.8 6.5 7.5 4.1 11.8 6.9 1.9 7.7 6.6 6.4 7.6 2.6 2.4 10.7 3.1 6.9 4.2 7.5 6.1 8.0 12.4 4.6 10.1 5.3 2.3 7.1 15.2 12.9 5.8 5.1 8.5 5.7 7.9 4.8 14.9 7.8 3.8 10.5 4.5 3.2 4.3 4.7 5.7 5.2 4.9 7.0 9.7 4.8 5.5 2.7 3.6 4.1 4.3 6.9 9.1 4.6 2.7 4.1 15.0 11.1 11.8 7.5 7.7 6.1 7.2 5.0 9.2 6.6 7.6 8.2 4.4 7.5 6.7 6.3 4.5 7.9 7.2 4.6 7.4 8.7 3.0 9.0 3.2 14.2 21.2 16.7 23.7 17.3 17.9 14.4 16.4 21.1 12.1 WDR70 FLJ10233 ENSG00000082068 "WD repeat domain 70" Q9NW82 5 37379212-37753435 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043064, HPA048149" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA043064: , HPA048149: " "unprognostic (2.55e-2)" "unprognostic (3.39e-3)" "unprognostic (8.87e-2)" "prognostic unfavourable (4.34e-4)" "unprognostic (4.40e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-3)" "unprognostic (1.17e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (6.34e-2)" "unprognostic (8.36e-2)" "unprognostic (9.75e-2)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "unprognostic (8.11e-2)" 17.5 13.4 15.4 21.9 22.8 16.3 17.7 30.9 21.1 15.7 16.3 12.0 16.9 10.4 19.6 13.5 15.0 15.6 10.0 13.0 15.8 8.7 11.2 11.8 13.0 18.8 16.2 13.0 18.6 13.9 12.6 14.4 14.0 17.9 13.2 14.3 7.9 15.6 14.4 36.3 17.2 13.3 16.2 18.3 14.0 13.9 12.7 16.5 13.9 13.2 8.4 15.1 17.4 15.7 12.7 15.8 12.6 17.5 11.1 10.3 7.1 9.0 6.0 12.0 15.1 12.1 12.0 16.3 11.6 10.9 13.4 11.4 9.8 9.5 14.8 6.9 11.2 8.4 9.9 10.6 15.0 14.1 12.3 11.2 18.3 6.8 9.1 18.7 10.0 11.5 8.2 10.2 14.2 11.0 13.9 6.2 8.3 6.1 12.0 9.2 8.2 10.7 13.9 29.9 15.1 6.8 10.8 10.3 9.7 38.3 8.5 8.4 11.2 11.9 12.5 12.2 11.7 11.9 9.1 8.3 12.3 17.2 8.2 16.8 10.1 6.2 14.5 12.6 8.8 17.5 9.7 11.4 10.3 9.5 15.3 12.7 10.2 9.8 3.5 11.1 15.8 15.8 9.8 7.1 15.4 22.8 30.9 21.1 15.8 8.7 16.2 13.0 17.9 16.5 WDR74 FLJ10439 ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 14.2 13.2 12.6 19.7 13.8 77.4 14.2 14.6 21.5 12.5 12.5 10.9 8.7 10.8 14.1 10.2 16.1 15.1 12.8 12.6 12.2 11.9 15.5 19.7 10.0 18.1 15.4 16.5 17.4 20.6 9.4 8.0 11.9 13.6 12.5 11.2 8.0 16.5 9.8 42.1 19.8 10.6 11.5 9.5 18.0 13.4 23.5 16.6 16.0 20.0 19.1 16.0 12.4 14.0 39.1 44.8 15.9 34.8 26.8 16.7 11.9 16.2 19.5 7.7 12.7 6.3 8.7 23.7 9.1 9.9 19.9 13.3 28.6 19.9 28.6 26.0 7.5 21.7 23.5 18.2 15.6 18.2 17.3 14.4 21.6 24.7 18.6 28.6 9.5 8.4 20.5 12.6 42.2 9.7 31.4 8.5 9.0 31.2 27.3 45.5 31.2 26.1 27.9 13.1 49.8 14.1 9.3 17.1 19.2 10.5 21.8 29.4 15.3 22.1 6.9 11.6 14.0 26.1 22.9 21.2 29.4 34.7 12.9 17.5 15.1 8.7 34.8 3.2 11.7 16.9 14.7 18.6 12.1 11.0 29.2 39.1 16.7 14.8 15.9 26.8 11.3 44.8 13.7 11.9 12.6 13.8 14.6 21.5 12.2 11.9 15.4 16.5 13.6 16.6 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826963-43868419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavourable (6.98e-4)" "prognostic unfavourable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavourable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavourable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 5.4 1.8 2.4 21.9 3.0 17.5 4.8 12.9 6.0 5.3 6.3 1.5 1.6 3.6 4.9 3.6 8.2 3.3 2.1 2.5 2.4 2.0 2.8 2.5 5.1 19.8 2.4 2.1 4.2 4.8 3.9 3.3 4.3 3.3 4.2 6.8 4.5 4.6 2.4 1.4 6.3 5.8 7.0 3.9 6.5 4.8 6.7 2.1 37.2 2.9 7.1 21.9 5.3 5.5 3.2 1.6 0.4 0.8 5.7 8.3 2.6 11.0 5.6 13.5 10.3 1.5 3.6 3.6 18.6 11.1 20.4 25.7 7.1 5.8 16.3 8.2 8.6 16.0 13.8 6.6 17.8 25.4 8.2 20.1 18.0 2.3 0.8 20.3 9.0 1.1 1.0 11.2 2.6 6.5 15.1 28.6 13.9 3.8 19.7 4.8 4.8 5.9 21.1 23.2 10.3 3.8 11.4 10.4 10.3 11.7 7.4 2.3 11.5 9.9 2.9 18.8 8.9 21.0 18.8 14.2 35.2 41.6 13.5 18.1 10.3 0.0 0.8 0.4 5.1 0.5 5.4 2.5 6.4 4.4 1.3 3.2 5.2 4.1 0.0 5.7 0.2 1.6 8.3 2.6 2.4 3.0 12.9 6.0 2.4 2.0 2.4 2.1 3.3 2.1 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 68.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favourable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 11.2 16.5 10.0 17.3 16.2 5.9 9.7 8.5 18.1 9.8 10.9 14.3 5.7 9.5 13.9 15.7 19.0 68.6 15.7 16.6 9.9 10.8 13.6 19.2 9.9 16.8 12.1 9.6 14.6 14.0 15.1 11.7 12.1 15.8 12.6 16.6 10.3 16.4 13.4 27.2 8.9 11.1 13.0 7.9 16.5 14.5 12.9 9.3 19.3 9.9 23.2 22.7 19.1 11.0 24.9 25.7 6.2 17.7 26.7 16.1 11.9 20.4 18.0 17.2 14.1 10.4 6.1 23.9 15.5 8.3 23.8 15.7 26.4 7.7 35.0 15.2 13.2 14.9 31.0 29.8 28.8 13.9 24.3 20.8 21.0 37.9 11.7 21.3 35.6 7.4 21.3 23.3 15.0 15.8 27.8 9.3 23.0 25.9 27.3 11.2 33.8 30.2 27.4 27.1 13.4 21.1 36.4 14.2 10.3 13.6 17.2 12.3 13.8 14.7 11.5 13.2 26.6 25.6 32.9 7.7 9.6 31.5 16.7 24.0 38.7 6.2 11.6 2.9 13.9 17.7 15.5 24.9 15.1 15.5 25.7 21.6 16.1 15.0 1.7 26.7 15.5 16.1 12.5 11.9 10.0 16.2 8.5 18.1 9.9 10.8 12.1 9.6 15.8 9.3 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favourable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 5.0 8.4 4.8 6.6 9.5 3.5 3.9 4.8 4.5 5.8 6.1 9.8 4.4 7.6 7.0 4.3 5.7 5.6 7.4 1.1 7.7 12.3 6.0 5.6 6.1 7.5 8.3 7.1 6.5 6.0 4.7 3.8 5.8 5.3 0.8 2.6 19.1 12.1 6.8 3.8 14.6 8.6 6.2 7.1 5.5 5.9 10.0 6.7 5.2 7.1 4.2 4.0 8.2 3.1 6.5 2.0 5.1 5.0 19.4 13.0 3.4 10.2 6.4 4.2 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: " "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.1 2.3 1.5 2.8 0.8 0.0 2.1 0.9 0.0 0.2 0.0 1.1 2.2 2.8 1.4 0.0 0.8 0.0 0.3 0.0 5.7 0.8 2.6 1.8 0.5 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 1.8 2.9 0.0 3.3 1.1 1.2 1.1 0.9 2.1 0.8 0.5 0.0 1.3 4.1 4.1 2.8 1.3 0.6 3.5 2.1 1.5 0.7 2.2 1.2 0.4 2.7 1.8 1.6 0.5 4.4 1.2 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641861 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favourable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 13.2 12.6 11.5 11.6 13.4 4.6 13.7 19.3 18.8 12.5 10.3 9.5 7.4 8.0 14.6 11.5 10.5 11.9 8.6 8.1 11.0 10.7 14.8 16.1 9.1 17.8 15.7 11.6 15.0 14.0 16.2 16.3 12.9 12.3 12.0 12.1 8.3 8.7 8.4 13.2 10.8 8.9 10.5 11.8 13.8 8.5 8.6 14.4 21.0 16.9 7.6 17.0 11.6 10.2 7.0 4.3 0.6 3.6 8.4 14.0 4.9 25.2 11.0 13.8 7.3 8.3 9.1 19.6 10.2 5.6 10.3 11.5 7.8 11.9 24.5 8.4 3.0 11.7 16.8 9.9 18.3 15.8 9.6 16.7 6.9 9.7 10.5 21.1 11.5 8.2 12.9 11.8 17.7 10.0 13.5 13.6 7.7 12.6 17.6 12.0 12.3 21.9 13.1 13.9 13.7 11.4 9.8 11.7 9.6 10.9 11.7 7.7 13.5 11.5 6.9 12.5 11.9 8.1 12.1 7.9 5.9 15.0 5.6 15.6 8.8 0.0 2.5 0.3 8.2 2.5 10.5 7.0 8.7 7.5 4.3 6.9 14.0 12.1 0.6 8.4 3.6 2.8 8.7 4.9 11.5 13.4 19.3 18.8 11.0 10.7 15.7 11.6 12.3 14.4 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: " "unprognostic (1.37e-2)" "prognostic favourable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.6 4.9 4.5 7.1 8.2 9.5 15.3 5.2 10.2 9.5 16.7 10.7 10.8 8.8 5.5 7.8 4.0 12.6 4.7 13.4 3.4 10.5 9.1 5.7 10.7 10.0 7.7 12.6 5.5 17.6 11.6 9.6 7.8 12.0 6.7 8.9 6.8 5.5 14.2 6.1 10.7 8.7 6.6 4.8 10.9 9.5 8.4 5.5 5.4 7.0 12.0 5.4 13.5 3.2 6.7 5.0 9.4 4.9 3.4 5.7 8.1 11.9 9.6 4.2 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 WDTC1 "ADP, DCAF9, KIAA1037" ENSG00000142784 "WD and tetratricopeptide repeats 1" Q8N5D0 1 27234516-27308633 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028177, HPA028180, HPA028182" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204" "unprognostic (3.18e-2)" "prognostic favourable (4.51e-4)" "unprognostic (5.69e-2)" "unprognostic (8.28e-2)" "unprognostic (3.31e-2)" "unprognostic (2.00e-3)" "unprognostic (1.25e-2)" "unprognostic (9.44e-2)" "unprognostic (2.44e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "prognostic favourable (8.84e-8)" "unprognostic (1.28e-1)" "unprognostic (9.33e-2)" "unprognostic (3.01e-2)" "unprognostic (2.51e-2)" 14.7 17.5 20.2 11.1 22.0 13.2 12.1 21.8 28.4 15.0 15.3 20.7 14.1 13.3 14.5 9.1 12.4 21.1 11.0 29.1 18.0 15.0 13.6 13.0 14.3 13.3 15.8 16.1 15.8 22.3 49.3 12.3 10.9 19.7 14.3 10.1 29.6 20.6 16.5 51.1 20.9 14.2 12.8 15.1 13.2 15.2 28.3 16.5 21.0 19.4 12.1 14.0 15.0 12.3 1.3 1.5 5.6 0.8 0.8 3.3 1.2 13.0 5.7 9.3 0.9 13.3 11.1 3.9 8.1 13.6 8.7 10.6 1.9 13.1 11.0 9.8 16.0 6.8 8.7 12.3 7.5 15.3 14.9 11.5 6.5 5.2 12.0 5.9 15.6 10.5 20.1 10.8 9.9 11.8 11.7 11.9 9.1 7.2 9.6 14.4 4.4 12.4 4.8 6.9 12.3 10.2 2.9 13.7 11.8 10.5 4.5 9.5 6.7 10.4 10.0 7.1 4.4 10.0 3.9 17.2 9.2 5.4 14.6 11.4 8.5 0.3 0.5 5.6 3.3 0.8 1.3 1.3 0.8 1.4 1.5 0.8 0.6 1.5 4.8 0.8 0.6 1.0 0.9 1.2 20.2 22.0 21.8 28.4 18.0 15.0 15.8 16.1 19.7 16.5 WDYHV1 "C8orf32, FLJ10204" ENSG00000156795 "WDYHV motif containing 1" Q96HA8 8 123416725-123467230 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: " "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 10.5 15.5 13.2 7.9 13.6 6.3 17.2 14.3 16.8 14.5 9.9 13.9 10.7 5.8 11.2 12.0 10.2 9.8 8.8 24.8 12.8 19.8 13.6 9.1 8.6 11.4 17.0 10.8 20.4 21.3 9.0 12.8 8.2 16.2 13.5 9.5 9.7 8.3 12.5 19.2 9.8 5.4 13.0 17.0 7.9 10.0 17.5 15.6 5.3 14.4 9.1 11.3 10.1 9.1 5.9 7.2 8.7 7.5 13.1 9.2 5.5 9.1 10.8 12.7 6.7 5.5 12.6 5.7 7.6 6.7 7.2 9.2 6.4 6.1 7.3 6.9 5.3 5.3 8.1 8.8 9.7 17.2 7.1 7.9 5.2 8.7 7.8 3.0 3.4 8.5 5.4 9.6 11.8 7.2 5.9 10.1 10.6 28.6 8.8 6.2 5.1 7.4 5.1 8.0 5.8 9.7 8.1 6.5 14.1 7.8 39.8 12.1 6.6 3.3 3.9 9.6 15.1 7.1 9.2 7.6 15.4 9.0 7.8 4.6 6.0 8.7 6.3 2.5 7.8 7.5 8.4 5.2 8.4 7.3 7.2 5.9 6.5 7.4 1.8 13.1 4.0 4.6 9.2 5.5 13.2 13.6 14.3 16.8 12.8 19.8 17.0 10.8 16.2 15.6 WIPF1 "WASPIP, WIP" ENSG00000115935 "WAS/WASL interacting protein family member 1" O43516 2 174559572-174682916 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 44.5;Karpas-707: 64.1;U-266/70: 51.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003739, CAB009737, HPA070706" Enhanced Approved "Plasma membrane,Cytosol" 290000 Cytosol "Plasma membrane" "CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: " "unprognostic (4.76e-2)" "unprognostic (4.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (2.27e-3)" "unprognostic (2.05e-1)" "unprognostic (1.21e-1)" "unprognostic (7.22e-2)" "unprognostic (1.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.14e-4)" "unprognostic (3.65e-2)" "unprognostic (5.43e-2)" "unprognostic (1.58e-1)" "unprognostic (2.50e-2)" 20.6 7.3 10.5 47.0 14.4 23.2 21.6 2.1 9.2 17.1 16.5 20.2 6.6 8.7 14.3 11.4 10.3 9.8 17.2 12.0 14.6 10.5 9.0 7.8 22.6 55.7 21.1 5.6 8.7 4.7 5.7 4.2 15.6 10.9 10.6 10.7 10.5 10.5 11.7 4.0 7.3 21.3 13.8 44.2 55.5 9.9 4.5 14.9 42.9 11.4 8.9 51.7 22.8 15.3 12.3 8.2 52.7 12.9 17.8 25.0 15.3 0.1 1.4 3.4 0.0 8.7 15.4 3.5 6.4 5.5 2.5 4.0 0.3 0.2 44.5 1.9 9.6 0.1 0.5 0.0 3.4 30.1 0.8 23.4 5.8 0.0 3.3 19.5 37.0 6.4 1.0 5.9 0.5 5.6 0.6 64.1 7.5 0.0 21.6 17.9 4.0 0.2 18.6 1.4 8.3 2.3 0.1 0.5 7.1 0.0 1.8 3.8 0.0 9.5 4.3 8.8 2.4 6.3 6.1 51.2 31.3 23.3 13.3 13.4 24.2 12.1 10.8 26.2 25.0 11.9 21.0 12.3 16.8 24.5 8.2 10.3 13.8 18.1 52.7 17.8 12.9 3.6 18.7 15.3 10.5 14.4 2.1 9.2 14.6 10.5 21.1 5.6 10.9 14.9 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 51.5;ASC TERT1: 39.4;HHSteC: 49.6;HSkMC: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 25.0;eosinophil: 53.0" "Lineage enriched" "Detected in all" 9 "granulocytes: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favourable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 18.4 11.0 6.0 6.5 10.0 10.5 19.6 7.6 9.6 16.1 15.9 7.8 39.7 5.7 9.0 12.9 8.1 6.7 10.7 34.8 5.3 3.7 20.2 11.5 14.4 12.2 8.5 5.3 6.9 23.9 10.0 10.2 33.5 9.4 8.4 17.9 11.5 30.2 19.3 49.3 11.8 7.7 10.0 7.5 8.9 14.5 4.6 6.5 1.6 10.0 25.2 9.8 10.3 10.3 1.1 2.2 53.0 5.7 2.5 3.1 3.3 1.0 2.1 1.9 2.8 51.5 39.4 10.4 7.5 36.1 3.0 9.8 1.6 1.6 0.5 3.4 16.1 0.8 0.7 4.8 5.4 0.9 0.9 7.4 0.7 9.2 49.6 0.5 10.8 41.4 8.9 12.0 16.5 13.6 0.4 18.8 9.1 6.4 0.1 1.4 0.3 3.2 0.1 6.6 7.3 4.6 3.7 0.5 2.5 1.7 23.6 38.3 12.2 2.1 12.9 15.0 2.2 6.9 1.8 16.5 18.6 2.2 22.6 3.6 6.6 25.0 4.6 53.0 3.1 5.5 1.4 1.1 0.8 3.0 2.2 0.4 0.0 1.5 9.7 2.5 5.7 1.5 0.6 3.3 6.0 10.0 7.6 9.6 5.3 3.7 8.5 5.3 9.4 6.5 WIPI2 "ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984" ENSG00000157954 "WD repeat domain, phosphoinositide interacting 2" Q9Y4P8 7 5190188-5233826 "Predicted intracellular proteins" Autophagy "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019852, HPA021488" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA019852: AB_1846589, HPA021488: AB_1846591" "unprognostic (5.79e-2)" "unprognostic (1.47e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (7.69e-5)" "unprognostic (1.96e-3)" "unprognostic (9.27e-3)" "unprognostic (4.60e-3)" "unprognostic (4.96e-2)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "prognostic favourable (9.78e-4)" "unprognostic (1.20e-1)" "prognostic favourable (2.05e-6)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (7.41e-2)" "unprognostic (6.98e-2)" 24.5 23.6 33.9 17.8 34.7 32.7 21.9 30.6 47.4 20.6 21.7 27.8 17.4 20.3 24.4 23.1 25.4 25.3 20.5 30.5 27.9 27.2 23.5 27.5 21.9 22.3 26.0 31.2 25.0 30.8 28.7 23.2 27.0 26.1 25.0 17.2 25.0 34.7 25.5 28.3 31.8 18.2 22.9 25.6 22.0 23.0 49.3 26.0 26.6 24.1 15.9 23.4 22.9 20.5 6.1 6.9 13.0 6.3 2.6 9.2 2.2 27.0 17.3 16.9 28.9 26.1 27.5 26.1 24.2 27.8 25.8 27.4 16.7 25.2 19.3 18.6 30.2 19.9 17.1 19.7 20.2 9.9 26.6 13.2 17.5 18.4 25.9 20.7 14.5 28.8 23.7 29.3 16.3 35.8 37.3 17.5 23.3 28.1 15.7 35.9 35.2 25.5 25.9 24.2 31.8 17.0 13.2 21.2 31.9 17.7 30.5 21.0 18.7 39.5 28.4 16.5 34.7 27.5 18.0 31.6 29.4 22.1 26.9 24.0 24.3 0.3 4.9 13.0 5.1 6.3 3.1 5.6 6.7 9.1 4.5 6.1 8.5 5.4 9.9 2.6 4.2 6.9 9.2 2.2 33.9 34.7 30.6 47.4 27.9 27.2 26.0 31.2 26.1 26.0 WIZ ZNF803 ENSG00000011451 "Widely interspaced zinc finger motifs" O95785 19 15419980-15449951 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: " "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavourable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 28.0 17.5 27.6 18.3 21.6 13.6 20.9 15.8 24.4 17.5 17.3 12.8 18.0 18.2 25.2 12.0 16.3 16.3 15.3 17.3 23.0 11.4 13.8 18.4 13.5 17.5 14.1 19.0 21.6 26.9 14.3 10.9 13.7 13.7 17.4 7.7 12.4 21.9 23.1 24.4 21.5 16.8 16.5 11.9 18.0 15.6 40.9 15.8 18.6 13.3 14.6 12.1 19.3 21.4 2.0 1.5 0.7 3.6 2.5 1.2 0.5 13.5 9.2 13.3 16.9 19.2 7.9 10.8 14.2 6.9 11.8 8.2 8.1 25.3 11.2 23.3 12.8 11.5 7.3 9.9 2.9 8.7 12.5 8.2 7.2 6.4 12.2 9.4 12.2 13.9 13.1 8.5 9.3 10.6 12.7 9.7 8.0 27.4 17.0 8.7 18.0 22.1 15.9 6.1 11.3 7.7 10.5 18.2 23.1 12.4 11.3 9.1 12.4 8.9 17.1 27.1 10.8 21.3 18.0 14.3 8.5 12.1 11.3 11.3 18.2 0.0 1.4 0.0 1.2 1.2 1.0 0.5 0.8 1.2 1.0 2.0 1.0 1.0 0.7 2.5 3.6 1.5 0.8 0.5 27.6 21.6 15.8 24.4 23.0 11.4 14.1 19.0 13.7 15.8 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 71.8;ASC TERT1: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA069520: " "prognostic favourable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favourable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favourable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 2.0 3.0 71.8 0.0 39.8 55.6 41.6 9.9 24.5 13.9 19.3 4.3 4.7 0.0 10.0 2.8 20.8 16.1 16.3 11.8 0.1 12.0 0.0 8.6 0.0 34.8 0.0 0.1 39.7 11.0 34.0 11.2 32.5 0.0 0.1 20.4 0.3 0.0 0.2 3.2 4.8 0.0 15.1 0.0 2.4 10.7 4.0 8.4 9.1 0.4 11.9 1.9 0.3 37.7 13.3 10.7 21.3 13.4 4.8 0.1 0.0 30.7 0.3 24.3 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.9;breast: 24.1" "Cell line enhanced" "Detected in some" "BEWO: 20.3;CACO-2: 6.5;CAPAN-2: 9.7;EFO-21: 32.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 6.6" "Lineage enriched" "Detected in many" 6 "NK-cells: 6.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050101, HPA063569" Uncertain Approved Centrosome,Cytosol "Secreted to extracellular matrix" Cytosol Centrosome "HPA050101: , HPA063569: " "prognostic favourable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 25.9 14.1 0.8 1.6 1.0 0.9 24.1 1.8 0.9 3.4 7.6 1.4 0.7 2.6 1.9 6.0 4.7 3.1 3.4 7.2 0.4 0.4 1.2 8.5 4.8 2.3 0.5 0.1 4.3 7.8 0.5 2.3 6.3 2.2 4.0 1.2 1.0 3.4 1.3 11.1 4.5 7.9 3.1 0.3 3.5 0.7 3.7 0.5 0.3 10.8 5.4 0.7 4.6 10.2 0.0 0.0 0.8 0.1 6.6 1.1 0.4 0.0 0.0 0.0 0.0 1.7 0.1 20.3 0.0 0.0 0.0 0.1 6.5 9.7 0.0 32.2 0.0 3.0 0.6 0.0 0.0 2.9 1.1 1.6 0.7 1.2 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 1.6 0.2 0.0 1.2 0.1 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.8 1.0 1.8 0.9 0.4 0.4 0.5 0.1 2.2 0.5 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 66.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.8;HSkMC: 12.9;TIME: 5.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA047274: , HPA066368: " "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 3.4 1.9 1.7 3.4 4.6 0.2 2.1 2.6 2.9 9.2 12.0 0.8 3.7 3.9 7.5 5.4 7.6 4.4 8.0 3.6 1.6 1.7 1.8 0.5 5.2 0.9 2.0 2.4 28.7 2.0 1.2 1.9 6.0 1.5 7.3 6.8 66.7 1.7 18.3 1.3 13.4 9.1 12.9 3.0 1.2 4.4 16.2 0.8 0.5 1.4 5.6 1.9 10.3 8.5 2.3 1.2 1.7 0.7 0.8 1.2 0.1 0.7 0.4 3.4 0.8 3.4 6.8 0.6 1.4 1.5 0.4 0.6 0.3 0.7 1.8 0.3 1.6 2.1 1.1 0.5 0.3 0.1 0.7 0.2 1.1 0.5 2.9 0.2 0.8 12.9 1.2 0.6 0.2 1.7 0.2 0.3 0.4 0.5 0.1 0.2 0.6 0.5 0.1 0.5 0.0 2.3 0.4 0.5 0.5 1.3 0.2 1.1 0.1 0.4 5.2 0.5 2.0 1.2 0.4 0.2 0.1 0.0 1.4 0.2 1.3 0.9 0.7 1.0 0.9 0.3 0.8 1.4 1.2 1.0 0.3 2.3 0.4 0.7 1.7 0.8 0.5 1.2 0.4 0.1 1.7 4.6 2.6 2.9 1.6 1.7 2.0 2.4 1.5 0.8 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: " "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavourable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favourable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 6.9 6.9 8.1 10.3 8.0 13.3 6.8 11.8 10.7 7.4 7.2 10.6 6.8 6.8 8.4 8.4 7.9 25.6 7.7 6.8 7.5 6.6 9.4 6.6 8.7 12.7 7.9 5.8 7.8 12.0 6.1 7.6 8.1 7.8 5.3 7.3 7.8 6.6 6.6 9.8 8.1 7.7 7.8 5.4 12.5 7.2 11.4 8.3 22.8 7.6 6.6 12.8 7.5 6.2 4.7 6.6 20.0 5.8 4.2 8.5 3.5 11.0 20.8 15.0 15.0 4.5 4.2 8.8 7.2 7.7 23.6 22.1 12.1 6.9 13.4 7.6 6.4 12.4 17.2 12.7 18.3 8.0 22.3 6.1 13.8 10.1 4.1 4.7 8.0 3.3 5.0 20.8 4.8 15.3 5.8 4.4 9.4 10.1 13.7 11.5 8.0 10.4 18.1 9.9 7.8 8.7 4.0 6.9 10.5 11.4 6.1 6.0 8.3 5.0 5.3 9.4 10.0 0.0 18.6 3.5 8.8 7.0 8.5 8.1 11.4 20.0 5.2 4.6 5.4 5.8 6.3 3.3 4.2 6.0 4.7 4.7 3.8 4.4 2.7 4.2 2.3 6.6 8.5 3.5 8.1 8.0 11.8 10.7 7.5 6.6 7.9 5.8 7.8 8.3 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.3;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.4 0.1 0.0 0.0 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 13.3 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 WWC3 "BM042, KIAA1280" ENSG00000047644 "WWC family member 3" Q9ULE0 X 10015562-10144478 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 56.9" "Cell line enhanced" "Detected in many" "T-47d: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039814 Uncertain Approved "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA039814: AB_10674987" "unprognostic (2.53e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (9.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (3.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.58e-2)" "unprognostic (4.91e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.06e-5)" "unprognostic (9.90e-2)" "unprognostic (2.09e-1)" "unprognostic (5.03e-2)" "unprognostic (4.50e-2)" 10.2 13.2 8.9 9.8 12.6 5.3 10.3 13.7 10.1 10.0 13.1 18.2 56.9 4.5 11.6 22.0 12.4 8.9 10.8 15.4 10.0 7.2 7.2 3.9 21.0 12.5 13.1 6.4 18.7 9.4 9.9 6.7 25.7 10.6 11.3 5.6 12.6 9.0 44.4 7.6 12.3 10.8 13.2 9.4 11.8 11.2 6.9 11.8 6.2 12.2 8.1 10.2 10.2 18.1 6.6 0.7 12.3 1.0 2.7 6.9 2.1 6.7 7.7 9.4 3.1 3.9 5.6 8.9 3.8 6.7 2.3 2.6 1.0 7.1 0.7 0.0 5.1 3.5 2.1 4.0 1.9 5.0 0.7 1.5 5.0 0.7 8.5 0.0 2.4 3.6 8.4 5.8 6.2 10.9 0.1 9.2 5.6 13.9 1.6 0.4 8.8 2.7 4.9 0.4 2.9 2.2 3.5 1.0 2.6 4.7 6.1 4.1 53.9 0.5 14.5 6.8 0.1 10.0 4.2 7.5 5.0 2.5 4.1 2.5 10.0 4.1 1.0 0.2 6.9 0.8 6.0 2.4 3.4 5.1 0.5 6.6 3.2 3.8 12.3 2.7 0.8 0.7 1.6 2.1 8.9 12.6 13.7 10.1 10.0 7.2 13.1 6.4 10.6 11.8 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099413-79212667 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA050992: " "prognostic unfavourable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favourable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 13.2 7.4 19.2 10.5 17.9 5.3 11.9 21.5 14.6 8.9 5.9 20.5 14.8 8.9 12.6 17.1 11.6 13.4 10.0 6.1 17.0 17.7 19.2 17.8 7.1 6.5 19.7 12.5 9.4 10.5 22.3 11.5 7.6 16.1 10.9 5.3 11.4 10.6 15.4 4.9 9.6 7.2 11.9 20.9 5.4 7.6 15.8 17.9 10.3 29.4 4.9 8.9 8.7 8.6 8.5 13.8 5.4 8.8 7.8 12.3 5.4 5.0 4.4 4.9 3.1 5.2 2.3 5.3 0.7 1.5 1.7 1.5 3.4 4.3 9.3 3.8 0.7 4.3 2.4 0.6 1.2 4.9 12.7 3.0 0.8 7.1 3.9 7.7 1.5 2.8 1.8 1.1 1.0 2.1 4.1 1.9 1.2 39.5 13.2 10.5 4.3 2.6 14.1 1.9 9.4 2.4 1.7 8.0 5.2 3.1 5.7 1.7 5.7 5.4 0.5 1.3 4.5 1.0 2.9 0.0 8.7 19.1 5.0 3.9 2.1 5.4 8.8 1.9 10.5 7.2 12.3 8.5 8.5 9.2 6.8 6.4 8.4 8.9 0.8 7.8 5.0 13.8 12.3 5.4 19.2 17.9 21.5 14.2 17.0 17.7 19.7 12.5 16.1 17.9 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342738-86478420 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favourable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 15.4 9.1 9.7 15.6 14.1 5.2 20.9 8.5 9.5 11.5 16.9 7.5 21.1 8.7 11.9 19.3 11.7 7.2 22.0 40.7 8.7 8.5 16.9 37.2 10.2 15.9 10.0 7.8 10.1 11.3 40.7 7.3 15.6 12.7 17.8 11.3 8.9 11.8 9.4 58.0 13.8 13.0 18.4 9.9 19.1 11.4 10.4 9.5 11.1 11.2 18.0 12.5 14.5 12.3 3.7 2.6 6.5 2.8 2.9 10.4 2.3 22.9 10.8 7.5 5.3 9.4 9.3 6.9 8.4 8.9 6.7 8.0 7.6 14.1 9.9 5.7 14.3 19.7 10.5 13.4 11.6 12.2 8.4 11.3 9.6 17.8 6.9 4.5 5.9 8.4 17.2 7.3 13.6 29.4 5.9 11.6 11.3 11.4 10.8 3.4 4.5 12.2 7.1 9.0 8.7 15.0 17.6 2.2 5.2 8.3 42.1 8.9 12.5 4.2 33.8 10.0 11.9 10.6 4.3 13.8 8.4 10.1 12.4 0.8 7.6 6.5 2.8 4.8 7.2 2.4 6.0 3.7 8.7 7.1 1.9 3.6 10.4 6.3 1.7 2.9 2.8 2.6 8.0 2.3 9.7 14.1 8.5 9.5 8.7 8.5 10.0 7.8 12.7 9.5 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 59.8;SK-MEL-30: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;memory CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: , HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 25.1 9.9 9.3 16.0 18.6 0.2 20.4 7.7 10.5 27.2 38.5 18.4 15.0 5.6 27.2 17.6 41.2 16.4 25.8 20.6 14.7 9.0 31.0 13.1 29.8 6.2 15.2 5.6 30.9 21.7 10.4 8.5 29.0 20.7 34.6 9.1 29.4 15.8 22.4 12.1 13.4 11.7 81.5 25.8 13.8 20.8 12.0 16.4 0.7 18.2 13.2 7.1 68.4 31.0 0.2 0.1 0.6 0.1 0.1 2.8 0.4 16.5 19.7 10.5 13.9 12.5 22.4 11.0 9.6 14.1 4.4 4.6 11.0 14.0 0.0 59.8 10.8 9.8 6.8 7.0 4.3 4.6 5.2 0.0 5.1 9.1 7.1 0.0 0.0 11.8 1.8 15.2 6.6 33.9 0.0 0.0 15.1 2.2 0.0 0.0 2.4 24.9 0.0 14.0 0.1 37.2 2.4 0.0 0.1 6.3 4.5 41.3 7.6 0.3 27.6 8.6 4.1 6.9 18.8 0.1 0.1 0.2 18.4 0.0 21.8 0.4 0.1 0.1 2.6 0.0 0.0 0.0 0.3 2.8 0.0 0.2 0.1 1.3 0.6 0.1 0.0 0.1 1.9 0.4 9.3 18.6 7.7 10.5 14.7 9.0 15.2 5.6 20.7 16.4 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629565 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048751: " "unprognostic (1.13e-1)" "prognostic favourable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favourable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favourable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 13.5 18.4 12.2 13.3 17.8 35.7 17.8 22.9 22.6 16.3 12.1 19.2 12.1 16.3 15.5 12.1 17.8 18.9 12.7 17.5 11.9 10.3 20.1 24.6 13.0 17.0 16.8 11.4 29.6 34.3 11.9 12.2 14.6 13.3 15.2 5.3 13.6 28.7 18.1 18.0 19.5 13.8 13.7 13.4 18.8 22.8 30.2 15.8 24.8 21.4 13.2 15.9 18.6 15.6 15.2 9.0 9.9 14.1 8.9 16.7 13.8 15.4 14.2 8.6 11.2 9.1 6.8 16.8 9.1 10.7 16.2 16.5 18.3 10.2 10.5 18.1 8.4 13.6 12.2 13.2 4.1 18.3 15.7 13.9 12.0 16.0 11.8 18.4 12.6 12.0 11.0 11.4 8.3 9.8 12.4 27.9 5.0 17.1 17.2 28.7 19.6 28.1 19.2 10.9 18.3 6.4 12.2 12.3 14.1 10.3 10.2 8.9 12.9 16.3 9.6 7.4 12.2 16.8 15.3 48.2 28.4 15.2 12.7 15.7 11.0 8.3 12.2 9.9 14.8 11.6 13.6 12.3 13.8 11.0 9.0 15.2 16.7 12.6 7.3 8.9 14.1 7.8 15.8 13.8 12.2 17.8 22.9 22.6 11.9 10.3 16.8 11.4 13.3 15.8 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 32.7;BJ hTERT+ SV40 Large T+ RasG12V: 33.8;HHSteC: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: " "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 1.9 0.1 0.2 0.5 2.7 6.2 0.2 2.5 10.3 32.7 33.8 0.2 2.9 0.5 0.8 3.8 1.2 0.0 0.5 3.7 4.4 0.1 0.7 0.3 0.4 15.0 0.4 3.1 2.8 0.0 4.3 0.1 2.7 0.2 10.6 1.0 0.1 2.2 8.7 0.2 0.8 4.2 0.1 0.2 0.0 1.8 0.2 0.2 1.2 0.2 5.5 0.3 12.0 0.3 0.4 0.3 0.9 0.1 1.5 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.2" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA052507: , HPA055941: " "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414715 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;liver: 32.5" "Cell line enhanced" "Detected in some" "BJ: 6.1;HBEC3-KT: 15.0;hTERT-HME1: 23.9;U-251 MG: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoplasm Nucleoli "HPA062641: , HPA069323: " "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favourable (8.73e-6)" 0.2 0.2 0.2 2.4 0.2 0.0 17.8 0.2 0.2 2.6 17.9 0.1 0.0 20.1 0.3 6.3 9.3 0.2 1.8 0.2 0.1 0.2 0.4 32.5 0.2 0.0 0.2 0.0 0.2 0.4 0.0 1.5 3.7 0.1 1.2 4.2 0.1 20.9 0.0 0.7 1.0 78.6 0.1 0.2 0.2 1.3 0.2 0.0 0.2 0.3 2.4 6.1 1.8 1.1 0.7 0.3 1.0 0.6 0.7 0.5 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.1 6.1 3.5 0.7 1.1 0.2 1.7 0.0 1.2 0.2 3.2 0.0 15.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.9 23.9 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.1 0.0 1.1 3.3 4.4 3.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 1.9 0.1 6.5 1.9 0.1 0.0 0.2 0.0 0.0 0.5 0.6 0.2 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.7 0.2 0.5 1.0 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.0 XIAP "API3, BIRC4, hILP" ENSG00000101966 "X-linked inhibitor of apoptosis" P98170 X 123859724-123913979 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway, Wnt signaling pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB009203, HPA042428" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009203: AB_2257167, HPA042428: " "prognostic unfavourable (9.21e-4)" "unprognostic (8.43e-2)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.40e-1)" "unprognostic (9.41e-2)" "unprognostic (1.95e-2)" "unprognostic (8.51e-2)" "unprognostic (9.17e-2)" "unprognostic (3.90e-2)" "unprognostic (7.50e-2)" "unprognostic (4.41e-2)" "unprognostic (3.15e-3)" "unprognostic (8.21e-3)" "unprognostic (2.26e-1)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 17.4 14.4 20.0 18.1 20.2 12.0 15.9 21.3 18.9 17.2 19.4 14.5 22.9 16.1 17.4 17.0 18.9 12.6 14.7 15.7 18.9 22.1 19.8 19.4 16.5 15.5 18.8 14.6 13.9 19.7 36.6 26.1 18.2 15.9 15.6 16.8 16.9 14.6 22.9 21.5 14.2 23.4 17.0 19.0 15.8 16.2 7.0 12.3 13.9 24.3 11.4 14.0 15.4 20.5 5.7 4.3 11.1 3.9 3.3 5.5 1.9 11.5 9.9 7.8 6.7 9.2 11.9 10.2 12.6 9.4 6.9 5.9 4.4 13.6 10.8 18.7 10.7 4.3 11.5 7.9 12.7 11.2 6.3 7.3 8.3 6.7 11.7 13.2 15.2 8.2 12.3 11.4 14.7 9.5 11.5 12.5 13.3 12.0 7.3 6.4 6.4 7.8 7.9 9.1 11.4 10.4 16.8 5.3 7.7 17.2 10.0 10.1 6.1 6.5 11.7 0.3 4.7 20.6 14.0 10.5 10.5 12.0 14.2 9.4 8.7 11.1 2.6 3.5 5.0 2.3 4.7 4.6 3.8 5.5 1.4 5.7 4.4 3.0 8.2 3.3 3.9 4.3 2.5 1.9 20.0 20.2 21.3 18.9 18.9 22.1 18.8 14.6 15.9 12.3 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Group enriched" "Detected in some" 5 "HSkMC: 9.1;LHCN-M2: 2.3;RH-30: 6.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell line enhanced" "Detected in many" "HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 8.2 0.1 0.0 1.5 8.8 0.0 0.0 0.0 2.4 24.7 1.4 0.0 0.0 12.7 2.0 0.0 0.4 0.0 0.0 0.0 15.9 6.3 0.0 0.9 0.1 11.7 3.1 3.2 0.0 0.0 11.2 0.0 0.6 2.3 0.0 0.4 0.8 0.0 1.2 3.1 0.0 0.0 0.4 0.0 1.3 5.4 8.9 0.0 0.1 6.8 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697357 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: " "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favourable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 18.7 17.5 20.1 17.1 21.0 10.6 17.4 26.8 20.8 20.3 25.2 17.2 11.7 20.6 25.5 15.4 18.9 15.0 19.5 12.9 17.2 15.3 24.9 24.2 14.8 16.7 18.6 17.5 17.2 14.5 23.0 23.1 12.8 17.7 20.3 13.6 16.4 16.1 21.7 43.3 16.3 22.2 27.5 17.1 16.2 25.1 6.4 15.8 15.7 31.5 11.9 21.6 22.0 16.4 22.2 23.4 12.7 15.8 19.7 21.6 11.3 23.4 5.5 8.2 10.1 10.1 9.8 5.7 6.4 10.1 11.7 7.9 14.3 19.7 13.2 6.2 7.0 11.8 6.5 7.7 9.9 9.0 13.1 10.4 12.0 7.9 11.0 12.2 12.6 8.5 8.4 5.4 5.6 13.0 14.3 10.4 6.4 7.3 15.9 14.8 5.6 9.2 16.3 17.6 11.2 18.6 9.2 11.6 11.6 9.1 7.1 8.3 10.2 7.5 8.1 4.1 10.2 16.2 13.8 18.4 14.7 8.3 10.2 8.8 8.0 6.0 13.3 12.7 16.2 13.1 18.7 19.5 17.7 15.6 13.5 22.2 21.6 18.6 1.5 19.7 15.8 23.4 18.3 11.3 20.1 21.0 26.8 20.8 17.2 15.3 18.6 17.5 17.7 15.8 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: , HPA069673: " "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favourable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favourable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.4 11.5 13.0 8.3 19.5 13.5 44.0 11.1 32.0 10.8 8.4 4.2 5.4 15.0 4.9 13.5 5.6 8.5 17.8 8.9 6.0 7.3 7.9 12.2 7.7 17.3 5.9 15.1 19.1 21.1 14.3 28.8 12.8 10.9 8.1 12.0 9.4 4.9 5.7 7.7 7.8 6.2 5.9 12.0 13.6 13.4 2.8 10.1 12.1 10.1 8.0 10.6 4.8 20.0 4.2 11.4 6.3 5.1 18.7 13.6 8.9 10.0 7.0 15.1 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell line enhanced" "Detected in some" "ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.4 0.0 6.2 32.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 XPO1 "CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61477849-61538626 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" 170000 "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: " "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavourable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 20.7 27.9 36.1 28.1 39.6 21.6 35.1 41.5 36.3 28.2 23.2 19.5 26.0 16.5 35.7 35.3 26.1 36.0 20.3 20.1 33.0 19.2 19.5 22.2 22.0 34.5 42.0 19.5 45.0 34.6 33.4 27.6 30.8 33.6 25.8 24.5 18.0 20.2 29.9 34.9 29.8 25.0 28.4 32.1 24.5 21.9 32.1 39.3 51.1 28.2 16.4 35.7 26.0 57.8 6.1 5.4 12.6 5.1 6.2 5.1 2.5 38.8 34.7 47.1 35.3 21.4 28.7 34.7 43.0 27.7 45.2 38.8 46.1 29.2 57.0 30.1 29.4 33.0 71.8 29.8 66.7 34.8 26.4 56.1 35.8 28.8 15.5 56.5 38.4 16.2 22.3 35.7 39.0 36.9 64.7 33.3 41.6 20.4 47.0 24.8 54.8 26.6 42.1 53.8 34.6 20.6 29.5 37.7 20.0 41.8 35.4 20.9 28.9 27.9 24.6 42.5 48.3 34.6 42.2 27.0 44.6 82.7 26.4 48.5 38.3 12.6 5.1 5.8 5.1 5.0 4.7 4.3 3.6 4.5 3.9 6.1 4.3 3.7 12.4 6.2 3.2 5.4 3.2 2.5 36.1 39.6 41.5 36.3 33.0 19.2 42.0 19.5 33.6 39.3 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA053768: " "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavourable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 8.9 6.6 4.9 6.9 9.6 10.9 7.9 13.6 11.1 7.5 6.7 11.6 7.9 5.0 11.4 5.9 7.5 7.3 4.9 12.8 6.1 5.3 6.9 6.1 7.7 8.6 8.0 5.3 9.0 7.8 8.1 12.9 6.8 10.2 7.3 7.6 10.7 7.4 7.4 47.3 8.2 7.2 8.2 8.3 8.6 6.7 7.9 8.0 14.3 8.4 6.3 12.3 7.8 7.3 3.1 2.7 3.1 6.0 3.1 4.0 1.2 6.6 5.0 8.3 7.9 4.0 7.1 8.6 7.6 5.6 9.0 7.5 10.2 8.4 14.7 4.1 7.3 11.0 19.1 10.3 16.8 10.0 5.5 23.3 6.3 6.9 6.1 20.4 7.6 6.9 6.5 9.1 17.3 10.8 11.0 4.9 8.5 5.5 9.7 9.0 9.4 4.7 10.8 13.7 6.1 6.3 8.1 9.5 6.6 6.5 9.5 7.8 5.6 11.2 8.9 6.4 5.0 7.8 10.8 3.2 4.8 12.2 3.1 13.1 9.5 3.1 2.0 2.1 3.4 2.3 4.0 3.1 2.9 2.9 2.7 2.6 3.6 3.5 0.0 3.1 6.0 2.0 2.7 1.2 4.9 9.6 13.6 11.1 6.1 5.3 8.0 5.3 10.2 8.0 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.4 20.4 18.0 19.3 12.5 19.9 20.7 35.2 31.9 41.3 41.8 28.6 20.4 20.2 30.4 32.0 18.6 42.7 27.0 50.2 45.5 26.5 22.1 28.8 31.8 29.6 30.8 24.9 15.6 20.1 36.6 36.3 23.7 40.2 10.2 27.9 31.9 37.0 36.8 30.5 19.5 34.8 21.4 33.5 15.3 14.5 35.2 19.1 17.4 29.1 15.4 20.9 20.4 25.1 34.9 23.4 29.7 29.3 23.9 30.2 30.0 26.6 32.2 29.4 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 XPOT XPO3 ENSG00000184575 "Exportin for tRNA" O43592 12 64404350-64451127 "Predicted intracellular proteins, Transporters" Transport "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048067, HPA057602" Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA048067: , HPA057602: " "unprognostic (4.53e-3)" "unprognostic (7.20e-2)" "unprognostic (1.38e-1)" "unprognostic (3.78e-3)" "unprognostic (1.01e-2)" "unprognostic (3.14e-1)" "prognostic unfavourable (1.81e-7)" "unprognostic (1.50e-2)" "unprognostic (2.22e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (8.87e-2)" "prognostic unfavourable (2.41e-12)" "unprognostic (2.72e-1)" "unprognostic (3.68e-1)" "unprognostic (5.20e-2)" "prognostic unfavourable (5.79e-4)" 19.3 19.4 20.7 19.3 22.8 26.9 29.9 17.9 21.7 16.9 12.4 18.7 13.2 10.5 16.1 19.8 21.3 12.5 12.6 12.7 19.0 19.4 14.7 35.7 18.3 18.9 22.4 15.5 17.3 30.1 21.4 18.5 18.6 23.5 15.3 14.7 15.8 21.3 13.7 15.6 17.3 11.6 16.7 21.7 14.5 14.7 17.9 21.3 18.2 48.7 14.1 21.4 15.8 27.8 7.9 10.2 10.1 7.5 11.1 14.7 6.5 17.5 12.2 12.4 15.5 18.7 20.0 22.7 23.5 19.7 15.8 14.4 12.1 6.0 35.6 16.8 29.6 13.2 23.5 18.1 23.0 22.2 12.4 19.8 11.3 10.6 33.1 36.4 17.9 14.2 46.7 17.5 54.3 14.0 32.9 71.7 16.7 21.5 20.1 14.5 23.6 21.8 16.0 14.9 26.6 8.6 10.4 13.8 16.2 13.8 15.8 34.0 28.1 36.3 14.7 12.4 12.6 17.8 18.3 45.1 34.6 27.6 27.6 28.5 20.1 5.8 7.5 10.1 10.9 7.5 14.7 7.9 12.4 11.3 10.2 5.3 11.4 9.6 2.3 11.1 6.7 3.5 10.3 6.5 20.7 22.8 17.9 21.2 19.0 19.4 22.4 15.5 23.5 21.3 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644779-152676165 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.7;testis: 11.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065153: " "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 1.3 1.3 3.4 4.5 2.0 5.4 2.4 4.4 2.6 1.6 1.5 2.5 0.6 1.1 1.9 2.2 2.6 1.3 0.6 2.5 3.3 1.1 1.1 1.3 1.4 3.0 1.9 1.9 2.0 1.2 0.4 1.3 7.2 2.7 1.5 2.9 0.6 1.5 1.3 1.1 1.6 1.9 1.3 1.8 1.8 1.5 11.7 2.2 12.7 1.2 1.1 3.6 1.3 1.6 1.8 1.0 3.1 1.1 1.1 1.6 0.6 7.4 4.5 6.6 7.1 0.8 0.7 7.6 5.4 1.9 4.7 4.6 5.6 6.5 10.6 4.2 2.1 5.4 5.3 4.4 8.5 5.0 5.5 7.6 6.0 3.1 0.3 11.3 3.7 0.5 0.4 7.6 2.0 1.6 15.7 9.1 2.7 5.2 10.4 2.7 8.7 4.0 8.4 8.8 5.9 1.4 4.9 6.3 6.0 6.0 2.6 1.1 2.2 2.4 3.1 6.2 2.8 5.8 9.9 3.3 6.4 9.3 3.3 6.1 8.1 2.0 0.9 1.5 1.6 0.6 1.1 1.3 1.3 1.1 0.3 1.8 1.6 0.8 3.1 1.1 1.1 1.0 1.5 0.6 3.4 2.0 4.4 2.6 3.3 1.1 1.9 1.9 2.7 2.2 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavourable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 16.5 12.4 9.9 16.2 15.5 24.4 15.9 23.8 15.7 15.7 17.5 7.5 12.4 14.7 15.2 14.2 13.4 11.5 11.0 10.1 8.4 6.8 9.6 21.7 15.9 16.1 11.7 9.0 17.4 13.2 17.4 26.5 23.6 10.7 12.5 13.0 8.2 14.4 13.3 21.2 17.2 25.0 14.4 15.2 16.2 11.7 11.8 10.9 30.8 12.9 10.8 15.3 15.0 15.2 7.4 6.1 18.3 4.7 4.3 8.4 2.5 9.8 1.9 4.5 3.8 5.0 8.4 2.7 4.6 6.2 6.0 7.4 1.7 2.9 3.9 4.8 6.1 3.8 4.0 2.3 9.2 9.9 3.1 5.8 3.3 1.5 4.4 5.8 5.9 6.6 2.7 4.3 5.6 5.3 3.8 9.4 5.4 1.9 5.0 3.0 1.4 2.1 4.1 57.1 4.9 2.9 5.0 2.6 3.3 8.3 4.5 3.5 5.5 4.5 7.3 4.2 2.3 4.8 3.9 13.5 6.9 6.3 3.9 3.1 3.6 18.3 4.7 12.2 8.3 4.2 5.8 7.4 6.4 7.4 2.3 6.0 8.4 5.8 17.2 4.3 4.0 6.1 4.6 2.5 9.9 15.5 23.8 15.7 8.4 6.8 11.7 9.0 10.7 10.9 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303304-21389827 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA047118: , HPA050485: " "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 42.9 35.1 12.5 24.5 17.7 38.3 30.4 18.0 16.4 26.8 22.8 18.6 23.3 14.4 38.6 25.2 22.1 30.6 21.8 19.3 13.7 10.3 31.4 35.3 27.5 33.4 17.4 12.1 32.1 26.4 30.0 35.3 26.5 15.9 25.7 20.1 19.1 27.6 25.0 36.8 23.0 21.6 24.1 18.6 40.9 23.2 27.4 18.3 41.1 31.3 20.4 30.6 33.1 21.7 16.0 30.6 35.0 33.9 21.7 24.6 23.8 27.2 32.4 35.8 27.4 26.8 33.0 35.4 25.1 32.8 33.5 39.1 21.6 31.3 26.8 15.0 26.2 32.4 40.2 42.2 43.0 12.1 20.3 34.6 12.2 40.7 23.6 31.1 30.3 31.2 21.4 36.8 32.4 28.7 27.8 23.1 31.0 21.3 45.8 20.6 27.8 21.9 33.6 60.8 22.8 28.5 28.9 27.8 36.1 29.2 36.1 26.8 20.2 37.1 26.4 33.7 25.3 7.6 31.6 20.4 26.2 28.8 13.0 14.6 25.3 15.1 33.9 23.8 18.6 27.2 24.6 16.0 20.4 20.2 30.6 15.1 21.8 21.0 35.0 21.7 32.7 13.2 24.0 23.8 12.5 17.7 18.0 16.4 13.7 10.3 17.4 12.1 15.9 18.3 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA039263: " "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 7.1 7.9 6.2 19.5 8.6 3.7 10.7 5.7 7.5 8.6 7.3 7.6 22.9 5.8 9.0 13.5 6.6 9.6 8.7 9.5 7.9 5.9 6.9 8.1 9.5 4.1 5.7 7.0 9.3 22.7 11.9 8.1 5.3 10.8 10.5 5.6 7.4 13.1 16.8 15.7 5.8 5.9 10.1 13.7 7.2 6.4 35.0 6.1 5.6 14.3 4.1 5.8 6.3 7.4 3.5 3.4 6.2 5.2 2.0 8.5 3.0 3.9 2.2 0.5 3.7 5.8 3.8 1.6 1.7 1.8 1.0 1.0 1.1 2.1 1.6 6.3 1.9 3.2 4.5 2.2 2.1 6.3 0.4 1.4 1.3 2.2 1.7 0.8 0.7 3.6 2.6 4.2 27.7 2.0 3.6 3.8 4.8 1.4 1.4 2.0 1.2 2.0 0.7 3.0 1.2 0.8 3.0 3.6 3.0 7.9 3.4 10.6 2.1 4.1 1.3 6.0 3.9 4.3 1.6 5.3 4.7 4.4 1.4 0.8 2.0 2.9 4.3 3.8 6.3 5.2 6.6 3.5 4.6 4.7 3.4 3.5 4.6 4.5 6.2 2.0 3.2 2.5 8.5 3.0 6.2 8.6 5.7 7.5 7.9 5.9 5.7 7.0 10.8 6.1 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Cell line enhanced" "Detected in many" "ASC diff: 18.8;U-2197: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.6 0.0 18.8 11.7 3.2 8.4 4.3 0.9 0.4 0.1 0.2 2.0 0.0 10.1 0.2 0.0 1.7 1.5 4.0 0.2 2.5 0.0 0.0 0.2 3.6 3.4 4.3 0.2 5.4 0.8 0.0 0.3 7.9 0.9 0.3 0.0 3.9 2.8 0.0 1.2 0.0 0.4 0.0 3.8 0.7 5.1 0.6 2.6 0.5 0.6 2.3 0.0 8.8 1.0 19.3 0.0 8.8 0.5 3.8 9.8 4.1 7.4 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 XYLT2 "PXYLT2, XT-II" ENSG00000015532 "Xylosyltransferase 2" Q9H1B5 17 50346092-50363138 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 53.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016456 Approved "Nuclear bodies,Cytosol" "Secreted to blood" 990000 "Nuclear bodies" Cytosol "HPA016456: AB_1858907" "unprognostic (1.52e-1)" "unprognostic (2.84e-1)" "unprognostic (1.65e-1)" "unprognostic (8.07e-2)" "unprognostic (1.90e-3)" "unprognostic (1.90e-1)" "unprognostic (7.29e-3)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.63e-2)" "unprognostic (5.15e-2)" "unprognostic (7.38e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-2)" 6.9 8.5 5.8 11.3 10.6 4.1 7.4 10.3 10.9 10.7 9.2 5.4 15.8 10.0 9.6 12.2 8.5 10.4 14.9 9.4 5.3 4.8 9.2 6.1 6.1 10.2 4.7 8.8 11.8 13.5 9.1 5.8 9.0 5.4 12.1 3.9 13.1 12.7 11.7 7.9 15.6 6.9 17.0 3.8 8.4 53.4 5.8 3.7 10.2 9.5 6.7 10.4 11.7 9.0 5.3 4.9 6.6 4.0 7.8 7.8 4.3 9.7 12.5 3.4 2.8 4.8 4.7 8.9 9.1 8.4 8.2 9.3 13.2 7.4 5.1 23.2 8.2 7.5 1.1 12.8 1.7 25.2 8.9 11.4 3.8 5.7 6.6 3.6 6.2 6.4 7.9 6.6 3.1 7.0 2.0 4.3 5.4 12.7 6.6 4.9 3.1 8.8 3.3 10.0 4.2 4.6 5.1 1.8 4.3 6.1 5.8 9.6 27.6 3.5 8.2 18.8 9.6 10.2 8.1 23.4 10.7 1.7 19.8 5.8 5.1 6.6 4.0 3.2 5.9 2.8 6.3 2.9 5.9 7.8 4.9 5.3 6.0 5.3 4.7 7.8 2.5 3.4 5.2 4.3 5.8 10.6 10.3 10.9 5.3 4.8 4.7 8.8 5.4 3.7 YAP1 YAP65 ENSG00000137693 "Yes associated protein 1" P46937 11 102110461-102233423 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009370, HPA038885, CAB069915, HPA070359" Enhanced Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: , HPA070359: " "unprognostic (9.56e-2)" "unprognostic (6.75e-2)" "unprognostic (2.08e-1)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.28e-1)" "unprognostic (2.66e-3)" "unprognostic (3.73e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (9.26e-2)" "unprognostic (4.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-2)" 27.1 15.8 11.6 12.1 10.0 0.0 34.9 7.0 9.5 37.5 21.3 7.0 40.1 9.8 51.7 33.3 36.9 25.5 34.6 18.8 12.5 6.0 17.3 32.1 26.2 7.6 9.3 6.1 41.1 8.9 18.9 6.4 34.0 15.0 34.8 11.4 21.7 22.2 35.2 27.8 23.4 15.1 58.2 17.2 7.6 18.2 15.6 9.7 2.6 34.0 25.7 12.6 42.3 41.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 11.6 10.9 30.5 14.9 33.3 31.8 25.5 27.5 31.5 26.8 22.1 27.2 28.4 0.0 22.7 35.9 20.7 15.1 39.2 28.5 3.4 5.3 0.0 14.9 18.5 25.5 0.0 0.5 25.4 25.8 29.4 48.0 8.3 0.0 0.0 30.3 5.6 0.5 0.0 14.4 10.4 0.0 17.2 0.0 19.8 20.9 0.1 1.0 32.4 12.2 9.2 22.1 0.1 9.1 38.2 15.0 19.1 11.5 0.0 0.0 0.1 11.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 11.6 10.0 7.0 9.5 12.5 6.0 9.3 6.1 15.0 9.7 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755902 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: , HPA074097: " "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavourable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 12.6 15.8 11.0 12.6 15.3 13.9 13.8 11.6 14.9 13.1 11.8 11.5 18.4 9.8 13.3 12.9 17.5 11.3 9.1 12.1 11.9 9.7 12.4 16.3 9.2 15.5 10.8 11.7 13.3 21.0 11.0 16.6 15.9 13.5 12.9 13.7 11.3 17.4 10.0 15.9 12.0 10.8 11.1 12.6 13.3 12.3 12.5 12.6 17.5 12.3 16.0 16.4 13.3 11.8 11.8 9.5 9.4 9.9 12.9 12.7 5.2 9.5 11.5 6.7 8.0 7.4 8.7 21.3 7.3 7.5 9.1 8.9 28.8 12.3 17.3 12.0 7.4 12.4 13.4 19.3 10.3 7.5 20.9 11.4 8.7 16.0 10.7 12.1 6.7 8.1 12.4 8.5 15.6 14.3 16.1 8.0 9.6 7.8 9.0 14.7 37.1 14.2 10.2 14.4 10.2 11.5 13.7 10.4 5.0 11.2 9.8 7.2 18.3 11.0 9.6 8.6 9.2 14.0 12.3 4.8 5.1 18.0 8.0 9.1 7.1 9.4 7.0 4.1 10.1 8.9 10.6 8.8 10.7 10.4 9.5 11.8 11.2 12.7 1.4 12.9 9.9 9.3 9.3 5.2 11.0 15.3 11.6 14.9 11.9 9.7 10.8 11.7 13.5 12.6 YBX1 "BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1" ENSG00000065978 "Y-box binding protein 1" P67809 1 42682427-42702349 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 128.1;testis: 426.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005875, HPA040304, HPA057159" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" 870000 Cytosol Vesicles "CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: " "unprognostic (8.59e-2)" "unprognostic (5.16e-2)" "unprognostic (9.27e-3)" "unprognostic (2.68e-3)" "unprognostic (7.76e-2)" "unprognostic (8.03e-3)" "prognostic unfavourable (9.87e-10)" "unprognostic (2.80e-2)" "unprognostic (2.31e-2)" "unprognostic (2.79e-3)" "unprognostic (7.51e-2)" "unprognostic (5.52e-2)" "prognostic unfavourable (3.59e-7)" "unprognostic (3.66e-2)" "unprognostic (2.44e-1)" "unprognostic (1.94e-2)" "unprognostic (3.25e-1)" 47.5 20.6 15.6 36.4 18.4 57.6 35.2 13.7 14.4 27.9 44.5 21.2 20.1 25.6 35.1 36.4 40.0 25.6 32.5 57.8 15.2 12.3 33.1 38.1 35.3 49.8 17.6 13.2 30.2 36.7 9.4 12.2 26.1 15.5 32.0 33.1 31.1 26.6 23.0 128.1 22.5 27.1 50.0 21.0 47.9 33.2 426.5 15.9 53.2 31.4 64.1 37.2 39.4 41.0 23.5 26.9 21.8 40.5 11.6 23.0 10.6 91.5 54.0 86.5 86.7 84.3 76.3 77.1 67.6 63.0 94.0 73.8 74.0 85.6 116.2 70.9 67.8 55.5 97.4 102.6 93.4 62.0 90.3 118.6 107.3 94.9 68.0 159.2 88.9 70.2 88.4 93.8 116.2 77.7 123.3 50.7 87.5 57.7 179.8 155.0 195.0 73.0 108.8 155.5 125.6 93.1 67.8 119.7 84.4 66.3 89.8 126.2 29.9 317.1 60.6 66.8 114.0 90.5 137.5 74.3 93.1 132.3 63.2 119.4 70.8 4.3 18.1 21.8 16.3 37.8 19.9 23.5 19.5 15.8 26.9 20.1 16.8 17.2 3.3 11.6 40.5 20.9 23.0 10.6 15.6 18.4 13.7 14.4 15.2 12.3 17.6 13.2 15.5 15.9 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359703-69390796 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA072532: " "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 10.0 13.4 10.7 12.9 11.7 33.1 15.6 21.2 16.0 9.4 10.3 8.2 5.6 11.4 10.6 13.6 12.7 10.8 7.3 10.2 10.2 11.4 13.0 12.6 8.8 17.6 13.8 8.1 10.7 19.2 6.0 14.7 9.2 11.5 9.6 12.1 12.1 12.1 9.0 12.5 9.5 11.2 9.7 11.7 12.1 10.3 51.6 10.9 22.6 12.2 13.4 16.7 10.1 9.8 13.5 10.7 14.7 15.1 12.8 23.1 13.0 17.2 8.8 17.4 10.8 4.1 6.6 13.9 10.4 11.2 18.5 15.5 10.2 5.1 35.1 10.2 5.6 13.4 13.8 10.6 18.2 17.1 15.1 20.1 7.1 12.4 5.7 29.1 17.8 4.8 13.6 9.8 14.7 10.5 17.0 42.9 9.0 8.6 41.0 31.9 24.3 12.2 21.8 16.4 17.1 10.4 15.7 19.3 13.2 10.8 10.5 17.0 20.1 17.3 6.2 7.6 7.7 21.1 12.6 11.4 13.9 38.3 8.2 14.0 13.3 5.2 7.8 14.7 13.5 11.0 15.1 13.2 18.9 14.1 10.7 13.5 23.1 19.5 4.0 12.8 15.1 8.9 18.3 13.0 10.7 11.7 21.2 16.0 10.2 11.4 13.8 8.1 11.5 10.9 YES1 "c-yes, HsT441, Yes" ENSG00000176105 "YES proto-oncogene 1, Src family tyrosine kinase" P07947 18 721588-812546 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 14.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004370, HPA026480" Approved Supported "Plasma membrane,Cytosol" 4300000 "Plasma membrane, Cytosol" "CAB004370: AB_627370, HPA026480: AB_1858921" "unprognostic (3.28e-1)" "unprognostic (1.62e-2)" "unprognostic (5.87e-2)" "unprognostic (2.47e-2)" "unprognostic (6.24e-2)" "unprognostic (4.24e-2)" "unprognostic (6.01e-2)" "unprognostic (1.03e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-3)" "prognostic unfavourable (2.46e-4)" "unprognostic (2.14e-1)" "unprognostic (8.12e-2)" "unprognostic (4.65e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (4.11e-1)" 26.2 13.1 17.0 9.4 15.6 2.6 47.2 6.7 12.8 15.8 23.8 8.9 13.7 18.2 13.1 17.4 22.0 10.7 14.9 17.9 14.8 12.4 22.6 43.2 23.6 13.7 15.8 6.6 13.2 21.4 16.7 10.7 31.3 16.8 12.2 17.3 6.5 23.7 21.0 10.6 12.3 24.8 18.8 16.8 34.5 15.5 13.6 12.0 8.1 16.8 15.6 7.1 21.9 17.5 0.1 0.1 14.7 0.0 1.0 2.5 0.6 14.2 7.1 22.4 17.5 13.5 16.7 26.4 9.5 19.4 11.2 15.4 16.8 10.5 0.0 10.1 16.1 8.3 20.9 16.8 22.0 0.0 7.1 4.2 7.0 11.7 11.0 3.2 7.6 12.7 18.1 16.9 18.9 37.8 18.4 6.3 15.9 9.8 1.9 4.2 14.2 9.1 2.4 17.6 1.2 16.3 16.9 4.6 5.3 19.6 14.9 12.4 10.3 6.8 32.5 27.7 30.7 20.8 25.5 5.5 2.7 0.8 10.5 4.7 16.4 14.7 0.0 0.9 2.5 0.0 1.6 0.1 0.5 1.4 0.0 0.0 1.2 1.9 0.0 1.0 0.0 0.1 0.1 0.6 17.0 15.6 6.7 12.8 14.8 12.4 15.8 6.6 16.8 12.0 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289170 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014840 Approved Supported "Golgi apparatus,Vesicles,Centriolar satellite" Vesicles "Golgi apparatus, Centriolar satellite" "HPA014840: AB_2217189" "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavourable (8.70e-4)" 16.0 19.7 11.3 12.4 11.7 6.4 18.9 8.0 16.5 17.3 21.4 19.3 18.5 26.1 19.4 24.8 18.5 16.4 24.6 20.1 9.8 9.2 26.2 138.8 16.5 16.0 12.8 9.4 21.2 55.2 18.9 26.8 24.7 12.3 16.8 17.9 16.5 24.4 19.2 32.3 14.3 32.1 19.1 15.2 12.8 19.4 16.9 10.7 16.4 28.2 26.4 17.7 18.2 13.7 27.4 40.4 5.5 38.9 13.3 23.6 26.1 20.6 34.2 10.7 19.5 36.2 39.0 19.6 30.4 32.7 26.0 25.8 32.4 25.4 17.6 29.9 42.7 31.5 16.3 28.6 20.8 20.0 18.7 10.9 26.6 40.1 40.4 15.3 16.6 26.9 38.9 26.8 43.7 24.3 20.3 31.0 22.6 50.2 18.3 16.2 10.8 35.8 14.1 16.4 52.5 22.0 18.8 15.7 15.4 16.4 28.5 26.9 41.9 11.3 21.4 22.0 18.6 44.2 14.0 20.8 21.5 15.8 34.5 14.5 24.2 4.9 28.0 5.5 21.8 38.9 23.6 27.4 18.8 20.3 33.2 22.6 15.1 17.2 2.8 13.3 37.2 40.4 15.2 26.1 11.3 11.7 8.0 16.5 9.8 9.2 12.8 9.4 12.3 10.7 YIF1B FinGER8 ENSG00000167645 "Yip1 interacting factor homolog B, membrane trafficking protein" Q5BJH7 19 38305104-38317273 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039328, HPA055257, HPA062675" Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA039328: , HPA055257: , HPA062675: " "unprognostic (2.51e-1)" "unprognostic (3.34e-1)" "unprognostic (1.38e-1)" "unprognostic (6.81e-2)" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.53e-5)" "unprognostic (1.37e-1)" "unprognostic (1.45e-2)" "unprognostic (5.53e-2)" "prognostic favourable (1.88e-4)" "unprognostic (4.57e-2)" "unprognostic (2.40e-2)" "unprognostic (3.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.64e-1)" "unprognostic (3.94e-3)" 15.8 16.5 18.6 24.1 21.3 46.0 17.1 19.3 34.4 13.9 15.8 27.4 13.9 15.7 12.4 12.4 17.5 14.8 13.0 18.4 21.8 19.6 16.7 59.7 17.6 25.2 23.5 24.0 13.9 21.0 10.8 15.1 18.2 25.9 12.4 12.9 13.5 21.2 12.0 20.3 14.3 14.2 14.2 27.1 24.3 11.5 13.5 20.9 18.2 11.7 16.6 15.7 15.6 12.5 10.8 67.3 38.5 35.9 9.1 14.6 24.3 11.6 30.1 13.5 15.9 19.6 18.3 10.7 28.6 21.9 21.3 31.4 14.6 8.9 20.6 12.6 32.9 7.5 23.8 14.9 8.1 21.8 12.5 31.6 13.5 15.1 27.2 22.0 37.5 15.0 13.4 21.8 9.5 19.7 40.6 57.2 18.9 12.5 23.1 26.4 10.3 9.6 24.0 16.4 31.5 13.6 11.1 9.8 16.4 9.4 21.3 15.2 8.3 44.2 18.8 21.1 21.1 30.3 22.5 21.5 31.6 13.6 27.3 40.6 15.1 15.4 35.9 38.5 14.6 26.2 12.8 10.8 13.8 13.0 67.3 8.4 11.5 11.6 9.8 9.1 14.7 28.4 12.8 24.3 18.6 21.3 19.3 34.4 21.8 19.6 23.5 24.0 25.9 20.9 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 11.8 16.4 9.2 8.3 9.3 13.5 12.9 12.0 16.8 16.0 13.8 11.9 15.3 17.0 14.4 26.7 17.1 17.6 16.7 11.9 9.7 10.6 16.4 34.3 11.8 9.6 10.7 10.3 18.4 56.4 11.1 40.7 35.5 11.9 14.0 8.4 16.6 53.5 20.7 11.1 11.2 14.6 8.8 8.4 10.2 18.4 52.0 10.6 11.0 22.1 12.9 12.5 13.9 13.8 10.8 22.3 16.2 14.7 7.2 9.8 6.7 23.1 8.6 5.7 9.1 14.6 13.7 11.8 18.6 21.6 12.6 18.0 25.6 19.2 4.6 30.4 19.2 18.1 4.4 17.8 3.6 15.0 16.1 9.1 9.6 13.8 23.7 15.1 18.8 13.3 12.7 8.9 13.9 9.8 11.3 24.9 8.6 39.6 9.5 15.5 11.0 20.7 8.3 5.3 23.2 12.1 11.0 17.3 8.7 13.0 20.7 17.6 19.7 21.1 14.3 16.0 5.9 23.1 13.2 37.0 14.4 8.4 25.4 26.6 17.0 16.2 13.2 5.6 9.8 14.7 7.6 10.8 7.9 9.0 14.8 7.2 7.0 9.8 2.1 7.2 12.4 22.3 7.8 6.7 9.2 9.3 12.0 16.8 9.7 10.6 10.7 10.3 11.9 10.6 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511827-43516990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: " "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 26.8 51.0 26.1 20.3 36.8 19.3 28.1 24.2 48.9 33.5 30.4 38.1 40.3 31.9 31.2 50.5 31.9 34.4 39.9 30.9 26.2 25.5 44.2 62.0 30.0 21.1 26.1 21.4 34.0 73.7 47.0 38.9 59.3 29.7 36.0 29.9 36.8 75.4 31.8 30.6 26.9 38.4 27.4 28.1 28.0 38.8 27.8 22.6 27.9 51.2 31.3 32.9 32.8 26.5 11.7 18.5 74.3 19.7 14.6 18.3 16.0 23.0 16.2 24.0 46.4 54.0 43.8 14.5 27.9 43.3 23.1 29.3 19.4 16.9 9.5 22.3 51.2 23.3 17.6 27.2 14.7 17.3 25.2 14.8 23.9 36.8 42.0 15.7 22.3 43.6 35.5 19.6 19.5 34.8 16.0 21.9 27.5 35.4 11.9 20.0 12.4 18.1 10.5 11.1 24.9 41.2 24.6 19.4 27.8 12.7 16.8 29.4 27.7 32.9 33.0 26.3 13.9 14.4 19.2 25.9 20.7 18.8 18.7 13.5 17.7 26.2 19.7 28.3 15.3 18.5 13.3 11.7 13.8 13.5 18.5 11.7 11.3 12.6 74.3 14.6 18.4 17.0 18.3 16.0 26.1 36.8 24.2 48.9 26.2 25.5 26.1 21.4 29.7 22.6 YIPF4 "FinGER4, MGC11061" ENSG00000119820 "Yip1 domain family member 4" Q9BSR8 2 32277910-32316594 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017884 Supported Supported "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus" "Vesicles, Plasma membrane" "HPA017884: AB_1853855" "unprognostic (5.61e-3)" "unprognostic (8.50e-2)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (7.64e-2)" "unprognostic (3.45e-2)" "unprognostic (3.61e-2)" "unprognostic (3.69e-1)" "unprognostic (8.70e-2)" "unprognostic (4.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (6.11e-2)" 15.2 15.3 15.7 12.3 19.2 6.0 19.5 24.9 27.2 15.6 16.0 21.7 16.9 13.6 19.6 17.7 15.3 13.3 12.3 19.1 17.7 16.5 18.7 24.0 13.4 12.9 18.5 13.3 17.9 32.9 14.2 22.3 19.2 17.6 16.1 15.0 15.4 24.1 14.2 16.8 16.5 14.6 15.8 17.7 15.4 14.7 15.2 16.3 18.7 23.6 12.2 13.6 14.6 14.2 5.0 5.8 16.5 6.0 7.0 5.4 4.4 8.3 4.2 8.4 7.5 9.8 12.6 4.4 7.2 7.3 7.6 5.0 5.6 6.4 4.5 5.1 7.8 6.6 8.9 6.3 9.9 7.2 13.8 7.2 9.9 10.1 11.6 9.5 6.2 8.7 12.2 6.8 10.9 6.4 9.8 9.4 8.2 5.5 7.4 10.0 6.8 7.3 5.2 12.4 8.4 8.1 3.6 9.5 9.1 6.2 6.3 10.7 3.5 8.1 7.1 10.1 4.8 7.0 6.8 14.0 17.2 5.4 15.9 9.3 5.5 12.5 6.0 5.9 5.0 5.4 4.3 5.0 5.1 4.7 4.9 4.8 5.4 4.7 16.5 7.0 5.2 5.8 4.7 4.4 15.7 19.2 24.9 18.9 17.7 16.5 18.5 13.3 17.6 16.3 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: , HPA073622: " "prognostic unfavourable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.12e-5)" "prognostic unfavourable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.4 7.7 10.0 7.9 24.0 26.0 9.1 39.2 26.6 17.7 28.6 12.2 12.1 6.3 18.9 42.5 10.6 9.5 19.2 23.9 8.8 8.3 4.6 13.4 12.4 19.4 10.3 7.7 19.6 18.0 15.8 13.0 16.7 4.9 10.6 23.8 6.0 5.0 5.9 6.4 8.4 5.4 14.9 10.4 11.0 10.2 6.8 8.4 13.6 7.3 17.4 15.2 6.8 64.4 20.9 10.1 20.1 15.4 9.7 15.9 8.0 19.9 9.9 15.1 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 YKT6 ENSG00000106636 "YKT6 v-SNARE homolog" O15498 7 44200968-44214294 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030817, HPA030818" Approved Approved Mitochondria,Cytosol Cytosol Mitochondria "HPA030817: AB_10599828, HPA030818: AB_10602102" "unprognostic (1.25e-1)" "unprognostic (7.35e-3)" "unprognostic (1.30e-3)" "unprognostic (7.80e-3)" "unprognostic (7.45e-3)" "prognostic unfavourable (4.64e-4)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.77e-3)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (8.65e-2)" "unprognostic (1.63e-1)" "unprognostic (2.01e-2)" "unprognostic (1.34e-2)" "unprognostic (7.66e-3)" 26.5 21.9 35.1 21.4 30.6 31.1 23.1 19.0 32.2 21.8 27.6 26.5 27.9 21.1 21.0 32.6 31.1 16.0 16.8 22.3 34.9 33.5 24.4 17.3 19.6 25.7 36.1 24.0 14.3 51.2 29.7 21.6 25.7 26.8 21.3 26.7 18.3 39.1 24.6 29.1 21.8 21.7 27.1 31.4 20.5 24.9 27.3 25.1 22.2 21.0 23.4 26.3 17.5 15.5 7.7 11.1 15.7 12.8 7.2 12.4 6.3 22.5 23.9 20.1 28.1 25.3 22.2 16.6 45.6 35.0 25.6 26.0 25.1 18.7 21.6 20.6 44.8 27.9 24.5 30.2 32.7 26.0 23.5 12.6 17.7 15.7 31.7 26.7 23.1 20.7 29.6 31.2 33.4 30.8 29.1 16.0 33.9 23.4 19.9 29.7 49.1 40.0 21.9 18.2 18.6 21.1 19.1 23.6 46.4 21.7 34.7 24.7 27.3 27.6 35.2 27.5 34.1 27.1 50.2 42.7 47.1 32.1 37.4 23.7 53.8 5.9 11.2 15.7 7.8 12.8 11.0 6.9 9.2 12.4 10.3 7.7 8.8 8.6 9.5 7.2 12.1 11.1 9.4 6.3 35.1 30.6 19.0 32.2 34.9 33.5 36.1 24.0 26.8 25.1 YLPM1 "C14orf170, PPP1R169, ZAP" ENSG00000119596 "YLP motif containing 1" P49750 14 74763366-74859435 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048070, HPA061123" Uncertain Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA048070: , HPA061123: AB_2684435" "unprognostic (2.17e-1)" "unprognostic (3.32e-2)" "unprognostic (3.95e-1)" "unprognostic (2.98e-1)" "unprognostic (3.79e-2)" "unprognostic (7.64e-2)" "unprognostic (3.22e-3)" "unprognostic (8.74e-2)" "unprognostic (3.60e-2)" "unprognostic (2.56e-1)" "unprognostic (7.83e-3)" "unprognostic (6.63e-2)" "prognostic favourable (6.08e-7)" "unprognostic (1.09e-2)" "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" 17.2 19.0 28.9 21.7 33.4 26.1 21.0 51.4 32.6 18.6 15.4 24.9 18.8 13.1 23.8 20.6 17.4 20.6 15.9 15.8 24.2 18.2 15.7 14.0 16.4 20.8 24.1 24.8 31.3 21.0 30.9 30.5 19.8 22.5 20.0 17.2 18.8 20.6 22.8 20.7 23.0 16.5 17.7 21.2 18.9 16.2 28.8 27.6 24.7 22.5 8.7 20.6 22.4 18.7 5.5 7.8 3.3 3.9 5.4 4.6 3.0 18.9 21.1 23.1 4.4 16.6 16.2 12.5 13.2 13.5 13.4 13.5 18.5 13.7 28.5 9.9 14.8 17.2 20.0 13.7 21.3 17.1 11.5 20.6 13.4 12.6 9.0 15.7 15.7 14.2 9.1 15.1 11.4 18.2 16.3 13.6 16.5 19.5 18.1 12.7 13.8 17.7 27.3 23.0 9.9 10.7 27.4 17.0 16.7 21.2 13.1 5.0 15.6 10.4 27.3 16.2 20.8 11.6 16.5 16.7 16.0 31.4 14.1 11.5 12.1 0.7 3.4 3.3 3.8 3.9 4.2 4.4 3.2 3.2 3.1 5.5 4.6 4.6 2.7 5.4 3.1 7.8 2.7 3.0 28.9 33.4 51.4 32.6 24.2 18.2 24.1 24.8 22.5 27.6 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: " "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.0 30.1 36.1 17.8 35.4 38.1 29.5 39.6 23.2 40.7 46.7 40.7 49.4 42.8 26.4 43.7 38.8 43.3 35.0 45.0 38.8 26.0 40.6 26.9 28.5 38.9 27.7 33.4 31.2 41.4 35.5 36.0 42.5 47.1 43.6 44.9 27.1 51.2 16.0 28.6 14.1 44.3 57.9 39.5 33.2 19.1 27.8 35.6 39.6 30.8 39.7 29.5 34.8 41.6 24.7 34.5 41.4 35.5 21.9 32.1 54.7 35.1 51.5 18.8 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.7" "Cell line enhanced" "Detected in many" "HEL: 39.4;K-562: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" 40000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 4.5 4.6 4.0 4.0 5.3 44.7 6.6 4.8 7.5 6.1 3.9 7.6 2.6 4.1 4.0 3.1 24.5 3.7 3.5 5.0 4.0 2.2 4.5 5.2 9.4 4.2 7.1 4.4 3.5 3.6 2.5 5.1 6.3 5.1 3.4 4.0 3.4 9.7 3.0 6.5 14.9 4.8 2.7 8.5 5.2 8.4 5.6 6.9 14.3 5.8 10.0 8.2 5.8 12.3 0.5 1.3 3.9 1.5 1.2 1.8 0.9 5.3 2.8 4.5 2.7 1.6 2.1 8.8 3.5 2.7 2.7 2.7 5.4 5.5 2.8 1.4 2.1 5.9 0.0 4.3 3.0 2.2 4.8 39.4 11.6 2.5 1.5 5.1 13.9 1.5 3.4 2.2 8.4 2.3 27.4 0.0 2.3 0.0 4.5 2.8 4.3 6.4 2.3 0.2 2.0 2.7 6.0 2.3 5.2 5.8 6.7 7.6 2.4 3.6 1.1 2.3 6.1 1.9 4.6 4.5 0.2 4.2 2.7 0.0 1.5 3.9 1.2 2.0 1.1 1.5 1.5 0.4 1.7 0.9 1.3 0.5 1.4 1.8 2.9 1.2 1.0 0.7 0.8 0.9 4.0 5.3 4.8 7.5 4.0 2.2 7.1 4.4 5.1 6.9 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 164.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA042809: " "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 29.6 32.5 39.0 20.1 38.2 164.9 32.9 34.2 52.9 31.2 34.6 20.7 38.2 19.4 28.7 40.9 35.1 25.6 30.8 26.1 38.1 39.5 40.5 29.8 31.9 30.5 35.3 32.5 30.0 23.4 24.6 26.0 48.1 36.4 33.8 22.2 33.1 28.7 47.6 27.7 26.1 29.1 36.8 30.6 29.6 27.2 31.4 18.3 34.2 39.0 20.6 28.2 40.1 25.2 21.3 35.0 72.4 31.9 12.5 21.6 30.9 10.0 5.5 12.1 5.9 34.3 33.3 10.3 14.2 44.0 8.3 12.8 4.5 10.4 5.9 9.7 28.6 5.4 2.8 14.5 11.7 26.2 5.4 3.1 2.5 7.3 29.3 1.0 7.3 34.3 29.5 15.6 20.1 15.6 4.3 10.6 22.2 5.2 3.2 7.2 6.7 6.6 1.9 16.3 5.6 27.6 19.5 4.9 14.9 7.2 7.0 17.6 7.8 5.8 20.4 22.4 8.6 6.1 3.9 25.3 9.9 7.9 16.0 2.8 9.0 41.7 19.6 43.1 13.6 21.8 13.5 21.3 16.6 15.9 18.2 17.4 16.0 14.1 72.4 12.5 31.9 35.0 21.6 30.9 39.0 38.2 34.2 52.9 38.1 39.5 35.3 32.5 36.4 18.3 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350089 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favourable (7.29e-5)" 22.1 16.6 25.1 28.8 33.2 101.8 24.3 38.4 25.8 30.3 20.8 24.4 24.0 16.7 29.2 25.1 25.4 20.2 17.6 18.5 23.5 19.6 19.8 19.5 21.1 26.8 26.1 23.4 39.7 24.2 27.6 32.4 33.2 22.8 25.2 21.3 13.8 22.7 30.2 32.9 26.1 21.2 27.6 25.4 23.6 20.6 17.7 35.1 30.2 23.8 20.2 26.7 34.8 30.3 18.0 15.1 41.6 9.3 7.5 11.1 3.2 17.4 10.5 21.5 12.9 12.9 11.3 17.8 19.2 12.2 12.1 12.7 12.9 16.1 28.6 15.8 9.8 13.2 20.1 16.9 19.7 21.2 12.2 21.8 15.0 14.3 13.3 23.0 16.9 10.6 18.4 10.8 25.9 13.0 20.6 16.8 17.6 13.3 26.8 20.8 16.1 10.4 23.5 24.3 12.7 18.9 20.3 18.6 14.6 16.8 18.2 13.9 14.2 16.1 13.8 13.9 14.7 9.5 12.7 17.6 11.8 29.9 9.4 15.0 12.7 20.2 8.3 14.7 9.9 5.0 7.7 12.7 8.0 7.9 4.6 18.0 11.1 9.2 41.6 7.5 9.3 15.1 7.3 3.2 25.1 33.2 38.4 25.8 23.5 19.6 26.1 23.4 22.8 35.1 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513683-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: " "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favourable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 15.2 16.3 12.4 18.5 16.8 12.8 15.3 25.2 26.1 16.5 12.7 11.7 9.0 13.6 17.7 14.6 16.1 14.2 12.2 13.0 10.4 10.5 14.3 18.3 12.4 18.7 12.8 10.2 19.9 14.7 35.5 26.2 10.3 18.6 12.8 15.3 14.9 15.5 13.3 18.5 16.5 16.5 13.2 13.7 19.3 13.4 20.5 13.3 19.7 16.2 15.4 18.4 14.7 14.8 9.5 5.5 4.2 4.9 5.7 5.7 1.7 11.1 10.0 13.1 22.0 7.3 9.7 14.3 8.6 9.6 11.1 17.3 7.0 6.3 20.3 6.2 7.2 10.9 15.7 19.3 14.5 8.7 14.2 11.0 18.0 9.4 10.8 8.8 9.8 7.9 7.5 6.9 12.8 15.3 10.8 9.4 9.7 3.7 12.1 6.3 6.0 6.6 5.1 11.3 15.7 9.2 14.8 10.5 8.8 11.6 8.5 8.8 11.9 7.9 13.3 17.0 5.9 8.7 11.7 9.6 12.0 12.7 9.8 10.1 7.2 0.0 4.3 4.2 4.5 2.8 5.3 9.5 5.3 4.8 3.6 8.1 5.7 4.7 1.8 5.7 4.9 5.5 3.7 1.7 12.4 16.8 25.2 26.1 10.4 10.5 12.8 10.2 18.6 13.3 YTHDF2 "CAHL, HGRG8, NY-REN-2" ENSG00000198492 "YTH N6-methyladenosine RNA binding protein 2" Q9Y5A9 1 28736621-28769775 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030063, HPA054080, HPA059621" Approved Enhanced "Cytosol,Cytoplasmic bodies" Cytosol "Cytoplasmic bodies" "HPA030063: , HPA054080: , HPA059621: AB_2684084" "unprognostic (8.75e-2)" "unprognostic (1.90e-2)" "unprognostic (4.66e-3)" "unprognostic (1.63e-1)" "unprognostic (3.03e-1)" "unprognostic (1.49e-1)" "prognostic unfavourable (6.14e-9)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (4.18e-2)" "unprognostic (1.69e-1)" "unprognostic (4.11e-2)" "unprognostic (2.07e-1)" "unprognostic (1.21e-1)" "unprognostic (6.38e-2)" "unprognostic (9.29e-2)" "unprognostic (6.97e-3)" 31.1 33.0 18.2 27.0 19.9 42.0 52.4 21.5 28.3 23.7 23.6 20.4 31.5 22.1 26.6 35.1 36.0 26.1 21.7 23.3 18.5 19.4 26.8 35.8 30.0 42.5 18.1 21.3 25.5 37.2 29.7 18.4 32.6 20.2 21.7 26.2 22.1 34.4 31.3 39.6 36.5 24.4 25.1 15.1 29.8 24.8 28.0 17.0 44.2 26.4 30.4 31.7 24.7 31.0 36.5 42.2 33.3 39.9 39.0 40.4 41.8 21.5 15.1 33.0 31.9 25.7 19.8 37.9 21.0 26.3 26.3 26.8 13.7 25.5 37.0 21.0 27.0 20.2 38.1 34.2 31.5 23.2 27.7 31.1 20.7 25.1 30.4 32.7 24.6 26.6 35.4 28.3 40.6 32.2 31.2 18.5 29.5 16.9 34.6 25.8 53.0 19.3 30.0 24.4 30.5 36.9 31.0 28.2 30.0 21.9 33.8 56.8 22.3 30.9 21.9 18.6 19.2 17.3 29.7 22.2 14.2 42.5 21.3 25.9 29.5 33.3 32.4 32.6 28.9 39.9 40.0 36.5 33.9 36.4 42.2 25.5 36.1 34.1 11.5 39.0 38.0 25.9 40.4 41.8 18.2 19.9 21.5 28.3 18.5 19.4 18.1 21.3 20.2 17.0 YTHDF3 FLJ31657 ENSG00000185728 "YTH N6-methyladenosine RNA binding protein 3" Q7Z739 8 63168553-63212786 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048703 Approved "Nuclear membrane,Nuclear speckles,Cytosol" "Nuclear speckles" "Nuclear membrane, Cytosol" "HPA048703: " "unprognostic (1.06e-2)" "unprognostic (9.89e-3)" "unprognostic (6.65e-3)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (7.87e-2)" "unprognostic (9.57e-2)" "unprognostic (2.07e-1)" "unprognostic (6.14e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (1.35e-3)" "unprognostic (1.11e-1)" 21.7 17.5 12.2 12.8 15.2 53.2 16.0 16.7 17.3 19.4 20.2 14.3 16.8 14.2 24.3 13.6 17.7 17.6 17.6 26.9 11.9 11.4 18.8 26.8 16.8 12.4 14.2 10.6 25.1 15.6 16.6 19.3 29.0 16.8 21.2 15.6 12.9 18.1 18.8 28.0 12.7 24.7 19.4 14.4 18.1 15.9 13.3 14.2 20.1 17.2 15.9 14.1 21.0 15.9 8.2 16.9 21.2 24.9 9.7 11.0 10.1 16.0 21.8 21.0 15.8 28.1 24.2 14.4 29.3 24.6 18.6 22.1 18.5 16.1 17.0 6.4 28.5 15.4 27.6 19.5 27.7 13.8 13.1 31.6 16.5 12.5 25.6 9.0 15.6 32.0 15.0 19.9 27.9 15.7 18.5 15.6 27.9 11.1 17.2 8.4 29.2 16.1 13.1 16.1 8.4 17.5 28.5 8.6 15.4 20.8 18.8 21.2 25.2 11.4 28.2 17.4 16.8 15.5 15.7 18.8 17.0 25.5 17.7 12.7 20.9 20.6 16.6 17.4 8.9 19.4 9.8 7.4 9.0 10.5 16.9 8.2 11.0 10.5 21.2 9.7 24.9 5.1 9.4 10.1 12.2 15.2 16.7 17.3 11.9 11.4 14.2 10.6 16.8 14.2 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol 210000000 Cytosol "Nucleoplasm, Nucleoli" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavourable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavourable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavourable (6.14e-4)" "prognostic unfavourable (1.91e-6)" "prognostic unfavourable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favourable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 51.8 39.3 31.7 30.4 52.8 46.7 43.0 47.2 46.0 58.2 51.1 81.8 58.8 55.4 49.5 62.3 55.2 44.7 87.8 69.6 21.2 27.3 41.2 34.6 48.5 35.0 66.7 39.9 36.5 65.7 45.6 58.9 58.2 44.4 26.8 59.7 61.3 52.0 55.0 29.9 61.2 40.9 46.0 43.0 62.3 58.0 33.9 36.1 80.0 85.6 55.1 62.3 64.2 66.0 90.5 46.5 51.0 48.0 17.9 32.6 50.8 66.1 44.7 46.0 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344272-1400378 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350, HPA061603" Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: " "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favourable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 55.2 54.3 107.5 35.3 87.1 32.7 37.3 71.5 118.4 28.4 40.2 60.9 23.8 40.2 35.9 54.1 43.1 44.2 23.4 57.7 92.3 81.9 64.5 50.9 32.8 25.4 94.1 77.9 40.2 40.2 41.0 37.9 45.1 73.7 35.0 42.5 27.9 42.4 27.7 135.9 36.8 36.2 32.2 101.1 26.2 38.5 46.0 53.6 30.9 47.5 36.5 37.2 31.6 32.1 19.2 41.5 17.2 36.2 15.0 23.3 31.5 77.8 58.2 70.5 59.3 31.2 36.1 67.8 50.4 29.7 45.0 34.9 104.0 32.0 52.9 59.2 41.7 54.1 59.7 50.9 63.8 36.5 111.3 36.9 48.6 44.5 37.3 35.3 37.8 32.7 37.6 45.0 69.0 54.1 42.3 38.2 57.8 37.9 46.7 28.2 64.6 37.8 56.8 33.3 37.5 45.8 45.1 39.3 59.7 60.6 24.9 39.4 47.2 32.7 51.1 43.7 37.1 55.1 88.9 24.0 44.3 44.4 52.4 42.3 63.1 17.2 31.8 8.6 12.4 36.2 15.6 19.2 18.7 13.9 41.5 16.1 17.0 14.3 10.8 15.0 30.9 28.8 23.3 31.5 107.5 87.1 71.5 90.2 92.3 81.9 94.1 77.9 73.7 53.6 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavourable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavourable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.1 46.7 41.4 52.5 42.4 24.5 18.7 43.2 21.4 26.8 29.2 29.3 40.0 52.4 14.9 38.3 34.8 51.8 47.7 37.8 35.5 22.6 49.6 32.0 32.5 38.7 60.5 48.6 26.8 45.8 31.3 64.9 42.6 68.1 59.3 40.0 35.0 43.2 44.7 45.9 32.8 50.7 41.9 57.9 42.1 25.4 22.2 61.7 47.9 61.4 30.6 42.7 36.7 44.9 52.4 30.5 46.4 57.7 19.7 36.9 80.7 47.1 57.3 55.8 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944461-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 154.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025918, HPA061603" Uncertain Approved Nucleoli,Cytosol 130000000 Cytosol Nucleoli "CAB025918: , HPA061603: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 21.5 18.6 87.9 20.6 47.4 16.3 19.3 41.9 154.3 13.7 24.4 10.0 4.3 17.2 13.1 14.1 14.0 16.4 18.6 15.2 78.8 59.1 11.7 11.5 25.0 13.5 35.5 101.6 10.0 16.7 5.2 10.4 22.4 49.5 12.3 20.1 6.8 9.9 15.6 13.9 9.9 17.4 25.9 19.4 12.8 26.9 3.7 9.1 6.3 10.5 5.5 15.1 18.5 10.6 8.1 16.6 14.9 14.4 17.7 12.8 9.6 67.9 27.2 30.4 17.7 18.5 17.1 19.3 66.1 32.7 38.1 43.6 28.8 23.7 40.1 16.1 60.6 32.9 36.4 36.3 36.0 35.5 31.7 23.7 21.4 25.7 18.7 76.3 26.5 15.5 19.4 32.1 22.9 31.1 32.7 29.4 29.0 27.4 23.1 35.1 36.2 29.8 33.2 41.9 21.3 24.0 29.4 65.4 21.5 37.6 26.3 23.5 15.0 18.9 49.7 38.5 38.5 28.2 41.9 16.4 25.3 50.2 27.9 30.8 33.8 7.8 14.4 14.9 5.7 11.8 8.1 8.1 7.0 8.1 16.6 7.6 2.8 3.6 8.7 17.7 12.2 4.5 12.8 9.6 87.9 47.4 41.9 126.3 78.8 59.1 35.5 101.6 49.5 9.1 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported Nucleoplasm,Nucleoli,Cytosol 120000000 Cytosol "Nucleoplasm, Nucleoli" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavourable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 42.7 64.5 58.5 56.5 46.1 63.8 55.0 58.8 57.9 61.8 51.9 48.5 37.7 55.4 30.7 84.2 40.3 64.9 64.1 79.8 136.3 52.8 51.8 42.1 51.8 35.3 49.8 31.4 43.1 37.7 67.4 44.0 69.3 50.8 33.5 75.9 29.8 88.2 50.9 99.3 74.4 64.6 75.9 67.8 68.0 38.3 55.7 94.4 53.5 55.5 42.5 34.5 25.7 63.1 77.7 55.1 67.2 89.6 34.2 46.8 73.1 66.4 52.1 64.4 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved Nucleoplasm,Nucleoli,Cytosol 760000000 Cytosol "Nucleoplasm, Nucleoli" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavourable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (2.28e-5)" "prognostic unfavourable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 138.9 67.6 129.0 37.0 32.1 40.8 63.9 65.3 85.0 88.5 86.2 47.0 91.2 62.5 70.9 103.7 60.5 81.1 93.1 134.8 55.3 32.0 59.0 51.2 30.4 42.3 24.6 67.7 37.8 126.9 73.1 116.5 79.4 67.0 61.3 75.6 50.5 101.6 43.7 43.6 70.9 43.3 37.6 42.9 85.1 78.5 72.2 51.5 49.7 49.3 103.4 71.4 29.1 64.6 44.9 65.9 54.1 58.5 39.1 46.4 76.7 74.3 46.5 183.7 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 YY1 "DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1" ENSG00000100811 "YY1 transcription factor" P25490 14 100238298-100282792 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001119, CAB009392" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" Nucleoplasm "Nucleoli fibrillar center, Vesicles" "CAB009392: AB_2218501, HPA001119: AB_1858930" "unprognostic (7.67e-2)" "unprognostic (8.08e-2)" "unprognostic (2.57e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (6.75e-3)" "unprognostic (8.31e-3)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.09e-1)" "unprognostic (4.26e-2)" "unprognostic (7.68e-3)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-2)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "unprognostic (2.30e-1)" "unprognostic (4.30e-1)" 32.7 28.8 26.3 27.0 25.8 45.3 33.8 33.6 26.4 28.1 37.6 24.9 34.6 26.4 29.5 33.7 34.1 24.4 27.4 38.3 27.6 21.9 31.4 42.8 31.8 30.6 26.5 21.1 26.9 27.7 32.5 23.6 35.2 24.1 29.3 28.2 21.5 25.6 23.1 39.9 27.2 31.0 25.9 26.5 30.6 25.3 22.6 25.8 60.2 40.9 23.3 35.2 29.7 47.0 8.2 6.3 14.2 7.0 12.0 9.0 3.0 23.7 12.5 25.8 20.5 20.6 25.8 28.0 23.6 21.3 25.7 26.0 15.1 39.9 36.3 33.6 20.5 24.9 28.1 24.3 35.1 28.2 22.7 33.8 14.6 19.4 19.1 40.3 29.5 15.6 29.2 17.7 24.4 24.3 26.2 25.4 24.2 29.5 43.8 22.0 27.0 21.6 35.8 35.9 19.7 28.8 23.5 27.5 20.4 31.5 22.7 31.9 35.0 37.0 22.1 16.0 20.0 38.8 20.6 26.6 27.0 50.3 22.2 26.1 20.6 5.1 7.0 14.2 5.5 5.9 7.0 6.3 7.6 7.7 6.1 8.2 7.1 6.8 12.2 12.0 4.5 6.3 9.0 3.0 26.3 25.8 33.6 26.4 27.6 21.9 26.5 21.1 24.1 25.8 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Cell line enhanced" "Detected in some" "HEL: 4.0;K-562: 15.9;MOLT-4: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195108-75209348 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA021468: AB_1858932, HPA053646: " "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.94e-4)" "unprognostic (2.23e-1)" 14.1 12.1 15.6 12.5 22.5 12.7 28.1 19.1 24.1 15.5 18.9 10.8 13.6 13.7 12.8 19.0 18.1 13.5 15.7 24.4 17.4 11.3 18.0 23.4 13.3 12.7 12.9 18.4 19.6 19.5 22.4 20.5 26.2 19.3 13.8 21.4 13.5 16.3 14.1 34.5 15.8 24.0 16.9 12.1 15.0 15.5 7.1 11.2 11.2 20.7 15.5 14.5 17.4 15.5 2.7 3.3 12.1 5.2 2.5 4.8 2.3 9.3 6.2 6.6 13.5 10.3 13.4 7.3 16.9 19.7 6.7 8.4 3.8 13.3 6.5 2.7 16.7 12.7 8.2 14.3 4.7 40.6 12.0 14.7 13.7 7.3 7.4 24.7 15.0 14.8 14.3 5.3 12.3 13.7 7.9 24.1 12.7 10.9 6.2 12.2 1.7 14.2 13.3 10.6 21.5 13.0 15.8 12.3 10.1 9.4 9.7 10.7 9.7 12.3 12.1 13.1 10.1 4.1 5.3 3.9 17.1 4.5 8.7 21.5 10.6 1.9 5.0 12.1 4.8 4.2 3.8 2.7 4.1 4.5 3.3 2.5 2.3 3.5 2.7 2.5 5.2 2.5 4.4 2.3 15.6 22.5 19.1 24.1 17.4 11.3 12.9 18.4 19.3 11.2 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Cell line enhanced" "Detected in many" "BEWO: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077591 Approved "Nucleoplasm,Nuclear membrane,Centrosome" Nucleoplasm "Nuclear membrane, Centrosome" "HPA077591: " "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.1 12.9 9.4 10.3 6.0 6.4 42.5 7.3 8.1 4.3 5.0 16.4 4.6 10.2 8.5 9.7 2.4 8.9 7.6 3.2 12.0 11.9 7.6 11.0 13.9 7.9 4.6 15.9 9.4 6.0 4.5 3.4 10.2 9.6 3.4 8.4 3.6 7.7 3.7 23.1 7.6 6.2 9.3 4.8 7.2 10.1 11.2 11.0 6.2 16.8 11.6 4.6 10.0 13.9 9.3 4.9 5.1 7.9 4.1 0.0 16.9 3.8 6.7 5.2 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595443 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 21.0;thyroid gland: 74.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 19.7;EFO-21: 13.7;HaCaT: 19.0;HBEC3-KT: 42.6;RPTEC TERT1: 28.4" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Region enriched" "Detected in single" 6 "basal ganglia: 1.4" "Cell type enhanced" "Detected in many" "naive B-cell: 4.0" "Group enriched" "Detected in many" 6 "B-cells: 4.0;T-cells: 2.5" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavourable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.1 0.9 1.4 0.0 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.0 0.2 0.2 8.1 11.1 0.2 0.1 0.1 0.0 0.3 0.1 5.6 3.4 0.1 0.1 1.2 0.1 0.0 0.4 4.0 0.1 0.1 0.0 0.1 1.7 0.1 0.1 1.3 0.3 0.1 0.1 0.1 0.1 0.2 0.2 21.0 74.5 7.5 7.4 0.2 6.2 4.0 0.0 0.1 0.0 0.5 2.5 0.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.1 13.7 0.0 19.0 0.0 42.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 3.6 0.6 0.3 0.0 4.0 1.9 2.5 0.1 0.5 0.0 0.0 1.1 0.3 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087323 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;MOLT-4: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA055995: " "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favourable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 14.4 5.2 8.0 3.0 16.6 3.4 13.0 6.7 10.8 10.5 6.9 20.5 6.4 5.7 15.8 12.7 3.8 10.6 5.3 6.5 9.5 6.2 18.0 16.2 7.3 3.3 22.7 7.2 12.2 10.9 13.9 9.0 3.6 9.5 7.8 6.5 8.3 8.3 10.3 3.7 3.9 5.0 13.0 10.5 5.0 8.7 4.0 13.7 5.2 16.4 1.6 2.8 5.4 5.8 0.2 1.8 0.3 1.1 0.1 0.8 0.2 3.3 2.7 3.6 19.6 15.0 1.0 0.2 1.1 3.3 1.7 4.6 5.8 1.6 0.0 7.3 2.2 0.4 1.9 1.2 1.5 1.1 3.6 2.6 5.9 6.6 9.0 3.5 1.0 16.8 4.5 0.8 3.4 5.5 0.0 7.3 1.0 3.3 18.5 0.5 2.3 1.6 7.7 6.8 1.0 8.1 1.2 3.9 8.3 3.9 3.3 5.6 4.9 2.4 2.2 1.5 3.0 3.4 4.5 5.3 5.0 7.5 2.4 6.7 3.5 0.0 1.1 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.2 0.8 0.8 0.3 0.1 0.1 1.8 0.0 0.2 8.0 16.6 6.7 10.8 9.5 6.2 22.7 7.2 9.5 13.7 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: , HPA050994: " "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavourable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favourable (3.87e-4)" 21.6 18.5 20.4 32.6 21.6 21.5 27.5 43.2 30.2 35.6 24.7 22.0 17.2 18.4 34.7 27.6 22.5 30.8 19.8 32.7 21.3 13.1 24.0 13.0 24.5 38.1 24.0 23.4 40.2 24.4 42.0 44.6 20.9 27.1 30.1 22.7 16.3 24.9 19.1 32.6 36.8 29.4 22.4 30.5 35.6 22.2 17.2 25.3 45.0 34.9 17.7 32.3 30.0 26.4 18.4 12.4 5.8 8.4 13.4 14.5 6.2 19.7 16.0 27.9 18.2 15.2 24.0 14.4 16.2 16.9 11.1 11.0 11.4 43.2 22.0 12.3 12.0 24.6 17.4 16.8 15.1 21.1 15.7 5.6 33.6 7.0 12.5 18.0 7.6 16.1 24.8 8.3 18.5 13.7 14.7 24.9 15.9 10.0 17.5 19.5 15.1 21.3 26.6 15.5 11.6 13.1 27.9 13.8 24.6 16.8 21.7 12.9 20.5 10.2 13.5 24.0 17.3 15.9 11.3 12.2 15.1 17.3 20.7 12.7 18.1 0.7 6.7 5.8 9.3 7.3 12.0 16.7 11.1 11.7 9.6 18.4 14.5 14.0 5.6 13.4 8.4 12.4 9.4 6.2 20.4 21.6 43.2 30.2 21.3 13.1 24.0 23.4 27.1 25.3 ZBED6 ENSG00000257315 "Zinc finger BED-type containing 6" P86452 1 203795714-203854999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA026439, HPA028490, HPA028526, HPA068807" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: " "unprognostic (1.79e-1)" "unprognostic (4.96e-3)" "unprognostic (4.81e-2)" "unprognostic (2.73e-1)" "unprognostic (6.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" "unprognostic (1.24e-2)" "unprognostic (2.28e-3)" "unprognostic (7.54e-3)" "unprognostic (1.56e-1)" "unprognostic (4.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.15e-3)" "unprognostic (1.47e-2)" 9.1 10.1 7.8 4.9 6.3 4.3 21.8 13.3 7.3 12.1 8.4 6.8 6.2 8.4 12.2 4.7 8.7 7.4 8.1 6.8 8.6 2.4 8.3 9.9 8.9 6.7 9.6 4.1 12.0 10.0 10.1 18.9 13.3 7.7 7.6 5.4 4.0 11.0 7.4 11.7 10.6 10.8 6.3 8.5 8.8 7.6 18.6 7.6 9.7 11.9 5.5 6.9 9.0 19.8 0.7 1.5 0.4 0.5 1.8 0.8 0.1 3.8 5.2 8.5 3.9 10.7 19.1 3.9 4.6 13.8 4.4 5.6 1.2 4.1 2.7 1.1 10.3 5.4 2.8 5.1 7.7 5.9 2.1 5.6 5.2 1.4 4.9 3.4 3.5 9.8 3.4 5.0 5.5 13.5 5.9 10.0 9.8 2.3 2.7 3.3 2.2 2.2 1.8 7.2 2.5 3.9 5.3 1.8 9.8 6.1 9.0 2.4 10.5 5.1 15.8 7.7 6.1 2.9 3.3 4.0 1.4 1.0 7.1 2.3 6.3 0.0 0.5 0.2 0.8 0.2 0.1 0.7 0.3 0.6 0.4 0.2 0.1 0.6 0.4 1.8 0.2 1.5 0.3 0.1 7.8 6.3 13.3 7.3 8.6 2.4 9.6 4.1 7.7 7.6 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150329789-150332721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.4;parathyroid gland: 11.3" "Cell line enhanced" "Detected in many" "HDLM-2: 40.1;K-562: 17.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: " "prognostic favourable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favourable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 0.4 37.4 0.4 2.6 0.4 1.7 0.8 0.3 0.2 1.1 1.4 1.6 2.0 0.2 1.2 1.9 0.4 0.4 0.3 0.6 1.8 5.6 1.5 3.9 0.3 3.1 3.2 11.3 2.5 0.0 1.5 1.5 1.1 0.9 0.1 2.2 2.1 0.6 0.1 2.3 1.7 0.3 1.8 3.7 1.3 0.8 3.6 1.0 2.8 1.0 2.8 3.5 2.4 4.4 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 6.2 4.7 2.5 2.2 0.0 1.8 0.0 0.0 0.3 40.1 3.2 3.1 6.6 10.5 1.3 0.0 4.7 0.8 2.4 0.0 0.0 0.2 17.2 6.7 0.0 2.0 7.6 1.8 3.0 0.0 0.0 0.3 5.6 2.1 8.9 8.5 4.9 6.8 1.9 0.3 0.5 2.1 0.1 0.0 0.0 0.0 0.0 5.4 1.5 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.7 0.7 3.2 2.2 2.4 3.4 0.7 3.6 3.5 2.9 2.8 2.8 0.2 1.0 2.2 2.4 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Cell line enhanced" "Detected in many" "EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.8 0.0 0.0 0.0 2.2 0.4 0.0 0.4 1.1 0.0 1.2 0.0 7.7 0.1 1.0 0.0 2.1 0.4 0.0 5.1 0.4 1.2 1.8 1.2 0.0 0.0 1.1 7.0 0.1 3.5 0.0 12.3 0.0 0.1 1.3 0.0 0.1 1.8 0.9 0.6 0.8 0.1 2.0 2.1 2.0 4.8 0.0 1.9 0.0 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 ZBTB1 "KIAA0997, ZNF909" ENSG00000126804 "Zinc finger and BTB domain containing 1" Q9Y2K1 14 64503712-64533690 "Predicted intracellular proteins, Transcription factors" "Differentiation, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050516 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA050516: " "unprognostic (4.09e-1)" "unprognostic (3.68e-1)" "unprognostic (1.08e-1)" "unprognostic (9.51e-2)" "unprognostic (1.28e-1)" "prognostic favourable (4.92e-4)" "unprognostic (1.11e-3)" "unprognostic (9.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.00e-1)" "unprognostic (9.65e-2)" "unprognostic (6.63e-2)" "unprognostic (3.34e-2)" "unprognostic (6.26e-2)" "unprognostic (2.23e-1)" "unprognostic (2.58e-1)" "unprognostic (3.27e-2)" 19.5 13.0 15.4 19.2 17.9 47.2 34.4 15.6 23.5 15.3 14.6 9.0 13.7 10.8 15.3 18.4 13.6 16.3 14.0 15.0 18.0 11.3 15.8 14.1 20.2 27.1 24.6 9.3 16.4 17.8 19.1 19.2 16.7 15.7 19.6 14.8 10.2 16.4 17.8 18.4 22.2 18.4 16.2 22.3 26.2 14.9 7.2 20.3 39.0 18.9 11.6 22.4 16.0 25.4 12.1 10.9 25.6 13.4 15.1 18.8 11.3 24.4 8.2 18.5 11.5 19.2 23.2 19.0 10.6 15.9 10.1 12.9 7.9 17.4 23.5 10.7 15.0 17.3 8.9 10.6 13.9 34.7 6.1 11.5 15.1 6.6 12.1 9.5 16.9 29.7 18.6 7.0 10.4 11.6 5.6 16.2 18.6 18.6 16.3 9.6 7.7 12.4 14.7 11.4 9.0 17.6 29.8 12.9 10.4 17.4 13.2 14.1 12.6 12.3 15.3 16.9 11.5 8.0 7.3 20.4 8.7 26.4 17.1 9.1 11.0 25.6 10.4 16.6 15.1 9.9 17.3 12.1 13.5 16.7 10.9 11.3 14.0 16.8 8.0 15.1 13.4 6.9 18.8 11.3 15.4 17.9 15.6 23.5 18.0 11.3 24.6 9.3 15.7 20.3 ZBTB2 "bA351K16.2, KIAA1483, ZNF437" ENSG00000181472 "Zinc finger and BTB domain containing 2" Q8N680 6 151364117-151391548 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023136, HPA023137, HPA023458, HPA023487" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945" "unprognostic (1.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.93e-1)" "unprognostic (2.42e-2)" "unprognostic (8.36e-3)" "unprognostic (1.08e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (6.36e-2)" "unprognostic (2.21e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (8.27e-2)" "prognostic unfavourable (9.36e-6)" "unprognostic (1.45e-1)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (7.73e-2)" 11.1 7.7 10.3 10.6 8.6 14.4 13.3 11.7 10.7 9.3 10.3 8.2 9.2 7.9 11.1 8.1 8.5 10.7 11.5 8.4 8.4 6.6 7.7 9.9 13.1 14.4 11.0 6.8 17.4 14.4 8.6 5.3 9.2 10.3 8.7 9.9 6.9 11.1 12.3 14.0 8.6 10.6 14.6 9.6 12.0 9.4 7.7 11.1 27.7 32.2 8.0 13.0 11.2 13.9 5.7 6.6 15.1 10.7 7.8 14.1 6.3 8.7 6.4 9.7 7.3 10.5 11.0 10.4 13.8 20.0 17.5 16.8 12.2 7.2 22.4 7.7 13.9 10.4 15.6 16.9 21.9 10.1 11.6 10.1 7.6 18.5 15.6 27.2 12.5 11.6 10.1 16.0 19.7 10.2 18.3 13.2 12.3 19.5 14.7 12.7 11.8 9.7 14.1 9.2 8.9 13.3 13.3 10.9 7.6 10.9 14.4 10.8 9.7 16.4 8.4 14.9 16.1 6.7 18.3 17.6 18.3 25.1 6.1 14.8 10.5 13.6 6.0 15.1 11.3 6.6 14.1 5.7 10.3 13.4 6.6 4.4 8.7 10.5 6.9 7.8 10.7 2.7 8.3 6.3 10.3 8.6 11.7 10.7 8.4 6.6 11.0 6.8 10.3 11.1 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314501-115147271 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA015551: , HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 10.7 7.3 6.3 2.9 12.3 4.0 6.2 17.3 9.3 7.2 4.2 10.8 5.3 1.7 6.6 17.4 3.5 4.9 4.3 6.1 9.7 5.2 9.8 9.8 4.4 3.3 14.9 3.7 12.7 5.9 5.3 26.1 2.2 11.5 10.0 2.7 7.9 5.4 9.2 12.1 4.4 4.0 7.5 19.2 4.4 3.9 44.6 14.2 2.1 9.1 8.1 3.3 5.2 5.0 18.2 4.3 7.8 3.6 4.1 7.7 2.7 2.3 4.3 1.7 4.1 6.3 2.7 0.0 1.8 3.8 1.1 0.9 2.5 0.8 0.6 6.0 4.6 0.1 6.0 1.0 1.1 0.5 0.1 0.6 2.1 1.9 1.5 0.3 0.0 2.7 0.3 2.5 0.8 1.2 0.1 1.0 6.4 0.0 0.3 0.2 0.4 0.2 0.2 5.1 0.0 4.2 0.0 0.4 1.0 0.8 0.0 1.3 0.0 0.5 7.1 1.6 5.5 0.3 2.6 1.6 0.0 0.3 2.5 0.4 1.9 7.8 1.4 5.1 6.1 2.0 4.2 18.2 6.0 5.6 1.6 10.7 7.7 6.6 3.1 4.1 3.6 4.3 2.8 2.7 6.3 12.3 17.3 9.3 9.7 5.2 14.9 3.7 11.5 14.2 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: , HPA049003: " "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavourable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.8 4.0 3.7 9.2 6.0 6.1 6.1 4.5 6.2 5.7 6.5 5.6 3.0 16.6 5.9 5.6 5.1 9.3 7.0 8.6 10.3 9.2 13.4 5.4 4.2 4.4 10.9 6.9 6.1 5.8 5.7 10.0 4.6 11.2 9.4 5.8 6.6 15.6 7.4 9.2 4.5 9.8 5.2 6.9 6.9 6.7 6.3 5.5 5.7 6.1 14.2 4.2 11.9 4.6 4.6 4.6 3.8 9.6 4.6 3.5 17.1 6.0 8.7 7.6 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 15.4 10.4 12.8 9.3 15.5 20.2 18.0 16.3 13.9 9.6 8.5 11.6 9.1 9.1 7.7 11.5 14.9 10.0 9.0 6.0 12.6 15.0 8.0 22.5 10.7 14.0 13.4 11.6 12.2 11.6 17.7 15.5 10.2 16.7 10.5 7.9 6.2 15.0 10.0 9.5 21.6 10.2 6.0 18.6 12.7 9.9 6.9 14.8 29.3 17.4 5.3 14.6 10.3 9.7 3.4 8.9 14.2 8.9 5.1 7.2 5.2 9.0 10.2 13.9 12.7 10.9 12.5 16.3 7.1 9.5 8.3 10.2 6.2 8.0 13.4 13.5 7.1 14.1 21.9 11.1 10.6 14.8 15.8 14.0 15.4 8.3 8.3 13.9 15.9 8.9 13.6 8.4 12.5 14.0 9.0 15.7 10.2 10.9 13.0 9.0 16.9 11.1 14.8 10.5 21.3 8.4 16.3 25.4 10.8 15.0 14.7 16.6 7.9 19.7 13.8 6.6 4.9 9.8 12.5 8.8 8.9 17.0 9.2 19.9 8.2 14.2 6.1 7.7 4.4 8.9 7.2 3.4 5.6 5.5 8.9 3.3 7.1 4.8 1.2 5.1 5.6 8.5 4.9 5.2 12.8 15.5 16.3 13.9 12.6 15.0 13.4 11.6 16.7 14.8 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.4 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.6 3.4 3.1 4.7 2.4 3.3 3.6 3.0 9.0 3.9 2.2 2.0 5.3 5.7 2.5 1.7 6.0 4.0 2.0 8.0 4.4 4.2 1.8 3.6 1.4 5.3 0.8 2.4 4.9 2.2 2.2 6.0 4.2 5.2 3.1 4.3 4.3 6.2 5.5 3.6 5.2 5.6 2.6 3.5 8.0 5.9 10.5 3.5 3.0 3.1 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: " "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favourable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favourable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 20.1 23.5 20.1 10.9 22.7 4.7 20.6 27.9 38.3 26.3 21.8 19.8 13.7 9.2 22.8 22.7 16.6 22.5 15.1 22.3 19.6 18.3 15.6 6.3 21.4 10.7 21.0 19.4 35.1 16.3 70.1 15.4 14.6 25.8 22.3 9.9 26.2 19.9 30.0 21.4 14.8 11.3 22.3 20.2 18.7 14.2 10.6 14.7 8.2 23.9 9.5 12.7 23.4 24.7 1.8 1.3 1.4 4.6 2.0 3.5 1.5 6.4 8.9 2.2 4.3 23.9 12.4 4.1 9.1 13.1 8.2 8.2 2.9 3.1 0.6 7.2 17.1 10.3 2.2 12.7 6.0 10.2 3.8 3.2 7.2 2.0 6.7 0.6 7.7 8.6 13.3 7.9 10.1 7.1 1.0 2.1 9.0 4.3 2.2 1.3 0.9 4.2 4.1 3.9 0.9 10.0 5.5 1.3 3.3 4.0 2.8 4.2 5.3 1.4 9.9 9.3 3.7 8.7 7.4 3.8 2.6 0.4 10.0 2.0 4.8 1.1 0.9 1.4 3.2 1.4 3.5 1.6 2.6 2.6 0.7 1.8 3.4 3.1 0.6 2.0 4.6 1.3 1.3 1.5 20.1 22.7 27.9 38.3 19.6 18.3 21.0 19.4 25.8 14.7 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: , HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavourable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.2 4.1 5.5 4.4 8.7 13.2 4.4 4.4 7.3 4.7 4.4 2.6 6.1 2.7 6.4 10.0 6.0 3.8 3.8 7.4 2.3 2.2 2.2 5.5 2.4 7.7 4.3 2.1 5.4 10.1 4.7 8.2 3.1 5.0 3.3 11.9 3.5 3.2 2.4 2.1 1.5 2.2 7.6 4.8 5.7 4.1 7.8 6.9 7.9 13.9 8.3 10.6 3.3 5.2 9.2 5.4 7.2 5.7 3.7 1.9 2.9 4.3 1.6 12.7 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favourable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 6.6 6.2 7.8 4.9 12.1 51.7 6.6 10.6 13.6 5.8 5.6 9.5 3.0 5.6 6.6 5.2 10.3 5.3 5.9 9.5 7.9 5.7 5.1 9.0 9.3 6.0 8.6 7.1 7.1 5.9 9.6 9.3 8.2 8.1 5.1 6.6 7.5 7.4 4.4 34.7 14.6 6.7 6.0 8.5 5.7 7.4 15.7 9.3 5.3 6.2 7.1 10.1 5.5 7.0 6.1 5.2 10.6 6.3 9.0 10.7 4.3 4.5 3.5 6.4 5.9 5.4 7.8 6.7 6.4 6.0 4.8 4.3 8.5 3.2 6.3 3.1 6.1 13.3 5.6 6.0 6.0 6.0 3.7 4.4 10.4 3.6 7.3 6.1 8.4 9.5 15.2 7.8 19.5 3.7 7.5 14.8 7.1 4.9 5.3 3.9 5.8 6.0 4.6 20.7 5.2 5.3 5.3 5.7 5.3 6.6 6.2 5.7 5.8 3.9 3.5 5.8 5.6 6.5 5.2 15.9 11.3 2.5 7.2 5.2 4.7 10.6 6.3 5.3 10.7 6.3 10.2 6.1 5.8 6.2 5.2 5.1 6.4 7.3 3.5 9.0 4.8 2.8 8.2 4.3 7.8 12.1 10.6 13.6 7.9 5.7 8.6 7.1 8.1 9.3 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6580001-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favourable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favourable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.8 12.0 9.6 15.1 12.6 13.3 12.3 11.1 16.3 13.5 12.2 12.7 21.4 11.7 13.2 15.1 12.7 14.2 17.6 9.6 8.9 7.5 12.9 21.6 14.3 17.1 7.0 11.3 19.9 15.8 17.1 14.0 10.7 11.4 17.2 13.2 16.9 12.6 11.7 10.9 14.4 17.2 11.3 8.8 17.1 12.9 28.2 10.3 19.9 18.4 7.4 15.9 13.0 14.4 7.5 7.8 26.7 6.8 6.6 6.4 5.3 3.8 4.7 7.5 10.9 8.3 6.4 3.9 3.9 4.7 7.6 8.2 4.8 8.9 12.8 7.0 3.4 7.3 11.3 7.8 6.1 13.0 10.7 10.4 13.6 4.7 9.9 16.7 28.2 6.4 6.1 7.3 11.8 5.5 10.2 8.4 5.6 7.4 8.2 12.0 5.6 8.2 9.3 7.0 14.1 6.8 3.6 14.6 6.7 5.9 13.5 9.0 7.8 13.4 6.1 5.2 3.4 5.6 4.9 9.2 7.9 19.8 4.8 13.4 3.0 10.9 6.8 26.7 6.0 4.2 6.0 6.5 4.7 5.7 7.8 7.5 6.4 5.5 10.0 6.6 6.6 5.0 3.8 5.3 9.6 12.6 11.1 16.3 8.9 7.5 7.0 11.3 11.4 10.3 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favourable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favourable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favourable (2.88e-5)" 7.3 5.4 5.0 6.0 9.0 11.8 6.8 9.2 8.7 7.2 6.2 9.9 3.4 4.5 9.5 7.0 5.6 6.3 5.3 6.2 6.1 5.1 4.7 5.9 6.5 7.5 6.8 5.3 10.6 7.7 6.0 13.3 5.6 8.9 7.9 4.4 7.1 10.0 6.5 10.1 4.8 6.3 6.5 6.1 9.2 6.0 10.3 6.7 6.7 8.1 5.0 8.5 7.8 5.8 2.9 1.9 12.1 2.7 3.2 6.4 1.8 2.1 3.5 4.3 7.2 5.8 6.1 5.1 2.6 5.1 5.7 4.4 3.0 4.0 7.4 2.7 2.9 3.6 7.5 4.3 5.9 2.4 2.9 8.6 2.3 4.2 4.9 5.2 3.2 3.9 3.6 5.2 3.4 5.7 4.4 4.0 5.3 3.4 10.3 10.2 7.3 4.7 6.2 5.6 4.6 2.3 3.7 5.2 5.0 5.7 2.2 5.7 3.1 5.1 5.5 5.2 2.3 3.4 5.5 4.9 4.8 6.3 3.7 4.4 5.0 3.7 2.6 12.1 6.4 2.7 5.0 2.2 3.6 6.0 1.9 2.9 4.1 4.7 6.2 3.2 2.2 0.4 3.2 1.8 5.0 9.0 9.2 8.7 6.1 5.1 6.8 5.3 8.9 6.7 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438114-37465399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: " "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 7.9 9.2 6.7 10.8 9.5 16.0 10.6 12.8 11.2 10.6 10.0 15.9 7.0 8.7 11.8 11.5 24.6 8.8 7.7 8.4 8.7 5.9 11.0 17.2 11.3 11.7 14.0 6.9 12.5 12.4 11.4 7.9 11.8 9.9 11.3 8.4 9.8 11.9 16.5 7.4 16.6 11.1 7.6 10.4 10.8 10.1 20.4 11.7 15.2 14.8 7.8 17.8 9.5 12.7 2.7 2.6 0.4 1.2 1.1 3.2 1.2 6.5 7.5 19.6 12.1 5.0 3.5 8.4 5.4 4.2 6.7 5.5 5.6 4.8 13.3 5.9 4.0 8.0 12.7 4.5 5.1 9.8 6.6 4.9 19.4 6.5 4.9 6.0 4.3 3.4 11.4 3.3 7.1 7.4 11.5 11.4 4.9 4.1 12.6 4.4 4.9 3.9 11.5 9.4 5.0 6.4 5.9 9.0 16.2 5.3 8.5 4.2 13.7 5.9 5.0 4.7 13.1 2.7 5.1 6.1 6.7 11.7 4.3 5.2 4.9 0.4 1.2 0.2 2.2 0.9 2.6 2.7 1.9 1.9 2.6 2.7 2.9 3.2 0.1 1.1 0.1 0.8 1.5 1.2 6.7 9.5 12.8 11.2 8.7 5.9 14.0 6.9 9.9 11.7 ZBTB6 "ZID, ZNF482" ENSG00000186130 "Zinc finger and BTB domain containing 6" Q15916 9 122908056-122913330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054111, HPA076894" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA054111: , HPA076894: " "unprognostic (9.74e-3)" "unprognostic (8.40e-2)" "unprognostic (1.45e-2)" "unprognostic (7.84e-2)" "prognostic favourable (2.06e-5)" "unprognostic (1.81e-1)" "unprognostic (2.39e-3)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (6.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "prognostic favourable (5.08e-4)" "unprognostic (4.31e-2)" "unprognostic (1.53e-1)" "unprognostic (2.67e-1)" "unprognostic (1.92e-2)" 11.9 10.4 10.7 11.8 12.2 5.2 12.9 17.7 13.2 13.7 9.4 9.0 10.7 10.4 12.6 8.2 11.6 9.4 7.3 9.7 10.2 9.4 11.0 9.2 12.4 26.2 15.6 10.3 13.8 10.0 11.6 14.0 14.1 10.5 10.2 9.0 6.3 9.9 11.4 14.0 10.0 15.0 10.0 13.2 14.0 9.7 9.5 14.4 22.7 13.8 10.1 16.0 11.1 9.3 2.1 2.3 11.8 3.9 3.8 4.0 2.4 4.0 4.7 7.7 7.0 8.2 7.9 7.8 6.9 8.4 6.9 6.2 4.9 5.2 6.5 4.3 6.2 18.6 8.0 8.4 8.6 9.2 6.4 6.9 10.2 4.5 8.1 9.0 12.5 6.5 12.9 6.3 10.5 6.3 7.2 8.0 9.9 7.6 9.1 6.1 9.7 8.2 4.9 21.3 9.0 7.2 6.7 9.8 12.7 10.6 10.4 6.5 13.0 6.0 6.4 7.6 5.9 7.6 7.9 14.1 16.9 1.7 8.8 6.2 7.6 11.8 2.3 3.3 2.0 2.5 2.7 2.1 2.8 1.9 2.3 1.7 4.0 3.5 3.0 3.8 3.9 1.3 2.9 2.4 10.7 12.2 17.7 12.1 10.2 9.4 15.6 10.3 10.5 14.4 ZBTB8A "BOZF1, FLJ90065, ZBTB8, ZNF916A" ENSG00000160062 "Zinc finger and BTB domain containing 8A" Q96BR9 1 32539427-32605939 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031768, HPA031769, HPA031770" Approved Approved "Nuclear speckles,Focal adhesion sites" "Nuclear speckles, Focal adhesion sites" "HPA031768: AB_10610568, HPA031769: , HPA031770: " "unprognostic (1.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.01e-1)" "unprognostic (7.40e-2)" "unprognostic (7.21e-2)" "unprognostic (2.85e-2)" "unprognostic (9.45e-5)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (7.83e-3)" "unprognostic (4.23e-3)" "unprognostic (1.78e-1)" "unprognostic (8.10e-2)" "unprognostic (2.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.47e-1)" "unprognostic (3.15e-2)" 8.8 4.9 4.4 3.2 5.0 2.3 19.1 11.1 5.9 13.6 6.2 4.8 12.2 3.8 12.7 8.6 7.2 7.8 5.7 6.9 4.4 3.4 5.7 4.4 14.0 1.9 3.3 4.5 8.6 10.9 10.7 8.9 5.5 7.9 7.8 6.2 6.9 9.9 11.4 10.3 4.8 4.2 15.4 5.2 2.7 6.4 6.2 3.5 1.8 11.2 6.6 3.0 9.1 7.6 1.6 2.1 4.1 1.0 2.6 1.0 0.5 6.5 1.8 7.7 8.3 5.5 7.4 5.8 6.5 5.2 6.2 6.3 0.8 5.3 5.3 4.5 7.0 5.2 7.6 5.2 5.5 1.4 5.1 0.3 6.5 2.8 7.1 1.2 0.4 5.0 7.5 4.5 11.9 6.9 1.1 3.8 6.2 6.7 3.6 0.6 7.0 2.7 6.5 11.2 4.2 3.8 6.8 6.5 5.9 9.2 4.6 8.7 6.0 3.0 7.1 8.3 6.8 11.3 4.7 7.0 3.3 4.1 5.7 1.3 3.4 4.1 1.0 0.8 0.8 0.6 1.0 0.8 0.7 0.7 0.7 1.6 0.8 0.9 3.8 2.6 0.8 2.1 0.6 0.5 4.4 5.0 11.1 5.9 4.4 3.4 3.3 4.5 7.9 3.5 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 11.4;U-698: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.2 0.1 5.1 0.8 2.6 0.2 11.4 0.1 0.2 0.0 0.0 1.8 0.0 1.8 1.7 0.1 0.0 4.9 2.0 0.7 2.0 0.0 6.8 0.0 0.0 0.0 2.5 6.7 0.2 0.2 3.0 3.0 0.0 2.7 0.6 2.2 0.6 0.4 0.0 3.2 0.4 3.4 3.1 2.3 2.7 2.3 0.6 0.4 3.4 0.2 1.1 0.5 0.4 1.6 0.3 0.1 1.0 1.2 0.0 1.9 12.9 0.2 2.2 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 ZC2HC1A "C8orf70, CGI-62, FAM164A" ENSG00000104427 "Zinc finger C2HC-type containing 1A" Q96GY0 8 78666047-78719765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 20.6;SK-BR-3: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.6;T-reg: 17.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024726 Approved Approved "Actin filaments,Cytosol" Cytosol "Actin filaments" "HPA024726: AB_1846597" "unprognostic (1.12e-1)" "unprognostic (3.02e-1)" "unprognostic (5.36e-3)" "unprognostic (4.00e-2)" "unprognostic (1.13e-1)" "unprognostic (7.79e-2)" "unprognostic (1.19e-7)" "unprognostic (2.96e-1)" "unprognostic (7.25e-2)" "prognostic unfavourable (9.00e-4)" "unprognostic (2.26e-1)" "unprognostic (1.63e-2)" "unprognostic (5.41e-2)" "prognostic unfavourable (5.85e-4)" "unprognostic (2.34e-1)" "unprognostic (5.40e-2)" "unprognostic (4.05e-3)" 7.6 6.2 16.1 6.1 21.2 2.0 14.3 23.6 20.0 12.7 8.0 8.4 6.7 3.3 19.7 9.1 11.5 19.5 10.0 8.1 16.5 15.7 8.3 2.9 12.6 5.1 11.9 22.6 23.6 4.9 26.1 26.1 11.4 25.8 12.8 7.8 5.0 7.5 10.9 4.2 43.1 5.8 13.1 13.8 5.9 5.8 8.6 11.0 1.5 19.8 4.2 8.4 11.0 12.1 5.1 3.3 20.6 8.1 0.6 17.7 1.5 2.4 3.0 5.6 4.6 12.1 12.7 2.4 6.7 4.5 3.4 4.3 0.8 4.3 4.1 2.8 6.8 2.0 3.3 3.7 5.0 13.4 2.1 0.4 2.8 2.4 7.2 0.6 1.3 9.1 6.4 2.7 8.3 4.6 0.7 20.6 7.1 2.3 0.8 1.2 1.4 4.8 0.0 7.2 0.8 5.0 5.2 2.2 8.8 5.3 38.6 7.3 1.0 0.1 3.8 10.6 4.4 4.8 3.3 5.1 5.2 2.7 5.0 0.0 4.0 20.6 3.9 0.1 0.1 4.1 0.0 5.1 4.0 0.2 3.3 3.3 1.2 0.4 0.1 0.6 8.1 0.2 17.7 1.5 16.1 21.2 23.6 20.0 16.5 15.7 11.9 22.6 25.8 11.0 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" "Nuclear speckles" Mitochondria "HPA050928: , HPA065062: " "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favourable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 5.9 4.7 1.0 5.2 0.3 0.3 2.7 0.5 2.0 2.6 1.1 7.5 10.9 5.5 4.2 0.5 2.3 0.0 0.1 1.8 5.8 0.6 1.4 1.6 2.6 3.6 0.1 3.6 1.0 0.6 3.4 0.1 1.5 7.8 2.4 1.3 1.3 0.6 0.7 1.7 3.2 0.1 0.3 2.7 5.9 0.3 9.5 2.3 3.4 3.0 2.7 4.3 1.7 0.8 1.6 1.9 2.8 1.1 5.5 8.2 2.8 2.4 1.0 0.8 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 ZC3H12A "FLJ23231, MCPIP1" ENSG00000163874 "Zinc finger CCCH-type containing 12A" Q5D1E8 1 37474552-37484379 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.7;tongue: 56.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.4;RT4: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032052, HPA032053" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "HPA032052: AB_10603241, HPA032053: AB_2674128" "unprognostic (2.35e-2)" "unprognostic (6.09e-3)" "unprognostic (1.51e-2)" "prognostic favourable (9.67e-4)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (9.03e-2)" "unprognostic (4.66e-3)" "unprognostic (1.05e-1)" "unprognostic (9.69e-3)" "unprognostic (9.01e-2)" "unprognostic (1.82e-2)" "prognostic unfavourable (5.95e-5)" "unprognostic (5.17e-2)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.77e-2)" 11.7 8.4 0.8 15.0 2.9 58.7 8.2 1.3 1.3 6.4 13.3 2.9 5.6 7.0 5.0 6.9 25.2 8.1 22.6 6.3 2.1 0.7 6.7 10.7 21.0 11.3 1.8 0.7 7.1 6.8 1.0 4.6 8.1 3.8 16.1 4.2 3.0 10.9 6.3 11.8 23.1 14.1 8.5 2.6 10.9 11.0 3.4 1.1 8.3 4.0 56.9 34.8 17.0 22.2 6.1 2.6 8.9 2.1 5.5 5.5 2.3 3.7 2.7 0.3 1.7 1.4 2.1 3.1 2.7 24.4 1.7 2.3 3.0 8.5 4.2 11.6 2.6 8.2 1.1 17.5 1.0 8.6 1.7 1.1 8.9 4.7 2.0 2.2 1.8 4.4 9.0 15.2 2.7 2.0 2.1 7.0 1.6 4.5 1.7 4.0 2.1 2.4 2.5 1.1 2.5 4.4 30.2 0.8 0.5 5.4 8.7 0.6 3.0 2.5 2.0 5.3 2.9 3.8 4.1 5.6 2.0 3.1 12.0 4.7 1.0 1.8 2.1 5.8 5.4 2.1 5.5 5.2 2.2 3.3 2.6 6.1 1.3 2.5 8.9 5.5 1.9 2.5 2.8 2.3 0.8 2.9 1.3 1.3 2.1 0.7 1.8 0.7 3.8 1.1 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell line enhanced" "Detected in many" "AF22: 5.2;Karpas-707: 4.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.3 0.9 2.6 0.5 3.9 0.1 0.5 2.8 6.1 1.9 1.1 0.9 2.6 0.8 0.4 2.0 1.1 0.5 2.8 2.5 1.2 0.5 0.6 0.7 1.7 3.3 0.1 2.7 2.7 0.0 1.8 1.1 0.3 2.4 0.0 0.3 0.9 1.8 1.5 0.4 1.3 0.0 1.5 0.2 1.0 0.7 1.3 0.8 0.7 0.4 0.8 1.8 0.2 0.3 0.4 5.2 0.8 0.0 0.0 0.7 1.3 2.8 0.0 0.8 0.7 0.5 0.8 0.3 1.4 0.8 1.3 0.0 0.1 0.8 3.8 1.7 2.4 0.7 0.1 1.6 0.4 0.2 0.0 0.1 0.0 0.0 0.9 4.2 0.1 0.0 2.2 0.6 2.1 1.1 2.5 0.2 1.0 0.1 0.2 0.2 2.5 0.0 0.2 0.2 0.1 1.3 0.0 0.1 1.0 1.7 0.5 0.9 1.0 1.7 3.3 2.2 0.0 0.6 0.4 0.1 0.6 0.2 0.5 0.9 0.8 0.8 0.2 1.3 1.8 0.8 0.7 0.8 0.2 0.8 0.4 0.2 ZC3H12C "KIAA1726, MCPIP3" ENSG00000149289 "Zinc finger CCCH-type containing 12C" Q9C0D7 11 110093361-110171841 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "basophil: 7.1" "Lineage enriched" "Detected in single" 23 "granulocytes: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038836, HPA038837" Approved Approved "Nuclear membrane,Golgi apparatus" "Nuclear membrane, Golgi apparatus" "HPA038836: , HPA038837: AB_10675953" "unprognostic (1.22e-1)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (6.96e-3)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "unprognostic (8.91e-3)" "unprognostic (1.30e-2)" "unprognostic (3.20e-1)" "unprognostic (2.34e-2)" "unprognostic (8.90e-2)" "prognostic favourable (9.90e-6)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (8.03e-2)" "unprognostic (1.11e-1)" 6.9 8.1 7.7 3.5 12.6 4.6 4.8 21.4 12.0 7.1 7.3 8.7 6.8 2.6 7.9 4.2 5.2 6.0 7.6 6.8 9.3 4.8 5.6 6.4 6.3 2.0 9.2 5.2 11.5 5.5 8.4 13.2 4.1 9.9 5.8 6.1 5.8 4.9 5.6 18.4 9.3 4.5 10.8 11.1 2.7 5.1 12.0 11.0 0.2 13.3 4.0 2.2 7.9 4.2 0.0 0.0 7.1 0.2 0.0 0.3 0.0 4.2 2.6 10.3 0.0 4.7 11.1 2.0 1.7 11.3 3.0 5.1 3.2 4.0 0.0 6.4 5.1 4.2 2.0 6.1 6.0 16.2 1.4 6.8 3.3 1.2 5.4 0.0 3.2 17.9 5.9 5.3 8.7 4.1 0.6 1.0 6.2 0.6 0.0 0.0 1.6 9.2 0.0 3.6 0.4 3.4 8.8 4.7 8.4 4.0 0.2 7.4 2.5 2.5 7.0 6.7 3.2 3.5 3.7 0.4 0.0 0.0 4.1 1.2 7.8 7.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 12.6 21.4 12.0 9.3 4.8 9.2 5.2 9.9 11.0 ZC3H12D "C6orf95, dJ281H8.1, MCPIP4" ENSG00000178199 "Zinc finger CCCH-type containing 12D" A2A288 6 149446795-149485061 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 38.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 26.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA036897 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA036897: AB_10672104" "unprognostic (2.89e-2)" "unprognostic (3.91e-4)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.47e-6)" "unprognostic (2.20e-2)" "unprognostic (2.50e-3)" "unprognostic (1.34e-1)" "unprognostic (3.30e-2)" "unprognostic (2.33e-2)" "unprognostic (1.86e-1)" "unprognostic (1.28e-4)" "unprognostic (1.21e-2)" "unprognostic (9.24e-3)" "unprognostic (6.99e-2)" "unprognostic (5.52e-2)" 3.3 0.8 0.5 33.4 1.0 3.4 1.2 0.7 0.6 0.8 3.0 0.1 1.0 3.0 0.6 1.2 0.8 0.8 0.9 0.6 0.5 0.7 1.3 0.8 2.0 10.6 0.5 0.0 0.4 0.7 0.0 0.6 0.8 0.5 0.7 1.5 0.9 2.0 0.2 0.4 1.1 7.7 0.4 0.7 9.5 0.7 0.7 0.4 4.8 0.9 1.6 38.1 1.7 0.6 3.2 1.7 1.3 2.7 0.7 7.2 1.5 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 6.2 0.1 0.0 0.1 0.0 0.0 0.1 26.4 0.2 0.2 0.8 2.1 0.0 2.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 1.9 0.0 0.0 5.4 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 3.5 0.0 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.3 2.0 0.1 1.3 1.8 0.4 0.3 1.0 0.5 3.1 3.2 1.5 1.7 3.2 2.0 0.5 1.3 0.7 2.7 1.0 7.2 1.5 0.5 1.0 0.7 0.6 0.5 0.7 0.5 0.0 0.5 0.4 ZC3H13 "DKFZp434D1812, KIAA0853" ENSG00000123200 "Zinc finger CCCH-type containing 13" Q5T200 13 45954465-46052759 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039340, HPA040140, HPA047806" Uncertain Approved "Nuclear membrane,Actin filaments" "Nuclear membrane, Actin filaments" "HPA039340: , HPA040140: , HPA047806: " "unprognostic (1.50e-1)" "unprognostic (6.28e-3)" "unprognostic (1.25e-1)" "unprognostic (2.22e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.77e-1)" "unprognostic (1.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.38e-1)" "prognostic favourable (2.69e-4)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.45e-1)" "unprognostic (9.21e-3)" 16.4 11.7 17.7 13.9 30.3 15.4 17.3 17.8 26.9 18.9 15.4 19.0 14.2 9.4 20.6 16.9 13.5 13.4 12.4 11.9 20.3 15.9 14.3 67.5 13.5 15.9 23.0 23.2 20.5 10.5 22.2 18.3 17.0 24.5 17.5 13.8 7.6 14.3 16.9 19.8 14.7 13.3 20.8 24.9 16.9 12.7 11.9 25.7 25.2 19.3 10.6 14.2 21.0 12.3 18.4 20.3 28.4 15.2 13.0 19.4 8.0 6.5 8.3 19.8 8.2 14.4 15.0 9.8 11.8 9.5 10.2 6.9 12.1 11.5 18.1 7.9 11.7 11.8 12.8 9.8 15.8 15.9 14.8 21.1 7.8 10.6 8.6 26.1 11.6 11.4 8.1 10.4 12.1 10.0 11.3 5.5 9.9 9.0 13.1 12.7 19.3 5.5 13.7 13.0 5.5 7.7 9.4 5.5 12.3 10.8 7.3 63.3 5.6 11.6 17.8 8.6 7.9 7.8 10.4 5.5 6.6 18.3 9.8 14.2 11.2 19.9 13.3 22.9 19.4 15.2 18.7 13.6 15.5 13.1 10.4 18.4 15.7 12.7 28.4 13.0 14.4 20.3 16.0 8.0 17.7 30.3 17.8 26.9 20.3 15.9 23.0 23.2 24.5 25.7 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562909-88627596 "Disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nuclear speckles" "Nuclear speckles" Nucleoli "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favourable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 13.5 12.6 16.2 10.8 16.4 9.7 13.3 23.4 19.6 14.0 15.3 14.3 17.5 10.6 17.2 15.5 12.4 15.8 10.4 12.3 14.8 8.4 15.2 24.9 13.9 9.1 16.1 16.3 17.1 19.4 19.3 24.1 14.8 16.0 14.9 16.6 11.3 18.0 16.3 15.4 13.6 15.2 14.8 11.2 9.4 12.7 73.1 14.1 9.3 19.4 8.2 11.4 16.2 12.8 13.3 17.4 21.7 21.1 18.5 17.7 13.3 16.1 31.1 28.5 22.5 22.7 22.0 28.9 24.8 22.5 35.2 31.1 22.1 25.4 22.5 17.9 25.2 19.9 20.2 23.1 48.0 18.9 15.2 11.0 22.2 18.0 22.8 24.0 14.4 17.6 27.2 27.4 27.5 22.9 21.4 10.4 31.8 34.3 21.7 13.3 18.1 27.4 19.0 36.5 9.8 23.7 29.0 21.4 19.2 30.9 35.4 17.3 32.3 15.8 16.8 42.8 26.2 18.0 24.6 13.3 11.5 25.1 21.0 11.8 19.6 12.9 16.0 21.7 15.9 20.0 17.7 13.3 15.5 17.5 17.4 12.0 14.7 14.7 2.9 18.5 21.1 9.5 13.2 13.3 16.2 16.4 23.4 19.6 14.8 8.4 16.1 16.3 16.0 14.1 ZC3H4 "C19orf7, KIAA1064" ENSG00000130749 "Zinc finger CCCH-type containing 4" Q9UPT8 19 47064187-47113752 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040934, HPA041068" Supported Enhanced Nucleoplasm,Cytosol 8500 Nucleoplasm Cytosol "HPA040934: AB_10795495, HPA041068: AB_10796567" "unprognostic (8.02e-3)" "unprognostic (3.68e-3)" "unprognostic (3.11e-2)" "unprognostic (1.91e-1)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (9.37e-2)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (2.93e-1)" "unprognostic (1.68e-2)" "unprognostic (1.53e-1)" "unprognostic (9.14e-2)" "unprognostic (3.00e-3)" "unprognostic (1.19e-1)" "unprognostic (5.90e-2)" "prognostic favourable (2.23e-4)" 12.0 8.2 8.6 14.5 16.9 8.5 18.2 25.6 13.9 8.9 9.6 14.7 9.8 11.5 12.8 6.0 11.8 10.4 6.5 8.2 9.3 7.6 9.2 10.9 19.9 14.1 16.5 5.2 14.6 12.5 10.4 45.4 15.4 13.9 9.7 7.2 10.8 11.8 10.4 14.1 13.5 11.5 8.5 26.0 16.0 11.5 14.5 12.4 17.5 10.5 9.3 11.5 10.3 24.0 5.2 6.8 6.2 3.7 5.2 5.6 1.2 8.7 13.8 8.6 12.2 4.8 3.0 8.7 7.1 4.0 6.7 4.5 9.8 9.9 18.6 5.2 4.8 15.3 3.7 10.0 4.2 11.4 6.1 13.2 8.3 7.4 4.2 12.6 14.2 5.1 2.8 6.1 4.9 5.4 12.7 7.1 4.3 15.3 14.2 21.2 12.7 4.7 22.3 7.4 8.4 5.0 14.4 10.5 14.8 10.8 9.0 5.2 9.5 10.1 9.5 9.1 8.9 5.8 9.9 9.3 7.5 16.6 7.1 10.2 12.9 4.6 2.2 3.2 5.5 3.7 5.6 5.2 4.9 5.5 2.9 5.1 4.3 4.8 6.2 5.2 3.5 6.8 3.1 1.2 8.6 16.9 25.6 13.9 9.3 7.6 16.5 5.2 13.9 12.4 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275594-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: , HPA076065: " "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 10.9 8.8 8.1 6.2 18.9 5.8 11.2 16.6 14.3 10.9 8.1 11.4 7.7 5.3 9.1 11.9 6.7 10.3 6.5 9.4 8.9 7.4 7.6 6.4 7.4 8.9 15.6 10.5 20.5 7.1 13.8 18.3 7.0 11.1 9.8 6.2 8.6 8.2 8.0 16.4 14.3 7.5 10.5 11.5 10.0 6.9 9.4 13.1 12.4 12.5 5.2 8.6 13.4 8.6 5.5 2.9 3.9 3.4 1.8 4.5 1.1 1.7 0.8 4.0 3.7 3.5 7.0 1.2 2.0 3.1 1.2 2.6 0.4 2.4 2.9 1.5 1.1 1.1 1.1 0.5 1.7 3.2 0.4 0.5 0.9 0.1 3.3 0.9 0.8 2.7 5.4 1.4 9.1 1.9 0.7 4.9 2.8 1.6 1.6 1.2 2.5 0.9 1.1 0.2 2.5 1.7 0.3 2.8 3.9 1.9 1.1 2.0 1.2 1.1 3.0 2.0 0.3 2.2 0.9 5.2 1.5 2.5 3.7 1.9 4.9 1.5 1.8 2.3 2.9 1.3 3.2 3.7 3.9 3.0 1.6 5.5 4.5 3.7 3.9 1.8 3.4 2.9 3.2 1.1 8.1 18.9 16.6 14.3 8.9 7.4 15.6 10.5 11.1 13.1 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211525-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA034803: , HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 6.5 7.9 13.0 9.0 15.9 9.1 13.6 18.2 19.6 7.5 7.7 7.2 9.1 8.8 8.4 7.5 16.1 8.8 4.5 13.7 11.1 8.6 9.2 9.8 5.0 12.8 11.6 12.6 10.3 15.4 15.2 35.7 6.2 13.6 9.8 10.4 5.2 11.3 11.7 33.1 12.5 8.3 7.6 13.7 11.7 7.8 14.1 13.8 12.6 12.2 12.8 13.8 9.0 12.4 7.2 4.7 2.4 2.8 8.7 10.6 2.9 11.7 5.7 7.3 7.6 4.2 4.6 11.5 3.7 3.2 5.3 4.4 13.7 4.6 24.5 7.0 2.6 7.1 10.7 7.5 7.1 8.6 4.9 16.2 6.3 6.9 6.6 15.0 7.5 5.7 15.1 10.2 16.0 3.9 20.6 6.8 4.1 7.7 16.2 13.7 6.8 16.2 11.4 12.6 10.0 4.8 5.2 11.0 8.6 7.0 7.6 15.8 6.0 8.1 5.2 7.0 8.9 4.9 9.4 12.3 14.6 24.1 5.0 12.6 2.7 2.4 2.8 0.9 5.1 2.3 10.6 6.4 5.1 5.3 2.9 7.2 8.8 7.5 1.5 8.7 2.7 4.7 5.1 2.9 13.0 15.9 18.2 19.6 11.1 8.6 11.6 12.6 13.6 13.8 ZC3HAV1 "FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043520-139109719 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: " "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavourable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favourable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 14.3 14.8 6.8 19.8 6.6 52.6 13.8 1.6 5.6 11.2 11.5 6.7 10.8 6.9 10.0 10.9 14.2 9.5 10.4 7.0 5.4 7.2 11.2 13.1 17.2 44.4 7.5 4.0 10.6 11.0 9.8 11.4 8.5 8.6 11.2 10.2 9.3 16.9 11.5 3.8 9.5 14.8 10.8 9.0 22.6 9.6 7.8 6.9 43.9 18.2 8.8 26.1 10.8 29.0 16.3 7.0 28.8 11.9 15.6 27.9 11.8 11.4 14.2 2.0 11.8 18.7 18.0 8.6 13.0 10.0 22.7 23.4 10.1 14.9 10.1 12.2 20.7 13.0 15.8 15.4 12.9 17.9 5.9 20.0 14.4 12.5 10.8 23.2 18.6 18.3 9.9 25.8 5.8 16.9 16.9 11.3 9.7 10.8 19.1 27.1 8.0 8.6 22.7 7.1 9.7 15.6 14.5 3.6 7.5 20.0 14.1 17.3 8.2 14.5 21.2 4.8 7.1 13.2 10.7 8.7 9.1 23.7 10.9 21.7 11.4 28.8 8.2 11.9 19.4 10.6 24.6 14.3 27.9 23.5 6.4 16.3 27.3 26.4 22.1 15.6 11.9 7.0 24.2 11.8 6.8 6.6 1.6 5.6 5.4 7.2 7.5 4.0 8.6 6.9 ZC3HC1 NIPA ENSG00000091732 "Zinc finger C3HC-type containing 1" Q86WB0 7 130018286-130051451 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019089, HPA024023" Enhanced Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA019089: AB_1858976, HPA024023: AB_1858977" "unprognostic (7.14e-3)" "unprognostic (4.07e-2)" "unprognostic (1.04e-2)" "prognostic unfavourable (3.36e-4)" "unprognostic (1.89e-1)" "unprognostic (3.39e-2)" "prognostic unfavourable (1.02e-6)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (5.11e-2)" "unprognostic (2.60e-2)" "unprognostic (1.53e-1)" 11.0 13.8 8.1 10.0 10.3 4.9 14.2 9.5 12.6 9.5 9.2 9.9 5.9 6.0 14.5 11.0 7.9 9.4 7.5 16.3 8.2 8.9 13.2 14.8 6.9 13.6 7.3 8.4 10.7 10.6 10.5 9.6 10.0 10.5 9.0 8.4 9.6 10.5 8.4 33.0 7.1 7.8 12.9 5.5 13.7 9.0 24.6 6.6 15.4 8.3 11.9 11.5 8.5 9.6 23.1 20.2 17.4 17.7 17.4 23.8 15.8 7.0 12.0 14.9 16.8 8.5 7.8 10.3 9.2 11.0 17.4 18.1 14.1 12.1 16.3 6.7 11.7 6.5 19.5 13.9 17.2 10.6 16.7 11.3 10.9 13.7 13.7 13.0 11.6 9.4 10.5 18.1 11.8 19.0 33.9 5.7 17.6 12.4 15.3 25.1 30.4 13.7 14.5 11.5 14.2 17.6 4.8 9.6 17.2 13.3 19.3 14.7 8.4 13.8 8.7 11.9 5.8 10.4 15.4 11.1 16.7 21.2 18.8 16.7 20.2 17.4 16.2 14.5 17.0 17.7 19.5 23.1 18.2 18.2 20.2 20.6 23.8 18.8 1.3 17.4 16.3 11.9 18.5 15.8 8.1 10.3 9.5 12.6 8.2 8.9 7.3 8.4 10.5 6.6 ZC4H2 "HCA127, KIAA1166, WWS" ENSG00000126970 "Zinc finger C4H2-type containing" Q9NQZ6 X 64915802-65034713 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.1;NTERA-2: 27.8;REH: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049584 Approved Approved Vesicles,Microtubules "Vesicles, Microtubules" "HPA049584: " "unprognostic (9.55e-3)" "unprognostic (1.03e-1)" "unprognostic (4.40e-1)" "unprognostic (1.56e-1)" "unprognostic (7.29e-3)" "unprognostic (9.71e-2)" "unprognostic (1.64e-3)" "unprognostic (9.72e-2)" "unprognostic (2.98e-1)" "unprognostic (3.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.44e-2)" "unprognostic (1.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.51e-5)" "unprognostic (5.34e-2)" 7.0 9.7 11.7 6.6 12.3 4.8 7.4 12.7 15.0 10.4 12.2 15.6 8.1 8.1 12.8 8.4 6.4 12.5 8.0 10.4 10.6 14.7 9.9 10.0 6.4 5.6 11.7 10.8 14.7 5.3 20.0 20.3 2.2 16.9 10.5 9.6 10.0 8.9 12.2 3.2 5.3 7.8 16.2 12.3 6.2 9.5 2.5 12.4 12.7 10.8 2.3 5.4 8.2 6.1 4.7 3.9 0.0 2.0 3.6 7.9 3.0 0.0 1.0 17.1 7.6 0.1 0.0 2.5 3.7 5.6 4.8 8.3 1.2 6.1 2.8 2.0 2.7 0.0 7.2 2.8 4.6 0.0 5.7 5.1 2.6 2.2 1.1 5.1 1.7 3.1 2.3 2.1 4.4 8.0 1.4 6.5 5.2 0.0 14.1 0.0 27.8 6.4 20.4 9.0 0.1 4.1 0.0 0.0 12.0 0.0 0.0 0.7 1.5 0.8 5.1 2.2 5.1 0.2 0.0 1.0 0.1 10.4 6.3 4.4 0.0 0.0 1.3 0.0 3.3 2.0 5.9 4.7 4.8 5.0 1.8 4.1 7.9 4.6 0.0 3.6 0.5 3.9 2.4 3.0 11.7 12.3 12.7 15.0 10.6 14.7 11.7 10.8 16.9 12.4 ZCCHC10 FLJ20094 ENSG00000155329 "Zinc finger CCHC-type containing 10" Q8TBK6 5 132996985-133026604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038944 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038944: AB_10673601" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (2.30e-2)" "unprognostic (4.77e-1)" "unprognostic (1.90e-3)" "unprognostic (1.23e-3)" "unprognostic (8.80e-2)" "unprognostic (1.89e-3)" "unprognostic (1.69e-1)" "unprognostic (2.03e-1)" "unprognostic (8.30e-3)" "unprognostic (1.36e-2)" "unprognostic (1.27e-1)" "unprognostic (8.85e-2)" "unprognostic (1.62e-1)" "unprognostic (8.89e-3)" 18.6 17.3 14.5 18.2 14.1 30.6 16.4 18.1 20.6 17.4 24.1 10.5 15.4 18.3 18.7 15.4 26.9 14.9 14.2 17.3 13.7 12.4 19.6 23.5 21.0 26.0 11.9 15.2 17.3 17.7 9.8 27.4 23.0 15.3 16.1 22.1 10.0 17.9 16.8 31.5 14.0 21.7 14.0 17.5 23.6 17.8 20.3 14.1 25.6 13.9 22.4 26.5 17.8 17.3 48.1 27.2 16.5 28.0 22.9 27.7 18.8 11.7 12.3 16.3 13.5 8.2 7.4 21.4 12.4 9.7 15.9 18.5 31.0 14.7 32.8 19.1 8.3 15.0 19.9 15.9 17.3 19.3 26.4 19.0 15.1 23.0 12.1 16.3 22.3 6.7 18.3 9.7 15.8 15.7 20.5 18.2 12.0 15.4 25.4 18.9 17.7 12.9 22.9 19.3 14.3 14.6 17.0 12.8 10.8 19.9 8.1 22.9 18.0 21.2 16.0 13.7 16.2 8.9 17.9 15.4 24.4 46.1 11.1 29.2 16.1 16.5 28.0 16.4 19.7 25.3 20.6 39.7 24.1 23.5 27.2 48.1 21.2 21.8 14.6 22.9 25.3 24.0 27.7 18.8 14.5 14.1 18.1 20.6 13.7 12.4 11.9 15.2 15.3 14.1 ZCCHC11 "KIAA0191, PAPD3, TUT4" ENSG00000134744 "Zinc finger CCHC-type containing 11" Q5TAX3 1 52408282-52553487 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavourable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 13.8 19.1 18.4 25.6 19.0 20.5 18.7 50.9 21.3 22.4 13.3 11.8 16.1 7.7 22.1 22.0 11.5 16.8 14.0 13.5 17.8 16.5 14.2 17.7 13.3 27.4 15.4 14.6 28.3 17.6 34.4 56.0 18.8 16.3 16.1 10.5 12.1 12.6 20.6 44.6 28.1 17.1 20.3 26.6 20.9 12.3 24.9 21.1 31.9 23.9 14.6 25.1 18.3 17.0 23.2 26.0 26.7 4.3 10.3 15.0 2.2 10.4 9.9 24.4 16.5 9.6 12.3 16.9 9.3 13.6 13.6 15.7 10.2 5.5 22.3 11.0 12.9 8.7 18.3 9.8 17.3 18.2 16.7 23.5 12.8 21.2 15.9 25.4 13.4 14.5 21.9 14.5 18.0 9.4 19.1 11.2 11.3 0.1 25.3 18.2 17.7 12.6 22.5 24.8 17.4 14.6 8.6 13.1 13.0 14.3 6.1 13.9 8.5 13.4 7.9 10.6 14.3 9.7 11.3 24.5 32.1 32.1 7.0 13.9 7.6 26.7 4.3 13.8 11.8 1.7 8.8 19.1 12.4 9.5 2.1 23.2 15.0 9.9 16.2 10.3 1.4 26.0 9.3 2.2 18.4 19.0 50.9 21.3 17.8 16.5 15.4 14.6 16.3 21.1 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 5.8 5.1 4.4 8.7 13.5 5.8 8.4 3.4 5.1 8.1 8.1 2.7 3.6 16.6 4.5 5.6 10.0 14.2 7.5 3.4 11.4 6.7 4.4 11.8 18.6 4.6 8.3 6.4 5.7 9.7 5.1 9.6 15.2 4.6 5.6 2.6 4.8 5.4 3.5 2.8 5.1 7.2 4.7 0.1 5.6 6.0 5.6 3.5 5.7 12.8 5.0 4.5 6.6 6.4 8.0 5.5 3.1 4.8 2.2 4.2 7.1 6.0 3.5 2.9 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in many" "ASC diff: 42.7;ASC TERT1: 36.7;BJ hTERT+: 28.0;HSkMC: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.7 42.7 36.7 0.7 7.4 28.0 4.4 5.1 0.8 0.0 0.0 4.0 14.8 0.0 0.5 0.1 3.7 1.8 1.9 0.3 2.2 0.9 11.1 1.1 0.6 38.1 0.4 3.9 1.0 0.9 1.4 1.6 3.7 0.3 0.0 4.4 0.7 9.2 0.1 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.2 1.1 2.1 0.6 4.2 3.9 11.5 2.5 2.8 1.8 0.0 8.7 1.4 15.0 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 ZCCHC4 "FLJ23024, HSPC052, ZGRF4" ENSG00000168228 "Zinc finger CCHC-type containing 4" Q9H5U6 4 25312785-25370383 "Predicted intracellular proteins" "Acyltransferase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035575, HPA035576" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles, Golgi apparatus" "HPA035575: , HPA035576: AB_10671516" "unprognostic (5.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (5.84e-2)" "unprognostic (2.80e-3)" "unprognostic (1.71e-1)" "unprognostic (3.00e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (1.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.59e-2)" "unprognostic (1.07e-2)" 11.5 10.3 9.7 14.6 12.8 8.1 12.4 13.1 12.4 11.3 9.5 12.8 12.5 8.9 14.6 10.4 9.1 11.7 8.0 10.6 9.0 6.5 9.3 8.8 8.7 11.5 13.7 7.0 15.4 9.4 12.7 11.6 10.7 9.8 10.9 10.0 11.6 10.0 10.3 16.6 10.4 10.4 13.5 10.0 12.4 9.1 11.2 10.9 15.0 11.3 7.6 11.1 11.0 12.7 6.5 4.4 2.4 3.8 6.5 7.5 3.9 3.8 2.4 8.0 3.6 6.3 8.0 7.1 9.9 10.5 11.6 13.5 3.7 10.3 6.4 2.8 6.0 3.1 7.7 7.2 16.3 1.5 4.2 5.9 5.3 6.3 8.0 9.6 4.4 6.2 8.1 11.1 8.7 5.5 10.5 3.3 9.8 2.8 9.9 12.7 11.0 5.2 6.7 12.2 3.9 6.2 4.0 7.5 5.2 4.3 3.6 6.3 5.2 5.9 4.4 9.8 4.0 6.3 13.1 6.4 8.0 9.3 10.5 9.4 9.3 2.4 3.2 1.0 5.3 3.8 7.5 6.0 6.8 6.4 4.4 6.5 6.7 7.3 1.8 6.5 3.6 3.5 6.5 3.9 9.7 12.8 13.1 12.4 9.0 6.5 13.7 7.0 9.8 10.9 ZCCHC6 "FLJ13409, KIAA1711, PAPD6, TUT7" ENSG00000083223 "Zinc finger CCHC-type containing 6" Q5VYS8 9 86287733-86354454 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Group enriched" "Detected in all" 5 "granulocytes: 42.1;monocytes: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 11.2 9.3 7.7 22.6 11.2 17.0 17.3 9.7 13.7 10.8 13.5 5.6 12.8 9.4 8.6 8.1 23.1 8.3 10.3 10.1 9.4 5.2 7.4 33.1 16.3 19.5 9.8 5.1 9.0 12.9 9.2 18.6 33.3 9.0 19.3 10.8 4.5 14.0 13.6 12.5 30.9 15.6 9.7 13.6 22.2 11.7 10.3 10.7 23.3 8.7 15.2 16.9 13.7 14.3 4.4 4.3 42.1 15.7 4.5 5.7 2.9 9.8 10.7 6.4 9.2 16.3 24.8 7.8 13.5 13.2 6.0 7.0 4.8 8.8 14.1 12.3 8.9 17.5 7.5 7.6 8.9 16.5 4.0 10.1 11.3 9.0 13.9 11.5 14.8 16.4 16.0 9.5 11.3 10.0 9.5 15.3 16.6 10.6 9.6 7.0 5.2 7.2 4.9 11.1 6.5 10.6 19.4 4.6 3.7 8.2 10.9 4.7 4.1 5.2 15.4 5.7 6.9 10.1 9.2 17.7 13.7 10.5 13.6 6.9 7.5 11.5 7.1 7.1 5.7 9.1 4.9 4.4 3.2 4.1 4.3 4.4 3.7 4.0 42.1 4.5 15.7 2.0 3.0 2.9 7.7 11.2 9.7 13.7 9.4 5.2 9.8 5.1 9.0 10.7 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120539-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 15.2 12.7 9.9 28.4 11.3 16.2 16.8 16.5 12.1 16.1 13.4 10.2 20.0 11.3 19.2 14.9 11.5 13.1 12.4 10.2 10.1 10.3 10.0 11.1 10.9 27.5 11.8 8.4 21.9 19.8 8.6 30.7 10.2 11.2 13.5 14.2 9.8 14.3 19.2 9.9 12.7 13.9 14.0 11.8 18.4 11.8 14.3 12.4 19.9 16.1 12.3 29.3 19.2 12.9 29.7 7.5 10.9 8.5 10.1 11.4 5.2 7.2 4.9 6.8 7.3 7.2 11.1 6.4 7.1 8.3 5.5 7.7 4.8 3.5 25.8 3.9 5.5 3.0 6.6 6.7 8.0 11.8 4.6 7.4 8.0 4.2 11.1 12.6 7.4 7.6 10.5 5.8 22.7 6.4 20.2 9.0 4.9 3.4 9.7 7.0 7.3 7.3 46.8 4.5 6.5 6.9 2.9 7.7 5.6 5.0 6.1 6.5 4.4 8.2 5.7 4.1 5.2 5.9 4.3 3.1 5.7 30.7 6.6 8.2 7.5 4.7 4.4 10.9 7.8 5.0 7.7 18.1 8.9 8.8 4.0 29.7 11.4 10.4 8.8 10.1 8.5 7.5 7.4 5.2 9.9 11.3 16.5 12.1 10.1 10.3 11.8 8.4 11.2 12.4 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301590-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 14.4 12.9 11.7 16.1 10.5 8.9 15.2 14.3 11.5 21.1 19.7 7.4 14.5 13.9 18.4 16.4 21.4 13.9 14.3 11.9 10.0 10.7 23.0 36.3 10.7 16.2 11.1 10.1 19.6 13.8 10.9 22.6 23.0 10.4 23.1 14.6 13.6 12.2 18.1 14.4 15.2 27.7 22.5 12.2 18.0 14.5 14.8 10.0 17.9 19.6 19.1 16.4 26.8 23.5 14.9 17.5 12.8 16.2 11.6 19.1 7.3 10.2 7.2 17.8 9.4 15.5 14.7 24.1 15.4 18.4 11.9 16.6 15.9 14.2 9.5 6.4 7.7 7.6 14.1 14.1 19.1 21.2 13.3 9.8 8.1 18.6 18.2 12.4 8.1 11.3 12.4 10.1 25.5 10.0 16.3 9.3 12.2 13.9 20.4 18.6 12.9 9.3 12.2 23.0 13.9 9.3 10.3 8.7 8.3 12.2 7.4 55.0 9.2 20.0 6.8 7.5 9.2 13.3 16.8 13.4 13.7 14.5 13.3 18.1 16.0 12.8 12.3 11.9 12.8 16.2 16.3 14.9 17.2 15.5 14.8 13.2 16.7 17.1 12.0 11.6 14.0 17.5 19.1 7.3 11.7 10.5 14.3 11.5 10.0 10.7 11.1 10.1 10.4 10.0 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell line enhanced" "Detected in many" "BEWO: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039121: , HPA050311: " "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.9 0.3 6.6 1.2 2.2 1.9 9.3 1.9 2.2 0.9 1.4 1.0 1.5 0.1 0.9 2.3 0.5 4.2 1.4 1.7 2.3 3.9 0.0 3.7 0.2 2.9 2.0 4.2 2.0 2.4 1.6 3.9 2.4 0.3 2.6 2.8 0.3 0.5 0.0 8.9 1.9 0.0 6.9 0.0 1.1 1.0 3.4 8.2 3.3 0.0 2.7 0.2 0.0 3.6 0.8 3.2 0.7 1.5 6.0 1.5 0.3 4.6 0.0 2.2 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Cell line enhanced" "Detected in many" "MCF7: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA059339: " "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.1 38.8 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.0 6.7 31.8 16.4 9.9 8.6 6.8 37.5 3.5 18.1 1.0 18.2 9.3 5.2 29.5 13.9 10.3 8.7 24.1 5.6 12.6 8.2 3.1 7.4 5.2 25.2 1.9 54.5 11.9 17.4 7.2 32.1 5.4 5.8 28.4 7.6 13.3 11.6 8.4 12.4 17.2 4.8 26.5 9.3 7.4 0.0 10.5 7.1 12.2 16.3 28.8 4.4 16.8 10.0 11.0 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 ZDHHC14 "FLJ20984, NEW1CP" ENSG00000175048 "Zinc finger DHHC-type containing 14" Q8IZN3 6 157381133-157678146 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063754 Approved Approved Nucleoli,Mitochondria Nucleoli Mitochondria "HPA063754: " "unprognostic (1.66e-2)" "unprognostic (1.27e-2)" "unprognostic (1.58e-2)" "unprognostic (3.98e-2)" "unprognostic (1.59e-1)" "unprognostic (6.78e-3)" "unprognostic (1.84e-1)" "unprognostic (6.02e-2)" "unprognostic (2.87e-2)" "unprognostic (1.63e-1)" "prognostic favourable (6.93e-4)" "unprognostic (3.94e-2)" "unprognostic (5.01e-3)" "unprognostic (1.89e-1)" "unprognostic (7.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.63e-1)" 6.4 3.9 9.0 4.4 10.8 4.8 3.6 15.6 16.2 7.4 5.3 22.1 2.9 6.2 22.6 2.6 4.2 4.8 5.3 11.1 10.6 8.8 6.9 8.7 6.4 4.8 15.8 7.1 3.3 5.7 12.7 3.7 5.1 15.3 7.9 4.0 9.1 4.6 3.8 4.7 3.3 8.6 13.7 22.0 6.4 8.1 6.3 11.8 0.7 3.8 1.5 5.7 5.3 5.0 1.5 4.2 0.0 0.1 0.4 0.9 0.4 1.7 1.8 0.5 2.5 1.4 1.0 5.8 2.7 2.5 1.9 1.7 2.2 1.2 4.2 0.9 2.1 0.8 1.4 1.4 1.7 32.7 2.1 8.2 0.6 1.0 1.9 1.1 1.8 0.7 1.5 2.0 0.8 2.9 6.6 3.1 1.1 1.1 0.7 2.7 1.0 2.1 0.1 0.3 2.5 3.9 0.7 4.2 1.2 3.1 2.0 2.3 0.3 1.3 4.0 2.9 2.1 5.6 3.4 0.7 0.8 0.6 1.0 2.9 3.1 0.0 0.1 0.0 0.5 0.0 0.9 1.5 0.4 0.4 0.0 0.8 0.0 0.3 0.0 0.4 0.0 4.2 0.0 0.4 9.0 10.8 15.6 16.2 10.6 8.8 15.8 7.1 15.3 11.8 ZDHHC15 "DHHC15, FLJ31812, MRX91" ENSG00000102383 "Zinc finger DHHC-type containing 15" Q96MV8 X 75368427-75523502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003618 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA003618: AB_2217686" "unprognostic (8.28e-2)" "unprognostic (1.73e-1)" "unprognostic (8.05e-2)" "unprognostic (1.62e-5)" "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (4.00e-4)" "unprognostic (1.96e-2)" "unprognostic (3.19e-1)" "unprognostic (8.70e-2)" "unprognostic (3.77e-3)" "unprognostic (1.40e-1)" "unprognostic (4.78e-13)" "unprognostic (2.60e-3)" "unprognostic (1.17e-2)" "unprognostic (1.09e-1)" "unprognostic (9.67e-4)" 3.0 5.4 4.9 1.5 6.8 1.1 5.3 6.2 9.9 5.8 3.4 3.9 2.4 1.3 6.5 3.7 3.2 4.5 3.3 5.4 5.9 8.7 5.3 1.2 4.1 1.6 4.8 5.3 8.5 4.7 5.0 8.7 0.7 7.0 4.0 2.3 5.4 12.7 6.9 1.6 2.8 1.8 5.2 6.4 2.9 2.1 2.6 3.1 2.0 6.6 2.1 1.5 2.6 3.1 0.3 0.4 0.7 0.2 0.5 1.6 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 3.9 0.0 4.1 0.1 3.7 0.0 0.0 5.7 0.0 3.1 0.0 1.6 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.0 0.0 0.7 2.8 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 1.6 1.1 0.7 0.5 0.1 0.4 0.0 0.3 4.9 6.8 6.2 9.6 5.9 8.7 4.8 5.3 7.0 3.1 ZDHHC16 APH2 ENSG00000171307 "Zinc finger DHHC-type containing 16" Q969W1 10 97446131-97457370 "Enzymes, Predicted membrane proteins" "Apoptosis, DNA damage" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039893, HPA040214" Uncertain Supported "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA039893: AB_10794757, HPA040214: AB_2676886" "unprognostic (4.44e-2)" "unprognostic (3.14e-2)" "unprognostic (3.34e-1)" "unprognostic (1.20e-2)" "unprognostic (8.75e-2)" "unprognostic (8.35e-3)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (5.49e-2)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (6.34e-2)" "unprognostic (1.93e-3)" "unprognostic (1.34e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-1)" 12.0 13.7 15.9 10.8 17.3 6.4 17.9 17.6 24.6 17.1 17.9 15.6 18.1 15.1 15.5 21.2 17.6 11.5 14.4 18.1 13.2 11.0 23.3 37.4 20.8 11.1 10.9 13.0 15.1 22.5 21.8 15.4 30.7 10.5 16.0 18.9 18.1 28.5 14.1 20.7 14.0 15.7 17.6 8.5 13.2 19.4 16.4 10.8 14.7 19.6 15.4 16.1 15.1 20.0 9.3 14.2 9.4 10.4 13.0 12.0 5.8 21.4 25.2 16.8 20.7 26.9 18.5 17.6 23.6 31.5 27.3 26.1 19.6 19.2 18.9 27.3 34.5 25.3 21.1 33.4 24.4 18.7 24.5 12.0 17.7 18.6 21.6 14.3 17.7 20.6 22.1 31.9 23.0 28.0 9.6 14.4 34.5 20.5 21.6 19.6 13.7 21.9 14.8 17.1 17.4 23.1 9.9 8.2 11.7 14.4 14.9 12.8 19.7 14.0 17.1 17.2 16.0 11.1 27.6 13.8 22.3 11.6 19.9 22.2 9.0 0.3 9.8 9.4 7.0 10.4 8.0 8.2 12.0 11.1 14.2 9.3 9.9 9.8 0.5 13.0 10.4 10.9 9.4 5.8 15.9 17.3 17.6 24.6 13.2 11.0 10.9 13.0 10.5 10.8 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type containing 17" Q8IUH5 12 76763588-76853696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 16.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: " "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 7.9 7.8 10.0 5.8 14.0 11.3 8.8 18.1 18.1 8.0 5.9 9.2 3.8 3.6 12.0 6.8 6.4 7.0 5.5 6.4 8.7 6.5 9.1 13.1 5.4 7.1 11.3 10.7 11.5 5.2 9.5 10.3 8.7 13.2 7.9 5.4 5.9 5.7 7.3 5.4 5.9 6.4 8.0 10.0 7.1 6.1 6.4 11.6 7.5 6.2 4.1 5.7 5.6 6.3 3.8 16.3 5.8 2.2 1.7 3.6 1.4 5.7 7.1 22.2 11.3 13.4 14.2 10.9 11.7 9.7 7.8 6.9 5.6 4.2 8.0 7.1 11.3 5.5 8.8 7.3 12.2 6.7 9.3 11.6 8.7 8.5 9.0 11.6 10.4 13.3 7.7 7.3 11.0 8.9 12.5 3.7 10.1 5.4 8.3 15.6 16.4 8.1 11.3 7.9 8.7 9.0 8.9 8.7 15.1 12.9 4.7 7.5 10.5 11.7 12.3 10.7 8.1 6.5 6.6 6.0 5.8 8.7 4.0 5.5 11.0 5.7 2.1 5.2 3.6 2.2 2.9 2.6 2.9 2.7 2.6 3.8 3.1 2.6 5.8 1.7 2.1 16.3 1.2 1.4 10.0 14.0 18.1 13.8 8.7 6.5 11.3 10.7 13.2 11.6 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.5 7.8 11.4 7.2 10.6 11.2 27.9 14.8 14.9 9.9 8.9 14.2 41.5 14.4 8.0 18.1 22.0 13.1 11.4 18.8 15.7 8.3 25.3 4.9 7.8 6.0 17.1 11.0 10.2 8.0 9.8 6.9 15.3 7.0 6.1 14.7 11.4 23.9 6.5 9.3 7.7 19.2 20.5 5.0 11.8 25.2 10.9 5.0 19.5 12.2 8.0 11.2 8.7 26.6 10.5 10.0 17.6 11.0 6.3 7.7 15.0 7.5 9.9 29.5 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 ZDHHC21 "DHHC21, DNZ1, HSPC097" ENSG00000175893 "Zinc finger DHHC-type containing 21" Q8IVQ6 9 14611071-14693471 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065254 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA065254: " "unprognostic (2.95e-2)" "unprognostic (1.45e-1)" "unprognostic (2.06e-2)" "unprognostic (2.01e-1)" "unprognostic (4.19e-2)" "unprognostic (2.58e-2)" "unprognostic (2.81e-2)" "unprognostic (1.13e-2)" "unprognostic (2.18e-2)" "unprognostic (8.37e-2)" "unprognostic (9.79e-3)" "unprognostic (3.97e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (8.87e-2)" "prognostic favourable (9.28e-6)" 6.5 10.8 15.9 7.9 16.8 4.2 11.6 29.0 22.6 7.8 8.5 9.3 3.8 12.2 9.8 11.7 14.4 7.5 6.7 9.0 13.8 10.4 9.4 4.8 9.2 11.1 9.4 16.5 10.0 8.4 11.5 22.2 7.8 14.8 10.0 9.9 6.6 8.3 7.4 7.7 15.7 12.6 7.7 9.9 9.5 7.9 7.3 9.7 4.7 11.3 9.9 10.7 7.7 11.3 5.2 1.4 0.5 0.8 2.8 1.7 0.6 5.3 2.7 5.4 3.5 0.9 1.0 4.2 6.8 2.1 2.4 2.8 1.3 2.5 5.3 1.7 4.8 3.5 3.7 2.2 3.5 10.6 2.9 22.5 6.0 2.6 2.9 3.9 7.5 1.8 5.2 2.8 1.8 14.2 1.8 0.6 4.3 2.9 0.9 3.8 3.8 5.2 0.0 2.6 2.6 7.6 5.9 3.3 8.9 3.1 3.9 2.1 4.9 6.5 10.1 1.8 2.7 1.7 6.2 2.2 4.1 0.0 3.7 0.2 1.8 0.5 0.4 0.1 1.2 0.8 1.3 5.2 1.2 1.1 0.2 3.5 0.8 1.2 0.0 2.8 0.6 1.4 1.7 0.6 15.9 16.8 29.0 22.6 13.8 10.4 9.4 16.5 14.8 9.7 ZDHHC24 ENSG00000174165 "Zinc finger DHHC-type containing 24" Q6UX98 11 66520637-66546238 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016619 Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA016619: AB_2288672" "unprognostic (2.77e-1)" "unprognostic (2.51e-1)" "unprognostic (2.52e-1)" "unprognostic (1.55e-3)" "prognostic unfavourable (3.28e-4)" "unprognostic (8.76e-2)" "unprognostic (7.74e-3)" "unprognostic (7.11e-2)" "unprognostic (6.20e-2)" "unprognostic (1.41e-1)" "unprognostic (3.73e-2)" "unprognostic (1.48e-1)" "unprognostic (8.10e-2)" "unprognostic (6.99e-3)" "unprognostic (3.10e-1)" "unprognostic (4.88e-1)" "unprognostic (1.35e-1)" 11.7 17.4 10.5 10.3 12.8 14.1 12.3 5.7 15.5 7.7 8.3 13.8 10.8 9.1 9.4 17.0 12.2 9.0 11.3 9.9 10.7 11.8 17.3 13.4 11.1 20.4 12.8 10.3 6.5 19.4 22.6 9.6 13.7 9.3 11.4 7.7 10.0 12.4 13.1 7.9 13.2 9.4 7.1 10.0 16.0 12.4 9.9 10.5 11.7 17.7 7.9 13.4 10.0 7.8 5.8 17.2 2.4 5.5 6.6 7.2 4.6 4.8 7.8 2.6 6.7 6.4 5.3 6.5 4.1 3.5 3.3 2.3 6.8 7.9 1.4 11.2 3.5 12.0 1.9 3.6 2.3 7.0 4.9 3.0 3.8 4.2 6.0 3.0 7.5 6.3 6.5 2.7 3.9 5.5 4.3 4.4 4.1 10.6 5.8 8.5 5.1 6.7 7.5 5.4 9.1 4.0 3.9 3.6 5.7 6.6 6.9 11.3 9.5 2.5 8.5 7.6 2.4 8.8 3.0 6.5 2.0 2.0 6.6 1.4 8.2 2.4 5.5 1.0 6.2 4.8 5.7 5.4 5.0 7.2 6.3 5.8 3.0 5.4 2.4 6.6 4.4 17.2 5.1 4.6 10.5 12.8 5.7 15.5 10.7 11.8 12.8 10.3 9.3 10.5 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavourable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 27.9 31.1 12.2 12.4 27.0 20.8 23.0 26.3 31.6 22.1 16.5 18.8 34.5 18.9 34.2 31.1 39.6 19.0 31.2 19.7 23.2 8.6 16.0 14.3 16.7 30.3 30.0 27.2 29.3 28.2 32.6 33.1 24.8 21.1 23.9 27.8 16.8 16.9 8.4 14.8 18.7 16.8 24.7 23.3 25.2 41.6 8.9 11.4 24.5 27.7 25.7 29.7 17.2 29.1 28.6 14.9 30.0 18.3 17.4 21.5 16.3 21.3 15.5 24.8 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type containing 7" Q9NXF8 16 84974181-85011535 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059642" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA019215: , HPA059642: " "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favourable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 23.4 20.9 17.7 25.4 14.7 40.3 45.8 17.8 20.0 23.7 26.8 15.5 15.6 19.7 27.7 18.6 20.4 19.2 29.1 24.9 13.0 11.6 23.4 21.3 31.3 36.3 15.5 14.5 21.8 30.0 31.1 15.2 25.1 14.8 24.1 24.3 18.1 18.7 18.4 36.5 23.1 25.5 31.1 14.9 27.1 32.3 18.6 13.9 16.1 19.9 25.8 18.8 27.7 28.9 2.0 6.9 8.5 10.6 1.5 3.0 3.5 20.0 17.7 9.4 11.2 41.6 31.4 12.9 18.6 36.1 29.3 14.6 18.6 23.6 9.2 10.9 30.0 21.2 12.0 24.5 37.0 5.3 9.6 7.2 7.5 21.1 17.4 12.5 7.0 25.9 28.2 23.9 13.8 15.0 21.4 3.2 18.5 24.0 8.5 12.0 14.5 12.9 10.6 8.6 5.0 28.8 26.5 8.0 10.1 24.0 13.5 11.6 25.5 7.6 21.9 17.7 13.5 16.7 10.8 11.1 15.3 20.9 16.8 9.4 14.0 6.7 10.6 8.5 2.5 8.8 3.0 1.6 2.4 2.0 6.9 2.0 1.8 2.6 7.1 1.5 7.2 4.7 0.6 3.5 17.7 14.7 17.8 20.0 13.0 11.6 15.5 14.5 14.8 13.9 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type containing 8" Q9ULC8 22 20129456-20148007 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavourable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 20.7 19.2 25.7 16.9 23.0 9.2 23.4 24.4 35.3 14.3 9.9 14.0 17.3 11.6 16.0 10.9 13.9 13.6 14.4 16.0 18.7 10.6 15.2 16.5 14.6 15.4 17.7 17.6 18.0 23.9 17.4 21.0 16.4 19.0 13.4 7.0 17.5 20.4 16.6 20.5 22.2 11.2 13.0 10.4 19.8 15.9 8.4 18.6 8.9 18.5 7.9 11.1 12.9 14.5 2.0 4.1 4.0 1.5 1.3 2.5 0.5 11.3 7.3 11.6 15.3 17.1 10.2 10.5 21.5 14.7 14.6 13.1 3.8 5.9 0.0 8.9 17.8 15.6 6.1 16.4 7.2 16.4 23.3 5.5 19.1 8.7 14.1 0.0 7.7 17.8 11.1 11.2 9.5 16.3 38.0 9.0 12.9 5.6 6.7 14.9 5.9 11.6 14.4 10.2 4.1 6.3 13.9 18.7 9.5 8.7 4.2 10.2 0.3 7.8 18.6 33.2 24.3 18.6 9.5 13.0 4.2 4.3 9.7 7.2 9.7 4.0 1.2 0.3 2.5 1.5 1.3 0.8 0.7 1.2 0.4 2.0 1.3 1.8 0.0 1.3 0.8 4.1 2.0 0.5 25.7 23.0 24.4 35.3 18.7 10.6 17.7 17.6 19.0 18.6 ZDHHC9 "CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type containing 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavourable (9.77e-5)" "prognostic unfavourable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 18.2 7.3 16.7 6.7 24.7 3.2 14.2 7.8 33.9 14.1 14.7 78.3 5.1 21.1 8.4 8.4 9.8 7.9 10.4 7.4 24.1 15.2 25.4 27.0 15.6 3.0 24.9 13.9 8.0 17.4 19.6 7.1 11.5 28.4 13.4 17.3 3.8 13.2 8.3 7.4 19.7 22.2 10.4 32.7 2.4 12.8 2.8 25.3 1.2 9.6 5.7 4.3 10.8 9.4 4.6 7.8 2.6 6.8 3.4 7.6 3.3 15.2 8.0 11.5 23.2 39.9 31.4 9.4 15.1 17.3 7.2 9.1 12.6 19.9 0.5 25.8 16.0 10.3 13.0 15.1 10.5 0.8 8.1 3.0 8.4 16.6 15.8 2.0 5.5 34.1 24.7 11.8 17.6 13.6 3.3 6.1 11.7 13.3 2.9 3.8 6.2 13.9 2.7 7.4 9.0 10.5 8.5 9.1 7.7 4.3 22.3 7.0 9.5 3.4 11.1 7.4 2.5 17.3 12.1 5.7 4.1 1.8 13.3 8.4 3.7 0.0 3.3 2.6 4.8 2.9 6.1 4.6 5.8 4.7 3.7 2.7 7.6 4.3 0.0 3.4 6.8 7.8 2.5 3.3 16.7 24.7 7.8 33.9 24.1 15.2 24.9 13.9 28.4 25.3 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell line enhanced" "Detected in many" "HEL: 38.4;THP-1: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.1 0.0 26.4 13.5 0.0 9.1 9.2 10.2 9.9 0.0 0.2 1.6 0.0 9.8 0.1 3.7 0.0 12.8 9.4 2.6 38.4 1.6 0.0 5.9 6.6 30.5 11.0 0.2 12.6 6.1 7.7 10.7 1.1 12.0 0.0 0.0 20.1 3.2 0.5 11.3 15.2 0.0 0.1 0.2 0.1 5.8 1.1 0.0 23.9 0.0 45.7 11.9 11.7 0.2 22.8 2.8 12.5 0.0 1.9 17.6 19.9 31.6 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 ZFAND1 FLJ14007 ENSG00000104231 "Zinc finger AN1-type containing 1" Q8TCF1 8 81701334-81732903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023383 Approved Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA023383: AB_1859008" "unprognostic (6.45e-2)" "unprognostic (1.48e-2)" "unprognostic (7.74e-2)" "unprognostic (8.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.04e-3)" "unprognostic (8.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.30e-2)" "unprognostic (3.77e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.35e-2)" "unprognostic (2.36e-2)" 18.9 17.7 12.5 10.8 23.2 14.8 25.8 24.3 25.9 22.8 19.4 8.6 16.0 16.1 21.6 17.9 19.9 20.8 14.4 14.8 12.7 15.8 19.6 26.6 16.2 13.8 14.8 16.2 35.8 35.1 16.0 31.1 12.6 27.4 23.7 18.7 10.3 23.3 18.1 16.9 13.5 20.2 23.7 16.5 17.5 20.3 10.3 13.2 19.0 42.6 16.1 17.0 26.7 21.3 18.5 20.0 6.4 13.9 17.2 25.1 16.8 19.3 6.2 8.6 7.6 11.9 24.0 8.7 11.6 15.7 10.2 13.4 6.8 15.4 19.1 13.8 8.8 13.2 10.0 16.7 15.4 16.0 10.0 10.9 10.5 8.0 21.9 13.3 7.3 19.5 40.2 7.1 69.7 12.7 16.4 27.4 10.5 12.7 16.5 9.6 2.5 19.6 11.3 7.4 8.5 12.8 18.0 8.8 5.7 8.3 5.3 19.0 17.6 9.9 8.1 7.6 11.1 10.8 16.1 10.9 6.7 11.7 9.0 1.2 5.8 6.4 13.9 3.9 11.3 10.2 19.4 18.5 18.5 15.0 20.0 13.4 25.1 18.7 1.4 17.2 11.8 11.6 21.1 16.8 12.5 23.2 24.3 25.9 12.7 15.8 14.8 16.2 27.4 13.2 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA035159: , HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favourable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.4 7.1 8.2 11.5 8.7 9.2 11.4 10.6 12.5 15.3 15.2 16.0 9.0 8.5 11.3 18.1 7.2 7.6 13.5 12.2 13.1 11.8 19.4 11.8 13.8 17.9 10.3 22.5 7.6 29.7 15.1 36.0 10.2 11.3 24.2 14.9 18.1 17.0 21.7 4.2 8.2 10.6 4.9 14.6 14.5 8.9 17.9 8.1 5.1 8.7 11.8 7.4 21.9 10.8 15.5 14.5 17.8 15.1 10.0 3.2 15.3 15.2 20.5 12.0 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819499-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 26.7 27.5 31.0 26.0 31.1 23.9 37.6 26.2 31.4 28.6 27.0 26.6 26.0 24.5 25.9 31.2 22.2 21.4 33.5 30.5 29.9 24.1 31.6 35.6 24.8 26.1 30.4 22.2 23.9 26.1 33.9 31.6 31.4 24.2 23.7 20.2 24.3 20.3 31.0 77.9 19.4 26.9 35.4 33.4 21.9 25.1 60.5 27.3 26.4 32.1 19.7 19.3 30.7 34.0 3.0 4.4 9.2 2.8 2.9 2.6 1.4 17.0 10.6 36.7 26.0 22.2 23.1 12.7 28.6 33.3 25.8 27.6 20.7 10.1 7.1 22.0 30.4 11.8 14.0 21.1 35.5 27.1 8.9 21.5 5.5 19.8 52.1 8.9 18.8 29.0 27.8 27.2 46.3 22.2 10.2 15.1 19.5 14.8 14.0 7.5 10.8 11.1 14.8 14.8 8.6 24.5 29.2 22.7 20.0 16.0 14.1 49.2 21.6 18.9 24.3 27.2 20.7 14.5 17.8 14.8 13.4 21.6 10.2 14.1 28.0 0.7 2.7 8.8 2.6 2.8 1.8 1.9 1.9 2.0 1.3 3.0 1.7 2.6 9.2 2.9 2.1 4.4 2.4 1.4 31.0 31.1 26.2 31.4 29.9 24.1 30.4 22.2 24.2 27.3 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Cell line enhanced" "Detected in all" "HDLM-2: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018129 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018129: AB_1859012" "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favourable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 21.8 22.4 26.4 11.7 34.3 16.3 20.0 25.9 36.1 13.9 10.9 2.7 20.7 12.2 15.7 40.5 24.5 60.9 10.1 20.9 82.5 9.4 9.6 12.9 13.7 25.3 13.8 14.3 21.4 18.8 14.6 16.3 24.7 9.2 16.2 16.4 5.8 18.0 7.8 34.2 15.6 14.1 13.7 12.9 45.5 21.3 19.4 17.3 16.4 18.0 21.1 8.0 12.1 18.8 11.6 14.3 20.5 17.7 23.3 20.3 6.4 15.6 9.4 28.8 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 68.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in single" 25 "dendritic cells: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA020989: , HPA063592: " "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 4.5 2.9 4.2 3.5 4.2 1.7 5.0 6.8 4.5 3.0 7.8 2.6 2.8 3.2 5.0 3.1 4.2 3.3 2.4 3.8 3.0 1.7 12.4 2.8 4.1 4.5 2.5 2.8 3.3 3.3 3.7 4.6 68.8 2.9 3.9 2.6 4.3 3.7 4.2 8.5 3.4 3.8 3.9 2.0 4.4 3.6 3.5 3.0 4.8 3.3 2.8 4.0 6.0 5.3 0.6 22.1 0.8 0.5 0.0 0.5 0.5 5.7 9.0 3.3 4.1 6.4 6.4 2.8 6.2 5.5 5.7 5.7 6.1 7.2 6.4 5.4 6.4 4.4 6.5 7.8 7.4 5.3 8.7 12.0 9.1 4.6 5.0 6.6 5.9 5.4 4.0 6.3 8.2 6.9 4.5 12.0 4.8 7.4 6.9 0.8 4.5 5.9 4.3 4.3 2.7 5.4 8.5 3.7 3.1 6.3 4.9 5.2 4.0 6.3 7.6 3.3 5.0 4.7 7.0 4.3 5.8 6.4 4.3 4.9 6.4 0.7 0.3 0.8 0.3 0.5 0.3 0.6 0.2 0.5 0.3 0.6 0.4 0.2 0.7 0.0 0.3 22.1 0.1 0.5 4.2 4.2 6.8 4.5 3.0 1.7 2.5 2.8 2.9 3.0 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609472-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavourable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 12.1 12.8 17.6 19.1 17.4 22.7 12.9 35.3 23.8 15.4 16.9 6.7 14.6 8.0 13.7 17.3 15.1 12.8 12.7 12.1 14.6 7.7 10.7 8.0 16.4 19.1 14.8 12.3 17.1 11.6 17.6 17.6 14.6 14.9 12.6 13.2 6.7 12.0 14.2 11.6 12.2 15.2 12.4 14.7 15.9 13.5 17.5 17.6 16.8 13.5 8.4 17.1 15.7 20.8 14.8 12.7 29.7 10.3 4.2 7.2 1.1 10.5 10.7 7.7 5.3 10.7 19.1 4.6 8.2 13.2 13.0 12.9 9.8 5.8 13.6 4.7 10.1 11.3 10.9 4.8 17.4 13.7 8.0 13.2 16.5 4.6 6.0 14.4 6.5 10.7 10.4 9.2 3.9 13.0 12.2 6.0 11.9 3.2 10.2 5.0 7.7 6.2 8.8 9.4 10.4 9.8 7.8 5.3 4.8 8.3 5.3 5.4 14.2 9.5 9.9 7.3 5.0 4.2 4.1 10.5 6.3 10.5 8.6 10.1 5.1 20.7 10.3 12.1 7.2 4.8 5.5 9.2 6.2 4.6 3.9 14.8 5.8 4.9 29.7 4.2 8.7 12.7 4.9 1.1 17.6 17.4 35.3 23.8 14.6 7.7 14.8 12.3 14.9 17.6 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.3 4.2 8.4 2.9 0.4 0.3 1.2 0.4 0.6 2.1 0.5 0.4 0.4 0.5 0.1 0.1 2.2 0.3 0.9 3.7 1.3 4.3 0.0 1.0 0.5 0.7 3.0 0.6 0.2 0.9 0.3 0.6 0.6 0.7 0.1 1.4 0.5 0.5 5.1 1.2 2.3 0.1 0.0 2.3 2.0 4.6 3.0 0.7 1.1 0.3 1.7 1.1 0.1 0.0 2.1 1.3 0.5 0.5 1.7 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 ZFHX4 "FLJ20980, ZFH4" ENSG00000091656 "Zinc finger homeobox 4" Q86UP3 8 76681219-76867285 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.1" "Cell line enhanced" "Detected in many" "HSkMC: 12.9;TIME: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023837 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA023837: AB_1859013" "unprognostic (2.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.63e-3)" "unprognostic (6.14e-8)" "unprognostic (3.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.79e-2)" "unprognostic (9.15e-4)" "unprognostic (3.18e-2)" "unprognostic (1.17e-3)" "unprognostic (6.20e-7)" "unprognostic (3.50e-3)" "unprognostic (2.51e-1)" "unprognostic (4.50e-4)" "unprognostic (5.89e-4)" 4.9 8.8 6.2 2.1 10.7 0.8 5.8 1.4 8.5 6.3 5.1 7.7 14.1 1.0 2.2 8.9 1.7 2.0 2.9 1.5 7.2 4.3 1.6 7.3 1.1 1.5 8.3 4.3 5.5 1.5 1.2 13.7 1.1 5.9 3.2 2.0 8.0 1.6 29.1 6.5 1.4 1.3 11.8 11.6 1.2 2.0 15.6 9.8 0.0 1.2 2.4 1.0 7.8 5.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 2.4 0.0 4.8 6.3 0.0 2.0 2.9 2.4 2.5 0.0 0.0 0.0 3.9 3.4 0.2 4.8 0.6 4.4 0.0 7.1 0.1 0.0 0.0 1.3 0.0 0.3 12.9 0.2 6.2 2.5 0.4 0.0 0.2 4.7 0.0 0.0 0.0 0.4 4.1 0.0 4.3 0.0 3.8 0.0 0.0 4.5 0.0 0.5 0.0 0.6 0.0 28.1 2.4 3.7 7.1 4.7 7.2 0.7 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 10.7 1.4 8.5 7.2 4.3 8.3 4.3 5.9 9.8 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556810 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 3.1 3.6 4.9 1.4 4.1 0.4 3.7 6.1 7.0 3.4 2.5 1.1 5.6 4.2 2.3 3.1 3.2 3.6 5.4 5.7 3.1 0.1 3.5 1.6 5.0 10.1 2.5 6.1 4.0 2.9 4.3 1.6 2.3 4.0 1.9 2.7 1.2 4.4 5.5 2.8 2.1 5.1 4.0 1.8 2.8 2.5 3.1 1.5 3.9 0.5 2.4 3.7 0.9 0.0 1.7 8.0 2.4 2.7 2.6 4.1 5.2 5.0 4.2 6.9 0.0 1.1 0.0 2.6 6.2 0.2 3.9 1.7 6.4 0.0 6.8 5.3 0.2 0.0 7.8 0.2 6.1 7.2 2.2 6.3 0.1 0.8 1.0 0.1 5.4 0.0 2.6 0.9 3.7 1.7 4.1 10.4 0.0 5.6 3.3 0.0 7.3 0.0 0.3 1.2 3.1 5.3 1.9 3.9 4.3 0.4 6.3 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.5 3.9 0.5 0.3 2.6 1.9 2.6 1.8 1.1 3.1 2.1 1.6 0.5 2.4 0.4 1.5 3.7 0.9 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078248-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.4;SH-SY5Y: 7.6;SiHa: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA053085: , HPA057290: " "unprognostic (3.71e-2)" "prognostic favourable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favourable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favourable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favourable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 4.9 6.3 11.0 10.0 10.4 1.9 8.9 19.6 14.7 6.8 8.9 11.9 9.6 13.0 6.9 6.9 6.7 11.2 6.3 12.4 9.8 7.6 10.2 3.3 7.3 9.2 7.9 8.3 9.9 11.3 16.6 10.8 5.2 11.4 7.9 10.9 7.4 10.7 15.4 33.3 6.7 11.3 6.3 8.5 10.2 8.3 9.9 11.8 10.6 11.1 3.5 11.2 6.6 5.7 5.4 1.4 1.4 2.2 1.9 4.3 1.6 0.0 1.3 0.3 0.0 1.2 0.6 0.0 2.8 0.0 2.1 2.5 5.5 2.5 0.0 4.0 2.7 5.6 0.0 0.0 1.2 0.0 0.1 0.2 2.0 0.0 3.9 0.0 7.4 1.9 0.0 1.5 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.2 0.3 0.5 0.0 0.8 1.8 3.4 3.4 3.5 7.6 6.9 5.7 3.6 3.4 5.4 0.0 0.0 1.1 2.0 4.0 0.1 0.2 0.0 0.0 0.0 3.2 0.0 2.0 1.4 2.8 2.2 1.7 2.1 1.6 2.5 1.4 5.4 4.3 3.0 0.2 1.9 1.9 0.9 1.6 1.6 11.0 10.4 19.6 14.7 9.8 7.6 7.9 8.3 11.4 11.8 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049112: " "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favourable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.6 6.4 4.3 8.2 3.9 2.4 3.5 2.7 2.2 0.0 1.8 4.3 1.9 2.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 1.9 2.3 0.0 0.9 2.3 0.8 3.1 6.2 1.5 0.4 3.8 5.5 0.0 0.0 0.0 7.8 0.0 0.0 10.6 0.6 2.0 0.0 6.5 6.1 7.4 1.6 1.4 6.3 0.0 0.6 6.2 2.7 7.3 3.6 1.5 2.8 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavourable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.3 4.9 6.6 5.7 4.5 5.8 4.3 2.3 8.5 5.8 5.6 5.9 3.9 6.4 5.6 5.8 5.4 5.6 4.2 6.2 6.5 5.0 5.5 4.3 8.0 1.9 3.1 4.7 8.0 5.4 8.1 3.9 10.5 3.9 4.0 12.7 5.2 2.1 7.3 11.3 2.8 4.0 1.4 3.7 6.4 6.3 8.7 12.1 3.3 6.4 8.5 3.9 4.1 6.4 11.5 5.0 6.8 6.3 4.7 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 ZFP62 "FLJ34231, ZET, ZNF755" ENSG00000196670 "ZFP62 zinc finger protein" Q8NB50 5 180847611-180861285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048629 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA048629: " "unprognostic (2.77e-2)" "unprognostic (1.77e-1)" "unprognostic (9.18e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.89e-2)" "unprognostic (9.49e-2)" "unprognostic (7.11e-3)" "unprognostic (7.29e-2)" "unprognostic (3.44e-2)" "unprognostic (1.05e-2)" "unprognostic (2.14e-1)" "unprognostic (4.34e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-2)" "unprognostic (2.29e-3)" 10.9 8.6 17.2 16.0 20.2 4.0 14.4 19.9 16.5 14.3 14.5 11.9 15.1 13.7 15.6 16.4 15.1 16.8 13.2 9.7 17.6 9.5 11.9 8.3 10.4 17.7 18.3 12.8 22.5 15.2 18.9 16.3 10.1 16.4 15.1 18.4 10.1 15.6 18.5 14.5 16.0 15.5 18.8 15.7 13.4 16.3 8.8 22.1 26.9 25.4 10.5 20.0 16.0 14.8 7.0 3.8 7.7 4.9 4.8 10.3 4.2 7.7 5.8 12.6 16.2 9.2 8.2 15.5 8.0 6.0 6.6 9.3 14.1 19.5 19.2 12.9 3.6 11.6 6.0 14.2 10.0 32.7 11.0 10.8 15.6 4.7 6.3 9.8 6.5 6.4 11.4 6.8 11.7 5.9 8.9 10.6 9.0 18.3 14.1 5.4 8.8 14.2 12.6 12.9 10.7 5.5 14.1 16.5 11.5 11.7 8.8 8.6 13.5 8.8 8.4 10.2 8.9 4.9 8.0 11.2 12.8 9.6 8.4 13.2 7.9 7.7 3.2 3.9 4.0 4.3 7.8 6.9 5.5 5.8 3.4 7.0 10.3 8.6 1.5 4.8 4.9 3.8 5.6 4.2 17.2 20.2 19.9 16.5 17.6 9.5 18.3 12.8 16.4 22.1 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.6 13.9 2.1 5.7 1.6 3.2 3.1 1.4 2.8 1.6 2.2 6.3 3.1 2.8 1.2 2.9 2.8 3.2 5.5 1.2 2.6 3.2 4.7 1.5 0.4 4.2 1.3 4.7 5.1 6.8 2.0 6.8 6.3 4.4 2.3 8.4 0.6 7.7 1.4 4.8 5.6 3.0 2.9 3.2 7.7 8.0 5.1 4.4 2.1 2.3 7.3 4.3 4.7 10.0 4.3 4.6 9.8 9.3 13.7 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: , HPA060470: " "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.8 2.8 3.4 4.3 7.0 9.1 1.6 1.2 7.4 5.8 4.1 0.2 0.0 0.9 8.9 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.8 1.3 5.0 1.5 3.2 0.0 0.0 6.8 0.0 11.5 0.0 7.9 1.5 9.7 5.8 2.2 3.5 4.2 0.1 8.7 0.0 0.5 5.5 1.6 5.1 0.4 2.5 4.4 4.5 5.8 5.1 3.5 11.4 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 ZFP90 "KIAA1954, NK10, ZNF756" ENSG00000184939 "ZFP90 zinc finger protein" Q8TF47 16 68530090-68576072 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029017 Uncertain Supported "Vesicles,Plasma membrane,Centrosome" "Vesicles, Plasma membrane, Centrosome" "HPA029017: AB_10669653" "unprognostic (3.27e-1)" "unprognostic (1.71e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (2.47e-1)" "unprognostic (3.68e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (7.33e-2)" "unprognostic (1.35e-3)" "unprognostic (3.43e-1)" "prognostic favourable (1.78e-4)" "unprognostic (1.47e-2)" "unprognostic (2.37e-1)" "unprognostic (1.33e-1)" "unprognostic (9.60e-2)" 9.6 9.0 16.9 11.5 19.3 7.8 16.2 24.0 19.5 14.2 8.9 18.9 10.4 4.4 15.8 18.2 7.6 14.3 9.5 10.3 15.5 19.8 11.6 7.9 9.6 12.4 16.7 20.5 18.1 8.7 29.1 16.5 8.3 20.0 13.1 9.3 11.4 8.7 13.6 10.0 13.2 8.3 13.6 16.1 13.2 11.2 11.6 19.6 15.8 11.0 3.6 15.5 11.3 9.6 5.8 2.6 7.8 1.9 5.2 8.8 3.0 7.1 7.8 14.7 13.9 13.1 14.0 6.6 6.8 7.8 9.3 10.8 5.5 4.8 7.7 8.8 8.6 6.8 9.0 8.6 10.7 6.7 3.7 1.9 1.5 9.2 10.2 0.0 7.3 12.1 14.2 8.6 12.0 7.4 3.8 2.9 11.4 12.8 7.6 7.4 5.5 5.9 14.1 5.1 5.1 6.4 5.1 16.7 12.7 19.4 1.5 7.3 11.7 10.2 5.3 8.8 5.3 7.4 3.9 5.6 10.4 9.4 2.9 2.7 7.0 7.8 1.7 2.8 6.4 1.9 8.8 5.8 6.0 7.4 2.4 4.1 8.7 7.5 0.5 5.2 1.3 2.6 6.8 3.0 16.9 19.3 24.0 19.5 15.5 19.8 16.7 20.5 20.0 19.6 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein" Q96JP5 11 58579111-58621042 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA024037, CAB025417" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB025417: , HPA024037: AB_1859051" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavourable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 17.1 14.7 20.1 13.6 25.6 32.0 14.9 24.4 21.7 15.3 18.1 23.2 15.8 16.2 16.3 11.8 16.3 13.6 13.8 26.5 20.3 15.4 16.3 19.4 15.0 14.4 20.8 18.1 14.9 14.3 26.7 17.0 14.2 19.7 13.1 21.9 11.2 14.5 15.5 33.8 17.5 19.6 16.9 21.6 15.0 13.9 71.0 19.4 15.7 16.8 14.6 15.9 17.8 21.4 4.6 7.0 5.4 5.0 3.7 5.4 2.8 24.5 14.1 16.6 16.8 15.9 19.3 9.1 20.3 38.2 23.6 20.2 7.7 26.0 29.4 20.1 25.6 21.9 16.8 21.6 31.1 15.6 9.4 19.4 14.4 8.3 18.1 24.4 32.0 16.8 21.2 33.1 38.8 23.3 19.2 27.9 30.3 8.2 21.1 13.5 8.7 13.8 16.4 28.0 19.5 17.3 23.7 17.8 14.2 25.9 23.9 33.1 26.6 18.4 26.1 29.8 20.6 44.8 22.5 16.2 11.9 24.5 26.3 13.8 30.3 3.9 5.0 3.5 5.4 4.5 3.0 4.5 3.3 3.3 4.9 4.6 3.6 4.6 5.4 3.7 4.2 7.0 2.6 2.8 20.1 25.6 24.4 21.7 20.3 15.4 20.8 18.1 19.7 19.4 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell line enhanced" "Detected in many" "HEL: 14.3;K-562: 21.2" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA046603: " "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favourable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.8 2.1 4.5 0.4 0.1 9.2 3.0 0.4 1.0 0.3 9.1 1.1 4.4 2.3 0.4 7.1 0.1 2.5 0.2 3.4 1.9 14.3 5.6 7.9 1.7 0.8 4.8 1.0 1.6 1.0 0.3 1.0 21.2 0.3 0.8 5.4 5.0 5.2 1.4 2.5 1.4 1.0 2.1 1.0 3.6 6.0 9.9 3.7 0.2 2.9 2.3 2.3 3.6 3.8 2.5 1.7 0.6 1.0 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 ZFX ZNF926 ENSG00000005889 "Zinc finger protein, X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: " "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 20.3 8.8 10.8 8.2 11.7 25.9 23.5 22.1 12.6 18.5 12.2 7.2 8.4 6.6 18.5 11.0 10.6 15.8 7.2 17.8 10.1 6.6 16.6 11.3 9.7 12.7 13.1 9.6 20.2 11.8 20.2 17.9 23.2 10.4 16.4 6.5 7.0 9.4 13.1 24.1 8.9 11.8 15.7 11.3 12.4 10.1 5.4 14.7 16.4 13.9 8.9 10.6 12.5 25.3 11.9 9.6 16.6 10.3 9.9 10.7 7.0 8.0 10.9 11.3 13.1 15.3 10.7 5.9 7.6 7.2 8.8 9.2 6.7 6.0 9.3 10.3 11.7 10.3 12.9 14.1 11.8 9.0 16.0 8.2 33.8 3.9 6.4 10.8 14.5 9.3 4.5 17.1 22.3 11.0 9.7 10.1 6.3 4.4 7.7 8.0 6.5 8.4 10.6 9.0 8.0 5.2 13.0 6.0 9.0 23.0 9.2 7.4 5.8 5.7 10.8 7.8 4.6 10.8 5.3 5.7 7.5 9.3 6.1 4.6 9.0 11.2 8.7 13.5 10.6 10.3 10.7 8.4 9.9 10.6 9.6 11.9 9.9 9.4 16.6 9.9 9.4 6.9 5.7 7.0 10.8 11.7 22.1 12.6 10.1 6.6 13.1 9.6 10.4 14.7 ZFY ZNF911 ENSG00000067646 "Zinc finger protein, Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: " "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favourable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 4.1 2.9 2.8 6.8 4.3 9.6 3.4 6.8 5.3 0.0 5.4 2.8 14.1 3.2 0.0 9.1 7.2 0.0 7.0 6.1 3.0 3.0 2.7 13.1 10.1 10.9 2.6 0.0 0.0 10.0 0.1 3.3 5.8 4.5 10.6 8.0 3.5 15.8 10.2 7.0 2.9 6.3 5.8 3.3 9.1 4.7 10.5 0.0 12.6 7.2 5.7 5.8 6.1 0.0 5.8 5.9 4.7 4.7 6.2 7.0 2.7 0.0 3.5 0.0 0.0 0.0 0.0 6.4 9.0 8.7 7.7 7.5 0.0 0.0 6.9 0.0 9.3 0.0 0.0 0.0 10.3 10.4 0.0 12.7 0.1 4.6 6.8 0.0 0.0 7.5 6.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 5.2 0.0 2.8 0.0 0.0 5.6 2.6 5.2 11.7 6.1 0.0 0.0 0.0 9.0 0.0 4.1 7.8 7.5 0.0 0.0 4.5 4.9 0.0 11.6 1.0 0.0 0.0 0.0 4.7 4.7 5.0 3.9 7.0 4.3 5.5 2.8 5.9 5.8 6.3 3.0 3.2 6.2 3.3 4.3 3.1 2.7 2.8 4.3 6.8 5.3 3.0 3.0 2.6 0.0 4.5 0.0 ZFYVE16 "KIAA0305, PPP1R69" ENSG00000039319 "Zinc finger FYVE-type containing 16" Q7Z3T8 5 80408013-80479350 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035935, HPA035936" Supported Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "HPA035935: AB_10672076, HPA035936: AB_10669662" "unprognostic (1.11e-1)" "unprognostic (3.98e-2)" "unprognostic (1.78e-2)" "unprognostic (3.26e-1)" "unprognostic (7.19e-2)" "unprognostic (2.57e-2)" "unprognostic (7.25e-3)" "unprognostic (6.91e-2)" "unprognostic (4.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.15e-1)" "unprognostic (3.04e-1)" "unprognostic (4.64e-2)" "unprognostic (4.95e-2)" "unprognostic (6.91e-2)" "unprognostic (4.23e-2)" 10.7 11.9 11.0 10.1 28.9 6.1 11.6 14.9 19.2 21.2 9.0 33.2 7.7 6.7 17.0 6.6 9.6 9.7 14.6 17.6 11.7 9.5 13.1 13.3 11.6 6.8 25.7 16.8 16.8 7.1 13.4 15.0 16.5 37.3 11.5 8.4 9.0 8.6 9.3 12.7 6.4 8.7 12.8 26.9 11.2 8.4 11.7 21.2 3.8 12.6 4.6 5.8 12.8 10.8 2.5 2.3 17.3 3.9 2.4 1.5 0.3 5.6 6.7 11.9 11.5 7.2 7.5 8.0 8.8 7.6 7.9 10.7 4.9 6.6 3.9 6.4 7.2 5.9 8.5 7.2 8.7 2.5 5.6 4.2 9.1 5.5 6.1 1.2 3.2 8.2 4.0 6.6 6.3 9.0 4.1 6.1 8.5 7.2 2.7 1.2 2.8 3.1 5.7 24.8 4.1 6.8 11.1 4.5 10.4 12.6 6.0 41.5 8.4 3.9 7.9 4.8 5.5 7.3 7.3 1.8 3.5 3.9 6.3 3.9 10.6 11.5 3.7 1.8 1.5 2.3 0.8 2.5 0.7 1.3 1.4 2.5 0.6 0.7 17.3 2.4 3.9 2.3 0.8 0.3 11.0 28.9 14.9 19.2 11.7 9.5 25.7 16.8 37.3 21.2 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: " "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favourable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favourable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 23.5 11.2 10.4 6.6 16.6 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 7.0 11.3 10.9 9.3 8.1 9.8 23.2 6.3 10.0 11.3 7.8 7.6 12.0 6.4 6.3 12.2 7.2 6.1 27.7 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.7 10.7 8.4 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell line enhanced" "Detected in many" "HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: " "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favourable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.1 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.6 0.0 1.9 3.2 3.8 1.2 0.3 0.6 9.5 1.3 0.2 4.2 0.3 4.3 0.7 11.0 3.0 0.6 1.1 0.1 3.0 1.8 8.1 0.9 2.2 0.1 11.9 0.1 8.1 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 2.4 0.3 0.5 1.7 0.0 5.4 0.1 12.6 9.1 0.1 5.3 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 ZFYVE9 "MADHIP, PPP1R173, SARA, SMADIP" ENSG00000157077 "Zinc finger FYVE-type containing 9" O95405 1 52142094-52346686 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017702, HPA065852, HPA065862" Approved Enhanced Vesicles,Cytosol "Vesicles, Cytosol" "CAB017702: AB_1128462, HPA065852: , HPA065862: " "unprognostic (5.05e-2)" "unprognostic (4.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.51e-1)" "unprognostic (7.15e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-3)" "unprognostic (6.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (2.47e-2)" "unprognostic (5.36e-2)" "unprognostic (1.17e-3)" "unprognostic (2.14e-1)" "unprognostic (3.69e-1)" "unprognostic (1.99e-3)" "unprognostic (1.73e-2)" 10.2 10.0 13.6 3.8 18.4 1.0 13.0 28.4 27.7 15.5 8.0 9.5 10.1 6.8 14.1 9.1 10.8 12.2 8.1 10.4 13.8 15.7 15.2 10.7 11.3 4.1 13.8 15.8 19.5 16.9 32.3 14.6 7.4 18.7 13.6 9.9 9.6 9.8 13.8 25.5 12.3 7.4 13.3 11.6 4.2 8.6 14.9 8.0 1.5 19.5 8.8 4.2 10.9 13.8 0.4 0.0 0.0 0.0 0.2 2.1 0.4 9.8 4.7 6.8 8.6 16.6 15.0 11.1 8.0 11.1 9.6 11.1 5.4 0.8 0.0 5.0 11.4 3.6 12.0 13.0 14.8 0.0 8.1 2.8 5.4 6.5 11.0 2.5 1.7 10.0 14.7 8.4 19.1 13.9 4.3 1.8 12.8 2.2 3.5 1.8 8.8 8.3 3.1 11.6 0.9 5.5 22.1 5.7 5.8 9.0 7.7 10.4 3.5 3.3 12.8 9.7 3.9 7.4 4.8 2.5 1.5 1.2 6.9 3.1 3.9 0.0 0.0 0.0 0.3 0.0 2.1 0.3 1.6 0.4 0.0 0.4 1.3 0.7 0.0 0.2 0.0 0.0 0.0 0.4 13.6 18.4 28.4 27.7 13.8 15.7 13.8 15.8 18.7 8.0 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell line enhanced" "Detected in some" "MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favourable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.8 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.0 1.5 0.0 3.1 0.0 0.0 0.0 6.3 1.8 1.6 1.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 2.6 0.2 18.8 0.0 0.3 0.1 3.6 0.0 0.0 5.9 0.1 4.4 0.0 0.0 0.0 17.4 0.0 15.9 0.0 2.2 0.0 0.4 1.3 0.0 0.0 0.3 0.2 0.2 4.5 0.2 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger, GATA-like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 26.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049855: " "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 0.5 0.9 2.5 2.0 6.5 0.9 1.0 8.0 5.4 1.4 0.9 2.2 2.1 0.7 0.6 2.6 1.8 0.6 2.9 3.4 2.4 3.0 1.0 3.6 1.0 3.9 3.1 1.9 4.8 2.0 3.4 0.3 5.1 2.5 1.4 4.8 1.6 0.2 0.9 2.6 1.4 3.7 5.3 1.4 1.2 0.9 0.3 0.3 0.1 0.3 0.0 1.0 0.1 0.4 1.0 1.4 0.5 0.9 0.4 3.5 0.8 0.2 0.7 1.5 1.0 0.3 1.5 0.7 0.2 1.4 1.0 0.3 0.2 1.3 4.5 1.4 1.3 0.5 0.6 0.0 0.4 0.8 2.1 0.7 0.4 0.2 1.4 1.0 0.9 1.5 0.1 26.0 2.2 1.6 1.4 0.6 0.6 0.6 0.6 1.2 1.4 0.3 0.3 1.2 2.0 0.4 0.5 2.0 2.4 2.0 0.2 5.1 6.0 0.6 0.4 6.6 0.9 0.0 0.3 0.0 1.0 0.1 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056705: " "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favourable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 9.3 9.8 9.6 13.6 14.5 14.5 8.0 20.2 13.2 7.6 8.9 12.0 10.8 11.1 12.9 6.1 9.1 8.1 11.2 8.8 10.3 7.1 11.7 56.1 7.2 11.0 16.9 10.7 7.3 12.6 8.3 10.8 9.0 14.2 8.3 3.9 8.0 14.0 8.8 9.2 10.5 10.8 9.4 8.5 11.7 10.3 14.9 15.0 11.3 8.0 5.8 13.5 8.3 9.2 15.6 21.7 19.2 16.4 20.2 23.8 13.0 8.5 11.1 4.3 7.0 3.6 2.5 10.1 8.9 5.9 14.2 5.9 23.7 11.8 8.9 17.1 5.0 15.8 2.9 10.6 1.8 6.0 7.7 8.4 9.6 24.2 7.1 5.2 14.9 6.4 9.0 5.8 2.3 7.7 9.1 8.4 4.6 8.6 12.8 12.4 7.1 13.9 13.6 3.3 9.1 7.9 8.0 8.3 10.3 12.7 14.4 7.9 9.9 14.8 8.7 22.2 7.9 8.4 11.4 8.3 13.1 12.3 14.0 5.2 9.9 6.6 16.0 19.2 23.8 16.4 23.1 15.6 20.4 21.5 15.1 14.5 20.3 20.5 17.0 20.2 13.2 21.7 19.8 13.0 9.6 14.5 20.2 13.2 10.3 7.1 16.9 10.7 14.2 15.0 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 8.6 7.4 11.4 5.0 11.0 25.9 8.7 10.3 10.7 8.5 6.2 5.9 8.9 8.1 7.3 8.1 10.4 5.9 5.4 8.7 11.2 5.0 7.1 9.7 9.7 8.7 9.6 7.4 8.7 6.8 7.1 12.7 7.1 8.8 8.7 9.9 4.5 9.0 8.7 11.9 9.9 9.3 7.7 11.4 10.5 6.6 5.1 11.7 5.8 10.5 4.6 10.2 7.5 11.6 5.5 4.6 8.0 8.3 4.8 8.5 3.3 3.0 3.9 2.9 2.0 1.8 2.0 2.1 1.3 1.4 3.3 2.6 3.1 2.4 1.8 1.2 2.2 2.1 3.2 1.7 5.0 2.9 6.6 5.3 2.7 3.7 1.8 1.1 2.9 2.7 2.7 2.7 1.7 3.9 4.3 2.5 2.9 9.4 4.4 3.4 0.7 4.4 3.5 1.9 2.4 2.3 3.1 4.4 3.2 2.8 23.9 1.4 3.5 1.0 0.3 1.4 2.7 2.3 3.1 3.6 4.4 3.8 2.0 2.9 1.0 3.1 5.7 8.0 4.1 8.3 3.7 5.5 5.3 3.5 4.6 4.6 4.4 3.6 1.8 4.8 5.9 4.0 8.5 3.3 11.4 11.0 10.3 10.7 11.2 5.0 9.6 7.4 8.8 11.7 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Cell line enhanced" "Detected in some" "AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030194: " "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.2 0.0 5.2 2.1 3.9 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 2.5 0.0 0.0 0.0 1.3 0.0 4.3 1.9 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in many" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.9 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.0 2.2 0.0 0.0 1.9 6.3 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.8 0.0 0.8 7.5 0.1 0.9 0.4 0.0 0.0 0.0 42.8 0.0 1.1 1.0 0.0 0.0 1.3 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell line enhanced" "Detected in some" "BEWO: 8.2;Hep G2: 9.6;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.0;U-266/84: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA071856 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA071856: " "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.1 6.7 17.8 19.5 18.4 22.5 6.7 10.2 12.5 6.1 6.2 4.0 8.7 10.3 13.1 11.4 7.6 10.2 8.8 11.8 9.9 6.2 8.3 8.2 10.4 10.4 15.9 10.0 15.0 14.2 8.3 27.8 13.5 19.2 9.0 12.1 12.1 15.1 9.5 7.2 8.4 8.9 9.1 9.2 10.3 14.4 20.8 24.8 15.9 20.9 18.0 10.6 10.6 20.2 13.5 13.2 15.6 10.3 10.5 18.2 10.7 9.2 11.4 17.6 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: " "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favourable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 3.4 4.0 5.9 2.6 5.8 4.5 4.8 6.2 7.6 6.1 3.7 7.3 3.5 2.0 6.4 4.4 2.2 4.9 2.9 5.0 5.3 6.5 4.4 4.5 3.4 5.6 5.2 5.1 10.5 3.3 11.8 8.0 4.7 5.4 4.7 3.0 5.5 4.0 5.0 7.5 2.0 3.0 5.2 5.1 3.3 3.1 12.7 4.6 6.7 5.8 4.4 3.2 4.1 3.0 0.7 1.6 0.9 0.6 2.0 1.4 0.5 2.3 2.3 10.5 6.5 4.2 4.0 4.2 2.5 3.8 3.7 3.7 5.9 1.7 7.6 2.8 2.9 1.7 6.9 3.4 4.6 4.1 4.8 4.5 4.1 9.1 5.6 3.5 2.3 5.4 4.1 3.6 6.1 2.9 8.0 3.7 3.5 2.4 8.8 3.8 5.7 2.2 10.5 7.7 1.6 3.1 3.3 8.3 8.3 3.1 2.8 2.8 3.4 5.9 2.9 6.2 4.1 2.4 3.9 5.1 4.2 9.1 2.1 2.9 3.6 0.0 0.6 0.9 0.7 0.4 1.0 0.5 1.1 0.8 0.8 0.7 1.1 1.4 0.0 2.0 0.5 1.6 0.2 0.5 5.9 5.8 6.2 7.6 5.3 6.5 5.2 5.1 5.4 4.6 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA048312: , HPA049906: , HPA071850: " "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 3.4 6.0 5.7 6.3 3.9 1.9 5.3 9.9 6.1 6.1 3.9 6.0 6.1 2.0 6.9 9.5 2.9 6.4 5.3 4.8 5.6 3.9 4.5 4.6 5.1 5.1 4.4 3.4 13.0 6.7 6.8 18.2 3.4 4.1 6.6 3.5 7.2 3.7 5.8 4.3 2.2 3.8 7.2 3.9 4.8 3.7 18.6 4.4 12.1 6.0 1.9 4.8 5.5 5.9 3.7 2.5 2.0 1.2 2.4 3.4 1.2 0.0 0.0 4.6 6.6 1.3 0.7 0.0 2.2 1.9 2.3 2.7 0.0 0.1 0.1 0.8 1.5 0.0 0.0 1.4 2.9 0.0 0.0 0.2 1.4 1.7 4.1 0.0 0.0 3.2 1.5 1.3 0.0 0.6 0.0 0.1 3.5 0.0 0.0 0.0 5.1 0.0 0.0 2.1 0.0 1.3 0.6 3.1 8.1 0.1 0.2 0.0 0.0 3.1 0.7 1.4 0.5 1.8 0.0 0.2 0.1 0.0 0.3 0.0 1.1 2.0 1.2 1.6 3.4 0.5 1.0 1.3 2.1 2.6 1.0 3.7 1.6 3.2 1.6 2.4 1.1 2.5 2.1 1.2 5.7 3.9 9.9 6.1 5.6 3.9 4.4 3.4 4.1 4.4 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141910-28159472 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 16.5 12.1 13.4 10.3 15.6 17.7 16.1 27.7 16.5 17.7 16.3 20.8 12.5 9.2 21.8 19.9 10.0 17.2 11.0 10.7 13.5 9.3 11.2 10.9 14.1 13.9 18.4 13.3 25.0 15.4 21.9 22.6 12.8 14.0 15.1 11.9 17.2 13.9 17.2 12.0 11.5 15.9 18.3 18.2 14.4 14.1 12.8 18.2 18.1 17.1 8.8 14.5 16.7 12.4 3.8 1.9 4.1 4.2 3.0 3.1 1.3 5.9 3.7 18.2 17.9 11.7 10.9 5.8 6.7 12.2 8.6 10.9 4.1 3.5 13.0 10.9 6.4 5.1 11.5 4.4 12.8 7.0 9.8 11.8 7.2 9.5 10.7 14.4 8.8 11.5 7.7 9.0 13.7 8.8 17.9 4.9 9.1 3.0 10.0 12.8 6.8 4.3 10.8 11.4 10.2 6.4 7.3 13.7 17.3 7.9 3.7 8.6 4.2 8.1 7.4 13.1 7.5 4.3 8.9 12.0 8.5 10.7 3.7 10.2 6.9 4.1 1.3 1.3 2.7 3.3 3.1 1.5 1.7 1.2 1.0 3.8 2.8 2.3 0.5 3.0 4.2 1.9 1.6 1.3 13.4 15.6 27.7 16.5 13.5 9.3 18.4 13.3 14.0 18.2 ZMAT2 "FLJ31121, hSNU23, Snu23" ENSG00000146007 "Zinc finger matrin-type 2" Q96NC0 5 140698680-140706676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036518 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036518: AB_10671960" "unprognostic (4.00e-1)" "unprognostic (2.43e-3)" "prognostic favourable (7.96e-4)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "unprognostic (1.60e-3)" "unprognostic (1.25e-3)" "unprognostic (2.16e-1)" "unprognostic (2.35e-1)" "unprognostic (3.38e-3)" "unprognostic (6.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.60e-3)" "unprognostic (2.54e-1)" "unprognostic (2.72e-2)" "unprognostic (2.91e-3)" "unprognostic (2.84e-2)" 25.3 25.1 36.7 19.9 50.4 32.1 31.9 31.2 52.4 23.6 26.7 16.0 24.9 17.7 27.7 29.1 29.7 27.1 17.6 18.1 60.2 27.6 31.2 29.4 21.3 25.3 28.4 53.8 26.5 17.6 36.5 21.9 24.1 33.6 22.7 30.0 13.9 24.6 26.5 102.9 25.1 19.9 25.2 36.1 26.2 24.7 15.2 19.8 24.4 23.7 29.8 33.9 20.9 30.7 12.3 11.8 42.5 15.1 11.2 17.1 11.5 22.2 37.5 24.4 41.5 40.0 26.9 32.8 23.3 25.5 32.4 35.4 57.4 37.3 25.1 37.8 39.8 21.4 34.5 46.5 41.3 27.4 30.7 20.3 45.4 39.8 25.4 47.3 27.0 30.9 35.9 33.3 39.1 27.3 22.6 28.0 29.8 34.2 38.2 33.2 18.1 24.1 26.8 28.8 27.3 28.4 32.6 29.0 22.2 32.8 32.9 34.2 45.1 41.7 22.6 28.5 15.4 14.7 35.5 18.3 37.1 28.4 30.4 33.1 21.6 20.9 15.1 23.6 13.4 12.3 17.1 12.3 14.8 13.7 10.9 12.0 14.0 14.7 42.5 11.2 12.0 11.8 13.9 11.5 36.7 50.4 31.2 52.4 60.2 27.6 28.4 53.8 33.6 19.8 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "AF22: 20.6;U-2197: 12.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA069813: , HPA071585: " "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79069035-79316528 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045144 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045144: AB_10962360" "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favourable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 24.7 21.1 15.9 15.8 18.9 20.0 24.1 43.7 35.7 41.5 21.3 23.8 26.0 16.5 42.4 18.0 28.1 22.2 35.5 25.1 19.0 17.1 17.4 13.9 23.5 13.7 22.2 15.7 44.3 20.2 14.6 12.7 18.7 22.1 21.9 13.0 33.3 24.6 26.9 38.0 24.5 21.2 25.6 16.4 36.2 21.4 8.4 21.5 16.0 33.3 22.4 16.5 25.6 30.1 1.0 4.6 5.7 6.1 5.4 2.3 1.8 7.1 9.0 17.1 7.3 17.9 5.1 6.0 6.9 12.5 4.9 2.8 2.6 3.3 3.7 5.6 16.1 10.2 2.8 5.1 2.6 8.0 1.5 13.1 3.4 7.8 12.6 7.2 27.8 6.7 5.7 7.0 5.0 7.8 5.0 19.6 4.1 13.6 7.2 11.3 5.0 13.8 32.2 3.2 3.7 3.6 6.1 17.9 26.2 4.5 55.0 14.2 17.6 7.1 10.9 18.6 7.6 9.3 8.8 3.6 6.3 0.0 24.4 13.0 3.5 1.8 3.7 2.7 2.3 6.1 1.6 1.0 1.6 1.2 4.6 0.4 0.6 1.2 5.7 5.4 5.1 4.5 1.6 1.8 15.9 18.9 43.7 19.1 19.0 17.1 22.2 15.7 22.1 21.5 ZMIZ2 "DKFZp761I2123, hZIMP7, KIAA1886, NET27, ZIMP7" ENSG00000122515 "Zinc finger MIZ-type containing 2" Q8NF64 7 44748581-44769881 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040716 Supported Supported Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA040716: AB_10805826" "unprognostic (2.28e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-2)" "unprognostic (2.21e-2)" "unprognostic (9.46e-3)" "unprognostic (1.01e-3)" "prognostic unfavourable (6.82e-5)" "unprognostic (2.47e-1)" "unprognostic (2.36e-1)" "unprognostic (2.73e-1)" "unprognostic (5.89e-2)" "unprognostic (4.58e-2)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (1.66e-1)" "unprognostic (1.15e-1)" "unprognostic (3.15e-3)" 14.3 16.0 31.7 24.5 31.5 19.8 13.3 24.0 43.2 12.7 15.2 22.9 17.5 23.8 16.4 16.8 16.8 17.3 17.3 15.9 28.2 15.4 19.0 10.1 18.3 24.0 17.0 27.2 17.9 32.3 19.8 23.0 11.0 17.0 16.4 12.5 16.5 32.5 23.0 18.7 31.1 22.2 17.9 16.5 28.8 21.3 20.8 17.5 16.7 25.1 14.0 19.1 15.5 13.2 4.9 4.1 1.0 2.4 3.4 2.5 0.9 14.1 16.3 7.7 14.8 5.2 3.5 8.1 7.3 6.9 6.3 7.6 9.3 22.3 9.8 11.5 7.6 19.5 4.7 8.3 3.8 23.1 9.0 3.9 15.3 7.3 10.7 5.6 8.7 5.3 5.1 9.8 6.5 11.6 11.5 22.3 9.2 13.6 12.5 15.6 14.4 15.9 15.7 4.2 12.7 7.3 10.9 27.2 18.0 9.8 19.3 4.4 18.3 8.7 17.2 6.0 13.2 16.1 16.7 32.8 10.4 7.6 11.6 10.0 24.5 1.0 1.6 0.7 2.5 2.4 1.6 2.7 1.2 1.8 1.6 4.9 0.8 0.9 0.7 3.4 1.2 4.1 1.1 0.9 31.7 31.5 24.0 43.2 28.2 15.4 17.0 27.2 17.0 17.5 ZMPSTE24 "FACE-1, HGPS, PRO1, STE24, Ste24p" ENSG00000084073 "Zinc metallopeptidase STE24" O75844 1 40258107-40294184 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006988 Approved Approved "Golgi apparatus,Cytosol" 13000 Cytosol "Golgi apparatus" "HPA006988: AB_1080659" "unprognostic (6.32e-2)" "unprognostic (1.63e-2)" "unprognostic (3.75e-3)" "unprognostic (4.63e-2)" "unprognostic (4.16e-3)" "unprognostic (1.37e-1)" "prognostic unfavourable (5.73e-6)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (1.84e-3)" "unprognostic (4.78e-2)" "unprognostic (7.96e-2)" "unprognostic (5.06e-2)" "unprognostic (3.65e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (6.34e-4)" "unprognostic (2.71e-2)" 21.6 24.2 17.6 15.4 19.6 6.5 18.6 10.7 21.3 20.9 20.6 14.9 27.0 17.9 29.7 19.7 21.4 19.9 20.7 20.8 17.1 16.9 34.2 48.7 16.2 23.1 21.9 17.0 16.0 20.4 39.8 17.0 23.0 23.5 21.7 23.3 15.6 18.9 19.0 19.1 14.7 20.9 25.2 19.2 17.7 19.0 10.7 17.9 20.9 20.6 14.7 18.4 19.1 16.7 15.1 25.8 15.1 23.9 24.2 22.5 20.3 20.7 13.9 10.8 8.1 28.7 23.0 21.0 21.8 18.2 24.6 22.5 15.1 36.0 17.9 15.1 26.6 21.6 22.0 20.0 28.4 16.8 14.1 17.3 14.8 13.8 16.4 27.8 21.7 16.6 20.6 21.0 9.1 17.3 18.3 18.0 23.3 9.7 16.8 8.3 20.7 14.5 14.6 19.2 22.2 21.8 20.1 11.3 13.3 20.1 44.9 27.0 16.5 76.8 17.1 22.3 16.3 20.7 26.4 11.1 29.6 15.6 24.4 19.5 23.6 15.1 20.0 13.6 17.9 23.9 21.5 15.1 19.1 18.9 25.8 11.6 17.0 22.5 11.8 24.2 22.7 16.9 22.3 20.3 17.6 19.6 10.7 21.3 17.1 16.9 21.9 17.0 23.5 17.9 ZMYM2 "FIM, MYM, RAMP, ZNF198" ENSG00000121741 "Zinc finger MYM-type containing 2" Q9UBW7 13 19958670-20091829 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031765 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA031765: AB_10601927" "unprognostic (2.96e-1)" "unprognostic (3.42e-3)" "unprognostic (1.85e-1)" "unprognostic (1.69e-1)" "unprognostic (7.71e-2)" "unprognostic (2.33e-1)" "unprognostic (2.66e-3)" "unprognostic (1.16e-1)" "unprognostic (6.78e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (2.80e-2)" "unprognostic (6.65e-3)" "unprognostic (2.05e-1)" "unprognostic (8.74e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.07e-4)" 15.0 17.3 15.9 18.1 23.3 22.2 16.1 23.9 26.8 18.3 16.8 14.0 13.7 13.3 20.0 14.0 18.5 16.1 15.7 17.1 14.4 12.0 17.3 13.7 15.4 14.2 12.9 20.2 21.7 16.2 17.1 32.1 14.0 23.2 19.4 13.8 13.8 18.2 17.6 19.7 18.3 14.5 15.3 16.2 16.3 16.0 44.5 16.5 38.0 24.3 10.4 19.7 19.5 17.2 5.5 6.3 7.4 5.9 5.4 7.9 3.5 6.3 5.7 22.0 9.5 9.7 10.5 10.5 6.6 10.6 8.6 10.3 8.8 13.1 15.2 6.1 9.3 10.2 16.2 7.1 11.7 6.1 4.6 26.9 8.6 4.4 9.8 22.7 8.2 10.3 13.3 6.8 7.1 14.6 10.2 10.8 11.8 9.0 21.9 6.4 20.4 3.6 24.5 24.0 7.1 6.7 9.3 25.8 25.7 12.8 9.2 12.0 12.2 16.2 8.5 4.3 6.8 5.2 3.5 8.6 6.7 15.7 3.6 5.3 10.2 0.2 5.2 4.0 5.5 5.9 6.7 5.5 7.5 5.6 6.1 4.5 7.9 6.9 7.4 5.4 4.9 6.3 5.4 3.5 15.9 23.3 23.9 26.8 14.4 12.0 12.9 20.2 23.2 16.5 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA051301: , HPA054802: " "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.7 10.4 31.9 16.1 9.3 20.3 11.8 15.2 23.0 18.6 24.3 11.2 12.8 23.8 9.4 19.0 8.3 22.1 11.2 26.9 13.4 15.3 29.0 12.1 9.5 17.0 24.8 13.2 15.3 10.1 18.0 17.1 20.6 31.6 6.5 22.5 7.7 21.0 13.8 26.6 9.9 23.6 20.5 11.5 13.3 16.9 18.4 17.9 18.3 13.4 20.8 10.9 18.9 24.8 17.3 18.0 7.6 16.3 7.2 13.3 18.3 12.5 19.0 16.5 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863636 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: " "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 10.2 10.6 7.4 10.5 8.6 11.4 10.7 18.2 11.9 9.7 8.5 6.0 6.2 6.9 9.3 10.6 12.4 8.5 10.9 9.0 8.5 5.6 7.6 7.8 8.9 10.6 13.7 5.5 11.0 8.2 6.4 18.6 8.1 9.2 9.7 7.5 7.6 9.5 9.4 9.5 8.7 10.7 9.7 13.2 9.6 8.1 25.2 10.6 22.1 10.8 7.5 12.3 10.9 10.9 12.8 9.9 15.6 8.7 9.3 13.1 5.4 6.5 3.4 8.0 6.2 5.7 9.0 2.9 6.4 9.9 10.1 8.6 8.2 13.0 9.0 6.7 9.2 6.2 5.8 7.4 11.9 7.2 4.6 16.9 6.1 5.6 17.6 12.4 9.1 11.0 9.0 5.5 10.5 10.4 6.8 7.9 9.6 16.1 9.0 12.4 4.2 5.2 10.1 10.0 3.6 8.6 7.3 7.3 7.0 7.9 6.8 20.6 10.2 10.6 8.3 5.7 4.1 7.5 4.4 12.9 5.7 13.5 5.5 5.3 9.0 15.6 7.0 9.9 11.7 6.3 12.4 12.8 13.1 11.2 7.0 11.1 10.4 11.1 13.7 9.3 8.7 9.9 10.5 5.4 7.4 8.6 18.2 11.9 8.5 5.6 13.7 5.5 9.2 10.6 ZMYND10 "BLU, CILD22" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50346852 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 55.7;testis: 99.4" "Cell line enhanced" "Detected in many" "T-47d: 10.4;U-87 MG: 7.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035255 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favourable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.1 0.1 1.9 0.2 4.8 0.3 0.6 0.3 0.8 1.6 0.1 5.5 0.2 0.2 0.9 4.6 0.2 55.7 0.3 0.1 2.6 3.1 0.5 0.2 4.7 0.2 0.2 0.3 4.2 0.2 1.4 1.6 0.1 10.2 0.1 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.5 0.2 0.1 99.4 1.2 0.1 0.8 0.1 0.1 0.1 0.0 0.4 1.1 0.8 0.7 3.8 2.5 0.5 2.7 1.0 0.4 0.8 1.0 1.6 0.8 0.4 1.7 2.9 0.9 0.2 1.4 1.0 1.1 1.7 0.6 2.4 0.1 0.3 1.1 1.1 2.5 3.5 0.1 0.1 0.7 1.2 0.1 0.3 3.7 0.2 0.2 0.6 0.6 0.4 1.4 0.5 3.4 0.0 1.1 1.0 0.1 0.8 3.6 0.1 2.9 1.1 0.3 0.8 0.2 10.4 0.9 0.0 0.8 0.7 1.8 0.2 1.3 0.6 0.3 7.3 3.3 0.2 0.3 0.4 0.3 2.5 0.4 1.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.8 3.8 0.7 0.4 0.1 0.5 1.9 4.8 0.3 0.8 2.6 3.1 0.2 0.3 10.2 1.2 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Cell line enhanced" "Detected in some" "A-431: 5.0;CAPAN-2: 4.7;HaCaT: 3.9;T-47d: 3.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.0 0.8 0.0 2.4 0.0 0.2 0.4 0.1 1.4 1.3 3.0 2.3 4.7 0.0 0.1 0.0 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.2 0.8 0.0 1.4 0.2 0.6 0.2 0.2 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 ZMYND19 MIZIP ENSG00000165724 "Zinc finger MYND-type containing 19" Q96E35 9 137582079-137590490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020642, HPA050761" Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA020642: AB_1859078, HPA050761: " "unprognostic (2.30e-2)" "unprognostic (9.62e-3)" "unprognostic (3.45e-2)" "unprognostic (7.99e-2)" "unprognostic (2.66e-1)" "unprognostic (1.90e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.18e-1)" "unprognostic (2.48e-1)" "unprognostic (1.35e-1)" "unprognostic (9.33e-2)" "unprognostic (1.99e-2)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (4.30e-2)" "unprognostic (1.62e-1)" "unprognostic (1.72e-1)" 9.5 11.6 11.9 10.3 14.2 9.1 15.5 13.1 20.6 8.5 9.2 7.3 12.3 10.1 8.1 7.5 16.5 8.4 8.4 9.5 12.7 11.0 8.1 12.8 9.3 12.3 9.7 13.0 10.7 26.2 8.0 11.5 9.9 10.2 10.8 6.9 7.9 14.2 9.0 13.7 19.1 8.0 11.7 7.4 9.8 14.4 41.8 9.6 9.2 8.2 9.0 10.6 8.5 10.1 1.9 2.6 0.8 4.7 0.4 3.3 0.4 10.5 16.8 16.0 17.3 8.7 8.4 16.2 14.6 9.8 16.1 12.4 19.8 10.8 19.2 16.9 9.6 26.9 19.5 14.6 5.1 12.4 18.9 9.9 31.2 15.3 13.5 21.3 13.1 6.6 22.6 14.6 14.4 8.5 24.0 8.5 9.7 35.7 24.7 32.5 23.2 23.5 27.1 14.1 29.4 9.8 9.0 23.2 15.2 14.1 30.4 12.7 20.4 33.2 8.0 19.9 15.0 29.4 23.5 8.2 19.5 20.6 12.3 16.6 13.6 0.0 0.9 0.8 1.4 4.7 3.3 1.9 1.0 0.7 0.9 1.0 1.6 1.3 0.0 0.4 0.5 2.6 2.7 0.4 11.9 14.2 13.1 20.6 12.7 11.0 9.7 13.0 10.2 9.6 ZMYND8 "PRKCBP1, RACK7" ENSG00000101040 "Zinc finger MYND-type containing 8" Q9ULU4 20 47209214-47356889 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020949 Approved Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA020949: AB_1857223" "prognostic unfavourable (2.56e-4)" "unprognostic (5.09e-2)" "unprognostic (5.84e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.67e-1)" "prognostic unfavourable (2.62e-4)" "unprognostic (2.10e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (8.64e-2)" "unprognostic (3.62e-1)" "prognostic unfavourable (7.06e-5)" "unprognostic (3.59e-2)" "unprognostic (7.50e-2)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" 11.9 30.2 22.0 18.3 26.9 24.1 16.1 33.2 30.5 12.1 15.0 18.1 24.1 11.8 11.2 37.4 15.2 17.7 13.4 10.0 21.0 18.1 12.3 9.5 11.9 13.3 28.7 17.8 15.5 13.1 17.0 43.2 12.6 23.0 10.7 16.0 14.8 14.6 17.0 15.9 17.8 15.0 9.6 17.4 16.8 20.9 13.7 30.0 25.5 12.1 6.2 17.8 17.5 12.6 15.3 12.6 19.3 5.9 12.4 9.4 3.0 8.0 5.1 27.5 11.0 4.7 6.7 18.1 6.4 5.3 6.8 7.0 31.7 7.8 7.7 10.6 4.8 5.6 11.8 28.6 10.3 3.3 4.5 32.3 1.8 27.9 17.3 3.4 17.1 6.5 13.3 7.5 29.0 18.3 26.0 5.3 12.3 9.3 1.2 13.2 26.0 7.3 16.2 4.5 6.6 9.2 14.7 11.6 4.4 3.0 9.8 13.2 5.1 6.6 42.7 7.4 5.2 7.1 5.9 3.8 7.0 7.0 24.9 5.4 24.1 19.3 5.9 7.6 7.0 5.6 6.9 11.1 7.0 7.1 3.5 15.3 9.4 9.3 15.4 12.4 4.8 12.6 6.7 3.0 22.0 26.9 33.2 30.5 21.0 18.1 28.7 17.8 23.0 30.0 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 9.9 0.0 11.1 4.7 6.0 4.0 3.6 5.0 3.4 3.6 2.2 0.0 5.6 4.0 1.6 6.3 3.3 3.7 0.0 5.8 7.3 9.3 3.7 3.3 4.4 2.5 4.9 3.1 5.4 6.0 4.0 5.2 0.0 5.9 1.1 10.6 9.4 10.2 4.1 8.8 6.3 4.9 3.9 7.2 10.0 6.3 8.0 1.1 3.3 6.2 4.3 3.9 3.7 3.4 3.4 3.3 0.2 0.0 11.6 1.1 1.6 3.3 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA054267: " "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.1 8.2 14.4 15.9 36.4 32.1 8.8 11.5 11.0 10.1 10.8 19.3 4.1 9.5 10.3 14.1 16.2 14.9 11.8 15.5 15.4 7.2 18.2 19.2 6.9 10.5 21.8 10.9 24.1 7.9 15.3 17.1 16.2 21.6 1.3 16.4 5.6 8.3 5.3 6.1 8.4 8.0 26.2 5.2 5.3 16.0 9.2 4.9 23.3 11.0 13.0 10.1 14.2 24.4 10.9 16.8 14.4 16.8 7.9 15.2 35.6 9.7 17.4 18.8 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270102-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 11.5" "Cell line enhanced" "Detected in many" "BEWO: 16.7;Hep G2: 19.6;NTERA-2: 10.2;REH: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 1.5 1.0 3.7 2.2 2.7 2.1 1.2 1.2 3.3 2.3 0.6 2.1 1.0 0.9 2.4 2.4 1.3 1.9 1.5 1.7 3.7 4.6 1.6 0.5 1.4 1.9 2.6 0.8 1.2 5.3 4.2 1.6 7.5 2.1 3.1 0.4 2.5 3.7 1.3 3.7 3.7 0.7 1.4 3.5 1.6 0.7 1.6 1.7 1.0 11.5 0.5 1.1 1.3 5.7 2.6 3.5 5.4 0.7 2.0 0.6 0.4 2.7 4.2 5.1 0.5 0.3 0.0 16.7 0.5 0.0 1.5 2.1 1.5 4.3 0.1 4.9 0.3 5.5 7.0 0.3 1.8 0.0 0.4 0.6 1.3 19.6 1.6 2.6 0.5 0.3 0.5 0.8 0.1 0.3 0.7 0.4 0.3 7.9 0.2 8.3 10.2 0.9 10.4 0.0 0.3 0.2 2.3 2.0 2.4 2.7 0.0 2.9 1.1 4.9 0.7 0.8 1.7 1.5 0.5 0.4 0.1 0.1 0.2 1.4 0.8 3.3 0.7 0.9 0.5 0.6 0.3 0.9 0.6 0.4 1.7 2.6 0.5 0.4 5.4 2.0 0.7 3.5 0.2 0.4 3.7 2.7 1.2 3.3 3.7 4.6 2.6 0.8 2.1 1.7 ZNF117 "H-plk, HPF9" ENSG00000152926 "Zinc finger protein 117" Q03924 7 64971776-65006684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 14.9;AN3-CA: 15.6;THP-1: 15.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" HPA031148 Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA031148: " "unprognostic (1.04e-1)" "unprognostic (3.04e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.35e-2)" "unprognostic (1.45e-2)" "unprognostic (1.24e-1)" "unprognostic (6.13e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-1)" "unprognostic (7.10e-2)" "prognostic unfavourable (2.17e-11)" "unprognostic (1.08e-1)" "unprognostic (9.19e-2)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" 11.1 13.2 1.3 3.4 1.5 2.1 7.1 2.1 3.7 3.1 2.1 0.5 4.2 6.5 5.2 2.8 5.6 2.7 1.1 1.3 2.3 0.9 3.9 2.6 1.0 5.0 2.1 2.4 4.0 5.3 2.8 2.2 3.6 2.4 0.6 4.2 1.6 2.8 1.3 3.4 1.8 5.3 3.4 2.6 2.5 4.5 1.0 0.7 6.2 1.9 0.9 0.6 0.2 1.2 0.1 14.9 15.6 5.7 2.6 8.4 3.2 0.8 0.8 1.6 0.6 6.4 5.5 2.7 1.6 1.0 1.7 0.4 1.8 1.6 1.5 2.5 0.4 3.0 0.5 0.0 1.5 3.3 0.6 0.6 0.6 2.5 10.1 3.7 3.7 2.7 5.6 5.7 6.3 0.2 7.4 1.0 1.1 2.0 2.4 2.3 12.7 1.6 0.7 0.7 2.8 15.8 7.4 4.5 0.5 2.7 2.0 2.5 4.7 2.9 1.6 7.1 2.7 0.4 0.6 1.0 0.6 1.9 0.6 1.0 0.4 0.4 0.7 1.0 0.4 0.4 6.2 0.9 0.5 0.7 0.5 0.2 ZNF12 "GIOT-3, KOX3, ZNF325" ENSG00000164631 "Zinc finger protein 12" P17014 7 6688433-6706923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063402 Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA063402: " "unprognostic (2.68e-1)" "unprognostic (6.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.84e-1)" "unprognostic (8.32e-2)" "unprognostic (1.74e-1)" "unprognostic (3.06e-3)" "unprognostic (1.41e-1)" "unprognostic (6.67e-2)" "unprognostic (2.89e-3)" "unprognostic (5.52e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" "unprognostic (2.10e-2)" "unprognostic (4.36e-2)" "unprognostic (8.46e-3)" 16.7 12.1 12.1 15.6 11.7 8.8 17.0 25.4 13.5 18.9 17.7 9.2 16.0 12.2 17.4 17.9 15.1 15.1 11.9 12.6 10.1 9.7 15.6 13.8 12.2 15.1 10.3 12.8 19.6 13.2 25.2 20.0 20.3 10.3 23.9 13.2 8.6 14.7 16.1 9.5 13.8 18.6 12.5 16.1 18.6 12.9 7.5 13.9 21.1 21.9 7.9 16.0 21.9 29.3 2.1 1.9 9.4 0.9 1.9 3.5 0.4 12.6 6.0 12.0 15.0 12.3 12.5 11.5 8.0 14.5 10.3 10.8 8.1 7.4 9.6 5.6 9.9 15.2 9.9 7.8 15.7 3.6 7.5 9.7 9.0 8.1 11.5 15.3 10.5 13.7 17.4 7.4 11.9 7.4 15.3 8.9 13.5 10.0 5.9 14.2 14.5 9.3 7.8 17.2 5.8 8.4 12.6 11.0 19.5 9.2 16.8 9.6 10.7 17.5 7.3 11.6 14.7 9.2 10.5 8.5 5.5 9.9 9.5 10.4 15.3 9.4 0.9 1.1 2.5 0.7 3.5 2.0 2.1 2.8 0.9 2.1 2.7 3.4 0.9 1.9 0.8 1.9 1.7 0.4 12.1 11.7 25.4 13.5 10.1 9.7 10.3 12.8 10.3 13.9 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome "Nucleoplasm, Centrosome" Nucleoli "HPA054961: " "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favourable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.6 4.9 5.9 12.3 2.7 3.3 9.1 2.6 2.4 4.0 5.0 8.5 3.4 8.7 7.6 2.1 7.6 12.1 7.0 5.6 4.2 19.6 27.2 12.2 7.6 3.4 13.4 13.6 4.5 6.2 3.9 10.3 2.9 9.7 14.8 2.9 6.4 9.9 30.9 14.6 8.6 6.4 8.1 6.0 3.8 32.5 10.6 5.4 5.2 5.2 3.0 4.2 4.3 4.2 12.7 7.1 4.3 6.8 15.7 8.6 10.3 3.4 7.9 4.3 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.7;salivary gland: 23.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favourable (1.03e-4)" 1.9 1.1 1.2 1.9 1.0 2.8 2.1 1.9 1.4 1.6 3.9 3.5 4.1 2.3 1.7 1.7 1.8 1.5 1.5 1.7 3.4 1.9 2.8 3.0 1.8 3.1 3.9 0.5 0.8 2.2 2.3 4.0 23.4 1.2 1.1 2.2 4.2 1.8 2.1 5.2 2.6 2.8 2.4 3.4 3.1 1.8 10.6 12.6 10.0 14.7 9.9 12.3 6.3 3.6 2.7 7.8 10.3 2.9 1.8 19.7 3.7 2.2 4.0 4.0 4.1 3.3 7.3 4.5 3.0 3.9 9.3 3.0 5.7 0.4 2.6 6.4 3.3 8.8 2.9 11.4 7.4 2.3 2.4 3.9 3.8 5.7 9.0 5.1 4.9 3.1 11.8 7.4 20.2 6.4 12.4 6.3 5.2 3.8 10.9 12.2 12.4 5.5 4.3 3.7 3.2 18.3 6.4 3.0 4.5 3.3 6.7 4.5 5.4 10.8 1.2 11.7 6.2 6.2 8.8 10.0 7.0 9.9 10.1 10.6 9.1 8.5 12.6 6.7 12.3 11.8 2.0 9.9 14.7 9.9 6.7 6.3 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA007023: , HPA027748: , HPA074630: " "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 16.0 14.3 15.0 18.6 16.7 24.3 20.3 24.8 18.5 18.9 13.0 10.6 10.3 10.0 19.3 10.3 15.3 13.4 13.3 10.8 15.1 13.0 12.3 14.8 12.6 21.6 12.8 14.6 21.6 16.1 13.9 17.3 20.0 14.2 13.9 13.8 8.1 11.9 16.0 16.5 18.2 12.9 16.5 11.9 16.1 12.5 31.0 13.0 27.2 15.5 15.3 17.2 15.5 18.0 13.0 8.9 7.9 7.1 11.7 18.3 7.4 10.4 6.4 13.9 18.5 13.2 9.1 11.8 13.8 11.3 13.8 11.7 10.0 9.4 21.1 11.3 9.2 7.4 16.4 8.7 19.5 10.2 14.5 13.0 36.7 7.4 12.2 22.4 10.6 8.2 16.7 10.1 16.6 10.5 16.5 22.6 15.6 10.1 21.9 28.3 9.2 10.6 14.5 21.3 16.4 11.6 10.2 8.6 12.7 35.2 17.1 17.7 9.5 21.4 7.8 17.3 16.1 8.8 12.9 9.1 12.9 24.0 9.1 29.6 11.5 7.9 6.1 4.1 15.0 7.1 15.3 10.1 14.9 14.5 8.9 13.0 18.3 14.6 3.1 11.7 4.8 8.5 10.8 7.4 15.0 16.7 24.8 18.5 15.1 13.0 12.8 14.6 14.2 13.0 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440222 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favourable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 2.9 4.7 4.0 2.5 5.9 0.8 5.1 11.8 8.5 5.9 4.1 6.6 4.5 2.5 4.2 7.2 3.5 7.9 4.7 5.9 6.0 4.5 6.2 2.1 3.6 3.3 4.4 5.5 7.6 4.3 15.3 12.1 3.7 5.9 6.1 2.4 5.4 5.8 6.7 3.7 4.7 2.6 5.9 4.2 4.5 3.6 7.2 6.0 3.1 10.8 2.8 4.3 5.7 6.3 3.9 2.9 2.0 2.6 2.6 5.7 2.1 1.7 2.1 4.8 1.7 5.6 4.6 0.2 3.6 4.5 3.0 2.7 0.1 1.4 4.5 0.3 4.4 1.8 0.0 5.4 2.1 0.7 8.2 0.8 1.4 1.0 5.0 1.7 3.0 5.1 1.9 5.1 3.2 2.6 0.7 0.5 5.6 0.6 1.0 0.1 4.9 1.7 0.6 1.1 1.3 1.8 2.0 4.3 4.4 1.4 1.3 1.5 0.3 4.4 3.3 3.1 0.4 0.8 0.7 5.9 1.1 0.0 1.5 0.1 1.9 0.0 1.9 2.0 2.2 2.2 5.7 2.9 2.9 1.2 2.9 3.9 4.6 3.7 0.2 2.6 2.6 2.4 2.5 2.1 4.0 5.9 11.8 8.5 6.0 4.5 4.4 5.5 5.9 6.0 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavourable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 10.0 10.1 12.4 11.4 15.9 5.6 20.8 25.4 18.4 13.9 11.6 14.4 12.6 7.7 18.2 24.9 13.2 14.2 11.2 10.6 12.0 12.0 12.1 9.6 10.6 7.4 10.3 12.1 19.5 12.5 17.9 24.7 12.5 14.1 14.9 10.2 9.2 13.6 13.9 17.2 22.2 8.1 15.7 12.1 12.5 9.9 8.9 13.2 7.1 14.7 9.3 9.5 10.0 12.1 5.4 5.4 3.4 4.5 10.7 8.7 3.5 6.8 7.6 6.0 8.6 14.7 10.2 12.7 6.5 9.6 8.3 12.1 6.0 8.2 1.8 3.9 7.7 15.2 5.7 17.0 7.9 1.9 4.0 4.7 6.4 13.3 11.1 4.0 0.7 9.9 11.7 6.9 20.4 8.0 5.5 2.0 7.1 6.9 4.9 6.5 4.9 7.6 4.3 8.2 4.4 8.1 4.7 8.5 8.7 5.0 13.6 9.3 5.2 10.9 5.6 8.9 4.3 6.2 6.4 6.6 6.6 0.6 2.7 2.7 5.0 1.2 4.3 3.4 8.7 3.0 5.8 4.7 7.4 5.9 5.4 5.4 5.8 6.8 1.5 10.7 4.5 2.8 5.5 3.5 12.4 15.9 25.4 18.4 12.0 12.0 10.3 12.1 14.1 13.2 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710471-19733097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049863 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049863: " "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favourable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favourable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 7.4 5.3 7.9 8.7 10.5 11.9 12.8 23.3 10.3 11.3 7.0 8.1 6.6 3.9 9.4 9.6 5.7 9.3 6.0 6.6 8.1 7.6 8.4 1.7 4.9 10.5 12.2 6.0 15.7 7.5 12.7 10.7 8.8 9.4 12.3 5.1 6.5 7.1 9.9 3.4 7.2 7.2 8.9 9.0 9.4 7.0 6.2 10.7 7.1 13.8 3.1 10.9 9.8 7.7 10.3 3.0 11.4 3.6 6.5 18.4 6.3 3.5 3.5 6.0 7.8 4.0 4.4 7.2 3.7 5.0 5.4 5.9 3.3 2.7 9.4 6.1 3.8 3.5 6.2 3.6 6.8 2.3 7.2 4.4 2.7 4.5 4.9 0.1 6.8 4.4 3.9 3.8 3.3 3.4 5.1 4.5 5.3 5.8 7.9 5.1 7.8 10.3 4.2 9.8 4.5 3.9 7.1 6.0 4.3 0.1 4.2 5.7 5.9 9.1 2.1 4.8 1.3 5.5 4.7 3.5 4.2 8.3 0.3 4.9 2.8 11.4 1.8 6.1 9.6 3.1 15.1 10.3 13.1 12.0 2.6 8.2 18.4 14.5 4.1 6.5 3.6 3.0 8.4 6.3 7.9 10.5 23.3 10.3 8.1 7.6 12.2 6.0 9.4 10.7 ZNF142 "KIAA0236, pHZ-49" ENSG00000115568 "Zinc finger protein 142" P52746 2 218637916-218659655 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049594 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA049594: " "unprognostic (2.17e-1)" "unprognostic (4.43e-1)" "unprognostic (8.20e-3)" "unprognostic (9.08e-2)" "unprognostic (3.54e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (2.94e-1)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" "unprognostic (9.63e-3)" "unprognostic (4.77e-2)" "unprognostic (1.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" 10.4 10.4 16.7 13.6 18.2 23.6 10.9 22.8 21.0 11.8 12.5 18.2 8.4 8.2 14.4 7.7 13.6 12.6 12.3 12.5 17.0 11.7 11.2 7.7 11.3 15.0 14.3 15.0 12.9 14.7 19.8 15.5 9.0 12.5 12.7 10.0 10.2 11.7 15.5 18.7 18.7 12.2 14.4 12.6 14.4 12.7 12.3 15.7 16.3 13.2 7.9 14.3 14.9 11.7 4.4 3.5 3.1 3.1 1.7 4.5 2.0 6.0 10.4 8.3 11.4 7.8 6.6 9.1 7.1 4.1 10.0 7.2 20.2 4.7 8.7 6.6 6.1 11.3 16.6 9.8 6.5 10.6 14.2 11.1 20.5 10.7 5.0 15.6 11.8 4.5 8.9 11.9 10.6 7.9 17.8 16.6 5.5 14.0 11.9 8.9 10.7 9.6 18.1 4.5 8.3 5.9 12.2 13.9 10.5 5.3 11.8 4.0 6.5 5.5 9.0 10.5 10.9 7.4 10.4 10.3 6.1 14.7 6.0 7.3 9.8 2.3 3.1 3.1 4.5 0.7 2.3 4.4 3.2 2.4 2.7 2.2 4.0 2.4 1.9 1.7 0.5 3.5 4.0 2.0 16.7 18.2 22.8 21.0 17.0 11.7 14.3 15.0 12.5 15.7 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA074818" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA003263: AB_1080672, HPA074818: " "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 22.7 9.8 11.6 13.6 11.7 20.9 16.4 25.4 11.8 16.8 14.7 11.0 12.8 11.8 20.8 19.5 14.7 13.4 10.7 13.2 11.9 10.8 11.9 12.1 14.0 18.0 12.6 8.7 18.8 10.7 10.3 24.0 15.7 11.4 17.4 12.9 11.7 14.9 13.0 27.0 12.8 13.5 16.1 15.2 18.7 11.6 20.4 13.8 27.4 18.8 10.4 17.3 25.0 21.8 13.0 12.0 31.2 15.6 10.2 17.0 10.5 15.0 14.6 18.5 12.1 15.1 14.1 16.7 16.7 13.6 12.9 14.2 20.5 18.8 14.9 7.8 13.6 17.2 17.8 13.3 19.5 14.9 21.6 14.1 21.6 14.2 12.5 19.5 14.2 12.3 16.0 17.5 15.5 12.8 15.1 18.3 14.1 13.0 17.8 8.0 20.6 15.4 16.3 16.8 9.2 11.4 18.5 12.7 12.4 18.5 12.6 10.9 11.7 10.9 12.4 17.2 12.2 11.9 14.7 9.1 15.5 25.5 10.9 11.2 9.7 20.6 14.2 31.2 17.0 13.9 15.3 13.0 15.2 13.8 12.0 11.2 14.2 12.2 25.7 10.2 15.6 5.8 16.6 10.5 11.6 11.7 25.4 11.8 11.9 10.8 12.6 8.7 11.4 13.8 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225561-125375354 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavourable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 10.5 9.2 12.5 13.4 17.4 5.3 9.4 18.4 17.7 10.7 8.9 4.1 3.3 5.7 11.2 8.3 8.9 10.2 8.6 11.7 11.2 7.2 10.6 9.0 8.8 8.8 11.9 11.8 14.5 7.7 15.7 18.2 7.6 10.5 9.1 9.2 6.7 10.3 12.2 12.2 7.6 8.0 11.0 7.6 8.6 7.4 9.5 10.9 25.4 24.4 3.2 10.8 10.7 9.8 13.9 7.3 29.7 12.1 18.8 17.3 10.2 18.1 12.0 13.1 11.6 11.7 12.7 9.9 16.5 19.4 18.6 17.8 11.3 10.1 14.6 11.6 24.4 14.9 14.3 12.5 26.6 6.5 5.5 18.0 14.5 5.8 8.7 12.3 18.2 10.2 13.1 17.5 18.5 12.7 8.8 12.5 13.7 14.2 15.2 4.5 8.4 10.3 11.1 14.4 8.2 10.7 20.3 11.4 9.5 22.1 11.2 18.4 13.9 12.4 16.4 14.2 15.3 17.7 10.5 10.9 12.4 22.3 10.6 7.9 13.0 2.5 8.7 17.4 13.4 8.4 13.8 13.8 11.8 12.5 7.3 13.9 17.3 13.5 29.7 18.8 12.1 6.5 10.8 10.2 12.5 17.4 18.4 17.7 11.2 7.2 11.9 11.8 10.5 10.9 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.0;HSkMC: 5.1;MOLT-4: 7.2;NTERA-2: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 2.8 5.9 7.9 5.7 10.2 2.5 4.3 17.9 9.3 3.1 5.7 2.6 9.9 2.2 2.8 3.6 4.4 3.1 4.1 5.6 7.8 3.1 3.8 1.8 3.6 8.8 2.2 6.4 3.4 3.4 11.9 11.5 6.0 5.1 4.5 2.8 7.3 5.0 12.6 3.1 2.0 5.4 5.6 3.6 8.4 3.2 2.3 3.9 11.4 10.5 0.6 8.3 6.6 2.1 3.1 1.5 5.1 0.3 2.7 3.2 0.8 0.2 0.4 9.0 0.3 0.0 0.0 0.6 1.3 0.0 0.0 0.1 0.2 0.4 0.5 0.2 2.2 0.3 0.0 0.0 0.3 0.3 0.7 0.3 1.3 0.2 3.2 0.5 0.9 5.1 0.0 0.6 0.0 0.1 0.4 0.7 2.0 0.2 7.2 0.4 5.0 0.2 0.3 0.9 0.2 0.1 1.2 0.5 0.3 0.4 0.3 0.1 0.4 0.6 0.2 0.2 0.5 0.2 0.4 0.9 0.3 0.5 0.1 0.3 0.2 1.8 0.3 5.1 1.1 0.1 3.2 1.3 0.6 1.5 0.3 3.1 1.0 1.4 1.9 2.7 0.2 1.5 0.1 0.8 7.9 10.2 17.9 9.3 7.8 3.1 2.2 6.4 5.1 3.9 ZNF155 pHZ-96 ENSG00000204920 "Zinc finger protein 155" Q12901 19 43967862-43998325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003220 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003220: AB_1080675" "unprognostic (2.71e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" "unprognostic (1.99e-1)" "unprognostic (7.98e-3)" "unprognostic (4.36e-2)" "unprognostic (2.98e-1)" "unprognostic (1.90e-1)" "unprognostic (3.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (6.57e-2)" 9.9 9.7 6.1 5.2 9.4 4.2 9.4 16.0 11.1 10.1 7.6 11.7 9.6 5.4 12.8 12.0 7.0 7.7 6.2 9.7 7.2 7.5 8.9 10.6 7.4 8.0 6.8 5.4 10.6 5.7 15.8 13.0 7.1 9.4 9.9 8.0 7.7 10.0 8.1 6.2 8.8 10.8 10.1 9.4 11.5 8.3 5.2 7.4 10.1 13.3 8.5 8.9 13.1 6.4 6.2 5.1 11.8 3.5 6.4 9.3 4.9 4.5 3.8 9.7 8.8 5.4 6.2 2.8 3.7 3.5 2.7 3.8 2.5 2.3 0.0 4.8 5.8 3.5 3.2 8.0 4.4 5.0 8.0 9.5 8.1 2.7 5.5 3.0 5.6 8.8 6.4 5.4 8.0 6.1 0.1 0.1 7.1 4.0 4.3 3.5 5.9 3.4 0.0 10.3 3.4 7.1 14.8 6.5 8.7 9.2 0.5 3.6 6.2 8.4 4.5 5.9 8.7 3.8 5.4 10.8 7.7 0.0 5.0 0.7 5.4 10.3 3.4 11.8 8.5 3.5 8.4 5.3 6.1 9.3 5.1 6.2 7.4 6.8 3.0 6.4 2.7 3.0 5.2 4.9 6.1 9.4 16.0 11.1 7.2 7.5 6.8 5.4 9.4 7.4 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: " "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favourable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 8.1 6.0 8.9 7.1 9.0 3.4 9.7 8.1 10.1 9.7 10.1 7.8 7.1 7.2 13.8 11.1 9.4 11.2 13.3 6.5 7.5 4.9 8.5 5.9 5.7 5.0 6.4 7.5 17.4 12.1 15.9 7.0 6.0 6.5 8.9 7.3 7.7 7.4 9.2 12.4 14.0 10.8 10.3 4.9 6.4 7.7 10.9 5.3 6.7 10.8 5.3 6.8 9.1 10.1 5.6 6.4 3.5 4.0 12.2 7.8 4.1 4.8 4.3 8.5 4.7 7.4 10.3 6.2 4.4 9.9 8.9 8.1 3.3 5.0 7.7 5.9 5.7 3.9 6.0 9.8 8.1 3.3 5.0 8.8 4.8 4.8 12.3 3.2 5.2 12.5 10.0 5.7 15.0 4.9 6.0 5.2 7.1 6.6 6.3 3.2 5.3 9.8 8.0 5.0 4.9 7.6 7.3 7.2 5.3 9.3 5.7 7.6 10.6 6.0 5.2 4.0 8.6 4.7 4.9 3.8 3.2 7.1 4.7 4.4 6.4 3.5 4.0 2.7 6.9 3.7 7.8 4.1 5.5 6.3 6.4 5.6 5.6 5.1 0.5 12.2 3.7 3.5 7.2 4.1 8.9 9.0 8.1 10.1 7.5 4.9 6.4 7.5 6.5 5.3 ZNF160 "F11, FLJ00032, HKr18, HZF5, KIAA1611, KR18" ENSG00000170949 "Zinc finger protein 160" Q9HCG1 19 53066606-53103436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023599 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA023599: AB_2218442" "unprognostic (1.18e-2)" "unprognostic (4.75e-2)" "unprognostic (1.16e-2)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (8.31e-3)" "unprognostic (2.65e-5)" "unprognostic (5.20e-2)" "unprognostic (4.11e-3)" "unprognostic (2.03e-1)" "unprognostic (3.12e-2)" "unprognostic (6.03e-3)" "unprognostic (2.71e-3)" "unprognostic (2.87e-1)" "unprognostic (4.63e-1)" "unprognostic (1.71e-1)" "prognostic favourable (2.67e-5)" 17.7 28.0 15.7 18.5 19.9 8.1 17.2 26.4 20.0 16.3 15.5 21.6 14.1 9.6 22.7 17.2 11.0 15.5 16.8 13.8 14.5 8.9 19.7 13.2 17.3 12.8 22.5 15.2 25.9 12.7 20.9 18.2 16.1 18.8 15.1 13.3 9.9 14.3 19.3 10.2 13.1 12.1 17.4 19.6 31.5 13.2 15.2 22.4 19.0 29.5 7.5 12.5 18.0 15.0 9.1 4.3 10.7 5.9 17.5 11.2 5.4 5.9 5.3 7.4 11.3 12.5 8.8 12.6 6.5 8.7 5.3 8.5 4.6 3.8 6.8 5.6 6.0 4.4 6.9 6.7 10.6 5.0 8.4 10.5 4.0 2.5 6.8 0.0 7.2 10.9 6.9 5.7 8.0 5.6 5.3 0.0 9.9 4.1 8.6 6.4 6.9 8.6 5.5 7.8 5.2 8.3 30.2 6.3 8.1 0.0 5.2 1.0 5.5 6.1 10.7 14.8 5.3 4.3 4.7 3.9 16.1 9.7 2.6 2.6 7.0 9.0 3.1 10.7 7.1 4.2 10.3 8.4 7.3 9.5 4.3 9.1 11.2 8.7 6.5 17.5 5.9 4.1 7.3 5.4 15.7 19.9 26.4 20.0 14.5 8.9 22.5 15.2 18.8 22.4 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080975-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.9" "Cell line enhanced" "Detected in many" "A-431: 10.9;BEWO: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" "Nuclear speckles, Microtubules" "HPA007247: " "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favourable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favourable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favourable (9.82e-5)" 0.4 0.8 1.2 2.1 1.7 0.7 2.2 1.3 2.4 1.5 2.6 0.9 7.9 2.0 1.1 6.3 2.5 1.8 0.6 0.8 1.7 1.1 3.5 2.7 2.6 0.9 0.8 0.3 0.7 5.4 3.1 7.7 6.2 4.0 1.2 3.6 0.6 2.5 1.3 0.4 1.0 3.4 0.4 0.5 1.0 2.2 23.9 0.5 1.2 3.1 1.4 2.5 1.2 1.2 8.6 4.2 1.6 0.6 0.2 1.7 0.5 10.9 0.7 0.7 0.6 0.3 0.5 19.4 0.4 0.5 0.8 0.7 7.6 8.2 1.0 3.2 0.2 4.2 1.8 5.4 0.6 0.2 3.0 0.3 1.2 8.2 0.3 1.8 1.5 0.3 3.0 0.6 8.0 0.2 1.8 0.3 0.5 3.2 0.4 2.1 1.6 0.9 1.3 0.6 6.3 4.4 5.4 8.0 0.6 0.8 9.6 0.8 4.4 0.3 0.1 0.6 0.9 0.3 0.7 2.7 7.2 2.8 0.3 2.1 0.3 0.0 0.3 1.6 0.7 0.6 1.5 6.0 0.9 0.5 1.2 8.6 1.7 1.3 1.1 0.2 0.2 4.2 0.4 0.5 1.2 1.7 1.3 2.4 1.7 1.1 0.8 0.3 4.0 0.5 ZNF169 MGC51961 ENSG00000175787 "Zinc finger protein 169" Q14929 9 94259311-94301454 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041769 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041769: " "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (3.27e-2)" "unprognostic (9.08e-3)" "unprognostic (1.18e-3)" "unprognostic (7.33e-2)" "unprognostic (2.27e-1)" "unprognostic (7.45e-2)" "unprognostic (6.79e-2)" "unprognostic (1.69e-2)" "unprognostic (1.49e-4)" "unprognostic (6.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (2.15e-4)" 4.5 4.2 6.5 8.5 10.9 5.9 7.8 12.7 13.5 7.4 6.7 8.3 4.4 5.6 7.7 8.7 4.1 7.5 5.7 4.6 8.6 5.7 5.5 3.2 5.0 11.0 9.8 8.5 9.4 5.2 5.9 4.9 4.3 8.2 6.6 11.1 5.8 7.2 5.6 8.6 10.0 8.6 6.6 7.1 10.6 8.1 4.3 9.5 10.5 8.0 5.0 10.0 6.9 6.5 9.5 4.5 6.1 6.9 6.7 9.1 3.4 4.0 3.5 4.0 7.0 1.9 5.0 4.5 1.4 2.8 3.1 3.3 2.4 6.0 9.7 2.0 2.3 8.0 8.2 3.7 4.2 5.5 8.8 6.8 8.0 4.5 2.9 10.3 7.0 4.3 4.1 2.6 4.2 3.9 6.1 3.0 3.9 3.9 4.7 5.7 6.5 4.3 4.2 2.8 3.2 2.8 3.6 4.1 4.9 2.8 4.9 2.0 3.1 4.5 4.2 2.9 3.7 3.6 3.1 5.2 1.9 2.0 2.7 6.8 2.7 3.2 6.5 6.1 5.5 6.9 6.9 6.3 6.2 3.9 4.5 9.5 6.7 9.1 5.6 6.7 5.0 4.2 6.5 3.4 6.5 10.9 12.7 13.5 8.6 5.7 9.8 8.5 8.2 9.5 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401235-3409370 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009656 Approved Supported "Nucleoplasm,Actin filaments,Cytosol" Nucleoplasm "Actin filaments, Cytosol" "HPA009656: AB_1080679" "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 10.0 11.6 11.1 9.0 16.0 5.7 12.8 15.8 24.3 13.0 14.8 18.1 9.4 9.6 16.8 18.8 11.0 17.7 13.4 15.3 11.8 12.0 11.1 9.9 8.7 11.6 15.1 10.5 21.0 9.1 28.5 15.2 8.2 15.7 14.7 11.7 16.1 12.2 18.2 14.1 11.4 9.7 16.8 13.3 11.9 10.5 13.5 15.7 18.8 12.2 9.1 12.8 14.8 10.8 9.5 6.9 23.1 6.4 6.8 11.5 6.7 6.2 10.3 11.9 13.4 14.5 10.5 8.2 5.9 14.6 12.8 11.7 8.1 10.9 21.6 9.4 10.4 9.0 11.0 9.8 12.1 13.7 11.3 11.2 9.7 9.8 10.4 12.7 13.5 12.5 11.6 10.8 10.8 10.8 17.6 9.8 13.1 10.4 12.6 10.6 13.0 12.8 18.1 13.3 17.0 9.4 3.2 11.2 8.7 11.5 12.8 9.8 12.5 14.2 8.7 9.6 10.4 7.6 7.7 12.1 13.1 17.1 5.1 8.0 9.0 13.1 5.7 23.1 9.1 6.4 8.7 9.5 9.4 10.2 6.9 7.1 11.5 8.5 6.8 6.8 4.2 3.6 8.8 6.7 11.1 16.0 15.8 24.3 11.8 12.0 15.1 10.5 15.7 15.7 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571298-51592508 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.7;RT4: 23.4;TIME: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002717 Uncertain Supported "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA002717: AB_1080681" "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (6.64e-4)" "unprognostic (3.50e-3)" 6.1 6.7 11.2 6.1 12.6 4.7 8.4 26.2 16.0 7.7 6.5 7.1 9.4 8.4 9.2 8.5 5.5 7.6 4.9 6.6 12.7 7.4 7.3 6.4 8.0 8.7 11.1 10.3 14.5 7.3 19.8 10.9 12.1 11.4 7.6 6.1 6.4 9.1 9.5 6.4 5.5 7.9 8.1 8.8 9.7 6.7 15.0 11.7 9.2 10.8 5.0 9.2 8.7 11.9 2.1 4.6 0.6 1.3 0.9 2.2 0.7 1.8 3.3 3.3 3.5 3.5 4.9 0.0 4.2 5.4 3.9 4.8 3.3 2.8 3.4 2.4 4.2 3.1 3.5 2.9 7.1 0.0 5.2 25.7 5.0 1.1 3.1 4.3 16.6 1.9 2.7 8.0 3.9 6.3 8.6 3.5 4.3 0.0 4.6 3.2 1.8 3.3 0.0 4.3 1.6 2.1 23.4 4.2 3.0 3.9 1.3 2.5 1.0 3.5 23.7 6.0 2.7 1.4 4.0 4.6 8.5 3.4 16.8 2.5 3.0 0.1 1.3 0.0 1.7 0.5 1.8 1.9 1.6 1.4 1.4 2.1 2.2 1.7 0.6 0.9 0.3 4.6 0.3 0.7 11.2 12.6 26.2 16.0 12.7 7.4 11.1 10.3 11.4 11.7 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997510 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favourable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favourable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 8.3 6.8 8.2 7.0 13.9 15.7 9.6 9.4 15.5 8.5 7.2 13.2 3.5 6.4 14.1 9.5 8.8 7.5 7.2 7.3 9.0 8.7 6.5 13.2 6.2 10.5 9.9 9.8 10.4 7.8 8.4 11.8 5.1 14.5 9.8 9.2 12.5 9.0 7.1 8.2 12.8 8.2 7.8 10.8 12.3 6.2 15.5 9.2 15.6 8.4 14.3 10.2 7.7 7.6 9.1 8.8 19.6 7.6 7.0 11.2 5.6 3.1 6.6 7.0 10.5 13.3 11.8 3.7 4.6 8.1 6.0 6.5 3.0 5.4 10.8 6.9 5.0 6.6 5.8 7.2 6.6 8.1 4.9 6.4 6.7 4.2 9.4 3.7 8.6 9.7 11.8 4.6 8.4 9.1 3.7 5.1 8.2 3.3 11.8 7.2 5.2 3.0 9.9 7.1 4.8 8.7 3.9 2.7 5.9 7.8 3.9 6.1 5.5 3.4 7.1 7.2 3.6 3.2 3.5 5.7 4.1 5.3 8.3 8.3 8.4 10.6 5.9 6.6 11.0 5.8 10.2 9.1 10.2 10.3 5.8 8.2 11.0 11.2 19.6 7.0 7.6 8.8 10.6 5.6 8.2 13.9 9.4 15.5 9.0 8.7 9.9 9.8 14.5 9.2 ZNF185 SCELL ENSG00000147394 "Zinc finger protein 185 with LIM domain" O15231 X 152914442-152973480 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.5;esophagus: 67.6" "Cell line enhanced" "Detected in many" "A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.6;monocytes: 13.9" "Low region specificity" "Detected in all" "HPA000400, HPA016438" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" 5400 "Plasma membrane, Cytosol" "Actin filaments, Focal adhesion sites" "HPA000400: AB_1080685, HPA016438: AB_1859109" "unprognostic (1.34e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" "unprognostic (9.75e-3)" "unprognostic (2.69e-1)" "unprognostic (2.49e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (7.94e-2)" "unprognostic (6.28e-2)" "prognostic unfavourable (3.30e-5)" "unprognostic (5.18e-2)" "unprognostic (8.12e-2)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" 3.9 1.7 1.8 2.0 3.2 0.8 1.8 2.7 2.0 14.3 1.8 1.4 10.7 0.0 3.8 93.5 67.6 3.1 2.0 1.9 1.7 0.8 2.0 1.1 3.3 3.1 2.1 1.1 1.2 0.9 0.1 2.3 4.0 1.7 4.2 0.3 1.3 10.1 28.1 1.5 9.9 1.2 1.4 1.2 3.7 0.8 1.9 2.0 1.2 3.9 1.4 6.6 2.1 22.8 0.4 3.8 21.6 13.9 0.2 0.6 10.2 31.0 6.6 0.6 0.4 0.8 1.0 1.4 1.5 0.1 3.9 0.5 0.2 9.4 0.4 36.9 2.3 4.4 0.9 25.6 15.9 0.3 0.6 2.0 2.7 1.0 1.8 0.1 0.1 0.7 18.4 0.4 15.1 19.7 0.1 0.3 0.1 7.3 0.1 0.1 0.4 22.7 0.1 0.1 0.2 2.0 2.9 0.2 2.1 0.0 5.9 0.9 6.0 0.6 60.4 0.2 13.4 0.7 1.1 0.3 0.2 0.2 0.4 2.2 0.4 21.6 13.9 5.7 0.5 12.9 0.3 0.4 0.4 0.6 3.8 0.3 0.6 0.3 9.5 0.2 10.2 2.5 0.5 10.2 1.8 3.2 2.7 2.0 1.7 0.8 2.1 1.1 1.7 2.0 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavourable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavourable (4.24e-4)" "prognostic unfavourable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favourable (4.79e-7)" 12.2 11.3 14.0 13.2 18.8 15.0 20.9 28.0 22.7 13.4 15.4 19.6 10.8 13.5 13.4 25.3 10.8 12.6 11.1 9.6 15.2 16.9 16.4 14.6 12.7 16.5 16.9 10.5 10.6 16.0 8.8 20.8 9.9 22.5 16.4 19.4 9.3 13.2 9.7 13.0 13.5 14.0 11.3 15.4 19.5 13.3 6.9 20.0 25.8 15.9 8.6 15.9 13.1 12.9 13.6 12.2 9.9 9.2 13.0 19.1 8.2 7.9 8.7 15.0 18.2 5.3 6.6 22.0 8.2 7.0 8.7 11.0 9.1 14.9 13.0 5.1 5.4 11.2 16.6 9.9 12.7 6.3 13.9 9.7 8.6 9.1 6.8 15.9 14.4 8.3 9.6 7.2 12.3 10.9 16.9 8.5 9.5 6.4 18.8 12.6 34.9 8.8 16.6 9.2 6.6 13.8 18.8 25.1 24.9 9.0 11.3 7.4 5.6 14.2 7.7 4.2 8.0 7.4 7.2 7.7 10.9 20.6 4.2 11.8 7.3 1.9 8.4 9.9 12.0 9.2 15.2 13.6 14.8 14.6 12.2 12.7 14.0 15.6 1.4 13.0 7.7 10.7 19.1 8.2 14.0 18.8 28.0 22.7 15.2 16.9 16.9 10.5 22.5 20.0 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favourable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.3 5.2 6.4 10.7 9.5 7.5 4.2 6.0 7.9 8.2 10.9 5.6 3.7 3.4 4.3 5.7 4.5 6.8 4.5 8.7 7.5 5.9 7.9 4.2 6.9 7.8 4.1 5.2 6.4 6.4 7.5 11.7 7.1 5.3 2.8 8.5 4.9 5.8 5.7 2.8 7.2 5.6 11.1 4.4 4.7 3.2 5.4 7.4 5.6 8.1 6.8 5.0 6.2 5.8 10.0 5.8 7.9 5.0 4.9 4.3 4.2 6.7 5.4 7.6 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.5" "Low lineage specificity" "Detected in all" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 3.3 4.0 2.7 3.5 4.0 4.9 6.3 3.5 3.7 7.3 4.4 2.3 9.5 1.8 6.3 7.8 4.5 10.3 2.7 2.5 3.0 2.8 5.6 2.6 3.6 4.3 2.8 1.3 6.6 6.1 4.0 9.5 3.8 4.0 9.1 4.4 2.7 4.6 4.0 1.9 6.2 7.5 3.9 2.9 6.0 4.4 14.8 3.8 8.9 9.3 3.9 3.9 5.3 4.5 2.3 2.2 18.5 2.2 6.0 3.3 1.0 3.3 0.1 4.6 9.6 2.1 3.5 3.5 2.9 5.3 2.7 3.8 1.0 1.8 3.1 3.3 3.4 2.1 2.5 2.1 2.8 2.5 0.7 1.3 3.5 1.6 1.2 0.1 3.0 2.9 4.6 1.1 1.6 1.6 2.0 0.5 5.7 1.3 4.0 3.6 7.8 2.6 3.0 2.6 1.7 3.4 7.3 2.0 4.6 2.7 1.9 3.9 3.6 5.2 0.0 6.4 2.2 6.3 2.0 5.2 2.9 3.1 0.4 0.0 2.5 9.7 2.2 5.1 1.5 1.1 1.5 1.5 1.3 1.5 1.2 2.3 1.4 1.2 18.5 6.0 2.0 2.2 3.3 1.0 2.7 4.0 3.5 3.7 3.0 2.8 2.8 1.3 4.0 3.8 ZNF202 "ZKSCAN10, ZSCAN42" ENSG00000166261 "Zinc finger protein 202" O95125 11 123724177-123741675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059229 Approved "Nucleoli,Nuclear bodies" Nucleoli "Nuclear bodies" "HPA059229: " "unprognostic (3.12e-2)" "unprognostic (7.75e-2)" "unprognostic (2.20e-2)" "unprognostic (4.49e-2)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (2.52e-6)" "unprognostic (1.23e-1)" "unprognostic (1.74e-3)" "unprognostic (2.80e-1)" "unprognostic (9.48e-2)" "unprognostic (1.30e-2)" "prognostic unfavourable (9.93e-7)" "unprognostic (2.61e-2)" "unprognostic (2.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" 7.2 6.5 9.2 16.1 11.6 6.0 10.4 11.9 10.9 9.5 8.2 9.2 8.1 5.6 13.1 13.9 8.8 9.7 6.1 6.2 7.3 5.5 6.6 7.3 7.8 10.6 10.5 6.4 15.1 14.1 11.1 11.5 8.2 7.0 10.6 11.0 7.2 9.2 8.6 8.5 10.9 8.9 12.3 7.0 14.1 8.0 24.0 7.8 8.9 10.3 5.4 11.7 9.1 10.5 4.1 3.6 0.1 3.6 3.0 5.6 3.0 4.0 5.9 10.6 12.8 5.0 7.2 8.4 6.2 5.3 6.1 5.3 6.5 10.8 12.2 6.0 5.0 10.3 10.8 7.3 8.5 5.1 6.4 20.1 3.8 7.0 6.7 12.3 6.2 5.3 15.1 6.8 20.7 7.0 11.3 8.0 7.7 4.3 10.6 16.2 17.0 9.2 13.3 7.0 4.5 5.7 7.7 7.7 8.8 5.5 6.8 4.4 11.4 8.6 5.7 11.5 6.9 8.1 6.4 5.5 3.7 8.3 3.1 13.6 7.5 0.0 2.1 0.1 3.8 3.6 3.4 3.4 4.8 4.9 3.6 4.1 5.6 5.0 0.0 3.0 1.5 2.3 4.0 3.0 9.2 11.6 11.9 10.9 7.3 5.5 10.5 6.4 7.0 7.8 ZNF211 "CH2H2-25, ZNF-25" ENSG00000121417 "Zinc finger protein 211" Q13398 19 57630395-57642779 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011340, HPA049967" Approved Approved "Mitochondria,Rods & Rings" Mitochondria "Rods & Rings" "HPA011340: , HPA049967: " "unprognostic (6.47e-2)" "unprognostic (3.28e-2)" "unprognostic (2.83e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-1)" "unprognostic (2.77e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "unprognostic (6.66e-2)" "unprognostic (1.03e-1)" "unprognostic (3.27e-3)" "unprognostic (1.83e-2)" "unprognostic (1.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (4.72e-3)" 8.8 11.3 11.1 10.1 13.5 24.2 11.7 18.3 14.2 10.1 10.0 17.5 14.8 5.2 12.3 13.2 7.2 10.9 9.3 11.5 11.0 10.4 11.3 6.5 11.1 13.3 12.0 12.4 13.4 7.3 25.7 16.7 13.9 12.2 12.6 10.2 15.4 8.7 14.9 6.8 12.0 12.5 10.3 10.7 17.7 17.6 6.1 9.1 17.7 16.5 5.4 15.1 12.9 10.3 10.5 7.6 12.7 6.2 7.0 13.7 6.5 3.9 2.6 11.7 10.5 6.8 6.9 6.8 5.6 6.9 8.0 5.3 2.0 2.4 3.8 2.5 5.8 0.9 5.5 8.4 16.9 4.7 13.7 7.3 5.7 4.9 5.9 5.1 7.7 6.3 10.2 6.0 5.6 6.1 1.6 4.8 9.8 1.8 10.3 3.5 4.8 6.2 6.4 8.8 3.3 6.9 15.3 5.4 7.5 6.7 3.4 2.5 3.6 7.2 3.8 8.1 4.0 3.4 4.6 6.8 8.6 7.9 2.2 4.2 4.8 7.9 6.2 12.7 8.4 5.9 13.7 8.8 11.1 12.1 7.6 10.5 13.2 9.3 8.3 7.0 3.9 1.6 11.8 6.5 11.1 13.5 18.3 14.2 11.0 10.4 12.0 12.4 12.2 9.1 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: " "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavourable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.3 10.6 4.7 11.2 4.6 3.8 5.9 6.2 2.5 3.3 3.8 3.4 7.0 4.1 6.1 4.0 8.2 2.2 6.8 1.3 8.5 8.2 2.9 11.7 6.6 8.8 7.0 7.6 3.7 8.5 4.6 1.7 2.4 7.4 9.2 2.1 14.5 6.5 8.6 8.1 8.1 8.8 5.5 7.5 2.6 2.3 9.8 8.5 9.3 5.6 4.4 7.3 12.1 6.0 6.7 6.1 7.5 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell line enhanced" "Detected in many" "U-698: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: " "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.7 0.6 1.3 1.6 5.7 6.1 5.2 3.2 6.3 0.2 0.1 8.5 2.0 3.2 3.0 5.0 6.0 6.0 0.0 6.9 0.1 0.8 0.1 1.2 5.3 0.4 2.8 2.9 0.1 6.5 5.0 10.0 3.0 1.3 0.1 0.2 0.2 8.4 1.7 0.2 0.1 1.0 0.2 4.7 0.1 0.2 0.0 2.1 0.2 0.2 2.1 2.4 2.0 5.7 2.3 0.1 0.4 0.1 17.8 4.5 0.3 1.7 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favourable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 4.8 7.7 8.1 5.1 9.1 8.0 8.3 18.3 12.6 6.2 4.4 7.5 5.3 2.9 5.1 7.3 3.5 5.5 6.4 7.5 11.5 8.2 5.9 5.1 5.7 7.2 8.8 7.8 8.9 5.4 6.6 12.7 5.4 10.7 6.6 5.0 5.7 6.9 6.4 3.7 4.5 5.0 6.0 9.3 8.8 5.5 15.4 11.1 10.3 7.6 5.0 7.3 8.5 6.6 7.6 4.0 8.9 3.6 6.1 9.7 4.0 3.9 4.6 7.8 7.1 6.0 6.1 0.4 4.2 7.5 4.9 7.7 2.4 2.5 1.3 6.5 4.6 1.3 5.4 4.0 6.3 5.7 5.9 6.4 5.8 3.7 7.6 0.2 5.9 4.6 5.4 4.1 7.0 4.6 1.2 2.7 6.1 0.5 4.4 2.6 4.7 2.2 0.1 8.3 2.1 4.1 12.3 4.2 9.6 6.8 1.3 5.7 1.7 6.3 3.4 5.5 5.3 3.2 5.2 11.2 9.1 0.1 2.9 0.1 6.0 8.9 3.6 7.0 9.2 2.3 7.7 7.4 8.7 8.9 3.6 7.6 9.7 7.3 7.5 6.1 2.8 4.0 6.0 4.0 8.1 9.1 18.3 12.6 11.5 8.2 8.8 7.8 10.7 11.1 ZNF223 ENSG00000178386 "Zinc finger protein 223" Q9UK11 19 44051367-44067991 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 21.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA067823 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA067823: " "unprognostic (6.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.42e-1)" "unprognostic (8.36e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (1.85e-1)" "unprognostic (6.32e-2)" "unprognostic (4.33e-1)" "unprognostic (4.95e-2)" "unprognostic (3.67e-1)" "unprognostic (2.58e-4)" 6.5 8.0 6.6 5.9 14.7 3.2 10.1 19.8 17.3 7.6 8.0 9.6 6.0 7.1 7.7 11.3 6.5 7.5 9.5 8.8 9.4 8.5 7.5 4.7 7.0 6.0 6.7 7.4 7.7 6.2 10.8 9.8 9.7 15.3 12.3 10.7 7.1 7.7 9.4 3.5 8.8 9.2 7.8 5.7 8.6 8.8 6.2 7.9 6.7 11.7 4.6 7.6 9.0 6.2 4.4 7.7 11.6 7.1 6.6 9.3 2.6 2.5 1.4 5.4 1.3 3.6 4.6 0.1 3.9 4.2 3.5 5.1 2.6 4.3 0.0 3.7 3.0 2.4 0.0 4.4 3.7 0.0 4.1 5.1 3.9 3.4 2.7 0.2 0.1 4.4 3.5 2.9 2.8 3.9 0.2 0.0 3.8 2.0 0.0 1.8 4.0 1.9 0.0 2.2 1.2 4.1 21.4 3.4 8.1 6.7 0.9 2.7 3.8 4.7 3.9 3.3 3.1 1.7 1.4 2.6 4.3 0.0 1.4 0.0 3.2 11.6 5.8 8.7 2.8 7.1 4.3 3.6 4.7 2.4 6.4 4.4 9.3 4.0 0.5 6.6 2.9 7.7 4.0 2.6 6.6 14.7 19.8 17.3 9.4 8.5 6.7 7.4 15.3 7.9 ZNF224 "BMZF-2, KOX22, ZNF255, ZNF27" ENSG00000267680 "Zinc finger protein 224" Q9NZL3 19 44094339-44109886 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054045 Approved Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA054045: " "unprognostic (1.01e-3)" "unprognostic (4.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.40e-3)" "unprognostic (8.47e-2)" "unprognostic (4.25e-4)" "unprognostic (9.61e-2)" "unprognostic (6.35e-3)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.81e-3)" "unprognostic (2.64e-2)" "prognostic unfavourable (5.32e-4)" "unprognostic (1.68e-1)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "prognostic favourable (1.53e-7)" 13.5 13.3 12.4 13.6 17.7 6.9 14.4 29.2 20.2 13.6 11.0 10.8 17.7 14.8 14.9 20.3 10.0 13.5 11.6 9.0 16.4 7.8 12.7 13.3 14.6 17.1 20.3 11.0 18.6 13.1 16.6 25.0 12.1 15.4 15.0 18.1 11.6 13.8 13.9 6.6 20.2 19.4 15.0 12.3 23.6 13.1 5.4 15.8 14.9 18.0 8.7 18.3 12.1 11.3 11.6 6.5 25.0 8.1 10.0 14.5 6.7 6.1 10.3 11.1 9.1 11.1 11.7 9.1 7.8 11.7 5.4 12.5 5.1 4.9 7.5 8.7 10.2 7.0 6.1 6.7 7.3 7.6 12.3 14.3 17.1 5.3 5.9 10.3 16.8 14.4 12.2 6.7 10.0 9.7 4.3 9.1 9.0 1.6 9.0 12.5 4.8 7.2 5.3 12.1 4.5 8.2 19.9 5.7 13.1 10.7 4.6 3.6 4.6 13.5 10.2 12.1 7.8 5.4 5.4 12.3 11.4 4.2 6.5 8.0 5.5 25.0 6.1 14.1 13.3 4.1 14.5 11.2 11.2 13.1 6.5 11.6 14.1 10.9 4.5 10.0 8.1 5.8 12.5 6.7 12.4 17.7 29.2 20.2 16.4 7.8 20.3 11.0 15.4 15.8 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favourable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 1.7 4.1 6.6 0.5 8.2 0.4 2.3 7.7 4.0 2.9 1.2 1.5 1.1 1.7 3.6 2.6 1.9 4.8 1.4 3.1 4.8 2.1 1.7 1.4 0.8 1.8 2.2 6.0 0.9 10.5 8.7 2.5 3.9 2.9 0.4 3.4 2.5 2.2 1.9 0.8 0.6 2.7 4.5 1.2 1.2 2.1 3.8 1.5 6.6 0.0 0.8 2.7 0.9 1.4 0.4 0.5 0.1 4.8 1.1 0.4 0.0 4.8 3.8 0.1 4.1 2.7 0.0 5.8 2.5 3.3 4.2 0.0 0.7 0.0 2.7 3.6 2.0 0.0 4.4 2.1 0.0 1.7 0.7 1.0 0.3 6.7 0.1 0.0 4.2 0.1 2.8 9.1 2.9 0.2 0.0 3.7 0.1 0.0 0.0 3.4 1.3 0.0 0.0 1.6 3.0 7.5 1.2 1.2 2.7 0.4 0.0 0.1 0.0 3.0 2.5 0.1 0.8 0.2 5.0 2.8 0.0 0.0 0.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.4 1.1 0.4 0.0 4.8 0.0 0.4 0.0 0.4 ZNF232 ZSCAN11 ENSG00000167840 "Zinc finger protein 232" Q9UNY5 17 5105541-5123116 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027309, HPA028611" Uncertain Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA027309: AB_10603464, HPA028611: " "unprognostic (4.20e-2)" "unprognostic (2.06e-3)" "unprognostic (3.69e-1)" "unprognostic (5.59e-3)" "unprognostic (5.21e-2)" "unprognostic (5.90e-3)" "prognostic unfavourable (4.66e-4)" "unprognostic (3.12e-2)" "unprognostic (5.46e-3)" "unprognostic (2.49e-2)" "prognostic favourable (6.55e-4)" "unprognostic (3.28e-2)" "unprognostic (3.49e-3)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (1.11e-1)" "unprognostic (8.61e-3)" 6.7 5.2 6.5 6.7 9.5 2.0 7.4 14.3 11.1 6.6 8.2 11.1 7.8 4.5 8.9 10.1 5.5 9.9 5.5 5.9 7.3 5.4 6.6 6.3 6.3 7.0 9.8 5.7 14.3 10.0 3.8 8.7 6.2 8.7 7.6 5.9 6.5 8.8 6.4 7.7 5.5 6.3 8.5 6.2 6.9 7.2 7.5 10.7 6.4 8.0 5.4 6.1 6.3 6.2 11.8 7.4 1.9 2.1 5.4 7.8 3.9 5.5 4.2 6.9 7.0 2.5 1.1 3.7 2.7 1.4 2.7 3.8 6.5 1.4 11.2 3.4 1.0 3.8 4.8 2.8 1.6 4.4 7.3 1.9 9.7 5.8 3.6 0.0 3.4 2.0 3.0 2.9 2.6 1.9 9.4 4.2 3.3 2.7 9.5 3.9 13.5 4.6 8.2 4.4 7.5 2.3 0.8 7.2 4.7 5.4 2.2 4.4 1.1 2.8 3.2 2.7 4.6 2.1 5.3 5.6 8.8 2.8 7.0 0.3 4.5 1.4 2.1 1.9 4.7 1.9 5.5 11.8 5.2 6.2 4.0 11.0 7.8 7.2 0.1 5.4 1.2 7.4 4.2 3.9 6.5 9.5 14.3 11.1 7.3 5.4 9.8 5.7 8.7 10.7 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.3 5.8 8.2 6.0 6.3 6.1 3.7 3.4 4.7 5.4 4.3 4.1 4.1 6.2 1.7 4.4 8.0 5.7 4.8 4.6 6.5 5.7 5.9 6.7 4.8 3.9 9.4 6.8 6.0 5.2 5.1 7.9 5.4 5.6 5.2 5.4 4.1 11.4 5.2 4.5 4.6 7.3 8.5 4.1 4.0 6.8 4.7 4.9 6.1 3.7 4.2 4.4 6.6 5.6 9.3 3.7 2.5 5.0 3.5 4.9 8.0 6.2 5.2 6.9 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 17.7;T-47d: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 4.2;T-cells: 8.8" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA030843: , HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavourable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 5.0 5.0 8.8 5.6 9.3 0.9 10.4 5.7 8.2 6.8 5.3 5.2 2.1 2.9 8.8 4.5 2.5 8.7 3.5 4.1 6.5 5.1 4.6 2.6 2.7 5.3 5.3 8.5 8.1 8.7 9.9 8.6 2.0 7.2 10.6 5.8 1.7 6.2 9.4 4.9 1.3 3.3 9.8 3.7 2.7 4.7 14.5 6.8 1.6 6.5 1.4 5.1 6.1 10.4 4.2 0.1 0.0 0.0 0.5 8.8 1.9 0.0 3.0 3.6 3.5 5.1 3.9 0.0 6.4 0.7 7.8 6.9 7.8 7.0 0.0 2.4 3.5 0.2 0.0 0.3 9.9 0.1 5.2 0.0 5.2 0.0 4.0 0.0 2.3 4.3 0.1 6.1 0.0 0.2 10.1 0.0 6.4 3.3 1.0 1.0 17.7 3.6 0.0 0.0 0.2 6.5 2.7 6.9 9.3 2.9 0.1 0.4 13.9 4.3 0.8 0.0 8.0 0.2 8.1 0.8 6.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.0 5.0 3.6 4.8 3.2 0.1 4.2 8.8 5.2 0.0 0.5 0.0 0.0 2.5 1.9 8.8 9.3 5.7 8.2 6.5 5.1 5.3 8.5 7.2 6.8 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949572-37976633 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 9.7 12.1 17.0 4.0 21.7 2.7 8.7 23.2 27.6 10.9 8.1 7.3 3.4 2.7 11.3 7.5 6.5 7.3 7.1 11.1 13.3 16.7 6.8 3.5 6.9 4.9 12.7 23.7 13.1 4.0 7.1 10.7 5.4 16.0 8.9 5.4 5.1 4.5 11.0 22.9 5.1 3.7 11.6 9.5 7.1 4.4 5.2 11.6 1.2 6.3 5.7 4.9 8.4 5.4 2.3 3.4 6.0 8.5 1.8 3.7 2.2 1.6 3.0 3.3 6.8 12.7 9.7 0.6 3.6 5.0 2.9 4.4 0.5 2.3 3.0 1.1 6.4 0.4 0.9 1.5 4.7 7.1 1.6 4.9 0.0 1.0 8.1 3.2 3.2 6.9 6.8 3.2 3.7 4.9 0.4 2.3 6.9 0.9 1.1 2.5 0.6 2.2 1.2 3.8 0.6 3.4 0.6 1.2 7.8 1.2 0.2 4.6 3.0 5.2 7.0 4.5 0.8 7.3 2.2 2.9 1.4 1.3 8.5 6.3 2.9 2.3 2.8 6.0 3.1 4.7 3.4 2.0 2.7 2.6 3.4 2.3 3.7 3.0 0.5 1.8 8.5 0.5 2.2 2.2 17.0 21.7 23.2 27.6 13.3 16.7 12.7 23.7 16.0 11.6 ZNF26 "FLJ20755, KOX20" ENSG00000198393 "Zinc finger protein 26" P17031 12 132986365-133032952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018329, HPA042406" Uncertain Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA018329: AB_1859157, HPA042406: " "unprognostic (7.31e-3)" "unprognostic (7.60e-3)" "unprognostic (7.26e-4)" "unprognostic (5.52e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.52e-3)" "unprognostic (3.00e-2)" "unprognostic (9.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-3)" "unprognostic (2.66e-12)" "unprognostic (8.24e-2)" "unprognostic (7.20e-2)" "unprognostic (1.94e-3)" "unprognostic (7.64e-4)" 9.9 7.7 7.3 10.5 10.6 19.4 13.2 11.1 12.8 7.8 7.7 11.3 10.2 7.8 12.7 18.3 7.6 9.5 11.6 6.7 7.6 6.6 9.1 11.6 9.5 12.8 9.9 8.1 11.4 11.9 7.7 11.9 8.8 9.9 12.4 8.5 11.1 11.2 8.6 7.4 13.0 9.5 8.8 7.5 15.7 7.6 11.8 11.3 12.0 11.6 9.2 12.8 8.6 9.6 7.5 3.5 9.3 2.9 6.5 9.6 5.5 4.2 3.7 4.6 5.5 1.9 3.0 9.3 3.3 4.2 4.8 3.6 1.7 3.5 3.0 4.9 3.3 2.9 3.3 3.3 5.9 2.2 5.5 7.0 3.5 1.9 3.2 11.7 8.0 3.7 3.9 5.4 7.6 2.6 5.4 0.8 4.1 3.7 8.8 8.0 11.3 5.9 8.5 6.9 5.7 2.3 6.7 5.7 12.4 4.3 3.2 4.1 9.4 7.5 4.4 6.1 5.8 5.3 5.2 3.4 0.2 14.4 3.7 5.3 7.1 9.3 2.6 6.0 8.2 2.9 8.6 5.5 7.4 6.5 3.5 7.5 9.6 8.0 2.4 6.5 2.2 3.0 6.1 5.5 7.3 10.6 11.1 12.8 7.6 6.6 9.9 8.1 9.9 11.3 ZNF260 "ozrf1, Zfp260" ENSG00000254004 "Zinc finger protein 260" Q3ZCT1 19 36510695-36528660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028806 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028806: AB_10795285" "unprognostic (1.34e-1)" "unprognostic (6.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.11e-3)" "unprognostic (3.55e-2)" "unprognostic (1.29e-3)" "unprognostic (7.83e-3)" "unprognostic (3.91e-1)" "unprognostic (1.13e-2)" "unprognostic (8.36e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-2)" "prognostic favourable (1.44e-4)" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (7.89e-3)" 8.4 9.4 10.3 7.6 16.8 2.3 12.0 18.4 14.1 10.8 7.0 6.2 9.4 6.2 11.2 7.9 8.0 8.4 8.2 7.5 11.2 9.5 11.6 8.5 7.3 12.4 17.1 9.1 13.4 6.6 20.4 19.5 10.9 11.9 10.3 7.1 5.9 8.8 7.6 4.8 10.0 7.7 8.1 20.6 8.3 8.1 4.5 15.4 17.3 14.7 5.5 9.7 10.7 8.4 5.9 3.2 6.8 3.5 4.1 7.2 3.0 7.8 8.0 18.5 13.9 5.7 8.8 8.1 6.9 7.4 6.4 8.2 3.6 4.4 5.2 11.3 5.5 3.0 9.3 4.3 9.8 6.8 4.0 7.6 6.1 4.0 8.0 3.8 6.4 7.9 7.1 6.6 10.1 8.5 6.0 5.7 12.7 4.2 14.2 2.4 11.7 3.4 9.5 11.5 3.8 7.1 14.1 13.4 14.7 15.3 8.2 5.6 6.9 7.3 7.3 11.1 11.6 6.5 6.1 7.4 14.1 12.1 0.3 4.1 14.9 6.8 2.8 3.0 4.0 2.5 4.2 5.1 5.3 3.2 3.2 5.9 7.2 5.5 1.6 4.1 3.5 2.2 4.6 3.0 10.3 16.8 18.4 14.1 11.2 9.5 17.1 9.1 11.9 15.4 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.4 11.0 13.2 19.1 10.5 13.9 17.1 11.7 18.0 14.1 15.3 12.0 13.4 31.3 12.2 15.0 10.8 17.8 11.9 14.2 17.2 17.8 14.2 14.7 11.5 12.3 21.0 17.5 16.0 24.9 12.8 18.8 12.0 16.0 21.4 11.5 11.7 19.3 16.2 24.5 9.5 31.5 13.3 24.6 9.8 8.5 19.1 20.0 12.8 13.9 14.2 15.3 25.2 12.4 14.9 14.4 11.0 10.9 22.9 24.2 37.8 5.8 10.6 10.5 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412598-9435578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: , HPA054110: " "unprognostic (2.50e-2)" "prognostic favourable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favourable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favourable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favourable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavourable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favourable (9.15e-5)" 14.7 12.1 11.0 21.5 12.5 12.8 17.6 19.0 10.0 21.8 15.7 13.1 9.6 8.6 17.2 55.8 12.7 14.6 12.8 11.7 8.2 5.4 10.9 10.4 15.8 21.0 14.5 4.9 18.9 11.2 12.5 19.8 13.0 11.4 23.8 15.7 14.4 14.4 13.5 9.3 19.1 20.8 17.0 10.9 31.3 13.5 13.0 11.4 34.6 20.8 7.3 23.4 14.4 14.2 6.9 3.8 5.6 5.5 12.6 13.0 5.1 10.6 2.7 7.9 15.1 5.7 11.1 6.4 11.8 10.0 9.8 16.3 5.7 4.6 11.9 7.6 5.8 4.0 10.0 6.3 11.7 3.3 16.5 16.3 14.6 8.3 5.1 9.3 10.1 10.5 8.7 5.3 8.2 7.8 8.5 0.1 9.0 1.0 13.6 45.8 8.3 9.0 6.1 8.2 8.3 7.6 13.3 6.8 10.7 5.4 6.4 6.6 4.7 7.2 7.1 9.1 3.5 13.7 6.0 19.5 25.8 14.2 2.8 8.9 6.8 4.8 4.1 5.6 13.0 4.8 8.5 6.0 7.2 9.2 3.3 6.9 10.6 10.2 3.6 12.6 5.5 3.8 8.7 5.1 11.0 12.5 19.0 10.0 8.2 5.4 14.5 4.9 11.4 11.4 ZNF268 HZF3 ENSG00000090612 "Zinc finger protein 268" Q14587 12 133181409-133214831 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001794 Approved Approved "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA001794: " "unprognostic (7.65e-2)" "unprognostic (2.78e-1)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.94e-1)" "unprognostic (4.91e-3)" "unprognostic (2.21e-1)" "unprognostic (7.63e-3)" "unprognostic (2.57e-2)" "unprognostic (6.59e-3)" "unprognostic (5.69e-2)" "unprognostic (2.30e-1)" "unprognostic (8.79e-2)" "unprognostic (1.53e-3)" 8.8 13.5 9.3 13.0 10.3 4.6 13.4 11.2 13.0 11.7 9.0 8.5 13.3 6.2 11.1 14.7 11.8 12.6 10.4 7.9 9.0 8.2 13.5 17.3 10.1 13.2 7.9 8.8 19.7 9.6 20.6 14.2 17.6 11.1 15.7 7.8 9.6 9.9 10.4 6.0 8.0 8.0 12.0 8.2 11.4 9.6 9.6 8.5 12.9 16.6 11.2 9.3 12.0 9.4 10.0 7.4 5.7 8.0 10.6 15.7 5.1 5.1 9.1 16.6 14.6 7.4 10.5 11.7 7.6 8.8 7.3 6.2 7.8 3.8 6.3 12.0 9.1 4.9 8.2 9.9 9.2 0.2 6.7 12.7 4.2 9.9 7.5 10.7 10.3 13.4 9.7 8.9 14.4 8.5 8.7 6.1 12.4 6.4 4.4 5.2 13.0 0.4 4.1 6.4 5.6 4.1 12.1 12.8 10.4 15.7 5.5 7.1 14.3 9.1 9.3 8.3 10.4 2.8 7.1 2.1 3.1 9.8 4.6 5.7 8.7 1.7 4.9 5.7 8.5 4.9 5.7 10.0 9.6 10.7 7.4 8.2 15.7 10.7 1.5 10.6 8.0 5.9 4.9 5.1 9.3 10.3 11.2 13.0 9.0 8.2 7.9 8.8 11.1 8.5 ZNF274 "ZKSCAN19, ZSCAN51" ENSG00000171606 "Zinc finger protein 274" Q96GC6 19 58183029-58213562 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028880 Uncertain Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA028880: AB_10601929" "unprognostic (2.38e-3)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (3.84e-1)" "prognostic favourable (6.16e-4)" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (6.57e-2)" "unprognostic (2.19e-1)" "unprognostic (5.61e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.58e-3)" 9.9 7.6 5.9 8.8 7.0 8.8 15.4 16.6 6.7 7.5 9.9 11.7 14.0 6.3 10.0 12.2 11.7 9.8 14.7 12.0 5.9 4.8 7.3 14.0 12.0 12.8 12.5 5.5 16.8 8.9 20.3 10.9 7.6 9.5 10.4 5.8 14.5 8.6 11.0 11.2 11.4 10.6 10.6 8.7 10.7 8.3 19.3 7.9 6.1 15.3 8.6 10.9 11.2 12.8 16.3 6.7 23.0 8.0 14.0 18.1 8.8 8.8 6.3 10.5 4.3 6.7 9.9 10.2 7.3 4.0 8.0 7.2 3.6 6.6 3.0 4.8 4.5 2.5 4.9 10.2 11.2 6.2 38.3 14.3 6.1 5.9 10.8 10.2 23.7 7.8 13.2 9.9 19.1 6.4 10.7 13.8 6.0 5.8 5.5 9.1 10.0 6.1 12.4 2.7 13.2 6.0 3.7 6.8 3.1 9.8 4.3 8.2 10.4 19.3 6.1 4.4 6.6 5.0 8.2 6.3 6.6 10.1 1.9 11.3 9.1 13.7 4.7 23.0 9.3 5.1 14.3 13.8 12.2 13.2 6.7 16.3 18.1 13.0 17.3 14.0 8.0 3.1 15.3 8.8 5.9 7.0 16.6 6.7 5.9 4.8 12.5 5.5 9.5 7.9 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavourable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.2 3.4 8.9 2.8 3.9 6.1 3.4 2.1 3.2 1.2 5.4 5.3 6.6 4.4 3.6 9.2 4.3 3.8 2.3 4.1 23.2 5.9 7.9 2.1 5.4 5.7 7.8 5.3 5.1 4.3 3.5 4.8 10.8 5.7 1.4 7.0 7.3 13.1 2.5 9.5 11.7 3.8 4.4 4.0 2.9 9.3 7.8 7.5 6.8 4.2 9.2 8.3 5.4 5.3 7.2 4.1 2.9 20.5 6.6 3.5 4.2 9.5 5.2 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206588-112343096 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favourable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.2 14.8 11.2 12.9 16.2 10.9 20.1 9.3 13.8 13.6 13.9 8.4 8.8 13.7 14.7 8.8 18.4 12.6 14.3 14.4 11.8 9.1 22.7 30.0 19.2 14.3 11.3 11.9 15.4 23.5 13.5 16.4 8.1 11.6 17.1 14.2 5.5 14.9 12.9 12.7 17.7 13.4 15.9 16.1 13.7 14.6 10.2 14.1 23.9 22.4 11.1 15.6 26.6 13.6 13.3 10.4 9.5 14.3 12.4 17.2 9.1 5.8 6.1 8.2 10.2 13.6 37.8 6.4 5.8 12.7 4.8 10.4 5.6 9.3 13.2 11.5 6.2 4.9 5.1 10.0 11.5 7.0 7.9 5.3 6.0 12.5 13.3 10.3 7.8 21.8 18.0 9.3 12.3 16.8 9.4 14.1 9.1 9.5 14.3 19.9 4.9 6.3 8.0 9.7 13.7 14.3 6.8 6.3 12.6 7.1 13.6 14.0 5.5 11.0 10.4 6.7 4.1 17.6 5.5 10.3 8.4 13.1 5.7 10.1 7.6 7.1 11.6 9.5 11.2 14.3 15.9 13.3 15.2 17.2 10.4 11.2 16.3 13.5 9.3 12.4 11.6 10.1 17.0 9.1 11.2 16.2 9.3 13.8 11.8 9.1 11.3 11.9 11.6 14.1 ZNF280C "FLJ20095, SUHW3, ZNF633" ENSG00000056277 "Zinc finger protein 280C" Q8ND82 X 130202711-130268899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051494, HPA055788" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051494: , HPA055788: " "unprognostic (2.97e-1)" "unprognostic (2.02e-1)" "unprognostic (3.97e-1)" "unprognostic (5.69e-3)" "unprognostic (2.98e-2)" "unprognostic (8.52e-2)" "unprognostic (1.16e-6)" "unprognostic (1.96e-2)" "unprognostic (3.33e-2)" "unprognostic (9.77e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-2)" "unprognostic (3.27e-8)" "unprognostic (1.71e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (6.85e-2)" 5.4 4.5 3.9 7.1 6.8 6.2 4.9 5.6 6.8 7.6 4.4 5.4 2.9 3.7 10.6 13.3 4.6 5.0 5.1 3.3 3.8 4.2 4.0 4.1 4.1 5.7 4.2 4.2 6.8 4.6 4.9 12.5 4.8 5.8 5.5 4.0 5.1 4.1 3.8 4.5 4.5 4.4 5.0 5.8 6.0 3.8 21.5 2.8 8.2 4.9 3.6 6.8 4.9 5.4 4.0 2.3 2.7 2.9 4.5 4.9 1.1 3.4 4.3 11.5 10.3 3.5 4.8 4.3 3.2 4.3 3.5 5.3 2.6 5.5 8.1 13.0 2.3 3.4 7.9 2.6 6.2 7.1 2.2 3.5 3.3 1.9 2.8 11.3 3.3 3.5 1.2 4.9 5.2 3.9 1.7 5.0 4.0 4.3 6.1 4.6 6.7 3.6 8.5 3.9 3.1 3.6 5.5 5.6 7.7 3.1 1.8 3.7 2.0 3.9 3.9 3.9 3.2 6.3 8.5 2.1 1.3 4.6 3.6 10.3 3.5 2.7 1.4 1.5 3.0 2.2 4.9 4.0 3.8 3.5 1.9 3.2 2.7 3.7 0.8 4.5 2.9 2.3 4.8 1.1 3.9 6.8 5.6 6.8 3.8 4.2 4.2 4.2 5.8 2.8 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630181-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 16.5 15.7 10.5 9.2 13.3 22.8 16.5 23.0 18.8 21.1 14.3 14.2 12.6 8.1 21.2 9.0 12.0 18.2 9.9 11.4 10.3 7.0 11.0 14.0 11.4 9.8 11.3 14.9 27.2 16.9 14.4 28.0 12.2 16.9 18.1 12.4 8.5 18.8 11.7 22.0 9.8 11.2 24.8 16.3 11.1 14.6 8.4 14.5 46.3 13.6 8.4 10.0 23.6 19.6 6.1 5.9 10.0 4.1 3.0 4.3 1.8 8.7 5.0 9.2 14.1 9.3 13.1 6.8 13.5 9.6 5.7 6.5 3.5 9.1 14.8 5.7 9.5 6.5 4.6 3.6 6.8 7.5 2.7 1.5 8.2 5.4 9.3 13.2 4.5 8.5 4.9 3.9 5.5 12.3 7.6 17.2 8.6 6.2 8.8 1.5 0.0 4.0 2.8 15.2 10.5 6.6 10.2 7.4 13.5 11.3 7.0 4.3 7.7 12.3 10.8 8.3 12.6 7.6 10.8 9.0 13.5 0.0 9.3 19.7 8.9 10.0 4.1 5.4 3.6 3.7 3.6 6.1 3.4 3.1 5.9 5.5 3.5 4.3 0.6 3.0 3.2 5.9 3.0 1.8 10.5 13.3 23.0 18.8 10.3 7.0 11.3 14.9 16.9 14.5 ZNF282 HUB1 ENSG00000170265 "Zinc finger protein 282" Q9UDV7 7 149195485-149226248 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024374 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024374: AB_1851322" "unprognostic (1.79e-1)" "unprognostic (6.97e-2)" "unprognostic (1.19e-3)" "unprognostic (5.23e-3)" "unprognostic (3.11e-2)" "unprognostic (3.70e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (2.73e-1)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" 13.6 11.7 12.6 12.7 11.5 17.5 13.1 20.7 18.1 19.1 16.1 16.6 16.8 17.7 17.9 14.1 17.9 17.2 18.1 12.5 10.2 8.4 12.4 14.4 12.3 11.2 10.8 11.8 18.5 26.6 12.2 12.3 24.9 10.8 21.4 7.8 13.3 17.8 15.8 20.7 19.5 14.5 15.1 8.9 15.2 14.6 6.4 12.9 14.2 14.1 16.3 12.7 17.0 13.8 3.9 2.4 3.5 1.8 1.8 3.4 1.0 11.5 11.5 6.8 16.2 6.0 7.1 10.0 10.6 7.8 9.4 9.4 10.5 12.7 11.7 16.0 6.6 12.9 7.9 10.1 3.6 17.6 28.1 9.8 7.5 8.8 8.9 12.3 11.1 8.1 13.7 9.0 9.9 9.7 18.8 9.2 5.0 13.6 25.8 18.2 21.9 14.5 16.9 6.6 16.2 5.1 11.2 15.4 14.8 11.7 14.2 9.7 9.1 12.0 12.1 13.4 3.0 16.0 15.3 13.3 7.9 8.7 11.2 10.7 11.4 0.0 1.8 3.5 2.1 1.5 2.3 0.9 2.7 2.1 1.0 3.9 1.4 1.8 1.8 1.8 1.7 2.4 3.4 1.0 12.6 11.5 20.7 18.1 10.2 8.4 10.8 11.8 10.8 12.9 ZNF286B "ZNF286C, ZNF286L, ZNF590" ENSG00000249459 "Zinc finger protein 286B" P0CG31 17 18658429-18682262 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA068125 Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA068125: " "unprognostic (3.15e-1)" "unprognostic (1.23e-1)" "unprognostic (3.81e-1)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.78e-2)" "unprognostic (1.47e-3)" "unprognostic (3.20e-1)" "unprognostic (5.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.05e-4)" "unprognostic (1.50e-1)" "unprognostic (9.20e-4)" "unprognostic (1.16e-1)" "unprognostic (3.82e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" 0.7 0.9 1.4 1.2 1.4 0.8 1.5 6.5 2.8 2.0 1.2 0.3 3.4 1.8 2.3 1.9 1.1 0.8 1.5 1.8 1.6 0.2 0.7 1.2 1.4 5.4 0.6 1.3 1.4 1.0 1.4 1.4 0.8 1.4 2.9 1.4 0.9 1.9 1.5 1.3 1.2 1.1 1.0 1.6 1.4 1.7 3.0 0.9 1.1 1.7 3.2 4.2 1.0 3.1 2.7 5.4 5.3 2.1 3.4 4.2 2.8 0.8 1.3 1.1 6.4 0.4 4.4 1.7 2.3 3.6 5.8 2.2 2.8 1.9 6.1 2.9 2.1 1.1 2.6 0.0 2.5 3.8 2.1 6.2 3.1 3.2 1.9 0.4 2.9 1.1 6.6 2.0 2.2 0.9 3.1 8.1 0.1 1.0 1.0 3.1 9.6 4.3 1.4 2.5 3.9 1.3 3.1 1.7 6.4 4.6 4.4 2.1 2.6 0.2 1.6 1.3 3.9 1.1 0.8 0.5 3.4 0.9 3.0 2.1 3.2 3.8 0.7 3.0 3.9 4.2 0.9 3.2 1.7 0.9 3.5 1.0 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87264196 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: " "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 11.8 10.2 15.2 16.7 16.8 31.1 14.5 31.1 19.7 15.0 13.9 10.3 11.4 11.2 16.4 15.1 11.1 11.1 9.8 11.6 13.6 9.0 9.8 10.8 9.7 14.8 18.2 9.8 20.6 12.5 14.6 20.7 12.3 15.3 14.0 10.2 12.0 15.0 11.2 9.3 14.0 15.7 12.3 18.6 12.2 11.6 8.7 19.6 25.6 14.1 5.7 16.5 22.6 22.9 16.7 10.4 35.8 7.6 4.3 8.3 3.0 6.2 3.7 12.6 11.1 7.3 6.6 13.2 4.9 6.3 5.8 8.1 6.3 4.4 9.7 7.2 6.4 6.5 7.8 7.4 12.7 21.9 5.9 13.1 4.8 5.1 5.4 10.4 6.0 6.5 7.3 5.7 7.5 5.3 9.5 15.0 6.3 3.5 6.0 9.4 6.3 3.4 12.7 12.6 3.7 5.2 13.6 9.4 13.3 6.2 4.2 4.7 4.2 12.6 6.0 7.8 5.5 5.7 7.7 13.9 9.0 6.6 8.6 9.1 5.6 18.0 7.6 7.9 6.9 2.2 6.5 16.6 7.4 7.5 3.2 16.7 8.3 7.1 35.8 4.3 2.3 10.4 7.1 3.0 15.2 16.8 31.1 19.7 13.6 9.0 18.2 9.8 15.3 19.6 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.8;lymphoid tissue: 26.2" "Cell line enhanced" "Detected in many" "Daudi: 16.3;SK-BR-3: 11.0;U-698: 19.1" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA046940: , HPA049576: " "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 1.4 0.8 2.4 22.8 3.4 10.5 7.3 6.6 1.4 3.0 7.1 0.4 3.2 6.4 1.0 1.2 11.3 1.4 4.0 1.4 2.0 1.7 1.4 1.0 3.4 15.9 1.1 0.1 0.6 2.7 0.3 3.5 0.7 0.8 2.4 1.0 0.8 13.8 3.4 0.8 6.2 10.1 0.6 1.3 16.9 5.5 2.6 0.6 4.3 1.7 9.5 26.2 2.0 2.7 29.8 26.7 14.7 6.2 14.7 3.5 2.6 3.0 2.1 0.0 0.4 0.0 0.2 1.7 0.5 0.0 0.2 0.2 3.4 1.2 16.3 1.9 0.1 5.7 0.8 1.3 0.0 3.4 4.3 4.8 0.9 3.3 0.9 2.7 5.1 0.7 0.6 0.7 0.0 0.4 3.4 5.8 0.0 4.6 0.2 4.5 1.9 4.3 9.1 0.0 9.8 0.4 1.1 3.1 0.3 2.0 11.0 0.1 2.4 5.4 1.1 0.0 1.7 0.1 0.0 6.0 6.0 19.1 0.1 3.4 0.1 14.7 3.6 5.7 3.0 6.2 3.5 29.8 1.6 3.3 8.8 22.4 0.7 1.7 1.8 14.7 5.8 26.7 1.4 2.6 2.4 3.4 6.6 1.4 2.0 1.7 1.1 0.1 0.8 0.6 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favourable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.7 8.2 3.5 8.8 6.4 4.1 0.1 3.6 2.6 3.4 3.7 5.8 1.2 0.0 4.8 2.3 2.3 10.1 5.2 4.2 0.0 4.8 2.7 4.5 4.4 3.2 3.6 2.5 3.5 4.6 3.4 4.5 5.2 8.8 0.0 5.3 2.8 2.6 1.6 4.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.7 0.0 0.1 3.4 3.3 1.0 3.8 7.1 3.7 2.6 4.9 2.4 11.6 1.0 1.4 0.0 4.1 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.2;HeLa: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 3.8" "Low lineage specificity" "Detected in all" "HPA028975, HPA051777" Uncertain Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA028975: , HPA051777: " "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavourable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 4.5 1.3 4.8 4.0 12.0 3.6 7.2 12.5 6.4 7.4 4.3 5.4 4.1 4.1 11.7 5.3 7.5 5.4 5.4 4.0 7.5 3.2 7.3 1.5 3.0 4.4 8.2 2.4 16.6 7.3 1.0 7.3 2.4 7.4 7.0 4.4 3.6 3.8 3.9 1.5 6.9 5.8 6.4 9.2 5.1 7.1 14.9 9.1 1.5 9.3 2.7 4.4 5.5 6.2 3.8 1.2 1.1 1.5 1.7 1.0 0.8 1.2 2.8 17.2 0.0 1.5 3.6 0.0 4.2 3.3 3.7 5.4 1.4 2.1 0.0 3.7 3.5 2.5 0.0 9.6 5.8 0.0 5.6 0.0 18.9 2.2 3.1 0.1 0.0 5.5 3.0 7.7 9.1 6.3 0.0 9.1 3.6 0.0 0.0 0.8 16.5 0.0 0.0 2.5 4.9 2.7 3.1 9.7 16.1 9.9 8.6 5.7 5.7 0.0 2.7 5.0 2.1 3.6 7.6 0.3 0.1 0.0 0.5 0.1 10.3 0.0 0.6 1.1 0.7 1.5 0.1 0.9 1.0 0.0 1.2 3.8 0.7 0.4 0.2 1.7 0.1 0.1 0.0 0.8 4.8 12.0 12.5 6.4 7.5 3.2 8.2 2.4 7.4 9.1 ZNF302 "ZNF135L, ZNF140L, ZNF327" ENSG00000089335 "Zinc finger protein 302" Q9NR11 19 34677639-34686397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059503 Approved "Vesicles,Cytokinetic bridge" "Vesicles, Cytokinetic bridge" "HPA059503: " "unprognostic (3.52e-1)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (2.03e-5)" "unprognostic (2.25e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-3)" "unprognostic (1.82e-2)" "unprognostic (4.63e-2)" "unprognostic (3.39e-2)" "prognostic unfavourable (5.41e-4)" "unprognostic (2.34e-1)" "unprognostic (1.21e-1)" "unprognostic (3.94e-2)" "prognostic favourable (9.85e-5)" 12.4 18.0 21.8 12.5 23.7 3.5 23.6 36.5 22.5 16.0 14.3 14.7 16.5 11.7 19.2 21.3 10.0 18.7 10.6 23.6 22.2 18.1 16.4 17.1 13.8 15.5 26.8 18.4 28.6 19.1 26.7 22.8 11.8 21.4 19.1 15.1 13.0 12.4 21.8 29.8 12.4 12.1 18.4 22.8 15.5 12.3 14.0 25.7 12.6 18.8 10.2 15.3 13.7 9.7 17.3 14.1 14.4 7.8 12.0 21.1 6.0 5.7 9.0 18.6 7.2 17.6 13.9 6.4 9.9 12.3 9.2 10.0 6.6 4.8 8.9 12.5 7.2 4.5 9.0 5.6 9.9 0.6 7.7 17.1 9.7 0.2 9.7 0.1 1.2 12.7 8.5 5.3 0.8 7.8 0.0 0.1 14.2 3.0 8.8 9.0 8.3 5.9 6.8 15.5 4.6 9.5 7.5 8.3 13.7 9.0 2.9 11.8 6.7 13.6 7.5 4.0 10.0 3.4 4.8 10.7 18.7 2.8 3.8 1.2 18.8 14.4 7.0 11.2 10.9 6.3 14.8 15.0 12.3 10.2 5.8 17.3 21.1 16.3 3.9 12.0 7.8 14.1 9.6 6.0 21.8 23.7 36.5 22.5 22.2 18.1 26.8 18.4 21.4 25.7 ZNF318 "HRIHFB2436, ZFP318" ENSG00000171467 "Zinc finger protein 318" Q5VUA4 6 43307134-43369478 "Predicted intracellular proteins" "Meiosis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 6.3" "Lineage enriched" "Detected in many" 4 "B-cells: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027022, HPA027031" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027022: AB_1859189, HPA027031: AB_1859190" "unprognostic (1.64e-1)" "unprognostic (3.80e-1)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (1.97e-2)" "unprognostic (3.02e-2)" "unprognostic (2.53e-3)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (3.37e-2)" "unprognostic (8.24e-2)" "unprognostic (3.47e-1)" "unprognostic (4.61e-3)" "unprognostic (3.61e-1)" "unprognostic (3.00e-1)" "unprognostic (2.82e-1)" "unprognostic (1.54e-2)" 8.3 7.1 14.2 15.3 13.7 9.9 12.2 24.7 17.7 12.5 8.9 10.4 9.2 7.1 12.7 11.1 7.0 9.0 7.1 7.6 12.8 6.3 7.3 8.3 9.2 23.6 15.4 9.4 13.2 8.6 14.6 8.0 7.9 11.4 10.2 8.2 7.9 7.9 8.6 8.6 11.7 10.0 9.2 9.0 14.6 6.8 39.2 16.8 10.0 13.7 4.7 23.6 9.8 10.9 6.3 0.9 0.4 0.7 0.7 1.4 0.5 16.1 4.1 11.9 19.7 10.4 9.4 5.8 7.0 9.3 8.5 7.5 4.2 2.1 25.8 4.0 9.3 7.4 13.2 6.2 11.2 6.7 6.7 7.1 5.2 6.8 5.2 12.6 5.8 6.0 6.5 7.2 6.4 6.6 9.5 12.9 9.0 5.7 3.8 8.1 5.3 3.9 4.7 11.5 4.1 4.8 3.9 10.9 6.7 5.5 4.8 5.8 6.0 17.7 6.6 12.1 6.0 8.0 7.0 7.7 6.2 18.4 3.8 9.7 6.7 0.0 0.7 0.0 1.4 0.5 0.4 1.4 1.2 0.9 0.9 6.3 0.9 1.0 0.4 0.7 0.4 0.7 1.2 0.5 14.2 13.7 24.7 17.7 12.8 6.3 15.4 9.4 11.4 16.8 ZNF32 KOX30 ENSG00000169740 "Zinc finger protein 32" P17041 10 43643859-43648856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA039148: " "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavourable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favourable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 14.4 16.2 24.4 12.4 23.6 4.4 29.2 21.1 20.1 20.2 20.4 19.0 18.0 7.9 21.9 37.7 12.6 20.7 14.7 26.1 22.2 20.8 22.1 17.7 13.7 12.2 27.7 17.7 28.7 26.0 18.7 20.3 10.3 22.5 22.5 15.1 14.7 18.5 25.4 45.7 14.4 11.0 23.4 19.8 14.2 14.5 8.6 25.8 15.4 25.8 14.5 15.4 17.9 25.4 14.2 11.2 8.5 6.9 23.0 21.7 10.3 9.8 8.8 13.3 20.1 24.6 26.6 4.3 8.8 26.8 16.6 15.0 5.9 5.1 0.0 15.7 18.8 5.9 8.5 8.6 12.2 10.8 9.4 2.6 5.5 6.8 23.1 0.2 8.1 27.2 19.9 10.2 12.5 12.5 7.6 0.0 20.8 9.0 9.8 9.0 10.3 4.6 15.2 15.0 2.2 16.6 3.9 17.1 15.2 7.3 5.4 13.8 20.1 9.2 5.3 9.3 11.3 6.7 2.1 5.9 15.5 0.0 3.3 6.3 8.6 4.1 6.9 8.5 19.3 6.1 19.1 13.3 15.5 21.4 11.2 14.2 20.0 21.7 0.6 23.0 5.4 9.5 10.8 10.3 24.4 23.6 21.1 20.1 22.2 20.8 27.7 17.7 22.5 25.8 ZNF320 "DKFZp686G16228, ZFPL" ENSG00000182986 "Zinc finger protein 320" A2RRD8 19 52863790-52897693 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.0;U-266/84: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: " "unprognostic (3.33e-2)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.25e-1)" "unprognostic (2.92e-2)" "unprognostic (7.12e-2)" "unprognostic (1.47e-4)" "unprognostic (8.90e-2)" "unprognostic (3.71e-3)" "unprognostic (2.75e-3)" "unprognostic (2.50e-1)" "unprognostic (2.01e-3)" "unprognostic (6.41e-3)" "unprognostic (1.32e-1)" "unprognostic (2.76e-1)" "unprognostic (7.65e-2)" "unprognostic (2.61e-3)" 6.3 8.6 10.5 8.7 11.7 8.3 9.9 15.5 12.2 10.8 9.9 9.4 27.7 7.1 13.8 12.7 7.0 11.3 9.5 9.8 9.0 7.0 11.8 2.5 7.1 6.8 9.1 10.1 15.5 10.3 17.7 15.7 15.7 10.9 12.1 10.9 9.7 9.7 23.8 7.4 13.1 7.8 8.6 11.4 9.8 8.7 6.3 12.6 8.9 13.0 5.3 6.8 19.4 11.0 5.0 3.7 5.9 3.4 10.1 5.1 2.6 3.4 0.3 4.6 10.6 0.7 1.6 8.0 1.7 1.6 2.9 3.9 1.4 1.2 3.1 3.2 2.1 1.8 0.0 0.6 1.3 0.0 1.2 4.0 4.8 0.0 2.1 0.4 4.2 2.6 1.6 3.7 0.4 2.0 3.4 0.5 2.3 0.0 3.5 3.5 5.4 3.2 4.1 5.8 4.2 1.6 24.0 4.0 8.3 0.1 2.7 1.6 2.9 0.0 2.2 1.6 3.5 0.7 3.4 6.2 19.8 2.8 0.1 0.1 2.3 3.1 3.3 2.6 3.9 3.4 3.5 3.2 2.6 2.9 2.6 5.0 4.7 5.1 5.9 10.1 2.6 3.7 2.5 2.6 10.5 11.7 15.5 12.2 9.0 7.0 9.1 10.1 10.9 12.6 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA043161: , HPA046692: " "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favourable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favourable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 8.8 9.7 7.7 5.4 10.9 0.4 10.1 10.6 15.4 13.1 8.6 7.9 9.5 6.9 12.7 10.8 6.8 9.2 11.5 13.3 8.4 6.9 9.5 7.0 7.9 6.7 8.8 7.0 14.8 6.9 15.0 18.0 8.6 11.8 12.3 8.6 8.6 8.2 15.5 7.7 5.0 7.9 9.7 10.7 8.7 7.6 8.2 12.5 4.3 13.6 6.7 7.2 11.8 8.4 11.2 7.9 10.5 11.2 17.6 11.4 4.9 5.7 4.4 17.3 19.8 11.4 15.2 6.2 7.7 10.2 10.8 13.1 8.5 3.6 7.0 18.6 6.7 7.3 12.8 5.0 13.5 10.8 11.6 12.3 5.7 8.3 12.9 0.0 11.2 9.3 17.7 7.1 8.1 9.3 14.1 7.5 11.8 3.3 8.6 10.3 5.0 5.3 9.7 12.2 9.9 6.7 9.2 14.0 14.8 9.2 8.7 16.2 8.1 8.0 9.2 18.0 7.2 7.3 7.8 7.9 15.8 6.7 3.9 2.0 18.1 3.3 8.7 10.5 11.4 7.4 8.3 11.2 5.8 7.4 7.0 10.5 6.8 9.9 8.3 17.6 11.2 7.9 4.4 4.9 7.7 10.9 10.6 15.4 8.4 6.9 8.8 7.0 11.8 12.5 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favourable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favourable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavourable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.0 5.1 3.5 5.3 4.0 3.5 3.8 3.3 4.1 3.3 3.0 4.5 2.0 6.3 3.1 2.7 5.1 4.5 4.5 1.6 5.5 34.8 4.4 3.9 2.1 3.2 7.3 5.2 2.6 5.6 4.7 2.2 2.3 6.2 4.1 3.6 3.3 6.5 4.0 2.8 7.8 7.0 4.4 4.0 2.4 8.2 7.1 5.6 3.6 5.8 2.5 2.9 5.3 4.1 10.0 2.2 3.5 5.6 6.0 6.0 3.2 5.0 3.6 3.1 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451604-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "NK-cell: 8.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 8.3" HPA023400 Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favourable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 7.4 6.2 6.9 8.3 12.4 5.0 9.0 11.4 12.6 8.7 5.9 7.6 9.8 5.9 8.5 5.0 8.4 9.0 6.8 4.7 6.6 5.5 6.2 6.6 7.3 6.8 9.1 7.0 10.2 10.1 8.0 8.4 4.8 8.8 7.5 6.1 8.4 8.9 8.5 8.2 11.2 6.0 7.4 5.3 10.3 8.0 11.3 9.3 9.4 8.0 6.0 6.4 9.3 6.9 1.1 0.6 1.3 1.0 8.3 1.3 0.7 4.2 7.1 3.9 6.4 2.8 2.4 2.8 3.8 2.8 3.1 2.3 2.5 1.8 5.8 2.4 2.2 3.6 5.1 3.5 2.4 5.8 28.8 5.0 5.3 1.0 2.9 8.1 7.4 2.4 3.6 3.5 3.0 2.2 7.2 3.5 3.2 2.8 6.0 1.9 2.1 4.1 5.7 5.1 3.4 2.0 8.5 9.3 5.3 3.6 5.9 0.9 2.2 2.3 2.6 7.5 1.9 4.0 6.1 7.7 6.9 4.3 3.0 3.5 2.9 0.0 1.0 0.1 1.3 0.6 0.9 0.5 0.6 0.9 0.6 1.1 1.3 0.9 1.3 8.3 0.4 0.6 0.4 0.7 6.9 12.4 11.4 12.6 6.6 5.5 9.1 7.0 8.8 9.3 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995112-90035531 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: , HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favourable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favourable (2.84e-4)" 12.7 13.4 18.4 12.7 27.8 45.2 17.7 20.2 18.5 11.8 14.1 23.2 16.3 18.5 18.3 17.1 17.5 11.9 13.9 12.5 19.2 15.2 13.4 15.2 11.5 15.3 26.1 14.1 21.8 20.2 14.4 18.0 14.5 22.8 13.3 20.7 23.9 15.7 9.4 19.2 14.5 18.9 17.8 31.3 11.0 14.6 10.6 27.8 17.3 14.1 10.5 15.1 11.9 17.2 6.8 8.4 3.6 6.1 7.8 4.3 2.2 16.9 15.5 24.1 11.5 10.8 5.1 25.5 17.2 6.7 14.3 8.9 14.4 12.3 21.2 12.3 8.8 15.3 25.1 11.2 19.6 12.4 12.0 19.1 15.1 13.0 3.6 22.4 9.4 4.5 5.3 14.2 9.0 8.2 25.5 9.3 11.4 8.0 23.1 12.8 22.7 17.6 16.5 24.5 5.7 11.8 19.0 21.2 13.8 19.8 18.4 8.4 10.1 5.9 11.2 16.8 16.9 14.1 17.0 7.9 7.7 21.2 4.0 17.7 10.7 2.1 5.1 3.6 4.0 6.1 3.2 4.2 3.2 3.4 4.0 6.8 3.2 4.3 2.5 7.8 4.6 8.4 2.8 2.2 18.4 27.8 20.2 18.5 19.2 15.2 26.1 14.1 22.8 27.8 ZNF329 FLJ12586 ENSG00000181894 "Zinc finger protein 329" Q86UD4 19 58126252-58155110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044373 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA044373: AB_10966569" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (6.01e-2)" "unprognostic (2.58e-1)" "unprognostic (6.53e-3)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "prognostic favourable (8.58e-9)" "unprognostic (9.23e-2)" "unprognostic (1.37e-2)" "unprognostic (1.78e-2)" "unprognostic (2.52e-1)" 7.1 7.2 9.2 5.2 11.7 10.3 11.7 15.9 14.7 10.8 6.9 8.1 5.7 3.5 10.6 10.7 5.6 10.5 7.0 6.7 9.2 10.0 11.8 8.0 6.9 6.8 8.5 6.7 11.2 5.4 20.4 10.7 7.9 10.6 10.1 6.1 9.7 7.1 9.1 2.7 7.2 5.9 9.6 6.5 8.2 6.1 23.7 7.6 8.6 11.3 3.5 8.0 8.7 15.1 8.0 5.0 6.4 1.7 5.3 7.6 2.2 3.2 1.7 7.6 13.2 6.2 6.4 0.1 4.2 8.9 4.6 3.5 1.4 2.5 2.0 2.3 7.5 1.1 1.3 5.8 5.6 1.5 10.3 6.6 2.3 2.4 6.0 3.9 6.4 6.6 6.2 4.5 9.2 5.9 1.6 8.8 6.5 1.1 6.7 2.4 5.7 5.6 3.7 7.5 2.0 4.9 6.5 5.1 4.8 6.7 0.8 3.3 7.6 2.2 3.6 12.0 3.3 1.1 0.0 5.2 15.3 4.8 2.6 0.1 6.9 4.8 1.6 6.4 2.5 1.7 4.4 5.8 4.8 4.3 2.1 8.0 7.6 4.6 4.9 5.3 1.1 5.0 2.1 2.2 9.2 11.7 15.9 14.7 9.2 10.0 8.5 6.7 10.6 7.6 ZNF334 bA179N14.1 ENSG00000198185 "Zinc finger protein 334" Q9HCZ1 20 46499630-46513559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.9;BEWO: 16.2;NTERA-2: 8.7;SCLC-21H: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NK-cell: 2.7;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 5 "dendritic cells: 3.6;NK-cells: 2.7" "Low region specificity" "Detected in all" HPA050022 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA050022: " "unprognostic (3.04e-2)" "unprognostic (1.28e-2)" "unprognostic (3.68e-1)" "unprognostic (2.74e-4)" "unprognostic (9.08e-2)" "unprognostic (5.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (3.62e-2)" "unprognostic (8.25e-2)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.55e-3)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "unprognostic (1.71e-3)" 3.1 7.3 11.1 2.2 14.3 1.9 9.5 18.2 12.0 6.4 2.6 8.1 11.5 2.9 9.2 13.4 2.4 12.1 5.8 2.1 9.8 7.8 6.8 4.1 4.7 2.1 5.8 6.9 22.5 7.5 2.9 20.4 7.0 11.5 12.8 3.5 7.0 6.8 10.0 1.5 3.0 3.8 4.9 7.6 3.1 7.0 8.3 8.8 2.7 10.8 1.7 1.8 5.2 4.5 0.4 3.6 0.2 0.5 2.7 0.1 0.1 0.0 0.0 12.9 0.1 0.9 0.1 16.2 1.1 0.1 1.0 0.1 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.2 0.5 0.0 2.7 4.1 0.1 4.6 3.5 0.1 0.0 4.2 0.0 1.1 0.0 0.1 2.7 0.0 0.1 0.0 0.0 7.3 8.7 1.1 0.0 0.0 0.0 3.5 3.1 10.8 6.1 0.0 0.3 0.2 0.0 3.6 0.0 0.1 5.9 0.1 0.0 1.0 5.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.1 2.7 0.0 3.6 0.0 0.1 11.1 14.3 18.2 12.0 9.8 7.8 5.8 6.9 11.5 8.8 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25674215-25696841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA044303: , HPA064219: " "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavourable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 10.4 9.8 11.7 9.0 14.3 10.8 13.6 49.5 14.8 17.9 14.6 16.1 13.3 7.0 19.8 19.4 9.6 18.0 9.0 8.4 10.9 9.8 9.4 6.9 13.5 12.3 15.1 14.2 23.1 8.4 20.3 19.0 9.3 11.2 16.6 10.9 11.0 8.6 17.2 11.9 12.9 11.1 15.4 9.4 13.4 8.7 7.0 14.9 19.0 12.2 6.0 11.0 14.3 26.1 3.8 3.9 4.8 3.9 5.3 9.6 3.8 7.8 14.5 11.6 8.1 9.4 12.0 9.7 6.9 6.1 5.4 6.7 2.9 7.4 10.0 6.6 6.2 12.9 7.8 22.3 7.4 3.6 6.1 6.2 9.4 12.6 8.3 5.5 6.7 11.1 20.0 6.2 18.5 8.3 5.4 8.9 10.3 8.9 15.0 10.2 3.1 10.3 9.4 10.9 4.9 5.5 8.7 9.5 10.1 7.0 11.1 9.3 6.5 7.7 11.0 11.5 6.1 7.6 8.9 12.5 6.7 3.6 5.5 4.7 9.2 0.0 2.4 4.8 7.2 3.9 7.9 3.8 6.0 6.8 3.9 3.2 8.4 9.6 0.1 5.3 2.2 3.9 3.9 3.8 11.7 14.3 49.5 14.8 10.9 9.8 15.1 14.2 11.2 14.9 ZNF33A "FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK" ENSG00000189180 "Zinc finger protein 33A" Q06730 10 38010650-38065088 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: " "unprognostic (1.85e-2)" "unprognostic (1.19e-1)" "unprognostic (7.68e-3)" "unprognostic (1.48e-1)" "unprognostic (3.42e-2)" "unprognostic (1.69e-3)" "unprognostic (7.96e-3)" "unprognostic (4.89e-3)" "unprognostic (6.73e-2)" "unprognostic (9.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (6.83e-2)" "unprognostic (7.39e-3)" 11.7 13.9 10.6 18.5 13.2 10.9 19.4 34.6 15.9 17.1 14.4 8.9 31.3 13.7 16.1 17.9 14.1 16.2 12.4 11.5 13.5 10.9 16.8 16.9 12.0 14.2 18.2 13.5 16.3 21.8 24.1 49.7 12.0 18.8 17.7 17.0 9.7 18.9 27.7 16.7 14.4 16.9 17.8 17.3 17.4 17.1 6.4 16.4 12.8 18.9 11.0 16.7 16.1 15.9 7.0 6.8 17.2 6.5 4.8 6.8 3.2 10.8 6.1 11.5 9.6 5.5 7.3 8.9 4.9 4.9 6.4 7.1 6.6 9.9 21.2 5.4 6.6 7.2 13.6 8.7 6.0 12.7 15.1 16.8 12.1 8.9 5.7 23.7 14.1 6.2 15.9 4.7 7.3 5.4 8.8 11.4 6.4 7.0 9.8 5.5 11.5 7.2 8.5 7.7 9.8 9.1 10.1 8.7 13.8 7.6 8.5 4.4 10.4 6.4 4.9 5.6 8.3 6.2 3.9 9.0 11.0 12.8 5.2 13.3 2.6 9.6 3.8 6.3 6.2 5.4 5.5 7.0 5.5 4.1 3.6 7.0 6.8 5.3 17.2 4.8 6.5 6.8 3.7 3.2 10.6 13.2 34.6 15.9 13.5 10.9 18.2 13.5 18.8 16.4 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638568 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: " "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 6.6 8.0 6.1 8.0 6.3 1.9 16.1 19.1 8.0 10.2 9.8 2.2 16.5 6.8 9.3 8.6 8.6 15.0 6.6 4.6 5.6 8.1 16.7 8.2 6.9 8.3 5.1 8.5 19.4 31.8 16.6 29.9 8.1 9.3 14.1 8.2 5.2 16.4 13.9 4.8 9.5 11.4 7.8 5.0 10.9 11.0 3.8 2.8 10.8 20.8 4.1 6.6 11.0 10.2 14.8 8.6 11.3 6.1 6.1 16.9 8.5 9.5 2.4 6.5 6.6 2.4 0.3 8.1 6.3 4.6 3.9 5.4 5.3 11.1 14.4 3.7 2.2 8.2 12.4 4.1 4.4 8.5 9.3 5.7 8.9 8.7 2.8 13.6 4.7 3.9 15.3 2.4 13.0 3.3 7.8 11.0 2.3 4.1 5.3 3.2 7.0 5.8 5.8 6.4 6.1 10.3 13.6 11.7 11.4 3.8 7.9 3.7 10.1 4.1 4.0 2.0 9.5 3.4 6.3 7.2 10.9 4.5 1.4 10.3 1.8 11.3 6.1 5.3 9.0 5.0 12.8 14.8 13.2 9.1 5.3 12.6 16.9 11.9 1.9 6.1 3.9 8.6 10.3 8.5 6.1 6.3 19.1 8.0 5.6 8.1 5.1 8.5 9.3 2.8 ZNF34 KOX32 ENSG00000196378 "Zinc finger protein 34" Q8IZ26 8 144773114-144787345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA053925, HPA060755, HPA066805" Uncertain Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA053925: , HPA060755: , HPA066805: " "unprognostic (2.54e-1)" "unprognostic (3.50e-1)" "unprognostic (5.01e-2)" "unprognostic (7.60e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-2)" "unprognostic (2.85e-2)" "unprognostic (1.40e-2)" "unprognostic (9.84e-3)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (5.80e-2)" "unprognostic (2.09e-3)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" 9.0 5.7 12.3 4.1 11.5 4.6 8.6 28.5 14.4 10.0 9.4 12.6 7.8 3.6 10.0 8.0 6.3 10.4 6.6 7.5 13.4 7.8 6.4 6.5 7.5 5.8 17.2 13.8 17.0 7.8 12.5 11.5 7.6 12.2 8.7 6.0 8.3 5.6 12.7 5.9 8.0 5.4 10.7 11.8 6.0 5.9 7.1 16.0 4.1 11.1 1.8 4.7 8.7 7.8 7.2 10.4 12.7 15.2 5.5 8.5 5.0 3.0 5.2 8.8 6.6 7.5 7.4 2.3 2.8 6.1 7.2 6.1 1.2 5.0 4.9 5.4 7.2 3.1 5.0 5.8 5.4 4.8 4.3 9.5 8.1 4.0 6.8 2.5 4.9 7.8 6.7 5.8 11.7 4.9 6.3 4.1 6.3 7.7 5.5 3.9 6.4 5.5 5.0 3.5 5.9 4.0 3.1 8.3 6.2 6.6 4.6 4.4 5.3 3.2 3.4 6.7 5.9 5.6 5.5 5.1 1.7 5.7 4.9 4.1 7.9 8.1 7.0 12.7 7.4 6.4 6.5 6.8 6.9 8.5 10.4 7.2 4.9 7.4 1.0 5.5 15.2 4.9 5.4 5.0 12.3 11.5 28.5 14.4 13.4 7.8 17.2 13.8 12.2 16.0 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: " "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favourable (3.93e-4)" "prognostic unfavourable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.1 3.0 4.0 2.9 2.1 11.0 2.8 1.7 2.7 1.3 6.1 5.2 3.7 3.7 1.9 3.5 2.7 4.8 0.9 3.6 2.7 4.2 3.3 2.8 1.0 2.4 4.6 2.0 2.9 2.1 1.2 2.7 2.2 1.5 2.3 3.7 2.2 1.0 2.5 4.2 2.5 1.3 1.8 1.5 6.2 2.1 1.9 8.1 5.4 1.0 6.2 2.1 2.1 3.5 1.2 0.8 2.2 1.2 1.6 2.9 4.3 1.6 2.6 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 ZNF350 "ZBRK1, ZFQR" ENSG00000256683 "Zinc finger protein 350" Q9GZX5 19 51964343-51986856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001521 Uncertain Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA001521: AB_1080705" "unprognostic (7.26e-3)" "unprognostic (4.02e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.03e-2)" "unprognostic (4.17e-2)" "unprognostic (7.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.08e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.25e-3)" "unprognostic (6.64e-3)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (8.30e-2)" "prognostic favourable (2.54e-4)" 10.5 6.5 10.1 5.9 14.4 25.6 16.3 19.9 10.2 8.8 8.3 9.2 7.1 6.4 9.8 10.3 8.0 7.5 6.3 8.4 13.4 6.5 9.0 6.3 7.5 10.1 14.8 10.9 10.6 6.9 9.0 14.2 10.4 10.0 32.1 10.7 6.3 8.3 8.0 10.3 9.5 12.9 7.9 14.9 11.4 8.5 8.1 14.0 13.6 12.5 6.7 10.1 11.6 7.6 10.1 8.4 29.8 9.0 13.0 12.0 4.9 0.7 4.4 5.6 6.5 7.7 6.7 1.1 4.7 6.2 4.6 9.5 0.0 3.3 2.0 3.6 5.2 5.5 5.0 6.5 6.4 0.0 10.0 8.0 6.8 3.9 6.4 2.0 10.2 10.3 9.7 6.2 7.1 5.4 2.1 0.1 5.7 2.6 7.9 9.4 3.5 6.5 3.8 8.3 6.3 7.5 11.5 4.6 6.2 0.0 5.7 4.6 9.5 7.4 5.6 5.1 3.7 3.0 4.5 1.6 2.5 2.6 1.0 0.1 5.5 29.8 7.1 15.6 10.6 7.8 10.8 10.1 10.2 10.2 8.4 10.0 12.0 9.5 19.4 13.0 9.0 5.5 8.1 4.9 10.1 14.4 19.9 10.2 13.4 6.5 14.8 10.9 10.0 14.0 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA052043: " "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favourable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavourable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.2 3.3 7.0 18.5 12.2 9.9 29.0 4.9 6.6 6.9 7.4 4.9 7.2 5.7 6.5 4.5 8.5 2.6 21.0 10.6 7.6 8.0 1.7 4.2 0.6 9.3 0.0 4.8 7.7 13.5 6.0 12.4 6.5 1.4 0.0 9.9 8.6 8.5 5.7 6.1 8.7 6.4 1.2 3.6 6.4 4.3 7.7 8.4 6.2 7.1 9.5 5.8 8.4 5.0 7.8 5.1 4.4 4.2 1.9 3.9 3.6 0.2 1.3 9.7 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060415-179083537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030904 Uncertain Supported "Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" "HPA030904: AB_10603842" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 6.4 4.9 6.6 4.6 7.9 1.2 8.2 12.9 8.9 9.3 7.4 7.7 6.5 2.6 10.6 4.1 5.6 7.8 5.4 5.6 7.7 3.4 4.6 3.0 6.6 6.5 9.4 5.3 15.0 5.3 3.4 3.5 6.5 6.7 9.0 3.5 5.7 4.3 7.3 5.5 4.1 5.1 8.8 5.7 6.4 5.3 4.5 9.3 5.5 9.8 3.1 6.8 6.5 10.5 1.3 0.9 0.8 2.0 1.5 3.3 1.5 0.8 1.2 9.6 15.5 5.1 8.2 0.0 4.3 3.8 4.8 5.5 0.0 1.9 0.0 5.2 4.7 3.0 0.0 1.5 9.2 0.0 0.1 0.0 0.4 0.0 4.8 0.0 2.2 6.1 1.4 4.8 0.0 2.3 0.1 0.0 5.7 0.5 8.8 0.0 6.9 0.0 0.0 0.0 0.0 1.8 0.3 6.0 10.0 6.9 0.1 4.6 4.0 3.6 2.8 0.0 6.5 4.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.5 0.5 2.2 0.9 2.2 1.3 2.9 2.0 0.9 1.3 3.3 2.8 0.0 1.5 2.0 0.1 1.7 1.5 6.6 7.9 12.9 8.4 7.7 3.4 9.4 5.3 6.7 9.3 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256545-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA059239: " "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 21.6 14.0 18.1 12.0 17.2 8.9 21.7 24.5 30.5 18.6 17.3 13.8 9.6 11.0 23.7 23.8 14.2 20.1 20.7 28.0 15.4 13.8 16.8 8.8 18.7 26.3 12.8 15.6 23.3 19.9 16.4 19.1 17.9 12.3 20.4 8.8 27.4 22.8 21.7 26.1 23.5 11.6 28.1 13.1 22.6 14.0 8.5 10.3 17.9 17.4 14.1 15.3 20.1 15.4 6.0 8.3 6.0 4.6 4.2 4.7 2.5 3.3 5.4 23.4 9.3 6.2 4.3 15.4 4.6 5.5 5.8 6.1 5.5 11.3 1.7 10.2 5.8 11.1 5.4 2.6 2.4 9.9 4.9 8.4 3.2 6.7 5.5 4.0 6.9 9.3 6.5 2.5 2.2 7.8 0.9 2.9 4.4 8.0 12.9 6.6 13.9 5.1 21.0 5.6 0.7 4.6 5.3 8.3 25.1 13.2 4.2 20.7 4.0 10.3 11.3 3.5 4.7 8.2 3.0 8.8 8.1 1.8 2.8 3.6 10.2 3.8 4.6 6.0 4.7 4.1 3.4 3.0 3.5 4.1 3.3 6.0 3.1 2.9 3.5 4.2 4.5 8.3 2.6 2.5 18.1 17.2 24.5 30.5 15.4 13.8 12.8 15.6 12.3 10.3 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell line enhanced" "Detected in many" "HaCaT: 17.2;PC-3: 11.1;U-251 MG: 14.3;U-87 MG: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" "Vesicles, Centriolar satellite" "HPA052446: " "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 17.2 0.5 0.3 2.9 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.8 0.8 0.7 0.4 0.6 4.2 2.1 0.7 0.5 0.8 11.1 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.1 0.3 3.1 1.2 5.6 0.6 14.3 0.2 0.5 0.3 10.2 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 ZNF383 FLJ35863 ENSG00000188283 "Zinc finger protein 383" Q8NA42 19 37217926-37248738 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063945 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA063945: " "unprognostic (1.92e-1)" "unprognostic (1.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.26e-2)" "unprognostic (3.72e-3)" "unprognostic (1.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.27e-3)" "unprognostic (1.66e-2)" "unprognostic (1.27e-1)" "prognostic favourable (9.97e-4)" "unprognostic (7.40e-2)" "unprognostic (5.44e-2)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.01e-3)" "prognostic favourable (3.71e-4)" 9.1 7.5 9.3 10.4 12.1 6.9 10.7 20.4 10.8 9.1 8.2 12.6 10.4 7.5 11.6 7.8 8.9 8.2 6.1 9.6 8.7 6.9 9.3 7.4 7.2 11.3 14.2 6.5 12.9 9.2 9.4 11.0 6.5 11.8 9.6 7.4 8.7 8.5 8.7 14.0 11.8 9.5 10.8 13.7 10.8 8.4 10.5 12.1 13.2 11.4 5.7 11.9 10.2 9.4 11.4 4.0 6.3 5.4 5.7 11.6 4.8 3.7 8.5 6.0 9.1 7.4 7.7 3.9 5.1 7.1 5.2 7.9 3.9 4.5 5.1 7.9 4.9 3.8 4.9 6.8 7.7 7.1 5.3 7.7 6.4 3.1 8.4 8.8 8.4 9.8 5.9 5.0 9.8 4.7 4.0 2.7 6.7 1.6 7.6 4.0 5.3 3.0 5.6 10.7 4.6 4.6 10.7 7.2 5.3 8.2 4.9 7.2 5.8 5.2 2.9 6.8 4.6 4.8 4.9 8.3 7.9 9.8 1.0 4.2 6.2 3.6 4.1 6.3 7.6 4.7 10.7 9.8 7.2 9.2 4.0 11.4 11.6 9.1 5.0 5.7 5.4 3.8 7.0 4.8 9.3 12.1 20.4 10.8 8.7 6.9 14.2 6.5 11.8 12.1 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.6" "Cell line enhanced" "Detected in many" "HaCaT: 28.8;HBEC3-KT: 27.4;HEL: 34.4;hTCEpi: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 10 "dendritic cells: 16.6;monocytes: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 23.7 4.3 23.6 16.3 27.3 16.8 7.9 13.2 32.5 7.9 5.7 12.8 2.3 4.8 3.2 10.7 28.1 6.2 8.9 4.3 18.4 22.6 2.3 3.8 11.6 8.9 31.8 15.4 2.0 2.0 13.8 8.5 12.6 19.4 10.3 5.4 35.5 8.9 10.1 5.9 81.6 5.7 8.7 16.4 13.9 4.4 2.1 16.1 5.5 18.1 21.9 21.9 25.8 14.9 0.8 16.6 1.6 16.8 0.0 0.2 6.6 0.8 3.4 5.2 6.5 6.0 4.0 14.3 0.6 2.6 2.7 2.3 6.9 2.5 1.9 2.3 1.4 28.8 1.9 27.4 0.9 1.8 2.7 34.4 2.2 1.3 2.7 0.5 24.1 3.5 30.9 3.0 7.7 1.6 16.5 0.1 1.2 15.3 1.6 4.9 2.9 2.7 6.1 0.4 6.7 2.1 22.5 2.3 10.4 0.2 19.5 1.4 23.0 14.4 1.7 1.5 3.4 1.7 1.7 0.5 0.1 1.6 6.1 1.6 3.8 1.6 15.3 0.0 0.0 16.8 0.0 0.6 0.0 0.0 16.6 0.8 0.0 0.2 1.2 0.0 11.9 1.6 0.0 6.6 23.6 27.3 13.2 32.5 18.4 22.6 31.8 15.4 19.4 16.1 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favourable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favourable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favourable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.7 7.7 5.2 10.9 8.1 5.6 10.3 6.6 8.8 7.7 7.5 8.1 8.5 9.2 9.5 6.8 7.5 7.0 8.4 7.6 6.7 9.2 9.1 9.1 8.9 6.5 12.9 15.9 7.3 7.3 7.5 8.0 8.7 13.0 18.5 7.0 14.5 13.3 21.2 11.6 9.2 7.6 5.7 16.1 8.3 11.1 6.2 12.9 7.7 18.7 12.4 4.8 16.1 9.1 9.3 9.4 13.4 8.2 15.2 15.9 15.0 6.6 13.1 9.8 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 ZNF395 "DKFZp434K1210, HDBP2, PBF, PRF-1" ENSG00000186918 "Zinc finger protein 395" Q9H8N7 8 28345585-28402701 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049382, HPA076275" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049382: , HPA076275: " "unprognostic (1.28e-1)" "unprognostic (3.02e-1)" "unprognostic (1.95e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-2)" "unprognostic (4.51e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (9.35e-3)" "unprognostic (8.90e-2)" "unprognostic (2.15e-2)" "unprognostic (7.08e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (5.71e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (2.46e-2)" "unprognostic (7.42e-2)" 17.4 10.7 10.0 13.3 10.9 18.6 19.0 7.4 10.1 16.8 22.5 9.7 13.4 12.1 12.0 11.9 27.2 16.9 14.1 15.0 10.4 5.4 13.1 19.5 11.3 18.0 9.0 6.8 33.8 27.8 9.8 9.5 19.6 7.6 22.1 8.3 13.7 21.7 11.1 13.8 23.2 16.3 13.8 8.8 11.9 14.2 12.3 10.8 9.6 18.2 10.2 25.3 27.5 27.6 13.7 6.4 10.6 4.2 3.3 7.2 2.1 48.7 7.0 6.7 18.4 5.1 7.5 19.3 6.0 10.5 4.8 11.5 11.1 8.6 23.3 20.7 9.3 10.6 6.0 14.7 9.5 3.8 4.7 5.8 1.4 2.2 5.3 2.3 2.5 13.0 20.3 0.8 12.7 2.5 5.9 5.2 6.7 8.3 10.9 7.5 10.4 8.2 10.7 7.2 7.7 11.2 9.7 18.5 19.2 1.5 3.7 9.6 7.3 5.8 0.7 10.3 12.5 5.5 2.5 6.4 3.3 15.3 27.1 4.8 9.0 6.7 4.2 10.6 4.8 0.8 4.6 10.0 5.6 5.6 1.6 13.7 7.2 4.9 1.8 3.3 0.6 6.4 2.1 2.1 10.0 10.9 7.4 10.1 10.4 5.4 9.0 6.8 7.6 10.8 ZNF397 "MGC13250, ZNF47, ZSCAN15" ENSG00000186812 "Zinc finger protein 397" Q8NF99 18 35241030-35267133 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026087 Uncertain Approved "Nucleoli,Plasma membrane,Microtubules,Cytosol" "Nucleoli, Plasma membrane, Cytosol" Microtubules "HPA026087: AB_1859243" "unprognostic (1.97e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-1)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.74e-3)" "unprognostic (1.45e-2)" "unprognostic (1.48e-2)" "unprognostic (3.28e-2)" "prognostic favourable (9.44e-4)" "unprognostic (2.46e-2)" "unprognostic (2.17e-3)" "unprognostic (3.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.06e-1)" "unprognostic (2.09e-3)" 15.1 17.7 20.3 16.8 31.1 5.7 20.6 23.9 26.4 16.2 15.0 27.9 16.7 13.3 22.7 16.5 13.4 15.2 12.9 14.6 20.2 13.8 14.9 12.7 13.6 18.8 34.8 19.3 23.6 17.1 25.3 24.8 14.7 25.6 18.4 18.0 13.8 17.5 16.3 15.0 17.2 15.9 18.9 30.5 19.0 16.7 11.9 35.1 22.0 20.2 8.3 19.2 17.3 16.8 13.3 8.1 12.4 9.4 4.8 9.4 2.2 2.9 5.8 13.8 12.5 15.3 13.0 6.6 6.1 6.1 3.0 4.0 2.1 4.2 15.1 5.5 4.8 8.1 8.9 6.6 4.3 9.5 5.5 0.6 7.6 6.1 5.1 7.2 5.5 5.8 9.0 3.6 10.6 1.9 8.8 10.6 7.8 6.4 12.1 5.6 11.9 2.3 12.8 4.0 10.7 6.3 7.9 15.0 12.9 9.9 5.3 5.9 9.2 5.4 3.0 10.2 5.7 3.4 2.7 17.2 6.4 8.8 9.0 5.1 9.6 9.4 5.1 8.4 6.6 8.0 4.8 10.3 6.3 5.3 3.6 13.3 9.4 6.5 12.4 4.8 9.4 8.1 3.2 2.2 20.3 31.1 23.9 26.4 20.2 13.8 34.8 19.3 25.6 35.1 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149182802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071533 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA071533: " "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 8.9 8.1 12.7 10.2 12.5 15.6 10.6 25.9 16.0 11.7 10.7 10.2 10.5 8.8 9.8 10.2 14.3 10.4 8.6 9.3 10.9 9.0 9.3 10.7 9.2 10.0 10.7 11.4 11.1 13.4 14.7 20.9 8.6 9.8 12.7 8.6 8.5 11.2 12.5 10.0 17.2 9.5 9.7 9.8 12.6 11.1 18.1 12.6 13.0 8.7 7.4 12.3 9.9 11.1 2.9 1.6 6.1 2.0 1.9 3.8 1.2 7.4 6.3 4.9 9.5 7.4 5.2 6.3 4.6 5.9 5.3 5.8 5.3 3.6 8.8 5.3 7.7 6.3 8.4 5.8 3.7 5.8 11.7 5.8 5.0 3.5 5.1 6.5 6.1 5.9 8.5 5.7 6.1 3.5 9.0 3.2 5.6 9.5 9.6 6.7 35.3 6.7 7.5 5.6 6.6 3.9 12.6 7.4 8.1 6.4 7.8 3.8 4.9 7.3 4.7 5.4 1.5 9.6 5.6 10.1 4.8 6.7 7.4 5.4 5.2 5.1 1.6 6.1 3.1 2.0 3.7 2.9 2.1 3.4 1.5 2.5 3.3 3.8 3.1 1.9 1.7 1.6 3.0 1.2 12.7 12.5 25.9 16.0 10.9 9.0 10.7 11.4 9.8 12.6 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872363-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4;U-2 OS: 30.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Intermediate filaments" Nucleoli "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: " "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 0.9 2.2 4.6 0.7 4.8 0.1 2.6 5.8 4.8 1.5 2.5 0.2 2.0 10.9 1.2 3.7 2.2 6.0 4.6 4.4 1.5 1.0 1.8 3.1 6.0 7.5 0.8 2.6 8.2 2.6 4.6 1.6 2.6 2.2 1.5 2.9 1.0 1.8 7.0 3.9 1.9 3.4 2.6 1.2 1.5 1.1 1.9 0.9 1.9 0.4 2.1 1.9 0.6 2.2 0.3 2.3 0.3 5.9 8.4 1.4 3.1 1.5 2.0 2.8 0.2 0.8 0.0 3.3 1.5 0.3 0.4 1.6 2.7 0.3 2.3 0.8 0.0 0.9 2.1 0.2 0.6 5.0 3.8 1.5 1.4 1.7 0.1 0.0 1.8 0.2 0.0 0.0 1.9 0.5 0.0 1.3 0.4 1.9 1.5 1.2 1.0 1.3 0.6 1.6 0.1 0.9 0.7 2.9 30.8 2.5 1.8 4.0 5.2 0.0 4.1 0.0 1.6 0.0 0.3 1.9 0.7 0.0 0.8 0.9 1.4 0.0 0.4 1.9 1.9 1.5 0.0 2.1 0.4 0.9 1.3 0.6 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: " "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favourable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 7.7 6.3 8.5 11.7 11.4 12.0 7.6 15.5 10.5 11.8 9.4 5.3 5.8 5.8 11.7 5.2 7.3 9.4 5.5 8.1 7.3 5.2 6.6 6.0 7.4 7.9 7.8 5.7 12.8 6.0 14.9 13.2 10.8 9.0 7.6 6.0 5.9 8.4 7.7 13.3 7.7 10.3 8.7 7.5 11.2 7.5 10.0 7.7 18.1 9.4 8.2 7.6 9.9 9.2 2.4 3.6 6.0 2.6 3.0 3.1 0.9 4.6 4.9 5.5 5.1 4.1 6.0 3.9 6.2 5.4 4.6 5.0 2.0 2.7 6.7 1.8 8.7 5.5 5.2 6.7 6.9 11.1 3.2 8.6 6.6 3.8 3.7 12.9 7.5 5.5 3.1 7.4 6.4 6.9 4.8 9.9 7.0 3.6 6.3 1.8 3.2 4.4 6.5 7.2 5.3 3.3 8.7 5.3 5.0 5.8 3.7 4.4 4.2 5.5 9.6 10.4 4.4 2.8 4.9 3.5 7.2 7.1 3.8 5.6 6.1 4.0 1.9 2.3 3.1 2.6 2.9 2.1 2.3 1.7 0.7 2.4 2.6 3.1 6.0 3.0 1.6 3.6 0.6 0.9 8.5 11.4 15.5 10.5 7.3 5.2 7.8 5.7 9.0 7.7 ZNF408 FLJ12827 ENSG00000175213 "Zinc finger protein 408" Q9H9D4 11 46700818-46705912 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017892 Uncertain Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA017892: AB_1859248" "unprognostic (7.54e-2)" "unprognostic (2.41e-1)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (6.59e-5)" "unprognostic (3.01e-2)" "unprognostic (6.89e-2)" "unprognostic (1.42e-1)" "unprognostic (7.13e-3)" "unprognostic (5.77e-2)" "unprognostic (3.38e-2)" "unprognostic (9.99e-3)" "unprognostic (9.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-2)" 7.5 5.8 6.6 7.9 7.8 20.8 10.4 11.9 8.4 9.3 11.4 6.9 5.8 8.6 9.9 4.3 9.7 8.1 8.6 8.8 6.6 5.3 6.2 14.8 5.6 10.7 7.4 3.7 9.6 16.4 4.2 6.6 11.7 4.9 9.6 5.0 6.6 13.8 8.0 11.3 11.3 8.2 6.1 8.4 9.2 8.9 13.1 6.5 14.2 10.8 6.6 9.9 10.4 13.0 11.9 9.9 10.0 11.1 7.6 14.6 9.3 4.0 9.9 4.7 8.3 5.9 5.1 12.1 5.4 7.7 11.2 8.4 8.9 4.6 6.5 5.1 6.6 10.5 5.8 10.8 4.0 4.9 12.0 6.1 6.4 10.6 11.1 6.7 8.9 10.3 10.6 5.7 8.0 5.5 9.5 5.8 4.6 13.2 7.7 12.8 19.2 12.1 8.6 7.0 9.9 5.8 10.8 6.6 8.6 10.7 13.5 8.5 11.8 11.1 6.2 11.1 7.3 9.1 10.8 8.3 7.2 9.5 7.2 7.3 8.9 5.2 10.4 10.0 12.7 11.1 9.7 9.3 12.0 14.6 9.9 11.9 13.7 10.4 9.6 7.6 8.1 7.7 10.7 9.3 6.6 7.8 11.9 8.4 6.6 5.3 7.4 3.7 4.9 6.5 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053769: " "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favourable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favourable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favourable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favourable (8.71e-4)" 16.6 16.2 14.3 13.6 22.7 20.8 10.6 17.6 28.6 13.2 10.9 22.4 5.6 21.4 16.6 10.0 11.6 11.6 9.7 9.9 14.1 11.4 12.0 13.1 10.7 15.8 15.5 14.8 16.7 13.7 9.2 15.3 14.0 17.3 15.8 4.6 13.4 20.5 14.1 23.6 25.5 16.6 7.7 12.5 22.8 19.1 13.6 20.3 19.9 15.7 6.1 13.5 11.8 12.3 3.0 3.4 5.4 2.1 2.5 2.7 1.2 5.4 4.7 2.6 4.1 0.7 1.6 5.7 4.1 1.6 2.7 2.5 4.1 2.7 7.5 12.0 1.3 7.6 0.8 3.4 0.4 6.7 18.9 4.7 4.3 4.9 3.7 4.1 6.4 3.0 2.5 2.2 0.8 1.1 6.2 11.1 1.7 6.7 9.2 23.9 7.7 13.4 10.8 1.3 7.5 1.9 4.5 8.9 13.9 4.5 3.5 3.7 6.6 4.8 4.3 8.0 4.1 11.6 5.3 16.2 6.7 5.9 6.4 3.5 4.3 3.0 1.6 0.8 1.8 1.4 1.0 2.5 2.7 2.7 1.6 3.0 2.6 2.6 5.4 2.5 2.1 3.4 1.4 1.2 14.3 22.7 17.6 28.6 14.1 11.4 15.5 14.8 17.3 20.3 ZNF415 ENSG00000170954 "Zinc finger protein 415" Q09FC8 19 53107879-53133077 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA005553 Approved Approved "Nucleoli fibrillar center,Microtubules" "Nucleoli fibrillar center, Microtubules" "HPA005553: AB_1859252" "unprognostic (2.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-3)" "unprognostic (2.18e-1)" "unprognostic (3.24e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-3)" "unprognostic (1.51e-1)" "unprognostic (1.06e-2)" "unprognostic (4.27e-2)" "unprognostic (1.28e-1)" "unprognostic (4.38e-2)" "unprognostic (2.84e-2)" 7.0 17.6 13.3 3.2 15.2 1.2 9.7 19.5 16.2 9.2 6.6 14.7 4.7 2.4 8.7 15.9 4.1 7.6 6.2 17.6 13.8 10.6 6.5 1.5 5.5 3.5 20.9 14.6 11.2 5.6 11.5 8.3 4.8 17.8 11.4 6.4 4.0 6.8 9.3 4.5 4.4 4.0 8.1 12.9 5.8 5.3 22.6 18.5 3.3 12.3 1.6 3.2 6.8 6.0 6.9 4.5 5.7 1.1 4.6 2.8 1.0 0.2 0.0 3.8 11.0 0.6 0.6 8.8 4.0 6.4 5.9 9.0 6.9 0.2 0.0 2.3 7.0 0.1 0.0 0.0 5.9 0.0 0.5 0.0 0.3 0.0 2.1 0.0 6.1 6.8 0.1 1.4 0.0 0.1 0.2 0.2 3.2 0.5 6.8 0.1 7.9 0.4 0.0 0.0 0.3 4.9 16.6 2.4 5.9 0.5 0.1 0.0 5.6 0.3 0.0 2.7 2.8 0.2 4.8 0.1 7.0 4.9 0.3 0.0 9.0 5.0 1.1 5.7 0.6 0.5 0.5 5.4 1.3 0.4 1.8 6.9 2.8 2.6 1.5 4.6 0.7 4.5 0.8 1.0 13.3 15.2 19.5 16.2 13.8 10.6 20.9 14.6 17.8 18.5 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578927 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA063318 Approved "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA063318: " "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favourable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 6.1 6.8 7.0 5.1 10.7 5.0 8.7 13.0 10.7 6.8 6.1 7.0 5.9 3.2 6.9 9.5 8.9 8.2 4.4 6.1 6.5 5.3 6.1 4.6 6.7 7.1 5.3 8.6 10.9 3.9 8.7 7.0 6.6 5.8 6.7 4.9 7.0 6.3 7.6 6.6 13.5 4.8 8.2 3.8 6.3 4.9 9.3 8.1 12.8 8.8 4.8 9.1 7.7 6.9 9.7 4.4 1.9 2.8 9.5 9.4 4.3 3.2 3.2 6.9 5.4 4.2 6.0 4.6 3.3 6.0 6.5 4.2 2.3 1.7 2.2 2.5 4.2 1.2 4.0 5.6 8.1 3.5 16.1 5.3 3.6 1.8 7.5 4.7 3.5 6.0 5.9 4.1 8.7 4.5 0.7 1.8 8.7 1.3 9.8 2.2 8.0 6.0 4.9 10.2 4.8 4.5 7.0 4.9 5.6 5.9 3.1 3.0 2.8 5.7 3.3 7.1 3.4 2.3 4.9 5.7 9.3 6.1 1.6 3.1 4.3 1.1 2.8 1.9 4.8 2.1 8.9 7.4 6.8 7.2 4.4 9.7 9.4 6.8 0.9 9.5 1.8 3.9 3.1 4.3 7.0 10.7 13.0 10.7 6.5 5.3 5.3 8.6 5.8 8.1 ZNF419 "ZAPHIR, ZNF419A" ENSG00000105136 "Zinc finger protein 419" Q96HQ0 19 57487711-57496097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003152, HPA003274" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716, HPA003274: AB_1080714" "unprognostic (3.50e-2)" "unprognostic (1.40e-5)" "unprognostic (1.12e-1)" "unprognostic (2.63e-2)" "unprognostic (2.55e-2)" "unprognostic (8.26e-2)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (3.18e-1)" "unprognostic (1.33e-1)" "unprognostic (8.55e-5)" "prognostic unfavourable (6.47e-4)" "unprognostic (1.20e-1)" "unprognostic (2.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.28e-1)" "prognostic favourable (2.53e-5)" 7.1 10.3 11.0 8.9 12.4 4.4 11.9 20.4 14.3 8.6 7.1 8.4 8.7 6.4 7.6 17.0 5.7 11.0 6.5 8.0 10.9 9.4 9.4 8.4 10.0 11.2 11.4 11.7 13.4 6.0 17.4 17.3 10.2 12.4 10.6 6.4 7.0 9.1 11.6 17.4 12.0 7.1 7.1 10.2 12.7 7.4 7.2 12.1 8.4 14.1 4.8 14.2 6.6 5.6 12.4 4.1 5.4 3.2 8.7 13.3 4.5 3.6 3.8 7.4 7.7 3.6 5.5 6.3 4.5 6.4 4.3 24.1 2.6 2.3 1.3 3.6 3.3 1.1 3.2 9.2 6.1 0.3 16.5 5.7 5.8 2.9 12.4 4.5 4.3 7.7 14.0 4.2 10.4 4.6 0.6 0.9 5.5 0.6 7.2 4.7 5.1 5.4 6.8 7.3 5.0 4.5 8.0 6.0 7.0 4.4 4.2 4.4 3.7 6.8 4.6 5.0 5.5 1.7 4.1 10.6 12.0 3.2 4.0 2.5 4.2 3.8 2.5 5.4 5.3 3.2 8.5 12.4 8.5 6.6 4.1 12.1 13.3 7.7 3.2 8.7 2.4 3.0 5.4 4.5 11.0 12.4 20.4 14.3 10.9 9.4 11.4 11.7 12.4 12.1 ZNF428 "C19orf37, MGC51082, Zfp428" ENSG00000131116 "Zinc finger protein 428" Q96B54 19 43607219-43619874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042596, HPA048072" Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA042596: , HPA048072: " "unprognostic (2.45e-3)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "unprognostic (6.31e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (3.22e-2)" "unprognostic (2.32e-2)" "unprognostic (2.53e-1)" "unprognostic (6.67e-2)" "prognostic favourable (3.60e-5)" "unprognostic (3.85e-1)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-2)" "unprognostic (4.00e-1)" "unprognostic (2.74e-2)" 18.8 31.2 36.8 15.8 37.6 18.9 9.2 25.9 48.8 13.7 14.2 14.4 8.8 17.0 18.8 14.9 8.8 13.0 18.4 19.9 31.3 28.7 17.4 15.5 13.1 15.5 27.0 31.1 19.2 19.4 9.8 19.2 12.7 18.0 20.1 6.3 14.8 21.7 13.2 37.7 6.6 13.7 17.2 22.2 16.8 16.6 19.7 17.0 17.8 16.6 8.7 8.9 10.0 11.4 7.8 7.1 9.4 3.2 3.1 8.5 1.0 11.0 8.9 13.9 23.0 5.4 3.9 6.6 8.4 3.9 5.9 6.3 5.5 7.4 18.7 19.3 6.4 2.7 5.6 1.5 1.9 15.8 23.6 20.5 9.3 9.2 10.5 16.0 17.0 7.2 3.5 5.2 2.8 8.3 21.4 11.8 6.1 11.7 39.5 28.7 9.3 6.2 39.4 6.4 13.7 7.1 6.7 26.8 31.3 12.2 7.5 18.8 4.6 23.1 16.3 7.1 20.3 6.8 12.8 13.3 15.9 32.8 10.3 16.4 15.7 2.5 2.5 9.4 7.8 1.4 4.4 5.2 7.1 7.4 2.7 7.8 8.5 3.7 1.3 3.1 3.2 7.1 4.1 1.0 36.8 37.6 25.9 48.8 31.3 28.7 27.0 31.1 18.0 17.0 ZNF436 "KIAA1710, Zfp46" ENSG00000125945 "Zinc finger protein 436" Q9C0F3 1 23359448-23369442 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.9;HSkMC: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043817 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043817: AB_10794774" "unprognostic (1.50e-1)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.10e-2)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.92e-1)" "unprognostic (9.51e-3)" "unprognostic (5.04e-2)" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (7.75e-3)" 14.5 18.6 10.1 4.7 13.0 2.9 12.9 13.6 15.8 10.7 8.7 11.8 8.6 6.3 15.1 17.5 18.4 10.2 11.2 11.7 9.9 6.1 6.7 4.3 7.8 5.6 12.9 9.6 20.3 8.1 11.6 6.5 8.5 11.3 12.1 6.9 6.3 16.9 13.4 7.2 15.6 6.1 12.7 12.6 8.0 6.8 10.4 10.0 5.7 12.3 9.7 8.0 12.5 11.2 1.6 2.8 1.6 2.1 6.6 2.3 1.6 2.7 1.7 6.4 3.4 7.2 14.9 3.0 2.4 3.4 3.2 3.8 1.0 2.4 1.8 2.8 3.5 3.4 11.3 4.3 3.5 2.3 2.4 2.0 3.6 1.6 2.9 0.8 1.4 27.2 6.1 2.7 3.2 4.6 2.4 1.3 3.4 1.3 2.0 1.5 0.2 2.8 2.7 2.7 1.8 2.6 7.1 2.9 3.7 7.0 3.6 2.7 2.0 1.0 3.6 2.8 2.1 2.2 1.4 2.1 2.5 1.6 2.2 1.6 2.2 0.0 1.8 1.6 2.0 2.1 2.0 1.3 1.4 2.1 2.8 1.6 2.3 2.0 1.3 6.6 2.0 0.4 2.2 1.6 10.1 13.0 13.6 15.8 9.9 6.1 12.9 9.6 11.3 10.0 ZNF438 bA330O11.1 ENSG00000183621 "Zinc finger protein 438" Q7Z4V0 10 30820207-31031937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 14.1;HUVEC TERT2: 14.3;U-937: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039843 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039843: AB_10795159" "unprognostic (1.69e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" "unprognostic (9.21e-2)" "unprognostic (4.75e-2)" "unprognostic (1.22e-2)" "unprognostic (3.98e-3)" "unprognostic (1.30e-1)" "unprognostic (4.65e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (4.85e-2)" "unprognostic (1.08e-2)" "unprognostic (9.96e-2)" "unprognostic (1.52e-1)" "unprognostic (8.52e-3)" "unprognostic (9.50e-2)" 21.8 5.8 9.8 10.0 10.2 7.9 9.7 11.8 9.9 10.6 12.9 13.0 2.6 6.2 22.6 11.3 8.3 10.2 9.2 13.8 9.3 6.2 6.2 8.6 12.0 7.1 10.1 6.6 10.2 4.5 6.6 17.3 6.4 9.6 9.0 6.9 7.7 9.5 9.6 29.1 8.9 7.6 14.3 8.6 13.6 8.3 10.1 11.9 7.7 15.8 8.7 5.2 10.5 12.1 3.1 3.1 14.1 7.8 3.8 3.9 3.5 2.7 2.7 2.4 2.1 14.1 9.9 1.3 2.2 3.2 3.4 4.3 0.1 3.3 3.7 2.6 3.8 0.7 1.2 1.6 4.9 8.5 0.9 1.6 1.5 0.1 7.9 1.2 1.7 4.7 2.9 4.9 2.8 14.3 3.1 2.6 4.7 2.0 4.2 7.1 0.2 1.1 1.9 3.4 2.1 4.8 0.7 1.7 1.9 1.1 0.4 1.5 1.1 12.0 5.9 1.6 2.7 4.6 2.7 0.6 1.0 0.0 3.1 18.8 1.1 1.4 7.8 3.3 2.3 7.4 1.7 1.2 1.8 3.0 2.4 3.1 3.6 2.0 14.1 3.8 4.4 3.1 3.9 3.5 9.8 10.2 11.8 9.9 9.3 6.2 10.1 6.6 9.6 11.9 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favourable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favourable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favourable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.5 1.0 2.7 4.8 2.7 2.7 11.8 5.2 2.3 8.2 7.3 4.8 2.0 3.6 6.4 4.9 3.8 3.5 3.6 7.1 0.0 3.2 3.4 4.7 12.7 3.8 0.0 9.2 2.9 5.6 5.0 6.5 3.2 2.2 0.7 5.2 3.7 5.2 5.9 2.7 6.1 3.5 6.1 4.4 4.9 8.5 3.1 3.7 6.5 2.5 1.6 5.4 5.7 3.7 9.9 2.6 9.6 4.4 7.6 9.5 3.4 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 ZNF442 FLJ14356 ENSG00000198342 "Zinc finger protein 442" Q9H7R0 19 12345949-12365905 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 8.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045738, HPA053407" Uncertain Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA045738: AB_10968057, HPA053407: " "unprognostic (2.61e-2)" "unprognostic (3.32e-2)" "unprognostic (1.59e-1)" "unprognostic (7.36e-2)" "unprognostic (1.28e-1)" "unprognostic (5.53e-2)" "unprognostic (6.64e-2)" "unprognostic (2.07e-2)" "unprognostic (3.17e-3)" "unprognostic (1.35e-1)" "unprognostic (7.52e-3)" "unprognostic (1.78e-1)" "unprognostic (1.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.80e-2)" "unprognostic (1.99e-2)" 4.7 3.1 2.8 5.5 6.0 1.5 5.1 8.3 3.8 6.6 3.4 1.0 2.9 1.9 5.5 5.5 3.8 5.5 2.0 3.9 2.6 2.5 8.1 5.2 3.4 3.6 2.7 2.4 17.1 4.8 4.3 5.2 3.1 7.1 6.2 3.9 4.3 3.0 6.8 8.0 3.6 2.6 8.7 5.0 4.7 2.7 3.5 3.4 3.9 5.8 2.5 3.1 8.5 4.6 5.7 1.3 5.0 1.0 1.0 3.4 0.9 0.3 0.1 2.8 3.6 1.8 1.0 0.4 3.8 1.1 3.4 2.7 2.7 0.9 3.2 1.2 2.0 0.8 2.3 1.9 3.3 0.1 0.5 0.2 4.1 2.4 1.4 0.1 3.2 1.5 2.0 1.4 0.5 0.4 4.6 0.4 3.1 2.5 3.8 0.6 2.3 1.6 0.2 4.2 0.1 1.4 2.1 0.2 0.7 0.0 0.2 0.0 3.7 2.5 0.1 4.5 2.2 5.6 2.3 3.4 8.5 0.1 0.2 0.1 1.7 1.0 0.7 5.0 2.0 1.0 1.3 5.7 1.3 1.2 1.3 1.3 3.4 2.1 1.7 1.0 0.9 1.2 0.1 0.9 2.8 6.0 8.3 3.8 2.6 2.5 2.7 2.4 7.1 3.4 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429707-12441112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: " "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favourable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favourable (3.91e-4)" 5.5 3.4 5.5 9.5 6.9 1.0 8.5 13.6 5.9 7.6 7.2 2.0 21.4 4.0 6.6 6.3 4.9 5.2 4.2 3.3 4.3 4.5 10.6 5.8 4.7 3.2 4.2 3.0 4.9 5.9 9.3 4.1 6.3 5.0 7.0 6.7 1.9 5.7 12.9 1.9 7.3 8.9 3.6 5.9 3.6 4.7 3.4 4.1 16.9 4.8 3.7 4.3 7.9 9.6 4.0 2.2 4.8 1.2 3.1 7.1 2.0 3.3 1.4 5.9 5.2 1.7 1.5 8.1 2.4 1.8 3.2 3.1 3.2 0.9 3.8 4.3 1.9 2.0 3.8 2.4 2.8 0.0 2.1 1.6 1.8 7.3 0.4 3.6 4.5 1.4 1.5 1.6 0.7 1.9 2.7 0.0 3.5 3.9 13.6 5.0 5.0 5.1 1.5 6.1 4.6 3.9 12.1 2.8 4.6 4.0 2.2 0.5 0.1 4.6 1.2 6.5 2.7 3.6 2.3 2.4 3.6 2.5 0.9 3.8 1.4 4.8 1.2 1.6 2.1 0.6 7.1 4.0 4.5 4.3 2.2 3.2 4.0 2.7 0.7 3.1 0.3 1.1 3.3 2.0 5.5 6.9 13.6 5.9 4.3 4.5 4.2 3.0 5.0 4.1 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA056895: , HPA065203: " "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favourable (1.87e-4)" 9.4 13.4 15.0 7.1 21.0 3.7 8.3 14.9 20.1 9.0 14.8 12.8 14.3 13.6 10.5 9.9 6.6 11.9 11.2 10.5 13.5 13.3 9.9 37.4 10.9 6.1 12.3 11.0 12.5 25.3 8.5 12.2 12.5 8.0 14.3 5.3 10.4 14.1 25.6 17.2 11.5 11.3 7.5 10.3 8.6 17.2 9.2 10.4 28.1 16.6 2.8 8.2 10.4 6.8 4.3 3.5 3.5 1.7 3.7 7.1 1.8 4.6 9.0 8.3 7.2 3.5 3.6 5.3 5.9 3.9 5.1 5.6 9.8 5.3 8.2 5.3 3.4 4.3 5.1 4.0 2.2 7.1 50.4 8.1 6.0 17.6 5.8 3.6 7.5 4.2 3.7 4.2 3.2 4.5 10.4 3.7 3.6 6.0 11.6 10.1 8.9 16.4 13.5 5.3 4.3 5.6 4.4 8.9 12.1 3.0 10.1 4.4 10.0 6.6 5.8 9.2 7.9 1.9 6.5 8.9 7.6 6.2 5.8 4.9 5.9 3.1 1.7 3.5 4.1 1.4 4.5 2.0 6.9 6.9 2.1 4.3 7.1 4.6 0.2 3.7 1.0 3.5 4.2 1.8 15.0 21.0 14.9 20.1 13.5 13.3 12.3 11.0 8.0 10.4 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.2 4.5 2.2 3.5 2.1 6.1 2.3 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.4 7.0 3.6 3.0 5.9 3.7 3.7 6.4 3.4 4.2 1.6 9.9 7.1 6.1 2.6 4.4 5.7 2.2 2.8 5.2 4.5 5.6 5.4 2.8 1.4 5.2 4.6 4.4 7.5 6.6 4.5 4.4 2.7 2.0 3.8 2.7 5.2 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 13.7 15.8 5.3 6.7 10.4 1.9 11.6 7.5 10.8 10.1 7.2 6.0 4.8 5.0 14.0 10.9 7.5 6.0 8.6 8.3 5.0 6.1 6.1 5.0 7.3 5.8 6.3 9.6 9.7 16.1 12.5 9.8 11.0 12.2 9.6 5.5 6.6 8.6 7.5 7.6 5.8 5.3 12.4 5.0 9.5 7.6 4.8 4.7 5.3 10.6 4.6 6.4 12.1 8.9 1.5 2.6 3.6 6.6 5.6 5.7 2.2 2.8 4.2 8.5 7.0 7.8 15.6 4.2 5.6 4.3 3.6 8.8 1.4 3.9 1.7 7.3 4.4 3.3 6.0 2.5 5.8 2.4 5.0 2.4 4.1 2.1 5.9 1.9 3.6 5.9 7.5 3.0 9.0 6.8 2.3 2.0 10.2 1.6 2.4 2.1 2.9 4.6 2.0 5.7 2.7 5.3 1.7 2.0 5.1 1.3 4.1 4.2 3.0 2.1 6.6 8.3 3.1 5.6 4.9 1.6 1.9 1.4 3.3 3.2 5.3 1.7 2.7 3.6 3.0 3.4 5.7 1.5 2.7 4.1 2.6 1.1 2.6 2.6 0.6 5.6 6.6 1.5 2.4 2.2 5.3 10.4 7.5 10.8 5.0 6.1 6.3 9.6 12.2 4.7 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.8 5.3 4.0 5.1 2.8 6.2 2.4 3.1 3.5 4.8 6.8 0.9 1.3 0.4 6.6 4.3 0.5 2.8 3.4 5.2 5.4 3.9 4.6 0.7 1.9 4.5 3.9 5.5 3.9 6.2 1.5 4.3 3.0 0.2 0.4 4.8 3.1 6.0 1.0 2.2 2.0 0.4 3.8 0.9 1.5 6.6 4.6 6.6 0.2 2.3 4.1 2.4 1.5 3.0 2.9 3.8 1.9 3.7 8.7 12.8 1.6 0.0 0.7 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Cell line enhanced" "Detected in many" "RT4: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: " "prognostic unfavourable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favourable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.1 0.8 5.6 9.8 6.0 4.5 16.4 4.9 6.2 6.4 9.5 6.0 3.8 9.4 5.0 5.2 3.2 3.9 5.0 8.4 0.0 5.7 7.2 6.2 2.6 12.1 0.4 9.2 7.0 6.0 7.9 6.5 5.3 7.1 0.4 5.6 1.4 9.0 5.8 6.9 6.0 5.4 8.1 6.3 8.6 46.1 5.8 8.5 6.2 5.6 1.5 7.4 5.6 4.3 2.1 5.6 2.9 7.2 3.8 13.6 8.4 0.5 0.8 7.9 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 ZNF470 "CZF-1, FLJ26175" ENSG00000197016 "Zinc finger protein 470" Q6ECI4 19 56567511-56588911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029000 Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA029000: AB_10603843" "unprognostic (1.40e-2)" "unprognostic (5.51e-2)" "unprognostic (5.91e-2)" "unprognostic (9.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.40e-2)" "unprognostic (7.11e-2)" "unprognostic (4.58e-2)" "unprognostic (6.91e-3)" "unprognostic (2.39e-2)" "unprognostic (3.45e-3)" "unprognostic (3.33e-3)" "unprognostic (3.89e-2)" "unprognostic (2.82e-2)" "unprognostic (4.68e-1)" "unprognostic (2.76e-3)" "unprognostic (2.88e-3)" 4.6 6.5 11.7 2.9 10.6 1.4 5.3 12.7 12.1 6.3 4.8 5.5 1.3 2.8 5.7 8.8 4.3 5.8 5.1 5.4 12.4 11.7 6.7 8.6 5.1 3.6 11.8 9.4 7.2 4.5 9.3 7.2 4.6 9.8 7.0 3.4 5.8 3.8 6.9 3.0 5.1 3.1 5.4 11.6 4.4 3.6 8.3 9.9 3.6 6.8 1.2 4.6 4.6 5.2 3.2 2.0 2.9 1.0 2.3 4.4 0.9 0.0 1.7 6.4 2.7 3.5 3.2 5.4 3.1 1.1 2.3 4.5 0.4 1.5 0.0 2.0 3.3 0.1 2.7 1.3 2.6 0.0 13.2 5.6 0.1 0.4 3.1 1.2 6.6 3.8 2.0 2.6 0.8 1.5 0.1 0.1 3.5 0.1 1.2 2.0 5.4 0.7 0.2 4.7 0.9 2.7 4.0 2.4 6.3 0.1 0.5 0.9 2.0 3.4 1.1 0.2 2.7 2.2 4.1 2.0 2.8 0.2 0.0 3.5 1.0 1.3 0.8 2.9 2.2 0.6 4.4 2.5 1.9 1.3 1.4 3.2 3.0 3.0 2.2 2.3 1.0 2.0 1.5 0.9 11.7 10.6 12.7 12.1 12.4 11.7 11.8 9.4 9.8 9.9 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.0 5.0 6.6 4.2 3.4 4.2 0.0 3.3 5.4 6.0 6.5 1.6 3.1 3.5 3.0 2.7 6.7 4.8 5.0 6.3 5.6 2.1 3.0 4.0 3.3 5.3 2.5 5.5 4.7 3.8 6.5 6.9 5.1 3.2 14.2 6.4 4.1 3.6 1.1 5.4 2.5 3.0 8.0 2.6 3.2 4.6 4.6 4.1 5.9 1.7 3.3 0.4 2.0 5.5 5.4 5.1 2.8 2.4 5.4 2.7 2.1 3.5 2.0 4.2 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.9 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.2 0.7 4.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.6 2.0 4.5 1.9 2.8 7.2 3.4 6.0 4.6 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 2.5 2.0 1.0 2.4 8.3 2.6 2.8 1.9 3.4 2.0 2.2 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384273 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.7;intestine: 25.8" "Cell line enhanced" "Detected in some" "HaCaT: 23.1;HDLM-2: 33.5;RT4: 18.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: " "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.4 0.4 5.7 0.4 18.5 0.3 1.2 2.9 14.2 0.5 3.2 17.0 0.0 25.8 0.5 2.3 0.9 0.5 0.6 0.4 15.1 1.1 0.3 0.5 0.3 19.8 6.0 0.7 0.3 0.3 0.0 4.1 21.4 0.6 1.1 0.0 0.6 0.4 0.3 2.2 12.5 0.4 29.7 0.3 0.6 1.2 12.8 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 6.7 1.1 0.3 0.0 0.0 0.1 0.2 0.3 0.4 0.4 2.6 6.2 0.1 0.4 0.0 23.1 0.6 2.5 0.3 33.5 0.7 0.1 0.7 0.2 0.0 0.0 0.3 0.0 6.1 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.7 0.6 0.0 2.9 0.0 0.1 18.6 5.5 1.0 1.6 0.2 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA047872: " "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.8 2.3 3.3 2.8 5.5 2.3 5.0 7.5 6.2 3.3 1.7 3.1 3.0 2.0 4.1 3.7 3.6 9.1 3.1 2.0 7.2 3.3 3.7 5.0 3.2 3.8 2.0 4.5 4.5 6.0 3.8 5.9 1.8 5.8 3.2 1.2 1.4 7.7 1.9 0.8 4.6 3.1 0.6 3.5 3.6 2.8 2.3 0.6 2.5 4.9 2.0 1.5 1.4 2.1 4.7 4.8 2.3 2.8 2.1 4.8 1.9 1.6 5.8 5.2 5.1 0.2 0.1 7.0 3.1 0.0 0.0 0.0 0.4 1.9 3.4 1.7 0.0 0.8 0.6 0.4 0.0 3.6 17.4 3.1 1.6 1.0 0.3 1.2 8.1 0.4 0.8 0.1 0.6 0.0 2.5 0.5 0.1 6.0 4.2 4.3 3.2 1.8 10.6 3.9 1.8 0.5 1.4 4.1 5.8 1.7 5.2 2.8 7.1 3.5 0.5 5.8 3.1 0.5 1.0 7.6 9.1 3.0 1.6 3.5 3.1 2.3 2.8 0.9 2.4 1.1 2.6 3.8 2.8 2.9 2.7 4.7 2.9 4.8 1.0 2.1 0.9 4.8 3.1 1.9 3.3 5.5 7.5 4.2 7.2 3.3 2.0 4.5 5.8 0.6 ZNF500 "KIAA0557, ZKSCAN18, ZSCAN50" ENSG00000103199 "Zinc finger protein 500" O60304 16 4748239-4767624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035498, HPA057963" Supported Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035498: AB_10602356, HPA057963: " "unprognostic (3.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.57e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (3.61e-3)" "unprognostic (8.72e-3)" "unprognostic (7.77e-3)" "unprognostic (1.45e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (4.07e-2)" "unprognostic (1.10e-2)" "prognostic favourable (3.41e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (3.19e-2)" 8.1 6.4 10.2 9.4 7.5 5.9 8.1 13.8 11.4 10.3 8.0 11.7 11.5 8.4 12.2 10.9 6.2 8.9 10.4 6.0 6.2 5.1 6.0 5.2 7.2 12.5 6.6 9.4 13.9 8.5 9.1 8.0 6.7 6.6 9.3 5.3 10.6 11.3 14.9 7.5 8.5 7.5 7.5 5.4 11.4 7.7 7.2 8.4 9.9 9.2 7.1 8.3 9.2 8.4 5.3 6.5 3.4 2.5 3.0 4.9 2.1 2.0 8.4 2.8 7.3 3.3 3.0 12.8 6.1 6.7 7.6 5.2 3.7 4.0 4.4 5.3 3.3 4.7 5.8 3.2 5.6 3.2 8.8 3.6 10.6 4.9 4.7 2.5 4.0 3.5 7.8 3.4 6.5 4.3 5.3 7.0 3.0 4.6 5.2 4.4 3.6 3.0 9.3 6.7 8.7 2.5 2.4 10.4 6.8 5.2 7.9 2.3 5.1 4.1 4.8 7.2 5.5 8.0 2.9 6.7 4.5 3.9 2.2 2.1 4.5 2.3 2.5 3.4 3.9 2.4 3.3 4.9 2.5 3.0 1.4 5.3 4.2 4.9 2.9 3.0 1.7 6.5 3.9 2.1 10.2 7.5 13.8 11.4 6.2 5.1 6.6 9.4 6.6 8.4 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.2;PC-3: 49.5;U-87 MG: 15.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavourable (3.50e-4)" "prognostic favourable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.6 2.4 0.5 1.5 0.9 0.6 0.5 2.4 6.8 0.0 4.5 1.5 3.1 0.2 1.6 0.4 0.0 38.2 0.0 4.1 7.9 2.9 1.9 4.3 6.5 1.6 1.2 0.7 0.1 0.0 0.0 0.8 0.8 0.0 6.0 0.0 49.5 0.0 1.9 0.0 0.9 1.3 1.4 1.7 2.8 0.2 8.2 0.3 1.3 1.2 5.0 5.6 10.3 4.2 0.0 0.0 0.0 15.4 8.8 3.9 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 ZNF507 KIAA1084 ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: " "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 10.9 8.7 11.3 16.0 13.1 13.5 12.0 18.4 16.4 12.0 11.4 9.0 10.2 10.0 12.4 9.8 9.6 12.2 10.3 10.1 9.4 8.1 9.0 11.1 8.2 10.5 12.3 10.3 18.6 10.9 13.6 15.7 16.9 11.1 10.7 9.9 6.8 11.0 9.6 21.0 8.6 14.7 11.9 12.9 9.6 9.7 28.3 13.0 17.1 18.7 10.0 10.5 11.0 20.1 4.0 0.4 2.3 1.4 2.0 4.7 1.4 9.1 18.2 13.6 8.4 8.9 14.0 11.0 8.2 8.1 7.6 8.5 10.5 7.2 13.6 10.2 7.9 5.3 19.8 10.2 14.7 10.5 17.9 13.9 8.8 7.1 10.7 11.6 7.6 8.8 7.8 9.7 15.8 10.2 20.5 11.0 8.0 5.7 12.4 3.8 14.6 5.8 13.0 15.8 5.5 4.6 10.2 11.2 9.7 10.9 7.4 9.0 5.8 8.4 10.8 12.2 13.1 7.1 10.6 10.7 12.4 14.1 8.6 8.6 11.0 0.4 0.1 2.3 4.1 0.0 4.7 2.5 3.1 2.8 0.0 4.0 4.2 3.4 2.0 2.0 1.4 0.4 2.4 1.4 11.3 13.1 18.4 16.4 9.4 8.1 12.3 10.3 11.1 13.0 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA049139: " "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favourable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.0 5.2 11.4 8.5 9.7 9.1 5.9 5.7 11.4 9.6 8.5 4.8 3.8 6.6 3.0 6.0 11.1 3.3 5.3 8.6 10.7 5.4 9.4 9.6 2.4 5.8 3.6 6.2 7.9 7.2 8.2 10.3 9.2 9.5 6.5 9.4 4.6 10.4 4.7 8.1 5.2 6.8 18.6 3.2 5.0 4.9 11.8 9.5 11.1 5.2 5.6 3.8 6.8 8.1 6.2 5.9 6.9 6.6 11.3 11.9 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95147330-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 7.1 7.6 7.8 5.1 16.4 1.7 12.7 14.9 12.9 10.4 10.5 15.7 12.0 9.4 15.0 27.1 8.1 11.5 6.7 8.4 14.2 8.4 9.8 5.0 8.4 7.0 17.0 9.9 20.6 9.6 12.5 23.5 7.9 11.5 12.1 9.6 10.1 11.5 11.6 12.0 11.6 9.4 10.6 12.5 8.9 10.0 19.8 18.0 14.0 15.2 10.3 7.8 8.9 10.9 7.7 5.2 10.4 5.3 6.4 11.3 5.5 14.6 5.2 13.7 9.1 10.3 13.7 10.5 5.8 6.2 9.3 10.0 7.6 5.5 2.3 2.9 6.2 8.9 7.2 5.4 10.7 4.8 9.6 2.7 6.9 6.2 4.3 1.5 7.4 8.3 16.4 5.9 4.2 4.6 7.5 2.7 7.3 7.0 3.9 7.4 4.6 5.1 7.1 4.8 5.2 6.3 6.2 12.8 9.3 6.1 3.0 6.2 5.6 5.4 4.8 6.7 9.2 2.2 4.7 7.8 5.7 3.8 7.4 3.1 4.4 10.4 5.3 9.9 5.1 2.6 6.1 7.3 6.8 4.8 5.2 7.7 11.3 9.2 1.5 6.4 3.0 4.1 7.1 5.5 7.8 16.4 14.9 12.9 14.2 8.4 17.0 9.9 11.5 18.0 ZNF516 "HsT287, KIAA0222" ENSG00000101493 "Zinc finger protein 516" Q92618 18 76358190-76495190 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015792 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA015792: AB_1859314" "prognostic favourable (7.09e-4)" "unprognostic (7.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.22e-3)" "unprognostic (3.33e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.63e-3)" "unprognostic (3.14e-1)" "unprognostic (3.29e-2)" "prognostic favourable (7.96e-4)" "unprognostic (5.87e-2)" "prognostic favourable (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" 4.2 5.4 8.3 5.7 9.9 15.1 4.7 2.0 4.8 20.8 5.9 4.5 18.6 4.1 25.2 8.0 6.3 15.8 3.9 3.5 5.1 2.9 3.4 5.1 5.0 4.2 4.7 3.9 17.0 4.6 8.7 10.8 2.6 6.4 7.3 1.8 13.1 6.4 13.3 8.6 6.3 4.1 9.1 3.3 6.3 4.5 18.6 4.6 3.0 4.8 4.0 4.9 8.0 10.9 0.4 1.6 12.2 2.2 1.0 0.6 0.4 1.4 1.7 12.2 16.0 3.6 5.4 1.5 9.2 7.7 2.0 3.7 3.4 5.6 7.9 1.9 9.8 3.3 6.6 8.8 1.4 0.0 5.2 0.7 0.0 7.4 8.9 5.2 5.3 10.2 4.0 4.2 4.4 2.2 0.0 0.0 2.0 3.2 0.1 9.3 6.1 0.4 3.4 1.2 4.1 3.2 6.9 12.2 7.6 0.1 0.0 9.9 2.0 21.2 1.5 4.6 8.0 0.1 0.9 0.0 0.2 6.1 2.7 3.7 11.8 2.7 2.2 3.0 0.1 1.5 0.6 0.1 0.2 0.1 1.6 0.4 0.6 0.3 12.2 1.0 1.6 1.0 0.0 0.4 8.3 9.9 2.0 4.8 5.1 2.9 4.7 3.9 6.4 4.6 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220271-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: , HPA056609: " "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 10.1 7.0 5.9 12.3 9.1 8.5 8.5 14.5 10.0 10.6 8.5 8.6 9.2 8.3 12.2 6.4 8.4 9.3 5.0 6.8 7.5 4.3 7.0 7.6 7.3 9.1 8.7 6.6 12.0 9.0 10.1 11.7 8.6 6.2 9.9 5.6 7.5 11.1 9.1 11.7 13.0 10.1 6.3 4.6 9.1 7.9 11.6 8.1 13.8 7.6 6.1 11.5 9.0 10.3 6.9 6.1 2.5 7.1 4.5 10.7 4.3 7.0 23.1 6.8 6.1 7.9 7.6 5.9 8.3 7.8 8.8 9.7 12.1 5.2 11.6 6.1 8.8 5.3 7.2 9.0 5.6 6.8 8.7 11.6 10.8 11.6 7.3 7.3 7.5 7.5 7.3 8.8 9.2 5.5 11.0 7.4 5.6 9.9 7.3 4.8 4.5 8.3 8.6 8.3 5.2 4.0 13.0 7.0 6.2 9.5 9.6 6.9 3.9 13.2 7.3 10.9 7.5 4.6 10.4 9.0 5.2 8.0 7.3 7.2 9.0 2.5 5.1 1.9 7.0 5.4 10.7 6.9 5.5 6.3 4.2 6.7 6.7 8.3 1.2 4.5 7.1 6.1 5.4 4.3 5.9 9.1 14.5 10.0 7.5 4.3 8.7 6.6 6.2 8.1 ZNF527 KIAA1829 ENSG00000189164 "Zinc finger protein 527" Q8NB42 19 37371061-37393066 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037740, HPA037741" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA037740: AB_10672284, HPA037741: " "unprognostic (4.36e-2)" "unprognostic (5.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-2)" "unprognostic (1.30e-2)" "unprognostic (9.26e-2)" "unprognostic (8.70e-3)" "unprognostic (6.47e-3)" "unprognostic (1.91e-1)" "unprognostic (6.05e-4)" "unprognostic (8.34e-3)" "unprognostic (8.92e-2)" "unprognostic (6.83e-2)" "unprognostic (1.44e-2)" "unprognostic (1.52e-3)" "unprognostic (3.17e-4)" 6.0 6.3 6.7 4.7 10.2 6.6 8.5 10.2 13.0 7.8 6.8 9.3 2.7 3.4 9.6 6.0 5.5 6.1 4.3 7.1 8.0 5.7 7.3 5.9 5.2 7.2 6.8 9.1 10.8 6.4 10.2 13.5 5.4 9.8 6.9 7.4 8.2 5.8 7.6 10.1 5.0 5.0 9.5 5.8 6.7 5.1 7.2 7.5 6.7 7.6 4.8 7.3 6.9 7.2 6.3 2.6 6.8 2.5 4.7 6.8 3.9 3.9 4.3 3.9 4.7 4.0 6.8 2.3 4.0 3.5 4.0 5.1 3.5 0.9 3.5 4.9 3.8 1.1 6.7 3.6 4.9 6.7 2.7 4.3 4.6 0.9 4.7 7.1 4.7 4.8 3.9 4.6 8.0 3.5 1.8 2.5 4.3 1.4 5.5 1.6 2.2 1.5 4.5 6.0 4.8 2.6 3.8 5.0 2.7 6.2 2.0 2.0 4.6 4.8 5.0 5.0 4.4 3.7 4.5 7.1 9.1 10.2 0.0 4.9 3.2 2.7 1.6 6.8 6.5 2.5 5.5 6.3 4.0 5.9 2.6 5.4 6.4 6.8 0.8 4.7 1.4 2.4 4.2 3.9 6.7 10.2 10.2 13.0 8.0 5.7 6.8 9.1 9.8 7.5 ZNF528 KIAA1827 ENSG00000167555 "Zinc finger protein 528" Q3MIS6 19 52397849-52418412 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 24.3;U-266/84: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA065435 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA065435: " "unprognostic (1.90e-2)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (3.73e-1)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "unprognostic (9.60e-2)" "unprognostic (4.81e-3)" "unprognostic (1.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.42e-2)" "unprognostic (2.98e-3)" "unprognostic (3.26e-3)" "unprognostic (2.78e-2)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" 9.8 11.7 16.6 8.9 20.2 5.8 12.2 21.1 21.4 12.4 9.1 15.7 7.9 5.5 15.3 21.7 10.0 15.6 11.4 11.4 15.3 11.2 11.1 5.2 9.3 9.3 17.5 11.4 21.3 6.4 12.7 21.0 10.9 15.3 13.4 10.0 13.3 12.8 12.1 7.6 12.6 7.5 9.8 15.6 11.8 10.0 13.8 22.0 8.2 19.9 5.1 11.5 12.6 10.8 10.5 8.4 10.6 5.0 16.5 12.7 3.4 0.1 0.0 2.9 17.5 6.8 8.4 7.4 6.5 10.8 4.0 9.0 0.2 3.2 0.1 1.6 8.0 2.0 0.0 4.3 5.1 0.0 4.8 2.7 1.0 1.6 10.0 0.1 7.4 8.5 7.5 4.4 0.0 9.5 1.7 0.3 5.8 0.1 9.8 1.4 7.6 4.6 0.1 11.8 3.1 4.9 24.3 12.2 10.1 0.0 0.5 4.1 11.7 1.5 10.9 7.0 8.1 2.7 8.8 0.3 30.6 5.9 3.5 0.1 10.8 7.1 5.0 10.6 6.7 4.7 12.7 7.3 8.1 10.0 5.0 10.5 8.0 7.1 1.4 16.5 5.0 8.4 8.9 3.4 16.6 20.2 21.1 21.4 15.3 11.2 17.5 11.4 15.3 22.0 ZNF532 FLJ10697 ENSG00000074657 "Zinc finger protein 532" Q9HCE3 18 58862600-58986480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015322 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015322: AB_2304947" "unprognostic (3.43e-1)" "unprognostic (4.36e-2)" "unprognostic (1.41e-3)" "prognostic unfavourable (6.46e-5)" "unprognostic (4.24e-1)" "unprognostic (5.84e-2)" "unprognostic (1.50e-3)" "unprognostic (7.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.09e-3)" "unprognostic (1.90e-1)" "unprognostic (7.60e-3)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "unprognostic (5.53e-2)" "prognostic unfavourable (5.76e-4)" 12.3 7.0 14.3 8.0 17.1 0.6 11.4 44.6 22.5 17.5 12.3 23.7 11.6 3.7 35.5 11.2 12.3 15.0 13.1 18.6 14.7 11.9 7.2 2.3 10.4 7.8 14.2 13.4 29.6 4.2 14.5 18.2 13.7 15.0 27.1 7.2 14.5 7.8 19.6 29.5 8.8 6.1 22.5 18.9 8.5 7.1 12.5 17.2 2.5 13.6 7.0 8.9 13.0 19.8 6.7 1.4 0.0 2.2 0.4 1.0 0.7 7.0 9.9 41.2 21.7 6.8 15.1 2.1 13.1 12.1 8.9 8.1 3.5 7.7 8.6 10.0 15.9 11.7 0.3 9.5 8.9 6.3 8.6 0.0 14.9 0.2 9.0 0.0 0.0 11.8 18.6 9.3 17.1 10.0 0.1 10.9 10.5 0.0 0.0 0.1 21.8 6.4 0.2 10.6 1.4 6.2 0.9 9.3 24.8 8.5 0.9 14.4 10.4 5.8 7.4 24.3 18.2 0.2 10.3 0.1 7.1 2.4 8.7 0.0 18.7 0.0 0.4 0.0 1.0 2.2 0.3 6.7 0.5 0.5 1.4 3.6 0.1 0.3 0.0 0.4 0.3 0.2 0.0 0.7 14.3 17.1 44.6 21.4 14.7 11.9 14.2 13.4 15.0 17.2 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA077341: " "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 8.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 23.8 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell line enhanced" "Detected in many" "ASC diff: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.7 2.7 6.9 4.1 0.2 1.0 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 1.0 1.8 0.9 0.9 3.7 2.7 1.0 1.2 0.0 1.8 1.2 2.0 1.9 2.5 0.7 0.0 0.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.5 1.4 1.6 0.8 0.6 0.4 2.8 3.1 1.0 0.3 0.3 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.7 2.0 2.6 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.0;U-87 MG: 3.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058541: , HPA076453: " "unprognostic (4.49e-2)" "prognostic favourable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.2 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA030838 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 4.1 5.1 5.0 3.7 7.1 2.5 4.7 7.9 6.6 4.2 3.6 7.6 7.3 2.0 6.3 3.8 2.8 5.7 2.9 4.9 4.7 3.8 4.8 5.5 3.2 3.8 7.9 4.4 7.3 3.7 6.5 8.5 3.1 6.8 4.6 2.7 5.2 2.9 6.1 5.6 3.8 3.4 5.3 8.3 5.4 3.1 20.8 7.9 6.6 6.0 2.8 4.4 3.6 3.3 2.7 2.8 2.6 2.4 2.5 4.7 1.2 0.2 4.6 2.0 2.6 4.7 3.4 0.3 1.8 2.8 2.2 3.0 0.2 0.6 2.5 2.1 1.6 0.2 1.0 0.3 3.3 2.6 3.3 3.2 3.2 1.7 2.5 3.2 2.2 2.7 2.0 1.3 3.5 2.8 4.0 6.1 2.3 0.6 1.5 0.7 0.7 0.5 1.8 1.7 1.2 1.1 0.4 1.4 1.5 1.0 0.2 1.8 0.9 1.4 1.1 0.7 1.5 0.3 1.4 4.6 4.4 0.5 1.7 1.3 1.4 1.6 1.5 2.6 3.7 2.4 2.5 2.7 2.4 2.2 2.8 2.4 4.7 4.1 1.1 2.5 1.2 0.7 3.0 1.2 5.0 7.1 7.9 6.6 4.7 3.8 7.9 4.4 6.8 7.9 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 13.4" "Group enriched" "Detected in all" 4 "B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8" HPA039511 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 4.7 6.2 7.3 11.8 11.0 5.9 9.3 18.8 10.3 5.2 5.8 8.0 4.0 3.6 7.2 7.7 3.9 8.0 6.9 5.4 9.0 6.2 5.6 2.6 7.6 8.8 9.5 7.0 11.2 4.5 12.5 13.8 6.9 7.0 8.3 4.4 6.5 5.6 6.7 5.4 7.3 6.1 7.3 10.6 9.9 5.2 7.2 8.5 11.2 9.1 3.0 9.7 6.5 11.6 4.7 1.8 1.8 1.2 13.4 5.8 2.1 1.3 1.8 7.2 6.0 2.2 1.8 1.7 3.4 4.1 3.3 16.3 1.9 1.3 2.0 2.4 3.1 0.8 2.3 4.9 5.5 0.2 13.4 9.1 1.4 2.7 3.1 7.5 6.4 3.2 3.8 3.4 4.7 2.1 0.1 0.3 6.0 0.8 8.4 3.2 6.2 4.8 6.0 6.0 4.1 1.3 3.5 3.0 5.3 0.1 0.5 3.9 4.1 5.9 1.7 6.4 4.4 0.3 4.9 3.4 9.9 6.3 1.1 2.6 5.8 0.7 1.0 1.8 3.0 0.8 4.1 2.7 4.1 4.6 1.8 4.7 5.8 3.7 0.8 13.4 1.2 1.6 2.4 2.1 7.3 11.0 18.8 10.3 9.0 6.2 9.5 7.0 7.0 8.5 ZNF550 MGC41917 ENSG00000251369 "Zinc finger protein 550" Q7Z398 19 57535257-57559863 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003251 Uncertain Approved Vesicles,Microtubules Vesicles Microtubules "HPA003251: AB_1080736" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-2)" "unprognostic (1.43e-1)" "unprognostic (2.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.61e-2)" "unprognostic (2.66e-3)" "unprognostic (3.46e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (8.33e-2)" "unprognostic (1.59e-1)" "unprognostic (2.69e-2)" "unprognostic (6.68e-3)" "unprognostic (1.52e-1)" 8.7 6.8 8.7 10.5 11.1 7.1 10.2 15.0 10.6 10.1 6.0 8.9 10.0 4.4 10.1 8.1 6.4 8.7 5.6 9.2 8.6 5.5 6.2 6.2 6.6 11.7 10.2 4.6 16.8 7.7 12.5 16.6 10.9 9.1 11.0 5.0 6.5 9.2 8.1 14.2 10.7 8.6 8.4 7.2 12.2 5.9 6.4 9.6 12.8 8.6 4.0 11.6 9.4 7.3 4.7 2.9 2.7 2.4 6.9 9.4 3.3 3.2 2.6 6.6 6.4 2.7 5.5 0.0 4.4 4.0 4.0 1.9 2.7 3.1 1.1 3.2 3.1 2.9 3.6 4.0 5.1 0.1 18.4 8.5 7.4 3.6 3.7 7.8 3.6 4.9 3.3 3.2 10.0 3.2 1.4 0.1 4.9 0.7 11.3 3.4 7.4 4.8 9.5 7.5 8.9 2.4 5.6 6.4 8.4 5.6 3.7 3.2 4.3 5.4 3.6 5.8 3.7 2.1 4.6 18.6 16.6 7.9 2.2 4.7 5.0 1.7 2.2 2.7 5.7 2.4 6.7 3.5 6.9 3.8 2.9 4.7 9.4 5.8 0.6 6.9 1.0 1.3 5.9 3.3 8.7 11.1 15.0 10.6 8.6 5.5 10.2 4.6 9.1 9.6 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038187: " "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favourable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 6.6 5.6 4.4 8.3 6.9 12.8 7.9 17.3 5.2 5.2 5.1 6.8 8.6 4.2 6.3 5.9 5.3 5.9 6.1 4.9 4.9 4.6 5.1 3.2 3.8 10.8 3.8 3.3 6.8 10.7 6.1 11.3 5.3 4.9 6.0 5.1 6.4 6.0 5.8 8.8 7.3 5.6 6.8 4.0 8.2 5.1 18.1 5.7 13.0 11.1 5.2 10.3 6.4 6.0 6.6 4.7 2.1 3.1 4.7 8.1 3.8 2.6 5.8 7.2 5.2 1.4 1.7 7.6 3.1 2.2 4.4 2.0 4.9 2.6 4.7 2.0 2.3 3.0 4.8 7.2 6.9 0.0 21.0 8.4 0.2 2.1 1.3 5.9 7.6 3.0 2.7 4.5 4.1 1.8 5.7 0.0 3.9 2.5 12.1 2.3 15.1 9.4 7.7 12.5 6.3 1.7 15.0 7.0 5.8 4.7 3.0 2.5 3.8 7.8 2.2 5.1 5.3 1.7 5.8 5.2 11.1 10.8 0.9 2.9 4.8 1.9 2.1 2.1 3.3 3.1 6.2 6.6 4.9 5.2 4.7 5.5 8.1 7.3 1.1 4.7 1.6 3.8 3.9 3.8 4.4 6.9 17.3 5.2 4.9 4.6 3.8 3.3 4.9 5.7 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819874-2835773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060247, HPA063358" Uncertain Supported Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA060247: , HPA063358: " "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favourable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favourable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favourable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favourable (5.00e-4)" 4.1 4.4 7.9 2.0 9.1 1.9 5.1 12.2 14.1 6.0 4.6 7.7 5.6 6.1 6.8 4.5 4.0 6.4 5.6 7.3 8.2 8.4 6.6 8.6 5.0 3.9 6.2 6.9 8.2 5.0 9.8 8.4 25.9 6.0 5.7 4.3 7.7 7.6 5.4 8.9 7.4 4.7 5.6 4.2 3.7 4.2 4.0 6.5 5.1 7.9 4.7 6.0 4.5 4.1 2.3 3.6 0.6 0.6 1.8 1.8 0.7 3.7 0.1 3.3 3.6 2.3 3.0 4.2 2.4 2.6 5.0 2.3 0.3 1.0 3.5 2.3 1.9 1.8 0.3 1.9 0.7 0.0 1.7 1.0 1.2 1.5 1.8 0.5 0.8 2.4 4.4 1.4 2.0 0.4 3.6 2.0 1.6 0.7 1.7 0.4 1.6 1.1 1.9 2.2 0.9 3.2 3.0 3.0 5.4 2.7 0.5 4.0 1.3 1.8 0.0 0.4 0.9 1.4 0.9 6.6 7.3 0.7 1.9 1.7 1.0 0.2 0.3 0.6 0.4 0.1 1.5 0.8 0.7 0.9 0.0 2.3 1.8 0.3 0.2 1.8 0.6 3.6 0.3 0.7 7.9 9.1 12.2 11.2 8.2 8.4 6.2 6.9 6.0 6.5 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favourable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favourable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favourable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favourable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.0 8.2 6.3 4.6 3.3 3.8 4.9 5.1 6.8 5.0 2.5 7.0 6.8 4.7 4.9 7.9 5.1 4.8 9.0 4.8 10.1 7.8 2.6 4.4 10.1 10.8 6.1 5.9 5.5 7.5 4.7 4.1 12.6 7.4 5.3 7.8 3.1 3.9 6.2 5.5 6.0 4.2 3.2 9.4 4.7 5.8 5.7 4.2 4.4 3.5 6.2 6.9 4.4 3.2 8.5 4.1 12.0 9.2 6.7 4.8 5.4 3.4 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 ZNF559 MGC13105 ENSG00000188321 "Zinc finger protein 559" Q9BR84 19 9323772-9351162 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA059632, HPA065485" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA059632: , HPA065485: " "unprognostic (1.35e-3)" "unprognostic (1.98e-1)" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (2.36e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.64e-3)" "prognostic favourable (6.99e-4)" "unprognostic (7.28e-3)" "unprognostic (4.04e-2)" "unprognostic (8.48e-2)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" 9.3 11.1 17.7 8.4 16.2 2.7 14.1 39.5 16.1 13.6 10.4 17.2 11.4 5.1 18.8 18.8 5.9 17.3 8.2 11.9 14.2 8.2 11.2 7.5 10.4 11.8 17.6 15.5 24.0 7.6 22.1 29.2 9.8 16.2 13.6 9.3 11.2 8.3 11.4 3.3 8.7 9.8 16.3 16.2 14.9 8.8 13.7 19.8 10.7 14.0 3.4 10.3 10.2 11.3 12.5 5.3 18.9 4.3 14.2 15.8 6.2 8.6 4.6 9.2 11.2 5.4 4.9 2.4 5.3 10.9 8.0 6.8 2.3 1.0 7.1 6.3 7.7 3.1 5.5 5.0 10.1 11.3 7.5 9.5 7.7 3.1 9.7 8.4 10.5 10.4 9.0 9.0 11.1 6.6 7.0 25.0 5.0 0.0 11.3 26.4 15.0 7.8 5.5 11.2 9.5 4.8 12.2 10.5 8.8 10.3 1.7 12.4 7.4 6.4 5.5 14.6 3.3 11.9 8.0 2.0 0.0 6.9 2.6 5.3 9.1 18.9 3.4 7.5 9.1 3.2 12.0 11.9 9.6 9.6 5.3 12.5 15.8 12.7 1.9 14.2 4.3 4.4 8.4 6.2 17.7 16.2 39.5 16.1 14.2 8.2 17.6 15.5 16.2 19.8 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Group enriched" "Detected in some" 5 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.9" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA045439: , HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182060-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 5.9 5.7 12.1 4.2 11.6 7.1 7.1 10.4 12.8 5.7 5.2 16.8 4.8 4.4 7.1 6.5 5.2 6.7 4.8 5.3 8.0 7.7 5.5 6.2 4.6 4.4 17.3 10.1 11.1 5.7 4.9 7.5 4.6 12.1 7.0 5.8 4.1 8.0 5.6 7.8 6.6 4.1 6.2 17.3 4.5 6.1 13.5 14.9 2.3 6.8 3.5 5.7 6.6 8.4 2.1 3.6 13.8 3.7 3.1 4.5 2.3 3.8 5.5 6.6 4.6 10.4 6.9 1.8 3.8 6.3 4.6 7.9 3.2 3.4 2.9 5.0 4.9 2.3 3.3 2.8 7.3 5.0 1.5 5.3 4.7 4.2 4.4 3.5 3.7 8.1 8.0 3.0 8.0 5.5 3.5 3.6 5.6 4.9 4.2 0.9 2.6 2.6 3.6 3.9 2.9 4.6 5.2 5.3 5.5 3.1 3.6 3.5 2.5 3.8 4.5 6.6 3.8 4.8 5.5 1.1 1.8 1.9 6.3 2.9 3.2 13.8 3.1 4.8 3.5 3.2 3.8 2.1 4.0 3.4 3.6 2.1 4.5 3.5 1.5 3.1 3.7 1.9 2.0 2.3 12.1 11.6 10.4 12.8 8.0 7.7 17.3 10.1 12.1 14.9 ZNF567 MGC45586 ENSG00000189042 "Zinc finger protein 567" Q8N184 19 36687612-36727701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023937 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023937: AB_1859351" "unprognostic (4.39e-3)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.03e-2)" "unprognostic (2.36e-2)" "unprognostic (6.57e-2)" "unprognostic (2.40e-2)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (1.54e-1)" "unprognostic (9.93e-2)" "unprognostic (1.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (7.24e-2)" "unprognostic (9.03e-2)" 5.9 7.0 6.3 6.7 6.9 5.0 10.2 12.2 10.2 8.0 6.3 4.7 6.6 3.8 9.2 7.5 7.8 7.0 5.5 5.3 7.7 6.0 6.0 7.7 5.8 8.6 7.1 2.3 8.4 4.9 10.4 15.8 13.0 8.0 9.3 5.0 5.1 7.3 12.1 7.4 5.6 5.5 9.7 9.1 7.2 5.5 14.2 9.6 9.0 8.3 3.3 8.2 6.6 7.5 8.8 3.9 7.0 2.3 7.9 8.2 3.0 6.7 5.3 9.8 8.7 5.6 5.5 9.3 5.0 7.7 5.7 9.2 3.0 2.4 4.3 6.1 4.5 1.8 9.0 5.2 7.8 8.4 4.6 8.1 5.9 2.9 5.2 10.2 6.2 8.6 6.3 5.4 10.6 6.6 3.1 2.3 6.8 4.2 13.1 3.9 9.4 4.3 6.5 13.5 6.1 3.7 10.4 7.3 7.9 9.3 4.6 4.9 5.9 6.9 4.1 7.6 7.7 3.8 5.6 8.8 7.3 14.3 0.0 4.1 6.6 5.7 2.3 7.0 7.7 2.0 6.3 7.3 8.2 7.1 3.9 8.8 8.2 8.2 1.3 7.9 2.0 2.7 6.6 3.0 6.3 6.9 12.2 10.2 7.7 6.0 7.1 2.3 8.0 9.6 ZNF569 "FLJ32053, ZAP1" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: " "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 5.8 7.8 10.9 6.1 11.1 7.7 6.6 20.9 10.6 6.9 5.0 6.4 3.8 3.2 7.2 9.5 4.4 6.5 4.5 7.7 8.0 11.2 6.9 6.0 4.6 7.2 8.6 8.7 10.9 3.7 8.8 18.5 5.5 10.6 6.6 3.5 5.2 4.5 5.6 7.2 6.5 4.1 6.3 10.2 6.2 4.2 20.1 11.3 9.6 10.5 3.8 5.9 6.4 4.7 7.2 3.2 7.1 4.0 6.2 11.3 3.2 2.8 5.8 6.6 11.0 5.5 4.9 3.2 5.1 3.1 5.7 6.1 1.9 1.2 3.3 7.5 3.8 1.0 7.3 2.0 6.0 7.6 4.4 8.6 1.4 3.2 3.3 1.6 3.5 3.4 1.3 5.7 0.1 4.5 2.8 0.6 7.9 1.7 10.9 3.7 7.8 4.1 7.0 8.4 3.5 4.0 2.7 5.7 8.9 0.2 1.3 2.9 4.9 6.9 4.4 4.4 9.1 3.4 8.3 9.4 16.0 13.1 0.3 3.6 7.0 4.9 2.6 7.1 8.7 3.3 7.7 6.1 7.8 8.1 2.8 7.2 11.3 8.9 2.7 6.2 4.0 3.2 7.8 3.2 10.9 11.1 20.9 10.6 8.0 11.2 8.6 8.7 10.6 11.3 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.7 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.2 6.3 5.7 1.3 2.4 0.8 5.3 1.7 9.5 2.1 15.8 3.5 4.8 3.0 5.0 9.0 11.6 13.6 9.5 6.4 2.1 3.2 9.7 1.3 0.8 3.0 3.9 3.2 6.9 7.7 15.8 13.2 0.5 0.8 6.5 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 6.2 6.4 7.3 4.2 8.6 7.2 7.6 14.1 9.5 6.3 4.6 8.6 5.2 4.3 7.5 10.8 4.8 5.0 6.8 5.3 5.8 4.1 5.3 4.2 6.0 4.1 10.0 5.7 8.4 6.8 6.7 11.7 5.7 6.2 5.5 4.9 5.9 6.4 5.6 5.3 7.8 5.3 6.9 6.8 5.3 7.5 10.0 9.5 4.5 9.8 4.0 6.2 7.4 6.2 6.3 3.3 3.3 2.6 3.6 5.7 1.0 1.0 3.6 2.8 2.4 1.4 3.4 1.2 2.3 2.7 0.9 2.2 3.5 2.8 3.5 2.3 2.1 2.2 2.8 3.8 3.4 1.8 1.9 4.0 5.4 1.8 1.4 3.3 2.6 3.0 1.4 4.8 2.1 2.8 1.8 1.6 0.7 1.4 2.7 2.0 4.5 0.4 2.8 5.7 1.1 0.2 1.6 3.7 3.7 4.6 1.5 0.4 3.5 3.1 1.0 3.2 3.3 2.8 3.8 4.2 5.3 5.7 0.8 0.4 2.6 3.2 1.0 3.3 4.2 1.2 3.4 3.4 3.5 4.5 1.9 6.3 5.7 4.4 0.4 3.6 2.6 3.3 2.0 1.0 7.3 8.6 14.1 9.5 5.8 4.1 10.0 5.7 6.2 9.5 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: " "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 8.8 3.9 10.5 3.8 10.0 2.5 3.2 12.3 13.5 4.9 13.8 6.8 2.9 5.6 4.7 4.0 2.4 3.6 4.6 3.6 6.6 4.2 3.9 3.2 3.6 3.9 5.4 6.2 6.3 2.3 3.0 5.2 2.0 6.7 5.5 7.1 5.1 5.0 4.1 12.9 4.8 6.4 3.4 6.0 5.8 4.7 1.9 6.5 2.4 3.3 2.3 4.2 3.5 3.7 3.0 1.9 0.8 0.9 7.0 4.4 1.3 2.9 2.6 0.6 0.8 4.0 3.3 0.2 1.9 1.2 0.7 1.0 0.6 1.1 0.6 1.3 1.4 1.6 0.1 0.3 0.3 4.1 0.5 2.2 0.9 0.5 0.9 0.9 2.7 1.9 1.1 1.0 0.2 0.6 0.8 4.1 1.2 1.9 11.6 0.3 0.2 1.3 6.3 0.0 1.5 0.7 1.7 0.6 1.0 1.5 1.9 1.9 0.5 1.0 2.0 3.7 2.5 0.8 1.4 2.2 3.1 1.7 2.3 2.6 3.8 0.1 0.9 0.6 3.0 0.5 1.2 1.5 2.8 2.9 1.3 3.0 4.4 3.2 0.8 7.0 0.3 1.9 2.3 1.3 10.5 10.0 12.3 13.5 6.6 4.2 5.4 6.2 6.7 6.5 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA050064: " "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 11.8 14.4 14.5 11.4 18.7 5.2 11.3 28.0 19.4 11.2 11.5 15.3 11.4 16.0 12.7 9.0 15.0 14.2 13.4 16.0 13.3 13.7 12.1 23.5 8.7 12.5 15.7 16.8 17.9 14.7 11.4 16.4 10.2 16.5 16.9 8.5 9.5 17.7 12.9 21.0 11.3 15.1 9.8 13.4 10.3 11.9 13.2 13.3 13.3 13.9 8.4 10.2 16.1 10.5 22.3 22.2 13.9 13.6 15.7 17.7 10.3 15.6 18.3 6.8 8.6 9.1 8.2 6.1 13.1 8.7 13.2 14.8 8.9 12.0 10.3 14.9 9.8 6.4 9.7 9.2 3.6 11.2 16.6 7.6 12.7 11.0 7.6 10.1 14.2 7.0 11.7 11.5 4.7 9.4 9.4 13.4 10.0 15.4 14.1 4.5 4.7 15.6 12.0 6.0 10.1 7.8 14.1 12.6 7.9 8.6 17.4 6.6 8.2 11.7 9.7 17.7 9.9 7.9 19.1 7.1 7.9 7.0 15.3 11.8 15.2 9.3 13.6 13.9 15.9 12.6 14.3 22.3 16.0 13.5 13.9 16.7 17.7 14.0 7.3 15.7 12.5 22.2 15.9 10.3 14.5 18.7 28.0 19.4 13.3 13.7 15.7 16.8 16.5 13.3 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041499: , HPA046761: " "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favourable (2.03e-4)" 7.9 6.8 13.4 5.8 15.5 4.2 13.9 14.6 12.1 10.2 10.9 9.9 15.5 5.1 12.3 11.1 6.3 10.0 8.9 8.0 14.8 5.6 11.0 5.5 6.8 5.6 7.6 8.7 27.2 7.1 17.4 7.5 10.1 9.9 17.4 7.6 17.2 12.9 16.1 9.4 22.3 8.1 14.4 11.0 10.1 7.1 22.5 14.9 3.8 16.3 5.2 6.3 8.8 10.2 9.4 3.2 7.1 4.0 4.6 4.6 1.8 1.2 0.1 6.6 8.1 11.4 12.4 0.0 7.7 2.9 3.0 6.1 0.8 1.0 1.3 0.8 3.5 2.1 2.6 1.6 1.6 0.0 7.6 12.7 0.1 1.1 8.9 2.8 4.3 9.7 5.0 4.4 1.3 1.5 2.8 0.0 3.8 0.0 7.8 3.6 7.6 0.2 3.4 3.3 2.3 4.9 2.9 2.7 1.4 1.9 0.9 6.5 1.3 3.1 1.0 5.6 7.7 1.6 2.8 5.4 0.0 1.7 1.5 0.5 8.9 7.1 2.6 5.7 1.7 4.0 4.6 9.4 3.0 3.6 2.8 5.1 3.8 2.4 1.2 4.6 3.0 3.2 1.4 1.8 13.4 15.5 14.6 12.1 14.8 5.6 7.6 8.7 9.9 14.9 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 4.8 8.7 7.7 4.7 8.9 2.7 6.3 9.4 9.0 4.7 4.9 7.8 3.6 2.3 7.9 13.5 4.8 6.1 6.4 8.0 8.2 7.1 5.9 4.8 5.2 8.0 9.6 3.9 10.2 4.0 7.5 11.4 5.4 8.9 8.4 2.7 4.4 4.1 5.5 3.5 5.6 3.3 5.5 7.7 7.2 3.4 8.9 13.1 7.8 13.8 2.2 3.7 5.4 5.9 5.9 3.4 5.9 3.3 11.0 6.5 2.8 0.0 1.0 5.9 1.2 1.5 1.5 0.0 2.4 2.5 1.6 1.2 0.0 0.3 0.0 1.6 1.3 0.0 0.7 0.3 1.2 0.0 23.8 5.7 0.0 0.4 2.5 1.5 4.6 5.3 1.3 1.0 0.0 0.9 1.3 0.0 0.9 0.0 3.3 3.6 3.3 0.0 1.5 2.0 2.1 1.3 3.3 0.0 3.9 0.0 0.8 0.0 2.7 3.1 1.0 3.1 6.3 0.8 3.2 5.1 5.5 3.6 0.2 0.3 1.7 4.3 2.2 5.9 4.4 3.3 6.5 5.9 5.2 4.4 3.3 4.3 3.8 4.8 0.5 11.0 2.4 3.4 1.6 2.8 7.7 8.9 9.4 9.0 8.2 7.1 9.6 3.9 8.9 13.1 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA023805: , HPA023957: " "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 7.2 5.9 7.9 3.9 9.3 2.3 4.7 11.6 12.4 5.6 4.6 5.6 3.7 3.2 6.1 5.5 3.6 5.8 5.4 5.0 7.7 7.3 6.6 5.9 6.6 4.5 7.5 6.3 11.2 5.9 7.3 8.4 4.7 8.3 6.0 3.5 3.3 2.6 4.7 4.8 2.1 3.1 6.2 7.6 5.4 3.9 15.8 7.6 5.0 7.9 2.1 4.1 4.4 5.7 6.3 3.5 9.4 4.7 9.2 7.4 2.8 0.0 1.9 4.6 0.0 3.3 2.6 0.0 5.7 5.8 2.6 2.2 0.2 0.6 4.3 2.8 5.2 0.2 1.8 1.8 2.9 2.0 10.0 5.6 0.0 1.0 3.7 4.6 5.1 3.7 2.8 3.8 1.9 2.6 2.1 1.6 8.6 0.0 5.7 1.6 1.1 1.9 2.9 8.8 3.2 2.1 4.2 2.6 4.0 0.0 0.5 1.5 2.9 6.0 1.7 13.8 3.7 2.6 11.2 5.9 10.8 6.7 0.3 1.2 4.9 9.4 2.2 4.7 4.9 3.2 7.2 6.3 4.0 4.5 2.5 5.5 7.4 4.4 1.0 9.2 4.7 3.5 4.9 2.8 7.9 9.3 11.6 12.4 7.7 7.3 7.5 6.3 8.3 7.6 ZNF585B "FLJ14928, SZFP41" ENSG00000245680 "Zinc finger protein 585B" Q52M93 19 37181579-37218153 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA075556 Approved "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA075556: " "unprognostic (9.53e-3)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.30e-2)" "unprognostic (9.52e-2)" "unprognostic (2.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.13e-1)" "unprognostic (3.11e-2)" "unprognostic (5.01e-2)" "unprognostic (3.56e-2)" "unprognostic (2.58e-1)" "unprognostic (3.26e-2)" "unprognostic (4.59e-2)" "unprognostic (2.79e-1)" "unprognostic (6.41e-2)" "unprognostic (4.18e-3)" 6.6 8.3 11.2 5.8 13.4 2.6 9.3 17.9 12.9 10.0 8.1 8.7 11.4 5.6 11.6 15.2 5.8 8.8 7.5 7.2 9.8 10.0 8.7 5.2 6.2 7.3 14.1 9.8 15.0 6.2 23.4 22.6 8.0 10.1 8.9 7.2 8.3 6.3 11.6 5.0 6.3 7.2 10.1 12.3 9.7 7.6 9.2 12.4 9.5 13.1 5.6 9.1 9.3 7.2 6.5 1.9 3.7 4.2 2.9 7.1 2.9 2.4 4.1 3.7 7.4 6.2 9.8 2.0 3.2 5.1 5.8 8.8 2.2 3.0 0.1 6.8 4.1 0.7 0.1 4.9 7.3 4.8 1.9 3.2 5.4 1.2 6.0 0.3 6.7 7.6 3.0 6.6 3.5 2.4 0.0 0.2 3.4 1.5 5.5 2.1 4.2 1.1 0.2 2.1 0.1 3.1 9.9 6.6 4.3 0.0 0.3 1.4 2.8 3.4 2.0 0.6 1.4 4.9 3.8 5.7 7.4 6.8 0.3 0.1 6.4 3.3 1.6 3.7 5.0 3.1 6.3 6.5 3.6 4.4 1.9 4.9 5.2 7.1 2.5 2.9 4.2 1.7 3.5 2.9 11.2 13.4 17.9 12.9 9.8 10.0 14.1 9.8 10.1 12.4 ZNF586 FLJ20070 ENSG00000083828 "Zinc finger protein 586" Q9NXT0 19 57769655-57819939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030306, HPA060782" Approved Approved "Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" Vesicles "HPA030306: , HPA060782: " "prognostic favourable (9.83e-5)" "unprognostic (1.60e-2)" "unprognostic (2.93e-1)" "unprognostic (1.72e-3)" "unprognostic (2.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.10e-2)" "unprognostic (1.02e-3)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (1.88e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (6.01e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "prognostic favourable (5.36e-4)" 7.6 6.9 11.7 12.3 11.7 27.3 10.6 22.4 13.8 8.5 7.7 6.6 14.7 7.9 9.1 10.0 10.8 8.9 9.2 10.0 11.8 4.4 8.5 7.8 16.5 16.2 9.3 8.7 13.9 8.4 6.6 13.4 9.0 8.4 13.5 8.1 9.8 14.3 18.4 33.3 12.4 10.2 7.7 8.7 16.2 9.8 7.0 13.0 11.6 10.7 8.8 12.2 12.0 11.5 7.2 6.1 20.8 6.6 6.3 10.0 5.2 5.0 4.4 6.0 7.1 3.0 2.7 10.0 3.6 3.5 5.0 2.6 2.0 5.1 10.6 0.4 3.2 3.7 1.1 4.8 9.0 1.6 24.2 8.3 10.0 1.3 5.2 7.9 7.6 4.5 5.6 3.5 5.5 5.8 5.3 0.6 5.8 1.7 8.0 5.6 8.9 11.6 8.1 2.3 13.4 5.7 13.0 8.7 4.0 1.7 5.1 3.8 5.4 6.2 3.2 6.7 3.7 0.3 5.9 11.9 14.7 11.2 3.6 0.9 4.8 4.4 6.6 20.5 6.1 5.5 5.9 5.2 7.9 6.5 6.1 7.2 10.0 9.0 20.8 6.3 3.6 4.7 9.9 5.2 11.7 11.7 22.4 13.8 11.8 4.4 9.3 8.7 8.4 13.0 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169871-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA054363: , HPA059387: " "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 11.7 11.5 9.4 10.7 9.4 15.7 18.3 7.2 12.1 9.0 11.7 7.0 12.1 11.4 8.7 9.0 10.9 8.4 11.3 14.5 8.9 10.0 13.5 30.8 7.7 16.8 10.0 7.0 11.6 36.2 9.7 9.3 12.7 10.9 10.4 5.8 5.9 15.9 12.0 59.3 9.8 11.0 6.5 7.3 13.0 15.2 9.3 8.3 5.4 15.1 17.2 9.2 10.6 10.1 23.5 26.8 0.7 25.0 16.1 21.7 14.1 20.0 11.0 3.8 13.3 3.7 4.8 20.1 8.9 4.5 10.4 10.0 16.9 12.2 23.4 16.5 5.6 13.1 12.9 11.6 3.8 14.0 41.2 15.9 9.0 25.6 15.9 21.9 14.0 8.8 11.4 11.5 12.1 8.7 23.9 9.1 6.1 15.3 8.9 40.8 15.0 39.3 11.2 6.6 23.6 7.4 8.8 10.1 11.0 10.8 27.2 34.0 11.3 12.4 9.0 10.0 11.9 21.0 16.6 17.9 18.0 25.3 11.8 45.6 12.8 0.1 15.7 0.2 14.2 25.0 13.3 23.5 20.1 14.0 21.7 22.7 15.0 14.3 0.7 16.1 25.0 26.8 21.7 14.1 9.4 9.4 7.2 12.1 8.9 10.0 10.0 7.0 10.9 8.3 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 4.9 6.2 6.3 9.9 7.4 2.6 8.5 18.2 10.1 6.7 4.4 8.3 8.3 4.3 10.4 11.9 4.7 6.7 6.3 5.1 7.5 7.0 6.1 5.3 4.8 5.3 6.8 7.3 7.8 7.1 13.5 10.9 5.5 6.2 6.1 5.3 6.6 4.2 9.4 10.2 6.7 4.1 7.7 7.8 6.8 5.4 22.4 7.8 7.4 9.2 4.2 4.4 4.5 4.8 6.8 4.4 6.4 5.0 2.9 7.3 2.6 1.8 1.1 5.4 13.8 2.8 2.6 4.6 4.1 1.9 1.6 2.9 1.3 2.2 1.7 1.3 3.4 3.6 1.5 3.2 2.1 1.4 2.1 3.9 3.3 1.3 3.1 1.7 1.8 6.1 0.5 1.9 2.9 1.3 2.3 5.9 9.6 5.8 4.2 1.6 2.8 1.3 1.9 1.2 3.2 5.4 3.2 3.1 8.1 2.8 1.4 2.0 4.1 5.0 3.2 4.0 1.1 0.3 1.8 2.1 5.2 2.2 4.8 1.4 2.5 6.4 2.8 4.5 4.8 2.3 6.7 6.4 5.2 4.2 3.6 6.8 6.2 7.3 3.1 2.9 5.0 4.4 5.6 2.6 6.3 7.4 18.2 10.1 7.5 7.0 6.8 7.3 6.2 7.8 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432422-3443542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.3" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 6.7 6.7 4.5 4.6 8.5 5.0 5.9 5.2 8.7 4.7 4.2 7.3 2.4 3.8 5.6 6.8 4.0 5.9 6.0 5.4 4.8 4.4 5.2 5.4 7.4 6.1 4.5 4.5 7.2 5.2 4.5 7.7 7.9 8.9 4.8 3.2 5.8 4.6 4.9 3.6 4.4 5.1 4.1 4.6 5.4 4.8 13.2 5.4 5.4 6.4 2.6 5.6 5.7 4.6 1.4 1.1 11.3 2.2 0.9 2.2 0.8 0.0 1.8 2.2 5.3 1.7 2.6 8.6 2.5 3.1 2.5 3.1 0.0 3.3 4.3 2.5 2.9 1.4 5.1 2.3 3.2 2.6 2.0 7.5 4.8 3.1 2.5 4.4 4.5 3.3 3.6 2.8 3.1 6.8 1.6 2.9 2.8 1.4 3.1 4.6 7.3 0.0 2.0 6.6 3.0 2.0 7.0 2.9 4.1 5.1 2.6 1.9 2.2 6.7 4.4 4.1 2.1 0.0 2.4 3.8 4.0 0.5 0.0 2.5 2.5 3.8 1.1 11.3 1.3 2.2 2.2 1.4 1.0 1.1 1.1 1.1 1.9 1.4 0.3 0.9 1.0 0.5 1.6 0.8 4.5 8.5 5.2 8.7 4.8 4.4 4.5 4.5 8.9 5.4 ZNF598 "FLJ00086, HEL2" ENSG00000167962 "Zinc finger protein 598" 16 1997654-2009823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041760, HPA041896" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041760: AB_10794787, HPA041896: AB_10796464" "unprognostic (9.43e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (6.76e-3)" "unprognostic (3.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.22e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (4.45e-2)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (4.69e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.81e-2)" "unprognostic (7.81e-2)" 8.4 6.1 4.1 9.1 9.4 14.3 13.9 10.6 9.5 8.3 7.7 8.8 4.7 9.9 8.7 4.0 10.0 7.1 4.8 5.6 5.2 4.1 5.9 12.2 7.8 9.1 4.2 7.1 9.8 24.8 6.5 12.9 8.1 6.4 8.9 3.2 6.8 15.6 7.3 12.9 15.3 9.9 9.5 2.9 11.8 12.4 10.1 6.1 10.0 7.7 10.6 12.5 6.8 7.6 1.8 3.2 0.6 0.9 1.2 1.7 0.5 9.9 12.8 3.3 7.9 3.0 4.1 9.5 7.4 3.8 4.9 3.9 13.9 6.0 9.9 9.3 4.8 11.7 5.4 9.2 1.3 14.1 30.8 7.7 13.6 7.6 13.5 12.3 8.8 4.5 12.6 7.8 15.1 5.3 17.3 15.5 2.5 17.1 11.7 19.1 9.6 15.6 26.7 6.5 23.1 2.4 3.6 15.8 12.9 7.5 9.3 12.0 6.5 20.6 8.6 10.5 12.5 9.0 13.9 17.4 15.4 13.0 4.5 11.8 9.6 0.6 0.6 0.2 1.2 0.7 1.7 1.1 1.2 0.9 0.7 1.8 1.1 1.6 0.4 1.2 0.9 3.2 0.3 0.5 4.1 9.4 10.6 9.5 5.2 4.1 4.2 7.1 6.4 6.1 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.3 2.7 5.9 5.5 6.6 8.9 3.2 2.0 5.5 4.9 5.8 2.3 3.6 0.6 5.7 3.7 2.8 3.9 2.5 6.1 0.6 4.9 4.1 5.4 6.6 5.0 0.9 4.7 8.0 3.7 2.2 2.3 5.6 6.9 0.5 7.6 2.1 10.3 4.3 2.6 0.2 5.6 5.6 3.3 6.1 1.3 7.1 10.1 6.6 1.2 3.9 3.5 0.5 3.0 4.9 5.5 3.6 2.1 6.2 6.7 0.5 3.0 0.1 4.6 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918308-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061970: , HPA062655: " "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 5.5 8.2 10.9 7.6 9.9 3.2 12.2 19.0 12.8 10.1 8.3 8.4 9.5 6.7 10.2 13.1 7.3 9.3 6.6 9.9 10.8 7.9 9.9 8.1 7.6 8.0 7.8 8.2 13.3 8.2 16.9 12.9 10.2 8.1 10.7 6.9 9.9 8.8 9.6 14.6 11.5 8.3 8.2 7.4 7.4 8.7 4.8 9.1 8.5 15.5 6.1 7.5 8.5 9.9 2.6 1.4 1.9 1.2 1.7 3.0 0.8 4.5 3.7 9.5 9.0 5.2 10.9 7.1 6.2 3.6 2.9 2.0 0.6 0.6 1.9 3.4 5.3 2.5 4.1 1.5 3.6 1.5 7.1 8.7 2.9 2.9 4.0 3.6 9.6 6.9 6.9 2.0 4.4 2.2 1.3 0.1 7.2 1.3 4.7 5.1 7.3 5.1 4.4 6.2 1.3 4.9 7.8 6.1 7.0 2.8 1.7 4.3 10.3 10.5 4.3 3.6 5.8 5.3 2.5 0.0 0.0 1.5 0.1 3.0 2.1 1.6 1.2 1.3 1.6 0.8 0.9 2.6 1.4 1.7 0.9 2.2 3.0 1.9 1.9 1.7 0.9 1.4 0.4 0.8 10.9 9.9 19.0 12.8 10.8 7.9 7.8 8.2 8.1 9.1 ZNF608 "DKFZp434M098, KIAA1281, NY-REN-36" ENSG00000168916 "Zinc finger protein 608" Q9ULD9 5 124636913-124748807 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 24.8;AN3-CA: 15.8;REH: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.2;naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005545, HPA076984" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA005545: AB_1080742, HPA076984: " "unprognostic (3.82e-2)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "prognostic unfavourable (5.47e-4)" "unprognostic (3.75e-1)" "unprognostic (2.26e-1)" "unprognostic (3.04e-2)" "unprognostic (5.02e-2)" "unprognostic (7.52e-2)" "unprognostic (5.24e-2)" "unprognostic (3.67e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (6.36e-2)" "unprognostic (2.80e-1)" "unprognostic (3.02e-1)" "unprognostic (9.56e-2)" 8.5 14.7 17.0 7.5 17.2 2.0 10.1 25.5 16.5 11.5 10.4 28.3 2.8 15.7 7.5 7.1 5.4 13.6 10.1 12.5 19.7 8.8 8.2 3.9 15.3 10.8 21.8 10.7 9.6 12.0 9.1 11.6 4.5 18.0 8.5 10.7 14.1 8.3 7.1 8.9 4.8 9.1 6.4 22.9 3.9 9.8 13.0 24.5 4.6 13.4 3.3 11.0 6.6 6.6 3.1 1.1 5.2 0.0 0.0 0.0 0.0 0.1 0.4 24.8 15.8 3.7 6.1 0.0 0.0 0.6 0.1 1.5 2.6 7.4 8.1 8.3 0.0 0.3 1.6 1.5 0.1 0.0 3.9 0.0 0.0 0.1 5.7 0.0 0.7 6.1 4.5 0.7 0.7 5.3 0.7 0.1 1.3 0.0 0.0 0.0 10.5 0.3 43.1 2.1 0.0 3.5 0.3 3.7 13.1 0.0 0.3 5.6 1.4 0.7 1.4 5.0 9.6 0.1 1.5 3.9 3.9 14.6 1.3 0.2 7.1 5.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 3.1 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 17.0 17.2 25.5 14.3 19.7 8.8 21.8 10.7 18.0 24.5 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 11.1 11.2 14.5 14.5 12.6 7.3 11.4 17.1 15.1 17.9 14.2 16.2 19.1 12.1 18.7 8.4 10.2 15.7 14.0 10.9 12.3 10.4 9.1 10.2 13.9 11.3 10.9 11.0 29.9 11.6 18.1 11.6 16.3 10.9 15.2 11.4 14.6 12.6 22.8 9.2 11.9 11.2 16.1 12.7 12.9 11.4 28.9 13.6 21.4 12.4 4.5 12.1 15.6 28.4 1.2 2.8 3.2 1.7 4.0 3.0 0.5 6.1 15.5 16.7 6.4 6.4 8.2 5.7 8.0 10.7 10.0 10.2 9.5 9.7 10.5 6.7 9.4 13.1 24.4 11.0 10.6 12.1 5.2 19.1 8.9 4.6 11.9 11.0 12.8 8.3 10.1 10.5 20.8 18.6 30.0 6.8 8.2 5.5 8.5 4.7 12.6 4.3 7.8 15.2 5.5 7.3 11.0 13.6 10.4 10.9 12.5 7.5 6.1 7.7 18.5 9.4 15.1 4.8 9.9 7.6 8.6 9.5 5.8 12.0 7.6 3.2 1.7 1.9 2.3 0.7 1.6 0.7 1.3 1.6 0.6 1.2 3.0 3.0 2.1 4.0 0.8 2.8 0.8 0.5 14.5 12.6 17.1 15.1 12.3 10.4 10.9 11.0 10.9 13.6 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favourable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.2 6.9 6.9 6.0 6.9 1.7 5.3 8.5 7.1 9.2 1.4 3.7 2.6 2.8 6.6 3.6 6.7 6.6 7.7 0.1 8.6 5.5 3.0 3.9 6.1 0.3 7.9 5.1 7.6 6.7 5.5 7.6 2.5 0.0 7.1 0.6 9.2 4.1 4.9 5.9 5.0 7.3 2.8 6.9 10.8 4.6 4.5 8.5 6.3 5.0 6.6 6.8 4.8 3.1 5.9 2.4 5.6 6.0 0.0 5.1 0.2 0.0 9.3 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.8 7.3 9.5 5.2 5.9 1.0 5.1 3.7 4.8 5.9 3.7 2.2 9.6 2.9 4.4 1.7 10.8 6.9 7.2 2.6 15.4 14.5 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 5.6 7.7 2.2 6.4 1.5 12.4 6.0 8.4 5.2 8.3 14.1 7.9 4.9 9.8 9.8 5.9 3.1 3.9 3.2 5.2 7.6 5.7 4.8 6.6 2.7 6.1 4.4 6.8 14.8 4.5 4.2 6.2 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA052422 Uncertain Approved Nucleoli,Mitochondria Mitochondria Nucleoli "HPA052422: " "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favourable (2.98e-4)" 10.2 7.4 11.9 6.0 16.4 7.5 10.1 20.7 12.2 8.2 8.8 7.3 6.9 5.2 12.0 7.8 6.5 9.8 7.6 8.5 8.5 7.1 9.5 6.1 7.6 6.2 11.7 9.8 15.7 7.5 16.6 17.8 8.3 9.9 26.9 5.8 8.0 7.7 11.0 7.2 7.2 6.0 9.6 12.8 7.9 6.7 5.5 13.6 7.3 11.7 3.8 6.1 11.1 8.8 4.7 4.8 6.9 4.4 12.0 7.8 3.8 1.3 5.2 5.8 11.8 10.6 7.7 4.4 3.9 6.6 5.4 5.6 1.1 1.4 2.1 2.2 4.7 1.4 4.0 2.6 5.0 0.3 8.9 6.7 5.2 4.0 8.3 0.0 4.0 6.6 2.8 8.6 9.1 2.9 0.0 0.0 4.1 0.4 0.0 3.5 6.0 8.8 4.2 9.1 3.7 3.7 9.1 5.2 4.5 4.8 4.5 3.2 6.5 3.3 5.2 5.1 5.9 3.3 2.8 4.0 10.5 2.6 3.0 0.0 8.2 6.9 3.0 5.8 3.7 4.4 7.8 3.9 6.6 5.3 4.8 4.7 6.6 4.3 4.1 12.0 2.7 2.9 5.7 3.8 11.9 16.4 20.7 12.2 8.5 7.1 11.7 9.8 9.9 13.6 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40490236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 8.8 7.6 6.3 9.2 9.5 9.0 9.2 7.9 8.7 7.0 6.7 13.3 8.4 7.3 9.3 6.6 6.4 8.4 8.9 6.9 7.8 5.8 7.1 8.1 9.6 18.0 12.7 9.2 9.4 12.3 14.0 6.6 6.3 7.3 7.0 8.2 9.7 8.6 10.4 8.5 7.3 7.5 7.6 9.6 9.0 7.3 3.8 9.3 6.0 10.2 5.0 9.4 8.0 6.8 4.1 4.5 5.1 4.5 5.2 5.1 2.7 2.7 4.0 4.7 4.1 6.8 7.2 1.7 3.6 4.4 7.0 6.9 1.2 3.9 0.3 2.2 3.4 3.0 4.3 7.4 7.6 4.7 1.6 8.2 3.2 1.9 7.2 5.8 7.4 5.8 5.6 7.1 10.5 6.4 5.4 3.9 4.3 3.4 0.1 2.6 2.5 3.6 1.6 4.8 4.5 2.9 6.3 3.0 3.1 4.0 5.9 3.2 4.8 3.8 4.9 5.1 3.9 2.8 4.1 2.2 2.8 0.3 3.1 3.6 5.3 2.8 3.2 5.1 3.0 4.5 3.3 3.3 3.0 3.8 4.5 4.1 3.1 3.9 3.8 5.2 4.3 2.8 5.1 2.7 6.3 9.5 7.9 8.7 7.8 5.8 12.7 9.2 7.3 9.3 ZNF622 "MGC17552, MGC2485, ZPR9" ENSG00000173545 "Zinc finger protein 622" Q969S3 5 16451519-16465792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036514, HPA036515" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Nucleoli" "HPA036514: , HPA036515: AB_10672224" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.00e-2)" "unprognostic (6.53e-2)" "unprognostic (8.24e-3)" "unprognostic (4.71e-3)" "unprognostic (1.06e-1)" "unprognostic (1.71e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (8.69e-2)" "unprognostic (5.93e-2)" "unprognostic (2.19e-1)" "unprognostic (7.42e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" 14.3 10.8 18.3 12.1 19.4 28.8 14.8 20.5 20.3 12.6 19.5 14.5 9.5 15.5 14.4 16.9 13.6 13.2 12.3 38.6 13.8 14.6 14.8 18.8 12.8 14.5 16.8 15.5 15.1 45.9 12.5 15.0 16.0 17.2 13.1 19.8 10.9 17.5 12.8 29.0 18.6 19.6 12.6 12.8 12.4 15.9 14.1 17.3 14.0 16.7 11.9 15.4 13.7 14.9 50.4 45.6 55.4 45.9 39.1 56.9 47.2 11.0 24.2 7.6 15.6 18.6 15.9 27.6 19.9 15.1 16.3 20.8 28.7 10.3 13.0 26.9 15.7 14.6 12.2 15.5 13.1 17.4 16.5 11.8 42.9 20.5 26.8 22.9 14.2 24.5 19.7 15.1 14.3 11.3 15.9 12.9 17.8 18.6 12.0 22.4 13.4 23.9 9.5 9.2 11.0 15.0 16.6 10.5 11.8 27.8 20.9 32.2 11.6 17.8 15.4 18.2 13.9 17.6 12.6 18.6 16.6 18.1 15.8 19.9 12.6 45.2 41.6 52.9 49.1 43.4 51.2 50.4 49.5 53.7 45.6 47.0 56.9 47.7 55.4 39.1 45.9 37.0 50.1 47.2 18.3 19.4 20.5 20.3 13.8 14.6 16.8 15.5 17.2 17.3 ZNF625 ENSG00000257591 "Zinc finger protein 625" Q96I27 19 12142090-12156729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA074014 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA074014: " "unprognostic (7.88e-3)" "unprognostic (6.74e-2)" "unprognostic (9.56e-2)" "unprognostic (8.75e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-3)" "unprognostic (4.72e-2)" "unprognostic (3.31e-2)" "unprognostic (6.23e-2)" "unprognostic (2.73e-1)" "unprognostic (5.49e-2)" "unprognostic (3.70e-2)" "unprognostic (8.29e-2)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.62e-1)" 4.9 5.2 6.7 3.4 5.4 3.8 8.5 11.2 8.3 7.2 5.1 5.6 7.5 2.8 8.3 10.6 4.7 6.0 4.7 3.7 6.0 8.8 6.0 2.8 4.8 5.2 6.6 5.5 13.1 5.4 6.9 9.4 6.4 6.4 7.3 3.5 7.5 4.0 7.1 2.0 7.3 3.3 6.6 4.7 5.8 3.8 4.6 2.9 1.0 8.7 3.2 3.9 7.3 7.2 1.4 0.4 1.3 0.5 2.9 2.1 0.7 0.7 0.0 6.5 10.8 2.8 2.0 1.1 2.8 3.5 4.0 4.5 0.1 0.2 0.0 5.0 2.1 0.7 0.0 3.5 3.8 0.0 2.0 2.9 0.0 2.9 1.3 0.2 4.1 1.7 1.4 3.3 2.1 3.1 0.0 0.0 6.0 2.1 0.1 1.3 7.8 3.9 0.2 5.8 0.0 3.4 8.7 4.4 3.0 0.0 0.1 2.2 4.7 0.2 2.4 9.3 4.2 6.9 3.6 7.1 5.6 0.0 2.2 0.0 3.3 0.7 0.4 0.2 0.7 0.5 0.9 0.5 1.0 1.2 0.4 1.4 1.5 1.2 1.3 2.9 0.1 0.3 2.1 0.7 6.7 5.4 11.2 6.8 6.0 8.8 6.6 5.5 6.4 2.9 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: " "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.5 6.0 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.8 2.2 4.1 2.2 3.3 3.0 0.5 7.3 0.1 0.8 1.1 9.3 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA049770: , HPA073463: " "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favourable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favourable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 10.3 8.4 9.9 10.1 11.1 10.5 17.5 15.6 12.8 13.8 9.2 11.1 15.4 8.1 16.7 14.6 7.9 19.4 10.1 8.4 9.2 10.0 15.4 11.0 9.6 10.3 12.3 10.0 20.9 19.7 9.3 17.8 9.8 10.3 13.4 11.0 12.5 11.6 14.8 7.7 10.1 8.5 14.1 9.6 9.9 9.2 12.1 11.8 17.4 19.9 7.8 11.3 11.9 13.8 10.2 8.0 13.4 5.6 7.9 8.9 4.8 4.7 3.9 12.8 15.7 5.8 6.1 7.2 7.1 8.4 8.1 8.2 3.3 3.3 3.5 7.1 5.5 4.3 5.1 6.9 9.1 6.3 2.3 10.0 2.5 6.3 11.0 5.6 5.8 7.3 9.9 5.5 12.2 8.9 9.4 5.1 10.6 9.9 9.0 5.7 9.4 8.6 10.0 9.7 4.8 9.2 7.5 17.8 12.8 9.3 5.2 9.8 9.2 16.0 7.8 8.7 4.0 4.9 4.9 7.3 7.0 3.9 4.0 9.3 7.1 13.4 4.9 7.8 5.4 5.6 6.4 10.2 6.6 6.6 8.0 6.9 8.9 7.9 2.6 7.9 5.3 3.1 3.6 4.8 9.9 11.1 15.6 12.8 9.2 10.0 12.3 10.0 10.3 11.8 ZNF629 "KIAA0326, ZNF65" ENSG00000102870 "Zinc finger protein 629" Q9UEG4 16 30778449-30787202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019550, HPA056051" Uncertain Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA019550: AB_1859386, HPA056051: " "unprognostic (1.03e-2)" "unprognostic (2.15e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (3.17e-1)" "unprognostic (6.38e-2)" "unprognostic (6.14e-2)" "unprognostic (2.98e-2)" "unprognostic (3.15e-1)" "unprognostic (6.24e-2)" "unprognostic (4.87e-3)" "unprognostic (2.66e-2)" "prognostic favourable (4.57e-10)" "unprognostic (8.41e-2)" "unprognostic (1.96e-1)" "unprognostic (5.71e-2)" "unprognostic (9.70e-2)" 8.6 12.8 8.4 5.2 12.7 6.3 9.4 15.1 21.1 11.3 9.8 16.4 8.2 9.4 13.6 8.4 7.4 11.9 9.2 19.5 9.0 7.7 10.9 8.2 9.0 3.4 9.4 7.9 15.6 8.9 30.2 9.1 6.5 12.2 9.6 8.1 14.8 10.4 11.5 14.0 12.0 10.3 11.9 7.6 6.7 10.5 6.4 8.9 11.8 9.9 10.2 6.7 11.2 7.4 0.3 2.9 0.8 1.6 1.4 1.3 0.7 6.2 10.3 16.0 12.3 7.9 7.4 2.4 7.1 10.4 11.1 9.5 6.3 5.8 1.1 6.9 11.5 7.5 7.8 9.4 7.5 0.2 11.7 8.7 9.1 6.5 8.5 3.0 5.4 12.2 7.1 6.9 5.8 5.9 12.7 0.2 9.7 13.3 4.5 4.0 8.4 4.3 15.6 12.4 0.5 9.4 10.3 15.2 17.1 6.9 13.0 1.7 9.7 11.3 7.1 10.6 6.9 7.1 5.3 0.2 0.0 0.3 6.9 7.8 3.5 0.0 1.6 0.8 0.3 0.2 0.5 0.2 0.3 0.2 1.3 0.3 1.3 1.0 0.1 1.4 0.4 2.9 0.0 0.7 8.4 12.7 15.1 21.1 9.0 7.7 9.4 7.9 12.2 8.9 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001053: , HPA068130: " "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 4.0 5.2 5.3 6.4 9.0 2.1 6.7 8.8 8.5 7.0 5.4 5.9 11.3 3.5 6.3 7.5 5.0 4.8 5.8 5.9 6.0 4.6 5.2 3.0 5.0 5.4 12.3 5.8 11.2 8.3 11.9 10.1 4.9 8.8 8.4 6.2 6.4 6.1 6.9 2.3 4.0 4.2 7.5 7.3 4.8 6.8 1.8 10.1 1.0 9.3 1.5 3.6 8.4 13.7 2.6 3.8 5.8 1.9 1.5 2.8 2.0 1.4 1.1 0.3 0.0 0.1 0.1 0.0 1.9 0.6 1.0 0.9 3.3 5.4 0.1 1.0 2.0 2.3 0.0 1.0 1.3 0.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 1.3 5.7 3.2 0.0 1.0 0.0 5.4 3.6 5.7 0.0 0.0 2.1 1.6 0.7 1.3 0.0 2.5 3.0 3.2 2.6 7.1 4.8 2.1 5.7 1.4 1.2 0.0 2.6 2.5 0.0 0.0 4.7 0.0 0.0 0.1 4.5 5.8 1.9 4.8 2.2 1.0 2.4 2.6 2.0 2.0 3.8 1.8 2.5 2.8 2.1 1.5 0.6 0.9 1.1 2.0 5.3 9.0 8.8 8.5 6.0 4.6 12.3 5.8 8.8 10.1 ZNF638 "MGC26130, NP220, ZFML, Zfp638" ENSG00000075292 "Zinc finger protein 638" Q14966 2 71276561-71435069 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036784, HPA057395" Supported Enhanced Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA036784: AB_10672478, HPA057395: " "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (7.57e-2)" "unprognostic (1.26e-3)" "unprognostic (2.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-2)" "unprognostic (5.68e-3)" "unprognostic (2.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (2.66e-3)" "unprognostic (3.28e-1)" "unprognostic (7.68e-2)" "unprognostic (1.93e-2)" "prognostic favourable (8.73e-5)" 20.7 19.1 22.4 14.9 26.0 18.7 19.8 51.3 25.5 19.8 19.7 23.4 13.0 11.3 26.0 14.8 17.3 20.1 14.3 16.0 20.1 11.9 18.7 22.9 16.4 16.9 25.4 19.9 31.1 15.4 28.9 46.7 16.9 23.9 17.2 14.7 14.1 20.6 15.5 33.2 16.9 15.8 18.4 22.7 16.0 17.3 21.0 29.7 26.0 22.5 11.2 16.1 26.6 17.8 14.8 10.2 32.4 12.8 11.8 14.1 6.0 14.8 21.4 32.9 15.3 19.4 21.4 25.4 17.0 19.7 14.5 13.0 20.4 14.6 24.4 15.8 15.5 12.6 30.5 17.4 21.1 24.8 17.0 32.1 23.4 18.5 16.8 29.2 21.8 13.5 17.0 15.5 29.0 22.2 32.0 14.4 21.0 14.9 20.6 21.7 28.5 13.8 17.7 49.9 17.0 15.5 22.7 25.4 16.7 20.9 14.7 21.4 13.7 18.1 22.7 18.0 26.2 13.3 17.0 11.8 18.2 24.2 15.1 19.2 19.4 32.4 10.1 18.7 11.4 9.5 10.6 14.5 10.6 10.4 7.9 14.8 14.1 10.3 17.1 11.8 12.8 10.2 8.9 6.0 22.4 26.0 51.3 25.5 20.1 11.9 25.4 19.9 23.9 29.7 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: " "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavourable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.1 10.9 5.8 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.5 7.8 6.3 11.5 14.0 6.1 6.8 8.8 5.1 4.9 14.1 7.1 6.2 9.8 12.7 7.9 11.5 6.7 20.4 16.6 12.1 2.6 5.9 12.4 12.5 7.8 8.3 4.1 6.9 10.1 9.9 10.4 5.9 6.9 6.3 11.9 10.9 12.3 9.4 12.5 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" Q8IZM8 3 88059274-88144665 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: , HPA049262: , HPA077939: " "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavourable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 18.2 8.9 10.9 13.2 11.6 15.1 12.6 18.6 13.3 13.5 11.8 9.8 13.5 9.7 14.0 12.1 14.4 9.5 10.8 10.4 11.3 8.5 11.0 15.4 11.8 12.3 13.9 10.3 14.7 9.5 12.8 21.8 11.9 11.1 12.8 9.8 10.7 12.5 10.2 13.9 14.9 13.4 13.1 15.8 10.1 10.0 12.3 14.8 22.2 13.4 9.4 12.0 16.6 14.6 2.6 2.3 10.0 2.0 6.5 4.0 1.7 4.6 1.9 3.4 4.7 7.5 6.2 3.0 6.1 5.6 4.1 5.9 2.9 2.8 7.4 4.3 5.3 3.1 3.6 5.7 8.3 4.5 2.0 4.6 2.6 2.1 5.6 5.2 5.2 6.1 5.7 4.6 5.5 5.6 3.1 6.0 9.3 3.6 5.2 4.8 1.8 3.2 3.6 2.3 3.5 4.0 6.1 2.5 2.2 4.5 3.6 11.7 4.9 4.1 6.3 9.2 6.1 34.5 4.4 6.9 4.7 5.2 7.5 5.0 5.9 10.0 1.9 2.7 2.9 2.0 3.3 1.8 3.2 4.0 2.3 2.6 3.9 2.6 2.7 6.5 1.4 1.1 2.2 1.7 10.9 11.6 18.6 13.3 11.3 8.5 13.9 10.3 11.1 14.8 ZNF655 "VIK, VIK-1" ENSG00000197343 "Zinc finger protein 655" Q8N720 7 99558406-99576453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029534, HPA050750" Uncertain Supported "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA029534: AB_10603008, HPA050750: " "prognostic favourable (7.12e-4)" "unprognostic (3.03e-2)" "unprognostic (9.62e-2)" "unprognostic (5.00e-1)" "unprognostic (1.51e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (3.93e-3)" "prognostic unfavourable (7.24e-4)" "unprognostic (2.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-2)" "unprognostic (1.12e-1)" 14.6 19.0 17.4 24.1 20.7 10.3 16.9 31.1 20.3 18.8 20.2 19.7 18.0 22.2 15.3 19.0 39.2 15.6 15.1 11.3 14.7 14.4 19.1 21.2 19.9 23.8 21.3 16.1 19.4 30.8 13.9 25.0 21.1 20.4 16.9 16.8 14.1 25.5 19.0 18.2 25.5 19.7 19.8 21.3 22.2 24.1 11.1 19.4 27.8 16.0 14.3 23.1 21.4 20.7 15.0 17.5 44.7 22.2 14.7 25.7 21.4 16.2 15.8 5.8 8.7 6.6 9.9 5.0 9.8 18.5 17.0 16.4 8.8 16.1 11.5 0.1 13.7 10.3 6.9 11.9 17.2 13.8 9.9 7.9 6.7 11.1 10.2 14.4 15.4 8.5 14.6 15.7 22.3 7.4 21.1 15.9 10.6 0.0 20.2 13.3 6.8 0.0 7.2 5.4 22.5 11.2 18.0 6.7 12.5 9.4 0.3 9.8 5.3 8.6 5.2 9.5 25.2 15.7 17.7 18.6 27.2 24.9 9.7 7.3 15.3 44.7 18.8 31.2 22.3 19.9 20.5 15.0 20.5 25.6 17.5 13.3 16.5 20.7 21.9 14.7 22.2 10.1 25.7 21.4 17.4 20.7 31.1 20.3 14.7 14.4 21.3 16.1 20.4 19.4 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 3.1 3.1 3.5 3.0 5.9 3.5 3.0 10.3 7.2 7.6 3.8 3.8 4.4 1.3 7.9 5.2 2.2 5.2 3.6 2.9 4.4 3.8 2.5 1.3 2.9 4.2 5.7 6.2 11.3 2.6 6.3 11.5 3.7 6.0 5.7 2.2 5.5 2.1 4.7 2.3 2.1 2.7 5.9 6.4 3.4 2.7 4.4 4.7 1.8 4.7 0.8 3.1 4.1 4.1 1.3 3.7 0.4 0.4 1.6 0.3 0.2 0.0 0.0 5.6 1.4 0.1 0.0 0.8 0.6 1.4 0.8 0.8 0.0 0.0 0.1 1.2 0.5 0.0 1.8 0.0 1.1 0.0 0.0 5.5 0.4 0.8 1.3 0.1 0.0 2.3 0.1 2.0 0.0 1.3 0.0 0.3 2.9 0.0 0.0 3.2 8.6 0.0 0.1 5.7 0.0 0.1 0.3 1.4 3.8 0.0 0.0 0.1 0.1 2.1 0.4 1.6 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.3 1.1 1.3 0.2 0.2 0.2 1.6 0.0 3.7 0.0 0.2 3.5 5.9 10.3 7.2 4.4 3.8 5.7 6.2 6.0 4.7 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavourable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.7 12.7 2.8 7.0 3.0 3.1 9.8 10.5 7.7 5.2 4.4 5.7 5.1 5.9 8.4 6.1 6.7 1.9 5.6 1.3 7.5 8.3 3.6 7.9 9.2 3.7 5.7 9.1 3.8 2.3 9.1 1.8 3.8 6.8 3.8 9.5 12.5 12.1 12.4 10.2 10.7 16.1 21.4 8.6 2.8 8.2 10.0 11.7 6.6 9.4 3.2 7.1 8.4 6.4 13.1 5.5 9.9 4.5 6.3 10.2 8.4 8.7 6.0 8.5 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 ZNF670 MGC12466 ENSG00000277462 "Zinc finger protein 670" Q9BS34 1 247036784-247078755 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003142 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003142: AB_1859404" "unprognostic (2.11e-1)" "unprognostic (8.04e-3)" "unprognostic (2.05e-3)" "unprognostic (9.98e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-1)" "unprognostic (1.26e-2)" "unprognostic (1.50e-2)" "unprognostic (1.63e-2)" "unprognostic (3.23e-2)" "unprognostic (9.88e-2)" "unprognostic (5.21e-3)" "unprognostic (2.19e-2)" "unprognostic (1.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "unprognostic (1.39e-2)" 3.5 2.2 3.1 2.9 5.5 0.7 6.2 12.0 6.1 4.1 2.6 3.2 0.0 2.8 5.7 3.4 1.9 3.7 3.8 2.5 4.5 3.9 3.0 4.0 3.4 1.8 1.3 5.5 2.8 3.1 1.3 1.4 4.0 3.4 3.5 2.5 1.9 3.1 1.6 2.6 2.4 4.3 2.9 3.1 3.3 4.8 2.7 5.4 3.7 3.0 4.7 4.2 1.0 6.6 4.1 1.7 2.3 2.8 6.5 2.3 3.7 2.7 7.7 9.5 1.9 3.4 17.9 4.9 3.3 5.8 5.8 3.2 4.0 6.1 8.1 3.0 3.2 8.5 3.8 11.0 4.6 1.0 5.4 1.8 4.8 1.7 6.8 3.3 1.9 3.9 3.8 7.3 3.7 7.8 2.7 5.8 1.5 7.9 3.3 14.4 4.8 8.2 9.6 5.8 3.5 8.3 8.9 8.1 6.8 2.7 3.8 2.8 14.2 2.3 3.5 4.1 2.6 5.4 5.2 9.8 12.5 1.3 4.9 4.5 0.0 2.0 1.7 4.4 2.3 2.3 6.6 4.1 4.6 4.1 5.9 6.5 4.9 0.2 2.8 1.4 2.3 3.0 2.3 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Cell line enhanced" "Detected in many" "NTERA-2: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023106 Approved Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.8 0.4 4.0 6.2 2.1 7.7 5.9 8.0 7.2 0.0 0.5 0.1 5.8 6.7 0.7 0.0 6.0 2.3 0.2 4.2 0.3 0.5 0.2 10.0 0.1 7.9 10.7 0.0 7.6 0.1 3.5 0.1 0.5 5.3 0.2 6.4 0.2 20.3 2.7 0.1 0.0 0.2 2.3 3.1 0.2 11.2 0.2 2.9 0.2 0.4 0.3 2.2 12.6 0.3 0.2 5.0 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.8 13.4 1.4 3.4 7.1 2.7 2.7 4.0 4.3 2.5 2.5 8.2 7.1 1.2 3.9 6.9 1.8 6.7 3.4 13.2 3.9 2.5 1.6 2.6 6.5 10.5 2.9 3.3 2.4 5.3 3.8 9.7 13.0 4.4 1.7 9.0 2.3 10.3 5.4 7.0 7.6 3.2 3.0 6.4 5.0 9.8 4.1 4.8 2.0 6.7 8.3 2.5 5.1 4.8 4.5 5.5 4.2 9.5 9.0 2.1 1.2 5.2 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531561-40548169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA059153: " "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favourable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 3.6 6.4 4.1 2.9 8.9 8.2 4.2 5.8 7.4 3.6 3.8 2.3 5.4 3.2 3.6 4.3 3.2 3.1 3.4 10.6 4.4 3.3 18.3 20.8 3.4 4.4 9.8 3.6 3.8 5.4 2.5 4.6 2.1 5.4 5.1 4.8 1.6 3.5 4.1 4.4 4.1 3.4 3.2 5.9 5.1 4.2 4.3 7.8 6.4 5.6 4.1 3.5 3.1 2.7 6.0 3.9 7.0 7.7 3.5 5.9 2.4 2.1 0.7 2.7 3.7 2.5 3.7 1.6 2.0 1.9 2.3 4.0 1.3 2.8 3.7 1.6 1.2 2.7 2.7 1.9 3.8 3.2 4.6 4.0 2.5 3.5 1.3 4.3 4.4 2.5 0.8 2.9 1.1 3.6 2.1 5.5 3.4 0.6 6.3 5.0 6.7 2.3 2.9 8.2 2.6 3.6 1.9 2.0 3.5 3.6 3.6 4.0 1.5 27.5 2.1 2.4 5.1 2.3 3.9 4.7 3.3 4.3 2.1 4.6 3.7 7.0 4.0 1.9 5.9 7.7 3.2 6.0 4.2 3.6 2.4 3.5 2.8 5.5 2.3 3.5 4.1 3.9 4.7 2.4 4.1 8.9 5.8 7.4 4.4 3.3 9.8 3.6 5.4 7.8 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favourable (5.90e-4)" "prognostic favourable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favourable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favourable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favourable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.6 5.8 5.9 6.2 11.3 2.9 2.5 4.4 6.1 3.7 2.9 1.8 11.7 4.1 8.9 5.5 5.7 1.6 2.8 4.1 12.0 3.6 2.8 2.3 1.4 3.0 3.8 12.5 5.8 6.2 4.0 4.8 3.7 2.9 9.5 4.2 4.6 10.9 4.3 2.1 1.9 9.3 2.4 6.0 6.5 2.5 8.5 9.4 1.5 11.6 9.8 12.7 6.4 2.9 3.2 3.5 3.8 3.4 13.5 9.4 4.3 9.9 3.3 5.5 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 ZNF689 FLJ90415 ENSG00000156853 "Zinc finger protein 689" Q96CS4 16 30602558-30624012 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054095, HPA055385" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA054095: , HPA055385: " "unprognostic (5.62e-2)" "unprognostic (2.36e-2)" "unprognostic (2.77e-3)" "unprognostic (2.73e-2)" "unprognostic (7.73e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (8.38e-2)" "unprognostic (5.83e-3)" "unprognostic (2.26e-1)" "prognostic favourable (9.89e-4)" "unprognostic (3.21e-1)" "unprognostic (1.58e-3)" "unprognostic (3.93e-2)" "unprognostic (5.23e-1)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" 5.9 5.7 5.6 4.7 7.5 7.8 15.0 7.5 10.7 7.4 6.2 8.6 5.4 6.7 8.5 4.1 3.7 6.4 6.1 5.2 4.7 4.5 5.2 6.3 4.9 5.2 8.0 4.9 8.0 7.2 11.8 7.7 4.6 4.8 6.1 4.6 7.7 4.8 7.1 6.7 3.8 6.7 6.0 4.8 7.3 5.7 28.2 8.2 11.4 6.7 4.3 6.5 6.8 4.6 4.4 9.6 2.7 10.5 9.3 6.0 4.4 3.4 6.2 8.7 9.1 3.8 3.7 4.3 4.3 6.4 7.1 6.9 7.3 2.7 10.0 6.8 3.8 2.7 10.9 4.7 5.7 8.2 18.5 8.5 5.4 11.1 4.0 8.3 6.5 3.5 4.5 4.8 4.9 5.0 10.0 5.8 4.5 5.2 15.3 7.9 9.9 6.4 19.4 8.4 9.0 3.0 3.5 11.0 6.6 3.1 5.8 4.9 6.0 7.3 3.9 9.3 3.9 4.5 5.9 10.8 12.4 12.1 3.4 9.2 8.9 0.2 6.8 2.7 5.9 10.0 4.3 4.4 5.0 6.0 9.6 3.7 4.5 4.2 0.4 9.3 10.5 3.6 4.7 4.4 5.6 7.5 7.5 10.7 4.7 4.5 8.0 4.9 4.8 8.2 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA062527: " "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavourable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favourable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.4 13.1 10.8 11.8 9.1 1.7 5.5 6.7 9.0 9.0 4.5 6.8 11.3 8.6 5.1 8.1 12.5 7.2 7.8 20.2 12.7 11.8 17.6 8.1 8.8 4.5 2.5 7.8 8.9 11.2 9.3 9.1 11.4 4.9 8.7 3.6 13.4 6.0 19.5 4.8 9.2 16.4 7.7 8.3 4.4 9.4 9.3 5.6 10.2 9.4 5.6 15.5 4.7 9.0 9.5 5.0 5.9 11.9 9.4 3.3 6.3 5.5 7.5 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059337: , HPA062792: " "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favourable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavourable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favourable (8.35e-5)" 5.6 8.7 15.3 7.9 25.0 11.1 10.7 27.7 22.3 11.6 8.1 16.5 17.8 8.3 13.6 15.1 9.7 13.1 9.4 7.4 20.1 11.6 9.7 8.6 6.9 9.8 30.4 14.3 17.2 12.2 18.4 13.8 8.1 21.2 14.9 7.0 7.7 21.9 11.1 11.5 19.6 8.9 9.2 18.3 10.0 8.7 22.9 25.7 6.6 11.3 9.2 7.8 9.1 8.8 4.6 4.4 4.8 2.1 10.6 6.4 2.8 4.8 5.1 4.3 10.7 3.7 1.9 18.6 4.1 1.4 4.7 3.0 5.8 7.0 6.0 8.5 2.0 6.9 6.5 6.2 3.4 8.9 4.3 7.0 10.8 1.6 2.8 7.9 5.7 2.4 7.9 4.8 12.8 4.3 14.5 4.4 2.1 3.4 4.0 16.3 8.7 11.1 13.6 2.7 12.0 9.0 3.6 8.5 6.3 4.4 7.8 8.4 9.5 12.9 3.0 2.1 3.5 2.3 5.6 12.4 7.8 3.7 4.6 10.5 3.5 0.0 2.1 1.9 5.7 1.6 4.9 4.6 4.5 6.0 4.4 3.8 6.4 4.6 4.8 10.6 1.4 3.5 4.7 2.8 15.3 25.0 27.7 22.3 20.1 11.6 30.4 14.3 21.2 25.7 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143298061 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA057855: , HPA072473: " "unprognostic (3.23e-2)" "prognostic unfavourable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavourable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favourable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 8.5 6.9 10.3 8.1 10.6 6.3 6.9 13.9 13.7 5.6 5.4 9.8 5.4 13.5 8.8 4.8 5.0 6.6 7.1 5.2 10.4 10.3 7.2 8.1 7.6 8.6 12.6 7.2 9.8 13.7 8.6 6.7 5.5 10.6 7.5 4.1 7.2 11.9 5.1 7.7 13.3 8.0 10.7 8.9 8.3 6.5 6.9 12.8 6.5 7.5 3.0 6.6 7.2 5.2 6.4 6.4 2.3 3.3 5.3 7.5 3.3 6.2 5.8 5.6 6.7 2.4 1.6 12.2 4.9 1.6 3.5 2.1 3.3 4.9 0.4 6.9 1.7 4.4 6.5 2.7 3.1 7.0 14.2 8.4 5.5 5.0 2.4 3.3 10.7 1.4 4.4 2.3 4.9 1.7 17.3 3.8 2.1 12.5 3.6 6.9 8.0 14.9 7.7 3.5 6.2 1.9 4.5 9.6 13.4 7.5 4.9 6.1 7.9 6.1 3.5 4.8 11.1 4.3 8.7 8.0 5.4 7.8 3.3 6.9 5.6 1.1 3.3 2.3 5.3 1.9 5.8 4.2 4.0 5.9 3.7 6.4 7.5 6.2 1.4 5.3 2.9 6.4 1.3 3.3 10.3 10.6 13.9 13.5 10.4 10.3 12.6 7.2 10.6 12.8 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favourable (4.89e-5)" 10.0 7.8 9.5 13.5 13.8 11.0 9.9 12.1 8.6 8.8 12.1 7.0 9.2 6.1 8.9 9.8 8.1 9.5 6.2 6.7 9.0 4.6 11.5 3.8 7.1 9.1 11.9 2.7 10.0 7.2 9.6 11.7 22.4 10.3 10.2 9.0 3.6 9.4 8.8 6.4 9.1 10.5 6.0 14.5 11.4 7.8 7.3 12.5 28.0 12.1 4.1 8.8 10.1 11.6 8.1 5.9 19.9 8.8 11.5 8.8 6.0 1.7 0.3 4.0 7.3 4.1 5.3 7.4 4.7 4.8 6.4 6.7 3.7 4.3 8.2 2.5 3.6 2.8 1.8 5.2 7.1 0.3 5.4 2.4 6.7 1.0 4.8 0.3 11.5 5.9 3.8 4.9 8.3 6.1 10.5 1.2 5.5 1.5 8.5 4.0 4.0 6.1 8.5 5.3 3.7 5.0 23.1 4.0 4.6 3.1 7.7 2.4 10.0 5.2 5.3 5.1 2.5 2.4 8.3 1.0 5.4 11.1 0.2 9.1 8.1 15.3 8.1 15.5 8.7 8.8 7.3 7.9 6.9 7.4 5.9 8.1 8.2 8.8 19.9 11.5 6.5 5.7 8.0 6.0 9.5 13.8 12.1 8.6 9.0 4.6 11.9 2.7 10.3 12.5 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595264-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 11.8 6.4 12.9 6.9 8.7 3.5 11.7 12.0 12.5 7.9 9.9 10.2 6.5 6.7 12.3 6.6 8.6 8.7 7.0 10.5 9.3 8.0 6.4 3.4 9.6 10.6 7.7 10.2 12.3 8.8 7.6 8.5 8.0 9.3 8.7 5.0 6.4 8.9 10.5 10.6 7.4 6.0 16.6 8.5 10.2 7.0 8.7 8.2 9.8 7.5 5.9 6.2 10.0 10.7 7.0 4.9 6.8 4.2 9.0 8.3 4.2 3.4 6.6 9.7 8.0 4.0 3.6 6.2 4.0 3.7 2.7 3.9 1.2 1.0 2.9 3.6 3.3 1.2 2.1 3.0 2.4 0.0 20.0 4.4 0.9 2.6 3.4 5.5 4.3 4.1 3.2 2.8 1.8 4.4 2.5 0.0 3.0 0.0 11.2 2.0 7.5 6.5 4.1 6.0 2.4 1.9 3.9 8.6 10.4 2.7 3.7 4.0 2.1 5.6 5.8 9.3 5.2 2.2 6.3 2.8 3.5 4.4 3.1 3.2 2.5 2.9 3.2 6.8 7.7 2.0 8.3 6.5 6.4 7.3 4.9 7.0 7.2 7.4 1.3 9.0 4.2 3.7 6.6 4.2 12.9 8.7 12.0 12.5 9.3 8.0 7.7 10.2 9.3 8.2 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA030226: , HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.7 6.8 13.1 4.9 1.8 2.6 6.8 6.0 5.6 4.4 5.7 4.8 5.3 5.9 2.8 5.8 4.0 3.3 8.6 2.5 3.7 6.1 10.7 2.7 8.1 3.7 3.1 16.7 4.4 4.7 9.5 5.2 7.6 3.6 4.0 1.7 14.8 6.9 8.6 10.2 4.4 8.5 2.9 6.4 1.8 7.2 12.0 8.1 8.0 29.0 4.1 6.3 10.7 10.8 9.2 4.5 2.7 4.7 3.3 1.6 5.7 7.0 9.2 4.7 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75709643-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 37.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 8.1 8.6 11.9 7.2 14.4 4.6 11.2 12.1 12.4 7.7 6.7 11.7 7.3 6.9 11.0 24.6 7.7 11.3 8.1 8.2 10.9 8.3 13.4 10.5 6.8 6.2 16.2 7.1 12.6 12.7 14.7 22.8 7.3 12.6 9.4 8.9 10.8 9.9 9.6 6.1 13.7 7.3 10.9 15.6 10.1 10.1 11.2 13.6 8.4 16.2 5.3 8.4 8.6 7.8 9.5 6.2 6.8 5.3 4.0 10.2 3.2 7.2 4.6 4.4 2.7 4.8 6.8 2.6 2.5 4.8 3.0 3.9 6.2 6.2 3.9 4.2 4.5 3.7 7.0 5.2 2.8 0.4 6.7 7.6 7.0 0.7 9.4 0.3 6.8 6.6 4.3 7.4 11.2 0.6 37.8 9.3 4.0 2.4 0.8 10.1 5.0 8.2 5.7 4.3 21.4 4.9 3.5 3.6 17.1 2.1 4.3 9.1 15.0 3.5 0.9 7.8 10.6 6.4 1.0 11.2 13.7 4.6 4.2 0.8 4.7 1.5 4.0 6.8 3.6 5.3 1.8 7.6 5.1 3.4 4.1 9.5 10.2 6.2 1.0 4.0 4.9 6.2 1.9 3.2 11.9 14.4 12.1 12.4 10.9 8.3 16.2 7.1 12.6 13.6 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041570 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 15.1 15.8 11.1 13.7 11.8 9.9 12.7 16.8 17.6 14.3 12.4 11.3 17.7 7.2 11.7 17.4 16.4 12.8 10.3 10.1 11.1 15.1 14.2 11.6 10.7 17.5 15.5 11.0 9.6 12.9 13.4 24.5 19.4 15.5 14.5 14.0 11.4 13.9 17.7 10.3 17.3 10.1 13.2 14.3 18.4 14.1 13.7 15.9 16.6 19.2 11.0 18.1 14.6 11.6 14.4 8.9 23.0 5.5 12.8 14.2 5.0 10.2 7.2 9.0 7.9 7.9 12.0 8.7 11.0 7.2 5.4 7.2 5.2 11.0 5.0 19.4 3.7 7.2 8.8 4.2 8.0 22.2 4.6 2.7 3.9 14.8 11.8 5.9 15.3 8.1 11.8 3.7 5.4 10.1 9.2 6.6 5.8 16.6 6.0 7.8 8.8 5.7 11.4 4.0 7.8 6.1 6.5 4.1 6.1 11.1 5.0 9.8 9.6 11.7 6.5 3.9 3.1 7.8 3.3 11.0 12.0 14.3 3.5 9.1 6.1 13.9 4.8 23.0 14.2 5.4 10.6 13.7 10.0 12.7 5.2 14.4 9.3 11.7 6.3 12.8 5.5 8.9 12.2 5.0 11.1 11.8 16.8 17.6 11.1 15.1 15.5 11.0 15.5 15.9 ZNF721 KIAA1982 ENSG00000182903 "Zinc finger protein 721" Q8TF20 4 425815-499156 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA065313 Approved "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA065313: " "unprognostic (2.23e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" "unprognostic (1.57e-1)" "unprognostic (6.91e-2)" "unprognostic (7.66e-2)" "unprognostic (1.51e-2)" "unprognostic (3.26e-2)" "unprognostic (3.48e-2)" "unprognostic (1.96e-2)" "unprognostic (3.43e-2)" "unprognostic (1.25e-1)" "unprognostic (5.12e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-3)" "prognostic favourable (2.76e-4)" 16.1 15.3 20.9 17.2 24.5 20.8 24.7 42.3 25.6 17.7 13.9 15.9 15.4 13.4 17.2 19.3 15.4 20.4 13.5 12.1 19.4 15.3 16.1 16.3 16.4 26.9 24.6 22.8 21.5 19.2 21.1 39.2 13.1 20.7 16.5 16.4 13.9 16.1 15.0 14.5 23.5 16.0 17.5 22.1 18.3 16.2 17.7 23.9 20.3 22.5 12.7 27.8 19.0 16.7 15.1 9.5 11.3 7.8 11.5 20.8 6.5 8.8 5.8 11.2 13.9 8.4 11.2 7.0 8.2 7.2 9.1 8.2 8.5 9.1 15.1 8.8 7.8 5.8 11.6 10.0 12.1 5.3 13.6 26.3 6.0 5.8 7.9 10.9 1.7 10.2 8.8 10.2 14.8 8.9 15.3 10.9 12.5 8.7 18.1 17.9 17.4 12.2 14.8 16.3 8.4 9.4 12.4 16.6 10.6 10.7 6.0 9.9 11.5 11.8 11.4 8.3 2.9 6.3 14.1 12.5 11.8 36.8 6.2 3.1 7.4 7.0 7.8 11.3 12.0 7.6 11.9 15.1 13.1 11.5 7.6 15.1 20.8 16.0 11.1 11.5 6.7 9.5 14.6 6.5 20.9 24.5 42.3 25.6 19.4 15.3 24.6 22.8 20.7 23.9 ZNF74 "Cos52, Zfp520, ZNF520" ENSG00000185252 "Zinc finger protein 74" Q16587 22 20394115-20408461 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003354 Approved Supported "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA003354: AB_1080747" "unprognostic (1.40e-1)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (1.02e-1)" "unprognostic (8.13e-3)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-1)" "unprognostic (1.20e-3)" "unprognostic (3.80e-2)" "unprognostic (1.10e-1)" "unprognostic (5.58e-2)" "unprognostic (3.04e-1)" "unprognostic (7.91e-2)" "unprognostic (1.44e-3)" 3.7 4.3 6.1 3.1 7.7 1.3 5.9 9.5 11.1 7.0 6.3 8.0 5.8 2.9 7.7 5.8 4.6 7.5 3.8 4.0 6.5 6.2 4.2 3.2 5.0 3.3 7.9 7.0 11.5 6.9 7.0 7.2 3.9 6.2 6.6 4.0 3.8 7.5 8.2 9.7 4.2 3.6 6.4 5.2 3.5 4.1 2.3 6.9 4.3 5.1 3.0 3.1 6.6 6.8 2.3 3.5 1.6 2.0 6.5 5.3 3.3 2.4 2.9 7.1 10.3 2.1 2.0 5.1 2.7 2.1 3.5 3.2 3.1 1.3 0.0 3.3 2.2 3.5 5.4 3.5 1.9 1.7 10.7 2.7 1.2 4.8 3.4 6.8 3.3 2.0 5.9 2.5 2.6 3.3 27.7 0.0 2.4 3.6 6.3 2.8 7.0 3.4 8.7 3.9 1.1 2.1 2.9 13.9 8.7 2.7 4.9 6.3 1.7 2.9 2.6 2.5 5.7 3.9 1.9 2.5 3.7 0.0 0.7 3.0 2.2 0.0 1.8 1.6 4.1 2.0 3.2 2.3 2.9 5.3 3.5 1.8 3.9 3.1 0.0 6.5 1.3 2.5 2.5 3.3 6.1 7.7 9.5 11.1 6.5 6.2 7.9 7.0 6.2 6.9 ZNF747 MGC2474 ENSG00000169955 "Zinc finger protein 747" Q9BV97 16 30530367-30535347 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003203, HPA069173" Uncertain Approved Centrosome,Cytosol "Centrosome, Cytosol" "HPA003203: AB_1080753, HPA069173: " "unprognostic (3.82e-2)" "prognostic favourable (6.53e-4)" "unprognostic (3.73e-2)" "unprognostic (1.31e-2)" "unprognostic (4.01e-2)" "unprognostic (4.30e-2)" "unprognostic (3.60e-1)" "unprognostic (1.22e-3)" "unprognostic (2.45e-2)" "unprognostic (3.66e-2)" "prognostic favourable (4.46e-4)" "unprognostic (1.01e-2)" "unprognostic (2.60e-3)" "unprognostic (2.27e-1)" "unprognostic (4.66e-2)" "unprognostic (3.00e-1)" "unprognostic (1.01e-1)" 12.5 10.5 11.0 8.9 12.4 5.7 10.3 13.1 19.4 14.1 11.3 18.5 6.3 9.6 14.3 10.3 8.9 11.8 10.5 13.2 10.3 8.9 11.4 17.0 8.4 9.3 11.5 8.0 13.2 15.5 23.1 10.4 6.2 10.6 14.6 9.2 13.6 11.2 15.3 14.1 11.0 10.5 11.8 9.4 11.4 10.2 12.4 13.3 18.2 11.8 6.7 9.0 12.8 8.8 8.8 8.1 9.0 4.8 6.6 8.9 4.1 3.8 3.7 1.2 6.1 4.9 4.3 6.2 3.2 4.8 4.6 4.5 2.2 4.9 8.3 2.2 3.8 5.7 2.8 4.0 2.0 9.8 6.2 7.2 4.0 3.4 5.4 3.3 10.3 4.9 5.1 3.7 5.8 3.0 2.0 7.2 3.2 4.2 14.8 4.6 7.2 2.5 17.7 0.4 7.6 4.0 2.0 8.6 7.6 4.8 3.2 3.5 6.2 6.6 2.4 5.9 2.7 4.6 0.1 13.7 9.6 4.7 1.2 5.1 6.9 9.0 4.8 6.4 4.5 2.6 5.2 7.4 5.1 5.2 6.0 8.8 8.9 6.6 2.7 6.6 2.4 8.1 3.8 4.1 11.0 12.4 13.1 19.4 10.3 8.9 11.5 8.0 10.6 13.3 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435329-57445485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: " "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 5.8 5.6 7.2 7.6 8.0 5.0 8.4 12.4 10.7 6.3 8.1 5.2 7.5 6.6 6.3 5.1 7.4 7.9 8.3 5.1 6.4 6.0 5.3 12.4 5.4 7.5 9.0 7.7 8.2 7.0 11.4 7.2 6.3 6.0 6.2 4.5 8.5 12.8 10.8 6.2 9.7 7.1 5.9 5.3 6.7 5.5 6.2 6.8 7.8 6.7 12.1 8.0 6.0 6.1 2.9 3.2 0.2 2.7 1.9 4.1 2.8 2.6 6.2 5.6 5.6 1.5 1.4 2.3 1.6 1.3 2.7 5.0 2.6 1.9 5.2 1.4 1.6 2.0 5.3 4.2 4.1 2.3 23.1 4.7 6.6 2.9 1.7 5.1 3.1 1.8 4.7 3.5 7.5 1.5 4.4 6.1 2.0 1.1 6.3 1.8 5.3 8.7 6.6 8.0 3.8 1.3 6.4 5.5 4.5 3.1 1.9 1.2 2.7 1.6 1.6 5.1 3.7 1.5 4.6 4.7 6.1 5.4 2.8 2.2 3.0 0.1 1.2 0.2 2.1 2.7 3.4 2.7 3.5 3.1 3.2 2.9 4.1 3.0 0.2 1.9 1.2 1.6 2.6 2.8 7.2 8.0 12.4 10.7 6.4 6.0 9.0 7.7 6.0 6.8 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 10.0 11.4 13.6 14.8 15.7 9.0 15.0 19.6 15.4 10.6 10.1 17.2 14.4 8.0 12.4 26.1 9.5 14.1 9.0 9.0 13.2 12.2 12.7 16.2 10.4 18.1 12.8 14.4 19.3 13.6 32.1 23.5 12.7 17.7 16.2 15.1 10.1 10.6 15.4 10.4 13.8 12.8 10.8 10.3 15.6 10.1 13.5 15.9 15.8 17.9 7.7 18.0 10.2 8.6 25.2 13.8 15.2 9.1 17.8 23.0 3.3 4.5 6.7 12.6 6.4 6.0 5.5 10.7 7.3 3.0 6.9 8.2 0.1 5.9 7.3 5.0 5.3 3.4 7.5 4.4 10.4 3.0 10.1 15.5 7.8 0.6 4.3 9.9 15.7 7.4 4.6 7.2 5.4 6.2 8.7 12.0 9.6 6.2 15.0 6.8 19.5 4.7 31.3 6.2 8.7 7.4 7.4 11.4 8.1 11.4 4.6 4.5 14.8 12.6 7.2 5.1 12.9 4.9 5.8 8.3 7.3 20.9 1.7 11.2 7.8 13.3 6.7 15.2 13.0 6.2 16.0 16.8 14.8 13.3 5.2 25.2 23.0 17.2 4.8 17.8 9.1 13.8 11.9 3.3 13.6 15.7 19.6 15.4 13.2 12.2 12.8 14.4 17.7 15.9 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344087 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favourable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favourable (7.42e-5)" 8.4 18.8 8.2 14.6 9.7 9.2 9.9 11.4 10.5 11.8 10.6 9.2 10.4 6.9 10.7 12.8 7.6 9.8 7.9 7.6 5.6 7.7 10.6 13.4 9.7 11.2 6.2 7.7 10.1 12.9 12.6 14.7 8.0 9.2 15.0 8.4 7.5 10.0 11.8 6.6 9.9 10.6 7.5 5.9 18.6 9.7 3.4 6.7 16.6 13.2 9.3 13.3 8.0 8.6 3.7 1.8 4.1 2.1 5.2 6.5 2.9 3.4 4.6 5.0 8.0 8.5 10.4 7.6 5.9 8.0 4.8 10.3 2.8 4.4 3.6 8.7 5.0 4.8 16.3 2.6 4.6 3.5 4.3 2.5 8.3 3.6 3.7 4.2 7.2 5.1 6.4 3.0 3.7 4.9 2.1 5.8 4.2 8.3 5.1 7.7 2.4 6.2 4.9 5.0 3.2 5.4 4.8 1.7 5.7 3.3 5.7 0.9 2.0 6.1 5.1 4.6 1.1 7.7 5.5 2.9 4.1 2.7 2.9 4.7 2.9 4.1 2.1 3.7 4.9 1.5 4.5 2.9 5.2 5.6 1.8 3.7 6.5 5.9 2.6 5.2 1.5 1.6 6.3 2.9 8.2 9.7 11.4 10.5 5.6 7.7 6.2 7.7 9.2 6.7 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favourable (1.18e-4)" "prognostic favourable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 9.2 20.0 16.0 14.6 18.4 8.5 11.3 27.2 17.8 11.4 11.5 18.1 14.5 11.9 12.5 18.5 10.4 13.7 12.7 20.8 14.8 9.6 14.1 13.0 10.6 15.0 15.3 12.3 19.5 13.9 19.5 31.4 19.7 16.9 15.6 10.2 21.8 16.0 16.6 45.1 10.5 13.1 10.6 13.6 18.3 12.2 19.9 16.4 12.6 24.0 10.3 14.6 12.4 11.0 10.5 7.4 5.4 9.3 9.3 16.0 8.8 6.6 6.1 13.5 14.9 5.7 8.8 9.7 5.7 9.7 9.7 7.7 4.5 8.9 14.4 8.5 8.6 3.8 11.3 8.7 5.7 21.5 17.0 13.8 9.3 7.2 11.4 7.0 8.2 10.7 5.5 11.2 10.5 8.8 10.2 15.3 8.7 14.5 11.6 8.1 6.6 5.9 11.3 7.0 13.3 8.7 9.3 21.1 7.8 7.0 8.9 17.2 13.4 22.6 6.7 6.8 5.9 4.6 8.2 15.4 10.7 13.5 5.9 11.0 17.9 3.8 6.6 5.4 16.0 8.6 12.7 10.0 11.7 11.3 7.4 10.5 12.5 13.0 2.0 9.3 9.3 3.7 9.0 8.8 16.0 18.4 27.2 17.8 14.8 9.6 15.3 12.3 16.9 16.4 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524001-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: " "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favourable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favourable (6.46e-4)" 11.7 9.2 12.7 12.0 15.6 8.0 17.8 11.1 12.2 11.4 26.0 13.9 11.5 20.4 13.1 7.4 12.6 13.1 11.2 26.2 11.1 9.3 18.9 14.4 8.6 4.7 13.5 6.0 15.9 14.3 25.4 11.5 10.1 11.5 14.2 12.1 13.9 17.5 16.0 56.6 11.2 31.6 16.0 12.8 13.1 11.7 14.0 14.4 3.8 10.1 14.2 7.8 14.1 24.5 3.7 1.8 3.1 1.9 1.8 0.5 0.6 10.0 12.6 14.3 13.9 7.0 8.1 11.3 7.6 8.6 12.7 11.1 8.0 14.0 6.3 11.8 5.3 13.4 9.5 9.1 7.6 14.2 20.1 14.9 8.4 11.1 17.6 9.9 47.2 7.1 20.3 9.7 12.6 8.4 17.3 10.8 6.5 27.7 3.6 23.9 13.4 10.4 18.8 9.5 15.6 9.3 5.2 17.0 18.8 4.3 23.1 29.0 22.8 24.9 5.6 13.4 10.2 7.5 8.4 16.0 11.7 7.8 11.2 15.5 13.4 0.2 1.4 3.1 0.1 1.9 0.4 3.7 0.5 0.2 1.8 1.4 0.4 0.1 1.7 1.8 0.3 1.7 0.1 0.6 12.7 15.6 11.1 12.2 11.1 9.3 13.5 6.0 11.5 14.4 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favourable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favourable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 6.3 6.6 6.6 5.4 8.9 5.6 13.2 18.2 9.8 8.4 6.1 8.4 9.9 4.1 8.5 8.5 7.5 7.3 4.2 7.4 5.9 5.8 6.4 6.3 12.7 6.6 7.0 7.8 9.7 8.2 8.2 8.2 8.2 6.5 6.9 6.4 8.9 11.4 6.7 6.1 8.3 6.1 8.7 5.5 6.8 8.1 8.3 4.3 9.6 8.8 4.0 9.3 6.4 6.7 5.5 3.7 1.3 3.1 3.9 6.2 3.3 4.7 2.2 10.8 6.3 2.3 3.0 4.9 2.9 4.3 5.8 6.9 7.3 1.9 5.3 2.4 3.2 3.8 7.0 4.7 9.8 0.4 5.2 6.4 3.4 8.1 5.7 0.2 5.3 4.6 6.5 4.5 6.7 8.0 8.4 0.0 3.9 5.2 7.8 4.6 2.4 3.1 8.9 8.3 3.7 4.6 7.4 4.4 8.3 4.4 4.2 5.0 4.0 11.1 3.8 2.4 3.1 6.8 5.2 5.5 5.3 2.5 6.2 0.1 4.4 0.0 2.7 1.3 5.5 2.6 6.2 5.5 5.8 5.9 3.7 5.3 4.5 6.2 0.2 3.9 3.1 3.0 2.8 3.3 6.6 8.9 18.2 9.8 5.9 5.8 7.0 7.8 6.5 4.3 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407297-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 26.4;REH: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA030730: , HPA046672: , HPA059398: " "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 6.6 6.7 15.3 5.0 14.5 4.0 5.3 10.7 18.3 6.6 6.1 4.9 6.6 4.5 10.4 7.2 4.6 7.5 6.1 4.6 13.4 10.6 9.2 8.6 4.1 3.3 8.8 16.9 10.8 7.3 8.1 6.2 2.4 8.8 10.1 5.4 4.0 4.9 12.3 18.2 6.1 4.3 9.6 5.1 3.6 4.8 3.7 8.1 1.9 5.4 3.5 4.2 6.8 5.6 6.6 3.7 1.9 2.5 1.8 6.2 2.7 3.1 3.5 4.9 4.0 7.1 3.0 3.8 4.5 2.2 2.9 3.0 1.5 1.5 3.7 7.8 2.3 2.3 5.1 2.0 3.0 1.3 26.4 3.1 2.4 4.7 3.6 1.5 3.7 4.5 1.6 3.7 2.2 2.9 7.6 2.3 2.4 5.6 3.7 5.1 3.9 2.8 16.9 3.7 2.4 1.7 1.2 7.8 4.8 2.4 2.2 2.9 2.8 1.8 2.6 4.9 5.8 2.8 3.3 3.4 3.7 1.9 3.2 3.4 3.1 1.0 1.1 0.7 3.6 2.5 4.9 2.7 4.3 4.2 2.8 6.6 6.2 3.7 1.9 1.8 0.5 3.7 4.4 2.7 15.3 14.5 10.7 18.3 13.4 10.6 8.8 16.9 8.8 8.1 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 9.0 10.3 7.3 7.0 10.8 10.7 12.5 15.4 11.3 6.0 7.7 6.0 11.2 8.2 8.4 11.4 6.8 8.7 8.4 7.3 7.2 6.9 8.2 4.9 8.1 16.1 8.6 7.8 12.1 5.6 16.0 14.6 8.7 8.2 9.7 7.1 9.6 9.0 8.1 17.8 10.7 7.9 8.8 9.7 11.3 6.9 8.8 4.7 12.7 12.3 6.2 10.4 9.2 9.6 14.8 6.9 16.2 4.8 8.9 17.2 5.8 1.8 3.2 5.5 7.2 4.0 4.9 0.3 5.3 8.0 4.7 19.6 3.3 2.6 3.4 2.9 3.5 1.4 2.7 5.6 7.0 0.1 17.1 5.8 0.4 1.9 7.6 4.4 4.7 11.2 8.0 3.4 13.6 3.3 0.2 0.6 6.0 0.4 8.2 3.1 5.7 9.5 4.5 8.8 5.3 3.3 6.4 5.9 7.2 0.9 2.5 6.1 4.1 8.1 2.8 7.5 3.4 1.9 5.6 8.7 8.9 5.6 2.8 4.3 6.7 16.2 4.8 7.6 8.4 3.6 13.6 11.8 10.4 9.0 6.4 14.8 17.2 13.8 2.2 8.9 3.1 6.9 7.2 5.8 7.3 10.8 15.4 11.3 7.2 6.9 8.6 7.8 8.2 4.7 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352245-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA030839: , HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 1.5 5.1 5.8 3.6 8.6 1.6 5.7 14.0 8.7 5.0 7.5 4.1 0.0 3.9 5.5 7.3 2.8 5.3 5.1 4.2 4.8 5.4 2.6 2.9 2.1 1.2 3.9 5.9 2.3 6.5 7.1 5.7 1.3 9.4 4.3 12.4 3.0 6.8 10.3 11.9 5.3 3.5 3.3 3.1 1.3 4.6 8.2 4.7 3.8 4.9 3.1 1.7 3.9 3.5 2.0 1.9 4.2 1.1 2.7 1.3 0.4 2.3 1.1 3.1 3.4 1.3 0.7 7.1 1.5 2.4 1.8 2.3 3.7 2.8 0.9 2.8 1.7 3.5 3.0 5.0 1.8 1.7 6.0 2.4 11.3 1.7 2.3 1.4 2.0 0.7 6.1 2.7 2.6 3.1 2.7 1.2 3.0 2.3 1.9 1.3 0.9 3.6 1.8 2.6 0.7 3.7 6.3 6.9 2.9 2.8 4.4 1.2 2.9 0.4 1.6 2.1 1.9 1.7 3.0 7.4 5.0 0.6 3.3 3.9 0.9 3.6 1.1 2.2 1.0 0.5 0.7 0.9 0.8 1.3 1.9 2.0 1.0 0.9 4.2 2.7 0.6 1.2 0.5 0.4 5.8 8.6 14.0 8.6 4.8 5.4 3.9 5.9 9.4 4.7 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746796-57758159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: " "unprognostic (6.73e-2)" "prognostic unfavourable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 5.8 9.8 14.0 10.8 15.9 19.4 12.2 34.9 15.2 9.4 8.6 7.9 17.3 8.4 8.2 29.9 7.8 10.3 6.9 9.8 11.0 9.5 10.7 9.5 8.6 11.0 10.7 8.9 12.4 7.1 17.0 18.8 10.2 12.8 11.9 9.3 9.6 10.8 13.4 11.4 8.6 8.7 7.3 9.6 11.6 10.0 8.7 15.0 19.3 14.5 6.0 10.7 10.7 8.0 4.2 2.5 11.1 2.4 7.5 4.3 2.1 4.6 3.9 12.5 8.3 2.1 6.4 5.4 3.7 6.5 6.5 4.3 2.3 5.0 5.2 3.4 3.3 3.0 6.5 6.4 10.4 4.9 23.8 7.1 9.2 2.6 4.7 3.9 5.7 7.3 5.4 4.3 4.7 5.0 4.7 3.8 8.4 2.0 12.8 3.7 7.3 8.2 8.3 9.5 5.9 4.8 14.7 14.3 10.3 6.8 5.7 4.0 5.8 5.6 4.5 7.0 3.8 0.6 5.5 10.6 11.8 8.7 4.2 3.7 5.7 7.9 2.4 11.1 1.8 1.7 3.9 3.5 2.8 3.4 2.2 4.2 4.3 3.2 6.2 7.5 2.1 2.5 2.3 2.1 14.0 15.9 34.9 15.2 11.0 9.5 10.7 8.9 12.8 15.0 ZNF778 FLJ31875 ENSG00000170100 "Zinc finger protein 778" Q96MU6 16 89217703-89237071 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.9" "Low lineage specificity" "Detected in all" "HPA052057, HPA057151" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA052057: , HPA057151: " "unprognostic (3.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.75e-3)" "unprognostic (7.04e-2)" "unprognostic (2.43e-1)" "unprognostic (1.66e-3)" "unprognostic (5.34e-2)" "unprognostic (1.29e-2)" "unprognostic (1.91e-1)" "unprognostic (3.57e-1)" "unprognostic (3.53e-7)" "unprognostic (2.51e-1)" "unprognostic (2.85e-7)" "unprognostic (3.22e-2)" "unprognostic (3.67e-1)" "unprognostic (8.46e-2)" "unprognostic (3.63e-2)" 5.9 6.7 9.3 4.7 9.5 4.1 6.6 11.2 9.8 5.4 5.8 8.8 4.4 3.1 6.9 5.1 6.0 6.1 3.7 6.0 7.4 4.7 8.7 5.9 5.8 4.6 8.9 6.7 5.8 12.0 22.4 8.9 5.4 7.5 6.5 5.0 6.1 6.3 7.8 10.4 8.2 4.9 6.7 8.1 5.7 6.8 12.5 7.8 4.1 8.4 5.5 6.3 6.9 6.8 1.7 2.0 10.9 2.7 1.4 4.1 1.5 4.1 2.1 6.7 5.7 4.2 3.6 8.8 3.2 5.1 4.8 2.5 6.4 2.4 2.0 5.8 3.8 3.3 9.2 4.4 7.6 0.8 6.5 5.5 4.2 3.1 2.4 1.6 3.2 2.7 3.1 6.2 4.4 3.9 6.2 1.0 3.9 10.9 3.1 2.4 10.0 4.0 8.7 15.7 0.7 2.4 3.8 13.5 10.1 7.4 3.6 2.7 11.3 3.2 4.7 5.2 3.8 3.0 3.9 3.5 5.2 4.2 7.3 3.2 3.2 10.9 1.7 3.9 4.1 2.0 2.1 1.3 1.9 2.1 2.0 1.7 1.5 2.6 0.6 1.4 2.7 0.8 2.3 1.5 9.3 9.5 11.2 9.8 7.4 4.7 8.9 6.7 7.5 7.8 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favourable (9.30e-4)" 6.9 9.2 11.1 8.6 8.5 4.1 7.7 12.8 10.8 8.7 6.6 5.8 13.9 5.7 8.2 10.8 10.4 7.8 7.8 6.7 7.1 6.1 7.9 11.8 7.0 11.3 10.5 8.9 8.6 11.0 15.8 14.1 7.0 6.8 7.9 6.0 6.8 10.0 11.4 4.5 8.0 9.1 6.0 10.4 12.0 8.2 7.9 9.7 7.8 11.2 5.3 11.3 8.8 7.9 3.9 4.6 8.4 7.7 3.3 5.9 2.5 4.8 9.2 6.0 5.6 5.5 5.0 4.3 5.6 4.5 4.6 7.1 6.0 3.3 4.3 3.7 2.7 4.1 3.8 3.2 5.1 7.4 5.2 6.8 7.6 5.7 4.9 7.0 5.6 5.2 3.6 4.7 3.9 4.7 7.6 7.3 3.9 2.8 2.8 2.4 4.8 2.9 2.3 10.6 2.5 3.8 10.0 3.7 7.1 8.4 3.2 3.7 4.0 8.5 3.5 5.7 7.6 5.1 4.5 7.2 6.3 4.3 3.6 4.9 3.8 2.7 5.4 8.4 3.9 4.9 5.1 3.7 4.2 3.5 4.6 3.9 5.9 5.1 4.7 3.3 7.7 3.6 4.5 2.5 11.1 8.5 12.8 10.8 7.1 6.1 10.5 8.9 6.8 9.7 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 6.3 8.2 12.4 9.8 18.8 3.3 10.3 22.2 14.0 8.2 8.5 8.2 11.6 5.7 10.8 12.3 5.5 10.0 6.6 12.5 9.4 7.2 9.4 6.7 5.9 9.7 8.1 10.8 16.6 8.1 10.5 24.7 7.1 11.6 9.7 7.6 9.3 7.9 10.5 6.9 7.1 7.6 9.7 7.8 9.2 7.2 5.0 11.4 8.7 14.0 6.4 9.8 9.1 8.2 4.2 5.9 1.5 3.2 2.3 5.1 1.3 2.6 3.4 5.8 4.0 3.5 2.3 0.0 3.0 2.2 3.3 4.4 6.2 2.4 6.4 2.8 3.1 1.5 4.8 1.9 4.0 5.4 2.4 5.0 6.1 3.9 2.4 7.4 4.2 3.4 1.2 4.6 2.9 3.1 5.2 8.7 3.4 1.2 2.4 1.2 5.7 3.6 3.5 10.2 2.2 1.9 14.2 6.4 6.8 5.3 2.3 1.9 2.7 3.2 5.6 3.3 8.1 5.7 4.6 6.6 8.5 5.0 3.0 3.9 2.7 0.1 3.2 1.5 2.8 2.8 2.9 2.5 3.4 3.3 2.4 4.2 5.1 4.2 0.6 2.3 1.8 5.9 1.9 1.3 12.4 18.8 22.2 14.0 9.4 7.2 8.1 10.8 11.6 11.4 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816472-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 5.3 4.2 7.4 7.4 8.4 2.5 7.6 19.8 8.0 7.5 5.3 6.9 5.9 6.1 7.9 8.5 5.2 5.5 5.8 4.0 6.8 4.5 7.1 5.5 4.4 5.9 5.9 4.8 9.3 12.7 11.8 15.1 4.9 7.7 7.5 6.9 5.4 8.0 7.3 9.2 8.6 7.1 5.3 6.5 6.4 6.6 13.9 8.3 6.0 8.8 2.5 7.4 5.6 10.8 2.3 0.2 0.7 0.5 1.0 2.2 0.4 2.9 2.3 5.8 8.9 1.6 2.2 4.0 2.8 2.8 4.5 3.4 2.7 3.0 5.7 3.7 2.0 4.1 5.1 1.8 4.5 5.7 2.2 5.2 4.7 2.7 1.7 7.2 3.7 1.3 3.8 3.7 1.9 1.5 7.0 5.8 2.7 4.9 7.6 3.5 4.3 5.1 6.8 7.1 1.9 3.1 1.9 5.9 4.5 3.8 2.3 3.0 4.3 4.2 3.3 6.0 3.5 6.0 3.1 5.5 3.9 2.7 2.4 1.8 4.3 0.0 0.5 0.2 1.1 0.5 2.2 2.0 1.0 0.0 0.2 2.3 0.9 0.7 0.7 1.0 0.2 0.2 0.6 0.4 7.4 8.4 19.8 8.0 6.8 4.5 5.9 4.8 7.7 8.3 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavourable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favourable (4.11e-4)" 10.1 8.1 11.4 14.4 14.9 6.5 15.1 14.3 15.8 11.5 9.4 15.4 9.9 10.0 13.1 11.2 8.2 13.0 11.0 7.2 11.6 7.7 8.5 4.6 8.6 16.1 13.1 18.4 17.2 11.2 9.4 10.2 7.2 12.5 13.0 9.7 12.2 9.3 13.5 11.6 12.6 12.2 20.1 15.4 17.7 9.1 9.2 12.5 2.9 11.8 6.2 15.0 9.9 16.1 3.8 2.7 0.5 4.5 1.5 3.2 1.1 3.3 3.4 5.7 4.1 3.8 7.2 5.4 2.2 1.1 5.0 2.2 5.4 6.4 11.6 5.6 3.5 2.2 4.0 4.2 2.2 3.1 3.6 7.4 7.5 1.1 8.7 4.8 9.3 7.5 8.8 4.5 5.6 3.3 5.9 5.9 4.1 7.2 7.2 7.5 12.8 4.7 1.6 0.5 10.1 5.6 5.7 4.6 9.6 8.5 4.0 5.7 4.4 9.8 5.0 4.0 0.9 2.2 4.7 9.2 5.8 0.1 5.7 1.7 8.7 0.3 1.1 0.5 3.2 2.2 2.5 2.3 2.0 2.0 1.3 3.8 2.7 2.2 0.4 1.5 4.5 2.7 1.2 1.1 11.4 14.9 14.3 15.8 11.6 7.7 13.1 18.4 12.5 12.5 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585771 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA030510 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA030510: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favourable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favourable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.9 8.7 15.8 7.9 13.6 4.8 8.3 26.8 16.6 10.9 7.7 14.7 8.7 14.2 12.4 9.8 6.9 10.2 8.3 6.2 12.6 7.6 7.8 6.1 6.5 8.7 15.7 12.2 14.7 9.1 11.9 12.7 6.1 11.8 10.8 8.2 10.8 10.5 9.5 9.2 12.6 10.7 7.5 9.5 9.5 12.4 3.9 19.2 8.8 9.9 4.3 8.8 10.4 9.6 5.1 5.4 4.9 5.1 3.3 3.5 1.0 4.9 0.4 4.8 6.4 6.0 6.8 1.5 4.3 3.9 4.5 3.4 6.6 7.9 5.1 5.1 4.1 7.0 0.1 2.8 2.6 3.4 1.3 6.2 13.7 1.5 4.4 0.5 10.7 4.4 6.1 3.0 2.8 4.7 5.8 6.4 4.1 8.5 6.1 5.8 2.8 2.8 16.2 5.5 2.5 4.2 5.1 13.3 9.4 3.5 4.4 2.6 5.6 5.3 7.0 1.8 4.8 4.0 0.3 0.9 2.6 2.1 5.7 3.8 7.2 4.7 2.6 1.0 2.3 1.6 2.5 5.1 2.8 1.9 1.9 3.1 3.5 2.7 4.9 3.3 5.1 5.4 3.3 1.0 15.8 13.6 26.8 16.6 12.6 7.6 15.7 12.2 11.8 19.2 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA021518: , HPA053459: " "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavourable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favourable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.4 8.0 6.4 10.8 3.9 1.6 9.2 2.7 2.9 3.1 2.4 4.2 4.2 6.3 6.6 1.9 5.1 3.9 3.7 2.0 6.8 6.0 3.1 4.7 5.3 3.3 6.1 4.2 2.3 4.2 3.8 2.7 2.8 5.5 3.6 2.8 13.8 10.3 10.4 11.8 6.1 7.7 3.2 4.1 2.5 6.2 7.7 12.1 6.7 6.4 5.0 4.1 2.9 3.6 3.6 2.1 6.2 3.9 13.2 9.7 3.5 6.0 3.9 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 11.8 11.7 3.8 8.0 1.1 2.4 10.0 6.2 2.4 4.2 4.8 6.9 7.4 8.5 0.4 2.6 9.4 2.4 5.0 1.9 11.2 43.4 13.5 5.9 10.4 6.2 12.9 11.9 3.2 4.9 3.5 6.1 3.1 16.1 9.6 2.4 7.5 8.0 16.3 12.1 22.2 10.0 5.6 10.8 4.3 7.9 14.7 14.3 6.5 12.8 11.4 7.9 18.4 6.6 16.0 11.4 6.7 16.9 20.4 14.9 8.2 9.2 8.7 7.4 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favourable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favourable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favourable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favourable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.2 4.5 6.0 3.6 6.8 4.0 16.9 5.6 6.8 6.7 7.7 4.8 2.1 4.8 2.3 4.1 7.0 4.5 6.8 5.3 4.8 2.9 3.3 7.3 5.3 8.0 7.8 5.3 4.0 7.7 8.3 6.7 6.9 5.6 7.2 6.3 4.9 6.1 2.9 4.8 5.8 5.1 8.4 6.8 2.8 3.3 6.9 4.6 10.6 5.5 3.2 7.2 4.5 4.8 4.3 3.9 4.2 4.3 9.8 20.8 6.2 5.5 2.4 7.1 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 12.0;HMC-1: 15.9;HUVEC TERT2: 10.7;SH-SY5Y: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035157: , HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favourable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 9.4 3.9 3.6 7.3 5.8 2.3 8.9 11.6 5.4 6.1 6.1 5.9 8.9 4.3 6.3 4.3 3.1 5.8 7.9 4.1 2.3 2.0 4.5 3.7 9.4 8.3 2.2 2.0 5.2 5.0 6.9 3.4 7.1 3.8 8.8 5.1 5.7 5.7 4.9 3.1 4.0 6.0 5.6 2.8 8.6 5.1 3.7 2.1 12.0 5.4 3.4 5.8 7.3 4.0 1.8 1.1 6.9 0.7 4.4 5.5 2.2 1.0 3.6 1.7 2.7 1.8 1.4 0.0 1.0 1.9 1.3 1.6 1.4 1.7 1.5 3.3 1.4 0.7 2.5 1.9 2.0 4.4 0.5 12.0 1.1 2.8 1.3 1.0 15.9 1.6 0.6 1.0 0.5 10.7 3.2 0.0 2.1 0.8 4.1 1.1 1.3 0.8 2.8 0.0 0.2 1.0 3.3 0.9 10.2 1.0 1.0 1.3 1.2 3.3 4.3 1.9 2.4 0.8 1.1 0.3 0.9 0.9 2.0 0.2 0.8 6.9 0.7 6.1 3.1 0.7 4.1 1.8 4.9 4.3 1.1 1.7 5.5 4.6 0.2 4.4 0.5 0.1 4.6 2.2 3.6 5.8 11.6 5.4 2.3 2.0 2.2 2.0 3.8 2.1 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.4 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 0.4 0.3 2.8 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.5 0.6 0.1 0.1 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.3 0.1 0.1 0.6 2.8 9.7 3.1 6.7 0.2 0.2 0.0 6.4 0.3 0.4 0.1 1.8 0.2 3.2 16.9 11.3 0.2 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 ZNF799 "HIT-40, MGC71805, ZNF842" ENSG00000196466 "Zinc finger protein 799" Q96GE5 19 12390016-12401271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: " "unprognostic (2.96e-1)" "unprognostic (1.10e-1)" "unprognostic (8.84e-2)" "prognostic favourable (2.39e-4)" "unprognostic (3.63e-2)" "unprognostic (5.18e-3)" "unprognostic (3.02e-1)" "unprognostic (8.83e-3)" "unprognostic (4.47e-5)" "unprognostic (1.45e-1)" "unprognostic (5.56e-3)" "unprognostic (6.55e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.04e-1)" "unprognostic (8.91e-3)" "unprognostic (1.23e-3)" 7.9 7.2 6.1 11.9 5.5 3.2 10.1 7.7 8.0 12.6 8.2 4.6 12.9 4.7 6.9 5.8 7.6 9.3 4.9 4.1 6.6 4.3 7.8 8.3 6.6 5.3 6.3 1.8 10.8 10.7 7.6 2.8 10.5 6.3 8.4 6.2 3.3 6.2 6.8 5.5 5.6 6.1 5.6 5.0 7.4 4.5 5.8 6.7 9.1 7.5 6.4 5.2 7.1 6.5 7.5 4.6 4.6 4.3 4.5 10.3 3.9 3.7 2.9 4.1 9.2 2.1 2.0 8.0 2.1 2.8 5.1 4.9 5.9 1.5 4.9 3.7 2.4 3.1 3.1 3.6 4.9 0.1 3.1 3.7 2.4 9.6 0.7 2.9 7.0 2.5 2.2 3.6 2.9 2.4 3.9 0.0 3.3 5.2 6.1 4.1 2.0 8.1 0.7 5.9 4.9 5.1 9.3 2.9 3.0 4.2 0.9 1.1 4.1 5.3 2.3 5.4 3.0 6.2 2.3 3.4 5.4 3.8 0.8 3.0 2.2 4.4 4.1 4.6 6.9 4.3 8.3 7.5 6.5 10.3 3.4 6.7 6.5 5.0 4.3 4.5 2.6 4.6 6.9 3.9 6.1 5.5 7.7 8.0 6.6 4.3 6.3 1.8 6.3 6.7 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278951-58302805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 2.7 3.1 4.6 2.7 5.5 7.7 4.3 6.4 7.5 3.4 2.6 6.1 2.7 3.0 4.9 4.0 2.8 3.5 2.8 3.7 4.7 3.4 2.2 3.4 3.4 4.1 3.3 3.8 3.1 7.5 4.3 3.8 4.1 3.3 3.1 4.4 3.0 3.7 2.1 6.6 2.2 3.9 4.6 4.5 3.6 3.5 4.3 9.2 3.9 1.5 3.5 3.0 3.9 2.3 1.6 4.7 2.4 1.9 1.9 1.9 2.2 3.2 4.8 8.6 3.0 2.7 3.9 1.1 1.8 1.2 1.4 3.5 1.6 2.7 1.4 1.9 2.1 3.5 3.8 1.5 2.1 13.9 5.4 6.1 2.9 2.7 1.8 4.4 4.8 2.3 2.0 3.9 2.1 2.8 1.2 2.4 2.4 4.1 2.5 4.2 2.2 4.7 4.4 1.9 2.2 7.7 8.1 4.4 3.3 2.4 1.0 2.3 3.4 3.0 8.6 2.2 1.3 2.2 4.3 3.4 3.5 1.5 0.1 2.2 3.6 2.4 1.6 1.6 1.3 1.9 1.5 1.4 1.2 1.6 2.3 1.5 1.7 4.7 1.9 1.0 1.4 0.7 1.9 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA023090: AB_1859457, HPA052194: " "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 17.5 11.2 10.8 14.4 11.7 61.7 18.7 18.6 12.7 11.9 11.9 6.3 12.8 10.3 14.6 10.4 15.4 13.5 11.6 9.5 10.2 5.9 8.9 14.4 16.5 20.7 13.5 9.2 15.2 15.3 16.2 18.6 10.8 12.6 10.5 10.5 7.1 15.1 16.1 14.9 22.7 14.8 11.5 15.7 15.2 13.1 19.1 12.8 22.4 12.7 10.9 13.8 14.4 15.5 14.2 12.0 16.9 6.8 18.9 17.2 5.9 8.9 4.7 5.5 9.6 8.0 10.7 5.3 8.7 10.3 9.0 8.7 4.3 8.6 15.3 5.4 8.2 6.6 9.0 9.3 12.4 13.4 5.3 9.8 4.8 4.0 10.1 13.4 18.9 9.1 8.6 9.9 13.4 9.5 12.1 15.8 9.7 6.8 14.8 9.7 4.6 6.2 9.2 7.8 10.1 6.6 11.3 7.9 8.3 8.6 34.1 11.1 4.0 9.2 10.2 15.1 4.8 9.9 10.2 18.9 8.3 22.1 11.2 12.3 12.5 16.9 6.8 10.1 13.3 6.3 14.0 12.0 10.0 13.5 7.0 14.2 16.4 17.2 6.0 18.9 6.6 12.0 13.8 5.9 10.8 11.7 18.6 12.7 10.2 5.9 13.5 9.2 12.6 12.8 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: " "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favourable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favourable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favourable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 13.8 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.8 2.6 2.4 2.7 1.9 4.6 2.0 3.8 3.9 5.2 0.5 1.0 0.7 1.7 0.9 3.0 3.1 3.5 2.1 1.3 2.3 1.6 1.9 3.3 3.3 1.4 0.9 5.5 0.6 6.0 2.9 4.5 3.5 0.4 13.9 6.6 1.8 1.2 1.5 4.7 3.0 4.6 3.3 3.4 1.2 0.9 4.7 2.3 10.5 1.1 2.6 3.1 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.1" "Cell line enhanced" "Detected in many" "U-266/84: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA073073 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA073073: " "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 2.6 2.8 4.9 2.4 5.9 1.9 4.3 8.0 4.8 2.9 2.6 2.3 5.0 1.7 3.6 2.0 2.2 3.1 1.8 2.4 3.3 2.5 2.6 1.8 2.2 2.8 6.4 2.9 5.3 2.1 3.8 3.4 3.6 3.3 3.6 1.6 1.6 2.6 3.0 1.9 3.5 2.1 4.8 4.4 2.8 2.3 20.1 5.1 3.4 5.2 1.0 2.9 3.1 4.7 3.3 1.4 4.2 0.8 2.1 4.9 1.0 0.0 1.2 3.3 0.1 1.8 2.8 1.4 3.7 2.1 4.6 7.0 0.1 0.6 0.1 4.3 2.3 0.7 0.0 2.6 5.4 0.0 5.2 1.8 0.1 0.1 1.8 0.0 5.2 2.8 2.6 5.0 0.0 0.5 0.0 0.1 4.9 0.8 0.7 0.8 5.5 0.0 0.0 4.4 1.6 1.2 5.4 3.7 5.5 0.1 0.0 3.1 3.4 0.3 1.4 2.9 3.9 3.7 3.9 9.6 14.7 6.2 0.0 0.0 6.8 4.2 0.6 2.9 3.2 0.7 4.2 2.2 3.2 4.9 1.0 3.3 4.1 4.2 1.3 2.1 0.8 1.4 3.2 1.0 4.9 5.9 8.0 4.8 3.3 2.5 6.4 2.9 3.3 5.1 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favourable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favourable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.6 7.9 10.3 18.6 4.8 8.2 17.7 6.8 5.6 8.5 7.0 3.0 7.4 9.0 5.6 4.6 8.5 6.7 17.1 6.6 12.0 12.7 6.2 7.2 5.0 4.3 5.8 5.5 6.5 12.9 16.5 15.4 11.3 13.2 11.8 11.9 16.1 8.8 9.4 13.8 8.0 19.2 6.3 5.6 7.6 7.1 5.6 17.5 5.6 7.2 6.0 16.2 9.6 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.0 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell line enriched" "Detected in many" 4 "BEWO: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" HPA063386 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA063386: " "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.6 0.0 1.6 0.0 0.0 31.3 0.2 0.1 0.2 0.2 2.0 2.4 2.2 2.3 0.0 1.9 0.7 3.0 0.2 0.0 0.3 0.0 3.1 1.0 0.0 0.0 0.0 0.1 1.3 0.2 6.0 0.6 0.0 0.0 0.2 1.7 0.0 0.0 0.8 3.3 0.0 0.0 0.1 7.1 0.8 0.2 0.0 0.5 3.7 0.0 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.5 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605405-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA068079: " "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 12.1 7.5 8.3 11.0 10.5 11.1 8.2 12.3 15.1 8.0 10.0 9.7 6.6 11.0 11.5 6.8 6.2 8.7 7.0 12.2 7.3 5.8 8.3 6.7 8.7 13.3 7.4 8.5 10.3 11.2 9.9 9.5 6.1 7.4 9.9 4.8 8.1 12.1 7.7 56.2 11.1 10.4 7.4 7.3 16.0 12.2 4.7 7.9 14.0 9.5 8.0 9.1 9.3 9.9 1.2 0.5 1.4 0.1 0.1 0.6 0.1 6.3 5.2 2.3 3.7 2.5 1.9 6.2 4.6 2.6 2.5 2.4 1.7 4.2 7.5 5.4 3.3 5.3 1.4 2.8 1.0 7.3 17.4 4.2 3.2 2.2 3.9 4.8 8.4 2.9 4.4 3.0 1.8 1.7 8.1 5.1 1.6 3.0 7.6 5.2 5.2 9.2 11.9 3.6 4.6 2.9 4.4 5.4 8.8 6.3 3.9 3.8 3.1 7.6 5.0 3.8 9.2 3.5 5.7 10.7 9.3 3.9 4.7 3.8 6.1 0.0 0.0 1.4 0.3 0.1 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.6 0.8 0.1 0.1 0.5 0.0 0.1 8.3 10.5 12.3 15.1 7.3 5.8 7.4 8.5 7.4 7.9 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 6.4" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA052735: " "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 1.1 1.4 0.4 1.5 3.1 5.8 0.8 2.5 2.4 1.5 1.2 0.4 0.0 0.6 1.8 1.2 1.4 1.2 1.4 0.7 1.9 0.5 7.7 2.5 1.5 1.4 4.4 0.3 2.4 5.0 0.8 2.4 5.1 7.4 1.4 1.2 0.4 3.2 0.3 0.5 1.0 1.3 1.4 1.9 1.3 1.2 4.6 2.2 1.7 1.4 0.0 1.3 1.2 1.7 0.3 0.1 0.5 0.0 1.5 0.5 0.1 3.1 0.0 1.7 6.4 0.1 0.0 3.8 1.0 0.5 1.3 1.7 2.5 0.4 1.4 1.5 0.4 0.8 0.6 0.9 1.2 0.0 0.9 1.8 0.0 3.5 0.0 1.2 3.4 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 2.9 1.7 3.6 0.5 2.5 3.4 0.0 2.2 2.3 1.8 0.4 0.0 0.1 0.3 3.3 3.9 0.0 1.9 1.4 1.5 1.8 1.3 3.8 0.3 0.0 0.6 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.5 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.4 3.1 2.5 2.4 1.9 0.5 4.4 0.3 7.4 2.2 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133106817-133130473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 3.6 5.3 7.0 4.0 9.3 4.2 5.4 13.2 7.2 4.6 4.4 3.6 2.6 3.4 5.5 4.6 2.9 4.0 2.9 3.5 7.9 3.3 3.4 2.9 2.9 4.3 7.8 2.7 6.4 3.8 4.9 8.8 3.0 6.6 3.8 3.5 2.3 4.5 4.0 4.3 6.9 3.3 4.5 7.0 4.5 4.0 14.0 8.9 4.2 5.6 2.9 3.8 4.3 4.5 2.9 1.6 2.3 1.2 2.4 2.7 0.7 1.5 1.7 4.6 0.3 1.9 2.2 3.0 0.8 0.9 1.2 1.0 1.3 0.7 0.3 1.3 1.0 2.1 2.4 1.2 1.3 0.1 2.3 3.8 5.0 1.7 0.9 3.4 2.7 1.6 1.2 1.8 1.6 1.0 2.3 0.8 1.5 1.0 3.8 4.1 2.9 1.9 3.5 2.6 1.5 0.9 2.7 4.6 2.9 3.0 1.1 1.0 3.1 1.4 1.8 2.4 2.4 2.0 1.3 0.5 0.2 3.1 0.6 1.3 1.8 2.0 1.2 1.4 1.8 0.7 1.6 1.9 1.7 1.7 0.6 2.9 2.7 2.3 2.3 2.4 0.8 1.6 1.1 0.7 7.0 9.3 13.2 7.2 7.9 3.3 7.8 2.7 6.6 8.9 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.3;seminal vesicle: 36.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.7;HBF TERT88: 6.5;NTERA-2: 16.5;U-2197: 6.9" "Cancer enhanced" "Detected in many" "testis cancer: 10.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 1.5 1.0 1.1 3.6 2.5 1.6 1.8 6.9 1.1 3.0 1.7 1.2 20.3 0.5 3.3 2.7 2.1 2.8 1.0 1.4 0.8 0.6 1.7 0.7 2.4 3.0 2.1 0.3 4.7 3.4 12.7 1.4 3.8 1.7 4.1 2.1 3.2 1.2 36.4 1.2 2.8 2.3 3.3 1.6 2.3 2.7 1.6 2.2 4.1 10.3 0.7 2.9 4.9 2.9 0.5 0.4 1.8 0.2 0.3 0.9 0.2 0.0 0.0 3.9 9.7 0.0 0.0 0.0 1.0 0.4 3.8 4.5 3.3 2.3 1.4 1.8 0.7 1.0 0.0 0.6 6.5 0.0 0.9 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.3 0.0 0.0 0.1 2.0 5.5 16.5 0.0 0.0 3.5 0.2 2.0 3.4 0.0 3.5 0.0 1.2 0.2 1.9 0.0 0.0 1.0 0.0 6.9 3.8 0.0 1.5 0.0 0.0 0.0 1.5 0.8 0.2 0.3 0.1 0.0 0.9 0.2 0.2 0.4 0.4 0.5 0.3 0.1 1.8 0.3 0.0 0.2 0.7 0.2 1.1 2.5 6.9 1.1 0.8 0.6 2.1 0.3 1.7 2.2 ZNHIT6 "BCD1, C1orf181, FLJ20729, NY-BR-75" ENSG00000117174 "Zinc finger HIT-type containing 6" Q9NWK9 1 85649423-85708433 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018132 Uncertain Approved "Nuclear speckles,Vesicles" "Nuclear speckles, Vesicles" "HPA018132: AB_1848789" "unprognostic (1.37e-1)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.27e-3)" "unprognostic (1.61e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (6.08e-6)" "unprognostic (1.11e-1)" "unprognostic (3.89e-2)" "unprognostic (8.48e-2)" "unprognostic (9.91e-3)" "unprognostic (2.92e-2)" "unprognostic (1.27e-3)" "unprognostic (5.91e-2)" "unprognostic (9.85e-2)" "unprognostic (1.15e-1)" "unprognostic (7.37e-2)" 18.5 12.6 20.7 15.9 28.0 15.5 21.5 19.2 25.6 23.5 13.8 21.4 14.2 9.0 20.4 14.9 19.9 14.6 12.0 12.4 22.5 18.8 12.9 10.3 12.9 19.4 21.5 20.5 21.9 11.5 17.4 20.3 15.1 19.5 17.4 14.0 8.1 15.3 15.1 15.7 17.1 12.0 19.8 26.1 14.5 11.0 11.0 26.6 14.8 17.4 13.8 18.9 19.5 25.7 7.6 6.0 1.3 2.3 5.7 6.4 2.5 12.9 9.5 9.0 8.2 19.5 18.4 11.5 17.4 16.9 11.9 11.6 9.4 6.9 10.2 20.9 10.6 11.1 15.4 10.7 19.4 14.4 13.4 20.9 10.7 10.7 17.2 33.8 8.4 17.7 9.9 16.0 14.0 13.9 19.7 13.8 17.9 5.3 19.5 8.3 12.9 16.7 16.1 19.7 11.6 17.9 25.8 8.6 5.6 13.7 18.7 18.5 9.0 8.7 15.9 15.2 10.3 12.9 24.6 8.9 9.1 29.3 3.3 20.9 13.5 1.3 2.1 0.2 5.7 2.3 6.4 5.6 5.1 6.4 3.6 7.6 6.4 6.3 0.3 5.7 1.9 6.0 5.4 2.5 20.7 28.0 19.2 25.6 22.5 18.8 21.5 20.5 19.5 26.6 ZRANB1 TRABID ENSG00000019995 "Zinc finger RANBP2-type containing 1" Q9UGI0 10 124942123-124988189 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029239, HPA029240, HPA029241" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205" "unprognostic (2.06e-1)" "unprognostic (5.16e-2)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (1.40e-1)" "unprognostic (9.53e-3)" "unprognostic (4.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (4.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.47e-2)" 5.1 9.3 4.9 1.9 4.7 7.9 5.3 11.9 6.0 6.3 5.2 1.4 5.9 5.2 4.1 4.4 3.6 7.3 4.6 4.0 4.2 10.4 4.2 2.5 4.4 8.6 3.1 7.1 3.9 3.9 4.6 3.3 3.4 5.8 18.0 5.2 3.0 6.3 3.8 2.8 3.6 7.7 3.8 3.9 4.2 4.8 3.4 1.4 4.6 1.1 3.8 4.4 0.8 7.7 4.4 9.5 6.9 14.8 12.5 4.0 7.6 20.8 14.5 16.9 6.6 6.1 8.1 5.7 9.6 5.6 12.0 5.6 19.6 8.6 5.9 4.6 5.1 7.1 31.6 6.9 3.5 13.8 16.5 10.6 22.8 9.1 0.6 6.7 7.8 6.1 8.1 6.0 3.4 4.8 7.0 6.7 3.6 6.4 5.6 4.8 8.1 6.4 5.0 8.4 5.5 5.9 6.7 6.2 6.4 5.1 9.4 7.2 6.2 9.4 7.0 4.9 3.0 2.1 1.1 3.0 2.2 0.4 1.9 2.4 2.6 2.2 0.9 3.4 4.4 3.3 4.6 3.8 0.5 1.4 2.2 0.8 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006637 Approved Approved Microtubules,Cytosol Cytosol Microtubules "HPA006637: AB_1080646" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 6.4 5.5 8.0 7.4 8.6 3.7 11.4 12.1 9.0 8.1 7.2 5.7 6.9 4.9 9.4 7.6 4.6 7.3 4.6 4.7 7.2 5.0 6.0 3.8 5.7 8.3 5.0 3.9 11.4 9.0 10.1 14.1 7.0 7.6 8.9 6.0 4.8 6.9 9.9 2.8 4.5 6.6 7.5 5.1 7.2 5.8 9.5 6.9 11.5 10.3 3.7 7.7 9.4 10.2 6.1 2.2 5.2 1.7 3.9 4.5 1.9 5.3 1.7 8.1 0.1 4.3 3.3 5.8 3.7 5.1 5.6 7.8 1.2 2.0 5.1 7.0 2.5 2.4 0.0 4.5 5.8 0.0 6.6 7.4 5.3 3.7 3.9 2.6 1.9 4.4 4.3 5.6 10.2 1.5 10.9 1.2 3.5 0.6 0.0 5.9 5.1 0.9 8.9 7.4 1.3 4.2 3.5 10.0 10.2 1.9 4.4 6.3 1.7 6.6 1.5 2.2 4.8 1.7 2.9 3.2 3.3 1.0 2.0 0.7 3.4 5.2 1.6 3.3 3.6 1.0 3.4 4.3 2.7 4.2 2.2 6.1 4.5 3.8 0.5 3.9 1.7 2.0 2.1 1.9 8.0 8.6 12.1 9.0 7.2 5.0 5.0 3.9 7.6 6.9 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favourable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favourable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favourable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.7 9.8 7.7 12.7 4.5 3.0 6.7 1.9 5.3 4.1 5.5 7.5 4.0 3.6 5.4 3.0 4.3 6.5 3.7 3.6 7.4 10.0 4.6 5.7 15.8 3.9 2.9 3.7 4.5 4.5 5.2 5.0 12.1 6.1 2.9 4.9 4.8 13.4 6.8 14.1 5.8 14.0 4.4 6.8 4.3 12.5 10.8 19.1 5.9 3.3 9.1 6.8 8.2 7.9 5.0 9.6 2.4 2.4 5.0 6.6 12.1 3.3 6.8 3.1 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 ZSCAN22 "HKR2, ZNF50" ENSG00000182318 "Zinc finger and SCAN domain containing 22" P10073 19 58327019-58342332 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006471 Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane, Cytosol" "Actin filaments" "HPA006471: AB_2221026" "unprognostic (5.55e-3)" "unprognostic (2.24e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (3.82e-2)" "unprognostic (2.47e-3)" "unprognostic (1.52e-1)" "unprognostic (2.91e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-3)" "unprognostic (5.00e-2)" "unprognostic (7.59e-2)" "unprognostic (2.59e-2)" "unprognostic (1.74e-1)" "unprognostic (5.22e-3)" "unprognostic (1.07e-1)" 4.8 5.6 4.1 8.5 6.1 3.0 10.8 9.3 6.2 6.7 4.8 4.7 9.3 5.1 5.7 4.2 6.1 4.6 3.5 4.9 4.3 4.1 4.2 7.7 4.8 4.8 9.7 3.7 7.8 7.3 9.4 9.1 5.3 6.8 5.1 4.3 2.7 7.0 9.2 6.1 8.1 5.2 5.6 3.9 5.2 5.5 5.7 6.2 8.0 6.5 4.3 6.4 4.6 5.3 3.2 3.0 2.7 2.3 3.2 5.6 2.3 2.8 5.2 2.8 4.3 3.4 2.0 3.1 2.4 1.2 1.5 1.4 2.7 2.0 2.3 1.6 2.0 2.2 4.0 2.7 1.6 3.5 17.8 4.8 4.8 2.5 2.7 3.8 5.0 2.4 2.7 3.3 3.5 2.2 4.8 4.4 2.6 2.3 1.9 1.8 2.4 5.8 2.6 4.4 3.9 1.6 3.8 4.5 3.2 3.5 4.9 2.2 2.3 2.6 2.0 8.1 2.4 2.0 4.1 4.4 6.0 1.7 3.2 2.7 2.8 0.3 2.1 2.7 5.6 1.8 3.9 2.6 3.3 4.6 3.0 3.2 2.9 2.9 0.7 3.2 2.3 1.4 2.6 2.3 4.1 6.1 9.3 6.2 4.3 4.1 9.7 3.7 6.8 6.2 ZSCAN25 "FLJ32468, ZNF498" ENSG00000197037 "Zinc finger and SCAN domain containing 25" Q6NSZ9 7 99616946-99632407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055127, HPA057173" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA055127: , HPA057173: " "unprognostic (2.21e-3)" "unprognostic (3.96e-2)" "unprognostic (4.45e-1)" "unprognostic (3.92e-2)" "unprognostic (5.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (1.57e-3)" "unprognostic (3.97e-2)" "unprognostic (8.44e-2)" "unprognostic (3.82e-3)" "unprognostic (9.98e-2)" "unprognostic (1.10e-2)" "unprognostic (5.21e-2)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (7.19e-3)" 10.8 10.0 11.4 12.2 12.5 12.3 14.5 18.5 14.6 11.3 11.0 13.1 16.9 7.4 14.5 11.7 12.7 12.4 9.6 7.7 9.4 6.9 9.4 9.1 10.0 16.4 10.3 12.2 18.5 12.3 15.0 12.3 9.4 9.2 12.7 8.6 10.3 15.4 13.9 9.7 15.6 10.8 12.6 8.7 13.6 10.3 15.7 11.0 14.9 11.2 8.7 11.8 11.7 11.4 3.3 3.0 5.5 4.2 4.2 9.0 4.7 5.7 2.7 7.9 9.0 3.5 2.7 7.8 6.4 5.4 7.3 7.6 7.1 4.8 8.1 7.4 5.2 7.5 8.5 7.3 9.2 4.5 7.2 5.4 4.5 6.1 6.0 12.4 4.9 4.2 9.3 5.8 6.2 4.6 15.1 6.6 5.1 6.3 17.9 17.3 14.5 6.2 7.5 8.1 8.6 3.1 7.8 5.4 13.3 8.4 12.7 9.0 3.5 8.6 3.3 11.5 9.2 6.6 10.6 5.9 9.3 13.9 6.1 7.8 16.8 5.5 3.8 4.8 7.4 4.2 9.0 3.3 5.1 6.9 3.0 2.9 8.7 8.4 4.6 4.2 3.7 2.4 7.2 4.7 11.4 12.5 18.5 14.6 9.4 6.9 10.3 12.2 9.2 11.0 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267010-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA027521: " "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavourable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavourable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favourable (1.68e-4)" 4.4 5.4 7.4 4.8 10.5 2.5 8.3 17.7 11.4 8.4 4.3 10.5 7.3 4.2 10.5 7.4 4.9 7.9 6.7 6.3 8.1 5.1 3.6 5.2 4.9 7.3 11.5 18.7 4.0 8.9 7.8 4.6 9.6 7.7 5.0 5.7 4.5 10.7 6.4 4.9 4.4 8.9 6.6 7.6 4.9 2.9 9.6 4.0 7.6 2.0 6.1 5.8 4.6 15.2 9.6 10.7 6.2 16.1 16.3 9.6 5.7 5.0 14.0 12.0 15.2 14.7 3.2 11.5 11.5 15.1 15.7 3.6 4.2 3.3 17.7 7.3 4.4 6.5 8.3 16.7 6.9 7.0 8.7 6.8 7.6 10.6 7.1 5.7 12.1 8.0 11.6 10.6 15.2 7.1 6.9 11.9 4.8 7.6 9.9 4.1 7.5 7.7 12.2 5.5 12.8 6.0 10.2 7.9 7.1 3.0 9.5 4.9 4.9 9.9 12.1 8.9 4.3 13.9 7.4 9.8 6.3 4.4 8.1 10.5 10.5 6.2 10.7 13.4 4.8 15.8 13.4 13.1 14.4 9.6 15.2 16.3 13.5 4.4 16.1 4.0 4.5 11.8 9.6 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 8.3 8.9 13.5 14.2 14.2 6.6 9.4 15.9 15.2 11.0 9.8 12.1 9.3 11.8 12.6 12.5 11.0 9.6 11.9 7.2 14.7 8.0 8.1 10.3 9.2 13.2 19.1 12.0 10.7 15.4 12.5 13.9 13.0 15.4 9.7 10.5 7.9 11.2 9.5 13.6 7.7 13.0 9.0 13.3 11.9 11.8 20.9 15.0 16.8 11.1 9.4 13.7 11.0 12.5 2.1 1.0 6.9 1.0 2.3 1.9 0.6 7.4 8.2 19.4 11.9 6.8 7.2 10.5 5.9 9.2 10.5 11.0 12.7 5.4 7.3 9.9 7.2 22.2 14.2 7.2 9.5 19.0 7.8 16.2 12.3 9.9 7.6 11.0 14.2 6.3 12.8 7.1 10.1 5.3 15.0 9.0 8.4 4.7 10.5 9.1 9.7 6.3 16.5 10.8 9.0 6.1 9.1 13.9 15.0 9.1 15.0 6.9 10.5 17.2 5.9 12.4 9.8 9.3 10.6 17.4 23.9 14.2 7.2 10.9 9.3 1.1 0.7 6.9 1.2 1.0 1.0 2.1 1.2 0.8 1.0 1.6 0.6 1.7 1.8 2.3 0.8 0.9 1.9 0.6 13.5 14.2 15.9 15.2 14.7 8.0 19.1 12.0 15.4 15.0 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.4 14.4 11.8 9.2 19.1 7.9 12.2 23.0 19.9 9.4 8.9 20.9 9.8 10.1 14.2 13.9 6.7 10.3 10.4 16.4 12.2 10.6 12.1 8.7 10.3 12.4 11.8 12.8 10.7 9.7 19.8 27.3 9.6 14.7 11.1 8.4 12.8 9.2 9.4 15.4 11.7 12.8 9.4 15.0 12.1 10.0 10.5 15.0 13.0 15.2 6.8 9.4 8.6 8.2 7.7 5.4 4.8 1.9 4.0 5.6 2.5 4.4 1.2 10.1 13.3 6.8 13.5 6.9 8.6 11.6 5.0 9.9 3.6 5.5 8.0 5.7 9.1 3.1 4.7 9.0 13.7 8.1 2.7 5.2 5.7 2.5 7.1 4.4 5.2 8.7 7.1 13.5 11.5 9.2 8.4 9.6 13.1 2.0 6.4 7.4 6.5 4.2 9.5 3.4 5.8 7.6 3.0 14.2 7.4 8.5 2.7 3.6 4.2 5.9 11.4 18.1 3.9 2.8 3.4 17.1 7.3 7.1 13.7 4.9 10.2 2.4 1.3 4.4 4.6 1.6 3.0 5.3 4.2 2.7 2.2 7.7 5.0 5.6 4.8 4.0 1.9 5.4 3.7 2.5 11.8 19.1 23.0 19.9 12.2 10.6 11.8 12.8 14.7 15.0 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 21.3;TIME: 16.0;U-2 OS: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 13.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.4" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favourable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.2 4.0 11.3 2.2 12.1 3.5 11.2 36.4 27.6 8.0 9.9 3.6 5.9 3.2 16.3 8.4 9.9 6.8 15.5 6.4 8.0 3.8 5.2 4.5 8.7 1.9 16.7 5.6 17.7 8.1 4.8 8.3 2.3 14.9 7.1 5.1 3.5 6.5 8.3 7.0 11.0 3.5 10.7 21.9 2.1 13.3 18.4 11.8 0.6 21.0 5.6 3.1 7.3 6.9 1.5 2.0 13.4 0.3 1.4 1.5 0.3 1.0 1.4 2.2 10.1 0.3 0.5 3.2 0.4 0.6 0.5 0.4 1.2 15.3 0.2 21.3 0.7 3.2 1.1 0.9 0.3 1.8 0.9 3.5 7.9 2.3 0.9 7.1 4.4 0.3 8.5 0.6 0.9 14.6 3.8 2.7 2.2 1.4 1.2 1.7 0.7 6.3 3.1 2.0 1.8 1.5 1.2 7.1 2.0 13.6 8.8 2.0 4.4 2.4 16.0 3.3 26.0 0.7 1.1 1.1 1.6 0.2 0.4 3.4 0.7 13.4 0.3 0.6 1.5 0.2 1.3 1.5 1.2 1.2 0.3 1.3 1.0 1.5 0.3 1.4 0.3 2.0 0.2 0.3 11.3 12.1 36.4 27.6 8.0 3.8 16.7 5.6 14.9 11.8 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041147: , HPA046751: " "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favourable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 11.3 13.8 7.3 7.6 11.4 10.2 7.8 17.2 15.7 7.3 8.5 10.4 5.6 8.8 10.1 7.8 9.3 9.3 10.1 9.8 7.5 7.7 12.8 11.3 6.9 9.5 6.9 8.5 12.6 14.1 10.0 11.4 12.2 6.3 10.3 7.7 14.1 10.4 8.1 27.3 12.3 10.6 9.1 8.1 12.2 8.7 9.0 9.5 16.1 11.5 9.8 13.3 9.6 7.0 5.4 4.4 6.9 3.7 1.2 5.3 1.4 6.3 8.0 6.0 7.2 10.9 6.4 6.1 4.3 5.7 10.0 9.2 18.2 7.5 7.6 13.2 6.3 15.3 9.7 12.3 7.5 2.9 5.7 9.9 10.0 12.4 6.7 8.0 10.2 9.1 10.4 8.3 8.0 7.7 8.7 6.1 5.7 19.2 9.0 6.6 3.3 9.0 6.9 8.7 5.3 6.4 9.4 8.0 5.1 15.1 22.3 5.1 13.2 6.0 6.3 10.9 6.8 5.8 6.3 6.1 4.3 7.7 8.6 6.3 5.5 3.8 2.9 6.9 1.0 3.7 0.7 5.4 3.7 1.6 1.6 5.1 5.3 4.7 3.1 1.2 3.5 4.4 3.0 1.4 7.3 11.4 17.2 15.7 7.5 7.7 6.9 8.5 6.3 9.5 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857617-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: , HPA060508: " "prognostic unfavourable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavourable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 5.1 9.6 8.3 5.6 8.2 2.2 5.7 15.2 9.6 6.1 6.7 6.3 5.2 7.4 6.7 8.9 5.9 6.8 5.4 6.0 7.3 7.2 5.6 7.0 5.9 9.3 6.2 7.4 9.0 5.0 6.9 9.5 5.3 6.7 6.1 7.3 9.4 5.4 5.4 3.9 6.7 7.4 5.5 6.0 10.5 5.8 9.5 6.3 13.7 5.9 2.9 11.2 6.1 4.7 4.3 3.8 3.2 8.5 3.3 6.3 2.1 2.1 1.7 5.3 3.0 6.5 4.6 3.1 3.3 4.0 6.1 6.1 7.3 3.3 6.6 11.5 2.8 3.5 7.6 3.5 4.6 4.0 3.2 6.4 3.3 4.7 7.9 3.6 8.7 4.2 4.0 4.6 2.9 5.2 5.8 3.2 4.6 10.5 4.9 7.1 2.0 7.2 4.9 4.9 4.8 1.7 1.3 7.0 3.5 5.3 6.2 4.2 3.0 9.4 5.1 6.2 2.0 2.3 2.0 6.9 3.6 4.2 5.2 4.3 2.0 2.1 2.3 3.2 3.0 3.2 6.3 4.3 3.3 4.2 3.8 3.6 3.2 4.3 1.7 3.3 8.5 2.3 4.9 2.1 8.3 8.2 15.2 9.6 7.3 7.2 6.2 7.4 6.7 6.3 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785582-73801797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favourable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 22.5 30.2 27.1 17.7 27.9 35.3 20.6 29.8 32.4 21.7 27.2 38.1 29.7 25.6 25.5 43.3 33.1 19.9 24.9 19.8 25.9 20.4 28.8 43.1 22.3 20.9 34.0 24.9 26.4 23.3 39.0 50.0 28.1 28.6 29.9 17.8 29.8 30.3 28.9 19.5 48.2 34.8 27.9 20.0 36.8 21.8 29.1 37.0 22.7 30.1 15.9 22.2 21.7 24.0 3.5 6.6 9.0 4.2 1.9 5.7 1.7 5.8 10.0 12.5 20.6 29.9 14.4 7.3 7.5 21.0 10.8 13.0 8.8 4.9 3.3 5.4 12.4 9.1 4.4 8.9 5.4 5.3 9.2 4.7 10.6 11.6 22.6 3.2 18.4 23.3 16.0 13.4 15.7 12.6 6.5 6.5 12.3 8.9 4.8 9.7 3.7 31.6 5.9 5.9 1.9 15.3 12.6 3.0 13.7 6.2 18.7 10.6 12.4 6.8 12.6 12.2 7.2 5.4 7.6 16.6 8.9 2.1 13.1 4.8 6.1 4.3 4.1 3.2 5.7 2.7 3.3 3.5 2.6 2.4 3.2 2.7 1.1 3.7 9.0 1.9 4.2 6.6 3.2 1.7 27.1 27.9 29.8 32.4 25.9 20.4 34.0 24.9 28.6 37.0 ZUFSP "C6orf113, dJ412I7.3" ENSG00000153975 "Zinc finger with UFM1 specific peptidase domain" Q96AP4 6 116635618-116668794 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 8.0 8.4 8.8 9.7 14.1 19.0 9.7 18.8 14.4 7.2 10.3 7.3 5.1 16.5 7.3 7.3 11.0 6.7 9.0 5.4 10.5 8.7 9.3 11.9 10.2 12.8 14.3 8.0 5.6 9.7 6.0 18.1 8.5 11.3 8.6 9.8 5.2 8.2 7.3 6.2 10.3 13.5 6.8 10.5 12.3 8.4 9.5 11.5 15.4 7.6 7.5 13.9 8.9 8.2 11.1 11.1 17.3 11.5 9.2 12.6 7.1 4.4 4.4 10.4 18.7 6.0 8.0 7.5 10.0 9.5 10.0 11.9 7.4 5.2 16.2 8.3 6.2 7.5 11.7 6.9 13.4 9.5 12.1 12.3 6.3 13.5 9.3 14.6 15.2 7.0 11.7 7.8 13.9 8.7 22.0 8.5 13.0 7.0 7.3 11.2 7.4 4.8 9.7 8.7 6.8 10.9 4.7 8.7 9.8 6.9 6.1 6.1 3.7 11.4 6.9 6.3 4.3 3.6 8.7 7.7 9.9 16.4 5.7 8.9 9.2 17.3 8.5 8.4 8.4 9.9 9.7 11.1 9.3 9.5 11.1 10.3 10.7 7.8 3.3 9.2 11.5 7.9 12.6 7.1 8.8 14.1 18.8 14.4 10.5 8.7 14.3 8.0 11.3 11.5 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773811 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favourable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavourable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 11.8 11.4 9.0 10.4 13.5 10.7 15.2 19.8 15.2 12.5 11.4 11.2 8.6 7.8 14.0 10.5 17.2 8.9 8.0 10.3 9.9 7.6 12.2 19.6 9.6 11.7 10.3 9.9 11.9 16.8 14.9 14.4 10.4 17.0 11.4 14.3 7.9 15.2 11.0 24.1 22.9 10.7 12.2 12.5 11.7 12.0 25.0 10.9 18.6 9.4 12.4 15.8 11.8 13.1 8.3 12.3 8.6 13.2 7.3 11.8 7.2 12.0 7.7 15.8 11.1 10.3 10.7 9.2 13.6 11.5 17.2 17.5 19.9 22.3 15.1 17.9 13.6 16.9 19.9 17.0 24.6 10.4 8.2 16.0 6.8 12.2 10.9 15.5 9.8 9.1 11.1 18.3 14.9 17.7 18.3 5.6 18.0 6.2 14.9 10.7 10.0 15.3 14.0 16.5 17.0 11.4 11.6 6.3 7.5 15.4 12.8 5.7 23.6 9.1 9.9 14.4 23.1 7.9 15.0 3.3 5.5 16.0 4.7 20.0 16.7 7.4 9.5 8.6 8.8 13.2 11.8 8.3 8.3 7.6 12.3 7.2 7.9 9.4 2.7 7.3 11.1 3.6 7.3 7.2 9.0 13.5 19.8 15.2 9.9 7.6 10.3 9.9 17.0 10.9 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavourable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavourable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.5 31.5 22.4 24.9 1.6 2.3 18.3 29.2 22.1 35.3 32.1 55.6 23.7 20.4 11.1 10.0 20.4 31.5 22.0 33.0 51.7 16.4 20.3 25.3 25.7 0.1 33.4 27.3 1.0 1.4 32.8 13.5 17.7 27.4 25.0 31.0 31.9 29.5 21.2 15.9 38.9 30.2 43.6 10.8 11.0 17.7 20.8 12.8 27.6 62.8 7.3 40.7 32.7 9.6 15.5 39.8 15.9 44.5 22.1 10.6 35.4 21.8 42.1 19.4 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726467-52827342 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favourable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favourable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 8.9 9.1 10.8 5.6 15.6 7.1 7.7 22.3 21.7 9.9 10.4 9.1 5.6 4.7 11.0 6.5 9.7 7.3 6.8 15.9 10.7 15.4 12.9 17.7 7.7 5.0 10.1 11.6 11.3 6.5 12.7 9.1 7.2 16.4 9.8 7.9 10.1 6.1 9.2 63.9 6.5 5.8 12.3 8.4 5.7 6.3 8.4 7.7 6.9 12.7 11.4 5.7 9.2 7.0 2.2 2.2 5.7 2.4 2.1 3.8 1.0 8.1 7.4 9.4 11.7 17.3 15.1 8.2 9.2 11.8 7.3 6.8 6.3 2.7 7.8 9.3 17.8 4.2 10.7 8.1 11.7 6.5 7.0 10.0 8.5 3.9 9.2 7.5 6.2 10.7 8.8 10.5 7.4 12.7 8.9 1.6 13.2 3.4 2.9 4.7 9.7 7.7 5.1 17.8 7.1 7.5 12.9 4.3 8.8 16.0 10.0 8.5 6.0 5.8 14.6 11.4 6.7 11.2 5.7 6.8 8.2 6.0 7.8 5.1 7.3 1.0 2.4 2.7 2.1 1.3 2.3 2.2 2.6 1.6 2.2 2.1 3.8 2.7 5.7 2.1 2.0 1.7 3.0 1.0 10.8 15.6 22.3 21.7 10.7 15.4 10.1 11.6 16.4 7.7 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143020 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favourable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 11.3 11.7 8.0 13.5 10.2 21.1 10.5 14.4 14.3 11.3 23.8 17.5 9.2 17.7 11.6 11.0 12.8 9.9 11.1 10.7 7.7 7.7 8.8 9.6 12.1 15.6 8.3 8.4 12.0 15.3 18.0 12.6 13.1 11.3 11.4 17.3 17.6 10.1 11.8 37.7 13.9 42.4 10.9 7.5 16.1 12.8 8.1 9.7 22.5 12.1 6.5 14.2 12.4 9.8 1.5 1.8 3.8 3.4 1.1 4.2 1.5 10.3 16.2 5.9 8.0 14.8 8.4 7.0 9.0 11.5 10.6 10.3 8.0 3.6 9.9 6.1 12.1 11.9 11.8 6.2 10.8 11.5 12.3 9.4 13.1 5.2 10.1 8.0 18.9 10.8 8.4 10.4 12.3 13.6 6.9 10.1 6.6 7.1 9.9 4.7 3.5 6.3 11.1 7.2 4.2 6.0 10.7 4.6 6.8 10.2 6.4 8.8 6.3 6.1 16.0 9.4 4.7 11.6 11.8 4.5 2.3 5.1 9.3 7.2 8.6 2.8 2.3 2.3 3.2 3.2 4.2 1.5 2.2 2.0 1.8 1.3 1.5 2.5 3.8 1.1 3.4 1.7 1.4 1.5 8.0 10.2 14.4 14.3 7.7 7.7 8.3 8.4 11.3 9.7